group_id,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00001,FUN_000185-T1,Peve_00037402,Pocillopora_meandrina_HIv1___RNAseq.g28886.t1,three_way,71.059,FUN_000185-T1,Q32LQ0,AMPE_BOVIN,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Bos taurus (Bovine),41.5,881.0,1.4e-197,691.4,sp|Q32LQ0|AMPE_BOVIN Glutamyl aminopeptidase OS=Bos taurus OX=9913 GN=ENPEP PE=2 SV=1,GO:0003081; GO:0004177; GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048870; GO:0050886; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; cell motility; endocrine process; catalytic activity, acting on a protein"
OG_00002,FUN_000189-T1,Peve_00038462,Pocillopora_meandrina_HIv1___RNAseq.g28888.t3,three_way,68.72583333333334,FUN_000189-T1,Q9DCT6,,,,,38.0,171.0,4.6e-18,92.8,sp|Q9DCT6|BAP18_MOUSE BPTF-associated chromatin complex component 1 OS=Mus musculus OX=10090 GN=Bacc1 PE=1 SV=1,,,,,,
OG_00003,FUN_000190-T1,Peve_00038463,Pocillopora_meandrina_HIv1___RNAseq.g28889.t1,three_way,55.1975,,,,,,,,,,,,,,,,,
OG_00004,FUN_000191-T1,Peve_00038464,Pocillopora_meandrina_HIv1___RNAseq.g28890.t1,three_way,72.047,FUN_000191-T1,Q95108,,,,,44.1,136.0,3.3e-29,129.4,"sp|Q95108|THIOM_BOVIN Thioredoxin, mitochondrial OS=Bos taurus OX=9913 GN=TXN2 PE=1 SV=2",,,,,,
OG_00005,FUN_000192-T1,Peve_00038466,Pocillopora_meandrina_HIv1___RNAseq.g28893.t1,three_way,81.15866666666666,FUN_000192-T1,Q1LWX3,,,,,54.3,188.0,3.5e-53,209.5,sp|Q1LWX3|NTAQ1_DANRE Protein N-terminal glutamine amidohydrolase OS=Danio rerio OX=7955 GN=ntaq1 PE=2 SV=1,,,,,,
OG_00006,FUN_000193-T1,Peve_00038467,Pocillopora_meandrina_HIv1___RNAseq.g28894.t1,three_way,70.21933333333334,FUN_000193-T1,Q5I0K7,,,,,53.2,158.0,3.4e-41,169.5,sp|Q5I0K7|ALG13_RAT UDP-N-acetylglucosamine transferase subunit ALG13 OS=Rattus norvegicus OX=10116 GN=Alg13 PE=1 SV=1,,,,,,
OG_00007,FUN_000194-T1,Peve_00038470,Pocillopora_meandrina_HIv1___RNAseq.g28898.t1,three_way,77.11833333333334,FUN_000194-T1,P70182,,,,,60.2,447.0,3.4e-147,523.5,sp|P70182|PI51A_MOUSE Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha OS=Mus musculus OX=10090 GN=Pip5k1a PE=1 SV=2,,,,,,
OG_00008,FUN_000195-T1,Peve_00038471,Pocillopora_meandrina_HIv1___RNAseq.g28899.t1,three_way,68.38,FUN_000195-T1,B8D9S0,,,,,38.5,148.0,9e-19,95.1,sp|B8D9S0|FMT_BUCA5 Methionyl-tRNA formyltransferase OS=Buchnera aphidicola subsp. Acyrthosiphon pisum (strain 5A) OX=563178 GN=fmt PE=3 SV=1,,,,,,
OG_00009,FUN_000197-T1,Peve_00027182,Pocillopora_meandrina_HIv1___RNAseq.g28901.t1,three_way,56.498333333333335,FUN_000197-T1,Q8TCT7,,,,,44.7,488.0,1.6e-89,331.6,sp|Q8TCT7|SPP2B_HUMAN Signal peptide peptidase-like 2B OS=Homo sapiens OX=9606 GN=SPPL2B PE=1 SV=2,,,,,,
OG_00010,FUN_000198-T1,Peve_00027181,Pocillopora_meandrina_HIv1___RNAseq.g28902.t1,three_way,59.28266666666666,,,,,,,,,,,,,,,,,
OG_00011,FUN_000200-T1,Peve_00027179,Pocillopora_meandrina_HIv1___RNAseq.g28904.t1,three_way,83.315,FUN_000200-T1,Q5R733,CPEB1_PONAB,,Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (CPEB-1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),68.9,267.0,7.1e-113,409.1,sp|Q5R733|CPEB1_PONAB Cytoplasmic polyadenylation element-binding protein 1 OS=Pongo abelii OX=9601 GN=CPEB1 PE=2 SV=1,GO:0000900; GO:0000932; GO:0005634; GO:0005737; GO:0006397; GO:0008135; GO:0014069; GO:0016020; GO:0030425; GO:0031440; GO:0032869; GO:0035925; GO:0043022; GO:0046872; GO:0071230; GO:0071456; GO:1990904; GO:2000766,cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; mRNA processing [GO:0006397]; negative regulation of cytoplasmic translation [GO:2000766]; regulation of mRNA 3'-end processing [GO:0031440],cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904],"metal ion binding [GO:0046872]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; translation factor activity, RNA binding [GO:0008135]",GO:0003723; GO:0005634; GO:0016071; GO:0043226; GO:0045182,RNA binding; nucleus; mRNA metabolic process; organelle; translation regulator activity
OG_00012,FUN_000202-T1,Peve_00024058,Pocillopora_meandrina_HIv1___RNAseq.g28907.t1,three_way,80.12266666666666,FUN_000202-T1,Q9TU32,,,,,40.9,479.0,8.4e-93,342.4,sp|Q9TU32|LMAN1_CHLAE Protein ERGIC-53 OS=Chlorocebus aethiops OX=9534 GN=LMAN1 PE=1 SV=1,,,,,,
OG_00013,FUN_000203-T1,Peve_00019866,Pocillopora_meandrina_HIv1___RNAseq.g28908.t1,three_way,91.96433333333331,FUN_000203-T1,Q4V7T8,,,,,53.5,217.0,1e-61,238.0,sp|Q4V7T8|ROP1L_XENLA Ropporin-1-like protein OS=Xenopus laevis OX=8355 GN=ropn1l PE=2 SV=1,,,,,,
OG_00014,FUN_000206-T1,Peve_00027728,Pocillopora_meandrina_HIv1___RNAseq.g28910.t1,three_way,70.863,,,,,,,,,,,,,,,,,
OG_00015,FUN_000208-T1,Peve_00027726,Pocillopora_meandrina_HIv1___RNAseq.g28911.t2,three_way,63.83766666666666,FUN_000208-T1,Q6NXR4,TTI2_HUMAN,,TELO2-interacting protein 2,Homo sapiens (Human),42.4,184.0,9.700000000000001e-34,144.8,sp|Q6NXR4|TTI2_HUMAN TELO2-interacting protein 2 OS=Homo sapiens OX=9606 GN=TTI2 PE=1 SV=1,GO:0005634; GO:0050821; GO:0110078; GO:2000003,positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821],nucleus [GO:0005634]; TTT Hsp90 cochaperone complex [GO:0110078],,GO:0005634; GO:0043226,nucleus; organelle
OG_00016,FUN_000210-T1,Peve_00022649,Pocillopora_meandrina_HIv1___TS.g6133.t2,three_way,62.794,FUN_000210-T1,Q9EQH2,ERAP1_MOUSE,,Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (VEGF-induced aminopeptidase),Mus musculus (Mouse),40.9,694.0,1.1e-145,518.8,sp|Q9EQH2|ERAP1_MOUSE Endoplasmic reticulum aminopeptidase 1 OS=Mus musculus OX=10090 GN=Erap1 PE=1 SV=2,GO:0002250; GO:0004177; GO:0005138; GO:0005576; GO:0005737; GO:0005789; GO:0006508; GO:0006509; GO:0008233; GO:0008235; GO:0008270; GO:0045766,adaptive immune response [GO:0002250]; membrane protein ectodomain proteolysis [GO:0006509]; positive regulation of angiogenesis [GO:0045766]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576],aminopeptidase activity [GO:0004177]; interleukin-6 receptor binding [GO:0005138]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005576; GO:0016787; GO:0140096,"immune system process; catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_00017,FUN_000212-T1,Peve_00007289,Pocillopora_meandrina_HIv1___RNAseq.g28915.t1,three_way,63.1635,FUN_000212-T1,Q95334,AMPE_PIG,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Sus scrofa (Pig),37.8,898.0,2.5e-173,610.9,sp|Q95334|AMPE_PIG Glutamyl aminopeptidase OS=Sus scrofa OX=9823 GN=ENPEP PE=1 SV=1,GO:0003081; GO:0004177; GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048870; GO:0050886; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; cell motility; endocrine process; catalytic activity, acting on a protein"
OG_00018,FUN_000213-T2,Peve_00002451,Pocillopora_meandrina_HIv1___RNAseq.g28916.t1,three_way,60.77916666666667,FUN_000213-T2,Q8LHH9,,,,,38.3,830.0,2.1000000000000001e-134,482.6,sp|Q8LHH9|SHL2_ORYSJ Probable RNA-dependent RNA polymerase SHL2 OS=Oryza sativa subsp. japonica OX=39947 GN=SHL2 PE=2 SV=1,,,,,,
OG_00019,FUN_000215-T1,Peve_00002445,Pocillopora_meandrina_HIv1___RNAseq.g28918.t1,three_way,61.82416666666666,FUN_000215-T1,P15541,,,,,34.2,918.0,1.8e-142,508.4,sp|P15541|AMPN_RABIT Aminopeptidase N OS=Oryctolagus cuniculus OX=9986 GN=ANPEP PE=1 SV=4,,,,,,
OG_00020,FUN_000216-T1,Peve_00018873,Pocillopora_meandrina_HIv1___RNAseq.g28926.t1,three_way,52.28366666666667,,,,,,,,,,,,,,,,,
OG_00021,FUN_000217-T1,Peve_00019413,Pocillopora_meandrina_HIv1___RNAseq.g28927.t1,three_way,72.92583333333333,FUN_000217-T1,Q6DFB7,,,,,28.5,572.0,8.9e-51,203.0,sp|Q6DFB7|POC5_XENLA Centrosomal protein POC5 OS=Xenopus laevis OX=8355 GN=poc5 PE=2 SV=1,,,,,,
OG_00022,FUN_000219-T1,Peve_00019412,Pocillopora_meandrina_HIv1___RNAseq.g28928.t1,three_way,64.90866666666666,,,,,,,,,,,,,,,,,
OG_00023,FUN_000220-T1,Peve_00012034,Pocillopora_meandrina_HIv1___RNAseq.g28929.t1,three_way,77.529,FUN_000220-T1,P12527,LOX5_RAT,,Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34),Rattus norvegicus (Rat),27.2,379.0,2.5e-34,148.7,sp|P12527|LOX5_RAT Polyunsaturated fatty acid 5-lipoxygenase OS=Rattus norvegicus OX=10116 GN=Alox5 PE=1 SV=3,GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005634; GO:0005635; GO:0005641; GO:0005737; GO:0005829; GO:0006691; GO:0006954; GO:0006959; GO:0007584; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030425; GO:0030501; GO:0031965; GO:0034440; GO:0036336; GO:0036403; GO:0042383; GO:0042593; GO:0045598; GO:0045907; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0055093; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904999; GO:2001301,arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of vasoconstriction [GO:0045907]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; response to hyperoxia [GO:0055093]; response to nutrient [GO:0007584],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383],arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506],GO:0002376; GO:0003013; GO:0003824; GO:0005634; GO:0005635; GO:0005829; GO:0005886; GO:0006629; GO:0006954; GO:0016491; GO:0016787; GO:0043226; GO:0048870,immune system process; circulatory system process; catalytic activity; nucleus; nuclear envelope; cytosol; plasma membrane; lipid metabolic process; inflammatory response; oxidoreductase activity; hydrolase activity; organelle; cell motility
OG_00024,FUN_000223-T1,Peve_00012031,Pocillopora_meandrina_HIv1___RNAseq.g28933.t1,three_way,77.22633333333333,FUN_000223-T1,Q80UY1,,,,,52.0,358.0,2.1e-107,390.6,sp|Q80UY1|CARME_MOUSE Carnosine N-methyltransferase OS=Mus musculus OX=10090 GN=Carnmt1 PE=1 SV=1,,,,,,
OG_00025,FUN_000226-T1,Peve_00012014,Pocillopora_meandrina_HIv1___RNAseq.g28941.t1,three_way,60.776,FUN_000226-T1,Q6P4K1,,,,,55.3,94.0,2.3e-23,112.1,sp|Q6P4K1|HDGR2_XENTR Hepatoma-derived growth factor-related protein 2 OS=Xenopus tropicalis OX=8364 GN=hdgfl2 PE=2 SV=1,,,,,,
OG_00025,FUN_000226-T1,Peve_00012014,Pocillopora_meandrina_HIv1___RNAseq.g28941.t1,three_way,60.776,FUN_000226-T1,Q6P4K1,,,,,36.7,79.0,2.4e-09,65.5,sp|Q6P4K1|HDGR2_XENTR Hepatoma-derived growth factor-related protein 2 OS=Xenopus tropicalis OX=8364 GN=hdgfl2 PE=2 SV=1,,,,,,
OG_00026,FUN_000229-T1,Peve_00012013,Pocillopora_meandrina_HIv1___RNAseq.g28944.t1,three_way,74.97,FUN_000229-T1,Q3ZBL9,,,,,41.9,284.0,2.3e-51,204.1,sp|Q3ZBL9|CCNH_BOVIN Cyclin-H OS=Bos taurus OX=9913 GN=CCNH PE=2 SV=1,,,,,,
OG_00027,FUN_000230-T1,Peve_00012012,Pocillopora_meandrina_HIv1___RNAseq.g28945.t1,three_way,54.19533333333334,FUN_000230-T1,Q5VTE6,ANGE2_HUMAN,,Protein angel homolog 2,Homo sapiens (Human),44.9,254.0,8.199999999999999e-53,209.9,sp|Q5VTE6|ANGE2_HUMAN Protein angel homolog 2 OS=Homo sapiens OX=9606 GN=ANGEL2 PE=1 SV=1,GO:0003730; GO:0003824; GO:0005737; GO:0005739; GO:0005759; GO:0015030; GO:0045930; GO:0070935; GO:0090616,3'-UTR-mediated mRNA stabilization [GO:0070935]; mitochondrial mRNA 3'-end processing [GO:0090616]; negative regulation of mitotic cell cycle [GO:0045930],Cajal body [GO:0015030]; cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],catalytic activity [GO:0003824]; mRNA 3'-UTR binding [GO:0003730],GO:0003723; GO:0003824; GO:0005739; GO:0016071; GO:0043226; GO:0140053,RNA binding; catalytic activity; mitochondrion; mRNA metabolic process; organelle; mitochondrial gene expression
OG_00028,FUN_000231-T1,Peve_00012025,Pocillopora_meandrina_HIv1___RNAseq.g28946.t1,three_way,54.33083333333334,FUN_000231-T1,Q1ZXH8,GXCDD_DICDI,,Guanine exchange factor for Rac 30,Dictyostelium discoideum (Social amoeba),36.5,203.0,4.3e-26,122.5,sp|Q1ZXH8|GXCDD_DICDI Guanine exchange factor for Rac 30 OS=Dictyostelium discoideum OX=44689 GN=gxcDD PE=4 SV=3,GO:0005085; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005938; GO:0008270; GO:0016020; GO:0030587; GO:0030670; GO:0031152; GO:0031267; GO:0032009; GO:0035556,aggregation involved in sorocarp development [GO:0031152]; intracellular signal transduction [GO:0035556]; sorocarp development [GO:0030587],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early phagosome [GO:0032009]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670],"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0005856; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,cytoskeleton; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_00029,FUN_000232-T1,Peve_00033351,Pocillopora_meandrina_HIv1___RNAseq.g28949.t1,three_way,73.66199999999999,FUN_000232-T1,Q9R111,GUAD_MOUSE,,Guanine deaminase (Guanase) (Guanine aminase) (EC 3.5.4.3) (Guanine aminohydrolase) (GAH),Mus musculus (Mouse),50.3,441.0,2.3e-118,427.2,sp|Q9R111|GUAD_MOUSE Guanine deaminase OS=Mus musculus OX=10090 GN=Gda PE=1 SV=1,GO:0000255; GO:0005829; GO:0006147; GO:0006161; GO:0008270; GO:0008892; GO:0043605; GO:0046038; GO:0046055,allantoin metabolic process [GO:0000255]; amide catabolic process [GO:0043605]; deoxyguanosine catabolic process [GO:0006161]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147],cytosol [GO:0005829],guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00030,FUN_000236-T1,Peve_00033366,Pocillopora_meandrina_HIv1___TS.g6172.t1,three_way,51.7605,,,,,,,,,,,,,,,,,
OG_00031,FUN_000237-T1,Peve_00033367,Pocillopora_meandrina_HIv1___RNAseq.g28953.t1,three_way,74.7705,FUN_000237-T1,Q2KHR2,RFX7_HUMAN,,DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2),Homo sapiens (Human),45.1,255.0,3.3999999999999997e-47,191.8,sp|Q2KHR2|RFX7_HUMAN DNA-binding protein RFX7 OS=Homo sapiens OX=9606 GN=RFX7 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000979; GO:0000981; GO:0005634; GO:0006357; GO:0045944; GO:1990837,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_00032,FUN_000238-T1,Peve_00033352,Pocillopora_meandrina_HIv1___RNAseq.g28954.t1,three_way,62.998666666666665,FUN_000238-T1,Q5ZI58,,,,,35.3,552.0,1e-61,239.6,sp|Q5ZI58|ATOSA_CHICK Atos homolog protein A OS=Gallus gallus OX=9031 GN=ATOSA PE=2 SV=2,,,,,,
OG_00033,FUN_000239-T1,Peve_00033353,Pocillopora_meandrina_HIv1___RNAseq.g28955.t1,three_way,97.61933333333332,FUN_000239-T1,Q2KHT7,,,,,89.3,84.0,1.7e-38,159.5,sp|Q2KHT7|RS27_BOVIN Small ribosomal subunit protein eS27 OS=Bos taurus OX=9913 GN=RPS27 PE=1 SV=3,,,,,,
OG_00034,FUN_000240-T1,Peve_00033355,Pocillopora_meandrina_HIv1___TS.g6176.t1,three_way,44.82333333333333,,,,,,,,,,,,,,,,,
OG_00035,FUN_000243-T1,Peve_00033358,Pocillopora_meandrina_HIv1___RNAseq.g28959.t1,three_way,67.30566666666667,,,,,,,,,,,,,,,,,
OG_00036,FUN_000245-T1,Peve_00033360,Pocillopora_meandrina_HIv1___RNAseq.g28960.t1,three_way,68.59933333333333,,,,,,,,,,,,,,,,,
OG_00037,FUN_000247-T2,Peve_00033364,Pocillopora_meandrina_HIv1___RNAseq.g28974.t1,three_way,71.2625,FUN_000247-T2,P22045,,,,,36.9,271.0,1.1e-36,157.1,"sp|P22045|PGFS_LEIMA 9,11-endoperoxide prostaglandin H2 reductase OS=Leishmania major OX=5664 GN=P100/11E PE=1 SV=3",,,,,,
OG_00038,FUN_000260-T1,Peve_00027791,Pocillopora_meandrina_HIv1___RNAseq.g28975.t1,three_way,62.275,FUN_000260-T1,Q3KPL3,,,,,33.9,165.0,2.7e-12,74.3,sp|Q3KPL3|LYSM2_XENLA LysM and putative peptidoglycan-binding domain-containing protein 2 OS=Xenopus laevis OX=8355 GN=lysmd2 PE=2 SV=2,,,,,,
OG_00039,FUN_000261-T1,Peve_00027784,Pocillopora_meandrina_HIv1___RNAseq.g28976.t1,three_way,77.24933333333334,,,,,,,,,,,,,,,,,
OG_00040,FUN_000263-T1,Peve_00027785,Pocillopora_meandrina_HIv1___RNAseq.g28977.t2,three_way,82.65166666666667,FUN_000263-T1,Q5ZLW3,,,,,49.3,690.0,7.099999999999998e-175,615.5,sp|Q5ZLW3|DYM_CHICK Dymeclin OS=Gallus gallus OX=9031 GN=DYM PE=2 SV=1,,,,,,
OG_00041,FUN_000264-T1,Peve_00027786,Pocillopora_meandrina_HIv1___RNAseq.g28978.t1,three_way,65.873,FUN_000264-T1,Q9W734,,,,,37.1,353.0,2.7e-54,214.2,sp|Q9W734|SMAD6_CHICK Mothers against decapentaplegic homolog 6 OS=Gallus gallus OX=9031 GN=SMAD6 PE=2 SV=1,,,,,,
OG_00042,FUN_000265-T1,Peve_00027789,Pocillopora_meandrina_HIv1___RNAseq.g28979.t1,three_way,91.153,FUN_000265-T1,P84023,SMAD3_CHICK,,Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (SMAD family member 3) (SMAD 3) (Smad3),Gallus gallus (Chicken),74.9,430.0,5.4e-189,661.8,sp|P84023|SMAD3_CHICK Mothers against decapentaplegic homolog 3 OS=Gallus gallus OX=9031 GN=SMAD3 PE=2 SV=1,GO:0000978; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0007179; GO:0009653; GO:0030154; GO:0032924; GO:0045944; GO:0046872; GO:0060395; GO:0070411; GO:0071141; GO:0071144,activin receptor signaling pathway [GO:0032924]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; positive regulation of transcription by RNA polymerase II [GO:0045944]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_00043,FUN_000270-T1,Peve_00027796,Pocillopora_meandrina_HIv1___RNAseq.g28983.t1,three_way,78.31466666666667,FUN_000270-T1,Q0P483,S2542_DANRE,,Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42),Danio rerio (Zebrafish) (Brachydanio rerio),51.5,324.0,5.3e-87,322.8,sp|Q0P483|S2542_DANRE Mitochondrial coenzyme A transporter SLC25A42 OS=Danio rerio OX=7955 GN=slc25a42 PE=2 SV=1,GO:0005347; GO:0005739; GO:0005743; GO:0007006; GO:0015217; GO:0015228; GO:0015866; GO:0015867; GO:0035349; GO:0043262; GO:0080121; GO:0080122,ADP transport [GO:0015866]; AMP transport [GO:0080121]; ATP transport [GO:0015867]; coenzyme A transmembrane transport [GO:0035349]; mitochondrial membrane organization [GO:0007006],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ADP phosphatase activity [GO:0043262]; ADP transmembrane transporter activity [GO:0015217]; AMP transmembrane transporter activity [GO:0080122]; ATP transmembrane transporter activity [GO:0005347]; coenzyme A transmembrane transporter activity [GO:0015228],GO:0003824; GO:0005215; GO:0005739; GO:0007005; GO:0016787; GO:0043226; GO:0055085; GO:0061024,catalytic activity; transporter activity; mitochondrion; mitochondrion organization; hydrolase activity; organelle; transmembrane transport; membrane organization
OG_00044,FUN_000272-T1,Peve_00027798,Pocillopora_meandrina_HIv1___RNAseq.g28985.t1,three_way,70.59733333333334,FUN_000272-T1,O75031,HSF2B_HUMAN,,Heat shock factor 2-binding protein,Homo sapiens (Human),43.2,190.0,5.9e-32,139.0,sp|O75031|HSF2B_HUMAN Heat shock factor 2-binding protein OS=Homo sapiens OX=9606 GN=HSF2BP PE=1 SV=1,GO:0005654; GO:0005694; GO:0005829; GO:0006366; GO:0007141; GO:0007144; GO:0007283; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; female meiosis I [GO:0007144]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366],chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0006351; GO:0022414; GO:0043226; GO:0140013,nucleoplasm; chromosome; cytosol; DNA repair; DNA-templated transcription; reproductive process; organelle; meiotic nuclear division
OG_00045,FUN_000276-T1,Peve_00044046,Pocillopora_meandrina_HIv1___RNAseq.g28996.t1,three_way,70.16666666666667,FUN_000276-T1,Q4N4N8,TXND_THEPA,,Thioredoxin domain-containing protein (Membrane protein 23) (mp23),Theileria parva (East coast fever infection agent),31.8,173.0,3.6e-17,90.1,sp|Q4N4N8|TXND_THEPA Thioredoxin domain-containing protein OS=Theileria parva OX=5875 GN=TP02_0602 PE=1 SV=1,GO:0005788; GO:0005789; GO:0015035; GO:0034976,response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],protein-disulfide reductase activity [GO:0015035],GO:0003824; GO:0016491; GO:0140096,"catalytic activity; oxidoreductase activity; catalytic activity, acting on a protein"
OG_00046,FUN_000281-T1,Peve_00033554,Pocillopora_meandrina_HIv1___RNAseq.g29077.t1,three_way,55.50666666666667,,,,,,,,,,,,,,,,,
OG_00047,FUN_000283-T1,Peve_00033555,Pocillopora_meandrina_HIv1___RNAseq.g29073.t1,three_way,79.09333333333333,FUN_000283-T1,Q9I8C7,,,,,46.3,322.0,4.6e-86,320.1,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_00048,FUN_000285-T1,Peve_00033562,Pocillopora_meandrina_HIv1___RNAseq.g29071.t1,three_way,75.66833333333334,FUN_000285-T1,Q8BYH7,,,,,30.3,307.0,1.2e-37,159.1,sp|Q8BYH7|TBC17_MOUSE TBC1 domain family member 17 OS=Mus musculus OX=10090 GN=Tbc1d17 PE=1 SV=2,,,,,,
OG_00049,FUN_000289-T1,Peve_00033565,Pocillopora_meandrina_HIv1___TS.g6289.t1,three_way,56.049,FUN_000289-T1,Q9UPM8,,,,,26.1,743.0,7.4e-53,210.3,sp|Q9UPM8|AP4E1_HUMAN AP-4 complex subunit epsilon-1 OS=Homo sapiens OX=9606 GN=AP4E1 PE=1 SV=2,,,,,,
OG_00050,FUN_000319-T1,Peve_00033573,Pocillopora_meandrina_HIv1___RNAseq.g29015.t1,three_way,79.55166666666666,FUN_000319-T1,O43396,,,,,57.0,207.0,1.3e-61,237.7,sp|O43396|TXNL1_HUMAN Thioredoxin-like protein 1 OS=Homo sapiens OX=9606 GN=TXNL1 PE=1 SV=3,,,,,,
OG_00051,FUN_000320-T1,Peve_00033574,Pocillopora_meandrina_HIv1___RNAseq.g29014.t1,three_way,81.34316666666668,FUN_000320-T1,Q9Y4E6,,,,,41.7,1189.0,5.3e-228,792.7,sp|Q9Y4E6|WDR7_HUMAN WD repeat-containing protein 7 OS=Homo sapiens OX=9606 GN=WDR7 PE=1 SV=2,,,,,,
OG_00052,FUN_000322-T1,Peve_00012600,Pocillopora_meandrina_HIv1___RNAseq.g29012.t1,three_way,71.85166666666667,FUN_000322-T1,Q9CZS3,CEP20_MOUSE,,Centrosomal protein 20 (FGFR1OP N-terminal-like protein) (FOP-related protein of 20 kDa) (LisH domain-containing protein FOPNL),Mus musculus (Mouse),73.7,118.0,7.3e-42,171.8,sp|Q9CZS3|CEP20_MOUSE Centrosomal protein 20 OS=Mus musculus OX=10090 GN=Cep20 PE=1 SV=1,GO:0005654; GO:0005737; GO:0005814; GO:0031514; GO:0034451; GO:0034453; GO:0036064; GO:0042802; GO:0060271,cilium assembly [GO:0060271]; microtubule anchoring [GO:0034453],centriolar satellite [GO:0034451]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654],identical protein binding [GO:0042802],GO:0005654; GO:0005815; GO:0005929; GO:0007010; GO:0043226; GO:0044782,nucleoplasm; microtubule organizing center; cilium; cytoskeleton organization; organelle; cilium organization
OG_00053,FUN_000323-T1,Peve_00012596,Pocillopora_meandrina_HIv1___RNAseq.g29002.t2,three_way,82.90066666666667,FUN_000323-T1,Q9QYF3,MYO5A_RAT,,"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle)",Rattus norvegicus (Rat),51.1,1879.0,0.0,1338.6,sp|Q9QYF3|MYO5A_RAT Unconventional myosin-Va OS=Rattus norvegicus OX=10116 GN=Myo5a PE=1 SV=1,GO:0000146; GO:0000149; GO:0001726; GO:0001750; GO:0003774; GO:0003779; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005764; GO:0005769; GO:0005770; GO:0005777; GO:0005783; GO:0005790; GO:0005794; GO:0005829; GO:0005882; GO:0005884; GO:0006582; GO:0006887; GO:0006892; GO:0007015; GO:0007268; GO:0007601; GO:0008021; GO:0015629; GO:0016020; GO:0016192; GO:0016236; GO:0016459; GO:0016461; GO:0016887; GO:0017075; GO:0017157; GO:0019901; GO:0030048; GO:0030050; GO:0030073; GO:0030141; GO:0030318; GO:0030424; GO:0030425; GO:0031267; GO:0031982; GO:0031987; GO:0032252; GO:0032400; GO:0032402; GO:0032433; GO:0032593; GO:0032869; GO:0033602; GO:0042417; GO:0042438; GO:0042470; GO:0042476; GO:0042552; GO:0042641; GO:0042642; GO:0042759; GO:0042802; GO:0043008; GO:0043025; GO:0043473; GO:0044877; GO:0048066; GO:0048306; GO:0048820; GO:0050808; GO:0050885; GO:0051015; GO:0051643; GO:0051967; GO:0055037; GO:0065003; GO:0072659; GO:0097718; GO:0098685; GO:0098794; GO:0098871; GO:0098978; GO:0099089; GO:0099566; GO:0099640; GO:0150103; GO:1900078; GO:1903078; GO:1904754; GO:1990904,"actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; axo-dendritic protein transport [GO:0099640]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; developmental pigmentation [GO:0048066]; dopamine metabolic process [GO:0042417]; endoplasmic reticulum localization [GO:0051643]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; macroautophagy [GO:0016236]; melanin biosynthetic process [GO:0042438]; melanin metabolic process [GO:0006582]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; myelination [GO:0042552]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; neuromuscular process controlling balance [GO:0050885]; odontogenesis [GO:0042476]; pigmentation [GO:0043473]; positive regulation of cellular response to insulin stimulus [GO:1900078]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein-containing complex assembly [GO:0065003]; reactive gliosis [GO:0150103]; regulation of exocytosis [GO:0017157]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601]","actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actomyosin [GO:0042641]; actomyosin, myosin complex part [GO:0042642]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; postsynaptic actin cytoskeleton [GO:0098871]; recycling endosome [GO:0055037]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; unconventional myosin complex [GO:0016461]; vesicle [GO:0031982]",actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075],GO:0003774; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0023052; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0050877; GO:0065003; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; lysosome; endosome; vacuole; peroxisome; endoplasmic reticulum; Golgi apparatus; cytosol; cytoskeleton; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; signaling; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; nervous system process; protein-containing complex assembly; protein localization to plasma membrane; ATP-dependent activity
OG_00054,FUN_000329-T1,Peve_00033549,Pocillopora_meandrina_HIv1___RNAseq.g29081.t1,three_way,98.41266666666668,FUN_000329-T1,O15182,CETN3_HUMAN,,Centrin-3,Homo sapiens (Human),80.2,167.0,1.2e-70,267.3,sp|O15182|CETN3_HUMAN Centrin-3 OS=Homo sapiens OX=9606 GN=CETN3 PE=1 SV=2,GO:0000226; GO:0005509; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0007098; GO:0008017; GO:0015031; GO:0031683; GO:0032391; GO:0036064; GO:0044615; GO:0051028; GO:0051301; GO:0070390,cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule cytoskeleton organization [GO:0000226]; mRNA transport [GO:0051028]; protein transport [GO:0015031],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; photoreceptor connecting cilium [GO:0032391]; transcription export complex 2 [GO:0070390],calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; microtubule binding [GO:0008017],GO:0005730; GO:0005815; GO:0007010; GO:0008092; GO:0043226,nucleolus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_00055,FUN_000330-T1,Peve_00033547,Pocillopora_meandrina_HIv1___RNAseq.g29083.t1,three_way,89.4465,FUN_000330-T1,A0A3G2LGI8,,,,,54.5,2571.0,0.0,2154.8,sp|A0A3G2LGI8|TLN_OSCPE Talin OS=Oscarella pearsei OX=1940113 GN=TLN PE=1 SV=1,,,,,,
OG_00056,FUN_000334-T1,Peve_00033540,Pocillopora_meandrina_HIv1___RNAseq.g29089.t1,three_way,52.14833333333333,FUN_000334-T1,Q6XHB2,ROCO4_DICDI,,Probable serine/threonine-protein kinase roco4 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 4),Dictyostelium discoideum (Social amoeba),25.8,419.0,1.4e-16,90.9,sp|Q6XHB2|ROCO4_DICDI Probable serine/threonine-protein kinase roco4 OS=Dictyostelium discoideum OX=44689 GN=roco4 PE=1 SV=1,GO:0000302; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006120; GO:0007165; GO:0031150; GO:0042331; GO:0106310,"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; phototaxis [GO:0042331]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]; sorocarp stalk development [GO:0031150]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005739; GO:0005829; GO:0006091; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; generation of precursor metabolites and energy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00057,FUN_000348-T1,Peve_00033538,Pocillopora_meandrina_HIv1___RNAseq.g29111.t1,three_way,42.8425,,,,,,,,,,,,,,,,,
OG_00058,FUN_000350-T1,Peve_00033537,Pocillopora_meandrina_HIv1___RNAseq.g29114.t1,three_way,92.17333333333332,FUN_000350-T1,P62490,,,,,86.6,216.0,1e-98,360.9,sp|P62490|RB11A_CANLF Ras-related protein Rab-11A OS=Canis lupus familiaris OX=9615 GN=RAB11A PE=2 SV=3,,,,,,
OG_00059,FUN_000351-T1,Peve_00033536,Pocillopora_meandrina_HIv1___RNAseq.g29115.t1,three_way,75.824,FUN_000351-T1,Q8BLA8,TRPA1_MOUSE,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Mus musculus (Mouse),25.2,1062.0,6.900000000000001e-80,300.8,sp|Q8BLA8|TRPA1_MOUSE Transient receptor potential cation channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Trpa1 PE=1 SV=1,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_00060,FUN_000352-T1,Peve_00033531,Pocillopora_meandrina_HIv1___RNAseq.g29116.t1,three_way,77.85483333333333,FUN_000352-T1,P18395,,,,,46.0,817.0,5.600000000000001e-180,632.9,sp|P18395|CSDE1_RAT Cold shock domain-containing protein E1 OS=Rattus norvegicus OX=10116 GN=Csde1 PE=2 SV=1,,,,,,
OG_00061,FUN_000371-T1,Peve_00033529,Pocillopora_meandrina_HIv1___RNAseq.g29119.t1,three_way,84.897,FUN_000371-T1,P61007,,,,,56.0,175.0,6.4e-54,211.8,sp|P61007|RAB8A_CANLF Ras-related protein Rab-8A OS=Canis lupus familiaris OX=9615 GN=RAB8A PE=1 SV=1,,,,,,
OG_00062,FUN_000372-T1,Peve_00033530,Pocillopora_meandrina_HIv1___RNAseq.g29118.t1,three_way,91.26166666666668,FUN_000372-T1,P55258,RAB8A_MOUSE,,Ras-related protein Rab-8A (EC 3.6.5.2) (Oncogene c-mel),Mus musculus (Mouse),79.6,186.0,1.1e-80,300.8,sp|P55258|RAB8A_MOUSE Ras-related protein Rab-8A OS=Mus musculus OX=10090 GN=Rab8a PE=1 SV=2,GO:0003924; GO:0005525; GO:0005654; GO:0005730; GO:0005764; GO:0005794; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0006904; GO:0006914; GO:0007030; GO:0007409; GO:0010008; GO:0010506; GO:0015629; GO:0019003; GO:0030140; GO:0030425; GO:0030496; GO:0030659; GO:0030670; GO:0031267; GO:0031489; GO:0032869; GO:0034451; GO:0036064; GO:0043005; GO:0043025; GO:0045335; GO:0048169; GO:0048210; GO:0051223; GO:0055037; GO:0055038; GO:0060170; GO:0060271; GO:0061512; GO:0072659; GO:0097546; GO:0097730; GO:0098887; GO:0098978; GO:0099003; GO:1990782,"autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; Golgi vesicle fusion to target membrane [GO:0048210]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; regulation of autophagy [GO:0010506]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport in synapse [GO:0099003]",actin cytoskeleton [GO:0015629]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; midbody [GO:0030496]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network transport vesicle [GO:0030140],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein tyrosine kinase binding [GO:1990782]; small GTPase binding [GO:0031267],GO:0003824; GO:0003924; GO:0005654; GO:0005730; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0006886; GO:0006914; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0061024; GO:0072659,catalytic activity; GTPase activity; nucleoplasm; nucleolus; lysosome; endosome; vacuole; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; intracellular protein transport; autophagy; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; membrane organization; protein localization to plasma membrane
OG_00063,FUN_000374-T1,Peve_00033526,Pocillopora_meandrina_HIv1___TS.g6338.t1,three_way,32.86933333333334,FUN_000374-T1,Q96EQ9,,,,,33.5,254.0,3.2e-30,136.7,sp|Q96EQ9|PRDM9_MOUSE Histone-lysine N-methyltransferase PRDM9 OS=Mus musculus OX=10090 GN=Prdm9 PE=1 SV=2,,,,,,
OG_00064,FUN_000375-T1,Peve_00028988,Pocillopora_meandrina_HIv1___RNAseq.g12644.t1,three_way,70.61166666666666,,,,,,,,,,,,,,,,,
OG_00065,FUN_000378-T1,Peve_00033520,Pocillopora_meandrina_HIv1___RNAseq.g29123.t1,three_way,81.29066666666667,FUN_000378-T1,O42479,,,,,70.2,372.0,8.7e-155,548.1,"sp|O42479|HEMH_CHICK Ferrochelatase, mitochondrial OS=Gallus gallus OX=9031 GN=FECH PE=1 SV=1",,,,,,
OG_00066,FUN_000384-T1,Peve_00033599,Pocillopora_meandrina_HIv1___RNAseq.g29126.t1,three_way,70.015,FUN_000384-T1,O43586,PPIP1_HUMAN,,Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1) (CD2-binding protein 1) (H-PIP),Homo sapiens (Human),35.0,428.0,1.0000000000000001e-65,252.3,sp|O43586|PPIP1_HUMAN Proline-serine-threonine phosphatase-interacting protein 1 OS=Homo sapiens OX=9606 GN=PSTPIP1 PE=1 SV=1,GO:0001931; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006897; GO:0006954; GO:0007155; GO:0007165; GO:0016020; GO:0030027; GO:0032154; GO:0042802; GO:0045087; GO:0048471,cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931],identical protein binding [GO:0042802],GO:0002376; GO:0005829; GO:0005856; GO:0005886; GO:0006954; GO:0007155; GO:0016192; GO:0043226; GO:0098542,immune system process; cytosol; cytoskeleton; plasma membrane; inflammatory response; cell adhesion; vesicle-mediated transport; organelle; defense response to other organism
OG_00067,FUN_000387-T1,Peve_00033598,Pocillopora_meandrina_HIv1___TS.g6342.t3c,three_way,83.94266666666667,FUN_000387-T1,Q64512,PTN13_MOUSE,,Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (PTP36) (Protein tyrosine phosphatase DPZPTP) (Protein tyrosine phosphatase PTP-BL) (Protein-tyrosine phosphatase RIP),Mus musculus (Mouse),28.3,1042.0,5.499999999999999e-90,334.0,sp|Q64512|PTN13_MOUSE Tyrosine-protein phosphatase non-receptor type 13 OS=Mus musculus OX=10090 GN=Ptpn13 PE=1 SV=2,GO:0004725; GO:0005634; GO:0005737; GO:0005856; GO:0030027; GO:0030496; GO:0051896,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nucleus [GO:0005634],protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005634; GO:0005856; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytoskeleton; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00068,FUN_000390-T1,Peve_00033596,Pocillopora_meandrina_HIv1___RNAseq.g2524.t1,three_way,49.54833333333334,,,,,,,,,,,,,,,,,
OG_00069,FUN_000391-T1,Peve_00033595,Pocillopora_meandrina_HIv1___RNAseq.g2525.t1,three_way,47.93233333333333,,,,,,,,,,,,,,,,,
OG_00070,FUN_000392-T1,Peve_00033592,Pocillopora_meandrina_HIv1___RNAseq.g2526.t1b,three_way,74.39316666666667,,,,,,,,,,,,,,,,,
OG_00071,FUN_000393-T1,Peve_00033591,Pocillopora_meandrina_HIv1___RNAseq.g2528.t1,three_way,82.34016666666666,FUN_000393-T1,P08429,,,,,65.9,349.0,9.9e-131,468.0,sp|P08429|RL4A_XENLA Large ribosomal subunit protein uL4A OS=Xenopus laevis OX=8355 GN=rpl4-a PE=2 SV=2,,,,,,
OG_00072,FUN_000395-T1,Peve_00033589,Pocillopora_meandrina_HIv1___RNAseq.g2531.t1,three_way,78.31366666666668,FUN_000395-T1,Q8SQ21,,,,,50.0,158.0,4.1e-34,146.0,sp|Q8SQ21|HINT2_BOVIN Adenosine 5'-monophosphoramidase HINT2 OS=Bos taurus OX=9913 GN=HINT2 PE=2 SV=1,,,,,,
OG_00073,FUN_000397-T1,Peve_00033585,Pocillopora_meandrina_HIv1___RNAseq.g2533.t1a,three_way,50.99,FUN_000397-T1,Q9H792,PEAK1_HUMAN,,Inactive tyrosine-protein kinase PEAK1 (Pseudopodium-enriched atypical kinase 1) (Sugen kinase 269) (Tyrosine-protein kinase SgK269),Homo sapiens (Human),25.8,512.0,3.1e-32,142.9,sp|Q9H792|PEAK1_HUMAN Inactive tyrosine-protein kinase PEAK1 OS=Homo sapiens OX=9606 GN=PEAK1 PE=1 SV=4,GO:0004672; GO:0004715; GO:0005829; GO:0005925; GO:0015629; GO:0016477; GO:0034446; GO:0042802; GO:0046777; GO:0048041; GO:0051893; GO:2000145,cell migration [GO:0016477]; focal adhesion assembly [GO:0048041]; protein autophosphorylation [GO:0046777]; regulation of cell motility [GO:2000145]; regulation of focal adhesion assembly [GO:0051893]; substrate adhesion-dependent cell spreading [GO:0034446],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925],identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672],GO:0003824; GO:0005829; GO:0005856; GO:0007155; GO:0016740; GO:0034330; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; cytosol; cytoskeleton; cell adhesion; transferase activity; cell junction organization; organelle; cell motility; catalytic activity, acting on a protein"
OG_00074,FUN_000398-T1,Peve_00033583,Pocillopora_meandrina_HIv1___RNAseq.g2535.t1,three_way,88.96866666666666,FUN_000398-T1,P52657,T2AG_HUMAN,,Transcription initiation factor IIA subunit 2 (General transcription factor IIA subunit 2) (TFIIA p12 subunit) (TFIIA-12) (TFIIAS) (Transcription initiation factor IIA gamma chain) (TFIIA-gamma),Homo sapiens (Human),79.4,107.0,6.799999999999999e-43,174.5,sp|P52657|T2AG_HUMAN Transcription initiation factor IIA subunit 2 OS=Homo sapiens OX=9606 GN=GTF2A2 PE=1 SV=1,GO:0001091; GO:0005634; GO:0005654; GO:0005669; GO:0005672; GO:0005829; GO:0006366; GO:0006367; GO:0016251; GO:0017025; GO:0042803; GO:0045944; GO:0046982; GO:0051123; GO:0060261; GO:0061629,positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669],protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TBP-class protein binding [GO:0017025],GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0043226; GO:0065003; GO:0140223,nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; general transcription initiation factor activity
OG_00075,FUN_000399-T1,Peve_00033552,Pocillopora_meandrina_HIv1___RNAseq.g2540.t1,three_way,93.53266666666669,FUN_000399-T1,Q0VC92,MGN2_BOVIN,,Protein mago nashi homolog 2,Bos taurus (Bovine),87.7,146.0,5.3e-71,268.5,sp|Q0VC92|MGN2_BOVIN Protein mago nashi homolog 2 OS=Bos taurus OX=9913 GN=MAGOHB PE=2 SV=1,GO:0000398; GO:0003723; GO:0005634; GO:0008380; GO:0035145; GO:0051028; GO:0071005; GO:0071006; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380]",catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_00076,FUN_000401-T1,Peve_00033535,Pocillopora_meandrina_HIv1___RNAseq.13430_t,three_way,67.23816666666667,FUN_000401-T1,Q8TDX6,,,,,40.5,375.0,2.6e-77,291.2,sp|Q8TDX6|CGAT1_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=CSGALNACT1 PE=1 SV=2,,,,,,
OG_00077,FUN_000402-T1,Peve_00033527,Pocillopora_meandrina_HIv1___RNAseq.g2543.t1,three_way,81.73866666666666,FUN_000402-T1,Q9NYL9,,,,,46.9,130.0,2.2e-23,110.2,sp|Q9NYL9|TMOD3_HUMAN Tropomodulin-3 OS=Homo sapiens OX=9606 GN=TMOD3 PE=1 SV=1,,,,,,
OG_00078,FUN_000403-T1,Peve_00033519,Pocillopora_meandrina_HIv1___RNAseq.g2544.t1,three_way,79.21583333333334,FUN_000403-T1,A0A0G2K2P5,ZO1_RAT,,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),Rattus norvegicus (Rat),28.2,1783.0,6.4e-140,500.7,sp|A0A0G2K2P5|ZO1_RAT Tight junction protein ZO-1 OS=Rattus norvegicus OX=10116 GN=Tjp1 PE=1 SV=1,GO:0001825; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0005921; GO:0005923; GO:0007605; GO:0008013; GO:0008284; GO:0009410; GO:0009986; GO:0014704; GO:0016020; GO:0016301; GO:0016323; GO:0016324; GO:0016327; GO:0019904; GO:0030036; GO:0030054; GO:0030335; GO:0031032; GO:0031410; GO:0032496; GO:0032991; GO:0034334; GO:0036305; GO:0043066; GO:0043116; GO:0043296; GO:0044325; GO:0045177; GO:0045216; GO:0045471; GO:0046581; GO:0050839; GO:0051493; GO:0051497; GO:0070160; GO:0070830; GO:0071000; GO:0071253; GO:0071277; GO:0071333; GO:0071896; GO:0090557; GO:0098609; GO:0150105; GO:1901888; GO:1902396; GO:1903672; GO:1905605; GO:2000049; GO:2000810,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; adherens junction maintenance [GO:0034334]; ameloblast differentiation [GO:0036305]; bicellular tight junction assembly [GO:0070830]; blastocyst formation [GO:0001825]; cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cellular response to calcium ion [GO:0071277]; cellular response to glucose stimulus [GO:0071333]; establishment of endothelial intestinal barrier [GO:0090557]; negative regulation of apoptotic process [GO:0043066]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of vascular permeability [GO:0043116]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of sprouting angiogenesis [GO:1903672]; protein localization to adherens junction [GO:0071896]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell-cell junction [GO:0150105]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cell junction assembly [GO:1901888]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; intercalated disc [GO:0014704]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; tight junction [GO:0070160],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; connexin binding [GO:0071253]; kinase activity [GO:0016301]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0003824; GO:0005634; GO:0005886; GO:0007010; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,circulatory system process; catalytic activity; nucleus; plasma membrane; cytoskeleton organization; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_00079,FUN_000407-T2,Peve_00033597,Pocillopora_meandrina_HIv1___RNAseq.g2545.t1,three_way,54.79116666666667,FUN_000407-T2,Q92859,NEO1_HUMAN,,Neogenin (Immunoglobulin superfamily DCC subclass member 2),Homo sapiens (Human),29.2,991.0,3.1e-102,374.8,sp|Q92859|NEO1_HUMAN Neogenin OS=Homo sapiens OX=9606 GN=NEO1 PE=1 SV=2,GO:0001764; GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0006879; GO:0007155; GO:0007411; GO:0007520; GO:0009306; GO:0009986; GO:0030426; GO:0030513; GO:0038023; GO:0039706; GO:0045296; GO:0048681; GO:0050709; GO:0060586; GO:0070700; GO:0097708; GO:0098609; GO:0098797; GO:0098839; GO:0098978; GO:0099550,"axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; intracellular iron ion homeostasis [GO:0006879]; multicellular organismal-level iron ion homeostasis [GO:0060586]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; protein secretion [GO:0009306]; regulation of DNA-templated transcription [GO:0006355]; trans-synaptic signaling, modulating synaptic transmission [GO:0099550]",cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular vesicle [GO:0097708]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; postsynaptic density membrane [GO:0098839],BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023],GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0007155; GO:0023052; GO:0043226; GO:0048870; GO:0060089,nucleoplasm; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; cell adhesion; signaling; organelle; cell motility; molecular transducer activity
OG_00080,FUN_000408-T1,Peve_00033593,Pocillopora_meandrina_HIv1___RNAseq.g2518.t1,three_way,59.73233333333334,FUN_000408-T1,Q8BP40,,,,,33.6,390.0,5.7e-51,203.4,sp|Q8BP40|PPA6_MOUSE Lysophosphatidic acid phosphatase type 6 OS=Mus musculus OX=10090 GN=Acp6 PE=1 SV=1,,,,,,
OG_00081,FUN_000409-T1,Peve_00033505,Pocillopora_meandrina_HIv1___RNAseq.g2517.t1,three_way,55.74733333333334,FUN_000409-T1,Q6A044,,,,,26.9,312.0,9.8e-18,93.2,sp|Q6A044|EREP2_MOUSE Protein ENTREP2 OS=Mus musculus OX=10090 GN=Entrep2 PE=2 SV=3,,,,,,
OG_00082,FUN_000411-T1,Peve_00010961,Pocillopora_meandrina_HIv1___RNAseq.g2317.t1,three_way,32.01166666666666,,,,,,,,,,,,,,,,,
OG_00083,FUN_000413-T1,Peve_00010960,Pocillopora_meandrina_HIv1___RNAseq.13206_t,three_way,53.89533333333333,,,,,,,,,,,,,,,,,
OG_00084,FUN_000418-T1,Peve_00010959,Pocillopora_meandrina_HIv1___RNAseq.g2319.t1,three_way,57.719,FUN_000418-T1,P9WEI9,,,,,28.9,501.0,4.9e-43,177.2,sp|P9WEI9|CLAP_AMPCV Cytochrome P450 monooxygenase claP OS=Ampulloclitocybe clavipes OX=56467 GN=claP PE=3 SV=1,,,,,,
OG_00085,FUN_000433-T1,Peve_00011195,Pocillopora_meandrina_HIv1___RNAseq.g2325.t1,three_way,73.84433333333334,FUN_000433-T1,P26714,,,,,33.7,291.0,2.3e-51,204.9,sp|P26714|GBRB_LYMST Gamma-aminobutyric acid receptor subunit beta OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_00086,FUN_000437-T1,Peve_00011193,Pocillopora_meandrina_HIv1___RNAseq.g2323.t1,three_way,77.881,FUN_000437-T1,F1MNN4,FBXW7_BOVIN,,F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7),Bos taurus (Bovine),36.4,195.0,1.9999999999999998e-26,122.5,sp|F1MNN4|FBXW7_BOVIN F-box/WD repeat-containing protein 7 OS=Bos taurus OX=9913 GN=FBXW7 PE=1 SV=3,GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006281; GO:0006974; GO:0007062; GO:0010629; GO:0010992; GO:0019005; GO:0030332; GO:0031146; GO:0031398; GO:0031625; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992],chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0030163; GO:0043226; GO:0060090; GO:0098772,nucleus; nucleoplasm; chromosome; DNA repair; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_00087,FUN_000440-T1,Peve_00003439,Pocillopora_meandrina_HIv1___RNAseq.g2328.t2,three_way,87.82716666666667,FUN_000440-T1,P11029,,,,,63.2,2251.0,0.0,2921.0,sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1,,,,,,
OG_00088,FUN_000442-T1,Peve_00003435,Pocillopora_meandrina_HIv1___RNAseq.g2332.t2,three_way,63.138333333333335,FUN_000442-T1,Q9MYV9,,,,,27.2,312.0,1.8e-23,111.7,sp|Q9MYV9|TRPC5_BOVIN Short transient receptor potential channel 5 OS=Bos taurus OX=9913 GN=TRPC5 PE=2 SV=2,,,,,,
OG_00089,FUN_000445-T1,Peve_00019114,Pocillopora_meandrina_HIv1___RNAseq.g2334.t1,three_way,76.51133333333333,,,,,,,,,,,,,,,,,
OG_00090,FUN_000448-T1,Peve_00019115,Pocillopora_meandrina_HIv1___RNAseq.g2336.t1,three_way,72.33566666666667,FUN_000448-T1,Q8N945,,,,,42.6,176.0,6e-33,142.1,sp|Q8N945|PRLD2_HUMAN PRELI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PRELID2 PE=1 SV=1,,,,,,
OG_00091,FUN_000449-T1,Peve_00019109,Pocillopora_meandrina_HIv1___RNAseq.g2337.t1,three_way,66.32566666666666,FUN_000449-T1,Q64378,FKBP5_MOUSE,,Peptidyl-prolyl cis-trans isomerase FKBP5 (PPIase FKBP5) (EC 5.2.1.8) (51 kDa FK506-binding protein) (51 kDa FKBP) (FKBP-51) (FK506-binding protein 5) (FKBP-5) (Rotamase),Mus musculus (Mouse),33.8,272.0,1.4e-28,128.3,sp|Q64378|FKBP5_MOUSE Peptidyl-prolyl cis-trans isomerase FKBP5 OS=Mus musculus OX=10090 GN=Fkbp5 PE=1 SV=1,GO:0003755; GO:0005654; GO:0005829; GO:0009617; GO:0030674; GO:0031072; GO:0042220; GO:0061077; GO:0097305,chaperone-mediated protein folding [GO:0061077]; response to alcohol [GO:0097305]; response to bacterium [GO:0009617]; response to cocaine [GO:0042220],cytosol [GO:0005829]; nucleoplasm [GO:0005654],heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005654; GO:0005829; GO:0016853; GO:0060090; GO:0140096,"catalytic activity; nucleoplasm; cytosol; isomerase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_00092,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),34.1,695.0,4.9e-100,368.2,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00092,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),47.9,71.0,4.6e-13,79.3,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00093,FUN_000468-T1,Peve_00005612,Pocillopora_meandrina_HIv1___RNAseq.g2422.t1,three_way,58.0275,,,,,,,,,,,,,,,,,
OG_00094,FUN_000469-T1,Peve_00005611,Pocillopora_meandrina_HIv1___RNAseq.13309_t,three_way,77.3,,,,,,,,,,,,,,,,,
OG_00095,FUN_000470-T1,Peve_00005610,Pocillopora_meandrina_HIv1___RNAseq.g2424.t1,three_way,78.67266666666667,,,,,,,,,,,,,,,,,
OG_00096,FUN_000471-T1,Peve_00005607,Pocillopora_meandrina_HIv1___RNAseq.g2425.t1,three_way,86.9565,,,,,,,,,,,,,,,,,
OG_00097,FUN_000473-T1,Peve_00029194,Pocillopora_meandrina_HIv1___TS.g4857.t1,three_way,80.56,FUN_000473-T1,P63138,GBRB2_RAT,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Rattus norvegicus (Rat),33.3,465.0,9.6e-62,239.2,sp|P63138|GBRB2_RAT Gamma-aminobutyric acid receptor subunit beta-2 OS=Rattus norvegicus OX=10116 GN=Gabrb2 PE=1 SV=1,GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0007214; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0048666; GO:0048787; GO:0051932; GO:0060119; GO:0060384; GO:0071420; GO:0090102; GO:0098978; GO:0098982; GO:0099507; GO:0099634; GO:1902476; GO:1902710; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; neuron development [GO:0048666]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynaptic active zone membrane [GO:0048787],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; inhibitory extracellular ligand-gated monoatomic ion channel activity [GO:0005237]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; anatomical structure development; transmembrane transport; molecular transducer activity
OG_00098,FUN_000478-T1,Peve_00038239,Pocillopora_meandrina_HIv1___TS.g4854.t1,three_way,80.23833333333333,FUN_000478-T1,Q9BLY8,,,,,37.9,306.0,2.7e-57,224.6,sp|Q9BLY8|GBRB_DROSI Gamma-aminobutyric acid receptor subunit beta OS=Drosophila simulans OX=7240 GN=Rdl PE=2 SV=1,,,,,,
OG_00099,FUN_000482-T1,Peve_00038234,Pocillopora_meandrina_HIv1___RNAseq.g2344.t1,three_way,63.321333333333335,FUN_000482-T1,O88854,,,,,38.6,308.0,1.6999999999999998e-43,178.3,sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2,,,,,,
OG_00100,FUN_000483-T1,Peve_00038235,Pocillopora_meandrina_HIv1___RNAseq.g2342.t1,three_way,68.861,FUN_000483-T1,Q8CFV2,,,,,27.0,559.0,5.399999999999999e-31,137.5,sp|Q8CFV2|F149A_MOUSE Protein FAM149A OS=Mus musculus OX=10090 GN=Fam149a PE=2 SV=1,,,,,,
OG_00101,FUN_000487-T1,Peve_00038237,Pocillopora_meandrina_HIv1___RNAseq.g2341.t1,three_way,53.97383333333333,FUN_000487-T1,P47747,,,,,28.1,302.0,2.6e-17,91.3,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_00102,FUN_000488-T1,Peve_00038241,Pocillopora_meandrina_HIv1___RNAseq.g2338.t1,three_way,92.94666666666666,FUN_000488-T1,Q5E9E6,,,,,80.0,215.0,6.099999999999999e-96,351.7,sp|Q5E9E6|RL10A_BOVIN Large ribosomal subunit protein uL1 OS=Bos taurus OX=9913 GN=RPL10A PE=2 SV=3,,,,,,
OG_00103,FUN_000489-T1,Peve_00043825,Pocillopora_meandrina_HIv1___TS.g4918.t1,three_way,64.97083333333333,FUN_000489-T1,Q12923,,,,,26.7,2887.0,7.2e-210,733.8,sp|Q12923|PTN13_HUMAN Tyrosine-protein phosphatase non-receptor type 13 OS=Homo sapiens OX=9606 GN=PTPN13 PE=1 SV=2,,,,,,
OG_00104,FUN_000490-T1,Peve_00043823,Pocillopora_meandrina_HIv1___RNAseq.g2411.t1,three_way,66.018,,,,,,,,,,,,,,,,,
OG_00105,FUN_000497-T1,Peve_00011626,Pocillopora_meandrina_HIv1___RNAseq.g2412.t1,three_way,53.04466666666666,FUN_000497-T1,Q9BWV3,,,,,28.1,459.0,2.9999999999999998e-36,154.5,sp|Q9BWV3|CDAC1_HUMAN Cytidine and dCMP deaminase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CDADC1 PE=1 SV=1,,,,,,
OG_00106,FUN_000498-T1,Peve_00024154,Pocillopora_meandrina_HIv1___RNAseq.g2413.t1,three_way,61.16866666666667,FUN_000498-T1,Q8VHI4,,,,,47.4,340.0,1.9e-80,302.4,sp|Q8VHI4|CARTF_MOUSE Calcium-responsive transcription factor OS=Mus musculus OX=10090 GN=Carf PE=2 SV=1,,,,,,
OG_00107,FUN_000499-T1,Peve_00024155,Pocillopora_meandrina_HIv1___RNAseq.g2414.t1,three_way,82.06683333333332,FUN_000499-T1,Q14432,PDE3A_HUMAN,,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)",Homo sapiens (Human),37.6,1034.0,2.2e-143,511.5,"sp|Q14432|PDE3A_HUMAN cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A OS=Homo sapiens OX=9606 GN=PDE3A PE=1 SV=3",GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0019933; GO:0019934; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072; GO:0141162,apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; membrane [GO:0016020],"3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284]",GO:0003013; GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0022414; GO:0060089; GO:0140110,circulatory system process; catalytic activity; cytosol; lipid metabolic process; hydrolase activity; reproductive process; molecular transducer activity; transcription regulator activity
OG_00108,FUN_000500-T1,Peve_00043826,Pocillopora_meandrina_HIv1___RNAseq.g2407.t1,three_way,79.243,FUN_000500-T1,Q58DN3,,,,,49.8,263.0,5.1e-68,259.2,sp|Q58DN3|TSN17_BOVIN Tetraspanin-17 OS=Bos taurus OX=9913 GN=TSPAN17 PE=1 SV=1,,,,,,
OG_00109,FUN_000501-T1,Peve_00043828,Pocillopora_meandrina_HIv1___RNAseq.g2406.t1,three_way,59.06433333333334,FUN_000501-T1,P11616,,,,,23.7,299.0,1.8e-08,61.6,sp|P11616|AA1R_CANLF Adenosine receptor A1 OS=Canis lupus familiaris OX=9615 GN=ADORA1 PE=2 SV=1,,,,,,
OG_00110,FUN_000502-T1,Peve_00043829,Pocillopora_meandrina_HIv1___RNAseq.g2405.t1,three_way,90.132,FUN_000502-T1,Q13557,,,,,65.7,478.0,3.1000000000000007e-180,632.9,sp|Q13557|KCC2D_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Homo sapiens OX=9606 GN=CAMK2D PE=1 SV=3,,,,,,
OG_00111,FUN_000503-T1,Peve_00043531,Pocillopora_meandrina_HIv1___RNAseq.g18598.t1,three_way,56.31033333333333,,,,,,,,,,,,,,,,,
OG_00112,FUN_000510-T1,Peve_00029232,Pocillopora_meandrina_HIv1___TS.g4915.t1,three_way,63.69983333333333,,,,,,,,,,,,,,,,,
OG_00113,FUN_000511-T1,Peve_00029231,Pocillopora_meandrina_HIv1___RNAseq.g2404.t1,three_way,60.635333333333335,,,,,,,,,,,,,,,,,
OG_00114,FUN_000531-T1,Peve_00008085,Pocillopora_meandrina_HIv1___RNAseq.g27136.t1,three_way,60.4415,FUN_000531-T1,P22671,,,,,27.0,293.0,3.3e-28,127.5,sp|P22671|OPSD_LETCA Rhodopsin OS=Lethenteron camtschaticum OX=980415 GN=RHO PE=2 SV=1,,,,,,
OG_00115,FUN_000533-T1,Peve_00039811,Pocillopora_meandrina_HIv1___RNAseq.g2384.t1,three_way,81.9405,FUN_000533-T1,P20693,,,,,34.0,147.0,3.6e-17,94.0,sp|P20693|FCER2_MOUSE Low affinity immunoglobulin epsilon Fc receptor OS=Mus musculus OX=10090 GN=Fcer2 PE=1 SV=1,,,,,,
OG_00116,FUN_000534-T1,Peve_00039809,Pocillopora_meandrina_HIv1___TS.g4886.t2,three_way,79.79933333333334,FUN_000534-T1,O75386,TULP3_HUMAN,,Tubby-related protein 3 (Tubby-like protein 3),Homo sapiens (Human),44.4,342.0,1.1e-60,235.3,sp|O75386|TULP3_HUMAN Tubby-related protein 3 OS=Homo sapiens OX=9606 GN=TULP3 PE=1 SV=2,GO:0001664; GO:0001843; GO:0005546; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005886; GO:0005929; GO:0005930; GO:0006355; GO:0007186; GO:0007420; GO:0008277; GO:0009952; GO:0019899; GO:0021953; GO:0031076; GO:0035091; GO:0036064; GO:0042733; GO:0044877; GO:0045879; GO:0048702; GO:0060348; GO:0060434; GO:0060831; GO:0061512; GO:0061548; GO:0097546; GO:0097731; GO:0120160,anterior/posterior pattern specification [GO:0009952]; bone development [GO:0060348]; brain development [GO:0007420]; bronchus morphogenesis [GO:0060434]; central nervous system neuron differentiation [GO:0021953]; embryonic camera-type eye development [GO:0031076]; embryonic digit morphogenesis [GO:0042733]; embryonic neurocranium morphogenesis [GO:0048702]; G protein-coupled receptor signaling pathway [GO:0007186]; ganglion development [GO:0061548]; negative regulation of smoothened signaling pathway [GO:0045879]; neural tube closure [GO:0001843]; protein localization to cilium [GO:0061512]; regulation of DNA-templated transcription [GO:0006355]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],9+0 non-motile cilium [GO:0097731]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; extracellular region [GO:0005576]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; intraciliary transport particle A binding [GO:0120160]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]",GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0008289; GO:0030154; GO:0043226; GO:0048856,extracellular region; nucleus; nucleoplasm; nucleolus; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; lipid binding; cell differentiation; organelle; anatomical structure development
OG_00117,FUN_000535-T1,Peve_00039805,Pocillopora_meandrina_HIv1___TS.g4883.t1,three_way,45.208,FUN_000535-T1,Q9Z2D7,,,,,27.8,399.0,2.5e-21,104.4,sp|Q9Z2D7|MBD4_MOUSE Methyl-CpG-binding domain protein 4 OS=Mus musculus OX=10090 GN=Mbd4 PE=1 SV=1,,,,,,
OG_00118,FUN_000536-T1,Peve_00039803,Pocillopora_meandrina_HIv1___TS.g4882.t1,three_way,81.95033333333333,FUN_000536-T1,Q921G8,,,,,55.2,944.0,5.600000000000001e-277,955.3,sp|Q921G8|GCP2_MOUSE Gamma-tubulin complex component 2 OS=Mus musculus OX=10090 GN=Tubgcp2 PE=1 SV=2,,,,,,
OG_00119,FUN_000537-T1,Peve_00039797,Pocillopora_meandrina_HIv1___RNAseq.g2375.t1,three_way,66.51866666666668,FUN_000537-T1,Q56A06,,,,,51.3,710.0,5.7e-140,500.0,sp|Q56A06|TMTC2_MOUSE Protein O-mannosyl-transferase TMTC2 OS=Mus musculus OX=10090 GN=Tmtc2 PE=2 SV=1,,,,,,
OG_00120,FUN_000538-T1,Peve_00039795,Pocillopora_meandrina_HIv1___RNAseq.g2374.t1,three_way,66.395,,,,,,,,,,,,,,,,,
OG_00121,FUN_000541-T1,Peve_00039832,Pocillopora_meandrina_HIv1___RNAseq.g2372.t1,three_way,65.99066666666667,FUN_000541-T1,P47747,,,,,24.9,301.0,9.8e-07,56.2,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_00122,FUN_000542-T1,Peve_00039829,Pocillopora_meandrina_HIv1___RNAseq.g2370.t1,three_way,61.55866666666667,FUN_000542-T1,P40657,,,,,45.3,148.0,5.2e-26,120.2,sp|P40657|SOX15_DROME Putative transcription factor SOX-15 OS=Drosophila melanogaster OX=7227 GN=Sox15 PE=2 SV=2,,,,,,
OG_00123,FUN_000544-T1,Peve_00039828,Pocillopora_meandrina_HIv1___RNAseq.g2369.t1,three_way,76.021,FUN_000544-T1,Q8IY45,,,,,52.4,252.0,2.1e-39,164.1,sp|Q8IY45|AMN1_HUMAN Protein AMN1 homolog OS=Homo sapiens OX=9606 GN=AMN1 PE=1 SV=4,,,,,,
OG_00124,FUN_000545-T1,Peve_00039827,Pocillopora_meandrina_HIv1___RNAseq.g2368.t1,three_way,90.48633333333332,FUN_000545-T1,Q9Y315,DEOC_HUMAN,,Deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase),Homo sapiens (Human),67.6,321.0,1.5999999999999999e-127,457.2,sp|Q9Y315|DEOC_HUMAN Deoxyribose-phosphate aldolase OS=Homo sapiens OX=9606 GN=DERA PE=1 SV=2,GO:0004139; GO:0005576; GO:0005654; GO:0005829; GO:0006098; GO:0009264; GO:0016052; GO:0034774; GO:0046121; GO:0046386; GO:1904813,carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386]; pentose-phosphate shunt [GO:0006098],cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; secretory granule lumen [GO:0034774],deoxyribose-phosphate aldolase activity [GO:0004139],GO:0003824; GO:0005576; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0016829; GO:0055086; GO:1901135,catalytic activity; extracellular region; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; lyase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00125,FUN_000549-T1,Peve_00035147,Pocillopora_meandrina_HIv1___RNAseq.g17849.t1,three_way,56.6745,FUN_000549-T1,Q5FVH4,AKTIP_RAT,,AKT-interacting protein (Fused toes protein homolog),Rattus norvegicus (Rat),37.8,135.0,3.5000000000000005e-22,106.7,sp|Q5FVH4|AKTIP_RAT AKT-interacting protein OS=Rattus norvegicus OX=10116 GN=Aktip PE=1 SV=1,GO:0005634; GO:0005886; GO:0006301; GO:0006915; GO:0007032; GO:0007040; GO:0008333; GO:0015031; GO:0030897; GO:0045022; GO:0061631; GO:0070534; GO:0070695; GO:1905719,apoptotic process [GO:0006915]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031],FHF complex [GO:0070695]; HOPS complex [GO:0030897]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0005886; GO:0006281; GO:0007040; GO:0012501; GO:0016192; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; DNA repair; lysosome organization; programmed cell death; vesicle-mediated transport; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00126,FUN_000550-T1,Peve_00039823,Pocillopora_meandrina_HIv1___RNAseq.g2362.t1,three_way,66.874,FUN_000550-T1,Q923Y6,,,,,23.8,332.0,7.3e-11,69.7,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_00127,FUN_000554-T1,Peve_00039816,Pocillopora_meandrina_HIv1___RNAseq.g2466.t1,three_way,58.334,,,,,,,,,,,,,,,,,
OG_00128,FUN_000555-T1,Peve_00039814,Pocillopora_meandrina_HIv1___RNAseq.g2464.t1,three_way,43.77966666666666,,,,,,,,,,,,,,,,,
OG_00129,FUN_000556-T1,Peve_00039813,Pocillopora_meandrina_HIv1___RNAseq.g2463.t1,three_way,76.964,FUN_000556-T1,P47747,,,,,27.6,322.0,1.8e-17,91.7,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_00130,FUN_000559-T1,Peve_00010241,Pocillopora_meandrina_HIv1___RNAseq.g2460.t1,three_way,74.06333333333333,FUN_000559-T1,Q14247,SRC8_HUMAN,,Src substrate cortactin (Amplaxin) (Oncogene EMS1),Homo sapiens (Human),65.2,66.0,8.9e-19,96.7,sp|Q14247|SRC8_HUMAN Src substrate cortactin OS=Homo sapiens OX=9606 GN=CTTN PE=1 SV=2,GO:0001726; GO:0002102; GO:0005522; GO:0005737; GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005884; GO:0005886; GO:0005905; GO:0005925; GO:0005938; GO:0006886; GO:0006898; GO:0006930; GO:0007165; GO:0008076; GO:0030027; GO:0030036; GO:0030139; GO:0030426; GO:0030516; GO:0030838; GO:0030863; GO:0043197; GO:0043231; GO:0045296; GO:0045987; GO:0048041; GO:0048812; GO:0048870; GO:0050921; GO:0060491; GO:0070064; GO:0071933; GO:0097062; GO:0097191; GO:0097581; GO:0098871; GO:0098885; GO:0098978; GO:1901524; GO:1990023; GO:2001237,"actin cytoskeleton organization [GO:0030036]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of chemotaxis [GO:0050921]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of cell projection assembly [GO:0060491]; regulation of mitophagy [GO:1901524]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]",actin filament [GO:0005884]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic actin cytoskeleton [GO:0098871]; ruffle [GO:0001726]; voltage-gated potassium channel complex [GO:0008076],Arp2/3 complex binding [GO:0071933]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; proline-rich region binding [GO:0070064],GO:0005783; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007010; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0048870,endoplasmic reticulum; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; intracellular protein transport; cytoskeleton organization; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; cell motility
OG_00131,FUN_000562-T1,Peve_00041890,Pocillopora_meandrina_HIv1___RNAseq.g2459.t1,three_way,63.26266666666667,FUN_000562-T1,Q149M9,,,,,31.4,969.0,3.3000000000000006e-111,405.2,sp|Q149M9|NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=NWD1 PE=1 SV=3,,,,,,
OG_00132,FUN_000563-T1,Peve_00041882,Pocillopora_meandrina_HIv1___RNAseq.g2457.t1,three_way,50.783,,,,,,,,,,,,,,,,,
OG_00133,FUN_000564-T1,Peve_00041880,Pocillopora_meandrina_HIv1___TS.g4968.t1,three_way,70.89666666666666,,,,,,,,,,,,,,,,,
OG_00134,FUN_000568-T1,Peve_00034143,Pocillopora_meandrina_HIv1___RNAseq.g2453.t1,three_way,59.7515,FUN_000568-T1,Q99816,TS101_HUMAN,,Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101),Homo sapiens (Human),36.5,307.0,9.999999999999999e-31,135.6,sp|Q99816|TS101_HUMAN Tumor susceptibility gene 101 protein OS=Homo sapiens OX=9606 GN=TSG101 PE=1 SV=2,GO:0000122; GO:0000813; GO:0001558; GO:0003677; GO:0003714; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005770; GO:0005771; GO:0005813; GO:0005829; GO:0005886; GO:0006858; GO:0007175; GO:0008285; GO:0008333; GO:0010008; GO:0016236; GO:0019076; GO:0030216; GO:0031625; GO:0031901; GO:0031902; GO:0036211; GO:0036258; GO:0039702; GO:0042059; GO:0042803; GO:0043130; GO:0043162; GO:0043328; GO:0043405; GO:0044877; GO:0046755; GO:0046790; GO:0048306; GO:0051301; GO:0051726; GO:0070062; GO:0090148; GO:0090543; GO:0097352; GO:1903543; GO:1903551; GO:1903774; GO:1990182; GO:2000397,autophagosome maturation [GO:0097352]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein modification process [GO:0036211]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790],GO:0003677; GO:0005730; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0006914; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0140110,DNA binding; nucleolus; endosome; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; autophagy; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; transcription regulator activity
OG_00135,FUN_000569-T1,Peve_00034755,Pocillopora_meandrina_HIv1___RNAseq.g2452.t1,three_way,73.191,FUN_000569-T1,Q9CXF4,,,,,39.4,632.0,6.3e-121,436.4,sp|Q9CXF4|TBC15_MOUSE TBC1 domain family member 15 OS=Mus musculus OX=10090 GN=Tbc1d15 PE=1 SV=1,,,,,,
OG_00136,FUN_000570-T1,Peve_00034728,Pocillopora_meandrina_HIv1___RNAseq.g2451.t1,three_way,62.78066666666667,,,,,,,,,,,,,,,,,
OG_00137,FUN_000574-T1,Peve_00034745,Pocillopora_meandrina_HIv1___TS.g4950.t1,three_way,68.503,FUN_000574-T1,Q54KD0,,,,,25.7,904.0,1.7e-76,289.7,sp|Q54KD0|Y7407_DICDI TPR repeat-containing protein DDB_G0287407 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0287407 PE=4 SV=1,,,,,,
OG_00138,FUN_000576-T1,Peve_00034748,Pocillopora_meandrina_HIv1___RNAseq.g2437.t1,three_way,77.08166666666666,FUN_000576-T1,Q9Z2D5,,,,,34.0,247.0,6.199999999999998e-29,129.4,sp|Q9Z2D5|NPY2R_CAVPO Neuropeptide Y receptor type 2 OS=Cavia porcellus OX=10141 GN=NPY2R PE=3 SV=1,,,,,,
OG_00139,FUN_000577-T1,Peve_00034749,Pocillopora_meandrina_HIv1___RNAseq.g2436.t1,three_way,60.07216666666667,,,,,,,,,,,,,,,,,
OG_00140,FUN_000578-T1,Peve_00034754,Pocillopora_meandrina_HIv1___TS.g4935.t1,three_way,56.79733333333333,FUN_000578-T1,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),45.6,329.0,2.2e-68,262.3,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_00141,FUN_000580-T1,Peve_00034764,Pocillopora_meandrina_HIv1___RNAseq.g29301.t1,three_way,44.83516666666667,FUN_000580-T1,Q7KM13,,,,,30.5,164.0,6.6e-08,60.5,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_00142,FUN_000582-T1,Peve_00034702,Pocillopora_meandrina_HIv1___TS.g6501.t1,three_way,59.576166666666666,FUN_000582-T1,D2X8K2,PA2_CONGI,,Phospholipase A2 A2-actitoxin-Cgg2a (A2-AITX-Cgg2a) (EC 3.1.1.4) (CgPLA2) (Phosphatidylcholine 2-acylhydrolase),Condylactis gigantea (Giant Caribbean anemone) (Condylactis passiflora),43.7,119.0,3.5e-25,116.3,sp|D2X8K2|PA2_CONGI Phospholipase A2 A2-actitoxin-Cgg2a OS=Condylactis gigantea OX=47073 PE=1 SV=1,GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0042151; GO:0044398; GO:0044470; GO:0044522; GO:0047498; GO:0050482; GO:0090729,arachidonate secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; venom-mediated edema in another organism [GO:0044398]; venom-mediated myocyte killing in another organism [GO:0044522]; venom-mediated suppression of blood coagulation [GO:0044470],extracellular region [GO:0005576]; nematocyst [GO:0042151],calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; toxin activity [GO:0090729],GO:0003824; GO:0005576; GO:0006629; GO:0008289; GO:0016787; GO:0043226; GO:0090729,catalytic activity; extracellular region; lipid metabolic process; lipid binding; hydrolase activity; organelle; toxin activity
OG_00143,FUN_000585-T1,Peve_00034705,Pocillopora_meandrina_HIv1___RNAseq.g29297.t1,three_way,50.52733333333334,FUN_000585-T1,Q6TLH3,,,,,33.4,326.0,2.6999999999999997e-31,137.5,sp|Q6TLH3|CUED2_DANRE CUE domain-containing protein 2 OS=Danio rerio OX=7955 GN=cuedc2 PE=2 SV=1,,,,,,
OG_00144,FUN_000586-T1,Peve_00025314,Pocillopora_meandrina_HIv1___TS.g6498.t2,three_way,63.92666666666666,FUN_000586-T1,O00339,MATN2_HUMAN,,Matrilin-2,Homo sapiens (Human),30.2,192.0,2.3e-14,82.4,sp|O00339|MATN2_HUMAN Matrilin-2 OS=Homo sapiens OX=9606 GN=MATN2 PE=1 SV=4,GO:0001764; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0007411; GO:0008347; GO:0030198; GO:0031012; GO:0031104; GO:0048678; GO:0062023; GO:0120216,axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; extracellular matrix organization [GO:0030198]; glial cell migration [GO:0008347]; neuron migration [GO:0001764]; response to axon injury [GO:0048678],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; matrilin complex [GO:0120216],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0048870,structural molecule activity; extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; cell motility
OG_00145,FUN_000588-T1,Peve_00025320,Pocillopora_meandrina_HIv1___RNAseq.g29293.t3,three_way,87.40333333333334,FUN_000588-T1,P28347,TEAD1_HUMAN,,Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13),Homo sapiens (Human),65.6,450.0,3.6000000000000002e-146,519.6,sp|P28347|TEAD1_HUMAN Transcriptional enhancer factor TEF-1 OS=Homo sapiens OX=9606 GN=TEAD1 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0030307; GO:0035329; GO:0045893; GO:0045944; GO:0048568; GO:0065003; GO:0140552; GO:1902895; GO:1990837,embryonic organ development [GO:0048568]; hippo signaling [GO:0035329]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_00146,FUN_000591-T1,Peve_00025321,Pocillopora_meandrina_HIv1___RNAseq.g29291.t1,three_way,71.13566666666667,,,,,,,,,,,,,,,,,
OG_00147,FUN_000592-T1,Peve_00025298,Pocillopora_meandrina_HIv1___RNAseq.g29290.t1,three_way,64.05,,,,,,,,,,,,,,,,,
OG_00148,FUN_000593-T1,Peve_00025299,Pocillopora_meandrina_HIv1___RNAseq.g29289.t1,three_way,64.65866666666666,,,,,,,,,,,,,,,,,
OG_00149,FUN_000595-T1,Peve_00041242,Pocillopora_meandrina_HIv1___RNAseq.g29286.t2,three_way,74.10266666666666,FUN_000595-T1,Q9DB41,,,,,53.4,313.0,5.4e-80,299.3,sp|Q9DB41|GHC2_MOUSE Mitochondrial glutamate carrier 2 OS=Mus musculus OX=10090 GN=Slc25a18 PE=1 SV=4,,,,,,
OG_00150,FUN_000596-T1,Peve_00041271,Pocillopora_meandrina_HIv1___RNAseq.g29285.t1,three_way,84.07066666666667,FUN_000596-T1,P36543,VATE1_HUMAN,,V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (p31) (Vacuolar proton pump subunit E 1),Homo sapiens (Human),61.9,226.0,6.7e-69,261.9,sp|P36543|VATE1_HUMAN V-type proton ATPase subunit E 1 OS=Homo sapiens OX=9606 GN=ATP6V1E1 PE=1 SV=1,GO:0000221; GO:0005765; GO:0005768; GO:0005829; GO:0005902; GO:0016241; GO:0016324; GO:0016469; GO:0030665; GO:0030672; GO:0046961; GO:0051117; GO:0070062; GO:0097401; GO:1902600,proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401],"apical plasma membrane [GO:0016324]; clathrin-coated vesicle membrane [GO:0030665]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; proton-transporting two-sector ATPase complex [GO:0016469]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V1 domain [GO:0000221]","ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0005768; GO:0005829; GO:0031410; GO:0043226; GO:0055085; GO:0140657,transporter activity; endosome; cytosol; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_00151,FUN_000597-T1,Peve_00041252,Pocillopora_meandrina_HIv1___RNAseq.g29284.t1,three_way,56.596,,,,,,,,,,,,,,,,,
OG_00152,FUN_000606-T1,Peve_00041267,Pocillopora_meandrina_HIv1___RNAseq.13383_t,three_way,76.453,FUN_000606-T1,Q9DA37,SAMD8_MOUSE,,Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8),Mus musculus (Mouse),52.1,411.0,1.9e-114,414.1,sp|Q9DA37|SAMD8_MOUSE Sphingomyelin synthase-related protein 1 OS=Mus musculus OX=10090 GN=Samd8 PE=1 SV=1,GO:0002950; GO:0005789; GO:0006686; GO:0016020; GO:0046513; GO:1905373; GO:2000303,ceramide biosynthetic process [GO:0046513]; ceramide phosphoethanolamine biosynthetic process [GO:1905373]; regulation of ceramide biosynthetic process [GO:2000303]; sphingomyelin biosynthetic process [GO:0006686],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],ceramide phosphoethanolamine synthase activity [GO:0002950],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_00153,FUN_000607-T1,Peve_00041268,Pocillopora_meandrina_HIv1___RNAseq.g2497.t1,three_way,77.315,FUN_000607-T1,Q16543,,,,,63.4,372.0,2.3e-90,334.0,sp|Q16543|CDC37_HUMAN Hsp90 co-chaperone Cdc37 OS=Homo sapiens OX=9606 GN=CDC37 PE=1 SV=1,,,,,,
OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),47.8,912.0,6.4999999999999985e-229,796.2,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_00154,FUN_000608-T1,Peve_00041270,Pocillopora_meandrina_HIv1___RNAseq.g2496.t1,three_way,75.2995,FUN_000608-T1,G3MWR8,MICA3_BOVIN,,[F-actin]-monooxygenase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),Bos taurus (Bovine),37.4,286.0,1.3e-27,127.5,sp|G3MWR8|MICA3_BOVIN [F-actin]-monooxygenase MICAL3 OS=Bos taurus OX=9913 GN=MICAL3 PE=3 SV=1,GO:0003779; GO:0005634; GO:0005819; GO:0005938; GO:0006887; GO:0007010; GO:0016709; GO:0030042; GO:0030496; GO:0042995; GO:0046872; GO:0071949; GO:0120501,actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887],cell cortex [GO:0005938]; cell projection [GO:0042995]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005634; GO:0007010; GO:0008092; GO:0016192; GO:0016491; GO:0043226,catalytic activity; nucleus; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; oxidoreductase activity; organelle
OG_00155,FUN_000609-T1,Peve_00013321,Pocillopora_meandrina_HIv1___RNAseq.g1721.t1,three_way,64.93366666666667,,,,,,,,,,,,,,,,,
OG_00156,FUN_000610-T1,Peve_00013320,Pocillopora_meandrina_HIv1___RNAseq.g1720.t1,three_way,70.32433333333333,,,,,,,,,,,,,,,,,
OG_00157,FUN_000612-T1,Peve_00023943,Pocillopora_meandrina_HIv1___RNAseq.g1719.t1,three_way,81.25433333333334,FUN_000612-T1,Q8N7B6,PACRL_HUMAN,,PACRG-like protein,Homo sapiens (Human),61.2,206.0,1.6e-61,237.3,sp|Q8N7B6|PACRL_HUMAN PACRG-like protein OS=Homo sapiens OX=9606 GN=PACRGL PE=1 SV=2,,,,,,
OG_00158,FUN_000614-T1,Peve_00036774,Pocillopora_meandrina_HIv1___RNAseq.g1715.t1,three_way,67.67916666666667,FUN_000614-T1,Q5ZLL7,,,,,44.8,397.0,5.2999999999999996e-92,340.1,sp|Q5ZLL7|WDR91_CHICK WD repeat-containing protein 91 OS=Gallus gallus OX=9031 GN=WDR91 PE=2 SV=1,,,,,,
OG_00159,FUN_000616-T1,Peve_00036773,Pocillopora_meandrina_HIv1___RNAseq.g1713.t1,three_way,72.57533333333333,FUN_000616-T1,P31729,,,,,58.0,162.0,2.7e-51,203.0,sp|P31729|OV16_ONCVO OV-16 antigen OS=Onchocerca volvulus OX=6282 GN=OV16 PE=2 SV=2,,,,,,
OG_00160,FUN_000617-T3,Peve_00036770,Pocillopora_meandrina_HIv1___RNAseq.g1710.t1,three_way,72.46133333333333,FUN_000617-T3,Q9Y3Q0,NALD2_HUMAN,,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),Homo sapiens (Human),41.7,762.0,2.4e-155,550.8,sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129,carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508],membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_00161,FUN_000618-T1,Peve_00043948,Pocillopora_meandrina_HIv1___TS.g4276.t2,three_way,66.084,FUN_000618-T1,Q6DRN3,NOC3L_DANRE,,Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein),Danio rerio (Zebrafish) (Brachydanio rerio),39.2,694.0,9.7e-120,432.6,sp|Q6DRN3|NOC3L_DANRE Nucleolar complex protein 3 homolog OS=Danio rerio OX=7955 GN=noc3l PE=2 SV=1,GO:0003682; GO:0005634; GO:0005730; GO:0006270; GO:0007517; GO:0019216,DNA replication initiation [GO:0006270]; muscle organ development [GO:0007517]; regulation of lipid metabolic process [GO:0019216],nucleolus [GO:0005730]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005730; GO:0043226; GO:0048856,nucleus; nucleolus; organelle; anatomical structure development
OG_00162,FUN_000620-T1,Peve_00017114,Pocillopora_meandrina_HIv1___RNAseq.g1866.t1,three_way,76.233,FUN_000620-T1,O95427,PIGN_HUMAN,,GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (GPI-ethanolamine transferase I) (GPI-ETI) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N),Homo sapiens (Human),53.5,939.0,5.1999999999999995e-264,912.1,sp|O95427|PIGN_HUMAN GPI ethanolamine phosphate transferase 1 OS=Homo sapiens OX=9606 GN=PIGN PE=1 SV=1,GO:0005789; GO:0005829; GO:0005886; GO:0006506; GO:0016020; GO:0051377,GPI anchor biosynthetic process [GO:0006506],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],mannose-ethanolamine phosphotransferase activity [GO:0051377],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016740; GO:1901135,catalytic activity; cytosol; plasma membrane; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_00163,FUN_000637-T1,Peve_00012867,Pocillopora_meandrina_HIv1___RNAseq.g16016.t1,three_way,83.68833333333333,FUN_000637-T1,O97125,,,,,74.2,613.0,9.1e-265,914.1,sp|O97125|HSP68_DROME Heat shock protein 68 OS=Drosophila melanogaster OX=7227 GN=Hsp68 PE=1 SV=1,,,,,,
OG_00164,FUN_000639-T1,Peve_00011494,Pocillopora_meandrina_HIv1___RNAseq.g1868.t2,three_way,79.212,FUN_000639-T1,Q9EQQ9,,,,,39.0,918.0,1.2000000000000001e-180,635.2,sp|Q9EQQ9|OGA_MOUSE Protein O-GlcNAcase OS=Mus musculus OX=10090 GN=Oga PE=1 SV=2,,,,,,
OG_00165,FUN_000640-T1,Peve_00030248,Pocillopora_meandrina_HIv1___RNAseq.g1812.t1,three_way,61.307,,,,,,,,,,,,,,,,,
OG_00166,FUN_000641-T1,Peve_00012249,Pocillopora_meandrina_HIv1___TS.g17921.t4,three_way,55.0825,FUN_000641-T1,A6QLA0,,,,,45.6,780.0,1.1e-188,662.1,sp|A6QLA0|NFX1_BOVIN Transcriptional repressor NF-X1 OS=Bos taurus OX=9913 GN=NFX1 PE=2 SV=1,,,,,,
OG_00167,FUN_000643-T2,Peve_00029422,Pocillopora_meandrina_HIv1___RNAseq.g1780.t1,three_way,52.015,FUN_000643-T2,Q8TF61,,,,,39.0,326.0,3.4e-57,225.3,sp|Q8TF61|FBX41_HUMAN F-box only protein 41 OS=Homo sapiens OX=9606 GN=FBXO41 PE=1 SV=5,,,,,,
OG_00168,FUN_000644-T1,Peve_00029424,Pocillopora_meandrina_HIv1___RNAseq.g1779.t1,three_way,59.83833333333333,FUN_000644-T1,Q9VUL9,FUCTA_DROME,,"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)",Drosophila melanogaster (Fruit fly),37.7,305.0,9.5e-51,202.2,sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2,GO:0005797; GO:0006486; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0036065; GO:0036071; GO:0046920,fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279],Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797],alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392],GO:0003824; GO:0006486; GO:0009101; GO:0016740; GO:0048856; GO:0140096; GO:1901135,"catalytic activity; protein glycosylation; glycoprotein biosynthetic process; transferase activity; anatomical structure development; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_00169,FUN_000645-T1,Peve_00029425,Pocillopora_meandrina_HIv1___RNAseq.g1773.t1,three_way,56.251666666666665,FUN_000645-T1,E7F7V7,,,,,24.4,316.0,2e-06,55.1,sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1,,,,,,
OG_00170,FUN_000856-T1,Peve_00017112,Pocillopora_meandrina_HIv1___RNAseq.g1864.t1,three_way,77.68833333333333,FUN_000856-T1,Q0VBU9,PLPP4_MOUSE,,Phospholipid phosphatase 4 (EC 3.1.3.4) (EC 3.6.1.75),Mus musculus (Mouse),51.3,230.0,3.6999999999999996e-68,259.6,sp|Q0VBU9|PLPP4_MOUSE Phospholipid phosphatase 4 OS=Mus musculus OX=10090 GN=Plpp4 PE=2 SV=1,GO:0000810; GO:0001835; GO:0006644; GO:0008195; GO:0016020; GO:0042802; GO:0046839; GO:0090279,blastocyst hatching [GO:0001835]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; regulation of calcium ion import [GO:0090279],membrane [GO:0016020],diacylglycerol diphosphate phosphatase activity [GO:0000810]; identical protein binding [GO:0042802]; phosphatidate phosphatase activity [GO:0008195],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_00171,FUN_000857-T1,Peve_00004526,Pocillopora_meandrina_HIv1___RNAseq.g1863.t1,three_way,95.30166666666666,FUN_000857-T1,P61162,,,,,85.9,376.0,7.4e-198,691.0,sp|P61162|ACTZ_CANLF Alpha-centractin OS=Canis lupus familiaris OX=9615 GN=ACTR1A PE=2 SV=1,,,,,,
OG_00172,FUN_000859-T2,Peve_00004524,Pocillopora_meandrina_HIv1___RNAseq.g1862.t1,three_way,78.86366666666667,FUN_000859-T2,Q13724,,,,,44.4,752.0,2.1000000000000001e-184,647.5,sp|Q13724|MOGS_HUMAN Mannosyl-oligosaccharide glucosidase OS=Homo sapiens OX=9606 GN=MOGS PE=1 SV=5,,,,,,
OG_00173,FUN_000861-T1,Peve_00004523,Pocillopora_meandrina_HIv1___RNAseq.g1861.t1,three_way,52.99133333333333,,,,,,,,,,,,,,,,,
OG_00174,FUN_000862-T1,Peve_00004534,Pocillopora_meandrina_HIv1___RNAseq.g1860.t1,three_way,73.89966666666666,FUN_000862-T1,Q9NTM9,CUTC_HUMAN,,Copper homeostasis protein cutC homolog,Homo sapiens (Human),62.0,245.0,3.3e-85,316.2,sp|Q9NTM9|CUTC_HUMAN Copper homeostasis protein cutC homolog OS=Homo sapiens OX=9606 GN=CUTC PE=1 SV=1,GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070,copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],copper ion binding [GO:0005507],GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0043226; GO:0065003,nucleus; nucleoplasm; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_00175,FUN_000863-T1,Peve_00004533,Pocillopora_meandrina_HIv1___RNAseq.g1859.t1,three_way,58.988,,,,,,,,,,,,,,,,,
OG_00176,FUN_000867-T1,Peve_00021321,Pocillopora_meandrina_HIv1___RNAseq.g1836.t1,three_way,73.21166666666667,FUN_000867-T1,P14272,KLKB1_RAT,,Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain],Rattus norvegicus (Rat),32.8,238.0,4.200000000000001e-33,144.1,sp|P14272|KLKB1_RAT Plasma kallikrein OS=Rattus norvegicus OX=10116 GN=Klkb1 PE=1 SV=1,GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0051919; GO:0097421,blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; liver regeneration [GO:0097421]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919],extracellular space [GO:0005615],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005615; GO:0006954; GO:0016787; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular space; inflammatory response; hydrolase activity; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_00177,FUN_000870-T1,Peve_00002066,Pocillopora_meandrina_HIv1___RNAseq.g1813.t1,three_way,92.69433333333332,FUN_000870-T1,P55039,DRG2_HUMAN,,Developmentally-regulated GTP-binding protein 2 (DRG-2) (Translation factor GTPase DRG2) (TRAFAC GTPase DRG2) (EC 3.6.5.-),Homo sapiens (Human),78.6,364.0,2.1000000000000002e-165,583.2,sp|P55039|DRG2_HUMAN Developmentally-regulated GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=DRG2 PE=1 SV=1,GO:0002181; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0016020; GO:0043231; GO:0046872,cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],GO:0002181; GO:0003723; GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226,cytoplasmic translation; RNA binding; catalytic activity; GTPase activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle
OG_00178,FUN_000871-T1,Peve_00002056,Pocillopora_meandrina_HIv1___RNAseq.g1814.t1,three_way,62.229,FUN_000871-T1,A6QPC8,,,,,34.4,323.0,5.6e-35,149.8,sp|A6QPC8|EID3_BOVIN EP300-interacting inhibitor of differentiation 3 OS=Bos taurus OX=9913 GN=EID3 PE=2 SV=1,,,,,,
OG_00179,FUN_000872-T1,Peve_00002057,Pocillopora_meandrina_HIv1___RNAseq.g1815.t1,three_way,56.59033333333333,FUN_000872-T1,Q08288,LYAR_MOUSE,,Cell growth-regulating nucleolar protein (Ly1 antibody-reactive protein) (Protein expressed in male leptotene and zygotene spermatocytes 264) (MLZ-264),Mus musculus (Mouse),40.4,406.0,2.3e-39,164.5,sp|Q08288|LYAR_MOUSE Cell growth-regulating nucleolar protein OS=Mus musculus OX=10090 GN=Lyar PE=1 SV=2,GO:0000122; GO:0001750; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0008270; GO:0042802; GO:0045087; GO:0045824; GO:0045943; GO:0048821; GO:0050766; GO:0140297; GO:0140416,erythrocyte development [GO:0048821]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750],DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; transcription regulator inhibitor activity [GO:0140416]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0048856; GO:0098542; GO:0098772,immune system process; DNA binding; nucleus; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; anatomical structure development; defense response to other organism; molecular function regulator activity
OG_00180,FUN_000873-T1,Peve_00002058,Pocillopora_meandrina_HIv1___RNAseq.g1816.t2,three_way,74.32466666666667,FUN_000873-T1,Q8R087,B4GT7_MOUSE,,"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein 4-beta-galactosyltransferase) (EC 2.4.1.133) (Xylosylprotein beta-1,4-galactosyltransferase)",Mus musculus (Mouse),61.2,242.0,6.8e-86,318.9,"sp|Q8R087|B4GT7_MOUSE Beta-1,4-galactosyltransferase 7 OS=Mus musculus OX=10090 GN=B4galt7 PE=2 SV=1",GO:0003831; GO:0005794; GO:0005975; GO:0006024; GO:0006029; GO:0006487; GO:0008378; GO:0016020; GO:0030145; GO:0032580; GO:0046525; GO:0048147; GO:0097435,carbohydrate metabolic process [GO:0005975]; glycosaminoglycan biosynthetic process [GO:0006024]; negative regulation of fibroblast proliferation [GO:0048147]; protein N-linked glycosylation [GO:0006487]; proteoglycan metabolic process [GO:0006029]; supramolecular fiber organization [GO:0097435],Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020],"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; galactosyltransferase activity [GO:0008378]; manganese ion binding [GO:0030145]; xylosylprotein 4-beta-galactosyltransferase activity [GO:0046525]",GO:0003824; GO:0005794; GO:0005975; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_00181,FUN_000876-T1,Peve_00039671,Pocillopora_meandrina_HIv1___RNAseq.g29425.t1,three_way,67.38333333333334,FUN_000876-T1,Q6PFL8,,,,,72.5,171.0,1.4e-71,270.8,sp|Q6PFL8|THYN1_DANRE Thymocyte nuclear protein 1 OS=Danio rerio OX=7955 GN=thyn1 PE=2 SV=1,,,,,,
OG_00182,FUN_000877-T1,Peve_00039677,Pocillopora_meandrina_HIv1___RNAseq.g29428.t1,three_way,82.03933333333333,FUN_000877-T1,Q86AQ7,,,,,42.2,211.0,5.0000000000000005e-37,156.0,sp|Q86AQ7|VAM7B_DICDI Vesicle-associated membrane protein 7B OS=Dictyostelium discoideum OX=44689 GN=vamp7B PE=3 SV=1,,,,,,
OG_00183,FUN_000878-T1,Peve_00039668,Pocillopora_meandrina_HIv1___RNAseq.g29429.t1,three_way,46.80466666666667,,,,,,,,,,,,,,,,,
OG_00184,FUN_000879-T1,Peve_00039669,Pocillopora_meandrina_HIv1___RNAseq.g29430.t1,three_way,82.648,FUN_000879-T1,Q5XK92,,,,,39.4,668.0,1.9e-117,425.2,sp|Q5XK92|CIP2A_XENLA Protein CIP2A homolog L OS=Xenopus laevis OX=8355 GN=cip2a.L PE=2 SV=1,,,,,,
OG_00185,FUN_000880-T1,Peve_00039672,Pocillopora_meandrina_HIv1___RNAseq.g29432.t1,three_way,73.261,FUN_000880-T1,P79795,NRP1_CHICK,,Neuropilin-1 (A5 protein),Gallus gallus (Chicken),35.6,180.0,9.8e-19,97.8,sp|P79795|NRP1_CHICK Neuropilin-1 OS=Gallus gallus OX=9031 GN=NRP1 PE=2 SV=1,GO:0001570; GO:0001755; GO:0002040; GO:0005021; GO:0005886; GO:0005925; GO:0007155; GO:0007411; GO:0008201; GO:0009611; GO:0010595; GO:0017154; GO:0022035; GO:0030424; GO:0030947; GO:0031966; GO:0032584; GO:0038085; GO:0043679; GO:0044295; GO:0046872; GO:0048010; GO:0048729; GO:0051491; GO:0070852; GO:0098743,axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell aggregation [GO:0098743]; neural crest cell migration [GO:0001755]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to wounding [GO:0009611]; rhombomere cell migration [GO:0022035]; sprouting angiogenesis [GO:0002040]; tissue morphogenesis [GO:0048729]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570],axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell body fiber [GO:0070852]; focal adhesion [GO:0005925]; growth cone membrane [GO:0032584]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886],heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0030154; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; cell differentiation; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_00186,FUN_000885-T1,Peve_00029323,Pocillopora_meandrina_HIv1___RNAseq.g29436.t1,three_way,58.51866666666667,,,,,,,,,,,,,,,,,
OG_00187,FUN_000891-T1,Peve_00017797,Pocillopora_meandrina_HIv1___RNAseq.g29442.t1,three_way,75.30383333333333,FUN_000891-T1,P47937,NK3R_MOUSE,,Neuromedin-K receptor (NKR) (NK-3 receptor) (NK-3R) (Neurokinin B receptor) (Tachykinin receptor 3),Mus musculus (Mouse),30.2,341.0,8.7e-28,127.1,sp|P47937|NK3R_MOUSE Neuromedin-K receptor OS=Mus musculus OX=10090 GN=Tacr3 PE=2 SV=2,GO:0004995; GO:0010460; GO:0032355; GO:0032590; GO:0032809; GO:0042053; GO:0042220; GO:0045777; GO:0060259; GO:0070474; GO:0097225; GO:1902093,positive regulation of blood pressure [GO:0045777]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of heart rate [GO:0010460]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of dopamine metabolic process [GO:0042053]; regulation of feeding behavior [GO:0060259]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355],dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; sperm midpiece [GO:0097225],tachykinin receptor activity [GO:0004995],GO:0060089,molecular transducer activity
OG_00188,FUN_000892-T1,Peve_00026758,Pocillopora_meandrina_HIv1___RNAseq.g29444.t1,three_way,81.38833333333334,,,,,,,,,,,,,,,,,
OG_00189,FUN_000894-T1,Peve_00026759,Pocillopora_meandrina_HIv1___RNAseq.g29445.t1,three_way,71.97566666666667,FUN_000894-T1,Q7SXV2,,,,,40.9,237.0,2.9999999999999997e-47,190.7,sp|Q7SXV2|AEBP2_DANRE Zinc finger protein AEBP2 OS=Danio rerio OX=7955 GN=aebp2 PE=2 SV=2,,,,,,
OG_00190,FUN_000895-T1,Peve_00026757,Pocillopora_meandrina_HIv1___RNAseq.g29446.t1,three_way,67.05616666666667,FUN_000895-T1,Q96K80,ZC3HA_HUMAN,,Zinc finger CCCH domain-containing protein 10,Homo sapiens (Human),32.8,241.0,3.5000000000000005e-22,107.1,sp|Q96K80|ZC3HA_HUMAN Zinc finger CCCH domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ZC3H10 PE=1 SV=1,GO:0003723; GO:0005634; GO:0008270; GO:0010608; GO:0035198; GO:0043484; GO:1903799,negative regulation of miRNA processing [GO:1903799]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of RNA splicing [GO:0043484],nucleus [GO:0005634],miRNA binding [GO:0035198]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005634; GO:0043226,RNA binding; nucleus; organelle
OG_00191,FUN_000896-T1,Peve_00009744,Pocillopora_meandrina_HIv1___TS.g6634.t1,three_way,41.8635,,,,,,,,,,,,,,,,,
OG_00192,FUN_000898-T1,Peve_00009741,Pocillopora_meandrina_HIv1___RNAseq.g29449.t1,three_way,80.12233333333333,FUN_000898-T1,O43903,GAS2_HUMAN,,Growth arrest-specific protein 2 (GAS-2),Homo sapiens (Human),42.6,256.0,1.3e-48,194.9,sp|O43903|GAS2_HUMAN Growth arrest-specific protein 2 OS=Homo sapiens OX=9606 GN=GAS2 PE=1 SV=1,GO:0001544; GO:0001547; GO:0001725; GO:0005829; GO:0005884; GO:0006915; GO:0008017; GO:0008360; GO:0008593; GO:0016020; GO:0030728; GO:0051015; GO:0051726; GO:0051764; GO:0071711,actin crosslink formation [GO:0051764]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell cycle [GO:0051726]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593],actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; microtubule binding [GO:0008017],GO:0005829; GO:0008092; GO:0012501; GO:0022414; GO:0030198,cytosol; cytoskeletal protein binding; programmed cell death; reproductive process; extracellular matrix organization
OG_00193,FUN_000899-T1,Peve_00009739,Pocillopora_meandrina_HIv1___RNAseq.g29450.t1,three_way,81.587,,,,,,,,,,,,,,,,,
OG_00194,FUN_000900-T1,Peve_00009738,Pocillopora_meandrina_HIv1___RNAseq.g29451.t1,three_way,81.18366666666667,FUN_000900-T1,Q5R787,,,,,37.9,533.0,2.6e-76,287.7,sp|Q5R787|ARFG3_PONAB ADP-ribosylation factor GTPase-activating protein 3 OS=Pongo abelii OX=9601 GN=ARFGAP3 PE=2 SV=1,,,,,,
OG_00195,FUN_000905-T1,Peve_00009733,Pocillopora_meandrina_HIv1___RNAseq.g29456.t1,three_way,66.77466666666666,FUN_000905-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),37.3,753.0,5.9e-130,466.5,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00196,FUN_000908-T1,Peve_00010044,Pocillopora_meandrina_HIv1___RNAseq.g29495.t1,three_way,77.85966666666667,FUN_000908-T1,Q8QG61,,,,,64.7,499.0,3.3e-210,732.6,sp|Q8QG61|CRY1_CHICK Cryptochrome-1 OS=Gallus gallus OX=9031 GN=CRY1 PE=2 SV=1,,,,,,
OG_00197,FUN_000909-T1,Peve_00010043,Pocillopora_meandrina_HIv1___RNAseq.g29494.t1,three_way,48.467,FUN_000909-T1,P46529,,,,,44.1,68.0,1.2e-10,68.2,sp|P46529|CDN1B_NEOVI Cyclin-dependent kinase inhibitor 1B (Fragment) OS=Neovison vison OX=452646 GN=CDKN1B PE=2 SV=1,,,,,,
OG_00198,FUN_000910-T1,Peve_00010061,Pocillopora_meandrina_HIv1___RNAseq.g29492.t1,three_way,79.57216666666666,FUN_000910-T1,P21521,,,,,57.7,317.0,9.1e-107,388.7,sp|P21521|SY65_DROME Synaptotagmin 1 OS=Drosophila melanogaster OX=7227 GN=Syt1 PE=1 SV=3,,,,,,
OG_00199,FUN_000912-T1,Peve_00010054,Pocillopora_meandrina_HIv1___RNAseq.g29489.t1,three_way,68.19866666666667,FUN_000912-T1,Q8BSF5,,,,,22.8,479.0,1.7e-26,122.9,sp|Q8BSF5|KLH38_MOUSE Kelch-like protein 38 OS=Mus musculus OX=10090 GN=Klhl38 PE=2 SV=1,,,,,,
OG_00200,FUN_000914-T1,Peve_00033029,Pocillopora_meandrina_HIv1___RNAseq.g29486.t1,three_way,88.95466666666667,FUN_000914-T1,Q6DCV0,WIPI4_XENLA,,WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45),Xenopus laevis (African clawed frog),60.8,352.0,4.8e-127,455.7,sp|Q6DCV0|WIPI4_XENLA WD repeat domain phosphoinositide-interacting protein 4 OS=Xenopus laevis OX=8355 GN=wdr45 PE=2 SV=1,GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005829; GO:0009267; GO:0030674; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0061723; GO:0080025; GO:1901981; GO:2000786,autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; pexophagy [GO:0000425]; positive regulation of autophagosome assembly [GO:2000786]; protein localization to phagophore assembly site [GO:0034497],cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-macromolecule adaptor activity [GO:0030674]",GO:0005829; GO:0005975; GO:0006091; GO:0006914; GO:0008289; GO:0060090,cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; autophagy; lipid binding; molecular adaptor activity
OG_00201,FUN_000915-T1,Peve_00044966,Pocillopora_meandrina_HIv1___RNAseq.g29485.t1,three_way,71.85666666666667,,,,,,,,,,,,,,,,,
OG_00202,FUN_000916-T1,Peve_00044970,Pocillopora_meandrina_HIv1___TS.g6672.t1,three_way,89.06833333333333,FUN_000916-T1,Q9R0N7,SYT7_MOUSE,,Synaptotagmin-7 (Synaptotagmin VII) (SytVII),Mus musculus (Mouse),54.8,270.0,1.4e-85,318.2,sp|Q9R0N7|SYT7_MOUSE Synaptotagmin-7 OS=Mus musculus OX=10090 GN=Syt7 PE=1 SV=1,GO:0000149; GO:0001778; GO:0001786; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0006909; GO:0008021; GO:0014059; GO:0017158; GO:0030425; GO:0030670; GO:0030672; GO:0032009; GO:0036465; GO:0042734; GO:0043025; GO:0043679; GO:0046850; GO:0046872; GO:0048791; GO:0050764; GO:0050796; GO:0070092; GO:0090119; GO:0090385; GO:0098978; GO:0098982; GO:0099502; GO:1990926; GO:1990927,calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of dopamine secretion [GO:0014059]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle-mediated cholesterol transport [GO:0090119],axon terminus [GO:0043679]; cytosol [GO:0005829]; dendrite [GO:0030425]; early phagosome [GO:0032009]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],"calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; SNARE binding [GO:0000149]",GO:0005764; GO:0005773; GO:0005777; GO:0005829; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,lysosome; vacuole; peroxisome; cytosol; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_00203,FUN_000918-T1,Peve_00044972,Pocillopora_meandrina_HIv1___RNAseq.g29483.t1,three_way,64.11866666666667,,,,,,,,,,,,,,,,,
OG_00204,FUN_000920-T1,Peve_00044963,Pocillopora_meandrina_HIv1___TS.g6665.t2,three_way,57.738166666666665,,,,,,,,,,,,,,,,,
OG_00205,FUN_000922-T1,Peve_00044965,Pocillopora_meandrina_HIv1___RNAseq.g29474.t1,three_way,68.2465,FUN_000922-T1,Q5T7P8,SYT6_HUMAN,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Homo sapiens (Human),41.6,296.0,4.8e-52,206.8,sp|Q5T7P8|SYT6_HUMAN Synaptotagmin-6 OS=Homo sapiens OX=9606 GN=SYT6 PE=1 SV=3,GO:0000149; GO:0005829; GO:0005886; GO:0007268; GO:0009898; GO:0016020; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0046872; GO:0060478; GO:0061891; GO:0070382; GO:0097038,acrosomal vesicle exocytosis [GO:0060478]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion sensor activity [GO:0061891]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005829; GO:0005886; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0098772; GO:0140299,cytosol; plasma membrane; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_00206,FUN_000924-T1,Peve_00044968,Pocillopora_meandrina_HIv1___RNAseq.g29471.t1,three_way,62.256166666666665,,,,,,,,,,,,,,,,,
OG_00207,FUN_000926-T1,Peve_00009718,Pocillopora_meandrina_HIv1___RNAseq.g29467.t1,three_way,63.42333333333334,FUN_000926-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),29.5,319.0,9.1e-33,142.9,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_00208,FUN_000927-T1,Peve_00009719,Pocillopora_meandrina_HIv1___RNAseq.g29466.t1,three_way,55.368,,,,,,,,,,,,,,,,,
OG_00209,FUN_000928-T1,Peve_00009720,Pocillopora_meandrina_HIv1___RNAseq.g29465.t1,three_way,77.15533333333333,FUN_000928-T1,B8A5I7,SSBP_DANRE,,"Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB)",Danio rerio (Zebrafish) (Brachydanio rerio),34.8,141.0,6.4e-17,88.6,"sp|B8A5I7|SSBP_DANRE Single-stranded DNA-binding protein, mitochondrial OS=Danio rerio OX=7955 GN=ssbp1 PE=1 SV=1",GO:0000002; GO:0003697; GO:0006260; GO:0008047; GO:0042645; GO:0090297,DNA replication [GO:0006260]; mitochondrial genome maintenance [GO:0000002]; positive regulation of mitochondrial DNA replication [GO:0090297],mitochondrial nucleoid [GO:0042645],enzyme activator activity [GO:0008047]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0006260; GO:0043226; GO:0098772,DNA binding; DNA replication; organelle; molecular function regulator activity
OG_00210,FUN_000929-T1,Peve_00009722,Pocillopora_meandrina_HIv1___RNAseq.g29464.t1,three_way,80.92766666666667,FUN_000929-T1,Q08BC4,,,,,39.0,569.0,5.3e-94,346.7,sp|Q08BC4|STPG2_DANRE Sperm-tail PG-rich repeat-containing protein 2 OS=Danio rerio OX=7955 GN=stpg2 PE=2 SV=1,,,,,,
OG_00211,FUN_000930-T1,Peve_00009721,Pocillopora_meandrina_HIv1___RNAseq.g29463.t1,three_way,75.37,FUN_000930-T1,A0LJ16,,,,,43.9,269.0,7.6e-61,235.7,sp|A0LJ16|PHNXL_SYNFM Phosphonoacetaldehyde hydrolase-like protein OS=Syntrophobacter fumaroxidans (strain DSM 10017 / MPOB) OX=335543 GN=phnX2 PE=3 SV=1,,,,,,
OG_00212,FUN_000931-T1,Peve_00009723,Pocillopora_meandrina_HIv1___RNAseq.g29462.t1,three_way,72.855,FUN_000931-T1,Q5E9J5,DHCR7_BOVIN,,"7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Cholesterol-5,6-epoxide hydrolase subunit DHCR7) (EC 3.3.2.11) (Sterol Delta(7)-reductase)",Bos taurus (Bovine),50.6,437.0,1.1000000000000002e-124,448.4,sp|Q5E9J5|DHCR7_BOVIN 7-dehydrocholesterol reductase OS=Bos taurus OX=9913 GN=DHCR7 PE=2 SV=1,GO:0005640; GO:0005789; GO:0006695; GO:0033490; GO:0033963; GO:0047598; GO:0050661; GO:0160020,cholesterol biosynthetic process [GO:0006695]; cholesterol biosynthetic process via lathosterol [GO:0033490]; positive regulation of ferroptosis [GO:0160020],endoplasmic reticulum membrane [GO:0005789]; nuclear outer membrane [GO:0005640],"7-dehydrocholesterol reductase activity [GO:0047598]; cholesterol-5,6-oxide hydrolase activity [GO:0033963]; NADP binding [GO:0050661]",GO:0003824; GO:0006629; GO:0016491; GO:0016787,catalytic activity; lipid metabolic process; oxidoreductase activity; hydrolase activity
OG_00213,FUN_000932-T1,Peve_00009724,Pocillopora_meandrina_HIv1___RNAseq.g29460.t1,three_way,85.761,FUN_000932-T1,P00516,,,,,65.8,619.0,1.3e-240,833.9,sp|P00516|KGP1_BOVIN cGMP-dependent protein kinase 1 OS=Bos taurus OX=9913 GN=PRKG1 PE=1 SV=2,,,,,,
OG_00214,FUN_000933-T1,Peve_00009727,Pocillopora_meandrina_HIv1___RNAseq.g29459.t1,three_way,43.35483333333333,,,,,,,,,,,,,,,,,
OG_00215,FUN_000934-T1,Peve_00009728,Pocillopora_meandrina_HIv1___RNAseq.g29458.t1,three_way,74.37933333333334,FUN_000934-T1,Q9BW85,YJU2_HUMAN,,Splicing factor YJU2 (Coiled-coil domain-containing protein 94),Homo sapiens (Human),68.8,173.0,7.7e-64,245.7,sp|Q9BW85|YJU2_HUMAN Splicing factor YJU2 OS=Homo sapiens OX=9606 GN=YJU2 PE=1 SV=1,GO:0000349; GO:0005654; GO:0008380; GO:0043518; GO:0046872; GO:0071006,"generation of catalytic spliceosome for first transesterification step [GO:0000349]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380]",nucleoplasm [GO:0005654]; U2-type catalytic step 1 spliceosome [GO:0071006],metal ion binding [GO:0046872],GO:0005654; GO:0065003,nucleoplasm; protein-containing complex assembly
OG_00216,FUN_000935-T1,Peve_00009730,Pocillopora_meandrina_HIv1___RNAseq.g29457.t1,three_way,84.785,FUN_000935-T1,Q5ZL33,STRAP_CHICK,,Serine-threonine kinase receptor-associated protein,Gallus gallus (Chicken),63.8,304.0,4.3e-114,412.5,sp|Q5ZL33|STRAP_CHICK Serine-threonine kinase receptor-associated protein OS=Gallus gallus OX=9031 GN=STRAP PE=2 SV=2,GO:0000122; GO:0000380; GO:0000387; GO:0003723; GO:0003729; GO:0005102; GO:0005634; GO:0005829; GO:0030182; GO:0030277; GO:0030512; GO:0032797; GO:0034719; GO:1990447,"alternative mRNA splicing, via spliceosome [GO:0000380]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; spliceosomal snRNP assembly [GO:0000387]",cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; U2 snRNP binding [GO:1990447],GO:0003723; GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0022600; GO:0030154; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; digestive system process; cell differentiation; organelle; protein-containing complex assembly
OG_00217,FUN_000943-T1,Peve_00010048,Pocillopora_meandrina_HIv1___RNAseq.g29499.t1,three_way,73.82233333333333,FUN_000943-T1,Q791V5,MTCH2_MOUSE,,Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein),Mus musculus (Mouse),41.5,284.0,2.7e-60,233.8,sp|Q791V5|MTCH2_MOUSE Mitochondrial carrier homolog 2 OS=Mus musculus OX=10090 GN=Mtch2 PE=1 SV=1,GO:0005739; GO:0005741; GO:0005743; GO:0006089; GO:0010635; GO:0010917; GO:0032977; GO:0035701; GO:0042775; GO:0043065; GO:0045040; GO:0045820; GO:0055088; GO:0061484; GO:0070585; GO:0071478; GO:0090152; GO:0097284; GO:1902108; GO:1902231; GO:2000738,cellular response to radiation [GO:0071478]; establishment of protein localization to mitochondrial membrane involved in mitochondrial fission [GO:0090152]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration [GO:0035701]; hepatocyte apoptotic process [GO:0097284]; lactate metabolic process [GO:0006089]; lipid homeostasis [GO:0055088]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; negative regulation of glycolytic process [GO:0045820]; negative regulation of mitochondrial membrane potential [GO:0010917]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of stem cell differentiation [GO:2000738]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein localization to mitochondrion [GO:0070585]; regulation of mitochondrial fusion [GO:0010635]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108],mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],membrane insertase activity [GO:0032977],GO:0005739; GO:0006091; GO:0007005; GO:0012501; GO:0043226; GO:0048870; GO:0061024; GO:0140104,mitochondrion; generation of precursor metabolites and energy; mitochondrion organization; programmed cell death; organelle; cell motility; membrane organization; molecular carrier activity
OG_00218,FUN_000944-T1,Peve_00010049,Pocillopora_meandrina_HIv1___RNAseq.g29500.t1,three_way,88.65833333333333,FUN_000944-T1,Q6P0H6,,,,,73.3,401.0,2.5e-167,589.7,sp|Q6P0H6|CSN4_DANRE COP9 signalosome complex subunit 4 OS=Danio rerio OX=7955 GN=cops4 PE=2 SV=1,,,,,,
OG_00219,FUN_000945-T1,Peve_00010050,Pocillopora_meandrina_HIv1___RNAseq.g29501.t1,three_way,70.498,,,,,,,,,,,,,,,,,
OG_00220,FUN_000946-T1,Peve_00031012,Pocillopora_meandrina_HIv1___TS.g6689.t1a,three_way,71.169,,,,,,,,,,,,,,,,,
OG_00221,FUN_000948-T1,Peve_00031011,Pocillopora_meandrina_HIv1___TS.g6689.t1b,three_way,66.4105,FUN_000948-T1,B1H1P9,,,,,42.3,345.0,2.5000000000000003e-72,274.2,sp|B1H1P9|PPAL_XENLA Lysosomal acid phosphatase OS=Xenopus laevis OX=8355 GN=acp2 PE=2 SV=1,,,,,,
OG_00222,FUN_000953-T1,Peve_00010057,Pocillopora_meandrina_HIv1___RNAseq.g29503.t1,three_way,81.21966666666667,,,,,,,,,,,,,,,,,
OG_00223,FUN_000957-T1,Peve_00010040,Pocillopora_meandrina_HIv1___RNAseq.g29507.t1,three_way,47.253166666666665,,,,,,,,,,,,,,,,,
OG_00224,FUN_000959-T1,Peve_00021381,Pocillopora_meandrina_HIv1___RNAseq.g2549.t1,three_way,47.7295,FUN_000959-T1,O18806,,,,,37.9,153.0,9.9e-26,120.9,sp|O18806|FA8_CANLF Coagulation factor VIII OS=Canis lupus familiaris OX=9615 GN=F8 PE=2 SV=1,,,,,,
OG_00225,FUN_000960-T1,Peve_00021379,Pocillopora_meandrina_HIv1___RNAseq.13437_t,three_way,86.795,FUN_000960-T1,P28271,ACOHC_MOUSE,,Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1),Mus musculus (Mouse),71.1,869.0,0.0,1303.1,sp|P28271|ACOHC_MOUSE Cytoplasmic aconitate hydratase OS=Mus musculus OX=10090 GN=Aco1 PE=1 SV=3,GO:0003994; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006099; GO:0006101; GO:0006417; GO:0006740; GO:0006879; GO:0009791; GO:0010040; GO:0010468; GO:0030350; GO:0046872; GO:0050892; GO:0051538; GO:0051539,citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; NADPH regeneration [GO:0006740]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]",GO:0003723; GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005829; GO:0006091; GO:0016829; GO:0022600; GO:0043226; GO:0055086,RNA binding; catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; cytosol; generation of precursor metabolites and energy; lyase activity; digestive system process; organelle; nucleobase-containing small molecule metabolic process
OG_00226,FUN_000961-T1,Peve_00008026,Pocillopora_meandrina_HIv1___TS.g5059.t2,three_way,69.25816666666667,FUN_000961-T1,Q26613,,,,,43.4,632.0,3.5e-159,563.9,sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1,,,,,,
OG_00227,FUN_000962-T1,Peve_00008025,Pocillopora_meandrina_HIv1___TS.g5027.t1,three_way,64.00016666666667,FUN_000962-T1,O73606,,,,,40.3,77.0,1.3e-06,56.2,sp|O73606|KCNG2_CHICK Voltage-gated potassium channel regulatory subunit KCNG2 OS=Gallus gallus OX=9031 GN=KCNG2 PE=2 SV=1,,,,,,
OG_00228,FUN_000971-T1,Peve_00007801,Pocillopora_meandrina_HIv1___RNAseq.g29136.t1,three_way,71.03666666666668,FUN_000971-T1,Q2QRV3,PIOX_ORYSJ,,Alpha-dioxygenase PIOX (EC 1.13.11.92) (Pathogen-induced oxygenase),Oryza sativa subsp. japonica (Rice),37.0,549.0,1.7999999999999998e-96,355.1,sp|Q2QRV3|PIOX_ORYSJ Alpha-dioxygenase PIOX OS=Oryza sativa subsp. japonica OX=39947 GN=PIOX PE=1 SV=2,GO:0001561; GO:0004601; GO:0009627; GO:0009737; GO:0012511; GO:0016702; GO:0020037; GO:0031408; GO:0034614; GO:0042742; GO:0046872; GO:0050832; GO:0071446; GO:0071732; GO:1902609,(R)-2-hydroxy-alpha-linolenic acid biosynthetic process [GO:1902609]; cellular response to nitric oxide [GO:0071732]; cellular response to reactive oxygen species [GO:0034614]; cellular response to salicylic acid stimulus [GO:0071446]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; fatty acid alpha-oxidation [GO:0001561]; oxylipin biosynthetic process [GO:0031408]; response to abscisic acid [GO:0009737]; systemic acquired resistance [GO:0009627],monolayer-surrounded lipid storage body [GO:0012511],"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]",GO:0003824; GO:0005811; GO:0006629; GO:0016209; GO:0016491; GO:0043226; GO:0098542,catalytic activity; lipid droplet; lipid metabolic process; antioxidant activity; oxidoreductase activity; organelle; defense response to other organism
OG_00229,FUN_000972-T1,Peve_00007807,Pocillopora_meandrina_HIv1___RNAseq.g29135.t2,three_way,69.94616666666667,FUN_000972-T1,Q99PL6,,,,,37.3,472.0,5.2e-68,260.0,sp|Q99PL6|UBXN6_MOUSE UBX domain-containing protein 6 OS=Mus musculus OX=10090 GN=Ubxn6 PE=1 SV=1,,,,,,
OG_00230,FUN_000973-T1,Peve_00007808,Pocillopora_meandrina_HIv1___RNAseq.g29134.t1,three_way,69.292,FUN_000973-T1,Q8WWB5,PIHD2_HUMAN,,PIH1 domain-containing protein 2,Homo sapiens (Human),29.7,310.0,1.4e-35,151.8,sp|Q8WWB5|PIHD2_HUMAN PIH1 domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PIH1D2 PE=1 SV=1,GO:0000492; GO:0005737; GO:0006364; GO:0031267; GO:0050821; GO:0097255; GO:0101031; GO:1990904,box C/D snoRNP assembly [GO:0000492]; protein stabilization [GO:0050821]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; protein folding chaperone complex [GO:0101031]; R2TP complex [GO:0097255]; ribonucleoprotein complex [GO:1990904],small GTPase binding [GO:0031267],GO:0065003,protein-containing complex assembly
OG_00231,FUN_000977-T1,Peve_00007809,Pocillopora_meandrina_HIv1___RNAseq.g29137.t1,three_way,71.25866666666667,FUN_000977-T1,P70451,,,,,38.0,843.0,1.9e-153,544.7,sp|P70451|FER_MOUSE Tyrosine-protein kinase Fer OS=Mus musculus OX=10090 GN=Fer PE=1 SV=2,,,,,,
OG_00232,FUN_000980-T1,Peve_00008728,Pocillopora_meandrina_HIv1___RNAseq.g29142.t1,three_way,75.67566666666666,FUN_000980-T1,Q99K85,,,,,62.8,368.0,9.4e-137,488.0,sp|Q99K85|SERC_MOUSE Phosphoserine aminotransferase OS=Mus musculus OX=10090 GN=Psat1 PE=1 SV=1,,,,,,
OG_00233,FUN_000987-T1,Peve_00022148,Pocillopora_meandrina_HIv1___RNAseq.g29210.t1,three_way,63.864666666666665,,,,,,,,,,,,,,,,,
OG_00234,FUN_000988-T1,Peve_00022149,Pocillopora_meandrina_HIv1___RNAseq.g29209.t1,three_way,82.41166666666666,FUN_000988-T1,Q92828,,,,,47.6,401.0,3.4e-101,370.5,sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2,,,,,,
OG_00235,FUN_000989-T1,Peve_00022150,Pocillopora_meandrina_HIv1___TS.g6419.t2,three_way,85.35733333333333,FUN_000989-T1,Q6NWZ9,CDO1_DANRE,,Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I),Danio rerio (Zebrafish) (Brachydanio rerio),61.7,188.0,1.1e-67,257.7,sp|Q6NWZ9|CDO1_DANRE Cysteine dioxygenase type 1 OS=Danio rerio OX=7955 GN=cdo1 PE=2 SV=1,GO:0008198; GO:0008270; GO:0016151; GO:0017172; GO:0019448; GO:0042412,L-cysteine catabolic process [GO:0019448]; taurine biosynthetic process [GO:0042412],,cysteine dioxygenase activity [GO:0017172]; ferrous iron binding [GO:0008198]; nickel cation binding [GO:0016151]; zinc ion binding [GO:0008270],GO:0003824; GO:0006520; GO:0006790; GO:0016491,catalytic activity; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity
OG_00236,FUN_000990-T1,Peve_00022152,Pocillopora_meandrina_HIv1___RNAseq.g29207.t1,three_way,69.63933333333333,,,,,,,,,,,,,,,,,
OG_00237,FUN_000992-T1,Peve_00004455,Pocillopora_meandrina_HIv1___RNAseq.g29194.t1,three_way,92.068,FUN_000992-T1,P82471,GNAQ_RAT,,Guanine nucleotide-binding protein G(q) subunit alpha (EC 3.6.5.-) (Guanine nucleotide-binding protein alpha-q),Rattus norvegicus (Rat),82.2,353.0,8.9e-169,594.3,sp|P82471|GNAQ_RAT Guanine nucleotide-binding protein G(q) subunit alpha OS=Rattus norvegicus OX=10116 GN=Gnaq PE=2 SV=2,GO:0001501; GO:0001508; GO:0001664; GO:0003924; GO:0003925; GO:0005096; GO:0005525; GO:0005737; GO:0005794; GO:0005834; GO:0005886; GO:0005901; GO:0007186; GO:0007189; GO:0007200; GO:0007206; GO:0007207; GO:0007208; GO:0007215; GO:0007218; GO:0007507; GO:0008217; GO:0009791; GO:0010543; GO:0016020; GO:0016322; GO:0021884; GO:0030234; GO:0030425; GO:0031683; GO:0031965; GO:0032024; GO:0034695; GO:0042711; GO:0042733; GO:0043066; GO:0043267; GO:0044297; GO:0044877; GO:0045634; GO:0046872; GO:0047391; GO:0048066; GO:0050821; GO:0060158; GO:0060828; GO:0086100; GO:0098793; GO:0099524; GO:1904888; GO:1990806,action potential [GO:0001508]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cranial skeletal system development [GO:1904888]; developmental pigmentation [GO:0048066]; embryonic digit morphogenesis [GO:0042733]; endothelin receptor signaling pathway [GO:0086100]; forebrain neuron development [GO:0021884]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate receptor signaling pathway [GO:0007215]; heart development [GO:0007507]; ligand-gated ion channel signaling pathway [GO:1990806]; maternal behavior [GO:0042711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; neuron remodeling [GO:0016322]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; phospholipase C-activating G protein-coupled glutamate receptor signaling pathway [GO:0007206]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of insulin secretion [GO:0032024]; post-embryonic development [GO:0009791]; protein stabilization [GO:0050821]; regulation of blood pressure [GO:0008217]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of melanocyte differentiation [GO:0045634]; regulation of platelet activation [GO:0010543]; response to prostaglandin E [GO:0034695]; skeletal system development [GO:0001501],caveola [GO:0005901]; cell body [GO:0044297]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; heterotrimeric G-protein complex [GO:0005834]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524]; presynapse [GO:0098793],alkylglycerophosphoethanolamine phosphodiesterase activity [GO:0047391]; enzyme regulator activity [GO:0030234]; G protein activity [GO:0003925]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0003924; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; GTPase activity; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_00238,FUN_000994-T1,Peve_00004444,Pocillopora_meandrina_HIv1___RNAseq.g29192.t1,three_way,83.734,,,,,,,,,,,,,,,,,
OG_00239,FUN_000995-T1,Peve_00004445,Pocillopora_meandrina_HIv1___RNAseq.g29191.t1,three_way,42.72733333333333,,,,,,,,,,,,,,,,,
OG_00240,FUN_000996-T1,Peve_00004446,Pocillopora_meandrina_HIv1___RNAseq.g29189.t1,three_way,48.307833333333335,,,,,,,,,,,,,,,,,
OG_00241,FUN_001004-T1,Peve_00015283,Pocillopora_meandrina_HIv1___RNAseq.g29176.t1,three_way,47.563,,,,,,,,,,,,,,,,,
OG_00242,FUN_001005-T1,Peve_00015285,Pocillopora_meandrina_HIv1___TS.g6390.t1,three_way,40.208,,,,,,,,,,,,,,,,,
OG_00243,FUN_001006-T1,Peve_00015278,Pocillopora_meandrina_HIv1___RNAseq.g29174.t1,three_way,60.991,FUN_001006-T1,Q498G2,,,,,27.4,727.0,1.3e-40,171.0,sp|Q498G2|CE152_XENLA Centrosomal protein of 152 kDa OS=Xenopus laevis OX=8355 GN=cep152 PE=2 SV=1,,,,,,
OG_00244,FUN_001007-T1,Peve_00015280,Pocillopora_meandrina_HIv1___RNAseq.g29172.t1,three_way,50.94766666666667,,,,,,,,,,,,,,,,,
OG_00245,FUN_001008-T1,Peve_00015281,Pocillopora_meandrina_HIv1___RNAseq.g29171.t1,three_way,51.759,,,,,,,,,,,,,,,,,
OG_00246,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_00247,FUN_001010-T1,Peve_00041051,Pocillopora_meandrina_HIv1___RNAseq.g29165.t1,three_way,58.97366666666667,FUN_001010-T1,Q5E9Y6,,,,,36.6,402.0,8.4e-51,202.6,sp|Q5E9Y6|PRUN1_BOVIN Exopolyphosphatase PRUNE1 OS=Bos taurus OX=9913 GN=PRUNE1 PE=2 SV=1,,,,,,
OG_00248,FUN_001011-T1,Peve_00041060,Pocillopora_meandrina_HIv1___RNAseq.g29164.t1,three_way,70.763,FUN_001011-T1,Q6ZUX7,LHPL2_HUMAN,,LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein),Homo sapiens (Human),43.1,232.0,6.4e-43,175.6,sp|Q6ZUX7|LHPL2_HUMAN LHFPL tetraspan subfamily member 2 protein OS=Homo sapiens OX=9606 GN=LHFPL2 PE=1 SV=2,GO:0005886; GO:0007338; GO:0016020; GO:0031092; GO:0046545; GO:0046546; GO:1905516,development of primary female sexual characteristics [GO:0046545]; development of primary male sexual characteristics [GO:0046546]; positive regulation of fertilization [GO:1905516]; single fertilization [GO:0007338],membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092],,GO:0005886; GO:0022414,plasma membrane; reproductive process
OG_00249,FUN_001012-T1,Peve_00041036,Pocillopora_meandrina_HIv1___TS.g6378.t1,three_way,76.26333333333334,FUN_001012-T1,P49641,MA2A2_HUMAN,,"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",Homo sapiens (Human),44.9,1158.0,9.3e-292,1004.6,sp|P49641|MA2A2_HUMAN Alpha-mannosidase 2x OS=Homo sapiens OX=9606 GN=MAN2A2 PE=1 SV=3,GO:0000139; GO:0004559; GO:0004572; GO:0006013; GO:0006486; GO:0006491; GO:0016799; GO:0030246; GO:0046872,mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486],Golgi membrane [GO:0000139],"alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]",GO:0003824; GO:0005975; GO:0006486; GO:0009101; GO:0016787; GO:1901135,catalytic activity; carbohydrate metabolic process; protein glycosylation; glycoprotein biosynthetic process; hydrolase activity; carbohydrate derivative metabolic process
OG_00250,FUN_001013-T1,Peve_00041041,Pocillopora_meandrina_HIv1___RNAseq.g29162.t1,three_way,71.989,FUN_001013-T1,Q5R6Z8,CYBP_PONAB,,Calcyclin-binding protein (CacyBP),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),42.5,221.0,1.6e-38,161.0,sp|Q5R6Z8|CYBP_PONAB Calcyclin-binding protein OS=Pongo abelii OX=9601 GN=CACYBP PE=2 SV=1,GO:0005634; GO:0005737; GO:0007507; GO:0015631; GO:0031625; GO:0044548,heart development [GO:0007507],cytoplasm [GO:0005737]; nucleus [GO:0005634],S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0008092; GO:0043226; GO:0048856,nucleus; cytoskeletal protein binding; organelle; anatomical structure development
OG_00251,FUN_001014-T1,Peve_00041042,Pocillopora_meandrina_HIv1___RNAseq.g29161.t1,three_way,98.13866666666668,FUN_001014-T1,Q2YDH6,,,,,78.2,197.0,7.300000000000001e-80,298.1,sp|Q2YDH6|AP3S1_BOVIN AP-3 complex subunit sigma-1 OS=Bos taurus OX=9913 GN=AP3S1 PE=2 SV=1,,,,,,
OG_00252,FUN_001016-T1,Peve_00041043,Pocillopora_meandrina_HIv1___RNAseq.g29160.t1,three_way,48.55133333333333,FUN_001016-T1,Q0IHU9,,,,,42.9,203.0,7.6e-44,180.6,sp|Q0IHU9|PRUN2_XENTR Protein prune homolog 2 OS=Xenopus tropicalis OX=8364 GN=Prune2 PE=2 SV=1,,,,,,
OG_00253,FUN_001017-T2,Peve_00041044,Pocillopora_meandrina_HIv1___RNAseq.g29159.t1,three_way,66.55,,,,,,,,,,,,,,,,,
OG_00254,FUN_001018-T1,Peve_00041046,Pocillopora_meandrina_HIv1___RNAseq.g29549.t1,three_way,53.75233333333333,FUN_001018-T1,Q5ZLD2,,,,,22.1,543.0,6.1e-20,100.5,sp|Q5ZLD2|DEP1B_CHICK DEP domain-containing protein 1B OS=Gallus gallus OX=9031 GN=DEPDC1B PE=2 SV=1,,,,,,
OG_00255,FUN_001019-T1,Peve_00041047,Pocillopora_meandrina_HIv1___RNAseq.g29550.t1,three_way,74.728,FUN_001019-T1,E1C1R4,,,,,44.2,1361.0,1.6999999999999999e-301,1036.9,sp|E1C1R4|UBP47_CHICK Ubiquitin carboxyl-terminal hydrolase 47 OS=Gallus gallus OX=9031 GN=USP47 PE=3 SV=1,,,,,,
OG_00256,FUN_001020-T1,Peve_00041048,Pocillopora_meandrina_HIv1___RNAseq.g29551.t1,three_way,71.137,FUN_001020-T1,Q6NVU6,UFSP1_HUMAN,,Ufm1-specific protease 1 (UfSP1) (EC 3.4.22.-),Homo sapiens (Human),45.8,216.0,1.3e-48,194.5,sp|Q6NVU6|UFSP1_HUMAN Ufm1-specific protease 1 OS=Homo sapiens OX=9606 GN=UFSP1 PE=1 SV=3,GO:0005829; GO:0006508; GO:0008234; GO:0051604; GO:0071567; GO:0071569,protein maturation [GO:0051604]; protein ufmylation [GO:0071569]; proteolysis [GO:0006508],cytosol [GO:0005829],cysteine-type peptidase activity [GO:0008234]; deUFMylase activity [GO:0071567],GO:0003824; GO:0005829; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; cytosol; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_00257,FUN_001021-T1,Peve_00041049,Pocillopora_meandrina_HIv1___RNAseq.g29605.t1,three_way,73.93249999999999,FUN_001021-T1,P25931,,,,,31.4,258.0,2.5000000000000002e-22,107.8,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_00258,FUN_001025-T1,Peve_00041055,Pocillopora_meandrina_HIv1___RNAseq.g16888.t1,three_way,40.96733333333333,,,,,,,,,,,,,,,,,
OG_00259,FUN_001028-T1,Peve_00041059,Pocillopora_meandrina_HIv1___RNAseq.g29614.t1,three_way,51.323,,,,,,,,,,,,,,,,,
OG_00260,FUN_001031-T1,Peve_00041063,Pocillopora_meandrina_HIv1___RNAseq.g29618.t2,three_way,62.334,,,,,,,,,,,,,,,,,
OG_00261,FUN_001032-T1,Peve_00041064,Pocillopora_meandrina_HIv1___RNAseq.g29619.t1,three_way,55.168,FUN_001032-T1,C3ZQF9,,,,,23.7,304.0,2e-14,81.6,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_00262,FUN_001033-T1,Peve_00041066,Pocillopora_meandrina_HIv1___RNAseq.g29620.t2,three_way,42.79083333333333,,,,,,,,,,,,,,,,,
OG_00263,FUN_001034-T1,Peve_00041067,Pocillopora_meandrina_HIv1___RNAseq.g29623.t1,three_way,38.97933333333333,,,,,,,,,,,,,,,,,
OG_00264,FUN_001041-T1,Peve_00028475,Pocillopora_meandrina_HIv1___TS.g6804.t1,three_way,83.21833333333333,FUN_001041-T1,Q7Z5V6,SAXO4_HUMAN,,Stabilizer of axonemal microtubules 4 (Protein phosphatase 1 regulatory subunit 32),Homo sapiens (Human),33.2,455.0,1.1e-62,242.3,sp|Q7Z5V6|SAXO4_HUMAN Stabilizer of axonemal microtubules 4 OS=Homo sapiens OX=9606 GN=SAXO4 PE=1 SV=1,GO:0005737; GO:0019902; GO:0030317; GO:0036064; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126],phosphatase binding [GO:0019902],GO:0005815; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,microtubule organizing center; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_00265,FUN_001043-T1,Peve_00035617,Pocillopora_meandrina_HIv1___RNAseq.g4491.t1,three_way,58.299,,,,,,,,,,,,,,,,,
OG_00266,FUN_001044-T1,Peve_00041039,Pocillopora_meandrina_HIv1___TS.g6802.t1a,three_way,45.7765,,,,,,,,,,,,,,,,,
OG_00267,FUN_001046-T1,Peve_00041040,Pocillopora_meandrina_HIv1___TS.g6802.t1b,three_way,57.10733333333334,,,,,,,,,,,,,,,,,
OG_00268,FUN_001047-T1,Peve_00017182,Pocillopora_meandrina_HIv1___RNAseq.g4933.t1,three_way,56.60166666666667,FUN_001047-T1,Q7ZTV5,FSHR_CAIMO,,Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor),Cairina moschata (Muscovy duck),25.5,322.0,7.3e-08,60.5,sp|Q7ZTV5|FSHR_CAIMO Follicle-stimulating hormone receptor OS=Cairina moschata OX=8855 GN=FSHR PE=2 SV=1,GO:0004963; GO:0005886; GO:0007186; GO:0007189; GO:0008528; GO:0008584; GO:0009755; GO:0010738; GO:0016020; GO:0042699; GO:0043235; GO:0051897; GO:0070374; GO:0071372,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; male gonad development [GO:0008584]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of protein kinase A signaling [GO:0010738],membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_00269,FUN_001048-T1,Peve_00021556,Pocillopora_meandrina_HIv1___TS.g6801.t1,three_way,49.020833333333336,,,,,,,,,,,,,,,,,
OG_00270,FUN_001049-T1,Peve_00021554,Pocillopora_meandrina_HIv1___RNAseq.g29627.t1,three_way,71.21166666666667,FUN_001049-T1,P28039,AOAH_HUMAN,,Acyloxyacyl hydrolase (EC 3.1.1.77) [Cleaved into: Acyloxyacyl hydrolase small subunit; Acyloxyacyl hydrolase large subunit],Homo sapiens (Human),42.7,583.0,9.299999999999999e-139,495.4,sp|P28039|AOAH_HUMAN Acyloxyacyl hydrolase OS=Homo sapiens OX=9606 GN=AOAH PE=1 SV=1,GO:0005509; GO:0005576; GO:0006631; GO:0009104; GO:0031410; GO:0050528; GO:0050728,fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]; negative regulation of inflammatory response [GO:0050728],cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576],acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509],GO:0003824; GO:0005576; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:1901135,catalytic activity; extracellular region; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; carbohydrate derivative metabolic process
OG_00271,FUN_001051-T1,Peve_00021557,Pocillopora_meandrina_HIv1___RNAseq.g29625.t1,three_way,81.868,FUN_001051-T1,Q92738,US6NL_HUMAN,,USP6 N-terminal-like protein (Related to the N-terminus of tre) (RN-tre),Homo sapiens (Human),57.3,372.0,8.9e-118,425.6,sp|Q92738|US6NL_HUMAN USP6 N-terminal-like protein OS=Homo sapiens OX=9606 GN=USP6NL PE=1 SV=3,GO:0005096; GO:0005829; GO:0005886; GO:0007030; GO:0019068; GO:0031267; GO:0031410; GO:0032588; GO:0035526; GO:0043547; GO:0048227; GO:1903358,"Golgi organization [GO:0007030]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport, plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068]",cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_00272,FUN_001052-T1,Peve_00021553,Pocillopora_meandrina_HIv1___RNAseq.g29624.t1,three_way,73.75933333333333,FUN_001052-T1,Q9UMQ3,BARX2_HUMAN,,Homeobox protein BarH-like 2,Homo sapiens (Human),64.1,64.0,2.1e-15,84.3,sp|Q9UMQ3|BARX2_HUMAN Homeobox protein BarH-like 2 OS=Homo sapiens OX=9606 GN=BARX2 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001502; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0006366; GO:0014902; GO:0015629; GO:0035914; GO:0045944; GO:1990837,cartilage condensation [GO:0001502]; myotube differentiation [GO:0014902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005856; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_00273,FUN_001053-T1,Peve_00023870,Pocillopora_meandrina_HIv1___RNAseq.g29644.t1,three_way,85.719,FUN_001053-T1,Q5REU4,,,,,58.1,904.0,2.8e-296,1019.2,sp|Q5REU4|SND1_PONAB Staphylococcal nuclease domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SND1 PE=2 SV=1,,,,,,
OG_00274,FUN_001054-T1,Peve_00023871,Pocillopora_meandrina_HIv1___RNAseq.g29645.t1,three_way,68.80666666666667,,,,,,,,,,,,,,,,,
OG_00275,FUN_001059-T1,Peve_00030107,Pocillopora_meandrina_HIv1___RNAseq.g29647.t1,three_way,70.47333333333333,FUN_001059-T1,P57093,PAHX_RAT,,"Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)",Rattus norvegicus (Rat),61.6,284.0,3.6e-103,376.3,"sp|P57093|PAHX_RAT Phytanoyl-CoA dioxygenase, peroxisomal OS=Rattus norvegicus OX=10116 GN=Phyh PE=1 SV=2",GO:0001561; GO:0003824; GO:0005777; GO:0006103; GO:0006720; GO:0008198; GO:0019606; GO:0031406; GO:0031418; GO:0048244; GO:0097089; GO:0097731,2-oxobutyrate catabolic process [GO:0019606]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089],9+0 non-motile cilium [GO:0097731]; peroxisome [GO:0005777],carboxylic acid binding [GO:0031406]; catalytic activity [GO:0003824]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244],GO:0003824; GO:0005777; GO:0005929; GO:0006629; GO:0016491; GO:0043226,catalytic activity; peroxisome; cilium; lipid metabolic process; oxidoreductase activity; organelle
OG_00276,FUN_001061-T2,Peve_00005407,Pocillopora_meandrina_HIv1___RNAseq.g29648.t1,three_way,69.14066666666666,FUN_001061-T2,P22758,,,,,40.8,686.0,2.2e-142,508.1,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_00277,FUN_001062-T1,Peve_00005412,Pocillopora_meandrina_HIv1___RNAseq.g29651.t1,three_way,79.03666666666666,,,,,,,,,,,,,,,,,
OG_00278,FUN_001063-T1,Peve_00005411,Pocillopora_meandrina_HIv1___RNAseq.g29652.t1,three_way,85.127,FUN_001063-T1,Q9UBK7,,,,,71.0,124.0,1.4e-49,197.2,sp|Q9UBK7|RBL2A_HUMAN Rab-like protein 2A OS=Homo sapiens OX=9606 GN=RABL2A PE=1 SV=1,,,,,,
OG_00279,FUN_001064-T1,Peve_00005413,Pocillopora_meandrina_HIv1___RNAseq.g29653.t1,three_way,61.42933333333333,FUN_001064-T1,P22758,,,,,41.1,671.0,1.3e-132,475.3,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_00280,FUN_001066-T1,Peve_00018849,Pocillopora_meandrina_HIv1___RNAseq.g29655.t1,three_way,63.10516666666666,FUN_001066-T1,P22758,,,,,39.4,695.0,3.2e-132,474.2,sp|P22758|TGM1_RABIT Protein-glutamine gamma-glutamyltransferase K OS=Oryctolagus cuniculus OX=9986 GN=TGM1 PE=2 SV=2,,,,,,
OG_00281,FUN_001067-T1,Peve_00029706,Pocillopora_meandrina_HIv1___RNAseq.g29656.t1,three_way,64.9165,FUN_001067-T1,A0AVK6,E2F8_HUMAN,,Transcription factor E2F8 (E2F-8),Homo sapiens (Human),40.1,304.0,1.1e-41,173.3,sp|A0AVK6|E2F8_HUMAN Transcription factor E2F8 OS=Homo sapiens OX=9606 GN=E2F8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001890; GO:0002040; GO:0003700; GO:0005654; GO:0005730; GO:0005829; GO:0006357; GO:0032466; GO:0032877; GO:0033301; GO:0042802; GO:0045944; GO:0048144; GO:0060707; GO:0060718; GO:0070365; GO:0090575; GO:1990837,cell cycle comprising mitosis without cytokinesis [GO:0033301]; chorionic trophoblast cell differentiation [GO:0060718]; fibroblast proliferation [GO:0048144]; hepatocyte differentiation [GO:0070365]; negative regulation of cytokinesis [GO:0032466]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of DNA endoreduplication [GO:0032877]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sprouting angiogenesis [GO:0002040]; trophoblast giant cell differentiation [GO:0060707],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0000278; GO:0003677; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,mitotic cell cycle; DNA binding; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00282,FUN_001068-T1,Peve_00019956,Pocillopora_meandrina_HIv1___RNAseq.g29658.t1,three_way,75.84883333333333,FUN_001068-T1,Q92621,NU205_HUMAN,,Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205),Homo sapiens (Human),41.1,2082.0,0.0,1488.8,sp|Q92621|NU205_HUMAN Nuclear pore complex protein Nup205 OS=Homo sapiens OX=9606 GN=NUP205 PE=1 SV=3,GO:0005635; GO:0005643; GO:0005829; GO:0006913; GO:0006999; GO:0015031; GO:0016020; GO:0017056; GO:0031965; GO:0034399; GO:0044611; GO:0051028; GO:0051292,mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005829; GO:0006913; GO:0065003,structural molecule activity; nuclear envelope; cytosol; nucleocytoplasmic transport; protein-containing complex assembly
OG_00283,FUN_001071-T1,Peve_00019958,Pocillopora_meandrina_HIv1___RNAseq.g29659.t2,three_way,62.99216666666667,FUN_001071-T1,Q8BUG5,,,,,37.3,434.0,2.1e-78,295.0,sp|Q8BUG5|CAYP2_MOUSE Calcyphosin-2 OS=Mus musculus OX=10090 GN=Caps2 PE=2 SV=2,,,,,,
OG_00284,FUN_001072-T1,Peve_00019957,Pocillopora_meandrina_HIv1___TS.g6834.t1,three_way,76.98933333333333,,,,,,,,,,,,,,,,,
OG_00285,FUN_001075-T1,Peve_00011328,Pocillopora_meandrina_HIv1___RNAseq.g29662.t2,three_way,73.35966666666667,FUN_001075-T1,O22719,,,,,23.3,430.0,5.6e-17,90.5,sp|O22719|LHTL3_ARATH Lysine histidine transporter-like 3 OS=Arabidopsis thaliana OX=3702 GN=At1g61270 PE=3 SV=2,,,,,,
OG_00286,FUN_001076-T1,Peve_00037405,Pocillopora_meandrina_HIv1___RNAseq.g2716.t1,three_way,76.12899999999999,FUN_001076-T1,Q75V66,ANO5_HUMAN,,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),Homo sapiens (Human),42.4,850.0,1.4e-187,658.3,sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; plasma membrane; organelle; transmembrane transport; membrane organization
OG_00287,FUN_001077-T1,Peve_00037392,Pocillopora_meandrina_HIv1___TS.g5224.t1,three_way,47.706,FUN_001077-T1,P13233,CN37_RAT,,"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)",Rattus norvegicus (Rat),28.8,416.0,1e-38,162.9,"sp|P13233|CN37_RAT 2',3'-cyclic-nucleotide 3'-phosphodiesterase OS=Rattus norvegicus OX=10116 GN=Cnp PE=1 SV=2",GO:0003723; GO:0004113; GO:0005615; GO:0005737; GO:0005741; GO:0005743; GO:0005902; GO:0007409; GO:0008344; GO:0009214; GO:0009636; GO:0016020; GO:0030551; GO:0030900; GO:0031143; GO:0032496; GO:0035748; GO:0035749; GO:0042470; GO:0042995; GO:0043209; GO:0046902; GO:0048471; GO:0048709,adult locomotory behavior [GO:0008344]; axonogenesis [GO:0007409]; cyclic nucleotide catabolic process [GO:0009214]; forebrain development [GO:0030900]; oligodendrocyte differentiation [GO:0048709]; regulation of mitochondrial membrane permeability [GO:0046902]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636],cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; myelin sheath [GO:0043209]; myelin sheath abaxonal region [GO:0035748]; myelin sheath adaxonal region [GO:0035749]; perinuclear region of cytoplasm [GO:0048471]; pseudopodium [GO:0031143],"2',3'-cyclic-nucleotide 3'-phosphodiesterase activity [GO:0004113]; cyclic nucleotide binding [GO:0030551]; RNA binding [GO:0003723]",GO:0003723; GO:0003824; GO:0005615; GO:0007005; GO:0016787; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0055086; GO:0061024,RNA binding; catalytic activity; extracellular space; mitochondrion organization; hydrolase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; membrane organization
OG_00288,FUN_001078-T1,Peve_00037393,Pocillopora_meandrina_HIv1___TS.g5223.t1a,three_way,65.36733333333333,,,,,,,,,,,,,,,,,
OG_00289,FUN_001079-T1,Peve_00037394,Pocillopora_meandrina_HIv1___RNAseq.g2713.t1,three_way,65.095,FUN_001079-T1,P19440,GGT1_HUMAN,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Homo sapiens (Human),38.9,542.0,5.2e-92,340.1,sp|P19440|GGT1_HUMAN Glutathione hydrolase 1 proenzyme OS=Homo sapiens OX=9606 GN=GGT1 PE=1 SV=2,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0019344; GO:0031179; GO:0031638; GO:0036374; GO:0050727; GO:0070062; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; organelle; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_00290,FUN_001081-T1,Peve_00037397,Pocillopora_meandrina_HIv1___RNAseq.g2712.t1,three_way,88.91366666666667,FUN_001081-T1,Q13557,,,,,72.0,468.0,8.2e-197,688.0,sp|Q13557|KCC2D_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Homo sapiens OX=9606 GN=CAMK2D PE=1 SV=3,,,,,,
OG_00291,FUN_001082-T1,Peve_00037398,Pocillopora_meandrina_HIv1___RNAseq.g2711.t1,three_way,87.09333333333333,FUN_001082-T1,Q6DKC0,,,,,71.6,327.0,1.3000000000000002e-124,447.6,sp|Q6DKC0|ERL2B_XENLA Erlin-2-B OS=Xenopus laevis OX=8355 GN=erlin2-b PE=2 SV=1,,,,,,
OG_00292,FUN_001083-T1,Peve_00037399,Pocillopora_meandrina_HIv1___RNAseq.g2710.t1,three_way,60.68333333333334,FUN_001083-T1,P05363,,,,,34.2,295.0,4.4e-33,143.7,sp|P05363|NK2R_BOVIN Substance-K receptor OS=Bos taurus OX=9913 GN=TACR2 PE=2 SV=1,,,,,,
OG_00293,FUN_001084-T2,Peve_00033071,Pocillopora_meandrina_HIv1___RNAseq.g2709.t1,three_way,59.259,FUN_001084-T2,O17239,,,,,24.3,301.0,3.6e-06,53.9,sp|O17239|NMUR2_CAEEL Neuromedin U receptor homolog nmur-2 OS=Caenorhabditis elegans OX=6239 GN=nmur-2 PE=3 SV=2,,,,,,
OG_00294,FUN_001085-T1,Peve_00003173,Pocillopora_meandrina_HIv1___RNAseq.g29389.t1,three_way,62.842,FUN_001085-T1,Q9W770,,,,,33.3,435.0,3.7000000000000004e-59,230.7,sp|Q9W770|SPON1_CHICK Spondin-1 OS=Gallus gallus OX=9031 GN=SPON1 PE=2 SV=1,,,,,,
OG_00295,FUN_001086-T1,Peve_00003185,Pocillopora_meandrina_HIv1___RNAseq.g29387.t1,three_way,66.87883333333333,FUN_001086-T1,Q6DRG7,MYPT1_DANRE,,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),Danio rerio (Zebrafish) (Brachydanio rerio),65.8,225.0,9.999999999999999e-33,143.7,sp|Q6DRG7|MYPT1_DANRE Protein phosphatase 1 regulatory subunit 12A OS=Danio rerio OX=7955 GN=ppp1r12a PE=2 SV=2,GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0017020; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0030510; GO:0031017; GO:0031672; GO:0046982; GO:0048812; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357,actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; neuron projection morphogenesis [GO:0048812]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165],A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018],14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0048856; GO:0098772,anatomical structure development; molecular function regulator activity
OG_00295,FUN_001086-T1,Peve_00003185,Pocillopora_meandrina_HIv1___RNAseq.g29387.t1,three_way,66.87883333333333,FUN_001086-T1,Q6DRG7,MYPT1_DANRE,,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),Danio rerio (Zebrafish) (Brachydanio rerio),81.6,38.0,1.9e-07,59.7,sp|Q6DRG7|MYPT1_DANRE Protein phosphatase 1 regulatory subunit 12A OS=Danio rerio OX=7955 GN=ppp1r12a PE=2 SV=2,GO:0001889; GO:0004857; GO:0005737; GO:0007165; GO:0007409; GO:0008045; GO:0008360; GO:0017020; GO:0019208; GO:0019901; GO:0021555; GO:0030018; GO:0030155; GO:0030510; GO:0031017; GO:0031672; GO:0046982; GO:0048812; GO:0051017; GO:0060028; GO:0070650; GO:0071889; GO:0072357,actin filament bundle assembly [GO:0051017]; actin filament bundle distribution [GO:0070650]; axonogenesis [GO:0007409]; convergent extension involved in axis elongation [GO:0060028]; exocrine pancreas development [GO:0031017]; liver development [GO:0001889]; midbrain-hindbrain boundary morphogenesis [GO:0021555]; motor neuron axon guidance [GO:0008045]; neuron projection morphogenesis [GO:0048812]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165],A band [GO:0031672]; cytoplasm [GO:0005737]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018],14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020]; phosphatase regulator activity [GO:0019208]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0048856; GO:0098772,anatomical structure development; molecular function regulator activity
OG_00296,FUN_001087-T1,Peve_00003172,Pocillopora_meandrina_HIv1___RNAseq.g29386.t1,three_way,70.96266666666666,,,,,,,,,,,,,,,,,
OG_00297,FUN_001088-T1,Peve_00003176,Pocillopora_meandrina_HIv1___RNAseq.g29383.t1,three_way,71.9695,,,,,,,,,,,,,,,,,
OG_00298,FUN_001089-T1,Peve_00003177,Pocillopora_meandrina_HIv1___RNAseq.g29382.t1,three_way,67.06783333333333,,,,,,,,,,,,,,,,,
OG_00299,FUN_001096-T2,Peve_00003180,Pocillopora_meandrina_HIv1___RNAseq.g29381.t1,three_way,83.893,,,,,,,,,,,,,,,,,
OG_00300,FUN_001098-T1,Peve_00003181,Pocillopora_meandrina_HIv1___RNAseq.g29379.t1a,three_way,85.81566666666667,FUN_001098-T1,Q5E964,,,,,55.2,375.0,4.9000000000000005e-117,422.5,sp|Q5E964|PSD13_BOVIN 26S proteasome non-ATPase regulatory subunit 13 OS=Bos taurus OX=9913 GN=PSMD13 PE=2 SV=1,,,,,,
OG_00301,FUN_001099-T1,Peve_00003182,Pocillopora_meandrina_HIv1___RNAseq.g29378.t1,three_way,56.94566666666667,FUN_001099-T1,Q9Z0E1,,,,,31.4,369.0,1.7e-37,158.3,sp|Q9Z0E1|M1AP_MOUSE Meiosis 1 arrest protein OS=Mus musculus OX=10090 GN=M1ap PE=1 SV=2,,,,,,
OG_00302,FUN_001101-T1,Peve_00003157,Pocillopora_meandrina_HIv1___RNAseq.g29377.t1,three_way,58.175666666666665,,,,,,,,,,,,,,,,,
OG_00303,FUN_001103-T1,Peve_00003160,Pocillopora_meandrina_HIv1___RNAseq.g29375.t1,three_way,39.9865,,,,,,,,,,,,,,,,,
OG_00304,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_00305,FUN_001107-T1,Peve_00029366,Pocillopora_meandrina_HIv1___RNAseq.g29366.t1,three_way,86.59933333333333,FUN_001107-T1,Q9GZN1,ARP6_HUMAN,,Actin-related protein 6 (hArp6) (hARPX),Homo sapiens (Human),60.3,398.0,3.2e-143,509.6,sp|Q9GZN1|ARP6_HUMAN Actin-related protein 6 OS=Homo sapiens OX=9606 GN=ACTR6 PE=1 SV=1,GO:0000786; GO:0000812; GO:0005634; GO:0005730; GO:0005737; GO:0005856; GO:0006338; GO:0006355; GO:0007000; GO:0016479; GO:0031491; GO:0045943,chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase I [GO:0016479]; nucleolus organization [GO:0007000]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of DNA-templated transcription [GO:0006355],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; nucleus [GO:0005634]; Swr1 complex [GO:0000812],nucleosome binding [GO:0031491],GO:0005634; GO:0005730; GO:0005856; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleolus; cytoskeleton; chromatin organization; regulation of DNA-templated transcription; organelle
OG_00306,FUN_001108-T1,Peve_00029386,Pocillopora_meandrina_HIv1___TS.g6556.t1,three_way,75.97966666666667,FUN_001108-T1,Q6PBP3,,,,,49.3,205.0,5.6e-43,175.6,sp|Q6PBP3|PXL2A_DANRE Peroxiredoxin-like 2A OS=Danio rerio OX=7955 GN=prxl2a PE=2 SV=2,,,,,,
OG_00307,FUN_001109-T1,Peve_00029332,Pocillopora_meandrina_HIv1___RNAseq.g29364.t1,three_way,74.86366666666667,FUN_001109-T1,Q571G4,LIN54_MOUSE,,Protein lin-54 homolog,Mus musculus (Mouse),44.9,499.0,9.2e-94,345.9,sp|Q571G4|LIN54_MOUSE Protein lin-54 homolog OS=Mus musculus OX=10090 GN=Lin54 PE=2 SV=2,GO:0001067; GO:0003680; GO:0034728; GO:0046872; GO:0090571,nucleosome organization [GO:0034728],RNA polymerase II transcription repressor complex [GO:0090571],metal ion binding [GO:0046872]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; transcription regulatory region nucleic acid binding [GO:0001067],GO:0003677; GO:0006325,DNA binding; chromatin organization
OG_00308,FUN_001110-T1,Peve_00029335,Pocillopora_meandrina_HIv1___RNAseq.g29363.t1,three_way,71.534,FUN_001110-T1,P15384,,,,,49.9,407.0,2.3e-84,314.7,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_00309,FUN_001111-T1,Peve_00029358,Pocillopora_meandrina_HIv1___RNAseq.g29362.t1,three_way,69.821,,,,,,,,,,,,,,,,,
OG_00310,FUN_001113-T1,Peve_00029360,Pocillopora_meandrina_HIv1___RNAseq.g29360.t1,three_way,39.53033333333333,,,,,,,,,,,,,,,,,
OG_00311,FUN_001114-T1,Peve_00029361,Pocillopora_meandrina_HIv1___RNAseq.g29359.t2,three_way,76.712,FUN_001114-T1,P56597,NDK5_HUMAN,,Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (3'-5' exonuclease NME5) (EC 3.1.-.-) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5),Homo sapiens (Human),61.8,207.0,6.7000000000000004e-74,278.5,sp|P56597|NDK5_HUMAN Nucleoside diphosphate kinase homolog 5 OS=Homo sapiens OX=9606 GN=NME5 PE=1 SV=1,GO:0001534; GO:0003341; GO:0003351; GO:0004550; GO:0005576; GO:0005929; GO:0006183; GO:0006228; GO:0006241; GO:0007283; GO:0007286; GO:0008408; GO:0009116; GO:0021591; GO:0036126; GO:0051649; GO:0060271; GO:0097729; GO:1902176,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591],9+2 motile cilium [GO:0097729]; cilium [GO:0005929]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126],3'-5' exonuclease activity [GO:0008408]; nucleoside diphosphate kinase activity [GO:0004550],GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0055086; GO:1901135,catalytic activity; extracellular region; cilium; microtubule-based movement; transferase activity; hydrolase activity; reproductive process; organelle; cilium organization; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00312,FUN_001115-T1,Peve_00029363,Pocillopora_meandrina_HIv1___RNAseq.g29357.t1,three_way,97.802,FUN_001115-T1,Q7ZUG0,RUXE_DANRE,,Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE),Danio rerio (Zebrafish) (Brachydanio rerio),86.5,89.0,6.1e-37,154.5,sp|Q7ZUG0|RUXE_DANRE Small nuclear ribonucleoprotein E OS=Danio rerio OX=7955 GN=snrpe PE=3 SV=1,GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]",cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_00313,FUN_001116-T2,Peve_00029365,Pocillopora_meandrina_HIv1___RNAseq.g29354.t1,three_way,60.4465,FUN_001116-T2,Q12912,IRAG2_HUMAN,,"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2]",Homo sapiens (Human),29.0,217.0,9e-15,84.7,"sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3",GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577,immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0002376; GO:0005635; GO:0005694; GO:0005815; GO:0005886; GO:0008092; GO:0022414; GO:0043226; GO:0061024,immune system process; nuclear envelope; chromosome; microtubule organizing center; plasma membrane; cytoskeletal protein binding; reproductive process; organelle; membrane organization
OG_00314,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_00315,FUN_001122-T1,Peve_00029372,Pocillopora_meandrina_HIv1___TS.g6543.t1,three_way,62.12316666666666,FUN_001122-T1,O75691,UTP20_HUMAN,,Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6),Homo sapiens (Human),32.2,1710.0,8.1e-220,766.1,sp|O75691|UTP20_HUMAN Small subunit processome component 20 homolog OS=Homo sapiens OX=9606 GN=UTP20 PE=1 SV=3,GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005654; GO:0005730; GO:0005737; GO:0005886; GO:0006364; GO:0008285; GO:0030686; GO:0030688; GO:0032040; GO:0042274,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; negative regulation of cell population proliferation [GO:0008285]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]","90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome, small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]",RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0005730; GO:0005886; GO:0043226,RNA binding; nucleoplasm; nucleolus; plasma membrane; organelle
OG_00316,FUN_001130-T1,Peve_00029377,Pocillopora_meandrina_HIv1___TS.g6539.t1,three_way,72.67933333333333,FUN_001130-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),37.5,680.0,2.8e-122,441.0,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_00317,FUN_001135-T1,Peve_00029383,Pocillopora_meandrina_HIv1___RNAseq.g29341.t1,three_way,76.26066666666667,FUN_001135-T1,G3M4F8,,,,,26.8,347.0,1.4e-17,92.0,sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1,,,,,,
OG_00318,FUN_001136-T1,Peve_00029384,Pocillopora_meandrina_HIv1___RNAseq.g29340.t1,three_way,69.62683333333334,FUN_001136-T1,Q9VCZ3,OCTB1_DROME,,Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R),Drosophila melanogaster (Fruit fly),30.7,319.0,1.9999999999999998e-26,121.3,sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1,GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410],membrane [GO:0016020]; plasma membrane [GO:0005886],adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_00319,FUN_001137-T1,Peve_00029385,Pocillopora_meandrina_HIv1___RNAseq.g29339.t1,three_way,81.55166666666666,FUN_001137-T1,Q9Y345,,,,,44.3,625.0,1.2e-152,541.6,sp|Q9Y345|SC6A5_HUMAN Sodium- and chloride-dependent glycine transporter 2 OS=Homo sapiens OX=9606 GN=SLC6A5 PE=1 SV=3,,,,,,
OG_00320,FUN_001139-T1,Peve_00029334,Pocillopora_meandrina_HIv1___RNAseq.g29336.t1,three_way,78.20866666666667,FUN_001139-T1,Q761V0,SC6A5_MOUSE,,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Mus musculus (Mouse),46.3,609.0,5.5e-158,559.3,sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1,GO:0001504; GO:0005886; GO:0015375; GO:0046872; GO:0098690; GO:0098793; GO:0098810,neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504],glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynapse [GO:0098793],glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_00321,FUN_001140-T2,Peve_00029337,Pocillopora_meandrina_HIv1___RNAseq.g29334.t1,three_way,83.7735,FUN_001140-T2,Q6DIR8,,,,,39.4,866.0,2.9999999999999998e-173,610.5,sp|Q6DIR8|PALD_XENTR Paladin OS=Xenopus tropicalis OX=8364 GN=pald1 PE=2 SV=1,,,,,,
OG_00322,FUN_001141-T1,Peve_00029338,Pocillopora_meandrina_HIv1___RNAseq.g29333.t1,three_way,78.69883333333334,FUN_001141-T1,Q8WML3,,,,,47.3,752.0,2.7000000000000007e-186,654.1,sp|Q8WML3|KAT6B_MACFA Histone acetyltransferase KAT6B OS=Macaca fascicularis OX=9541 GN=KAT6B PE=2 SV=1,,,,,,
OG_00323,FUN_001142-T1,Peve_00029340,Pocillopora_meandrina_HIv1___RNAseq.g29332.t1,three_way,72.95883333333333,FUN_001142-T1,Q91827,,,,,38.8,178.0,1.4999999999999998e-24,114.4,sp|Q91827|AR1_XENLA Apoptosis regulator R1 (Fragment) OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_00324,FUN_001144-T1,Peve_00029341,Pocillopora_meandrina_HIv1___RNAseq.g29331.t1,three_way,57.1545,,,,,,,,,,,,,,,,,
OG_00325,FUN_001145-T1,Peve_00029342,Pocillopora_meandrina_HIv1___RNAseq.g29330.t1,three_way,78.29899999999999,FUN_001145-T1,B5X3I1,,,,,56.2,210.0,6.3e-45,182.2,sp|B5X3I1|WASC3_SALSA WASH complex subunit 3 OS=Salmo salar OX=8030 GN=washc3 PE=2 SV=1,,,,,,
OG_00326,FUN_001146-T1,Peve_00029343,Pocillopora_meandrina_HIv1___RNAseq.g29329.t1,three_way,41.167,,,,,,,,,,,,,,,,,
OG_00327,FUN_001147-T1,Peve_00029344,Pocillopora_meandrina_HIv1___TS.g6522.t1,three_way,73.868,FUN_001147-T1,Q17QK3,CBPQ_BOVIN,,Carboxypeptidase Q (EC 3.4.17.-) (Plasma glutamate carboxypeptidase),Bos taurus (Bovine),57.9,470.0,3.5e-152,539.7,sp|Q17QK3|CBPQ_BOVIN Carboxypeptidase Q OS=Bos taurus OX=9913 GN=CPQ PE=2 SV=1,GO:0004180; GO:0005615; GO:0005737; GO:0005764; GO:0005783; GO:0005794; GO:0006508; GO:0006590; GO:0042246; GO:0042803; GO:0043171; GO:0046872; GO:0070573,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; thyroid hormone generation [GO:0006590]; tissue regeneration [GO:0042246],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764],carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005794; GO:0006575; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; endoplasmic reticulum; Golgi apparatus; modified amino acid metabolic process; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00328,FUN_001148-T1,Peve_00002869,Pocillopora_meandrina_HIv1___RNAseq.g29326.t1,three_way,83.11733333333333,FUN_001148-T1,Q99LI7,,,,,55.9,709.0,2.5e-234,813.1,sp|Q99LI7|CSTF3_MOUSE Cleavage stimulation factor subunit 3 OS=Mus musculus OX=10090 GN=Cstf3 PE=1 SV=1,,,,,,
OG_00329,FUN_001150-T1,Peve_00002868,Pocillopora_meandrina_HIv1___RNAseq.g29325.t1,three_way,67.18033333333334,FUN_001150-T1,Q5PPY2,,,,,37.7,199.0,5.5e-25,115.9,sp|Q5PPY2|BORC5_XENLA BLOC-1-related complex subunit 5 OS=Xenopus laevis OX=8355 GN=borcs5 PE=2 SV=1,,,,,,
OG_00330,FUN_001151-T1,Peve_00002867,Pocillopora_meandrina_HIv1___RNAseq.g29324.t1,three_way,82.99033333333333,FUN_001151-T1,Q6TEM9,MYLIA_DANRE,,E3 ubiquitin-protein ligase MYLIP-A (EC 2.3.2.27) (Myosin regulatory light chain-interacting protein A) (MIR-A) (RING-type E3 ubiquitin transferase MYLIP-A),Danio rerio (Zebrafish) (Brachydanio rerio),31.2,480.0,1.4999999999999998e-62,241.9,sp|Q6TEM9|MYLIA_DANRE E3 ubiquitin-protein ligase MYLIP-A OS=Danio rerio OX=7955 GN=mylipa PE=1 SV=2,GO:0004842; GO:0005737; GO:0005829; GO:0005856; GO:0006511; GO:0007369; GO:0008270; GO:0016567; GO:0030178,gastrulation [GO:0007369]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005856; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00331,FUN_001152-T1,Peve_00002865,Pocillopora_meandrina_HIv1___RNAseq.g29323.t1,three_way,64.47866666666667,FUN_001152-T1,Q8CH62,,,,,48.5,132.0,2.9e-06,53.1,sp|Q8CH62|LTO1_MOUSE Protein LTO1 homolog OS=Mus musculus OX=10090 GN=Lto1 PE=1 SV=1,,,,,,
OG_00332,FUN_001153-T1,Peve_00002864,Pocillopora_meandrina_HIv1___RNAseq.g29322.t2,three_way,50.12916666666666,,,,,,,,,,,,,,,,,
OG_00333,FUN_001154-T1,Peve_00002863,Pocillopora_meandrina_HIv1___RNAseq.g29321.t1,three_way,78.88166666666666,FUN_001154-T1,Q5RF73,,,,,51.2,283.0,2.5e-79,297.0,sp|Q5RF73|TMM19_PONAB Transmembrane protein 19 OS=Pongo abelii OX=9601 GN=TMEM19 PE=2 SV=1,,,,,,
OG_00334,FUN_001155-T1,Peve_00002861,Pocillopora_meandrina_HIv1___RNAseq.g29319.t1,three_way,85.69133333333333,FUN_001155-T1,O08734,BAK_MOUSE,,Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK),Mus musculus (Mouse),46.4,112.0,3.1e-24,113.2,sp|O08734|BAK_MOUSE Bcl-2 homologous antagonist/killer OS=Mus musculus OX=10090 GN=Bak1 PE=1 SV=3,GO:0001776; GO:0001782; GO:0001783; GO:0001836; GO:0001974; GO:0002262; GO:0002352; GO:0005739; GO:0005741; GO:0005783; GO:0005829; GO:0008053; GO:0008285; GO:0008630; GO:0009410; GO:0009620; GO:0010046; GO:0010225; GO:0010248; GO:0010332; GO:0010524; GO:0010629; GO:0015288; GO:0031018; GO:0031072; GO:0031100; GO:0031334; GO:0031966; GO:0032471; GO:0034644; GO:0035108; GO:0042542; GO:0042802; GO:0042803; GO:0043065; GO:0044325; GO:0044346; GO:0044877; GO:0045471; GO:0045862; GO:0046872; GO:0046902; GO:0046930; GO:0046982; GO:0048597; GO:0048872; GO:0050673; GO:0051087; GO:0051400; GO:0051649; GO:0051726; GO:0051881; GO:0060068; GO:0060402; GO:0070059; GO:0070242; GO:0071260; GO:0090200; GO:0090201; GO:0097145; GO:0097192; GO:1901029; GO:1901030; GO:1902262,animal organ regeneration [GO:0031100]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell negative selection [GO:0002352]; blood vessel remodeling [GO:0001974]; calcium ion transport into cytosol [GO:0060402]; cellular response to mechanical stimulus [GO:0071260]; cellular response to UV [GO:0034644]; endocrine pancreas development [GO:0031018]; epithelial cell proliferation [GO:0050673]; establishment of localization in cell [GO:0051649]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fibroblast apoptotic process [GO:0044346]; homeostasis of number of cells [GO:0048872]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; leukocyte homeostasis [GO:0001776]; limb morphogenesis [GO:0035108]; mitochondrial fusion [GO:0008053]; myeloid cell homeostasis [GO:0002262]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of gene expression [GO:0010629]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of proteolysis [GO:0045862]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; post-embryonic camera-type eye morphogenesis [GO:0048597]; regulation of cell cycle [GO:0051726]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to ethanol [GO:0045471]; response to fungus [GO:0009620]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to mycotoxin [GO:0010046]; response to UV-C [GO:0010225]; response to xenobiotic stimulus [GO:0009410]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],BAK complex [GO:0097145]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; pore complex [GO:0046930],BH domain binding [GO:0051400]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; porin activity [GO:0015288]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0005215; GO:0005739; GO:0005783; GO:0005829; GO:0007005; GO:0012501; GO:0022414; GO:0043226; GO:0048856; GO:0055085; GO:0061024,immune system process; transporter activity; mitochondrion; endoplasmic reticulum; cytosol; mitochondrion organization; programmed cell death; reproductive process; organelle; anatomical structure development; transmembrane transport; membrane organization
OG_00335,FUN_001156-T1,Peve_00002858,Pocillopora_meandrina_HIv1___RNAseq.g29318.t1,three_way,61.01533333333333,,,,,,,,,,,,,,,,,
OG_00336,FUN_001157-T1,Peve_00002857,Pocillopora_meandrina_HIv1___RNAseq.g29317.t1,three_way,83.7075,FUN_001157-T1,Q6DGV1,CELF4_DANRE,,CUGBP Elav-like family member 4 (CELF-4) (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4),Danio rerio (Zebrafish) (Brachydanio rerio),46.6,513.0,4.2e-108,393.3,sp|Q6DGV1|CELF4_DANRE CUGBP Elav-like family member 4 OS=Danio rerio OX=7955 GN=celf4 PE=2 SV=1,GO:0000381; GO:0003729; GO:0005634; GO:0005737; GO:0006376; GO:0048026; GO:1990904,"mRNA splice site recognition [GO:0006376]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]",cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],mRNA binding [GO:0003729],GO:0003723; GO:0005634; GO:0043226; GO:0065003,RNA binding; nucleus; organelle; protein-containing complex assembly
OG_00337,FUN_001158-T1,Peve_00043471,Pocillopora_meandrina_HIv1___RNAseq.g29220.t1,three_way,76.751,FUN_001158-T1,Q7ZXG7,,,,,68.5,232.0,3.9e-96,352.4,sp|Q7ZXG7|GAMTA_XENLA Guanidinoacetate N-methyltransferase A OS=Xenopus laevis OX=8355 GN=gamt-a PE=2 SV=1,,,,,,
OG_00338,FUN_001160-T1,Peve_00043472,Pocillopora_meandrina_HIv1___RNAseq.g29219.t1,three_way,80.853,FUN_001160-T1,P50416,CPT1A_HUMAN,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Homo sapiens (Human),40.4,798.0,1.7e-154,548.1,"sp|P50416|CPT1A_HUMAN Carnitine O-palmitoyltransferase 1, liver isoform OS=Homo sapiens OX=9606 GN=CPT1A PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0006853; GO:0007584; GO:0009410; GO:0009437; GO:0010883; GO:0016020; GO:0030674; GO:0030855; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0055085; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; transmembrane transport; molecular adaptor activity
OG_00339,FUN_001163-T1,Peve_00002997,Pocillopora_meandrina_HIv1___RNAseq.g29217.t1,three_way,74.614,FUN_001163-T1,Q96HA9,PX11C_HUMAN,,Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma) (PEX11-gamma),Homo sapiens (Human),36.3,237.0,9.6e-40,165.2,sp|Q96HA9|PX11C_HUMAN Peroxisomal membrane protein 11C OS=Homo sapiens OX=9606 GN=PEX11G PE=1 SV=1,GO:0005777; GO:0005778; GO:0016559; GO:0032991; GO:0044375,peroxisome fission [GO:0016559]; regulation of peroxisome size [GO:0044375],peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],,GO:0005777; GO:0043226,peroxisome; organelle
OG_00340,FUN_001165-T1,Peve_00002994,Pocillopora_meandrina_HIv1___RNAseq.g29215.t1,three_way,48.952333333333335,FUN_001165-T1,Q5PQ89,,,,,35.6,132.0,2.3e-13,79.3,sp|Q5PQ89|AN34B_XENLA Ankyrin repeat domain-containing protein 34B OS=Xenopus laevis OX=8355 GN=ankrd34b PE=2 SV=1,,,,,,
OG_00341,FUN_001166-T1,Peve_00015995,Pocillopora_meandrina_HIv1___RNAseq.g29155.t1,three_way,70.502,FUN_001166-T1,B0UYT5,,,,,32.6,344.0,5.6e-38,160.6,sp|B0UYT5|MFD6B_DANRE Major facilitator superfamily domain-containing protein 6-B OS=Danio rerio OX=7955 GN=mfsd6b PE=3 SV=1,,,,,,
OG_00342,FUN_001167-T1,Peve_00015996,Pocillopora_meandrina_HIv1___RNAseq.g29154.t1,three_way,76.15266666666666,FUN_001167-T1,Q01617,,,,,51.7,172.0,6.1e-35,149.4,sp|Q01617|CPO_DROME Protein couch potato OS=Drosophila melanogaster OX=7227 GN=cpo PE=2 SV=4,,,,,,
OG_00343,FUN_001168-T1,Peve_00015997,Pocillopora_meandrina_HIv1___RNAseq.g29153.t1,three_way,86.27633333333334,FUN_001168-T1,A4IJ21,,,,,52.2,255.0,2.3e-13,78.6,sp|A4IJ21|MNS1_XENTR Meiosis-specific nuclear structural protein 1 OS=Xenopus tropicalis OX=8364 GN=mns1 PE=2 SV=1,,,,,,
OG_00344,FUN_001171-T1,Peve_00034802,Pocillopora_meandrina_HIv1___RNAseq.g29143.t1,three_way,52.29566666666666,FUN_001171-T1,D4AUF1,,,,,27.1,129.0,8.7e-06,54.3,sp|D4AUF1|WSCD1_ARTBC WSC domain-containing protein ARB_07867 OS=Arthroderma benhamiae (strain ATCC MYA-4681 / CBS 112371) OX=663331 GN=ARB_07867 PE=1 SV=1,,,,,,
OG_00345,FUN_001172-T1,Peve_00034801,Pocillopora_meandrina_HIv1___RNAseq.g29144.t1,three_way,58.16183333333333,FUN_001172-T1,O60678,ANM3_HUMAN,,Protein arginine N-methyltransferase 3 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3),Homo sapiens (Human),47.6,538.0,1.7e-131,471.1,sp|O60678|ANM3_HUMAN Protein arginine N-methyltransferase 3 OS=Homo sapiens OX=9606 GN=PRMT3 PE=1 SV=4,GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0008168; GO:0008270; GO:0016274; GO:0031397; GO:0032259; GO:0035241; GO:0035242; GO:0042054; GO:0044020; GO:0045669; GO:0045815; GO:1900053,chromatin remodeling [GO:0006338]; methylation [GO:0032259]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of DNA-templated transcription [GO:0006355]; transcription initiation-coupled chromatin remodeling [GO:0045815],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; methyltransferase activity [GO:0008168]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00346,FUN_001173-T1,Peve_00034800,Pocillopora_meandrina_HIv1___RNAseq.g29145.t1,three_way,74.758,FUN_001173-T1,Q8IV38,,,,,51.8,417.0,3.2e-86,320.5,sp|Q8IV38|ANKY2_HUMAN Ankyrin repeat and MYND domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ANKMY2 PE=1 SV=1,,,,,,
OG_00347,FUN_001174-T1,Peve_00002993,Pocillopora_meandrina_HIv1___RNAseq.g29214.t1,three_way,71.508,FUN_001174-T1,P00377,,,,,41.3,184.0,6.499999999999998e-41,168.7,sp|P00377|DYR_PIG Dihydrofolate reductase OS=Sus scrofa OX=9823 GN=DHFR PE=1 SV=1,,,,,,
OG_00348,FUN_001175-T1,Peve_00015994,Pocillopora_meandrina_HIv1___RNAseq.g29156.t1,three_way,64.6045,FUN_001175-T1,Q1LUQ4,,,,,24.8,568.0,1.6e-35,152.5,sp|Q1LUQ4|MFD6A_DANRE Major facilitator superfamily domain-containing protein 6-A OS=Danio rerio OX=7955 GN=mfsd6a PE=3 SV=1,,,,,,
OG_00349,FUN_001176-T1,Peve_00015993,Pocillopora_meandrina_HIv1___TS.g6373.t1,three_way,71.25133333333333,FUN_001176-T1,O43451,MGA_HUMAN,,"Maltase-glucoamylase (Alpha-1,4-glucosidase) (EC 3.2.1.20)",Homo sapiens (Human),48.8,853.0,2.6e-247,856.7,sp|O43451|MGA_HUMAN Maltase-glucoamylase OS=Homo sapiens OX=9606 GN=MGAM PE=1 SV=6,GO:0000025; GO:0003824; GO:0004339; GO:0004558; GO:0004574; GO:0005886; GO:0005983; GO:0016160; GO:0016324; GO:0030246; GO:0070062; GO:0070821; GO:0101003; GO:1901027,dextrin catabolic process [GO:1901027]; maltose catabolic process [GO:0000025]; starch catabolic process [GO:0005983],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821],"alpha-1,4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1,4-alpha-glucosidase activity [GO:0004339]; oligo-1,6-glucosidase activity [GO:0004574]",GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0043226,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; organelle
OG_00350,FUN_001177-T2,Peve_00027161,Pocillopora_meandrina_HIv1___TS.g6731.t1,three_way,57.35983333333333,,,,,,,,,,,,,,,,,
OG_00351,FUN_001178-T1,Peve_00027159,Pocillopora_meandrina_HIv1___RNAseq.g29546.t1,three_way,73.34033333333333,FUN_001178-T1,Q9NUJ3,T11L1_HUMAN,,T-complex protein 11-like protein 1,Homo sapiens (Human),39.4,447.0,1.8e-84,314.7,sp|Q9NUJ3|T11L1_HUMAN T-complex protein 11-like protein 1 OS=Homo sapiens OX=9606 GN=TCP11L1 PE=1 SV=1,GO:0005874; GO:0007165,signal transduction [GO:0007165],microtubule [GO:0005874],,,
OG_00352,FUN_001180-T1,Peve_00018946,Pocillopora_meandrina_HIv1___RNAseq.g29544.t1,three_way,57.39666666666667,FUN_001180-T1,E9Q7E2,ARID2_MOUSE,,AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200),Mus musculus (Mouse),33.1,834.0,1.3e-106,390.2,sp|E9Q7E2|ARID2_MOUSE AT-rich interactive domain-containing protein 2 OS=Mus musculus OX=10090 GN=Arid2 PE=1 SV=1,GO:0000776; GO:0000785; GO:0003007; GO:0003677; GO:0005654; GO:0005667; GO:0005886; GO:0006337; GO:0006338; GO:0006357; GO:0008270; GO:0008285; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0030336; GO:0042592; GO:0045582; GO:0045597; GO:0045663; GO:0045944; GO:0048568; GO:0060038; GO:0060982; GO:0070316; GO:0072359; GO:1905168; GO:2000045; GO:2000781; GO:2000819,cardiac muscle cell proliferation [GO:0060038]; chromatin remodeling [GO:0006338]; circulatory system development [GO:0072359]; coronary artery morphogenesis [GO:0060982]; embryonic organ development [GO:0048568]; heart morphogenesis [GO:0003007]; homeostatic process [GO:0042592]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0005886; GO:0006325; GO:0006355; GO:0043226; GO:0048856,DNA binding; nucleoplasm; plasma membrane; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development
OG_00353,FUN_001181-T1,Peve_00018945,Pocillopora_meandrina_HIv1___RNAseq.g29543.t1,three_way,82.81166666666667,FUN_001181-T1,A8WH18,,,,,63.5,482.0,5e-176,619.0,sp|A8WH18|NARFL_XENTR Cytosolic Fe-S cluster assembly factor narfl OS=Xenopus tropicalis OX=8364 GN=narfl PE=2 SV=1,,,,,,
OG_00354,FUN_001184-T1,Peve_00040983,Pocillopora_meandrina_HIv1___RNAseq.g29541.t1,three_way,94.182,FUN_001184-T1,Q5ZIA5,COPB_CHICK,,Coatomer subunit beta (Beta-coat protein) (Beta-COP),Gallus gallus (Chicken),73.1,963.0,0.0,1363.6,sp|Q5ZIA5|COPB_CHICK Coatomer subunit beta OS=Gallus gallus OX=9031 GN=COPB1 PE=2 SV=1,GO:0000139; GO:0005198; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0030126,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886],COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi membrane [GO:0000139],structural molecule activity [GO:0005198],GO:0005198; GO:0005829; GO:0006886; GO:0016192,structural molecule activity; cytosol; intracellular protein transport; vesicle-mediated transport
OG_00355,FUN_001185-T1,Peve_00040986,Pocillopora_meandrina_HIv1___RNAseq.g29540.t1,three_way,52.84166666666667,FUN_001185-T1,C0HL13,LRP2_PIG,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Sus scrofa (Pig),41.7,412.0,3.4e-63,245.0,sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1,GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167,coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0016192; GO:0022414; GO:0048856; GO:0050877; GO:0055085,vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process; transmembrane transport
OG_00356,FUN_001188-T1,Peve_00009673,Pocillopora_meandrina_HIv1___TS.g6724.t2,three_way,43.03966666666667,,,,,,,,,,,,,,,,,
OG_00357,FUN_001189-T1,Peve_00009676,Pocillopora_meandrina_HIv1___RNAseq.g29537.t1,three_way,76.39316666666667,FUN_001189-T1,Q93063,EXT2_HUMAN,,Exostosin-2 (EC 2.4.1.224) (Exostosin glycosyltransferase 2) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Heparan sulfate co-polymerase subunit EXT1) (Multiple exostoses protein 2),Homo sapiens (Human),50.1,711.0,2.0000000000000002e-212,740.3,sp|Q93063|EXT2_HUMAN Exostosin-2 OS=Homo sapiens OX=9606 GN=EXT2 PE=1 SV=1,GO:0000139; GO:0000271; GO:0001503; GO:0001707; GO:0002062; GO:0005783; GO:0005794; GO:0006024; GO:0006487; GO:0008217; GO:0010467; GO:0015012; GO:0015020; GO:0016020; GO:0016757; GO:0030210; GO:0042044; GO:0042311; GO:0042328; GO:0043541; GO:0044344; GO:0046872; GO:0046982; GO:0050508; GO:0050509; GO:0050891; GO:0051923; GO:0055078; GO:0060047; GO:0060350; GO:0070062; GO:1902494,cellular response to fibroblast growth factor stimulus [GO:0044344]; chondrocyte differentiation [GO:0002062]; endochondral bone morphogenesis [GO:0060350]; fluid transport [GO:0042044]; gene expression [GO:0010467]; glycosaminoglycan biosynthetic process [GO:0006024]; heart contraction [GO:0060047]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; mesoderm formation [GO:0001707]; multicellular organismal-level water homeostasis [GO:0050891]; ossification [GO:0001503]; polysaccharide biosynthetic process [GO:0000271]; protein N-linked glycosylation [GO:0006487]; regulation of blood pressure [GO:0008217]; sodium ion homeostasis [GO:0055078]; sulfation [GO:0051923]; vasodilation [GO:0042311],catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; UDP-N-acetylglucosamine transferase complex [GO:0043541],glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; glycosyltransferase activity [GO:0016757]; heparan sulfate N-acetylglucosaminyltransferase activity [GO:0042328]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982],GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006790; GO:0009101; GO:0016740; GO:0030154; GO:0043226; GO:1901135,circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; cell differentiation; organelle; carbohydrate derivative metabolic process
OG_00358,FUN_001190-T1,Peve_00014645,Pocillopora_meandrina_HIv1___TS.g6722.t2,three_way,77.6545,FUN_001190-T1,Q7SYD5,SC31A_DANRE,,Protein transport protein Sec31A (SEC31-like protein 1) (SEC31-related protein A),Danio rerio (Zebrafish) (Brachydanio rerio),41.3,1314.0,9.899999999999999e-226,785.4,sp|Q7SYD5|SC31A_DANRE Protein transport protein Sec31A OS=Danio rerio OX=7955 GN=sec31a PE=2 SV=1,GO:0001889; GO:0005198; GO:0005789; GO:0007029; GO:0015031; GO:0030127; GO:0030134; GO:0055123; GO:0070971; GO:0090110,COPII-coated vesicle cargo loading [GO:0090110]; digestive system development [GO:0055123]; endoplasmic reticulum organization [GO:0007029]; liver development [GO:0001889]; protein transport [GO:0015031],COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789],structural molecule activity [GO:0005198],GO:0005198; GO:0031410; GO:0043226; GO:0048856,structural molecule activity; cytoplasmic vesicle; organelle; anatomical structure development
OG_00359,FUN_001192-T1,Peve_00006923,Pocillopora_meandrina_HIv1___RNAseq.g29528.t2,three_way,68.40133333333334,FUN_001192-T1,Q5RGE6,,,,,42.7,511.0,3.2000000000000002e-111,403.7,sp|Q5RGE6|HSP7E_DANRE Heat shock 70 kDa protein 14 OS=Danio rerio OX=7955 GN=hspa14 PE=2 SV=1,,,,,,
OG_00360,FUN_001193-T1,Peve_00006937,Pocillopora_meandrina_HIv1___RNAseq.g29527.t1,three_way,63.272,FUN_001193-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),34.4,326.0,6.6e-40,166.4,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_00361,FUN_001195-T1,Peve_00006935,Pocillopora_meandrina_HIv1___RNAseq.g29525.t1,three_way,41.97683333333333,,,,,,,,,,,,,,,,,
OG_00362,FUN_001197-T1,Peve_00022306,Pocillopora_meandrina_HIv1___RNAseq.g29523.t1,three_way,67.18616666666667,FUN_001197-T1,Q2YDF6,RT35_BOVIN,,"Small ribosomal subunit protein mS35 (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt) (28S ribosomal protein S35, mitochondrial) (MRP-S35) (S35mt)",Bos taurus (Bovine),52.7,182.0,1.4e-49,198.0,sp|Q2YDF6|RT35_BOVIN Small ribosomal subunit protein mS35 OS=Bos taurus OX=9913 GN=MRPS35 PE=1 SV=1,GO:0003735; GO:0005743; GO:0005763; GO:0005829; GO:0032543,mitochondrial translation [GO:0032543],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763],structural constituent of ribosome [GO:0003735],GO:0005198; GO:0005829,structural molecule activity; cytosol
OG_00363,FUN_001198-T1,Peve_00022305,Pocillopora_meandrina_HIv1___RNAseq.g29522.t1,three_way,79.51466666666667,FUN_001198-T1,O94394,,,,,27.7,159.0,2.2e-08,61.6,sp|O94394|YQF1_SCHPO Uncharacterized WD repeat-containing protein C126.01c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPCC126.01c PE=4 SV=2,,,,,,
OG_00364,FUN_001200-T1,Peve_00033830,Pocillopora_meandrina_HIv1___RNAseq.g29521.t1,three_way,66.02566666666667,FUN_001200-T1,Q7Z2W9,,,,,46.2,130.0,5e-24,112.8,sp|Q7Z2W9|RM21_HUMAN Large ribosomal subunit protein bL21m OS=Homo sapiens OX=9606 GN=MRPL21 PE=1 SV=2,,,,,,
OG_00365,FUN_001204-T1,Peve_00033826,Pocillopora_meandrina_HIv1___RNAseq.g29520.t1,three_way,71.753,FUN_001204-T1,Q5VXJ0,LIPK_HUMAN,,Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2),Homo sapiens (Human),40.4,396.0,2.8000000000000002e-89,330.5,sp|Q5VXJ0|LIPK_HUMAN Lipase member K OS=Homo sapiens OX=9606 GN=LIPK PE=1 SV=2,GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268,cornification [GO:0070268]; lipid catabolic process [GO:0016042],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231],lipoprotein lipase activity [GO:0004465],GO:0003824; GO:0005576; GO:0006629; GO:0012501; GO:0016787; GO:0043226,catalytic activity; extracellular region; lipid metabolic process; programmed cell death; hydrolase activity; organelle
OG_00366,FUN_001207-T1,Peve_00033822,Pocillopora_meandrina_HIv1___RNAseq.g29518.t1,three_way,95.258,FUN_001207-T1,Q3ZBH0,TCPB_BOVIN,,T-complex protein 1 subunit beta (TCP-1-beta) (EC 3.6.1.-) (CCT-beta),Bos taurus (Bovine),77.3,532.0,2.6999999999999997e-230,799.3,sp|Q3ZBH0|TCPB_BOVIN T-complex protein 1 subunit beta OS=Bos taurus OX=9913 GN=CCT2 PE=1 SV=3,GO:0002199; GO:0005524; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0016887; GO:0031625; GO:0032212; GO:0044297; GO:0050821; GO:0051082; GO:0051086; GO:0051131; GO:0090666; GO:0140662; GO:1904874,binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666],cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; zona pellucida receptor complex [GO:0002199],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003824; GO:0006457; GO:0016787; GO:0044183; GO:0065003; GO:0140657,catalytic activity; protein folding; hydrolase activity; protein folding chaperone; protein-containing complex assembly; ATP-dependent activity
OG_00367,FUN_001208-T1,Peve_00033821,Pocillopora_meandrina_HIv1___RNAseq.g29517.t1,three_way,90.25683333333336,FUN_001208-T1,P55745,,,,,73.9,184.0,3.9e-74,279.3,sp|P55745|RAB21_CANLF Ras-related protein Rab-21 OS=Canis lupus familiaris OX=9615 GN=RAB21 PE=3 SV=3,,,,,,
OG_00368,FUN_001209-T1,Peve_00033820,Pocillopora_meandrina_HIv1___RNAseq.g29516.t1,three_way,79.10166666666666,FUN_001209-T1,Q1JQD2,GRWD1_BOVIN,,Glutamate-rich WD repeat-containing protein 1,Bos taurus (Bovine),50.0,416.0,2.6000000000000002e-110,400.6,sp|Q1JQD2|GRWD1_BOVIN Glutamate-rich WD repeat-containing protein 1 OS=Bos taurus OX=9913 GN=GRWD1 PE=2 SV=1,GO:0003682; GO:0003688; GO:0005634; GO:0005694; GO:0005730; GO:0006260; GO:0006334; GO:0006337; GO:0042254; GO:0042393,DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; ribosome biogenesis [GO:0042254],chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393],GO:0003677; GO:0005634; GO:0005694; GO:0005730; GO:0006260; GO:0006325; GO:0042254; GO:0042393; GO:0043226; GO:0065003,DNA binding; nucleus; chromosome; nucleolus; DNA replication; chromatin organization; ribosome biogenesis; histone binding; organelle; protein-containing complex assembly
OG_00369,FUN_001210-T1,Peve_00033819,Pocillopora_meandrina_HIv1___RNAseq.g29515.t1,three_way,72.2315,FUN_001210-T1,O74362,,,,,37.0,243.0,2.2e-35,150.6,sp|O74362|ESF2_SCHPO Pre-rRNA-processing protein esf2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=esf2 PE=1 SV=1,,,,,,
OG_00370,FUN_001211-T1,Peve_00033815,Pocillopora_meandrina_HIv1___RNAseq.g29514.t2c,three_way,72.93533333333333,FUN_001211-T1,Q9VZS6,,,,,40.4,275.0,2.8e-55,217.6,sp|Q9VZS6|NSMA_DROME Putative neutral sphingomyelinase OS=Drosophila melanogaster OX=7227 GN=nSMase PE=2 SV=2,,,,,,
OG_00371,FUN_001212-T1,Peve_00033814,Pocillopora_meandrina_HIv1___RNAseq.g29513.t1,three_way,80.26333333333334,,,,,,,,,,,,,,,,,
OG_00372,FUN_001213-T1,Peve_00033813,Pocillopora_meandrina_HIv1___RNAseq.g29512.t1,three_way,79.601,FUN_001213-T1,P20072,,,,,62.2,312.0,2.2e-105,384.4,sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2,,,,,,
OG_00373,FUN_001215-T1,Peve_00009931,Pocillopora_meandrina_HIv1___RNAseq.g29508.t1,three_way,74.34766666666667,FUN_001215-T1,O08684,,,,,42.6,975.0,8.6e-222,771.9,sp|O08684|PLD1_CRIGR Phospholipase D1 OS=Cricetulus griseus OX=10029 GN=PLD1 PE=2 SV=1,,,,,,
OG_00374,FUN_001217-T1,Peve_00035371,Pocillopora_meandrina_HIv1___RNAseq.g2551.t1,three_way,78.48366666666666,FUN_001217-T1,Q8BGF9,,,,,38.9,306.0,9.1e-58,225.3,sp|Q8BGF9|S2544_MOUSE Solute carrier family 25 member 44 OS=Mus musculus OX=10090 GN=Slc25a44 PE=1 SV=1,,,,,,
OG_00375,FUN_001218-T1,Peve_00035378,Pocillopora_meandrina_HIv1___RNAseq.g2553.t1,three_way,71.45866666666666,FUN_001218-T1,Q3USF0,,,,,34.4,209.0,1.2e-29,132.1,"sp|Q3USF0|B3GN6_MOUSE Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase OS=Mus musculus OX=10090 GN=B3gnt6 PE=2 SV=2",,,,,,
OG_00376,FUN_001219-T1,Peve_00035350,Pocillopora_meandrina_HIv1___RNAseq.g2554.t1,three_way,81.54166666666667,FUN_001219-T1,Q8BGF9,,,,,47.2,307.0,1.1e-74,281.6,sp|Q8BGF9|S2544_MOUSE Solute carrier family 25 member 44 OS=Mus musculus OX=10090 GN=Slc25a44 PE=1 SV=1,,,,,,
OG_00377,FUN_001224-T1,Peve_00014731,Pocillopora_meandrina_HIv1___TS.g6450.t1,three_way,65.06166666666667,,,,,,,,,,,,,,,,,
OG_00378,FUN_001225-T1,Peve_00034577,Pocillopora_meandrina_HIv1___RNAseq.g29243.t1,three_way,81.21866666666666,FUN_001225-T1,Q4PZA2,ECE1_MOUSE,,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),Mus musculus (Mouse),41.7,533.0,4.6e-123,443.4,sp|Q4PZA2|ECE1_MOUSE Endothelin-converting enzyme 1 OS=Mus musculus OX=10090 GN=Ece1 PE=1 SV=1,GO:0001921; GO:0004222; GO:0005768; GO:0005794; GO:0007411; GO:0008270; GO:0009897; GO:0009986; GO:0010467; GO:0010814; GO:0010815; GO:0010816; GO:0016486; GO:0031175; GO:0033093; GO:0034959; GO:0035050; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0060385; GO:0097492; GO:1902287,axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492],cell surface [GO:0009986]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Weibel-Palade body [GO:0033093],metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005794; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; endosome; Golgi apparatus; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_00379,FUN_001227-T1,Peve_00031371,Pocillopora_meandrina_HIv1___RNAseq.g29244.t2,three_way,82.9945,FUN_001227-T1,Q8N4P6,,,,,36.3,526.0,2.4e-40,168.3,sp|Q8N4P6|LRC71_HUMAN Leucine-rich repeat-containing protein 71 OS=Homo sapiens OX=9606 GN=LRRC71 PE=1 SV=1,,,,,,
OG_00380,FUN_001228-T1,Peve_00027708,Pocillopora_meandrina_HIv1___RNAseq.g29245.t1,three_way,84.69233333333334,FUN_001228-T1,Q569D5,,,,,71.9,469.0,1.8e-212,740.0,sp|Q569D5|SBP1_XENTR Methanethiol oxidase OS=Xenopus tropicalis OX=8364 GN=selenbp1 PE=2 SV=1,,,,,,
OG_00381,FUN_001233-T1,Peve_00022952,Pocillopora_meandrina_HIv1___RNAseq.g29020.t1,three_way,84.606,FUN_001233-T1,Q32L68,,,,,36.4,349.0,3.4e-46,187.2,sp|Q32L68|HM20B_BOVIN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related OS=Bos taurus OX=9913 GN=HMG20B PE=2 SV=1,,,,,,
OG_00382,FUN_001234-T1,Peve_00002838,Pocillopora_meandrina_HIv1___RNAseq.g29021.t1,three_way,91.84033333333332,FUN_001234-T1,P67810,,,,,84.5,174.0,6.000000000000001e-81,301.6,sp|P67810|SC11A_BOVIN Signal peptidase complex catalytic subunit SEC11A OS=Bos taurus OX=9913 GN=SEC11A PE=2 SV=1,,,,,,
OG_00383,FUN_001235-T1,Peve_00002839,Pocillopora_meandrina_HIv1___TS.g5021.t3,three_way,88.22116666666666,FUN_001235-T1,Q60520,SIN3A_MOUSE,,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),Mus musculus (Mouse),56.3,1191.0,0.0,1134.4,sp|Q60520|SIN3A_MOUSE Paired amphipathic helix protein Sin3a OS=Mus musculus OX=10090 GN=Sin3a PE=1 SV=3,GO:0000122; GO:0000776; GO:0001701; GO:0002218; GO:0002230; GO:0002244; GO:0003677; GO:0003682; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0006260; GO:0006355; GO:0008104; GO:0010817; GO:0010971; GO:0017053; GO:0021895; GO:0030336; GO:0030512; GO:0030516; GO:0031507; GO:0042754; GO:0043066; GO:0044877; GO:0045666; GO:0045892; GO:0048511; GO:0051595; GO:0060337; GO:0061629; GO:0070822; GO:0071333; GO:0072736; GO:0140416; GO:1900181; GO:1902455; GO:1902459; GO:1903351,activation of innate immune response [GO:0002218]; cellular response to dopamine [GO:1903351]; cellular response to glucose stimulus [GO:0071333]; cellular response to tert-butyl hydroperoxide [GO:0072736]; cerebral cortex neuron differentiation [GO:0021895]; DNA replication [GO:0006260]; hematopoietic progenitor cell differentiation [GO:0002244]; heterochromatin formation [GO:0031507]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of stem cell population maintenance [GO:1902459]; protein localization [GO:0008104]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; regulation of hormone levels [GO:0010817]; response to methylglyoxal [GO:0051595]; rhythmic process [GO:0048511]; type I interferon-mediated signaling pathway [GO:0060337],kinetochore [GO:0000776]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416],GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006260; GO:0006325; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; RNA binding; nucleus; nucleoplasm; nucleolus; DNA replication; chromatin organization; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_00384,FUN_001236-T2,Peve_00002840,Pocillopora_meandrina_HIv1___RNAseq.g2513.t1,three_way,67.85933333333332,FUN_001236-T2,Q61907,PEMT_MOUSE,,Phosphatidylethanolamine N-methyltransferase (PEAMT) (PEMT) (EC 2.1.1.17) (EC 2.1.1.71) (Phospholipid methyltransferase) (PLMT),Mus musculus (Mouse),46.0,187.0,9.2e-45,181.8,sp|Q61907|PEMT_MOUSE Phosphatidylethanolamine N-methyltransferase OS=Mus musculus OX=10090 GN=Pemt PE=1 SV=4,GO:0000773; GO:0001835; GO:0004608; GO:0005739; GO:0005740; GO:0005789; GO:0005829; GO:0006656; GO:0006686; GO:0008757; GO:0031966; GO:0032259; GO:0120162,blastocyst hatching [GO:0001835]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]; positive regulation of cold-induced thermogenesis [GO:0120162]; sphingomyelin biosynthetic process [GO:0006686],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial envelope [GO:0005740]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],phosphatidyl-N-methylethanolamine N-methyltransferase activity [GO:0000773]; phosphatidylethanolamine N-methyltransferase activity [GO:0004608]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0005739; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; cytosol; lipid metabolic process; transferase activity; organelle
OG_00385,FUN_001237-T1,Peve_00002841,Pocillopora_meandrina_HIv1___RNAseq.g2514.t1,three_way,72.78383333333333,,,,,,,,,,,,,,,,,
OG_00386,FUN_001238-T1,Peve_00002842,Pocillopora_meandrina_HIv1___RNAseq.g2515.t2,three_way,45.375,FUN_001238-T1,Q8IVU1,,,,,32.5,517.0,1.1e-67,260.4,sp|Q8IVU1|IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 OS=Homo sapiens OX=9606 GN=IGDCC3 PE=1 SV=2,,,,,,
OG_00387,FUN_001240-T1,Peve_00022815,Pocillopora_meandrina_HIv1___RNAseq.g2312.t1,three_way,75.67566666666667,,,,,,,,,,,,,,,,,
OG_00388,FUN_001241-T1,Peve_00022814,Pocillopora_meandrina_HIv1___TS.g4819.t1,three_way,90.189,FUN_001241-T1,Q5BJ41,CNOT6_XENLA,,CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase),Xenopus laevis (African clawed frog),59.0,558.0,8e-140,498.8,sp|Q5BJ41|CNOT6_XENLA CCR4-NOT transcription complex subunit 6 OS=Xenopus laevis OX=8355 GN=cnot6 PE=1 SV=1,GO:0000175; GO:0000289; GO:0003713; GO:0003723; GO:0004532; GO:0004535; GO:0005634; GO:0005737; GO:0006417; GO:0030014; GO:0035279; GO:0046872; GO:0070966,"miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417]",CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0031047; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_00389,FUN_001244-T1,Peve_00037040,Pocillopora_meandrina_HIv1___RNAseq.g2296.t1,three_way,77.55366666666667,FUN_001244-T1,Q5MNH6,,,,,28.5,253.0,1e-20,102.1,sp|Q5MNH6|LOLO2_EPIUN 2-oxoglutarate-dependent dioxygenase lolO2 OS=Epichloe uncinata OX=5050 GN=lolO2 PE=1 SV=1,,,,,,
OG_00390,FUN_001246-T1,Peve_00037027,Pocillopora_meandrina_HIv1___RNAseq.g2298.t1,three_way,69.81466666666667,FUN_001246-T1,Q7LL04,,,,,34.3,297.0,3.9e-30,133.7,sp|Q7LL04|YQK1_SCHPO UPF0676 protein C1494.01 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPCC1494.01 PE=3 SV=2,,,,,,
OG_00391,FUN_001249-T1,Peve_00004684,Pocillopora_meandrina_HIv1___RNAseq.g2306.t1,three_way,61.718,FUN_001249-T1,P34888,WNT1_CAEEL,,Protein Wnt-1,Caenorhabditis elegans,28.9,384.0,5.9e-32,139.8,sp|P34888|WNT1_CAEEL Protein Wnt-1 OS=Caenorhabditis elegans OX=6239 GN=cwn-1 PE=2 SV=1,GO:0001708; GO:0001764; GO:0005109; GO:0005125; GO:0005615; GO:0005737; GO:0005886; GO:0010468; GO:0016055; GO:0030182; GO:0030971; GO:0040028; GO:0045165; GO:0048018; GO:0060070; GO:0097402; GO:0097475; GO:1904936; GO:1905485; GO:1905488; GO:1905491,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell fate specification [GO:0001708]; interneuron migration [GO:1904936]; motor neuron migration [GO:0097475]; neuroblast migration [GO:0097402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; positive regulation of anterior/posterior axon guidance [GO:1905488]; positive regulation of motor neuron migration [GO:1905485]; positive regulation of sensory neuron axon guidance [GO:1905491]; regulation of gene expression [GO:0010468]; regulation of vulval development [GO:0040028]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971],GO:0005615; GO:0005886; GO:0030154; GO:0048018; GO:0048870; GO:0098772,extracellular space; plasma membrane; cell differentiation; receptor ligand activity; cell motility; molecular function regulator activity
OG_00392,FUN_001251-T1,Peve_00004681,Pocillopora_meandrina_HIv1___RNAseq.g2309.t1,three_way,55.928666666666665,,,,,,,,,,,,,,,,,
OG_00393,FUN_001252-T1,Peve_00004683,Pocillopora_meandrina_HIv1___RNAseq.g2310.t1a,three_way,70.51333333333334,FUN_001252-T1,P20072,,,,,55.4,314.0,2.1e-97,357.8,sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2,,,,,,
OG_00394,FUN_001255-T1,Peve_00008793,Pocillopora_meandrina_HIv1___RNAseq.g2172.t1,three_way,80.75366666666667,FUN_001255-T1,Q6P2B1,TNPO3_MOUSE,,Transportin-3,Mus musculus (Mouse),46.8,921.0,1.1999999999999999e-244,847.8,sp|Q6P2B1|TNPO3_MOUSE Transportin-3 OS=Mus musculus OX=10090 GN=Tnpo3 PE=1 SV=1,GO:0005635; GO:0005642; GO:0005654; GO:0005829; GO:0006606; GO:0031267; GO:0042802,protein import into nucleus [GO:0006606],annulate lamellae [GO:0005642]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654],identical protein binding [GO:0042802]; small GTPase binding [GO:0031267],GO:0005635; GO:0005654; GO:0005829; GO:0006886; GO:0006913,nuclear envelope; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_00395,FUN_001256-T1,Peve_00008794,Pocillopora_meandrina_HIv1___RNAseq.g2171.t1,three_way,58.515,FUN_001256-T1,Q8C0V1,TERB1_MOUSE,,Telomere repeats-binding bouquet formation protein 1 (Coiled-coil domain-containing protein 79),Mus musculus (Mouse),29.2,380.0,6.3999999999999995e-31,137.1,sp|Q8C0V1|TERB1_MOUSE Telomere repeats-binding bouquet formation protein 1 OS=Mus musculus OX=10090 GN=Terb1 PE=1 SV=2,GO:0000781; GO:0005635; GO:0005637; GO:0007129; GO:0045141; GO:0070197; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; meiotic telomere clustering [GO:0045141],"chromosome, telomeric region [GO:0000781]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]",,GO:0005635; GO:0006281; GO:0022414,nuclear envelope; DNA repair; reproductive process
OG_00396,FUN_001258-T1,Peve_00008780,Pocillopora_meandrina_HIv1___RNAseq.g2178.t1,three_way,48.20666666666666,FUN_001258-T1,F7J220,,,,,29.4,595.0,1.9e-54,216.1,sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1,,,,,,
OG_00397,FUN_001264-T1,Peve_00008779,Pocillopora_meandrina_HIv1___RNAseq.g2179.t1,three_way,87.813,FUN_001264-T1,Q62862,MP2K5_RAT,,Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5),Rattus norvegicus (Rat),60.5,430.0,2.4e-147,523.5,sp|Q62862|MP2K5_RAT Dual specificity mitogen-activated protein kinase kinase 5 OS=Rattus norvegicus OX=10116 GN=Map2k5 PE=1 SV=1,GO:0000122; GO:0000165; GO:0004672; GO:0004707; GO:0004708; GO:0004713; GO:0005524; GO:0005819; GO:0005829; GO:0007507; GO:0016020; GO:0030307; GO:0032717; GO:0034115; GO:0034392; GO:0043124; GO:0045944; GO:0046872; GO:0048009; GO:0050679; GO:0051247; GO:0060761; GO:0070375; GO:0071363; GO:0090051; GO:0106310; GO:2000342; GO:2001240,cellular response to growth factor stimulus [GO:0071363]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; insulin-like growth factor receptor signaling pathway [GO:0048009]; MAPK cascade [GO:0000165]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytosol [GO:0005829]; membrane [GO:0016020]; spindle [GO:0005819],ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00398,FUN_001267-T1,Peve_00008777,Pocillopora_meandrina_HIv1___RNAseq.13067_t,three_way,88.795,FUN_001267-T1,P50637,,,,,43.7,158.0,1.2e-38,161.0,sp|P50637|TSPO_MOUSE Translocator protein OS=Mus musculus OX=10090 GN=Tspo PE=1 SV=1,,,,,,
OG_00399,FUN_001270-T1,Peve_00008764,Pocillopora_meandrina_HIv1___RNAseq.g2183.t1,three_way,76.675,FUN_001270-T1,Q9NWT6,HIF1N_HUMAN,,Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase),Homo sapiens (Human),59.9,319.0,1.2e-120,434.5,sp|Q9NWT6|HIF1N_HUMAN Hypoxia-inducible factor 1-alpha inhibitor OS=Homo sapiens OX=9606 GN=HIF1AN PE=1 SV=2,GO:0000122; GO:0003714; GO:0005112; GO:0005654; GO:0005737; GO:0005829; GO:0008198; GO:0008270; GO:0019826; GO:0030947; GO:0031406; GO:0036139; GO:0036140; GO:0042803; GO:0045663; GO:0045746; GO:0048471; GO:0051059; GO:0061629; GO:0062101; GO:0071532; GO:2001214,negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],[protein]-asparagine 3-dioxygenase activity [GO:0036140]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxygen sensor activity [GO:0019826]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0016491; GO:0060090; GO:0098772; GO:0140096; GO:0140110; GO:0140299,"catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; oxidoreductase activity; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein; transcription regulator activity; molecular sensor activity"
OG_00400,FUN_001271-T1,Peve_00008757,Pocillopora_meandrina_HIv1___RNAseq.g2184.t1,three_way,83.30966666666667,FUN_001271-T1,P0C605,KGP1_MOUSE,,cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI),Mus musculus (Mouse),58.6,630.0,9.7e-210,731.5,sp|P0C605|KGP1_MOUSE cGMP-dependent protein kinase 1 OS=Mus musculus OX=10090 GN=Prkg1 PE=1 SV=1,GO:0001669; GO:0001764; GO:0004672; GO:0004674; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0006468; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043087; GO:0045986; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0106310; GO:1904706; GO:1904753; GO:2000224,cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; regulation of testosterone biosynthetic process [GO:2000224]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003012; GO:0003824; GO:0005654; GO:0005794; GO:0005886; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0098772; GO:0140096,"muscle system process; catalytic activity; nucleoplasm; Golgi apparatus; plasma membrane; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00401,FUN_001272-T1,Peve_00008789,Pocillopora_meandrina_HIv1___RNAseq.g2185.t1,three_way,76.56533333333333,FUN_001272-T1,P70445,4EBP2_MOUSE,,Eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2) (eIF4E-binding protein 2) (Phosphorylated heat- and acid-stable protein regulated by insulin 2) (PHAS-II),Mus musculus (Mouse),52.6,114.0,7.5e-19,94.7,sp|P70445|4EBP2_MOUSE Eukaryotic translation initiation factor 4E-binding protein 2 OS=Mus musculus OX=10090 GN=Eif4ebp2 PE=1 SV=1,GO:0005634; GO:0006446; GO:0007613; GO:0008190; GO:0008286; GO:0030371; GO:0031929; GO:0035176; GO:0045947; GO:0048167; GO:0050804; GO:0071598; GO:0098794,insulin receptor signaling pathway [GO:0008286]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of translational initiation [GO:0045947]; regulation of synaptic plasticity [GO:0048167]; regulation of translational initiation [GO:0006446]; social behavior [GO:0035176]; TOR signaling [GO:0031929],neuronal ribonucleoprotein granule [GO:0071598]; nucleus [GO:0005634]; postsynapse [GO:0098794],eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371],GO:0005634; GO:0043226; GO:0045182; GO:0050877,nucleus; organelle; translation regulator activity; nervous system process
OG_00402,FUN_001289-T1,Peve_00037015,Pocillopora_meandrina_HIv1___TS.g4708.t1a,three_way,81.49916666666667,FUN_001289-T1,Q9ULJ6,,,,,45.5,1166.0,3.5e-155,550.8,sp|Q9ULJ6|ZMIZ1_HUMAN Zinc finger MIZ domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZMIZ1 PE=1 SV=3,,,,,,
OG_00403,FUN_001290-T1,Peve_00037014,Pocillopora_meandrina_HIv1___TS.g4708.t1b,three_way,90.79066666666668,FUN_001290-T1,P10860,DHE3_RAT,,"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3) (Memory-related gene 2 protein) (MRG-2)",Rattus norvegicus (Rat),65.2,500.0,6.2e-198,691.8,"sp|P10860|DHE3_RAT Glutamate dehydrogenase 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Glud1 PE=1 SV=2",GO:0004352; GO:0004353; GO:0004354; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005783; GO:0006537; GO:0006538; GO:0006541; GO:0007616; GO:0010044; GO:0019899; GO:0021549; GO:0032024; GO:0042803; GO:0043531; GO:0070403; GO:0070728; GO:0072350,cerebellum development [GO:0021549]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; long-term memory [GO:0007616]; positive regulation of insulin secretion [GO:0032024]; response to aluminum ion [GO:0010044]; tricarboxylic acid metabolic process [GO:0072350],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase (NADP+) activity [GO:0004354]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; L-leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005739; GO:0005783; GO:0006520; GO:0016491; GO:0043226; GO:0048856; GO:0050877,catalytic activity; mitochondrion; endoplasmic reticulum; amino acid metabolic process; oxidoreductase activity; organelle; anatomical structure development; nervous system process
OG_00404,FUN_001292-T1,Peve_00037004,Pocillopora_meandrina_HIv1___RNAseq.g2226.t1,three_way,63.83866666666667,,,,,,,,,,,,,,,,,
OG_00405,FUN_001294-T1,Peve_00037005,Pocillopora_meandrina_HIv1___RNAseq.g2227.t1,three_way,50.46566666666666,,,,,,,,,,,,,,,,,
OG_00406,FUN_001295-T1,Peve_00037003,Pocillopora_meandrina_HIv1___RNAseq.g2228.t1,three_way,73.60816666666666,,,,,,,,,,,,,,,,,
OG_00407,FUN_001296-T1,Peve_00037002,Pocillopora_meandrina_HIv1___RNAseq.g2229.t1,three_way,52.16783333333333,,,,,,,,,,,,,,,,,
OG_00408,FUN_001298-T1,Peve_00037001,Pocillopora_meandrina_HIv1___RNAseq.g2230.t1,three_way,69.0665,,,,,,,,,,,,,,,,,
OG_00409,FUN_001299-T1,Peve_00036999,Pocillopora_meandrina_HIv1___RNAseq.g2232.t1,three_way,50.557,,,,,,,,,,,,,,,,,
OG_00410,FUN_001307-T1,Peve_00036989,Pocillopora_meandrina_HIv1___RNAseq.g2244.t1,three_way,33.9975,,,,,,,,,,,,,,,,,
OG_00411,FUN_001309-T1,Peve_00036985,Pocillopora_meandrina_HIv1___RNAseq.g2248.t1,three_way,53.03933333333333,,,,,,,,,,,,,,,,,
OG_00412,FUN_001310-T1,Peve_00036984,Pocillopora_meandrina_HIv1___RNAseq.g2249.t1,three_way,83.714,FUN_001310-T1,Q3SYV5,TSN33_BOVIN,,Tetraspanin-33 (Tspan-33),Bos taurus (Bovine),38.1,252.0,1.3e-50,201.4,sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1,GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659,protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005886; GO:0051604; GO:0072659,plasma membrane; protein maturation; protein localization to plasma membrane
OG_00413,FUN_001312-T1,Peve_00036981,Pocillopora_meandrina_HIv1___RNAseq.g2250.t1,three_way,72.822,FUN_001312-T1,Q04609,FOLH1_HUMAN,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen) (PSM) (PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase),Homo sapiens (Human),37.4,754.0,1.8e-137,491.5,sp|Q04609|FOLH1_HUMAN Glutamate carboxypeptidase 2 OS=Homo sapiens OX=9606 GN=FOLH1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005737; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0035609; GO:0046872; GO:0070062; GO:1904492; GO:1904493,C-terminal protein deglutamylation [GO:0035609]; folic acid-containing compound metabolic process [GO:0006760]; proteolysis [GO:0006508],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00414,FUN_001316-T1,Peve_00036964,Pocillopora_meandrina_HIv1___RNAseq.g2261.t1,three_way,53.97383333333333,FUN_001316-T1,Q8IVL1,,,,,36.1,388.0,7.2e-66,255.0,sp|Q8IVL1|NAV2_HUMAN Neuron navigator 2 OS=Homo sapiens OX=9606 GN=NAV2 PE=1 SV=3,,,,,,
OG_00415,FUN_001317-T1,Peve_00036963,Pocillopora_meandrina_HIv1___TS.g4770.t2,three_way,81.075,FUN_001317-T1,Q8WU76,,,,,35.4,675.0,5.7e-108,393.3,sp|Q8WU76|SCFD2_HUMAN Sec1 family domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCFD2 PE=1 SV=2,,,,,,
OG_00416,FUN_001318-T1,Peve_00036962,Pocillopora_meandrina_HIv1___TS.g4771.t1b,three_way,45.996,,,,,,,,,,,,,,,,,
OG_00417,FUN_001320-T1,Peve_00005008,Pocillopora_meandrina_HIv1___RNAseq.g5443.t1,three_way,65.57416666666667,,,,,,,,,,,,,,,,,
OG_00418,FUN_001323-T1,Peve_00036961,Pocillopora_meandrina_HIv1___RNAseq.g2265.t1,three_way,51.98283333333333,,,,,,,,,,,,,,,,,
OG_00419,FUN_001324-T1,Peve_00036959,Pocillopora_meandrina_HIv1___RNAseq.g2267.t1,three_way,69.84416666666667,,,,,,,,,,,,,,,,,
OG_00420,FUN_001325-T1,Peve_00036958,Pocillopora_meandrina_HIv1___RNAseq.g2268.t1,three_way,83.70033333333333,FUN_001325-T1,P81004,,,,,62.9,280.0,5.2e-103,375.6,sp|P81004|VDAC2_XENLA Non-selective voltage-gated ion channel VDAC2 OS=Xenopus laevis OX=8355 GN=vdac2 PE=1 SV=1,,,,,,
OG_00421,FUN_001328-T1,Peve_00036956,Pocillopora_meandrina_HIv1___RNAseq.g2270.t1b,three_way,79.90283333333333,FUN_001328-T1,Q5F471,,,,,41.4,903.0,8.500000000000001e-174,612.5,sp|Q5F471|PP6R3_CHICK Serine/threonine-protein phosphatase 6 regulatory subunit 3 OS=Gallus gallus OX=9031 GN=PPP6R3 PE=2 SV=1,,,,,,
OG_00422,FUN_001330-T1,Peve_00036948,Pocillopora_meandrina_HIv1___TS.g21139.t2a,three_way,69.44166666666666,FUN_001330-T1,Q9Z0K8,,,,,47.4,489.0,2.3e-117,424.1,sp|Q9Z0K8|VNN1_MOUSE Pantetheinase OS=Mus musculus OX=10090 GN=Vnn1 PE=1 SV=3,,,,,,
OG_00423,FUN_001331-T1,Peve_00036947,Pocillopora_meandrina_HIv1___RNAseq.g2277.t1,three_way,71.115,,,,,,,,,,,,,,,,,
OG_00424,FUN_001332-T1,Peve_00020579,Pocillopora_meandrina_HIv1___TS.g4787.t1,three_way,68.45233333333334,FUN_001332-T1,Q9CZR2,NALD2_MOUSE,,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylaspartylglutamate peptidase II) (NAAG-peptidase II) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),Mus musculus (Mouse),38.3,694.0,9.8e-141,502.3,sp|Q9CZR2|NALD2_MOUSE N-acetylated-alpha-linked acidic dipeptidase 2 OS=Mus musculus OX=10090 GN=Naalad2 PE=1 SV=2,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008233; GO:0009056; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129,carboxylic acid catabolic process [GO:0046395]; catabolic process [GO:0009056]; proteolysis [GO:0006508],membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; peptidase activity [GO:0008233],GO:0003824; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_00425,FUN_001333-T1,Peve_00036946,Pocillopora_meandrina_HIv1___RNAseq.g2283.t1,three_way,78.30966666666667,FUN_001333-T1,Q502W6,VWA3B_HUMAN,,von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B),Homo sapiens (Human),34.1,167.0,4.3e-21,105.1,sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3,GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_00426,FUN_001334-T1,Peve_00036945,Pocillopora_meandrina_HIv1___RNAseq.g2284.t1,three_way,82.78666666666666,,,,,,,,,,,,,,,,,
OG_00427,FUN_001335-T1,Peve_00036944,Pocillopora_meandrina_HIv1___RNAseq.g2285.t1,three_way,72.06533333333333,FUN_001335-T1,Q8IYJ1,CPNE9_HUMAN,,Copine-9 (Copine IX),Homo sapiens (Human),33.5,462.0,1.0000000000000001e-72,275.8,sp|Q8IYJ1|CPNE9_HUMAN Copine-9 OS=Homo sapiens OX=9606 GN=CPNE9 PE=1 SV=3,GO:0005544; GO:0005615; GO:0005886; GO:0030154; GO:0046872; GO:0070062; GO:0071277; GO:1903861,cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],calcium-dependent phospholipid binding [GO:0005544]; metal ion binding [GO:0046872],GO:0005615; GO:0005886; GO:0008289; GO:0030154; GO:0043226,extracellular space; plasma membrane; lipid binding; cell differentiation; organelle
OG_00428,FUN_001336-T1,Peve_00036943,Pocillopora_meandrina_HIv1___RNAseq.g2286.t1,three_way,80.96633333333334,FUN_001336-T1,Q86UD5,SL9B2_HUMAN,,Sodium/hydrogen exchanger 9B2 (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Homo sapiens (Human),47.8,485.0,6.2e-115,416.0,sp|Q86UD5|SL9B2_HUMAN Sodium/hydrogen exchanger 9B2 OS=Homo sapiens OX=9606 GN=SLC9B2 PE=1 SV=2,GO:0005739; GO:0005743; GO:0005886; GO:0006814; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0034220; GO:0042802; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:0098662; GO:2001206,clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; inorganic cation transmembrane transport [GO:0098662]; lithium ion transport [GO:0010351]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672],identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005739; GO:0005768; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870; GO:0055085,transporter activity; mitochondrion; endosome; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility; transmembrane transport
OG_00429,FUN_001337-T1,Peve_00036942,Pocillopora_meandrina_HIv1___RNAseq.g2287.t1,three_way,75.98033333333333,FUN_001337-T1,C3ZWH9,,,,,45.1,133.0,1.7e-30,133.7,sp|C3ZWH9|CID2A_BRAFL CDGSH iron-sulfur domain-containing protein 2 homolog A OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_285975 PE=3 SV=1,,,,,,
OG_00430,FUN_001338-T1,Peve_00036941,Pocillopora_meandrina_HIv1___TS.g4798.t2,three_way,67.19033333333333,FUN_001338-T1,Q8C9W3,ATS2_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI),Mus musculus (Mouse),31.2,954.0,4.4e-135,484.6,sp|Q8C9W3|ATS2_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Mus musculus OX=10090 GN=Adamts2 PE=1 SV=2,GO:0004222; GO:0005576; GO:0007283; GO:0008233; GO:0008270; GO:0016485; GO:0030199; GO:0030324; GO:0030574; GO:0031012; GO:0043588,collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; lung development [GO:0030324]; protein processing [GO:0016485]; skin development [GO:0043588]; spermatogenesis [GO:0007283],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_00431,FUN_001341-T1,Peve_00036939,Pocillopora_meandrina_HIv1___RNAseq.g2290.t1,three_way,95.667,FUN_001341-T1,P25867,UBCD1_DROME,,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),Drosophila melanogaster (Fruit fly),95.2,147.0,5.000000000000001e-81,301.6,sp|P25867|UBCD1_DROME Ubiquitin-conjugating enzyme E2-17 kDa OS=Drosophila melanogaster OX=7227 GN=eff PE=1 SV=1,GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625],GO:0000278; GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"mitotic cell cycle; immune system process; catalytic activity; nucleus; cytosol; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_00432,FUN_001342-T1,Peve_00036938,Pocillopora_meandrina_HIv1___RNAseq.g12407.t1,three_way,61.44533333333334,FUN_001342-T1,Q923E4,SIR1_MOUSE,,NAD-dependent protein deacetylase sirtuin-1 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-1) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (SIR2alpha) (Sir2) (mSIR2a) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)],Mus musculus (Mouse),46.3,546.0,7.9e-130,466.1,sp|Q923E4|SIR1_MOUSE NAD-dependent protein deacetylase sirtuin-1 OS=Mus musculus OX=10090 GN=Sirt1 PE=1 SV=2,GO:0000012; GO:0000122; GO:0000183; GO:0000720; GO:0000731; GO:0000785; GO:0000791; GO:0000792; GO:0000978; GO:0001525; GO:0001542; GO:0001650; GO:0001678; GO:0001934; GO:0001938; GO:0002039; GO:0002821; GO:0003713; GO:0003714; GO:0004857; GO:0005634; GO:0005637; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006476; GO:0006642; GO:0007179; GO:0007283; GO:0007346; GO:0007517; GO:0007623; GO:0008047; GO:0008284; GO:0008630; GO:0009267; GO:0010824; GO:0010868; GO:0010875; GO:0010883; GO:0010906; GO:0016239; GO:0016567; GO:0016605; GO:0016922; GO:0017136; GO:0019213; GO:0019899; GO:0019904; GO:0030225; GO:0030512; GO:0031393; GO:0031507; GO:0031648; GO:0032007; GO:0032041; GO:0032071; GO:0032088; GO:0032436; GO:0032868; GO:0032922; GO:0032991; GO:0033210; GO:0033553; GO:0033558; GO:0034391; GO:0034979; GO:0035098; GO:0035331; GO:0035356; GO:0035358; GO:0042149; GO:0042326; GO:0042393; GO:0042542; GO:0042595; GO:0042632; GO:0042771; GO:0042802; GO:0042981; GO:0043065; GO:0043066; GO:0043124; GO:0043161; GO:0043398; GO:0043425; GO:0043433; GO:0043518; GO:0043524; GO:0043536; GO:0044321; GO:0045348; GO:0045599; GO:0045722; GO:0045739; GO:0045766; GO:0045786; GO:0045892; GO:0045944; GO:0046015; GO:0046628; GO:0046872; GO:0046969; GO:0046970; GO:0050872; GO:0051019; GO:0051152; GO:0051658; GO:0051897; GO:0051898; GO:0055089; GO:0060766; GO:0060907; GO:0061773; GO:0070301; GO:0070403; GO:0070857; GO:0070914; GO:0071356; GO:0071456; GO:0071479; GO:0090335; GO:0090400; GO:0097009; GO:0106230; GO:0106231; GO:0140416; GO:0140861; GO:0140937; GO:0141208; GO:0160012; GO:1902166; GO:1902176; GO:1902237; GO:1904179; GO:1990254; GO:1990830; GO:1990841; GO:2000111; GO:2000481; GO:2000655; GO:2000757; GO:2000773; GO:2000774; GO:2000781,"angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol homeostasis [GO:0042632]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA repair-dependent chromatin remodeling [GO:0140861]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; fatty acid homeostasis [GO:0055089]; heterochromatin formation [GO:0031507]; intracellular glucose homeostasis [GO:0001678]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage differentiation [GO:0030225]; maintenance of nucleus location [GO:0051658]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of triglyceride biosynthetic process [GO:0010868]; ovulation from ovarian follicle [GO:0001542]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein depropionylation [GO:0106230]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; rDNA heterochromatin formation [GO:0000183]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of centrosome duplication [GO:0010824]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of smooth muscle cell apoptotic process [GO:0034391]; regulation of transcription by glucose [GO:0046015]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eNoSc complex [GO:0061773]; ESC/E(Z) complex [GO:0035098]; euchromatin [GO:0000791]; fibrillar center [GO:0001650]; heterochromatin [GO:0000792]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; rDNA heterochromatin [GO:0033553],"bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase activity, NAD-dependent [GO:0017136]; histone H3K14 deacetylase activity, NAD-dependent [GO:0032041]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; histone H4K12 deacetylase activity, hydrolytic mechanism [GO:0140937]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone decrotonylase activity [GO:0160012]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; NAD-dependent protein lysine delactylase activity [GO:0141208]; NAD-dependent protein-lysine depropionylase activity [GO:0106231]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0006629; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0030163; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; protein catabolic process; histone binding; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_00433,FUN_001343-T1,Peve_00037042,Pocillopora_meandrina_HIv1___RNAseq.g2294.t1,three_way,96.12966666666668,FUN_001343-T1,Q5M9B7,,,,,76.2,147.0,1.1000000000000004e-59,230.7,sp|Q5M9B7|OSTCB_XENLA Oligosaccharyltransferase complex subunit ostc-B OS=Xenopus laevis OX=8355 GN=ostc-b PE=2 SV=1,,,,,,
OG_00434,FUN_001344-T1,Peve_00037041,Pocillopora_meandrina_HIv1___TS.g4804.t1,three_way,84.807,FUN_001344-T1,Q9DGA5,CDK1_ORYCU,,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),Oryzias curvinotus (Hynann ricefish) (Aplocheilus curvinotus),68.6,299.0,4.0999999999999997e-120,432.6,sp|Q9DGA5|CDK1_ORYCU Cyclin-dependent kinase 1 OS=Oryzias curvinotus OX=104658 GN=cdk1 PE=2 SV=1,GO:0000086; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007095; GO:0008353; GO:0051301; GO:0106310,cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic G2 DNA damage checkpoint signaling [GO:0007095],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00435,FUN_001345-T1,Peve_00023386,Pocillopora_meandrina_HIv1___RNAseq.g1880.t1,three_way,69.794,FUN_001345-T1,P82917,,,,,62.5,40.0,1.5e-06,53.5,sp|P82917|RT18C_BOVIN Small ribosomal subunit protein bS18m OS=Bos taurus OX=9913 GN=MRPS18C PE=1 SV=2,,,,,,
OG_00436,FUN_001347-T1,Peve_00023385,Pocillopora_meandrina_HIv1___RNAseq.g1879.t1,three_way,63.254,FUN_001347-T1,Q3TCJ1,ABRX2_MOUSE,,BRISC complex subunit Abraxas 2 (Abraxas brother protein 1) (Protein FAM175B),Mus musculus (Mouse),29.9,274.0,4.2e-25,117.5,sp|Q3TCJ1|ABRX2_MOUSE BRISC complex subunit Abraxas 2 OS=Mus musculus OX=10090 GN=Abraxas2 PE=1 SV=1,GO:0000278; GO:0000922; GO:0002931; GO:0005634; GO:0005737; GO:0005874; GO:0007059; GO:0008017; GO:0008608; GO:0031593; GO:0043066; GO:0051301; GO:0070536; GO:0070552; GO:0071497; GO:0090307,attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; cellular response to freezing [GO:0071497]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of apoptotic process [GO:0043066]; protein K63-linked deubiquitination [GO:0070536]; response to ischemia [GO:0002931],BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922],microtubule binding [GO:0008017]; polyubiquitin modification-dependent protein binding [GO:0031593],GO:0000278; GO:0005634; GO:0007010; GO:0007059; GO:0008092; GO:0043226,mitotic cell cycle; nucleus; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; organelle
OG_00437,FUN_001348-T1,Peve_00023407,Pocillopora_meandrina_HIv1___RNAseq.g1877.t1,three_way,60.797,,,,,,,,,,,,,,,,,
OG_00438,FUN_001349-T1,Peve_00023406,Pocillopora_meandrina_HIv1___RNAseq.g1876.t1,three_way,83.4015,FUN_001349-T1,Q8IYW2,,,,,31.7,2766.0,0.0,1193.3,sp|Q8IYW2|CFA46_HUMAN Cilia- and flagella-associated protein 46 OS=Homo sapiens OX=9606 GN=CFAP46 PE=1 SV=3,,,,,,
OG_00439,FUN_001350-T1,Peve_00023405,Pocillopora_meandrina_HIv1___RNAseq.g1875.t1,three_way,48.55,FUN_001350-T1,Q8BM75,ARI5B_MOUSE,,AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (Developmentally and sexually retarded with transient immune abnormalities protein) (Desrt) (MRF1-like) (Modulator recognition factor protein 2) (MRF-2),Mus musculus (Mouse),24.0,758.0,3.3e-43,179.1,sp|Q8BM75|ARI5B_MOUSE AT-rich interactive domain-containing protein 5B OS=Mus musculus OX=10090 GN=Arid5b PE=1 SV=3,GO:0000122; GO:0000976; GO:0001822; GO:0003713; GO:0005634; GO:0008584; GO:0008585; GO:0009791; GO:0010761; GO:0030325; GO:0035264; GO:0045444; GO:0048008; GO:0048468; GO:0048644; GO:0048705; GO:0060021; GO:0060325; GO:0060612; GO:0060613; GO:1990830,adipose tissue development [GO:0060612]; adrenal gland development [GO:0030325]; cell development [GO:0048468]; cellular response to leukemia inhibitory factor [GO:1990830]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; fibroblast migration [GO:0010761]; kidney development [GO:0001822]; male gonad development [GO:0008584]; multicellular organism growth [GO:0035264]; muscle organ morphogenesis [GO:0048644]; negative regulation of transcription by RNA polymerase II [GO:0000122]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705],nucleus [GO:0005634],transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; molecular adaptor activity; transcription regulator activity
OG_00440,FUN_001351-T1,Peve_00023404,Pocillopora_meandrina_HIv1___RNAseq.g1874.t1,three_way,52.506,,,,,,,,,,,,,,,,,
OG_00441,FUN_001354-T1,Peve_00028939,Pocillopora_meandrina_HIv1___RNAseq.g1872.t2,three_way,86.42,FUN_001354-T1,Q6PFX9,TNKS1_MOUSE,,Poly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Protein poly-ADP-ribosyltransferase tankyrase-1) (EC 2.4.2.-) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) (Tankyrase-1) (TANK1),Mus musculus (Mouse),72.8,1146.0,4.9e-232,806.2,sp|Q6PFX9|TNKS1_MOUSE Poly [ADP-ribose] polymerase tankyrase-1 OS=Mus musculus OX=10090 GN=Tnks PE=1 SV=1,GO:0000139; GO:0000209; GO:0000781; GO:0003950; GO:0005643; GO:0005794; GO:0005813; GO:0005829; GO:0008270; GO:0015031; GO:0016055; GO:0016604; GO:0016779; GO:0031965; GO:0032212; GO:0042393; GO:0045944; GO:0051028; GO:0051301; GO:0070198; GO:0070212; GO:0070213; GO:0090263; GO:0097431; GO:0140806; GO:0140807; GO:1904355; GO:1904357; GO:1904908; GO:1990404,"cell division [GO:0051301]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome, telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; Wnt signaling pathway [GO:0016055]","centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]",histone binding [GO:0042393]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005815; GO:0005829; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; microtubule organizing center; cytosol; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_00442,FUN_001355-T1,Peve_00028946,Pocillopora_meandrina_HIv1___TS.g4661.t1a,three_way,69.34483333333333,FUN_001355-T1,Q3UDE2,,,,,45.6,654.0,3.9e-159,563.1,sp|Q3UDE2|TTL12_MOUSE Tubulin--tyrosine ligase-like protein 12 OS=Mus musculus OX=10090 GN=Ttll12 PE=1 SV=1,,,,,,
OG_00443,FUN_001356-T1,Peve_00005527,Pocillopora_meandrina_HIv1___RNAseq.g2154.t1,three_way,89.02,FUN_001356-T1,Q571I9,,,,,42.8,828.0,1.5e-185,651.4,sp|Q571I9|A16A1_MOUSE Aldehyde dehydrogenase family 16 member A1 OS=Mus musculus OX=10090 GN=Aldh16a1 PE=1 SV=2,,,,,,
OG_00444,FUN_001363-T1,Peve_00005010,Pocillopora_meandrina_HIv1___RNAseq.g2149.t1,three_way,43.592,,,,,,,,,,,,,,,,,
OG_00445,FUN_001364-T1,Peve_00036776,Pocillopora_meandrina_HIv1___RNAseq.g2147.t1,three_way,89.03099999999999,FUN_001364-T1,Q9BSF8,,,,,69.5,272.0,4.9999999999999995e-112,406.0,sp|Q9BSF8|BTBDA_HUMAN BTB/POZ domain-containing protein 10 OS=Homo sapiens OX=9606 GN=BTBD10 PE=1 SV=2,,,,,,
OG_00446,FUN_001365-T1,Peve_00036758,Pocillopora_meandrina_HIv1___RNAseq.g2146.t1,three_way,57.00483333333334,FUN_001365-T1,Q9QYI5,,,,,42.6,176.0,5.699999999999999e-24,112.8,sp|Q9QYI5|DNJB2_MOUSE DnaJ homolog subfamily B member 2 OS=Mus musculus OX=10090 GN=Dnajb2 PE=1 SV=3,,,,,,
OG_00447,FUN_001367-T1,Peve_00036761,Pocillopora_meandrina_HIv1___RNAseq.g2144.t1,three_way,66.2335,FUN_001367-T1,Q13610,,,,,52.7,495.0,6.1999999999999995e-105,382.9,sp|Q13610|PWP1_HUMAN Periodic tryptophan protein 1 homolog OS=Homo sapiens OX=9606 GN=PWP1 PE=1 SV=1,,,,,,
OG_00448,FUN_001368-T1,Peve_00036766,Pocillopora_meandrina_HIv1___RNAseq.g2143.t1,three_way,71.84766666666667,FUN_001368-T1,Q5EB30,,,,,63.9,230.0,1.6e-37,157.9,sp|Q5EB30|CMA1A_XENTR Ciliary microtubule associated protein 1A OS=Xenopus tropicalis OX=8364 GN=cimap1a PE=2 SV=1,,,,,,
OG_00449,FUN_001369-T1,Peve_00035683,Pocillopora_meandrina_HIv1___RNAseq.g2141.t1,three_way,82.50766666666667,FUN_001369-T1,A0A1L8F5J9,NMDZ1_XENLA,,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",Xenopus laevis (African clawed frog),50.5,876.0,2.8e-243,843.2,"sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1",GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839,calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725],neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_00450,FUN_001370-T2,Peve_00025098,Pocillopora_meandrina_HIv1___RNAseq.g2140.t1,three_way,55.64983333333333,FUN_001370-T2,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),39.1,422.0,6.900000000000001e-67,257.3,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_00451,FUN_001372-T1,Peve_00025095,Pocillopora_meandrina_HIv1___RNAseq.g2138.t1,three_way,56.2025,FUN_001372-T1,F1R332,,,,,30.3,297.0,2.2e-25,118.2,sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2,,,,,,
OG_00452,FUN_001376-T1,Peve_00025093,Pocillopora_meandrina_HIv1___RNAseq.g2137.t1,three_way,67.909,FUN_001376-T1,C3ZQF9,,,,,34.8,293.0,3.9999999999999995e-31,137.1,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_00453,FUN_001377-T1,Peve_00021886,Pocillopora_meandrina_HIv1___RNAseq.g2136.t1,three_way,56.78516666666667,,,,,,,,,,,,,,,,,
OG_00454,FUN_001381-T2,Peve_00035160,Pocillopora_meandrina_HIv1___RNAseq.g2133.t1,three_way,56.10666666666667,FUN_001381-T2,O97512,,,,,31.4,299.0,2.0000000000000002e-23,111.7,sp|O97512|NK3R_RABIT Neuromedin-K receptor OS=Oryctolagus cuniculus OX=9986 GN=TACR3 PE=2 SV=2,,,,,,
OG_00455,FUN_001384-T1,Peve_00019346,Pocillopora_meandrina_HIv1___TS.g4636.t2,three_way,67.6845,,,,,,,,,,,,,,,,,
OG_00456,FUN_001385-T1,Peve_00019351,Pocillopora_meandrina_HIv1___RNAseq.g2129.t1,three_way,85.12266666666667,FUN_001385-T1,O75398,DEAF1_HUMAN,,Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5),Homo sapiens (Human),43.0,291.0,1.5e-50,202.2,sp|O75398|DEAF1_HUMAN Deformed epidermal autoregulatory factor 1 homolog OS=Homo sapiens OX=9606 GN=DEAF1 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0001650; GO:0001662; GO:0001843; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0006366; GO:0007281; GO:0008270; GO:0008542; GO:0009653; GO:0033599; GO:0045892; GO:0045893; GO:0048706; GO:0090575,anatomical structure morphogenesis [GO:0009653]; behavioral fear response [GO:0001662]; embryonic skeletal system development [GO:0048706]; germ cell development [GO:0007281]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542],chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005576; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0050877; GO:0140110,DNA binding; extracellular region; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_00457,FUN_001388-T1,Peve_00019354,Pocillopora_meandrina_HIv1___RNAseq.g2127.t1,three_way,77.53466666666667,FUN_001388-T1,Q62739,RAB3I_RAT,,Rab-3A-interacting protein (Rab3A-interacting protein) (Rabin-3) (SSX2-interacting protein),Rattus norvegicus (Rat),39.6,217.0,1.2e-33,145.6,sp|Q62739|RAB3I_RAT Rab-3A-interacting protein OS=Rattus norvegicus OX=10116 GN=Rab3ip PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006612; GO:0015031; GO:0030027; GO:0031267; GO:0042802; GO:0045724; GO:0048471; GO:0051020; GO:0051490; GO:0120229; GO:1990635,negative regulation of filopodium assembly [GO:0051490]; positive regulation of cilium assembly [GO:0045724]; protein localization to motile cilium [GO:0120229]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031],centrosome [GO:0005813]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proximal dendrite [GO:1990635],GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; small GTPase binding [GO:0031267],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0043226; GO:0098772,nucleus; nucleoplasm; microtubule organizing center; cytosol; organelle; molecular function regulator activity
OG_00458,FUN_001389-T1,Peve_00019355,Pocillopora_meandrina_HIv1___RNAseq.g2126.t1,three_way,44.8,,,,,,,,,,,,,,,,,
OG_00459,FUN_001390-T1,Peve_00019357,Pocillopora_meandrina_HIv1___RNAseq.g2125.t1,three_way,56.40733333333333,,,,,,,,,,,,,,,,,
OG_00460,FUN_001392-T1,Peve_00019358,Pocillopora_meandrina_HIv1___RNAseq.g2123.t1,three_way,90.084,,,,,,,,,,,,,,,,,
OG_00461,FUN_001393-T1,Peve_00019359,Pocillopora_meandrina_HIv1___RNAseq.g2122.t1,three_way,60.874500000000005,,,,,,,,,,,,,,,,,
OG_00462,FUN_001394-T1,Peve_00019360,Pocillopora_meandrina_HIv1___RNAseq.g2121.t1,three_way,76.95333333333333,FUN_001394-T1,A9JRD8,BTB6A_DANRE,,BTB/POZ domain-containing protein 6-A,Danio rerio (Zebrafish) (Brachydanio rerio),32.9,389.0,1.7e-56,222.2,sp|A9JRD8|BTB6A_DANRE BTB/POZ domain-containing protein 6-A OS=Danio rerio OX=7955 GN=btbd6a PE=1 SV=2,GO:0005634; GO:0005829; GO:0022008; GO:0050767,neurogenesis [GO:0022008]; regulation of neurogenesis [GO:0050767],cytosol [GO:0005829]; nucleus [GO:0005634],,GO:0005634; GO:0005829; GO:0030154; GO:0043226,nucleus; cytosol; cell differentiation; organelle
OG_00463,FUN_001395-T1,Peve_00019361,Pocillopora_meandrina_HIv1___RNAseq.g2119.t1,three_way,87.46033333333334,FUN_001395-T1,Q9EQS0,,,,,68.1,320.0,1.3e-121,437.6,sp|Q9EQS0|TALDO_RAT Transaldolase OS=Rattus norvegicus OX=10116 GN=Taldo1 PE=1 SV=2,,,,,,
OG_00464,FUN_001397-T1,Peve_00019363,Pocillopora_meandrina_HIv1___RNAseq.g2114.t1,three_way,76.95933333333333,FUN_001397-T1,Q05AK5,,,,,27.6,453.0,4.4e-38,160.6,sp|Q05AK5|MYLIB_DANRE E3 ubiquitin-protein ligase MYLIP-B OS=Danio rerio OX=7955 GN=mylipb PE=2 SV=1,,,,,,
OG_00465,FUN_001401-T1,Peve_00008770,Pocillopora_meandrina_HIv1___RNAseq.g2113.t1,three_way,79.55216666666666,FUN_001401-T1,Q8C8M1,SHCAF_MOUSE,,SIN3-HDAC complex-associated factor (Protein FAM60A) (Tera protein),Mus musculus (Mouse),43.0,235.0,2.4e-40,167.2,sp|Q8C8M1|SHCAF_MOUSE SIN3-HDAC complex-associated factor OS=Mus musculus OX=10090 GN=Sinhcaf PE=1 SV=1,GO:0000122; GO:0005634; GO:0008284; GO:0030336; GO:0030512; GO:0045596; GO:0070822; GO:1902455; GO:1902459,negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of stem cell population maintenance [GO:1902459],nucleus [GO:0005634]; Sin3-type complex [GO:0070822],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_00466,FUN_001402-T1,Peve_00008766,Pocillopora_meandrina_HIv1___TS.g4618.t1,three_way,89.81483333333334,FUN_001402-T1,P38976,,,,,74.9,195.0,1.2e-74,280.8,sp|P38976|RAS2_HYDVU Ras-like protein RAS2 OS=Hydra vulgaris OX=6087 GN=RAS2 PE=2 SV=1,,,,,,
OG_00467,FUN_001403-T1,Peve_00008765,Pocillopora_meandrina_HIv1___RNAseq.g2111.t1,three_way,78.99133333333334,FUN_001403-T1,Q8AYK6,,,,,49.5,509.0,2.5e-117,424.1,sp|Q8AYK6|WEE1A_XENLA Wee1-like protein kinase 1-A OS=Xenopus laevis OX=8355 GN=wee1-a PE=2 SV=1,,,,,,
OG_00468,FUN_001404-T1,Peve_00008762,Pocillopora_meandrina_HIv1___RNAseq.g2109.t1,three_way,61.63733333333334,FUN_001404-T1,Q556Y8,DUSPR_DICDI,,Probable rhodanese domain-containing dual specificity protein phosphatase (EC 3.1.3.16) (EC 3.1.3.48),Dictyostelium discoideum (Social amoeba),37.2,172.0,7.7e-30,133.3,sp|Q556Y8|DUSPR_DICDI Probable rhodanese domain-containing dual specificity protein phosphatase OS=Dictyostelium discoideum OX=44689 GN=DDB_G0273199 PE=3 SV=1,GO:0004721; GO:0004722; GO:0005737; GO:0007165; GO:0008330; GO:0017017; GO:0030587; GO:0033550; GO:0043409; GO:0072718,negative regulation of MAPK cascade [GO:0043409]; response to cisplatin [GO:0072718]; signal transduction [GO:0007165]; sorocarp development [GO:0030587],cytoplasm [GO:0005737],MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0016787; GO:0048856; GO:0140096,"catalytic activity; hydrolase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_00469,FUN_001405-T1,Peve_00008761,Pocillopora_meandrina_HIv1___RNAseq.g2108.t1,three_way,74.93433333333333,FUN_001405-T1,Q920G9,,,,,45.3,433.0,4.4e-107,389.8,sp|Q920G9|GMCL1_MOUSE Germ cell-less protein-like 1 OS=Mus musculus OX=10090 GN=Gmcl1 PE=1 SV=2,,,,,,
OG_00470,FUN_001406-T1,Peve_00008759,Pocillopora_meandrina_HIv1___RNAseq.g2107.t1,three_way,73.627,FUN_001406-T1,Q61701,,,,,37.9,290.0,2.0999999999999998e-47,191.0,sp|Q61701|ELAV4_MOUSE ELAV-like protein 4 OS=Mus musculus OX=10090 GN=Elavl4 PE=1 SV=1,,,,,,
OG_00471,FUN_001407-T1,Peve_00008758,Pocillopora_meandrina_HIv1___RNAseq.g2106.t1,three_way,80.07066666666667,FUN_001407-T1,Q8NFH4,NUP37_HUMAN,,Nucleoporin Nup37 (p37) (Nup107-160 subcomplex subunit Nup37),Homo sapiens (Human),46.6,322.0,3.4e-82,306.6,sp|Q8NFH4|NUP37_HUMAN Nucleoporin Nup37 OS=Homo sapiens OX=9606 GN=NUP37 PE=1 SV=1,GO:0000776; GO:0005634; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006913; GO:0007059; GO:0015031; GO:0031080; GO:0051028; GO:0051301,cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006913; GO:0007059; GO:0043226,nucleus; nuclear envelope; nucleoplasm; cytosol; nucleocytoplasmic transport; chromosome segregation; organelle
OG_00472,FUN_001411-T1,Peve_00008755,Pocillopora_meandrina_HIv1___RNAseq.g2103.t1,three_way,87.10533333333333,FUN_001411-T1,Q06234,,,,,45.9,122.0,3.3e-14,79.7,sp|Q06234|ASCL1_XENLA Achaete-scute homolog 1 OS=Xenopus laevis OX=8355 GN=ascl1 PE=2 SV=1,,,,,,
OG_00473,FUN_001412-T1,Peve_00008754,Pocillopora_meandrina_HIv1___RNAseq.g2102.t1,three_way,75.09233333333333,FUN_001412-T1,O35972,,,,,50.4,115.0,8.4e-27,121.3,sp|O35972|RM23_MOUSE Large ribosomal subunit protein uL23m OS=Mus musculus OX=10090 GN=Mrpl23 PE=1 SV=1,,,,,,
OG_00474,FUN_001413-T1,Peve_00008749,Pocillopora_meandrina_HIv1___RNAseq.g2101.t1,three_way,46.56633333333333,,,,,,,,,,,,,,,,,
OG_00475,FUN_001414-T1,Peve_00008747,Pocillopora_meandrina_HIv1___RNAseq.g2100.t1,three_way,79.928,FUN_001414-T1,P50553,ASCL1_HUMAN,,Achaete-scute homolog 1 (ASH-1) (hASH1) (Class A basic helix-loop-helix protein 46) (bHLHa46),Homo sapiens (Human),60.3,63.0,3.9e-13,76.6,sp|P50553|ASCL1_HUMAN Achaete-scute homolog 1 OS=Homo sapiens OX=9606 GN=ASCL1 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003358; GO:0003359; GO:0003676; GO:0003682; GO:0003700; GO:0005634; GO:0007219; GO:0007346; GO:0007400; GO:0007405; GO:0007423; GO:0007507; GO:0010468; GO:0014003; GO:0021527; GO:0021530; GO:0021750; GO:0021892; GO:0021902; GO:0021954; GO:0021987; GO:0022008; GO:0030182; GO:0030856; GO:0032526; GO:0042802; GO:0043025; GO:0043066; GO:0043425; GO:0043525; GO:0045665; GO:0045666; GO:0045747; GO:0045787; GO:0045892; GO:0045944; GO:0046983; GO:0048469; GO:0048485; GO:0048663; GO:0048665; GO:0048666; GO:0048935; GO:0050767; GO:0050769; GO:0050883; GO:0051593; GO:0060163; GO:0060165; GO:0060166; GO:0060487; GO:0060579; GO:0061100; GO:0061102; GO:0061103; GO:0061104; GO:0061549; GO:0070849; GO:0070888; GO:0071259; GO:0090575; GO:0097475; GO:1990837; GO:2000179,"adrenal chromaffin cell differentiation [GO:0061104]; carotid body glomus cell differentiation [GO:0061103]; cell maturation [GO:0048469]; cellular response to magnetism [GO:0071259]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; cerebral cortex GABAergic interneuron differentiation [GO:0021892]; commitment of neuronal cell to specific neuron type in forebrain [GO:0021902]; heart development [GO:0007507]; lung epithelial cell differentiation [GO:0060487]; lung neuroendocrine cell differentiation [GO:0061100]; motor neuron migration [GO:0097475]; musculoskeletal movement, spinal reflex action [GO:0050883]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuron fate specification [GO:0048665]; noradrenergic neuron development [GO:0003358]; noradrenergic neuron fate commitment [GO:0003359]; Notch signaling pathway [GO:0007219]; olfactory pit development [GO:0060166]; oligodendrocyte development [GO:0014003]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell cycle [GO:0045787]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell differentiation [GO:0030856]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neurogenesis [GO:0050767]; regulation of timing of subpallium neuron differentiation [GO:0060165]; response to epidermal growth factor [GO:0070849]; response to folic acid [GO:0051593]; response to retinoic acid [GO:0032526]; sensory organ development [GO:0007423]; spinal cord association neuron differentiation [GO:0021527]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; stomach neuroendocrine cell differentiation [GO:0061102]; subpallium neuron fate commitment [GO:0060163]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; ventral spinal cord interneuron fate commitment [GO:0060579]; vestibular nucleus development [GO:0021750]",chromatin [GO:0000785]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"bHLH transcription factor binding [GO:0043425]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_00476,FUN_001415-T1,Peve_00008745,Pocillopora_meandrina_HIv1___RNAseq.g2099.t2,three_way,70.42699999999999,FUN_001415-T1,Q9NQ34,,,,,30.7,179.0,6e-14,79.0,sp|Q9NQ34|TMM9B_HUMAN Transmembrane protein 9B OS=Homo sapiens OX=9606 GN=TMEM9B PE=1 SV=1,,,,,,
OG_00477,FUN_001416-T1,Peve_00008744,Pocillopora_meandrina_HIv1___RNAseq.g2098.t1,three_way,82.74133333333333,FUN_001416-T1,Q924X7,STK33_MOUSE,,Serine/threonine-protein kinase 33 (EC 2.7.11.1),Mus musculus (Mouse),54.2,345.0,2e-101,370.9,sp|Q924X7|STK33_MOUSE Serine/threonine-protein kinase 33 OS=Mus musculus OX=10090 GN=Stk33 PE=1 SV=2,GO:0002177; GO:0004674; GO:0005524; GO:0007283; GO:0046777; GO:0048471; GO:0106310; GO:1905198,manchette assembly [GO:1905198]; protein autophosphorylation [GO:0046777]; spermatogenesis [GO:0007283],manchette [GO:0002177]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0140096,"catalytic activity; transferase activity; reproductive process; catalytic activity, acting on a protein"
OG_00478,FUN_001417-T1,Peve_00008743,Pocillopora_meandrina_HIv1___RNAseq.g2096.t1,three_way,84.827,FUN_001417-T1,Q8C5L3,CNOT2_MOUSE,,CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2),Mus musculus (Mouse),43.2,562.0,2.8e-94,347.8,sp|Q8C5L3|CNOT2_MOUSE CCR4-NOT transcription complex subunit 2 OS=Mus musculus OX=10090 GN=Cnot2 PE=1 SV=2,GO:0000122; GO:0001222; GO:0001829; GO:0004535; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006417; GO:0010606; GO:0030014; GO:0030015; GO:0031047; GO:0033147; GO:2000036,negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829],CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],poly(A)-specific ribonuclease activity [GO:0004535]; transcription corepressor binding [GO:0001222],GO:0003824; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0031047; GO:0140098,"catalytic activity; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; regulatory ncRNA-mediated gene silencing; catalytic activity, acting on RNA"
OG_00479,FUN_001418-T1,Peve_00008742,Pocillopora_meandrina_HIv1___RNAseq.g2097.t1,three_way,81.65133333333334,FUN_001418-T1,P32198,CPT1A_RAT,,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-)",Rattus norvegicus (Rat),49.2,765.0,3.5e-218,759.6,"sp|P32198|CPT1A_RAT Carnitine O-palmitoyltransferase 1, liver isoform OS=Rattus norvegicus OX=10116 GN=Cpt1a PE=1 SV=2",GO:0001666; GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0007584; GO:0009410; GO:0009437; GO:0030674; GO:0030855; GO:0031667; GO:0031998; GO:0032000; GO:0042755; GO:0042802; GO:0043279; GO:0045089; GO:0045471; GO:0046222; GO:0046320; GO:0050796; GO:0071398; GO:0097421; GO:1904772,aflatoxin metabolic process [GO:0046222]; carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of innate immune response [GO:0045089]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; response to alkaloid [GO:0043279]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to nutrient [GO:0007584]; response to nutrient levels [GO:0031667]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006629; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; lipid metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity
OG_00480,FUN_001422-T3,Peve_00008797,Pocillopora_meandrina_HIv1___RNAseq.g2170.t1,three_way,83.918,FUN_001422-T3,Q6A078,CE290_MOUSE,,Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein homolog) (Nephrocystin-6),Mus musculus (Mouse),38.2,2233.0,0.0,1093.6,sp|Q6A078|CE290_MOUSE Centrosomal protein of 290 kDa OS=Mus musculus OX=10090 GN=Cep290 PE=1 SV=2,GO:0000226; GO:0001750; GO:0001822; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0007163; GO:0007368; GO:0007507; GO:0008104; GO:0015031; GO:0030902; GO:0030916; GO:0031410; GO:0032391; GO:0032991; GO:0034451; GO:0034976; GO:0035869; GO:0036038; GO:0042462; GO:0045494; GO:0045893; GO:0048793; GO:0060041; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:0120200; GO:0120205; GO:0120206; GO:1905349; GO:1905515,ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; establishment or maintenance of cell polarity [GO:0007163]; eye photoreceptor cell development [GO:0042462]; heart development [GO:0007507]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; microtubule cytoskeleton organization [GO:0000226]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; pronephros development [GO:0048793]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; response to endoplasmic reticulum stress [GO:0034976]; retina development in camera-type eye [GO:0060041],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]; photoreceptor proximal connecting cilium [GO:0120205]; protein-containing complex [GO:0032991]; rod photoreceptor outer segment [GO:0120200],,GO:0005634; GO:0005815; GO:0005829; GO:0006355; GO:0007010; GO:0007163; GO:0031410; GO:0043226; GO:0044782; GO:0048856,nucleus; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; establishment or maintenance of cell polarity; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development
OG_00481,FUN_001423-T1,Peve_00008791,Pocillopora_meandrina_HIv1___RNAseq.g2174.t1,three_way,80.44866666666667,FUN_001423-T1,Q5THR3,EFCB6_HUMAN,,EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP),Homo sapiens (Human),26.7,1522.0,2.7e-164,581.6,sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1,GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126],calcium ion binding [GO:0005509],GO:0005654; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleoplasm; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_00482,FUN_001424-T1,Peve_00008792,Pocillopora_meandrina_HIv1___TS.g4679.t3,three_way,67.32566666666666,,,,,,,,,,,,,,,,,
OG_00483,FUN_001447-T1,Peve_00019961,Pocillopora_meandrina_HIv1___RNAseq.g1952.t1,three_way,57.163,FUN_001447-T1,Q61824,,,,,37.3,714.0,8.5e-130,466.5,sp|Q61824|ADA12_MOUSE Disintegrin and metalloproteinase domain-containing protein 12 OS=Mus musculus OX=10090 GN=Adam12 PE=1 SV=2,,,,,,
OG_00484,FUN_001448-T1,Peve_00012532,Pocillopora_meandrina_HIv1___RNAseq.g1951.t1,three_way,74.123,FUN_001448-T1,Q3T0S0,,,,,40.2,127.0,2.3e-21,103.6,sp|Q3T0S0|TM128_BOVIN Transmembrane protein 128 OS=Bos taurus OX=9913 GN=TMEM128 PE=2 SV=1,,,,,,
OG_00485,FUN_001450-T1,Peve_00018452,Pocillopora_meandrina_HIv1___RNAseq.g1956.t1,three_way,82.06483333333334,FUN_001450-T1,Q804S6,,,,,65.5,58.0,1.1e-12,74.7,sp|Q804S6|EMX1_DANRE Homeobox protein EMX1 OS=Danio rerio OX=7955 GN=emx1 PE=2 SV=1,,,,,,
OG_00486,FUN_001452-T1,Peve_00018443,Pocillopora_meandrina_HIv1___RNAseq.g1955.t1,three_way,69.77166666666668,FUN_001452-T1,O08983,HPS1_MOUSE,,BLOC-3 complex member HPS1 (Hermansky-Pudlak syndrome 1 protein homolog),Mus musculus (Mouse),24.2,615.0,2.3e-23,112.1,sp|O08983|HPS1_MOUSE BLOC-3 complex member HPS1 OS=Mus musculus OX=10090 GN=Hps1 PE=2 SV=2,GO:0000902; GO:0003016; GO:0005085; GO:0005737; GO:0006629; GO:0006882; GO:0006954; GO:0007040; GO:0007283; GO:0007338; GO:0007596; GO:0009306; GO:0010467; GO:0016192; GO:0030318; GO:0030324; GO:0031085; GO:0031410; GO:0032816; GO:0033299; GO:0043473; GO:0046907; GO:0048069; GO:0055088; GO:0060041; GO:0060155; GO:0060425; GO:1903232,blood coagulation [GO:0007596]; cell morphogenesis [GO:0000902]; eye pigmentation [GO:0048069]; gene expression [GO:0010467]; inflammatory response [GO:0006954]; intracellular transport [GO:0046907]; intracellular zinc ion homeostasis [GO:0006882]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; pigmentation [GO:0043473]; platelet dense granule organization [GO:0060155]; positive regulation of natural killer cell activation [GO:0032816]; protein secretion [GO:0009306]; respiratory system process [GO:0003016]; retina development in camera-type eye [GO:0060041]; secretion of lysosomal enzymes [GO:0033299]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192],BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003016; GO:0006629; GO:0006954; GO:0007040; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0098772,respiratory system process; lipid metabolic process; inflammatory response; lysosome organization; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_00487,FUN_001453-T1,Peve_00018442,Pocillopora_meandrina_HIv1___RNAseq.g1954.t1,three_way,80.51,FUN_001453-T1,Q9UBR2,CATZ_HUMAN,,Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X),Homo sapiens (Human),61.6,297.0,1.4000000000000003e-111,404.1,sp|Q9UBR2|CATZ_HUMAN Cathepsin Z OS=Homo sapiens OX=9606 GN=CTSZ PE=1 SV=1,GO:0002003; GO:0004180; GO:0004197; GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0005788; GO:0005886; GO:0005938; GO:0006508; GO:0008234; GO:0009986; GO:0010757; GO:0016807; GO:0030134; GO:0030426; GO:0031410; GO:0033116; GO:0035580; GO:0043231; GO:0051603; GO:0060441; GO:0062023; GO:0070062; GO:1904813,angiotensin maturation [GO:0002003]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of plasminogen activation [GO:0010757]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580],carboxypeptidase activity [GO:0004180]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234],GO:0003824; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; lysosome; vacuole; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_00488,FUN_001454-T1,Peve_00018435,Pocillopora_meandrina_HIv1___RNAseq.g27059.t1,three_way,67.482,,,,,,,,,,,,,,,,,
OG_00489,FUN_001455-T1,Peve_00018433,Pocillopora_meandrina_HIv1___RNAseq.g1953.t1,three_way,74.87066666666666,FUN_001455-T1,O94844,RHBT1_HUMAN,,Rho-related BTB domain-containing protein 1,Homo sapiens (Human),39.0,693.0,1.2e-113,412.1,sp|O94844|RHBT1_HUMAN Rho-related BTB domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RHOBTB1 PE=1 SV=2,GO:0003924; GO:0005525; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007264; GO:0008360; GO:0010008; GO:0019901; GO:0030865; GO:0031410; GO:0032956; GO:0042995,actin filament organization [GO:0007015]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264],cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; hydrolase activity; cytoplasmic vesicle; organelle
OG_00490,FUN_001456-T1,Peve_00027104,Pocillopora_meandrina_HIv1___RNAseq.g1958.t1,three_way,74.524,FUN_001456-T1,B3DK16,,,,,47.5,244.0,6.1e-63,242.3,sp|B3DK16|PCF5A_DANRE Polycomb group RING finger protein 5-A OS=Danio rerio OX=7955 GN=pcgf5a PE=2 SV=1,,,,,,
OG_00491,FUN_001461-T1,Peve_00027130,Pocillopora_meandrina_HIv1___TS.g4468.t1,three_way,90.859,FUN_001461-T1,Q8BTQ0,PCGF3_MOUSE,,Polycomb group RING finger protein 3 (RING finger protein 3A),Mus musculus (Mouse),57.9,242.0,6.200000000000001e-73,275.4,sp|Q8BTQ0|PCGF3_MOUSE Polycomb group RING finger protein 3 OS=Mus musculus OX=10090 GN=PcgF3 PE=1 SV=1,GO:0005654; GO:0008270; GO:0031519; GO:0060816; GO:0140862,random inactivation of X chromosome [GO:0060816],nucleoplasm [GO:0005654]; PcG protein complex [GO:0031519],histone H2AK119 ubiquitin ligase activity [GO:0140862]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006325; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; chromatin organization; transferase activity; catalytic activity, acting on a protein"
OG_00492,FUN_001462-T1,Peve_00027129,Pocillopora_meandrina_HIv1___RNAseq.g1962.t1,three_way,78.42083333333333,FUN_001462-T1,Q7ZYZ7,PCGF1_DANRE,,Polycomb group RING finger protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),49.2,244.0,2.4e-59,230.3,sp|Q7ZYZ7|PCGF1_DANRE Polycomb group RING finger protein 1 OS=Danio rerio OX=7955 GN=pcgf1 PE=3 SV=1,GO:0000122; GO:0006338; GO:0008270; GO:0021915; GO:0031519; GO:0035102; GO:0048589; GO:1990841,chromatin remodeling [GO:0006338]; developmental growth [GO:0048589]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915],PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102],promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270],GO:0006325; GO:0006355; GO:0048856,chromatin organization; regulation of DNA-templated transcription; anatomical structure development
OG_00493,FUN_001463-T1,Peve_00027128,Pocillopora_meandrina_HIv1___RNAseq.g1963.t1,three_way,62.418,FUN_001463-T1,Q5S007,LRRK2_HUMAN,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin),Homo sapiens (Human),28.8,2337.0,8.6e-257,889.4,sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2,GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005615; GO:0005654; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0007040; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0061024; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; extracellular space; nucleoplasm; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_00494,FUN_001464-T1,Peve_00027126,Pocillopora_meandrina_HIv1___RNAseq.g1964.t1,three_way,83.3075,FUN_001464-T1,Q5ZJN1,,,,,57.2,187.0,5.100000000000001e-59,229.6,sp|Q5ZJN1|RTF2_CHICK Replication termination factor 2 OS=Gallus gallus OX=9031 GN=RTF2 PE=2 SV=1,,,,,,
OG_00495,FUN_001465-T1,Peve_00027124,Pocillopora_meandrina_HIv1___RNAseq.g1965.t1,three_way,84.74733333333333,FUN_001465-T1,Q6GLP4,RMD5A_XENLA,,E3 ubiquitin-protein ligase RMND5A (EC 2.3.2.27) (Protein RMD5 homolog A),Xenopus laevis (African clawed frog),50.1,391.0,3.7e-115,416.4,sp|Q6GLP4|RMD5A_XENLA E3 ubiquitin-protein ligase RMND5A OS=Xenopus laevis OX=8355 GN=rmnd5a PE=1 SV=1,GO:0000151; GO:0000209; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008270; GO:0034657; GO:0043161; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; cytosol [GO:0005829]; GID complex [GO:0034657]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_00496,FUN_001466-T1,Peve_00027123,Pocillopora_meandrina_HIv1___RNAseq.g1967.t1,three_way,67.97266666666667,FUN_001466-T1,A0JNK3,HTRA2_BOVIN,,"Serine protease HTRA2, mitochondrial (EC 3.4.21.108)",Bos taurus (Bovine),47.0,334.0,1.0999999999999999e-75,285.4,"sp|A0JNK3|HTRA2_BOVIN Serine protease HTRA2, mitochondrial OS=Bos taurus OX=9913 GN=HTRA2 PE=2 SV=1",GO:0004252; GO:0005739; GO:0005758; GO:0006508; GO:0006915; GO:0012501; GO:0031966; GO:0043065,apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065]; programmed cell death [GO:0012501]; proteolysis [GO:0006508],mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005739; GO:0012501; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; programmed cell death; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00497,FUN_001467-T3,Peve_00027122,Pocillopora_meandrina_HIv1___RNAseq.g1968.t1,three_way,81.8265,FUN_001467-T3,Q8CDM8,,,,,50.3,760.0,4.1e-197,689.5,sp|Q8CDM8|FHI2A_MOUSE FHF complex subunit HOOK interacting protein 2A OS=Mus musculus OX=10090 GN=Fhip2a PE=1 SV=2,,,,,,
OG_00498,FUN_001471-T1,Peve_00022129,Pocillopora_meandrina_HIv1___RNAseq.g22905.t1,three_way,60.35333333333333,,,,,,,,,,,,,,,,,
OG_00499,FUN_001472-T1,Peve_00026259,Pocillopora_meandrina_HIv1___RNAseq.g1911.t1,three_way,72.17666666666666,FUN_001472-T1,Q8VHT6,AS3MT_RAT,,Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase),Rattus norvegicus (Rat),46.2,366.0,6.1e-86,319.3,sp|Q8VHT6|AS3MT_RAT Arsenite methyltransferase OS=Rattus norvegicus OX=10116 GN=As3mt PE=1 SV=1,GO:0005829; GO:0008276; GO:0008757; GO:0009404; GO:0018872; GO:0030791; GO:0032259; GO:0046685,arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; response to arsenic-containing substance [GO:0046685]; toxin metabolic process [GO:0009404],cytosol [GO:0005829],arsenite methyltransferase activity [GO:0030791]; protein methyltransferase activity [GO:0008276]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_00500,FUN_001473-T1,Peve_00029354,Pocillopora_meandrina_HIv1___TS.g4480.t1,three_way,91.325,FUN_001473-T1,Q5ZLT0,,,,,70.9,1080.0,0.0,1511.1,sp|Q5ZLT0|XPO7_CHICK Exportin-7 OS=Gallus gallus OX=9031 GN=XPO7 PE=2 SV=1,,,,,,
OG_00501,FUN_001476-T1,Peve_00044705,Pocillopora_meandrina_HIv1___RNAseq.g1913.t1,three_way,79.40833333333333,FUN_001476-T1,O73742,,,,,51.9,605.0,1.0000000000000001e-159,565.1,sp|O73742|COE3_XENLA Transcription factor COE3 OS=Xenopus laevis OX=8355 GN=coe3 PE=2 SV=2,,,,,,
OG_00502,FUN_001477-T1,Peve_00011493,Pocillopora_meandrina_HIv1___RNAseq.g1914.t1,three_way,81.65333333333334,FUN_001477-T1,P33731,,,,,47.5,503.0,3.9e-133,476.5,sp|P33731|SRP72_CANLF Signal recognition particle subunit SRP72 OS=Canis lupus familiaris OX=9615 GN=SRP72 PE=1 SV=3,,,,,,
OG_00503,FUN_001479-T1,Peve_00029353,Pocillopora_meandrina_HIv1___RNAseq.g1915.t1,three_way,60.45516666666666,FUN_001479-T1,Q8NFT6,DBF4B_HUMAN,,Protein DBF4 homolog B (Activator of S phase kinase-like protein 1) (ASK-like protein 1) (Chiffon homolog B) (Dbf4-related factor 1),Homo sapiens (Human),25.6,347.0,4.1e-20,100.9,sp|Q8NFT6|DBF4B_HUMAN Protein DBF4 homolog B OS=Homo sapiens OX=9606 GN=DBF4B PE=1 SV=1,GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008284; GO:0010571; GO:0010971; GO:0019901; GO:0030295; GO:0031431; GO:0043231; GO:0043539; GO:1901987,positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987],cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0043226; GO:0098772,nucleus; nucleoplasm; organelle; molecular function regulator activity
OG_00504,FUN_001480-T1,Peve_00029351,Pocillopora_meandrina_HIv1___RNAseq.g1916.t1,three_way,74.41033333333333,FUN_001480-T1,Q91770,,,,,43.8,169.0,1e-21,105.1,sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1,,,,,,
OG_00505,FUN_001481-T1,Peve_00029350,Pocillopora_meandrina_HIv1___TS.g4427.t1,three_way,71.991,,,,,,,,,,,,,,,,,
OG_00506,FUN_001482-T1,Peve_00029349,Pocillopora_meandrina_HIv1___TS.g4428.t1,three_way,67.89966666666666,FUN_001482-T1,Q6GLB9,,,,,75.4,69.0,1.4e-20,101.3,sp|Q6GLB9|EMX1_XENTR Homeobox protein EMX1 OS=Xenopus tropicalis OX=8364 GN=emx1 PE=2 SV=1,,,,,,
OG_00507,FUN_001483-T1,Peve_00029348,Pocillopora_meandrina_HIv1___RNAseq.g1919.t1,three_way,97.90966666666668,FUN_001483-T1,P31410,,,,,89.2,493.0,5.5e-257,887.9,sp|P31410|VATB_HELVI V-type proton ATPase subunit B OS=Heliothis virescens OX=7102 GN=VHA55 PE=2 SV=1,,,,,,
OG_00508,FUN_001484-T1,Peve_00029347,Pocillopora_meandrina_HIv1___RNAseq.g1910.t1,three_way,71.71783333333333,FUN_001484-T1,Q6NRH3,,,,,43.7,268.0,5.1999999999999996e-46,187.2,sp|Q6NRH3|CC149_XENLA Coiled-coil domain-containing protein 149 OS=Xenopus laevis OX=8355 GN=ccdc149 PE=2 SV=1,,,,,,
OG_00509,FUN_001493-T1,Peve_00002848,Pocillopora_meandrina_HIv1___RNAseq.g1906.t1,three_way,65.069,FUN_001493-T1,Q9NQA5,TRPV5_HUMAN,,Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3),Homo sapiens (Human),28.2,170.0,3.5e-07,58.9,sp|Q9NQA5|TRPV5_HUMAN Transient receptor potential cation channel subfamily V member 5 OS=Homo sapiens OX=9606 GN=TRPV5 PE=1 SV=3,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016324; GO:0034704; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809],apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003014; GO:0005215; GO:0005886; GO:0055085; GO:0065003,renal system process; transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_00510,FUN_001497-T1,Peve_00012117,Pocillopora_meandrina_HIv1___RNAseq.g1894.t1,three_way,57.794,,,,,,,,,,,,,,,,,
OG_00511,FUN_001503-T1,Peve_00018430,Pocillopora_meandrina_HIv1___RNAseq.g1086.t1,three_way,61.830666666666666,FUN_001503-T1,P86982,,,,,41.6,137.0,3.9e-21,103.6,sp|P86982|IMSP1_RUDPH Insoluble matrix shell protein 1 (Fragment) OS=Ruditapes philippinarum OX=129788 PE=1 SV=1,,,,,,
OG_00512,FUN_001504-T1,Peve_00012115,Pocillopora_meandrina_HIv1___RNAseq.g1890.t1,three_way,97.17433333333334,FUN_001504-T1,A5PJW8,RPB2_BOVIN,,DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (RNA-directed RNA polymerase II subunit RPB2) (EC 2.7.7.48),Bos taurus (Bovine),87.3,1174.0,0.0,2134.4,sp|A5PJW8|RPB2_BOVIN DNA-directed RNA polymerase II subunit RPB2 OS=Bos taurus OX=9913 GN=POLR2B PE=1 SV=1,GO:0000781; GO:0003677; GO:0003682; GO:0003899; GO:0003968; GO:0005665; GO:0005739; GO:0006366; GO:0008270; GO:0016787; GO:0032549; GO:0071667,transcription by RNA polymerase II [GO:0006366],"chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; RNA polymerase II, core complex [GO:0005665]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; hydrolase activity [GO:0016787]; ribonucleoside binding [GO:0032549]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005739; GO:0006351; GO:0016740; GO:0016787; GO:0043226; GO:0140098,"DNA binding; catalytic activity; mitochondrion; DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_00513,FUN_001505-T1,Peve_00012116,Pocillopora_meandrina_HIv1___RNAseq.g1889.t1,three_way,55.97966666666667,,,,,,,,,,,,,,,,,
OG_00514,FUN_001507-T1,Peve_00012118,Pocillopora_meandrina_HIv1___TS.g4396.t1a,three_way,54.123666666666665,FUN_001507-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),42.2,398.0,5.3e-88,328.2,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_00515,FUN_001508-T1,Peve_00012119,Pocillopora_meandrina_HIv1___TS.g4395.t1,three_way,53.312666666666665,FUN_001508-T1,O94941,,,,,27.1,609.0,6.5e-44,180.3,sp|O94941|RNF37_HUMAN RING finger protein 37 OS=Homo sapiens OX=9606 GN=UBOX5 PE=1 SV=1,,,,,,
OG_00516,FUN_001509-T1,Peve_00012120,Pocillopora_meandrina_HIv1___RNAseq.g1886.t1,three_way,70.55866666666667,,,,,,,,,,,,,,,,,
OG_00517,FUN_001511-T1,Peve_00012124,Pocillopora_meandrina_HIv1___RNAseq.g1885.t1,three_way,62.00266666666667,,,,,,,,,,,,,,,,,
OG_00518,FUN_001515-T1,Peve_00012126,Pocillopora_meandrina_HIv1___RNAseq.g1884.t1,three_way,81.4485,FUN_001515-T1,A2A259,PK2L1_MOUSE,,Polycystin-2-like protein 1 (Polycystin-2L1) (Polycystic kidney disease 2-like 1 protein) (Polycystin-2 homolog),Mus musculus (Mouse),21.7,300.0,3.4e-09,65.5,sp|A2A259|PK2L1_MOUSE Polycystin-2-like protein 1 OS=Mus musculus OX=10090 GN=Pkd2l1 PE=1 SV=1,GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0009415; GO:0015269; GO:0015629; GO:0031410; GO:0034703; GO:0034704; GO:0042802; GO:0043235; GO:0044325; GO:0050912; GO:0051262; GO:0051289; GO:0051371; GO:0060170; GO:0071467; GO:0071468; GO:0097730; GO:0098662; GO:0160128; GO:1990760,cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transport [GO:0006812]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; smoothened signaling pathway [GO:0007224],actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; pH-gated monoatomic ion channel activity [GO:0160128]; sodium channel activity [GO:0005272]; transmembrane transporter binding [GO:0044325],GO:0005215; GO:0005783; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0008092; GO:0031410; GO:0043226; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,transporter activity; endoplasmic reticulum; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeletal protein binding; cytoplasmic vesicle; organelle; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_00519,FUN_001517-T1,Peve_00012127,Pocillopora_meandrina_HIv1___TS.g4391.t1,three_way,84.86149999999999,FUN_001517-T1,Q3SZ40,,,,,56.4,535.0,3.6000000000000003e-158,559.7,sp|Q3SZ40|DDX56_BOVIN Probable ATP-dependent RNA helicase DDX56 OS=Bos taurus OX=9913 GN=DDX56 PE=2 SV=1,,,,,,
OG_00520,FUN_001519-T1,Peve_00042520,Pocillopora_meandrina_HIv1___TS.g4541.t1,three_way,73.94266666666667,FUN_001519-T1,Q6QDP7,CR3L2_RAT,,Cyclic AMP-responsive element-binding protein 3-like protein 2 (cAMP-responsive element-binding protein 3-like protein 2) (SCI-related protein Ra69) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2],Rattus norvegicus (Rat),38.3,334.0,6.8e-34,146.7,sp|Q6QDP7|CR3L2_RAT Cyclic AMP-responsive element-binding protein 3-like protein 2 OS=Rattus norvegicus OX=10116 GN=Creb3l2 PE=2 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0002062; GO:0005634; GO:0005783; GO:0005789; GO:0006357; GO:0006888; GO:0006986; GO:0010628; GO:0010976; GO:0034976; GO:0035497; GO:0045893; GO:0045944; GO:0051216; GO:0097038,cartilage development [GO:0051216]; chondrocyte differentiation [GO:0002062]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038],"cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005783; GO:0006355; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_00521,FUN_001520-T1,Peve_00042519,Pocillopora_meandrina_HIv1___RNAseq.g2039.t1,three_way,43.881166666666665,,,,,,,,,,,,,,,,,
OG_00522,FUN_001522-T1,Peve_00042518,Pocillopora_meandrina_HIv1___RNAseq.g2040.t1,three_way,96.534,FUN_001522-T1,B1WBM3,,,,,57.6,99.0,1e-20,100.9,sp|B1WBM3|TM138_RAT Transmembrane protein 138 OS=Rattus norvegicus OX=10116 GN=Tmem138 PE=2 SV=1,,,,,,
OG_00523,FUN_001527-T1,Peve_00000631,Pocillopora_meandrina_HIv1___RNAseq.g2042.t1,three_way,55.81666666666667,FUN_001527-T1,Q9TTQ9,,,,,32.9,207.0,8.6e-19,96.3,sp|Q9TTQ9|GPR83_CANLF G-protein coupled receptor 83 OS=Canis lupus familiaris OX=9615 GN=GPR83 PE=2 SV=1,,,,,,
OG_00524,FUN_001528-T1,Peve_00000629,Pocillopora_meandrina_HIv1___RNAseq.g2043.t1,three_way,74.13533333333334,FUN_001528-T1,Q9TTQ9,,,,,26.6,218.0,1e-13,79.3,sp|Q9TTQ9|GPR83_CANLF G-protein coupled receptor 83 OS=Canis lupus familiaris OX=9615 GN=GPR83 PE=2 SV=1,,,,,,
OG_00525,FUN_001529-T3,Peve_00000626,Pocillopora_meandrina_HIv1___RNAseq.g2044.t1,three_way,76.09666666666666,FUN_001529-T3,O75912,DGKI_HUMAN,,Diacylglycerol kinase iota (DAG kinase iota) (DGK-iota) (EC 2.7.1.107),Homo sapiens (Human),45.7,999.0,2.3e-238,827.0,sp|O75912|DGKI_HUMAN Diacylglycerol kinase iota OS=Homo sapiens OX=9606 GN=DGKI PE=1 SV=2,GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006654; GO:0007200; GO:0014069; GO:0030168; GO:0030424; GO:0030672; GO:0032991; GO:0035556; GO:0043197; GO:0045202; GO:0046339; GO:0046834; GO:0097060; GO:0098978,diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle membrane [GO:0030672],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006629; GO:0016740; GO:0043226,catalytic activity; nucleus; cytosol; plasma membrane; lipid metabolic process; transferase activity; organelle
OG_00526,FUN_001530-T1,Peve_00000625,Pocillopora_meandrina_HIv1___RNAseq.g2045.t2,three_way,82.98033333333333,FUN_001530-T1,Q2KIH7,PH4H_BOVIN,,Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase),Bos taurus (Bovine),64.8,423.0,7.6e-165,581.6,sp|Q2KIH7|PH4H_BOVIN Phenylalanine-4-hydroxylase OS=Bos taurus OX=9913 GN=PAH PE=2 SV=1,GO:0004505; GO:0005506; GO:0006559; GO:0006571,L-phenylalanine catabolic process [GO:0006559]; tyrosine biosynthetic process [GO:0006571],,iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505],GO:0003824; GO:0006520; GO:0016491,catalytic activity; amino acid metabolic process; oxidoreductase activity
OG_00527,FUN_001531-T1,Peve_00000632,Pocillopora_meandrina_HIv1___RNAseq.g2047.t1,three_way,79.239,FUN_001531-T1,A2RSQ0,,,,,43.6,1377.0,1.4e-312,1074.7,sp|A2RSQ0|DEN5B_MOUSE DENN domain-containing protein 5B OS=Mus musculus OX=10090 GN=Dennd5b PE=1 SV=2,,,,,,
OG_00528,FUN_001532-T1,Peve_00000627,Pocillopora_meandrina_HIv1___RNAseq.g2048.t1,three_way,76.9355,FUN_001532-T1,Q80W14,,,,,53.5,593.0,3.1e-96,354.8,sp|Q80W14|PR40B_MOUSE Pre-mRNA-processing factor 40 homolog B OS=Mus musculus OX=10090 GN=Prpf40b PE=1 SV=2,,,,,,
OG_00529,FUN_001534-T1,Peve_00014191,Pocillopora_meandrina_HIv1___RNAseq.12922_t,three_way,52.932500000000005,FUN_001534-T1,O13024,,,,,52.7,110.0,1.1e-20,104.0,sp|O13024|INCEA_XENLA Inner centromere protein A OS=Xenopus laevis OX=8355 GN=incenp-a PE=1 SV=1,,,,,,
OG_00530,FUN_001535-T1,Peve_00014195,Pocillopora_meandrina_HIv1___RNAseq.g2057.t1,three_way,71.78833333333333,FUN_001535-T1,Q9Y4D2,,,,,34.3,829.0,1.1e-127,459.5,sp|Q9Y4D2|DGLA_HUMAN Diacylglycerol lipase-alpha OS=Homo sapiens OX=9606 GN=DAGLA PE=1 SV=3,,,,,,
OG_00531,FUN_001545-T1,Peve_00033291,Pocillopora_meandrina_HIv1___RNAseq.g15386.t1,three_way,49.809666666666665,,,,,,,,,,,,,,,,,
OG_00532,FUN_001546-T1,Peve_00020469,Pocillopora_meandrina_HIv1___RNAseq.g2063.t1,three_way,72.07600000000001,FUN_001546-T1,Q02372,,,,,40.3,124.0,1.7e-17,90.9,"sp|Q02372|NDUB8_BOVIN NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial OS=Bos taurus OX=9913 GN=NDUFB8 PE=1 SV=1",,,,,,
OG_00533,FUN_001547-T1,Peve_00020470,Pocillopora_meandrina_HIv1___RNAseq.g2064.t1,three_way,91.406,FUN_001547-T1,E9Q8T7,DYH1_MOUSE,,Dynein axonemal heavy chain 1 (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (mDHC7),Mus musculus (Mouse),64.2,4208.0,0.0,5480.6,sp|E9Q8T7|DYH1_MOUSE Dynein axonemal heavy chain 1 OS=Mus musculus OX=10090 GN=Dnah1 PE=1 SV=1,GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005874; GO:0007288; GO:0008569; GO:0030317; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060294,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; sperm axoneme assembly [GO:0007288],extracellular region [GO:0005576]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; cytoskeleton organization; microtubule-based movement; isomerase activity; reproductive process; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_00534,FUN_001548-T1,Peve_00003913,Pocillopora_meandrina_HIv1___RNAseq.g2065.t1,three_way,79.53066666666668,FUN_001548-T1,Q8N2Z9,CENPS_HUMAN,,Centromere protein S (CENP-S) (Apoptosis-inducing TAF9-like domain-containing protein 1) (FANCM-associated histone fold protein 1) (FANCM-interacting histone fold protein 1) (Fanconi anemia-associated polypeptide of 16 kDa),Homo sapiens (Human),48.0,123.0,1.9e-26,120.2,sp|Q8N2Z9|CENPS_HUMAN Centromere protein S OS=Homo sapiens OX=9606 GN=CENPS PE=1 SV=1,GO:0000712; GO:0000785; GO:0000939; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006974; GO:0007059; GO:0031297; GO:0031398; GO:0036297; GO:0043240; GO:0046982; GO:0051301; GO:0071821,cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; positive regulation of protein ubiquitination [GO:0031398]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; inner kinetochore [GO:0000939]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0007059; GO:0022414; GO:0043226,DNA binding; nucleus; nucleoplasm; cytosol; DNA repair; chromosome segregation; reproductive process; organelle
OG_00535,FUN_001550-T1,Peve_00003916,Pocillopora_meandrina_HIv1___RNAseq.g2091.t1,three_way,65.51033333333334,FUN_001550-T1,Q54I58,,,,,32.0,219.0,6.2e-26,119.4,sp|Q54I58|NIPSN_DICDI Protein NipSnap homolog OS=Dictyostelium discoideum OX=44689 GN=nipsnap PE=3 SV=1,,,,,,
OG_00536,FUN_001551-T1,Peve_00003917,Pocillopora_meandrina_HIv1___RNAseq.g2092.t1,three_way,79.706,,,,,,,,,,,,,,,,,
OG_00537,FUN_001553-T1,Peve_00003908,Pocillopora_meandrina_HIv1___RNAseq.g1998.t1,three_way,60.30766666666667,FUN_001553-T1,Q9UQF2,JIP1_HUMAN,,C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1),Homo sapiens (Human),40.5,242.0,1.5e-50,201.8,sp|Q9UQF2|JIP1_HUMAN C-Jun-amino-terminal kinase-interacting protein 1 OS=Homo sapiens OX=9606 GN=MAPK8IP1 PE=1 SV=1,GO:0004860; GO:0005078; GO:0005634; GO:0005737; GO:0005789; GO:0005829; GO:0005886; GO:0006355; GO:0007254; GO:0008432; GO:0016192; GO:0019894; GO:0031434; GO:0031435; GO:0031966; GO:0043025; GO:0043508; GO:0044294; GO:0044295; GO:0044302; GO:0045202; GO:0046328; GO:0046330; GO:0048471; GO:2000564; GO:2001243,"JNK cascade [GO:0007254]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of JNK cascade [GO:0046330]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]; regulation of DNA-templated transcription [GO:0006355]; regulation of JNK cascade [GO:0046328]; vesicle-mediated transport [GO:0016192]",axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dentate gyrus mossy fiber [GO:0044302]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202],JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase inhibitor activity [GO:0004860],GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0008092; GO:0016192; GO:0043226; GO:0060090; GO:0098772,nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeletal protein binding; vesicle-mediated transport; organelle; molecular adaptor activity; molecular function regulator activity
OG_00538,FUN_001554-T1,Peve_00027305,Pocillopora_meandrina_HIv1___RNAseq.g2001.t1,three_way,66.06466666666667,FUN_001554-T1,Q924H0,,,,,27.7,303.0,2.2e-23,113.2,sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2,,,,,,
OG_00539,FUN_001558-T1,Peve_00027303,Pocillopora_meandrina_HIv1___RNAseq.g2006.t1,three_way,48.07383333333333,,,,,,,,,,,,,,,,,
OG_00540,FUN_001562-T1,Peve_00013899,Pocillopora_meandrina_HIv1___RNAseq.g2018.t1,three_way,83.21833333333333,FUN_001562-T1,Q8IWZ3,,,,,58.1,812.0,4.4e-82,308.9,sp|Q8IWZ3|ANKH1_HUMAN Ankyrin repeat and KH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKHD1 PE=1 SV=1,,,,,,
OG_00541,FUN_001567-T1,Peve_00037806,Pocillopora_meandrina_HIv1___TS.g4529.t1,three_way,50.96366666666667,FUN_001567-T1,O17185,SUP9_CAEEL,,Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38),Caenorhabditis elegans,28.6,241.0,9.5e-19,95.9,sp|O17185|SUP9_CAEEL Two pore potassium channel protein sup-9 OS=Caenorhabditis elegans OX=6239 GN=sup-9 PE=1 SV=2,GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0036195; GO:0055120; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937],muscle cell projection membrane [GO:0036195]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120],outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_00542,FUN_001573-T1,Peve_00010783,Pocillopora_meandrina_HIv1___RNAseq.g2028.t1,three_way,70.1815,FUN_001573-T1,A7T1N0,TMP2L_NEMVE,,Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2),Nematostella vectensis (Starlet sea anemone),30.8,1292.0,5.1e-158,560.5,sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1,GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604,calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725],plasma membrane [GO:0005886],ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872],GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0055085,catalytic activity; transporter activity; plasma membrane; hydrolase activity; transmembrane transport
OG_00543,FUN_001577-T1,Peve_00010785,Pocillopora_meandrina_HIv1___RNAseq.g2029.t1,three_way,69.47,FUN_001577-T1,Q6A039,,,,,55.0,453.0,3.1e-134,480.7,sp|Q6A039|TBC12_MOUSE TBC1 domain family member 12 OS=Mus musculus OX=10090 GN=Tbc1d12 PE=1 SV=2,,,,,,
OG_00544,FUN_001579-T1,Peve_00005420,Pocillopora_meandrina_HIv1___RNAseq.g2031.t1,three_way,69.11233333333334,,,,,,,,,,,,,,,,,
OG_00545,FUN_001581-T1,Peve_00005421,Pocillopora_meandrina_HIv1___RNAseq.g2032.t2,three_way,70.417,FUN_001581-T1,O43301,,,,,52.4,660.0,5.3e-199,696.0,sp|O43301|HS12A_HUMAN Heat shock 70 kDa protein 12A OS=Homo sapiens OX=9606 GN=HSPA12A PE=1 SV=2,,,,,,
OG_00546,FUN_001582-T1,Peve_00005424,Pocillopora_meandrina_HIv1___RNAseq.12901_t,three_way,90.39033333333332,FUN_001582-T1,Q8CIB6,,,,,64.3,112.0,1.2e-34,147.1,sp|Q8CIB6|TM230_MOUSE Transmembrane protein 230 OS=Mus musculus OX=10090 GN=Tmem230 PE=1 SV=1,,,,,,
OG_00547,FUN_001583-T1,Peve_00005423,Pocillopora_meandrina_HIv1___RNAseq.g2035.t1,three_way,72.56533333333333,,,,,,,,,,,,,,,,,
OG_00548,FUN_001587-T1,Peve_00005425,Pocillopora_meandrina_HIv1___RNAseq.g2036.t2,three_way,66.00816666666667,FUN_001587-T1,Q8R3B7,BRD8_MOUSE,,Bromodomain-containing protein 8,Mus musculus (Mouse),26.4,981.0,8.299999999999999e-46,187.2,sp|Q8R3B7|BRD8_MOUSE Bromodomain-containing protein 8 OS=Mus musculus OX=10090 GN=Brd8 PE=1 SV=2,GO:0000786; GO:0000812; GO:0003713; GO:0005739; GO:0006325; GO:0035267; GO:0042981; GO:0045893; GO:0045944; GO:0046966; GO:0051726; GO:0097067; GO:1905168; GO:2000779,cellular response to thyroid hormone stimulus [GO:0097067]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair [GO:2000779],mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleosome [GO:0000786]; Swr1 complex [GO:0000812],nuclear thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713],GO:0005739; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,mitochondrion; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_00549,FUN_001590-T1,Peve_00023229,Pocillopora_meandrina_HIv1___RNAseq.g1994.t1,three_way,58.80866666666667,FUN_001590-T1,Q9VAN6,SLBP_DROME,,Histone RNA hairpin-binding protein (Histone stem-loop-binding protein),Drosophila melanogaster (Fruit fly),46.8,79.0,1.9e-16,88.2,sp|Q9VAN6|SLBP_DROME Histone RNA hairpin-binding protein OS=Drosophila melanogaster OX=7227 GN=Slbp PE=1 SV=1,GO:0003729; GO:0005634; GO:0005737; GO:0006398; GO:0007076; GO:0035613; GO:0051028; GO:0071204; GO:0071207; GO:1990825,mitotic chromosome condensation [GO:0007076]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA transport [GO:0051028],cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleus [GO:0005634],histone pre-mRNA stem-loop binding [GO:0071207]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_00550,FUN_001591-T1,Peve_00023228,Pocillopora_meandrina_HIv1___RNAseq.g1993.t1,three_way,76.23216666666666,FUN_001591-T1,Q9H0F5,,,,,47.2,125.0,2.9e-30,134.4,sp|Q9H0F5|RNF38_HUMAN E3 ubiquitin-protein ligase RNF38 OS=Homo sapiens OX=9606 GN=RNF38 PE=1 SV=4,,,,,,
OG_00551,FUN_001592-T1,Peve_00023231,Pocillopora_meandrina_HIv1___RNAseq.g1991.t1,three_way,51.281666666666666,FUN_001592-T1,O35144,TERF2_MOUSE,,Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein),Mus musculus (Mouse),20.8,457.0,4.8e-06,54.3,sp|O35144|TERF2_MOUSE Telomeric repeat-binding factor 2 OS=Mus musculus OX=10090 GN=Terf2 PE=1 SV=3,GO:0000723; GO:0000781; GO:0000782; GO:0001673; GO:0001701; GO:0003691; GO:0003720; GO:0005654; GO:0016233; GO:0016604; GO:0019899; GO:0030424; GO:0031627; GO:0031848; GO:0032206; GO:0032208; GO:0032211; GO:0042162; GO:0042803; GO:0044877; GO:0061820; GO:0070187; GO:0070198; GO:0098505; GO:0099088; GO:1904354; GO:1904430; GO:1905839; GO:2000773,"axonal transport of messenger ribonucleoprotein complex [GO:0099088]; in utero embryonic development [GO:0001701]; negative regulation of cellular senescence [GO:2000773]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere capping [GO:1904354]; negative regulation of telomere maintenance via recombination [GO:0032208]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomeric D-loop disassembly [GO:1905839]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820]; telomeric loop formation [GO:0031627]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; telomere cap complex [GO:0000782]",double-stranded telomeric DNA binding [GO:0003691]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomerase activity [GO:0003720]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0007018; GO:0016740; GO:0032200; GO:0043226; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule-based movement; transferase activity; telomere organization; organelle; anatomical structure development; catalytic activity, acting on DNA"
OG_00552,FUN_001595-T1,Peve_00004149,Pocillopora_meandrina_HIv1___TS.g4491.t1,three_way,73.311,FUN_001595-T1,Q9LMG7,PPA2_ARATH,,Probable inactive purple acid phosphatase 2,Arabidopsis thaliana (Mouse-ear cress),34.2,573.0,7.2e-83,309.7,sp|Q9LMG7|PPA2_ARATH Probable inactive purple acid phosphatase 2 OS=Arabidopsis thaliana OX=3702 GN=PAP2 PE=2 SV=1,GO:0003993; GO:0005576; GO:0005739; GO:0005740; GO:0005768; GO:0005794; GO:0005802; GO:0006109; GO:0006626; GO:0009507; GO:0009941; GO:0030943; GO:0045040; GO:0046872,protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; regulation of carbohydrate metabolic process [GO:0006109],chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; trans-Golgi network [GO:0005802],acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]; mitochondrion targeting sequence binding [GO:0030943],GO:0003824; GO:0005576; GO:0005739; GO:0005768; GO:0005794; GO:0007005; GO:0009536; GO:0016787; GO:0031410; GO:0043226; GO:0061024,catalytic activity; extracellular region; mitochondrion; endosome; Golgi apparatus; mitochondrion organization; plastid; hydrolase activity; cytoplasmic vesicle; organelle; membrane organization
OG_00553,FUN_001596-T1,Peve_00004147,Pocillopora_meandrina_HIv1___RNAseq.g1984.t1,three_way,49.91966666666666,,,,,,,,,,,,,,,,,
OG_00554,FUN_001599-T1,Peve_00004146,Pocillopora_meandrina_HIv1___RNAseq.g1982.t1,three_way,81.72066666666667,FUN_001599-T1,Q9Y2D4,EXC6B_HUMAN,,Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2),Homo sapiens (Human),50.0,800.0,4.7e-223,775.8,sp|Q9Y2D4|EXC6B_HUMAN Exocyst complex component 6B OS=Homo sapiens OX=9606 GN=EXOC6B PE=1 SV=3,GO:0000145; GO:0000281; GO:0006886; GO:0006887; GO:0006893; GO:0006904; GO:0090148; GO:0090522,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522],exocyst [GO:0000145],,GO:0000910; GO:0006886; GO:0016192; GO:0061024,cytokinesis; intracellular protein transport; vesicle-mediated transport; membrane organization
OG_00555,FUN_001603-T1,Peve_00043865,Pocillopora_meandrina_HIv1___RNAseq.g1979.t2,three_way,62.14733333333333,FUN_001603-T1,Q8BFW6,ENTP3_MOUSE,,Ectonucleoside triphosphate diphosphohydrolase 3 (NTPDase 3) (EC 3.6.1.5) (Ecto-ATP diphosphohydrolase 3) (Ecto-ATPDase 3) (Ecto-ATPase 3),Mus musculus (Mouse),37.9,443.0,4.9e-78,293.5,sp|Q8BFW6|ENTP3_MOUSE Ectonucleoside triphosphate diphosphohydrolase 3 OS=Mus musculus OX=10090 GN=Entpd3 PE=1 SV=1,GO:0004050; GO:0005524; GO:0005886; GO:0009134; GO:0009143; GO:0017110; GO:0017111,nucleoside diphosphate catabolic process [GO:0009134]; nucleoside triphosphate catabolic process [GO:0009143],plasma membrane [GO:0005886],apyrase activity [GO:0004050]; ATP binding [GO:0005524]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111],GO:0003824; GO:0005886; GO:0016787; GO:0055086,catalytic activity; plasma membrane; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_00556,FUN_001608-T2,Peve_00045305,Pocillopora_meandrina_HIv1___RNAseq.g1923.t1,three_way,86.59616666666666,FUN_001608-T2,Q5W8I8,VGL2A_DANRE,,Vesicular glutamate transporter 2.1 (Protein blumenkohl) (Solute carrier family 17 member 6-B) (Vesicular glutamate transporter 2-A),Danio rerio (Zebrafish) (Brachydanio rerio),43.0,470.0,2e-108,394.4,sp|Q5W8I8|VGL2A_DANRE Vesicular glutamate transporter 2.1 OS=Danio rerio OX=7955 GN=slc17a6b PE=2 SV=2,GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0006817; GO:0007268; GO:0007601; GO:0008021; GO:0015386; GO:0015813; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0051938; GO:0055062; GO:0060076; GO:0098700; GO:0140788,"chemical synaptic transmission [GO:0007268]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]; visual perception [GO:0007601]",chloride channel complex [GO:0034707]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamate uniporter activity [GO:0140788]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0050877; GO:0055085,transporter activity; plasma membrane; signaling; cytoplasmic vesicle; organelle; nervous system process; transmembrane transport
OG_00557,FUN_001609-T1,Peve_00045306,Pocillopora_meandrina_HIv1___RNAseq.g1922.t2,three_way,88.042,FUN_001609-T1,A6QLI1,VGLU2_BOVIN,,Vesicular glutamate transporter 2 (VGluT2) (Solute carrier family 17 member 6),Bos taurus (Bovine),42.1,454.0,2.5e-100,367.5,sp|A6QLI1|VGLU2_BOVIN Vesicular glutamate transporter 2 OS=Bos taurus OX=9913 GN=SLC17A6 PE=2 SV=1,GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0006817; GO:0008021; GO:0015386; GO:0015813; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0051938; GO:0055062; GO:0060076; GO:0098700; GO:0140788; GO:1990384,"hyaloid vascular plexus regression [GO:1990384]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]",chloride channel complex [GO:0034707]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamate uniporter activity [GO:0140788]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0055085,transporter activity; plasma membrane; signaling; cytoplasmic vesicle; organelle; transmembrane transport
OG_00558,FUN_001612-T1,Peve_00045309,Pocillopora_meandrina_HIv1___RNAseq.g1976.t1,three_way,61.33033333333333,FUN_001612-T1,Q8CAQ8,,,,,35.7,771.0,1.3000000000000001e-37,159.8,sp|Q8CAQ8|MIC60_MOUSE MICOS complex subunit Mic60 OS=Mus musculus OX=10090 GN=Immt PE=1 SV=1,,,,,,
OG_00559,FUN_001613-T1,Peve_00045310,Pocillopora_meandrina_HIv1___TS.g4484.t1,three_way,71.21433333333333,FUN_001613-T1,P97931,UNG_MOUSE,,Uracil-DNA glycosylase (UDG) (EC 3.2.2.27),Mus musculus (Mouse),55.3,311.0,6.6e-91,335.5,sp|P97931|UNG_MOUSE Uracil-DNA glycosylase OS=Mus musculus OX=10090 GN=Ung PE=1 SV=3,GO:0003684; GO:0004844; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0016446; GO:0016447; GO:0043024; GO:0045190; GO:0097510,"base-excision repair, AP site formation via deaminated base removal [GO:0097510]; DNA repair [GO:0006281]; isotype switching [GO:0045190]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]",mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],damaged DNA binding [GO:0003684]; ribosomal small subunit binding [GO:0043024]; uracil DNA N-glycosylase activity [GO:0004844],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0140097,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_00560,FUN_001614-T1,Peve_00045296,Pocillopora_meandrina_HIv1___RNAseq.g1942.t1,three_way,60.5375,FUN_001614-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),40.2,371.0,1.1e-71,272.7,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_00561,FUN_001615-T1,Peve_00045297,Pocillopora_meandrina_HIv1___TS.g4451.t1,three_way,50.0765,,,,,,,,,,,,,,,,,
OG_00562,FUN_001616-T1,Peve_00045298,Pocillopora_meandrina_HIv1___RNAseq.g1944.t1,three_way,70.12516666666666,FUN_001616-T1,Q9HCL2,GPAT1_HUMAN,,"Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15)",Homo sapiens (Human),32.5,764.0,1.4999999999999999e-105,385.6,"sp|Q9HCL2|GPAT1_HUMAN Glycerol-3-phosphate acyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=GPAM PE=1 SV=3",GO:0001817; GO:0004366; GO:0005739; GO:0005741; GO:0005886; GO:0006631; GO:0006637; GO:0006650; GO:0006651; GO:0006654; GO:0006655; GO:0006924; GO:0009749; GO:0016024; GO:0019432; GO:0040018; GO:0042104; GO:0050798; GO:0051607; GO:0055089; GO:0055091; GO:0070236,activated T cell proliferation [GO:0050798]; activation-induced cell death of T cells [GO:0006924]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; defense response to virus [GO:0051607]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid homeostasis [GO:0055089]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of activation-induced cell death of T cells [GO:0070236]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid homeostasis [GO:0055091]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of multicellular organism growth [GO:0040018]; regulation of cytokine production [GO:0001817]; response to glucose [GO:0009749]; triglyceride biosynthetic process [GO:0019432],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],glycerol-3-phosphate O-acyltransferase activity [GO:0004366],GO:0002376; GO:0003824; GO:0005739; GO:0005886; GO:0006629; GO:0006790; GO:0012501; GO:0016740; GO:0043226; GO:0055086,immune system process; catalytic activity; mitochondrion; plasma membrane; lipid metabolic process; sulfur compound metabolic process; programmed cell death; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_00563,FUN_001618-T1,Peve_00045302,Pocillopora_meandrina_HIv1___RNAseq.g1946.t1,three_way,77.34833333333333,FUN_001618-T1,Q95JJ0,SG196_MACFA,,Protein O-mannose kinase (POMK) (EC 2.7.1.183) (Protein kinase-like protein SgK196) (Sugen kinase 196),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),45.8,297.0,7.7e-75,282.3,sp|Q95JJ0|SG196_MACFA Protein O-mannose kinase OS=Macaca fascicularis OX=9541 GN=POMK PE=2 SV=2,GO:0004672; GO:0005524; GO:0005789; GO:0006493; GO:0016773; GO:0019200; GO:0046835,carbohydrate phosphorylation [GO:0046835]; protein O-linked glycosylation [GO:0006493],endoplasmic reticulum membrane [GO:0005789],"ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; protein kinase activity [GO:0004672]",GO:0003824; GO:0005975; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_00564,FUN_001619-T1,Peve_00045303,Pocillopora_meandrina_HIv1___RNAseq.g1947.t1,three_way,70.21316666666667,FUN_001619-T1,Q9BPX3,CND3_HUMAN,,Condensin complex subunit 3 (Chromosome-associated protein G) (Condensin subunit CAP-G) (hCAP-G) (Melanoma antigen NY-MEL-3) (Non-SMC condensin I complex subunit G) (XCAP-G homolog),Homo sapiens (Human),41.5,959.0,1.3e-181,638.6,sp|Q9BPX3|CND3_HUMAN Condensin complex subunit 3 OS=Homo sapiens OX=9606 GN=NCAPG PE=1 SV=1,GO:0000779; GO:0000793; GO:0000794; GO:0000796; GO:0005634; GO:0005737; GO:0005829; GO:0007076; GO:0016020; GO:0051301; GO:0051984; GO:1905820; GO:1905821,cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820],"condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]",,GO:0000228; GO:0005634; GO:0005694; GO:0005829; GO:0043226,nuclear chromosome; nucleus; chromosome; cytosol; organelle
OG_00565,FUN_001621-T1,Peve_00012529,Pocillopora_meandrina_HIv1___RNAseq.g1948.t1,three_way,82.54650000000001,FUN_001621-T1,Q8VCD6,,,,,61.8,152.0,1.3e-48,194.5,sp|Q8VCD6|REEP2_MOUSE Receptor expression-enhancing protein 2 OS=Mus musculus OX=10090 GN=Reep2 PE=1 SV=2,,,,,,
OG_00566,FUN_001622-T1,Peve_00012530,Pocillopora_meandrina_HIv1___TS.g4457.t1,three_way,69.43533333333333,FUN_001622-T1,Q9EPK6,SIL1_MOUSE,,Nucleotide exchange factor SIL1,Mus musculus (Mouse),37.6,457.0,7.6e-72,272.7,sp|Q9EPK6|SIL1_MOUSE Nucleotide exchange factor SIL1 OS=Mus musculus OX=10090 GN=Sil1 PE=1 SV=2,GO:0000774; GO:0005783; GO:0005788; GO:0015031; GO:0042802,protein transport [GO:0015031],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802],GO:0005783; GO:0043226; GO:0098772,endoplasmic reticulum; organelle; molecular function regulator activity
OG_00567,FUN_001623-T1,Peve_00042510,Pocillopora_meandrina_HIv1___RNAseq.g2168.t1,three_way,37.91416666666667,,,,,,,,,,,,,,,,,
OG_00568,FUN_001624-T2,Peve_00042511,Pocillopora_meandrina_HIv1___TS.g4673.t1,three_way,69.09666666666666,FUN_001624-T2,Q8NHX9,TPC2_HUMAN,,Two pore channel protein 2 (Two pore calcium channel protein 2),Homo sapiens (Human),44.0,728.0,2e-149,531.2,sp|Q8NHX9|TPC2_HUMAN Two pore channel protein 2 OS=Homo sapiens OX=9606 GN=TPCN2 PE=1 SV=2,GO:0005245; GO:0005262; GO:0005764; GO:0005765; GO:0005829; GO:0006874; GO:0006939; GO:0007040; GO:0010008; GO:0010506; GO:0015280; GO:0017157; GO:0019065; GO:0019722; GO:0019901; GO:0031902; GO:0033162; GO:0033280; GO:0034220; GO:0034702; GO:0035725; GO:0036020; GO:0042802; GO:0048086; GO:0051209; GO:0051452; GO:0072345; GO:0075509; GO:0080025; GO:0090117; GO:0097682,calcium-mediated signaling [GO:0019722]; endocytosis involved in viral entry into host cell [GO:0075509]; endosome to lysosome transport of low-density lipoprotein particle [GO:0090117]; intracellular calcium ion homeostasis [GO:0006874]; intracellular pH reduction [GO:0051452]; lysosome organization [GO:0007040]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of developmental pigmentation [GO:0048086]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagy [GO:0010506]; regulation of exocytosis [GO:0017157]; release of sequestered calcium ion into cytosol [GO:0051209]; response to vitamin D [GO:0033280]; smooth muscle contraction [GO:0006939]; sodium ion transmembrane transport [GO:0035725],cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome membrane [GO:0010008]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162]; monoatomic ion channel complex [GO:0034702],"calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; intracellularly phosphatidylinositol-3,5-bisphosphate-gated monatomic cation channel activity [GO:0097682]; ligand-gated sodium channel activity [GO:0015280]; NAADP-sensitive calcium-release channel activity [GO:0072345]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]",GO:0003012; GO:0005215; GO:0005764; GO:0005773; GO:0005829; GO:0007040; GO:0008289; GO:0016192; GO:0043226; GO:0055085,muscle system process; transporter activity; lysosome; vacuole; cytosol; lysosome organization; lipid binding; vesicle-mediated transport; organelle; transmembrane transport
OG_00569,FUN_001626-T1,Peve_00042512,Pocillopora_meandrina_HIv1___RNAseq.g2166.t1,three_way,64.553,FUN_001626-T1,Q5UEM7,CR3L4_RAT,,Cyclic AMP-responsive element-binding protein 3-like protein 4 (cAMP-responsive element-binding protein 3-like protein 4) (Androgen-induced basic leucine zipper protein) (AIbZIP) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 4],Rattus norvegicus (Rat),48.4,122.0,2.9e-21,104.0,sp|Q5UEM7|CR3L4_RAT Cyclic AMP-responsive element-binding protein 3-like protein 4 OS=Rattus norvegicus OX=10116 GN=Creb3l4 PE=2 SV=1,GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0006357; GO:0006986; GO:0007283; GO:0031965; GO:0045944; GO:1990837,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005794; GO:0006355; GO:0022414; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; endoplasmic reticulum; Golgi apparatus; regulation of DNA-templated transcription; reproductive process; organelle; transcription regulator activity
OG_00570,FUN_001628-T1,Peve_00009929,Pocillopora_meandrina_HIv1___RNAseq.g2165.t1,three_way,85.88366666666667,FUN_001628-T1,P49706,,,,,57.9,290.0,2.8e-88,326.6,sp|P49706|CCND2_CHICK G1/S-specific cyclin-D2 OS=Gallus gallus OX=9031 GN=CCND2 PE=3 SV=1,,,,,,
OG_00571,FUN_001630-T1,Peve_00009934,Pocillopora_meandrina_HIv1___RNAseq.g2163.t1,three_way,60.408,FUN_001630-T1,Q7KM13,,,,,40.7,167.0,8.1e-17,90.1,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_00572,FUN_001631-T1,Peve_00029327,Pocillopora_meandrina_HIv1___RNAseq.g2162.t1,three_way,60.284333333333336,FUN_001631-T1,Q5FWK3,RHG01_MOUSE,,Rho GTPase-activating protein 1 (Rho-type GTPase-activating protein 1),Mus musculus (Mouse),47.0,372.0,3.2e-91,337.4,sp|Q5FWK3|RHG01_MOUSE Rho GTPase-activating protein 1 OS=Mus musculus OX=10090 GN=Arhgap1 PE=1 SV=1,GO:0001726; GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0007264; GO:0010008; GO:0016197; GO:0017124; GO:0031252; GO:0031267; GO:0033572; GO:0048471; GO:0097443; GO:2001136,endosomal transport [GO:0016197]; negative regulation of endocytic recycling [GO:2001136]; small GTPase-mediated signal transduction [GO:0007264]; transferrin transport [GO:0033572],cell leading edge [GO:0031252]; cilium [GO:0005929]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; sorting endosome [GO:0097443],GTPase activator activity [GO:0005096]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267],GO:0005768; GO:0005829; GO:0005886; GO:0005929; GO:0016192; GO:0031410; GO:0043226; GO:0098772,endosome; cytosol; plasma membrane; cilium; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_00573,FUN_001632-T1,Peve_00029329,Pocillopora_meandrina_HIv1___RNAseq.g2161.t1,three_way,72.24716666666667,FUN_001632-T1,B0BLT0,,,,,57.5,106.0,1.4e-27,124.0,sp|B0BLT0|ZN593_XENTR Zinc finger protein 593 OS=Xenopus tropicalis OX=8364 GN=znf593 PE=2 SV=1,,,,,,
OG_00574,FUN_001633-T1,Peve_00029328,Pocillopora_meandrina_HIv1___RNAseq.g2159.t1,three_way,47.73266666666667,,,,,,,,,,,,,,,,,
OG_00575,FUN_001636-T1,Peve_00030249,Pocillopora_meandrina_HIv1___RNAseq.g2156.t1,three_way,45.20433333333334,,,,,,,,,,,,,,,,,
OG_00576,FUN_001638-T1,Peve_00009933,Pocillopora_meandrina_HIv1___TS.g14306.t1,three_way,61.513666666666666,FUN_001638-T1,Q9UGK8,SRGEF_HUMAN,,Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor) (DelGEF) (Guanine nucleotide exchange factor-related protein),Homo sapiens (Human),41.6,401.0,2.7000000000000003e-73,277.3,sp|Q9UGK8|SRGEF_HUMAN Secretion-regulating guanine nucleotide exchange factor OS=Homo sapiens OX=9606 GN=SERGEF PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0050709,negative regulation of protein secretion [GO:0050709]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005634; GO:0005654; GO:0005829; GO:0043226; GO:0098772,nucleus; nucleoplasm; cytosol; organelle; molecular function regulator activity
OG_00577,FUN_001639-T1,Peve_00020138,Pocillopora_meandrina_HIv1___RNAseq.g29422.t1,three_way,78.42066666666666,FUN_001639-T1,Q5ZIH2,,,,,53.5,445.0,6.7e-134,479.2,sp|Q5ZIH2|MON1A_CHICK Vacuolar fusion protein MON1 homolog A OS=Gallus gallus OX=9031 GN=MON1A PE=2 SV=1,,,,,,
OG_00578,FUN_001640-T1,Peve_00020144,Pocillopora_meandrina_HIv1___RNAseq.g29421.t1,three_way,56.805166666666665,FUN_001640-T1,Q9EP86,,,,,27.3,322.0,5.5e-20,100.1,sp|Q9EP86|NPFF1_RAT Neuropeptide FF receptor 1 OS=Rattus norvegicus OX=10116 GN=Npffr1 PE=1 SV=1,,,,,,
OG_00579,FUN_001648-T2,Peve_00020140,Pocillopora_meandrina_HIv1___RNAseq.g29417.t1,three_way,71.33033333333333,FUN_001648-T2,P24539,AT5F1_HUMAN,,"ATP synthase peripheral stalk subunit b, mitochondrial (ATP synthase F(0) complex subunit B1, mitochondrial) (ATP synthase peripheral stalk-membrane subunit b) (ATP synthase proton-transporting mitochondrial F(0) complex subunit B1) (ATP synthase subunit b) (ATPase subunit b)",Homo sapiens (Human),35.3,235.0,3.6000000000000003e-28,126.7,"sp|P24539|AT5F1_HUMAN ATP synthase peripheral stalk subunit b, mitochondrial OS=Homo sapiens OX=9606 GN=ATP5PB PE=1 SV=2",GO:0005634; GO:0005739; GO:0005743; GO:0005759; GO:0015078; GO:0015986; GO:0016020; GO:0021762; GO:0042776; GO:0045259,proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; substantia nigra development [GO:0021762],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; proton-transporting ATP synthase complex [GO:0045259],proton transmembrane transporter activity [GO:0015078],GO:0005215; GO:0005634; GO:0005739; GO:0043226; GO:0048856; GO:0055086; GO:1901135,transporter activity; nucleus; mitochondrion; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00580,FUN_001653-T1,Peve_00038366,Pocillopora_meandrina_HIv1___RNAseq.g29408.t1,three_way,69.88033333333334,,,,,,,,,,,,,,,,,
OG_00581,FUN_001654-T1,Peve_00038365,Pocillopora_meandrina_HIv1___RNAseq.g29407.t1,three_way,87.83066666666666,FUN_001654-T1,Q4R7Y4,GBLP_MACFA,,"Small ribosomal subunit protein RACK1 (Guanine nucleotide-binding protein subunit beta-2-like 1) [Cleaved into: Small ribosomal subunit protein RACK1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),83.1,313.0,2.1e-132,473.4,sp|Q4R7Y4|GBLP_MACFA Small ribosomal subunit protein RACK1 OS=Macaca fascicularis OX=9541 GN=GNB2L1 PE=2 SV=3,GO:0001891; GO:0001934; GO:0005080; GO:0005634; GO:0005737; GO:0005840; GO:0006915; GO:0007369; GO:0030178; GO:0030292; GO:0030308; GO:0030335; GO:0030425; GO:0030496; GO:0030971; GO:0031334; GO:0032436; GO:0032880; GO:0042169; GO:0042998; GO:0043022; GO:0043025; GO:0043065; GO:0043204; GO:0043547; GO:0045182; GO:0048471; GO:0048511; GO:0050765; GO:0051302; GO:0051726; GO:0071363; GO:1990904; GO:2000114; GO:2000543,apoptotic process [GO:0006915]; cellular response to growth factor stimulus [GO:0071363]; gastrulation [GO:0007369]; negative regulation of cell growth [GO:0030308]; negative regulation of phagocytosis [GO:0050765]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gastrulation [GO:2000543]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; positive regulation of GTPase activity [GO:0043547]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; dendrite [GO:0030425]; midbody [GO:0030496]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840],protein kinase C binding [GO:0005080]; protein tyrosine kinase inhibitor activity [GO:0030292]; receptor tyrosine kinase binding [GO:0030971]; ribosome binding [GO:0043022]; SH2 domain binding [GO:0042169]; translation regulator activity [GO:0045182],GO:0005634; GO:0005840; GO:0012501; GO:0043226; GO:0045182; GO:0098772,nucleus; ribosome; programmed cell death; organelle; translation regulator activity; molecular function regulator activity
OG_00582,FUN_001655-T1,Peve_00038364,Pocillopora_meandrina_HIv1___RNAseq.g29406.t1,three_way,93.90866666666666,FUN_001655-T1,P53621,COPA_HUMAN,,Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin],Homo sapiens (Human),75.2,1228.0,0.0,1507.7,sp|P53621|COPA_HUMAN Coatomer subunit alpha OS=Homo sapiens OX=9606 GN=COPA PE=1 SV=2,GO:0000139; GO:0003729; GO:0005179; GO:0005198; GO:0005615; GO:0005737; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0016020; GO:0030126; GO:0030133; GO:0030157; GO:0030426; GO:0070062; GO:0099612; GO:1902463,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; pancreatic juice secretion [GO:0030157]; protein localization to axon [GO:0099612]; protein localization to cell leading edge [GO:1902463]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133],hormone activity [GO:0005179]; mRNA binding [GO:0003729]; structural molecule activity [GO:0005198],GO:0003723; GO:0005198; GO:0005615; GO:0005829; GO:0006886; GO:0016192; GO:0022600; GO:0031410; GO:0043226; GO:0048018; GO:0098772,RNA binding; structural molecule activity; extracellular space; cytosol; intracellular protein transport; vesicle-mediated transport; digestive system process; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_00583,FUN_001656-T1,Peve_00038363,Pocillopora_meandrina_HIv1___RNAseq.g29405.t1,three_way,83.438,FUN_001656-T1,A0PJE2,DHR12_HUMAN,,Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1) (Protein SDR40C1),Homo sapiens (Human),58.9,319.0,1.4e-104,380.9,sp|A0PJE2|DHR12_HUMAN Dehydrogenase/reductase SDR family member 12 OS=Homo sapiens OX=9606 GN=DHRS12 PE=1 SV=2,GO:0016491,,,oxidoreductase activity [GO:0016491],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_00584,FUN_001657-T1,Peve_00038362,Pocillopora_meandrina_HIv1___RNAseq.g29404.t1,three_way,76.9125,FUN_001657-T1,Q5ZK05,,,,,53.3,276.0,1e-67,258.5,sp|Q5ZK05|TOLIP_CHICK Toll-interacting protein OS=Gallus gallus OX=9031 GN=TOLLIP PE=2 SV=1,,,,,,
OG_00585,FUN_001658-T1,Peve_00038361,Pocillopora_meandrina_HIv1___RNAseq.g29403.t1,three_way,89.375,FUN_001658-T1,Q5RBE5,,,,,70.9,323.0,2.9e-134,479.6,sp|Q5RBE5|FCL_PONAB GDP-L-fucose synthase OS=Pongo abelii OX=9601 GN=GFUS PE=2 SV=1,,,,,,
OG_00586,FUN_001664-T1,Peve_00038398,Pocillopora_meandrina_HIv1___RNAseq.g29392.t1,three_way,64.99366666666667,FUN_001664-T1,Q5ZML9,,,,,43.8,500.0,6.500000000000002e-110,399.4,sp|Q5ZML9|SETD3_CHICK Actin-histidine N-methyltransferase OS=Gallus gallus OX=9031 GN=SETD3 PE=2 SV=1,,,,,,
OG_00587,FUN_001665-T1,Peve_00038394,Pocillopora_meandrina_HIv1___RNAseq.g29391.t1,three_way,65.37583333333333,FUN_001665-T1,C3ZQF9,,,,,34.8,339.0,8.8e-39,162.5,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_00588,FUN_001671-T2,Peve_00038393,Pocillopora_meandrina_HIv1___RNAseq.g29390.t1,three_way,54.833666666666666,FUN_001671-T2,O60293,,,,,28.7,1468.0,5.8000000000000005e-133,478.0,sp|O60293|ZC3H1_HUMAN Zinc finger C3H1 domain-containing protein OS=Homo sapiens OX=9606 GN=ZFC3H1 PE=1 SV=3,,,,,,
OG_00589,FUN_001720-T1,Peve_00041622,Pocillopora_meandrina_HIv1___RNAseq.g2704.t1,three_way,55.93233333333333,FUN_001720-T1,P25931,,,,,27.8,360.0,1.6e-26,122.1,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_00590,FUN_001723-T1,Peve_00041635,Pocillopora_meandrina_HIv1___TS.g5211.t1,three_way,45.939,,,,,,,,,,,,,,,,,
OG_00591,FUN_001725-T1,Peve_00041636,Pocillopora_meandrina_HIv1___RNAseq.g2701.t1,three_way,76.361,FUN_001725-T1,Q9I8C7,,,,,35.9,337.0,9e-52,205.7,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_00592,FUN_001727-T3,Peve_00007898,Pocillopora_meandrina_HIv1___RNAseq.g2700.t1,three_way,82.50633333333333,FUN_001727-T3,P32297,ACHA3_HUMAN,,Neuronal acetylcholine receptor subunit alpha-3,Homo sapiens (Human),37.1,472.0,2.7000000000000003e-87,324.3,sp|P32297|ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 OS=Homo sapiens OX=9606 GN=CHRNA3 PE=1 SV=4,GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006811; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0014056; GO:0015276; GO:0015464; GO:0016020; GO:0016607; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0043231; GO:0044853; GO:0045202; GO:0045211; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098878; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005730; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; nucleolus; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; signaling; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_00593,FUN_001728-T1,Peve_00007897,Pocillopora_meandrina_HIv1___RNAseq.g2699.t1,three_way,58.2605,,,,,,,,,,,,,,,,,
OG_00594,FUN_001730-T1,Peve_00007904,Pocillopora_meandrina_HIv1___RNAseq.g2698.t1,three_way,67.64,,,,,,,,,,,,,,,,,
OG_00595,FUN_001731-T1,Peve_00007902,Pocillopora_meandrina_HIv1___RNAseq.g2695.t1,three_way,72.17533333333334,FUN_001731-T1,Q9Y6N5,SQOR_HUMAN,,"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.8) (Sulfide dehydrogenase-like) (Sulfide quinone oxidoreductase)",Homo sapiens (Human),51.2,430.0,5.9e-138,492.3,"sp|Q9Y6N5|SQOR_HUMAN Sulfide:quinone oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=SQOR PE=1 SV=1",GO:0005739; GO:0005743; GO:0048038; GO:0070221; GO:0070224; GO:0071949; GO:0106436,"sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],FAD binding [GO:0071949]; glutathione-dependent sulfide quinone oxidoreductase activity [GO:0106436]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224],GO:0003824; GO:0005739; GO:0006790; GO:0016491; GO:0043226,catalytic activity; mitochondrion; sulfur compound metabolic process; oxidoreductase activity; organelle
OG_00596,FUN_001733-T1,Peve_00007896,Pocillopora_meandrina_HIv1___RNAseq.g2642.t1,three_way,61.95166666666667,FUN_001733-T1,P27544,CERS1_HUMAN,,Ceramide synthase 1 (CerS1) (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1) (Sphingoid base N-stearoyltransferase CERS1) (EC 2.3.1.299),Homo sapiens (Human),43.5,269.0,6.9e-55,216.1,sp|P27544|CERS1_HUMAN Ceramide synthase 1 OS=Homo sapiens OX=9606 GN=CERS1 PE=1 SV=1,GO:0005783; GO:0005789; GO:0007420; GO:0010614; GO:0016020; GO:0030148; GO:0036146; GO:0043231; GO:0046325; GO:0046513; GO:0050291; GO:0071466; GO:0071492; GO:0072721; GO:1901526,brain development [GO:0007420]; cellular response to dithiothreitol [GO:0072721]; cellular response to mycotoxin [GO:0036146]; cellular response to UV-A [GO:0071492]; cellular response to xenobiotic stimulus [GO:0071466]; ceramide biosynthetic process [GO:0046513]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of D-glucose import [GO:0046325]; positive regulation of mitophagy [GO:1901526]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],sphingosine N-acyltransferase activity [GO:0050291],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226; GO:0048856,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle; anatomical structure development
OG_00597,FUN_001735-T1,Peve_00025009,Pocillopora_meandrina_HIv1___RNAseq.g2644.t1,three_way,79.81366666666666,FUN_001735-T1,P04464,,,,,36.7,147.0,4e-22,105.9,sp|P04464|CALM_WHEAT Calmodulin OS=Triticum aestivum OX=4565 PE=1 SV=3,,,,,,
OG_00598,FUN_001739-T1,Peve_00025011,Pocillopora_meandrina_HIv1___RNAseq.g2646.t1,three_way,73.694,FUN_001739-T1,A7S4N4,,,,,41.6,267.0,9.2e-50,199.5,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_00599,FUN_001747-T1,Peve_00023224,Pocillopora_meandrina_HIv1___RNAseq.13551_t,three_way,50.601,,,,,,,,,,,,,,,,,
OG_00600,FUN_001748-T1,Peve_00027254,Pocillopora_meandrina_HIv1___RNAseq.g2653.t1,three_way,40.879666666666665,,,,,,,,,,,,,,,,,
OG_00601,FUN_001749-T1,Peve_00019400,Pocillopora_meandrina_HIv1___RNAseq.g2654.t1,three_way,72.93033333333334,FUN_001749-T1,Q0V8G2,GABP2_BOVIN,,GA-binding protein subunit beta-2 (GABP subunit beta-2) (GABPB-2),Bos taurus (Bovine),88.4,69.0,1.2e-25,120.2,sp|Q0V8G2|GABP2_BOVIN GA-binding protein subunit beta-2 OS=Bos taurus OX=9913 GN=GABPB2 PE=2 SV=2,GO:0000976; GO:0005634; GO:0042802; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],nucleus [GO:0005634],identical protein binding [GO:0042802]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_00602,FUN_001750-T1,Peve_00019399,Pocillopora_meandrina_HIv1___RNAseq.g2655.t1,three_way,82.17433333333334,,,,,,,,,,,,,,,,,
OG_00603,FUN_001764-T1,Peve_00031949,Pocillopora_meandrina_HIv1___RNAseq.g2672.t1,three_way,81.31933333333333,FUN_001764-T1,P49582,,,,,39.7,174.0,3.9e-35,149.8,sp|P49582|ACHA7_MOUSE Neuronal acetylcholine receptor subunit alpha-7 OS=Mus musculus OX=10090 GN=Chrna7 PE=1 SV=1,,,,,,
OG_00604,FUN_001765-T1,Peve_00023733,Pocillopora_meandrina_HIv1___RNAseq.13574_t,three_way,60.79216666666667,,,,,,,,,,,,,,,,,
OG_00605,FUN_001766-T1,Peve_00023732,Pocillopora_meandrina_HIv1___RNAseq.g2675.t1,three_way,76.47133333333333,,,,,,,,,,,,,,,,,
OG_00606,FUN_001768-T1,Peve_00035581,Pocillopora_meandrina_HIv1___RNAseq.g2678.t1c,three_way,73.253,,,,,,,,,,,,,,,,,
OG_00607,FUN_001769-T1,Peve_00035580,Pocillopora_meandrina_HIv1___RNAseq.g2678.t1a,three_way,61.7965,,,,,,,,,,,,,,,,,
OG_00608,FUN_001771-T1,Peve_00035574,Pocillopora_meandrina_HIv1___RNAseq.g2680.t1,three_way,97.479,FUN_001771-T1,Q6P4J8,,,,,83.6,482.0,7.6e-166,585.1,sp|Q6P4J8|SMU1_XENTR WD40 repeat-containing protein SMU1 OS=Xenopus tropicalis OX=8364 GN=smu1 PE=2 SV=1,,,,,,
OG_00609,FUN_001772-T1,Peve_00035573,Pocillopora_meandrina_HIv1___RNAseq.g2681.t1,three_way,55.65416666666667,,,,,,,,,,,,,,,,,
OG_00610,FUN_001775-T1,Peve_00035572,Pocillopora_meandrina_HIv1___RNAseq.g2682.t1,three_way,56.172,,,,,,,,,,,,,,,,,
OG_00611,FUN_001777-T1,Peve_00035594,Pocillopora_meandrina_HIv1___RNAseq.g2684.t2,three_way,77.261,FUN_001777-T1,Q969G6,RIFK_HUMAN,,Riboflavin kinase (EC 2.7.1.26) (ATP:riboflavin 5'-phosphotransferase) (Flavokinase),Homo sapiens (Human),63.0,154.0,5.6e-51,202.2,sp|Q969G6|RIFK_HUMAN Riboflavin kinase OS=Homo sapiens OX=9606 GN=RFK PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006771; GO:0006915; GO:0008531; GO:0009231; GO:0009398; GO:0033864; GO:0046872; GO:0072388; GO:0072593,apoptotic process [GO:0006915]; flavin adenine dinucleotide biosynthetic process [GO:0072388]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531],GO:0003824; GO:0005739; GO:0005829; GO:0006766; GO:0012501; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; cytosol; vitamin metabolic process; programmed cell death; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00612,FUN_001778-T1,Peve_00035593,Pocillopora_meandrina_HIv1___RNAseq.g2685.t1,three_way,54.77516666666666,FUN_001778-T1,Q80VL1,TDRKH_MOUSE,,Tudor and KH domain-containing protein (Tudor domain-containing protein 2),Mus musculus (Mouse),31.1,549.0,2.7e-66,255.4,sp|Q80VL1|TDRKH_MOUSE Tudor and KH domain-containing protein OS=Mus musculus OX=10090 GN=Tdrkh PE=1 SV=1,GO:0003723; GO:0005737; GO:0005739; GO:0005829; GO:0007140; GO:0007283; GO:0009566; GO:0030154; GO:0034587; GO:0071546; GO:0071547,cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; pi-body [GO:0071546]; piP-body [GO:0071547],RNA binding [GO:0003723],GO:0003723; GO:0005739; GO:0005829; GO:0022414; GO:0030154; GO:0043226; GO:0140013,RNA binding; mitochondrion; cytosol; reproductive process; cell differentiation; organelle; meiotic nuclear division
OG_00613,FUN_001779-T1,Peve_00026506,Pocillopora_meandrina_HIv1___TS.g5198.t1,three_way,47.594,,,,,,,,,,,,,,,,,
OG_00614,FUN_001780-T1,Peve_00026505,Pocillopora_meandrina_HIv1___RNAseq.g2691.t1,three_way,90.58533333333334,FUN_001780-T1,B5X0W9,,,,,53.4,193.0,7.7e-54,211.8,sp|B5X0W9|ISOC1_SALSA Isochorismatase domain-containing protein 1 OS=Salmo salar OX=8030 GN=isoc1 PE=2 SV=1,,,,,,
OG_00615,FUN_001781-T1,Peve_00011615,Pocillopora_meandrina_HIv1___RNAseq.g2692.t1,three_way,85.85766666666667,FUN_001781-T1,A0A2R8QP51,DPP9_DANRE,,Dipeptidyl peptidase 9 (EC 3.4.14.5),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,852.0,7.8e-219,761.9,sp|A0A2R8QP51|DPP9_DANRE Dipeptidyl peptidase 9 OS=Danio rerio OX=7955 GN=dpp9 PE=3 SV=1,GO:0004177; GO:0005634; GO:0006508; GO:0008236; GO:0008239; GO:0050727,proteolysis [GO:0006508]; regulation of inflammatory response [GO:0050727],nucleus [GO:0005634],aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00616,FUN_001782-T1,Peve_00011614,Pocillopora_meandrina_HIv1___RNAseq.g2693.t1,three_way,67.33749999999999,FUN_001782-T1,Q08DU8,BL1S6_BOVIN,,Biogenesis of lysosome-related organelles complex 1 subunit 6 (BLOC-1 subunit 6) (Pallid protein homolog) (Pallidin),Bos taurus (Bovine),35.2,88.0,1.2e-13,77.8,sp|Q08DU8|BL1S6_BOVIN Biogenesis of lysosome-related organelles complex 1 subunit 6 OS=Bos taurus OX=9913 GN=BLOC1S6 PE=1 SV=1,GO:0001725; GO:0001726; GO:0001822; GO:0002936; GO:0003016; GO:0003158; GO:0005737; GO:0005768; GO:0005925; GO:0006536; GO:0006541; GO:0006605; GO:0006644; GO:0007596; GO:0007613; GO:0008089; GO:0009410; GO:0010467; GO:0014823; GO:0021542; GO:0021854; GO:0030133; GO:0030318; GO:0031083; GO:0031175; GO:0031201; GO:0031941; GO:0032402; GO:0032816; GO:0033299; GO:0033484; GO:0035264; GO:0035646; GO:0042311; GO:0042745; GO:0042803; GO:0043227; GO:0044291; GO:0046034; GO:0046085; GO:0046907; GO:0048286; GO:0048490; GO:0048872; GO:0050942; GO:0051015; GO:0051017; GO:0055088; GO:0060090; GO:0060271; GO:0061025; GO:0070938; GO:0071364; GO:0071806; GO:1904115; GO:1905144; GO:1990742,actin filament bundle assembly [GO:0051017]; adenosine metabolic process [GO:0046085]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; ATP metabolic process [GO:0046034]; blood coagulation [GO:0007596]; bradykinin biosynthetic process [GO:0002936]; cellular response to epidermal growth factor stimulus [GO:0071364]; cilium assembly [GO:0060271]; circadian sleep/wake cycle [GO:0042745]; dentate gyrus development [GO:0021542]; endosome to melanosome transport [GO:0035646]; endothelium development [GO:0003158]; gene expression [GO:0010467]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; homeostasis of number of cells [GO:0048872]; hypothalamus development [GO:0021854]; intracellular nitric oxide homeostasis [GO:0033484]; intracellular transport [GO:0046907]; kidney development [GO:0001822]; lipid homeostasis [GO:0055088]; lung alveolus development [GO:0048286]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; membrane fusion [GO:0061025]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; neuron projection development [GO:0031175]; phospholipid metabolic process [GO:0006644]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of pigment cell differentiation [GO:0050942]; protein targeting [GO:0006605]; protein transmembrane transport [GO:0071806]; respiratory system process [GO:0003016]; response to acetylcholine [GO:1905144]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; secretion of lysosomal enzymes [GO:0033299]; vasodilation [GO:0042311],axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell-cell contact zone [GO:0044291]; contractile ring [GO:0070938]; cytoplasm [GO:0005737]; endosome [GO:0005768]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; membrane-bounded organelle [GO:0043227]; microvesicle [GO:1990742]; ruffle [GO:0001726]; SNARE complex [GO:0031201]; stress fiber [GO:0001725]; transport vesicle [GO:0030133],actin filament binding [GO:0051015]; molecular adaptor activity [GO:0060090]; protein homodimerization activity [GO:0042803],GO:0003013; GO:0003016; GO:0005768; GO:0006520; GO:0006629; GO:0007018; GO:0008092; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0055085; GO:0055086; GO:0060090; GO:0061024; GO:1901135,circulatory system process; respiratory system process; endosome; amino acid metabolic process; lipid metabolic process; microtubule-based movement; cytoskeletal protein binding; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; nervous system process; transmembrane transport; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; carbohydrate derivative metabolic process
OG_00617,FUN_001783-T1,Peve_00011612,Pocillopora_meandrina_HIv1___RNAseq.g2641.t1,three_way,49.378166666666665,,,,,,,,,,,,,,,,,
OG_00618,FUN_001784-T1,Peve_00011611,Pocillopora_meandrina_HIv1___RNAseq.g2640.t1a,three_way,76.89133333333334,FUN_001784-T1,Q91ZR4,NEK8_MOUSE,,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8),Mus musculus (Mouse),40.8,650.0,1.2e-118,429.9,sp|Q91ZR4|NEK8_MOUSE Serine/threonine-protein kinase Nek8 OS=Mus musculus OX=10090 GN=Nek8 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310,animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330],centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_00619,FUN_001787-T1,Peve_00008715,Pocillopora_meandrina_HIv1___RNAseq.g2639.t1,three_way,71.26766666666667,FUN_001787-T1,Q9HCE0,EPG5_HUMAN,,Ectopic P granules protein 5 homolog,Homo sapiens (Human),30.6,2484.0,0.0,1120.1,sp|Q9HCE0|EPG5_HUMAN Ectopic P granules protein 5 homolog OS=Homo sapiens OX=9606 GN=EPG5 PE=1 SV=2,GO:0002385; GO:0005737; GO:0005764; GO:0006511; GO:0006862; GO:0006954; GO:0006986; GO:0008333; GO:0010467; GO:0032456; GO:0034162; GO:0034342; GO:0046530; GO:0048471; GO:0048874; GO:0048877; GO:0051402; GO:0051607; GO:0070841; GO:0097352; GO:0098544; GO:0140454; GO:0140888; GO:1990786,autophagosome maturation [GO:0097352]; cellular response to dsDNA [GO:1990786]; defense response to virus [GO:0051607]; endocytic recycling [GO:0032456]; endosome to lysosome transport [GO:0008333]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; inclusion body assembly [GO:0070841]; inflammatory response [GO:0006954]; interferon-mediated signaling pathway [GO:0140888]; maintenance of protein complex location [GO:0098544]; mucosal immune response [GO:0002385]; neuron apoptotic process [GO:0051402]; nucleotide transport [GO:0006862]; photoreceptor cell differentiation [GO:0046530]; protein aggregate center assembly [GO:0140454]; response to type III interferon [GO:0034342]; response to unfolded protein [GO:0006986]; toll-like receptor 9 signaling pathway [GO:0034162]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],,GO:0002376; GO:0005764; GO:0005773; GO:0006954; GO:0012501; GO:0016192; GO:0030154; GO:0043226,immune system process; lysosome; vacuole; inflammatory response; programmed cell death; vesicle-mediated transport; cell differentiation; organelle
OG_00620,FUN_001788-T1,Peve_00008725,Pocillopora_meandrina_HIv1___RNAseq.g2638.t2,three_way,72.532,FUN_001788-T1,A1L243,,,,,44.0,184.0,4.1e-34,146.4,sp|A1L243|MESD_DANRE LRP chaperone MESD OS=Danio rerio OX=7955 GN=mesd PE=2 SV=2,,,,,,
OG_00621,FUN_001790-T1,Peve_00008717,Pocillopora_meandrina_HIv1___RNAseq.g2637.t1,three_way,37.53366666666667,,,,,,,,,,,,,,,,,
OG_00622,FUN_001793-T1,Peve_00008718,Pocillopora_meandrina_HIv1___RNAseq.g2635.t1a,three_way,54.11416666666666,FUN_001793-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.2,112.0,1.9e-13,79.3,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_00623,FUN_001794-T1,Peve_00037091,Pocillopora_meandrina_HIv1___RNAseq.g15131.t1,three_way,57.70583333333334,FUN_001794-T1,P05183,CP3A2_RAT,,Cytochrome P450 3A2 (EC 1.14.14.1) (CYPIIIA2) (Cytochrome P450-PCN2) (Cytochrome P450/6-beta-A) (Testosterone 6-beta-hydroxylase),Rattus norvegicus (Rat),39.3,504.0,7.000000000000001e-90,332.8,sp|P05183|CP3A2_RAT Cytochrome P450 3A2 OS=Rattus norvegicus OX=10116 GN=Cyp3a2 PE=1 SV=2,GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006706; GO:0006805; GO:0008202; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016098; GO:0016491; GO:0019899; GO:0020037; GO:0030343; GO:0032451; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0050649; GO:0062181; GO:0070576; GO:0070989; GO:0101020; GO:0101021,alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789],"1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity
OG_00624,FUN_001801-T3,Peve_00029857,Pocillopora_meandrina_HIv1___TS.g5140.t1,three_way,37.006166666666665,,,,,,,,,,,,,,,,,
OG_00625,FUN_001841-T2,Peve_00006792,Pocillopora_meandrina_HIv1___TS.g5135.t1,three_way,79.20983333333334,FUN_001841-T2,Q69CM7,MYBPP_RAT,,MYCBP-associated protein (Organ of Corti membrane-associated protein of 106 kDa),Rattus norvegicus (Rat),29.3,941.0,1.6e-91,339.0,sp|Q69CM7|MYBPP_RAT MYCBP-associated protein OS=Rattus norvegicus OX=10116 GN=Mycbpap PE=1 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005886; GO:0006897; GO:0007268; GO:0007283; GO:0019897; GO:0030125; GO:0030154; GO:0030276,cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; spermatogenesis [GO:0007283],clathrin vesicle coat [GO:0030125]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886],clathrin binding [GO:0030276]; phospholipid binding [GO:0005543],GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0022414; GO:0023052; GO:0030154; GO:0031410; GO:0043226,endosome; plasma membrane; lipid binding; vesicle-mediated transport; reproductive process; signaling; cell differentiation; cytoplasmic vesicle; organelle
OG_00626,FUN_001842-T1,Peve_00006790,Pocillopora_meandrina_HIv1___RNAseq.g2620.t1,three_way,88.205,FUN_001842-T1,Q9GKQ9,,,,,60.2,558.0,1.9e-172,607.1,sp|Q9GKQ9|SMAD4_PIG Mothers against decapentaplegic homolog 4 OS=Sus scrofa OX=9823 GN=SMAD4 PE=2 SV=1,,,,,,
OG_00627,FUN_001845-T1,Peve_00006788,Pocillopora_meandrina_HIv1___RNAseq.g2618.t1,three_way,61.23066666666666,FUN_001845-T1,Q13395,TARB1_HUMAN,,tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 (EC 2.1.1.34) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185),Homo sapiens (Human),29.4,1429.0,3.8e-169,597.8,sp|Q13395|TARB1_HUMAN tRNA (guanosine(18)-2'-O)-methyltransferase TARBP1 OS=Homo sapiens OX=9606 GN=TARBP1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0006357; GO:0016423; GO:0030488; GO:0141100,regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488],nucleus [GO:0005634],RNA binding [GO:0003723]; tRNA (guanine(18)-2'-O)-methyltransferase activity [GO:0141100]; tRNA (guanine) methyltransferase activity [GO:0016423],GO:0003723; GO:0003824; GO:0005634; GO:0006355; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_00628,FUN_001846-T1,Peve_00025830,Pocillopora_meandrina_HIv1___RNAseq.g2614.t1,three_way,80.36166666666666,FUN_001846-T1,Q695T7,S6A19_HUMAN,,Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1),Homo sapiens (Human),43.0,560.0,6.299999999999999e-129,462.6,sp|Q695T7|S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(0)AT1 OS=Homo sapiens OX=9606 GN=SLC6A19 PE=1 SV=1,GO:0005886; GO:0006865; GO:0007584; GO:0015171; GO:0015175; GO:0015293; GO:0015804; GO:0016324; GO:0019058; GO:0031526; GO:0035725; GO:0070062,amino acid transport [GO:0006865]; neutral amino acid transport [GO:0015804]; response to nutrient [GO:0007584]; sodium ion transmembrane transport [GO:0035725]; viral life cycle [GO:0019058],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; symporter activity [GO:0015293],GO:0005215; GO:0005886; GO:0043226; GO:0055085,transporter activity; plasma membrane; organelle; transmembrane transport
OG_00629,FUN_001847-T1,Peve_00025829,Pocillopora_meandrina_HIv1___RNAseq.g2613.t1,three_way,82.766,FUN_001847-T1,O88576,S6A18_MOUSE,,Sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3),Mus musculus (Mouse),51.0,486.0,7.500000000000001e-145,515.4,sp|O88576|S6A18_MOUSE Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Mus musculus OX=10090 GN=Slc6a18 PE=1 SV=1,GO:0003333; GO:0005886; GO:0006836; GO:0015175; GO:0015804; GO:0016324; GO:0031526; GO:0140931; GO:1990297,amino acid transmembrane transport [GO:0003333]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; renal amino acid absorption [GO:1990297],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],neutral L-amino acid transmembrane transporter activity [GO:0015175]; neutral L-amino acid:sodium:chloride symporter activity [GO:0140931],GO:0003014; GO:0005215; GO:0005886; GO:0055085,renal system process; transporter activity; plasma membrane; transmembrane transport
OG_00630,FUN_001848-T1,Peve_00018077,Pocillopora_meandrina_HIv1___RNAseq.g2612.t1a,three_way,57.900333333333336,FUN_001848-T1,Q9NH13,,,,,25.7,346.0,5.4e-20,100.9,sp|Q9NH13|RP43_RIFPA Exoskeleton protein RP43 OS=Riftia pachyptila OX=6426 PE=1 SV=1,,,,,,
OG_00631,FUN_001853-T1,Peve_00018078,Pocillopora_meandrina_HIv1___RNAseq.g2603.t1,three_way,57.54833333333333,FUN_001853-T1,O60494,CUBN_HUMAN,,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Homo sapiens (Human),32.9,237.0,3.9e-29,130.6,sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5,GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_00632,FUN_001855-T1,Peve_00023234,Pocillopora_meandrina_HIv1___RNAseq.g2602.t1,three_way,57.73216666666667,FUN_001855-T1,B8VIU6,,,,,43.4,145.0,4.1e-23,110.5,sp|B8VIU6|USOM5_ACRMI Uncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_00633,FUN_001856-T1,Peve_00043869,Pocillopora_meandrina_HIv1___RNAseq.g2601.t1,three_way,76.085,FUN_001856-T1,P70699,LYAG_MOUSE,,Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase),Mus musculus (Mouse),49.0,880.0,5.4e-247,855.5,sp|P70699|LYAG_MOUSE Lysosomal alpha-glucosidase OS=Mus musculus OX=10090 GN=Gaa PE=1 SV=2,GO:0002026; GO:0002086; GO:0003007; GO:0004558; GO:0005764; GO:0005765; GO:0005977; GO:0005980; GO:0006941; GO:0007040; GO:0007626; GO:0009888; GO:0016020; GO:0030246; GO:0035904; GO:0043181; GO:0043896; GO:0046716; GO:0050884; GO:0050885; GO:0060048; GO:0061723; GO:0120282,aorta development [GO:0035904]; cardiac muscle contraction [GO:0060048]; diaphragm contraction [GO:0002086]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; heart morphogenesis [GO:0003007]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; muscle cell cellular homeostasis [GO:0046716]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; regulation of the force of heart contraction [GO:0002026]; striated muscle contraction [GO:0006941]; tissue development [GO:0009888]; vacuolar sequestering [GO:0043181],autolysosome lumen [GO:0120282]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],"alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; glucan 1,6-alpha-glucosidase activity [GO:0043896]",GO:0003012; GO:0003016; GO:0003824; GO:0005764; GO:0005773; GO:0005975; GO:0006091; GO:0006914; GO:0007040; GO:0016787; GO:0043226; GO:0048856; GO:0050877,muscle system process; respiratory system process; catalytic activity; lysosome; vacuole; carbohydrate metabolic process; generation of precursor metabolites and energy; autophagy; lysosome organization; hydrolase activity; organelle; anatomical structure development; nervous system process
OG_00634,FUN_001857-T1,Peve_00009168,Pocillopora_meandrina_HIv1___TS.g9153.t1,three_way,64.31066666666666,,,,,,,,,,,,,,,,,
OG_00635,FUN_001860-T1,Peve_00032178,Pocillopora_meandrina_HIv1___RNAseq.g2600.t1,three_way,73.505,FUN_001860-T1,Q10741,ADA10_BOVIN,,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (Myelin-associated metalloproteinase) (CD antigen CD156c),Bos taurus (Bovine),45.6,754.0,1.3e-175,618.2,sp|Q10741|ADA10_BOVIN Disintegrin and metalloproteinase domain-containing protein 10 OS=Bos taurus OX=9913 GN=ADAM10 PE=1 SV=1,GO:0000139; GO:0001701; GO:0002315; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0007162; GO:0007219; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042803; GO:0042987; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:1901342; GO:1902945,adherens junction organization [GO:0034332]; amyloid precursor protein catabolic process [GO:0042987]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; marginal zone B cell differentiation [GO:0002315]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch signaling pathway [GO:0007219]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612],adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124],GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005886; GO:0016787; GO:0030154; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0065003; GO:0140096,"immune system process; catalytic activity; nucleus; Golgi apparatus; plasma membrane; hydrolase activity; cell differentiation; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein maturation; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_00636,FUN_001861-T1,Peve_00042514,Pocillopora_meandrina_HIv1___RNAseq.g2599.t1,three_way,41.965,,,,,,,,,,,,,,,,,
OG_00637,FUN_001862-T1,Peve_00033944,Pocillopora_meandrina_HIv1___RNAseq.g2597.t1,three_way,40.38966666666666,FUN_001862-T1,Q8N8G2,,,,,42.6,68.0,8.8e-06,52.8,sp|Q8N8G2|VGLL2_HUMAN Transcription cofactor vestigial-like protein 2 OS=Homo sapiens OX=9606 GN=VGLL2 PE=1 SV=1,,,,,,
OG_00638,FUN_001867-T1,Peve_00030491,Pocillopora_meandrina_HIv1___RNAseq.g2595.t1,three_way,85.47733333333333,FUN_001867-T1,Q02241,KIF23_HUMAN,,Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1),Homo sapiens (Human),44.4,967.0,2.9e-197,690.3,sp|Q02241|KIF23_HUMAN Kinesin-like protein KIF23 OS=Homo sapiens OX=9606 GN=KIF23 PE=1 SV=3,GO:0000022; GO:0000281; GO:0003777; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0005925; GO:0007018; GO:0008017; GO:0016887; GO:0030496; GO:0032467; GO:0051256; GO:0072686; GO:0090543; GO:0097149,microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle elongation [GO:0000022]; mitotic spindle midzone assembly [GO:0051256]; positive regulation of cytokinesis [GO:0032467],centralspindlin complex [GO:0097149]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0000910; GO:0003774; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytokinesis; cytoskeletal motor activity; catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_00639,FUN_001878-T1,Peve_00030498,Pocillopora_meandrina_HIv1___TS.g5107.t1,three_way,86.158,FUN_001878-T1,Q6NZ06,,,,,53.7,367.0,2.1e-100,367.5,sp|Q6NZ06|ILF2_DANRE Interleukin enhancer-binding factor 2 homolog OS=Danio rerio OX=7955 GN=ilf2 PE=2 SV=1,,,,,,
OG_00640,FUN_001879-T1,Peve_00030499,Pocillopora_meandrina_HIv1___RNAseq.g2593.t1,three_way,62.20333333333333,FUN_001879-T1,Q6NTR1,,,,,38.1,691.0,1.8e-112,408.3,sp|Q6NTR1|EFNMT_XENLA eEF1A lysine and N-terminal methyltransferase OS=Xenopus laevis OX=8355 GN=mettl13 PE=2 SV=1,,,,,,
OG_00641,FUN_001882-T1,Peve_00030484,Pocillopora_meandrina_HIv1___TS.g5105.t1,three_way,67.033,,,,,,,,,,,,,,,,,
OG_00642,FUN_001883-T1,Peve_00030486,Pocillopora_meandrina_HIv1___RNAseq.g2592.t1,three_way,67.79133333333333,FUN_001883-T1,P55814,,,,,55.6,90.0,3.9e-23,109.8,sp|P55814|OAZ1_XENLA Ornithine decarboxylase antizyme 1 OS=Xenopus laevis OX=8355 GN=oaz1 PE=2 SV=2,,,,,,
OG_00643,FUN_001887-T1,Peve_00030489,Pocillopora_meandrina_HIv1___RNAseq.g29129.t1,three_way,64.38266666666667,FUN_001887-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),40.6,286.0,1.8000000000000002e-44,181.8,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_00644,FUN_001889-T1,Peve_00030492,Pocillopora_meandrina_HIv1___RNAseq.g2578.t2,three_way,70.65033333333334,,,,,,,,,,,,,,,,,
OG_00645,FUN_001898-T1,Peve_00018649,Pocillopora_meandrina_HIv1___RNAseq.g2575.t1,three_way,94.408,FUN_001898-T1,Q32LN7,SKI8_BOVIN,,"Superkiller complex protein 8 (Ski8) (WD repeat-containing protein 61) [Cleaved into: Superkiller complex protein 8, N-terminally processed (WD repeat-containing protein 61, N-terminally processed)]",Bos taurus (Bovine),62.2,119.0,2.0000000000000002e-44,181.0,sp|Q32LN7|SKI8_BOVIN Superkiller complex protein 8 OS=Bos taurus OX=9913 GN=SKIC8 PE=2 SV=1,GO:0000791; GO:0005634; GO:0005737; GO:0006368; GO:0016055; GO:0016593; GO:0045638; GO:0055087; GO:0070478; GO:0072344,"negative regulation of myeloid cell differentiation [GO:0045638]; nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; rescue of stalled ribosome [GO:0072344]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055]",Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nucleus [GO:0005634]; Ski complex [GO:0055087],,GO:0005634; GO:0016071; GO:0043226,nucleus; mRNA metabolic process; organelle
OG_00646,FUN_001899-T1,Peve_00018640,Pocillopora_meandrina_HIv1___RNAseq.g2574.t1,three_way,74.81766666666667,,,,,,,,,,,,,,,,,
OG_00647,FUN_001900-T1,Peve_00018641,Pocillopora_meandrina_HIv1___RNAseq.g2573.t1,three_way,68.03933333333333,FUN_001900-T1,Q9D1I6,,,,,40.7,140.0,1.2e-20,101.3,sp|Q9D1I6|RM14_MOUSE Large ribosomal subunit protein uL14m OS=Mus musculus OX=10090 GN=Mrpl14 PE=1 SV=1,,,,,,
OG_00648,FUN_001901-T1,Peve_00018643,Pocillopora_meandrina_HIv1___TS.g5085.t1,three_way,66.03566666666667,,,,,,,,,,,,,,,,,
OG_00649,FUN_001904-T1,Peve_00013091,Pocillopora_meandrina_HIv1___RNAseq.g2569.t1,three_way,67.893,FUN_001904-T1,Q9SF91,,,,,41.7,211.0,8.3e-40,165.2,sp|Q9SF91|RAE1E_ARATH Ras-related protein RABE1e OS=Arabidopsis thaliana OX=3702 GN=RABE1E PE=1 SV=1,,,,,,
OG_00650,FUN_001905-T1,Peve_00013092,Pocillopora_meandrina_HIv1___RNAseq.g2568.t1,three_way,52.91466666666667,FUN_001905-T1,Q9TVU5,,,,,34.3,166.0,1e-20,101.7,sp|Q9TVU5|RAB1_THEPA Ras-related protein Rab-1 OS=Theileria parva OX=5875 GN=rab1 PE=1 SV=1,,,,,,
OG_00651,FUN_001908-T1,Peve_00024474,Pocillopora_meandrina_HIv1___RNAseq.g2562.t1,three_way,77.906,FUN_001908-T1,Q3T108,,,,,59.8,194.0,2.7e-67,256.5,sp|Q3T108|PSB4_BOVIN Proteasome subunit beta type-4 OS=Bos taurus OX=9913 GN=PSMB4 PE=1 SV=1,,,,,,
OG_00652,FUN_001909-T1,Peve_00019769,Pocillopora_meandrina_HIv1___RNAseq.g2561.t1,three_way,83.65633333333334,FUN_001909-T1,Q5E9F6,VPS72_BOVIN,,Vacuolar protein sorting-associated protein 72 homolog (Transcription factor-like 1),Bos taurus (Bovine),39.7,315.0,2.8e-28,127.5,sp|Q5E9F6|VPS72_BOVIN Vacuolar protein sorting-associated protein 72 homolog OS=Bos taurus OX=9913 GN=VPS72 PE=2 SV=1,GO:0000786; GO:0003677; GO:0005634; GO:0016607; GO:0032991; GO:0035019; GO:0035267; GO:0042393; GO:0045815; GO:0051726; GO:0140713; GO:1905168,positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of cell cycle [GO:0051726]; somatic stem cell population maintenance [GO:0035019]; transcription initiation-coupled chromatin remodeling [GO:0045815],NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleosome [GO:0000786]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],DNA binding [GO:0003677]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713],GO:0003677; GO:0005634; GO:0006325; GO:0042393; GO:0043226; GO:0140104,DNA binding; nucleus; chromatin organization; histone binding; organelle; molecular carrier activity
OG_00653,FUN_001917-T1,Peve_00024476,Pocillopora_meandrina_HIv1___TS.g5073.t1,three_way,50.27666666666666,,,,,,,,,,,,,,,,,
OG_00654,FUN_001940-T1,Peve_00024481,Pocillopora_meandrina_HIv1___RNAseq.20168_t,three_way,77.20733333333334,FUN_001940-T1,Q87PP5,,,,,35.6,547.0,4.6e-98,360.5,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_00655,FUN_001941-T1,Peve_00024483,Pocillopora_meandrina_HIv1___TS.g6439.t1,three_way,68.33433333333333,FUN_001941-T1,Q6IPM2,IQCE_HUMAN,,IQ domain-containing protein E,Homo sapiens (Human),30.0,433.0,1.4e-21,107.1,sp|Q6IPM2|IQCE_HUMAN IQ domain-containing protein E OS=Homo sapiens OX=9606 GN=IQCE PE=1 SV=2,GO:0005929; GO:0035108; GO:0060170,limb morphogenesis [GO:0035108],ciliary membrane [GO:0060170]; cilium [GO:0005929],,GO:0005929; GO:0043226,cilium; organelle
OG_00656,FUN_001943-T1,Peve_00041248,Pocillopora_meandrina_HIv1___RNAseq.g2485.t1,three_way,67.74316666666667,FUN_001943-T1,Q3TC46,PATL1_MOUSE,,Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b),Mus musculus (Mouse),27.4,602.0,3.4e-40,168.3,sp|Q3TC46|PATL1_MOUSE Protein PAT1 homolog 1 OS=Mus musculus OX=10090 GN=Patl1 PE=1 SV=2,GO:0000290; GO:0000932; GO:0002151; GO:0003723; GO:0005737; GO:0005829; GO:0008266; GO:0016605; GO:0016607; GO:0017148; GO:0030014; GO:0030371; GO:0033962; GO:0034046,deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962],CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605],G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371],GO:0003723; GO:0005829; GO:0016071; GO:0043226; GO:0045182,RNA binding; cytosol; mRNA metabolic process; organelle; translation regulator activity
OG_00657,FUN_001944-T1,Peve_00030386,Pocillopora_meandrina_HIv1___RNAseq.g29312.t1,three_way,71.12366666666667,FUN_001944-T1,Q5QNP2,TA13C_DANRE,,Trace amine-associated receptor 13c,Danio rerio (Zebrafish) (Brachydanio rerio),30.0,297.0,2.8e-12,74.3,sp|Q5QNP2|TA13C_DANRE Trace amine-associated receptor 13c OS=Danio rerio OX=7955 GN=taar13c PE=1 SV=1,GO:0001594; GO:0004984; GO:0005886; GO:0007186; GO:0007606; GO:0008227; GO:0009995; GO:0016020; GO:0019808; GO:0019810; GO:0050911; GO:1990834,detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; response to odorant [GO:1990834]; sensory perception of chemical stimulus [GO:0007606]; soluble molecule recognition [GO:0009995],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled amine receptor activity [GO:0008227]; olfactory receptor activity [GO:0004984]; polyamine binding [GO:0019808]; putrescine binding [GO:0019810]; trace-amine receptor activity [GO:0001594],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_00658,FUN_001948-T1,Peve_00043455,Pocillopora_meandrina_HIv1___RNAseq.g29223.t1,three_way,69.442,FUN_001948-T1,Q5XHF8,VIP2_XENLA,,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2),Xenopus laevis (African clawed frog),52.8,1036.0,1.1999999999999998e-299,1031.2,sp|Q5XHF8|VIP2_XENLA Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 OS=Xenopus laevis OX=8355 GN=ppip5k2 PE=2 SV=1,GO:0000827; GO:0000828; GO:0000832; GO:0005524; GO:0005829; GO:0006020; GO:0032958; GO:0033857; GO:0052723,inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958],cytosol [GO:0005829],"5-diphosphoinositol pentakisphosphate 1-kinase activity [GO:0033857]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]",GO:0003824; GO:0005829; GO:0016740,catalytic activity; cytosol; transferase activity
OG_00659,FUN_001950-T2,Peve_00043450,Pocillopora_meandrina_HIv1___RNAseq.g29225.t2,three_way,79.51583333333333,FUN_001950-T2,P23508,CRCM_HUMAN,,Colorectal mutant cancer protein (Protein MCC),Homo sapiens (Human),38.4,495.0,1.3e-64,250.0,sp|P23508|CRCM_HUMAN Colorectal mutant cancer protein OS=Homo sapiens OX=9606 GN=MCC PE=1 SV=2,GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007165; GO:0010633; GO:0016055; GO:0030027; GO:0038023; GO:0045184; GO:0050680; GO:0090090,establishment of protein localization [GO:0045184]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],signaling receptor activity [GO:0038023],GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleus; nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_00660,FUN_001952-T1,Peve_00024485,Pocillopora_meandrina_HIv1___RNAseq.g29226.t1,three_way,75.02666666666667,FUN_001952-T1,D3UW23,AMPE_BITRH,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Rhiminopeptidase A),Bitis rhinoceros (West African gaboon viper) (Vipera rhinoceros),41.8,928.0,1.4e-203,711.4,sp|D3UW23|AMPE_BITRH Glutamyl aminopeptidase OS=Bitis rhinoceros OX=715877 PE=1 SV=1,GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0042277; GO:0043171; GO:0070006,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_00661,FUN_001954-T1,Peve_00024484,Pocillopora_meandrina_HIv1___RNAseq.g29228.t1,three_way,86.64866666666667,FUN_001954-T1,Q6FIF0,ZFAN6_HUMAN,,AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3),Homo sapiens (Human),38.9,208.0,1.9e-29,130.6,sp|Q6FIF0|ZFAN6_HUMAN AN1-type zinc finger protein 6 OS=Homo sapiens OX=9606 GN=ZFAND6 PE=1 SV=2,GO:0003677; GO:0005829; GO:0006625; GO:0006915; GO:0008270; GO:0015031; GO:0031593; GO:0043066; GO:0043122; GO:0071356,apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; protein targeting to peroxisome [GO:0006625]; protein transport [GO:0015031]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cytosol [GO:0005829],DNA binding [GO:0003677]; polyubiquitin modification-dependent protein binding [GO:0031593]; zinc ion binding [GO:0008270],GO:0003677; GO:0005829; GO:0012501,DNA binding; cytosol; programmed cell death
OG_00662,FUN_001955-T1,Peve_00041246,Pocillopora_meandrina_HIv1___RNAseq.g2487.t1,three_way,54.437666666666665,,,,,,,,,,,,,,,,,
OG_00663,FUN_001956-T1,Peve_00041245,Pocillopora_meandrina_HIv1___RNAseq.g2488.t1,three_way,90.275,FUN_001956-T1,Q76LT9,,,,,83.5,79.0,3.3999999999999997e-31,135.2,sp|Q76LT9|TM258_CHICK Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TMEM258 OS=Gallus gallus OX=9031 GN=TMEM258 PE=3 SV=1,,,,,,
OG_00664,FUN_001957-T1,Peve_00041244,Pocillopora_meandrina_HIv1___RNAseq.g2489.t1,three_way,78.50733333333334,FUN_001957-T1,Q8CHW4,EI2BE_MOUSE,,Translation initiation factor eIF2B subunit epsilon (eIF2B GDP-GTP exchange factor subunit epsilon),Mus musculus (Mouse),41.6,671.0,1e-123,445.7,sp|Q8CHW4|EI2BE_MOUSE Translation initiation factor eIF2B subunit epsilon OS=Mus musculus OX=10090 GN=Eif2b5 PE=1 SV=1,GO:0001541; GO:0002183; GO:0003743; GO:0005085; GO:0005634; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0009408; GO:0009749; GO:0014002; GO:0014003; GO:0021766; GO:0031369; GO:0034976; GO:0042552; GO:0043065; GO:0043434; GO:0045948; GO:0048708; GO:0050852,astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; cytoplasmic translational initiation [GO:0002183]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634],guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0005634; GO:0005829; GO:0030154; GO:0043226; GO:0048856; GO:0098772,immune system process; nucleus; cytosol; cell differentiation; organelle; anatomical structure development; molecular function regulator activity
OG_00665,FUN_001963-T1,Peve_00041243,Pocillopora_meandrina_HIv1___RNAseq.g2490.t1,three_way,53.78566666666666,FUN_001963-T1,B3EWZ8,,,,,46.8,141.0,3.5e-29,131.7,sp|B3EWZ8|ECT_ACRMI Ectin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_00666,FUN_001965-T1,Peve_00041286,Pocillopora_meandrina_HIv1___RNAseq.g2491.t1,three_way,59.866166666666665,,,,,,,,,,,,,,,,,
OG_00667,FUN_001966-T1,Peve_00041285,Pocillopora_meandrina_HIv1___RNAseq.g2492.t1,three_way,65.555,,,,,,,,,,,,,,,,,
OG_00668,FUN_002033-T1,Peve_00000490,Pocillopora_meandrina_HIv1___RNAseq.g10112.t1,three_way,37.79416666666667,,,,,,,,,,,,,,,,,
OG_00669,FUN_002034-T1,Peve_00001971,Pocillopora_meandrina_HIv1___RNAseq.g10113.t1,three_way,36.083666666666666,,,,,,,,,,,,,,,,,
OG_00670,FUN_002073-T1,Peve_00013323,Pocillopora_meandrina_HIv1___RNAseq.g1722.t1,three_way,64.35900000000001,FUN_002073-T1,Q8C206,,,,,33.9,289.0,6.599999999999998e-41,169.5,sp|Q8C206|GP157_MOUSE G-protein coupled receptor 157 OS=Mus musculus OX=10090 GN=Gpr157 PE=1 SV=1,,,,,,
OG_00671,FUN_002079-T1,Peve_00036467,Pocillopora_meandrina_HIv1___RNAseq.g1723.t1,three_way,66.33500000000001,FUN_002079-T1,Q99614,,,,,45.6,160.0,7.2e-36,152.5,sp|Q99614|TTC1_HUMAN Tetratricopeptide repeat protein 1 OS=Homo sapiens OX=9606 GN=TTC1 PE=1 SV=1,,,,,,
OG_00672,FUN_002080-T1,Peve_00042452,Pocillopora_meandrina_HIv1___TS.g4232.t1,three_way,60.9945,FUN_002080-T1,P22607,FGFR3_HUMAN,,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333),Homo sapiens (Human),42.2,792.0,4.3e-148,526.9,sp|P22607|FGFR3_HUMAN Fibroblast growth factor receptor 3 OS=Homo sapiens OX=9606 GN=FGFR3 PE=1 SV=1,GO:0000165; GO:0001501; GO:0001958; GO:0002062; GO:0003416; GO:0004713; GO:0005007; GO:0005524; GO:0005576; GO:0005783; GO:0005794; GO:0005886; GO:0007259; GO:0007267; GO:0008284; GO:0008543; GO:0009986; GO:0010518; GO:0017134; GO:0030133; GO:0030282; GO:0035988; GO:0042531; GO:0042802; GO:0043235; GO:0043410; GO:0048640; GO:0051897; GO:0060349; GO:0070374; GO:0070977; GO:1902178,bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; skeletal system development [GO:0001501],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_00673,FUN_002084-T1,Peve_00006417,Pocillopora_meandrina_HIv1___RNAseq.g1717.t2,three_way,43.899,FUN_002084-T1,P37237,FGF8_MOUSE,,Fibroblast growth factor 8 (FGF-8) (Androgen-induced growth factor) (AIGF) (Heparin-binding growth factor 8) (HBGF-8),Mus musculus (Mouse),31.5,143.0,7.9e-17,89.0,sp|P37237|FGF8_MOUSE Fibroblast growth factor 8 OS=Mus musculus OX=10090 GN=Fgf8 PE=1 SV=1,GO:0000165; GO:0001569; GO:0001656; GO:0001658; GO:0001759; GO:0001822; GO:0001839; GO:0001947; GO:0001974; GO:0003007; GO:0003148; GO:0003151; GO:0003198; GO:0005576; GO:0006915; GO:0006979; GO:0007368; GO:0007507; GO:0008045; GO:0008078; GO:0008083; GO:0008283; GO:0008284; GO:0008406; GO:0008543; GO:0009410; GO:0009792; GO:0009897; GO:0010628; GO:0021537; GO:0021543; GO:0021544; GO:0021798; GO:0021846; GO:0021884; GO:0023019; GO:0030324; GO:0030539; GO:0030878; GO:0030916; GO:0030917; GO:0033563; GO:0035050; GO:0035108; GO:0035116; GO:0035265; GO:0035909; GO:0042056; GO:0042472; GO:0042476; GO:0042487; GO:0043066; GO:0043524; GO:0045165; GO:0045745; GO:0045840; GO:0046622; GO:0048699; GO:0048702; GO:0048853; GO:0051402; GO:0051781; GO:0055026; GO:0060037; GO:0060128; GO:0060129; GO:0060348; GO:0060425; GO:0060445; GO:0070374; GO:0071542; GO:0072089; GO:0090134; GO:0120223; GO:0140014; GO:2000648,aorta morphogenesis [GO:0035909]; apoptotic process [GO:0006915]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell fate commitment [GO:0045165]; cell migration involved in mesendoderm migration [GO:0090134]; cell population proliferation [GO:0008283]; cell proliferation in forebrain [GO:0021846]; corticotropin hormone secreting cell differentiation [GO:0060128]; determination of left/right symmetry [GO:0007368]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axon guidance [GO:0033563]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic neurocranium morphogenesis [GO:0048702]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; forebrain neuron development [GO:0021884]; generation of neurons [GO:0048699]; gonad development [GO:0008406]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; kidney development [GO:0001822]; larynx morphogenesis [GO:0120223]; limb morphogenesis [GO:0035108]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesodermal cell migration [GO:0008078]; metanephros development [GO:0001656]; midbrain-hindbrain boundary development [GO:0030917]; mitotic nuclear division [GO:0140014]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle tissue development [GO:0055026]; negative regulation of neuron apoptotic process [GO:0043524]; neural plate morphogenesis [GO:0001839]; neuron apoptotic process [GO:0051402]; odontogenesis [GO:0042476]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; pallium development [GO:0021543]; pharyngeal system development [GO:0060037]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of organ growth [GO:0046622]; positive regulation of stem cell proliferation [GO:2000648]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell proliferation [GO:0072089]; subpallium development [GO:0021544]; telencephalon development [GO:0021537]; thyroid gland development [GO:0030878]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129],external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083],GO:0005576; GO:0012501; GO:0022414; GO:0030154; GO:0048018; GO:0048856; GO:0048870; GO:0098772; GO:0140014,extracellular region; programmed cell death; reproductive process; cell differentiation; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity; mitotic nuclear division
OG_00674,FUN_002085-T1,Peve_00006425,Pocillopora_meandrina_HIv1___RNAseq.g1726.t1,three_way,71.64233333333334,FUN_002085-T1,O60258,FGF17_HUMAN,,Fibroblast growth factor 17 (FGF-17),Homo sapiens (Human),35.8,173.0,5e-23,109.8,sp|O60258|FGF17_HUMAN Fibroblast growth factor 17 OS=Homo sapiens OX=9606 GN=FGF17 PE=1 SV=1,GO:0005105; GO:0005111; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0007399; GO:0008083; GO:0008284; GO:0008543; GO:0022008; GO:0030334; GO:0043410,cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0005576; GO:0005615; GO:0023052; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; signaling; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_00675,FUN_002087-T1,Peve_00006424,Pocillopora_meandrina_HIv1___RNAseq.g1727.t1,three_way,59.805,FUN_002087-T1,Q90722,FGF8_CHICK,,Fibroblast growth factor 8 (FGF-8) (Heparin-binding growth factor 8) (HBGF-8),Gallus gallus (Chicken),38.4,177.0,1.2e-24,115.2,sp|Q90722|FGF8_CHICK Fibroblast growth factor 8 OS=Gallus gallus OX=9031 GN=FGF8 PE=2 SV=1,GO:0005105; GO:0005111; GO:0005615; GO:0005737; GO:0008083; GO:0008284; GO:0008543; GO:0009880; GO:0009953; GO:0010628; GO:0022008; GO:0030177; GO:0030334; GO:0043410; GO:0045893; GO:0045944; GO:0051781; GO:0060173; GO:0060174; GO:0060684,dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; epithelial-mesenchymal cell signaling [GO:0060684]; fibroblast growth factor receptor signaling pathway [GO:0008543]; limb bud formation [GO:0060174]; limb development [GO:0060173]; neurogenesis [GO:0022008]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell migration [GO:0030334],cytoplasm [GO:0005737]; extracellular space [GO:0005615],growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0005615; GO:0006355; GO:0023052; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; signaling; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_00676,FUN_002091-T1,Peve_00006423,Pocillopora_meandrina_HIv1___RNAseq.g1728.t1,three_way,69.36916666666666,FUN_002091-T1,Q08E39,SPY2_BOVIN,,Protein sprouty homolog 2 (Spry-2),Bos taurus (Bovine),55.8,77.0,2.6e-20,100.9,sp|Q08E39|SPY2_BOVIN Protein sprouty homolog 2 OS=Bos taurus OX=9913 GN=SPRY2 PE=2 SV=1,GO:0000132; GO:0005634; GO:0005829; GO:0007605; GO:0008285; GO:0008543; GO:0010628; GO:0010719; GO:0015629; GO:0016525; GO:0019901; GO:0030291; GO:0030335; GO:0030512; GO:0031345; GO:0031397; GO:0032587; GO:0035924; GO:0040037; GO:0042472; GO:0043066; GO:0043539; GO:0045165; GO:0045742; GO:0046580; GO:0048513; GO:0051387; GO:0051897; GO:0055105; GO:0060437; GO:0060449; GO:0070371; GO:0070373; GO:0070374; GO:1900747; GO:1902747; GO:1990752; GO:1990830,animal organ development [GO:0048513]; bud elongation involved in lung branching [GO:0060449]; cell fate commitment [GO:0045165]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung growth [GO:0060437]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell projection organization [GO:0031345]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of lens fiber cell differentiation [GO:1902747]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of cell migration [GO:0030335]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; sensory perception of sound [GO:0007605],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; microtubule end [GO:1990752]; nucleus [GO:0005634]; ruffle membrane [GO:0032587],protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase inhibitor activity [GO:0030291]; ubiquitin-protein transferase inhibitor activity [GO:0055105],GO:0005634; GO:0005829; GO:0005856; GO:0007010; GO:0043226; GO:0048856; GO:0050877; GO:0098772,nucleus; cytosol; cytoskeleton; cytoskeleton organization; organelle; anatomical structure development; nervous system process; molecular function regulator activity
OG_00677,FUN_002092-T1,Peve_00004296,Pocillopora_meandrina_HIv1___RNAseq.g1730.t2,three_way,68.856,FUN_002092-T1,H3BCW1,ADPRS_LATCH,,ADP-ribosylhydrolase ARH3 (ADP-ribose glycohydrolase ARH3) (LchARH3) (ADP-ribosylhydrolase 3) (O-acetyl-ADP-ribose deacetylase ARH3) (EC 3.5.1.-) (Poly(ADP-ribose) glycohydrolase ARH3) (EC 3.2.1.143) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) ([Protein ADP-ribosylserine] hydrolase) (EC 3.2.2.-),Latimeria chalumnae (Coelacanth),40.8,355.0,2.2e-61,237.7,sp|H3BCW1|ADPRS_LATCH ADP-ribosylhydrolase ARH3 OS=Latimeria chalumnae OX=7897 GN=adprs PE=1 SV=1,GO:0000287; GO:0004649; GO:0005634; GO:0005694; GO:0005759; GO:0006281; GO:0060546; GO:0140290; GO:0140292,DNA repair [GO:0006281]; negative regulation of necroptotic process [GO:0060546]; peptidyl-serine ADP-deribosylation [GO:0140290],chromosome [GO:0005694]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634],ADP-ribosylserine hydrolase activity [GO:0140292]; magnesium ion binding [GO:0000287]; poly(ADP-ribose) glycohydrolase activity [GO:0004649],GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; DNA repair; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00678,FUN_002093-T1,Peve_00004291,Pocillopora_meandrina_HIv1___RNAseq.g1731.t2,three_way,44.53733333333333,,,,,,,,,,,,,,,,,
OG_00679,FUN_002102-T1,Peve_00004294,Pocillopora_meandrina_HIv1___RNAseq.g1737.t1,three_way,59.12716666666666,FUN_002102-T1,P18461,,,,,37.9,833.0,3.8e-141,503.8,sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus OX=9031 GN=FGFR2 PE=2 SV=1,,,,,,
OG_00680,FUN_002105-T1,Peve_00028438,Pocillopora_meandrina_HIv1___RNAseq.g1739.t1,three_way,80.535,FUN_002105-T1,Q5EBF1,5NTC_XENTR,,Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (EC 3.1.3.99) (Cytosolic nucleoside phosphotransferase 5'N) (EC 2.7.1.77),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),62.7,472.0,9.999999999999999e-173,608.2,sp|Q5EBF1|5NTC_XENTR Cytosolic purine 5'-nucleotidase OS=Xenopus tropicalis OX=8364 GN=nt5c2 PE=2 SV=1,GO:0005524; GO:0005829; GO:0008253; GO:0042802; GO:0046037; GO:0046040; GO:0046054; GO:0046872; GO:0050146; GO:0050483; GO:0050484; GO:0106411,dGMP metabolic process [GO:0046054]; GMP metabolic process [GO:0046037]; IMP metabolic process [GO:0046040],cytosol [GO:0005829],5'-nucleotidase activity [GO:0008253]; ATP binding [GO:0005524]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; metal ion binding [GO:0046872]; nucleoside phosphotransferase activity [GO:0050146]; XMP 5'-nucleosidase activity [GO:0106411],GO:0003824; GO:0005829; GO:0016740; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; transferase activity; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00681,FUN_002115-T1,Peve_00035152,Pocillopora_meandrina_HIv1___RNAseq.g1741.t1,three_way,74.249,FUN_002115-T1,Q8BP78,,,,,63.8,163.0,1.6e-60,234.2,sp|Q8BP78|F10C1_MOUSE Protein FRA10AC1 homolog OS=Mus musculus OX=10090 GN=Fra10ac1 PE=1 SV=3,,,,,,
OG_00682,FUN_002200-T1,Peve_00043658,Pocillopora_meandrina_HIv1___RNAseq.g30301.t1,three_way,78.49766666666667,FUN_002200-T1,Q14746,,,,,39.1,750.0,7.1e-144,512.7,sp|Q14746|COG2_HUMAN Conserved oligomeric Golgi complex subunit 2 OS=Homo sapiens OX=9606 GN=COG2 PE=1 SV=1,,,,,,
OG_00683,FUN_002350-T1,Peve_00022329,Pocillopora_meandrina_HIv1___RNAseq.g31.t1,three_way,87.33500000000001,FUN_002350-T1,O76924,,,,,52.7,482.0,2.5e-145,516.9,sp|O76924|ARI2_DROME Potential E3 ubiquitin-protein ligase ariadne-2 OS=Drosophila melanogaster OX=7227 GN=ari-2 PE=1 SV=1,,,,,,
OG_00684,FUN_002351-T2,Peve_00035726,Pocillopora_meandrina_HIv1___RNAseq.g32.t1,three_way,66.9635,FUN_002351-T2,Q5XIX3,DCR1C_RAT,,Protein artemis (EC 3.1.-.-) (DNA cross-link repair 1C protein) (SNM1-like protein),Rattus norvegicus (Rat),42.9,371.0,2.4e-87,324.7,sp|Q5XIX3|DCR1C_RAT Protein artemis OS=Rattus norvegicus OX=10116 GN=Dclre1c PE=1 SV=1,GO:0000014; GO:0000723; GO:0002250; GO:0003684; GO:0005634; GO:0006302; GO:0006303; GO:0006310; GO:0008409; GO:0010212; GO:0030183; GO:0033151; GO:0035312; GO:0036297; GO:0051276; GO:0070419,adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; chromosome organization [GO:0051276]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; response to ionizing radiation [GO:0010212]; telomere maintenance [GO:0000723]; V(D)J recombination [GO:0033151],nonhomologous end joining complex [GO:0070419]; nucleus [GO:0005634],5'-3' DNA exonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; damaged DNA binding [GO:0003684]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0030154; GO:0032200; GO:0043226; GO:0140097,"immune system process; DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; cell differentiation; telomere organization; organelle; catalytic activity, acting on DNA"
OG_00685,FUN_002352-T1,Peve_00022332,Pocillopora_meandrina_HIv1___RNAseq.g33.t1,three_way,56.47666666666667,FUN_002352-T1,Q69ZL1,,,,,41.2,658.0,7.2e-121,437.6,"sp|Q69ZL1|FGD6_MOUSE FYVE, RhoGEF and PH domain-containing protein 6 OS=Mus musculus OX=10090 GN=Fgd6 PE=1 SV=2",,,,,,
OG_00686,FUN_002355-T1,Peve_00023010,Pocillopora_meandrina_HIv1___RNAseq.g38.t1,three_way,67.03033333333333,FUN_002355-T1,Q0VCH3,,,,,43.4,113.0,1.3e-23,110.5,sp|Q0VCH3|CDPF1_BOVIN Cysteine-rich DPF motif domain-containing protein 1 OS=Bos taurus OX=9913 GN=CDPF1 PE=2 SV=1,,,,,,
OG_00687,FUN_002358-T1,Peve_00014905,Pocillopora_meandrina_HIv1___RNAseq.g42.t1,three_way,69.67566666666666,FUN_002358-T1,Q19297,,,,,43.6,94.0,8.4e-17,88.2,sp|Q19297|YZ73_CAEEL Uncharacterized monothiol glutaredoxin F10D7.3 OS=Caenorhabditis elegans OX=6239 GN=F10D7.3 PE=3 SV=2,,,,,,
OG_00688,FUN_002360-T1,Peve_00029564,Pocillopora_meandrina_HIv1___RNAseq.g51.t1,three_way,43.132333333333335,,,,,,,,,,,,,,,,,
OG_00689,FUN_002362-T1,Peve_00014901,Pocillopora_meandrina_HIv1___RNAseq.g52.t1,three_way,77.31,,,,,,,,,,,,,,,,,
OG_00690,FUN_002376-T1,Peve_00034047,Pocillopora_meandrina_HIv1___RNAseq.g24.t1,three_way,56.32666666666667,FUN_002376-T1,P35409,,,,,28.4,345.0,9.9e-19,96.7,sp|P35409|GLHR_ANTEL Probable glycoprotein hormone G-protein coupled receptor OS=Anthopleura elegantissima OX=6110 PE=2 SV=1,,,,,,
OG_00691,FUN_002378-T1,Peve_00034013,Pocillopora_meandrina_HIv1___RNAseq.g21.t1,three_way,75.79133333333333,FUN_002378-T1,Q8TCT0,CERK1_HUMAN,,Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4),Homo sapiens (Human),45.1,457.0,4.400000000000001e-111,403.3,sp|Q8TCT0|CERK1_HUMAN Ceramide kinase OS=Homo sapiens OX=9606 GN=CERK PE=1 SV=1,GO:0000287; GO:0001729; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006688; GO:0016020,ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; magnesium ion binding [GO:0000287],GO:0003824; GO:0005886; GO:0006629; GO:0016740; GO:1901135,catalytic activity; plasma membrane; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_00692,FUN_002379-T1,Peve_00034020,Pocillopora_meandrina_HIv1___RNAseq.g20.t2,three_way,83.75166666666667,FUN_002379-T1,Q00537,CDK17_HUMAN,,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),Homo sapiens (Human),57.9,525.0,3.6e-160,566.2,sp|Q00537|CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens OX=9606 GN=CDK17 PE=1 SV=2,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0106310; GO:1901987,protein phosphorylation [GO:0006468]; regulation of cell cycle phase transition [GO:1901987],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00693,FUN_002382-T1,Peve_00034022,Pocillopora_meandrina_HIv1___RNAseq.g14908.t1,three_way,68.7255,FUN_002382-T1,Q4R2Y9,ABHD2_MACFA,,Monoacylglycerol lipase ABHD2 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Acetylesterase) (EC 3.1.1.6) (Triacylglycerol lipase) (EC 3.1.1.79),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),40.2,408.0,1.7e-86,321.2,sp|Q4R2Y9|ABHD2_MACFA Monoacylglycerol lipase ABHD2 OS=Macaca fascicularis OX=9541 GN=ABHD2 PE=2 SV=1,GO:0001669; GO:0003707; GO:0004806; GO:0007340; GO:0008126; GO:0009611; GO:0014909; GO:0014912; GO:0032570; GO:0036126; GO:0042562; GO:0043401; GO:0046464; GO:0047372; GO:0048240; GO:0051792; GO:0051793; GO:0097524; GO:0120516,acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of smooth muscle cell migration [GO:0014912]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; smooth muscle cell migration [GO:0014909]; sperm capacitation [GO:0048240]; steroid hormone receptor signaling pathway [GO:0043401],acrosomal vesicle [GO:0001669]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524],acetylesterase activity [GO:0008126]; diacylglycerol lipase activity [GO:0120516]; hormone binding [GO:0042562]; monoacylglycerol lipase activity [GO:0047372]; nuclear steroid receptor activity [GO:0003707]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005886; GO:0005929; GO:0006629; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0048870; GO:0060089; GO:0140110,catalytic activity; plasma membrane; cilium; lipid metabolic process; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; cell motility; molecular transducer activity; transcription regulator activity
OG_00694,FUN_002404-T1,Peve_00034027,Pocillopora_meandrina_HIv1___RNAseq.g14812.t1,three_way,68.69066666666666,FUN_002404-T1,G5E8P0,,,,,33.2,1574.0,2.5e-156,555.1,sp|G5E8P0|GCP6_MOUSE Gamma-tubulin complex component 6 OS=Mus musculus OX=10090 GN=Tubgcp6 PE=1 SV=1,,,,,,
OG_00695,FUN_002406-T1,Peve_00034029,Pocillopora_meandrina_HIv1___RNAseq.g14842.t1,three_way,82.38833333333334,FUN_002406-T1,Q86TL2,STIMA_HUMAN,,Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (Transmembrane protein 110),Homo sapiens (Human),50.2,259.0,2.8000000000000002e-59,230.3,sp|Q86TL2|STIMA_HUMAN Store-operated calcium entry regulator STIMATE OS=Homo sapiens OX=9606 GN=STIMATE PE=1 SV=1,GO:0002115; GO:0005246; GO:0005789; GO:0016020; GO:0032237; GO:0032541; GO:0140268,activation of store-operated calcium channel activity [GO:0032237]; store-operated calcium entry [GO:0002115],cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020],calcium channel regulator activity [GO:0005246],GO:0098772,molecular function regulator activity
OG_00696,FUN_002425-T1,Peve_00034031,Pocillopora_meandrina_HIv1___RNAseq.g14843.t1,three_way,39.469,,,,,,,,,,,,,,,,,
OG_00697,FUN_002426-T1,Peve_00034032,Pocillopora_meandrina_HIv1___RNAseq.g14845.t1,three_way,40.11133333333333,,,,,,,,,,,,,,,,,
OG_00698,FUN_002428-T1,Peve_00034033,Pocillopora_meandrina_HIv1___RNAseq.g14846.t1,three_way,88.449,,,,,,,,,,,,,,,,,
OG_00699,FUN_002429-T1,Peve_00034034,Pocillopora_meandrina_HIv1___RNAseq.g14851.t1,three_way,83.17716666666666,FUN_002429-T1,P09215,KPCD_RAT,,Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],Rattus norvegicus (Rat),51.9,696.0,1.1e-207,724.5,sp|P09215|KPCD_RAT Protein kinase C delta type OS=Rattus norvegicus OX=10116 GN=Prkcd PE=1 SV=1,GO:0001666; GO:0004672; GO:0004674; GO:0004697; GO:0004699; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0005911; GO:0006915; GO:0006974; GO:0006979; GO:0008047; GO:0008270; GO:0009410; GO:0009612; GO:0009749; GO:0016020; GO:0016064; GO:0016363; GO:0018105; GO:0019899; GO:0019901; GO:0023021; GO:0030837; GO:0032869; GO:0032930; GO:0032956; GO:0032963; GO:0034351; GO:0034599; GO:0034644; GO:0035556; GO:0036019; GO:0042100; GO:0042119; GO:0042149; GO:0042307; GO:0042325; GO:0042542; GO:0042742; GO:0043065; GO:0043200; GO:0043409; GO:0043410; GO:0043560; GO:0043687; GO:0045471; GO:0046326; GO:0046627; GO:0048471; GO:0050728; GO:0051490; GO:0060326; GO:0070301; GO:0070779; GO:0070976; GO:0071447; GO:0090331; GO:0090398; GO:0099524; GO:0106310; GO:0120283; GO:1904385; GO:1904627; GO:2000303; GO:2000304; GO:2000753; GO:2000755; GO:2001235,apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cellular response to angiotensin [GO:1904385]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular response to insulin stimulus [GO:0032869]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular senescence [GO:0090398]; collagen metabolic process [GO:0032963]; D-aspartate import across plasma membrane [GO:0070779]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; immunoglobulin mediated immune response [GO:0016064]; intracellular signal transduction [GO:0035556]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of platelet aggregation [GO:0090331]; neutrophil activation [GO:0042119]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of D-glucose import [GO:0046326]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; post-translational protein modification [GO:0043687]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of ceramide biosynthetic process [GO:2000303]; regulation of phosphorylation [GO:0042325]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to oxidative stress [GO:0006979]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to xenobiotic stimulus [GO:0009410]; termination of signal transduction [GO:0023021],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome [GO:0036019]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic cytosol [GO:0099524],"ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; protein tyrosine kinase activity [GO:0004713]; TIR domain binding [GO:0070976]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0005886; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048870; GO:0055085; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; plasma membrane; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; cell motility; transmembrane transport; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00700,FUN_002432-T1,Peve_00034035,Pocillopora_meandrina_HIv1___RNAseq.g14853.t1,three_way,70.14033333333333,FUN_002432-T1,A4IIM3,SIN1_XENTR,,Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),41.0,525.0,2.2e-99,364.4,sp|A4IIM3|SIN1_XENTR Target of rapamycin complex 2 subunit MAPKAP1 OS=Xenopus tropicalis OX=8364 GN=mapkap1 PE=2 SV=1,GO:0000139; GO:0005547; GO:0005634; GO:0005741; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0005886; GO:0031901; GO:0031902; GO:0031932; GO:0038203; GO:0048471; GO:0140767,TORC2 signaling [GO:0038203],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; TORC2 complex [GO:0031932],"enzyme-substrate adaptor activity [GO:0140767]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]",GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005886; GO:0008289; GO:0031410; GO:0043226; GO:0060090,nucleus; lysosome; endosome; vacuole; endoplasmic reticulum; plasma membrane; lipid binding; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_00701,FUN_002451-T1,Peve_00043794,Pocillopora_meandrina_HIv1___RNAseq.g14889.t1,three_way,85.959,FUN_002451-T1,P47897,SYQ_HUMAN,,Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS),Homo sapiens (Human),62.5,778.0,1.2e-290,1000.3,sp|P47897|SYQ_HUMAN Glutamine--tRNA ligase OS=Homo sapiens OX=9606 GN=QARS1 PE=1 SV=1,GO:0004819; GO:0004860; GO:0005524; GO:0005737; GO:0005759; GO:0005829; GO:0006418; GO:0006425; GO:0007420; GO:0017101; GO:0019901; GO:0032873; GO:0032991; GO:0045892; GO:2001234,brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stress-activated MAPK cascade [GO:0032873]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860],GO:0003824; GO:0005829; GO:0006355; GO:0006399; GO:0006520; GO:0016874; GO:0048856; GO:0098772; GO:0140098,"catalytic activity; cytosol; regulation of DNA-templated transcription; tRNA metabolic process; amino acid metabolic process; ligase activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on RNA"
OG_00702,FUN_002452-T1,Peve_00043792,Pocillopora_meandrina_HIv1___RNAseq.g14890.t1,three_way,76.96466666666667,FUN_002452-T1,B9EJX3,,,,,37.0,154.0,4.3e-13,76.3,sp|B9EJX3|SMIP1_MOUSE Protein SPMIP1 OS=Mus musculus OX=10090 GN=Spmip1 PE=2 SV=1,,,,,,
OG_00703,FUN_002453-T1,Peve_00023668,Pocillopora_meandrina_HIv1___RNAseq.g14891.t1,three_way,78.35433333333334,,,,,,,,,,,,,,,,,
OG_00704,FUN_002454-T2,Peve_00023669,Pocillopora_meandrina_HIv1___RNAseq.g14892.t1,three_way,71.75366666666666,FUN_002454-T2,Q9N0P9,,,,,51.2,254.0,6.2e-71,269.6,sp|Q9N0P9|PIM1_BOVIN Serine/threonine-protein kinase pim-1 OS=Bos taurus OX=9913 GN=PIM1 PE=2 SV=1,,,,,,
OG_00705,FUN_002455-T1,Peve_00034009,Pocillopora_meandrina_HIv1___TS.g4040.t1,three_way,71.398,,,,,,,,,,,,,,,,,
OG_00706,FUN_002463-T1,Peve_00034010,Pocillopora_meandrina_HIv1___RNAseq.g14902.t1,three_way,92.76133333333334,FUN_002463-T1,P55861,,,,,73.9,789.0,7.3e-312,1070.8,sp|P55861|MCM2_XENLA DNA replication licensing factor mcm2 OS=Xenopus laevis OX=8355 GN=mcm2 PE=1 SV=2,,,,,,
OG_00707,FUN_002468-T1,Peve_00034015,Pocillopora_meandrina_HIv1___RNAseq.g14904.t1,three_way,48.50066666666667,,,,,,,,,,,,,,,,,
OG_00708,FUN_002469-T1,Peve_00034012,Pocillopora_meandrina_HIv1___TS.g4051.t1,three_way,74.81733333333334,FUN_002469-T1,Q7TMY8,HUWE1_MOUSE,,"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (E3Histone) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",Mus musculus (Mouse),41.0,4757.0,0.0,2664.4,sp|Q7TMY8|HUWE1_MOUSE E3 ubiquitin-protein ligase HUWE1 OS=Mus musculus OX=10090 GN=Huwe1 PE=1 SV=5,GO:0000209; GO:0003677; GO:0004842; GO:0005634; GO:0005737; GO:0005739; GO:0006284; GO:0006513; GO:0030154; GO:0031398; GO:0032922; GO:0035359; GO:0043123; GO:0043161; GO:0061630; GO:0070936; GO:0140852; GO:0141198,base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; circadian regulation of gene expression [GO:0032922]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone ubiquitin ligase activity [GO:0140852]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; transferase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_00709,FUN_002473-T1,Peve_00033998,Pocillopora_meandrina_HIv1___RNAseq.g14856.t1,three_way,72.90066666666667,FUN_002473-T1,Q3SZH7,LKHA4_BOVIN,,Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4),Bos taurus (Bovine),52.6,578.0,8.8e-180,631.7,sp|Q3SZH7|LKHA4_BOVIN Leukotriene A-4 hydrolase OS=Bos taurus OX=9913 GN=LTA4H PE=2 SV=3,GO:0004177; GO:0004301; GO:0004463; GO:0005634; GO:0005829; GO:0006508; GO:0008237; GO:0008270; GO:0019370; GO:0043171; GO:0045148,leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],cytosol [GO:0005829]; nucleus [GO:0005634],aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metallopeptidase activity [GO:0008237]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00710,FUN_002577-T1,Peve_00025545,Pocillopora_meandrina_HIv1___RNAseq.g25716.t1,three_way,77.45466666666667,FUN_002577-T1,Q6NU27,,,,,52.6,196.0,2.5000000000000002e-58,226.9,sp|Q6NU27|I4E3B_XENLA Eukaryotic translation initiation factor 4E type 3-B OS=Xenopus laevis OX=8355 GN=eif4e3-b PE=2 SV=1,,,,,,
OG_00711,FUN_002578-T1,Peve_00011540,Pocillopora_meandrina_HIv1___RNAseq.g25721.t1,three_way,67.49366666666667,FUN_002578-T1,Q9JMA7,,,,,37.9,496.0,6.6e-88,326.2,sp|Q9JMA7|CP341_MOUSE Cytochrome P450 3A41 OS=Mus musculus OX=10090 GN=Cyp3a41a PE=1 SV=2,,,,,,
OG_00712,FUN_002580-T1,Peve_00025541,Pocillopora_meandrina_HIv1___TS.g9163.t1,three_way,57.59933333333333,FUN_002580-T1,Q6AZD4,,,,,48.1,160.0,1.2e-45,186.4,sp|Q6AZD4|IMP2L_DANRE Mitochondrial inner membrane protease subunit 2 OS=Danio rerio OX=7955 GN=immp2l PE=2 SV=1,,,,,,
OG_00713,FUN_002581-T1,Peve_00002776,Pocillopora_meandrina_HIv1___RNAseq.g25723.t1,three_way,84.074,FUN_002581-T1,Q6C7A6,NBP35_YARLI,,Cytosolic Fe-S cluster assembly factor NBP35 (Nucleotide-binding protein 35),Yarrowia lipolytica (strain CLIB 122 / E 150) (Yeast) (Candida lipolytica),51.3,298.0,1.8e-85,317.4,sp|Q6C7A6|NBP35_YARLI Cytosolic Fe-S cluster assembly factor NBP35 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) OX=284591 GN=NBP35 PE=3 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539; GO:0140663,iron-sulfur cluster assembly [GO:0016226],cytosol [GO:0005829]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]",GO:0005634; GO:0005829; GO:0043226; GO:0140104; GO:0140657,nucleus; cytosol; organelle; molecular carrier activity; ATP-dependent activity
OG_00714,FUN_002582-T1,Peve_00002778,Pocillopora_meandrina_HIv1___RNAseq.g25727.t1,three_way,60.239666666666665,,,,,,,,,,,,,,,,,
OG_00715,FUN_002583-T1,Peve_00002780,Pocillopora_meandrina_HIv1___RNAseq.g12794.t1,three_way,45.603,,,,,,,,,,,,,,,,,
OG_00716,FUN_002647-T1,Peve_00040086,Pocillopora_meandrina_HIv1___RNAseq.g25712.t1a,three_way,55.442,FUN_002647-T1,Q91ZW8,,,,,36.7,120.0,5.1e-14,79.3,sp|Q91ZW8|C209D_MOUSE CD209 antigen-like protein D OS=Mus musculus OX=10090 GN=Cd209d PE=2 SV=1,,,,,,
OG_00717,FUN_002649-T1,Peve_00040095,Pocillopora_meandrina_HIv1___RNAseq.g25705.t1,three_way,67.51933333333334,,,,,,,,,,,,,,,,,
OG_00718,FUN_002650-T1,Peve_00040096,Pocillopora_meandrina_HIv1___RNAseq.g25706.t1,three_way,65.42783333333333,FUN_002650-T1,Q8K2I9,FBH1_MOUSE,,F-box DNA helicase 1 (EC 5.6.2.4) (DNA 3'-5' helicase 1) (F-box only protein 18),Mus musculus (Mouse),38.3,757.0,1.4000000000000002e-124,449.5,sp|Q8K2I9|FBH1_MOUSE F-box DNA helicase 1 OS=Mus musculus OX=10090 GN=Fbh1 PE=1 SV=1,GO:0000724; GO:0000785; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0006308; GO:0006974; GO:0015616; GO:0016567; GO:0016887; GO:0019005; GO:0031297; GO:0043138; GO:0072429; GO:1902231; GO:2000042,DNA catabolic process [GO:0006308]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; protein ubiquitination [GO:0016567]; replication fork processing [GO:0031297]; response to intra-S DNA damage checkpoint signaling [GO:0072429],chromatin [GO:0000785]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA translocase activity [GO:0015616]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_00719,FUN_002654-T1,Peve_00040098,Pocillopora_meandrina_HIv1___TS.g156.t1,three_way,48.64333333333333,FUN_002654-T1,Q9NQU5,PAK6_HUMAN,,Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6),Homo sapiens (Human),58.8,34.0,6.2e-06,53.1,sp|Q9NQU5|PAK6_HUMAN Serine/threonine-protein kinase PAK 6 OS=Homo sapiens OX=9606 GN=PAK6 PE=1 SV=1,GO:0001650; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006915; GO:0007010; GO:0007612; GO:0007613; GO:0007626; GO:0009267; GO:0014069; GO:0030054; GO:0035556; GO:0043408; GO:0045296; GO:0106310; GO:0140058; GO:1990138,apoptotic process [GO:0006915]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613]; neuron projection arborization [GO:0140058]; neuron projection extension [GO:1990138]; regulation of DNA-templated transcription [GO:0006355]; regulation of MAPK cascade [GO:0043408],cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; cadherin binding [GO:0045296]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0007010; GO:0012501; GO:0016740; GO:0043226; GO:0050877; GO:0140096,"catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; transferase activity; organelle; nervous system process; catalytic activity, acting on a protein"
OG_00720,FUN_002660-T3,Peve_00011551,Pocillopora_meandrina_HIv1___TS.g4023.t2,three_way,77.11,,,,,,,,,,,,,,,,,
OG_00721,FUN_002661-T1,Peve_00043790,Pocillopora_meandrina_HIv1___RNAseq.g14882.t1a,three_way,78.43133333333333,FUN_002661-T1,Q00709,,,,,40.5,116.0,4.1e-20,99.8,sp|Q00709|BCL2_CHICK Apoptosis regulator Bcl-2 OS=Gallus gallus OX=9031 GN=BCL2 PE=2 SV=1,,,,,,
OG_00722,FUN_002666-T1,Peve_00025542,Pocillopora_meandrina_HIv1___RNAseq.g20659.t1,three_way,55.13616666666667,FUN_002666-T1,A8MY62,,,,,30.6,494.0,1.8e-54,215.3,sp|A8MY62|BLML_HUMAN Putative beta-lactamase-like 1 OS=Homo sapiens OX=9606 GN=LACTBL1 PE=1 SV=2,,,,,,
OG_00723,FUN_002667-T1,Peve_00005211,Pocillopora_meandrina_HIv1___TS.g27716.t1,three_way,60.518,FUN_002667-T1,Q60854,,,,,42.2,379.0,7.6e-73,275.8,sp|Q60854|SPB6_MOUSE Serpin B6 OS=Mus musculus OX=10090 GN=Serpinb6 PE=1 SV=1,,,,,,
OG_00724,FUN_002669-T1,Peve_00019954,Pocillopora_meandrina_HIv1___RNAseq.g20691.t1,three_way,60.89933333333333,FUN_002669-T1,Q5XGL1,,,,,29.7,263.0,5.6e-26,119.8,sp|Q5XGL1|CENPK_XENLA Centromere protein K OS=Xenopus laevis OX=8355 GN=cenpk PE=2 SV=2,,,,,,
OG_00725,FUN_002670-T1,Peve_00005202,Pocillopora_meandrina_HIv1___TS.g27719.t1,three_way,57.01833333333333,FUN_002670-T1,Q2KJ34,,,,,30.4,184.0,6.3e-13,76.6,sp|Q2KJ34|HBP1_BOVIN HMG box-containing protein 1 OS=Bos taurus OX=9913 GN=HBP1 PE=2 SV=1,,,,,,
OG_00726,FUN_002678-T1,Peve_00007261,Pocillopora_meandrina_HIv1___RNAseq.g20695.t1,three_way,59.48833333333333,FUN_002678-T1,O60462,NRP2_HUMAN,,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),Homo sapiens (Human),34.8,158.0,1.1e-17,92.4,sp|O60462|NRP2_HUMAN Neuropilin-2 OS=Homo sapiens OX=9606 GN=NRP2 PE=1 SV=3,GO:0001525; GO:0001938; GO:0002116; GO:0003148; GO:0005021; GO:0005576; GO:0005886; GO:0007155; GO:0007411; GO:0008201; GO:0010595; GO:0016020; GO:0017154; GO:0019838; GO:0019955; GO:0021612; GO:0021637; GO:0021649; GO:0021675; GO:0021785; GO:0021828; GO:0030424; GO:0036486; GO:0038023; GO:0042802; GO:0045211; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0071526; GO:0097374; GO:0097490; GO:0097491; GO:0098978; GO:0099175; GO:1901166; GO:1903375; GO:1904835; GO:1990830,angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116],cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0003824; GO:0005576; GO:0005886; GO:0007155; GO:0016740; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; extracellular region; plasma membrane; cell adhesion; transferase activity; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_00727,FUN_002690-T1,Peve_00009951,Pocillopora_meandrina_HIv1___RNAseq.g20729.t1,three_way,49.989,FUN_002690-T1,Q3ZBG4,HES1_BOVIN,,Transcription factor HES-1 (Hairy and enhancer of split 1),Bos taurus (Bovine),59.4,64.0,4.6e-11,69.7,sp|Q3ZBG4|HES1_BOVIN Transcription factor HES-1 OS=Bos taurus OX=9913 GN=HES1 PE=2 SV=1,GO:0000122; GO:0001227; GO:0005634; GO:0007219; GO:0021861; GO:0042531; GO:0042803; GO:0043388; GO:0043565; GO:0045665; GO:0045892; GO:0046425; GO:0046427; GO:0048711; GO:0048715; GO:0050767; GO:0060253; GO:0065003; GO:0070888; GO:0071820; GO:2000974; GO:2000978,forebrain radial glial cell differentiation [GO:0021861]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of DNA binding [GO:0043388]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein-containing complex assembly [GO:0065003]; regulation of neurogenesis [GO:0050767]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425],nucleus [GO:0005634],"DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; N-box binding [GO:0071820]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0065003; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; protein-containing complex assembly; transcription regulator activity
OG_00728,FUN_002692-T1,Peve_00009945,Pocillopora_meandrina_HIv1___RNAseq.28787_t,three_way,69.85,FUN_002692-T1,Q90VV1,HES4B_XENLA,,Transcription factor HES-4-B (Hairy and enhancer of split 4-B) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2b),Xenopus laevis (African clawed frog),36.8,247.0,1.6000000000000002e-23,111.3,sp|Q90VV1|HES4B_XENLA Transcription factor HES-4-B OS=Xenopus laevis OX=8355 GN=hes4-b PE=1 SV=1,GO:0000122; GO:0000978; GO:0002088; GO:0005634; GO:0007219; GO:0007517; GO:0014029; GO:0021501; GO:0033504; GO:0043066; GO:0043565; GO:0045892; GO:0046982; GO:0048642; GO:0050767,floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; prechordal plate formation [GO:0021501]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development
OG_00729,FUN_002695-T1,Peve_00009946,Pocillopora_meandrina_HIv1___RNAseq.g20725.t1,three_way,61.78816666666667,FUN_002695-T1,Q90VV1,HES4B_XENLA,,Transcription factor HES-4-B (Hairy and enhancer of split 4-B) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2b),Xenopus laevis (African clawed frog),37.6,194.0,7.2e-20,99.0,sp|Q90VV1|HES4B_XENLA Transcription factor HES-4-B OS=Xenopus laevis OX=8355 GN=hes4-b PE=1 SV=1,GO:0000122; GO:0000978; GO:0002088; GO:0005634; GO:0007219; GO:0007517; GO:0014029; GO:0021501; GO:0033504; GO:0043066; GO:0043565; GO:0045892; GO:0046982; GO:0048642; GO:0050767,floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; Notch signaling pathway [GO:0007219]; prechordal plate formation [GO:0021501]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development
OG_00730,FUN_002696-T1,Peve_00009947,Pocillopora_meandrina_HIv1___RNAseq.g20723.t1,three_way,84.3565,FUN_002696-T1,Q9UP83,COG5_HUMAN,,Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (13S Golgi transport complex 90 kDa subunit) (GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1),Homo sapiens (Human),55.5,804.0,8.6e-244,844.7,sp|Q9UP83|COG5_HUMAN Conserved oligomeric Golgi complex subunit 5 OS=Homo sapiens OX=9606 GN=COG5 PE=1 SV=4,GO:0000139; GO:0000301; GO:0005654; GO:0005794; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0048219; GO:0070085,"glycosylation [GO:0070085]; Golgi organization [GO:0007030]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588],,GO:0005654; GO:0005794; GO:0005829; GO:0016192; GO:0043226,nucleoplasm; Golgi apparatus; cytosol; vesicle-mediated transport; organelle
OG_00731,FUN_002697-T1,Peve_00034498,Pocillopora_meandrina_HIv1___RNAseq.g20722.t1,three_way,78.81233333333333,FUN_002697-T1,C1C4R8,DHRS6_AQUCT,,Dehydrogenase/reductase SDR family member 6 (EC 1.1.1.-) ((R)-beta-hydroxybutyrate dehydrogenase) (3-hydroxybutyrate dehydrogenase type 2) (EC 1.1.1.30) (4-oxo-L-proline reductase) (EC 1.1.1.104) (Oxidoreductase UCPA) (Short chain dehydrogenase/reductase family 15C member 1),Aquarana catesbeiana (American bullfrog) (Rana catesbeiana),63.9,244.0,5.9e-83,308.9,sp|C1C4R8|DHRS6_AQUCT Dehydrogenase/reductase SDR family member 6 OS=Aquarana catesbeiana OX=8400 GN=bdh2 PE=2 SV=1,GO:0003858; GO:0005737; GO:0006629; GO:0016617; GO:0016628; GO:0019290; GO:0042168,heme metabolic process [GO:0042168]; lipid metabolic process [GO:0006629]; siderophore biosynthetic process [GO:0019290],cytoplasm [GO:0005737],"3-hydroxybutyrate dehydrogenase activity [GO:0003858]; 4-oxoproline reductase activity [GO:0016617]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_00732,FUN_002698-T1,Peve_00034497,Pocillopora_meandrina_HIv1___RNAseq.g20728.t1,three_way,72.25633333333333,FUN_002698-T1,Q6IRB2,HES1A_XENLA,,Transcription factor HES-1-A (Hairy and enhancer of split 1-A) (Protein hairy-1) (Xhairy-1) (Xhairy1) (Xlh1),Xenopus laevis (African clawed frog),39.2,245.0,2.4e-26,120.6,sp|Q6IRB2|HES1A_XENLA Transcription factor HES-1-A OS=Xenopus laevis OX=8355 GN=hes1-a PE=1 SV=1,GO:0000122; GO:0000978; GO:0005634; GO:0007219; GO:0043425; GO:0043565; GO:0045665; GO:0045892; GO:0046982; GO:0048635; GO:0050767,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],bHLH transcription factor binding [GO:0043425]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_00733,FUN_002700-T1,Peve_00043786,Pocillopora_meandrina_HIv1___RNAseq.g14882.t1c,three_way,78.37583333333333,FUN_002700-T1,Q96SK2,,,,,32.7,510.0,9.1e-70,266.2,sp|Q96SK2|TM209_HUMAN Transmembrane protein 209 OS=Homo sapiens OX=9606 GN=TMEM209 PE=1 SV=2,,,,,,
OG_00734,FUN_002714-T1,Peve_00027875,Pocillopora_meandrina_HIv1___TS.g27685.t1,three_way,53.21833333333333,,,,,,,,,,,,,,,,,
OG_00735,FUN_002716-T1,Peve_00027493,Pocillopora_meandrina_HIv1___RNAseq.g20658.t1,three_way,59.64266666666666,,,,,,,,,,,,,,,,,
OG_00736,FUN_002718-T1,Peve_00025049,Pocillopora_meandrina_HIv1___RNAseq.g20657.t1,three_way,73.45766666666667,FUN_002718-T1,Q66H43,,,,,48.1,104.0,2.7999999999999998e-24,113.6,sp|Q66H43|BORC6_RAT BLOC-1-related complex subunit 6 OS=Rattus norvegicus OX=10116 GN=Borcs6 PE=2 SV=2,,,,,,
OG_00737,FUN_002719-T1,Peve_00025047,Pocillopora_meandrina_HIv1___RNAseq.g14939.t2,three_way,87.38666666666667,FUN_002719-T1,Q8IWF6,,,,,56.7,557.0,5.699999999999999e-181,635.6,sp|Q8IWF6|DEN6A_HUMAN Protein DENND6A OS=Homo sapiens OX=9606 GN=DENND6A PE=1 SV=1,,,,,,
OG_00738,FUN_002720-T1,Peve_00025045,Pocillopora_meandrina_HIv1___RNAseq.g14938.t1,three_way,56.15233333333333,,,,,,,,,,,,,,,,,
OG_00739,FUN_002721-T1,Peve_00025046,Pocillopora_meandrina_HIv1___RNAseq.g14941.t1,three_way,84.38783333333333,,,,,,,,,,,,,,,,,
OG_00740,FUN_002722-T1,Peve_00025044,Pocillopora_meandrina_HIv1___RNAseq.g14942.t1,three_way,92.84816666666669,FUN_002722-T1,Q16656,NRF1_HUMAN,,Nuclear respiratory factor 1 (NRF-1) (Alpha palindromic-binding protein) (Alpha-pal),Homo sapiens (Human),69.2,299.0,5.400000000000002e-110,399.4,sp|Q16656|NRF1_HUMAN Nuclear respiratory factor 1 OS=Homo sapiens OX=9606 GN=NRF1 PE=1 SV=1,GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0042803; GO:0045944; GO:0070062,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_00741,FUN_002723-T1,Peve_00025040,Pocillopora_meandrina_HIv1___RNAseq.g14943.t1,three_way,95.002,FUN_002723-T1,Q96HN2,SAHH3_HUMAN,,Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.13.2.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2),Homo sapiens (Human),79.1,470.0,2.7e-219,762.7,sp|Q96HN2|SAHH3_HUMAN Adenosylhomocysteinase 3 OS=Homo sapiens OX=9606 GN=AHCYL2 PE=1 SV=1,GO:0005783; GO:0005829; GO:0006730; GO:0016787; GO:0033353; GO:0043005,one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005],hydrolase activity [GO:0016787],GO:0003824; GO:0005783; GO:0005829; GO:0006790; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; cytosol; sulfur compound metabolic process; hydrolase activity; organelle
OG_00742,FUN_002724-T1,Peve_00025037,Pocillopora_meandrina_HIv1___RNAseq.g14944.t1a,three_way,71.285,,,,,,,,,,,,,,,,,
OG_00743,FUN_002725-T1,Peve_00025036,Pocillopora_meandrina_HIv1___TS.g9334.t1,three_way,68.36066666666667,,,,,,,,,,,,,,,,,
OG_00744,FUN_002726-T1,Peve_00025035,Pocillopora_meandrina_HIv1___RNAseq.g14946.t1,three_way,66.20533333333333,FUN_002726-T1,Q13286,,,,,25.6,356.0,1.6e-13,79.0,sp|Q13286|CLN3_HUMAN Battenin OS=Homo sapiens OX=9606 GN=CLN3 PE=1 SV=1,,,,,,
OG_00745,FUN_002730-T1,Peve_00019122,Pocillopora_meandrina_HIv1___RNAseq.g20653.t1,three_way,42.13933333333333,,,,,,,,,,,,,,,,,
OG_00746,FUN_002736-T1,Peve_00041437,Pocillopora_meandrina_HIv1___RNAseq.g14951.t1,three_way,65.202,FUN_002736-T1,Q9BXT6,M10L1_HUMAN,,RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1),Homo sapiens (Human),39.3,1153.0,1.4e-221,771.5,sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196,germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; cytosol; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_00747,FUN_002767-T1,Peve_00005055,Pocillopora_meandrina_HIv1___RNAseq.g14961.t1,three_way,87.17333333333333,FUN_002767-T1,P18708,,,,,57.5,736.0,3.7e-241,835.9,sp|P18708|NSF_CRIGR Vesicle-fusing ATPase OS=Cricetulus griseus OX=10029 GN=NSF PE=1 SV=1,,,,,,
OG_00748,FUN_002805-T1,Peve_00018547,Pocillopora_meandrina_HIv1___RNAseq.g14957.t1,three_way,49.68866666666666,FUN_002805-T1,Q5SY16,NOL9_HUMAN,,Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.78) (Nucleolar protein 9),Homo sapiens (Human),31.2,592.0,2.6e-70,268.5,sp|Q5SY16|NOL9_HUMAN Polynucleotide 5'-hydroxyl-kinase NOL9 OS=Homo sapiens OX=9606 GN=NOL9 PE=1 SV=1,GO:0000448; GO:0000460; GO:0003723; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0016020; GO:0045111; GO:0046404; GO:0051731; GO:0051736,"cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460]",intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005856; GO:0016740; GO:0043226,RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytoskeleton; transferase activity; organelle
OG_00749,FUN_002806-T2,Peve_00044239,Pocillopora_meandrina_HIv1___RNAseq.g14970.t1b,three_way,71.58233333333334,,,,,,,,,,,,,,,,,
OG_00750,FUN_002807-T1,Peve_00044270,Pocillopora_meandrina_HIv1___RNAseq.g14969.t1,three_way,74.78366666666668,FUN_002807-T1,Q8BX57,PXK_MOUSE,,"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)",Mus musculus (Mouse),47.6,435.0,3.4e-114,413.7,sp|Q8BX57|PXK_MOUSE PX domain-containing protein kinase-like protein OS=Mus musculus OX=10090 GN=Pxk PE=1 SV=2,GO:0003779; GO:0004672; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0032780; GO:0032991; GO:0034451; GO:0035091; GO:0043271; GO:0050804,inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of monoatomic ion transport [GO:0043271],centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein kinase activity [GO:0004672],GO:0003824; GO:0005829; GO:0005886; GO:0006954; GO:0008092; GO:0008289; GO:0016740; GO:0140096,"catalytic activity; cytosol; plasma membrane; inflammatory response; cytoskeletal protein binding; lipid binding; transferase activity; catalytic activity, acting on a protein"
OG_00751,FUN_002808-T1,Peve_00044269,Pocillopora_meandrina_HIv1___RNAseq.g14968.t1,three_way,67.566,FUN_002808-T1,Q9UNF1,MAGD2_HUMAN,,Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen),Homo sapiens (Human),35.8,201.0,2.1e-32,141.0,sp|Q9UNF1|MAGD2_HUMAN Melanoma-associated antigen D2 OS=Homo sapiens OX=9606 GN=MAGED2 PE=1 SV=2,GO:0000122; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0007565; GO:0016020; GO:0031093; GO:0070294,female pregnancy [GO:0007565]; negative regulation of transcription by RNA polymerase II [GO:0000122]; renal sodium ion absorption [GO:0070294],cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093],,GO:0003014; GO:0005576; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0022414; GO:0043226,renal system process; extracellular region; nucleus; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle
OG_00752,FUN_002810-T1,Peve_00044262,Pocillopora_meandrina_HIv1___RNAseq.g14965.t1,three_way,65.89033333333333,FUN_002810-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),31.8,2393.0,1e-280,969.5,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_00753,FUN_002811-T1,Peve_00025579,Pocillopora_meandrina_HIv1___RNAseq.g14963.t1,three_way,63.69916666666666,FUN_002811-T1,Q6DDT4,APEX2_XENLA,,DNA-(apurinic or apyrimidinic site) endonuclease 2 (EC 3.1.11.2),Xenopus laevis (African clawed frog),48.5,546.0,1.8e-136,487.6,sp|Q6DDT4|APEX2_XENLA DNA-(apurinic or apyrimidinic site) endonuclease 2 OS=Xenopus laevis OX=8355 GN=apex2.L PE=1 SV=1,GO:0003677; GO:0003906; GO:0004519; GO:0005634; GO:0005694; GO:0005739; GO:0006284; GO:0008081; GO:0008270; GO:0008311,base-excision repair [GO:0006284],chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634],DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0005739; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; chromosome; mitochondrion; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_00754,FUN_002813-T1,Peve_00044244,Pocillopora_meandrina_HIv1___RNAseq.g14958.t1,three_way,72.313,FUN_002813-T1,C4A0D9,BAP1_BRAFL,,Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1),Branchiostoma floridae (Florida lancelet) (Amphioxus),39.8,694.0,2.9999999999999997e-97,357.5,sp|C4A0D9|BAP1_BRAFL Ubiquitin carboxyl-terminal hydrolase BAP1 OS=Branchiostoma floridae OX=7739 GN=BAP1 PE=3 SV=1,GO:0001558; GO:0003682; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0016579; GO:0031507; GO:0035517; GO:0045892; GO:0051726; GO:0071108,heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; PR-DUB complex [GO:0035517],chromatin binding [GO:0003682]; cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0006325; GO:0006355; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00755,FUN_002814-T1,Peve_00004587,Pocillopora_meandrina_HIv1___TS.g9362.t1,three_way,66.345,FUN_002814-T1,Q9EQD2,NPFF2_RAT,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor),Rattus norvegicus (Rat),29.3,307.0,3e-32,141.0,sp|Q9EQD2|NPFF2_RAT Neuropeptide FF receptor 2 OS=Rattus norvegicus OX=10116 GN=Npffr2 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_00756,FUN_002871-T1,Peve_00013073,Pocillopora_meandrina_HIv1___TS.g15581.t1,three_way,81.83266666666667,FUN_002871-T1,Q21086,GNL3_CAEEL,,Guanine nucleotide-binding protein-like 3 homolog (Nucleostemin-1),Caenorhabditis elegans,46.8,457.0,2.7e-109,397.5,sp|Q21086|GNL3_CAEEL Guanine nucleotide-binding protein-like 3 homolog OS=Caenorhabditis elegans OX=6239 GN=nst-1 PE=3 SV=1,GO:0002119; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0007281; GO:0040014; GO:0042127,germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell population proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0022414; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; reproductive process; organelle; anatomical structure development
OG_00757,FUN_003163-T1,Peve_00013072,Pocillopora_meandrina_HIv1___RNAseq.g6226.t1,three_way,84.06066666666666,FUN_003163-T1,P54996,,,,,66.8,479.0,3.9e-200,699.1,sp|P54996|G6PD_TAKRU Glucose-6-phosphate 1-dehydrogenase OS=Takifugu rubripes OX=31033 GN=g6pd PE=3 SV=1,,,,,,
OG_00758,FUN_003164-T1,Peve_00019151,Pocillopora_meandrina_HIv1___RNAseq.g6225.t1,three_way,73.69,,,,,,,,,,,,,,,,,
OG_00759,FUN_003165-T1,Peve_00013725,Pocillopora_meandrina_HIv1___RNAseq.g6224.t1,three_way,89.89566666666667,FUN_003165-T1,Q5U4C9,DYRK2_MOUSE,,Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1),Mus musculus (Mouse),67.4,556.0,1.1e-208,727.6,sp|Q5U4C9|DYRK2_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 2 OS=Mus musculus OX=10090 GN=Dyrk2 PE=2 SV=1,GO:0000151; GO:0000287; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0007224; GO:0030145; GO:0042771; GO:0045725; GO:0070885; GO:0106310; GO:1990904,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; smoothened signaling pathway [GO:0007224],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00760,FUN_003166-T1,Peve_00013723,Pocillopora_meandrina_HIv1___RNAseq.g6223.t1,three_way,65.014,FUN_003166-T1,C0HAC0,FBXL5_SALSA,,F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5),Salmo salar (Atlantic salmon),34.3,759.0,7.2e-78,293.1,sp|C0HAC0|FBXL5_SALSA F-box/LRR-repeat protein 5 OS=Salmo salar OX=8030 GN=fbxl5 PE=2 SV=1,GO:0005506; GO:0005634; GO:0006879; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0051536,intracellular iron ion homeostasis [GO:0006879]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536],GO:0005634; GO:0030163; GO:0043226,nucleus; protein catabolic process; organelle
OG_00761,FUN_003384-T2,Peve_00000967,Pocillopora_meandrina_HIv1___TS.g15574.t2,three_way,69.08866666666667,,,,,,,,,,,,,,,,,
OG_00762,FUN_003388-T1,Peve_00014446,Pocillopora_meandrina_HIv1___TS.g13629.t1,three_way,66.48599999999999,,,,,,,,,,,,,,,,,
OG_00763,FUN_003432-T1,Peve_00013657,Pocillopora_meandrina_HIv1___RNAseq.g22188.t1,three_way,69.05233333333334,FUN_003432-T1,Q9HC36,MRM3_HUMAN,,"rRNA methyltransferase 3, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1)",Homo sapiens (Human),33.2,313.0,7.499999999999998e-41,169.1,"sp|Q9HC36|MRM3_HUMAN rRNA methyltransferase 3, mitochondrial OS=Homo sapiens OX=9606 GN=MRM3 PE=1 SV=2",GO:0000451; GO:0003723; GO:0005739; GO:0005759; GO:0006364; GO:0042802; GO:0070039,rRNA 2'-O-methylation [GO:0000451]; rRNA processing [GO:0006364],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039],GO:0003723; GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on RNA"
OG_00764,FUN_003433-T1,Peve_00010310,Pocillopora_meandrina_HIv1___RNAseq.g9161.t1,three_way,48.00683333333333,,,,,,,,,,,,,,,,,
OG_00765,FUN_003434-T1,Peve_00010306,Pocillopora_meandrina_HIv1___RNAseq.g9162.t1,three_way,49.788,,,,,,,,,,,,,,,,,
OG_00766,FUN_003489-T1,Peve_00020062,Pocillopora_meandrina_HIv1___RNAseq.g24644.t1,three_way,58.79866666666666,,,,,,,,,,,,,,,,,
OG_00767,FUN_003693-T1,Peve_00040660,Pocillopora_meandrina_HIv1___RNAseq.g30052.t1,three_way,45.812,FUN_003693-T1,P06582,,,,,43.8,80.0,2.9e-12,75.1,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_00768,FUN_003711-T1,Peve_00001358,Pocillopora_meandrina_HIv1___RNAseq.g17371.t1,three_way,72.969,FUN_003711-T1,A7SJ66,,,,,65.6,160.0,3.1e-60,232.6,sp|A7SJ66|U587_NEMVE UPF0587 protein v1g245604 OS=Nematostella vectensis OX=45351 GN=v1g245604 PE=3 SV=1,,,,,,
OG_00769,FUN_003713-T1,Peve_00001357,Pocillopora_meandrina_HIv1___RNAseq.g17373.t2,three_way,74.59033333333333,FUN_003713-T1,A7RX69,TIKI1_NEMVE,,Metalloprotease TIKI homolog (EC 3.4.-.-),Nematostella vectensis (Starlet sea anemone),59.5,373.0,5.5e-129,462.6,sp|A7RX69|TIKI1_NEMVE Metalloprotease TIKI homolog OS=Nematostella vectensis OX=45351 GN=v1g27680 PE=2 SV=2,GO:0004222; GO:0006508; GO:0016020; GO:0030178; GO:0046872,negative regulation of Wnt signaling pathway [GO:0030178]; proteolysis [GO:0006508],membrane [GO:0016020],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_00770,FUN_003718-T1,Peve_00001366,Pocillopora_meandrina_HIv1___RNAseq.g26671.t1,three_way,75.134,FUN_003718-T1,P37193,,,,,70.1,134.0,2.9999999999999995e-54,213.0,"sp|P37193|ADXH1_DROME Adrenodoxin-like protein 1, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Fdx1 PE=2 SV=3",,,,,,
OG_00771,FUN_003839-T1,Peve_00042654,Pocillopora_meandrina_HIv1___RNAseq.g11160.t1,three_way,68.94483333333334,FUN_003839-T1,Q9Z254,GIPC1_RAT,,PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin),Rattus norvegicus (Rat),59.0,290.0,3.8e-93,343.2,sp|Q9Z254|GIPC1_RAT PDZ domain-containing protein GIPC1 OS=Rattus norvegicus OX=10116 GN=Gipc1 PE=1 SV=2,GO:0003779; GO:0005102; GO:0005737; GO:0005829; GO:0005903; GO:0005938; GO:0006605; GO:0007268; GO:0008021; GO:0012506; GO:0014047; GO:0016020; GO:0017022; GO:0030139; GO:0030165; GO:0030511; GO:0031410; GO:0031647; GO:0032435; GO:0032467; GO:0042802; GO:0043197; GO:0043198; GO:0043542; GO:0048023; GO:0048167; GO:0098685; GO:0098761; GO:0098793; GO:0098794; GO:0098978; GO:0099171,cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167],brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506],actin binding [GO:0003779]; identical protein binding [GO:0042802]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102],GO:0005829; GO:0008092; GO:0023052; GO:0031410; GO:0043226; GO:0048870,cytosol; cytoskeletal protein binding; signaling; cytoplasmic vesicle; organelle; cell motility
OG_00772,FUN_003840-T1,Peve_00003890,Pocillopora_meandrina_HIv1___RNAseq.g11708.t1,three_way,63.461333333333336,FUN_003840-T1,A7MBJ4,PTPRF_BOVIN,,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),Bos taurus (Bovine),31.0,1540.0,1.8e-162,575.5,sp|A7MBJ4|PTPRF_BOVIN Receptor-type tyrosine-protein phosphatase F OS=Bos taurus OX=9913 GN=PTPRF PE=2 SV=1,GO:0004725; GO:0007165; GO:0008201; GO:0016020; GO:0016477; GO:0035335; GO:0099560; GO:1900121,cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560],membrane [GO:0016020],heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0007155; GO:0016787; GO:0048870; GO:0140096,"catalytic activity; cell adhesion; hydrolase activity; cell motility; catalytic activity, acting on a protein"
OG_00773,FUN_003843-T1,Peve_00042650,Pocillopora_meandrina_HIv1___TS.g7797.t1,three_way,79.19866666666667,FUN_003843-T1,P51687,SUOX_HUMAN,,"Sulfite oxidase, mitochondrial (EC 1.8.3.1)",Homo sapiens (Human),58.0,500.0,1.3e-169,597.8,"sp|P51687|SUOX_HUMAN Sulfite oxidase, mitochondrial OS=Homo sapiens OX=9606 GN=SUOX PE=1 SV=2",GO:0005739; GO:0005758; GO:0005759; GO:0006790; GO:0008482; GO:0020037; GO:0030151; GO:0043546,sulfur compound metabolic process [GO:0006790],mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482],GO:0003824; GO:0005739; GO:0006790; GO:0016491; GO:0043226,catalytic activity; mitochondrion; sulfur compound metabolic process; oxidoreductase activity; organelle
OG_00774,FUN_003845-T1,Peve_00042665,Pocillopora_meandrina_HIv1___RNAseq.g11682.t1,three_way,60.23533333333334,,,,,,,,,,,,,,,,,
OG_00775,FUN_003847-T1,Peve_00009243,Pocillopora_meandrina_HIv1___RNAseq.g11165.t1,three_way,62.71566666666666,FUN_003847-T1,Q80TL4,PHF24_MOUSE,,PHD finger protein 24,Mus musculus (Mouse),30.2,268.0,2.8e-31,137.9,sp|Q80TL4|PHF24_MOUSE PHD finger protein 24 OS=Mus musculus OX=10090 GN=Phf24 PE=1 SV=2,GO:0007214; GO:0008270; GO:0008277; GO:0030672; GO:0032228; GO:0050966; GO:0098978,"detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic transmission, GABAergic [GO:0032228]",glutamatergic synapse [GO:0098978]; synaptic vesicle membrane [GO:0030672],zinc ion binding [GO:0008270],GO:0023052,signaling
OG_00776,FUN_003849-T2,Peve_00018009,Pocillopora_meandrina_HIv1___RNAseq.g16676.t1,three_way,81.325,FUN_003849-T2,Q8R1A4,DOCK7_MOUSE,,Dedicator of cytokinesis protein 7 (Protein moonlight),Mus musculus (Mouse),52.9,2155.0,0.0,2026.1,sp|Q8R1A4|DOCK7_MOUSE Dedicator of cytokinesis protein 7 OS=Mus musculus OX=10090 GN=Dock7 PE=1 SV=3,GO:0002244; GO:0005085; GO:0007264; GO:0022027; GO:0030424; GO:0031267; GO:0031594; GO:0043473; GO:0050767; GO:0098698; GO:0120163,hematopoietic progenitor cell differentiation [GO:0002244]; interkinetic nuclear migration [GO:0022027]; negative regulation of cold-induced thermogenesis [GO:0120163]; pigmentation [GO:0043473]; postsynaptic specialization assembly [GO:0098698]; regulation of neurogenesis [GO:0050767]; small GTPase-mediated signal transduction [GO:0007264],axon [GO:0030424]; neuromuscular junction [GO:0031594],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0030154; GO:0098772,cell differentiation; molecular function regulator activity
OG_00777,FUN_003851-T1,Peve_00037763,Pocillopora_meandrina_HIv1___RNAseq.g11583.t1,three_way,81.71166666666666,FUN_003851-T1,O57321,,,,,55.2,433.0,3.6e-121,436.8,sp|O57321|EAA1_AMBTI Excitatory amino acid transporter 1 OS=Ambystoma tigrinum OX=8305 GN=SLC1A3 PE=1 SV=1,,,,,,
OG_00778,FUN_003852-T2,Peve_00012768,Pocillopora_meandrina_HIv1___RNAseq.g11582.t1,three_way,50.0285,FUN_003852-T2,Q9QYT7,,,,,39.9,318.0,3.4e-54,214.5,sp|Q9QYT7|PIGQ_MOUSE Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q OS=Mus musculus OX=10090 GN=Pigq PE=1 SV=3,,,,,,
OG_00779,FUN_003853-T1,Peve_00012764,Pocillopora_meandrina_HIv1___RNAseq.g11579.t1,three_way,86.138,FUN_003853-T1,P32929,CGL_HUMAN,,Cystathionine gamma-lyase (CGL) (CSE) (EC 4.4.1.1) (Cysteine desulfhydrase) (Cysteine-protein sulfhydrase) (Gamma-cystathionase) (Homocysteine desulfhydrase) (EC 4.4.1.2),Homo sapiens (Human),69.3,388.0,2.2e-155,550.1,sp|P32929|CGL_HUMAN Cystathionine gamma-lyase OS=Homo sapiens OX=9606 GN=CTH PE=1 SV=3,GO:0004123; GO:0005516; GO:0005737; GO:0005829; GO:0006534; GO:0006629; GO:0018272; GO:0019343; GO:0019344; GO:0019346; GO:0030170; GO:0030968; GO:0042802; GO:0043123; GO:0044524; GO:0044540; GO:0047982; GO:0051289; GO:0070062; GO:0070814; GO:0080146; GO:0098606; GO:1904831; GO:1990830; GO:2001234,cellular response to leukemia inhibitory factor [GO:1990830]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process via cystathionine [GO:0019343]; cysteine metabolic process [GO:0006534]; endoplasmic reticulum unfolded protein response [GO:0030968]; hydrogen sulfide biosynthetic process [GO:0070814]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic signaling pathway [GO:2001234]; positive regulation of aortic smooth muscle cell differentiation [GO:1904831]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protein homotetramerization [GO:0051289]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; transsulfuration [GO:0019346],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],calmodulin binding [GO:0005516]; cystathionine gamma-lyase activity [GO:0004123]; homocysteine desulfhydrase activity [GO:0047982]; identical protein binding [GO:0042802]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; selenocystathionine gamma-lyase activity [GO:0098606],GO:0003824; GO:0005829; GO:0006520; GO:0006629; GO:0006790; GO:0016829; GO:0043226; GO:0065003,catalytic activity; cytosol; amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; lyase activity; organelle; protein-containing complex assembly
OG_00780,FUN_003878-T1,Peve_00009218,Pocillopora_meandrina_HIv1___RNAseq.g11578.t2,three_way,60.194833333333335,FUN_003878-T1,Q7TT28,,,,,47.5,438.0,1.0999999999999998e-105,385.2,sp|Q7TT28|REXO1_MOUSE RNA exonuclease 1 homolog OS=Mus musculus OX=10090 GN=Rexo1 PE=1 SV=1,,,,,,
OG_00781,FUN_003881-T1,Peve_00023686,Pocillopora_meandrina_HIv1___RNAseq.g11577.t1,three_way,74.771,FUN_003881-T1,Q66KE8,,,,,30.9,459.0,4.3e-50,201.4,sp|Q66KE8|CCD78_XENLA Coiled-coil domain-containing protein 78 OS=Xenopus laevis OX=8355 GN=ccdc78 PE=2 SV=1,,,,,,
OG_00782,FUN_003887-T2,Peve_00015148,Pocillopora_meandrina_HIv1___RNAseq.g11575.t1,three_way,95.60633333333334,FUN_003887-T2,Q8MJ44,,,,,82.6,350.0,6.9000000000000005e-174,611.3,sp|Q8MJ44|KAPCA_CANLF cAMP-dependent protein kinase catalytic subunit alpha OS=Canis lupus familiaris OX=9615 GN=PRKACA PE=1 SV=3,,,,,,
OG_00783,FUN_003893-T1,Peve_00015146,Pocillopora_meandrina_HIv1___RNAseq.g11573.t1,three_way,87.305,FUN_003893-T1,Q9H2P9,,,,,65.8,272.0,9.3e-105,381.3,sp|Q9H2P9|DPH5_HUMAN Diphthine methyl ester synthase OS=Homo sapiens OX=9606 GN=DPH5 PE=1 SV=2,,,,,,
OG_00784,FUN_003894-T1,Peve_00015142,Pocillopora_meandrina_HIv1___RNAseq.g11707.t1,three_way,79.82766666666667,FUN_003894-T1,P35574,,,,,51.0,1345.0,0.0,1379.0,sp|P35574|GDE_RABIT Glycogen debranching enzyme OS=Oryctolagus cuniculus OX=9986 GN=AGL PE=1 SV=1,,,,,,
OG_00785,FUN_003898-T1,Peve_00015139,Pocillopora_meandrina_HIv1___RNAseq.g11571.t1,three_way,73.035,FUN_003898-T1,O59028,,,,,39.7,307.0,6.6e-56,219.5,sp|O59028|MDH_PYRHO Malate dehydrogenase OS=Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) OX=70601 GN=mdh PE=1 SV=1,,,,,,
OG_00786,FUN_003899-T1,Peve_00015155,Pocillopora_meandrina_HIv1___RNAseq.g11681.t1,three_way,79.42999999999999,FUN_003899-T1,Q9V0D5,,,,,38.2,353.0,3.4000000000000007e-65,250.4,sp|Q9V0D5|MDH_PYRAB Malate dehydrogenase OS=Pyrococcus abyssi (strain GE5 / Orsay) OX=272844 GN=mdh PE=3 SV=1,,,,,,
OG_00787,FUN_003900-T1,Peve_00025157,Pocillopora_meandrina_HIv1___RNAseq.g17184.t1,three_way,80.535,FUN_003900-T1,Q69ZJ7,RIC1_MOUSE,,Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1),Mus musculus (Mouse),40.0,1396.0,3.9e-284,979.5,sp|Q69ZJ7|RIC1_MOUSE Guanine nucleotide exchange factor subunit RIC1 OS=Mus musculus OX=10090 GN=Ric1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547,"intracellular protein transport [GO:0006886]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005829; GO:0006886; GO:0016192; GO:0098772,cytosol; intracellular protein transport; vesicle-mediated transport; molecular function regulator activity
OG_00788,FUN_003901-T1,Peve_00012083,Pocillopora_meandrina_HIv1___RNAseq.g17185.t1,three_way,78.26033333333334,FUN_003901-T1,Q4KM73,KCY_RAT,,UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK),Rattus norvegicus (Rat),58.6,191.0,3.2e-57,223.0,sp|Q4KM73|KCY_RAT UMP-CMP kinase OS=Rattus norvegicus OX=10116 GN=Cmpk1 PE=1 SV=2,GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005737; GO:0006207; GO:0006225; GO:0006227; GO:0006240; GO:0009041; GO:0018963; GO:0022602; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0050145,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; CDP biosynthetic process [GO:0046705]; dCDP biosynthetic process [GO:0006240]; dUDP biosynthetic process [GO:0006227]; ovulation cycle process [GO:0022602]; phthalate metabolic process [GO:0018963]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; nucleus [GO:0005634],(d)CMP kinase activity [GO:0004127]; ATP binding [GO:0005524]; CMP kinase activity [GO:0036430]; dCMP kinase activity [GO:0036431]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862]; UMP/dUMP kinase activity [GO:0009041],GO:0003824; GO:0005634; GO:0016740; GO:0022414; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; transferase activity; reproductive process; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00789,FUN_003934-T1,Peve_00006586,Pocillopora_meandrina_HIv1___RNAseq.g11751.t1,three_way,62.47316666666666,FUN_003934-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),34.2,184.0,3e-23,113.2,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_00790,FUN_003935-T1,Peve_00041379,Pocillopora_meandrina_HIv1___RNAseq.g11752.t1,three_way,90.497,FUN_003935-T1,Q2M2T6,,,,,72.6,84.0,2.0000000000000002e-29,129.4,sp|Q2M2T6|ASTER_BOVIN PAT complex subunit Asterix OS=Bos taurus OX=9913 GN=WDR83OS PE=3 SV=1,,,,,,
OG_00791,FUN_003937-T1,Peve_00041383,Pocillopora_meandrina_HIv1___RNAseq.g11755.t1,three_way,80.51333333333334,FUN_003937-T1,Q9N4X8,,,,,26.7,217.0,9.7e-14,79.0,sp|Q9N4X8|GSTPA_CAEEL Glutathione S-transferase P 10 OS=Caenorhabditis elegans OX=6239 GN=gst-10 PE=1 SV=3,,,,,,
OG_00792,FUN_003938-T1,Peve_00041389,Pocillopora_meandrina_HIv1___TS.g7868.t1,three_way,40.8085,,,,,,,,,,,,,,,,,
OG_00793,FUN_003940-T1,Peve_00038457,Pocillopora_meandrina_HIv1___RNAseq.g11757.t1,three_way,58.294,FUN_003940-T1,Q6DG99,,,,,53.7,95.0,7.6e-19,96.3,sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1,,,,,,
OG_00794,FUN_003971-T1,Peve_00044928,Pocillopora_meandrina_HIv1___RNAseq.g12507.t1,three_way,40.891666666666666,,,,,,,,,,,,,,,,,
OG_00795,FUN_003978-T1,Peve_00009042,Pocillopora_meandrina_HIv1___RNAseq.g11761.t1,three_way,85.38833333333334,FUN_003978-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),67.5,40.0,1.8e-06,54.7,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_00796,FUN_003982-T1,Peve_00038451,Pocillopora_meandrina_HIv1___TS.g7876.t1,three_way,62.93233333333333,,,,,,,,,,,,,,,,,
OG_00797,FUN_003985-T1,Peve_00038452,Pocillopora_meandrina_HIv1___RNAseq.g12629.t1,three_way,66.10633333333334,FUN_003985-T1,O75970,MPDZ_HUMAN,,Multiple PDZ domain protein (Multi-PDZ domain protein 1),Homo sapiens (Human),36.1,183.0,4.6e-26,120.2,sp|O75970|MPDZ_HUMAN Multiple PDZ domain protein OS=Homo sapiens OX=9606 GN=MPDZ PE=1 SV=2,GO:0005737; GO:0005886; GO:0005923; GO:0014069; GO:0016324; GO:0016327; GO:0030425; GO:0045177; GO:0120192,tight junction assembly [GO:0120192],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],,GO:0005886; GO:0034330; GO:0043226,plasma membrane; cell junction organization; organelle
OG_00798,FUN_003990-T1,Peve_00038455,Pocillopora_meandrina_HIv1___RNAseq.g17198.t1,three_way,89.71566666666666,FUN_003990-T1,Q6DHU4,,,,,74.7,190.0,1.4e-81,304.7,sp|Q6DHU4|PR38A_DANRE Pre-mRNA-splicing factor 38A OS=Danio rerio OX=7955 GN=prpf38a PE=2 SV=1,,,,,,
OG_00799,FUN_003992-T1,Peve_00038456,Pocillopora_meandrina_HIv1___RNAseq.g17199.t1,three_way,69.46000000000001,FUN_003992-T1,Q0GGW5,STK11_CHICK,,Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1 homolog) (LKB1),Gallus gallus (Chicken),45.7,234.0,4.7e-49,196.4,sp|Q0GGW5|STK11_CHICK Serine/threonine-protein kinase STK11 OS=Gallus gallus OX=9031 GN=STK11 PE=2 SV=1,GO:0000287; GO:0001558; GO:0001944; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006468; GO:0006470; GO:0006974; GO:0007165; GO:0009267; GO:0009410; GO:0010212; GO:0016020; GO:0019901; GO:0030010; GO:0030111; GO:0030295; GO:0030308; GO:0032147; GO:0042593; GO:0046777; GO:0072332; GO:0090090; GO:0106310; GO:1901610,activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; establishment of cell polarity [GO:0030010]; glucose homeostasis [GO:0042593]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; positive regulation of vesicle transport along microtubule [GO:1901610]; protein autophosphorylation [GO:0046777]; protein dephosphorylation [GO:0006470]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of Wnt signaling pathway [GO:0030111]; response to ionizing radiation [GO:0010212]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; vasculature development [GO:0001944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; p53 binding [GO:0002039]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0007163; GO:0016740; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; nucleus; mitochondrion; cytosol; establishment or maintenance of cell polarity; transferase activity; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00800,FUN_003996-T1,Peve_00038453,Pocillopora_meandrina_HIv1___RNAseq.g17200.t1,three_way,59.2325,FUN_003996-T1,P24524,GLRA3_RAT,,Glycine receptor subunit alpha-3,Rattus norvegicus (Rat),27.8,399.0,5.9e-36,153.3,sp|P24524|GLRA3_RAT Glycine receptor subunit alpha-3 OS=Rattus norvegicus OX=10116 GN=Glra3 PE=1 SV=1,GO:0004888; GO:0005886; GO:0016594; GO:0016934; GO:0016935; GO:0022852; GO:0030425; GO:0042734; GO:0043204; GO:0046872; GO:0051260; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0099171; GO:0099634; GO:1902476,cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic membrane [GO:0042734],extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888],GO:0005215; GO:0005886; GO:0055085; GO:0060089; GO:0065003,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity; protein-containing complex assembly
OG_00801,FUN_003999-T1,Peve_00034334,Pocillopora_meandrina_HIv1___RNAseq.g11693.t1,three_way,63.882666666666665,FUN_003999-T1,P21956,MFGM_MOUSE,,Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (MP47),Mus musculus (Mouse),32.1,346.0,3.3e-32,141.0,sp|P21956|MFGM_MOUSE Lactadherin OS=Mus musculus OX=10090 GN=Mfge8 PE=1 SV=3,GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0043277; GO:0050766; GO:0062023,"angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]",acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615],integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786],GO:0005615; GO:0007155; GO:0008289; GO:0016192; GO:0022414; GO:0061024,extracellular space; cell adhesion; lipid binding; vesicle-mediated transport; reproductive process; membrane organization
OG_00802,FUN_004000-T1,Peve_00034331,Pocillopora_meandrina_HIv1___RNAseq.g11698.t1,three_way,63.14333333333333,FUN_004000-T1,Q8CJ12,AGRG2_MOUSE,,"Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Mouse epididymis-specific protein 6) (Me6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)]",Mus musculus (Mouse),34.0,379.0,1.9e-50,203.4,sp|Q8CJ12|AGRG2_MOUSE Adhesion G-protein coupled receptor G2 OS=Mus musculus OX=10090 GN=Adgrg2 PE=1 SV=1,GO:0004930; GO:0005829; GO:0007166; GO:0007189; GO:0007286; GO:0016324,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; spermatid development [GO:0007286],apical plasma membrane [GO:0016324]; cytosol [GO:0005829],G protein-coupled receptor activity [GO:0004930],GO:0005829; GO:0022414; GO:0048856; GO:0060089,cytosol; reproductive process; anatomical structure development; molecular transducer activity
OG_00803,FUN_004001-T1,Peve_00034328,Pocillopora_meandrina_HIv1___RNAseq.g11699.t1,three_way,70.47566666666667,FUN_004001-T1,Q90240,CBPD_ANAPL,,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) (p170),Anas platyrhynchos (Mallard) (Anas boschas),54.0,376.0,4.3e-119,430.3,sp|Q90240|CBPD_ANAPL Carboxypeptidase D OS=Anas platyrhynchos OX=8839 GN=CPD PE=1 SV=1,GO:0004181; GO:0005615; GO:0005886; GO:0006508; GO:0006518; GO:0008270; GO:0016020; GO:0016485,peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_00804,FUN_004002-T1,Peve_00034341,Pocillopora_meandrina_HIv1___RNAseq.g11700.t1,three_way,74.56816666666667,FUN_004002-T1,Q90240,CBPD_ANAPL,,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) (p170),Anas platyrhynchos (Mallard) (Anas boschas),57.2,299.0,3.6e-102,373.2,sp|Q90240|CBPD_ANAPL Carboxypeptidase D OS=Anas platyrhynchos OX=8839 GN=CPD PE=1 SV=1,GO:0004181; GO:0005615; GO:0005886; GO:0006508; GO:0006518; GO:0008270; GO:0016020; GO:0016485,peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_00805,FUN_004003-T1,Peve_00034340,Pocillopora_meandrina_HIv1___RNAseq.g11702.t1,three_way,76.87066666666666,FUN_004003-T1,O35819,,,,,73.6,106.0,5.5e-11,70.1,sp|O35819|KLF6_RAT Krueppel-like factor 6 OS=Rattus norvegicus OX=10116 GN=Klf6 PE=2 SV=2,,,,,,
OG_00806,FUN_004005-T1,Peve_00026904,Pocillopora_meandrina_HIv1___RNAseq.g11703.t1a,three_way,73.09533333333333,FUN_004005-T1,A8K855,EFCB7_HUMAN,,EF-hand calcium-binding domain-containing protein 7,Homo sapiens (Human),37.3,616.0,9.3e-107,389.0,sp|A8K855|EFCB7_HUMAN EF-hand calcium-binding domain-containing protein 7 OS=Homo sapiens OX=9606 GN=EFCAB7 PE=1 SV=1,GO:0005509; GO:0005929; GO:0008589; GO:0009898; GO:0042307; GO:0045944; GO:0060170; GO:0098797; GO:0120229; GO:1903569,positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to ciliary membrane [GO:1903569]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to motile cilium [GO:0120229]; regulation of smoothened signaling pathway [GO:0008589],ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic side of plasma membrane [GO:0009898]; plasma membrane protein complex [GO:0098797],calcium ion binding [GO:0005509],GO:0005929; GO:0006355; GO:0043226,cilium; regulation of DNA-templated transcription; organelle
OG_00807,FUN_004006-T1,Peve_00044933,Pocillopora_meandrina_HIv1___RNAseq.g11690.t1,three_way,87.45700000000001,FUN_004006-T1,P03967,RASD_DICDI,,Ras-like protein rasD (EC 3.6.5.2) (Transforming protein p23 homolog),Dictyostelium discoideum (Social amoeba),39.9,193.0,7.1e-35,148.7,sp|P03967|RASD_DICDI Ras-like protein rasD OS=Dictyostelium discoideum OX=44689 GN=rasD PE=1 SV=2,GO:0000281; GO:0003924; GO:0003925; GO:0004860; GO:0005525; GO:0005811; GO:0005829; GO:0005886; GO:0006935; GO:0009617; GO:0019003; GO:0019887; GO:0031005; GO:0042331; GO:0043052; GO:0043422; GO:0046956; GO:0051019; GO:0070371; GO:0070685; GO:0140582; GO:1905301,adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway [GO:0140582]; chemotaxis [GO:0006935]; ERK1 and ERK2 cascade [GO:0070371]; mitotic cytokinesis [GO:0000281]; phototaxis [GO:0042331]; positive phototaxis [GO:0046956]; regulation of macropinocytosis [GO:1905301]; response to bacterium [GO:0009617]; thermotaxis [GO:0043052],cytosol [GO:0005829]; lipid droplet [GO:0005811]; macropinocytic cup [GO:0070685]; plasma membrane [GO:0005886],filamin binding [GO:0031005]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase B binding [GO:0043422]; protein kinase inhibitor activity [GO:0004860]; protein kinase regulator activity [GO:0019887],GO:0000910; GO:0003824; GO:0003924; GO:0005811; GO:0005829; GO:0005886; GO:0008092; GO:0016787; GO:0043226; GO:0098772,cytokinesis; catalytic activity; GTPase activity; lipid droplet; cytosol; plasma membrane; cytoskeletal protein binding; hydrolase activity; organelle; molecular function regulator activity
OG_00808,FUN_004007-T1,Peve_00044893,Pocillopora_meandrina_HIv1___RNAseq.g11703.t1b,three_way,74.065,FUN_004007-T1,O95405,,,,,43.3,743.0,2.8000000000000003e-161,571.2,sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2,,,,,,
OG_00809,FUN_004008-T1,Peve_00044894,Pocillopora_meandrina_HIv1___RNAseq.g11704.t1,three_way,84.40533333333333,FUN_004008-T1,Q9SKC9,,,,,46.2,78.0,1.3e-13,76.6,sp|Q9SKC9|NDUB7_ARATH NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 OS=Arabidopsis thaliana OX=3702 GN=At2g02050 PE=1 SV=1,,,,,,
OG_00810,FUN_004010-T1,Peve_00044898,Pocillopora_meandrina_HIv1___RNAseq.g11691.t1,three_way,58.72366666666667,FUN_004010-T1,Q9BYK8,,,,,26.8,1587.0,5.9e-113,411.4,sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7,,,,,,
OG_00811,FUN_004011-T1,Peve_00044901,Pocillopora_meandrina_HIv1___RNAseq.g24674.t1,three_way,43.192,,,,,,,,,,,,,,,,,
OG_00812,FUN_004015-T2,Peve_00034335,Pocillopora_meandrina_HIv1___RNAseq.g11692.t1,three_way,62.5775,,,,,,,,,,,,,,,,,
OG_00813,FUN_004017-T1,Peve_00034338,Pocillopora_meandrina_HIv1___TS.g8778.t1,three_way,87.63,FUN_004017-T1,Q12882,,,,,70.3,1018.0,0.0,1517.7,sp|Q12882|DPYD_HUMAN Dihydropyrimidine dehydrogenase [NADP(+)] OS=Homo sapiens OX=9606 GN=DPYD PE=1 SV=2,,,,,,
OG_00814,FUN_004027-T1,Peve_00003948,Pocillopora_meandrina_HIv1___RNAseq.g12642.t1,three_way,68.265,,,,,,,,,,,,,,,,,
OG_00815,FUN_004028-T1,Peve_00003960,Pocillopora_meandrina_HIv1___RNAseq.g12640.t1,three_way,59.62266666666667,FUN_004028-T1,Q8R1P4,,,,,37.8,209.0,4.8e-29,129.4,sp|Q8R1P4|ATG10_MOUSE Ubiquitin-like-conjugating enzyme ATG10 OS=Mus musculus OX=10090 GN=Atg10 PE=1 SV=1,,,,,,
OG_00816,FUN_004029-T1,Peve_00003922,Pocillopora_meandrina_HIv1___TS.g18515.t2,three_way,93.10066666666664,FUN_004029-T1,Q9R050,,,,,40.6,414.0,1.6999999999999998e-53,211.5,sp|Q9R050|SSBP3_RAT Single-stranded DNA-binding protein 3 OS=Rattus norvegicus OX=10116 GN=Ssbp3 PE=1 SV=1,,,,,,
OG_00817,FUN_004035-T1,Peve_00008958,Pocillopora_meandrina_HIv1___RNAseq.g11552.t1,three_way,38.5565,,,,,,,,,,,,,,,,,
OG_00818,FUN_004036-T1,Peve_00013897,Pocillopora_meandrina_HIv1___RNAseq.g12511.t1,three_way,63.136,FUN_004036-T1,Q641Z7,ASM3A_RAT,,"Cyclic GMP-AMP phosphodiesterase SMPDL3A (2',3'-cGAMP phosphodiesterase SMPDL3A) (EC 3.1.4.-) (Acid sphingomyelinase-like phosphodiesterase 3a) (ASM-like phosphodiesterase 3a) (EC 3.6.1.15)",Rattus norvegicus (Rat),29.2,366.0,6.299999999999998e-35,150.2,sp|Q641Z7|ASM3A_RAT Cyclic GMP-AMP phosphodiesterase SMPDL3A OS=Rattus norvegicus OX=10116 GN=Smpdl3a PE=2 SV=1,GO:0005576; GO:0005615; GO:0008081; GO:0008270; GO:0009143; GO:0016887; GO:0160049,negative regulation of cGAS/STING signaling pathway [GO:0160049]; nucleoside triphosphate catabolic process [GO:0009143],extracellular region [GO:0005576]; extracellular space [GO:0005615],ATP hydrolysis activity [GO:0016887]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0055086,catalytic activity; extracellular region; extracellular space; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_00819,FUN_004037-T1,Peve_00008959,Pocillopora_meandrina_HIv1___RNAseq.g11548.t1,three_way,60.19866666666667,,,,,,,,,,,,,,,,,
OG_00820,FUN_004038-T1,Peve_00008961,Pocillopora_meandrina_HIv1___RNAseq.g11549.t1,three_way,96.45366666666666,FUN_004038-T1,Q2KJ81,AP1M1_BOVIN,,AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin),Bos taurus (Bovine),81.5,422.0,8.299999999999998e-206,717.6,sp|Q2KJ81|AP1M1_BOVIN AP-1 complex subunit mu-1 OS=Bos taurus OX=9913 GN=AP1M1 PE=1 SV=3,GO:0005794; GO:0006886; GO:0016192; GO:0030131; GO:0030136; GO:0030665; GO:0035615,intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; Golgi apparatus [GO:0005794],clathrin adaptor activity [GO:0035615],GO:0005794; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090,Golgi apparatus; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_00821,FUN_004039-T1,Peve_00008962,Pocillopora_meandrina_HIv1___RNAseq.g11550.t1,three_way,79.03166666666667,FUN_004039-T1,D3YXK1,SAMD1_MOUSE,,Sterile alpha motif domain-containing protein 1 (SAM domain-containing protein 1) (Atherin),Mus musculus (Mouse),54.7,75.0,7.5e-17,90.1,sp|D3YXK1|SAMD1_MOUSE Sterile alpha motif domain-containing protein 1 OS=Mus musculus OX=10090 GN=Samd1 PE=1 SV=1,GO:0000122; GO:0003677; GO:0003682; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0030169; GO:0034439; GO:0051260; GO:0090077; GO:0160217,chromatin organization [GO:0006325]; foam cell differentiation [GO:0090077]; lipoprotein lipid oxidation [GO:0034439]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription initiation-coupled chromatin remodeling [GO:0160217]; protein homooligomerization [GO:0051260],chromosome [GO:0005694]; extracellular space [GO:0005615]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; low-density lipoprotein particle binding [GO:0030169],GO:0003677; GO:0005615; GO:0005634; GO:0005694; GO:0006325; GO:0006355; GO:0006629; GO:0030154; GO:0043226; GO:0065003,DNA binding; extracellular space; nucleus; chromosome; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_00822,FUN_004041-T1,Peve_00003961,Pocillopora_meandrina_HIv1___TS.g18508.t1,three_way,50.96333333333333,FUN_004041-T1,Q9UMZ3,PTPRQ_HUMAN,,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q),Homo sapiens (Human),22.8,219.0,1.7e-06,55.8,sp|Q9UMZ3|PTPRQ_HUMAN Phosphatidylinositol phosphatase PTPRQ OS=Homo sapiens OX=9606 GN=PTPRQ PE=1 SV=2,GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0034485; GO:0043235; GO:0043813; GO:0045598; GO:0050910; GO:0052629; GO:0120044,detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; regulation of fat cell differentiation [GO:0045598],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044],"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein tyrosine phosphatase activity [GO:0004725]",GO:0003824; GO:0016787; GO:0050877; GO:0140096,"catalytic activity; hydrolase activity; nervous system process; catalytic activity, acting on a protein"
OG_00823,FUN_004050-T1,Peve_00003959,Pocillopora_meandrina_HIv1___RNAseq.g12634.t1,three_way,73.86366666666666,FUN_004050-T1,A2VDD2,,,,,41.5,130.0,1.7e-19,97.4,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_00824,FUN_004053-T1,Peve_00003958,Pocillopora_meandrina_HIv1___RNAseq.g12635.t1,three_way,54.064,,,,,,,,,,,,,,,,,
OG_00825,FUN_004054-T1,Peve_00003957,Pocillopora_meandrina_HIv1___RNAseq.g12636.t1,three_way,93.765,FUN_004054-T1,Q28DV3,HDAC3_XENTR,,Histone deacetylase 3 (HD3) (EC 3.5.1.98) (Protein deacetylase HDAC3) (EC 3.5.1.-) (Protein deacylase HDAC3) (EC 3.5.1.-),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),70.9,423.0,2.2e-182,639.8,sp|Q28DV3|HDAC3_XENTR Histone deacetylase 3 OS=Xenopus tropicalis OX=8364 GN=hdac3 PE=2 SV=1,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005694; GO:0005737; GO:0005829; GO:0017053; GO:0032922; GO:0033558; GO:0042752; GO:0046872; GO:0141221; GO:0160008; GO:0160009; GO:0160010; GO:0160216,circadian regulation of gene expression [GO:0032922]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone decrotonylase activity [GO:0160009]; metal ion binding [GO:0046872]; protein de-2-hydroxyisobutyrylase activity [GO:0160010]; protein decrotonylase activity [GO:0160008]; protein lysine deacetylase activity [GO:0033558]; protein lysine delactylase activity [GO:0160216]; transcription corepressor activity [GO:0003714]",GO:0003824; GO:0005634; GO:0005694; GO:0005829; GO:0006355; GO:0016787; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; cytosol; regulation of DNA-templated transcription; hydrolase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_00826,FUN_004055-T1,Peve_00004708,Pocillopora_meandrina_HIv1___TS.g18498.t1,three_way,83.49266666666666,FUN_004055-T1,Q29RZ2,,,,,66.3,596.0,1e-236,820.8,sp|Q29RZ2|PPWD1_BOVIN Peptidylprolyl isomerase domain and WD repeat-containing protein 1 OS=Bos taurus OX=9913 GN=PPWD1 PE=2 SV=1,,,,,,
OG_00827,FUN_004056-T1,Peve_00007130,Pocillopora_meandrina_HIv1___TS.g18499.t1,three_way,72.9045,FUN_004056-T1,Q6P0Q8,MAST2_HUMAN,,Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1),Homo sapiens (Human),43.5,1429.0,1.8999999999999997e-236,821.2,sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MAST2 PE=1 SV=2,GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005886; GO:0006468; GO:0007010; GO:0008017; GO:0015630; GO:0019902; GO:0032655; GO:0035556; GO:0048515; GO:0106310,cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of interleukin-12 production [GO:0032655]; spermatid differentiation [GO:0048515],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; phosphatase binding [GO:0019902]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_00828,FUN_004058-T1,Peve_00007134,Pocillopora_meandrina_HIv1___RNAseq.g17244.t1a,three_way,47.307,,,,,,,,,,,,,,,,,
OG_00829,FUN_004060-T1,Peve_00028225,Pocillopora_meandrina_HIv1___RNAseq.g17246.t2,three_way,51.38283333333333,FUN_004060-T1,O97827,,,,,33.2,554.0,1.4000000000000001e-74,282.3,sp|O97827|AGRL3_BOVIN Adhesion G protein-coupled receptor L3 OS=Bos taurus OX=9913 GN=ADGRL3 PE=2 SV=1,,,,,,
OG_00830,FUN_004061-T1,Peve_00024041,Pocillopora_meandrina_HIv1___RNAseq.g12603.t1,three_way,78.07933333333334,FUN_004061-T1,Q95LM1,,,,,47.3,146.0,1.4e-32,142.1,sp|Q95LM1|UBE2U_MACFA Ubiquitin-conjugating enzyme E2 U OS=Macaca fascicularis OX=9541 GN=UBE2U PE=2 SV=1,,,,,,
OG_00831,FUN_004062-T1,Peve_00024030,Pocillopora_meandrina_HIv1___RNAseq.g12604.t1,three_way,78.593,FUN_004062-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),67.0,212.0,1.2e-19,98.2,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_00832,FUN_004073-T1,Peve_00006663,Pocillopora_meandrina_HIv1___RNAseq.g17238.t1,three_way,67.30466666666666,FUN_004073-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),26.8,313.0,3.7e-23,110.5,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_00833,FUN_004078-T1,Peve_00006662,Pocillopora_meandrina_HIv1___RNAseq.g17237.t1,three_way,69.94466666666666,FUN_004078-T1,B1AS42,NB5R5_MOUSE,,NADH-cytochrome b5 reductase-like (EC 1.6.2.2),Mus musculus (Mouse),39.5,311.0,1e-63,245.4,sp|B1AS42|NB5R5_MOUSE NADH-cytochrome b5 reductase-like OS=Mus musculus OX=10090 GN=Cyb5rl PE=2 SV=1,GO:0004128; GO:0005654; GO:0005789,,endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]",GO:0003824; GO:0005654; GO:0016491,catalytic activity; nucleoplasm; oxidoreductase activity
OG_00834,FUN_004079-T1,Peve_00007133,Pocillopora_meandrina_HIv1___RNAseq.g17243.t1,three_way,61.05466666666667,FUN_004079-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),36.1,651.0,7.7e-94,347.4,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_00835,FUN_004084-T1,Peve_00006656,Pocillopora_meandrina_HIv1___RNAseq.g17235.t1,three_way,83.86,FUN_004084-T1,Q8IWG1,DNAI3_HUMAN,,Dynein axonemal intermediate chain 3 (Testis development protein NYD-SP29) (WD repeat-containing protein 63),Homo sapiens (Human),48.8,801.0,4.1e-223,776.2,sp|Q8IWG1|DNAI3_HUMAN Dynein axonemal intermediate chain 3 OS=Homo sapiens OX=9606 GN=DNAI3 PE=1 SV=1,GO:0005737; GO:0005858; GO:0030336; GO:0034316; GO:0036156; GO:0036159; GO:0045503; GO:0045504; GO:0045669; GO:0060294; GO:0071933,cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of cell migration [GO:0030336]; positive regulation of osteoblast differentiation [GO:0045669],axonemal dynein complex [GO:0005858]; cytoplasm [GO:0005737]; inner dynein arm [GO:0036156],Arp2/3 complex binding [GO:0071933]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503],GO:0007018; GO:0065003,microtubule-based movement; protein-containing complex assembly
OG_00836,FUN_004086-T1,Peve_00024027,Pocillopora_meandrina_HIv1___RNAseq.g12611.t1,three_way,91.55833333333334,FUN_004086-T1,Q9UNQ2,,,,,71.2,313.0,3.5e-129,462.6,sp|Q9UNQ2|DIM1_HUMAN Dimethyladenosine transferase OS=Homo sapiens OX=9606 GN=DIMT1 PE=1 SV=1,,,,,,
OG_00837,FUN_004087-T1,Peve_00024026,Pocillopora_meandrina_HIv1___RNAseq.g12612.t1,three_way,69.48666666666666,FUN_004087-T1,Q8NE22,,,,,43.2,294.0,6.8e-60,232.3,sp|Q8NE22|SETD9_HUMAN SET domain-containing protein 9 OS=Homo sapiens OX=9606 GN=SETD9 PE=1 SV=2,,,,,,
OG_00838,FUN_004088-T1,Peve_00024024,Pocillopora_meandrina_HIv1___RNAseq.29948_t,three_way,59.1695,FUN_004088-T1,Q0KIA2,,,,,44.8,232.0,3.5e-49,197.6,sp|Q0KIA2|Y9801_DROME PP2C-like domain-containing protein CG9801 OS=Drosophila melanogaster OX=7227 GN=CG9801 PE=2 SV=1,,,,,,
OG_00839,FUN_004089-T1,Peve_00024043,Pocillopora_meandrina_HIv1___RNAseq.g12616.t1,three_way,76.65216666666667,FUN_004089-T1,Q7T105,,,,,36.7,349.0,1.8e-48,195.3,sp|Q7T105|MIER1_XENLA Mesoderm induction early response protein 1 OS=Xenopus laevis OX=8355 GN=mier1 PE=2 SV=1,,,,,,
OG_00840,FUN_004090-T1,Peve_00040112,Pocillopora_meandrina_HIv1___RNAseq.g13727.t1,three_way,62.88,FUN_004090-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),28.1,424.0,3.3e-32,142.5,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_00841,FUN_004092-T1,Peve_00004703,Pocillopora_meandrina_HIv1___RNAseq.g12617.t1,three_way,83.72866666666667,FUN_004092-T1,Q6GPB9,,,,,44.4,793.0,2.2e-173,610.9,sp|Q6GPB9|DNAI4_XENLA Dynein axonemal intermediate chain 4 OS=Xenopus laevis OX=8355 GN=dnai4 PE=2 SV=1,,,,,,
OG_00842,FUN_004093-T1,Peve_00003956,Pocillopora_meandrina_HIv1___RNAseq.g12637.t1,three_way,72.56333333333333,FUN_004093-T1,O60235,TM11D_HUMAN,,Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain],Homo sapiens (Human),44.9,245.0,7.2e-58,225.7,sp|O60235|TM11D_HUMAN Transmembrane protease serine 11D OS=Homo sapiens OX=9606 GN=TMPRSS11D PE=1 SV=1,GO:0004252; GO:0005576; GO:0005886; GO:0006508; GO:0007585; GO:0008233; GO:0070062,proteolysis [GO:0006508]; respiratory gaseous exchange by respiratory system [GO:0007585],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_00843,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_00844,FUN_004095-T1,Peve_00028986,Pocillopora_meandrina_HIv1___RNAseq.g11568.t1,three_way,55.16966666666666,FUN_004095-T1,Q96S53,TESK2_HUMAN,,Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2),Homo sapiens (Human),50.5,287.0,5.2e-76,287.0,sp|Q96S53|TESK2_HUMAN Dual specificity testis-specific protein kinase 2 OS=Homo sapiens OX=9606 GN=TESK2 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007283; GO:0016604; GO:0030036; GO:0046872; GO:0048041; GO:0106310,actin cytoskeleton organization [GO:0030036]; focal adhesion assembly [GO:0048041]; protein phosphorylation [GO:0006468]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0007010; GO:0016740; GO:0022414; GO:0034330; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytoskeleton organization; transferase activity; reproductive process; cell junction organization; organelle; catalytic activity, acting on a protein"
OG_00845,FUN_004096-T1,Peve_00028982,Pocillopora_meandrina_HIv1___RNAseq.g11567.t1,three_way,81.59833333333333,FUN_004096-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),38.9,257.0,1.6000000000000002e-44,181.8,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_00846,FUN_004097-T1,Peve_00028981,Pocillopora_meandrina_HIv1___RNAseq.g11566.t1,three_way,55.645,FUN_004097-T1,Q0V8E4,,,,,39.4,787.0,1.6000000000000004e-130,468.4,sp|Q0V8E4|ASND1_BOVIN Asparagine synthetase domain-containing protein 1 OS=Bos taurus OX=9913 GN=ASNSD1 PE=2 SV=1,,,,,,
OG_00847,FUN_004098-T1,Peve_00028980,Pocillopora_meandrina_HIv1___RNAseq.g11565.t1,three_way,82.82433333333333,FUN_004098-T1,A7RQM5,ASNA_NEMVE,,ATPase ASNA1 homolog (EC 3.6.-.-) (Arsenical pump-driving ATPase homolog) (Arsenite-stimulated ATPase),Nematostella vectensis (Starlet sea anemone),80.4,327.0,1.3e-153,543.9,sp|A7RQM5|ASNA_NEMVE ATPase ASNA1 homolog OS=Nematostella vectensis OX=45351 GN=v1g161623 PE=3 SV=1,GO:0005524; GO:0016887; GO:0043529; GO:0046872; GO:0071816,tail-anchored membrane protein insertion into ER membrane [GO:0071816],GET complex [GO:0043529],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872],GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_00848,FUN_004099-T2,Peve_00018046,Pocillopora_meandrina_HIv1___RNAseq.g11659.t2,three_way,83.43266666666666,FUN_004099-T2,P0CB50,,,,,70.1,194.0,1.6e-79,297.4,sp|P0CB50|PRDX1_CHICK Peroxiredoxin-1 OS=Gallus gallus OX=9031 GN=PRDX1 PE=1 SV=1,,,,,,
OG_00849,FUN_004100-T1,Peve_00030718,Pocillopora_meandrina_HIv1___RNAseq.g11660.t1,three_way,75.31516666666667,FUN_004100-T1,Q32NH8,PLCD4_XENLA,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4)",Xenopus laevis (African clawed frog),41.4,749.0,1e-145,518.8,"sp|Q32NH8|PLCD4_XENLA 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 OS=Xenopus laevis OX=8355 GN=plcd4 PE=2 SV=1",GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0005886; GO:0016042; GO:0035556,intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calcium ion binding [GO:0005509]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]",GO:0003824; GO:0005634; GO:0005783; GO:0005886; GO:0006629; GO:0016787; GO:0043226,catalytic activity; nucleus; endoplasmic reticulum; plasma membrane; lipid metabolic process; hydrolase activity; organelle
OG_00850,FUN_004109-T1,Peve_00029005,Pocillopora_meandrina_HIv1___RNAseq.g11657.t1,three_way,69.28733333333334,FUN_004109-T1,Q811I0,,,,,35.7,283.0,1.5e-37,158.3,sp|Q811I0|ATPF1_MOUSE ATP synthase mitochondrial F1 complex assembly factor 1 OS=Mus musculus OX=10090 GN=Atpaf1 PE=1 SV=1,,,,,,
OG_00851,FUN_004110-T1,Peve_00015644,Pocillopora_meandrina_HIv1___RNAseq.g11664.t1,three_way,73.29766666666667,FUN_004110-T1,Q5ZL21,MMAC_CHICK,,Cyanocobalamin reductase / alkylcobalamin dealkylase (Alkylcobalamin:glutathione S-alkyltransferase) (EC 2.5.1.151) (CblC) (Cyanocobalamin reductase (cyanide-eliminating)) (EC 1.16.1.6) (Methylmalonic aciduria and homocystinuria type C protein) (MMACHC),Gallus gallus (Chicken),51.5,233.0,3.2e-64,246.5,sp|Q5ZL21|MMAC_CHICK Cyanocobalamin reductase / alkylcobalamin dealkylase OS=Gallus gallus OX=9031 GN=MMACHC PE=2 SV=1,GO:0005737; GO:0005829; GO:0006749; GO:0009235; GO:0016491; GO:0016740; GO:0031419; GO:0032451; GO:0033787; GO:0043295; GO:0070988; GO:0071949,cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749],cytoplasm [GO:0005737]; cytosol [GO:0005829],cobalamin binding [GO:0031419]; cyanocobalamin reductase (cyanide-eliminating) (NADP+) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740],GO:0003824; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740,catalytic activity; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity
OG_00852,FUN_004114-T1,Peve_00015643,Pocillopora_meandrina_HIv1___RNAseq.g11665.t1,three_way,81.109,FUN_004114-T1,Q4R5E4,,,,,61.4,568.0,4.5e-207,722.2,sp|Q4R5E4|PGM1_MACFA Phosphoglucomutase-1 OS=Macaca fascicularis OX=9541 GN=PGM1 PE=2 SV=3,,,,,,
OG_00853,FUN_004115-T1,Peve_00008071,Pocillopora_meandrina_HIv1___RNAseq.g11666.t1,three_way,69.32233333333333,FUN_004115-T1,O94632,EGT1_SCHPO,,Ergothioneine biosynthesis protein 1 (Meiotically up-regulated gene 158 protein) [Includes: L-histidine N(alpha)-methyltransferase (EC 2.1.1.44); Hercynylcysteine S-oxide synthase (EC 1.21.3.10)],Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),28.3,184.0,1.9e-09,66.2,sp|O94632|EGT1_SCHPO Ergothioneine biosynthesis protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt1 PE=1 SV=4,GO:0004497; GO:0005509; GO:0005634; GO:0005829; GO:0032259; GO:0051321; GO:0052699; GO:0052706; GO:0061686; GO:1903257,ergothioneine biosynthetic process [GO:0052699]; meiotic cell cycle [GO:0051321]; methylation [GO:0032259]; selenoneine biosynthetic process [GO:1903257],cytosol [GO:0005829]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; hercynylcysteine sulfoxide synthase activity [GO:0061686]; L-histidine N(alpha)-methyltransferase activity [GO:0052706]; monooxygenase activity [GO:0004497],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016491; GO:0016740; GO:0022414; GO:0043226,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; transferase activity; reproductive process; organelle
OG_00854,FUN_004117-T1,Peve_00038521,Pocillopora_meandrina_HIv1___RNAseq.g11674.t1,three_way,85.43533333333333,FUN_004117-T1,F1Q8K0,RAD54_DANRE,,DNA repair and recombination protein RAD54-like (EC 3.6.4.12),Danio rerio (Zebrafish) (Brachydanio rerio),66.8,744.0,3.7e-292,1005.4,sp|F1Q8K0|RAD54_DANRE DNA repair and recombination protein RAD54-like OS=Danio rerio OX=7955 GN=rad54l PE=1 SV=1,GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0007131; GO:0008094; GO:0015616; GO:0016787; GO:0045003,double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; reciprocal meiotic recombination [GO:0007131],nucleus [GO:0005634],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]",GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_00855,FUN_004118-T1,Peve_00038523,Pocillopora_meandrina_HIv1___RNAseq.g11675.t1,three_way,73.94633333333333,FUN_004118-T1,Q9D6Z0,ALKB7_MOUSE,,"Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7)",Mus musculus (Mouse),55.4,168.0,3.8e-49,196.4,"sp|Q9D6Z0|ALKB7_MOUSE Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial OS=Mus musculus OX=10090 GN=Alkbh7 PE=1 SV=1",GO:0005739; GO:0005759; GO:0006631; GO:0006974; GO:0010883; GO:0046872; GO:0051213; GO:1902445,DNA damage response [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0006629; GO:0007005; GO:0016491; GO:0043226; GO:0061024,catalytic activity; mitochondrion; lipid metabolic process; mitochondrion organization; oxidoreductase activity; organelle; membrane organization
OG_00856,FUN_004119-T1,Peve_00038524,Pocillopora_meandrina_HIv1___RNAseq.g11676.t1,three_way,73.58566666666667,,,,,,,,,,,,,,,,,
OG_00857,FUN_004120-T1,Peve_00038526,Pocillopora_meandrina_HIv1___RNAseq.g11677.t1,three_way,73.13033333333333,FUN_004120-T1,Q8IZS6,,,,,35.3,119.0,1.4e-13,77.8,sp|Q8IZS6|DYLT2_HUMAN Dynein light chain Tctex-type protein 2 OS=Homo sapiens OX=9606 GN=DYNLT2 PE=1 SV=1,,,,,,
OG_00858,FUN_004121-T2,Peve_00029608,Pocillopora_meandrina_HIv1___RNAseq.g11680.t2,three_way,75.833,FUN_004121-T2,Q6DCG4,RHBGB_XENLA,,Ammonium transporter Rh type B-B (Rhesus blood group family type B glycoprotein B) (Rh family type B glycoprotein B) (Rh type B glycoprotein B),Xenopus laevis (African clawed frog),48.8,445.0,1.9999999999999998e-110,401.0,sp|Q6DCG4|RHBGB_XENLA Ammonium transporter Rh type B-B OS=Xenopus laevis OX=8355 GN=rhbg-b PE=2 SV=1,GO:0005886; GO:0008519; GO:0016323; GO:0030659; GO:0072488; GO:0097272,ammonium homeostasis [GO:0097272]; ammonium transmembrane transport [GO:0072488],basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886],ammonium channel activity [GO:0008519],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_00859,FUN_004123-T1,Peve_00009572,Pocillopora_meandrina_HIv1___RNAseq.g11558.t1,three_way,79.28416666666666,,,,,,,,,,,,,,,,,
OG_00860,FUN_004124-T1,Peve_00009573,Pocillopora_meandrina_HIv1___RNAseq.g11559.t1,three_way,64.94416666666666,FUN_004124-T1,Q6IFY7,,,,,40.0,185.0,2.4e-28,127.1,sp|Q6IFY7|RTN1A_XENLA Reticulon-1-A OS=Xenopus laevis OX=8355 GN=rtn1-a PE=2 SV=1,,,,,,
OG_00861,FUN_004125-T1,Peve_00004370,Pocillopora_meandrina_HIv1___RNAseq.g11563.t1,three_way,43.042,FUN_004125-T1,Q20201,,,,,59.0,83.0,6e-23,109.8,sp|Q20201|SOX3_CAEEL Transcription factor sox-3 OS=Caenorhabditis elegans OX=6239 GN=sox-3 PE=2 SV=1,,,,,,
OG_00862,FUN_004127-T1,Peve_00004367,Pocillopora_meandrina_HIv1___RNAseq.g11562.t1,three_way,66.90633333333334,FUN_004127-T1,Q2I327,,,,,32.2,357.0,2.5e-27,124.8,sp|Q2I327|DMTA2_XIPMA Doublesex- and mab-3-related transcription factor A2 OS=Xiphophorus maculatus OX=8083 GN=dmrta2 PE=2 SV=1,,,,,,
OG_00863,FUN_004128-T1,Peve_00021772,Pocillopora_meandrina_HIv1___RNAseq.g16786.t1,three_way,47.478,,,,,,,,,,,,,,,,,
OG_00864,FUN_004129-T1,Peve_00021773,Pocillopora_meandrina_HIv1___RNAseq.g16787.t1,three_way,36.23266666666667,,,,,,,,,,,,,,,,,
OG_00865,FUN_004131-T1,Peve_00009433,Pocillopora_meandrina_HIv1___RNAseq.g16790.t1,three_way,49.26166666666666,,,,,,,,,,,,,,,,,
OG_00866,FUN_004140-T2,Peve_00009429,Pocillopora_meandrina_HIv1___RNAseq.g11564.t1,three_way,92.6315,FUN_004140-T2,Q07343,PDE4B_HUMAN,,"3',5'-cyclic-AMP phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32) (cAMP-specific phosphodiesterase 4B)",Homo sapiens (Human),56.3,551.0,1.1e-168,595.1,"sp|Q07343|PDE4B_HUMAN 3',5'-cyclic-AMP phosphodiesterase 4B OS=Homo sapiens OX=9606 GN=PDE4B PE=1 SV=1",GO:0000930; GO:0001780; GO:0004115; GO:0005246; GO:0005813; GO:0005829; GO:0005891; GO:0006198; GO:0008021; GO:0014069; GO:0019933; GO:0030018; GO:0030552; GO:0030593; GO:0032729; GO:0032743; GO:0043015; GO:0043197; GO:0044325; GO:0046872; GO:0047555; GO:0050852; GO:0050900; GO:0060076; GO:0071222; GO:0071466; GO:0071872; GO:0071878; GO:0086004; GO:1901898; GO:1902514,cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; leukocyte migration [GO:0050900]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; neutrophil homeostasis [GO:0001780]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of type II interferon production [GO:0032729]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of cardiac muscle cell contraction [GO:0086004]; T cell receptor signaling pathway [GO:0050852],centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; gamma-tubulin complex [GO:0000930]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021]; voltage-gated calcium channel complex [GO:0005891]; Z disc [GO:0030018],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium channel regulator activity [GO:0005246]; cAMP binding [GO:0030552]; gamma-tubulin binding [GO:0043015]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]",GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0048870; GO:0055086; GO:0098772; GO:1901135,immune system process; catalytic activity; microtubule organizing center; cytosol; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; cell motility; nucleobase-containing small molecule metabolic process; molecular function regulator activity; carbohydrate derivative metabolic process
OG_00867,FUN_004142-T1,Peve_00004368,Pocillopora_meandrina_HIv1___RNAseq.g144.t1,three_way,51.94683333333333,FUN_004142-T1,Q5T890,ER6L2_HUMAN,,DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) (DNA repair and recombination protein RAD26-like) (Excision repair cross-complementation group 6-like 2),Homo sapiens (Human),31.5,1000.0,5.999999999999999e-93,344.0,sp|Q5T890|ER6L2_HUMAN DNA excision repair protein ERCC-6-like 2 OS=Homo sapiens OX=9606 GN=ERCC6L2 PE=1 SV=3,GO:0000775; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0006974; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0097680,cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; interstrand cross-link repair [GO:0036297],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0006281; GO:0016787; GO:0016853; GO:0043226; GO:0140657,DNA binding; catalytic activity; nucleus; mitochondrion; microtubule organizing center; DNA repair; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_00868,FUN_004150-T1,Peve_00021770,Pocillopora_meandrina_HIv1___RNAseq.g16785.t1,three_way,52.79866666666667,,,,,,,,,,,,,,,,,
OG_00869,FUN_004156-T1,Peve_00031561,Pocillopora_meandrina_HIv1___RNAseq.g16776.t1,three_way,93.97166666666666,FUN_004156-T1,Q5F359,,,,,67.0,188.0,1.2e-68,260.8,sp|Q5F359|TPPC5_CHICK Trafficking protein particle complex subunit 5 OS=Gallus gallus OX=9031 GN=TRAPPC5 PE=2 SV=1,,,,,,
OG_00870,FUN_004158-T1,Peve_00031569,Pocillopora_meandrina_HIv1___RNAseq.g16773.t1,three_way,68.55266666666667,FUN_004158-T1,Q96SL4,GPX7_HUMAN,,Glutathione peroxidase 7 (GPx-7) (GSHPx-7) (EC 1.11.1.9) (CL683),Homo sapiens (Human),50.3,151.0,2.7e-39,163.3,sp|Q96SL4|GPX7_HUMAN Glutathione peroxidase 7 OS=Homo sapiens OX=9606 GN=GPX7 PE=1 SV=1,GO:0004096; GO:0004601; GO:0004602; GO:0005576; GO:0005783; GO:0005788; GO:0034599,cellular response to oxidative stress [GO:0034599],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576],catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601],GO:0003824; GO:0005576; GO:0005783; GO:0016209; GO:0016491; GO:0043226,catalytic activity; extracellular region; endoplasmic reticulum; antioxidant activity; oxidoreductase activity; organelle
OG_00871,FUN_004159-T1,Peve_00031547,Pocillopora_meandrina_HIv1___TS.g17596.t1,three_way,54.01833333333333,,,,,,,,,,,,,,,,,
OG_00872,FUN_004160-T1,Peve_00031557,Pocillopora_meandrina_HIv1___RNAseq.g16770.t1,three_way,82.089,FUN_004160-T1,Q6QI06,RICTR_MOUSE,,Rapamycin-insensitive companion of mTOR (AVO3 homolog) (mAVO3) (Protein pianissimo),Mus musculus (Mouse),48.6,1035.0,4.7e-280,966.5,sp|Q6QI06|RICTR_MOUSE Rapamycin-insensitive companion of mTOR OS=Mus musculus OX=10090 GN=Rictor PE=1 SV=2,GO:0001932; GO:0001938; GO:0005524; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005886; GO:0007010; GO:0008270; GO:0008610; GO:0009792; GO:0010468; GO:0019901; GO:0030036; GO:0030307; GO:0030335; GO:0030838; GO:0031669; GO:0031932; GO:0032008; GO:0038203; GO:0043022; GO:0043066; GO:0043539; GO:0050727; GO:0051896; GO:0051897; GO:0140767; GO:1902554; GO:2000114,actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein phosphorylation [GO:0001932]; TORC2 signaling [GO:0038203],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; serine/threonine protein kinase complex [GO:1902554]; TORC2 complex [GO:0031932],ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270],GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0006629; GO:0007010; GO:0043226; GO:0048856; GO:0060090; GO:0098772,lysosome; vacuole; endoplasmic reticulum; plasma membrane; lipid metabolic process; cytoskeleton organization; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_00873,FUN_004162-T1,Peve_00031559,Pocillopora_meandrina_HIv1___RNAseq.24438_t,three_way,37.080333333333336,,,,,,,,,,,,,,,,,
OG_00874,FUN_004163-T1,Peve_00031560,Pocillopora_meandrina_HIv1___RNAseq.g16740.t1,three_way,73.09966666666666,FUN_004163-T1,Q4R3J0,RTCA_MACFA,,RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),53.2,361.0,1.9999999999999998e-110,400.6,sp|Q4R3J0|RTCA_MACFA RNA 3'-terminal phosphate cyclase OS=Macaca fascicularis OX=9541 GN=RTCA PE=2 SV=1,GO:0003963; GO:0005524; GO:0005654; GO:0006396,RNA processing [GO:0006396],nucleoplasm [GO:0005654],ATP binding [GO:0005524]; RNA-3'-phosphate cyclase activity [GO:0003963],GO:0003824; GO:0005654; GO:0009975; GO:0016874; GO:0140098,"catalytic activity; nucleoplasm; cyclase activity; ligase activity; catalytic activity, acting on RNA"
OG_00875,FUN_004164-T1,Peve_00031562,Pocillopora_meandrina_HIv1___RNAseq.g16741.t2,three_way,58.028333333333336,FUN_004164-T1,Q6GQ33,CMKMT_XENLA,,Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60),Xenopus laevis (African clawed frog),41.3,276.0,1.4999999999999998e-49,198.0,sp|Q6GQ33|CMKMT_XENLA Calmodulin-lysine N-methyltransferase OS=Xenopus laevis OX=8355 GN=camkmt PE=1 SV=1,GO:0005634; GO:0005737; GO:0018025; GO:0032259,methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],calmodulin-lysine N-methyltransferase activity [GO:0018025],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00876,FUN_004165-T1,Peve_00031563,Pocillopora_meandrina_HIv1___RNAseq.g16742.t1,three_way,88.557,FUN_004165-T1,Q8N6S4,AN13C_HUMAN,,Ankyrin repeat domain-containing protein 13C,Homo sapiens (Human),64.4,430.0,1.1000000000000002e-165,584.3,sp|Q8N6S4|AN13C_HUMAN Ankyrin repeat domain-containing protein 13C OS=Homo sapiens OX=9606 GN=ANKRD13C PE=1 SV=2,GO:0005102; GO:0005737; GO:0005783; GO:0005789; GO:0006612; GO:0006621; GO:0048471; GO:0071799; GO:0140597; GO:2000209,cellular response to prostaglandin D stimulus [GO:0071799]; protein retention in ER lumen [GO:0006621]; protein targeting to membrane [GO:0006612]; regulation of anoikis [GO:2000209],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471],protein carrier chaperone [GO:0140597]; signaling receptor binding [GO:0005102],GO:0005783; GO:0043226; GO:0140104,endoplasmic reticulum; organelle; molecular carrier activity
OG_00877,FUN_004170-T1,Peve_00031564,Pocillopora_meandrina_HIv1___RNAseq.g16738.t1,three_way,85.395,,,,,,,,,,,,,,,,,
OG_00878,FUN_004171-T1,Peve_00031567,Pocillopora_meandrina_HIv1___TS.g17567.t1,three_way,78.7845,FUN_004171-T1,Q865S1,,,,,55.2,1283.0,0.0,1110.1,sp|Q865S1|AP3D1_BOVIN AP-3 complex subunit delta-1 OS=Bos taurus OX=9913 GN=AP3D1 PE=1 SV=2,,,,,,
OG_00879,FUN_004172-T1,Peve_00035080,Pocillopora_meandrina_HIv1___TS.g17566.t1,three_way,84.42933333333333,FUN_004172-T1,Q9H841,,,,,50.5,291.0,9.2e-76,285.4,sp|Q9H841|NPAL2_HUMAN NIPA-like protein 2 OS=Homo sapiens OX=9606 GN=NIPAL2 PE=1 SV=2,,,,,,
OG_00880,FUN_004174-T1,Peve_00019597,Pocillopora_meandrina_HIv1___TS.g17559.t2,three_way,57.525333333333336,FUN_004174-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),35.1,1661.0,5.0999999999999996e-250,867.1,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_00881,FUN_004196-T2,Peve_00030899,Pocillopora_meandrina_HIv1___RNAseq.g17013.t1,three_way,51.406666666666666,FUN_004196-T2,Q60988,STIL_MOUSE,,SCL-interrupting locus protein homolog,Mus musculus (Mouse),25.4,1322.0,1.7e-66,256.5,sp|Q60988|STIL_MOUSE SCL-interrupting locus protein homolog OS=Mus musculus OX=10090 GN=Stil PE=1 SV=2,GO:0000578; GO:0001701; GO:0001843; GO:0001947; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005938; GO:0006915; GO:0007052; GO:0007224; GO:0007368; GO:0021915; GO:0030900; GO:0030903; GO:0033504; GO:0035264; GO:0043066; GO:0046599; GO:0046601; GO:0051298; GO:0060236; GO:0071539; GO:0120099; GO:1900087; GO:1905515; GO:1905832,apoptotic process [GO:0006915]; centrosome duplication [GO:0051298]; determination of left/right symmetry [GO:0007368]; embryonic axis specification [GO:0000578]; floor plate development [GO:0033504]; forebrain development [GO:0030900]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; mitotic spindle organization [GO:0007052]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; notochord development [GO:0030903]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; protein localization to centrosome [GO:0071539]; regulation of centriole replication [GO:0046599]; regulation of mitotic spindle organization [GO:0060236]; smoothened signaling pathway [GO:0007224],cell cortex [GO:0005938]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; procentriole replication complex [GO:0120099],,GO:0005815; GO:0005829; GO:0007010; GO:0012501; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytosol; cytoskeleton organization; programmed cell death; organelle; cilium organization; anatomical structure development
OG_00882,FUN_004197-T1,Peve_00030901,Pocillopora_meandrina_HIv1___RNAseq.g17019.t1,three_way,60.303666666666665,FUN_004197-T1,Q9H6X5,,,,,37.4,147.0,5.9e-19,97.1,sp|Q9H6X5|CS044_HUMAN Uncharacterized protein C19orf44 OS=Homo sapiens OX=9606 GN=C19orf44 PE=1 SV=1,,,,,,
OG_00883,FUN_004198-T1,Peve_00030902,Pocillopora_meandrina_HIv1___RNAseq.g17020.t1,three_way,77.056,FUN_004198-T1,A2VDD2,,,,,46.6,178.0,5.9e-36,152.5,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_00884,FUN_004199-T1,Peve_00030912,Pocillopora_meandrina_HIv1___RNAseq.g17021.t1,three_way,61.85633333333333,FUN_004199-T1,D3YTS9,PPAT_MOUSE,,Testicular acid phosphatase (EC 3.1.3.2) (Acid phosphatase 4),Mus musculus (Mouse),26.8,332.0,8.2e-14,79.7,sp|D3YTS9|PPAT_MOUSE Testicular acid phosphatase OS=Mus musculus OX=10090 GN=Acp4 PE=1 SV=2,GO:0003993; GO:0004725; GO:0010955; GO:0010977; GO:0016020; GO:0030971; GO:0042476; GO:0048168; GO:0120154; GO:1990264,negative regulation of ERBB4 signaling pathway [GO:0120154]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein processing [GO:0010955]; odontogenesis [GO:0042476]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; regulation of neuronal synaptic plasticity [GO:0048168],membrane [GO:0016020],acid phosphatase activity [GO:0003993]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_00885,FUN_004200-T1,Peve_00030913,Pocillopora_meandrina_HIv1___RNAseq.g17022.t1,three_way,70.74116666666667,FUN_004200-T1,Q5ZJ32,,,,,41.7,103.0,4.3e-11,68.9,sp|Q5ZJ32|SOSSC_CHICK SOSS complex subunit C OS=Gallus gallus OX=9031 GN=INIP PE=3 SV=1,,,,,,
OG_00886,FUN_004201-T1,Peve_00030920,Pocillopora_meandrina_HIv1___RNAseq.g17023.t1,three_way,67.14383333333333,,,,,,,,,,,,,,,,,
OG_00887,FUN_004202-T1,Peve_00008456,Pocillopora_meandrina_HIv1___RNAseq.g16814.t1,three_way,83.68566666666666,FUN_004202-T1,Q91W43,GCSP_MOUSE,,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))",Mus musculus (Mouse),66.0,968.0,0.0,1327.0,"sp|Q91W43|GCSP_MOUSE Glycine dehydrogenase (decarboxylating), mitochondrial OS=Mus musculus OX=10090 GN=Gldc PE=1 SV=1",GO:0004375; GO:0005654; GO:0005739; GO:0005886; GO:0005960; GO:0006546; GO:0016594; GO:0016829; GO:0019464; GO:0019899; GO:0030170; GO:0036255; GO:0042803; GO:0065003; GO:0070280; GO:1903442; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein-containing complex assembly [GO:0065003]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005886; GO:0006520; GO:0016491; GO:0016829; GO:0043226; GO:0065003,catalytic activity; nucleoplasm; mitochondrion; plasma membrane; amino acid metabolic process; oxidoreductase activity; lyase activity; organelle; protein-containing complex assembly
OG_00888,FUN_004203-T1,Peve_00008457,Pocillopora_meandrina_HIv1___RNAseq.g16813.t1,three_way,71.75666666666666,FUN_004203-T1,Q9W256,,,,,48.1,81.0,2.8e-17,89.4,sp|Q9W256|DPOE4_DROME DNA polymerase epsilon subunit 4 OS=Drosophila melanogaster OX=7227 GN=PolE4 PE=2 SV=1,,,,,,
OG_00889,FUN_004204-T1,Peve_00018652,Pocillopora_meandrina_HIv1___RNAseq.g16708.t1,three_way,74.196,FUN_004204-T1,Q96LT7,CI072_HUMAN,,Guanine nucleotide exchange factor C9orf72,Homo sapiens (Human),32.5,459.0,9.2e-60,232.6,sp|Q96LT7|CI072_HUMAN Guanine nucleotide exchange factor C9orf72 OS=Homo sapiens OX=9606 GN=C9orf72 PE=1 SV=2,GO:0000932; GO:0001933; GO:0005085; GO:0005096; GO:0005615; GO:0005634; GO:0005737; GO:0005764; GO:0005768; GO:0005776; GO:0005829; GO:0006897; GO:0006914; GO:0010494; GO:0010506; GO:0016239; GO:0030425; GO:0031267; GO:0031965; GO:0032045; GO:0032880; GO:0034063; GO:0043204; GO:0043231; GO:0044295; GO:0044304; GO:0045920; GO:0048675; GO:0050777; GO:0061909; GO:0090543; GO:0098686; GO:0098693; GO:0098794; GO:0098978; GO:0099523; GO:0110053; GO:1902774; GO:1903432; GO:2000785,autophagosome-lysosome fusion [GO:0061909]; autophagy [GO:0006914]; axon extension [GO:0048675]; endocytosis [GO:0006897]; late endosome to lysosome transport [GO:1902774]; negative regulation of exocytosis [GO:0045920]; negative regulation of immune response [GO:0050777]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of macroautophagy [GO:0016239]; regulation of actin filament organization [GO:0110053]; regulation of autophagosome assembly [GO:2000785]; regulation of autophagy [GO:0010506]; regulation of protein localization [GO:0032880]; regulation of synaptic vesicle cycle [GO:0098693]; regulation of TORC1 signaling [GO:1903432]; stress granule assembly [GO:0034063],autophagosome [GO:0005776]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; main axon [GO:0044304]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005615; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0098772,extracellular space; nucleus; lysosome; endosome; vacuole; cytosol; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; molecular function regulator activity
OG_00890,FUN_004205-T1,Peve_00027996,Pocillopora_meandrina_HIv1___RNAseq.g11214.t1,three_way,62.80466666666667,FUN_004205-T1,Q8WWF8,,,,,38.6,184.0,4.4e-29,129.4,sp|Q8WWF8|CAPSL_HUMAN Calcyphosin-like protein OS=Homo sapiens OX=9606 GN=CAPSL PE=1 SV=4,,,,,,
OG_00891,FUN_004206-T1,Peve_00011052,Pocillopora_meandrina_HIv1___RNAseq.g11215.t1,three_way,57.277,FUN_004206-T1,F4INN2,,,,,33.9,165.0,2e-17,90.9,sp|F4INN2|GGP4_ARATH Gamma-glutamyl peptidase 4 OS=Arabidopsis thaliana OX=3702 GN=GGP4 PE=3 SV=1,,,,,,
OG_00892,FUN_004207-T1,Peve_00011047,Pocillopora_meandrina_HIv1___RNAseq.g11217.t1,three_way,88.71266666666666,FUN_004207-T1,Q28GD4,,,,,45.9,362.0,7.100000000000001e-73,275.8,sp|Q28GD4|ELAV2_XENTR ELAV-like protein 2 OS=Xenopus tropicalis OX=8364 GN=elavl2 PE=2 SV=2,,,,,,
OG_00893,FUN_004208-T2,Peve_00011048,Pocillopora_meandrina_HIv1___RNAseq.g11218.t1,three_way,83.40266666666666,FUN_004208-T2,P51688,SPHM_HUMAN,,N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase),Homo sapiens (Human),63.4,432.0,4.3e-168,592.4,sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1,GO:0005764; GO:0006027; GO:0008340; GO:0008484; GO:0016250; GO:0030200; GO:0043202; GO:0046872; GO:0061744; GO:0070062,determination of adult lifespan [GO:0008340]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; motor behavior [GO:0061744],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],metal ion binding [GO:0046872]; N-sulfoglucosamine sulfohydrolase activity [GO:0016250]; sulfuric ester hydrolase activity [GO:0008484],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_00894,FUN_004209-T1,Peve_00011049,Pocillopora_meandrina_HIv1___RNAseq.g11219.t1,three_way,75.62133333333334,FUN_004209-T1,A7SN31,MTAP_NEMVE,,S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase),Nematostella vectensis (Starlet sea anemone),65.2,270.0,1.1e-108,394.4,sp|A7SN31|MTAP_NEMVE S-methyl-5'-thioadenosine phosphorylase OS=Nematostella vectensis OX=45351 GN=v1g214799 PE=3 SV=1,GO:0005634; GO:0005829; GO:0006166; GO:0017061; GO:0019509,L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166],cytosol [GO:0005829]; nucleus [GO:0005634],S-methyl-5-thioadenosine phosphorylase activity [GO:0017061],GO:0003824; GO:0005634; GO:0005829; GO:0006520; GO:0006790; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; cytosol; amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_00895,FUN_004210-T1,Peve_00011050,Pocillopora_meandrina_HIv1___RNAseq.g11220.t2a,three_way,60.159,FUN_004210-T1,Q15717,ELAV1_HUMAN,,ELAV-like protein 1 (Hu-antigen R) (HuR),Homo sapiens (Human),38.7,315.0,4.6e-50,200.3,sp|Q15717|ELAV1_HUMAN ELAV-like protein 1 OS=Homo sapiens OX=9606 GN=ELAVL1 PE=1 SV=2,GO:0000512; GO:0000932; GO:0003723; GO:0003725; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0006606; GO:0008283; GO:0009749; GO:0010494; GO:0010508; GO:0016020; GO:0016528; GO:0019901; GO:0031410; GO:0032930; GO:0035198; GO:0035925; GO:0042803; GO:0045727; GO:0045772; GO:0048255; GO:0051260; GO:0060965; GO:0061157; GO:0070935; GO:0098794; GO:0098978; GO:0106222; GO:1990904; GO:2000036,3'-UTR-mediated mRNA stabilization [GO:0070935]; cell population proliferation [GO:0008283]; lncRNA-mediated post-transcriptional gene silencing [GO:0000512]; mRNA destabilization [GO:0061157]; mRNA stabilization [GO:0048255]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; positive regulation of autophagosome size [GO:0045772]; positive regulation of autophagy [GO:0010508]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of translation [GO:0045727]; protein homooligomerization [GO:0051260]; protein import into nucleus [GO:0006606]; regulation of stem cell population maintenance [GO:2000036]; response to glucose [GO:0009749],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; sarcoplasm [GO:0016528],double-stranded RNA binding [GO:0003725]; lncRNA binding [GO:0106222]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006886; GO:0006913; GO:0031047; GO:0031410; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; endoplasmic reticulum; cytosol; intracellular protein transport; nucleocytoplasmic transport; regulatory ncRNA-mediated gene silencing; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_00896,FUN_004211-T1,Peve_00008870,Pocillopora_meandrina_HIv1___RNAseq.g11221.t1,three_way,62.995,FUN_004211-T1,Q66IC8,,,,,34.2,117.0,2.6e-16,86.3,sp|Q66IC8|DYLT5_DANRE Dynein light chain Tctex-type 5 OS=Danio rerio OX=7955 GN=dynlt5 PE=2 SV=1,,,,,,
OG_00897,FUN_004212-T1,Peve_00008869,Pocillopora_meandrina_HIv1___RNAseq.g11222.t1,three_way,77.88033333333334,FUN_004212-T1,A2VDD2,,,,,49.1,116.0,3.2000000000000003e-28,126.7,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_00898,FUN_004213-T1,Peve_00008868,Pocillopora_meandrina_HIv1___RNAseq.g11223.t1,three_way,82.36266666666667,FUN_004213-T1,Q16739,CEGT_HUMAN,,Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (Glycosylceramide synthase) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase),Homo sapiens (Human),43.0,386.0,9.999999999999999e-92,338.6,sp|Q16739|CEGT_HUMAN Ceramide glucosyltransferase OS=Homo sapiens OX=9606 GN=UGCG PE=1 SV=1,GO:0000139; GO:0006497; GO:0006679; GO:0006688; GO:0008120; GO:0008544; GO:0009966; GO:0016020; GO:0030154; GO:0030216; GO:0033210; GO:0048666; GO:0061436; GO:0098856; GO:1903575,cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid biosynthetic process [GO:0006688]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966],Golgi membrane [GO:0000139]; membrane [GO:0016020],ceramide glucosyltransferase activity [GO:0008120],GO:0003824; GO:0006629; GO:0016740; GO:0022600; GO:0030154; GO:0048856; GO:0061024; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; digestive system process; cell differentiation; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_00899,FUN_004222-T1,Peve_00008875,Pocillopora_meandrina_HIv1___RNAseq.g11224.t1,three_way,60.746833333333335,,,,,,,,,,,,,,,,,
OG_00900,FUN_004223-T1,Peve_00008874,Pocillopora_meandrina_HIv1___RNAseq.g11225.t1,three_way,46.84133333333333,FUN_004223-T1,Q5RDC7,,,,,26.8,287.0,5.7e-15,82.8,sp|Q5RDC7|RWDD3_PONAB RWD domain-containing protein 3 OS=Pongo abelii OX=9601 GN=RWDD3 PE=2 SV=1,,,,,,
OG_00901,FUN_004224-T1,Peve_00008873,Pocillopora_meandrina_HIv1___RNAseq.g11226.t1,three_way,84.43166666666667,FUN_004224-T1,Q32KV4,DC2L1_BOVIN,,Cytoplasmic dynein 2 light intermediate chain 1,Bos taurus (Bovine),49.7,342.0,9.800000000000001e-86,318.5,sp|Q32KV4|DC2L1_BOVIN Cytoplasmic dynein 2 light intermediate chain 1 OS=Bos taurus OX=9913 GN=DYNC2LI1 PE=2 SV=1,GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005930; GO:0035721; GO:0035735; GO:0035869; GO:0036064; GO:0045504; GO:1902017,intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874],dynein heavy chain binding [GO:0045504],GO:0005815; GO:0007018,microtubule organizing center; microtubule-based movement
OG_00902,FUN_004225-T1,Peve_00008866,Pocillopora_meandrina_HIv1___RNAseq.g11227.t1,three_way,81.6255,FUN_004225-T1,Q8BHI9,,,,,63.7,366.0,7.2e-134,478.8,sp|Q8BHI9|NIM1_MOUSE Serine/threonine-protein kinase NIM1 OS=Mus musculus OX=10090 GN=Nim1k PE=2 SV=1,,,,,,
OG_00903,FUN_004226-T1,Peve_00012172,Pocillopora_meandrina_HIv1___RNAseq.g11228.t1,three_way,71.90066666666667,FUN_004226-T1,Q5EA53,T2FA_BOVIN,,General transcription factor IIF subunit 1 (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha),Bos taurus (Bovine),51.5,546.0,1.4e-43,179.1,sp|Q5EA53|T2FA_BOVIN General transcription factor IIF subunit 1 OS=Bos taurus OX=9913 GN=GTF2F1 PE=2 SV=1,GO:0001096; GO:0003677; GO:0005669; GO:0005674; GO:0006367; GO:0006368; GO:0009615; GO:0016251; GO:0019211; GO:0019903; GO:0019904; GO:0030054; GO:0032091; GO:0032968; GO:0045944; GO:1990841,negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; response to virus [GO:0009615]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367],cell junction [GO:0030054]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIF complex [GO:0005674],DNA binding [GO:0003677]; phosphatase activator activity [GO:0019211]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TFIIF-class transcription factor complex binding [GO:0001096],GO:0003677; GO:0006355; GO:0098772; GO:0140223,DNA binding; regulation of DNA-templated transcription; molecular function regulator activity; general transcription initiation factor activity
OG_00904,FUN_004230-T1,Peve_00004624,Pocillopora_meandrina_HIv1___RNAseq.g12558.t1,three_way,76.36133333333333,FUN_004230-T1,Q5PQA4,,,,,27.9,276.0,6.5e-18,94.4,sp|Q5PQA4|NB5R2_XENLA NADH-cytochrome b5 reductase 2 OS=Xenopus laevis OX=8355 GN=cyb5r2 PE=2 SV=1,,,,,,
OG_00905,FUN_004231-T1,Peve_00004622,Pocillopora_meandrina_HIv1___RNAseq.g12557.t1,three_way,62.44083333333334,FUN_004231-T1,Q9Z1N2,ORC1_MOUSE,,Origin recognition complex subunit 1,Mus musculus (Mouse),61.6,398.0,3.2e-132,474.2,sp|Q9Z1N2|ORC1_MOUSE Origin recognition complex subunit 1 OS=Mus musculus OX=10090 GN=Orc1 PE=1 SV=2,GO:0000781; GO:0003677; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005664; GO:0006260; GO:0006270; GO:0016887; GO:0046872,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270],"chromosome, telomeric region [GO:0000781]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006260; GO:0016787; GO:0043226,DNA binding; catalytic activity; nucleus; nucleoplasm; DNA replication; hydrolase activity; organelle
OG_00906,FUN_004233-T1,Peve_00004620,Pocillopora_meandrina_HIv1___RNAseq.g12556.t1,three_way,86.73,FUN_004233-T1,P80363,,,,,44.2,199.0,5.6999999999999995e-46,185.7,sp|P80363|CCB23_FAXLI Crustacean calcium-binding protein 23 OS=Faxonius limosus OX=28379 PE=1 SV=1,,,,,,
OG_00907,FUN_004235-T1,Peve_00037954,Pocillopora_meandrina_HIv1___RNAseq.g11536.t1,three_way,58.8465,FUN_004235-T1,Q6UXP7,,,,,44.5,227.0,5.3e-42,172.6,sp|Q6UXP7|F151B_HUMAN Protein FAM151B OS=Homo sapiens OX=9606 GN=FAM151B PE=1 SV=2,,,,,,
OG_00908,FUN_004236-T1,Peve_00037955,Pocillopora_meandrina_HIv1___RNAseq.g11535.t1,three_way,62.013666666666666,FUN_004236-T1,Q8R507,FKTN_MOUSE,,Ribitol-5-phosphate transferase FKTN (EC 2.7.8.-) (Fukutin) (Fukuyama-type congenital muscular dystrophy protein) (Ribitol-5-phosphate transferase),Mus musculus (Mouse),52.7,292.0,6.3e-92,339.3,sp|Q8R507|FKTN_MOUSE Ribitol-5-phosphate transferase FKTN OS=Mus musculus OX=10090 GN=Fktn PE=1 SV=1,GO:0000139; GO:0001764; GO:0005634; GO:0005783; GO:0005794; GO:0005801; GO:0006486; GO:0006493; GO:0007420; GO:0008285; GO:0016780; GO:0021695; GO:0021987; GO:0035269; GO:0046329; GO:0060049; GO:0071711; GO:0098528,basement membrane organization [GO:0071711]; brain development [GO:0007420]; cerebellar cortex development [GO:0021695]; cerebral cortex development [GO:0021987]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of JNK cascade [GO:0046329]; neuron migration [GO:0001764]; protein glycosylation [GO:0006486]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049]; skeletal muscle fiber differentiation [GO:0098528],cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],"phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0006486; GO:0009101; GO:0016740; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:1901135,catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; protein glycosylation; glycoprotein biosynthetic process; transferase activity; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; cell motility; carbohydrate derivative metabolic process
OG_00909,FUN_004237-T1,Peve_00017641,Pocillopora_meandrina_HIv1___RNAseq.g11534.t1,three_way,79.0,,,,,,,,,,,,,,,,,
OG_00910,FUN_004238-T1,Peve_00006799,Pocillopora_meandrina_HIv1___RNAseq.g11533.t1,three_way,59.7285,,,,,,,,,,,,,,,,,
OG_00911,FUN_004239-T1,Peve_00017639,Pocillopora_meandrina_HIv1___RNAseq.g11532.t1,three_way,83.35266666666666,,,,,,,,,,,,,,,,,
OG_00912,FUN_004246-T1,Peve_00019439,Pocillopora_meandrina_HIv1___RNAseq.g11530.t1,three_way,76.00466666666667,FUN_004246-T1,Q2T9T9,,,,,28.8,393.0,4.6e-38,160.6,sp|Q2T9T9|FBXW9_BOVIN F-box/WD repeat-containing protein 9 OS=Bos taurus OX=9913 GN=FBXW9 PE=2 SV=1,,,,,,
OG_00913,FUN_004247-T1,Peve_00019440,Pocillopora_meandrina_HIv1___RNAseq.g11529.t1,three_way,67.11033333333333,FUN_004247-T1,P41233,,,,,40.9,2521.0,0.0,1671.4,sp|P41233|ABCA1_MOUSE Phospholipid-transporting ATPase ABCA1 OS=Mus musculus OX=10090 GN=Abca1 PE=1 SV=4,,,,,,
OG_00914,FUN_004251-T1,Peve_00006779,Pocillopora_meandrina_HIv1___RNAseq.g11526.t1,three_way,72.405,FUN_004251-T1,Q3ULD5,,,,,49.4,557.0,2.4e-139,497.3,"sp|Q3ULD5|MCCB_MOUSE Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Mus musculus OX=10090 GN=Mccc2 PE=1 SV=1",,,,,,
OG_00915,FUN_004252-T1,Peve_00001934,Pocillopora_meandrina_HIv1___RNAseq.g11419.t1,three_way,88.62766666666667,FUN_004252-T1,Q96MC6,,,,,67.7,439.0,6.8e-170,598.6,sp|Q96MC6|MF14A_HUMAN Hippocampus abundant transcript 1 protein OS=Homo sapiens OX=9606 GN=MFSD14A PE=1 SV=2,,,,,,
OG_00916,FUN_004253-T1,Peve_00001928,Pocillopora_meandrina_HIv1___RNAseq.g11418.t1,three_way,75.71549999999999,FUN_004253-T1,Q9MA55,,,,,30.2,364.0,6e-33,143.7,sp|Q9MA55|ACBP4_ARATH Acyl-CoA-binding domain-containing protein 4 OS=Arabidopsis thaliana OX=3702 GN=ACBP4 PE=1 SV=1,,,,,,
OG_00917,FUN_004254-T1,Peve_00008964,Pocillopora_meandrina_HIv1___RNAseq.g11417.t1,three_way,77.678,FUN_004254-T1,Q8C0T1,,,,,27.2,489.0,1.4e-37,160.2,sp|Q8C0T1|FM1AB_MOUSE Protein fem-1 homolog A-like OS=Mus musculus OX=10090 GN=Fem1al PE=2 SV=1,,,,,,
OG_00918,FUN_004255-T1,Peve_00008965,Pocillopora_meandrina_HIv1___TS.g7526.t1,three_way,53.65533333333333,,,,,,,,,,,,,,,,,
OG_00919,FUN_004259-T1,Peve_00008970,Pocillopora_meandrina_HIv1___RNAseq.g11409.t1,three_way,73.10466666666666,FUN_004259-T1,Q9NTN3,,,,,64.4,278.0,1.5e-97,357.5,sp|Q9NTN3|S35D1_HUMAN Nucleotide sugar transporter SLC35D1 OS=Homo sapiens OX=9606 GN=SLC35D1 PE=1 SV=1,,,,,,
OG_00920,FUN_004261-T1,Peve_00008971,Pocillopora_meandrina_HIv1___RNAseq.g11410.t1,three_way,69.04033333333334,FUN_004261-T1,Q2F7Z7,,,,,32.3,297.0,9.2e-29,129.0,sp|Q2F7Z7|TMM59_PIG Transmembrane protein 59 OS=Sus scrofa OX=9823 GN=TMEM59 PE=2 SV=1,,,,,,
OG_00921,FUN_004263-T1,Peve_00008934,Pocillopora_meandrina_HIv1___RNAseq.g11364.t1,three_way,72.5965,,,,,,,,,,,,,,,,,
OG_00922,FUN_004264-T1,Peve_00008933,Pocillopora_meandrina_HIv1___RNAseq.g11655.t1,three_way,77.1215,FUN_004264-T1,P53349,M3K1_MOUSE,,Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1),Mus musculus (Mouse),36.4,1345.0,9.2e-204,712.2,sp|P53349|M3K1_MOUSE Mitogen-activated protein kinase kinase kinase 1 OS=Mus musculus OX=10090 GN=Map3k1 PE=1 SV=3,GO:0002011; GO:0003382; GO:0004672; GO:0004706; GO:0004708; GO:0005524; GO:0005829; GO:0007179; GO:0007254; GO:0008092; GO:0008270; GO:0008637; GO:0030334; GO:0030838; GO:0031941; GO:0042060; GO:0043010; GO:0061029; GO:0070160; GO:0106310,apoptotic mitochondrial changes [GO:0008637]; camera-type eye development [GO:0043010]; epithelial cell morphogenesis [GO:0003382]; eyelid development in camera-type eye [GO:0061029]; JNK cascade [GO:0007254]; morphogenesis of an epithelial sheet [GO:0002011]; positive regulation of actin filament polymerization [GO:0030838]; regulation of cell migration [GO:0030334]; transforming growth factor beta receptor signaling pathway [GO:0007179]; wound healing [GO:0042060],cytosol [GO:0005829]; filamentous actin [GO:0031941]; tight junction [GO:0070160],ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase activity [GO:0004708]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0007005; GO:0008092; GO:0016740; GO:0042060; GO:0048856; GO:0140096,"catalytic activity; cytosol; mitochondrion organization; cytoskeletal protein binding; transferase activity; wound healing; anatomical structure development; catalytic activity, acting on a protein"
OG_00923,FUN_004265-T1,Peve_00021038,Pocillopora_meandrina_HIv1___RNAseq.g11654.t1,three_way,45.958666666666666,,,,,,,,,,,,,,,,,
OG_00924,FUN_004266-T1,Peve_00021034,Pocillopora_meandrina_HIv1___RNAseq.g11360.t1,three_way,80.82633333333334,,,,,,,,,,,,,,,,,
OG_00925,FUN_004268-T1,Peve_00021035,Pocillopora_meandrina_HIv1___RNAseq.g11361.t1,three_way,71.7055,,,,,,,,,,,,,,,,,
OG_00926,FUN_004269-T1,Peve_00021033,Pocillopora_meandrina_HIv1___RNAseq.g11362.t1,three_way,67.267,,,,,,,,,,,,,,,,,
OG_00927,FUN_004270-T1,Peve_00021042,Pocillopora_meandrina_HIv1___RNAseq.g11363.t1,three_way,74.17066666666666,FUN_004270-T1,O35459,,,,,53.2,297.0,1.8e-91,337.4,"sp|O35459|ECH1_MOUSE Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial OS=Mus musculus OX=10090 GN=Ech1 PE=1 SV=1",,,,,,
OG_00928,FUN_004272-T1,Peve_00008943,Pocillopora_meandrina_HIv1___RNAseq.g11367.t1,three_way,57.94233333333333,,,,,,,,,,,,,,,,,
OG_00929,FUN_004274-T1,Peve_00008944,Pocillopora_meandrina_HIv1___RNAseq.g12548.t1,three_way,41.06316666666667,,,,,,,,,,,,,,,,,
OG_00930,FUN_004275-T1,Peve_00008946,Pocillopora_meandrina_HIv1___RNAseq.g12553.t1,three_way,69.154,FUN_004275-T1,Q7ZVP8,TM38B_DANRE,,Trimeric intracellular cation channel type B (TRIC-B) (TRICB) (Transmembrane protein 38B),Danio rerio (Zebrafish) (Brachydanio rerio),35.1,251.0,9.999999999999999e-32,138.7,sp|Q7ZVP8|TM38B_DANRE Trimeric intracellular cation channel type B OS=Danio rerio OX=7955 GN=tmem38b PE=2 SV=1,GO:0005267; GO:0005783; GO:0005789; GO:0030500; GO:0031101; GO:0042802; GO:0051279; GO:1903010,fin regeneration [GO:0031101]; regulation of bone development [GO:1903010]; regulation of bone mineralization [GO:0030500]; regulation of release of sequestered calcium ion into cytosol [GO:0051279],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],identical protein binding [GO:0042802]; potassium channel activity [GO:0005267],GO:0005215; GO:0005783; GO:0043226; GO:0048856,transporter activity; endoplasmic reticulum; organelle; anatomical structure development
OG_00931,FUN_004276-T1,Peve_00008947,Pocillopora_meandrina_HIv1___TS.g18429.t1,three_way,69.30033333333334,FUN_004276-T1,Q9I8J6,,,,,41.7,168.0,5.7e-26,119.8,sp|Q9I8J6|EBP2_XENLA Probable rRNA-processing protein EBP2 OS=Xenopus laevis OX=8355 GN=ebna1bp2 PE=2 SV=1,,,,,,
OG_00932,FUN_004277-T1,Peve_00008949,Pocillopora_meandrina_HIv1___RNAseq.g12518.t1,three_way,65.70383333333334,FUN_004277-T1,F7C1E2,,,,,36.2,345.0,4.2e-48,193.4,sp|F7C1E2|SARAF_XENTR Store-operated calcium entry-associated regulatory factor OS=Xenopus tropicalis OX=8364 GN=saraf PE=3 SV=2,,,,,,
OG_00933,FUN_004280-T1,Peve_00008953,Pocillopora_meandrina_HIv1___RNAseq.g12516.t1,three_way,53.32783333333333,FUN_004280-T1,Q1LV50,,,,,25.3,288.0,7.3e-16,86.3,sp|Q1LV50|CENPP_DANRE Centromere protein P OS=Danio rerio OX=7955 GN=cenpp PE=2 SV=1,,,,,,
OG_00934,FUN_004282-T1,Peve_00030013,Pocillopora_meandrina_HIv1___TS.g18389.t1,three_way,77.80233333333334,FUN_004282-T1,Q6P5L8,,,,,63.1,415.0,7.1e-144,511.9,sp|Q6P5L8|HSDL2_DANRE Hydroxysteroid dehydrogenase-like protein 2 OS=Danio rerio OX=7955 GN=hsdl2 PE=2 SV=1,,,,,,
OG_00935,FUN_004284-T1,Peve_00030010,Pocillopora_meandrina_HIv1___RNAseq.g12512.t1,three_way,59.60416666666666,FUN_004284-T1,Q9V576,WUN_DROME,,Putative phosphatidate phosphatase (EC 3.1.3.4) (Germ cell guidance factor) (Phosphatidic acid phosphatase type 2) (Protein wunen),Drosophila melanogaster (Fruit fly),35.2,261.0,1.2999999999999998e-43,178.3,sp|Q9V576|WUN_DROME Putative phosphatidate phosphatase OS=Drosophila melanogaster OX=7227 GN=wun PE=1 SV=2,GO:0005886; GO:0005918; GO:0006644; GO:0007165; GO:0007424; GO:0008195; GO:0008354; GO:0016328; GO:0016791; GO:0019991; GO:0030703; GO:0035233; GO:0035234; GO:0045177; GO:0045824; GO:0046839; GO:0050829,defense response to Gram-negative bacterium [GO:0050829]; ectopic germ cell programmed cell death [GO:0035234]; eggshell formation [GO:0030703]; germ cell migration [GO:0008354]; germ cell repulsion [GO:0035233]; negative regulation of innate immune response [GO:0045824]; open tracheal system development [GO:0007424]; phospholipid dephosphorylation [GO:0046839]; phospholipid metabolic process [GO:0006644]; septate junction assembly [GO:0019991]; signal transduction [GO:0007165],apical part of cell [GO:0045177]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; septate junction [GO:0005918],phosphatase activity [GO:0016791]; phosphatidate phosphatase activity [GO:0008195],GO:0003824; GO:0005886; GO:0006629; GO:0012501; GO:0016787; GO:0022414; GO:0034330; GO:0048856; GO:0048870,catalytic activity; plasma membrane; lipid metabolic process; programmed cell death; hydrolase activity; reproductive process; cell junction organization; anatomical structure development; cell motility
OG_00936,FUN_004285-T1,Peve_00018587,Pocillopora_meandrina_HIv1___TS.g7877.t1,three_way,51.23383333333334,FUN_004285-T1,Q15811,,,,,38.4,86.0,2.3e-07,60.1,sp|Q15811|ITSN1_HUMAN Intersectin-1 OS=Homo sapiens OX=9606 GN=ITSN1 PE=1 SV=3,,,,,,
OG_00937,FUN_004286-T1,Peve_00018586,Pocillopora_meandrina_HIv1___RNAseq.g11765.t1,three_way,67.23033333333333,FUN_004286-T1,Q6NU91,,,,,42.3,515.0,5.9e-106,386.3,sp|Q6NU91|NOC4B_XENLA Nucleolar complex protein 4 homolog B OS=Xenopus laevis OX=8355 GN=noc4l-b PE=2 SV=1,,,,,,
OG_00938,FUN_004288-T1,Peve_00029197,Pocillopora_meandrina_HIv1___RNAseq.g11767.t1,three_way,35.059,,,,,,,,,,,,,,,,,
OG_00939,FUN_004290-T1,Peve_00008387,Pocillopora_meandrina_HIv1___RNAseq.g11768.t1,three_way,59.25366666666667,FUN_004290-T1,P41180,CASR_HUMAN,,Extracellular calcium-sensing receptor (CaR) (CaSR) (hCasR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1),Homo sapiens (Human),28.5,868.0,9.7e-87,323.2,sp|P41180|CASR_HUMAN Extracellular calcium-sensing receptor OS=Homo sapiens OX=9606 GN=CASR PE=1 SV=3,GO:0001503; GO:0002931; GO:0004435; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0007635; GO:0008284; GO:0009653; GO:0009986; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042802; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; anatomical structure morphogenesis [GO:0009653]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chemosensory behavior [GO:0007635]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; vasodilation [GO:0042311],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],"amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325]",GO:0003013; GO:0003824; GO:0005886; GO:0016787; GO:0048856; GO:0055085; GO:0060089,circulatory system process; catalytic activity; plasma membrane; hydrolase activity; anatomical structure development; transmembrane transport; molecular transducer activity
OG_00940,FUN_004291-T1,Peve_00008388,Pocillopora_meandrina_HIv1___RNAseq.g11769.t1,three_way,79.22033333333333,FUN_004291-T1,Q6NYT1,,,,,50.8,195.0,5.1e-46,186.0,sp|Q6NYT1|MED8_DANRE Mediator of RNA polymerase II transcription subunit 8 OS=Danio rerio OX=7955 GN=med8 PE=2 SV=1,,,,,,
OG_00941,FUN_004292-T1,Peve_00008379,Pocillopora_meandrina_HIv1___RNAseq.g11770.t1,three_way,65.67333333333333,FUN_004292-T1,Q08CD5,RXLT1_DANRE,,"Ribitol-5-phosphate xylosyltransferase 1 (EC 2.4.2.61) (Transmembrane protein 5) (UDP-D-xylose:ribitol-5-phosphate beta1,4-xylosyltransferase)",Danio rerio (Zebrafish) (Brachydanio rerio),50.6,332.0,1.6e-100,367.9,sp|Q08CD5|RXLT1_DANRE Ribitol-5-phosphate xylosyltransferase 1 OS=Danio rerio OX=7955 GN=rxylt1 PE=2 SV=2,GO:0000139; GO:0005794; GO:0035269; GO:0120053,protein O-linked mannosylation [GO:0035269],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],"ribitol beta-1,4-xylosyltransferase activity [GO:0120053]",GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_00942,FUN_004293-T1,Peve_00008382,Pocillopora_meandrina_HIv1___RNAseq.g11771.t1,three_way,62.1905,FUN_004293-T1,A2A9C3,SZT2_MOUSE,,KICSTOR complex protein SZT2 (Seizure threshold 2 protein) (Transcript increased in glutamate resistance) (TIGR),Mus musculus (Mouse),30.2,3639.0,0.0,1353.6,sp|A2A9C3|SZT2_MOUSE KICSTOR complex protein SZT2 OS=Mus musculus OX=10090 GN=Szt2 PE=1 SV=1,GO:0005765; GO:0005777; GO:0007417; GO:0009791; GO:0021540; GO:0031667; GO:0034198; GO:0042149; GO:0043473; GO:0061462; GO:0061700; GO:0140007; GO:1901668; GO:1904262; GO:1990130,cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; central nervous system development [GO:0007417]; corpus callosum morphogenesis [GO:0021540]; negative regulation of TORC1 signaling [GO:1904262]; pigmentation [GO:0043473]; post-embryonic development [GO:0009791]; protein localization to lysosome [GO:0061462]; regulation of superoxide dismutase activity [GO:1901668]; response to nutrient levels [GO:0031667],GATOR1 complex [GO:1990130]; GATOR2 complex [GO:0061700]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; peroxisome [GO:0005777],,GO:0005777; GO:0043226; GO:0048856,peroxisome; organelle; anatomical structure development
OG_00943,FUN_004295-T1,Peve_00015845,Pocillopora_meandrina_HIv1___TS.g7893.t1,three_way,62.836666666666666,FUN_004295-T1,O96952,,,,,47.5,101.0,6.5e-21,101.7,sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1,,,,,,
OG_00944,FUN_004298-T1,Peve_00018886,Pocillopora_meandrina_HIv1___RNAseq.g11773.t1,three_way,95.47533333333332,FUN_004298-T1,P25228,RAB3_DROME,,Ras-related protein Rab-3,Drosophila melanogaster (Fruit fly),80.5,221.0,7.7e-102,371.3,sp|P25228|RAB3_DROME Ras-related protein Rab-3 OS=Drosophila melanogaster OX=7227 GN=Rab3 PE=1 SV=1,GO:0000287; GO:0003924; GO:0005525; GO:0005768; GO:0005886; GO:0006887; GO:0007269; GO:0008021; GO:0015031; GO:0016192; GO:0031489; GO:0031630; GO:0031982; GO:0032482; GO:0045202; GO:0046718; GO:0046928; GO:0048172; GO:0048786; GO:0048789; GO:0048790,cytoskeletal matrix organization at active zone [GO:0048789]; exocytosis [GO:0006887]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of neurotransmitter secretion [GO:0046928]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; symbiont entry into host cell [GO:0046718]; vesicle-mediated transport [GO:0016192],endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; myosin V binding [GO:0031489],GO:0003824; GO:0003924; GO:0005768; GO:0005886; GO:0007010; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0034330; GO:0043226,catalytic activity; GTPase activity; endosome; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; cell junction organization; organelle
OG_00945,FUN_004302-T1,Peve_00033935,Pocillopora_meandrina_HIv1___RNAseq.g11774.t1,three_way,84.65366666666667,FUN_004302-T1,Q90988,SMC2_CHICK,,Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome scaffold protein ScII),Gallus gallus (Chicken),61.0,1173.0,6.6999999999999996e-264,912.1,sp|Q90988|SMC2_CHICK Structural maintenance of chromosomes protein 2 OS=Gallus gallus OX=9031 GN=SMC2 PE=2 SV=1,GO:0000785; GO:0000793; GO:0000796; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0007076; GO:0016887; GO:0051301,cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],chromatin [GO:0000785]; condensed chromosome [GO:0000793]; condensin complex [GO:0000796]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682],GO:0003824; GO:0005634; GO:0005694; GO:0016787; GO:0043226,catalytic activity; nucleus; chromosome; hydrolase activity; organelle
OG_00946,FUN_004303-T1,Peve_00033932,Pocillopora_meandrina_HIv1___RNAseq.g11775.t1,three_way,66.79366666666667,FUN_004303-T1,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),39.8,698.0,4.9e-140,500.0,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_00947,FUN_004306-T1,Peve_00033931,Pocillopora_meandrina_HIv1___RNAseq.g11777.t1,three_way,85.68866666666666,FUN_004306-T1,Q86VS8,HOOK3_HUMAN,,Protein Hook homolog 3 (h-hook3) (hHK3),Homo sapiens (Human),49.9,711.0,5.7e-82,307.0,sp|Q86VS8|HOOK3_HUMAN Protein Hook homolog 3 OS=Homo sapiens OX=9606 GN=HOOK3 PE=1 SV=2,GO:0000242; GO:0005737; GO:0005801; GO:0005813; GO:0005874; GO:0007032; GO:0007040; GO:0008017; GO:0008333; GO:0015031; GO:0022027; GO:0030705; GO:0031122; GO:0034451; GO:0034452; GO:0034454; GO:0042802; GO:0045022; GO:0045503; GO:0045505; GO:0050768; GO:0051645; GO:0051959; GO:0070695; GO:0071539; GO:0097150; GO:1905719,cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein transport [GO:0015031],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242],dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0007040; GO:0008092; GO:0016192; GO:0043226,microtubule organizing center; cytoskeleton organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; organelle
OG_00948,FUN_004307-T1,Peve_00033930,Pocillopora_meandrina_HIv1___RNAseq.g11779.t1,three_way,63.568666666666665,FUN_004307-T1,O96952,,,,,51.0,102.0,1.3e-23,111.3,sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1,,,,,,
OG_00949,FUN_004308-T1,Peve_00033939,Pocillopora_meandrina_HIv1___RNAseq.g16898.t1,three_way,74.65783333333333,,,,,,,,,,,,,,,,,
OG_00950,FUN_004310-T1,Peve_00033937,Pocillopora_meandrina_HIv1___RNAseq.g16984.t1,three_way,77.72666666666666,FUN_004310-T1,Q9JJT0,,,,,62.3,374.0,1.7e-141,503.8,sp|Q9JJT0|RCL1_MOUSE RNA 3'-terminal phosphate cyclase-like protein OS=Mus musculus OX=10090 GN=Rcl1 PE=2 SV=1,,,,,,
OG_00951,FUN_004311-T1,Peve_00033936,Pocillopora_meandrina_HIv1___RNAseq.g16985.t1,three_way,93.19266666666668,FUN_004311-T1,Q32PE0,RPAB2_BOVIN,,"DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (RPB6 homolog)",Bos taurus (Bovine),89.7,78.0,2e-33,143.3,"sp|Q32PE0|RPAB2_BOVIN DNA-directed RNA polymerases I, II, and III subunit RPABC2 OS=Bos taurus OX=9913 GN=POLR2F PE=1 SV=1",GO:0003677; GO:0003899; GO:0005634; GO:0005665; GO:0005666; GO:0005736; GO:0006360; GO:0006366; GO:0042797,transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; tRNA transcription by RNA polymerase III [GO:0042797],"nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II, core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]",DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899],GO:0003677; GO:0003824; GO:0005634; GO:0006351; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"DNA binding; catalytic activity; nucleus; DNA-templated transcription; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_00952,FUN_004312-T1,Peve_00033934,Pocillopora_meandrina_HIv1___RNAseq.g16986.t1,three_way,70.072,FUN_004312-T1,Q98864,,,,,42.5,1133.0,1.3999999999999999e-244,847.8,sp|Q98864|PTC1_DANRE Protein patched homolog 1 OS=Danio rerio OX=7955 GN=ptch1 PE=2 SV=1,,,,,,
OG_00953,FUN_004313-T1,Peve_00033929,Pocillopora_meandrina_HIv1___RNAseq.g16987.t1,three_way,67.48483333333334,FUN_004313-T1,Q90693,,,,,37.8,1339.0,2e-235,817.8,sp|Q90693|PTC1_CHICK Protein patched homolog 1 OS=Gallus gallus OX=9031 GN=PTCH1 PE=1 SV=1,,,,,,
OG_00954,FUN_004316-T1,Peve_00031173,Pocillopora_meandrina_HIv1___RNAseq.g16988.t1,three_way,69.04466666666667,FUN_004316-T1,Q6BRB7,,,,,27.9,140.0,3e-10,67.4,sp|Q6BRB7|ERG6_DEBHA Sterol 24-C-methyltransferase OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) OX=284592 GN=ERG6 PE=3 SV=1,,,,,,
OG_00955,FUN_004317-T1,Peve_00016511,Pocillopora_meandrina_HIv1___RNAseq.g16989.t1,three_way,64.531,FUN_004317-T1,Q3ZCD7,TECR_BOVIN,,"Very-long-chain enoyl-CoA reductase (EC 1.3.1.93) (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase) (TER)",Bos taurus (Bovine),51.6,304.0,3.5000000000000004e-89,329.7,sp|Q3ZCD7|TECR_BOVIN Very-long-chain enoyl-CoA reductase OS=Bos taurus OX=9913 GN=TECR PE=2 SV=1,GO:0005783; GO:0005789; GO:0006665; GO:0006694; GO:0016491; GO:0030497; GO:0042761; GO:0102758,fatty acid elongation [GO:0030497]; sphingolipid metabolic process [GO:0006665]; steroid biosynthetic process [GO:0006694]; very long-chain fatty acid biosynthetic process [GO:0042761],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle
OG_00956,FUN_004320-T1,Peve_00016509,Pocillopora_meandrina_HIv1___TS.g17822.t1,three_way,44.053333333333335,,,,,,,,,,,,,,,,,
OG_00957,FUN_004321-T1,Peve_00016506,Pocillopora_meandrina_HIv1___RNAseq.g11786.t1,three_way,75.91266666666667,FUN_004321-T1,P54357,,,,,42.0,143.0,3.7e-23,109.4,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_00958,FUN_004322-T1,Peve_00016504,Pocillopora_meandrina_HIv1___TS.g7899.t1,three_way,40.04683333333333,,,,,,,,,,,,,,,,,
OG_00959,FUN_004323-T1,Peve_00016503,Pocillopora_meandrina_HIv1___RNAseq.g11211.t1,three_way,62.519666666666666,FUN_004323-T1,P16066,ANPRA_HUMAN,,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),Homo sapiens (Human),52.7,237.0,1.3e-61,239.2,sp|P16066|ANPRA_HUMAN Atrial natriuretic peptide receptor 1 OS=Homo sapiens OX=9606 GN=NPR1 PE=1 SV=1,GO:0001653; GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007166; GO:0007168; GO:0007589; GO:0008217; GO:0008528; GO:0010753; GO:0016525; GO:0016941; GO:0017046; GO:0019934; GO:0030308; GO:0035810; GO:0035815; GO:0042417; GO:0042562; GO:0043114; GO:0043235; GO:0048662; GO:0097746; GO:1990620,blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114],ANPR-A receptor complex [GO:1990620]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; G protein-coupled peptide receptor activity [GO:0008528]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672],GO:0003013; GO:0003014; GO:0003824; GO:0005886; GO:0009975; GO:0016740; GO:0016829; GO:0055086; GO:0060089; GO:0140096; GO:1901135,"circulatory system process; renal system process; catalytic activity; plasma membrane; cyclase activity; transferase activity; lyase activity; nucleobase-containing small molecule metabolic process; molecular transducer activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_00960,FUN_004324-T1,Peve_00016500,Pocillopora_meandrina_HIv1___RNAseq.g11781.t1,three_way,60.91866666666666,FUN_004324-T1,Q9BDJ3,,,,,45.5,99.0,3.6e-20,99.0,sp|Q9BDJ3|THIO_CALJA Thioredoxin OS=Callithrix jacchus OX=9483 GN=TXN PE=3 SV=3,,,,,,
OG_00961,FUN_004330-T1,Peve_00016550,Pocillopora_meandrina_HIv1___RNAseq.g12529.t1,three_way,89.566,FUN_004330-T1,A6QPA3,,,,,37.2,277.0,1.1999999999999999e-41,171.8,sp|A6QPA3|BTBDJ_BOVIN BTB/POZ domain-containing protein 19 OS=Bos taurus OX=9913 GN=BTBD19 PE=2 SV=1,,,,,,
OG_00962,FUN_004331-T1,Peve_00016476,Pocillopora_meandrina_HIv1___TS.g18404.t1,three_way,55.634,FUN_004331-T1,Q9V9S7,,,,,33.4,347.0,5.9e-43,177.9,sp|Q9V9S7|SYDE_DROME Rho GTPase-activating protein 100F OS=Drosophila melanogaster OX=7227 GN=RhoGAP100F PE=1 SV=2,,,,,,
OG_00963,FUN_004332-T1,Peve_00016477,Pocillopora_meandrina_HIv1___RNAseq.g12532.t1,three_way,86.59233333333333,FUN_004332-T1,Q9UNH5,CC14A_HUMAN,,Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A),Homo sapiens (Human),60.3,459.0,1.4000000000000002e-161,570.9,sp|Q9UNH5|CC14A_HUMAN Dual specificity protein phosphatase CDC14A OS=Homo sapiens OX=9606 GN=CDC14A PE=1 SV=1,GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005654; GO:0005730; GO:0005737; GO:0005783; GO:0005813; GO:0005829; GO:0007096; GO:0007605; GO:0032426; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686; GO:1902636,cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426],protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005730; GO:0005783; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0016787; GO:0043226; GO:0044782; GO:0050877; GO:0140096,"catalytic activity; nucleoplasm; nucleolus; endoplasmic reticulum; microtubule organizing center; cytosol; cilium; cytoskeleton organization; hydrolase activity; organelle; cilium organization; nervous system process; catalytic activity, acting on a protein"
OG_00964,FUN_004333-T1,Peve_00016478,Pocillopora_meandrina_HIv1___RNAseq.g12533.t1,three_way,66.423,,,,,,,,,,,,,,,,,
OG_00965,FUN_004335-T1,Peve_00016479,Pocillopora_meandrina_HIv1___RNAseq.g12535.t1,three_way,64.53633333333333,FUN_004335-T1,P17972,KCNAW_DROME,,Potassium voltage-gated channel protein Shaw (Shaw2),Drosophila melanogaster (Fruit fly),41.2,434.0,8.2e-93,343.2,sp|P17972|KCNAW_DROME Potassium voltage-gated channel protein Shaw OS=Drosophila melanogaster OX=7227 GN=Shaw PE=2 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0022843; GO:0030431; GO:0032590; GO:0032809; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; sleep [GO:0030431],axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_00966,FUN_004336-T1,Peve_00016480,Pocillopora_meandrina_HIv1___RNAseq.g12536.t1,three_way,66.4225,FUN_004336-T1,P17972,KCNAW_DROME,,Potassium voltage-gated channel protein Shaw (Shaw2),Drosophila melanogaster (Fruit fly),40.4,436.0,4.6e-91,337.4,sp|P17972|KCNAW_DROME Potassium voltage-gated channel protein Shaw OS=Drosophila melanogaster OX=7227 GN=Shaw PE=2 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0022843; GO:0030431; GO:0032590; GO:0032809; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; sleep [GO:0030431],axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_00967,FUN_004338-T1,Peve_00016481,Pocillopora_meandrina_HIv1___TS.g18411.t1,three_way,46.418,,,,,,,,,,,,,,,,,
OG_00968,FUN_004339-T1,Peve_00016482,Pocillopora_meandrina_HIv1___RNAseq.g12538.t1,three_way,82.318,FUN_004339-T1,E9Q3T6,PRD14_MOUSE,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Mus musculus (Mouse),45.6,320.0,2.4e-68,261.2,sp|E9Q3T6|PRD14_MOUSE PR domain zinc finger protein 14 OS=Mus musculus OX=10090 GN=Prdm14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0032259; GO:0040029; GO:0040037; GO:0045814; GO:0048873; GO:0060818; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of gene expression [GO:0010468]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_00969,FUN_004342-T1,Peve_00016486,Pocillopora_meandrina_HIv1___RNAseq.g12543.t1,three_way,62.193333333333335,FUN_004342-T1,Q9Y5Q9,,,,,36.5,824.0,3.9e-142,507.3,sp|Q9Y5Q9|TF3C3_HUMAN General transcription factor 3C polypeptide 3 OS=Homo sapiens OX=9606 GN=GTF3C3 PE=1 SV=1,,,,,,
OG_00970,FUN_004344-T1,Peve_00016489,Pocillopora_meandrina_HIv1___TS.g17663.t1,three_way,63.24366666666667,FUN_004344-T1,Q5BIM1,,,,,27.3,501.0,9.1e-49,196.8,sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1,,,,,,
OG_00971,FUN_004345-T1,Peve_00016491,Pocillopora_meandrina_HIv1___RNAseq.g16895.t1,three_way,48.77833333333333,,,,,,,,,,,,,,,,,
OG_00972,FUN_004346-T1,Peve_00016493,Pocillopora_meandrina_HIv1___RNAseq.g16896.t1,three_way,82.173,FUN_004346-T1,Q8BRK8,AAPK2_MOUSE,,5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31),Mus musculus (Mouse),58.6,561.0,3.1e-179,629.8,sp|Q8BRK8|AAPK2_MOUSE 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Mus musculus OX=10090 GN=Prkaa2 PE=1 SV=3,GO:0003682; GO:0004674; GO:0004679; GO:0004712; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006468; GO:0006633; GO:0006695; GO:0006914; GO:0008610; GO:0010468; GO:0010494; GO:0010508; GO:0010629; GO:0014850; GO:0016055; GO:0016241; GO:0016607; GO:0030424; GO:0030425; GO:0031588; GO:0031669; GO:0032007; GO:0034599; GO:0036064; GO:0042149; GO:0042593; GO:0042752; GO:0043025; GO:0043066; GO:0045821; GO:0046872; GO:0047322; GO:0048511; GO:0055089; GO:0062028; GO:0070507; GO:0071277; GO:0071333; GO:0071380; GO:0071466; GO:0097009; GO:0106310; GO:0140823; GO:1903829; GO:1903944; GO:1904262; GO:1904428; GO:1905691; GO:1990044,autophagy [GO:0006914]; cellular response to calcium ion [GO:0071277]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cellular response to xenobiotic stimulus [GO:0071466]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; lipid biosynthetic process [GO:0008610]; lipid droplet disassembly [GO:1905691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of glycolytic process [GO:0045821]; positive regulation of protein localization [GO:1903829]; protein localization to lipid droplet [GO:1990044]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634],[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone H2BS36 kinase activity [GO:0140823]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712],GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; lipid metabolic process; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_00973,FUN_004347-T1,Peve_00016492,Pocillopora_meandrina_HIv1___RNAseq.g16897.t1,three_way,84.23366666666666,FUN_004347-T1,Q1JPJ8,,,,,63.9,538.0,1.2e-207,724.2,sp|Q1JPJ8|THOP1_BOVIN Thimet oligopeptidase OS=Bos taurus OX=9913 GN=THOP1 PE=2 SV=3,,,,,,
OG_00974,FUN_004350-T1,Peve_00016543,Pocillopora_meandrina_HIv1___RNAseq.g12505.t1,three_way,81.94066666666667,FUN_004350-T1,P28288,ABCD3_HUMAN,,ATP-binding cassette sub-family D member 3 (EC 3.1.2.-) (EC 7.6.2.-) (70 kDa peroxisomal membrane protein) (PMP70),Homo sapiens (Human),66.0,617.0,2.3e-245,849.7,sp|P28288|ABCD3_HUMAN ATP-binding cassette sub-family D member 3 OS=Homo sapiens OX=9606 GN=ABCD3 PE=1 SV=1,GO:0000038; GO:0005324; GO:0005524; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006633; GO:0006635; GO:0006699; GO:0007031; GO:0009410; GO:0015721; GO:0015910; GO:0016020; GO:0016887; GO:0042626; GO:0042760; GO:0042803; GO:0043231; GO:0047617; GO:0140359; GO:1903512,bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; fatty acid beta-oxidation [GO:0006635]; fatty acid biosynthetic process [GO:0006633]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; phytanic acid metabolic process [GO:1903512]; response to xenobiotic stimulus [GO:0009410]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_00975,FUN_004351-T1,Peve_00016542,Pocillopora_meandrina_HIv1___RNAseq.g12503.t1,three_way,91.29333333333334,FUN_004351-T1,Q5NC57,CF144_MOUSE,,Cilia- and flagella-associated protein 144 (Testis highly expressed protein 6),Mus musculus (Mouse),44.4,117.0,3.8e-19,95.9,sp|Q5NC57|CF144_MOUSE Cilia- and flagella-associated protein 144 OS=Mus musculus OX=10090 GN=Cfap144 PE=1 SV=2,GO:0005813; GO:0030317; GO:0036064; GO:0036126; GO:0097546; GO:0160112,flagellated sperm motility [GO:0030317],axonemal B tubule inner sheath [GO:0160112]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; sperm flagellum [GO:0036126],,GO:0005815; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,microtubule organizing center; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_00976,FUN_004354-T1,Peve_00016538,Pocillopora_meandrina_HIv1___RNAseq.g11213.t1,three_way,76.011,FUN_004354-T1,P43141,,,,,28.8,316.0,1.3e-14,82.4,sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1,,,,,,
OG_00977,FUN_004356-T1,Peve_00016494,Pocillopora_meandrina_HIv1___RNAseq.g12547.t1,three_way,92.93433333333331,FUN_004356-T1,Q9R1K5,FZR1_MOUSE,,Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog),Mus musculus (Mouse),72.8,500.0,3.4e-203,709.1,sp|Q9R1K5|FZR1_MOUSE Fizzy-related protein homolog OS=Mus musculus OX=10090 GN=Fzr1 PE=1 SV=1,GO:0005654; GO:0006281; GO:0007095; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031965; GO:0040020; GO:0051301; GO:0051603; GO:0070306; GO:0097027; GO:1904668; GO:1990756; GO:2000773,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; DNA repair [GO:0006281]; lens fiber cell differentiation [GO:0070306]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of cellular senescence [GO:2000773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of meiotic nuclear division [GO:0040020],nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654],anaphase-promoting complex binding [GO:0010997]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005654; GO:0006281; GO:0030154; GO:0030163; GO:0060090; GO:0098772,nucleoplasm; DNA repair; cell differentiation; protein catabolic process; molecular adaptor activity; molecular function regulator activity
OG_00978,FUN_004358-T1,Peve_00016483,Pocillopora_meandrina_HIv1___RNAseq.g12546.t1,three_way,66.67666666666668,FUN_004358-T1,P0CL18,,,,,39.6,618.0,1.2e-125,451.8,sp|P0CL18|EIF2D_RABIT Eukaryotic translation initiation factor 2D OS=Oryctolagus cuniculus OX=9986 GN=EIF2D PE=1 SV=1,,,,,,
OG_00979,FUN_004359-T1,Peve_00016475,Pocillopora_meandrina_HIv1___RNAseq.g11450.t1,three_way,60.76133333333333,FUN_004359-T1,Q1LZA4,,,,,36.1,404.0,9.6e-59,229.6,sp|Q1LZA4|PIGW_BOVIN Glucosaminyl-phosphatidylinositol-acyltransferase PIGW OS=Bos taurus OX=9913 GN=PIGW PE=2 SV=1,,,,,,
OG_00980,FUN_004360-T1,Peve_00016540,Pocillopora_meandrina_HIv1___RNAseq.g11449.t1,three_way,67.69066666666667,,,,,,,,,,,,,,,,,
OG_00981,FUN_004361-T1,Peve_00016675,Pocillopora_meandrina_HIv1___RNAseq.g11448.t1,three_way,87.992,FUN_004361-T1,Q6DC04,CARM1_DANRE,,Histone-arginine methyltransferase CARM1 (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4),Danio rerio (Zebrafish) (Brachydanio rerio),59.8,435.0,4.5e-141,502.7,sp|Q6DC04|CARM1_DANRE Histone-arginine methyltransferase CARM1 OS=Danio rerio OX=7955 GN=carm1 PE=2 SV=1,GO:0000976; GO:0003713; GO:0005634; GO:0005829; GO:0006338; GO:0006355; GO:0008757; GO:0016274; GO:0032259; GO:0033146; GO:0035242; GO:0035642; GO:0043596; GO:0045600; GO:0048742; GO:0070611; GO:0071932; GO:0140903,chromatin remodeling [GO:0006338]; methylation [GO:0032259]; positive regulation of fat cell differentiation [GO:0045600]; regulation of DNA-templated transcription [GO:0006355]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of skeletal muscle fiber development [GO:0048742]; replication fork reversal [GO:0071932],cytosol [GO:0005829]; nuclear replication fork [GO:0043596]; nucleus [GO:0005634],histone H3R17 methyltransferase activity [GO:0035642]; histone H3R2 methyltransferase activity [GO:0070611]; histone H3R26 methyltransferase activity [GO:0140903]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_00982,FUN_004365-T1,Peve_00008937,Pocillopora_meandrina_HIv1___TS.g7532.t1,three_way,75.77499999999999,FUN_004365-T1,Q6PC91,,,,,64.1,156.0,5.7e-44,178.7,sp|Q6PC91|BT3L4_DANRE Transcription factor BTF3 homolog 4 OS=Danio rerio OX=7955 GN=btf3l4 PE=2 SV=1,,,,,,
OG_00983,FUN_004367-T1,Peve_00024409,Pocillopora_meandrina_HIv1___RNAseq.g4890.t1,three_way,77.31616666666667,,,,,,,,,,,,,,,,,
OG_00984,FUN_004368-T1,Peve_00024412,Pocillopora_meandrina_HIv1___RNAseq.g4893.t1,three_way,74.18766666666667,FUN_004368-T1,Q60928,GGT1_MOUSE,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Mus musculus (Mouse),40.7,562.0,8.2e-101,369.4,sp|Q60928|GGT1_MOUSE Glutathione hydrolase 1 proenzyme OS=Mus musculus OX=10090 GN=Ggt1 PE=1 SV=1,GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006536; GO:0006749; GO:0006750; GO:0006751; GO:0007283; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068,cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982],glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_00985,FUN_004371-T1,Peve_00010721,Pocillopora_meandrina_HIv1___RNAseq.g16617.t1,three_way,61.81466666666667,FUN_004371-T1,P18505,GBRB1_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) (GABAAR subunit beta-1),Homo sapiens (Human),36.7,294.0,6.199999999999999e-53,209.9,sp|P18505|GBRB1_HUMAN Gamma-aminobutyric acid receptor subunit beta-1 OS=Homo sapiens OX=9606 GN=GABRB1 PE=1 SV=2,GO:0004890; GO:0005635; GO:0005886; GO:0006811; GO:0007165; GO:0007214; GO:0009636; GO:0015276; GO:0021954; GO:0022851; GO:0030425; GO:0032570; GO:0034707; GO:0042698; GO:0048787; GO:0050811; GO:0071420; GO:0098685; GO:0098982; GO:0099507; GO:0099634; GO:0150047; GO:1902476; GO:1902711; GO:1904315,cellular response to histamine [GO:0071420]; central nervous system neuron development [GO:0021954]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; monoatomic ion transport [GO:0006811]; ovulation cycle [GO:0042698]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; signal transduction [GO:0007165],chloride channel complex [GO:0034707]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634]; presynaptic active zone membrane [GO:0048787]; Schaffer collateral - CA1 synapse [GO:0098685],G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; GABA receptor binding [GO:0050811]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; ligand-gated monoatomic ion channel activity [GO:0015276]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005635; GO:0005886; GO:0022414; GO:0023052; GO:0048856; GO:0055085; GO:0060089,transporter activity; nuclear envelope; plasma membrane; reproductive process; signaling; anatomical structure development; transmembrane transport; molecular transducer activity
OG_00986,FUN_004373-T2,Peve_00007253,Pocillopora_meandrina_HIv1___TS.g17451.t1,three_way,60.50866666666667,FUN_004373-T2,P16621,,,,,38.6,2020.0,0.0,1295.0,sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2,,,,,,
OG_00987,FUN_004374-T1,Peve_00008061,Pocillopora_meandrina_HIv1___RNAseq.g16620.t1,three_way,61.492666666666665,FUN_004374-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),58.1,210.0,8.2e-11,68.9,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_00988,FUN_004375-T1,Peve_00008062,Pocillopora_meandrina_HIv1___RNAseq.g16792.t1,three_way,78.937,FUN_004375-T1,Q7KWX9,,,,,46.4,224.0,2.9e-54,213.4,sp|Q7KWX9|EXOS3_DICDI Putative exosome complex component rrp40 OS=Dictyostelium discoideum OX=44689 GN=exosc3 PE=3 SV=1,,,,,,
OG_00989,FUN_004376-T1,Peve_00024391,Pocillopora_meandrina_HIv1___RNAseq.g16803.t2,three_way,67.07766666666667,FUN_004376-T1,B0UYI1,,,,,44.7,208.0,3.2e-36,153.3,sp|B0UYI1|TEAN2_DANRE Transcription elongation factor A N-terminal and central domain-containing protein 2 OS=Danio rerio OX=7955 GN=tceanc2 PE=3 SV=1,,,,,,
OG_00990,FUN_004377-T1,Peve_00024392,Pocillopora_meandrina_HIv1___RNAseq.g16802.t1,three_way,68.536,FUN_004377-T1,Q96DX4,,,,,36.3,182.0,3.4e-23,112.8,sp|Q96DX4|RSPRY_HUMAN RING finger and SPRY domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RSPRY1 PE=1 SV=1,,,,,,
OG_00991,FUN_004378-T1,Peve_00008066,Pocillopora_meandrina_HIv1___RNAseq.g16801.t1,three_way,63.01283333333333,FUN_004378-T1,P13994,YJU2B_HUMAN,,Probable splicing factor YJU2B (Coiled-coil domain-containing protein 130),Homo sapiens (Human),54.2,310.0,8.3e-87,322.4,sp|P13994|YJU2B_HUMAN Probable splicing factor YJU2B OS=Homo sapiens OX=9606 GN=YJU2B PE=1 SV=2,GO:0000398; GO:0005684; GO:0008380; GO:0009615; GO:0071014,"mRNA splicing, via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA splicing [GO:0008380]",post-mRNA release spliceosomal complex [GO:0071014]; U2-type spliceosomal complex [GO:0005684],,GO:0016071,mRNA metabolic process
OG_00992,FUN_004379-T1,Peve_00008069,Pocillopora_meandrina_HIv1___TS.g17623.t1,three_way,59.47683333333333,FUN_004379-T1,A2AJ76,HMCN2_MOUSE,,Hemicentin-2,Mus musculus (Mouse),31.6,190.0,1.7e-16,89.7,sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0030054; GO:0032154; GO:0062023,,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],calcium ion binding [GO:0005509],GO:0005576; GO:0030312; GO:0031012,extracellular region; external encapsulating structure; extracellular matrix
OG_00993,FUN_004380-T1,Peve_00008070,Pocillopora_meandrina_HIv1___RNAseq.g16799.t1,three_way,42.53966666666667,FUN_004380-T1,A2VDD2,,,,,31.6,98.0,7.1e-06,53.5,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_00994,FUN_004402-T1,Peve_00009341,Pocillopora_meandrina_HIv1___TS.g8719.t1,three_way,63.466166666666666,FUN_004402-T1,F4JG10,,,,,38.8,366.0,3.3e-66,254.2,"sp|F4JG10|XYN3_ARATH Endo-1,4-beta-xylanase 3 OS=Arabidopsis thaliana OX=3702 GN=XYN3 PE=2 SV=1",,,,,,
OG_00995,FUN_004404-T1,Peve_00009336,Pocillopora_meandrina_HIv1___RNAseq.g16887.t1,three_way,41.942,,,,,,,,,,,,,,,,,
OG_00996,FUN_004405-T1,Peve_00009337,Pocillopora_meandrina_HIv1___RNAseq.g4938.t1,three_way,84.16833333333334,FUN_004405-T1,P55809,SCOT1_HUMAN,,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (SCOT) (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) (Succinyl-CoA:3-oxoacid CoA transferase)",Homo sapiens (Human),70.6,490.0,9.6e-204,711.1,"sp|P55809|SCOT1_HUMAN Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=OXCT1 PE=1 SV=1",GO:0005739; GO:0005759; GO:0007507; GO:0007584; GO:0008260; GO:0009410; GO:0009725; GO:0014823; GO:0035774; GO:0042182; GO:0042594; GO:0042802; GO:0045471; GO:0046952; GO:0060612; GO:1902224,adipose tissue development [GO:0060612]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone body metabolic process [GO:1902224]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; succinyl-CoA:3-oxo-acid CoA-transferase activity [GO:0008260],GO:0003824; GO:0005739; GO:0006091; GO:0006629; GO:0016740; GO:0043226; GO:0048856,catalytic activity; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; transferase activity; organelle; anatomical structure development
OG_00997,FUN_004406-T1,Peve_00017185,Pocillopora_meandrina_HIv1___RNAseq.g4937.t1,three_way,59.73633333333333,FUN_004406-T1,Q9BUJ2,,,,,50.9,389.0,1.8e-111,404.8,sp|Q9BUJ2|HNRL1_HUMAN Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Homo sapiens OX=9606 GN=HNRNPUL1 PE=1 SV=2,,,,,,
OG_00998,FUN_004407-T1,Peve_00017184,Pocillopora_meandrina_HIv1___RNAseq.g4936.t1,three_way,80.429,FUN_004407-T1,Q96KB5,,,,,50.2,303.0,6.2e-71,269.2,sp|Q96KB5|TOPK_HUMAN Lymphokine-activated killer T-cell-originated protein kinase OS=Homo sapiens OX=9606 GN=PBK PE=1 SV=3,,,,,,
OG_00999,FUN_004409-T1,Peve_00024220,Pocillopora_meandrina_HIv1___TS.g8710.t1,three_way,72.84100000000001,FUN_004409-T1,Q92889,,,,,53.6,928.0,4.8000000000000004e-267,922.2,sp|Q92889|XPF_HUMAN DNA repair endonuclease XPF OS=Homo sapiens OX=9606 GN=ERCC4 PE=1 SV=3,,,,,,
OG_01000,FUN_004414-T1,Peve_00008395,Pocillopora_meandrina_HIv1___RNAseq.g11587.t1,three_way,70.18283333333333,FUN_004414-T1,P04464,,,,,38.7,111.0,4.9e-17,89.4,sp|P04464|CALM_WHEAT Calmodulin OS=Triticum aestivum OX=4565 PE=1 SV=3,,,,,,
OG_01001,FUN_004415-T1,Peve_00028020,Pocillopora_meandrina_HIv1___RNAseq.g11586.t2,three_way,58.41816666666666,FUN_004415-T1,Q9D2E2,,,,,39.2,487.0,1.3e-82,308.5,sp|Q9D2E2|TOE1_MOUSE Target of EGR1 protein 1 OS=Mus musculus OX=10090 GN=Toe1 PE=1 SV=1,,,,,,
OG_01002,FUN_004421-T1,Peve_00026932,Pocillopora_meandrina_HIv1___RNAseq.g16665.t1,three_way,58.136,FUN_004421-T1,F1NWE3,,,,,29.1,1542.0,2.5e-170,601.7,sp|F1NWE3|PTPRS_CHICK Receptor-type tyrosine-protein phosphatase S OS=Gallus gallus OX=9031 GN=PTPRS PE=1 SV=3,,,,,,
OG_01003,FUN_004422-T1,Peve_00033980,Pocillopora_meandrina_HIv1___RNAseq.g16629.t1,three_way,82.34533333333334,FUN_004422-T1,Q9H553,ALG2_HUMAN,,"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)",Homo sapiens (Human),57.3,393.0,2.2000000000000003e-124,447.2,"sp|Q9H553|ALG2_HUMAN Alpha-1,3/1,6-mannosyltransferase ALG2 OS=Homo sapiens OX=9606 GN=ALG2 PE=1 SV=1",GO:0000033; GO:0004378; GO:0005789; GO:0006486; GO:0006487; GO:0006488; GO:0012505; GO:0016020; GO:0098554; GO:0102704,dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487],cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],"alpha-1,3-mannosyltransferase activity [GO:0000033]; GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0004378]; GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity [GO:0102704]",GO:0003824; GO:0006486; GO:0009101; GO:0016740; GO:1901135,catalytic activity; protein glycosylation; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_01004,FUN_004424-T1,Peve_00024113,Pocillopora_meandrina_HIv1___RNAseq.g16706.t1,three_way,72.08833333333334,FUN_004424-T1,P63080,GBRB3_MOUSE,,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3),Mus musculus (Mouse),29.6,433.0,4.2e-51,203.8,sp|P63080|GBRB3_MOUSE Gamma-aminobutyric acid receptor subunit beta-3 OS=Mus musculus OX=10090 GN=Gabrb3 PE=1 SV=1,GO:0004890; GO:0005216; GO:0005886; GO:0007214; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030659; GO:0034707; GO:0035176; GO:0035640; GO:0042747; GO:0042802; GO:0043197; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]",cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; monoatomic ion channel activity [GO:0005216]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0022414; GO:0023052; GO:0034330; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; reproductive process; signaling; cell junction organization; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_01005,FUN_004427-T1,Peve_00033227,Pocillopora_meandrina_HIv1___RNAseq.g11386.t1,three_way,54.113166666666665,FUN_004427-T1,Q9I829,,,,,32.1,427.0,1.5e-45,185.3,sp|Q9I829|KCNA1_ONCMY Shaker-related potassium channel tsha2 OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1,,,,,,
OG_01006,FUN_004428-T1,Peve_00033224,Pocillopora_meandrina_HIv1___RNAseq.g11385.t1,three_way,75.577,FUN_004428-T1,Q0IUU4,CML2_ORYSJ,,Putative calmodulin-like protein 2,Oryza sativa subsp. japonica (Rice),42.6,141.0,1.2e-25,117.9,sp|Q0IUU4|CML2_ORYSJ Putative calmodulin-like protein 2 OS=Oryza sativa subsp. japonica OX=39947 GN=CML2 PE=3 SV=2,GO:0005509; GO:0005737; GO:0016020; GO:0030234,,cytoplasm [GO:0005737]; membrane [GO:0016020],calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234],GO:0098772,molecular function regulator activity
OG_01007,FUN_004431-T1,Peve_00033220,Pocillopora_meandrina_HIv1___RNAseq.g11379.t1,three_way,81.504,FUN_004431-T1,Q7ZW46,,,,,57.3,321.0,2.5e-101,370.2,sp|Q7ZW46|S35B4_DANRE UDP-xylose and UDP-N-acetylglucosamine transporter OS=Danio rerio OX=7955 GN=slc35b4 PE=2 SV=1,,,,,,
OG_01008,FUN_004432-T1,Peve_00033218,Pocillopora_meandrina_HIv1___RNAseq.g11372.t1,three_way,78.27866666666667,FUN_004432-T1,Q6YC49,,,,,66.1,316.0,2.6e-109,396.7,sp|Q6YC49|S35A3_BOVIN UDP-N-acetylglucosamine transporter OS=Bos taurus OX=9913 GN=SLC35A3 PE=1 SV=1,,,,,,
OG_01009,FUN_004436-T1,Peve_00033216,Pocillopora_meandrina_HIv1___RNAseq.g11488.t1,three_way,71.79266666666666,FUN_004436-T1,Q9H3R0,,,,,38.8,1037.0,4.0999999999999996e-191,669.8,sp|Q9H3R0|KDM4C_HUMAN Lysine-specific demethylase 4C OS=Homo sapiens OX=9606 GN=KDM4C PE=1 SV=2,,,,,,
OG_01010,FUN_004437-T1,Peve_00033214,Pocillopora_meandrina_HIv1___RNAseq.g11487.t2,three_way,77.86816666666667,FUN_004437-T1,Q8NI36,WDR36_HUMAN,,WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP),Homo sapiens (Human),45.4,904.0,1.5e-236,820.8,sp|Q8NI36|WDR36_HUMAN WD repeat-containing protein 36 OS=Homo sapiens OX=9606 GN=WDR36 PE=1 SV=2,GO:0003723; GO:0005654; GO:0006364; GO:0007601; GO:0032040; GO:0034388; GO:0042274,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; visual perception [GO:0007601],nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0050877,RNA binding; nucleoplasm; nervous system process
OG_01011,FUN_004438-T1,Peve_00033213,Pocillopora_meandrina_HIv1___RNAseq.g11482.t1,three_way,40.127,,,,,,,,,,,,,,,,,
OG_01012,FUN_004440-T1,Peve_00033212,Pocillopora_meandrina_HIv1___RNAseq.g11481.t1,three_way,80.817,FUN_004440-T1,Q9UNH6,SNX7_HUMAN,,Sorting nexin-7,Homo sapiens (Human),48.7,191.0,7.4e-49,195.7,sp|Q9UNH6|SNX7_HUMAN Sorting nexin-7 OS=Homo sapiens OX=9606 GN=SNX7 PE=1 SV=1,GO:0000407; GO:0000423; GO:0005769; GO:0015031; GO:0031901; GO:0032456; GO:0034727; GO:0035091; GO:0061709; GO:2000786,endocytic recycling [GO:0032456]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of autophagosome assembly [GO:2000786]; protein transport [GO:0015031]; reticulophagy [GO:0061709],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; phagophore assembly site [GO:0000407],phosphatidylinositol binding [GO:0035091],GO:0005768; GO:0006914; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; autophagy; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_01013,FUN_004441-T1,Peve_00033211,Pocillopora_meandrina_HIv1___RNAseq.g11480.t1,three_way,74.31,FUN_004441-T1,Q0P5N6,ARL16_HUMAN,,ADP-ribosylation factor-like protein 16,Homo sapiens (Human),43.7,174.0,6.4000000000000005e-28,125.6,sp|Q0P5N6|ARL16_HUMAN ADP-ribosylation factor-like protein 16 OS=Homo sapiens OX=9606 GN=ARL16 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005737,,cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016787,catalytic activity; GTPase activity; hydrolase activity
OG_01014,FUN_004442-T1,Peve_00033209,Pocillopora_meandrina_HIv1___RNAseq.g11479.t1,three_way,73.821,FUN_004442-T1,A7MB63,CTNS_BOVIN,,Cystinosin,Bos taurus (Bovine),50.5,333.0,2.9e-91,337.0,sp|A7MB63|CTNS_BOVIN Cystinosin OS=Bos taurus OX=9913 GN=CTNS PE=2 SV=1,GO:0005765; GO:0015031; GO:0015184; GO:0015295; GO:0015811; GO:0033162; GO:0042438; GO:0042470; GO:0048021,L-cystine transport [GO:0015811]; melanin biosynthetic process [GO:0042438]; protein transport [GO:0015031]; regulation of melanin biosynthetic process [GO:0048021],lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162],L-cystine transmembrane transporter activity [GO:0015184]; solute:proton symporter activity [GO:0015295],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_01015,FUN_004443-T1,Peve_00033208,Pocillopora_meandrina_HIv1___RNAseq.g11478.t1,three_way,62.060833333333335,FUN_004443-T1,Q9VE04,,,,,49.1,53.0,1.6e-06,53.9,sp|Q9VE04|RM55_DROME Large ribosomal subunit protein mL55 OS=Drosophila melanogaster OX=7227 GN=mRpL55 PE=1 SV=1,,,,,,
OG_01016,FUN_004444-T1,Peve_00033206,Pocillopora_meandrina_HIv1___RNAseq.g11477.t1,three_way,38.297666666666665,,,,,,,,,,,,,,,,,
OG_01017,FUN_004446-T1,Peve_00024328,Pocillopora_meandrina_HIv1___RNAseq.g12519.t3,three_way,72.83733333333333,FUN_004446-T1,Q6DCD1,,,,,55.2,554.0,3.5000000000000005e-180,632.9,sp|Q6DCD1|FGGY_XENLA FGGY carbohydrate kinase domain-containing protein OS=Xenopus laevis OX=8355 GN=fggy PE=2 SV=2,,,,,,
OG_01018,FUN_004447-T1,Peve_00024327,Pocillopora_meandrina_HIv1___RNAseq.g11246.t1,three_way,84.03683333333333,FUN_004447-T1,Q9UPU5,UBP24_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),Homo sapiens (Human),45.2,2673.0,0.0,2190.2,sp|Q9UPU5|UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens OX=9606 GN=USP24 PE=1 SV=3,GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0016579; GO:0031647,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01019,FUN_004448-T1,Peve_00024324,Pocillopora_meandrina_HIv1___RNAseq.g11247.t1,three_way,61.9365,FUN_004448-T1,Q3UVK0,ERMP1_MOUSE,,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),Mus musculus (Mouse),39.5,837.0,2.0000000000000003e-164,581.3,sp|Q3UVK0|ERMP1_MOUSE Endoplasmic reticulum metallopeptidase 1 OS=Mus musculus OX=10090 GN=Ermp1 PE=1 SV=2,GO:0005789; GO:0006508; GO:0008235; GO:0030968; GO:0034599; GO:0046872,cellular response to oxidative stress [GO:0034599]; endoplasmic reticulum unfolded protein response [GO:0030968]; proteolysis [GO:0006508],endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_01020,FUN_004451-T1,Peve_00024321,Pocillopora_meandrina_HIv1___RNAseq.g11302.t1,three_way,62.96066666666667,,,,,,,,,,,,,,,,,
OG_01021,FUN_004453-T1,Peve_00024317,Pocillopora_meandrina_HIv1___RNAseq.g5040.t1,three_way,69.144,FUN_004453-T1,Q5GN48,DMD_PIG,,Dystrophin,Sus scrofa (Pig),36.3,557.0,9.2e-96,352.4,sp|Q5GN48|DMD_PIG Dystrophin OS=Sus scrofa OX=9823 GN=DMD PE=1 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0007519; GO:0008270; GO:0016010; GO:0042383; GO:0045211; GO:0048666; GO:0055001; GO:0090257; GO:0099536; GO:0120025,muscle cell development [GO:0055001]; neuron development [GO:0048666]; regulation of muscle system process [GO:0090257]; skeletal muscle tissue development [GO:0007519]; synaptic signaling [GO:0099536],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; plasma membrane bounded cell projection [GO:0120025]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383],actin binding [GO:0003779]; zinc ion binding [GO:0008270],GO:0005856; GO:0005886; GO:0008092; GO:0023052; GO:0043226; GO:0048856,cytoskeleton; plasma membrane; cytoskeletal protein binding; signaling; organelle; anatomical structure development
OG_01022,FUN_004454-T1,Peve_00024315,Pocillopora_meandrina_HIv1___RNAseq.g5041.t1,three_way,68.369,FUN_004454-T1,E3TDS3,,,,,43.1,334.0,5.1e-71,269.6,sp|E3TDS3|MTG1_ICTPU Mitochondrial ribosome-associated GTPase 1 OS=Ictalurus punctatus OX=7998 GN=mtg1 PE=2 SV=1,,,,,,
OG_01023,FUN_004455-T1,Peve_00024319,Pocillopora_meandrina_HIv1___RNAseq.g4970.t1,three_way,67.10066666666667,FUN_004455-T1,Q16651,PRSS8_HUMAN,,Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain],Homo sapiens (Human),39.0,249.0,2.0999999999999999e-41,173.3,sp|Q16651|PRSS8_HUMAN Prostasin OS=Homo sapiens OX=9606 GN=PRSS8 PE=1 SV=1,GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0010765; GO:0070062,positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005576; GO:0005615; GO:0005886; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; plasma membrane; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01024,FUN_004456-T1,Peve_00028023,Pocillopora_meandrina_HIv1___RNAseq.g4969.t1,three_way,72.8845,FUN_004456-T1,A2VDD2,,,,,28.7,178.0,1.5e-13,77.8,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_01025,FUN_004459-T1,Peve_00028021,Pocillopora_meandrina_HIv1___RNAseq.g4967.t1,three_way,62.04566666666667,,,,,,,,,,,,,,,,,
OG_01026,FUN_004460-T1,Peve_00023637,Pocillopora_meandrina_HIv1___RNAseq.g4961.t1,three_way,70.61033333333333,,,,,,,,,,,,,,,,,
OG_01027,FUN_004461-T1,Peve_00023630,Pocillopora_meandrina_HIv1___RNAseq.g4962.t1,three_way,86.20783333333334,FUN_004461-T1,E7FDB3,,,,,57.7,71.0,3.2e-18,93.6,sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1,,,,,,
OG_01028,FUN_004463-T1,Peve_00038481,Pocillopora_meandrina_HIv1___RNAseq.g4958.t1,three_way,50.50533333333333,,,,,,,,,,,,,,,,,
OG_01029,FUN_004464-T1,Peve_00007170,Pocillopora_meandrina_HIv1___RNAseq.g4957.t1,three_way,65.17666666666668,FUN_004464-T1,P54726,RD23A_MOUSE,,UV excision repair protein RAD23 homolog A (HR23A) (mHR23A),Mus musculus (Mouse),56.6,373.0,1.9e-52,208.0,sp|P54726|RD23A_MOUSE UV excision repair protein RAD23 homolog A OS=Mus musculus OX=10090 GN=Rad23a PE=1 SV=2,GO:0000502; GO:0003684; GO:0005654; GO:0005794; GO:0005829; GO:0006289; GO:0006974; GO:0019900; GO:0031593; GO:0031648; GO:0032436; GO:0043161; GO:0045070; GO:0045787; GO:1990381,DNA damage response [GO:0006974]; nucleotide-excision repair [GO:0006289]; positive regulation of cell cycle [GO:0045787]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of viral genome replication [GO:0045070]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502],damaged DNA binding [GO:0003684]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin-specific protease binding [GO:1990381],GO:0003677; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0030163; GO:0043226,DNA binding; nucleoplasm; Golgi apparatus; cytosol; DNA repair; protein catabolic process; organelle
OG_01030,FUN_004465-T1,Peve_00007162,Pocillopora_meandrina_HIv1___RNAseq.g4956.t1,three_way,76.52466666666666,FUN_004465-T1,P70032,,,,,39.7,633.0,2.2e-128,461.1,sp|P70032|PLK1_XENLA Serine/threonine-protein kinase PLK1 OS=Xenopus laevis OX=8355 GN=plk1 PE=1 SV=1,,,,,,
OG_01031,FUN_004466-T1,Peve_00007163,Pocillopora_meandrina_HIv1___RNAseq.g4955.t1,three_way,66.68966666666667,,,,,,,,,,,,,,,,,
OG_01032,FUN_004467-T1,Peve_00007165,Pocillopora_meandrina_HIv1___RNAseq.g4954.t1,three_way,70.01933333333334,,,,,,,,,,,,,,,,,
OG_01033,FUN_004468-T1,Peve_00007166,Pocillopora_meandrina_HIv1___RNAseq.g4953.t1,three_way,63.32233333333333,FUN_004468-T1,P23727,P85A_BOVIN,,Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha),Bos taurus (Bovine),32.1,636.0,1.2e-79,299.7,sp|P23727|P85A_BOVIN Phosphatidylinositol 3-kinase regulatory subunit alpha OS=Bos taurus OX=9913 GN=PIK3R1 PE=1 SV=1,GO:0001678; GO:0005068; GO:0005158; GO:0005159; GO:0005634; GO:0005942; GO:0005943; GO:0008286; GO:0015031; GO:0032869; GO:0033120; GO:0034446; GO:0034976; GO:0035014; GO:0042307; GO:0042802; GO:0043066; GO:0043125; GO:0043491; GO:0043548; GO:0043560; GO:0045944; GO:0046326; GO:0046854; GO:0046935; GO:0048009; GO:0050821; GO:0140767; GO:0141038; GO:1900103; GO:1903078,cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular glucose homeostasis [GO:0001678]; negative regulation of apoptotic process [GO:0043066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446],"nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]",1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; enzyme-substrate adaptor activity [GO:0140767]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0005634; GO:0006355; GO:0006629; GO:0007155; GO:0043226; GO:0060090; GO:0098772,nucleus; regulation of DNA-templated transcription; lipid metabolic process; cell adhesion; organelle; molecular adaptor activity; molecular function regulator activity
OG_01034,FUN_004469-T1,Peve_00007167,Pocillopora_meandrina_HIv1___RNAseq.g4952.t1,three_way,86.357,FUN_004469-T1,P14211,CALR_MOUSE,,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP),Mus musculus (Mouse),77.3,198.0,5.6e-85,315.5,sp|P14211|CALR_MOUSE Calreticulin OS=Mus musculus OX=10090 GN=Calr PE=1 SV=1,GO:0000122; GO:0001669; GO:0001849; GO:0002502; GO:0003729; GO:0005049; GO:0005178; GO:0005506; GO:0005509; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005783; GO:0005788; GO:0005790; GO:0005829; GO:0005840; GO:0006611; GO:0007283; GO:0008284; GO:0009410; GO:0009897; GO:0010595; GO:0010628; GO:0016020; GO:0017148; GO:0030246; GO:0030866; GO:0031625; GO:0032355; GO:0033018; GO:0033144; GO:0033574; GO:0034504; GO:0040020; GO:0042277; GO:0042562; GO:0042824; GO:0044183; GO:0044194; GO:0044322; GO:0045335; GO:0045665; GO:0045787; GO:0048387; GO:0048471; GO:0050681; GO:0050766; GO:0050821; GO:0051082; GO:0055007; GO:0060473; GO:0071257; GO:0071285; GO:0090398; GO:0098586; GO:0098794; GO:0098978; GO:0140313; GO:1900026; GO:1901164; GO:1901224; GO:1901652; GO:1903416; GO:1904614; GO:2000510,cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of meiotic nuclear division [GO:0040020]; response to biphenyl [GO:1904614]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to peptide [GO:1901652]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynapse [GO:0098794]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003723; GO:0005576; GO:0005615; GO:0005635; GO:0005739; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0005840; GO:0006355; GO:0006886; GO:0006913; GO:0007010; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044183; GO:0065003; GO:0140104; GO:0140313,RNA binding; extracellular region; extracellular space; nuclear envelope; mitochondrion; lysosome; vacuole; endoplasmic reticulum; cytosol; ribosome; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; protein folding chaperone; protein-containing complex assembly; molecular carrier activity; molecular sequestering activity
OG_01035,FUN_004470-T1,Peve_00007168,Pocillopora_meandrina_HIv1___RNAseq.g4951.t1,three_way,73.086,FUN_004470-T1,P0C872,,,,,55.9,311.0,1.5e-106,387.5,sp|P0C872|JMJD7_MOUSE Bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 OS=Mus musculus OX=10090 GN=Jmjd7 PE=1 SV=1,,,,,,
OG_01036,FUN_004471-T1,Peve_00007169,Pocillopora_meandrina_HIv1___RNAseq.g4950.t1,three_way,83.27766666666666,FUN_004471-T1,Q5R610,,,,,54.5,200.0,3.7e-55,216.1,sp|Q5R610|COMD2_PONAB COMM domain-containing protein 2 OS=Pongo abelii OX=9601 GN=COMMD2 PE=2 SV=1,,,,,,
OG_01037,FUN_004472-T1,Peve_00007171,Pocillopora_meandrina_HIv1___RNAseq.g4949.t1,three_way,82.363,FUN_004472-T1,Q13042,,,,,53.3,533.0,1.6e-165,584.3,sp|Q13042|CDC16_HUMAN Cell division cycle protein 16 homolog OS=Homo sapiens OX=9606 GN=CDC16 PE=1 SV=2,,,,,,
OG_01038,FUN_004473-T1,Peve_00007172,Pocillopora_meandrina_HIv1___RNAseq.g4948.t1,three_way,45.68216666666667,FUN_004473-T1,P98081,DAB_DROME,,Protein disabled,Drosophila melanogaster (Fruit fly),41.4,157.0,2.5e-28,129.4,sp|P98081|DAB_DROME Protein disabled OS=Drosophila melanogaster OX=7227 GN=Dab PE=1 SV=2,GO:0005118; GO:0005829; GO:0006898; GO:0007349; GO:0007391; GO:0008045; GO:0016319; GO:0017124; GO:0030424; GO:0035591; GO:0042051; GO:0045874; GO:0048488; GO:0072583; GO:0098793,cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; positive regulation of sevenless signaling pathway [GO:0045874]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle endocytosis [GO:0048488],axon [GO:0030424]; cytosol [GO:0005829]; presynapse [GO:0098793],sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591],GO:0005829; GO:0016192; GO:0048856; GO:0060090,cytosol; vesicle-mediated transport; anatomical structure development; molecular adaptor activity
OG_01039,FUN_004474-T1,Peve_00007173,Pocillopora_meandrina_HIv1___RNAseq.g4947.t1,three_way,57.66016666666667,FUN_004474-T1,Q7TN02,MED26_MOUSE,,Mediator of RNA polymerase II transcription subunit 26 (Cofactor required for Sp1 transcriptional activation subunit 7) (CRSP complex subunit 7) (Mediator complex subunit 26),Mus musculus (Mouse),62.8,78.0,3.2e-18,94.4,sp|Q7TN02|MED26_MOUSE Mediator of RNA polymerase II transcription subunit 26 OS=Mus musculus OX=10090 GN=Med26 PE=1 SV=1,GO:0003712; GO:0005634; GO:0005654; GO:0006357; GO:0016592; GO:0032968; GO:0051123; GO:0060261; GO:0070847,positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123],core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_01040,FUN_004477-T1,Peve_00033228,Pocillopora_meandrina_HIv1___RNAseq.g4945.t1,three_way,66.27733333333333,FUN_004477-T1,Q8BLA8,TRPA1_MOUSE,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Mus musculus (Mouse),27.2,949.0,1.1e-65,253.4,sp|Q8BLA8|TRPA1_MOUSE Transient receptor potential cation channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Trpa1 PE=1 SV=1,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_01041,FUN_004481-T1,Peve_00008403,Pocillopora_meandrina_HIv1___RNAseq.g11617.t2,three_way,80.77366666666667,FUN_004481-T1,Q96LB3,,,,,39.8,553.0,9.4e-89,329.3,sp|Q96LB3|IFT74_HUMAN Intraflagellar transport protein 74 homolog OS=Homo sapiens OX=9606 GN=IFT74 PE=1 SV=1,,,,,,
OG_01042,FUN_004484-T1,Peve_00008405,Pocillopora_meandrina_HIv1___RNAseq.g11620.t1,three_way,75.61533333333334,FUN_004484-T1,Q68CZ6,HAUS3_HUMAN,,HAUS augmin-like complex subunit 3,Homo sapiens (Human),30.7,625.0,4.4e-70,267.3,sp|Q68CZ6|HAUS3_HUMAN HAUS augmin-like complex subunit 3 OS=Homo sapiens OX=9606 GN=HAUS3 PE=1 SV=1,GO:0005654; GO:0005739; GO:0005813; GO:0005815; GO:0005829; GO:0005929; GO:0007098; GO:0010968; GO:0015630; GO:0031023; GO:0036064; GO:0045171; GO:0051225; GO:0051301; GO:0070652; GO:0072686; GO:1990498,cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule organizing center organization [GO:0031023]; regulation of microtubule nucleation [GO:0010968]; spindle assembly [GO:0051225],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; HAUS complex [GO:0070652]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0043226,nucleoplasm; mitochondrion; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; organelle
OG_01043,FUN_004485-T1,Peve_00008396,Pocillopora_meandrina_HIv1___RNAseq.g11621.t1,three_way,67.02483333333333,FUN_004485-T1,O95801,TTC4_HUMAN,,Tetratricopeptide repeat protein 4 (TPR repeat protein 4),Homo sapiens (Human),42.7,377.0,1.4e-71,271.6,sp|O95801|TTC4_HUMAN Tetratricopeptide repeat protein 4 OS=Homo sapiens OX=9606 GN=TTC4 PE=1 SV=3,GO:0005634; GO:0005654; GO:0005737; GO:0006457; GO:0030544; GO:0045087; GO:0051607; GO:0051879,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; protein folding [GO:0006457],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879],GO:0002376; GO:0005634; GO:0005654; GO:0006457; GO:0043226; GO:0098542,immune system process; nucleus; nucleoplasm; protein folding; organelle; defense response to other organism
OG_01044,FUN_004486-T1,Peve_00003217,Pocillopora_meandrina_HIv1___RNAseq.g11622.t1,three_way,43.216,,,,,,,,,,,,,,,,,
OG_01045,FUN_004491-T1,Peve_00003206,Pocillopora_meandrina_HIv1___RNAseq.g11626.t1,three_way,79.37166666666667,FUN_004491-T1,Q9NXG6,,,,,38.8,361.0,2.6e-64,247.7,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_01046,FUN_004492-T1,Peve_00003207,Pocillopora_meandrina_HIv1___RNAseq.g11629.t2,three_way,64.24166666666667,,,,,,,,,,,,,,,,,
OG_01047,FUN_004494-T1,Peve_00003208,Pocillopora_meandrina_HIv1___RNAseq.g11630.t1,three_way,64.765,FUN_004494-T1,Q9LN20,,,,,33.0,176.0,9.2e-14,79.7,sp|Q9LN20|P4H3_ARATH Probable prolyl 4-hydroxylase 3 OS=Arabidopsis thaliana OX=3702 GN=P4H3 PE=2 SV=1,,,,,,
OG_01048,FUN_004495-T1,Peve_00003209,Pocillopora_meandrina_HIv1___RNAseq.g11631.t1,three_way,70.42516666666667,FUN_004495-T1,Q8N543,OGFD1_HUMAN,,Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (Termination and polyadenylation 1 homolog) (uS12 prolyl 3-hydroxylase),Homo sapiens (Human),45.4,515.0,7.400000000000001e-124,445.7,sp|Q8N543|OGFD1_HUMAN Prolyl 3-hydroxylase OGFOD1 OS=Homo sapiens OX=9606 GN=OGFOD1 PE=1 SV=1,GO:0005506; GO:0005654; GO:0005737; GO:0005829; GO:0006449; GO:0008283; GO:0010494; GO:0018126; GO:0019511; GO:0031418; GO:0031543; GO:0031544; GO:0034063,cell population proliferation [GO:0008283]; peptidyl-proline hydroxylation [GO:0019511]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543],GO:0003824; GO:0005654; GO:0005829; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_01049,FUN_004496-T1,Peve_00003210,Pocillopora_meandrina_HIv1___RNAseq.g11632.t1,three_way,95.43133333333331,FUN_004496-T1,Q3ZBK6,LSM4_BOVIN,,U6 snRNA-associated Sm-like protein LSm4,Bos taurus (Bovine),87.4,87.0,6.4e-43,174.5,sp|Q3ZBK6|LSM4_BOVIN U6 snRNA-associated Sm-like protein LSm4 OS=Bos taurus OX=9913 GN=LSM4 PE=2 SV=1,GO:0000387; GO:0000398; GO:0000932; GO:0000956; GO:0005634; GO:0005688; GO:0005829; GO:0016020; GO:0017070; GO:0033962; GO:0042731; GO:0046540; GO:0071005; GO:0097526; GO:0120115,"mRNA splicing, via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; P-body assembly [GO:0033962]; spliceosomal snRNP assembly [GO:0000387]",cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688],PH domain binding [GO:0042731]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_01050,FUN_004497-T1,Peve_00003211,Pocillopora_meandrina_HIv1___RNAseq.g11633.t1,three_way,64.20400000000001,FUN_004497-T1,Q13585,MTR1L_HUMAN,,Melatonin-related receptor (G protein-coupled receptor 50) (H9) [Cleaved into: C-terminal domain],Homo sapiens (Human),26.8,314.0,5.7e-19,96.7,sp|Q13585|MTR1L_HUMAN Melatonin-related receptor OS=Homo sapiens OX=9606 GN=GPR50 PE=1 SV=3,GO:0004930; GO:0005654; GO:0005886; GO:0007186; GO:0007267; GO:0008502; GO:0014069,cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186],nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502],GO:0005654; GO:0005886; GO:0023052; GO:0043226; GO:0060089,nucleoplasm; plasma membrane; signaling; organelle; molecular transducer activity
OG_01051,FUN_004498-T1,Peve_00024329,Pocillopora_meandrina_HIv1___RNAseq.g12520.t1,three_way,62.72133333333333,FUN_004498-T1,Q55C09,,,,,26.8,369.0,1.2e-25,119.4,sp|Q55C09|SGMA_DICDI Sphingomyelin phosphodiesterase A OS=Dictyostelium discoideum OX=44689 GN=sgmA PE=3 SV=1,,,,,,
OG_01052,FUN_004499-T1,Peve_00020440,Pocillopora_meandrina_HIv1___RNAseq.g11393.t1,three_way,62.835,FUN_004499-T1,Q2YMB3,,,,,42.6,277.0,4e-47,189.9,sp|Q2YMB3|NHAA_BRUA2 Na(+)/H(+) antiporter NhaA OS=Brucella abortus (strain 2308) OX=359391 GN=nhaA PE=3 SV=2,,,,,,
OG_01053,FUN_004503-T1,Peve_00026071,Pocillopora_meandrina_HIv1___RNAseq.g12523.t1,three_way,43.45516666666667,FUN_004503-T1,Q5VXU9,SHOC1_HUMAN,,Protein shortage in chiasmata 1 ortholog (EC 3.6.-.-) (Protein ZIP2 homolog) (MZIP2),Homo sapiens (Human),24.5,538.0,1.3e-17,93.6,sp|Q5VXU9|SHOC1_HUMAN Protein shortage in chiasmata 1 ortholog OS=Homo sapiens OX=9606 GN=SHOC1 PE=1 SV=1,GO:0000712; GO:0000794; GO:0003697; GO:0005694; GO:0007130; GO:0007131; GO:0016887,reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130],chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794],ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006310; GO:0016787; GO:0022414; GO:0043226,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA recombination; hydrolase activity; reproductive process; organelle
OG_01054,FUN_004506-T1,Peve_00044059,Pocillopora_meandrina_HIv1___RNAseq.g11391.t1,three_way,79.72433333333333,FUN_004506-T1,Q96NR8,RDH12_HUMAN,,Retinol dehydrogenase 12 (EC 1.1.1.300) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2),Homo sapiens (Human),54.7,298.0,9.599999999999999e-82,305.1,sp|Q96NR8|RDH12_HUMAN Retinol dehydrogenase 12 OS=Homo sapiens OX=9606 GN=RDH12 PE=1 SV=3,GO:0001523; GO:0001917; GO:0004745; GO:0005789; GO:0007601; GO:0042572; GO:0045494; GO:0052650; GO:0060342; GO:0102354; GO:0110095,cellular detoxification of aldehyde [GO:0110095]; photoreceptor cell maintenance [GO:0045494]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],endoplasmic reticulum membrane [GO:0005789]; photoreceptor inner segment [GO:0001917]; photoreceptor inner segment membrane [GO:0060342],11-cis-retinol dehydrogenase activity [GO:0102354]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0006629; GO:0016491; GO:0050877; GO:0098754,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process; detoxification
OG_01055,FUN_004508-T1,Peve_00012959,Pocillopora_meandrina_HIv1___RNAseq.g11640.t1,three_way,76.12733333333334,FUN_004508-T1,H9JW43,,,,,39.8,364.0,4.4e-76,286.6,sp|H9JW43|CDA8_BOMMO Chitin deacetylase 8 OS=Bombyx mori OX=7091 GN=CDA8 PE=1 SV=2,,,,,,
OG_01056,FUN_004509-T1,Peve_00012958,Pocillopora_meandrina_HIv1___RNAseq.g11641.t1,three_way,58.72666666666667,,,,,,,,,,,,,,,,,
OG_01057,FUN_004510-T1,Peve_00012957,Pocillopora_meandrina_HIv1___RNAseq.g11642.t1,three_way,73.2265,,,,,,,,,,,,,,,,,
OG_01058,FUN_004511-T1,Peve_00012956,Pocillopora_meandrina_HIv1___RNAseq.g11643.t1,three_way,75.28316666666667,FUN_004511-T1,P48025,KSYK_MOUSE,,Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase),Mus musculus (Mouse),38.4,688.0,7.7e-116,419.5,sp|P48025|KSYK_MOUSE Tyrosine-protein kinase SYK OS=Mus musculus OX=10090 GN=Syk PE=1 SV=2,GO:0001525; GO:0001775; GO:0001784; GO:0001819; GO:0001820; GO:0001945; GO:0002092; GO:0002223; GO:0002250; GO:0002281; GO:0002283; GO:0002366; GO:0002554; GO:0002752; GO:0004674; GO:0004713; GO:0004715; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006606; GO:0007159; GO:0007166; GO:0007167; GO:0007186; GO:0007229; GO:0010543; GO:0010803; GO:0016170; GO:0018108; GO:0019370; GO:0019722; GO:0019815; GO:0019901; GO:0019902; GO:0030183; GO:0030593; GO:0031334; GO:0031623; GO:0032009; GO:0032481; GO:0032725; GO:0032733; GO:0032735; GO:0032752; GO:0032753; GO:0032755; GO:0032757; GO:0032760; GO:0032765; GO:0032928; GO:0032930; GO:0032991; GO:0033630; GO:0035325; GO:0035556; GO:0038063; GO:0038156; GO:0042101; GO:0042169; GO:0042492; GO:0042742; GO:0043274; GO:0043303; GO:0043306; GO:0043313; GO:0043366; GO:0043410; GO:0045087; GO:0045579; GO:0045588; GO:0045780; GO:0046638; GO:0046641; GO:0048514; GO:0050764; GO:0050850; GO:0050853; GO:0051649; GO:0070372; GO:0071226; GO:0071396; GO:0071404; GO:0071639; GO:0090237; GO:0090330; GO:0097110; GO:0097190; GO:0097242; GO:0120162; GO:1904263; GO:1904646; GO:1990858,adaptive immune response [GO:0002250]; amyloid-beta clearance [GO:0097242]; angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of localization in cell [GO:0051649]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-delta T cell differentiation [GO:0042492]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; mast cell degranulation [GO:0043303]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytokine production [GO:0001819]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; protein import into nucleus [GO:0006606]; receptor internalization [GO:0031623]; regulation of arachidonate secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion [GO:0001820]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101],ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; Toll-like receptor binding [GO:0035325],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006886; GO:0006913; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; intracellular protein transport; nucleocytoplasmic transport; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; defense response to other organism; catalytic activity, acting on a protein"
OG_01059,FUN_004514-T1,Peve_00044065,Pocillopora_meandrina_HIv1___RNAseq.g11652.t1,three_way,77.31266666666667,FUN_004514-T1,P54731,FAF1_MOUSE,,FAS-associated factor 1,Mus musculus (Mouse),40.6,672.0,1.3e-112,408.7,sp|P54731|FAF1_MOUSE FAS-associated factor 1 OS=Mus musculus OX=10090 GN=Faf1 PE=1 SV=2,GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0019901; GO:0019904; GO:0030155; GO:0031072; GO:0031625; GO:0034098; GO:0036337; GO:0042176; GO:0043124; GO:0043130; GO:0045732; GO:0045740; GO:0048471; GO:0051059; GO:1902043; GO:1990917,apoptotic process [GO:0006915]; Fas signaling pathway [GO:0036337]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein catabolic process [GO:0045732]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0012501; GO:0043226,nucleus; nuclear envelope; nucleoplasm; cytosol; programmed cell death; organelle
OG_01060,FUN_004515-T1,Peve_00044063,Pocillopora_meandrina_HIv1___RNAseq.g11318.t1,three_way,65.01150000000001,FUN_004515-T1,Q9Z1P7,,,,,39.5,253.0,1.3e-45,186.8,sp|Q9Z1P7|KANK3_MOUSE KN motif and ankyrin repeat domain-containing protein 3 OS=Mus musculus OX=10090 GN=Kank3 PE=1 SV=1,,,,,,
OG_01061,FUN_004516-T1,Peve_00044061,Pocillopora_meandrina_HIv1___RNAseq.g11314.t1,three_way,78.90283333333333,,,,,,,,,,,,,,,,,
OG_01062,FUN_004517-T1,Peve_00044062,Pocillopora_meandrina_HIv1___RNAseq.g11317.t1,three_way,69.30250000000001,FUN_004517-T1,Q5R5M5,ENPP3_PONAB,,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (Alkaline phosphodiesterase I) (EC 3.1.4.1) (Dinucleoside polyphosphatase) (EC 3.6.1.-) (Nucleotide diphosphatase) (Nucleotide pyrophosphatase) (NPPase) (EC 3.6.1.9) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),35.5,766.0,1.2e-133,478.8,sp|Q5R5M5|ENPP3_PONAB Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 OS=Pongo abelii OX=9601 GN=ENPP3 PE=2 SV=1,GO:0002276; GO:0003676; GO:0004081; GO:0004528; GO:0005509; GO:0005524; GO:0005576; GO:0005886; GO:0006220; GO:0008270; GO:0009143; GO:0009897; GO:0016324; GO:0033007; GO:0034432; GO:0036219; GO:0036221; GO:0046034; GO:0047429; GO:0047693; GO:0047710; GO:0050728; GO:0070667,ATP metabolic process [GO:0046034]; basophil activation involved in immune response [GO:0002276]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of mast cell proliferation [GO:0070667]; nucleoside triphosphate catabolic process [GO:0009143]; pyrimidine nucleotide metabolic process [GO:0006220],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; calcium ion binding [GO:0005509]; GTP diphosphatase activity [GO:0036219]; nucleic acid binding [GO:0003676]; nucleoside triphosphate diphosphatase activity [GO:0047429]; phosphodiesterase I activity [GO:0004528]; UTP diphosphatase activity [GO:0036221]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0055086; GO:1901135,immune system process; catalytic activity; extracellular region; plasma membrane; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01063,FUN_004519-T1,Peve_00044060,Pocillopora_meandrina_HIv1___RNAseq.g11313.t1,three_way,81.71333333333332,FUN_004519-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),48.6,395.0,8.699999999999999e-94,345.5,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_01064,FUN_004521-T1,Peve_00044057,Pocillopora_meandrina_HIv1___RNAseq.g11304.t1,three_way,66.62666666666667,FUN_004521-T1,Q8CGF5,,,,,39.5,243.0,6.4e-47,189.1,sp|Q8CGF5|TLCD4_MOUSE TLC domain-containing protein 4 OS=Mus musculus OX=10090 GN=Tlcd4 PE=2 SV=1,,,,,,
OG_01065,FUN_004525-T1,Peve_00003214,Pocillopora_meandrina_HIv1___RNAseq.g11634.t1,three_way,83.67433333333334,FUN_004525-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),49.4,857.0,3.7e-242,839.3,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_01066,FUN_004546-T1,Peve_00042939,Pocillopora_meandrina_HIv1___RNAseq.g7628.t1,three_way,71.06,FUN_004546-T1,Q80W37,,,,,47.8,347.0,1.9e-84,314.3,sp|Q80W37|SPN1_MOUSE Snurportin-1 OS=Mus musculus OX=10090 GN=Snupn PE=2 SV=1,,,,,,
OG_01067,FUN_004547-T1,Peve_00042940,Pocillopora_meandrina_HIv1___RNAseq.g7627.t1,three_way,64.15966666666667,FUN_004547-T1,Q8IPH9,SLOB_DROME,,Slowpoke-binding protein,Drosophila melanogaster (Fruit fly),34.8,342.0,2.8e-48,194.5,sp|Q8IPH9|SLOB_DROME Slowpoke-binding protein OS=Drosophila melanogaster OX=7227 GN=Slob PE=1 SV=2,GO:0004672; GO:0005737; GO:0007274; GO:0042391; GO:0042594; GO:0045202; GO:0050804,modulation of chemical synaptic transmission [GO:0050804]; neuromuscular synaptic transmission [GO:0007274]; regulation of membrane potential [GO:0042391]; response to starvation [GO:0042594],cytoplasm [GO:0005737]; synapse [GO:0045202],protein kinase activity [GO:0004672],GO:0003824; GO:0016740; GO:0023052; GO:0140096,"catalytic activity; transferase activity; signaling; catalytic activity, acting on a protein"
OG_01068,FUN_004549-T1,Peve_00042944,Pocillopora_meandrina_HIv1___RNAseq.15379_t,three_way,64.58533333333334,FUN_004549-T1,P9WIT2,,,,,20.5,493.0,1.5e-10,69.3,"sp|P9WIT2|GULDH_MYCTO L-gulono-1,4-lactone dehydrogenase OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=MT1821 PE=3 SV=1",,,,,,
OG_01069,FUN_004550-T1,Peve_00042945,Pocillopora_meandrina_HIv1___RNAseq.g8335.t1,three_way,57.596833333333336,FUN_004550-T1,C3ZQF9,,,,,27.2,327.0,1.5999999999999999e-24,115.5,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_01070,FUN_004552-T1,Peve_00016050,Pocillopora_meandrina_HIv1___RNAseq.g8237.t1,three_way,60.591,FUN_004552-T1,Q9EP86,,,,,30.0,303.0,1.6e-27,125.2,sp|Q9EP86|NPFF1_RAT Neuropeptide FF receptor 1 OS=Rattus norvegicus OX=10116 GN=Npffr1 PE=1 SV=1,,,,,,
OG_01071,FUN_004553-T1,Peve_00016048,Pocillopora_meandrina_HIv1___RNAseq.g8235.t1,three_way,65.80633333333333,FUN_004553-T1,P47802,,,,,41.3,305.0,3.9e-65,250.0,sp|P47802|MTX1_MOUSE Metaxin-1 OS=Mus musculus OX=10090 GN=Mtx1 PE=1 SV=1,,,,,,
OG_01072,FUN_004554-T1,Peve_00016046,Pocillopora_meandrina_HIv1___RNAseq.g8234.t1,three_way,72.76433333333334,FUN_004554-T1,P20700,LMNB1_HUMAN,,Lamin-B1,Homo sapiens (Human),33.0,542.0,1.7e-60,235.3,sp|P20700|LMNB1_HUMAN Lamin-B1 OS=Homo sapiens OX=9606 GN=LMNB1 PE=1 SV=2,GO:0005200; GO:0005634; GO:0005635; GO:0005637; GO:0005638; GO:0005652; GO:0005654; GO:0006998; GO:0007097; GO:0016020; GO:0016363; GO:0031507; GO:0031965; GO:0043274; GO:0051664; GO:0090435; GO:0160123; GO:1990837,heterochromatin formation [GO:0031507]; nuclear envelope organization [GO:0006998]; nuclear migration [GO:0007097]; nuclear pore localization [GO:0051664]; protein localization to nuclear envelope [GO:0090435],lamin filament [GO:0005638]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],phospholipase binding [GO:0043274]; sequence-specific double-stranded DNA binding [GO:1990837]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of nuclear lamina [GO:0160123],GO:0003677; GO:0005198; GO:0005634; GO:0005635; GO:0005654; GO:0006325; GO:0043226; GO:0061024,DNA binding; structural molecule activity; nucleus; nuclear envelope; nucleoplasm; chromatin organization; organelle; membrane organization
OG_01073,FUN_004557-T1,Peve_00016044,Pocillopora_meandrina_HIv1___RNAseq.g8230.t1,three_way,62.48366666666666,FUN_004557-T1,Q8R368,DAAF4_MOUSE,,Dynein axonemal assembly factor 4 (Dyslexia susceptibility 1 candidate gene 1 protein homolog),Mus musculus (Mouse),30.4,316.0,9.3e-29,129.0,sp|Q8R368|DAAF4_MOUSE Dynein axonemal assembly factor 4 OS=Mus musculus OX=10090 GN=Dnaaf4 PE=1 SV=2,GO:0001764; GO:0003341; GO:0003351; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007368; GO:0007507; GO:0007611; GO:0030331; GO:0033146; GO:0036158; GO:0036159; GO:0043005; GO:0051649; GO:0061136; GO:0097730; GO:0120293,cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; heart development [GO:0007507]; inner dynein arm assembly [GO:0036159]; learning or memory [GO:0007611]; neuron migration [GO:0001764]; outer dynein arm assembly [GO:0036158]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of proteasomal protein catabolic process [GO:0061136],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886],nuclear estrogen receptor binding [GO:0030331],GO:0005576; GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007018; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0065003,extracellular region; nucleus; microtubule organizing center; cytosol; plasma membrane; cilium; microtubule-based movement; organelle; anatomical structure development; cell motility; nervous system process; protein-containing complex assembly
OG_01074,FUN_004560-T1,Peve_00016042,Pocillopora_meandrina_HIv1___RNAseq.g8228.t1,three_way,65.01533333333333,FUN_004560-T1,Q16595,,,,,60.7,117.0,2.1e-36,153.7,"sp|Q16595|FRDA_HUMAN Frataxin, mitochondrial OS=Homo sapiens OX=9606 GN=FXN PE=1 SV=2",,,,,,
OG_01075,FUN_004561-T1,Peve_00016041,Pocillopora_meandrina_HIv1___RNAseq.g8227.t1,three_way,96.68433333333334,FUN_004561-T1,Q3ZCF6,APC11_BOVIN,,Anaphase-promoting complex subunit 11 (APC11) (Cyclosome subunit 11),Bos taurus (Bovine),85.7,77.0,1.4999999999999999e-40,166.4,sp|Q3ZCF6|APC11_BOVIN Anaphase-promoting complex subunit 11 OS=Bos taurus OX=9913 GN=ANAPC11 PE=3 SV=1,GO:0005634; GO:0005680; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031145; GO:0045842; GO:0051301; GO:0061630; GO:0070936; GO:0070979; GO:0097602; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],anaphase-promoting complex [GO:0005680]; cytoplasm [GO:0005737]; nucleus [GO:0005634],cullin family protein binding [GO:0097602]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_01076,FUN_004562-T1,Peve_00016040,Pocillopora_meandrina_HIv1___RNAseq.g8226.t1,three_way,71.31733333333334,,,,,,,,,,,,,,,,,
OG_01077,FUN_004565-T1,Peve_00016039,Pocillopora_meandrina_HIv1___RNAseq.g8225.t1,three_way,68.57933333333332,FUN_004565-T1,Q5ZIQ3,HNRPK_CHICK,,Heterogeneous nuclear ribonucleoprotein K (hnRNP K),Gallus gallus (Chicken),41.7,199.0,1.2e-35,151.8,sp|Q5ZIQ3|HNRPK_CHICK Heterogeneous nuclear ribonucleoprotein K OS=Gallus gallus OX=9031 GN=HNRNPK PE=2 SV=1,GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0045892; GO:1990904,mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; RNA splicing [GO:0008380],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_01078,FUN_004566-T1,Peve_00016038,Pocillopora_meandrina_HIv1___RNAseq.g8224.t1,three_way,70.882,FUN_004566-T1,P16393,,,,,46.1,915.0,5.0000000000000005e-208,726.1,sp|P16393|HMDH_STRPU 3-hydroxy-3-methylglutaryl-coenzyme A reductase OS=Strongylocentrotus purpuratus OX=7668 GN=HMGCR PE=2 SV=2,,,,,,
OG_01079,FUN_004567-T1,Peve_00016037,Pocillopora_meandrina_HIv1___RNAseq.g8223.t1,three_way,80.84933333333333,FUN_004567-T1,Q9UGJ1,GCP4_HUMAN,,Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76),Homo sapiens (Human),49.0,670.0,2.8e-171,603.6,sp|Q9UGJ1|GCP4_HUMAN Gamma-tubulin complex component 4 OS=Homo sapiens OX=9606 GN=TUBGCP4 PE=1 SV=1,GO:0000278; GO:0000922; GO:0000930; GO:0000931; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0015630; GO:0016020; GO:0031122; GO:0043015; GO:0051225; GO:0051321; GO:0055037; GO:0065003,cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; protein-containing complex assembly [GO:0065003]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; recycling endosome [GO:0055037]; spindle pole [GO:0000922],gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0005198; GO:0005768; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0008092; GO:0022414; GO:0031410; GO:0043226; GO:0065003,mitotic cell cycle; structural molecule activity; endosome; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_01080,FUN_004568-T1,Peve_00041493,Pocillopora_meandrina_HIv1___RNAseq.g6639.t1,three_way,81.07966666666665,FUN_004568-T1,Q9JHS4,CLPX_MOUSE,,"ATP-dependent clpX-like chaperone, mitochondrial (EC 3.6.4.10) (ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial) (Caseinolytic mitochondrial matrix peptidase chaperone subunit)",Mus musculus (Mouse),56.7,527.0,5.9e-152,539.3,"sp|Q9JHS4|CLPX_MOUSE ATP-dependent clpX-like chaperone, mitochondrial OS=Mus musculus OX=10090 GN=Clpx PE=1 SV=2",GO:0004176; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0008270; GO:0009368; GO:0009841; GO:0016504; GO:0016887; GO:0042645; GO:0046034; GO:0046983; GO:0051082; GO:0051603; GO:0140662,ATP metabolic process [GO:0046034]; proteolysis involved in protein catabolic process [GO:0051603],cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; ATP-dependent protein folding chaperone [GO:0140662]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0044183; GO:0055086; GO:0098772; GO:0140096; GO:0140657; GO:1901135,"catalytic activity; nucleoplasm; mitochondrion; cytosol; hydrolase activity; organelle; protein folding chaperone; nucleobase-containing small molecule metabolic process; molecular function regulator activity; catalytic activity, acting on a protein; ATP-dependent activity; carbohydrate derivative metabolic process"
OG_01081,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),27.6,757.0,3.2999999999999997e-41,172.6,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01081,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),34.8,224.0,3.6e-27,125.9,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01082,FUN_004570-T1,Peve_00041478,Pocillopora_meandrina_HIv1___RNAseq.g6646.t1a,three_way,78.209,FUN_004570-T1,Q6NRZ4,,,,,43.9,640.0,5.6e-150,532.7,sp|Q6NRZ4|CERT_XENLA Ceramide transfer protein OS=Xenopus laevis OX=8355 GN=cert1 PE=2 SV=1,,,,,,
OG_01083,FUN_004573-T1,Peve_00041481,Pocillopora_meandrina_HIv1___RNAseq.g6645.t1,three_way,57.525666666666666,FUN_004573-T1,P12394,,,,,34.0,509.0,1.3e-72,275.4,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_01084,FUN_004574-T1,Peve_00041482,Pocillopora_meandrina_HIv1___RNAseq.g6609.t1,three_way,86.89866666666667,FUN_004574-T1,B1H1E4,ARI1_XENTR,,E3 ubiquitin-protein ligase arih1 (EC 2.3.2.31) (Protein ariadne-1 homolog) (ARI-1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),67.5,465.0,3.9e-197,689.1,sp|B1H1E4|ARI1_XENTR E3 ubiquitin-protein ligase arih1 OS=Xenopus tropicalis OX=8364 GN=arih1 PE=2 SV=1,GO:0004842; GO:0005737; GO:0008270; GO:0016567; GO:0016604; GO:0097413,protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01085,FUN_004576-T1,Peve_00041483,Pocillopora_meandrina_HIv1___RNAseq.g6608.t1,three_way,90.46966666666668,FUN_004576-T1,Q712K3,UB2R2_HUMAN,,Ubiquitin-conjugating enzyme E2 R2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R2) (Ubiquitin carrier protein R2) (Ubiquitin-conjugating enzyme E2-CDC34B) (Ubiquitin-protein ligase R2),Homo sapiens (Human),77.4,195.0,5.7e-87,322.0,sp|Q712K3|UB2R2_HUMAN Ubiquitin-conjugating enzyme E2 R2 OS=Homo sapiens OX=9606 GN=UBE2R2 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0006513; GO:0061631; GO:0070936,protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_01086,FUN_004577-T1,Peve_00016268,Pocillopora_meandrina_HIv1___RNAseq.g6607.t1,three_way,87.703,FUN_004577-T1,P07902,GALT_HUMAN,,Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase),Homo sapiens (Human),63.7,344.0,8.699999999999999e-135,481.5,sp|P07902|GALT_HUMAN Galactose-1-phosphate uridylyltransferase OS=Homo sapiens OX=9606 GN=GALT PE=1 SV=3,GO:0005737; GO:0005794; GO:0005829; GO:0006011; GO:0006012; GO:0008108; GO:0008270; GO:0033499,"galactose catabolic process via UDP-galactose, Leloir pathway [GO:0033499]; galactose metabolic process [GO:0006012]; UDP-alpha-D-glucose metabolic process [GO:0006011]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794],UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005829; GO:0005975; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; Golgi apparatus; cytosol; carbohydrate metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01087,FUN_004580-T1,Peve_00016266,Pocillopora_meandrina_HIv1___RNAseq.g6606.t1,three_way,55.715,FUN_004580-T1,Q6NXI6,RPRD2_MOUSE,,Regulation of nuclear pre-mRNA domain-containing protein 2,Mus musculus (Mouse),33.6,387.0,5.4e-46,188.3,sp|Q6NXI6|RPRD2_MOUSE Regulation of nuclear pre-mRNA domain-containing protein 2 OS=Mus musculus OX=10090 GN=Rprd2 PE=1 SV=1,GO:0097550; GO:0099122,,transcription preinitiation complex [GO:0097550],RNA polymerase II C-terminal domain binding [GO:0099122],,
OG_01088,FUN_004581-T1,Peve_00012389,Pocillopora_meandrina_HIv1___RNAseq.g6605.t2,three_way,90.10633333333334,FUN_004581-T1,Q9D0R2,SYTC_MOUSE,,"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonine--tRNA ligase, cytoplasmic) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)",Mus musculus (Mouse),72.3,678.0,3.7e-307,1055.0,"sp|Q9D0R2|SYTC_MOUSE Threonine--tRNA ligase 1, cytoplasmic OS=Mus musculus OX=10090 GN=Tars1 PE=1 SV=2",GO:0004829; GO:0005524; GO:0005737; GO:0006435; GO:0008270; GO:0042802,threonyl-tRNA aminoacylation [GO:0006435],cytoplasm [GO:0005737],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; zinc ion binding [GO:0008270],GO:0003824; GO:0006399; GO:0006520; GO:0016874; GO:0140098,"catalytic activity; tRNA metabolic process; amino acid metabolic process; ligase activity; catalytic activity, acting on RNA"
OG_01089,FUN_004582-T1,Peve_00012392,Pocillopora_meandrina_HIv1___RNAseq.g6604.t1,three_way,71.762,,,,,,,,,,,,,,,,,
OG_01090,FUN_004583-T1,Peve_00012403,Pocillopora_meandrina_HIv1___RNAseq.g6603.t1,three_way,58.695,,,,,,,,,,,,,,,,,
OG_01091,FUN_004584-T1,Peve_00012393,Pocillopora_meandrina_HIv1___RNAseq.g6602.t1,three_way,49.74033333333333,,,,,,,,,,,,,,,,,
OG_01092,FUN_004588-T1,Peve_00012396,Pocillopora_meandrina_HIv1___RNAseq.g6598.t1,three_way,60.343833333333336,,,,,,,,,,,,,,,,,
OG_01093,FUN_004589-T1,Peve_00012398,Pocillopora_meandrina_HIv1___RNAseq.g6595.t2,three_way,64.044,,,,,,,,,,,,,,,,,
OG_01094,FUN_004590-T1,Peve_00012400,Pocillopora_meandrina_HIv1___RNAseq.g6593.t1,three_way,69.279,FUN_004590-T1,Q9CXK4,,,,,36.7,210.0,1.2e-30,134.8,sp|Q9CXK4|SWET1_MOUSE Sugar transporter SWEET1 OS=Mus musculus OX=10090 GN=Slc50a1 PE=2 SV=1,,,,,,
OG_01095,FUN_004591-T2,Peve_00012404,Pocillopora_meandrina_HIv1___RNAseq.g6591.t1,three_way,63.417,,,,,,,,,,,,,,,,,
OG_01096,FUN_004593-T1,Peve_00020634,Pocillopora_meandrina_HIv1___RNAseq.g7294.t1,three_way,55.47133333333333,,,,,,,,,,,,,,,,,
OG_01097,FUN_004595-T1,Peve_00012406,Pocillopora_meandrina_HIv1___RNAseq.g6590.t1,three_way,80.80433333333333,,,,,,,,,,,,,,,,,
OG_01098,FUN_004598-T1,Peve_00012407,Pocillopora_meandrina_HIv1___RNAseq.g6588.t1,three_way,65.93233333333333,,,,,,,,,,,,,,,,,
OG_01099,FUN_004599-T1,Peve_00012408,Pocillopora_meandrina_HIv1___RNAseq.g6587.t1,three_way,88.329,FUN_004599-T1,Q7Z7E8,UB2Q1_HUMAN,,Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1),Homo sapiens (Human),48.1,397.0,5.3e-95,349.4,sp|Q7Z7E8|UB2Q1_HUMAN Ubiquitin-conjugating enzyme E2 Q1 OS=Homo sapiens OX=9606 GN=UBE2Q1 PE=1 SV=1,GO:0000209; GO:0001967; GO:0005524; GO:0005634; GO:0005829; GO:0007566; GO:0007617; GO:0009566; GO:0030175; GO:0061458; GO:0061631; GO:0070459,embryo implantation [GO:0007566]; fertilization [GO:0009566]; mating behavior [GO:0007617]; prolactin secretion [GO:0070459]; protein polyubiquitination [GO:0000209]; reproductive system development [GO:0061458]; suckling behavior [GO:0001967],cytosol [GO:0005829]; filopodium [GO:0030175]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01100,FUN_004601-T1,Peve_00020781,Pocillopora_meandrina_HIv1___RNAseq.g6777.t1,three_way,49.251333333333335,,,,,,,,,,,,,,,,,
OG_01101,FUN_004611-T1,Peve_00012413,Pocillopora_meandrina_HIv1___RNAseq.g8690.t1,three_way,80.02066666666667,FUN_004611-T1,A6NNM8,TTL13_HUMAN,,Tubulin polyglutamylase TTLL13 (EC 6.3.2.-) (Tubulin tyrosine ligase like 13) (Tubulin tyrosine ligase-like family member 13 pseudogene) (Tubulin--tyrosine ligase-like protein 13),Homo sapiens (Human),51.5,699.0,2.1e-193,677.6,sp|A6NNM8|TTL13_HUMAN Tubulin polyglutamylase TTLL13 OS=Homo sapiens OX=9606 GN=TTLL13 PE=1 SV=2,GO:0001578; GO:0005524; GO:0005829; GO:0005874; GO:0015631; GO:0036064; GO:0036211; GO:0046872; GO:0070740; GO:0106438,microtubule bundle formation [GO:0001578]; protein modification process [GO:0036211],ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule [GO:0005874],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0016874; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; ligase activity; catalytic activity, acting on a protein"
OG_01102,FUN_004616-T1,Peve_00012390,Pocillopora_meandrina_HIv1___RNAseq.g8689.t1,three_way,73.84366666666666,FUN_004616-T1,F1PZV2,,,,,45.6,456.0,1.4e-106,388.3,sp|F1PZV2|MFS12_CANLF Major facilitator superfamily domain-containing protein 12 OS=Canis lupus familiaris OX=9615 GN=MFSD12 PE=1 SV=3,,,,,,
OG_01103,FUN_004620-T1,Peve_00029180,Pocillopora_meandrina_HIv1___RNAseq.g8688.t1,three_way,70.79233333333333,FUN_004620-T1,Q6NUT3,MFS12_HUMAN,,Major facilitator superfamily domain-containing protein 12,Homo sapiens (Human),47.9,447.0,4.8e-110,399.8,sp|Q6NUT3|MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens OX=9606 GN=MFSD12 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_01104,FUN_004622-T1,Peve_00039255,Pocillopora_meandrina_HIv1___RNAseq.g8687.t2,three_way,71.77533333333334,FUN_004622-T1,Q9WYJ1,,,,,38.8,322.0,1.8e-51,204.5,sp|Q9WYJ1|TSAL_THEMA L-threonine ammonia-lyase OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0356 PE=1 SV=1,,,,,,
OG_01105,FUN_004624-T1,Peve_00039250,Pocillopora_meandrina_HIv1___RNAseq.g8088.t1,three_way,67.861,FUN_004624-T1,Q3UHC2,LRRK1_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1),Mus musculus (Mouse),29.8,1808.0,4.400000000000001e-211,737.6,sp|Q3UHC2|LRRK1_MOUSE Leucine-rich repeat serine/threonine-protein kinase 1 OS=Mus musculus OX=10090 GN=Lrrk1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005525; GO:0005739; GO:0005829; GO:0005886; GO:0035556; GO:0036035; GO:0042802; GO:0045453; GO:0046872; GO:0090263; GO:0106310; GO:1902533,bone resorption [GO:0045453]; intracellular signal transduction [GO:0035556]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005739; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; plasma membrane; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01106,FUN_004625-T1,Peve_00039248,Pocillopora_meandrina_HIv1___RNAseq.g8089.t1,three_way,76.86866666666667,FUN_004625-T1,Q8CG46,SMC5_MOUSE,,Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (mSMC5) (Protein expressed in male leptotene and zygotene spermatocytes 453) (MLZ-453),Mus musculus (Mouse),38.8,1073.0,5.9e-184,646.4,sp|Q8CG46|SMC5_MOUSE Structural maintenance of chromosomes protein 5 OS=Mus musculus OX=10090 GN=Smc5 PE=1 SV=1,GO:0000217; GO:0000722; GO:0000724; GO:0000775; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0005737; GO:0006974; GO:0007059; GO:0016605; GO:0016607; GO:0019827; GO:0030054; GO:0030261; GO:0030915; GO:0034184; GO:0035061; GO:0035861; GO:0044772; GO:0044828; GO:0051301; GO:0051984; GO:0071459; GO:0090398,"cell division [GO:0051301]; cellular senescence [GO:0090398]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle phase transition [GO:0044772]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; protein localization to chromosome, centromeric region [GO:0071459]; stem cell population maintenance [GO:0019827]; telomere maintenance via recombination [GO:0000722]","cell junction [GO:0030054]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]",ATP binding [GO:0005524]; DNA secondary structure binding [GO:0000217],GO:0003677; GO:0005634; GO:0005694; GO:0006281; GO:0006310; GO:0007059; GO:0032200; GO:0043226,DNA binding; nucleus; chromosome; DNA repair; DNA recombination; chromosome segregation; telomere organization; organelle
OG_01107,FUN_004626-T1,Peve_00039247,Pocillopora_meandrina_HIv1___TS.g19833.t1,three_way,41.262166666666666,,,,,,,,,,,,,,,,,
OG_01108,FUN_004630-T1,Peve_00024470,Pocillopora_meandrina_HIv1___RNAseq.g506.t1b,three_way,50.06933333333333,FUN_004630-T1,Q15485,FCN2_HUMAN,,Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35),Homo sapiens (Human),50.0,208.0,3.3e-50,202.2,sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2,GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370],antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005576; GO:0005615; GO:0043226; GO:0098542,immune system process; extracellular region; extracellular space; organelle; defense response to other organism
OG_01109,FUN_004640-T2,Peve_00039268,Pocillopora_meandrina_HIv1___TS.g1348.t1,three_way,61.31,FUN_004640-T2,Q9TV66,,,,,46.2,556.0,1.7e-121,438.3,sp|Q9TV66|HCN4_RABIT Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 OS=Oryctolagus cuniculus OX=9986 GN=HCN4 PE=1 SV=1,,,,,,
OG_01110,FUN_004641-T1,Peve_00039266,Pocillopora_meandrina_HIv1___RNAseq.g7601.t1,three_way,84.26666666666667,FUN_004641-T1,Q0MQA3,,,,,61.3,119.0,7e-36,151.4,sp|Q0MQA3|NDUA6_PONPY NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 OS=Pongo pygmaeus OX=9600 GN=NDUFA6 PE=2 SV=3,,,,,,
OG_01111,FUN_004642-T1,Peve_00039264,Pocillopora_meandrina_HIv1___TS.g1351.t1,three_way,45.49066666666667,,,,,,,,,,,,,,,,,
OG_01112,FUN_004651-T1,Peve_00035138,Pocillopora_meandrina_HIv1___RNAseq.g8738.t1,three_way,59.5195,,,,,,,,,,,,,,,,,
OG_01113,FUN_004652-T1,Peve_00035139,Pocillopora_meandrina_HIv1___RNAseq.g8739.t1,three_way,72.61366666666666,,,,,,,,,,,,,,,,,
OG_01114,FUN_004657-T1,Peve_00035095,Pocillopora_meandrina_HIv1___RNAseq.g8740.t1,three_way,89.96,FUN_004657-T1,P21575,,,,,67.2,589.0,7.3e-232,804.7,sp|P21575|DYN1_RAT Dynamin-1 OS=Rattus norvegicus OX=10116 GN=Dnm1 PE=1 SV=2,,,,,,
OG_01115,FUN_004658-T1,Peve_00035112,Pocillopora_meandrina_HIv1___TS.g20468.t1,three_way,44.65983333333333,,,,,,,,,,,,,,,,,
OG_01116,FUN_004660-T1,Peve_00035113,Pocillopora_meandrina_HIv1___TS.g20469.t1,three_way,89.59433333333334,,,,,,,,,,,,,,,,,
OG_01117,FUN_004661-T1,Peve_00035114,Pocillopora_meandrina_HIv1___TS.g20470.t1,three_way,62.39216666666666,FUN_004661-T1,Q2KJ63,KLKB1_BOVIN,,Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain],Bos taurus (Bovine),33.2,250.0,1.4e-30,136.3,sp|Q2KJ63|KLKB1_BOVIN Plasma kallikrein OS=Bos taurus OX=9913 GN=KLKB1 PE=2 SV=1,GO:0004252; GO:0005576; GO:0006508; GO:0006954; GO:0007596; GO:0042730; GO:0042803,blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; proteolysis [GO:0006508],extracellular region [GO:0005576],protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0006954; GO:0016787; GO:0140096,"catalytic activity; extracellular region; inflammatory response; hydrolase activity; catalytic activity, acting on a protein"
OG_01118,FUN_004663-T1,Peve_00035116,Pocillopora_meandrina_HIv1___RNAseq.g8745.t1,three_way,40.65533333333333,,,,,,,,,,,,,,,,,
OG_01119,FUN_004681-T1,Peve_00035120,Pocillopora_meandrina_HIv1___RNAseq.g8769.t1,three_way,60.601333333333336,,,,,,,,,,,,,,,,,
OG_01120,FUN_004682-T1,Peve_00035121,Pocillopora_meandrina_HIv1___RNAseq.g8768.t1,three_way,34.754333333333335,,,,,,,,,,,,,,,,,
OG_01121,FUN_004684-T1,Peve_00035122,Pocillopora_meandrina_HIv1___RNAseq.g8765.t1,three_way,65.35983333333333,FUN_004684-T1,Q07008,NOTC1_RAT,,Neurogenic locus notch homolog protein 1 (Notch 1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Rattus norvegicus (Rat),42.2,628.0,7.7e-77,291.2,sp|Q07008|NOTC1_RAT Neurogenic locus notch homolog protein 1 OS=Rattus norvegicus OX=10116 GN=Notch1 PE=1 SV=3,GO:0000122; GO:0000987; GO:0001228; GO:0001554; GO:0001669; GO:0001701; GO:0001726; GO:0001837; GO:0001889; GO:0001947; GO:0002040; GO:0002052; GO:0002085; GO:0002193; GO:0002437; GO:0003151; GO:0003157; GO:0003160; GO:0003162; GO:0003169; GO:0003180; GO:0003181; GO:0003182; GO:0003184; GO:0003192; GO:0003197; GO:0003198; GO:0003203; GO:0003207; GO:0003208; GO:0003209; GO:0003213; GO:0003214; GO:0003219; GO:0003222; GO:0003241; GO:0003252; GO:0003264; GO:0003270; GO:0003273; GO:0003332; GO:0003344; GO:0003682; GO:0003713; GO:0004857; GO:0004888; GO:0005112; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005856; GO:0005886; GO:0005912; GO:0006357; GO:0006366; GO:0006606; GO:0006915; GO:0006959; GO:0007219; GO:0007221; GO:0007283; GO:0007368; GO:0007386; GO:0007409; GO:0007440; GO:0007492; GO:0007507; GO:0008283; GO:0008284; GO:0008285; GO:0008544; GO:0008593; GO:0009912; GO:0009957; GO:0009986; GO:0010001; GO:0010467; GO:0010468; GO:0010614; GO:0010628; GO:0010629; GO:0010667; GO:0010718; GO:0010812; GO:0010832; GO:0014031; GO:0014807; GO:0016324; GO:0017156; GO:0019899; GO:0021515; GO:0021915; GO:0021953; GO:0030027; GO:0030154; GO:0030163; GO:0030182; GO:0030216; GO:0030279; GO:0030324; GO:0030326; GO:0030334; GO:0030335; GO:0030513; GO:0030514; GO:0030900; GO:0031069; GO:0031100; GO:0031410; GO:0031490; GO:0031902; GO:0032495; GO:0032496; GO:0032966; GO:0035116; GO:0035148; GO:0035914; GO:0035924; GO:0042127; GO:0042246; GO:0042670; GO:0042802; GO:0043065; GO:0043069; GO:0043086; GO:0043235; GO:0045070; GO:0045603; GO:0045607; GO:0045608; GO:0045618; GO:0045662; GO:0045665; GO:0045668; GO:0045687; GO:0045747; GO:0045892; GO:0045893; GO:0045944; GO:0045955; GO:0046427; GO:0046533; GO:0046579; GO:0048103; GO:0048663; GO:0048708; GO:0048709; GO:0048711; GO:0048715; GO:0048754; GO:0048845; GO:0048873; GO:0050673; GO:0050678; GO:0050679; GO:0050680; GO:0050767; GO:0050768; GO:0051152; GO:0055008; GO:0060038; GO:0060045; GO:0060253; GO:0060271; GO:0060317; GO:0060354; GO:0060379; GO:0060411; GO:0060412; GO:0060528; GO:0060740; GO:0060768; GO:0060842; GO:0060843; GO:0060948; GO:0060956; GO:0060979; GO:0060982; GO:0061101; GO:0061314; GO:0061344; GO:0061384; GO:0062043; GO:0070168; GO:0070374; GO:0070986; GO:0071228; GO:0071372; GO:0071456; GO:0071944; GO:0072017; GO:0072044; GO:0072091; GO:0072144; GO:0072148; GO:0072538; GO:0090051; GO:0090090; GO:0097150; GO:0097400; GO:0098685; GO:0098839; GO:0098978; GO:0099565; GO:0120163; GO:0140537; GO:1901201; GO:1902263; GO:1902339; GO:1903849; GO:2000048; GO:2000737; GO:2000811; GO:2000974; GO:2001027,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process [GO:0006915]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation [GO:0030154]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cell population proliferation [GO:0008283]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; central nervous system neuron differentiation [GO:0021953]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; endocardial cell differentiation [GO:0060956]; endocardial cushion development [GO:0003197]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epidermis development [GO:0008544]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of programmed cell death [GO:0043069]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of gene expression [GO:0010468]; regulation of inner ear auditory receptor cell differentiation [GO:0045607]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous blood vessel morphogenesis [GO:0048845]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685],"calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003677; GO:0005634; GO:0005783; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006954; GO:0012501; GO:0016192; GO:0022414; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0060090; GO:0098772; GO:0140110,immune system process; DNA binding; nucleus; endoplasmic reticulum; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; inflammatory response; programmed cell death; vesicle-mediated transport; reproductive process; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular transducer activity; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_01122,FUN_004690-T1,Peve_00035123,Pocillopora_meandrina_HIv1___RNAseq.g8764.t2,three_way,68.1555,FUN_004690-T1,Q8BX70,VP13C_MOUSE,,Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C),Mus musculus (Mouse),30.1,3835.0,0.0,1442.9,sp|Q8BX70|VP13C_MOUSE Intermembrane lipid transfer protein VPS13C OS=Mus musculus OX=10090 GN=Vps13c PE=1 SV=2,GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006869; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:1905090,lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of type 2 mitophagy [GO:1905090]; response to insulin [GO:0032868],cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741],,GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0007005; GO:0031410; GO:0043226,lysosome; endosome; vacuole; lipid droplet; cytosol; mitochondrion organization; cytoplasmic vesicle; organelle
OG_01123,FUN_004691-T1,Peve_00019711,Pocillopora_meandrina_HIv1___TS.g20478.t1,three_way,79.91966666666667,FUN_004691-T1,Q9Y2I6,NINL_HUMAN,,Ninein-like protein,Homo sapiens (Human),30.6,517.0,7.299999999999998e-47,191.8,sp|Q9Y2I6|NINL_HUMAN Ninein-like protein OS=Homo sapiens OX=9606 GN=NINL PE=1 SV=2,GO:0005509; GO:0005813; GO:0005829; GO:0005874; GO:0034454,microtubule anchoring at centrosome [GO:0034454],centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874],calcium ion binding [GO:0005509],GO:0005815; GO:0005829; GO:0007010,microtubule organizing center; cytosol; cytoskeleton organization
OG_01124,FUN_004693-T1,Peve_00003276,Pocillopora_meandrina_HIv1___RNAseq.g8747.t1,three_way,73.396,,,,,,,,,,,,,,,,,
OG_01125,FUN_004694-T1,Peve_00003273,Pocillopora_meandrina_HIv1___RNAseq.g8770.t1,three_way,48.989,FUN_004694-T1,Q8C341,SUCO_MOUSE,,SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia) (SUN-like protein 1),Mus musculus (Mouse),26.4,924.0,1.1e-44,184.1,sp|Q8C341|SUCO_MOUSE SUN domain-containing ossification factor OS=Mus musculus OX=10090 GN=Suco PE=1 SV=3,GO:0001503; GO:0005791; GO:0016020; GO:0030867; GO:0032967; GO:0045669; GO:0046850,ossification [GO:0001503]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of bone remodeling [GO:0046850],membrane [GO:0016020]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867],,GO:0005783; GO:0043226,endoplasmic reticulum; organelle
OG_01126,FUN_004695-T1,Peve_00044672,Pocillopora_meandrina_HIv1___RNAseq.g8771.t1,three_way,71.41250000000001,,,,,,,,,,,,,,,,,
OG_01127,FUN_004696-T1,Peve_00044673,Pocillopora_meandrina_HIv1___RNAseq.g8775.t1,three_way,45.049,,,,,,,,,,,,,,,,,
OG_01128,FUN_004698-T1,Peve_00044677,Pocillopora_meandrina_HIv1___RNAseq.g8778.t1,three_way,56.21066666666667,,,,,,,,,,,,,,,,,
OG_01129,FUN_004699-T1,Peve_00044676,Pocillopora_meandrina_HIv1___RNAseq.g8779.t2,three_way,49.28933333333333,,,,,,,,,,,,,,,,,
OG_01130,FUN_004700-T1,Peve_00044679,Pocillopora_meandrina_HIv1___RNAseq.g8781.t1,three_way,89.18666666666667,FUN_004700-T1,Q2YDN4,,,,,29.7,357.0,5.1e-35,150.2,sp|Q2YDN4|TEKL1_BOVIN Tektin-like protein 1 OS=Bos taurus OX=9913 GN=TEKTL1 PE=1 SV=1,,,,,,
OG_01131,FUN_004701-T1,Peve_00044680,Pocillopora_meandrina_HIv1___RNAseq.g8782.t1a,three_way,91.32133333333331,,,,,,,,,,,,,,,,,
OG_01132,FUN_004702-T1,Peve_00044681,Pocillopora_meandrina_HIv1___RNAseq.g8782.t1b,three_way,68.05683333333333,,,,,,,,,,,,,,,,,
OG_01133,FUN_004708-T1,Peve_00005088,Pocillopora_meandrina_HIv1___RNAseq.g8792.t1,three_way,52.22983333333333,,,,,,,,,,,,,,,,,
OG_01134,FUN_004711-T1,Peve_00005084,Pocillopora_meandrina_HIv1___RNAseq.g8798.t1,three_way,84.41083333333333,FUN_004711-T1,Q8CFW7,C2D2A_MOUSE,,Coiled-coil and C2 domain-containing protein 2A,Mus musculus (Mouse),42.9,1526.0,8.4e-310,1065.1,sp|Q8CFW7|C2D2A_MOUSE Coiled-coil and C2 domain-containing protein 2A OS=Mus musculus OX=10090 GN=Cc2d2a PE=1 SV=1,GO:0001822; GO:0001843; GO:0005737; GO:0005856; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:1904491; GO:1905515; GO:1990403,axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224],ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; MKS complex [GO:0036038],,GO:0005856; GO:0007010; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeleton organization; organelle; cilium organization; anatomical structure development
OG_01135,FUN_004712-T1,Peve_00005082,Pocillopora_meandrina_HIv1___RNAseq.g8797.t1,three_way,60.751666666666665,,,,,,,,,,,,,,,,,
OG_01136,FUN_004714-T1,Peve_00005079,Pocillopora_meandrina_HIv1___RNAseq.g8807.t1,three_way,78.63366666666667,FUN_004714-T1,Q5R5N8,,,,,54.3,1021.0,0.0,1082.0,sp|Q5R5N8|DI3L1_PONAB DIS3-like exonuclease 1 OS=Pongo abelii OX=9601 GN=DIS3L PE=2 SV=1,,,,,,
OG_01137,FUN_004717-T1,Peve_00005076,Pocillopora_meandrina_HIv1___RNAseq.g8823.t1,three_way,46.57366666666667,,,,,,,,,,,,,,,,,
OG_01138,FUN_004718-T1,Peve_00011539,Pocillopora_meandrina_HIv1___RNAseq.g8832.t1,three_way,75.06166666666667,FUN_004718-T1,Q92546,RGP1_HUMAN,,RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog),Homo sapiens (Human),41.7,405.0,1.1e-80,302.0,sp|Q92546|RGP1_HUMAN RAB6A-GEF complex partner protein 2 OS=Homo sapiens OX=9606 GN=RGP1 PE=1 SV=1,GO:0000139; GO:0005085; GO:0005829; GO:0005886; GO:0016020; GO:0031267; GO:0032588; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547,"negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066]; trans-Golgi network membrane [GO:0032588],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005829; GO:0005886; GO:0016192; GO:0098772,cytosol; plasma membrane; vesicle-mediated transport; molecular function regulator activity
OG_01139,FUN_004719-T1,Peve_00005066,Pocillopora_meandrina_HIv1___RNAseq.g8835.t1,three_way,49.309333333333335,FUN_004719-T1,Q9CQX8,KGD4_MOUSE,,Alpha-ketoglutarate dehydrogenase component 4 (Alpha-ketoglutarate dehydrogenase subunit 4),Mus musculus (Mouse),38.5,96.0,3.3e-09,62.4,sp|Q9CQX8|KGD4_MOUSE Alpha-ketoglutarate dehydrogenase component 4 OS=Mus musculus OX=10090 GN=Kgd4 PE=1 SV=1,GO:0005739; GO:0006099; GO:0006103; GO:0030674; GO:0045252,2-oxoglutarate metabolic process [GO:0006103]; tricarboxylic acid cycle [GO:0006099],mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252],protein-macromolecule adaptor activity [GO:0030674],GO:0005739; GO:0043226; GO:0060090,mitochondrion; organelle; molecular adaptor activity
OG_01140,FUN_004720-T1,Peve_00005067,Pocillopora_meandrina_HIv1___RNAseq.g8836.t1,three_way,72.571,FUN_004720-T1,Q2F5J3,,,,,40.6,180.0,1.5e-18,94.4,sp|Q2F5J3|PYM_BOMMO Partner of Y14 and mago OS=Bombyx mori OX=7091 GN=Pym PE=2 SV=1,,,,,,
OG_01141,FUN_004721-T1,Peve_00005068,Pocillopora_meandrina_HIv1___RNAseq.g8837.t2,three_way,47.232,,,,,,,,,,,,,,,,,
OG_01142,FUN_004722-T1,Peve_00005069,Pocillopora_meandrina_HIv1___RNAseq.g8838.t1,three_way,79.66,FUN_004722-T1,B0VYY5,COX5A_NOTPR,,"Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)",Notamacropus parma (Parma wallaby) (Macropus parma),67.3,101.0,1.1e-34,147.1,"sp|B0VYY5|COX5A_NOTPR Cytochrome c oxidase subunit 5A, mitochondrial OS=Notamacropus parma OX=413582 GN=COX5A PE=2 SV=1",GO:0005743; GO:0006123; GO:0045277; GO:0046872,"mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]",mitochondrial inner membrane [GO:0005743]; respiratory chain complex IV [GO:0045277],metal ion binding [GO:0046872],GO:0006091,generation of precursor metabolites and energy
OG_01143,FUN_004723-T1,Peve_00005075,Pocillopora_meandrina_HIv1___RNAseq.g8839.t1,three_way,56.89366666666667,FUN_004723-T1,Q8WZ42,TITIN_HUMAN,,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),Homo sapiens (Human),25.3,194.0,5.5e-09,64.7,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,GO:0000794; GO:0002020; GO:0003009; GO:0003300; GO:0004672; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0045214; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733,cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433],GO:0000228; GO:0003012; GO:0003824; GO:0005198; GO:0005576; GO:0005694; GO:0005829; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"nuclear chromosome; muscle system process; catalytic activity; structural molecule activity; extracellular region; chromosome; cytosol; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01144,FUN_004736-T1,Peve_00026106,Pocillopora_meandrina_HIv1___RNAseq.g8831.t1,three_way,87.41533333333334,FUN_004736-T1,Q9VWH4,,,,,72.9,332.0,5.9e-139,495.4,"sp|Q9VWH4|IDH3A_DROME Probable isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Idh3a PE=2 SV=1",,,,,,
OG_01145,FUN_004737-T1,Peve_00016797,Pocillopora_meandrina_HIv1___RNAseq.g8830.t1,three_way,67.98533333333333,FUN_004737-T1,P41413,,,,,45.9,878.0,2.6000000000000007e-196,688.0,sp|P41413|PCSK5_RAT Proprotein convertase subtilisin/kexin type 5 OS=Rattus norvegicus OX=10116 GN=Pcsk5 PE=2 SV=3,,,,,,
OG_01146,FUN_004738-T1,Peve_00016798,Pocillopora_meandrina_HIv1___RNAseq.g8827.t1,three_way,48.4955,FUN_004738-T1,B7ZD04,SFR1_DANRE,,Swi5-dependent recombination DNA repair protein 1 homolog (Meiosis protein 5 homolog),Danio rerio (Zebrafish) (Brachydanio rerio),26.9,201.0,8.1e-07,55.5,sp|B7ZD04|SFR1_DANRE Swi5-dependent recombination DNA repair protein 1 homolog OS=Danio rerio OX=7955 GN=sfr1 PE=2 SV=1,GO:0000724; GO:0003713; GO:0005634; GO:0032798; GO:0045893,double-strand break repair via homologous recombination [GO:0000724]; positive regulation of DNA-templated transcription [GO:0045893],nucleus [GO:0005634]; Swi5-Sfr1 complex [GO:0032798],transcription coactivator activity [GO:0003713],GO:0005634; GO:0006281; GO:0006310; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; DNA repair; DNA recombination; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_01147,FUN_004740-T1,Peve_00007775,Pocillopora_meandrina_HIv1___RNAseq.g8829.t1,three_way,86.16033333333334,FUN_004740-T1,Q92963,RIT1_HUMAN,,GTP-binding protein Rit1 (EC 3.6.5.2) (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1),Homo sapiens (Human),61.7,196.0,1.1e-62,241.1,sp|Q92963|RIT1_HUMAN GTP-binding protein Rit1 OS=Homo sapiens OX=9606 GN=RIT1 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005516; GO:0005525; GO:0005886; GO:0007165; GO:0007265; GO:0019003,Ras protein signal transduction [GO:0007265]; signal transduction [GO:0007165],plasma membrane [GO:0005886],calmodulin binding [GO:0005516]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; plasma membrane; hydrolase activity; molecular function regulator activity
OG_01148,FUN_004747-T1,Peve_00007770,Pocillopora_meandrina_HIv1___RNAseq.g8813.t1,three_way,66.33366666666667,,,,,,,,,,,,,,,,,
OG_01149,FUN_004748-T1,Peve_00007768,Pocillopora_meandrina_HIv1___RNAseq.g8814.t1,three_way,81.6025,FUN_004748-T1,Q8C7R4,UBA6_MOUSE,,Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2),Mus musculus (Mouse),56.9,1018.0,0.0,1156.0,sp|Q8C7R4|UBA6_MOUSE Ubiquitin-like modifier-activating enzyme 6 OS=Mus musculus OX=10090 GN=Uba6 PE=1 SV=1,GO:0004839; GO:0005524; GO:0006511; GO:0007612; GO:0007626; GO:0016567; GO:0019780; GO:0021764; GO:0021766; GO:0060996,amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],,ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839],GO:0003824; GO:0016874; GO:0048856; GO:0050877; GO:0140096; GO:0140657,"catalytic activity; ligase activity; anatomical structure development; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_01150,FUN_004749-T1,Peve_00007765,Pocillopora_meandrina_HIv1___RNAseq.g8815.t3,three_way,45.58733333333333,FUN_004749-T1,P27447,,,,,37.6,93.0,4.9e-07,57.8,sp|P27447|YES_XIPHE Tyrosine-protein kinase Yes OS=Xiphophorus hellerii OX=8084 GN=yes PE=2 SV=3,,,,,,
OG_01151,FUN_004752-T1,Peve_00007764,Pocillopora_meandrina_HIv1___RNAseq.g8818.t1,three_way,85.092,FUN_004752-T1,P27463,,,,,69.5,485.0,1.3e-195,684.9,sp|P27463|AL1A1_CHICK Aldehyde dehydrogenase 1A1 OS=Gallus gallus OX=9031 GN=ALDH1A1 PE=2 SV=1,,,,,,
OG_01152,FUN_004753-T2,Peve_00003223,Pocillopora_meandrina_HIv1___RNAseq.g6702.t2,three_way,54.237,FUN_004753-T2,P46616,,,,,25.5,325.0,9.3e-09,62.8,sp|P46616|AA2AR_CAVPO Adenosine receptor A2a OS=Cavia porcellus OX=10141 GN=ADORA2A PE=2 SV=1,,,,,,
OG_01153,FUN_004754-T1,Peve_00003224,Pocillopora_meandrina_HIv1___RNAseq.g6701.t1,three_way,83.28666666666666,FUN_004754-T1,Q6NZ07,NCLN_DANRE,,BOS complex subunit ncln (Nicalin-1) (Nicastrin-like protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),48.7,573.0,7.4e-141,502.3,sp|Q6NZ07|NCLN_DANRE BOS complex subunit ncln OS=Danio rerio OX=7955 GN=ncln PE=2 SV=1,GO:0003140; GO:0005789; GO:0009966; GO:0043022; GO:0048484; GO:0160063; GO:0160064; GO:1900108,determination of left/right asymmetry in lateral mesoderm [GO:0003140]; enteric nervous system development [GO:0048484]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; negative regulation of nodal signaling pathway [GO:1900108]; regulation of signal transduction [GO:0009966],endoplasmic reticulum membrane [GO:0005789]; multi-pass translocon complex [GO:0160064],ribosome binding [GO:0043022],GO:0048856,anatomical structure development
OG_01154,FUN_004755-T1,Peve_00031387,Pocillopora_meandrina_HIv1___RNAseq.g6700.t1,three_way,84.58933333333333,,,,,,,,,,,,,,,,,
OG_01155,FUN_004766-T1,Peve_00019319,Pocillopora_meandrina_HIv1___RNAseq.g6698.t2,three_way,68.8935,FUN_004766-T1,Q5R4N8,,,,,40.4,779.0,6.3e-146,519.6,sp|Q5R4N8|A2MG_PONAB Alpha-2-macroglobulin OS=Pongo abelii OX=9601 GN=A2M PE=2 SV=1,,,,,,
OG_01156,FUN_004767-T1,Peve_00007781,Pocillopora_meandrina_HIv1___RNAseq.g6697.t1,three_way,76.52799999999999,FUN_004767-T1,O57457,,,,,44.1,474.0,3.5e-96,354.4,sp|O57457|E41LA_DANRE Band 4.1-like protein 4 OS=Danio rerio OX=7955 GN=epb41l4a PE=2 SV=1,,,,,,
OG_01157,FUN_004768-T1,Peve_00002138,Pocillopora_meandrina_HIv1___RNAseq.g6696.t1,three_way,59.955666666666666,FUN_004768-T1,Q9UDY8,MALT1_HUMAN,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),Homo sapiens (Human),29.2,713.0,3.7e-62,241.1,sp|Q9UDY8|MALT1_HUMAN Mucosa-associated lymphoid tissue lymphoma translocation protein 1 OS=Homo sapiens OX=9606 GN=MALT1 PE=1 SV=1,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006952; GO:0008233; GO:0009620; GO:0031398; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0032991; GO:0036094; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043066; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0051168; GO:0051603; GO:0061133; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096]; protein-containing complex [GO:0032991],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; small molecule binding [GO:0036094]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01158,FUN_004776-T1,Peve_00037750,Pocillopora_meandrina_HIv1___RNAseq.g6695.t1,three_way,65.822,FUN_004776-T1,Q2TBA3,MALT1_MOUSE,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase),Mus musculus (Mouse),29.1,709.0,3.5e-63,244.6,sp|Q2TBA3|MALT1_MOUSE Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog OS=Mus musculus OX=10090 GN=Malt1 PE=1 SV=2,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005829; GO:0006508; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051168; GO:0051603; GO:0061133; GO:0071222; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; cellular response to lipopolysaccharide [GO:0071222]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; protease binding [GO:0002020]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01159,FUN_004777-T1,Peve_00037749,Pocillopora_meandrina_HIv1___RNAseq.g6694.t2,three_way,76.02633333333334,FUN_004777-T1,P46859,,,,,34.6,179.0,1.2e-21,104.8,sp|P46859|GNTK_ECOLI Thermoresistant gluconokinase OS=Escherichia coli (strain K12) OX=83333 GN=gntK PE=1 SV=4,,,,,,
OG_01160,FUN_004779-T1,Peve_00037747,Pocillopora_meandrina_HIv1___RNAseq.g6693.t1,three_way,80.62566666666666,FUN_004779-T1,A2A2Y4,FRMD3_HUMAN,,FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O),Homo sapiens (Human),49.3,341.0,6.399999999999999e-96,352.8,sp|A2A2Y4|FRMD3_HUMAN FERM domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FRMD3 PE=1 SV=1,GO:0005856; GO:0008092; GO:0016020; GO:0031032,actomyosin structure organization [GO:0031032],cytoskeleton [GO:0005856]; membrane [GO:0016020],cytoskeletal protein binding [GO:0008092],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_01161,FUN_004780-T1,Peve_00037744,Pocillopora_meandrina_HIv1___RNAseq.g6689.t1,three_way,84.39833333333334,FUN_004780-T1,Q6P3J5,EF2_DANRE,,Elongation factor 2b (EF-2) (EC 3.6.5.-),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,858.0,0.0,1342.8,sp|Q6P3J5|EF2_DANRE Elongation factor 2b OS=Danio rerio OX=7955 GN=eef2b PE=1 SV=1,GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005829; GO:0006414; GO:0043009; GO:0043022; GO:0071466; GO:1990904,cellular response to xenobiotic stimulus [GO:0071466]; chordate embryonic development [GO:0043009]; translational elongation [GO:0006414],cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856,catalytic activity; GTPase activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development
OG_01162,FUN_004781-T1,Peve_00037742,Pocillopora_meandrina_HIv1___RNAseq.g6688.t1,three_way,84.00166666666667,FUN_004781-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),31.8,534.0,1.1e-64,249.6,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01163,FUN_004783-T1,Peve_00037741,Pocillopora_meandrina_HIv1___RNAseq.g8518.t1,three_way,78.20333333333333,FUN_004783-T1,Q95KV7,NDUAD_BOVIN,,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic-interferon-induced mortality 19 protein) (GRIM-19) (NADH-ubiquinone oxidoreductase B16.6 subunit),Bos taurus (Bovine),55.0,120.0,5.7e-33,141.7,sp|Q95KV7|NDUAD_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 OS=Bos taurus OX=9913 GN=NDUFA13 PE=1 SV=3,GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0006915; GO:0008137; GO:0045271; GO:0045892,apoptotic process [GO:0006915]; negative regulation of DNA-templated transcription [GO:0045892],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; respiratory chain complex I [GO:0045271],NADH dehydrogenase (ubiquinone) activity [GO:0008137],GO:0005215; GO:0005654; GO:0005739; GO:0006355; GO:0012501; GO:0043226,transporter activity; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; programmed cell death; organelle
OG_01164,FUN_004784-T1,Peve_00037754,Pocillopora_meandrina_HIv1___RNAseq.g8519.t1,three_way,81.05533333333334,,,,,,,,,,,,,,,,,
OG_01165,FUN_004785-T1,Peve_00037753,Pocillopora_meandrina_HIv1___RNAseq.g27039.t1,three_way,60.36183333333333,FUN_004785-T1,Q9CQX4,PAF15_MOUSE,,PCNA-associated factor (HCV NS5A-transactivated protein 9 homolog) (PCNA-associated factor of 15 kDa) (PAF15) (p15PAF) (PCNA-clamp-associated factor),Mus musculus (Mouse),37.6,109.0,9e-08,57.8,sp|Q9CQX4|PAF15_MOUSE PCNA-associated factor OS=Mus musculus OX=10090 GN=Pclaf PE=1 SV=1,GO:0003682; GO:0005634; GO:0005813; GO:0006260; GO:0006974; GO:0007098; GO:0009411; GO:0019985; GO:0048471; GO:0051726; GO:0060090,centrosome cycle [GO:0007098]; DNA damage response [GO:0006974]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985],centrosome [GO:0005813]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090],GO:0005634; GO:0005815; GO:0006260; GO:0006281; GO:0043226; GO:0060090,nucleus; microtubule organizing center; DNA replication; DNA repair; organelle; molecular adaptor activity
OG_01166,FUN_004786-T1,Peve_00037743,Pocillopora_meandrina_HIv1___RNAseq.g8520.t1,three_way,93.30766666666666,FUN_004786-T1,Q8C4X2,,,,,80.6,330.0,1.9e-155,550.1,sp|Q8C4X2|KC1G3_MOUSE Casein kinase I isoform gamma-3 OS=Mus musculus OX=10090 GN=Csnk1g3 PE=1 SV=2,,,,,,
OG_01167,FUN_004787-T1,Peve_00010251,Pocillopora_meandrina_HIv1___RNAseq.g8521.t1,three_way,75.73400000000001,FUN_004787-T1,Q6TFL3,,,,,37.2,807.0,6.2e-84,313.9,sp|Q6TFL3|CC171_HUMAN Coiled-coil domain-containing protein 171 OS=Homo sapiens OX=9606 GN=CCDC171 PE=1 SV=1,,,,,,
OG_01168,FUN_004791-T1,Peve_00010255,Pocillopora_meandrina_HIv1___RNAseq.g8522.t1,three_way,63.762,FUN_004791-T1,P56705,WNT4_HUMAN,,Protein Wnt-4,Homo sapiens (Human),39.4,322.0,1.9e-62,241.1,sp|P56705|WNT4_HUMAN Protein Wnt-4 OS=Homo sapiens OX=9606 GN=WNT4 PE=1 SV=4,GO:0001658; GO:0001822; GO:0001837; GO:0001838; GO:0001889; GO:0003714; GO:0005109; GO:0005125; GO:0005576; GO:0005615; GO:0005737; GO:0005788; GO:0005796; GO:0005886; GO:0008543; GO:0008584; GO:0008585; GO:0009267; GO:0009986; GO:0010629; GO:0010894; GO:0022407; GO:0030182; GO:0030237; GO:0030325; GO:0030336; GO:0030501; GO:0030666; GO:0031012; GO:0032349; GO:0032967; GO:0033080; GO:0035567; GO:0040037; GO:0042445; GO:0043410; GO:0045165; GO:0045596; GO:0045669; GO:0045836; GO:0045892; GO:0045893; GO:0048018; GO:0048599; GO:0051145; GO:0051496; GO:0051894; GO:0060008; GO:0060070; GO:0060126; GO:0060129; GO:0060231; GO:0060748; GO:0061045; GO:0061180; GO:0061184; GO:0061205; GO:0061369; GO:0070062; GO:0071560; GO:0072033; GO:0072034; GO:0072162; GO:0072174; GO:0072273; GO:0097190; GO:0140013; GO:1904238; GO:2000019; GO:2000066; GO:2000180; GO:2000225; GO:2001234,adrenal gland development [GO:0030325]; apoptotic signaling pathway [GO:0097190]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; meiotic nuclear division [GO:0140013]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; pericyte cell differentiation [GO:1904238]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; Sertoli cell differentiation [GO:0060008]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005576; GO:0005615; GO:0005886; GO:0006355; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048018; GO:0048856; GO:0060090; GO:0098772; GO:0140013; GO:0140110,immune system process; extracellular region; extracellular space; plasma membrane; regulation of DNA-templated transcription; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; receptor ligand activity; anatomical structure development; molecular adaptor activity; molecular function regulator activity; meiotic nuclear division; transcription regulator activity
OG_01169,FUN_004792-T1,Peve_00010256,Pocillopora_meandrina_HIv1___RNAseq.g8523.t1,three_way,63.660500000000006,,,,,,,,,,,,,,,,,
OG_01170,FUN_004793-T1,Peve_00010258,Pocillopora_meandrina_HIv1___RNAseq.g8524.t1,three_way,83.33366666666667,FUN_004793-T1,Q66JT5,,,,,46.5,256.0,2.1e-62,240.7,sp|Q66JT5|TPGS2_MOUSE Tubulin polyglutamylase complex subunit 2 OS=Mus musculus OX=10090 GN=Tpgs2 PE=1 SV=2,,,,,,
OG_01171,FUN_004795-T1,Peve_00010263,Pocillopora_meandrina_HIv1___RNAseq.g8536.t1,three_way,53.3395,FUN_004795-T1,Q56A10,ZN608_MOUSE,,Zinc finger protein 608,Mus musculus (Mouse),41.6,219.0,6.9e-29,132.1,sp|Q56A10|ZN608_MOUSE Zinc finger protein 608 OS=Mus musculus OX=10090 GN=Znf608 PE=1 SV=1,GO:0000122; GO:0008270; GO:0033085,negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of transcription by RNA polymerase II [GO:0000122],,zinc ion binding [GO:0008270],GO:0006355,regulation of DNA-templated transcription
OG_01172,FUN_004797-T1,Peve_00010271,Pocillopora_meandrina_HIv1___RNAseq.g8564.t1,three_way,55.6755,FUN_004797-T1,Q9DBN1,STR6L_MOUSE,,Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2),Mus musculus (Mouse),28.0,633.0,1.8e-62,242.3,sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1,GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939,establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939],plasma membrane [GO:0005886],retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_01173,FUN_004799-T1,Peve_00027138,Pocillopora_meandrina_HIv1___TS.g20303.t1b,three_way,56.354,FUN_004799-T1,Q9UKP4,ATS7_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-),Homo sapiens (Human),29.2,343.0,6.6e-28,127.9,sp|Q9UKP4|ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens OX=9606 GN=ADAMTS7 PE=1 SV=2,GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773,cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0140096; GO:1901135,"catalytic activity; extracellular region; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01174,FUN_004803-T2,Peve_00023849,Pocillopora_meandrina_HIv1___RNAseq.g8569.t1,three_way,51.61816666666667,FUN_004803-T2,A7E2V4,ZSWM8_HUMAN,,Zinc finger SWIM domain-containing protein 8,Homo sapiens (Human),29.1,453.0,2.6e-39,166.4,sp|A7E2V4|ZSWM8_HUMAN Zinc finger SWIM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=ZSWIM8 PE=1 SV=1,GO:0005829; GO:0006515; GO:0008270; GO:0016567; GO:0031462; GO:0031463; GO:0043161; GO:0140958; GO:1990756; GO:2000627,positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein ubiquitination [GO:0016567]; target-directed miRNA degradation [GO:0140958],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829],ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270],GO:0005829; GO:0030163; GO:0060090,cytosol; protein catabolic process; molecular adaptor activity
OG_01175,FUN_004804-T1,Peve_00023846,Pocillopora_meandrina_HIv1___RNAseq.g8570.t1,three_way,91.52233333333334,FUN_004804-T1,Q28104,COPE_BOVIN,,Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP),Bos taurus (Bovine),60.8,296.0,4.4e-100,365.9,sp|Q28104|COPE_BOVIN Coatomer subunit epsilon OS=Bos taurus OX=9913 GN=COPE PE=1 SV=3,GO:0000139; GO:0005198; GO:0005654; GO:0006888; GO:0006890; GO:0006891; GO:0015031; GO:0030126; GO:0099612,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein localization to axon [GO:0099612]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654],structural molecule activity [GO:0005198],GO:0005198; GO:0005654; GO:0016192,structural molecule activity; nucleoplasm; vesicle-mediated transport
OG_01176,FUN_004809-T1,Peve_00023841,Pocillopora_meandrina_HIv1___TS.g20309.t1,three_way,59.93666666666667,,,,,,,,,,,,,,,,,
OG_01177,FUN_004816-T1,Peve_00023831,Pocillopora_meandrina_HIv1___RNAseq.g8574.t1,three_way,59.54533333333333,FUN_004816-T1,Q25490,,,,,22.5,1034.0,1.2e-35,155.2,sp|Q25490|APLP_MANSE Apolipophorins OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_01178,FUN_004817-T1,Peve_00023828,Pocillopora_meandrina_HIv1___RNAseq.g8576.t1,three_way,76.47766666666666,FUN_004817-T1,Q9VIP7,,,,,51.0,257.0,1.2999999999999998e-69,264.6,sp|Q9VIP7|ACASE_DROME Alkaline ceramidase OS=Drosophila melanogaster OX=7227 GN=bwa PE=2 SV=2,,,,,,
OG_01179,FUN_004828-T1,Peve_00023842,Pocillopora_meandrina_HIv1___RNAseq.g8581.t1,three_way,67.07333333333332,,,,,,,,,,,,,,,,,
OG_01180,FUN_004829-T1,Peve_00021957,Pocillopora_meandrina_HIv1___RNAseq.g8582.t1,three_way,65.48383333333334,,,,,,,,,,,,,,,,,
OG_01181,FUN_004831-T2,Peve_00013711,Pocillopora_meandrina_HIv1___RNAseq.g8583.t1,three_way,66.76283333333333,,,,,,,,,,,,,,,,,
OG_01182,FUN_004832-T1,Peve_00013708,Pocillopora_meandrina_HIv1___RNAseq.g8584.t1,three_way,78.78366666666666,,,,,,,,,,,,,,,,,
OG_01183,FUN_004833-T1,Peve_00041797,Pocillopora_meandrina_HIv1___RNAseq.g8607.t1,three_way,66.8355,FUN_004833-T1,Q6JAN0,AGRV1_DANRE,,Adhesion G-protein coupled receptor V1 (EC 3.4.-.-) (G-protein coupled receptor 98) (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Very large G-protein coupled receptor 1),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,6348.0,0.0,2524.2,sp|Q6JAN0|AGRV1_DANRE Adhesion G-protein coupled receptor V1 OS=Danio rerio OX=7955 GN=adgrv1 PE=2 SV=1,GO:0001917; GO:0001965; GO:0004930; GO:0005737; GO:0007166; GO:0007186; GO:0007194; GO:0007601; GO:0007605; GO:0010739; GO:0010855; GO:0016787; GO:0031647; GO:0032420; GO:0042462; GO:0060171; GO:0071277; GO:0097264,cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; eye photoreceptor cell development [GO:0042462]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of protein kinase A signaling [GO:0010739]; regulation of protein stability [GO:0031647]; self proteolysis [GO:0097264]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; stereocilium [GO:0032420]; stereocilium membrane [GO:0060171],adenylate cyclase inhibitor activity [GO:0010855]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; hydrolase activity [GO:0016787],GO:0003824; GO:0016787; GO:0048856; GO:0050877; GO:0060089; GO:0098772,catalytic activity; hydrolase activity; anatomical structure development; nervous system process; molecular transducer activity; molecular function regulator activity
OG_01184,FUN_004834-T1,Peve_00019417,Pocillopora_meandrina_HIv1___RNAseq.g8609.t1,three_way,70.38799999999999,FUN_004834-T1,Q9UKP4,ATS7_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-),Homo sapiens (Human),45.7,924.0,7.5e-249,862.1,sp|Q9UKP4|ATS7_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 7 OS=Homo sapiens OX=9606 GN=ADAMTS7 PE=1 SV=2,GO:0002062; GO:0004222; GO:0005576; GO:0005788; GO:0006029; GO:0006508; GO:0008237; GO:0009986; GO:0030198; GO:0030199; GO:0031012; GO:0032331; GO:0043931; GO:0046872; GO:0051603; GO:0071347; GO:0071356; GO:0071773,cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; negative regulation of chondrocyte differentiation [GO:0032331]; ossification involved in bone maturation [GO:0043931]; proteoglycan metabolic process [GO:0006029]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0140096; GO:1901135,"catalytic activity; extracellular region; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01185,FUN_004835-T1,Peve_00019419,Pocillopora_meandrina_HIv1___RNAseq.g8610.t1,three_way,73.24,FUN_004835-T1,Q96PU9,,,,,46.6,238.0,5.4e-51,202.6,sp|Q96PU9|CMA1A_HUMAN Ciliary microtubule associated protein 1A OS=Homo sapiens OX=9606 GN=CIMAP1A PE=1 SV=1,,,,,,
OG_01186,FUN_004836-T1,Peve_00019420,Pocillopora_meandrina_HIv1___RNAseq.g8611.t1,three_way,80.11233333333334,FUN_004836-T1,Q8WUQ7,CATIN_HUMAN,,Splicing factor Cactin (Renal carcinoma antigen NY-REN-24),Homo sapiens (Human),60.5,580.0,1.1e-156,555.1,sp|Q8WUQ7|CATIN_HUMAN Splicing factor Cactin OS=Homo sapiens OX=9606 GN=CACTIN PE=1 SV=3,GO:0000398; GO:0001933; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005829; GO:0016607; GO:0031665; GO:0032088; GO:0032688; GO:0032717; GO:0032720; GO:0034122; GO:0043124; GO:0045087; GO:0045292; GO:0045824; GO:0060339; GO:0071013; GO:0071222; GO:0071347; GO:0071356,"cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; innate immune response [GO:0045087]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of innate immune response [GO:0045824]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0016071; GO:0043226; GO:0098542,immune system process; RNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle; defense response to other organism
OG_01187,FUN_004838-T1,Peve_00019421,Pocillopora_meandrina_HIv1___RNAseq.g8612.t1b,three_way,74.21666666666667,FUN_004838-T1,P43681,ACHA4_HUMAN,,Neuronal acetylcholine receptor subunit alpha-4,Homo sapiens (Human),41.8,325.0,5.9e-75,283.1,sp|P43681|ACHA4_HUMAN Neuronal acetylcholine receptor subunit alpha-4 OS=Homo sapiens OX=9606 GN=CHRNA4 PE=1 SV=2,GO:0001508; GO:0001666; GO:0005886; GO:0005892; GO:0006281; GO:0006811; GO:0006816; GO:0006979; GO:0007165; GO:0007268; GO:0007271; GO:0007274; GO:0009897; GO:0014059; GO:0015276; GO:0015464; GO:0016020; GO:0019233; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0042113; GO:0042166; GO:0042391; GO:0042734; GO:0043005; GO:0043025; GO:0045202; GO:0045211; GO:0050877; GO:0050890; GO:0051899; GO:0060080; GO:0095500; GO:0098878,"acetylcholine receptor signaling pathway [GO:0095500]; action potential [GO:0001508]; B cell activation [GO:0042113]; behavioral response to nicotine [GO:0035095]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; cognition [GO:0050890]; DNA repair [GO:0006281]; inhibitory postsynaptic potential [GO:0060080]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; regulation of dopamine secretion [GO:0014059]; regulation of membrane potential [GO:0042391]; response to hypoxia [GO:0001666]; response to nicotine [GO:0035094]; response to oxidative stress [GO:0006979]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0002376; GO:0005215; GO:0005886; GO:0006281; GO:0023052; GO:0050877; GO:0055085; GO:0060089,immune system process; transporter activity; plasma membrane; DNA repair; signaling; nervous system process; transmembrane transport; molecular transducer activity
OG_01188,FUN_004841-T1,Peve_00019429,Pocillopora_meandrina_HIv1___RNAseq.g8617.t1,three_way,76.224,FUN_004841-T1,P32297,ACHA3_HUMAN,,Neuronal acetylcholine receptor subunit alpha-3,Homo sapiens (Human),35.1,490.0,2.6e-86,320.9,sp|P32297|ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 OS=Homo sapiens OX=9606 GN=CHRNA3 PE=1 SV=4,GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006811; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0014056; GO:0015276; GO:0015464; GO:0016020; GO:0016607; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0043231; GO:0044853; GO:0045202; GO:0045211; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098878; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005730; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; nucleolus; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; signaling; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_01189,FUN_004843-T1,Peve_00019430,Pocillopora_meandrina_HIv1___RNAseq.g8619.t1,three_way,44.587,,,,,,,,,,,,,,,,,
OG_01190,FUN_004844-T1,Peve_00019431,Pocillopora_meandrina_HIv1___RNAseq.g8621.t1,three_way,65.215,,,,,,,,,,,,,,,,,
OG_01191,FUN_004845-T1,Peve_00019432,Pocillopora_meandrina_HIv1___RNAseq.g8622.t1,three_way,81.704,FUN_004845-T1,Q9PTS8,ACHA9_CHICK,,Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9),Gallus gallus (Chicken),39.9,476.0,7.3000000000000015e-87,322.8,sp|Q9PTS8|ACHA9_CHICK Neuronal acetylcholine receptor subunit alpha-9 OS=Gallus gallus OX=9031 GN=CHRNA9 PE=1 SV=1,GO:0005231; GO:0005262; GO:0005886; GO:0007268; GO:0022848; GO:0022850; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:1902495; GO:1904315,chemical synaptic transmission [GO:0007268]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391],neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; transmembrane transporter complex [GO:1902495],acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; serotonin-gated monoatomic cation channel activity [GO:0022850]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_01192,FUN_004850-T1,Peve_00013710,Pocillopora_meandrina_HIv1___RNAseq.g8605.t1,three_way,55.08,FUN_004850-T1,Q9EP86,,,,,22.8,320.0,2.5e-12,74.7,sp|Q9EP86|NPFF1_RAT Neuropeptide FF receptor 1 OS=Rattus norvegicus OX=10116 GN=Npffr1 PE=1 SV=1,,,,,,
OG_01193,FUN_004851-T1,Peve_00043739,Pocillopora_meandrina_HIv1___RNAseq.g8640.t1,three_way,62.76883333333333,FUN_004851-T1,Q04912,RON_HUMAN,,Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain],Homo sapiens (Human),35.8,293.0,2.2e-49,198.7,sp|Q04912|RON_HUMAN Macrophage-stimulating protein receptor OS=Homo sapiens OX=9606 GN=MST1R PE=1 SV=3,GO:0001725; GO:0004714; GO:0005011; GO:0005524; GO:0005773; GO:0005886; GO:0006909; GO:0006952; GO:0007165; GO:0007169; GO:0007338; GO:0007399; GO:0008284; GO:0009615; GO:0009986; GO:0016477; GO:0019899; GO:0043235; GO:0043406; GO:0045087; GO:0051897,cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; defense response [GO:0006952]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; phagocytosis [GO:0006909]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to virus [GO:0009615]; signal transduction [GO:0007165]; single fertilization [GO:0007338],cell surface [GO:0009986]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; vacuole [GO:0005773],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; macrophage colony-stimulating factor receptor activity [GO:0005011]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005773; GO:0005886; GO:0016192; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0098542; GO:0140096,"immune system process; catalytic activity; vacuole; plasma membrane; vesicle-mediated transport; transferase activity; reproductive process; organelle; anatomical structure development; cell motility; molecular transducer activity; defense response to other organism; catalytic activity, acting on a protein"
OG_01194,FUN_004852-T1,Peve_00043740,Pocillopora_meandrina_HIv1___RNAseq.g8639.t1,three_way,66.92133333333334,FUN_004852-T1,P70473,AMACR_RAT,,Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-arylpropionyl-CoA epimerase) (2-methylacyl-CoA racemase),Rattus norvegicus (Rat),53.2,280.0,6.7e-82,305.4,sp|P70473|AMACR_RAT Alpha-methylacyl-CoA racemase OS=Rattus norvegicus OX=10116 GN=Amacr PE=1 SV=3,GO:0005737; GO:0005739; GO:0005777; GO:0006631; GO:0006699; GO:0008111; GO:0008206,bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; peroxisome [GO:0005777],alpha-methylacyl-CoA racemase activity [GO:0008111],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016853; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; isomerase activity; organelle
OG_01195,FUN_004853-T1,Peve_00043741,Pocillopora_meandrina_HIv1___RNAseq.g8638.t1,three_way,86.89533333333333,FUN_004853-T1,Q86X52,CHSS1_HUMAN,,Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1),Homo sapiens (Human),39.8,533.0,1.5e-102,374.8,sp|Q86X52|CHSS1_HUMAN Chondroitin sulfate synthase 1 OS=Homo sapiens OX=9606 GN=CHSY1 PE=1 SV=3,GO:0000139; GO:0002063; GO:0005576; GO:0009954; GO:0016020; GO:0030279; GO:0031667; GO:0032580; GO:0045880; GO:0046872; GO:0047238; GO:0050510; GO:0050650; GO:0051923; GO:0060349,bone morphogenesis [GO:0060349]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; negative regulation of ossification [GO:0030279]; positive regulation of smoothened signaling pathway [GO:0045880]; proximal/distal pattern formation [GO:0009954]; response to nutrient levels [GO:0031667]; sulfation [GO:0051923],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; membrane [GO:0016020],glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510],GO:0003824; GO:0005576; GO:0006790; GO:0009101; GO:0016740; GO:0048856; GO:1901135,catalytic activity; extracellular region; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_01196,FUN_004854-T1,Peve_00043744,Pocillopora_meandrina_HIv1___RNAseq.g8636.t1,three_way,55.40316666666666,,,,,,,,,,,,,,,,,
OG_01197,FUN_004855-T1,Peve_00043745,Pocillopora_meandrina_HIv1___RNAseq.15663_t,three_way,76.852,FUN_004855-T1,Q6NXE6,ARMC6_HUMAN,,Armadillo repeat-containing protein 6,Homo sapiens (Human),38.6,298.0,8.2e-45,183.0,sp|Q6NXE6|ARMC6_HUMAN Armadillo repeat-containing protein 6 OS=Homo sapiens OX=9606 GN=ARMC6 PE=1 SV=2,GO:0002244; GO:0005829,hematopoietic progenitor cell differentiation [GO:0002244],cytosol [GO:0005829],,GO:0005829; GO:0030154,cytosol; cell differentiation
OG_01198,FUN_004860-T1,Peve_00043706,Pocillopora_meandrina_HIv1___RNAseq.g8634.t1,three_way,74.22133333333333,FUN_004860-T1,Q5U2Q4,PAR16_RAT,,Protein mono-ADP-ribosyltransferase PARP16 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 15) (Poly [ADP-ribose] polymerase 16) (PARP-16),Rattus norvegicus (Rat),46.6,313.0,9.4e-80,298.5,sp|Q5U2Q4|PAR16_RAT Protein mono-ADP-ribosyltransferase PARP16 OS=Rattus norvegicus OX=10116 GN=Parp16 PE=2 SV=1,GO:0003950; GO:0005635; GO:0005783; GO:0005789; GO:0016779; GO:0019900; GO:0030968; GO:0036498; GO:0043539; GO:0070213; GO:0071782; GO:0140804; GO:0140806; GO:0140807; GO:1990404; GO:1990830; GO:2000766,cellular response to leukemia inhibitory factor [GO:1990830]; endoplasmic reticulum unfolded protein response [GO:0030968]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of cytoplasmic translation [GO:2000766]; protein auto-ADP-ribosylation [GO:0070213],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; nuclear envelope [GO:0005635],kinase binding [GO:0019900]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-lysine ADP-ribosyltransferase activity [GO:0140804]; nucleotidyltransferase activity [GO:0016779]; protein serine/threonine kinase activator activity [GO:0043539],GO:0003824; GO:0005635; GO:0005783; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nuclear envelope; endoplasmic reticulum; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01199,FUN_004862-T1,Peve_00043709,Pocillopora_meandrina_HIv1___RNAseq.g8631.t2,three_way,66.93066666666667,FUN_004862-T1,Q9JJQ0,,,,,43.5,540.0,3.3e-122,440.3,"sp|Q9JJQ0|PIGB_MOUSE GPI alpha-1,2-mannosyltransferase 3 OS=Mus musculus OX=10090 GN=Pigb PE=2 SV=2",,,,,,
OG_01200,FUN_004864-T1,Peve_00043710,Pocillopora_meandrina_HIv1___RNAseq.g8629.t1,three_way,43.367666666666665,,,,,,,,,,,,,,,,,
OG_01201,FUN_004865-T1,Peve_00043712,Pocillopora_meandrina_HIv1___RNAseq.g8628.t1,three_way,55.48716666666667,FUN_004865-T1,Q5F416,,,,,38.2,228.0,8.000000000000001e-29,129.8,sp|Q5F416|TIPIN_CHICK TIMELESS-interacting protein OS=Gallus gallus OX=9031 GN=TIPIN PE=2 SV=1,,,,,,
OG_01202,FUN_004866-T1,Peve_00043716,Pocillopora_meandrina_HIv1___RNAseq.g8626.t1,three_way,62.815333333333335,FUN_004866-T1,Q1JV40,HVCN1_CIOIN,,Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1) (Voltage sensor domain-only protein),Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis),45.6,114.0,9.8e-18,91.7,sp|Q1JV40|HVCN1_CIOIN Voltage-gated hydrogen channel 1 OS=Ciona intestinalis OX=7719 GN=HVCN1 PE=2 SV=1,GO:0005886; GO:0030171; GO:0034702; GO:0071294; GO:0071467; GO:1902600,cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600],monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],voltage-gated proton channel activity [GO:0030171],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01203,FUN_004867-T1,Peve_00043717,Pocillopora_meandrina_HIv1___RNAseq.g8625.t1,three_way,77.072,FUN_004867-T1,O00471,EXOC5_HUMAN,,Exocyst complex component 5 (Exocyst complex component Sec10) (hSec10),Homo sapiens (Human),47.9,710.0,3e-176,620.2,sp|O00471|EXOC5_HUMAN Exocyst complex component 5 OS=Homo sapiens OX=9606 GN=EXOC5 PE=1 SV=1,GO:0000145; GO:0000281; GO:0001736; GO:0005737; GO:0005829; GO:0006887; GO:0006892; GO:0006893; GO:0006904; GO:0015031; GO:0030496; GO:0031267; GO:0072659; GO:0090148; GO:0090522; GO:1904019; GO:1905515,epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; non-motile cilium assembly [GO:1905515]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle tethering involved in exocytosis [GO:0090522],cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496],small GTPase binding [GO:0031267],GO:0000910; GO:0005829; GO:0012501; GO:0016192; GO:0044782; GO:0061024; GO:0072659,cytokinesis; cytosol; programmed cell death; vesicle-mediated transport; cilium organization; membrane organization; protein localization to plasma membrane
OG_01204,FUN_004870-T1,Peve_00043738,Pocillopora_meandrina_HIv1___RNAseq.g8641.t1,three_way,89.86433333333333,FUN_004870-T1,Q1ZXJ0,,,,,32.5,873.0,3.9e-114,414.1,sp|Q1ZXJ0|CLCD_DICDI Chloride channel protein D OS=Dictyostelium discoideum OX=44689 GN=clcD PE=3 SV=1,,,,,,
OG_01205,FUN_004872-T1,Peve_00043730,Pocillopora_meandrina_HIv1___RNAseq.g8648.t1,three_way,59.46183333333333,,,,,,,,,,,,,,,,,
OG_01206,FUN_004873-T1,Peve_00043731,Pocillopora_meandrina_HIv1___TS.g20376.t1,three_way,42.24266666666667,,,,,,,,,,,,,,,,,
OG_01207,FUN_004880-T1,Peve_00043729,Pocillopora_meandrina_HIv1___RNAseq.g8656.t1,three_way,70.81866666666667,FUN_004880-T1,Q6DFB8,,,,,33.7,1627.0,1.2e-223,778.9,sp|Q6DFB8|TTC37_XENLA Tetratricopeptide repeat protein 37 OS=Xenopus laevis OX=8355 GN=ttc37 PE=2 SV=1,,,,,,
OG_01208,FUN_004881-T1,Peve_00043727,Pocillopora_meandrina_HIv1___RNAseq.g8658.t1,three_way,72.80466666666666,FUN_004881-T1,Q8IWZ8,SUGP1_HUMAN,,SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4),Homo sapiens (Human),55.6,169.0,3.8999999999999995e-46,187.2,sp|Q8IWZ8|SUGP1_HUMAN SURP and G-patch domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SUGP1 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005654; GO:0005681; GO:0006397; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0016071,RNA binding; nucleoplasm; mRNA metabolic process
OG_01209,FUN_004882-T1,Peve_00043725,Pocillopora_meandrina_HIv1___TS.g20387.t1,three_way,68.81266666666667,FUN_004882-T1,Q6DH02,RM24_DANRE,,"Large ribosomal subunit protein uL24m (39S ribosomal protein L24, mitochondrial) (L24mt) (MRP-L24)",Danio rerio (Zebrafish) (Brachydanio rerio),51.2,168.0,1.8e-43,177.6,sp|Q6DH02|RM24_DANRE Large ribosomal subunit protein uL24m OS=Danio rerio OX=7955 GN=mrpl24 PE=2 SV=1,GO:0003723; GO:0003735; GO:0005739; GO:0005762; GO:0006412; GO:0006754; GO:0045333,ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; translation [GO:0006412],mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005739; GO:0006091; GO:0043226; GO:0055086; GO:1901135,RNA binding; structural molecule activity; mitochondrion; generation of precursor metabolites and energy; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01210,FUN_004887-T1,Peve_00005850,Pocillopora_meandrina_HIv1___RNAseq.g10661.t1,three_way,61.143166666666666,FUN_004887-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),31.4,1097.0,1.9e-124,450.7,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01211,FUN_004890-T1,Peve_00043724,Pocillopora_meandrina_HIv1___RNAseq.g8662.t1,three_way,58.45816666666666,FUN_004890-T1,Q7JK24,,,,,31.0,242.0,1.1e-22,109.0,"sp|Q7JK24|B3GT1_GORGO Beta-1,3-galactosyltransferase 1 OS=Gorilla gorilla gorilla OX=9595 GN=B3GALT1 PE=3 SV=1",,,,,,
OG_01212,FUN_004891-T1,Peve_00043723,Pocillopora_meandrina_HIv1___RNAseq.g8663.t1,three_way,69.44433333333333,FUN_004891-T1,Q7T381,BOKB_DANRE,,Bcl-2-related ovarian killer protein homolog B (zBok2),Danio rerio (Zebrafish) (Brachydanio rerio),37.4,107.0,7.8e-10,65.5,sp|Q7T381|BOKB_DANRE Bcl-2-related ovarian killer protein homolog B OS=Danio rerio OX=7955 GN=bokb PE=2 SV=1,GO:0005741; GO:0006915; GO:0015267; GO:0042981,apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981],mitochondrial outer membrane [GO:0005741],channel activity [GO:0015267],GO:0005215; GO:0012501,transporter activity; programmed cell death
OG_01213,FUN_004892-T1,Peve_00043722,Pocillopora_meandrina_HIv1___RNAseq.g8664.t1,three_way,65.85383333333333,FUN_004892-T1,P59889,,,,,36.4,302.0,8.300000000000001e-38,159.1,sp|P59889|S39A1_DANRE Zinc transporter ZIP1 OS=Danio rerio OX=7955 GN=slc39a1 PE=2 SV=1,,,,,,
OG_01214,FUN_004895-T1,Peve_00043720,Pocillopora_meandrina_HIv1___RNAseq.15695_t,three_way,69.655,FUN_004895-T1,Q61532,MK06_MOUSE,,Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) (Extracellular signal-regulated kinase 3) (ERK-3),Mus musculus (Mouse),44.8,330.0,5.8e-81,303.1,sp|Q61532|MK06_MOUSE Mitogen-activated protein kinase 6 OS=Mus musculus OX=10090 GN=Mapk6 PE=1 SV=3,GO:0004672; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0019901; GO:0032156; GO:0032991; GO:0046982; GO:0060999; GO:0106310,positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156],ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01215,FUN_004896-T1,Peve_00043742,Pocillopora_meandrina_HIv1___RNAseq.g8668.t1,three_way,71.73666666666666,FUN_004896-T1,Q641Z2,,,,,41.9,571.0,3.6e-125,450.3,sp|Q641Z2|PTN9_RAT Tyrosine-protein phosphatase non-receptor type 9 OS=Rattus norvegicus OX=10116 GN=Ptpn9 PE=2 SV=1,,,,,,
OG_01216,FUN_004897-T1,Peve_00015867,Pocillopora_meandrina_HIv1___RNAseq.g8671.t1,three_way,80.57000000000001,FUN_004897-T1,Q9Y3U8,,,,,63.4,93.0,7.6e-25,114.4,sp|Q9Y3U8|RL36_HUMAN Large ribosomal subunit protein eL36 OS=Homo sapiens OX=9606 GN=RPL36 PE=1 SV=3,,,,,,
OG_01217,FUN_004898-T1,Peve_00015868,Pocillopora_meandrina_HIv1___RNAseq.g8672.t1,three_way,81.91366666666667,FUN_004898-T1,F1RQM2,AGM1_PIG,,Phosphoacetylglucosamine mutase (PAGM) (PGlcNAc mutase) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3),Sus scrofa (Pig),58.6,534.0,1.9999999999999998e-172,607.1,sp|F1RQM2|AGM1_PIG Phosphoacetylglucosamine mutase OS=Sus scrofa OX=9823 GN=PGM3 PE=1 SV=2,GO:0000287; GO:0004610; GO:0005975; GO:0006048; GO:0030097,carbohydrate metabolic process [GO:0005975]; hemopoiesis [GO:0030097]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],,magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610],GO:0003824; GO:0005975; GO:0016853; GO:0048856; GO:0055086; GO:1901135,catalytic activity; carbohydrate metabolic process; isomerase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01218,FUN_004899-T1,Peve_00015869,Pocillopora_meandrina_HIv1___RNAseq.g8673.t1,three_way,88.71466666666667,FUN_004899-T1,Q2KJG3,,,,,66.2,544.0,6.499999999999999e-222,771.5,"sp|Q2KJG3|SYNC_BOVIN Asparagine--tRNA ligase, cytoplasmic OS=Bos taurus OX=9913 GN=NARS PE=2 SV=3",,,,,,
OG_01219,FUN_004900-T1,Peve_00015870,Pocillopora_meandrina_HIv1___TS.g20400.t1,three_way,76.45466666666667,FUN_004900-T1,Q9QYV8,DPOG1_RAT,,DNA polymerase subunit gamma-1 (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (5'-deoxyribose-phosphate lyase) (EC 4.2.99.-) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha),Rattus norvegicus (Rat),49.4,1219.0,0.0,1146.7,sp|Q9QYV8|DPOG1_RAT DNA polymerase subunit gamma-1 OS=Rattus norvegicus OX=10116 GN=Polg PE=2 SV=1,GO:0000262; GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0004527; GO:0005739; GO:0005759; GO:0005760; GO:0006261; GO:0006264; GO:0006284; GO:0006287; GO:0008310; GO:0008340; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0045004; GO:0046872; GO:0051575; GO:0055093; GO:0071333,"base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; determination of adult lifespan [GO:0008340]; DNA replication proofreading [GO:0045004]; DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]",gamma DNA polymerase complex [GO:0005760]; mitochondrial chromosome [GO:0000262]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195],3'-5' exonuclease activity [GO:0008408]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; protease binding [GO:0002020]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310],GO:0003677; GO:0003824; GO:0005694; GO:0005739; GO:0006260; GO:0006281; GO:0016740; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; chromosome; mitochondrion; DNA replication; DNA repair; transferase activity; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_01220,FUN_004902-T1,Peve_00028647,Pocillopora_meandrina_HIv1___RNAseq.g8330.t1,three_way,50.007,,,,,,,,,,,,,,,,,
OG_01221,FUN_004903-T1,Peve_00028646,Pocillopora_meandrina_HIv1___RNAseq.g8331.t1,three_way,93.306,FUN_004903-T1,A5PK63,,,,,79.9,134.0,9.9e-55,214.2,sp|A5PK63|RS17_BOVIN Small ribosomal subunit protein eS17 OS=Bos taurus OX=9913 GN=RPS17 PE=2 SV=1,,,,,,
OG_01222,FUN_004904-T1,Peve_00028659,Pocillopora_meandrina_HIv1___RNAseq.g8332.t1,three_way,63.89233333333333,FUN_004904-T1,Q8BGZ3,DCA12_MOUSE,,DDB1- and CUL4-associated factor 12 (WD repeat-containing protein 40A),Mus musculus (Mouse),41.8,411.0,4.5e-81,303.1,sp|Q8BGZ3|DCA12_MOUSE DDB1- and CUL4-associated factor 12 OS=Mus musculus OX=10090 GN=Dcaf12 PE=2 SV=1,GO:0005634; GO:0005813; GO:0005829; GO:0010506; GO:0016567; GO:0042110; GO:0080008; GO:0140627; GO:1990756,protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; T cell activation [GO:0042110]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],centrosome [GO:0005813]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nucleus [GO:0005634],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0005634; GO:0005815; GO:0005829; GO:0030163; GO:0043226; GO:0060090,immune system process; nucleus; microtubule organizing center; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_01223,FUN_004905-T1,Peve_00028658,Pocillopora_meandrina_HIv1___RNAseq.g8333.t1,three_way,69.76066666666667,FUN_004905-T1,Q61555,FBN2_MOUSE,,Fibrillin-2 [Cleaved into: Placensin],Mus musculus (Mouse),53.2,2537.0,9.1e-126,454.5,sp|Q61555|FBN2_MOUSE Fibrillin-2 OS=Mus musculus OX=10090 GN=Fbn2 PE=1 SV=2,GO:0001527; GO:0005179; GO:0005509; GO:0005576; GO:0030326; GO:0030501; GO:0035108; GO:0035583; GO:0043010; GO:0045669; GO:0048048; GO:0060346; GO:0062023,bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527],calcium ion binding [GO:0005509]; hormone activity [GO:0005179],GO:0005576; GO:0048018; GO:0048856; GO:0098772,extracellular region; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01224,FUN_004906-T1,Peve_00028645,Pocillopora_meandrina_HIv1___RNAseq.g8339.t1,three_way,59.44766666666666,FUN_004906-T1,A3KPW7,,,,,36.2,320.0,1.6999999999999998e-49,198.4,sp|A3KPW7|PTAR1_DANRE Protein prenyltransferase alpha subunit repeat-containing protein 1 OS=Danio rerio OX=7955 GN=ptar1 PE=2 SV=1,,,,,,
OG_01225,FUN_004907-T1,Peve_00026331,Pocillopora_meandrina_HIv1___RNAseq.g8340.t1,three_way,55.694,FUN_004907-T1,Q9WTY1,,,,,38.0,213.0,7.8e-26,120.2,sp|Q9WTY1|PDCD7_MOUSE Programmed cell death protein 7 OS=Mus musculus OX=10090 GN=Pdcd7 PE=1 SV=1,,,,,,
OG_01226,FUN_004908-T1,Peve_00035196,Pocillopora_meandrina_HIv1___RNAseq.g8342.t1,three_way,75.12066666666666,FUN_004908-T1,Q6PEC0,,,,,59.6,114.0,2.9e-35,149.4,sp|Q6PEC0|AP4A_RAT Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] OS=Rattus norvegicus OX=10116 GN=Nudt2 PE=2 SV=3,,,,,,
OG_01227,FUN_004909-T1,Peve_00026333,Pocillopora_meandrina_HIv1___RNAseq.g8343.t1,three_way,58.292,FUN_004909-T1,Q5T7B8,KIF24_HUMAN,,Kinesin-like protein KIF24,Homo sapiens (Human),42.5,631.0,7.1e-116,419.9,sp|Q5T7B8|KIF24_HUMAN Kinesin-like protein KIF24 OS=Homo sapiens OX=9606 GN=KIF24 PE=1 SV=2,GO:0003777; GO:0005524; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0007018; GO:0007019; GO:0008017; GO:0032991; GO:0042802; GO:0060271; GO:1902018,cilium assembly [GO:0060271]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; negative regulation of cilium assembly [GO:1902018],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; microtubule [GO:0005874]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_01228,FUN_004910-T1,Peve_00028228,Pocillopora_meandrina_HIv1___TS.g20086.t1,three_way,85.51783333333333,FUN_004910-T1,Q16959,,,,,63.3,654.0,2.5e-231,803.1,"sp|Q16959|DYI2_HELCR Dynein intermediate chain 2, ciliary OS=Heliocidaris crassispina OX=1043166 PE=2 SV=1",,,,,,
OG_01229,FUN_004913-T1,Peve_00034774,Pocillopora_meandrina_HIv1___RNAseq.g8346.t1,three_way,79.94333333333333,FUN_004913-T1,Q99M01,,,,,55.9,401.0,7.4e-133,475.3,"sp|Q99M01|SYFM_MOUSE Phenylalanine--tRNA ligase, mitochondrial OS=Mus musculus OX=10090 GN=Fars2 PE=1 SV=1",,,,,,
OG_01230,FUN_004914-T1,Peve_00044505,Pocillopora_meandrina_HIv1___RNAseq.g8347.t1,three_way,71.40666666666667,FUN_004914-T1,P12527,LOX5_RAT,,Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34),Rattus norvegicus (Rat),31.6,395.0,1.2999999999999998e-43,179.1,sp|P12527|LOX5_RAT Polyunsaturated fatty acid 5-lipoxygenase OS=Rattus norvegicus OX=10116 GN=Alox5 PE=1 SV=3,GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005634; GO:0005635; GO:0005641; GO:0005737; GO:0005829; GO:0006691; GO:0006954; GO:0006959; GO:0007584; GO:0016363; GO:0016525; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030425; GO:0030501; GO:0031965; GO:0034440; GO:0036336; GO:0036403; GO:0042383; GO:0042593; GO:0045598; GO:0045907; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0055093; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904999; GO:2001301,arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of vasoconstriction [GO:0045907]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; response to hyperoxia [GO:0055093]; response to nutrient [GO:0007584],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcolemma [GO:0042383],arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506],GO:0002376; GO:0003013; GO:0003824; GO:0005634; GO:0005635; GO:0005829; GO:0005886; GO:0006629; GO:0006954; GO:0016491; GO:0016787; GO:0043226; GO:0048870,immune system process; circulatory system process; catalytic activity; nucleus; nuclear envelope; cytosol; plasma membrane; lipid metabolic process; inflammatory response; oxidoreductase activity; hydrolase activity; organelle; cell motility
OG_01231,FUN_004916-T1,Peve_00044501,Pocillopora_meandrina_HIv1___RNAseq.g8349.t1,three_way,65.203,FUN_004916-T1,Q9BXW7,,,,,43.7,389.0,6.600000000000001e-78,292.7,sp|Q9BXW7|HDHD5_HUMAN Haloacid dehalogenase-like hydrolase domain-containing 5 OS=Homo sapiens OX=9606 GN=HDHD5 PE=1 SV=1,,,,,,
OG_01232,FUN_004917-T1,Peve_00044500,Pocillopora_meandrina_HIv1___TS.g20092.t1,three_way,76.50533333333333,,,,,,,,,,,,,,,,,
OG_01233,FUN_004918-T1,Peve_00044507,Pocillopora_meandrina_HIv1___RNAseq.g8351.t1,three_way,63.02783333333333,FUN_004918-T1,B2RUR8,OTU7B_MOUSE,,OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne),Mus musculus (Mouse),41.4,529.0,4.6e-93,344.0,sp|B2RUR8|OTU7B_MOUSE OTU domain-containing protein 7B OS=Mus musculus OX=10090 GN=Otud7b PE=1 SV=1,GO:0000122; GO:0001701; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0008234; GO:0008270; GO:0016579; GO:0032717; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:1900181; GO:1904262; GO:1904515; GO:1990380,adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"immune system process; DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01234,FUN_004919-T1,Peve_00044506,Pocillopora_meandrina_HIv1___RNAseq.g8352.t1,three_way,72.428,FUN_004919-T1,Q16566,KCC4_HUMAN,,Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR),Homo sapiens (Human),63.4,290.0,1e-102,374.8,sp|Q16566|KCC4_HUMAN Calcium/calmodulin-dependent protein kinase type IV OS=Homo sapiens OX=9606 GN=CAMK4 PE=1 SV=1,GO:0001650; GO:0002250; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0006468; GO:0006954; GO:0007165; GO:0007616; GO:0009931; GO:0033081; GO:0035556; GO:0043011; GO:0045670; GO:0045893; GO:0070062; GO:0106310,adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; positive regulation of DNA-templated transcription [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005783; GO:0006355; GO:0006954; GO:0016740; GO:0030154; GO:0043226; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; endoplasmic reticulum; regulation of DNA-templated transcription; inflammatory response; transferase activity; cell differentiation; organelle; nervous system process; catalytic activity, acting on a protein"
OG_01235,FUN_004920-T1,Peve_00044504,Pocillopora_meandrina_HIv1___RNAseq.g8353.t1,three_way,57.138666666666666,FUN_004920-T1,Q06441,,,,,45.8,938.0,1.4e-86,322.8,sp|Q06441|TSP4_XENLA Thrombospondin-4 OS=Xenopus laevis OX=8355 GN=thbs4 PE=2 SV=1,,,,,,
OG_01236,FUN_004921-T1,Peve_00044503,Pocillopora_meandrina_HIv1___TS.g20096.t1,three_way,79.03483333333334,,,,,,,,,,,,,,,,,
OG_01237,FUN_004923-T2,Peve_00034765,Pocillopora_meandrina_HIv1___RNAseq.g8361.t1,three_way,65.8205,FUN_004923-T2,Q9Z1T2,TSP4_MOUSE,,Thrombospondin-4,Mus musculus (Mouse),47.5,927.0,1e-105,386.3,sp|Q9Z1T2|TSP4_MOUSE Thrombospondin-4 OS=Mus musculus OX=10090 GN=Thbs4 PE=1 SV=1,GO:0001938; GO:0005178; GO:0005509; GO:0005604; GO:0005615; GO:0005783; GO:0006986; GO:0008083; GO:0008201; GO:0016525; GO:0016529; GO:0034103; GO:0034976; GO:0048266; GO:0048771; GO:0051451; GO:0051781; GO:0062023; GO:0071603; GO:0090023,behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178],GO:0005615; GO:0005783; GO:0007155; GO:0030312; GO:0031012; GO:0043226; GO:0048018; GO:0048870; GO:0098772,extracellular space; endoplasmic reticulum; cell adhesion; external encapsulating structure; extracellular matrix; organelle; receptor ligand activity; cell motility; molecular function regulator activity
OG_01238,FUN_004924-T1,Peve_00034321,Pocillopora_meandrina_HIv1___RNAseq.g8362.t1,three_way,53.07116666666667,FUN_004924-T1,Q92733,PRCC_HUMAN,,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),Homo sapiens (Human),42.9,156.0,6.3e-20,100.5,sp|Q92733|PRCC_HUMAN Proline-rich protein PRCC OS=Homo sapiens OX=9606 GN=PRCC PE=1 SV=1,GO:0005634; GO:0005654; GO:0016607; GO:0051726,regulation of cell cycle [GO:0051726],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0043226,nucleus; nucleoplasm; organelle
OG_01239,FUN_004925-T1,Peve_00034767,Pocillopora_meandrina_HIv1___RNAseq.g8363.t1,three_way,75.504,,,,,,,,,,,,,,,,,
OG_01240,FUN_004926-T1,Peve_00034769,Pocillopora_meandrina_HIv1___RNAseq.g8365.t1,three_way,75.525,,,,,,,,,,,,,,,,,
OG_01241,FUN_004929-T1,Peve_00034771,Pocillopora_meandrina_HIv1___RNAseq.g8368.t1,three_way,72.67233333333333,,,,,,,,,,,,,,,,,
OG_01242,FUN_004932-T1,Peve_00034773,Pocillopora_meandrina_HIv1___RNAseq.g8372.t1,three_way,69.01916666666666,,,,,,,,,,,,,,,,,
OG_01243,FUN_004933-T1,Peve_00014403,Pocillopora_meandrina_HIv1___RNAseq.g8373.t1,three_way,72.1075,,,,,,,,,,,,,,,,,
OG_01244,FUN_004939-T1,Peve_00014400,Pocillopora_meandrina_HIv1___RNAseq.g8389.t1,three_way,65.75466666666667,,,,,,,,,,,,,,,,,
OG_01245,FUN_004940-T1,Peve_00024453,Pocillopora_meandrina_HIv1___RNAseq.g8391.t1,three_way,69.185,FUN_004940-T1,O15126,SCAM1_HUMAN,,Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1),Homo sapiens (Human),41.6,339.0,9.2e-50,199.1,sp|O15126|SCAM1_HUMAN Secretory carrier-associated membrane protein 1 OS=Homo sapiens OX=9606 GN=SCAMP1 PE=1 SV=2,GO:0005802; GO:0005886; GO:0006887; GO:0006892; GO:0006897; GO:0015031; GO:0016020; GO:0019904; GO:0030136; GO:0030672; GO:0032588; GO:0035579; GO:0042589; GO:0051649; GO:0055038,endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031],clathrin-coated vesicle [GO:0030136]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule membrane [GO:0035579]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589],protein domain specific binding [GO:0019904],GO:0005886; GO:0016192; GO:0031410; GO:0043226,plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_01246,FUN_004941-T1,Peve_00024450,Pocillopora_meandrina_HIv1___TS.g20127.t1,three_way,74.99733333333333,FUN_004941-T1,A2RUC4,TYW5_HUMAN,,tRNA wybutosine-synthesizing protein 5 (hTYW5) (tRNA yW-synthesizing protein 5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase),Homo sapiens (Human),28.9,249.0,2.1e-16,88.6,sp|A2RUC4|TYW5_HUMAN tRNA wybutosine-synthesizing protein 5 OS=Homo sapiens OX=9606 GN=TYW5 PE=1 SV=1,GO:0000049; GO:0005506; GO:0005737; GO:0031591; GO:0042803; GO:0102524,wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524],GO:0003723; GO:0003824; GO:0006399; GO:0016491; GO:0140098; GO:1901135,"RNA binding; catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_01247,FUN_004942-T1,Peve_00043266,Pocillopora_meandrina_HIv1___RNAseq.g8393.t1,three_way,76.48333333333333,FUN_004942-T1,O75347,TBCA_HUMAN,,Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A) (CFA),Homo sapiens (Human),54.2,107.0,3.9e-22,105.5,sp|O75347|TBCA_HUMAN Tubulin-specific chaperone A OS=Homo sapiens OX=9606 GN=TBCA PE=1 SV=3,GO:0003723; GO:0005730; GO:0005737; GO:0005874; GO:0006457; GO:0007021; GO:0007023; GO:0015630; GO:0015631; GO:0048487; GO:0051087,post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730],beta-tubulin binding [GO:0048487]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; tubulin binding [GO:0015631],GO:0003723; GO:0005730; GO:0005856; GO:0006457; GO:0008092; GO:0043226; GO:0065003,RNA binding; nucleolus; cytoskeleton; protein folding; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_01248,FUN_004947-T1,Peve_00043267,Pocillopora_meandrina_HIv1___RNAseq.g8394.t1,three_way,76.3205,FUN_004947-T1,Q9BY12,SCAPE_HUMAN,,S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291),Homo sapiens (Human),41.5,1440.0,9.2e-140,500.0,sp|Q9BY12|SCAPE_HUMAN S phase cyclin A-associated protein in the endoplasmic reticulum OS=Homo sapiens OX=9606 GN=SCAPER PE=1 SV=2,GO:0001547; GO:0003676; GO:0005654; GO:0005783; GO:0005829; GO:0007283; GO:0008270; GO:0016607; GO:0060041; GO:0061827; GO:0072520; GO:1990917,antral ovarian follicle growth [GO:0001547]; retina development in camera-type eye [GO:0060041]; seminiferous tubule development [GO:0072520]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ooplasm [GO:1990917]; sperm head [GO:0061827],nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0005654; GO:0005783; GO:0005829; GO:0022414; GO:0043226; GO:0048856,nucleoplasm; endoplasmic reticulum; cytosol; reproductive process; organelle; anatomical structure development
OG_01249,FUN_004949-T1,Peve_00043273,Pocillopora_meandrina_HIv1___RNAseq.g8396.t1,three_way,89.491,FUN_004949-T1,P50211,,,,,57.0,335.0,2.3e-100,367.1,sp|P50211|ISL1_CHICK Insulin gene enhancer protein ISL-1 OS=Gallus gallus OX=9031 GN=ISL1 PE=1 SV=1,,,,,,
OG_01250,FUN_004969-T1,Peve_00043270,Pocillopora_meandrina_HIv1___TS.g20136.t1,three_way,49.14716666666666,,,,,,,,,,,,,,,,,
OG_01251,FUN_004979-T1,Peve_00031942,Pocillopora_meandrina_HIv1___TS.g20137.t4,three_way,53.51116666666667,FUN_004979-T1,Q13332,,,,,34.1,249.0,7.1e-29,131.3,sp|Q13332|PTPRS_HUMAN Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens OX=9606 GN=PTPRS PE=1 SV=3,,,,,,
OG_01252,FUN_004983-T1,Peve_00015860,Pocillopora_meandrina_HIv1___TS.g20141.t1,three_way,57.64366666666667,FUN_004983-T1,O35568,FBLN3_RAT,,EGF-containing fibulin-like extracellular matrix protein 1 (Fibulin-3) (FIBL-3) (T16 protein),Rattus norvegicus (Rat),46.9,64.0,6.5e-08,62.4,sp|O35568|FBLN3_RAT EGF-containing fibulin-like extracellular matrix protein 1 OS=Rattus norvegicus OX=10116 GN=Efemp1 PE=1 SV=1,GO:0005006; GO:0005154; GO:0005509; GO:0005604; GO:0005615; GO:0006355; GO:0007173; GO:0008083; GO:0008284; GO:0010977; GO:0018108; GO:0031012; GO:0031346; GO:0032331; GO:0043010; GO:0048048; GO:0048050; GO:1903975,camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of neuron projection development [GO:0010977]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell projection organization [GO:0031346]; post-embryonic eye morphogenesis [GO:0048050]; regulation of DNA-templated transcription [GO:0006355]; regulation of glial cell migration [GO:1903975],basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; epidermal growth factor receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083],GO:0003824; GO:0005615; GO:0006355; GO:0016740; GO:0030312; GO:0031012; GO:0048018; GO:0048856; GO:0060089; GO:0098772; GO:0140096,"catalytic activity; extracellular space; regulation of DNA-templated transcription; transferase activity; external encapsulating structure; extracellular matrix; receptor ligand activity; anatomical structure development; molecular transducer activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01253,FUN_004984-T1,Peve_00015858,Pocillopora_meandrina_HIv1___RNAseq.g8407.t1,three_way,53.24016666666667,,,,,,,,,,,,,,,,,
OG_01254,FUN_004985-T1,Peve_00015857,Pocillopora_meandrina_HIv1___RNAseq.g7568.t1,three_way,84.217,FUN_004985-T1,Q6TGY8,,,,,57.4,282.0,9.5e-87,321.6,sp|Q6TGY8|EMC2_DANRE ER membrane protein complex subunit 2 OS=Danio rerio OX=7955 GN=emc2 PE=2 SV=1,,,,,,
OG_01255,FUN_004986-T1,Peve_00015856,Pocillopora_meandrina_HIv1___RNAseq.g7569.t1,three_way,84.39133333333334,FUN_004986-T1,P97390,,,,,66.1,564.0,1.8000000000000003e-214,746.9,sp|P97390|VPS45_MOUSE Vacuolar protein sorting-associated protein 45 OS=Mus musculus OX=10090 GN=Vps45 PE=1 SV=1,,,,,,
OG_01256,FUN_004988-T1,Peve_00015878,Pocillopora_meandrina_HIv1___RNAseq.g8683.t1,three_way,55.67733333333334,FUN_004988-T1,Q5EAR6,VMA22_DANRE,,Vacuolar ATPase assembly protein VMA22 (Coiled-coil domain-containing protein 115),Danio rerio (Zebrafish) (Brachydanio rerio),34.2,219.0,2.6e-18,94.0,sp|Q5EAR6|VMA22_DANRE Vacuolar ATPase assembly protein VMA22 OS=Danio rerio OX=7955 GN=vma22 PE=2 SV=1,GO:0005764; GO:0005768; GO:0005783; GO:0005793; GO:0006879; GO:0016471; GO:0030137; GO:0051082; GO:0070072,intracellular iron ion homeostasis [GO:0006879]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],COPI-coated vesicle [GO:0030137]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; lysosome [GO:0005764]; vacuolar proton-transporting V-type ATPase complex [GO:0016471],unfolded protein binding [GO:0051082],GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0031410; GO:0043226; GO:0065003,lysosome; endosome; vacuole; endoplasmic reticulum; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_01257,FUN_004989-T1,Peve_00015880,Pocillopora_meandrina_HIv1___RNAseq.g8684.t1,three_way,92.291,FUN_004989-T1,Q3ZCK9,,,,,73.6,216.0,1.1e-90,334.3,sp|Q3ZCK9|PSA4_BOVIN Proteasome subunit alpha type-4 OS=Bos taurus OX=9913 GN=PSMA4 PE=1 SV=1,,,,,,
OG_01258,FUN_004990-T1,Peve_00015881,Pocillopora_meandrina_HIv1___RNAseq.g8685.t1,three_way,78.06383333333333,FUN_004990-T1,Q7Z2Z2,EFL1_HUMAN,,Elongation factor-like GTPase 1 (EC 3.6.5.-) (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A),Homo sapiens (Human),53.6,1185.0,0.0,1171.8,sp|Q7Z2Z2|EFL1_HUMAN Elongation factor-like GTPase 1 OS=Homo sapiens OX=9606 GN=EFL1 PE=1 SV=2,GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0042256; GO:0043022; GO:0046039; GO:1990904,cytosolic ribosome assembly [GO:0042256]; GTP metabolic process [GO:0046039],cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; GTPase activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01259,FUN_005018-T1,Peve_00015875,Pocillopora_meandrina_HIv1___RNAseq.g8677.t1,three_way,82.69383333333333,FUN_005018-T1,Q6GPM1,,,,,45.6,799.0,4e-132,474.2,sp|Q6GPM1|ZFR_XENLA Zinc finger RNA-binding protein OS=Xenopus laevis OX=8355 GN=zfr PE=2 SV=1,,,,,,
OG_01260,FUN_005021-T1,Peve_00032188,Pocillopora_meandrina_HIv1___RNAseq.g27443.t1,three_way,52.18333333333334,,,,,,,,,,,,,,,,,
OG_01261,FUN_005023-T1,Peve_00028649,Pocillopora_meandrina_HIv1___RNAseq.g8329.t1,three_way,83.2865,FUN_005023-T1,A2BEA6,,,,,62.1,195.0,1.3e-58,228.8,sp|A2BEA6|ARI3A_DANRE AT-rich interactive domain-containing protein 3A OS=Danio rerio OX=7955 GN=arid3a PE=1 SV=1,,,,,,
OG_01262,FUN_005024-T1,Peve_00028650,Pocillopora_meandrina_HIv1___RNAseq.g8327.t1,three_way,62.04933333333333,,,,,,,,,,,,,,,,,
OG_01263,FUN_005028-T1,Peve_00028653,Pocillopora_meandrina_HIv1___RNAseq.g8323.t2,three_way,41.00666666666667,,,,,,,,,,,,,,,,,
OG_01264,FUN_005029-T2,Peve_00028655,Pocillopora_meandrina_HIv1___RNAseq.g8322.t1,three_way,73.07566666666666,FUN_005029-T2,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),30.9,278.0,3.5000000000000003e-34,147.9,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_01265,FUN_005032-T2,Peve_00028657,Pocillopora_meandrina_HIv1___RNAseq.g8319.t1,three_way,77.08016666666667,FUN_005032-T2,B6ZLK2,CHD1_CHICK,,Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.-) (ATP-dependent helicase CHD1),Gallus gallus (Chicken),53.7,1444.0,0.0,1282.7,sp|B6ZLK2|CHD1_CHICK Chromodomain-helicase-DNA-binding protein 1 OS=Gallus gallus OX=9031 GN=CHD1 PE=1 SV=1,GO:0000775; GO:0000785; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0016887; GO:0034728; GO:0042393; GO:0140658,nucleosome organization [GO:0034728],"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393],GO:0003677; GO:0003824; GO:0005634; GO:0006325; GO:0016787; GO:0016853; GO:0042393; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; chromatin organization; hydrolase activity; isomerase activity; histone binding; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_01266,FUN_005033-T1,Peve_00016746,Pocillopora_meandrina_HIv1___RNAseq.g8318.t1,three_way,64.74883333333332,FUN_005033-T1,Q91XE9,CR3L3_MOUSE,,Cyclic AMP-responsive element-binding protein 3-like protein 3 (cAMP-responsive element-binding protein 3-like protein 3) (Transcription factor CREB-H) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 3],Mus musculus (Mouse),44.7,152.0,6.2e-22,106.7,sp|Q91XE9|CR3L3_MOUSE Cyclic AMP-responsive element-binding protein 3-like protein 3 OS=Mus musculus OX=10090 GN=Creb3l3 PE=1 SV=1,GO:0000977; GO:0001228; GO:0005634; GO:0005654; GO:0005789; GO:0005829; GO:0006986; GO:0016020; GO:0034976; GO:0042803; GO:0045944; GO:0046982,positive regulation of transcription by RNA polymerase II [GO:0045944]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_01267,FUN_005034-T1,Peve_00016744,Pocillopora_meandrina_HIv1___TS.g20060.t1,three_way,63.778666666666666,FUN_005034-T1,Q6R755,,,,,36.2,116.0,3.7e-15,82.8,sp|Q6R755|BCL2_CANLF Apoptosis regulator Bcl-2 OS=Canis lupus familiaris OX=9615 GN=BCL2 PE=2 SV=1,,,,,,
OG_01268,FUN_005036-T1,Peve_00016743,Pocillopora_meandrina_HIv1___RNAseq.g8315.t1,three_way,67.82966666666667,FUN_005036-T1,Q99853,FOXB1_HUMAN,,Forkhead box protein B1 (Transcription factor FKH-5),Homo sapiens (Human),61.9,181.0,2.2999999999999998e-55,217.2,sp|Q99853|FOXB1_HUMAN Forkhead box protein B1 OS=Homo sapiens OX=9606 GN=FOXB1 PE=1 SV=3,GO:0000785; GO:0000978; GO:0000981; GO:0001655; GO:0001756; GO:0005634; GO:0006357; GO:0007412; GO:0007595; GO:0008542; GO:0009653; GO:0021510; GO:0021767; GO:0021794; GO:0021855; GO:0022029; GO:0030154; GO:0030901; GO:0033504; GO:0043524; GO:0043565; GO:0061030; GO:0061374; GO:0061377; GO:0061379; GO:0061381; GO:1990837,anatomical structure morphogenesis [GO:0009653]; axon target recognition [GO:0007412]; cell differentiation [GO:0030154]; cell migration in diencephalon [GO:0061381]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; floor plate development [GO:0033504]; hypothalamus cell migration [GO:0021855]; inferior colliculus development [GO:0061379]; lactation [GO:0007595]; mammary gland lobule development [GO:0061377]; mammillary body development [GO:0021767]; mammillothalamic axonal tract development [GO:0061374]; midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of transcription by RNA polymerase II [GO:0006357]; somitogenesis [GO:0001756]; spinal cord development [GO:0021510]; telencephalon cell migration [GO:0022029]; thalamus development [GO:0021794]; urogenital system development [GO:0001655]; visual learning [GO:0008542],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_01269,FUN_005037-T1,Peve_00016741,Pocillopora_meandrina_HIv1___RNAseq.g8314.t1,three_way,56.831,FUN_005037-T1,Q6GLK2,THEM4_XENLA,,Acyl-coenzyme A thioesterase THEM4 (Acyl-CoA thioesterase THEM4) (EC 3.1.2.2) (Thioesterase superfamily member 4),Xenopus laevis (African clawed frog),35.5,200.0,5.9e-25,116.3,sp|Q6GLK2|THEM4_XENLA Acyl-coenzyme A thioesterase THEM4 OS=Xenopus laevis OX=8355 GN=them4 PE=2 SV=2,GO:0005743; GO:0005758; GO:0006631; GO:0006915; GO:0016787; GO:0032587,apoptotic process [GO:0006915]; fatty acid metabolic process [GO:0006631],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; ruffle membrane [GO:0032587],hydrolase activity [GO:0016787],GO:0003824; GO:0006629; GO:0012501; GO:0016787,catalytic activity; lipid metabolic process; programmed cell death; hydrolase activity
OG_01270,FUN_005038-T1,Peve_00016739,Pocillopora_meandrina_HIv1___RNAseq.15354_t,three_way,78.13883333333332,FUN_005038-T1,Q568D2,,,,,42.8,304.0,1.8e-61,237.7,sp|Q568D2|CF161_DANRE Cilia- and flagella-associated protein 161 OS=Danio rerio OX=7955 GN=cfap161 PE=2 SV=1,,,,,,
OG_01271,FUN_005040-T1,Peve_00016737,Pocillopora_meandrina_HIv1___RNAseq.g20176.t1,three_way,50.495333333333335,FUN_005040-T1,A2RU49,HYKK_HUMAN,,Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1),Homo sapiens (Human),29.6,412.0,1e-38,162.5,sp|A2RU49|HYKK_HUMAN Hydroxylysine kinase OS=Homo sapiens OX=9606 GN=HYKK PE=1 SV=2,GO:0005759; GO:0006554; GO:0019202; GO:0047992,lysine catabolic process [GO:0006554],mitochondrial matrix [GO:0005759],amino acid kinase activity [GO:0019202]; hydroxylysine kinase activity [GO:0047992],GO:0003824; GO:0006520; GO:0016740,catalytic activity; amino acid metabolic process; transferase activity
OG_01272,FUN_005047-T1,Peve_00016733,Pocillopora_meandrina_HIv1___RNAseq.g8309.t1,three_way,74.50066666666667,FUN_005047-T1,Q90744,NAGAB_CHICK,,Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B),Gallus gallus (Chicken),50.6,389.0,1.8e-115,417.5,sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1,GO:0004557; GO:0005737; GO:0005764; GO:0006629; GO:0008456; GO:0009311; GO:0016139,glycoside catabolic process [GO:0016139]; lipid metabolic process [GO:0006629]; oligosaccharide metabolic process [GO:0009311],cytoplasm [GO:0005737]; lysosome [GO:0005764],alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456],GO:0003824; GO:0005764; GO:0005773; GO:0005975; GO:0006629; GO:0016787; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_01273,FUN_005050-T1,Peve_00016732,Pocillopora_meandrina_HIv1___RNAseq.g8308.t1,three_way,70.75333333333333,FUN_005050-T1,Q96KP1,,,,,40.4,89.0,1.7e-08,62.0,sp|Q96KP1|EXOC2_HUMAN Exocyst complex component 2 OS=Homo sapiens OX=9606 GN=EXOC2 PE=1 SV=1,,,,,,
OG_01274,FUN_005052-T2,Peve_00016731,Pocillopora_meandrina_HIv1___RNAseq.g8307.t1,three_way,71.36033333333333,FUN_005052-T2,Q98D10,,,,,24.9,305.0,3.6e-13,77.4,sp|Q98D10|XYLD_RHILO Putative D-xylulose reductase OS=Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) OX=266835 GN=mlr4915 PE=3 SV=1,,,,,,
OG_01275,FUN_005053-T1,Peve_00016727,Pocillopora_meandrina_HIv1___RNAseq.g8306.t2,three_way,75.827,FUN_005053-T1,Q9BRS8,LARP6_HUMAN,,La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6),Homo sapiens (Human),30.5,442.0,8e-37,156.4,sp|Q9BRS8|LARP6_HUMAN La-related protein 6 OS=Homo sapiens OX=9606 GN=LARP6 PE=1 SV=1,GO:0003729; GO:0005634; GO:0005737; GO:0006396; GO:0006417; GO:0017022; GO:0032967; GO:0035613; GO:0048027; GO:1990825; GO:1990904,positive regulation of collagen biosynthetic process [GO:0032967]; regulation of translation [GO:0006417]; RNA processing [GO:0006396],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0008092; GO:0043226,RNA binding; nucleus; cytoskeletal protein binding; organelle
OG_01276,FUN_005056-T1,Peve_00016747,Pocillopora_meandrina_HIv1___RNAseq.g8303.t1,three_way,56.921,FUN_005056-T1,P42568,AF9_HUMAN,,Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3),Homo sapiens (Human),38.0,92.0,2.1e-09,65.1,sp|P42568|AF9_HUMAN Protein AF-9 OS=Homo sapiens OX=9606 GN=MLLT3 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007379; GO:0008023; GO:0009952; GO:0010467; GO:0042393; GO:0045893; GO:0060090; GO:0060218; GO:0070062; GO:0070577; GO:0090090; GO:0140030; GO:0140044; GO:0140072; GO:0140119; GO:1902275; GO:2000035; GO:2000096,"anterior/posterior pattern specification [GO:0009952]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of chromatin organization [GO:1902275]; regulation of stem cell division [GO:2000035]; segment specification [GO:0007379]",chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; histone H3K9ac reader activity [GO:0140072]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; molecular adaptor activity [GO:0060090],GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0060090,DNA binding; nucleus; nucleoplasm; chromosome; cytosol; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; molecular adaptor activity
OG_01277,FUN_005057-T1,Peve_00016734,Pocillopora_meandrina_HIv1___RNAseq.g8302.t1,three_way,72.20533333333333,FUN_005057-T1,Q8K596,NAC2_MOUSE,,Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2),Mus musculus (Mouse),37.3,499.0,1.4e-72,275.8,sp|Q8K596|NAC2_MOUSE Sodium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc8a2 PE=1 SV=1,GO:0002931; GO:0005432; GO:0005516; GO:0005886; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0010468; GO:0014069; GO:0015085; GO:0016323; GO:0035725; GO:0043679; GO:0045202; GO:0046872; GO:0048172; GO:0050808; GO:0050890; GO:0051480; GO:0060291; GO:0070050; GO:0070588; GO:0098815; GO:0099608; GO:0106056; GO:1902533; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cognition [GO:0050890]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; modulation of excitatory postsynaptic potential [GO:0098815]; neuron cellular homeostasis [GO:0070050]; positive regulation of intracellular signal transduction [GO:1902533]; regulation of action potential firing pattern [GO:0099608]; regulation of calcineurin-mediated signaling [GO:0106056]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of gene expression [GO:0010468]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; response to ischemia [GO:0002931]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808],axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],calcium ion transmembrane transporter activity [GO:0015085]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0055085,transporter activity; plasma membrane; cell junction organization; organelle; nervous system process; transmembrane transport
OG_01278,FUN_005058-T1,Peve_00016724,Pocillopora_meandrina_HIv1___RNAseq.g8301.t1,three_way,65.66266666666667,,,,,,,,,,,,,,,,,
OG_01279,FUN_005059-T2,Peve_00030172,Pocillopora_meandrina_HIv1___TS.g20044.t1,three_way,73.71433333333334,FUN_005059-T2,Q16348,,,,,37.5,704.0,2.9e-116,421.0,sp|Q16348|S15A2_HUMAN Solute carrier family 15 member 2 OS=Homo sapiens OX=9606 GN=SLC15A2 PE=1 SV=2,,,,,,
OG_01280,FUN_005061-T1,Peve_00030179,Pocillopora_meandrina_HIv1___RNAseq.g1034.t1,three_way,97.5,FUN_005061-T1,P62312,LSM6_HUMAN,,U6 snRNA-associated Sm-like protein LSm6,Homo sapiens (Human),94.6,74.0,3.8e-35,148.3,sp|P62312|LSM6_HUMAN U6 snRNA-associated Sm-like protein LSm6 OS=Homo sapiens OX=9606 GN=LSM6 PE=1 SV=1,GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005730; GO:0005732; GO:0005737; GO:0005829; GO:0006402; GO:0008033; GO:0008380; GO:0030490; GO:0030532; GO:0046540; GO:0046982; GO:0071005; GO:0120115,"maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; tRNA processing [GO:0008033]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; small nuclear ribonucleoprotein complex [GO:0030532]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688],protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006399; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; nucleolus; cytosol; tRNA metabolic process; mRNA metabolic process; organelle
OG_01281,FUN_005062-T1,Peve_00030182,Pocillopora_meandrina_HIv1___TS.g20038.t1,three_way,69.87166666666667,FUN_005062-T1,Q5M7P5,,,,,46.0,1111.0,8.000000000000001e-272,938.3,sp|Q5M7P5|NOL6_XENTR Nucleolar protein 6 OS=Xenopus tropicalis OX=8364 GN=nol6 PE=2 SV=1,,,,,,
OG_01282,FUN_005063-T1,Peve_00030190,Pocillopora_meandrina_HIv1___RNAseq.g8293.t1,three_way,74.4175,FUN_005063-T1,B2RR83,YTDC2_MOUSE,,3'-5' RNA helicase YTHDC2 (EC 3.6.4.13) (Keen to exit meiosis leaving testes under-populated protein) (Ketu) (YTH domain-containing protein C2) (mYTHDC2),Mus musculus (Mouse),47.1,1526.0,0.0,1282.7,sp|B2RR83|YTDC2_MOUSE 3'-5' RNA helicase YTHDC2 OS=Mus musculus OX=10090 GN=Ythdc2 PE=1 SV=1,GO:0003723; GO:0005524; GO:0005737; GO:0005783; GO:0007286; GO:0016887; GO:0034458; GO:0034612; GO:0035770; GO:0044829; GO:0048471; GO:0048599; GO:0051321; GO:0051729; GO:0070063; GO:0070555; GO:1990247,"germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; meiotic cell cycle [GO:0051321]; oocyte development [GO:0048599]; positive regulation by host of viral genome replication [GO:0044829]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; spermatid development [GO:0007286]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein granule [GO:0035770],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063],GO:0003723; GO:0003824; GO:0005783; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0140098; GO:0140657,"RNA binding; catalytic activity; endoplasmic reticulum; hydrolase activity; isomerase activity; reproductive process; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01283,FUN_005101-T1,Peve_00007482,Pocillopora_meandrina_HIv1___RNAseq.g8276.t1,three_way,63.833666666666666,FUN_005101-T1,P20585,MSH3_HUMAN,,DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1),Homo sapiens (Human),44.8,859.0,3.4e-194,680.2,sp|P20585|MSH3_HUMAN DNA mismatch repair protein Msh3 OS=Homo sapiens OX=9606 GN=MSH3 PE=1 SV=4,GO:0003690; GO:0005524; GO:0005634; GO:0005654; GO:0006281; GO:0006298; GO:0006312; GO:0016020; GO:0016447; GO:0019899; GO:0030983; GO:0032302; GO:0043570; GO:0045910; GO:0140664,DNA repair [GO:0006281]; maintenance of DNA repeat elements [GO:0043570]; mismatch repair [GO:0006298]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; somatic recombination of immunoglobulin gene segments [GO:0016447],membrane [GO:0016020]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01284,FUN_005105-T1,Peve_00007471,Pocillopora_meandrina_HIv1___RNAseq.g8274.t1,three_way,65.54833333333333,FUN_005105-T1,Q43116,,,,,31.2,125.0,1.3e-11,71.2,sp|Q43116|PDI_RICCO Protein disulfide-isomerase OS=Ricinus communis OX=3988 PE=2 SV=1,,,,,,
OG_01285,FUN_005106-T1,Peve_00007470,Pocillopora_meandrina_HIv1___RNAseq.g8273.t1,three_way,77.06266666666667,FUN_005106-T1,Q90744,NAGAB_CHICK,,Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B),Gallus gallus (Chicken),56.7,386.0,2.7e-129,463.4,sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1,GO:0004557; GO:0005737; GO:0005764; GO:0006629; GO:0008456; GO:0009311; GO:0016139,glycoside catabolic process [GO:0016139]; lipid metabolic process [GO:0006629]; oligosaccharide metabolic process [GO:0009311],cytoplasm [GO:0005737]; lysosome [GO:0005764],alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456],GO:0003824; GO:0005764; GO:0005773; GO:0005975; GO:0006629; GO:0016787; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_01286,FUN_005107-T1,Peve_00007469,Pocillopora_meandrina_HIv1___RNAseq.g26543.t1,three_way,43.97966666666667,,,,,,,,,,,,,,,,,
OG_01287,FUN_005108-T1,Peve_00007468,Pocillopora_meandrina_HIv1___RNAseq.g8270.t1,three_way,63.20066666666666,FUN_005108-T1,Q96B86,,,,,35.5,361.0,3.8e-52,207.2,sp|Q96B86|RGMA_HUMAN Repulsive guidance molecule A OS=Homo sapiens OX=9606 GN=RGMA PE=1 SV=4,,,,,,
OG_01288,FUN_005111-T1,Peve_00007466,Pocillopora_meandrina_HIv1___RNAseq.g8272.t1,three_way,81.19166666666666,FUN_005111-T1,Q90744,NAGAB_CHICK,,Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B),Gallus gallus (Chicken),53.2,389.0,1.1e-125,451.4,sp|Q90744|NAGAB_CHICK Alpha-N-acetylgalactosaminidase OS=Gallus gallus OX=9031 GN=NAGA PE=1 SV=1,GO:0004557; GO:0005737; GO:0005764; GO:0006629; GO:0008456; GO:0009311; GO:0016139,glycoside catabolic process [GO:0016139]; lipid metabolic process [GO:0006629]; oligosaccharide metabolic process [GO:0009311],cytoplasm [GO:0005737]; lysosome [GO:0005764],alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456],GO:0003824; GO:0005764; GO:0005773; GO:0005975; GO:0006629; GO:0016787; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_01289,FUN_005112-T1,Peve_00007464,Pocillopora_meandrina_HIv1___RNAseq.g8269.t1,three_way,68.84,FUN_005112-T1,P30101,PDIA3_HUMAN,,Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60),Homo sapiens (Human),50.3,477.0,7.9e-123,442.2,sp|P30101|PDIA3_HUMAN Protein disulfide-isomerase A3 OS=Homo sapiens OX=9606 GN=PDIA3 PE=1 SV=4,GO:0002250; GO:0002502; GO:0003723; GO:0003756; GO:0004197; GO:0004629; GO:0005615; GO:0005634; GO:0005783; GO:0005788; GO:0005925; GO:0006457; GO:0009986; GO:0015035; GO:0015036; GO:0034975; GO:0034976; GO:0042470; GO:0042802; GO:0042824; GO:0045335; GO:0055038; GO:0061779; GO:0070062; GO:0070527; GO:0097191; GO:0098761; GO:0106222; GO:2001238,adaptive immune response [GO:0002250]; cellular response to interleukin-7 [GO:0098761]; extrinsic apoptotic signaling pathway [GO:0097191]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; platelet aggregation [GO:0070527]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; recycling endosome membrane [GO:0055038]; Tapasin-ERp57 complex [GO:0061779],cysteine-type endopeptidase activity [GO:0004197]; disulfide oxidoreductase activity [GO:0015036]; identical protein binding [GO:0042802]; lncRNA binding [GO:0106222]; phospholipase C activity [GO:0004629]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0003824; GO:0005615; GO:0005634; GO:0005783; GO:0006457; GO:0007155; GO:0016491; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0065003; GO:0140096,"immune system process; RNA binding; catalytic activity; extracellular space; nucleus; endoplasmic reticulum; protein folding; cell adhesion; oxidoreductase activity; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_01290,FUN_005113-T1,Peve_00007463,Pocillopora_meandrina_HIv1___RNAseq.g8268.t1,three_way,72.56616666666666,FUN_005113-T1,O15945,ARNT_DROME,,Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango),Drosophila melanogaster (Fruit fly),57.4,378.0,5.4e-115,416.8,sp|O15945|ARNT_DROME Aryl hydrocarbon receptor nuclear translocator homolog OS=Drosophila melanogaster OX=7227 GN=tgo PE=1 SV=3,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0034751; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575,appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_01291,FUN_005114-T1,Peve_00007462,Pocillopora_meandrina_HIv1___RNAseq.g8267.t1,three_way,89.027,FUN_005114-T1,Q9Y6I4,UBP3_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3),Homo sapiens (Human),49.9,531.0,1.3e-149,531.2,sp|Q9Y6I4|UBP3_HUMAN Ubiquitin carboxyl-terminal hydrolase 3 OS=Homo sapiens OX=9606 GN=USP3 PE=1 SV=2,GO:0000785; GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0006508; GO:0008270; GO:0016579; GO:0036464; GO:0042393; GO:0090543; GO:0140861; GO:0140936; GO:0140950,DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; histone binding [GO:0042393]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0016787; GO:0042393; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; DNA repair; chromatin organization; hydrolase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_01292,FUN_005115-T1,Peve_00007461,Pocillopora_meandrina_HIv1___RNAseq.g8266.t1,three_way,64.81533333333333,FUN_005115-T1,Q8BUN9,NCKX2_MOUSE,,Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2),Mus musculus (Mouse),44.7,622.0,6.2e-134,479.6,sp|Q8BUN9|NCKX2_MOUSE Sodium/potassium/calcium exchanger 2 OS=Mus musculus OX=10090 GN=Slc24a2 PE=1 SV=1,GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007602; GO:0007612; GO:0007613; GO:0008273; GO:0015293; GO:0016020; GO:0034220; GO:0036368; GO:0051649; GO:0060291; GO:0060292; GO:0070050; GO:0071486; GO:0098703; GO:0098793; GO:0098794,calcium ion import across plasma membrane [GO:0098703]; calcium ion transport [GO:0006816]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; establishment of localization in cell [GO:0051649]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; monoatomic ion transmembrane transport [GO:0034220]; neuron cellular homeostasis [GO:0070050]; phototransduction [GO:0007602],membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]",GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_01293,FUN_005117-T1,Peve_00007460,Pocillopora_meandrina_HIv1___RNAseq.g8265.t1,three_way,71.62033333333333,FUN_005117-T1,O88801,HOME2_RAT,,Homer protein homolog 2 (Homer-2) (Cupidin) (VASP/Ena-related gene up-regulated during seizure and LTP 2) (Vesl-2),Rattus norvegicus (Rat),49.3,221.0,4.7e-47,190.3,sp|O88801|HOME2_RAT Homer protein homolog 2 OS=Rattus norvegicus OX=10116 GN=Homer2 PE=1 SV=1,GO:0003779; GO:0005737; GO:0005886; GO:0007216; GO:0007605; GO:0008277; GO:0014069; GO:0019722; GO:0019904; GO:0030160; GO:0030425; GO:0032426; GO:0032703; GO:0035254; GO:0035256; GO:0042802; GO:0043025; GO:0043229; GO:0044877; GO:0045177; GO:0048148; GO:0070885; GO:0098978; GO:2001256,behavioral response to cocaine [GO:0048148]; calcium-mediated signaling [GO:0019722]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intracellular organelle [GO:0043229]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; synaptic receptor adaptor activity [GO:0030160],GO:0005886; GO:0008092; GO:0043226; GO:0050877; GO:0060090,plasma membrane; cytoskeletal protein binding; organelle; nervous system process; molecular adaptor activity
OG_01294,FUN_005118-T1,Peve_00026683,Pocillopora_meandrina_HIv1___RNAseq.g8264.t1,three_way,92.74866666666668,FUN_005118-T1,Q9VQ93,GOLP3_DROME,,Golgi phosphoprotein 3 homolog sauron (Protein rotini),Drosophila melanogaster (Fruit fly),72.3,267.0,1.4000000000000003e-111,404.1,sp|Q9VQ93|GOLP3_DROME Golgi phosphoprotein 3 homolog sauron OS=Drosophila melanogaster OX=7227 GN=sau PE=1 SV=1,GO:0000139; GO:0000281; GO:0000301; GO:0000915; GO:0005794; GO:0005802; GO:0005829; GO:0006890; GO:0007030; GO:0007053; GO:0007110; GO:0007111; GO:0007112; GO:0010314; GO:0031267; GO:0031410; GO:0031985; GO:0032154; GO:0032266; GO:0036089; GO:0043001; GO:0046718; GO:0048194; GO:0051225; GO:0070273; GO:0070300; GO:0090307; GO:0140312; GO:0140450,"actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; protein targeting to Golgi apparatus [GO:0140450]; retrograde transport, vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053]; symbiont entry into host cell [GO:0046718]",cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],cargo adaptor activity [GO:0140312]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; small GTPase binding [GO:0031267],GO:0000910; GO:0005794; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0072659,cytokinesis; Golgi apparatus; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane
OG_01295,FUN_005120-T1,Peve_00026681,Pocillopora_meandrina_HIv1___TS.g20003.t1,three_way,92.25233333333334,FUN_005120-T1,P37380,,,,,81.6,185.0,9.3e-77,287.7,sp|P37380|RL17_PODCA Large ribosomal subunit protein uL22 OS=Podocoryna carnea OX=6096 GN=RPL17 PE=2 SV=1,,,,,,
OG_01296,FUN_005122-T1,Peve_00026675,Pocillopora_meandrina_HIv1___RNAseq.g8260.t1,three_way,63.93033333333333,,,,,,,,,,,,,,,,,
OG_01297,FUN_005131-T1,Peve_00027431,Pocillopora_meandrina_HIv1___RNAseq.g22688.t1,three_way,57.669,FUN_005131-T1,P12256,,,,,31.2,321.0,7.1e-39,162.9,sp|P12256|PAC_LYSSH Penicillin V acylase OS=Lysinibacillus sphaericus OX=1421 PE=1 SV=1,,,,,,
OG_01298,FUN_005132-T1,Peve_00026674,Pocillopora_meandrina_HIv1___TS.g20000.t1,three_way,85.70366666666666,FUN_005132-T1,Q91348,,,,,60.1,439.0,3.7e-156,552.7,"sp|Q91348|F26L_CHICK 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase OS=Gallus gallus OX=9031 PE=2 SV=2",,,,,,
OG_01299,FUN_005133-T1,Peve_00026671,Pocillopora_meandrina_HIv1___RNAseq.g8258.t1,three_way,85.96366666666667,FUN_005133-T1,Q05116,,,,,70.0,377.0,4.3e-148,525.8,sp|Q05116|MP2K1_XENLA Dual specificity mitogen-activated protein kinase kinase 1 OS=Xenopus laevis OX=8355 GN=map2k1 PE=1 SV=2,,,,,,
OG_01300,FUN_005154-T1,Peve_00042947,Pocillopora_meandrina_HIv1___RNAseq.g8252.t1,three_way,70.104,FUN_005154-T1,O02813,,,,,30.7,316.0,2.7e-20,100.9,sp|O02813|NPY1R_CANLF Neuropeptide Y receptor type 1 OS=Canis lupus familiaris OX=9615 GN=NPY1R PE=2 SV=2,,,,,,
OG_01301,FUN_005155-T1,Peve_00014626,Pocillopora_meandrina_HIv1___RNAseq.g8081.t2,three_way,50.48,,,,,,,,,,,,,,,,,
OG_01302,FUN_005157-T1,Peve_00035209,Pocillopora_meandrina_HIv1___RNAseq.g8082.t1,three_way,71.84466666666667,,,,,,,,,,,,,,,,,
OG_01303,FUN_005158-T1,Peve_00035210,Pocillopora_meandrina_HIv1___RNAseq.g8083.t1,three_way,74.65233333333333,FUN_005158-T1,Q9CQS5,RIOK2_MOUSE,,Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2),Mus musculus (Mouse),49.2,549.0,1.8e-130,467.6,sp|Q9CQS5|RIOK2_MOUSE Serine/threonine-protein kinase RIO2 OS=Mus musculus OX=10090 GN=Riok2 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0030071; GO:0030490; GO:0030688; GO:0046777; GO:0046872; GO:0106310; GO:2000208; GO:2000234,maturation of SSU-rRNA [GO:0030490]; positive regulation of ribosomal small subunit export from nucleus [GO:2000208]; positive regulation of rRNA processing [GO:2000234]; protein autophosphorylation [GO:0046777]; regulation of mitotic metaphase/anaphase transition [GO:0030071],"cytoplasm [GO:0005737]; preribosome, small subunit precursor [GO:0030688]",ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_01304,FUN_005159-T1,Peve_00014624,Pocillopora_meandrina_HIv1___TS.g19826.t1,three_way,59.108,FUN_005159-T1,Q9DEN4,FXD3A_XENLA,,Forkhead box protein D3-A (FoxD3-A) (FoxD3a) (Fork head domain-related protein 6) (FKH-6) (Forkhead protein 6) (xFD-6) (xFKH6),Xenopus laevis (African clawed frog),37.4,230.0,1.9e-25,118.2,sp|Q9DEN4|FXD3A_XENLA Forkhead box protein D3-A OS=Xenopus laevis OX=8355 GN=foxd3-a PE=1 SV=1,GO:0000978; GO:0000981; GO:0001707; GO:0003677; GO:0005634; GO:0006357; GO:0007399; GO:0009653; GO:0014034; GO:0030154; GO:0045892; GO:0050768; GO:0050769,anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; mesoderm formation [GO:0001707]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neurogenesis [GO:0050768]; nervous system development [GO:0007399]; neural crest cell fate commitment [GO:0014034]; positive regulation of neurogenesis [GO:0050769]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_01305,FUN_005160-T1,Peve_00031230,Pocillopora_meandrina_HIv1___RNAseq.g8085.t1,three_way,81.42233333333333,FUN_005160-T1,Q9DC69,,,,,48.7,374.0,2.7e-90,334.0,"sp|Q9DC69|NDUA9_MOUSE NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial OS=Mus musculus OX=10090 GN=Ndufa9 PE=1 SV=2",,,,,,
OG_01306,FUN_005161-T1,Peve_00015385,Pocillopora_meandrina_HIv1___RNAseq.g8087.t1,three_way,63.32866666666666,,,,,,,,,,,,,,,,,
OG_01307,FUN_005164-T1,Peve_00015381,Pocillopora_meandrina_HIv1___TS.g1318.t1,three_way,62.24966666666667,,,,,,,,,,,,,,,,,
OG_01308,FUN_005166-T1,Peve_00015380,Pocillopora_meandrina_HIv1___RNAseq.g8086.t1,three_way,81.01533333333333,FUN_005166-T1,Q9Y3D8,,,,,66.3,163.0,2.3e-61,236.5,sp|Q9Y3D8|KAD6_HUMAN Adenylate kinase isoenzyme 6 OS=Homo sapiens OX=9606 GN=AK6 PE=1 SV=1,,,,,,
OG_01309,FUN_005171-T1,Peve_00004281,Pocillopora_meandrina_HIv1___RNAseq.g7588.t1,three_way,75.09433333333332,,,,,,,,,,,,,,,,,
OG_01310,FUN_005172-T1,Peve_00004280,Pocillopora_meandrina_HIv1___RNAseq.g7586.t1,three_way,47.22166666666666,,,,,,,,,,,,,,,,,
OG_01311,FUN_005173-T1,Peve_00004279,Pocillopora_meandrina_HIv1___RNAseq.g7577.t1b,three_way,72.15116666666667,FUN_005173-T1,Q8WXI9,P66B_HUMAN,,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),Homo sapiens (Human),42.0,143.0,4.5e-21,104.8,sp|Q8WXI9|P66B_HUMAN Transcriptional repressor p66-beta OS=Homo sapiens OX=9606 GN=GATAD2B PE=1 SV=1,GO:0000122; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0006338; GO:0008270; GO:0016581; GO:0016607; GO:0032991; GO:0042659; GO:0043565; GO:0045892; GO:0045893; GO:2000736,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; protein-containing complex [GO:0032991]",sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_01312,FUN_005175-T1,Peve_00011874,Pocillopora_meandrina_HIv1___RNAseq.g7581.t1,three_way,61.32216666666667,FUN_005175-T1,Q9VW71,,,,,22.0,2889.0,4.9e-74,283.1,sp|Q9VW71|FAT2_DROME Fat-like cadherin-related tumor suppressor homolog OS=Drosophila melanogaster OX=7227 GN=kug PE=2 SV=3,,,,,,
OG_01313,FUN_005176-T1,Peve_00030152,Pocillopora_meandrina_HIv1___RNAseq.g7583.t1,three_way,39.89633333333333,FUN_005176-T1,O95393,BMP10_HUMAN,,Bone morphogenetic protein 10 (BMP-10),Homo sapiens (Human),25.7,358.0,4.6e-21,103.6,sp|O95393|BMP10_HUMAN Bone morphogenetic protein 10 OS=Homo sapiens OX=9606 GN=BMP10 PE=1 SV=1,GO:0001822; GO:0005125; GO:0005179; GO:0005576; GO:0005615; GO:0005737; GO:0007155; GO:0007512; GO:0008083; GO:0009986; GO:0010596; GO:0010613; GO:0010614; GO:0010628; GO:0030018; GO:0030308; GO:0030336; GO:0030509; GO:0031433; GO:0032924; GO:0033612; GO:0045214; GO:0045893; GO:0055009; GO:0055010; GO:0055015; GO:0055117; GO:0060038; GO:0060045; GO:0060298; GO:0060347; GO:0060391; GO:0061036; GO:1903242; GO:2000138,activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018],cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433],GO:0005576; GO:0005615; GO:0006355; GO:0007010; GO:0007155; GO:0008092; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01314,FUN_005177-T1,Peve_00022720,Pocillopora_meandrina_HIv1___RNAseq.g7584.t1,three_way,78.689,FUN_005177-T1,Q7Z401,MYCPP_HUMAN,,C-myc promoter-binding protein (DENN domain-containing protein 4A),Homo sapiens (Human),34.8,1885.0,8.6e-282,971.8,sp|Q7Z401|MYCPP_HUMAN C-myc promoter-binding protein OS=Homo sapiens OX=9606 GN=DENND4A PE=1 SV=2,GO:0003677; GO:0005085; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0032483,regulation of DNA-templated transcription [GO:0006355]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_01315,FUN_005178-T1,Peve_00022721,Pocillopora_meandrina_HIv1___RNAseq.g7585.t1,three_way,63.69316666666666,FUN_005178-T1,Q5ZM55,,,,,28.4,627.0,5.7e-31,137.5,sp|Q5ZM55|FEM1B_CHICK Protein fem-1 homolog B OS=Gallus gallus OX=9031 GN=FEM1B PE=2 SV=1,,,,,,
OG_01316,FUN_005181-T1,Peve_00039094,Pocillopora_meandrina_HIv1___RNAseq.g8093.t1,three_way,72.30133333333333,FUN_005181-T1,O81916,,,,,31.0,261.0,3.9e-27,123.6,sp|O81916|YC22_ARATH Uncharacterized calcium-binding protein At1g02270 OS=Arabidopsis thaliana OX=3702 GN=At1g02270 PE=2 SV=2,,,,,,
OG_01317,FUN_005182-T1,Peve_00023411,Pocillopora_meandrina_HIv1___RNAseq.g8094.t1,three_way,60.54366666666667,FUN_005182-T1,Q9UGM3,,,,,32.5,830.0,4.2e-95,352.1,sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,,,,,,
OG_01318,FUN_005183-T2,Peve_00017162,Pocillopora_meandrina_HIv1___RNAseq.g8095.t1,three_way,55.7445,FUN_005183-T2,A0JMF1,,,,,26.8,358.0,7.6e-14,81.6,sp|A0JMF1|CTC1_DANRE CST complex subunit CTC1 OS=Danio rerio OX=7955 GN=ctc1 PE=2 SV=1,,,,,,
OG_01319,FUN_005184-T3,Peve_00017161,Pocillopora_meandrina_HIv1___RNAseq.g8096.t1,three_way,72.63616666666667,FUN_005184-T3,Q9TU19,,,,,39.0,515.0,1.1e-103,379.0,sp|Q9TU19|NPHP1_CANLF Nephrocystin-1 (Fragment) OS=Canis lupus familiaris OX=9615 GN=NPHP1 PE=1 SV=1,,,,,,
OG_01320,FUN_005185-T2,Peve_00017160,Pocillopora_meandrina_HIv1___TS.g19840.t1,three_way,64.452,FUN_005185-T2,Q9UGM3,,,,,27.0,1446.0,2.1e-110,402.9,sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,,,,,,
OG_01321,FUN_005186-T1,Peve_00017157,Pocillopora_meandrina_HIv1___RNAseq.g8099.t1,three_way,56.33233333333334,,,,,,,,,,,,,,,,,
OG_01322,FUN_005189-T1,Peve_00017153,Pocillopora_meandrina_HIv1___TS.g19845.t2b,three_way,59.13133333333333,FUN_005189-T1,Q6PD21,SHB_MOUSE,,SH2 domain-containing adapter protein B,Mus musculus (Mouse),57.5,106.0,1.9e-31,138.7,sp|Q6PD21|SHB_MOUSE SH2 domain-containing adapter protein B OS=Mus musculus OX=10090 GN=Shb PE=1 SV=2,GO:0001525; GO:0001568; GO:0001784; GO:0005654; GO:0005829; GO:0005886; GO:0006915; GO:0030097; GO:0030159; GO:0036464; GO:0042100; GO:0045624; GO:0045931; GO:0048514; GO:0050852; GO:0071425; GO:1900194,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; negative regulation of oocyte maturation [GO:1900194]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of T-helper cell differentiation [GO:0045624]; T cell receptor signaling pathway [GO:0050852],cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],phosphotyrosine residue binding [GO:0001784]; signaling receptor complex adaptor activity [GO:0030159],GO:0002376; GO:0005654; GO:0005829; GO:0005886; GO:0012501; GO:0043226; GO:0048856; GO:0060090,immune system process; nucleoplasm; cytosol; plasma membrane; programmed cell death; organelle; anatomical structure development; molecular adaptor activity
OG_01323,FUN_005193-T1,Peve_00017151,Pocillopora_meandrina_HIv1___RNAseq.g8103.t1,three_way,58.305,FUN_005193-T1,P55249,LX12E_MOUSE,,"Polyunsaturated fatty acid (12S)/(13S)-lipoxygenase, epidermal-type (EC 1.13.11.-) (Arachidonate (12S)-lipoxygenase, epidermal-type) (12-LOX-e) (e(12S)-LOX) (EC 1.13.11.31) (Linoleate (13S)-lipoxygenase)",Mus musculus (Mouse),26.7,484.0,9.5e-28,126.7,"sp|P55249|LX12E_MOUSE Polyunsaturated fatty acid (12S)/(13S)-lipoxygenase, epidermal-type OS=Mus musculus OX=10090 GN=Alox12e PE=1 SV=1",GO:0004052; GO:0005506; GO:0005737; GO:0016165; GO:0019369; GO:0019372; GO:0034440,arachidonate metabolic process [GO:0019369]; lipid oxidation [GO:0034440]; lipoxygenase pathway [GO:0019372],cytoplasm [GO:0005737],arachidonate 12(S)-lipoxygenase activity [GO:0004052]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_01324,FUN_005194-T1,Peve_00001277,Pocillopora_meandrina_HIv1___RNAseq.g15136.t1,three_way,66.81283333333333,,,,,,,,,,,,,,,,,
OG_01325,FUN_005197-T1,Peve_00017150,Pocillopora_meandrina_HIv1___RNAseq.g8105.t1,three_way,77.661,FUN_005197-T1,Q9DBT9,,,,,62.3,823.0,0.0,1102.8,"sp|Q9DBT9|M2GD_MOUSE Dimethylglycine dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Dmgdh PE=1 SV=1",,,,,,
OG_01326,FUN_005202-T1,Peve_00031640,Pocillopora_meandrina_HIv1___TS.g19875.t2,three_way,66.72316666666667,FUN_005202-T1,Q21974,UNC8_CAEEL,,Degenerin unc-8 (Putative ligand-gated sodium channel unc-8) (Uncoordinated protein 8),Caenorhabditis elegans,31.3,393.0,2.8e-39,164.9,sp|Q21974|UNC8_CAEEL Degenerin unc-8 OS=Caenorhabditis elegans OX=6239 GN=unc-8 PE=2 SV=1,GO:0005261; GO:0005886; GO:0006812; GO:0015280; GO:0016322; GO:0035725; GO:0040011; GO:0043025,locomotion [GO:0040011]; monoatomic cation transport [GO:0006812]; neuron remodeling [GO:0016322]; sodium ion transmembrane transport [GO:0035725],neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01327,FUN_005210-T1,Peve_00035497,Pocillopora_meandrina_HIv1___RNAseq.g8128.t1,three_way,51.63633333333333,,,,,,,,,,,,,,,,,
OG_01328,FUN_005216-T1,Peve_00035486,Pocillopora_meandrina_HIv1___RNAseq.g8126.t1,three_way,74.56533333333333,FUN_005216-T1,Q32ZE2,,,,,31.3,323.0,1.4999999999999998e-24,115.2,sp|Q32ZE2|AA2BR_RABIT Adenosine receptor A2b OS=Oryctolagus cuniculus OX=9986 GN=ADORA2B PE=2 SV=1,,,,,,
OG_01329,FUN_005218-T1,Peve_00035487,Pocillopora_meandrina_HIv1___RNAseq.g8125.t1,three_way,55.37466666666667,,,,,,,,,,,,,,,,,
OG_01330,FUN_005220-T1,Peve_00035492,Pocillopora_meandrina_HIv1___TS.g19865.t1,three_way,97.09066666666666,FUN_005220-T1,Q9TTR8,,,,,73.7,266.0,5e-111,402.1,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_01331,FUN_005225-T1,Peve_00035494,Pocillopora_meandrina_HIv1___RNAseq.g8119.t1,three_way,73.70533333333333,FUN_005225-T1,Q03161,,,,,37.1,278.0,2.5e-41,170.6,sp|Q03161|YMY9_YEAST Glucose-6-phosphate 1-epimerase OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YMR099C PE=1 SV=1,,,,,,
OG_01332,FUN_005226-T1,Peve_00035495,Pocillopora_meandrina_HIv1___RNAseq.g8118.t1,three_way,70.23566666666666,FUN_005226-T1,Q91W67,,,,,35.7,336.0,9.3e-22,105.9,sp|Q91W67|UBL7_MOUSE Ubiquitin-like protein 7 OS=Mus musculus OX=10090 GN=Ubl7 PE=1 SV=2,,,,,,
OG_01333,FUN_005230-T1,Peve_00042881,Pocillopora_meandrina_HIv1___RNAseq.g8115.t1,three_way,67.631,FUN_005230-T1,Q8C9M2,,,,,67.3,49.0,1.1e-13,79.7,sp|Q8C9M2|CCD15_MOUSE Coiled-coil domain-containing protein 15 OS=Mus musculus OX=10090 GN=Ccdc15 PE=2 SV=2,,,,,,
OG_01334,FUN_005231-T1,Peve_00042864,Pocillopora_meandrina_HIv1___RNAseq.g8114.t1,three_way,62.04833333333334,FUN_005231-T1,P97801,SMN_MOUSE,,Survival motor neuron protein,Mus musculus (Mouse),42.1,126.0,5.1e-20,100.1,sp|P97801|SMN_MOUSE Survival motor neuron protein OS=Mus musculus OX=10090 GN=Smn1 PE=1 SV=1,GO:0000387; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006353; GO:0007019; GO:0007409; GO:0010975; GO:0015030; GO:0030018; GO:0030137; GO:0030426; GO:0032797; GO:0033120; GO:0034719; GO:0036464; GO:0043005; GO:0043204; GO:0097504,axonogenesis [GO:0007409]; DNA-templated transcription termination [GO:0006353]; microtubule depolymerization [GO:0007019]; positive regulation of RNA splicing [GO:0033120]; regulation of neuron projection development [GO:0010975]; spliceosomal snRNP assembly [GO:0000387],Cajal body [GO:0015030]; COPI-coated vesicle [GO:0030137]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; Z disc [GO:0030018],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0007010; GO:0031410; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; cytoskeleton organization; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_01335,FUN_005232-T1,Peve_00042865,Pocillopora_meandrina_HIv1___RNAseq.g8113.t1,three_way,74.91566666666667,FUN_005232-T1,Q76IC5,,,,,45.0,189.0,2.5e-43,176.8,sp|Q76IC5|PGPI_RAT Pyroglutamyl-peptidase 1 OS=Rattus norvegicus OX=10116 GN=Pgpep1 PE=1 SV=1,,,,,,
OG_01336,FUN_005233-T1,Peve_00042866,Pocillopora_meandrina_HIv1___RNAseq.g8112.t1,three_way,74.7625,FUN_005233-T1,Q1RMR0,,,,,49.1,114.0,7.200000000000001e-28,125.6,sp|Q1RMR0|RPC7L_BOVIN DNA-directed RNA polymerase III subunit RPC7-like OS=Bos taurus OX=9913 GN=POLR3GL PE=2 SV=1,,,,,,
OG_01337,FUN_005234-T1,Peve_00042867,Pocillopora_meandrina_HIv1___RNAseq.g8111.t1,three_way,51.85633333333333,,,,,,,,,,,,,,,,,
OG_01338,FUN_005235-T1,Peve_00042868,Pocillopora_meandrina_HIv1___RNAseq.g8110.t1,three_way,58.79666666666667,,,,,,,,,,,,,,,,,
OG_01339,FUN_005238-T1,Peve_00014029,Pocillopora_meandrina_HIv1___RNAseq.g8109.t1,three_way,79.287,,,,,,,,,,,,,,,,,
OG_01340,FUN_005239-T1,Peve_00014036,Pocillopora_meandrina_HIv1___RNAseq.g8108.t1,three_way,64.7975,FUN_005239-T1,Q6GPB8,,,,,46.3,549.0,2.3e-128,460.7,sp|Q6GPB8|DBR1A_XENLA Lariat debranching enzyme A OS=Xenopus laevis OX=8355 GN=dbr1-a PE=2 SV=1,,,,,,
OG_01341,FUN_005242-T1,Peve_00014454,Pocillopora_meandrina_HIv1___RNAseq.g8138.t1,three_way,65.22766666666666,FUN_005242-T1,Q6P2C0,,,,,24.4,698.0,2.4e-40,168.7,sp|Q6P2C0|WDR93_HUMAN WD repeat-containing protein 93 OS=Homo sapiens OX=9606 GN=WDR93 PE=1 SV=1,,,,,,
OG_01342,FUN_005243-T1,Peve_00014457,Pocillopora_meandrina_HIv1___RNAseq.g8139.t1,three_way,80.71866666666666,FUN_005243-T1,Q9Z211,,,,,32.9,246.0,2.3e-24,114.0,sp|Q9Z211|PX11A_MOUSE Peroxisomal membrane protein 11A OS=Mus musculus OX=10090 GN=Pex11a PE=1 SV=1,,,,,,
OG_01343,FUN_005244-T1,Peve_00003366,Pocillopora_meandrina_HIv1___RNAseq.g8140.t2,three_way,77.56250000000001,FUN_005244-T1,Q8TDJ6,,,,,34.9,3319.0,0.0,1533.5,sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2,,,,,,
OG_01344,FUN_005245-T1,Peve_00003365,Pocillopora_meandrina_HIv1___RNAseq.g8141.t1,three_way,80.43633333333334,FUN_005245-T1,Q9D0U1,,,,,45.5,211.0,2.5e-48,193.7,sp|Q9D0U1|DTWD2_MOUSE tRNA-uridine aminocarboxypropyltransferase 2 OS=Mus musculus OX=10090 GN=Dtwd2 PE=2 SV=1,,,,,,
OG_01345,FUN_005246-T1,Peve_00003364,Pocillopora_meandrina_HIv1___RNAseq.g8142.t1,three_way,58.970333333333336,,,,,,,,,,,,,,,,,
OG_01346,FUN_005247-T1,Peve_00003363,Pocillopora_meandrina_HIv1___RNAseq.g8143.t1,three_way,51.63783333333333,FUN_005247-T1,P59926,,,,,27.9,287.0,1.6e-12,75.9,sp|P59926|SYT15_RAT Synaptotagmin-15 OS=Rattus norvegicus OX=10116 GN=Syt15 PE=2 SV=1,,,,,,
OG_01347,FUN_005248-T1,Peve_00003362,Pocillopora_meandrina_HIv1___RNAseq.g8144.t1,three_way,61.9315,,,,,,,,,,,,,,,,,
OG_01348,FUN_005249-T1,Peve_00003361,Pocillopora_meandrina_HIv1___TS.g19887.t1,three_way,76.38766666666666,FUN_005249-T1,Q6PH18,,,,,52.1,374.0,5.9e-101,369.4,sp|Q6PH18|N2F1B_DANRE Nuclear receptor subfamily 2 group F member 1-B OS=Danio rerio OX=7955 GN=nr2f1b PE=2 SV=1,,,,,,
OG_01349,FUN_005251-T1,Peve_00003359,Pocillopora_meandrina_HIv1___RNAseq.g8148.t1,three_way,73.81333333333333,FUN_005251-T1,A4UTP7,MEF2C_PIG,,Myocyte-specific enhancer factor 2C,Sus scrofa (Pig),48.2,305.0,3.9e-58,227.3,sp|A4UTP7|MEF2C_PIG Myocyte-specific enhancer factor 2C OS=Sus scrofa OX=9823 GN=MEF2C PE=2 SV=1,GO:0000122; GO:0000165; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001568; GO:0001649; GO:0001782; GO:0001947; GO:0001958; GO:0001974; GO:0002062; GO:0002467; GO:0002634; GO:0003138; GO:0003139; GO:0003151; GO:0003185; GO:0003211; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006959; GO:0007507; GO:0007519; GO:0007521; GO:0007611; GO:0010628; GO:0010629; GO:0014033; GO:0016528; GO:0016607; GO:0030182; GO:0030220; GO:0030279; GO:0030318; GO:0030501; GO:0030890; GO:0032991; GO:0035051; GO:0035984; GO:0042100; GO:0043524; GO:0045652; GO:0045663; GO:0045666; GO:0045669; GO:0045893; GO:0045944; GO:0046983; GO:0048643; GO:0048666; GO:0050853; GO:0051145; GO:0055012; GO:0060025; GO:0060045; GO:0061333; GO:0071222; GO:0071277; GO:0071374; GO:0071466; GO:0071498; GO:0071560; GO:0072102; GO:0072160; GO:2000111; GO:2000727; GO:2000987; GO:2001013; GO:2001016,B cell homeostasis [GO:0001782]; B cell proliferation [GO:0042100]; B cell receptor signaling pathway [GO:0050853]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac ventricle formation [GO:0003211]; cardiocyte differentiation [GO:0035051]; cellular response to calcium ion [GO:0071277]; cellular response to fluid shear stress [GO:0071498]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; endochondral ossification [GO:0001958]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; germinal center formation [GO:0002467]; glomerulus morphogenesis [GO:0072102]; heart development [GO:0007507]; heart looping [GO:0001947]; humoral immune response [GO:0006959]; learning or memory [GO:0007611]; MAPK cascade [GO:0000165]; melanocyte differentiation [GO:0030318]; muscle cell fate determination [GO:0007521]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule epithelial cell differentiation [GO:0072160]; neural crest cell differentiation [GO:0014033]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; platelet formation [GO:0030220]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary heart field specification [GO:0003138]; regulation of germinal center formation [GO:0002634]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of synaptic activity [GO:0060025]; renal tubule morphogenesis [GO:0061333]; secondary heart field specification [GO:0003139]; sinoatrial valve morphogenesis [GO:0003185]; skeletal muscle tissue development [GO:0007519]; smooth muscle cell differentiation [GO:0051145]; ventricular cardiac muscle cell differentiation [GO:0055012],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcoplasm [GO:0016528],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]",GO:0002376; GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140110,immune system process; DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_01350,FUN_005253-T1,Peve_00003358,Pocillopora_meandrina_HIv1___RNAseq.g8149.t1,three_way,40.75233333333333,,,,,,,,,,,,,,,,,
OG_01351,FUN_005258-T1,Peve_00003357,Pocillopora_meandrina_HIv1___RNAseq.g8150.t1,three_way,89.47800000000001,FUN_005258-T1,Q7ZYG4,,,,,59.9,212.0,7.4e-46,185.3,sp|Q7ZYG4|OSTF1_XENLA Osteoclast-stimulating factor 1 OS=Xenopus laevis OX=8355 GN=ostf1 PE=2 SV=1,,,,,,
OG_01352,FUN_005260-T1,Peve_00003354,Pocillopora_meandrina_HIv1___RNAseq.g8151.t1,three_way,68.60516666666666,FUN_005260-T1,Q6PCN7,HLTF_MOUSE,,Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (P113) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3) (TNF-response element-binding protein),Mus musculus (Mouse),43.8,843.0,2.9e-177,624.4,sp|Q6PCN7|HLTF_MOUSE Helicase-like transcription factor OS=Mus musculus OX=10090 GN=Hltf PE=1 SV=1,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0006325; GO:0008094; GO:0008270; GO:0016363; GO:0016567; GO:0016740; GO:0016818; GO:0031625; GO:0042789; GO:0045944; GO:0050767; GO:0090575,chromatin organization [GO:0006325]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of neurogenesis [GO:0050767],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase II transcription regulator complex [GO:0090575],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005654; GO:0005730; GO:0006325; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; nucleolus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_01353,FUN_005265-T1,Peve_00003353,Pocillopora_meandrina_HIv1___RNAseq.g8152.t1,three_way,57.54216666666667,FUN_005265-T1,Q8BH97,RCN3_MOUSE,,Reticulocalbin-3,Mus musculus (Mouse),34.2,149.0,1.2e-11,72.0,sp|Q8BH97|RCN3_MOUSE Reticulocalbin-3 OS=Mus musculus OX=10090 GN=Rcn3 PE=1 SV=1,GO:0005509; GO:0005783; GO:0005788; GO:0009306; GO:0010952; GO:0015031; GO:0032964; GO:0036503; GO:0043129; GO:0051896; GO:0055091; GO:0060428,collagen biosynthetic process [GO:0032964]; ERAD pathway [GO:0036503]; lung epithelium development [GO:0060428]; phospholipid homeostasis [GO:0055091]; positive regulation of peptidase activity [GO:0010952]; protein secretion [GO:0009306]; protein transport [GO:0015031]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; surfactant homeostasis [GO:0043129],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509],GO:0005783; GO:0030163; GO:0043226; GO:0048856,endoplasmic reticulum; protein catabolic process; organelle; anatomical structure development
OG_01354,FUN_005267-T1,Peve_00003352,Pocillopora_meandrina_HIv1___RNAseq.g8154.t1,three_way,58.39033333333333,FUN_005267-T1,B5X4E0,,,,,38.4,289.0,2.6000000000000003e-44,180.6,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_01355,FUN_005268-T1,Peve_00003350,Pocillopora_meandrina_HIv1___RNAseq.g8155.t1,three_way,61.187333333333335,,,,,,,,,,,,,,,,,
OG_01356,FUN_005270-T1,Peve_00003341,Pocillopora_meandrina_HIv1___RNAseq.g8160.t1,three_way,74.97566666666667,FUN_005270-T1,O95163,ELP1_HUMAN,,Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) (p150),Homo sapiens (Human),45.8,1348.0,0.0,1135.9,sp|O95163|ELP1_HUMAN Elongator complex protein 1 OS=Homo sapiens OX=9606 GN=ELP1 PE=1 SV=3,GO:0000049; GO:0002098; GO:0002926; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0033588,regulation of translation [GO:0006417]; tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation [GO:0002926]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; cytosol [GO:0005829]; elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634],tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005829; GO:0006399; GO:0043226,RNA binding; nucleus; cytosol; tRNA metabolic process; organelle
OG_01357,FUN_005271-T1,Peve_00003340,Pocillopora_meandrina_HIv1___RNAseq.g8161.t2,three_way,41.66616666666667,,,,,,,,,,,,,,,,,
OG_01358,FUN_005272-T1,Peve_00003339,Pocillopora_meandrina_HIv1___RNAseq.g8162.t1,three_way,71.95033333333333,,,,,,,,,,,,,,,,,
OG_01359,FUN_005291-T1,Peve_00006172,Pocillopora_meandrina_HIv1___RNAseq.g1670.t1,three_way,61.57833333333333,,,,,,,,,,,,,,,,,
OG_01360,FUN_005303-T1,Peve_00003331,Pocillopora_meandrina_HIv1___RNAseq.g8168.t1,three_way,74.298,FUN_005303-T1,Q64267,XPA_MOUSE,,DNA repair protein complementing XP-A cells homolog (Xeroderma pigmentosum group A-complementing protein homolog),Mus musculus (Mouse),49.4,269.0,4.6e-56,219.5,sp|Q64267|XPA_MOUSE DNA repair protein complementing XP-A cells homolog OS=Mus musculus OX=10090 GN=Xpa PE=1 SV=2,GO:0003684; GO:0005634; GO:0005662; GO:0005829; GO:0006281; GO:0006289; GO:0006979; GO:0008270; GO:0008630; GO:0009411; GO:0009636; GO:0009650; GO:0010506; GO:0016604; GO:0019904; GO:0034504; GO:0035264; GO:0042803; GO:0060261; GO:1990837,DNA repair [GO:0006281]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein localization to nucleus [GO:0034504]; regulation of autophagy [GO:0010506]; response to oxidative stress [GO:0006979]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; UV protection [GO:0009650],cytosol [GO:0005829]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nucleus [GO:0005634],damaged DNA binding [GO:0003684]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005829; GO:0006281; GO:0006355; GO:0043226,DNA binding; nucleus; cytosol; DNA repair; regulation of DNA-templated transcription; organelle
OG_01361,FUN_005304-T1,Peve_00003330,Pocillopora_meandrina_HIv1___RNAseq.g8169.t1,three_way,81.89466666666667,FUN_005304-T1,Q8R092,,,,,28.2,188.0,9.1e-14,79.0,sp|Q8R092|CA043_MOUSE Protein C1orf43 homolog OS=Mus musculus OX=10090 PE=2 SV=1,,,,,,
OG_01362,FUN_005305-T1,Peve_00003319,Pocillopora_meandrina_HIv1___TS.g19912.t1,three_way,46.79333333333334,,,,,,,,,,,,,,,,,
OG_01363,FUN_005306-T1,Peve_00003318,Pocillopora_meandrina_HIv1___TS.g19913.t1,three_way,62.791500000000006,FUN_005306-T1,O35598,ADA10_MOUSE,,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),Mus musculus (Mouse),33.5,487.0,1.4999999999999998e-68,261.9,sp|O35598|ADA10_MOUSE Disintegrin and metalloproteinase domain-containing protein 10 OS=Mus musculus OX=10090 GN=Adam10 PE=1 SV=2,GO:0000139; GO:0001701; GO:0004175; GO:0004222; GO:0005634; GO:0005737; GO:0005794; GO:0005798; GO:0005886; GO:0005912; GO:0006468; GO:0006509; GO:0006913; GO:0007162; GO:0007219; GO:0007220; GO:0008237; GO:0008284; GO:0008593; GO:0009986; GO:0010629; GO:0010820; GO:0014069; GO:0016485; GO:0017124; GO:0019901; GO:0030136; GO:0030307; GO:0030424; GO:0030425; GO:0034332; GO:0034612; GO:0038004; GO:0042117; GO:0042169; GO:0042803; GO:0046872; GO:0046930; GO:0046931; GO:0051089; GO:0062023; GO:0070573; GO:0090102; GO:0097038; GO:0097060; GO:0097197; GO:0098696; GO:0098978; GO:0099173; GO:0099175; GO:0140249; GO:0140448; GO:1901342; GO:1902945,adherens junction organization [GO:0034332]; cochlea development [GO:0090102]; constitutive protein ectodomain proteolysis [GO:0051089]; epidermal growth factor receptor ligand maturation [GO:0038004]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; negative regulation of gene expression [GO:0010629]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; pore complex assembly [GO:0046931]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein catabolic process at postsynapse [GO:0140249]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Notch signaling pathway [GO:0008593]; regulation of postsynapse organization [GO:0099175]; regulation of vasculature development [GO:1901342]; response to tumor necrosis factor [GO:0034612]; signaling receptor ligand precursor processing [GO:0140448],adherens junction [GO:0005912]; axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated vesicle [GO:0030136]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; pore complex [GO:0046930]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; tetraspanin-enriched microdomain [GO:0097197],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124],GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005886; GO:0006913; GO:0016787; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0065003; GO:0140096,"immune system process; catalytic activity; nucleus; Golgi apparatus; plasma membrane; nucleocytoplasmic transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein maturation; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_01364,FUN_005307-T1,Peve_00003314,Pocillopora_meandrina_HIv1___RNAseq.g8172.t1,three_way,66.42383333333333,FUN_005307-T1,A7YSY2,AFG2B_BOVIN,,ATPase family gene 2 protein homolog B (EC 3.6.4.10) (AFG2 AAA ATPase homolog B) (Ribosome biogenesis protein SPATA5L1) (Spermatogenesis-associated protein 5-like protein 1),Bos taurus (Bovine),41.4,789.0,4.1000000000000005e-161,570.1,sp|A7YSY2|AFG2B_BOVIN ATPase family gene 2 protein homolog B OS=Bos taurus OX=9913 GN=AFG2B PE=2 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0016887; GO:0030970; GO:0031593; GO:0034098; GO:0042273; GO:0042802; GO:0043161; GO:0051228; GO:0097352; GO:1990275,"autophagosome maturation [GO:0097352]; mitotic spindle disassembly [GO:0051228]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ribosomal large subunit biogenesis [GO:0042273]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; preribosome binding [GO:1990275],GO:0003824; GO:0005634; GO:0005829; GO:0006886; GO:0007010; GO:0016787; GO:0030163; GO:0043226,catalytic activity; nucleus; cytosol; intracellular protein transport; cytoskeleton organization; hydrolase activity; protein catabolic process; organelle
OG_01365,FUN_005308-T1,Peve_00003313,Pocillopora_meandrina_HIv1___RNAseq.g8173.t1,three_way,54.452,,,,,,,,,,,,,,,,,
OG_01366,FUN_005313-T1,Peve_00003312,Pocillopora_meandrina_HIv1___RNAseq.g8174.t1,three_way,94.14516666666668,FUN_005313-T1,Q04727,TLE4_HUMAN,,Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4),Homo sapiens (Human),84.8,356.0,3.9e-180,632.1,sp|Q04727|TLE4_HUMAN Transducin-like enhancer protein 4 OS=Homo sapiens OX=9606 GN=TLE4 PE=1 SV=3,GO:0000122; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0016055; GO:0090090; GO:0140297; GO:1990830; GO:1990907,cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Wnt signaling pathway [GO:0016055],beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_01367,FUN_005315-T1,Peve_00003311,Pocillopora_meandrina_HIv1___RNAseq.g8175.t1,three_way,70.18966666666667,FUN_005315-T1,Q9UPR3,SMG5_HUMAN,,Nonsense-mediated mRNA decay factor SMG5 (EST1-like protein B) (LPTS-RP1) (LPTS-interacting protein) (SMG-5 homolog) (hSMG-5),Homo sapiens (Human),31.7,851.0,3.6e-72,274.6,sp|Q9UPR3|SMG5_HUMAN Nonsense-mediated mRNA decay factor SMG5 OS=Homo sapiens OX=9606 GN=SMG5 PE=1 SV=3,GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0031625; GO:0032204; GO:0032210; GO:0035303; GO:0036464; GO:0042162; GO:0042826; GO:0051721; GO:0070034,"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625],GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0006913; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; cytosol; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_01368,FUN_005316-T1,Peve_00003310,Pocillopora_meandrina_HIv1___RNAseq.g8176.t1,three_way,89.855,FUN_005316-T1,Q9UNP9,,,,,70.9,296.0,2.3e-124,446.8,sp|Q9UNP9|PPIE_HUMAN Peptidyl-prolyl cis-trans isomerase E OS=Homo sapiens OX=9606 GN=PPIE PE=1 SV=1,,,,,,
OG_01369,FUN_005317-T1,Peve_00003309,Pocillopora_meandrina_HIv1___TS.g19921.t1,three_way,65.96866666666666,FUN_005317-T1,P08478,,,,,39.8,711.0,9.3e-138,492.3,sp|P08478|AMDA_XENLA Peptidyl-glycine alpha-amidating monooxygenase A OS=Xenopus laevis OX=8355 GN=pam-a PE=1 SV=3,,,,,,
OG_01370,FUN_005320-T1,Peve_00003308,Pocillopora_meandrina_HIv1___RNAseq.g8181.t1,three_way,77.714,FUN_005320-T1,Q9GZV8,PRD14_HUMAN,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Homo sapiens (Human),41.4,116.0,6.2e-22,107.1,sp|Q9GZV8|PRD14_HUMAN PR domain zinc finger protein 14 OS=Homo sapiens OX=9606 GN=PRDM14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0006357; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0030718; GO:0031490; GO:0032259; GO:0040037; GO:0043231; GO:0045814; GO:0048873; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357]",intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_01371,FUN_005321-T1,Peve_00003307,Pocillopora_meandrina_HIv1___TS.g19924.t1,three_way,52.27433333333333,FUN_005321-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),45.8,155.0,2.6000000000000003e-32,141.0,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_01372,FUN_005322-T1,Peve_00003306,Pocillopora_meandrina_HIv1___RNAseq.g8184.t1,three_way,57.38966666666666,FUN_005322-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),52.9,136.0,2.8e-39,164.9,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_01372,FUN_005322-T1,Peve_00003306,Pocillopora_meandrina_HIv1___RNAseq.g8184.t1,three_way,57.38966666666666,FUN_005322-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),38.1,63.0,8.4e-07,57.0,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_01373,FUN_005324-T1,Peve_00003304,Pocillopora_meandrina_HIv1___RNAseq.g8186.t1,three_way,67.634,FUN_005324-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),33.7,315.0,8.000000000000001e-38,159.8,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_01374,FUN_005330-T1,Peve_00003301,Pocillopora_meandrina_HIv1___TS.g19931.t1,three_way,58.007000000000005,FUN_005330-T1,A6QPM3,PRDM6_BOVIN,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6),Bos taurus (Bovine),32.9,313.0,3e-37,157.9,sp|A6QPM3|PRDM6_BOVIN Putative histone-lysine N-methyltransferase PRDM6 OS=Bos taurus OX=9913 GN=PRDM6 PE=2 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0010468; GO:0022008; GO:0032259; GO:0042802; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; regulation of gene expression [GO:0010468],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_01375,FUN_005331-T1,Peve_00003302,Pocillopora_meandrina_HIv1___TS.g19933.t1,three_way,77.45716666666667,FUN_005331-T1,A0JN62,CE120_BOVIN,,Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100),Bos taurus (Bovine),42.1,525.0,8.4e-83,309.3,sp|A0JN62|CE120_BOVIN Centrosomal protein of 120 kDa OS=Bos taurus OX=9913 GN=CEP120 PE=2 SV=2,GO:0005737; GO:0005813; GO:0005814; GO:0007098; GO:0010825; GO:0021987; GO:0022008; GO:0022027; GO:0030953; GO:0045724; GO:1903724; GO:1904951,astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737],,GO:0005815; GO:0007010; GO:0030154; GO:0043226; GO:0048856,microtubule organizing center; cytoskeleton organization; cell differentiation; organelle; anatomical structure development
OG_01376,FUN_005333-T1,Peve_00003300,Pocillopora_meandrina_HIv1___RNAseq.g8193.t1,three_way,71.21333333333332,,,,,,,,,,,,,,,,,
OG_01377,FUN_005334-T1,Peve_00003299,Pocillopora_meandrina_HIv1___RNAseq.g8195.t1,three_way,91.017,FUN_005334-T1,Q9CQ46,,,,,65.4,156.0,1.9e-55,216.9,sp|Q9CQ46|DRC8_MOUSE Dynein regulatory complex protein 8 OS=Mus musculus OX=10090 GN=Efcab2 PE=1 SV=1,,,,,,
OG_01378,FUN_005335-T1,Peve_00035219,Pocillopora_meandrina_HIv1___RNAseq.g8197.t1,three_way,80.54866666666666,FUN_005335-T1,Q9Z1N9,,,,,49.1,1628.0,0.0,1434.9,sp|Q9Z1N9|UN13B_MOUSE Protein unc-13 homolog B OS=Mus musculus OX=10090 GN=Unc13b PE=1 SV=2,,,,,,
OG_01379,FUN_005336-T1,Peve_00003298,Pocillopora_meandrina_HIv1___RNAseq.g8196.t1,three_way,77.24866666666667,FUN_005336-T1,Q5ZK14,,,,,57.0,100.0,7e-21,101.3,sp|Q5ZK14|DDA1_CHICK DET1- and DDB1-associated protein 1 OS=Gallus gallus OX=9031 GN=DDA1 PE=3 SV=1,,,,,,
OG_01380,FUN_005337-T1,Peve_00035211,Pocillopora_meandrina_HIv1___RNAseq.g8198.t1,three_way,71.58449999999999,FUN_005337-T1,Q0II22,RN126_BOVIN,,E3 ubiquitin-protein ligase RNF126 (EC 2.3.2.27) (RING finger protein 126),Bos taurus (Bovine),38.8,291.0,3.2e-43,176.8,sp|Q0II22|RN126_BOVIN E3 ubiquitin-protein ligase RNF126 OS=Bos taurus OX=9913 GN=RNF126 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0006513; GO:0008270; GO:0016567; GO:0035519; GO:0042059; GO:0042127; GO:0042147; GO:0043161; GO:0043162; GO:0044314; GO:0061630; GO:0070534; GO:0070936; GO:0071629; GO:1905168,"cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; retrograde transport, endosome to Golgi [GO:0042147]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0016192; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; vesicle-mediated transport; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_01381,FUN_005338-T1,Peve_00035212,Pocillopora_meandrina_HIv1___RNAseq.g8199.t1,three_way,54.7785,FUN_005338-T1,Q9QWF0,,,,,37.2,479.0,2.4e-36,155.6,sp|Q9QWF0|CAF1A_MOUSE Chromatin assembly factor 1 subunit A OS=Mus musculus OX=10090 GN=Chaf1a PE=1 SV=1,,,,,,
OG_01382,FUN_005339-T1,Peve_00035213,Pocillopora_meandrina_HIv1___RNAseq.g8200.t1,three_way,93.732,FUN_005339-T1,Q32P79,,,,,78.6,117.0,6.1e-50,198.0,sp|Q32P79|RPB11_BOVIN DNA-directed RNA polymerase II subunit RPB11 OS=Bos taurus OX=9913 GN=POLR2J PE=1 SV=1,,,,,,
OG_01383,FUN_005349-T1,Peve_00035217,Pocillopora_meandrina_HIv1___RNAseq.g8206.t1,three_way,72.3535,FUN_005349-T1,Q9W0M3,KDM8_DROME,,Jumonji C domain-containing protein 5 (EC 1.14.11.73) (EC 3.4.-.-) (Lysine-specific demethylase 8),Drosophila melanogaster (Fruit fly),23.6,233.0,1.3e-14,82.4,sp|Q9W0M3|KDM8_DROME Jumonji C domain-containing protein 5 OS=Drosophila melanogaster OX=7227 GN=JMJD5 PE=2 SV=2,GO:0000086; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0045892; GO:0046872; GO:0048511; GO:0048512; GO:0051864; GO:0106157; GO:0140680,circadian behavior [GO:0048512]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of DNA-templated transcription [GO:0045892]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; metal ion binding [GO:0046872]; peptidyl-arginine 3-dioxygenase activity [GO:0106157],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_01384,FUN_005352-T1,Peve_00016030,Pocillopora_meandrina_HIv1___TS.g19950.t1,three_way,73.10666666666667,FUN_005352-T1,A2ASI5,SCN3A_MOUSE,,Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3),Mus musculus (Mouse),34.4,1484.0,1.1e-178,629.4,sp|A2ASI5|SCN3A_MOUSE Sodium channel protein type 3 subunit alpha OS=Mus musculus OX=10090 GN=Scn3a PE=1 SV=1,GO:0001518; GO:0005248; GO:0005272; GO:0005886; GO:0009925; GO:0016020; GO:0016528; GO:0048266; GO:0086010,behavioral response to pain [GO:0048266]; membrane depolarization during action potential [GO:0086010],basal plasma membrane [GO:0009925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasm [GO:0016528]; voltage-gated sodium channel complex [GO:0001518],sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_01385,FUN_005354-T1,Peve_00016052,Pocillopora_meandrina_HIv1___TS.g19952.t1,three_way,78.38366666666667,FUN_005354-T1,A4FUY7,,,,,63.4,145.0,1.7e-48,193.7,sp|A4FUY7|MOC2B_BOVIN Molybdopterin synthase catalytic subunit OS=Bos taurus OX=9913 GN=MOCS2 PE=2 SV=2,,,,,,
OG_01386,FUN_005355-T1,Peve_00016031,Pocillopora_meandrina_HIv1___RNAseq.g8213.t1,three_way,76.06266666666666,FUN_005355-T1,Q2TBL4,,,,,45.5,534.0,9.5e-119,428.7,sp|Q2TBL4|RPC3_BOVIN DNA-directed RNA polymerase III subunit RPC3 OS=Bos taurus OX=9913 GN=POLR3C PE=2 SV=1,,,,,,
OG_01387,FUN_005356-T1,Peve_00016032,Pocillopora_meandrina_HIv1___RNAseq.g8215.t1,three_way,63.59766666666667,FUN_005356-T1,Q96I13,ABHD8_HUMAN,,Protein ABHD8 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 8) (Abhydrolase domain-containing protein 8),Homo sapiens (Human),47.5,242.0,2.6e-58,227.6,sp|Q96I13|ABHD8_HUMAN Protein ABHD8 OS=Homo sapiens OX=9606 GN=ABHD8 PE=1 SV=1,GO:0005737; GO:0005739; GO:0006654; GO:0042171; GO:0052689; GO:0055088; GO:0070062; GO:1900226,lipid homeostasis [GO:0055088]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; phosphatidic acid biosynthetic process [GO:0006654],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739],carboxylic ester hydrolase activity [GO:0052689]; lysophosphatidic acid acyltransferase activity [GO:0042171],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_01388,FUN_005362-T1,Peve_00016034,Pocillopora_meandrina_HIv1___RNAseq.g8219.t1,three_way,76.58716666666668,FUN_005362-T1,Q96P56,,,,,38.1,546.0,1.8e-46,188.7,sp|Q96P56|CTSR2_HUMAN Cation channel sperm-associated protein 2 OS=Homo sapiens OX=9606 GN=CATSPER2 PE=1 SV=2,,,,,,
OG_01389,FUN_005363-T1,Peve_00016035,Pocillopora_meandrina_HIv1___RNAseq.g8221.t1,three_way,93.72233333333334,FUN_005363-T1,Q7L5Y6,DET1_HUMAN,,DET1 homolog (De-etiolated-1 homolog),Homo sapiens (Human),66.1,481.0,1.1e-185,651.0,sp|Q7L5Y6|DET1_HUMAN DET1 homolog OS=Homo sapiens OX=9606 GN=DET1 PE=1 SV=2,GO:0005634; GO:0016567; GO:0031461; GO:0031464; GO:0031625; GO:0032436; GO:0044877; GO:0065003; GO:0080008; GO:1990756,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleus [GO:0005634],protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0043226; GO:0060090; GO:0065003,nucleus; organelle; molecular adaptor activity; protein-containing complex assembly
OG_01390,FUN_005365-T1,Peve_00016036,Pocillopora_meandrina_HIv1___RNAseq.g8222.t1,three_way,83.86883333333333,FUN_005365-T1,O01727,,,,,80.4,189.0,2.9000000000000006e-86,319.7,sp|O01727|RS6_BRAFL Small ribosomal subunit protein eS6 OS=Branchiostoma floridae OX=7739 GN=RPS6 PE=3 SV=1,,,,,,
OG_01391,FUN_005366-T1,Peve_00041492,Pocillopora_meandrina_HIv1___RNAseq.g6638.t1,three_way,90.41666666666669,FUN_005366-T1,Q9CR47,,,,,71.3,174.0,1.5999999999999999e-62,240.7,sp|Q9CR47|NSA2_MOUSE Ribosome biogenesis protein NSA2 homolog OS=Mus musculus OX=10090 GN=Nsa2 PE=2 SV=1,,,,,,
OG_01392,FUN_005367-T1,Peve_00041491,Pocillopora_meandrina_HIv1___RNAseq.g6637.t3,three_way,81.581,,,,,,,,,,,,,,,,,
OG_01393,FUN_005369-T1,Peve_00041469,Pocillopora_meandrina_HIv1___RNAseq.g6632.t2,three_way,79.86133333333333,FUN_005369-T1,Q9UPW5,CBPC1_HUMAN,,Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1 homolog) (Protein deglutamylase CCP1),Homo sapiens (Human),42.5,1201.0,9.6e-233,808.5,sp|Q9UPW5|CBPC1_HUMAN Cytosolic carboxypeptidase 1 OS=Homo sapiens OX=9606 GN=AGTPBP1 PE=1 SV=3,GO:0001754; GO:0004181; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006508; GO:0007005; GO:0007628; GO:0008270; GO:0008285; GO:0015630; GO:0015631; GO:0021702; GO:0021772; GO:0021954; GO:0034451; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0050905; GO:0060041; GO:0098957; GO:0098958; GO:1904115; GO:2000060,adult walking behavior [GO:0007628]; anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; eye photoreceptor cell differentiation [GO:0001754]; mitochondrion organization [GO:0007005]; negative regulation of cell population proliferation [GO:0008285]; neuromuscular process [GO:0050905]; olfactory bulb development [GO:0021772]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; retina development in camera-type eye [GO:0060041]; retrograde axonal transport of mitochondrion [GO:0098958],axon cytoplasm [GO:1904115]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007005; GO:0007018; GO:0008092; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; mitochondrion organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_01394,FUN_005370-T1,Peve_00041485,Pocillopora_meandrina_HIv1___RNAseq.g6633.t1,three_way,84.67533333333334,,,,,,,,,,,,,,,,,
OG_01395,FUN_005371-T1,Peve_00041486,Pocillopora_meandrina_HIv1___RNAseq.g6634.t1,three_way,94.56833333333331,FUN_005371-T1,Q99JW4,LIMS1_MOUSE,,LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1),Mus musculus (Mouse),65.5,322.0,2.5e-128,459.9,sp|Q99JW4|LIMS1_MOUSE LIM and senescent cell antigen-like-containing domain protein 1 OS=Mus musculus OX=10090 GN=Lims1 PE=1 SV=3,GO:0003779; GO:0005886; GO:0005925; GO:0007160; GO:0007163; GO:0007229; GO:0043009; GO:0045216; GO:0046872; GO:0061351; GO:0097284; GO:0098609; GO:1903944; GO:1904055; GO:1990705; GO:2000178; GO:2000346; GO:2001046,cell-cell adhesion [GO:0098609]; cell-cell junction organization [GO:0045216]; cell-matrix adhesion [GO:0007160]; cholangiocyte proliferation [GO:1990705]; chordate embryonic development [GO:0043009]; establishment or maintenance of cell polarity [GO:0007163]; hepatocyte apoptotic process [GO:0097284]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cholangiocyte proliferation [GO:1904055]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of neural precursor cell proliferation [GO:2000178]; neural precursor cell proliferation [GO:0061351]; positive regulation of integrin-mediated signaling pathway [GO:2001046],focal adhesion [GO:0005925]; plasma membrane [GO:0005886],actin binding [GO:0003779]; metal ion binding [GO:0046872],GO:0005886; GO:0007155; GO:0007163; GO:0008092; GO:0012501; GO:0034330; GO:0048856,plasma membrane; cell adhesion; establishment or maintenance of cell polarity; cytoskeletal protein binding; programmed cell death; cell junction organization; anatomical structure development
OG_01396,FUN_005372-T2,Peve_00041488,Pocillopora_meandrina_HIv1___RNAseq.g6635.t1,three_way,84.41483333333333,FUN_005372-T2,P19120,HSP7C_BOVIN,,Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8),Bos taurus (Bovine),82.6,650.0,4.8e-293,1008.1,sp|P19120|HSP7C_BOVIN Heat shock cognate 71 kDa protein OS=Bos taurus OX=9913 GN=HSPA8 PE=1 SV=2,GO:0000974; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005765; GO:0005829; GO:0005886; GO:0006397; GO:0008380; GO:0016191; GO:0016887; GO:0030674; GO:0031072; GO:0042026; GO:0042470; GO:0044183; GO:0045892; GO:0051085; GO:0061740; GO:0072318; GO:0098793; GO:0140662; GO:1990904,chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; RNA splicing [GO:0008380]; synaptic vesicle uncoating [GO:0016191],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005634; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0006457; GO:0006886; GO:0016071; GO:0016787; GO:0031410; GO:0043226; GO:0044183; GO:0060090; GO:0140657,catalytic activity; nucleus; nucleolus; cytosol; plasma membrane; regulation of DNA-templated transcription; protein folding; intracellular protein transport; mRNA metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; protein folding chaperone; molecular adaptor activity; ATP-dependent activity
OG_01397,FUN_005373-T1,Peve_00041490,Pocillopora_meandrina_HIv1___RNAseq.g6636.t1,three_way,82.66833333333334,FUN_005373-T1,Q9H857,,,,,47.5,457.0,6.1e-121,436.0,sp|Q9H857|NT5D2_HUMAN 5'-nucleotidase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NT5DC2 PE=1 SV=1,,,,,,
OG_01398,FUN_005386-T1,Peve_00044218,Pocillopora_meandrina_HIv1___RNAseq.g6615.t1,three_way,58.902,,,,,,,,,,,,,,,,,
OG_01399,FUN_005387-T1,Peve_00044223,Pocillopora_meandrina_HIv1___RNAseq.g6614.t1,three_way,86.572,FUN_005387-T1,Q32LQ4,,,,,68.3,262.0,1.9e-105,384.0,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_01400,FUN_005389-T1,Peve_00042934,Pocillopora_meandrina_HIv1___RNAseq.g7680.t1,three_way,74.071,,,,,,,,,,,,,,,,,
OG_01401,FUN_005416-T1,Peve_00010106,Pocillopora_meandrina_HIv1___RNAseq.g6846.t1,three_way,58.453,,,,,,,,,,,,,,,,,
OG_01402,FUN_005455-T1,Peve_00002285,Pocillopora_meandrina_HIv1___TS.g303.t2,three_way,84.47483333333334,FUN_005455-T1,P80311,PPIB_BOVIN,,Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP),Bos taurus (Bovine),72.0,211.0,2.4e-84,313.2,sp|P80311|PPIB_BOVIN Peptidyl-prolyl cis-trans isomerase B OS=Bos taurus OX=9913 GN=PPIB PE=1 SV=4,GO:0003755; GO:0005654; GO:0005737; GO:0005788; GO:0006457; GO:0016018; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0043231; GO:0044829; GO:0048471; GO:0050821; GO:0060348; GO:0061077; GO:0070063,bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; protein stabilization [GO:0050821],cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991],cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063],GO:0002376; GO:0003824; GO:0005654; GO:0006457; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"immune system process; catalytic activity; nucleoplasm; protein folding; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_01403,FUN_005467-T1,Peve_00002034,Pocillopora_meandrina_HIv1___TS.g362.t1,three_way,65.028,FUN_005467-T1,Q25197,,,,,37.8,1370.0,2.5e-238,827.4,sp|Q25197|HTK7_HYDVU Putative insulin-like peptide receptor OS=Hydra vulgaris OX=6087 GN=HTK7 PE=2 SV=1,,,,,,
OG_01404,FUN_005470-T1,Peve_00002032,Pocillopora_meandrina_HIv1___RNAseq.g6626.t1,three_way,74.86033333333333,FUN_005470-T1,Q07817,B2CL1_HUMAN,,Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X),Homo sapiens (Human),38.9,126.0,2.2e-19,97.1,sp|Q07817|B2CL1_HUMAN Bcl-2-like protein 1 OS=Homo sapiens OX=9606 GN=BCL2L1 PE=1 SV=1,GO:0001541; GO:0001701; GO:0001836; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005813; GO:0005829; GO:0006897; GO:0007281; GO:0007283; GO:0008584; GO:0008630; GO:0008637; GO:0009566; GO:0010507; GO:0015267; GO:0019901; GO:0030672; GO:0031965; GO:0032465; GO:0032946; GO:0034097; GO:0035234; GO:0040008; GO:0042802; GO:0043065; GO:0043066; GO:0043524; GO:0044565; GO:0046898; GO:0046902; GO:0050673; GO:0051093; GO:0051402; GO:0051434; GO:0051607; GO:0051881; GO:0071230; GO:0071312; GO:0071480; GO:0071839; GO:0090201; GO:0097048; GO:0097136; GO:0097192; GO:0097284; GO:1900118; GO:1901029; GO:1902042; GO:1902230; GO:1902236; GO:1903077; GO:2000242; GO:2000669; GO:2000811; GO:2001240; GO:2001243,apoptotic mitochondrial changes [GO:0008637]; apoptotic process in bone marrow cell [GO:0071839]; cellular response to alkaloid [GO:0071312]; cellular response to amino acid stimulus [GO:0071230]; cellular response to gamma radiation [GO:0071480]; defense response to virus [GO:0051607]; dendritic cell apoptotic process [GO:0097048]; dendritic cell proliferation [GO:0044565]; ectopic germ cell programmed cell death [GO:0035234]; endocytosis [GO:0006897]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fertilization [GO:0009566]; germ cell development [GO:0007281]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; male gonad development [GO:0008584]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of developmental process [GO:0051093]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of reproductive process [GO:2000242]; neuron apoptotic process [GO:0051402]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mononuclear cell proliferation [GO:0032946]; regulation of cytokinesis [GO:0032465]; regulation of growth [GO:0040008]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; response to cycloheximide [GO:0046898]; response to cytokine [GO:0034097]; spermatogenesis [GO:0007283],Bcl-2 family protein complex [GO:0097136]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; synaptic vesicle membrane [GO:0030672],BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901],GO:0005215; GO:0005739; GO:0005783; GO:0005815; GO:0005829; GO:0007005; GO:0012501; GO:0016192; GO:0022414; GO:0043226; GO:0048856; GO:0061024,transporter activity; mitochondrion; endoplasmic reticulum; microtubule organizing center; cytosol; mitochondrion organization; programmed cell death; vesicle-mediated transport; reproductive process; organelle; anatomical structure development; membrane organization
OG_01405,FUN_005473-T1,Peve_00002044,Pocillopora_meandrina_HIv1___RNAseq.g6627.t2,three_way,52.35033333333333,FUN_005473-T1,Q5N8Z0,,,,,28.4,278.0,5.1e-06,55.1,sp|Q5N8Z0|DRB1_ORYSJ Double-stranded RNA-binding protein 1 OS=Oryza sativa subsp. japonica OX=39947 GN=DRB1 PE=2 SV=1,,,,,,
OG_01406,FUN_005474-T1,Peve_00002031,Pocillopora_meandrina_HIv1___RNAseq.g6629.t1,three_way,83.245,FUN_005474-T1,Q5ZJH6,ULK3_CHICK,,Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3),Gallus gallus (Chicken),55.8,439.0,4.3e-137,489.6,sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus OX=9031 GN=ULK3 PE=2 SV=1,GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0010506; GO:0034045; GO:0034727; GO:0042594; GO:0045879; GO:0045880; GO:0046777; GO:0061709; GO:0106310,autophagosome assembly [GO:0000045]; mitophagy [GO:0000423]; negative regulation of smoothened signaling pathway [GO:0045879]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01407,FUN_005476-T1,Peve_00041489,Pocillopora_meandrina_HIv1___RNAseq.g6630.t1,three_way,45.82566666666667,,,,,,,,,,,,,,,,,
OG_01408,FUN_005479-T1,Peve_00001976,Pocillopora_meandrina_HIv1___RNAseq.g6643.t1,three_way,83.39633333333333,FUN_005479-T1,P50904,,,,,47.7,900.0,1.4e-237,824.3,sp|P50904|RASA1_RAT Ras GTPase-activating protein 1 OS=Rattus norvegicus OX=10116 GN=Rasa1 PE=1 SV=1,,,,,,
OG_01409,FUN_005480-T1,Peve_00001975,Pocillopora_meandrina_HIv1___RNAseq.g6644.t1,three_way,42.841166666666666,,,,,,,,,,,,,,,,,
OG_01410,FUN_005530-T1,Peve_00010766,Pocillopora_meandrina_HIv1___RNAseq.g9778.t1,three_way,49.900666666666666,,,,,,,,,,,,,,,,,
OG_01411,FUN_005697-T1,Peve_00008482,Pocillopora_meandrina_HIv1___RNAseq.g19565.t1,three_way,83.81866666666667,FUN_005697-T1,O93308,,,,,50.9,1241.0,1.7e-278,960.7,sp|O93308|SMC1A_XENLA Structural maintenance of chromosomes protein 1A OS=Xenopus laevis OX=8355 GN=smc1a PE=1 SV=1,,,,,,
OG_01412,FUN_005699-T1,Peve_00008484,Pocillopora_meandrina_HIv1___RNAseq.g19564.t1,three_way,83.19833333333334,FUN_005699-T1,Q6GR66,,,,,44.3,61.0,6.7e-11,67.8,sp|Q6GR66|T10B_XENLA Mitochondrial import inner membrane translocase subunit Tim10 B OS=Xenopus laevis OX=8355 GN=timm10b PE=2 SV=1,,,,,,
OG_01413,FUN_005700-T1,Peve_00008485,Pocillopora_meandrina_HIv1___RNAseq.g19563.t1,three_way,75.503,FUN_005700-T1,Q9Z2V9,,,,,40.4,213.0,5.4e-36,152.9,sp|Q9Z2V9|CCNI_MOUSE Cyclin-I OS=Mus musculus OX=10090 GN=Ccni PE=2 SV=4,,,,,,
OG_01414,FUN_005720-T1,Peve_00004974,Pocillopora_meandrina_HIv1___TS.g28923.t1a,three_way,74.88166666666666,FUN_005720-T1,Q9W5Y0,NEP3_DROME,,Neprilysin-3 (EC 3.4.24.11),Drosophila melanogaster (Fruit fly),36.2,746.0,2.1e-140,501.1,sp|Q9W5Y0|NEP3_DROME Neprilysin-3 OS=Drosophila melanogaster OX=7227 GN=Nep3 PE=2 SV=2,GO:0004222; GO:0005886; GO:0006508; GO:0008237; GO:0016020; GO:0016485; GO:0016486; GO:0046872,peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; proteolysis [GO:0006508],membrane [GO:0016020]; plasma membrane [GO:0005886],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_01415,FUN_005721-T1,Peve_00039599,Pocillopora_meandrina_HIv1___RNAseq.g19559.t1,three_way,43.07233333333333,,,,,,,,,,,,,,,,,
OG_01416,FUN_005722-T1,Peve_00039598,Pocillopora_meandrina_HIv1___RNAseq.g8780.t1,three_way,70.38866666666667,,,,,,,,,,,,,,,,,
OG_01417,FUN_005724-T1,Peve_00039588,Pocillopora_meandrina_HIv1___RNAseq.g19450.t2,three_way,56.91033333333333,,,,,,,,,,,,,,,,,
OG_01418,FUN_005725-T1,Peve_00039545,Pocillopora_meandrina_HIv1___RNAseq.g19424.t1,three_way,40.257666666666665,,,,,,,,,,,,,,,,,
OG_01419,FUN_005730-T1,Peve_00004979,Pocillopora_meandrina_HIv1___RNAseq.3034_t,three_way,61.8795,FUN_005730-T1,Q6BEA0,PLXA4_DANRE,,Plexin-A4,Danio rerio (Zebrafish) (Brachydanio rerio),37.4,1904.0,3.2e-310,1066.6,sp|Q6BEA0|PLXA4_DANRE Plexin-A4 OS=Danio rerio OX=7955 GN=plxna4 PE=2 SV=1,GO:0001763; GO:0002116; GO:0005886; GO:0007411; GO:0007414; GO:0007416; GO:0016020; GO:0017154; GO:0030334; GO:0071526,axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; regulation of cell migration [GO:0030334]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416],membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116],semaphorin receptor activity [GO:0017154],GO:0005886; GO:0034330; GO:0060089,plasma membrane; cell junction organization; molecular transducer activity
OG_01420,FUN_005748-T1,Peve_00020863,Pocillopora_meandrina_HIv1___RNAseq.g19540.t1,three_way,82.027,FUN_005748-T1,Q5RFI8,,,,,54.7,602.0,3.7e-191,669.5,sp|Q5RFI8|PGM2_PONAB Phosphopentomutase OS=Pongo abelii OX=9601 GN=PGM2 PE=2 SV=3,,,,,,
OG_01421,FUN_005749-T1,Peve_00020858,Pocillopora_meandrina_HIv1___RNAseq.g19556.t1,three_way,50.93933333333333,,,,,,,,,,,,,,,,,
OG_01422,FUN_005751-T1,Peve_00020859,Pocillopora_meandrina_HIv1___RNAseq.g19446.t2,three_way,80.624,FUN_005751-T1,Q8CBC7,,,,,65.6,294.0,4.9e-107,389.0,sp|Q8CBC7|TRM7_MOUSE tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase OS=Mus musculus OX=10090 GN=Ftsj1 PE=1 SV=1,,,,,,
OG_01423,FUN_005753-T1,Peve_00038388,Pocillopora_meandrina_HIv1___RNAseq.g19557.t1,three_way,71.96666666666667,FUN_005753-T1,Q15269,PWP2_HUMAN,,Periodic tryptophan protein 2 homolog,Homo sapiens (Human),49.4,877.0,1.7e-250,867.1,sp|Q15269|PWP2_HUMAN Periodic tryptophan protein 2 homolog OS=Homo sapiens OX=9606 GN=PWP2 PE=1 SV=2,GO:0000028; GO:0000462; GO:0003723; GO:0005654; GO:0032040; GO:0034388; GO:0042274,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]",nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0065003,RNA binding; nucleoplasm; protein-containing complex assembly
OG_01424,FUN_005808-T1,Peve_00004975,Pocillopora_meandrina_HIv1___RNAseq.g19447.t1,three_way,71.41199999999999,FUN_005808-T1,Q2HJE4,UBP15_BOVIN,,Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15),Bos taurus (Bovine),56.1,919.0,3.100000000000001e-277,956.1,sp|Q2HJE4|UBP15_BOVIN Ubiquitin carboxyl-terminal hydrolase 15 OS=Bos taurus OX=9913 GN=USP15 PE=2 SV=1,GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005739; GO:0006508; GO:0030509; GO:0030512; GO:0035520; GO:0140673; GO:1905035; GO:1990167,BMP signaling pathway [GO:0030509]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of antifungal innate immune response [GO:1905035]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein K27-linked deubiquitination [GO:1990167]; proteolysis [GO:0006508]; transcription elongation-coupled chromatin remodeling [GO:0140673],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005739; GO:0006325; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; mitochondrion; chromatin organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01425,FUN_005812-T1,Peve_00039600,Pocillopora_meandrina_HIv1___RNAseq.g19558.t1,three_way,91.84433333333334,FUN_005812-T1,Q8WXX0,DYH7_HUMAN,,Dynein axonemal heavy chain 7 (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2),Homo sapiens (Human),54.7,4000.0,0.0,4338.5,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,GO:0003341; GO:0003777; GO:0005509; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0008569; GO:0016887; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285; GO:0060294; GO:0097729,cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],9+2 motile cilium [GO:0097729]; axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_01426,FUN_005814-T1,Peve_00004967,Pocillopora_meandrina_HIv1___RNAseq.g19530.t1,three_way,80.68183333333334,FUN_005814-T1,Q06187,BTK_HUMAN,,Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase),Homo sapiens (Human),41.3,658.0,7.8e-147,522.3,sp|Q06187|BTK_HUMAN Tyrosine-protein kinase BTK OS=Homo sapiens OX=9606 GN=BTK PE=1 SV=3,GO:0001780; GO:0001805; GO:0001812; GO:0002250; GO:0002344; GO:0002553; GO:0002639; GO:0002721; GO:0002755; GO:0002902; GO:0004713; GO:0004715; GO:0005524; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007498; GO:0008270; GO:0016004; GO:0018108; GO:0019722; GO:0030167; GO:0030889; GO:0030890; GO:0031410; GO:0032496; GO:0032693; GO:0032755; GO:0032760; GO:0034614; GO:0035556; GO:0038095; GO:0042113; GO:0042802; GO:0043123; GO:0043274; GO:0045087; GO:0045121; GO:0045579; GO:0048469; GO:0048471; GO:0050766; GO:0050852; GO:0050853; GO:0051092; GO:0061516; GO:0071226; GO:0097190; GO:0098761; GO:0141111; GO:0150153; GO:1900227; GO:1901647; GO:1990959,adaptive immune response [GO:0002250]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; B cell affinity maturation [GO:0002344]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell maturation [GO:0048469]; cellular response to interleukin-7 [GO:0098761]; cellular response to molecule of fungal origin [GO:0071226]; cellular response to reactive oxygen species [GO:0034614]; eosinophil homeostasis [GO:1990959]; Fc-epsilon receptor signaling pathway [GO:0038095]; histamine secretion by mast cell [GO:0002553]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; mesoderm development [GO:0007498]; monocyte proliferation [GO:0061516]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of interleukin-10 production [GO:0032693]; neutrophil homeostasis [GO:0001780]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-17A production [GO:0150153]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of phagocytosis [GO:0050766]; positive regulation of synoviocyte proliferation [GO:1901647]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I hypersensitivity [GO:0001812]; positive regulation of type III hypersensitivity [GO:0001805]; proteoglycan catabolic process [GO:0030167]; regulation of B cell apoptotic process [GO:0002902]; regulation of B cell cytokine production [GO:0002721]; response to lipopolysaccharide [GO:0032496]; T cell receptor signaling pathway [GO:0050852],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],"ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0008289; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0098542; GO:0098772; GO:0140096; GO:1901135,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid binding; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01427,FUN_005815-T1,Peve_00004973,Pocillopora_meandrina_HIv1___RNAseq.g19533.t1,three_way,81.48533333333333,FUN_005815-T1,Q3ZCL5,,,,,56.9,267.0,3.8e-80,300.1,sp|Q3ZCL5|ARFP2_BOVIN Arfaptin-2 OS=Bos taurus OX=9913 GN=ARFIP2 PE=2 SV=1,,,,,,
OG_01428,FUN_005821-T1,Peve_00034064,Pocillopora_meandrina_HIv1___TS.g29038.t2,three_way,69.24366666666667,FUN_005821-T1,Q9JLG8,,,,,50.0,640.0,1.2e-182,641.7,sp|Q9JLG8|CAN15_MOUSE Calpain-15 OS=Mus musculus OX=10090 GN=Capn15 PE=1 SV=1,,,,,,
OG_01429,FUN_005822-T3,Peve_00034062,Pocillopora_meandrina_HIv1___RNAseq.g19653.t1,three_way,66.30766666666668,FUN_005822-T3,Q2ABP2,,,,,41.0,234.0,2e-40,167.5,sp|Q2ABP2|PGAP2_CRIGR Acyltransferase PGAP2 OS=Cricetulus griseus OX=10029 GN=Pgap2 PE=1 SV=1,,,,,,
OG_01430,FUN_005823-T1,Peve_00034061,Pocillopora_meandrina_HIv1___RNAseq.g19654.t2,three_way,62.922666666666665,FUN_005823-T1,Q2ABP2,,,,,44.8,210.0,3.1e-41,170.2,sp|Q2ABP2|PGAP2_CRIGR Acyltransferase PGAP2 OS=Cricetulus griseus OX=10029 GN=Pgap2 PE=1 SV=1,,,,,,
OG_01431,FUN_005824-T1,Peve_00034060,Pocillopora_meandrina_HIv1___RNAseq.g19655.t1,three_way,78.75233333333333,FUN_005824-T1,Q5R9T6,,,,,43.8,297.0,1.8e-72,274.2,sp|Q5R9T6|WDR55_PONAB WD repeat-containing protein 55 OS=Pongo abelii OX=9601 GN=WDR55 PE=2 SV=1,,,,,,
OG_01432,FUN_005830-T1,Peve_00034057,Pocillopora_meandrina_HIv1___RNAseq.g19658.t1,three_way,67.821,FUN_005830-T1,Q5D0K2,,,,,29.0,365.0,1.8e-26,121.7,sp|Q5D0K2|CCKAR_CANLF Cholecystokinin receptor type A OS=Canis lupus familiaris OX=9615 GN=CCKAR PE=2 SV=1,,,,,,
OG_01433,FUN_005832-T2,Peve_00034054,Pocillopora_meandrina_HIv1___RNAseq.g19672.t1,three_way,60.95,FUN_005832-T2,Q3L254,WNT7B_CHICK,,Protein Wnt-7b,Gallus gallus (Chicken),47.4,333.0,2.7e-88,327.0,sp|Q3L254|WNT7B_CHICK Protein Wnt-7b OS=Gallus gallus OX=9031 GN=WNT7B PE=2 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0021871; GO:0030182; GO:0045165; GO:0046330; GO:0048144; GO:0060070; GO:0070307; GO:0071300; GO:0072089,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089],extracellular space [GO:0005615],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01434,FUN_005833-T1,Peve_00034072,Pocillopora_meandrina_HIv1___RNAseq.g19671.t1,three_way,61.641,,,,,,,,,,,,,,,,,
OG_01435,FUN_005856-T1,Peve_00034053,Pocillopora_meandrina_HIv1___TS.g29054.t1,three_way,52.05916666666666,FUN_005856-T1,P41221,WNT5A_HUMAN,,Protein Wnt-5a,Homo sapiens (Human),41.0,376.0,1.5e-79,298.1,sp|P41221|WNT5A_HUMAN Protein Wnt-5a OS=Homo sapiens OX=9606 GN=WNT5A PE=1 SV=2,GO:0001736; GO:0001756; GO:0001822; GO:0001837; GO:0001843; GO:0001938; GO:0001947; GO:0002053; GO:0002088; GO:0002720; GO:0003138; GO:0003139; GO:0003281; GO:0003283; GO:0003323; GO:0003344; GO:0003408; GO:0005109; GO:0005115; GO:0005125; GO:0005543; GO:0005576; GO:0005615; GO:0005788; GO:0005796; GO:0005886; GO:0006954; GO:0007200; GO:0007223; GO:0007254; GO:0007411; GO:0007442; GO:0007494; GO:0008104; GO:0008543; GO:0008584; GO:0008595; GO:0009986; GO:0010463; GO:0010595; GO:0010628; GO:0010631; GO:0010742; GO:0010820; GO:0010976; GO:0016055; GO:0019904; GO:0021891; GO:0030182; GO:0030216; GO:0030324; GO:0030509; GO:0030514; GO:0030666; GO:0030669; GO:0031012; GO:0032722; GO:0032729; GO:0032731; GO:0032755; GO:0032757; GO:0032760; GO:0035567; GO:0036342; GO:0036517; GO:0036518; GO:0040037; GO:0042060; GO:0042733; GO:0043032; GO:0043066; GO:0043122; GO:0043410; GO:0045165; GO:0045198; GO:0045599; GO:0045732; GO:0045766; GO:0045778; GO:0045807; GO:0045836; GO:0045892; GO:0045893; GO:0045944; GO:0046330; GO:0048018; GO:0048022; GO:0048146; GO:0048341; GO:0048570; GO:0048706; GO:0048806; GO:0048843; GO:0048846; GO:0048850; GO:0050680; GO:0050727; GO:0050729; GO:0050807; GO:0051216; GO:0051885; GO:0051897; GO:0051964; GO:0060028; GO:0060029; GO:0060065; GO:0060067; GO:0060068; GO:0060070; GO:0060071; GO:0060157; GO:0060324; GO:0060340; GO:0060599; GO:0060638; GO:0060686; GO:0060744; GO:0060750; GO:0060760; GO:0060762; GO:0060809; GO:0060907; GO:0061036; GO:0062009; GO:0070062; GO:0070242; GO:0070245; GO:0071222; GO:0071277; GO:0071300; GO:0071346; GO:0071425; GO:0071560; GO:0072201; GO:0090009; GO:0090090; GO:0090103; GO:0097325; GO:0098685; GO:0098794; GO:0098978; GO:0099054; GO:0099068; GO:0099170; GO:0099175; GO:0099566; GO:0140013; GO:0150012; GO:1900020; GO:1902035; GO:1902379; GO:1902474; GO:1904861; GO:1904862; GO:1904934; GO:1904948; GO:2000049; GO:2000052; GO:2001235,"anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular response to calcium ion [GO:0071277]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to type II interferon [GO:0071346]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell migration [GO:0010631]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inflammatory response [GO:0006954]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; macrophage derived foam cell differentiation [GO:0010742]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; meiotic nuclear division [GO:0140013]; melanocyte proliferation [GO:0097325]; mesenchymal cell proliferation [GO:0010463]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midbrain dopaminergic neuron differentiation [GO:1904948]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; pericardium morphogenesis [GO:0003344]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type II interferon production [GO:0032729]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein localization [GO:0008104]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; thymocyte apoptotic process [GO:0070242]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; ventricular septum development [GO:0003281]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing [GO:0042060]",cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685],chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115],GO:0005576; GO:0005615; GO:0005886; GO:0006355; GO:0006954; GO:0007163; GO:0008289; GO:0012501; GO:0022414; GO:0023052; GO:0030154; GO:0030312; GO:0031012; GO:0034330; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772; GO:0140013,extracellular region; extracellular space; plasma membrane; regulation of DNA-templated transcription; inflammatory response; establishment or maintenance of cell polarity; lipid binding; programmed cell death; reproductive process; signaling; cell differentiation; external encapsulating structure; extracellular matrix; cell junction organization; wound healing; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity; meiotic nuclear division
OG_01436,FUN_005858-T1,Peve_00015774,Pocillopora_meandrina_HIv1___RNAseq.g19665.t1,three_way,77.938,FUN_005858-T1,Q8IV35,,,,,25.4,906.0,2.2e-77,292.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_01437,FUN_005873-T1,Peve_00015756,Pocillopora_meandrina_HIv1___RNAseq.g19664.t1,three_way,58.21833333333333,,,,,,,,,,,,,,,,,
OG_01438,FUN_005874-T1,Peve_00015757,Pocillopora_meandrina_HIv1___RNAseq.g19661.t1,three_way,73.067,FUN_005874-T1,G4WMX4,,,,,27.8,356.0,4.6e-27,123.6,sp|G4WMX4|RYAR_TRICA RYamide receptor OS=Tribolium castaneum OX=7070 GN=RYa-R PE=2 SV=1,,,,,,
OG_01439,FUN_005875-T1,Peve_00015759,Pocillopora_meandrina_HIv1___RNAseq.g19660.t1,three_way,59.60816666666667,FUN_005875-T1,A0A287A2K5,,,,,26.7,390.0,7.1e-19,96.7,sp|A0A287A2K5|GASR_PIG Gastrin/cholecystokinin type B receptor OS=Sus scrofa OX=9823 GN=CCKBR PE=3 SV=1,,,,,,
OG_01440,FUN_005878-T1,Peve_00015762,Pocillopora_meandrina_HIv1___RNAseq.g19674.t1,three_way,82.214,FUN_005878-T1,Q9Y619,ORNT1_HUMAN,,Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15),Homo sapiens (Human),54.9,288.0,1.4e-85,317.8,sp|Q9Y619|ORNT1_HUMAN Mitochondrial ornithine transporter 1 OS=Homo sapiens OX=9606 GN=SLC25A15 PE=1 SV=1,GO:0000050; GO:0000064; GO:0005739; GO:0005743; GO:0015189; GO:0015297; GO:0016020; GO:0061459; GO:1903401; GO:1903826; GO:1990575,L-arginine transmembrane transport [GO:1903826]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; urea cycle [GO:0000050],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],antiporter activity [GO:0015297]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],GO:0005215; GO:0005739; GO:0043226; GO:0055085; GO:0071941,transporter activity; mitochondrion; organelle; transmembrane transport; nitrogen cycle metabolic process
OG_01441,FUN_005881-T1,Peve_00015763,Pocillopora_meandrina_HIv1___RNAseq.g19675.t1,three_way,86.64433333333334,FUN_005881-T1,Q58DT4,P5CR1_BOVIN,,"Pyrroline-5-carboxylate reductase 1, mitochondrial (P5C reductase 1) (P5CR 1) (EC 1.5.1.2)",Bos taurus (Bovine),47.6,267.0,7.6000000000000005e-59,228.8,"sp|Q58DT4|P5CR1_BOVIN Pyrroline-5-carboxylate reductase 1, mitochondrial OS=Bos taurus OX=9913 GN=PYCR1 PE=2 SV=1",GO:0004735; GO:0005739; GO:0006561; GO:0034599; GO:0042802; GO:0051881; GO:0055129; GO:1903377,cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881],mitochondrion [GO:0005739],identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735],GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; organelle
OG_01442,FUN_005882-T1,Peve_00015765,Pocillopora_meandrina_HIv1___RNAseq.g19676.t1,three_way,71.35633333333334,,,,,,,,,,,,,,,,,
OG_01443,FUN_005883-T1,Peve_00015767,Pocillopora_meandrina_HIv1___RNAseq.g19677.t1,three_way,79.88083333333334,FUN_005883-T1,Q6XPS3,TPTE2_HUMAN,,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)",Homo sapiens (Human),46.4,468.0,6e-103,376.3,"sp|Q6XPS3|TPTE2_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 OS=Homo sapiens OX=9606 GN=TPTE2 PE=1 SV=2",GO:0000139; GO:0005216; GO:0005737; GO:0005789; GO:0005829; GO:0006661; GO:0016314; GO:0051800,phosphatidylinositol biosynthetic process [GO:0006661],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],"monoatomic ion channel activity [GO:0005216]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity [GO:0051800]",GO:0003824; GO:0005215; GO:0005829; GO:0006629; GO:0016787,catalytic activity; transporter activity; cytosol; lipid metabolic process; hydrolase activity
OG_01444,FUN_005890-T1,Peve_00015769,Pocillopora_meandrina_HIv1___RNAseq.g19679.t1,three_way,69.12316666666668,FUN_005890-T1,O94868,,,,,36.6,673.0,7.4e-94,346.7,sp|O94868|FCSD2_HUMAN F-BAR and double SH3 domains protein 2 OS=Homo sapiens OX=9606 GN=FCHSD2 PE=1 SV=3,,,,,,
OG_01445,FUN_005893-T1,Peve_00015773,Pocillopora_meandrina_HIv1___RNAseq.g19681.t1,three_way,81.42,FUN_005893-T1,G5EBX9,PPE_CAEEL,,Serine/threonine-protein phosphatase with EF-hands pef-1 (CePPEF) (EC 3.1.3.16) (Phosphatase with EF hands 1),Caenorhabditis elegans,49.7,580.0,1.8e-162,574.3,sp|G5EBX9|PPE_CAEEL Serine/threonine-protein phosphatase with EF-hands pef-1 OS=Caenorhabditis elegans OX=6239 GN=pef-1 PE=1 SV=1,GO:0004722; GO:0005506; GO:0005509; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0030145; GO:0030424; GO:0030425; GO:0043025; GO:0043204; GO:0050906,detection of stimulus involved in sensory perception [GO:0050906],axon [GO:0030424]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0005929; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; cilium; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01446,FUN_005894-T1,Peve_00035818,Pocillopora_meandrina_HIv1___RNAseq.g19682.t1,three_way,75.725,FUN_005894-T1,Q9BVK2,ALG8_HUMAN,,"Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)",Homo sapiens (Human),55.1,296.0,6.5e-84,312.4,"sp|Q9BVK2|ALG8_HUMAN Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG8 PE=1 SV=2",GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0018279; GO:0042283; GO:0098553,dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553],"dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_01447,FUN_005896-T1,Peve_00035817,Pocillopora_meandrina_HIv1___RNAseq.3177_t,three_way,67.3925,FUN_005896-T1,Q8K2Y0,,,,,39.0,141.0,1.2e-15,86.3,sp|Q8K2Y0|OBI1_MOUSE ORC ubiquitin ligase 1 OS=Mus musculus OX=10090 GN=Obi1 PE=1 SV=2,,,,,,
OG_01448,FUN_005899-T1,Peve_00035816,Pocillopora_meandrina_HIv1___RNAseq.3178_t,three_way,96.55533333333334,FUN_005899-T1,Q15319,PO4F3_HUMAN,,"POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C)",Homo sapiens (Human),59.5,259.0,1.4e-66,254.6,"sp|Q15319|PO4F3_HUMAN POU domain, class 4, transcription factor 3 OS=Homo sapiens OX=9606 GN=POU4F3 PE=1 SV=1",GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007601; GO:0007605; GO:0021562; GO:0031290; GO:0042472; GO:0042491; GO:0045944; GO:0048675; GO:0050885; GO:0051402; GO:1990837,axon extension [GO:0048675]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290]; sensory perception of sound [GO:0007605]; vestibulocochlear nerve development [GO:0021562]; visual perception [GO:0007601],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_01449,FUN_005901-T2,Peve_00035822,Pocillopora_meandrina_HIv1___RNAseq.g18983.t2,three_way,79.461,FUN_005901-T2,O94915,FRYL_HUMAN,,Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein),Homo sapiens (Human),36.1,3093.0,0.0,1690.2,sp|O94915|FRYL_HUMAN Protein furry homolog-like OS=Homo sapiens OX=9606 GN=FRYL PE=1 SV=2,GO:0000902; GO:0005938; GO:0030427; GO:0031175,cell morphogenesis [GO:0000902]; neuron projection development [GO:0031175],cell cortex [GO:0005938]; site of polarized growth [GO:0030427],,,
OG_01450,FUN_005904-T1,Peve_00035815,Pocillopora_meandrina_HIv1___RNAseq.2460_t,three_way,73.63866666666667,FUN_005904-T1,P55115,,,,,42.3,239.0,1e-48,195.3,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_01451,FUN_005905-T1,Peve_00033233,Pocillopora_meandrina_HIv1___RNAseq.g19576.t1,three_way,48.1295,FUN_005905-T1,Q8JI28,,,,,24.0,271.0,2.7e-13,77.8,sp|Q8JI28|TLL1_XENLA Tolloid-like protein 1 OS=Xenopus laevis OX=8355 GN=tll1 PE=1 SV=1,,,,,,
OG_01452,FUN_005908-T1,Peve_00038389,Pocillopora_meandrina_HIv1___RNAseq.g19573.t1,three_way,84.7165,FUN_005908-T1,P23634,AT2B4_HUMAN,,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),Homo sapiens (Human),59.0,1089.0,0.0,1226.8,sp|P23634|AT2B4_HUMAN Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens OX=9606 GN=ATP2B4 PE=1 SV=2,GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005739; GO:0005886; GO:0005901; GO:0005929; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036064; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145,calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832],basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080],GO:0003012; GO:0003013; GO:0003824; GO:0005215; GO:0005739; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0098772; GO:0140657,muscle system process; circulatory system process; catalytic activity; transporter activity; mitochondrion; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; microtubule-based movement; hydrolase activity; reproductive process; organelle; anatomical structure development; cell motility; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_01453,FUN_005909-T1,Peve_00038382,Pocillopora_meandrina_HIv1___RNAseq.g19572.t1,three_way,90.43466666666669,FUN_005909-T1,A7S3I2,,,,,87.0,69.0,2.9e-24,112.8,sp|A7S3I2|BBIP1_NEMVE BBSome-interacting protein 1 OS=Nematostella vectensis OX=45351 GN=bbip1 PE=3 SV=1,,,,,,
OG_01454,FUN_005910-T1,Peve_00038357,Pocillopora_meandrina_HIv1___TS.g28951.t2,three_way,53.465833333333336,FUN_005910-T1,Q4AC94,C2CD3_HUMAN,,C2 domain-containing protein 3,Homo sapiens (Human),31.7,1538.0,2.5e-185,651.7,sp|Q4AC94|C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=C2CD3 PE=1 SV=4,GO:0001701; GO:0001947; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0034451; GO:0036064; GO:0042733; GO:0060271; GO:0061511; GO:0071539; GO:1905515,brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815],,GO:0005815; GO:0005829; GO:0043226; GO:0044782; GO:0048856; GO:0051604,microtubule organizing center; cytosol; organelle; cilium organization; anatomical structure development; protein maturation
OG_01455,FUN_005913-T1,Peve_00008487,Pocillopora_meandrina_HIv1___RNAseq.g19569.t1,three_way,86.37333333333333,FUN_005913-T1,Q922V4,,,,,67.2,497.0,3.8999999999999996e-90,333.6,sp|Q922V4|PLRG1_MOUSE Pleiotropic regulator 1 OS=Mus musculus OX=10090 GN=Plrg1 PE=1 SV=1,,,,,,
OG_01456,FUN_005914-T1,Peve_00008476,Pocillopora_meandrina_HIv1___RNAseq.g19568.t1,three_way,83.68299999999999,FUN_005914-T1,Q3T199,,,,,93.0,143.0,3.5000000000000007e-71,268.9,sp|Q3T199|RS23_BOVIN Small ribosomal subunit protein uS12 OS=Bos taurus OX=9913 GN=RPS23 PE=1 SV=1,,,,,,
OG_01457,FUN_005931-T1,Peve_00011544,Pocillopora_meandrina_HIv1___TS.g26522.t1,three_way,59.55316666666667,,,,,,,,,,,,,,,,,
OG_01458,FUN_005970-T1,Peve_00015060,Pocillopora_meandrina_HIv1___RNAseq.g19790.t1,three_way,78.61566666666667,FUN_005970-T1,A7RPT4,NNRE_NEMVE,,NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase),Nematostella vectensis (Starlet sea anemone),71.1,228.0,3.5e-98,359.4,sp|A7RPT4|NNRE_NEMVE NAD(P)H-hydrate epimerase OS=Nematostella vectensis OX=45351 GN=v1g228490 PE=3 SV=1,GO:0000166; GO:0005739; GO:0046872; GO:0052856,,mitochondrion [GO:0005739],metal ion binding [GO:0046872]; NAD(P)HX epimerase activity [GO:0052856]; nucleotide binding [GO:0000166],GO:0003824; GO:0005739; GO:0016853; GO:0043226,catalytic activity; mitochondrion; isomerase activity; organelle
OG_01459,FUN_005992-T1,Peve_00010277,Pocillopora_meandrina_HIv1___RNAseq.g8613.t1,three_way,66.958,FUN_005992-T1,P15848,ARSB_HUMAN,,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),Homo sapiens (Human),46.5,495.0,9.999999999999999e-123,441.8,sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1,GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813,autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0006914; GO:0007040; GO:0016787; GO:0043226; GO:0048870,catalytic activity; extracellular region; lysosome; vacuole; autophagy; lysosome organization; hydrolase activity; organelle; cell motility
OG_01460,FUN_005994-T2,Peve_00008882,Pocillopora_meandrina_HIv1___RNAseq.g19943.t1,three_way,67.73166666666667,FUN_005994-T2,Q6YBV0,S36A4_HUMAN,,Neutral amino acid uniporter 4 (Solute carrier family 36 member 4),Homo sapiens (Human),43.1,418.0,7.6e-86,319.3,sp|Q6YBV0|S36A4_HUMAN Neutral amino acid uniporter 4 OS=Homo sapiens OX=9606 GN=SLC36A4 PE=1 SV=1,GO:0003333; GO:0005765; GO:0005774; GO:0005886; GO:0015180; GO:0015193; GO:0015196; GO:0015293; GO:0015808; GO:0015824; GO:0015827; GO:1904271; GO:1904556,amino acid transmembrane transport [GO:0003333]; L-alanine transport [GO:0015808]; L-proline import across plasma membrane [GO:1904271]; L-tryptophan transmembrane transport [GO:1904556]; proline transport [GO:0015824]; tryptophan transport [GO:0015827],lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774],L-alanine transmembrane transporter activity [GO:0015180]; L-proline transmembrane transporter activity [GO:0015193]; L-tryptophan transmembrane transporter activity [GO:0015196]; symporter activity [GO:0015293],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01461,FUN_005995-T1,Peve_00036053,Pocillopora_meandrina_HIv1___RNAseq.g19942.t1,three_way,83.26333333333334,FUN_005995-T1,A7RNG8,,,,,68.4,598.0,7.599999999999999e-229,794.7,sp|A7RNG8|CCD22_NEMVE Coiled-coil domain-containing protein 22 homolog OS=Nematostella vectensis OX=45351 GN=v1g180167 PE=3 SV=1,,,,,,
OG_01462,FUN_005996-T1,Peve_00036051,Pocillopora_meandrina_HIv1___TS.g29328.t1,three_way,73.044,FUN_005996-T1,Q6GMK0,MGT4B_DANRE,,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb) (GlcNAc-T IVb) (GnT-IVb) (N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb)",Danio rerio (Zebrafish) (Brachydanio rerio),50.6,508.0,6e-143,509.2,"sp|Q6GMK0|MGT4B_DANRE Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B OS=Danio rerio OX=7955 GN=mgat4bQ9UQ53 PE=2 SV=1",GO:0000139; GO:0005783; GO:0005793; GO:0005795; GO:0006486; GO:0006487; GO:0008375; GO:0008454; GO:0046872,protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]",GO:0003824; GO:0005783; GO:0006486; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; protein glycosylation; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01463,FUN_005998-T1,Peve_00036045,Pocillopora_meandrina_HIv1___RNAseq.g19934.t1,three_way,70.90683333333334,FUN_005998-T1,P23780,BGAL_MOUSE,,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),Mus musculus (Mouse),50.4,625.0,1.3e-181,637.9,sp|P23780|BGAL_MOUSE Beta-galactosidase OS=Mus musculus OX=10090 GN=Glb1 PE=1 SV=1,GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0006516; GO:0006689; GO:0016020; GO:0016787; GO:0016936; GO:0019388; GO:0042340; GO:0042803; GO:0051413; GO:1904016,galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; keratan sulfate proteoglycan catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020],beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0005975; GO:0006629; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; Golgi apparatus; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_01464,FUN_006000-T1,Peve_00036040,Pocillopora_meandrina_HIv1___RNAseq.3462_t,three_way,85.708,FUN_006000-T1,Q8CIH9,PUR1_MOUSE,,Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT),Mus musculus (Mouse),60.8,533.0,4.7e-179,629.0,sp|Q8CIH9|PUR1_MOUSE Amidophosphoribosyltransferase OS=Mus musculus OX=10090 GN=Ppat PE=1 SV=1,GO:0004044; GO:0006177; GO:0006189; GO:0009113; GO:0044208; GO:0046872; GO:0051539; GO:0097294,'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113],,"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]",GO:0003824; GO:0016740; GO:0055086; GO:1901135,catalytic activity; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01465,FUN_006001-T1,Peve_00036061,Pocillopora_meandrina_HIv1___RNAseq.g19928.t1,three_way,87.754,FUN_006001-T1,P38024,,,,,60.3,330.0,1.3e-116,421.0,sp|P38024|PUR6_CHICK Multifunctional protein ADE2 OS=Gallus gallus OX=9031 GN=AIRC PE=2 SV=1,,,,,,
OG_01466,FUN_006002-T1,Peve_00036060,Pocillopora_meandrina_HIv1___RNAseq.g19927.t1,three_way,76.86133333333333,FUN_006002-T1,A0A1U8QWA2,ATR12_EMENI,,Glycine betaine reductase ATRR (Nonribosomal peptide synthetase-like protein ATRR) [Includes: Carboxylic acid reductase (EC 1.2.1.-); Aldehyde reductase (EC 1.1.1.-)],Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) (Aspergillus nidulans),38.2,1317.0,3.3e-237,823.5,sp|A0A1U8QWA2|ATR12_EMENI Glycine betaine reductase ATRR OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=ATRR PE=1 SV=1,GO:0009058; GO:0016491; GO:0031177,biosynthetic process [GO:0009058],,oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_01467,FUN_006003-T1,Peve_00036052,Pocillopora_meandrina_HIv1___RNAseq.g19926.t1,three_way,75.86866666666667,FUN_006003-T1,O43818,U3IP2_HUMAN,,U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K),Homo sapiens (Human),54.7,369.0,7.7e-54,213.0,sp|O43818|U3IP2_HUMAN U3 small nucleolar RNA-interacting protein 2 OS=Homo sapiens OX=9606 GN=RRP9 PE=1 SV=1,GO:0003723; GO:0005654; GO:0005730; GO:0006364; GO:0030515; GO:0031428; GO:0032040; GO:0034511; GO:0042274,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],box C/D methylation guide snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040],RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511],GO:0003723; GO:0005654; GO:0005730; GO:0043226,RNA binding; nucleoplasm; nucleolus; organelle
OG_01468,FUN_006004-T1,Peve_00036048,Pocillopora_meandrina_HIv1___RNAseq.g19925.t1,three_way,79.33333333333333,FUN_006004-T1,Q7T0P7,,,,,50.5,196.0,3.7e-47,189.5,sp|Q7T0P7|ATP23_XENLA Mitochondrial inner membrane protease ATP23 homolog OS=Xenopus laevis OX=8355 GN=atp23 PE=2 SV=1,,,,,,
OG_01469,FUN_006006-T1,Peve_00032352,Pocillopora_meandrina_HIv1___RNAseq.g19922.t1,three_way,81.52133333333333,FUN_006006-T1,Q8BXX9,,,,,35.5,214.0,1.0999999999999998e-24,115.2,sp|Q8BXX9|CC169_MOUSE Coiled-coil domain-containing protein 169 OS=Mus musculus OX=10090 GN=Ccdc169 PE=2 SV=2,,,,,,
OG_01470,FUN_006007-T1,Peve_00032351,Pocillopora_meandrina_HIv1___RNAseq.g19921.t1,three_way,81.028,FUN_006007-T1,Q3SZW1,TSSK1_BOVIN,,Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1),Bos taurus (Bovine),50.7,268.0,1.2e-68,261.5,sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus OX=9913 GN=TSSK1B PE=2 SV=1,GO:0000226; GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005737; GO:0007286; GO:0031514; GO:0035556; GO:0050321; GO:0106310,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; motile cilium [GO:0031514],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005929; GO:0007010; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cilium; cytoskeleton organization; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_01471,FUN_006008-T1,Peve_00032350,Pocillopora_meandrina_HIv1___RNAseq.g19920.t1,three_way,68.60783333333333,,,,,,,,,,,,,,,,,
OG_01472,FUN_006009-T1,Peve_00032112,Pocillopora_meandrina_HIv1___RNAseq.g28362.t1,three_way,43.14983333333333,,,,,,,,,,,,,,,,,
OG_01473,FUN_006011-T1,Peve_00032349,Pocillopora_meandrina_HIv1___TS.g29304.t1,three_way,62.3305,,,,,,,,,,,,,,,,,
OG_01474,FUN_006026-T1,Peve_00043468,Pocillopora_meandrina_HIv1___RNAseq.g11262.t1,three_way,44.10966666666667,FUN_006026-T1,Q07409,,,,,29.4,282.0,1.1e-22,110.5,sp|Q07409|CNTN3_MOUSE Contactin-3 OS=Mus musculus OX=10090 GN=Cntn3 PE=1 SV=2,,,,,,
OG_01475,FUN_006038-T1,Peve_00023433,Pocillopora_meandrina_HIv1___RNAseq.g20251.t1,three_way,65.71133333333333,FUN_006038-T1,Q7T2C4,S26A5_DANRE,,Prestin (Solute carrier family 26 member 5),Danio rerio (Zebrafish) (Brachydanio rerio),37.0,686.0,1.8e-115,418.3,sp|Q7T2C4|S26A5_DANRE Prestin OS=Danio rerio OX=7955 GN=slc26a5 PE=2 SV=1,GO:0005737; GO:0005886; GO:0006821; GO:0008271; GO:0015075; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0016020; GO:0019531; GO:0019532; GO:0042391; GO:0160044; GO:0160046; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; oxalate transport [GO:0019532]; regulation of membrane potential [GO:0042391]; sulfate transmembrane transport [GO:1902358],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; formate transmembrane transporter activity [GO:0015499]; monoatomic ion transmembrane transporter activity [GO:0015075]; oxalate transmembrane transporter activity [GO:0019531]; oxalate:chloride antiporter activity [GO:0160046]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01476,FUN_006039-T1,Peve_00040858,Pocillopora_meandrina_HIv1___RNAseq.g20511.t1,three_way,58.39266666666667,FUN_006039-T1,Q5F457,,,,,34.4,209.0,2.5e-24,114.4,sp|Q5F457|WBP4_CHICK WW domain-binding protein 4 OS=Gallus gallus OX=9031 GN=WBP4 PE=2 SV=1,,,,,,
OG_01477,FUN_006040-T1,Peve_00040857,Pocillopora_meandrina_HIv1___RNAseq.g20517.t1,three_way,86.46933333333332,FUN_006040-T1,Q8BMJ2,SYLC_MOUSE,,"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)",Mus musculus (Mouse),62.8,1063.0,0.0,1428.3,"sp|Q8BMJ2|SYLC_MOUSE Leucine--tRNA ligase, cytoplasmic OS=Mus musculus OX=10090 GN=Lars1 PE=1 SV=2",GO:0002161; GO:0004819; GO:0004823; GO:0005096; GO:0005524; GO:0005764; GO:0005783; GO:0005829; GO:0006425; GO:0006429; GO:0008361; GO:0016604; GO:0017101; GO:0071233; GO:1904263; GO:1990253,cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604],aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823],GO:0003824; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0006399; GO:0006520; GO:0016874; GO:0043226; GO:0098772; GO:0140098,"catalytic activity; lysosome; vacuole; endoplasmic reticulum; cytosol; tRNA metabolic process; amino acid metabolic process; ligase activity; organelle; molecular function regulator activity; catalytic activity, acting on RNA"
OG_01478,FUN_006041-T1,Peve_00040856,Pocillopora_meandrina_HIv1___TS.g29901.t1a,three_way,85.28133333333334,FUN_006041-T1,Q5M823,NUDC2_RAT,,NudC domain-containing protein 2,Rattus norvegicus (Rat),58.0,150.0,6.2e-50,198.4,sp|Q5M823|NUDC2_RAT NudC domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Nudcd2 PE=2 SV=1,GO:0000776; GO:0000922; GO:0005737; GO:0005813; GO:0006457; GO:0051082,protein folding [GO:0006457],centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; spindle pole [GO:0000922],unfolded protein binding [GO:0051082],GO:0005815; GO:0006457; GO:0043226,microtubule organizing center; protein folding; organelle
OG_01479,FUN_006042-T1,Peve_00017140,Pocillopora_meandrina_HIv1___RNAseq.g20180.t1,three_way,75.429,FUN_006042-T1,Q99JW2,,,,,59.5,393.0,1.2e-140,501.1,sp|Q99JW2|ACY1_MOUSE Aminoacylase-1 OS=Mus musculus OX=10090 GN=Acy1 PE=1 SV=1,,,,,,
OG_01480,FUN_006106-T1,Peve_00034999,Pocillopora_meandrina_HIv1___TS.g16643.t1,three_way,41.91333333333333,,,,,,,,,,,,,,,,,
OG_01481,FUN_006108-T1,Peve_00011648,Pocillopora_meandrina_HIv1___RNAseq.g20395.t1,three_way,81.35466666666666,FUN_006108-T1,Q8BYW9,,,,,55.0,484.0,1.7e-161,570.9,sp|Q8BYW9|EOGT_MOUSE EGF domain-specific O-linked N-acetylglucosamine transferase OS=Mus musculus OX=10090 GN=Eogt PE=1 SV=1,,,,,,
OG_01482,FUN_006116-T1,Peve_00011320,Pocillopora_meandrina_HIv1___RNAseq.g20399.t1,three_way,43.202666666666666,FUN_006116-T1,A0A0K3AV08,MLK1_CAEEL,,Mitogen-activated protein kinase kinase kinase mlk-1 (EC 2.7.11.25) (Mixed lineage kinase homolog 1),Caenorhabditis elegans,29.0,207.0,7.1e-10,67.4,sp|A0A0K3AV08|MLK1_CAEEL Mitogen-activated protein kinase kinase kinase mlk-1 OS=Caenorhabditis elegans OX=6239 GN=mlk-1 PE=1 SV=1,GO:0000165; GO:0001934; GO:0004672; GO:0004709; GO:0005080; GO:0005524; GO:0005737; GO:0007165; GO:0007254; GO:0008340; GO:0019901; GO:0030971; GO:0031103; GO:0038066; GO:0042594; GO:0046688; GO:0046872; GO:0048680; GO:0048691; GO:0050829; GO:0097110; GO:0106310,axon regeneration [GO:0031103]; defense response to Gram-negative bacterium [GO:0050829]; determination of adult lifespan [GO:0008340]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of axon regeneration [GO:0048680]; positive regulation of protein phosphorylation [GO:0001934]; response to copper ion [GO:0046688]; response to starvation [GO:0042594]; signal transduction [GO:0007165],cytoplasm [GO:0005737],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein serine kinase activity [GO:0106310]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_01483,FUN_006117-T1,Peve_00011322,Pocillopora_meandrina_HIv1___RNAseq.g20401.t1,three_way,36.36283333333333,,,,,,,,,,,,,,,,,
OG_01484,FUN_006118-T1,Peve_00011316,Pocillopora_meandrina_HIv1___RNAseq.g20403.t1,three_way,34.93533333333333,,,,,,,,,,,,,,,,,
OG_01485,FUN_006156-T1,Peve_00034472,Pocillopora_meandrina_HIv1___RNAseq.g21109.t1,three_way,57.96266666666666,,,,,,,,,,,,,,,,,
OG_01486,FUN_006162-T1,Peve_00024180,Pocillopora_meandrina_HIv1___RNAseq.g20422.t1,three_way,46.14,FUN_006162-T1,Q90827,,,,,30.2,129.0,2.5e-09,65.1,sp|Q90827|NEL_CHICK Protein NEL OS=Gallus gallus OX=9031 GN=NEL PE=2 SV=1,,,,,,
OG_01487,FUN_006163-T1,Peve_00023605,Pocillopora_meandrina_HIv1___RNAseq.g20424.t1,three_way,83.34083333333334,FUN_006163-T1,Q8NI27,,,,,59.9,1202.0,0.0,1382.1,sp|Q8NI27|THOC2_HUMAN THO complex subunit 2 OS=Homo sapiens OX=9606 GN=THOC2 PE=1 SV=2,,,,,,
OG_01488,FUN_006164-T1,Peve_00023606,Pocillopora_meandrina_HIv1___RNAseq.g20425.t1,three_way,70.08466666666666,FUN_006164-T1,Q9X1H7,,,,,41.6,173.0,2.1e-27,124.4,sp|Q9X1H7|ENGB_THEMA Probable GTP-binding protein EngB OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=engB PE=1 SV=1,,,,,,
OG_01489,FUN_006165-T1,Peve_00023607,Pocillopora_meandrina_HIv1___RNAseq.g20426.t1,three_way,60.60533333333333,FUN_006165-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),33.7,5014.0,0.0,2299.2,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_01490,FUN_006166-T1,Peve_00021031,Pocillopora_meandrina_HIv1___RNAseq.g20430.t1,three_way,77.292,FUN_006166-T1,Q9VQ37,RIM2_DROME,,Mitochondrial carrier protein Rim2,Drosophila melanogaster (Fruit fly),46.1,345.0,5.000000000000001e-78,292.7,sp|Q9VQ37|RIM2_DROME Mitochondrial carrier protein Rim2 OS=Drosophila melanogaster OX=7227 GN=Rim2 PE=2 SV=2,GO:0000002; GO:0005739; GO:0005743; GO:0006390; GO:0007005; GO:0015218; GO:0030302; GO:0040011; GO:0045333; GO:0048311; GO:1990519,cellular respiration [GO:0045333]; deoxynucleotide transport [GO:0030302]; locomotion [GO:0040011]; mitochondrial genome maintenance [GO:0000002]; mitochondrial transcription [GO:0006390]; mitochondrion distribution [GO:0048311]; mitochondrion organization [GO:0007005]; pyrimidine nucleotide import into mitochondrion [GO:1990519],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],pyrimidine nucleotide transmembrane transporter activity [GO:0015218],GO:0005215; GO:0005739; GO:0006091; GO:0006351; GO:0007005; GO:0043226; GO:0055085,transporter activity; mitochondrion; generation of precursor metabolites and energy; DNA-templated transcription; mitochondrion organization; organelle; transmembrane transport
OG_01491,FUN_006167-T2,Peve_00021030,Pocillopora_meandrina_HIv1___RNAseq.g20429.t1,three_way,75.59433333333334,FUN_006167-T2,Q06S87,,,,,54.3,116.0,2.3e-27,125.6,sp|Q06S87|HIUH_DANRE 5-hydroxyisourate hydrolase OS=Danio rerio OX=7955 GN=urah PE=1 SV=1,,,,,,
OG_01492,FUN_006168-T1,Peve_00021029,Pocillopora_meandrina_HIv1___RNAseq.g20428.t1,three_way,70.18666666666667,FUN_006168-T1,Q07G10,,,,,42.8,661.0,8.4e-152,538.9,sp|Q07G10|ALKB8_XENTR tRNA (carboxymethyluridine(34)-5-O)-methyltransferase alkbh8 OS=Xenopus tropicalis OX=8364 GN=alkbh8 PE=2 SV=2,,,,,,
OG_01493,FUN_006169-T1,Peve_00021028,Pocillopora_meandrina_HIv1___RNAseq.g20427.t1,three_way,83.96716666666667,FUN_006169-T1,Q80UV9,TAF1_MOUSE,,Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250),Mus musculus (Mouse),45.8,1844.0,0.0,1349.7,sp|Q80UV9|TAF1_MOUSE Transcription initiation factor TFIID subunit 1 OS=Mus musculus OX=10090 GN=Taf1 PE=1 SV=2,GO:0003677; GO:0004402; GO:0004674; GO:0005524; GO:0005634; GO:0005669; GO:0016251; GO:0017025; GO:0042789; GO:0045120; GO:0051123; GO:0060261; GO:0071339; GO:0106310; GO:1990841,mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123],MLL1 complex [GO:0071339]; nucleus [GO:0005634]; pronucleus [GO:0045120]; transcription factor TFIID complex [GO:0005669],ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; promoter-specific chromatin binding [GO:1990841]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025],GO:0003677; GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0043226; GO:0065003; GO:0140096; GO:0140223,"DNA binding; catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; general transcription initiation factor activity"
OG_01494,FUN_006172-T1,Peve_00028675,Pocillopora_meandrina_HIv1___RNAseq.g20432.t1,three_way,61.756,FUN_006172-T1,Q9QXG2,,,,,42.3,684.0,1.2000000000000002e-124,448.7,sp|Q9QXG2|RAE1_MOUSE Rab proteins geranylgeranyltransferase component A 1 OS=Mus musculus OX=10090 GN=Chm PE=1 SV=1,,,,,,
OG_01495,FUN_006218-T1,Peve_00020212,Pocillopora_meandrina_HIv1___RNAseq.g20436.t1,three_way,60.865,,,,,,,,,,,,,,,,,
OG_01496,FUN_006220-T1,Peve_00020217,Pocillopora_meandrina_HIv1___RNAseq.g20437.t1,three_way,69.87716666666667,FUN_006220-T1,P83094,STIM_DROME,,Stromal interaction molecule homolog,Drosophila melanogaster (Fruit fly),37.4,390.0,8.200000000000001e-59,229.9,sp|P83094|STIM_DROME Stromal interaction molecule homolog OS=Drosophila melanogaster OX=7227 GN=Stim PE=1 SV=1,GO:0002115; GO:0005246; GO:0005509; GO:0005513; GO:0005783; GO:0005789; GO:0005886; GO:0006874; GO:0007476; GO:0012505; GO:0015279; GO:0016020; GO:0022416; GO:0048763; GO:0051924; GO:0140268,chaeta development [GO:0022416]; detection of calcium ion [GO:0005513]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular calcium ion homeostasis [GO:0006874]; regulation of calcium ion transport [GO:0051924]; store-operated calcium entry [GO:0002115],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; store-operated calcium channel activity [GO:0015279],GO:0005215; GO:0005783; GO:0005886; GO:0043226; GO:0048856; GO:0098772,transporter activity; endoplasmic reticulum; plasma membrane; organelle; anatomical structure development; molecular function regulator activity
OG_01497,FUN_006221-T1,Peve_00020216,Pocillopora_meandrina_HIv1___RNAseq.g20438.t1,three_way,86.56566666666667,FUN_006221-T1,O00244,ATOX1_HUMAN,,Copper transport protein ATOX1 (Metal transport protein ATX1),Homo sapiens (Human),57.8,64.0,2.1e-13,75.9,sp|O00244|ATOX1_HUMAN Copper transport protein ATOX1 OS=Homo sapiens OX=9606 GN=ATOX1 PE=1 SV=1,GO:0005507; GO:0005829; GO:0006825; GO:0006878; GO:0006979; GO:0016530; GO:0016531; GO:0032767; GO:0043066; GO:0051117; GO:0060003; GO:1903136,copper ion export [GO:0060003]; copper ion transport [GO:0006825]; intracellular copper ion homeostasis [GO:0006878]; negative regulation of apoptotic process [GO:0043066]; response to oxidative stress [GO:0006979],cytosol [GO:0005829],ATPase binding [GO:0051117]; copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; metallochaperone activity [GO:0016530],GO:0005829; GO:0055085; GO:0140104,cytosol; transmembrane transport; molecular carrier activity
OG_01498,FUN_006222-T1,Peve_00020211,Pocillopora_meandrina_HIv1___RNAseq.g20439.t1,three_way,85.01766666666667,FUN_006222-T1,P56560,,,,,53.5,505.0,2.2e-152,540.4,sp|P56560|AOFB_BOVIN Amine oxidase [flavin-containing] B OS=Bos taurus OX=9913 GN=MAOB PE=1 SV=4,,,,,,
OG_01499,FUN_006223-T1,Peve_00011448,Pocillopora_meandrina_HIv1___RNAseq.g20440.t1,three_way,75.15666666666667,FUN_006223-T1,A5A6P2,ASAH1_PANTR,,Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylethanolamine hydrolase ASAH1) (EC 3.5.1.-) (N-acylsphingosine amidohydrolase) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta],Pan troglodytes (Chimpanzee),52.0,367.0,7.8e-118,425.2,sp|A5A6P2|ASAH1_PANTR Acid ceramidase OS=Pan troglodytes OX=9598 GN=ASAH1 PE=2 SV=1,GO:0005615; GO:0005764; GO:0006631; GO:0016020; GO:0017040; GO:0017064; GO:0030216; GO:0046512; GO:0046513; GO:0046514; GO:0050810; GO:0062098; GO:0071356,cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; ceramide catabolic process [GO:0046514]; fatty acid metabolic process [GO:0006631]; keratinocyte differentiation [GO:0030216]; regulation of programmed necrotic cell death [GO:0062098]; regulation of steroid biosynthetic process [GO:0050810]; sphingosine biosynthetic process [GO:0046512],extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020],fatty acid amide hydrolase activity [GO:0017064]; N-acylsphingosine amidohydrolase activity [GO:0017040],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0006629; GO:0016787; GO:0030154; GO:0043226,catalytic activity; extracellular space; lysosome; vacuole; lipid metabolic process; hydrolase activity; cell differentiation; organelle
OG_01500,FUN_006226-T1,Peve_00002944,Pocillopora_meandrina_HIv1___RNAseq.g20394.t1,three_way,49.45166666666667,,,,,,,,,,,,,,,,,
OG_01501,FUN_006227-T1,Peve_00002943,Pocillopora_meandrina_HIv1___TS.g29772.t1,three_way,66.25183333333334,FUN_006227-T1,P49793,,,,,37.4,1753.0,1.3e-226,788.9,sp|P49793|NUP98_RAT Nuclear pore complex protein Nup98-Nup96 OS=Rattus norvegicus OX=10116 GN=Nup98 PE=1 SV=2,,,,,,
OG_01502,FUN_006229-T1,Peve_00025164,Pocillopora_meandrina_HIv1___RNAseq.g20450.t1,three_way,71.557,,,,,,,,,,,,,,,,,
OG_01503,FUN_006230-T1,Peve_00002942,Pocillopora_meandrina_HIv1___RNAseq.g20449.t1,three_way,69.12416666666667,FUN_006230-T1,Q5SZK8,FREM2_HUMAN,,FRAS1-related extracellular matrix protein 2 (ECM3 homolog),Homo sapiens (Human),41.5,1242.0,4.8e-265,916.0,sp|Q5SZK8|FREM2_HUMAN FRAS1-related extracellular matrix protein 2 OS=Homo sapiens OX=9606 GN=FREM2 PE=1 SV=3,GO:0001654; GO:0001822; GO:0002009; GO:0005604; GO:0005886; GO:0007154; GO:0007155; GO:0007507; GO:0009653; GO:0042733; GO:0046872; GO:0048839; GO:0062023; GO:0070062,anatomical structure morphogenesis [GO:0009653]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; embryonic digit morphogenesis [GO:0042733]; eye development [GO:0001654]; heart development [GO:0007507]; inner ear development [GO:0048839]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],metal ion binding [GO:0046872],GO:0005886; GO:0007155; GO:0030312; GO:0031012; GO:0043226; GO:0048856,plasma membrane; cell adhesion; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_01504,FUN_006236-T1,Peve_00011453,Pocillopora_meandrina_HIv1___RNAseq.g20448.t1,three_way,65.54733333333333,,,,,,,,,,,,,,,,,
OG_01505,FUN_006237-T1,Peve_00030695,Pocillopora_meandrina_HIv1___RNAseq.g20447.t1,three_way,90.30166666666666,FUN_006237-T1,Q9GP16,,,,,72.4,123.0,3.5e-48,192.2,sp|Q9GP16|RL31_HELVI Large ribosomal subunit protein eL31 OS=Heliothis virescens OX=7102 GN=RpL31 PE=2 SV=1,,,,,,
OG_01506,FUN_006238-T1,Peve_00011450,Pocillopora_meandrina_HIv1___RNAseq.g20446.t1,three_way,77.295,FUN_006238-T1,P52875,,,,,63.8,229.0,1.2e-68,261.5,sp|P52875|TM165_MOUSE Putative divalent cation/proton antiporter TMEM165 OS=Mus musculus OX=10090 GN=Tmem165 PE=1 SV=2,,,,,,
OG_01507,FUN_006242-T1,Peve_00011455,Pocillopora_meandrina_HIv1___RNAseq.g20444.t1,three_way,65.56483333333334,FUN_006242-T1,Q6GQJ2,JADE1_XENLA,,Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17),Xenopus laevis (African clawed frog),44.8,511.0,5.6e-120,433.7,sp|Q6GQJ2|JADE1_XENLA Protein Jade-1 OS=Xenopus laevis OX=8355 GN=jade1 PE=2 SV=1,GO:0000123; GO:0005634; GO:0005737; GO:0005856; GO:0006357; GO:0006915; GO:0008270; GO:0042995,apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0005856; GO:0006355; GO:0012501; GO:0043226,nucleus; cytoskeleton; regulation of DNA-templated transcription; programmed cell death; organelle
OG_01508,FUN_006243-T1,Peve_00011454,Pocillopora_meandrina_HIv1___RNAseq.g20442.t1,three_way,64.56066666666666,FUN_006243-T1,Q805E5,,,,,43.8,306.0,4.1e-67,256.5,sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1,,,,,,
OG_01509,FUN_006244-T1,Peve_00002945,Pocillopora_meandrina_HIv1___RNAseq.g20390.t1a,three_way,45.627,,,,,,,,,,,,,,,,,
OG_01510,FUN_006245-T1,Peve_00002946,Pocillopora_meandrina_HIv1___RNAseq.g20390.t1b,three_way,45.26566666666667,,,,,,,,,,,,,,,,,
OG_01511,FUN_006248-T1,Peve_00033332,Pocillopora_meandrina_HIv1___RNAseq.g20387.t1,three_way,74.98666666666666,FUN_006248-T1,O95831,AIFM1_HUMAN,,"Apoptosis-inducing factor 1, mitochondrial (EC 1.6.99.-) (Programmed cell death protein 8)",Homo sapiens (Human),55.4,509.0,4.2e-169,596.3,"sp|O95831|AIFM1_HUMAN Apoptosis-inducing factor 1, mitochondrial OS=Homo sapiens OX=9606 GN=AIFM1 PE=1 SV=1",GO:0002931; GO:0003677; GO:0003954; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005758; GO:0005829; GO:0006915; GO:0009636; GO:0016174; GO:0016651; GO:0030182; GO:0033108; GO:0043065; GO:0043525; GO:0045041; GO:0046983; GO:0048471; GO:0060545; GO:0070059; GO:0070301; GO:0071392; GO:0071456; GO:0071732; GO:0071949; GO:0072572; GO:0160203; GO:1902065; GO:1904045,apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to nitric oxide [GO:0071732]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial disulfide relay system [GO:0160203]; mitochondrial respiratory chain complex assembly [GO:0033108]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of necroptotic process [GO:0060545]; positive regulation of neuron apoptotic process [GO:0043525]; protein import into mitochondrial intermembrane space [GO:0045041]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065]; response to toxic substance [GO:0009636],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],"DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADH dehydrogenase activity [GO:0003954]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; poly-ADP-D-ribose binding [GO:0072572]; protein dimerization activity [GO:0046983]",GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0012501; GO:0016491; GO:0030154; GO:0043226; GO:0055085; GO:0065003,DNA binding; catalytic activity; nucleus; mitochondrion; cytosol; protein folding; programmed cell death; oxidoreductase activity; cell differentiation; organelle; transmembrane transport; protein-containing complex assembly
OG_01512,FUN_006249-T1,Peve_00012681,Pocillopora_meandrina_HIv1___TS.g29765.t1,three_way,86.62883333333333,FUN_006249-T1,Q0IHY5,,,,,48.2,170.0,3.8e-40,167.2,sp|Q0IHY5|EMC7_XENTR Endoplasmic reticulum membrane protein complex subunit 7 OS=Xenopus tropicalis OX=8364 GN=emc7 PE=2 SV=1,,,,,,
OG_01513,FUN_006252-T1,Peve_00012680,Pocillopora_meandrina_HIv1___RNAseq.g20383.t1,three_way,74.47933333333333,,,,,,,,,,,,,,,,,
OG_01514,FUN_006253-T1,Peve_00012679,Pocillopora_meandrina_HIv1___RNAseq.g20382.t1,three_way,89.648,FUN_006253-T1,P37235,HPCL1_HUMAN,,Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3),Homo sapiens (Human),51.6,188.0,6.6e-52,205.3,sp|P37235|HPCL1_HUMAN Hippocalcin-like protein 1 OS=Homo sapiens OX=9606 GN=HPCAL1 PE=1 SV=3,GO:0005509; GO:0009966; GO:0016020,regulation of signal transduction [GO:0009966],membrane [GO:0016020],calcium ion binding [GO:0005509],,
OG_01515,FUN_006255-T1,Peve_00012684,Pocillopora_meandrina_HIv1___TS.g29759.t1b,three_way,59.60883333333333,,,,,,,,,,,,,,,,,
OG_01516,FUN_006259-T1,Peve_00031978,Pocillopora_meandrina_HIv1___TS.g29759.t1a,three_way,91.737,FUN_006259-T1,Q8R323,,,,,75.8,351.0,2.9e-159,562.8,sp|Q8R323|RFC3_MOUSE Replication factor C subunit 3 OS=Mus musculus OX=10090 GN=Rfc3 PE=1 SV=1,,,,,,
OG_01517,FUN_006260-T1,Peve_00031151,Pocillopora_meandrina_HIv1___RNAseq.g20377.t1,three_way,71.08483333333334,FUN_006260-T1,C3ZQF9,,,,,36.6,303.0,1.8e-37,158.3,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_01518,FUN_006261-T1,Peve_00015046,Pocillopora_meandrina_HIv1___RNAseq.g20376.t1,three_way,47.83533333333333,,,,,,,,,,,,,,,,,
OG_01519,FUN_006265-T1,Peve_00019723,Pocillopora_meandrina_HIv1___RNAseq.g20373.t1a,three_way,47.14333333333334,,,,,,,,,,,,,,,,,
OG_01520,FUN_006266-T1,Peve_00019724,Pocillopora_meandrina_HIv1___RNAseq.g20372.t1,three_way,75.93266666666666,,,,,,,,,,,,,,,,,
OG_01521,FUN_006275-T1,Peve_00019725,Pocillopora_meandrina_HIv1___RNAseq.g20370.t1,three_way,75.4355,FUN_006275-T1,Q8R3S6,,,,,43.7,924.0,1.3e-200,701.4,sp|Q8R3S6|EXOC1_MOUSE Exocyst complex component 1 OS=Mus musculus OX=10090 GN=Exoc1 PE=1 SV=4,,,,,,
OG_01522,FUN_006276-T1,Peve_00031100,Pocillopora_meandrina_HIv1___RNAseq.g20369.t1,three_way,84.9125,FUN_006276-T1,Q8K5C0,GRHL2_MOUSE,,Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3),Mus musculus (Mouse),32.7,620.0,2.6999999999999998e-70,268.1,sp|Q8K5C0|GRHL2_MOUSE Grainyhead-like protein 2 homolog OS=Mus musculus OX=10090 GN=Grhl2 PE=2 SV=1,GO:0001161; GO:0001228; GO:0001701; GO:0001843; GO:0003208; GO:0003382; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005911; GO:0006355; GO:0006357; GO:0007155; GO:0007420; GO:0008544; GO:0010468; GO:0016020; GO:0021915; GO:0030216; GO:0030323; GO:0031490; GO:0034329; GO:0035264; GO:0042733; GO:0042802; GO:0043010; GO:0043565; GO:0045893; GO:0045944; GO:0048568; GO:0048701; GO:0060324; GO:0060463; GO:0060487; GO:0060672; GO:0061713; GO:0070830; GO:0090132; GO:0140297,anterior neural tube closure [GO:0061713]; bicellular tight junction assembly [GO:0070830]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; cardiac ventricle morphogenesis [GO:0003208]; cell adhesion [GO:0007155]; cell junction assembly [GO:0034329]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic organ development [GO:0048568]; epidermis development [GO:0008544]; epithelial cell morphogenesis [GO:0003382]; epithelial cell morphogenesis involved in placental branching [GO:0060672]; epithelium migration [GO:0090132]; face development [GO:0060324]; in utero embryonic development [GO:0001701]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; lung lobe morphogenesis [GO:0060463]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory tube development [GO:0030323],cell-cell junction [GO:0005911]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007155; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell adhesion; cell differentiation; cell junction organization; organelle; anatomical structure development; transcription regulator activity
OG_01523,FUN_006278-T1,Peve_00018295,Pocillopora_meandrina_HIv1___RNAseq.g20361.t1,three_way,65.20033333333333,FUN_006278-T1,A1Z7G7,LPHN_DROME,,Latrophilin Cirl,Drosophila melanogaster (Fruit fly),22.5,329.0,7e-12,74.7,sp|A1Z7G7|LPHN_DROME Latrophilin Cirl OS=Drosophila melanogaster OX=7227 GN=Cirl PE=1 SV=2,GO:0004888; GO:0004930; GO:0005886; GO:0007166; GO:0008344; GO:0019230; GO:0030246; GO:0140897,adult locomotory behavior [GO:0008344]; cell surface receptor signaling pathway [GO:0007166]; proprioception [GO:0019230],plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; mechanoreceptor activity [GO:0140897]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_01524,FUN_006320-T1,Peve_00021264,Pocillopora_meandrina_HIv1___RNAseq.g20359.t1,three_way,67.9575,FUN_006320-T1,Q8BV79,,,,,30.9,2660.0,1.4999999999999998e-286,988.8,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_01525,FUN_006321-T1,Peve_00021265,Pocillopora_meandrina_HIv1___RNAseq.g20358.t1,three_way,74.99366666666667,FUN_006321-T1,Q3KNI6,DAAF6_MOUSE,,Dynein axonemal assembly factor 6 (PIH1 domain-containing protein 3),Mus musculus (Mouse),34.6,185.0,4.4e-21,102.8,sp|Q3KNI6|DAAF6_MOUSE Dynein axonemal assembly factor 6 OS=Mus musculus OX=10090 GN=Dnaaf6 PE=1 SV=1,GO:0003341; GO:0005737; GO:0005802; GO:0030317; GO:0036158; GO:0036159; GO:0045505; GO:0051087; GO:0070286,axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158],cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802],dynein intermediate chain binding [GO:0045505]; protein-folding chaperone binding [GO:0051087],GO:0007018; GO:0022414; GO:0048870; GO:0065003,microtubule-based movement; reproductive process; cell motility; protein-containing complex assembly
OG_01526,FUN_006322-T1,Peve_00012582,Pocillopora_meandrina_HIv1___RNAseq.g20357.t1,three_way,67.18433333333333,,,,,,,,,,,,,,,,,
OG_01527,FUN_006323-T1,Peve_00012583,Pocillopora_meandrina_HIv1___RNAseq.g20356.t1,three_way,61.63033333333333,,,,,,,,,,,,,,,,,
OG_01528,FUN_006324-T1,Peve_00012577,Pocillopora_meandrina_HIv1___RNAseq.g20355.t1,three_way,36.373,,,,,,,,,,,,,,,,,
OG_01529,FUN_006328-T1,Peve_00012587,Pocillopora_meandrina_HIv1___RNAseq.g20352.t1,three_way,90.09566666666666,FUN_006328-T1,O43772,MCAT_HUMAN,,Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (CACT) (Solute carrier family 25 member 20),Homo sapiens (Human),61.7,298.0,5.4e-109,395.6,sp|O43772|MCAT_HUMAN Mitochondrial carnitine/acylcarnitine carrier protein OS=Homo sapiens OX=9606 GN=SLC25A20 PE=1 SV=1,GO:0001701; GO:0005476; GO:0005739; GO:0005740; GO:0005743; GO:0005829; GO:0006839; GO:0006853; GO:0015227; GO:1902603,carnitine shuttle [GO:0006853]; carnitine transmembrane transport [GO:1902603]; in utero embryonic development [GO:0001701]; mitochondrial transport [GO:0006839],cytosol [GO:0005829]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],carnitine:O-acyl-L-carnitine antiporter activity [GO:0005476]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227],GO:0005215; GO:0005739; GO:0005829; GO:0043226; GO:0048856; GO:0055085,transporter activity; mitochondrion; cytosol; organelle; anatomical structure development; transmembrane transport
OG_01530,FUN_006329-T1,Peve_00012586,Pocillopora_meandrina_HIv1___RNAseq.g20351.t1,three_way,88.88233333333334,FUN_006329-T1,P09623,DLDH_PIG,,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase)",Sus scrofa (Pig),75.5,470.0,1.1e-207,724.2,"sp|P09623|DLDH_PIG Dihydrolipoyl dehydrogenase, mitochondrial OS=Sus scrofa OX=9823 GN=DLD PE=1 SV=1",GO:0001669; GO:0004148; GO:0005634; GO:0005739; GO:0005759; GO:0006090; GO:0006103; GO:0031514; GO:0045252; GO:0050660,2-oxoglutarate metabolic process [GO:0006103]; pyruvate metabolic process [GO:0006090],acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252],dihydrolipoyl dehydrogenase (NADH) activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660],GO:0003824; GO:0005634; GO:0005739; GO:0005929; GO:0016491; GO:0031410; GO:0043226,catalytic activity; nucleus; mitochondrion; cilium; oxidoreductase activity; cytoplasmic vesicle; organelle
OG_01531,FUN_006330-T1,Peve_00012584,Pocillopora_meandrina_HIv1___TS.g29728.t1,three_way,74.3075,FUN_006330-T1,Q8IZ81,,,,,46.7,289.0,6.6e-67,255.8,sp|Q8IZ81|ELMD2_HUMAN ELMO domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ELMOD2 PE=1 SV=1,,,,,,
OG_01532,FUN_006331-T1,Peve_00012580,Pocillopora_meandrina_HIv1___RNAseq.g20347.t1,three_way,69.86616666666667,FUN_006331-T1,Q92545,TM131_HUMAN,,Transmembrane protein 131 (Protein RW1),Homo sapiens (Human),41.2,1098.0,1.3000000000000002e-218,762.3,sp|Q92545|TM131_HUMAN Transmembrane protein 131 OS=Homo sapiens OX=9606 GN=TMEM131 PE=1 SV=3,GO:0005518; GO:0016020; GO:0032964,collagen biosynthetic process [GO:0032964],membrane [GO:0016020],collagen binding [GO:0005518],,
OG_01533,FUN_006336-T1,Peve_00026066,Pocillopora_meandrina_HIv1___TS.g29722.t1,three_way,94.48533333333332,FUN_006336-T1,Q3ZC01,CNOT7_BOVIN,,CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (CCR4-associated factor 1) (CAF-1),Bos taurus (Bovine),73.1,208.0,6.8000000000000015e-87,321.6,sp|Q3ZC01|CNOT7_BOVIN CCR4-NOT transcription complex subunit 7 OS=Bos taurus OX=9913 GN=CNOT7 PE=2 SV=1,GO:0000175; GO:0000288; GO:0000289; GO:0000290; GO:0000932; GO:0003714; GO:0004532; GO:0004535; GO:0006417; GO:0008284; GO:0008285; GO:0016607; GO:0030014; GO:0030015; GO:0031047; GO:0033962; GO:0034584; GO:0035279; GO:0045070; GO:0045944; GO:0046872; GO:0051607; GO:0060213; GO:0060339; GO:0140297; GO:0140991; GO:1900153,"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; P-body assembly [GO:0033962]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]",CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nuclear speck [GO:0016607]; P-body [GO:0000932],3'-5'-RNA exonuclease activity [GO:0000175]; DNA-binding transcription factor binding [GO:0140297]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA exonuclease activity [GO:0004532]; transcription corepressor activity [GO:0003714],GO:0003723; GO:0003824; GO:0006355; GO:0016071; GO:0016787; GO:0031047; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_01534,FUN_006339-T1,Peve_00026068,Pocillopora_meandrina_HIv1___RNAseq.g20341.t1,three_way,67.9555,FUN_006339-T1,Q8NHP6,MSPD2_HUMAN,,Motile sperm domain-containing protein 2,Homo sapiens (Human),34.7,473.0,2.8e-65,251.5,sp|Q8NHP6|MSPD2_HUMAN Motile sperm domain-containing protein 2 OS=Homo sapiens OX=9606 GN=MOSPD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0006935; GO:0012505; GO:0016020; GO:0033149; GO:0035579; GO:0044232; GO:0051260; GO:0090023; GO:0090026; GO:0140042; GO:0140284,chemotaxis [GO:0006935]; lipid droplet formation [GO:0140042]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023]; protein homooligomerization [GO:0051260],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; membrane [GO:0016020]; organelle membrane contact site [GO:0044232]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],FFAT motif binding [GO:0033149],GO:0005783; GO:0005886; GO:0043226; GO:0065003,endoplasmic reticulum; plasma membrane; organelle; protein-containing complex assembly
OG_01535,FUN_006366-T1,Peve_00007380,Pocillopora_meandrina_HIv1___TS.g29720.t1,three_way,65.41333333333334,,,,,,,,,,,,,,,,,
OG_01536,FUN_006367-T1,Peve_00007381,Pocillopora_meandrina_HIv1___TS.g29719.t1,three_way,89.19266666666667,FUN_006367-T1,Q6DKM1,,,,,59.0,261.0,2.3e-78,293.5,sp|Q6DKM1|UN50A_XENLA Protein unc-50 homolog A OS=Xenopus laevis OX=8355 GN=unc50-a PE=2 SV=1,,,,,,
OG_01537,FUN_006368-T3,Peve_00007383,Pocillopora_meandrina_HIv1___RNAseq.g20337.t1,three_way,62.754666666666665,,,,,,,,,,,,,,,,,
OG_01538,FUN_006369-T1,Peve_00007373,Pocillopora_meandrina_HIv1___TS.g29715.t2,three_way,76.103,FUN_006369-T1,Q9P055,,,,,42.9,294.0,3.8e-62,240.0,sp|Q9P055|JKAMP_HUMAN JNK1/MAPK8-associated membrane protein OS=Homo sapiens OX=9606 GN=JKAMP PE=1 SV=4,,,,,,
OG_01539,FUN_006374-T1,Peve_00021373,Pocillopora_meandrina_HIv1___RNAseq.g20329.t1,three_way,50.056333333333335,,,,,,,,,,,,,,,,,
OG_01540,FUN_006408-T1,Peve_00027298,Pocillopora_meandrina_HIv1___TS.g29704.t1,three_way,36.219166666666666,,,,,,,,,,,,,,,,,
OG_01541,FUN_006411-T1,Peve_00018195,Pocillopora_meandrina_HIv1___RNAseq.g20262.t1,three_way,76.773,FUN_006411-T1,Q9NTJ4,,,,,49.9,1007.0,1.9e-293,1010.0,sp|Q9NTJ4|MA2C1_HUMAN Alpha-mannosidase 2C1 OS=Homo sapiens OX=9606 GN=MAN2C1 PE=1 SV=1,,,,,,
OG_01542,FUN_006414-T1,Peve_00043556,Pocillopora_meandrina_HIv1___RNAseq.g20274.t1,three_way,74.46766666666667,FUN_006414-T1,Q0ZDF7,,,,,46.1,154.0,4.3e-28,126.3,sp|Q0ZDF7|URAD_AMICA 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase OS=Amia calva OX=7924 GN=urad PE=3 SV=1,,,,,,
OG_01543,FUN_006417-T1,Peve_00043554,Pocillopora_meandrina_HIv1___RNAseq.g20276.t1,three_way,82.23,FUN_006417-T1,Q3SZV5,,,,,57.5,127.0,3.1e-32,139.4,sp|Q3SZV5|POMP_BOVIN Proteasome maturation protein OS=Bos taurus OX=9913 GN=POMP PE=2 SV=1,,,,,,
OG_01544,FUN_006418-T1,Peve_00043553,Pocillopora_meandrina_HIv1___RNAseq.g20277.t1,three_way,85.8545,FUN_006418-T1,Q1KL12,,,,,61.2,80.0,1.7e-18,94.4,sp|Q1KL12|HXA3A_TAKRU Homeobox protein Hox-A3a OS=Takifugu rubripes OX=31033 GN=hoxa3a PE=3 SV=1,,,,,,
OG_01545,FUN_006419-T1,Peve_00043552,Pocillopora_meandrina_HIv1___RNAseq.g20279.t1,three_way,62.79966666666667,FUN_006419-T1,P14837,,,,,43.8,121.0,8.7e-15,82.0,sp|P14837|PDX1_XENLA Pancreas/duodenum homeobox protein 1 OS=Xenopus laevis OX=8355 GN=pdx1 PE=2 SV=2,,,,,,
OG_01546,FUN_006421-T1,Peve_00043551,Pocillopora_meandrina_HIv1___RNAseq.g20280.t2,three_way,73.73433333333334,FUN_006421-T1,A7RS11,,,,,57.5,207.0,3.2e-66,253.1,sp|A7RS11|HPF1_NEMVE Histone PARylation factor 1 OS=Nematostella vectensis OX=45351 GN=HPF1 PE=1 SV=1,,,,,,
OG_01547,FUN_006422-T1,Peve_00043549,Pocillopora_meandrina_HIv1___RNAseq.g20281.t1,three_way,93.65066666666668,FUN_006422-T1,Q9UKJ5,,,,,60.1,168.0,6.999999999999999e-55,214.9,sp|Q9UKJ5|CHIC2_HUMAN Cysteine-rich hydrophobic domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CHIC2 PE=1 SV=1,,,,,,
OG_01548,FUN_006423-T1,Peve_00043548,Pocillopora_meandrina_HIv1___RNAseq.g20282.t1,three_way,80.98466666666667,,,,,,,,,,,,,,,,,
OG_01549,FUN_006424-T1,Peve_00043547,Pocillopora_meandrina_HIv1___RNAseq.g20283.t1,three_way,78.26599999999999,FUN_006424-T1,Q6DMN8,,,,,45.0,202.0,4.2e-46,186.4,sp|Q6DMN8|SPAT4_PANTR Spermatogenesis-associated protein 4 OS=Pan troglodytes OX=9598 GN=SPATA4 PE=2 SV=1,,,,,,
OG_01550,FUN_006425-T1,Peve_00043546,Pocillopora_meandrina_HIv1___TS.g29666.t1,three_way,69.39816666666667,FUN_006425-T1,Q96P50,,,,,30.0,253.0,1.1e-26,124.4,"sp|Q96P50|ACAP3_HUMAN Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ACAP3 PE=1 SV=2",,,,,,
OG_01551,FUN_006427-T1,Peve_00043545,Pocillopora_meandrina_HIv1___RNAseq.g20285.t1,three_way,86.59366666666666,FUN_006427-T1,Q2TA46,,,,,66.7,108.0,2.7e-35,149.4,sp|Q2TA46|UBL3_BOVIN Ubiquitin-like protein 3 OS=Bos taurus OX=9913 GN=UBL3 PE=3 SV=1,,,,,,
OG_01552,FUN_006428-T1,Peve_00043558,Pocillopora_meandrina_HIv1___TS.g29668.t1c,three_way,83.68366666666667,FUN_006428-T1,Q8BHH2,,,,,60.8,204.0,6.3e-66,251.9,sp|Q8BHH2|RAB9B_MOUSE Ras-related protein Rab-9B OS=Mus musculus OX=10090 GN=Rab9b PE=1 SV=1,,,,,,
OG_01553,FUN_006432-T1,Peve_00024929,Pocillopora_meandrina_HIv1___RNAseq.g20289.t1,three_way,89.45733333333334,FUN_006432-T1,Q5ZL74,VAMP7_CHICK,,Vesicle-associated membrane protein 7 (Synaptobrevin-like protein 1),Gallus gallus (Chicken),68.0,222.0,1.7e-67,257.3,sp|Q5ZL74|VAMP7_CHICK Vesicle-associated membrane protein 7 OS=Gallus gallus OX=9031 GN=VAMP7 PE=2 SV=1,GO:0000149; GO:0005484; GO:0005765; GO:0005789; GO:0005794; GO:0006887; GO:0006888; GO:0006906; GO:0006911; GO:0008333; GO:0015031; GO:0016192; GO:0017156; GO:0030658; GO:0030670; GO:0031201; GO:0031902; GO:0043005; GO:0043308; GO:0043312; GO:0045202; GO:0045335,"calcium-ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; neutrophil degranulation [GO:0043312]; phagocytosis, engulfment [GO:0006911]; protein transport [GO:0015031]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192]",endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; SNARE complex [GO:0031201]; synapse [GO:0045202]; transport vesicle membrane [GO:0030658],SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],GO:0002376; GO:0005794; GO:0016192; GO:0031410; GO:0043226; GO:0060090; GO:0061024,immune system process; Golgi apparatus; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization
OG_01554,FUN_006434-T1,Peve_00024932,Pocillopora_meandrina_HIv1___RNAseq.g20291.t1,three_way,72.47,,,,,,,,,,,,,,,,,
OG_01555,FUN_006435-T1,Peve_00024931,Pocillopora_meandrina_HIv1___RNAseq.g20292.t1,three_way,81.35366666666667,FUN_006435-T1,Q9ULJ7,,,,,44.8,542.0,4.500000000000001e-130,467.6,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_01556,FUN_006436-T1,Peve_00024930,Pocillopora_meandrina_HIv1___RNAseq.g20293.t1,three_way,69.03933333333335,FUN_006436-T1,Q8BW70,,,,,34.7,1038.0,8.4e-156,552.7,sp|Q8BW70|UBP38_MOUSE Ubiquitin carboxyl-terminal hydrolase 38 OS=Mus musculus OX=10090 GN=Usp38 PE=1 SV=2,,,,,,
OG_01557,FUN_006438-T1,Peve_00038436,Pocillopora_meandrina_HIv1___RNAseq.g20295.t1,three_way,78.40966666666667,FUN_006438-T1,P29146,,,,,49.8,566.0,8.6e-155,548.9,sp|P29146|NECA_HYDVU PC3-like endoprotease variant A OS=Hydra vulgaris OX=6087 PE=2 SV=1,,,,,,
OG_01558,FUN_006439-T1,Peve_00038430,Pocillopora_meandrina_HIv1___RNAseq.g20296.t1,three_way,83.673,,,,,,,,,,,,,,,,,
OG_01559,FUN_006440-T1,Peve_00038429,Pocillopora_meandrina_HIv1___RNAseq.g20297.t1,three_way,60.88666666666666,FUN_006440-T1,Q9GZS1,RPA49_HUMAN,,DNA-directed RNA polymerase I subunit RPA49 (RNA polymerase I subunit A49) (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53),Homo sapiens (Human),30.1,405.0,2.9e-38,161.0,sp|Q9GZS1|RPA49_HUMAN DNA-directed RNA polymerase I subunit RPA49 OS=Homo sapiens OX=9606 GN=POLR1E PE=1 SV=3,GO:0001179; GO:0001188; GO:0001650; GO:0003677; GO:0005654; GO:0005730; GO:0005736; GO:0006361; GO:0006362; GO:0042790,nucleolar large rRNA transcription by RNA polymerase I [GO:0042790]; RNA polymerase I preinitiation complex assembly [GO:0001188]; transcription elongation by RNA polymerase I [GO:0006362]; transcription initiation at RNA polymerase I promoter [GO:0006361],fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736],DNA binding [GO:0003677]; RNA polymerase I general transcription initiation factor binding [GO:0001179],GO:0003677; GO:0005654; GO:0005730; GO:0006351; GO:0043226; GO:0065003,DNA binding; nucleoplasm; nucleolus; DNA-templated transcription; organelle; protein-containing complex assembly
OG_01560,FUN_006441-T1,Peve_00038428,Pocillopora_meandrina_HIv1___RNAseq.g20299.t1,three_way,62.89866666666667,,,,,,,,,,,,,,,,,
OG_01561,FUN_006442-T1,Peve_00038427,Pocillopora_meandrina_HIv1___RNAseq.g20301.t1,three_way,91.59233333333331,FUN_006442-T1,Q9DF58,ILK_CHICK,,Scaffold protein ILK (ILK-1) (ILK-2) (Inactive integrin-linked kinase) (p59ILK),Gallus gallus (Chicken),62.6,449.0,7.4e-112,405.6,sp|Q9DF58|ILK_CHICK Scaffold protein ILK OS=Gallus gallus OX=9031 GN=ILK PE=1 SV=1,GO:0000287; GO:0000785; GO:0000902; GO:0001658; GO:0003151; GO:0004672; GO:0005178; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005925; GO:0005938; GO:0007052; GO:0007165; GO:0007229; GO:0008284; GO:0010761; GO:0015629; GO:0019901; GO:0021675; GO:0022011; GO:0030017; GO:0030027; GO:0030030; GO:0030513; GO:0033209; GO:0034446; GO:0043123; GO:0043491; GO:0045197; GO:0045669; GO:0045893; GO:0061351; GO:0070836; GO:0072697; GO:0090263; GO:1900026; GO:2000178,branching involved in ureteric bud morphogenesis [GO:0001658]; caveola assembly [GO:0070836]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; fibroblast migration [GO:0010761]; integrin-mediated signaling pathway [GO:0007229]; mitotic spindle organization [GO:0007052]; myelination in peripheral nervous system [GO:0022011]; negative regulation of neural precursor cell proliferation [GO:2000178]; nerve development [GO:0021675]; neural precursor cell proliferation [GO:0061351]; outflow tract morphogenesis [GO:0003151]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to cell cortex [GO:0072697]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446]; tumor necrosis factor-mediated signaling pathway [GO:0033209],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcomere [GO:0030017],ATP binding [GO:0005524]; integrin binding [GO:0005178]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901],GO:0003824; GO:0005654; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0007163; GO:0016740; GO:0043226; GO:0048856; GO:0048870; GO:0061024; GO:0140096,"catalytic activity; nucleoplasm; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; transferase activity; organelle; anatomical structure development; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_01562,FUN_006443-T1,Peve_00038426,Pocillopora_meandrina_HIv1___RNAseq.g20302.t1,three_way,77.858,FUN_006443-T1,Q8IVH4,MMAA_HUMAN,,"Methylmalonic aciduria type A protein, mitochondrial (EC 3.6.-.-)",Homo sapiens (Human),62.8,336.0,5.9e-118,425.6,"sp|Q8IVH4|MMAA_HUMAN Methylmalonic aciduria type A protein, mitochondrial OS=Homo sapiens OX=9606 GN=MMAA PE=1 SV=1",GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009235; GO:0042802; GO:0042803; GO:0140104,cobalamin metabolic process [GO:0009235],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular carrier activity [GO:0140104]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0140104,catalytic activity; GTPase activity; mitochondrion; cytosol; hydrolase activity; organelle; molecular carrier activity
OG_01563,FUN_006445-T1,Peve_00038424,Pocillopora_meandrina_HIv1___RNAseq.g20304.t1,three_way,55.6855,,,,,,,,,,,,,,,,,
OG_01564,FUN_006446-T2,Peve_00038423,Pocillopora_meandrina_HIv1___RNAseq.g20305.t1,three_way,34.80533333333334,,,,,,,,,,,,,,,,,
OG_01565,FUN_006447-T1,Peve_00038421,Pocillopora_meandrina_HIv1___RNAseq.3855_t,three_way,43.964333333333336,,,,,,,,,,,,,,,,,
OG_01566,FUN_006448-T1,Peve_00038420,Pocillopora_meandrina_HIv1___RNAseq.g20307.t1a,three_way,70.55933333333333,,,,,,,,,,,,,,,,,
OG_01567,FUN_006449-T1,Peve_00038439,Pocillopora_meandrina_HIv1___RNAseq.g20307.t1b,three_way,72.05333333333333,FUN_006449-T1,Q6ZWJ1,STXB4_HUMAN,,Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip),Homo sapiens (Human),28.6,768.0,1.2e-64,250.0,sp|Q6ZWJ1|STXB4_HUMAN Syntaxin-binding protein 4 OS=Homo sapiens OX=9606 GN=STXBP4 PE=1 SV=2,GO:0006605; GO:0006974; GO:0008286; GO:0010827; GO:0010838; GO:0019905; GO:0031410; GO:0045335; GO:0050821; GO:0061178; GO:0070062; GO:0071346; GO:1902808,cellular response to type II interferon [GO:0071346]; DNA damage response [GO:0006974]; insulin receptor signaling pathway [GO:0008286]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of D-glucose transmembrane transport [GO:0010827]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178],cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; phagocytic vesicle [GO:0045335],syntaxin binding [GO:0019905],GO:0031410; GO:0043226,cytoplasmic vesicle; organelle
OG_01568,FUN_006563-T1,Peve_00021263,Pocillopora_meandrina_HIv1___RNAseq.g3959.t1,three_way,53.48216666666666,FUN_006563-T1,Q2EMV9,PAR14_MOUSE,,Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14),Mus musculus (Mouse),28.8,820.0,1.1e-90,337.4,sp|Q2EMV9|PAR14_MOUSE Protein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3,GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0045087; GO:0060336; GO:0140807; GO:1902216; GO:1990404,innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_01569,FUN_006567-T1,Peve_00020672,Pocillopora_meandrina_HIv1___RNAseq.g20308.t1,three_way,60.93666666666667,,,,,,,,,,,,,,,,,
OG_01570,FUN_006568-T1,Peve_00038422,Pocillopora_meandrina_HIv1___RNAseq.g20309.t1,three_way,78.6515,FUN_006568-T1,Q08DP6,,,,,49.5,588.0,1.7e-150,534.6,sp|Q08DP6|RHG10_BOVIN Rho GTPase-activating protein 10 OS=Bos taurus OX=9913 GN=ARHGAP10 PE=2 SV=1,,,,,,
OG_01571,FUN_006571-T1,Peve_00011459,Pocillopora_meandrina_HIv1___RNAseq.g20311.t2,three_way,68.144,FUN_006571-T1,Q61191,HCFC1_MOUSE,,Host cell factor 1 (HCF) (HCF-1) (C1 factor) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6],Mus musculus (Mouse),74.4,387.0,1.5e-185,651.7,sp|Q61191|HCFC1_MOUSE Host cell factor 1 OS=Mus musculus OX=10090 GN=Hcfc1 PE=1 SV=2,GO:0000122; GO:0000123; GO:0000978; GO:0001835; GO:0003682; GO:0003713; GO:0005634; GO:0005737; GO:0006325; GO:0010628; GO:0019046; GO:0031490; GO:0042802; GO:0043025; GO:0043254; GO:0044545; GO:0045893; GO:0045944; GO:0048188; GO:0050821; GO:0062023; GO:0071339; GO:0140297,blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of protein-containing complex assembly [GO:0043254]; release from viral latency [GO:0019046],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; NSL complex [GO:0044545]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188],chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_01572,FUN_006572-T1,Peve_00011458,Pocillopora_meandrina_HIv1___RNAseq.g20312.t1,three_way,75.527,FUN_006572-T1,A7RFT2,,,,,58.7,346.0,7.7e-117,421.8,sp|A7RFT2|CD123_NEMVE Cell division cycle protein 123 homolog OS=Nematostella vectensis OX=45351 GN=cdc123 PE=3 SV=1,,,,,,
OG_01573,FUN_006573-T1,Peve_00011457,Pocillopora_meandrina_HIv1___RNAseq.g20313.t1,three_way,82.19833333333334,FUN_006573-T1,P46850,RTCB_ECOLI,,RNA-splicing ligase RtcB (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase),Escherichia coli (strain K12),60.3,401.0,8.1e-135,481.9,sp|P46850|RTCB_ECOLI RNA-splicing ligase RtcB OS=Escherichia coli (strain K12) OX=83333 GN=rtcB PE=1 SV=3,GO:0003909; GO:0005525; GO:0006281; GO:0006396; GO:0006974; GO:0030145; GO:0042245; GO:0170057,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; RNA processing [GO:0006396]; RNA repair [GO:0042245],,DNA ligase activity [GO:0003909]; GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; RNA ligase (GTP) activity [GO:0170057],GO:0003824; GO:0006281; GO:0016874; GO:0140097; GO:0140098,"catalytic activity; DNA repair; ligase activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_01574,FUN_006578-T1,Peve_00018194,Pocillopora_meandrina_HIv1___RNAseq.g20266.t1,three_way,88.35233333333333,FUN_006578-T1,P49139,,,,,62.1,346.0,1.4e-126,454.1,sp|P49139|MAPK2_RABIT MAP kinase-activated protein kinase 2 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=MAPKAPK2 PE=1 SV=2,,,,,,
OG_01575,FUN_006580-T1,Peve_00015619,Pocillopora_meandrina_HIv1___RNAseq.g20273.t1,three_way,43.7885,FUN_006580-T1,Q04589,FGFR1_RAT,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Rattus norvegicus (Rat),33.2,675.0,2.7000000000000002e-89,332.8,sp|Q04589|FGFR1_RAT Fibroblast growth factor receptor 1 OS=Rattus norvegicus OX=10116 GN=Fgfr1 PE=1 SV=1,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0002931; GO:0004713; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007565; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010966; GO:0010976; GO:0017134; GO:0019827; GO:0021769; GO:0021827; GO:0021847; GO:0021954; GO:0022028; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0031667; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0043536; GO:0043583; GO:0044344; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050839; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0070640; GO:0071222; GO:0071344; GO:0071420; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:1990090; GO:2000491; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to histamine [GO:0071420]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nerve growth factor stimulus [GO:1990090]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; female pregnancy [GO:0007565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postnatal olfactory bulb interneuron migration [GO:0021827]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; regulation of stem cell proliferation [GO:0072091]; response to ischemia [GO:0002931]; response to nutrient levels [GO:0031667]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0022414; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; reproductive process; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_01576,FUN_006581-T1,Peve_00015613,Pocillopora_meandrina_HIv1___RNAseq.g20271.t1,three_way,58.029,FUN_006581-T1,P18460,,,,,34.3,769.0,1.3e-91,339.3,sp|P18460|FGFR3_CHICK Fibroblast growth factor receptor 3 OS=Gallus gallus OX=9031 GN=FGFR3 PE=2 SV=1,,,,,,
OG_01577,FUN_006584-T1,Peve_00015615,Pocillopora_meandrina_HIv1___TS.g29653.t1,three_way,61.70333333333333,,,,,,,,,,,,,,,,,
OG_01578,FUN_006602-T1,Peve_00044173,Pocillopora_meandrina_HIv1___RNAseq.g1176.t1,three_way,76.88266666666667,FUN_006602-T1,O60733,PLPL9_HUMAN,,85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9),Homo sapiens (Human),42.7,822.0,1.3000000000000002e-133,478.8,sp|O60733|PLPL9_HUMAN 85/88 kDa calcium-independent phospholipase A2 OS=Homo sapiens OX=9606 GN=PLA2G6 PE=1 SV=2,GO:0003847; GO:0004622; GO:0004623; GO:0005516; GO:0005615; GO:0005739; GO:0005829; GO:0005886; GO:0006935; GO:0015630; GO:0016607; GO:0016787; GO:0017171; GO:0019731; GO:0031143; GO:0034638; GO:0035774; GO:0035965; GO:0038096; GO:0042802; GO:0046338; GO:0046469; GO:0046473; GO:0047499; GO:0052816; GO:2000304,antibacterial humoral response [GO:0019731]; cardiolipin acyl-chain remodeling [GO:0035965]; chemotaxis [GO:0006935]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; platelet activating factor metabolic process [GO:0046469]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774],cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; serine hydrolase activity [GO:0017171],GO:0002376; GO:0003824; GO:0005615; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006629; GO:0016787; GO:0043226; GO:0098542,immune system process; catalytic activity; extracellular space; mitochondrion; cytosol; cytoskeleton; plasma membrane; lipid metabolic process; hydrolase activity; organelle; defense response to other organism
OG_01579,FUN_006613-T2,Peve_00023430,Pocillopora_meandrina_HIv1___RNAseq.g20254.t1,three_way,74.73116666666667,FUN_006613-T2,Q7T2C4,S26A5_DANRE,,Prestin (Solute carrier family 26 member 5),Danio rerio (Zebrafish) (Brachydanio rerio),34.5,730.0,3.7e-114,414.1,sp|Q7T2C4|S26A5_DANRE Prestin OS=Danio rerio OX=7955 GN=slc26a5 PE=2 SV=1,GO:0005737; GO:0005886; GO:0006821; GO:0008271; GO:0015075; GO:0015106; GO:0015108; GO:0015116; GO:0015499; GO:0016020; GO:0019531; GO:0019532; GO:0042391; GO:0160044; GO:0160046; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; oxalate transport [GO:0019532]; regulation of membrane potential [GO:0042391]; sulfate transmembrane transport [GO:1902358],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; formate transmembrane transporter activity [GO:0015499]; monoatomic ion transmembrane transporter activity [GO:0015075]; oxalate transmembrane transporter activity [GO:0019531]; oxalate:chloride antiporter activity [GO:0160046]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; sulfate:chloride antiporter activity [GO:0160044],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01580,FUN_006614-T1,Peve_00040860,Pocillopora_meandrina_HIv1___RNAseq.g20509.t1,three_way,66.381,FUN_006614-T1,Q5SSI6,,,,,41.4,493.0,2.2e-97,357.8,sp|Q5SSI6|UTP18_MOUSE U3 small nucleolar RNA-associated protein 18 homolog OS=Mus musculus OX=10090 GN=Utp18 PE=1 SV=1,,,,,,
OG_01581,FUN_006617-T1,Peve_00040861,Pocillopora_meandrina_HIv1___RNAseq.g20508.t1,three_way,60.46966666666667,,,,,,,,,,,,,,,,,
OG_01582,FUN_006618-T1,Peve_00040864,Pocillopora_meandrina_HIv1___RNAseq.g20177.t1,three_way,59.501333333333335,FUN_006618-T1,P17124,,,,,31.8,151.0,7.6e-06,52.4,sp|P17124|HRH2_CANLF Histamine H2 receptor OS=Canis lupus familiaris OX=9615 GN=HRH2 PE=1 SV=1,,,,,,
OG_01583,FUN_006619-T1,Peve_00040865,Pocillopora_meandrina_HIv1___RNAseq.g20179.t1,three_way,71.24033333333334,FUN_006619-T1,Q92598,HS105_HUMAN,,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein) (Heat shock protein family H member 1),Homo sapiens (Human),51.3,686.0,5.6e-181,636.0,sp|Q92598|HS105_HUMAN Heat shock protein 105 kDa OS=Homo sapiens OX=9606 GN=HSPH1 PE=1 SV=1,GO:0000774; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005874; GO:0006457; GO:0006986; GO:0032991; GO:0043014; GO:0045345; GO:0051085; GO:0051135; GO:0070062; GO:0071682; GO:0140662,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of NK T cell activation [GO:0051135]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],adenyl-nucleotide exchange factor activity [GO:0000774]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATP-dependent protein folding chaperone [GO:0140662],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006457; GO:0008092; GO:0043226; GO:0044183; GO:0098772; GO:0140657,extracellular region; nucleus; nucleoplasm; cytosol; protein folding; cytoskeletal protein binding; organelle; protein folding chaperone; molecular function regulator activity; ATP-dependent activity
OG_01584,FUN_006621-T1,Peve_00040867,Pocillopora_meandrina_HIv1___RNAseq.g20504.t1,three_way,51.0425,FUN_006621-T1,Q8WWI1,LMO7_HUMAN,,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),Homo sapiens (Human),43.5,131.0,4.7e-23,112.8,sp|Q8WWI1|LMO7_HUMAN LIM domain only protein 7 OS=Homo sapiens OX=9606 GN=LMO7 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005635; GO:0005737; GO:0005739; GO:0005829; GO:0005925; GO:0009986; GO:0016324; GO:0016567; GO:0023051; GO:0030155; GO:0045944; GO:0046872,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; regulation of cell adhesion [GO:0030155]; regulation of signaling [GO:0023051],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005635; GO:0005739; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nuclear envelope; mitochondrion; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01585,FUN_006622-T1,Peve_00040868,Pocillopora_meandrina_HIv1___RNAseq.g20175.t1,three_way,45.07566666666666,,,,,,,,,,,,,,,,,
OG_01586,FUN_006624-T1,Peve_00040869,Pocillopora_meandrina_HIv1___RNAseq.g20171.t1,three_way,48.2,,,,,,,,,,,,,,,,,
OG_01587,FUN_006625-T1,Peve_00040870,Pocillopora_meandrina_HIv1___RNAseq.g20170.t1,three_way,54.812666666666665,,,,,,,,,,,,,,,,,
OG_01588,FUN_006627-T1,Peve_00040871,Pocillopora_meandrina_HIv1___RNAseq.g20168.t1,three_way,32.273,,,,,,,,,,,,,,,,,
OG_01589,FUN_006629-T1,Peve_00040873,Pocillopora_meandrina_HIv1___RNAseq.g20167.t1,three_way,52.60733333333334,,,,,,,,,,,,,,,,,
OG_01590,FUN_006630-T1,Peve_00040874,Pocillopora_meandrina_HIv1___TS.g29548.t1b,three_way,50.953833333333336,,,,,,,,,,,,,,,,,
OG_01591,FUN_006631-T1,Peve_00040841,Pocillopora_meandrina_HIv1___TS.g29548.t1a,three_way,67.0835,,,,,,,,,,,,,,,,,
OG_01592,FUN_006632-T1,Peve_00040842,Pocillopora_meandrina_HIv1___RNAseq.g20164.t1,three_way,91.31466666666668,FUN_006632-T1,Q8IYE0,CC146_HUMAN,,Coiled-coil domain-containing protein 146,Homo sapiens (Human),47.2,932.0,2e-175,617.8,sp|Q8IYE0|CC146_HUMAN Coiled-coil domain-containing protein 146 OS=Homo sapiens OX=9606 GN=CCDC146 PE=1 SV=2,GO:0000902; GO:0005813; GO:0005814; GO:0005856; GO:0005930; GO:0006997; GO:0007286; GO:0007288; GO:0007338; GO:0008283; GO:0010467; GO:0030496; GO:0036064; GO:0036126; GO:0044877; GO:0120212; GO:0120316; GO:1905198,cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; gene expression [GO:0010467]; manchette assembly [GO:1905198]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286],axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; midbody [GO:0030496]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212],protein-containing complex binding [GO:0044877],GO:0005815; GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; cilium organization; anatomical structure development
OG_01593,FUN_006634-T1,Peve_00040843,Pocillopora_meandrina_HIv1___TS.g29546.t1b,three_way,57.3695,FUN_006634-T1,Q9NY47,,,,,30.1,951.0,1.1e-87,326.2,sp|Q9NY47|CA2D2_HUMAN Voltage-dependent calcium channel subunit alpha-2/delta-2 OS=Homo sapiens OX=9606 GN=CACNA2D2 PE=1 SV=2,,,,,,
OG_01594,FUN_006636-T1,Peve_00024051,Pocillopora_meandrina_HIv1___RNAseq.g20236.t1,three_way,88.66666666666667,FUN_006636-T1,Q12756,,,,,37.3,475.0,5e-70,267.3,sp|Q12756|KIF1A_HUMAN Kinesin-like protein KIF1A OS=Homo sapiens OX=9606 GN=KIF1A PE=1 SV=2,,,,,,
OG_01595,FUN_006637-T1,Peve_00024050,Pocillopora_meandrina_HIv1___RNAseq.g20237.t1,three_way,73.5665,FUN_006637-T1,Q9P2Q2,FRM4A_HUMAN,,FERM domain-containing protein 4A,Homo sapiens (Human),44.8,504.0,7.7000000000000005e-118,426.4,sp|Q9P2Q2|FRM4A_HUMAN FERM domain-containing protein 4A OS=Homo sapiens OX=9606 GN=FRMD4A PE=1 SV=3,GO:0005737; GO:0005856; GO:0005912; GO:0005923; GO:0030674; GO:0050709; GO:0050714; GO:0090162,establishment of epithelial cell polarity [GO:0090162]; negative regulation of protein secretion [GO:0050709]; positive regulation of protein secretion [GO:0050714],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],protein-macromolecule adaptor activity [GO:0030674],GO:0005856; GO:0007163; GO:0043226; GO:0060090,cytoskeleton; establishment or maintenance of cell polarity; organelle; molecular adaptor activity
OG_01596,FUN_006638-T1,Peve_00031797,Pocillopora_meandrina_HIv1___RNAseq.g20238.t1,three_way,98.24133333333332,FUN_006638-T1,Q2KHX4,,,,,89.9,476.0,2.4e-249,862.4,sp|Q2KHX4|S61A2_BOVIN Protein transport protein Sec61 subunit alpha isoform 2 OS=Bos taurus OX=9913 GN=SEC61A2 PE=2 SV=3,,,,,,
OG_01597,FUN_006639-T1,Peve_00033034,Pocillopora_meandrina_HIv1___RNAseq.g20239.t1,three_way,79.87783333333333,FUN_006639-T1,P53992,SC24C_HUMAN,,Protein transport protein Sec24C (SEC24-related protein C),Homo sapiens (Human),58.8,770.0,3.3e-276,953.0,sp|P53992|SC24C_HUMAN Protein transport protein Sec24C OS=Homo sapiens OX=9606 GN=SEC24C PE=1 SV=3,GO:0000149; GO:0001701; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0030127; GO:0070971; GO:0090110,COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; in utero embryonic development [GO:0001701]; intracellular protein transport [GO:0006886],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507],SNARE binding [GO:0000149]; zinc ion binding [GO:0008270],GO:0005829; GO:0006886; GO:0016192; GO:0048856,cytosol; intracellular protein transport; vesicle-mediated transport; anatomical structure development
OG_01598,FUN_006640-T1,Peve_00033036,Pocillopora_meandrina_HIv1___RNAseq.g20240.t1,three_way,66.11666666666667,FUN_006640-T1,Q56P28,,,,,33.7,175.0,2.7e-23,110.2,sp|Q56P28|PRAF3_PIG PRA1 family protein 3 OS=Sus scrofa OX=9823 GN=ARL6IP5 PE=2 SV=1,,,,,,
OG_01599,FUN_006642-T1,Peve_00040855,Pocillopora_meandrina_HIv1___TS.g29901.t1b,three_way,61.857,FUN_006642-T1,P60924,DELE1_RAT,,"DAP3-binding cell death enhancer 1 (DAP3-binding cell death enhancer 1, long form) (DELE1(L)) (Death ligand signal enhancer) [Cleaved into: DAP3-binding cell death enhancer 1 short form (DELE1(S)) (S-DELE1)]",Rattus norvegicus (Rat),35.4,113.0,3.8e-08,61.2,sp|P60924|DELE1_RAT DAP3-binding cell death enhancer 1 OS=Rattus norvegicus OX=10116 GN=Dele1 PE=2 SV=2,GO:0005739; GO:0005741; GO:0005743; GO:0005829; GO:0006974; GO:0008625; GO:0033554; GO:0043539; GO:0140467; GO:0140468; GO:1901526; GO:1990641,cellular response to stress [GO:0033554]; DNA damage response [GO:0006974]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; positive regulation of mitophagy [GO:1901526]; response to iron ion starvation [GO:1990641],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],protein serine/threonine kinase activator activity [GO:0043539],GO:0005739; GO:0005829; GO:0043226; GO:0098772,mitochondrion; cytosol; organelle; molecular function regulator activity
OG_01600,FUN_006643-T1,Peve_00004067,Pocillopora_meandrina_HIv1___RNAseq.g19945.t1,three_way,67.05933333333333,FUN_006643-T1,P53184,,,,,32.7,226.0,7.9e-21,102.8,sp|P53184|PNC1_YEAST Nicotinamidase OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PNC1 PE=1 SV=1,,,,,,
OG_01601,FUN_006644-T1,Peve_00029043,Pocillopora_meandrina_HIv1___RNAseq.g19946.t1,three_way,68.10000000000001,FUN_006644-T1,Q5QNP2,TA13C_DANRE,,Trace amine-associated receptor 13c,Danio rerio (Zebrafish) (Brachydanio rerio),27.8,277.0,2.4e-07,58.2,sp|Q5QNP2|TA13C_DANRE Trace amine-associated receptor 13c OS=Danio rerio OX=7955 GN=taar13c PE=1 SV=1,GO:0001594; GO:0004984; GO:0005886; GO:0007186; GO:0007606; GO:0008227; GO:0009995; GO:0016020; GO:0019808; GO:0019810; GO:0050911; GO:1990834,detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; G protein-coupled receptor signaling pathway [GO:0007186]; response to odorant [GO:1990834]; sensory perception of chemical stimulus [GO:0007606]; soluble molecule recognition [GO:0009995],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled amine receptor activity [GO:0008227]; olfactory receptor activity [GO:0004984]; polyamine binding [GO:0019808]; putrescine binding [GO:0019810]; trace-amine receptor activity [GO:0001594],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_01602,FUN_006645-T1,Peve_00029047,Pocillopora_meandrina_HIv1___RNAseq.g19947.t1,three_way,43.628166666666665,,,,,,,,,,,,,,,,,
OG_01603,FUN_006646-T1,Peve_00029030,Pocillopora_meandrina_HIv1___RNAseq.g19948.t1,three_way,55.7015,FUN_006646-T1,Q9BY77,PDIP3_HUMAN,,Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein) (p46) (S6K1 Aly/REF-like target) (SKAR),Homo sapiens (Human),50.7,69.0,2.3e-13,78.2,sp|Q9BY77|PDIP3_HUMAN Polymerase delta-interacting protein 3 OS=Homo sapiens OX=9606 GN=POLDIP3 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016607; GO:0016973; GO:0036464; GO:0044877; GO:0045727,poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006913; GO:0043226,RNA binding; nucleus; nucleoplasm; cytosol; nucleocytoplasmic transport; organelle
OG_01604,FUN_006647-T2,Peve_00029031,Pocillopora_meandrina_HIv1___RNAseq.g19949.t1,three_way,79.54766666666666,FUN_006647-T2,Q9Z142,,,,,48.1,206.0,6.9e-51,202.2,sp|Q9Z142|TMM33_RAT Transmembrane protein 33 OS=Rattus norvegicus OX=10116 GN=Tmem33 PE=2 SV=1,,,,,,
OG_01605,FUN_006649-T1,Peve_00029032,Pocillopora_meandrina_HIv1___RNAseq.g19952.t1,three_way,81.72066666666667,FUN_006649-T1,Q9W7L4,,,,,61.3,333.0,1.2e-117,424.5,sp|Q9W7L4|LDHB_SCEUN L-lactate dehydrogenase B chain OS=Sceloporus undulatus OX=8520 GN=LDHB PE=2 SV=3,,,,,,
OG_01606,FUN_006650-T1,Peve_00029034,Pocillopora_meandrina_HIv1___RNAseq.g19953.t1,three_way,78.253,FUN_006650-T1,Q9UI36,DACH1_HUMAN,,Dachshund homolog 1 (Dach1),Homo sapiens (Human),27.6,479.0,9.2e-19,96.7,sp|Q9UI36|DACH1_HUMAN Dachshund homolog 1 OS=Homo sapiens OX=9606 GN=DACH1 PE=1 SV=4,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001967; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0007585; GO:0010944; GO:0016607; GO:0030336; GO:0033262; GO:0044342; GO:0045892; GO:0046545; GO:0048147; GO:0060244; GO:2000279,development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription by RNA polymerase II [GO:0006357]; respiratory gaseous exchange by respiratory system [GO:0007585]; suckling behavior [GO:0001967]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0022414; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; reproductive process; organelle; transcription regulator activity
OG_01607,FUN_006651-T1,Peve_00029038,Pocillopora_meandrina_HIv1___RNAseq.g19954.t1,three_way,73.84383333333334,FUN_006651-T1,Q96M89,,,,,35.0,448.0,2.3e-63,245.0,sp|Q96M89|CC138_HUMAN Coiled-coil domain-containing protein 138 OS=Homo sapiens OX=9606 GN=CCDC138 PE=1 SV=1,,,,,,
OG_01608,FUN_006652-T1,Peve_00029039,Pocillopora_meandrina_HIv1___RNAseq.g19955.t1,three_way,64.58433333333333,FUN_006652-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),32.4,1666.0,2.3000000000000004e-224,781.6,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_01609,FUN_006654-T1,Peve_00029040,Pocillopora_meandrina_HIv1___TS.g29343.t1,three_way,81.31466666666667,FUN_006654-T1,Q8IZU2,,,,,51.7,1313.0,0.0,1184.1,sp|Q8IZU2|WDR17_HUMAN WD repeat-containing protein 17 OS=Homo sapiens OX=9606 GN=WDR17 PE=1 SV=2,,,,,,
OG_01610,FUN_006655-T1,Peve_00029041,Pocillopora_meandrina_HIv1___RNAseq.g19957.t1,three_way,66.52833333333334,,,,,,,,,,,,,,,,,
OG_01611,FUN_006656-T1,Peve_00029042,Pocillopora_meandrina_HIv1___RNAseq.3492_t,three_way,56.7115,FUN_006656-T1,Q9HC56,,,,,32.8,704.0,2.2e-87,325.5,sp|Q9HC56|PCDH9_HUMAN Protocadherin-9 OS=Homo sapiens OX=9606 GN=PCDH9 PE=1 SV=2,,,,,,
OG_01612,FUN_006692-T1,Peve_00029050,Pocillopora_meandrina_HIv1___RNAseq.g19966.t1,three_way,46.55916666666666,,,,,,,,,,,,,,,,,
OG_01613,FUN_006702-T1,Peve_00028381,Pocillopora_meandrina_HIv1___RNAseq.g19982.t1,three_way,56.388,,,,,,,,,,,,,,,,,
OG_01614,FUN_006704-T1,Peve_00022810,Pocillopora_meandrina_HIv1___TS.g29383.t1,three_way,78.106,FUN_006704-T1,O15439,MRP4_HUMAN,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4),Homo sapiens (Human),33.8,1096.0,4.1e-167,590.9,sp|O15439|MRP4_HUMAN ATP-binding cassette sub-family C member 4 OS=Homo sapiens OX=9606 GN=ABCC4 PE=1 SV=3,GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0043231; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003013; GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016192; GO:0016491; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,circulatory system process; catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; vesicle-mediated transport; oxidoreductase activity; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_01615,FUN_006706-T1,Peve_00022745,Pocillopora_meandrina_HIv1___RNAseq.g19996.t1,three_way,57.7245,FUN_006706-T1,Q8VE88,,,,,36.3,411.0,8e-51,203.4,sp|Q8VE88|F1142_MOUSE Protein FAM114A2 OS=Mus musculus OX=10090 GN=Fam114a2 PE=1 SV=2,,,,,,
OG_01616,FUN_006723-T1,Peve_00039552,Pocillopora_meandrina_HIv1___TS.g29394.t1,three_way,61.66466666666667,,,,,,,,,,,,,,,,,
OG_01617,FUN_006726-T1,Peve_00039553,Pocillopora_meandrina_HIv1___RNAseq.g20012.t1,three_way,75.165,FUN_006726-T1,O75976,,,,,54.5,404.0,2.9e-127,457.2,sp|O75976|CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2,,,,,,
OG_01618,FUN_006727-T1,Peve_00039555,Pocillopora_meandrina_HIv1___RNAseq.g20013.t1,three_way,71.43566666666666,FUN_006727-T1,Q3UTQ8,CDKL5_MOUSE,,Cyclin-dependent kinase-like 5 (EC 2.7.11.22),Mus musculus (Mouse),44.0,616.0,8.800000000000001e-125,449.5,sp|Q3UTQ8|CDKL5_MOUSE Cyclin-dependent kinase-like 5 OS=Mus musculus OX=10090 GN=Cdkl5 PE=1 SV=1,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0016301; GO:0034504; GO:0036064; GO:0097542; GO:0106310; GO:1902017,protein localization to nucleus [GO:0034504]; regulation of cilium assembly [GO:1902017],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01619,FUN_006728-T1,Peve_00039557,Pocillopora_meandrina_HIv1___RNAseq.g20014.t1,three_way,68.159,,,,,,,,,,,,,,,,,
OG_01620,FUN_006729-T1,Peve_00039560,Pocillopora_meandrina_HIv1___RNAseq.g20015.t1,three_way,68.16666666666667,FUN_006729-T1,O55240,RDH5_MOUSE,,Retinol dehydrogenase 5 (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (11-cis retinol dehydrogenase) (11-cis RDH) (11-cis RoDH) (9-cis retinol dehydrogenase) (Cis-retinol dehydrogenase),Mus musculus (Mouse),44.6,285.0,1.7999999999999996e-68,261.2,sp|O55240|RDH5_MOUSE Retinol dehydrogenase 5 OS=Mus musculus OX=10090 GN=Rdh5 PE=1 SV=1,GO:0001523; GO:0004745; GO:0005788; GO:0005789; GO:0007601; GO:0008202; GO:0042572; GO:0042803; GO:0044297; GO:0047023; GO:0047044; GO:0106429,retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; visual perception [GO:0007601],cell body [GO:0044297]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],"11-cis-retinol dehydrogenase [GO:0106429]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0006629; GO:0016491; GO:0050877,catalytic activity; lipid metabolic process; oxidoreductase activity; nervous system process
OG_01621,FUN_006730-T1,Peve_00039561,Pocillopora_meandrina_HIv1___TS.g29404.t2,three_way,70.635,FUN_006730-T1,Q9CQF6,,,,,50.4,254.0,2.0000000000000002e-72,273.9,sp|Q9CQF6|ADPPT_MOUSE L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase OS=Mus musculus OX=10090 GN=Aasdhppt PE=1 SV=1,,,,,,
OG_01622,FUN_006731-T1,Peve_00039563,Pocillopora_meandrina_HIv1___RNAseq.g20017.t1,three_way,82.17733333333334,FUN_006731-T1,Q7ZVK4,,,,,55.0,387.0,1.3e-112,407.9,sp|Q7ZVK4|VPS36_DANRE Vacuolar protein-sorting-associated protein 36 OS=Danio rerio OX=7955 GN=vps36 PE=2 SV=1,,,,,,
OG_01623,FUN_006732-T1,Peve_00039564,Pocillopora_meandrina_HIv1___RNAseq.g20521.t1,three_way,90.959,FUN_006732-T1,Q2KIE4,,,,,66.3,178.0,6.2e-65,248.4,sp|Q2KIE4|MCTS1_BOVIN Malignant T-cell-amplified sequence 1 OS=Bos taurus OX=9913 GN=MCTS1 PE=2 SV=1,,,,,,
OG_01624,FUN_006733-T1,Peve_00039566,Pocillopora_meandrina_HIv1___RNAseq.g20522.t1,three_way,76.06866666666667,FUN_006733-T1,Q8N5Y2,,,,,30.1,509.0,1.4e-43,178.7,sp|Q8N5Y2|MS3L1_HUMAN MSL complex subunit 3 OS=Homo sapiens OX=9606 GN=MSL3 PE=1 SV=1,,,,,,
OG_01625,FUN_006735-T1,Peve_00039568,Pocillopora_meandrina_HIv1___RNAseq.g20524.t1,three_way,56.051,FUN_006735-T1,P47747,,,,,26.1,307.0,6.6e-12,73.2,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_01626,FUN_006737-T1,Peve_00039571,Pocillopora_meandrina_HIv1___RNAseq.g20526.t1,three_way,59.85133333333333,,,,,,,,,,,,,,,,,
OG_01627,FUN_006738-T2,Peve_00039572,Pocillopora_meandrina_HIv1___TS.g29909.t1,three_way,82.94,FUN_006738-T2,Q2KI84,HARS1_BOVIN,,"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)",Bos taurus (Bovine),68.3,492.0,1.5000000000000002e-193,677.2,"sp|Q2KI84|HARS1_BOVIN Histidine--tRNA ligase, cytoplasmic OS=Bos taurus OX=9913 GN=HARS1 PE=2 SV=1",GO:0003723; GO:0004821; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0006427; GO:0032543; GO:0042802; GO:0042803,histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0005829; GO:0006399; GO:0006520; GO:0016874; GO:0043226; GO:0140098,"RNA binding; catalytic activity; mitochondrion; cytosol; tRNA metabolic process; amino acid metabolic process; ligase activity; organelle; catalytic activity, acting on RNA"
OG_01628,FUN_006742-T1,Peve_00039577,Pocillopora_meandrina_HIv1___RNAseq.g20528.t1,three_way,72.99733333333333,FUN_006742-T1,A6QLE6,ANO4_BOVIN,,Anoctamin-4 (Transmembrane protein 16D),Bos taurus (Bovine),30.5,846.0,3.9999999999999995e-91,337.8,sp|A6QLE6|ANO4_BOVIN Anoctamin-4 OS=Bos taurus OX=9913 GN=ANO4 PE=2 SV=1,GO:0005229; GO:0005886; GO:0006869; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; lipid transport [GO:0006869],plasma membrane [GO:0005886],intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_01629,FUN_006743-T1,Peve_00039580,Pocillopora_meandrina_HIv1___RNAseq.g20529.t1,three_way,83.342,FUN_006743-T1,Q9FIV6,,,,,51.0,414.0,2.1e-120,434.5,"sp|Q9FIV6|DGP10_ARATH Protease Do-like 10, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=DEGP10 PE=2 SV=1",,,,,,
OG_01630,FUN_006744-T1,Peve_00039581,Pocillopora_meandrina_HIv1___RNAseq.g20530.t1,three_way,63.90916666666666,FUN_006744-T1,Q8BNA6,FAT3_MOUSE,,Protocadherin Fat 3 (FAT tumor suppressor homolog 3),Mus musculus (Mouse),33.8,4122.0,0.0,2094.3,sp|Q8BNA6|FAT3_MOUSE Protocadherin Fat 3 OS=Mus musculus OX=10090 GN=Fat3 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0010842; GO:0016358; GO:0030425; GO:0048667; GO:1904936; GO:2000171,cell morphogenesis involved in neuron differentiation [GO:0048667]; dendrite development [GO:0016358]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; interneuron migration [GO:1904936]; negative regulation of dendrite development [GO:2000171]; retina layer formation [GO:0010842],dendrite [GO:0030425]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0048856; GO:0048870,plasma membrane; cell adhesion; anatomical structure development; cell motility
OG_01631,FUN_006748-T1,Peve_00029637,Pocillopora_meandrina_HIv1___TS.g29913.t1,three_way,74.56133333333334,FUN_006748-T1,P19804,NDKB_RAT,,Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (Histidine protein kinase NDKB) (EC 2.7.13.3) (P18),Rattus norvegicus (Rat),77.0,148.0,1.1e-61,238.0,sp|P19804|NDKB_RAT Nucleoside diphosphate kinase B OS=Rattus norvegicus OX=10116 GN=Nme2 PE=1 SV=1,GO:0001726; GO:0002762; GO:0003677; GO:0003713; GO:0004550; GO:0004673; GO:0004674; GO:0005504; GO:0005524; GO:0005634; GO:0005737; GO:0005882; GO:0006183; GO:0006228; GO:0006241; GO:0007189; GO:0007229; GO:0009142; GO:0010976; GO:0019003; GO:0019215; GO:0019899; GO:0030027; GO:0031966; GO:0034599; GO:0042802; GO:0042981; GO:0043066; GO:0045618; GO:0045682; GO:0045893; GO:0045944; GO:0046872; GO:0048471; GO:0050679; GO:0051880; GO:0060416; GO:0071333; GO:0071398; GO:0071944; GO:1901363,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228],cell periphery [GO:0071944]; cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726],ATP binding [GO:0005524]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; heterocyclic compound binding [GO:1901363]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0008289; GO:0016740; GO:0043226; GO:0055086; GO:0060090; GO:0140096; GO:0140110; GO:1901135,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; lipid binding; transferase activity; organelle; nucleobase-containing small molecule metabolic process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity; carbohydrate derivative metabolic process"
OG_01632,FUN_006750-T1,Peve_00029281,Pocillopora_meandrina_HIv1___RNAseq.g20533.t1,three_way,80.3975,FUN_006750-T1,Q9H3E2,,,,,37.7,871.0,3.8e-161,570.5,sp|Q9H3E2|SNX25_HUMAN Sorting nexin-25 OS=Homo sapiens OX=9606 GN=SNX25 PE=1 SV=2,,,,,,
OG_01633,FUN_006751-T1,Peve_00029280,Pocillopora_meandrina_HIv1___RNAseq.g20534.t1,three_way,72.00433333333334,FUN_006751-T1,Q9UJV9,,,,,36.0,486.0,7e-80,299.7,sp|Q9UJV9|DDX41_HUMAN Probable ATP-dependent RNA helicase DDX41 OS=Homo sapiens OX=9606 GN=DDX41 PE=1 SV=2,,,,,,
OG_01634,FUN_006767-T1,Peve_00042019,Pocillopora_meandrina_HIv1___RNAseq.g20040.t1,three_way,56.25966666666667,,,,,,,,,,,,,,,,,
OG_01635,FUN_006768-T1,Peve_00027410,Pocillopora_meandrina_HIv1___RNAseq.g20031.t1,three_way,80.81033333333333,FUN_006768-T1,Q07E02,,,,,54.7,128.0,9.8e-40,164.5,sp|Q07E02|CAV1_ORNAN Caveolin-1 OS=Ornithorhynchus anatinus OX=9258 GN=CAV1 PE=3 SV=1,,,,,,
OG_01636,FUN_006769-T1,Peve_00027411,Pocillopora_meandrina_HIv1___RNAseq.g20028.t1,three_way,57.7305,FUN_006769-T1,Q9Y2U8,MAN1_HUMAN,,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),Homo sapiens (Human),42.9,317.0,7.4e-55,216.9,sp|Q9Y2U8|MAN1_HUMAN Inner nuclear membrane protein Man1 OS=Homo sapiens OX=9606 GN=LEMD3 PE=1 SV=2,GO:0003677; GO:0005637; GO:0016020; GO:0030512; GO:0030514; GO:0031965; GO:0032926; GO:1990446,negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],DNA binding [GO:0003677]; U1 snRNP binding [GO:1990446],GO:0003677,DNA binding
OG_01637,FUN_006771-T1,Peve_00027409,Pocillopora_meandrina_HIv1___RNAseq.g20026.t1,three_way,45.833333333333336,,,,,,,,,,,,,,,,,
OG_01638,FUN_006775-T2,Peve_00012348,Pocillopora_meandrina_HIv1___RNAseq.g20025.t1,three_way,76.58,FUN_006775-T2,Q9H237,PORCN_HUMAN,,Protein-serine O-palmitoleoyltransferase porcupine (EC 2.3.1.250) (Protein MG61),Homo sapiens (Human),38.9,455.0,5.1e-87,323.2,sp|Q9H237|PORCN_HUMAN Protein-serine O-palmitoleoyltransferase porcupine OS=Homo sapiens OX=9606 GN=PORCN PE=1 SV=2,GO:0005783; GO:0005789; GO:0006497; GO:0009100; GO:0016020; GO:0016055; GO:0017147; GO:0030258; GO:0032281; GO:0045234; GO:0061355; GO:0098978; GO:0099072; GO:1990698,glycoprotein metabolic process [GO:0009100]; lipid modification [GO:0030258]; protein lipidation [GO:0006497]; protein palmitoleylation [GO:0045234]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055],AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020],palmitoleoyltransferase activity [GO:1990698]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_01639,FUN_006776-T1,Peve_00012349,Pocillopora_meandrina_HIv1___RNAseq.g20024.t1,three_way,61.361666666666665,FUN_006776-T1,Q5F489,,,,,35.5,262.0,1.3e-30,136.3,sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1,,,,,,
OG_01639,FUN_006776-T1,Peve_00012349,Pocillopora_meandrina_HIv1___RNAseq.g20024.t1,three_way,61.361666666666665,FUN_006776-T1,Q5F489,,,,,54.2,72.0,2.9e-14,82.0,sp|Q5F489|TAF3_CHICK Transcription initiation factor TFIID subunit 3 OS=Gallus gallus OX=9031 GN=TAF3 PE=2 SV=1,,,,,,
OG_01640,FUN_006777-T1,Peve_00012351,Pocillopora_meandrina_HIv1___TS.g29411.t1,three_way,62.50533333333333,FUN_006777-T1,Q8CFG5,CA2D3_RAT,,Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3],Rattus norvegicus (Rat),29.8,1024.0,4.8e-117,424.1,sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1,GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314,calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174],GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891],calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0098772,transporter activity; molecular function regulator activity
OG_01641,FUN_006778-T1,Peve_00042981,Pocillopora_meandrina_HIv1___TS.g29885.t1,three_way,45.0235,FUN_006778-T1,P16092,FGFR1_MOUSE,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Mus musculus (Mouse),33.7,784.0,2.6e-100,368.6,sp|P16092|FGFR1_MOUSE Fibroblast growth factor receptor 1 OS=Mus musculus OX=10090 GN=Fgfr1 PE=1 SV=2,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010966; GO:0010976; GO:0017134; GO:0021769; GO:0021847; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042803; GO:0043235; GO:0043536; GO:0043583; GO:0045666; GO:0045787; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cementum mineralization [GO:0071529]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_01642,FUN_006790-T1,Peve_00028070,Pocillopora_meandrina_HIv1___RNAseq.g20501.t1,three_way,54.868,FUN_006790-T1,P35918,,,,,31.5,961.0,9.8e-99,363.6,sp|P35918|VGFR2_MOUSE Vascular endothelial growth factor receptor 2 OS=Mus musculus OX=10090 GN=Kdr PE=1 SV=2,,,,,,
OG_01643,FUN_006793-T1,Peve_00028369,Pocillopora_meandrina_HIv1___TS.g11476.t1,three_way,50.69533333333333,FUN_006793-T1,P79798,,,,,22.7,295.0,5.4e-06,53.5,sp|P79798|OPSD_MYRBE Rhodopsin (Fragment) OS=Myripristis berndti OX=47700 GN=rho PE=2 SV=1,,,,,,
OG_01644,FUN_006795-T1,Peve_00019184,Pocillopora_meandrina_HIv1___RNAseq.g20497.t1,three_way,61.56066666666667,FUN_006795-T1,Q9EP86,,,,,27.3,337.0,2.3e-13,78.2,sp|Q9EP86|NPFF1_RAT Neuropeptide FF receptor 1 OS=Rattus norvegicus OX=10116 GN=Npffr1 PE=1 SV=1,,,,,,
OG_01645,FUN_006796-T1,Peve_00019185,Pocillopora_meandrina_HIv1___RNAseq.g20496.t1,three_way,33.34466666666667,FUN_006796-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),28.9,287.0,1.3e-17,92.4,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_01646,FUN_006798-T1,Peve_00019182,Pocillopora_meandrina_HIv1___RNAseq.g20494.t1,three_way,82.02783333333333,FUN_006798-T1,Q32NR4,,,,,44.1,256.0,4.7e-57,223.8,sp|Q32NR4|TTC29_XENLA Tetratricopeptide repeat protein 29 OS=Xenopus laevis OX=8355 GN=ttc29 PE=2 SV=1,,,,,,
OG_01647,FUN_006799-T1,Peve_00019091,Pocillopora_meandrina_HIv1___RNAseq.g20493.t1,three_way,63.5435,FUN_006799-T1,O08623,SQSTM_RAT,,Sequestosome-1 (Protein kinase C-zeta-interacting protein) (PKC-zeta-interacting protein) (Ubiquitin-binding protein p62),Rattus norvegicus (Rat),22.9,462.0,1.0999999999999998e-24,115.9,sp|O08623|SQSTM_RAT Sequestosome-1 OS=Rattus norvegicus OX=10116 GN=Sqstm1 PE=1 SV=1,GO:0000122; GO:0000407; GO:0000423; GO:0000425; GO:0000932; GO:0001659; GO:0002376; GO:0002931; GO:0005080; GO:0005737; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0010508; GO:0016234; GO:0016235; GO:0016236; GO:0016605; GO:0019899; GO:0019901; GO:0030017; GO:0030154; GO:0030163; GO:0030674; GO:0031397; GO:0031625; GO:0033554; GO:0034144; GO:0035255; GO:0035591; GO:0035973; GO:0038023; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0043232; GO:0044753; GO:0044754; GO:0044877; GO:0045202; GO:0061635; GO:0070342; GO:0070530; GO:0071211; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:0098978; GO:0110076; GO:0140036; GO:0140311; GO:0140313; GO:0140693; GO:0140694; GO:1900273; GO:1903078; GO:1905719,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; cellular response to stress [GO:0033554]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; membraneless organelle assembly [GO:0140694]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pexophagy [GO:0000425]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; inclusion body [GO:0016234]; intracellular membraneless organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; synapse [GO:0045202],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; molecular sequestering activity [GO:0140313]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0002376; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006914; GO:0012501; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0060089; GO:0060090; GO:0140313,immune system process; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; autophagy; programmed cell death; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity; molecular adaptor activity; molecular sequestering activity
OG_01648,FUN_006802-T1,Peve_00040415,Pocillopora_meandrina_HIv1___RNAseq.g15311.t1,three_way,49.62916666666666,FUN_006802-T1,Q9UBM8,MGT4C_HUMAN,,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-acetylglucosaminyltransferase IV homolog) (hGnT-IV-H) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GlcNAc-T IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)",Homo sapiens (Human),32.2,410.0,6.4e-54,213.4,"sp|Q9UBM8|MGT4C_HUMAN Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Homo sapiens OX=9606 GN=MGAT4C PE=2 SV=2",GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0019082; GO:0046872,protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082],Golgi membrane [GO:0000139],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]",GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_01649,FUN_006803-T2,Peve_00029309,Pocillopora_meandrina_HIv1___RNAseq.g20491.t1,three_way,82.40566666666668,FUN_006803-T2,A1L1C7,PAN3_XENTR,,PAN2-PAN3 deadenylation complex subunit pan3 (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 3) (PAN deadenylation complex subunit 3),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),51.1,626.0,6.2e-166,585.9,sp|A1L1C7|PAN3_XENTR PAN2-PAN3 deadenylation complex subunit pan3 OS=Xenopus tropicalis OX=8364 GN=pan3 PE=2 SV=1,GO:0000289; GO:0000932; GO:0003723; GO:0004672; GO:0005524; GO:0006397; GO:0008270; GO:0010606; GO:0031251,mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],P-body [GO:0000932]; PAN complex [GO:0031251],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01650,FUN_006805-T1,Peve_00023740,Pocillopora_meandrina_HIv1___RNAseq.g20488.t1a,three_way,80.63166666666666,FUN_006805-T1,Q52T38,ZDH22_ARATH,,Protein S-acyltransferase 24 (EC 2.3.1.225) (Ankyrin repeat-containing S-palmitoyltransferase) (Palmitoyltransferase TIP1) (Protein TIP GROWTH DEFECTIVE 1) (AtTIP1) (Zinc finger DHHC domain-containing protein TIP1),Arabidopsis thaliana (Mouse-ear cress),32.0,222.0,5.1e-27,124.0,sp|Q52T38|ZDH22_ARATH Protein S-acyltransferase 24 OS=Arabidopsis thaliana OX=3702 GN=PAT24 PE=1 SV=1,GO:0000035; GO:0000139; GO:0005768; GO:0005794; GO:0005802; GO:0009932; GO:0016417; GO:0019706; GO:0030659; GO:2000652; GO:2001006,cell tip growth [GO:0009932]; regulation of cellulose biosynthetic process [GO:2001006]; regulation of secondary cell wall biogenesis [GO:2000652],cytoplasmic vesicle membrane [GO:0030659]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],acyl binding [GO:0000035]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; S-acyltransferase activity [GO:0016417],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_01651,FUN_006818-T1,Peve_00023739,Pocillopora_meandrina_HIv1___RNAseq.g20487.t1,three_way,58.067,FUN_006818-T1,Q92913,FGF13_HUMAN,,Fibroblast growth factor 13 (FGF-13) (Fibroblast growth factor homologous factor 2) (FHF-2),Homo sapiens (Human),28.2,124.0,6e-06,52.0,sp|Q92913|FGF13_HUMAN Fibroblast growth factor 13 OS=Homo sapiens OX=9606 GN=FGF13 PE=1 SV=1,GO:0000165; GO:0001764; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005886; GO:0006814; GO:0007026; GO:0007165; GO:0007267; GO:0007399; GO:0007612; GO:0007613; GO:0008017; GO:0008083; GO:0014704; GO:0016328; GO:0017080; GO:0021766; GO:0021795; GO:0022008; GO:0030175; GO:0030424; GO:0030425; GO:0030426; GO:0042383; GO:0043005; GO:0044325; GO:0045200; GO:0046785; GO:0048487; GO:0048671; GO:0048755; GO:0072659; GO:0098909; GO:1904862; GO:1905152,branching morphogenesis of a nerve [GO:0048755]; cell-cell signaling [GO:0007267]; cerebral cortex cell migration [GO:0021795]; establishment of neuroblast polarity [GO:0045200]; hippocampus development [GO:0021766]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; microtubule polymerization [GO:0046785]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; positive regulation of voltage-gated sodium channel activity [GO:1905152]; protein localization to plasma membrane [GO:0072659]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],beta-tubulin binding [GO:0048487]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325],GO:0005634; GO:0005829; GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0023052; GO:0030154; GO:0034330; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0050877; GO:0065003; GO:0072659; GO:0098772,nucleus; cytosol; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; signaling; cell differentiation; cell junction organization; organelle; receptor ligand activity; anatomical structure development; cell motility; nervous system process; protein-containing complex assembly; protein localization to plasma membrane; molecular function regulator activity
OG_01652,FUN_006820-T1,Peve_00023762,Pocillopora_meandrina_HIv1___RNAseq.g20483.t1,three_way,85.8165,FUN_006820-T1,Q9WU06,AVIL_RAT,,Advillin (Peripheral nervous system villin-like protein) (Pervin),Rattus norvegicus (Rat),43.3,843.0,3.9e-191,669.8,sp|Q9WU06|AVIL_RAT Advillin OS=Rattus norvegicus OX=10116 GN=Avil PE=2 SV=2,GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480,actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005856; GO:0008092; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeletal protein binding; lipid binding; organelle; cilium organization; anatomical structure development
OG_01653,FUN_006821-T1,Peve_00023763,Pocillopora_meandrina_HIv1___RNAseq.g20482.t1,three_way,90.73766666666668,FUN_006821-T1,Q9HD45,,,,,69.3,554.0,6.7e-206,718.4,sp|Q9HD45|TM9S3_HUMAN Transmembrane 9 superfamily member 3 OS=Homo sapiens OX=9606 GN=TM9SF3 PE=1 SV=2,,,,,,
OG_01654,FUN_006822-T1,Peve_00023764,Pocillopora_meandrina_HIv1___RNAseq.g20481.t1,three_way,73.873,FUN_006822-T1,Q6TNS2,,,,,38.8,330.0,5.6e-66,253.1,sp|Q6TNS2|PK1IP_DANRE p21-activated protein kinase-interacting protein 1-like OS=Danio rerio OX=7955 GN=pak1ip1 PE=2 SV=1,,,,,,
OG_01655,FUN_006824-T1,Peve_00023768,Pocillopora_meandrina_HIv1___RNAseq.g20478.t1,three_way,48.65733333333333,FUN_006824-T1,Q566X8,DMX1B_DANRE,,Diencephalon/mesencephalon homeobox protein 1-B,Danio rerio (Zebrafish) (Brachydanio rerio),70.0,90.0,1.1e-25,118.6,sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074,midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_01656,FUN_006826-T1,Peve_00023770,Pocillopora_meandrina_HIv1___RNAseq.g20475.t1,three_way,76.18166666666667,,,,,,,,,,,,,,,,,
OG_01657,FUN_006827-T2,Peve_00023772,Pocillopora_meandrina_HIv1___RNAseq.g20474.t1,three_way,59.91866666666667,FUN_006827-T2,Q566X8,DMX1B_DANRE,,Diencephalon/mesencephalon homeobox protein 1-B,Danio rerio (Zebrafish) (Brachydanio rerio),60.8,97.0,1.8e-21,104.4,sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074,midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_01658,FUN_006829-T1,Peve_00023773,Pocillopora_meandrina_HIv1___RNAseq.g20472.t1,three_way,62.132333333333335,FUN_006829-T1,Q566X8,DMX1B_DANRE,,Diencephalon/mesencephalon homeobox protein 1-B,Danio rerio (Zebrafish) (Brachydanio rerio),50.8,122.0,1e-21,105.1,sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074,midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_01659,FUN_006830-T1,Peve_00023775,Pocillopora_meandrina_HIv1___RNAseq.g20471.t1,three_way,73.49133333333333,FUN_006830-T1,Q9U637,,,,,37.9,198.0,7.3e-17,89.0,sp|Q9U637|PITX_BRABE Pituitary homeobox x OS=Branchiostoma belcheri OX=7741 GN=Ptx PE=2 SV=1,,,,,,
OG_01660,FUN_006843-T1,Peve_00023777,Pocillopora_meandrina_HIv1___RNAseq.g20469.t1,three_way,55.36333333333334,,,,,,,,,,,,,,,,,
OG_01661,FUN_006844-T1,Peve_00023779,Pocillopora_meandrina_HIv1___RNAseq.g20468.t1,three_way,65.999,,,,,,,,,,,,,,,,,
OG_01662,FUN_006845-T1,Peve_00023780,Pocillopora_meandrina_HIv1___RNAseq.g20467.t2,three_way,74.246,FUN_006845-T1,Q8AWB5,,,,,49.5,386.0,1.9e-105,384.4,sp|Q8AWB5|OFUT3_CHICK GDP-fucose protein O-fucosyltransferase 3 OS=Gallus gallus OX=9031 GN=FUT10 PE=2 SV=2,,,,,,
OG_01663,FUN_006846-T1,Peve_00023781,Pocillopora_meandrina_HIv1___RNAseq.g20466.t1,three_way,87.019,FUN_006846-T1,Q6AYU1,,,,,50.3,316.0,2.6e-84,313.5,sp|Q6AYU1|MO4L1_RAT Mortality factor 4-like protein 1 OS=Rattus norvegicus OX=10116 GN=Morf4l1 PE=2 SV=1,,,,,,
OG_01664,FUN_006847-T1,Peve_00023782,Pocillopora_meandrina_HIv1___TS.g29850.t1,three_way,69.21333333333334,FUN_006847-T1,Q32LC7,G3BP1_BOVIN,,Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA/RNA helicase G3BP),Bos taurus (Bovine),34.1,446.0,6.8e-48,193.4,sp|Q32LC7|G3BP1_BOVIN Ras GTPase-activating protein-binding protein 1 OS=Bos taurus OX=9913 GN=G3BP1 PE=2 SV=1,GO:0003677; GO:0003678; GO:0003724; GO:0003729; GO:0004519; GO:0005524; GO:0005634; GO:0005829; GO:0010494; GO:0016887; GO:0033677; GO:0034063; GO:0043024; GO:0043204; GO:0045087; GO:0140693,innate immune response [GO:0045087]; stress granule assembly [GO:0034063],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; perikaryon [GO:0043204],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA/RNA helicase activity [GO:0033677]; endonuclease activity [GO:0004519]; molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; ribosomal small subunit binding [GO:0043024]; RNA helicase activity [GO:0003724],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0060090; GO:0098542; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; cytosol; hydrolase activity; isomerase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01665,FUN_006848-T1,Peve_00023783,Pocillopora_meandrina_HIv1___RNAseq.g20485.t1,three_way,69.09166666666667,,,,,,,,,,,,,,,,,
OG_01666,FUN_006849-T1,Peve_00012331,Pocillopora_meandrina_HIv1___RNAseq.g20486.t1,three_way,55.838,,,,,,,,,,,,,,,,,
OG_01667,FUN_006852-T1,Peve_00042993,Pocillopora_meandrina_HIv1___RNAseq.g20241.t1,three_way,74.726,,,,,,,,,,,,,,,,,
OG_01668,FUN_006855-T1,Peve_00042995,Pocillopora_meandrina_HIv1___RNAseq.g19915.t1,three_way,55.54816666666667,FUN_006855-T1,Q3KRG3,,,,,36.7,109.0,2.5e-20,100.5,sp|Q3KRG3|TSR2_DANRE Pre-rRNA-processing protein TSR2 homolog OS=Danio rerio OX=7955 GN=tsr2 PE=2 SV=1,,,,,,
OG_01669,FUN_006856-T1,Peve_00016201,Pocillopora_meandrina_HIv1___RNAseq.g19911.t1,three_way,74.561,FUN_006856-T1,P24861,,,,,48.5,454.0,1.7e-95,351.3,sp|P24861|CCNA_PATVU G2/mitotic-specific cyclin-A OS=Patella vulgata OX=6465 PE=2 SV=1,,,,,,
OG_01670,FUN_006857-T1,Peve_00016203,Pocillopora_meandrina_HIv1___RNAseq.g19910.t1b,three_way,63.460166666666666,FUN_006857-T1,B9EJ80,PDZD8_MOUSE,,PDZ domain-containing protein 8,Mus musculus (Mouse),28.5,1009.0,2.5000000000000004e-80,302.0,sp|B9EJ80|PDZD8_MOUSE PDZ domain-containing protein 8 OS=Mus musculus OX=10090 GN=Pdzd8 PE=1 SV=1,GO:0005739; GO:0005789; GO:0006869; GO:0007010; GO:0008270; GO:0008289; GO:0022604; GO:0044233; GO:0051560; GO:1990456,cytoskeleton organization [GO:0007010]; lipid transport [GO:0006869]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; regulation of cell morphogenesis [GO:0022604],endoplasmic reticulum membrane [GO:0005789]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; zinc ion binding [GO:0008270],GO:0005739; GO:0007010; GO:0008289; GO:0043226,mitochondrion; cytoskeleton organization; lipid binding; organelle
OG_01671,FUN_006858-T1,Peve_00006602,Pocillopora_meandrina_HIv1___RNAseq.g19910.t1a,three_way,92.78333333333332,FUN_006858-T1,Q27802,,,,,65.6,4362.0,0.0,5570.0,sp|Q27802|DYHC2_TRIGR Cytoplasmic dynein 2 heavy chain 1 OS=Tripneustes gratilla OX=7673 GN=DYH1B PE=2 SV=2,,,,,,
OG_01672,FUN_006861-T1,Peve_00006606,Pocillopora_meandrina_HIv1___RNAseq.g19909.t1,three_way,69.55666666666666,FUN_006861-T1,O97860,,,,,48.4,304.0,4.8e-84,312.8,sp|O97860|PPA5_RABIT Tartrate-resistant acid phosphatase type 5 OS=Oryctolagus cuniculus OX=9986 GN=ACP5 PE=2 SV=1,,,,,,
OG_01673,FUN_006864-T2,Peve_00003792,Pocillopora_meandrina_HIv1___RNAseq.g19906.t1,three_way,83.79033333333334,FUN_006864-T2,P20000,ALDH2_BOVIN,,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)",Bos taurus (Bovine),68.6,510.0,5.1000000000000004e-213,741.9,"sp|P20000|ALDH2_BOVIN Aldehyde dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ALDH2 PE=1 SV=2",GO:0004029; GO:0005739; GO:0005759; GO:0006068; GO:0008957; GO:0018937; GO:0046185; GO:0051287; GO:0106435; GO:1903179; GO:1905627,aldehyde catabolic process [GO:0046185]; ethanol catabolic process [GO:0006068]; nitroglycerin metabolic process [GO:0018937]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; carboxylesterase activity [GO:0106435]; NAD binding [GO:0051287]; phenylacetaldehyde dehydrogenase (NAD+) activity [GO:0008957],GO:0003824; GO:0005739; GO:0016491; GO:0016787; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; hydrolase activity; organelle
OG_01674,FUN_006869-T2,Peve_00039239,Pocillopora_meandrina_HIv1___RNAseq.g19796.t1,three_way,64.51466666666667,FUN_006869-T2,P00530,,,,,25.6,437.0,2e-18,96.7,sp|P00530|FPS_FUJSV Tyrosine-protein kinase transforming protein Fps OS=Fujinami sarcoma virus OX=11885 GN=V-FPS PE=3 SV=1,,,,,,
OG_01675,FUN_006872-T1,Peve_00039240,Pocillopora_meandrina_HIv1___RNAseq.g19797.t2,three_way,68.479,FUN_006872-T1,Q13286,,,,,49.5,404.0,1.9e-96,354.4,sp|Q13286|CLN3_HUMAN Battenin OS=Homo sapiens OX=9606 GN=CLN3 PE=1 SV=1,,,,,,
OG_01676,FUN_006873-T1,Peve_00039241,Pocillopora_meandrina_HIv1___RNAseq.g19799.t2,three_way,50.80566666666667,FUN_006873-T1,P31371,FGF9_HUMAN,,Fibroblast growth factor 9 (FGF-9) (Glia-activating factor) (GAF) (Heparin-binding growth factor 9) (HBGF-9),Homo sapiens (Human),34.6,127.0,1.1e-14,81.6,sp|P31371|FGF9_HUMAN Fibroblast growth factor 9 OS=Homo sapiens OX=9606 GN=FGF9 PE=1 SV=3,GO:0000122; GO:0001525; GO:0001649; GO:0001654; GO:0002053; GO:0002062; GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0006606; GO:0007165; GO:0007224; GO:0007267; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008584; GO:0010463; GO:0010628; GO:0021762; GO:0022008; GO:0030178; GO:0030238; GO:0030326; GO:0030334; GO:0030949; GO:0032924; GO:0032927; GO:0042472; GO:0043410; GO:0045880; GO:0048010; GO:0048505; GO:0048566; GO:0048706; GO:0050679; GO:0051781; GO:0060011; GO:0060038; GO:0060045; GO:0060070; GO:0060484; GO:0072089; GO:0090263; GO:1904707; GO:1904754; GO:1905931; GO:2000648,activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle cell proliferation [GO:0060038]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung-associated mesenchyme development [GO:0060484]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; mesenchymal cell proliferation [GO:0010463]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; negative regulation of Wnt signaling pathway [GO:0030178]; neurogenesis [GO:0022008]; osteoblast differentiation [GO:0001649]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein import into nucleus [GO:0006606]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; Sertoli cell proliferation [GO:0060011]; signal transduction [GO:0007165]; smoothened signaling pathway [GO:0007224]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201],GO:0005576; GO:0005615; GO:0006355; GO:0006886; GO:0006913; GO:0022414; GO:0023052; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; reproductive process; signaling; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01677,FUN_006885-T1,Peve_00009911,Pocillopora_meandrina_HIv1___RNAseq.g19833.t1,three_way,60.03416666666667,FUN_006885-T1,O94966,,,,,42.5,738.0,3.1999999999999995e-151,537.7,sp|O94966|UBP19_HUMAN Ubiquitin carboxyl-terminal hydrolase 19 OS=Homo sapiens OX=9606 GN=USP19 PE=1 SV=2,,,,,,
OG_01678,FUN_006886-T1,Peve_00009910,Pocillopora_meandrina_HIv1___RNAseq.g19832.t3,three_way,80.65033333333334,FUN_006886-T1,A2CI35,,,,,46.3,934.0,7.7e-244,845.1,sp|A2CI35|DUSTY_STRPU Dual serine/threonine and tyrosine protein kinase OS=Strongylocentrotus purpuratus OX=7668 GN=DSTYK PE=2 SV=1,,,,,,
OG_01679,FUN_006889-T1,Peve_00009369,Pocillopora_meandrina_HIv1___RNAseq.g19815.t1,three_way,70.95,FUN_006889-T1,P61328,FGF12_HUMAN,,Fibroblast growth factor 12 (FGF-12) (Fibroblast growth factor homologous factor 1) (FHF-1) (Myocyte-activating factor),Homo sapiens (Human),29.0,131.0,3.1e-16,87.0,sp|P61328|FGF12_HUMAN Fibroblast growth factor 12 OS=Homo sapiens OX=9606 GN=FGF12 PE=1 SV=1,GO:0005615; GO:0005634; GO:0005737; GO:0007165; GO:0007254; GO:0007267; GO:0007268; GO:0007399; GO:0007507; GO:0008083; GO:0008201; GO:0008344; GO:0010765; GO:0017080; GO:0022008; GO:0044325; GO:0045202; GO:0050905; GO:0086002; GO:0098908; GO:1902305; GO:1905150,adult locomotory behavior [GO:0008344]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; heart development [GO:0007507]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuromuscular process [GO:0050905]; positive regulation of sodium ion transport [GO:0010765]; regulation of neuronal action potential [GO:0098908]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; synapse [GO:0045202],growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325],GO:0005615; GO:0005634; GO:0023052; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0050877; GO:0098772,extracellular space; nucleus; signaling; cell differentiation; organelle; receptor ligand activity; anatomical structure development; nervous system process; molecular function regulator activity
OG_01680,FUN_006890-T1,Peve_00009370,Pocillopora_meandrina_HIv1___RNAseq.g19814.t1,three_way,60.797666666666665,FUN_006890-T1,Q19791,GON1_CAEEL,,A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1),Caenorhabditis elegans,25.1,338.0,3.3e-18,94.4,sp|Q19791|GON1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs gon-1 OS=Caenorhabditis elegans OX=6239 GN=gon-1 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005604; GO:0005783; GO:0005794; GO:0006508; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0030198; GO:0031012; GO:0048644; GO:1905607,cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]; proteolysis [GO:0006508],basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0016192; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; vesicle-mediated transport; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_01681,FUN_006895-T1,Peve_00024785,Pocillopora_meandrina_HIv1___RNAseq.g19813.t1,three_way,69.905,,,,,,,,,,,,,,,,,
OG_01682,FUN_006898-T1,Peve_00024786,Pocillopora_meandrina_HIv1___RNAseq.g19811.t1,three_way,86.23733333333332,FUN_006898-T1,Q28GW8,MELK_XENTR,,Maternal embryonic leucine zipper kinase (EC 2.7.11.1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),44.6,673.0,2.2e-154,547.4,sp|Q28GW8|MELK_XENTR Maternal embryonic leucine zipper kinase OS=Xenopus tropicalis OX=8364 GN=melk PE=2 SV=1,GO:0004674; GO:0004715; GO:0005509; GO:0005524; GO:0005886; GO:0005938; GO:0006915; GO:0008016; GO:0008283; GO:0008289; GO:0030097; GO:0043065; GO:0046777; GO:0048821; GO:0061351; GO:0106310,apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; erythrocyte development [GO:0048821]; hemopoiesis [GO:0030097]; neural precursor cell proliferation [GO:0061351]; positive regulation of apoptotic process [GO:0043065]; protein autophosphorylation [GO:0046777]; regulation of heart contraction [GO:0008016],cell cortex [GO:0005938]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005886; GO:0008289; GO:0012501; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; lipid binding; programmed cell death; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_01683,FUN_006901-T1,Peve_00044416,Pocillopora_meandrina_HIv1___RNAseq.g19809.t1,three_way,59.586,,,,,,,,,,,,,,,,,
OG_01684,FUN_006903-T1,Peve_00044428,Pocillopora_meandrina_HIv1___TS.g29196.t1,three_way,63.49766666666667,,,,,,,,,,,,,,,,,
OG_01685,FUN_006917-T1,Peve_00044394,Pocillopora_meandrina_HIv1___RNAseq.g19806.t1,three_way,80.5865,FUN_006917-T1,E2RQ08,RPN1_CANLF,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Ribophorin I) (RPN-I) (Ribophorin-1),Canis lupus familiaris (Dog) (Canis familiaris),50.0,580.0,2.0000000000000003e-165,583.9,sp|E2RQ08|RPN1_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 OS=Canis lupus familiaris OX=9615 GN=RPN1 PE=1 SV=1,GO:0005791; GO:0005829; GO:0006486; GO:0008250; GO:0018279; GO:0160226; GO:0160227,protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279],cytosol [GO:0005829]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226]; oligosaccharyltransferase complex B [GO:0160227]; rough endoplasmic reticulum [GO:0005791],,GO:0005783; GO:0005829; GO:0006486; GO:0009101; GO:0043226; GO:1901135,endoplasmic reticulum; cytosol; protein glycosylation; glycoprotein biosynthetic process; organelle; carbohydrate derivative metabolic process
OG_01686,FUN_006918-T1,Peve_00044398,Pocillopora_meandrina_HIv1___TS.g29194.t1a,three_way,53.57366666666667,,,,,,,,,,,,,,,,,
OG_01687,FUN_006920-T1,Peve_00044401,Pocillopora_meandrina_HIv1___RNAseq.g19804.t1,three_way,87.06683333333334,FUN_006920-T1,Q28CH8,,,,,65.9,208.0,5.100000000000001e-74,278.9,sp|Q28CH8|YIPF6_XENTR Protein YIPF6 OS=Xenopus tropicalis OX=8364 GN=yipf6 PE=2 SV=1,,,,,,
OG_01688,FUN_006922-T1,Peve_00044403,Pocillopora_meandrina_HIv1___RNAseq.g19841.t1,three_way,67.363,FUN_006922-T1,Q9NX08,COMD8_HUMAN,,COMM domain-containing protein 8,Homo sapiens (Human),35.6,177.0,3.5e-26,119.8,sp|Q9NX08|COMD8_HUMAN COMM domain-containing protein 8 OS=Homo sapiens OX=9606 GN=COMMD8 PE=1 SV=1,GO:0005654; GO:0005829; GO:0007165; GO:0051059,signal transduction [GO:0007165],cytosol [GO:0005829]; nucleoplasm [GO:0005654],NF-kappaB binding [GO:0051059],GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_01689,FUN_006923-T1,Peve_00044404,Pocillopora_meandrina_HIv1___RNAseq.g19842.t1,three_way,83.92933333333333,FUN_006923-T1,Q9HAQ2,KIF9_HUMAN,,Kinesin-like protein KIF9,Homo sapiens (Human),47.7,773.0,3.3e-192,673.3,sp|Q9HAQ2|KIF9_HUMAN Kinesin-like protein KIF9 OS=Homo sapiens OX=9606 GN=KIF9 PE=1 SV=4,GO:0002102; GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0016887; GO:0022617; GO:0031982; GO:0036126; GO:0042802; GO:0071801; GO:1901317; GO:1903008,extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of flagellated sperm motility [GO:1901317]; regulation of podosome assembly [GO:0071801],cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; sperm flagellum [GO:0036126]; vesicle [GO:0031982],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0030198; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; extracellular matrix organization; organelle; ATP-dependent activity
OG_01690,FUN_006926-T1,Peve_00044420,Pocillopora_meandrina_HIv1___RNAseq.g20103.t1,three_way,62.54266666666667,FUN_006926-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),32.8,717.0,1.2e-106,389.0,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_01691,FUN_006927-T1,Peve_00044421,Pocillopora_meandrina_HIv1___RNAseq.g20102.t1,three_way,71.53333333333333,FUN_006927-T1,P19059,,,,,35.6,489.0,1.8e-77,291.6,sp|P19059|DMPC_PSEUF 2-hydroxymuconic semialdehyde dehydrogenase OS=Pseudomonas sp. (strain CF600) OX=79676 GN=dmpC PE=3 SV=1,,,,,,
OG_01692,FUN_006929-T1,Peve_00044422,Pocillopora_meandrina_HIv1___RNAseq.g20101.t1,three_way,69.52066666666667,,,,,,,,,,,,,,,,,
OG_01693,FUN_006933-T1,Peve_00001506,Pocillopora_meandrina_HIv1___RNAseq.g20114.t1,three_way,46.326166666666666,,,,,,,,,,,,,,,,,
OG_01694,FUN_006935-T1,Peve_00036200,Pocillopora_meandrina_HIv1___RNAseq.g20119.t1,three_way,82.61133333333333,,,,,,,,,,,,,,,,,
OG_01695,FUN_006936-T2,Peve_00001498,Pocillopora_meandrina_HIv1___RNAseq.g20120.t2,three_way,80.58433333333333,FUN_006936-T2,A7SBF0,,,,,67.5,664.0,3.9999999999999994e-279,961.8,sp|A7SBF0|INT9_NEMVE Integrator complex subunit 9 homolog OS=Nematostella vectensis OX=45351 GN=ints9 PE=3 SV=1,,,,,,
OG_01696,FUN_006938-T1,Peve_00001500,Pocillopora_meandrina_HIv1___RNAseq.g20121.t1,three_way,63.46966666666667,,,,,,,,,,,,,,,,,
OG_01697,FUN_006940-T1,Peve_00042017,Pocillopora_meandrina_HIv1___RNAseq.g20151.t1,three_way,87.24366666666667,FUN_006940-T1,Q9Z2D1,MTMR2_MOUSE,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR2 (EC 3.1.3.95) (Myotubularin-related protein 2) (Phosphatidylinositol-3-phosphate phosphatase)",Mus musculus (Mouse),65.8,526.0,2.8e-210,733.0,"sp|Q9Z2D1|MTMR2_MOUSE Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR2 OS=Mus musculus OX=10090 GN=Mtmr2 PE=1 SV=3",GO:0002091; GO:0004438; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0008021; GO:0014069; GO:0030424; GO:0031642; GO:0031901; GO:0032288; GO:0042552; GO:0042802; GO:0043197; GO:0046488; GO:0046856; GO:0048471; GO:0048666; GO:0052629; GO:0052866; GO:0060304; GO:0090394; GO:0097060; GO:0097062; GO:2000643; GO:2000645,dendritic spine maintenance [GO:0097062]; myelin assembly [GO:0032288]; myelination [GO:0042552]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of myelination [GO:0031642]; negative regulation of receptor catabolic process [GO:2000645]; negative regulation of receptor internalization [GO:0002091]; neuron development [GO:0048666]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; positive regulation of early endosome to late endosome transport [GO:2000643]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome membrane [GO:0031901]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774],"identical protein binding [GO:0042802]; phosphatidylinositol phosphate phosphatase activity [GO:0052866]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]",GO:0003824; GO:0005634; GO:0005829; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856,catalytic activity; nucleus; cytosol; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development
OG_01698,FUN_006941-T1,Peve_00042016,Pocillopora_meandrina_HIv1___RNAseq.g20150.t1,three_way,80.58666666666667,FUN_006941-T1,Q32N90,,,,,36.0,566.0,4.4e-100,367.9,sp|Q32N90|MBTD1_XENLA MBT domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=mbtd1 PE=2 SV=1,,,,,,
OG_01699,FUN_006942-T1,Peve_00014295,Pocillopora_meandrina_HIv1___RNAseq.g20148.t2,three_way,70.609,FUN_006942-T1,P23770,,,,,42.9,385.0,1.3e-66,255.4,sp|P23770|GATA2_XENLA GATA-binding factor 2 OS=Xenopus laevis OX=8355 GN=gata2 PE=2 SV=1,,,,,,
OG_01700,FUN_006943-T1,Peve_00014293,Pocillopora_meandrina_HIv1___RNAseq.g20147.t1,three_way,84.57433333333333,FUN_006943-T1,Q5RCK6,SYT10_PONAB,,Synaptotagmin-10 (Synaptotagmin X) (SytX),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),33.1,257.0,5.3999999999999985e-25,116.7,sp|Q5RCK6|SYT10_PONAB Synaptotagmin-10 OS=Pongo abelii OX=9601 GN=SYT10 PE=2 SV=1,GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0007268; GO:0007608; GO:0017156; GO:0030276; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0070382; GO:0098793; GO:0098978,calcium-ion regulated exocytosis [GO:0017156]; chemical synaptic transmission [GO:0007268]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; sensory perception of smell [GO:0007608],exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]",GO:0005886; GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0050877,plasma membrane; lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; nervous system process
OG_01701,FUN_006944-T1,Peve_00020225,Pocillopora_meandrina_HIv1___TS.g29510.t1,three_way,85.65633333333334,FUN_006944-T1,Q96P70,IPO9_HUMAN,,Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9),Homo sapiens (Human),60.4,916.0,2.2e-310,1066.2,sp|Q96P70|IPO9_HUMAN Importin-9 OS=Homo sapiens OX=9606 GN=IPO9 PE=1 SV=3,GO:0005635; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0016020; GO:0031144; GO:0031267; GO:0042393; GO:0061608; GO:0140713,proteasome localization [GO:0031144]; protein import into nucleus [GO:0006606],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654],histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nuclear import signal receptor activity [GO:0061608]; small GTPase binding [GO:0031267],GO:0005635; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0042393; GO:0140104,nuclear envelope; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; histone binding; molecular carrier activity
OG_01702,FUN_006945-T1,Peve_00020224,Pocillopora_meandrina_HIv1___RNAseq.g20125.t1a,three_way,59.897,FUN_006945-T1,Q9LKA4,,,,,47.9,48.0,2.1e-06,53.9,sp|Q9LKA4|UBA2C_ARATH UBP1-associated protein 2C OS=Arabidopsis thaliana OX=3702 GN=UBA2C PE=2 SV=1,,,,,,
OG_01703,FUN_006948-T1,Peve_00001502,Pocillopora_meandrina_HIv1___RNAseq.g20123.t1,three_way,82.16266666666667,FUN_006948-T1,Q9GZQ3,COMD5_HUMAN,,COMM domain-containing protein 5 (Hypertension-related calcium-regulated gene protein) (HCaRG),Homo sapiens (Human),47.3,201.0,1.8e-42,174.1,sp|Q9GZQ3|COMD5_HUMAN COMM domain-containing protein 5 OS=Homo sapiens OX=9606 GN=COMMD5 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005829; GO:0043226,nucleus; nucleoplasm; cytosol; organelle
OG_01704,FUN_006949-T1,Peve_00001501,Pocillopora_meandrina_HIv1___RNAseq.g20122.t1,three_way,65.41066666666667,FUN_006949-T1,Q9D4H7,,,,,35.5,617.0,9e-100,365.9,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_01705,FUN_006950-T1,Peve_00035084,Pocillopora_meandrina_HIv1___RNAseq.g20153.t1,three_way,71.223,FUN_006950-T1,Q502W6,VWA3B_HUMAN,,von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B),Homo sapiens (Human),35.3,1239.0,4.6e-206,720.7,sp|Q502W6|VWA3B_HUMAN von Willebrand factor A domain-containing protein 3B OS=Homo sapiens OX=9606 GN=VWA3B PE=1 SV=3,GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_01706,FUN_006978-T1,Peve_00033079,Pocillopora_meandrina_HIv1___RNAseq.g20234.t1,three_way,63.92183333333333,,,,,,,,,,,,,,,,,
OG_01707,FUN_006980-T1,Peve_00035600,Pocillopora_meandrina_HIv1___RNAseq.g20230.t1,three_way,88.05,FUN_006980-T1,Q14141,,,,,67.7,331.0,4.400000000000001e-130,466.1,sp|Q14141|SEPT6_HUMAN Septin-6 OS=Homo sapiens OX=9606 GN=SEPTIN6 PE=1 SV=4,,,,,,
OG_01708,FUN_006981-T1,Peve_00045261,Pocillopora_meandrina_HIv1___TS.g29608.t2a,three_way,80.34333333333333,FUN_006981-T1,Q86XE3,MICU3_HUMAN,,"Calcium uptake protein 3, mitochondrial (hMICU3) (EF-hand domain-containing family member A2)",Homo sapiens (Human),35.0,203.0,1.0000000000000001e-24,115.2,"sp|Q86XE3|MICU3_HUMAN Calcium uptake protein 3, mitochondrial OS=Homo sapiens OX=9606 GN=MICU3 PE=1 SV=1",GO:0001956; GO:0005246; GO:0005509; GO:0005739; GO:0005743; GO:0005758; GO:0036444; GO:0046982; GO:0051560; GO:0061891; GO:0071277; GO:1990246,calcium import into the mitochondrion [GO:0036444]; cellular response to calcium ion [GO:0071277]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of neurotransmitter secretion [GO:0001956],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; uniplex complex [GO:1990246],calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; protein heterodimerization activity [GO:0046982],GO:0005739; GO:0043226; GO:0055085; GO:0098772; GO:0140299,mitochondrion; organelle; transmembrane transport; molecular function regulator activity; molecular sensor activity
OG_01709,FUN_006982-T1,Peve_00045260,Pocillopora_meandrina_HIv1___TS.g29608.t2b,three_way,78.57366666666667,FUN_006982-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),44.9,187.0,1.9e-40,167.5,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_01710,FUN_006983-T1,Peve_00045259,Pocillopora_meandrina_HIv1___RNAseq.3765_t,three_way,61.745333333333335,FUN_006983-T1,O42412,IOD3_CHICK,,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),Gallus gallus (Chicken),38.7,248.0,5.7e-40,166.0,sp|O42412|IOD3_CHICK Thyroxine 5-deiodinase (Fragment) OS=Gallus gallus OX=9031 GN=DIO3 PE=1 SV=3,GO:0004800; GO:0005886; GO:0010008; GO:0033798; GO:0042403; GO:0042404; GO:0042446,hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone metabolic process [GO:0042403],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006575; GO:0016491,catalytic activity; plasma membrane; modified amino acid metabolic process; oxidoreductase activity
OG_01711,FUN_006985-T1,Peve_00045265,Pocillopora_meandrina_HIv1___RNAseq.g20222.t1,three_way,77.84,FUN_006985-T1,Q05086,UBE3A_HUMAN,,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54),Homo sapiens (Human),53.1,755.0,9.8e-221,768.1,sp|Q05086|UBE3A_HUMAN Ubiquitin-protein ligase E3A OS=Homo sapiens OX=9606 GN=UBE3A PE=1 SV=4,GO:0000209; GO:0000502; GO:0001541; GO:0003713; GO:0004842; GO:0005634; GO:0005829; GO:0006508; GO:0006511; GO:0007420; GO:0008021; GO:0008270; GO:0030521; GO:0031398; GO:0032570; GO:0035037; GO:0042752; GO:0043161; GO:0045944; GO:0048167; GO:0048511; GO:0050847; GO:0051865; GO:0051897; GO:0060736; GO:0061630; GO:0070936; GO:0098978; GO:0099524; GO:1904262; GO:1905528; GO:2000058,androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; proteasome complex [GO:0000502]; synaptic vesicle [GO:0008021],transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016192; GO:0016740; GO:0022414; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; vesicle-mediated transport; transferase activity; reproductive process; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_01712,FUN_006986-T1,Peve_00009622,Pocillopora_meandrina_HIv1___RNAseq.g20224.t1,three_way,77.79516666666666,FUN_006986-T1,O60841,IF2P_HUMAN,,Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2),Homo sapiens (Human),72.7,593.0,6e-261,902.5,sp|O60841|IF2P_HUMAN Eukaryotic translation initiation factor 5B OS=Homo sapiens OX=9606 GN=EIF5B PE=1 SV=4,GO:0000049; GO:0003723; GO:0003743; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006413; GO:0006446; GO:0042255; GO:0045202; GO:0046872,regulation of translational initiation [GO:0006446]; ribosome assembly [GO:0042255]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; synapse [GO:0045202],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0016787,RNA binding; catalytic activity; GTPase activity; cytosol; hydrolase activity
OG_01713,FUN_006988-T1,Peve_00009621,Pocillopora_meandrina_HIv1___RNAseq.g20160.t1,three_way,80.87866666666667,FUN_006988-T1,P57760,STK16_RAT,,Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2),Rattus norvegicus (Rat),40.4,297.0,1.4999999999999999e-55,218.0,sp|P57760|STK16_RAT Serine/threonine-protein kinase 16 OS=Rattus norvegicus OX=10116 GN=Stk16 PE=2 SV=2,GO:0000978; GO:0004672; GO:0004674; GO:0004715; GO:0005524; GO:0005737; GO:0005794; GO:0005798; GO:0005829; GO:0005886; GO:0016604; GO:0045944; GO:0048471; GO:0071560; GO:0106310,cellular response to transforming growth factor beta stimulus [GO:0071560]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0003824; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"DNA binding; catalytic activity; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_01714,FUN_006993-T1,Peve_00035643,Pocillopora_meandrina_HIv1___RNAseq.g20066.t1,three_way,70.74966666666667,FUN_006993-T1,Q8N5T2,,,,,49.8,522.0,1.8999999999999998e-138,494.2,sp|Q8N5T2|TBC19_HUMAN TBC1 domain family member 19 OS=Homo sapiens OX=9606 GN=TBC1D19 PE=1 SV=2,,,,,,
OG_01715,FUN_006995-T1,Peve_00035637,Pocillopora_meandrina_HIv1___RNAseq.g20064.t1,three_way,61.722166666666666,,,,,,,,,,,,,,,,,
OG_01716,FUN_007001-T2,Peve_00035633,Pocillopora_meandrina_HIv1___RNAseq.g20061.t1,three_way,70.36216666666665,FUN_007001-T2,Q2VIQ3,KIF4B_HUMAN,,Chromosome-associated kinesin KIF4B (Chromokinesin-B),Homo sapiens (Human),40.7,1167.0,3.4e-162,574.3,sp|Q2VIQ3|KIF4B_HUMAN Chromosome-associated kinesin KIF4B OS=Homo sapiens OX=9606 GN=KIF4B PE=1 SV=2,GO:0000281; GO:0003677; GO:0003777; GO:0005524; GO:0005829; GO:0005874; GO:0005875; GO:0007018; GO:0007052; GO:0008017; GO:0016363; GO:0046872; GO:0051231; GO:0051256; GO:0051536,microtubule-based movement [GO:0007018]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; mitotic spindle organization [GO:0007052]; spindle elongation [GO:0051231],cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nuclear matrix [GO:0016363],ATP binding [GO:0005524]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0000910; GO:0003677; GO:0003774; GO:0003824; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0140657,cytokinesis; DNA binding; cytoskeletal motor activity; catalytic activity; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_01717,FUN_007003-T1,Peve_00042624,Pocillopora_meandrina_HIv1___RNAseq.g20030.t1,three_way,54.010666666666665,FUN_007003-T1,Q8UUY8,,,,,25.6,207.0,7.6e-06,53.1,sp|Q8UUY8|ADRB2_ONCMY Beta-2 adrenergic receptor OS=Oncorhynchus mykiss OX=8022 GN=adrb2 PE=2 SV=1,,,,,,
OG_01718,FUN_007004-T1,Peve_00008302,Pocillopora_meandrina_HIv1___TS.g29423.t1b,three_way,89.50533333333333,FUN_007004-T1,Q5BIP7,,,,,69.2,347.0,2.7e-142,506.5,"sp|Q5BIP7|LIAS_BOVIN Lipoyl synthase, mitochondrial OS=Bos taurus OX=9913 GN=LIAS PE=2 SV=1",,,,,,
OG_01719,FUN_007005-T2,Peve_00016928,Pocillopora_meandrina_HIv1___TS.g29423.t1a,three_way,82.74166666666666,FUN_007005-T2,Q9P2G9,KLHL8_HUMAN,,Kelch-like protein 8,Homo sapiens (Human),42.3,338.0,7.9e-79,296.2,sp|Q9P2G9|KLHL8_HUMAN Kelch-like protein 8 OS=Homo sapiens OX=9606 GN=KLHL8 PE=1 SV=4,GO:0005654; GO:0005737; GO:0006511; GO:0016567; GO:0031463; GO:0043161; GO:1990756,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0030163; GO:0060090,nucleoplasm; protein catabolic process; molecular adaptor activity
OG_01720,FUN_007007-T1,Peve_00016932,Pocillopora_meandrina_HIv1___TS.g29917.t1,three_way,45.16033333333333,,,,,,,,,,,,,,,,,
OG_01721,FUN_007008-T1,Peve_00044388,Pocillopora_meandrina_HIv1___TS.g27386.t2,three_way,40.379333333333335,FUN_007008-T1,Q6UW56,ARAID_HUMAN,,All-trans retinoic acid-induced differentiation factor (Apoptosis-related protein 3) (APR-3) (p18),Homo sapiens (Human),32.0,203.0,1.6e-20,101.3,sp|Q6UW56|ARAID_HUMAN All-trans retinoic acid-induced differentiation factor OS=Homo sapiens OX=9606 GN=ATRAID PE=1 SV=2,GO:0005635; GO:0005765; GO:0005886; GO:0006855; GO:0010468; GO:0030154; GO:0030501; GO:0033689; GO:0042177; GO:0042910; GO:0043231; GO:0045669; GO:0048471,cell differentiation [GO:0030154]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of gene expression [GO:0010468]; xenobiotic transmembrane transport [GO:0006855],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005635; GO:0005886; GO:0030154; GO:0043226; GO:0055085,transporter activity; nuclear envelope; plasma membrane; cell differentiation; organelle; transmembrane transport
OG_01722,FUN_007010-T2,Peve_00021640,Pocillopora_meandrina_HIv1___RNAseq.g20536.t1,three_way,59.11533333333334,FUN_007010-T2,Q7TS74,CKP2L_MOUSE,,Cytoskeleton-associated protein 2-like (Radial fiber and mitotic spindle protein) (Radmis),Mus musculus (Mouse),26.1,326.0,2e-10,68.9,sp|Q7TS74|CKP2L_MOUSE Cytoskeleton-associated protein 2-like OS=Mus musculus OX=10090 GN=Ckap2l PE=1 SV=1,GO:0000922; GO:0005813; GO:0005829; GO:0005929; GO:0072686,,centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922],,GO:0005815; GO:0005829; GO:0005929; GO:0043226,microtubule organizing center; cytosol; cilium; organelle
OG_01723,FUN_007011-T1,Peve_00021642,Pocillopora_meandrina_HIv1___RNAseq.g20537.t1,three_way,77.91333333333333,FUN_007011-T1,Q9Y2L1,RRP44_HUMAN,,Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44),Homo sapiens (Human),56.1,547.0,7.1e-173,608.6,sp|Q9Y2L1|RRP44_HUMAN Exosome complex exonuclease RRP44 OS=Homo sapiens OX=9606 GN=DIS3 PE=1 SV=2,GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000288; GO:0003723; GO:0004519; GO:0005085; GO:0005634; GO:0005654; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0016075; GO:0071031; GO:0071034,"CUT catabolic process [GO:0071034]; nuclear mRNA surveillance of mRNA 3'-end processing [GO:0071031]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]",cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0098772; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; mRNA metabolic process; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on RNA"
OG_01724,FUN_007013-T1,Peve_00021641,Pocillopora_meandrina_HIv1___RNAseq.g20538.t1,three_way,66.045,,,,,,,,,,,,,,,,,
OG_01725,FUN_007016-T1,Peve_00037185,Pocillopora_meandrina_HIv1___RNAseq.g20539.t1,three_way,82.81733333333334,FUN_007016-T1,P41565,,,,,56.6,339.0,1.9e-104,381.3,"sp|P41565|IDHG1_RAT Isocitrate dehydrogenase [NAD] subunit gamma 1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Idh3g PE=1 SV=2",,,,,,
OG_01726,FUN_007018-T1,Peve_00037184,Pocillopora_meandrina_HIv1___RNAseq.g20540.t2,three_way,66.14666666666666,FUN_007018-T1,Q3SX07,PUS3_BOVIN,,tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3),Bos taurus (Bovine),43.8,283.0,3.8e-62,240.0,sp|Q3SX07|PUS3_BOVIN tRNA pseudouridine(38/39) synthase OS=Bos taurus OX=9913 GN=PUS3 PE=2 SV=1,GO:0003723; GO:0005634; GO:0005737; GO:0009982; GO:0031119; GO:0160154; GO:1990481,mRNA pseudouridine synthesis [GO:1990481]; tRNA pseudouridine synthesis [GO:0031119],cytoplasm [GO:0005737]; nucleus [GO:0005634],pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine(38/39) synthase activity [GO:0160154],GO:0003723; GO:0003824; GO:0005634; GO:0006399; GO:0016071; GO:0016853; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; tRNA metabolic process; mRNA metabolic process; isomerase activity; organelle; catalytic activity, acting on RNA"
OG_01727,FUN_007019-T1,Peve_00037183,Pocillopora_meandrina_HIv1___TS.g29924.t1,three_way,69.06633333333333,FUN_007019-T1,P0DPD6,ECE2_HUMAN,,Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71),Homo sapiens (Human),35.5,761.0,4e-129,463.8,sp|P0DPD6|ECE2_HUMAN Endothelin-converting enzyme 2 OS=Homo sapiens OX=9606 GN=ECE2 PE=1 SV=1,GO:0000139; GO:0004222; GO:0005886; GO:0007186; GO:0007267; GO:0008168; GO:0016485; GO:0016486; GO:0030658; GO:0030659; GO:0032259; GO:0046872,cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; methylation [GO:0032259]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485],cytoplasmic vesicle membrane [GO:0030659]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; methyltransferase activity [GO:0008168],GO:0003824; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; transferase activity; hydrolase activity; signaling; protein maturation; catalytic activity, acting on a protein"
OG_01728,FUN_007020-T1,Peve_00037180,Pocillopora_meandrina_HIv1___RNAseq.g20542.t1,three_way,63.67233333333333,FUN_007020-T1,Q6ZZY0,,,,,46.9,497.0,1.3e-139,499.6,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_01729,FUN_007023-T2,Peve_00032897,Pocillopora_meandrina_HIv1___RNAseq.g20021.t2,three_way,56.138,,,,,,,,,,,,,,,,,
OG_01730,FUN_007024-T1,Peve_00032896,Pocillopora_meandrina_HIv1___RNAseq.g20020.t1,three_way,90.27,FUN_007024-T1,O49447,ADT3_ARATH,,"ADP,ATP carrier protein 3, mitochondrial (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3)",Arabidopsis thaliana (Mouse-ear cress),66.6,308.0,3.2e-110,399.8,"sp|O49447|ADT3_ARATH ADP,ATP carrier protein 3, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=AAC3 PE=1 SV=1",GO:0005471; GO:0005739; GO:0005743; GO:0005886; GO:0009941; GO:0015865; GO:0016020; GO:0140021; GO:1990544,mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; purine nucleotide transport [GO:0015865],chloroplast envelope [GO:0009941]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP:ADP antiporter activity [GO:0005471],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_01731,FUN_007026-T1,Peve_00037182,Pocillopora_meandrina_HIv1___RNAseq.g20544.t1,three_way,86.548,FUN_007026-T1,Q9GMB8,,,,,66.1,516.0,2.2e-192,673.3,"sp|Q9GMB8|SYSC_BOVIN Serine--tRNA ligase, cytoplasmic OS=Bos taurus OX=9913 GN=SARS1 PE=2 SV=3",,,,,,
OG_01732,FUN_007043-T1,Peve_00031917,Pocillopora_meandrina_HIv1___TS.g2809.t1,three_way,46.273,FUN_007043-T1,P81139,LIPR2_CAVPO,,Pancreatic lipase-related protein 2 (PL-RP2) (Cytotoxic T lymphocyte lipase) (GPL) (Galactolipase) (EC 3.1.1.26) (Triacylglycerol lipase) (EC 3.1.1.3),Cavia porcellus (Guinea pig),36.6,292.0,1.1999999999999999e-39,166.4,sp|P81139|LIPR2_CAVPO Pancreatic lipase-related protein 2 OS=Cavia porcellus OX=10141 GN=PNLIPRP2 PE=1 SV=1,GO:0004465; GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0006629; GO:0006644; GO:0009395; GO:0019376; GO:0019433; GO:0042589; GO:0043005; GO:0047372; GO:0047714,galactolipid catabolic process [GO:0019376]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; triglyceride catabolic process [GO:0019433],extracellular space [GO:0005615]; neuron projection [GO:0043005]; zymogen granule membrane [GO:0042589],calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; lipoprotein lipase activity [GO:0004465]; monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005615; GO:0006629; GO:0016787; GO:1901135,catalytic activity; extracellular space; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_01733,FUN_007051-T1,Peve_00003801,Pocillopora_meandrina_HIv1___RNAseq.g20221.t1,three_way,60.40166666666666,,,,,,,,,,,,,,,,,
OG_01734,FUN_007053-T1,Peve_00003800,Pocillopora_meandrina_HIv1___RNAseq.g20070.t1,three_way,78.94083333333333,FUN_007053-T1,Q8VDL9,GLIS2_MOUSE,,Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein) (Zinc finger protein GLI5),Mus musculus (Mouse),53.3,90.0,4.900000000000002e-22,107.1,sp|Q8VDL9|GLIS2_MOUSE Zinc finger protein GLIS2 OS=Mus musculus OX=10090 GN=Glis2 PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0001227; GO:0001228; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0007399; GO:0008270; GO:0016607; GO:0045879; GO:0045892; GO:0045893; GO:0045944; GO:0061005; GO:0061484; GO:0097730; GO:1900182,cell differentiation involved in kidney development [GO:0061005]; hematopoietic stem cell homeostasis [GO:0061484]; kidney development [GO:0001822]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005929; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cilium; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_01735,FUN_007054-T1,Peve_00003799,Pocillopora_meandrina_HIv1___RNAseq.g20071.t1,three_way,78.438,FUN_007054-T1,Q01664,TFAP4_HUMAN,,Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41),Homo sapiens (Human),53.6,140.0,7.5e-27,122.5,sp|Q01664|TFAP4_HUMAN Transcription factor AP-4 OS=Homo sapiens OX=9606 GN=TFAP4 PE=1 SV=2,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0008285; GO:0010629; GO:0017053; GO:0030330; GO:0042803; GO:0042826; GO:0043065; GO:0043392; GO:0043565; GO:0043922; GO:0043923; GO:0045736; GO:0045892; GO:0045893; GO:0065003; GO:0070888; GO:0071549; GO:1901990; GO:1990837,"cellular response to dexamethasone stimulus [GO:0071549]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein-containing complex assembly [GO:0065003]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0043226; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; transcription regulator activity
OG_01736,FUN_007055-T1,Peve_00003798,Pocillopora_meandrina_HIv1___RNAseq.g20072.t1,three_way,88.616,FUN_007055-T1,Q5SQX6,CYFP2_MOUSE,,Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121),Mus musculus (Mouse),61.2,1252.0,0.0,1540.4,sp|Q5SQX6|CYFP2_MOUSE Cytoplasmic FMR1-interacting protein 2 OS=Mus musculus OX=10090 GN=Cyfip2 PE=1 SV=2,GO:0005634; GO:0005737; GO:0006915; GO:0030833; GO:0031175; GO:0031209; GO:0031267; GO:0043005; GO:0045202; GO:0045862; GO:0048471; GO:0051388; GO:0097484; GO:0098609; GO:0150052,apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; dendrite extension [GO:0097484]; neuron projection development [GO:0031175]; positive regulation of neurotrophin TRK receptor signaling pathway [GO:0051388]; positive regulation of proteolysis [GO:0045862]; regulation of actin filament polymerization [GO:0030833]; regulation of postsynapse assembly [GO:0150052],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCAR complex [GO:0031209]; synapse [GO:0045202],small GTPase binding [GO:0031267],GO:0005634; GO:0007155; GO:0012501; GO:0043226,nucleus; cell adhesion; programmed cell death; organelle
OG_01737,FUN_007056-T1,Peve_00003796,Pocillopora_meandrina_HIv1___RNAseq.g20073.t1,three_way,72.12466666666667,FUN_007056-T1,Q9VXB5,,,,,46.6,148.0,3.5e-27,122.9,sp|Q9VXB5|RM22_DROME Large ribosomal subunit protein uL22m OS=Drosophila melanogaster OX=7227 GN=mRpL22 PE=2 SV=2,,,,,,
OG_01738,FUN_007057-T1,Peve_00003777,Pocillopora_meandrina_HIv1___TS.g29459.t2,three_way,64.8275,FUN_007057-T1,Q8BX17,GEMI5_MOUSE,,Gem-associated protein 5 (Gemin5),Mus musculus (Mouse),39.4,1203.0,2.2e-212,741.5,sp|Q8BX17|GEMI5_MOUSE Gem-associated protein 5 OS=Mus musculus OX=10090 GN=Gemin5 PE=1 SV=2,GO:0000340; GO:0000387; GO:0003730; GO:0005829; GO:0006412; GO:0006417; GO:0017069; GO:0030619; GO:0030621; GO:0032797; GO:0034718; GO:0034719; GO:0043022; GO:0097504,regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412],cytosol [GO:0005829]; Gemini of Cajal bodies [GO:0097504]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719],mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621],GO:0003723; GO:0005829; GO:0043226; GO:0065003,RNA binding; cytosol; organelle; protein-containing complex assembly
OG_01739,FUN_007060-T1,Peve_00022328,Pocillopora_meandrina_HIv1___TS.g29460.t1,three_way,77.21333333333334,FUN_007060-T1,Q90X46,GP161_DANRE,,G-protein coupled receptor 161,Danio rerio (Zebrafish) (Brachydanio rerio),28.9,308.0,3.6e-35,150.6,sp|Q90X46|GP161_DANRE G-protein coupled receptor 161 OS=Danio rerio OX=7955 GN=gpr161 PE=2 SV=2,GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0007368; GO:0051924; GO:0055037; GO:0060170; GO:1901621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; determination of left/right symmetry [GO:0007368]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; regulation of calcium ion transport [GO:0051924],ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037],G protein-coupled receptor activity [GO:0004930],GO:0005768; GO:0005929; GO:0031410; GO:0043226; GO:0060089,endosome; cilium; cytoplasmic vesicle; organelle; molecular transducer activity
OG_01740,FUN_007062-T1,Peve_00025326,Pocillopora_meandrina_HIv1___RNAseq.g20109.t1,three_way,70.79983333333334,FUN_007062-T1,Q8IX03,KIBRA_HUMAN,,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),Homo sapiens (Human),29.0,1136.0,8.3e-51,204.1,sp|Q8IX03|KIBRA_HUMAN Protein KIBRA OS=Homo sapiens OX=9606 GN=WWC1 PE=1 SV=1,GO:0000122; GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0006355; GO:0008285; GO:0016477; GO:0019900; GO:0030010; GO:0032386; GO:0032587; GO:0035329; GO:0035330; GO:0035331; GO:0035591; GO:0043410; GO:0046621; GO:0048471; GO:0060090,cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; hippo signaling [GO:0035329]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of MAPK cascade [GO:0043410]; regulation of DNA-templated transcription [GO:0006355]; regulation of hippo signaling [GO:0035330]; regulation of intracellular transport [GO:0032386],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle membrane [GO:0032587],kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0007163; GO:0043226; GO:0048870; GO:0060090; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_01741,FUN_007063-T1,Peve_00025323,Pocillopora_meandrina_HIv1___RNAseq.g20108.t1,three_way,58.986666666666665,FUN_007063-T1,Q568G4,,,,,38.2,165.0,8.4e-23,108.6,sp|Q568G4|EFC11_DANRE EF-hand calcium-binding domain-containing protein 11 OS=Danio rerio OX=7955 GN=efcab11 PE=2 SV=1,,,,,,
OG_01742,FUN_007064-T1,Peve_00008212,Pocillopora_meandrina_HIv1___RNAseq.g20107.t1,three_way,83.80433333333333,FUN_007064-T1,Q66HG8,RED_RAT,,Protein Red (Cytokine IK) (IK factor),Rattus norvegicus (Rat),54.1,603.0,1e-108,395.6,sp|Q66HG8|RED_RAT Protein Red OS=Rattus norvegicus OX=10116 GN=Ik PE=1 SV=1,GO:0000228; GO:0000278; GO:0000398; GO:0005634; GO:0005654; GO:0005737; GO:0007094; GO:0034501; GO:0042802; GO:0071005; GO:0097431,"mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501]",cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005],identical protein binding [GO:0042802],GO:0000228; GO:0000278; GO:0005634; GO:0005654; GO:0005694; GO:0016071; GO:0043226,nuclear chromosome; mitotic cell cycle; nucleus; nucleoplasm; chromosome; mRNA metabolic process; organelle
OG_01743,FUN_007065-T1,Peve_00008223,Pocillopora_meandrina_HIv1___RNAseq.g20106.t1,three_way,76.10866666666666,FUN_007065-T1,Q5RC69,DCTD_PONAB,,Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),71.7,166.0,5.6999999999999996e-70,265.4,sp|Q5RC69|DCTD_PONAB Deoxycytidylate deaminase OS=Pongo abelii OX=9601 GN=DCTD PE=2 SV=1,GO:0004132; GO:0005737; GO:0006220; GO:0008270; GO:0009165; GO:0009972; GO:0043174; GO:0070694,cytidine deamination [GO:0009972]; nucleoside salvage [GO:0043174]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220],cytoplasm [GO:0005737],5-hydroxymethyl-dUMP N-hydrolase activity [GO:0070694]; dCMP deaminase activity [GO:0004132]; zinc ion binding [GO:0008270],GO:0003824; GO:0016787; GO:0055086; GO:1901135,catalytic activity; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01744,FUN_007067-T1,Peve_00016332,Pocillopora_meandrina_HIv1___RNAseq.g20098.t1,three_way,67.65816666666666,FUN_007067-T1,Q95NN1,,,,,63.9,355.0,8.400000000000002e-119,428.7,"sp|Q95NN1|T23O_TRICA Tryptophan 2,3-dioxygenase OS=Tribolium castaneum OX=7070 PE=2 SV=1",,,,,,
OG_01745,FUN_007069-T1,Peve_00019900,Pocillopora_meandrina_HIv1___RNAseq.g20089.t1,three_way,62.687666666666665,,,,,,,,,,,,,,,,,
OG_01746,FUN_007072-T2,Peve_00019898,Pocillopora_meandrina_HIv1___RNAseq.g20086.t1,three_way,53.24433333333334,FUN_007072-T2,B1AT66,MOT7_MOUSE,,Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6),Mus musculus (Mouse),24.3,202.0,2.2e-15,85.1,sp|B1AT66|MOT7_MOUSE Monocarboxylate transporter 7 OS=Mus musculus OX=10090 GN=Slc16a6 PE=1 SV=1,GO:0005368; GO:0016323,,basolateral plasma membrane [GO:0016323],taurine transmembrane transporter activity [GO:0005368],GO:0005215,transporter activity
OG_01747,FUN_007073-T1,Peve_00019897,Pocillopora_meandrina_HIv1___RNAseq.g20081.t1,three_way,71.9425,FUN_007073-T1,Q9DER7,,,,,47.7,870.0,3e-256,886.3,sp|Q9DER7|TLL1_CHICK Tolloid-like protein 1 OS=Gallus gallus OX=9031 GN=TLL1 PE=2 SV=1,,,,,,
OG_01748,FUN_007075-T1,Peve_00019894,Pocillopora_meandrina_HIv1___RNAseq.g20079.t1,three_way,81.41866666666667,FUN_007075-T1,B2RQR8,ECE2_MOUSE,,Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71),Mus musculus (Mouse),39.7,685.0,3.2e-147,523.9,sp|B2RQR8|ECE2_MOUSE Endothelin-converting enzyme 2 OS=Mus musculus OX=10090 GN=Ece2 PE=1 SV=1,GO:0000139; GO:0004222; GO:0005802; GO:0016486; GO:0030658; GO:0046872,peptide hormone processing [GO:0016486],Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_01749,FUN_007077-T1,Peve_00019891,Pocillopora_meandrina_HIv1___RNAseq.g20078.t1,three_way,66.15066666666667,FUN_007077-T1,Q0EEE2,PTHD3_MOUSE,,Patched domain-containing protein 3 (RND-type protein RNDEu-3),Mus musculus (Mouse),26.8,850.0,2.2e-62,242.3,sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0097225,,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225],,GO:0005783; GO:0005886; GO:0043226,endoplasmic reticulum; plasma membrane; organelle
OG_01750,FUN_007084-T1,Peve_00019890,Pocillopora_meandrina_HIv1___RNAseq.g20077.t2,three_way,43.15733333333333,FUN_007084-T1,Q99PF6,,,,,38.2,173.0,8.5e-17,90.9,sp|Q99PF6|GAB1_MESAU GRB2-associated-binding protein 1 OS=Mesocricetus auratus OX=10036 GN=GAB1 PE=2 SV=1,,,,,,
OG_01751,FUN_007085-T1,Peve_00019888,Pocillopora_meandrina_HIv1___RNAseq.g20076.t1,three_way,70.81283333333333,FUN_007085-T1,Q5E9X4,LRC59_BOVIN,,"Leucine-rich repeat-containing protein 59 [Cleaved into: Leucine-rich repeat-containing protein 59, N-terminally processed]",Bos taurus (Bovine),70.4,159.0,3.4e-14,80.5,sp|Q5E9X4|LRC59_BOVIN Leucine-rich repeat-containing protein 59 OS=Bos taurus OX=9913 GN=LRRC59 PE=2 SV=1,GO:0005635; GO:0005789; GO:0042645,,endoplasmic reticulum membrane [GO:0005789]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635],,GO:0005635; GO:0043226,nuclear envelope; organelle
OG_01752,FUN_007092-T1,Peve_00019879,Pocillopora_meandrina_HIv1___RNAseq.g19058.t1,three_way,57.32516666666667,FUN_007092-T1,Q8CDI6,,,,,27.6,174.0,1.1e-07,61.2,sp|Q8CDI6|CD158_MOUSE Coiled-coil domain-containing protein 158 OS=Mus musculus OX=10090 GN=Ccdc158 PE=2 SV=1,,,,,,
OG_01753,FUN_007094-T1,Peve_00019886,Pocillopora_meandrina_HIv1___RNAseq.g20104.t1,three_way,51.37266666666667,FUN_007094-T1,P82279,CRUM1_HUMAN,,Protein crumbs homolog 1,Homo sapiens (Human),56.8,37.0,1.3e-06,55.5,sp|P82279|CRUM1_HUMAN Protein crumbs homolog 1 OS=Homo sapiens OX=9606 GN=CRB1 PE=1 SV=2,GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0008104; GO:0010001; GO:0010467; GO:0010842; GO:0016324; GO:0032991; GO:0035003; GO:0035845; GO:0042462; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0071482; GO:0097386,blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; protein localization [GO:0008104]; retina layer formation [GO:0010842],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003],calcium ion binding [GO:0005509],GO:0005576; GO:0005886; GO:0007155; GO:0007163; GO:0023052; GO:0030154; GO:0048856; GO:0061024,extracellular region; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; signaling; cell differentiation; anatomical structure development; membrane organization
OG_01754,FUN_007095-T1,Peve_00033786,Pocillopora_meandrina_HIv1___RNAseq.g19054.t1,three_way,42.20366666666666,FUN_007095-T1,O70244,,,,,23.5,247.0,3.9e-06,54.3,sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2,,,,,,
OG_01755,FUN_007098-T1,Peve_00033785,Pocillopora_meandrina_HIv1___RNAseq.g19052.t1,three_way,33.566,,,,,,,,,,,,,,,,,
OG_01756,FUN_007099-T1,Peve_00033789,Pocillopora_meandrina_HIv1___RNAseq.g19050.t1,three_way,37.558,,,,,,,,,,,,,,,,,
OG_01757,FUN_007100-T1,Peve_00033790,Pocillopora_meandrina_HIv1___RNAseq.g19049.t1b,three_way,84.0445,FUN_007100-T1,O95714,HERC2_HUMAN,,E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2),Homo sapiens (Human),53.6,4960.0,0.0,4944.0,sp|O95714|HERC2_HUMAN E3 ubiquitin-protein ligase HERC2 OS=Homo sapiens OX=9606 GN=HERC2 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005654; GO:0005737; GO:0005814; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0006974; GO:0007283; GO:0008270; GO:0016020; GO:0016567; GO:0030182; GO:0031625; GO:0032183; GO:0043161; GO:0045746; GO:0061630,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; intracellular protein transport [GO:0006886]; negative regulation of Notch signaling pathway [GO:0045746]; neuron differentiation [GO:0030182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],centriole [GO:0005814]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006886; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; plasma membrane; DNA repair; intracellular protein transport; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01758,FUN_007101-T2,Peve_00033792,Pocillopora_meandrina_HIv1___RNAseq.g19049.t1a,three_way,71.41833333333334,FUN_007101-T2,Q80T79,CSMD3_MOUSE,,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),Mus musculus (Mouse),37.4,361.0,2.8e-67,259.2,sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3,GO:0005886; GO:0050773,regulation of dendrite development [GO:0050773],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_01759,FUN_007111-T1,Peve_00017835,Pocillopora_meandrina_HIv1___RNAseq.g19017.t1,three_way,39.03566666666666,,,,,,,,,,,,,,,,,
OG_01760,FUN_007115-T1,Peve_00017834,Pocillopora_meandrina_HIv1___TS.g28404.t1,three_way,70.838,FUN_007115-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),30.5,1384.0,1.1e-164,582.8,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_01761,FUN_007116-T1,Peve_00043797,Pocillopora_meandrina_HIv1___RNAseq.g18996.t1,three_way,88.80166666666666,FUN_007116-T1,Q32LE3,,,,,67.9,159.0,9e-33,141.7,sp|Q32LE3|CETN1_BOVIN Centrin-1 OS=Bos taurus OX=9913 GN=CETN1 PE=2 SV=1,,,,,,
OG_01762,FUN_007117-T1,Peve_00043801,Pocillopora_meandrina_HIv1___RNAseq.g18998.t1,three_way,71.51549999999999,FUN_007117-T1,O35565,FGF10_MOUSE,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Mus musculus (Mouse),30.2,129.0,4.2e-10,67.0,sp|O35565|FGF10_MOUSE Fibroblast growth factor 10 OS=Mus musculus OX=10090 GN=Fgf10 PE=2 SV=1,GO:0000132; GO:0000278; GO:0001525; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005111; GO:0005615; GO:0005634; GO:0005886; GO:0006935; GO:0007267; GO:0007368; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008544; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010468; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030036; GO:0030177; GO:0030324; GO:0030538; GO:0030855; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0035108; GO:0035265; GO:0042056; GO:0042060; GO:0042246; GO:0042472; GO:0042475; GO:0042693; GO:0043616; GO:0045739; GO:0045747; GO:0045893; GO:0045931; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048286; GO:0048514; GO:0048536; GO:0048538; GO:0048557; GO:0048565; GO:0048566; GO:0048645; GO:0048730; GO:0048752; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060173; GO:0060174; GO:0060425; GO:0060428; GO:0060430; GO:0060436; GO:0060441; GO:0060445; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060541; GO:0060594; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in salivary gland morphogenesis [GO:0060445]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; inner ear morphogenesis [GO:0042472]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mammary gland specification [GO:0060594]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros morphogenesis [GO:0003338]; mitotic cell cycle [GO:0000278]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; positive regulation of Wnt signaling pathway [GO:0030177]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of gene expression [GO:0010468]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; respiratory system development [GO:0060541]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland morphogenesis [GO:0007435]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; semicircular canal morphogenesis [GO:0048752]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0000278; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_01763,FUN_007118-T1,Peve_00043802,Pocillopora_meandrina_HIv1___RNAseq.g18999.t1,three_way,83.32566666666666,FUN_007118-T1,Q9XVI9,,,,,34.0,97.0,2.8e-12,73.6,sp|Q9XVI9|MLC5_CAEEL Myosin-2 essential light chain OS=Caenorhabditis elegans OX=6239 GN=mlc-5 PE=1 SV=1,,,,,,
OG_01764,FUN_007119-T1,Peve_00043804,Pocillopora_meandrina_HIv1___RNAseq.g19000.t1,three_way,66.69666666666666,FUN_007119-T1,Q498J9,,,,,50.0,192.0,1.3000000000000002e-44,181.0,sp|Q498J9|MBLC1_XENLA Metallo-beta-lactamase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=mblac1 PE=2 SV=2,,,,,,
OG_01765,FUN_007120-T1,Peve_00043805,Pocillopora_meandrina_HIv1___RNAseq.g19001.t1,three_way,78.95066666666666,FUN_007120-T1,Q5RJZ6,,,,,54.7,117.0,1.2e-20,100.9,sp|Q5RJZ6|SCOC_RAT Short coiled-coil protein OS=Rattus norvegicus OX=10116 GN=Scoc PE=2 SV=1,,,,,,
OG_01766,FUN_007121-T1,Peve_00043806,Pocillopora_meandrina_HIv1___RNAseq.g19005.t1,three_way,76.08166666666666,FUN_007121-T1,F1R8P4,GLRA2_DANRE,,Glycine receptor subunit alpha-2,Danio rerio (Zebrafish) (Brachydanio rerio),37.9,393.0,1.8e-73,278.1,sp|F1R8P4|GLRA2_DANRE Glycine receptor subunit alpha-2 OS=Danio rerio OX=7955 GN=glra2 PE=3 SV=2,GO:0004888; GO:0005254; GO:0016594; GO:0022824; GO:0034707; GO:0042995; GO:0045211; GO:0046872,,cell projection [GO:0042995]; chloride channel complex [GO:0034707]; postsynaptic membrane [GO:0045211],chloride channel activity [GO:0005254]; glycine binding [GO:0016594]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824],GO:0005215; GO:0060089,transporter activity; molecular transducer activity
OG_01767,FUN_007124-T1,Peve_00043808,Pocillopora_meandrina_HIv1___RNAseq.g19007.t1,three_way,62.52783333333333,FUN_007124-T1,P35218,CAH5A_HUMAN,,"Carbonic anhydrase 5A, mitochondrial (EC 4.2.1.1) (Carbonate dehydratase VA) (Carbonic anhydrase VA) (CA-VA)",Homo sapiens (Human),36.5,244.0,1.4e-38,162.9,"sp|P35218|CAH5A_HUMAN Carbonic anhydrase 5A, mitochondrial OS=Homo sapiens OX=9606 GN=CA5A PE=1 SV=1",GO:0004089; GO:0005737; GO:0005739; GO:0005759; GO:0008270,,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0016829; GO:0043226,catalytic activity; mitochondrion; lyase activity; organelle
OG_01768,FUN_007125-T1,Peve_00012337,Pocillopora_meandrina_HIv1___RNAseq.g19008.t1a,three_way,45.29433333333333,,,,,,,,,,,,,,,,,
OG_01769,FUN_007126-T1,Peve_00012336,Pocillopora_meandrina_HIv1___RNAseq.g19009.t1,three_way,74.4505,,,,,,,,,,,,,,,,,
OG_01770,FUN_007137-T1,Peve_00019729,Pocillopora_meandrina_HIv1___RNAseq.g19685.t1,three_way,58.20933333333333,FUN_007137-T1,Q4V8V2,NUD17_DANRE,,m7GpppN-mRNA hydrolase NUDT17 (EC 3.6.1.62) (Nucleoside diphosphate-linked moiety X motif 17) (Nudix motif 17),Danio rerio (Zebrafish) (Brachydanio rerio),41.2,262.0,2.3e-46,187.6,sp|Q4V8V2|NUD17_DANRE m7GpppN-mRNA hydrolase NUDT17 OS=Danio rerio OX=7955 GN=nudt17 PE=2 SV=1,GO:0005777; GO:0006734; GO:0006742; GO:0019677; GO:0035529; GO:0046872,NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742],peroxisome [GO:0005777],metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529],GO:0003824; GO:0005777; GO:0016787; GO:0043226; GO:0055086,catalytic activity; peroxisome; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_01771,FUN_007139-T1,Peve_00019740,Pocillopora_meandrina_HIv1___TS.g29075.t1,three_way,46.34583333333333,FUN_007139-T1,P13497,BMP1_HUMAN,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Homo sapiens (Human),36.4,121.0,8.3e-14,79.3,sp|P13497|BMP1_HUMAN Bone morphogenetic protein 1 OS=Homo sapiens OX=9606 GN=BMP1 PE=1 SV=2,GO:0001501; GO:0001502; GO:0001503; GO:0004222; GO:0004252; GO:0005125; GO:0005509; GO:0005576; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0030199; GO:0031982; GO:0042802; GO:0061036,cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501],extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0030198; GO:0043226; GO:0048018; GO:0048856; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; extracellular region; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; extracellular matrix organization; organelle; receptor ligand activity; anatomical structure development; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01772,FUN_007140-T1,Peve_00019741,Pocillopora_meandrina_HIv1___RNAseq.3188_t,three_way,68.71666666666667,,,,,,,,,,,,,,,,,
OG_01773,FUN_007141-T1,Peve_00019742,Pocillopora_meandrina_HIv1___RNAseq.g19690.t1,three_way,77.7825,FUN_007141-T1,Q5XGY1,,,,,62.0,674.0,8.3e-187,655.2,sp|Q5XGY1|TSR1_XENLA Pre-rRNA-processing protein TSR1 homolog OS=Xenopus laevis OX=8355 GN=tsr1 PE=2 SV=1,,,,,,
OG_01774,FUN_007143-T1,Peve_00016773,Pocillopora_meandrina_HIv1___RNAseq.g19708.t1,three_way,74.94533333333334,FUN_007143-T1,Q99JY4,,,,,54.4,309.0,8.999999999999999e-94,345.5,sp|Q99JY4|TRABD_MOUSE TraB domain-containing protein OS=Mus musculus OX=10090 GN=Trabd PE=1 SV=1,,,,,,
OG_01775,FUN_007144-T1,Peve_00031718,Pocillopora_meandrina_HIv1___RNAseq.g19710.t1,three_way,84.50666666666666,FUN_007144-T1,Q9ULR3,PPM1H_HUMAN,,Protein phosphatase 1H (EC 3.1.3.16),Homo sapiens (Human),45.3,475.0,2.5e-100,367.5,sp|Q9ULR3|PPM1H_HUMAN Protein phosphatase 1H OS=Homo sapiens OX=9606 GN=PPM1H PE=1 SV=2,GO:0004721; GO:0004741; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0007165; GO:0042802; GO:0098978,signal transduction [GO:0007165],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],[pyruvate dehydrogenase (acetyl-transferring)]-phosphatase activity [GO:0004741]; identical protein binding [GO:0042802]; phosphoprotein phosphatase activity [GO:0004721],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01776,FUN_007147-T1,Peve_00028251,Pocillopora_meandrina_HIv1___RNAseq.g19713.t1,three_way,84.04533333333333,FUN_007147-T1,A3KMV5,UBA1_BOVIN,,Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Ubiquitin-activating enzyme E1),Bos taurus (Bovine),64.7,1057.0,0.0,1406.3,sp|A3KMV5|UBA1_BOVIN Ubiquitin-like modifier-activating enzyme 1 OS=Bos taurus OX=9913 GN=UBA1 PE=2 SV=1,GO:0004839; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006511; GO:0006974; GO:0016567,DNA damage response [GO:0006974]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839],GO:0003824; GO:0005634; GO:0005739; GO:0016874; GO:0043226; GO:0140096; GO:0140657,"catalytic activity; nucleus; mitochondrion; ligase activity; organelle; catalytic activity, acting on a protein; ATP-dependent activity"
OG_01777,FUN_007148-T1,Peve_00028252,Pocillopora_meandrina_HIv1___RNAseq.g19712.t1,three_way,76.93933333333332,FUN_007148-T1,Q4R6T7,IQUB_MACFA,,IQ motif and ubiquitin-like domain-containing protein,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),50.9,633.0,6.800000000000001e-178,625.9,sp|Q4R6T7|IQUB_MACFA IQ motif and ubiquitin-like domain-containing protein OS=Macaca fascicularis OX=9541 GN=IQUB PE=2 SV=2,GO:0001534; GO:0001669; GO:0007618; GO:0030317; GO:0036126; GO:0060271; GO:0097729,cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; mating [GO:0007618],9+2 motile cilium [GO:0097729]; acrosomal vesicle [GO:0001669]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782; GO:0048870,cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization; cell motility
OG_01778,FUN_007150-T1,Peve_00028250,Pocillopora_meandrina_HIv1___RNAseq.g19714.t1,three_way,81.34100000000001,FUN_007150-T1,Q96DB2,HDA11_HUMAN,,Histone deacetylase 11 (HD11) (EC 3.5.1.98),Homo sapiens (Human),63.6,319.0,6.7e-119,428.7,sp|Q96DB2|HDA11_HUMAN Histone deacetylase 11 OS=Homo sapiens OX=9606 GN=HDAC11 PE=1 SV=1,GO:0000118; GO:0004407; GO:0005634; GO:0005886; GO:0006325; GO:0040029; GO:0140297; GO:0141221,chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029],histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; chromatin organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01779,FUN_007151-T1,Peve_00028249,Pocillopora_meandrina_HIv1___RNAseq.g19715.t1,three_way,89.094,FUN_007151-T1,Q9H4K1,,,,,43.0,374.0,1.4e-71,271.6,sp|Q9H4K1|RIBC2_HUMAN RIB43A-like with coiled-coils protein 2 OS=Homo sapiens OX=9606 GN=RIBC2 PE=1 SV=2,,,,,,
OG_01780,FUN_007152-T1,Peve_00028248,Pocillopora_meandrina_HIv1___RNAseq.g19716.t1,three_way,58.192,,,,,,,,,,,,,,,,,
OG_01781,FUN_007154-T1,Peve_00028245,Pocillopora_meandrina_HIv1___RNAseq.g19717.t1,three_way,57.98466666666666,FUN_007154-T1,P98095,FBLN2_HUMAN,,Fibulin-2 (FIBL-2),Homo sapiens (Human),25.7,288.0,3.1e-13,79.0,sp|P98095|FBLN2_HUMAN Fibulin-2 OS=Homo sapiens OX=9606 GN=FBLN2 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005576; GO:0010811; GO:0030023; GO:0031012; GO:0050840; GO:0062023; GO:1903561,positive regulation of cell-substrate adhesion [GO:0010811],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561],calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030312; GO:0031012; GO:0043226,structural molecule activity; extracellular region; external encapsulating structure; extracellular matrix; organelle
OG_01782,FUN_007155-T1,Peve_00028244,Pocillopora_meandrina_HIv1___TS.g29111.t1,three_way,72.6365,FUN_007155-T1,Q9PT84,,,,,43.9,471.0,5.1e-99,363.6,sp|Q9PT84|KCNH6_CHICK Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Gallus gallus OX=9031 GN=KCNH6 PE=2 SV=2,,,,,,
OG_01783,FUN_007157-T1,Peve_00028237,Pocillopora_meandrina_HIv1___RNAseq.g19721.t1,three_way,84.35466666666667,FUN_007157-T1,Q02370,,,,,59.3,91.0,1.5e-25,116.7,sp|Q02370|NDUA2_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 OS=Bos taurus OX=9913 GN=NDUFA2 PE=1 SV=2,,,,,,
OG_01784,FUN_007160-T1,Peve_00028234,Pocillopora_meandrina_HIv1___RNAseq.g19727.t1,three_way,78.381,FUN_007160-T1,Q9JMD3,STA10_MOUSE,,START domain-containing protein 10 (StARD10) (PCTP-like protein) (PCTP-L) (Serologically defined colon cancer antigen 28 homolog) (StAR-related lipid transfer protein 10),Mus musculus (Mouse),43.5,237.0,4.3e-54,213.0,sp|Q9JMD3|STA10_MOUSE START domain-containing protein 10 OS=Mus musculus OX=10090 GN=Stard10 PE=1 SV=1,GO:0005829; GO:0005902; GO:0006869; GO:0008289; GO:0016020; GO:0031514; GO:0032782; GO:0035360; GO:0046581,bile acid secretion [GO:0032782]; lipid transport [GO:0006869]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360],cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514],lipid binding [GO:0008289],GO:0005829; GO:0005929; GO:0008289; GO:0043226,cytosol; cilium; lipid binding; organelle
OG_01785,FUN_007161-T1,Peve_00042489,Pocillopora_meandrina_HIv1___RNAseq.g19738.t2,three_way,80.99133333333333,FUN_007161-T1,P46019,KPB2_HUMAN,,"Phosphorylase b kinase regulatory subunit alpha, liver isoform (Phosphorylase kinase alpha L subunit)",Homo sapiens (Human),48.8,1257.0,0.0,1095.9,"sp|P46019|KPB2_HUMAN Phosphorylase b kinase regulatory subunit alpha, liver isoform OS=Homo sapiens OX=9606 GN=PHKA2 PE=1 SV=1",GO:0004689; GO:0005516; GO:0005829; GO:0005886; GO:0005964; GO:0005975; GO:0005977; GO:0006091; GO:0036211,carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; protein modification process [GO:0036211],cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886],calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689],GO:0003824; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0016740; GO:0140096,"catalytic activity; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; catalytic activity, acting on a protein"
OG_01786,FUN_007162-T1,Peve_00042490,Pocillopora_meandrina_HIv1___RNAseq.g19739.t1,three_way,62.22566666666667,,,,,,,,,,,,,,,,,
OG_01787,FUN_007164-T1,Peve_00042488,Pocillopora_meandrina_HIv1___TS.g29132.t1,three_way,44.758833333333335,FUN_007164-T1,Q2RBN7,,,,,32.4,108.0,7.2e-09,63.5,sp|Q2RBN7|CLH1_ORYSJ Clathrin heavy chain 1 OS=Oryza sativa subsp. japonica OX=39947 GN=Os11g0104900 PE=3 SV=1,,,,,,
OG_01788,FUN_007166-T1,Peve_00042484,Pocillopora_meandrina_HIv1___RNAseq.g19745.t1,three_way,75.658,FUN_007166-T1,P57695,,,,,37.9,457.0,8.7e-76,285.8,sp|P57695|GLRA1_BOVIN Glycine receptor subunit alpha-1 OS=Bos taurus OX=9913 GN=GLRA1 PE=1 SV=1,,,,,,
OG_01789,FUN_007169-T1,Peve_00026948,Pocillopora_meandrina_HIv1___RNAseq.g19749.t1,three_way,52.4205,FUN_007169-T1,P51587,BRCA2_HUMAN,,Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein),Homo sapiens (Human),31.1,1439.0,3.1e-152,542.3,sp|P51587|BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens OX=9606 GN=BRCA2 PE=1 SV=4,GO:0000152; GO:0000722; GO:0000724; GO:0000781; GO:0000800; GO:0001556; GO:0001833; GO:0002020; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0007141; GO:0007283; GO:0007420; GO:0008585; GO:0010165; GO:0010225; GO:0010332; GO:0010484; GO:0010485; GO:0030141; GO:0030330; GO:0032465; GO:0032991; GO:0033593; GO:0033600; GO:0042771; GO:0042802; GO:0043015; GO:0045893; GO:0045931; GO:0051298; GO:0070200; GO:0071425; GO:0071479; GO:0090398; GO:1990391; GO:1990426; GO:2000001,"brain development [GO:0007420]; cellular response to ionizing radiation [GO:0071479]; cellular senescence [GO:0090398]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hematopoietic stem cell proliferation [GO:0071425]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of cytokinesis [GO:0032465]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA-templated transcription [GO:0006355]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]","BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; lateral element [GO:0000800]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]",gamma-tubulin binding [GO:0043015]; histone H3 acetyltransferase activity [GO:0010484]; histone H4 acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006310; GO:0006355; GO:0008092; GO:0016740; GO:0022414; GO:0031410; GO:0032200; GO:0043226; GO:0048856; GO:0140013; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; DNA recombination; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; reproductive process; cytoplasmic vesicle; telomere organization; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on a protein"
OG_01790,FUN_007170-T1,Peve_00002487,Pocillopora_meandrina_HIv1___TS.g29141.t1,three_way,81.03533333333334,,,,,,,,,,,,,,,,,
OG_01791,FUN_007171-T1,Peve_00019731,Pocillopora_meandrina_HIv1___RNAseq.g19751.t1,three_way,75.6985,FUN_007171-T1,Q7ZW24,,,,,56.6,498.0,2e-160,567.4,"sp|Q7ZW24|ALG11_DANRE GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase OS=Danio rerio OX=7955 GN=alg11 PE=2 SV=2",,,,,,
OG_01792,FUN_007172-T1,Peve_00019754,Pocillopora_meandrina_HIv1___RNAseq.g19765.t1b,three_way,69.35266666666666,FUN_007172-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),43.9,1072.0,5.8e-264,912.1,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_01793,FUN_007174-T1,Peve_00042728,Pocillopora_meandrina_HIv1___TS.g29157.t2,three_way,69.60000000000001,FUN_007174-T1,Q58DN4,,,,,53.4,380.0,2.5e-108,393.7,sp|Q58DN4|PPME1_BOVIN Protein phosphatase methylesterase 1 OS=Bos taurus OX=9913 GN=PPME1 PE=2 SV=3,,,,,,
OG_01794,FUN_007176-T1,Peve_00042729,Pocillopora_meandrina_HIv1___RNAseq.g19768.t1,three_way,76.79599999999999,FUN_007176-T1,Q9CQ22,LTOR1_MOUSE,,Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18),Mus musculus (Mouse),41.8,165.0,3.7e-21,102.8,sp|Q9CQ22|LTOR1_MOUSE Ragulator complex protein LAMTOR1 OS=Mus musculus OX=10090 GN=Lamtor1 PE=1 SV=1,GO:0001558; GO:0001919; GO:0005085; GO:0005764; GO:0005765; GO:0007032; GO:0007040; GO:0008104; GO:0010874; GO:0016197; GO:0031669; GO:0031902; GO:0032008; GO:0032418; GO:0038202; GO:0042632; GO:0043410; GO:0043495; GO:0045121; GO:0051020; GO:0060620; GO:0071230; GO:0071986; GO:0072657; GO:0150032; GO:1904263; GO:1990877,cellular response to amino acid stimulus [GO:0071230]; cellular response to nutrient levels [GO:0031669]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to lysosome [GO:0150032]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization [GO:0008104]; protein localization to membrane [GO:0072657]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919]; TORC1 signaling [GO:0038202],FNIP-folliculin RagC/D GAP [GO:1990877]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; Ragulator complex [GO:0071986],GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-membrane adaptor activity [GO:0043495],GO:0005764; GO:0005773; GO:0007040; GO:0016192; GO:0043226; GO:0060090; GO:0098772,lysosome; vacuole; lysosome organization; vesicle-mediated transport; organelle; molecular adaptor activity; molecular function regulator activity
OG_01795,FUN_007180-T1,Peve_00042731,Pocillopora_meandrina_HIv1___RNAseq.g19780.t1,three_way,75.47366666666666,FUN_007180-T1,P95329,,,,,40.0,475.0,2.5e-97,357.5,sp|P95329|MASY_MYXXD Malate synthase OS=Myxococcus xanthus (strain DK1622) OX=246197 GN=mls PE=3 SV=2,,,,,,
OG_01796,FUN_007181-T1,Peve_00015050,Pocillopora_meandrina_HIv1___RNAseq.g19781.t1,three_way,79.889,FUN_007181-T1,Q80UM3,NAA15_MOUSE,,"N-alpha-acetyltransferase 15, NatA auxiliary subunit (N-terminal acetyltransferase 1) (NMDA receptor-regulated protein 1) (Protein tubedown-1)",Mus musculus (Mouse),59.2,833.0,7.7e-267,921.4,"sp|Q80UM3|NAA15_MOUSE N-alpha-acetyltransferase 15, NatA auxiliary subunit OS=Mus musculus OX=10090 GN=Naa15 PE=1 SV=1",GO:0001525; GO:0005634; GO:0005737; GO:0008080; GO:0030154; GO:0048471,angiogenesis [GO:0001525]; cell differentiation [GO:0030154],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],N-acetyltransferase activity [GO:0008080],GO:0003824; GO:0005634; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nucleus; transferase activity; cell differentiation; organelle
OG_01797,FUN_007182-T1,Peve_00015051,Pocillopora_meandrina_HIv1___RNAseq.g19782.t1,three_way,84.865,FUN_007182-T1,Q9H920,,,,,62.4,303.0,1.3e-116,421.0,sp|Q9H920|RN121_HUMAN E3 ubiquitin ligase RNF121 OS=Homo sapiens OX=9606 GN=RNF121 PE=1 SV=1,,,,,,
OG_01798,FUN_007183-T1,Peve_00017407,Pocillopora_meandrina_HIv1___RNAseq.g19787.t1,three_way,70.00833333333333,FUN_007183-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),45.2,1072.0,3.400000000000001e-277,956.1,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_01799,FUN_007221-T1,Peve_00043688,Pocillopora_meandrina_HIv1___RNAseq.g30308.t1,three_way,71.555,FUN_007221-T1,Q6P0D1,,,,,36.5,96.0,1.4e-07,57.8,sp|Q6P0D1|ZNT6_DANRE Zinc transporter 6 OS=Danio rerio OX=7955 GN=slc30a6 PE=2 SV=1,,,,,,
OG_01800,FUN_007227-T1,Peve_00043654,Pocillopora_meandrina_HIv1___RNAseq.g30300.t1,three_way,45.69566666666667,,,,,,,,,,,,,,,,,
OG_01801,FUN_007229-T1,Peve_00043687,Pocillopora_meandrina_HIv1___TS.g22606.t1,three_way,68.12899999999999,,,,,,,,,,,,,,,,,
OG_01802,FUN_007332-T1,Peve_00043671,Pocillopora_meandrina_HIv1___RNAseq.g30303.t1,three_way,92.95366666666666,FUN_007332-T1,Q2YDE4,,,,,78.9,246.0,5.2e-115,415.2,sp|Q2YDE4|PSA6_BOVIN Proteasome subunit alpha type-6 OS=Bos taurus OX=9913 GN=PSMA6 PE=1 SV=1,,,,,,
OG_01803,FUN_007337-T1,Peve_00043689,Pocillopora_meandrina_HIv1___RNAseq.g30307.t1,three_way,76.888,FUN_007337-T1,Q6P7Q4,LGUL_RAT,,Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase),Rattus norvegicus (Rat),66.3,169.0,3.1e-65,249.6,sp|Q6P7Q4|LGUL_RAT Lactoylglutathione lyase OS=Rattus norvegicus OX=10116 GN=Glo1 PE=1 SV=3,GO:0004462; GO:0005654; GO:0005829; GO:0005886; GO:0006357; GO:0006749; GO:0008270; GO:0009438; GO:0030316; GO:0043066,glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0006575; GO:0006790; GO:0016829; GO:0030154,catalytic activity; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; modified amino acid metabolic process; sulfur compound metabolic process; lyase activity; cell differentiation
OG_01804,FUN_007338-T1,Peve_00043690,Pocillopora_meandrina_HIv1___RNAseq.27619_t,three_way,62.425666666666665,,,,,,,,,,,,,,,,,
OG_01805,FUN_007604-T1,Peve_00044475,Pocillopora_meandrina_HIv1___RNAseq.g5801.t1,three_way,91.57266666666666,FUN_007604-T1,P23381,SYWC_HUMAN,,"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]",Homo sapiens (Human),68.7,402.0,3.4e-162,572.8,"sp|P23381|SYWC_HUMAN Tryptophan--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=WARS1 PE=1 SV=2",GO:0001525; GO:0004830; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006436; GO:0006469; GO:0008285; GO:0010628; GO:0019210; GO:0019901; GO:0019904; GO:0031334; GO:0032991; GO:0042803; GO:0045765; GO:0070062,angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; translation [GO:0006412]; tryptophanyl-tRNA aminoacylation [GO:0006436],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830],GO:0003824; GO:0005634; GO:0005829; GO:0006399; GO:0006520; GO:0016874; GO:0043226; GO:0098772; GO:0140098,"catalytic activity; nucleus; cytosol; tRNA metabolic process; amino acid metabolic process; ligase activity; organelle; molecular function regulator activity; catalytic activity, acting on RNA"
OG_01806,FUN_007605-T1,Peve_00044474,Pocillopora_meandrina_HIv1___RNAseq.g5807.t1,three_way,74.639,FUN_007605-T1,Q86W24,NAL14_HUMAN,,"NACHT, LRR and PYD domains-containing protein 14 (Nucleotide-binding oligomerization domain protein 5)",Homo sapiens (Human),29.0,217.0,7.6e-06,52.8,"sp|Q86W24|NAL14_HUMAN NACHT, LRR and PYD domains-containing protein 14 OS=Homo sapiens OX=9606 GN=NLRP14 PE=1 SV=1",GO:0005524; GO:0005737; GO:0007283; GO:0030154; GO:0050727,cell differentiation [GO:0030154]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737],ATP binding [GO:0005524],GO:0022414; GO:0030154,reproductive process; cell differentiation
OG_01807,FUN_007606-T1,Peve_00034276,Pocillopora_meandrina_HIv1___TS.g24525.t2,three_way,41.922,,,,,,,,,,,,,,,,,
OG_01808,FUN_007607-T1,Peve_00034273,Pocillopora_meandrina_HIv1___RNAseq.g5809.t1,three_way,55.49466666666667,FUN_007607-T1,Q8R2S1,,,,,31.8,525.0,3.5e-63,245.0,sp|Q8R2S1|RPKL1_MOUSE Ribosomal protein S6 kinase-like 1 OS=Mus musculus OX=10090 GN=Rps6kl1 PE=1 SV=1,,,,,,
OG_01809,FUN_007627-T1,Peve_00001036,Pocillopora_meandrina_HIv1___RNAseq.g9139.t1,three_way,62.01466666666666,,,,,,,,,,,,,,,,,
OG_01810,FUN_007645-T1,Peve_00034272,Pocillopora_meandrina_HIv1___RNAseq.g5810.t1,three_way,52.86483333333334,FUN_007645-T1,O16099,,,,,36.6,503.0,1e-81,305.8,sp|O16099|MAL2_DROVI Maltase 2 OS=Drosophila virilis OX=7244 GN=Mal-B2 PE=3 SV=2,,,,,,
OG_01811,FUN_007646-T1,Peve_00034271,Pocillopora_meandrina_HIv1___RNAseq.g5811.t1,three_way,71.30533333333334,FUN_007646-T1,Q92994,,,,,44.1,551.0,3.1e-91,337.4,sp|Q92994|TF3B_HUMAN Transcription factor IIIB 90 kDa subunit OS=Homo sapiens OX=9606 GN=BRF1 PE=1 SV=1,,,,,,
OG_01812,FUN_007668-T1,Peve_00014362,Pocillopora_meandrina_HIv1___RNAseq.g5893.t1,three_way,51.5685,,,,,,,,,,,,,,,,,
OG_01813,FUN_007669-T1,Peve_00014361,Pocillopora_meandrina_HIv1___RNAseq.g5891.t1,three_way,42.031666666666666,,,,,,,,,,,,,,,,,
OG_01814,FUN_007677-T1,Peve_00034811,Pocillopora_meandrina_HIv1___RNAseq.g5865.t1,three_way,70.54666666666667,FUN_007677-T1,Q9TRY0,,,,,30.6,186.0,2.9e-17,90.1,sp|Q9TRY0|FKBP4_BOVIN Peptidyl-prolyl cis-trans isomerase FKBP4 OS=Bos taurus OX=9913 GN=FKBP4 PE=1 SV=4,,,,,,
OG_01815,FUN_007678-T1,Peve_00013716,Pocillopora_meandrina_HIv1___RNAseq.g5864.t1,three_way,73.167,FUN_007678-T1,O95433,,,,,47.3,347.0,9.9e-88,325.1,sp|O95433|AHSA1_HUMAN Activator of 90 kDa heat shock protein ATPase homolog 1 OS=Homo sapiens OX=9606 GN=AHSA1 PE=1 SV=1,,,,,,
OG_01816,FUN_007688-T1,Peve_00001056,Pocillopora_meandrina_HIv1___RNAseq.g18040.t1,three_way,82.33016666666667,FUN_007688-T1,Q68FW6,,,,,34.5,397.0,8.7e-49,196.1,sp|Q68FW6|PPR36_RAT Protein phosphatase 1 regulatory subunit 36 OS=Rattus norvegicus OX=10116 GN=Ppp1r36 PE=2 SV=1,,,,,,
OG_01817,FUN_007690-T1,Peve_00012973,Pocillopora_meandrina_HIv1___RNAseq.g18009.t1b,three_way,56.254666666666665,,,,,,,,,,,,,,,,,
OG_01818,FUN_007691-T1,Peve_00012972,Pocillopora_meandrina_HIv1___RNAseq.g18008.t1,three_way,45.01766666666666,,,,,,,,,,,,,,,,,
OG_01819,FUN_007692-T1,Peve_00012970,Pocillopora_meandrina_HIv1___TS.g20995.t1,three_way,65.00733333333334,,,,,,,,,,,,,,,,,
OG_01820,FUN_007693-T1,Peve_00026595,Pocillopora_meandrina_HIv1___RNAseq.g18006.t2,three_way,58.693666666666665,FUN_007693-T1,B0BM95,ACTMP_XENTR,,Actin maturation protease (EC 3.4.11.-) (Actin aminopeptidase ACTMAP),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),38.7,261.0,1.1e-41,171.8,sp|B0BM95|ACTMP_XENTR Actin maturation protease OS=Xenopus tropicalis OX=8364 GN=actmap PE=2 SV=2,GO:0004239; GO:0005737; GO:0016485,protein processing [GO:0016485],cytoplasm [GO:0005737],initiator methionyl aminopeptidase activity [GO:0004239],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_01821,FUN_007694-T1,Peve_00026596,Pocillopora_meandrina_HIv1___RNAseq.g18005.t1,three_way,80.34066666666666,FUN_007694-T1,Q9H307,,,,,52.2,274.0,2.5e-25,117.9,sp|Q9H307|PININ_HUMAN Pinin OS=Homo sapiens OX=9606 GN=PNN PE=1 SV=5,,,,,,
OG_01822,FUN_007695-T1,Peve_00026597,Pocillopora_meandrina_HIv1___RNAseq.g18003.t1,three_way,72.62466666666667,,,,,,,,,,,,,,,,,
OG_01823,FUN_007696-T1,Peve_00026598,Pocillopora_meandrina_HIv1___RNAseq.g17999.t1,three_way,72.92433333333334,FUN_007696-T1,O14772,FPGT_HUMAN,,Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30) (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase),Homo sapiens (Human),42.2,588.0,1.1e-115,418.7,sp|O14772|FPGT_HUMAN Fucose-1-phosphate guanylyltransferase OS=Homo sapiens OX=9606 GN=FPGT PE=1 SV=3,GO:0005525; GO:0005737; GO:0005829; GO:0006004; GO:0042350; GO:0047341,fucose metabolic process [GO:0006004]; GDP-L-fucose biosynthetic process [GO:0042350],cytoplasm [GO:0005737]; cytosol [GO:0005829],fucose-1-phosphate guanylyltransferase activity [GO:0047341]; GTP binding [GO:0005525],GO:0003824; GO:0005829; GO:0005975; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_01824,FUN_007697-T1,Peve_00028498,Pocillopora_meandrina_HIv1___RNAseq.g17998.t1,three_way,93.42266666666669,FUN_007697-T1,F1QMV3,,,,,64.5,155.0,1.8e-52,206.8,sp|F1QMV3|TPC6B_DANRE Trafficking protein particle complex subunit 6b OS=Danio rerio OX=7955 GN=trappc6b PE=2 SV=1,,,,,,
OG_01825,FUN_007699-T1,Peve_00030615,Pocillopora_meandrina_HIv1___RNAseq.g17995.t1,three_way,69.25383333333333,FUN_007699-T1,G3M4F8,,,,,26.0,315.0,2.5e-17,91.3,sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1,,,,,,
OG_01826,FUN_007700-T1,Peve_00029067,Pocillopora_meandrina_HIv1___TS.g21014.t1,three_way,75.481,,,,,,,,,,,,,,,,,
OG_01827,FUN_007701-T1,Peve_00031491,Pocillopora_meandrina_HIv1___RNAseq.g18026.t1,three_way,51.928666666666665,FUN_007701-T1,P49852,HMP_BACSU,,Flavohemoprotein (Flavohemoglobin) (Hemoglobin-like protein) (Nitric oxide dioxygenase) (NO oxygenase) (NOD) (EC 1.14.12.17),Bacillus subtilis (strain 168),30.3,132.0,1e-11,72.0,sp|P49852|HMP_BACSU Flavohemoprotein OS=Bacillus subtilis (strain 168) OX=224308 GN=hmp PE=2 SV=1,GO:0005344; GO:0005737; GO:0008941; GO:0009636; GO:0019825; GO:0020037; GO:0046210; GO:0046872; GO:0071500; GO:0071949,cellular response to nitrosative stress [GO:0071500]; nitric oxide catabolic process [GO:0046210]; response to toxic substance [GO:0009636],cytoplasm [GO:0005737],FAD binding [GO:0071949]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase NAD(P)H activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],GO:0003824; GO:0016491; GO:0140104,catalytic activity; oxidoreductase activity; molecular carrier activity
OG_01828,FUN_007708-T1,Peve_00013719,Pocillopora_meandrina_HIv1___RNAseq.g5861.t1,three_way,82.725,FUN_007708-T1,Q70CQ2,UBP34_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34),Homo sapiens (Human),42.6,3491.0,0.0,2497.2,sp|Q70CQ2|UBP34_HUMAN Ubiquitin carboxyl-terminal hydrolase 34 OS=Homo sapiens OX=9606 GN=USP34 PE=1 SV=2,GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016055; GO:0016579; GO:0031647; GO:0071108; GO:0090263,positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01829,FUN_007725-T1,Peve_00023369,Pocillopora_meandrina_HIv1___RNAseq.g15954.t1,three_way,47.985,,,,,,,,,,,,,,,,,
OG_01830,FUN_007734-T1,Peve_00040334,Pocillopora_meandrina_HIv1___TS.g17440.t1a,three_way,59.74733333333333,,,,,,,,,,,,,,,,,
OG_01831,FUN_007741-T1,Peve_00033319,Pocillopora_meandrina_HIv1___RNAseq.g19460.t1,three_way,73.28466666666667,,,,,,,,,,,,,,,,,
OG_01832,FUN_007748-T1,Peve_00033175,Pocillopora_meandrina_HIv1___RNAseq.g5860.t1,three_way,75.091,FUN_007748-T1,Q5ZKL5,,,,,33.3,672.0,1.5e-98,362.1,sp|Q5ZKL5|PPCEL_CHICK Prolyl endopeptidase-like OS=Gallus gallus OX=9031 GN=PREPL PE=2 SV=1,,,,,,
OG_01833,FUN_007754-T1,Peve_00033184,Pocillopora_meandrina_HIv1___RNAseq.g5848.t1,three_way,46.0635,,,,,,,,,,,,,,,,,
OG_01834,FUN_007757-T1,Peve_00033187,Pocillopora_meandrina_HIv1___RNAseq.g5845.t1,three_way,55.31933333333333,FUN_007757-T1,Q91740,,,,,26.7,206.0,1.4e-12,75.5,sp|Q91740|FINC_XENLA Fibronectin OS=Xenopus laevis OX=8355 GN=fn1 PE=2 SV=1,,,,,,
OG_01835,FUN_007759-T1,Peve_00032248,Pocillopora_meandrina_HIv1___RNAseq.g5842.t1,three_way,94.467,FUN_007759-T1,Q9Y5K8,,,,,72.2,245.0,2.2e-89,330.1,sp|Q9Y5K8|VATD_HUMAN V-type proton ATPase subunit D OS=Homo sapiens OX=9606 GN=ATP6V1D PE=1 SV=1,,,,,,
OG_01836,FUN_007760-T1,Peve_00032249,Pocillopora_meandrina_HIv1___RNAseq.g5841.t1,three_way,86.78966666666666,FUN_007760-T1,O35587,TMEDA_MESAU,,Transmembrane emp24 domain-containing protein 10 (Protein TMED10) (21 kDa transmembrane-trafficking protein) (Integral membrane protein p23) (Transmembrane protein Tmp21) (p24 family protein delta-1) (p24delta1),Mesocricetus auratus (Golden hamster),65.6,192.0,4.4e-67,255.8,sp|O35587|TMEDA_MESAU Transmembrane emp24 domain-containing protein 10 OS=Mesocricetus auratus OX=10036 GN=TMED10 PE=1 SV=1,GO:0000139; GO:0005789; GO:0005793; GO:0005886; GO:0006886; GO:0006890; GO:0007030; GO:0008320; GO:0019905; GO:0030137; GO:0030140; GO:0030658; GO:0032732; GO:0033116; GO:0035964; GO:0042470; GO:0042589; GO:0045055; GO:0050714; GO:0070765; GO:0106272; GO:0106273; GO:1902003,"COPI-coated vesicle budding [GO:0035964]; cytosol to ERGIC protein transport [GO:0106273]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of protein secretion [GO:0050714]; protein localization to ERGIC [GO:0106272]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI-coated vesicle [GO:0030137]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi membrane [GO:0000139]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],protein transmembrane transporter activity [GO:0008320]; syntaxin binding [GO:0019905],GO:0005215; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0061024,transporter activity; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_01837,FUN_007773-T1,Peve_00036438,Pocillopora_meandrina_HIv1___RNAseq.g5836.t1,three_way,57.734,FUN_007773-T1,Q8JFW4,,,,,39.7,378.0,5.499999999999999e-63,243.0,sp|Q8JFW4|ADAT3_DANRE Probable inactive tRNA-specific adenosine deaminase-like protein 3 OS=Danio rerio OX=7955 GN=adat3 PE=2 SV=2,,,,,,
OG_01838,FUN_007775-T1,Peve_00032268,Pocillopora_meandrina_HIv1___TS.g24628.t2,three_way,66.44866666666667,FUN_007775-T1,Q9HAV4,XPO5_HUMAN,,Exportin-5 (Exp5) (Ran-binding protein 21),Homo sapiens (Human),34.6,1233.0,3.5e-196,687.2,sp|Q9HAV4|XPO5_HUMAN Exportin-5 OS=Homo sapiens OX=9606 GN=XPO5 PE=1 SV=1,GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1905172,miRNA metabolic process [GO:0010586]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565],mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0140104,RNA binding; nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular carrier activity
OG_01839,FUN_007785-T1,Peve_00032269,Pocillopora_meandrina_HIv1___RNAseq.g5904.t3,three_way,77.73566666666667,FUN_007785-T1,Q7ZZC8,NEK9_XENLA,,Serine/threonine-protein kinase Nek9 (xNek9) (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9),Xenopus laevis (African clawed frog),45.7,637.0,6e-157,556.2,sp|Q7ZZC8|NEK9_XENLA Serine/threonine-protein kinase Nek9 OS=Xenopus laevis OX=8355 GN=nek9 PE=2 SV=1,GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0019901; GO:0030295; GO:0046872; GO:0051301; GO:0106310,cell division [GO:0051301]; mitotic cell cycle [GO:0000278],centrosome [GO:0005813]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000278; GO:0003824; GO:0005815; GO:0016740; GO:0098772; GO:0140096,"mitotic cell cycle; catalytic activity; microtubule organizing center; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01840,FUN_007786-T1,Peve_00022059,Pocillopora_meandrina_HIv1___RNAseq.g5903.t1,three_way,66.8125,,,,,,,,,,,,,,,,,
OG_01841,FUN_007787-T1,Peve_00022035,Pocillopora_meandrina_HIv1___RNAseq.12156_t,three_way,56.774,,,,,,,,,,,,,,,,,
OG_01842,FUN_007788-T1,Peve_00022036,Pocillopora_meandrina_HIv1___RNAseq.g5901.t1,three_way,61.594,FUN_007788-T1,Q9BW66,CINP_HUMAN,,Cyclin-dependent kinase 2-interacting protein (CDK2-interacting protein),Homo sapiens (Human),30.9,191.0,1.6e-17,91.3,sp|Q9BW66|CINP_HUMAN Cyclin-dependent kinase 2-interacting protein OS=Homo sapiens OX=9606 GN=CINP PE=1 SV=1,GO:0005634; GO:0006260; GO:0006281; GO:0042273; GO:0051301; GO:1990275,cell division [GO:0051301]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; ribosomal large subunit biogenesis [GO:0042273],nucleus [GO:0005634],preribosome binding [GO:1990275],GO:0005634; GO:0006260; GO:0006281; GO:0043226,nucleus; DNA replication; DNA repair; organelle
OG_01843,FUN_007789-T1,Peve_00022037,Pocillopora_meandrina_HIv1___RNAseq.g5900.t1,three_way,86.02133333333333,FUN_007789-T1,Q9NZ32,,,,,56.1,155.0,3.4e-44,179.5,sp|Q9NZ32|ARP10_HUMAN Actin-related protein 10 OS=Homo sapiens OX=9606 GN=ACTR10 PE=1 SV=1,,,,,,
OG_01844,FUN_007790-T1,Peve_00022038,Pocillopora_meandrina_HIv1___RNAseq.g5899.t1,three_way,82.86166666666666,FUN_007790-T1,Q8R1Q9,,,,,56.1,305.0,1.3000000000000001e-89,331.3,sp|Q8R1Q9|RBSK_MOUSE Ribokinase OS=Mus musculus OX=10090 GN=Rbks PE=1 SV=1,,,,,,
OG_01845,FUN_007791-T1,Peve_00022040,Pocillopora_meandrina_HIv1___TS.g24621.t1,three_way,47.446,FUN_007791-T1,Q9UHC1,MLH3_HUMAN,,DNA mismatch repair protein Mlh3 (MutL protein homolog 3),Homo sapiens (Human),27.8,1446.0,1.3e-121,439.5,sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3,GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664,female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130],chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0043226; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; hydrolase activity; reproductive process; organelle; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01846,FUN_007795-T1,Peve_00022050,Pocillopora_meandrina_HIv1___TS.g21334.t1,three_way,60.86366666666667,FUN_007795-T1,Q9NR09,BIRC6_HUMAN,,Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),Homo sapiens (Human),29.0,4083.0,0.0,1173.3,sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3,GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237,apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802],cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; nucleus; endosome; microtubule organizing center; cytosol; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01847,FUN_007797-T1,Peve_00022051,Pocillopora_meandrina_HIv1___RNAseq.g18343.t2,three_way,54.4715,,,,,,,,,,,,,,,,,
OG_01848,FUN_007798-T1,Peve_00022052,Pocillopora_meandrina_HIv1___RNAseq.g18342.t1,three_way,82.26133333333333,FUN_007798-T1,Q9UGV2,,,,,42.5,325.0,1.2e-66,255.0,sp|Q9UGV2|NDRG3_HUMAN Protein NDRG3 OS=Homo sapiens OX=9606 GN=NDRG3 PE=1 SV=2,,,,,,
OG_01849,FUN_007799-T1,Peve_00022053,Pocillopora_meandrina_HIv1___RNAseq.g18341.t1,three_way,65.1245,FUN_007799-T1,Q9UHY8,FEZ2_HUMAN,,Fasciculation and elongation protein zeta-2 (Zygin II) (Zygin-2),Homo sapiens (Human),30.6,268.0,2e-21,104.8,sp|Q9UHY8|FEZ2_HUMAN Fasciculation and elongation protein zeta-2 OS=Homo sapiens OX=9606 GN=FEZ2 PE=1 SV=2,GO:0005737; GO:0007165; GO:0007399; GO:0007411; GO:0030424; GO:1902902,axon guidance [GO:0007411]; negative regulation of autophagosome assembly [GO:1902902]; nervous system development [GO:0007399]; signal transduction [GO:0007165],axon [GO:0030424]; cytoplasm [GO:0005737],,GO:0048856,anatomical structure development
OG_01850,FUN_007800-T1,Peve_00022054,Pocillopora_meandrina_HIv1___RNAseq.g18340.t1,three_way,66.119,FUN_007800-T1,Q8CES0,NAA30_MOUSE,,N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit),Mus musculus (Mouse),76.1,163.0,2.7000000000000007e-65,250.4,sp|Q8CES0|NAA30_MOUSE N-alpha-acetyltransferase 30 OS=Mus musculus OX=10090 GN=Naa30 PE=1 SV=2,GO:0004596; GO:0005634; GO:0005737; GO:0031417; GO:0050821; GO:0120518,protein stabilization [GO:0050821],cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634],protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01851,FUN_007801-T1,Peve_00022055,Pocillopora_meandrina_HIv1___RNAseq.g18338.t1,three_way,56.8715,,,,,,,,,,,,,,,,,
OG_01852,FUN_007803-T2,Peve_00022056,Pocillopora_meandrina_HIv1___RNAseq.g18339.t1,three_way,75.05483333333333,FUN_007803-T2,Q96JM7,,,,,34.7,862.0,6.800000000000001e-134,479.9,sp|Q96JM7|LMBL3_HUMAN Lethal(3)malignant brain tumor-like protein 3 OS=Homo sapiens OX=9606 GN=L3MBTL3 PE=1 SV=2,,,,,,
OG_01853,FUN_007804-T1,Peve_00022057,Pocillopora_meandrina_HIv1___RNAseq.g18346.t1,three_way,62.281666666666666,,,,,,,,,,,,,,,,,
OG_01854,FUN_007806-T1,Peve_00022058,Pocillopora_meandrina_HIv1___RNAseq.g18348.t2,three_way,53.281333333333336,,,,,,,,,,,,,,,,,
OG_01855,FUN_007807-T1,Peve_00022060,Pocillopora_meandrina_HIv1___RNAseq.g18349.t1,three_way,61.16866666666667,FUN_007807-T1,Q9UNW1,,,,,32.3,446.0,2.1e-56,221.5,sp|Q9UNW1|MINP1_HUMAN Multiple inositol polyphosphate phosphatase 1 OS=Homo sapiens OX=9606 GN=MINPP1 PE=1 SV=1,,,,,,
OG_01856,FUN_007808-T1,Peve_00022061,Pocillopora_meandrina_HIv1___RNAseq.g18350.t1,three_way,71.29266666666666,FUN_007808-T1,Q58D06,,,,,38.4,378.0,2.9e-69,263.8,sp|Q58D06|WDR74_BOVIN WD repeat-containing protein 74 OS=Bos taurus OX=9913 GN=WDR74 PE=2 SV=1,,,,,,
OG_01857,FUN_007810-T1,Peve_00036348,Pocillopora_meandrina_HIv1___TS.g21371.t1,three_way,48.23233333333334,,,,,,,,,,,,,,,,,
OG_01858,FUN_007812-T1,Peve_00038752,Pocillopora_meandrina_HIv1___RNAseq.g18383.t1,three_way,50.623333333333335,FUN_007812-T1,P26201,CD36_BOVIN,,Platelet glycoprotein 4 (Glycoprotein IIIb) (GPIIIB) (PAS IV) (PAS-4) (Platelet glycoprotein IV) (GPIV) (CD antigen CD36),Bos taurus (Bovine),23.6,203.0,3.2e-12,75.1,sp|P26201|CD36_BOVIN Platelet glycoprotein 4 OS=Bos taurus OX=9913 GN=CD36 PE=1 SV=5,GO:0005041; GO:0005044; GO:0005794; GO:0005901; GO:0006898; GO:0007155; GO:0007204; GO:0009986; GO:0016020; GO:0016324; GO:0019915; GO:0030169; GO:0030299; GO:0031526; GO:0031623; GO:0032731; GO:0033993; GO:0034197; GO:0034383; GO:0042953; GO:0044539; GO:0045121; GO:0050892; GO:0050909; GO:0070374; GO:0070508; GO:0070542; GO:0070543; GO:0071404; GO:0071726; GO:0097009; GO:0150094; GO:1900227; GO:1990000,amyloid fibril formation [GO:1990000]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; cell adhesion [GO:0007155]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol import [GO:0070508]; energy homeostasis [GO:0097009]; intestinal absorption [GO:0050892]; intestinal cholesterol absorption [GO:0030299]; lipid storage [GO:0019915]; lipoprotein transport [GO:0042953]; long-chain fatty acid import into cell [GO:0044539]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; response to fatty acid [GO:0070542]; response to linoleic acid [GO:0070543]; response to lipid [GO:0033993]; sensory perception of taste [GO:0050909]; triglyceride transport [GO:0034197],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; caveola [GO:0005901]; cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane raft [GO:0045121],low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044],GO:0005794; GO:0007155; GO:0016192; GO:0022600; GO:0038024; GO:0043226; GO:0050877,Golgi apparatus; cell adhesion; vesicle-mediated transport; digestive system process; cargo receptor activity; organelle; nervous system process
OG_01859,FUN_007818-T1,Peve_00038749,Pocillopora_meandrina_HIv1___RNAseq.g18385.t1,three_way,58.894666666666666,FUN_007818-T1,Q9YGL3,,,,,27.4,518.0,1.1e-42,176.0,sp|Q9YGL3|NR2E1_ORYLA Nuclear receptor subfamily 2 group E member 1 OS=Oryzias latipes OX=8090 GN=nr2e1 PE=2 SV=1,,,,,,
OG_01860,FUN_007819-T1,Peve_00038748,Pocillopora_meandrina_HIv1___RNAseq.g18386.t1,three_way,62.80433333333333,FUN_007819-T1,Q803U7,,,,,52.0,344.0,8e-93,343.2,sp|Q803U7|EXO1_DANRE Exonuclease 1 OS=Danio rerio OX=7955 GN=exo1 PE=2 SV=1,,,,,,
OG_01861,FUN_007820-T1,Peve_00038747,Pocillopora_meandrina_HIv1___RNAseq.g18387.t1,three_way,88.67333333333333,FUN_007820-T1,Q9BSR8,YIPF4_HUMAN,,Protein YIPF4 (YIP1 family member 4),Homo sapiens (Human),60.4,230.0,1.4e-67,257.7,sp|Q9BSR8|YIPF4_HUMAN Protein YIPF4 OS=Homo sapiens OX=9606 GN=YIPF4 PE=1 SV=1,GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006888; GO:0043231; GO:0048280,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle fusion with Golgi apparatus [GO:0048280],endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],,GO:0005783; GO:0005794; GO:0005886; GO:0016192; GO:0043226; GO:0061024,endoplasmic reticulum; Golgi apparatus; plasma membrane; vesicle-mediated transport; organelle; membrane organization
OG_01862,FUN_007821-T1,Peve_00038746,Pocillopora_meandrina_HIv1___RNAseq.g18388.t1,three_way,57.14966666666667,,,,,,,,,,,,,,,,,
OG_01863,FUN_007823-T1,Peve_00038744,Pocillopora_meandrina_HIv1___RNAseq.21899_t,three_way,75.6335,FUN_007823-T1,Q3U1V8,M3K9_MOUSE,,Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25),Mus musculus (Mouse),51.9,617.0,1.8999999999999998e-138,495.0,sp|Q3U1V8|M3K9_MOUSE Mitogen-activated protein kinase kinase kinase 9 OS=Mus musculus OX=10090 GN=Map3k9 PE=2 SV=2,GO:0004709; GO:0005524; GO:0006915; GO:0106310,apoptotic process [GO:0006915],,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_01864,FUN_007824-T1,Peve_00032624,Pocillopora_meandrina_HIv1___RNAseq.g18390.t1,three_way,76.27866666666667,FUN_007824-T1,Q8CE96,,,,,41.7,458.0,4.7e-88,326.6,sp|Q8CE96|TRM6_MOUSE tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 OS=Mus musculus OX=10090 GN=Trmt6 PE=1 SV=1,,,,,,
OG_01865,FUN_007831-T1,Peve_00003984,Pocillopora_meandrina_HIv1___TS.g21380.t1,three_way,84.41716666666666,FUN_007831-T1,Q98UF7,,,,,46.0,1960.0,0.0,1525.0,sp|Q98UF7|PCX1_TAKRU Pecanex-like protein 1 OS=Takifugu rubripes OX=31033 GN=pcnx1 PE=3 SV=1,,,,,,
OG_01866,FUN_007832-T1,Peve_00003986,Pocillopora_meandrina_HIv1___RNAseq.g29997.t1,three_way,76.73700000000001,FUN_007832-T1,Q7Q107,,,,,61.9,202.0,2.9e-67,256.9,sp|Q7Q107|MED6_ANOGA Mediator of RNA polymerase II transcription subunit 6 OS=Anopheles gambiae OX=7165 GN=MED6 PE=3 SV=3,,,,,,
OG_01867,FUN_007833-T1,Peve_00003987,Pocillopora_meandrina_HIv1___RNAseq.g18399.t1,three_way,68.14616666666667,,,,,,,,,,,,,,,,,
OG_01868,FUN_007834-T1,Peve_00003993,Pocillopora_meandrina_HIv1___RNAseq.g18432.t1b,three_way,72.9755,FUN_007834-T1,Q3UFK8,,,,,35.4,378.0,1.6e-61,238.4,sp|Q3UFK8|FRMD8_MOUSE FERM domain-containing protein 8 OS=Mus musculus OX=10090 GN=Frmd8 PE=1 SV=2,,,,,,
OG_01869,FUN_007836-T1,Peve_00019311,Pocillopora_meandrina_HIv1___RNAseq.g18432.t1a,three_way,61.774,FUN_007836-T1,E7FEV0,,,,,27.2,2195.0,1.0000000000000001e-187,659.8,sp|E7FEV0|WDR81_DANRE WD repeat-containing protein 81 OS=Danio rerio OX=7955 GN=wdr81 PE=2 SV=1,,,,,,
OG_01870,FUN_007837-T1,Peve_00019310,Pocillopora_meandrina_HIv1___RNAseq.g18433.t1,three_way,78.51033333333334,FUN_007837-T1,Q1L9A2,OPA3_DANRE,,Optic atrophy 3 protein homolog,Danio rerio (Zebrafish) (Brachydanio rerio),48.6,148.0,5.8e-32,138.7,sp|Q1L9A2|OPA3_DANRE Optic atrophy 3 protein homolog OS=Danio rerio OX=7955 GN=opa3 PE=3 SV=1,GO:0005739; GO:0007626; GO:0019216; GO:0031413; GO:0050881,locomotory behavior [GO:0007626]; musculoskeletal movement [GO:0050881]; regulation of buoyancy [GO:0031413]; regulation of lipid metabolic process [GO:0019216],mitochondrion [GO:0005739],,GO:0005739; GO:0043226; GO:0050877,mitochondrion; organelle; nervous system process
OG_01871,FUN_007838-T1,Peve_00019309,Pocillopora_meandrina_HIv1___RNAseq.g18420.t1,three_way,79.68333333333334,,,,,,,,,,,,,,,,,
OG_01872,FUN_007839-T1,Peve_00019308,Pocillopora_meandrina_HIv1___TS.g21414.t1,three_way,62.15633333333333,FUN_007839-T1,Q61830,,,,,29.1,299.0,1.1e-23,112.8,sp|Q61830|MRC1_MOUSE Macrophage mannose receptor 1 OS=Mus musculus OX=10090 GN=Mrc1 PE=1 SV=2,,,,,,
OG_01873,FUN_007842-T1,Peve_00040457,Pocillopora_meandrina_HIv1___RNAseq.21938_t,three_way,93.767,FUN_007842-T1,Q7SXL3,,,,,89.7,214.0,4.7e-92,339.0,sp|Q7SXL3|TBP_DANRE TATA-box-binding protein OS=Danio rerio OX=7955 GN=tbp PE=1 SV=1,,,,,,
OG_01874,FUN_007846-T1,Peve_00014226,Pocillopora_meandrina_HIv1___RNAseq.g20393.t1,three_way,68.34366666666666,FUN_007846-T1,Q9TTR8,,,,,36.1,382.0,1.5e-58,228.4,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_01875,FUN_007848-T1,Peve_00039903,Pocillopora_meandrina_HIv1___RNAseq.g18285.t1,three_way,77.36716666666668,FUN_007848-T1,B1ANS9,,,,,38.4,690.0,2.6e-135,485.0,sp|B1ANS9|WDR64_HUMAN WD repeat-containing protein 64 OS=Homo sapiens OX=9606 GN=WDR64 PE=1 SV=1,,,,,,
OG_01876,FUN_007849-T1,Peve_00039898,Pocillopora_meandrina_HIv1___RNAseq.g18286.t1,three_way,90.37933333333334,FUN_007849-T1,O00470,MEIS1_HUMAN,,Homeobox protein Meis1,Homo sapiens (Human),58.7,349.0,4.1e-94,347.1,sp|O00470|MEIS1_HUMAN Homeobox protein Meis1 OS=Homo sapiens OX=9606 GN=MEIS1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001654; GO:0002089; GO:0003677; GO:0003682; GO:0005634; GO:0005667; GO:0007420; GO:0007626; GO:0008284; GO:0009880; GO:0009887; GO:0030097; GO:0035855; GO:0045638; GO:0045665; GO:0045944; GO:0060216; GO:0061049,angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cell growth involved in cardiac muscle cell development [GO:0061049]; definitive hemopoiesis [GO:0060216]; embryonic pattern specification [GO:0009880]; eye development [GO:0001654]; hemopoiesis [GO:0030097]; lens morphogenesis in camera-type eye [GO:0002089]; locomotory behavior [GO:0007626]; megakaryocyte development [GO:0035855]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944],chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_01877,FUN_007850-T1,Peve_00021800,Pocillopora_meandrina_HIv1___RNAseq.g18287.t1,three_way,66.41766666666666,,,,,,,,,,,,,,,,,
OG_01878,FUN_007851-T1,Peve_00021799,Pocillopora_meandrina_HIv1___RNAseq.g18290.t1,three_way,87.72033333333333,FUN_007851-T1,Q28HL3,,,,,51.1,276.0,2.6e-78,293.5,sp|Q28HL3|CDIN1_XENTR CDAN1-interacting nuclease 1 OS=Xenopus tropicalis OX=8364 GN=cdin1 PE=2 SV=1,,,,,,
OG_01879,FUN_007852-T1,Peve_00021798,Pocillopora_meandrina_HIv1___TS.g21280.t1a,three_way,73.76766666666667,FUN_007852-T1,A5PJS2,,,,,56.2,242.0,1.5e-72,274.2,sp|A5PJS2|S5A1_BOVIN 3-oxo-5-alpha-steroid 4-dehydrogenase 1 OS=Bos taurus OX=9913 GN=SRD5A1 PE=2 SV=1,,,,,,
OG_01880,FUN_007856-T1,Peve_00021797,Pocillopora_meandrina_HIv1___RNAseq.g18293.t1,three_way,48.038,,,,,,,,,,,,,,,,,
OG_01881,FUN_007857-T1,Peve_00024166,Pocillopora_meandrina_HIv1___RNAseq.g18294.t1,three_way,59.664,FUN_007857-T1,Q5T6L9,,,,,33.1,602.0,5.7e-82,307.0,sp|Q5T6L9|EMARD_HUMAN Endoplasmic reticulum membrane-associated RNA degradation protein OS=Homo sapiens OX=9606 GN=ERMARD PE=1 SV=1,,,,,,
OG_01882,FUN_007858-T1,Peve_00024167,Pocillopora_meandrina_HIv1___RNAseq.g18296.t1,three_way,70.038,FUN_007858-T1,O96099,,,,,41.0,83.0,8e-10,64.3,sp|O96099|FAD5B_DICDI Acyl-lipid (8-3)-desaturase B OS=Dictyostelium discoideum OX=44689 GN=fadB PE=1 SV=1,,,,,,
OG_01883,FUN_007859-T1,Peve_00044447,Pocillopora_meandrina_HIv1___RNAseq.g18297.t1,three_way,66.80633333333333,FUN_007859-T1,Q8R3J5,CHAC1_MOUSE,,Glutathione-specific gamma-glutamylcyclotransferase 1 (Gamma-GCG 1) (EC 4.3.2.7) (Blocks Notch protein) (Botch) (Cation transport regulator-like protein 1),Mus musculus (Mouse),48.9,180.0,7.299999999999999e-49,195.3,sp|Q8R3J5|CHAC1_MOUSE Glutathione-specific gamma-glutamylcyclotransferase 1 OS=Mus musculus OX=10090 GN=Chac1 PE=1 SV=2,GO:0005112; GO:0005802; GO:0005829; GO:0006751; GO:0006986; GO:0007219; GO:0010955; GO:0022008; GO:0045746; GO:0061771; GO:0061928; GO:0070059,glutathione catabolic process [GO:0006751]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; response to caloric restriction [GO:0061771]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; trans-Golgi network [GO:0005802],glutathione specific gamma-glutamylcyclotransferase activity [GO:0061928]; Notch binding [GO:0005112],GO:0003824; GO:0005829; GO:0006575; GO:0006790; GO:0016829; GO:0030154,catalytic activity; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; lyase activity; cell differentiation
OG_01884,FUN_007860-T1,Peve_00044448,Pocillopora_meandrina_HIv1___TS.g21287.t1,three_way,81.536,FUN_007860-T1,Q6ZPV2,,,,,48.0,1450.0,1.3e-305,1051.2,sp|Q6ZPV2|INO80_MOUSE Chromatin-remodeling ATPase INO80 OS=Mus musculus OX=10090 GN=Ino80 PE=1 SV=2,,,,,,
OG_01885,FUN_007864-T1,Peve_00044449,Pocillopora_meandrina_HIv1___RNAseq.g18299.t1,three_way,76.96966666666667,FUN_007864-T1,Q96P50,,,,,44.0,209.0,1.4999999999999999e-40,169.5,"sp|Q96P50|ACAP3_HUMAN Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ACAP3 PE=1 SV=2",,,,,,
OG_01886,FUN_007865-T1,Peve_00044450,Pocillopora_meandrina_HIv1___RNAseq.g18300.t1,three_way,55.03033333333333,,,,,,,,,,,,,,,,,
OG_01887,FUN_007866-T1,Peve_00044451,Pocillopora_meandrina_HIv1___RNAseq.g18302.t1,three_way,87.58333333333333,FUN_007866-T1,Q07352,TISB_HUMAN,,"mRNA decay activator protein ZFP36L1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (TPA-induced sequence 11b) (Zinc finger protein 36, C3H1 type-like 1) (ZFP36-like 1)",Homo sapiens (Human),93.3,30.0,2.2e-11,71.2,sp|Q07352|TISB_HUMAN mRNA decay activator protein ZFP36L1 OS=Homo sapiens OX=9606 GN=ZFP36L1 PE=1 SV=1,GO:0000165; GO:0000288; GO:0000932; GO:0001570; GO:0003342; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006417; GO:0006915; GO:0007507; GO:0008270; GO:0008283; GO:0009611; GO:0010468; GO:0010837; GO:0021915; GO:0031086; GO:0031440; GO:0032869; GO:0033077; GO:0035264; GO:0035925; GO:0038066; GO:0043488; GO:0043491; GO:0044344; GO:0045577; GO:0045600; GO:0045616; GO:0045647; GO:0045657; GO:0045661; GO:0048382; GO:0051028; GO:0060710; GO:0061158; GO:0070371; GO:0071320; GO:0071356; GO:0071364; GO:0071375; GO:0071385; GO:0071456; GO:0071472; GO:0071560; GO:0071889; GO:0072091; GO:0097403; GO:1900153; GO:1901991; GO:1902172; GO:1904582; GO:1990904,"3'-UTR-mediated mRNA destabilization [GO:0061158]; apoptotic process [GO:0006915]; cell population proliferation [GO:0008283]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to raffinose [GO:0097403]; cellular response to salt stress [GO:0071472]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chorio-allantoic fusion [GO:0060710]; ERK1 and ERK2 cascade [GO:0070371]; heart development [GO:0007507]; MAPK cascade [GO:0000165]; mesendoderm development [GO:0048382]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of mitotic cell cycle phase transition [GO:1901991]; neural tube development [GO:0021915]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, deadenylation-independent decay [GO:0031086]; p38MAPK cascade [GO:0038066]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; proepicardium development [GO:0003342]; regulation of B cell differentiation [GO:0045577]; regulation of gene expression [GO:0010468]; regulation of keratinocyte apoptotic process [GO:1902172]; regulation of keratinocyte differentiation [GO:0045616]; regulation of keratinocyte proliferation [GO:0010837]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of mRNA stability [GO:0043488]; regulation of myoblast differentiation [GO:0045661]; regulation of stem cell proliferation [GO:0072091]; regulation of translation [GO:0006417]; response to wounding [GO:0009611]; T cell differentiation in thymus [GO:0033077]; vasculogenesis [GO:0001570]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; ribonucleoprotein complex [GO:1990904],14-3-3 protein binding [GO:0071889]; DNA binding [GO:0003677]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0007155; GO:0012501; GO:0016071; GO:0030154; GO:0043226; GO:0048856,immune system process; DNA binding; RNA binding; nucleus; cytosol; cell adhesion; programmed cell death; mRNA metabolic process; cell differentiation; organelle; anatomical structure development
OG_01888,FUN_007869-T1,Peve_00009888,Pocillopora_meandrina_HIv1___RNAseq.g18305.t1,three_way,80.55466666666666,,,,,,,,,,,,,,,,,
OG_01889,FUN_007871-T1,Peve_00009886,Pocillopora_meandrina_HIv1___RNAseq.g18307.t1,three_way,66.36216666666667,FUN_007871-T1,Q13613,,,,,32.8,466.0,6.600000000000002e-60,234.2,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_01890,FUN_007872-T1,Peve_00009884,Pocillopora_meandrina_HIv1___RNAseq.g18276.t1,three_way,41.83983333333333,,,,,,,,,,,,,,,,,
OG_01891,FUN_007877-T1,Peve_00009879,Pocillopora_meandrina_HIv1___TS.g21243.t1,three_way,32.146166666666666,,,,,,,,,,,,,,,,,
OG_01892,FUN_007888-T3,Peve_00009873,Pocillopora_meandrina_HIv1___RNAseq.g18250.t1,three_way,60.7555,FUN_007888-T3,Q96PE2,ARHGH_HUMAN,,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),Homo sapiens (Human),32.1,224.0,1.9e-20,102.8,sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056,actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0007010; GO:0098772,cytosol; cytoskeleton organization; molecular function regulator activity
OG_01893,FUN_007891-T1,Peve_00009872,Pocillopora_meandrina_HIv1___RNAseq.g18248.t1,three_way,58.57216666666667,,,,,,,,,,,,,,,,,
OG_01894,FUN_007892-T1,Peve_00009871,Pocillopora_meandrina_HIv1___RNAseq.g18244.t2,three_way,59.311,FUN_007892-T1,Q80UF4,SDCG8_MOUSE,,Serologically defined colon cancer antigen 8 homolog (Centrosomal colon cancer autoantigen protein) (mCCCAP),Mus musculus (Mouse),34.7,496.0,1.8e-15,86.3,sp|Q80UF4|SDCG8_MOUSE Serologically defined colon cancer antigen 8 homolog OS=Mus musculus OX=10090 GN=Sdccag8 PE=1 SV=1,GO:0001764; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0007098; GO:0030010; GO:0030030; GO:0031023; GO:0034451; GO:0035148; GO:0036064; GO:0097733; GO:1902017,cell projection organization [GO:0030030]; centrosome cycle [GO:0007098]; establishment of cell polarity [GO:0030010]; microtubule organizing center organization [GO:0031023]; neuron migration [GO:0001764]; regulation of cilium assembly [GO:1902017]; tube formation [GO:0035148],cell-cell junction [GO:0005911]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor cell cilium [GO:0097733],,GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0007163; GO:0043226; GO:0048870,nucleoplasm; microtubule organizing center; cytosol; cilium; establishment or maintenance of cell polarity; organelle; cell motility
OG_01895,FUN_007895-T1,Peve_00009865,Pocillopora_meandrina_HIv1___RNAseq.g18241.t1a,three_way,47.54166666666666,,,,,,,,,,,,,,,,,
OG_01896,FUN_007896-T1,Peve_00040697,Pocillopora_meandrina_HIv1___RNAseq.g30048.t1,three_way,77.057,FUN_007896-T1,Q96BY7,ATG2B_HUMAN,,Autophagy-related protein 2 homolog B,Homo sapiens (Human),38.0,2230.0,0.0,1251.9,sp|Q96BY7|ATG2B_HUMAN Autophagy-related protein 2 homolog B OS=Homo sapiens OX=9606 GN=ATG2B PE=1 SV=5,GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005783; GO:0005789; GO:0005811; GO:0032266; GO:0034045; GO:0034727; GO:0043231; GO:0043495; GO:0061709; GO:0061723; GO:0061908; GO:0120013,autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; glycophagy [GO:0061723]; pexophagy [GO:0000425]; piecemeal microautophagy of the nucleus [GO:0034727]; reticulophagy [GO:0061709],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; phagophore [GO:0061908]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],lipid transfer activity [GO:0120013]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-membrane adaptor activity [GO:0043495],GO:0005215; GO:0005783; GO:0005811; GO:0005975; GO:0006091; GO:0006914; GO:0008289; GO:0043226; GO:0060090,transporter activity; endoplasmic reticulum; lipid droplet; carbohydrate metabolic process; generation of precursor metabolites and energy; autophagy; lipid binding; organelle; molecular adaptor activity
OG_01897,FUN_007904-T1,Peve_00040656,Pocillopora_meandrina_HIv1___RNAseq.g30059.t1,three_way,60.9685,FUN_007904-T1,P06582,,,,,37.0,100.0,1.1e-11,72.0,sp|P06582|HSP12_CAEEL Heat shock protein hsp-16.2 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.2 PE=2 SV=1,,,,,,
OG_01898,FUN_007909-T1,Peve_00040664,Pocillopora_meandrina_HIv1___RNAseq.g30061.t1,three_way,70.45833333333333,FUN_007909-T1,A8J4S9,TREA_APIME,,"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)",Apis mellifera (Honeybee),45.2,571.0,1.9999999999999997e-152,540.8,sp|A8J4S9|TREA_APIME Trehalase OS=Apis mellifera OX=7460 PE=1 SV=1,GO:0004555; GO:0005993; GO:0016020,trehalose catabolic process [GO:0005993],membrane [GO:0016020],"alpha,alpha-trehalase activity [GO:0004555]",GO:0003824; GO:0005975; GO:0016787,catalytic activity; carbohydrate metabolic process; hydrolase activity
OG_01899,FUN_007910-T1,Peve_00040665,Pocillopora_meandrina_HIv1___RNAseq.g30062.t1,three_way,77.52666666666667,,,,,,,,,,,,,,,,,
OG_01900,FUN_007913-T1,Peve_00040669,Pocillopora_meandrina_HIv1___RNAseq.g30116.t1,three_way,84.62366666666667,FUN_007913-T1,O82201,,,,,64.7,119.0,4.6e-40,165.2,sp|O82201|AP4S_ARATH AP-4 complex subunit sigma OS=Arabidopsis thaliana OX=3702 GN=At2g19790 PE=1 SV=1,,,,,,
OG_01901,FUN_007914-T1,Peve_00040670,Pocillopora_meandrina_HIv1___RNAseq.g30117.t1,three_way,58.692,,,,,,,,,,,,,,,,,
OG_01902,FUN_007915-T1,Peve_00040671,Pocillopora_meandrina_HIv1___RNAseq.g30118.t1,three_way,55.7275,,,,,,,,,,,,,,,,,
OG_01903,FUN_007917-T1,Peve_00040673,Pocillopora_meandrina_HIv1___RNAseq.g30120.t1,three_way,66.04833333333333,,,,,,,,,,,,,,,,,
OG_01904,FUN_007918-T1,Peve_00040674,Pocillopora_meandrina_HIv1___RNAseq.g30119.t1,three_way,52.329166666666666,FUN_007918-T1,Q9D6X6,,,,,34.3,289.0,4.4e-36,153.7,sp|Q9D6X6|PRS23_MOUSE Serine protease 23 OS=Mus musculus OX=10090 GN=Prss23 PE=2 SV=2,,,,,,
OG_01905,FUN_007919-T1,Peve_00040675,Pocillopora_meandrina_HIv1___RNAseq.g30121.t1,three_way,90.73183333333331,FUN_007919-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),63.3,608.0,1.6e-207,724.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01906,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),61.6,620.0,3.3e-199,697.6,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01906,FUN_007920-T1,Peve_00040676,Pocillopora_meandrina_HIv1___RNAseq.g30096.t1,three_way,80.76266666666666,FUN_007920-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),40.4,146.0,3.2e-29,132.9,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_01907,FUN_007921-T1,Peve_00040678,Pocillopora_meandrina_HIv1___RNAseq.g30088.t1,three_way,83.092,FUN_007921-T1,P02513,,,,,42.2,90.0,6.3e-14,79.3,sp|P02513|HSP17_CAEEL Heat shock protein Hsp-16.48/Hsp-16.49 OS=Caenorhabditis elegans OX=6239 GN=hsp-16.48 PE=2 SV=1,,,,,,
OG_01908,FUN_007922-T1,Peve_00040679,Pocillopora_meandrina_HIv1___RNAseq.g30087.t1,three_way,86.508,FUN_007922-T1,Q4V7N3,,,,,63.6,162.0,2.0999999999999998e-55,216.9,sp|Q4V7N3|STYXA_XENLA Serine/threonine/tyrosine-interacting protein A OS=Xenopus laevis OX=8355 GN=styx-a PE=2 SV=1,,,,,,
OG_01909,FUN_007923-T1,Peve_00040680,Pocillopora_meandrina_HIv1___RNAseq.g30085.t1,three_way,80.15333333333334,FUN_007923-T1,Q9HAT8,PELI2_HUMAN,,E3 ubiquitin-protein ligase pellino homolog 2 (Pellino-2) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 2),Homo sapiens (Human),54.2,402.0,2.4e-123,443.7,sp|Q9HAT8|PELI2_HUMAN E3 ubiquitin-protein ligase pellino homolog 2 OS=Homo sapiens OX=9606 GN=PELI2 PE=1 SV=1,GO:0000209; GO:0001934; GO:0005829; GO:0008592; GO:0034450; GO:0043123; GO:0043410; GO:0061630,positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; protein polyubiquitination [GO:0000209]; regulation of Toll signaling pathway [GO:0008592],cytosol [GO:0005829],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_01910,FUN_007925-T1,Peve_00040685,Pocillopora_meandrina_HIv1___RNAseq.g30084.t1,three_way,71.54366666666667,,,,,,,,,,,,,,,,,
OG_01911,FUN_007927-T1,Peve_00040689,Pocillopora_meandrina_HIv1___RNAseq.g18108.t1,three_way,68.03966666666666,FUN_007927-T1,Q10AZ7,GPA3_ORYSJ,,Protein GLUTELIN PRECURSOR ACCUMULATION 3,Oryza sativa subsp. japonica (Rice),24.2,194.0,2.9e-12,75.1,sp|Q10AZ7|GPA3_ORYSJ Protein GLUTELIN PRECURSOR ACCUMULATION 3 OS=Oryza sativa subsp. japonica OX=39947 GN=GPA3 PE=1 SV=1,GO:0000325; GO:0000326; GO:0005802; GO:0006886,intracellular protein transport [GO:0006886],plant-type vacuole [GO:0000325]; protein storage vacuole [GO:0000326]; trans-Golgi network [GO:0005802],,GO:0005773; GO:0006886; GO:0043226,vacuole; intracellular protein transport; organelle
OG_01912,FUN_007928-T1,Peve_00040690,Pocillopora_meandrina_HIv1___RNAseq.g18109.t1,three_way,62.142833333333336,,,,,,,,,,,,,,,,,
OG_01913,FUN_007929-T1,Peve_00040692,Pocillopora_meandrina_HIv1___RNAseq.g18115.t1,three_way,57.39533333333333,,,,,,,,,,,,,,,,,
OG_01914,FUN_007939-T1,Peve_00040694,Pocillopora_meandrina_HIv1___RNAseq.g18118.t1,three_way,57.98416666666667,FUN_007939-T1,Q5RET9,SDE2_PONAB,,Splicing regulator SDE2 (Replication stress response regulator SDE2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),34.2,415.0,1.7e-38,161.8,sp|Q5RET9|SDE2_PONAB Splicing regulator SDE2 OS=Pongo abelii OX=9601 GN=SDE2 PE=2 SV=1,GO:0000479; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0030515; GO:0045292; GO:0051301,"cell division [GO:0051301]; DNA replication [GO:0006260]; endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; mRNA cis splicing, via spliceosome [GO:0045292]",cytoplasm [GO:0005737]; nucleus [GO:0005634],DNA binding [GO:0003677]; snoRNA binding [GO:0030515],GO:0003677; GO:0003723; GO:0005634; GO:0006260; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; DNA replication; mRNA metabolic process; organelle
OG_01915,FUN_007941-T1,Peve_00040695,Pocillopora_meandrina_HIv1___RNAseq.g18119.t1,three_way,41.262,,,,,,,,,,,,,,,,,
OG_01916,FUN_007943-T1,Peve_00040696,Pocillopora_meandrina_HIv1___RNAseq.g18120.t1,three_way,83.53,FUN_007943-T1,Q9NW15,,,,,28.6,623.0,1.9e-60,235.3,sp|Q9NW15|ANO10_HUMAN Anoctamin-10 OS=Homo sapiens OX=9606 GN=ANO10 PE=1 SV=2,,,,,,
OG_01917,FUN_007944-T1,Peve_00040700,Pocillopora_meandrina_HIv1___RNAseq.g18121.t1,three_way,72.07933333333334,FUN_007944-T1,Q6DC77,MPRGB_DANRE,,Membrane progestin receptor gamma-B (mPR gamma-B) (Progestin and adipoQ receptor family member V-B),Danio rerio (Zebrafish) (Brachydanio rerio),35.7,325.0,5.9e-45,183.0,sp|Q6DC77|MPRGB_DANRE Membrane progestin receptor gamma-B OS=Danio rerio OX=7955 GN=paqr5b PE=2 SV=1,GO:0005496; GO:0016020; GO:0038023; GO:0048477,oogenesis [GO:0048477],membrane [GO:0016020],signaling receptor activity [GO:0038023]; steroid binding [GO:0005496],GO:0008289; GO:0022414; GO:0048856; GO:0060089,lipid binding; reproductive process; anatomical structure development; molecular transducer activity
OG_01918,FUN_007947-T1,Peve_00021143,Pocillopora_meandrina_HIv1___TS.g21111.t2,three_way,56.5525,,,,,,,,,,,,,,,,,
OG_01919,FUN_007948-T1,Peve_00044442,Pocillopora_meandrina_HIv1___RNAseq.g18135.t1,three_way,64.81733333333334,FUN_007948-T1,Q3TTY0,PLB1_MOUSE,,"Phospholipase B1, membrane-associated (Phospholipase B) (Lysophospholipase) (EC 3.1.1.5) (Phospholipase A2) (EC 3.1.1.4) (Phospholipase B/lipase) (PLB/LIP) (Triacylglycerol lipase) (EC 3.1.1.3)",Mus musculus (Mouse),39.7,345.0,6.200000000000002e-66,253.4,"sp|Q3TTY0|PLB1_MOUSE Phospholipase B1, membrane-associated OS=Mus musculus OX=10090 GN=Plb1 PE=1 SV=2",GO:0004622; GO:0004806; GO:0016324; GO:0019433; GO:0031526; GO:0034478; GO:0034638; GO:0046338; GO:0046340; GO:0047499; GO:0050253; GO:2000344,diacylglycerol catabolic process [GO:0046340]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol catabolic process [GO:0034478]; positive regulation of acrosome reaction [GO:2000344]; triglyceride catabolic process [GO:0019433],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526],calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_01920,FUN_007949-T1,Peve_00027153,Pocillopora_meandrina_HIv1___RNAseq.g18136.t1,three_way,84.04533333333333,FUN_007949-T1,Q93104,,,,,68.6,102.0,9e-37,154.1,sp|Q93104|ERH_AEDAE Enhancer of rudimentary homolog OS=Aedes aegypti OX=7159 PE=3 SV=1,,,,,,
OG_01921,FUN_007951-T1,Peve_00039191,Pocillopora_meandrina_HIv1___RNAseq.g30068.t1,three_way,75.82233333333333,,,,,,,,,,,,,,,,,
OG_01922,FUN_007955-T1,Peve_00039190,Pocillopora_meandrina_HIv1___RNAseq.g30069.t1,three_way,83.08366666666667,FUN_007955-T1,Q9NRK6,ABCBA_HUMAN,,"ATP-binding cassette sub-family B member 10, mitochondrial (ABC-mitochondrial erythroid protein) (ABC-me protein) (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (EC 7.6.2.-) (Mitochondrial ATP-binding cassette 2) (M-ABC2)",Homo sapiens (Human),62.2,579.0,5e-200,699.1,"sp|Q9NRK6|ABCBA_HUMAN ATP-binding cassette sub-family B member 10, mitochondrial OS=Homo sapiens OX=9606 GN=ABCB10 PE=1 SV=2",GO:0005524; GO:0005739; GO:0005743; GO:0006783; GO:0006839; GO:0016887; GO:0031966; GO:0034514; GO:0042803; GO:0045648; GO:0046872; GO:0046985; GO:0048821; GO:0070455; GO:0140359; GO:0170037,erythrocyte development [GO:0048821]; export from the mitochondrion [GO:0170037]; heme biosynthetic process [GO:0006783]; mitochondrial transport [GO:0006839]; mitochondrial unfolded protein response [GO:0034514]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of hemoglobin biosynthetic process [GO:0046985],mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0043226; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; hydrolase activity; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_01923,FUN_007957-T1,Peve_00039189,Pocillopora_meandrina_HIv1___RNAseq.g30070.t1,three_way,65.248,FUN_007957-T1,P25703,,,,,42.9,403.0,6.099999999999999e-75,282.7,sp|P25703|BMP2A_XENLA Bone morphogenetic protein 2-A OS=Xenopus laevis OX=8355 GN=bmp2-a PE=2 SV=1,,,,,,
OG_01924,FUN_007960-T1,Peve_00039187,Pocillopora_meandrina_HIv1___RNAseq.g30071.t1,three_way,67.50933333333333,,,,,,,,,,,,,,,,,
OG_01925,FUN_007961-T1,Peve_00039186,Pocillopora_meandrina_HIv1___RNAseq.g30072.t1,three_way,79.55666666666667,FUN_007961-T1,Q9UQM7,KCC2A_HUMAN,,Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17),Homo sapiens (Human),36.8,302.0,1.4e-52,208.4,sp|Q9UQM7|KCC2A_HUMAN Calcium/calmodulin-dependent protein kinase type II subunit alpha OS=Homo sapiens OX=9606 GN=CAMK2A PE=1 SV=2,GO:0000082; GO:0002931; GO:0004674; GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005954; GO:0006468; GO:0006816; GO:0010666; GO:0014069; GO:0016301; GO:0030666; GO:0035254; GO:0035458; GO:0038166; GO:0042802; GO:0042803; GO:0043005; GO:0043197; GO:0046427; GO:0046872; GO:0046928; GO:0048168; GO:0051092; GO:0051346; GO:0051928; GO:0060291; GO:0060996; GO:0071346; GO:0106310; GO:1902108; GO:1903076; GO:1990443; GO:2000124; GO:2001222,angiotensin-activated signaling pathway [GO:0038166]; calcium ion transport [GO:0006816]; cellular response to interferon-beta [GO:0035458]; cellular response to type II interferon [GO:0071346]; dendritic spine development [GO:0060996]; G1/S transition of mitotic cell cycle [GO:0000082]; long-term synaptic potentiation [GO:0060291]; negative regulation of hydrolase activity [GO:0051346]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; protein phosphorylation [GO:0006468]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of neuron migration [GO:2001222]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein localization to plasma membrane [GO:1903076]; response to ischemia [GO:0002931],calcium- and calmodulin-dependent protein kinase complex [GO:0005954]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; glutamate receptor binding [GO:0035254]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006355; GO:0007005; GO:0016740; GO:0043226; GO:0048856; GO:0061024; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; regulation of DNA-templated transcription; mitochondrion organization; transferase activity; organelle; anatomical structure development; membrane organization; catalytic activity, acting on a protein"
OG_01926,FUN_007963-T1,Peve_00030095,Pocillopora_meandrina_HIv1___RNAseq.g30028.t1,three_way,80.453,FUN_007963-T1,Q6PBN2,AIDA_DANRE,,"Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist)",Danio rerio (Zebrafish) (Brachydanio rerio),45.6,307.0,7.1e-71,268.9,"sp|Q6PBN2|AIDA_DANRE Axin interactor, dorsalization-associated protein OS=Danio rerio OX=7955 GN=aida PE=1 SV=1",GO:0009953; GO:0016020; GO:0031333; GO:0035091; GO:0043508; GO:0046329; GO:0048264; GO:2000016,determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of JNK cascade [GO:0046329]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of protein-containing complex assembly [GO:0031333],membrane [GO:0016020],phosphatidylinositol binding [GO:0035091],GO:0008289,lipid binding
OG_01927,FUN_007964-T1,Peve_00030094,Pocillopora_meandrina_HIv1___RNAseq.g30026.t1,three_way,69.93233333333333,FUN_007964-T1,Q66HG4,,,,,48.8,281.0,1.6e-70,267.7,sp|Q66HG4|GALM_RAT Galactose mutarotase OS=Rattus norvegicus OX=10116 GN=Galm PE=1 SV=1,,,,,,
OG_01928,FUN_007965-T1,Peve_00030093,Pocillopora_meandrina_HIv1___RNAseq.g30027.t1,three_way,56.10933333333333,,,,,,,,,,,,,,,,,
OG_01929,FUN_007966-T1,Peve_00030090,Pocillopora_meandrina_HIv1___RNAseq.g30025.t1,three_way,38.349833333333336,,,,,,,,,,,,,,,,,
OG_01930,FUN_007967-T1,Peve_00030088,Pocillopora_meandrina_HIv1___RNAseq.g30023.t1,three_way,56.617,,,,,,,,,,,,,,,,,
OG_01931,FUN_007968-T1,Peve_00030087,Pocillopora_meandrina_HIv1___RNAseq.g30022.t1,three_way,49.753,,,,,,,,,,,,,,,,,
OG_01932,FUN_007971-T1,Peve_00030081,Pocillopora_meandrina_HIv1___RNAseq.g30013.t1,three_way,62.339,,,,,,,,,,,,,,,,,
OG_01933,FUN_007972-T1,Peve_00030080,Pocillopora_meandrina_HIv1___RNAseq.g30012.t1,three_way,50.04383333333333,,,,,,,,,,,,,,,,,
OG_01934,FUN_007973-T1,Peve_00030074,Pocillopora_meandrina_HIv1___RNAseq.g30008.t1,three_way,60.6855,FUN_007973-T1,Q9TTK4,,,,,27.2,4160.0,0.0,1187.2,sp|Q9TTK4|LYST_BOVIN Lysosomal-trafficking regulator OS=Bos taurus OX=9913 GN=LYST PE=1 SV=1,,,,,,
OG_01935,FUN_007976-T1,Peve_00040181,Pocillopora_meandrina_HIv1___RNAseq.g18173.t1,three_way,73.17483333333334,FUN_007976-T1,P14866,HNRPL_HUMAN,,Heterogeneous nuclear ribonucleoprotein L (hnRNP L),Homo sapiens (Human),43.1,450.0,3.8e-87,323.6,sp|P14866|HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2,GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0016020; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045892; GO:0070062; GO:0097157; GO:1990904,"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; synapse [GO:0045202],mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_01936,FUN_007977-T1,Peve_00040182,Pocillopora_meandrina_HIv1___RNAseq.g18172.t1,three_way,58.66166666666667,FUN_007977-T1,O60566,BUB1B_HUMAN,,Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (hBUBR1) (Mitotic checkpoint kinase MAD3L) (Protein SSK1),Homo sapiens (Human),35.7,420.0,2.9e-63,245.7,sp|O60566|BUB1B_HUMAN Mitotic checkpoint serine/threonine-protein kinase BUB1 beta OS=Homo sapiens OX=9606 GN=BUB1B PE=1 SV=3,GO:0000776; GO:0000940; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0006915; GO:0007091; GO:0007094; GO:0033597; GO:0036064; GO:0048471; GO:0051301; GO:0051754; GO:0071459; GO:0106310,"apoptotic process [GO:0006915]; cell division [GO:0051301]; meiotic sister chromatid cohesion, centromeric [GO:0051754]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to chromosome, centromeric region [GO:0071459]",anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01937,FUN_007979-T1,Peve_00040184,Pocillopora_meandrina_HIv1___TS.g21156.t1,three_way,67.77283333333332,FUN_007979-T1,F4NUJ6,,,,,44.9,441.0,1.2e-101,371.7,sp|F4NUJ6|TRM5_BATDJ tRNA (guanine(37)-N(1))-methyltransferase OS=Batrachochytrium dendrobatidis (strain JAM81 / FGSC 10211) OX=684364 GN=TRM5 PE=3 SV=1,,,,,,
OG_01938,FUN_007980-T1,Peve_00040185,Pocillopora_meandrina_HIv1___RNAseq.g18169.t1,three_way,77.59366666666666,FUN_007980-T1,B6NXD5,BABA2_BRAFL,,BRISC and BRCA1-A complex member 2 (BRCA1-A complex subunit BRE) (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein),Branchiostoma floridae (Florida lancelet) (Amphioxus),43.6,381.0,4.2e-92,339.7,sp|B6NXD5|BABA2_BRAFL BRISC and BRCA1-A complex member 2 OS=Branchiostoma floridae OX=7739 GN=BABAM2 PE=3 SV=1,GO:0005634; GO:0005737; GO:0006302; GO:0006325; GO:0006915; GO:0007095; GO:0010212; GO:0031593; GO:0045739; GO:0051301; GO:0070531; GO:0070552,apoptotic process [GO:0006915]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212],BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634],polyubiquitin modification-dependent protein binding [GO:0031593],GO:0005634; GO:0006281; GO:0006325; GO:0012501; GO:0043226,nucleus; DNA repair; chromatin organization; programmed cell death; organelle
OG_01939,FUN_007981-T1,Peve_00040186,Pocillopora_meandrina_HIv1___RNAseq.g18168.t2,three_way,61.64066666666667,FUN_007981-T1,Q8CIF6,SIDT2_MOUSE,,SID1 transmembrane family member 2,Mus musculus (Mouse),26.6,418.0,4.4e-25,118.2,sp|Q8CIF6|SIDT2_MOUSE SID1 transmembrane family member 2 OS=Mus musculus OX=10090 GN=Sidt2 PE=1 SV=1,GO:0000902; GO:0003323; GO:0003677; GO:0003725; GO:0005764; GO:0005765; GO:0005886; GO:0006401; GO:0009749; GO:0035612; GO:0035650; GO:0042593; GO:0044342; GO:0050658; GO:0051032; GO:0061178,cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342],lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032],GO:0003677; GO:0003723; GO:0005215; GO:0005764; GO:0005773; GO:0005886; GO:0043226; GO:0048856,DNA binding; RNA binding; transporter activity; lysosome; vacuole; plasma membrane; organelle; anatomical structure development
OG_01940,FUN_007990-T1,Peve_00040190,Pocillopora_meandrina_HIv1___RNAseq.g18166.t1,three_way,74.74333333333333,FUN_007990-T1,Q61103,REQU_MOUSE,,"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)",Mus musculus (Mouse),41.2,391.0,2.7e-74,280.8,sp|Q61103|REQU_MOUSE Zinc finger protein ubi-d4 OS=Mus musculus OX=10090 GN=Dpf2 PE=1 SV=1,GO:0000785; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006338; GO:0006357; GO:0006915; GO:0008270; GO:0016514; GO:0030071; GO:0070316; GO:0140015; GO:0140046; GO:1902459; GO:1905454; GO:2000045; GO:2000781; GO:2000819,apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],histone H3K14ac reader activity [GO:0140015]; histone H4K16ac reader activity [GO:0140046]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006325; GO:0006355; GO:0012501; GO:0043226; GO:0060090,nucleus; nucleoplasm; microtubule organizing center; cytosol; chromatin organization; regulation of DNA-templated transcription; programmed cell death; organelle; molecular adaptor activity
OG_01941,FUN_007993-T1,Peve_00018053,Pocillopora_meandrina_HIv1___RNAseq.g5090.t1,three_way,42.72566666666666,FUN_007993-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),25.9,587.0,7.1e-39,163.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_01942,FUN_007995-T1,Peve_00018055,Pocillopora_meandrina_HIv1___RNAseq.g18162.t1,three_way,60.7,FUN_007995-T1,Q13308,,,,,32.5,1058.0,5.8e-147,523.5,sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,,,,,,
OG_01943,FUN_007997-T1,Peve_00005544,Pocillopora_meandrina_HIv1___TS.g21145.t1,three_way,55.695,FUN_007997-T1,Q56X76,RH39_ARATH,,DEAD-box ATP-dependent RNA helicase 39 (EC 3.6.4.13),Arabidopsis thaliana (Mouse-ear cress),36.5,438.0,9.999999999999999e-69,262.7,sp|Q56X76|RH39_ARATH DEAD-box ATP-dependent RNA helicase 39 OS=Arabidopsis thaliana OX=3702 GN=RH39 PE=2 SV=2,GO:0003724; GO:0003729; GO:0005524; GO:0009507; GO:0016887; GO:0070180; GO:0110102; GO:1901259,chloroplast rRNA processing [GO:1901259]; ribulose bisphosphate carboxylase complex assembly [GO:0110102],chloroplast [GO:0009507],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; large ribosomal subunit rRNA binding [GO:0070180]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0009536; GO:0016787; GO:0016853; GO:0043226; GO:0065003; GO:0140098; GO:0140657,"RNA binding; catalytic activity; plastid; hydrolase activity; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on RNA; ATP-dependent activity"
OG_01944,FUN_007998-T1,Peve_00005543,Pocillopora_meandrina_HIv1___RNAseq.g18158.t1,three_way,63.6235,,,,,,,,,,,,,,,,,
OG_01945,FUN_008000-T1,Peve_00022011,Pocillopora_meandrina_HIv1___RNAseq.g18155.t1,three_way,76.23933333333333,FUN_008000-T1,P51948,MAT1_HUMAN,,CDK-activating kinase assembly factor MAT1 (CDK7/cyclin-H assembly factor) (Cyclin-G1-interacting protein) (Menage a trois) (RING finger protein 66) (RING finger protein MAT1) (p35) (p36),Homo sapiens (Human),46.0,313.0,6.999999999999998e-69,262.3,sp|P51948|MAT1_HUMAN CDK-activating kinase assembly factor MAT1 OS=Homo sapiens OX=9606 GN=MNAT1 PE=1 SV=1,GO:0000082; GO:0000307; GO:0000439; GO:0005654; GO:0005675; GO:0006281; GO:0006289; GO:0006357; GO:0006367; GO:0007512; GO:0008270; GO:0021591; GO:0043066; GO:0048661; GO:0051592; GO:0061575; GO:0070516; GO:0070985; GO:2000045,adult heart development [GO:0007512]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; response to calcium ion [GO:0051592]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ventricular system development [GO:0021591],CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985],cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; zinc ion binding [GO:0008270],GO:0005654; GO:0006281; GO:0006355; GO:0048856; GO:0098772,nucleoplasm; DNA repair; regulation of DNA-templated transcription; anatomical structure development; molecular function regulator activity
OG_01946,FUN_008001-T1,Peve_00006650,Pocillopora_meandrina_HIv1___TS.g21139.t2b,three_way,61.92966666666666,FUN_008001-T1,Q8IWY9,CDAN1_HUMAN,,Codanin-1,Homo sapiens (Human),30.4,1310.0,1.6e-117,426.0,sp|Q8IWY9|CDAN1_HUMAN Codanin-1 OS=Homo sapiens OX=9606 GN=CDAN1 PE=1 SV=4,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0008104; GO:0012505; GO:0051170,chromatin organization [GO:0006325]; import into nucleus [GO:0051170]; protein localization [GO:0008104],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005829; GO:0005886; GO:0006325; GO:0006913; GO:0043226,nucleus; cytosol; plasma membrane; chromatin organization; nucleocytoplasmic transport; organelle
OG_01947,FUN_008003-T1,Peve_00006648,Pocillopora_meandrina_HIv1___RNAseq.g18148.t1,three_way,64.2115,FUN_008003-T1,Q9HAW4,CLSPN_HUMAN,,Claspin (hClaspin),Homo sapiens (Human),32.9,304.0,3.5e-24,114.4,sp|Q9HAW4|CLSPN_HUMAN Claspin OS=Homo sapiens OX=9606 GN=CLSPN PE=1 SV=3,GO:0000076; GO:0000077; GO:0000217; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0007095; GO:0010997; GO:0018105; GO:0032147; GO:0033314,activation of protein kinase activity [GO:0032147]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; peptidyl-serine phosphorylation [GO:0018105],Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],anaphase-promoting complex binding [GO:0010997]; DNA secondary structure binding [GO:0000217],GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0043226,DNA binding; nucleus; nucleoplasm; Golgi apparatus; DNA repair; organelle
OG_01948,FUN_008005-T1,Peve_00031191,Pocillopora_meandrina_HIv1___TS.g21131.t1,three_way,83.46333333333334,FUN_008005-T1,Q2KJF9,,,,,44.1,290.0,1.9999999999999998e-54,214.2,sp|Q2KJF9|T2EB_BOVIN General transcription factor IIE subunit 2 OS=Bos taurus OX=9913 GN=GTF2E2 PE=2 SV=1,,,,,,
OG_01949,FUN_008006-T1,Peve_00011919,Pocillopora_meandrina_HIv1___RNAseq.g30330.t1,three_way,59.504,FUN_008006-T1,P31684,,,,,42.4,535.0,1.5e-116,422.5,sp|P31684|4CL1_SOLTU 4-coumarate--CoA ligase 1 OS=Solanum tuberosum OX=4113 GN=4CL1 PE=3 SV=1,,,,,,
OG_01950,FUN_008015-T1,Peve_00031318,Pocillopora_meandrina_HIv1___RNAseq.g30337.t1a,three_way,61.85166666666667,FUN_008015-T1,P14912,,,,,38.4,536.0,5.5e-99,363.2,sp|P14912|4CL1_PETCR 4-coumarate--CoA ligase 1 OS=Petroselinum crispum OX=4043 GN=4CL1 PE=2 SV=1,,,,,,
OG_01951,FUN_008016-T1,Peve_00031315,Pocillopora_meandrina_HIv1___RNAseq.g30338.t1,three_way,69.895,FUN_008016-T1,Q6GYQ0,RGPA1_HUMAN,,Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240),Homo sapiens (Human),36.5,2122.0,0.0,1175.6,sp|Q6GYQ0|RGPA1_HUMAN Ral GTPase-activating protein subunit alpha-1 OS=Homo sapiens OX=9606 GN=RALGAPA1 PE=1 SV=1,GO:0005096; GO:0005634; GO:0005737; GO:0046982; GO:0051056; GO:0090630,activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; nucleus [GO:0005634],GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982],GO:0005634; GO:0043226; GO:0098772,nucleus; organelle; molecular function regulator activity
OG_01952,FUN_008018-T1,Peve_00031314,Pocillopora_meandrina_HIv1___RNAseq.g30339.t1,three_way,80.18366666666667,FUN_008018-T1,P18754,RCC1_HUMAN,,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),Homo sapiens (Human),49.0,433.0,2.4e-107,390.6,sp|P18754|RCC1_HUMAN Regulator of chromosome condensation OS=Homo sapiens OX=9606 GN=RCC1 PE=1 SV=1,GO:0000082; GO:0000785; GO:0000794; GO:0003682; GO:0005085; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0007052; GO:0007059; GO:0007084; GO:0007088; GO:0007346; GO:0016032; GO:0031267; GO:0031491; GO:0031492; GO:0032991; GO:0042393; GO:0043199; GO:0046982; GO:0051225; GO:0051301; GO:1901673,cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; regulation of mitotic spindle assembly [GO:1901673]; spindle assembly [GO:0051225]; viral process [GO:0016032],chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199],GO:0000228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0007010; GO:0007059; GO:0042393; GO:0043226; GO:0061024; GO:0098772,nuclear chromosome; DNA binding; nucleus; nucleoplasm; chromosome; cytoskeleton organization; chromosome segregation; histone binding; organelle; membrane organization; molecular function regulator activity
OG_01953,FUN_008019-T1,Peve_00031304,Pocillopora_meandrina_HIv1___RNAseq.g30340.t1,three_way,72.098,FUN_008019-T1,Q9CXE6,XRCC3_MOUSE,,DNA repair protein XRCC3 (X-ray repair cross-complementing protein 3),Mus musculus (Mouse),45.8,347.0,1.1999999999999998e-69,265.0,sp|Q9CXE6|XRCC3_MOUSE DNA repair protein XRCC3 OS=Mus musculus OX=10090 GN=Xrcc3 PE=2 SV=1,GO:0000400; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005759; GO:0005829; GO:0008821; GO:0010824; GO:0033065; GO:0036297; GO:0048471; GO:0071140; GO:0090267; GO:0090656; GO:0140664,double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; resolution of mitotic recombination intermediates [GO:0071140]; t-circle formation [GO:0090656]; telomere maintenance via recombination [GO:0000722],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0032200; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; telomere organization; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01954,FUN_008020-T1,Peve_00031302,Pocillopora_meandrina_HIv1___RNAseq.g30341.t1,three_way,85.20216666666667,FUN_008020-T1,P27448,MARK3_HUMAN,,MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78),Homo sapiens (Human),52.2,826.0,3.2000000000000005e-201,703.4,sp|P27448|MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens OX=9606 GN=MARK3 PE=1 SV=5,GO:0000226; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0010389; GO:0019903; GO:0030425; GO:0035331; GO:0035556; GO:0048156; GO:0050321; GO:0070062; GO:0106310; GO:1900181,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to nucleus [GO:1900181]; protein phosphorylation [GO:0006468]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005829; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01955,FUN_008021-T1,Peve_00031303,Pocillopora_meandrina_HIv1___RNAseq.g30342.t1,three_way,69.569,,,,,,,,,,,,,,,,,
OG_01956,FUN_008023-T1,Peve_00011345,Pocillopora_meandrina_HIv1___RNAseq.g30348.t1,three_way,75.81166666666667,FUN_008023-T1,Q4R8N7,,,,,50.2,518.0,2.2e-115,417.5,sp|Q4R8N7|STIP1_MACFA Stress-induced-phosphoprotein 1 OS=Macaca fascicularis OX=9541 GN=STIP1 PE=2 SV=1,,,,,,
OG_01957,FUN_008025-T1,Peve_00011341,Pocillopora_meandrina_HIv1___RNAseq.g30350.t1,three_way,62.04266666666667,,,,,,,,,,,,,,,,,
OG_01958,FUN_008028-T1,Peve_00011346,Pocillopora_meandrina_HIv1___RNAseq.g30353.t1,three_way,77.145,FUN_008028-T1,P48556,PSMD8_HUMAN,,26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14) (p31),Homo sapiens (Human),58.9,263.0,2.9999999999999996e-84,313.2,sp|P48556|PSMD8_HUMAN 26S proteasome non-ATPase regulatory subunit 8 OS=Homo sapiens OX=9606 GN=PSMD8 PE=1 SV=2,GO:0000502; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0008541; GO:0022624; GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, lid subcomplex [GO:0008541]",,GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_01959,FUN_008029-T1,Peve_00011343,Pocillopora_meandrina_HIv1___RNAseq.g30354.t1,three_way,75.087,,,,,,,,,,,,,,,,,
OG_01960,FUN_008035-T1,Peve_00045156,Pocillopora_meandrina_HIv1___RNAseq.g30368.t1,three_way,62.588,FUN_008035-T1,Q9WVJ4,SYJ2B_RAT,,Synaptojanin-2-binding protein (Mitochondrial outer membrane protein 25) (NPW16),Rattus norvegicus (Rat),48.1,77.0,4.3e-13,76.3,sp|Q9WVJ4|SYJ2B_RAT Synaptojanin-2-binding protein OS=Rattus norvegicus OX=10116 GN=Synj2bp PE=1 SV=2,GO:0001937; GO:0005739; GO:0005741; GO:0006605; GO:0007266; GO:0008593; GO:0009986; GO:0010596; GO:0016525; GO:0030100; GO:0032927; GO:0048312; GO:0070373; GO:0070699; GO:1903671,intracellular distribution of mitochondria [GO:0048312]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of activin receptor signaling pathway [GO:0032927]; protein targeting [GO:0006605]; regulation of endocytosis [GO:0030100]; regulation of Notch signaling pathway [GO:0008593]; Rho protein signal transduction [GO:0007266],cell surface [GO:0009986]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],type II activin receptor binding [GO:0070699],GO:0005739; GO:0043226,mitochondrion; organelle
OG_01961,FUN_008036-T1,Peve_00045157,Pocillopora_meandrina_HIv1___TS.g22662.t1,three_way,59.35066666666667,FUN_008036-T1,A1A5Z0,G6PC3_DANRE,,Glucose-6-phosphatase 3 (G-6-Pase 3) (G6Pase 3) (EC 3.1.3.9),Danio rerio (Zebrafish) (Brachydanio rerio),36.1,355.0,4.799999999999999e-53,209.9,sp|A1A5Z0|G6PC3_DANRE Glucose-6-phosphatase 3 OS=Danio rerio OX=7955 GN=g6pc3 PE=2 SV=1,GO:0002244; GO:0004346; GO:0005789; GO:0006094; GO:0016020; GO:0051156,gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; hematopoietic progenitor cell differentiation [GO:0002244],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],glucose-6-phosphatase activity [GO:0004346],GO:0003824; GO:0005975; GO:0016787; GO:0030154; GO:1901135,catalytic activity; carbohydrate metabolic process; hydrolase activity; cell differentiation; carbohydrate derivative metabolic process
OG_01962,FUN_008045-T1,Peve_00045144,Pocillopora_meandrina_HIv1___RNAseq.g30364.t1,three_way,63.13066666666666,FUN_008045-T1,Q0P4W3,,,,,41.6,125.0,3e-26,119.4,sp|Q0P4W3|RMD2_XENTR Regulator of microtubule dynamics protein 2 OS=Xenopus tropicalis OX=8364 GN=rmdn2 PE=2 SV=1,,,,,,
OG_01963,FUN_008046-T1,Peve_00045145,Pocillopora_meandrina_HIv1___RNAseq.g30363.t1,three_way,54.59633333333333,,,,,,,,,,,,,,,,,
OG_01964,FUN_008047-T1,Peve_00045146,Pocillopora_meandrina_HIv1___RNAseq.g30362.t2,three_way,56.651333333333326,,,,,,,,,,,,,,,,,
OG_01965,FUN_008048-T1,Peve_00045148,Pocillopora_meandrina_HIv1___TS.g22657.t1,three_way,69.3655,,,,,,,,,,,,,,,,,
OG_01966,FUN_008049-T1,Peve_00045150,Pocillopora_meandrina_HIv1___RNAseq.g30360.t1,three_way,52.505,,,,,,,,,,,,,,,,,
OG_01967,FUN_008051-T1,Peve_00045153,Pocillopora_meandrina_HIv1___RNAseq.g30357.t1,three_way,45.46666666666667,,,,,,,,,,,,,,,,,
OG_01968,FUN_008058-T1,Peve_00017188,Pocillopora_meandrina_HIv1___RNAseq.g17900.t1,three_way,70.506,FUN_008058-T1,Q8AWD2,MOCS3_DANRE,,Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)],Danio rerio (Zebrafish) (Brachydanio rerio),53.7,492.0,1e-135,485.0,sp|Q8AWD2|MOCS3_DANRE Adenylyltransferase and sulfurtransferase MOCS3 OS=Danio rerio OX=7955 GN=mocs3 PE=2 SV=1,GO:0002098; GO:0002143; GO:0004792; GO:0005524; GO:0005737; GO:0005829; GO:0006777; GO:0016779; GO:0016783; GO:0032447; GO:0034227; GO:0042292; GO:0046872; GO:0061604; GO:0061605,Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292],GO:0003824; GO:0005829; GO:0006399; GO:0016740; GO:0016874; GO:0140096; GO:0140657,"catalytic activity; cytosol; tRNA metabolic process; transferase activity; ligase activity; catalytic activity, acting on a protein; ATP-dependent activity"
OG_01969,FUN_008060-T1,Peve_00017191,Pocillopora_meandrina_HIv1___RNAseq.g17907.t1,three_way,77.13,,,,,,,,,,,,,,,,,
OG_01970,FUN_008061-T1,Peve_00017192,Pocillopora_meandrina_HIv1___RNAseq.g17906.t1,three_way,53.46666666666666,,,,,,,,,,,,,,,,,
OG_01971,FUN_008065-T1,Peve_00041867,Pocillopora_meandrina_HIv1___RNAseq.g5205.t1,three_way,64.48016666666666,FUN_008065-T1,O00534,,,,,36.3,772.0,1.8e-121,438.3,sp|O00534|VMA5A_HUMAN von Willebrand factor A domain-containing protein 5A OS=Homo sapiens OX=9606 GN=VWA5A PE=1 SV=2,,,,,,
OG_01972,FUN_008075-T2,Peve_00013209,Pocillopora_meandrina_HIv1___TS.g22375.t1a,three_way,80.586,FUN_008075-T2,P47990,XDH_CHICK,,Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)],Gallus gallus (Chicken),61.2,1361.0,0.0,1679.1,sp|P47990|XDH_CHICK Xanthine dehydrogenase/oxidase OS=Gallus gallus OX=9031 GN=XDH PE=1 SV=1,GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0005829; GO:0009115; GO:0030151; GO:0034418; GO:0043546; GO:0050660; GO:0051537; GO:0070674; GO:0071949,urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777],"2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]",GO:0003824; GO:0005615; GO:0005777; GO:0005829; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; peroxisome; cytosol; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_01973,FUN_008078-T1,Peve_00041219,Pocillopora_meandrina_HIv1___RNAseq.g30081.t1,three_way,69.93933333333334,FUN_008078-T1,Q9VBW0,,,,,52.6,76.0,2.2e-14,80.1,sp|Q9VBW0|SAYS1_DROME SAYSvFN domain-containing protein 1 OS=Drosophila melanogaster OX=7227 GN=Saysd1 PE=2 SV=1,,,,,,
OG_01974,FUN_008079-T1,Peve_00041217,Pocillopora_meandrina_HIv1___RNAseq.g30082.t1,three_way,88.34400000000001,FUN_008079-T1,Q9Z2Q4,,,,,69.2,1253.0,0.0,1754.2,sp|Q9Z2Q4|METH_RAT Methionine synthase OS=Rattus norvegicus OX=10116 GN=Mtr PE=1 SV=1,,,,,,
OG_01975,FUN_008082-T1,Peve_00041208,Pocillopora_meandrina_HIv1___RNAseq.21590_t,three_way,82.247,FUN_008082-T1,Q8NI22,MCFD2_HUMAN,,Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein),Homo sapiens (Human),48.1,104.0,1.6e-20,100.5,sp|Q8NI22|MCFD2_HUMAN Multiple coagulation factor deficiency protein 2 OS=Homo sapiens OX=9606 GN=MCFD2 PE=1 SV=1,GO:0005509; GO:0005789; GO:0005794; GO:0012507; GO:0015031; GO:0016192; GO:0033116,protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794],calcium ion binding [GO:0005509],GO:0005794; GO:0016192; GO:0043226,Golgi apparatus; vesicle-mediated transport; organelle
OG_01976,FUN_008083-T1,Peve_00041206,Pocillopora_meandrina_HIv1___RNAseq.g18090.t1,three_way,74.70133333333332,,,,,,,,,,,,,,,,,
OG_01977,FUN_008084-T1,Peve_00041226,Pocillopora_meandrina_HIv1___RNAseq.g18089.t1,three_way,77.60133333333333,FUN_008084-T1,Q9VAI1,CIA30_DROME,,"Complex I intermediate-associated protein 30, mitochondrial (NADH:ubiquinone oxidoreductase complex assembly factor 1)",Drosophila melanogaster (Fruit fly),35.7,213.0,1.6e-28,127.9,"sp|Q9VAI1|CIA30_DROME Complex I intermediate-associated protein 30, mitochondrial OS=Drosophila melanogaster OX=7227 GN=NdufAF1 PE=1 SV=1",GO:0001666; GO:0005739; GO:0006120; GO:0009408; GO:0032981; GO:0042594; GO:0051082; GO:0055093; GO:1990204,"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to heat [GO:0009408]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to starvation [GO:0042594]",mitochondrion [GO:0005739]; oxidoreductase complex [GO:1990204],unfolded protein binding [GO:0051082],GO:0005739; GO:0006091; GO:0043226; GO:0065003,mitochondrion; generation of precursor metabolites and energy; organelle; protein-containing complex assembly
OG_01978,FUN_008085-T1,Peve_00041225,Pocillopora_meandrina_HIv1___RNAseq.g18088.t1,three_way,66.205,FUN_008085-T1,Q80ZM8,,,,,51.3,197.0,2.7e-49,197.2,sp|Q80ZM8|CRLS1_MOUSE Cardiolipin synthase (CMP-forming) OS=Mus musculus OX=10090 GN=Crls1 PE=1 SV=1,,,,,,
OG_01979,FUN_008086-T1,Peve_00041202,Pocillopora_meandrina_HIv1___RNAseq.g18086.t1a,three_way,72.75416666666666,FUN_008086-T1,Q5ZMM1,,,,,55.5,443.0,4.7e-146,519.6,sp|Q5ZMM1|RIOX1_CHICK Ribosomal oxygenase 1 OS=Gallus gallus OX=9031 GN=RIOX1 PE=2 SV=1,,,,,,
OG_01980,FUN_008087-T1,Peve_00018940,Pocillopora_meandrina_HIv1___RNAseq.g18085.t1,three_way,47.927,,,,,,,,,,,,,,,,,
OG_01981,FUN_008088-T1,Peve_00033650,Pocillopora_meandrina_HIv1___RNAseq.g30114.t1,three_way,54.91016666666667,FUN_008088-T1,B3EWY9,,,,,96.6,1521.0,0.0,2828.9,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_01982,FUN_008090-T1,Peve_00033656,Pocillopora_meandrina_HIv1___RNAseq.g30101.t1,three_way,80.22983333333333,FUN_008090-T1,P58405,STRN3_RAT,,Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen),Rattus norvegicus (Rat),44.9,824.0,2.1e-171,604.4,sp|P58405|STRN3_RAT Striatin-3 OS=Rattus norvegicus OX=10116 GN=Strn3 PE=1 SV=2,GO:0005516; GO:0005654; GO:0005794; GO:0005886; GO:0019901; GO:0030425; GO:0030674; GO:0031267; GO:0032355; GO:0032991; GO:0033147; GO:0035331; GO:0043025; GO:0044877; GO:0045892; GO:0051721; GO:0070016; GO:0090443; GO:0098794,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hippo signaling [GO:0035331]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; response to estradiol [GO:0032355],dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],GO:0005654; GO:0005794; GO:0005886; GO:0006355; GO:0043226; GO:0060090,nucleoplasm; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_01983,FUN_008091-T1,Peve_00033658,Pocillopora_meandrina_HIv1___RNAseq.g30100.t1,three_way,44.40233333333333,,,,,,,,,,,,,,,,,
OG_01984,FUN_008092-T1,Peve_00033659,Pocillopora_meandrina_HIv1___TS.g22395.t1,three_way,50.162333333333336,,,,,,,,,,,,,,,,,
OG_01985,FUN_008093-T1,Peve_00038989,Pocillopora_meandrina_HIv1___RNAseq.g30098.t1,three_way,63.867666666666665,FUN_008093-T1,Q8BGQ1,SPE39_MOUSE,,Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction),Mus musculus (Mouse),38.4,385.0,1.5e-67,258.8,sp|Q8BGQ1|SPE39_MOUSE Spermatogenesis-defective protein 39 homolog OS=Mus musculus OX=10090 GN=Vipas39 PE=1 SV=1,GO:0005737; GO:0005769; GO:0005770; GO:0005794; GO:0006886; GO:0007283; GO:0008333; GO:0030154; GO:0030199; GO:0032963; GO:0043687; GO:0044877; GO:0055037; GO:0099023,cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; post-translational protein modification [GO:0043687]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; recycling endosome [GO:0055037]; vesicle tethering complex [GO:0099023],protein-containing complex binding [GO:0044877],GO:0005768; GO:0005794; GO:0006886; GO:0016192; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226,endosome; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle
OG_01986,FUN_008094-T1,Peve_00039003,Pocillopora_meandrina_HIv1___RNAseq.g30132.t1,three_way,76.141,FUN_008094-T1,Q8BJ37,TYDP1_MOUSE,,Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) (Protein expressed in male leptotene and zygotene spermatocytes 501) (MLZ-501),Mus musculus (Mouse),52.5,451.0,4e-133,476.5,sp|Q8BJ37|TYDP1_MOUSE Tyrosyl-DNA phosphodiesterase 1 OS=Mus musculus OX=10090 GN=Tdp1 PE=1 SV=2,GO:0000012; GO:0004527; GO:0005634; GO:0006281; GO:0017005,DNA repair [GO:0006281]; single strand break repair [GO:0000012],nucleus [GO:0005634],3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; exonuclease activity [GO:0004527],GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"catalytic activity; nucleus; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_01987,FUN_008095-T1,Peve_00038997,Pocillopora_meandrina_HIv1___RNAseq.g30134.t1,three_way,81.409,FUN_008095-T1,Q5E951,TBCB_BOVIN,,Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B),Bos taurus (Bovine),48.1,243.0,2.3000000000000002e-59,230.3,sp|Q5E951|TBCB_BOVIN Tubulin-folding cofactor B OS=Bos taurus OX=9913 GN=TBCB PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0007021; GO:0007023; GO:0007399; GO:0030154; GO:0031122; GO:0035371; GO:0043014; GO:0051010,cell differentiation [GO:0030154]; cytoplasmic microtubule organization [GO:0031122]; nervous system development [GO:0007399]; post-chaperonin tubulin folding pathway [GO:0007023]; tubulin complex assembly [GO:0007021],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634],alpha-tubulin binding [GO:0043014]; microtubule plus-end binding [GO:0051010],GO:0005634; GO:0005829; GO:0006457; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0065003,nucleus; cytosol; protein folding; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly
OG_01988,FUN_008096-T1,Peve_00038988,Pocillopora_meandrina_HIv1___RNAseq.g30135.t1,three_way,71.50766666666667,FUN_008096-T1,Q96L50,,,,,39.4,411.0,9.9e-42,172.6,sp|Q96L50|LLR1_HUMAN Leucine-rich repeat protein 1 OS=Homo sapiens OX=9606 GN=LRR1 PE=1 SV=2,,,,,,
OG_01989,FUN_008097-T1,Peve_00038885,Pocillopora_meandrina_HIv1___RNAseq.g30136.t1,three_way,71.65733333333334,FUN_008097-T1,Q9ES70,NEK6_MOUSE,,Serine/threonine-protein kinase Nek6 (EC 2.7.11.34) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6),Mus musculus (Mouse),27.1,277.0,4.3e-23,110.5,sp|Q9ES70|NEK6_MOUSE Serine/threonine-protein kinase Nek6 OS=Mus musculus OX=10090 GN=Nek6 PE=1 SV=1,GO:0000287; GO:0000922; GO:0001222; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007059; GO:0016607; GO:0019894; GO:0019901; GO:0030071; GO:0031625; GO:0032991; GO:0034451; GO:0046777; GO:0051301; GO:0106310; GO:0140297,apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of mitotic metaphase/anaphase transition [GO:0030071],centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005829; GO:0007059; GO:0008092; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; chromosome segregation; cytoskeletal protein binding; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01990,FUN_008098-T1,Peve_00038884,Pocillopora_meandrina_HIv1___RNAseq.g30141.t1,three_way,74.036,FUN_008098-T1,Q9NQC3,RTN4_HUMAN,,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),Homo sapiens (Human),38.9,190.0,1.3e-26,121.7,sp|Q9NQC3|RTN4_HUMAN Reticulon-4 OS=Homo sapiens OX=9606 GN=RTN4 PE=1 SV=2,GO:0001825; GO:0002523; GO:0003723; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0007029; GO:0007413; GO:0007420; GO:0010634; GO:0014069; GO:0021801; GO:0022009; GO:0030054; GO:0030182; GO:0030308; GO:0030334; GO:0030517; GO:0031625; GO:0033601; GO:0034165; GO:0035022; GO:0035441; GO:0042803; GO:0042981; GO:0043005; GO:0043025; GO:0045202; GO:0045296; GO:0045766; GO:0046872; GO:0050804; GO:0050821; GO:0051292; GO:0051897; GO:0060317; GO:0060907; GO:0061462; GO:0070161; GO:0071456; GO:0071782; GO:0071786; GO:0071787; GO:0090156; GO:0098826; GO:0098978; GO:0120078; GO:0150052; GO:1902430; GO:1902624; GO:1905523; GO:1905552; GO:1905580; GO:1905653; GO:1990809; GO:2000172; GO:2000347; GO:2001213,apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; brain development [GO:0007420]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell adhesion involved in sprouting angiogenesis [GO:0120078]; cell migration involved in vasculogenesis [GO:0035441]; cellular response to hypoxia [GO:0071456]; central nervous system vasculogenesis [GO:0022009]; cerebral cortex radial glia-guided migration [GO:0021801]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; intracellular sphingolipid homeostasis [GO:0090156]; leukocyte migration involved in inflammatory response [GO:0002523]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of axon extension [GO:0030517]; negative regulation of cell growth [GO:0030308]; negative regulation of vasculogenesis [GO:2001213]; neuron differentiation [GO:0030182]; nuclear pore complex assembly [GO:0051292]; positive regulation of angiogenesis [GO:0045766]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of macrophage migration [GO:1905523]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334]; regulation of postsynapse assembly [GO:0150052],anchoring junction [GO:0070161]; cell junction [GO:0030054]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625],GO:0002376; GO:0003723; GO:0005635; GO:0005783; GO:0005886; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0061024; GO:0065003,immune system process; RNA binding; nuclear envelope; endoplasmic reticulum; plasma membrane; cell adhesion; programmed cell death; cell differentiation; organelle; anatomical structure development; cell motility; membrane organization; protein-containing complex assembly
OG_01991,FUN_008099-T1,Peve_00038883,Pocillopora_meandrina_HIv1___RNAseq.g30140.t1,three_way,82.39933333333333,FUN_008099-T1,O94806,KPCD3_HUMAN,,Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu),Homo sapiens (Human),56.9,822.0,2.4e-263,909.8,sp|O94806|KPCD3_HUMAN Serine/threonine-protein kinase D3 OS=Homo sapiens OX=9606 GN=PRKD3 PE=1 SV=1,GO:0004674; GO:0004697; GO:0005524; GO:0005654; GO:0005829; GO:0005886; GO:0006468; GO:0007200; GO:0008270; GO:0016301; GO:0030148; GO:0035556; GO:0036064; GO:0106310,intracellular signal transduction [GO:0035556]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148],ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0006629; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; microtubule organizing center; cytosol; plasma membrane; lipid metabolic process; transferase activity; catalytic activity, acting on a protein"
OG_01992,FUN_008100-T1,Peve_00038880,Pocillopora_meandrina_HIv1___RNAseq.g30139.t1,three_way,44.18833333333333,,,,,,,,,,,,,,,,,
OG_01993,FUN_008101-T1,Peve_00038876,Pocillopora_meandrina_HIv1___RNAseq.g30155.t1,three_way,89.95933333333333,FUN_008101-T1,Q5R7R9,SNW1_PONAB,,SNW domain-containing protein 1 (Nuclear protein SkiP) (Ski-interacting protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),63.8,544.0,5.800000000000001e-178,625.5,sp|Q5R7R9|SNW1_PONAB SNW domain-containing protein 1 OS=Pongo abelii OX=9601 GN=SNW1 PE=2 SV=1,GO:0000122; GO:0000398; GO:0003713; GO:0003714; GO:0005634; GO:0016363; GO:0016922; GO:0030511; GO:0042771; GO:0042809; GO:0042974; GO:0045944; GO:0046332; GO:0048026; GO:0048384; GO:0048385; GO:0050769; GO:0070562; GO:0071007,"intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384]",nuclear matrix [GO:0016363]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007],nuclear receptor binding [GO:0016922]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear vitamin D receptor binding [GO:0042809]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0140110,nucleus; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_01994,FUN_008103-T1,Peve_00017193,Pocillopora_meandrina_HIv1___RNAseq.g17899.t1,three_way,61.52516666666666,FUN_008103-T1,Q3T1I9,,,,,33.8,1354.0,5.6000000000000005e-182,640.2,sp|Q3T1I9|RPAP1_RAT RNA polymerase II-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Rpap1 PE=1 SV=1,,,,,,
OG_01995,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_01996,FUN_008107-T1,Peve_00019589,Pocillopora_meandrina_HIv1___RNAseq.21377_t,three_way,82.86116666666668,FUN_008107-T1,Q2PFW9,,,,,36.0,458.0,2.5000000000000002e-58,227.6,sp|Q2PFW9|NOVA1_MACFA RNA-binding protein Nova-1 OS=Macaca fascicularis OX=9541 GN=NOVA1 PE=2 SV=1,,,,,,
OG_01997,FUN_008108-T1,Peve_00019590,Pocillopora_meandrina_HIv1___RNAseq.g17896.t1,three_way,76.08733333333333,FUN_008108-T1,P31669,,,,,54.0,985.0,1.6999999999999996e-286,986.9,sp|P31669|PARP1_XENLA Poly [ADP-ribose] polymerase 1 (Fragment) OS=Xenopus laevis OX=8355 GN=parp1 PE=2 SV=1,,,,,,
OG_01998,FUN_008109-T1,Peve_00006535,Pocillopora_meandrina_HIv1___RNAseq.g17895.t1,three_way,62.32033333333333,,,,,,,,,,,,,,,,,
OG_01999,FUN_008110-T1,Peve_00006537,Pocillopora_meandrina_HIv1___RNAseq.g17894.t1,three_way,57.97233333333333,FUN_008110-T1,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),34.8,310.0,1.3e-45,187.2,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_02000,FUN_008111-T1,Peve_00022340,Pocillopora_meandrina_HIv1___RNAseq.g17893.t1,three_way,53.2585,FUN_008111-T1,B3EWY9,,,,,33.3,1402.0,3.9e-139,498.4,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02001,FUN_008114-T1,Peve_00022341,Pocillopora_meandrina_HIv1___TS.g20878.t2,three_way,60.10933333333333,,,,,,,,,,,,,,,,,
OG_02002,FUN_008116-T1,Peve_00022343,Pocillopora_meandrina_HIv1___RNAseq.g17889.t1,three_way,64.144,FUN_008116-T1,Q76L87,,,,,37.2,261.0,3.8e-27,124.0,sp|Q76L87|DMTA2_ORYLA Doublesex- and mab-3-related transcription factor A2 OS=Oryzias latipes OX=8090 GN=dmrta2 PE=3 SV=1,,,,,,
OG_02003,FUN_008117-T1,Peve_00022344,Pocillopora_meandrina_HIv1___RNAseq.21365_t,three_way,73.45166666666667,FUN_008117-T1,Q08DJ7,,,,,45.6,215.0,1.3000000000000002e-44,181.0,sp|Q08DJ7|AAR2_BOVIN Protein AAR2 homolog OS=Bos taurus OX=9913 GN=AAR2 PE=2 SV=1,,,,,,
OG_02004,FUN_008119-T1,Peve_00022345,Pocillopora_meandrina_HIv1___RNAseq.g17886.t1,three_way,94.39433333333334,,,,,,,,,,,,,,,,,
OG_02005,FUN_008120-T1,Peve_00022346,Pocillopora_meandrina_HIv1___RNAseq.g17885.t1,three_way,95.69133333333332,FUN_008120-T1,Q8VD72,TTC8_MOUSE,,Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein homolog),Mus musculus (Mouse),61.7,379.0,2.4e-83,310.8,sp|Q8VD72|TTC8_MOUSE Tetratricopeptide repeat protein 8 OS=Mus musculus OX=10090 GN=Ttc8 PE=1 SV=1,GO:0001650; GO:0001736; GO:0005737; GO:0005814; GO:0005929; GO:0007411; GO:0007608; GO:0015031; GO:0016020; GO:0021772; GO:0032391; GO:0032880; GO:0034451; GO:0034464; GO:0035264; GO:0036064; GO:0045198; GO:0045444; GO:0048560; GO:0051492; GO:0060122; GO:0060170; GO:0060219; GO:0060271; GO:0061326; GO:0061629; GO:0072659; GO:1903251; GO:1905515,axon guidance [GO:0007411]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; fat cell differentiation [GO:0045444]; inner ear receptor cell stereocilium organization [GO:0060122]; multi-ciliated epithelial cell differentiation [GO:1903251]; multicellular organism growth [GO:0035264]; non-motile cilium assembly [GO:1905515]; olfactory bulb development [GO:0021772]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of protein localization [GO:0032880]; regulation of stress fiber assembly [GO:0051492]; renal tubule development [GO:0061326]; sensory perception of smell [GO:0007608],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0005815; GO:0005929; GO:0007163; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0072659,microtubule organizing center; cilium; establishment or maintenance of cell polarity; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein localization to plasma membrane
OG_02006,FUN_008121-T1,Peve_00022347,Pocillopora_meandrina_HIv1___RNAseq.g17884.t1,three_way,60.455666666666666,FUN_008121-T1,Q5TCY1,TTBK1_HUMAN,,Tau-tubulin kinase 1 (EC 2.7.11.1) (Brain-derived tau kinase),Homo sapiens (Human),65.9,308.0,9.2e-116,419.9,sp|Q5TCY1|TTBK1_HUMAN Tau-tubulin kinase 1 OS=Homo sapiens OX=9606 GN=TTBK1 PE=1 SV=2,GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005875; GO:0007165; GO:0007611; GO:0010628; GO:0010629; GO:0018105; GO:0018107; GO:0018108; GO:0021762; GO:0032273; GO:0043025; GO:0048156; GO:0048471; GO:0050321; GO:0061890; GO:0106310; GO:1903980,learning or memory [GO:0007611]; negative regulation of gene expression [GO:0010629]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of astrocyte activation [GO:0061890]; positive regulation of gene expression [GO:0010628]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of protein polymerization [GO:0032273]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_02007,FUN_008122-T1,Peve_00022348,Pocillopora_meandrina_HIv1___RNAseq.g17883.t1,three_way,77.1465,FUN_008122-T1,Q8R4P9,MRP7_MOUSE,,ATP-binding cassette sub-family C member 10 (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 7),Mus musculus (Mouse),49.7,1236.0,0.0,1107.0,sp|Q8R4P9|MRP7_MOUSE ATP-binding cassette sub-family C member 10 OS=Mus musculus OX=10090 GN=Abcc10 PE=1 SV=1,GO:0005524; GO:0006691; GO:0006869; GO:0008559; GO:0009925; GO:0015431; GO:0016323; GO:0016887; GO:0071716; GO:0140359,leukotriene metabolic process [GO:0006691]; leukotriene transport [GO:0071716]; lipid transport [GO:0006869],basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323],ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005215; GO:0016787; GO:0140657,catalytic activity; transporter activity; hydrolase activity; ATP-dependent activity
OG_02008,FUN_008124-T1,Peve_00037845,Pocillopora_meandrina_HIv1___TS.g20865.t1c,three_way,71.69683333333333,FUN_008124-T1,Q86X10,,,,,37.7,1615.0,9.4e-255,882.1,sp|Q86X10|RLGPB_HUMAN Ral GTPase-activating protein subunit beta OS=Homo sapiens OX=9606 GN=RALGAPB PE=1 SV=1,,,,,,
OG_02009,FUN_008125-T1,Peve_00037858,Pocillopora_meandrina_HIv1___TS.g22275.t2,three_way,83.81533333333334,FUN_008125-T1,I0IUP3,,,,,59.4,783.0,9.4e-262,904.4,sp|I0IUP3|MCM8_CHICK DNA helicase MCM8 OS=Gallus gallus OX=9031 GN=MCM8 PE=1 SV=1,,,,,,
OG_02010,FUN_008129-T1,Peve_00037859,Pocillopora_meandrina_HIv1___RNAseq.g29986.t1,three_way,67.05333333333333,FUN_008129-T1,Q9QZE7,,,,,42.8,257.0,1.9e-53,211.5,sp|Q9QZE7|TSNAX_MOUSE Translin-associated protein X OS=Mus musculus OX=10090 GN=Tsnax PE=1 SV=1,,,,,,
OG_02011,FUN_008183-T1,Peve_00018748,Pocillopora_meandrina_HIv1___RNAseq.g29991.t1,three_way,78.25766666666667,FUN_008183-T1,K4CJJ1,,,,,26.0,481.0,5.5e-26,120.6,"sp|K4CJJ1|NCED2_SOLLC 9-cis-epoxycarotenoid dioxygenase NCED2, chloroplastic OS=Solanum lycopersicum OX=4081 GN=NCED2 PE=2 SV=1",,,,,,
OG_02012,FUN_008185-T1,Peve_00018749,Pocillopora_meandrina_HIv1___RNAseq.g29992.t1,three_way,52.86033333333334,FUN_008185-T1,O57382,,,,,29.0,317.0,5.399999999999999e-31,137.5,sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1,,,,,,
OG_02013,FUN_008186-T1,Peve_00018750,Pocillopora_meandrina_HIv1___TS.g22292.t1,three_way,69.749,FUN_008186-T1,Q91YJ5,,,,,47.6,553.0,7.4e-132,472.6,"sp|Q91YJ5|IF2M_MOUSE Translation initiation factor IF-2, mitochondrial OS=Mus musculus OX=10090 GN=Mtif2 PE=1 SV=2",,,,,,
OG_02014,FUN_008187-T1,Peve_00010858,Pocillopora_meandrina_HIv1___RNAseq.g29995.t1,three_way,91.01733333333334,FUN_008187-T1,O75582,KS6A5_HUMAN,,Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL),Homo sapiens (Human),63.9,723.0,1.5e-266,920.2,sp|O75582|KS6A5_HUMAN Ribosomal protein S6 kinase alpha-5 OS=Homo sapiens OX=9606 GN=RPS6KA5 PE=1 SV=1,GO:0000287; GO:0001818; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0006468; GO:0006954; GO:0007411; GO:0032793; GO:0035175; GO:0035556; GO:0038202; GO:0043687; GO:0044022; GO:0044024; GO:0045892; GO:0045944; GO:0051092; GO:0070498; GO:0099175; GO:0106310,axon guidance [GO:0007411]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of cytokine production [GO:0001818]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-translational protein modification [GO:0043687]; protein phosphorylation [GO:0006468]; regulation of DNA-templated transcription [GO:0006355]; regulation of postsynapse organization [GO:0099175]; TORC1 signaling [GO:0038202],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; histone H3S10 kinase activity [GO:0035175]; histone H3S28 kinase activity [GO:0044022]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0006954; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; inflammatory response; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02015,FUN_008188-T1,Peve_00010859,Pocillopora_meandrina_HIv1___RNAseq.g29996.t1,three_way,81.78566666666667,FUN_008188-T1,Q99NB1,ACS2L_MOUSE,,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1) (Propionate--CoA ligase) (EC 6.2.1.17)",Mus musculus (Mouse),62.1,612.0,1.7e-229,797.0,"sp|Q99NB1|ACS2L_MOUSE Acetyl-coenzyme A synthetase 2-like, mitochondrial OS=Mus musculus OX=10090 GN=Acss1 PE=1 SV=1",GO:0003987; GO:0005524; GO:0005739; GO:0005759; GO:0006085; GO:0016208; GO:0019413; GO:0019427; GO:0019542; GO:0050218,acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; propionate-CoA ligase activity [GO:0050218],GO:0003824; GO:0005739; GO:0006629; GO:0006790; GO:0016874; GO:0043226; GO:0055086; GO:0140657,catalytic activity; mitochondrion; lipid metabolic process; sulfur compound metabolic process; ligase activity; organelle; nucleobase-containing small molecule metabolic process; ATP-dependent activity
OG_02016,FUN_008193-T1,Peve_00033874,Pocillopora_meandrina_HIv1___RNAseq.g30167.t1,three_way,91.72483333333334,FUN_008193-T1,O70435,,,,,73.6,254.0,1.6e-103,377.1,sp|O70435|PSA3_MOUSE Proteasome subunit alpha type-3 OS=Mus musculus OX=10090 GN=Psma3 PE=1 SV=3,,,,,,
OG_02017,FUN_008194-T1,Peve_00022158,Pocillopora_meandrina_HIv1___RNAseq.g30170.t1,three_way,74.29066666666667,FUN_008194-T1,Q99538,LGMN_HUMAN,,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (AEP) (Protease, cysteine 1)",Homo sapiens (Human),62.9,280.0,2.7e-100,366.7,sp|Q99538|LGMN_HUMAN Legumain OS=Homo sapiens OX=9606 GN=LGMN PE=1 SV=1,GO:0003014; GO:0004197; GO:0005576; GO:0005737; GO:0005764; GO:0005770; GO:0006508; GO:0006624; GO:0007613; GO:0008233; GO:0008284; GO:0008306; GO:0010447; GO:0010629; GO:0019886; GO:0032801; GO:0035729; GO:0036021; GO:0040015; GO:0042359; GO:0043202; GO:0043524; GO:0045177; GO:0045931; GO:0048156; GO:0048471; GO:0051603; GO:0051604; GO:0061133; GO:0070062; GO:0071277; GO:0090026; GO:0097061; GO:1900273; GO:1901185; GO:1904646; GO:2001028,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; associative learning [GO:0008306]; cellular response to amyloid-beta [GO:1904646]; cellular response to calcium ion [GO:0071277]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; dendritic spine organization [GO:0097061]; memory [GO:0007613]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; protein maturation [GO:0051604]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; response to acidic pH [GO:0010447]; vacuolar protein processing [GO:0006624]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endolysosome lumen [GO:0036021]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; late endosome [GO:0005770]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; peptidase activity [GO:0008233]; tau protein binding [GO:0048156],GO:0002376; GO:0003014; GO:0003824; GO:0005576; GO:0005764; GO:0005768; GO:0005773; GO:0006629; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0050877; GO:0051604; GO:0098772; GO:0140096,"immune system process; renal system process; catalytic activity; extracellular region; lysosome; endosome; vacuole; lipid metabolic process; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; nervous system process; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02018,FUN_008201-T1,Peve_00022159,Pocillopora_meandrina_HIv1___RNAseq.g30172.t1,three_way,86.45133333333334,FUN_008201-T1,Q6ZMV9,,,,,67.2,488.0,1.9e-183,643.7,sp|Q6ZMV9|KIF6_HUMAN Kinesin-like protein KIF6 OS=Homo sapiens OX=9606 GN=KIF6 PE=1 SV=3,,,,,,
OG_02019,FUN_008207-T1,Peve_00008313,Pocillopora_meandrina_HIv1___RNAseq.g30175.t1,three_way,31.211666666666662,,,,,,,,,,,,,,,,,
OG_02020,FUN_008209-T1,Peve_00008317,Pocillopora_meandrina_HIv1___TS.g22471.t1,three_way,67.10233333333333,,,,,,,,,,,,,,,,,
OG_02021,FUN_008210-T1,Peve_00027982,Pocillopora_meandrina_HIv1___RNAseq.g30179.t1,three_way,58.69616666666667,,,,,,,,,,,,,,,,,
OG_02022,FUN_008211-T1,Peve_00027427,Pocillopora_meandrina_HIv1___TS.g22475.t1,three_way,37.799166666666665,,,,,,,,,,,,,,,,,
OG_02023,FUN_008213-T1,Peve_00027980,Pocillopora_meandrina_HIv1___RNAseq.g30181.t1,three_way,74.93733333333333,FUN_008213-T1,Q5PQ59,,,,,55.7,230.0,1.4e-72,274.2,sp|Q5PQ59|ALKB6_XENLA Probable RNA/DNA demethylase ALKBH6 OS=Xenopus laevis OX=8355 GN=alkbh6 PE=2 SV=1,,,,,,
OG_02024,FUN_008214-T1,Peve_00005268,Pocillopora_meandrina_HIv1___RNAseq.g30183.t1,three_way,49.18816666666667,FUN_008214-T1,A0A8J1LLF7,DICRS_XENLA,,Endoribonuclease Dicer-S (EC 3.1.26.3),Xenopus laevis (African clawed frog),28.8,2019.0,7.3e-172,607.1,sp|A0A8J1LLF7|DICRS_XENLA Endoribonuclease Dicer-S OS=Xenopus laevis OX=8355 GN=dicer1.S PE=3 SV=1,GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0030422; GO:0031054; GO:0070578,apoptotic DNA fragmentation [GO:0006309]; pre-miRNA processing [GO:0031054]; siRNA processing [GO:0030422],cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578],ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02025,FUN_008215-T1,Peve_00005269,Pocillopora_meandrina_HIv1___RNAseq.g30184.t1,three_way,71.14333333333333,FUN_008215-T1,Q8VCX6,,,,,42.6,394.0,6.2e-84,312.8,sp|Q8VCX6|KPTN_MOUSE KICSTOR complex protein kaptin OS=Mus musculus OX=10090 GN=Kptn PE=2 SV=1,,,,,,
OG_02026,FUN_008222-T1,Peve_00012571,Pocillopora_meandrina_HIv1___RNAseq.g30186.t1,three_way,67.59533333333333,FUN_008222-T1,Q8BY02,,,,,30.9,256.0,3.4e-26,120.6,sp|Q8BY02|NKRF_MOUSE NF-kappa-B-repressing factor OS=Mus musculus OX=10090 GN=Nkrf PE=2 SV=3,,,,,,
OG_02027,FUN_008228-T1,Peve_00039965,Pocillopora_meandrina_HIv1___RNAseq.g30194.t1,three_way,60.135,FUN_008228-T1,O13076,,,,,27.2,316.0,2e-16,88.2,sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1,,,,,,
OG_02028,FUN_008229-T1,Peve_00039966,Pocillopora_meandrina_HIv1___RNAseq.g30195.t1,three_way,59.528666666666666,FUN_008229-T1,P13466,,,,,41.4,70.0,5.5e-08,60.8,sp|P13466|GELA_DICDI Gelation factor OS=Dictyostelium discoideum OX=44689 GN=abpC PE=1 SV=1,,,,,,
OG_02029,FUN_008230-T1,Peve_00039952,Pocillopora_meandrina_HIv1___RNAseq.g30197.t1,three_way,57.42633333333333,FUN_008230-T1,P35363,5HT2A_MOUSE,,5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A),Mus musculus (Mouse),28.6,325.0,1.2e-20,102.4,sp|P35363|5HT2A_MOUSE 5-hydroxytryptamine receptor 2A OS=Mus musculus OX=10090 GN=Htr2a PE=1 SV=1,GO:0001587; GO:0001659; GO:0002720; GO:0004993; GO:0005883; GO:0005901; GO:0006096; GO:0006874; GO:0007204; GO:0007208; GO:0007613; GO:0008284; GO:0009410; GO:0010513; GO:0014059; GO:0014824; GO:0014832; GO:0030296; GO:0030424; GO:0031410; GO:0031652; GO:0042734; GO:0042802; GO:0043025; GO:0043198; GO:0043267; GO:0043525; GO:0044380; GO:0044877; GO:0045211; GO:0045600; GO:0045821; GO:0045907; GO:0046960; GO:0048148; GO:0050729; GO:0050965; GO:0050966; GO:0051209; GO:0051378; GO:0051967; GO:0070374; GO:0070852; GO:0071886; GO:0098666; GO:0098978; GO:0099171; GO:0099589; GO:1900119; GO:1901731; GO:2000573,"artery smooth muscle contraction [GO:0014824]; behavioral response to cocaine [GO:0048148]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; glycolytic process [GO:0006096]; intracellular calcium ion homeostasis [GO:0006874]; memory [GO:0007613]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of synaptic transmission, glutamatergic [GO:0051967]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glycolytic process [GO:0045821]; positive regulation of heat generation [GO:0031652]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of vasoconstriction [GO:0045907]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein localization to cytoskeleton [GO:0044380]; regulation of dopamine secretion [GO:0014059]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; sensitization [GO:0046960]; temperature homeostasis [GO:0001659]; urinary bladder smooth muscle contraction [GO:0014832]",axon [GO:0030424]; caveola [GO:0005901]; cell body fiber [GO:0070852]; cytoplasmic vesicle [GO:0031410]; dendritic shaft [GO:0043198]; G protein-coupled serotonin receptor complex [GO:0098666]; glutamatergic synapse [GO:0098978]; neurofilament [GO:0005883]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],"1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; G protein-coupled serotonin receptor activity [GO:0004993]; Gq/11-coupled serotonin receptor activity [GO:0001587]; identical protein binding [GO:0042802]; protein tyrosine kinase activator activity [GO:0030296]; protein-containing complex binding [GO:0044877]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589]",GO:0003012; GO:0003013; GO:0005975; GO:0006091; GO:0031410; GO:0043226; GO:0050877; GO:0055085; GO:0055086; GO:0060089; GO:0098772; GO:1901135,muscle system process; circulatory system process; carbohydrate metabolic process; generation of precursor metabolites and energy; cytoplasmic vesicle; organelle; nervous system process; transmembrane transport; nucleobase-containing small molecule metabolic process; molecular transducer activity; molecular function regulator activity; carbohydrate derivative metabolic process
OG_02030,FUN_008231-T1,Peve_00039954,Pocillopora_meandrina_HIv1___TS.g22494.t1,three_way,70.35033333333334,,,,,,,,,,,,,,,,,
OG_02031,FUN_008232-T1,Peve_00039956,Pocillopora_meandrina_HIv1___RNAseq.g30199.t1,three_way,66.05233333333334,FUN_008232-T1,Q6DC37,,,,,28.3,304.0,4e-22,107.1,sp|Q6DC37|HNMT_DANRE Histamine N-methyltransferase OS=Danio rerio OX=7955 GN=hnmt PE=2 SV=1,,,,,,
OG_02032,FUN_008233-T1,Peve_00039958,Pocillopora_meandrina_HIv1___RNAseq.21398_t,three_way,65.03,FUN_008233-T1,Q90964,FOXG1_CHICK,,Forkhead box protein G1 (FoxG1) (Brain factor 1) (BF-1) (BF1) (cBF-1) (CEQ 3-1) (Forkhead-related protein FKHL1) (N-62-5) (Proto-oncogene C-QIN),Gallus gallus (Chicken),61.5,187.0,2.1999999999999997e-53,211.1,sp|Q90964|FOXG1_CHICK Forkhead box protein G1 OS=Gallus gallus OX=9031 GN=FOXG1 PE=2 SV=1,GO:0000122; GO:0002052; GO:0003700; GO:0005634; GO:0006357; GO:0007346; GO:0007405; GO:0009953; GO:0016199; GO:0021852; GO:0042472; GO:0045665; GO:0045666; GO:0045787; GO:0048664; GO:1990837,axon midline choice point recognition [GO:0016199]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; positive regulation of cell cycle [GO:0045787]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron differentiation [GO:0045666]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; sequence-specific double-stranded DNA binding [GO:1990837],GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cell motility; transcription regulator activity
OG_02033,FUN_008234-T1,Peve_00039959,Pocillopora_meandrina_HIv1___TS.g20911.t1b,three_way,72.315,,,,,,,,,,,,,,,,,
OG_02034,FUN_008235-T1,Peve_00039963,Pocillopora_meandrina_HIv1___RNAseq.g17926.t1,three_way,70.18299999999999,FUN_008235-T1,P46718,,,,,44.8,375.0,1.1e-82,308.5,sp|P46718|PDCD2_MOUSE Programmed cell death protein 2 OS=Mus musculus OX=10090 GN=Pdcd2 PE=2 SV=2,,,,,,
OG_02035,FUN_008237-T1,Peve_00003879,Pocillopora_meandrina_HIv1___RNAseq.g17928.t1,three_way,82.36666666666666,FUN_008237-T1,Q29RK2,PYC_BOVIN,,"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)",Bos taurus (Bovine),65.5,1165.0,0.0,1567.0,"sp|Q29RK2|PYC_BOVIN Pyruvate carboxylase, mitochondrial OS=Bos taurus OX=9913 GN=PC PE=2 SV=2",GO:0004736; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0046872,gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; pyruvate metabolic process [GO:0006090],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736],GO:0003824; GO:0005739; GO:0005975; GO:0006629; GO:0016874; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lipid metabolic process; ligase activity; organelle
OG_02036,FUN_008238-T1,Peve_00003880,Pocillopora_meandrina_HIv1___RNAseq.g17929.t1,three_way,69.81566666666667,FUN_008238-T1,Q8R2K4,TAF6L_MOUSE,,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (TAF6L) (PCAF-associated factor 65-alpha) (PAF65-alpha),Mus musculus (Mouse),43.2,472.0,5.600000000000001e-89,330.1,sp|Q8R2K4|TAF6L_MOUSE TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L OS=Mus musculus OX=10090 GN=Taf6l PE=1 SV=1,GO:0000124; GO:0005634; GO:0005669; GO:0006282; GO:0006355; GO:0006367; GO:0016251; GO:0043484; GO:0045893; GO:0046695; GO:0046982; GO:1904672,positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of somatic stem cell population maintenance [GO:1904672]; transcription initiation at RNA polymerase II promoter [GO:0006367],nucleus [GO:0005634]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669],protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0005634; GO:0006355; GO:0043226; GO:0140223,nucleus; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_02037,FUN_008239-T1,Peve_00031796,Pocillopora_meandrina_HIv1___TS.g20917.t2b,three_way,81.074,FUN_008239-T1,Q6T938,FIBP_DANRE,,Acidic fibroblast growth factor intracellular-binding protein B (aFGF intracellular-binding protein B) (FGF-1 intracellular-binding protein B),Danio rerio (Zebrafish) (Brachydanio rerio),42.8,367.0,1.7e-82,307.8,sp|Q6T938|FIBP_DANRE Acidic fibroblast growth factor intracellular-binding protein B OS=Danio rerio OX=7955 GN=fibpb PE=1 SV=1,GO:0005634; GO:0007368; GO:0012505; GO:0016020; GO:0017134; GO:0060026; GO:0060271; GO:0070121,cilium assembly [GO:0060271]; convergent extension [GO:0060026]; determination of left/right symmetry [GO:0007368]; Kupffer's vesicle development [GO:0070121],endomembrane system [GO:0012505]; membrane [GO:0016020]; nucleus [GO:0005634],fibroblast growth factor binding [GO:0017134],GO:0005634; GO:0043226; GO:0044782; GO:0048856,nucleus; organelle; cilium organization; anatomical structure development
OG_02038,FUN_008242-T1,Peve_00031783,Pocillopora_meandrina_HIv1___RNAseq.g17937.t1,three_way,69.76933333333334,,,,,,,,,,,,,,,,,
OG_02039,FUN_008244-T1,Peve_00031788,Pocillopora_meandrina_HIv1___RNAseq.g17947.t1,three_way,64.75966666666667,FUN_008244-T1,P47747,,,,,30.3,333.0,3.8e-23,110.5,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_02040,FUN_008245-T1,Peve_00031789,Pocillopora_meandrina_HIv1___RNAseq.g17949.t1,three_way,80.146,,,,,,,,,,,,,,,,,
OG_02041,FUN_008246-T1,Peve_00031790,Pocillopora_meandrina_HIv1___RNAseq.g17950.t1,three_way,76.36933333333333,FUN_008246-T1,Q3LXA3,TKFC_HUMAN,,Triokinase/FMN cyclase (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) [Includes: ATP-dependent dihydroxyacetone kinase (DHA kinase) (EC 2.7.1.28) (EC 2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase); FAD-AMP lyase (cyclizing) (EC 4.6.1.15) (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase)],Homo sapiens (Human),48.7,591.0,8.3e-143,508.8,sp|Q3LXA3|TKFC_HUMAN Triokinase/FMN cyclase OS=Homo sapiens OX=9606 GN=TKFC PE=1 SV=2,GO:0004371; GO:0005524; GO:0005634; GO:0005829; GO:0005975; GO:0019563; GO:0034012; GO:0039534; GO:0045088; GO:0046835; GO:0046872; GO:0050354; GO:0061624; GO:0070062,carbohydrate metabolic process [GO:0005975]; carbohydrate phosphorylation [GO:0046835]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354],GO:0003824; GO:0005634; GO:0005829; GO:0005975; GO:0009975; GO:0016740; GO:0016829; GO:0043226; GO:1901135,catalytic activity; nucleus; cytosol; carbohydrate metabolic process; cyclase activity; transferase activity; lyase activity; organelle; carbohydrate derivative metabolic process
OG_02042,FUN_008247-T1,Peve_00031791,Pocillopora_meandrina_HIv1___RNAseq.g17951.t1,three_way,61.4625,FUN_008247-T1,Q9WU25,,,,,27.1,350.0,3.1e-24,114.4,sp|Q9WU25|ADA1A_CAVPO Alpha-1A adrenergic receptor OS=Cavia porcellus OX=10141 GN=ADRA1A PE=2 SV=2,,,,,,
OG_02043,FUN_008248-T1,Peve_00031792,Pocillopora_meandrina_HIv1___RNAseq.g17952.t2,three_way,55.662,FUN_008248-T1,P83618,,,,,25.9,185.0,9.7e-14,78.6,sp|P83618|RN28_PANGI Ribonuclease-like storage protein OS=Panax ginseng OX=4054 PE=1 SV=2,,,,,,
OG_02044,FUN_008249-T1,Peve_00031793,Pocillopora_meandrina_HIv1___RNAseq.g17953.t1,three_way,65.32433333333334,FUN_008249-T1,A0A1L8ER70,,,,,28.1,317.0,4.8e-20,100.1,sp|A0A1L8ER70|HYLS1_XENLA Centriolar and ciliogenesis-associated protein HYLS1 OS=Xenopus laevis OX=8355 GN=hyls-1 PE=1 SV=1,,,,,,
OG_02045,FUN_008250-T1,Peve_00025019,Pocillopora_meandrina_HIv1___RNAseq.21440_t,three_way,71.38866666666667,FUN_008250-T1,Q9DCU6,,,,,44.4,216.0,2.7999999999999997e-41,170.6,sp|Q9DCU6|RM04_MOUSE Large ribosomal subunit protein uL4m OS=Mus musculus OX=10090 GN=Mrpl4 PE=1 SV=1,,,,,,
OG_02046,FUN_008253-T1,Peve_00009137,Pocillopora_meandrina_HIv1___RNAseq.g17956.t1,three_way,98.44433333333332,FUN_008253-T1,Q5E9B8,RPB7_BOVIN,,DNA-directed RNA polymerase II subunit RPB7 (RNA polymerase II subunit B7) (DNA-directed RNA polymerase II subunit G),Bos taurus (Bovine),92.6,95.0,3.7e-46,185.3,sp|Q5E9B8|RPB7_BOVIN DNA-directed RNA polymerase II subunit RPB7 OS=Bos taurus OX=9913 GN=POLR2G PE=1 SV=1,GO:0000932; GO:0000956; GO:0003697; GO:0003727; GO:0005634; GO:0005665; GO:0006366; GO:0006367; GO:0031369; GO:0045948; GO:0060213,nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],"nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II, core complex [GO:0005665]",single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369],GO:0003677; GO:0003723; GO:0005634; GO:0006351; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; DNA-templated transcription; mRNA metabolic process; organelle
OG_02047,FUN_008254-T2,Peve_00009135,Pocillopora_meandrina_HIv1___RNAseq.g17957.t1,three_way,62.647333333333336,FUN_008254-T2,Q9NS73,MBIP1_HUMAN,,MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein),Homo sapiens (Human),40.4,225.0,8.3e-35,149.1,sp|Q9NS73|MBIP1_HUMAN MAP3K12-binding inhibitory protein 1 OS=Homo sapiens OX=9606 GN=MBIP PE=1 SV=2,GO:0000122; GO:0004860; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0006357; GO:0010628; GO:0042802; GO:0045995; GO:0046330; GO:0051302; GO:0051726; GO:0072686; GO:0140672,negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357],ATAC complex [GO:0140672]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],identical protein binding [GO:0042802]; protein kinase inhibitor activity [GO:0004860],GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0043226; GO:0098772,nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_02048,FUN_008256-T1,Peve_00035501,Pocillopora_meandrina_HIv1___RNAseq.g17961.t1,three_way,85.40433333333334,FUN_008256-T1,Q9Y6V7,DDX49_HUMAN,,Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49),Homo sapiens (Human),60.0,423.0,1.2e-141,504.6,sp|Q9Y6V7|DDX49_HUMAN Probable ATP-dependent RNA helicase DDX49 OS=Homo sapiens OX=9606 GN=DDX49 PE=1 SV=1,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016887; GO:0030307; GO:0044357,positive regulation of cell growth [GO:0030307]; regulation of rRNA stability [GO:0044357]; rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02049,FUN_008259-T1,Peve_00042075,Pocillopora_meandrina_HIv1___RNAseq.g17963.t1,three_way,74.48566666666667,FUN_008259-T1,O88559,MEN1_MOUSE,,Menin,Mus musculus (Mouse),42.6,599.0,3.6e-116,420.2,sp|O88559|MEN1_MOUSE Menin OS=Mus musculus OX=10090 GN=Men1 PE=1 SV=2,GO:0000122; GO:0000781; GO:0000976; GO:0001216; GO:0001503; GO:0001776; GO:0002051; GO:0002076; GO:0003677; GO:0003682; GO:0005634; GO:0005737; GO:0006338; GO:0008283; GO:0008285; GO:0010468; GO:0010628; GO:0017053; GO:0030097; GO:0035097; GO:0035265; GO:0043565; GO:0044342; GO:0044346; GO:0045668; GO:0045669; GO:0045815; GO:0045893; GO:0045944; GO:0046621; GO:0048144; GO:0048147; GO:0048704; GO:0048863; GO:0051301; GO:0051781; GO:0060021; GO:0060135; GO:0072089; GO:1904691; GO:2000045; GO:2000271; GO:2000647; GO:2000738,cell division [GO:0051301]; cell population proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; embryonic skeletal system morphogenesis [GO:0048704]; fibroblast apoptotic process [GO:0044346]; fibroblast proliferation [GO:0048144]; hemopoiesis [GO:0030097]; leukocyte homeostasis [GO:0001776]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of organ growth [GO:0046621]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type B pancreatic cell proliferation [GO:1904691]; organ growth [GO:0035265]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast fate commitment [GO:0002051]; positive regulation of cell division [GO:0051781]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of gene expression [GO:0010628]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; transcription initiation-coupled chromatin remodeling [GO:0045815]; type B pancreatic cell proliferation [GO:0044342],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]",chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976],GO:0002376; GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02050,FUN_008260-T1,Peve_00042074,Pocillopora_meandrina_HIv1___RNAseq.g17965.t1,three_way,81.01316666666668,FUN_008260-T1,P59325,,,,,52.8,390.0,5.0000000000000004e-105,382.9,sp|P59325|IF5_MOUSE Eukaryotic translation initiation factor 5 OS=Mus musculus OX=10090 GN=Eif5 PE=1 SV=1,,,,,,
OG_02051,FUN_008262-T1,Peve_00042082,Pocillopora_meandrina_HIv1___RNAseq.g17968.t1,three_way,88.03216666666667,FUN_008262-T1,Q6DEL2,,,,,55.3,582.0,2.1e-189,663.7,sp|Q6DEL2|CLPT1_DANRE Putative lipid scramblase CLPTM1 OS=Danio rerio OX=7955 GN=clptm1 PE=2 SV=1,,,,,,
OG_02052,FUN_008263-T1,Peve_00000654,Pocillopora_meandrina_HIv1___RNAseq.g17971.t1,three_way,71.01950000000001,FUN_008263-T1,Q6UWP7,LCLT1_HUMAN,,Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (EC 2.3.1.51) (Acyl-CoA:lysocardiolipin acyltransferase 1),Homo sapiens (Human),48.1,341.0,4.8e-93,342.8,sp|Q6UWP7|LCLT1_HUMAN Lysocardiolipin acyltransferase 1 OS=Homo sapiens OX=9606 GN=LCLAT1 PE=1 SV=1,GO:0003841; GO:0005783; GO:0005789; GO:0005829; GO:0006654; GO:0008374; GO:0012505; GO:0016020; GO:0016024; GO:0016746; GO:0035965; GO:0036149,cardiolipin acyl-chain remodeling [GO:0035965]; CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149],cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746]; O-acyltransferase activity [GO:0008374],GO:0003824; GO:0005783; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; cytosol; lipid metabolic process; transferase activity; organelle
OG_02053,FUN_008264-T1,Peve_00000655,Pocillopora_meandrina_HIv1___RNAseq.g17972.t1,three_way,81.23766666666667,FUN_008264-T1,Q7T3H2,INS1B_DANRE,,Insulinoma-associated protein 1b (Insulinoma-associated 1-like protein b) (Zinc finger protein IA-1b),Danio rerio (Zebrafish) (Brachydanio rerio),46.3,244.0,2.8000000000000002e-33,144.4,sp|Q7T3H2|INS1B_DANRE Insulinoma-associated protein 1b OS=Danio rerio OX=7955 GN=insm1b PE=2 SV=1,GO:0000122; GO:0000978; GO:0001227; GO:0003309; GO:0003310; GO:0003700; GO:0005634; GO:0008270; GO:0010564; GO:0017053; GO:0030182; GO:0031490; GO:0060290,negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; pancreatic A cell differentiation [GO:0003310]; regulation of cell cycle process [GO:0010564]; transdifferentiation [GO:0060290]; type B pancreatic cell differentiation [GO:0003309],nucleus [GO:0005634]; transcription repressor complex [GO:0017053],"chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_02054,FUN_008265-T1,Peve_00000648,Pocillopora_meandrina_HIv1___RNAseq.g17974.t1,three_way,68.76833333333335,FUN_008265-T1,Q07282,,,,,30.1,113.0,2e-07,58.9,"sp|Q07282|TCR5_ECOLX Tetracycline resistance protein, class E OS=Escherichia coli OX=562 GN=tetA PE=3 SV=1",,,,,,
OG_02055,FUN_008266-T1,Peve_00000650,Pocillopora_meandrina_HIv1___RNAseq.g17976.t1,three_way,56.130833333333335,FUN_008266-T1,Q64LD2,WDR25_HUMAN,,WD repeat-containing protein 25,Homo sapiens (Human),42.7,309.0,5.1e-77,290.0,sp|Q64LD2|WDR25_HUMAN WD repeat-containing protein 25 OS=Homo sapiens OX=9606 GN=WDR25 PE=1 SV=3,,,,,,
OG_02056,FUN_008267-T1,Peve_00001964,Pocillopora_meandrina_HIv1___RNAseq.g17977.t1,three_way,65.56033333333333,FUN_008267-T1,Q6Z690,,,,,29.3,208.0,7.3e-12,72.8,sp|Q6Z690|LDL1_ORYSJ Lysine-specific histone demethylase 1 homolog 1 OS=Oryza sativa subsp. japonica OX=39947 GN=Os02g0755200 PE=2 SV=1,,,,,,
OG_02057,FUN_008269-T1,Peve_00001963,Pocillopora_meandrina_HIv1___RNAseq.g17978.t1,three_way,76.93733333333333,FUN_008269-T1,Q803S3,,,,,59.7,293.0,2.1e-99,363.6,sp|Q803S3|MEMO1_DANRE Protein MEMO1 OS=Danio rerio OX=7955 GN=memo1 PE=2 SV=1,,,,,,
OG_02058,FUN_008272-T1,Peve_00001961,Pocillopora_meandrina_HIv1___RNAseq.g17980.t1,three_way,78.47733333333333,FUN_008272-T1,P55807,,,,,29.5,237.0,2.9e-15,84.7,sp|P55807|NRT2_CHICK NAD(P)(+)--arginine ADP-ribosyltransferase 2 OS=Gallus gallus OX=9031 PE=2 SV=1,,,,,,
OG_02059,FUN_008273-T1,Peve_00001960,Pocillopora_meandrina_HIv1___RNAseq.g17981.t1,three_way,91.13633333333333,FUN_008273-T1,Q96M32,KAD7_HUMAN,,Adenylate kinase 7 (AK 7) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 7),Homo sapiens (Human),53.6,705.0,2.2e-187,657.1,sp|Q96M32|KAD7_HUMAN Adenylate kinase 7 OS=Homo sapiens OX=9606 GN=AK7 PE=1 SV=3,GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005737; GO:0005829; GO:0030030; GO:0031514,cell projection organization [GO:0030030],cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514],(d)CMP kinase activity [GO:0004127]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550],GO:0003824; GO:0005829; GO:0005929; GO:0016740; GO:0043226,catalytic activity; cytosol; cilium; transferase activity; organelle
OG_02060,FUN_008274-T1,Peve_00001959,Pocillopora_meandrina_HIv1___RNAseq.g17982.t1,three_way,77.99233333333333,FUN_008274-T1,Q9VMU8,SENJU_DROME,,UDP-galactose transporter senju,Drosophila melanogaster (Fruit fly),51.4,350.0,1.2e-85,318.2,sp|Q9VMU8|SENJU_DROME UDP-galactose transporter senju OS=Drosophila melanogaster OX=7227 GN=senju PE=1 SV=2,GO:0000139; GO:0002225; GO:0005459; GO:0005794; GO:0005797; GO:0045751; GO:0045824; GO:0055085; GO:0060050; GO:0072334,negative regulation of innate immune response [GO:0045824]; negative regulation of Toll signaling pathway [GO:0045751]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of protein glycosylation [GO:0060050]; transmembrane transport [GO:0055085]; UDP-galactose transmembrane transport [GO:0072334],Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139],UDP-galactose transmembrane transporter activity [GO:0005459],GO:0005215; GO:0005794; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; organelle; transmembrane transport
OG_02061,FUN_008275-T1,Peve_00001958,Pocillopora_meandrina_HIv1___RNAseq.g17983.t1,three_way,79.60266666666666,FUN_008275-T1,Q4JIM4,PSN1_CHICK,,Presenilin-1 (PS-1) (EC 3.4.23.-) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit],Gallus gallus (Chicken),60.3,411.0,9.9e-123,441.8,sp|Q4JIM4|PSN1_CHICK Presenilin-1 OS=Gallus gallus OX=9031 GN=PSEN1 PE=1 SV=1,GO:0000139; GO:0005739; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006509; GO:0006915; GO:0007155; GO:0007219; GO:0016020; GO:0016485; GO:0030424; GO:0034205; GO:0035556; GO:0042325; GO:0042500; GO:0042982; GO:0045202; GO:0055074; GO:0060828; GO:0070765,amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; apoptotic process [GO:0006915]; calcium ion homeostasis [GO:0055074]; cell adhesion [GO:0007155]; intracellular signal transduction [GO:0035556]; membrane protein ectodomain proteolysis [GO:0006509]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of phosphorylation [GO:0042325],axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; synapse [GO:0045202],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]",GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005886; GO:0007155; GO:0012501; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; plasma membrane; cell adhesion; programmed cell death; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_02062,FUN_008276-T1,Peve_00001957,Pocillopora_meandrina_HIv1___RNAseq.g17984.t1,three_way,85.17366666666668,FUN_008276-T1,Q2T9S3,,,,,63.1,314.0,7e-109,395.2,sp|Q2T9S3|RPC6_BOVIN DNA-directed RNA polymerase III subunit RPC6 OS=Bos taurus OX=9913 GN=POLR3F PE=2 SV=1,,,,,,
OG_02063,FUN_008277-T1,Peve_00001956,Pocillopora_meandrina_HIv1___RNAseq.g17985.t1,three_way,62.73766666666667,,,,,,,,,,,,,,,,,
OG_02064,FUN_008278-T1,Peve_00001955,Pocillopora_meandrina_HIv1___RNAseq.g17986.t1,three_way,91.496,FUN_008278-T1,Q5RBG4,KAT5_PONAB,,Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (Lysine acetyltransferase 5) (Protein 2-hydroxyisobutyryltransferase KAT5) (EC 2.3.1.-) (Protein acetyltransferase KAT5) (EC 2.3.1.-) (Protein crotonyltransferase KAT5) (EC 2.3.1.-) (Protein lactyltransferase KAT5) (EC 2.3.1.-),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),67.0,470.0,1.1e-174,614.4,sp|Q5RBG4|KAT5_PONAB Histone acetyltransferase KAT5 OS=Pongo abelii OX=9601 GN=KAT5 PE=2 SV=1,GO:0000132; GO:0000724; GO:0000776; GO:0000812; GO:0000922; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005730; GO:0005737; GO:0006289; GO:0006302; GO:0006974; GO:0007286; GO:0008270; GO:0010508; GO:0010867; GO:0018394; GO:0030330; GO:0032777; GO:0035267; GO:0042149; GO:0042753; GO:0043998; GO:0045087; GO:0045591; GO:0045663; GO:0045893; GO:0045944; GO:0046972; GO:0048471; GO:0061733; GO:0062033; GO:0106226; GO:0120300; GO:0140064; GO:0140065; GO:1902036; GO:1902425; GO:1905168; GO:1905691,"cellular response to glucose starvation [GO:0042149]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of mitotic spindle orientation [GO:0000132]; innate immune response [GO:0045087]; lipid droplet disassembly [GO:1905691]; nucleotide-excision repair [GO:0006289]; peptidyl-lysine acetylation [GO:0018394]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagy [GO:0010508]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of mitotic sister chromatid segregation [GO:0062033]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of hematopoietic stem cell differentiation [GO:1902036]; spermatid development [GO:0007286]",cytoplasm [GO:0005737]; kinetochore [GO:0000776]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; piccolo histone acetyltransferase complex [GO:0032777]; spindle pole [GO:0000922]; Swr1 complex [GO:0000812],chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone H2A acetyltransferase activity [GO:0043998]; histone H4K16 acetyltransferase activity [GO:0046972]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide crotonyltransferase activity [GO:0140064]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005730; GO:0006281; GO:0006310; GO:0006355; GO:0007010; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0140096; GO:0140110,"immune system process; catalytic activity; nucleus; nucleolus; DNA repair; DNA recombination; regulation of DNA-templated transcription; cytoskeleton organization; transferase activity; reproductive process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein; transcription regulator activity"
OG_02065,FUN_008279-T1,Peve_00001967,Pocillopora_meandrina_HIv1___RNAseq.g17987.t1,three_way,61.07833333333333,FUN_008279-T1,Q8TDX7,NEK7_HUMAN,,Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7),Homo sapiens (Human),27.6,250.0,2e-22,108.2,sp|Q8TDX7|NEK7_HUMAN Serine/threonine-protein kinase Nek7 OS=Homo sapiens OX=9606 GN=NEK7 PE=1 SV=1,GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032206; GO:0035865; GO:0046872; GO:0051225; GO:0106310; GO:0140677; GO:1900227,cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomere maintenance [GO:0032206]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02066,FUN_008280-T1,Peve_00001965,Pocillopora_meandrina_HIv1___RNAseq.g17988.t1,three_way,85.35566666666666,FUN_008280-T1,A7RP64,PNO1_NEMVE,,RNA-binding protein pno1,Nematostella vectensis (Starlet sea anemone),74.9,235.0,7.3e-98,358.2,sp|A7RP64|PNO1_NEMVE RNA-binding protein pno1 OS=Nematostella vectensis OX=45351 GN=pno1 PE=3 SV=1,GO:0003723; GO:0005634; GO:0005730; GO:0032040; GO:0042274,ribosomal small subunit biogenesis [GO:0042274],nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005730; GO:0043226,RNA binding; nucleus; nucleolus; organelle
OG_02067,FUN_008281-T1,Peve_00001962,Pocillopora_meandrina_HIv1___RNAseq.g17989.t1,three_way,70.79683333333334,,,,,,,,,,,,,,,,,
OG_02068,FUN_008282-T1,Peve_00022943,Pocillopora_meandrina_HIv1___RNAseq.g17990.t1,three_way,61.2045,FUN_008282-T1,A0A974H8H3,DICRL_XENLA,,Endoribonuclease Dicer-L (EC 3.1.26.3),Xenopus laevis (African clawed frog),31.1,1891.0,3.0000000000000003e-224,780.8,sp|A0A974H8H3|DICRL_XENLA Endoribonuclease Dicer-L OS=Xenopus laevis OX=8355 GN=dicer1.L PE=2 SV=1,GO:0003723; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005634; GO:0005737; GO:0006309; GO:0030422; GO:0031054; GO:0070578,apoptotic DNA fragmentation [GO:0006309]; pre-miRNA processing [GO:0031054]; siRNA processing [GO:0030422],cytoplasm [GO:0005737]; nucleus [GO:0005634]; RISC-loading complex [GO:0070578],ATP binding [GO:0005524]; deoxyribonuclease I activity [GO:0004530]; helicase activity [GO:0004386]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02069,FUN_008283-T1,Peve_00038050,Pocillopora_meandrina_HIv1___RNAseq.g17993.t1,three_way,71.20333333333333,FUN_008283-T1,Q6P158,DHX57_HUMAN,,Putative ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57),Homo sapiens (Human),45.4,1347.0,2.2e-308,1060.1,sp|Q6P158|DHX57_HUMAN Putative ATP-dependent RNA helicase DHX57 OS=Homo sapiens OX=9606 GN=DHX57 PE=1 SV=2,GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0008270; GO:0016887,,,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016787; GO:0016853; GO:0140098; GO:0140657,"RNA binding; catalytic activity; hydrolase activity; isomerase activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02070,FUN_008285-T1,Peve_00015340,Pocillopora_meandrina_HIv1___RNAseq.g17924.t1,three_way,57.32183333333333,FUN_008285-T1,Q9Z2I4,,,,,29.1,268.0,6.6e-24,114.0,sp|Q9Z2I4|ROBO3_MOUSE Roundabout homolog 3 OS=Mus musculus OX=10090 GN=Robo3 PE=1 SV=3,,,,,,
OG_02071,FUN_008286-T1,Peve_00038047,Pocillopora_meandrina_HIv1___RNAseq.g18024.t1,three_way,78.08533333333334,,,,,,,,,,,,,,,,,
OG_02072,FUN_008288-T1,Peve_00018507,Pocillopora_meandrina_HIv1___RNAseq.g18021.t1,three_way,64.77133333333333,FUN_008288-T1,C1C4M3,STN1_AQUCT,,CST complex subunit STN1 (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog),Aquarana catesbeiana (American bullfrog) (Rana catesbeiana),26.2,279.0,2.7e-21,104.4,sp|C1C4M3|STN1_AQUCT CST complex subunit STN1 OS=Aquarana catesbeiana OX=8400 GN=stn1 PE=2 SV=1,GO:0000723; GO:0000781; GO:0005634; GO:0010833; GO:0016233; GO:0043047; GO:1990879,telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833],"chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]; nucleus [GO:0005634]",single-stranded telomeric DNA binding [GO:0043047],GO:0003677; GO:0005634; GO:0032200; GO:0043226,DNA binding; nucleus; telomere organization; organelle
OG_02073,FUN_008289-T1,Peve_00018506,Pocillopora_meandrina_HIv1___RNAseq.g18019.t1,three_way,82.752,FUN_008289-T1,Q19980,GCH1_CAEEL,,GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I),Caenorhabditis elegans,72.6,186.0,1.3e-74,280.8,sp|Q19980|GCH1_CAEEL GTP cyclohydrolase 1 OS=Caenorhabditis elegans OX=6239 GN=cat-4 PE=1 SV=1,GO:0003934; GO:0005525; GO:0005737; GO:0006585; GO:0006729; GO:0008270; GO:0042438; GO:0046654,dopamine biosynthetic process from tyrosine [GO:0006585]; melanin biosynthetic process [GO:0042438]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654],cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270],GO:0003824; GO:0006520; GO:0006575; GO:0016787,catalytic activity; amino acid metabolic process; modified amino acid metabolic process; hydrolase activity
OG_02074,FUN_008290-T1,Peve_00018505,Pocillopora_meandrina_HIv1___RNAseq.g18018.t1,three_way,70.76516666666666,FUN_008290-T1,Q5PRF9,SMAG2_HUMAN,,Protein Smaug homolog 2 (Smaug 2) (hSmaug2) (Sterile alpha motif domain-containing protein 4B) (SAM domain-containing protein 4B),Homo sapiens (Human),32.0,719.0,1.7e-72,275.4,sp|Q5PRF9|SMAG2_HUMAN Protein Smaug homolog 2 OS=Homo sapiens OX=9606 GN=SAMD4B PE=1 SV=1,GO:0000289; GO:0000932; GO:0003723; GO:0003729; GO:0005634; GO:0005829; GO:0030371,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289],cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation repressor activity [GO:0030371],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0045182,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; translation regulator activity
OG_02075,FUN_008292-T1,Peve_00034576,Pocillopora_meandrina_HIv1___RNAseq.g18017.t1,three_way,51.1595,,,,,,,,,,,,,,,,,
OG_02076,FUN_008293-T1,Peve_00012969,Pocillopora_meandrina_HIv1___RNAseq.g18016.t1,three_way,83.616,FUN_008293-T1,Q88S50,,,,,29.2,113.0,2.7e-09,63.2,sp|Q88S50|RHAM_LACPL L-rhamnose mutarotase OS=Lactiplantibacillus plantarum (strain ATCC BAA-793 / NCIMB 8826 / WCFS1) OX=220668 GN=rhaM PE=3 SV=1,,,,,,
OG_02077,FUN_008294-T1,Peve_00012968,Pocillopora_meandrina_HIv1___RNAseq.g18015.t1,three_way,77.446,FUN_008294-T1,Q9NW38,FANCL_HUMAN,,E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein) (Fanconi anemia-associated polypeptide of 43 kDa) (FAAP43) (RING-type E3 ubiquitin transferase FANCL),Homo sapiens (Human),47.3,372.0,1.6e-102,374.4,sp|Q9NW38|FANCL_HUMAN E3 ubiquitin-protein ligase FANCL OS=Homo sapiens OX=9606 GN=FANCL PE=1 SV=2,GO:0000785; GO:0004842; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006281; GO:0006513; GO:0006974; GO:0007276; GO:0008270; GO:0016604; GO:0031625; GO:0036297; GO:0042127; GO:0043231; GO:0043240; GO:0061630,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; gamete generation [GO:0007276]; interstrand cross-link repair [GO:0036297]; protein monoubiquitination [GO:0006513]; regulation of cell population proliferation [GO:0042127],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005635; GO:0005654; GO:0005829; GO:0006281; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; nuclear envelope; nucleoplasm; cytosol; DNA repair; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_02078,FUN_008295-T1,Peve_00012967,Pocillopora_meandrina_HIv1___RNAseq.g18014.t1,three_way,51.149,,,,,,,,,,,,,,,,,
OG_02079,FUN_008296-T1,Peve_00012966,Pocillopora_meandrina_HIv1___RNAseq.g18012.t1,three_way,75.1305,FUN_008296-T1,Q86TM6,SYVN1_HUMAN,,E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1),Homo sapiens (Human),80.5,333.0,1.9e-153,544.3,sp|Q86TM6|SYVN1_HUMAN E3 ubiquitin-protein ligase synoviolin OS=Homo sapiens OX=9606 GN=SYVN1 PE=1 SV=2,GO:0000836; GO:0000839; GO:0002327; GO:0005654; GO:0005783; GO:0005789; GO:0005790; GO:0006511; GO:0008270; GO:0012505; GO:0016020; GO:0016567; GO:0030970; GO:0036503; GO:0036513; GO:0043161; GO:0044322; GO:0050821; GO:0051082; GO:0051087; GO:0051117; GO:0061630; GO:0070936; GO:0140297; GO:1902236; GO:1904380; GO:1990381,"endoplasmic reticulum mannose trimming [GO:1904380]; ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",Derlin-1 retrotranslocation complex [GO:0036513]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; smooth endoplasmic reticulum [GO:0005790],ATPase binding [GO:0051117]; DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-specific protease binding [GO:1990381]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005654; GO:0005783; GO:0006886; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0140096; GO:1901135,"immune system process; catalytic activity; nucleoplasm; endoplasmic reticulum; intracellular protein transport; transferase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02080,FUN_008298-T1,Peve_00012965,Pocillopora_meandrina_HIv1___RNAseq.g18011.t1,three_way,81.52933333333333,FUN_008298-T1,P23790,,,,,54.3,230.0,2.3e-51,204.9,sp|P23790|SRF_XENLA Serum response factor OS=Xenopus laevis OX=8355 GN=srf PE=2 SV=1,,,,,,
OG_02081,FUN_008304-T1,Peve_00024678,Pocillopora_meandrina_HIv1___RNAseq.g5792.t1,three_way,57.404,,,,,,,,,,,,,,,,,
OG_02082,FUN_008305-T1,Peve_00015427,Pocillopora_meandrina_HIv1___RNAseq.g5791.t1,three_way,61.97,FUN_008305-T1,Q9BQP7,MGME1_HUMAN,,Mitochondrial genome maintenance exonuclease 1 (EC 3.1.-.-),Homo sapiens (Human),40.1,202.0,5.200000000000001e-32,140.2,sp|Q9BQP7|MGME1_HUMAN Mitochondrial genome maintenance exonuclease 1 OS=Homo sapiens OX=9606 GN=MGME1 PE=1 SV=1,GO:0000002; GO:0005739; GO:0005759; GO:0006264; GO:0008297; GO:0017108; GO:0043504; GO:0045145,mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; mitochondrial genome maintenance [GO:0000002],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],5'-flap endonuclease activity [GO:0017108]; single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145]; single-stranded DNA exodeoxyribonuclease activity [GO:0008297],GO:0003824; GO:0005739; GO:0006260; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"catalytic activity; mitochondrion; DNA replication; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_02083,FUN_008306-T1,Peve_00015428,Pocillopora_meandrina_HIv1___TS.g24507.t2,three_way,73.73883333333333,FUN_008306-T1,Q9CQE8,,,,,50.2,245.0,1.6e-63,244.2,"sp|Q9CQE8|RTRAF_MOUSE RNA transcription, translation and transport factor protein OS=Mus musculus OX=10090 GN=RTRAF PE=1 SV=1",,,,,,
OG_02084,FUN_008307-T1,Peve_00015429,Pocillopora_meandrina_HIv1___RNAseq.g5789.t1,three_way,71.01916666666666,FUN_008307-T1,Q3SYV5,TSN33_BOVIN,,Tetraspanin-33 (Tspan-33),Bos taurus (Bovine),40.9,252.0,4.3e-47,189.9,sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1,GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659,protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005886; GO:0051604; GO:0072659,plasma membrane; protein maturation; protein localization to plasma membrane
OG_02085,FUN_008308-T1,Peve_00015425,Pocillopora_meandrina_HIv1___TS.g24505.t2,three_way,78.96333333333334,FUN_008308-T1,Q8R2E9,ERO1B_MOUSE,,ERO1-like protein beta (ERO1-L-beta) (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductase beta) (Endoplasmic reticulum oxidoreductin-1-like protein B) (Oxidoreductin-1-L-beta),Mus musculus (Mouse),47.8,446.0,3.2e-116,420.2,sp|Q8R2E9|ERO1B_MOUSE ERO1-like protein beta OS=Mus musculus OX=10090 GN=Ero1b PE=1 SV=1,GO:0005788; GO:0005789; GO:0006888; GO:0015035; GO:0015036; GO:0016020; GO:0016972; GO:0030070; GO:0030198; GO:0034975; GO:0042593; GO:0045454; GO:0051604; GO:0071949,cell redox homeostasis [GO:0045454]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; insulin processing [GO:0030070]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation [GO:0051604],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],disulfide oxidoreductase activity [GO:0015036]; FAD binding [GO:0071949]; protein-disulfide reductase activity [GO:0015035]; thiol oxidase activity [GO:0016972],GO:0003824; GO:0006457; GO:0016192; GO:0016491; GO:0030198; GO:0051604; GO:0140096,"catalytic activity; protein folding; vesicle-mediated transport; oxidoreductase activity; extracellular matrix organization; protein maturation; catalytic activity, acting on a protein"
OG_02086,FUN_008309-T1,Peve_00025219,Pocillopora_meandrina_HIv1___RNAseq.g5787.t1,three_way,69.14583333333333,FUN_008309-T1,A7S4N4,,,,,37.3,212.0,1.3e-22,109.8,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_02087,FUN_008310-T1,Peve_00025220,Pocillopora_meandrina_HIv1___TS.g24645.t1,three_way,67.89999999999999,FUN_008310-T1,P37985,,,,,44.3,70.0,4.1e-07,56.2,sp|P37985|RS1_DICD3 Small ribosomal subunit protein bS1 OS=Dickeya dadantii (strain 3937) OX=198628 GN=rpsA PE=3 SV=2,,,,,,
OG_02088,FUN_008314-T1,Peve_00026747,Pocillopora_meandrina_HIv1___RNAseq.g5785.t1,three_way,57.846,,,,,,,,,,,,,,,,,
OG_02089,FUN_008319-T1,Peve_00005687,Pocillopora_meandrina_HIv1___RNAseq.g5431.t1,three_way,41.333333333333336,,,,,,,,,,,,,,,,,
OG_02090,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02091,FUN_008329-T1,Peve_00007606,Pocillopora_meandrina_HIv1___RNAseq.g5444.t1,three_way,68.1515,FUN_008329-T1,Q80TN7,NAV3_MOUSE,,Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1),Mus musculus (Mouse),34.7,101.0,5e-13,78.2,sp|Q80TN7|NAV3_MOUSE Neuron navigator 3 OS=Mus musculus OX=10090 GN=Nav3 PE=1 SV=2,GO:0005524; GO:0005634; GO:0005635; GO:0005640; GO:0016887; GO:0022008,neurogenesis [GO:0022008],nuclear envelope [GO:0005635]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005634; GO:0005635; GO:0016787; GO:0030154; GO:0043226,catalytic activity; nucleus; nuclear envelope; hydrolase activity; cell differentiation; organelle
OG_02092,FUN_008331-T3,Peve_00007611,Pocillopora_meandrina_HIv1___RNAseq.g5441.t1,three_way,61.8445,FUN_008331-T3,O15040,TCPR2_HUMAN,,Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297),Homo sapiens (Human),24.6,1344.0,7.3e-81,304.3,sp|O15040|TCPR2_HUMAN Tectonin beta-propeller repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=TECPR2 PE=1 SV=4,GO:0005737; GO:0006914; GO:0032527,autophagy [GO:0006914]; protein exit from endoplasmic reticulum [GO:0032527],cytoplasm [GO:0005737],,GO:0006886; GO:0006914,intracellular protein transport; autophagy
OG_02093,FUN_008333-T1,Peve_00040480,Pocillopora_meandrina_HIv1___RNAseq.g5440.t1,three_way,84.943,FUN_008333-T1,O15160,,,,,63.2,261.0,9.3e-97,354.8,sp|O15160|RPAC1_HUMAN DNA-directed RNA polymerases I and III subunit RPAC1 OS=Homo sapiens OX=9606 GN=POLR1C PE=1 SV=1,,,,,,
OG_02094,FUN_008365-T1,Peve_00005520,Pocillopora_meandrina_HIv1___RNAseq.g5716.t1,three_way,73.69866666666667,FUN_008365-T1,H9J9M0,,,,,27.5,258.0,2.9e-20,100.5,sp|H9J9M0|CDA1_BOMMO Chitin deacetylase 1 OS=Bombyx mori OX=7091 GN=CDA1 PE=1 SV=1,,,,,,
OG_02095,FUN_008367-T1,Peve_00014479,Pocillopora_meandrina_HIv1___RNAseq.g5715.t1,three_way,60.782,FUN_008367-T1,Q5S007,LRRK2_HUMAN,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-) (Dardarin),Homo sapiens (Human),21.4,1717.0,2.7e-72,276.6,sp|Q5S007|LRRK2_HUMAN Leucine-rich repeat serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=LRRK2 PE=1 SV=2,GO:0000139; GO:0000149; GO:0000165; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0004709; GO:0005096; GO:0005524; GO:0005525; GO:0005615; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0006979; GO:0007005; GO:0007029; GO:0007030; GO:0007040; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008017; GO:0008104; GO:0008340; GO:0009267; GO:0010506; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016242; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0021772; GO:0022028; GO:0030159; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031344; GO:0031398; GO:0031410; GO:0031647; GO:0031965; GO:0031966; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034260; GO:0034599; GO:0034614; GO:0035542; GO:0035556; GO:0035564; GO:0035640; GO:0035641; GO:0035751; GO:0036064; GO:0036479; GO:0039706; GO:0040012; GO:0042391; GO:0042802; GO:0042803; GO:0043005; GO:0043025; GO:0043068; GO:0043195; GO:0043204; GO:0043231; GO:0043410; GO:0044325; GO:0044753; GO:0044754; GO:0045335; GO:0045746; GO:0046039; GO:0046777; GO:0048312; GO:0048812; GO:0051018; GO:0051646; GO:0051900; GO:0051966; GO:0060070; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070062; GO:0070585; GO:0070971; GO:0070973; GO:0071287; GO:0090140; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1901030; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902823; GO:1902902; GO:1903215; GO:1903217; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; exploration behavior [GO:0035640]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; lysosome organization [GO:0007040]; MAPK cascade [GO:0000165]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of GTPase activity [GO:0034260]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; olfactory bulb development [GO:0021772]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to mitochondrion [GO:0070585]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell projection organization [GO:0031344]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of membrane potential [GO:0042391]; regulation of mitochondrial depolarization [GO:0051900]; regulation of mitochondrial fission [GO:0090140]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of SNARE complex assembly [GO:0035542]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; response to oxidative stress [GO:0006979]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body, internal vesicle [GO:0097487]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; co-receptor binding [GO:0039706]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; microtubule binding [GO:0008017]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005615; GO:0005654; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0007040; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0061024; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; extracellular space; nucleoplasm; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; lysosome organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02096,FUN_008368-T1,Peve_00014481,Pocillopora_meandrina_HIv1___RNAseq.g5704.t1,three_way,73.814,FUN_008368-T1,Q8TB61,,,,,51.3,394.0,1.4e-97,358.2,sp|Q8TB61|S35B2_HUMAN Adenosine 3'-phospho 5'-phosphosulfate transporter 1 OS=Homo sapiens OX=9606 GN=SLC35B2 PE=1 SV=1,,,,,,
OG_02097,FUN_008369-T1,Peve_00014482,Pocillopora_meandrina_HIv1___RNAseq.g28730.t1,three_way,91.93933333333334,FUN_008369-T1,Q969Q6,P2R3C_HUMAN,,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma (Protein phosphatase subunit G5PR) (Rhabdomyosarcoma antigen MU-RMS-40.6A/6C),Homo sapiens (Human),78.8,443.0,1.9e-203,709.9,sp|Q969Q6|P2R3C_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma OS=Homo sapiens OX=9606 GN=PPP2R3C PE=1 SV=1,GO:0000226; GO:0001782; GO:0002759; GO:0005654; GO:0005794; GO:0005813; GO:0005829; GO:0005929; GO:0015629; GO:0016604; GO:0030865; GO:0035303; GO:0043029; GO:0045579; GO:0046872; GO:0048536; GO:0051900,B cell homeostasis [GO:0001782]; cortical cytoskeleton organization [GO:0030865]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of B cell differentiation [GO:0045579]; regulation of antimicrobial humoral response [GO:0002759]; regulation of dephosphorylation [GO:0035303]; regulation of mitochondrial depolarization [GO:0051900]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029],actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654],metal ion binding [GO:0046872],GO:0002376; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0043226; GO:0048856,immune system process; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; organelle; anatomical structure development
OG_02098,FUN_008370-T1,Peve_00007056,Pocillopora_meandrina_HIv1___RNAseq.g5701.t1,three_way,69.50716666666666,FUN_008370-T1,F1QCP6,TAZ_DANRE,,Tafazzin (Taz) (EC 2.3.1.-),Danio rerio (Zebrafish) (Brachydanio rerio),48.6,220.0,8.700000000000001e-58,226.1,sp|F1QCP6|TAZ_DANRE Tafazzin OS=Danio rerio OX=7955 GN=tafazzin PE=2 SV=1,GO:0001947; GO:0005739; GO:0005741; GO:0005743; GO:0007007; GO:0007507; GO:0031966; GO:0035965; GO:0045823; GO:0047184,cardiolipin acyl-chain remodeling [GO:0035965]; heart development [GO:0007507]; heart looping [GO:0001947]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of heart contraction [GO:0045823],mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184],GO:0003824; GO:0005739; GO:0006629; GO:0007005; GO:0016740; GO:0043226; GO:0048856; GO:0061024,catalytic activity; mitochondrion; lipid metabolic process; mitochondrion organization; transferase activity; organelle; anatomical structure development; membrane organization
OG_02099,FUN_008372-T1,Peve_00007053,Pocillopora_meandrina_HIv1___RNAseq.g5699.t1,three_way,75.01,,,,,,,,,,,,,,,,,
OG_02100,FUN_008373-T1,Peve_00007049,Pocillopora_meandrina_HIv1___RNAseq.g5698.t1,three_way,56.7935,FUN_008373-T1,Q9NR16,,,,,29.6,1021.0,1.3e-107,393.3,sp|Q9NR16|C163B_HUMAN Scavenger receptor cysteine-rich type 1 protein M160 OS=Homo sapiens OX=9606 GN=CD163L1 PE=1 SV=2,,,,,,
OG_02101,FUN_008377-T1,Peve_00024686,Pocillopora_meandrina_HIv1___RNAseq.g18396.t1,three_way,53.3375,,,,,,,,,,,,,,,,,
OG_02102,FUN_008381-T1,Peve_00002115,Pocillopora_meandrina_HIv1___RNAseq.g18435.t2,three_way,41.09916666666667,FUN_008381-T1,Q8IW19,APLF_HUMAN,,Aprataxin and PNK-like factor (EC 3.1.-.-) (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1),Homo sapiens (Human),30.1,522.0,2.7e-22,109.0,sp|Q8IW19|APLF_HUMAN Aprataxin and PNK-like factor OS=Homo sapiens OX=9606 GN=APLF PE=1 SV=1,GO:0000012; GO:0000166; GO:0003906; GO:0004520; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006974; GO:0007566; GO:0008270; GO:0008408; GO:0010717; GO:0035861; GO:0042393; GO:0044183; GO:0045191; GO:0071168; GO:0072572; GO:0090734; GO:0140713; GO:0140861; GO:0160002,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; embryo implantation [GO:0007566]; protein localization to chromatin [GO:0071168]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of isotype switching [GO:0045191]; single strand break repair [GO:0000012],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861],3'-5' exonuclease activity [GO:0008408]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; DNA endonuclease activity [GO:0004520]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; histone binding [GO:0042393]; histone chaperone activity [GO:0140713]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose binding [GO:0072572]; protein folding chaperone [GO:0044183]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006325; GO:0016787; GO:0022414; GO:0042393; GO:0043226; GO:0044183; GO:0140097; GO:0140104,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; chromatin organization; hydrolase activity; reproductive process; histone binding; organelle; protein folding chaperone; catalytic activity, acting on DNA; molecular carrier activity"
OG_02103,FUN_008382-T1,Peve_00002119,Pocillopora_meandrina_HIv1___TS.g21432.t1,three_way,43.963,FUN_008382-T1,Q9Y3Q0,NALD2_HUMAN,,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),Homo sapiens (Human),31.3,747.0,3.3999999999999998e-68,261.2,sp|Q9Y3Q0|NALD2_HUMAN N-acetylated-alpha-linked acidic dipeptidase 2 OS=Homo sapiens OX=9606 GN=NAALAD2 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0008236; GO:0008239; GO:0016020; GO:0016805; GO:0046395; GO:0046872; GO:0050129,carboxylic acid catabolic process [GO:0046395]; proteolysis [GO:0006508],membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_02104,FUN_008383-T1,Peve_00005318,Pocillopora_meandrina_HIv1___TS.g24875.t1b,three_way,94.05366666666669,FUN_008383-T1,Q15436,SC23A_HUMAN,,Protein transport protein Sec23A (hSec23A) (SEC23-related protein A),Homo sapiens (Human),74.7,775.0,0.0,1215.3,sp|Q15436|SC23A_HUMAN Protein transport protein Sec23A OS=Homo sapiens OX=9606 GN=SEC23A PE=1 SV=2,GO:0000139; GO:0005096; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0008270; GO:0012507; GO:0030127; GO:0048471; GO:0070971; GO:0072659; GO:0090110,COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; protein localization to plasma membrane [GO:0072659],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005783; GO:0005829; GO:0006886; GO:0043226; GO:0072659; GO:0098772,endoplasmic reticulum; cytosol; intracellular protein transport; organelle; protein localization to plasma membrane; molecular function regulator activity
OG_02105,FUN_008388-T1,Peve_00028173,Pocillopora_meandrina_HIv1___RNAseq.g6171.t1,three_way,80.39633333333333,FUN_008388-T1,Q9Z1N4,BPNT1_RAT,,"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (3'-phosphoadenosine 5'-phosphate phosphatase) (PAP phosphatase) (Bisphosphate 3'-nucleotidase 1) (BPntase 1) (Inositol-polyphosphate 1-phosphatase) (EC 3.1.3.57) (RnPIP) (scHAL2 analogous 3)",Rattus norvegicus (Rat),51.8,305.0,9.999999999999999e-87,321.6,"sp|Q9Z1N4|BPNT1_RAT 3'(2'),5'-bisphosphate nucleotidase 1 OS=Rattus norvegicus OX=10116 GN=Bpnt1 PE=1 SV=1",GO:0000287; GO:0004441; GO:0008441; GO:0046854,phosphatidylinositol phosphate biosynthetic process [GO:0046854],,"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; inositol-1,4-bisphosphate 1-phosphatase activity [GO:0004441]; magnesium ion binding [GO:0000287]",GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_02106,FUN_008389-T1,Peve_00028172,Pocillopora_meandrina_HIv1___RNAseq.g6172.t1,three_way,59.283,,,,,,,,,,,,,,,,,
OG_02107,FUN_008390-T1,Peve_00028171,Pocillopora_meandrina_HIv1___RNAseq.12433_t,three_way,87.16266666666667,FUN_008390-T1,Q54BM3,,,,,41.3,300.0,1.1e-64,248.4,sp|Q54BM3|MCFG_DICDI Mitochondrial substrate carrier family protein G OS=Dictyostelium discoideum OX=44689 GN=mcfG PE=2 SV=1,,,,,,
OG_02108,FUN_008392-T1,Peve_00043610,Pocillopora_meandrina_HIv1___RNAseq.g6178.t1,three_way,70.05766666666668,,,,,,,,,,,,,,,,,
OG_02109,FUN_008394-T1,Peve_00043609,Pocillopora_meandrina_HIv1___RNAseq.g6176.t1,three_way,97.93,FUN_008394-T1,Q6IP65,,,,,87.8,287.0,1e-141,504.2,sp|Q6IP65|CNOT9_XENLA CCR4-NOT transcription complex subunit 9 OS=Xenopus laevis OX=8355 GN=cnot9 PE=2 SV=1,,,,,,
OG_02110,FUN_008395-T1,Peve_00002123,Pocillopora_meandrina_HIv1___RNAseq.g18434.t1,three_way,74.5655,,,,,,,,,,,,,,,,,
OG_02111,FUN_008396-T1,Peve_00043608,Pocillopora_meandrina_HIv1___RNAseq.g6175.t1,three_way,71.88550000000001,FUN_008396-T1,Q9EQC5,SCYL1_MOUSE,,N-terminal kinase-like protein (105 kDa kinase-like protein) (Mitosis-associated kinase-like protein NTKL) (SCY1-like protein 1),Mus musculus (Mouse),51.4,675.0,2.1e-182,641.0,sp|Q9EQC5|SCYL1_MOUSE N-terminal kinase-like protein OS=Mus musculus OX=10090 GN=Scyl1 PE=1 SV=1,GO:0004672; GO:0005524; GO:0005737; GO:0005793; GO:0005794; GO:0005801; GO:0005813; GO:0005829; GO:0006890; GO:0006954; GO:0008104; GO:0021522; GO:0030126; GO:0048666,"inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; spinal cord motor neuron differentiation [GO:0021522]",centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; protein kinase activity [GO:0004672],GO:0003824; GO:0005794; GO:0005815; GO:0005829; GO:0006954; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; microtubule organizing center; cytosol; inflammatory response; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02112,FUN_008397-T1,Peve_00043603,Pocillopora_meandrina_HIv1___RNAseq.g6179.t1,three_way,31.29733333333333,FUN_008397-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),35.4,99.0,4.4e-07,60.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_02113,FUN_008398-T1,Peve_00043601,Pocillopora_meandrina_HIv1___RNAseq.g6180.t1,three_way,65.416,FUN_008398-T1,Q640B4,,,,,48.7,587.0,2e-144,514.2,sp|Q640B4|MUS81_XENTR Structure-specific endonuclease subunit MUS81 OS=Xenopus tropicalis OX=8364 GN=mus81 PE=2 SV=1,,,,,,
OG_02114,FUN_008399-T1,Peve_00043600,Pocillopora_meandrina_HIv1___RNAseq.g6181.t1,three_way,83.61133333333333,FUN_008399-T1,P41823,,,,,35.0,300.0,9.3e-43,176.4,sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2,,,,,,
OG_02115,FUN_008400-T1,Peve_00043703,Pocillopora_meandrina_HIv1___TS.g24890.t1,three_way,85.94066666666667,FUN_008400-T1,O00180,KCNK1_HUMAN,,Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1),Homo sapiens (Human),39.4,246.0,1.8000000000000002e-44,181.4,sp|O00180|KCNK1_HUMAN Potassium channel subfamily K member 1 OS=Homo sapiens OX=9606 GN=KCNK1 PE=1 SV=1,GO:0005242; GO:0005267; GO:0005272; GO:0005886; GO:0006813; GO:0008076; GO:0014047; GO:0016020; GO:0016324; GO:0022834; GO:0022841; GO:0030425; GO:0031526; GO:0034705; GO:0035094; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0046982; GO:0055037; GO:0060075; GO:0071468; GO:0071805; GO:0097060; GO:1902476; GO:1902937; GO:1905030,cellular response to acidic pH [GO:0071468]; chloride transmembrane transport [GO:1902476]; glutamate secretion [GO:0014047]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076],identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; ligand-gated channel activity [GO:0022834]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982]; sodium channel activity [GO:0005272]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_02116,FUN_008401-T1,Peve_00043702,Pocillopora_meandrina_HIv1___RNAseq.g6183.t1,three_way,61.59283333333333,FUN_008401-T1,Q9QUG2,POLK_MOUSE,,DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP),Mus musculus (Mouse),47.0,624.0,1.1e-141,505.4,sp|Q9QUG2|POLK_MOUSE DNA polymerase kappa OS=Mus musculus OX=10090 GN=Polk PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0006281; GO:0006297; GO:0006974; GO:0008270; GO:0016604; GO:0034644; GO:0042276; GO:0060090; GO:0090734,"cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleotide-excision repair, DNA gap filling [GO:0006297]",nuclear body [GO:0016604]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0043226; GO:0060090; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on DNA"
OG_02117,FUN_008402-T1,Peve_00001054,Pocillopora_meandrina_HIv1___RNAseq.g18036.t1,three_way,81.348,FUN_008402-T1,Q9U518,,,,,45.7,552.0,1.3e-134,481.5,sp|Q9U518|ASPG_DIRIM L-asparaginase OS=Dirofilaria immitis OX=6287 PE=1 SV=1,,,,,,
OG_02118,FUN_008403-T1,Peve_00001052,Pocillopora_meandrina_HIv1___RNAseq.g18035.t1,three_way,75.79083333333332,FUN_008403-T1,Q9U518,,,,,39.1,594.0,1.1e-117,425.6,sp|Q9U518|ASPG_DIRIM L-asparaginase OS=Dirofilaria immitis OX=6287 PE=1 SV=1,,,,,,
OG_02119,FUN_008404-T1,Peve_00031485,Pocillopora_meandrina_HIv1___RNAseq.g18034.t1,three_way,63.198,,,,,,,,,,,,,,,,,
OG_02120,FUN_008405-T1,Peve_00031474,Pocillopora_meandrina_HIv1___RNAseq.g18033.t1,three_way,67.898,,,,,,,,,,,,,,,,,
OG_02121,FUN_008408-T1,Peve_00031489,Pocillopora_meandrina_HIv1___RNAseq.g18028.t1,three_way,87.17083333333333,FUN_008408-T1,Q3B7D2,SPTC2_RAT,,Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Serine-palmitoyl-CoA transferase 2) (SPT 2),Rattus norvegicus (Rat),68.8,487.0,1.2999999999999998e-198,694.1,sp|Q3B7D2|SPTC2_RAT Serine palmitoyltransferase 2 OS=Rattus norvegicus OX=10116 GN=Sptlc2 PE=1 SV=1,GO:0004758; GO:0005789; GO:0006686; GO:0017059; GO:0030148; GO:0030170; GO:0035902; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:1904504,adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; positive regulation of lipophagy [GO:1904504]; response to immobilization stress [GO:0035902]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059],pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],GO:0003824; GO:0006629; GO:0016740; GO:0048856,catalytic activity; lipid metabolic process; transferase activity; anatomical structure development
OG_02122,FUN_008415-T1,Peve_00015094,Pocillopora_meandrina_HIv1___RNAseq.g18042.t1,three_way,72.59683333333334,FUN_008415-T1,Q9H2M9,RBGPR_HUMAN,,Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit),Homo sapiens (Human),37.2,1459.0,3.7e-242,840.1,sp|Q9H2M9|RBGPR_HUMAN Rab3 GTPase-activating protein non-catalytic subunit OS=Homo sapiens OX=9606 GN=RAB3GAP2 PE=1 SV=1,GO:0005096; GO:0005776; GO:0005789; GO:0005829; GO:0005886; GO:0006886; GO:0008047; GO:0016236; GO:0030234; GO:0031267; GO:0032991; GO:0042734; GO:0043087; GO:0097051; GO:0099536; GO:1903061; GO:1903373; GO:2000786,establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of protein lipidation [GO:1903061]; regulation of GTPase activity [GO:0043087]; synaptic signaling [GO:0099536],autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991],enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0023052; GO:0043226; GO:0098772,vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; signaling; organelle; molecular function regulator activity
OG_02123,FUN_008416-T1,Peve_00015092,Pocillopora_meandrina_HIv1___TS.g21032.t1,three_way,90.54233333333332,FUN_008416-T1,Q8BRF7,,,,,66.5,635.0,3.5e-240,832.4,sp|Q8BRF7|SCFD1_MOUSE Sec1 family domain-containing protein 1 OS=Mus musculus OX=10090 GN=Scfd1 PE=1 SV=1,,,,,,
OG_02124,FUN_008418-T1,Peve_00009794,Pocillopora_meandrina_HIv1___RNAseq.g18045.t1,three_way,95.60633333333334,FUN_008418-T1,P53488,,,,,89.1,359.0,1.2e-192,673.7,sp|P53488|ARP2_CHICK Actin-related protein 2 OS=Gallus gallus OX=9031 GN=ACTR2 PE=2 SV=1,,,,,,
OG_02125,FUN_008421-T1,Peve_00009791,Pocillopora_meandrina_HIv1___RNAseq.g18048.t1,three_way,87.42933333333333,FUN_008421-T1,Q5U3G6,,,,,56.0,273.0,3.8e-78,293.1,sp|Q5U3G6|YIF1B_DANRE Protein YIF1B OS=Danio rerio OX=7955 GN=yif1b PE=2 SV=2,,,,,,
OG_02126,FUN_008426-T1,Peve_00009790,Pocillopora_meandrina_HIv1___RNAseq.g18049.t1,three_way,71.14483333333332,FUN_008426-T1,Q5ZIF1,,,,,47.5,358.0,2.4e-87,323.9,sp|Q5ZIF1|APMAP_CHICK Adipocyte plasma membrane-associated protein OS=Gallus gallus OX=9031 GN=APMAP PE=2 SV=1,,,,,,
OG_02127,FUN_008427-T1,Peve_00009802,Pocillopora_meandrina_HIv1___RNAseq.g18050.t1,three_way,83.52233333333334,FUN_008427-T1,P11178,,,,,69.3,339.0,5.2e-138,492.3,"sp|P11178|ODBA_BOVIN 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial OS=Bos taurus OX=9913 GN=BCKDHA PE=1 SV=1",,,,,,
OG_02128,FUN_008428-T1,Peve_00009801,Pocillopora_meandrina_HIv1___RNAseq.g18051.t1,three_way,69.97866666666667,FUN_008428-T1,Q9NQT4,EXOS5_HUMAN,,Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B),Homo sapiens (Human),41.1,202.0,7.2e-36,151.8,sp|Q9NQT4|EXOS5_HUMAN Exosome complex component RRP46 OS=Homo sapiens OX=9606 GN=EXOSC5 PE=1 SV=1,GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000791; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0006402; GO:0016075; GO:0034475; GO:0045006; GO:0051607; GO:0071028; GO:0071051; GO:0101019,defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; mRNA catabolic process [GO:0006402]; nuclear mRNA surveillance [GO:0071028]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016071; GO:0016073; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; mRNA metabolic process; snRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_02129,FUN_008429-T1,Peve_00003895,Pocillopora_meandrina_HIv1___RNAseq.g18052.t1,three_way,69.39333333333333,FUN_008429-T1,Q2KJ64,,,,,47.1,310.0,5.4e-81,302.8,sp|Q2KJ64|ARGI1_BOVIN Arginase-1 OS=Bos taurus OX=9913 GN=ARG1 PE=2 SV=1,,,,,,
OG_02130,FUN_008430-T1,Peve_00003896,Pocillopora_meandrina_HIv1___RNAseq.g18053.t1,three_way,88.144,FUN_008430-T1,P61022,CHP1_MOUSE,,Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22) (Sid 470) (p24),Mus musculus (Mouse),60.0,200.0,5.8e-61,235.3,sp|P61022|CHP1_MOUSE Calcineurin B homologous protein 1 OS=Mus musculus OX=10090 GN=Chp1 PE=1 SV=2,GO:0000139; GO:0001578; GO:0001933; GO:0004860; GO:0005509; GO:0005634; GO:0005737; GO:0005783; GO:0005793; GO:0005886; GO:0006469; GO:0006611; GO:0008017; GO:0010923; GO:0015385; GO:0015630; GO:0019900; GO:0022406; GO:0030133; GO:0031122; GO:0031397; GO:0031953; GO:0032088; GO:0032417; GO:0042308; GO:0045121; GO:0048306; GO:0050821; GO:0051222; GO:0051453; GO:0060050; GO:0061024; GO:0061025; GO:0070885; GO:0071073; GO:0071468; GO:0090314; GO:1990351,cellular response to acidic pH [GO:0071468]; cytoplasmic microtubule organization [GO:0031122]; membrane docking [GO:0022406]; membrane fusion [GO:0061025]; membrane organization [GO:0061024]; microtubule bundle formation [GO:0001578]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of phospholipid biosynthetic process [GO:0071073]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of protein transport [GO:0051222]; positive regulation of sodium:proton antiporter activity [GO:0032417]; protein export from nucleus [GO:0006611]; protein stabilization [GO:0050821]; regulation of intracellular pH [GO:0051453],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; transporter complex [GO:1990351],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; protein kinase inhibitor activity [GO:0004860]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005634; GO:0005783; GO:0005856; GO:0005886; GO:0006355; GO:0006886; GO:0006913; GO:0007010; GO:0008092; GO:0031410; GO:0043226; GO:0061024; GO:0098772,transporter activity; nucleus; endoplasmic reticulum; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; cytoskeletal protein binding; cytoplasmic vesicle; organelle; membrane organization; molecular function regulator activity
OG_02131,FUN_008435-T1,Peve_00003897,Pocillopora_meandrina_HIv1___RNAseq.g18054.t1,three_way,72.38416666666667,FUN_008435-T1,Q2KIU0,VTI1B_BOVIN,,Vesicle transport through interaction with t-SNAREs homolog 1B,Bos taurus (Bovine),37.8,225.0,9.9e-33,141.7,sp|Q2KIU0|VTI1B_BOVIN Vesicle transport through interaction with t-SNAREs homolog 1B OS=Bos taurus OX=9913 GN=VTI1B PE=2 SV=1,GO:0000149; GO:0005484; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006891; GO:0006896; GO:0012507; GO:0016236; GO:0031201; GO:0031901; GO:0031902; GO:0042147; GO:0048280; GO:0055038; GO:1903076,"Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]",cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201],SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0016192; GO:0043226; GO:0060090; GO:0061024,Golgi apparatus; cytosol; intracellular protein transport; autophagy; vesicle-mediated transport; organelle; molecular adaptor activity; membrane organization
OG_02132,FUN_008436-T1,Peve_00003898,Pocillopora_meandrina_HIv1___RNAseq.g18055.t1,three_way,83.60333333333334,FUN_008436-T1,Q07889,SOS1_HUMAN,,Son of sevenless homolog 1 (SOS-1),Homo sapiens (Human),56.7,1047.0,0.0,1162.9,sp|Q07889|SOS1_HUMAN Son of sevenless homolog 1 OS=Homo sapiens OX=9606 GN=SOS1 PE=1 SV=1,GO:0001782; GO:0001942; GO:0002931; GO:0003209; GO:0003344; GO:0005085; GO:0005096; GO:0005154; GO:0005737; GO:0005829; GO:0005886; GO:0006357; GO:0007165; GO:0007173; GO:0007265; GO:0007296; GO:0007411; GO:0008286; GO:0008543; GO:0014044; GO:0014069; GO:0017124; GO:0019221; GO:0019901; GO:0033081; GO:0035264; GO:0038095; GO:0042110; GO:0042127; GO:0042129; GO:0042552; GO:0043025; GO:0045742; GO:0046982; GO:0048009; GO:0048011; GO:0048514; GO:0050853; GO:0050900; GO:0051057; GO:0060021; GO:0061029; GO:0061384; GO:0098978; GO:0140693; GO:1904693; GO:1905360; GO:2000973,axon guidance [GO:0007411]; B cell homeostasis [GO:0001782]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cardiac atrium morphogenesis [GO:0003209]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; eyelid development in camera-type eye [GO:0061029]; Fc-epsilon receptor signaling pathway [GO:0038095]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle development [GO:0001942]; heart trabecula morphogenesis [GO:0061384]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; leukocyte migration [GO:0050900]; midbrain morphogenesis [GO:1904693]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; neurotrophin TRK receptor signaling pathway [GO:0048011]; pericardium morphogenesis [GO:0003344]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; Ras protein signal transduction [GO:0007265]; regulation of cell population proliferation [GO:0042127]; regulation of pro-B cell differentiation [GO:2000973]; regulation of T cell differentiation in thymus [GO:0033081]; regulation of T cell proliferation [GO:0042129]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vitellogenesis [GO:0007296],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; GTPase complex [GO:1905360]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],epidermal growth factor receptor binding [GO:0005154]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; molecular condensate scaffold activity [GO:0140693]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124],GO:0002376; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0098772,immune system process; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; anatomical structure development; cell motility; molecular adaptor activity; molecular function regulator activity
OG_02133,FUN_008438-T1,Peve_00024973,Pocillopora_meandrina_HIv1___RNAseq.g18056.t1,three_way,83.8915,FUN_008438-T1,A7SMW7,,,,,69.4,448.0,5.4e-187,655.2,"sp|A7SMW7|L2HDH_NEMVE L-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g172254 PE=3 SV=1",,,,,,
OG_02134,FUN_008440-T1,Peve_00024976,Pocillopora_meandrina_HIv1___RNAseq.g18057.t1,three_way,74.42933333333333,FUN_008440-T1,Q8CDU6,,,,,34.3,685.0,9.8e-96,353.2,sp|Q8CDU6|HECD2_MOUSE Probable E3 ubiquitin-protein ligase HECTD2 OS=Mus musculus OX=10090 GN=Hectd2 PE=1 SV=2,,,,,,
OG_02135,FUN_008441-T1,Peve_00024975,Pocillopora_meandrina_HIv1___RNAseq.g18058.t2,three_way,73.75633333333333,FUN_008441-T1,Q96EK6,,,,,47.3,182.0,4.5e-42,172.6,sp|Q96EK6|GNA1_HUMAN Glucosamine 6-phosphate N-acetyltransferase OS=Homo sapiens OX=9606 GN=GNPNAT1 PE=1 SV=1,,,,,,
OG_02136,FUN_008442-T1,Peve_00024978,Pocillopora_meandrina_HIv1___RNAseq.g18060.t1,three_way,83.17033333333333,FUN_008442-T1,Q9C026,TRIM9_HUMAN,,E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING finger protein 91) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9),Homo sapiens (Human),44.3,704.0,9.099999999999999e-175,615.1,sp|Q9C026|TRIM9_HUMAN E3 ubiquitin-protein ligase TRIM9 OS=Homo sapiens OX=9606 GN=TRIM9 PE=1 SV=1,GO:0005737; GO:0005856; GO:0008021; GO:0008270; GO:0016567; GO:0019904; GO:0030425; GO:0042803; GO:0043161; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; synaptic vesicle [GO:0008021],protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005856; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_02137,FUN_008443-T1,Peve_00024979,Pocillopora_meandrina_HIv1___TS.g21051.t1,three_way,76.96133333333333,FUN_008443-T1,P82458,TRI18_RAT,,E3 ubiquitin-protein ligase Midline-1 (EC 2.3.2.27) (RING finger protein Midline-1) (RING-type E3 ubiquitin transferase Midline-1) (Tripartite motif-containing protein 18),Rattus norvegicus (Rat),28.6,704.0,1.1e-67,260.4,sp|P82458|TRI18_RAT E3 ubiquitin-protein ligase Midline-1 OS=Rattus norvegicus OX=10116 GN=Mid1 PE=2 SV=1,GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005881; GO:0007026; GO:0008017; GO:0008270; GO:0015630; GO:0016740; GO:0019899; GO:0031625; GO:0032874; GO:0034451; GO:0035372; GO:0042802; GO:0042803; GO:0051219; GO:0070507,negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein localization to microtubule [GO:0035372]; regulation of microtubule cytoskeleton organization [GO:0070507],centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transferase activity [GO:0016740]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005829; GO:0005856; GO:0008092; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; cytosol; cytoskeleton; cytoskeletal protein binding; transferase activity; organelle
OG_02138,FUN_008444-T1,Peve_00024981,Pocillopora_meandrina_HIv1___RNAseq.g18062.t1,three_way,96.66966666666669,FUN_008444-T1,P61201,CSN2_HUMAN,,COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15),Homo sapiens (Human),86.9,443.0,8.1e-220,764.2,sp|P61201|CSN2_HUMAN COP9 signalosome complex subunit 2 OS=Homo sapiens OX=9606 GN=COPS2 PE=1 SV=1,GO:0000122; GO:0000338; GO:0001833; GO:0001834; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006366; GO:0006468; GO:0007165; GO:0008180; GO:0030182; GO:0035914; GO:0045116; GO:2000434,inner cell mass cell proliferation [GO:0001833]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; protein deneddylation [GO:0000338]; protein neddylation [GO:0045116]; protein phosphorylation [GO:0006468]; regulation of protein neddylation [GO:2000434]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366]; trophectodermal cell proliferation [GO:0001834],COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_02139,FUN_008445-T1,Peve_00024982,Pocillopora_meandrina_HIv1___RNAseq.g18063.t1,three_way,75.278,,,,,,,,,,,,,,,,,
OG_02140,FUN_008446-T1,Peve_00025572,Pocillopora_meandrina_HIv1___RNAseq.g18064.t1,three_way,96.747,FUN_008446-T1,Q2NL22,IF4A3_BOVIN,,"Eukaryotic initiation factor 4A-III (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic translation initiation factor 4A isoform 3) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed]",Bos taurus (Bovine),88.3,402.0,8.8e-205,714.1,sp|Q2NL22|IF4A3_BOVIN Eukaryotic initiation factor 4A-III OS=Bos taurus OX=9913 GN=EIF4A3 PE=2 SV=3,GO:0000184; GO:0000381; GO:0000398; GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0008143; GO:0016607; GO:0016887; GO:0017148; GO:0035145; GO:0045727; GO:0048701; GO:0051028; GO:0071006; GO:0071013; GO:2000622,"embryonic cranial skeleton morphogenesis [GO:0048701]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000622]; rRNA processing [GO:0006364]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleolus; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02141,FUN_008447-T1,Peve_00025571,Pocillopora_meandrina_HIv1___TS.g21055.t1,three_way,82.89383333333333,FUN_008447-T1,Q8BYM7,RSH4A_MOUSE,,Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3),Mus musculus (Mouse),54.9,495.0,6.1e-121,436.0,sp|Q8BYM7|RSH4A_MOUSE Radial spoke head protein 4 homolog A OS=Mus musculus OX=10090 GN=Rsph4a PE=1 SV=2,GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005930; GO:0051649; GO:0060294; GO:0062177; GO:0097729; GO:0120221; GO:0120336; GO:0120337; GO:0120338,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 2 [GO:0120337]; radial spoke head 3 [GO:0120338],,GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0065003,extracellular region; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_02142,FUN_008448-T1,Peve_00025570,Pocillopora_meandrina_HIv1___RNAseq.21564_t,three_way,64.99516666666666,FUN_008448-T1,Q9H4B6,SAV1_HUMAN,,Protein salvador homolog 1 (45 kDa WW domain protein) (hWW45),Homo sapiens (Human),56.9,181.0,1.4999999999999998e-24,115.9,sp|Q9H4B6|SAV1_HUMAN Protein salvador homolog 1 OS=Homo sapiens OX=9606 GN=SAV1 PE=1 SV=2,GO:0001942; GO:0005634; GO:0005737; GO:0005829; GO:0008285; GO:0030216; GO:0035329; GO:0042802; GO:0043065; GO:0043539; GO:0045600; GO:0050673; GO:0050680; GO:0050821; GO:0060038; GO:0060044; GO:0060090; GO:0060412; GO:0060487; GO:0060575; GO:0097283; GO:0140537; GO:1902174; GO:2000036,cardiac muscle cell proliferation [GO:0060038]; epithelial cell proliferation [GO:0050673]; hair follicle development [GO:0001942]; hippo signaling [GO:0035329]; intestinal epithelial cell differentiation [GO:0060575]; keratinocyte apoptotic process [GO:0097283]; keratinocyte differentiation [GO:0030216]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of keratinocyte apoptotic process [GO:1902174]; protein stabilization [GO:0050821]; regulation of stem cell population maintenance [GO:2000036]; ventricular septum morphogenesis [GO:0060412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; protein serine/threonine kinase activator activity [GO:0043539]; transcription regulator activator activity [GO:0140537],GO:0005634; GO:0005829; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; cytosol; programmed cell death; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_02143,FUN_008449-T1,Peve_00027473,Pocillopora_meandrina_HIv1___RNAseq.g18067.t1,three_way,83.48466666666667,,,,,,,,,,,,,,,,,
OG_02144,FUN_008450-T1,Peve_00015484,Pocillopora_meandrina_HIv1___RNAseq.g18070.t1,three_way,41.653,FUN_008450-T1,Q9QVP9,FAK2_MOUSE,,Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK),Mus musculus (Mouse),37.5,277.0,1.7e-45,187.2,sp|Q9QVP9|FAK2_MOUSE Protein-tyrosine kinase 2-beta OS=Mus musculus OX=10090 GN=Ptk2b PE=1 SV=2,GO:0001764; GO:0001954; GO:0002040; GO:0002250; GO:0002315; GO:0004672; GO:0004683; GO:0004715; GO:0005524; GO:0005634; GO:0005856; GO:0005925; GO:0005938; GO:0006968; GO:0007010; GO:0007030; GO:0007166; GO:0007172; GO:0007229; GO:0008284; GO:0008285; GO:0008360; GO:0010595; GO:0010758; GO:0010976; GO:0014069; GO:0017146; GO:0018108; GO:0030027; GO:0030155; GO:0030425; GO:0030426; GO:0030502; GO:0030546; GO:0030838; GO:0030865; GO:0032956; GO:0033209; GO:0035235; GO:0035255; GO:0043025; GO:0043066; GO:0043267; GO:0043524; GO:0044297; GO:0045453; GO:0045638; GO:0045766; GO:0045860; GO:0046330; GO:0048010; GO:0048471; GO:0051279; GO:0051897; GO:0051968; GO:0060291; GO:0070098; GO:0070374; GO:0071300; GO:0071498; GO:0086100; GO:0097440; GO:0098793; GO:0098978; GO:0099092; GO:0099151; GO:0099602; GO:2000060; GO:2000463; GO:2000538,"adaptive immune response [GO:0002250]; bone resorption [GO:0045453]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to fluid shear stress [GO:0071498]; cellular response to retinoic acid [GO:0071300]; chemokine-mediated signaling pathway [GO:0070098]; cortical cytoskeleton organization [GO:0030865]; cytoskeleton organization [GO:0007010]; endothelin receptor signaling pathway [GO:0086100]; Golgi organization [GO:0007030]; integrin-mediated signaling pathway [GO:0007229]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic potentiation [GO:0060291]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of potassium ion transport [GO:0043267]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion [GO:0030155]; regulation of cell shape [GO:0008360]; regulation of macrophage chemotaxis [GO:0010758]; regulation of postsynaptic density assembly [GO:0099151]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; signal complex assembly [GO:0007172]; sprouting angiogenesis [GO:0002040]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]","apical dendrite [GO:0097440]; cell body [GO:0044297]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; NMDA selective glutamate receptor complex [GO:0017146]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; presynapse [GO:0098793]",ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; ionotropic glutamate receptor binding [GO:0035255]; neurotransmitter receptor regulator activity [GO:0099602]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; signaling receptor activator activity [GO:0030546],GO:0002376; GO:0003824; GO:0005634; GO:0005856; GO:0007010; GO:0016740; GO:0030154; GO:0043226; GO:0048870; GO:0065003; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; cytoskeleton; cytoskeleton organization; transferase activity; cell differentiation; organelle; cell motility; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02145,FUN_008451-T1,Peve_00015483,Pocillopora_meandrina_HIv1___RNAseq.g18071.t1,three_way,76.60533333333333,,,,,,,,,,,,,,,,,
OG_02146,FUN_008453-T1,Peve_00031938,Pocillopora_meandrina_HIv1___RNAseq.g18072.t1,three_way,62.222166666666666,FUN_008453-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),43.1,218.0,9.7e-57,221.9,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_02147,FUN_008455-T1,Peve_00011009,Pocillopora_meandrina_HIv1___RNAseq.g18074.t1,three_way,89.681,FUN_008455-T1,Q6ZMW3,,,,,62.3,1980.0,0.0,2556.9,sp|Q6ZMW3|EMAL6_HUMAN Echinoderm microtubule-associated protein-like 6 OS=Homo sapiens OX=9606 GN=EML6 PE=1 SV=2,,,,,,
OG_02148,FUN_008456-T1,Peve_00011006,Pocillopora_meandrina_HIv1___TS.g21065.t1,three_way,57.86566666666666,FUN_008456-T1,Q7TN88,,,,,24.0,1765.0,2e-126,456.4,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_02149,FUN_008469-T2,Peve_00028805,Pocillopora_meandrina_HIv1___TS.g21072.t1,three_way,57.63733333333333,FUN_008469-T2,B8UU59,PK1L_ACRMI,,Polycystin-1-related protein (Polycystic kidney disease 1-related protein),Acropora millepora (Staghorn coral) (Heteropora millepora),33.5,373.0,5e-53,212.2,sp|B8UU59|PK1L_ACRMI Polycystin-1-related protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005261; GO:0005886; GO:0005929; GO:0006816,calcium ion transport [GO:0006816],cilium [GO:0005929]; plasma membrane [GO:0005886],monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_02150,FUN_008473-T1,Peve_00023658,Pocillopora_meandrina_HIv1___RNAseq.g16416.t1,three_way,77.08333333333333,FUN_008473-T1,P90893,,,,,36.6,454.0,6.1e-78,293.1,sp|P90893|YM9I_CAEEL Putative serine protease F56F10.1 OS=Caenorhabditis elegans OX=6239 GN=F56F10.1 PE=1 SV=2,,,,,,
OG_02151,FUN_008477-T1,Peve_00028799,Pocillopora_meandrina_HIv1___RNAseq.g30399.t1,three_way,80.93683333333333,,,,,,,,,,,,,,,,,
OG_02152,FUN_008479-T1,Peve_00028798,Pocillopora_meandrina_HIv1___RNAseq.g30398.t1,three_way,78.626,FUN_008479-T1,Q21279,,,,,37.7,459.0,7.099999999999999e-90,332.8,sp|Q21279|TTL15_CAEEL Probable tubulin polyglutamylase ttll-15 OS=Caenorhabditis elegans OX=6239 GN=ttll-15 PE=2 SV=3,,,,,,
OG_02153,FUN_008483-T1,Peve_00028795,Pocillopora_meandrina_HIv1___TS.g22693.t1,three_way,46.4765,,,,,,,,,,,,,,,,,
OG_02154,FUN_008484-T2,Peve_00028794,Pocillopora_meandrina_HIv1___RNAseq.g30394.t1,three_way,58.80383333333334,FUN_008484-T2,Q8BK35,NOP53_MOUSE,,Ribosome biogenesis protein NOP53 (Glioma tumor suppressor candidate region gene 2 protein) (PreS1-binding protein),Mus musculus (Mouse),34.6,448.0,5.4e-35,150.2,sp|Q8BK35|NOP53_MOUSE Ribosome biogenesis protein NOP53 OS=Mus musculus OX=10090 GN=Nop53 PE=1 SV=1,GO:0000027; GO:0000122; GO:0001650; GO:0001932; GO:0002039; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0007095; GO:0008097; GO:0031333; GO:0032435; GO:0032436; GO:0033553; GO:0039535; GO:0042802; GO:0042981; GO:0050821; GO:0051726; GO:0051898; GO:0071456; GO:1901797; GO:1901837; GO:1902570; GO:1903006; GO:1903715; GO:1990173,cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; ribosomal large subunit assembly [GO:0000027],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553],5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006355; GO:0043226; GO:0065003,RNA binding; nucleoplasm; nucleolus; cytosol; DNA repair; regulation of DNA-templated transcription; organelle; protein-containing complex assembly
OG_02155,FUN_008486-T1,Peve_00028792,Pocillopora_meandrina_HIv1___RNAseq.g30385.t1,three_way,68.478,FUN_008486-T1,Q6R5J2,DISP1_DANRE,,Protein dispatched homolog 1 (Protein chameleon),Danio rerio (Zebrafish) (Brachydanio rerio),35.0,925.0,2.2e-151,538.1,sp|Q6R5J2|DISP1_DANRE Protein dispatched homolog 1 OS=Danio rerio OX=7955 GN=disp1 PE=2 SV=1,GO:0007224; GO:0007519; GO:0008015; GO:0009887; GO:0009952; GO:0016020; GO:0021984; GO:0031290; GO:0042694; GO:0048701; GO:0048839,adenohypophysis development [GO:0021984]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; blood circulation [GO:0008015]; embryonic cranial skeleton morphogenesis [GO:0048701]; inner ear development [GO:0048839]; muscle cell fate specification [GO:0042694]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle tissue development [GO:0007519]; smoothened signaling pathway [GO:0007224],membrane [GO:0016020],,GO:0003013; GO:0048856,circulatory system process; anatomical structure development
OG_02156,FUN_008487-T1,Peve_00028789,Pocillopora_meandrina_HIv1___RNAseq.g30384.t1,three_way,57.028333333333336,,,,,,,,,,,,,,,,,
OG_02157,FUN_008489-T1,Peve_00028786,Pocillopora_meandrina_HIv1___RNAseq.g30382.t1,three_way,82.557,FUN_008489-T1,O77475,,,,,27.0,281.0,3.2000000000000003e-27,124.0,sp|O77475|CPESY_DROME Ceramide phosphoethanolamine synthase OS=Drosophila melanogaster OX=7227 GN=Cpes PE=1 SV=1,,,,,,
OG_02158,FUN_008490-T1,Peve_00028832,Pocillopora_meandrina_HIv1___RNAseq.g30381.t1,three_way,71.13933333333334,FUN_008490-T1,Q6A070,TGRM1_MOUSE,,TOG array regulator of axonemal microtubules protein 1 (Crescerin-1) (Protein FAM179B),Mus musculus (Mouse),27.4,2074.0,5.2e-149,531.2,sp|Q6A070|TGRM1_MOUSE TOG array regulator of axonemal microtubules protein 1 OS=Mus musculus OX=10090 GN=Togaram1 PE=1 SV=3,GO:0005737; GO:0005929; GO:0031116; GO:0035082; GO:0036064; GO:1905515,axoneme assembly [GO:0035082]; non-motile cilium assembly [GO:1905515]; positive regulation of microtubule polymerization [GO:0031116],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005815; GO:0005929; GO:0007010; GO:0043226; GO:0044782,microtubule organizing center; cilium; cytoskeleton organization; organelle; cilium organization
OG_02159,FUN_008493-T1,Peve_00043695,Pocillopora_meandrina_HIv1___RNAseq.g6186.t1,three_way,78.713,FUN_008493-T1,B9U3F2,DISP3_CHICK,,Protein dispatched homolog 3 (Patched domain-containing protein 2) (Thyroid hormone receptor up-regulated protein 1) (TRUP1),Gallus gallus (Chicken),24.4,504.0,1.5e-19,100.1,sp|B9U3F2|DISP3_CHICK Protein dispatched homolog 3 OS=Gallus gallus OX=9031 GN=DISP3 PE=1 SV=1,GO:0005737; GO:0005783; GO:0005789; GO:0008203; GO:0009725; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0042632; GO:0045665; GO:0045834; GO:2000179,cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; response to hormone [GO:0009725],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965],,GO:0005783; GO:0006629; GO:0030154; GO:0043226,endoplasmic reticulum; lipid metabolic process; cell differentiation; organelle
OG_02160,FUN_008496-T1,Peve_00010569,Pocillopora_meandrina_HIv1___RNAseq.g5883.t1,three_way,57.5785,FUN_008496-T1,P47748,,,,,27.1,303.0,4.6e-17,90.5,sp|P47748|OPRX_CAVPO Nociceptin receptor OS=Cavia porcellus OX=10141 GN=OPRL1 PE=2 SV=1,,,,,,
OG_02161,FUN_008497-T1,Peve_00010572,Pocillopora_meandrina_HIv1___RNAseq.g5884.t1a,three_way,83.45016666666668,FUN_008497-T1,Q08DB5,STX5_BOVIN,,Syntaxin-5,Bos taurus (Bovine),53.1,307.0,8.5e-71,268.9,sp|Q08DB5|STX5_BOVIN Syntaxin-5 OS=Bos taurus OX=9913 GN=STX5 PE=2 SV=1,GO:0000139; GO:0000149; GO:0005484; GO:0005829; GO:0006886; GO:0006888; GO:0006906; GO:0012505; GO:0031201; GO:0031982; GO:0033116; GO:0034498; GO:0045732; GO:0048278; GO:0090166; GO:1903358,early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; SNARE complex [GO:0031201]; vesicle [GO:0031982],SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],GO:0005829; GO:0006886; GO:0016192; GO:0043226; GO:0060090; GO:0061024,cytosol; intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity; membrane organization
OG_02162,FUN_008498-T2,Peve_00010573,Pocillopora_meandrina_HIv1___RNAseq.g5885.t1,three_way,67.58433333333333,FUN_008498-T2,Q8BNQ3,G137B_MOUSE,,Integral membrane protein GPR137B (Transmembrane 7 superfamily member 1 protein),Mus musculus (Mouse),40.6,347.0,2.1000000000000002e-58,228.0,sp|Q8BNQ3|G137B_MOUSE Integral membrane protein GPR137B OS=Mus musculus OX=10090 GN=Gpr137b PE=1 SV=2,GO:0005765; GO:0006914; GO:0043030; GO:0045671; GO:0045779; GO:0150032; GO:1904263,autophagy [GO:0006914]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; positive regulation of protein localization to lysosome [GO:0150032]; positive regulation of TORC1 signaling [GO:1904263]; regulation of macrophage activation [GO:0043030],lysosomal membrane [GO:0005765],,GO:0006914,autophagy
OG_02163,FUN_008499-T1,Peve_00010577,Pocillopora_meandrina_HIv1___RNAseq.g5887.t1,three_way,57.13483333333333,FUN_008499-T1,Q06194,FA8_MOUSE,,Coagulation factor VIII (Procoagulant component),Mus musculus (Mouse),39.2,153.0,3.6e-26,122.9,sp|Q06194|FA8_MOUSE Coagulation factor VIII OS=Mus musculus OX=10090 GN=F8 PE=2 SV=2,GO:0005507; GO:0005576; GO:0006953; GO:0007596; GO:0016491,acute-phase response [GO:0006953]; blood coagulation [GO:0007596],extracellular region [GO:0005576],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005576; GO:0006954; GO:0016491,catalytic activity; extracellular region; inflammatory response; oxidoreductase activity
OG_02164,FUN_008512-T1,Peve_00000372,Pocillopora_meandrina_HIv1___RNAseq.g425.t1,three_way,73.32933333333334,FUN_008512-T1,P51955,NEK2_HUMAN,,Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1),Homo sapiens (Human),69.3,270.0,6e-113,409.1,sp|P51955|NEK2_HUMAN Serine/threonine-protein kinase Nek2 OS=Homo sapiens OX=9606 GN=NEK2 PE=1 SV=1,GO:0000278; GO:0000776; GO:0000794; GO:0000922; GO:0001824; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005929; GO:0006468; GO:0007059; GO:0007088; GO:0019903; GO:0030496; GO:0032206; GO:0032991; GO:0036064; GO:0045171; GO:0046602; GO:0046777; GO:0046872; GO:0051225; GO:0051299; GO:0051301; GO:0051321; GO:0051988; GO:0090307; GO:0106310; GO:1903126,blastocyst development [GO:0001824]; cell division [GO:0051301]; centrosome separation [GO:0051299]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly [GO:0090307]; negative regulation of centriole-centriole cohesion [GO:1903126]; positive regulation of telomere maintenance [GO:0032206]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of mitotic centrosome separation [GO:0046602]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000228; GO:0000278; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"nuclear chromosome; mitotic cell cycle; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; chromosome segregation; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02165,FUN_008514-T1,Peve_00040307,Pocillopora_meandrina_HIv1___RNAseq.g14867.t1,three_way,78.29833333333333,FUN_008514-T1,Q58A42,DD3_DICDI,,Protein DD3-3,Dictyostelium discoideum (Social amoeba),40.4,584.0,2.4999999999999998e-112,407.9,sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_02166,FUN_008515-T1,Peve_00040305,Pocillopora_meandrina_HIv1___TS.g4011.t1,three_way,81.11066666666667,FUN_008515-T1,Q5U680,,,,,52.1,261.0,4.0999999999999986e-68,259.6,sp|Q5U680|SAMC_MOUSE Mitochondrial S-adenosylmethionine carrier protein OS=Mus musculus OX=10090 GN=Slc25a26 PE=1 SV=2,,,,,,
OG_02167,FUN_008516-T1,Peve_00042439,Pocillopora_meandrina_HIv1___RNAseq.g14800.t1,three_way,88.02866666666667,FUN_008516-T1,P35435,,,,,60.6,279.0,8.8e-85,315.1,"sp|P35435|ATPG_RAT ATP synthase F(1) complex subunit gamma, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5f1c PE=1 SV=2",,,,,,
OG_02168,FUN_008517-T1,Peve_00042434,Pocillopora_meandrina_HIv1___TS.g3919.t1b,three_way,62.54983333333333,FUN_008517-T1,Q9ESJ4,,,,,38.8,402.0,5.6e-78,293.5,sp|Q9ESJ4|SPN90_MOUSE NCK-interacting protein with SH3 domain OS=Mus musculus OX=10090 GN=Nckipsd PE=1 SV=2,,,,,,
OG_02169,FUN_008518-T1,Peve_00012216,Pocillopora_meandrina_HIv1___RNAseq.g14771.t1,three_way,62.01233333333333,FUN_008518-T1,Q28ES8,,,,,37.0,487.0,1.1e-74,282.0,sp|Q28ES8|CTU2_XENTR Cytoplasmic tRNA 2-thiolation protein 2 OS=Xenopus tropicalis OX=8364 GN=ctu2 PE=2 SV=1,,,,,,
OG_02170,FUN_008519-T1,Peve_00012215,Pocillopora_meandrina_HIv1___RNAseq.g14770.t1,three_way,83.706,FUN_008519-T1,A7S1L6,FUCT1_NEMVE,,GDP-fucose transporter 1 (Solute carrier family 35 member C1 homolog),Nematostella vectensis (Starlet sea anemone),74.3,327.0,5.7e-136,485.3,sp|A7S1L6|FUCT1_NEMVE GDP-fucose transporter 1 OS=Nematostella vectensis OX=45351 GN=slc35c1 PE=3 SV=1,GO:0000139; GO:0005457; GO:0005794; GO:0015297; GO:0036085,GDP-fucose import into Golgi lumen [GO:0036085],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],antiporter activity [GO:0015297]; GDP-fucose transmembrane transporter activity [GO:0005457],GO:0005215; GO:0005794; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; organelle; transmembrane transport
OG_02171,FUN_008520-T1,Peve_00012214,Pocillopora_meandrina_HIv1___TS.g3916.t1,three_way,73.04066666666667,FUN_008520-T1,Q8AVC3,,,,,26.2,462.0,1.9e-32,141.7,sp|Q8AVC3|G6PT3_XENLA Glucose-6-phosphate exchanger SLC37A2 OS=Xenopus laevis OX=8355 GN=slc37a2 PE=2 SV=1,,,,,,
OG_02172,FUN_008521-T1,Peve_00023090,Pocillopora_meandrina_HIv1___RNAseq.24125_t,three_way,85.33366666666667,FUN_008521-T1,A6QL50,,,,,52.4,143.0,2.5e-43,176.4,sp|A6QL50|FA72A_BOVIN Protein FAM72A OS=Bos taurus OX=9913 GN=FAM72A PE=1 SV=1,,,,,,
OG_02173,FUN_008522-T1,Peve_00012217,Pocillopora_meandrina_HIv1___RNAseq.g14762.t2,three_way,80.53666666666668,FUN_008522-T1,Q9UPE1,,,,,59.4,547.0,7.599999999999999e-136,485.7,sp|Q9UPE1|SRPK3_HUMAN SRSF protein kinase 3 OS=Homo sapiens OX=9606 GN=SRPK3 PE=1 SV=2,,,,,,
OG_02174,FUN_008523-T1,Peve_00012210,Pocillopora_meandrina_HIv1___RNAseq.g14753.t1,three_way,78.93833333333333,FUN_008523-T1,Q8NBL1,PGLT1_HUMAN,,Protein O-glucosyltransferase 1 (EC 2.4.1.376) (CAP10-like 46 kDa protein) (hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein) (O-glucosyltransferase Rumi homolog) (hRumi) (Protein O-xylosyltransferase POGLUT1) (EC 2.4.2.63),Homo sapiens (Human),61.8,356.0,2.9e-139,496.5,sp|Q8NBL1|PGLT1_HUMAN Protein O-glucosyltransferase 1 OS=Homo sapiens OX=9606 GN=POGLUT1 PE=1 SV=1,GO:0001756; GO:0005783; GO:0005788; GO:0006493; GO:0007369; GO:0010470; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0045747; GO:0046527; GO:0048318; GO:0048339; GO:0060537; GO:0072359; GO:0140561; GO:0140562,axial mesoderm development [GO:0048318]; circulatory system development [GO:0072359]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; paraxial mesoderm development [GO:0048339]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470]; somitogenesis [GO:0001756],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252],GO:0003824; GO:0005783; GO:0009101; GO:0016740; GO:0043226; GO:0048856; GO:1901135,catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; transferase activity; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_02175,FUN_008524-T1,Peve_00027673,Pocillopora_meandrina_HIv1___RNAseq.g14752.t1,three_way,75.38833333333334,FUN_008524-T1,Q4R6K2,ZNT1_MACFA,,Proton-coupled zinc antiporter SLC30A1 (Solute carrier family 30 member 1),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),39.8,462.0,2.9e-73,277.3,sp|Q4R6K2|ZNT1_MACFA Proton-coupled zinc antiporter SLC30A1 OS=Macaca fascicularis OX=9541 GN=SLC30A1 PE=2 SV=1,GO:0000139; GO:0005789; GO:0005886; GO:0006882; GO:0010312; GO:0016323; GO:0019855; GO:0030659; GO:0031965; GO:0042742; GO:0046872; GO:0062111; GO:0140826; GO:0140882,defense response to bacterium [GO:0042742]; detoxification of zinc ion [GO:0010312]; intracellular zinc ion homeostasis [GO:0006882]; zinc export across plasma membrane [GO:0140882]; zinc ion import into organelle [GO:0062111],basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],calcium channel inhibitor activity [GO:0019855]; metal ion binding [GO:0046872]; zinc:proton antiporter activity [GO:0140826],GO:0005215; GO:0005886; GO:0055085; GO:0098754; GO:0098772,transporter activity; plasma membrane; transmembrane transport; detoxification; molecular function regulator activity
OG_02176,FUN_008525-T2,Peve_00019201,Pocillopora_meandrina_HIv1___TS.g3901.t1,three_way,50.440666666666665,FUN_008525-T2,Q9P2N4,ATS9_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-),Homo sapiens (Human),35.7,1772.0,0.0,1103.6,sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4,GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671,aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005783; GO:0007155; GO:0016192; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; endoplasmic reticulum; cell adhesion; vesicle-mediated transport; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02177,FUN_008528-T1,Peve_00029541,Pocillopora_meandrina_HIv1___RNAseq.g14749.t1,three_way,54.26616666666667,,,,,,,,,,,,,,,,,
OG_02178,FUN_008529-T1,Peve_00029539,Pocillopora_meandrina_HIv1___RNAseq.g14748.t1,three_way,87.92666666666666,FUN_008529-T1,M9PBE2,,,,,56.6,113.0,1.4e-32,142.1,sp|M9PBE2|HAKAI_DROME E3 ubiquitin-protein ligase Hakai OS=Drosophila melanogaster OX=7227 GN=Hakai PE=1 SV=1,,,,,,
OG_02179,FUN_008530-T1,Peve_00011877,Pocillopora_meandrina_HIv1___RNAseq.g14745.t1,three_way,87.72200000000001,,,,,,,,,,,,,,,,,
OG_02180,FUN_008531-T1,Peve_00011876,Pocillopora_meandrina_HIv1___RNAseq.g14744.t1,three_way,54.064,,,,,,,,,,,,,,,,,
OG_02181,FUN_008534-T1,Peve_00014007,Pocillopora_meandrina_HIv1___RNAseq.g14740.t1,three_way,62.36966666666667,FUN_008534-T1,Q28E45,MCM10_XENTR,,Protein MCM10 homolog,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),36.7,645.0,4.0999999999999996e-92,340.9,sp|Q28E45|MCM10_XENTR Protein MCM10 homolog OS=Xenopus tropicalis OX=8364 GN=mcm10 PE=2 SV=1,GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0008270,DNA damage response [GO:0006974]; DNA replication initiation [GO:0006270],nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0043226,DNA binding; nucleus; organelle
OG_02182,FUN_008535-T1,Peve_00014003,Pocillopora_meandrina_HIv1___RNAseq.g14739.t1,three_way,73.097,FUN_008535-T1,Q6ZUG5,,,,,37.1,493.0,2.9000000000000006e-89,332.0,sp|Q6ZUG5|YC006_HUMAN Uncharacterized protein FLJ43738 OS=Homo sapiens OX=9606 PE=1 SV=1,,,,,,
OG_02183,FUN_008536-T1,Peve_00044627,Pocillopora_meandrina_HIv1___RNAseq.24098_t,three_way,66.34983333333334,,,,,,,,,,,,,,,,,
OG_02184,FUN_008537-T1,Peve_00044625,Pocillopora_meandrina_HIv1___RNAseq.g14737.t1,three_way,73.81949999999999,FUN_008537-T1,Q7Z6B7,SRGP1_HUMAN,,SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13),Homo sapiens (Human),33.9,834.0,3.3e-120,434.5,sp|Q7Z6B7|SRGP1_HUMAN SLIT-ROBO Rho GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=SRGAP1 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0007266; GO:0016477; GO:0030336; GO:0031267,cell migration [GO:0016477]; negative regulation of cell migration [GO:0030336]; Rho protein signal transduction [GO:0007266],cytoplasm [GO:0005737]; cytosol [GO:0005829],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0048870; GO:0098772,cytosol; cell motility; molecular function regulator activity
OG_02185,FUN_008538-T1,Peve_00014613,Pocillopora_meandrina_HIv1___RNAseq.g14663.t1,three_way,63.84633333333333,FUN_008538-T1,A4QND0,,,,,39.7,131.0,4.6e-20,99.0,sp|A4QND0|UBL4A_XENTR Ubiquitin-like protein 4A OS=Xenopus tropicalis OX=8364 GN=ubl4a PE=2 SV=1,,,,,,
OG_02186,FUN_008540-T1,Peve_00014611,Pocillopora_meandrina_HIv1___RNAseq.g14661.t1,three_way,66.877,FUN_008540-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),40.3,295.0,2.3e-52,210.3,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_02187,FUN_008541-T1,Peve_00026391,Pocillopora_meandrina_HIv1___RNAseq.g6362.t1,three_way,76.138,,,,,,,,,,,,,,,,,
OG_02188,FUN_008542-T1,Peve_00013759,Pocillopora_meandrina_HIv1___RNAseq.g6360.t1,three_way,88.51266666666666,FUN_008542-T1,Q299F9,,,,,61.9,357.0,9e-99,361.7,sp|Q299F9|FAM50_DROPS Protein FAM50 homolog OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=GA11514 PE=3 SV=1,,,,,,
OG_02189,FUN_008543-T1,Peve_00013760,Pocillopora_meandrina_HIv1___RNAseq.g6359.t1,three_way,63.07300000000001,FUN_008543-T1,Q8IXR9,,,,,34.4,375.0,2.6e-50,201.8,sp|Q8IXR9|CL056_HUMAN Uncharacterized protein C12orf56 OS=Homo sapiens OX=9606 GN=C12orf56 PE=2 SV=3,,,,,,
OG_02190,FUN_008544-T1,Peve_00013775,Pocillopora_meandrina_HIv1___RNAseq.g6331.t2,three_way,81.17266666666667,FUN_008544-T1,Q99MD6,TRXR3_MOUSE,,Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2),Mus musculus (Mouse),60.5,588.0,1.7000000000000002e-209,730.3,sp|Q99MD6|TRXR3_MOUSE Thioredoxin reductase 3 OS=Mus musculus OX=10090 GN=Txnrd3 PE=1 SV=3,GO:0001825; GO:0004791; GO:0005634; GO:0005783; GO:0006749; GO:0007283; GO:0030154; GO:0045454; GO:0050660,blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],flavin adenine dinucleotide binding [GO:0050660]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005783; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_02191,FUN_008545-T1,Peve_00013778,Pocillopora_meandrina_HIv1___RNAseq.g6330.t1,three_way,84.39466666666667,FUN_008545-T1,Q26619,,,,,56.8,380.0,3.4e-113,409.8,sp|Q26619|KAPR_STRPU cAMP-dependent protein kinase type II regulatory subunit OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_02192,FUN_008547-T1,Peve_00034512,Pocillopora_meandrina_HIv1___RNAseq.g6327.t1,three_way,36.30383333333333,,,,,,,,,,,,,,,,,
OG_02193,FUN_008548-T1,Peve_00013780,Pocillopora_meandrina_HIv1___RNAseq.g6326.t1,three_way,74.56866666666666,FUN_008548-T1,Q6INP8,,,,,33.3,474.0,7.7e-62,240.4,sp|Q6INP8|MED1_XENLA Mediator of RNA polymerase II transcription subunit 1 OS=Xenopus laevis OX=8355 GN=med1 PE=2 SV=1,,,,,,
OG_02194,FUN_008549-T1,Peve_00035549,Pocillopora_meandrina_HIv1___RNAseq.g6325.t1,three_way,84.30933333333333,FUN_008549-T1,B2RRD7,BRPF1_MOUSE,,Peregrin (Bromodomain and PHD finger-containing protein 1),Mus musculus (Mouse),45.3,1287.0,2.5999999999999998e-250,867.1,sp|B2RRD7|BRPF1_MOUSE Peregrin OS=Mus musculus OX=10090 GN=Brpf1 PE=1 SV=1,GO:0000123; GO:0001570; GO:0001841; GO:0003677; GO:0005634; GO:0005737; GO:0006338; GO:0008270; GO:0010698; GO:0035726; GO:0048145; GO:0070776,chromatin remodeling [GO:0006338]; common myeloid progenitor cell proliferation [GO:0035726]; neural tube formation [GO:0001841]; regulation of fibroblast proliferation [GO:0048145]; vasculogenesis [GO:0001570],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleus [GO:0005634],acetyltransferase activator activity [GO:0010698]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0030154; GO:0043226; GO:0098772,DNA binding; nucleus; chromatin organization; cell differentiation; organelle; molecular function regulator activity
OG_02195,FUN_008551-T1,Peve_00044743,Pocillopora_meandrina_HIv1___RNAseq.g68.t1,three_way,78.64366666666668,FUN_008551-T1,Q8NCE2,MTMRE_HUMAN,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR14 (EC 3.1.3.95) (HCV NS5A-transactivated protein 4 splice variant A-binding protein 1) (NS5ATP4ABP1) (Myotubularin-related protein 14) (Phosphatidylinositol-3-phosphate phosphatase) (hJumpy)",Homo sapiens (Human),47.7,606.0,1.2e-136,488.4,"sp|Q8NCE2|MTMRE_HUMAN Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR14 OS=Homo sapiens OX=9606 GN=MTMR14 PE=1 SV=2",GO:0001726; GO:0004438; GO:0004722; GO:0005829; GO:0006661; GO:0016236; GO:0048471; GO:0052629,macroautophagy [GO:0016236]; phosphatidylinositol biosynthetic process [GO:0006661],cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726],"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein serine/threonine phosphatase activity [GO:0004722]",GO:0003824; GO:0005829; GO:0006629; GO:0006914; GO:0016787; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; autophagy; hydrolase activity; catalytic activity, acting on a protein"
OG_02196,FUN_008558-T1,Peve_00044735,Pocillopora_meandrina_HIv1___RNAseq.g69.t1,three_way,76.34233333333333,FUN_008558-T1,F1MUG2,,,,,47.2,212.0,1.6e-43,177.9,sp|F1MUG2|CEP41_BOVIN Centrosomal protein of 41 kDa OS=Bos taurus OX=9913 GN=CEP41 PE=3 SV=2,,,,,,
OG_02197,FUN_008561-T1,Peve_00044734,Pocillopora_meandrina_HIv1___RNAseq.g70.t1,three_way,79.849,FUN_008561-T1,Q07646,,,,,48.7,318.0,3.7e-84,313.2,sp|Q07646|MEST_MOUSE Mesoderm-specific transcript protein OS=Mus musculus OX=10090 GN=Mest PE=2 SV=1,,,,,,
OG_02198,FUN_008562-T1,Peve_00044733,Pocillopora_meandrina_HIv1___TS.g25491.t1,three_way,80.36,,,,,,,,,,,,,,,,,
OG_02199,FUN_008567-T1,Peve_00044730,Pocillopora_meandrina_HIv1___RNAseq.g72.t1b,three_way,65.37433333333333,,,,,,,,,,,,,,,,,
OG_02200,FUN_008569-T1,Peve_00044727,Pocillopora_meandrina_HIv1___RNAseq.g12789.t1,three_way,62.34433333333333,,,,,,,,,,,,,,,,,
OG_02201,FUN_008576-T1,Peve_00044725,Pocillopora_meandrina_HIv1___RNAseq.g12787.t1,three_way,63.60733333333333,,,,,,,,,,,,,,,,,
OG_02202,FUN_008577-T1,Peve_00028423,Pocillopora_meandrina_HIv1___RNAseq.g12779.t1,three_way,77.05433333333333,FUN_008577-T1,Q80Y56,,,,,37.4,505.0,3.3e-76,287.3,sp|Q80Y56|RBNS5_MOUSE Rabenosyn-5 OS=Mus musculus OX=10090 GN=Rbsn PE=1 SV=1,,,,,,
OG_02203,FUN_008578-T1,Peve_00028420,Pocillopora_meandrina_HIv1___RNAseq.g12780.t1,three_way,73.47233333333334,FUN_008578-T1,Q9VY28,,,,,42.7,157.0,1.5e-28,127.5,sp|Q9VY28|RT25_DROME Small ribosomal subunit protein mS25 OS=Drosophila melanogaster OX=7227 GN=mRpS25 PE=1 SV=1,,,,,,
OG_02204,FUN_008579-T1,Peve_00028419,Pocillopora_meandrina_HIv1___RNAseq.g12781.t1,three_way,51.49733333333333,,,,,,,,,,,,,,,,,
OG_02205,FUN_008580-T1,Peve_00028418,Pocillopora_meandrina_HIv1___RNAseq.g12782.t1,three_way,65.03466666666667,,,,,,,,,,,,,,,,,
OG_02206,FUN_008581-T1,Peve_00028410,Pocillopora_meandrina_HIv1___RNAseq.g12783.t1,three_way,70.744,FUN_008581-T1,O42260,,,,,41.7,259.0,1.3e-50,201.4,sp|O42260|GEMI2_XENLA Gem-associated protein 2 OS=Xenopus laevis OX=8355 GN=gemin2 PE=2 SV=1,,,,,,
OG_02207,FUN_008583-T1,Peve_00028408,Pocillopora_meandrina_HIv1___RNAseq.g12778.t1,three_way,81.406,FUN_008583-T1,Q5RB35,MKLN1_PONAB,,Muskelin,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),61.2,738.0,2.1e-273,943.0,sp|Q5RB35|MKLN1_PONAB Muskelin OS=Pongo abelii OX=9601 GN=MKLN1 PE=2 SV=1,GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030036; GO:0042803; GO:0098895; GO:0098968; GO:0098982; GO:0099003; GO:0099164,actin cytoskeleton organization [GO:0030036]; cell-matrix adhesion [GO:0007160]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport in synapse [GO:0099003],cell cortex [GO:0005938]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; nucleoplasm [GO:0005654]; postsynaptic endosome membrane [GO:0098895]; postsynaptic specialization membrane of symmetric synapse [GO:0099164]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151],protein homodimerization activity [GO:0042803],GO:0005654; GO:0005829; GO:0007010; GO:0007155; GO:0016192,nucleoplasm; cytosol; cytoskeleton organization; cell adhesion; vesicle-mediated transport
OG_02208,FUN_008584-T1,Peve_00028405,Pocillopora_meandrina_HIv1___TS.g119.t1,three_way,55.215,,,,,,,,,,,,,,,,,
OG_02209,FUN_008585-T1,Peve_00026589,Pocillopora_meandrina_HIv1___TS.g118.t1,three_way,43.182,FUN_008585-T1,Q5VU97,CAHD1_HUMAN,,VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1),Homo sapiens (Human),25.5,1077.0,8.3e-84,313.9,sp|Q5VU97|CAHD1_HUMAN VWFA and cache domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CACHD1 PE=1 SV=2,GO:0005245; GO:0005891,,voltage-gated calcium channel complex [GO:0005891],voltage-gated calcium channel activity [GO:0005245],GO:0005215,transporter activity
OG_02210,FUN_008586-T1,Peve_00028409,Pocillopora_meandrina_HIv1___RNAseq.g12772.t1,three_way,68.07300000000001,FUN_008586-T1,Q8K0U4,,,,,37.4,623.0,1.5e-107,391.7,sp|Q8K0U4|HS12A_MOUSE Heat shock 70 kDa protein 12A OS=Mus musculus OX=10090 GN=Hspa12a PE=1 SV=1,,,,,,
OG_02211,FUN_008587-T1,Peve_00028398,Pocillopora_meandrina_HIv1___RNAseq.g12773.t1,three_way,39.733,,,,,,,,,,,,,,,,,
OG_02212,FUN_008594-T1,Peve_00002263,Pocillopora_meandrina_HIv1___RNAseq.g12762.t1,three_way,68.02633333333334,FUN_008594-T1,P02469,LAMB1_MOUSE,,Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta),Mus musculus (Mouse),43.3,1409.0,5.4e-246,853.2,sp|P02469|LAMB1_MOUSE Laminin subunit beta-1 OS=Mus musculus OX=10090 GN=Lamb1 PE=1 SV=3,GO:0005178; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005607; GO:0005615; GO:0005634; GO:0007162; GO:0007566; GO:0007611; GO:0016477; GO:0019899; GO:0021812; GO:0030335; GO:0031012; GO:0031175; GO:0034446; GO:0035987; GO:0042476; GO:0043208; GO:0043256; GO:0043257; GO:0043259; GO:0045785; GO:0048471; GO:0051149; GO:0062023; GO:0098637; GO:0110011; GO:2001046,cell migration [GO:0016477]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; learning or memory [GO:0007611]; negative regulation of cell adhesion [GO:0007162]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; substrate adhesion-dependent cell spreading [GO:0034446],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein complex involved in cell-matrix adhesion [GO:0098637],enzyme binding [GO:0019899]; extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; integrin binding [GO:0005178],GO:0005198; GO:0005576; GO:0005615; GO:0005634; GO:0007155; GO:0008289; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048870; GO:0050877,structural molecule activity; extracellular region; extracellular space; nucleus; cell adhesion; lipid binding; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; cell motility; nervous system process
OG_02213,FUN_008598-T1,Peve_00040010,Pocillopora_meandrina_HIv1___TS.g13357.t1,three_way,50.58566666666667,,,,,,,,,,,,,,,,,
OG_02214,FUN_008599-T1,Peve_00002260,Pocillopora_meandrina_HIv1___RNAseq.g12757.t1,three_way,66.727,FUN_008599-T1,Q9BV10,,,,,46.6,451.0,8.3e-102,373.2,"sp|Q9BV10|ALG12_HUMAN Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase OS=Homo sapiens OX=9606 GN=ALG12 PE=1 SV=1",,,,,,
OG_02215,FUN_008604-T2,Peve_00020824,Pocillopora_meandrina_HIv1___RNAseq.g12756.t2,three_way,78.7245,FUN_008604-T2,O75131,CPNE3_HUMAN,,Copine-3 (Copine III),Homo sapiens (Human),56.5,531.0,1.1e-170,601.3,sp|O75131|CPNE3_HUMAN Copine-3 OS=Homo sapiens OX=9606 GN=CPNE3 PE=1 SV=1,GO:0003723; GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0035577; GO:0038128; GO:0046872; GO:0048306; GO:0070062; GO:0071277; GO:0071363,cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335],azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0008289; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; plasma membrane; lipid binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02216,FUN_008605-T1,Peve_00020826,Pocillopora_meandrina_HIv1___RNAseq.g12755.t1,three_way,59.71116666666666,FUN_008605-T1,Q4V8X0,,,,,39.7,267.0,3e-41,170.6,sp|Q4V8X0|TPRA1_DANRE Transmembrane protein adipocyte-associated 1 homolog OS=Danio rerio OX=7955 GN=tpra1 PE=2 SV=1,,,,,,
OG_02217,FUN_008610-T1,Peve_00035550,Pocillopora_meandrina_HIv1___RNAseq.g6324.t1,three_way,95.465,FUN_008610-T1,Q9I8E6,,,,,69.2,877.0,0.0,1204.5,sp|Q9I8E6|COPG2_TAKRU Coatomer subunit gamma-2 OS=Takifugu rubripes OX=31033 GN=copg2 PE=3 SV=1,,,,,,
OG_02218,FUN_008613-T1,Peve_00040317,Pocillopora_meandrina_HIv1___RNAseq.g6266.t1,three_way,44.564,FUN_008613-T1,Q3LU41,,,,,47.1,68.0,4.1e-10,67.0,sp|Q3LU41|PROP1_THEGE Homeobox protein prophet of Pit-1 OS=Theropithecus gelada OX=9565 GN=PROP1 PE=3 SV=1,,,,,,
OG_02219,FUN_008614-T1,Peve_00040315,Pocillopora_meandrina_HIv1___RNAseq.g6261.t1,three_way,64.44066666666667,FUN_008614-T1,O18499,,,,,34.0,374.0,6.1e-56,220.7,sp|O18499|ACT1_SACKO Actin-1 OS=Saccoglossus kowalevskii OX=10224 PE=2 SV=1,,,,,,
OG_02220,FUN_008615-T1,Peve_00015389,Pocillopora_meandrina_HIv1___RNAseq.g12744.t1,three_way,73.05916666666667,FUN_008615-T1,O35161,CELR1_MOUSE,,Cadherin EGF LAG seven-pass G-type receptor 1,Mus musculus (Mouse),33.5,2618.0,0.0,1375.5,sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3,GO:0001736; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007166; GO:0007266; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475,anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell surface receptor signaling pathway [GO:0007166]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060],membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005886; GO:0007155; GO:0042060; GO:0048856; GO:0048870; GO:0060089,nucleoplasm; plasma membrane; cell adhesion; wound healing; anatomical structure development; cell motility; molecular transducer activity
OG_02221,FUN_008616-T2,Peve_00015392,Pocillopora_meandrina_HIv1___RNAseq.g12745.t1,three_way,74.7925,FUN_008616-T2,E7FDW2,,,,,28.2,602.0,3.1000000000000003e-57,225.3,sp|E7FDW2|PZR3B_DANRE E3 ubiquitin-protein ligase PDZRN3-B OS=Danio rerio OX=7955 GN=pdzrn3b PE=1 SV=1,,,,,,
OG_02222,FUN_008617-T1,Peve_00015391,Pocillopora_meandrina_HIv1___TS.g89.t1,three_way,78.33666666666666,FUN_008617-T1,Q5XTS1,PLPL8_RABIT,,Calcium-independent phospholipase A2-gamma (EC 3.1.1.-) (EC 3.1.1.5) (Group VIB calcium-independent phospholipase A2) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (Patatin-like phospholipase domain-containing protein 8),Oryctolagus cuniculus (Rabbit),47.3,427.0,2.2000000000000007e-111,404.1,sp|Q5XTS1|PLPL8_RABIT Calcium-independent phospholipase A2-gamma OS=Oryctolagus cuniculus OX=9986 GN=PNPLA8 PE=1 SV=1,GO:0004622; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0008970; GO:0016020; GO:0016042; GO:0019369; GO:0031966; GO:0032048; GO:0047499; GO:0055088; GO:0070328,arachidonate metabolic process [GO:0019369]; cardiolipin metabolic process [GO:0032048]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; triglyceride homeostasis [GO:0070328],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; phospholipase A1 activity [GO:0008970],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016787; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; hydrolase activity; organelle
OG_02223,FUN_008619-T1,Peve_00015390,Pocillopora_meandrina_HIv1___RNAseq.g6258.t1,three_way,84.62133333333334,FUN_008619-T1,Q9HC24,LFG4_HUMAN,,Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein),Homo sapiens (Human),54.6,227.0,5.3e-64,245.7,sp|Q9HC24|LFG4_HUMAN Protein lifeguard 4 OS=Homo sapiens OX=9606 GN=TMBIM4 PE=1 SV=3,GO:0000139; GO:0005262; GO:0005789; GO:0005795; GO:0006915; GO:0007626; GO:0016020; GO:0030968; GO:0043066; GO:0043524; GO:0050848,apoptotic process [GO:0006915]; endoplasmic reticulum unfolded protein response [GO:0030968]; locomotory behavior [GO:0007626]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of calcium-mediated signaling [GO:0050848],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020],calcium channel activity [GO:0005262],GO:0005215; GO:0012501,transporter activity; programmed cell death
OG_02224,FUN_008623-T1,Peve_00015387,Pocillopora_meandrina_HIv1___RNAseq.g6256.t1,three_way,65.94366666666667,,,,,,,,,,,,,,,,,
OG_02225,FUN_008629-T1,Peve_00035603,Pocillopora_meandrina_HIv1___RNAseq.g14909.t1,three_way,89.81700000000001,FUN_008629-T1,Q96G21,IMP4_HUMAN,,U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4) (Brix domain-containing protein 4),Homo sapiens (Human),67.2,290.0,3.4e-110,399.4,sp|Q96G21|IMP4_HUMAN U3 small nucleolar ribonucleoprotein protein IMP4 OS=Homo sapiens OX=9606 GN=IMP4 PE=1 SV=1,GO:0001650; GO:0005654; GO:0005730; GO:0006364; GO:0030490; GO:0030515; GO:0030684; GO:0032040; GO:0034457; GO:0042134; GO:0042274,maturation of SSU-rRNA [GO:0030490]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome [GO:0030684]; small-subunit processome [GO:0032040],rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515],GO:0003723; GO:0005654; GO:0005730; GO:0043226,RNA binding; nucleoplasm; nucleolus; organelle
OG_02226,FUN_008631-T1,Peve_00012388,Pocillopora_meandrina_HIv1___RNAseq.g14912.t1,three_way,62.56166666666666,,,,,,,,,,,,,,,,,
OG_02227,FUN_008633-T1,Peve_00012386,Pocillopora_meandrina_HIv1___RNAseq.g14915.t1,three_way,74.2705,FUN_008633-T1,Q8VDT1,,,,,45.9,573.0,4.5e-140,500.0,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_02228,FUN_008634-T1,Peve_00021941,Pocillopora_meandrina_HIv1___RNAseq.g14919.t2,three_way,51.94316666666667,FUN_008634-T1,P42166,LAP2A_HUMAN,,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]",Homo sapiens (Human),35.0,197.0,9.1e-16,85.9,"sp|P42166|LAP2A_HUMAN Lamina-associated polypeptide 2, isoform alpha OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2",GO:0000785; GO:0003677; GO:0005521; GO:0005634; GO:0005635; GO:0045296,,chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nucleus [GO:0005634],cadherin binding [GO:0045296]; DNA binding [GO:0003677]; lamin binding [GO:0005521],GO:0003677; GO:0005634; GO:0005635; GO:0043226,DNA binding; nucleus; nuclear envelope; organelle
OG_02229,FUN_008635-T1,Peve_00024235,Pocillopora_meandrina_HIv1___RNAseq.g14918.t1,three_way,76.26733333333334,FUN_008635-T1,Q6NWJ4,DNJC2_DANRE,,DnaJ homolog subfamily C member 2,Danio rerio (Zebrafish) (Brachydanio rerio),55.8,618.0,1.4000000000000002e-124,448.4,sp|Q6NWJ4|DNJC2_DANRE DnaJ homolog subfamily C member 2 OS=Danio rerio OX=7955 GN=dnajc2 PE=2 SV=1,GO:0003682; GO:0005634; GO:0005829; GO:0006450; GO:0030544; GO:0042393; GO:0043022; GO:0045893; GO:0051083; GO:0061649,'de novo' cotranslational protein folding [GO:0051083]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of translational fidelity [GO:0006450],cytosol [GO:0005829]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; ubiquitin-modified histone reader activity [GO:0061649],GO:0005634; GO:0005829; GO:0006355; GO:0006457; GO:0042393; GO:0043226; GO:0060090,nucleus; cytosol; regulation of DNA-templated transcription; protein folding; histone binding; organelle; molecular adaptor activity
OG_02230,FUN_008636-T1,Peve_00021943,Pocillopora_meandrina_HIv1___RNAseq.g14917.t1,three_way,58.11366666666667,,,,,,,,,,,,,,,,,
OG_02231,FUN_008641-T1,Peve_00021174,Pocillopora_meandrina_HIv1___RNAseq.30196_t,three_way,85.19133333333333,FUN_008641-T1,A6QP15,,,,,63.5,469.0,9.1e-177,621.3,"sp|A6QP15|HOT_BOVIN Hydroxyacid-oxoacid transhydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ADHFE1 PE=2 SV=1",,,,,,
OG_02232,FUN_008642-T1,Peve_00031673,Pocillopora_meandrina_HIv1___RNAseq.g9.t1,three_way,77.27466666666666,FUN_008642-T1,Q3ZC89,MAP2_BOVIN,,Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M),Bos taurus (Bovine),79.0,367.0,2.6e-176,619.8,sp|Q3ZC89|MAP2_BOVIN Methionine aminopeptidase 2 OS=Bos taurus OX=9913 GN=METAP2 PE=2 SV=1,GO:0004177; GO:0004239; GO:0005737; GO:0006508; GO:0008235; GO:0046872; GO:0070006,proteolysis [GO:0006508],cytoplasm [GO:0005737],aminopeptidase activity [GO:0004177]; initiator methionyl aminopeptidase activity [GO:0004239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_02233,FUN_008644-T1,Peve_00031674,Pocillopora_meandrina_HIv1___RNAseq.g10.t1,three_way,70.55633333333333,FUN_008644-T1,Q5E965,C56D2_BOVIN,,Transmembrane reductase CYB561D2 (EC 7.2.1.3) (Cytochrome b561 domain-containing protein 2),Bos taurus (Bovine),39.0,205.0,8.500000000000001e-33,142.1,sp|Q5E965|C56D2_BOVIN Transmembrane reductase CYB561D2 OS=Bos taurus OX=9913 GN=CYB561D2 PE=2 SV=1,GO:0005783; GO:0005789; GO:0020037; GO:0030659; GO:0031982; GO:0046872; GO:0140571; GO:0140575; GO:0140576,ascorbate homeostasis [GO:0140576],cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; vesicle [GO:0031982],heme binding [GO:0020037]; metal ion binding [GO:0046872]; transmembrane ascorbate ferrireductase activity [GO:0140571]; transmembrane monodehydroascorbate reductase activity [GO:0140575],GO:0003824; GO:0005215; GO:0005783; GO:0016491; GO:0043226,catalytic activity; transporter activity; endoplasmic reticulum; oxidoreductase activity; organelle
OG_02234,FUN_008645-T1,Peve_00031675,Pocillopora_meandrina_HIv1___RNAseq.g12.t1,three_way,70.55616666666667,,,,,,,,,,,,,,,,,
OG_02235,FUN_008646-T1,Peve_00021172,Pocillopora_meandrina_HIv1___RNAseq.g13.t1,three_way,77.26433333333333,FUN_008646-T1,Q8IVJ1,S41A1_HUMAN,,Solute carrier family 41 member 1,Homo sapiens (Human),59.2,448.0,1.1e-141,505.0,sp|Q8IVJ1|S41A1_HUMAN Solute carrier family 41 member 1 OS=Homo sapiens OX=9606 GN=SLC41A1 PE=1 SV=2,GO:0005886; GO:0010961; GO:0015095; GO:0015693; GO:0016323; GO:0022857; GO:0022890; GO:0030001; GO:0032991; GO:0061768; GO:0071286; GO:1903830,cellular response to magnesium ion [GO:0071286]; intracellular magnesium ion homeostasis [GO:0010961]; magnesium ion transmembrane transport [GO:1903830]; magnesium ion transport [GO:0015693]; metal ion transport [GO:0030001],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],inorganic cation transmembrane transporter activity [GO:0022890]; magnesium ion transmembrane transporter activity [GO:0015095]; magnesium:sodium antiporter activity [GO:0061768]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_02236,FUN_008648-T1,Peve_00021173,Pocillopora_meandrina_HIv1___RNAseq.g14.t1,three_way,67.93333333333332,,,,,,,,,,,,,,,,,
OG_02237,FUN_008649-T1,Peve_00035682,Pocillopora_meandrina_HIv1___RNAseq.g15.t1,three_way,97.37233333333332,FUN_008649-T1,Q32LN1,UBE2H_BOVIN,,Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (Ubiquitin carrier protein H) (Ubiquitin-protein ligase H),Bos taurus (Bovine),73.8,183.0,4.0000000000000004e-72,272.3,sp|Q32LN1|UBE2H_BOVIN Ubiquitin-conjugating enzyme E2 H OS=Bos taurus OX=9913 GN=UBE2H PE=2 SV=1,GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0006511; GO:0043161; GO:0061631; GO:0070936; GO:0070979,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02238,FUN_008650-T1,Peve_00032564,Pocillopora_meandrina_HIv1___RNAseq.g16.t1,three_way,59.9695,FUN_008650-T1,Q99LJ2,,,,,46.0,502.0,4.8999999999999996e-120,433.0,sp|Q99LJ2|ABTB1_MOUSE Ankyrin repeat and BTB/POZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Abtb1 PE=2 SV=1,,,,,,
OG_02239,FUN_008651-T1,Peve_00032563,Pocillopora_meandrina_HIv1___RNAseq.g17.t1,three_way,64.352,,,,,,,,,,,,,,,,,
OG_02240,FUN_008652-T1,Peve_00032562,Pocillopora_meandrina_HIv1___RNAseq.g18.t1,three_way,57.517,FUN_008652-T1,Q9Y3I1,,,,,31.2,478.0,3.6e-46,187.6,sp|Q9Y3I1|FBX7_HUMAN F-box only protein 7 OS=Homo sapiens OX=9606 GN=FBXO7 PE=1 SV=1,,,,,,
OG_02241,FUN_008653-T1,Peve_00044595,Pocillopora_meandrina_HIv1___RNAseq.g19.t1,three_way,89.93266666666666,FUN_008653-T1,A4IFK2,,,,,65.2,299.0,1.8e-109,397.1,sp|A4IFK2|S35E3_BOVIN Solute carrier family 35 member E3 OS=Bos taurus OX=9913 GN=SLC35E3 PE=2 SV=1,,,,,,
OG_02242,FUN_008659-T1,Peve_00016766,Pocillopora_meandrina_HIv1___RNAseq.g14869.t1,three_way,64.205,FUN_008659-T1,Q8NA03,,,,,27.0,359.0,3e-08,61.6,sp|Q8NA03|FSIP1_HUMAN Fibrous sheath-interacting protein 1 OS=Homo sapiens OX=9606 GN=FSIP1 PE=1 SV=1,,,,,,
OG_02243,FUN_008660-T1,Peve_00002968,Pocillopora_meandrina_HIv1___RNAseq.g14873.t1,three_way,90.71133333333331,FUN_008660-T1,H9BW96,,,,,88.4,207.0,3.8e-101,369.0,sp|H9BW96|RAB7_EPICO Ras-related protein rab7 OS=Epinephelus coioides OX=94232 GN=rab7 PE=1 SV=1,,,,,,
OG_02244,FUN_008661-T1,Peve_00002969,Pocillopora_meandrina_HIv1___RNAseq.g14876.t1,three_way,82.85233333333333,FUN_008661-T1,P51650,SSDH_RAT,,"Succinate-semialdehyde dehydrogenase, mitochondrial (SSADH) (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)",Rattus norvegicus (Rat),62.6,478.0,4.1e-180,632.5,"sp|P51650|SSDH_RAT Succinate-semialdehyde dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Aldh5a1 PE=1 SV=2",GO:0004777; GO:0005739; GO:0006105; GO:0006536; GO:0007417; GO:0009448; GO:0009450; GO:0009791; GO:0031406; GO:0042802; GO:0045202; GO:0051287; GO:0051932,"central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glutamate metabolic process [GO:0006536]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]; synaptic transmission, GABAergic [GO:0051932]",mitochondrion [GO:0005739]; synapse [GO:0045202],carboxylic acid binding [GO:0031406]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777],GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0023052; GO:0043226; GO:0048856,catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; signaling; organelle; anatomical structure development
OG_02245,FUN_008662-T1,Peve_00044718,Pocillopora_meandrina_HIv1___RNAseq.g14877.t1,three_way,86.88,FUN_008662-T1,Q8CDU4,,,,,32.1,669.0,8.7e-92,339.7,sp|Q8CDU4|FXL13_MOUSE F-box and leucine-rich repeat protein 13 OS=Mus musculus OX=10090 GN=Fbxl13 PE=1 SV=2,,,,,,
OG_02246,FUN_008663-T1,Peve_00044714,Pocillopora_meandrina_HIv1___RNAseq.g14878.t1,three_way,73.19,FUN_008663-T1,P13439,UMPS_MOUSE,,Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMPdecase)],Mus musculus (Mouse),52.2,467.0,2.1e-133,477.2,sp|P13439|UMPS_MOUSE Uridine 5'-monophosphate synthase OS=Mus musculus OX=10090 GN=Umps PE=1 SV=3,GO:0004588; GO:0004590; GO:0005634; GO:0005737; GO:0006207; GO:0006225; GO:0044205,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; nucleus [GO:0005634],orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590],GO:0003824; GO:0005634; GO:0016740; GO:0016829; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; transferase activity; lyase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02247,FUN_008664-T1,Peve_00044713,Pocillopora_meandrina_HIv1___RNAseq.g14879.t1,three_way,78.34966666666666,FUN_008664-T1,A1YFA7,PQBP1_GORGO,,Polyglutamine-binding protein 1 (PQBP-1) (Polyglutamine tract-binding protein 1),Gorilla gorilla gorilla (Western lowland gorilla),33.6,295.0,1.1e-27,125.2,sp|A1YFA7|PQBP1_GORGO Polyglutamine-binding protein 1 OS=Gorilla gorilla gorilla OX=9595 GN=PQBP1 PE=3 SV=1,GO:0000380; GO:0002218; GO:0002230; GO:0003690; GO:0005737; GO:0005829; GO:0010494; GO:0016604; GO:0016607; GO:0031175; GO:0032481; GO:0036064; GO:0043021; GO:0043484; GO:0045087; GO:0048814; GO:0051607; GO:0071360; GO:0071598,"activation of innate immune response [GO:0002218]; alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484]",ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear body [GO:0016604]; nuclear speck [GO:0016607],double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021],GO:0002376; GO:0003677; GO:0005815; GO:0005829; GO:0016071; GO:0043226; GO:0098542,immune system process; DNA binding; microtubule organizing center; cytosol; mRNA metabolic process; organelle; defense response to other organism
OG_02248,FUN_008665-T1,Peve_00044711,Pocillopora_meandrina_HIv1___RNAseq.g64.t1,three_way,73.61466666666666,FUN_008665-T1,Q6RHR9,,,,,33.7,1372.0,3.9e-185,650.6,"sp|Q6RHR9|MAGI1_MOUSE Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Magi1 PE=1 SV=1",,,,,,
OG_02249,FUN_008668-T1,Peve_00044707,Pocillopora_meandrina_HIv1___RNAseq.g67.t1,three_way,96.41,FUN_008668-T1,Q6NZW8,,,,,86.2,130.0,1.1e-62,240.7,sp|Q6NZW8|AR8BA_DANRE ADP-ribosylation factor-like protein 8B-A OS=Danio rerio OX=7955 GN=arl8ba PE=2 SV=1,,,,,,
OG_02250,FUN_008694-T1,Peve_00040327,Pocillopora_meandrina_HIv1___RNAseq.g6276.t1,three_way,91.75133333333332,FUN_008694-T1,A7RKF6,RTCB_NEMVE,,RNA-splicing ligase RtcB homolog (EC 6.5.1.8) (3'-phosphate/5'-hydroxy nucleic acid ligase),Nematostella vectensis (Starlet sea anemone),88.7,468.0,5.5e-247,854.7,sp|A7RKF6|RTCB_NEMVE RNA-splicing ligase RtcB homolog OS=Nematostella vectensis OX=45351 GN=v1g198406 PE=3 SV=1,GO:0005525; GO:0005634; GO:0006388; GO:0046872; GO:0072669; GO:0170057,"tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]",nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669],GTP binding [GO:0005525]; metal ion binding [GO:0046872]; RNA ligase (GTP) activity [GO:0170057],GO:0003824; GO:0005634; GO:0006399; GO:0016874; GO:0043226; GO:0140098,"catalytic activity; nucleus; tRNA metabolic process; ligase activity; organelle; catalytic activity, acting on RNA"
OG_02251,FUN_008695-T1,Peve_00045002,Pocillopora_meandrina_HIv1___RNAseq.g26979.t1,three_way,61.26166666666666,,,,,,,,,,,,,,,,,
OG_02252,FUN_008697-T1,Peve_00045001,Pocillopora_meandrina_HIv1___RNAseq.g26978.t1,three_way,53.163833333333336,,,,,,,,,,,,,,,,,
OG_02253,FUN_008699-T1,Peve_00035972,Pocillopora_meandrina_HIv1___RNAseq.g6277.t1,three_way,57.66416666666667,FUN_008699-T1,Q9ESV0,,,,,40.4,639.0,1.6e-122,441.8,sp|Q9ESV0|DDX24_MOUSE ATP-dependent RNA helicase DDX24 OS=Mus musculus OX=10090 GN=Ddx24 PE=1 SV=2,,,,,,
OG_02254,FUN_008700-T1,Peve_00025639,Pocillopora_meandrina_HIv1___RNAseq.g12731.t1,three_way,66.20166666666667,,,,,,,,,,,,,,,,,
OG_02255,FUN_008701-T1,Peve_00034980,Pocillopora_meandrina_HIv1___RNAseq.g25726.t1,three_way,81.37066666666666,FUN_008701-T1,Q925U4,,,,,59.6,530.0,3.8e-185,649.4,sp|Q925U4|EDEM1_MOUSE ER degradation-enhancing alpha-mannosidase-like protein 1 OS=Mus musculus OX=10090 GN=Edem1 PE=1 SV=1,,,,,,
OG_02256,FUN_008702-T1,Peve_00034981,Pocillopora_meandrina_HIv1___RNAseq.g25725.t1,three_way,77.15733333333334,FUN_008702-T1,Q99685,MGLL_HUMAN,,Monoglyceride lipase (MGL) (EC 3.1.1.23) (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase) (MAGL),Homo sapiens (Human),45.5,279.0,6.900000000000002e-66,252.3,sp|Q99685|MGLL_HUMAN Monoglyceride lipase OS=Homo sapiens OX=9606 GN=MGLL PE=1 SV=2,GO:0004622; GO:0005789; GO:0005829; GO:0005886; GO:0006629; GO:0006633; GO:0006954; GO:0009966; GO:0016020; GO:0019369; GO:0019433; GO:0042803; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:2000124,acylglycerol catabolic process [GO:0046464]; arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; monoacylglycerol catabolic process [GO:0052651]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],lysophospholipase activity [GO:0004622]; monoacylglycerol lipase activity [GO:0047372]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0006954; GO:0016787,catalytic activity; cytosol; plasma membrane; lipid metabolic process; inflammatory response; hydrolase activity
OG_02257,FUN_008703-T1,Peve_00034982,Pocillopora_meandrina_HIv1___RNAseq.g25724.t1,three_way,65.04466666666667,FUN_008703-T1,Q4R684,,,,,36.8,288.0,1.1e-45,185.3,sp|Q4R684|AMZ2_MACFA Archaemetzincin-2 OS=Macaca fascicularis OX=9541 GN=AMZ2 PE=2 SV=2,,,,,,
OG_02258,FUN_008705-T1,Peve_00034987,Pocillopora_meandrina_HIv1___RNAseq.g25667.t1,three_way,69.49066666666667,,,,,,,,,,,,,,,,,
OG_02259,FUN_008706-T1,Peve_00034988,Pocillopora_meandrina_HIv1___RNAseq.g25666.t1,three_way,78.29466666666666,FUN_008706-T1,P55145,MANF_HUMAN,,Mesencephalic astrocyte-derived neurotrophic factor (Arginine-rich protein) (Protein ARMET),Homo sapiens (Human),55.3,170.0,1.0999999999999999e-47,191.0,sp|P55145|MANF_HUMAN Mesencephalic astrocyte-derived neurotrophic factor OS=Homo sapiens OX=9606 GN=MANF PE=1 SV=3,GO:0002014; GO:0003723; GO:0005576; GO:0005615; GO:0005634; GO:0005783; GO:0005788; GO:0005829; GO:0008083; GO:0031175; GO:0033018; GO:0036500; GO:0071542; GO:0120146; GO:1905897,ATF6-mediated unfolded protein response [GO:0036500]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; regulation of response to endoplasmic reticulum stress [GO:1905897]; vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure [GO:0002014],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; sarcoplasmic reticulum lumen [GO:0033018],growth factor activity [GO:0008083]; RNA binding [GO:0003723]; sulfatide binding [GO:0120146],GO:0003013; GO:0003723; GO:0005576; GO:0005615; GO:0005634; GO:0005783; GO:0005829; GO:0008289; GO:0030154; GO:0043226; GO:0048018; GO:0098772,circulatory system process; RNA binding; extracellular region; extracellular space; nucleus; endoplasmic reticulum; cytosol; lipid binding; cell differentiation; organelle; receptor ligand activity; molecular function regulator activity
OG_02260,FUN_008707-T1,Peve_00034989,Pocillopora_meandrina_HIv1___TS.g9102.t1,three_way,77.2585,FUN_008707-T1,Q99246,,,,,52.7,1458.0,0.0,1323.9,sp|Q99246|CAC1D_MOUSE Voltage-dependent L-type calcium channel subunit alpha-1D OS=Mus musculus OX=10090 GN=Cacna1d PE=1 SV=3,,,,,,
OG_02261,FUN_008709-T1,Peve_00033504,Pocillopora_meandrina_HIv1___RNAseq.g25665.t2,three_way,54.63916666666667,FUN_008709-T1,Q3U564,,,,,46.0,113.0,6.6e-18,93.2,sp|Q3U564|DCP1B_MOUSE mRNA-decapping enzyme 1B OS=Mus musculus OX=10090 GN=Dcp1b PE=1 SV=1,,,,,,
OG_02262,FUN_008710-T1,Peve_00025636,Pocillopora_meandrina_HIv1___RNAseq.g25661.t1,three_way,60.197,FUN_008710-T1,O43463,SUV91_HUMAN,,Histone-lysine N-methyltransferase SUV39H1 (EC 2.1.1.355) (Histone H3-K9 methyltransferase 1) (H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1) (Su(var)3-9 homolog 1),Homo sapiens (Human),50.0,310.0,1.7000000000000002e-74,281.6,sp|O43463|SUV91_HUMAN Histone-lysine N-methyltransferase SUV39H1 OS=Homo sapiens OX=9606 GN=SUV39H1 PE=1 SV=1,GO:0000122; GO:0000183; GO:0000775; GO:0000792; GO:0000794; GO:0000976; GO:0000977; GO:0001835; GO:0003682; GO:0005634; GO:0005652; GO:0005654; GO:0005677; GO:0005730; GO:0005886; GO:0006282; GO:0006325; GO:0006364; GO:0006974; GO:0007623; GO:0008270; GO:0008340; GO:0008757; GO:0030154; GO:0030500; GO:0031410; GO:0032259; GO:0033553; GO:0040014; GO:0042054; GO:0042149; GO:0044725; GO:0045786; GO:0045892; GO:0046015; GO:0046974; GO:0061773; GO:0071456; GO:0097009; GO:0140938; GO:0140947; GO:0140949; GO:2000772,blastocyst hatching [GO:0001835]; cell differentiation [GO:0030154]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; chromatin organization [GO:0006325]; circadian rhythm [GO:0007623]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; energy homeostasis [GO:0097009]; epigenetic programming in the zygotic pronuclei [GO:0044725]; methylation [GO:0032259]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; rDNA heterochromatin formation [GO:0000183]; regulation of bone mineralization [GO:0030500]; regulation of cellular senescence [GO:2000772]; regulation of DNA repair [GO:0006282]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by glucose [GO:0046015]; rRNA processing [GO:0006364],"chromatin silencing complex [GO:0005677]; chromosome, centromeric region [GO:0000775]; condensed nuclear chromosome [GO:0000794]; cytoplasmic vesicle [GO:0031410]; eNoSc complex [GO:0061773]; heterochromatin [GO:0000792]; nuclear lamina [GO:0005652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rDNA heterochromatin [GO:0033553]",chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H3K9me2 methyltransferase activity [GO:0140947]; histone methyltransferase activity [GO:0042054]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270],GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005886; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0140096,"nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; plasma membrane; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_02263,FUN_008711-T1,Peve_00025640,Pocillopora_meandrina_HIv1___RNAseq.g25660.t1,three_way,79.735,FUN_008711-T1,Q2KI14,NAA10_BOVIN,,N-alpha-acetyltransferase 10 (EC 2.3.1.255) (N-terminal acetyltransferase complex ARD1 subunit homolog A) (NatA catalytic subunit Naa10),Bos taurus (Bovine),88.2,152.0,1.5e-74,280.8,sp|Q2KI14|NAA10_BOVIN N-alpha-acetyltransferase 10 OS=Bos taurus OX=9913 GN=NAA10 PE=2 SV=1,GO:0004596; GO:0005634; GO:0005737; GO:0006474; GO:0008999; GO:0031415; GO:1990189; GO:1990190; GO:2000719,"N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric [GO:2000719]",cytoplasm [GO:0005737]; NatA complex [GO:0031415]; nucleus [GO:0005634],protein N-terminal-serine acetyltransferase activity [GO:1990189]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596]; protein-N-terminal-alanine acetyltransferase activity [GO:0008999]; protein-N-terminal-glutamate acetyltransferase activity [GO:1990190],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_02264,FUN_008712-T1,Peve_00025641,Pocillopora_meandrina_HIv1___RNAseq.g25658.t1,three_way,73.17433333333334,,,,,,,,,,,,,,,,,
OG_02265,FUN_008713-T2,Peve_00025642,Pocillopora_meandrina_HIv1___RNAseq.g25652.t1,three_way,84.41833333333334,FUN_008713-T2,Q8BW96,KCC1D_MOUSE,,Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM-KI delta) (CaMKI delta) (CaM kinase ID) (CaMKI-like protein kinase) (CKLiK) (mCKLiK),Mus musculus (Mouse),68.4,329.0,5.4e-129,462.2,sp|Q8BW96|KCC1D_MOUSE Calcium/calmodulin-dependent protein kinase type 1D OS=Mus musculus OX=10090 GN=Camk1d PE=1 SV=2,GO:0004683; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0006954; GO:0007399; GO:0010976; GO:0032793; GO:0043065; GO:0043066; GO:0050766; GO:0050773; GO:0060267; GO:0071622; GO:0090023; GO:0106310,inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; nervous system development [GO:0007399]; positive regulation of apoptotic process [GO:0043065]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis [GO:0050766]; positive regulation of respiratory burst [GO:0060267]; regulation of dendrite development [GO:0050773]; regulation of granulocyte chemotaxis [GO:0071622],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0006355; GO:0006954; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; inflammatory response; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02266,FUN_008714-T1,Peve_00025638,Pocillopora_meandrina_HIv1___RNAseq.g12730.t1,three_way,76.49233333333333,FUN_008714-T1,Q32P85,,,,,57.8,90.0,1.3e-22,107.1,sp|Q32P85|DLRB2_BOVIN Dynein light chain roadblock-type 2 OS=Bos taurus OX=9913 GN=DYNLRB2 PE=3 SV=1,,,,,,
OG_02267,FUN_008716-T1,Peve_00034975,Pocillopora_meandrina_HIv1___RNAseq.g74.t1,three_way,91.29516666666667,FUN_008716-T1,P16036,,,,,73.7,354.0,1.1e-145,517.7,sp|P16036|S25A3_RAT Solute carrier family 25 member 3 OS=Rattus norvegicus OX=10116 GN=Slc25a3 PE=1 SV=1,,,,,,
OG_02268,FUN_008718-T1,Peve_00035347,Pocillopora_meandrina_HIv1___RNAseq.g76.t1,three_way,81.45666666666666,FUN_008718-T1,Q80ZJ7,,,,,25.9,382.0,7.5e-25,116.3,sp|Q80ZJ7|SNX32_MOUSE Sorting nexin-32 OS=Mus musculus OX=10090 GN=Snx32 PE=2 SV=1,,,,,,
OG_02269,FUN_008725-T1,Peve_00034536,Pocillopora_meandrina_HIv1___RNAseq.g25644.t1,three_way,43.35033333333333,,,,,,,,,,,,,,,,,
OG_02270,FUN_008729-T1,Peve_00013706,Pocillopora_meandrina_HIv1___TS.g68.t1,three_way,80.84783333333333,FUN_008729-T1,Q80TR8,DCAF1_MOUSE,,DDB1- and CUL4-associated factor 1 (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1),Mus musculus (Mouse),47.6,1400.0,0.0,1181.8,sp|Q80TR8|DCAF1_MOUSE DDB1- and CUL4-associated factor 1 OS=Mus musculus OX=10090 GN=Dcaf1 PE=1 SV=4,GO:0000122; GO:0001650; GO:0005524; GO:0005654; GO:0005737; GO:0005813; GO:0008180; GO:0016567; GO:0030183; GO:0030331; GO:0033151; GO:0035212; GO:0043161; GO:0043687; GO:0045732; GO:0080008; GO:0106310; GO:1990244; GO:1990756,B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein catabolic process [GO:0045732]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151],centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; histone H2AT120 kinase activity [GO:1990244]; nuclear estrogen receptor binding [GO:0030331]; protein serine kinase activity [GO:0106310]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0003824; GO:0005654; GO:0005815; GO:0006310; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0060090; GO:0140096,"immune system process; catalytic activity; nucleoplasm; microtubule organizing center; DNA recombination; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_02271,FUN_008740-T1,Peve_00013702,Pocillopora_meandrina_HIv1___RNAseq.g12735.t1,three_way,71.64699999999999,,,,,,,,,,,,,,,,,
OG_02272,FUN_008748-T1,Peve_00015782,Pocillopora_meandrina_HIv1___RNAseq.g12748.t1,three_way,61.57383333333333,,,,,,,,,,,,,,,,,
OG_02273,FUN_008751-T1,Peve_00036317,Pocillopora_meandrina_HIv1___RNAseq.g12715.t1,three_way,71.39533333333334,FUN_008751-T1,Q5I082,,,,,47.7,222.0,4.3e-55,216.1,sp|Q5I082|TWF1_XENTR Twinfilin-1 OS=Xenopus tropicalis OX=8364 GN=twf1 PE=2 SV=1,,,,,,
OG_02274,FUN_008752-T1,Peve_00015784,Pocillopora_meandrina_HIv1___RNAseq.g12714.t1,three_way,88.82533333333333,FUN_008752-T1,Q6DBU5,GMPPB_DANRE,,Mannose-1-phosphate guanylyltransferase catalytic subunit beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta),Danio rerio (Zebrafish) (Brachydanio rerio),74.5,361.0,1.7e-143,510.4,sp|Q6DBU5|GMPPB_DANRE Mannose-1-phosphate guanylyltransferase catalytic subunit beta OS=Danio rerio OX=7955 GN=gmppb PE=1 SV=1,GO:0004475; GO:0005525; GO:0005737; GO:0006486; GO:0007519; GO:0009298; GO:0046872; GO:0048666; GO:0055001,GDP-mannose biosynthetic process [GO:0009298]; muscle cell development [GO:0055001]; neuron development [GO:0048666]; protein glycosylation [GO:0006486]; skeletal muscle tissue development [GO:0007519],cytoplasm [GO:0005737],GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase (GTP) activity [GO:0004475]; metal ion binding [GO:0046872],GO:0003824; GO:0006486; GO:0016740; GO:0048856; GO:0055086; GO:1901135,catalytic activity; protein glycosylation; transferase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02275,FUN_008753-T1,Peve_00036728,Pocillopora_meandrina_HIv1___RNAseq.g12713.t1b,three_way,79.75733333333334,FUN_008753-T1,A0A5F9C6I2,RN123_RABIT,,E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123),Oryctolagus cuniculus (Rabbit),39.1,1291.0,9.8e-265,914.8,sp|A0A5F9C6I2|RN123_RABIT E3 ubiquitin-protein ligase RNF123 OS=Oryctolagus cuniculus OX=9986 GN=RNF123 PE=1 SV=2,GO:0005737; GO:0008270; GO:0016567; GO:0051603; GO:0051604; GO:0061630,protein maturation [GO:0051604]; protein ubiquitination [GO:0016567]; proteolysis involved in protein catabolic process [GO:0051603],cytoplasm [GO:0005737],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0051604; GO:0140096,"catalytic activity; transferase activity; protein maturation; catalytic activity, acting on a protein"
OG_02276,FUN_008755-T1,Peve_00036725,Pocillopora_meandrina_HIv1___RNAseq.g12713.t1a,three_way,39.9395,FUN_008755-T1,A4QUF0,,,,,22.7,216.0,4.2e-06,54.3,"sp|A4QUF0|PABP_PYRO7 Polyadenylate-binding protein, cytoplasmic and nuclear OS=Pyricularia oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) OX=242507 GN=PAB1 PE=3 SV=1",,,,,,
OG_02277,FUN_008768-T1,Peve_00036720,Pocillopora_meandrina_HIv1___RNAseq.g12705.t1,three_way,76.76466666666667,FUN_008768-T1,Q1LXK4,,,,,38.7,1047.0,7.500000000000001e-184,646.0,sp|Q1LXK4|M10B1_DANRE Putative helicase mov-10-B.1 OS=Danio rerio OX=7955 GN=mov10b.1 PE=2 SV=2,,,,,,
OG_02278,FUN_008769-T1,Peve_00036718,Pocillopora_meandrina_HIv1___RNAseq.g12704.t1,three_way,66.35966666666667,FUN_008769-T1,Q9JHZ4,GRAP1_RAT,,GRIP1-associated protein 1 (GRASP-1) [Cleaved into: GRASP-1 C-terminal chain (30kDa C-terminus form)],Rattus norvegicus (Rat),33.5,179.0,7.9e-18,94.4,sp|Q9JHZ4|GRAP1_RAT GRIP1-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Gripap1 PE=1 SV=1,GO:0005085; GO:0005654; GO:0005829; GO:0015031; GO:0030424; GO:0030425; GO:0035255; GO:0042734; GO:0042802; GO:0043025; GO:0055038; GO:0098685; GO:0098978; GO:0098998; GO:0099152; GO:0099158; GO:1903828; GO:1903910,"negative regulation of protein localization [GO:1903828]; negative regulation of receptor clustering [GO:1903910]; protein transport [GO:0015031]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158]",axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; presynaptic membrane [GO:0042734]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685],guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255],GO:0005654; GO:0005829; GO:0098772,nucleoplasm; cytosol; molecular function regulator activity
OG_02279,FUN_008771-T1,Peve_00036717,Pocillopora_meandrina_HIv1___RNAseq.g12703.t1,three_way,83.727,FUN_008771-T1,Q95LL3,,,,,53.3,510.0,1.5e-138,494.6,sp|Q95LL3|TB22B_MACFA TBC1 domain family member 22B OS=Macaca fascicularis OX=9541 GN=TBC1D22B PE=2 SV=1,,,,,,
OG_02280,FUN_008772-T1,Peve_00036716,Pocillopora_meandrina_HIv1___RNAseq.g12702.t1,three_way,55.00416666666666,FUN_008772-T1,P30974,,,,,26.0,412.0,1.6e-18,95.9,sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2,,,,,,
OG_02281,FUN_008776-T1,Peve_00036712,Pocillopora_meandrina_HIv1___RNAseq.g12696.t1,three_way,60.681666666666665,FUN_008776-T1,P52703,,,,,21.1,380.0,1.2e-10,69.3,sp|P52703|DRD3_CHLAE D(3) dopamine receptor OS=Chlorocebus aethiops OX=9534 GN=DRD3 PE=2 SV=1,,,,,,
OG_02282,FUN_008778-T1,Peve_00036709,Pocillopora_meandrina_HIv1___RNAseq.g12697.t1,three_way,60.762,FUN_008778-T1,F1R332,,,,,28.5,337.0,5.8e-20,100.1,sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2,,,,,,
OG_02283,FUN_008780-T1,Peve_00042607,Pocillopora_meandrina_HIv1___RNAseq.g12692.t1,three_way,65.86266666666667,FUN_008780-T1,Q9BRU9,UTP23_HUMAN,,rRNA-processing protein UTP23 homolog,Homo sapiens (Human),42.3,196.0,2.1e-36,154.1,sp|Q9BRU9|UTP23_HUMAN rRNA-processing protein UTP23 homolog OS=Homo sapiens OX=9606 GN=UTP23 PE=1 SV=2,GO:0000480; GO:0003723; GO:0003730; GO:0005730; GO:0032040; GO:0048027; GO:0070181,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]",nucleolus [GO:0005730]; small-subunit processome [GO:0032040],mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181],GO:0003723; GO:0005730; GO:0043226,RNA binding; nucleolus; organelle
OG_02284,FUN_008781-T1,Peve_00042606,Pocillopora_meandrina_HIv1___RNAseq.g12693.t1,three_way,80.42633333333333,,,,,,,,,,,,,,,,,
OG_02285,FUN_008791-T1,Peve_00042603,Pocillopora_meandrina_HIv1___RNAseq.g12694.t1,three_way,75.31266666666667,FUN_008791-T1,Q08BB2,P2012_DANRE,,N-fatty-acyl-amino acid synthase/hydrolase PM20D1.2 (EC 3.5.1.114) (EC 3.5.1.14) (Peptidase M20 domain-containing protein 1.2),Danio rerio (Zebrafish) (Brachydanio rerio),45.3,444.0,2.6e-115,417.2,sp|Q08BB2|P2012_DANRE N-fatty-acyl-amino acid synthase/hydrolase PM20D1.2 OS=Danio rerio OX=7955 GN=pm20d1.2 PE=2 SV=1,GO:0004046; GO:0004181; GO:0005615; GO:0006508; GO:0006520; GO:0006629; GO:0006631; GO:0016811; GO:0016829; GO:0022904; GO:0043604; GO:0043605; GO:0046872; GO:0097009; GO:1990845,adaptive thermogenesis [GO:1990845]; amide biosynthetic process [GO:0043604]; amide catabolic process [GO:0043605]; amino acid metabolic process [GO:0006520]; energy homeostasis [GO:0097009]; fatty acid metabolic process [GO:0006631]; lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; respiratory electron transport chain [GO:0022904],extracellular space [GO:0005615],"aminoacylase activity [GO:0004046]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]",GO:0003824; GO:0005615; GO:0006091; GO:0006520; GO:0006629; GO:0016787; GO:0016829; GO:0140096,"catalytic activity; extracellular space; generation of precursor metabolites and energy; amino acid metabolic process; lipid metabolic process; hydrolase activity; lyase activity; catalytic activity, acting on a protein"
OG_02286,FUN_008792-T3,Peve_00042602,Pocillopora_meandrina_HIv1___RNAseq.g12689.t1,three_way,64.93566666666666,FUN_008792-T3,P13676,,,,,41.8,728.0,1.2e-156,555.1,sp|P13676|ACPH_RAT Acylamino-acid-releasing enzyme OS=Rattus norvegicus OX=10116 GN=Apeh PE=1 SV=1,,,,,,
OG_02287,FUN_008794-T1,Peve_00042601,Pocillopora_meandrina_HIv1___RNAseq.g12688.t1,three_way,83.54666666666667,FUN_008794-T1,Q9EQX9,UBE2N_RAT,,Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (Bendless-like ubiquitin-conjugating enzyme) (E2 ubiquitin-conjugating enzyme N) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N),Rattus norvegicus (Rat),85.7,147.0,3.8999999999999995e-68,258.8,sp|Q9EQX9|UBE2N_RAT Ubiquitin-conjugating enzyme E2 N OS=Rattus norvegicus OX=10116 GN=Ube2n PE=1 SV=1,GO:0000151; GO:0000209; GO:0000724; GO:0000729; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006301; GO:0006511; GO:0006513; GO:0016567; GO:0031371; GO:0031372; GO:0031625; GO:0032991; GO:0043123; GO:0043130; GO:0043161; GO:0045739; GO:0050852; GO:0061631; GO:0070534; GO:0097027; GO:0098794; GO:0098978; GO:0140252; GO:0140374; GO:1902523; GO:1902533; GO:1904262; GO:2000781,antiviral innate immune response [GO:0140374]; DNA double-strand break processing [GO:0000729]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation protein catabolic process at postsynapse [GO:0140252]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0006310; GO:0016740; GO:0030163; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; DNA repair; DNA recombination; transferase activity; protein catabolic process; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02288,FUN_008795-T1,Peve_00042598,Pocillopora_meandrina_HIv1___RNAseq.g12685.t1a,three_way,70.187,FUN_008795-T1,Q8IYQ7,,,,,47.4,685.0,3.8e-168,593.2,sp|Q8IYQ7|THNS1_HUMAN Threonine synthase-like 1 OS=Homo sapiens OX=9606 GN=THNSL1 PE=1 SV=2,,,,,,
OG_02289,FUN_008798-T1,Peve_00042590,Pocillopora_meandrina_HIv1___RNAseq.g54.t1,three_way,49.41266666666667,,,,,,,,,,,,,,,,,
OG_02290,FUN_008802-T1,Peve_00034042,Pocillopora_meandrina_HIv1___RNAseq.g25.t1,three_way,61.15833333333333,FUN_008802-T1,Q58588,,,,,20.7,367.0,1.6e-13,79.0,sp|Q58588|Y1187_METJA Uncharacterized protein MJ1187 OS=Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) OX=243232 GN=MJ1187 PE=1 SV=1,,,,,,
OG_02291,FUN_008858-T1,Peve_00002939,Pocillopora_meandrina_HIv1___TS.g25452.t1,three_way,61.41666666666667,,,,,,,,,,,,,,,,,
OG_02292,FUN_008860-T1,Peve_00002936,Pocillopora_meandrina_HIv1___RNAseq.g30.t1,three_way,63.93383333333333,FUN_008860-T1,Q96M96,,,,,41.2,556.0,2.9e-110,401.4,"sp|Q96M96|FGD4_HUMAN FYVE, RhoGEF and PH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FGD4 PE=1 SV=2",,,,,,
OG_02293,FUN_008871-T1,Peve_00000781,Pocillopora_meandrina_HIv1___RNAseq.g4009.t1,three_way,72.09516666666667,FUN_008871-T1,Q5RID7,,,,,45.6,401.0,2.6000000000000002e-110,400.6,sp|Q5RID7|SNX17_DANRE Sorting nexin-17 OS=Danio rerio OX=7955 GN=snx17 PE=2 SV=1,,,,,,
OG_02294,FUN_008872-T1,Peve_00000784,Pocillopora_meandrina_HIv1___RNAseq.g4010.t1,three_way,45.396166666666666,,,,,,,,,,,,,,,,,
OG_02295,FUN_008873-T1,Peve_00000783,Pocillopora_meandrina_HIv1___RNAseq.g4014.t1,three_way,73.41233333333334,FUN_008873-T1,Q4V7N4,,,,,43.6,181.0,1.7e-33,144.1,sp|Q4V7N4|TMA16_XENLA Translation machinery-associated protein 16 OS=Xenopus laevis OX=8355 GN=tma16 PE=2 SV=1,,,,,,
OG_02296,FUN_008874-T1,Peve_00000786,Pocillopora_meandrina_HIv1___RNAseq.g4012.t1,three_way,67.04350000000001,,,,,,,,,,,,,,,,,
OG_02297,FUN_008876-T1,Peve_00028551,Pocillopora_meandrina_HIv1___RNAseq.g3984.t1,three_way,72.74733333333333,FUN_008876-T1,Q9QYC7,VKGC_MOUSE,,Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase),Mus musculus (Mouse),52.3,583.0,2e-180,634.0,sp|Q9QYC7|VKGC_MOUSE Vitamin K-dependent gamma-carboxylase OS=Mus musculus OX=10090 GN=Ggcx PE=1 SV=1,GO:0005788; GO:0005789; GO:0008488; GO:0042373; GO:0046929; GO:0051604; GO:1903011; GO:2000225,negative regulation of bone development [GO:1903011]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of testosterone biosynthetic process [GO:2000225]; protein maturation [GO:0051604]; vitamin K metabolic process [GO:0042373],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],gamma-glutamyl carboxylase activity [GO:0008488],GO:0003824; GO:0016829; GO:0051604,catalytic activity; lyase activity; protein maturation
OG_02298,FUN_008877-T1,Peve_00043352,Pocillopora_meandrina_HIv1___TS.g30031.t1,three_way,72.87216666666667,FUN_008877-T1,Q8IZQ1,WDFY3_HUMAN,,WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy),Homo sapiens (Human),36.1,2785.0,0.0,1567.7,sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2,GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204,aggrephagy [GO:0035973],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605],1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270],GO:0005635; GO:0005654; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006914; GO:0008289; GO:0043226,nuclear envelope; nucleoplasm; nucleolus; vacuole; cytosol; plasma membrane; autophagy; lipid binding; organelle
OG_02299,FUN_008878-T1,Peve_00043353,Pocillopora_meandrina_HIv1___TS.g30034.t1,three_way,62.21333333333333,FUN_008878-T1,A7RDN6,RNLS_MOUSE,,Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C) (mMAO-C),Mus musculus (Mouse),39.9,351.0,1.3e-66,255.0,sp|A7RDN6|RNLS_MOUSE Renalase OS=Mus musculus OX=10090 GN=Rnls PE=1 SV=2,GO:0003073; GO:0003214; GO:0005576; GO:0016491; GO:0016651; GO:0042414; GO:0042415; GO:0042417; GO:0055062; GO:0060047; GO:0071873,cardiac left ventricle morphogenesis [GO:0003214]; dopamine metabolic process [GO:0042417]; epinephrine metabolic process [GO:0042414]; heart contraction [GO:0060047]; norepinephrine metabolic process [GO:0042415]; phosphate ion homeostasis [GO:0055062]; regulation of systemic arterial blood pressure [GO:0003073]; response to norepinephrine [GO:0071873],extracellular region [GO:0005576],"oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]",GO:0003013; GO:0003824; GO:0005576; GO:0016491,circulatory system process; catalytic activity; extracellular region; oxidoreductase activity
OG_02300,FUN_008879-T1,Peve_00043354,Pocillopora_meandrina_HIv1___RNAseq.g14471.t1,three_way,77.52583333333332,FUN_008879-T1,O93310,,,,,39.9,642.0,2.8e-79,297.7,sp|O93310|RAD21_XENLA Double-strand-break repair protein rad21 homolog OS=Xenopus laevis OX=8355 GN=rad21 PE=1 SV=1,,,,,,
OG_02301,FUN_008880-T1,Peve_00032863,Pocillopora_meandrina_HIv1___RNAseq.g14470.t1,three_way,69.333,,,,,,,,,,,,,,,,,
OG_02302,FUN_008881-T1,Peve_00032861,Pocillopora_meandrina_HIv1___RNAseq.g14469.t1,three_way,94.62233333333332,FUN_008881-T1,Q96DI7,SNR40_HUMAN,,U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57),Homo sapiens (Human),68.7,345.0,7.6e-96,352.1,sp|Q96DI7|SNR40_HUMAN U5 small nuclear ribonucleoprotein 40 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP40 PE=1 SV=1,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0005732; GO:0005829; GO:0006396; GO:0008380; GO:0016607; GO:0046540; GO:0071007; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; cytosol; mRNA metabolic process; organelle
OG_02303,FUN_008882-T1,Peve_00032041,Pocillopora_meandrina_HIv1___RNAseq.g14468.t1,three_way,62.712,FUN_008882-T1,Q32KN7,,,,,41.7,192.0,3.3e-26,120.9,sp|Q32KN7|ZC21B_BOVIN Zinc finger C2HC domain-containing protein 1B OS=Bos taurus OX=9913 GN=ZC2HC1B PE=2 SV=1,,,,,,
OG_02304,FUN_008883-T1,Peve_00000778,Pocillopora_meandrina_HIv1___RNAseq.g4008.t1,three_way,80.12833333333333,FUN_008883-T1,Q15084,,,,,59.1,440.0,3.5999999999999996e-151,536.2,sp|Q15084|PDIA6_HUMAN Protein disulfide-isomerase A6 OS=Homo sapiens OX=9606 GN=PDIA6 PE=1 SV=1,,,,,,
OG_02305,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,42.3,137.0,2.1e-31,140.2,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_02305,FUN_008884-T1,Peve_00000789,Pocillopora_meandrina_HIv1___RNAseq.g4007.t1,three_way,51.95433333333333,FUN_008884-T1,Q8CCJ9,,,,,46.9,128.0,2.5e-29,133.3,sp|Q8CCJ9|P20L1_MOUSE PHD finger protein 20-like protein 1 OS=Mus musculus OX=10090 GN=Phf20l1 PE=1 SV=2,,,,,,
OG_02306,FUN_008885-T1,Peve_00000788,Pocillopora_meandrina_HIv1___RNAseq.g4006.t1,three_way,70.33433333333333,FUN_008885-T1,P23906,,,,,53.2,109.0,1.4e-32,141.4,sp|P23906|IRF2_MOUSE Interferon regulatory factor 2 OS=Mus musculus OX=10090 GN=Irf2 PE=1 SV=1,,,,,,
OG_02307,FUN_008886-T1,Peve_00000787,Pocillopora_meandrina_HIv1___RNAseq.g4005.t1,three_way,34.86216666666667,,,,,,,,,,,,,,,,,
OG_02308,FUN_008887-T1,Peve_00000779,Pocillopora_meandrina_HIv1___RNAseq.g4004.t1,three_way,73.50366666666666,FUN_008887-T1,Q0VD32,CRBL2_BOVIN,,cAMP-responsive element-binding protein-like 2,Bos taurus (Bovine),61.9,84.0,8.4e-21,101.7,sp|Q0VD32|CRBL2_BOVIN cAMP-responsive element-binding protein-like 2 OS=Bos taurus OX=9913 GN=CREBL2 PE=1 SV=1,GO:0003677; GO:0003700; GO:0005634; GO:0006355; GO:0016604; GO:0030154; GO:0033138; GO:0045600; GO:0045893; GO:0046326; GO:0046889; GO:0050821,cell differentiation [GO:0030154]; positive regulation of D-glucose import [GO:0046326]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355],nuclear body [GO:0016604]; nucleus [GO:0005634],DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_02309,FUN_008889-T1,Peve_00020945,Pocillopora_meandrina_HIv1___RNAseq.g4003.t1,three_way,51.47683333333334,FUN_008889-T1,D3Z8E6,CAMP1_RAT,,Calmodulin-regulated spectrin-associated protein 1,Rattus norvegicus (Rat),43.7,142.0,7.000000000000001e-32,142.1,sp|D3Z8E6|CAMP1_RAT Calmodulin-regulated spectrin-associated protein 1 OS=Rattus norvegicus OX=10116 GN=Camsap1 PE=1 SV=2,GO:0000226; GO:0005516; GO:0005737; GO:0005874; GO:0007010; GO:0007026; GO:0008017; GO:0022604; GO:0030507; GO:0031113; GO:0031122; GO:0031175; GO:0036449; GO:0051011,cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule minus-end [GO:0036449],calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507],GO:0007010; GO:0008092,cytoskeleton organization; cytoskeletal protein binding
OG_02310,FUN_008890-T1,Peve_00020949,Pocillopora_meandrina_HIv1___TS.g30044.t1,three_way,46.27166666666667,,,,,,,,,,,,,,,,,
OG_02311,FUN_008898-T1,Peve_00041461,Pocillopora_meandrina_HIv1___RNAseq.g3963.t1,three_way,52.316500000000005,FUN_008898-T1,Q2EMV9,PAR14_MOUSE,,Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14),Mus musculus (Mouse),31.0,775.0,1.8e-87,326.6,sp|Q2EMV9|PAR14_MOUSE Protein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3,GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0045087; GO:0060336; GO:0140807; GO:1902216; GO:1990404,innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_02312,FUN_008903-T1,Peve_00013993,Pocillopora_meandrina_HIv1___RNAseq.g4000.t1,three_way,73.99,FUN_008903-T1,Q9VU77,JMJD7_DROME,,Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 (EC 1.14.11.63) (EC 3.4.-.-) (Jumonji domain containing protein 7),Drosophila melanogaster (Fruit fly),29.7,296.0,2.5e-29,131.3,sp|Q9VU77|JMJD7_DROME Bifunctional peptidase and (3S)-lysyl hydroxylase JMJD7 OS=Drosophila melanogaster OX=7227 GN=JMJD7 PE=1 SV=1,GO:0004175; GO:0005634; GO:0005737; GO:0008198; GO:0016706; GO:0042802; GO:0048512; GO:0106155,circadian behavior [GO:0048512],cytoplasm [GO:0005737]; nucleus [GO:0005634],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; endopeptidase activity [GO:0004175]; ferrous iron binding [GO:0008198]; identical protein binding [GO:0042802]; peptidyl-lysine 3-dioxygenase activity [GO:0106155],GO:0003824; GO:0005634; GO:0016491; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; oxidoreductase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02313,FUN_008904-T1,Peve_00013985,Pocillopora_meandrina_HIv1___RNAseq.g4001.t1,three_way,69.22716666666668,FUN_008904-T1,P14198,,,,,37.4,155.0,5.7e-14,79.3,sp|P14198|AAC4_DICDI AAC-rich mRNA clone AAC4 protein OS=Dictyostelium discoideum OX=44689 GN=AAC4 PE=2 SV=3,,,,,,
OG_02314,FUN_008905-T1,Peve_00002351,Pocillopora_meandrina_HIv1___RNAseq.g3969.t1,three_way,81.32466666666667,FUN_008905-T1,Q8BVE3,,,,,47.0,330.0,6.3e-81,302.4,sp|Q8BVE3|VATH_MOUSE V-type proton ATPase subunit H OS=Mus musculus OX=10090 GN=Atp6v1h PE=1 SV=1,,,,,,
OG_02315,FUN_008906-T1,Peve_00027550,Pocillopora_meandrina_HIv1___RNAseq.g3970.t1,three_way,79.61966666666666,FUN_008906-T1,Q96MD2,KICS2_HUMAN,,KICSTOR subunit 2 (KICSTOR complex protein C12orf66),Homo sapiens (Human),45.2,418.0,2.3e-100,367.5,sp|Q96MD2|KICS2_HUMAN KICSTOR subunit 2 OS=Homo sapiens OX=9606 GN=KICS2 PE=1 SV=5,GO:0005764; GO:0005765; GO:0034198; GO:0042149; GO:0045171; GO:0061462; GO:0140007; GO:1904262,cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462],intercellular bridge [GO:0045171]; KICSTOR complex [GO:0140007]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],,GO:0005764; GO:0005773; GO:0043226,lysosome; vacuole; organelle
OG_02316,FUN_008907-T1,Peve_00027548,Pocillopora_meandrina_HIv1___RNAseq.g3972.t1,three_way,56.05233333333333,FUN_008907-T1,Q8CH34,ZP4_RAT,,Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4) (Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4],Rattus norvegicus (Rat),27.7,332.0,4.3e-14,80.5,sp|Q8CH34|ZP4_RAT Zona pellucida sperm-binding protein 4 OS=Rattus norvegicus OX=10116 GN=Zp4 PE=2 SV=1,GO:0002922; GO:0005576; GO:0005886; GO:0007339; GO:0032190; GO:0035804; GO:0035805; GO:0042102; GO:0042802; GO:0060468; GO:0060478; GO:0062023; GO:2000344; GO:2000360,acrosomal vesicle exocytosis [GO:0060478]; binding of sperm to zona pellucida [GO:0007339]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of humoral immune response [GO:0002922]; positive regulation of T cell proliferation [GO:0042102]; prevention of polyspermy [GO:0060468],collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],acrosin binding [GO:0032190]; identical protein binding [GO:0042802]; structural constituent of egg coat [GO:0035804],GO:0005198; GO:0005576; GO:0005886; GO:0016192; GO:0030312; GO:0031012,structural molecule activity; extracellular region; plasma membrane; vesicle-mediated transport; external encapsulating structure; extracellular matrix
OG_02317,FUN_008908-T1,Peve_00017912,Pocillopora_meandrina_HIv1___TS.g30016.t1,three_way,61.309333333333335,FUN_008908-T1,G8HTB6,,,,,95.7,349.0,1.3e-187,657.1,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02318,FUN_008909-T1,Peve_00017911,Pocillopora_meandrina_HIv1___RNAseq.g3974.t1,three_way,62.283166666666666,FUN_008909-T1,Q9EQZ7,,,,,32.2,1005.0,1.6e-93,346.7,sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1,,,,,,
OG_02319,FUN_008911-T1,Peve_00019472,Pocillopora_meandrina_HIv1___RNAseq.g3976.t1,three_way,68.34216666666667,FUN_008911-T1,O60266,ADCY3_HUMAN,,"Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3)",Homo sapiens (Human),39.5,1100.0,4.3e-204,713.4,sp|O60266|ADCY3_HUMAN Adenylate cyclase type 3 OS=Homo sapiens OX=9606 GN=ADCY3 PE=1 SV=3,GO:0004016; GO:0005516; GO:0005524; GO:0005737; GO:0005794; GO:0005886; GO:0005929; GO:0006171; GO:0007165; GO:0007189; GO:0007338; GO:0007340; GO:0007608; GO:0008355; GO:0016020; GO:0030317; GO:0035556; GO:0046872; GO:0060170; GO:1904322,acrosome reaction [GO:0007340]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; flagellated sperm motility [GO:0030317]; intracellular signal transduction [GO:0035556]; olfactory learning [GO:0008355]; sensory perception of smell [GO:0007608]; signal transduction [GO:0007165]; single fertilization [GO:0007338],ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886],adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0005886; GO:0005929; GO:0007018; GO:0009975; GO:0016829; GO:0022414; GO:0043226; GO:0048870; GO:0050877; GO:0055086; GO:1901135,catalytic activity; Golgi apparatus; plasma membrane; cilium; microtubule-based movement; cyclase activity; lyase activity; reproductive process; organelle; cell motility; nervous system process; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02320,FUN_008912-T1,Peve_00033001,Pocillopora_meandrina_HIv1___RNAseq.g3977.t1,three_way,63.34133333333334,,,,,,,,,,,,,,,,,
OG_02321,FUN_008913-T1,Peve_00033015,Pocillopora_meandrina_HIv1___RNAseq.g3978.t1,three_way,86.956,FUN_008913-T1,Q56K14,RLA1_BOVIN,,Large ribosomal subunit protein P1 (60S acidic ribosomal protein P1),Bos taurus (Bovine),67.7,65.0,1.8e-17,90.1,sp|Q56K14|RLA1_BOVIN Large ribosomal subunit protein P1 OS=Bos taurus OX=9913 GN=RPLP1 PE=3 SV=1,GO:0002181; GO:0003735; GO:0006414; GO:0022625; GO:0030295; GO:0043021,cytoplasmic translation [GO:0002181]; translational elongation [GO:0006414],cytosolic large ribosomal subunit [GO:0022625],protein kinase activator activity [GO:0030295]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0098772,cytoplasmic translation; structural molecule activity; molecular function regulator activity
OG_02322,FUN_008914-T1,Peve_00033017,Pocillopora_meandrina_HIv1___TS.g30021.t1,three_way,89.15066666666667,FUN_008914-T1,Q9UJT0,,,,,67.3,477.0,2.1999999999999998e-189,663.3,sp|Q9UJT0|TBE_HUMAN Tubulin epsilon chain OS=Homo sapiens OX=9606 GN=TUBE1 PE=1 SV=1,,,,,,
OG_02323,FUN_008915-T1,Peve_00033002,Pocillopora_meandrina_HIv1___RNAseq.g3980.t1,three_way,93.944,FUN_008915-T1,P58375,,,,,80.4,112.0,2.2e-45,183.0,sp|P58375|RL30_SPOFR Large ribosomal subunit protein eL30 OS=Spodoptera frugiperda OX=7108 GN=RpL30 PE=3 SV=1,,,,,,
OG_02324,FUN_008916-T1,Peve_00033003,Pocillopora_meandrina_HIv1___RNAseq.g3981.t1,three_way,69.72566666666667,FUN_008916-T1,Q8JHF4,,,,,30.0,120.0,1.1e-07,59.3,sp|Q8JHF4|PAL1A_DANRE Protein PALS1 OS=Danio rerio OX=7955 GN=pals1a PE=1 SV=2,,,,,,
OG_02325,FUN_008917-T1,Peve_00033005,Pocillopora_meandrina_HIv1___RNAseq.g3982.t1,three_way,74.89333333333333,FUN_008917-T1,Q6V5K9,,,,,46.8,269.0,1e-59,232.6,sp|Q6V5K9|ZN474_MOUSE Zinc finger protein 474 OS=Mus musculus OX=10090 GN=Znf474 PE=2 SV=2,,,,,,
OG_02326,FUN_008918-T2,Peve_00033006,Pocillopora_meandrina_HIv1___TS.g30030.t1,three_way,71.68133333333333,FUN_008918-T2,Q78KK3,,,,,40.6,389.0,7.000000000000001e-75,282.7,sp|Q78KK3|S67A1_MOUSE Solute carrier family 22 member 18 OS=Mus musculus OX=10090 GN=Slc67a1 PE=1 SV=2,,,,,,
OG_02327,FUN_008919-T1,Peve_00020782,Pocillopora_meandrina_HIv1___RNAseq.g3998.t1,three_way,71.58416666666666,FUN_008919-T1,Q5R7U7,,,,,42.5,537.0,3.1000000000000004e-104,380.6,sp|Q5R7U7|DCTN4_PONAB Dynactin subunit 4 OS=Pongo abelii OX=9601 GN=DCTN4 PE=2 SV=1,,,,,,
OG_02328,FUN_008921-T1,Peve_00006943,Pocillopora_meandrina_HIv1___TS.g30078.t1,three_way,78.52199999999999,FUN_008921-T1,F1PCT7,,,,,39.1,591.0,6.2e-114,412.9,sp|F1PCT7|RPN2_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 OS=Canis lupus familiaris OX=9615 GN=RPN2 PE=1 SV=3,,,,,,
OG_02329,FUN_008922-T1,Peve_00006942,Pocillopora_meandrina_HIv1___RNAseq.g4040.t1,three_way,58.734,,,,,,,,,,,,,,,,,
OG_02330,FUN_008923-T1,Peve_00006941,Pocillopora_meandrina_HIv1___RNAseq.g4041.t1,three_way,53.84133333333333,,,,,,,,,,,,,,,,,
OG_02331,FUN_008924-T1,Peve_00028630,Pocillopora_meandrina_HIv1___RNAseq.g14267.t1,three_way,80.87533333333333,FUN_008924-T1,O76756,,,,,75.1,209.0,9.5e-86,317.8,sp|O76756|RS8_APIME Small ribosomal subunit protein eS8 OS=Apis mellifera OX=7460 GN=RpS8 PE=2 SV=2,,,,,,
OG_02332,FUN_008927-T1,Peve_00036396,Pocillopora_meandrina_HIv1___RNAseq.g4036.t1,three_way,85.159,FUN_008927-T1,Q6P268,PDCL3_DANRE,,Phosducin-like protein 3 (Viral IAP-associated factor 1 homolog),Danio rerio (Zebrafish) (Brachydanio rerio),52.8,248.0,2e-63,243.8,sp|Q6P268|PDCL3_DANRE Phosducin-like protein 3 OS=Danio rerio OX=7955 GN=pdcl3 PE=2 SV=1,GO:0001525; GO:0005737; GO:0005783; GO:0006457; GO:0006915; GO:0010628; GO:0043184; GO:0044183; GO:0048471,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; positive regulation of gene expression [GO:0010628]; protein folding [GO:0006457],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],protein folding chaperone [GO:0044183]; vascular endothelial growth factor receptor 2 binding [GO:0043184],GO:0005783; GO:0006457; GO:0012501; GO:0043226; GO:0044183,endoplasmic reticulum; protein folding; programmed cell death; organelle; protein folding chaperone
OG_02333,FUN_008928-T1,Peve_00036394,Pocillopora_meandrina_HIv1___RNAseq.g4037.t1,three_way,51.568333333333335,FUN_008928-T1,O43320,FGF16_HUMAN,,Fibroblast growth factor 16 (FGF-16),Homo sapiens (Human),39.1,128.0,1.2e-16,88.2,sp|O43320|FGF16_HUMAN Fibroblast growth factor 16 OS=Homo sapiens OX=9606 GN=FGF16 PE=1 SV=1,GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008284; GO:0008543; GO:0009266; GO:0009887; GO:0022008; GO:0030334; GO:0043410; GO:2000546,animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; neurogenesis [GO:0022008]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell migration [GO:0030334]; response to temperature stimulus [GO:0009266]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083],GO:0005576; GO:0005615; GO:0023052; GO:0030154; GO:0048018; GO:0098772,extracellular region; extracellular space; signaling; cell differentiation; receptor ligand activity; molecular function regulator activity
OG_02334,FUN_008929-T1,Peve_00036393,Pocillopora_meandrina_HIv1___RNAseq.g4038.t1,three_way,35.83316666666667,,,,,,,,,,,,,,,,,
OG_02335,FUN_008930-T1,Peve_00036392,Pocillopora_meandrina_HIv1___RNAseq.g14260.t1,three_way,86.96233333333333,FUN_008930-T1,Q9H5Z1,DHX35_HUMAN,,Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35),Homo sapiens (Human),65.6,677.0,2.9e-259,896.0,sp|Q9H5Z1|DHX35_HUMAN Probable ATP-dependent RNA helicase DHX35 OS=Homo sapiens OX=9606 GN=DHX35 PE=1 SV=2,GO:0000398; GO:0001701; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005654; GO:0016887; GO:0071013,"in utero embryonic development [GO:0001701]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005654; GO:0016071; GO:0016787; GO:0016853; GO:0048856; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleoplasm; mRNA metabolic process; hydrolase activity; isomerase activity; anatomical structure development; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02336,FUN_008931-T1,Peve_00036391,Pocillopora_meandrina_HIv1___RNAseq.g14259.t1,three_way,74.031,FUN_008931-T1,Q8BSY0,ASPH_MOUSE,,Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase),Mus musculus (Mouse),55.5,429.0,5.6e-143,509.2,sp|Q8BSY0|ASPH_MOUSE Aspartyl/asparaginyl beta-hydroxylase OS=Mus musculus OX=10090 GN=Asph PE=1 SV=1,GO:0005737; GO:0005886; GO:0007389; GO:0008283; GO:0008285; GO:0016020; GO:0031647; GO:0032541; GO:0033017; GO:0035108; GO:0045862; GO:0046872; GO:0060021; GO:0060325; GO:0062101; GO:1901879,cell population proliferation [GO:0008283]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; positive regulation of proteolysis [GO:0045862]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; roof of mouth development [GO:0060021],cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017],metal ion binding [GO:0046872]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101],GO:0003824; GO:0005886; GO:0016491; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; oxidoreductase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_02337,FUN_008933-T1,Peve_00036390,Pocillopora_meandrina_HIv1___RNAseq.g14258.t1,three_way,90.02433333333333,FUN_008933-T1,A6QQY2,,,,,39.1,92.0,1.2e-09,65.5,sp|A6QQY2|KLH13_BOVIN Kelch-like protein 13 OS=Bos taurus OX=9913 GN=KLHL13 PE=2 SV=1,,,,,,
OG_02338,FUN_008934-T1,Peve_00036402,Pocillopora_meandrina_HIv1___RNAseq.g14257.t1,three_way,76.08966666666667,FUN_008934-T1,A5D7I4,EXT1_BOVIN,,Exostosin-1 (EC 2.4.1.225) (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase),Bos taurus (Bovine),50.3,749.0,7.999999999999999e-217,755.0,sp|A5D7I4|EXT1_BOVIN Exostosin-1 OS=Bos taurus OX=9913 GN=EXT1 PE=2 SV=1,GO:0000139; GO:0000271; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005783; GO:0005789; GO:0005794; GO:0006024; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0010803; GO:0014033; GO:0015012; GO:0015020; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1902494; GO:1904888; GO:1990823,"antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; glycosaminoglycan biosynthetic process [GO:0006024]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal-level water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; polysaccharide biosynthetic process [GO:0000271]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]",catalytic complex [GO:1902494]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; synapse [GO:0045202],acetylglucosaminyltransferase activity [GO:0008375]; glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0050508]; glucuronosyltransferase activity [GO:0015020]; metal ion binding [GO:0046872]; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity [GO:0050509]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003013; GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006790; GO:0006954; GO:0007155; GO:0009101; GO:0016740; GO:0023052; GO:0030154; GO:0030163; GO:0030198; GO:0034330; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:1901135,immune system process; circulatory system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; sulfur compound metabolic process; inflammatory response; cell adhesion; glycoprotein biosynthetic process; transferase activity; signaling; cell differentiation; protein catabolic process; extracellular matrix organization; cell junction organization; wound healing; organelle; anatomical structure development; cell motility; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_02339,FUN_008935-T1,Peve_00036395,Pocillopora_meandrina_HIv1___TS.g5740.t1,three_way,79.28566666666667,FUN_008935-T1,A0JM56,,,,,51.8,1431.0,1.4000000000000001e-186,655.6,sp|A0JM56|LRRC9_XENTR Leucine-rich repeat-containing protein 9 OS=Xenopus tropicalis OX=8364 GN=lrrc9 PE=2 SV=2,,,,,,
OG_02340,FUN_008938-T1,Peve_00007199,Pocillopora_meandrina_HIv1___RNAseq.g4080.t1,three_way,43.816833333333335,FUN_008938-T1,Q5F4A1,,,,,43.0,300.0,1.6000000000000001e-71,272.3,sp|Q5F4A1|G2E3_CHICK G2/M phase-specific E3 ubiquitin-protein ligase OS=Gallus gallus OX=9031 GN=G2E3 PE=2 SV=1,,,,,,
OG_02341,FUN_008940-T1,Peve_00007194,Pocillopora_meandrina_HIv1___TS.g30103.t1,three_way,71.29533333333333,FUN_008940-T1,P31422,GRM3_RAT,,Metabotropic glutamate receptor 3 (mGluR3),Rattus norvegicus (Rat),41.0,808.0,1.2999999999999998e-173,611.7,sp|P31422|GRM3_RAT Metabotropic glutamate receptor 3 OS=Rattus norvegicus OX=10116 GN=Grm3 PE=1 SV=1,GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170,"cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]",astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110],GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772,plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity
OG_02342,FUN_008943-T1,Peve_00007197,Pocillopora_meandrina_HIv1___RNAseq.g4061.t1,three_way,52.650666666666666,,,,,,,,,,,,,,,,,
OG_02343,FUN_008944-T1,Peve_00011189,Pocillopora_meandrina_HIv1___RNAseq.g4060.t1,three_way,64.23383333333334,FUN_008944-T1,Q6P0U3,,,,,31.3,211.0,1.6000000000000002e-23,112.1,sp|Q6P0U3|RSLBB_DANRE Ras-like protein family member 11B OS=Danio rerio OX=7955 GN=rasl11b PE=2 SV=1,,,,,,
OG_02344,FUN_008945-T3,Peve_00011190,Pocillopora_meandrina_HIv1___RNAseq.g4059.t1,three_way,61.92066666666667,FUN_008945-T3,Q3T1J2,MBOA2_RAT,,Membrane-bound glycerophospholipid O-acyltransferase 2 (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase) (LPAAT) (Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4) (Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophospholipid acyltransferase 2) (LPLAT 2) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2),Rattus norvegicus (Rat),40.0,407.0,2.3e-76,287.7,sp|Q3T1J2|MBOA2_RAT Membrane-bound glycerophospholipid O-acyltransferase 2 OS=Rattus norvegicus OX=10116 GN=Mboat2 PE=2 SV=2,GO:0003841; GO:0005789; GO:0008654; GO:0016020; GO:0016746; GO:0030258; GO:0032330; GO:0036150; GO:0036151; GO:0036152; GO:0047184; GO:0106262; GO:0106263,lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; acyltransferase activity [GO:0016746],GO:0003824; GO:0006575; GO:0006629; GO:0016740,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity
OG_02345,FUN_008946-T1,Peve_00011182,Pocillopora_meandrina_HIv1___TS.g30097.t1,three_way,63.37166666666667,FUN_008946-T1,Q6ZWT7,MBOA2_HUMAN,,Membrane-bound glycerophospholipid O-acyltransferase 2 (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase MBOAT2) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase MBOAT2) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine MBOAT2 O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase) (LPAAT) (Lyso-PA acyltransferase) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 4) (Lyso-PC acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophospholipid acyltransferase 2) (LPLAT 2) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2),Homo sapiens (Human),39.6,475.0,4.3e-92,340.1,sp|Q6ZWT7|MBOA2_HUMAN Membrane-bound glycerophospholipid O-acyltransferase 2 OS=Homo sapiens OX=9606 GN=MBOAT2 PE=1 SV=2,GO:0003841; GO:0005789; GO:0008654; GO:0016020; GO:0016746; GO:0030258; GO:0032330; GO:0036150; GO:0036151; GO:0036152; GO:0047144; GO:0047184; GO:0106262; GO:0106263,lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; regulation of chondrocyte differentiation [GO:0032330],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; acyltransferase activity [GO:0016746],GO:0003824; GO:0006575; GO:0006629; GO:0016740,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity
OG_02346,FUN_008947-T1,Peve_00011183,Pocillopora_meandrina_HIv1___RNAseq.g4057.t1,three_way,74.78516666666667,,,,,,,,,,,,,,,,,
OG_02347,FUN_008948-T1,Peve_00011184,Pocillopora_meandrina_HIv1___RNAseq.g4056.t1,three_way,58.87466666666667,,,,,,,,,,,,,,,,,
OG_02348,FUN_008949-T1,Peve_00011191,Pocillopora_meandrina_HIv1___RNAseq.g4054.t1,three_way,69.88833333333334,FUN_008949-T1,Q2TAA2,IAH1_HUMAN,,Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-),Homo sapiens (Human),38.6,233.0,6.6e-44,179.1,sp|Q2TAA2|IAH1_HUMAN Isoamyl acetate-hydrolyzing esterase 1 homolog OS=Homo sapiens OX=9606 GN=IAH1 PE=1 SV=1,GO:0010467; GO:0016042; GO:0016788; GO:0042802,gene expression [GO:0010467]; lipid catabolic process [GO:0016042],,"hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]",GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_02349,FUN_008950-T1,Peve_00004875,Pocillopora_meandrina_HIv1___RNAseq.g4053.t1,three_way,83.50966666666666,FUN_008950-T1,Q7T0Y4,,,,,44.0,753.0,1.2e-122,442.2,sp|Q7T0Y4|DRC1_XENLA Dynein regulatory complex protein 1 OS=Xenopus laevis OX=8355 GN=drc1 PE=2 SV=1,,,,,,
OG_02350,FUN_008951-T1,Peve_00008912,Pocillopora_meandrina_HIv1___RNAseq.29356_t,three_way,82.56166666666667,FUN_008951-T1,Q6IRP4,,,,,49.8,301.0,2.3e-82,307.4,sp|Q6IRP4|ABHDD_XENLA Protein ABHD13 OS=Xenopus laevis OX=8355 GN=abhd13 PE=2 SV=1,,,,,,
OG_02351,FUN_008952-T1,Peve_00037679,Pocillopora_meandrina_HIv1___RNAseq.g4051.t1,three_way,70.46833333333333,FUN_008952-T1,Q8TDM6,,,,,31.0,1363.0,9.8e-134,480.3,sp|Q8TDM6|DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4,,,,,,
OG_02352,FUN_008953-T2,Peve_00037684,Pocillopora_meandrina_HIv1___TS.g30089.t1,three_way,80.953,FUN_008953-T2,G5E8K5,ANK3_MOUSE,,Ankyrin-3 (ANK-3) (Ankyrin-G),Mus musculus (Mouse),36.2,624.0,2.2e-100,369.4,sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1,GO:0005764; GO:0005886; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043194; GO:0043266; GO:0044325; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0090314; GO:0098794; GO:0099103; GO:0099612; GO:1900827; GO:1902260,axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018],cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; transmembrane transporter binding [GO:0044325],GO:0005764; GO:0005773; GO:0005783; GO:0005856; GO:0005886; GO:0008092; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659; GO:0098772,lysosome; vacuole; endoplasmic reticulum; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane; molecular function regulator activity
OG_02352,FUN_008953-T2,Peve_00037684,Pocillopora_meandrina_HIv1___TS.g30089.t1,three_way,80.953,FUN_008953-T2,G5E8K5,ANK3_MOUSE,,Ankyrin-3 (ANK-3) (Ankyrin-G),Mus musculus (Mouse),57.1,42.0,3.5e-05,53.1,sp|G5E8K5|ANK3_MOUSE Ankyrin-3 OS=Mus musculus OX=10090 GN=Ank3 PE=1 SV=1,GO:0005764; GO:0005886; GO:0007165; GO:0007409; GO:0007411; GO:0007528; GO:0008092; GO:0009986; GO:0010628; GO:0010650; GO:0010765; GO:0010960; GO:0014069; GO:0014704; GO:0014731; GO:0016020; GO:0016529; GO:0017080; GO:0019228; GO:0030018; GO:0030315; GO:0030424; GO:0030425; GO:0030507; GO:0030674; GO:0031594; GO:0033268; GO:0033270; GO:0034112; GO:0042383; GO:0043194; GO:0043266; GO:0044325; GO:0045202; GO:0045211; GO:0045296; GO:0045760; GO:0045838; GO:0050808; GO:0071286; GO:0071709; GO:0072659; GO:0090314; GO:0098794; GO:0099103; GO:0099612; GO:1900827; GO:1902260,axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; positive regulation of action potential [GO:0045760]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018],cadherin binding [GO:0045296]; channel activator activity [GO:0099103]; cytoskeletal protein binding [GO:0008092]; protein-macromolecule adaptor activity [GO:0030674]; sodium channel regulator activity [GO:0017080]; spectrin binding [GO:0030507]; transmembrane transporter binding [GO:0044325],GO:0005764; GO:0005773; GO:0005783; GO:0005856; GO:0005886; GO:0008092; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659; GO:0098772,lysosome; vacuole; endoplasmic reticulum; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane; molecular function regulator activity
OG_02353,FUN_008955-T1,Peve_00037682,Pocillopora_meandrina_HIv1___RNAseq.g4048.t1,three_way,75.81333333333333,FUN_008955-T1,Q149N8,,,,,35.5,1772.0,5.0000000000000005e-278,959.5,sp|Q149N8|SHPRH_HUMAN E3 ubiquitin-protein ligase SHPRH OS=Homo sapiens OX=9606 GN=SHPRH PE=1 SV=2,,,,,,
OG_02354,FUN_008956-T1,Peve_00021626,Pocillopora_meandrina_HIv1___RNAseq.g4047.t1,three_way,86.82350000000001,FUN_008956-T1,Q9NV58,,,,,68.9,360.0,7.5e-154,545.4,sp|Q9NV58|RN19A_HUMAN E3 ubiquitin-protein ligase RNF19A OS=Homo sapiens OX=9606 GN=RNF19A PE=1 SV=3,,,,,,
OG_02355,FUN_008958-T1,Peve_00021624,Pocillopora_meandrina_HIv1___RNAseq.g4045.t1,three_way,88.27633333333334,FUN_008958-T1,P36241,,,,,80.5,77.0,5.2e-27,121.7,sp|P36241|RL19_DROME Large ribosomal subunit protein eL19 OS=Drosophila melanogaster OX=7227 GN=RpL19 PE=1 SV=2,,,,,,
OG_02356,FUN_008959-T1,Peve_00021629,Pocillopora_meandrina_HIv1___RNAseq.g4044.t1,three_way,87.273,FUN_008959-T1,Q9UKD2,,,,,61.5,218.0,1.2e-78,294.3,sp|Q9UKD2|MRT4_HUMAN mRNA turnover protein 4 homolog OS=Homo sapiens OX=9606 GN=MRTO4 PE=1 SV=2,,,,,,
OG_02357,FUN_008960-T1,Peve_00021628,Pocillopora_meandrina_HIv1___RNAseq.g4043.t1,three_way,50.3,,,,,,,,,,,,,,,,,
OG_02358,FUN_008961-T1,Peve_00006948,Pocillopora_meandrina_HIv1___RNAseq.g4042.t1,three_way,60.446,,,,,,,,,,,,,,,,,
OG_02359,FUN_008962-T1,Peve_00007353,Pocillopora_meandrina_HIv1___RNAseq.g3914.t1,three_way,53.4015,FUN_008962-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),31.7,489.0,3.1e-54,214.9,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02360,FUN_008964-T1,Peve_00007334,Pocillopora_meandrina_HIv1___RNAseq.13698_t,three_way,63.264,FUN_008964-T1,Q8BKN5,,,,,34.9,1036.0,4.9e-148,526.9,sp|Q8BKN5|GCP5_MOUSE Gamma-tubulin complex component 5 OS=Mus musculus OX=10090 GN=Tubgcp5 PE=2 SV=2,,,,,,
OG_02361,FUN_008965-T1,Peve_00007333,Pocillopora_meandrina_HIv1___RNAseq.g14278.t1,three_way,81.40533333333333,,,,,,,,,,,,,,,,,
OG_02362,FUN_008967-T1,Peve_00007330,Pocillopora_meandrina_HIv1___RNAseq.g14273.t1,three_way,70.74066666666667,FUN_008967-T1,Q9UBI4,,,,,35.1,350.0,6.9e-45,183.0,sp|Q9UBI4|STML1_HUMAN Stomatin-like protein 1 OS=Homo sapiens OX=9606 GN=STOML1 PE=1 SV=1,,,,,,
OG_02363,FUN_008968-T1,Peve_00007329,Pocillopora_meandrina_HIv1___TS.g5755.t2,three_way,62.23483333333333,FUN_008968-T1,A8F4F7,,,,,34.1,211.0,5.5e-25,116.3,sp|A8F4F7|RL1_PSELT Large ribosomal subunit protein uL1 OS=Pseudothermotoga lettingae (strain ATCC BAA-301 / DSM 14385 / NBRC 107922 / TMO) OX=416591 GN=rplA PE=3 SV=1,,,,,,
OG_02364,FUN_008969-T1,Peve_00007346,Pocillopora_meandrina_HIv1___RNAseq.g14271.t1,three_way,68.706,FUN_008969-T1,Q9NWM8,FKB14_HUMAN,,Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (22 kDa FK506-binding protein) (22 kDa FKBP) (FKBP-22) (FK506-binding protein 14) (FKBP-14) (Rotamase),Homo sapiens (Human),43.3,194.0,6.7e-38,159.5,sp|Q9NWM8|FKB14_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP14 OS=Homo sapiens OX=9606 GN=FKBP14 PE=1 SV=1,GO:0003755; GO:0005509; GO:0005788,,endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0016853; GO:0140096,"catalytic activity; isomerase activity; catalytic activity, acting on a protein"
OG_02365,FUN_008972-T1,Peve_00025074,Pocillopora_meandrina_HIv1___RNAseq.g14268.t1,three_way,56.09883333333333,FUN_008972-T1,Q9BXT4,TDRD1_HUMAN,,Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1),Homo sapiens (Human),22.4,961.0,1.9e-35,153.3,sp|Q9BXT4|TDRD1_HUMAN Tudor domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TDRD1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_02366,FUN_008973-T1,Peve_00044338,Pocillopora_meandrina_HIv1___RNAseq.g3943.t1,three_way,66.187,FUN_008973-T1,P70057,,,,,37.0,573.0,1.6e-83,312.4,sp|P70057|KCNQ1_XENLA Potassium voltage-gated channel subfamily KQT member 1 OS=Xenopus laevis OX=8355 GN=kcnq1 PE=1 SV=2,,,,,,
OG_02367,FUN_008974-T1,Peve_00007753,Pocillopora_meandrina_HIv1___RNAseq.g3944.t1,three_way,88.335,FUN_008974-T1,Q803I2,,,,,65.2,356.0,1.8e-140,500.4,sp|Q803I2|ERGI3_DANRE Endoplasmic reticulum-Golgi intermediate compartment protein 3 OS=Danio rerio OX=7955 GN=ergic3 PE=2 SV=1,,,,,,
OG_02368,FUN_008977-T1,Peve_00007755,Pocillopora_meandrina_HIv1___TS.g30074.t1,three_way,58.336333333333336,,,,,,,,,,,,,,,,,
OG_02369,FUN_008978-T1,Peve_00017852,Pocillopora_meandrina_HIv1___RNAseq.g14265.t1,three_way,33.91433333333333,,,,,,,,,,,,,,,,,
OG_02370,FUN_008979-T1,Peve_00017853,Pocillopora_meandrina_HIv1___RNAseq.g14264.t1,three_way,94.62366666666668,FUN_008979-T1,Q9XT06,,,,,75.7,540.0,1.7e-230,800.0,sp|Q9XT06|TCPA_MONDO T-complex protein 1 subunit alpha OS=Monodelphis domestica OX=13616 GN=TCP1 PE=2 SV=1,,,,,,
OG_02371,FUN_008980-T1,Peve_00017855,Pocillopora_meandrina_HIv1___RNAseq.g3908.t1,three_way,81.208,FUN_008980-T1,Q5XI41,TRAM1_RAT,,Translocating chain-associated membrane protein 1 (Protein TRAM1),Rattus norvegicus (Rat),43.0,377.0,4e-79,296.6,sp|Q5XI41|TRAM1_RAT Translocating chain-associated membrane protein 1 OS=Rattus norvegicus OX=10116 GN=Tram1 PE=1 SV=3,GO:0005783; GO:0005789; GO:0006613; GO:0006616; GO:0006986; GO:0045048,"cotranslational protein targeting to membrane [GO:0006613]; protein insertion into ER membrane [GO:0045048]; response to unfolded protein [GO:0006986]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0005783; GO:0006886; GO:0043226; GO:0055085,endoplasmic reticulum; intracellular protein transport; organelle; transmembrane transport
OG_02372,FUN_008981-T1,Peve_00017856,Pocillopora_meandrina_HIv1___RNAseq.g3907.t1,three_way,83.092,FUN_008981-T1,Q9UK96,,,,,33.1,505.0,5.8e-66,254.2,sp|Q9UK96|FBX10_HUMAN F-box only protein 10 OS=Homo sapiens OX=9606 GN=FBXO10 PE=1 SV=3,,,,,,
OG_02373,FUN_008983-T1,Peve_00017858,Pocillopora_meandrina_HIv1___RNAseq.g3906.t1,three_way,57.8225,FUN_008983-T1,Q63187,ELOA1_RAT,,Elongin-A (EloA) (Elongin 110 kDa subunit) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110) (Transcription elongation factor B polypeptide 3),Rattus norvegicus (Rat),32.7,370.0,1.2e-35,152.5,sp|Q63187|ELOA1_RAT Elongin-A OS=Rattus norvegicus OX=10116 GN=Eloa PE=1 SV=1,GO:0003690; GO:0006357; GO:0006367; GO:0006368; GO:0008023; GO:0070449; GO:0090734,regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367],elongin complex [GO:0070449]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023],double-stranded DNA binding [GO:0003690],GO:0003677; GO:0006355,DNA binding; regulation of DNA-templated transcription
OG_02374,FUN_008984-T1,Peve_00029644,Pocillopora_meandrina_HIv1___RNAseq.g3905.t1,three_way,78.63966666666667,FUN_008984-T1,Q9NSN8,,,,,34.6,448.0,3e-69,264.2,sp|Q9NSN8|SNTG1_HUMAN Gamma-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTG1 PE=1 SV=1,,,,,,
OG_02375,FUN_008985-T1,Peve_00034872,Pocillopora_meandrina_HIv1___RNAseq.g3902.t1,three_way,86.08683333333333,FUN_008985-T1,O35491,CLK2_MOUSE,,Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2),Mus musculus (Mouse),68.3,338.0,2.4e-142,506.9,sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus OX=10090 GN=Clk2 PE=1 SV=2,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0006468; GO:0010212; GO:0016607; GO:0032526; GO:0043484; GO:0045721; GO:0046777; GO:0106310,negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526],nuclear speck [GO:0016607]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02376,FUN_008986-T1,Peve_00031142,Pocillopora_meandrina_HIv1___RNAseq.g3901.t1,three_way,77.067,,,,,,,,,,,,,,,,,
OG_02377,FUN_008988-T1,Peve_00001694,Pocillopora_meandrina_HIv1___RNAseq.g3899.t2,three_way,77.95366666666666,,,,,,,,,,,,,,,,,
OG_02378,FUN_008989-T1,Peve_00001693,Pocillopora_meandrina_HIv1___RNAseq.g3898.t1,three_way,97.019,FUN_008989-T1,Q9Y3B4,SF3B6_HUMAN,,"Splicing factor 3B subunit 6 (Pre-mRNA branch site protein p14) (SF3b 14 kDa subunit) (SF3B14a) (Spliceosome-associated protein, 14-kDa) (Splicing factor 3b, subunit 6, 14kDa)",Homo sapiens (Human),78.7,122.0,3.7e-53,208.8,sp|Q9Y3B4|SF3B6_HUMAN Splicing factor 3B subunit 6 OS=Homo sapiens OX=9606 GN=SF3B6 PE=1 SV=1,GO:0000398; GO:0001825; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:1903241,"blastocyst formation [GO:0001825]; mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_02379,FUN_008991-T1,Peve_00023810,Pocillopora_meandrina_HIv1___RNAseq.g3896.t1,three_way,96.42866666666669,FUN_008991-T1,Q2KJI2,STT3A_BOVIN,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18),Bos taurus (Bovine),85.0,695.0,0.0,1212.6,sp|Q2KJI2|STT3A_BOVIN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A OS=Bos taurus OX=9913 GN=STT3A PE=2 SV=1,GO:0004579; GO:0008250; GO:0018279; GO:0043686; GO:0043687; GO:0046872,co-translational protein modification [GO:0043686]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279],oligosaccharyltransferase complex [GO:0008250],dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872],GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_02380,FUN_008993-T1,Peve_00031637,Pocillopora_meandrina_HIv1___RNAseq.g3893.t1,three_way,84.04233333333333,FUN_008993-T1,A7S4N4,,,,,51.9,426.0,7.2e-118,425.6,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_02381,FUN_008994-T1,Peve_00013183,Pocillopora_meandrina_HIv1___RNAseq.g3910.t1,three_way,75.73266666666666,FUN_008994-T1,Q5ZM65,,,,,54.3,411.0,3.8e-123,443.4,sp|Q5ZM65|PTSS1_CHICK Phosphatidylserine synthase 1 OS=Gallus gallus OX=9031 GN=PTDSS1 PE=2 SV=2,,,,,,
OG_02382,FUN_008996-T1,Peve_00013185,Pocillopora_meandrina_HIv1___RNAseq.g3912.t1,three_way,70.09033333333333,,,,,,,,,,,,,,,,,
OG_02383,FUN_009000-T1,Peve_00021056,Pocillopora_meandrina_HIv1___RNAseq.g14306.t1b,three_way,50.9255,,,,,,,,,,,,,,,,,
OG_02384,FUN_009006-T1,Peve_00029130,Pocillopora_meandrina_HIv1___RNAseq.g14283.t1,three_way,69.471,FUN_009006-T1,Q96RG2,,,,,34.2,1207.0,2.8e-153,544.7,sp|Q96RG2|PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=PASK PE=1 SV=3,,,,,,
OG_02385,FUN_009007-T1,Peve_00029131,Pocillopora_meandrina_HIv1___RNAseq.g14284.t1,three_way,70.31566666666667,,,,,,,,,,,,,,,,,
OG_02386,FUN_009008-T1,Peve_00031170,Pocillopora_meandrina_HIv1___RNAseq.13704_t,three_way,75.398,FUN_009008-T1,Q6SKR2,HEMK2_MOUSE,,Methyltransferase HEMK2 (HemK methyltransferase family member 2) (M.HsaHemK2P) (Lysine N-methyltransferase 9) (EC 2.1.1.-) (Methylarsonite methyltransferase N6AMT1) (EC 2.1.1.-) (Methyltransferase N6AMT1) (Protein N(5)-glutamine methyltransferase) (EC 2.1.1.-),Mus musculus (Mouse),56.0,209.0,1.6000000000000004e-59,230.7,sp|Q6SKR2|HEMK2_MOUSE Methyltransferase HEMK2 OS=Mus musculus OX=10090 GN=Hemk2 PE=1 SV=1,GO:0003676; GO:0005634; GO:0008276; GO:0009404; GO:0018364; GO:0018872; GO:0030307; GO:0030791; GO:0032259; GO:0032991; GO:0036009; GO:0045814; GO:0045815; GO:0140984; GO:1904047,"arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of cell growth [GO:0030307]; toxin metabolic process [GO:0009404]; transcription initiation-coupled chromatin remodeling [GO:0045815]",nucleus [GO:0005634]; protein-containing complex [GO:0032991],arsenite methyltransferase activity [GO:0030791]; histone H4K12 methyltransferase activity [GO:0140984]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-glutamine N-methyltransferase activity [GO:0036009]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0005634; GO:0006325; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromatin organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02387,FUN_009009-T1,Peve_00031168,Pocillopora_meandrina_HIv1___RNAseq.g14286.t1,three_way,79.08683333333333,FUN_009009-T1,E1BYJ2,,,,,50.9,1325.0,0.0,1195.6,sp|E1BYJ2|MSH6_CHICK DNA mismatch repair protein Msh6 OS=Gallus gallus OX=9031 GN=MSH6 PE=3 SV=2,,,,,,
OG_02388,FUN_009010-T1,Peve_00031167,Pocillopora_meandrina_HIv1___RNAseq.g14287.t1,three_way,69.723,FUN_009010-T1,Q505B7,ARCH_MOUSE,,Protein archease (Protein ZBTB8OS),Mus musculus (Mouse),67.9,78.0,3.7e-24,112.5,sp|Q505B7|ARCH_MOUSE Protein archease OS=Mus musculus OX=10090 GN=Zbtb8os PE=1 SV=2,GO:0006388; GO:0046872; GO:0072669,"tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]",tRNA-splicing ligase complex [GO:0072669],metal ion binding [GO:0046872],GO:0006399,tRNA metabolic process
OG_02389,FUN_009013-T1,Peve_00021063,Pocillopora_meandrina_HIv1___RNAseq.g14290.t1,three_way,76.79733333333333,FUN_009013-T1,P18870,,,,,28.6,318.0,5.5e-19,96.7,sp|P18870|JUN_CHICK Transcription factor Jun OS=Gallus gallus OX=9031 GN=JUN PE=1 SV=2,,,,,,
OG_02390,FUN_009014-T1,Peve_00021062,Pocillopora_meandrina_HIv1___RNAseq.g14291.t1,three_way,68.24033333333333,FUN_009014-T1,Q3U0M1,TPPC9_MOUSE,,Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein),Mus musculus (Mouse),31.7,1140.0,3e-141,504.6,sp|Q3U0M1|TPPC9_MOUSE Trafficking protein particle complex subunit 9 OS=Mus musculus OX=10090 GN=Trappc9 PE=1 SV=2,GO:0005737; GO:0005783; GO:0006888; GO:0006901; GO:0021987; GO:0030182; GO:0099022; GO:1990071,cerebral cortex development [GO:0021987]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neuron differentiation [GO:0030182]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; TRAPPII protein complex [GO:1990071],,GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048856,endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development
OG_02391,FUN_009017-T1,Peve_00021060,Pocillopora_meandrina_HIv1___RNAseq.g14292.t1,three_way,60.70033333333333,FUN_009017-T1,Q9NVV5,,,,,39.2,222.0,2.9e-38,160.2,sp|Q9NVV5|AIG1_HUMAN Androgen-induced gene 1 protein OS=Homo sapiens OX=9606 GN=AIG1 PE=1 SV=3,,,,,,
OG_02392,FUN_009019-T1,Peve_00021058,Pocillopora_meandrina_HIv1___RNAseq.g14304.t1,three_way,74.17666666666666,FUN_009019-T1,O14649,KCNK3_HUMAN,,Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1),Homo sapiens (Human),36.5,208.0,5.5e-32,139.8,sp|O14649|KCNK3_HUMAN Potassium channel subfamily K member 3 OS=Homo sapiens OX=9606 GN=KCNK3 PE=1 SV=1,GO:0003029; GO:0005216; GO:0005252; GO:0005267; GO:0005272; GO:0005886; GO:0006813; GO:0007268; GO:0009410; GO:0015271; GO:0022841; GO:0034220; GO:0044548; GO:0045202; GO:0046872; GO:0046982; GO:0051481; GO:0060075; GO:0071294; GO:0071456; GO:0071468; GO:0071805; GO:0090102; GO:0099605,cellular response to acidic pH [GO:0071468]; cellular response to hypoxia [GO:0071456]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; cochlea development [GO:0090102]; detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [GO:0003029]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of action potential firing rate [GO:0099605]; regulation of resting membrane potential [GO:0060075]; response to xenobiotic stimulus [GO:0009410],plasma membrane [GO:0005886]; synapse [GO:0045202],metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; open rectifier potassium channel activity [GO:0005252]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982]; S100 protein binding [GO:0044548]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0023052; GO:0048856; GO:0055085,transporter activity; plasma membrane; signaling; anatomical structure development; transmembrane transport
OG_02393,FUN_009021-T1,Peve_00044339,Pocillopora_meandrina_HIv1___RNAseq.g3922.t1,three_way,71.4215,,,,,,,,,,,,,,,,,
OG_02394,FUN_009022-T1,Peve_00044352,Pocillopora_meandrina_HIv1___RNAseq.g3941.t1,three_way,75.0855,FUN_009022-T1,Q1AAU6,ASAP1_RAT,,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)",Rattus norvegicus (Rat),38.6,1193.0,7.400000000000001e-201,702.6,"sp|Q1AAU6|ASAP1_RAT Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Asap1 PE=1 SV=2",GO:0000139; GO:0001786; GO:0002102; GO:0005096; GO:0005546; GO:0005547; GO:0008270; GO:0032588; GO:0043197; GO:0060271; GO:0061000; GO:0061512; GO:0098978; GO:0099175; GO:1903527,cilium assembly [GO:0060271]; negative regulation of dendritic spine development [GO:0061000]; positive regulation of membrane tubulation [GO:1903527]; protein localization to cilium [GO:0061512]; regulation of postsynapse organization [GO:0099175],dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; podosome [GO:0002102]; trans-Golgi network membrane [GO:0032588],"GTPase activator activity [GO:0005096]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; zinc ion binding [GO:0008270]",GO:0008289; GO:0043226; GO:0044782; GO:0098772,lipid binding; organelle; cilium organization; molecular function regulator activity
OG_02395,FUN_009023-T1,Peve_00044350,Pocillopora_meandrina_HIv1___RNAseq.g3942.t1,three_way,93.496,FUN_009023-T1,Q92519,TRIB2_HUMAN,,Tribbles homolog 2 (TRB-2),Homo sapiens (Human),54.1,338.0,2.2e-100,367.1,sp|Q92519|TRIB2_HUMAN Tribbles homolog 2 OS=Homo sapiens OX=9606 GN=TRIB2 PE=1 SV=1,GO:0004860; GO:0005634; GO:0005737; GO:0005856; GO:0031434; GO:0031625; GO:0032436; GO:0032693; GO:0043405; GO:0045599; GO:0055106; GO:0061629,negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of MAP kinase activity [GO:0043405],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase inhibitor activity [GO:0004860]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase regulator activity [GO:0055106],GO:0005634; GO:0005856; GO:0043226; GO:0098772,nucleus; cytoskeleton; organelle; molecular function regulator activity
OG_02396,FUN_009026-T1,Peve_00017792,Pocillopora_meandrina_HIv1___RNAseq.g14344.t1,three_way,55.13933333333333,FUN_009026-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),33.5,346.0,4.5e-42,173.7,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_02397,FUN_009033-T3,Peve_00013834,Pocillopora_meandrina_HIv1___RNAseq.g14347.t1,three_way,72.43633333333334,FUN_009033-T3,Q8K135,K319L_MOUSE,,Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR),Mus musculus (Mouse),43.9,807.0,1.4e-171,605.5,sp|Q8K135|K319L_MOUSE Dyslexia-associated protein KIAA0319-like protein OS=Mus musculus OX=10090 GN=Kiaa0319l PE=1 SV=1,GO:0000139; GO:0001675; GO:0001764; GO:0005730; GO:0005802; GO:0005886; GO:0007283; GO:0010996; GO:0019065; GO:0030317; GO:0031410; GO:0120211,acrosome assembly [GO:0001675]; flagellated sperm motility [GO:0030317]; neuron migration [GO:0001764]; proacrosomal vesicle fusion [GO:0120211]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; response to auditory stimulus [GO:0010996]; spermatogenesis [GO:0007283],cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],,GO:0005730; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870; GO:0061024,nucleolus; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility; membrane organization
OG_02398,FUN_009036-T1,Peve_00013828,Pocillopora_meandrina_HIv1___RNAseq.g14346.t1,three_way,54.13,,,,,,,,,,,,,,,,,
OG_02399,FUN_009037-T1,Peve_00013831,Pocillopora_meandrina_HIv1___RNAseq.g14345.t1,three_way,83.23316666666666,,,,,,,,,,,,,,,,,
OG_02400,FUN_009039-T1,Peve_00033720,Pocillopora_meandrina_HIv1___RNAseq.g14374.t1,three_way,60.694,,,,,,,,,,,,,,,,,
OG_02401,FUN_009042-T1,Peve_00033723,Pocillopora_meandrina_HIv1___RNAseq.g14377.t1,three_way,63.53966666666667,FUN_009042-T1,O95551,TYDP2_HUMAN,,Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (hTDP2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (ETS1-associated protein 2) (ETS1-associated protein II) (EAPII) (TRAF and TNF receptor-associated protein) (Tyrosyl-RNA phosphodiesterase) (VPg unlinkase),Homo sapiens (Human),39.8,334.0,1.2e-61,238.4,sp|O95551|TYDP2_HUMAN Tyrosyl-DNA phosphodiesterase 2 OS=Homo sapiens OX=9606 GN=TDP2 PE=1 SV=1,GO:0000287; GO:0003697; GO:0003714; GO:0004518; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0007166; GO:0016235; GO:0016604; GO:0016605; GO:0030145; GO:0036317; GO:0048666; GO:0070260,cell surface receptor signaling pathway [GO:0007166]; double-strand break repair [GO:0006302]; neuron development [GO:0048666],aggresome [GO:0016235]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],5'-tyrosyl-DNA phosphodiesterase activity [GO:0070260]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714]; tyrosyl-RNA phosphodiesterase activity [GO:0036317],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0016787; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140098; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; hydrolase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; transcription regulator activity"
OG_02402,FUN_009043-T1,Peve_00033724,Pocillopora_meandrina_HIv1___RNAseq.g14380.t1,three_way,66.07533333333333,FUN_009043-T1,Q6P3K3,FBX9_DANRE,,F-box only protein 9,Danio rerio (Zebrafish) (Brachydanio rerio),39.8,437.0,1.3e-81,305.1,sp|Q6P3K3|FBX9_DANRE F-box only protein 9 OS=Danio rerio OX=7955 GN=fbxo9 PE=2 SV=1,GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032006,protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005],,GO:0030163,protein catabolic process
OG_02403,FUN_009044-T1,Peve_00002709,Pocillopora_meandrina_HIv1___RNAseq.g14411.t2,three_way,67.5345,FUN_009044-T1,O35604,NPC1_MOUSE,,NPC intracellular cholesterol transporter 1 (Niemann-Pick C1 protein),Mus musculus (Mouse),48.0,1270.0,1.3e-312,1073.5,sp|O35604|NPC1_MOUSE NPC intracellular cholesterol transporter 1 OS=Mus musculus OX=10090 GN=Npc1 PE=1 SV=2,GO:0001889; GO:0005576; GO:0005635; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006486; GO:0006897; GO:0006914; GO:0007041; GO:0007628; GO:0008203; GO:0008206; GO:0009410; GO:0010467; GO:0010878; GO:0012501; GO:0015485; GO:0015918; GO:0016020; GO:0016125; GO:0016236; GO:0016242; GO:0022008; GO:0030301; GO:0031579; GO:0031902; GO:0031982; GO:0032365; GO:0032367; GO:0033344; GO:0042632; GO:0045121; GO:0046686; GO:0046718; GO:0048471; GO:0051649; GO:0071383; GO:0071404; GO:0090150; GO:0120020; GO:1904036; GO:1904262; GO:2000900,adult walking behavior [GO:0007628]; autophagy [GO:0006914]; bile acid metabolic process [GO:0008206]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to steroid hormone stimulus [GO:0071383]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; cyclodextrin metabolic process [GO:2000900]; endocytosis [GO:0006897]; establishment of localization in cell [GO:0051649]; establishment of protein localization to membrane [GO:0090150]; gene expression [GO:0010467]; intracellular cholesterol transport [GO:0032367]; intracellular lipid transport [GO:0032365]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; macroautophagy [GO:0016236]; membrane raft organization [GO:0031579]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of macroautophagy [GO:0016242]; negative regulation of TORC1 signaling [GO:1904262]; neurogenesis [GO:0022008]; programmed cell death [GO:0012501]; protein glycosylation [GO:0006486]; response to cadmium ion [GO:0046686]; response to xenobiotic stimulus [GO:0009410]; sterol metabolic process [GO:0016125]; sterol transport [GO:0015918]; symbiont entry into host cell [GO:0046718],endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020],GO:0005215; GO:0005576; GO:0005635; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0005975; GO:0006486; GO:0006629; GO:0006914; GO:0008289; GO:0012501; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0061024,transporter activity; extracellular region; nuclear envelope; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; carbohydrate metabolic process; protein glycosylation; lipid metabolic process; autophagy; lipid binding; programmed cell death; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; membrane organization
OG_02404,FUN_009053-T1,Peve_00032043,Pocillopora_meandrina_HIv1___RNAseq.g14499.t1,three_way,60.631166666666665,FUN_009053-T1,Q68FD7,FNIP1_MOUSE,,Folliculin-interacting protein 1,Mus musculus (Mouse),29.9,1162.0,7.4e-115,416.8,sp|Q68FD7|FNIP1_MOUSE Folliculin-interacting protein 1 OS=Mus musculus OX=10090 GN=Fnip1 PE=1 SV=1,GO:0000122; GO:0001783; GO:0002327; GO:0002904; GO:0005737; GO:0005765; GO:0005829; GO:0008047; GO:0008285; GO:0009267; GO:0019899; GO:0031334; GO:0031929; GO:0032007; GO:0032008; GO:0042030; GO:0051087; GO:1904263; GO:1905672; GO:2000973,B cell apoptotic process [GO:0001783]; cellular response to starvation [GO:0009267]; immature B cell differentiation [GO:0002327]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of lysosome organization [GO:1905672]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of pro-B cell differentiation [GO:2000973]; TOR signaling [GO:0031929],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765],ATPase inhibitor activity [GO:0042030]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; protein-folding chaperone binding [GO:0051087],GO:0002376; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0098772,immune system process; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; molecular function regulator activity
OG_02405,FUN_009054-T1,Peve_00032030,Pocillopora_meandrina_HIv1___RNAseq.g14498.t1,three_way,59.42516666666667,FUN_009054-T1,Q9WVK8,CP46A_MOUSE,,Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1),Mus musculus (Mouse),32.7,493.0,1.3e-67,258.8,sp|Q9WVK8|CP46A_MOUSE Cholesterol 24-hydroxylase OS=Mus musculus OX=10090 GN=Cyp46a1 PE=1 SV=1,GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044,cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805],dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793],cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_02406,FUN_009055-T1,Peve_00032032,Pocillopora_meandrina_HIv1___RNAseq.g14497.t1,three_way,46.194,,,,,,,,,,,,,,,,,
OG_02407,FUN_009056-T1,Peve_00032033,Pocillopora_meandrina_HIv1___RNAseq.g14479.t1,three_way,51.15833333333333,,,,,,,,,,,,,,,,,
OG_02408,FUN_009228-T2,Peve_00014803,Pocillopora_meandrina_HIv1___RNAseq.g6343.t1,three_way,63.64683333333333,FUN_009228-T2,Q24JV9,,,,,50.0,106.0,4.5000000000000003e-23,113.6,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02409,FUN_009268-T1,Peve_00032035,Pocillopora_meandrina_HIv1___RNAseq.g3994.t1,three_way,78.74633333333333,FUN_009268-T1,Q4R516,ELOV5_MACFA,,Very long chain fatty acid elongase 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Elongation of very long chain fatty acids protein 5) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),35.5,231.0,4.8e-25,116.3,sp|Q4R516|ELOV5_MACFA Very long chain fatty acid elongase 5 OS=Macaca fascicularis OX=9541 GN=ELOVL5 PE=2 SV=1,GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0042761; GO:0043025; GO:0097447,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",dendrite [GO:0030425]; dendritic tree [GO:0097447]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0006629; GO:0006790; GO:0016740; GO:0055086,catalytic activity; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process
OG_02410,FUN_009269-T1,Peve_00032037,Pocillopora_meandrina_HIv1___RNAseq.g3995.t1,three_way,77.785,FUN_009269-T1,A0A0C5PHQ7,ELOV5_TACFU,,Very long chain fatty acid elongase 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Elongation of very long chain fatty acids protein 5) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5),Tachysurus fulvidraco (Yellow catfish) (Pimelodus fulvidraco),33.8,228.0,1.0999999999999998e-24,115.2,sp|A0A0C5PHQ7|ELOV5_TACFU Very long chain fatty acid elongase 5 OS=Tachysurus fulvidraco OX=1234273 GN=ELOVL5 PE=2 SV=1,GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0030425; GO:0034625; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0006629; GO:0006790; GO:0016740; GO:0055086,catalytic activity; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process
OG_02411,FUN_009270-T1,Peve_00032038,Pocillopora_meandrina_HIv1___RNAseq.g3996.t1,three_way,56.53483333333333,,,,,,,,,,,,,,,,,
OG_02412,FUN_009271-T1,Peve_00032040,Pocillopora_meandrina_HIv1___RNAseq.g14262.t1,three_way,73.62033333333333,FUN_009271-T1,Q56585,,,,,50.5,99.0,4.8e-22,105.5,sp|Q56585|BOLA_VIBAL DNA-binding transcriptional regulator BolA OS=Vibrio alginolyticus OX=663 GN=bolA PE=3 SV=1,,,,,,
OG_02413,FUN_009273-T1,Peve_00038894,Pocillopora_meandrina_HIv1___RNAseq.g24167.t1,three_way,69.17233333333334,,,,,,,,,,,,,,,,,
OG_02414,FUN_009283-T1,Peve_00000866,Pocillopora_meandrina_HIv1___RNAseq.g15507.t1,three_way,65.01933333333334,,,,,,,,,,,,,,,,,
OG_02415,FUN_009296-T1,Peve_00041170,Pocillopora_meandrina_HIv1___RNAseq.g14453.t3,three_way,46.81766666666667,,,,,,,,,,,,,,,,,
OG_02416,FUN_009298-T1,Peve_00041169,Pocillopora_meandrina_HIv1___RNAseq.g14449.t1,three_way,55.967,,,,,,,,,,,,,,,,,
OG_02417,FUN_009301-T1,Peve_00025384,Pocillopora_meandrina_HIv1___RNAseq.g14448.t1,three_way,83.23466666666667,FUN_009301-T1,Q867C9,,,,,59.6,757.0,8.799999999999999e-268,924.5,"sp|Q867C9|PFKAM_HORSE ATP-dependent 6-phosphofructokinase, muscle type OS=Equus caballus OX=9796 GN=PFKM PE=2 SV=3",,,,,,
OG_02418,FUN_009304-T1,Peve_00005826,Pocillopora_meandrina_HIv1___RNAseq.g14445.t1,three_way,85.81966666666666,FUN_009304-T1,B7PRF6,,,,,65.6,180.0,3.7e-70,265.8,sp|B7PRF6|MTND_IXOSC Acireductone dioxygenase OS=Ixodes scapularis OX=6945 GN=IscW_ISCW007295 PE=3 SV=1,,,,,,
OG_02419,FUN_009306-T1,Peve_00005827,Pocillopora_meandrina_HIv1___RNAseq.g14444.t1,three_way,51.80683333333334,,,,,,,,,,,,,,,,,
OG_02420,FUN_009308-T1,Peve_00021835,Pocillopora_meandrina_HIv1___RNAseq.g14442.t1,three_way,91.04433333333331,FUN_009308-T1,Q0MQI6,,,,,83.0,442.0,4.8e-226,785.0,"sp|Q0MQI6|NDUV1_PANTR NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial OS=Pan troglodytes OX=9598 GN=NDUFV1 PE=2 SV=1",,,,,,
OG_02421,FUN_009312-T2,Peve_00021837,Pocillopora_meandrina_HIv1___RNAseq.g14441.t1,three_way,44.22516666666667,,,,,,,,,,,,,,,,,
OG_02422,FUN_009345-T1,Peve_00038086,Pocillopora_meandrina_HIv1___RNAseq.g14423.t1,three_way,83.58233333333334,FUN_009345-T1,P08923,LTK_MOUSE,,Leukocyte tyrosine kinase receptor (EC 2.7.10.1),Mus musculus (Mouse),42.7,96.0,3e-08,61.6,sp|P08923|LTK_MOUSE Leukocyte tyrosine kinase receptor OS=Mus musculus OX=10090 GN=Ltk PE=1 SV=3,GO:0004672; GO:0004714; GO:0005524; GO:0005783; GO:0005886; GO:0007169; GO:0008283; GO:0010666; GO:0010976; GO:0016020; GO:0030298; GO:0038083; GO:0043066; GO:0051897; GO:0071300,cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005783; GO:0005886; GO:0016740; GO:0043226; GO:0060089; GO:0098772; GO:0140096,"catalytic activity; endoplasmic reticulum; plasma membrane; transferase activity; organelle; molecular transducer activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02423,FUN_009347-T1,Peve_00038083,Pocillopora_meandrina_HIv1___TS.g5898.t2,three_way,74.7065,FUN_009347-T1,Q66IL0,,,,,50.3,378.0,6.8e-101,369.0,sp|Q66IL0|CHID1_XENTR Chitinase domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=chid1 PE=2 SV=1,,,,,,
OG_02424,FUN_009349-T1,Peve_00038081,Pocillopora_meandrina_HIv1___RNAseq.g14427.t2,three_way,67.24183333333333,,,,,,,,,,,,,,,,,
OG_02425,FUN_009350-T1,Peve_00038079,Pocillopora_meandrina_HIv1___RNAseq.g14430.t1,three_way,69.01966666666667,FUN_009350-T1,Q9I829,,,,,40.0,455.0,7.3e-64,246.5,sp|Q9I829|KCNA1_ONCMY Shaker-related potassium channel tsha2 OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1,,,,,,
OG_02426,FUN_009351-T1,Peve_00038078,Pocillopora_meandrina_HIv1___RNAseq.g14431.t1,three_way,69.298,FUN_009351-T1,Q9I829,,,,,43.1,392.0,5.1e-73,276.6,sp|Q9I829|KCNA1_ONCMY Shaker-related potassium channel tsha2 OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1,,,,,,
OG_02427,FUN_009353-T1,Peve_00038076,Pocillopora_meandrina_HIv1___TS.g5893.t2,three_way,91.464,FUN_009353-T1,Q99K70,RRAGC_MOUSE,,Ras-related GTP-binding protein C (Rag C) (RagC) (EC 3.6.5.-) (GTPase-interacting protein 2) (TIB929),Mus musculus (Mouse),72.1,380.0,5.3999999999999995e-151,535.4,sp|Q99K70|RRAGC_MOUSE Ras-related GTP-binding protein C OS=Mus musculus OX=10090 GN=Rragc PE=1 SV=1,GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0019003; GO:0032008; GO:0034198; GO:0043200; GO:0043495; GO:0046982; GO:0051020; GO:0060090; GO:0061462; GO:0072657; GO:0140767; GO:1904263; GO:1990877,cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein localization to lysosome [GO:0061462]; protein localization to membrane [GO:0072657]; response to amino acid [GO:0043200],cytoplasm [GO:0005737]; FNIP-folliculin RagC/D GAP [GO:1990877]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],enzyme-substrate adaptor activity [GO:0140767]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; molecular adaptor activity [GO:0060090]; protein heterodimerization activity [GO:0046982]; protein-membrane adaptor activity [GO:0043495],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0016787; GO:0043226; GO:0060090,catalytic activity; GTPase activity; nucleus; nucleoplasm; lysosome; vacuole; hydrolase activity; organelle; molecular adaptor activity
OG_02428,FUN_009369-T1,Peve_00011042,Pocillopora_meandrina_HIv1___RNAseq.g14409.t1,three_way,62.123666666666665,FUN_009369-T1,A8KBE0,,,,,31.3,823.0,3.5e-86,321.2,sp|A8KBE0|OXR1_XENTR Oxidation resistance protein 1 OS=Xenopus tropicalis OX=8364 GN=oxr1 PE=2 SV=2,,,,,,
OG_02429,FUN_009381-T1,Peve_00026823,Pocillopora_meandrina_HIv1___RNAseq.g14538.t3,three_way,54.836,FUN_009381-T1,Q9WUU9,GANP_MOUSE,,Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase),Mus musculus (Mouse),29.7,1638.0,3.1000000000000003e-161,571.6,sp|Q9WUU9|GANP_MOUSE Germinal-center associated nuclear protein OS=Mus musculus OX=10090 GN=Mcm3ap PE=1 SV=2,GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390,nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390],chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; histone H3 acetyltransferase activity [GO:0010484]; nucleic acid binding [GO:0003676],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0006913; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; chromatin organization; nucleocytoplasmic transport; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_02430,FUN_009383-T1,Peve_00026822,Pocillopora_meandrina_HIv1___RNAseq.g14536.t2,three_way,52.69433333333333,FUN_009383-T1,O57382,,,,,33.2,238.0,1.9e-27,125.9,sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1,,,,,,
OG_02431,FUN_009401-T1,Peve_00004579,Pocillopora_meandrina_HIv1___RNAseq.g4531.t1,three_way,45.29166666666666,,,,,,,,,,,,,,,,,
OG_02432,FUN_009438-T1,Peve_00031029,Pocillopora_meandrina_HIv1___RNAseq.g25068.t1,three_way,73.89733333333334,,,,,,,,,,,,,,,,,
OG_02433,FUN_009439-T1,Peve_00031030,Pocillopora_meandrina_HIv1___RNAseq.g25069.t1c,three_way,55.01983333333333,FUN_009439-T1,P59723,HIF1N_DANRE,,Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Hypoxia-inducible factor asparagine hydroxylase),Danio rerio (Zebrafish) (Brachydanio rerio),44.6,267.0,1.4999999999999998e-62,241.9,sp|P59723|HIF1N_DANRE Hypoxia-inducible factor 1-alpha inhibitor OS=Danio rerio OX=7955 GN=hif1an PE=2 SV=2,GO:0005634; GO:0005737; GO:0008198; GO:0008270; GO:0030947; GO:0031406; GO:0036139; GO:0036140; GO:0042803; GO:0045746; GO:0048471; GO:0062101; GO:1901343,negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of vasculature development [GO:1901343]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],[protein]-asparagine 3-dioxygenase activity [GO:0036140]; carboxylic acid binding [GO:0031406]; ferrous iron binding [GO:0008198]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_02434,FUN_009440-T1,Peve_00031031,Pocillopora_meandrina_HIv1___RNAseq.g25069.t1a,three_way,94.56366666666666,FUN_009440-T1,Q5PQ44,,,,,80.0,230.0,1.8e-99,363.6,sp|Q5PQ44|CF299_XENLA Cilia- and flagella-associated protein 299 OS=Xenopus laevis OX=8355 GN=cfap299 PE=2 SV=1,,,,,,
OG_02435,FUN_009441-T1,Peve_00031034,Pocillopora_meandrina_HIv1___RNAseq.g25070.t1,three_way,55.70133333333333,,,,,,,,,,,,,,,,,
OG_02436,FUN_009442-T1,Peve_00031035,Pocillopora_meandrina_HIv1___RNAseq.g25071.t1,three_way,65.98966666666666,FUN_009442-T1,Q9UMS0,,,,,65.8,193.0,2.4e-71,270.4,"sp|Q9UMS0|NFU1_HUMAN NFU1 iron-sulfur cluster scaffold homolog, mitochondrial OS=Homo sapiens OX=9606 GN=NFU1 PE=1 SV=2",,,,,,
OG_02437,FUN_009450-T1,Peve_00009284,Pocillopora_meandrina_HIv1___RNAseq.g25115.t1,three_way,64.19466666666666,FUN_009450-T1,Q9DBW0,CP4V2_MOUSE,,Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),Mus musculus (Mouse),47.4,508.0,6.2e-131,469.2,sp|Q9DBW0|CP4V2_MOUSE Cytochrome P450 4V2 OS=Mus musculus OX=10090 GN=Cyp4v2 PE=1 SV=1,GO:0005506; GO:0005789; GO:0010430; GO:0020037; GO:0102033,fatty acid omega-oxidation [GO:0010430],endoplasmic reticulum membrane [GO:0005789],heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_02438,FUN_009454-T1,Peve_00036253,Pocillopora_meandrina_HIv1___RNAseq.g11907.t1,three_way,65.61333333333333,,,,,,,,,,,,,,,,,
OG_02439,FUN_009459-T2,Peve_00010355,Pocillopora_meandrina_HIv1___RNAseq.g25133.t1,three_way,61.281333333333336,FUN_009459-T2,Q24JV9,,,,,58.1,105.0,3.1999999999999997e-31,139.0,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_02440,FUN_009463-T1,Peve_00031026,Pocillopora_meandrina_HIv1___RNAseq.g25060.t1,three_way,72.952,,,,,,,,,,,,,,,,,
OG_02441,FUN_009464-T1,Peve_00031025,Pocillopora_meandrina_HIv1___RNAseq.g25059.t1,three_way,87.40733333333333,FUN_009464-T1,Q6IML7,,,,,66.2,260.0,1.6e-101,370.5,sp|Q6IML7|DJC27_RAT DnaJ homolog subfamily C member 27 OS=Rattus norvegicus OX=10116 GN=Dnajc27 PE=2 SV=1,,,,,,
OG_02442,FUN_009488-T1,Peve_00016361,Pocillopora_meandrina_HIv1___RNAseq.g28392.t1,three_way,82.25866666666667,FUN_009488-T1,Q95J75,,,,,55.1,207.0,2e-60,233.8,sp|Q95J75|S2532_MACFA Solute carrier family 25 member 32 OS=Macaca fascicularis OX=9541 GN=SLC25A32 PE=2 SV=1,,,,,,
OG_02443,FUN_009512-T1,Peve_00040630,Pocillopora_meandrina_HIv1___TS.g24209.t1,three_way,57.00666666666667,FUN_009512-T1,A6LX31,,,,,46.4,252.0,2.1e-56,221.5,sp|A6LX31|Y2760_CLOB8 Putative hydro-lyase Cbei_2760 OS=Clostridium beijerinckii (strain ATCC 51743 / NCIMB 8052) OX=290402 GN=Cbei_2760 PE=3 SV=1,,,,,,
OG_02444,FUN_009515-T1,Peve_00013293,Pocillopora_meandrina_HIv1___RNAseq.g24489.t1,three_way,58.22533333333333,,,,,,,,,,,,,,,,,
OG_02445,FUN_009516-T1,Peve_00013666,Pocillopora_meandrina_HIv1___RNAseq.g24490.t1,three_way,64.20366666666666,FUN_009516-T1,Q8BL86,,,,,45.3,278.0,4.5e-70,266.2,sp|Q8BL86|MBLC2_MOUSE Acyl-coenzyme A thioesterase MBLAC2 OS=Mus musculus OX=10090 GN=Mblac2 PE=1 SV=2,,,,,,
OG_02446,FUN_009517-T1,Peve_00009091,Pocillopora_meandrina_HIv1___RNAseq.g24504.t1,three_way,60.57866666666666,,,,,,,,,,,,,,,,,
OG_02447,FUN_009518-T1,Peve_00014185,Pocillopora_meandrina_HIv1___RNAseq.g24502.t1,three_way,48.7565,,,,,,,,,,,,,,,,,
OG_02448,FUN_009519-T1,Peve_00014186,Pocillopora_meandrina_HIv1___RNAseq.g24501.t1,three_way,81.64666666666666,FUN_009519-T1,Q02874,H2AY_RAT,,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (H2A.y) (H2A/y),Rattus norvegicus (Rat),55.9,381.0,1.7e-101,370.9,sp|Q02874|H2AY_RAT Core histone macro-H2A.1 OS=Rattus norvegicus OX=10116 GN=Macroh2a1 PE=1 SV=5,GO:0000122; GO:0000182; GO:0000228; GO:0000785; GO:0000786; GO:0000793; GO:0000976; GO:0000977; GO:0001740; GO:0002082; GO:0003682; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006281; GO:0006334; GO:0007549; GO:0010385; GO:0019216; GO:0019899; GO:0019901; GO:0030291; GO:0030527; GO:0031490; GO:0031492; GO:0031507; GO:0034184; GO:0040029; GO:0045618; GO:0045814; GO:0045815; GO:0046982; GO:0071169; GO:0072570; GO:0090734; GO:0160002; GO:1901837; GO:1902688; GO:1902750; GO:1902882; GO:1903226; GO:1904815; GO:1990841,"DNA repair [GO:0006281]; epigenetic regulation of gene expression [GO:0040029]; establishment of protein localization to chromatin [GO:0071169]; heterochromatin formation [GO:0031507]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of protein localization to chromosome, telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of NAD metabolic process [GO:1902688]; regulation of oxidative phosphorylation [GO:0002082]; regulation of response to oxidative stress [GO:1902882]; sex-chromosome dosage compensation [GO:0007549]; transcription initiation-coupled chromatin remodeling [GO:0045815]",Barr body [GO:0001740]; chromatin [GO:0000785]; condensed chromosome [GO:0000793]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; site of DNA damage [GO:0090734],ADP-D-ribose binding [GO:0072570]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; double-stranded methylated DNA binding [GO:0010385]; enzyme binding [GO:0019899]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; structural constituent of chromatin [GO:0030527]; transcription cis-regulatory region binding [GO:0000976],GO:0000228; GO:0003677; GO:0005198; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006325; GO:0006355; GO:0043226; GO:0065003; GO:0098772,nuclear chromosome; DNA binding; structural molecule activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; chromatin organization; regulation of DNA-templated transcription; organelle; protein-containing complex assembly; molecular function regulator activity
OG_02449,FUN_009521-T1,Peve_00014188,Pocillopora_meandrina_HIv1___TS.g12441.t1,three_way,74.73466666666667,,,,,,,,,,,,,,,,,
OG_02450,FUN_009522-T1,Peve_00014189,Pocillopora_meandrina_HIv1___RNAseq.g24498.t1,three_way,77.1415,FUN_009522-T1,Q27403,GCM_DROME,,Transcription factor glial cells missing (Protein glide),Drosophila melanogaster (Fruit fly),34.7,118.0,2.6e-14,81.6,sp|Q27403|GCM_DROME Transcription factor glial cells missing OS=Drosophila melanogaster OX=7227 GN=gcm PE=1 SV=2,GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0005634; GO:0006357; GO:0007403; GO:0007516; GO:0010001; GO:0010468; GO:0010628; GO:0021782; GO:0030182; GO:0031290; GO:0035165; GO:0035289; GO:0042063; GO:0042387; GO:0042690; GO:0045610; GO:0045687; GO:0045893; GO:0045944; GO:0048813; GO:0050764; GO:0060252; GO:0060857,dendrite morphogenesis [GO:0048813]; embryonic crystal cell differentiation [GO:0035165]; establishment of glial blood-brain barrier [GO:0060857]; glial cell development [GO:0021782]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; gliogenesis [GO:0042063]; hemocyte development [GO:0007516]; negative regulation of crystal cell differentiation [GO:0042690]; neuron differentiation [GO:0030182]; plasmatocyte differentiation [GO:0042387]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; regulation of hemocyte differentiation [GO:0045610]; regulation of phagocytosis [GO:0050764]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal ganglion cell axon guidance [GO:0031290],nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0002376; GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02451,FUN_009528-T1,Peve_00014183,Pocillopora_meandrina_HIv1___RNAseq.g24497.t1,three_way,84.42966666666666,,,,,,,,,,,,,,,,,
OG_02452,FUN_009530-T1,Peve_00009552,Pocillopora_meandrina_HIv1___RNAseq.g24495.t1,three_way,46.4995,FUN_009530-T1,Q460N3,PAR15_HUMAN,,Protein mono-ADP-ribosyltransferase PARP15 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3) (Poly [ADP-ribose] polymerase 15) (PARP-15),Homo sapiens (Human),27.4,201.0,6.3e-14,80.9,sp|Q460N3|PAR15_HUMAN Protein mono-ADP-ribosyltransferase PARP15 OS=Homo sapiens OX=9606 GN=PARP15 PE=1 SV=2,GO:0000122; GO:0003714; GO:0003950; GO:0005634; GO:0005737; GO:0010629; GO:0016779; GO:0070212; GO:0070403; GO:0140806; GO:0140807; GO:1990404,negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein poly-ADP-ribosylation [GO:0070212],cytoplasm [GO:0005737]; nucleus [GO:0005634],NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02453,FUN_009531-T1,Peve_00009558,Pocillopora_meandrina_HIv1___RNAseq.g24494.t1,three_way,90.84233333333331,FUN_009531-T1,A7SG48,,,,,76.9,91.0,3.6e-37,155.2,sp|A7SG48|U728_NEMVE UPF0728 protein v1g117062 OS=Nematostella vectensis OX=45351 GN=v1g117062 PE=3 SV=1,,,,,,
OG_02454,FUN_009532-T1,Peve_00009560,Pocillopora_meandrina_HIv1___RNAseq.g24493.t1,three_way,88.02533333333334,FUN_009532-T1,Q148N0,,,,,64.9,976.0,0.0,1304.7,sp|Q148N0|ODO1_BOVIN 2-oxoglutarate dehydrogenase complex component E1 OS=Bos taurus OX=9913 GN=OGDH PE=1 SV=1,,,,,,
OG_02455,FUN_009533-T1,Peve_00009554,Pocillopora_meandrina_HIv1___RNAseq.g24492.t1,three_way,81.537,FUN_009533-T1,Q27958,DPOLB_BOVIN,,DNA polymerase beta (EC 2.7.7.7) (5'-deoxyribose-phosphate lyase) (5'-dRP lyase) (EC 4.2.99.-) (AP lyase) (EC 4.2.99.18),Bos taurus (Bovine),65.8,336.0,2.1999999999999998e-121,436.8,sp|Q27958|DPOLB_BOVIN DNA polymerase beta OS=Bos taurus OX=9913 GN=POLB PE=2 SV=3,GO:0003677; GO:0003887; GO:0005634; GO:0005737; GO:0006261; GO:0006284; GO:0006303; GO:0006974; GO:0016829; GO:0046872; GO:0051575; GO:0140078,base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA-templated DNA replication [GO:0006261]; double-strand break repair via nonhomologous end joining [GO:0006303],cytoplasm [GO:0005737]; nucleus [GO:0005634],5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; lyase activity [GO:0016829]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_02456,FUN_009640-T1,Peve_00032789,Pocillopora_meandrina_HIv1___RNAseq.g24615.t1,three_way,48.79566666666667,,,,,,,,,,,,,,,,,
OG_02457,FUN_009641-T1,Peve_00021801,Pocillopora_meandrina_HIv1___RNAseq.g24616.t1,three_way,92.12033333333332,FUN_009641-T1,A6N6J5,WDR35_RAT,,WD repeat-containing protein 35 (Naofen),Rattus norvegicus (Rat),68.2,1188.0,0.0,1680.6,sp|A6N6J5|WDR35_RAT WD repeat-containing protein 35 OS=Rattus norvegicus OX=10116 GN=Wdr35 PE=1 SV=1,GO:0005813; GO:0005930; GO:0009636; GO:0010629; GO:0030991; GO:0032496; GO:0035721; GO:0036064; GO:0042073; GO:0045019; GO:0045907; GO:0060271; GO:0061512; GO:0071333; GO:0071356; GO:0071466; GO:0090200; GO:0097421; GO:1990830; GO:2001238,cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; liver regeneration [GO:0097421]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vasoconstriction [GO:0045907]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to toxic substance [GO:0009636],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; intraciliary transport particle A [GO:0030991],,GO:0003013; GO:0005815; GO:0007018; GO:0044782; GO:0048856,circulatory system process; microtubule organizing center; microtubule-based movement; cilium organization; anatomical structure development
OG_02458,FUN_009648-T1,Peve_00003561,Pocillopora_meandrina_HIv1___RNAseq.g24588.t1,three_way,67.06866666666667,FUN_009648-T1,O62714,,,,,32.4,893.0,4.8e-129,463.8,sp|O62714|CASR_PIG Extracellular calcium-sensing receptor OS=Sus scrofa OX=9823 GN=CASR PE=2 SV=3,,,,,,
OG_02459,FUN_009649-T1,Peve_00003562,Pocillopora_meandrina_HIv1___RNAseq.g24589.t1,three_way,62.382666666666665,FUN_009649-T1,P48442,CASR_RAT,,Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR),Rattus norvegicus (Rat),26.8,892.0,1e-78,296.6,sp|P48442|CASR_RAT Extracellular calcium-sensing receptor OS=Rattus norvegicus OX=10116 GN=Casr PE=1 SV=1,GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; vasodilation [GO:0042311],apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0005886; GO:0048856; GO:0055085; GO:0060089,circulatory system process; plasma membrane; anatomical structure development; transmembrane transport; molecular transducer activity
OG_02460,FUN_009650-T1,Peve_00003560,Pocillopora_meandrina_HIv1___RNAseq.7841_t,three_way,45.96933333333333,FUN_009650-T1,P35400,GRM7_RAT,,Metabotropic glutamate receptor 7 (mGluR7),Rattus norvegicus (Rat),23.1,726.0,1.9999999999999997e-28,129.0,sp|P35400|GRM7_RAT Metabotropic glutamate receptor 7 OS=Rattus norvegicus OX=10116 GN=Grm7 PE=1 SV=1,GO:0001640; GO:0001642; GO:0001661; GO:0001662; GO:0005245; GO:0005246; GO:0005516; GO:0005886; GO:0005938; GO:0007196; GO:0007216; GO:0007268; GO:0007605; GO:0007611; GO:0007613; GO:0007614; GO:0008066; GO:0008306; GO:0009986; GO:0010855; GO:0014050; GO:0016020; GO:0016595; GO:0019226; GO:0030165; GO:0030424; GO:0030425; GO:0030534; GO:0032279; GO:0032991; GO:0033555; GO:0042734; GO:0042802; GO:0043025; GO:0043195; GO:0043198; GO:0043235; GO:0043524; GO:0043679; GO:0045211; GO:0046983; GO:0048306; GO:0048786; GO:0048787; GO:0050877; GO:0051966; GO:0061564; GO:0070085; GO:0070905; GO:0098978; GO:0098982; GO:0099171,"adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adult behavior [GO:0030534]; associative learning [GO:0008306]; axon development [GO:0061564]; behavioral fear response [GO:0001662]; chemical synaptic transmission [GO:0007268]; conditioned taste aversion [GO:0001661]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glycosylation [GO:0070085]; learning or memory [GO:0007611]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system process [GO:0050877]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of sound [GO:0007605]; short-term memory [GO:0007614]; transmission of nerve impulse [GO:0019226]",asymmetric synapse [GO:0032279]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic active zone membrane [GO:0048787]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; terminal bouton [GO:0043195],adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO:0001640]; adenylate cyclase inhibitor activity [GO:0010855]; calcium channel regulator activity [GO:0005246]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; glutamate binding [GO:0016595]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983]; serine binding [GO:0070905]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0060089; GO:0098772,transporter activity; plasma membrane; signaling; nervous system process; molecular transducer activity; molecular function regulator activity
OG_02461,FUN_009652-T1,Peve_00003559,Pocillopora_meandrina_HIv1___RNAseq.g24585.t1,three_way,79.35933333333334,FUN_009652-T1,Q7ZYQ6,,,,,61.2,448.0,2.3e-169,596.7,sp|Q7ZYQ6|DCA13_XENLA DDB1- and CUL4-associated factor 13 OS=Xenopus laevis OX=8355 GN=dcaf13 PE=2 SV=1,,,,,,
OG_02462,FUN_009653-T1,Peve_00003556,Pocillopora_meandrina_HIv1___RNAseq.g24584.t1,three_way,83.244,FUN_009653-T1,Q8TD35,,,,,31.7,161.0,1.1e-08,61.6,sp|Q8TD35|LKAM1_HUMAN Protein LKAAEAR1 OS=Homo sapiens OX=9606 GN=LKAAEAR1 PE=1 SV=3,,,,,,
OG_02463,FUN_009654-T1,Peve_00003555,Pocillopora_meandrina_HIv1___RNAseq.g24583.t1,three_way,69.71183333333333,FUN_009654-T1,A6H8T7,CBPC2_DANRE,,Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2) (Protein deglutamylase CCP2) (Testis-expressed protein 25),Danio rerio (Zebrafish) (Brachydanio rerio),48.3,484.0,1.8e-128,462.2,sp|A6H8T7|CBPC2_DANRE Cytosolic carboxypeptidase 2 OS=Danio rerio OX=7955 GN=zte25 PE=2 SV=1,GO:0004181; GO:0005737; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0035610; GO:0036064,protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508],centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02464,FUN_009655-T1,Peve_00003554,Pocillopora_meandrina_HIv1___RNAseq.g24582.t1,three_way,64.32866666666666,,,,,,,,,,,,,,,,,
OG_02465,FUN_009656-T1,Peve_00003553,Pocillopora_meandrina_HIv1___RNAseq.g24581.t1,three_way,62.471,FUN_009656-T1,P31946,1433B_HUMAN,,"14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]",Homo sapiens (Human),64.4,250.0,2.1e-74,280.4,sp|P31946|1433B_HUMAN 14-3-3 protein beta/alpha OS=Homo sapiens OX=9606 GN=YWHAB PE=1 SV=3,GO:0004860; GO:0004864; GO:0005634; GO:0005737; GO:0005774; GO:0005829; GO:0005925; GO:0006605; GO:0007165; GO:0008104; GO:0016020; GO:0017053; GO:0019899; GO:0019904; GO:0042308; GO:0042470; GO:0042802; GO:0042826; GO:0044877; GO:0045296; GO:0045744; GO:0045892; GO:0045944; GO:0048471; GO:0050815; GO:0051219; GO:0070062; GO:0140311,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of protein import into nucleus [GO:0042308]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; protein targeting [GO:0006605]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription repressor complex [GO:0017053]; vacuolar membrane [GO:0005774],cadherin binding [GO:0045296]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein phosphatase inhibitor activity [GO:0004864]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877],GO:0005634; GO:0005829; GO:0006355; GO:0031410; GO:0043226; GO:0098772; GO:0140313,nucleus; cytosol; regulation of DNA-templated transcription; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sequestering activity
OG_02466,FUN_009657-T1,Peve_00003563,Pocillopora_meandrina_HIv1___RNAseq.g24580.t1,three_way,75.67483333333332,FUN_009657-T1,Q3SZ85,,,,,56.0,116.0,8.6e-31,134.4,sp|Q3SZ85|PTRD1_BOVIN Putative peptidyl-tRNA hydrolase PTRHD1 OS=Bos taurus OX=9913 GN=PTRHD1 PE=2 SV=2,,,,,,
OG_02467,FUN_009661-T1,Peve_00003551,Pocillopora_meandrina_HIv1___RNAseq.g24577.t1,three_way,94.95166666666668,FUN_009661-T1,Q3ZCF3,SKP1_BOVIN,,S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (S-phase kinase-associated protein 1A) (p19A) (p19skp1),Bos taurus (Bovine),84.7,163.0,3.2e-57,222.6,sp|Q3ZCF3|SKP1_BOVIN S-phase kinase-associated protein 1 OS=Bos taurus OX=9913 GN=SKP1 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0016567; GO:0019005; GO:0031146; GO:0031467; GO:0097602,protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],cullin family protein binding [GO:0097602],GO:0005634; GO:0005829; GO:0030163; GO:0043226,nucleus; cytosol; protein catabolic process; organelle
OG_02468,FUN_009667-T1,Peve_00009664,Pocillopora_meandrina_HIv1___RNAseq.g24575.t1,three_way,87.4595,,,,,,,,,,,,,,,,,
OG_02469,FUN_009671-T1,Peve_00009662,Pocillopora_meandrina_HIv1___RNAseq.g24573.t3,three_way,83.01083333333334,FUN_009671-T1,Q9NQB0,,,,,67.8,143.0,2.4e-48,194.5,sp|Q9NQB0|TF7L2_HUMAN Transcription factor 7-like 2 OS=Homo sapiens OX=9606 GN=TCF7L2 PE=1 SV=2,,,,,,
OG_02470,FUN_009672-T1,Peve_00009665,Pocillopora_meandrina_HIv1___RNAseq.g24572.t1,three_way,83.64766666666667,FUN_009672-T1,Q96AJ9,VTI1A_HUMAN,,Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2),Homo sapiens (Human),53.4,189.0,1.2999999999999999e-46,187.6,sp|Q96AJ9|VTI1A_HUMAN Vesicle transport through interaction with t-SNAREs homolog 1A OS=Homo sapiens OX=9606 GN=VTI1A PE=1 SV=2,GO:0000139; GO:0000149; GO:0005484; GO:0005768; GO:0005776; GO:0005789; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006891; GO:0006896; GO:0006914; GO:0008021; GO:0012507; GO:0016236; GO:0030136; GO:0031201; GO:0031902; GO:0032456; GO:0032588; GO:0042147; GO:0043025; GO:0044306; GO:0048280; GO:0048471; GO:0050882,"autophagy [GO:0006914]; endocytic recycling [GO:0032456]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882]",autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588],SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],GO:0005768; GO:0005773; GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0050877; GO:0060090; GO:0061024,endosome; vacuole; Golgi apparatus; cytosol; intracellular protein transport; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; nervous system process; molecular adaptor activity; membrane organization
OG_02471,FUN_009673-T1,Peve_00009666,Pocillopora_meandrina_HIv1___RNAseq.g24571.t1,three_way,77.39833333333334,FUN_009673-T1,Q8WU67,ABHD3_HUMAN,,Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3),Homo sapiens (Human),45.5,378.0,2.5e-98,360.5,sp|Q8WU67|ABHD3_HUMAN Phospholipase ABHD3 OS=Homo sapiens OX=9606 GN=ABHD3 PE=1 SV=2,GO:0004623; GO:0005886; GO:0006656; GO:0008126; GO:0008970; GO:0046470; GO:0047372; GO:0051792; GO:0051793,medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470],plasma membrane [GO:0005886],acetylesterase activity [GO:0008126]; monoacylglycerol lipase activity [GO:0047372]; phospholipase A1 activity [GO:0008970]; phospholipase A2 activity [GO:0004623],GO:0003824; GO:0005886; GO:0006629; GO:0016787,catalytic activity; plasma membrane; lipid metabolic process; hydrolase activity
OG_02472,FUN_009674-T1,Peve_00009258,Pocillopora_meandrina_HIv1___RNAseq.g24570.t1,three_way,65.10866666666666,FUN_009674-T1,Q7ZW47,,,,,34.7,625.0,1.4e-71,272.3,sp|Q7ZW47|STAU2_DANRE Double-stranded RNA-binding protein Staufen homolog 2 OS=Danio rerio OX=7955 GN=stau2 PE=2 SV=2,,,,,,
OG_02473,FUN_009675-T1,Peve_00009262,Pocillopora_meandrina_HIv1___RNAseq.g24569.t1,three_way,75.73666666666666,FUN_009675-T1,Q8K078,SO4A1_MOUSE,,Solute carrier organic anion transporter family member 4A1 (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),Mus musculus (Mouse),38.1,637.0,2.3e-114,414.5,sp|Q8K078|SO4A1_MOUSE Solute carrier organic anion transporter family member 4A1 OS=Mus musculus OX=10090 GN=Slco4a1 PE=1 SV=2,GO:0005886; GO:0006811; GO:0008514; GO:0015132; GO:0015711,monoatomic ion transport [GO:0006811]; organic anion transport [GO:0015711],plasma membrane [GO:0005886],organic anion transmembrane transporter activity [GO:0008514]; prostaglandin transmembrane transporter activity [GO:0015132],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_02474,FUN_009677-T1,Peve_00024097,Pocillopora_meandrina_HIv1___RNAseq.g24567.t1,three_way,78.88666666666667,FUN_009677-T1,Q54LV8,,,,,59.6,94.0,9.6e-25,114.0,sp|Q54LV8|RL34_DICDI Large ribosomal subunit protein eL34 OS=Dictyostelium discoideum OX=44689 GN=rpl34 PE=3 SV=1,,,,,,
OG_02475,FUN_009736-T1,Peve_00033566,Pocillopora_meandrina_HIv1___RNAseq.g29063.t1,three_way,57.04183333333333,FUN_009736-T1,G5EBQ8,CHS2_CAEEL,,Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2),Caenorhabditis elegans,32.1,764.0,9.100000000000001e-104,380.6,sp|G5EBQ8|CHS2_CAEEL Chitin synthase chs-2 OS=Caenorhabditis elegans OX=6239 GN=chs-2 PE=1 SV=1,GO:0004100; GO:0005886; GO:0006031; GO:0061063,chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063],plasma membrane [GO:0005886],chitin synthase activity [GO:0004100],GO:0003824; GO:0005886; GO:0016740; GO:1901135,catalytic activity; plasma membrane; transferase activity; carbohydrate derivative metabolic process
OG_02476,FUN_009764-T1,Peve_00002102,Pocillopora_meandrina_HIv1___RNAseq.g24565.t1b,three_way,82.993,FUN_009764-T1,Q9USM7,,,,,42.9,168.0,3e-25,116.7,sp|Q9USM7|TIM23_SCHPO Mitochondrial import inner membrane translocase subunit tim23 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=tim23 PE=3 SV=1,,,,,,
OG_02477,FUN_009765-T1,Peve_00002101,Pocillopora_meandrina_HIv1___RNAseq.g24565.t1a,three_way,89.815,FUN_009765-T1,Q5ZKH0,TF2H5_CHICK,,General transcription factor IIH subunit 5 (General transcription factor IIH polypeptide 5) (TFB5 ortholog) (TFIIH basal transcription factor complex TTD-A subunit) (TFIIH subunit p8),Gallus gallus (Chicken),71.4,70.0,2e-22,105.9,sp|Q5ZKH0|TF2H5_CHICK General transcription factor IIH subunit 5 OS=Gallus gallus OX=9031 GN=GTF2H5 PE=3 SV=1,GO:0000439; GO:0005654; GO:0005675; GO:0005737; GO:0006294; GO:0006366; GO:0006367,"nucleotide-excision repair, preincision complex assembly [GO:0006294]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]",cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675],,GO:0005654; GO:0006351; GO:0065003,nucleoplasm; DNA-templated transcription; protein-containing complex assembly
OG_02478,FUN_009766-T1,Peve_00002099,Pocillopora_meandrina_HIv1___RNAseq.g24563.t1,three_way,57.70433333333334,,,,,,,,,,,,,,,,,
OG_02479,FUN_009767-T1,Peve_00002100,Pocillopora_meandrina_HIv1___RNAseq.g24564.t1,three_way,61.841,,,,,,,,,,,,,,,,,
OG_02480,FUN_009769-T1,Peve_00033679,Pocillopora_meandrina_HIv1___RNAseq.g24562.t1,three_way,52.39666666666667,FUN_009769-T1,Q6XL69,,,,,33.6,292.0,7.1e-34,147.1,sp|Q6XL69|OPN4_RUTRU Melanopsin OS=Rutilus rutilus OX=48668 GN=opn4 PE=2 SV=1,,,,,,
OG_02481,FUN_009771-T1,Peve_00002097,Pocillopora_meandrina_HIv1___RNAseq.g24559.t1,three_way,79.394,FUN_009771-T1,Q9WVK7,HCDH_RAT,,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)",Rattus norvegicus (Rat),65.4,286.0,9.4e-104,378.3,"sp|Q9WVK7|HCDH_RAT Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Hadh PE=2 SV=1",GO:0003857; GO:0005654; GO:0005739; GO:0005759; GO:0006635; GO:0007283; GO:0009410; GO:0009725; GO:0014823; GO:0030154; GO:0032868; GO:0042802; GO:0046676; GO:0050796; GO:0070403; GO:0120162,cell differentiation [GO:0030154]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]; response to hormone [GO:0009725]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; spermatogenesis [GO:0007283],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; identical protein binding [GO:0042802]; NAD+ binding [GO:0070403],GO:0003824; GO:0005654; GO:0005739; GO:0006629; GO:0016491; GO:0022414; GO:0030154; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; lipid metabolic process; oxidoreductase activity; reproductive process; cell differentiation; organelle
OG_02482,FUN_009776-T1,Peve_00002105,Pocillopora_meandrina_HIv1___TS.g12502.t1,three_way,70.31866666666666,FUN_009776-T1,Q9JID6,,,,,50.2,665.0,5.3e-189,662.5,sp|Q9JID6|ACSL1_CAVPO Long-chain-fatty-acid--CoA ligase 1 OS=Cavia porcellus OX=10141 GN=ACSL1 PE=2 SV=1,,,,,,
OG_02483,FUN_009777-T1,Peve_00002096,Pocillopora_meandrina_HIv1___RNAseq.g24558.t1,three_way,79.21533333333333,FUN_009777-T1,Q9JID6,,,,,48.5,699.0,1e-192,674.9,sp|Q9JID6|ACSL1_CAVPO Long-chain-fatty-acid--CoA ligase 1 OS=Cavia porcellus OX=10141 GN=ACSL1 PE=2 SV=1,,,,,,
OG_02484,FUN_009778-T1,Peve_00026798,Pocillopora_meandrina_HIv1___RNAseq.g24554.t1,three_way,71.61233333333334,FUN_009778-T1,P41216,,,,,47.2,642.0,8e-176,618.6,sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2,,,,,,
OG_02485,FUN_009817-T1,Peve_00020547,Pocillopora_meandrina_HIv1___RNAseq.g24553.t1,three_way,74.48683333333334,FUN_009817-T1,Q3UQI9,,,,,37.9,771.0,2.3e-118,427.9,sp|Q3UQI9|MINY4_MOUSE Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 OS=Mus musculus OX=10090 GN=Mindy4 PE=1 SV=1,,,,,,
OG_02486,FUN_009818-T1,Peve_00042916,Pocillopora_meandrina_HIv1___RNAseq.g24548.t1,three_way,67.266,FUN_009818-T1,Q8MIR4,,,,,38.3,574.0,3.8e-94,347.1,sp|Q8MIR4|COASY_PIG Bifunctional coenzyme A synthase OS=Sus scrofa OX=9823 GN=COASY PE=1 SV=1,,,,,,
OG_02487,FUN_009819-T1,Peve_00042915,Pocillopora_meandrina_HIv1___RNAseq.g24549.t1,three_way,82.49433333333333,FUN_009819-T1,Q711T7,NADE_MOUSE,,Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase) (NH3-dependent NAD(+) synthetase-like protein),Mus musculus (Mouse),68.4,708.0,4.4e-291,1001.9,sp|Q711T7|NADE_MOUSE Glutamine-dependent NAD(+) synthetase OS=Mus musculus OX=10090 GN=Nadsyn1 PE=1 SV=1,GO:0003952; GO:0004359; GO:0005524; GO:0005829; GO:0008795; GO:0009435; GO:0034354; GO:0034355,'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; NAD biosynthetic process [GO:0009435]; NAD biosynthetic process via the salvage pathway [GO:0034355],cytosol [GO:0005829],ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD+ synthase activity [GO:0008795],GO:0003824; GO:0005829; GO:0006520; GO:0016787; GO:0016874; GO:0055086,catalytic activity; cytosol; amino acid metabolic process; hydrolase activity; ligase activity; nucleobase-containing small molecule metabolic process
OG_02488,FUN_009820-T1,Peve_00042914,Pocillopora_meandrina_HIv1___RNAseq.g24547.t1,three_way,81.36066666666666,FUN_009820-T1,Q6NZ09,,,,,50.5,380.0,2.1e-54,214.5,sp|Q6NZ09|ADRM1_DANRE Proteasomal ubiquitin receptor ADRM1 OS=Danio rerio OX=7955 GN=adrm1b PE=1 SV=1,,,,,,
OG_02489,FUN_009821-T1,Peve_00042913,Pocillopora_meandrina_HIv1___RNAseq.g24546.t1,three_way,47.9915,,,,,,,,,,,,,,,,,
OG_02490,FUN_009822-T1,Peve_00042911,Pocillopora_meandrina_HIv1___RNAseq.g24544.t1,three_way,83.21233333333333,FUN_009822-T1,O77460,,,,,68.7,211.0,6.9e-87,321.6,sp|O77460|IPYR_DROME Inorganic pyrophosphatase OS=Drosophila melanogaster OX=7227 GN=Nurf-38 PE=1 SV=3,,,,,,
OG_02491,FUN_009825-T1,Peve_00042910,Pocillopora_meandrina_HIv1___RNAseq.g24543.t1,three_way,67.082,FUN_009825-T1,Q8NC69,KCTD6_HUMAN,,BTB/POZ domain-containing protein KCTD6 (KCASH3 protein) (Potassium channel tetramerization domain-containing protein 6),Homo sapiens (Human),62.2,98.0,8.7e-27,122.1,sp|Q8NC69|KCTD6_HUMAN BTB/POZ domain-containing protein KCTD6 OS=Homo sapiens OX=9606 GN=KCTD6 PE=1 SV=2,GO:0005829; GO:0006511; GO:0016567; GO:0030506; GO:0031430; GO:0042802; GO:0045879; GO:0051260; GO:0097602,negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; M band [GO:0031430],ankyrin binding [GO:0030506]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802],GO:0005829; GO:0008092; GO:0065003,cytosol; cytoskeletal protein binding; protein-containing complex assembly
OG_02492,FUN_009826-T1,Peve_00042909,Pocillopora_meandrina_HIv1___TS.g12488.t1,three_way,47.22083333333333,FUN_009826-T1,Q91WI7,,,,,34.6,257.0,1.2e-30,136.0,sp|Q91WI7|ITFG2_MOUSE KICSTOR complex protein ITFG2 OS=Mus musculus OX=10090 GN=Itfg2 PE=2 SV=1,,,,,,
OG_02493,FUN_009827-T1,Peve_00042907,Pocillopora_meandrina_HIv1___RNAseq.g24538.t1,three_way,56.699,FUN_009827-T1,Q0IHA2,,,,,41.0,278.0,2.7e-48,193.7,sp|Q0IHA2|ELP6_XENLA Elongator complex protein 6 OS=Xenopus laevis OX=8355 GN=elp6 PE=2 SV=1,,,,,,
OG_02494,FUN_009828-T1,Peve_00042906,Pocillopora_meandrina_HIv1___TS.g12483.t2,three_way,70.49633333333334,FUN_009828-T1,Q58D00,,,,,50.3,344.0,9.999999999999999e-51,202.2,sp|Q58D00|FBXW2_BOVIN F-box/WD repeat-containing protein 2 OS=Bos taurus OX=9913 GN=FBXW2 PE=2 SV=1,,,,,,
OG_02495,FUN_009829-T1,Peve_00042905,Pocillopora_meandrina_HIv1___RNAseq.g24536.t1,three_way,71.46266666666666,FUN_009829-T1,Q9VKA4,,,,,35.4,539.0,1.8e-89,332.0,sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3,,,,,,
OG_02496,FUN_009830-T2,Peve_00034091,Pocillopora_meandrina_HIv1___RNAseq.g24529.t1,three_way,75.58566666666667,,,,,,,,,,,,,,,,,
OG_02497,FUN_009835-T1,Peve_00000517,Pocillopora_meandrina_HIv1___RNAseq.g24530.t2,three_way,68.508,FUN_009835-T1,Q6PDN3,MYLK_MOUSE,,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",Mus musculus (Mouse),46.4,371.0,2.3e-87,327.0,"sp|Q6PDN3|MYLK_MOUSE Myosin light chain kinase, smooth muscle OS=Mus musculus OX=10090 GN=Mylk PE=1 SV=3",GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0005911; GO:0006939; GO:0014820; GO:0019899; GO:0030027; GO:0032154; GO:0035865; GO:0046872; GO:0071277; GO:0071466; GO:0098969,cellular response to calcium ion [GO:0071277]; cellular response to potassium ion [GO:0035865]; cellular response to xenobiotic stimulus [GO:0071466]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820],cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725],actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687],GO:0003012; GO:0003824; GO:0008092; GO:0016192; GO:0016740; GO:0140096,"muscle system process; catalytic activity; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_02498,FUN_009837-T1,Peve_00000550,Pocillopora_meandrina_HIv1___RNAseq.g24514.t1,three_way,66.32433333333333,FUN_009837-T1,Q7PIR5,,,,,34.9,461.0,2.1e-83,311.2,sp|Q7PIR5|TRET1_ANOGA Facilitated trehalose transporter Tret1 OS=Anopheles gambiae OX=7165 GN=Tret1 PE=1 SV=3,,,,,,
OG_02499,FUN_009842-T1,Peve_00009093,Pocillopora_meandrina_HIv1___RNAseq.g24508.t1,three_way,68.48066666666666,FUN_009842-T1,Q9NY64,SL2A8_HUMAN,,"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)",Homo sapiens (Human),43.6,463.0,1.5e-97,358.2,"sp|Q9NY64|SL2A8_HUMAN Solute carrier family 2, facilitated glucose transporter member 8 OS=Homo sapiens OX=9606 GN=SLC2A8 PE=1 SV=3",GO:0001666; GO:0005353; GO:0005536; GO:0005765; GO:0005886; GO:0005975; GO:0007141; GO:0008021; GO:0008286; GO:0008645; GO:0015755; GO:0016020; GO:0030669; GO:0033300; GO:0055056; GO:0070837; GO:1904659,carbohydrate metabolic process [GO:0005975]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; fructose transmembrane transport [GO:0015755]; hexose transmembrane transport [GO:0008645]; insulin receptor signaling pathway [GO:0008286]; male meiosis I [GO:0007141]; response to hypoxia [GO:0001666],clathrin-coated endocytic vesicle membrane [GO:0030669]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021],D-glucose binding [GO:0005536]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; fructose transmembrane transporter activity [GO:0005353],GO:0005215; GO:0005886; GO:0005975; GO:0022414; GO:0031410; GO:0043226; GO:0055085; GO:0140013,transporter activity; plasma membrane; carbohydrate metabolic process; reproductive process; cytoplasmic vesicle; organelle; transmembrane transport; meiotic nuclear division
OG_02500,FUN_009849-T1,Peve_00030326,Pocillopora_meandrina_HIv1___RNAseq.27460_t,three_way,66.62333333333333,FUN_009849-T1,P55024,,,,,37.1,474.0,1.3e-99,365.2,sp|P55024|TYRO_CHICK Tyrosinase OS=Gallus gallus OX=9031 GN=TYR PE=2 SV=1,,,,,,
OG_02501,FUN_009856-T1,Peve_00009092,Pocillopora_meandrina_HIv1___RNAseq.g24507.t1,three_way,69.30833333333334,,,,,,,,,,,,,,,,,
OG_02502,FUN_009857-T2,Peve_00009100,Pocillopora_meandrina_HIv1___RNAseq.g24506.t1,three_way,84.31183333333333,FUN_009857-T2,Q92005,,,,,85.1,462.0,2.2e-231,802.7,sp|Q92005|EF1A_DANRE Elongation factor 1-alpha OS=Danio rerio OX=7955 GN=eef1a PE=2 SV=1,,,,,,
OG_02503,FUN_009858-T1,Peve_00009097,Pocillopora_meandrina_HIv1___RNAseq.g24505.t1,three_way,80.89733333333334,,,,,,,,,,,,,,,,,
OG_02504,FUN_009960-T1,Peve_00007862,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1b,three_way,73.25516666666667,,,,,,,,,,,,,,,,,
OG_02505,FUN_009961-T1,Peve_00036464,Pocillopora_meandrina_HIv1___RNAseq.g24242.t1,three_way,77.88566666666667,FUN_009961-T1,Q90ZC7,KCMA1_XENLA,,"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (xSlo)",Xenopus laevis (African clawed frog),45.5,1111.0,7.3e-262,905.2,sp|Q90ZC7|KCMA1_XENLA Calcium-activated potassium channel subunit alpha-1 OS=Xenopus laevis OX=8355 GN=kcnma1 PE=2 SV=1,GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805,potassium ion transmembrane transport [GO:0071805],monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211],large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_02506,FUN_010017-T1,Peve_00036453,Pocillopora_meandrina_HIv1___RNAseq.g24247.t1,three_way,69.965,FUN_010017-T1,Q9H2I8,,,,,53.6,151.0,4.3e-35,149.1,sp|Q9H2I8|LRMDA_HUMAN Leucine-rich melanocyte differentiation-associated protein OS=Homo sapiens OX=9606 GN=LRMDA PE=1 SV=1,,,,,,
OG_02507,FUN_010019-T1,Peve_00036456,Pocillopora_meandrina_HIv1___TS.g12195.t1a,three_way,70.6275,FUN_010019-T1,Q7Z5K2,WAPL_HUMAN,,Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor),Homo sapiens (Human),38.7,545.0,3.8e-92,340.9,sp|Q7Z5K2|WAPL_HUMAN Wings apart-like protein homolog OS=Homo sapiens OX=9606 GN=WAPL PE=1 SV=1,GO:0000070; GO:0000775; GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0008156; GO:0035562; GO:0043231; GO:0045171; GO:0045875; GO:0051301; GO:0071168; GO:0072686; GO:0140083,cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; protein localization to chromatin [GO:0071168],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP-dependent protein-DNA unloader activity [GO:0140083],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007059; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; chromosome segregation; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02508,FUN_010020-T1,Peve_00036457,Pocillopora_meandrina_HIv1___RNAseq.g24255.t1,three_way,74.96866666666666,FUN_010020-T1,Q7ZWN6,Z703A_XENLA,,Zinc finger protein 703-A,Xenopus laevis (African clawed frog),29.2,517.0,1.9e-22,108.6,sp|Q7ZWN6|Z703A_XENLA Zinc finger protein 703-A OS=Xenopus laevis OX=8355 GN=znf703-a PE=2 SV=2,GO:0005634; GO:0005737; GO:0008270; GO:0016363; GO:0017015; GO:0030335; GO:0034111; GO:0034333; GO:0045892; GO:0051726; GO:0060828,adherens junction assembly [GO:0034333]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0006355; GO:0034330; GO:0043226,nucleus; regulation of DNA-templated transcription; cell junction organization; organelle
OG_02509,FUN_010108-T1,Peve_00015789,Pocillopora_meandrina_HIv1___RNAseq.g21842.t1,three_way,43.70616666666667,,,,,,,,,,,,,,,,,
OG_02510,FUN_010170-T1,Peve_00023113,Pocillopora_meandrina_HIv1___RNAseq.g14645.t1,three_way,56.741166666666665,,,,,,,,,,,,,,,,,
OG_02511,FUN_010518-T1,Peve_00003566,Pocillopora_meandrina_HIv1___RNAseq.g12949.t1,three_way,56.06633333333333,FUN_010518-T1,Q5BKC9,NGEF_RAT,,Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor),Rattus norvegicus (Rat),35.8,573.0,2.1e-92,342.4,sp|Q5BKC9|NGEF_RAT Ephexin-1 OS=Rattus norvegicus OX=10116 GN=Ngef PE=1 SV=2,GO:0005085; GO:0005737; GO:0007399; GO:0016020; GO:0030154; GO:0030426; GO:0032956; GO:0043087; GO:0046875; GO:0048013; GO:0061002; GO:0098794; GO:0098978; GO:1905806,cell differentiation [GO:0030154]; ephrin receptor signaling pathway [GO:0048013]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of synapse pruning [GO:1905806],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; postsynapse [GO:0098794],ephrin receptor binding [GO:0046875]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0030154; GO:0048856; GO:0098772,cell differentiation; anatomical structure development; molecular function regulator activity
OG_02512,FUN_010555-T1,Peve_00032733,Pocillopora_meandrina_HIv1___RNAseq.g21411.t1,three_way,87.566,FUN_010555-T1,Q9R244,TRPC2_MOUSE,,Short transient receptor potential channel 2 (TrpC2) (Transient receptor protein 2) (TRP-2) (mTrp2),Mus musculus (Mouse),25.4,508.0,1.8e-30,137.1,sp|Q9R244|TRPC2_MOUSE Short transient receptor potential channel 2 OS=Mus musculus OX=10090 GN=Trpc2 PE=2 SV=2,GO:0000012; GO:0000139; GO:0002118; GO:0002121; GO:0002124; GO:0003684; GO:0005516; GO:0005634; GO:0005635; GO:0005789; GO:0005886; GO:0006816; GO:0007204; GO:0007340; GO:0008050; GO:0010468; GO:0012505; GO:0015279; GO:0019236; GO:0019992; GO:0032590; GO:0048047; GO:0070679; GO:1902436,"acrosome reaction [GO:0007340]; aggressive behavior [GO:0002118]; calcium ion transport [GO:0006816]; female courtship behavior [GO:0008050]; inter-male aggressive behavior [GO:0002121]; mating behavior, sex discrimination [GO:0048047]; negative regulation of male mating behavior [GO:1902436]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of gene expression [GO:0010468]; response to pheromone [GO:0019236]; single strand break repair [GO:0000012]; territorial aggressive behavior [GO:0002124]",dendrite membrane [GO:0032590]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calmodulin binding [GO:0005516]; damaged DNA binding [GO:0003684]; diacylglycerol binding [GO:0019992]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0003677; GO:0005215; GO:0005634; GO:0005635; GO:0005886; GO:0006281; GO:0008289; GO:0022414; GO:0043226,DNA binding; transporter activity; nucleus; nuclear envelope; plasma membrane; DNA repair; lipid binding; reproductive process; organelle
OG_02513,FUN_010557-T1,Peve_00032715,Pocillopora_meandrina_HIv1___TS.g26164.t1,three_way,92.39433333333334,FUN_010557-T1,Q2KII4,ELOC_BOVIN,,Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1),Bos taurus (Bovine),88.0,108.0,5.8e-51,201.4,sp|Q2KII4|ELOC_BOVIN Elongin-C OS=Bos taurus OX=9913 GN=ELOC PE=1 SV=1,GO:0006511; GO:0016567; GO:0030674; GO:0031466; GO:0070449,protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],Cul5-RING ubiquitin ligase complex [GO:0031466]; elongin complex [GO:0070449],protein-macromolecule adaptor activity [GO:0030674],GO:0060090,molecular adaptor activity
OG_02514,FUN_010558-T3,Peve_00032721,Pocillopora_meandrina_HIv1___RNAseq.g21414.t1,three_way,80.07333333333334,FUN_010558-T3,Q3KQ80,,,,,42.1,316.0,1e-56,222.2,sp|Q3KQ80|STPG1_XENLA O(6)-methylguanine-induced apoptosis 2 OS=Xenopus laevis OX=8355 GN=stpg1 PE=2 SV=1,,,,,,
OG_02515,FUN_010573-T1,Peve_00032730,Pocillopora_meandrina_HIv1___RNAseq.g21525.t1,three_way,71.62433333333333,FUN_010573-T1,Q7RTU0,,,,,44.0,109.0,1.2e-12,74.3,sp|Q7RTU0|TCF24_HUMAN Transcription factor 24 OS=Homo sapiens OX=9606 GN=TCF24 PE=1 SV=3,,,,,,
OG_02516,FUN_010575-T1,Peve_00032734,Pocillopora_meandrina_HIv1___RNAseq.g21523.t1,three_way,73.19066666666667,FUN_010575-T1,Q9C091,GRB1L_HUMAN,,GREB1-like protein (Growth regulation by estrogen in breast cancer 1-like protein),Homo sapiens (Human),33.4,1940.0,6.8e-250,866.3,sp|Q9C091|GRB1L_HUMAN GREB1-like protein OS=Homo sapiens OX=9606 GN=GREB1L PE=1 SV=2,GO:0001656; GO:0001658; GO:0001822; GO:0002009; GO:0003151; GO:0003231; GO:0016020; GO:0030539; GO:0035050; GO:0042254; GO:0048384; GO:0055007; GO:0060065; GO:0061205; GO:0072177,branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac muscle cell differentiation [GO:0055007]; cardiac ventricle development [GO:0003231]; embryonic heart tube development [GO:0035050]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; mesonephric duct development [GO:0072177]; metanephros development [GO:0001656]; morphogenesis of an epithelium [GO:0002009]; outflow tract morphogenesis [GO:0003151]; paramesonephric duct development [GO:0061205]; retinoic acid receptor signaling pathway [GO:0048384]; ribosome biogenesis [GO:0042254]; uterus development [GO:0060065],membrane [GO:0016020],,GO:0022414; GO:0030154; GO:0042254; GO:0048856,reproductive process; cell differentiation; ribosome biogenesis; anatomical structure development
OG_02517,FUN_010576-T1,Peve_00032735,Pocillopora_meandrina_HIv1___RNAseq.g21522.t1,three_way,61.242666666666665,,,,,,,,,,,,,,,,,
OG_02518,FUN_010578-T1,Peve_00032737,Pocillopora_meandrina_HIv1___RNAseq.g21520.t1,three_way,58.39266666666666,FUN_010578-T1,Q8SX37,CDIPT_DROME,,CDP-diacylglycerol--inositol 3-phosphatidyltransferase (CDIPT) (EC 2.7.8.11) (Phosphatidylinositol synthase),Drosophila melanogaster (Fruit fly),37.2,188.0,9.999999999999999e-27,121.7,sp|Q8SX37|CDIPT_DROME CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Drosophila melanogaster OX=7227 GN=Pis PE=1 SV=1,GO:0003881; GO:0005794; GO:0006661; GO:0007602; GO:0016324; GO:0016328; GO:0046872; GO:0071711,basement membrane organization [GO:0071711]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602],apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328],CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0006629; GO:0016740; GO:0030198; GO:0043226,catalytic activity; Golgi apparatus; lipid metabolic process; transferase activity; extracellular matrix organization; organelle
OG_02519,FUN_010579-T1,Peve_00032738,Pocillopora_meandrina_HIv1___RNAseq.g21519.t1,three_way,42.1245,FUN_010579-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),23.7,329.0,4.3e-11,71.2,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_02520,FUN_010583-T1,Peve_00032748,Pocillopora_meandrina_HIv1___RNAseq.g21517.t1,three_way,94.21833333333332,FUN_010583-T1,Q28FC1,UBE2W_XENTR,,Ubiquitin-conjugating enzyme E2 W (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme W) (N-terminal E2 ubiquitin-conjugating enzyme) (EC 2.3.2.25) (Ubiquitin carrier protein W) (Ubiquitin-protein ligase W),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),73.3,150.0,1.2e-66,253.8,sp|Q28FC1|UBE2W_XENTR Ubiquitin-conjugating enzyme E2 W OS=Xenopus tropicalis OX=8364 GN=ube2w PE=2 SV=1,GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006515; GO:0043161; GO:0061631; GO:0071218,cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0006281; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA repair; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02521,FUN_010586-T1,Peve_00032749,Pocillopora_meandrina_HIv1___RNAseq.g21514.t1,three_way,59.089333333333336,FUN_010586-T1,Q28EM3,PARI_XENTR,,PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),24.7,636.0,5.9000000000000005e-30,134.0,sp|Q28EM3|PARI_XENTR PCNA-interacting partner OS=Xenopus tropicalis OX=8364 GN=parpbp PE=2 SV=2,GO:0000785; GO:0003677; GO:0005634; GO:0005737; GO:0006281; GO:2000042,DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0006281; GO:0043226,DNA binding; nucleus; DNA repair; organelle
OG_02522,FUN_010588-T1,Peve_00032700,Pocillopora_meandrina_HIv1___RNAseq.g21512.t1,three_way,83.79533333333333,FUN_010588-T1,Q6INX4,,,,,58.8,434.0,3.0000000000000003e-161,569.7,sp|Q6INX4|ENOF1_XENLA Mitochondrial enolase superfamily member 1 OS=Xenopus laevis OX=8355 GN=enosf1 PE=2 SV=1,,,,,,
OG_02523,FUN_010591-T1,Peve_00032703,Pocillopora_meandrina_HIv1___RNAseq.g21510.t1,three_way,77.489,FUN_010591-T1,B1VTI5,GRIF_STRGG,,Grixazone synthase (EC 1.10.3.15) (Phenoxazinone synthase) (PHS) (o-aminophenol oxidase) (EC 1.10.3.4),Streptomyces griseus subsp. griseus (strain JCM 4626 / CBS 651.72 / NBRC 13350 / KCC S-0626 / ISP 5235),30.5,269.0,1.4e-13,79.0,sp|B1VTI5|GRIF_STRGG Grixazone synthase OS=Streptomyces griseus subsp. griseus (strain JCM 4626 / CBS 651.72 / NBRC 13350 / KCC S-0626 / ISP 5235) OX=455632 GN=griF PE=1 SV=1,GO:0005507; GO:0017000; GO:0050149,antibiotic biosynthetic process [GO:0017000],,copper ion binding [GO:0005507]; o-aminophenol oxidase activity [GO:0050149],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_02524,FUN_010592-T2,Peve_00032705,Pocillopora_meandrina_HIv1___RNAseq.g21509.t1,three_way,78.5945,FUN_010592-T2,E9PVD1,CCD62_MOUSE,,Coiled-coil domain-containing protein 62,Mus musculus (Mouse),29.6,324.0,1.0000000000000001e-29,133.3,sp|E9PVD1|CCD62_MOUSE Coiled-coil domain-containing protein 62 OS=Mus musculus OX=10090 GN=Ccdc62 PE=1 SV=1,GO:0001669; GO:0001835; GO:0003713; GO:0005634; GO:0007286; GO:0030331; GO:0030520; GO:0045944; GO:0071392,blastocyst hatching [GO:0001835]; cellular response to estradiol stimulus [GO:0071392]; estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; nucleus [GO:0005634],nuclear estrogen receptor binding [GO:0030331]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0006355; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; regulation of DNA-templated transcription; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_02525,FUN_010597-T1,Peve_00032712,Pocillopora_meandrina_HIv1___RNAseq.g21497.t1,three_way,66.67666666666666,FUN_010597-T1,Q9LQV2,,,,,31.0,432.0,1.0999999999999999e-47,193.0,sp|Q9LQV2|RDR1_ARATH RNA-dependent RNA polymerase 1 OS=Arabidopsis thaliana OX=3702 GN=RDR1 PE=2 SV=1,,,,,,
OG_02526,FUN_010598-T1,Peve_00032709,Pocillopora_meandrina_HIv1___RNAseq.g21501.t1,three_way,41.12233333333334,FUN_010598-T1,O82504,,,,,24.5,420.0,8.599999999999999e-24,113.6,sp|O82504|RDR2_ARATH RNA-dependent RNA polymerase 2 OS=Arabidopsis thaliana OX=3702 GN=RDR2 PE=1 SV=1,,,,,,
OG_02527,FUN_010601-T1,Peve_00032713,Pocillopora_meandrina_HIv1___RNAseq.g21495.t1,three_way,71.13166666666666,,,,,,,,,,,,,,,,,
OG_02528,FUN_010603-T1,Peve_00032714,Pocillopora_meandrina_HIv1___RNAseq.g21494.t1,three_way,81.04033333333334,FUN_010603-T1,O54992,,,,,46.6,468.0,1.4e-121,438.0,sp|O54992|MAPK5_MOUSE MAP kinase-activated protein kinase 5 OS=Mus musculus OX=10090 GN=Mapkapk5 PE=1 SV=1,,,,,,
OG_02529,FUN_010604-T1,Peve_00032717,Pocillopora_meandrina_HIv1___RNAseq.g21493.t1,three_way,50.83316666666667,,,,,,,,,,,,,,,,,
OG_02530,FUN_010605-T1,Peve_00032718,Pocillopora_meandrina_HIv1___RNAseq.g21492.t1,three_way,67.90016666666666,FUN_010605-T1,Q9ULK6,,,,,40.0,95.0,5.7e-13,77.0,sp|Q9ULK6|RN150_HUMAN RING finger protein 150 OS=Homo sapiens OX=9606 GN=RNF150 PE=1 SV=2,,,,,,
OG_02531,FUN_010606-T1,Peve_00032719,Pocillopora_meandrina_HIv1___RNAseq.g21491.t1,three_way,76.36316666666666,FUN_010606-T1,Q5SSZ7,ZNRF3_MOUSE,,E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3),Mus musculus (Mouse),50.3,302.0,2.7e-80,300.8,sp|Q5SSZ7|ZNRF3_MOUSE E3 ubiquitin-protein ligase ZNRF3 OS=Mus musculus OX=10090 GN=Znrf3 PE=1 SV=1,GO:0004842; GO:0005109; GO:0005886; GO:0006511; GO:0008270; GO:0016055; GO:0016567; GO:0030178; GO:0038018; GO:0060173; GO:0060828; GO:0072089; GO:0090090; GO:2000051; GO:2000095,"limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055]",plasma membrane [GO:0005886],frizzled binding [GO:0005109]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_02532,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_02533,FUN_010612-T1,Peve_00013341,Pocillopora_meandrina_HIv1___RNAseq.g21490.t1,three_way,91.46666666666668,FUN_010612-T1,Q5RBL6,GOSR1_PONAB,,Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),61.8,238.0,2e-77,290.4,sp|Q5RBL6|GOSR1_PONAB Golgi SNAP receptor complex member 1 OS=Pongo abelii OX=9601 GN=GOSR1 PE=2 SV=1,GO:0000139; GO:0005484; GO:0005797; GO:0005801; GO:0006888; GO:0006906; GO:0015031; GO:0031201; GO:0048219,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; protein transport [GO:0015031]; vesicle fusion [GO:0006906],cis-Golgi network [GO:0005801]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; SNARE complex [GO:0031201],SNAP receptor activity [GO:0005484],GO:0016192; GO:0043226; GO:0060090; GO:0061024,vesicle-mediated transport; organelle; molecular adaptor activity; membrane organization
OG_02534,FUN_010613-T1,Peve_00013441,Pocillopora_meandrina_HIv1___RNAseq.g21489.t1,three_way,59.64266666666666,FUN_010613-T1,Q569U0,,,,,43.5,835.0,1.6000000000000002e-170,601.7,sp|Q569U0|MYO19_XENLA Unconventional myosin-XIX OS=Xenopus laevis OX=8355 GN=myo19 PE=2 SV=1,,,,,,
OG_02535,FUN_010614-T1,Peve_00013367,Pocillopora_meandrina_HIv1___RNAseq.g21488.t1,three_way,71.218,FUN_010614-T1,A7SWH1,PESC_NEMVE,,Pescadillo homolog,Nematostella vectensis (Starlet sea anemone),65.3,444.0,5.3e-170,599.0,sp|A7SWH1|PESC_NEMVE Pescadillo homolog OS=Nematostella vectensis OX=45351 GN=v1g194255 PE=3 SV=1,GO:0000463; GO:0000466; GO:0003723; GO:0005654; GO:0030687; GO:0043021; GO:0070545,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]","nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome, large subunit precursor [GO:0030687]",ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723],GO:0003723; GO:0005654,RNA binding; nucleoplasm
OG_02536,FUN_010615-T1,Peve_00013370,Pocillopora_meandrina_HIv1___RNAseq.g21487.t1,three_way,60.214333333333336,FUN_010615-T1,Q8HZ58,,,,,23.2,293.0,1.3e-09,67.0,sp|Q8HZ58|CCHCR_PONPY Coiled-coil alpha-helical rod protein 1 OS=Pongo pygmaeus OX=9600 GN=CCHCR1 PE=3 SV=1,,,,,,
OG_02537,FUN_010620-T1,Peve_00031460,Pocillopora_meandrina_HIv1___TS.g26115.t1,three_way,50.77283333333333,FUN_010620-T1,O14514,AGRB1_HUMAN,,Adhesion G protein-coupled receptor B1 (Brain-specific angiogenesis inhibitor 1) [Cleaved into: Vasculostatin-40 (Vstat40); Vasculostatin-120 (Vstat120)],Homo sapiens (Human),29.6,659.0,2e-63,246.9,sp|O14514|AGRB1_HUMAN Adhesion G protein-coupled receptor B1 OS=Homo sapiens OX=9606 GN=ADGRB1 PE=1 SV=2,GO:0001530; GO:0001786; GO:0001891; GO:0004930; GO:0005615; GO:0005886; GO:0005911; GO:0005925; GO:0006910; GO:0007155; GO:0007165; GO:0007166; GO:0007186; GO:0007189; GO:0007409; GO:0007422; GO:0007517; GO:0008285; GO:0010596; GO:0014069; GO:0016020; GO:0016525; GO:0030165; GO:0030425; GO:0031397; GO:0042177; GO:0043197; GO:0043277; GO:0043652; GO:0045087; GO:0048167; GO:0048471; GO:0050829; GO:0051965; GO:1901741; GO:1903428,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]",cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786],GO:0002376; GO:0005615; GO:0005886; GO:0007155; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0060089; GO:0061024; GO:0098542,immune system process; extracellular space; plasma membrane; cell adhesion; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; molecular transducer activity; membrane organization; defense response to other organism
OG_02538,FUN_010621-T1,Peve_00010093,Pocillopora_meandrina_HIv1___RNAseq.g20926.t1,three_way,86.82916666666667,FUN_010621-T1,Q32PW3,,,,,56.5,901.0,4.6000000000000006e-303,1042.0,sp|Q32PW3|TAF2_DANRE Transcription initiation factor TFIID subunit 2 OS=Danio rerio OX=7955 GN=taf2 PE=2 SV=2,,,,,,
OG_02539,FUN_010622-T1,Peve_00010090,Pocillopora_meandrina_HIv1___RNAseq.g20925.t1,three_way,73.781,,,,,,,,,,,,,,,,,
OG_02540,FUN_010623-T1,Peve_00004505,Pocillopora_meandrina_HIv1___RNAseq.g21294.t1,three_way,68.17916666666667,FUN_010623-T1,Q91VZ6,SMAP1_MOUSE,,Stromal membrane-associated protein 1,Mus musculus (Mouse),63.0,138.0,4.2999999999999996e-46,187.2,sp|Q91VZ6|SMAP1_MOUSE Stromal membrane-associated protein 1 OS=Mus musculus OX=10090 GN=Smap1 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005886; GO:0008270; GO:0030276; GO:0045648; GO:2000369,positive regulation of erythrocyte differentiation [GO:0045648]; regulation of clathrin-dependent endocytosis [GO:2000369],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],clathrin binding [GO:0030276]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005886; GO:0098772,plasma membrane; molecular function regulator activity
OG_02541,FUN_010624-T1,Peve_00004472,Pocillopora_meandrina_HIv1___TS.g26046.t2,three_way,68.38433333333333,FUN_010624-T1,Q6NSQ7,,,,,44.8,415.0,2.5000000000000003e-78,294.3,sp|Q6NSQ7|LTV1_MOUSE Protein LTV1 homolog OS=Mus musculus OX=10090 GN=Ltv1 PE=1 SV=2,,,,,,
OG_02542,FUN_010625-T1,Peve_00004473,Pocillopora_meandrina_HIv1___RNAseq.g21297.t1,three_way,62.984,,,,,,,,,,,,,,,,,
OG_02543,FUN_010626-T1,Peve_00004474,Pocillopora_meandrina_HIv1___RNAseq.g21298.t1,three_way,89.19266666666667,FUN_010626-T1,Q91YL3,,,,,66.8,400.0,5.5e-149,528.9,sp|Q91YL3|UCKL1_MOUSE Uridine-cytidine kinase-like 1 OS=Mus musculus OX=10090 GN=Uckl1 PE=1 SV=1,,,,,,
OG_02544,FUN_010629-T1,Peve_00004477,Pocillopora_meandrina_HIv1___RNAseq.g21301.t1,three_way,72.79866666666668,,,,,,,,,,,,,,,,,
OG_02545,FUN_010630-T1,Peve_00004479,Pocillopora_meandrina_HIv1___RNAseq.g21302.t1,three_way,47.447833333333335,,,,,,,,,,,,,,,,,
OG_02546,FUN_010633-T1,Peve_00004481,Pocillopora_meandrina_HIv1___RNAseq.g21305.t1,three_way,37.91866666666667,FUN_010633-T1,Q6P0J3,SP8_DANRE,,Transcription factor Sp8,Danio rerio (Zebrafish) (Brachydanio rerio),48.8,84.0,4.1e-15,84.7,sp|Q6P0J3|SP8_DANRE Transcription factor Sp8 OS=Danio rerio OX=7955 GN=sp8b PE=2 SV=1,GO:0000978; GO:0000981; GO:0003690; GO:0005634; GO:0006357; GO:0008270; GO:0030326; GO:0035118; GO:0045743,embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_02547,FUN_010634-T1,Peve_00009631,Pocillopora_meandrina_HIv1___RNAseq.g21306.t1,three_way,52.05883333333333,,,,,,,,,,,,,,,,,
OG_02548,FUN_010635-T1,Peve_00009633,Pocillopora_meandrina_HIv1___RNAseq.g21307.t2,three_way,60.11416666666666,FUN_010635-T1,P07996,TSP1_HUMAN,,Thrombospondin-1 (Glycoprotein G),Homo sapiens (Human),59.6,525.0,5.4e-56,221.5,sp|P07996|TSP1_HUMAN Thrombospondin-1 OS=Homo sapiens OX=9606 GN=THBS1 PE=1 SV=2,GO:0001666; GO:0001786; GO:0001937; GO:0001953; GO:0001968; GO:0002020; GO:0002040; GO:0002544; GO:0002581; GO:0002605; GO:0004866; GO:0005178; GO:0005201; GO:0005509; GO:0005576; GO:0005577; GO:0005615; GO:0005783; GO:0005788; GO:0006915; GO:0006954; GO:0006955; GO:0006986; GO:0007155; GO:0008201; GO:0008284; GO:0008285; GO:0009410; GO:0009612; GO:0009749; GO:0009897; GO:0009986; GO:0010595; GO:0010596; GO:0010748; GO:0010751; GO:0010754; GO:0010757; GO:0010759; GO:0010763; GO:0016477; GO:0016525; GO:0016529; GO:0017134; GO:0018149; GO:0030141; GO:0030169; GO:0030194; GO:0030335; GO:0030511; GO:0031012; GO:0031091; GO:0031093; GO:0032026; GO:0032570; GO:0032693; GO:0032695; GO:0032720; GO:0032760; GO:0032914; GO:0033574; GO:0034605; GO:0034976; GO:0038060; GO:0040037; GO:0042327; GO:0042803; GO:0043032; GO:0043066; GO:0043236; GO:0043394; GO:0043410; GO:0043536; GO:0043537; GO:0043652; GO:0045727; GO:0045766; GO:0048266; GO:0048661; GO:0050431; GO:0050921; GO:0051592; GO:0051895; GO:0051897; GO:0051918; GO:0062023; GO:0070051; GO:0070052; GO:0070062; GO:0071356; GO:0071363; GO:0090051; GO:1902043; GO:1903588; GO:1903671; GO:2000353; GO:2000379; GO:2001027; GO:2001237,apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide-cGMP-mediated signaling [GO:0038060]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phosphorylation [GO:0042327]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141],calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; endopeptidase inhibitor activity [GO:0004866]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431],GO:0002376; GO:0005198; GO:0005576; GO:0005615; GO:0005783; GO:0006954; GO:0007155; GO:0008289; GO:0012501; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048870; GO:0061024; GO:0098772,immune system process; structural molecule activity; extracellular region; extracellular space; endoplasmic reticulum; inflammatory response; cell adhesion; lipid binding; programmed cell death; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; cell motility; membrane organization; molecular function regulator activity
OG_02549,FUN_010637-T1,Peve_00009635,Pocillopora_meandrina_HIv1___RNAseq.g21308.t1,three_way,68.79866666666666,FUN_010637-T1,P0CB87,,,,,40.6,64.0,2.4e-07,56.2,sp|P0CB87|NDUS5_PONAB NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 OS=Pongo abelii OX=9601 GN=NDUFS5 PE=3 SV=1,,,,,,
OG_02550,FUN_010638-T1,Peve_00009636,Pocillopora_meandrina_HIv1___RNAseq.g21309.t1,three_way,85.60366666666667,FUN_010638-T1,P79733,RIR2_DANRE,,Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase protein R2 class I) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit),Danio rerio (Zebrafish) (Brachydanio rerio),79.4,335.0,5.3e-151,535.4,sp|P79733|RIR2_DANRE Ribonucleoside-diphosphate reductase subunit M2 OS=Danio rerio OX=7955 GN=rrm2 PE=1 SV=1,GO:0004748; GO:0005829; GO:0009263; GO:0046872,deoxyribonucleotide biosynthetic process [GO:0009263],cytosol [GO:0005829],"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",GO:0003824; GO:0005829; GO:0016491; GO:0055086; GO:1901135,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02551,FUN_010639-T1,Peve_00031436,Pocillopora_meandrina_HIv1___RNAseq.g21310.t1,three_way,70.05816666666666,FUN_010639-T1,D4A2Y9,PEX13_RAT,,Peroxisomal membrane protein PEX13 (Peroxin-13),Rattus norvegicus (Rat),45.8,212.0,4.4e-48,193.7,sp|D4A2Y9|PEX13_RAT Peroxisomal membrane protein PEX13 OS=Rattus norvegicus OX=10116 GN=Pex13 PE=1 SV=3,GO:0001561; GO:0001764; GO:0001967; GO:0005777; GO:0005778; GO:0007626; GO:0008320; GO:0016560; GO:0016561; GO:0021795; GO:0034614; GO:0060152; GO:1990429,"cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; fatty acid alpha-oxidation [GO:0001561]; locomotory behavior [GO:0007626]; microtubule-based peroxisome localization [GO:0060152]; neuron migration [GO:0001764]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, translocation [GO:0016561]; suckling behavior [GO:0001967]",peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],protein transmembrane transporter activity [GO:0008320],GO:0005215; GO:0005777; GO:0006629; GO:0006886; GO:0043226; GO:0048870; GO:0055085,transporter activity; peroxisome; lipid metabolic process; intracellular protein transport; organelle; cell motility; transmembrane transport
OG_02552,FUN_010640-T1,Peve_00031464,Pocillopora_meandrina_HIv1___RNAseq.g21361.t1,three_way,91.932,FUN_010640-T1,Q6GL89,IF2A_XENTR,,Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),71.2,312.0,6.1e-121,435.3,sp|Q6GL89|IF2A_XENTR Eukaryotic translation initiation factor 2 subunit 1 OS=Xenopus tropicalis OX=8364 GN=eif2s1 PE=2 SV=1,GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0010494; GO:0032057; GO:0034198; GO:0034644; GO:0034976; GO:0036499,cellular response to amino acid starvation [GO:0034198]; cellular response to UV [GO:0034644]; negative regulation of translational initiation in response to stress [GO:0032057]; PERK-mediated unfolded protein response [GO:0036499]; response to endoplasmic reticulum stress [GO:0034976],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850],RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0005829; GO:0043226,RNA binding; cytosol; organelle
OG_02553,FUN_010642-T1,Peve_00031452,Pocillopora_meandrina_HIv1___RNAseq.g21332.t1,three_way,77.005,FUN_010642-T1,Q8N157,AHI1_HUMAN,,Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1),Homo sapiens (Human),45.0,667.0,2.1999999999999998e-166,588.2,sp|Q8N157|AHI1_HUMAN Jouberin OS=Homo sapiens OX=9606 GN=AHI1 PE=1 SV=1,GO:0001738; GO:0001947; GO:0002092; GO:0005813; GO:0005814; GO:0005829; GO:0005911; GO:0005912; GO:0005929; GO:0007169; GO:0007417; GO:0008104; GO:0010842; GO:0016192; GO:0030862; GO:0030902; GO:0035844; GO:0035845; GO:0036038; GO:0036064; GO:0039008; GO:0042802; GO:0043066; GO:0044458; GO:0045944; GO:0050795; GO:0060271; GO:0065001; GO:0071599; GO:0097730,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; cloaca development [GO:0035844]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; morphogenesis of a polarized epithelium [GO:0001738]; motile cilium assembly [GO:0044458]; negative regulation of apoptotic process [GO:0043066]; otic vesicle development [GO:0071599]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of polarized epithelial cell differentiation [GO:0030862]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pronephric nephron tubule morphogenesis [GO:0039008]; protein localization [GO:0008104]; regulation of behavior [GO:0050795]; retina layer formation [GO:0010842]; specification of axis polarity [GO:0065001]; vesicle-mediated transport [GO:0016192],adherens junction [GO:0005912]; cell-cell junction [GO:0005911]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; MKS complex [GO:0036038]; non-motile cilium [GO:0097730],identical protein binding [GO:0042802],GO:0005815; GO:0005829; GO:0005929; GO:0006355; GO:0016192; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytosol; cilium; regulation of DNA-templated transcription; vesicle-mediated transport; organelle; cilium organization; anatomical structure development
OG_02554,FUN_010643-T1,Peve_00031455,Pocillopora_meandrina_HIv1___RNAseq.g21331.t1,three_way,67.60733333333333,FUN_010643-T1,Q6GM78,ASGL1_XENLA,,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],Xenopus laevis (African clawed frog),47.9,311.0,6.4e-70,265.8,sp|Q6GM78|ASGL1_XENLA Isoaspartyl peptidase/L-asparaginase OS=Xenopus laevis OX=8355 GN=asrgl1 PE=2 SV=1,GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917],asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798],GO:0003824; GO:0006520; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; hydrolase activity; catalytic activity, acting on a protein"
OG_02555,FUN_010644-T1,Peve_00031456,Pocillopora_meandrina_HIv1___RNAseq.g21330.t1,three_way,73.147,FUN_010644-T1,Q6GM78,ASGL1_XENLA,,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],Xenopus laevis (African clawed frog),47.9,317.0,2.7999999999999997e-68,260.4,sp|Q6GM78|ASGL1_XENLA Isoaspartyl peptidase/L-asparaginase OS=Xenopus laevis OX=8355 GN=asrgl1 PE=2 SV=1,GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917],asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798],GO:0003824; GO:0006520; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; hydrolase activity; catalytic activity, acting on a protein"
OG_02556,FUN_010650-T1,Peve_00031459,Pocillopora_meandrina_HIv1___RNAseq.g21328.t1,three_way,34.82783333333334,,,,,,,,,,,,,,,,,
OG_02557,FUN_010654-T1,Peve_00031468,Pocillopora_meandrina_HIv1___RNAseq.g21322.t1,three_way,49.04883333333333,FUN_010654-T1,Q5FWF5,ESCO1_HUMAN,,N-acetyltransferase ESCO1 (EC 2.3.1.-) (CTF7 homolog 1) (Establishment factor-like protein 1) (EFO1) (EFO1p) (hEFO1) (Establishment of cohesion 1 homolog 1) (ECO1 homolog 1) (ESO1 homolog 1),Homo sapiens (Human),47.1,240.0,5.2e-58,227.3,sp|Q5FWF5|ESCO1_HUMAN N-acetyltransferase ESCO1 OS=Homo sapiens OX=9606 GN=ESCO1 PE=1 SV=3,GO:0000785; GO:0005634; GO:0005654; GO:0005694; GO:0006275; GO:0007062; GO:0007064; GO:0008080; GO:0008270; GO:0016407; GO:0018394; GO:0034421; GO:0042802; GO:0061733,mitotic sister chromatid cohesion [GO:0007064]; peptidyl-lysine acetylation [GO:0018394]; post-translational protein acetylation [GO:0034421]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062],chromatin [GO:0000785]; chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; identical protein binding [GO:0042802]; N-acetyltransferase activity [GO:0008080]; protein-lysine-acetyltransferase activity [GO:0061733]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02558,FUN_010655-T1,Peve_00031469,Pocillopora_meandrina_HIv1___RNAseq.g21321.t1,three_way,33.870000000000005,,,,,,,,,,,,,,,,,
OG_02559,FUN_010656-T2,Peve_00031470,Pocillopora_meandrina_HIv1___RNAseq.g21320.t1,three_way,60.860166666666665,FUN_010656-T2,Q5ZKG3,DNA2_CHICK,,DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)],Gallus gallus (Chicken),36.6,831.0,2.5e-139,498.4,sp|Q5ZKG3|DNA2_CHICK DNA replication ATP-dependent helicase/nuclease DNA2 OS=Gallus gallus OX=9031 GN=DNA2 PE=2 SV=2,GO:0000076; GO:0000729; GO:0003677; GO:0003723; GO:0004518; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006260; GO:0006264; GO:0006284; GO:0016887; GO:0016890; GO:0017108; GO:0017116; GO:0033567; GO:0043137; GO:0043139; GO:0045740; GO:0046872; GO:0051539; GO:0071932,"base-excision repair [GO:0006284]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; DNA replication, Okazaki fragment processing [GO:0033567]; DNA replication, removal of RNA primer [GO:0043137]; mitochondrial DNA replication [GO:0006264]; positive regulation of DNA replication [GO:0045740]; replication fork reversal [GO:0071932]",cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; 5'-flap endonuclease activity [GO:0017108]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; RNA binding [GO:0003723]; single-stranded DNA helicase activity [GO:0017116]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0006260; GO:0006281; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; DNA replication; DNA repair; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02560,FUN_010659-T1,Peve_00031472,Pocillopora_meandrina_HIv1___RNAseq.g21313.t1,three_way,90.361,FUN_010659-T1,Q76I81,,,,,81.8,121.0,1.5999999999999996e-53,209.9,sp|Q76I81|RS12_BOVIN Small ribosomal subunit protein eS12 OS=Bos taurus OX=9913 GN=RPS12 PE=2 SV=1,,,,,,
OG_02561,FUN_010660-T1,Peve_00031473,Pocillopora_meandrina_HIv1___RNAseq.g21312.t1,three_way,68.91783333333333,,,,,,,,,,,,,,,,,
OG_02562,FUN_010661-T1,Peve_00031438,Pocillopora_meandrina_HIv1___RNAseq.g21311.t1,three_way,73.56683333333334,FUN_010661-T1,O43491,E41L2_HUMAN,,Band 4.1-like protein 2 (Erythrocyte membrane protein band 4.1-like 2) (Generally expressed protein 4.1) (4.1G),Homo sapiens (Human),49.4,336.0,2.6e-87,325.1,sp|O43491|E41L2_HUMAN Band 4.1-like protein 2 OS=Homo sapiens OX=9606 GN=EPB41L2 PE=1 SV=1,GO:0003779; GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0005938; GO:0008091; GO:0030054; GO:0030507; GO:0030866; GO:0031032; GO:0042731; GO:0051301; GO:0070062; GO:1904778,actomyosin structure organization [GO:0031032]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of protein localization to cell cortex [GO:1904778],cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spectrin [GO:0008091],actin binding [GO:0003779]; PH domain binding [GO:0042731]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198],GO:0005198; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,structural molecule activity; nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_02563,FUN_010662-T1,Peve_00031441,Pocillopora_meandrina_HIv1___RNAseq.g21360.t1,three_way,72.268,FUN_010662-T1,Q8BZT9,LACC1_MOUSE,,Purine nucleoside phosphorylase LACC1 (EC 2.4.2.1) (Adenosine deaminase LACC1) (EC 3.5.4.4) (Fatty acid metabolism-immunity nexus) (Guanosine phosphorylase LACC1) (Laccase domain-containing protein 1) (S-methyl-5'-thioadenosine phosphorylase LACC1) (EC 2.4.2.28),Mus musculus (Mouse),42.9,266.0,7.3e-54,213.0,sp|Q8BZT9|LACC1_MOUSE Purine nucleoside phosphorylase LACC1 OS=Mus musculus OX=10090 GN=Lacc1 PE=1 SV=1,GO:0002221; GO:0002720; GO:0004000; GO:0004731; GO:0005634; GO:0005737; GO:0005777; GO:0005783; GO:0006954; GO:0017061; GO:0030641; GO:0045087; GO:0046872; GO:0047975; GO:0050727; GO:0070431; GO:1900542,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of cytokine production involved in immune response [GO:0002720]; regulation of cellular pH [GO:0030641]; regulation of inflammatory response [GO:0050727]; regulation of purine nucleotide metabolic process [GO:1900542],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; peroxisome [GO:0005777],adenosine deaminase activity [GO:0004000]; guanosine phosphorylase activity [GO:0047975]; metal ion binding [GO:0046872]; purine-nucleoside phosphorylase activity [GO:0004731]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061],GO:0002376; GO:0003824; GO:0005634; GO:0005777; GO:0005783; GO:0006954; GO:0016740; GO:0016787; GO:0043226; GO:0098542,immune system process; catalytic activity; nucleus; peroxisome; endoplasmic reticulum; inflammatory response; transferase activity; hydrolase activity; organelle; defense response to other organism
OG_02564,FUN_010663-T1,Peve_00031442,Pocillopora_meandrina_HIv1___RNAseq.g21359.t1,three_way,44.581500000000005,FUN_010663-T1,Q99MV1,TDRD1_MOUSE,,Tudor domain-containing protein 1,Mus musculus (Mouse),28.6,814.0,2.1e-72,277.7,sp|Q99MV1|TDRD1_MOUSE Tudor domain-containing protein 1 OS=Mus musculus OX=10090 GN=Tdrd1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0007281; GO:0007283; GO:0008270; GO:0033391; GO:0034587; GO:0043186; GO:0045202; GO:0051321; GO:0071546; GO:0141196; GO:1990904,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005829; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,cytosol; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_02565,FUN_010664-T1,Peve_00031444,Pocillopora_meandrina_HIv1___RNAseq.g21358.t1,three_way,89.18366666666667,FUN_010664-T1,O46629,ECHB_BOVIN,,"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]",Bos taurus (Bovine),74.7,442.0,6.5e-191,668.3,"sp|O46629|ECHB_BOVIN Trifunctional enzyme subunit beta, mitochondrial OS=Bos taurus OX=9913 GN=HADHB PE=2 SV=1",GO:0003985; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0016507; GO:0050633,fatty acid beta-oxidation [GO:0006635],endoplasmic reticulum [GO:0005783]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741],acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-myristoyltransferase activity [GO:0050633],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_02566,FUN_010665-T1,Peve_00031446,Pocillopora_meandrina_HIv1___RNAseq.g21357.t1,three_way,77.2065,,,,,,,,,,,,,,,,,
OG_02567,FUN_010667-T1,Peve_00031447,Pocillopora_meandrina_HIv1___TS.g26107.t1,three_way,77.829,FUN_010667-T1,O04287,,,,,57.0,93.0,1.9e-26,119.8,sp|O04287|FKB12_VICFA Peptidyl-prolyl cis-trans isomerase FKBP12 OS=Vicia faba OX=3906 GN=FKBP12 PE=1 SV=1,,,,,,
OG_02568,FUN_010668-T1,Peve_00031448,Pocillopora_meandrina_HIv1___RNAseq.g21354.t1,three_way,71.776,FUN_010668-T1,Q6GLL2,ABH6A_XENLA,,Monoacylglycerol lipase abhd6-A (EC 3.1.1.23) (Abhydrolase domain-containing protein 6-A),Xenopus laevis (African clawed frog),39.1,289.0,3.3e-56,220.3,sp|Q6GLL2|ABH6A_XENLA Monoacylglycerol lipase abhd6-A OS=Xenopus laevis OX=8355 GN=abhd6-a PE=2 SV=1,GO:0005765; GO:0016020; GO:0031902; GO:0031966; GO:0032281; GO:0046464; GO:0047372; GO:0052651; GO:2001311,acylglycerol catabolic process [GO:0046464]; lysobisphosphatidic acid metabolic process [GO:2001311]; monoacylglycerol catabolic process [GO:0052651],AMPA glutamate receptor complex [GO:0032281]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966],monoacylglycerol lipase activity [GO:0047372],GO:0003824; GO:0006629; GO:0016787; GO:1901135,catalytic activity; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_02569,FUN_010670-T1,Peve_00031450,Pocillopora_meandrina_HIv1___RNAseq.g21352.t1,three_way,64.264,FUN_010670-T1,Q9BVH7,SIA7E_HUMAN,,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E)",Homo sapiens (Human),30.2,242.0,2.8e-19,97.8,"sp|Q9BVH7|SIA7E_HUMAN Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 OS=Homo sapiens OX=9606 GN=ST6GALNAC5 PE=1 SV=1",GO:0000139; GO:0001574; GO:0001665; GO:0006486; GO:0006688; GO:0008373; GO:0009311; GO:0009312,ganglioside biosynthetic process [GO:0001574]; glycosphingolipid biosynthetic process [GO:0006688]; oligosaccharide biosynthetic process [GO:0009312]; oligosaccharide metabolic process [GO:0009311]; protein glycosylation [GO:0006486],Golgi membrane [GO:0000139],"alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity [GO:0001665]; sialyltransferase activity [GO:0008373]",GO:0003824; GO:0005975; GO:0006486; GO:0006629; GO:0016740; GO:1901135,catalytic activity; carbohydrate metabolic process; protein glycosylation; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_02570,FUN_010672-T1,Peve_00031451,Pocillopora_meandrina_HIv1___RNAseq.g21351.t1,three_way,71.39183333333334,FUN_010672-T1,Q9UL68,,,,,56.0,175.0,1.5e-17,93.2,sp|Q9UL68|MYT1L_HUMAN Myelin transcription factor 1-like protein OS=Homo sapiens OX=9606 GN=MYT1L PE=1 SV=3,,,,,,
OG_02570,FUN_010672-T1,Peve_00031451,Pocillopora_meandrina_HIv1___RNAseq.g21351.t1,three_way,71.39183333333334,FUN_010672-T1,Q9UL68,,,,,73.0,37.0,1.8e-10,69.7,sp|Q9UL68|MYT1L_HUMAN Myelin transcription factor 1-like protein OS=Homo sapiens OX=9606 GN=MYT1L PE=1 SV=3,,,,,,
OG_02570,FUN_010672-T1,Peve_00031451,Pocillopora_meandrina_HIv1___RNAseq.g21351.t1,three_way,71.39183333333334,FUN_010672-T1,Q9UL68,,,,,51.2,41.0,3e-05,52.4,sp|Q9UL68|MYT1L_HUMAN Myelin transcription factor 1-like protein OS=Homo sapiens OX=9606 GN=MYT1L PE=1 SV=3,,,,,,
OG_02571,FUN_010674-T1,Peve_00044786,Pocillopora_meandrina_HIv1___RNAseq.g21350.t1,three_way,81.68766666666667,FUN_010674-T1,O75116,ROCK2_HUMAN,,"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)",Homo sapiens (Human),50.3,445.0,8.199999999999999e-109,396.7,sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=4,GO:0000281; GO:0001837; GO:0001934; GO:0002020; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007266; GO:0008270; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0036464; GO:0042752; GO:0043410; GO:0044788; GO:0045019; GO:0045616; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061133; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; mitotic cytokinesis [GO:0000281]; modulation by host of viral process [GO:0044788]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; zinc ion binding [GO:0008270],GO:0000910; GO:0003012; GO:0003013; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0030154; GO:0043226; GO:0072659; GO:0098772; GO:0140096,"cytokinesis; muscle system process; circulatory system process; RNA binding; catalytic activity; structural molecule activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; cell differentiation; organelle; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02572,FUN_010675-T1,Peve_00044784,Pocillopora_meandrina_HIv1___RNAseq.g21349.t1,three_way,66.34933333333333,FUN_010675-T1,Q8K2L8,,,,,46.4,435.0,4.8e-112,407.1,sp|Q8K2L8|TPC12_MOUSE Trafficking protein particle complex subunit 12 OS=Mus musculus OX=10090 GN=Trappc12 PE=1 SV=2,,,,,,
OG_02573,FUN_010679-T1,Peve_00044779,Pocillopora_meandrina_HIv1___RNAseq.g21345.t1,three_way,75.95,FUN_010679-T1,Q5FVA9,,,,,67.7,368.0,5.899999999999999e-147,521.9,sp|Q5FVA9|RAE1L_XENTR mRNA export factor OS=Xenopus tropicalis OX=8364 GN=rae1 PE=2 SV=1,,,,,,
OG_02574,FUN_010680-T1,Peve_00044789,Pocillopora_meandrina_HIv1___RNAseq.g21344.t1,three_way,49.747,,,,,,,,,,,,,,,,,
OG_02575,FUN_010681-T1,Peve_00044788,Pocillopora_meandrina_HIv1___TS.g26095.t1,three_way,79.83833333333334,,,,,,,,,,,,,,,,,
OG_02576,FUN_010682-T1,Peve_00044787,Pocillopora_meandrina_HIv1___TS.g26094.t1,three_way,77.71233333333333,FUN_010682-T1,Q9CQN6,,,,,50.5,109.0,3.1999999999999998e-24,112.5,sp|Q9CQN6|TM14C_MOUSE Transmembrane protein 14C OS=Mus musculus OX=10090 GN=Tmem14c PE=1 SV=1,,,,,,
OG_02577,FUN_010683-T1,Peve_00044783,Pocillopora_meandrina_HIv1___RNAseq.g21341.t1,three_way,83.25483333333332,FUN_010683-T1,Q3UVG3,,,,,57.1,847.0,9.8e-267,921.0,sp|Q3UVG3|F91A1_MOUSE Protein FAM91A1 OS=Mus musculus OX=10090 GN=Fam91a1 PE=1 SV=1,,,,,,
OG_02578,FUN_010686-T1,Peve_00044781,Pocillopora_meandrina_HIv1___RNAseq.g21340.t1,three_way,38.60366666666667,,,,,,,,,,,,,,,,,
OG_02579,FUN_010687-T1,Peve_00012870,Pocillopora_meandrina_HIv1___RNAseq.g21338.t1,three_way,86.60833333333333,FUN_010687-T1,Q60670,SIK1_MOUSE,,Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (HRT-20) (Myocardial SNF1-like kinase) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK),Mus musculus (Mouse),43.8,130.0,4.5000000000000003e-23,109.0,sp|Q60670|SIK1_MOUSE Serine/threonine-protein kinase SIK1 OS=Mus musculus OX=10090 GN=Sik1 PE=1 SV=3,GO:0000122; GO:0000287; GO:0002028; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0007346; GO:0008140; GO:0010830; GO:0010868; GO:0019901; GO:0032792; GO:0035556; GO:0042826; GO:0043153; GO:0043276; GO:0045595; GO:0045721; GO:0046777; GO:0048511; GO:0055007; GO:0071889; GO:0106310; GO:2000210,anoikis [GO:0043276]; cardiac muscle cell differentiation [GO:0055007]; entrainment of circadian clock by photoperiod [GO:0043153]; intracellular signal transduction [GO:0035556]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of anoikis [GO:2000210]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell differentiation [GO:0045595]; regulation of mitotic cell cycle [GO:0007346]; regulation of myotube differentiation [GO:0010830]; regulation of sodium ion transport [GO:0002028]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; nucleus [GO:0005634],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; cAMP response element binding protein binding [GO:0008140]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0006355; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; programmed cell death; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_02580,FUN_010696-T1,Peve_00040382,Pocillopora_meandrina_HIv1___RNAseq.g6938.t1,three_way,55.94833333333333,FUN_010696-T1,F4JTS8,NOV_ARATH,,Protein NO VEIN (Protein EMBRYO DEFECTIVE 2597),Arabidopsis thaliana (Mouse-ear cress),26.4,2000.0,7.3e-152,541.2,sp|F4JTS8|NOV_ARATH Protein NO VEIN OS=Arabidopsis thaliana OX=3702 GN=NOV PE=1 SV=1,GO:0001708; GO:0005634; GO:0009793; GO:0009926; GO:0010305; GO:0019827; GO:0048364,auxin polar transport [GO:0009926]; cell fate specification [GO:0001708]; embryo development ending in seed dormancy [GO:0009793]; leaf vascular tissue pattern formation [GO:0010305]; root development [GO:0048364]; stem cell population maintenance [GO:0019827],nucleus [GO:0005634],,GO:0005634; GO:0022414; GO:0043226; GO:0048856,nucleus; reproductive process; organelle; anatomical structure development
OG_02581,FUN_010697-T1,Peve_00012866,Pocillopora_meandrina_HIv1___RNAseq.g21335.t1,three_way,68.102,FUN_010697-T1,P27808,MGAT1_MOUSE,,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)",Mus musculus (Mouse),57.1,333.0,8.599999999999999e-115,415.2,"sp|P27808|MGAT1_MOUSE Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Mus musculus OX=10090 GN=Mgat1 PE=1 SV=1",GO:0000139; GO:0001701; GO:0003827; GO:0006049; GO:0008375; GO:0018279; GO:0030145; GO:0048471,in utero embryonic development [GO:0001701]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049],Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]",GO:0003824; GO:0009101; GO:0016740; GO:0048856; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_02582,FUN_010698-T2,Peve_00012865,Pocillopora_meandrina_HIv1___RNAseq.g21334.t1,three_way,91.03233333333333,FUN_010698-T2,P49721,PSB2_HUMAN,,Proteasome subunit beta type-2 (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I) (Proteasome subunit beta-4) (beta-4),Homo sapiens (Human),68.1,191.0,9.3e-75,281.2,sp|P49721|PSB2_HUMAN Proteasome subunit beta type-2 OS=Homo sapiens OX=9606 GN=PSMB2 PE=1 SV=1,GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005839; GO:0016020; GO:0019774; GO:0043161; GO:0070062,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]",,GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_02583,FUN_010702-T1,Peve_00022610,Pocillopora_meandrina_HIv1___RNAseq.g20975.t1,three_way,89.09666666666666,FUN_010702-T1,Q922G7,,,,,52.3,354.0,2e-96,354.4,sp|Q922G7|TEKT2_MOUSE Tektin-2 OS=Mus musculus OX=10090 GN=Tekt2 PE=1 SV=1,,,,,,
OG_02584,FUN_010703-T1,Peve_00022609,Pocillopora_meandrina_HIv1___TS.g25727.t1,three_way,70.271,,,,,,,,,,,,,,,,,
OG_02585,FUN_010704-T1,Peve_00022606,Pocillopora_meandrina_HIv1___RNAseq.g20971.t1,three_way,46.75866666666666,FUN_010704-T1,Q9ULB1,NRX1A_HUMAN,,Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha),Homo sapiens (Human),26.5,321.0,5.8e-22,107.1,sp|Q9ULB1|NRX1A_HUMAN Neurexin-1 OS=Homo sapiens OX=9606 GN=NRXN1 PE=1 SV=1,GO:0005246; GO:0005509; GO:0005730; GO:0005783; GO:0005886; GO:0007158; GO:0007268; GO:0007269; GO:0007411; GO:0007416; GO:0007612; GO:0009986; GO:0030534; GO:0031965; GO:0031982; GO:0033130; GO:0035176; GO:0038023; GO:0042297; GO:0042734; GO:0042995; GO:0043025; GO:0050839; GO:0050885; GO:0051965; GO:0051968; GO:0071625; GO:0090129; GO:0097104; GO:0097109; GO:0097116; GO:0097118; GO:0097119; GO:2000463,"adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625]",cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982],acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023],GO:0005730; GO:0005783; GO:0005886; GO:0007155; GO:0023052; GO:0034330; GO:0043226; GO:0050877; GO:0060089; GO:0061024; GO:0098772,nucleolus; endoplasmic reticulum; plasma membrane; cell adhesion; signaling; cell junction organization; organelle; nervous system process; molecular transducer activity; membrane organization; molecular function regulator activity
OG_02586,FUN_010706-T1,Peve_00022605,Pocillopora_meandrina_HIv1___RNAseq.g20970.t1,three_way,33.39483333333334,,,,,,,,,,,,,,,,,
OG_02587,FUN_010707-T1,Peve_00005096,Pocillopora_meandrina_HIv1___RNAseq.g8834.t1,three_way,53.306333333333335,FUN_010707-T1,A0A2B4RP11,,,,,26.2,378.0,3.4e-14,81.6,sp|A0A2B4RP11|CGLR1_STYPI Cyclic GMP-AMP synthase-like receptor 1 OS=Stylophora pistillata OX=50429 GN=cGLR1 PE=1 SV=1,,,,,,
OG_02588,FUN_010708-T1,Peve_00022604,Pocillopora_meandrina_HIv1___RNAseq.g20967.t1,three_way,50.522,,,,,,,,,,,,,,,,,
OG_02589,FUN_010709-T1,Peve_00022594,Pocillopora_meandrina_HIv1___RNAseq.g20962.t1,three_way,45.36966666666667,FUN_010709-T1,Q21313,EPI1_CAEEL,,Laminin-like protein epi-1 (Laminin alphaB) (Laminin subunit alpha epi-1),Caenorhabditis elegans,29.1,110.0,3.4e-06,55.1,sp|Q21313|EPI1_CAEEL Laminin-like protein epi-1 OS=Caenorhabditis elegans OX=6239 GN=epi-1 PE=1 SV=1,GO:0001764; GO:0005201; GO:0005576; GO:0005604; GO:0007155; GO:0007411; GO:0007414; GO:0009408; GO:0009887; GO:0009888; GO:0016477; GO:0022414; GO:0040017; GO:0042127; GO:0051788; GO:0071711,animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; neuron migration [GO:0001764]; positive regulation of locomotion [GO:0040017]; regulation of cell population proliferation [GO:0042127]; reproductive process [GO:0022414]; response to heat [GO:0009408]; response to misfolded protein [GO:0051788]; tissue development [GO:0009888],basement membrane [GO:0005604]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0007155; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0048870,structural molecule activity; extracellular region; cell adhesion; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; cell motility
OG_02590,FUN_010710-T1,Peve_00022582,Pocillopora_meandrina_HIv1___TS.g25714.t1,three_way,70.848,,,,,,,,,,,,,,,,,
OG_02591,FUN_010711-T1,Peve_00022576,Pocillopora_meandrina_HIv1___RNAseq.g20960.t1,three_way,81.52633333333333,FUN_010711-T1,Q9UHY1,NRBP_HUMAN,,Nuclear receptor-binding protein,Homo sapiens (Human),54.0,470.0,1.6e-136,487.6,sp|Q9UHY1|NRBP_HUMAN Nuclear receptor-binding protein OS=Homo sapiens OX=9606 GN=NRBP1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005938; GO:0006888; GO:0006974; GO:0012505; GO:0016020; GO:0030027; GO:0042803,DNA damage response [GO:0006974]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005654; GO:0016192; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_02592,FUN_010712-T1,Peve_00022571,Pocillopora_meandrina_HIv1___RNAseq.g20959.t1,three_way,69.79433333333333,FUN_010712-T1,Q96NA8,,,,,31.0,200.0,1.8e-14,81.6,sp|Q96NA8|TSNA1_HUMAN t-SNARE domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TSNARE1 PE=1 SV=2,,,,,,
OG_02593,FUN_010713-T1,Peve_00022566,Pocillopora_meandrina_HIv1___RNAseq.g20958.t1,three_way,82.25733333333334,FUN_010713-T1,Q8R3G1,PP1R8_MOUSE,,Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8),Mus musculus (Mouse),53.2,365.0,6.9e-92,339.0,sp|Q8R3G1|PP1R8_MOUSE Nuclear inhibitor of protein phosphatase 1 OS=Mus musculus OX=10090 GN=Ppp1r8 PE=1 SV=1,GO:0003677; GO:0003723; GO:0004864; GO:0005681; GO:0006397; GO:0008283; GO:0008380; GO:0016607; GO:0019888,cell population proliferation [GO:0008283]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0016071; GO:0043226; GO:0098772,DNA binding; RNA binding; mRNA metabolic process; organelle; molecular function regulator activity
OG_02594,FUN_010714-T1,Peve_00022559,Pocillopora_meandrina_HIv1___RNAseq.g20957.t1,three_way,53.61783333333334,FUN_010714-T1,Q8WV22,NSE1_HUMAN,,Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 2.3.2.27),Homo sapiens (Human),34.5,258.0,3.2e-35,150.2,sp|Q8WV22|NSE1_HUMAN Non-structural maintenance of chromosomes element 1 homolog OS=Homo sapiens OX=9606 GN=NSMCE1 PE=1 SV=5,GO:0000724; GO:0000775; GO:0000781; GO:0004842; GO:0005634; GO:0005654; GO:0006974; GO:0008270; GO:0016925; GO:0030915; GO:0032204; GO:0043231; GO:0046983; GO:0061630; GO:0097431; GO:0140588,chromatin looping [GO:0140588]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; protein sumoylation [GO:0016925]; regulation of telomere maintenance [GO:0032204],"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]",protein dimerization activity [GO:0046983]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02595,FUN_010716-T1,Peve_00022598,Pocillopora_meandrina_HIv1___RNAseq.g20955.t1,three_way,82.276,FUN_010716-T1,P17713,,,,,64.1,512.0,3.7e-192,672.5,sp|P17713|STK_HYDVU Tyrosine-protein kinase STK OS=Hydra vulgaris OX=6087 GN=STK PE=2 SV=1,,,,,,
OG_02596,FUN_010717-T1,Peve_00022590,Pocillopora_meandrina_HIv1___RNAseq.g20954.t1,three_way,77.32616666666667,FUN_010717-T1,Q9V9J3,SRC42_DROME,,Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41),Drosophila melanogaster (Fruit fly),57.2,530.0,1.7e-168,594.0,sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster OX=7227 GN=Src42A PE=1 SV=1,GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136; GO:0106016,"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005886; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; cytosol; plasma membrane; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_02597,FUN_010718-T1,Peve_00029907,Pocillopora_meandrina_HIv1___RNAseq.g20953.t1,three_way,54.03416666666666,,,,,,,,,,,,,,,,,
OG_02598,FUN_010719-T1,Peve_00029906,Pocillopora_meandrina_HIv1___RNAseq.g20952.t1,three_way,68.09400000000001,FUN_010719-T1,P10606,COX5B_HUMAN,,"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb)",Homo sapiens (Human),44.8,87.0,2.1e-13,77.0,"sp|P10606|COX5B_HUMAN Cytochrome c oxidase subunit 5B, mitochondrial OS=Homo sapiens OX=9606 GN=COX5B PE=1 SV=2",GO:0004129; GO:0005739; GO:0005743; GO:0006123; GO:0007585; GO:0031966; GO:0045277; GO:0045333; GO:0046872,"cellular respiration [GO:0045333]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; respiratory gaseous exchange by respiratory system [GO:0007585]",mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; respiratory chain complex IV [GO:0045277],cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872],GO:0005215; GO:0005739; GO:0006091; GO:0043226,transporter activity; mitochondrion; generation of precursor metabolites and energy; organelle
OG_02599,FUN_010720-T1,Peve_00029905,Pocillopora_meandrina_HIv1___RNAseq.g20949.t2,three_way,83.7885,FUN_010720-T1,P58197,AP2A_RAT,,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),Rattus norvegicus (Rat),63.4,227.0,3.3e-68,260.8,sp|P58197|AP2A_RAT Transcription factor AP-2-alpha OS=Rattus norvegicus OX=10116 GN=Tfap2a PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001501; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:1990837; GO:2000378,anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559],clathrin-coated pit [GO:0005905]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0012501; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; extracellular matrix organization; organelle; anatomical structure development; cell motility; nervous system process; molecular adaptor activity; transcription regulator activity
OG_02600,FUN_010726-T1,Peve_00038971,Pocillopora_meandrina_HIv1___RNAseq.g20947.t1,three_way,72.91166666666666,FUN_010726-T1,Q17QM4,EPT1_BOVIN,,Ethanolaminephosphotransferase 1 (EC 2.7.8.1) (Selenoprotein I) (SelI),Bos taurus (Bovine),44.5,380.0,3.2999999999999996e-90,333.6,sp|Q17QM4|EPT1_BOVIN Ethanolaminephosphotransferase 1 OS=Bos taurus OX=9913 GN=SELENOI PE=2 SV=3,GO:0004307; GO:0005789; GO:0005794; GO:0006646; GO:0008611; GO:0042552; GO:0046872,ether lipid biosynthetic process [GO:0008611]; myelination [GO:0042552]; phosphatidylethanolamine biosynthetic process [GO:0006646],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0006629; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; lipid metabolic process; transferase activity; organelle
OG_02601,FUN_010727-T1,Peve_00038972,Pocillopora_meandrina_HIv1___RNAseq.g20946.t1,three_way,71.91666666666667,FUN_010727-T1,Q6GL75,,,,,42.6,383.0,3.6000000000000003e-81,303.5,sp|Q6GL75|DCC1_XENTR Sister chromatid cohesion protein DCC1 OS=Xenopus tropicalis OX=8364 GN=dscc1 PE=2 SV=1,,,,,,
OG_02602,FUN_010728-T1,Peve_00038973,Pocillopora_meandrina_HIv1___RNAseq.g20945.t1,three_way,73.28566666666667,FUN_010728-T1,Q503V9,,,,,57.0,186.0,2.6e-54,213.4,sp|Q503V9|ENDUB_DANRE Uridylate-specific endoribonuclease B OS=Danio rerio OX=7955 GN=endoub PE=2 SV=1,,,,,,
OG_02603,FUN_010729-T1,Peve_00038974,Pocillopora_meandrina_HIv1___RNAseq.g20944.t1,three_way,63.30516666666667,,,,,,,,,,,,,,,,,
OG_02604,FUN_010732-T1,Peve_00038975,Pocillopora_meandrina_HIv1___RNAseq.g20943.t1,three_way,75.52716666666667,FUN_010732-T1,Q5R8H5,,,,,40.5,296.0,1.5e-48,195.3,sp|Q5R8H5|T2EA_PONAB General transcription factor IIE subunit 1 OS=Pongo abelii OX=9601 GN=GTF2E1 PE=2 SV=1,,,,,,
OG_02605,FUN_010733-T1,Peve_00038976,Pocillopora_meandrina_HIv1___RNAseq.g20942.t1,three_way,87.03433333333334,FUN_010733-T1,A7SA47,,,,,70.1,318.0,1.1e-125,451.1,sp|A7SA47|EIF3H_NEMVE Eukaryotic translation initiation factor 3 subunit H OS=Nematostella vectensis OX=45351 GN=v1g168210 PE=3 SV=1,,,,,,
OG_02606,FUN_010735-T1,Peve_00038977,Pocillopora_meandrina_HIv1___RNAseq.g20941.t1,three_way,82.79933333333334,FUN_010735-T1,Q9V9J3,SRC42_DROME,,Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41),Drosophila melanogaster (Fruit fly),64.1,468.0,4.3999999999999985e-177,622.5,sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster OX=7227 GN=Src42A PE=1 SV=1,GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136; GO:0106016,"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005886; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; cytosol; plasma membrane; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_02607,FUN_010736-T1,Peve_00038978,Pocillopora_meandrina_HIv1___RNAseq.g20940.t1,three_way,50.23233333333334,FUN_010736-T1,Q95209,SORL_RABIT,,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),Oryctolagus cuniculus (Rabbit),28.3,762.0,9.3e-88,327.4,sp|Q95209|SORL_RABIT Sortilin-related receptor OS=Oryctolagus cuniculus OX=9986 GN=SORL1 PE=1 SV=1,GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845,adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],,GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226,extracellular space; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_02608,FUN_010739-T1,Peve_00038405,Pocillopora_meandrina_HIv1___RNAseq.g20938.t1,three_way,35.7685,,,,,,,,,,,,,,,,,
OG_02609,FUN_010740-T1,Peve_00038406,Pocillopora_meandrina_HIv1___TS.g25693.t1,three_way,77.805,FUN_010740-T1,P21291,CSRP1_HUMAN,,Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1) (Epididymis luminal protein 141) (HEL-141),Homo sapiens (Human),48.3,176.0,9.1e-43,174.9,sp|P21291|CSRP1_HUMAN Cysteine and glycine-rich protein 1 OS=Homo sapiens OX=9606 GN=CSRP1 PE=1 SV=3,GO:0003723; GO:0005634; GO:0005737; GO:0005925; GO:0008270; GO:0008307; GO:0030018; GO:0042805; GO:0045214; GO:0060537; GO:0070062; GO:0070527,muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018],actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270],GO:0003723; GO:0005198; GO:0005634; GO:0007010; GO:0007155; GO:0008092; GO:0043226; GO:0048856,RNA binding; structural molecule activity; nucleus; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; organelle; anatomical structure development
OG_02610,FUN_010743-T1,Peve_00038408,Pocillopora_meandrina_HIv1___RNAseq.g20934.t1,three_way,39.4255,,,,,,,,,,,,,,,,,
OG_02611,FUN_010745-T1,Peve_00038409,Pocillopora_meandrina_HIv1___TS.g25690.t1,three_way,79.04633333333334,FUN_010745-T1,O75153,,,,,47.6,1302.0,0.0,1138.6,sp|O75153|CLU_HUMAN Clustered mitochondria protein homolog OS=Homo sapiens OX=9606 GN=CLUH PE=1 SV=2,,,,,,
OG_02612,FUN_010746-T1,Peve_00038410,Pocillopora_meandrina_HIv1___RNAseq.g20932.t1,three_way,83.767,FUN_010746-T1,Q96QK8,,,,,62.9,70.0,3.9e-19,95.1,sp|Q96QK8|SIM14_HUMAN Small integral membrane protein 14 OS=Homo sapiens OX=9606 GN=SMIM14 PE=1 SV=1,,,,,,
OG_02613,FUN_010752-T1,Peve_00004504,Pocillopora_meandrina_HIv1___RNAseq.g21293.t1,three_way,75.95133333333334,,,,,,,,,,,,,,,,,
OG_02614,FUN_010753-T1,Peve_00004503,Pocillopora_meandrina_HIv1___RNAseq.g21292.t1,three_way,87.76683333333334,FUN_010753-T1,Q9NV56,,,,,61.1,90.0,1.4e-26,120.9,sp|Q9NV56|MRGBP_HUMAN MRG/MORF4L-binding protein OS=Homo sapiens OX=9606 GN=MRGBP PE=1 SV=1,,,,,,
OG_02615,FUN_010754-T1,Peve_00026373,Pocillopora_meandrina_HIv1___RNAseq.g20930.t1a,three_way,48.37133333333333,,,,,,,,,,,,,,,,,
OG_02616,FUN_010755-T1,Peve_00008039,Pocillopora_meandrina_HIv1___RNAseq.g20929.t1,three_way,67.73883333333333,FUN_010755-T1,A7RM45,,,,,60.1,552.0,4.8e-161,569.3,sp|A7RM45|LMBD1_NEMVE Probable lysosomal cobalamin transporter OS=Nematostella vectensis OX=45351 GN=v1g160387 PE=3 SV=1,,,,,,
OG_02617,FUN_010756-T1,Peve_00008040,Pocillopora_meandrina_HIv1___RNAseq.g20928.t1,three_way,75.21683333333334,FUN_010756-T1,P33610,,,,,53.5,460.0,2e-140,500.7,sp|P33610|PRI2_MOUSE DNA primase large subunit OS=Mus musculus OX=10090 GN=Prim2 PE=1 SV=1,,,,,,
OG_02618,FUN_010757-T1,Peve_00008041,Pocillopora_meandrina_HIv1___RNAseq.g20927.t1,three_way,44.125,,,,,,,,,,,,,,,,,
OG_02619,FUN_010760-T1,Peve_00008042,Pocillopora_meandrina_HIv1___TS.g25680.t1b,three_way,57.45583333333333,FUN_010760-T1,A0A1S4F2V5,,,,,37.6,319.0,2e-51,206.1,sp|A0A1S4F2V5|CATL_AEDAE Cathepsin L-like peptidase OS=Aedes aegypti OX=7159 PE=1 SV=1,,,,,,
OG_02620,FUN_010763-T1,Peve_00008038,Pocillopora_meandrina_HIv1___RNAseq.g20924.t1,three_way,83.1185,FUN_010763-T1,O46382,,,,,58.7,1985.0,0.0,2090.5,sp|O46382|BIG1_BOVIN Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Bos taurus OX=9913 GN=ARFGEF1 PE=1 SV=1,,,,,,
OG_02621,FUN_010767-T1,Peve_00004501,Pocillopora_meandrina_HIv1___RNAseq.g21289.t1,three_way,81.65766666666667,FUN_010767-T1,A5HUI5,AMPE_GLOBR,,Aminopeptidase A (AP-A) (APA) (EC 3.4.11.7) (Glutamyl aminopeptidase) (EAP),Gloydius brevicauda (Korean slamosa snake) (Agkistrodon halys brevicaudus),37.6,896.0,1.4999999999999999e-173,611.7,sp|A5HUI5|AMPE_GLOBR Aminopeptidase A OS=Gloydius brevicauda OX=3148161 PE=1 SV=2,GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0042277; GO:0043171; GO:0070006,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_02622,FUN_010769-T1,Peve_00004500,Pocillopora_meandrina_HIv1___RNAseq.g21287.t1,three_way,72.27866666666667,FUN_010769-T1,F1MV99,,,,,25.5,286.0,3.5e-11,70.9,sp|F1MV99|SSR5_BOVIN Somatostatin receptor type 5 OS=Bos taurus OX=9913 GN=SSTR5 PE=3 SV=2,,,,,,
OG_02623,FUN_010772-T1,Peve_00004496,Pocillopora_meandrina_HIv1___RNAseq.g21195.t1,three_way,63.85333333333333,FUN_010772-T1,Q8HZN9,,,,,24.3,276.0,1.8e-09,65.1,sp|Q8HZN9|BKRB1_PIG B1 bradykinin receptor OS=Sus scrofa OX=9823 GN=BDKRB1 PE=3 SV=1,,,,,,
OG_02624,FUN_010774-T1,Peve_00004493,Pocillopora_meandrina_HIv1___RNAseq.g21201.t1,three_way,81.71166666666666,FUN_010774-T1,Q9PWA0,,,,,45.9,133.0,1.7000000000000002e-27,124.0,sp|Q9PWA0|RGS17_CHICK Regulator of G-protein signaling 17 OS=Gallus gallus OX=9031 GN=RGS17 PE=2 SV=1,,,,,,
OG_02625,FUN_010775-T1,Peve_00004492,Pocillopora_meandrina_HIv1___RNAseq.g21202.t1,three_way,84.75166666666667,FUN_010775-T1,Q15560,TCEA2_HUMAN,,Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l),Homo sapiens (Human),48.7,306.0,6.9e-69,262.3,sp|Q15560|TCEA2_HUMAN Transcription elongation factor A protein 2 OS=Homo sapiens OX=9606 GN=TCEA2 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005654; GO:0005813; GO:0006354; GO:0006357; GO:0006368; GO:0008023; GO:0008270; GO:0032784; GO:0036064,DNA-templated transcription elongation [GO:0006354]; regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; microtubule organizing center; regulation of DNA-templated transcription; organelle
OG_02626,FUN_010776-T1,Peve_00004491,Pocillopora_meandrina_HIv1___RNAseq.g21203.t1,three_way,66.07983333333334,,,,,,,,,,,,,,,,,
OG_02627,FUN_010779-T1,Peve_00004487,Pocillopora_meandrina_HIv1___TS.g25955.t1,three_way,91.82266666666666,FUN_010779-T1,Q9D1P2,KAT8_MOUSE,,"Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (Males-absent on the first protein homolog) (mMof) (Protein acetyltransferase KAT8) (EC 2.3.1.-) (Protein propionyltransferase KAT8) (EC 2.3.1.-)",Mus musculus (Mouse),76.1,397.0,6.4e-180,631.7,sp|Q9D1P2|KAT8_MOUSE Histone acetyltransferase KAT8 OS=Mus musculus OX=10090 GN=Kat8 PE=1 SV=1,GO:0000123; GO:0000776; GO:0003713; GO:0005634; GO:0005694; GO:0005739; GO:0008270; GO:0009048; GO:0010506; GO:0010719; GO:0016363; GO:0016407; GO:0019899; GO:0022008; GO:0030099; GO:0032480; GO:0035166; GO:0043995; GO:0043996; GO:0044545; GO:0045815; GO:0045892; GO:0045893; GO:0046972; GO:0048477; GO:0050684; GO:0060261; GO:0061629; GO:0061733; GO:0061920; GO:0071339; GO:0072487; GO:1902726; GO:1903108; GO:1990841,dosage compensation by inactivation of X chromosome [GO:0009048]; myeloid cell differentiation [GO:0030099]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of type I interferon production [GO:0032480]; neurogenesis [GO:0022008]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of skeletal muscle satellite cell differentiation [GO:1902726]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; regulation of autophagy [GO:0010506]; regulation of mitochondrial transcription [GO:1903108]; regulation of mRNA processing [GO:0050684]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromosome [GO:0005694]; histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; NSL complex [GO:0044545]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone H4K16 acetyltransferase activity [GO:0046972]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; promoter-specific chromatin binding [GO:1990841]; protein propionyltransferase activity [GO:0061920]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005694; GO:0005739; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; chromosome; mitochondrion; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02628,FUN_010781-T1,Peve_00004485,Pocillopora_meandrina_HIv1___RNAseq.g21208.t1,three_way,64.70333333333333,FUN_010781-T1,P70102,,,,,44.1,143.0,8.7e-27,121.7,sp|P70102|MCA3_CRIGR Eukaryotic translation elongation factor 1 epsilon-1 OS=Cricetulus griseus OX=10029 GN=EEF1E1 PE=2 SV=1,,,,,,
OG_02629,FUN_010782-T1,Peve_00004484,Pocillopora_meandrina_HIv1___TS.g25957.t1,three_way,63.164,,,,,,,,,,,,,,,,,
OG_02630,FUN_010783-T1,Peve_00004471,Pocillopora_meandrina_HIv1___RNAseq.g21210.t1,three_way,72.516,FUN_010783-T1,Q8IXJ9,,,,,32.9,429.0,7.2e-42,173.7,sp|Q8IXJ9|ASXL1_HUMAN Polycomb group protein ASXL1 OS=Homo sapiens OX=9606 GN=ASXL1 PE=1 SV=4,,,,,,
OG_02631,FUN_010784-T1,Peve_00004483,Pocillopora_meandrina_HIv1___RNAseq.g21211.t1,three_way,60.87499999999999,,,,,,,,,,,,,,,,,
OG_02632,FUN_010785-T1,Peve_00004470,Pocillopora_meandrina_HIv1___RNAseq.g21212.t1,three_way,83.021,FUN_010785-T1,Q0VCR6,DIESL_BOVIN,,"DGAT1/2-independent enzyme synthesizing storage lipids (DIESL) (EC 2.3.1.-) (2-acylglycerol/1,2-diacylglycerol O-acyltransferase) (Monoacylglycerol/Diacylglycerol O-acyltransferase) (MGAT/DGAT) (EC 2.3.1.20, EC 2.3.1.22) (Transmembrane protein 68)",Bos taurus (Bovine),49.2,254.0,1.7e-70,267.7,sp|Q0VCR6|DIESL_BOVIN DGAT1/2-independent enzyme synthesizing storage lipids OS=Bos taurus OX=9913 GN=TMEM68 PE=2 SV=1,GO:0005789; GO:0016020; GO:0019432; GO:0046027,triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],phospholipid:diacylglycerol acyltransferase activity [GO:0046027],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_02633,FUN_010786-T1,Peve_00014207,Pocillopora_meandrina_HIv1___RNAseq.g21213.t1,three_way,53.632,,,,,,,,,,,,,,,,,
OG_02634,FUN_010796-T1,Peve_00007588,Pocillopora_meandrina_HIv1___RNAseq.g21226.t1,three_way,85.93299999999999,FUN_010796-T1,Q7ZTL7,,,,,64.3,414.0,4.5e-159,562.4,sp|Q7ZTL7|BCS1_XENLA Mitochondrial chaperone BCS1 OS=Xenopus laevis OX=8355 GN=bcs1l PE=2 SV=1,,,,,,
OG_02635,FUN_010802-T1,Peve_00007033,Pocillopora_meandrina_HIv1___TS.g25986.t1,three_way,47.278,FUN_010802-T1,Q8NDA2,,,,,20.6,880.0,4.9e-29,131.7,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_02636,FUN_010803-T1,Peve_00021409,Pocillopora_meandrina_HIv1___RNAseq.g21236.t1,three_way,82.66833333333334,FUN_010803-T1,Q9BSC4,,,,,62.3,687.0,1.6999999999999999e-205,717.2,sp|Q9BSC4|NOL10_HUMAN Nucleolar protein 10 OS=Homo sapiens OX=9606 GN=NOL10 PE=1 SV=1,,,,,,
OG_02637,FUN_010804-T1,Peve_00021406,Pocillopora_meandrina_HIv1___RNAseq.g21235.t1,three_way,52.90833333333333,,,,,,,,,,,,,,,,,
OG_02638,FUN_010805-T1,Peve_00006505,Pocillopora_meandrina_HIv1___RNAseq.g26670.t1,three_way,61.43866666666667,FUN_010805-T1,P31228,OXDD_BOVIN,,D-aspartate oxidase (DASOX) (DASPO) (DDO) (EC 1.4.3.1),Bos taurus (Bovine),26.8,406.0,3.7999999999999995e-24,114.0,sp|P31228|OXDD_BOVIN D-aspartate oxidase OS=Bos taurus OX=9913 GN=DDO PE=1 SV=3,GO:0005737; GO:0005782; GO:0005829; GO:0008445; GO:0019478; GO:0047821; GO:0050877; GO:0071949,D-amino acid catabolic process [GO:0019478]; nervous system process [GO:0050877],cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782],D-aspartate oxidase activity [GO:0008445]; D-glutamate oxidase activity [GO:0047821]; FAD binding [GO:0071949],GO:0003824; GO:0005829; GO:0006520; GO:0016491; GO:0050877,catalytic activity; cytosol; amino acid metabolic process; oxidoreductase activity; nervous system process
OG_02639,FUN_010807-T1,Peve_00006506,Pocillopora_meandrina_HIv1___RNAseq.g20902.t1,three_way,83.408,FUN_010807-T1,Q9QXG4,ACSA_MOUSE,,"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17)",Mus musculus (Mouse),65.8,679.0,2.2e-280,966.1,"sp|Q9QXG4|ACSA_MOUSE Acetyl-coenzyme A synthetase, cytoplasmic OS=Mus musculus OX=10090 GN=Acss2 PE=1 SV=2",GO:0003682; GO:0003713; GO:0003987; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006085; GO:0006629; GO:0007616; GO:0050218,acetyl-CoA biosynthetic process [GO:0006085]; lipid metabolic process [GO:0006629]; long-term memory [GO:0007616],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; propionate-CoA ligase activity [GO:0050218]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005829; GO:0006629; GO:0006790; GO:0016874; GO:0043226; GO:0050877; GO:0055086; GO:0060090; GO:0140110; GO:0140657,catalytic activity; nucleus; cytosol; lipid metabolic process; sulfur compound metabolic process; ligase activity; organelle; nervous system process; nucleobase-containing small molecule metabolic process; molecular adaptor activity; transcription regulator activity; ATP-dependent activity
OG_02640,FUN_010808-T1,Peve_00006509,Pocillopora_meandrina_HIv1___RNAseq.g20903.t1,three_way,79.348,FUN_010808-T1,Q3TYL0,,,,,49.1,489.0,1.2e-64,249.2,sp|Q3TYL0|IQAK1_MOUSE IQ motif and ankyrin repeat domain-containing protein 1 OS=Mus musculus OX=10090 GN=Iqank1 PE=1 SV=3,,,,,,
OG_02641,FUN_010809-T1,Peve_00034256,Pocillopora_meandrina_HIv1___TS.g25664.t1,three_way,62.525333333333336,FUN_010809-T1,Q49LS8,,,,,33.2,365.0,2.1e-46,188.3,sp|Q49LS8|XKR6_TETNG XK-related protein 6 OS=Tetraodon nigroviridis OX=99883 GN=xkr6 PE=2 SV=1,,,,,,
OG_02642,FUN_010810-T1,Peve_00006510,Pocillopora_meandrina_HIv1___RNAseq.g20905.t1,three_way,54.041,FUN_010810-T1,Q49LS8,,,,,31.2,420.0,1e-51,207.2,sp|Q49LS8|XKR6_TETNG XK-related protein 6 OS=Tetraodon nigroviridis OX=99883 GN=xkr6 PE=2 SV=1,,,,,,
OG_02643,FUN_010811-T1,Peve_00006518,Pocillopora_meandrina_HIv1___RNAseq.g20907.t1,three_way,57.91116666666667,FUN_010811-T1,Q0P4V4,,,,,29.0,715.0,7.6e-73,276.9,sp|Q0P4V4|KTU_XENTR Protein kintoun OS=Xenopus tropicalis OX=8364 GN=dnaaf2 PE=2 SV=1,,,,,,
OG_02644,FUN_010814-T1,Peve_00006521,Pocillopora_meandrina_HIv1___RNAseq.g20908.t1,three_way,94.45533333333331,FUN_010814-T1,Q96BR1,SGK3_HUMAN,,Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like),Homo sapiens (Human),64.1,485.0,1e-175,617.8,sp|Q96BR1|SGK3_HUMAN Serine/threonine-protein kinase Sgk3 OS=Homo sapiens OX=9606 GN=SGK3 PE=1 SV=1,GO:0001558; GO:0004672; GO:0004674; GO:0005246; GO:0005524; GO:0005769; GO:0005829; GO:0006468; GO:0015459; GO:0017080; GO:0017081; GO:0030334; GO:0035091; GO:0035556; GO:0042127; GO:0051090; GO:0055037; GO:0106310; GO:2001240,intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-binding transcription factor activity [GO:0051090],cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037],ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; chloride channel regulator activity [GO:0017081]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; sodium channel regulator activity [GO:0017080],GO:0003824; GO:0005768; GO:0005829; GO:0006355; GO:0008289; GO:0016740; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endosome; cytosol; regulation of DNA-templated transcription; lipid binding; transferase activity; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02645,FUN_010818-T1,Peve_00006523,Pocillopora_meandrina_HIv1___RNAseq.g20909.t1,three_way,90.38933333333334,FUN_010818-T1,Q8R4V0,SGK3_RAT,,Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like),Rattus norvegicus (Rat),62.1,451.0,9.6e-163,574.7,sp|Q8R4V0|SGK3_RAT Serine/threonine-protein kinase Sgk3 OS=Rattus norvegicus OX=10116 GN=Sgk3 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005769; GO:0015459; GO:0031410; GO:0035091; GO:0035556; GO:0055037; GO:0060090; GO:0106310; GO:2001240,intracellular signal transduction [GO:0035556]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240],cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; recycling endosome [GO:0055037],ATP binding [GO:0005524]; molecular adaptor activity [GO:0060090]; phosphatidylinositol binding [GO:0035091]; potassium channel regulator activity [GO:0015459]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005768; GO:0008289; GO:0016740; GO:0031410; GO:0043226; GO:0060090; GO:0098772; GO:0140096,"catalytic activity; endosome; lipid binding; transferase activity; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02646,FUN_010827-T1,Peve_00006524,Pocillopora_meandrina_HIv1___RNAseq.g20910.t1,three_way,77.81533333333333,FUN_010827-T1,Q80UK8,,,,,45.5,1277.0,4.8e-286,985.7,sp|Q80UK8|INT2_MOUSE Integrator complex subunit 2 OS=Mus musculus OX=10090 GN=Ints2 PE=1 SV=2,,,,,,
OG_02647,FUN_010829-T1,Peve_00017534,Pocillopora_meandrina_HIv1___RNAseq.g20912.t1,three_way,43.3975,,,,,,,,,,,,,,,,,
OG_02648,FUN_010830-T1,Peve_00017535,Pocillopora_meandrina_HIv1___RNAseq.g20913.t1,three_way,81.01133333333334,FUN_010830-T1,Q9NXB0,MKS1_HUMAN,,Tectonic-like complex member MKS1 (Meckel syndrome type 1 protein),Homo sapiens (Human),42.4,557.0,5.1e-126,453.0,sp|Q9NXB0|MKS1_HUMAN Tectonic-like complex member MKS1 OS=Homo sapiens OX=9606 GN=MKS1 PE=1 SV=2,GO:0001843; GO:0003271; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007368; GO:0008589; GO:0010669; GO:0016020; GO:0036038; GO:0036064; GO:0042733; GO:0044458; GO:0048706; GO:0048754; GO:0060122; GO:0060271; GO:0060322; GO:0060411; GO:0060828; GO:0061009; GO:1905515; GO:1990403; GO:2000095,"branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway [GO:0008589]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271]",centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005730; GO:0005815; GO:0005829; GO:0043226; GO:0044782; GO:0048856,nucleoplasm; nucleolus; microtubule organizing center; cytosol; organelle; cilium organization; anatomical structure development
OG_02649,FUN_010831-T1,Peve_00017536,Pocillopora_meandrina_HIv1___RNAseq.g20914.t1,three_way,75.07333333333334,FUN_010831-T1,P09057,DCOR_RAT,,Ornithine decarboxylase (ODC) (EC 4.1.1.17),Rattus norvegicus (Rat),53.1,409.0,6.7e-132,472.2,sp|P09057|DCOR_RAT Ornithine decarboxylase OS=Rattus norvegicus OX=10116 GN=Odc1 PE=1 SV=1,GO:0001822; GO:0004586; GO:0005737; GO:0005829; GO:0006595; GO:0008283; GO:0008284; GO:0009446; GO:0009615; GO:0033387; GO:0042176; GO:0042803; GO:0048471,"cell population proliferation [GO:0008283]; kidney development [GO:0001822]; polyamine metabolic process [GO:0006595]; positive regulation of cell population proliferation [GO:0008284]; putrescine biosynthetic process [GO:0009446]; putrescine biosynthetic process from arginine, via ornithine [GO:0033387]; regulation of protein catabolic process [GO:0042176]; response to virus [GO:0009615]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],ornithine decarboxylase activity [GO:0004586]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016829; GO:0048856,catalytic activity; cytosol; amino acid metabolic process; lyase activity; anatomical structure development
OG_02650,FUN_010832-T1,Peve_00017537,Pocillopora_meandrina_HIv1___RNAseq.g20916.t1,three_way,73.97983333333333,FUN_010832-T1,Q13118,KLF10_HUMAN,,Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1),Homo sapiens (Human),62.6,179.0,2.5e-12,74.7,sp|Q13118|KLF10_HUMAN Krueppel-like factor 10 OS=Homo sapiens OX=9606 GN=KLF10 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001046; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0007267; GO:0007623; GO:0008270; GO:0008285; GO:0009267; GO:0030282; GO:0035019; GO:0042752; GO:0045672; GO:0045892; GO:0045944; GO:1990837,bone mineralization [GO:0030282]; cell-cell signaling [GO:0007267]; cellular response to starvation [GO:0009267]; circadian rhythm [GO:0007623]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; somatic stem cell population maintenance [GO:0035019],chromatin [GO:0000785]; nucleus [GO:0005634],"core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0023052; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; signaling; organelle; anatomical structure development; transcription regulator activity
OG_02651,FUN_010834-T1,Peve_00017533,Pocillopora_meandrina_HIv1___RNAseq.g20918.t1,three_way,72.55833333333334,FUN_010834-T1,P25931,,,,,29.8,319.0,2.5e-34,148.3,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_02652,FUN_010835-T1,Peve_00030776,Pocillopora_meandrina_HIv1___RNAseq.g20920.t1,three_way,69.44516666666667,FUN_010835-T1,Q8BFW9,,,,,39.7,574.0,5.3e-110,399.8,"sp|Q8BFW9|GTR12_MOUSE Solute carrier family 2, facilitated glucose transporter member 12 OS=Mus musculus OX=10090 GN=Slc2a12 PE=2 SV=1",,,,,,
OG_02653,FUN_010836-T1,Peve_00026374,Pocillopora_meandrina_HIv1___RNAseq.g20930.t1b,three_way,63.647,,,,,,,,,,,,,,,,,
OG_02654,FUN_010837-T1,Peve_00014586,Pocillopora_meandrina_HIv1___RNAseq.g21011.t1,three_way,84.75966666666666,FUN_010837-T1,Q3MHP1,UB2L3_BOVIN,,Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (Ubiquitin carrier protein L3) (Ubiquitin-protein ligase L3),Bos taurus (Bovine),80.5,154.0,1.7e-71,270.0,sp|Q3MHP1|UB2L3_BOVIN Ubiquitin-conjugating enzyme E2 L3 OS=Bos taurus OX=9913 GN=UBE2L3 PE=2 SV=1,GO:0000209; GO:0003713; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006511; GO:0008283; GO:0016567; GO:0044770; GO:0061631; GO:0070979; GO:0071383; GO:0071385,cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA-templated transcription [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_02655,FUN_010838-T1,Peve_00014585,Pocillopora_meandrina_HIv1___RNAseq.g21010.t1,three_way,86.72466666666666,FUN_010838-T1,Q4V7Z0,,,,,63.6,280.0,6.3e-101,368.6,sp|Q4V7Z0|GPN3_XENLA GPN-loop GTPase 3 OS=Xenopus laevis OX=8355 GN=gpn3 PE=2 SV=1,,,,,,
OG_02656,FUN_010839-T1,Peve_00014584,Pocillopora_meandrina_HIv1___RNAseq.g21009.t1,three_way,68.30383333333333,FUN_010839-T1,Q8TAC1,,,,,46.9,128.0,1.1000000000000001e-30,134.4,sp|Q8TAC1|RFESD_HUMAN Rieske domain-containing protein OS=Homo sapiens OX=9606 GN=RFESD PE=1 SV=1,,,,,,
OG_02657,FUN_010840-T3,Peve_00014596,Pocillopora_meandrina_HIv1___RNAseq.g21008.t1,three_way,71.34866666666667,FUN_010840-T3,Q05B79,DHX36_BOVIN,,ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein),Bos taurus (Bovine),49.9,1010.0,5.3e-265,915.6,sp|Q05B79|DHX36_BOVIN ATP-dependent DNA/RNA helicase DHX36 OS=Bos taurus OX=9913 GN=DHX36 PE=1 SV=1,GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:0140640; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]",GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006355; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0098542; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; defense response to other organism; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02658,FUN_010841-T1,Peve_00024826,Pocillopora_meandrina_HIv1___RNAseq.g21007.t1,three_way,64.80283333333334,FUN_010841-T1,Q8NDL9,CBPC5_HUMAN,,Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5),Homo sapiens (Human),47.5,703.0,2.5e-179,630.9,sp|Q8NDL9|CBPC5_HUMAN Cytosolic carboxypeptidase-like protein 5 OS=Homo sapiens OX=9606 GN=AGBL5 PE=1 SV=1,GO:0004181; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0015630; GO:0015631; GO:0030496; GO:0035608; GO:0035609; GO:0035610; GO:0035611; GO:0051607; GO:0072686,C-terminal protein deglutamylation [GO:0035609]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_02659,FUN_010842-T1,Peve_00024825,Pocillopora_meandrina_HIv1___RNAseq.g21006.t1,three_way,78.08566666666667,FUN_010842-T1,Q8NEA4,,,,,44.2,181.0,4e-36,152.9,sp|Q8NEA4|FBX36_HUMAN F-box only protein 36 OS=Homo sapiens OX=9606 GN=FBXO36 PE=1 SV=2,,,,,,
OG_02660,FUN_010874-T1,Peve_00030154,Pocillopora_meandrina_HIv1___RNAseq.g21026.t1,three_way,89.481,FUN_010874-T1,Q6DUZ9,,,,,47.3,391.0,1.4999999999999999e-92,341.3,sp|Q6DUZ9|EIPR1_GEKJA EARP-interacting protein homolog OS=Gekko japonicus OX=146911 GN=eipr1 PE=2 SV=1,,,,,,
OG_02661,FUN_010875-T1,Peve_00009757,Pocillopora_meandrina_HIv1___RNAseq.g7085.t1,three_way,62.856,FUN_010875-T1,Q99LH1,,,,,67.8,466.0,6.2e-182,639.4,sp|Q99LH1|NOG2_MOUSE Nucleolar GTP-binding protein 2 OS=Mus musculus OX=10090 GN=Gnl2 PE=1 SV=2,,,,,,
OG_02662,FUN_010878-T1,Peve_00009759,Pocillopora_meandrina_HIv1___TS.128_t,three_way,78.95733333333334,FUN_010878-T1,Q86WA6,BPHL_HUMAN,,Serine hydrolase BPHL (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA) (L-homocysteine-thiolactonase BPHL) (Valacyclovir hydrolase) (VACVase) (Valacyclovirase),Homo sapiens (Human),57.3,253.0,1.5e-85,317.4,sp|Q86WA6|BPHL_HUMAN Serine hydrolase BPHL OS=Homo sapiens OX=9606 GN=BPHL PE=1 SV=1,GO:0005739; GO:0005741; GO:0006520; GO:0006805; GO:0009636; GO:0017171; GO:0047658; GO:0050667,amino acid metabolic process [GO:0006520]; homocysteine metabolic process [GO:0050667]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],alpha-amino-acid esterase activity [GO:0047658]; serine hydrolase activity [GO:0017171],GO:0003824; GO:0005739; GO:0006520; GO:0006790; GO:0016787; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; sulfur compound metabolic process; hydrolase activity; organelle
OG_02663,FUN_010879-T1,Peve_00035832,Pocillopora_meandrina_HIv1___RNAseq.g21030.t1,three_way,86.78866666666667,FUN_010879-T1,Q2KJI3,CYRIB_BOVIN,,CYFIP-related Rac1 interactor B (Protein FAM49B),Bos taurus (Bovine),65.7,327.0,8.4e-116,418.3,sp|Q2KJI3|CYRIB_BOVIN CYFIP-related Rac1 interactor B OS=Bos taurus OX=9913 GN=CYRIB PE=2 SV=1,GO:0001916; GO:0005739; GO:0005929; GO:0016020; GO:0023030; GO:0030334; GO:0030837; GO:0031267; GO:0032729; GO:0050870; GO:0050920; GO:0051058; GO:0071219; GO:0090140; GO:2000114; GO:2000568,cellular response to molecule of bacterial origin [GO:0071219]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of type II interferon production [GO:0032729]; regulation of cell migration [GO:0030334]; regulation of chemotaxis [GO:0050920]; regulation of establishment of cell polarity [GO:2000114]; regulation of mitochondrial fission [GO:0090140],cilium [GO:0005929]; membrane [GO:0016020]; mitochondrion [GO:0005739],"MHC class Ib protein binding, via antigen binding groove [GO:0023030]; small GTPase binding [GO:0031267]",GO:0005739; GO:0005929; GO:0043226,mitochondrion; cilium; organelle
OG_02664,FUN_010883-T1,Peve_00035843,Pocillopora_meandrina_HIv1___RNAseq.g21034.t1,three_way,65.3205,,,,,,,,,,,,,,,,,
OG_02665,FUN_010884-T1,Peve_00035834,Pocillopora_meandrina_HIv1___TS.g25786.t1,three_way,35.30566666666667,,,,,,,,,,,,,,,,,
OG_02666,FUN_010885-T1,Peve_00035837,Pocillopora_meandrina_HIv1___RNAseq.g21004.t1,three_way,46.05866666666667,FUN_010885-T1,Q5VXM1,,,,,36.7,109.0,4e-09,64.7,sp|Q5VXM1|CDCP2_HUMAN CUB domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CDCP2 PE=2 SV=2,,,,,,
OG_02667,FUN_010886-T1,Peve_00035836,Pocillopora_meandrina_HIv1___RNAseq.g21003.t1,three_way,77.347,FUN_010886-T1,A7YW81,,,,,42.1,126.0,2.2e-24,113.2,sp|A7YW81|TM234_BOVIN Transmembrane protein 234 OS=Bos taurus OX=9913 GN=TMEM234 PE=2 SV=1,,,,,,
OG_02668,FUN_010887-T1,Peve_00035839,Pocillopora_meandrina_HIv1___RNAseq.g21002.t1,three_way,87.91066666666666,FUN_010887-T1,Q32LP2,RADI_BOVIN,,Radixin,Bos taurus (Bovine),67.4,307.0,5e-129,463.0,sp|Q32LP2|RADI_BOVIN Radixin OS=Bos taurus OX=9913 GN=RDX PE=2 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0008360; GO:0030175; GO:0032154; GO:0045177; GO:0050839; GO:0051693; GO:0120044; GO:1902115; GO:1902966; GO:2000643,actin filament capping [GO:0051693]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839],GO:0005856; GO:0005886; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_02669,FUN_010888-T1,Peve_00035840,Pocillopora_meandrina_HIv1___RNAseq.g21001.t1,three_way,71.89333333333333,FUN_010888-T1,Q8VCM5,MUL1_MOUSE,,Mitochondrial ubiquitin ligase activator of NFKB 1 (EC 2.3.2.27) (E3 ubiquitin-protein ligase MUL1) (Growth inhibition and death E3 ligase) (Protein Hades) (RING-type E3 ubiquitin transferase NFKB 1),Mus musculus (Mouse),34.8,339.0,9.3e-59,228.8,sp|Q8VCM5|MUL1_MOUSE Mitochondrial ubiquitin ligase activator of NFKB 1 OS=Mus musculus OX=10090 GN=Mul1 PE=1 SV=2,GO:0000209; GO:0000266; GO:0002039; GO:0005739; GO:0005741; GO:0005777; GO:0006915; GO:0008270; GO:0010637; GO:0016567; GO:0016925; GO:0019789; GO:0030424; GO:0031625; GO:0031647; GO:0031648; GO:0033235; GO:0042802; GO:0043025; GO:0043123; GO:0045824; GO:0050689; GO:0050821; GO:0051646; GO:0051881; GO:0051898; GO:0060339; GO:0061630; GO:0071360; GO:0071650; GO:0090141; GO:1901028; GO:1903861; GO:1905091,apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; mitochondrial fission [GO:0000266]; mitochondrion localization [GO:0051646]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of defense response to virus by host [GO:0050689]; negative regulation of innate immune response [GO:0045824]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite extension [GO:1903861]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of type 2 mitophagy [GO:1905091]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; protein sumoylation [GO:0016925]; protein ubiquitination [GO:0016567]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901028]; regulation of protein stability [GO:0031647],axon [GO:0030424]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisome [GO:0005777],identical protein binding [GO:0042802]; p53 binding [GO:0002039]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0005777; GO:0007005; GO:0012501; GO:0016740; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; mitochondrion; peroxisome; mitochondrion organization; programmed cell death; transferase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_02670,FUN_010893-T1,Peve_00016445,Pocillopora_meandrina_HIv1___RNAseq.g20998.t1,three_way,66.386,FUN_010893-T1,Q9UHC3,,,,,28.6,479.0,4.4e-49,197.2,sp|Q9UHC3|ASIC3_HUMAN Acid-sensing ion channel 3 OS=Homo sapiens OX=9606 GN=ASIC3 PE=1 SV=2,,,,,,
OG_02671,FUN_010896-T1,Peve_00044943,Pocillopora_meandrina_HIv1___RNAseq.g20992.t1,three_way,75.72,FUN_010896-T1,Q10075,PCS_SCHPO,,Glutathione gamma-glutamylcysteinyltransferase (EC 2.3.2.15) (Phytochelatin synthase),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),44.3,235.0,1.8e-53,211.1,sp|Q10075|PCS_SCHPO Glutathione gamma-glutamylcysteinyltransferase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC3H1.10 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0010273; GO:0016756; GO:0046870; GO:0046938; GO:0071276; GO:0098849,cellular detoxification of cadmium ion [GO:0098849]; cellular response to cadmium ion [GO:0071276]; detoxification of copper ion [GO:0010273]; phytochelatin biosynthetic process [GO:0046938],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cadmium ion binding [GO:0046870]; glutathione gamma-glutamylcysteinyltransferase activity [GO:0016756],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0098754,catalytic activity; nucleus; cytosol; transferase activity; organelle; detoxification
OG_02672,FUN_010897-T1,Peve_00044944,Pocillopora_meandrina_HIv1___RNAseq.91_t,three_way,74.07666666666667,FUN_010897-T1,D3ZAT9,,,,,38.3,227.0,9.3e-45,181.8,sp|D3ZAT9|FAXC_RAT Failed axon connections homolog OS=Rattus norvegicus OX=10116 GN=Faxc PE=3 SV=1,,,,,,
OG_02673,FUN_010898-T1,Peve_00044945,Pocillopora_meandrina_HIv1___RNAseq.g20990.t1,three_way,73.07133333333333,FUN_010898-T1,Q9GZU0,,,,,57.6,229.0,3.4e-76,286.2,sp|Q9GZU0|CF062_HUMAN Uncharacterized protein C6orf62 OS=Homo sapiens OX=9606 GN=C6orf62 PE=1 SV=1,,,,,,
OG_02674,FUN_010919-T1,Peve_00044947,Pocillopora_meandrina_HIv1___RNAseq.g20988.t2,three_way,84.51416666666667,FUN_010919-T1,Q91437,PYR1_SQUAC,,Multifunctional protein CAD (Carbamoyl phosphate synthetase 2-aspartate transcarbamylase-dihydroorotase) [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Glutamine amidotransferase (GATase) (GLNase) (EC 3.5.1.2); Ammonium-dependent carbamoyl phosphate synthase (CPS) (CPSase) (EC 6.3.4.16); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)],Squalus acanthias (Spiny dogfish),66.0,2277.0,0.0,2989.9,sp|Q91437|PYR1_SQUAC Multifunctional protein CAD OS=Squalus acanthias OX=7797 GN=CAD PE=2 SV=1,GO:0004070; GO:0004087; GO:0004088; GO:0004151; GO:0004359; GO:0005524; GO:0005634; GO:0005951; GO:0006207; GO:0006526; GO:0006541; GO:0008270; GO:0016597; GO:0044205,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541]; L-arginine biosynthetic process [GO:0006526],carbamoyl-phosphate synthase complex [GO:0005951]; nucleus [GO:0005634],amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; glutaminase activity [GO:0004359]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006520; GO:0016740; GO:0016787; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; amino acid metabolic process; transferase activity; hydrolase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02675,FUN_010920-T1,Peve_00025754,Pocillopora_meandrina_HIv1___RNAseq.g21799.t1,three_way,91.52566666666668,FUN_010920-T1,P63009,,,,,72.2,956.0,0.0,1317.0,sp|P63009|AP2B1_BOVIN AP-2 complex subunit beta OS=Bos taurus OX=9913 GN=AP2B1 PE=1 SV=2,,,,,,
OG_02676,FUN_010925-T1,Peve_00005955,Pocillopora_meandrina_HIv1___RNAseq.g21797.t1,three_way,57.31033333333333,,,,,,,,,,,,,,,,,
OG_02677,FUN_010927-T1,Peve_00005956,Pocillopora_meandrina_HIv1___TS.g26549.t1,three_way,49.63933333333333,,,,,,,,,,,,,,,,,
OG_02678,FUN_010928-T1,Peve_00005957,Pocillopora_meandrina_HIv1___TS.g26544.t1,three_way,74.984,,,,,,,,,,,,,,,,,
OG_02679,FUN_010929-T1,Peve_00005959,Pocillopora_meandrina_HIv1___RNAseq.g20983.t1,three_way,77.19966666666666,FUN_010929-T1,Q29RS4,IN80E_BOVIN,,INO80 complex subunit E (Coiled-coil domain-containing protein 95),Bos taurus (Bovine),70.3,64.0,1.3e-16,88.6,sp|Q29RS4|IN80E_BOVIN INO80 complex subunit E OS=Bos taurus OX=9913 GN=INO80E PE=2 SV=1,GO:0006281; GO:0006310; GO:0006338; GO:0031011,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],Ino80 complex [GO:0031011],,GO:0006281; GO:0006310; GO:0006325,DNA repair; DNA recombination; chromatin organization
OG_02680,FUN_010930-T1,Peve_00005960,Pocillopora_meandrina_HIv1___RNAseq.g20982.t1a,three_way,40.99766666666667,,,,,,,,,,,,,,,,,
OG_02681,FUN_010931-T1,Peve_00005964,Pocillopora_meandrina_HIv1___RNAseq.g20986.t1,three_way,70.11850000000001,FUN_010931-T1,Q9DBE9,SPB1_MOUSE,,pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 (EC 2.1.1.-) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3),Mus musculus (Mouse),47.7,830.0,1.7e-162,574.7,sp|Q9DBE9|SPB1_MOUSE pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ3 OS=Mus musculus OX=10090 GN=Ftsj3 PE=1 SV=1,GO:0001510; GO:0005654; GO:0005694; GO:0005730; GO:0008649; GO:0030688; GO:0062105,RNA methylation [GO:0001510],"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]",RNA 2'-O-methyltransferase activity [GO:0062105]; rRNA methyltransferase activity [GO:0008649],GO:0003824; GO:0005654; GO:0005694; GO:0005730; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleoplasm; chromosome; nucleolus; transferase activity; organelle; catalytic activity, acting on RNA"
OG_02682,FUN_010940-T1,Peve_00005965,Pocillopora_meandrina_HIv1___RNAseq.g20987.t1,three_way,71.95466666666667,FUN_010940-T1,Q6P1V4,,,,,58.3,841.0,1.9e-226,787.3,sp|Q6P1V4|EIF3C_XENTR Eukaryotic translation initiation factor 3 subunit C OS=Xenopus tropicalis OX=8364 GN=eif3c PE=2 SV=1,,,,,,
OG_02683,FUN_010941-T1,Peve_00005967,Pocillopora_meandrina_HIv1___RNAseq.g21806.t1,three_way,91.54933333333334,FUN_010941-T1,E2QWQ2,NLK_CANLF,,Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase),Canis lupus familiaris (Dog) (Canis familiaris),72.8,390.0,1.6000000000000002e-164,580.5,sp|E2QWQ2|NLK_CANLF Serine/threonine-protein kinase NLK OS=Canis lupus familiaris OX=9615 GN=NLK PE=3 SV=1,GO:0000287; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0007179; GO:0016055; GO:0030178; GO:0031625; GO:0035556; GO:0042169; GO:0050821; GO:0071470; GO:0106310; GO:0140297; GO:1904262; GO:1904894,cellular response to osmotic stress [GO:0071470]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH2 domain binding [GO:0042169]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02684,FUN_010942-T2,Peve_00040402,Pocillopora_meandrina_HIv1___RNAseq.g21807.t1,three_way,57.24416666666667,FUN_010942-T2,Q9EST3,4ET_MOUSE,,Eukaryotic translation initiation factor 4E transporter (4E-T) (eIF4E transporter) (CD40 ligand-activated specific transcript 4) (Eukaryotic translation initiation factor 4E nuclear import factor 1),Mus musculus (Mouse),25.5,842.0,3.3e-29,132.5,sp|Q9EST3|4ET_MOUSE Eukaryotic translation initiation factor 4E transporter OS=Mus musculus OX=10090 GN=Eif4enif1 PE=1 SV=2,GO:0000932; GO:0003729; GO:0005049; GO:0005634; GO:0005737; GO:0005829; GO:0006412; GO:0006606; GO:0016605; GO:0016607; GO:0017148; GO:0019827; GO:0019900; GO:0030182; GO:0033962; GO:0035278; GO:0045665; GO:0048255; GO:0060213; GO:0106289,miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA stabilization [GO:0048255]; negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106289]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; neuron differentiation [GO:0030182]; P-body assembly [GO:0033962]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; protein import into nucleus [GO:0006606]; stem cell population maintenance [GO:0019827]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; PML body [GO:0016605],kinase binding [GO:0019900]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049],GO:0003723; GO:0005634; GO:0005829; GO:0006886; GO:0006913; GO:0030154; GO:0031047; GO:0043226; GO:0140104,RNA binding; nucleus; cytosol; intracellular protein transport; nucleocytoplasmic transport; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; molecular carrier activity
OG_02685,FUN_010945-T1,Peve_00040401,Pocillopora_meandrina_HIv1___RNAseq.g21808.t1,three_way,86.82433333333333,FUN_010945-T1,P04636,MDHM_RAT,,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)",Rattus norvegicus (Rat),65.3,320.0,9.3e-115,414.8,"sp|P04636|MDHM_RAT Malate dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Mdh2 PE=1 SV=2",GO:0005737; GO:0005739; GO:0005759; GO:0006094; GO:0006099; GO:0006108; GO:0006734; GO:0009060; GO:0016020; GO:0016615; GO:0030060; GO:0042802; GO:0042803; GO:0043490; GO:0046554; GO:0051087,aerobic respiration [GO:0009060]; gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; malate-aspartate shuttle [GO:0043490]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; L-malate dehydrogenase (NAD+) activity [GO:0030060]; L-malate dehydrogenase (NADP+) activity [GO:0046554]; malate dehydrogenase activity [GO:0016615]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087],GO:0003824; GO:0005739; GO:0005975; GO:0006091; GO:0016491; GO:0043226; GO:0055086,catalytic activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_02686,FUN_010946-T1,Peve_00040400,Pocillopora_meandrina_HIv1___RNAseq.g21809.t1,three_way,75.744,FUN_010946-T1,Q9Y6J8,STYL1_HUMAN,,Serine/threonine/tyrosine-interacting-like protein 1 (Dual specificity phosphatase inhibitor MK-STYX) (Dual specificity protein phosphatase 24) (Inactive dual specificity protein phosphatase MK-STYX) (Map kinase phosphatase-like protein MK-STYX),Homo sapiens (Human),38.3,324.0,1.4999999999999999e-55,218.0,sp|Q9Y6J8|STYL1_HUMAN Serine/threonine/tyrosine-interacting-like protein 1 OS=Homo sapiens OX=9606 GN=STYXL1 PE=1 SV=1,GO:0001691; GO:0005739; GO:0005759; GO:0010976; GO:0019212; GO:0019903; GO:0035556; GO:0062030; GO:2001242; GO:2001244,intracellular signal transduction [GO:0035556]; negative regulation of stress granule assembly [GO:0062030]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; regulation of intrinsic apoptotic signaling pathway [GO:2001242],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],phosphatase inhibitor activity [GO:0019212]; protein phosphatase binding [GO:0019903]; pseudophosphatase activity [GO:0001691],GO:0005739; GO:0043226; GO:0098772,mitochondrion; organelle; molecular function regulator activity
OG_02687,FUN_010947-T1,Peve_00040399,Pocillopora_meandrina_HIv1___RNAseq.g21805.t1,three_way,64.768,,,,,,,,,,,,,,,,,
OG_02688,FUN_010948-T1,Peve_00040396,Pocillopora_meandrina_HIv1___RNAseq.921_t,three_way,64.41233333333334,FUN_010948-T1,O89001,,,,,51.3,392.0,5.8e-115,416.0,sp|O89001|CBPD_MOUSE Carboxypeptidase D OS=Mus musculus OX=10090 GN=Cpd PE=1 SV=2,,,,,,
OG_02689,FUN_010949-T1,Peve_00040395,Pocillopora_meandrina_HIv1___RNAseq.g21802.t1,three_way,77.62,FUN_010949-T1,Q7ZU90,CHD1L_DANRE,,Chromodomain-helicase-DNA-binding protein 1-like (EC 3.6.4.-),Danio rerio (Zebrafish) (Brachydanio rerio),52.9,877.0,3.7999999999999996e-235,816.2,sp|Q7ZU90|CHD1L_DANRE Chromodomain-helicase-DNA-binding protein 1-like OS=Danio rerio OX=7955 GN=chd1l PE=2 SV=1,GO:0000166; GO:0003678; GO:0005524; GO:0005634; GO:0006281; GO:0006338; GO:0006974; GO:0007420; GO:0016887; GO:0031491; GO:0035861; GO:0140566; GO:0140658; GO:0160004,brain development [GO:0007420]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA repair [GO:0006281],nucleus [GO:0005634]; site of double-strand break [GO:0035861],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; histone reader activity [GO:0140566]; nucleosome binding [GO:0031491]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004],GO:0003824; GO:0005634; GO:0006281; GO:0006325; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140657,"catalytic activity; nucleus; DNA repair; chromatin organization; hydrolase activity; isomerase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02690,FUN_010950-T1,Peve_00040405,Pocillopora_meandrina_HIv1___RNAseq.g21821.t1,three_way,69.54883333333333,FUN_010950-T1,Q7TN88,,,,,38.0,403.0,5.7e-77,292.4,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_02691,FUN_010951-T1,Peve_00015013,Pocillopora_meandrina_HIv1___TS.g26577.t1,three_way,51.42233333333333,,,,,,,,,,,,,,,,,
OG_02692,FUN_010955-T1,Peve_00015012,Pocillopora_meandrina_HIv1___RNAseq.g21823.t1,three_way,51.78366666666667,,,,,,,,,,,,,,,,,
OG_02693,FUN_010956-T1,Peve_00015009,Pocillopora_meandrina_HIv1___RNAseq.g21824.t1,three_way,40.20633333333333,,,,,,,,,,,,,,,,,
OG_02694,FUN_010957-T1,Peve_00035899,Pocillopora_meandrina_HIv1___RNAseq.g21825.t1,three_way,53.990833333333335,,,,,,,,,,,,,,,,,
OG_02695,FUN_010959-T1,Peve_00007919,Pocillopora_meandrina_HIv1___RNAseq.g21826.t1,three_way,37.18416666666666,,,,,,,,,,,,,,,,,
OG_02696,FUN_010960-T1,Peve_00007918,Pocillopora_meandrina_HIv1___RNAseq.g21827.t1,three_way,80.13816666666666,FUN_010960-T1,Q5F259,AN13B_MOUSE,,Ankyrin repeat domain-containing protein 13B,Mus musculus (Mouse),45.7,532.0,1.2e-126,455.3,sp|Q5F259|AN13B_MOUSE Ankyrin repeat domain-containing protein 13B OS=Mus musculus OX=10090 GN=Ankrd13b PE=2 SV=1,GO:0002091; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0048471; GO:0140036,negative regulation of receptor internalization [GO:0002091],cytoplasm [GO:0005737]; early endosome [GO:0005769]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ubiquitin-modified protein reader activity [GO:0140036],GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0060090,endosome; plasma membrane; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_02697,FUN_010962-T1,Peve_00007923,Pocillopora_meandrina_HIv1___TS.g26730.t1,three_way,80.4425,FUN_010962-T1,Q3U319,BRE1B_MOUSE,,E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B),Mus musculus (Mouse),32.2,997.0,1.5e-111,405.6,sp|Q3U319|BRE1B_MOUSE E3 ubiquitin-protein ligase BRE1B OS=Mus musculus OX=10090 GN=Rnf40 PE=1 SV=2,GO:0003730; GO:0004842; GO:0005654; GO:0006325; GO:0008270; GO:0016567; GO:0031625; GO:0033503; GO:0042803; GO:0045944,chromatin organization [GO:0006325]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567],HULC complex [GO:0033503]; nucleoplasm [GO:0005654],mRNA 3'-UTR binding [GO:0003730]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0140096,"RNA binding; catalytic activity; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; catalytic activity, acting on a protein"
OG_02698,FUN_010966-T1,Peve_00007917,Pocillopora_meandrina_HIv1___RNAseq.g21968.t1,three_way,49.817166666666665,,,,,,,,,,,,,,,,,
OG_02699,FUN_010968-T1,Peve_00035956,Pocillopora_meandrina_HIv1___RNAseq.g21969.t2,three_way,64.66499999999999,FUN_010968-T1,Q98TZ8,,,,,34.2,161.0,1.2e-22,107.8,sp|Q98TZ8|FLOT2_DANRE Flotillin-2a OS=Danio rerio OX=7955 GN=flot2a PE=2 SV=2,,,,,,
OG_02700,FUN_010973-T1,Peve_00029718,Pocillopora_meandrina_HIv1___RNAseq.g21963.t1,three_way,35.476,,,,,,,,,,,,,,,,,
OG_02701,FUN_010974-T1,Peve_00029717,Pocillopora_meandrina_HIv1___RNAseq.g21962.t1,three_way,91.15866666666666,FUN_010974-T1,A7RM20,,,,,76.0,321.0,2.4e-152,539.7,sp|A7RM20|EIF3I_NEMVE Eukaryotic translation initiation factor 3 subunit I OS=Nematostella vectensis OX=45351 GN=v1g239264 PE=3 SV=1,,,,,,
OG_02702,FUN_010977-T1,Peve_00013380,Pocillopora_meandrina_HIv1___RNAseq.g22016.t2,three_way,61.6055,FUN_010977-T1,Q8VCM2,NOXO1_MOUSE,,NADPH oxidase organizer 1 (Nox organizer 1) (Sorting nexin-28),Mus musculus (Mouse),34.5,110.0,2e-12,76.3,sp|Q8VCM2|NOXO1_MOUSE NADPH oxidase organizer 1 OS=Mus musculus OX=10090 GN=Noxo1 PE=1 SV=2,GO:0005886; GO:0006801; GO:0016176; GO:0019899; GO:0022617; GO:0035091; GO:0043020,extracellular matrix disassembly [GO:0022617]; superoxide metabolic process [GO:0006801],NADPH oxidase complex [GO:0043020]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; superoxide-generating NADPH oxidase activator activity [GO:0016176],GO:0005886; GO:0008289; GO:0030198; GO:0098772,plasma membrane; lipid binding; extracellular matrix organization; molecular function regulator activity
OG_02703,FUN_010978-T1,Peve_00013381,Pocillopora_meandrina_HIv1___RNAseq.g22015.t1,three_way,71.64766666666667,FUN_010978-T1,Q9JMB7,PIWL1_MOUSE,,Piwi-like protein 1 (EC 3.1.26.-),Mus musculus (Mouse),50.6,765.0,4.9e-237,822.4,sp|Q9JMB7|PIWL1_MOUSE Piwi-like protein 1 OS=Mus musculus OX=10090 GN=Piwil1 PE=1 SV=1,GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0007283; GO:0007286; GO:0019901; GO:0031047; GO:0033391; GO:0034584; GO:0035092; GO:0043186; GO:0046872; GO:0051321; GO:0097433; GO:0140262; GO:0140990; GO:0140991; GO:0141006; GO:2000765,meiotic cell cycle [GO:0051321]; piRNA-mediated gene silencing by mRNA destabilization [GO:0140991]; primary piRNA processing [GO:0140990]; regulation of cytoplasmic translation [GO:2000765]; regulatory ncRNA-mediated gene silencing [GO:0031047]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186],metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; protein kinase binding [GO:0019901]; RNA endonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140098,"RNA binding; catalytic activity; nucleus; cytosol; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_02704,FUN_010979-T2,Peve_00013382,Pocillopora_meandrina_HIv1___RNAseq.g22013.t1,three_way,50.22,,,,,,,,,,,,,,,,,
OG_02705,FUN_010980-T1,Peve_00013383,Pocillopora_meandrina_HIv1___RNAseq.g22012.t1,three_way,61.09616666666667,FUN_010980-T1,Q80VP5,,,,,57.7,71.0,2.3e-18,93.6,sp|Q80VP5|MTRFR_MOUSE Mitochondrial translation release factor in rescue OS=Mus musculus OX=10090 GN=Mtrfr PE=1 SV=1,,,,,,
OG_02706,FUN_010982-T1,Peve_00013385,Pocillopora_meandrina_HIv1___RNAseq.g22010.t1,three_way,75.501,FUN_010982-T1,A1A4V9,CF119_HUMAN,,Cilia- and flagella-associated protein 119 (Coiled-coil domain-containing protein 189),Homo sapiens (Human),47.2,127.0,1.1e-25,118.2,sp|A1A4V9|CF119_HUMAN Cilia- and flagella-associated protein 119 OS=Homo sapiens OX=9606 GN=CFAP119 PE=1 SV=1,GO:0001534; GO:0001669; GO:0005737; GO:0007338; GO:0010467; GO:0097228; GO:0120316,gene expression [GO:0010467]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; radial spoke [GO:0001534]; sperm principal piece [GO:0097228],,GO:0022414; GO:0031410; GO:0043226; GO:0044782,reproductive process; cytoplasmic vesicle; organelle; cilium organization
OG_02707,FUN_010984-T1,Peve_00013386,Pocillopora_meandrina_HIv1___RNAseq.g22009.t1,three_way,79.6975,FUN_010984-T1,Q7Z3V4,UBE3B_HUMAN,,Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B),Homo sapiens (Human),50.4,1075.0,3.1e-310,1065.8,sp|Q7Z3V4|UBE3B_HUMAN Ubiquitin-protein ligase E3B OS=Homo sapiens OX=9606 GN=UBE3B PE=1 SV=3,GO:0000209; GO:0005739; GO:0006511; GO:0014069; GO:0061630; GO:0098978; GO:0150052,protein polyubiquitination [GO:0000209]; regulation of postsynapse assembly [GO:0150052]; ubiquitin-dependent protein catabolic process [GO:0006511],glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; postsynaptic density [GO:0014069],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02708,FUN_010985-T1,Peve_00013387,Pocillopora_meandrina_HIv1___RNAseq.g22008.t1,three_way,72.90966666666667,FUN_010985-T1,Q96JM7,,,,,33.9,840.0,2.1e-129,464.9,sp|Q96JM7|LMBL3_HUMAN Lethal(3)malignant brain tumor-like protein 3 OS=Homo sapiens OX=9606 GN=L3MBTL3 PE=1 SV=2,,,,,,
OG_02709,FUN_010986-T1,Peve_00013392,Pocillopora_meandrina_HIv1___RNAseq.g22007.t2,three_way,74.76766666666667,FUN_010986-T1,Q96LW2,,,,,38.4,315.0,3.4e-61,237.3,sp|Q96LW2|KS6R_HUMAN Ribosomal protein S6 kinase-related protein OS=Homo sapiens OX=9606 GN=RSKR PE=1 SV=3,,,,,,
OG_02710,FUN_010988-T1,Peve_00013393,Pocillopora_meandrina_HIv1___TS.g26769.t2,three_way,57.87616666666666,FUN_010988-T1,Q6NWI1,,,,,32.3,189.0,1.5e-11,72.0,sp|Q6NWI1|RSRC2_DANRE Arginine/serine-rich coiled-coil protein 2 OS=Danio rerio OX=7955 GN=rsrc2 PE=2 SV=1,,,,,,
OG_02711,FUN_010989-T1,Peve_00013395,Pocillopora_meandrina_HIv1___RNAseq.g22004.t1c,three_way,72.40866666666666,,,,,,,,,,,,,,,,,
OG_02712,FUN_010990-T1,Peve_00013396,Pocillopora_meandrina_HIv1___TS.g29847.t1,three_way,54.55116666666667,FUN_010990-T1,Q6J4K2,NCLX_HUMAN,,"Mitochondrial sodium/calcium exchanger protein (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Sodium/potassium/calcium exchanger 6) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)",Homo sapiens (Human),39.1,539.0,1.6e-99,365.2,sp|Q6J4K2|NCLX_HUMAN Mitochondrial sodium/calcium exchanger protein OS=Homo sapiens OX=9606 GN=SLC8B1 PE=1 SV=2,GO:0005432; GO:0005739; GO:0005743; GO:0005886; GO:0006811; GO:0006851; GO:0006874; GO:0015368; GO:0016020; GO:0030061; GO:0031966; GO:0042383; GO:0042593; GO:0042803; GO:0050796; GO:0051480; GO:0051560; GO:0086036; GO:0086038; GO:0099093; GO:1901623; GO:2001256,calcium export from the mitochondrion [GO:0099093]; glucose homeostasis [GO:0042593]; intracellular calcium ion homeostasis [GO:0006874]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; monoatomic ion transport [GO:0006811]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of insulin secretion [GO:0050796]; regulation of lymphocyte chemotaxis [GO:1901623]; regulation of store-operated calcium entry [GO:2001256],membrane [GO:0016020]; mitochondrial crista [GO:0030061]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],calcium:monoatomic cation antiporter activity [GO:0015368]; calcium:sodium antiporter activity [GO:0005432]; calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential [GO:0086038]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_02713,FUN_010993-T1,Peve_00013400,Pocillopora_meandrina_HIv1___RNAseq.g22001.t1,three_way,60.675,,,,,,,,,,,,,,,,,
OG_02714,FUN_010997-T1,Peve_00013403,Pocillopora_meandrina_HIv1___RNAseq.g22025.t1,three_way,73.773,FUN_010997-T1,P78330,SERB_HUMAN,,Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase),Homo sapiens (Human),57.1,219.0,8.8e-70,265.0,sp|P78330|SERB_HUMAN Phosphoserine phosphatase OS=Homo sapiens OX=9606 GN=PSPH PE=1 SV=2,GO:0000287; GO:0001701; GO:0005737; GO:0005829; GO:0006563; GO:0006564; GO:0009612; GO:0031667; GO:0033574; GO:0036424; GO:0042802; GO:0042803,in utero embryonic development [GO:0001701]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574],cytoplasm [GO:0005737]; cytosol [GO:0005829],identical protein binding [GO:0042802]; L-phosphoserine phosphatase activity [GO:0036424]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016787; GO:0048856,catalytic activity; cytosol; amino acid metabolic process; hydrolase activity; anatomical structure development
OG_02715,FUN_010998-T1,Peve_00013404,Pocillopora_meandrina_HIv1___TS.g26787.t1,three_way,43.73383333333333,,,,,,,,,,,,,,,,,
OG_02716,FUN_010999-T1,Peve_00013407,Pocillopora_meandrina_HIv1___RNAseq.g22023.t1,three_way,83.44866666666667,FUN_010999-T1,A4IF93,,,,,42.4,582.0,1.5999999999999999e-127,458.0,sp|A4IF93|TBCC1_BOVIN TBCC domain-containing protein 1 OS=Bos taurus OX=9913 GN=TBCCD1 PE=2 SV=1,,,,,,
OG_02717,FUN_011000-T1,Peve_00013408,Pocillopora_meandrina_HIv1___RNAseq.g22022.t1,three_way,93.14033333333332,FUN_011000-T1,A7S8T5,,,,,85.2,304.0,7.2e-122,438.3,sp|A7S8T5|CCD42_NEMVE Coiled-coil domain-containing protein 42 homolog OS=Nematostella vectensis OX=45351 GN=v1g187067 PE=3 SV=1,,,,,,
OG_02718,FUN_011001-T1,Peve_00013415,Pocillopora_meandrina_HIv1___RNAseq.g22019.t1,three_way,62.246,FUN_011001-T1,A8WFU8,KIF22_DANRE,,Kinesin-like protein KIF22,Danio rerio (Zebrafish) (Brachydanio rerio),41.6,632.0,3.4e-120,433.7,sp|A8WFU8|KIF22_DANRE Kinesin-like protein KIF22 OS=Danio rerio OX=7955 GN=kif22 PE=2 SV=1,GO:0001756; GO:0001966; GO:0003677; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005871; GO:0005874; GO:0007018; GO:0007409; GO:0007420; GO:0008017; GO:0016887; GO:0021952; GO:0048592,axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; eye morphogenesis [GO:0048592]; microtubule-based movement [GO:0007018]; somitogenesis [GO:0001756]; thigmotaxis [GO:0001966],cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003677; GO:0003774; GO:0003824; GO:0005634; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0140657,DNA binding; cytoskeletal motor activity; catalytic activity; nucleus; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; anatomical structure development; ATP-dependent activity
OG_02719,FUN_011046-T1,Peve_00013440,Pocillopora_meandrina_HIv1___RNAseq.g21485.t2,three_way,75.79966666666667,FUN_011046-T1,Q567Y6,,,,,48.7,187.0,3.3999999999999995e-53,209.9,sp|Q567Y6|IFT22_DANRE Intraflagellar transport protein 22 homolog OS=Danio rerio OX=7955 GN=ift22 PE=2 SV=1,,,,,,
OG_02720,FUN_011048-T1,Peve_00013435,Pocillopora_meandrina_HIv1___RNAseq.g21483.t1,three_way,68.41766666666666,FUN_011048-T1,Q5PQT2,MTMR3_RAT,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase)",Rattus norvegicus (Rat),37.4,1193.0,2.4e-206,720.7,"sp|Q5PQT2|MTMR3_RAT Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Rattus norvegicus OX=10116 GN=Mtmr3 PE=1 SV=1",GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0008138; GO:0008270; GO:0016020; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785,cellular response to glucose starvation [GO:0042149]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],"molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0060090; GO:0061024; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; hydrolase activity; molecular adaptor activity; membrane organization; catalytic activity, acting on a protein"
OG_02721,FUN_011049-T1,Peve_00013424,Pocillopora_meandrina_HIv1___TS.g26228.t1,three_way,60.9865,,,,,,,,,,,,,,,,,
OG_02722,FUN_011051-T1,Peve_00022611,Pocillopora_meandrina_HIv1___RNAseq.g20976.t1,three_way,89.26266666666666,FUN_011051-T1,Q7T312,,,,,73.6,208.0,1.3e-58,227.6,sp|Q7T312|CCD25_DANRE Coiled-coil domain-containing protein 25 OS=Danio rerio OX=7955 GN=ccdc25 PE=1 SV=1,,,,,,
OG_02723,FUN_011058-T1,Peve_00009503,Pocillopora_meandrina_HIv1___RNAseq.g22353.t1,three_way,79.46733333333333,FUN_011058-T1,P57772,SELB_HUMAN,,"Selenocysteine-specific elongation factor (EC 3.6.5.-) (Elongation factor sec) (Eukaryotic elongation factor, selenocysteine-tRNA-specific)",Homo sapiens (Human),58.6,594.0,1.7999999999999998e-190,667.2,sp|P57772|SELB_HUMAN Selenocysteine-specific elongation factor OS=Homo sapiens OX=9606 GN=EEFSEC PE=1 SV=4,GO:0000049; GO:0001514; GO:0003746; GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0035368; GO:0043021; GO:1990904,selenocysteine incorporation [GO:0001514],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0003924; GO:0005634; GO:0016787; GO:0043226,RNA binding; catalytic activity; GTPase activity; nucleus; hydrolase activity; organelle
OG_02724,FUN_011059-T1,Peve_00009502,Pocillopora_meandrina_HIv1___RNAseq.g22348.t1,three_way,91.228,FUN_011059-T1,P63271,,,,,62.7,110.0,6.599999999999998e-41,167.9,sp|P63271|SPT4A_MOUSE Transcription elongation factor SPT4-A OS=Mus musculus OX=10090 GN=Supt4h1a PE=2 SV=1,,,,,,
OG_02725,FUN_011065-T1,Peve_00009498,Pocillopora_meandrina_HIv1___TS.g27087.t1,three_way,52.62766666666667,,,,,,,,,,,,,,,,,
OG_02726,FUN_011068-T3,Peve_00009495,Pocillopora_meandrina_HIv1___RNAseq.g22350.t1,three_way,48.02816666666667,,,,,,,,,,,,,,,,,
OG_02727,FUN_011179-T1,Peve_00006850,Pocillopora_meandrina_HIv1___RNAseq.g22322.t1,three_way,55.33916666666666,FUN_011179-T1,Q0V9E9,KMT5A_XENTR,,N-lysine methyltransferase KMT5A (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine-specific methylase 5A) (SET domain-containing protein 8),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),50.6,174.0,1.2999999999999998e-47,191.8,sp|Q0V9E9|KMT5A_XENTR N-lysine methyltransferase KMT5A OS=Xenopus tropicalis OX=8364 GN=kmt5a PE=2 SV=1,GO:0005634; GO:0005694; GO:0032259; GO:0042054; GO:0051301; GO:0140944,cell division [GO:0051301]; methylation [GO:0032259],chromosome [GO:0005694]; nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054],GO:0003824; GO:0005634; GO:0005694; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02728,FUN_011252-T1,Peve_00024318,Pocillopora_meandrina_HIv1___RNAseq.g11307.t1,three_way,52.192,,,,,,,,,,,,,,,,,
OG_02729,FUN_011256-T1,Peve_00006851,Pocillopora_meandrina_HIv1___RNAseq.g22321.t1,three_way,72.50033333333333,FUN_011256-T1,Q9R1S4,XBP1_RAT,,"X-box-binding protein 1 (Hepatocarcinogenesis-related transcription factor) (HTF) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]",Rattus norvegicus (Rat),64.4,90.0,3.4e-15,83.6,sp|Q9R1S4|XBP1_RAT X-box-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Xbp1 PE=2 SV=1,GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001525; GO:0001889; GO:0001935; GO:0002071; GO:0002639; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006355; GO:0006366; GO:0006511; GO:0007517; GO:0007584; GO:0008284; GO:0009410; GO:0010506; GO:0030335; GO:0030968; GO:0031017; GO:0031490; GO:0031648; GO:0034976; GO:0035356; GO:0035470; GO:0035924; GO:0042149; GO:0042632; GO:0042802; GO:0043066; GO:0043565; GO:0044389; GO:0045348; GO:0045579; GO:0045582; GO:0045600; GO:0045766; GO:0045944; GO:0046982; GO:0051602; GO:0055089; GO:0055092; GO:0060096; GO:0060612; GO:0060691; GO:0070059; GO:0071222; GO:0071230; GO:0071236; GO:0071353; GO:0071375; GO:0071498; GO:0071499; GO:0090575; GO:0098793; GO:1900100; GO:1902236; GO:1903489; GO:1990418; GO:1990830; GO:1990837; GO:2000347,"adipose tissue development [GO:0060612]; angiogenesis [GO:0001525]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cholesterol homeostasis [GO:0042632]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; epithelial cell maturation involved in salivary gland development [GO:0060691]; exocrine pancreas development [GO:0031017]; fatty acid homeostasis [GO:0055089]; glandular epithelial cell maturation [GO:0002071]; intracellular triglyceride homeostasis [GO:0035356]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; liver development [GO:0001889]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; positive regulation of angiogenesis [GO:0045766]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of lactation [GO:1903489]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular wound healing [GO:0035470]; protein destabilization [GO:0031648]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; response to electrical stimulus [GO:0051602]; response to endoplasmic reticulum stress [GO:0034976]; response to insulin-like growth factor stimulus [GO:1990418]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; serotonin secretion, neurotransmission [GO:0060096]; sterol homeostasis [GO:0055092]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; presynapse [GO:0098793]; RNA polymerase II transcription regulator complex [GO:0090575],"chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin-like protein ligase binding [GO:0044389]",GO:0003677; GO:0005634; GO:0005783; GO:0006351; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; DNA-templated transcription; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_02730,FUN_011258-T1,Peve_00030534,Pocillopora_meandrina_HIv1___RNAseq.g22312.t1,three_way,68.89616666666667,FUN_011258-T1,A7MBS7,THS7A_DANRE,,Thrombospondin type-1 domain-containing protein 7A,Danio rerio (Zebrafish) (Brachydanio rerio),37.6,85.0,3.7e-08,60.5,sp|A7MBS7|THS7A_DANRE Thrombospondin type-1 domain-containing protein 7A OS=Danio rerio OX=7955 GN=thsd7aa PE=1 SV=2,GO:0001525; GO:0002040; GO:0003094; GO:0005886; GO:0008593; GO:0030036; GO:0032835; GO:0042995; GO:0043534; GO:0048675; GO:0072015,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; axon extension [GO:0048675]; blood vessel endothelial cell migration [GO:0043534]; glomerular filtration [GO:0003094]; glomerulus development [GO:0032835]; podocyte development [GO:0072015]; regulation of Notch signaling pathway [GO:0008593]; sprouting angiogenesis [GO:0002040],cell projection [GO:0042995]; plasma membrane [GO:0005886],,GO:0003014; GO:0005886; GO:0007010; GO:0048856; GO:0048870,renal system process; plasma membrane; cytoskeleton organization; anatomical structure development; cell motility
OG_02731,FUN_011259-T1,Peve_00032917,Pocillopora_meandrina_HIv1___RNAseq.g20815.t1,three_way,43.78766666666667,,,,,,,,,,,,,,,,,
OG_02732,FUN_011260-T1,Peve_00006852,Pocillopora_meandrina_HIv1___RNAseq.g22320.t1,three_way,87.39433333333334,FUN_011260-T1,Q5EAJ7,,,,,70.2,888.0,0.0,1094.7,sp|Q5EAJ7|MVP_STRPU Major vault protein OS=Strongylocentrotus purpuratus OX=7668 GN=MVP PE=1 SV=1,,,,,,
OG_02733,FUN_011263-T1,Peve_00030535,Pocillopora_meandrina_HIv1___RNAseq.g22311.t1,three_way,85.00733333333334,FUN_011263-T1,Q7ZTI5,,,,,56.7,134.0,1.0000000000000001e-29,131.0,sp|Q7ZTI5|MED21_DANRE Mediator of RNA polymerase II transcription subunit 21 OS=Danio rerio OX=7955 GN=med21 PE=2 SV=1,,,,,,
OG_02734,FUN_011264-T1,Peve_00030536,Pocillopora_meandrina_HIv1___RNAseq.g22310.t1,three_way,79.29683333333332,FUN_011264-T1,P02401,,,,,70.6,68.0,7.3e-19,94.7,sp|P02401|RLA2_RAT Large ribosomal subunit protein P2 OS=Rattus norvegicus OX=10116 GN=Rplp2 PE=1 SV=2,,,,,,
OG_02735,FUN_011273-T1,Peve_00042902,Pocillopora_meandrina_HIv1___RNAseq.g22332.t1,three_way,93.65966666666668,FUN_011273-T1,P80317,TCPZ_MOUSE,,T-complex protein 1 subunit zeta (TCP-1-zeta) (EC 3.6.1.-) (CCT-zeta-1),Mus musculus (Mouse),79.5,531.0,1e-240,833.9,sp|P80317|TCPZ_MOUSE T-complex protein 1 subunit zeta OS=Mus musculus OX=10090 GN=Cct6a PE=1 SV=3,GO:0001669; GO:0002199; GO:0005524; GO:0005832; GO:0007339; GO:0016887; GO:0044297; GO:0051082; GO:0140662,binding of sperm to zona pellucida [GO:0007339],acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; zona pellucida receptor complex [GO:0002199],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082],GO:0003824; GO:0016787; GO:0031410; GO:0043226; GO:0044183; GO:0140657,catalytic activity; hydrolase activity; cytoplasmic vesicle; organelle; protein folding chaperone; ATP-dependent activity
OG_02736,FUN_011275-T1,Peve_00030526,Pocillopora_meandrina_HIv1___RNAseq.g22313.t1,three_way,75.04266666666666,FUN_011275-T1,Q9D273,MMAB_MOUSE,,Corrinoid adenosyltransferase MMAB (EC 2.5.1.-) (ATP:co(I)rrinoid adenosyltransferase MMAB) (Methylmalonic aciduria type B homolog),Mus musculus (Mouse),56.5,186.0,4.3e-56,219.2,sp|Q9D273|MMAB_MOUSE Corrinoid adenosyltransferase MMAB OS=Mus musculus OX=10090 GN=Mmab PE=1 SV=1,GO:0005524; GO:0005739; GO:0008817; GO:0009235; GO:0016765; GO:0031419,cobalamin metabolic process [GO:0009235],mitochondrion [GO:0005739],"ATP binding [GO:0005524]; cobalamin binding [GO:0031419]; corrinoid adenosyltransferase activity [GO:0008817]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]",GO:0003824; GO:0005739; GO:0016740; GO:0043226,catalytic activity; mitochondrion; transferase activity; organelle
OG_02737,FUN_011277-T2,Peve_00030529,Pocillopora_meandrina_HIv1___RNAseq.g22289.t1,three_way,96.88166666666666,FUN_011277-T2,Q68FD5,CLH1_MOUSE,,Clathrin heavy chain 1,Mus musculus (Mouse),83.6,1648.0,0.0,2817.7,sp|Q68FD5|CLH1_MOUSE Clathrin heavy chain 1 OS=Mus musculus OX=10090 GN=Cltc PE=1 SV=3,GO:0003725; GO:0005198; GO:0005739; GO:0005819; GO:0005905; GO:0006886; GO:0006914; GO:0016020; GO:0019901; GO:0030117; GO:0030130; GO:0030132; GO:0031523; GO:0032051; GO:0032991; GO:0042470; GO:0043209; GO:0051301; GO:0071439; GO:0072318; GO:0090307; GO:0098684; GO:0098835; GO:0098843; GO:0098978; GO:1900126,autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat disassembly [GO:0072318]; intracellular protein transport [GO:0006886]; mitotic spindle assembly [GO:0090307]; negative regulation of hyaluronan biosynthetic process [GO:1900126],clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated pit [GO:0005905]; glutamatergic synapse [GO:0098978]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; Myb complex [GO:0031523]; myelin sheath [GO:0043209]; photoreceptor ribbon synapse [GO:0098684]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; spindle [GO:0005819],clathrin light chain binding [GO:0032051]; double-stranded RNA binding [GO:0003725]; protein kinase binding [GO:0019901]; structural molecule activity [GO:0005198],GO:0003723; GO:0005198; GO:0005739; GO:0006886; GO:0006914; GO:0007010; GO:0031410; GO:0043226,RNA binding; structural molecule activity; mitochondrion; intracellular protein transport; autophagy; cytoskeleton organization; cytoplasmic vesicle; organelle
OG_02738,FUN_011279-T1,Peve_00030533,Pocillopora_meandrina_HIv1___RNAseq.g16628.t1,three_way,79.54599999999999,FUN_011279-T1,Q96FV9,THOC1_HUMAN,,THO complex subunit 1 (Nuclear matrix protein p84) (p84N5) (hTREX84),Homo sapiens (Human),57.0,530.0,2.1999999999999998e-166,587.0,sp|Q96FV9|THOC1_HUMAN THO complex subunit 1 OS=Homo sapiens OX=9606 GN=THOC1 PE=1 SV=1,GO:0000346; GO:0000347; GO:0000445; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0006406; GO:0006915; GO:0007165; GO:0008380; GO:0016363; GO:0016607,apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346],DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006913; GO:0012501; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; nucleocytoplasmic transport; programmed cell death; mRNA metabolic process; organelle
OG_02739,FUN_011280-T1,Peve_00037297,Pocillopora_meandrina_HIv1___RNAseq.g22318.t1,three_way,82.50566666666667,FUN_011280-T1,Q5FW48,,,,,49.3,282.0,2.3000000000000002e-74,280.4,sp|Q5FW48|ASPDH_XENTR Aspartate dehydrogenase domain-containing protein OS=Xenopus tropicalis OX=8364 GN=aspdh PE=2 SV=1,,,,,,
OG_02740,FUN_011283-T1,Peve_00037294,Pocillopora_meandrina_HIv1___RNAseq.g22317.t1,three_way,93.90933333333334,FUN_011283-T1,Q8VHI7,,,,,53.9,453.0,2.5e-124,447.2,sp|Q8VHI7|DRC2_MOUSE Dynein regulatory complex subunit 2 OS=Mus musculus OX=10090 GN=Ccdc65 PE=1 SV=1,,,,,,
OG_02741,FUN_011284-T1,Peve_00033625,Pocillopora_meandrina_HIv1___RNAseq.g22145.t2,three_way,53.47266666666667,FUN_011284-T1,Q5M775,CYTSB_HUMAN,,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),Homo sapiens (Human),46.2,106.0,1.9e-21,106.3,sp|Q5M775|CYTSB_HUMAN Cytospin-B OS=Homo sapiens OX=9606 GN=SPECC1 PE=1 SV=1,GO:0001650; GO:0001824; GO:0005654; GO:0005815; GO:0005829; GO:0008306; GO:0016020; GO:0030036; GO:0031941; GO:0043231; GO:0045177,actin cytoskeleton organization [GO:0030036]; associative learning [GO:0008306]; blastocyst development [GO:0001824],apical part of cell [GO:0045177]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; filamentous actin [GO:0031941]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0048856; GO:0050877,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; organelle; anatomical structure development; nervous system process
OG_02742,FUN_011306-T4,Peve_00013672,Pocillopora_meandrina_HIv1___RNAseq.g22191.t1,three_way,76.84033333333333,FUN_011306-T4,A7SLX5,DPH1_NEMVE,,2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1),Nematostella vectensis (Starlet sea anemone),64.2,464.0,3.5000000000000003e-168,592.8,sp|A7SLX5|DPH1_NEMVE 2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 OS=Nematostella vectensis OX=45351 GN=dph1 PE=3 SV=1,GO:0017183; GO:0046872; GO:0051539; GO:0090560; GO:0120513,protein histidyl modification to diphthamide [GO:0017183],2-(3-amino-3-carboxypropyl)histidine synthase complex [GO:0120513],"2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]",GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_02743,FUN_011307-T1,Peve_00042903,Pocillopora_meandrina_HIv1___RNAseq.g22315.t1,three_way,85.486,FUN_011307-T1,Q07994,,,,,59.8,478.0,1.3e-170,600.9,sp|Q07994|NCPR_MUSDO NADPH--cytochrome P450 reductase OS=Musca domestica OX=7370 PE=2 SV=1,,,,,,
OG_02744,FUN_011308-T1,Peve_00024988,Pocillopora_meandrina_HIv1___RNAseq.g22351.t1,three_way,73.087,FUN_011308-T1,Q8L7W2,,,,,39.7,214.0,6.1e-43,176.0,sp|Q8L7W2|NUDT8_ARATH Nudix hydrolase 8 OS=Arabidopsis thaliana OX=3702 GN=NUDT8 PE=2 SV=2,,,,,,
OG_02745,FUN_011322-T1,Peve_00039481,Pocillopora_meandrina_HIv1___TS.g19552.t1,three_way,71.28733333333334,,,,,,,,,,,,,,,,,
OG_02746,FUN_011329-T1,Peve_00036413,Pocillopora_meandrina_HIv1___RNAseq.g6727.t1,three_way,83.97566666666667,,,,,,,,,,,,,,,,,
OG_02747,FUN_011341-T1,Peve_00013284,Pocillopora_meandrina_HIv1___RNAseq.g293.t1,three_way,53.55266666666667,,,,,,,,,,,,,,,,,
OG_02748,FUN_011416-T1,Peve_00033619,Pocillopora_meandrina_HIv1___TS.g27041.t2,three_way,80.652,FUN_011416-T1,Q14165,MLEC_HUMAN,,Malectin,Homo sapiens (Human),54.3,245.0,9.6e-67,255.0,sp|Q14165|MLEC_HUMAN Malectin OS=Homo sapiens OX=9606 GN=MLEC PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0008250; GO:0016020; GO:0019899; GO:0030246; GO:0035579,,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899],GO:0005783; GO:0005886; GO:0043226,endoplasmic reticulum; plasma membrane; organelle
OG_02749,FUN_011417-T1,Peve_00033618,Pocillopora_meandrina_HIv1___RNAseq.g22280.t1,three_way,70.39466666666667,FUN_011417-T1,Q5ND56,,,,,31.5,251.0,1.9e-31,137.9,sp|Q5ND56|TLC3A_MOUSE TLC domain-containing protein 3A OS=Mus musculus OX=10090 GN=Tlcd3a PE=3 SV=1,,,,,,
OG_02750,FUN_011418-T1,Peve_00033617,Pocillopora_meandrina_HIv1___TS.g27039.t1,three_way,80.7965,FUN_011418-T1,Q96ES7,,,,,62.4,290.0,1.7999999999999998e-96,354.0,sp|Q96ES7|SGF29_HUMAN SAGA-associated factor 29 OS=Homo sapiens OX=9606 GN=SGF29 PE=1 SV=1,,,,,,
OG_02751,FUN_011680-T1,Peve_00027006,Pocillopora_meandrina_HIv1___TS.g16787.t2,three_way,51.315666666666665,FUN_011680-T1,Q58DQ5,RT09_BOVIN,,"Small ribosomal subunit protein uS9m (28S ribosomal protein S9, mitochondrial) (MRP-S9) (S9mt)",Bos taurus (Bovine),38.9,211.0,8.200000000000001e-32,139.8,sp|Q58DQ5|RT09_BOVIN Small ribosomal subunit protein uS9m OS=Bos taurus OX=9913 GN=MRPS9 PE=1 SV=3,GO:0003723; GO:0003735; GO:0005743; GO:0005763; GO:0006412,translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198,RNA binding; structural molecule activity
OG_02752,FUN_011681-T1,Peve_00027007,Pocillopora_meandrina_HIv1___RNAseq.g23914.t1,three_way,78.4315,FUN_011681-T1,Q13492,,,,,59.6,349.0,2.0000000000000001e-112,407.5,sp|Q13492|PICAL_HUMAN Phosphatidylinositol-binding clathrin assembly protein OS=Homo sapiens OX=9606 GN=PICALM PE=1 SV=2,,,,,,
OG_02753,FUN_011682-T1,Peve_00027009,Pocillopora_meandrina_HIv1___RNAseq.g23916.t1,three_way,59.67133333333334,FUN_011682-T1,Q8K4Z4,,,,,26.8,317.0,1.8e-17,91.7,sp|Q8K4Z4|ADRB2_CAVPO Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1,,,,,,
OG_02754,FUN_011684-T1,Peve_00027010,Pocillopora_meandrina_HIv1___RNAseq.g23917.t1b,three_way,67.25733333333334,FUN_011684-T1,Q9KX40,,,,,31.0,187.0,4.1e-13,78.2,sp|Q9KX40|ESTB_BURGA Esterase EstB OS=Burkholderia gladioli OX=28095 GN=estB PE=1 SV=1,,,,,,
OG_02755,FUN_011686-T1,Peve_00027012,Pocillopora_meandrina_HIv1___TS.g16793.t1,three_way,69.86533333333334,FUN_011686-T1,Q5U2R1,,,,,41.5,347.0,1.8e-64,248.1,sp|Q5U2R1|DLP1_RAT All trans-polyprenyl-diphosphate synthase PDSS2 OS=Rattus norvegicus OX=10116 GN=Pdss2 PE=2 SV=1,,,,,,
OG_02756,FUN_011693-T1,Peve_00027018,Pocillopora_meandrina_HIv1___RNAseq.g23907.t1,three_way,70.913,FUN_011693-T1,Q96A49,SYAP1_HUMAN,,Synapse-associated protein 1 (BSD domain-containing signal transducer and Akt interactor protein) (BSTA),Homo sapiens (Human),41.0,346.0,6.2e-48,193.0,sp|Q96A49|SYAP1_HUMAN Synapse-associated protein 1 OS=Homo sapiens OX=9606 GN=SYAP1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0009898; GO:0030154; GO:0030424; GO:0030425; GO:0030426; GO:0032869; GO:0036120; GO:0038203; GO:0042734; GO:0043204; GO:0045202; GO:0045211; GO:0045600; GO:0048172; GO:0048471; GO:0070062; GO:0071364; GO:0071902; GO:1990314,cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; TORC2 signaling [GO:0038203],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202],,GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0030154; GO:0043226,nucleus; nucleoplasm; Golgi apparatus; cytosol; cell differentiation; organelle
OG_02757,FUN_011694-T1,Peve_00027019,Pocillopora_meandrina_HIv1___RNAseq.g23906.t1,three_way,85.10883333333334,FUN_011694-T1,Q9UBI9,,,,,36.0,405.0,1.5e-61,238.4,sp|Q9UBI9|HDC_HUMAN Headcase protein homolog OS=Homo sapiens OX=9606 GN=HECA PE=1 SV=1,,,,,,
OG_02758,FUN_011695-T1,Peve_00027020,Pocillopora_meandrina_HIv1___RNAseq.g23905.t1,three_way,90.05033333333333,FUN_011695-T1,Q6EE31,TCPQ_CHICK,,T-complex protein 1 subunit theta (TCP-1-theta) (EC 3.6.1.-) (CCT-theta),Gallus gallus (Chicken),68.4,545.0,5.500000000000002e-218,758.4,sp|Q6EE31|TCPQ_CHICK T-complex protein 1 subunit theta OS=Gallus gallus OX=9031 GN=CCT8 PE=1 SV=3,GO:0005524; GO:0005813; GO:0005832; GO:0006457; GO:0016887; GO:0042995; GO:0051082; GO:0140662,protein folding [GO:0006457],cell projection [GO:0042995]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; unfolded protein binding [GO:0051082],GO:0003824; GO:0005815; GO:0006457; GO:0016787; GO:0044183; GO:0140657,catalytic activity; microtubule organizing center; protein folding; hydrolase activity; protein folding chaperone; ATP-dependent activity
OG_02759,FUN_011696-T1,Peve_00010715,Pocillopora_meandrina_HIv1___RNAseq.g23904.t1,three_way,73.33366666666667,FUN_011696-T1,A8XJZ8,,,,,45.2,93.0,1.1e-14,83.2,sp|A8XJZ8|LST2_CAEBR Lateral signaling target protein 2 OS=Caenorhabditis briggsae OX=6238 GN=lst-2 PE=3 SV=1,,,,,,
OG_02760,FUN_011697-T1,Peve_00010714,Pocillopora_meandrina_HIv1___RNAseq.g23831.t1,three_way,71.151,,,,,,,,,,,,,,,,,
OG_02761,FUN_011698-T1,Peve_00018061,Pocillopora_meandrina_HIv1___RNAseq.g23828.t1,three_way,91.74833333333332,FUN_011698-T1,P31365,,,,,51.6,320.0,9.5e-71,268.9,"sp|P31365|P3F2A_XENLA POU domain, class 3, transcription factor 2-A OS=Xenopus laevis OX=8355 GN=pou3f2-a PE=2 SV=2",,,,,,
OG_02762,FUN_011699-T1,Peve_00018060,Pocillopora_meandrina_HIv1___RNAseq.g23827.t1,three_way,86.615,FUN_011699-T1,P47836,,,,,73.9,241.0,3.3e-106,386.0,sp|P47836|RS4_CHICK Small ribosomal subunit protein eS4 OS=Gallus gallus OX=9031 GN=RPS4 PE=1 SV=2,,,,,,
OG_02763,FUN_011701-T1,Peve_00018057,Pocillopora_meandrina_HIv1___RNAseq.g23825.t1,three_way,69.27133333333333,FUN_011701-T1,Q9CZJ1,,,,,49.8,205.0,8.9e-46,185.3,sp|Q9CZJ1|UTP11_MOUSE Probable U3 small nucleolar RNA-associated protein 11 OS=Mus musculus OX=10090 GN=Utp11 PE=2 SV=1,,,,,,
OG_02764,FUN_011702-T1,Peve_00025136,Pocillopora_meandrina_HIv1___RNAseq.g23824.t1,three_way,84.61633333333333,FUN_011702-T1,P59235,,,,,43.8,379.0,2.3e-90,334.0,sp|P59235|NUP43_MOUSE Nucleoporin Nup43 OS=Mus musculus OX=10090 GN=Nup43 PE=1 SV=2,,,,,,
OG_02765,FUN_011703-T1,Peve_00025150,Pocillopora_meandrina_HIv1___RNAseq.g23822.t1,three_way,80.578,FUN_011703-T1,Q7TQE7,,,,,32.6,334.0,7.4e-35,149.8,sp|Q7TQE7|MACA2_MOUSE Putative tyrosine carboxypeptidase MATCAP2 OS=Mus musculus OX=10090 GN=Matcap2 PE=2 SV=2,,,,,,
OG_02766,FUN_011704-T1,Peve_00025152,Pocillopora_meandrina_HIv1___RNAseq.g23821.t1,three_way,60.856,,,,,,,,,,,,,,,,,
OG_02767,FUN_011706-T2,Peve_00025155,Pocillopora_meandrina_HIv1___RNAseq.g23820.t1,three_way,66.33966666666666,FUN_011706-T2,O95835,LATS1_HUMAN,,Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts),Homo sapiens (Human),38.3,1163.0,3.9e-172,607.1,sp|O95835|LATS1_HUMAN Serine/threonine-protein kinase LATS1 OS=Homo sapiens OX=9606 GN=LATS1 PE=1 SV=1,GO:0000082; GO:0000086; GO:0000287; GO:0000819; GO:0000922; GO:0001827; GO:0001828; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0008104; GO:0009755; GO:0017015; GO:0019901; GO:0030216; GO:0030331; GO:0030496; GO:0030833; GO:0033146; GO:0035329; GO:0043065; GO:0043254; GO:0045736; GO:0046620; GO:0051301; GO:0060644; GO:0090090; GO:0098794; GO:0098978; GO:0099151; GO:0106310; GO:1900181; GO:1900227; GO:2000058,cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynapse [GO:0098794]; spindle pole [GO:0000922],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0007059; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; chromosome segregation; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_02768,FUN_011707-T1,Peve_00025137,Pocillopora_meandrina_HIv1___TS.g16696.t1,three_way,79.247,,,,,,,,,,,,,,,,,
OG_02769,FUN_011708-T1,Peve_00025139,Pocillopora_meandrina_HIv1___RNAseq.g23818.t1,three_way,43.605,,,,,,,,,,,,,,,,,
OG_02770,FUN_011709-T1,Peve_00025138,Pocillopora_meandrina_HIv1___RNAseq.g23817.t1,three_way,57.62166666666666,,,,,,,,,,,,,,,,,
OG_02771,FUN_011710-T1,Peve_00025140,Pocillopora_meandrina_HIv1___RNAseq.g23816.t1,three_way,86.54816666666667,FUN_011710-T1,Q9JJ31,CUL5_RAT,,Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1),Rattus norvegicus (Rat),71.6,784.0,0.0,1121.3,sp|Q9JJ31|CUL5_RAT Cullin-5 OS=Rattus norvegicus OX=10116 GN=Cul5 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005000; GO:0005634; GO:0016567; GO:0019005; GO:0021799; GO:0021942; GO:0030674; GO:0031146; GO:0031466; GO:0031625; GO:0038026; GO:0043161; GO:0051480; GO:0070979; GO:0090734; GO:0160072; GO:2001222,cerebral cortex radially oriented cell migration [GO:0021799]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; radial glia guided migration of Purkinje cell [GO:0021942]; reelin-mediated signaling pathway [GO:0038026]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of neuron migration [GO:2001222]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul5-RING ubiquitin ligase complex [GO:0031466]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; site of DNA damage [GO:0090734],protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; vasopressin receptor activity [GO:0005000],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0048870; GO:0060089; GO:0060090; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; cell motility; molecular transducer activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_02772,FUN_011715-T1,Peve_00039450,Pocillopora_meandrina_HIv1___TS.g16690.t1,three_way,68.57283333333334,FUN_011715-T1,P56476,GBRR2_MOUSE,,Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABAAR subunit rho-2) (GABA(C) receptor),Mus musculus (Mouse),32.3,427.0,1.9e-49,198.4,sp|P56476|GBRR2_MOUSE Gamma-aminobutyric acid receptor subunit rho-2 OS=Mus musculus OX=10090 GN=Gabrr2 PE=1 SV=4,GO:0004890; GO:0006821; GO:0007214; GO:0007601; GO:0019904; GO:0022851; GO:0030424; GO:0034707; GO:0045211; GO:0097708; GO:0098982; GO:1904315,chloride transport [GO:0006821]; gamma-aminobutyric acid signaling pathway [GO:0007214]; visual perception [GO:0007601],axon [GO:0030424]; chloride channel complex [GO:0034707]; GABA-ergic synapse [GO:0098982]; intracellular vesicle [GO:0097708]; postsynaptic membrane [GO:0045211],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; protein domain specific binding [GO:0019904]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0023052; GO:0043226; GO:0050877; GO:0060089,transporter activity; signaling; organelle; nervous system process; molecular transducer activity
OG_02773,FUN_011716-T1,Peve_00039703,Pocillopora_meandrina_HIv1___TS.g16734.t1,three_way,63.82533333333333,FUN_011716-T1,Q9UBS5,,,,,31.7,715.0,1.3e-98,362.5,sp|Q9UBS5|GABR1_HUMAN Gamma-aminobutyric acid type B receptor subunit 1 OS=Homo sapiens OX=9606 GN=GABBR1 PE=1 SV=1,,,,,,
OG_02774,FUN_011717-T1,Peve_00039711,Pocillopora_meandrina_HIv1___TS.g16733.t1,three_way,54.548,FUN_011717-T1,Q95MH6,,,,,24.8,282.0,4e-17,90.5,sp|Q95MH6|GNRR2_CHLAE Gonadotropin-releasing hormone II receptor OS=Chlorocebus aethiops OX=9534 GN=GNRHR2 PE=2 SV=1,,,,,,
OG_02775,FUN_011723-T1,Peve_00039705,Pocillopora_meandrina_HIv1___RNAseq.g23852.t1,three_way,65.70083333333334,FUN_011723-T1,Q8C142,ARH_MOUSE,,Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein homolog),Mus musculus (Mouse),31.4,287.0,7.900000000000001e-28,126.3,sp|Q8C142|ARH_MOUSE Low density lipoprotein receptor adapter protein 1 OS=Mus musculus OX=10090 GN=Ldlrap1 PE=1 SV=3,GO:0001540; GO:0001784; GO:0005102; GO:0005546; GO:0005737; GO:0005769; GO:0005829; GO:0005883; GO:0008203; GO:0009898; GO:0009925; GO:0030159; GO:0030276; GO:0031623; GO:0034383; GO:0035612; GO:0035615; GO:0035650; GO:0042632; GO:0042982; GO:0048260; GO:0050750; GO:0055037; GO:0071345; GO:0090118; GO:1903076; GO:1904707; GO:1905581; GO:1905602,amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein localization to plasma membrane [GO:1903076],basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; recycling endosome [GO:0055037],"amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159]",GO:0005768; GO:0005829; GO:0006629; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0060090,endosome; cytosol; lipid metabolic process; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_02776,FUN_011724-T1,Peve_00039706,Pocillopora_meandrina_HIv1___RNAseq.g23851.t1,three_way,75.24866666666667,FUN_011724-T1,Q6ZV70,,,,,39.1,238.0,1.7999999999999998e-35,151.0,sp|Q6ZV70|LANC3_HUMAN LanC-like protein 3 OS=Homo sapiens OX=9606 GN=LANCL3 PE=1 SV=2,,,,,,
OG_02777,FUN_011725-T1,Peve_00039709,Pocillopora_meandrina_HIv1___RNAseq.g23849.t1,three_way,80.71566666666666,FUN_011725-T1,Q4R918,KIF25_MACFA,,Kinesin-like protein KIF25,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),41.1,604.0,4.1000000000000004e-111,403.7,sp|Q4R918|KIF25_MACFA Kinesin-like protein KIF25 OS=Macaca fascicularis OX=9541 GN=KIF25 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647,establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; protein-containing complex assembly; ATP-dependent activity
OG_02778,FUN_011727-T1,Peve_00001116,Pocillopora_meandrina_HIv1___RNAseq.g23847.t1,three_way,87.899,FUN_011727-T1,Q6PUR6,,,,,66.2,278.0,8.1e-108,391.7,sp|Q6PUR6|GPN2_DANRE GPN-loop GTPase 2 OS=Danio rerio OX=7955 GN=gpn2 PE=2 SV=1,,,,,,
OG_02779,FUN_011729-T1,Peve_00001119,Pocillopora_meandrina_HIv1___RNAseq.g23842.t1,three_way,77.98466666666667,FUN_011729-T1,Q9Y233,PDE10_HUMAN,,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17)",Homo sapiens (Human),39.8,757.0,1.0000000000000001e-159,565.5,"sp|Q9Y233|PDE10_HUMAN cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A OS=Homo sapiens OX=9606 GN=PDE10A PE=1 SV=2",GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0010754; GO:0019933; GO:0030552; GO:0030553; GO:0046069; GO:0046872; GO:0047555; GO:0098978; GO:0106070; GO:0141161,cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of cAMP/PKA signal transduction [GO:0141161],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02780,FUN_011730-T1,Peve_00016389,Pocillopora_meandrina_HIv1___RNAseq.g24032.t1,three_way,59.05316666666667,FUN_011730-T1,A1DWM3,,,,,25.7,572.0,6.300000000000001e-38,160.2,sp|A1DWM3|MFSD6_PIG Major facilitator superfamily domain-containing protein 6 OS=Sus scrofa OX=9823 GN=MFSD6 PE=2 SV=1,,,,,,
OG_02781,FUN_011731-T1,Peve_00001120,Pocillopora_meandrina_HIv1___RNAseq.g23841.t1,three_way,57.08383333333333,,,,,,,,,,,,,,,,,
OG_02782,FUN_011733-T1,Peve_00001121,Pocillopora_meandrina_HIv1___RNAseq.g23840.t2,three_way,53.03233333333333,FUN_011733-T1,Q6ZPR6,,,,,30.4,1491.0,1.3e-160,569.3,sp|Q6ZPR6|IBTK_MOUSE Inhibitor of Bruton tyrosine kinase OS=Mus musculus OX=10090 GN=Ibtk PE=1 SV=3,,,,,,
OG_02783,FUN_011737-T1,Peve_00034109,Pocillopora_meandrina_HIv1___RNAseq.g23903.t1,three_way,84.22266666666667,FUN_011737-T1,Q8K363,,,,,65.2,546.0,1.8e-201,703.7,sp|Q8K363|DDX18_MOUSE ATP-dependent RNA helicase DDX18 OS=Mus musculus OX=10090 GN=Ddx18 PE=1 SV=1,,,,,,
OG_02784,FUN_011739-T1,Peve_00034110,Pocillopora_meandrina_HIv1___RNAseq.g23880.t1,three_way,77.65533333333333,,,,,,,,,,,,,,,,,
OG_02785,FUN_011740-T1,Peve_00034096,Pocillopora_meandrina_HIv1___RNAseq.g23881.t1,three_way,76.12266666666666,,,,,,,,,,,,,,,,,
OG_02786,FUN_011741-T1,Peve_00015648,Pocillopora_meandrina_HIv1___RNAseq.g23891.t1,three_way,43.050666666666665,,,,,,,,,,,,,,,,,
OG_02787,FUN_011742-T1,Peve_00034107,Pocillopora_meandrina_HIv1___RNAseq.g23889.t1,three_way,84.64933333333333,FUN_011742-T1,Q6GL42,,,,,34.7,366.0,3.2000000000000004e-44,180.6,sp|Q6GL42|TM39A_XENTR Transmembrane protein 39A OS=Xenopus tropicalis OX=8364 GN=tmem39a PE=2 SV=1,,,,,,
OG_02788,FUN_011743-T1,Peve_00034106,Pocillopora_meandrina_HIv1___RNAseq.g23888.t1,three_way,67.74666666666667,FUN_011743-T1,P46616,,,,,26.2,328.0,4.8e-18,93.6,sp|P46616|AA2AR_CAVPO Adenosine receptor A2a OS=Cavia porcellus OX=10141 GN=ADORA2A PE=2 SV=1,,,,,,
OG_02789,FUN_011745-T1,Peve_00034105,Pocillopora_meandrina_HIv1___RNAseq.g23887.t1,three_way,65.875,FUN_011745-T1,P49406,,,,,41.1,168.0,1.7e-21,104.8,sp|P49406|RM19_HUMAN Large ribosomal subunit protein bL19m OS=Homo sapiens OX=9606 GN=MRPL19 PE=1 SV=2,,,,,,
OG_02790,FUN_011746-T1,Peve_00034104,Pocillopora_meandrina_HIv1___RNAseq.g23886.t1,three_way,89.25333333333334,FUN_011746-T1,A7SD85,CDC5L_NEMVE,,Cell division cycle 5-related protein (Cdc5-like protein),Nematostella vectensis (Starlet sea anemone),75.6,807.0,0.0,1146.3,sp|A7SD85|CDC5L_NEMVE Cell division cycle 5-related protein OS=Nematostella vectensis OX=45351 GN=cdc5l PE=3 SV=1,GO:0000398; GO:0000974; GO:0000977; GO:0000981; GO:0003723; GO:0005681; GO:0005737; GO:0006281; GO:0006357,"DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; regulation of transcription by RNA polymerase II [GO:0006357]",cytoplasm [GO:0005737]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0003723; GO:0006281; GO:0006355; GO:0016071; GO:0140110,DNA binding; RNA binding; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; transcription regulator activity
OG_02791,FUN_011747-T1,Peve_00034099,Pocillopora_meandrina_HIv1___RNAseq.9509_t,three_way,56.78566666666666,FUN_011747-T1,C5H5C4,NOT1A_DANRE,,Palmitoleoyl-protein carboxylesterase notum1a (EC 3.1.1.98),Danio rerio (Zebrafish) (Brachydanio rerio),40.0,417.0,7.7e-82,305.8,sp|C5H5C4|NOT1A_DANRE Palmitoleoyl-protein carboxylesterase notum1a OS=Danio rerio OX=7955 GN=notum1a PE=2 SV=1,GO:0004621; GO:0005576; GO:0009952; GO:0016055; GO:0021532; GO:0030178; GO:0090090; GO:1990697; GO:1990699,anterior/posterior pattern specification [GO:0009952]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube patterning [GO:0021532]; protein depalmitoleylation [GO:1990697]; Wnt signaling pathway [GO:0016055],extracellular region [GO:0005576],glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005576; GO:0016787; GO:0030163,catalytic activity; extracellular region; hydrolase activity; protein catabolic process
OG_02792,FUN_011749-T1,Peve_00034098,Pocillopora_meandrina_HIv1___RNAseq.g23883.t1,three_way,76.81333333333333,FUN_011749-T1,P48279,,,,,25.2,222.0,9.8e-07,55.5,sp|P48279|YCF39_CYAPA Photosystem II assembly factor Ycf39 OS=Cyanophora paradoxa OX=2762 GN=ycf39 PE=3 SV=1,,,,,,
OG_02793,FUN_011755-T1,Peve_00015652,Pocillopora_meandrina_HIv1___RNAseq.g23894.t1,three_way,85.19933333333333,FUN_011755-T1,Q6NXD2,CHM2B_DANRE,,Charged multivesicular body protein 2b (Chromatin-modifying protein 2b) (CHMP2b),Danio rerio (Zebrafish) (Brachydanio rerio),43.1,153.0,2.3e-07,57.4,sp|Q6NXD2|CHM2B_DANRE Charged multivesicular body protein 2b OS=Danio rerio OX=7955 GN=chmp2b PE=2 SV=1,GO:0000815; GO:0005771; GO:0005829; GO:0015031; GO:0031902; GO:0032509; GO:0045324,endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031],cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771],,GO:0005768; GO:0005829; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_02794,FUN_011756-T1,Peve_00015649,Pocillopora_meandrina_HIv1___RNAseq.g23892.t1,three_way,64.516,,,,,,,,,,,,,,,,,
OG_02795,FUN_011758-T1,Peve_00037784,Pocillopora_meandrina_HIv1___RNAseq.g23896.t1,three_way,91.42466666666668,FUN_011758-T1,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),63.4,4613.0,0.0,5645.5,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_02796,FUN_011761-T1,Peve_00005550,Pocillopora_meandrina_HIv1___TS.g16681.t2,three_way,83.095,FUN_011761-T1,Q8TBF4,,,,,75.6,131.0,1.9e-54,213.4,sp|Q8TBF4|ZCRB1_HUMAN Zinc finger CCHC-type and RNA-binding motif-containing protein 1 OS=Homo sapiens OX=9606 GN=ZCRB1 PE=1 SV=2,,,,,,
OG_02797,FUN_011764-T1,Peve_00035077,Pocillopora_meandrina_HIv1___RNAseq.g23801.t1,three_way,73.43533333333333,FUN_011764-T1,O95684,CEP43_HUMAN,,Centrosomal protein 43 (FGFR1 oncogene partner),Homo sapiens (Human),41.7,422.0,3.699999999999999e-43,177.2,sp|O95684|CEP43_HUMAN Centrosomal protein 43 OS=Homo sapiens OX=9606 GN=CEP43 PE=1 SV=1,GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0006469; GO:0008284; GO:0019901; GO:0030030; GO:0030292; GO:0030307; GO:0030335; GO:0034453; GO:0042803; GO:0042995; GO:0048471,cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284],cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein tyrosine kinase inhibitor activity [GO:0030292],GO:0005634; GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; cytoskeleton organization; organelle; molecular function regulator activity
OG_02798,FUN_011765-T1,Peve_00035074,Pocillopora_meandrina_HIv1___RNAseq.g23800.t1,three_way,86.81066666666666,FUN_011765-T1,P43246,MSH2_HUMAN,,DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2),Homo sapiens (Human),59.3,934.0,0.0,1095.9,sp|P43246|MSH2_HUMAN DNA mismatch repair protein Msh2 OS=Homo sapiens OX=9606 GN=MSH2 PE=1 SV=1,GO:0000781; GO:0001701; GO:0002204; GO:0003677; GO:0003682; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0006119; GO:0006281; GO:0006298; GO:0006301; GO:0006302; GO:0006312; GO:0007281; GO:0008047; GO:0008094; GO:0008340; GO:0008584; GO:0010165; GO:0010224; GO:0016020; GO:0016446; GO:0016447; GO:0016887; GO:0019237; GO:0019724; GO:0030183; GO:0031573; GO:0032137; GO:0032301; GO:0032302; GO:0042771; GO:0042803; GO:0043524; GO:0043570; GO:0045190; GO:0045910; GO:0048298; GO:0048304; GO:0140664,B cell differentiation [GO:0030183]; B cell mediated immunity [GO:0019724]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; germ cell development [GO:0007281]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; maintenance of DNA repeat elements [GO:0043570]; male gonad development [GO:0008584]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination [GO:0006312]; negative regulation of DNA recombination [GO:0045910]; negative regulation of neuron apoptotic process [GO:0043524]; oxidative phosphorylation [GO:0006119]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; postreplication repair [GO:0006301]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447]; somatic recombination of immunoglobulin genes involved in immune response [GO:0002204],"chromosome, telomeric region [GO:0000781]; membrane [GO:0016020]; MutSalpha complex [GO:0032301]; MutSbeta complex [GO:0032302]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; guanine/thymine mispair binding [GO:0032137]; protein homodimerization activity [GO:0042803]",GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006091; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; generation of precursor metabolites and energy; DNA repair; DNA recombination; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_02799,FUN_011766-T1,Peve_00029899,Pocillopora_meandrina_HIv1___RNAseq.g23799.t1,three_way,72.32466666666667,,,,,,,,,,,,,,,,,
OG_02800,FUN_011771-T1,Peve_00034384,Pocillopora_meandrina_HIv1___RNAseq.g23368.t2,three_way,81.78533333333334,FUN_011771-T1,Q08170,SRSF4_HUMAN,,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",Homo sapiens (Human),62.6,171.0,4.5e-53,209.9,sp|Q08170|SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_02801,FUN_011772-T2,Peve_00034382,Pocillopora_meandrina_HIv1___RNAseq.g23369.t1,three_way,80.90816666666667,FUN_011772-T2,Q3T9Z9,,,,,45.5,363.0,7.700000000000001e-73,276.2,sp|Q3T9Z9|ZUP1_MOUSE Zinc finger-containing ubiquitin peptidase 1 OS=Mus musculus OX=10090 GN=Zup1 PE=2 SV=2,,,,,,
OG_02802,FUN_011773-T1,Peve_00034381,Pocillopora_meandrina_HIv1___TS.g16253.t1,three_way,62.79166666666667,,,,,,,,,,,,,,,,,
OG_02803,FUN_011774-T1,Peve_00034380,Pocillopora_meandrina_HIv1___RNAseq.g23371.t1,three_way,90.731,FUN_011774-T1,Q503E9,,,,,72.2,532.0,1.8e-88,328.2,sp|Q503E9|IMA6_DANRE Importin subunit alpha-6 OS=Danio rerio OX=7955 GN=kpna5 PE=2 SV=3,,,,,,
OG_02804,FUN_011775-T1,Peve_00027008,Pocillopora_meandrina_HIv1___RNAseq.g23912.t1,three_way,57.56633333333333,FUN_011775-T1,P29146,,,,,55.3,590.0,6.4e-188,659.8,sp|P29146|NECA_HYDVU PC3-like endoprotease variant A OS=Hydra vulgaris OX=6087 PE=2 SV=1,,,,,,
OG_02805,FUN_011776-T1,Peve_00006118,Pocillopora_meandrina_HIv1___RNAseq.g23292.t1,three_way,81.48183333333333,FUN_011776-T1,Q01196,RUNX1_HUMAN,,Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit),Homo sapiens (Human),48.8,320.0,7.1e-71,269.6,sp|Q01196|RUNX1_HUMAN Runt-related transcription factor 1 OS=Homo sapiens OX=9606 GN=RUNX1 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001503; GO:0002062; GO:0002573; GO:0003677; GO:0003700; GO:0005509; GO:0005524; GO:0005634; GO:0005654; GO:0006357; GO:0010755; GO:0016513; GO:0030097; GO:0030099; GO:0030182; GO:0030853; GO:0030854; GO:0032743; GO:0032967; GO:0042803; GO:0043231; GO:0043371; GO:0043378; GO:0045595; GO:0045766; GO:0045893; GO:0045944; GO:0046982; GO:0048935; GO:0060043; GO:0061026; GO:0071425; GO:0140297; GO:1903055; GO:1905203,"cardiac muscle tissue regeneration [GO:0061026]; chondrocyte differentiation [GO:0002062]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; myeloid leukocyte differentiation [GO:0002573]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; ossification [GO:0001503]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell differentiation [GO:0045595]; regulation of connective tissue replacement [GO:1905203]; regulation of plasminogen activation [GO:0010755]; regulation of transcription by RNA polymerase II [GO:0006357]",chromatin [GO:0000785]; core-binding factor complex [GO:0016513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02806,FUN_011777-T1,Peve_00006119,Pocillopora_meandrina_HIv1___RNAseq.g23293.t1,three_way,79.81966666666666,FUN_011777-T1,O75486,,,,,41.0,339.0,1.9e-50,201.4,sp|O75486|SUPT3_HUMAN Transcription initiation protein SPT3 homolog OS=Homo sapiens OX=9606 GN=SUPT3H PE=1 SV=3,,,,,,
OG_02807,FUN_011778-T1,Peve_00006120,Pocillopora_meandrina_HIv1___RNAseq.g23294.t1,three_way,92.68933333333334,FUN_011778-T1,Q80Y75,DJB13_MOUSE,,DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein),Mus musculus (Mouse),63.5,315.0,1.6e-116,420.6,sp|Q80Y75|DJB13_MOUSE DnaJ homolog subfamily B member 13 OS=Mus musculus OX=10090 GN=Dnajb13 PE=1 SV=1,GO:0001534; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0006457; GO:0007618; GO:0030317; GO:0031514; GO:0036126; GO:0051082; GO:0097729; GO:0120212; GO:1904158,axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; protein folding [GO:0006457],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126]; sperm head-tail coupling apparatus [GO:0120212],unfolded protein binding [GO:0051082],GO:0005576; GO:0005929; GO:0006457; GO:0007018; GO:0022414; GO:0043226; GO:0048870,extracellular region; cilium; protein folding; microtubule-based movement; reproductive process; organelle; cell motility
OG_02808,FUN_011780-T1,Peve_00041237,Pocillopora_meandrina_HIv1___RNAseq.g23304.t1,three_way,75.61466666666666,FUN_011780-T1,A7S2N8,UFL1_NEMVE,,E3 UFM1-protein ligase 1 homolog (EC 2.3.2.-) (E3 UFM1-protein transferase 1 homolog),Nematostella vectensis (Starlet sea anemone),58.5,792.0,1.6e-234,813.9,sp|A7S2N8|UFL1_NEMVE E3 UFM1-protein ligase 1 homolog OS=Nematostella vectensis OX=45351 GN=v1g184952 PE=3 SV=1,GO:0005789; GO:0034976; GO:0061666; GO:0061709; GO:0071568; GO:0071569,protein ufmylation [GO:0071569]; response to endoplasmic reticulum stress [GO:0034976]; reticulophagy [GO:0061709],endoplasmic reticulum membrane [GO:0005789],UFM1 ligase activity [GO:0061666]; UFM1 transferase activity [GO:0071568],GO:0003824; GO:0006914; GO:0016740; GO:0140096,"catalytic activity; autophagy; transferase activity; catalytic activity, acting on a protein"
OG_02809,FUN_011782-T1,Peve_00041236,Pocillopora_meandrina_HIv1___RNAseq.g23305.t1,three_way,58.14066666666667,FUN_011782-T1,Q8R149,,,,,48.5,204.0,3.2e-45,184.5,sp|Q8R149|BUD13_MOUSE BUD13 homolog OS=Mus musculus OX=10090 GN=Bud13 PE=1 SV=1,,,,,,
OG_02810,FUN_011785-T1,Peve_00041233,Pocillopora_meandrina_HIv1___RNAseq.g23258.t1c,three_way,64.76466666666667,,,,,,,,,,,,,,,,,
OG_02811,FUN_011794-T1,Peve_00034591,Pocillopora_meandrina_HIv1___RNAseq.g23258.t1a,three_way,52.43483333333333,,,,,,,,,,,,,,,,,
OG_02812,FUN_011795-T1,Peve_00034593,Pocillopora_meandrina_HIv1___RNAseq.g23257.t1,three_way,60.46166666666667,FUN_011795-T1,Q1ZZH0,,,,,28.2,515.0,1e-41,172.9,sp|Q1ZZH0|GRM4_MACFA Metabotropic glutamate receptor 4 OS=Macaca fascicularis OX=9541 GN=GRM4 PE=2 SV=1,,,,,,
OG_02813,FUN_011796-T1,Peve_00034594,Pocillopora_meandrina_HIv1___RNAseq.g23256.t1,three_way,42.5015,,,,,,,,,,,,,,,,,
OG_02814,FUN_011801-T1,Peve_00017066,Pocillopora_meandrina_HIv1___RNAseq.g23253.t1,three_way,85.05433333333333,FUN_011801-T1,Q80W54,FACE1_MOUSE,,CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog),Mus musculus (Mouse),59.5,477.0,6.3e-154,545.4,sp|Q80W54|FACE1_MOUSE CAAX prenyl protease 1 homolog OS=Mus musculus OX=10090 GN=Zmpste24 PE=1 SV=2,GO:0001889; GO:0001942; GO:0003007; GO:0003229; GO:0003231; GO:0003417; GO:0003690; GO:0004175; GO:0004222; GO:0005635; GO:0005637; GO:0005789; GO:0006281; GO:0006325; GO:0006355; GO:0006629; GO:0006925; GO:0006974; GO:0006997; GO:0006998; GO:0007346; GO:0007628; GO:0008016; GO:0008340; GO:0008360; GO:0008544; GO:0010506; GO:0010628; GO:0010629; GO:0010906; GO:0016020; GO:0016485; GO:0019216; GO:0030282; GO:0030327; GO:0030500; GO:0031901; GO:0031902; GO:0032006; GO:0032350; GO:0032991; GO:0035264; GO:0040014; GO:0040029; GO:0043007; GO:0043516; GO:0044029; GO:0046872; GO:0048145; GO:0048538; GO:0050688; GO:0050905; GO:0051276; GO:0051604; GO:0055013; GO:0060307; GO:0060993; GO:0061337; GO:0061762; GO:0070302; GO:0071480; GO:0071586; GO:0072423; GO:1903463; GO:1903522; GO:1903799; GO:1990036; GO:2000730; GO:2000772,"adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle cell development [GO:0055013]; cardiac ventricle development [GO:0003231]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; epigenetic regulation of gene expression [GO:0040029]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA processing [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; prenylated protein catabolic process [GO:0030327]; protein maturation [GO:0051604]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of DNA-templated transcription [GO:0006355]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229]",early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991],double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003677; GO:0003824; GO:0005635; GO:0006281; GO:0006325; GO:0006355; GO:0006629; GO:0012501; GO:0016787; GO:0048856; GO:0050877; GO:0051604; GO:0061024; GO:0140096,"DNA binding; catalytic activity; nuclear envelope; DNA repair; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; programmed cell death; hydrolase activity; anatomical structure development; nervous system process; protein maturation; membrane organization; catalytic activity, acting on a protein"
OG_02815,FUN_011802-T1,Peve_00028440,Pocillopora_meandrina_HIv1___RNAseq.g23252.t1,three_way,63.55466666666666,FUN_011802-T1,B9FAF3,KN14E_ORYSJ,,Kinesin-like protein KIN-14E,Oryza sativa subsp. japonica (Rice),45.6,377.0,1.2e-84,316.2,sp|B9FAF3|KN14E_ORYSJ Kinesin-like protein KIN-14E OS=Oryza sativa subsp. japonica OX=39947 GN=KIN14E PE=2 SV=1,GO:0003777; GO:0005524; GO:0005874; GO:0007017; GO:0007018; GO:0008017; GO:0015630,microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017],microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005856; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; ATP-dependent activity
OG_02816,FUN_011803-T1,Peve_00028441,Pocillopora_meandrina_HIv1___RNAseq.g23250.t1,three_way,44.53766666666667,,,,,,,,,,,,,,,,,
OG_02817,FUN_011804-T1,Peve_00013011,Pocillopora_meandrina_HIv1___RNAseq.g23249.t1,three_way,75.94800000000001,FUN_011804-T1,Q5BIM8,ERCC8_BOVIN,,DNA excision repair protein ERCC-8,Bos taurus (Bovine),48.9,368.0,1.3e-104,381.3,sp|Q5BIM8|ERCC8_BOVIN DNA excision repair protein ERCC-8 OS=Bos taurus OX=9913 GN=ERCC8 PE=2 SV=1,GO:0000012; GO:0000109; GO:0000209; GO:0005634; GO:0006283; GO:0006974; GO:0006979; GO:0009411; GO:0016363; GO:0031464; GO:0032991; GO:0043161; GO:0045739; GO:0051865; GO:0080008; GO:0090734; GO:0097680; GO:1990756,DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; positive regulation of DNA repair [GO:0045739]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; single strand break repair [GO:0000012]; transcription-coupled nucleotide-excision repair [GO:0006283],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; nuclear matrix [GO:0016363]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of DNA damage [GO:0090734],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0006281; GO:0030163; GO:0043226; GO:0060090,nucleus; DNA repair; protein catabolic process; organelle; molecular adaptor activity
OG_02818,FUN_011805-T1,Peve_00013012,Pocillopora_meandrina_HIv1___RNAseq.g23248.t1,three_way,90.09666666666666,FUN_011805-T1,Q5FW05,,,,,77.1,340.0,3.5e-152,539.3,sp|Q5FW05|CTU1_XENTR Cytoplasmic tRNA 2-thiolation protein 1 OS=Xenopus tropicalis OX=8364 GN=ctu1 PE=2 SV=1,,,,,,
OG_02819,FUN_011806-T1,Peve_00013013,Pocillopora_meandrina_HIv1___RNAseq.g23247.t1,three_way,51.883,FUN_011806-T1,O60287,,,,,28.8,1032.0,1.2e-91,340.9,sp|O60287|NPA1P_HUMAN Nucleolar pre-ribosomal-associated protein 1 OS=Homo sapiens OX=9606 GN=URB1 PE=1 SV=4,,,,,,
OG_02820,FUN_011808-T1,Peve_00020938,Pocillopora_meandrina_HIv1___RNAseq.g23246.t1,three_way,76.82233333333333,,,,,,,,,,,,,,,,,
OG_02821,FUN_011809-T1,Peve_00020918,Pocillopora_meandrina_HIv1___RNAseq.g23245.t1b,three_way,79.96799999999999,FUN_011809-T1,Q5TH69,,,,,30.1,2503.0,1.9e-256,888.3,sp|Q5TH69|BIG3_HUMAN Brefeldin A-inhibited guanine nucleotide-exchange protein 3 OS=Homo sapiens OX=9606 GN=ARFGEF3 PE=1 SV=3,,,,,,
OG_02822,FUN_011810-T1,Peve_00020919,Pocillopora_meandrina_HIv1___RNAseq.g23237.t1,three_way,64.20366666666666,,,,,,,,,,,,,,,,,
OG_02823,FUN_011811-T1,Peve_00020920,Pocillopora_meandrina_HIv1___RNAseq.g23236.t1,three_way,76.99633333333334,FUN_011811-T1,Q8SZA8,,,,,54.0,126.0,2.3e-29,130.2,"sp|Q8SZA8|ADXH2_DROME Adrenodoxin-like protein 2, mitochondrial OS=Drosophila melanogaster OX=7227 GN=Fdx2 PE=2 SV=1",,,,,,
OG_02824,FUN_011814-T1,Peve_00020927,Pocillopora_meandrina_HIv1___RNAseq.g23235.t1,three_way,75.693,FUN_011814-T1,Q71B07,,,,,48.0,710.0,7.7000000000000015e-180,632.1,sp|Q71B07|D19L3_MOUSE Protein C-mannosyl-transferase DPY19L3 OS=Mus musculus OX=10090 GN=Dpy19l3 PE=1 SV=2,,,,,,
OG_02825,FUN_011840-T1,Peve_00020928,Pocillopora_meandrina_HIv1___RNAseq.g23234.t1,three_way,63.09916666666667,FUN_011840-T1,Q5ZIH9,,,,,41.1,419.0,1.1e-60,236.1,sp|Q5ZIH9|CC174_CHICK Coiled-coil domain-containing protein 174 OS=Gallus gallus OX=9031 GN=CCDC174 PE=2 SV=1,,,,,,
OG_02826,FUN_011841-T1,Peve_00020934,Pocillopora_meandrina_HIv1___RNAseq.g23233.t1,three_way,49.15833333333333,,,,,,,,,,,,,,,,,
OG_02827,FUN_011842-T1,Peve_00034375,Pocillopora_meandrina_HIv1___RNAseq.g23372.t1,three_way,85.59066666666666,FUN_011842-T1,O46560,,,,,58.2,304.0,8.999999999999999e-94,345.1,sp|O46560|PDXK_PIG Pyridoxal kinase OS=Sus scrofa OX=9823 GN=PDXK PE=1 SV=1,,,,,,
OG_02828,FUN_011843-T1,Peve_00034373,Pocillopora_meandrina_HIv1___RNAseq.g23373.t1,three_way,84.43299999999999,FUN_011843-T1,Q9SEE4,,,,,41.8,297.0,9.3e-61,235.3,sp|Q9SEE4|PIRL_SOLLC Pirin-like protein OS=Solanum lycopersicum OX=4081 PE=2 SV=1,,,,,,
OG_02829,FUN_011844-T1,Peve_00034372,Pocillopora_meandrina_HIv1___RNAseq.g23374.t1,three_way,76.01283333333333,FUN_011844-T1,Q8VHI6,WASF3_MOUSE,,Actin-binding protein WASF3 (Protein WAVE-3) (Wiskott-Aldrich syndrome protein family member 3) (WASP family protein member 3),Mus musculus (Mouse),40.6,502.0,1.2e-40,169.1,sp|Q8VHI6|WASF3_MOUSE Actin-binding protein WASF3 OS=Mus musculus OX=10090 GN=Wasf3 PE=1 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0007010; GO:0008360; GO:0014003; GO:0030027; GO:0030032; GO:0030036; GO:0031643; GO:0097386; GO:0098794; GO:0098885; GO:0098978,actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; regulation of cell shape [GO:0008360],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; glial cell projection [GO:0097386]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794],actin binding [GO:0003779],GO:0005856; GO:0007010; GO:0008092; GO:0034330; GO:0043226; GO:0048856,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; cell junction organization; organelle; anatomical structure development
OG_02830,FUN_011845-T1,Peve_00034371,Pocillopora_meandrina_HIv1___RNAseq.g23375.t1,three_way,84.46166666666666,FUN_011845-T1,Q16798,,,,,61.5,551.0,2.1e-202,706.8,"sp|Q16798|MAON_HUMAN NADP-dependent malic enzyme, mitochondrial OS=Homo sapiens OX=9606 GN=ME3 PE=1 SV=2",,,,,,
OG_02831,FUN_011846-T1,Peve_00034370,Pocillopora_meandrina_HIv1___RNAseq.g23376.t1,three_way,70.376,,,,,,,,,,,,,,,,,
OG_02832,FUN_011847-T1,Peve_00034369,Pocillopora_meandrina_HIv1___RNAseq.g23377.t1,three_way,85.74533333333333,FUN_011847-T1,Q29RZ0,THIL_BOVIN,,"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase)",Bos taurus (Bovine),69.6,401.0,2.4e-155,550.1,"sp|Q29RZ0|THIL_BOVIN Acetyl-CoA acetyltransferase, mitochondrial OS=Bos taurus OX=9913 GN=ACAT1 PE=2 SV=1",GO:0003985; GO:0005739; GO:0006635; GO:0046872,fatty acid beta-oxidation [GO:0006635],mitochondrion [GO:0005739],acetyl-CoA C-acetyltransferase activity [GO:0003985]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_02833,FUN_011848-T1,Peve_00034362,Pocillopora_meandrina_HIv1___TS.g16261.t2,three_way,56.089333333333336,,,,,,,,,,,,,,,,,
OG_02834,FUN_011851-T1,Peve_00034359,Pocillopora_meandrina_HIv1___TS.g16263.t1,three_way,69.67533333333333,FUN_011851-T1,Q9PWH2,,,,,45.6,572.0,1.4e-140,501.5,sp|Q9PWH2|FZD10_CHICK Frizzled-10 OS=Gallus gallus OX=9031 GN=FZD10 PE=1 SV=1,,,,,,
OG_02835,FUN_011853-T1,Peve_00034403,Pocillopora_meandrina_HIv1___RNAseq.g23381.t1,three_way,67.724,FUN_011853-T1,Q3ZBE6,,,,,37.9,443.0,1.8e-72,274.6,sp|Q3ZBE6|TM135_BOVIN Transmembrane protein 135 OS=Bos taurus OX=9913 GN=TMEM135 PE=2 SV=1,,,,,,
OG_02836,FUN_011855-T1,Peve_00034401,Pocillopora_meandrina_HIv1___RNAseq.g23382.t1,three_way,65.68350000000001,FUN_011855-T1,Q5R673,RIOX2_PONAB,,Ribosomal oxygenase 2 (Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA) (EC 1.14.11.79) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),33.7,409.0,5.4e-54,213.8,sp|Q5R673|RIOX2_PONAB Ribosomal oxygenase 2 OS=Pongo abelii OX=9601 GN=RIOX2 PE=2 SV=1,GO:0005654; GO:0005730; GO:0032453; GO:0036139; GO:0042254; GO:0042802; GO:0046872; GO:0051864,ribosome biogenesis [GO:0042254],nucleolus [GO:0005730]; nucleoplasm [GO:0005654],histone H3K36 demethylase activity [GO:0051864]; histone H3K4 demethylase activity [GO:0032453]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-histidine dioxygenase activity [GO:0036139],GO:0003824; GO:0005654; GO:0005730; GO:0016491; GO:0042254; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; nucleolus; oxidoreductase activity; ribosome biogenesis; organelle; catalytic activity, acting on a protein"
OG_02837,FUN_011861-T1,Peve_00006759,Pocillopora_meandrina_HIv1___TS.g16269.t1,three_way,62.36083333333333,,,,,,,,,,,,,,,,,
OG_02838,FUN_011862-T1,Peve_00006757,Pocillopora_meandrina_HIv1___RNAseq.g23386.t1,three_way,36.42133333333333,FUN_011862-T1,Q32PP1,MRNIP_DANRE,,MRN complex-interacting protein (MRN-interacting protein),Danio rerio (Zebrafish) (Brachydanio rerio),44.9,127.0,1.5e-21,105.1,sp|Q32PP1|MRNIP_DANRE MRN complex-interacting protein OS=Danio rerio OX=7955 GN=mrnip PE=2 SV=1,GO:0003682; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0045860; GO:0071168; GO:1905168; GO:2001032,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromatin [GO:0071168]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; response to ionizing radiation [GO:0010212],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005654; GO:0006281; GO:0043226,nucleus; nucleoplasm; DNA repair; organelle
OG_02839,FUN_011863-T1,Peve_00006756,Pocillopora_meandrina_HIv1___RNAseq.g23387.t1,three_way,83.105,FUN_011863-T1,Q24439,,,,,45.1,206.0,5.8e-44,179.1,"sp|Q24439|ATPO_DROME ATP synthase subunit O, mitochondrial OS=Drosophila melanogaster OX=7227 GN=ATPsynO PE=2 SV=2",,,,,,
OG_02840,FUN_011864-T1,Peve_00006755,Pocillopora_meandrina_HIv1___RNAseq.g23388.t1,three_way,63.86766666666667,,,,,,,,,,,,,,,,,
OG_02841,FUN_011865-T1,Peve_00006754,Pocillopora_meandrina_HIv1___RNAseq.g23392.t1,three_way,81.326,FUN_011865-T1,Q921W4,,,,,48.3,321.0,2.4e-73,277.3,sp|Q921W4|QORL1_MOUSE Quinone oxidoreductase-like protein 1 OS=Mus musculus OX=10090 GN=Cryzl1 PE=1 SV=1,,,,,,
OG_02842,FUN_011866-T1,Peve_00014172,Pocillopora_meandrina_HIv1___RNAseq.g23393.t1,three_way,82.23866666666666,FUN_011866-T1,Q5U3Y5,,,,,57.9,159.0,2.9999999999999997e-47,189.5,sp|Q5U3Y5|SFT2A_RAT Vesicle transport protein SFT2A OS=Rattus norvegicus OX=10116 GN=Sft2d1 PE=2 SV=1,,,,,,
OG_02843,FUN_011867-T1,Peve_00005279,Pocillopora_meandrina_HIv1___RNAseq.g26657.t1,three_way,72.6535,,,,,,,,,,,,,,,,,
OG_02844,FUN_011870-T1,Peve_00018846,Pocillopora_meandrina_HIv1___RNAseq.g23394.t1,three_way,71.88266666666667,FUN_011870-T1,Q9QXE2,,,,,43.5,566.0,1.6e-122,442.2,sp|Q9QXE2|DPOLL_MOUSE DNA polymerase lambda OS=Mus musculus OX=10090 GN=Poll PE=2 SV=1,,,,,,
OG_02845,FUN_011871-T1,Peve_00018844,Pocillopora_meandrina_HIv1___RNAseq.g23396.t1,three_way,78.22483333333334,FUN_011871-T1,Q9UA35,,,,,47.3,545.0,2e-125,451.1,sp|Q9UA35|S28A3_EPTST Solute carrier family 28 member 3 OS=Eptatretus stoutii OX=7765 GN=SLC28A3 PE=2 SV=1,,,,,,
OG_02846,FUN_011873-T1,Peve_00018843,Pocillopora_meandrina_HIv1___TS.g16282.t1,three_way,69.31633333333333,FUN_011873-T1,Q9C0E2,XPO4_HUMAN,,Exportin-4 (Exp4),Homo sapiens (Human),41.9,1157.0,2.2000000000000003e-253,877.1,sp|Q9C0E2|XPO4_HUMAN Exportin-4 OS=Homo sapiens OX=9606 GN=XPO4 PE=1 SV=2,GO:0005049; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006611; GO:0031267; GO:0046827,positive regulation of protein export from nucleus [GO:0046827]; protein export from nucleus [GO:0006611],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],nuclear export signal receptor activity [GO:0005049]; small GTPase binding [GO:0031267],GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0140104,nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular carrier activity
OG_02847,FUN_011874-T1,Peve_00018842,Pocillopora_meandrina_HIv1___RNAseq.g23398.t1,three_way,40.03266666666667,FUN_011874-T1,O08863,BIRC3_MOUSE,,Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 2) (C-IAP2) (Inhibitor of apoptosis protein 1) (mIAP1) (RING-type E3 ubiquitin transferase BIRC3),Mus musculus (Mouse),25.2,397.0,2.7e-15,85.9,sp|O08863|BIRC3_MOUSE Baculoviral IAP repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Birc3 PE=1 SV=2,GO:0005634; GO:0005737; GO:0006915; GO:0008270; GO:0016740; GO:0042326; GO:0042981; GO:0060546; GO:0070266; GO:0071356; GO:1901222; GO:1902916; GO:2000378,apoptotic process [GO:0006915]; cellular response to tumor necrosis factor [GO:0071356]; necroptotic process [GO:0070266]; negative regulation of necroptotic process [GO:0060546]; negative regulation of phosphorylation [GO:0042326]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of protein polyubiquitination [GO:1902916]; regulation of apoptotic process [GO:0042981]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222],cytoplasm [GO:0005737]; nucleus [GO:0005634],transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0012501; GO:0016740; GO:0043226,catalytic activity; nucleus; programmed cell death; transferase activity; organelle
OG_02848,FUN_011875-T1,Peve_00018841,Pocillopora_meandrina_HIv1___RNAseq.g23399.t1,three_way,82.79483333333333,FUN_011875-T1,P61758,PFD3_HUMAN,,Prefoldin subunit 3 (HIBBJ46) (von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1),Homo sapiens (Human),63.9,166.0,4.4e-57,222.6,sp|P61758|PFD3_HUMAN Prefoldin subunit 3 OS=Homo sapiens OX=9606 GN=VBP1 PE=1 SV=4,GO:0001540; GO:0005634; GO:0005737; GO:0005829; GO:0006457; GO:0007017; GO:0007021; GO:0015631; GO:0016272; GO:0043231; GO:0051082; GO:0061077; GO:1905907,chaperone-mediated protein folding [GO:0061077]; microtubule-based process [GO:0007017]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; prefoldin complex [GO:0016272],amyloid-beta binding [GO:0001540]; tubulin binding [GO:0015631]; unfolded protein binding [GO:0051082],GO:0005634; GO:0005829; GO:0006457; GO:0008092; GO:0043226; GO:0065003,nucleus; cytosol; protein folding; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_02849,FUN_011876-T1,Peve_00018839,Pocillopora_meandrina_HIv1___RNAseq.g23400.t1,three_way,55.41233333333333,FUN_011876-T1,Q9C0D7,ZC12C_HUMAN,,Probable ribonuclease ZC3H12C (EC 3.1.-.-) (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C),Homo sapiens (Human),45.0,351.0,3.6e-69,264.6,sp|Q9C0D7|ZC12C_HUMAN Probable ribonuclease ZC3H12C OS=Homo sapiens OX=9606 GN=ZC3H12C PE=1 SV=2,GO:0003729; GO:0004521; GO:0005634; GO:0008270; GO:0036464,,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; organelle; catalytic activity, acting on RNA"
OG_02850,FUN_011882-T1,Peve_00018836,Pocillopora_meandrina_HIv1___RNAseq.g23402.t1,three_way,89.64316666666666,FUN_011882-T1,O14602,,,,,84.8,145.0,2.7e-50,199.5,"sp|O14602|IF1AY_HUMAN Eukaryotic translation initiation factor 1A, Y-chromosomal OS=Homo sapiens OX=9606 GN=EIF1AY PE=1 SV=4",,,,,,
OG_02851,FUN_011883-T1,Peve_00018835,Pocillopora_meandrina_HIv1___RNAseq.g23403.t1,three_way,66.81966666666666,FUN_011883-T1,Q6DE40,,,,,53.6,405.0,3e-129,463.4,"sp|Q6DE40|MANEA_XENLA Glycoprotein endo-alpha-1,2-mannosidase OS=Xenopus laevis OX=8355 GN=manea PE=2 SV=1",,,,,,
OG_02852,FUN_011884-T1,Peve_00018834,Pocillopora_meandrina_HIv1___RNAseq.g23404.t1,three_way,69.9975,FUN_011884-T1,P48553,TPC10_HUMAN,,Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein) (EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1),Homo sapiens (Human),32.6,1271.0,3.4000000000000005e-167,590.9,sp|P48553|TPC10_HUMAN Trafficking protein particle complex subunit 10 OS=Homo sapiens OX=9606 GN=TRAPPC10 PE=1 SV=2,GO:0005737; GO:0005829; GO:0006888; GO:0006891; GO:0006901; GO:0030008; GO:0034498; GO:0099022; GO:1990071,early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022],cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071],,GO:0005829; GO:0016192,cytosol; vesicle-mediated transport
OG_02853,FUN_011890-T1,Peve_00042786,Pocillopora_meandrina_HIv1___RNAseq.g13675.t1,three_way,73.18133333333333,FUN_011890-T1,Q9ULI1,,,,,28.0,898.0,2.4e-78,296.2,sp|Q9ULI1|NWD2_HUMAN NACHT and WD repeat domain-containing protein 2 OS=Homo sapiens OX=9606 GN=NWD2 PE=1 SV=3,,,,,,
OG_02854,FUN_011892-T1,Peve_00008036,Pocillopora_meandrina_HIv1___RNAseq.g23808.t1,three_way,61.0615,FUN_011892-T1,E1C231,,,,,33.0,1901.0,8.200000000000001e-258,892.5,sp|E1C231|LTN1_CHICK E3 ubiquitin-protein ligase listerin OS=Gallus gallus OX=9031 GN=LTN1 PE=3 SV=1,,,,,,
OG_02855,FUN_011893-T1,Peve_00008033,Pocillopora_meandrina_HIv1___TS.g16684.t2,three_way,72.4585,FUN_011893-T1,Q9WVE9,ITSN1_RAT,,Intersectin-1 (EH domain and SH3 domain regulator of endocytosis 1),Rattus norvegicus (Rat),40.1,1088.0,5.1e-58,228.0,sp|Q9WVE9|ITSN1_RAT Intersectin-1 OS=Rattus norvegicus OX=10116 GN=Itsn1 PE=1 SV=2,GO:0005085; GO:0005509; GO:0005635; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006887; GO:0006897; GO:0007264; GO:0007267; GO:0008104; GO:0015031; GO:0016197; GO:0019209; GO:0030027; GO:0030139; GO:0042734; GO:0043025; GO:0043195; GO:0043197; GO:0043524; GO:0044305; GO:0048488; GO:0051402; GO:0051897; GO:0055037; GO:0060090; GO:0060124; GO:0060999; GO:0070064; GO:0097440; GO:0097708; GO:0098833; GO:0098843; GO:0098871; GO:0098978; GO:0099175; GO:0150007; GO:1905274; GO:2001288,cell-cell signaling [GO:0007267]; clathrin-dependent synaptic vesicle endocytosis [GO:0150007]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; exocytosis [GO:0006887]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; positive regulation of caveolin-mediated endocytosis [GO:2001288]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of modification of postsynaptic actin cytoskeleton [GO:1905274]; regulation of postsynapse organization [GO:0099175]; small GTPase-mediated signal transduction [GO:0007264]; synaptic vesicle endocytosis [GO:0048488],apical dendrite [GO:0097440]; calyx of Held [GO:0044305]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone [GO:0098833]; presynaptic membrane [GO:0042734]; recycling endosome [GO:0055037]; terminal bouton [GO:0043195],calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinase activator activity [GO:0019209]; molecular adaptor activity [GO:0060090]; proline-rich region binding [GO:0070064],GO:0005635; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0060090; GO:0098772,nuclear envelope; endosome; cytosol; cytoskeleton; plasma membrane; programmed cell death; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular function regulator activity
OG_02856,FUN_011897-T1,Peve_00021535,Pocillopora_meandrina_HIv1___RNAseq.g23805.t1,three_way,66.613,FUN_011897-T1,Q8BH18,,,,,50.0,416.0,3.4000000000000003e-122,441.4,sp|Q8BH18|TM117_MOUSE Transmembrane protein 117 OS=Mus musculus OX=10090 GN=Tmem117 PE=1 SV=1,,,,,,
OG_02857,FUN_011899-T1,Peve_00010113,Pocillopora_meandrina_HIv1___RNAseq.g23787.t1,three_way,67.8275,FUN_011899-T1,Q5R9B8,DCAF6_PONAB,,DDB1- and CUL4-associated factor 6 (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),39.1,843.0,7.8e-144,512.7,sp|Q5R9B8|DCAF6_PONAB DDB1- and CUL4-associated factor 6 OS=Pongo abelii OX=9601 GN=DCAF6 PE=2 SV=2,GO:0005634; GO:0005737; GO:0016567; GO:0045944; GO:0080008,positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_02858,FUN_011900-T1,Peve_00010115,Pocillopora_meandrina_HIv1___RNAseq.g23788.t1,three_way,86.81633333333333,FUN_011900-T1,Q9GRC0,,,,,48.8,256.0,1.1e-61,238.4,sp|Q9GRC0|MOS_PATPE Serine/threonine-protein kinase mos OS=Patiria pectinifera OX=7594 GN=mos PE=1 SV=1,,,,,,
OG_02859,FUN_011901-T1,Peve_00032854,Pocillopora_meandrina_HIv1___TS.g16663.t2,three_way,70.4165,FUN_011901-T1,A7MBI0,PACN1_BOVIN,,Protein kinase C and casein kinase substrate in neurons protein 1,Bos taurus (Bovine),33.7,306.0,7.9e-41,169.5,sp|A7MBI0|PACN1_BOVIN Protein kinase C and casein kinase substrate in neurons protein 1 OS=Bos taurus OX=9913 GN=PACSIN1 PE=2 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043679; GO:0048488; GO:0048812; GO:0072657; GO:0097320; GO:1900006,actin filament organization [GO:0007015]; cytoskeleton organization [GO:0007010]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; protein localization to membrane [GO:0072657]; regulation of endocytosis [GO:0030100]; synaptic vesicle endocytosis [GO:0048488],axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; ruffle membrane [GO:0032587],phospholipid binding [GO:0005543],GO:0005768; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_02860,FUN_011903-T1,Peve_00042804,Pocillopora_meandrina_HIv1___TS.g16668.t1,three_way,62.521166666666666,FUN_011903-T1,G5ECB2,GABR2_CAEEL,,Gamma-aminobutyric acid type B receptor subunit 2,Caenorhabditis elegans,30.0,687.0,9.1e-78,293.1,sp|G5ECB2|GABR2_CAEEL Gamma-aminobutyric acid type B receptor subunit 2 OS=Caenorhabditis elegans OX=6239 GN=gbb-2 PE=1 SV=1,GO:0004965; GO:0007186; GO:0007214; GO:0009410; GO:0032223; GO:0038039; GO:0040012; GO:1902712,"G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of synaptic transmission, cholinergic [GO:0032223]; regulation of locomotion [GO:0040012]; response to xenobiotic stimulus [GO:0009410]",G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039],G protein-coupled GABA receptor activity [GO:0004965],GO:0023052; GO:0060089,signaling; molecular transducer activity
OG_02861,FUN_011906-T1,Peve_00026367,Pocillopora_meandrina_HIv1___RNAseq.g23365.t1,three_way,91.1335,FUN_011906-T1,Q61371,,,,,70.8,718.0,5.900000000000001e-170,599.4,sp|Q61371|IFT88_MOUSE Intraflagellar transport protein 88 homolog OS=Mus musculus OX=10090 GN=Ift88 PE=1 SV=2,,,,,,
OG_02862,FUN_011907-T1,Peve_00014640,Pocillopora_meandrina_HIv1___RNAseq.g23364.t1,three_way,57.48433333333333,,,,,,,,,,,,,,,,,
OG_02863,FUN_011910-T1,Peve_00039385,Pocillopora_meandrina_HIv1___RNAseq.g23362.t1,three_way,65.31233333333333,FUN_011910-T1,A5D9D4,,,,,33.9,584.0,4.6e-82,307.0,sp|A5D9D4|MSTO1_BOVIN Protein misato homolog 1 OS=Bos taurus OX=9913 GN=MSTO1 PE=2 SV=2,,,,,,
OG_02864,FUN_011911-T1,Peve_00039386,Pocillopora_meandrina_HIv1___RNAseq.g23361.t1,three_way,83.54433333333334,FUN_011911-T1,Q96VG1,,,,,50.9,57.0,7.7e-12,70.9,sp|Q96VG1|YBAI_SCHPO Uncharacterized protein C119.18 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC119.18 PE=3 SV=1,,,,,,
OG_02865,FUN_011912-T1,Peve_00020699,Pocillopora_meandrina_HIv1___RNAseq.g23360.t1,three_way,69.96266666666666,FUN_011912-T1,Q92562,FIG4_HUMAN,,"Polyphosphoinositide phosphatase (EC 3.1.3.-) (EC 3.1.3.36) (EC 3.1.3.86) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4) (EC 3.1.3.16)",Homo sapiens (Human),45.8,1014.0,7.2e-216,752.3,sp|Q92562|FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens OX=9606 GN=FIG4 PE=1 SV=1,GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037,locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033],early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037],"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722]",GO:0003824; GO:0005768; GO:0005811; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endosome; lipid droplet; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02866,FUN_011913-T1,Peve_00010940,Pocillopora_meandrina_HIv1___RNAseq.g23315.t1,three_way,81.39533333333333,FUN_011913-T1,Q5F2N3,OFUT3_DANRE,,GDP-fucose protein O-fucosyltransferase 3 (EC 2.4.1.221) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10),Danio rerio (Zebrafish) (Brachydanio rerio),29.8,295.0,1.5e-26,122.1,sp|Q5F2N3|OFUT3_DANRE GDP-fucose protein O-fucosyltransferase 3 OS=Danio rerio OX=7955 GN=fut10 PE=2 SV=3,GO:0000139; GO:0005783; GO:0005789; GO:0036065; GO:0046920; GO:0046922; GO:0050714,fucosylation [GO:0036065]; positive regulation of protein secretion [GO:0050714],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],alpha-(1->3)-fucosyltransferase activity [GO:0046920]; peptide-O-fucosyltransferase activity [GO:0046922],GO:0003824; GO:0005783; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02867,FUN_011917-T1,Peve_00010930,Pocillopora_meandrina_HIv1___RNAseq.g23316.t1,three_way,66.30183333333333,FUN_011917-T1,Q80Y44,,,,,58.7,543.0,1.5e-178,627.9,sp|Q80Y44|DDX10_MOUSE Probable ATP-dependent RNA helicase DDX10 OS=Mus musculus OX=10090 GN=Ddx10 PE=1 SV=2,,,,,,
OG_02868,FUN_011918-T1,Peve_00010931,Pocillopora_meandrina_HIv1___RNAseq.g23317.t1,three_way,63.510333333333335,FUN_011918-T1,B2Z449,CYTB_PAROL,,Cystatin-B (PoCystatin-B) (Stefin-B),Paralichthys olivaceus (Bastard halibut) (Hippoglossus olivaceus),53.6,97.0,1.8e-21,103.2,sp|B2Z449|CYTB_PAROL Cystatin-B OS=Paralichthys olivaceus OX=8255 PE=1 SV=1,GO:0004869; GO:0005737; GO:0005829; GO:0045087; GO:0071220,cellular response to bacterial lipoprotein [GO:0071220]; innate immune response [GO:0045087],cytoplasm [GO:0005737]; cytosol [GO:0005829],cysteine-type endopeptidase inhibitor activity [GO:0004869],GO:0002376; GO:0005829; GO:0098542; GO:0098772,immune system process; cytosol; defense response to other organism; molecular function regulator activity
OG_02869,FUN_011919-T1,Peve_00010933,Pocillopora_meandrina_HIv1___RNAseq.g23318.t1,three_way,75.38133333333333,FUN_011919-T1,A4FUI1,,,,,53.3,135.0,1.1e-35,151.0,sp|A4FUI1|MIX23_BOVIN Protein MIX23 OS=Bos taurus OX=9913 GN=MIX23 PE=2 SV=1,,,,,,
OG_02870,FUN_011920-T1,Peve_00010935,Pocillopora_meandrina_HIv1___RNAseq.g23319.t1,three_way,55.29366666666667,FUN_011920-T1,A4Q9E4,TTLL2_MOUSE,,Probable tubulin polyglutamylase TTLL2 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 2),Mus musculus (Mouse),50.2,331.0,9.5e-98,359.4,sp|A4Q9E4|TTLL2_MOUSE Probable tubulin polyglutamylase TTLL2 OS=Mus musculus OX=10090 GN=Ttll2 PE=2 SV=1,GO:0005524; GO:0036211; GO:0046872; GO:0070740,protein modification process [GO:0036211],,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tubulin-glutamic acid ligase activity [GO:0070740],GO:0003824; GO:0016874; GO:0140096,"catalytic activity; ligase activity; catalytic activity, acting on a protein"
OG_02871,FUN_011921-T1,Peve_00010936,Pocillopora_meandrina_HIv1___TS.g16202.t2,three_way,78.23433333333332,FUN_011921-T1,Q7T3F7,,,,,46.4,323.0,2e-77,290.8,sp|Q7T3F7|CHRD1_DANRE Cysteine and histidine-rich domain-containing protein 1 OS=Danio rerio OX=7955 GN=chordc1 PE=2 SV=1,,,,,,
OG_02872,FUN_011922-T1,Peve_00002208,Pocillopora_meandrina_HIv1___TS.g16203.t1,three_way,84.6935,FUN_011922-T1,Q9C102,GLT1_SCHPO,,Glutamate synthase [NADH] (EC 1.4.1.14) (Glutamine-oxoglutarate aminotransferase) (GOGAT),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),51.7,2161.0,0.0,2202.6,sp|Q9C102|GLT1_SCHPO Glutamate synthase [NADH] OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=glt1 PE=1 SV=1,GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0016040; GO:0016639; GO:0019676; GO:0050660; GO:0051538; GO:0097054,ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054],cytosol [GO:0005829]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO:0016639]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; oxidoreductase activity; organelle
OG_02873,FUN_011923-T1,Peve_00002205,Pocillopora_meandrina_HIv1___RNAseq.g23322.t1,three_way,50.577333333333335,FUN_011923-T1,G4WMX4,,,,,25.0,316.0,5.8e-14,80.1,sp|G4WMX4|RYAR_TRICA RYamide receptor OS=Tribolium castaneum OX=7070 GN=RYa-R PE=2 SV=1,,,,,,
OG_02874,FUN_011924-T1,Peve_00008895,Pocillopora_meandrina_HIv1___RNAseq.g23323.t2,three_way,64.81983333333334,FUN_011924-T1,Q6PCF7,UBE2Z_XENLA,,Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z),Xenopus laevis (African clawed frog),57.8,249.0,2.7e-84,313.5,sp|Q6PCF7|UBE2Z_XENLA Ubiquitin-conjugating enzyme E2 Z OS=Xenopus laevis OX=8355 GN=ube2z PE=2 SV=2,GO:0004869; GO:0005524; GO:0005634; GO:0005737; GO:0006915; GO:0016567; GO:0043066; GO:0061631,apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0012501; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; programmed cell death; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02875,FUN_011925-T1,Peve_00008894,Pocillopora_meandrina_HIv1___RNAseq.g23324.t1,three_way,81.14933333333333,FUN_011925-T1,Q9NYS0,KBRS1_HUMAN,,NF-kappa-B inhibitor-interacting Ras-like protein 1 (I-kappa-B-interacting Ras-like protein 1) (Kappa B-Ras protein 1) (KappaB-Ras1),Homo sapiens (Human),44.4,169.0,1.8e-36,154.1,sp|Q9NYS0|KBRS1_HUMAN NF-kappa-B inhibitor-interacting Ras-like protein 1 OS=Homo sapiens OX=9606 GN=NKIRAS1 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005783; GO:0005829; GO:0010803; GO:0032484; GO:0032794; GO:0043124; GO:0043129; GO:0048286,lung alveolus development [GO:0048286]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; Ral protein signal transduction [GO:0032484]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; surfactant homeostasis [GO:0043129],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783],GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005783; GO:0005829; GO:0016787; GO:0043226; GO:0048856,catalytic activity; GTPase activity; endoplasmic reticulum; cytosol; hydrolase activity; organelle; anatomical structure development
OG_02876,FUN_011926-T1,Peve_00039377,Pocillopora_meandrina_HIv1___RNAseq.g23327.t1,three_way,50.42033333333333,,,,,,,,,,,,,,,,,
OG_02877,FUN_011927-T1,Peve_00039378,Pocillopora_meandrina_HIv1___RNAseq.g23328.t1,three_way,81.451,FUN_011927-T1,O60476,MA1A2_HUMAN,,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)",Homo sapiens (Human),52.3,623.0,1e-183,644.8,"sp|O60476|MA1A2_HUMAN Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB OS=Homo sapiens OX=9606 GN=MAN1A2 PE=1 SV=1",GO:0000139; GO:0004571; GO:0005509; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0006491; GO:0007585; GO:0016020; GO:0036503; GO:0048286; GO:0070062; GO:1904381,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; Golgi apparatus mannose trimming [GO:1904381]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange by respiratory system [GO:0007585],endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0006486; GO:0009101; GO:0016787; GO:0030163; GO:0043226; GO:0048856; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein glycosylation; glycoprotein biosynthetic process; hydrolase activity; protein catabolic process; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_02878,FUN_011928-T1,Peve_00039387,Pocillopora_meandrina_HIv1___RNAseq.g23329.t1,three_way,69.43666666666667,FUN_011928-T1,Q5E9H9,ABHDA_BOVIN,,"Palmitoyl-protein thioesterase ABHD10, mitochondrial (EC 3.1.2.22) (Acyl-protein thioesterase ABHD10) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10) (Mycophenolic acid acyl-glucuronide esterase, mitochondrial) (EC 3.1.1.93)",Bos taurus (Bovine),44.6,251.0,9.7e-64,245.0,"sp|Q5E9H9|ABHDA_BOVIN Palmitoyl-protein thioesterase ABHD10, mitochondrial OS=Bos taurus OX=9913 GN=ABHD10 PE=2 SV=1",GO:0002084; GO:0004553; GO:0005739; GO:0008474; GO:0102390,protein depalmitoylation [GO:0002084],mitochondrion [GO:0005739],"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; mycophenolic acid acyl-glucuronide esterase activity [GO:0102390]; palmitoyl-(protein) hydrolase activity [GO:0008474]",GO:0003824; GO:0005739; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_02879,FUN_011929-T1,Peve_00039637,Pocillopora_meandrina_HIv1___RNAseq.g23330.t1,three_way,69.50066666666667,FUN_011929-T1,Q54MF3,CANB2_DICDI,,Calcineurin subunit B type 2 (Calcineurin regulatory subunit 2) (Protein phosphatase 2B regulatory subunit 2),Dictyostelium discoideum (Social amoeba),24.2,161.0,1e-11,71.6,sp|Q54MF3|CANB2_DICDI Calcineurin subunit B type 2 OS=Dictyostelium discoideum OX=44689 GN=cnbB PE=3 SV=1,GO:0005509; GO:0005955; GO:0008597; GO:0019902; GO:0097720,calcineurin-mediated signaling [GO:0097720],calcineurin complex [GO:0005955],calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; phosphatase binding [GO:0019902],GO:0098772,molecular function regulator activity
OG_02880,FUN_011930-T2,Peve_00039636,Pocillopora_meandrina_HIv1___RNAseq.g23331.t1,three_way,68.039,FUN_011930-T2,Q2WG76,RIPP2_MOUSE,,Protein ripply2,Mus musculus (Mouse),37.9,87.0,3e-10,66.2,sp|Q2WG76|RIPP2_MOUSE Protein ripply2 OS=Mus musculus OX=10090 GN=Ripply2 PE=2 SV=1,GO:0001503; GO:0001756; GO:0005634; GO:0005654; GO:0007219; GO:0007368; GO:0009798; GO:0010468; GO:0032525; GO:0036342; GO:0060349,axis specification [GO:0009798]; bone morphogenesis [GO:0060349]; determination of left/right symmetry [GO:0007368]; Notch signaling pathway [GO:0007219]; ossification [GO:0001503]; post-anal tail morphogenesis [GO:0036342]; regulation of gene expression [GO:0010468]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756],nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0043226,nucleus; nucleoplasm; organelle
OG_02881,FUN_011931-T1,Peve_00039635,Pocillopora_meandrina_HIv1___RNAseq.g23332.t1,three_way,79.66666666666667,FUN_011931-T1,Q8CAY6,,,,,62.2,389.0,6.4e-139,495.4,"sp|Q8CAY6|THIC_MOUSE Acetyl-CoA acetyltransferase, cytosolic OS=Mus musculus OX=10090 GN=Acat2 PE=1 SV=2",,,,,,
OG_02882,FUN_011932-T1,Peve_00039643,Pocillopora_meandrina_HIv1___RNAseq.g23333.t1,three_way,85.123,FUN_011932-T1,Q8AVQ6,,,,,57.1,231.0,5.8e-66,252.3,sp|Q8AVQ6|SYF2_XENLA Pre-mRNA-splicing factor syf2 OS=Xenopus laevis OX=8355 GN=syf2 PE=2 SV=1,,,,,,
OG_02883,FUN_011933-T1,Peve_00039642,Pocillopora_meandrina_HIv1___RNAseq.g23334.t1,three_way,74.492,FUN_011933-T1,Q9TZM3,,,,,26.5,2417.0,9.3e-178,627.1,sp|Q9TZM3|LRK1_CAEEL Leucine-rich repeat serine/threonine-protein kinase 1 OS=Caenorhabditis elegans OX=6239 GN=lrk-1 PE=1 SV=6,,,,,,
OG_02884,FUN_011934-T1,Peve_00015898,Pocillopora_meandrina_HIv1___RNAseq.g23335.t1,three_way,74.07766666666667,FUN_011934-T1,Q3T100,MGST3_BOVIN,,"Glutathione S-transferase 3, mitochondrial (EC 2.5.1.-) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (LTC4 synthase MGST3) (EC 4.4.1.20)",Bos taurus (Bovine),51.5,136.0,8.1e-33,141.4,"sp|Q3T100|MGST3_BOVIN Glutathione S-transferase 3, mitochondrial OS=Bos taurus OX=9913 GN=MGST3 PE=2 SV=1",GO:0004364; GO:0004464; GO:0004602; GO:0005635; GO:0005741; GO:0005783; GO:0006692; GO:0019369; GO:0019370; GO:0042802,arachidonate metabolic process [GO:0019369]; leukotriene biosynthetic process [GO:0019370]; prostanoid metabolic process [GO:0006692],endoplasmic reticulum [GO:0005783]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635],glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464],GO:0003824; GO:0005635; GO:0005783; GO:0006629; GO:0016209; GO:0016491; GO:0016740; GO:0016829; GO:0043226,catalytic activity; nuclear envelope; endoplasmic reticulum; lipid metabolic process; antioxidant activity; oxidoreductase activity; transferase activity; lyase activity; organelle
OG_02885,FUN_011935-T1,Peve_00036731,Pocillopora_meandrina_HIv1___RNAseq.g26615.t1,three_way,51.94433333333333,FUN_011935-T1,Q805E5,,,,,35.8,279.0,7.2e-34,146.0,sp|Q805E5|CHSTE_DANRE Carbohydrate sulfotransferase 14 OS=Danio rerio OX=7955 GN=chst14 PE=2 SV=1,,,,,,
OG_02886,FUN_011936-T1,Peve_00015901,Pocillopora_meandrina_HIv1___TS.g16218.t1,three_way,61.47666666666667,FUN_011936-T1,Q9GLP1,,,,,36.6,186.0,4.7e-22,107.8,sp|Q9GLP1|FA5_PIG Coagulation factor V OS=Sus scrofa OX=9823 GN=F5 PE=2 SV=1,,,,,,
OG_02887,FUN_011941-T1,Peve_00013077,Pocillopora_meandrina_HIv1___RNAseq.g23341.t1,three_way,69.871,FUN_011941-T1,A7SPW6,,,,,55.2,290.0,6.5e-81,302.4,"sp|A7SPW6|EFTS_NEMVE Elongation factor Ts, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g215604 PE=3 SV=1",,,,,,
OG_02888,FUN_011943-T1,Peve_00013082,Pocillopora_meandrina_HIv1___RNAseq.g22061.t1,three_way,61.978,FUN_011943-T1,P21729,,,,,26.2,302.0,7.2e-14,79.7,sp|P21729|GRPR_MOUSE Gastrin-releasing peptide receptor OS=Mus musculus OX=10090 GN=Grpr PE=1 SV=2,,,,,,
OG_02889,FUN_011944-T1,Peve_00016922,Pocillopora_meandrina_HIv1___RNAseq.g9188.t1,three_way,71.43466666666666,FUN_011944-T1,Q6Q759,SPG17_HUMAN,,Sperm-associated antigen 17 (Projection protein PF6 homolog),Homo sapiens (Human),31.0,2357.0,6.9000000000000005e-174,614.0,sp|Q6Q759|SPG17_HUMAN Sperm-associated antigen 17 OS=Homo sapiens OX=9606 GN=SPAG17 PE=1 SV=1,GO:0001669; GO:0002177; GO:0003351; GO:0005576; GO:0005794; GO:0005874; GO:0007283; GO:0031514; GO:0044458; GO:1904158; GO:1905198; GO:1990716; GO:1990953,axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; motile cilium assembly [GO:0044458]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; manchette [GO:0002177]; microtubule [GO:0005874]; motile cilium [GO:0031514],,GO:0005576; GO:0005794; GO:0005929; GO:0006886; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782,extracellular region; Golgi apparatus; cilium; intracellular protein transport; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization
OG_02890,FUN_011945-T1,Peve_00016921,Pocillopora_meandrina_HIv1___RNAseq.g9189.t2,three_way,87.27733333333333,FUN_011945-T1,Q9YH18,,,,,42.9,324.0,4.7e-59,229.6,sp|Q9YH18|QKI_CHICK KH domain-containing RNA-binding protein QKI OS=Gallus gallus OX=9031 GN=QKI PE=2 SV=2,,,,,,
OG_02891,FUN_011946-T1,Peve_00016920,Pocillopora_meandrina_HIv1___RNAseq.g9190.t1,three_way,81.93116666666667,FUN_011946-T1,O75937,DNJC8_HUMAN,,DnaJ homolog subfamily C member 8 (Splicing protein spf31),Homo sapiens (Human),46.0,163.0,6.8e-34,145.6,sp|O75937|DNJC8_HUMAN DnaJ homolog subfamily C member 8 OS=Homo sapiens OX=9606 GN=DNAJC8 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005829; GO:0030544; GO:0045171,,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],Hsp70 protein binding [GO:0030544],GO:0005634; GO:0005654; GO:0005829; GO:0043226,nucleus; nucleoplasm; cytosol; organelle
OG_02892,FUN_011947-T1,Peve_00016919,Pocillopora_meandrina_HIv1___RNAseq.g9191.t1,three_way,79.90299999999999,FUN_011947-T1,Q8N5D0,WDTC1_HUMAN,,WD and tetratricopeptide repeats protein 1,Homo sapiens (Human),50.3,723.0,1.3e-187,657.9,sp|Q8N5D0|WDTC1_HUMAN WD and tetratricopeptide repeats protein 1 OS=Homo sapiens OX=9606 GN=WDTC1 PE=1 SV=2,GO:0000122; GO:0001701; GO:0004857; GO:0005654; GO:0005737; GO:0005829; GO:0006006; GO:0008361; GO:0016567; GO:0032869; GO:0035264; GO:0042393; GO:0042826; GO:0045717; GO:0055082; GO:0080008,cellular response to insulin stimulus [GO:0032869]; glucose metabolic process [GO:0006006]; in utero embryonic development [GO:0001701]; intracellular chemical homeostasis [GO:0055082]; multicellular organism growth [GO:0035264]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; regulation of cell size [GO:0008361],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826],GO:0005654; GO:0005829; GO:0005975; GO:0006355; GO:0042393; GO:0048856; GO:0098772,nucleoplasm; cytosol; carbohydrate metabolic process; regulation of DNA-templated transcription; histone binding; anatomical structure development; molecular function regulator activity
OG_02893,FUN_011950-T1,Peve_00016916,Pocillopora_meandrina_HIv1___RNAseq.g24086.t1,three_way,85.28399999999999,FUN_011950-T1,Q5XIV0,,,,,62.7,327.0,7.4e-113,408.7,sp|Q5XIV0|TET5C_RAT Terminal nucleotidyltransferase 5C OS=Rattus norvegicus OX=10116 GN=Tent5c PE=2 SV=1,,,,,,
OG_02894,FUN_011951-T1,Peve_00016914,Pocillopora_meandrina_HIv1___RNAseq.g24085.t1,three_way,83.9735,FUN_011951-T1,A7T167,,,,,68.2,509.0,2.3e-202,706.4,sp|A7T167|GDAP2_NEMVE Protein GDAP2 homolog OS=Nematostella vectensis OX=45351 GN=gdap2 PE=3 SV=1,,,,,,
OG_02895,FUN_011952-T1,Peve_00010553,Pocillopora_meandrina_HIv1___RNAseq.g24084.t1,three_way,79.57983333333334,FUN_011952-T1,Q6ZTR5,CFA47_HUMAN,,Cilia- and flagella-associated protein 47,Homo sapiens (Human),33.2,3239.0,0.0,1751.5,sp|Q6ZTR5|CFA47_HUMAN Cilia- and flagella-associated protein 47 OS=Homo sapiens OX=9606 GN=CFAP47 PE=1 SV=5,GO:0005737; GO:0005856; GO:0005929; GO:0007288; GO:0031514; GO:0060271; GO:0120212,cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm head-tail coupling apparatus [GO:0120212],,GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0044782,cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; cilium organization
OG_02896,FUN_011953-T1,Peve_00018991,Pocillopora_meandrina_HIv1___RNAseq.g24083.t1,three_way,75.15899999999999,,,,,,,,,,,,,,,,,
OG_02897,FUN_011955-T2,Peve_00027881,Pocillopora_meandrina_HIv1___RNAseq.g24080.t2,three_way,41.57966666666667,,,,,,,,,,,,,,,,,
OG_02898,FUN_011956-T3,Peve_00027888,Pocillopora_meandrina_HIv1___RNAseq.g23736.t1,three_way,67.98933333333333,FUN_011956-T3,Q66KI9,,,,,34.9,387.0,2.4e-50,201.1,sp|Q66KI9|NSUN4_XENTR 5-cytosine rRNA methyltransferase NSUN4 OS=Xenopus tropicalis OX=8364 GN=nsun4 PE=2 SV=1,,,,,,
OG_02899,FUN_011957-T1,Peve_00027894,Pocillopora_meandrina_HIv1___RNAseq.g23735.t1,three_way,62.81966666666667,FUN_011957-T1,Q92734,TFG_HUMAN,,Protein TFG (TRK-fused gene protein),Homo sapiens (Human),46.5,243.0,5.1e-40,166.8,sp|Q92734|TFG_HUMAN Protein TFG OS=Homo sapiens OX=9606 GN=TFG PE=1 SV=2,GO:0005737; GO:0005829; GO:0006888; GO:0042802; GO:0043123; GO:0043231; GO:0048208; GO:0070971,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; intracellular membrane-bounded organelle [GO:0043231],identical protein binding [GO:0042802],GO:0005829; GO:0016192; GO:0043226; GO:0065003,cytosol; vesicle-mediated transport; organelle; protein-containing complex assembly
OG_02900,FUN_011959-T1,Peve_00027953,Pocillopora_meandrina_HIv1___TS.g16613.t1,three_way,82.48033333333333,FUN_011959-T1,Q9X248,,,,,38.3,248.0,3.8999999999999996e-39,163.3,sp|Q9X248|FABG_THEMA 3-oxoacyl-[acyl-carrier-protein] reductase FabG OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=fabG PE=3 SV=1,,,,,,
OG_02901,FUN_011960-T1,Peve_00027955,Pocillopora_meandrina_HIv1___RNAseq.g23739.t1,three_way,72.62466666666667,FUN_011960-T1,P82931,,,,,46.2,65.0,2.7e-11,69.3,sp|P82931|RT06_BOVIN Small ribosomal subunit protein bS6m OS=Bos taurus OX=9913 GN=MRPS6 PE=1 SV=4,,,,,,
OG_02902,FUN_011961-T1,Peve_00032575,Pocillopora_meandrina_HIv1___RNAseq.g12963.t1,three_way,70.89166666666667,FUN_011961-T1,Q5ZID0,,,,,42.0,300.0,3.1e-64,246.9,sp|Q5ZID0|NMRL1_CHICK NmrA-like family domain-containing protein 1 OS=Gallus gallus OX=9031 GN=NMRAL1 PE=2 SV=1,,,,,,
OG_02903,FUN_011973-T1,Peve_00001000,Pocillopora_meandrina_HIv1___RNAseq.g23724.t1,three_way,61.82216666666667,FUN_011973-T1,Q54G43,SHKE_DICDI,,Dual specificity protein kinase shkE (EC 2.7.11.1) (SH2 domain-containing protein 5) (SH2 domain-containing protein E),Dictyostelium discoideum (Social amoeba),31.5,251.0,1.8e-23,113.2,sp|Q54G43|SHKE_DICDI Dual specificity protein kinase shkE OS=Dictyostelium discoideum OX=44689 GN=shkE PE=3 SV=1,GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0106310,signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_02904,FUN_011974-T1,Peve_00000999,Pocillopora_meandrina_HIv1___RNAseq.g23723.t1,three_way,49.84633333333333,FUN_011974-T1,Q9BQF6,SENP7_HUMAN,,Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7),Homo sapiens (Human),48.3,321.0,1.3e-68,263.1,sp|Q9BQF6|SENP7_HUMAN Sentrin-specific protease 7 OS=Homo sapiens OX=9606 GN=SENP7 PE=1 SV=4,GO:0005634; GO:0005737; GO:0006508; GO:0016926; GO:0070139; GO:0099523; GO:0099524; GO:0140374,antiviral innate immune response [GO:0140374]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523],SUMO-specific endopeptidase activity [GO:0070139],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; hydrolase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_02905,FUN_011975-T1,Peve_00000996,Pocillopora_meandrina_HIv1___RNAseq.g23721.t1,three_way,79.435,,,,,,,,,,,,,,,,,
OG_02906,FUN_011976-T1,Peve_00000992,Pocillopora_meandrina_HIv1___RNAseq.g23720.t1,three_way,69.319,FUN_011976-T1,P48442,CASR_RAT,,Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR),Rattus norvegicus (Rat),32.8,885.0,1.6e-116,422.2,sp|P48442|CASR_RAT Extracellular calcium-sensing receptor OS=Rattus norvegicus OX=10116 GN=Casr PE=1 SV=1,GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; vasodilation [GO:0042311],apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0005886; GO:0048856; GO:0055085; GO:0060089,circulatory system process; plasma membrane; anatomical structure development; transmembrane transport; molecular transducer activity
OG_02907,FUN_011984-T1,Peve_00000523,Pocillopora_meandrina_HIv1___TS.g16589.t1,three_way,64.19166666666666,FUN_011984-T1,Q8JHI3,AR13B_DANRE,,ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1) (Protein scorpion),Danio rerio (Zebrafish) (Brachydanio rerio),53.8,208.0,2.5e-62,241.1,sp|Q8JHI3|AR13B_DANRE ADP-ribosylation factor-like protein 13B OS=Danio rerio OX=7955 GN=arl13b PE=1 SV=1,GO:0003924; GO:0005525; GO:0005929; GO:0007224; GO:0021532; GO:0021830; GO:0021943; GO:0031514; GO:0035845; GO:0060170; GO:0060271; GO:0097500; GO:0097730; GO:1905515,cilium assembly [GO:0060271]; formation of radial glial scaffolds [GO:0021943]; interneuron migration from the subpallium to the cortex [GO:0021830]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; receptor localization to non-motile cilium [GO:0097500]; smoothened signaling pathway [GO:0007224],ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005929; GO:0016787; GO:0043226; GO:0044782; GO:0048870,catalytic activity; GTPase activity; cilium; hydrolase activity; organelle; cilium organization; cell motility
OG_02908,FUN_011985-T1,Peve_00000524,Pocillopora_meandrina_HIv1___RNAseq.g23714.t1,three_way,77.837,FUN_011985-T1,P21872,,,,,57.5,1039.0,0.0,1168.3,sp|P21872|PUR2_CHICK Trifunctional purine biosynthetic protein adenosine-3 OS=Gallus gallus OX=9031 GN=GART PE=1 SV=1,,,,,,
OG_02909,FUN_011986-T1,Peve_00000525,Pocillopora_meandrina_HIv1___RNAseq.g23713.t1,three_way,73.51033333333334,FUN_011986-T1,Q8WWV3,RT4I1_HUMAN,,"NAD(P)H oxidoreductase RTN4IP1, mitochondrial (EC 1.6.5.-) (NOGO-interacting mitochondrial protein) (Reticulon-4-interacting protein 1)",Homo sapiens (Human),47.3,368.0,1.7e-86,321.2,"sp|Q8WWV3|RT4I1_HUMAN NAD(P)H oxidoreductase RTN4IP1, mitochondrial OS=Homo sapiens OX=9606 GN=RTN4IP1 PE=1 SV=2",GO:0005739; GO:0005741; GO:0005759; GO:0006744; GO:0007399; GO:0008270; GO:0008753; GO:0050773,nervous system development [GO:0007399]; regulation of dendrite development [GO:0050773]; ubiquinone biosynthetic process [GO:0006744],mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],NADPH dehydrogenase (quinone) activity [GO:0008753]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0016491; GO:0043226; GO:0048856,catalytic activity; mitochondrion; oxidoreductase activity; organelle; anatomical structure development
OG_02910,FUN_011987-T1,Peve_00000526,Pocillopora_meandrina_HIv1___RNAseq.g23712.t1,three_way,80.10666666666667,FUN_011987-T1,Q9ULU4,,,,,39.1,266.0,5e-53,210.7,sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,,,,,,
OG_02910,FUN_011987-T1,Peve_00000526,Pocillopora_meandrina_HIv1___RNAseq.g23712.t1,three_way,80.10666666666667,FUN_011987-T1,Q9ULU4,,,,,55.6,36.0,3.2e-07,58.5,sp|Q9ULU4|ZMYD8_HUMAN MYND-type zinc finger-containing chromatin reader ZMYND8 OS=Homo sapiens OX=9606 GN=ZMYND8 PE=1 SV=2,,,,,,
OG_02911,FUN_011990-T1,Peve_00000527,Pocillopora_meandrina_HIv1___RNAseq.g23707.t1,three_way,59.033,FUN_011990-T1,Q9CXC3,,,,,40.8,245.0,1.6000000000000002e-44,181.8,sp|Q9CXC3|MGME1_MOUSE Mitochondrial genome maintenance exonuclease 1 OS=Mus musculus OX=10090 GN=Mgme1 PE=2 SV=1,,,,,,
OG_02912,FUN_011991-T1,Peve_00000528,Pocillopora_meandrina_HIv1___RNAseq.g23706.t1,three_way,78.50233333333333,FUN_011991-T1,P11620,,,,,48.9,174.0,5.2e-39,162.5,sp|P11620|YPT1_SCHPO GTP-binding protein ypt1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ypt1 PE=1 SV=2,,,,,,
OG_02913,FUN_011992-T1,Peve_00000522,Pocillopora_meandrina_HIv1___TS.g16579.t1,three_way,77.61966666666667,FUN_011992-T1,P0DMN7,,,,,40.4,161.0,5.4e-26,119.0,sp|P0DMN7|DCAM1_MOUSE S-adenosylmethionine decarboxylase proenzyme 1 OS=Mus musculus OX=10090 GN=Amd1 PE=1 SV=1,,,,,,
OG_02914,FUN_011994-T1,Peve_00000554,Pocillopora_meandrina_HIv1___RNAseq.g23703.t1,three_way,56.40566666666667,,,,,,,,,,,,,,,,,
OG_02915,FUN_011997-T1,Peve_00000551,Pocillopora_meandrina_HIv1___RNAseq.g23699.t1,three_way,66.9665,FUN_011997-T1,Q4QRH7,,,,,43.4,348.0,3.2e-76,287.0,sp|Q4QRH7|PEX16_DANRE Peroxisomal membrane protein PEX16 OS=Danio rerio OX=7955 GN=pex16 PE=2 SV=1,,,,,,
OG_02916,FUN_011998-T1,Peve_00000538,Pocillopora_meandrina_HIv1___RNAseq.g24022.t1,three_way,87.02483333333333,FUN_011998-T1,A5PK71,PACRG_BOVIN,,Parkin coregulated gene protein,Bos taurus (Bovine),82.6,201.0,4.8e-99,362.1,sp|A5PK71|PACRG_BOVIN Parkin coregulated gene protein OS=Bos taurus OX=9913 GN=PACRG PE=1 SV=1,GO:0001664; GO:0002177; GO:0003779; GO:0005829; GO:0005879; GO:0007286; GO:0008104; GO:0030317; GO:0030544; GO:0031625; GO:0031982; GO:0043005; GO:0043014; GO:0044297; GO:0048487; GO:0051879; GO:0097225; GO:0097386; GO:0160112,flagellated sperm motility [GO:0030317]; protein localization [GO:0008104]; spermatid development [GO:0007286],axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; cell body [GO:0044297]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; manchette [GO:0002177]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982],actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625],GO:0005829; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870,cytosol; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility
OG_02917,FUN_011999-T1,Peve_00000537,Pocillopora_meandrina_HIv1___RNAseq.g24023.t1,three_way,65.6775,FUN_011999-T1,Q9CR26,VTA1_MOUSE,,Vacuolar protein sorting-associated protein VTA1 homolog (SKD1-binding protein 1) (SBP1),Mus musculus (Mouse),46.1,310.0,1.4e-64,248.1,sp|Q9CR26|VTA1_MOUSE Vacuolar protein sorting-associated protein VTA1 homolog OS=Mus musculus OX=10090 GN=Vta1 PE=1 SV=1,GO:0005654; GO:0005737; GO:0005829; GO:0010008; GO:0015031; GO:0032511,late endosome to vacuole transport via multivesicular body sorting pathway [GO:0032511]; protein transport [GO:0015031],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829; GO:0016192,nucleoplasm; cytosol; vesicle-mediated transport
OG_02918,FUN_012001-T1,Peve_00000536,Pocillopora_meandrina_HIv1___RNAseq.g24024.t1,three_way,59.24283333333334,FUN_012001-T1,Q60902,EP15R_MOUSE,,Epidermal growth factor receptor substrate 15-like 1 (Epidermal growth factor receptor pathway substrate 15-related sequence) (Eps15-rs) (Eps15-related protein) (Eps15R),Mus musculus (Mouse),34.3,137.0,4.6e-13,78.6,sp|Q60902|EP15R_MOUSE Epidermal growth factor receptor substrate 15-like 1 OS=Mus musculus OX=10090 GN=Eps15l1 PE=1 SV=3,GO:0005509; GO:0005634; GO:0030132; GO:0048488; GO:0098793,synaptic vesicle endocytosis [GO:0048488],clathrin coat of coated pit [GO:0030132]; nucleus [GO:0005634]; presynapse [GO:0098793],calcium ion binding [GO:0005509],GO:0005634; GO:0016192; GO:0043226,nucleus; vesicle-mediated transport; organelle
OG_02919,FUN_012002-T1,Peve_00016380,Pocillopora_meandrina_HIv1___TS.g16894.t1,three_way,74.423,,,,,,,,,,,,,,,,,
OG_02920,FUN_012003-T1,Peve_00016378,Pocillopora_meandrina_HIv1___RNAseq.g24026.t1,three_way,71.5695,FUN_012003-T1,Q5VVH5,IKBP1_HUMAN,,Interleukin-1 receptor-associated kinase 1-binding protein 1 (IRAK1-binding protein 1),Homo sapiens (Human),45.4,119.0,6.2e-23,109.0,sp|Q5VVH5|IKBP1_HUMAN Interleukin-1 receptor-associated kinase 1-binding protein 1 OS=Homo sapiens OX=9606 GN=IRAK1BP1 PE=1 SV=1,GO:0005634; GO:0005737; GO:0006955; GO:0035591; GO:0043123,immune response [GO:0006955]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],cytoplasm [GO:0005737]; nucleus [GO:0005634],signaling adaptor activity [GO:0035591],GO:0002376; GO:0005634; GO:0043226; GO:0060090,immune system process; nucleus; organelle; molecular adaptor activity
OG_02921,FUN_012004-T1,Peve_00016377,Pocillopora_meandrina_HIv1___RNAseq.g24027.t1,three_way,69.86833333333334,FUN_012004-T1,Q1L864,JGN1B_DANRE,,Protein jagunal homolog 1-B,Danio rerio (Zebrafish) (Brachydanio rerio),34.8,187.0,7.4e-23,108.6,sp|Q1L864|JGN1B_DANRE Protein jagunal homolog 1-B OS=Danio rerio OX=7955 GN=jagn1b PE=3 SV=1,GO:0002446; GO:0005783; GO:0005789; GO:0007029; GO:0015031; GO:0016192; GO:0030223; GO:0038158; GO:0050832; GO:1990266,defense response to fungus [GO:0050832]; endoplasmic reticulum organization [GO:0007029]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; neutrophil differentiation [GO:0030223]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0002376; GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048870,immune system process; endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; cell motility
OG_02922,FUN_012008-T1,Peve_00016374,Pocillopora_meandrina_HIv1___RNAseq.g24029.t1,three_way,89.249,FUN_012008-T1,Q17QU4,RB39B_BOVIN,,Ras-related protein Rab-39B (EC 3.6.5.2),Bos taurus (Bovine),54.0,187.0,9.1e-56,218.4,sp|Q17QU4|RB39B_BOVIN Ras-related protein Rab-39B OS=Bos taurus OX=9913 GN=RAB39B PE=2 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0005886; GO:0006914; GO:0010506; GO:0015031; GO:0016192; GO:0030659; GO:0031489; GO:0032482; GO:0043005; GO:0050808,autophagy [GO:0006914]; protein transport [GO:0015031]; Rab protein signal transduction [GO:0032482]; regulation of autophagy [GO:0010506]; synapse organization [GO:0050808]; vesicle-mediated transport [GO:0016192],cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489],GO:0003824; GO:0003924; GO:0005794; GO:0005886; GO:0006914; GO:0008092; GO:0016192; GO:0016787; GO:0034330; GO:0043226; GO:0098772,catalytic activity; GTPase activity; Golgi apparatus; plasma membrane; autophagy; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell junction organization; organelle; molecular function regulator activity
OG_02923,FUN_012009-T1,Peve_00016403,Pocillopora_meandrina_HIv1___RNAseq.g24030.t1,three_way,73.988,FUN_012009-T1,Q8IXU6,,,,,45.4,350.0,6.800000000000001e-74,279.3,sp|Q8IXU6|S35F2_HUMAN Solute carrier family 35 member F2 OS=Homo sapiens OX=9606 GN=SLC35F2 PE=1 SV=1,,,,,,
OG_02924,FUN_012011-T3,Peve_00016379,Pocillopora_meandrina_HIv1___RNAseq.g24033.t1,three_way,51.42816666666666,FUN_012011-T3,P15989,,,,,26.4,182.0,3e-06,54.7,sp|P15989|CO6A3_CHICK Collagen alpha-3(VI) chain OS=Gallus gallus OX=9031 GN=COL6A3 PE=2 SV=2,,,,,,
OG_02925,FUN_012012-T1,Peve_00030428,Pocillopora_meandrina_HIv1___RNAseq.g24037.t1,three_way,73.38199999999999,FUN_012012-T1,O95935,TBX18_HUMAN,,T-box transcription factor TBX18 (T-box protein 18),Homo sapiens (Human),53.3,336.0,3.9999999999999996e-86,320.1,sp|O95935|TBX18_HUMAN T-box transcription factor TBX18 OS=Homo sapiens OX=9606 GN=TBX18 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001708; GO:0001756; GO:0003163; GO:0005634; GO:0005654; GO:0006357; GO:0016331; GO:0021999; GO:0042803; GO:0045893; GO:0051145; GO:0060930; GO:0060931; GO:0072189; GO:0090090; GO:0090103; GO:0090571; GO:0098907; GO:1990837,cell fate specification [GO:0001708]; cochlea morphogenesis [GO:0090103]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural plate anterior/posterior regionalization [GO:0021999]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of SA node cell action potential [GO:0098907]; regulation of transcription by RNA polymerase II [GO:0006357]; sinoatrial node cell development [GO:0060931]; sinoatrial node cell fate commitment [GO:0060930]; sinoatrial node development [GO:0003163]; smooth muscle cell differentiation [GO:0051145]; somitogenesis [GO:0001756]; ureter development [GO:0072189],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription repressor complex [GO:0090571],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_02926,FUN_012013-T1,Peve_00030433,Pocillopora_meandrina_HIv1___RNAseq.g24039.t1,three_way,69.86566666666667,FUN_012013-T1,P32297,ACHA3_HUMAN,,Neuronal acetylcholine receptor subunit alpha-3,Homo sapiens (Human),33.8,547.0,1.2e-74,282.3,sp|P32297|ACHA3_HUMAN Neuronal acetylcholine receptor subunit alpha-3 OS=Homo sapiens OX=9606 GN=CHRNA3 PE=1 SV=4,GO:0005730; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005892; GO:0006811; GO:0006940; GO:0007165; GO:0007271; GO:0007274; GO:0007399; GO:0007626; GO:0014056; GO:0015276; GO:0015464; GO:0016020; GO:0016607; GO:0022848; GO:0030425; GO:0034220; GO:0034703; GO:0035094; GO:0035095; GO:0036064; GO:0042166; GO:0042391; GO:0043005; GO:0043025; GO:0043231; GO:0044853; GO:0045202; GO:0045211; GO:0048814; GO:0051899; GO:0060079; GO:0060084; GO:0095500; GO:0098878; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of smooth muscle contraction [GO:0006940]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; neurotransmitter receptor complex [GO:0098878]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine binding [GO:0042166]; acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005730; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; nucleolus; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; signaling; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_02927,FUN_012020-T1,Peve_00030377,Pocillopora_meandrina_HIv1___RNAseq.g24050.t1,three_way,58.77833333333333,FUN_012020-T1,Q5UAW9,GP157_HUMAN,,G-protein coupled receptor 157,Homo sapiens (Human),34.6,289.0,1.7e-39,164.9,sp|Q5UAW9|GP157_HUMAN G-protein coupled receptor 157 OS=Homo sapiens OX=9606 GN=GPR157 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0007200; GO:0048512; GO:0060019; GO:0060170,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; radial glial cell differentiation [GO:0060019],ciliary membrane [GO:0060170]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0030154; GO:0060089,plasma membrane; cell differentiation; molecular transducer activity
OG_02928,FUN_012021-T1,Peve_00030378,Pocillopora_meandrina_HIv1___RNAseq.g24048.t1,three_way,70.96433333333333,FUN_012021-T1,A7S5D9,IYD_NEMVE,,Iodotyrosine deiodinase (EC 1.21.1.1) (Halotyrosine dehalogenase),Nematostella vectensis (Starlet sea anemone),62.6,195.0,1.6999999999999999e-68,260.8,sp|A7S5D9|IYD_NEMVE Iodotyrosine deiodinase OS=Nematostella vectensis OX=45351 GN=v1g105379 PE=1 SV=1,GO:0005886; GO:0006570; GO:0010181; GO:0016491; GO:0140616,tyrosine metabolic process [GO:0006570],plasma membrane [GO:0005886],FMN binding [GO:0010181]; iodotyrosine deiodinase activity [GO:0140616]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005886; GO:0006520; GO:0016491,catalytic activity; plasma membrane; amino acid metabolic process; oxidoreductase activity
OG_02929,FUN_012028-T1,Peve_00030379,Pocillopora_meandrina_HIv1___RNAseq.g24047.t2,three_way,77.09433333333334,FUN_012028-T1,Q14192,FHL2_HUMAN,,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),Homo sapiens (Human),42.1,273.0,1.7000000000000002e-74,282.0,sp|Q14192|FHL2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3,GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885,atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018],bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_02930,FUN_012029-T1,Peve_00044958,Pocillopora_meandrina_HIv1___RNAseq.g24045.t1,three_way,82.663,FUN_012029-T1,P11533,,,,,29.7,3968.0,0.0,1575.5,sp|P11533|DMD_CHICK Dystrophin OS=Gallus gallus OX=9031 GN=DMD PE=2 SV=1,,,,,,
OG_02931,FUN_012032-T1,Peve_00037666,Pocillopora_meandrina_HIv1___RNAseq.g24056.t1,three_way,69.892,,,,,,,,,,,,,,,,,
OG_02932,FUN_012033-T1,Peve_00037665,Pocillopora_meandrina_HIv1___RNAseq.g24057.t1,three_way,77.83616666666667,FUN_012033-T1,Q5ZIN1,NUDC_CHICK,,Nuclear migration protein nudC (Nuclear distribution protein C homolog),Gallus gallus (Chicken),62.9,329.0,2.6e-77,290.4,sp|Q5ZIN1|NUDC_CHICK Nuclear migration protein nudC OS=Gallus gallus OX=9031 GN=NUDC PE=2 SV=1,GO:0005737; GO:0005874; GO:0006457; GO:0007052; GO:0007080; GO:0030496; GO:0051082; GO:0051301; GO:0072686,cell division [GO:0051301]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle organization [GO:0007052]; protein folding [GO:0006457],cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686],unfolded protein binding [GO:0051082],GO:0006457; GO:0007010; GO:0043226,protein folding; cytoskeleton organization; organelle
OG_02933,FUN_012034-T1,Peve_00008591,Pocillopora_meandrina_HIv1___RNAseq.g23629.t1,three_way,44.91766666666667,,,,,,,,,,,,,,,,,
OG_02934,FUN_012035-T1,Peve_00037664,Pocillopora_meandrina_HIv1___RNAseq.g24058.t1,three_way,60.38016666666667,FUN_012035-T1,Q29RT6,KI20A_BOVIN,,Kinesin-like protein KIF20A,Bos taurus (Bovine),35.5,843.0,4.8e-114,414.8,sp|Q29RT6|KI20A_BOVIN Kinesin-like protein KIF20A OS=Bos taurus OX=9913 GN=KIF20A PE=2 SV=1,GO:0000281; GO:0001578; GO:0003777; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005819; GO:0005871; GO:0005874; GO:0007018; GO:0008017; GO:0015031; GO:0016887; GO:0030496; GO:0032465; GO:0061952,microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465],cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0000910; GO:0003774; GO:0003824; GO:0005634; GO:0005794; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0061024; GO:0140657,cytokinesis; cytoskeletal motor activity; catalytic activity; nucleus; Golgi apparatus; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; membrane organization; ATP-dependent activity
OG_02935,FUN_012040-T1,Peve_00016079,Pocillopora_meandrina_HIv1___RNAseq.g24061.t1,three_way,58.10066666666667,,,,,,,,,,,,,,,,,
OG_02936,FUN_012041-T2,Peve_00016078,Pocillopora_meandrina_HIv1___RNAseq.g24062.t1,three_way,80.87033333333333,FUN_012041-T2,Q5TCS8,KAD9_HUMAN,,Adenylate kinase 9 (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2),Homo sapiens (Human),43.5,1918.0,0.0,1171.4,sp|Q5TCS8|KAD9_HUMAN Adenylate kinase 9 OS=Homo sapiens OX=9606 GN=AK9 PE=1 SV=2,GO:0004017; GO:0004127; GO:0004550; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006225; GO:0015630; GO:0016887; GO:0031514; GO:0031965; GO:0033862; GO:0036430; GO:0036431; GO:0046705; GO:0047506; GO:0050145,CDP biosynthetic process [GO:0046705]; UDP biosynthetic process [GO:0006225],cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],(d)CMP kinase activity [GO:0004127]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CMP kinase activity [GO:0036430]; dCMP kinase activity [GO:0036431]; deoxyadenylate kinase activity [GO:0047506]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; UMP kinase activity [GO:0033862],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005929; GO:0016740; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; cilium; transferase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02937,FUN_012044-T1,Peve_00013735,Pocillopora_meandrina_HIv1___RNAseq.g24064.t1,three_way,82.75833333333333,FUN_012044-T1,Q3T022,SAP18_BOVIN,,Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p18),Bos taurus (Bovine),64.5,141.0,1.1e-44,181.0,sp|Q3T022|SAP18_BOVIN Histone deacetylase complex subunit SAP18 OS=Bos taurus OX=9913 GN=SAP18 PE=2 SV=1,GO:0000381; GO:0003714; GO:0005634; GO:0005737; GO:0006397; GO:0008380; GO:0016607; GO:0043065; GO:0045892; GO:0048025; GO:0061574,"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0140110,nucleus; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_02938,FUN_012045-T1,Peve_00013736,Pocillopora_meandrina_HIv1___RNAseq.g23652.t1,three_way,86.85833333333333,FUN_012045-T1,O73770,,,,,41.0,183.0,2.4999999999999998e-31,137.1,sp|O73770|DGCR6_CHICK Protein DGCR6 OS=Gallus gallus OX=9031 GN=DGCR6 PE=2 SV=1,,,,,,
OG_02939,FUN_012046-T1,Peve_00013730,Pocillopora_meandrina_HIv1___TS.g16525.t1,three_way,75.98333333333333,FUN_012046-T1,Q9Y5B6,PAXB1_HUMAN,,PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1),Homo sapiens (Human),38.1,839.0,2.6e-119,431.4,sp|Q9Y5B6|PAXB1_HUMAN PAX3- and PAX7-binding protein 1 OS=Homo sapiens OX=9606 GN=PAXBP1 PE=1 SV=2,GO:0000398; GO:0003677; GO:0005634; GO:0005829; GO:0006366; GO:0007517; GO:0014842; GO:0045944; GO:1990226; GO:2000288,"mRNA splicing, via spliceosome [GO:0000398]; muscle organ development [GO:0007517]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; transcription by RNA polymerase II [GO:0006366]",cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone methyltransferase binding [GO:1990226],GO:0003677; GO:0005634; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0043226; GO:0048856,DNA binding; nucleus; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; organelle; anatomical structure development
OG_02940,FUN_012049-T1,Peve_00004088,Pocillopora_meandrina_HIv1___RNAseq.g23650.t3,three_way,68.88266666666667,FUN_012049-T1,E7EZG2,MY9AA_DANRE,,Unconventional myosin-IXAa (Myosin IXAa),Danio rerio (Zebrafish) (Brachydanio rerio),33.3,2215.0,4.1e-257,890.2,sp|E7EZG2|MY9AA_DANRE Unconventional myosin-IXAa OS=Danio rerio OX=7955 GN=myo9aa PE=3 SV=1,GO:0000146; GO:0005096; GO:0005524; GO:0005737; GO:0005884; GO:0007626; GO:0008270; GO:0016020; GO:0016459; GO:0035556; GO:0036269; GO:0044295; GO:0045198; GO:0045202; GO:0048675; GO:0051015; GO:0061564; GO:0098529,"axon development [GO:0061564]; axon extension [GO:0048675]; establishment of epithelial cell apical/basal polarity [GO:0045198]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; swimming behavior [GO:0036269]",actin filament [GO:0005884]; axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; membrane [GO:0016020]; myosin complex [GO:0016459]; synapse [GO:0045202],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; microfilament motor activity [GO:0000146]; zinc ion binding [GO:0008270],GO:0003774; GO:0003824; GO:0007163; GO:0008092; GO:0016853; GO:0030154; GO:0034330; GO:0098772; GO:0140657,cytoskeletal motor activity; catalytic activity; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; cell differentiation; cell junction organization; molecular function regulator activity; ATP-dependent activity
OG_02941,FUN_012050-T2,Peve_00004087,Pocillopora_meandrina_HIv1___RNAseq.g23649.t1,three_way,70.43433333333333,,,,,,,,,,,,,,,,,
OG_02942,FUN_012054-T3,Peve_00004085,Pocillopora_meandrina_HIv1___RNAseq.g23646.t1,three_way,73.15266666666666,FUN_012054-T3,Q7Z020,,,,,22.2,504.0,9.3e-26,120.9,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02943,FUN_012057-T1,Peve_00004082,Pocillopora_meandrina_HIv1___RNAseq.g23643.t1,three_way,60.314,FUN_012057-T1,Q8BLA8,TRPA1_MOUSE,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Mus musculus (Mouse),26.4,796.0,3.1e-39,165.2,sp|Q8BLA8|TRPA1_MOUSE Transient receptor potential cation channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Trpa1 PE=1 SV=1,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_02944,FUN_012058-T1,Peve_00004101,Pocillopora_meandrina_HIv1___RNAseq.g23641.t1,three_way,54.401,FUN_012058-T1,Q7Z020,,,,,28.9,662.0,1.1999999999999999e-46,190.3,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02945,FUN_012059-T1,Peve_00004100,Pocillopora_meandrina_HIv1___RNAseq.g23640.t1,three_way,57.582,,,,,,,,,,,,,,,,,
OG_02946,FUN_012060-T1,Peve_00004099,Pocillopora_meandrina_HIv1___RNAseq.g23639.t1,three_way,57.973,FUN_012060-T1,Q32PP9,,,,,53.0,83.0,1.2e-19,98.6,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_02947,FUN_012062-T1,Peve_00004098,Pocillopora_meandrina_HIv1___RNAseq.g23638.t1,three_way,41.775,,,,,,,,,,,,,,,,,
OG_02948,FUN_012066-T1,Peve_00004089,Pocillopora_meandrina_HIv1___RNAseq.g23637.t1,three_way,63.71233333333333,FUN_012066-T1,Q7Z020,,,,,25.4,562.0,7.2e-37,157.9,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02949,FUN_012067-T1,Peve_00004104,Pocillopora_meandrina_HIv1___RNAseq.g23636.t1,three_way,67.023,FUN_012067-T1,Q7Z020,,,,,28.6,553.0,9.3e-45,184.1,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02950,FUN_012068-T1,Peve_00004102,Pocillopora_meandrina_HIv1___RNAseq.g23635.t1,three_way,68.446,FUN_012068-T1,Q7Z020,,,,,26.3,578.0,1.1e-39,167.2,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_02951,FUN_012070-T1,Peve_00025863,Pocillopora_meandrina_HIv1___TS.g16508.t1,three_way,72.754,,,,,,,,,,,,,,,,,
OG_02952,FUN_012072-T1,Peve_00025864,Pocillopora_meandrina_HIv1___RNAseq.g23632.t1,three_way,87.756,FUN_012072-T1,Q32L77,CFA95_BOVIN,,Cilia- and flagella-associated protein 95,Bos taurus (Bovine),41.5,200.0,4.3e-36,152.9,sp|Q32L77|CFA95_BOVIN Cilia- and flagella-associated protein 95 OS=Bos taurus OX=9913 GN=CFAP95 PE=1 SV=1,GO:0005737; GO:0005879; GO:0005886; GO:0030317; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126],,GO:0005886; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,plasma membrane; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_02953,FUN_012073-T1,Peve_00025862,Pocillopora_meandrina_HIv1___TS.g16505.t2,three_way,61.68833333333333,FUN_012073-T1,Q3U3W5,ANM9_MOUSE,,Protein arginine N-methyltransferase 9 (Protein arginine N-methyltransferase 10) (EC 2.1.1.320),Mus musculus (Mouse),33.8,864.0,6.1e-123,443.4,sp|Q3U3W5|ANM9_MOUSE Protein arginine N-methyltransferase 9 OS=Mus musculus OX=10090 GN=Prmt9 PE=2 SV=2,GO:0005737; GO:0006397; GO:0016274; GO:0032259; GO:0035243,methylation [GO:0032259]; mRNA processing [GO:0006397],cytoplasm [GO:0005737],protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243],GO:0003824; GO:0016071; GO:0016740; GO:0140096,"catalytic activity; mRNA metabolic process; transferase activity; catalytic activity, acting on a protein"
OG_02954,FUN_012097-T1,Peve_00007422,Pocillopora_meandrina_HIv1___RNAseq.g23949.t1,three_way,67.32366666666667,FUN_012097-T1,A0A1W2P884,,,,,30.2,473.0,2.6e-15,85.5,sp|A0A1W2P884|CE85L_MOUSE Centrosomal protein of 85 kDa-like OS=Mus musculus OX=10090 GN=Cep85l PE=3 SV=1,,,,,,
OG_02955,FUN_012100-T1,Peve_00007424,Pocillopora_meandrina_HIv1___RNAseq.g23948.t1,three_way,81.48233333333333,FUN_012100-T1,B4F7A7,CEP57_RAT,,Centrosomal protein of 57 kDa (Cep57) (Translokin),Rattus norvegicus (Rat),36.2,447.0,2.8e-56,221.1,sp|B4F7A7|CEP57_RAT Centrosomal protein of 57 kDa OS=Rattus norvegicus OX=10116 GN=Cep57 PE=1 SV=2,GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0007286; GO:0008017; GO:0008543; GO:0017134; GO:0034451; GO:0042803; GO:0043015; GO:0051260,fibroblast growth factor receptor signaling pathway [GO:0008543]; protein homooligomerization [GO:0051260]; spermatid development [GO:0007286],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634],fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0005794; GO:0005815; GO:0005829; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0065003,nucleus; Golgi apparatus; microtubule organizing center; cytosol; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; protein-containing complex assembly
OG_02956,FUN_012101-T1,Peve_00007425,Pocillopora_meandrina_HIv1___TS.g16821.t1,three_way,77.79899999999999,FUN_012101-T1,Q6PF24,,,,,51.5,1000.0,2.2e-308,1059.7,"sp|Q6PF24|PREP_XENLA Presequence protease, mitochondrial OS=Xenopus laevis OX=8355 GN=pitrm1 PE=2 SV=1",,,,,,
OG_02957,FUN_012102-T1,Peve_00007426,Pocillopora_meandrina_HIv1___RNAseq.g23946.t1,three_way,60.24616666666667,FUN_012102-T1,P18956,GGT_ECOLI,,Glutathione hydrolase proenzyme (EC 3.4.19.13) (Gamma-glutamyltranspeptidase proenzyme) (GGT) (EC 2.3.2.2) [Cleaved into: Glutathione hydrolase large chain; Glutathione hydrolase small chain],Escherichia coli (strain K12),30.7,267.0,7.900000000000002e-22,107.5,sp|P18956|GGT_ECOLI Glutathione hydrolase proenzyme OS=Escherichia coli (strain K12) OX=83333 GN=ggt PE=1 SV=1,GO:0006750; GO:0006751; GO:0030288; GO:0034722; GO:0036374; GO:0042597; GO:0043102; GO:0097264; GO:0103068,amino acid salvage [GO:0043102]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; self proteolysis [GO:0097264],outer membrane-bounded periplasmic space [GO:0030288]; periplasmic space [GO:0042597],gamma-glutamyl-peptidase activity [GO:0034722]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068],GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0016740; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_02958,FUN_012103-T1,Peve_00007420,Pocillopora_meandrina_HIv1___TS.g16819.t1,three_way,55.96083333333333,FUN_012103-T1,B1WAS2,HUNK_XENTR,,Hormonally up-regulated neu tumor-associated kinase homolog (EC 2.7.11.1) (Serine/threonine-protein kinase MAK-V),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),41.5,135.0,5.5e-23,110.9,sp|B1WAS2|HUNK_XENTR Hormonally up-regulated neu tumor-associated kinase homolog OS=Xenopus tropicalis OX=8364 GN=hunk PE=2 SV=1,GO:0004674; GO:0005524; GO:0106310,,,ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_02959,FUN_012105-T1,Peve_00000984,Pocillopora_meandrina_HIv1___RNAseq.9341_t,three_way,72.279,,,,,,,,,,,,,,,,,
OG_02960,FUN_012106-T1,Peve_00029236,Pocillopora_meandrina_HIv1___RNAseq.g23936.t1,three_way,58.132666666666665,FUN_012106-T1,P78417,GSTO1_HUMAN,,Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R),Homo sapiens (Human),44.1,222.0,2.4e-45,183.7,sp|P78417|GSTO1_HUMAN Glutathione S-transferase omega-1 OS=Homo sapiens OX=9606 GN=GSTO1 PE=1 SV=2,GO:0004364; GO:0005737; GO:0005829; GO:0006749; GO:0010880; GO:0010881; GO:0014810; GO:0016491; GO:0019852; GO:0042178; GO:0045174; GO:0050610; GO:0051280; GO:0051281; GO:0070062; GO:0071243,cellular response to arsenic-containing substance [GO:0071243]; glutathione metabolic process [GO:0006749]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005829; GO:0005975; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0016740; GO:0043226,catalytic activity; cytosol; carbohydrate metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; transferase activity; organelle
OG_02961,FUN_012108-T1,Peve_00045237,Pocillopora_meandrina_HIv1___TS.g16812.t1,three_way,73.217,FUN_012108-T1,E1C2Z0,,,,,28.3,1249.0,3.4e-138,494.6,sp|E1C2Z0|MMS22_CHICK Protein MMS22-like OS=Gallus gallus OX=9031 GN=MMS22L PE=3 SV=1,,,,,,
OG_02962,FUN_012109-T1,Peve_00045236,Pocillopora_meandrina_HIv1___RNAseq.g23941.t1,three_way,81.87883333333333,FUN_012109-T1,O43390,,,,,62.4,388.0,5e-135,483.0,sp|O43390|HNRPR_HUMAN Heterogeneous nuclear ribonucleoprotein R OS=Homo sapiens OX=9606 GN=HNRNPR PE=1 SV=1,,,,,,
OG_02963,FUN_012113-T1,Peve_00045239,Pocillopora_meandrina_HIv1___RNAseq.g23944.t1,three_way,73.61,FUN_012113-T1,Q86U90,YRDC_HUMAN,,Threonylcarbamoyl-AMP synthase (EC 2.7.7.87) (Dopamine receptor-interacting protein 3) (Ischemia/reperfusion-inducible protein homolog) (hIRIP),Homo sapiens (Human),53.8,212.0,6.100000000000001e-57,222.2,sp|Q86U90|YRDC_HUMAN Threonylcarbamoyl-AMP synthase OS=Homo sapiens OX=9606 GN=YRDC PE=1 SV=1,GO:0000049; GO:0002949; GO:0003725; GO:0005737; GO:0005739; GO:0005886; GO:0006450; GO:0016779; GO:0051051; GO:0061710,negative regulation of transport [GO:0051051]; regulation of translational fidelity [GO:0006450]; tRNA threonylcarbamoyladenosine modification [GO:0002949],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],double-stranded RNA binding [GO:0003725]; L-threonylcarbamoyladenylate synthase [GO:0061710]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005739; GO:0005886; GO:0006399; GO:0016740; GO:0043226,RNA binding; catalytic activity; mitochondrion; plasma membrane; tRNA metabolic process; transferase activity; organelle
OG_02964,FUN_012118-T1,Peve_00001673,Pocillopora_meandrina_HIv1___RNAseq.g23934.t1,three_way,73.89166666666667,FUN_012118-T1,Q924W5,SMC6_MOUSE,,Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (mSMC6),Mus musculus (Mouse),40.5,1070.0,1.4e-188,661.8,sp|Q924W5|SMC6_MOUSE Structural maintenance of chromosomes protein 6 OS=Mus musculus OX=10090 GN=Smc6 PE=1 SV=1,GO:0000217; GO:0000722; GO:0000775; GO:0000781; GO:0000803; GO:0005524; GO:0005634; GO:0006302; GO:0006974; GO:0016605; GO:0016607; GO:0016887; GO:0030915; GO:0031625; GO:0035061; GO:0035861; GO:0044828; GO:0051984; GO:0090398; GO:0097431,cellular senescence [GO:0090398]; DNA damage response [GO:0006974]; double-strand break repair [GO:0006302]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of chromosome segregation [GO:0051984]; telomere maintenance via recombination [GO:0000722],"chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; interchromatin granule [GO:0035061]; mitotic spindle pole [GO:0097431]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; sex chromosome [GO:0000803]; site of double-strand break [GO:0035861]; Smc5-Smc6 complex [GO:0030915]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA secondary structure binding [GO:0000217]; ubiquitin protein ligase binding [GO:0031625],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0006310; GO:0016787; GO:0032200; GO:0043226,DNA binding; catalytic activity; nucleus; chromosome; DNA repair; DNA recombination; hydrolase activity; telomere organization; organelle
OG_02965,FUN_012119-T2,Peve_00035451,Pocillopora_meandrina_HIv1___RNAseq.g23933.t1,three_way,52.12533333333333,,,,,,,,,,,,,,,,,
OG_02966,FUN_012120-T1,Peve_00035447,Pocillopora_meandrina_HIv1___TS.g16803.t2,three_way,75.527,FUN_012120-T1,Q8VIH3,S28A3_RAT,,Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (rCNT3),Rattus norvegicus (Rat),47.3,499.0,1.3e-119,431.8,sp|Q8VIH3|S28A3_RAT Solute carrier family 28 member 3 OS=Rattus norvegicus OX=10116 GN=Slc28a3 PE=2 SV=1,GO:0001895; GO:0005886; GO:0015213; GO:0015389; GO:0015390; GO:0015860; GO:0015862; GO:0015864; GO:0031526; GO:0072531; GO:1901642,nucleoside transmembrane transport [GO:1901642]; purine nucleoside transmembrane transport [GO:0015860]; pyrimidine nucleoside transport [GO:0015864]; pyrimidine-containing compound transmembrane transport [GO:0072531]; retina homeostasis [GO:0001895]; uridine transmembrane transport [GO:0015862],brush border membrane [GO:0031526]; plasma membrane [GO:0005886],purine-specific nucleoside:sodium symporter activity [GO:0015390]; pyrimidine- and adenosine-specific:sodium symporter activity [GO:0015389]; uridine transmembrane transporter activity [GO:0015213],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_02967,FUN_012126-T1,Peve_00035474,Pocillopora_meandrina_HIv1___RNAseq.g23920.t1,three_way,60.626333333333335,FUN_012126-T1,B3EWY9,,,,,38.6,166.0,3.9999999999999994e-28,128.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02968,FUN_012130-T1,Peve_00035469,Pocillopora_meandrina_HIv1___RNAseq.g23786.t1,three_way,43.8205,FUN_012130-T1,Q5R7K9,,,,,32.1,156.0,7.5e-10,66.6,sp|Q5R7K9|EDIL3_PONAB EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Pongo abelii OX=9601 GN=EDIL3 PE=2 SV=1,,,,,,
OG_02969,FUN_012132-T1,Peve_00035465,Pocillopora_meandrina_HIv1___RNAseq.g23782.t1,three_way,56.359,FUN_012132-T1,Q07113,MPRI_MOUSE,,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),Mus musculus (Mouse),30.7,2462.0,7.5e-280,966.1,sp|Q07113|MPRI_MOUSE Cation-independent mannose-6-phosphate receptor OS=Mus musculus OX=10090 GN=Igf2r PE=1 SV=1,GO:0000139; GO:0001889; GO:0001965; GO:0001972; GO:0005520; GO:0005537; GO:0005615; GO:0005634; GO:0005641; GO:0005768; GO:0005769; GO:0005770; GO:0005802; GO:0007041; GO:0007186; GO:0007283; GO:0009791; GO:0009986; GO:0010008; GO:0016020; GO:0019899; GO:0030118; GO:0030139; GO:0030140; GO:0031100; GO:0031995; GO:0032526; GO:0038023; GO:0042802; GO:0043065; GO:0044794; GO:0048471; GO:0051219; GO:1904772; GO:1905394,animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; positive regulation by host of viral process [GO:0044794]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; response to retinoic acid [GO:0032526]; response to tetrachloromethane [GO:1904772]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; clathrin coat [GO:0030118]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; late endosome [GO:0005770]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140],D-mannose binding [GO:0005537]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; retromer complex binding [GO:1905394]; signaling receptor activity [GO:0038023],GO:0005615; GO:0005634; GO:0005768; GO:0008289; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060089,extracellular space; nucleus; endosome; lipid binding; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular transducer activity
OG_02970,FUN_012133-T1,Peve_00035464,Pocillopora_meandrina_HIv1___RNAseq.g23781.t1,three_way,49.23333333333333,,,,,,,,,,,,,,,,,
OG_02971,FUN_012134-T1,Peve_00035463,Pocillopora_meandrina_HIv1___RNAseq.g23780.t2,three_way,75.01566666666668,FUN_012134-T1,Q32L92,CNN3_BOVIN,,"Calponin-3 (Calponin, acidic isoform)",Bos taurus (Bovine),36.9,130.0,1.5e-15,84.0,sp|Q32L92|CNN3_BOVIN Calponin-3 OS=Bos taurus OX=9913 GN=CNN3 PE=2 SV=1,GO:0005516; GO:0007015; GO:0008017; GO:0015629; GO:0031032; GO:0051015,actin filament organization [GO:0007015]; actomyosin structure organization [GO:0031032],actin cytoskeleton [GO:0015629],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_02972,FUN_012136-T1,Peve_00035460,Pocillopora_meandrina_HIv1___RNAseq.g23778.t1,three_way,82.50333333333333,FUN_012136-T1,Q5XFX0,,,,,41.0,200.0,5.1e-33,142.5,sp|Q5XFX0|TAGL2_RAT Transgelin-2 OS=Rattus norvegicus OX=10116 GN=Tagln2 PE=1 SV=1,,,,,,
OG_02973,FUN_012138-T1,Peve_00035457,Pocillopora_meandrina_HIv1___RNAseq.g23776.t1,three_way,70.50333333333333,FUN_012138-T1,Q8NCR3,,,,,42.0,255.0,1.2e-51,205.7,sp|Q8NCR3|MFI_HUMAN Protein MFI OS=Homo sapiens OX=9606 GN=MFI PE=1 SV=1,,,,,,
OG_02974,FUN_012139-T1,Peve_00001103,Pocillopora_meandrina_HIv1___RNAseq.g23864.t3,three_way,77.9845,FUN_012139-T1,Q8N7X0,ADGB_HUMAN,,Androglobin,Homo sapiens (Human),29.8,1939.0,1.4e-185,652.5,sp|Q8N7X0|ADGB_HUMAN Androglobin OS=Homo sapiens OX=9606 GN=ADGB PE=1 SV=3,GO:0004198; GO:0006508; GO:0007286; GO:0019825; GO:0020037; GO:0046872; GO:0097225; GO:0097227,proteolysis [GO:0006508]; spermatid development [GO:0007286],sperm annulus [GO:0097227]; sperm midpiece [GO:0097225],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825],GO:0003824; GO:0016787; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; hydrolase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_02975,FUN_012141-T1,Peve_00001102,Pocillopora_meandrina_HIv1___RNAseq.9491_t,three_way,51.589,,,,,,,,,,,,,,,,,
OG_02976,FUN_012142-T1,Peve_00001101,Pocillopora_meandrina_HIv1___RNAseq.g23866.t1,three_way,57.71,,,,,,,,,,,,,,,,,
OG_02977,FUN_012144-T1,Peve_00035455,Pocillopora_meandrina_HIv1___RNAseq.g23870.t1,three_way,72.23966666666666,FUN_012144-T1,Q9GRC0,,,,,46.6,268.0,2.6e-56,220.7,sp|Q9GRC0|MOS_PATPE Serine/threonine-protein kinase mos OS=Patiria pectinifera OX=7594 GN=mos PE=1 SV=1,,,,,,
OG_02978,FUN_012145-T1,Peve_00033299,Pocillopora_meandrina_HIv1___RNAseq.g23871.t1,three_way,72.78233333333333,FUN_012145-T1,Q9Y6R4,M3K4_HUMAN,,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),Homo sapiens (Human),35.0,1732.0,4.6e-247,856.7,sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2,GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745,chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_02979,FUN_012146-T1,Peve_00035472,Pocillopora_meandrina_HIv1___RNAseq.g23770.t1,three_way,61.387166666666666,FUN_012146-T1,A4IHY1,,,,,27.7,253.0,1.4000000000000002e-23,111.7,sp|A4IHY1|PSMG1_XENTR Proteasome assembly chaperone 1 OS=Xenopus tropicalis OX=8364 GN=psmg1 PE=2 SV=1,,,,,,
OG_02980,FUN_012150-T1,Peve_00035454,Pocillopora_meandrina_HIv1___RNAseq.9397_t,three_way,84.231,FUN_012150-T1,Q00796,DHSO_HUMAN,,"Sorbitol dehydrogenase (SDH) (EC 1.1.1.-) ((R,R)-butanediol dehydrogenase) (EC 1.1.1.4) (L-iditol 2-dehydrogenase) (EC 1.1.1.14) (Polyol dehydrogenase) (Ribitol dehydrogenase) (RDH) (EC 1.1.1.56) (Xylitol dehydrogenase) (XDH) (EC 1.1.1.9)",Homo sapiens (Human),58.6,263.0,1.2e-85,317.8,sp|Q00796|DHSO_HUMAN Sorbitol dehydrogenase OS=Homo sapiens OX=9606 GN=SORD PE=1 SV=4,GO:0000721; GO:0003939; GO:0005615; GO:0005829; GO:0006006; GO:0006062; GO:0008270; GO:0016020; GO:0019640; GO:0030246; GO:0030317; GO:0031514; GO:0031966; GO:0042802; GO:0046370; GO:0046526; GO:0047833; GO:0050255; GO:0051160; GO:0051164; GO:0051287; GO:0070062,D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; glucose metabolic process [GO:0006006]; sorbitol catabolic process [GO:0006062]; xylitol catabolic process [GO:0051160]; xylitol metabolic process [GO:0051164],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514],"(R,R)-butanediol dehydrogenase activity [GO:0000721]; carbohydrate binding [GO:0030246]; D-sorbitol dehydrogenase (acceptor) activity [GO:0047833]; D-xylulose reductase activity [GO:0046526]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase (NAD+) activity [GO:0003939]; NAD binding [GO:0051287]; ribitol 2-dehydrogenase (NAD+) activity [GO:0050255]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005615; GO:0005829; GO:0005929; GO:0005975; GO:0007018; GO:0016491; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; extracellular space; cytosol; cilium; carbohydrate metabolic process; microtubule-based movement; oxidoreductase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_02981,FUN_012151-T1,Peve_00035456,Pocillopora_meandrina_HIv1___RNAseq.g23773.t1,three_way,68.10066666666667,FUN_012151-T1,Q91W96,,,,,33.8,769.0,1.4999999999999999e-92,342.4,sp|Q91W96|APC4_MOUSE Anaphase-promoting complex subunit 4 OS=Mus musculus OX=10090 GN=Anapc4 PE=1 SV=1,,,,,,
OG_02982,FUN_012152-T1,Peve_00035458,Pocillopora_meandrina_HIv1___TS.g16648.t1,three_way,75.35416666666667,FUN_012152-T1,Q8NEN0,,,,,32.3,885.0,5.2e-117,423.7,sp|Q8NEN0|ARMC2_HUMAN Armadillo repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=ARMC2 PE=1 SV=4,,,,,,
OG_02983,FUN_012153-T1,Peve_00040788,Pocillopora_meandrina_HIv1___RNAseq.g23437.t1,three_way,74.26066666666667,FUN_012153-T1,Q5EA89,,,,,36.4,308.0,8e-20,99.4,sp|Q5EA89|FA76A_BOVIN Protein FAM76A OS=Bos taurus OX=9913 GN=FAM76A PE=2 SV=1,,,,,,
OG_02984,FUN_012154-T1,Peve_00040790,Pocillopora_meandrina_HIv1___RNAseq.g23436.t1,three_way,76.696,,,,,,,,,,,,,,,,,
OG_02985,FUN_012155-T1,Peve_00040791,Pocillopora_meandrina_HIv1___RNAseq.g23435.t1,three_way,55.4285,FUN_012155-T1,E7FA21,,,,,24.2,854.0,6.6e-38,161.0,sp|E7FA21|SMR8A_DANRE Guanine nucleotide exchange protein smcr8a OS=Danio rerio OX=7955 GN=smcr8a PE=3 SV=1,,,,,,
OG_02986,FUN_012156-T1,Peve_00040786,Pocillopora_meandrina_HIv1___RNAseq.g23443.t3,three_way,55.64566666666666,FUN_012156-T1,Q2PFX0,,,,,47.5,524.0,3.5000000000000007e-118,426.8,sp|Q2PFX0|ATE1_MACFA Arginyl-tRNA--protein transferase 1 OS=Macaca fascicularis OX=9541 GN=ATE1 PE=2 SV=1,,,,,,
OG_02987,FUN_012159-T1,Peve_00040785,Pocillopora_meandrina_HIv1___RNAseq.g23444.t1,three_way,81.69933333333333,FUN_012159-T1,Q6DGJ3,,,,,64.5,93.0,6e-25,114.8,sp|Q6DGJ3|TIM13_DANRE Mitochondrial import inner membrane translocase subunit Tim13 OS=Danio rerio OX=7955 GN=timm13 PE=3 SV=1,,,,,,
OG_02988,FUN_012160-T1,Peve_00040793,Pocillopora_meandrina_HIv1___RNAseq.g23445.t1,three_way,80.09966666666666,FUN_012160-T1,O09173,HGD_MOUSE,,"Homogentisate 1,2-dioxygenase (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",Mus musculus (Mouse),70.1,431.0,3.9e-190,665.6,"sp|O09173|HGD_MOUSE Homogentisate 1,2-dioxygenase OS=Mus musculus OX=10090 GN=Hgd PE=1 SV=2",GO:0004411; GO:0006520; GO:0006559; GO:0006572; GO:0042802; GO:0046872,amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],,"homogentisate 1,2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]",GO:0003824; GO:0006520; GO:0016491,catalytic activity; amino acid metabolic process; oxidoreductase activity
OG_02989,FUN_012161-T1,Peve_00008621,Pocillopora_meandrina_HIv1___TS.g16331.t1,three_way,59.656,,,,,,,,,,,,,,,,,
OG_02990,FUN_012166-T1,Peve_00008632,Pocillopora_meandrina_HIv1___RNAseq.g23449.t1,three_way,81.14583333333333,FUN_012166-T1,Q9HU55,,,,,37.2,78.0,2.7e-11,71.6,sp|Q9HU55|GLRX_PSEAE Glutaredoxin OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=grx PE=3 SV=1,,,,,,
OG_02991,FUN_012167-T1,Peve_00034816,Pocillopora_meandrina_HIv1___RNAseq.g23450.t1,three_way,80.72966666666667,FUN_012167-T1,Q5M9P8,ARL6_DANRE,,ADP-ribosylation factor-like protein 6,Danio rerio (Zebrafish) (Brachydanio rerio),70.7,184.0,2.5e-74,279.6,sp|Q5M9P8|ARL6_DANRE ADP-ribosylation factor-like protein 6 OS=Danio rerio OX=7955 GN=arl6 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005737; GO:0005930; GO:0006886; GO:0007368; GO:0007369; GO:0007601; GO:0008593; GO:0016192; GO:0032402; GO:0033339; GO:0046872; GO:0060170; GO:0060271; GO:0061512; GO:0070121,cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular protein transport [GO:0006886]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pectoral fin development [GO:0033339]; protein localization to cilium [GO:0061512]; regulation of Notch signaling pathway [GO:0008593]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0003824; GO:0003924; GO:0006886; GO:0016192; GO:0016787; GO:0044782; GO:0048856; GO:0050877,catalytic activity; GTPase activity; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cilium organization; anatomical structure development; nervous system process
OG_02992,FUN_012168-T1,Peve_00008634,Pocillopora_meandrina_HIv1___RNAseq.g23451.t1,three_way,70.15,FUN_012168-T1,Q8WV93,AFG1L_HUMAN,,AFG1-like ATPase (Lactation elevated protein 1) (EC 3.6.-.-) (Protein AFG1 homolog),Homo sapiens (Human),50.5,289.0,2.5000000000000003e-78,293.9,sp|Q8WV93|AFG1L_HUMAN AFG1-like ATPase OS=Homo sapiens OX=9606 GN=AFG1L PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0007005; GO:0016887; GO:0031966; GO:0035694; GO:0141164,mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein quality control [GO:0141164]; mitochondrion organization [GO:0007005],cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0043226,catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; organelle
OG_02993,FUN_012169-T1,Peve_00008636,Pocillopora_meandrina_HIv1___RNAseq.g23452.t1,three_way,71.68166666666667,,,,,,,,,,,,,,,,,
OG_02994,FUN_012170-T1,Peve_00008637,Pocillopora_meandrina_HIv1___RNAseq.g23453.t1,three_way,85.069,FUN_012170-T1,P08559,ODPA_HUMAN,,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)",Homo sapiens (Human),58.4,389.0,1.4e-133,477.6,"sp|P08559|ODPA_HUMAN Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial OS=Homo sapiens OX=9606 GN=PDHA1 PE=1 SV=3",GO:0004739; GO:0005634; GO:0005730; GO:0005739; GO:0005759; GO:0006006; GO:0006086; GO:0006099; GO:0034604; GO:0045254; GO:0046872,glucose metabolic process [GO:0006006]; pyruvate decarboxylation to acetyl-CoA [GO:0006086]; tricarboxylic acid cycle [GO:0006099],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; pyruvate dehydrogenase complex [GO:0045254],metal ion binding [GO:0046872]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604],GO:0003824; GO:0005634; GO:0005730; GO:0005739; GO:0005975; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; nucleus; nucleolus; mitochondrion; carbohydrate metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_02995,FUN_012171-T1,Peve_00008639,Pocillopora_meandrina_HIv1___RNAseq.g23454.t1,three_way,61.8345,FUN_012171-T1,Q9R0Q1,SYTL4_MOUSE,,Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin),Mus musculus (Mouse),27.0,880.0,4.1e-66,254.6,sp|Q9R0Q1|SYTL4_MOUSE Synaptotagmin-like protein 4 OS=Mus musculus OX=10090 GN=Sytl4 PE=1 SV=1,GO:0001778; GO:0005543; GO:0005768; GO:0005886; GO:0006886; GO:0006887; GO:0008270; GO:0030073; GO:0030141; GO:0030658; GO:0031267; GO:0032418; GO:0042043; GO:0045921; GO:0046676; GO:0050714; GO:0071985; GO:1905684,exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684],endosome [GO:0005768]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; transport vesicle membrane [GO:0030658],neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0005768; GO:0005886; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; plasma membrane; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_02996,FUN_012175-T1,Peve_00026930,Pocillopora_meandrina_HIv1___RNAseq.g23456.t1,three_way,70.13366666666667,,,,,,,,,,,,,,,,,
OG_02997,FUN_012176-T1,Peve_00040994,Pocillopora_meandrina_HIv1___RNAseq.g23858.t1,three_way,63.23466666666666,FUN_012176-T1,Q709C8,VP13C_HUMAN,,Intermembrane lipid transfer protein VPS13C (Vacuolar protein sorting-associated protein 13C),Homo sapiens (Human),24.7,4222.0,0.0,1083.2,sp|Q709C8|VP13C_HUMAN Intermembrane lipid transfer protein VPS13C OS=Homo sapiens OX=9606 GN=VPS13C PE=1 SV=1,GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005770; GO:0005789; GO:0005811; GO:0005829; GO:0006623; GO:0006869; GO:0006895; GO:0007005; GO:0031902; GO:0032127; GO:0032868; GO:0045053; GO:0070062; GO:1905090,Golgi to endosome transport [GO:0006895]; lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; negative regulation of type 2 mitophagy [GO:1905090]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; response to insulin [GO:0032868],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense core granule membrane [GO:0032127]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitochondrial outer membrane [GO:0005741],,GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0006886; GO:0007005; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; lipid droplet; cytosol; intracellular protein transport; mitochondrion organization; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_02998,FUN_012177-T1,Peve_00040996,Pocillopora_meandrina_HIv1___RNAseq.g23859.t1,three_way,91.90766666666669,FUN_012177-T1,P18654,KS6A3_MOUSE,,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),Mus musculus (Mouse),67.4,742.0,1e-291,1003.8,sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus OX=10090 GN=Rps6ka3 PE=1 SV=2,GO:0000287; GO:0002224; GO:0004674; GO:0005524; GO:0005654; GO:0005730; GO:0005829; GO:0019901; GO:0032496; GO:0035556; GO:0043066; GO:0045944; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_02999,FUN_012178-T1,Peve_00040999,Pocillopora_meandrina_HIv1___RNAseq.g23862.t1,three_way,94.48333333333332,FUN_012178-T1,Q7ZTY4,,,,,88.7,424.0,2.9e-198,692.6,sp|Q7ZTY4|RBBP7_DANRE Histone-binding protein RBBP7 OS=Danio rerio OX=7955 GN=rbbp7 PE=2 SV=1,,,,,,
OG_03000,FUN_012179-T1,Peve_00001104,Pocillopora_meandrina_HIv1___RNAseq.g23863.t1,three_way,61.80133333333333,FUN_012179-T1,Q61503,5NTD_MOUSE,,5'-nucleotidase (5'-NT) (EC 3.1.3.35) (EC 3.1.3.5) (EC 3.1.3.89) (EC 3.1.3.91) (EC 3.1.3.99) (5'-deoxynucleotidase) (Ecto-5'-nucleotidase) (IMP-specific 5'-nucleotidase) (Thymidylate 5'-phosphatase) (CD antigen CD73),Mus musculus (Mouse),44.1,535.0,7.7e-125,449.1,sp|Q61503|5NTD_MOUSE 5'-nucleotidase OS=Mus musculus OX=10090 GN=Nt5e PE=1 SV=2,GO:0000166; GO:0002953; GO:0005654; GO:0005829; GO:0005886; GO:0006196; GO:0007159; GO:0008253; GO:0008270; GO:0009897; GO:0016020; GO:0033198; GO:0042802; GO:0046032; GO:0046034; GO:0046086; GO:0050340; GO:0050483; GO:0050484; GO:0050728; GO:0055074; GO:0140928,adenosine biosynthetic process [GO:0046086]; ADP catabolic process [GO:0046032]; AMP catabolic process [GO:0006196]; ATP metabolic process [GO:0046034]; calcium ion homeostasis [GO:0055074]; inhibition of non-skeletal tissue mineralization [GO:0140928]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of inflammatory response [GO:0050728]; response to ATP [GO:0033198],cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],5'-deoxynucleotidase activity [GO:0002953]; 5'-nucleotidase activity [GO:0008253]; GMP 5'-nucleotidase activity [GO:0050484]; identical protein binding [GO:0042802]; IMP 5'-nucleotidase activity [GO:0050483]; nucleotide binding [GO:0000166]; thymidylate 5'-phosphatase activity [GO:0050340]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0005886; GO:0007155; GO:0016787; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; plasma membrane; cell adhesion; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03001,FUN_012180-T1,Peve_00020513,Pocillopora_meandrina_HIv1___RNAseq.g23512.t1,three_way,61.40383333333333,FUN_012180-T1,J9HGJ1,,,,,34.1,88.0,9.7e-08,59.3,sp|J9HGJ1|LTRIN_AEDAE Lymphotoxin beta receptor inhibitor OS=Aedes aegypti OX=7159 GN=AaeL_AAEL017253 PE=1 SV=1,,,,,,
OG_03002,FUN_012186-T1,Peve_00027770,Pocillopora_meandrina_HIv1___RNAseq.g23458.t1,three_way,82.305,FUN_012186-T1,Q9Z0V5,PRDX4_RAT,,Peroxiredoxin-4 (EC 1.11.1.24) (Antioxidant enzyme AOE372) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372) (Thioredoxin-dependent peroxiredoxin 4),Rattus norvegicus (Rat),71.4,245.0,1.3e-97,357.5,sp|Q9Z0V5|PRDX4_RAT Peroxiredoxin-4 OS=Rattus norvegicus OX=10116 GN=Prdx4 PE=2 SV=1,GO:0005615; GO:0005737; GO:0005783; GO:0005790; GO:0005829; GO:0006979; GO:0007283; GO:0008379; GO:0008584; GO:0030198; GO:0042744; GO:0042802; GO:0045454; GO:0060090; GO:0072593; GO:0140313; GO:2000255,cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; smooth endoplasmic reticulum [GO:0005790],identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; molecular sequestering activity [GO:0140313]; thioredoxin peroxidase activity [GO:0008379],GO:0003824; GO:0005615; GO:0005783; GO:0005829; GO:0016209; GO:0016491; GO:0022414; GO:0030198; GO:0043226; GO:0048856; GO:0060090; GO:0140313,catalytic activity; extracellular space; endoplasmic reticulum; cytosol; antioxidant activity; oxidoreductase activity; reproductive process; extracellular matrix organization; organelle; anatomical structure development; molecular adaptor activity; molecular sequestering activity
OG_03003,FUN_012187-T2,Peve_00027771,Pocillopora_meandrina_HIv1___RNAseq.g23457.t1,three_way,57.22,,,,,,,,,,,,,,,,,
OG_03004,FUN_012192-T1,Peve_00013741,Pocillopora_meandrina_HIv1___RNAseq.g23419.t1,three_way,64.87933333333334,FUN_012192-T1,Q9NFP5,,,,,41.6,101.0,5.9e-11,68.2,sp|Q9NFP5|SH3BG_DROME SH3 domain-binding glutamic acid-rich protein homolog OS=Drosophila melanogaster OX=7227 GN=Sh3beta PE=1 SV=2,,,,,,
OG_03005,FUN_012193-T1,Peve_00013740,Pocillopora_meandrina_HIv1___RNAseq.g23420.t1,three_way,60.66016666666667,FUN_012193-T1,Q91VW3,,,,,44.8,87.0,1.9e-17,89.7,sp|Q91VW3|SH3L3_MOUSE SH3 domain-binding glutamic acid-rich-like protein 3 OS=Mus musculus OX=10090 GN=Sh3bgrl3 PE=1 SV=1,,,,,,
OG_03006,FUN_012194-T1,Peve_00013739,Pocillopora_meandrina_HIv1___RNAseq.g23421.t2,three_way,77.17933333333333,FUN_012194-T1,Q6NYU7,,,,,59.0,249.0,1.1e-77,291.2,sp|Q6NYU7|UPP_DANRE Uracil phosphoribosyltransferase homolog OS=Danio rerio OX=7955 GN=uprt PE=2 SV=1,,,,,,
OG_03007,FUN_012213-T1,Peve_00005378,Pocillopora_meandrina_HIv1___RNAseq.g23428.t1,three_way,70.069,,,,,,,,,,,,,,,,,
OG_03008,FUN_012217-T1,Peve_00005368,Pocillopora_meandrina_HIv1___RNAseq.g23434.t1,three_way,65.92999999999999,,,,,,,,,,,,,,,,,
OG_03009,FUN_012218-T1,Peve_00005373,Pocillopora_meandrina_HIv1___TS.g16318.t1,three_way,65.238,FUN_012218-T1,Q008S8,,,,,35.3,405.0,6.800000000000001e-58,226.5,sp|Q008S8|ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens OX=9606 GN=ECT2L PE=1 SV=2,,,,,,
OG_03010,FUN_012223-T1,Peve_00036373,Pocillopora_meandrina_HIv1___RNAseq.g23540.t1,three_way,64.77566666666667,FUN_012223-T1,Q8N3L3,TXLNB_HUMAN,,Beta-taxilin (Muscle-derived protein 77) (hMDP77),Homo sapiens (Human),37.5,341.0,1.3999999999999999e-24,116.3,sp|Q8N3L3|TXLNB_HUMAN Beta-taxilin OS=Homo sapiens OX=9606 GN=TXLNB PE=1 SV=3,GO:0005737; GO:0019905,,cytoplasm [GO:0005737],syntaxin binding [GO:0019905],,
OG_03011,FUN_012229-T2,Peve_00020576,Pocillopora_meandrina_HIv1___TS.g16417.t1,three_way,92.94133333333332,FUN_012229-T2,Q9TTF0,,,,,47.9,378.0,1.1e-92,341.7,sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2,,,,,,
OG_03012,FUN_012231-T1,Peve_00020571,Pocillopora_meandrina_HIv1___RNAseq.g23534.t1,three_way,91.59733333333332,FUN_012231-T1,Q9TTF0,,,,,43.9,305.0,1.1e-58,228.4,sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2,,,,,,
OG_03013,FUN_012233-T1,Peve_00020570,Pocillopora_meandrina_HIv1___RNAseq.g23532.t1,three_way,77.52283333333334,FUN_012233-T1,Q1WG82,ZGLP1_MOUSE,,GATA-type zinc finger protein 1 (GATA-like protein 1) (GLP-1),Mus musculus (Mouse),51.1,88.0,2.1e-17,91.3,sp|Q1WG82|ZGLP1_MOUSE GATA-type zinc finger protein 1 OS=Mus musculus OX=10090 GN=Zglp1 PE=2 SV=1,GO:0000122; GO:0000981; GO:0005634; GO:0007283; GO:0008270; GO:0043565; GO:0045944; GO:0048599,negative regulation of transcription by RNA polymerase II [GO:0000122]; oocyte development [GO:0048599]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_03014,FUN_012234-T1,Peve_00020569,Pocillopora_meandrina_HIv1___RNAseq.g23531.t1,three_way,78.257,FUN_012234-T1,Q2TA00,,,,,27.3,359.0,1.6e-28,128.6,sp|Q2TA00|CCD83_BOVIN Coiled-coil domain-containing protein 83 OS=Bos taurus OX=9913 GN=CCDC83 PE=2 SV=1,,,,,,
OG_03015,FUN_012235-T1,Peve_00020568,Pocillopora_meandrina_HIv1___RNAseq.g23530.t1,three_way,93.81266666666666,FUN_012235-T1,Q9UMY4,,,,,74.2,155.0,6e-67,255.0,sp|Q9UMY4|SNX12_HUMAN Sorting nexin-12 OS=Homo sapiens OX=9606 GN=SNX12 PE=1 SV=4,,,,,,
OG_03016,FUN_012236-T1,Peve_00020567,Pocillopora_meandrina_HIv1___RNAseq.g23529.t1,three_way,64.901,FUN_012236-T1,Q75AE1,,,,,28.7,394.0,3.8999999999999995e-28,127.9,sp|Q75AE1|ROK1_EREGS ATP-dependent RNA helicase ROK1 OS=Eremothecium gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=ROK1 PE=3 SV=1,,,,,,
OG_03017,FUN_012237-T1,Peve_00020565,Pocillopora_meandrina_HIv1___TS.g16409.t1,three_way,77.12433333333334,FUN_012237-T1,P52649,,,,,48.8,562.0,8.6e-150,531.9,sp|P52649|CY24B_PIG NADPH oxidase 2 OS=Sus scrofa OX=9823 GN=CYBB PE=2 SV=3,,,,,,
OG_03018,FUN_012238-T1,Peve_00020585,Pocillopora_meandrina_HIv1___RNAseq.g23526.t1,three_way,78.7625,FUN_012238-T1,Q8BIQ5,,,,,69.3,215.0,1.0000000000000001e-71,272.7,sp|Q8BIQ5|CSTF2_MOUSE Cleavage stimulation factor subunit 2 OS=Mus musculus OX=10090 GN=Cstf2 PE=1 SV=2,,,,,,
OG_03018,FUN_012238-T1,Peve_00020585,Pocillopora_meandrina_HIv1___RNAseq.g23526.t1,three_way,78.7625,FUN_012238-T1,Q8BIQ5,,,,,73.3,45.0,2.1e-08,62.4,sp|Q8BIQ5|CSTF2_MOUSE Cleavage stimulation factor subunit 2 OS=Mus musculus OX=10090 GN=Cstf2 PE=1 SV=2,,,,,,
OG_03019,FUN_012239-T1,Peve_00020584,Pocillopora_meandrina_HIv1___TS.g16406.t3,three_way,55.63166666666667,FUN_012239-T1,Q8BGT0,OSTM1_MOUSE,,Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit) (Grey-lethal protein),Mus musculus (Mouse),27.2,239.0,1.4e-20,101.7,sp|Q8BGT0|OSTM1_MOUSE Osteopetrosis-associated transmembrane protein 1 OS=Mus musculus OX=10090 GN=Ostm1 PE=1 SV=1,GO:0005765; GO:0005829; GO:0030316; GO:0030321; GO:0034707,osteoclast differentiation [GO:0030316]; transepithelial chloride transport [GO:0030321],chloride channel complex [GO:0034707]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765],,GO:0005829; GO:0030154,cytosol; cell differentiation
OG_03020,FUN_012240-T1,Peve_00020563,Pocillopora_meandrina_HIv1___TS.g16404.t1,three_way,71.79433333333333,FUN_012240-T1,Q7XJJ7,,,,,38.9,525.0,8.899999999999999e-92,339.3,sp|Q7XJJ7|FAAH_ARATH Fatty acid amide hydrolase OS=Arabidopsis thaliana OX=3702 GN=FAAH PE=1 SV=1,,,,,,
OG_03021,FUN_012241-T1,Peve_00018303,Pocillopora_meandrina_HIv1___RNAseq.g23522.t2,three_way,67.49,FUN_012241-T1,O14497,ARI1A_HUMAN,,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",Homo sapiens (Human),36.1,711.0,1.3e-109,400.2,sp|O14497|ARI1A_HUMAN AT-rich interactive domain-containing protein 1A OS=Homo sapiens OX=9606 GN=ARID1A PE=1 SV=3,GO:0000785; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016514; GO:0016922; GO:0030071; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_03022,FUN_012243-T1,Peve_00018301,Pocillopora_meandrina_HIv1___RNAseq.g23521.t1,three_way,59.33766666666666,FUN_012243-T1,O43320,FGF16_HUMAN,,Fibroblast growth factor 16 (FGF-16),Homo sapiens (Human),32.0,125.0,9.1e-14,78.6,sp|O43320|FGF16_HUMAN Fibroblast growth factor 16 OS=Homo sapiens OX=9606 GN=FGF16 PE=1 SV=1,GO:0005104; GO:0005576; GO:0005615; GO:0005737; GO:0007165; GO:0007267; GO:0008083; GO:0008284; GO:0008543; GO:0009266; GO:0009887; GO:0022008; GO:0030334; GO:0043410; GO:2000546,animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; fibroblast growth factor receptor signaling pathway [GO:0008543]; neurogenesis [GO:0022008]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell migration [GO:0030334]; response to temperature stimulus [GO:0009266]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083],GO:0005576; GO:0005615; GO:0023052; GO:0030154; GO:0048018; GO:0098772,extracellular region; extracellular space; signaling; cell differentiation; receptor ligand activity; molecular function regulator activity
OG_03023,FUN_012245-T1,Peve_00020521,Pocillopora_meandrina_HIv1___RNAseq.g23518.t1,three_way,75.14033333333333,FUN_012245-T1,O95822,DCMC_HUMAN,,"Malonyl-CoA decarboxylase, mitochondrial (MCD) (EC 4.1.1.9)",Homo sapiens (Human),41.4,423.0,9.8e-93,343.2,"sp|O95822|DCMC_HUMAN Malonyl-CoA decarboxylase, mitochondrial OS=Homo sapiens OX=9606 GN=MLYCD PE=1 SV=3",GO:0002931; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006085; GO:0006633; GO:0006637; GO:0007584; GO:0010906; GO:0019395; GO:0031998; GO:0042802; GO:0046321; GO:0050080; GO:2001294,acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931]; response to nutrient [GO:0007584],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0006790; GO:0016829; GO:0043226; GO:0055086,catalytic activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; sulfur compound metabolic process; lyase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03024,FUN_012250-T1,Peve_00020519,Pocillopora_meandrina_HIv1___RNAseq.g23517.t1,three_way,75.335,FUN_012250-T1,Q5T5C0,STXB5_HUMAN,,Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1),Homo sapiens (Human),38.5,1156.0,1.6e-208,728.0,sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807],acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075],GO:0005829; GO:0005886; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_03025,FUN_012251-T3,Peve_00020516,Pocillopora_meandrina_HIv1___RNAseq.g23515.t3,three_way,59.599,,,,,,,,,,,,,,,,,
OG_03026,FUN_012252-T1,Peve_00020515,Pocillopora_meandrina_HIv1___RNAseq.g23514.t1,three_way,91.8,FUN_012252-T1,Q12874,SF3A3_HUMAN,,Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61),Homo sapiens (Human),69.7,501.0,9.6e-193,674.5,sp|Q12874|SF3A3_HUMAN Splicing factor 3A subunit 3 OS=Homo sapiens OX=9606 GN=SF3A3 PE=1 SV=1,GO:0000375; GO:0000389; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0006397; GO:0008270; GO:0016607; GO:0071005; GO:0071013; GO:1903241,"mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]",catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_03027,FUN_012253-T1,Peve_00020514,Pocillopora_meandrina_HIv1___RNAseq.g23513.t1,three_way,77.68166666666667,,,,,,,,,,,,,,,,,
OG_03028,FUN_012254-T1,Peve_00036363,Pocillopora_meandrina_HIv1___RNAseq.g23560.t1a,three_way,48.51266666666667,FUN_012254-T1,Q6NV72,,,,,22.0,641.0,1.3e-16,89.7,sp|Q6NV72|WDCP_MOUSE WD repeat and coiled-coil-containing protein OS=Mus musculus OX=10090 GN=Wdcp PE=2 SV=2,,,,,,
OG_03029,FUN_012257-T2,Peve_00036357,Pocillopora_meandrina_HIv1___TS.g16433.t1,three_way,75.69800000000001,FUN_012257-T2,Q795M8,,,,,37.6,93.0,5.2e-06,54.3,sp|Q795M8|YUGO_BACSU Putative potassium channel protein YugO OS=Bacillus subtilis (strain 168) OX=224308 GN=yugO PE=4 SV=2,,,,,,
OG_03030,FUN_012261-T1,Peve_00036354,Pocillopora_meandrina_HIv1___RNAseq.g23549.t1,three_way,84.05866666666667,FUN_012261-T1,E1BNG3,ASCC3_BOVIN,,Activating signal cointegrator 1 complex subunit 3 (EC 5.6.2.4),Bos taurus (Bovine),60.5,2206.0,0.0,2650.5,sp|E1BNG3|ASCC3_BOVIN Activating signal cointegrator 1 complex subunit 3 OS=Bos taurus OX=9913 GN=ascc3 PE=3 SV=1,GO:0003676; GO:0005524; GO:0005634; GO:0005829; GO:0006307; GO:0016607; GO:0016887; GO:0032790; GO:0043138; GO:0072344; GO:1990116,DNA alkylation repair [GO:0006307]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676],GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0016787; GO:0016853; GO:0030163; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; cytosol; DNA repair; hydrolase activity; isomerase activity; protein catabolic process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03031,FUN_012265-T1,Peve_00036383,Pocillopora_meandrina_HIv1___RNAseq.9171_t,three_way,76.63199999999999,FUN_012265-T1,Q86SQ9,DHDDS_HUMAN,,Dehydrodolichyl diphosphate synthase complex subunit DHDDS (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m),Homo sapiens (Human),62.4,274.0,2.3e-95,350.5,sp|Q86SQ9|DHDDS_HUMAN Dehydrodolichyl diphosphate synthase complex subunit DHDDS OS=Homo sapiens OX=9606 GN=DHDDS PE=1 SV=3,GO:0005783; GO:0005789; GO:0006489; GO:0016094; GO:0019408; GO:0045547; GO:0046872; GO:1904423,dolichol biosynthetic process [GO:0019408]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol biosynthetic process [GO:0016094],dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],"ditrans,polycis-polyprenyl diphosphate synthase [(2E,6E)-farnesyl diphosphate specific] activity [GO:0045547]; metal ion binding [GO:0046872]",GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_03032,FUN_012266-T1,Peve_00036382,Pocillopora_meandrina_HIv1___RNAseq.g23541.t2,three_way,83.19966666666666,FUN_012266-T1,Q921C3,BRWD1_MOUSE,,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),Mus musculus (Mouse),45.5,1509.0,1.3e-305,1051.2,sp|Q921C3|BRWD1_MOUSE Bromodomain and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Brwd1 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005930; GO:0006357; GO:0007010; GO:0008360; GO:0031514,cytoskeleton organization [GO:0007010]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357],axoneme [GO:0005930]; cytosol [GO:0005829]; motile cilium [GO:0031514]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005929; GO:0006355; GO:0007010; GO:0043226,nucleus; nucleoplasm; nucleolus; cytosol; cilium; regulation of DNA-templated transcription; cytoskeleton organization; organelle
OG_03033,FUN_012271-T1,Peve_00023574,Pocillopora_meandrina_HIv1___RNAseq.g23875.t1,three_way,82.19366666666667,FUN_012271-T1,Q9JJ80,,,,,58.3,259.0,1.8e-85,317.4,sp|Q9JJ80|RPF2_MOUSE Ribosome production factor 2 homolog OS=Mus musculus OX=10090 GN=Rpf2 PE=2 SV=2,,,,,,
OG_03034,FUN_012272-T1,Peve_00023575,Pocillopora_meandrina_HIv1___RNAseq.g23876.t1,three_way,55.248,,,,,,,,,,,,,,,,,
OG_03035,FUN_012273-T1,Peve_00023570,Pocillopora_meandrina_HIv1___RNAseq.g23877.t1,three_way,69.00583333333333,FUN_012273-T1,Q8WUA2,,,,,69.7,373.0,1.7e-149,530.8,sp|Q8WUA2|PPIL4_HUMAN Peptidyl-prolyl cis-trans isomerase-like 4 OS=Homo sapiens OX=9606 GN=PPIL4 PE=1 SV=1,,,,,,
OG_03036,FUN_012274-T1,Peve_00026376,Pocillopora_meandrina_HIv1___RNAseq.g23878.t1,three_way,73.09366666666666,FUN_012274-T1,Q76I89,NDC80_CHICK,,Kinetochore protein NDC80 homolog (Kinetochore protein Hec1) (Kinetochore-associated protein 2),Gallus gallus (Chicken),35.0,491.0,2.9e-69,264.6,sp|Q76I89|NDC80_CHICK Kinetochore protein NDC80 homolog OS=Gallus gallus OX=9031 GN=NDC80 PE=1 SV=1,GO:0000132; GO:0000776; GO:0005813; GO:0005829; GO:0007052; GO:0007057; GO:0007059; GO:0008017; GO:0008315; GO:0014841; GO:0016607; GO:0030332; GO:0031262; GO:0031647; GO:0042802; GO:0051298; GO:0051301; GO:0051310; GO:0051315; GO:0051383; GO:0090267; GO:0140483,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; G2/MI transition of meiotic cell cycle [GO:0008315]; kinetochore organization [GO:0051383]; metaphase chromosome alignment [GO:0051310]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of protein stability [GO:0031647]; skeletal muscle satellite cell proliferation [GO:0014841]; spindle assembly involved in female meiosis I [GO:0007057],centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; Ndc80 complex [GO:0031262]; nuclear speck [GO:0016607],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; kinetochore adaptor activity [GO:0140483]; microtubule binding [GO:0008017],GO:0005815; GO:0005829; GO:0007010; GO:0007059; GO:0008092; GO:0022414; GO:0043226; GO:0060090,microtubule organizing center; cytosol; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; reproductive process; organelle; molecular adaptor activity
OG_03037,FUN_012275-T1,Peve_00012592,Pocillopora_meandrina_HIv1___RNAseq.g23879.t1,three_way,84.85633333333332,FUN_012275-T1,Q63481,RAB7L_RAT,,Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29),Rattus norvegicus (Rat),28.6,213.0,8.6e-15,83.2,sp|Q63481|RAB7L_RAT Ras-related protein Rab-7L1 OS=Rattus norvegicus OX=10116 GN=Rab29 PE=1 SV=1,GO:0000139; GO:0001921; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0031965; GO:0031982; GO:0032438; GO:0042110; GO:0042147; GO:0042470; GO:0044788; GO:0048471; GO:0050862; GO:0055037; GO:0060271; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1903441; GO:1905279; GO:1990748,"cell differentiation [GO:0030154]; cellular detoxification [GO:1990748]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; modulation by host of viral process [GO:0044788]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]",cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; vesicle [GO:0031982],dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005739; GO:0005768; GO:0005773; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0008092; GO:0016192; GO:0016787; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0044782; GO:0098754,immune system process; catalytic activity; GTPase activity; nucleoplasm; mitochondrion; endosome; vacuole; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; intracellular protein transport; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; cilium organization; detoxification
OG_03038,FUN_012276-T1,Peve_00014709,Pocillopora_meandrina_HIv1___RNAseq.g23566.t1,three_way,68.43366666666667,FUN_012276-T1,Q18297,TRPA1_CAEEL,,Transient receptor potential cation channel subfamily A member 1 homolog,Caenorhabditis elegans,32.3,541.0,6.1e-52,208.0,sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5,GO:0005216; GO:0005886; GO:0043025; GO:0097730,,neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],monoatomic ion channel activity [GO:0005216],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_03039,FUN_012278-T1,Peve_00010528,Pocillopora_meandrina_HIv1___RNAseq.g23570.t1,three_way,80.52133333333333,FUN_012278-T1,Q9D5W4,,,,,40.4,708.0,7.8e-127,456.1,sp|Q9D5W4|CCD81_MOUSE Coiled-coil domain-containing protein 81 OS=Mus musculus OX=10090 GN=Ccdc81 PE=2 SV=1,,,,,,
OG_03040,FUN_012279-T1,Peve_00014710,Pocillopora_meandrina_HIv1___RNAseq.g23569.t1,three_way,80.28833333333333,FUN_012279-T1,Q8BHB4,,,,,63.4,938.0,2.5e-138,494.6,sp|Q8BHB4|WDR3_MOUSE WD repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Wdr3 PE=1 SV=1,,,,,,
OG_03041,FUN_012280-T1,Peve_00014713,Pocillopora_meandrina_HIv1___RNAseq.g23568.t1,three_way,69.50166666666667,FUN_012280-T1,Q9JJZ4,UB2J1_MOUSE,,Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1),Mus musculus (Mouse),62.2,222.0,5.8e-73,276.2,sp|Q9JJZ4|UB2J1_MOUSE Ubiquitin-conjugating enzyme E2 J1 OS=Mus musculus OX=10090 GN=Ube2j1 PE=1 SV=2,GO:0000836; GO:0005524; GO:0007286; GO:0010935; GO:0016567; GO:0018279; GO:0031625; GO:0032680; GO:0036503; GO:0061631; GO:1904153,"ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; regulation of macrophage cytokine production [GO:0010935]; regulation of tumor necrosis factor production [GO:0032680]; spermatid development [GO:0007286]",Hrd1p ubiquitin ligase complex [GO:0000836],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0009101; GO:0016740; GO:0022414; GO:0030163; GO:0048856; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; reproductive process; protein catabolic process; anatomical structure development; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03042,FUN_012281-T1,Peve_00024232,Pocillopora_meandrina_HIv1___RNAseq.g23579.t1,three_way,65.3465,FUN_012281-T1,Q5TB80,CE162_HUMAN,,Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog),Homo sapiens (Human),31.5,791.0,2.9e-91,339.0,sp|Q5TB80|CE162_HUMAN Centrosomal protein of 162 kDa OS=Homo sapiens OX=9606 GN=CEP162 PE=1 SV=2,GO:0005654; GO:0005794; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005879; GO:0034451; GO:0036064; GO:0043231; GO:0060271,cilium assembly [GO:0060271],axonemal microtubule [GO:0005879]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; spindle [GO:0005819],,GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0043226; GO:0044782,nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; organelle; cilium organization
OG_03043,FUN_012283-T1,Peve_00032794,Pocillopora_meandrina_HIv1___RNAseq.g23577.t1,three_way,67.15466666666667,FUN_012283-T1,Q32PF3,,,,,51.5,99.0,1.4e-15,84.3,sp|Q32PF3|PCNP_BOVIN PEST proteolytic signal-containing nuclear protein OS=Bos taurus OX=9913 GN=PCNP PE=2 SV=1,,,,,,
OG_03044,FUN_012284-T1,Peve_00023640,Pocillopora_meandrina_HIv1___RNAseq.g23576.t1,three_way,72.237,FUN_012284-T1,P35365,,,,,28.8,340.0,1.9e-22,108.2,sp|P35365|5HT5B_RAT 5-hydroxytryptamine receptor 5B OS=Rattus norvegicus OX=10116 GN=Htr5b PE=2 SV=1,,,,,,
OG_03045,FUN_012285-T1,Peve_00010523,Pocillopora_meandrina_HIv1___RNAseq.g23575.t1,three_way,61.77216666666666,FUN_012285-T1,A1L2Q8,,,,,41.9,265.0,1.7e-55,217.6,sp|A1L2Q8|P5CR3_XENLA Pyrroline-5-carboxylate reductase 3 OS=Xenopus laevis OX=8355 GN=pycr3 PE=2 SV=2,,,,,,
OG_03046,FUN_012292-T1,Peve_00036368,Pocillopora_meandrina_HIv1___RNAseq.g23561.t1,three_way,74.99983333333333,FUN_012292-T1,Q20191,,,,,45.5,189.0,7.3e-45,183.0,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_03047,FUN_012293-T1,Peve_00036366,Pocillopora_meandrina_HIv1___RNAseq.g23562.t1,three_way,84.339,FUN_012293-T1,Q96JB1,,,,,26.2,4649.0,0.0,1572.4,sp|Q96JB1|DYH8_HUMAN Dynein axonemal heavy chain 8 OS=Homo sapiens OX=9606 GN=DNAH8 PE=1 SV=2,,,,,,
OG_03048,FUN_012295-T1,Peve_00036365,Pocillopora_meandrina_HIv1___RNAseq.g23560.t1b,three_way,72.36266666666667,FUN_012295-T1,D3ZGS3,OCRL_RAT,,"Inositol polyphosphate 5-phosphatase OCRL (EC 3.1.3.36) (EC 3.1.3.56) (Inositol polyphosphate 5-phosphatase OCRL-1) (OCRL-1) (Phosphatidylinositol 3,4,5-triphosphate 5-phosphatase) (EC 3.1.3.86)",Rattus norvegicus (Rat),48.5,616.0,3.2e-174,613.6,sp|D3ZGS3|OCRL_RAT Inositol polyphosphate 5-phosphatase OCRL OS=Rattus norvegicus OX=10116 GN=Ocrl PE=1 SV=1,GO:0001701; GO:0001750; GO:0004439; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005802; GO:0005886; GO:0005905; GO:0007165; GO:0016020; GO:0030136; GO:0030670; GO:0031267; GO:0031901; GO:0034485; GO:0043005; GO:0046856; GO:0052658; GO:0052659; GO:0052745; GO:0060271,cilium assembly [GO:0060271]; in utero embryonic development [GO:0001701]; phosphatidylinositol dephosphorylation [GO:0046856]; signal transduction [GO:0007165],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; phagocytic vesicle membrane [GO:0030670]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],"GTPase activator activity [GO:0005096]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; small GTPase binding [GO:0031267]",GO:0003824; GO:0005634; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0098772,catalytic activity; nucleus; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_03049,FUN_012296-T1,Peve_00002353,Pocillopora_meandrina_HIv1___RNAseq.g23873.t1,three_way,63.77733333333334,FUN_012296-T1,Q4R3G4,,,,,23.3,1242.0,3.8999999999999995e-46,189.1,sp|Q4R3G4|RNF17_MACFA RING finger protein 17 OS=Macaca fascicularis OX=9541 GN=RNF17 PE=2 SV=2,,,,,,
OG_03050,FUN_012297-T1,Peve_00002352,Pocillopora_meandrina_HIv1___RNAseq.g23872.t1,three_way,57.568,FUN_012297-T1,Q13112,CAF1B_HUMAN,,Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60) (M-phase phosphoprotein 7),Homo sapiens (Human),42.2,566.0,2.3e-104,381.3,sp|Q13112|CAF1B_HUMAN Chromatin assembly factor 1 subunit B OS=Homo sapiens OX=9606 GN=CHAF1B PE=1 SV=1,GO:0000785; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0006334; GO:0006335; GO:0032991; GO:0033186; GO:0042393; GO:0051082,DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin assembly [GO:0006335]; nucleosome assembly [GO:0006334],CAF-1 complex [GO:0033186]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; histone binding [GO:0042393]; unfolded protein binding [GO:0051082],GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0006325; GO:0042393; GO:0043226; GO:0065003,nucleus; nucleoplasm; DNA replication; DNA repair; chromatin organization; histone binding; organelle; protein-containing complex assembly
OG_03051,FUN_012298-T1,Peve_00038614,Pocillopora_meandrina_HIv1___RNAseq.g23768.t1,three_way,61.748,,,,,,,,,,,,,,,,,
OG_03052,FUN_012299-T1,Peve_00038613,Pocillopora_meandrina_HIv1___RNAseq.g23767.t1,three_way,72.542,,,,,,,,,,,,,,,,,
OG_03053,FUN_012300-T1,Peve_00038610,Pocillopora_meandrina_HIv1___RNAseq.g23766.t1,three_way,69.763,,,,,,,,,,,,,,,,,
OG_03054,FUN_012301-T1,Peve_00038608,Pocillopora_meandrina_HIv1___TS.g16639.t1,three_way,72.16116666666667,FUN_012301-T1,Q5ZK88,PSPC1_CHICK,,Paraspeckle component 1,Gallus gallus (Chicken),51.0,247.0,5.6e-66,253.4,sp|Q5ZK88|PSPC1_CHICK Paraspeckle component 1 OS=Gallus gallus OX=9031 GN=PSPC1 PE=2 SV=1,GO:0001650; GO:0002218; GO:0003723; GO:0005634; GO:0006355; GO:0016607; GO:0042382; GO:0042752; GO:0045892; GO:0140694,activation of innate immune response [GO:0002218]; membraneless organelle assembly [GO:0140694]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355],fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; paraspeckles [GO:0042382],RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005634; GO:0006355; GO:0043226,immune system process; RNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_03055,FUN_012302-T1,Peve_00038607,Pocillopora_meandrina_HIv1___RNAseq.g23764.t1,three_way,58.20183333333334,FUN_012302-T1,Q640M1,,,,,32.3,764.0,3.5e-72,274.6,sp|Q640M1|UT14A_MOUSE U3 small nucleolar RNA-associated protein 14 homolog A OS=Mus musculus OX=10090 GN=Utp14a PE=1 SV=1,,,,,,
OG_03056,FUN_012303-T1,Peve_00038606,Pocillopora_meandrina_HIv1___RNAseq.g23763.t1,three_way,76.919,FUN_012303-T1,Q9NRZ5,PLCD_HUMAN,,1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta),Homo sapiens (Human),37.2,379.0,4.7e-67,256.5,sp|Q9NRZ5|PLCD_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase delta OS=Homo sapiens OX=9606 GN=AGPAT4 PE=1 SV=1,GO:0003841; GO:0005741; GO:0005783; GO:0005789; GO:0006654; GO:0008654; GO:0012505; GO:0016024,CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid biosynthetic process [GO:0008654],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_03057,FUN_012315-T1,Peve_00038609,Pocillopora_meandrina_HIv1___RNAseq.g23742.t1,three_way,75.115,FUN_012315-T1,Q63159,COQ3_RAT,,"Ubiquinone biosynthesis O-methyltransferase, mitochondrial (3-demethylubiquinol 3-O-methyltransferase) (EC 2.1.1.64) (3-demethylubiquinone 3-O-methyltransferase) (EC 2.1.1.-) (Polyprenyldihydroxybenzoate methyltransferase) (EC 2.1.1.114)",Rattus norvegicus (Rat),47.0,247.0,2.6000000000000003e-60,233.8,"sp|Q63159|COQ3_RAT Ubiquinone biosynthesis O-methyltransferase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Coq3 PE=2 SV=2",GO:0005739; GO:0005743; GO:0005759; GO:0006071; GO:0006744; GO:0008171; GO:0010420; GO:0031314; GO:0032259; GO:0061542; GO:0110142; GO:0120537,glycerol metabolic process [GO:0006071]; methylation [GO:0032259]; ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ubiquinone biosynthesis complex [GO:0110142],3-demethylubiquinol 3-O-methyltransferase activity [GO:0061542]; 3-demethylubiquinone 3-O-methyltransferase activity [GO:0120537]; O-methyltransferase activity [GO:0008171]; polyprenyldihydroxybenzoate methyltransferase activity [GO:0010420],GO:0003824; GO:0005739; GO:0005975; GO:0016740; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; transferase activity; organelle
OG_03058,FUN_012316-T1,Peve_00038604,Pocillopora_meandrina_HIv1___RNAseq.g23743.t1,three_way,72.05633333333333,FUN_012316-T1,Q6DHR8,NGBR_DANRE,,"Dehydrodolichyl diphosphate synthase complex subunit nus1 (EC 2.5.1.87) (Di-trans,poly-cis-decaprenylcistransferase) (Nogo-B receptor) (NgBR) (Nuclear undecaprenyl pyrophosphate synthase 1 homolog)",Danio rerio (Zebrafish) (Brachydanio rerio),41.0,205.0,1.6e-42,174.5,sp|Q6DHR8|NGBR_DANRE Dehydrodolichyl diphosphate synthase complex subunit nus1 OS=Danio rerio OX=7955 GN=nus1 PE=2 SV=1,GO:0002040; GO:0005789; GO:0006486; GO:0019408; GO:0032367; GO:0036269; GO:0045547; GO:1904423,dolichol biosynthetic process [GO:0019408]; intracellular cholesterol transport [GO:0032367]; protein glycosylation [GO:0006486]; sprouting angiogenesis [GO:0002040]; swimming behavior [GO:0036269],dehydrodolichyl diphosphate synthase complex [GO:1904423]; endoplasmic reticulum membrane [GO:0005789],"ditrans,polycis-polyprenyl diphosphate synthase [(2E,6E)-farnesyl diphosphate specific] activity [GO:0045547]",GO:0003824; GO:0006486; GO:0016740,catalytic activity; protein glycosylation; transferase activity
OG_03059,FUN_012317-T1,Peve_00038600,Pocillopora_meandrina_HIv1___RNAseq.g23744.t1,three_way,77.02933333333333,FUN_012317-T1,O75027,ABCB7_HUMAN,,"Iron-sulfur clusters transporter ABCB7, mitochondrial (ATP-binding cassette sub-family B member 7, mitochondrial) (ATP-binding cassette transporter 7) (ABC transporter 7 protein)",Homo sapiens (Human),62.2,640.0,2.1e-225,783.5,"sp|O75027|ABCB7_HUMAN Iron-sulfur clusters transporter ABCB7, mitochondrial OS=Homo sapiens OX=9606 GN=ABCB7 PE=1 SV=2",GO:0005524; GO:0005739; GO:0005743; GO:0006879; GO:0015232; GO:0016226; GO:0016887; GO:0034755; GO:0042626; GO:0042802; GO:0042803; GO:0055085; GO:0070455; GO:0140466; GO:0140481; GO:1903331; GO:1903427,intracellular iron ion homeostasis [GO:0006879]; iron ion transmembrane transport [GO:0034755]; iron-sulfur cluster assembly [GO:0016226]; iron-sulfur cluster export from the mitochondrion [GO:0140466]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of heme biosynthetic process [GO:0070455]; positive regulation of iron-sulfur cluster assembly [GO:1903331]; transmembrane transport [GO:0055085],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ABC-type iron-sulfur cluster transporter activity [GO:0140481]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; heme transmembrane transporter activity [GO:0015232]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_03060,FUN_012324-T1,Peve_00022884,Pocillopora_meandrina_HIv1___RNAseq.g23750.t1,three_way,74.87566666666666,,,,,,,,,,,,,,,,,
OG_03061,FUN_012325-T1,Peve_00022885,Pocillopora_meandrina_HIv1___RNAseq.g23751.t1,three_way,82.00566666666667,FUN_012325-T1,Q8R3S2,TSN33_MOUSE,,Tetraspanin-33 (Tspan-33) (Penumbra) (mPen) (Proerythroblast new membrane),Mus musculus (Mouse),45.7,258.0,7.699999999999999e-56,218.8,sp|Q8R3S2|TSN33_MOUSE Tetraspanin-33 OS=Mus musculus OX=10090 GN=Tspan33 PE=1 SV=1,GO:0005737; GO:0005912; GO:0009986; GO:0019899; GO:0046930; GO:0046931; GO:0051604; GO:0072659; GO:0097197,pore complex assembly [GO:0046931]; protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; pore complex [GO:0046930]; tetraspanin-enriched microdomain [GO:0097197],enzyme binding [GO:0019899],GO:0051604; GO:0065003; GO:0072659,protein maturation; protein-containing complex assembly; protein localization to plasma membrane
OG_03062,FUN_012326-T1,Peve_00023484,Pocillopora_meandrina_HIv1___RNAseq.g23752.t1,three_way,88.28433333333334,FUN_012326-T1,Q64331,MYO6_MOUSE,,Unconventional myosin-VI (Protein twist) (Unconventional myosin-6),Mus musculus (Mouse),58.0,1266.0,0.0,1217.2,sp|Q64331|MYO6_MOUSE Unconventional myosin-VI OS=Mus musculus OX=10090 GN=Myo6 PE=1 SV=2,GO:0003774; GO:0005516; GO:0005524; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0005903; GO:0005905; GO:0006605; GO:0006897; GO:0007268; GO:0007416; GO:0007605; GO:0007626; GO:0008104; GO:0012506; GO:0014047; GO:0014069; GO:0015031; GO:0016358; GO:0016459; GO:0030136; GO:0030175; GO:0030424; GO:0032587; GO:0042472; GO:0042491; GO:0043025; GO:0045202; GO:0048167; GO:0048471; GO:0048839; GO:0051015; GO:0071257; GO:0098683; GO:0098685; GO:0098833; GO:0098871; GO:0098884; GO:0098978; GO:0099171,cellular response to electrical stimulus [GO:0071257]; chemical synaptic transmission [GO:0007268]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; glutamate secretion [GO:0014047]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein localization [GO:0008104]; protein targeting [GO:0006605]; protein transport [GO:0015031]; regulation of synaptic plasticity [GO:0048167]; sensory perception of sound [GO:0007605]; synapse assembly [GO:0007416],axon [GO:0030424]; brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cochlear hair cell ribbon synapse [GO:0098683]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; microvillus [GO:0005902]; myosin complex [GO:0016459]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; presynaptic endocytic zone [GO:0098833]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; vesicle membrane [GO:0012506],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774],GO:0003774; GO:0005634; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0023052; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,cytoskeletal motor activity; nucleus; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; signaling; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_03063,FUN_012329-T1,Peve_00023485,Pocillopora_meandrina_HIv1___RNAseq.g23753.t1,three_way,67.88033333333334,FUN_012329-T1,Q6GMR7,FAAH2_HUMAN,,Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2),Homo sapiens (Human),47.5,495.0,4e-120,433.3,sp|Q6GMR7|FAAH2_HUMAN Fatty-acid amide hydrolase 2 OS=Homo sapiens OX=9606 GN=FAAH2 PE=1 SV=1,GO:0005811; GO:0016020; GO:0016042; GO:0017064; GO:0019369,arachidonate metabolic process [GO:0019369]; lipid catabolic process [GO:0016042],lipid droplet [GO:0005811]; membrane [GO:0016020],fatty acid amide hydrolase activity [GO:0017064],GO:0003824; GO:0005811; GO:0006629; GO:0016787; GO:0043226,catalytic activity; lipid droplet; lipid metabolic process; hydrolase activity; organelle
OG_03064,FUN_012330-T1,Peve_00023487,Pocillopora_meandrina_HIv1___RNAseq.g23754.t1,three_way,75.646,FUN_012330-T1,Q9Y6P5,SESN1_HUMAN,,Sestrin-1 (EC 1.11.1.-) (p53-regulated protein PA26),Homo sapiens (Human),47.5,465.0,7.5e-119,429.1,sp|Q9Y6P5|SESN1_HUMAN Sestrin-1 OS=Homo sapiens OX=9606 GN=SESN1 PE=1 SV=2,GO:0001650; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0016239; GO:0016684; GO:0030308; GO:0034198; GO:0042149; GO:0051896; GO:0070728; GO:0071233; GO:0072593; GO:0098869; GO:1901031; GO:1904262; GO:1990253,cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of macroautophagy [GO:0016239]; reactive oxygen species metabolic process [GO:0072593]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of response to reactive oxygen species [GO:1901031],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"L-leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016491; GO:0043226; GO:0098754,catalytic activity; nucleus; nucleoplasm; cytosol; oxidoreductase activity; organelle; detoxification
OG_03065,FUN_012332-T1,Peve_00028483,Pocillopora_meandrina_HIv1___RNAseq.g23757.t1,three_way,42.109,,,,,,,,,,,,,,,,,
OG_03066,FUN_012333-T1,Peve_00028481,Pocillopora_meandrina_HIv1___RNAseq.g23758.t1,three_way,69.9595,FUN_012333-T1,O43524,,,,,35.0,546.0,1.9999999999999998e-50,201.8,sp|O43524|FOXO3_HUMAN Forkhead box protein O3 OS=Homo sapiens OX=9606 GN=FOXO3 PE=1 SV=1,,,,,,
OG_03067,FUN_012335-T1,Peve_00015495,Pocillopora_meandrina_HIv1___RNAseq.g24076.t1,three_way,72.52133333333333,,,,,,,,,,,,,,,,,
OG_03068,FUN_012338-T1,Peve_00021550,Pocillopora_meandrina_HIv1___RNAseq.g24073.t1,three_way,51.0305,,,,,,,,,,,,,,,,,
OG_03069,FUN_012339-T1,Peve_00042526,Pocillopora_meandrina_HIv1___RNAseq.g23282.t1,three_way,69.46783333333333,FUN_012339-T1,Q3T174,,,,,59.3,150.0,7.3e-42,172.6,sp|Q3T174|TAF12_BOVIN Transcription initiation factor TFIID subunit 12 OS=Bos taurus OX=9913 GN=TAF12 PE=2 SV=1,,,,,,
OG_03070,FUN_012340-T1,Peve_00042542,Pocillopora_meandrina_HIv1___RNAseq.g23343.t1,three_way,61.76633333333333,FUN_012340-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),30.7,205.0,2.5e-17,91.7,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_03071,FUN_012342-T1,Peve_00042522,Pocillopora_meandrina_HIv1___RNAseq.g23653.t1,three_way,87.34433333333332,FUN_012342-T1,Q5XHA8,,,,,67.8,590.0,9.099999999999999e-243,840.9,sp|Q5XHA8|PYG1A_XENLA CTP synthase 1-A OS=Xenopus laevis OX=8355 GN=ctps1-a PE=2 SV=1,,,,,,
OG_03072,FUN_012343-T1,Peve_00012045,Pocillopora_meandrina_HIv1___TS.g16934.t2,three_way,67.75016666666667,FUN_012343-T1,E1C7T6,,,,,29.5,237.0,9e-14,79.7,sp|E1C7T6|TYW5_CHICK tRNA wybutosine-synthesizing protein 5 OS=Gallus gallus OX=9031 GN=TYW5 PE=3 SV=1,,,,,,
OG_03073,FUN_012345-T1,Peve_00012046,Pocillopora_meandrina_HIv1___RNAseq.g24066.t1,three_way,75.6655,,,,,,,,,,,,,,,,,
OG_03074,FUN_012346-T1,Peve_00012047,Pocillopora_meandrina_HIv1___RNAseq.g24067.t1,three_way,82.01583333333333,FUN_012346-T1,Q7ZVB1,,,,,81.2,197.0,8.7e-44,178.3,sp|Q7ZVB1|CHM1B_DANRE Charged multivesicular body protein 1b OS=Danio rerio OX=7955 GN=chmp1b PE=2 SV=1,,,,,,
OG_03075,FUN_012347-T1,Peve_00012044,Pocillopora_meandrina_HIv1___RNAseq.g24068.t1,three_way,72.92833333333333,FUN_012347-T1,Q9UGM6,SYWM_HUMAN,,"Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS)",Homo sapiens (Human),48.6,329.0,9.8e-91,335.1,"sp|Q9UGM6|SYWM_HUMAN Tryptophan--tRNA ligase, mitochondrial OS=Homo sapiens OX=9606 GN=WARS2 PE=1 SV=1",GO:0001570; GO:0004830; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005886; GO:0006418; GO:0045766; GO:0070183,mitochondrial tryptophanyl-tRNA aminoacylation [GO:0070183]; positive regulation of angiogenesis [GO:0045766]; tRNA aminoacylation for protein translation [GO:0006418]; vasculogenesis [GO:0001570],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830],GO:0003824; GO:0005654; GO:0005739; GO:0005886; GO:0006399; GO:0006520; GO:0016874; GO:0030154; GO:0043226; GO:0140098,"catalytic activity; nucleoplasm; mitochondrion; plasma membrane; tRNA metabolic process; amino acid metabolic process; ligase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_03076,FUN_012348-T1,Peve_00029070,Pocillopora_meandrina_HIv1___RNAseq.g24069.t1,three_way,66.19800000000001,FUN_012348-T1,P0C8E4,M3K7_RAT,,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25),Rattus norvegicus (Rat),36.2,796.0,1.6e-112,408.7,sp|P0C8E4|M3K7_RAT Mitogen-activated protein kinase kinase kinase 7 OS=Rattus norvegicus OX=10116 GN=Map3k7 PE=1 SV=1,GO:0000165; GO:0000287; GO:0001223; GO:0001525; GO:0001649; GO:0001666; GO:0001841; GO:0002726; GO:0004674; GO:0004707; GO:0004708; GO:0004709; GO:0005114; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006954; GO:0006955; GO:0007179; GO:0007249; GO:0007252; GO:0007254; GO:0008349; GO:0010508; GO:0010629; GO:0014069; GO:0016239; GO:0030971; GO:0031625; GO:0032743; GO:0034142; GO:0035173; GO:0038066; GO:0038172; GO:0038173; GO:0042742; GO:0042802; GO:0043123; GO:0043276; GO:0043410; GO:0043507; GO:0045787; GO:0045793; GO:0046330; GO:0051403; GO:0060348; GO:0060546; GO:0070498; GO:0071356; GO:0071456; GO:0071560; GO:0097110; GO:0097190; GO:0106310; GO:0120283; GO:0140297; GO:0140672; GO:1901224; GO:1902443; GO:1904385; GO:1904707; GO:1904754; GO:1990450; GO:1990776; GO:2000377; GO:2000378; GO:2001234,angiogenesis [GO:0001525]; anoikis [GO:0043276]; apoptotic signaling pathway [GO:0097190]; bone development [GO:0060348]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; defense response to bacterium [GO:0042742]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of gene expression [GO:0010629]; negative regulation of necroptotic process [GO:0060546]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of ripoptosome assembly involved in necroptotic process [GO:1902443]; neural tube formation [GO:0001841]; osteoblast differentiation [GO:0001649]; p38MAPK cascade [GO:0038066]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell size [GO:0045793]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to angiotensin [GO:1990776]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; toll-like receptor 4 signaling pathway [GO:0034142]; transforming growth factor beta receptor signaling pathway [GO:0007179],ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; histone kinase activity [GO:0035173]; identical protein binding [GO:0042802]; linear polyubiquitin binding [GO:1990450]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625],GO:0002376; GO:0003824; GO:0005829; GO:0005886; GO:0006954; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; cytosol; plasma membrane; inflammatory response; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03077,FUN_012349-T1,Peve_00021548,Pocillopora_meandrina_HIv1___RNAseq.9691_t,three_way,89.12533333333333,FUN_012349-T1,B3EX35,KATL1_SORAR,,Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 5.6.1.1) (p60 katanin-like 1),Sorex araneus (Eurasian common shrew) (European shrew),62.4,519.0,1.3e-168,594.3,sp|B3EX35|KATL1_SORAR Katanin p60 ATPase-containing subunit A-like 1 OS=Sorex araneus OX=42254 GN=KATNAL1 PE=3 SV=1,GO:0000922; GO:0005524; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0007283; GO:0008017; GO:0008568; GO:0016887; GO:0051013,microtubule severing [GO:0051013]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule severing ATPase activity [GO:0008568],GO:0003824; GO:0005815; GO:0007010; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140096; GO:0140657,"catalytic activity; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on a protein; ATP-dependent activity"
OG_03078,FUN_012350-T1,Peve_00042525,Pocillopora_meandrina_HIv1___RNAseq.g23281.t1,three_way,96.66666666666669,FUN_012350-T1,Q5ZI57,,,,,72.2,180.0,6.499999999999999e-75,281.6,sp|Q5ZI57|TPPC3_CHICK Trafficking protein particle complex subunit 3 OS=Gallus gallus OX=9031 GN=TRAPPC3 PE=2 SV=1,,,,,,
OG_03079,FUN_012351-T1,Peve_00042524,Pocillopora_meandrina_HIv1___RNAseq.g23280.t1,three_way,33.19883333333333,,,,,,,,,,,,,,,,,
OG_03080,FUN_012352-T1,Peve_00042523,Pocillopora_meandrina_HIv1___RNAseq.g23279.t1,three_way,78.2095,FUN_012352-T1,Q2KIT4,,,,,47.1,365.0,5.2e-84,312.8,sp|Q2KIT4|DNJB4_BOVIN DnaJ homolog subfamily B member 4 OS=Bos taurus OX=9913 GN=DNAJB4 PE=2 SV=1,,,,,,
OG_03081,FUN_012353-T1,Peve_00042562,Pocillopora_meandrina_HIv1___RNAseq.g23278.t2,three_way,88.492,FUN_012353-T1,Q6ZQ88,KDM1A_MOUSE,,Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2),Mus musculus (Mouse),68.2,692.0,4.4e-274,945.3,sp|Q6ZQ88|KDM1A_MOUSE Lysine-specific histone demethylase 1A OS=Mus musculus OX=10090 GN=Kdm1a PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006357; GO:0006366; GO:0010569; GO:0010718; GO:0010725; GO:0016491; GO:0019899; GO:0021983; GO:0030154; GO:0030851; GO:0031398; GO:0032452; GO:0032453; GO:0032454; GO:0032880; GO:0032991; GO:0034644; GO:0043426; GO:0045648; GO:0045654; GO:0045944; GO:0050660; GO:0050681; GO:0050767; GO:0050768; GO:0055001; GO:0061629; GO:0071480; GO:0106222; GO:0120162; GO:0140297; GO:0140682; GO:0140684; GO:0140861; GO:0160217; GO:1990138; GO:1990391; GO:1990841; GO:2000179; GO:2000648,cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; DNA repair-dependent chromatin remodeling [GO:0140861]; granulocyte differentiation [GO:0030851]; muscle cell development [GO:0055001]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription initiation-coupled chromatin remodeling [GO:0160217]; neuron projection extension [GO:1990138]; pituitary gland development [GO:0021983]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of neurogenesis [GO:0050767]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; DNA repair complex [GO:1990391]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; FAD-dependent H3K4me/H3K4me3 demethylase activity [GO:0140682]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone H3K4 demethylase activity [GO:0032453]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me2/H3K9me3 demethylase activity [GO:0140684]; lncRNA binding [GO:0106222]; MRF binding [GO:0043426]; nuclear androgen receptor binding [GO:0050681]; oxidoreductase activity [GO:0016491]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0006325; GO:0006351; GO:0006355; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"DNA binding; RNA binding; catalytic activity; nucleus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_03082,FUN_012355-T1,Peve_00042561,Pocillopora_meandrina_HIv1___RNAseq.g23276.t1,three_way,84.687,FUN_012355-T1,Q9P2C4,,,,,54.3,464.0,5.1e-135,482.6,sp|Q9P2C4|TM181_HUMAN Transmembrane protein 181 OS=Homo sapiens OX=9606 GN=TMEM181 PE=1 SV=3,,,,,,
OG_03083,FUN_012356-T1,Peve_00042559,Pocillopora_meandrina_HIv1___RNAseq.g23275.t1,three_way,61.93366666666667,,,,,,,,,,,,,,,,,
OG_03084,FUN_012357-T1,Peve_00042558,Pocillopora_meandrina_HIv1___TS.g16156.t2,three_way,49.562333333333335,,,,,,,,,,,,,,,,,
OG_03085,FUN_012358-T1,Peve_00042557,Pocillopora_meandrina_HIv1___RNAseq.g23273.t1,three_way,74.58133333333333,FUN_012358-T1,Q24133,DNAJ1_DROME,,DnaJ protein homolog 1 (DROJ1),Drosophila melanogaster (Fruit fly),53.0,332.0,1.4e-84,314.7,sp|Q24133|DNAJ1_DROME DnaJ protein homolog 1 OS=Drosophila melanogaster OX=7227 GN=DnaJ-1 PE=1 SV=3,GO:0005829; GO:0006457; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0140297,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408],cytosol [GO:0005829],DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005829; GO:0006457,cytosol; protein folding
OG_03086,FUN_012359-T1,Peve_00042556,Pocillopora_meandrina_HIv1___RNAseq.g23272.t1,three_way,74.21950000000001,FUN_012359-T1,Q9UDY4,DNJB4_HUMAN,,DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog) (HSP40 homolog) (Heat shock protein 40 homolog) (Human liver DnaJ-like protein),Homo sapiens (Human),45.7,341.0,5.000000000000001e-81,302.8,sp|Q9UDY4|DNJB4_HUMAN DnaJ homolog subfamily B member 4 OS=Homo sapiens OX=9606 GN=DNAJB4 PE=1 SV=1,GO:0000122; GO:0001671; GO:0005654; GO:0005829; GO:0005886; GO:0006986; GO:0009408; GO:0030018; GO:0051082; GO:0051085; GO:0051087,chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; Z disc [GO:0030018],ATPase activator activity [GO:0001671]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0098772,nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; molecular function regulator activity
OG_03087,FUN_012360-T1,Peve_00042555,Pocillopora_meandrina_HIv1___RNAseq.g23271.t1,three_way,62.67783333333333,,,,,,,,,,,,,,,,,
OG_03088,FUN_012361-T1,Peve_00042554,Pocillopora_meandrina_HIv1___RNAseq.g23270.t1,three_way,67.283,FUN_012361-T1,Q8BUB6,,,,,41.5,277.0,8.2e-60,232.3,sp|Q8BUB6|UST_MOUSE Uronyl 2-sulfotransferase OS=Mus musculus OX=10090 GN=Ust PE=2 SV=3,,,,,,
OG_03089,FUN_012362-T1,Peve_00042553,Pocillopora_meandrina_HIv1___RNAseq.g23269.t1,three_way,86.978,FUN_012362-T1,Q9YGL7,,,,,68.4,133.0,1.1e-44,181.4,sp|Q9YGL7|PIT1_CHICK Pituitary-specific positive transcription factor 1 OS=Gallus gallus OX=9031 GN=POU1F1 PE=2 SV=1,,,,,,
OG_03090,FUN_012363-T1,Peve_00042552,Pocillopora_meandrina_HIv1___RNAseq.g23268.t1,three_way,71.113,FUN_012363-T1,Q32L99,,,,,56.1,344.0,5.8e-107,389.0,sp|Q32L99|PTGR2_BOVIN Prostaglandin reductase 2 OS=Bos taurus OX=9913 GN=PTGR2 PE=2 SV=1,,,,,,
OG_03091,FUN_012365-T1,Peve_00042551,Pocillopora_meandrina_HIv1___RNAseq.g23359.t1,three_way,60.10966666666666,,,,,,,,,,,,,,,,,
OG_03092,FUN_012366-T1,Peve_00042545,Pocillopora_meandrina_HIv1___RNAseq.g23358.t1a,three_way,69.351,FUN_012366-T1,E9PYK3,PARP4_MOUSE,,Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) (mVparp),Mus musculus (Mouse),38.6,1245.0,9.999999999999999e-231,802.7,sp|E9PYK3|PARP4_MOUSE Protein mono-ADP-ribosyltransferase PARP4 OS=Mus musculus OX=10090 GN=Parp4 PE=1 SV=1,GO:0003950; GO:0005634; GO:0005654; GO:0005819; GO:0005829; GO:0005876; GO:0006954; GO:0016779; GO:0019899; GO:0036211; GO:0140806; GO:0140807; GO:1990404; GO:1990904,inflammatory response [GO:0006954]; protein modification process [GO:0036211],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; spindle microtubule [GO:0005876],enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006954; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; inflammatory response; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03093,FUN_012378-T1,Peve_00042531,Pocillopora_meandrina_HIv1___RNAseq.g23353.t1,three_way,64.31700000000001,FUN_012378-T1,Q9JKK0,,,,,34.0,194.0,7.4e-20,99.0,sp|Q9JKK0|RCAN3_MOUSE Calcipressin-3 OS=Mus musculus OX=10090 GN=Rcan3 PE=2 SV=1,,,,,,
OG_03094,FUN_012379-T1,Peve_00042533,Pocillopora_meandrina_HIv1___TS.g16234.t1b,three_way,77.48716666666667,FUN_012379-T1,P91620,SIF2_DROME,,"Protein still life, isoforms C/SIF type 2",Drosophila melanogaster (Fruit fly),32.8,1044.0,4.7e-133,477.6,"sp|P91620|SIF2_DROME Protein still life, isoforms C/SIF type 2 OS=Drosophila melanogaster OX=7227 GN=sif PE=2 SV=2",GO:0005085; GO:0007264; GO:0016020; GO:0030036; GO:0045202; GO:0050770; GO:0050772; GO:0050803; GO:0051491,actin cytoskeleton organization [GO:0030036]; positive regulation of axonogenesis [GO:0050772]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of synapse structure or activity [GO:0050803]; small GTPase-mediated signal transduction [GO:0007264],membrane [GO:0016020]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0007010; GO:0098772,cytoskeleton organization; molecular function regulator activity
OG_03095,FUN_012380-T1,Peve_00042535,Pocillopora_meandrina_HIv1___RNAseq.g23350.t1,three_way,70.097,FUN_012380-T1,Q9BRP4,PAAF1_HUMAN,,Proteasomal ATPase-associated factor 1 (Protein G-16) (WD repeat-containing protein 71),Homo sapiens (Human),51.5,396.0,4.1e-56,220.3,sp|Q9BRP4|PAAF1_HUMAN Proteasomal ATPase-associated factor 1 OS=Homo sapiens OX=9606 GN=PAAF1 PE=1 SV=2,GO:0000124; GO:0000502; GO:0005669; GO:0005829; GO:0006367,transcription initiation at RNA polymerase II promoter [GO:0006367],cytosol [GO:0005829]; proteasome complex [GO:0000502]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669],,GO:0005829,cytosol
OG_03096,FUN_012381-T1,Peve_00015999,Pocillopora_meandrina_HIv1___RNAseq.g23344.t1,three_way,59.2625,FUN_012381-T1,Q924V1,NOX4_RAT,,NADPH oxidase 4 (EC 1.6.3.1) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase),Rattus norvegicus (Rat),42.4,556.0,9.999999999999999e-123,442.2,sp|Q924V1|NOX4_RAT NADPH oxidase 4 OS=Rattus norvegicus OX=10116 GN=Nox4 PE=1 SV=2,GO:0000902; GO:0001666; GO:0001725; GO:0003015; GO:0005634; GO:0005739; GO:0005783; GO:0005789; GO:0005886; GO:0005925; GO:0006801; GO:0006952; GO:0008285; GO:0010467; GO:0010729; GO:0014911; GO:0016174; GO:0016175; GO:0016324; GO:0016529; GO:0020037; GO:0042554; GO:0043020; GO:0043065; GO:0045453; GO:0048471; GO:0050664; GO:0050667; GO:0051496; GO:0051897; GO:0055007; GO:0070374; GO:0071288; GO:0071320; GO:0071333; GO:0071347; GO:0071480; GO:0071560; GO:0071944; GO:0072341; GO:0072593; GO:0097038; GO:0106292; GO:0106294; GO:1990782; GO:2000379; GO:2000573,bone resorption [GO:0045453]; cardiac muscle cell differentiation [GO:0055007]; cell morphogenesis [GO:0000902]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to interleukin-1 [GO:0071347]; cellular response to mercury ion [GO:0071288]; cellular response to transforming growth factor beta stimulus [GO:0071560]; defense response [GO:0006952]; gene expression [GO:0010467]; heart process [GO:0003015]; homocysteine metabolic process [GO:0050667]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; response to hypoxia [GO:0001666]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801],apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; NADPH oxidase complex [GO:0043020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcoplasmic reticulum [GO:0016529]; stress fiber [GO:0001725],"heme binding [GO:0020037]; modified amino acid binding [GO:0072341]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADPH oxidase H202-forming activity [GO:0106294]; oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor [GO:0050664]; protein tyrosine kinase binding [GO:1990782]; superoxide-generating NAD(P)H oxidase activity [GO:0016175]; superoxide-generating NADPH oxidase activity [GO:0106292]",GO:0003013; GO:0003824; GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0006520; GO:0006790; GO:0016491; GO:0030154; GO:0043226,circulatory system process; catalytic activity; nucleus; mitochondrion; endoplasmic reticulum; plasma membrane; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; cell differentiation; organelle
OG_03097,FUN_012384-T1,Peve_00030646,Pocillopora_meandrina_HIv1___TS.g16227.t2,three_way,74.24833333333333,FUN_012384-T1,Q6P4K5,,,,,68.0,197.0,2.6e-64,247.7,sp|Q6P4K5|FL2D_XENTR Pre-mRNA-splicing regulator WTAP OS=Xenopus tropicalis OX=8364 GN=wtap PE=2 SV=1,,,,,,
OG_03098,FUN_012385-T1,Peve_00030647,Pocillopora_meandrina_HIv1___RNAseq.g23346.t1,three_way,76.08833333333334,FUN_012385-T1,Q99ND9,,,,,51.5,231.0,8.2e-43,175.3,sp|Q99ND9|RWDD1_RAT RWD domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Rwdd1 PE=2 SV=1,,,,,,
OG_03099,FUN_012386-T1,Peve_00030648,Pocillopora_meandrina_HIv1___RNAseq.g23347.t1,three_way,52.83716666666666,,,,,,,,,,,,,,,,,
OG_03100,FUN_012387-T1,Peve_00042538,Pocillopora_meandrina_HIv1___TS.g16230.t1,three_way,60.22266666666667,FUN_012387-T1,O04854,,,,,39.0,236.0,9.6e-43,175.3,sp|O04854|CAMT_EUCGU Caffeoyl-CoA O-methyltransferase OS=Eucalyptus gunnii OX=3933 PE=2 SV=1,,,,,,
OG_03101,FUN_012388-T1,Peve_00029782,Pocillopora_meandrina_HIv1___RNAseq.g23654.t1,three_way,67.31333333333333,,,,,,,,,,,,,,,,,
OG_03102,FUN_012389-T1,Peve_00022228,Pocillopora_meandrina_HIv1___RNAseq.g23655.t1,three_way,46.341166666666666,,,,,,,,,,,,,,,,,
OG_03103,FUN_012390-T1,Peve_00022229,Pocillopora_meandrina_HIv1___RNAseq.g23656.t1,three_way,66.252,,,,,,,,,,,,,,,,,
OG_03104,FUN_012391-T1,Peve_00022230,Pocillopora_meandrina_HIv1___RNAseq.g23657.t1,three_way,59.73266666666667,FUN_012391-T1,Q6DRM0,GET1_DANRE,,Guided entry of tail-anchored proteins factor 1 (Tail-anchored protein insertion receptor WRB) (Tryptophan-rich basic protein),Danio rerio (Zebrafish) (Brachydanio rerio),31.2,157.0,2.2e-16,87.4,sp|Q6DRM0|GET1_DANRE Guided entry of tail-anchored proteins factor 1 OS=Danio rerio OX=7955 GN=get1 PE=2 SV=1,GO:0001964; GO:0005783; GO:0005789; GO:0007507; GO:0007605; GO:0010996; GO:0043495; GO:0043529; GO:0060041; GO:0071816,heart development [GO:0007507]; response to auditory stimulus [GO:0010996]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GET complex [GO:0043529],protein-membrane adaptor activity [GO:0043495],GO:0005783; GO:0043226; GO:0048856; GO:0050877; GO:0060090,endoplasmic reticulum; organelle; anatomical structure development; nervous system process; molecular adaptor activity
OG_03105,FUN_012401-T1,Peve_00023473,Pocillopora_meandrina_HIv1___RNAseq.g23668.t1,three_way,63.751666666666665,,,,,,,,,,,,,,,,,
OG_03106,FUN_012402-T1,Peve_00023469,Pocillopora_meandrina_HIv1___RNAseq.g23670.t1,three_way,45.885,FUN_012402-T1,Q6UXI7,VITRN_HUMAN,,Vitrin,Homo sapiens (Human),28.8,184.0,5.1e-15,84.7,sp|Q6UXI7|VITRN_HUMAN Vitrin OS=Homo sapiens OX=9606 GN=VIT PE=1 SV=1,GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198,extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510],extracellular region [GO:0005576]; interstitial matrix [GO:0005614],glycosaminoglycan binding [GO:0005539],GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_03107,FUN_012403-T1,Peve_00023468,Pocillopora_meandrina_HIv1___RNAseq.g23671.t1,three_way,40.333,,,,,,,,,,,,,,,,,
OG_03108,FUN_012405-T1,Peve_00002856,Pocillopora_meandrina_HIv1___RNAseq.g9951.t1,three_way,66.98066666666666,,,,,,,,,,,,,,,,,
OG_03109,FUN_012412-T1,Peve_00037990,Pocillopora_meandrina_HIv1___RNAseq.g23677.t1,three_way,55.126,,,,,,,,,,,,,,,,,
OG_03110,FUN_012413-T1,Peve_00037989,Pocillopora_meandrina_HIv1___RNAseq.g23678.t1,three_way,80.74566666666666,FUN_012413-T1,Q28HM1,TFB1M_XENTR,,"Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)",Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),40.6,335.0,5.3e-73,276.2,"sp|Q28HM1|TFB1M_XENTR Dimethyladenosine transferase 1, mitochondrial OS=Xenopus tropicalis OX=8364 GN=tfb1m PE=2 SV=1",GO:0000179; GO:0003677; GO:0003723; GO:0005739; GO:0031167; GO:1904047,rRNA methylation [GO:0031167],mitochondrion [GO:0005739],"DNA binding [GO:0003677]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; S-adenosyl-L-methionine binding [GO:1904047]",GO:0003677; GO:0003723; GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on RNA"
OG_03111,FUN_012414-T1,Peve_00037988,Pocillopora_meandrina_HIv1___RNAseq.g23679.t1,three_way,75.20233333333333,FUN_012414-T1,Q04892,,,,,39.6,164.0,6.9e-21,102.4,sp|Q04892|SOX14_MOUSE Transcription factor SOX-14 OS=Mus musculus OX=10090 GN=Sox14 PE=2 SV=2,,,,,,
OG_03112,FUN_012416-T1,Peve_00042097,Pocillopora_meandrina_HIv1___RNAseq.g23680.t1,three_way,89.04616666666666,FUN_012416-T1,Q9HD26,,,,,55.4,372.0,4.6e-102,372.9,sp|Q9HD26|GOPC_HUMAN Golgi-associated PDZ and coiled-coil motif-containing protein OS=Homo sapiens OX=9606 GN=GOPC PE=1 SV=1,,,,,,
OG_03113,FUN_012418-T1,Peve_00026919,Pocillopora_meandrina_HIv1___RNAseq.g23687.t1,three_way,85.58083333333333,FUN_012418-T1,Q4V7D3,MACOI_RAT,,Macoilin (Macoilin-1) (Transmembrane protein 57),Rattus norvegicus (Rat),39.0,715.0,7.6e-111,402.9,sp|Q4V7D3|MACOI_RAT Macoilin OS=Rattus norvegicus OX=10116 GN=Maco1 PE=1 SV=1,GO:0005634; GO:0006935; GO:0007420; GO:0008017; GO:0023041; GO:0030424; GO:0030867; GO:0031965; GO:0043005; GO:0044306; GO:0045202,brain development [GO:0007420]; chemotaxis [GO:0006935]; neuronal signal transduction [GO:0023041],axon [GO:0030424]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202],microtubule binding [GO:0008017],GO:0005634; GO:0008092; GO:0043226; GO:0048856,nucleus; cytoskeletal protein binding; organelle; anatomical structure development
OG_03114,FUN_012419-T1,Peve_00026917,Pocillopora_meandrina_HIv1___TS.g16564.t1,three_way,78.13533333333334,FUN_012419-T1,Q8HXQ3,,,,,68.6,153.0,6.3999999999999995e-55,214.9,sp|Q8HXQ3|SODC_HYLLA Superoxide dismutase [Cu-Zn] OS=Hylobates lar OX=9580 GN=SOD1 PE=2 SV=3,,,,,,
OG_03115,FUN_012420-T1,Peve_00026918,Pocillopora_meandrina_HIv1___RNAseq.g23691.t1,three_way,83.90433333333334,FUN_012420-T1,Q9EQS3,,,,,59.2,76.0,1.2e-19,97.4,sp|Q9EQS3|MYCBP_MOUSE c-Myc-binding protein OS=Mus musculus OX=10090 GN=Mycbp PE=1 SV=5,,,,,,
OG_03116,FUN_012430-T1,Peve_00026925,Pocillopora_meandrina_HIv1___RNAseq.g23681.t1,three_way,55.942,FUN_012430-T1,Q7TXL8,,,,,25.4,2226.0,7.9e-140,501.5,sp|Q7TXL8|PPSC_MYCBO Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) OX=233413 GN=ppsC PE=1 SV=1,,,,,,
OG_03117,FUN_012465-T1,Peve_00000724,Pocillopora_meandrina_HIv1___RNAseq.g24004.t1,three_way,90.188,FUN_012465-T1,P63030,,,,,73.1,78.0,2.9e-29,129.0,sp|P63030|MPC1_MOUSE Mitochondrial pyruvate carrier 1 OS=Mus musculus OX=10090 GN=Mpc1 PE=1 SV=1,,,,,,
OG_03118,FUN_012466-T1,Peve_00034217,Pocillopora_meandrina_HIv1___RNAseq.g24003.t1,three_way,65.63133333333333,FUN_012466-T1,P46029,,,,,41.7,672.0,1.1e-136,488.8,sp|P46029|S15A2_RABIT Solute carrier family 15 member 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC15A2 PE=1 SV=1,,,,,,
OG_03119,FUN_012467-T1,Peve_00007948,Pocillopora_meandrina_HIv1___RNAseq.g23979.t1,three_way,72.50066666666666,FUN_012467-T1,Q9HF54,,,,,41.9,186.0,3.7e-35,150.2,sp|Q9HF54|RHO1_EREGS GTP-binding protein RHO1 OS=Eremothecium gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=RHO1 PE=3 SV=1,,,,,,
OG_03120,FUN_012469-T1,Peve_00007945,Pocillopora_meandrina_HIv1___RNAseq.g27161.t1,three_way,62.98266666666667,FUN_012469-T1,Q9XTR8,,,,,29.8,302.0,2.6e-34,147.9,sp|Q9XTR8|LIP1_CAEEL Lipase ZK262.3 OS=Caenorhabditis elegans OX=6239 GN=txt-8 PE=1 SV=1,,,,,,
OG_03121,FUN_012475-T1,Peve_00004003,Pocillopora_meandrina_HIv1___RNAseq.g23989.t1,three_way,76.35766666666667,FUN_012475-T1,Q9D6D8,,,,,49.7,286.0,2.5e-79,297.0,sp|Q9D6D8|PPIL6_MOUSE Probable inactive peptidyl-prolyl cis-trans isomerase-like 6 OS=Mus musculus OX=10090 GN=Ppil6 PE=1 SV=2,,,,,,
OG_03122,FUN_012476-T1,Peve_00004005,Pocillopora_meandrina_HIv1___RNAseq.g23990.t1,three_way,74.48633333333333,FUN_012476-T1,O15247,CLIC2_HUMAN,,Chloride intracellular channel protein 2 (Glutaredoxin-like oxidoreductase CLIC2) (EC 1.8.-.-) (Glutaredoxin-like peroxidase CLIC2) (EC 1.11.1.-) (XAP121),Homo sapiens (Human),31.7,230.0,1.5e-23,111.3,sp|O15247|CLIC2_HUMAN Chloride intracellular channel protein 2 OS=Homo sapiens OX=9606 GN=CLIC2 PE=1 SV=3,GO:0004602; GO:0005254; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006821; GO:0007165; GO:0010880; GO:0010881; GO:0016020; GO:0034707,chloride transport [GO:0006821]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165],chloride channel complex [GO:0034707]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; glutathione peroxidase activity [GO:0004602],GO:0003824; GO:0005215; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016209; GO:0016491; GO:0043226,catalytic activity; transporter activity; nucleus; nucleoplasm; cytosol; plasma membrane; antioxidant activity; oxidoreductase activity; organelle
OG_03123,FUN_012477-T1,Peve_00004006,Pocillopora_meandrina_HIv1___RNAseq.g23991.t1,three_way,62.38933333333333,,,,,,,,,,,,,,,,,
OG_03124,FUN_012480-T1,Peve_00003996,Pocillopora_meandrina_HIv1___RNAseq.g23993.t1,three_way,91.423,FUN_012480-T1,Q5IRJ7,,,,,45.3,128.0,2.4e-23,109.8,sp|Q5IRJ7|PROF4_RAT Profilin-4 OS=Rattus norvegicus OX=10116 GN=Pfn4 PE=1 SV=1,,,,,,
OG_03125,FUN_012481-T1,Peve_00003997,Pocillopora_meandrina_HIv1___TS.g16861.t1,three_way,79.94766666666666,,,,,,,,,,,,,,,,,
OG_03126,FUN_012482-T1,Peve_00004001,Pocillopora_meandrina_HIv1___RNAseq.g23996.t2,three_way,49.154,FUN_012482-T1,O15287,FANCG_HUMAN,,Fanconi anemia group G protein (Protein FACG) (DNA repair protein XRCC9),Homo sapiens (Human),26.7,243.0,4.6e-08,61.6,sp|O15287|FANCG_HUMAN Fanconi anemia group G protein OS=Homo sapiens OX=9606 GN=FANCG PE=1 SV=1,GO:0000785; GO:0001541; GO:0003684; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006974; GO:0007005; GO:0007286; GO:0009314; GO:0016607; GO:0036297; GO:0043240,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; mitochondrion organization [GO:0007005]; ovarian follicle development [GO:0001541]; response to radiation [GO:0009314]; spermatid development [GO:0007286],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],damaged DNA binding [GO:0003684],GO:0003677; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0007005; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleoplasm; mitochondrion; cytosol; DNA repair; mitochondrion organization; reproductive process; organelle; anatomical structure development
OG_03127,FUN_012485-T1,Peve_00010916,Pocillopora_meandrina_HIv1___RNAseq.g24000.t1,three_way,82.52933333333333,FUN_012485-T1,Q28DT7,,,,,66.6,356.0,4.8e-145,515.8,sp|Q28DT7|EED_XENTR Polycomb protein eed OS=Xenopus tropicalis OX=8364 GN=eed PE=2 SV=1,,,,,,
OG_03128,FUN_012486-T1,Peve_00010917,Pocillopora_meandrina_HIv1___RNAseq.g24001.t1,three_way,49.27766666666667,,,,,,,,,,,,,,,,,
OG_03129,FUN_012488-T1,Peve_00010911,Pocillopora_meandrina_HIv1___RNAseq.g24002.t1,three_way,66.74766666666667,FUN_012488-T1,Q2T9Y1,,,,,38.2,288.0,2e-35,151.0,sp|Q2T9Y1|CC026_BOVIN Uncharacterized protein C3orf26 homolog OS=Bos taurus OX=9913 PE=2 SV=1,,,,,,
OG_03130,FUN_012490-T1,Peve_00007944,Pocillopora_meandrina_HIv1___RNAseq.g23964.t1,three_way,84.40183333333333,FUN_012490-T1,E9PZZ1,PRD13_MOUSE,,PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13),Mus musculus (Mouse),55.2,87.0,6.6e-20,100.1,sp|E9PZZ1|PRD13_MOUSE PR domain zinc finger protein 13 OS=Mus musculus OX=10090 GN=Prdm13 PE=2 SV=1,GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0021979; GO:0022008; GO:0032259; GO:0042054; GO:0061629; GO:0097154,GABAergic neuron differentiation [GO:0097154]; hypothalamus cell differentiation [GO:0021979]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_03131,FUN_012492-T1,Peve_00007943,Pocillopora_meandrina_HIv1___RNAseq.g23965.t1,three_way,36.31166666666667,,,,,,,,,,,,,,,,,
OG_03132,FUN_012494-T1,Peve_00007950,Pocillopora_meandrina_HIv1___RNAseq.g23966.t1,three_way,73.58933333333333,FUN_012494-T1,A1ZAY1,DLISH_DROME,,SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains),Drosophila melanogaster (Fruit fly),30.5,419.0,7.6e-41,169.5,sp|A1ZAY1|DLISH_DROME SH3 domain-containing protein Dlish OS=Drosophila melanogaster OX=7227 GN=Dlish PE=1 SV=1,GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219,establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251],apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219],cadherin binding [GO:0045296],GO:0005929; GO:0007163; GO:0043226,cilium; establishment or maintenance of cell polarity; organelle
OG_03133,FUN_012495-T1,Peve_00007942,Pocillopora_meandrina_HIv1___RNAseq.g23967.t1,three_way,78.17366666666666,FUN_012495-T1,P02607,,,,,45.3,148.0,2.4e-30,133.3,sp|P02607|MYL6_CHICK Myosin light polypeptide 6 OS=Gallus gallus OX=9031 GN=MYL6 PE=1 SV=3,,,,,,
OG_03134,FUN_012496-T2,Peve_00035862,Pocillopora_meandrina_HIv1___RNAseq.g7423.t2,three_way,38.0025,FUN_012496-T2,Q68D06,SLN13_HUMAN,,Schlafen family member 13 (EC 3.1.-.-) (Schlafen-13) (hSLFN13),Homo sapiens (Human),25.6,843.0,4.000000000000001e-65,251.5,sp|Q68D06|SLN13_HUMAN Schlafen family member 13 OS=Homo sapiens OX=9606 GN=SLFN13 PE=1 SV=1,GO:0000049; GO:0004521; GO:0005524; GO:0005737; GO:0008270; GO:0016075; GO:0016078; GO:0051607,defense response to virus [GO:0051607]; rRNA catabolic process [GO:0016075]; tRNA decay [GO:0016078],cytoplasm [GO:0005737],ATP binding [GO:0005524]; RNA endonuclease activity [GO:0004521]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0006399; GO:0140098,"RNA binding; catalytic activity; tRNA metabolic process; catalytic activity, acting on RNA"
OG_03135,FUN_012514-T1,Peve_00035872,Pocillopora_meandrina_HIv1___RNAseq.g23968.t1,three_way,64.965,FUN_012514-T1,Q9WVS6,,,,,40.9,286.0,8.3e-64,245.4,sp|Q9WVS6|PRKN_MOUSE E3 ubiquitin-protein ligase parkin OS=Mus musculus OX=10090 GN=Prkn PE=1 SV=1,,,,,,
OG_03136,FUN_012517-T1,Peve_00022375,Pocillopora_meandrina_HIv1___TS.g16844.t1a,three_way,77.47516666666667,,,,,,,,,,,,,,,,,
OG_03137,FUN_012518-T1,Peve_00022370,Pocillopora_meandrina_HIv1___RNAseq.g23957.t1,three_way,84.53366666666666,FUN_012518-T1,Q8CHX6,MBTP2_MOUSE,,Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P),Mus musculus (Mouse),40.6,508.0,4.7e-104,379.8,sp|Q8CHX6|MBTP2_MOUSE Membrane-bound transcription factor site-2 protease OS=Mus musculus OX=10090 GN=Mbtps2 PE=2 SV=1,GO:0000139; GO:0004222; GO:0005737; GO:0005789; GO:0007095; GO:0008203; GO:0031293; GO:0034976; GO:0045542; GO:0045944; GO:0046872; GO:0051604; GO:0070977; GO:0140537,bone maturation [GO:0070977]; cholesterol metabolic process [GO:0008203]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein maturation [GO:0051604]; response to endoplasmic reticulum stress [GO:0034976],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; transcription regulator activator activity [GO:0140537],GO:0003824; GO:0006355; GO:0006629; GO:0016787; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; regulation of DNA-templated transcription; lipid metabolic process; hydrolase activity; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03138,FUN_012520-T1,Peve_00014742,Pocillopora_meandrina_HIv1___RNAseq.g23959.t1,three_way,84.107,FUN_012520-T1,A8E4N3,RSPH3_BOVIN,,Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2),Bos taurus (Bovine),64.0,331.0,1.3e-102,374.8,sp|A8E4N3|RSPH3_BOVIN Radial spoke head protein 3 homolog OS=Bos taurus OX=9913 GN=RSPH3 PE=2 SV=1,GO:0001535; GO:0005929; GO:0097729,,9+2 motile cilium [GO:0097729]; cilium [GO:0005929]; radial spoke head [GO:0001535],,GO:0005929; GO:0043226,cilium; organelle
OG_03139,FUN_012521-T1,Peve_00029780,Pocillopora_meandrina_HIv1___RNAseq.g23961.t1,three_way,79.82916666666667,FUN_012521-T1,Q3SZ90,RL13A_BOVIN,,Large ribosomal subunit protein uL13 (60S ribosomal protein L13a),Bos taurus (Bovine),63.1,195.0,5.899999999999999e-68,259.6,sp|Q3SZ90|RL13A_BOVIN Large ribosomal subunit protein uL13 OS=Bos taurus OX=9913 GN=RPL13A PE=2 SV=3,GO:0003729; GO:0003735; GO:0005840; GO:0006412; GO:0017148; GO:0022625; GO:0032496; GO:0042592; GO:0045202; GO:0048246; GO:0060425; GO:0071346; GO:0097452; GO:1901194,cellular response to type II interferon [GO:0071346]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; synapse [GO:0045202],mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002376; GO:0003723; GO:0005198; GO:0005840; GO:0043226; GO:0048870,immune system process; RNA binding; structural molecule activity; ribosome; organelle; cell motility
OG_03140,FUN_012524-T1,Peve_00029781,Pocillopora_meandrina_HIv1___RNAseq.g23963.t1,three_way,62.26433333333333,,,,,,,,,,,,,,,,,
OG_03141,FUN_012525-T1,Peve_00019857,Pocillopora_meandrina_HIv1___RNAseq.g23978.t1,three_way,41.14233333333333,FUN_012525-T1,Q9H4Q3,PRD13_HUMAN,,PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13),Homo sapiens (Human),58.3,84.0,7.9999999999999985e-25,117.1,sp|Q9H4Q3|PRD13_HUMAN PR domain zinc finger protein 13 OS=Homo sapiens OX=9606 GN=PRDM13 PE=1 SV=2,GO:0000122; GO:0003677; GO:0003682; GO:0005634; GO:0008270; GO:0010468; GO:0021979; GO:0032259; GO:0042054; GO:0061629; GO:0097154,GABAergic neuron differentiation [GO:0097154]; hypothalamus cell differentiation [GO:0021979]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468],nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone methyltransferase activity [GO:0042054]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_03142,FUN_012527-T1,Peve_00013904,Pocillopora_meandrina_HIv1___RNAseq.g23975.t1,three_way,73.94666666666667,FUN_012527-T1,Q6REY9,,,,,36.4,571.0,4.2e-87,325.1,sp|Q6REY9|RHG20_RAT Rho GTPase-activating protein 20 OS=Rattus norvegicus OX=10116 GN=Arhgap20 PE=1 SV=2,,,,,,
OG_03143,FUN_012528-T1,Peve_00013908,Pocillopora_meandrina_HIv1___RNAseq.g23974.t1,three_way,64.574,FUN_012528-T1,Q14149,MORC3_HUMAN,,MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3),Homo sapiens (Human),59.4,483.0,9.3e-152,539.3,sp|Q14149|MORC3_HUMAN MORC family CW-type zinc finger protein 3 OS=Homo sapiens OX=9606 GN=MORC3 PE=1 SV=3,GO:0000122; GO:0000785; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006468; GO:0008270; GO:0009791; GO:0016363; GO:0016605; GO:0016887; GO:0018105; GO:0030674; GO:0032688; GO:0035064; GO:0048147; GO:0050821; GO:0051457; GO:0140002; GO:0140374; GO:2000774,antiviral innate immune response [GO:0140374]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cellular senescence [GO:2000774]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821],chromatin [GO:0000785]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; histone H3K4me3 reader activity [GO:0140002]; methylated histone binding [GO:0035064]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016787; GO:0043226; GO:0060090; GO:0098542,immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; hydrolase activity; organelle; molecular adaptor activity; defense response to other organism
OG_03144,FUN_012530-T1,Peve_00013909,Pocillopora_meandrina_HIv1___TS.g16844.t1b,three_way,95.39133333333334,FUN_012530-T1,P20461,,,,,86.7,458.0,1.3e-228,793.5,sp|P20461|IF2G_PIG Eukaryotic translation initiation factor 2 subunit 3 OS=Sus scrofa OX=9823 GN=EIF2S3 PE=1 SV=2,,,,,,
OG_03145,FUN_012531-T1,Peve_00013910,Pocillopora_meandrina_HIv1___RNAseq.g23956.t1c,three_way,73.822,FUN_012531-T1,Q32LP2,RADI_BOVIN,,Radixin,Bos taurus (Bovine),71.5,583.0,2.8e-132,473.8,sp|Q32LP2|RADI_BOVIN Radixin OS=Bos taurus OX=9913 GN=RDX PE=2 SV=1,GO:0003779; GO:0005737; GO:0005856; GO:0005886; GO:0005902; GO:0005912; GO:0008360; GO:0030175; GO:0032154; GO:0045177; GO:0050839; GO:0051693; GO:0120044; GO:1902115; GO:1902966; GO:2000643,actin filament capping [GO:0051693]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein localization to early endosome [GO:1902966]; regulation of cell shape [GO:0008360]; regulation of organelle assembly [GO:1902115],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; stereocilium base [GO:0120044],actin binding [GO:0003779]; cell adhesion molecule binding [GO:0050839],GO:0005856; GO:0005886; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_03146,FUN_012532-T1,Peve_00013905,Pocillopora_meandrina_HIv1___RNAseq.g23955.t1,three_way,55.178666666666665,,,,,,,,,,,,,,,,,
OG_03147,FUN_012533-T1,Peve_00034230,Pocillopora_meandrina_HIv1___RNAseq.g23954.t1,three_way,57.28066666666667,,,,,,,,,,,,,,,,,
OG_03148,FUN_012534-T1,Peve_00034224,Pocillopora_meandrina_HIv1___RNAseq.g23953.t1,three_way,94.06183333333334,FUN_012534-T1,Q148M7,,,,,70.2,121.0,2e-40,166.4,sp|Q148M7|TAF13_BOVIN Transcription initiation factor TFIID subunit 13 OS=Bos taurus OX=9913 GN=TAF13 PE=2 SV=1,,,,,,
OG_03149,FUN_012535-T1,Peve_00034223,Pocillopora_meandrina_HIv1___RNAseq.g23952.t1,three_way,72.12466666666667,,,,,,,,,,,,,,,,,
OG_03150,FUN_012536-T1,Peve_00034222,Pocillopora_meandrina_HIv1___RNAseq.g23951.t1,three_way,83.14166666666667,FUN_012536-T1,Q5RES3,,,,,52.9,87.0,3.9e-17,88.6,sp|Q5RES3|LYRM2_PONAB LYR motif-containing protein 2 OS=Pongo abelii OX=9601 GN=LYRM2 PE=3 SV=1,,,,,,
OG_03151,FUN_012539-T1,Peve_00034216,Pocillopora_meandrina_HIv1___TS.g16499.t1,three_way,63.20733333333334,FUN_012539-T1,Q14AT2,,,,,30.0,447.0,4.1000000000000004e-44,180.6,sp|Q14AT2|TEX11_MOUSE Testis-expressed protein 11 OS=Mus musculus OX=10090 GN=Tex11 PE=1 SV=1,,,,,,
OG_03152,FUN_012541-T1,Peve_00034215,Pocillopora_meandrina_HIv1___RNAseq.g23624.t1,three_way,57.71133333333333,FUN_012541-T1,P50747,BPL1_HUMAN,,Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)],Homo sapiens (Human),36.2,599.0,5.300000000000001e-100,366.7,sp|P50747|BPL1_HUMAN Biotin--protein ligase OS=Homo sapiens OX=9606 GN=HLCS PE=1 SV=1,GO:0000785; GO:0004077; GO:0005524; GO:0005652; GO:0005737; GO:0005739; GO:0005829; GO:0006768; GO:0009374; GO:0016363; GO:0019899; GO:0042802; GO:0043687; GO:0070781,biotin metabolic process [GO:0006768]; post-translational protein modification [GO:0043687]; response to biotin [GO:0070781],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363],ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin--[biotin carboxyl-carrier protein] ligase activity [GO:0004077]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802],GO:0003824; GO:0005739; GO:0005829; GO:0006790; GO:0016874; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; cytosol; sulfur compound metabolic process; ligase activity; organelle; catalytic activity, acting on a protein"
OG_03153,FUN_012542-T1,Peve_00034213,Pocillopora_meandrina_HIv1___RNAseq.g23623.t1,three_way,74.7105,FUN_012542-T1,O15442,,,,,51.8,251.0,1.3e-72,274.6,sp|O15442|MPPD1_HUMAN Metallophosphoesterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=MPPED1 PE=1 SV=3,,,,,,
OG_03154,FUN_012545-T1,Peve_00030392,Pocillopora_meandrina_HIv1___RNAseq.g23621.t1,three_way,90.88266666666668,FUN_012545-T1,Q9DC48,,,,,66.9,550.0,4.2999999999999986e-229,795.4,sp|Q9DC48|PRP17_MOUSE Pre-mRNA-processing factor 17 OS=Mus musculus OX=10090 GN=Cdc40 PE=1 SV=1,,,,,,
OG_03155,FUN_012546-T1,Peve_00030399,Pocillopora_meandrina_HIv1___RNAseq.g23612.t1,three_way,72.47733333333333,FUN_012546-T1,O43719,HTSF1_HUMAN,,17S U2 SnRNP complex component HTATSF1 (HIV Tat-specific factor 1) (Tat-SF1),Homo sapiens (Human),44.5,384.0,5.600000000000001e-89,329.3,sp|O43719|HTSF1_HUMAN 17S U2 SnRNP complex component HTATSF1 OS=Homo sapiens OX=9606 GN=HTATSF1 PE=1 SV=1,GO:0000398; GO:0000724; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0035861; GO:0140463; GO:0160004; GO:1903241; GO:1990166,"double-strand break repair via homologous recombination [GO:0000724]; mRNA splicing, via spliceosome [GO:0000398]; protein localization to site of double-strand break [GO:1990166]; U2-type prespliceosome assembly [GO:1903241]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684],chromatin-protein adaptor activity [GO:0140463]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016071; GO:0043226; GO:0060090; GO:0065003,RNA binding; nucleus; nucleoplasm; DNA repair; DNA recombination; mRNA metabolic process; organelle; molecular adaptor activity; protein-containing complex assembly
OG_03156,FUN_012547-T1,Peve_00030402,Pocillopora_meandrina_HIv1___RNAseq.g23610.t1,three_way,79.964,FUN_012547-T1,O00628,PEX7_HUMAN,,Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7),Homo sapiens (Human),54.8,157.0,6.7e-51,202.6,sp|O00628|PEX7_HUMAN Peroxisomal targeting signal 2 receptor OS=Homo sapiens OX=9606 GN=PEX7 PE=1 SV=1,GO:0001764; GO:0001958; GO:0005053; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006625; GO:0006635; GO:0007031; GO:0008611; GO:0016558; GO:0019899; GO:0042803,endochondral ossification [GO:0001958]; ether lipid biosynthetic process [GO:0008611]; fatty acid beta-oxidation [GO:0006635]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein targeting to peroxisome [GO:0006625],cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],enzyme binding [GO:0019899]; peroxisome matrix targeting signal-2 binding [GO:0005053]; protein homodimerization activity [GO:0042803],GO:0005777; GO:0005829; GO:0006629; GO:0006886; GO:0007031; GO:0043226; GO:0048870; GO:0055085,peroxisome; cytosol; lipid metabolic process; intracellular protein transport; peroxisome organization; organelle; cell motility; transmembrane transport
OG_03157,FUN_012548-T1,Peve_00030413,Pocillopora_meandrina_HIv1___RNAseq.g23609.t1,three_way,63.32366666666667,FUN_012548-T1,Q8NBP5,,,,,33.7,409.0,6.600000000000001e-57,223.0,sp|Q8NBP5|MFSD9_HUMAN Major facilitator superfamily domain-containing protein 9 OS=Homo sapiens OX=9606 GN=MFSD9 PE=1 SV=2,,,,,,
OG_03158,FUN_012554-T1,Peve_00030421,Pocillopora_meandrina_HIv1___RNAseq.g23587.t2,three_way,58.8805,,,,,,,,,,,,,,,,,
OG_03159,FUN_012555-T1,Peve_00030423,Pocillopora_meandrina_HIv1___RNAseq.g23586.t1,three_way,88.37933333333334,FUN_012555-T1,Q9D023,MPC2_MOUSE,,Mitochondrial pyruvate carrier 2 (Brain protein 44),Mus musculus (Mouse),59.5,116.0,2.1e-32,139.8,sp|Q9D023|MPC2_MOUSE Mitochondrial pyruvate carrier 2 OS=Mus musculus OX=10090 GN=Mpc2 PE=1 SV=1,GO:0005739; GO:0005743; GO:0006086; GO:0006850; GO:0035774; GO:0042802; GO:0050833,mitochondrial pyruvate transmembrane transport [GO:0006850]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; pyruvate decarboxylation to acetyl-CoA [GO:0006086],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; pyruvate transmembrane transporter activity [GO:0050833],GO:0005215; GO:0005739; GO:0006790; GO:0043226; GO:0055085; GO:0055086,transporter activity; mitochondrion; sulfur compound metabolic process; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process
OG_03160,FUN_012556-T1,Peve_00030424,Pocillopora_meandrina_HIv1___RNAseq.g23585.t1,three_way,70.635,FUN_012556-T1,Q4V8S3,,,,,44.0,91.0,9e-11,68.2,sp|Q4V8S3|TM242_DANRE Transmembrane protein 242 OS=Danio rerio OX=7955 GN=tmem242 PE=2 SV=2,,,,,,
OG_03161,FUN_012557-T1,Peve_00030425,Pocillopora_meandrina_HIv1___TS.g16464.t1,three_way,86.991,FUN_012557-T1,Q8IZN3,ZDH14_HUMAN,,Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14),Homo sapiens (Human),65.3,303.0,6.5e-121,435.6,sp|Q8IZN3|ZDH14_HUMAN Palmitoyltransferase ZDHHC14 OS=Homo sapiens OX=9606 GN=ZDHHC14 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580,peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0003824; GO:0005783; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03162,FUN_012560-T1,Peve_00016376,Pocillopora_meandrina_HIv1___RNAseq.g23583.t2,three_way,80.59633333333333,FUN_012560-T1,O19072,,,,,62.7,316.0,7.9e-115,415.2,"sp|O19072|OTC_PIG Ornithine transcarbamylase, mitochondrial (Fragment) OS=Sus scrofa OX=9823 GN=OTC PE=2 SV=1",,,,,,
OG_03163,FUN_012561-T1,Peve_00016373,Pocillopora_meandrina_HIv1___RNAseq.g23582.t1,three_way,69.20983333333334,FUN_012561-T1,Q92834,RPGR_HUMAN,,X-linked retinitis pigmentosa GTPase regulator,Homo sapiens (Human),44.0,448.0,1.1e-68,263.1,sp|Q92834|RPGR_HUMAN X-linked retinitis pigmentosa GTPase regulator OS=Homo sapiens OX=9606 GN=RPGR PE=1 SV=2,GO:0001750; GO:0003723; GO:0005085; GO:0005737; GO:0005794; GO:0005813; GO:0006511; GO:0006886; GO:0007601; GO:0010508; GO:0016567; GO:0032391; GO:0036064; GO:0036126; GO:0042073; GO:0042462; GO:0060271; GO:0061630; GO:0097499,cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; positive regulation of autophagy [GO:0010508]; protein localization to non-motile cilium [GO:0097499]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; sperm flagellum [GO:0036126],guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630],GO:0003723; GO:0003824; GO:0005794; GO:0005815; GO:0005929; GO:0006886; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0098772; GO:0140096,"RNA binding; catalytic activity; Golgi apparatus; microtubule organizing center; cilium; intracellular protein transport; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; nervous system process; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03164,FUN_012568-T1,Peve_00015690,Pocillopora_meandrina_HIv1___RNAseq.g12854.t1,three_way,56.830333333333336,,,,,,,,,,,,,,,,,
OG_03165,FUN_012571-T1,Peve_00015689,Pocillopora_meandrina_HIv1___RNAseq.g12855.t1,three_way,43.12116666666667,FUN_012571-T1,P0C6Y7,PRDM9_RAT,,Histone-lysine N-methyltransferase PRDM9 (PR domain zinc finger protein 9) (PR domain-containing protein 9) (Protein-lysine N-methyltransferase PRDM9) (EC 2.1.1.-) ([histone H3]-lysine36 N-trimethyltransferase PRDM9) (EC 2.1.1.359) ([histone H3]-lysine4 N-trimethyltransferase PRDM9) (EC 2.1.1.354) ([histone H3]-lysine9 N-trimethyltransferase PRDM9) (EC 2.1.1.355) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase PRDM9) (EC 2.1.1.361),Rattus norvegicus (Rat),40.5,173.0,1.4e-32,143.3,sp|P0C6Y7|PRDM9_RAT Histone-lysine N-methyltransferase PRDM9 OS=Rattus norvegicus OX=10116 GN=Prdm9 PE=3 SV=1,GO:0000785; GO:0000976; GO:0005634; GO:0006311; GO:0007127; GO:0007129; GO:0007283; GO:0007292; GO:0008270; GO:0010468; GO:0010844; GO:0010845; GO:0032259; GO:0042800; GO:0042803; GO:0043066; GO:0043565; GO:0045944; GO:0046975; GO:0048232; GO:0060903; GO:0140941; GO:0140944; GO:0140949; GO:0140955; GO:0140999; GO:1905516; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; male gamete generation [GO:0048232]; meiosis I [GO:0007127]; meiotic gene conversion [GO:0006311]; methylation [GO:0032259]; negative regulation of apoptotic process [GO:0043066]; positive regulation of fertilization [GO:1905516]; positive regulation of meiosis I [GO:0060903]; positive regulation of reciprocal meiotic recombination [GO:0010845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; nucleus [GO:0005634],histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone H3K9 trimethyltransferase activity [GO:0140949]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; protein homodimerization activity [GO:0042803]; recombination hotspot binding [GO:0010844]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0140013; GO:0140096,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_03166,FUN_012588-T1,Peve_00038785,Pocillopora_meandrina_HIv1___TS.g2635.t1,three_way,81.07383333333334,FUN_012588-T1,Q18297,TRPA1_CAEEL,,Transient receptor potential cation channel subfamily A member 1 homolog,Caenorhabditis elegans,30.8,568.0,2.3e-54,216.1,sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5,GO:0005216; GO:0005886; GO:0043025; GO:0097730,,neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],monoatomic ion channel activity [GO:0005216],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_03167,FUN_012589-T1,Peve_00038783,Pocillopora_meandrina_HIv1___RNAseq.g13638.t1,three_way,75.37183333333333,FUN_012589-T1,Q9D572,,,,,36.1,485.0,1.2e-72,275.4,sp|Q9D572|UBX11_MOUSE UBX domain-containing protein 11 OS=Mus musculus OX=10090 GN=Ubxn11 PE=1 SV=1,,,,,,
OG_03168,FUN_012590-T1,Peve_00038782,Pocillopora_meandrina_HIv1___RNAseq.g13637.t1,three_way,72.70233333333334,FUN_012590-T1,Q53FA7,QORX_HUMAN,,Quinone oxidoreductase PIG3 (EC 1.6.5.5) (NADPH:quinone reductase PIG3) (Tumor protein p53-inducible protein 3) (Protein PIG3) (p53-induced gene 3 protein),Homo sapiens (Human),53.7,322.0,9.4e-97,355.1,sp|Q53FA7|QORX_HUMAN Quinone oxidoreductase PIG3 OS=Homo sapiens OX=9606 GN=TP53I3 PE=1 SV=2,GO:0003960; GO:0005829; GO:0006739; GO:0042803; GO:0048038; GO:0070402,NADP metabolic process [GO:0006739],cytosol [GO:0005829],NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038],GO:0003824; GO:0005829; GO:0016491; GO:0055086,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_03169,FUN_012591-T1,Peve_00038779,Pocillopora_meandrina_HIv1___RNAseq.g13635.t2,three_way,63.194,FUN_012591-T1,Q96PZ0,PUS7_HUMAN,,Pseudouridylate synthase 7 homolog (EC 5.4.99.-),Homo sapiens (Human),44.0,577.0,1.9e-143,511.1,sp|Q96PZ0|PUS7_HUMAN Pseudouridylate synthase 7 homolog OS=Homo sapiens OX=9606 GN=PUS7 PE=1 SV=2,GO:0001522; GO:0003723; GO:0005634; GO:0006397; GO:0008380; GO:0009982; GO:0017148; GO:0019899; GO:0031119; GO:0160150; GO:1902036; GO:1990481; GO:2000380,mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; pseudouridine synthesis [GO:0001522]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119],nucleus [GO:0005634],enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine(13) synthase activity [GO:0160150],GO:0003723; GO:0003824; GO:0005634; GO:0006399; GO:0016071; GO:0016853; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; tRNA metabolic process; mRNA metabolic process; isomerase activity; organelle; catalytic activity, acting on RNA"
OG_03170,FUN_012592-T1,Peve_00038776,Pocillopora_meandrina_HIv1___RNAseq.g13634.t1,three_way,58.254333333333335,,,,,,,,,,,,,,,,,
OG_03171,FUN_012594-T1,Peve_00042400,Pocillopora_meandrina_HIv1___RNAseq.g13631.t1,three_way,63.02033333333333,FUN_012594-T1,Q91YI6,GLD2_MOUSE,,Poly(A) RNA polymerase GLD2 (mGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4) (Terminal nucleotidyltransferase 2),Mus musculus (Mouse),35.1,328.0,2.3e-38,161.0,sp|Q91YI6|GLD2_MOUSE Poly(A) RNA polymerase GLD2 OS=Mus musculus OX=10090 GN=Tent2 PE=1 SV=1,GO:0002244; GO:0005524; GO:0005634; GO:0005737; GO:0031124; GO:0046872; GO:0071044; GO:0140958; GO:1990817; GO:2000626,hematopoietic progenitor cell differentiation [GO:0002244]; histone mRNA catabolic process [GO:0071044]; mRNA 3'-end processing [GO:0031124]; negative regulation of miRNA catabolic process [GO:2000626]; target-directed miRNA degradation [GO:0140958],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nucleus; mRNA metabolic process; transferase activity; cell differentiation; organelle
OG_03172,FUN_012595-T1,Peve_00042401,Pocillopora_meandrina_HIv1___TS.g2626.t1,three_way,93.69466666666666,FUN_012595-T1,Q8BWD8,,,,,81.7,367.0,3.4e-181,636.0,sp|Q8BWD8|CDK19_MOUSE Cyclin-dependent kinase 19 OS=Mus musculus OX=10090 GN=Cdk19 PE=2 SV=1,,,,,,
OG_03173,FUN_012598-T1,Peve_00042799,Pocillopora_meandrina_HIv1___RNAseq.g13673.t1,three_way,66.95833333333333,FUN_012598-T1,Q8VE96,,,,,38.5,369.0,1.1e-51,205.7,sp|Q8VE96|S35F6_MOUSE Solute carrier family 35 member F6 OS=Mus musculus OX=10090 GN=Slc35f6 PE=1 SV=1,,,,,,
OG_03174,FUN_012606-T1,Peve_00011510,Pocillopora_meandrina_HIv1___RNAseq.g18401.t1,three_way,36.155,,,,,,,,,,,,,,,,,
OG_03175,FUN_012608-T1,Peve_00042800,Pocillopora_meandrina_HIv1___RNAseq.g13674.t1,three_way,89.57833333333333,FUN_012608-T1,Q7T3I0,ZC4H2_DANRE,,Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127 homolog) (Hepatocellular carcinoma-associated antigen 127-like),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,225.0,6.3e-46,185.7,sp|Q7T3I0|ZC4H2_DANRE Zinc finger C4H2 domain-containing protein OS=Danio rerio OX=7955 GN=zc4h2 PE=2 SV=1,GO:0005634; GO:0005737; GO:0007399; GO:0007528; GO:0008270; GO:0021522; GO:0036269; GO:0045211; GO:0045666; GO:0048665; GO:0048666; GO:0050885,nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process controlling balance [GO:0050885]; neuron development [GO:0048666]; neuron fate specification [GO:0048665]; positive regulation of neuron differentiation [GO:0045666]; spinal cord motor neuron differentiation [GO:0021522]; swimming behavior [GO:0036269],cytoplasm [GO:0005737]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211],zinc ion binding [GO:0008270],GO:0005634; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0050877,nucleus; cell differentiation; cell junction organization; organelle; anatomical structure development; nervous system process
OG_03176,FUN_012611-T1,Peve_00040819,Pocillopora_meandrina_HIv1___RNAseq.g13692.t1,three_way,81.25366666666666,FUN_012611-T1,Q64674,,,,,68.6,283.0,1.6e-115,417.2,sp|Q64674|SPEE_MOUSE Spermidine synthase OS=Mus musculus OX=10090 GN=Srm PE=1 SV=1,,,,,,
OG_03177,FUN_012612-T1,Peve_00040814,Pocillopora_meandrina_HIv1___TS.g2699.t1,three_way,59.31666666666666,FUN_012612-T1,Q19269,NAS14_CAEEL,,Zinc metalloproteinase nas-14 (EC 3.4.24.-) (Nematode astacin 14),Caenorhabditis elegans,37.7,257.0,2.8e-39,164.1,sp|Q19269|NAS14_CAEEL Zinc metalloproteinase nas-14 OS=Caenorhabditis elegans OX=6239 GN=nas-14 PE=2 SV=2,GO:0004222; GO:0005576; GO:0006508; GO:0008270,proteolysis [GO:0006508],extracellular region [GO:0005576],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_03178,FUN_012624-T1,Peve_00040101,Pocillopora_meandrina_HIv1___RNAseq.g13730.t1,three_way,77.34,FUN_012624-T1,Q6AYY8,,,,,59.8,485.0,1.6e-169,597.4,sp|Q6AYY8|ACATN_RAT Acetyl-coenzyme A transporter 1 OS=Rattus norvegicus OX=10116 GN=Slc33a1 PE=2 SV=1,,,,,,
OG_03179,FUN_012625-T1,Peve_00040110,Pocillopora_meandrina_HIv1___RNAseq.g13729.t1,three_way,75.87533333333333,FUN_012625-T1,Q55FK2,RAB6_DICDI,,Ras-related protein Rab-6,Dictyostelium discoideum (Social amoeba),48.7,189.0,7.6e-44,178.7,sp|Q55FK2|RAB6_DICDI Ras-related protein Rab-6 OS=Dictyostelium discoideum OX=44689 GN=rab6 PE=3 SV=1,GO:0003924; GO:0005525; GO:0005794; GO:0005811; GO:0005829; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0042147; GO:0140220,"intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; pathogen-containing vacuole [GO:0140220],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005794; GO:0005811; GO:0005829; GO:0006886; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; Golgi apparatus; lipid droplet; cytosol; intracellular protein transport; vesicle-mediated transport; hydrolase activity; organelle
OG_03180,FUN_012628-T1,Peve_00040111,Pocillopora_meandrina_HIv1___RNAseq.g13728.t1,three_way,73.136,FUN_012628-T1,Q5BKR2,SL9B2_MOUSE,,Sodium/hydrogen exchanger 9B2 (NHA-oc) (Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Soditlum/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),Mus musculus (Mouse),50.6,451.0,9.2e-114,412.1,sp|Q5BKR2|SL9B2_MOUSE Sodium/hydrogen exchanger 9B2 OS=Mus musculus OX=10090 GN=Slc9b2 PE=1 SV=2,GO:0005765; GO:0005886; GO:0010008; GO:0010348; GO:0010351; GO:0015385; GO:0016323; GO:0016324; GO:0030317; GO:0030672; GO:0031966; GO:0042802; GO:0046872; GO:0055037; GO:0055038; GO:0055078; GO:0061178; GO:0072583; GO:0097228; GO:2001206,clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; lithium ion transport [GO:0010351]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion homeostasis [GO:0055078],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672],identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; metal ion binding [GO:0046872]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005768; GO:0005886; GO:0007018; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048870,transporter activity; endosome; plasma membrane; microtubule-based movement; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_03181,FUN_012630-T1,Peve_00040109,Pocillopora_meandrina_HIv1___RNAseq.g22915.t2,three_way,37.121,,,,,,,,,,,,,,,,,
OG_03182,FUN_012632-T1,Peve_00036812,Pocillopora_meandrina_HIv1___RNAseq.g22913.t2,three_way,71.34533333333333,,,,,,,,,,,,,,,,,
OG_03183,FUN_012638-T1,Peve_00036816,Pocillopora_meandrina_HIv1___RNAseq.g22910.t1,three_way,71.77066666666667,FUN_012638-T1,Q6P1A2,MBOA5_HUMAN,,Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5),Homo sapiens (Human),39.7,448.0,1.9999999999999998e-91,337.8,sp|Q6P1A2|MBOA5_HUMAN Lysophospholipid acyltransferase 5 OS=Homo sapiens OX=9606 GN=LPCAT3 PE=1 SV=1,GO:0003841; GO:0005789; GO:0006656; GO:0016020; GO:0030258; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047144; GO:0047184; GO:0050728; GO:0071617; GO:0090158; GO:0106262; GO:0106263; GO:1903573; GO:1905885,chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; lipid modification [GO:0030258]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; very-low-density lipoprotein particle assembly [GO:0034379],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617],GO:0003824; GO:0006575; GO:0006629; GO:0016740; GO:0061024; GO:0065003,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity; membrane organization; protein-containing complex assembly
OG_03184,FUN_012639-T1,Peve_00036806,Pocillopora_meandrina_HIv1___RNAseq.g22909.t1,three_way,74.95033333333333,FUN_012639-T1,Q5THJ4,VP13D_HUMAN,,Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D),Homo sapiens (Human),35.7,4659.0,0.0,2452.2,sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2,GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526,lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623],extracellular exosome [GO:0070062]; mitochondrion [GO:0005739],,GO:0005739; GO:0006886; GO:0007005; GO:0043226,mitochondrion; intracellular protein transport; mitochondrion organization; organelle
OG_03185,FUN_012640-T1,Peve_00041557,Pocillopora_meandrina_HIv1___RNAseq.g22908.t1,three_way,69.78033333333333,FUN_012640-T1,Q7T2D1,,,,,37.7,326.0,1.2e-61,238.4,sp|Q7T2D1|RD10B_DANRE Retinol dehydrogenase 10-B OS=Danio rerio OX=7955 GN=rdh10b PE=2 SV=2,,,,,,
OG_03186,FUN_012655-T1,Peve_00022124,Pocillopora_meandrina_HIv1___RNAseq.g22896.t1,three_way,83.30833333333334,FUN_012655-T1,B3TP03,CTR2_CHICK,,Cationic amino acid transporter 2 (CAT-2) (CAT2) (cCAT-2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2),Gallus gallus (Chicken),41.7,653.0,5.0000000000000004e-130,466.5,sp|B3TP03|CTR2_CHICK Cationic amino acid transporter 2 OS=Gallus gallus OX=9031 GN=SLC7A2 PE=2 SV=1,GO:0000064; GO:0005737; GO:0005794; GO:0005886; GO:0015189; GO:0031410; GO:0061459; GO:0097638; GO:0097639; GO:1903352,L-arginine import across plasma membrane [GO:0097638]; L-lysine import across plasma membrane [GO:0097639]; L-ornithine transmembrane transport [GO:1903352],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],GO:0005215; GO:0005794; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_03187,FUN_012657-T1,Peve_00022119,Pocillopora_meandrina_HIv1___RNAseq.g22895.t1,three_way,70.13616666666667,FUN_012657-T1,Q9UK58,,,,,56.1,173.0,6.700000000000001e-48,193.0,sp|Q9UK58|CCNL1_HUMAN Cyclin-L1 OS=Homo sapiens OX=9606 GN=CCNL1 PE=1 SV=1,,,,,,
OG_03188,FUN_012659-T1,Peve_00020498,Pocillopora_meandrina_HIv1___RNAseq.8480_t,three_way,56.535,FUN_012659-T1,Q6P1S2,CC033_HUMAN,,Protein C3orf33 (Protein AC3-33),Homo sapiens (Human),30.2,215.0,1.4000000000000002e-22,108.2,sp|Q6P1S2|CC033_HUMAN Protein C3orf33 OS=Homo sapiens OX=9606 GN=C3orf33 PE=1 SV=2,GO:0005615; GO:0005739; GO:0016020; GO:0051090; GO:0070373,negative regulation of ERK1 and ERK2 cascade [GO:0070373]; regulation of DNA-binding transcription factor activity [GO:0051090],extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739],,GO:0005615; GO:0005739; GO:0006355; GO:0043226,extracellular space; mitochondrion; regulation of DNA-templated transcription; organelle
OG_03189,FUN_012660-T1,Peve_00020497,Pocillopora_meandrina_HIv1___RNAseq.g22893.t1,three_way,86.607,FUN_012660-T1,Q8C811,,,,,49.4,265.0,7.899999999999999e-62,238.8,sp|Q8C811|S35E2_MOUSE Solute carrier family 35 member E2A OS=Mus musculus OX=10090 GN=Slc35e2a PE=2 SV=1,,,,,,
OG_03190,FUN_012662-T1,Peve_00020495,Pocillopora_meandrina_HIv1___RNAseq.g22891.t1,three_way,60.961666666666666,FUN_012662-T1,Q8BZ20,,,,,32.8,649.0,2e-78,295.0,sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3,,,,,,
OG_03191,FUN_012664-T1,Peve_00025332,Pocillopora_meandrina_HIv1___RNAseq.g22887.t1,three_way,83.10666666666667,,,,,,,,,,,,,,,,,
OG_03192,FUN_012668-T1,Peve_00008661,Pocillopora_meandrina_HIv1___RNAseq.g22886.t1,three_way,85.77733333333333,,,,,,,,,,,,,,,,,
OG_03193,FUN_012670-T1,Peve_00008660,Pocillopora_meandrina_HIv1___RNAseq.g22885.t1,three_way,76.15866666666666,FUN_012670-T1,Q5F464,,,,,48.0,256.0,2.8e-72,273.5,sp|Q5F464|LPP_CHICK Lipoma-preferred partner homolog OS=Gallus gallus OX=9031 GN=LPP PE=2 SV=1,,,,,,
OG_03194,FUN_012671-T1,Peve_00008659,Pocillopora_meandrina_HIv1___RNAseq.g22884.t1,three_way,86.19333333333334,FUN_012671-T1,A2BIG9,,,,,58.9,73.0,7.6e-19,94.4,"sp|A2BIG9|NAA38_DANRE N-alpha-acetyltransferase 38, NatC auxiliary subunit OS=Danio rerio OX=7955 GN=naa38 PE=3 SV=1",,,,,,
OG_03195,FUN_012674-T1,Peve_00008658,Pocillopora_meandrina_HIv1___RNAseq.g22883.t2,three_way,87.56833333333333,FUN_012674-T1,Q6NRQ7,,,,,60.9,138.0,3e-43,176.0,sp|Q6NRQ7|SSU72_XENLA RNA polymerase II subunit A C-terminal domain phosphatase SSU72 OS=Xenopus laevis OX=8355 GN=ssu72 PE=2 SV=1,,,,,,
OG_03196,FUN_012675-T1,Peve_00025241,Pocillopora_meandrina_HIv1___RNAseq.g22881.t1,three_way,86.62966666666667,FUN_012675-T1,Q9UNL2,,,,,60.6,180.0,9.9e-55,214.5,sp|Q9UNL2|SSRG_HUMAN Translocon-associated protein subunit gamma OS=Homo sapiens OX=9606 GN=SSR3 PE=1 SV=1,,,,,,
OG_03197,FUN_012676-T2,Peve_00007941,Pocillopora_meandrina_HIv1___RNAseq.g22880.t1,three_way,67.345,FUN_012676-T2,D3ZD32,CHD5_RAT,,Chromodomain-helicase-DNA-binding protein 5 (CHD-5) (EC 3.6.4.-) (ATP-dependent helicase CHD5),Rattus norvegicus (Rat),50.5,1778.0,0.0,1577.4,sp|D3ZD32|CHD5_RAT Chromodomain-helicase-DNA-binding protein 5 OS=Rattus norvegicus OX=10116 GN=Chd5 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000792; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0006338; GO:0006357; GO:0006366; GO:0008270; GO:0008285; GO:0016581; GO:0016887; GO:0021895; GO:0035092; GO:0042393; GO:0042826; GO:0045595; GO:0061628; GO:0140658; GO:1901798,cerebral cortex neuron differentiation [GO:0021895]; chromatin remodeling [GO:0006338]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of cell differentiation [GO:0045595]; regulation of transcription by RNA polymerase II [GO:0006357]; sperm DNA condensation [GO:0035092]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; heterochromatin [GO:0000792]; nucleus [GO:0005634]; NuRD complex [GO:0016581],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; histone deacetylase binding [GO:0042826]; histone H3K27me3 reader activity [GO:0061628]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006325; GO:0006351; GO:0006355; GO:0016787; GO:0016853; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; cell differentiation; histone binding; organelle; molecular adaptor activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03198,FUN_012677-T1,Peve_00042301,Pocillopora_meandrina_HIv1___RNAseq.g22878.t1,three_way,73.87016666666666,FUN_012677-T1,Q9C0J8,WDR33_HUMAN,,pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa),Homo sapiens (Human),74.4,406.0,2.2e-161,571.2,sp|Q9C0J8|WDR33_HUMAN pre-mRNA 3' end processing protein WDR33 OS=Homo sapiens OX=9606 GN=WDR33 PE=1 SV=2,GO:0001650; GO:0003723; GO:0005581; GO:0005634; GO:0005654; GO:0005847; GO:0006301; GO:0007283; GO:0031124,mRNA 3'-end processing [GO:0031124]; postreplication repair [GO:0006301]; spermatogenesis [GO:0007283],collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0016071; GO:0022414; GO:0043226,RNA binding; nucleus; nucleoplasm; DNA repair; mRNA metabolic process; reproductive process; organelle
OG_03199,FUN_012684-T1,Peve_00042302,Pocillopora_meandrina_HIv1___RNAseq.g22874.t1,three_way,80.24466666666666,FUN_012684-T1,P52209,6PGD_HUMAN,,"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)",Homo sapiens (Human),76.5,481.0,1.5999999999999998e-221,770.0,"sp|P52209|6PGD_HUMAN 6-phosphogluconate dehydrogenase, decarboxylating OS=Homo sapiens OX=9606 GN=PGD PE=1 SV=3",GO:0004616; GO:0005634; GO:0005829; GO:0006098; GO:0009051; GO:0019322; GO:0019521; GO:0030246; GO:0031406; GO:0050661; GO:0070062,"D-gluconate metabolic process [GO:0019521]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]",cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],carbohydrate binding [GO:0030246]; carboxylic acid binding [GO:0031406]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616],GO:0003824; GO:0005634; GO:0005829; GO:0005975; GO:0006091; GO:0016491; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03200,FUN_012686-T1,Peve_00022396,Pocillopora_meandrina_HIv1___RNAseq.g22872.t1,three_way,86.87833333333333,FUN_012686-T1,Q90687,PTN11_CHICK,,Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (SH-PTP2) (cSH-PTP2),Gallus gallus (Chicken),62.2,579.0,1.2e-202,707.6,sp|Q90687|PTN11_CHICK Tyrosine-protein phosphatase non-receptor type 11 OS=Gallus gallus OX=9031 GN=PTPN11 PE=2 SV=1,GO:0004725; GO:0004726; GO:0005634; GO:0005737; GO:0030971; GO:0032331; GO:0038127; GO:0045778; GO:0050839; GO:0070374; GO:0071364,cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB signaling pathway [GO:0038127]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ossification [GO:0045778],cytoplasm [GO:0005737]; nucleus [GO:0005634],cell adhesion molecule binding [GO:0050839]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03201,FUN_012687-T1,Peve_00022398,Pocillopora_meandrina_HIv1___RNAseq.g22871.t1,three_way,44.837833333333336,,,,,,,,,,,,,,,,,
OG_03202,FUN_012688-T1,Peve_00016837,Pocillopora_meandrina_HIv1___RNAseq.g22865.t1,three_way,53.63766666666667,,,,,,,,,,,,,,,,,
OG_03203,FUN_012689-T1,Peve_00016816,Pocillopora_meandrina_HIv1___RNAseq.g22864.t1,three_way,78.05083333333333,FUN_012689-T1,Q9YHY6,,,,,42.0,1454.0,3.1999999999999995e-300,1033.1,sp|Q9YHY6|CND1_XENLA Condensin complex subunit 1 OS=Xenopus laevis OX=8355 GN=ncapd2 PE=1 SV=1,,,,,,
OG_03204,FUN_012693-T1,Peve_00016824,Pocillopora_meandrina_HIv1___TS.g15743.t1,three_way,82.26066666666667,FUN_012693-T1,Q7L8C5,SYT13_HUMAN,,Synaptotagmin-13 (Synaptotagmin XIII) (SytXIII),Homo sapiens (Human),29.4,194.0,6.1e-11,70.5,sp|Q7L8C5|SYT13_HUMAN Synaptotagmin-13 OS=Homo sapiens OX=9606 GN=SYT13 PE=1 SV=1,GO:0000149; GO:0005544; GO:0005886; GO:0016192; GO:0017158; GO:0030133; GO:0030424; GO:0030672; GO:0031045; GO:0043231; GO:0061891; GO:0070382; GO:0099502; GO:2000300,calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of synaptic vesicle exocytosis [GO:2000300]; vesicle-mediated transport [GO:0016192],axon [GO:0030424]; dense core granule [GO:0031045]; exocytic vesicle [GO:0070382]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; transport vesicle [GO:0030133],calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149],GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_03205,FUN_012696-T1,Peve_00016827,Pocillopora_meandrina_HIv1___RNAseq.g22856.t1,three_way,62.6505,FUN_012696-T1,Q5F3A1,,,,,56.6,290.0,9.4e-52,205.7,sp|Q5F3A1|SEC62_CHICK Translocation protein SEC62 OS=Gallus gallus OX=9031 GN=SEC62 PE=2 SV=1,,,,,,
OG_03206,FUN_012698-T1,Peve_00016828,Pocillopora_meandrina_HIv1___RNAseq.g22855.t1,three_way,79.2805,FUN_012698-T1,Q62901,RERE_RAT,,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-related protein),Rattus norvegicus (Rat),46.5,514.0,8.900000000000001e-124,446.4,sp|Q62901|RERE_RAT Arginine-glutamic acid dipeptide repeats protein OS=Rattus norvegicus OX=10116 GN=Rere PE=1 SV=2,GO:0000118; GO:0003682; GO:0003713; GO:0003714; GO:0005634; GO:0006338; GO:0008270; GO:0016605; GO:0021549; GO:0021691; GO:0021930; GO:0021942; GO:0043565; GO:0048755; GO:0048813,branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942],histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605],chromatin binding [GO:0003682]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; chromatin organization; organelle; anatomical structure development; cell motility; molecular adaptor activity; transcription regulator activity
OG_03207,FUN_012699-T1,Peve_00016830,Pocillopora_meandrina_HIv1___RNAseq.g22854.t1,three_way,70.60966666666667,FUN_012699-T1,O94923,GLCE_HUMAN,,D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase),Homo sapiens (Human),44.1,612.0,9.099999999999999e-137,488.8,sp|O94923|GLCE_HUMAN D-glucuronyl C5-epimerase OS=Homo sapiens OX=9606 GN=GLCE PE=1 SV=3,GO:0000139; GO:0005509; GO:0005794; GO:0008284; GO:0015012; GO:0016857; GO:0030210; GO:0031345; GO:0042803; GO:0047464; GO:0060391,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; negative regulation of cell projection organization [GO:0031345]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of SMAD protein signal transduction [GO:0060391],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],"calcium ion binding [GO:0005509]; heparosan-N-sulfate-glucuronate 5-epimerase activity [GO:0047464]; protein homodimerization activity [GO:0042803]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]",GO:0003824; GO:0005794; GO:0009101; GO:0016853; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; isomerase activity; organelle; carbohydrate derivative metabolic process
OG_03208,FUN_012700-T1,Peve_00016832,Pocillopora_meandrina_HIv1___RNAseq.g12826.t1,three_way,67.51966666666667,FUN_012700-T1,Q12794,,,,,39.9,353.0,2.5e-73,278.1,sp|Q12794|HYAL1_HUMAN Hyaluronidase-1 OS=Homo sapiens OX=9606 GN=HYAL1 PE=1 SV=2,,,,,,
OG_03209,FUN_012701-T1,Peve_00016835,Pocillopora_meandrina_HIv1___RNAseq.g12828.t1,three_way,66.00966666666667,,,,,,,,,,,,,,,,,
OG_03210,FUN_012706-T2,Peve_00023540,Pocillopora_meandrina_HIv1___RNAseq.g12890.t1,three_way,85.963,FUN_012706-T2,Q53EV4,LRC23_HUMAN,,Leucine-rich repeat-containing protein 23 (Leucine-rich protein B7),Homo sapiens (Human),51.4,276.0,3.3e-48,193.7,sp|Q53EV4|LRC23_HUMAN Leucine-rich repeat-containing protein 23 OS=Homo sapiens OX=9606 GN=LRRC23 PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0030317; GO:0036126; GO:0062177,flagellated sperm motility [GO:0030317]; radial spoke assembly [GO:0062177],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; sperm flagellum [GO:0036126],,GO:0005829; GO:0005856; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0065003,cytosol; cytoskeleton; cilium; microtubule-based movement; reproductive process; organelle; cell motility; protein-containing complex assembly
OG_03211,FUN_012707-T1,Peve_00004150,Pocillopora_meandrina_HIv1___RNAseq.g12831.t1,three_way,67.89066666666668,FUN_012707-T1,A7YY53,ADPRM_BOVIN,,Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase (EC 3.6.1.13) (EC 3.6.1.16) (EC 3.6.1.53) (ADPRibase-Mn) (CDP-choline phosphohydrolase),Bos taurus (Bovine),41.1,333.0,1.1e-70,268.5,sp|A7YY53|ADPRM_BOVIN Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase OS=Bos taurus OX=9913 GN=ADPRM PE=2 SV=2,GO:0008663; GO:0030145; GO:0047631; GO:0047734,,,"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; ADP-ribose diphosphatase activity [GO:0047631]; CDP-glycerol diphosphatase activity [GO:0047734]; manganese ion binding [GO:0030145]",GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_03212,FUN_012708-T1,Peve_00004160,Pocillopora_meandrina_HIv1___RNAseq.g12832.t1,three_way,54.59816666666666,,,,,,,,,,,,,,,,,
OG_03213,FUN_012710-T1,Peve_00004152,Pocillopora_meandrina_HIv1___RNAseq.g12834.t1,three_way,52.82866666666666,,,,,,,,,,,,,,,,,
OG_03214,FUN_012711-T1,Peve_00000958,Pocillopora_meandrina_HIv1___RNAseq.g12836.t1c,three_way,66.162,FUN_012711-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),32.7,284.0,9.999999999999999e-33,142.9,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_03215,FUN_012733-T1,Peve_00013152,Pocillopora_meandrina_HIv1___RNAseq.8836_t,three_way,69.916,FUN_012733-T1,Q9ESQ4,NMUR2_RAT,,Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor TGR-1) (G-protein-coupled receptor FM-4),Rattus norvegicus (Rat),23.5,328.0,2.7e-08,61.2,sp|Q9ESQ4|NMUR2_RAT Neuromedin-U receptor 2 OS=Rattus norvegicus OX=10116 GN=Nmur2 PE=1 SV=2,GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0051930,arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265],membrane [GO:0016020]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188],GO:0005215; GO:0005886; GO:0060089,transporter activity; plasma membrane; molecular transducer activity
OG_03216,FUN_012740-T1,Peve_00045176,Pocillopora_meandrina_HIv1___RNAseq.g23183.t1a,three_way,66.55333333333333,,,,,,,,,,,,,,,,,
OG_03217,FUN_012741-T1,Peve_00045175,Pocillopora_meandrina_HIv1___RNAseq.g23182.t1,three_way,85.23633333333333,FUN_012741-T1,P57076,CF298_HUMAN,,Cilia- and flagella-associated protein 298 (Protein kurly homolog),Homo sapiens (Human),55.0,289.0,1.1e-89,331.3,sp|P57076|CF298_HUMAN Cilia- and flagella-associated protein 298 OS=Homo sapiens OX=9606 GN=CFAP298 PE=1 SV=1,GO:0003352; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0036064; GO:0043231; GO:0060271,cilium assembly [GO:0060271]; regulation of cilium movement [GO:0003352],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0043226; GO:0044782,nucleus; nucleoplasm; microtubule organizing center; cytosol; organelle; cilium organization
OG_03218,FUN_012742-T1,Peve_00045169,Pocillopora_meandrina_HIv1___RNAseq.g23181.t1,three_way,60.48133333333333,,,,,,,,,,,,,,,,,
OG_03219,FUN_012747-T1,Peve_00035931,Pocillopora_meandrina_HIv1___RNAseq.g23180.t1,three_way,36.22733333333333,,,,,,,,,,,,,,,,,
OG_03220,FUN_012757-T1,Peve_00044225,Pocillopora_meandrina_HIv1___TS.g16058.t1,three_way,41.0565,,,,,,,,,,,,,,,,,
OG_03221,FUN_012758-T1,Peve_00010982,Pocillopora_meandrina_HIv1___RNAseq.g23173.t2,three_way,87.95,FUN_012758-T1,Q7TNL3,STK40_MOUSE,,Serine/threonine-protein kinase 40 (EC 2.7.11.1) (Serine/threonine-protein kinase lyk4),Mus musculus (Mouse),58.1,454.0,1.5e-136,487.6,sp|Q7TNL3|STK40_MOUSE Serine/threonine-protein kinase 40 OS=Mus musculus OX=10090 GN=Stk40 PE=1 SV=1,GO:0003016; GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0010468; GO:0030324; GO:0035264; GO:0043066; GO:0043408; GO:0048286; GO:0060425; GO:0106310,glycogen metabolic process [GO:0005977]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung morphogenesis [GO:0060425]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; regulation of gene expression [GO:0010468]; regulation of MAPK cascade [GO:0043408]; respiratory system process [GO:0003016],cytosol [GO:0005829]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003016; GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0048856; GO:0140096,"respiratory system process; catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_03222,FUN_012759-T1,Peve_00010986,Pocillopora_meandrina_HIv1___RNAseq.g23172.t2,three_way,59.90533333333333,FUN_012759-T1,Q496A3,SPAS1_HUMAN,,Spermatogenesis-associated serine-rich protein 1,Homo sapiens (Human),44.3,106.0,1.2e-16,88.6,sp|Q496A3|SPAS1_HUMAN Spermatogenesis-associated serine-rich protein 1 OS=Homo sapiens OX=9606 GN=SPATS1 PE=1 SV=2,,,,,,
OG_03223,FUN_012762-T1,Peve_00010989,Pocillopora_meandrina_HIv1___RNAseq.g23171.t1,three_way,76.07233333333333,FUN_012762-T1,Q7SXM0,HDAC8_DANRE,,Histone deacetylase 8 (HD8) (EC 3.5.1.98) (Protein deacetylase HDAC8) (EC 3.5.1.-) (Protein decrotonylase HDAC8) (EC 3.5.1.-),Danio rerio (Zebrafish) (Brachydanio rerio),56.0,364.0,4.9e-128,459.1,sp|Q7SXM0|HDAC8_DANRE Histone deacetylase 8 OS=Danio rerio OX=7955 GN=hdac8 PE=2 SV=1,GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0007417; GO:0031507; GO:0046872; GO:0070050; GO:0141221; GO:0160009,central nervous system development [GO:0007417]; heterochromatin formation [GO:0031507]; neuron cellular homeostasis [GO:0070050],chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634],"histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone decrotonylase activity [GO:0160009]; metal ion binding [GO:0046872]",GO:0003824; GO:0005634; GO:0005694; GO:0006325; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; chromosome; chromatin organization; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03224,FUN_012764-T2,Peve_00006134,Pocillopora_meandrina_HIv1___TS.g16045.t1,three_way,49.54133333333333,FUN_012764-T2,Q5RFG8,UBE3D_PONAB,,E3 ubiquitin-protein ligase E3D (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase E3D) (UbcH10-binding protein with a HECT-like domain) (Ubiquitin-conjugating enzyme E2C-binding protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,359.0,8.100000000000001e-28,126.3,sp|Q5RFG8|UBE3D_PONAB E3 ubiquitin-protein ligase E3D OS=Pongo abelii OX=9601 GN=UBE3D PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005829; GO:0006513; GO:0030332; GO:0031624; GO:0043161; GO:0051865; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],cyclin binding [GO:0030332]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03225,FUN_012766-T1,Peve_00026363,Pocillopora_meandrina_HIv1___RNAseq.g23151.t1c,three_way,53.47366666666667,,,,,,,,,,,,,,,,,
OG_03226,FUN_012768-T1,Peve_00011054,Pocillopora_meandrina_HIv1___RNAseq.g13663.t1,three_way,69.79666666666667,FUN_012768-T1,Q91Y77,,,,,32.0,456.0,3.9999999999999994e-68,260.4,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_03227,FUN_012769-T1,Peve_00016323,Pocillopora_meandrina_HIv1___RNAseq.g13659.t1,three_way,77.668,FUN_012769-T1,Q68EJ0,NB5R4_RAT,,Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R),Rattus norvegicus (Rat),42.8,544.0,7.9e-116,419.1,sp|Q68EJ0|NB5R4_RAT Cytochrome b5 reductase 4 OS=Rattus norvegicus OX=10116 GN=Cyb5r4 PE=1 SV=2,GO:0003958; GO:0004128; GO:0005737; GO:0005783; GO:0006739; GO:0006801; GO:0016174; GO:0016653; GO:0020037; GO:0030073; GO:0042593; GO:0046677; GO:0046872; GO:0048468; GO:0048471; GO:0050660; GO:0072593,cell development [GO:0048468]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; NADP metabolic process [GO:0006739]; reactive oxygen species metabolic process [GO:0072593]; response to antibiotic [GO:0046677]; superoxide metabolic process [GO:0006801],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]",GO:0003824; GO:0005783; GO:0016491; GO:0043226; GO:0048856; GO:0055086,catalytic activity; endoplasmic reticulum; oxidoreductase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_03228,FUN_012770-T1,Peve_00007595,Pocillopora_meandrina_HIv1___RNAseq.g13655.t1,three_way,69.76033333333334,FUN_012770-T1,P14755,,,,,48.1,310.0,5.4e-80,299.3,sp|P14755|CRYL1_RABIT Lambda-crystallin OS=Oryctolagus cuniculus OX=9986 GN=CRYL1 PE=1 SV=3,,,,,,
OG_03229,FUN_012771-T1,Peve_00007601,Pocillopora_meandrina_HIv1___RNAseq.g13654.t2,three_way,53.73383333333333,FUN_012771-T1,B2RUR8,OTU7B_MOUSE,,OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne),Mus musculus (Mouse),38.2,275.0,7.200000000000001e-44,181.0,sp|B2RUR8|OTU7B_MOUSE OTU domain-containing protein 7B OS=Mus musculus OX=10090 GN=Otud7b PE=1 SV=1,GO:0000122; GO:0001701; GO:0002250; GO:0002385; GO:0003677; GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0008234; GO:0008270; GO:0016579; GO:0032717; GO:0035871; GO:0043124; GO:0070530; GO:0070536; GO:0071108; GO:1900181; GO:1904262; GO:1904515; GO:1990380,adaptive immune response [GO:0002250]; in utero embryonic development [GO:0001701]; mucosal immune response [GO:0002385]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234]; DNA binding [GO:0003677]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"immune system process; DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03230,FUN_012772-T1,Peve_00007600,Pocillopora_meandrina_HIv1___RNAseq.g13653.t1,three_way,86.02266666666667,FUN_012772-T1,Q9DFQ7,,,,,76.6,111.0,5.199999999999999e-43,175.6,sp|Q9DFQ7|RL24_GILMI Large ribosomal subunit protein eL24 OS=Gillichthys mirabilis OX=8222 GN=rpl24 PE=2 SV=2,,,,,,
OG_03231,FUN_012774-T1,Peve_00007593,Pocillopora_meandrina_HIv1___RNAseq.g13651.t1,three_way,88.069,FUN_012774-T1,O43741,,,,,45.0,280.0,3.1e-60,233.4,sp|O43741|AAKB2_HUMAN 5'-AMP-activated protein kinase subunit beta-2 OS=Homo sapiens OX=9606 GN=PRKAB2 PE=1 SV=1,,,,,,
OG_03232,FUN_012776-T1,Peve_00017056,Pocillopora_meandrina_HIv1___RNAseq.g12856.t1,three_way,72.44733333333333,FUN_012776-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),31.8,349.0,3.9e-40,167.5,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_03233,FUN_012778-T1,Peve_00017055,Pocillopora_meandrina_HIv1___RNAseq.g12882.t1,three_way,73.01033333333334,FUN_012778-T1,A7RL75,,,,,52.5,179.0,4e-40,166.4,sp|A7RL75|TTC36_NEMVE Tetratricopeptide repeat protein 36 homolog OS=Nematostella vectensis OX=45351 GN=ttc36 PE=3 SV=1,,,,,,
OG_03234,FUN_012779-T1,Peve_00017054,Pocillopora_meandrina_HIv1___RNAseq.g12883.t1,three_way,75.45166666666667,FUN_012779-T1,Q9WVK0,ATRAP_MOUSE,,Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein),Mus musculus (Mouse),46.3,121.0,1.7000000000000002e-22,107.5,sp|Q9WVK0|ATRAP_MOUSE Type-1 angiotensin II receptor-associated protein OS=Mus musculus OX=10090 GN=Agtrap PE=1 SV=2,GO:0000139; GO:0001666; GO:0004945; GO:0005789; GO:0005886; GO:0005938; GO:0008217; GO:0030659,regulation of blood pressure [GO:0008217]; response to hypoxia [GO:0001666],cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],angiotensin type II receptor activity [GO:0004945],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_03235,FUN_012784-T1,Peve_00018305,Pocillopora_meandrina_HIv1___TS.g1875.t1,three_way,84.45266666666667,FUN_012784-T1,Q6IWH7,ANO7_HUMAN,,Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G),Homo sapiens (Human),47.9,816.0,1.4e-205,718.4,sp|Q6IWH7|ANO7_HUMAN Anoctamin-7 OS=Homo sapiens OX=9606 GN=ANO7 PE=1 SV=2,GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0034220; GO:0046983; GO:0061588; GO:0070161; GO:1902476,calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220],anchoring junction [GO:0070161]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; organelle; transmembrane transport; membrane organization
OG_03236,FUN_012786-T1,Peve_00018304,Pocillopora_meandrina_HIv1___RNAseq.g12888.t1,three_way,86.545,FUN_012786-T1,Q6IWH7,ANO7_HUMAN,,Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G),Homo sapiens (Human),45.7,879.0,2.2e-213,743.8,sp|Q6IWH7|ANO7_HUMAN Anoctamin-7 OS=Homo sapiens OX=9606 GN=ANO7 PE=1 SV=2,GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0034220; GO:0046983; GO:0061588; GO:0070161; GO:1902476,calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220],anchoring junction [GO:0070161]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; organelle; transmembrane transport; membrane organization
OG_03237,FUN_012787-T1,Peve_00023538,Pocillopora_meandrina_HIv1___TS.g1877.t1,three_way,62.16516666666666,FUN_012787-T1,Q920Q2,REV1_MOUSE,,DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase),Mus musculus (Mouse),33.0,1286.0,1.2e-152,542.3,sp|Q920Q2|REV1_MOUSE DNA repair protein REV1 OS=Mus musculus OX=10090 GN=Rev1 PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0009411; GO:0017125; GO:0042276; GO:0046872,error-prone translesion synthesis [GO:0042276]; response to UV [GO:0009411],nucleus [GO:0005634],damaged DNA binding [GO:0003684]; deoxycytidyl transferase activity [GO:0017125]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_03238,FUN_012788-T1,Peve_00010079,Pocillopora_meandrina_HIv1___RNAseq.g12891.t1,three_way,80.43083333333334,FUN_012788-T1,Q5RCR5,,,,,56.2,274.0,4.7e-94,345.9,sp|Q5RCR5|SUMF2_PONAB Inactive C-alpha-formylglycine-generating enzyme 2 OS=Pongo abelii OX=9601 GN=SUMF2 PE=2 SV=1,,,,,,
OG_03239,FUN_012791-T1,Peve_00010078,Pocillopora_meandrina_HIv1___RNAseq.g12892.t1,three_way,69.30466666666666,FUN_012791-T1,Q54UQ4,RBSK_DICDI,,Ribokinase (RK) (EC 2.7.1.15),Dictyostelium discoideum (Social amoeba),29.6,321.0,6.6e-36,152.9,sp|Q54UQ4|RBSK_DICDI Ribokinase OS=Dictyostelium discoideum OX=44689 GN=rbsk PE=3 SV=2,GO:0004747; GO:0005524; GO:0005634; GO:0005737; GO:0019303; GO:0046872,D-ribose catabolic process [GO:0019303],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747],GO:0003824; GO:0005634; GO:0005975; GO:0016740; GO:0043226,catalytic activity; nucleus; carbohydrate metabolic process; transferase activity; organelle
OG_03240,FUN_012792-T1,Peve_00010083,Pocillopora_meandrina_HIv1___RNAseq.g12893.t1,three_way,83.07816666666666,FUN_012792-T1,P78364,PHC1_HUMAN,,Polyhomeotic-like protein 1 (hPH1) (Early development regulatory protein 1),Homo sapiens (Human),34.1,296.0,9.7e-33,142.1,sp|P78364|PHC1_HUMAN Polyhomeotic-like protein 1 OS=Homo sapiens OX=9606 GN=PHC1 PE=1 SV=3,GO:0001739; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006338; GO:0008270; GO:0016604; GO:0031519; GO:0035102; GO:0042393; GO:0045892; GO:0071300; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to retinoic acid [GO:0071300]; chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892],nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle
OG_03241,FUN_012795-T1,Peve_00022361,Pocillopora_meandrina_HIv1___TS.g1884.t1,three_way,59.97133333333333,FUN_012795-T1,Q05793,PGBM_MOUSE,,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) [Cleaved into: Endorepellin; LG3 peptide],Mus musculus (Mouse),32.0,1366.0,6.4e-204,713.0,sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1,GO:0001525; GO:0001958; GO:0002020; GO:0002062; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007420; GO:0008104; GO:0030198; GO:0031012; GO:0048704; GO:0048738; GO:0060351; GO:0062023,angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796],calcium ion binding [GO:0005509]; protease binding [GO:0002020],GO:0005576; GO:0016192; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; vesicle-mediated transport; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_03242,FUN_012801-T1,Peve_00019853,Pocillopora_meandrina_HIv1___RNAseq.g12895.t1,three_way,85.11566666666667,FUN_012801-T1,Q9WUA2,,,,,60.4,589.0,2.1000000000000002e-213,743.4,sp|Q9WUA2|SYFB_MOUSE Phenylalanine--tRNA ligase beta subunit OS=Mus musculus OX=10090 GN=Farsb PE=1 SV=2,,,,,,
OG_03243,FUN_012870-T1,Peve_00003570,Pocillopora_meandrina_HIv1___TS.g1932.t2,three_way,76.04733333333334,FUN_012870-T1,D2GXS7,,,,,41.0,78.0,4e-12,74.7,sp|D2GXS7|TRIM2_AILME Tripartite motif-containing protein 2 OS=Ailuropoda melanoleuca OX=9646 GN=TRIM2 PE=3 SV=1,,,,,,
OG_03244,FUN_012875-T1,Peve_00003564,Pocillopora_meandrina_HIv1___RNAseq.g12950.t1,three_way,90.85866666666666,FUN_012875-T1,Q8UW59,PARK7_CHICK,,Protein/nucleic acid deglycase DJ-1 (EC 3.1.2.-) (EC 3.5.1.-) (EC 3.5.1.124) (Maillard deglycase) (Parkinson disease protein 7 homolog) (Parkinsonism-associated deglycase) (Protein DJ-1) (DJ-1),Gallus gallus (Chicken),56.5,184.0,2.8e-52,206.5,sp|Q8UW59|PARK7_CHICK Protein/nucleic acid deglycase DJ-1 OS=Gallus gallus OX=9031 GN=PARK7 PE=2 SV=1,GO:0001963; GO:0002866; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005886; GO:0006281; GO:0006508; GO:0006914; GO:0006954; GO:0006979; GO:0007338; GO:0008233; GO:0008344; GO:0016684; GO:0030073; GO:0033864; GO:0034599; GO:0036524; GO:0042542; GO:0042593; GO:0042803; GO:0043523; GO:0045121; GO:0046295; GO:0050821; GO:0051583; GO:0061691; GO:0098793; GO:0106044; GO:0106045; GO:0106046; GO:1903189; GO:1903427; GO:2000277,"adult locomotory behavior [GO:0008344]; autophagy [GO:0006914]; cellular response to oxidative stress [GO:0034599]; detoxification of hydrogen peroxide [GO:0061691]; DNA repair [GO:0006281]; dopamine uptake involved in synaptic transmission [GO:0051583]; glucose homeostasis [GO:0042593]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation [GO:0106044]; guanine deglycation, glyoxal removal [GO:0106046]; guanine deglycation, methylglyoxal removal [GO:0106045]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; positive regulation of acute inflammatory response to antigenic stimulus [GO:0002866]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of oxidative phosphorylation uncoupler activity [GO:2000277]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of neuron apoptotic process [GO:0043523]; response to hydrogen peroxide [GO:0042542]; response to oxidative stress [GO:0006979]; single fertilization [GO:0007338]; synaptic transmission, dopaminergic [GO:0001963]",cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793],"mRNA binding [GO:0003729]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peptidase activity [GO:0008233]; protein deglycase activity [GO:0036524]; protein homodimerization activity [GO:0042803]",GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005783; GO:0005886; GO:0006281; GO:0006914; GO:0006954; GO:0016491; GO:0016787; GO:0022414; GO:0023052; GO:0043226; GO:0055086; GO:0098754; GO:0140096,"RNA binding; catalytic activity; nucleus; mitochondrion; endoplasmic reticulum; plasma membrane; DNA repair; autophagy; inflammatory response; oxidoreductase activity; hydrolase activity; reproductive process; signaling; organelle; nucleobase-containing small molecule metabolic process; detoxification; catalytic activity, acting on a protein"
OG_03245,FUN_012880-T1,Peve_00029266,Pocillopora_meandrina_HIv1___RNAseq.g12951.t1,three_way,80.52533333333334,,,,,,,,,,,,,,,,,
OG_03246,FUN_012889-T1,Peve_00033084,Pocillopora_meandrina_HIv1___RNAseq.g13862.t1,three_way,72.43866666666666,FUN_012889-T1,P53111,,,,,34.3,361.0,2.6e-35,151.0,sp|P53111|ARI1_YEAST NADPH-dependent aldehyde reductase ARI1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=ARI1 PE=1 SV=1,,,,,,
OG_03247,FUN_012926-T1,Peve_00000427,Pocillopora_meandrina_HIv1___TS.g1951.t2a,three_way,82.53266666666667,FUN_012926-T1,D3ZG27,UBIA1_RAT,,UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-) (EC 2.5.1.39),Rattus norvegicus (Rat),58.4,293.0,3.7e-86,319.7,sp|D3ZG27|UBIA1_RAT UbiA prenyltransferase domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Ubiad1 PE=3 SV=1,GO:0000139; GO:0001885; GO:0004659; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006744; GO:0009233; GO:0009234; GO:0016020; GO:0016209; GO:0031966; GO:0042371; GO:0042374; GO:0072359,circulatory system development [GO:0072359]; endothelial cell development [GO:0001885]; menaquinone biosynthetic process [GO:0009234]; menaquinone metabolic process [GO:0009233]; phylloquinone metabolic process [GO:0042374]; ubiquinone biosynthetic process [GO:0006744]; vitamin K biosynthetic process [GO:0042371],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634],antioxidant activity [GO:0016209]; prenyltransferase activity [GO:0004659],GO:0003824; GO:0005634; GO:0005783; GO:0006766; GO:0016209; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; endoplasmic reticulum; vitamin metabolic process; antioxidant activity; transferase activity; organelle; anatomical structure development
OG_03248,FUN_012927-T1,Peve_00000417,Pocillopora_meandrina_HIv1___RNAseq.g12969.t1,three_way,70.33383333333335,FUN_012927-T1,P08510,,,,,55.7,397.0,3.6e-99,363.6,sp|P08510|KCNAS_DROME Potassium voltage-gated channel protein Shaker OS=Drosophila melanogaster OX=7227 GN=Sh PE=1 SV=3,,,,,,
OG_03249,FUN_012969-T1,Peve_00000418,Pocillopora_meandrina_HIv1___RNAseq.g12970.t1,three_way,89.426,FUN_012969-T1,Q02978,M2OM_HUMAN,,Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (alpha-oxoglutarate carrier) (Solute carrier family 25 member 11) (SLC25A11),Homo sapiens (Human),72.0,286.0,6.6e-120,431.8,sp|Q02978|M2OM_HUMAN Mitochondrial 2-oxoglutarate/malate carrier protein OS=Homo sapiens OX=9606 GN=SLC25A11 PE=1 SV=3,GO:0003723; GO:0005634; GO:0005739; GO:0005743; GO:0005886; GO:0006094; GO:0006869; GO:0015367; GO:0022857; GO:0043490,gluconeogenesis [GO:0006094]; lipid transport [GO:0006869]; malate-aspartate shuttle [GO:0043490],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],oxoglutarate:malate antiporter activity [GO:0015367]; RNA binding [GO:0003723]; transmembrane transporter activity [GO:0022857],GO:0003723; GO:0005215; GO:0005634; GO:0005739; GO:0005886; GO:0005975; GO:0043226; GO:0055086,RNA binding; transporter activity; nucleus; mitochondrion; plasma membrane; carbohydrate metabolic process; organelle; nucleobase-containing small molecule metabolic process
OG_03250,FUN_012970-T1,Peve_00000426,Pocillopora_meandrina_HIv1___RNAseq.g12971.t1,three_way,92.84033333333332,FUN_012970-T1,A1Z6E0,GUS_DROME,,Protein gustavus,Drosophila melanogaster (Fruit fly),59.8,281.0,4.3e-97,355.9,sp|A1Z6E0|GUS_DROME Protein gustavus OS=Drosophila melanogaster OX=7227 GN=gus PE=1 SV=2,GO:0005634; GO:0005737; GO:0005938; GO:0007281; GO:0007314; GO:0007315; GO:0007472; GO:0008104; GO:0008354; GO:0019005; GO:0031466; GO:0035017; GO:0035556; GO:0043161; GO:0045495; GO:0045732; GO:0046843; GO:0048471; GO:0070449,cuticle pattern formation [GO:0035017]; dorsal appendage formation [GO:0046843]; germ cell development [GO:0007281]; germ cell migration [GO:0008354]; intracellular signal transduction [GO:0035556]; oocyte anterior/posterior axis specification [GO:0007314]; pole plasm assembly [GO:0007315]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization [GO:0008104]; wing disc morphogenesis [GO:0007472],cell cortex [GO:0005938]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; elongin complex [GO:0070449]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pole plasm [GO:0045495]; SCF ubiquitin ligase complex [GO:0019005],,GO:0005634; GO:0022414; GO:0030163; GO:0043226; GO:0048856; GO:0048870,nucleus; reproductive process; protein catabolic process; organelle; anatomical structure development; cell motility
OG_03251,FUN_012973-T1,Peve_00026801,Pocillopora_meandrina_HIv1___RNAseq.g12974.t1,three_way,78.81466666666667,FUN_012973-T1,B1AJZ9,FHAD1_HUMAN,,Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1),Homo sapiens (Human),25.4,1528.0,7.0000000000000006e-34,148.3,sp|B1AJZ9|FHAD1_HUMAN Forkhead-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FHAD1 PE=1 SV=2,GO:0036126,,sperm flagellum [GO:0036126],,GO:0005929; GO:0043226,cilium; organelle
OG_03252,FUN_012983-T1,Peve_00028830,Pocillopora_meandrina_HIv1___RNAseq.g30380.t2,three_way,73.10633333333334,,,,,,,,,,,,,,,,,
OG_03253,FUN_013011-T1,Peve_00011640,Pocillopora_meandrina_HIv1___RNAseq.g16598.t1,three_way,60.175,,,,,,,,,,,,,,,,,
OG_03254,FUN_013022-T1,Peve_00032576,Pocillopora_meandrina_HIv1___RNAseq.g12959.t1,three_way,71.19483333333334,FUN_013022-T1,Q674X7,KAZRN_HUMAN,,Kazrin,Homo sapiens (Human),35.2,693.0,1.8e-94,348.6,sp|Q674X7|KAZRN_HUMAN Kazrin OS=Homo sapiens OX=9606 GN=KAZN PE=1 SV=2,GO:0001533; GO:0005654; GO:0005829; GO:0005856; GO:0016607; GO:0030057; GO:0031424,keratinization [GO:0031424],cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; desmosome [GO:0030057]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0043226,nucleoplasm; cytosol; cytoskeleton; plasma membrane; organelle
OG_03255,FUN_013023-T1,Peve_00032574,Pocillopora_meandrina_HIv1___RNAseq.g12958.t1,three_way,85.64083333333333,,,,,,,,,,,,,,,,,
OG_03256,FUN_013024-T1,Peve_00032573,Pocillopora_meandrina_HIv1___RNAseq.g12957.t1,three_way,92.86466666666666,FUN_013024-T1,Q9UNL4,,,,,66.7,93.0,4.8e-28,125.2,sp|Q9UNL4|ING4_HUMAN Inhibitor of growth protein 4 OS=Homo sapiens OX=9606 GN=ING4 PE=1 SV=1,,,,,,
OG_03257,FUN_013027-T2,Peve_00032585,Pocillopora_meandrina_HIv1___RNAseq.g12956.t1,three_way,68.18766666666667,FUN_013027-T2,P47736,RPGP1_HUMAN,,Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1),Homo sapiens (Human),48.6,414.0,2.6e-101,371.7,sp|P47736|RPGP1_HUMAN Rap1 GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RAP1GAP PE=1 SV=2,GO:0000139; GO:0002250; GO:0003924; GO:0005096; GO:0005737; GO:0005769; GO:0005829; GO:0006909; GO:0007165; GO:0016020; GO:0022409; GO:0030424; GO:0030425; GO:0031267; GO:0042803; GO:0043025; GO:0043087; GO:0043547; GO:0045665; GO:0050766; GO:0051056; GO:0051649; GO:0098609; GO:1903697; GO:1904442; GO:1990792,adaptive immune response [GO:0002250]; cell-cell adhesion [GO:0098609]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; establishment of localization in cell [GO:0051649]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; phagocytosis [GO:0006909]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025],GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],GO:0002376; GO:0003824; GO:0003924; GO:0005768; GO:0005829; GO:0007155; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0098772,immune system process; catalytic activity; GTPase activity; endosome; cytosol; cell adhesion; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_03258,FUN_013057-T1,Peve_00000416,Pocillopora_meandrina_HIv1___RNAseq.g12966.t1,three_way,71.59333333333333,FUN_013057-T1,Q6DBQ8,CPTP_DANRE,,Ceramide-1-phosphate transfer protein (Glycolipid transfer protein domain-containing protein 1) (CPTP),Danio rerio (Zebrafish) (Brachydanio rerio),38.5,135.0,2e-17,90.1,sp|Q6DBQ8|CPTP_DANRE Ceramide-1-phosphate transfer protein OS=Danio rerio OX=7955 GN=cptp PE=2 SV=1,GO:0005543; GO:0005640; GO:0005794; GO:0005829; GO:0005886; GO:0010008; GO:0010507; GO:0032691; GO:0035627; GO:0120009; GO:1900226; GO:1902387; GO:1902388; GO:1902389,ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226],cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886],ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; phospholipid binding [GO:0005543],GO:0005215; GO:0005794; GO:0005829; GO:0005886; GO:0008289; GO:0043226; GO:0061024,transporter activity; Golgi apparatus; cytosol; plasma membrane; lipid binding; organelle; membrane organization
OG_03259,FUN_013077-T2,Peve_00027399,Pocillopora_meandrina_HIv1___RNAseq.g13103.t1,three_way,65.751,,,,,,,,,,,,,,,,,
OG_03260,FUN_013083-T1,Peve_00027384,Pocillopora_meandrina_HIv1___RNAseq.g13104.t1,three_way,71.1305,FUN_013083-T1,Q6ZUK4,,,,,31.6,367.0,9.999999999999999e-33,142.5,sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1,,,,,,
OG_03261,FUN_013085-T1,Peve_00027392,Pocillopora_meandrina_HIv1___RNAseq.g13092.t2,three_way,58.874,FUN_013085-T1,Q8IZH2,XRN1_HUMAN,,5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog),Homo sapiens (Human),45.9,1541.0,0.0,1238.8,sp|Q8IZH2|XRN1_HUMAN 5'-3' exoribonuclease 1 OS=Homo sapiens OX=9606 GN=XRN1 PE=1 SV=1,GO:0000932; GO:0000956; GO:0002151; GO:0003723; GO:0004534; GO:0005634; GO:0005829; GO:0005886; GO:0016020; GO:0016075; GO:0017148; GO:0030425; GO:0032211; GO:0033574; GO:0043025; GO:0051880; GO:0070034; GO:0071028; GO:0071044; GO:0071409; GO:1905795,cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; rRNA catabolic process [GO:0016075],cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886],5'-3' RNA exonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; plasma membrane; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03262,FUN_013088-T1,Peve_00027394,Pocillopora_meandrina_HIv1___RNAseq.g13094.t1,three_way,69.50316666666667,FUN_013088-T1,Q5U249,,,,,30.1,1421.0,9.9e-154,546.6,sp|Q5U249|ELYS_XENLA Protein ELYS OS=Xenopus laevis OX=8355 GN=ahctf1 PE=1 SV=1,,,,,,
OG_03263,FUN_013089-T1,Peve_00034077,Pocillopora_meandrina_HIv1___RNAseq.g216.t1,three_way,78.51933333333334,FUN_013089-T1,Q8WXG1,RSAD2_HUMAN,,"S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (SAND) (EC 4.2.-.-) (Cytomegalovirus-induced gene 5 protein) (Radical S-adenosyl methionine domain-containing protein 2) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) (Viperin)",Homo sapiens (Human),74.7,292.0,4.3e-134,479.2,sp|Q8WXG1|RSAD2_HUMAN S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 OS=Homo sapiens OX=9606 GN=RSAD2 PE=1 SV=1,GO:0001650; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0005789; GO:0005794; GO:0005811; GO:0009615; GO:0016829; GO:0034157; GO:0034165; GO:0035710; GO:0043367; GO:0045071; GO:0045087; GO:0046872; GO:0050709; GO:0050778; GO:0051539; GO:0051607; GO:2000553,"CD4-positive, alpha-beta T cell activation [GO:0035710]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of protein secretion [GO:0050709]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; response to virus [GO:0009615]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],"4 iron, 4 sulfur cluster binding [GO:0051539]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]",GO:0002376; GO:0003824; GO:0005739; GO:0005783; GO:0005794; GO:0005811; GO:0016829; GO:0030154; GO:0043226; GO:0098542,immune system process; catalytic activity; mitochondrion; endoplasmic reticulum; Golgi apparatus; lipid droplet; lyase activity; cell differentiation; organelle; defense response to other organism
OG_03264,FUN_013106-T1,Peve_00027393,Pocillopora_meandrina_HIv1___RNAseq.g13093.t1,three_way,69.684,FUN_013106-T1,Q6P1B1,,,,,47.2,494.0,6.8999999999999985e-127,455.7,sp|Q6P1B1|XPP1_MOUSE Xaa-Pro aminopeptidase 1 OS=Mus musculus OX=10090 GN=Xpnpep1 PE=1 SV=1,,,,,,
OG_03265,FUN_013121-T1,Peve_00000437,Pocillopora_meandrina_HIv1___RNAseq.g23034.t1,three_way,98.58766666666668,FUN_013121-T1,Q9GJW7,GBRAP_BOVIN,,Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein),Bos taurus (Bovine),96.6,116.0,7.400000000000002e-59,227.6,sp|Q9GJW7|GBRAP_BOVIN Gamma-aminobutyric acid receptor-associated protein OS=Bos taurus OX=9913 GN=GABARAP PE=3 SV=2,GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000423; GO:0005764; GO:0005776; GO:0005790; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008429; GO:0008625; GO:0015031; GO:0015629; GO:0031410; GO:0031625; GO:0032436; GO:0035020; GO:0048487; GO:0050811; GO:0097225; GO:0097352; GO:0098696; GO:0098982; GO:1902524,autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; mitophagy [GO:0000423]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein transport [GO:0015031]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rac protein signal transduction [GO:0035020],actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; GABA-ergic synapse [GO:0098982]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225],beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; ubiquitin protein ligase binding [GO:0031625],GO:0005764; GO:0005773; GO:0005783; GO:0005856; GO:0005886; GO:0006914; GO:0007010; GO:0008092; GO:0008289; GO:0031410; GO:0043226,lysosome; vacuole; endoplasmic reticulum; cytoskeleton; plasma membrane; autophagy; cytoskeleton organization; cytoskeletal protein binding; lipid binding; cytoplasmic vesicle; organelle
OG_03266,FUN_013122-T1,Peve_00000436,Pocillopora_meandrina_HIv1___RNAseq.g23037.t1,three_way,49.27933333333333,FUN_013122-T1,Q6BD04,GPR54_ORENI,,G-protein coupled receptor 54,Oreochromis niloticus (Nile tilapia) (Tilapia nilotica),27.0,300.0,1.1e-14,82.4,sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1,GO:0004930; GO:0005886,,plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_03267,FUN_013135-T1,Peve_00013805,Pocillopora_meandrina_HIv1___TS.g15910.t1,three_way,63.35666666666666,FUN_013135-T1,P05208,CEL2A_MOUSE,,Chymotrypsin-like elastase family member 2A (EC 3.4.21.71) (Elastase-2) (Elastase-2A),Mus musculus (Mouse),37.8,275.0,4.1999999999999996e-47,189.9,sp|P05208|CEL2A_MOUSE Chymotrypsin-like elastase family member 2A OS=Mus musculus OX=10090 GN=Cela2a PE=1 SV=1,GO:0004175; GO:0004252; GO:0005576; GO:0006508; GO:0017171; GO:0032868; GO:0036457; GO:0050796; GO:0061436; GO:0062023; GO:0090330; GO:1901143,establishment of skin barrier [GO:0061436]; insulin catabolic process [GO:1901143]; proteolysis [GO:0006508]; regulation of insulin secretion [GO:0050796]; regulation of platelet aggregation [GO:0090330]; response to insulin [GO:0032868],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457],endopeptidase activity [GO:0004175]; serine hydrolase activity [GO:0017171]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0030163; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; protein catabolic process; anatomical structure development; catalytic activity, acting on a protein"
OG_03268,FUN_013137-T1,Peve_00042384,Pocillopora_meandrina_HIv1___RNAseq.g23023.t1,three_way,71.50933333333333,FUN_013137-T1,Q7M3E1,,,,,42.1,254.0,7.8e-44,179.5,sp|Q7M3E1|CTRC_BOVIN Chymotrypsin-C OS=Bos taurus OX=9913 GN=CTRC PE=1 SV=2,,,,,,
OG_03269,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_03270,FUN_013139-T1,Peve_00042385,Pocillopora_meandrina_HIv1___RNAseq.g23012.t1,three_way,50.720333333333336,FUN_013139-T1,Q63341,MMP12_RAT,,Macrophage metalloelastase (MME) (EC 3.4.24.65) (Matrix metalloproteinase-12) (MMP-12),Rattus norvegicus (Rat),36.7,267.0,1.2e-34,148.7,sp|Q63341|MMP12_RAT Macrophage metalloelastase OS=Rattus norvegicus OX=10116 GN=Mmp12 PE=2 SV=1,GO:0000122; GO:0001046; GO:0001666; GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0005634; GO:0005737; GO:0006508; GO:0006606; GO:0008270; GO:0009410; GO:0010628; GO:0030198; GO:0030574; GO:0031012; GO:0032727; GO:0035313; GO:0043565; GO:0045944; GO:0048286; GO:0050679; GO:0050691; GO:0060054; GO:0060309; GO:0060339; GO:0060340; GO:0060435; GO:0098586; GO:1901163; GO:1904905,"bronchiole development [GO:0060435]; cellular response to virus [GO:0098586]; collagen catabolic process [GO:0030574]; elastin catabolic process [GO:0060309]; extracellular matrix organization [GO:0030198]; lung alveolus development [GO:0048286]; negative regulation of endothelial cell-matrix adhesion via fibronectin [GO:1904905]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; regulation of defense response to virus by host [GO:0050691]; regulation of trophoblast cell migration [GO:1901163]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; wound healing, spreading of epidermal cells [GO:0035313]",cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; core promoter sequence-specific DNA binding [GO:0001046]; metalloendopeptidase activity [GO:0004222]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005615; GO:0005634; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030163; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096; GO:1901135,"DNA binding; catalytic activity; extracellular space; nucleus; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; protein catabolic process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03271,FUN_013144-T1,Peve_00042388,Pocillopora_meandrina_HIv1___RNAseq.g23011.t1,three_way,77.73966666666666,,,,,,,,,,,,,,,,,
OG_03272,FUN_013145-T1,Peve_00027383,Pocillopora_meandrina_HIv1___RNAseq.g13822.t1,three_way,65.41383333333333,FUN_013145-T1,Q01780,EXOSX_HUMAN,,Exosome complex component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2),Homo sapiens (Human),45.4,707.0,2.4e-159,564.3,sp|Q01780|EXOSX_HUMAN Exosome complex component 10 OS=Homo sapiens OX=9606 GN=EXOSC10 PE=1 SV=2,GO:0000166; GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000184; GO:0000460; GO:0000467; GO:0000791; GO:0000956; GO:0003723; GO:0003727; GO:0004532; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006281; GO:0006364; GO:0006396; GO:0006401; GO:0016020; GO:0032040; GO:0032211; GO:0042274; GO:0046872; GO:0070034; GO:0071028; GO:0071034; GO:0071035; GO:0071036; GO:0071037; GO:0071038; GO:0071039; GO:0071040; GO:0071044; GO:0071051; GO:0101019; GO:1904872; GO:1905746,"CUT catabolic process [GO:0071034]; DNA repair [GO:0006281]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent antisense transcript catabolic process [GO:0071040]; nuclear polyadenylation-dependent CUT catabolic process [GO:0071039]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent snoRNA catabolic process [GO:0071036]; nuclear polyadenylation-dependent snRNA catabolic process [GO:0071037]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; ribosomal small subunit biogenesis [GO:0042274]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]",cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA exonuclease activity [GO:0004532]; single-stranded RNA binding [GO:0003727]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006399; GO:0016071; GO:0016073; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; tRNA metabolic process; mRNA metabolic process; snRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03273,FUN_013146-T1,Peve_00024360,Pocillopora_meandrina_HIv1___RNAseq.g13823.t1,three_way,75.41933333333333,FUN_013146-T1,Q5U247,,,,,34.6,673.0,1e-96,355.9,sp|Q5U247|EXOC8_XENLA Exocyst complex component 8 OS=Xenopus laevis OX=8355 GN=exoc8 PE=2 SV=1,,,,,,
OG_03274,FUN_013153-T1,Peve_00022450,Pocillopora_meandrina_HIv1___RNAseq.g12978.t1,three_way,39.60333333333333,,,,,,,,,,,,,,,,,
OG_03275,FUN_013154-T1,Peve_00022448,Pocillopora_meandrina_HIv1___RNAseq.g12979.t1,three_way,50.74516666666667,FUN_013154-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),29.3,369.0,1.8000000000000002e-28,130.2,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_03276,FUN_013155-T1,Peve_00022447,Pocillopora_meandrina_HIv1___RNAseq.g12980.t1,three_way,66.7205,FUN_013155-T1,P47843,GTR3_SHEEP,,"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)",Ovis aries (Sheep),45.7,466.0,1.4e-101,371.7,"sp|P47843|GTR3_SHEEP Solute carrier family 2, facilitated glucose transporter member 3 OS=Ovis aries OX=9940 GN=SLC2A3 PE=2 SV=1",GO:0005354; GO:0005536; GO:0005886; GO:0015757; GO:0016020; GO:0042995; GO:0043204; GO:0046323; GO:0055056; GO:0070837; GO:1904659,D-glucose import [GO:0046323]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; galactose transmembrane transport [GO:0015757],cell projection [GO:0042995]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],D-glucose binding [GO:0005536]; D-glucose transmembrane transporter activity [GO:0055056]; galactose transmembrane transporter activity [GO:0005354],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_03277,FUN_013156-T1,Peve_00022446,Pocillopora_meandrina_HIv1___RNAseq.g12981.t1,three_way,74.53133333333334,FUN_013156-T1,Q6P3S6,FBX42_HUMAN,,F-box only protein 42 (Just one F-box and Kelch domain-containing protein),Homo sapiens (Human),45.5,321.0,8.000000000000001e-76,285.8,sp|Q6P3S6|FBX42_HUMAN F-box only protein 42 OS=Homo sapiens OX=9606 GN=FBXO42 PE=1 SV=1,GO:0019005; GO:1990756,,SCF ubiquitin ligase complex [GO:0019005],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0060090,molecular adaptor activity
OG_03278,FUN_013159-T1,Peve_00022444,Pocillopora_meandrina_HIv1___RNAseq.g12984.t1,three_way,74.17133333333334,FUN_013159-T1,Q3SYV5,TSN33_BOVIN,,Tetraspanin-33 (Tspan-33),Bos taurus (Bovine),40.2,251.0,1.2999999999999998e-47,191.4,sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1,GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659,protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005886; GO:0051604; GO:0072659,plasma membrane; protein maturation; protein localization to plasma membrane
OG_03279,FUN_013160-T1,Peve_00022443,Pocillopora_meandrina_HIv1___RNAseq.g12985.t1,three_way,77.27183333333333,FUN_013160-T1,Q9ES00,UBE4B_MOUSE,,Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2),Mus musculus (Mouse),42.6,1179.0,4.6000000000000005e-243,842.8,sp|Q9ES00|UBE4B_MOUSE Ubiquitin conjugation factor E4 B OS=Mus musculus OX=10090 GN=Ube4b PE=1 SV=3,GO:0000151; GO:0000209; GO:0003222; GO:0005524; GO:0005634; GO:0005737; GO:0006457; GO:0006511; GO:0006513; GO:0008626; GO:0009411; GO:0016567; GO:0019899; GO:0030163; GO:0031175; GO:0034450; GO:0034976; GO:0036503; GO:0043161; GO:0051082; GO:0051865; GO:0061630,ERAD pathway [GO:0036503]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082],GO:0003824; GO:0005634; GO:0006457; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; protein folding; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03280,FUN_013161-T1,Peve_00022442,Pocillopora_meandrina_HIv1___TS.g1972.t2,three_way,72.94316666666667,FUN_013161-T1,Q08170,SRSF4_HUMAN,,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",Homo sapiens (Human),55.6,187.0,1.4999999999999999e-53,211.1,sp|Q08170|SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_03281,FUN_013162-T1,Peve_00022440,Pocillopora_meandrina_HIv1___RNAseq.g13110.t3,three_way,66.35566666666666,FUN_013162-T1,Q924H0,,,,,27.5,360.0,9.1e-18,92.8,sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2,,,,,,
OG_03282,FUN_013314-T1,Peve_00022437,Pocillopora_meandrina_HIv1___RNAseq.g12993.t1,three_way,71.73,FUN_013314-T1,Q5XF89,AT133_MOUSE,,Polyamine-transporting ATPase 13A3 (Putrescine transporting ATPase) (EC 7.6.2.16),Mus musculus (Mouse),47.0,1186.0,5.4e-279,962.2,sp|Q5XF89|AT133_MOUSE Polyamine-transporting ATPase 13A3 OS=Mus musculus OX=10090 GN=Atp13a3 PE=1 SV=1,GO:0005524; GO:0015594; GO:0015662; GO:0016887; GO:0019829; GO:0031901; GO:0031902; GO:0046872; GO:0055038; GO:0140358,,early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; recycling endosome membrane [GO:0055038],ABC-type putrescine transporter activity [GO:0015594]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled monoatomic cation transmembrane transporter activity [GO:0019829]; metal ion binding [GO:0046872]; P-type ion transporter activity [GO:0015662]; P-type transmembrane transporter activity [GO:0140358],GO:0003824; GO:0005215; GO:0016787; GO:0140657,catalytic activity; transporter activity; hydrolase activity; ATP-dependent activity
OG_03283,FUN_013319-T1,Peve_00024429,Pocillopora_meandrina_HIv1___TS.g12277.t1a,three_way,72.86233333333334,,,,,,,,,,,,,,,,,
OG_03284,FUN_013321-T1,Peve_00022436,Pocillopora_meandrina_HIv1___RNAseq.g12987.t1,three_way,43.632333333333335,,,,,,,,,,,,,,,,,
OG_03285,FUN_013323-T1,Peve_00027397,Pocillopora_meandrina_HIv1___RNAseq.g941.t1,three_way,74.55333333333333,FUN_013323-T1,Q9D2I5,ARMC9_MOUSE,,LisH domain-containing protein ARMC9,Mus musculus (Mouse),50.8,675.0,6.9e-166,585.9,sp|Q9D2I5|ARMC9_MOUSE LisH domain-containing protein ARMC9 OS=Mus musculus OX=10090 GN=Armc9 PE=1 SV=1,GO:0005737; GO:0005814; GO:0005929; GO:0036064; GO:0045880; GO:0060271; GO:0097542,cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005815; GO:0005929; GO:0043226; GO:0044782,microtubule organizing center; cilium; organelle; cilium organization
OG_03286,FUN_013326-T1,Peve_00022536,Pocillopora_meandrina_HIv1___RNAseq.g13101.t1,three_way,85.618,FUN_013326-T1,A8JF70,ODA1_CHLRE,,Outer dynein arm protein 1 (Docking complex component 2),Chlamydomonas reinhardtii (Chlamydomonas smithii),32.0,500.0,5.699999999999999e-53,210.3,sp|A8JF70|ODA1_CHLRE Outer dynein arm protein 1 OS=Chlamydomonas reinhardtii OX=3055 GN=ODA1 PE=1 SV=1,GO:0036157; GO:0036158; GO:0060294,cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158],outer dynein arm [GO:0036157],,GO:0007018; GO:0065003,microtubule-based movement; protein-containing complex assembly
OG_03287,FUN_013327-T1,Peve_00022435,Pocillopora_meandrina_HIv1___TS.g2081.t2,three_way,73.69733333333333,FUN_013327-T1,Q3B7Z2,OSBP1_MOUSE,,Oxysterol-binding protein 1,Mus musculus (Mouse),43.5,310.0,1.6e-66,254.6,sp|Q3B7Z2|OSBP1_MOUSE Oxysterol-binding protein 1 OS=Mus musculus OX=10090 GN=Osbp PE=1 SV=3,GO:0000139; GO:0005654; GO:0005730; GO:0005789; GO:0005802; GO:0005829; GO:0006686; GO:0015914; GO:0015918; GO:0019904; GO:0030054; GO:0032367; GO:0035627; GO:0035774; GO:0048471; GO:0070273; GO:0120015; GO:1904411,ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918],cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802],phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol transfer activity [GO:0120015],GO:0005215; GO:0005654; GO:0005730; GO:0005829; GO:0006629; GO:0008289; GO:0043226,transporter activity; nucleoplasm; nucleolus; cytosol; lipid metabolic process; lipid binding; organelle
OG_03288,FUN_013329-T1,Peve_00022430,Pocillopora_meandrina_HIv1___RNAseq.g12994.t1,three_way,67.42033333333333,FUN_013329-T1,Q8IS64,,,,,36.0,688.0,9.5e-131,469.2,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_03289,FUN_013330-T1,Peve_00022425,Pocillopora_meandrina_HIv1___RNAseq.g12990.t1a,three_way,66.249,FUN_013330-T1,P42893,,,,,37.2,686.0,2.6000000000000003e-133,477.6,sp|P42893|ECE1_RAT Endothelin-converting enzyme 1 OS=Rattus norvegicus OX=10116 GN=Ece1 PE=1 SV=2,,,,,,
OG_03290,FUN_013331-T1,Peve_00022419,Pocillopora_meandrina_HIv1___RNAseq.g12990.t1b,three_way,57.703833333333336,,,,,,,,,,,,,,,,,
OG_03291,FUN_013350-T1,Peve_00041996,Pocillopora_meandrina_HIv1___TS.g2168.t1a,three_way,66.735,FUN_013350-T1,Q8CBF3,EPHB1_MOUSE,,Ephrin type-B receptor 1 (EC 2.7.10.1),Mus musculus (Mouse),38.3,975.0,3.2e-176,620.5,sp|Q8CBF3|EPHB1_MOUSE Ephrin type-B receptor 1 OS=Mus musculus OX=10090 GN=Ephb1 PE=1 SV=1,GO:0001525; GO:0001771; GO:0005005; GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0007411; GO:0008046; GO:0014719; GO:0016020; GO:0021545; GO:0021631; GO:0021934; GO:0021952; GO:0022008; GO:0030010; GO:0030424; GO:0030425; GO:0031290; GO:0031589; GO:0031901; GO:0032433; GO:0044877; GO:0045121; GO:0046328; GO:0046777; GO:0048013; GO:0048593; GO:0050804; GO:0050965; GO:0051965; GO:0060326; GO:0060996; GO:0060997; GO:0061351; GO:0070372; GO:0098978; GO:1902723; GO:1902725,angiogenesis [GO:0001525]; axon guidance [GO:0007411]; camera-type eye morphogenesis [GO:0048593]; cell chemotaxis [GO:0060326]; cell-substrate adhesion [GO:0031589]; central nervous system projection neuron axonogenesis [GO:0021952]; cranial nerve development [GO:0021545]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; hindbrain tangential cell migration [GO:0021934]; immunological synapse formation [GO:0001771]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; optic nerve morphogenesis [GO:0021631]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; retinal ganglion cell axon guidance [GO:0031290]; skeletal muscle satellite cell activation [GO:0014719],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; axon guidance receptor activity [GO:0008046]; protein-containing complex binding [GO:0044877]; transmembrane-ephrin receptor activity [GO:0005005],GO:0003824; GO:0005783; GO:0005829; GO:0005886; GO:0007155; GO:0007163; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endoplasmic reticulum; cytosol; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; transferase activity; cell differentiation; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_03292,FUN_013354-T2,Peve_00041984,Pocillopora_meandrina_HIv1___RNAseq.g13178.t1,three_way,92.6225,FUN_013354-T2,P42345,MTOR_HUMAN,,Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1) (Tyrosine-protein kinase mTOR) (EC 2.7.10.2),Homo sapiens (Human),64.6,2550.0,0.0,3192.9,sp|P42345|MTOR_HUMAN Serine/threonine-protein kinase mTOR OS=Homo sapiens OX=9606 GN=MTOR PE=1 SV=1,GO:0000139; GO:0000822; GO:0001002; GO:0001003; GO:0001006; GO:0001156; GO:0001558; GO:0002296; GO:0003007; GO:0003179; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005741; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005829; GO:0005886; GO:0006112; GO:0006207; GO:0006954; GO:0006974; GO:0007010; GO:0007281; GO:0008361; GO:0009267; GO:0009408; GO:0009615; GO:0009791; GO:0010507; GO:0010592; GO:0010718; GO:0010831; GO:0012505; GO:0016020; GO:0016236; GO:0016241; GO:0016242; GO:0016605; GO:0019228; GO:0030307; GO:0030425; GO:0030838; GO:0031295; GO:0031529; GO:0031641; GO:0031648; GO:0031667; GO:0031669; GO:0031670; GO:0031929; GO:0031931; GO:0031932; GO:0032869; GO:0032956; GO:0033173; GO:0034198; GO:0035264; GO:0038202; GO:0038203; GO:0042752; GO:0042802; GO:0043022; GO:0043066; GO:0043200; GO:0043276; GO:0044325; GO:0045335; GO:0045670; GO:0045727; GO:0045792; GO:0045821; GO:0045945; GO:0045948; GO:0046627; GO:0046889; GO:0048266; GO:0048709; GO:0048714; GO:0050821; GO:0050882; GO:0051219; GO:0051496; GO:0051549; GO:0051897; GO:0055013; GO:0060048; GO:0061431; GO:0070885; GO:0071230; GO:0071233; GO:0071456; GO:0071470; GO:0090559; GO:0097700; GO:0106310; GO:1900034; GO:1900181; GO:1901796; GO:1901838; GO:1902554; GO:1903691; GO:1904059; GO:1904690; GO:1905671; GO:1905672; GO:1905857; GO:1990253; GO:2000060; GO:2000785,"'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anoikis [GO:0043276]; behavioral response to pain [GO:0048266]; calcineurin-NFAT signaling cascade [GO:0033173]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to methionine [GO:0061431]; cellular response to nutrient [GO:0031670]; cellular response to nutrient levels [GO:0031669]; cellular response to osmotic stress [GO:0071470]; cellular response to starvation [GO:0009267]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; inflammatory response [GO:0006954]; macroautophagy [GO:0016236]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lysosome organization [GO:1905672]; negative regulation of macroautophagy [GO:0016242]; negative regulation of protein localization to nucleus [GO:1900181]; neuronal action potential [GO:0019228]; oligodendrocyte differentiation [GO:0048709]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of glycolytic process [GO:0045821]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of pentose-phosphate shunt [GO:1905857]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagosome assembly [GO:2000785]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of locomotor rhythm [GO:1904059]; regulation of lysosome organization [GO:1905671]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of signal transduction by p53 class mediator [GO:1901796]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient levels [GO:0031667]; response to virus [GO:0009615]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; TORC2 signaling [GO:0038203]; vascular endothelial cell response to laminar fluid shear stress [GO:0097700]; voluntary musculoskeletal movement [GO:0050882]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; PML body [GO:0016605]; serine/threonine protein kinase complex [GO:1902554]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006]; TFIIIC-class transcription factor complex binding [GO:0001156]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0003012; GO:0003677; GO:0003824; GO:0005634; GO:0005635; GO:0005654; GO:0005764; GO:0005773; GO:0005783; GO:0005829; GO:0005886; GO:0006091; GO:0006355; GO:0006914; GO:0006954; GO:0007010; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:0140096,"immune system process; muscle system process; DNA binding; catalytic activity; nucleus; nuclear envelope; nucleoplasm; lysosome; vacuole; endoplasmic reticulum; cytosol; plasma membrane; generation of precursor metabolites and energy; regulation of DNA-templated transcription; autophagy; inflammatory response; cytoskeleton organization; programmed cell death; transferase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein"
OG_03293,FUN_013357-T1,Peve_00001204,Pocillopora_meandrina_HIv1___TS.g2335.t2,three_way,57.15766666666666,FUN_013357-T1,P58340,MLF1_HUMAN,,Myeloid leukemia factor 1 (Myelodysplasia-myeloid leukemia factor 1),Homo sapiens (Human),40.2,234.0,1.7e-35,151.4,sp|P58340|MLF1_HUMAN Myeloid leukemia factor 1 OS=Homo sapiens OX=9606 GN=MLF1 PE=1 SV=1,GO:0002318; GO:0003677; GO:0005634; GO:0005737; GO:0005929; GO:0006351; GO:0006355; GO:0019904; GO:0036064; GO:0048471; GO:1901796; GO:1902806,DNA-templated transcription [GO:0006351]; myeloid progenitor cell differentiation [GO:0002318]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of DNA-templated transcription [GO:0006355]; regulation of signal transduction by p53 class mediator [GO:1901796],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],DNA binding [GO:0003677]; protein domain specific binding [GO:0019904],GO:0003677; GO:0005634; GO:0005815; GO:0005929; GO:0006351; GO:0006355; GO:0030154; GO:0043226,DNA binding; nucleus; microtubule organizing center; cilium; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle
OG_03294,FUN_013359-T1,Peve_00001202,Pocillopora_meandrina_HIv1___TS.g2338.t1,three_way,77.81466666666667,,,,,,,,,,,,,,,,,
OG_03295,FUN_013361-T1,Peve_00001200,Pocillopora_meandrina_HIv1___RNAseq.g13338.t1,three_way,50.56066666666667,FUN_013361-T1,P24409,,,,,46.7,169.0,8.2e-33,141.7,sp|P24409|RAB10_CANLF Ras-related protein Rab-10 OS=Canis lupus familiaris OX=9615 GN=RAB10 PE=1 SV=1,,,,,,
OG_03296,FUN_013363-T1,Peve_00001194,Pocillopora_meandrina_HIv1___RNAseq.g13339.t1,three_way,64.70333333333333,FUN_013363-T1,P61007,,,,,60.4,169.0,2.2e-55,216.9,sp|P61007|RAB8A_CANLF Ras-related protein Rab-8A OS=Canis lupus familiaris OX=9615 GN=RAB8A PE=1 SV=1,,,,,,
OG_03297,FUN_013364-T1,Peve_00001193,Pocillopora_meandrina_HIv1___RNAseq.g13340.t1,three_way,82.5465,FUN_013364-T1,P61026,RAB10_HUMAN,,Ras-related protein Rab-10 (EC 3.6.5.2),Homo sapiens (Human),66.7,177.0,9.8e-67,254.6,sp|P61026|RAB10_HUMAN Ras-related protein Rab-10 OS=Homo sapiens OX=9606 GN=RAB10 PE=1 SV=1,GO:0000139; GO:0003925; GO:0005525; GO:0005764; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0005929; GO:0006887; GO:0006893; GO:0007409; GO:0010008; GO:0016020; GO:0016192; GO:0016197; GO:0019003; GO:0019882; GO:0030659; GO:0030667; GO:0030670; GO:0030859; GO:0031489; GO:0032593; GO:0032869; GO:0043001; GO:0045055; GO:0045200; GO:0048471; GO:0055037; GO:0055038; GO:0070062; GO:0070382; GO:0071782; GO:0071786; GO:0072659; GO:0090150; GO:0097051; GO:0098641; GO:0099503; GO:1903361,antigen processing and presentation [GO:0019882]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; establishment of protein localization to membrane [GO:0090150]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; regulated exocytosis [GO:0045055]; vesicle-mediated transport [GO:0016192],adherens junction [GO:0005912]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; endosome membrane [GO:0010008]; exocytic vesicle [GO:0070382]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; insulin-responsive compartment [GO:0032593]; lysosome [GO:0005764]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; secretory granule membrane [GO:0030667]; secretory vesicle [GO:0099503]; trans-Golgi network [GO:0005802],cadherin binding involved in cell-cell adhesion [GO:0098641]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; myosin V binding [GO:0031489],GO:0002376; GO:0003824; GO:0003924; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0030154; GO:0031410; GO:0043226; GO:0072659; GO:0098631; GO:0098772,immune system process; catalytic activity; GTPase activity; lysosome; endosome; vacuole; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; cilium; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell differentiation; cytoplasmic vesicle; organelle; protein localization to plasma membrane; cell adhesion mediator activity; molecular function regulator activity
OG_03298,FUN_013365-T1,Peve_00001191,Pocillopora_meandrina_HIv1___RNAseq.g13342.t1,three_way,66.11066666666666,FUN_013365-T1,Q8IS64,,,,,46.9,685.0,1.8e-185,651.0,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_03299,FUN_013366-T1,Peve_00001190,Pocillopora_meandrina_HIv1___RNAseq.g13343.t1,three_way,74.01916666666666,FUN_013366-T1,Q28IJ3,,,,,50.0,80.0,6.2e-13,74.7,sp|Q28IJ3|PXL2B_XENTR Prostamide/prostaglandin F synthase OS=Xenopus tropicalis OX=8364 GN=prxl2b PE=2 SV=1,,,,,,
OG_03300,FUN_013368-T1,Peve_00001209,Pocillopora_meandrina_HIv1___RNAseq.g13344.t1,three_way,89.73183333333333,FUN_013368-T1,Q96C19,,,,,64.6,161.0,5.9e-50,198.7,sp|Q96C19|EFHD2_HUMAN EF-hand domain-containing protein D2 OS=Homo sapiens OX=9606 GN=EFHD2 PE=1 SV=1,,,,,,
OG_03301,FUN_013369-T1,Peve_00001207,Pocillopora_meandrina_HIv1___RNAseq.g22997.t2,three_way,76.74266666666666,FUN_013369-T1,A4II73,,,,,44.0,216.0,8.9e-47,188.3,sp|A4II73|OVCA2_XENTR Esterase OVCA2 OS=Xenopus tropicalis OX=8364 GN=ovca2 PE=2 SV=2,,,,,,
OG_03302,FUN_013373-T1,Peve_00001201,Pocillopora_meandrina_HIv1___RNAseq.g22996.t1,three_way,81.58533333333334,FUN_013373-T1,P56399,,,,,54.9,856.0,3.3e-275,949.1,sp|P56399|UBP5_MOUSE Ubiquitin carboxyl-terminal hydrolase 5 OS=Mus musculus OX=10090 GN=Usp5 PE=1 SV=1,,,,,,
OG_03303,FUN_013374-T1,Peve_00001189,Pocillopora_meandrina_HIv1___RNAseq.g22992.t1,three_way,43.78233333333333,FUN_013374-T1,Q86SQ4,AGRG6_HUMAN,,"Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: Adhesion G-protein coupled receptor G6, N-terminal fragment (ADGRG6 N-terminal fragment) (ADGRG6-NTF); Adhesion G-protein coupled receptor G6, C-terminal fragment (ADGRG6 C-terminal fragment) (ADGRG6-CTF)]",Homo sapiens (Human),26.1,253.0,2.9e-12,75.5,sp|Q86SQ4|AGRG6_HUMAN Adhesion G-protein coupled receptor G6 OS=Homo sapiens OX=9606 GN=ADGRG6 PE=1 SV=3,GO:0001890; GO:0004175; GO:0004930; GO:0005518; GO:0005737; GO:0005789; GO:0005886; GO:0007166; GO:0007186; GO:0007188; GO:0007189; GO:0007193; GO:0007399; GO:0009986; GO:0014037; GO:0016020; GO:0022011; GO:0030500; GO:0042552; GO:0043236; GO:0050840; GO:0051216; GO:0060347; GO:0060856; GO:1903670,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; establishment of blood-brain barrier [GO:0060856]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; nervous system development [GO:0007399]; placenta development [GO:0001890]; regulation of bone mineralization [GO:0030500]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236],GO:0003824; GO:0005886; GO:0016787; GO:0030154; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; cell differentiation; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_03304,FUN_013376-T1,Peve_00020453,Pocillopora_meandrina_HIv1___RNAseq.g22987.t1,three_way,90.733,FUN_013376-T1,Q9H0C1,ZMY12_HUMAN,,Zinc finger MYND domain-containing protein 12,Homo sapiens (Human),50.7,363.0,1.6e-96,354.4,sp|Q9H0C1|ZMY12_HUMAN Zinc finger MYND domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ZMYND12 PE=1 SV=3,GO:0007288; GO:0008270; GO:0030317; GO:0036126,flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288],sperm flagellum [GO:0036126],zinc ion binding [GO:0008270],GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cell motility
OG_03305,FUN_013377-T1,Peve_00020454,Pocillopora_meandrina_HIv1___RNAseq.g22986.t1,three_way,67.67733333333334,FUN_013377-T1,Q7TS68,,,,,46.7,469.0,2.0000000000000001e-112,407.5,sp|Q7TS68|NSUN6_MOUSE tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 OS=Mus musculus OX=10090 GN=Nsun6 PE=2 SV=2,,,,,,
OG_03306,FUN_013378-T1,Peve_00020455,Pocillopora_meandrina_HIv1___RNAseq.g22985.t2,three_way,65.02866666666667,FUN_013378-T1,Q5QD15,TAAR4_MOUSE,,Trace amine-associated receptor 4 (TaR-4) (Trace amine receptor 4) (mTaar4) (2-phenylethylamine receptor),Mus musculus (Mouse),26.1,272.0,6.8e-16,86.7,sp|Q5QD15|TAAR4_MOUSE Trace amine-associated receptor 4 OS=Mus musculus OX=10090 GN=Taar4 PE=1 SV=1,GO:0001594; GO:0001662; GO:0005886; GO:0007606; GO:0007635; GO:0008227; GO:1990080,behavioral fear response [GO:0001662]; chemosensory behavior [GO:0007635]; sensory perception of chemical stimulus [GO:0007606],plasma membrane [GO:0005886],2-phenylethylamine receptor activity [GO:1990080]; G protein-coupled amine receptor activity [GO:0008227]; trace-amine receptor activity [GO:0001594],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_03307,FUN_013379-T1,Peve_00020447,Pocillopora_meandrina_HIv1___RNAseq.g22984.t2,three_way,67.94,,,,,,,,,,,,,,,,,
OG_03308,FUN_013381-T1,Peve_00015988,Pocillopora_meandrina_HIv1___RNAseq.g22983.t2b,three_way,81.351,FUN_013381-T1,Q4FZX7,,,,,53.0,183.0,8.099999999999998e-41,168.3,sp|Q4FZX7|SRPRB_RAT Signal recognition particle receptor subunit beta OS=Rattus norvegicus OX=10116 GN=Srprb PE=2 SV=1,,,,,,
OG_03309,FUN_013385-T1,Peve_00015992,Pocillopora_meandrina_HIv1___RNAseq.g22980.t2,three_way,65.83083333333333,FUN_013385-T1,Q24180,DEAF1_DROME,,Deformed epidermal autoregulatory factor 1 (Protein DEAF-1),Drosophila melanogaster (Fruit fly),45.2,84.0,2.6e-16,87.8,sp|Q24180|DEAF1_DROME Deformed epidermal autoregulatory factor 1 OS=Drosophila melanogaster OX=7227 GN=Deaf1 PE=1 SV=1,GO:0000981; GO:0003700; GO:0005634; GO:0005700; GO:0006357; GO:0008270; GO:0009792; GO:0043565; GO:0045893; GO:0050776,embryo development ending in birth or egg hatching [GO:0009792]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of immune response [GO:0050776]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]; polytene chromosome [GO:0005700],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005694; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; chromosome; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_03310,FUN_013387-T1,Peve_00034571,Pocillopora_meandrina_HIv1___RNAseq.g22979.t1,three_way,82.8835,FUN_013387-T1,Q3UY96,,,,,33.7,1633.0,7.6e-245,849.4,sp|Q3UY96|CFA74_MOUSE Cilia- and flagella-associated protein 74 OS=Mus musculus OX=10090 GN=Cfap74 PE=2 SV=3,,,,,,
OG_03311,FUN_013389-T1,Peve_00031288,Pocillopora_meandrina_HIv1___TS.g15861.t1,three_way,67.08366666666667,,,,,,,,,,,,,,,,,
OG_03312,FUN_013390-T1,Peve_00030638,Pocillopora_meandrina_HIv1___RNAseq.g22976.t1,three_way,70.00083333333333,FUN_013390-T1,Q26613,,,,,37.5,651.0,5.9e-132,473.8,sp|Q26613|EMAP_STRPU 77 kDa echinoderm microtubule-associated protein OS=Strongylocentrotus purpuratus OX=7668 GN=EMAP PE=2 SV=1,,,,,,
OG_03313,FUN_013391-T1,Peve_00028095,Pocillopora_meandrina_HIv1___RNAseq.g22975.t1,three_way,66.52533333333334,,,,,,,,,,,,,,,,,
OG_03314,FUN_013392-T1,Peve_00028094,Pocillopora_meandrina_HIv1___RNAseq.g22974.t2,three_way,67.61166666666666,,,,,,,,,,,,,,,,,
OG_03315,FUN_013393-T2,Peve_00028093,Pocillopora_meandrina_HIv1___TS.g15814.t1,three_way,82.98983333333334,FUN_013393-T2,Q9WU45,CLCN2_CAVPO,,Chloride channel protein 2 (ClC-2),Cavia porcellus (Guinea pig),49.5,831.0,5.4e-204,712.6,sp|Q9WU45|CLCN2_CAVPO Chloride channel protein 2 OS=Cavia porcellus OX=10141 GN=CLCN2 PE=1 SV=1,GO:0005247; GO:0005886; GO:0016323; GO:0030424; GO:0032347; GO:0032591; GO:0034707; GO:0045211,regulation of aldosterone biosynthetic process [GO:0032347],axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; chloride channel complex [GO:0034707]; dendritic spine membrane [GO:0032591]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],voltage-gated chloride channel activity [GO:0005247],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_03316,FUN_013394-T1,Peve_00028092,Pocillopora_meandrina_HIv1___RNAseq.g22932.t1,three_way,67.747,FUN_013394-T1,Q7ZVH1,,,,,31.2,321.0,1e-37,159.1,sp|Q7ZVH1|MPRGA_DANRE Membrane progestin receptor gamma-A OS=Danio rerio OX=7955 GN=paqr5a PE=2 SV=2,,,,,,
OG_03317,FUN_013395-T1,Peve_00028089,Pocillopora_meandrina_HIv1___RNAseq.g22934.t1,three_way,42.45616666666667,,,,,,,,,,,,,,,,,
OG_03318,FUN_013396-T1,Peve_00028088,Pocillopora_meandrina_HIv1___TS.g15820.t1,three_way,43.746,,,,,,,,,,,,,,,,,
OG_03319,FUN_013398-T1,Peve_00028083,Pocillopora_meandrina_HIv1___RNAseq.g22937.t1,three_way,72.81966666666666,FUN_013398-T1,Q5U367,PLOD3_RAT,,"Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]",Rattus norvegicus (Rat),51.6,705.0,5.899999999999999e-231,802.0,sp|Q5U367|PLOD3_RAT Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 OS=Rattus norvegicus OX=10116 GN=Plod3 PE=1 SV=1,GO:0001701; GO:0001886; GO:0005506; GO:0005615; GO:0005783; GO:0005788; GO:0005789; GO:0005791; GO:0005794; GO:0005802; GO:0006493; GO:0008104; GO:0008475; GO:0017185; GO:0021915; GO:0030199; GO:0031418; GO:0032870; GO:0032963; GO:0033823; GO:0036094; GO:0042311; GO:0046872; GO:0046947; GO:0048730; GO:0050211; GO:0060425; GO:0062023; GO:0070831,basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311],collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; small molecule binding [GO:0036094],GO:0003013; GO:0003824; GO:0005615; GO:0005783; GO:0005794; GO:0006520; GO:0006575; GO:0009101; GO:0016491; GO:0016740; GO:0030198; GO:0043226; GO:0048856; GO:0140096; GO:1901135,"circulatory system process; catalytic activity; extracellular space; endoplasmic reticulum; Golgi apparatus; amino acid metabolic process; modified amino acid metabolic process; glycoprotein biosynthetic process; oxidoreductase activity; transferase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03320,FUN_013399-T1,Peve_00028082,Pocillopora_meandrina_HIv1___RNAseq.g22938.t1,three_way,78.69366666666667,FUN_013399-T1,Q7T3H7,,,,,49.5,194.0,3.4e-48,193.0,sp|Q7T3H7|MED18_DANRE Mediator of RNA polymerase II transcription subunit 18 OS=Danio rerio OX=7955 GN=med18 PE=2 SV=1,,,,,,
OG_03321,FUN_013400-T1,Peve_00028081,Pocillopora_meandrina_HIv1___RNAseq.g22939.t1,three_way,70.60533333333333,FUN_013400-T1,B5DE31,YBOX1_DANRE,,Y-box-binding protein 1 (YB-1) (ZfY1) (Y-box transcription factor),Danio rerio (Zebrafish) (Brachydanio rerio),77.6,107.0,1e-40,168.7,sp|B5DE31|YBOX1_DANRE Y-box-binding protein 1 OS=Danio rerio OX=7955 GN=ybx1 PE=1 SV=1,GO:0000932; GO:0001556; GO:0003676; GO:0003723; GO:0005634; GO:0006397; GO:0007343; GO:0008190; GO:0008327; GO:0008380; GO:0008544; GO:0010468; GO:0017148; GO:0035198; GO:0043009; GO:0045947; GO:0048025; GO:0048255; GO:0048598; GO:0050658; GO:0050686; GO:0051031; GO:0051236; GO:0062153; GO:0070062; GO:1990428; GO:2000773,"chordate embryonic development [GO:0043009]; egg activation [GO:0007343]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; establishment of RNA localization [GO:0051236]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of mRNA processing [GO:0050686]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; oocyte maturation [GO:0001556]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]",extracellular exosome [GO:0070062]; nucleus [GO:0005634]; P-body [GO:0000932],C5-methylcytidine-containing RNA reader activity [GO:0062153]; eukaryotic initiation factor 4E binding [GO:0008190]; methyl-CpG binding [GO:0008327]; miRNA binding [GO:0035198]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0060090,DNA binding; RNA binding; nucleus; mRNA metabolic process; reproductive process; organelle; anatomical structure development; molecular adaptor activity
OG_03322,FUN_013401-T1,Peve_00028079,Pocillopora_meandrina_HIv1___RNAseq.g22940.t1,three_way,79.2775,FUN_013401-T1,Q9NPF2,CHSTB_HUMAN,,Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1),Homo sapiens (Human),40.3,283.0,1.9999999999999998e-53,211.1,sp|Q9NPF2|CHSTB_HUMAN Carbohydrate sulfotransferase 11 OS=Homo sapiens OX=9606 GN=CHST11 PE=1 SV=1,GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016020; GO:0016051; GO:0030166; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0050650; GO:0050659,apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179],Golgi membrane [GO:0000139]; membrane [GO:0016020],chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005975; GO:0009101; GO:0012501; GO:0016740; GO:0048856; GO:1901135,catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; programmed cell death; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_03323,FUN_013402-T1,Peve_00028078,Pocillopora_meandrina_HIv1___RNAseq.g22941.t1,three_way,64.31,FUN_013402-T1,O57472,CHRD_DANRE,,Chordin (Protein chordino),Danio rerio (Zebrafish) (Brachydanio rerio),28.9,931.0,3.0000000000000003e-117,424.5,sp|O57472|CHRD_DANRE Chordin OS=Danio rerio OX=7955 GN=chd PE=2 SV=1,GO:0001756; GO:0001947; GO:0003143; GO:0005615; GO:0007368; GO:0009948; GO:0009953; GO:0010159; GO:0030510; GO:0030514; GO:0035143; GO:0035162; GO:0036122; GO:0043049; GO:0048264; GO:0060030; GO:0061371; GO:0070121,anterior/posterior axis specification [GO:0009948]; caudal fin morphogenesis [GO:0035143]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; determination of ventral identity [GO:0048264]; dorsal convergence [GO:0060030]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; embryonic hemopoiesis [GO:0035162]; heart looping [GO:0001947]; Kupffer's vesicle development [GO:0070121]; negative regulation of BMP signaling pathway [GO:0030514]; otic placode formation [GO:0043049]; regulation of BMP signaling pathway [GO:0030510]; somitogenesis [GO:0001756]; specification of animal organ position [GO:0010159],extracellular space [GO:0005615],BMP binding [GO:0036122],GO:0005615; GO:0048856; GO:0048870,extracellular space; anatomical structure development; cell motility
OG_03324,FUN_013404-T1,Peve_00028077,Pocillopora_meandrina_HIv1___TS.g15827.t1b,three_way,83.703,FUN_013404-T1,A5PJ65,,,,,65.1,192.0,1.2e-66,254.2,sp|A5PJ65|RER1_BOVIN Protein RER1 OS=Bos taurus OX=9913 GN=RER1 PE=2 SV=2,,,,,,
OG_03325,FUN_013405-T1,Peve_00028076,Pocillopora_meandrina_HIv1___TS.g15827.t1a,three_way,51.6765,FUN_013405-T1,P29594,CASP2_MOUSE,,Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12],Mus musculus (Mouse),27.8,460.0,3.1e-36,154.5,sp|P29594|CASP2_MOUSE Caspase-2 OS=Mus musculus OX=10090 GN=Casp2 PE=1 SV=5,GO:0001554; GO:0003407; GO:0004197; GO:0005634; GO:0005730; GO:0005737; GO:0006974; GO:0016485; GO:0019904; GO:0030330; GO:0035234; GO:0042802; GO:0043065; GO:0043066; GO:0043525; GO:0071260; GO:0097190; GO:0097192; GO:1905369; GO:2001235,"apoptotic signaling pathway [GO:0097190]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]",cytoplasm [GO:0005737]; endopeptidase complex [GO:1905369]; nucleolus [GO:0005730]; nucleus [GO:0005634],cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904],GO:0003824; GO:0005634; GO:0005730; GO:0012501; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; nucleus; nucleolus; programmed cell death; hydrolase activity; reproductive process; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_03326,FUN_013417-T1,Peve_00028080,Pocillopora_meandrina_HIv1___RNAseq.g22948.t1,three_way,78.34883333333333,,,,,,,,,,,,,,,,,
OG_03327,FUN_013418-T1,Peve_00028073,Pocillopora_meandrina_HIv1___RNAseq.g22949.t1,three_way,55.11866666666667,FUN_013418-T1,Q8X187,,,,,28.7,143.0,4e-10,67.4,sp|Q8X187|CALM_PAXIN Calmodulin OS=Paxillus involutus OX=71150 GN=calA PE=2 SV=3,,,,,,
OG_03328,FUN_013419-T1,Peve_00038577,Pocillopora_meandrina_HIv1___RNAseq.g22950.t1,three_way,58.92666666666667,FUN_013419-T1,P54213,,,,,26.5,162.0,5.9e-10,67.4,sp|P54213|CATR_DUNSA Caltractin OS=Dunaliella salina OX=3046 PE=2 SV=1,,,,,,
OG_03329,FUN_013420-T1,Peve_00038576,Pocillopora_meandrina_HIv1___RNAseq.g22951.t1,three_way,63.70666666666667,,,,,,,,,,,,,,,,,
OG_03330,FUN_013421-T1,Peve_00038575,Pocillopora_meandrina_HIv1___TS.g15837.t1,three_way,55.18933333333333,FUN_013421-T1,P42893,,,,,35.5,707.0,1.3000000000000002e-124,448.7,sp|P42893|ECE1_RAT Endothelin-converting enzyme 1 OS=Rattus norvegicus OX=10116 GN=Ece1 PE=1 SV=2,,,,,,
OG_03331,FUN_013422-T1,Peve_00038574,Pocillopora_meandrina_HIv1___RNAseq.g22954.t1,three_way,64.75666666666666,FUN_013422-T1,Q60715,P4HA1_MOUSE,,"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)",Mus musculus (Mouse),39.2,541.0,3e-99,364.0,sp|Q60715|P4HA1_MOUSE Prolyl 4-hydroxylase subunit alpha-1 OS=Mus musculus OX=10090 GN=P4ha1 PE=1 SV=2,GO:0004656; GO:0005506; GO:0005739; GO:0005788; GO:0016222; GO:0030199; GO:0031418; GO:0042802,collagen fibril organization [GO:0030199],endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222],identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656],GO:0003824; GO:0005739; GO:0016491; GO:0030198; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; oxidoreductase activity; extracellular matrix organization; organelle; catalytic activity, acting on a protein"
OG_03332,FUN_013545-T1,Peve_00038572,Pocillopora_meandrina_HIv1___RNAseq.g22955.t1a,three_way,83.74533333333333,FUN_013545-T1,Q99570,PI3R4_HUMAN,,Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein),Homo sapiens (Human),51.6,1405.0,0.0,1382.1,sp|Q99570|PI3R4_HUMAN Phosphoinositide 3-kinase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PIK3R4 PE=1 SV=3,GO:0000425; GO:0004672; GO:0004674; GO:0005524; GO:0005770; GO:0005776; GO:0005829; GO:0005929; GO:0005930; GO:0006468; GO:0006622; GO:0006623; GO:0010506; GO:0015630; GO:0016020; GO:0016241; GO:0030670; GO:0032465; GO:0032801; GO:0034271; GO:0034272; GO:0035032; GO:0036064; GO:0036092; GO:0042149; GO:0043231; GO:0043491; GO:0045022; GO:0045171; GO:0045324; GO:0071561; GO:0097352; GO:0106310,autophagosome maturation [GO:0097352]; cellular response to glucose starvation [GO:0042149]; early endosome to late endosome transport [GO:0045022]; late endosome to vacuole transport [GO:0045324]; pexophagy [GO:0000425]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; protein phosphorylation [GO:0006468]; protein targeting to lysosome [GO:0006622]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241],"autophagosome [GO:0005776]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]",ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005768; GO:0005773; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; vacuole; microtubule organizing center; cytosol; cytoskeleton; cilium; lipid metabolic process; intracellular protein transport; autophagy; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_03333,FUN_013553-T1,Peve_00024215,Pocillopora_meandrina_HIv1___RNAseq.g22958.t1,three_way,59.68833333333333,FUN_013553-T1,Q5R5W2,TADBP_PONAB,,TAR DNA-binding protein 43 (TDP-43),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),49.7,145.0,3.1e-32,140.6,sp|Q5R5W2|TADBP_PONAB TAR DNA-binding protein 43 OS=Pongo abelii OX=9601 GN=TARDBP PE=2 SV=1,GO:0000785; GO:0003677; GO:0003723; GO:0005730; GO:0005739; GO:0006397; GO:0008380; GO:0010468; GO:0016607; GO:0031647; GO:0042752,mRNA processing [GO:0006397]; regulation of circadian rhythm [GO:0042752]; regulation of gene expression [GO:0010468]; regulation of protein stability [GO:0031647]; RNA splicing [GO:0008380],chromatin [GO:0000785]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730],DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005730; GO:0005739; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleolus; mitochondrion; mRNA metabolic process; organelle
OG_03334,FUN_013555-T1,Peve_00024216,Pocillopora_meandrina_HIv1___RNAseq.g22959.t1,three_way,90.33133333333332,FUN_013555-T1,Q9YHT2,,,,,83.1,249.0,8.500000000000001e-126,451.4,"sp|Q9YHT2|SDHB_CHICK Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial OS=Gallus gallus OX=9031 GN=SDHB PE=1 SV=1",,,,,,
OG_03335,FUN_013556-T1,Peve_00038569,Pocillopora_meandrina_HIv1___RNAseq.g22960.t1,three_way,59.44166666666667,FUN_013556-T1,Q6NR09,EGRAP_DROME,,EGFR adapter protein,Drosophila melanogaster (Fruit fly),34.3,137.0,7.7e-13,77.0,sp|Q6NR09|EGRAP_DROME EGFR adapter protein OS=Drosophila melanogaster OX=7227 GN=Egfrap PE=1 SV=1,GO:0005925; GO:0030971; GO:0042059; GO:0045179,negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],apical cortex [GO:0045179]; focal adhesion [GO:0005925],receptor tyrosine kinase binding [GO:0030971],,
OG_03336,FUN_013557-T1,Peve_00038567,Pocillopora_meandrina_HIv1___RNAseq.g22961.t1,three_way,93.49333333333334,FUN_013557-T1,Q62074,KPCI_MOUSE,,Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (nPKC-iota),Mus musculus (Mouse),69.2,591.0,1.5e-245,850.1,sp|Q62074|KPCI_MOUSE Protein kinase C iota type OS=Mus musculus OX=10090 GN=Prkci PE=1 SV=3,GO:0000139; GO:0004672; GO:0004674; GO:0004699; GO:0005524; GO:0005543; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005903; GO:0005923; GO:0005929; GO:0007015; GO:0008270; GO:0010976; GO:0015630; GO:0016324; GO:0016477; GO:0031252; GO:0032869; GO:0034351; GO:0035089; GO:0042462; GO:0043220; GO:0043524; GO:0045171; GO:0045177; GO:0045197; GO:0045216; GO:0046326; GO:0048194; GO:0051092; GO:0060252; GO:0070555; GO:0098685; GO:0098978; GO:0099072; GO:0106310; GO:0120157; GO:1903078; GO:2000353,actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular response to insulin stimulus [GO:0032869]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of D-glucose import [GO:0046326]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; brush border [GO:0005903]; cell leading edge [GO:0031252]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; PAR polarity complex [GO:0120157]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220],"ATP binding [GO:0005524]; diacylglycerol-dependent, calcium-independent serine/threonine kinase activity [GO:0004699]; phospholipid binding [GO:0005543]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005634; GO:0005768; GO:0005829; GO:0005856; GO:0005929; GO:0006355; GO:0007163; GO:0008289; GO:0016740; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0061024; GO:0140096,"catalytic activity; nucleus; endosome; cytosol; cytoskeleton; cilium; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; lipid binding; transferase activity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_03337,FUN_013559-T1,Peve_00036543,Pocillopora_meandrina_HIv1___RNAseq.g22968.t1,three_way,88.23,FUN_013559-T1,P47756,CAPZB_HUMAN,,F-actin-capping protein subunit beta (CapZ beta),Homo sapiens (Human),80.8,271.0,1.9999999999999999e-128,459.9,sp|P47756|CAPZB_HUMAN F-actin-capping protein subunit beta OS=Homo sapiens OX=9606 GN=CAPZB PE=1 SV=5,GO:0003779; GO:0005829; GO:0005856; GO:0005903; GO:0007010; GO:0008154; GO:0008290; GO:0014069; GO:0015629; GO:0016020; GO:0022604; GO:0030017; GO:0030027; GO:0030032; GO:0030863; GO:0045296; GO:0051016; GO:0070062; GO:0071203; GO:0098685; GO:0098686; GO:0120212,actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; regulation of cell morphogenesis [GO:0022604],actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cortical cytoskeleton [GO:0030863]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; F-actin capping protein complex [GO:0008290]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; sarcomere [GO:0030017]; Schaffer collateral - CA1 synapse [GO:0098685]; sperm head-tail coupling apparatus [GO:0120212]; WASH complex [GO:0071203],actin binding [GO:0003779]; cadherin binding [GO:0045296],GO:0005829; GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_03338,FUN_013562-T1,Peve_00018191,Pocillopora_meandrina_HIv1___RNAseq.g22973.t1,three_way,41.28366666666666,,,,,,,,,,,,,,,,,
OG_03339,FUN_013568-T1,Peve_00018158,Pocillopora_meandrina_HIv1___RNAseq.g22926.t1,three_way,46.446666666666665,,,,,,,,,,,,,,,,,
OG_03340,FUN_013570-T1,Peve_00018159,Pocillopora_meandrina_HIv1___RNAseq.g13476.t1,three_way,85.26566666666666,FUN_013570-T1,Q9CPV0,TM107_MOUSE,,Transmembrane protein 107,Mus musculus (Mouse),52.7,129.0,1.4e-32,140.6,sp|Q9CPV0|TM107_MOUSE Transmembrane protein 107 OS=Mus musculus OX=10090 GN=Tmem107 PE=1 SV=1,GO:0003127; GO:0007368; GO:0010468; GO:0016020; GO:0021532; GO:0035869; GO:0036038; GO:0042733; GO:0044782; GO:0060021; GO:0060271; GO:0097094; GO:1904491; GO:1905515,cilium assembly [GO:0060271]; cilium organization [GO:0044782]; craniofacial suture morphogenesis [GO:0097094]; detection of nodal flow [GO:0003127]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; regulation of gene expression [GO:0010468]; roof of mouth development [GO:0060021],ciliary transition zone [GO:0035869]; membrane [GO:0016020]; MKS complex [GO:0036038],,GO:0044782; GO:0048856,cilium organization; anatomical structure development
OG_03341,FUN_013571-T1,Peve_00018157,Pocillopora_meandrina_HIv1___RNAseq.g13477.t1,three_way,64.70566666666667,,,,,,,,,,,,,,,,,
OG_03342,FUN_013572-T1,Peve_00022291,Pocillopora_meandrina_HIv1___RNAseq.g13520.t1,three_way,69.9175,FUN_013572-T1,Q9TRC7,AOC1_PIG,,Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein) (Amine oxidase copper domain-containing protein 1) (Histaminase),Sus scrofa (Pig),39.3,746.0,1.2e-157,558.5,sp|Q9TRC7|AOC1_PIG Diamine oxidase [copper-containing] OS=Sus scrofa OX=9823 GN=AOC1 PE=1 SV=3,GO:0005507; GO:0005509; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0009445; GO:0042803; GO:0048038; GO:0050232; GO:0052597; GO:0052598; GO:0070062,putrescine metabolic process [GO:0009445],bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; primary methylamine oxidase activity [GO:0008131]; protein homodimerization activity [GO:0042803]; putrescine oxidase activity [GO:0050232]; quinone binding [GO:0048038],GO:0003824; GO:0005615; GO:0005886; GO:0016491; GO:0043226,catalytic activity; extracellular space; plasma membrane; oxidoreductase activity; organelle
OG_03343,FUN_013573-T1,Peve_00026650,Pocillopora_meandrina_HIv1___RNAseq.g13522.t1,three_way,62.46266666666667,FUN_013573-T1,Q9NXK6,,,,,31.4,328.0,2.7000000000000004e-32,141.0,sp|Q9NXK6|PAQR5_HUMAN Membrane progestin receptor gamma OS=Homo sapiens OX=9606 GN=PAQR5 PE=1 SV=2,,,,,,
OG_03344,FUN_013578-T1,Peve_00026649,Pocillopora_meandrina_HIv1___RNAseq.g13513.t1,three_way,39.562666666666665,,,,,,,,,,,,,,,,,
OG_03345,FUN_013581-T1,Peve_00018187,Pocillopora_meandrina_HIv1___RNAseq.g13505.t1,three_way,65.99316666666667,FUN_013581-T1,Q5XI57,TTL10_RAT,,Protein polyglycylase TTLL10 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 10),Rattus norvegicus (Rat),48.2,394.0,7.7e-103,376.7,sp|Q5XI57|TTL10_RAT Protein polyglycylase TTLL10 OS=Rattus norvegicus OX=10116 GN=Ttll10 PE=2 SV=2,GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0015630; GO:0018094; GO:0046872; GO:0070735; GO:0070737,protein polyglycylation [GO:0018094],axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity [GO:0070735]; protein-glycine ligase activity, elongating [GO:0070737]",GO:0003824; GO:0005856; GO:0005929; GO:0016874; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; cilium; ligase activity; organelle; catalytic activity, acting on a protein"
OG_03346,FUN_013582-T1,Peve_00018189,Pocillopora_meandrina_HIv1___RNAseq.g13504.t1,three_way,62.93,,,,,,,,,,,,,,,,,
OG_03347,FUN_013583-T1,Peve_00018188,Pocillopora_meandrina_HIv1___RNAseq.g13503.t1,three_way,63.407,FUN_013583-T1,Q5RDQ4,,,,,41.8,91.0,2e-11,70.9,sp|Q5RDQ4|CH033_PONAB UPF0488 protein C8orf33 homolog OS=Pongo abelii OX=9601 PE=2 SV=1,,,,,,
OG_03348,FUN_013584-T1,Peve_00018186,Pocillopora_meandrina_HIv1___RNAseq.g13502.t1,three_way,72.53633333333333,,,,,,,,,,,,,,,,,
OG_03349,FUN_013585-T1,Peve_00018185,Pocillopora_meandrina_HIv1___RNAseq.g13501.t1,three_way,78.13466666666666,FUN_013585-T1,O35454,CLCN6_MOUSE,,H(+)/Cl(-) exchange transporter 6 (Chloride channel protein 6) (ClC-6) (Chloride transport protein 6),Mus musculus (Mouse),54.1,857.0,1.0999999999999999e-249,864.4,sp|O35454|CLCN6_MOUSE H(+)/Cl(-) exchange transporter 6 OS=Mus musculus OX=10090 GN=Clcn6 PE=1 SV=1,GO:0005247; GO:0005524; GO:0006821; GO:0015297; GO:0031902,chloride transport [GO:0006821],late endosome membrane [GO:0031902],antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247],GO:0005215,transporter activity
OG_03350,FUN_013586-T1,Peve_00018184,Pocillopora_meandrina_HIv1___TS.g2494.t1,three_way,61.21066666666667,,,,,,,,,,,,,,,,,
OG_03351,FUN_013587-T1,Peve_00018181,Pocillopora_meandrina_HIv1___RNAseq.g13494.t1,three_way,61.905,FUN_013587-T1,A1A5V9,,,,,27.1,303.0,1.1e-27,125.6,sp|A1A5V9|ELP5_DANRE Elongator complex protein 5 OS=Danio rerio OX=7955 GN=elp5 PE=2 SV=1,,,,,,
OG_03352,FUN_013588-T1,Peve_00018182,Pocillopora_meandrina_HIv1___TS.g2490.t1,three_way,50.96683333333333,FUN_013588-T1,Q5XJP0,B3G5B_DANRE,,"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase B (EC 2.4.1.206) (Lactotriaosylceramide synthase B) (Lc(3)Cer synthase B) (Lc3 synthase B) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5B) (BGnT-5B) (Beta-1,3-Gn-T5B) (Beta-1,3-N-acetylglucosaminyltransferase 5B) (Beta3Gn-T5B)",Danio rerio (Zebrafish) (Brachydanio rerio),33.0,215.0,1.4000000000000002e-23,112.1,"sp|Q5XJP0|B3G5B_DANRE Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase B OS=Danio rerio OX=7955 GN=b3gnt5b PE=2 SV=1",GO:0000139; GO:0006493; GO:0016757; GO:0047256,protein O-linked glycosylation [GO:0006493],Golgi membrane [GO:0000139],"glycosyltransferase activity [GO:0016757]; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity [GO:0047256]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_03353,FUN_013589-T1,Peve_00018180,Pocillopora_meandrina_HIv1___RNAseq.g13493.t1,three_way,79.63766666666666,FUN_013589-T1,Q4KKZ1,,,,,39.8,181.0,3.5e-28,126.7,sp|Q4KKZ1|CF107_MOUSE Cilia- and flagella-associated protein 107 OS=Mus musculus OX=10090 GN=Cfap107 PE=1 SV=2,,,,,,
OG_03354,FUN_013590-T1,Peve_00018179,Pocillopora_meandrina_HIv1___RNAseq.g13492.t1,three_way,62.60416666666666,FUN_013590-T1,Q9CR24,NUDT8_MOUSE,,Mitochondrial coenzyme A diphosphatase NUDT8 (EC 3.6.1.-) (EC 3.6.1.77) (Nucleoside diphosphate-linked moiety X motif 8) (Nudix motif 8),Mus musculus (Mouse),43.2,206.0,4.8e-35,149.8,sp|Q9CR24|NUDT8_MOUSE Mitochondrial coenzyme A diphosphatase NUDT8 OS=Mus musculus OX=10090 GN=Nudt8 PE=1 SV=1,GO:0000287; GO:0005739; GO:0005759; GO:0010945; GO:0015938; GO:0030145; GO:0036114; GO:0044580; GO:0046356; GO:1901289; GO:1902859; GO:2001294,acetyl-CoA catabolic process [GO:0046356]; butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA catabolic process [GO:1902859]; succinyl-CoA catabolic process [GO:1901289],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],coenzyme A diphosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145],GO:0003824; GO:0005739; GO:0006629; GO:0006790; GO:0016787; GO:0043226; GO:0055086,catalytic activity; mitochondrion; lipid metabolic process; sulfur compound metabolic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03355,FUN_013591-T1,Peve_00018178,Pocillopora_meandrina_HIv1___RNAseq.g13491.t1,three_way,67.64033333333333,FUN_013591-T1,Q9Y2Q3,GSTK1_HUMAN,,Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13),Homo sapiens (Human),55.1,216.0,6.900000000000002e-66,251.9,sp|Q9Y2Q3|GSTK1_HUMAN Glutathione S-transferase kappa 1 OS=Homo sapiens OX=9606 GN=GSTK1 PE=1 SV=3,GO:0004364; GO:0004602; GO:0005739; GO:0005759; GO:0005777; GO:0005782; GO:0005829; GO:0006749; GO:0016020; GO:0030855; GO:0070062,epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0006575; GO:0006790; GO:0016209; GO:0016491; GO:0016740; GO:0030154; GO:0043226,catalytic activity; mitochondrion; peroxisome; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; antioxidant activity; oxidoreductase activity; transferase activity; cell differentiation; organelle
OG_03356,FUN_013593-T1,Peve_00018176,Pocillopora_meandrina_HIv1___RNAseq.g13486.t1,three_way,88.194,FUN_013593-T1,O95619,YETS4_HUMAN,,YEATS domain-containing protein 4 (Glioma-amplified sequence 41) (Gas41) (NuMA-binding protein 1) (NuBI-1) (NuBI1),Homo sapiens (Human),62.1,224.0,2.1999999999999998e-75,283.5,sp|O95619|YETS4_HUMAN YEATS domain-containing protein 4 OS=Homo sapiens OX=9606 GN=YEATS4 PE=1 SV=1,GO:0000278; GO:0000786; GO:0005200; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0016363; GO:0031965; GO:0035267; GO:0042393; GO:0042981; GO:0045893; GO:0051726; GO:0140044; GO:0140119; GO:1905168; GO:2000779,chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of transcription by RNA polymerase II [GO:0006357],NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634],histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0005198; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0060090,mitotic cell cycle; structural molecule activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; molecular adaptor activity
OG_03357,FUN_013594-T1,Peve_00029572,Pocillopora_meandrina_HIv1___RNAseq.g6546.t1,three_way,67.05166666666666,,,,,,,,,,,,,,,,,
OG_03358,FUN_013595-T1,Peve_00034270,Pocillopora_meandrina_HIv1___RNAseq.g13485.t1,three_way,69.64366666666666,FUN_013595-T1,P21728,DRD1_HUMAN,,D(1A) dopamine receptor (Dopamine D1 receptor),Homo sapiens (Human),25.8,368.0,3.4e-16,87.4,sp|P21728|DRD1_HUMAN D(1A) dopamine receptor OS=Homo sapiens OX=9606 GN=DRD1 PE=1 SV=1,GO:0001588; GO:0001659; GO:0001661; GO:0001662; GO:0001965; GO:0001975; GO:0004930; GO:0004952; GO:0005634; GO:0005789; GO:0005886; GO:0005929; GO:0006606; GO:0007187; GO:0007189; GO:0007191; GO:0007212; GO:0007416; GO:0007613; GO:0007617; GO:0007625; GO:0007628; GO:0008542; GO:0009410; GO:0014002; GO:0015872; GO:0019226; GO:0019228; GO:0021542; GO:0021756; GO:0021853; GO:0030335; GO:0030432; GO:0032795; GO:0035106; GO:0035240; GO:0035249; GO:0042053; GO:0042311; GO:0042417; GO:0042711; GO:0042734; GO:0043197; GO:0043268; GO:0043410; GO:0045211; GO:0046323; GO:0046959; GO:0046960; GO:0048148; GO:0051281; GO:0051584; GO:0051968; GO:0060134; GO:0060158; GO:0060170; GO:0060291; GO:0060292; GO:0071870; GO:0071880; GO:0097648; GO:0097730; GO:0098978; GO:0098982; GO:0099010; GO:0099171; GO:1990763; GO:2001224,"adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult walking behavior [GO:0007628]; astrocyte development [GO:0014002]; behavioral fear response [GO:0001662]; behavioral response to cocaine [GO:0048148]; cellular response to catecholamine stimulus [GO:0071870]; cerebral cortex GABAergic interneuron migration [GO:0021853]; conditioned taste aversion [GO:0001661]; D-glucose import [GO:0046323]; dentate gyrus development [GO:0021542]; dopamine metabolic process [GO:0042417]; dopamine transport [GO:0015872]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; grooming behavior [GO:0007625]; habituation [GO:0046959]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; maternal behavior [GO:0042711]; mating behavior [GO:0007617]; memory [GO:0007613]; modification of postsynaptic structure [GO:0099010]; neuronal action potential [GO:0019228]; operant conditioning [GO:0035106]; peristalsis [GO:0030432]; phospholipase C-activating dopamine receptor signaling pathway [GO:0060158]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein import into nucleus [GO:0006606]; regulation of dopamine metabolic process [GO:0042053]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; response to amphetamine [GO:0001975]; response to xenobiotic stimulus [GO:0009410]; sensitization [GO:0046960]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; synaptic transmission, glutamatergic [GO:0035249]; temperature homeostasis [GO:0001659]; transmission of nerve impulse [GO:0019226]; vasodilation [GO:0042311]; visual learning [GO:0008542]",ciliary membrane [GO:0060170]; cilium [GO:0005929]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; G protein-coupled receptor complex [GO:0097648]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],"arrestin family protein binding [GO:1990763]; dopamine binding [GO:0035240]; dopamine neurotransmitter receptor activity [GO:0004952]; dopamine neurotransmitter receptor activity, coupled via Gs [GO:0001588]; G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; heterotrimeric G-protein binding [GO:0032795]",GO:0003012; GO:0003013; GO:0005634; GO:0005886; GO:0005929; GO:0006886; GO:0006913; GO:0022414; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0060089,muscle system process; circulatory system process; nucleus; plasma membrane; cilium; intracellular protein transport; nucleocytoplasmic transport; reproductive process; signaling; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; molecular transducer activity
OG_03359,FUN_013596-T1,Peve_00018172,Pocillopora_meandrina_HIv1___RNAseq.g13484.t1,three_way,75.14,FUN_013596-T1,Q4DJ07,,,,,34.4,279.0,1.7e-37,159.8,"sp|Q4DJ07|PGFS_TRYCC 9,11-endoperoxide prostaglandin H2 reductase OS=Trypanosoma cruzi (strain CL Brener) OX=353153 GN=Tc00.1047053511287.49 PE=1 SV=2",,,,,,
OG_03360,FUN_013597-T1,Peve_00018171,Pocillopora_meandrina_HIv1___TS.g2479.t1,three_way,67.01816666666667,,,,,,,,,,,,,,,,,
OG_03361,FUN_013599-T1,Peve_00018167,Pocillopora_meandrina_HIv1___RNAseq.14767_t,three_way,48.52133333333333,,,,,,,,,,,,,,,,,
OG_03362,FUN_013601-T1,Peve_00018166,Pocillopora_meandrina_HIv1___RNAseq.g13480.t1,three_way,70.76016666666666,,,,,,,,,,,,,,,,,
OG_03363,FUN_013603-T1,Peve_00018165,Pocillopora_meandrina_HIv1___RNAseq.g13479.t1,three_way,65.08200000000001,FUN_013603-T1,H3BPM6,,,,,34.7,199.0,1.4000000000000001e-33,144.4,sp|H3BPM6|MKROS_HUMAN MKRN2 opposite strand protein OS=Homo sapiens OX=9606 GN=MKRN2OS PE=1 SV=1,,,,,,
OG_03364,FUN_013606-T1,Peve_00002653,Pocillopora_meandrina_HIv1___RNAseq.g13526.t1,three_way,79.673,FUN_013606-T1,Q60HE5,,,,,52.4,614.0,6.400000000000001e-186,652.1,sp|Q60HE5|MTHR_MACFA Methylenetetrahydrofolate reductase (NADPH) OS=Macaca fascicularis OX=9541 GN=MTHFR PE=2 SV=1,,,,,,
OG_03365,FUN_013608-T1,Peve_00002652,Pocillopora_meandrina_HIv1___RNAseq.g13524.t1,three_way,66.57066666666667,,,,,,,,,,,,,,,,,
OG_03366,FUN_013610-T1,Peve_00002650,Pocillopora_meandrina_HIv1___RNAseq.g13529.t1,three_way,95.495,FUN_013610-T1,O15514,RPB4_HUMAN,,DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit) (RPB16),Homo sapiens (Human),77.5,142.0,4.9e-54,211.8,sp|O15514|RPB4_HUMAN DNA-directed RNA polymerase II subunit RPB4 OS=Homo sapiens OX=9606 GN=POLR2D PE=1 SV=1,GO:0000166; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006366; GO:0006367; GO:0016607; GO:0031369,transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],"cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]",nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369],GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0043226,nucleus; nucleoplasm; cytosol; DNA-templated transcription; organelle
OG_03367,FUN_013611-T1,Peve_00002648,Pocillopora_meandrina_HIv1___RNAseq.g13531.t1,three_way,90.91866666666668,FUN_013611-T1,Q8NFJ9,,,,,57.6,587.0,5e-188,659.1,sp|Q8NFJ9|BBS1_HUMAN BBSome complex member BBS1 OS=Homo sapiens OX=9606 GN=BBS1 PE=1 SV=1,,,,,,
OG_03368,FUN_013613-T1,Peve_00002659,Pocillopora_meandrina_HIv1___RNAseq.g13533.t1,three_way,54.56916666666667,FUN_013613-T1,Q9P2K9,DISP3_HUMAN,,Protein dispatched homolog 3 (Patched domain-containing protein 2),Homo sapiens (Human),35.0,1203.0,7.2e-160,566.6,sp|Q9P2K9|DISP3_HUMAN Protein dispatched homolog 3 OS=Homo sapiens OX=9606 GN=DISP3 PE=1 SV=2,GO:0005737; GO:0005783; GO:0005789; GO:0007224; GO:0008203; GO:0016020; GO:0030154; GO:0030659; GO:0031965; GO:0032368; GO:0042632; GO:0045665; GO:0045834; GO:2000179,cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of lipid metabolic process [GO:0045834]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of lipid transport [GO:0032368]; smoothened signaling pathway [GO:0007224],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965],,GO:0005783; GO:0006629; GO:0030154; GO:0043226,endoplasmic reticulum; lipid metabolic process; cell differentiation; organelle
OG_03369,FUN_013615-T1,Peve_00002656,Pocillopora_meandrina_HIv1___RNAseq.g13534.t1,three_way,66.598,FUN_013615-T1,Q6Y7W8,,,,,35.4,621.0,1.4999999999999999e-40,170.2,sp|Q6Y7W8|GGYF2_MOUSE GRB10-interacting GYF protein 2 OS=Mus musculus OX=10090 GN=Gigyf2 PE=1 SV=2,,,,,,
OG_03370,FUN_013616-T1,Peve_00002647,Pocillopora_meandrina_HIv1___RNAseq.g13535.t1,three_way,68.612,FUN_013616-T1,Q9Y2G8,DJC16_HUMAN,,DnaJ homolog subfamily C member 16 (Endoplasmic reticulum DNA J domain-containing protein 8) (ER-resident protein ERdj8) (ERdj8),Homo sapiens (Human),31.9,781.0,3.7e-95,350.9,sp|Q9Y2G8|DJC16_HUMAN DnaJ homolog subfamily C member 16 OS=Homo sapiens OX=9606 GN=DNAJC16 PE=1 SV=3,GO:0005789; GO:0016243,regulation of autophagosome size [GO:0016243],endoplasmic reticulum membrane [GO:0005789],,,
OG_03371,FUN_013617-T1,Peve_00035878,Pocillopora_meandrina_HIv1___RNAseq.g13536.t1,three_way,73.67233333333334,FUN_013617-T1,Q5T089,,,,,72.7,44.0,3.4e-13,78.2,sp|Q5T089|MORN1_HUMAN MORN repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=MORN1 PE=1 SV=2,,,,,,
OG_03372,FUN_013618-T1,Peve_00014992,Pocillopora_meandrina_HIv1___RNAseq.g13537.t1,three_way,60.133,FUN_013618-T1,Q9WUU9,GANP_MOUSE,,Germinal-center associated nuclear protein (GANP) (EC 2.3.1.48) (GC-associated DNA primase),Mus musculus (Mouse),34.9,347.0,2.5e-45,184.5,sp|Q9WUU9|GANP_MOUSE Germinal-center associated nuclear protein OS=Mus musculus OX=10090 GN=Mcm3ap PE=1 SV=2,GO:0003676; GO:0003682; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005829; GO:0010484; GO:0015031; GO:0016446; GO:0016973; GO:0031965; GO:0034728; GO:0042393; GO:0044615; GO:0070390,nucleosome organization [GO:0034728]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031]; somatic hypermutation of immunoglobulin genes [GO:0016446],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390],chromatin binding [GO:0003682]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; histone H3 acetyltransferase activity [GO:0010484]; nucleic acid binding [GO:0003676],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006325; GO:0006913; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; chromatin organization; nucleocytoplasmic transport; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_03373,FUN_013619-T1,Peve_00014990,Pocillopora_meandrina_HIv1___RNAseq.g13538.t1,three_way,54.383,FUN_013619-T1,F4JAU3,P4H2_ARATH,,Prolyl 4-hydroxylase 2 (AtP4H-2) (AtP4H2) (EC 1.14.11.2),Arabidopsis thaliana (Mouse-ear cress),31.1,180.0,2.5e-16,88.2,sp|F4JAU3|P4H2_ARATH Prolyl 4-hydroxylase 2 OS=Arabidopsis thaliana OX=3702 GN=P4H2 PE=1 SV=1,GO:0000137; GO:0000139; GO:0004656; GO:0005506; GO:0005768; GO:0005789; GO:0005794; GO:0005802; GO:0018401; GO:0031418; GO:0080147,peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; root hair cell development [GO:0080147],endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656],GO:0003824; GO:0005768; GO:0005794; GO:0006520; GO:0006575; GO:0016491; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endosome; Golgi apparatus; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03374,FUN_013620-T1,Peve_00014987,Pocillopora_meandrina_HIv1___RNAseq.g13541.t1,three_way,88.12266666666667,FUN_013620-T1,B9GCH9,UREA_ORYSJ,,Urease (EC 3.5.1.5) (Urea amidohydrolase),Oryza sativa subsp. japonica (Rice),62.3,862.0,3.4e-307,1055.4,sp|B9GCH9|UREA_ORYSJ Urease OS=Oryza sativa subsp. japonica OX=39947 GN=Os12g0234800 PE=3 SV=2,GO:0009039; GO:0016151; GO:0035550; GO:0043419,urea catabolic process [GO:0043419],urease complex [GO:0035550],nickel cation binding [GO:0016151]; urease activity [GO:0009039],GO:0003824; GO:0016787; GO:0071941,catalytic activity; hydrolase activity; nitrogen cycle metabolic process
OG_03375,FUN_013621-T1,Peve_00014986,Pocillopora_meandrina_HIv1___RNAseq.g13542.t1,three_way,98.82,FUN_013621-T1,P63171,DYLT1_BOVIN,,Dynein light chain Tctex-type 1 (T-complex testis-specific protein 1 homolog),Bos taurus (Bovine),84.1,113.0,1.5999999999999996e-53,210.3,sp|P63171|DYLT1_BOVIN Dynein light chain Tctex-type 1 OS=Bos taurus OX=9913 GN=DYNLT1 PE=1 SV=1,GO:0000132; GO:0005737; GO:0005794; GO:0005819; GO:0005868; GO:0005874; GO:0006886; GO:0007018; GO:0007399; GO:0008277; GO:0043001; GO:0045505; GO:0050768; GO:0051301,cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; microtubule-based movement [GO:0007018]; negative regulation of neurogenesis [GO:0050768]; nervous system development [GO:0007399]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; spindle [GO:0005819],dynein intermediate chain binding [GO:0045505],GO:0005794; GO:0006886; GO:0007010; GO:0007018; GO:0016192; GO:0043226; GO:0048856; GO:0072659,Golgi apparatus; intracellular protein transport; cytoskeleton organization; microtubule-based movement; vesicle-mediated transport; organelle; anatomical structure development; protein localization to plasma membrane
OG_03376,FUN_013622-T1,Peve_00014995,Pocillopora_meandrina_HIv1___RNAseq.g13543.t1,three_way,92.35383333333333,FUN_013622-T1,A7HHN3,,,,,71.4,217.0,1.1e-84,314.3,sp|A7HHN3|UREG_ANADF Urease accessory protein UreG OS=Anaeromyxobacter sp. (strain Fw109-5) OX=404589 GN=ureG PE=3 SV=1,,,,,,
OG_03377,FUN_013623-T1,Peve_00014994,Pocillopora_meandrina_HIv1___RNAseq.g13544.t1,three_way,69.24266666666666,FUN_013623-T1,A9GP79,,,,,32.0,256.0,1.0999999999999998e-24,115.5,sp|A9GP79|URED_SORC5 Urease accessory protein UreD OS=Sorangium cellulosum (strain So ce56) OX=448385 GN=ureD PE=3 SV=2,,,,,,
OG_03378,FUN_013626-T1,Peve_00013600,Pocillopora_meandrina_HIv1___RNAseq.g13546.t1,three_way,86.476,FUN_013626-T1,P49915,GUAA_HUMAN,,GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase),Homo sapiens (Human),65.0,666.0,4.9e-264,911.8,sp|P49915|GUAA_HUMAN GMP synthase [glutamine-hydrolyzing] OS=Homo sapiens OX=9606 GN=GMPS PE=1 SV=1,GO:0003921; GO:0003922; GO:0005524; GO:0005829; GO:0006177; GO:0009113; GO:0009168,GMP biosynthetic process [GO:0006177]; purine nucleobase biosynthetic process [GO:0009113]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168],cytosol [GO:0005829],ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921],GO:0003824; GO:0005829; GO:0016874; GO:0055086; GO:1901135,catalytic activity; cytosol; ligase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03379,FUN_013627-T1,Peve_00018598,Pocillopora_meandrina_HIv1___RNAseq.g13548.t1,three_way,66.10166666666667,,,,,,,,,,,,,,,,,
OG_03380,FUN_013628-T1,Peve_00018590,Pocillopora_meandrina_HIv1___RNAseq.g13551.t1,three_way,57.17233333333333,,,,,,,,,,,,,,,,,
OG_03381,FUN_013631-T1,Peve_00039074,Pocillopora_meandrina_HIv1___RNAseq.g13554.t1,three_way,65.295,FUN_013631-T1,Q6PBI8,,,,,24.7,296.0,4.9e-17,90.1,sp|Q6PBI8|TM177_DANRE Transmembrane protein 177 OS=Danio rerio OX=7955 GN=tmem177 PE=2 SV=1,,,,,,
OG_03382,FUN_013634-T1,Peve_00039087,Pocillopora_meandrina_HIv1___RNAseq.g13560.t1,three_way,39.31766666666667,,,,,,,,,,,,,,,,,
OG_03383,FUN_013638-T1,Peve_00039072,Pocillopora_meandrina_HIv1___RNAseq.g13562.t1,three_way,66.89450000000001,FUN_013638-T1,Q3V3Z3,AGRG5_MOUSE,,"Adhesion G-protein coupled receptor G5 (G-protein coupled receptor 114) (G-protein coupled receptor PGR27) [Cleaved into: Adhesion G-protein coupled receptor G5, N-terminal fragment (ADGRG5 N-terminal fragment); Adhesion G-protein coupled receptor G5, C-terminal fragment (ADGRG5 C-terminal fragment)]",Mus musculus (Mouse),29.5,292.0,5.4e-16,87.4,sp|Q3V3Z3|AGRG5_MOUSE Adhesion G-protein coupled receptor G5 OS=Mus musculus OX=10090 GN=Adgrg5 PE=1 SV=3,GO:0004930; GO:0005886; GO:0007166; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_03384,FUN_013639-T1,Peve_00014498,Pocillopora_meandrina_HIv1___TS.g2558.t1,three_way,58.3175,FUN_013639-T1,Q1ZZH1,,,,,29.3,869.0,6.0999999999999995e-99,364.0,sp|Q1ZZH1|GRM3_MACFA Metabotropic glutamate receptor 3 OS=Macaca fascicularis OX=9541 GN=GRM3 PE=2 SV=1,,,,,,
OG_03385,FUN_013640-T1,Peve_00014495,Pocillopora_meandrina_HIv1___RNAseq.g13566.t1,three_way,63.574666666666666,FUN_013640-T1,P11456,,,,,38.0,216.0,1.2e-35,151.8,sp|P11456|MPRD_BOVIN Cation-dependent mannose-6-phosphate receptor OS=Bos taurus OX=9913 GN=M6PR PE=1 SV=1,,,,,,
OG_03386,FUN_013641-T1,Peve_00019982,Pocillopora_meandrina_HIv1___RNAseq.g13568.t1,three_way,45.04066666666667,,,,,,,,,,,,,,,,,
OG_03387,FUN_013642-T1,Peve_00019984,Pocillopora_meandrina_HIv1___RNAseq.g13569.t1,three_way,66.811,FUN_013642-T1,O12947,,,,,54.0,215.0,3.2e-68,260.0,sp|O12947|ICMT_XENLA Protein-S-isoprenylcysteine O-methyltransferase OS=Xenopus laevis OX=8355 GN=icmt PE=1 SV=1,,,,,,
OG_03388,FUN_013649-T1,Peve_00012813,Pocillopora_meandrina_HIv1___RNAseq.g2586.t1,three_way,66.73133333333334,FUN_013649-T1,Q8K4H1,KFA_MOUSE,,Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF),Mus musculus (Mouse),39.9,288.0,2.6000000000000004e-57,223.8,sp|Q8K4H1|KFA_MOUSE Kynurenine formamidase OS=Mus musculus OX=10090 GN=Afmid PE=1 SV=1,GO:0004061; GO:0005634; GO:0005737; GO:0005829; GO:0019441; GO:0034354,'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; L-tryptophan catabolic process to kynurenine [GO:0019441],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],arylformamidase activity [GO:0004061],GO:0003824; GO:0005634; GO:0005829; GO:0006520; GO:0016787; GO:0043226; GO:0055086,catalytic activity; nucleus; cytosol; amino acid metabolic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03389,FUN_014089-T1,Peve_00007744,Pocillopora_meandrina_HIv1___RNAseq.g15612.t1,three_way,71.63983333333333,FUN_014089-T1,Q91VS8,FARP2_MOUSE,,"FERM, ARHGEF and pleckstrin domain-containing protein 2 (FERM domain including RhoGEF) (FIR) (FERM, RhoGEF and pleckstrin domain-containing protein 2)",Mus musculus (Mouse),36.0,1242.0,1.5999999999999998e-191,671.8,"sp|Q91VS8|FARP2_MOUSE FERM, ARHGEF and pleckstrin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Farp2 PE=1 SV=2",GO:0005085; GO:0005737; GO:0005829; GO:0005856; GO:0007155; GO:0008092; GO:0016322; GO:0016601; GO:0022405; GO:0030036; GO:0030316; GO:0033623; GO:0071526; GO:0071800,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; semaphorin-plexin signaling pathway [GO:0071526],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829],cytoskeletal protein binding [GO:0008092]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005856; GO:0007010; GO:0007155; GO:0008092; GO:0030154; GO:0043226; GO:0065003; GO:0098772,cytosol; cytoskeleton; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; cell differentiation; organelle; protein-containing complex assembly; molecular function regulator activity
OG_03390,FUN_014102-T1,Peve_00007747,Pocillopora_meandrina_HIv1___RNAseq.g15315.t2,three_way,69.33183333333334,FUN_014102-T1,Q3U3V8,,,,,26.0,799.0,1.2e-43,179.9,sp|Q3U3V8|XRRA1_MOUSE X-ray radiation resistance-associated protein 1 OS=Mus musculus OX=10090 GN=Xrra1 PE=2 SV=1,,,,,,
OG_03391,FUN_014103-T1,Peve_00039614,Pocillopora_meandrina_HIv1___TS.g10372.t1,three_way,79.18366666666667,FUN_014103-T1,Q6P5E4,UGGG1_MOUSE,,UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1),Mus musculus (Mouse),47.0,1520.0,0.0,1354.3,sp|Q6P5E4|UGGG1_MOUSE UDP-glucose:glycoprotein glucosyltransferase 1 OS=Mus musculus OX=10090 GN=Uggt1 PE=1 SV=4,GO:0003980; GO:0005788; GO:0005793; GO:0006486; GO:0032991; GO:0051082,protein glycosylation [GO:0006486],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein-containing complex [GO:0032991],UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082],GO:0003824; GO:0006486; GO:0016740; GO:0043226,catalytic activity; protein glycosylation; transferase activity; organelle
OG_03392,FUN_014119-T1,Peve_00024141,Pocillopora_meandrina_HIv1___RNAseq.g15594.t1,three_way,66.026,,,,,,,,,,,,,,,,,
OG_03393,FUN_014123-T2,Peve_00030269,Pocillopora_meandrina_HIv1___RNAseq.g15590.t1,three_way,84.48033333333333,FUN_014123-T2,O73787,,,,,51.1,915.0,1.7e-251,870.5,sp|O73787|GCP3_XENLA Gamma-tubulin complex component 3 homolog OS=Xenopus laevis OX=8355 GN=tubgcp3 PE=1 SV=1,,,,,,
OG_03394,FUN_014166-T1,Peve_00026508,Pocillopora_meandrina_HIv1___RNAseq.g7362.t1,three_way,57.504,FUN_014166-T1,Q9H2K2,,,,,28.4,211.0,3.9e-08,62.0,sp|Q9H2K2|TNKS2_HUMAN Poly [ADP-ribose] polymerase tankyrase-2 OS=Homo sapiens OX=9606 GN=TNKS2 PE=1 SV=1,,,,,,
OG_03395,FUN_014169-T1,Peve_00037817,Pocillopora_meandrina_HIv1___TS.g11124.t1,three_way,91.21866666666666,FUN_014169-T1,Q6P2Y2,,,,,74.1,143.0,4.1e-56,220.3,sp|Q6P2Y2|DAW1_XENTR Dynein assembly factor with WD repeat domains 1 OS=Xenopus tropicalis OX=8364 GN=daw1 PE=2 SV=1,,,,,,
OG_03396,FUN_014250-T1,Peve_00035867,Pocillopora_meandrina_HIv1___RNAseq.g22963.t1,three_way,77.14866666666667,,,,,,,,,,,,,,,,,
OG_03397,FUN_014262-T1,Peve_00023414,Pocillopora_meandrina_HIv1___RNAseq.g16120.t1,three_way,89.313,FUN_014262-T1,O35343,IMA3_MOUSE,,Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4),Mus musculus (Mouse),70.0,513.0,4.5e-113,409.8,sp|O35343|IMA3_MOUSE Importin subunit alpha-3 OS=Mus musculus OX=10090 GN=Kpna4 PE=1 SV=1,GO:0001673; GO:0005643; GO:0005654; GO:0005829; GO:0006606; GO:0006607; GO:0008139; GO:0010467; GO:0014046; GO:0031965; GO:0042542; GO:0042564; GO:0061608,dopamine secretion [GO:0014046]; gene expression [GO:0010467]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; response to hydrogen peroxide [GO:0042542],cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654],nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139],GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0140104,nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular carrier activity
OG_03398,FUN_014264-T1,Peve_00021332,Pocillopora_meandrina_HIv1___RNAseq.g16097.t2,three_way,75.2415,FUN_014264-T1,Q32KU6,,,,,36.5,244.0,9.7e-39,162.2,sp|Q32KU6|TSN6_BOVIN Tetraspanin-6 OS=Bos taurus OX=9913 GN=TSPAN6 PE=2 SV=1,,,,,,
OG_03399,FUN_014438-T1,Peve_00020049,Pocillopora_meandrina_HIv1___RNAseq.g24661.t1,three_way,86.73333333333333,FUN_014438-T1,Q0VG85,,,,,31.7,944.0,1.5e-123,446.8,sp|Q0VG85|CC162_MOUSE Coiled-coil domain-containing protein 162 OS=Mus musculus OX=10090 GN=Ccdc162 PE=1 SV=4,,,,,,
OG_03400,FUN_014439-T1,Peve_00000664,Pocillopora_meandrina_HIv1___TS.g12605.t1,three_way,76.63716666666666,FUN_014439-T1,O43913,,,,,52.0,431.0,1.4999999999999999e-120,434.5,sp|O43913|ORC5_HUMAN Origin recognition complex subunit 5 OS=Homo sapiens OX=9606 GN=ORC5 PE=1 SV=1,,,,,,
OG_03401,FUN_014440-T1,Peve_00002505,Pocillopora_meandrina_HIv1___TS.g8856.t1b,three_way,69.38566666666667,FUN_014440-T1,Q692V3,,,,,30.4,918.0,3e-104,381.7,sp|Q692V3|TTC41_MOUSE Tetratricopeptide repeat protein 41 OS=Mus musculus OX=10090 GN=Ttc41 PE=1 SV=1,,,,,,
OG_03402,FUN_014441-T1,Peve_00009614,Pocillopora_meandrina_HIv1___RNAseq.g22836.t1,three_way,66.44333333333333,FUN_014441-T1,Q6PDY2,AEDO_MOUSE,,2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase),Mus musculus (Mouse),34.8,264.0,2.0000000000000002e-29,131.0,sp|Q6PDY2|AEDO_MOUSE 2-aminoethanethiol dioxygenase OS=Mus musculus OX=10090 GN=Ado PE=1 SV=2,GO:0005506; GO:0005739; GO:0047800; GO:0071456,cellular response to hypoxia [GO:0071456],mitochondrion [GO:0005739],cysteamine dioxygenase activity [GO:0047800]; iron ion binding [GO:0005506],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_03403,FUN_014442-T1,Peve_00009611,Pocillopora_meandrina_HIv1___RNAseq.g22833.t1,three_way,60.98433333333333,FUN_014442-T1,Q55C17,,,,,27.9,247.0,2.8e-16,87.4,sp|Q55C17|TECR_DICDI Very-long-chain enoyl-CoA reductase OS=Dictyostelium discoideum OX=44689 GN=gpsn2 PE=3 SV=1,,,,,,
OG_03404,FUN_014447-T1,Peve_00009610,Pocillopora_meandrina_HIv1___TS.g27599.t1,three_way,86.17,FUN_014447-T1,Q15012,LAP4A_HUMAN,,Lysosomal-associated transmembrane protein 4A (Golgi 4-transmembrane-spanning transporter MTP),Homo sapiens (Human),34.1,217.0,1.2e-28,128.3,sp|Q15012|LAP4A_HUMAN Lysosomal-associated transmembrane protein 4A OS=Homo sapiens OX=9606 GN=LAPTM4A PE=1 SV=1,GO:0005765; GO:0005794; GO:0031902,,Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765],,GO:0005794; GO:0043226,Golgi apparatus; organelle
OG_03405,FUN_014448-T1,Peve_00009609,Pocillopora_meandrina_HIv1___RNAseq.g22831.t1,three_way,56.61333333333334,,,,,,,,,,,,,,,,,
OG_03406,FUN_014449-T1,Peve_00009606,Pocillopora_meandrina_HIv1___RNAseq.1985_t,three_way,77.316,FUN_014449-T1,Q54BU4,ABCB1_DICDI,,ABC transporter B family member 1 (ABC transporter ABCB.1),Dictyostelium discoideum (Social amoeba),51.9,620.0,1.3e-162,575.1,sp|Q54BU4|ABCB1_DICDI ABC transporter B family member 1 OS=Dictyostelium discoideum OX=44689 GN=abcB1 PE=3 SV=1,GO:0005524; GO:0006935; GO:0006972; GO:0016020; GO:0016887; GO:0031154; GO:0042626; GO:0055085; GO:0140359,chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085],membrane [GO:0016020],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626],GO:0003824; GO:0005215; GO:0016787; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_03407,FUN_014451-T1,Peve_00009605,Pocillopora_meandrina_HIv1___RNAseq.g22828.t1,three_way,66.653,FUN_014451-T1,O88831,KKCC2_RAT,,Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta),Rattus norvegicus (Rat),42.3,220.0,2.2e-29,131.0,sp|O88831|KKCC2_RAT Calcium/calmodulin-dependent protein kinase kinase 2 OS=Rattus norvegicus OX=10116 GN=Camkk2 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004683; GO:0005509; GO:0005516; GO:0005524; GO:0005654; GO:0005829; GO:0006468; GO:0030295; GO:0043005; GO:0046777; GO:0061762; GO:0106310,CAMKK-AMPK signaling cascade [GO:0061762]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03408,FUN_014455-T1,Peve_00009604,Pocillopora_meandrina_HIv1___RNAseq.g22825.t1,three_way,61.887,FUN_014455-T1,P54797,,,,,39.2,293.0,4.1e-50,199.9,sp|P54797|TNG2_MOUSE Transport and Golgi organization 2 homolog OS=Mus musculus OX=10090 GN=Tango2 PE=1 SV=2,,,,,,
OG_03409,FUN_014456-T1,Peve_00009600,Pocillopora_meandrina_HIv1___RNAseq.g22824.t1,three_way,65.45816666666667,FUN_014456-T1,O35551,RABE1_MOUSE,,Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha),Mus musculus (Mouse),33.5,367.0,7.700000000000001e-38,160.6,sp|O35551|RABE1_MOUSE Rab GTPase-binding effector protein 1 OS=Mus musculus OX=10090 GN=Rabep1 PE=1 SV=2,GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0055037; GO:0098978; GO:0099149; GO:1903441,apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037],growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803],GO:0005768; GO:0005829; GO:0012501; GO:0016192; GO:0031410; GO:0043226; GO:0048018; GO:0098772,endosome; cytosol; programmed cell death; vesicle-mediated transport; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_03410,FUN_014457-T1,Peve_00009599,Pocillopora_meandrina_HIv1___RNAseq.g22823.t1,three_way,39.088,,,,,,,,,,,,,,,,,
OG_03411,FUN_014458-T1,Peve_00009596,Pocillopora_meandrina_HIv1___RNAseq.g22643.t1,three_way,79.978,FUN_014458-T1,Q9Y4P3,,,,,50.7,371.0,2.9e-108,393.7,sp|Q9Y4P3|TBL2_HUMAN Transducin beta-like protein 2 OS=Homo sapiens OX=9606 GN=TBL2 PE=1 SV=1,,,,,,
OG_03412,FUN_014459-T1,Peve_00014816,Pocillopora_meandrina_HIv1___RNAseq.g22644.t1,three_way,83.04233333333333,FUN_014459-T1,Q7YRC1,,,,,43.9,321.0,4.3e-77,289.7,sp|Q7YRC1|AIP_BOVIN AH receptor-interacting protein OS=Bos taurus OX=9913 GN=AIP PE=2 SV=1,,,,,,
OG_03413,FUN_014461-T1,Peve_00014815,Pocillopora_meandrina_HIv1___RNAseq.g22645.t1,three_way,61.391666666666666,FUN_014461-T1,Q3T0X9,,,,,38.1,113.0,6e-13,75.1,sp|Q3T0X9|DPOD4_BOVIN DNA polymerase delta subunit 4 OS=Bos taurus OX=9913 GN=POLD4 PE=1 SV=1,,,,,,
OG_03414,FUN_014462-T1,Peve_00023416,Pocillopora_meandrina_HIv1___RNAseq.g22646.t2,three_way,80.2825,FUN_014462-T1,Q9C086,IN80B_HUMAN,,INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog) (hIes2) (PAP-1-associated protein 1) (PAPA-1) (Zinc finger HIT domain-containing protein 4),Homo sapiens (Human),52.8,195.0,3.8e-12,73.9,sp|Q9C086|IN80B_HUMAN INO80 complex subunit B OS=Homo sapiens OX=9606 GN=INO80B PE=1 SV=2,GO:0000723; GO:0005654; GO:0005730; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0008270; GO:0016604; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],Ino80 complex [GO:0031011]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],zinc ion binding [GO:0008270],GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226,nucleoplasm; nucleolus; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle
OG_03415,FUN_014463-T1,Peve_00034300,Pocillopora_meandrina_HIv1___RNAseq.g22648.t1,three_way,67.13816666666666,FUN_014463-T1,O75976,,,,,41.7,1280.0,2.4e-275,950.7,sp|O75976|CBPD_HUMAN Carboxypeptidase D OS=Homo sapiens OX=9606 GN=CPD PE=1 SV=2,,,,,,
OG_03416,FUN_014465-T1,Peve_00011746,Pocillopora_meandrina_HIv1___RNAseq.g22649.t1,three_way,48.73266666666667,,,,,,,,,,,,,,,,,
OG_03417,FUN_014466-T1,Peve_00011744,Pocillopora_meandrina_HIv1___RNAseq.g22650.t1,three_way,75.11433333333333,,,,,,,,,,,,,,,,,
OG_03418,FUN_014467-T1,Peve_00011745,Pocillopora_meandrina_HIv1___RNAseq.g22651.t1c,three_way,76.04933333333334,,,,,,,,,,,,,,,,,
OG_03419,FUN_014473-T1,Peve_00014814,Pocillopora_meandrina_HIv1___TS.g27417.t2,three_way,71.68266666666668,FUN_014473-T1,P17405,ASM_HUMAN,,"Sphingomyelin phosphodiesterase (EC 3.1.4.12) (EC 3.1.4.3) (Acid sphingomyelinase) (aSMase) [Cleaved into: Sphingomyelin phosphodiesterase, processed form]",Homo sapiens (Human),45.2,547.0,9.1e-134,478.8,sp|P17405|ASM_HUMAN Sphingomyelin phosphodiesterase OS=Homo sapiens OX=9606 GN=SMPD1 PE=1 SV=5,GO:0001778; GO:0004767; GO:0005615; GO:0005764; GO:0005768; GO:0005811; GO:0005886; GO:0006684; GO:0006685; GO:0007165; GO:0007399; GO:0008203; GO:0008270; GO:0009410; GO:0009615; GO:0010212; GO:0016798; GO:0023021; GO:0034340; GO:0034480; GO:0034612; GO:0034644; GO:0036019; GO:0042060; GO:0042220; GO:0042599; GO:0043065; GO:0043202; GO:0043409; GO:0045807; GO:0046479; GO:0046513; GO:0046598; GO:0046718; GO:0061750; GO:0070062; GO:0070555; GO:0071277,cellular response to calcium ion [GO:0071277]; cellular response to UV [GO:0034644]; ceramide biosynthetic process [GO:0046513]; cholesterol metabolic process [GO:0008203]; glycosphingolipid catabolic process [GO:0046479]; negative regulation of MAPK cascade [GO:0043409]; nervous system development [GO:0007399]; plasma membrane repair [GO:0001778]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of viral entry into host cell [GO:0046598]; response to cocaine [GO:0042220]; response to interleukin-1 [GO:0070555]; response to ionizing radiation [GO:0010212]; response to tumor necrosis factor [GO:0034612]; response to type I interferon [GO:0034340]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sphingomyelin catabolic process [GO:0006685]; sphingomyelin metabolic process [GO:0006684]; symbiont entry into host cell [GO:0046718]; termination of signal transduction [GO:0023021]; wound healing [GO:0042060],endolysosome [GO:0036019]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lipid droplet [GO:0005811]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886],"acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphatidylcholine phospholipase C activity [GO:0034480]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005615; GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0042060; GO:0043226; GO:0048856; GO:0061024; GO:1901135,catalytic activity; extracellular space; lysosome; endosome; vacuole; lipid droplet; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; wound healing; organelle; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_03420,FUN_014474-T1,Peve_00030525,Pocillopora_meandrina_HIv1___TS.g27573.t1,three_way,70.30083333333333,FUN_014474-T1,Q00174,LAMA_DROME,,Laminin subunit alpha (Laminin A chain),Drosophila melanogaster (Fruit fly),35.5,3904.0,3.4e-306,1054.3,sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2,GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711,"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]",axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021],extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048856; GO:0098542,immune system process; structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism
OG_03421,FUN_014475-T1,Peve_00015334,Pocillopora_meandrina_HIv1___RNAseq.g22820.t1,three_way,87.77716666666667,FUN_014475-T1,Q501Q9,MK15_XENLA,,Mitogen-activated protein kinase 15 (EC 2.7.11.24),Xenopus laevis (African clawed frog),72.5,353.0,5.7999999999999996e-151,535.8,sp|Q501Q9|MK15_XENLA Mitogen-activated protein kinase 15 OS=Xenopus laevis OX=8355 GN=mapk15 PE=1 SV=1,GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0005911; GO:0005929; GO:0035253; GO:0035556; GO:0036064; GO:0106310; GO:1902017,intracellular signal transduction [GO:0035556]; regulation of cilium assembly [GO:1902017],cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cilium; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03422,FUN_014476-T1,Peve_00037307,Pocillopora_meandrina_HIv1___RNAseq.g22818.t1,three_way,61.25033333333334,,,,,,,,,,,,,,,,,
OG_03423,FUN_014477-T1,Peve_00037306,Pocillopora_meandrina_HIv1___RNAseq.g22817.t1,three_way,73.20533333333333,FUN_014477-T1,Q9NZ71,,,,,43.0,1046.0,9.9e-235,815.1,sp|Q9NZ71|RTEL1_HUMAN Regulator of telomere elongation helicase 1 OS=Homo sapiens OX=9606 GN=RTEL1 PE=1 SV=2,,,,,,
OG_03424,FUN_014478-T1,Peve_00037305,Pocillopora_meandrina_HIv1___RNAseq.g22816.t2,three_way,65.88550000000001,,,,,,,,,,,,,,,,,
OG_03425,FUN_014480-T1,Peve_00037298,Pocillopora_meandrina_HIv1___RNAseq.g22815.t1,three_way,78.496,FUN_014480-T1,Q6AZJ9,,,,,63.9,83.0,3e-28,125.9,sp|Q6AZJ9|RS21_XENLA Small ribosomal subunit protein eS21 OS=Xenopus laevis OX=8355 GN=rps21 PE=1 SV=1,,,,,,
OG_03426,FUN_014481-T1,Peve_00037299,Pocillopora_meandrina_HIv1___RNAseq.g22814.t1,three_way,43.44533333333333,,,,,,,,,,,,,,,,,
OG_03427,FUN_014483-T1,Peve_00037300,Pocillopora_meandrina_HIv1___RNAseq.g22813.t2,three_way,92.40566666666666,FUN_014483-T1,Q6NVL5,ELP3_XENTR,,Elongator complex protein 3 (EC 2.3.1.311) (tRNA uridine(34) acetyltransferase),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),81.4,532.0,7.4e-262,904.0,sp|Q6NVL5|ELP3_XENTR Elongator complex protein 3 OS=Xenopus tropicalis OX=8364 GN=elp3 PE=2 SV=1,GO:0000049; GO:0001755; GO:0002098; GO:0005634; GO:0005737; GO:0006357; GO:0008607; GO:0031397; GO:0046872; GO:0050821; GO:0051539; GO:0106261,negative regulation of protein ubiquitination [GO:0031397]; neural crest cell migration [GO:0001755]; protein stabilization [GO:0050821]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; phosphorylase kinase regulator activity [GO:0008607]; tRNA binding [GO:0000049]; tRNA uridine(34) acetyltransferase activity [GO:0106261]",GO:0003723; GO:0003824; GO:0005634; GO:0006355; GO:0006399; GO:0016740; GO:0043226; GO:0048870; GO:0098772; GO:0140098,"RNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; tRNA metabolic process; transferase activity; organelle; cell motility; molecular function regulator activity; catalytic activity, acting on RNA"
OG_03428,FUN_014484-T1,Peve_00037302,Pocillopora_meandrina_HIv1___RNAseq.g22812.t1,three_way,51.21066666666667,FUN_014484-T1,Q84JS1,,,,,35.1,365.0,1.5e-57,226.1,sp|Q84JS1|PAE6_ARATH Pectin acetylesterase 6 OS=Arabidopsis thaliana OX=3702 GN=PAE6 PE=2 SV=1,,,,,,
OG_03429,FUN_014485-T1,Peve_00037303,Pocillopora_meandrina_HIv1___RNAseq.g22811.t1,three_way,75.97416666666666,FUN_014485-T1,O35887,,,,,29.0,155.0,5.5e-09,63.5,sp|O35887|CALU_MOUSE Calumenin OS=Mus musculus OX=10090 GN=Calu PE=1 SV=1,,,,,,
OG_03430,FUN_014486-T2,Peve_00037296,Pocillopora_meandrina_HIv1___RNAseq.g22810.t1,three_way,88.033,FUN_014486-T2,P56517,,,,,86.1,432.0,4.3e-227,788.9,sp|P56517|HDAC1_CHICK Histone deacetylase 1 OS=Gallus gallus OX=9031 GN=HDAC1 PE=2 SV=1,,,,,,
OG_03431,FUN_014487-T1,Peve_00037295,Pocillopora_meandrina_HIv1___RNAseq.1965_t,three_way,57.88816666666667,FUN_014487-T1,Q9D4H7,,,,,33.6,619.0,5e-91,337.0,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_03432,FUN_014489-T1,Peve_00033868,Pocillopora_meandrina_HIv1___RNAseq.g22519.t1,three_way,84.413,FUN_014489-T1,A0JNN3,,,,,71.8,110.0,7.6e-23,108.2,sp|A0JNN3|MED31_BOVIN Mediator of RNA polymerase II transcription subunit 31 OS=Bos taurus OX=9913 GN=MED31 PE=2 SV=1,,,,,,
OG_03433,FUN_014490-T1,Peve_00013878,Pocillopora_meandrina_HIv1___RNAseq.g22518.t4,three_way,79.35166666666667,FUN_014490-T1,Q0V8A3,CAST1_BOVIN,,Cytosolic arginine sensor for mTORC1 subunit 1 (GATS-like protein 3),Bos taurus (Bovine),42.6,329.0,7.499999999999999e-69,262.3,sp|Q0V8A3|CAST1_BOVIN Cytosolic arginine sensor for mTORC1 subunit 1 OS=Bos taurus OX=9913 GN=CASTOR1 PE=2 SV=1,GO:0005829; GO:0034618; GO:0140311; GO:1903577; GO:1904262,cellular response to L-arginine [GO:1903577]; negative regulation of TORC1 signaling [GO:1904262],cytosol [GO:0005829],arginine binding [GO:0034618]; protein sequestering activity [GO:0140311],GO:0005829; GO:0140313,cytosol; molecular sequestering activity
OG_03434,FUN_014491-T1,Peve_00013879,Pocillopora_meandrina_HIv1___RNAseq.g22517.t1,three_way,91.102,FUN_014491-T1,Q5ZIY4,SBDS_CHICK,,Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog),Gallus gallus (Chicken),73.7,251.0,1.1e-101,370.9,sp|Q5ZIY4|SBDS_CHICK Ribosome maturation protein SBDS OS=Gallus gallus OX=9031 GN=SBDS PE=2 SV=1,GO:0000922; GO:0002244; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0007052; GO:0008017; GO:0019843; GO:0030282; GO:0030595; GO:0042256; GO:0043022; GO:0048539,bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cytosolic ribosome assembly [GO:0042256]; hematopoietic progenitor cell differentiation [GO:0002244]; leukocyte chemotaxis [GO:0030595]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843],GO:0002376; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0048870,immune system process; RNA binding; nucleoplasm; nucleolus; cytosol; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; cell motility
OG_03435,FUN_014492-T1,Peve_00024063,Pocillopora_meandrina_HIv1___RNAseq.g22516.t1,three_way,57.00866666666666,FUN_014492-T1,Q9DB28,,,,,38.6,145.0,4.2e-26,119.4,sp|Q9DB28|POP5_MOUSE Ribonuclease P/MRP protein subunit POP5 OS=Mus musculus OX=10090 GN=Pop5 PE=1 SV=1,,,,,,
OG_03436,FUN_014494-T1,Peve_00024062,Pocillopora_meandrina_HIv1___RNAseq.g22515.t1,three_way,81.14283333333333,FUN_014494-T1,Q2KHP8,,,,,71.8,429.0,2.0000000000000003e-187,656.8,sp|Q2KHP8|TYW1_XENLA S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase TYW1 OS=Xenopus laevis OX=8355 GN=tyw1 PE=2 SV=1,,,,,,
OG_03437,FUN_014496-T1,Peve_00037309,Pocillopora_meandrina_HIv1___RNAseq.g22808.t1,three_way,67.33000000000001,FUN_014496-T1,Q9UPY8,MARE3_HUMAN,,Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3) (EBF3) (End-binding protein 3) (EB3) (RP3),Homo sapiens (Human),41.6,250.0,1.1e-40,168.3,sp|Q9UPY8|MARE3_HUMAN Microtubule-associated protein RP/EB family member 3 OS=Homo sapiens OX=9606 GN=MAPRE3 PE=1 SV=1,GO:0005737; GO:0005815; GO:0008017; GO:0008104; GO:0015630; GO:0030496; GO:0031110; GO:0031113; GO:0035371; GO:0035372; GO:0042802; GO:0043539; GO:0045893; GO:0048471; GO:0051010; GO:0051225; GO:0051233; GO:0051301; GO:0120283; GO:1905721,cell division [GO:0051301]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule [GO:0035372]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; mitotic spindle astral microtubule end [GO:1905721]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233],identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283],GO:0005815; GO:0005856; GO:0006355; GO:0007010; GO:0008092; GO:0043226; GO:0098772,microtubule organizing center; cytoskeleton; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle; molecular function regulator activity
OG_03438,FUN_014497-T1,Peve_00037310,Pocillopora_meandrina_HIv1___RNAseq.1964_t,three_way,81.125,FUN_014497-T1,Q5R8D0,,,,,65.0,343.0,1.3e-132,474.2,sp|Q5R8D0|GALE_PONAB UDP-glucose 4-epimerase OS=Pongo abelii OX=9601 GN=GALE PE=2 SV=1,,,,,,
OG_03439,FUN_014498-T1,Peve_00013882,Pocillopora_meandrina_HIv1___RNAseq.g22640.t1,three_way,72.19283333333334,,,,,,,,,,,,,,,,,
OG_03440,FUN_014499-T1,Peve_00013881,Pocillopora_meandrina_HIv1___TS.g27403.t1,three_way,65.235,FUN_014499-T1,Q6DE37,GXLT2_XENLA,,Glucoside xylosyltransferase 2 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 4),Xenopus laevis (African clawed frog),52.9,280.0,3.6000000000000004e-86,320.1,sp|Q6DE37|GXLT2_XENLA Glucoside xylosyltransferase 2 OS=Xenopus laevis OX=8355 GN=gxylt2 PE=2 SV=1,GO:0016020; GO:0016266; GO:0035252; GO:0140563,O-glycan processing [GO:0016266],membrane [GO:0016020],"UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity [GO:0140563]; UDP-xylosyltransferase activity [GO:0035252]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_03441,FUN_014501-T1,Peve_00013880,Pocillopora_meandrina_HIv1___RNAseq.g22638.t1,three_way,67.336,FUN_014501-T1,P06734,FCER2_HUMAN,,Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form],Homo sapiens (Human),32.5,126.0,1.1e-07,60.1,sp|P06734|FCER2_HUMAN Low affinity immunoglobulin epsilon Fc receptor OS=Homo sapiens OX=9606 GN=FCER2 PE=1 SV=1,GO:0002020; GO:0002450; GO:0002925; GO:0005178; GO:0005886; GO:0006955; GO:0009897; GO:0010628; GO:0019769; GO:0019863; GO:0030246; GO:0038096; GO:0038187; GO:0042116; GO:0042742; GO:0046872; GO:0070062; GO:0160006,B cell antigen processing and presentation [GO:0002450]; defense response to bacterium [GO:0042742]; Fc receptor-mediated immune complex endocytosis [GO:0160006]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; macrophage activation [GO:0042116]; positive regulation of gene expression [GO:0010628]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925],external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; low-affinity IgE receptor activity [GO:0019769]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; protease binding [GO:0002020],GO:0002376; GO:0005886; GO:0016192; GO:0043226; GO:0060089,immune system process; plasma membrane; vesicle-mediated transport; organelle; molecular transducer activity
OG_03442,FUN_014502-T1,Peve_00025868,Pocillopora_meandrina_HIv1___RNAseq.g22637.t1,three_way,80.94816666666667,FUN_014502-T1,Q9DG67,,,,,56.6,657.0,2.3e-210,733.4,sp|Q9DG67|RA54B_CHICK DNA repair and recombination protein RAD54B OS=Gallus gallus OX=9031 GN=RAD54B PE=2 SV=1,,,,,,
OG_03443,FUN_014505-T1,Peve_00015333,Pocillopora_meandrina_HIv1___RNAseq.g22635.t1,three_way,78.76633333333334,FUN_014505-T1,Q9ULV4,COR1C_HUMAN,,Coronin-1C (Coronin-3) (hCRNN4),Homo sapiens (Human),47.5,472.0,3e-116,420.2,sp|Q9ULV4|COR1C_HUMAN Coronin-1C OS=Homo sapiens OX=9606 GN=CORO1C PE=1 SV=1,GO:0001755; GO:0001932; GO:0001933; GO:0005925; GO:0005938; GO:0006909; GO:0007015; GO:0007165; GO:0010008; GO:0010632; GO:0010633; GO:0010762; GO:0015629; GO:0016197; GO:0016328; GO:0016600; GO:0021591; GO:0022038; GO:0030017; GO:0030027; GO:0031267; GO:0032587; GO:0042383; GO:0044387; GO:0045184; GO:0045202; GO:0051015; GO:0051893; GO:0051895; GO:0090148; GO:0090630; GO:0097750; GO:0140285; GO:1900024; GO:1900025; GO:1900027; GO:2000394,actin filament organization [GO:0007015]; activation of GTPase activity [GO:0090630]; corpus callosum development [GO:0022038]; endosomal transport [GO:0016197]; endosome fission [GO:0140285]; endosome membrane tubulation [GO:0097750]; establishment of protein localization [GO:0045184]; membrane fission [GO:0090148]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neural crest cell migration [GO:0001755]; phagocytosis [GO:0006909]; positive regulation of lamellipodium morphogenesis [GO:2000394]; regulation of epithelial cell migration [GO:0010632]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein phosphorylation [GO:0001932]; regulation of ruffle assembly [GO:1900027]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; signal transduction [GO:0007165]; ventricular system development [GO:0021591],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; endosome membrane [GO:0010008]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; ruffle membrane [GO:0032587]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; synapse [GO:0045202],actin filament binding [GO:0051015]; small GTPase binding [GO:0031267],GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0043226; GO:0048856; GO:0048870; GO:0061024,cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; organelle; anatomical structure development; cell motility; membrane organization
OG_03444,FUN_014506-T1,Peve_00015332,Pocillopora_meandrina_HIv1___RNAseq.g22634.t1,three_way,64.51866666666666,FUN_014506-T1,Q5XHG1,NSMA3_XENLA,,Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III),Xenopus laevis (African clawed frog),32.9,828.0,6.3e-106,386.7,sp|Q5XHG1|NSMA3_XENLA Sphingomyelin phosphodiesterase 4 OS=Xenopus laevis OX=8355 GN=smpd4 PE=2 SV=2,GO:0000139; GO:0004767; GO:0005635; GO:0005783; GO:0005789; GO:0006685; GO:0042383; GO:0046475; GO:0046513; GO:0046872; GO:0050290; GO:0071356,cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; sarcolemma [GO:0042383],metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290],GO:0003824; GO:0005635; GO:0005783; GO:0005886; GO:0006629; GO:0016787; GO:0043226,catalytic activity; nuclear envelope; endoplasmic reticulum; plasma membrane; lipid metabolic process; hydrolase activity; organelle
OG_03445,FUN_014509-T1,Peve_00031996,Pocillopora_meandrina_HIv1___RNAseq.g22632.t1,three_way,69.32416666666667,FUN_014509-T1,Q5F3V0,SMYD4_CHICK,,Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4),Gallus gallus (Chicken),28.4,401.0,4.9999999999999996e-26,121.3,sp|Q5F3V0|SMYD4_CHICK Protein-lysine N-methyltransferase SMYD4 OS=Gallus gallus OX=9031 GN=SMYD4 PE=2 SV=1,GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0008270; GO:0032259; GO:0042826,heart development [GO:0007507]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],histone deacetylase binding [GO:0042826]; methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; transferase activity; organelle; anatomical structure development
OG_03446,FUN_014510-T1,Peve_00024077,Pocillopora_meandrina_HIv1___RNAseq.g22630.t1,three_way,76.287,FUN_014510-T1,Q8CG45,ARK72_RAT,,Aflatoxin B1 aldehyde reductase member 2 (rAFAR2) (EC 1.1.1.n11) (Succinic semialdehyde reductase) (SSA reductase),Rattus norvegicus (Rat),52.2,322.0,1.1e-94,348.2,sp|Q8CG45|ARK72_RAT Aflatoxin B1 aldehyde reductase member 2 OS=Rattus norvegicus OX=10116 GN=Akr7a2 PE=1 SV=2,GO:0004032; GO:0004033; GO:0005635; GO:0005737; GO:0005739; GO:0005795; GO:0006629; GO:0019119; GO:0044597; GO:0044598,daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629],cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635],"aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]",GO:0003824; GO:0005635; GO:0005739; GO:0006629; GO:0016491; GO:0016787; GO:0043226; GO:1901135,catalytic activity; nuclear envelope; mitochondrion; lipid metabolic process; oxidoreductase activity; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_03447,FUN_014512-T1,Peve_00032000,Pocillopora_meandrina_HIv1___TS.g27391.t1,three_way,41.315000000000005,,,,,,,,,,,,,,,,,
OG_03448,FUN_014517-T1,Peve_00029595,Pocillopora_meandrina_HIv1___RNAseq.g22623.t1,three_way,93.971,FUN_014517-T1,Q5RHH4,IF172_DANRE,,Intraflagellar transport protein 172 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),71.9,1260.0,0.0,1846.6,sp|Q5RHH4|IF172_DANRE Intraflagellar transport protein 172 homolog OS=Danio rerio OX=7955 GN=ift172 PE=2 SV=1,GO:0005929; GO:0005930; GO:0030992; GO:0032006; GO:0036064; GO:0042073; GO:0045494; GO:0048793; GO:0060041; GO:0060271,cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041],axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992],,GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_03449,FUN_014522-T1,Peve_00044386,Pocillopora_meandrina_HIv1___TS.g27385.t1,three_way,62.00833333333333,,,,,,,,,,,,,,,,,
OG_03450,FUN_014523-T1,Peve_00044381,Pocillopora_meandrina_HIv1___RNAseq.g22620.t2,three_way,65.71566666666666,,,,,,,,,,,,,,,,,
OG_03451,FUN_014525-T1,Peve_00044380,Pocillopora_meandrina_HIv1___RNAseq.g22618.t1,three_way,89.524,FUN_014525-T1,Q7PPA5,,,,,70.7,996.0,0.0,1408.7,sp|Q7PPA5|ATC1_ANOGA Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type OS=Anopheles gambiae OX=7165 GN=SERCA PE=3 SV=5,,,,,,
OG_03452,FUN_014527-T1,Peve_00044379,Pocillopora_meandrina_HIv1___RNAseq.g22617.t1,three_way,81.44616666666667,FUN_014527-T1,O15297,PPM1D_HUMAN,,Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1),Homo sapiens (Human),51.3,277.0,1.2e-79,298.5,sp|O15297|PPM1D_HUMAN Protein phosphatase 1D OS=Homo sapiens OX=9606 GN=PPM1D PE=1 SV=1,GO:0000086; GO:0004674; GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006346; GO:0006470; GO:0008285; GO:0009267; GO:0009314; GO:0009617; GO:0030330; GO:0035970; GO:0045814; GO:0046872; GO:0051019; GO:0060260; GO:1902531,"cellular response to starvation [GO:0009267]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression, epigenetic [GO:0045814]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470]; regulation of intracellular signal transduction [GO:1902531]; regulation of transcription initiation by RNA polymerase II [GO:0060260]; response to bacterium [GO:0009617]; response to radiation [GO:0009314]",cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03453,FUN_014528-T1,Peve_00044378,Pocillopora_meandrina_HIv1___RNAseq.g22616.t1,three_way,85.47933333333333,FUN_014528-T1,P56839,,,,,81.2,292.0,4.7e-137,488.8,sp|P56839|PEPM_MYTED Phosphoenolpyruvate phosphomutase OS=Mytilus edulis OX=6550 PE=1 SV=3,,,,,,
OG_03454,FUN_014529-T1,Peve_00044375,Pocillopora_meandrina_HIv1___RNAseq.g22615.t1,three_way,84.25116666666666,FUN_014529-T1,P61267,,,,,57.3,267.0,9.1e-74,278.5,sp|P61267|STX1B_BOVIN Syntaxin-1B OS=Bos taurus OX=9913 GN=STX1B PE=1 SV=1,,,,,,
OG_03455,FUN_014530-T1,Peve_00044383,Pocillopora_meandrina_HIv1___RNAseq.g22614.t1,three_way,89.24866666666667,FUN_014530-T1,P52301,,,,,86.3,211.0,6.7e-106,384.8,sp|P52301|RAN_XENLA GTP-binding nuclear protein Ran OS=Xenopus laevis OX=8355 GN=ran PE=1 SV=2,,,,,,
OG_03456,FUN_014531-T1,Peve_00044374,Pocillopora_meandrina_HIv1___RNAseq.g22613.t1,three_way,83.917,FUN_014531-T1,Q95JY5,,,,,44.1,136.0,6.800000000000001e-28,125.2,sp|Q95JY5|SAM15_MACFA Sterile alpha motif domain-containing protein 15 OS=Macaca fascicularis OX=9541 GN=SAMD15 PE=2 SV=2,,,,,,
OG_03457,FUN_014533-T1,Peve_00040829,Pocillopora_meandrina_HIv1___RNAseq.g22609.t1,three_way,87.76966666666667,FUN_014533-T1,Q9UBR1,BUP1_HUMAN,,Beta-ureidopropionase (EC 3.5.1.6) (BUP-1) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase),Homo sapiens (Human),71.8,379.0,2.1e-163,576.6,sp|Q9UBR1|BUP1_HUMAN Beta-ureidopropionase OS=Homo sapiens OX=9606 GN=UPB1 PE=1 SV=1,GO:0001701; GO:0001889; GO:0003837; GO:0005829; GO:0006248; GO:0006249; GO:0033396; GO:0042803; GO:0046050; GO:0046079; GO:0046135; GO:0051260; GO:0051289; GO:0070062,beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; protein homooligomerization [GO:0051260]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside catabolic process [GO:0046135]; UMP catabolic process [GO:0046050],cytosol [GO:0005829]; extracellular exosome [GO:0070062],beta-ureidopropionase activity [GO:0003837]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006520; GO:0016787; GO:0043226; GO:0048856; GO:0055086; GO:0065003; GO:1901135,catalytic activity; cytosol; amino acid metabolic process; hydrolase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_03458,FUN_014534-T1,Peve_00040836,Pocillopora_meandrina_HIv1___RNAseq.g22608.t1,three_way,82.51333333333334,FUN_014534-T1,Q5ZLG0,,,,,64.0,655.0,3.3e-257,889.0,sp|Q5ZLG0|AACS_CHICK Acetoacetyl-CoA synthetase OS=Gallus gallus OX=9031 GN=AACS PE=2 SV=1,,,,,,
OG_03459,FUN_014536-T1,Peve_00040838,Pocillopora_meandrina_HIv1___RNAseq.g22607.t1,three_way,36.9925,,,,,,,,,,,,,,,,,
OG_03460,FUN_014539-T1,Peve_00036006,Pocillopora_meandrina_HIv1___RNAseq.g22603.t1,three_way,85.63466666666666,FUN_014539-T1,Q0IIF7,UBP14_BOVIN,,Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14),Bos taurus (Bovine),61.5,496.0,5e-178,625.5,sp|Q0IIF7|UBP14_BOVIN Ubiquitin carboxyl-terminal hydrolase 14 OS=Bos taurus OX=9913 GN=USP14 PE=2 SV=3,GO:0000502; GO:0004843; GO:0005737; GO:0005886; GO:0016579; GO:0043161; GO:0045087; GO:0070628; GO:1904293,innate immune response [GO:0045087]; negative regulation of ERAD pathway [GO:1904293]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502],cysteine-type deubiquitinase activity [GO:0004843]; proteasome binding [GO:0070628],GO:0002376; GO:0003824; GO:0005886; GO:0016787; GO:0030163; GO:0098542; GO:0140096,"immune system process; catalytic activity; plasma membrane; hydrolase activity; protein catabolic process; defense response to other organism; catalytic activity, acting on a protein"
OG_03461,FUN_014542-T1,Peve_00035999,Pocillopora_meandrina_HIv1___RNAseq.g22596.t1,three_way,85.815,FUN_014542-T1,Q7T0U5,,,,,67.7,158.0,2.2999999999999998e-55,216.5,sp|Q7T0U5|ARC3B_XENLA Actin-related protein 2/3 complex subunit 3-B OS=Xenopus laevis OX=8355 GN=arpc3-b PE=2 SV=1,,,,,,
OG_03462,FUN_014543-T1,Peve_00035998,Pocillopora_meandrina_HIv1___RNAseq.g22595.t1,three_way,76.62,FUN_014543-T1,Q7K556,TTD14_DROME,,TRPL translocation defect protein 14,Drosophila melanogaster (Fruit fly),53.4,294.0,5.800000000000001e-89,328.9,sp|Q7K556|TTD14_DROME TRPL translocation defect protein 14 OS=Drosophila melanogaster OX=7227 GN=Ttd14 PE=1 SV=1,GO:0005525; GO:0005829; GO:0015031; GO:0035091; GO:0045494; GO:0070300,photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031],cytosol [GO:0005829],GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0008289,cytosol; lipid binding
OG_03463,FUN_014544-T1,Peve_00035997,Pocillopora_meandrina_HIv1___RNAseq.g22594.t1,three_way,59.593,FUN_014544-T1,A2VDX7,,,,,34.7,369.0,6.9e-50,199.5,sp|A2VDX7|EXO5_BOVIN Exonuclease V OS=Bos taurus OX=9913 GN=EXO5 PE=2 SV=2,,,,,,
OG_03464,FUN_014545-T1,Peve_00035995,Pocillopora_meandrina_HIv1___RNAseq.g22593.t1,three_way,72.14533333333333,FUN_014545-T1,Q5ZIT9,MFSD1_CHICK,,Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1),Gallus gallus (Chicken),31.1,212.0,1.8e-17,91.3,sp|Q5ZIT9|MFSD1_CHICK Lysosomal dipeptide transporter MFSD1 OS=Gallus gallus OX=9031 GN=MFSD1 PE=2 SV=1,GO:0005764; GO:0005765; GO:0042803; GO:0050821; GO:0061462; GO:0141204; GO:0160178,dipeptide transmembrane transport from lysosomal lumen to cytosol [GO:0141204]; protein localization to lysosome [GO:0061462]; protein stabilization [GO:0050821],lysosomal membrane [GO:0005765]; lysosome [GO:0005764],dipeptide uniporter activity [GO:0160178]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005764; GO:0005773; GO:0043226; GO:0055085,transporter activity; lysosome; vacuole; organelle; transmembrane transport
OG_03465,FUN_014550-T1,Peve_00009693,Pocillopora_meandrina_HIv1___RNAseq.g22700.t1,three_way,69.54233333333333,FUN_014550-T1,Q58728,,,,,38.4,271.0,2.9e-47,191.0,sp|Q58728|Y1332_METJA Uncharacterized GTP-binding protein MJ1332 OS=Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) OX=243232 GN=MJ1332 PE=3 SV=1,,,,,,
OG_03466,FUN_014551-T1,Peve_00009116,Pocillopora_meandrina_HIv1___RNAseq.g22699.t1,three_way,69.395,FUN_014551-T1,Q84JE8,,,,,45.0,191.0,4.4e-42,172.9,sp|Q84JE8|ZDP_ARATH Polynucleotide 3'-phosphatase ZDP OS=Arabidopsis thaliana OX=3702 GN=ZDP PE=1 SV=1,,,,,,
OG_03467,FUN_014552-T1,Peve_00009117,Pocillopora_meandrina_HIv1___RNAseq.g22698.t1,three_way,65.17083333333333,FUN_014552-T1,Q9Y4C8,,,,,44.6,998.0,6.599999999999999e-198,692.6,sp|Q9Y4C8|RBM19_HUMAN Probable RNA-binding protein 19 OS=Homo sapiens OX=9606 GN=RBM19 PE=1 SV=3,,,,,,
OG_03468,FUN_014553-T1,Peve_00035991,Pocillopora_meandrina_HIv1___RNAseq.g22697.t1,three_way,82.49233333333333,FUN_014553-T1,P29674,,,,,52.4,315.0,1.2e-80,301.6,sp|P29674|LHX1_XENLA LIM/homeobox protein Lhx1 OS=Xenopus laevis OX=8355 GN=lhx1 PE=1 SV=1,,,,,,
OG_03469,FUN_014554-T1,Peve_00035992,Pocillopora_meandrina_HIv1___RNAseq.g22696.t1,three_way,75.109,FUN_014554-T1,P0DL28,FBXW8_RAT,,F-box/WD repeat-containing protein 8 (F-box and WD-40 domain-containing protein 8),Rattus norvegicus (Rat),42.7,178.0,5.8e-39,162.2,sp|P0DL28|FBXW8_RAT F-box/WD repeat-containing protein 8 OS=Rattus norvegicus OX=10116 GN=Fbxw8 PE=1 SV=1,GO:0005737; GO:0005794; GO:0005814; GO:0005829; GO:0006511; GO:0007030; GO:0008283; GO:0016567; GO:0019005; GO:0031467; GO:0032436; GO:0036064; GO:0043161; GO:0046627; GO:0048471; GO:0050775; GO:0060271; GO:0060712; GO:0060716; GO:1990393; GO:1990756,cell population proliferation [GO:0008283]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511],3M complex [GO:1990393]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005794; GO:0005815; GO:0005829; GO:0030163; GO:0043226; GO:0044782; GO:0048856; GO:0060090,Golgi apparatus; microtubule organizing center; cytosol; protein catabolic process; organelle; cilium organization; anatomical structure development; molecular adaptor activity
OG_03470,FUN_014556-T1,Peve_00035993,Pocillopora_meandrina_HIv1___RNAseq.g22695.t1,three_way,72.46883333333334,FUN_014556-T1,E1BLT8,ZDHC5_BOVIN,,Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5),Bos taurus (Bovine),52.3,243.0,9.6e-70,265.4,sp|E1BLT8|ZDHC5_BOVIN Palmitoyltransferase ZDHHC5 OS=Bos taurus OX=9913 GN=ZDHHC5 PE=3 SV=1,GO:0005654; GO:0005886; GO:0006869; GO:0016409; GO:0019706; GO:0030425; GO:0045087; GO:0045335; GO:0062208; GO:0072659; GO:0098794; GO:0098978; GO:0140639; GO:1900227; GO:1903078; GO:1905171,innate immune response [GO:0045087]; lipid transport [GO:0006869]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of pattern recognition receptor signaling pathway [GO:0062208]; positive regulation of protein localization to phagocytic vesicle [GO:1905171]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein localization to plasma membrane [GO:0072659],dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0002376; GO:0003824; GO:0005654; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0072659; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleoplasm; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; protein localization to plasma membrane; defense response to other organism; catalytic activity, acting on a protein"
OG_03471,FUN_014558-T1,Peve_00035994,Pocillopora_meandrina_HIv1___RNAseq.g22694.t1,three_way,76.857,FUN_014558-T1,A0JN61,,,,,60.5,76.0,8e-18,91.3,sp|A0JN61|RPC9_BOVIN DNA-directed RNA polymerase III subunit RPC9 OS=Bos taurus OX=9913 GN=CRCP PE=2 SV=1,,,,,,
OG_03472,FUN_014560-T1,Peve_00009691,Pocillopora_meandrina_HIv1___RNAseq.g22702.t1,three_way,77.68633333333334,FUN_014560-T1,Q96NN9,,,,,45.9,510.0,5.4e-137,489.6,sp|Q96NN9|AIFM3_HUMAN Apoptosis-inducing factor 3 OS=Homo sapiens OX=9606 GN=AIFM3 PE=1 SV=1,,,,,,
OG_03473,FUN_014561-T1,Peve_00023543,Pocillopora_meandrina_HIv1___RNAseq.g22703.t1,three_way,65.42583333333333,FUN_014561-T1,Q96S52,PIGS_HUMAN,,GPI-anchor transamidase component PIGS (Phosphatidylinositol-glycan biosynthesis class S protein),Homo sapiens (Human),36.6,508.0,2.9e-81,304.3,sp|Q96S52|PIGS_HUMAN GPI-anchor transamidase component PIGS OS=Homo sapiens OX=9606 GN=PIGS PE=1 SV=3,GO:0005789; GO:0006506; GO:0016020; GO:0016255; GO:0042765; GO:0180046,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046],endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020],,GO:0006629; GO:0051604; GO:1901135,lipid metabolic process; protein maturation; carbohydrate derivative metabolic process
OG_03474,FUN_014562-T1,Peve_00023544,Pocillopora_meandrina_HIv1___TS.g27467.t2,three_way,54.1165,FUN_014562-T1,Q14BV6,,,,,46.6,298.0,2.8999999999999997e-75,283.5,sp|Q14BV6|YDJC_MOUSE Carbohydrate deacetylase OS=Mus musculus OX=10090 GN=Ydjc PE=2 SV=2,,,,,,
OG_03475,FUN_014566-T1,Peve_00023547,Pocillopora_meandrina_HIv1___TS.g27470.t1,three_way,72.471,FUN_014566-T1,Q8L870,,,,,35.0,223.0,7.6e-34,145.6,sp|Q8L870|GCC1_ARATH Guanylyl cyclase 1 OS=Arabidopsis thaliana OX=3702 GN=GC1 PE=1 SV=1,,,,,,
OG_03476,FUN_014567-T1,Peve_00009686,Pocillopora_meandrina_HIv1___RNAseq.g22708.t1,three_way,95.495,FUN_014567-T1,O44437,,,,,81.4,118.0,1.0999999999999999e-47,190.7,sp|O44437|SMD3_DROME Small nuclear ribonucleoprotein Sm D3 OS=Drosophila melanogaster OX=7227 GN=SmD3 PE=1 SV=1,,,,,,
OG_03477,FUN_014570-T1,Peve_00027632,Pocillopora_meandrina_HIv1___TS.g27472.t1,three_way,47.568,FUN_014570-T1,A2AAY5,SPD2B_MOUSE,,SH3 and PX domain-containing protein 2B (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains),Mus musculus (Mouse),39.8,284.0,3e-50,201.4,sp|A2AAY5|SPD2B_MOUSE SH3 and PX domain-containing protein 2B OS=Mus musculus OX=10090 GN=Sh3pxd2b PE=1 SV=1,GO:0001501; GO:0001654; GO:0002051; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0010628; GO:0032266; GO:0040018; GO:0042169; GO:0042995; GO:0045600; GO:0048705; GO:0051496; GO:0060348; GO:0060378; GO:0060612; GO:0070161; GO:0070273; GO:0071800; GO:0072657; GO:0080025; GO:1904179; GO:1904888,adipose tissue development [GO:0060612]; bone development [GO:0060348]; cranial skeletal system development [GO:1904888]; eye development [GO:0001654]; heart development [GO:0007507]; osteoblast fate commitment [GO:0002051]; podosome assembly [GO:0071800]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to membrane [GO:0072657]; regulation of brood size [GO:0060378]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; superoxide metabolic process [GO:0006801],anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]",GO:0008289; GO:0022414; GO:0043226; GO:0048856; GO:0065003,lipid binding; reproductive process; organelle; anatomical structure development; protein-containing complex assembly
OG_03478,FUN_014572-T1,Peve_00027631,Pocillopora_meandrina_HIv1___RNAseq.1861_t,three_way,78.95566666666666,FUN_014572-T1,Q6DDL7,,,,,50.4,282.0,2.6000000000000007e-71,270.4,sp|Q6DDL7|UN93A_XENLA Protein unc-93 homolog A OS=Xenopus laevis OX=8355 GN=unc93a PE=2 SV=1,,,,,,
OG_03479,FUN_014573-T3,Peve_00027630,Pocillopora_meandrina_HIv1___RNAseq.g22711.t1,three_way,76.72633333333333,FUN_014573-T3,Q6DFR1,,,,,31.8,494.0,5.1e-54,213.8,sp|Q6DFR1|S22AF_XENTR Solute carrier family 22 member 15 OS=Xenopus tropicalis OX=8364 GN=slc22a15 PE=2 SV=2,,,,,,
OG_03480,FUN_014574-T1,Peve_00027629,Pocillopora_meandrina_HIv1___TS.g27474.t1,three_way,69.878,FUN_014574-T1,Q9VCA2,,,,,36.1,527.0,8.1e-84,312.8,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_03481,FUN_014575-T1,Peve_00037170,Pocillopora_meandrina_HIv1___RNAseq.g22712.t1,three_way,86.77133333333333,FUN_014575-T1,Q0IIF2,,,,,60.7,300.0,5.3e-94,345.9,sp|Q0IIF2|EI2BA_BOVIN Translation initiation factor eIF2B subunit alpha OS=Bos taurus OX=9913 GN=EIF2B1 PE=2 SV=1,,,,,,
OG_03482,FUN_014584-T1,Peve_00001487,Pocillopora_meandrina_HIv1___RNAseq.g22720.t1,three_way,49.659333333333336,FUN_014584-T1,Q1L5Z9,LONF2_HUMAN,,LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192),Homo sapiens (Human),31.0,625.0,2.6999999999999997e-68,261.5,sp|Q1L5Z9|LONF2_HUMAN LON peptidase N-terminal domain and RING finger protein 2 OS=Homo sapiens OX=9606 GN=LONRF2 PE=1 SV=3,GO:0005737; GO:0006515; GO:0008270; GO:0021522; GO:0031175; GO:0043021; GO:0043524; GO:0050905; GO:0051402; GO:0051787; GO:0061630; GO:0061744,motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737],misfolded protein binding [GO:0051787]; ribonucleoprotein complex binding [GO:0043021]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0012501; GO:0016740; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; programmed cell death; transferase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_03483,FUN_014585-T1,Peve_00001488,Pocillopora_meandrina_HIv1___RNAseq.g22722.t1,three_way,62.20133333333333,,,,,,,,,,,,,,,,,
OG_03484,FUN_014586-T1,Peve_00001489,Pocillopora_meandrina_HIv1___RNAseq.g22723.t1,three_way,55.93383333333333,FUN_014586-T1,Q7T2Z5,UNC5C_CHICK,,Netrin receptor UNC5C (Protein unc-5 homolog 3) (cUNC-5H3) (Protein unc-5 homolog C),Gallus gallus (Chicken),42.2,102.0,3.3e-18,96.3,sp|Q7T2Z5|UNC5C_CHICK Netrin receptor UNC5C OS=Gallus gallus OX=9031 GN=UNC5C PE=2 SV=1,GO:0005042; GO:0005886; GO:0007411; GO:0009986; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0045202; GO:1990791,axon guidance [GO:0007411]; dorsal root ganglion development [GO:1990791],cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202],netrin receptor activity [GO:0005042],GO:0005886; GO:0048856; GO:0060089,plasma membrane; anatomical structure development; molecular transducer activity
OG_03485,FUN_014587-T1,Peve_00011851,Pocillopora_meandrina_HIv1___RNAseq.g22725.t1,three_way,61.32233333333333,FUN_014587-T1,Q6DRD9,ABHDB_DANRE,,sn-1-specific diacylglycerol lipase ABHD11 (EC 3.1.1.116) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein homolog),Danio rerio (Zebrafish) (Brachydanio rerio),42.0,274.0,1.3000000000000002e-57,224.9,sp|Q6DRD9|ABHDB_DANRE sn-1-specific diacylglycerol lipase ABHD11 OS=Danio rerio OX=7955 GN=abhd11 PE=2 SV=1,GO:0005739; GO:0005759; GO:0006629; GO:0016298; GO:0045252; GO:0052689,lipid metabolic process [GO:0006629],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252],carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298],GO:0003824; GO:0005739; GO:0006629; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; hydrolase activity; organelle
OG_03486,FUN_014589-T1,Peve_00011858,Pocillopora_meandrina_HIv1___TS.g27493.t1,three_way,81.65599999999999,FUN_014589-T1,O43147,,,,,45.5,1038.0,4.3e-227,789.6,sp|O43147|SGSM2_HUMAN Small G protein signaling modulator 2 OS=Homo sapiens OX=9606 GN=SGSM2 PE=1 SV=4,,,,,,
OG_03487,FUN_014593-T1,Peve_00031716,Pocillopora_meandrina_HIv1___RNAseq.g22732.t1,three_way,66.336,FUN_014593-T1,Q9EP86,,,,,27.3,311.0,1.9e-19,98.2,sp|Q9EP86|NPFF1_RAT Neuropeptide FF receptor 1 OS=Rattus norvegicus OX=10116 GN=Npffr1 PE=1 SV=1,,,,,,
OG_03488,FUN_014594-T1,Peve_00030566,Pocillopora_meandrina_HIv1___RNAseq.g22733.t1b,three_way,79.34916666666666,,,,,,,,,,,,,,,,,
OG_03489,FUN_014595-T1,Peve_00024866,Pocillopora_meandrina_HIv1___RNAseq.g22735.t1,three_way,81.23733333333334,FUN_014595-T1,Q96GQ5,RUSF1_HUMAN,,RUS family member 1,Homo sapiens (Human),44.4,408.0,1.2e-87,325.9,sp|Q96GQ5|RUSF1_HUMAN RUS family member 1 OS=Homo sapiens OX=9606 GN=RUSF1 PE=1 SV=2,GO:0016020,,membrane [GO:0016020],,,
OG_03490,FUN_014596-T1,Peve_00035166,Pocillopora_meandrina_HIv1___RNAseq.g22736.t1,three_way,71.495,FUN_014596-T1,Q4V7D6,NIF3L_RAT,,NIF3-like protein 1,Rattus norvegicus (Rat),48.5,363.0,3.2e-89,330.1,sp|Q4V7D6|NIF3L_RAT NIF3-like protein 1 OS=Rattus norvegicus OX=10116 GN=Nif3l1 PE=1 SV=1,GO:0000122; GO:0005634; GO:0005737; GO:0005739; GO:0030182; GO:0042802; GO:0045893; GO:0061629,negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0005634; GO:0005739; GO:0006355; GO:0030154; GO:0043226,nucleus; mitochondrion; regulation of DNA-templated transcription; cell differentiation; organelle
OG_03491,FUN_014598-T1,Peve_00010088,Pocillopora_meandrina_HIv1___RNAseq.g22739.t1,three_way,60.3855,FUN_014598-T1,Q8VIP2,,,,,36.9,279.0,3.8e-32,142.1,sp|Q8VIP2|MLXPL_RAT Carbohydrate-responsive element-binding protein OS=Rattus norvegicus OX=10116 GN=Mlxipl PE=1 SV=1,,,,,,
OG_03492,FUN_014601-T1,Peve_00034546,Pocillopora_meandrina_HIv1___RNAseq.g22743.t1,three_way,50.54366666666667,,,,,,,,,,,,,,,,,
OG_03493,FUN_014602-T1,Peve_00028207,Pocillopora_meandrina_HIv1___RNAseq.g22747.t1,three_way,77.274,FUN_014602-T1,Q9CXS4,CENPV_MOUSE,,Centromere protein V (CENP-V) (Proline-rich protein 6),Mus musculus (Mouse),58.8,131.0,2.4e-45,183.0,sp|Q9CXS4|CENPV_MOUSE Centromere protein V OS=Mus musculus OX=10090 GN=Cenpv PE=1 SV=2,GO:0000776; GO:0001667; GO:0005634; GO:0005654; GO:0005829; GO:0015630; GO:0016846; GO:0030496; GO:0031508; GO:0031965; GO:0032467; GO:0033044; GO:0034508; GO:0046872; GO:0051233; GO:0051301,ameboidal-type cell migration [GO:0001667]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044],cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233],carbon-sulfur lyase activity [GO:0016846]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0006325; GO:0016829; GO:0043226; GO:0048870; GO:0065003,catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; chromatin organization; lyase activity; organelle; cell motility; protein-containing complex assembly
OG_03494,FUN_014603-T1,Peve_00028206,Pocillopora_meandrina_HIv1___RNAseq.g22748.t1,three_way,56.717,FUN_014603-T1,Q6DIQ1,,,,,38.1,218.0,2.4e-35,150.6,sp|Q6DIQ1|GL1D1_XENTR Glycosyltransferase 1 domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=glt1d1 PE=2 SV=1,,,,,,
OG_03495,FUN_014604-T1,Peve_00028205,Pocillopora_meandrina_HIv1___RNAseq.g22749.t1,three_way,70.68266666666666,FUN_014604-T1,A2BGR3,,,,,54.5,635.0,3.2000000000000004e-185,650.2,sp|A2BGR3|ERC6L_DANRE DNA excision repair protein ERCC-6-like OS=Danio rerio OX=7955 GN=ercc6l PE=1 SV=1,,,,,,
OG_03496,FUN_014605-T1,Peve_00001902,Pocillopora_meandrina_HIv1___RNAseq.g22752.t1,three_way,91.59133333333334,FUN_014605-T1,Q14254,FLOT2_HUMAN,,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1),Homo sapiens (Human),58.5,417.0,1.6999999999999998e-105,384.4,sp|Q14254|FLOT2_HUMAN Flotillin-2 OS=Homo sapiens OX=9606 GN=FLOT2 PE=1 SV=2,GO:0001931; GO:0002020; GO:0002080; GO:0005768; GO:0005886; GO:0005901; GO:0005912; GO:0005925; GO:0007155; GO:0008544; GO:0010629; GO:0016020; GO:0016323; GO:0016600; GO:0030027; GO:0030139; GO:0031410; GO:0031982; GO:0032839; GO:0043123; GO:0043231; GO:0044291; GO:0044860; GO:0045661; GO:0048471; GO:0050821; GO:0070062; GO:0072659; GO:0098937; GO:0098978; GO:0099072; GO:1902992; GO:1903905,anterograde dendritic transport [GO:0098937]; cell adhesion [GO:0007155]; epidermis development [GO:0008544]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of gene expression [GO:0010629]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of establishment of T cell polarity [GO:1903905]; protein localization to plasma membrane [GO:0072659]; protein localization to plasma membrane raft [GO:0044860]; protein stabilization [GO:0050821]; regulation of myoblast differentiation [GO:0045661]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],acrosomal membrane [GO:0002080]; adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell contact zone [GO:0044291]; cytoplasmic vesicle [GO:0031410]; dendrite cytoplasm [GO:0032839]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; vesicle [GO:0031982],protease binding [GO:0002020],GO:0005768; GO:0005886; GO:0007018; GO:0007155; GO:0031410; GO:0043226; GO:0048856; GO:0072659,endosome; plasma membrane; microtubule-based movement; cell adhesion; cytoplasmic vesicle; organelle; anatomical structure development; protein localization to plasma membrane
OG_03497,FUN_014606-T1,Peve_00002397,Pocillopora_meandrina_HIv1___RNAseq.g22772.t1,three_way,87.05833333333334,FUN_014606-T1,O14735,,,,,66.0,162.0,4.5e-54,212.2,sp|O14735|CDIPT_HUMAN CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Homo sapiens OX=9606 GN=CDIPT PE=1 SV=1,,,,,,
OG_03498,FUN_014607-T1,Peve_00002391,Pocillopora_meandrina_HIv1___RNAseq.g22765.t1,three_way,71.34233333333333,FUN_014607-T1,Q4QMZ7,,,,,31.5,127.0,8.9e-10,65.9,"sp|Q4QMZ7|APAH_HAEI8 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical OS=Haemophilus influenzae (strain 86-028NP) OX=281310 GN=apaH PE=3 SV=1",,,,,,
OG_03499,FUN_014608-T1,Peve_00002424,Pocillopora_meandrina_HIv1___RNAseq.g22764.t1,three_way,78.122,FUN_014608-T1,Q8SX37,CDIPT_DROME,,CDP-diacylglycerol--inositol 3-phosphatidyltransferase (CDIPT) (EC 2.7.8.11) (Phosphatidylinositol synthase),Drosophila melanogaster (Fruit fly),44.0,84.0,1.2e-09,65.1,sp|Q8SX37|CDIPT_DROME CDP-diacylglycerol--inositol 3-phosphatidyltransferase OS=Drosophila melanogaster OX=7227 GN=Pis PE=1 SV=1,GO:0003881; GO:0005794; GO:0006661; GO:0007602; GO:0016324; GO:0016328; GO:0046872; GO:0071711,basement membrane organization [GO:0071711]; phosphatidylinositol biosynthetic process [GO:0006661]; phototransduction [GO:0007602],apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328],CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; metal ion binding [GO:0046872],GO:0003824; GO:0005794; GO:0006629; GO:0016740; GO:0030198; GO:0043226,catalytic activity; Golgi apparatus; lipid metabolic process; transferase activity; extracellular matrix organization; organelle
OG_03500,FUN_014610-T1,Peve_00027567,Pocillopora_meandrina_HIv1___TS.g27529.t1,three_way,75.49566666666666,FUN_014610-T1,P27465,,,,,48.5,361.0,3.7e-97,356.7,"sp|P27465|PISD_CRIGR Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Cricetulus griseus OX=10029 GN=Pisd PE=1 SV=2",,,,,,
OG_03501,FUN_014611-T1,Peve_00027568,Pocillopora_meandrina_HIv1___TS.g27528.t1,three_way,54.368,,,,,,,,,,,,,,,,,
OG_03502,FUN_014612-T1,Peve_00027569,Pocillopora_meandrina_HIv1___RNAseq.g22760.t1,three_way,63.5955,FUN_014612-T1,A2CEI4,,,,,30.4,756.0,3.1e-94,347.8,sp|A2CEI4|NUP88_DANRE Nucleoporin 88 OS=Danio rerio OX=7955 GN=nup88 PE=1 SV=1,,,,,,
OG_03503,FUN_014613-T1,Peve_00001900,Pocillopora_meandrina_HIv1___RNAseq.g22759.t1,three_way,82.95233333333333,FUN_014613-T1,Q92616,GCN1_HUMAN,,Stalled ribosome sensor GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1),Homo sapiens (Human),50.3,2683.0,0.0,2509.9,sp|Q92616|GCN1_HUMAN Stalled ribosome sensor GCN1 OS=Homo sapiens OX=9606 GN=GCN1 PE=1 SV=7,GO:0003723; GO:0005737; GO:0005829; GO:0005840; GO:0006417; GO:0008135; GO:0016020; GO:0019887; GO:0022626; GO:0034198; GO:0043539; GO:0045296; GO:0055106; GO:0060090; GO:0072344; GO:0140469; GO:0160127; GO:0170011,cellular response to amino acid starvation [GO:0034198]; GCN2-mediated signaling [GO:0140469]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; ribosome [GO:0005840],"cadherin binding [GO:0045296]; molecular adaptor activity [GO:0060090]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activator activity [GO:0043539]; RNA binding [GO:0003723]; stalled ribosome sensor activity [GO:0170011]; translation factor activity, RNA binding [GO:0008135]; ubiquitin-protein transferase regulator activity [GO:0055106]",GO:0003723; GO:0005829; GO:0005840; GO:0043226; GO:0060090; GO:0098772; GO:0140299,RNA binding; cytosol; ribosome; organelle; molecular adaptor activity; molecular function regulator activity; molecular sensor activity
OG_03504,FUN_014614-T1,Peve_00001898,Pocillopora_meandrina_HIv1___RNAseq.g22758.t1,three_way,90.642,FUN_014614-T1,Q6PC78,RN185_DANRE,,E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) (RING-type E3 ubiquitin transferase RNF185),Danio rerio (Zebrafish) (Brachydanio rerio),75.0,160.0,5.8e-63,241.9,sp|Q6PC78|RN185_DANRE E3 ubiquitin-protein ligase RNF185 OS=Danio rerio OX=7955 GN=rnf185 PE=2 SV=1,GO:0005741; GO:0005789; GO:0006511; GO:0006914; GO:0008270; GO:0036503; GO:0044314; GO:0044390; GO:0045087; GO:0051607; GO:0060340; GO:0061630,autophagy [GO:0006914]; defense response to virus [GO:0051607]; ERAD pathway [GO:0036503]; innate immune response [GO:0045087]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K27-linked ubiquitination [GO:0044314]; ubiquitin-dependent protein catabolic process [GO:0006511],endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein conjugating enzyme binding [GO:0044390]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0006914; GO:0016740; GO:0030163; GO:0098542; GO:0140096,"immune system process; catalytic activity; autophagy; transferase activity; protein catabolic process; defense response to other organism; catalytic activity, acting on a protein"
OG_03505,FUN_014615-T1,Peve_00001904,Pocillopora_meandrina_HIv1___RNAseq.1913_t,three_way,90.09,FUN_014615-T1,Q15370,ELOB_HUMAN,,Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2),Homo sapiens (Human),66.3,104.0,5.9e-34,144.8,sp|Q15370|ELOB_HUMAN Elongin-B OS=Homo sapiens OX=9606 GN=ELOB PE=1 SV=1,GO:0001222; GO:0005654; GO:0005829; GO:0006367; GO:0006368; GO:0016567; GO:0030891; GO:0031462; GO:0031466; GO:0031625; GO:0032436; GO:0065003; GO:0070449; GO:0140958,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; target-directed miRNA degradation [GO:0140958]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul5-RING ubiquitin ligase complex [GO:0031466]; cytosol [GO:0005829]; elongin complex [GO:0070449]; nucleoplasm [GO:0005654]; VCB complex [GO:0030891],transcription corepressor binding [GO:0001222]; ubiquitin protein ligase binding [GO:0031625],GO:0005654; GO:0005829; GO:0065003,nucleoplasm; cytosol; protein-containing complex assembly
OG_03506,FUN_014616-T1,Peve_00001903,Pocillopora_meandrina_HIv1___RNAseq.g22756.t1,three_way,96.60133333333332,FUN_014616-T1,Q6IP91,,,,,90.6,309.0,1.3e-168,593.6,sp|Q6IP91|PP4C_XENLA Serine/threonine-protein phosphatase 4 catalytic subunit OS=Xenopus laevis OX=8355 GN=ppp4c PE=2 SV=1,,,,,,
OG_03507,FUN_014617-T2,Peve_00002398,Pocillopora_meandrina_HIv1___RNAseq.g22768.t1,three_way,61.22316666666666,FUN_014617-T2,Q96F81,DISP1_HUMAN,,Protein dispatched homolog 1,Homo sapiens (Human),35.4,1037.0,4.9e-151,537.0,sp|Q96F81|DISP1_HUMAN Protein dispatched homolog 1 OS=Homo sapiens OX=9606 GN=DISP1 PE=1 SV=3,GO:0007224; GO:0007225; GO:0007368; GO:0009880; GO:0009953; GO:0015833; GO:0016020; GO:0016323; GO:0050708; GO:0060539; GO:0070207; GO:0140104,determination of left/right symmetry [GO:0007368]; diaphragm development [GO:0060539]; dorsal/ventral pattern formation [GO:0009953]; embryonic pattern specification [GO:0009880]; patched ligand maturation [GO:0007225]; peptide transport [GO:0015833]; protein homotrimerization [GO:0070207]; regulation of protein secretion [GO:0050708]; smoothened signaling pathway [GO:0007224],basolateral plasma membrane [GO:0016323]; membrane [GO:0016020],molecular carrier activity [GO:0140104],GO:0048856; GO:0051604; GO:0065003; GO:0140104,anatomical structure development; protein maturation; protein-containing complex assembly; molecular carrier activity
OG_03508,FUN_014618-T1,Peve_00002400,Pocillopora_meandrina_HIv1___RNAseq.g22773.t1,three_way,83.10666666666667,FUN_014618-T1,O88637,,,,,60.2,379.0,4.7e-131,469.2,sp|O88637|PCY2_RAT Ethanolamine-phosphate cytidylyltransferase OS=Rattus norvegicus OX=10116 GN=Pcyt2 PE=1 SV=1,,,,,,
OG_03509,FUN_014619-T1,Peve_00002405,Pocillopora_meandrina_HIv1___RNAseq.g22775.t1,three_way,73.92766666666667,,,,,,,,,,,,,,,,,
OG_03510,FUN_014621-T1,Peve_00002408,Pocillopora_meandrina_HIv1___RNAseq.g22778.t1,three_way,70.79983333333334,FUN_014621-T1,A4QNN3,UBP30_XENTR,,Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),39.8,450.0,2.7e-74,280.8,sp|A4QNN3|UBP30_XENTR Ubiquitin carboxyl-terminal hydrolase 30 OS=Xenopus tropicalis OX=8364 GN=usp30 PE=2 SV=1,GO:0000422; GO:0004197; GO:0004843; GO:0005739; GO:0005741; GO:0006508; GO:0008053; GO:0016579; GO:0035871; GO:0044313,autophagy of mitochondrion [GO:0000422]; mitochondrial fusion [GO:0008053]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K6-linked deubiquitination [GO:0044313]; proteolysis [GO:0006508],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005739; GO:0006914; GO:0007005; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; autophagy; mitochondrion organization; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03511,FUN_014622-T1,Peve_00002409,Pocillopora_meandrina_HIv1___RNAseq.g22779.t1,three_way,69.165,FUN_014622-T1,Q6GNG8,,,,,57.8,109.0,3e-27,123.2,sp|Q6GNG8|PKRI1_XENLA PRKR-interacting protein 1 homolog OS=Xenopus laevis OX=8355 GN=prkrip1 PE=2 SV=1,,,,,,
OG_03512,FUN_014623-T1,Peve_00002410,Pocillopora_meandrina_HIv1___RNAseq.g22780.t1,three_way,64.8355,,,,,,,,,,,,,,,,,
OG_03513,FUN_014624-T1,Peve_00002411,Pocillopora_meandrina_HIv1___RNAseq.g22781.t1,three_way,98.58133333333332,FUN_014624-T1,P48727,,,,,90.4,332.0,4.9999999999999996e-182,638.3,sp|P48727|GLC7B_CAEEL Serine/threonine-protein phosphatase PP1-beta OS=Caenorhabditis elegans OX=6239 GN=gsp-2 PE=1 SV=1,,,,,,
OG_03514,FUN_014625-T1,Peve_00002412,Pocillopora_meandrina_HIv1___TS.g27550.t1,three_way,56.03566666666666,,,,,,,,,,,,,,,,,
OG_03515,FUN_014626-T1,Peve_00002414,Pocillopora_meandrina_HIv1___RNAseq.g22784.t1,three_way,94.20133333333334,FUN_014626-T1,Q3MHR3,,,,,94.4,89.0,2.3e-44,179.5,"sp|Q3MHR3|DYL2_BOVIN Dynein light chain 2, cytoplasmic OS=Bos taurus OX=9913 GN=DYNLL2 PE=3 SV=1",,,,,,
OG_03516,FUN_014627-T1,Peve_00002415,Pocillopora_meandrina_HIv1___TS.g27554.t1,three_way,87.76583333333333,FUN_014627-T1,Q5ZML3,,,,,65.0,200.0,3.2e-57,223.4,sp|Q5ZML3|SRSF1_CHICK Serine/arginine-rich splicing factor 1 OS=Gallus gallus OX=9031 GN=SRSF1 PE=1 SV=3,,,,,,
OG_03517,FUN_014630-T1,Peve_00002417,Pocillopora_meandrina_HIv1___RNAseq.g22787.t1,three_way,63.39333333333334,FUN_014630-T1,Q5R5S1,,,,,31.7,612.0,1.1999999999999999e-75,285.8,sp|Q5R5S1|FBX21_PONAB F-box only protein 21 OS=Pongo abelii OX=9601 GN=FBXO21 PE=2 SV=1,,,,,,
OG_03518,FUN_014631-T1,Peve_00002419,Pocillopora_meandrina_HIv1___RNAseq.g22788.t1,three_way,71.69266666666667,FUN_014631-T1,Q99J99,THTM_MOUSE,,3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2),Mus musculus (Mouse),49.3,284.0,5.9e-78,292.4,sp|Q99J99|THTM_MOUSE 3-mercaptopyruvate sulfurtransferase OS=Mus musculus OX=10090 GN=Mpst PE=1 SV=4,GO:0001822; GO:0001889; GO:0004792; GO:0005737; GO:0005739; GO:0005743; GO:0016784; GO:0019346; GO:0021510; GO:0042802; GO:0043005; GO:0045202; GO:0070814,hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; spinal cord development [GO:0021510]; transsulfuration [GO:0019346],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202],3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792],GO:0003824; GO:0005739; GO:0006520; GO:0006790; GO:0016740; GO:0043226; GO:0048856,catalytic activity; mitochondrion; amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle; anatomical structure development
OG_03519,FUN_014632-T1,Peve_00002420,Pocillopora_meandrina_HIv1___RNAseq.g22789.t1,three_way,80.7705,FUN_014632-T1,Q9D4V7,RABL3_MOUSE,,Rab-like protein 3,Mus musculus (Mouse),48.9,233.0,4.1e-56,219.9,sp|Q9D4V7|RABL3_MOUSE Rab-like protein 3 OS=Mus musculus OX=10090 GN=Rabl3 PE=1 SV=1,GO:0001779; GO:0005525; GO:0030183; GO:0033077; GO:0042803; GO:0046578; GO:0050821; GO:1903059,B cell differentiation [GO:0030183]; natural killer cell differentiation [GO:0001779]; protein stabilization [GO:0050821]; regulation of protein lipidation [GO:1903059]; regulation of Ras protein signal transduction [GO:0046578]; T cell differentiation in thymus [GO:0033077],,GTP binding [GO:0005525]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0030154,immune system process; cell differentiation
OG_03520,FUN_014633-T1,Peve_00002421,Pocillopora_meandrina_HIv1___RNAseq.g22790.t1,three_way,53.859,,,,,,,,,,,,,,,,,
OG_03521,FUN_014636-T1,Peve_00002422,Pocillopora_meandrina_HIv1___RNAseq.g22791.t1,three_way,71.30749999999999,FUN_014636-T1,Q8N309,,,,,37.9,348.0,9.999999999999999e-54,213.0,sp|Q8N309|LRC43_HUMAN Leucine-rich repeat-containing protein 43 OS=Homo sapiens OX=9606 GN=LRRC43 PE=1 SV=2,,,,,,
OG_03522,FUN_014637-T1,Peve_00002423,Pocillopora_meandrina_HIv1___RNAseq.g22792.t1,three_way,83.999,FUN_014637-T1,P15651,,,,,74.8,377.0,4.1e-165,582.4,"sp|P15651|ACADS_RAT Short-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Acads PE=1 SV=2",,,,,,
OG_03523,FUN_014638-T1,Peve_00002425,Pocillopora_meandrina_HIv1___RNAseq.g22793.t1,three_way,53.5595,FUN_014638-T1,Q8IWL3,HSC20_HUMAN,,"Iron-sulfur cluster co-chaperone protein HscB (DnaJ homolog subfamily C member 20) [Cleaved into: Iron-sulfur cluster co-chaperone protein HscB, cytoplasmic (C-HSC20); Iron-sulfur cluster co-chaperone protein HscB, mitochondrial]",Homo sapiens (Human),39.7,189.0,3.3e-26,120.2,sp|Q8IWL3|HSC20_HUMAN Iron-sulfur cluster co-chaperone protein HscB OS=Homo sapiens OX=9606 GN=HSCB PE=1 SV=3,GO:0001671; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0016226; GO:0042802; GO:0044571; GO:0046872; GO:0051087; GO:0051259; GO:0060215; GO:0060319,[2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; primitive erythrocyte differentiation [GO:0060319]; primitive hemopoiesis [GO:0060215]; protein complex oligomerization [GO:0051259],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATPase activator activity [GO:0001671]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein-folding chaperone binding [GO:0051087],GO:0005654; GO:0005739; GO:0005829; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098772,nucleoplasm; mitochondrion; cytosol; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_03524,FUN_014639-T1,Peve_00002428,Pocillopora_meandrina_HIv1___RNAseq.g22796.t1,three_way,65.458,FUN_014639-T1,Q9Y2B2,PIGL_HUMAN,,N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase (EC 3.5.1.89) (Phosphatidylinositol-glycan biosynthesis class L protein) (PIG-L),Homo sapiens (Human),50.5,214.0,9.999999999999999e-54,212.2,sp|Q9Y2B2|PIGL_HUMAN N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase OS=Homo sapiens OX=9606 GN=PIGL PE=1 SV=1,GO:0000225; GO:0005783; GO:0005789; GO:0006506,GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],N-acetylglucosaminylphosphatidylinositol deacetylase activity [GO:0000225],GO:0003824; GO:0005783; GO:0006629; GO:0016787; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; lipid metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_03525,FUN_014640-T1,Peve_00002429,Pocillopora_meandrina_HIv1___RNAseq.g22797.t1,three_way,52.65283333333333,,,,,,,,,,,,,,,,,
OG_03526,FUN_014641-T1,Peve_00002430,Pocillopora_meandrina_HIv1___RNAseq.g22798.t1,three_way,72.066,FUN_014641-T1,Q96CM3,,,,,36.0,250.0,5.5e-33,142.9,"sp|Q96CM3|RUSD4_HUMAN Pseudouridylate synthase RPUSD4, mitochondrial OS=Homo sapiens OX=9606 GN=RPUSD4 PE=1 SV=1",,,,,,
OG_03527,FUN_014642-T1,Peve_00002431,Pocillopora_meandrina_HIv1___RNAseq.g22799.t1,three_way,84.71566666666666,FUN_014642-T1,Q5XGY9,,,,,59.0,205.0,1.2e-64,247.7,sp|Q5XGY9|MND1_XENLA Meiotic nuclear division protein 1 homolog OS=Xenopus laevis OX=8355 GN=mnd1 PE=2 SV=1,,,,,,
OG_03528,FUN_014643-T1,Peve_00002386,Pocillopora_meandrina_HIv1___RNAseq.g22800.t1,three_way,82.04466666666667,FUN_014643-T1,Q9DAX9,,,,,52.4,435.0,1.7e-119,431.0,sp|Q9DAX9|APBP2_MOUSE Amyloid protein-binding protein 2 OS=Mus musculus OX=10090 GN=Appbp2 PE=2 SV=1,,,,,,
OG_03529,FUN_014644-T1,Peve_00002387,Pocillopora_meandrina_HIv1___TS.g27455.t1,three_way,73.52783333333333,FUN_014644-T1,Q5SPX1,,,,,38.6,345.0,6.2e-48,194.1,sp|Q5SPX1|CC157_MOUSE Coiled-coil domain-containing protein 157 OS=Mus musculus OX=10090 GN=Ccdc157 PE=1 SV=1,,,,,,
OG_03530,FUN_014645-T1,Peve_00002388,Pocillopora_meandrina_HIv1___TS.g27454.t2,three_way,69.99833333333333,FUN_014645-T1,A3KGZ2,,,,,56.8,333.0,1.0999999999999998e-105,384.8,sp|A3KGZ2|OGFD2_DANRE 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 OS=Danio rerio OX=7955 GN=ogfod2 PE=2 SV=1,,,,,,
OG_03531,FUN_014646-T1,Peve_00025654,Pocillopora_meandrina_HIv1___RNAseq.g22686.t1,three_way,77.64233333333333,FUN_014646-T1,Q9D1L0,,,,,56.7,60.0,7.4e-11,68.6,sp|Q9D1L0|CHCH2_MOUSE Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 OS=Mus musculus OX=10090 GN=Chchd2 PE=2 SV=1,,,,,,
OG_03532,FUN_014647-T1,Peve_00007619,Pocillopora_meandrina_HIv1___RNAseq.g22685.t1,three_way,82.742,FUN_014647-T1,A0JPI9,,,,,44.3,79.0,3.8e-13,77.8,sp|A0JPI9|LR74A_RAT Leucine-rich repeat-containing protein 74A OS=Rattus norvegicus OX=10116 GN=Lrrc74a PE=2 SV=1,,,,,,
OG_03533,FUN_014650-T1,Peve_00007591,Pocillopora_meandrina_HIv1___RNAseq.g22683.t1,three_way,81.068,FUN_014650-T1,Q8CHV6,TAD2A_MOUSE,,Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein),Mus musculus (Mouse),46.0,430.0,3.4e-109,396.7,sp|Q8CHV6|TAD2A_MOUSE Transcriptional adapter 2-alpha OS=Mus musculus OX=10090 GN=Tada2a PE=1 SV=1,GO:0000124; GO:0000278; GO:0003677; GO:0003713; GO:0005634; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0031647; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140672,chromatin organization [GO:0006325]; mitotic cell cycle [GO:0000278]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; regulation of transcription by RNA polymerase II [GO:0006357],ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; SAGA complex [GO:0000124],DNA binding [GO:0003677]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0000278; GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,mitotic cell cycle; DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_03534,FUN_014653-T1,Peve_00007592,Pocillopora_meandrina_HIv1___TS.g27445.t1,three_way,63.556,FUN_014653-T1,Q2KHM9,MOONR_HUMAN,,Protein moonraker (MNR) (OFD1- and FOPNL-interacting protein),Homo sapiens (Human),26.4,982.0,3.3e-31,138.7,sp|Q2KHM9|MOONR_HUMAN Protein moonraker OS=Homo sapiens OX=9606 GN=KIAA0753 PE=1 SV=3,GO:0005783; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0005929; GO:0007099; GO:0034451; GO:0036064; GO:0046872; GO:0051537; GO:0060271; GO:0061824; GO:0071539,centriole replication [GO:0007099]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; protein localization to centrosome [GO:0071539],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; microtubule organizing center [GO:0005815],"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]",GO:0005783; GO:0005815; GO:0005829; GO:0005929; GO:0043226; GO:0044782,endoplasmic reticulum; microtubule organizing center; cytosol; cilium; organelle; cilium organization
OG_03535,FUN_014654-T1,Peve_00014507,Pocillopora_meandrina_HIv1___RNAseq.g22584.t1,three_way,41.90116666666666,,,,,,,,,,,,,,,,,
OG_03536,FUN_014655-T1,Peve_00014508,Pocillopora_meandrina_HIv1___TS.g27346.t1,three_way,45.942,,,,,,,,,,,,,,,,,
OG_03537,FUN_014656-T1,Peve_00014509,Pocillopora_meandrina_HIv1___RNAseq.g22582.t1,three_way,63.82566666666667,FUN_014656-T1,Q6GQD5,RN146_XENLA,,E3 ubiquitin-protein ligase rnf146 (EC 2.3.2.27) (RING finger protein 146) (RING-type E3 ubiquitin transferase rnf146),Xenopus laevis (African clawed frog),42.9,254.0,2.1e-48,194.1,sp|Q6GQD5|RN146_XENLA E3 ubiquitin-protein ligase rnf146 OS=Xenopus laevis OX=8355 GN=rnf146 PE=2 SV=1,GO:0004842; GO:0005634; GO:0005737; GO:0005829; GO:0006511; GO:0008270; GO:0016055; GO:0051865; GO:0061630; GO:0070936; GO:0072572; GO:0090263,positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],poly-ADP-D-ribose binding [GO:0072572]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03538,FUN_014657-T1,Peve_00014510,Pocillopora_meandrina_HIv1___RNAseq.g22581.t2,three_way,74.71600000000001,FUN_014657-T1,Q9NUQ2,PLCE_HUMAN,,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon),Homo sapiens (Human),45.6,261.0,1.9e-63,244.2,sp|Q9NUQ2|PLCE_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon OS=Homo sapiens OX=9606 GN=AGPAT5 PE=1 SV=3,GO:0002244; GO:0003841; GO:0005635; GO:0005730; GO:0005739; GO:0005741; GO:0005783; GO:0005789; GO:0006639; GO:0006654; GO:0008654; GO:0012505; GO:0016024; GO:0016746; GO:0036149,acylglycerol metabolic process [GO:0006639]; CDP-diacylglycerol biosynthetic process [GO:0016024]; hematopoietic progenitor cell differentiation [GO:0002244]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phospholipid biosynthetic process [GO:0008654],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; acyltransferase activity [GO:0016746],GO:0003824; GO:0005635; GO:0005730; GO:0005739; GO:0005783; GO:0006629; GO:0016740; GO:0030154; GO:0043226,catalytic activity; nuclear envelope; nucleolus; mitochondrion; endoplasmic reticulum; lipid metabolic process; transferase activity; cell differentiation; organelle
OG_03539,FUN_014659-T1,Peve_00014504,Pocillopora_meandrina_HIv1___TS.g27418.t1,three_way,76.663,FUN_014659-T1,Q8TB45,DPTOR_HUMAN,,DEP domain-containing mTOR-interacting protein (hDEPTOR) (DEP domain-containing protein 6),Homo sapiens (Human),51.2,84.0,3.5e-17,89.0,sp|Q8TB45|DPTOR_HUMAN DEP domain-containing mTOR-interacting protein OS=Homo sapiens OX=9606 GN=DEPTOR PE=1 SV=2,GO:0004860; GO:0005085; GO:0005096; GO:0005765; GO:0005886; GO:0006469; GO:0007186; GO:0010508; GO:0030291; GO:0032007; GO:0035556; GO:0045792; GO:0070300; GO:1903940; GO:1904262; GO:2001236,G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of cell size [GO:0045792]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of TORC2 signaling [GO:1903940]; positive regulation of autophagy [GO:0010508]; regulation of extrinsic apoptotic signaling pathway [GO:2001236],lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine kinase inhibitor activity [GO:0030291],GO:0005886; GO:0008289; GO:0098772,plasma membrane; lipid binding; molecular function regulator activity
OG_03540,FUN_014660-T1,Peve_00032454,Pocillopora_meandrina_HIv1___RNAseq.g22661.t1,three_way,97.681,FUN_014660-T1,Q2YDI3,,,,,92.9,113.0,1.6e-58,226.5,sp|Q2YDI3|YPEL2_BOVIN Protein yippee-like 2 OS=Bos taurus OX=9913 GN=YPEL2 PE=3 SV=1,,,,,,
OG_03541,FUN_014667-T1,Peve_00040977,Pocillopora_meandrina_HIv1___TS.g27436.t1a,three_way,60.659666666666666,,,,,,,,,,,,,,,,,
OG_03542,FUN_014668-T2,Peve_00040978,Pocillopora_meandrina_HIv1___RNAseq.g22673.t1,three_way,55.113,,,,,,,,,,,,,,,,,
OG_03543,FUN_014669-T1,Peve_00030804,Pocillopora_meandrina_HIv1___RNAseq.g22674.t1,three_way,79.45733333333332,FUN_014669-T1,Q9FIC3,BOLA2_ARATH,,Protein BOLA2,Arabidopsis thaliana (Mouse-ear cress),59.0,78.0,1.9e-19,96.3,sp|Q9FIC3|BOLA2_ARATH Protein BOLA2 OS=Arabidopsis thaliana OX=3702 GN=BOLA2 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006879; GO:0006979; GO:0010039; GO:0051537; GO:0051604,intracellular iron ion homeostasis [GO:0006879]; protein maturation [GO:0051604]; response to iron ion [GO:0010039]; response to oxidative stress [GO:0006979],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"2 iron, 2 sulfur cluster binding [GO:0051537]",GO:0005634; GO:0005829; GO:0005886; GO:0043226; GO:0051604,nucleus; cytosol; plasma membrane; organelle; protein maturation
OG_03544,FUN_014670-T1,Peve_00030803,Pocillopora_meandrina_HIv1___RNAseq.g22675.t1,three_way,86.73983333333334,FUN_014670-T1,Q13356,PPIL2_HUMAN,,RING-type E3 ubiquitin-protein ligase PPIL2 (EC 2.3.2.27) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (Probable inactive peptidyl-prolyl cis-trans isomerase-like 2) (PPIase) (Rotamase PPIL2),Homo sapiens (Human),58.3,527.0,1.1e-178,627.9,sp|Q13356|PPIL2_HUMAN RING-type E3 ubiquitin-protein ligase PPIL2 OS=Homo sapiens OX=9606 GN=PPIL2 PE=1 SV=1,GO:0000209; GO:0005634; GO:0005654; GO:0005737; GO:0005796; GO:0005886; GO:0006397; GO:0006457; GO:0008380; GO:0034450; GO:0061630; GO:0071013; GO:0072659,mRNA processing [GO:0006397]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein polyubiquitination [GO:0000209]; RNA splicing [GO:0008380],catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Golgi lumen [GO:0005796]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0005654; GO:0005886; GO:0006457; GO:0016071; GO:0016740; GO:0043226; GO:0072659; GO:0140096,"catalytic activity; nucleus; nucleoplasm; plasma membrane; protein folding; mRNA metabolic process; transferase activity; organelle; protein localization to plasma membrane; catalytic activity, acting on a protein"
OG_03545,FUN_014672-T1,Peve_00013037,Pocillopora_meandrina_HIv1___TS.g27442.t1,three_way,77.41466666666668,FUN_014672-T1,Q8N9F7,GDPD1_HUMAN,,Lysophospholipase D GDPD1 (EC 3.1.4.-) (Glycerophosphodiester phosphodiesterase 4) (Glycerophosphodiester phosphodiesterase domain-containing protein 1),Homo sapiens (Human),51.2,303.0,2.2e-84,313.9,sp|Q8N9F7|GDPD1_HUMAN Lysophospholipase D GDPD1 OS=Homo sapiens OX=9606 GN=GDPD1 PE=1 SV=2,GO:0004622; GO:0005783; GO:0005789; GO:0008081; GO:0016020; GO:0046475; GO:0046872; GO:0048471; GO:0070291,glycerophospholipid catabolic process [GO:0046475]; N-acylethanolamine metabolic process [GO:0070291],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471],lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081],GO:0003824; GO:0005783; GO:0006629; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; hydrolase activity; organelle
OG_03546,FUN_014673-T1,Peve_00013033,Pocillopora_meandrina_HIv1___RNAseq.g22680.t1,three_way,77.56683333333334,FUN_014673-T1,Q96AY4,TTC28_HUMAN,,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),Homo sapiens (Human),44.3,828.0,5.7e-171,604.4,sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4,GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301,cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922],kinase binding [GO:0019900],GO:0005815,microtubule organizing center
OG_03547,FUN_014674-T1,Peve_00014503,Pocillopora_meandrina_HIv1___RNAseq.g22585.t1,three_way,70.135,FUN_014674-T1,Q9JKV2,CILK1_MOUSE,,Serine/threonine-protein kinase ICK (EC 2.7.11.1) (Intestinal cell kinase) (mICK) (MAK-related kinase) (MRK),Mus musculus (Mouse),80.5,287.0,3.8e-139,496.5,sp|Q9JKV2|CILK1_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus OX=10090 GN=Cilk1 PE=1 SV=2,GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005929; GO:0006468; GO:0007165; GO:0035556; GO:0035720; GO:0035721; GO:0036064; GO:0042073; GO:0060271; GO:0097542; GO:0097546; GO:0106310,cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary anterograde transport [GO:0035720]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; cilium; microtubule-based movement; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_03548,FUN_014677-T1,Peve_00004255,Pocillopora_meandrina_HIv1___RNAseq.g22586.t1,three_way,75.49233333333333,FUN_014677-T1,Q9SS90,RGLG1_ARATH,,E3 ubiquitin-protein ligase RGLG1 (EC 2.3.2.27) (RING domain ligase 1),Arabidopsis thaliana (Mouse-ear cress),50.8,266.0,1.6999999999999999e-68,261.2,sp|Q9SS90|RGLG1_ARATH E3 ubiquitin-protein ligase RGLG1 OS=Arabidopsis thaliana OX=3702 GN=RGLG1 PE=1 SV=1,GO:0004842; GO:0005634; GO:0005886; GO:0008270; GO:0009738; GO:0009789; GO:0061630; GO:0070534; GO:0080148,abscisic acid-activated signaling pathway [GO:0009738]; negative regulation of response to water deprivation [GO:0080148]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789]; protein K63-linked ubiquitination [GO:0070534],nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005886; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03549,FUN_014679-T1,Peve_00004252,Pocillopora_meandrina_HIv1___RNAseq.g22587.t1,three_way,65.30366666666667,FUN_014679-T1,Q5U508,,,,,40.3,528.0,3.8e-107,390.2,sp|Q5U508|TBCE_XENLA Tubulin-specific chaperone E OS=Xenopus laevis OX=8355 GN=tbce PE=2 SV=1,,,,,,
OG_03550,FUN_014682-T1,Peve_00004258,Pocillopora_meandrina_HIv1___RNAseq.g22590.t1,three_way,83.26683333333334,FUN_014682-T1,Q9UJX3,APC7_HUMAN,,Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7),Homo sapiens (Human),39.4,523.0,2.5000000000000002e-104,380.9,sp|Q9UJX3|APC7_HUMAN Anaphase-promoting complex subunit 7 OS=Homo sapiens OX=9606 GN=ANAPC7 PE=1 SV=5,GO:0000792; GO:0005634; GO:0005654; GO:0005680; GO:0005819; GO:0005829; GO:0007346; GO:0007420; GO:0015630; GO:0016567; GO:0019903; GO:0031145; GO:0043231; GO:0045171; GO:0045842; GO:0051301; GO:0051445; GO:0070936; GO:0070979; GO:0072686; GO:0140767; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; brain development [GO:0007420]; cell division [GO:0051301]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],enzyme-substrate adaptor activity [GO:0140767]; protein phosphatase binding [GO:0019903],GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0030163; GO:0043226; GO:0048856; GO:0060090,nucleus; nucleoplasm; cytosol; cytoskeleton; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity
OG_03551,FUN_014683-T2,Peve_00033420,Pocillopora_meandrina_HIv1___RNAseq.g22591.t1,three_way,70.162,FUN_014683-T2,Q9Y3E5,PTH2_HUMAN,,"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription 1)",Homo sapiens (Human),59.4,160.0,4.0000000000000006e-45,182.6,"sp|Q9Y3E5|PTH2_HUMAN Peptidyl-tRNA hydrolase 2, mitochondrial OS=Homo sapiens OX=9606 GN=PTRH2 PE=1 SV=1",GO:0004045; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0010629; GO:0016020; GO:2000210; GO:2000811,apoptotic process [GO:0006915]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],peptidyl-tRNA hydrolase activity [GO:0004045],GO:0003824; GO:0005739; GO:0005829; GO:0012501; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; mitochondrion; cytosol; programmed cell death; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03552,FUN_014685-T1,Peve_00004254,Pocillopora_meandrina_HIv1___RNAseq.g22592.t1,three_way,38.47933333333334,,,,,,,,,,,,,,,,,
OG_03553,FUN_014686-T1,Peve_00004249,Pocillopora_meandrina_HIv1___RNAseq.g22822.t1,three_way,85.706,FUN_014686-T1,Q8BH64,EHD2_MOUSE,,EH domain-containing protein 2,Mus musculus (Mouse),25.2,218.0,9.4e-06,53.1,sp|Q8BH64|EHD2_MOUSE EH domain-containing protein 2 OS=Mus musculus OX=10090 GN=Ehd2 PE=1 SV=1,GO:0005509; GO:0005524; GO:0005525; GO:0005829; GO:0005886; GO:0005901; GO:0006897; GO:0016020; GO:0016787; GO:0019904; GO:0030866; GO:0032456; GO:0042802; GO:0048471; GO:0055038; GO:0072659; GO:0097320; GO:1901741; GO:2001137,cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; plasma membrane tubulation [GO:0097320]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; protein localization to plasma membrane [GO:0072659],caveola [GO:0005901]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904],GO:0003824; GO:0005829; GO:0005886; GO:0007010; GO:0016192; GO:0016787; GO:0061024; GO:0072659,catalytic activity; cytosol; plasma membrane; cytoskeleton organization; vesicle-mediated transport; hydrolase activity; membrane organization; protein localization to plasma membrane
OG_03554,FUN_014690-T1,Peve_00028116,Pocillopora_meandrina_HIv1___RNAseq.g22821.t1,three_way,83.69500000000001,FUN_014690-T1,Q8NFA0,UBP32_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32),Homo sapiens (Human),44.8,1747.0,0.0,1401.3,sp|Q8NFA0|UBP32_HUMAN Ubiquitin carboxyl-terminal hydrolase 32 OS=Homo sapiens OX=9606 GN=USP32 PE=1 SV=1,GO:0000139; GO:0004843; GO:0005509; GO:0005794; GO:0005829; GO:0006508; GO:0016579; GO:1904263,positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005794; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03555,FUN_014693-T1,Peve_00006835,Pocillopora_meandrina_HIv1___RNAseq.g22555.t1,three_way,67.01950000000001,FUN_014693-T1,Q8R3V6,,,,,37.2,309.0,2.4e-31,137.5,sp|Q8R3V6|CUED1_MOUSE CUE domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cuedc1 PE=2 SV=2,,,,,,
OG_03556,FUN_014694-T1,Peve_00006830,Pocillopora_meandrina_HIv1___RNAseq.g22552.t1,three_way,85.36166666666666,FUN_014694-T1,Q9VX98,,,,,52.0,171.0,4.5e-42,172.6,sp|Q9VX98|DENR_DROME Density-regulated protein homolog OS=Drosophila melanogaster OX=7227 GN=DENR PE=1 SV=3,,,,,,
OG_03557,FUN_014703-T1,Peve_00021211,Pocillopora_meandrina_HIv1___RNAseq.g22536.t1,three_way,58.56033333333333,,,,,,,,,,,,,,,,,
OG_03558,FUN_014704-T1,Peve_00021212,Pocillopora_meandrina_HIv1___RNAseq.g22535.t1,three_way,50.87083333333333,,,,,,,,,,,,,,,,,
OG_03559,FUN_014706-T1,Peve_00021213,Pocillopora_meandrina_HIv1___RNAseq.g22534.t1,three_way,85.49499999999999,FUN_014706-T1,Q2KIR8,,,,,63.2,307.0,4.6e-117,422.5,"sp|Q2KIR8|TDH_BOVIN L-threonine 3-dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=TDH PE=2 SV=1",,,,,,
OG_03560,FUN_014707-T1,Peve_00021214,Pocillopora_meandrina_HIv1___RNAseq.g22533.t1,three_way,80.39150000000001,FUN_014707-T1,P50897,PPT1_HUMAN,,Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.2) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1),Homo sapiens (Human),64.8,273.0,4.1e-106,386.0,sp|P50897|PPT1_HUMAN Palmitoyl-protein thioesterase 1 OS=Homo sapiens OX=9606 GN=PPT1 PE=1 SV=1,GO:0002084; GO:0005576; GO:0005634; GO:0005764; GO:0005765; GO:0005794; GO:0005829; GO:0006897; GO:0006898; GO:0006907; GO:0007042; GO:0007269; GO:0007399; GO:0007420; GO:0007601; GO:0007625; GO:0008021; GO:0008306; GO:0008344; GO:0008474; GO:0015031; GO:0016020; GO:0016042; GO:0030149; GO:0030163; GO:0030308; GO:0030424; GO:0030425; GO:0030672; GO:0031579; GO:0034164; GO:0035727; GO:0043025; GO:0043066; GO:0043202; GO:0043231; GO:0043524; GO:0045121; GO:0046949; GO:0048260; GO:0048549; GO:0048666; GO:0050803; GO:0052816; GO:0070062; GO:0099523; GO:0120146,adult locomotory behavior [GO:0008344]; associative learning [GO:0008306]; brain development [GO:0007420]; endocytosis [GO:0006897]; fatty-acyl-CoA biosynthetic process [GO:0046949]; grooming behavior [GO:0007625]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; nervous system development [GO:0007399]; neuron development [GO:0048666]; neurotransmitter secretion [GO:0007269]; pinocytosis [GO:0006907]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein catabolic process [GO:0030163]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; sphingolipid catabolic process [GO:0030149]; visual perception [GO:0007601],axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; lysophosphatidic acid binding [GO:0035727]; palmitoyl-(protein) hydrolase activity [GO:0008474]; sulfatide binding [GO:0120146],GO:0003824; GO:0005576; GO:0005634; GO:0005764; GO:0005773; GO:0005794; GO:0005829; GO:0006629; GO:0006790; GO:0008289; GO:0016192; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:0061024; GO:0140096,"catalytic activity; extracellular region; nucleus; lysosome; vacuole; Golgi apparatus; cytosol; lipid metabolic process; sulfur compound metabolic process; lipid binding; vesicle-mediated transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; membrane organization; catalytic activity, acting on a protein"
OG_03561,FUN_014709-T1,Peve_00004188,Pocillopora_meandrina_HIv1___RNAseq.g22531.t1,three_way,88.661,FUN_014709-T1,Q62559,IFT52_MOUSE,,Intraflagellar transport protein 52 homolog (Protein NGD5),Mus musculus (Mouse),67.5,421.0,5e-164,578.9,sp|Q62559|IFT52_MOUSE Intraflagellar transport protein 52 homolog OS=Mus musculus OX=10090 GN=Ift52 PE=1 SV=2,GO:0001841; GO:0001947; GO:0005813; GO:0005814; GO:0005929; GO:0007224; GO:0007368; GO:0009953; GO:0010839; GO:0030992; GO:0032391; GO:0035720; GO:0036064; GO:0042073; GO:0042733; GO:0043616; GO:0044292; GO:0060271; GO:0070613; GO:0097542; GO:0097546; GO:0097733; GO:1905515,cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391],,GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0044782,microtubule organizing center; cilium; microtubule-based movement; organelle; cilium organization
OG_03562,FUN_014710-T1,Peve_00004185,Pocillopora_meandrina_HIv1___TS.g27294.t1,three_way,91.096,FUN_014710-T1,Q5SPC5,OTOF_DANRE,,Otoferlin (Fer-1-like protein 2),Danio rerio (Zebrafish) (Brachydanio rerio),49.8,2026.0,0.0,1855.5,sp|Q5SPC5|OTOF_DANRE Otoferlin OS=Danio rerio OX=7955 GN=otof PE=3 SV=1,GO:0000139; GO:0001964; GO:0005509; GO:0005789; GO:0007009; GO:0007605; GO:0010996; GO:0016079; GO:0016082; GO:0016323; GO:0030672; GO:0035612; GO:0036465; GO:0042995; GO:0048787; GO:0050885,neuromuscular process controlling balance [GO:0050885]; plasma membrane organization [GO:0007009]; response to auditory stimulus [GO:0010996]; sensory perception of sound [GO:0007605]; startle response [GO:0001964]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle recycling [GO:0036465],basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; presynaptic active zone membrane [GO:0048787]; synaptic vesicle membrane [GO:0030672],AP-2 adaptor complex binding [GO:0035612]; calcium ion binding [GO:0005509],GO:0016192; GO:0050877; GO:0061024; GO:0065003,vesicle-mediated transport; nervous system process; membrane organization; protein-containing complex assembly
OG_03563,FUN_014712-T1,Peve_00028586,Pocillopora_meandrina_HIv1___RNAseq.g22528.t1,three_way,51.81133333333333,,,,,,,,,,,,,,,,,
OG_03564,FUN_014713-T1,Peve_00028587,Pocillopora_meandrina_HIv1___RNAseq.g22527.t1,three_way,84.00266666666667,FUN_014713-T1,Q96DM3,,,,,53.3,647.0,7.699999999999999e-198,691.8,sp|Q96DM3|RMC1_HUMAN Regulator of MON1-CCZ1 complex OS=Homo sapiens OX=9606 GN=RMC1 PE=1 SV=2,,,,,,
OG_03565,FUN_014714-T1,Peve_00023481,Pocillopora_meandrina_HIv1___RNAseq.g22526.t1,three_way,80.59266666666667,FUN_014714-T1,Q6GQN5,PPR42_DANRE,,Protein phosphatase 1 regulatory subunit 42 (Leucine-rich repeat-containing protein 67),Danio rerio (Zebrafish) (Brachydanio rerio),66.7,252.0,2.1e-35,151.4,sp|Q6GQN5|PPR42_DANRE Protein phosphatase 1 regulatory subunit 42 OS=Danio rerio OX=7955 GN=ppp1r42 PE=2 SV=1,GO:0002177; GO:0003779; GO:0005737; GO:0005813; GO:0005815; GO:0015630; GO:0015631; GO:0070840,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815],actin binding [GO:0003779]; dynein complex binding [GO:0070840]; tubulin binding [GO:0015631],GO:0005815; GO:0005856; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton; cytoskeletal protein binding; organelle
OG_03566,FUN_014715-T1,Peve_00023482,Pocillopora_meandrina_HIv1___RNAseq.g22525.t1,three_way,70.94933333333333,FUN_014715-T1,Q5RA75,,,,,35.2,1159.0,4.4e-158,560.5,sp|Q5RA75|F135A_PONAB Protein FAM135A OS=Pongo abelii OX=9601 GN=FAM135A PE=2 SV=1,,,,,,
OG_03567,FUN_014716-T2,Peve_00022399,Pocillopora_meandrina_HIv1___RNAseq.g22524.t1,three_way,51.833666666666666,FUN_014716-T2,P49791,,,,,27.7,285.0,6.9e-16,88.6,sp|P49791|NU153_RAT Nuclear pore complex protein Nup153 OS=Rattus norvegicus OX=10116 GN=Nup153 PE=1 SV=1,,,,,,
OG_03568,FUN_014718-T1,Peve_00006840,Pocillopora_meandrina_HIv1___RNAseq.g22503.t1,three_way,67.64766666666667,FUN_014718-T1,Q5PP32,,,,,34.4,340.0,6.1e-35,149.8,sp|Q5PP32|WTR25_ARATH WAT1-related protein At3g45870 OS=Arabidopsis thaliana OX=3702 GN=At3g45870 PE=2 SV=1,,,,,,
OG_03569,FUN_014720-T1,Peve_00006843,Pocillopora_meandrina_HIv1___RNAseq.g22498.t1,three_way,63.56933333333333,FUN_014720-T1,Q9VCR7,,,,,26.0,204.0,1.7e-07,58.5,sp|Q9VCR7|CTNS_DROME Cystinosin OS=Drosophila melanogaster OX=7227 GN=Ctns PE=1 SV=2,,,,,,
OG_03570,FUN_014724-T1,Peve_00006846,Pocillopora_meandrina_HIv1___RNAseq.g22497.t1,three_way,52.973,,,,,,,,,,,,,,,,,
OG_03571,FUN_014725-T1,Peve_00006848,Pocillopora_meandrina_HIv1___RNAseq.g22496.t1,three_way,80.2465,FUN_014725-T1,Q9WTV0,SEC12_RAT,,Guanine nucleotide-exchange factor SEC12 (Mammalian guanine nucleotide exchange factor Sec12) (mSec12) (Prolactin regulatory element-binding protein),Rattus norvegicus (Rat),33.7,403.0,4.7e-49,196.8,sp|Q9WTV0|SEC12_RAT Guanine nucleotide-exchange factor SEC12 OS=Rattus norvegicus OX=10116 GN=Preb PE=1 SV=2,GO:0000978; GO:0003400; GO:0005085; GO:0005634; GO:0005789; GO:0006888; GO:0015031; GO:0045944; GO:0048208; GO:0051020; GO:0070971,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein transport [GO:0015031]; regulation of COPII vesicle coating [GO:0003400],endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0005634; GO:0006355; GO:0016192; GO:0043226; GO:0065003; GO:0098772,DNA binding; nucleus; regulation of DNA-templated transcription; vesicle-mediated transport; organelle; protein-containing complex assembly; molecular function regulator activity
OG_03572,FUN_014726-T1,Peve_00009492,Pocillopora_meandrina_HIv1___RNAseq.g22493.t1,three_way,44.585,,,,,,,,,,,,,,,,,
OG_03573,FUN_014727-T1,Peve_00009517,Pocillopora_meandrina_HIv1___RNAseq.g22492.t1,three_way,75.87566666666666,FUN_014727-T1,A9KJR7,,,,,25.7,222.0,8.7e-11,68.9,sp|A9KJR7|UREF_LACP7 Urease accessory protein UreF OS=Lachnoclostridium phytofermentans (strain ATCC 700394 / DSM 18823 / ISDg) OX=357809 GN=ureF PE=3 SV=1,,,,,,
OG_03574,FUN_014728-T1,Peve_00009505,Pocillopora_meandrina_HIv1___RNAseq.g22491.t1,three_way,50.2435,,,,,,,,,,,,,,,,,
OG_03575,FUN_014729-T1,Peve_00009500,Pocillopora_meandrina_HIv1___RNAseq.g22490.t1,three_way,91.43733333333331,,,,,,,,,,,,,,,,,
OG_03576,FUN_014730-T1,Peve_00009496,Pocillopora_meandrina_HIv1___RNAseq.g22489.t1,three_way,68.61999999999999,FUN_014730-T1,Q5R831,,,,,64.4,267.0,5e-92,339.3,sp|Q5R831|S35B3_PONAB Adenosine 3'-phospho 5'-phosphosulfate transporter 2 OS=Pongo abelii OX=9601 GN=SLC35B3 PE=2 SV=1,,,,,,
OG_03577,FUN_014731-T1,Peve_00010437,Pocillopora_meandrina_HIv1___TS.g27252.t1,three_way,82.48166666666667,FUN_014731-T1,Q7SXP2,,,,,58.6,526.0,3.1e-189,662.9,sp|Q7SXP2|ULA1_DANRE NEDD8-activating enzyme E1 regulatory subunit OS=Danio rerio OX=7955 GN=nae1 PE=2 SV=2,,,,,,
OG_03578,FUN_014733-T1,Peve_00010436,Pocillopora_meandrina_HIv1___RNAseq.g22485.t1,three_way,84.49266666666666,FUN_014733-T1,A5D7E2,TM9S4_BOVIN,,Transmembrane 9 superfamily member 4,Bos taurus (Bovine),59.6,596.0,1.1e-203,711.1,sp|A5D7E2|TM9S4_BOVIN Transmembrane 9 superfamily member 4 OS=Bos taurus OX=9913 GN=TM9SF4 PE=2 SV=2,GO:0001666; GO:0005769; GO:0005794; GO:0006909; GO:0007155; GO:0016020; GO:0051453; GO:0070072; GO:0070863; GO:0072657; GO:2000010,cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],,GO:0005768; GO:0005794; GO:0007155; GO:0016192; GO:0031410; GO:0043226; GO:0065003,endosome; Golgi apparatus; cell adhesion; vesicle-mediated transport; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_03579,FUN_014734-T1,Peve_00010435,Pocillopora_meandrina_HIv1___RNAseq.1641_t,three_way,71.44800000000001,,,,,,,,,,,,,,,,,
OG_03580,FUN_014735-T1,Peve_00010434,Pocillopora_meandrina_HIv1___RNAseq.g22482.t1,three_way,69.71300000000001,FUN_014735-T1,O15400,STX7_HUMAN,,Syntaxin-7,Homo sapiens (Human),38.0,221.0,1.3e-21,105.1,sp|O15400|STX7_HUMAN Syntaxin-7 OS=Homo sapiens OX=9606 GN=STX7 PE=1 SV=4,GO:0000149; GO:0001772; GO:0001916; GO:0005484; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0006886; GO:0006906; GO:0008021; GO:0012505; GO:0019869; GO:0019905; GO:0030139; GO:0031201; GO:0031901; GO:0031982; GO:0042582; GO:0048278; GO:0048471; GO:0051640; GO:0055037; GO:0070062; GO:0070820; GO:0070925; GO:1902685; GO:1903076,intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982],chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0006886; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0098772,lysosome; endosome; vacuole; plasma membrane; intracellular protein transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; molecular function regulator activity
OG_03581,FUN_014736-T1,Peve_00010443,Pocillopora_meandrina_HIv1___RNAseq.g22481.t1,three_way,65.606,,,,,,,,,,,,,,,,,
OG_03582,FUN_014737-T1,Peve_00010440,Pocillopora_meandrina_HIv1___RNAseq.g22480.t1c,three_way,64.17166666666667,FUN_014737-T1,Q6PAY6,,,,,40.4,421.0,2.1e-80,301.2,sp|Q6PAY6|HYPDH_XENLA Hydroxyproline dehydrogenase OS=Xenopus laevis OX=8355 GN=prodh2 PE=2 SV=1,,,,,,
OG_03583,FUN_014738-T1,Peve_00010439,Pocillopora_meandrina_HIv1___TS.g27242.t1,three_way,73.03666666666666,FUN_014738-T1,Q08AX9,,,,,40.9,648.0,2.6999999999999998e-121,437.6,sp|Q08AX9|SANBR_XENLA SANT and BTB domain regulator of class switch recombination OS=Xenopus laevis OX=8355 GN=sanbr PE=2 SV=1,,,,,,
OG_03584,FUN_014740-T1,Peve_00027516,Pocillopora_meandrina_HIv1___RNAseq.g22474.t1,three_way,83.22066666666666,FUN_014740-T1,Q2XWK0,,,,,45.2,334.0,1.8e-73,277.7,sp|Q2XWK0|SVOP_XENLA Synaptic vesicle 2-related protein OS=Xenopus laevis OX=8355 GN=svop PE=2 SV=1,,,,,,
OG_03585,FUN_014741-T1,Peve_00027513,Pocillopora_meandrina_HIv1___RNAseq.g22473.t1,three_way,84.87833333333333,FUN_014741-T1,Q28GJ2,,,,,51.9,314.0,7.7e-95,348.6,sp|Q28GJ2|CK054_XENTR Ester hydrolase C11orf54 homolog OS=Xenopus tropicalis OX=8364 GN=TEgg069a24.1 PE=2 SV=1,,,,,,
OG_03586,FUN_014742-T1,Peve_00036169,Pocillopora_meandrina_HIv1___RNAseq.g22472.t1,three_way,71.57566666666666,FUN_014742-T1,Q502L2,PGAM5_DANRE,,"Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Phosphoglycerate mutase family member 5)",Danio rerio (Zebrafish) (Brachydanio rerio),50.6,233.0,2.1e-67,257.3,"sp|Q502L2|PGAM5_DANRE Serine/threonine-protein phosphatase PGAM5, mitochondrial OS=Danio rerio OX=7955 GN=pgam5 PE=2 SV=2",GO:0004722; GO:0005739; GO:0005741; GO:0012501; GO:0090141,positive regulation of mitochondrial fission [GO:0090141]; programmed cell death [GO:0012501],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005739; GO:0012501; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; programmed cell death; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03587,FUN_014743-T1,Peve_00007238,Pocillopora_meandrina_HIv1___RNAseq.g22471.t2,three_way,64.66933333333333,FUN_014743-T1,Q5YCC5,,,,,31.2,557.0,2.8e-64,248.1,sp|Q5YCC5|TMC7_CHICK Transmembrane channel-like protein 7 OS=Gallus gallus OX=9031 GN=Tmc7 PE=2 SV=1,,,,,,
OG_03588,FUN_014744-T1,Peve_00007241,Pocillopora_meandrina_HIv1___TS.g27235.t1,three_way,59.247,,,,,,,,,,,,,,,,,
OG_03589,FUN_014747-T1,Peve_00007244,Pocillopora_meandrina_HIv1___RNAseq.g22469.t1,three_way,58.21233333333333,FUN_014747-T1,P0DMW7,,,,,67.3,52.0,1e-16,87.0,sp|P0DMW7|VKT3B_ACTEQ PI-actitoxin-Aeq3b OS=Actinia equina OX=6106 PE=1 SV=1,,,,,,
OG_03590,FUN_014748-T1,Peve_00007239,Pocillopora_meandrina_HIv1___RNAseq.g22468.t1,three_way,49.17,,,,,,,,,,,,,,,,,
OG_03591,FUN_014749-T1,Peve_00007240,Pocillopora_meandrina_HIv1___RNAseq.g22454.t1,three_way,56.16033333333333,FUN_014749-T1,Q795M8,,,,,40.2,97.0,6.1e-08,60.8,sp|Q795M8|YUGO_BACSU Putative potassium channel protein YugO OS=Bacillus subtilis (strain 168) OX=224308 GN=yugO PE=4 SV=2,,,,,,
OG_03592,FUN_014750-T1,Peve_00016985,Pocillopora_meandrina_HIv1___TS.g27214.t1,three_way,76.65533333333333,FUN_014750-T1,Q5F2F2,ABH15_MOUSE,,Protein ABHD15 (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15),Mus musculus (Mouse),36.8,353.0,1.6e-52,208.4,sp|Q5F2F2|ABH15_MOUSE Protein ABHD15 OS=Mus musculus OX=10090 GN=Abhd15 PE=1 SV=1,GO:0005576; GO:0016042; GO:0060612,adipose tissue development [GO:0060612]; lipid catabolic process [GO:0016042],extracellular region [GO:0005576],,GO:0005576; GO:0006629; GO:0048856,extracellular region; lipid metabolic process; anatomical structure development
OG_03593,FUN_014751-T1,Peve_00039157,Pocillopora_meandrina_HIv1___RNAseq.g22448.t2,three_way,67.324,,,,,,,,,,,,,,,,,
OG_03594,FUN_014752-T1,Peve_00039159,Pocillopora_meandrina_HIv1___TS.g27211.t1c,three_way,80.13483333333333,FUN_014752-T1,Q04678,,,,,57.2,617.0,2e-173,610.9,sp|Q04678|SSRP1_CHICK FACT complex subunit SSRP1 OS=Gallus gallus OX=9031 GN=SSRP1 PE=2 SV=2,,,,,,
OG_03595,FUN_014754-T1,Peve_00039160,Pocillopora_meandrina_HIv1___RNAseq.g22445.t1,three_way,85.86266666666667,FUN_014754-T1,Q8TCT6,SPPL3_HUMAN,,Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin homologous protein 1) (PSH1) (Presenilin-like protein 4),Homo sapiens (Human),58.8,386.0,5.9e-118,425.6,sp|Q8TCT6|SPPL3_HUMAN Signal peptide peptidase-like 3 OS=Homo sapiens OX=9606 GN=SPPL3 PE=1 SV=2,GO:0005791; GO:0005794; GO:0005886; GO:0006465; GO:0007204; GO:0016020; GO:0030660; GO:0033116; GO:0033619; GO:0042500; GO:0042803; GO:0043231; GO:0050852; GO:0070886; GO:0098553; GO:0098554,membrane protein proteolysis [GO:0033619]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; signal peptide processing [GO:0006465]; T cell receptor signaling pathway [GO:0050852],cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle membrane [GO:0030660]; intracellular membrane-bounded organelle [GO:0043231]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]",GO:0002376; GO:0003824; GO:0005783; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"immune system process; catalytic activity; endoplasmic reticulum; Golgi apparatus; plasma membrane; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_03596,FUN_014755-T1,Peve_00039152,Pocillopora_meandrina_HIv1___RNAseq.g22443.t1,three_way,62.79233333333333,FUN_014755-T1,Q9CQK1,,,,,36.1,144.0,2.5e-17,90.1,sp|Q9CQK1|ZNHI3_MOUSE Zinc finger HIT domain-containing protein 3 OS=Mus musculus OX=10090 GN=Znhit3 PE=1 SV=1,,,,,,
OG_03597,FUN_014756-T1,Peve_00039153,Pocillopora_meandrina_HIv1___RNAseq.g22442.t1,three_way,67.01416666666667,FUN_014756-T1,Q07066,,,,,38.9,180.0,1.1e-35,151.4,sp|Q07066|PXMP2_RAT Peroxisomal membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Pxmp2 PE=1 SV=2,,,,,,
OG_03598,FUN_014757-T2,Peve_00039154,Pocillopora_meandrina_HIv1___RNAseq.g22441.t1,three_way,71.00266666666667,FUN_014757-T2,Q9HA64,,,,,56.0,309.0,2.2e-102,373.6,sp|Q9HA64|KT3K_HUMAN Ketosamine-3-kinase OS=Homo sapiens OX=9606 GN=FN3KRP PE=1 SV=2,,,,,,
OG_03599,FUN_014758-T1,Peve_00039156,Pocillopora_meandrina_HIv1___RNAseq.g22440.t1,three_way,60.02083333333333,,,,,,,,,,,,,,,,,
OG_03600,FUN_014764-T1,Peve_00000342,Pocillopora_meandrina_HIv1___RNAseq.g22434.t1,three_way,79.31733333333334,FUN_014764-T1,P70645,,,,,53.3,465.0,1.3e-151,537.7,sp|P70645|BLMH_RAT Bleomycin hydrolase OS=Rattus norvegicus OX=10116 GN=Blmh PE=1 SV=1,,,,,,
OG_03601,FUN_014766-T1,Peve_00000344,Pocillopora_meandrina_HIv1___RNAseq.g25733.t1,three_way,55.24966666666667,FUN_014766-T1,Q6XQG8,,,,,22.7,436.0,2.1e-18,95.1,sp|Q6XQG8|CHST7_RAT Carbohydrate sulfotransferase 7 OS=Rattus norvegicus OX=10116 GN=Chst7 PE=2 SV=1,,,,,,
OG_03602,FUN_014769-T1,Peve_00000348,Pocillopora_meandrina_HIv1___RNAseq.g22568.t1,three_way,57.41133333333333,,,,,,,,,,,,,,,,,
OG_03603,FUN_014770-T1,Peve_00014608,Pocillopora_meandrina_HIv1___RNAseq.g22567.t1,three_way,76.14166666666667,FUN_014770-T1,A2BFP5,,,,,43.0,900.0,7.000000000000001e-186,652.5,sp|A2BFP5|S12A9_DANRE Solute carrier family 12 member 9 OS=Danio rerio OX=7955 GN=slc12a9 PE=3 SV=1,,,,,,
OG_03604,FUN_014771-T1,Peve_00014607,Pocillopora_meandrina_HIv1___RNAseq.g22566.t1,three_way,79.51866666666668,FUN_014771-T1,Q8K370,,,,,57.8,1018.0,0.0,1177.2,sp|Q8K370|ACD10_MOUSE Acyl-CoA dehydrogenase family member 10 OS=Mus musculus OX=10090 GN=Acad10 PE=1 SV=1,,,,,,
OG_03605,FUN_014775-T1,Peve_00014601,Pocillopora_meandrina_HIv1___RNAseq.g22562.t1,three_way,51.923,,,,,,,,,,,,,,,,,
OG_03606,FUN_014776-T1,Peve_00014600,Pocillopora_meandrina_HIv1___RNAseq.g22561.t1,three_way,82.719,FUN_014776-T1,Q96EX2,,,,,40.1,287.0,1.4e-62,241.9,sp|Q96EX2|RNFT2_HUMAN E3 ubiquitin-protein ligase RNFT2 OS=Homo sapiens OX=9606 GN=RNFT2 PE=1 SV=2,,,,,,
OG_03607,FUN_014783-T1,Peve_00014593,Pocillopora_meandrina_HIv1___RNAseq.g22511.t1,three_way,54.09,FUN_014783-T1,B3EWZ8,,,,,39.9,158.0,6.1e-23,110.9,sp|B3EWZ8|ECT_ACRMI Ectin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_03608,FUN_014785-T2,Peve_00001849,Pocillopora_meandrina_HIv1___RNAseq.g22512.t1a,three_way,42.24616666666667,,,,,,,,,,,,,,,,,
OG_03609,FUN_014787-T1,Peve_00001877,Pocillopora_meandrina_HIv1___RNAseq.g22513.t1,three_way,64.53133333333334,,,,,,,,,,,,,,,,,
OG_03610,FUN_014789-T1,Peve_00001864,Pocillopora_meandrina_HIv1___RNAseq.g22432.t1,three_way,51.39383333333333,,,,,,,,,,,,,,,,,
OG_03611,FUN_014790-T1,Peve_00001852,Pocillopora_meandrina_HIv1___RNAseq.g22431.t1,three_way,64.38333333333333,,,,,,,,,,,,,,,,,
OG_03612,FUN_014793-T1,Peve_00015736,Pocillopora_meandrina_HIv1___RNAseq.g22428.t1,three_way,75.05016666666667,FUN_014793-T1,A1L2H9,RFA2B_XENLA,,Replication protein A 32 kDa subunit-B (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34),Xenopus laevis (African clawed frog),44.4,295.0,4e-56,219.9,sp|A1L2H9|RFA2B_XENLA Replication protein A 32 kDa subunit-B OS=Xenopus laevis OX=8355 GN=rpa2-b PE=2 SV=1,GO:0000076; GO:0000723; GO:0000724; GO:0000781; GO:0000785; GO:0003684; GO:0003697; GO:0005634; GO:0005662; GO:0006260; GO:0006284; GO:0006289; GO:0006298; GO:0016605; GO:0034502; GO:0035861; GO:0042162; GO:2000001,base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; protein localization to chromosome [GO:0034502]; regulation of DNA damage checkpoint [GO:2000001]; telomere maintenance [GO:0000723],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication factor A complex [GO:0005662]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]",damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0032200; GO:0043226,DNA binding; nucleus; DNA replication; DNA repair; DNA recombination; telomere organization; organelle
OG_03613,FUN_014794-T1,Peve_00026741,Pocillopora_meandrina_HIv1___RNAseq.g22427.t1,three_way,80.99583333333334,,,,,,,,,,,,,,,,,
OG_03614,FUN_014796-T1,Peve_00026742,Pocillopora_meandrina_HIv1___RNAseq.g22420.t1,three_way,83.09333333333333,FUN_014796-T1,Q8CFG5,CA2D3_RAT,,Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3],Rattus norvegicus (Rat),26.6,632.0,1.9e-50,203.0,sp|Q8CFG5|CA2D3_RAT Voltage-dependent calcium channel subunit alpha-2/delta-3 OS=Rattus norvegicus OX=10116 GN=Cacna2d3 PE=1 SV=1,GO:0005245; GO:0005246; GO:0005891; GO:0006816; GO:0046872; GO:0048787; GO:0098982; GO:0099174; GO:1990314,calcium ion transport [GO:0006816]; cellular response to insulin-like growth factor stimulus [GO:1990314]; regulation of presynapse organization [GO:0099174],GABA-ergic synapse [GO:0098982]; presynaptic active zone membrane [GO:0048787]; voltage-gated calcium channel complex [GO:0005891],calcium channel regulator activity [GO:0005246]; metal ion binding [GO:0046872]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0098772,transporter activity; molecular function regulator activity
OG_03615,FUN_014797-T1,Peve_00030148,Pocillopora_meandrina_HIv1___RNAseq.g22417.t1,three_way,47.177,FUN_014797-T1,P62597,,,,,33.1,302.0,2.9e-37,158.7,sp|P62597|POTE1_CHICK Protection of telomeres protein 1 OS=Gallus gallus OX=9031 GN=POT1 PE=1 SV=1,,,,,,
OG_03616,FUN_014798-T1,Peve_00028870,Pocillopora_meandrina_HIv1___RNAseq.g22416.t1,three_way,83.49866666666667,FUN_014798-T1,O00560,SDCB1_HUMAN,,Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1),Homo sapiens (Human),53.2,301.0,5.7e-84,312.4,sp|O00560|SDCB1_HUMAN Syntenin-1 OS=Homo sapiens OX=9606 GN=SDCBP PE=1 SV=1,GO:0000122; GO:0002091; GO:0005109; GO:0005137; GO:0005546; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0005895; GO:0005912; GO:0005925; GO:0006612; GO:0006930; GO:0007265; GO:0007268; GO:0007346; GO:0008093; GO:0008284; GO:0010718; GO:0016020; GO:0030036; GO:0030307; GO:0030335; GO:0030511; GO:0031965; GO:0035556; GO:0035578; GO:0042327; GO:0042470; GO:0042802; GO:0045121; GO:0045202; GO:0045545; GO:0046330; GO:0046982; GO:0070062; GO:0072562; GO:0140311; GO:1903543; GO:1903553; GO:1903561,"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]",adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],"cytoskeletal anchor activity [GO:0008093]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; syndecan binding [GO:0045545]",GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0007010; GO:0008289; GO:0023052; GO:0031410; GO:0043226; GO:0060090; GO:0140313,extracellular region; extracellular space; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; lipid binding; signaling; cytoplasmic vesicle; organelle; molecular adaptor activity; molecular sequestering activity
OG_03617,FUN_014799-T1,Peve_00010345,Pocillopora_meandrina_HIv1___RNAseq.g22415.t1,three_way,94.784,FUN_014799-T1,A7RWP6,EIF3E_NEMVE,,Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6),Nematostella vectensis (Starlet sea anemone),85.1,450.0,2.8e-220,766.9,sp|A7RWP6|EIF3E_NEMVE Eukaryotic translation initiation factor 3 subunit E OS=Nematostella vectensis OX=45351 GN=v1g163572 PE=3 SV=1,GO:0001732; GO:0003743; GO:0005634; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0071540,formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; nucleus [GO:0005634]",translation initiation factor activity [GO:0003743],GO:0005634; GO:0043226; GO:0065003,nucleus; organelle; protein-containing complex assembly
OG_03618,FUN_014803-T1,Peve_00010343,Pocillopora_meandrina_HIv1___RNAseq.g22413.t1,three_way,74.0495,FUN_014803-T1,Q3UQ28,PXDN_MOUSE,,Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Mus musculus (Mouse),52.2,1478.0,0.0,1216.8,sp|Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus musculus OX=10090 GN=Pxdn PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0003824; GO:0005198; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003,catalytic activity; structural molecule activity; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly
OG_03619,FUN_014805-T1,Peve_00010342,Pocillopora_meandrina_HIv1___RNAseq.g22412.t1,three_way,59.00483333333333,,,,,,,,,,,,,,,,,
OG_03620,FUN_014806-T1,Peve_00010347,Pocillopora_meandrina_HIv1___RNAseq.g22410.t1,three_way,77.63433333333333,FUN_014806-T1,Q2YDR3,,,,,46.2,346.0,1.7e-76,287.7,sp|Q2YDR3|IMPA3_DANRE Inositol monophosphatase 3 OS=Danio rerio OX=7955 GN=bpnt2 PE=2 SV=1,,,,,,
OG_03621,FUN_014808-T1,Peve_00023295,Pocillopora_meandrina_HIv1___RNAseq.g22408.t1,three_way,88.98733333333334,FUN_014808-T1,Q86YT6,MIB1_HUMAN,,E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2),Homo sapiens (Human),73.7,1031.0,0.0,1109.7,sp|Q86YT6|MIB1_HUMAN E3 ubiquitin-protein ligase MIB1 OS=Homo sapiens OX=9606 GN=MIB1 PE=1 SV=1,GO:0001568; GO:0001701; GO:0001756; GO:0001841; GO:0001947; GO:0004842; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006897; GO:0007219; GO:0008270; GO:0014069; GO:0016567; GO:0021953; GO:0031410; GO:0034451; GO:0045665; GO:0045807; GO:0061630; GO:0098978,blood vessel development [GO:0001568]; central nervous system neuron differentiation [GO:0021953]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756]; ubiquitin-dependent protein catabolic process [GO:0006511],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0005886; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; plasma membrane; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03622,FUN_014809-T1,Peve_00023296,Pocillopora_meandrina_HIv1___RNAseq.g22406.t1,three_way,73.80983333333333,FUN_014809-T1,Q3LFU0,CP1A1_BALAC,,Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),Balaenoptera acutorostrata (Common minke whale) (Balaena rostrata),33.7,486.0,1.4e-69,265.8,sp|Q3LFU0|CP1A1_BALAC Cytochrome P450 1A1 OS=Balaenoptera acutorostrata OX=9767 GN=CYP1A1 PE=2 SV=1,GO:0004508; GO:0005506; GO:0005743; GO:0005789; GO:0006631; GO:0006694; GO:0008210; GO:0020037; GO:0030544; GO:0042446; GO:0042448; GO:0042572; GO:0051879; GO:0101020; GO:0101021; GO:0106256,estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694],endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743],estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_03623,FUN_014810-T1,Peve_00022206,Pocillopora_meandrina_HIv1___RNAseq.g22405.t1,three_way,74.15333333333334,FUN_014810-T1,Q9NXZ2,,,,,46.8,577.0,2.1e-146,521.2,sp|Q9NXZ2|DDX43_HUMAN Probable ATP-dependent RNA helicase DDX43 OS=Homo sapiens OX=9606 GN=DDX43 PE=1 SV=2,,,,,,
OG_03624,FUN_014812-T1,Peve_00022208,Pocillopora_meandrina_HIv1___RNAseq.g22403.t1,three_way,61.155,,,,,,,,,,,,,,,,,
OG_03625,FUN_014814-T1,Peve_00038796,Pocillopora_meandrina_HIv1___RNAseq.g22400.t1,three_way,65.43366666666667,FUN_014814-T1,Q08CA1,,,,,37.2,341.0,9.999999999999999e-51,202.2,sp|Q08CA1|GDPP1_DANRE GDP-D-glucose phosphorylase 1 OS=Danio rerio OX=7955 GN=gdpgp1 PE=2 SV=1,,,,,,
OG_03626,FUN_014816-T1,Peve_00038835,Pocillopora_meandrina_HIv1___RNAseq.g22398.t1,three_way,68.18233333333333,FUN_014816-T1,B3EWZ5,,,,,29.2,813.0,6.300000000000001e-73,277.3,sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_03626,FUN_014816-T1,Peve_00038835,Pocillopora_meandrina_HIv1___RNAseq.g22398.t1,three_way,68.18233333333333,FUN_014816-T1,B3EWZ5,,,,,36.7,354.0,2.1e-60,235.7,sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_03627,FUN_014818-T1,Peve_00038833,Pocillopora_meandrina_HIv1___RNAseq.g22396.t1,three_way,36.711666666666666,,,,,,,,,,,,,,,,,
OG_03628,FUN_014844-T1,Peve_00038815,Pocillopora_meandrina_HIv1___RNAseq.g22389.t1,three_way,69.21433333333333,FUN_014844-T1,C0HL13,LRP2_PIG,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Sus scrofa (Pig),31.5,305.0,4.3e-34,149.8,sp|C0HL13|LRP2_PIG Low-density lipoprotein receptor-related protein 2 OS=Sus scrofa OX=9823 GN=LRP2 PE=1 SV=1,GO:0001843; GO:0003139; GO:0003148; GO:0003223; GO:0005509; GO:0005905; GO:0006898; GO:0007605; GO:0008584; GO:0009897; GO:0016324; GO:0017124; GO:0030001; GO:0030424; GO:0030425; GO:0030514; GO:0031526; GO:0031904; GO:0043235; GO:0050769; GO:0051087; GO:0060068; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1905167,coronary artery morphogenesis [GO:0060982]; folate import across plasma membrane [GO:1904447]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223],apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0016192; GO:0022414; GO:0048856; GO:0050877; GO:0055085,vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process; transmembrane transport
OG_03629,FUN_014846-T1,Peve_00038813,Pocillopora_meandrina_HIv1___RNAseq.g22386.t2,three_way,83.38516666666666,FUN_014846-T1,P97526,NF1_RAT,,Neurofibromin (Neurofibromatosis-related protein NF-1),Rattus norvegicus (Rat),46.1,2783.0,0.0,2161.0,sp|P97526|NF1_RAT Neurofibromin OS=Rattus norvegicus OX=10116 GN=Nf1 PE=1 SV=1,GO:0000165; GO:0001525; GO:0001649; GO:0001656; GO:0001666; GO:0001889; GO:0001935; GO:0001937; GO:0001938; GO:0001952; GO:0001953; GO:0002686; GO:0005096; GO:0005634; GO:0005730; GO:0005737; GO:0005886; GO:0006606; GO:0006915; GO:0007154; GO:0007265; GO:0007269; GO:0007405; GO:0007406; GO:0007420; GO:0007422; GO:0007507; GO:0007519; GO:0008017; GO:0008283; GO:0008285; GO:0008429; GO:0008542; GO:0008625; GO:0010468; GO:0010626; GO:0010976; GO:0014009; GO:0014010; GO:0014037; GO:0014044; GO:0016477; GO:0016525; GO:0016601; GO:0021510; GO:0021764; GO:0021897; GO:0021915; GO:0021987; GO:0022011; GO:0030036; GO:0030198; GO:0030199; GO:0030316; GO:0030325; GO:0030336; GO:0030424; GO:0030425; GO:0031210; GO:0032228; GO:0032991; GO:0033024; GO:0033027; GO:0033028; GO:0033034; GO:0034605; GO:0035021; GO:0036135; GO:0042060; GO:0042127; GO:0042308; GO:0043065; GO:0043408; GO:0043409; GO:0043473; GO:0043491; GO:0043525; GO:0043535; GO:0043547; GO:0045124; GO:0045545; GO:0045664; GO:0045671; GO:0045685; GO:0045765; GO:0046580; GO:0046929; GO:0048144; GO:0048147; GO:0048169; GO:0048485; GO:0048593; GO:0048708; GO:0048709; GO:0048712; GO:0048715; GO:0048745; GO:0048820; GO:0048844; GO:0048853; GO:0050890; GO:0051402; GO:0060253; GO:0060291; GO:0061534; GO:0061535; GO:0070372; GO:0070662; GO:0070667; GO:0071549; GO:0071887; GO:0072089; GO:0097192; GO:0097529; GO:0098597; GO:0098793; GO:0098926; GO:0098978; GO:0099159; GO:0099175; GO:1900148; GO:1900271; GO:1904707; GO:1904738; GO:1904753; GO:1990090; GO:1990874; GO:2000108; GO:2000647; GO:2001241,"actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; amygdala development [GO:0021764]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; astrocyte differentiation [GO:0048708]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; cognition [GO:0050890]; collagen fibril organization [GO:0030199]; endothelial cell proliferation [GO:0001935]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fibroblast proliferation [GO:0048144]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; gamma-aminobutyric acid secretion, neurotransmission [GO:0061534]; glial cell proliferation [GO:0014009]; glutamate secretion, neurotransmission [GO:0061535]; hair follicle maturation [GO:0048820]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; liver development [GO:0001889]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; mast cell apoptotic process [GO:0033024]; mast cell proliferation [GO:0070662]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; myeloid cell apoptotic process [GO:0033028]; myeloid leukocyte migration [GO:0097529]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell proliferation [GO:0070667]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of Schwann cell migration [GO:1900148]; negative regulation of Schwann cell proliferation [GO:0010626]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; neural tube development [GO:0021915]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; neurotransmitter secretion [GO:0007269]; observational learning [GO:0098597]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; pigmentation [GO:0043473]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte apoptotic process [GO:2000108]; positive regulation of mast cell apoptotic process [GO:0033027]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; postsynaptic signal transduction [GO:0098926]; protein import into nucleus [GO:0006606]; Rac protein signal transduction [GO:0016601]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of bone resorption [GO:0045124]; regulation of cell population proliferation [GO:0042127]; regulation of cell-matrix adhesion [GO:0001952]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of gene expression [GO:0010468]; regulation of glial cell differentiation [GO:0045685]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of MAPK cascade [GO:0043408]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron differentiation [GO:0045664]; regulation of postsynapse organization [GO:0099175]; regulation of synaptic transmission, GABAergic [GO:0032228]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; Schwann cell migration [GO:0036135]; Schwann cell proliferation [GO:0014010]; skeletal muscle tissue development [GO:0007519]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; stem cell proliferation [GO:0072089]; sympathetic nervous system development [GO:0048485]; vascular associated smooth muscle cell migration [GO:1904738]; vascular associated smooth muscle cell proliferation [GO:1990874]; visual learning [GO:0008542]; wound healing [GO:0042060]",axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein-containing complex [GO:0032991],GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545],GO:0002376; GO:0005634; GO:0005730; GO:0005886; GO:0006886; GO:0006913; GO:0007010; GO:0008092; GO:0008289; GO:0012501; GO:0030154; GO:0030198; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0098772,immune system process; nucleus; nucleolus; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; cytoskeletal protein binding; lipid binding; programmed cell death; cell differentiation; extracellular matrix organization; wound healing; organelle; anatomical structure development; cell motility; nervous system process; molecular function regulator activity
OG_03630,FUN_014847-T1,Peve_00038811,Pocillopora_meandrina_HIv1___RNAseq.g22384.t1,three_way,66.74766666666666,,,,,,,,,,,,,,,,,
OG_03631,FUN_014848-T1,Peve_00038810,Pocillopora_meandrina_HIv1___RNAseq.g22383.t1,three_way,69.762,FUN_014848-T1,Q9SJM7,URH1_ARATH,,Uridine nucleosidase 1 (EC 3.2.2.3) (Adenosine nucleosidase) (EC 3.2.2.7) (Inosine nucleosidase) (EC 3.2.2.2) (Nucleoside hydrolase 1) (Uridine ribohydrolase 1) (Xanthosine nucleosidase) (EC 3.2.2.-),Arabidopsis thaliana (Mouse-ear cress),34.5,287.0,1.8e-32,141.4,sp|Q9SJM7|URH1_ARATH Uridine nucleosidase 1 OS=Arabidopsis thaliana OX=3702 GN=URH1 PE=1 SV=2,GO:0005829; GO:0006152; GO:0006218; GO:0042802; GO:0042803; GO:0045437; GO:0046982; GO:0047622; GO:0047724; GO:0072585,purine nucleoside catabolic process [GO:0006152]; uridine catabolic process [GO:0006218],cytosol [GO:0005829],adenosine nucleosidase activity [GO:0047622]; identical protein binding [GO:0042802]; inosine nucleosidase activity [GO:0047724]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; uridine nucleosidase activity [GO:0045437]; xanthosine nucleotidase activity [GO:0072585],GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03632,FUN_014849-T1,Peve_00038808,Pocillopora_meandrina_HIv1___RNAseq.g22382.t1,three_way,61.39833333333333,FUN_014849-T1,P34147,,,,,38.3,459.0,2e-83,311.2,sp|P34147|RACA_DICDI Rho-related protein racA OS=Dictyostelium discoideum OX=44689 GN=racA PE=1 SV=2,,,,,,
OG_03633,FUN_014852-T1,Peve_00038812,Pocillopora_meandrina_HIv1___RNAseq.g22380.t1b,three_way,70.72466666666666,FUN_014852-T1,Q9BW91,NUDT9_HUMAN,,"ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)",Homo sapiens (Human),52.1,317.0,2.1e-89,330.5,"sp|Q9BW91|NUDT9_HUMAN ADP-ribose pyrophosphatase, mitochondrial OS=Homo sapiens OX=9606 GN=NUDT9 PE=1 SV=1",GO:0005739; GO:0005759; GO:0005829; GO:0016604; GO:0019144; GO:0030054; GO:0031965; GO:0046032; GO:0047631; GO:0055086; GO:0070062,ADP catabolic process [GO:0046032]; nucleobase-containing small molecule metabolic process [GO:0055086],cell junction [GO:0030054]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965],ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144],GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03634,FUN_014854-T1,Peve_00038807,Pocillopora_meandrina_HIv1___TS.g27144.t2,three_way,77.016,FUN_014854-T1,Q99MP8,BRAP_MOUSE,,BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING-type E3 ubiquitin transferase BRAP2),Mus musculus (Mouse),45.8,594.0,5.2e-139,496.1,sp|Q99MP8|BRAP_MOUSE BRCA1-associated protein OS=Mus musculus OX=10090 GN=Brap PE=1 SV=1,GO:0000151; GO:0000165; GO:0003676; GO:0005654; GO:0005737; GO:0005829; GO:0007265; GO:0008139; GO:0008270; GO:0009968; GO:0016567; GO:0031965; GO:0042802; GO:0061630,MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151],identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_03635,FUN_014855-T1,Peve_00038800,Pocillopora_meandrina_HIv1___RNAseq.g22371.t1,three_way,96.05733333333332,FUN_014855-T1,Q6P2Q9,PRP8_HUMAN,,Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220),Homo sapiens (Human),92.1,2321.0,0.0,4492.2,sp|Q6P2Q9|PRP8_HUMAN Pre-mRNA-processing-splicing factor 8 OS=Homo sapiens OX=9606 GN=PRPF8 PE=1 SV=2,GO:0000244; GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005682; GO:0006397; GO:0008380; GO:0016020; GO:0016607; GO:0017070; GO:0030619; GO:0030620; GO:0030623; GO:0046540; GO:0070530; GO:0071005; GO:0071006; GO:0071007; GO:0071013; GO:0071222; GO:0071356; GO:0097157,"cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_03636,FUN_014856-T1,Peve_00024574,Pocillopora_meandrina_HIv1___RNAseq.g22372.t1,three_way,92.46416666666669,FUN_014856-T1,A7SXK3,TMED_NEMVE,,Transmembrane emp24 domain-containing protein,Nematostella vectensis (Starlet sea anemone),81.3,203.0,3.6e-90,332.4,sp|A7SXK3|TMED_NEMVE Transmembrane emp24 domain-containing protein OS=Nematostella vectensis OX=45351 GN=v1g194562 PE=3 SV=1,GO:0005783; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0030134; GO:0030659,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794],,GO:0005783; GO:0005794; GO:0006886; GO:0016192; GO:0031410; GO:0043226,endoplasmic reticulum; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_03637,FUN_014857-T2,Peve_00024575,Pocillopora_meandrina_HIv1___RNAseq.1529_t,three_way,61.16066666666666,FUN_014857-T2,Q9CQL5,,,,,39.0,136.0,5.1e-20,99.8,sp|Q9CQL5|RM18_MOUSE Large ribosomal subunit protein uL18m OS=Mus musculus OX=10090 GN=Mrpl18 PE=1 SV=1,,,,,,
OG_03638,FUN_014858-T1,Peve_00024576,Pocillopora_meandrina_HIv1___RNAseq.g22374.t1,three_way,82.99766666666666,FUN_014858-T1,Q7ZXK9,,,,,61.6,352.0,1.5e-96,354.8,sp|Q7ZXK9|NLE1_XENLA Notchless protein homolog 1 OS=Xenopus laevis OX=8355 GN=nle1 PE=2 SV=1,,,,,,
OG_03639,FUN_014861-T1,Peve_00016000,Pocillopora_meandrina_HIv1___RNAseq.g22368.t1,three_way,62.06,FUN_014861-T1,Q69ZM6,STK36_MOUSE,,Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog),Mus musculus (Mouse),25.5,1026.0,5.9e-57,224.6,sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus OX=10090 GN=Stk36 PE=1 SV=3,GO:0001222; GO:0003351; GO:0004674; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007224; GO:0007420; GO:0009791; GO:0035082; GO:0042995; GO:0045880; GO:0046872; GO:0051090; GO:0060271; GO:0106310,axoneme assembly [GO:0035082]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090]; smoothened signaling pathway [GO:0007224],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transcription corepressor binding [GO:0001222],GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005856; GO:0006355; GO:0007010; GO:0007018; GO:0016740; GO:0043226; GO:0044782; GO:0048856; GO:0140096,"catalytic activity; extracellular region; nucleus; cytosol; cytoskeleton; regulation of DNA-templated transcription; cytoskeleton organization; microtubule-based movement; transferase activity; organelle; cilium organization; anatomical structure development; catalytic activity, acting on a protein"
OG_03640,FUN_014864-T1,Peve_00016002,Pocillopora_meandrina_HIv1___RNAseq.g22366.t1,three_way,81.65433333333333,FUN_014864-T1,P81628,,,,,47.1,204.0,3.0999999999999995e-43,176.8,sp|P81628|ERP29_CHICK Endoplasmic reticulum resident protein 29 (Fragment) OS=Gallus gallus OX=9031 GN=ERP29 PE=1 SV=2,,,,,,
OG_03641,FUN_014865-T2,Peve_00016003,Pocillopora_meandrina_HIv1___RNAseq.g22367.t1,three_way,77.8655,FUN_014865-T2,Q3SZR8,SRSF3_BOVIN,,"Serine/arginine-rich splicing factor 3 (Splicing factor, arginine/serine-rich 3)",Bos taurus (Bovine),69.0,71.0,1.6000000000000002e-22,107.1,sp|Q3SZR8|SRSF3_BOVIN Serine/arginine-rich splicing factor 3 OS=Bos taurus OX=9913 GN=SRSF3 PE=2 SV=1,GO:0003723; GO:0003729; GO:0005737; GO:0006406; GO:0016607; GO:0045292; GO:0048024; GO:0160134,"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; regulation of mRNA splicing, via spliceosome [GO:0048024]",cytoplasm [GO:0005737]; nuclear speck [GO:0016607],mRNA binding [GO:0003729]; protein-RNA sequence-specific adaptor activity [GO:0160134]; RNA binding [GO:0003723],GO:0003723; GO:0006913; GO:0016071; GO:0043226; GO:0060090,RNA binding; nucleocytoplasmic transport; mRNA metabolic process; organelle; molecular adaptor activity
OG_03642,FUN_014868-T1,Peve_00012983,Pocillopora_meandrina_HIv1___RNAseq.g21041.t1,three_way,63.503,,,,,,,,,,,,,,,,,
OG_03643,FUN_014871-T1,Peve_00012980,Pocillopora_meandrina_HIv1___RNAseq.g21043.t2a,three_way,72.989,FUN_014871-T1,Q05B54,,,,,27.7,213.0,3.2e-12,73.6,sp|Q05B54|TM134_BOVIN Transmembrane protein 134 OS=Bos taurus OX=9913 GN=TMEM134 PE=2 SV=2,,,,,,
OG_03644,FUN_014875-T1,Peve_00012982,Pocillopora_meandrina_HIv1___RNAseq.g21044.t1,three_way,69.73266666666667,,,,,,,,,,,,,,,,,
OG_03645,FUN_014876-T1,Peve_00013646,Pocillopora_meandrina_HIv1___RNAseq.g21045.t1,three_way,76.93633333333334,FUN_014876-T1,P22061,PIMT_HUMAN,,Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase),Homo sapiens (Human),60.5,223.0,5.6e-76,285.4,sp|P22061|PIMT_HUMAN Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Homo sapiens OX=9606 GN=PCMT1 PE=1 SV=4,GO:0004719; GO:0005737; GO:0005829; GO:0006479; GO:0030091; GO:0045296; GO:0070062; GO:1903561,protein methylation [GO:0006479]; protein repair [GO:0030091],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561],cadherin binding [GO:0045296]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719],GO:0003824; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03646,FUN_014877-T1,Peve_00013644,Pocillopora_meandrina_HIv1___RNAseq.g21046.t1,three_way,63.173,,,,,,,,,,,,,,,,,
OG_03647,FUN_014879-T1,Peve_00013641,Pocillopora_meandrina_HIv1___RNAseq.g21048.t1,three_way,70.70233333333334,FUN_014879-T1,Q8LAD0,PDX2_ARATH,,Probable pyridoxal 5'-phosphate synthase subunit PDX2 (AtPDX2) (EC 4.3.3.6) (Protein EMBRYO DEFECTIVE 2407) (Pyridoxal 5'-phosphate synthase glutaminase subunit) (EC 3.5.1.2),Arabidopsis thaliana (Mouse-ear cress),40.9,247.0,4.4e-42,172.9,sp|Q8LAD0|PDX2_ARATH Probable pyridoxal 5'-phosphate synthase subunit PDX2 OS=Arabidopsis thaliana OX=3702 GN=PDX2 PE=1 SV=1,GO:0004359; GO:0005829; GO:0036381; GO:0042819; GO:0042823; GO:0046982,pyridoxal phosphate biosynthetic process [GO:0042823]; vitamin B6 biosynthetic process [GO:0042819],cytosol [GO:0005829],glutaminase activity [GO:0004359]; protein heterodimerization activity [GO:0046982]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381],GO:0003824; GO:0005829; GO:0006766; GO:0016787; GO:0016829,catalytic activity; cytosol; vitamin metabolic process; hydrolase activity; lyase activity
OG_03648,FUN_014880-T1,Peve_00013648,Pocillopora_meandrina_HIv1___RNAseq.g21049.t1,three_way,87.48833333333333,FUN_014880-T1,Q8WPW2,,,,,74.9,275.0,5.2e-112,405.6,sp|Q8WPW2|PDX1_SUBDO Pyridoxal 5'-phosphate synthase subunit SNZERR OS=Suberites domuncula OX=55567 GN=SNZERR PE=2 SV=2,,,,,,
OG_03649,FUN_014881-T1,Peve_00013647,Pocillopora_meandrina_HIv1___RNAseq.g21050.t1,three_way,51.534666666666666,FUN_014881-T1,P97864,CASP7_MOUSE,,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],Mus musculus (Mouse),34.0,256.0,4.0000000000000003e-29,130.6,sp|P97864|CASP7_MOUSE Caspase-7 OS=Mus musculus OX=10090 GN=Casp7 PE=1 SV=2,GO:0001650; GO:0003723; GO:0004190; GO:0004197; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007507; GO:0009411; GO:0016485; GO:0030163; GO:0042742; GO:0044346; GO:0051146; GO:0051402; GO:0051604; GO:0070227; GO:0071222; GO:0072734; GO:0097194; GO:1905686,cellular response to lipopolysaccharide [GO:0071222]; cellular response to staurosporine [GO:0072734]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; fibroblast apoptotic process [GO:0044346]; heart development [GO:0007507]; lymphocyte apoptotic process [GO:0070227]; neuron apoptotic process [GO:0051402]; positive regulation of plasma membrane repair [GO:1905686]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0012501; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"RNA binding; catalytic activity; extracellular space; nucleus; nucleoplasm; cytosol; plasma membrane; programmed cell death; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_03650,FUN_014882-T1,Peve_00013645,Pocillopora_meandrina_HIv1___RNAseq.g21054.t1,three_way,56.43533333333333,FUN_014882-T1,Q5SSG4,GA2L2_MOUSE,,GAS2-like protein 2 (Growth arrest-specific protein 2-like 2),Mus musculus (Mouse),35.9,473.0,1.6999999999999998e-53,213.0,sp|Q5SSG4|GA2L2_MOUSE GAS2-like protein 2 OS=Mus musculus OX=10090 GN=Gas2l2 PE=1 SV=1,GO:0001578; GO:0001725; GO:0001965; GO:0005737; GO:0005884; GO:0005886; GO:0007026; GO:0008017; GO:0008093; GO:0035371; GO:0036064; GO:0045745; GO:0051015; GO:0060296; GO:1904825,microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; protein localization to microtubule plus-end [GO:1904825]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; plasma membrane [GO:0005886]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; cytoskeletal anchor activity [GO:0008093]; G-protein alpha-subunit binding [GO:0001965]; microtubule binding [GO:0008017],GO:0005815; GO:0005886; GO:0007010; GO:0008092; GO:0060090,microtubule organizing center; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; molecular adaptor activity
OG_03651,FUN_014883-T1,Peve_00032212,Pocillopora_meandrina_HIv1___RNAseq.g21057.t1,three_way,86.76933333333334,FUN_014883-T1,A1L0Y5,,,,,78.5,288.0,2.8e-130,466.5,sp|A1L0Y5|SEP2B_XENTR Septin-2B OS=Xenopus tropicalis OX=8364 GN=sept2-B PE=2 SV=1,,,,,,
OG_03652,FUN_014885-T1,Peve_00003527,Pocillopora_meandrina_HIv1___TS.g25809.t1,three_way,62.263,,,,,,,,,,,,,,,,,
OG_03653,FUN_014886-T1,Peve_00003525,Pocillopora_meandrina_HIv1___RNAseq.g21061.t1,three_way,63.435833333333335,FUN_014886-T1,P53668,LIMK1_MOUSE,,LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (KIZ-1),Mus musculus (Mouse),37.8,521.0,1.1e-85,318.9,sp|P53668|LIMK1_MOUSE LIM domain kinase 1 OS=Mus musculus OX=10090 GN=Limk1 PE=1 SV=1,GO:0001673; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0016020; GO:0016607; GO:0030027; GO:0031072; GO:0031625; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051496; GO:0098794; GO:0098978; GO:0106310; GO:1990948,axon extension [GO:0048675]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; stress fiber assembly [GO:0043149],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794],ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03654,FUN_014890-T1,Peve_00003524,Pocillopora_meandrina_HIv1___RNAseq.g21063.t1,three_way,80.91116666666667,FUN_014890-T1,Q9BT92,TCHP_HUMAN,,Trichoplein keratin filament-binding protein (Protein TCHP) (Mitochondrial protein with oncostatic activity) (Mitostatin) (Tumor suppressor protein),Homo sapiens (Human),54.1,135.0,7.5e-30,132.5,sp|Q9BT92|TCHP_HUMAN Trichoplein keratin filament-binding protein OS=Homo sapiens OX=9606 GN=TCHP PE=1 SV=1,GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0006915; GO:0030030; GO:0030057; GO:0030308; GO:0031965; GO:0036064; GO:0045095; GO:0045179; GO:1902018,apoptotic process [GO:0006915]; cell projection organization [GO:0030030]; negative regulation of cell growth [GO:0030308]; negative regulation of cilium assembly [GO:1902018],apical cortex [GO:0045179]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],,GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0012501; GO:0043226,mitochondrion; microtubule organizing center; cytosol; plasma membrane; cilium; programmed cell death; organelle
OG_03655,FUN_014891-T1,Peve_00003550,Pocillopora_meandrina_HIv1___RNAseq.g21064.t1,three_way,52.26566666666667,,,,,,,,,,,,,,,,,
OG_03656,FUN_014892-T1,Peve_00003549,Pocillopora_meandrina_HIv1___RNAseq.g21108.t1,three_way,89.12416666666667,FUN_014892-T1,Q96AX1,VP33A_HUMAN,,Vacuolar protein sorting-associated protein 33A (hVPS33A),Homo sapiens (Human),56.3,606.0,8.2e-186,651.7,sp|Q96AX1|VP33A_HUMAN Vacuolar protein sorting-associated protein 33A OS=Homo sapiens OX=9606 GN=VPS33A PE=1 SV=1,GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0010008; GO:0016192; GO:0030136; GO:0030220; GO:0030897; GO:0031902; GO:0032400; GO:0032418; GO:0033263; GO:0034058; GO:0035542; GO:0035751; GO:0048070; GO:0048471; GO:0097352,autophagosome maturation [GO:0097352]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; melanosome localization [GO:0032400]; platelet formation [GO:0030220]; regulation of developmental pigmentation [GO:0048070]; regulation of lysosomal lumen pH [GO:0035751]; regulation of SNARE complex assembly [GO:0035542]; vesicle-mediated transport [GO:0016192],autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],,GO:0005764; GO:0005768; GO:0005773; GO:0006886; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0061024,lysosome; endosome; vacuole; intracellular protein transport; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; membrane organization
OG_03657,FUN_014893-T1,Peve_00003548,Pocillopora_meandrina_HIv1___RNAseq.g21106.t1,three_way,54.15466666666666,,,,,,,,,,,,,,,,,
OG_03658,FUN_014895-T1,Peve_00003547,Pocillopora_meandrina_HIv1___RNAseq.g21105.t1,three_way,67.7525,FUN_014895-T1,Q0VH32,,,,,50.8,122.0,6.399999999999998e-25,116.3,sp|Q0VH32|MNT_XENLA Max-binding protein MNT OS=Xenopus laevis OX=8355 GN=mnt PE=2 SV=1,,,,,,
OG_03659,FUN_014896-T1,Peve_00003546,Pocillopora_meandrina_HIv1___RNAseq.g21104.t1,three_way,65.60683333333333,FUN_014896-T1,Q69ZX6,MOR2A_MOUSE,,ATPase MORC2A (EC 3.6.1.-) (MORC family CW-type zinc finger protein 2A) (Zinc finger CW-type coiled-coil domain protein 1),Mus musculus (Mouse),41.3,920.0,5.7999999999999996e-151,536.6,sp|Q69ZX6|MOR2A_MOUSE ATPase MORC2A OS=Mus musculus OX=10090 GN=Morc2a PE=1 SV=2,GO:0000287; GO:0000792; GO:0003682; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006338; GO:0006974; GO:0008270; GO:0016363; GO:0016887; GO:0042393; GO:0042803; GO:0140719; GO:0141005,chromatin remodeling [GO:0006338]; constitutive heterochromatin formation [GO:0140719]; DNA damage response [GO:0006974]; transposable element silencing by heterochromatin formation [GO:0141005],cytoplasm [GO:0005737]; cytosol [GO:0005829]; heterochromatin [GO:0000792]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0016787; GO:0042393; GO:0043226,catalytic activity; nucleus; cytosol; chromatin organization; hydrolase activity; histone binding; organelle
OG_03660,FUN_014897-T1,Peve_00003545,Pocillopora_meandrina_HIv1___RNAseq.g21065.t1,three_way,70.15983333333334,FUN_014897-T1,Q9Y4D8,,,,,34.5,4127.0,0.0,2025.4,sp|Q9Y4D8|HECD4_HUMAN Probable E3 ubiquitin-protein ligase HECTD4 OS=Homo sapiens OX=9606 GN=HECTD4 PE=1 SV=5,,,,,,
OG_03661,FUN_014899-T1,Peve_00003543,Pocillopora_meandrina_HIv1___RNAseq.g21066.t1,three_way,81.57033333333334,FUN_014899-T1,Q13889,TF2H3_HUMAN,,General transcription factor IIH subunit 3 (Basic transcription factor 2 34 kDa subunit) (BTF2 p34) (General transcription factor IIH polypeptide 3) (TFIIH basal transcription factor complex p34 subunit),Homo sapiens (Human),51.8,311.0,1.6e-84,314.3,sp|Q13889|TF2H3_HUMAN General transcription factor IIH subunit 3 OS=Homo sapiens OX=9606 GN=GTF2H3 PE=1 SV=2,GO:0000438; GO:0000439; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006289; GO:0006355; GO:0006366; GO:0008270; GO:0016251; GO:0097550,DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; regulation of DNA-templated transcription [GO:0006355]; transcription by RNA polymerase II [GO:0006366],core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550],RNA polymerase II general transcription initiation factor activity [GO:0016251]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0043226; GO:0140223,nucleus; nucleoplasm; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_03662,FUN_014900-T1,Peve_00003542,Pocillopora_meandrina_HIv1___RNAseq.g21067.t1,three_way,61.59133333333333,FUN_014900-T1,Q9WVS8,,,,,64.2,355.0,5.7e-129,463.8,sp|Q9WVS8|MK07_MOUSE Mitogen-activated protein kinase 7 OS=Mus musculus OX=10090 GN=Mapk7 PE=1 SV=1,,,,,,
OG_03663,FUN_014902-T1,Peve_00003541,Pocillopora_meandrina_HIv1___RNAseq.g21068.t1,three_way,76.1935,FUN_014902-T1,Q6TEK8,VKORL_TAKRU,,Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4),Takifugu rubripes (Japanese pufferfish) (Fugu rubripes),50.0,150.0,1.2e-35,151.0,sp|Q6TEK8|VKORL_TAKRU Vitamin K epoxide reductase complex subunit 1-like protein 1 OS=Takifugu rubripes OX=31033 GN=vkorc1l1 PE=1 SV=1,GO:0005789; GO:0042373; GO:0047057; GO:0048038,vitamin K metabolic process [GO:0042373],endoplasmic reticulum membrane [GO:0005789],quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_03664,FUN_014903-T1,Peve_00003540,Pocillopora_meandrina_HIv1___RNAseq.g21069.t1,three_way,57.27183333333333,,,,,,,,,,,,,,,,,
OG_03665,FUN_014904-T1,Peve_00003539,Pocillopora_meandrina_HIv1___RNAseq.g21070.t2,three_way,68.95866666666666,FUN_014904-T1,Q0VA77,,,,,40.7,393.0,5.3e-77,289.7,sp|Q0VA77|ENPP4_XENTR Bis(5'-adenosyl)-triphosphatase enpp4 OS=Xenopus tropicalis OX=8364 GN=enpp4 PE=2 SV=1,,,,,,
OG_03666,FUN_014905-T1,Peve_00003537,Pocillopora_meandrina_HIv1___RNAseq.g21071.t1,three_way,89.49799999999999,FUN_014905-T1,P14866,HNRPL_HUMAN,,Heterogeneous nuclear ribonucleoprotein L (hnRNP L),Homo sapiens (Human),46.7,210.0,4.3e-39,163.7,sp|P14866|HNRPL_HUMAN Heterogeneous nuclear ribonucleoprotein L OS=Homo sapiens OX=9606 GN=HNRNPL PE=1 SV=2,GO:0000381; GO:0000785; GO:0000976; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006396; GO:0006397; GO:0016020; GO:0035770; GO:0043484; GO:0045120; GO:0045202; GO:0045892; GO:0070062; GO:0097157; GO:1990904,"mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA processing [GO:0006396]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; synapse [GO:0045202],mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_03667,FUN_014907-T1,Peve_00003536,Pocillopora_meandrina_HIv1___RNAseq.g21072.t1,three_way,37.61533333333333,,,,,,,,,,,,,,,,,
OG_03668,FUN_014908-T1,Peve_00003535,Pocillopora_meandrina_HIv1___RNAseq.g21073.t1,three_way,82.90766666666666,FUN_014908-T1,P62253,UB2G1_HUMAN,,"Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed]",Homo sapiens (Human),76.2,164.0,5.2e-74,278.5,sp|P62253|UB2G1_HUMAN Ubiquitin-conjugating enzyme E2 G1 OS=Homo sapiens OX=9606 GN=UBE2G1 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005524; GO:0005829; GO:0006511; GO:0031625; GO:0043161; GO:0061631; GO:0070062; GO:0070534; GO:0070936,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; extracellular exosome [GO:0070062],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03669,FUN_014909-T1,Peve_00003534,Pocillopora_meandrina_HIv1___RNAseq.g21074.t1,three_way,64.27283333333332,,,,,,,,,,,,,,,,,
OG_03670,FUN_014912-T1,Peve_00003532,Pocillopora_meandrina_HIv1___RNAseq.g21075.t1,three_way,60.845,,,,,,,,,,,,,,,,,
OG_03671,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_03672,FUN_014922-T1,Peve_00022028,Pocillopora_meandrina_HIv1___RNAseq.g21080.t1,three_way,79.228,,,,,,,,,,,,,,,,,
OG_03673,FUN_014924-T1,Peve_00006268,Pocillopora_meandrina_HIv1___RNAseq.g21081.t1,three_way,64.52166666666666,FUN_014924-T1,Q6PAJ1,BCR_MOUSE,,Breakpoint cluster region protein (EC 2.7.11.1),Mus musculus (Mouse),38.2,798.0,1.9999999999999997e-142,508.8,sp|Q6PAJ1|BCR_MOUSE Breakpoint cluster region protein OS=Mus musculus OX=10090 GN=Bcr PE=1 SV=3,GO:0002692; GO:0003014; GO:0004674; GO:0005085; GO:0005096; GO:0005524; GO:0005829; GO:0005886; GO:0006909; GO:0007264; GO:0007420; GO:0014069; GO:0016477; GO:0030036; GO:0030216; GO:0030424; GO:0032496; GO:0032991; GO:0035023; GO:0042472; GO:0043114; GO:0043197; GO:0043312; GO:0043314; GO:0048041; GO:0048872; GO:0050728; GO:0050766; GO:0050804; GO:0050885; GO:0051649; GO:0051726; GO:0060216; GO:0060268; GO:0060313; GO:0065002; GO:0071222; GO:0090630; GO:0098685; GO:0098978; GO:0106310; GO:1905517; GO:1905522; GO:2000378,actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; brain development [GO:0007420]; cell migration [GO:0016477]; cellular response to lipopolysaccharide [GO:0071222]; definitive hemopoiesis [GO:0060216]; establishment of localization in cell [GO:0051649]; focal adhesion assembly [GO:0048041]; homeostasis of number of cells [GO:0048872]; inner ear morphogenesis [GO:0042472]; intracellular protein transmembrane transport [GO:0065002]; keratinocyte differentiation [GO:0030216]; macrophage migration [GO:1905517]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neutrophil degranulation [GO:0043314]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of respiratory burst [GO:0060268]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; phagocytosis [GO:0006909]; positive regulation of phagocytosis [GO:0050766]; regulation of cell cycle [GO:0051726]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; renal system process [GO:0003014]; response to lipopolysaccharide [GO:0032496]; small GTPase-mediated signal transduction [GO:0007264],axon [GO:0030424]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003013; GO:0003014; GO:0003824; GO:0005829; GO:0005886; GO:0006886; GO:0007010; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0098772; GO:0140096,"immune system process; circulatory system process; renal system process; catalytic activity; cytosol; plasma membrane; intracellular protein transport; cytoskeleton organization; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; molecular function regulator activity; catalytic activity, acting on a protein"
OG_03674,FUN_014925-T1,Peve_00006270,Pocillopora_meandrina_HIv1___RNAseq.g21082.t1,three_way,77.86116666666666,FUN_014925-T1,Q9I9E0,,,,,43.7,581.0,9.9e-52,206.5,sp|Q9I9E0|TAOK3_CHICK Serine/threonine-protein kinase TAO3 OS=Gallus gallus OX=9031 GN=TAOK3 PE=2 SV=2,,,,,,
OG_03675,FUN_014926-T1,Peve_00006272,Pocillopora_meandrina_HIv1___RNAseq.g21084.t1,three_way,75.862,FUN_014926-T1,Q1KZG4,FHIT_BOVIN,,"Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Adenosine 5'-monophosphoramidase FHIT) (EC 3.9.1.-) (Adenylylsulfatase) (EC 3.6.2.1) (Adenylylsulfate-ammonia adenylyltransferase) (EC 2.7.7.51) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase) (Fragile histidine triad protein)",Bos taurus (Bovine),56.2,146.0,2.9e-42,172.9,sp|Q1KZG4|FHIT_BOVIN Bis(5'-adenosyl)-triphosphatase OS=Bos taurus OX=9913 GN=FHIT PE=2 SV=1,GO:0000166; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006163; GO:0015964; GO:0031625; GO:0032435; GO:0043530; GO:0047352; GO:0047627; GO:0047710; GO:0072332,diadenosine triphosphate catabolic process [GO:0015964]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; purine nucleotide metabolic process [GO:0006163],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],adenosine 5'-monophosphoramidase activity [GO:0043530]; adenylylsulfatase activity [GO:0047627]; adenylylsulfate-ammonia adenylyltransferase activity [GO:0047352]; bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; nucleotide binding [GO:0000166]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0016740; GO:0016787; GO:0043226; GO:0055086,catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; transferase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03676,FUN_014928-T1,Peve_00033454,Pocillopora_meandrina_HIv1___RNAseq.g21087.t1a,three_way,85.25866666666667,FUN_014928-T1,Q15735,PI5PA_HUMAN,,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (EC 3.1.3.36) (Inositol polyphosphate 5-phosphatase J) (Phosphatidylinositol 1,3,4,5-tetrakisphosphate 5-phosphatase) (EC 3.1.3.56) (Phosphatidylinositol 1,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.56)",Homo sapiens (Human),35.4,429.0,4.4e-69,263.5,"sp|Q15735|PI5PA_HUMAN Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A OS=Homo sapiens OX=9606 GN=INPP5J PE=1 SV=3",GO:0001726; GO:0004439; GO:0005737; GO:0005829; GO:0005886; GO:0006661; GO:0010977; GO:0017124; GO:0030426; GO:0031115; GO:0034485; GO:0043005; GO:0043198; GO:0043647; GO:0046030; GO:0046856; GO:0052658; GO:0052659,inositol phosphate metabolic process [GO:0043647]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of neuron projection development [GO:0010977]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1,4,5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; SH3 domain binding [GO:0017124]",GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016787,catalytic activity; cytosol; plasma membrane; lipid metabolic process; hydrolase activity
OG_03677,FUN_014931-T1,Peve_00037145,Pocillopora_meandrina_HIv1___RNAseq.g21089.t1,three_way,68.721,FUN_014931-T1,Q4FAT7,,,,,40.9,580.0,7.9e-123,442.6,sp|Q4FAT7|BGLR_PIG Beta-glucuronidase OS=Sus scrofa OX=9823 GN=GUSB PE=3 SV=1,,,,,,
OG_03678,FUN_014932-T1,Peve_00037144,Pocillopora_meandrina_HIv1___RNAseq.g21090.t2,three_way,93.364,FUN_014932-T1,P26818,,,,,66.9,680.0,9.099999999999999e-271,934.1,sp|P26818|ARBK2_BOVIN G protein-coupled receptor kinase 3 OS=Bos taurus OX=9913 GN=GRK3 PE=2 SV=1,,,,,,
OG_03679,FUN_014936-T1,Peve_00037142,Pocillopora_meandrina_HIv1___TS.g25845.t1,three_way,36.94866666666667,,,,,,,,,,,,,,,,,
OG_03680,FUN_014939-T1,Peve_00037138,Pocillopora_meandrina_HIv1___RNAseq.g21096.t2,three_way,83.04633333333334,FUN_014939-T1,Q2KJ16,PHKG2_BOVIN,,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-2)",Bos taurus (Bovine),53.3,360.0,1.2e-111,404.8,"sp|Q2KJ16|PHKG2_BOVIN Phosphorylase b kinase gamma catalytic chain, liver/testis isoform OS=Bos taurus OX=9913 GN=PHKG2 PE=2 SV=1",GO:0004689; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0005964; GO:0005977; GO:0005980; GO:0007165; GO:0045819,glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; positive regulation of glycogen catabolic process [GO:0045819]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphorylase kinase complex [GO:0005964],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; phosphorylase kinase activity [GO:0004689],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0140096,"catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; catalytic activity, acting on a protein"
OG_03681,FUN_014940-T1,Peve_00037136,Pocillopora_meandrina_HIv1___RNAseq.g21097.t1,three_way,75.71733333333333,FUN_014940-T1,Q8WV93,AFG1L_HUMAN,,AFG1-like ATPase (Lactation elevated protein 1) (EC 3.6.-.-) (Protein AFG1 homolog),Homo sapiens (Human),35.5,434.0,6.200000000000002e-66,253.4,sp|Q8WV93|AFG1L_HUMAN AFG1-like ATPase OS=Homo sapiens OX=9606 GN=AFG1L PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0007005; GO:0016887; GO:0031966; GO:0035694; GO:0141164,mitochondrial protein catabolic process [GO:0035694]; mitochondrial protein quality control [GO:0141164]; mitochondrion organization [GO:0007005],cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0043226,catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; organelle
OG_03682,FUN_014941-T2,Peve_00037149,Pocillopora_meandrina_HIv1___RNAseq.g21098.t1,three_way,78.08300000000001,FUN_014941-T2,O43435,TBX1_HUMAN,,T-box transcription factor TBX1 (T-box protein 1) (Testis-specific T-box protein),Homo sapiens (Human),74.4,203.0,2.7e-85,317.4,sp|O43435|TBX1_HUMAN T-box transcription factor TBX1 OS=Homo sapiens OX=9606 GN=TBX1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001568; GO:0001708; GO:0001755; GO:0001934; GO:0001945; GO:0002053; GO:0003007; GO:0003148; GO:0003151; GO:0003677; GO:0005634; GO:0006357; GO:0007368; GO:0007389; GO:0007498; GO:0007507; GO:0007517; GO:0007605; GO:0008283; GO:0008284; GO:0009952; GO:0021644; GO:0030855; GO:0030878; GO:0035019; GO:0035176; GO:0035909; GO:0042471; GO:0042472; GO:0042473; GO:0042474; GO:0042475; GO:0042693; GO:0042803; GO:0043410; GO:0043565; GO:0043587; GO:0044344; GO:0045596; GO:0045893; GO:0045944; GO:0046983; GO:0048384; GO:0048514; GO:0048538; GO:0048644; GO:0048701; GO:0048703; GO:0048752; GO:0048844; GO:0050679; GO:0060017; GO:0060023; GO:0060037; GO:0060325; GO:0060415; GO:0060982; GO:0070166; GO:0071300; GO:0090103; GO:0097152; GO:1990837; GO:2000027; GO:2001037; GO:2001054,angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; aorta morphogenesis [GO:0035909]; artery morphogenesis [GO:0048844]; blood vessel development [GO:0001568]; blood vessel morphogenesis [GO:0048514]; cell fate specification [GO:0001708]; cell population proliferation [GO:0008283]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to retinoic acid [GO:0071300]; cochlea morphogenesis [GO:0090103]; coronary artery morphogenesis [GO:0060982]; determination of left/right symmetry [GO:0007368]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic viscerocranium morphogenesis [GO:0048703]; enamel mineralization [GO:0070166]; epithelial cell differentiation [GO:0030855]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; inner ear morphogenesis [GO:0042472]; lymph vessel development [GO:0001945]; mesenchymal cell apoptotic process [GO:0097152]; mesoderm development [GO:0007498]; middle ear morphogenesis [GO:0042474]; muscle cell fate commitment [GO:0042693]; muscle organ development [GO:0007517]; muscle organ morphogenesis [GO:0048644]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell differentiation [GO:0045596]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tongue muscle cell differentiation [GO:2001037]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of animal organ morphogenesis [GO:2000027]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; soft palate development [GO:0060023]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tongue morphogenesis [GO:0043587]; vagus nerve morphogenesis [GO:0021644],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_03683,FUN_014942-T1,Peve_00037148,Pocillopora_meandrina_HIv1___RNAseq.g21099.t1,three_way,86.43466666666666,FUN_014942-T1,Q8AX98,TBX1A_XENLA,,T-box transcription factor TBX1-A (T-box protein 1-A),Xenopus laevis (African clawed frog),74.0,196.0,1.3e-84,315.1,sp|Q8AX98|TBX1A_XENLA T-box transcription factor TBX1-A OS=Xenopus laevis OX=8355 GN=tbx1-a PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0003700; GO:0005634; GO:0006357; GO:0045944; GO:0050793; GO:0060788; GO:0071300,cell fate specification [GO:0001708]; cellular response to retinoic acid [GO:0071300]; ectodermal placode formation [GO:0060788]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_03684,FUN_014944-T1,Peve_00037147,Pocillopora_meandrina_HIv1___RNAseq.g21100.t1,three_way,64.583,,,,,,,,,,,,,,,,,
OG_03685,FUN_014945-T1,Peve_00037135,Pocillopora_meandrina_HIv1___RNAseq.g21101.t1,three_way,68.88033333333333,FUN_014945-T1,Q6WBX8,RAD9B_HUMAN,,Cell cycle checkpoint control protein RAD9B (DNA repair exonuclease rad9 homolog B) (hRAD9B),Homo sapiens (Human),43.9,287.0,2.2e-65,251.5,sp|Q6WBX8|RAD9B_HUMAN Cell cycle checkpoint control protein RAD9B OS=Homo sapiens OX=9606 GN=RAD9B PE=1 SV=2,GO:0000076; GO:0005634; GO:0005654; GO:0006281; GO:0030896; GO:0031573; GO:0071479,cellular response to ionizing radiation [GO:0071479]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573],checkpoint clamp complex [GO:0030896]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0006281; GO:0043226,nucleus; nucleoplasm; DNA repair; organelle
OG_03686,FUN_014948-T1,Peve_00024855,Pocillopora_meandrina_HIv1___RNAseq.g21115.t1,three_way,80.74033333333334,FUN_014948-T1,Q04336,,,,,46.8,939.0,1.3999999999999998e-250,867.5,sp|Q04336|YM54_YEAST Uncharacterized protein YMR196W OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YMR196W PE=1 SV=1,,,,,,
OG_03687,FUN_014949-T1,Peve_00006235,Pocillopora_meandrina_HIv1___RNAseq.g21116.t1,three_way,79.29216666666667,FUN_014949-T1,Q9Y6J0,,,,,36.0,1819.0,9e-282,972.2,sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1,,,,,,
OG_03688,FUN_014950-T1,Peve_00006243,Pocillopora_meandrina_HIv1___RNAseq.g21117.t1,three_way,81.29683333333332,FUN_014950-T1,O60671,,,,,66.7,90.0,1.7e-26,119.8,sp|O60671|RAD1_HUMAN Cell cycle checkpoint protein RAD1 OS=Homo sapiens OX=9606 GN=RAD1 PE=1 SV=1,,,,,,
OG_03689,FUN_014951-T1,Peve_00006245,Pocillopora_meandrina_HIv1___RNAseq.g21118.t1,three_way,71.575,FUN_014951-T1,A8WGF7,,,,,52.3,459.0,5e-126,453.0,sp|A8WGF7|SPNS1_XENTR Protein spinster homolog 1 OS=Xenopus tropicalis OX=8364 GN=spns1 PE=2 SV=2,,,,,,
OG_03690,FUN_014952-T1,Peve_00006246,Pocillopora_meandrina_HIv1___RNAseq.g21119.t1,three_way,65.61866666666666,,,,,,,,,,,,,,,,,
OG_03691,FUN_014954-T1,Peve_00006248,Pocillopora_meandrina_HIv1___RNAseq.g21121.t1,three_way,69.067,,,,,,,,,,,,,,,,,
OG_03692,FUN_014955-T1,Peve_00006252,Pocillopora_meandrina_HIv1___RNAseq.g21122.t1,three_way,81.403,FUN_014955-T1,Q7ZVT5,,,,,35.8,282.0,3.9999999999999995e-42,173.3,sp|Q7ZVT5|ROGDI_DANRE Protein rogdi homolog OS=Danio rerio OX=7955 GN=rogdi PE=2 SV=1,,,,,,
OG_03693,FUN_014956-T1,Peve_00006253,Pocillopora_meandrina_HIv1___RNAseq.g21123.t1,three_way,76.81133333333334,FUN_014956-T1,Q8BHT6,B3GLT_MOUSE,,"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)",Mus musculus (Mouse),48.6,432.0,2.1e-120,434.1,"sp|Q8BHT6|B3GLT_MOUSE Beta-1,3-glucosyltransferase OS=Mus musculus OX=10090 GN=B3glct PE=1 SV=3",GO:0001501; GO:0005789; GO:0006004; GO:0007420; GO:0009306; GO:0010467; GO:0016757; GO:0036066; GO:0043010; GO:0044782; GO:0060021; GO:0060173; GO:0060271; GO:1904888,brain development [GO:0007420]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; cranial skeletal system development [GO:1904888]; fucose metabolic process [GO:0006004]; gene expression [GO:0010467]; limb development [GO:0060173]; protein O-linked fucosylation [GO:0036066]; protein secretion [GO:0009306]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501],endoplasmic reticulum membrane [GO:0005789],glycosyltransferase activity [GO:0016757],GO:0003824; GO:0005975; GO:0009101; GO:0016740; GO:0044782; GO:0048856; GO:1901135,catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; cilium organization; anatomical structure development; carbohydrate derivative metabolic process
OG_03694,FUN_014962-T1,Peve_00006256,Pocillopora_meandrina_HIv1___RNAseq.g21125.t1,three_way,52.742666666666665,,,,,,,,,,,,,,,,,
OG_03695,FUN_014964-T1,Peve_00006258,Pocillopora_meandrina_HIv1___RNAseq.g21128.t1,three_way,88.101,FUN_014964-T1,A7S338,LIS1_NEMVE,,Lissencephaly-1 homolog,Nematostella vectensis (Starlet sea anemone),86.2,348.0,4.0000000000000006e-80,300.1,sp|A7S338|LIS1_NEMVE Lissencephaly-1 homolog OS=Nematostella vectensis OX=45351 GN=v1g242515 PE=3 SV=1,GO:0000132; GO:0000776; GO:0005635; GO:0005813; GO:0005875; GO:0005881; GO:0007097; GO:0031023; GO:0047496; GO:0051010; GO:0051012; GO:0051301; GO:0070840; GO:1990234,cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; vesicle transport along microtubule [GO:0047496],centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; nuclear envelope [GO:0005635]; transferase complex [GO:1990234],dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010],GO:0005635; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0043226,nuclear envelope; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; organelle
OG_03696,FUN_014965-T1,Peve_00006259,Pocillopora_meandrina_HIv1___RNAseq.g21129.t1,three_way,85.602,FUN_014965-T1,Q8TBY9,,,,,45.2,938.0,2.5999999999999998e-244,846.7,sp|Q8TBY9|CF251_HUMAN Cilia- and flagella-associated protein 251 OS=Homo sapiens OX=9606 GN=CFAP251 PE=1 SV=2,,,,,,
OG_03697,FUN_014966-T1,Peve_00006260,Pocillopora_meandrina_HIv1___RNAseq.g21130.t1c,three_way,72.1375,FUN_014966-T1,Q96FN5,,,,,39.6,493.0,3.2e-84,314.7,sp|Q96FN5|KIF12_HUMAN Kinesin-like protein KIF12 OS=Homo sapiens OX=9606 GN=KIF12 PE=1 SV=3,,,,,,
OG_03698,FUN_014969-T1,Peve_00006263,Pocillopora_meandrina_HIv1___RNAseq.g21132.t2,three_way,67.03883333333333,FUN_014969-T1,B2RXZ1,PNDC1_MOUSE,,Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1),Mus musculus (Mouse),35.4,463.0,4.3e-65,250.4,sp|B2RXZ1|PNDC1_MOUSE Poly(A)-specific ribonuclease PNLDC1 OS=Mus musculus OX=10090 GN=Pnldc1 PE=1 SV=1,GO:0000184; GO:0000289; GO:0001825; GO:0003723; GO:0004535; GO:0005783; GO:0005789; GO:0007283; GO:0034587; GO:0046872,"blastocyst formation [GO:0001825]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005783; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0140098,"RNA binding; catalytic activity; endoplasmic reticulum; mRNA metabolic process; hydrolase activity; reproductive process; organelle; catalytic activity, acting on RNA"
OG_03699,FUN_014970-T1,Peve_00006264,Pocillopora_meandrina_HIv1___RNAseq.g21133.t1,three_way,54.491166666666665,FUN_014970-T1,P18887,XRCC1_HUMAN,,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),Homo sapiens (Human),42.3,123.0,4.6e-20,100.9,sp|P18887|XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens OX=9606 GN=XRCC1 PE=1 SV=3,GO:0000012; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006302; GO:0006303; GO:0010836; GO:0019899; GO:0021766; GO:0032356; GO:0033194; GO:0061819; GO:0070522; GO:0072572; GO:0090734; GO:0160002; GO:1905051; GO:1905765; GO:1990599,base-excision repair [GO:0006284]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; regulation of base-excision repair [GO:1905051]; response to hydroperoxide [GO:0033194]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]",3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; poly-ADP-D-ribose binding [GO:0072572],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016787; GO:0032200; GO:0043226; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; hydrolase activity; telomere organization; organelle; anatomical structure development; catalytic activity, acting on DNA"
OG_03700,FUN_014972-T1,Peve_00006265,Pocillopora_meandrina_HIv1___RNAseq.g21134.t1,three_way,36.17366666666666,,,,,,,,,,,,,,,,,
OG_03701,FUN_014973-T1,Peve_00006266,Pocillopora_meandrina_HIv1___RNAseq.g21135.t1,three_way,47.29233333333333,,,,,,,,,,,,,,,,,
OG_03702,FUN_014974-T1,Peve_00006267,Pocillopora_meandrina_HIv1___TS.g25888.t1,three_way,80.358,,,,,,,,,,,,,,,,,
OG_03703,FUN_014975-T1,Peve_00024846,Pocillopora_meandrina_HIv1___RNAseq.g21114.t1,three_way,68.426,FUN_014975-T1,Q6DGR4,,,,,47.2,343.0,1.5e-86,321.2,sp|Q6DGR4|HGH1_DANRE Protein HGH1 homolog OS=Danio rerio OX=7955 GN=hgh1 PE=2 SV=1,,,,,,
OG_03704,FUN_014977-T1,Peve_00024843,Pocillopora_meandrina_HIv1___RNAseq.g21138.t1,three_way,72.322,FUN_014977-T1,Q2XWK0,,,,,47.3,461.0,2.1e-115,417.5,sp|Q2XWK0|SVOP_XENLA Synaptic vesicle 2-related protein OS=Xenopus laevis OX=8355 GN=svop PE=2 SV=1,,,,,,
OG_03705,FUN_014978-T1,Peve_00024839,Pocillopora_meandrina_HIv1___RNAseq.g21140.t1,three_way,50.67916666666667,,,,,,,,,,,,,,,,,
OG_03706,FUN_014979-T1,Peve_00024840,Pocillopora_meandrina_HIv1___RNAseq.g21139.t1,three_way,48.621833333333335,,,,,,,,,,,,,,,,,
OG_03707,FUN_014980-T3,Peve_00024829,Pocillopora_meandrina_HIv1___RNAseq.g21142.t1,three_way,72.68066666666667,FUN_014980-T3,P51577,,,,,52.3,392.0,5.2000000000000004e-110,399.4,sp|P51577|P2RX4_RAT P2X purinoceptor 4 OS=Rattus norvegicus OX=10116 GN=P2rx4 PE=1 SV=1,,,,,,
OG_03708,FUN_014981-T1,Peve_00039942,Pocillopora_meandrina_HIv1___TS.g25894.t1,three_way,81.89766666666667,FUN_014981-T1,Q8CCN5,BCAS3_MOUSE,,BCAS3 microtubule associated cell migration factor (Breast carcinoma-amplified sequence 3 homolog) (K20D4) (Protein rudhira),Mus musculus (Mouse),47.1,768.0,1.1e-178,628.6,sp|Q8CCN5|BCAS3_MOUSE BCAS3 microtubule associated cell migration factor OS=Mus musculus OX=10090 GN=Bcas3 PE=1 SV=2,GO:0000407; GO:0000791; GO:0001525; GO:0003682; GO:0005634; GO:0005737; GO:0005881; GO:0006914; GO:0007267; GO:0010595; GO:0031252; GO:0032956; GO:0035091; GO:0043085; GO:0045111; GO:0045944; GO:0048487; GO:0071391; GO:0071944,angiogenesis [GO:0001525]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin cytoskeleton organization [GO:0032956],cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; euchromatin [GO:0000791]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407],beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; phosphatidylinositol binding [GO:0035091],GO:0005634; GO:0005856; GO:0006355; GO:0006914; GO:0008092; GO:0008289; GO:0023052; GO:0043226,nucleus; cytoskeleton; regulation of DNA-templated transcription; autophagy; cytoskeletal protein binding; lipid binding; signaling; organelle
OG_03709,FUN_014983-T1,Peve_00039940,Pocillopora_meandrina_HIv1___RNAseq.g21145.t1,three_way,62.897,,,,,,,,,,,,,,,,,
OG_03710,FUN_014984-T1,Peve_00039939,Pocillopora_meandrina_HIv1___RNAseq.g21146.t1,three_way,63.29966666666667,FUN_014984-T1,Q29RU9,SOX_BOVIN,,Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase),Bos taurus (Bovine),43.6,397.0,5.7e-87,322.8,sp|Q29RU9|SOX_BOVIN Peroxisomal sarcosine oxidase OS=Bos taurus OX=9913 GN=PIPOX PE=2 SV=2,GO:0005777; GO:0008115; GO:0033514; GO:0050031; GO:0050660,L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514],peroxisome [GO:0005777],flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115],GO:0003824; GO:0005777; GO:0006520; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; peroxisome; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03711,FUN_014985-T1,Peve_00039936,Pocillopora_meandrina_HIv1___RNAseq.g21148.t1,three_way,95.19833333333334,FUN_014985-T1,Q61025,IFT20_MOUSE,,Intraflagellar transport protein 20 homolog (mIFT20),Mus musculus (Mouse),82.0,100.0,1.4e-37,156.8,sp|Q61025|IFT20_MOUSE Intraflagellar transport protein 20 homolog OS=Mus musculus OX=10090 GN=Ift20 PE=1 SV=1,GO:0001669; GO:0001736; GO:0001750; GO:0001822; GO:0002046; GO:0002177; GO:0005737; GO:0005794; GO:0005801; GO:0005813; GO:0005814; GO:0005902; GO:0005929; GO:0007224; GO:0007283; GO:0008542; GO:0022008; GO:0030992; GO:0031267; GO:0031410; GO:0031514; GO:0032391; GO:0032420; GO:0034067; GO:0035720; GO:0035845; GO:0036064; GO:0036372; GO:0042073; GO:0043005; GO:0044292; GO:0045198; GO:0045724; GO:0051642; GO:0055007; GO:0060122; GO:0060271; GO:0060828; GO:0061351; GO:0061512; GO:0071806; GO:0072659; GO:0090102; GO:0097546; GO:1902017; GO:1902636; GO:2000583; GO:2000785,cardiac muscle cell differentiation [GO:0055007]; centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]; opsin transport [GO:0036372]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; protein transmembrane transport [GO:0071806]; regulation of autophagosome assembly [GO:2000785]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cilium assembly [GO:1902017]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; visual learning [GO:0008542],acrosomal vesicle [GO:0001669]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; kinociliary basal body [GO:1902636]; manchette [GO:0002177]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; stereocilium [GO:0032420],opsin binding [GO:0002046]; small GTPase binding [GO:0031267],GO:0005794; GO:0005815; GO:0005929; GO:0007018; GO:0007163; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0055085; GO:0072659,Golgi apparatus; microtubule organizing center; cilium; microtubule-based movement; establishment or maintenance of cell polarity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; nervous system process; transmembrane transport; protein localization to plasma membrane
OG_03712,FUN_014986-T1,Peve_00039934,Pocillopora_meandrina_HIv1___RNAseq.g21149.t1,three_way,93.70633333333332,FUN_014986-T1,Q9H3F6,BACD3_HUMAN,,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10),Homo sapiens (Human),66.9,278.0,1.7e-101,370.5,sp|Q9H3F6|BACD3_HUMAN BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 OS=Homo sapiens OX=9606 GN=KCTD10 PE=1 SV=1,GO:0005112; GO:0005654; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0031463; GO:0035024; GO:0042802; GO:0043161; GO:0051260,negative regulation of Rho protein signal transduction [GO:0035024]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; Notch binding [GO:0005112],GO:0005654; GO:0005829; GO:0005886; GO:0030163; GO:0065003,nucleoplasm; cytosol; plasma membrane; protein catabolic process; protein-containing complex assembly
OG_03713,FUN_014987-T1,Peve_00039946,Pocillopora_meandrina_HIv1___RNAseq.g21150.t1,three_way,82.91666666666667,FUN_014987-T1,O14874,,,,,55.7,368.0,1.4e-109,397.9,sp|O14874|BCKD_HUMAN Branched-chain alpha-ketoacid dehydrogenase kinase OS=Homo sapiens OX=9606 GN=BCKDK PE=1 SV=2,,,,,,
OG_03714,FUN_014988-T1,Peve_00039945,Pocillopora_meandrina_HIv1___RNAseq.252_t,three_way,72.728,,,,,,,,,,,,,,,,,
OG_03715,FUN_014989-T1,Peve_00039944,Pocillopora_meandrina_HIv1___RNAseq.g21153.t1,three_way,81.51683333333334,FUN_014989-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),30.1,482.0,2.6e-59,231.1,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_03716,FUN_014991-T1,Peve_00032857,Pocillopora_meandrina_HIv1___RNAseq.g21154.t2,three_way,83.89333333333333,FUN_014991-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),30.0,621.0,3.3e-94,347.4,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_03717,FUN_014992-T1,Peve_00032856,Pocillopora_meandrina_HIv1___RNAseq.g21155.t1,three_way,77.725,FUN_014992-T1,O15254,ACOX3_HUMAN,,Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase),Homo sapiens (Human),52.3,692.0,5.3e-205,715.7,sp|O15254|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens OX=9606 GN=ACOX3 PE=1 SV=2,GO:0005504; GO:0005777; GO:0005782; GO:0005829; GO:0016020; GO:0016402; GO:0033540; GO:0050660; GO:0071949,fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540],cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402],GO:0003824; GO:0005777; GO:0005829; GO:0006629; GO:0008289; GO:0016491; GO:0043226,catalytic activity; peroxisome; cytosol; lipid metabolic process; lipid binding; oxidoreductase activity; organelle
OG_03718,FUN_014993-T1,Peve_00031667,Pocillopora_meandrina_HIv1___RNAseq.g21156.t1,three_way,73.09666666666666,FUN_014993-T1,P51659,DHB4_HUMAN,,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]",Homo sapiens (Human),53.7,751.0,2e-231,803.5,sp|P51659|DHB4_HUMAN Peroxisomal multifunctional enzyme type 2 OS=Homo sapiens OX=9606 GN=HSD17B4 PE=1 SV=3,GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0004303; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0006636; GO:0008209; GO:0008210; GO:0016020; GO:0016853; GO:0018812; GO:0033540; GO:0033989; GO:0036109; GO:0036111; GO:0036112; GO:0042759; GO:0042803; GO:0044594; GO:0060009; GO:0106386; GO:1901570,alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid derivative biosynthetic process [GO:1901570]; long-chain fatty acid biosynthetic process [GO:0042759]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111],cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],"(3R)-hydroxyacyl-CoA dehydrogenase (NAD+) activity [GO:0106386]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; enoyl-CoA hydratase activity [GO:0004300]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0005777; GO:0005829; GO:0006629; GO:0006790; GO:0016491; GO:0016829; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0055086,catalytic activity; peroxisome; cytosol; lipid metabolic process; sulfur compound metabolic process; oxidoreductase activity; lyase activity; isomerase activity; reproductive process; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_03719,FUN_014995-T1,Peve_00010955,Pocillopora_meandrina_HIv1___RNAseq.g21158.t1,three_way,83.375,FUN_014995-T1,Q23979,MY61F_DROME,,Unconventional myosin IC (MyoIC) (Brush border myosin IB) (BBMIB) (Myosin-IB) (MIB) (Unconventional myosin 1C) (Myo1C),Drosophila melanogaster (Fruit fly),55.3,1014.0,0.0,1112.4,sp|Q23979|MY61F_DROME Unconventional myosin IC OS=Drosophila melanogaster OX=7227 GN=Myo61F PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005546; GO:0005737; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0007368; GO:0007498; GO:0015629; GO:0016459; GO:0030048; GO:0032528; GO:0042742; GO:0048803; GO:0051015,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; defense response to bacterium [GO:0042742]; determination of left/right symmetry [GO:0007368]; endocytosis [GO:0006897]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; mesoderm development [GO:0007498]; microvillus organization [GO:0032528],actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; myosin complex [GO:0016459]; plasma membrane [GO:0005886],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0003774; GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0016192; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; isomerase activity; reproductive process; organelle; anatomical structure development; ATP-dependent activity
OG_03720,FUN_015005-T1,Peve_00034681,Pocillopora_meandrina_HIv1___RNAseq.g21250.t1,three_way,83.25866666666667,FUN_015005-T1,P20132,SDHL_HUMAN,,L-serine dehydratase/L-threonine deaminase (SDH) (EC 4.3.1.17) (Hepatic serine dehydratase) (hSDH) (L-serine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19),Homo sapiens (Human),53.6,321.0,8.999999999999999e-94,345.1,sp|P20132|SDHL_HUMAN L-serine dehydratase/L-threonine deaminase OS=Homo sapiens OX=9606 GN=SDS PE=1 SV=2,GO:0003941; GO:0004794; GO:0005739; GO:0005829; GO:0006094; GO:0006565; GO:0006629; GO:0030170; GO:0042803; GO:0042866,gluconeogenesis [GO:0006094]; L-serine catabolic process [GO:0006565]; lipid metabolic process [GO:0006629]; pyruvate biosynthetic process [GO:0042866],cytosol [GO:0005829]; mitochondrion [GO:0005739],L-serine ammonia-lyase activity [GO:0003941]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; threonine deaminase activity [GO:0004794],GO:0003824; GO:0005739; GO:0005829; GO:0005975; GO:0006520; GO:0006629; GO:0016829; GO:0043226,catalytic activity; mitochondrion; cytosol; carbohydrate metabolic process; amino acid metabolic process; lipid metabolic process; lyase activity; organelle
OG_03721,FUN_015006-T1,Peve_00034682,Pocillopora_meandrina_HIv1___RNAseq.352_t,three_way,82.70633333333333,FUN_015006-T1,Q96QT6,PHF12_HUMAN,,PHD finger protein 12 (PHD factor 1) (Pf1),Homo sapiens (Human),31.1,1037.0,1.8e-99,365.5,sp|Q96QT6|PHF12_HUMAN PHD finger protein 12 OS=Homo sapiens OX=9606 GN=PHF12 PE=1 SV=2,GO:0000122; GO:0001222; GO:0003714; GO:0005634; GO:0005654; GO:0008270; GO:0017053; GO:0035091; GO:0045892; GO:0070822,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; transcription repressor complex [GO:0017053],phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0008289; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; lipid binding; organelle; molecular adaptor activity; transcription regulator activity
OG_03722,FUN_015007-T1,Peve_00034683,Pocillopora_meandrina_HIv1___RNAseq.g21247.t1,three_way,90.045,FUN_015007-T1,A6NIH7,U119B_HUMAN,,Protein unc-119 homolog B,Homo sapiens (Human),68.4,193.0,2.3000000000000002e-74,280.0,sp|A6NIH7|U119B_HUMAN Protein unc-119 homolog B OS=Homo sapiens OX=9606 GN=UNC119B PE=1 SV=1,GO:0005829; GO:0005929; GO:0007399; GO:0008289; GO:0035869; GO:0042953; GO:0060271,cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399],ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829],lipid binding [GO:0008289],GO:0005829; GO:0005929; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytosol; cilium; lipid binding; organelle; cilium organization; anatomical structure development
OG_03723,FUN_015008-T1,Peve_00034684,Pocillopora_meandrina_HIv1___RNAseq.g21246.t1,three_way,93.515,FUN_015008-T1,Q08E38,PRP19_BOVIN,,Pre-mRNA-processing factor 19 (EC 2.3.2.27) (PRP19/PSO4 homolog) (RING-type E3 ubiquitin transferase PRP19),Bos taurus (Bovine),72.0,507.0,3.9e-186,652.5,sp|Q08E38|PRP19_BOVIN Pre-mRNA-processing factor 19 OS=Bos taurus OX=9913 GN=PRPF19 PE=2 SV=1,GO:0000077; GO:0000244; GO:0000245; GO:0000398; GO:0000974; GO:0001833; GO:0004842; GO:0005634; GO:0005662; GO:0005737; GO:0005811; GO:0005819; GO:0006303; GO:0008104; GO:0008610; GO:0010498; GO:0016607; GO:0034450; GO:0035861; GO:0042802; GO:0048026; GO:0061630; GO:0070534; GO:0071006; GO:0071007,"DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; protein localization [GO:0008104]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]",cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0005811; GO:0006281; GO:0006629; GO:0016071; GO:0016740; GO:0030163; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; lipid droplet; DNA repair; lipid metabolic process; mRNA metabolic process; transferase activity; protein catabolic process; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_03724,FUN_015009-T1,Peve_00034685,Pocillopora_meandrina_HIv1___RNAseq.g21245.t1,three_way,73.11366666666666,,,,,,,,,,,,,,,,,
OG_03725,FUN_015010-T1,Peve_00034686,Pocillopora_meandrina_HIv1___RNAseq.g21244.t1,three_way,58.71366666666667,FUN_015010-T1,Q86UW9,DTX2_HUMAN,,Probable E3 ubiquitin-protein ligase DTX2 (EC 2.3.2.27) (Protein deltex-2) (Deltex2) (hDTX2) (RING finger protein 58) (RING-type E3 ubiquitin transferase DTX2),Homo sapiens (Human),35.4,605.0,4.6e-88,326.6,sp|Q86UW9|DTX2_HUMAN Probable E3 ubiquitin-protein ligase DTX2 OS=Homo sapiens OX=9606 GN=DTX2 PE=1 SV=3,GO:0005654; GO:0005737; GO:0007219; GO:0008270; GO:0016567; GO:0031965; GO:0061630,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; transferase activity; catalytic activity, acting on a protein"
OG_03726,FUN_015011-T1,Peve_00034687,Pocillopora_meandrina_HIv1___RNAseq.g21243.t1,three_way,52.35133333333333,FUN_015011-T1,Q8BSY0,ASPH_MOUSE,,Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase),Mus musculus (Mouse),34.5,197.0,3.9e-27,123.6,sp|Q8BSY0|ASPH_MOUSE Aspartyl/asparaginyl beta-hydroxylase OS=Mus musculus OX=10090 GN=Asph PE=1 SV=1,GO:0005737; GO:0005886; GO:0007389; GO:0008283; GO:0008285; GO:0016020; GO:0031647; GO:0032541; GO:0033017; GO:0035108; GO:0045862; GO:0046872; GO:0060021; GO:0060325; GO:0062101; GO:1901879,cell population proliferation [GO:0008283]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell population proliferation [GO:0008285]; pattern specification process [GO:0007389]; positive regulation of proteolysis [GO:0045862]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; roof of mouth development [GO:0060021],cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017],metal ion binding [GO:0046872]; peptidyl-aspartic acid 3-dioxygenase activity [GO:0062101],GO:0003824; GO:0005886; GO:0016491; GO:0048856; GO:0140096,"catalytic activity; plasma membrane; oxidoreductase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_03727,FUN_015012-T1,Peve_00034688,Pocillopora_meandrina_HIv1___RNAseq.g21242.t1,three_way,71.958,,,,,,,,,,,,,,,,,
OG_03728,FUN_015021-T2,Peve_00034691,Pocillopora_meandrina_HIv1___RNAseq.g21238.t1,three_way,93.31283333333334,FUN_015021-T2,Q8IVF4,DYH10_HUMAN,,Dynein axonemal heavy chain 10 (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10),Homo sapiens (Human),64.5,4571.0,0.0,5881.6,sp|Q8IVF4|DYH10_HUMAN Dynein axonemal heavy chain 10 OS=Homo sapiens OX=9606 GN=DNAH10 PE=1 SV=4,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_03729,FUN_015022-T1,Peve_00004790,Pocillopora_meandrina_HIv1___TS.g25933.t1,three_way,69.6595,FUN_015022-T1,Q9Z0J4,,,,,46.8,1462.0,0.0,1275.0,sp|Q9Z0J4|NOS1_MOUSE Nitric oxide synthase 1 OS=Mus musculus OX=10090 GN=Nos1 PE=1 SV=1,,,,,,
OG_03730,FUN_015023-T1,Peve_00004786,Pocillopora_meandrina_HIv1___RNAseq.g21191.t1,three_way,57.76283333333333,FUN_015023-T1,Q8RWN2,,,,,31.9,492.0,1.3e-51,205.7,sp|Q8RWN2|ZIF1_ARATH Protein ZINC INDUCED FACILITATOR 1 OS=Arabidopsis thaliana OX=3702 GN=ZIF1 PE=1 SV=2,,,,,,
OG_03731,FUN_015024-T1,Peve_00004784,Pocillopora_meandrina_HIv1___RNAseq.g21180.t1,three_way,68.43833333333333,FUN_015024-T1,Q3T0M7,,,,,55.6,180.0,7e-47,188.7,sp|Q3T0M7|RANG_BOVIN Ran-specific GTPase-activating protein OS=Bos taurus OX=9913 GN=RANBP1 PE=2 SV=1,,,,,,
OG_03732,FUN_015025-T1,Peve_00004783,Pocillopora_meandrina_HIv1___RNAseq.g21179.t1,three_way,93.3515,FUN_015025-T1,P43690,,,,,82.5,365.0,2.3e-175,616.3,sp|P43690|DRG1_XENLA Developmentally-regulated GTP-binding protein 1 OS=Xenopus laevis OX=8355 GN=drg1 PE=1 SV=1,,,,,,
OG_03733,FUN_015026-T1,Peve_00004782,Pocillopora_meandrina_HIv1___RNAseq.g21178.t1,three_way,77.89583333333333,FUN_015026-T1,A4FU69,EFCB5_HUMAN,,EF-hand calcium-binding domain-containing protein 5,Homo sapiens (Human),28.9,1341.0,1.9e-133,478.8,sp|A4FU69|EFCB5_HUMAN EF-hand calcium-binding domain-containing protein 5 OS=Homo sapiens OX=9606 GN=EFCAB5 PE=1 SV=3,GO:0005509,,,calcium ion binding [GO:0005509],,
OG_03734,FUN_015032-T1,Peve_00004777,Pocillopora_meandrina_HIv1___TS.g25919.t1,three_way,82.122,FUN_015032-T1,Q9IAK8,TBX5A_DANRE,,T-box transcription factor TBX5-A (zftbx5a) (T-box protein 5) (zTbx5),Danio rerio (Zebrafish) (Brachydanio rerio),62.0,221.0,1.4e-79,298.5,sp|Q9IAK8|TBX5A_DANRE T-box transcription factor TBX5-A OS=Danio rerio OX=7955 GN=tbx5a PE=2 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0001947; GO:0003007; GO:0003143; GO:0003146; GO:0003190; GO:0003206; GO:0003218; GO:0003294; GO:0003342; GO:0003344; GO:0003700; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0006357; GO:0007389; GO:0007507; GO:0009887; GO:0015629; GO:0021554; GO:0032991; GO:0032993; GO:0033339; GO:0035050; GO:0035118; GO:0035138; GO:0036302; GO:0043565; GO:0045893; GO:0045944; GO:0055007; GO:0060042; GO:0060174; GO:0061026; GO:0061629,animal organ morphogenesis [GO:0009887]; atrial ventricular junction remodeling [GO:0003294]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; cardiac chamber morphogenesis [GO:0003206]; cardiac left ventricle formation [GO:0003218]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle tissue regeneration [GO:0061026]; cell fate specification [GO:0001708]; DNA-templated transcription [GO:0006351]; embryonic heart tube development [GO:0035050]; embryonic heart tube morphogenesis [GO:0003143]; embryonic pectoral fin morphogenesis [GO:0035118]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; limb bud formation [GO:0060174]; optic nerve development [GO:0021554]; pattern specification process [GO:0007389]; pectoral fin development [GO:0033339]; pectoral fin morphogenesis [GO:0035138]; pericardium morphogenesis [GO:0003344]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proepicardium development [GO:0003342]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retina morphogenesis in camera-type eye [GO:0060042],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005856; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_03735,FUN_015034-T1,Peve_00031808,Pocillopora_meandrina_HIv1___RNAseq.g21166.t1,three_way,75.782,FUN_015034-T1,Q7ZTU9,TBX2_DANRE,,T-box transcription factor TBX2b (T-box protein 2b),Danio rerio (Zebrafish) (Brachydanio rerio),58.5,270.0,1.5e-81,305.1,sp|Q7ZTU9|TBX2_DANRE T-box transcription factor TBX2b OS=Danio rerio OX=7955 GN=tbx2b PE=1 SV=4,GO:0000785; GO:0000978; GO:0000981; GO:0001702; GO:0001708; GO:0001947; GO:0003205; GO:0005634; GO:0006357; GO:0007155; GO:0007420; GO:0008016; GO:0021538; GO:0021982; GO:0030509; GO:0030903; GO:0035050; GO:0035777; GO:0036302; GO:0042074; GO:0042461; GO:0042671; GO:0043704; GO:0045893; GO:0046548; GO:0046549; GO:0046551; GO:0048318; GO:0048663; GO:0048793; GO:0060219; GO:0070365; GO:0072019; GO:0072068,atrioventricular canal development [GO:0036302]; axial mesoderm development [GO:0048318]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; camera-type eye photoreceptor cell differentiation [GO:0060219]; cardiac chamber development [GO:0003205]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration involved in gastrulation [GO:0042074]; embryonic heart tube development [GO:0035050]; epithalamus development [GO:0021538]; gastrulation with mouth forming second [GO:0001702]; heart looping [GO:0001947]; hepatocyte differentiation [GO:0070365]; late distal convoluted tubule development [GO:0072068]; neuron fate commitment [GO:0048663]; notochord development [GO:0030903]; photoreceptor cell development [GO:0042461]; photoreceptor cell fate specification [GO:0043704]; pineal gland development [GO:0021982]; positive regulation of DNA-templated transcription [GO:0045893]; pronephric distal tubule development [GO:0035777]; pronephros development [GO:0048793]; proximal convoluted tubule development [GO:0072019]; regulation of heart contraction [GO:0008016]; regulation of transcription by RNA polymerase II [GO:0006357]; retinal cone cell development [GO:0046549]; retinal cone cell fate commitment [GO:0046551]; retinal cone cell fate determination [GO:0042671]; retinal rod cell development [GO:0046548],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0007155; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell adhesion; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_03736,FUN_015036-T1,Peve_00024712,Pocillopora_meandrina_HIv1___RNAseq.g21165.t1,three_way,78.18966666666667,FUN_015036-T1,Q9BZ72,PITM2_HUMAN,,"Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2) (PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3) (NIR-3)",Homo sapiens (Human),42.6,1386.0,1.2e-287,991.1,sp|Q9BZ72|PITM2_HUMAN Membrane-associated phosphatidylinositol transfer protein 2 OS=Homo sapiens OX=9606 GN=PITPNM2 PE=1 SV=1,GO:0005509; GO:0005737; GO:0005829; GO:0006661; GO:0008525; GO:0008526; GO:0012505; GO:0016020; GO:0030971; GO:0031210; GO:0035091,phosphatidylinositol biosynthetic process [GO:0006661],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020],calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; receptor tyrosine kinase binding [GO:0030971],GO:0005215; GO:0005829; GO:0006629; GO:0008289,transporter activity; cytosol; lipid metabolic process; lipid binding
OG_03737,FUN_015038-T1,Peve_00024408,Pocillopora_meandrina_HIv1___RNAseq.g21253.t1,three_way,68.02199999999999,FUN_015038-T1,P11023,RAB3A_BOVIN,,Ras-related protein Rab-3A (EC 3.6.5.2) (SMG P25A),Bos taurus (Bovine),45.0,171.0,1.1e-41,171.4,sp|P11023|RAB3A_BOVIN Ras-related protein Rab-3A OS=Bos taurus OX=9913 GN=RAB3A PE=1 SV=3,GO:0003016; GO:0003924; GO:0005525; GO:0005764; GO:0005768; GO:0005829; GO:0005886; GO:0007005; GO:0007274; GO:0007409; GO:0008021; GO:0009791; GO:0015031; GO:0016020; GO:0016079; GO:0016188; GO:0017157; GO:0030324; GO:0030424; GO:0030672; GO:0031489; GO:0031630; GO:0048786; GO:0048790; GO:0050975; GO:0051602; GO:0060478; GO:0098793; GO:0098794,acrosomal vesicle exocytosis [GO:0060478]; axonogenesis [GO:0007409]; lung development [GO:0030324]; maintenance of presynaptic active zone structure [GO:0048790]; mitochondrion organization [GO:0007005]; neuromuscular synaptic transmission [GO:0007274]; post-embryonic development [GO:0009791]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; respiratory system process [GO:0003016]; response to electrical stimulus [GO:0051602]; sensory perception of touch [GO:0050975]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle maturation [GO:0016188],axon [GO:0030424]; cytosol [GO:0005829]; endosome [GO:0005768]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489],GO:0003016; GO:0003824; GO:0003924; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0007005; GO:0008092; GO:0016192; GO:0016787; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877,respiratory system process; catalytic activity; GTPase activity; lysosome; endosome; vacuole; cytosol; plasma membrane; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process
OG_03738,FUN_015042-T1,Peve_00024407,Pocillopora_meandrina_HIv1___TS.g26003.t2,three_way,78.902,FUN_015042-T1,P22059,OSBP1_HUMAN,,Oxysterol-binding protein 1,Homo sapiens (Human),53.7,789.0,3.4e-206,719.9,sp|P22059|OSBP1_HUMAN Oxysterol-binding protein 1 OS=Homo sapiens OX=9606 GN=OSBP PE=1 SV=1,GO:0000139; GO:0005654; GO:0005730; GO:0005737; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006686; GO:0006699; GO:0008142; GO:0015914; GO:0015918; GO:0016020; GO:0019904; GO:0030054; GO:0032367; GO:0032934; GO:0035627; GO:0035774; GO:0048471; GO:0070273; GO:0097038; GO:0120015; GO:1904411,bile acid biosynthetic process [GO:0006699]; ceramide transport [GO:0035627]; intracellular cholesterol transport [GO:0032367]; phospholipid transport [GO:0015914]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of secretory granule organization [GO:1904411]; sphingomyelin biosynthetic process [GO:0006686]; sterol transport [GO:0015918],cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transfer activity [GO:0120015],GO:0005215; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0008289; GO:0043226,transporter activity; nucleoplasm; nucleolus; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; lipid binding; organelle
OG_03739,FUN_015043-T1,Peve_00031329,Pocillopora_meandrina_HIv1___RNAseq.g21254.t1,three_way,69.51966666666667,,,,,,,,,,,,,,,,,
OG_03740,FUN_015044-T1,Peve_00031330,Pocillopora_meandrina_HIv1___RNAseq.g21255.t1,three_way,47.4195,,,,,,,,,,,,,,,,,
OG_03741,FUN_015046-T1,Peve_00001162,Pocillopora_meandrina_HIv1___TS.g26014.t1,three_way,75.864,FUN_015046-T1,Q6GQ82,,,,,68.8,362.0,9.9e-136,484.6,sp|Q6GQ82|SNF5_XENLA SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 OS=Xenopus laevis OX=8355 GN=smarcb1 PE=2 SV=1,,,,,,
OG_03742,FUN_015047-T1,Peve_00001170,Pocillopora_meandrina_HIv1___TS.g26015.t1,three_way,73.43133333333333,FUN_015047-T1,Q8C1R0,,,,,48.1,156.0,1.4e-36,154.1,sp|Q8C1R0|TSSK5_MOUSE Testis-specific serine/threonine-protein kinase 5 OS=Mus musculus OX=10090 GN=Tssk5 PE=2 SV=2,,,,,,
OG_03743,FUN_015050-T1,Peve_00001172,Pocillopora_meandrina_HIv1___RNAseq.g21265.t1,three_way,70.01583333333333,FUN_015050-T1,Q8CHW5,,,,,38.3,120.0,7.4e-10,67.4,sp|Q8CHW5|BICL2_MOUSE BICD family-like cargo adapter 2 OS=Mus musculus OX=10090 GN=Bicdl2 PE=1 SV=1,,,,,,
OG_03744,FUN_015051-T1,Peve_00001163,Pocillopora_meandrina_HIv1___RNAseq.g21266.t1,three_way,95.305,FUN_015051-T1,P83876,TXN4A_HUMAN,,Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD),Homo sapiens (Human),91.5,142.0,2.7e-76,285.8,sp|P83876|TXN4A_HUMAN Thioredoxin-like protein 4A OS=Homo sapiens OX=9606 GN=TXNL4A PE=1 SV=1,GO:0000245; GO:0000375; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0046540; GO:0051301; GO:0071005,"cell division [GO:0051301]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],,GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0043226; GO:0065003,nucleus; nucleoplasm; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_03745,FUN_015052-T1,Peve_00001164,Pocillopora_meandrina_HIv1___RNAseq.g21267.t1,three_way,66.9325,FUN_015052-T1,Q6DFQ2,,,,,33.2,340.0,5.7e-31,136.7,sp|Q6DFQ2|NCBP3_XENTR Nuclear cap-binding protein subunit 3 OS=Xenopus tropicalis OX=8364 GN=ncbp3 PE=2 SV=1,,,,,,
OG_03746,FUN_015053-T1,Peve_00001165,Pocillopora_meandrina_HIv1___RNAseq.g21269.t1,three_way,62.7195,FUN_015053-T1,Q99KR6,,,,,34.2,366.0,1.8e-46,188.0,sp|Q99KR6|RNF34_MOUSE E3 ubiquitin-protein ligase RNF34 OS=Mus musculus OX=10090 GN=Rnf34 PE=1 SV=1,,,,,,
OG_03747,FUN_015055-T1,Peve_00001167,Pocillopora_meandrina_HIv1___RNAseq.g21271.t1,three_way,81.48649999999999,FUN_015055-T1,Q8BR65,SDS3_MOUSE,,Sin3 histone deacetylase corepressor complex component SDS3 (Suppressor of defective silencing 3 protein homolog),Mus musculus (Mouse),37.1,264.0,1.3e-29,132.1,sp|Q8BR65|SDS3_MOUSE Sin3 histone deacetylase corepressor complex component SDS3 OS=Mus musculus OX=10090 GN=Suds3 PE=1 SV=1,GO:0000122; GO:0001835; GO:0005634; GO:0006338; GO:0006915; GO:0030336; GO:0030512; GO:0042802; GO:0042826; GO:0045892; GO:0070822; GO:1902455; GO:1902459,apoptotic process [GO:0006915]; blastocyst hatching [GO:0001835]; chromatin remodeling [GO:0006338]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459],nucleus [GO:0005634]; Sin3-type complex [GO:0070822],histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802],GO:0005634; GO:0006325; GO:0006355; GO:0012501; GO:0043226,nucleus; chromatin organization; regulation of DNA-templated transcription; programmed cell death; organelle
OG_03748,FUN_015056-T1,Peve_00001169,Pocillopora_meandrina_HIv1___RNAseq.g21272.t1,three_way,93.25166666666668,FUN_015056-T1,Q9QZ88,VPS29_MOUSE,,Vacuolar protein sorting-associated protein 29 (Vesicle protein sorting 29),Mus musculus (Mouse),81.9,182.0,5.8e-87,321.6,sp|Q9QZ88|VPS29_MOUSE Vacuolar protein sorting-associated protein 29 OS=Mus musculus OX=10090 GN=Vps29 PE=1 SV=1,GO:0005829; GO:0006896; GO:0010008; GO:0015031; GO:0030904; GO:0030906; GO:0032456; GO:0042147; GO:0046872,"endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]","cytosol [GO:0005829]; endosome membrane [GO:0010008]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]",metal ion binding [GO:0046872],GO:0005829; GO:0016192,cytosol; vesicle-mediated transport
OG_03749,FUN_015057-T1,Peve_00032169,Pocillopora_meandrina_HIv1___TS.g26024.t1,three_way,87.627,FUN_015057-T1,Q9GZP9,DERL2_HUMAN,,Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa),Homo sapiens (Human),77.8,239.0,6.8e-102,371.7,sp|Q9GZP9|DERL2_HUMAN Derlin-2 OS=Homo sapiens OX=9606 GN=DERL2 PE=1 SV=1,GO:0001967; GO:0005047; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0008284; GO:0016020; GO:0030307; GO:0030968; GO:0030970; GO:0036503; GO:0044877; GO:1904153,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; retrograde protein transport, ER to cytosol [GO:0030970]; suckling behavior [GO:0001967]",early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; late endosome [GO:0005770]; membrane [GO:0016020],protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047],GO:0005768; GO:0005783; GO:0006886; GO:0030163; GO:0031410; GO:0043226,endosome; endoplasmic reticulum; intracellular protein transport; protein catabolic process; cytoplasmic vesicle; organelle
OG_03750,FUN_015058-T1,Peve_00015746,Pocillopora_meandrina_HIv1___RNAseq.g21275.t1,three_way,87.12433333333333,FUN_015058-T1,Q5U4U5,,,,,50.7,146.0,5.8e-34,145.6,sp|Q5U4U5|TIM22_XENLA Mitochondrial import inner membrane translocase subunit Tim22 OS=Xenopus laevis OX=8355 GN=timm22 PE=2 SV=1,,,,,,
OG_03751,FUN_015059-T1,Peve_00015744,Pocillopora_meandrina_HIv1___TS.g26027.t1b,three_way,56.31366666666667,,,,,,,,,,,,,,,,,
OG_03752,FUN_015061-T1,Peve_00015752,Pocillopora_meandrina_HIv1___RNAseq.g21278.t1,three_way,60.377,FUN_015061-T1,Q9UH36,,,,,47.6,187.0,2.4e-42,174.1,sp|Q9UH36|SRR1L_HUMAN SRR1-like protein OS=Homo sapiens OX=9606 GN=SRRD PE=1 SV=1,,,,,,
OG_03753,FUN_015062-T1,Peve_00015751,Pocillopora_meandrina_HIv1___RNAseq.g21279.t1,three_way,81.46366666666667,FUN_015062-T1,Q9H773,DCTP1_HUMAN,,dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein),Homo sapiens (Human),58.9,141.0,2.9e-39,162.9,sp|Q9H773|DCTP1_HUMAN dCTP pyrophosphatase 1 OS=Homo sapiens OX=9606 GN=DCTPP1 PE=1 SV=1,GO:0000287; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006253; GO:0009143; GO:0032556; GO:0042262; GO:0042802; GO:0047429; GO:0047840,dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03754,FUN_015063-T1,Peve_00015750,Pocillopora_meandrina_HIv1___RNAseq.g21280.t1,three_way,81.313,FUN_015063-T1,P00130,,,,,62.7,51.0,5.2e-14,77.8,sp|P00130|QCR9_BOVIN Cytochrome b-c1 complex subunit 9 OS=Bos taurus OX=9913 GN=UQCR10 PE=1 SV=3,,,,,,
OG_03755,FUN_015064-T1,Peve_00022382,Pocillopora_meandrina_HIv1___RNAseq.g21281.t1,three_way,76.39266666666667,FUN_015064-T1,A7STV9,,,,,52.6,272.0,7.9e-80,298.5,sp|A7STV9|SLX1_NEMVE Structure-specific endonuclease subunit SLX1 homolog OS=Nematostella vectensis OX=45351 GN=v1g174298 PE=3 SV=1,,,,,,
OG_03756,FUN_015065-T1,Peve_00022386,Pocillopora_meandrina_HIv1___RNAseq.g21282.t1,three_way,90.77866666666668,FUN_015065-T1,Q8K3J1,NDUS8_MOUSE,,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 7.1.1.2) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit)",Mus musculus (Mouse),83.6,177.0,7.5e-59,228.4,"sp|Q8K3J1|NDUS8_MOUSE NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial OS=Mus musculus OX=10090 GN=Ndufs8 PE=1 SV=1",GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0032981; GO:0042776; GO:0045271; GO:0046872; GO:0051539,"aerobic respiration [GO:0009060]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]",GO:0005215; GO:0005739; GO:0006091; GO:0043226; GO:0055086; GO:0065003; GO:1901135,transporter activity; mitochondrion; generation of precursor metabolites and energy; organelle; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_03757,FUN_015066-T1,Peve_00022387,Pocillopora_meandrina_HIv1___RNAseq.g21283.t1,three_way,82.09666666666666,FUN_015066-T1,E1BY51,,,,,54.4,149.0,1.4e-39,164.1,sp|E1BY51|TMM17_CHICK Transmembrane protein 17 OS=Gallus gallus OX=9031 GN=TMEM17 PE=3 SV=1,,,,,,
OG_03758,FUN_015067-T1,Peve_00022388,Pocillopora_meandrina_HIv1___RNAseq.g21284.t1,three_way,54.923,,,,,,,,,,,,,,,,,
OG_03759,FUN_015068-T1,Peve_00022389,Pocillopora_meandrina_HIv1___RNAseq.g21285.t1,three_way,87.73183333333334,FUN_015068-T1,Q969V4,TEKT1_HUMAN,,Tektin-1,Homo sapiens (Human),52.9,397.0,1.9e-111,404.1,sp|Q969V4|TEKT1_HUMAN Tektin-1 OS=Homo sapiens OX=9606 GN=TEKT1 PE=1 SV=1,GO:0005634; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0160111,cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005856; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,nucleus; cytoskeleton; cilium; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_03760,FUN_015069-T1,Peve_00022383,Pocillopora_meandrina_HIv1___RNAseq.g21194.t1,three_way,77.7035,FUN_015069-T1,O96017,CHK2_HUMAN,,Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2),Homo sapiens (Human),52.3,442.0,1.4999999999999998e-127,458.0,sp|O96017|CHK2_HUMAN Serine/threonine-protein kinase Chk2 OS=Homo sapiens OX=9606 GN=CHEK2 PE=1 SV=1,GO:0000077; GO:0000086; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0006302; GO:0006355; GO:0006468; GO:0006974; GO:0008630; GO:0016605; GO:0019901; GO:0030163; GO:0030330; GO:0031573; GO:0031625; GO:0033554; GO:0042176; GO:0042770; GO:0042771; GO:0042802; GO:0042803; GO:0044773; GO:0045893; GO:0046777; GO:0046872; GO:0050821; GO:0051301; GO:0070242; GO:0071466; GO:0071480; GO:0090307; GO:0090399; GO:0106310; GO:1901796; GO:1903416; GO:1903926; GO:2000002; GO:2000210; GO:2000785,"cell division [GO:0051301]; cellular response to bisphenol A [GO:1903926]; cellular response to gamma radiation [GO:0071480]; cellular response to stress [GO:0033554]; cellular response to xenobiotic stimulus [GO:0071466]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint signaling [GO:0044773]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of anoikis [GO:2000210]; positive regulation of DNA-templated transcription [GO:0045893]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of autophagosome assembly [GO:2000785]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein catabolic process [GO:0042176]; regulation of signal transduction by p53 class mediator [GO:1901796]; replicative senescence [GO:0090399]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; thymocyte apoptotic process [GO:0070242]",cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0006281; GO:0006355; GO:0007010; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; Golgi apparatus; DNA repair; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03761,FUN_015071-T1,Peve_00025600,Pocillopora_meandrina_HIv1___RNAseq.g21190.t1,three_way,51.34466666666667,,,,,,,,,,,,,,,,,
OG_03762,FUN_015074-T1,Peve_00004705,Pocillopora_meandrina_HIv1___TS.g18493.t1,three_way,61.51,FUN_015074-T1,Q9VUL9,FUCTA_DROME,,"Glycoprotein 3-alpha-L-fucosyltransferase A (EC 2.4.1.214) (Core alpha-(1,3)-fucosyltransferase)",Drosophila melanogaster (Fruit fly),35.0,349.0,4.199999999999999e-43,177.9,sp|Q9VUL9|FUCTA_DROME Glycoprotein 3-alpha-L-fucosyltransferase A OS=Drosophila melanogaster OX=7227 GN=FucTA PE=1 SV=2,GO:0005797; GO:0006486; GO:0007399; GO:0018279; GO:0018392; GO:0032580; GO:0036065; GO:0036071; GO:0046920,fucosylation [GO:0036065]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279],Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797],alpha-(1->3)-fucosyltransferase activity [GO:0046920]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392],GO:0003824; GO:0006486; GO:0009101; GO:0016740; GO:0048856; GO:0140096; GO:1901135,"catalytic activity; protein glycosylation; glycoprotein biosynthetic process; transferase activity; anatomical structure development; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03763,FUN_015086-T1,Peve_00025601,Pocillopora_meandrina_HIv1___RNAseq.g21189.t1,three_way,82.73233333333333,FUN_015086-T1,O18835,,,,,54.3,619.0,1.3e-195,684.5,sp|O18835|BGLR_CANLF Beta-glucuronidase OS=Canis lupus familiaris OX=9615 GN=GUSB PE=1 SV=1,,,,,,
OG_03764,FUN_015089-T1,Peve_00010705,Pocillopora_meandrina_HIv1___RNAseq.g21187.t1,three_way,72.56533333333334,FUN_015089-T1,Q71F56,MD13L_HUMAN,,Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like),Homo sapiens (Human),29.0,2382.0,7.899999999999999e-204,713.4,sp|Q71F56|MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens OX=9606 GN=MED13L PE=1 SV=1,GO:0003713; GO:0005654; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592]; nucleoplasm [GO:0005654],transcription coactivator activity [GO:0003713],GO:0005654; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_03765,FUN_015090-T1,Peve_00010706,Pocillopora_meandrina_HIv1___RNAseq.g21186.t1,three_way,63.61833333333333,FUN_015090-T1,Q8HZ69,,,,,41.6,505.0,3.8e-115,416.8,sp|Q8HZ69|FMO2_GORGO Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Gorilla gorilla gorilla OX=9595 GN=FMO2 PE=3 SV=3,,,,,,
OG_03766,FUN_015091-T1,Peve_00010707,Pocillopora_meandrina_HIv1___RNAseq.g21185.t1,three_way,59.72,,,,,,,,,,,,,,,,,
OG_03767,FUN_015095-T1,Peve_00043821,Pocillopora_meandrina_HIv1___RNAseq.g22283.t1,three_way,81.09083333333334,FUN_015095-T1,Q8IZ69,TRM2A_HUMAN,,tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.35) (mRNA (uracil-5-)-methyltransferase TRMT2A) (EC 2.1.1.-),Homo sapiens (Human),40.3,618.0,9.4e-120,432.6,sp|Q8IZ69|TRM2A_HUMAN tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens OX=9606 GN=TRMT2A PE=1 SV=2,GO:0003723; GO:0005829; GO:0006397; GO:0008033; GO:0008169; GO:0030697; GO:0032259,methylation [GO:0032259]; mRNA processing [GO:0006397]; tRNA processing [GO:0008033],cytosol [GO:0005829],"C-methyltransferase activity [GO:0008169]; RNA binding [GO:0003723]; tRNA (uracil(54)-C5)-methyltransferase activity, S-adenosyl methionine-dependent [GO:0030697]",GO:0003723; GO:0003824; GO:0005829; GO:0006399; GO:0016071; GO:0016740; GO:0140098,"RNA binding; catalytic activity; cytosol; tRNA metabolic process; mRNA metabolic process; transferase activity; catalytic activity, acting on RNA"
OG_03768,FUN_015096-T1,Peve_00043816,Pocillopora_meandrina_HIv1___RNAseq.g22282.t2,three_way,74.82266666666666,,,,,,,,,,,,,,,,,
OG_03769,FUN_015098-T1,Peve_00009747,Pocillopora_meandrina_HIv1___RNAseq.g22143.t1,three_way,73.82233333333333,FUN_015098-T1,Q8R2J9,RA51C_CRIGR,,DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2),Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),53.1,352.0,1e-99,365.2,sp|Q8R2J9|RA51C_CRIGR DNA repair protein RAD51 homolog 3 OS=Cricetulus griseus OX=10029 GN=RAD51C PE=2 SV=1,GO:0000400; GO:0000707; GO:0000722; GO:0000724; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0007062; GO:0007066; GO:0007131; GO:0007141; GO:0007283; GO:0008821; GO:0010971; GO:0030054; GO:0033063; GO:0033065; GO:0048471; GO:0140664,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; female meiosis sister chromatid cohesion [GO:0007066]; male meiosis I [GO:0007141]; meiotic DNA recombinase assembly [GO:0000707]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; sister chromatid cohesion [GO:0007062]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722],cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; Rad51C-XRCC3 complex [GO:0033065]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0065003; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; DNA repair; DNA recombination; hydrolase activity; reproductive process; telomere organization; organelle; protein-containing complex assembly; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_03770,FUN_015099-T1,Peve_00029475,Pocillopora_meandrina_HIv1___RNAseq.g22142.t1,three_way,61.8635,FUN_015099-T1,P27615,SCRB2_RAT,,Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36),Rattus norvegicus (Rat),35.1,450.0,3e-80,300.8,sp|P27615|SCRB2_RAT Lysosome membrane protein 2 OS=Rattus norvegicus OX=10116 GN=Scarb2 PE=1 SV=2,GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0007605; GO:0010976; GO:0015485; GO:0015917; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043470; GO:0051087; GO:0099638,aminophospholipid transport [GO:0015917]; endosome to plasma membrane protein transport [GO:0099638]; positive regulation of neuron projection development [GO:0010976]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470]; sensory perception of sound [GO:0007605],endocytic vesicle membrane [GO:0030666]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; scavenger receptor activity [GO:0005044],GO:0005886; GO:0006886; GO:0008289; GO:0016192; GO:0038024; GO:0050877; GO:0072659,plasma membrane; intracellular protein transport; lipid binding; vesicle-mediated transport; cargo receptor activity; nervous system process; protein localization to plasma membrane
OG_03771,FUN_015100-T1,Peve_00027023,Pocillopora_meandrina_HIv1___RNAseq.g22141.t1,three_way,83.81099999999999,FUN_015100-T1,Q5U3N5,,,,,51.7,238.0,6.2e-63,242.3,sp|Q5U3N5|PPTC7_DANRE Protein phosphatase PTC7 homolog OS=Danio rerio OX=7955 GN=pptc7 PE=2 SV=1,,,,,,
OG_03772,FUN_015101-T1,Peve_00027022,Pocillopora_meandrina_HIv1___RNAseq.g22124.t1,three_way,62.69583333333333,FUN_015101-T1,P47708,RP3A_MOUSE,,Rabphilin-3A (Exophilin-1),Mus musculus (Mouse),37.0,683.0,1.8e-109,398.3,sp|P47708|RP3A_MOUSE Rabphilin-3A OS=Mus musculus OX=10090 GN=Rph3a PE=1 SV=2,GO:0005509; GO:0005544; GO:0005546; GO:0006886; GO:0008270; GO:0008430; GO:0016082; GO:0019898; GO:0030141; GO:0030672; GO:0031267; GO:0032991; GO:0042301; GO:0043005; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0061669; GO:0070679,intracellular protein transport [GO:0006886]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle priming [GO:0016082],dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0006886; GO:0008289; GO:0031410; GO:0043226; GO:0065003,intracellular protein transport; lipid binding; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_03773,FUN_015102-T1,Peve_00036873,Pocillopora_meandrina_HIv1___RNAseq.g22122.t1,three_way,57.66816666666666,,,,,,,,,,,,,,,,,
OG_03774,FUN_015103-T1,Peve_00036870,Pocillopora_meandrina_HIv1___RNAseq.g22120.t1,three_way,72.14483333333332,FUN_015103-T1,Q9CWK3,,,,,38.8,343.0,6.8e-44,179.5,sp|Q9CWK3|CD2B2_MOUSE CD2 antigen cytoplasmic tail-binding protein 2 OS=Mus musculus OX=10090 GN=Cd2bp2 PE=1 SV=1,,,,,,
OG_03775,FUN_015104-T1,Peve_00036871,Pocillopora_meandrina_HIv1___RNAseq.g22119.t3,three_way,78.71466666666666,FUN_015104-T1,Q5ZKJ5,,,,,31.5,496.0,7.6e-55,216.5,sp|Q5ZKJ5|MF13A_CHICK Transmembrane protein 180 OS=Gallus gallus OX=9031 GN=MFSD13A PE=2 SV=1,,,,,,
OG_03776,FUN_015106-T1,Peve_00036874,Pocillopora_meandrina_HIv1___RNAseq.g22117.t1,three_way,57.995666666666665,FUN_015106-T1,O57422,,,,,26.6,335.0,1.5000000000000002e-22,108.6,sp|O57422|OPN4B_XENLA Melanopsin-B OS=Xenopus laevis OX=8355 GN=opn4b PE=2 SV=1,,,,,,
OG_03777,FUN_015107-T1,Peve_00036875,Pocillopora_meandrina_HIv1___TS.g26879.t1,three_way,68.18,FUN_015107-T1,Q86YT5,S13A5_HUMAN,,Na(+)/citrate cotransporter (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) (Solute carrier family 13 member 5),Homo sapiens (Human),45.1,618.0,1.4e-138,495.0,sp|Q86YT5|S13A5_HUMAN Na(+)/citrate cotransporter OS=Homo sapiens OX=9606 GN=SLC13A5 PE=1 SV=1,GO:0005343; GO:0005654; GO:0005829; GO:0005886; GO:0015137; GO:0015141; GO:0015729; GO:0015741; GO:0015742; GO:0015744; GO:0015746; GO:0017153; GO:0042802; GO:0055085; GO:0071285,alpha-ketoglutarate transport [GO:0015742]; cellular response to lithium ion [GO:0071285]; citrate transport [GO:0015746]; fumarate transport [GO:0015741]; oxaloacetate transport [GO:0015729]; succinate transport [GO:0015744]; transmembrane transport [GO:0055085],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],citrate transmembrane transporter activity [GO:0015137]; identical protein binding [GO:0042802]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141],GO:0005215; GO:0005654; GO:0005829; GO:0005886; GO:0055085,transporter activity; nucleoplasm; cytosol; plasma membrane; transmembrane transport
OG_03778,FUN_015108-T3,Peve_00004795,Pocillopora_meandrina_HIv1___RNAseq.g22097.t1,three_way,74.72233333333334,FUN_015108-T3,Q1JP63,,,,,48.8,463.0,2.5e-127,457.2,sp|Q1JP63|SVOP_BOVIN Synaptic vesicle 2-related protein OS=Bos taurus OX=9913 GN=SVOP PE=2 SV=1,,,,,,
OG_03779,FUN_015109-T1,Peve_00024001,Pocillopora_meandrina_HIv1___RNAseq.g21738.t1,three_way,67.93483333333333,FUN_015109-T1,Q9QXZ0,MACF1_MOUSE,,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 (Actin cross-linking family 7)",Mus musculus (Mouse),25.3,2944.0,1.6e-256,890.6,"sp|Q9QXZ0|MACF1_MOUSE Microtubule-actin cross-linking factor 1, isoforms 1/2/3/4 OS=Mus musculus OX=10090 GN=Macf1 PE=1 SV=2",GO:0001707; GO:0003779; GO:0005509; GO:0005737; GO:0005794; GO:0005874; GO:0005938; GO:0006620; GO:0007163; GO:0008017; GO:0008104; GO:0010632; GO:0014069; GO:0015629; GO:0015630; GO:0016020; GO:0016055; GO:0016477; GO:0016887; GO:0030177; GO:0030334; GO:0032587; GO:0032886; GO:0042060; GO:0043001; GO:0045104; GO:0051011; GO:0051015; GO:0051893; GO:0150011,cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; Golgi to plasma membrane protein transport [GO:0043001]; intermediate filament cytoskeleton organization [GO:0045104]; mesoderm formation [GO:0001707]; positive regulation of Wnt signaling pathway [GO:0030177]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of epithelial cell migration [GO:0010632]; regulation of focal adhesion assembly [GO:0051893]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection arborization [GO:0150011]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011],GO:0003824; GO:0005794; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016787; GO:0042060; GO:0043226; GO:0048870; GO:0072659,catalytic activity; Golgi apparatus; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; wound healing; organelle; cell motility; protein localization to plasma membrane
OG_03780,FUN_015110-T1,Peve_00024794,Pocillopora_meandrina_HIv1___RNAseq.g7729.t1,three_way,38.797,FUN_015110-T1,P82596,,,,,31.1,135.0,1e-08,65.5,sp|P82596|PLC_HALLA Perlucin OS=Haliotis laevigata OX=36097 PE=1 SV=3,,,,,,
OG_03781,FUN_015136-T1,Peve_00001089,Pocillopora_meandrina_HIv1___RNAseq.g21740.t1,three_way,78.34933333333333,FUN_015136-T1,A1L2R7,,,,,47.0,230.0,7.499999999999999e-53,208.8,sp|A1L2R7|TACAN_XENLA Transmembrane protein 120A OS=Xenopus laevis OX=8355 GN=tmem120a.L PE=2 SV=1,,,,,,
OG_03782,FUN_015138-T1,Peve_00001080,Pocillopora_meandrina_HIv1___RNAseq.g21743.t1,three_way,64.8045,FUN_015138-T1,Q8BIY1,,,,,43.3,540.0,2.6e-92,340.9,sp|Q8BIY1|GPTC3_MOUSE G patch domain-containing protein 3 OS=Mus musculus OX=10090 GN=Gpatch3 PE=2 SV=1,,,,,,
OG_03783,FUN_015139-T1,Peve_00001081,Pocillopora_meandrina_HIv1___RNAseq.g21744.t1,three_way,90.96066666666668,FUN_015139-T1,Q5PPV3,,,,,63.0,238.0,5.199999999999999e-24,112.8,sp|Q5PPV3|MORN3_XENLA MORN repeat-containing protein 3 OS=Xenopus laevis OX=8355 GN=morn3 PE=2 SV=1,,,,,,
OG_03784,FUN_015140-T1,Peve_00001082,Pocillopora_meandrina_HIv1___RNAseq.g21745.t1,three_way,84.37516666666667,FUN_015140-T1,Q9U6B8,,,,,57.0,193.0,1.6e-51,204.1,sp|Q9U6B8|ORAI1_DROME Calcium release-activated calcium channel protein 1 OS=Drosophila melanogaster OX=7227 GN=Orai PE=1 SV=1,,,,,,
OG_03785,FUN_015145-T1,Peve_00001083,Pocillopora_meandrina_HIv1___RNAseq.g21746.t2,three_way,73.53316666666667,FUN_015145-T1,Q640I9,,,,,30.3,1123.0,1.7999999999999998e-141,505.0,sp|Q640I9|KDM2B_XENLA Lysine-specific demethylase 2B OS=Xenopus laevis OX=8355 GN=kdm2b PE=2 SV=1,,,,,,
OG_03786,FUN_015146-T1,Peve_00001085,Pocillopora_meandrina_HIv1___TS.g26499.t3,three_way,47.95283333333333,,,,,,,,,,,,,,,,,
OG_03787,FUN_015147-T1,Peve_00020566,Pocillopora_meandrina_HIv1___RNAseq.g29743.t1,three_way,50.849,,,,,,,,,,,,,,,,,
OG_03788,FUN_015152-T1,Peve_00001875,Pocillopora_meandrina_HIv1___RNAseq.g21757.t1,three_way,65.66483333333333,,,,,,,,,,,,,,,,,
OG_03789,FUN_015154-T1,Peve_00001872,Pocillopora_meandrina_HIv1___RNAseq.g21760.t1,three_way,82.07333333333334,FUN_015154-T1,Q6P423,,,,,58.1,1348.0,0.0,1575.8,sp|Q6P423|MED23_XENLA Mediator of RNA polymerase II transcription subunit 23 OS=Xenopus laevis OX=8355 GN=med23 PE=2 SV=1,,,,,,
OG_03790,FUN_015155-T1,Peve_00001868,Pocillopora_meandrina_HIv1___RNAseq.g21762.t1,three_way,71.99633333333334,FUN_015155-T1,B6NK32,,,,,57.8,64.0,4.8e-15,81.6,sp|B6NK32|LYRM9_BRAFL LYR motif-containing protein 9 OS=Branchiostoma floridae OX=7739 GN=LYRM9 PE=3 SV=1,,,,,,
OG_03791,FUN_015156-T2,Peve_00001867,Pocillopora_meandrina_HIv1___RNAseq.g21763.t1,three_way,63.6845,FUN_015156-T2,Q6NS15,MED15_XENLA,,Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (xARC105) (Mediator complex subunit 15),Xenopus laevis (African clawed frog),37.3,314.0,2.2e-45,185.3,sp|Q6NS15|MED15_XENLA Mediator of RNA polymerase II transcription subunit 15 OS=Xenopus laevis OX=8355 GN=med15 PE=1 SV=1,GO:0003712; GO:0005654; GO:0005737; GO:0006355; GO:0070847,regulation of DNA-templated transcription [GO:0006355],core mediator complex [GO:0070847]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654],transcription coregulator activity [GO:0003712],GO:0005654; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_03792,FUN_015158-T1,Peve_00001862,Pocillopora_meandrina_HIv1___RNAseq.g21765.t1,three_way,81.74516666666666,FUN_015158-T1,Q96DH6,,,,,47.2,335.0,2.3e-67,257.7,sp|Q96DH6|MSI2H_HUMAN RNA-binding protein Musashi homolog 2 OS=Homo sapiens OX=9606 GN=MSI2 PE=1 SV=1,,,,,,
OG_03793,FUN_015164-T1,Peve_00001860,Pocillopora_meandrina_HIv1___TS.g25730.t1,three_way,68.88416666666667,FUN_015164-T1,Q14667,,,,,30.3,2363.0,1.9999999999999998e-285,984.6,sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3,,,,,,
OG_03794,FUN_015166-T1,Peve_00014587,Pocillopora_meandrina_HIv1___TS.g26527.t1,three_way,56.14866666666667,,,,,,,,,,,,,,,,,
OG_03795,FUN_015167-T1,Peve_00014588,Pocillopora_meandrina_HIv1___RNAseq.g21772.t1,three_way,74.31233333333333,,,,,,,,,,,,,,,,,
OG_03796,FUN_015168-T1,Peve_00014589,Pocillopora_meandrina_HIv1___TS.g26536.t1,three_way,55.26583333333333,,,,,,,,,,,,,,,,,
OG_03797,FUN_015169-T1,Peve_00014590,Pocillopora_meandrina_HIv1___RNAseq.902_t,three_way,69.61416666666666,,,,,,,,,,,,,,,,,
OG_03798,FUN_015177-T1,Peve_00001851,Pocillopora_meandrina_HIv1___RNAseq.g21784.t1,three_way,38.772666666666666,,,,,,,,,,,,,,,,,
OG_03799,FUN_015179-T1,Peve_00001854,Pocillopora_meandrina_HIv1___RNAseq.g21786.t1,three_way,59.745333333333335,,,,,,,,,,,,,,,,,
OG_03800,FUN_015183-T1,Peve_00023878,Pocillopora_meandrina_HIv1___RNAseq.g22309.t1,three_way,61.66833333333334,FUN_015183-T1,Q86US8,EST1A_HUMAN,,Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a),Homo sapiens (Human),34.5,918.0,1.3e-129,466.1,sp|Q86US8|EST1A_HUMAN Telomerase-binding protein EST1A OS=Homo sapiens OX=9606 GN=SMG6 PE=1 SV=2,GO:0000184; GO:0000781; GO:0003723; GO:0004521; GO:0005634; GO:0005697; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006406; GO:0032204; GO:0032210; GO:0035303; GO:0036064; GO:0042162; GO:0043021; GO:0046872; GO:0070034; GO:0070182; GO:1904354,"mRNA export from nucleus [GO:0006406]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of telomere maintenance [GO:0032204]; regulation of telomere maintenance via telomerase [GO:0032210]","chromosome, telomeric region [GO:0000781]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; telomerase holoenzyme complex [GO:0005697]",DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0005815; GO:0005829; GO:0005886; GO:0006913; GO:0016071; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; nucleolus; microtubule organizing center; cytosol; plasma membrane; nucleocytoplasmic transport; mRNA metabolic process; organelle; catalytic activity, acting on RNA"
OG_03801,FUN_015184-T1,Peve_00023889,Pocillopora_meandrina_HIv1___RNAseq.g22343.t1,three_way,40.410833333333336,FUN_015184-T1,P34331,PLK1_CAEEL,,Serine/threonine-protein kinase plk-1 (EC 2.7.11.21) (Polo-like kinase 1),Caenorhabditis elegans,29.1,292.0,1.2e-19,100.1,sp|P34331|PLK1_CAEEL Serine/threonine-protein kinase plk-1 OS=Caenorhabditis elegans OX=6239 GN=plk-1 PE=1 SV=4,GO:0000776; GO:0000793; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0007077; GO:0007098; GO:0007147; GO:0030496; GO:0040038; GO:0045132; GO:0051233; GO:0051726; GO:0106310; GO:0110039,centrosome cycle [GO:0007098]; female meiosis II [GO:0007147]; meiotic chromosome segregation [GO:0045132]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic spindle organization [GO:0007052]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of nematode male tail tip morphogenesis [GO:0110039]; regulation of cell cycle [GO:0051726],centrosome [GO:0005813]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005634; GO:0005694; GO:0005815; GO:0007010; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0061024; GO:0140013; GO:0140096,"cytokinesis; catalytic activity; nucleus; chromosome; microtubule organizing center; cytoskeleton organization; chromosome segregation; transferase activity; reproductive process; organelle; membrane organization; meiotic nuclear division; catalytic activity, acting on a protein"
OG_03802,FUN_015186-T1,Peve_00019714,Pocillopora_meandrina_HIv1___RNAseq.g22308.t1,three_way,66.40933333333334,,,,,,,,,,,,,,,,,
OG_03803,FUN_015187-T1,Peve_00013021,Pocillopora_meandrina_HIv1___RNAseq.g22307.t1,three_way,65.45766666666667,FUN_015187-T1,O88845,AKA10_MOUSE,,"A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10)",Mus musculus (Mouse),33.2,596.0,9.3e-79,296.2,"sp|O88845|AKA10_MOUSE A-kinase anchor protein 10, mitochondrial OS=Mus musculus OX=10090 GN=Akap10 PE=1 SV=3",GO:0005739; GO:0005829; GO:0005886; GO:0008104; GO:0032991; GO:0051018,protein localization [GO:0008104],cytosol [GO:0005829]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],protein kinase A binding [GO:0051018],GO:0005739; GO:0005829; GO:0005886; GO:0043226,mitochondrion; cytosol; plasma membrane; organelle
OG_03804,FUN_015190-T2,Peve_00013035,Pocillopora_meandrina_HIv1___RNAseq.g22302.t2,three_way,57.41966666666666,FUN_015190-T2,Q9Y483,,,,,40.9,110.0,2.1e-18,97.4,sp|Q9Y483|MTF2_HUMAN Metal-response element-binding transcription factor 2 OS=Homo sapiens OX=9606 GN=MTF2 PE=1 SV=3,,,,,,
OG_03805,FUN_015192-T1,Peve_00013032,Pocillopora_meandrina_HIv1___RNAseq.g22303.t1,three_way,69.30916666666666,FUN_015192-T1,Q8WY54,PPM1E_HUMAN,,Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA),Homo sapiens (Human),52.3,367.0,7.700000000000001e-98,359.0,sp|Q8WY54|PPM1E_HUMAN Protein phosphatase 1E OS=Homo sapiens OX=9606 GN=PPM1E PE=1 SV=3,GO:0004722; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006469; GO:0007165; GO:0032991; GO:0035970; GO:0046872; GO:0051496; GO:0071222; GO:0071466,cellular response to lipopolysaccharide [GO:0071222]; cellular response to xenobiotic stimulus [GO:0071466]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03806,FUN_015193-T1,Peve_00013020,Pocillopora_meandrina_HIv1___RNAseq.g22296.t1,three_way,76.85266666666666,FUN_015193-T1,Q6PCX9,TRI37_MOUSE,,E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37),Mus musculus (Mouse),79.4,447.0,4.6e-210,733.0,sp|Q6PCX9|TRI37_MOUSE E3 ubiquitin-protein ligase TRIM37 OS=Mus musculus OX=10090 GN=Trim37 PE=1 SV=1,GO:0000122; GO:0003682; GO:0003713; GO:0005164; GO:0005694; GO:0005737; GO:0005778; GO:0005829; GO:0006513; GO:0008270; GO:0016235; GO:0016558; GO:0031625; GO:0035098; GO:0042803; GO:0045814; GO:0046600; GO:0048471; GO:0050821; GO:0051865; GO:0061630; GO:0070842; GO:0140862,"aggresome assembly [GO:0070842]; negative regulation of centriole replication [GO:0046600]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; protein import into peroxisome matrix [GO:0016558]; protein monoubiquitination [GO:0006513]; protein stabilization [GO:0050821]",aggresome [GO:0016235]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal membrane [GO:0005778],chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005694; GO:0005829; GO:0006325; GO:0006355; GO:0006886; GO:0007031; GO:0016740; GO:0043226; GO:0055085; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; chromosome; cytosol; chromatin organization; regulation of DNA-templated transcription; intracellular protein transport; peroxisome organization; transferase activity; organelle; transmembrane transport; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_03807,FUN_015216-T1,Peve_00040600,Pocillopora_meandrina_HIv1___RNAseq.g22340.t1,three_way,74.71933333333332,FUN_015216-T1,Q58DM4,ALKB2_BOVIN,,DNA oxidative demethylase ALKBH2 (EC 1.14.11.33) (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2),Bos taurus (Bovine),48.1,264.0,2.2e-66,255.0,sp|Q58DM4|ALKB2_BOVIN DNA oxidative demethylase ALKBH2 OS=Bos taurus OX=9913 GN=ALKBH2 PE=2 SV=1,GO:0000182; GO:0005654; GO:0005730; GO:0006307; GO:0008198; GO:0035516; GO:0051747,DNA alkylation repair [GO:0006307],nucleolus [GO:0005730]; nucleoplasm [GO:0005654],broad specificity oxidative DNA demethylase activity [GO:0035516]; cytosine C-5 DNA demethylase activity [GO:0051747]; ferrous iron binding [GO:0008198]; rDNA binding [GO:0000182],GO:0003677; GO:0003824; GO:0005654; GO:0005730; GO:0006281; GO:0016491; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleoplasm; nucleolus; DNA repair; oxidoreductase activity; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_03808,FUN_015217-T1,Peve_00040606,Pocillopora_meandrina_HIv1___RNAseq.g22338.t1,three_way,55.619166666666665,FUN_015217-T1,Q2TBW5,,,,,28.6,420.0,6.9e-27,123.2,sp|Q2TBW5|ZNHI2_BOVIN Zinc finger HIT domain-containing protein 2 OS=Bos taurus OX=9913 GN=ZNHIT2 PE=2 SV=1,,,,,,
OG_03809,FUN_015218-T1,Peve_00022749,Pocillopora_meandrina_HIv1___RNAseq.g22337.t1,three_way,67.37333333333333,FUN_015218-T1,Q9NXW9,ALKB4_HUMAN,,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 (Alkylated DNA repair protein alkB homolog 4) (DNA N6-methyl adenine demethylase ALKBH4) (EC 1.14.11.51) (Lysine-specific demethylase ALKBH4) (EC 1.14.11.-),Homo sapiens (Human),49.6,232.0,7.100000000000001e-59,228.8,sp|Q9NXW9|ALKB4_HUMAN Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 OS=Homo sapiens OX=9606 GN=ALKBH4 PE=1 SV=1,GO:0003779; GO:0005730; GO:0005737; GO:0016706; GO:0030496; GO:0031032; GO:0032451; GO:0035516; GO:0036090; GO:0046872; GO:0070938; GO:0070988; GO:0140457; GO:0141131; GO:0141137,"actomyosin structure organization [GO:0031032]; cleavage furrow ingression [GO:0036090]; demethylation [GO:0070988]; positive regulation of gene expression, epigenetic [GO:0141137]",contractile ring [GO:0070938]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleolus [GO:0005730],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; actin binding [GO:0003779]; broad specificity oxidative DNA demethylase activity [GO:0035516]; demethylase activity [GO:0032451]; DNA N6-methyladenine demethylase activity [GO:0141131]; metal ion binding [GO:0046872]; protein demethylase activity [GO:0140457],GO:0003824; GO:0005730; GO:0006325; GO:0007010; GO:0008092; GO:0016491; GO:0043226; GO:0061024; GO:0140096; GO:0140097,"catalytic activity; nucleolus; chromatin organization; cytoskeleton organization; cytoskeletal protein binding; oxidoreductase activity; organelle; membrane organization; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_03810,FUN_015219-T1,Peve_00023888,Pocillopora_meandrina_HIv1___RNAseq.g22336.t1,three_way,80.74166666666666,FUN_015219-T1,Q6GM71,LRWD1_XENLA,,Leucine-rich repeat and WD repeat-containing protein 1 (ORC-associated protein) (ORCA) (Origin recognition complex-associated protein),Xenopus laevis (African clawed frog),26.8,728.0,4.2e-63,244.2,sp|Q6GM71|LRWD1_XENLA Leucine-rich repeat and WD repeat-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrwd1 PE=2 SV=1,GO:0000776; GO:0000781; GO:0003682; GO:0005634; GO:0005664; GO:0005721; GO:0005737; GO:0005813; GO:0006260; GO:0006325; GO:0008327; GO:0061628; GO:0071169,chromatin organization [GO:0006325]; DNA replication [GO:0006260]; establishment of protein localization to chromatin [GO:0071169],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nuclear origin of replication recognition complex [GO:0005664]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]",chromatin binding [GO:0003682]; histone H3K27me3 reader activity [GO:0061628]; methyl-CpG binding [GO:0008327],GO:0003677; GO:0005634; GO:0005815; GO:0006260; GO:0006325; GO:0043226; GO:0060090,DNA binding; nucleus; microtubule organizing center; DNA replication; chromatin organization; organelle; molecular adaptor activity
OG_03811,FUN_015220-T1,Peve_00013668,Pocillopora_meandrina_HIv1___RNAseq.g22190.t1,three_way,70.237,FUN_015220-T1,Q9CPV4,,,,,64.0,289.0,7.3e-108,391.7,sp|Q9CPV4|GLOD4_MOUSE Glyoxalase domain-containing protein 4 OS=Mus musculus OX=10090 GN=Glod4 PE=1 SV=1,,,,,,
OG_03812,FUN_015222-T1,Peve_00013653,Pocillopora_meandrina_HIv1___RNAseq.g22187.t1,three_way,59.37533333333334,FUN_015222-T1,Q9UHJ6,SHPK_HUMAN,,Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein),Homo sapiens (Human),41.5,472.0,3.3e-94,347.1,sp|Q9UHJ6|SHPK_HUMAN Sedoheptulokinase OS=Homo sapiens OX=9606 GN=SHPK PE=1 SV=4,GO:0005524; GO:0005737; GO:0005829; GO:0005975; GO:0006098; GO:0009052; GO:0016310; GO:0035963; GO:0043030; GO:0050277; GO:0050727; GO:0071222; GO:0071353,"carbohydrate metabolic process [GO:0005975]; cellular response to interleukin-13 [GO:0035963]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]; phosphorylation [GO:0016310]; regulation of inflammatory response [GO:0050727]; regulation of macrophage activation [GO:0043030]",cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; sedoheptulokinase activity [GO:0050277],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03813,FUN_015223-T1,Peve_00013652,Pocillopora_meandrina_HIv1___RNAseq.g22186.t1,three_way,75.90233333333333,FUN_015223-T1,Q8K4C0,FMO5_RAT,,Flavin-containing monooxygenase 5 (FMO 5) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (NADPH oxidase) (EC 1.6.3.1),Rattus norvegicus (Rat),49.9,539.0,1.1999999999999998e-153,544.7,sp|Q8K4C0|FMO5_RAT Flavin-containing monooxygenase 5 OS=Rattus norvegicus OX=10116 GN=Fmo5 PE=1 SV=3,GO:0004031; GO:0004497; GO:0004499; GO:0005789; GO:0006629; GO:0006805; GO:0050660; GO:0050661; GO:0090181; GO:0106294,lipid metabolic process [GO:0006629]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"aldehyde oxidase activity [GO:0004031]; flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_03814,FUN_015225-T1,Peve_00013662,Pocillopora_meandrina_HIv1___RNAseq.g22184.t1,three_way,77.971,FUN_015225-T1,Q6IRI9,FMO2_RAT,,Dimethylaniline monooxygenase [N-oxide-forming] 2 (EC 1.14.13.-) (Dimethylaniline oxidase 2) (Pulmonary flavin-containing monooxygenase 2) (FMO 2),Rattus norvegicus (Rat),47.2,525.0,3.3e-138,493.4,sp|Q6IRI9|FMO2_RAT Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Rattus norvegicus OX=10116 GN=Fmo2 PE=2 SV=3,GO:0004497; GO:0004499; GO:0005789; GO:0006082; GO:0006739; GO:0006805; GO:0009404; GO:0016020; GO:0046322; GO:0050660; GO:0050661; GO:0072592; GO:0097009,energy homeostasis [GO:0097009]; NADP metabolic process [GO:0006739]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],"flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",GO:0003824; GO:0016491; GO:0055086,catalytic activity; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_03815,FUN_015226-T1,Peve_00016437,Pocillopora_meandrina_HIv1___RNAseq.g22183.t1,three_way,58.229,FUN_015226-T1,Q9R008,,,,,41.3,407.0,1.5e-74,281.6,sp|Q9R008|KIME_MOUSE Mevalonate kinase OS=Mus musculus OX=10090 GN=Mvk PE=1 SV=1,,,,,,
OG_03816,FUN_015227-T1,Peve_00016436,Pocillopora_meandrina_HIv1___RNAseq.g22182.t1,three_way,55.849833333333336,,,,,,,,,,,,,,,,,
OG_03817,FUN_015228-T1,Peve_00016435,Pocillopora_meandrina_HIv1___RNAseq.g22181.t1,three_way,74.00666666666666,FUN_015228-T1,Q8R216,SIR4_MOUSE,,"NAD-dependent protein lipoamidase sirtuin-4, mitochondrial (EC 2.3.1.-) (NAD-dependent ADP-ribosyltransferase sirtuin-4) (EC 2.4.2.-) (NAD-dependent protein biotinylase sirtuin-4) (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-4) (EC 2.3.1.286) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4)",Mus musculus (Mouse),59.6,280.0,1.5e-93,344.4,"sp|Q8R216|SIR4_MOUSE NAD-dependent protein lipoamidase sirtuin-4, mitochondrial OS=Mus musculus OX=10090 GN=Sirt4 PE=1 SV=3",GO:0000820; GO:0003950; GO:0005739; GO:0005743; GO:0005759; GO:0006541; GO:0006974; GO:0008270; GO:0010667; GO:0016779; GO:0034979; GO:0034983; GO:0046322; GO:0046676; GO:0046889; GO:0061690; GO:0070403; GO:0071456; GO:0072350; GO:0106419; GO:0106420; GO:0140803; GO:1903217; GO:1904182,cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; glutamine metabolic process [GO:0006541]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of insulin secretion [GO:0046676]; negative regulation of protein processing involved in protein targeting to mitochondrion [GO:1903217]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of lipid biosynthetic process [GO:0046889]; regulation of glutamine family amino acid metabolic process [GO:0000820]; regulation of pyruvate dehydrogenase activity [GO:1904182]; tricarboxylic acid metabolic process [GO:0072350],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],lipoamidase activity [GO:0061690]; NAD+ binding [GO:0070403]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD-dependent protein biotinidase activity [GO:0106420]; NAD-dependent protein lipoamidase activity [GO:0106419]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03818,FUN_015229-T1,Peve_00016434,Pocillopora_meandrina_HIv1___RNAseq.g22180.t1,three_way,49.66866666666667,,,,,,,,,,,,,,,,,
OG_03819,FUN_015230-T1,Peve_00025468,Pocillopora_meandrina_HIv1___RNAseq.g22179.t1,three_way,80.00733333333334,FUN_015230-T1,A7RFA1,,,,,61.3,357.0,4.800000000000001e-130,465.7,sp|A7RFA1|PTER_NEMVE Phosphotriesterase-related protein OS=Nematostella vectensis OX=45351 GN=v1g177083 PE=3 SV=1,,,,,,
OG_03820,FUN_015231-T1,Peve_00016438,Pocillopora_meandrina_HIv1___RNAseq.g22178.t1,three_way,73.793,FUN_015231-T1,Q9CWQ2,,,,,39.3,135.0,2.2e-23,110.2,sp|Q9CWQ2|ZSWM7_MOUSE Zinc finger SWIM domain-containing protein 7 OS=Mus musculus OX=10090 GN=Zswim7 PE=2 SV=1,,,,,,
OG_03821,FUN_015232-T1,Peve_00014806,Pocillopora_meandrina_HIv1___RNAseq.g22177.t1,three_way,66.82233333333333,FUN_015232-T1,P09482,ACHA4_CHICK,,Neuronal acetylcholine receptor subunit alpha-4,Gallus gallus (Chicken),37.8,381.0,1.4e-65,252.3,sp|P09482|ACHA4_CHICK Neuronal acetylcholine receptor subunit alpha-4 OS=Gallus gallus OX=9031 GN=CHRNA4 PE=1 SV=1,GO:0004888; GO:0005886; GO:0005892; GO:0007271; GO:0007274; GO:0022848; GO:0034220; GO:0035094; GO:0043005; GO:0045202; GO:0045211; GO:0051899; GO:0095500,"acetylcholine receptor signaling pathway [GO:0095500]; membrane depolarization [GO:0051899]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; response to nicotine [GO:0035094]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_03822,FUN_015236-T2,Peve_00003466,Pocillopora_meandrina_HIv1___TS.g26934.t1,three_way,62.57566666666666,FUN_015236-T2,Q91X60,ACHA2_MOUSE,,Neuronal acetylcholine receptor subunit alpha-2,Mus musculus (Mouse),38.2,325.0,4.3e-61,237.3,sp|Q91X60|ACHA2_MOUSE Neuronal acetylcholine receptor subunit alpha-2 OS=Mus musculus OX=10090 GN=Chrna2 PE=2 SV=1,GO:0005654; GO:0005892; GO:0015464; GO:0022848; GO:0034703; GO:0045171; GO:0045211; GO:0048167; GO:0050997; GO:0071316; GO:0071944; GO:0098828; GO:0098878; GO:0120111; GO:1901363; GO:1905144,cellular response to nicotine [GO:0071316]; modulation of inhibitory postsynaptic potential [GO:0098828]; regulation of synaptic plasticity [GO:0048167]; response to acetylcholine [GO:1905144],acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cell periphery [GO:0071944]; intercellular bridge [GO:0045171]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; postsynaptic membrane [GO:0045211],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0060089,transporter activity; nucleoplasm; molecular transducer activity
OG_03823,FUN_015237-T1,Peve_00003463,Pocillopora_meandrina_HIv1___RNAseq.g22172.t1,three_way,61.821666666666665,FUN_015237-T1,P49582,,,,,39.0,228.0,2e-37,158.3,sp|P49582|ACHA7_MOUSE Neuronal acetylcholine receptor subunit alpha-7 OS=Mus musculus OX=10090 GN=Chrna7 PE=1 SV=1,,,,,,
OG_03824,FUN_015239-T1,Peve_00003462,Pocillopora_meandrina_HIv1___RNAseq.g22171.t1,three_way,77.89233333333334,FUN_015239-T1,Q8CAM5,,,,,52.4,254.0,7.7e-72,271.9,sp|Q8CAM5|RAB36_MOUSE Ras-related protein Rab-36 OS=Mus musculus OX=10090 GN=Rab36 PE=1 SV=1,,,,,,
OG_03825,FUN_015245-T1,Peve_00003467,Pocillopora_meandrina_HIv1___RNAseq.g22163.t1,three_way,72.38283333333334,FUN_015245-T1,Q6VAB6,KSR2_HUMAN,,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),Homo sapiens (Human),33.3,953.0,6.5e-104,380.2,sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2,GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162,calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; cytosol; plasma membrane; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_03826,FUN_015256-T1,Peve_00014304,Pocillopora_meandrina_HIv1___RNAseq.g22207.t1,three_way,71.4415,FUN_015256-T1,G1SE76,,,,,76.7,146.0,2.9999999999999995e-54,213.0,sp|G1SE76|RL23A_RABIT Large ribosomal subunit protein uL23 OS=Oryctolagus cuniculus OX=9986 GN=RPL23A PE=1 SV=1,,,,,,
OG_03827,FUN_015257-T1,Peve_00014297,Pocillopora_meandrina_HIv1___RNAseq.g22208.t1,three_way,54.744,,,,,,,,,,,,,,,,,
OG_03828,FUN_015258-T1,Peve_00014298,Pocillopora_meandrina_HIv1___RNAseq.g22209.t1,three_way,46.362,FUN_015258-T1,Q8BHE0,,,,,37.9,145.0,7e-15,83.2,sp|Q8BHE0|PRR11_MOUSE Proline-rich protein 11 OS=Mus musculus OX=10090 GN=Prr11 PE=2 SV=1,,,,,,
OG_03829,FUN_015262-T1,Peve_00044772,Pocillopora_meandrina_HIv1___RNAseq.g22284.t1,three_way,66.1165,FUN_015262-T1,Q91XW8,FKBP6_MOUSE,,Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (36 kDa FKBP) (FKBP-36) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36),Mus musculus (Mouse),38.3,298.0,7e-52,206.5,sp|Q91XW8|FKBP6_MOUSE Inactive peptidyl-prolyl cis-trans isomerase FKBP6 OS=Mus musculus OX=10090 GN=Fkbp6 PE=1 SV=1,GO:0000795; GO:0001650; GO:0005654; GO:0005737; GO:0005829; GO:0006457; GO:0007283; GO:0015630; GO:0030154; GO:0031047; GO:0034587; GO:0042802; GO:0045070; GO:0045171; GO:0051321; GO:0051879; GO:0141196,cell differentiation [GO:0030154]; meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; regulatory ncRNA-mediated gene silencing [GO:0031047]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795],Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802],GO:0005654; GO:0005829; GO:0005856; GO:0006325; GO:0006457; GO:0022414; GO:0030154; GO:0031047; GO:0043226,nucleoplasm; cytosol; cytoskeleton; chromatin organization; protein folding; reproductive process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle
OG_03830,FUN_015263-T1,Peve_00044771,Pocillopora_meandrina_HIv1___RNAseq.g22216.t1,three_way,70.697,FUN_015263-T1,Q9CQM5,,,,,45.2,115.0,2.1e-22,106.7,sp|Q9CQM5|TXD17_MOUSE Thioredoxin domain-containing protein 17 OS=Mus musculus OX=10090 GN=Txndc17 PE=1 SV=1,,,,,,
OG_03831,FUN_015264-T1,Peve_00044770,Pocillopora_meandrina_HIv1___RNAseq.g22217.t1,three_way,60.812,,,,,,,,,,,,,,,,,
OG_03832,FUN_015272-T1,Peve_00044766,Pocillopora_meandrina_HIv1___TS.g26974.t1,three_way,61.09433333333334,FUN_015272-T1,Q5ZIA0,MET16_CHICK,,RNA N(6)-adenosine-methyltransferase METTL16 (EC 2.1.1.348) (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346),Gallus gallus (Chicken),47.3,389.0,1.9e-95,351.3,sp|Q5ZIA0|MET16_CHICK RNA N(6)-adenosine-methyltransferase METTL16 OS=Gallus gallus OX=9031 GN=METTL16 PE=2 SV=1,GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0061157; GO:0070475; GO:0120048; GO:0120049,"mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]",cytoplasm [GO:0005737]; nucleus [GO:0005634],mRNA m(6)A methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629],GO:0003723; GO:0003824; GO:0005634; GO:0006790; GO:0016071; GO:0016073; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; sulfur compound metabolic process; mRNA metabolic process; snRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_03833,FUN_015275-T1,Peve_00014300,Pocillopora_meandrina_HIv1___RNAseq.g22211.t1,three_way,69.08766666666666,FUN_015275-T1,B5X5N3,SKA2_SALSA,,SKA complex subunit 2 (Protein FAM33A) (Spindle and kinetochore-associated protein 2),Salmo salar (Atlantic salmon),29.1,234.0,9.7e-15,82.0,sp|B5X5N3|SKA2_SALSA SKA complex subunit 2 OS=Salmo salar OX=8030 GN=ska2 PE=2 SV=1,GO:0000070; GO:0000940; GO:0005737; GO:0005876; GO:0007080; GO:0008017; GO:0031110; GO:0051301; GO:0051315; GO:0072687,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110],cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876],microtubule binding [GO:0008017],GO:0007059; GO:0008092; GO:0043226,chromosome segregation; cytoskeletal protein binding; organelle
OG_03834,FUN_015291-T1,Peve_00022865,Pocillopora_meandrina_HIv1___RNAseq.g22113.t1,three_way,61.755,FUN_015291-T1,O75771,RA51D_HUMAN,,DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD),Homo sapiens (Human),40.4,319.0,2.5e-56,220.7,sp|O75771|RA51D_HUMAN DNA repair protein RAD51 homolog 4 OS=Homo sapiens OX=9606 GN=RAD51D PE=1 SV=1,GO:0000722; GO:0000723; GO:0000724; GO:0000781; GO:0003677; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0005815; GO:0006281; GO:0007131; GO:0008094; GO:0016887; GO:0033063; GO:0036297; GO:0042148; GO:0043015; GO:0051726; GO:0140664,DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; reciprocal meiotic recombination [GO:0007131]; regulation of cell cycle [GO:0051726]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; gamma-tubulin binding [GO:0043015]; single-stranded DNA binding [GO:0003697]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0006310; GO:0008092; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; DNA recombination; cytoskeletal protein binding; hydrolase activity; reproductive process; telomere organization; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_03835,FUN_015292-T1,Peve_00025007,Pocillopora_meandrina_HIv1___RNAseq.g22112.t1,three_way,67.77799999999999,FUN_015292-T1,P22439,,,,,48.2,448.0,2.2e-101,370.9,sp|P22439|ODPX_BOVIN Pyruvate dehydrogenase protein X component OS=Bos taurus OX=9913 GN=PDHX PE=1 SV=3,,,,,,
OG_03836,FUN_015293-T1,Peve_00022868,Pocillopora_meandrina_HIv1___RNAseq.g22111.t2,three_way,70.97083333333333,FUN_015293-T1,Q08D69,,,,,31.1,892.0,3.5e-113,411.0,sp|Q08D69|MED16_XENTR Mediator of RNA polymerase II transcription subunit 16 OS=Xenopus tropicalis OX=8364 GN=med16 PE=2 SV=1,,,,,,
OG_03837,FUN_015294-T1,Peve_00022864,Pocillopora_meandrina_HIv1___RNAseq.g22110.t1,three_way,50.94466666666667,FUN_015294-T1,Q5EBL4,RIPL1_HUMAN,,RILP-like protein 1 (Rab-interacting lysosomal-like protein 1),Homo sapiens (Human),34.1,217.0,6.2e-22,107.1,sp|Q5EBL4|RIPL1_HUMAN RILP-like protein 1 OS=Homo sapiens OX=9606 GN=RILPL1 PE=1 SV=1,GO:0003382; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005886; GO:0005929; GO:0007263; GO:0031267; GO:0036064; GO:0046983; GO:0051959; GO:0060271; GO:1903445,cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; nitric oxide mediated signal transduction [GO:0007263]; protein transport from ciliary membrane to plasma membrane [GO:1903445],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0043226; GO:0044782; GO:0061024; GO:0072659,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; cilium; intracellular protein transport; organelle; cilium organization; membrane organization; protein localization to plasma membrane
OG_03838,FUN_015297-T1,Peve_00004803,Pocillopora_meandrina_HIv1___RNAseq.g22107.t1,three_way,74.56266666666667,FUN_015297-T1,F1NZI4,,,,,39.2,683.0,1.8e-131,471.5,sp|F1NZI4|PGGHG_CHICK Protein-glucosylgalactosylhydroxylysine glucosidase OS=Gallus gallus OX=9031 GN=PGGHG PE=1 SV=3,,,,,,
OG_03839,FUN_015298-T1,Peve_00004801,Pocillopora_meandrina_HIv1___RNAseq.g22106.t1,three_way,63.3705,FUN_015298-T1,Q8QFX1,,,,,28.4,1242.0,2.4e-83,313.2,sp|Q8QFX1|RIMB2_CHICK RIMS-binding protein 2 OS=Gallus gallus OX=9031 GN=RIMBP2 PE=1 SV=1,,,,,,
OG_03840,FUN_015300-T1,Peve_00004800,Pocillopora_meandrina_HIv1___RNAseq.g22105.t1,three_way,84.87466666666667,FUN_015300-T1,Q9Y2S7,,,,,62.0,308.0,4.2e-107,389.4,sp|Q9Y2S7|PDIP2_HUMAN Polymerase delta-interacting protein 2 OS=Homo sapiens OX=9606 GN=POLDIP2 PE=1 SV=1,,,,,,
OG_03841,FUN_015303-T1,Peve_00004798,Pocillopora_meandrina_HIv1___TS.g26862.t2,three_way,86.89800000000001,FUN_015303-T1,P42207,,,,,64.0,331.0,1.8e-122,440.7,sp|P42207|SEPT1_DROME Septin-1 OS=Drosophila melanogaster OX=7227 GN=Septin1 PE=1 SV=1,,,,,,
OG_03842,FUN_015304-T1,Peve_00004797,Pocillopora_meandrina_HIv1___RNAseq.g22098.t1,three_way,76.9795,FUN_015304-T1,Q174D3,,,,,51.8,114.0,2.2e-23,110.9,sp|Q174D3|MED19_AEDAE Mediator of RNA polymerase II transcription subunit 19 OS=Aedes aegypti OX=7159 GN=MED19 PE=3 SV=1,,,,,,
OG_03843,FUN_015308-T1,Peve_00024022,Pocillopora_meandrina_HIv1___RNAseq.g21734.t1,three_way,74.93433333333334,FUN_015308-T1,Q9WU01,KHDR2_MOUSE,,"KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1) (SLM-1) (mSLM-1)",Mus musculus (Mouse),53.1,226.0,9.8e-56,218.8,"sp|Q9WU01|KHDR2_MOUSE KH domain-containing, RNA-binding, signal transduction-associated protein 2 OS=Mus musculus OX=10090 GN=Khdrbs2 PE=1 SV=1",GO:0005634; GO:0006397; GO:0008143; GO:0008266; GO:0017124; GO:0042169; GO:0048024,"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]",nucleus [GO:0005634],poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_03844,FUN_015310-T1,Peve_00023980,Pocillopora_meandrina_HIv1___RNAseq.g21733.t1,three_way,53.04566666666667,FUN_015310-T1,Q924H0,,,,,28.4,310.0,2.8000000000000004e-22,107.5,sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2,,,,,,
OG_03845,FUN_015318-T1,Peve_00023982,Pocillopora_meandrina_HIv1___RNAseq.g21728.t1,three_way,82.93366666666667,FUN_015318-T1,Q5QNI2,,,,,31.0,532.0,4.7999999999999997e-54,213.8,sp|Q5QNI2|NCL1_ORYSJ Sodium/calcium exchanger NCL1 OS=Oryza sativa subsp. japonica OX=39947 GN=NCL1 PE=2 SV=1,,,,,,
OG_03846,FUN_015325-T1,Peve_00023983,Pocillopora_meandrina_HIv1___RNAseq.g21727.t1,three_way,67.91250000000001,FUN_015325-T1,Q9VKJ9,C2D1_DROME,,Coiled-coil and C2 domain-containing protein 1-like (Lethal (2) giant discs 1 protein),Drosophila melanogaster (Fruit fly),40.0,758.0,1e-103,379.8,sp|Q9VKJ9|C2D1_DROME Coiled-coil and C2 domain-containing protein 1-like OS=Drosophila melanogaster OX=7227 GN=l(2)gd1 PE=1 SV=1,GO:0000281; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0005737; GO:0005829; GO:0005938; GO:0006357; GO:0006886; GO:0007219; GO:0007423; GO:0007472; GO:0008586; GO:0010008; GO:0016197; GO:0016327; GO:0032509; GO:0045035; GO:0045746; GO:0048132; GO:0048749; GO:0098592; GO:1901981; GO:1905367,compound eye development [GO:0048749]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; positive regulation of intralumenal vesicle formation [GO:1905367]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472],apicolateral plasma membrane [GO:0016327]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; phosphatidylinositol phosphate binding [GO:1901981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0000910; GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0006886; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0140110,cytokinesis; DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; transcription regulator activity
OG_03847,FUN_015338-T2,Peve_00023985,Pocillopora_meandrina_HIv1___RNAseq.g21723.t1,three_way,71.78633333333333,FUN_015338-T2,Q5BJE1,CC178_HUMAN,,Coiled-coil domain-containing protein 178,Homo sapiens (Human),30.5,131.0,2.5e-09,66.2,sp|Q5BJE1|CC178_HUMAN Coiled-coil domain-containing protein 178 OS=Homo sapiens OX=9606 GN=CCDC178 PE=1 SV=3,GO:0036064,,ciliary basal body [GO:0036064],,GO:0005815,microtubule organizing center
OG_03848,FUN_015339-T1,Peve_00023987,Pocillopora_meandrina_HIv1___TS.g26471.t1,three_way,94.288,FUN_015339-T1,Q6PC72,CIB2_DANRE,,Calcium and integrin-binding family member 2,Danio rerio (Zebrafish) (Brachydanio rerio),47.3,188.0,1.6000000000000002e-44,180.6,sp|Q6PC72|CIB2_DANRE Calcium and integrin-binding family member 2 OS=Danio rerio OX=7955 GN=cib2 PE=2 SV=1,GO:0000287; GO:0001750; GO:0001917; GO:0005509; GO:0005737; GO:0007638; GO:0032420; GO:0042383; GO:0043010; GO:0048884; GO:0055074; GO:0071944,calcium ion homeostasis [GO:0055074]; camera-type eye development [GO:0043010]; mechanosensory behavior [GO:0007638]; neuromast development [GO:0048884],cell periphery [GO:0071944]; cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; sarcolemma [GO:0042383]; stereocilium [GO:0032420],calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287],GO:0005886; GO:0048856,plasma membrane; anatomical structure development
OG_03849,FUN_015340-T1,Peve_00011273,Pocillopora_meandrina_HIv1___RNAseq.g21716.t1,three_way,56.37466666666666,FUN_015340-T1,Q6NTW1,,,,,36.2,343.0,6.6e-45,183.3,sp|Q6NTW1|BSC1B_XENLA BSD domain-containing protein 1-B OS=Xenopus laevis OX=8355 GN=bsdc1-b PE=2 SV=1,,,,,,
OG_03850,FUN_015341-T1,Peve_00011271,Pocillopora_meandrina_HIv1___RNAseq.g21717.t1,three_way,80.268,FUN_015341-T1,A0A1S4F2V5,,,,,44.7,311.0,4.2e-66,254.2,sp|A0A1S4F2V5|CATL_AEDAE Cathepsin L-like peptidase OS=Aedes aegypti OX=7159 PE=1 SV=1,,,,,,
OG_03851,FUN_015343-T1,Peve_00011270,Pocillopora_meandrina_HIv1___TS.g26467.t1,three_way,68.14433333333334,FUN_015343-T1,Q9WTK8,SPO11_MOUSE,,Meiotic recombination protein SPO11 (EC 5.6.2.2),Mus musculus (Mouse),52.6,171.0,1.7e-51,204.5,sp|Q9WTK8|SPO11_MOUSE Meiotic recombination protein SPO11 OS=Mus musculus OX=10090 GN=Spo11 PE=1 SV=2,GO:0000781; GO:0001541; GO:0003677; GO:0003918; GO:0005524; GO:0005654; GO:0007129; GO:0007130; GO:0007131; GO:0007141; GO:0007286; GO:0034502; GO:0042138; GO:0045141; GO:0046872; GO:0048477; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; male meiosis I [GO:0007141]; meiotic DNA double-strand break formation [GO:0042138]; meiotic telomere clustering [GO:0045141]; oogenesis [GO:0048477]; ovarian follicle development [GO:0001541]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130],"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]","ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; metal ion binding [GO:0046872]",GO:0003677; GO:0003824; GO:0005654; GO:0006281; GO:0006310; GO:0016853; GO:0022414; GO:0048856; GO:0140013; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; DNA repair; DNA recombination; isomerase activity; reproductive process; anatomical structure development; meiotic nuclear division; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03852,FUN_015344-T1,Peve_00011267,Pocillopora_meandrina_HIv1___TS.g26468.t1,three_way,95.928,FUN_015344-T1,Q9V359,,,,,70.9,206.0,5.3e-79,295.4,sp|Q9V359|VPS28_DROME Vacuolar protein sorting-associated protein 28 homolog OS=Drosophila melanogaster OX=7227 GN=Vps28 PE=1 SV=1,,,,,,
OG_03853,FUN_015345-T1,Peve_00011268,Pocillopora_meandrina_HIv1___RNAseq.g21720.t1,three_way,74.91566666666667,FUN_015345-T1,Q5M7F8,,,,,39.9,138.0,9.200000000000001e-22,105.1,sp|Q5M7F8|CM2CA_XENLA Ciliary microtubule inner protein 2C OS=Xenopus laevis OX=8355 GN=cimip2ca PE=2 SV=1,,,,,,
OG_03854,FUN_015346-T1,Peve_00017513,Pocillopora_meandrina_HIv1___RNAseq.g21715.t1,three_way,54.33833333333333,,,,,,,,,,,,,,,,,
OG_03855,FUN_015347-T1,Peve_00017516,Pocillopora_meandrina_HIv1___RNAseq.g21714.t1,three_way,73.20033333333333,FUN_015347-T1,Q0VCH8,,,,,48.9,178.0,3.9999999999999995e-42,172.9,sp|Q0VCH8|TMM65_BOVIN Transmembrane protein 65 OS=Bos taurus OX=9913 GN=TMEM65 PE=2 SV=1,,,,,,
OG_03856,FUN_015349-T1,Peve_00017518,Pocillopora_meandrina_HIv1___RNAseq.g21711.t1,three_way,74.874,FUN_015349-T1,Q54TR1,CFAD_DICDI,,Counting factor associated protein D,Dictyostelium discoideum (Social amoeba),29.7,528.0,3.8000000000000003e-59,231.1,sp|Q54TR1|CFAD_DICDI Counting factor associated protein D OS=Dictyostelium discoideum OX=44689 GN=cfaD PE=1 SV=1,GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0031288; GO:0031410; GO:0072659; GO:0140986; GO:1903665; GO:2001235,G protein-coupled chemorepellent receptor signaling pathway [GO:0140986]; immune response [GO:0006955]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; sorocarp morphogenesis [GO:0031288],cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764],,GO:0002376; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0031410; GO:0043226; GO:0072659,immune system process; extracellular region; extracellular space; lysosome; vacuole; cytoplasmic vesicle; organelle; protein localization to plasma membrane
OG_03857,FUN_015350-T1,Peve_00017519,Pocillopora_meandrina_HIv1___RNAseq.g21710.t1,three_way,76.06583333333333,FUN_015350-T1,P13277,,,,,36.8,321.0,1.5999999999999998e-49,199.1,sp|P13277|CYSP1_HOMAM Digestive cysteine proteinase 1 OS=Homarus americanus OX=6706 GN=LCP1 PE=1 SV=2,,,,,,
OG_03858,FUN_015352-T1,Peve_00017515,Pocillopora_meandrina_HIv1___RNAseq.g21698.t1,three_way,68.03,FUN_015352-T1,P07098,LIPF_HUMAN,,Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3),Homo sapiens (Human),53.2,370.0,9.900000000000001e-111,401.7,sp|P07098|LIPF_HUMAN Gastric triacylglycerol lipase OS=Homo sapiens OX=9606 GN=LIPF PE=1 SV=1,GO:0004806; GO:0005576; GO:0005739; GO:0006108; GO:0006641; GO:0008289; GO:0016042; GO:0016615; GO:0043231,lipid catabolic process [GO:0016042]; malate metabolic process [GO:0006108]; triglyceride metabolic process [GO:0006641],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; malate dehydrogenase activity [GO:0016615]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005576; GO:0005739; GO:0006629; GO:0008289; GO:0016491; GO:0016787; GO:0043226,catalytic activity; extracellular region; mitochondrion; lipid metabolic process; lipid binding; oxidoreductase activity; hydrolase activity; organelle
OG_03859,FUN_015357-T1,Peve_00000218,Pocillopora_meandrina_HIv1___RNAseq.g21699.t1,three_way,59.97833333333333,FUN_015357-T1,Q18297,TRPA1_CAEEL,,Transient receptor potential cation channel subfamily A member 1 homolog,Caenorhabditis elegans,26.7,737.0,7.4e-60,234.2,sp|Q18297|TRPA1_CAEEL Transient receptor potential cation channel subfamily A member 1 homolog OS=Caenorhabditis elegans OX=6239 GN=trpa-1 PE=2 SV=5,GO:0005216; GO:0005886; GO:0043025; GO:0097730,,neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],monoatomic ion channel activity [GO:0005216],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_03860,FUN_015360-T1,Peve_00000225,Pocillopora_meandrina_HIv1___RNAseq.g21701.t1,three_way,89.93766666666667,FUN_015360-T1,Q5VU57,CBPC6_HUMAN,,Cytosolic carboxypeptidase 6 (EC 3.4.17.24) (ATP/GTP-binding protein-like 4) (Protein deglutamylase CCP6),Homo sapiens (Human),66.1,472.0,3.8e-191,669.1,sp|Q5VU57|CBPC6_HUMAN Cytosolic carboxypeptidase 6 OS=Homo sapiens OX=9606 GN=AGBL4 PE=1 SV=3,GO:0004181; GO:0005737; GO:0005794; GO:0005814; GO:0005829; GO:0006508; GO:0008270; GO:0008285; GO:0015630; GO:0015631; GO:0021954; GO:0035608; GO:0035609; GO:0035610; GO:0036064; GO:0051607; GO:0098957; GO:0098958; GO:0120222; GO:1904115; GO:2000060,anterograde axonal transport of mitochondrion [GO:0098957]; C-terminal protein deglutamylation [GO:0035609]; central nervous system neuron development [GO:0021954]; defense response to virus [GO:0051607]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein deglutamylation [GO:0035608]; protein side chain deglutamylation [GO:0035610]; proteolysis [GO:0006508]; regulation of blastocyst development [GO:0120222]; retrograde axonal transport of mitochondrion [GO:0098958],axon cytoplasm [GO:1904115]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule cytoskeleton [GO:0015630],metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0007018; GO:0008092; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03861,FUN_015361-T1,Peve_00000232,Pocillopora_meandrina_HIv1___RNAseq.g21702.t1,three_way,42.016,,,,,,,,,,,,,,,,,
OG_03862,FUN_015365-T1,Peve_00000208,Pocillopora_meandrina_HIv1___RNAseq.g21709.t1,three_way,84.68366666666667,FUN_015365-T1,P91119,PDE5_CAEEL,,"Probable 3',5'-cyclic phosphodiesterase pde-5 (EC 3.1.4.17)",Caenorhabditis elegans,44.3,774.0,3.4e-175,617.1,"sp|P91119|PDE5_CAEEL Probable 3',5'-cyclic phosphodiesterase pde-5 OS=Caenorhabditis elegans OX=6239 GN=pde-5 PE=3 SV=3",GO:0004115; GO:0004118; GO:0006935; GO:0007602; GO:0007635; GO:0008340; GO:0010446; GO:0010628; GO:0010754; GO:0019933; GO:0032528; GO:0042542; GO:0046872; GO:0047555,cAMP-mediated signaling [GO:0019933]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542],,"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]",GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_03863,FUN_015366-T1,Peve_00000210,Pocillopora_meandrina_HIv1___RNAseq.g21696.t1,three_way,87.96916666666667,FUN_015366-T1,Q9D8V0,SPP_MOUSE,,Signal peptide peptidase (EC 3.4.23.-) (Minor histocompatibility antigen H13) (Presenilin-like protein 3) (Signal peptide peptidase-like 1),Mus musculus (Mouse),64.6,350.0,7.2e-124,445.3,sp|Q9D8V0|SPP_MOUSE Signal peptide peptidase OS=Mus musculus OX=10090 GN=Hm13 PE=1 SV=1,GO:0001701; GO:0005783; GO:0005789; GO:0005791; GO:0005886; GO:0008233; GO:0009986; GO:0031625; GO:0033619; GO:0036513; GO:0042500; GO:0042803; GO:0098553; GO:0098554; GO:1904211,"in utero embryonic development [GO:0001701]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]",cell surface [GO:0009986]; cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005783; GO:0005886; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endoplasmic reticulum; plasma membrane; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03864,FUN_015372-T1,Peve_00000220,Pocillopora_meandrina_HIv1___RNAseq.g21694.t1,three_way,63.956,FUN_015372-T1,Q9H6I2,SOX17_HUMAN,,Transcription factor SOX-17,Homo sapiens (Human),47.8,178.0,6.5e-29,129.8,sp|Q9H6I2|SOX17_HUMAN Transcription factor SOX-17 OS=Homo sapiens OX=9606 GN=SOX17 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001570; GO:0001656; GO:0001706; GO:0001714; GO:0001828; GO:0001947; GO:0003142; GO:0003143; GO:0003151; GO:0005634; GO:0005654; GO:0005667; GO:0006355; GO:0006357; GO:0007283; GO:0007493; GO:0007507; GO:0008013; GO:0010467; GO:0010628; GO:0016055; GO:0021903; GO:0023019; GO:0030308; GO:0031648; GO:0035050; GO:0042074; GO:0043279; GO:0045732; GO:0045893; GO:0045944; GO:0045995; GO:0048617; GO:0048866; GO:0050821; GO:0060214; GO:0060913; GO:0060914; GO:0060956; GO:0061009; GO:0061010; GO:0061031; GO:0061629; GO:0072091; GO:0072189; GO:0090090; GO:1903226; GO:1990830; GO:2000035; GO:2000043; GO:2000738,angiogenesis [GO:0001525]; cardiac cell fate determination [GO:0060913]; cardiogenic plate morphogenesis [GO:0003142]; cell migration involved in gastrulation [GO:0042074]; cellular response to leukemia inhibitory factor [GO:1990830]; common bile duct development [GO:0061009]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cell differentiation [GO:0060956]; endocardium formation [GO:0060214]; endoderm formation [GO:0001706]; endodermal cell fate determination [GO:0007493]; endodermal cell fate specification [GO:0001714]; endodermal digestive tract morphogenesis [GO:0061031]; gallbladder development [GO:0061010]; gene expression [GO:0010467]; heart development [GO:0007507]; heart formation [GO:0060914]; heart looping [GO:0001947]; inner cell mass cellular morphogenesis [GO:0001828]; metanephros development [GO:0001656]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; outflow tract morphogenesis [GO:0003151]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endodermal cell differentiation [GO:1903226]; positive regulation of gene expression [GO:0010628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of cardiac cell fate specification [GO:2000043]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of stem cell division [GO:2000035]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to alkaloid [GO:0043279]; rostrocaudal neural tube patterning [GO:0021903]; signal transduction involved in regulation of gene expression [GO:0023019]; spermatogenesis [GO:0007283]; stem cell fate specification [GO:0048866]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_03865,FUN_015373-T1,Peve_00000221,Pocillopora_meandrina_HIv1___RNAseq.g10184.t1,three_way,76.64383333333333,FUN_015373-T1,Q01320,TOP2A_MOUSE,,"DNA topoisomerase 2-alpha (EC 5.6.2.2) (DNA topoisomerase II, alpha isozyme)",Mus musculus (Mouse),67.5,1208.0,0.0,1654.4,sp|Q01320|TOP2A_MOUSE DNA topoisomerase 2-alpha OS=Mus musculus OX=10090 GN=Top2a PE=1 SV=2,GO:0000228; GO:0000287; GO:0000775; GO:0000793; GO:0001673; GO:0002244; GO:0003682; GO:0003918; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005814; GO:0006265; GO:0006325; GO:0006974; GO:0007059; GO:0007143; GO:0008301; GO:0009330; GO:0030261; GO:0030263; GO:0040016; GO:0042752; GO:0042803; GO:0043065; GO:0043130; GO:0045870; GO:0045944; GO:0046982; GO:0048511; GO:0051309; GO:1990904,apoptotic chromosome condensation [GO:0030263]; chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of apoptotic process [GO:0043065]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511],"centriole [GO:0005814]; chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex [GO:0009330]; male germ cell nucleus [GO:0001673]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]","ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding, bending [GO:0008301]; DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; ubiquitin binding [GO:0043130]",GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006355; GO:0007059; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140097; GO:0140657,"nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; isomerase activity; reproductive process; cell differentiation; organelle; meiotic nuclear division; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03866,FUN_015376-T1,Peve_00034026,Pocillopora_meandrina_HIv1___RNAseq.g14841.t2,three_way,51.12266666666667,FUN_015376-T1,Q9I9D5,,,,,36.3,146.0,1.4e-13,78.2,sp|Q9I9D5|RX1_PSAFA Retinal homeobox protein Rx1 OS=Psalidodon fasciatus OX=223369 GN=rx1 PE=2 SV=1,,,,,,
OG_03867,FUN_015377-T1,Peve_00000222,Pocillopora_meandrina_HIv1___RNAseq.g21693.t1,three_way,79.768,FUN_015377-T1,Q32LJ2,ARFRP_BOVIN,,ADP-ribosylation factor-related protein 1 (ARF-related protein 1),Bos taurus (Bovine),58.2,201.0,7.3e-67,255.0,sp|Q32LJ2|ARFRP_BOVIN ADP-ribosylation factor-related protein 1 OS=Bos taurus OX=9913 GN=ARFRP1 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005794; GO:0006886; GO:0034067; GO:0043001,Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067],Golgi apparatus [GO:0005794],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005794; GO:0006886; GO:0016192; GO:0016787; GO:0043226; GO:0072659,catalytic activity; GTPase activity; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; hydrolase activity; organelle; protein localization to plasma membrane
OG_03868,FUN_015378-T1,Peve_00000223,Pocillopora_meandrina_HIv1___RNAseq.g21692.t1,three_way,46.99966666666667,,,,,,,,,,,,,,,,,
OG_03869,FUN_015381-T1,Peve_00000227,Pocillopora_meandrina_HIv1___TS.g26436.t1,three_way,62.752,,,,,,,,,,,,,,,,,
OG_03870,FUN_015388-T1,Peve_00006063,Pocillopora_meandrina_HIv1___RNAseq.g21662.t1,three_way,81.37566666666667,FUN_015388-T1,Q5ZKT8,,,,,48.2,228.0,1.1e-50,201.4,sp|Q5ZKT8|RM15_CHICK Large ribosomal subunit protein uL15m OS=Gallus gallus OX=9031 GN=MRPL15 PE=2 SV=1,,,,,,
OG_03871,FUN_015401-T1,Peve_00006062,Pocillopora_meandrina_HIv1___TS.g26410.t1,three_way,59.00933333333333,FUN_015401-T1,Q02363,ID2_HUMAN,,DNA-binding protein inhibitor ID-2 (Class B basic helix-loop-helix protein 26) (bHLHb26) (Inhibitor of DNA binding 2) (Inhibitor of differentiation 2),Homo sapiens (Human),50.0,72.0,3.5e-14,79.3,sp|Q02363|ID2_HUMAN DNA-binding protein inhibitor ID-2 OS=Homo sapiens OX=9606 GN=ID2 PE=1 SV=1,GO:0000122; GO:0000791; GO:0001656; GO:0001779; GO:0001966; GO:0003149; GO:0003166; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007507; GO:0007623; GO:0008344; GO:0010628; GO:0010629; GO:0014003; GO:0019216; GO:0021772; GO:0030182; GO:0030183; GO:0032922; GO:0032991; GO:0033598; GO:0042752; GO:0043153; GO:0043353; GO:0043433; GO:0044325; GO:0045475; GO:0045578; GO:0045600; GO:0045648; GO:0045651; GO:0045664; GO:0045668; GO:0045777; GO:0045892; GO:0045893; GO:0046983; GO:0048469; GO:0048541; GO:0048557; GO:0048661; GO:0048663; GO:0048667; GO:0048708; GO:0048711; GO:0048715; GO:0050872; GO:0051148; GO:0060612; GO:0060749; GO:0061030; GO:0061031; GO:0061629; GO:0071285; GO:0071542; GO:0090398; GO:0140416; GO:1904339; GO:2000045; GO:2000177,adipose tissue development [GO:0060612]; adult locomotory behavior [GO:0008344]; astrocyte differentiation [GO:0048708]; B cell differentiation [GO:0030183]; bundle of His development [GO:0003166]; cell maturation [GO:0048469]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to lithium ion [GO:0071285]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; dopaminergic neuron differentiation [GO:0071542]; embryonic digestive tract morphogenesis [GO:0048557]; endodermal digestive tract morphogenesis [GO:0061031]; entrainment of circadian clock by photoperiod [GO:0043153]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; heart development [GO:0007507]; locomotor rhythm [GO:0045475]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; membranous septum morphogenesis [GO:0003149]; metanephros development [GO:0001656]; natural killer cell differentiation [GO:0001779]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; neuron fate commitment [GO:0048663]; olfactory bulb development [GO:0021772]; oligodendrocyte development [GO:0014003]; Peyer's patch development [GO:0048541]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of blood pressure [GO:0045777]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of circadian rhythm [GO:0042752]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lipid metabolic process [GO:0019216]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; thigmotaxis [GO:0001966]; white fat cell differentiation [GO:0050872],cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],protein dimerization activity [GO:0046983]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140110,immune system process; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; transcription regulator activity
OG_03872,FUN_015402-T1,Peve_00006057,Pocillopora_meandrina_HIv1___TS.g26409.t1,three_way,53.396,FUN_015402-T1,P61593,,,,,27.6,821.0,6.4e-45,184.1,sp|P61593|MCPH1_PANTR Microcephalin OS=Pan troglodytes OX=9598 GN=MCPH1 PE=3 SV=1,,,,,,
OG_03873,FUN_015403-T1,Peve_00000197,Pocillopora_meandrina_HIv1___RNAseq.g21683.t3,three_way,65.7255,FUN_015403-T1,P26591,,,,,26.3,890.0,1.6e-73,279.3,sp|P26591|GLRK_LYMST Glutamate receptor OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_03874,FUN_015405-T1,Peve_00000200,Pocillopora_meandrina_HIv1___RNAseq.g21681.t1,three_way,86.47533333333334,FUN_015405-T1,Q26619,,,,,47.3,383.0,1.5e-89,331.3,sp|Q26619|KAPR_STRPU cAMP-dependent protein kinase type II regulatory subunit OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_03875,FUN_015406-T1,Peve_00000203,Pocillopora_meandrina_HIv1___RNAseq.g21679.t1,three_way,55.48783333333333,,,,,,,,,,,,,,,,,
OG_03876,FUN_015407-T1,Peve_00000205,Pocillopora_meandrina_HIv1___RNAseq.g21678.t1,three_way,83.027,FUN_015407-T1,P55088,,,,,45.0,222.0,3.6e-50,199.9,sp|P55088|AQP4_MOUSE Aquaporin-4 OS=Mus musculus OX=10090 GN=Aqp4 PE=1 SV=2,,,,,,
OG_03877,FUN_015410-T1,Peve_00026944,Pocillopora_meandrina_HIv1___TS.g26425.t1,three_way,75.58566666666667,,,,,,,,,,,,,,,,,
OG_03878,FUN_015411-T1,Peve_00026943,Pocillopora_meandrina_HIv1___RNAseq.g21674.t1,three_way,92.28733333333334,FUN_015411-T1,Q7ZVM1,WASC5_DANRE,,WASH complex subunit 5 (WASH complex subunit strumpellin),Danio rerio (Zebrafish) (Brachydanio rerio),67.2,1161.0,0.0,1580.8,sp|Q7ZVM1|WASC5_DANRE WASH complex subunit 5 OS=Danio rerio OX=7955 GN=washc5 PE=2 SV=1,GO:0005768; GO:0005769; GO:0007032; GO:0007409; GO:0015031; GO:0030041; GO:0048666; GO:0048738; GO:0051125; GO:0060047; GO:0071203; GO:0140285; GO:1905304,actin filament polymerization [GO:0030041]; axonogenesis [GO:0007409]; cardiac muscle tissue development [GO:0048738]; endosome fission [GO:0140285]; endosome organization [GO:0007032]; heart contraction [GO:0060047]; neuron development [GO:0048666]; protein transport [GO:0015031]; regulation of actin nucleation [GO:0051125]; regulation of cardiac myofibril assembly [GO:1905304],early endosome [GO:0005769]; endosome [GO:0005768]; WASH complex [GO:0071203],,GO:0003013; GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0065003,circulatory system process; endosome; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly
OG_03879,FUN_015412-T1,Peve_00000196,Pocillopora_meandrina_HIv1___RNAseq.g21684.t1,three_way,60.65833333333333,FUN_015412-T1,O62809,,,,,24.8,319.0,1.1e-12,75.9,sp|O62809|OX2R_PIG Orexin receptor type 2 OS=Sus scrofa OX=9823 GN=HCRTR2 PE=2 SV=2,,,,,,
OG_03880,FUN_015414-T1,Peve_00000229,Pocillopora_meandrina_HIv1___TS.g26435.t1,three_way,64.94816666666667,FUN_015414-T1,Q9Z2W8,,,,,38.5,436.0,1.3e-81,305.4,sp|Q9Z2W8|GRIA4_MOUSE Glutamate receptor 4 OS=Mus musculus OX=10090 GN=Gria4 PE=1 SV=2,,,,,,
OG_03881,FUN_015423-T1,Peve_00011818,Pocillopora_meandrina_HIv1___RNAseq.g21657.t1,three_way,82.22166666666666,FUN_015423-T1,Q5E9X1,,,,,78.6,140.0,3.3000000000000004e-57,223.8,sp|Q5E9X1|NFYC_BOVIN Nuclear transcription factor Y subunit gamma OS=Bos taurus OX=9913 GN=NFYC PE=2 SV=1,,,,,,
OG_03882,FUN_015424-T1,Peve_00011815,Pocillopora_meandrina_HIv1___RNAseq.g21656.t1,three_way,94.874,FUN_015424-T1,Q6PC30,CSN5_DANRE,,COP9 signalosome complex subunit 5 (Signalosome subunit 5) (EC 3.4.-.-),Danio rerio (Zebrafish) (Brachydanio rerio),84.4,327.0,2.1e-159,563.1,sp|Q6PC30|CSN5_DANRE COP9 signalosome complex subunit 5 OS=Danio rerio OX=7955 GN=cops5 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008021; GO:0008180; GO:0008237; GO:0019784; GO:0043066; GO:0046872; GO:0048471; GO:0051091; GO:0051726; GO:0060118,negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726]; vestibular receptor cell development [GO:0060118],COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021],deNEDDylase activity [GO:0019784]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03883,FUN_015428-T1,Peve_00033605,Pocillopora_meandrina_HIv1___RNAseq.1500_t,three_way,71.406,,,,,,,,,,,,,,,,,
OG_03884,FUN_015429-T1,Peve_00033649,Pocillopora_meandrina_HIv1___RNAseq.g22262.t1,three_way,84.209,FUN_015429-T1,Q5ZI89,,,,,48.9,1121.0,0.0,1077.0,sp|Q5ZI89|TPC11_CHICK Trafficking protein particle complex subunit 11 OS=Gallus gallus OX=9031 GN=TRAPPC11 PE=2 SV=1,,,,,,
OG_03885,FUN_015430-T1,Peve_00024665,Pocillopora_meandrina_HIv1___RNAseq.g24150.t1,three_way,47.89966666666667,FUN_015430-T1,P34324,,,,,25.0,132.0,1.7e-07,58.5,sp|P34324|BAT15_CAEEL BTB and MATH domain-containing protein 15 (Fragment) OS=Caenorhabditis elegans OX=6239 GN=bath-15 PE=1 SV=2,,,,,,
OG_03886,FUN_015434-T1,Peve_00033645,Pocillopora_meandrina_HIv1___RNAseq.g22219.t1,three_way,88.301,FUN_015434-T1,P53448,,,,,75.0,356.0,4.4e-147,522.3,sp|P53448|ALDOC_CARAU Fructose-bisphosphate aldolase C OS=Carassius auratus OX=7957 GN=aldoc PE=2 SV=2,,,,,,
OG_03887,FUN_015436-T1,Peve_00033643,Pocillopora_meandrina_HIv1___RNAseq.g22285.t1,three_way,77.14,FUN_015436-T1,O55125,,,,,51.8,247.0,4.6e-75,282.7,sp|O55125|NIPS1_MOUSE Protein NipSnap homolog 1 OS=Mus musculus OX=10090 GN=Nipsnap1 PE=1 SV=1,,,,,,
OG_03888,FUN_015440-T1,Peve_00033627,Pocillopora_meandrina_HIv1___RNAseq.g22270.t1,three_way,58.71233333333333,FUN_015440-T1,Q64077,,,,,23.8,294.0,4e-11,70.9,sp|Q64077|NK2R_CAVPO Substance-K receptor OS=Cavia porcellus OX=10141 GN=TACR2 PE=2 SV=1,,,,,,
OG_03889,FUN_015442-T1,Peve_00024428,Pocillopora_meandrina_HIv1___RNAseq.g22272.t2,three_way,80.65666666666667,FUN_015442-T1,Q7KZ85,SPT6H_HUMAN,,Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),Homo sapiens (Human),55.5,1411.0,0.0,1521.5,sp|Q7KZ85|SPT6H_HUMAN Transcription elongation factor SPT6 OS=Homo sapiens OX=9606 GN=SUPT6H PE=1 SV=2,GO:0001825; GO:0003677; GO:0003723; GO:0005654; GO:0006368; GO:0006397; GO:0008023; GO:0008380; GO:0031491; GO:0034728; GO:0042393; GO:0045191; GO:0051028; GO:0051147; GO:0140673,blastocyst formation [GO:0001825]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nucleosome organization [GO:0034728]; regulation of isotype switching [GO:0045191]; regulation of muscle cell differentiation [GO:0051147]; RNA splicing [GO:0008380]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673],nucleoplasm [GO:0005654]; transcription elongation factor complex [GO:0008023],DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005654; GO:0006325; GO:0016071; GO:0042393,DNA binding; RNA binding; nucleoplasm; chromatin organization; mRNA metabolic process; histone binding
OG_03890,FUN_015443-T1,Peve_00013024,Pocillopora_meandrina_HIv1___RNAseq.g22268.t1,three_way,73.08466666666666,FUN_015443-T1,A7S4N4,,,,,57.8,455.0,6.6e-129,462.2,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_03891,FUN_015445-T1,Peve_00013658,Pocillopora_meandrina_HIv1___TS.g26948.t2,three_way,62.11333333333334,FUN_015445-T1,O75140,DEPD5_HUMAN,,GATOR1 complex protein DEPDC5 (DEP domain-containing protein 5),Homo sapiens (Human),33.7,1699.0,4.9e-238,826.6,sp|O75140|DEPD5_HUMAN GATOR1 complex protein DEPDC5 OS=Homo sapiens OX=9606 GN=DEPDC5 PE=1 SV=2,GO:0005096; GO:0005764; GO:0005765; GO:0005829; GO:0010508; GO:0031267; GO:0034198; GO:0035556; GO:0044877; GO:0048471; GO:1904262; GO:1990130,cellular response to amino acid starvation [GO:0034198]; intracellular signal transduction [GO:0035556]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508],cytosol [GO:0005829]; GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471],GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267],GO:0005764; GO:0005773; GO:0005829; GO:0043226; GO:0098772,lysosome; vacuole; cytosol; organelle; molecular function regulator activity
OG_03892,FUN_015447-T1,Peve_00013023,Pocillopora_meandrina_HIv1___RNAseq.g22267.t1,three_way,56.257333333333335,FUN_015447-T1,P27889,HNF1B_MOUSE,,Hepatocyte nuclear factor 1-beta (HNF-1-beta) (HNF-1B) (Homeoprotein LFB3) (Transcription factor 2) (TCF-2),Mus musculus (Mouse),49.7,332.0,4.1e-71,270.8,sp|P27889|HNF1B_MOUSE Hepatocyte nuclear factor 1-beta OS=Mus musculus OX=10090 GN=Hnf1b PE=1 SV=2,GO:0000122; GO:0000976; GO:0000981; GO:0000987; GO:0001706; GO:0001714; GO:0001822; GO:0001826; GO:0001889; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006915; GO:0007219; GO:0007492; GO:0009749; GO:0009952; GO:0010467; GO:0010628; GO:0030073; GO:0030111; GO:0030902; GO:0031018; GO:0035565; GO:0039020; GO:0042802; GO:0042803; GO:0043066; GO:0045893; GO:0045944; GO:0048557; GO:0048754; GO:0048806; GO:0050673; GO:0060261; GO:0060429; GO:0060677; GO:0060993; GO:0061017; GO:0061296; GO:0072095; GO:0072164; GO:0072176; GO:0072177; GO:0072179; GO:0072181; GO:1900200; GO:1900212; GO:1990841,anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; embryonic digestive tract morphogenesis [GO:0048557]; endocrine pancreas development [GO:0031018]; endoderm development [GO:0007492]; endoderm formation [GO:0001706]; endodermal cell fate specification [GO:0001714]; epithelial cell proliferation [GO:0050673]; epithelium development [GO:0060429]; gene expression [GO:0010467]; genitalia development [GO:0048806]; hepatoblast differentiation [GO:0061017]; hindbrain development [GO:0030902]; inner cell mass cell differentiation [GO:0001826]; insulin secretion [GO:0030073]; kidney development [GO:0001822]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; mesenchymal cell apoptotic process involved in metanephros development [GO:1900200]; mesonephric duct development [GO:0072177]; mesonephric duct formation [GO:0072181]; mesonephric tubule development [GO:0072164]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis [GO:0061296]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephric duct development [GO:0072176]; nephric duct formation [GO:0072179]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; pronephric nephron tubule development [GO:0039020]; regulation of branch elongation involved in ureteric bud branching [GO:0072095]; regulation of pronephros size [GO:0035565]; regulation of Wnt signaling pathway [GO:0030111]; response to glucose [GO:0009749]; ureteric bud elongation [GO:0060677],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_03893,FUN_015448-T1,Peve_00013022,Pocillopora_meandrina_HIv1___RNAseq.g22266.t1,three_way,60.5595,FUN_015448-T1,Q08E13,RNF10_BOVIN,,E3 ubiquitin-protein ligase RNF10 (EC 2.3.2.27) (RING finger protein 10),Bos taurus (Bovine),39.1,791.0,5.5e-107,390.2,sp|Q08E13|RNF10_BOVIN E3 ubiquitin-protein ligase RNF10 OS=Bos taurus OX=9913 GN=RNF10 PE=2 SV=1,GO:0000976; GO:0005634; GO:0005737; GO:0006513; GO:0008270; GO:0031643; GO:0045944; GO:0061630; GO:1990116,positive regulation of myelination [GO:0031643]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein monoubiquitination [GO:0006513]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytoplasm [GO:0005737]; nucleus [GO:0005634],transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_03894,FUN_015462-T1,Peve_00013016,Pocillopora_meandrina_HIv1___RNAseq.g22294.t1,three_way,39.99133333333333,,,,,,,,,,,,,,,,,
OG_03895,FUN_015470-T1,Peve_00009523,Pocillopora_meandrina_HIv1___RNAseq.g20981.t1,three_way,61.727,FUN_015470-T1,Q12872,SFSWA_HUMAN,,"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)",Homo sapiens (Human),40.4,451.0,5e-19,97.8,"sp|Q12872|SFSWA_HUMAN Splicing factor, suppressor of white-apricot homolog OS=Homo sapiens OX=9606 GN=SFSWAP PE=1 SV=3",GO:0000380; GO:0000395; GO:0003723; GO:0005634; GO:0048025,"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA 5'-splice site recognition [GO:0000395]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]",nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_03896,FUN_015474-T1,Peve_00009512,Pocillopora_meandrina_HIv1___TS.g26531.t2,three_way,73.673,FUN_015474-T1,Q14CX7,NAA25_HUMAN,,"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)",Homo sapiens (Human),36.3,980.0,6.4000000000000005e-161,569.7,"sp|Q14CX7|NAA25_HUMAN N-alpha-acetyltransferase 25, NatB auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA25 PE=1 SV=1",GO:0005737; GO:0005794; GO:0005829; GO:0007010; GO:0010698; GO:0031416,cytoskeleton organization [GO:0007010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416],acetyltransferase activator activity [GO:0010698],GO:0005794; GO:0005829; GO:0007010; GO:0043226; GO:0098772,Golgi apparatus; cytosol; cytoskeleton organization; organelle; molecular function regulator activity
OG_03897,FUN_015475-T1,Peve_00009511,Pocillopora_meandrina_HIv1___RNAseq.g16116.t1,three_way,69.93583333333333,FUN_015475-T1,Q9CPR1,,,,,47.8,186.0,5.4e-37,155.6,sp|Q9CPR1|RWDD4_MOUSE RWD domain-containing protein 4 OS=Mus musculus OX=10090 GN=Rwdd4 PE=2 SV=1,,,,,,
OG_03898,FUN_015476-T1,Peve_00040441,Pocillopora_meandrina_HIv1___RNAseq.g18726.t1,three_way,63.078333333333326,,,,,,,,,,,,,,,,,
OG_03899,FUN_015485-T1,Peve_00009508,Pocillopora_meandrina_HIv1___TS.g25731.t1,three_way,66.67466666666667,FUN_015485-T1,Q9EP89,LACTB_MOUSE,,"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)",Mus musculus (Mouse),44.9,432.0,2.1e-105,384.0,"sp|Q9EP89|LACTB_MOUSE Serine beta-lactamase-like protein LACTB, mitochondrial OS=Mus musculus OX=10090 GN=Lactb PE=1 SV=1",GO:0005739; GO:0005829; GO:0006508; GO:0006629; GO:0008233; GO:0019216; GO:0042802,lipid metabolic process [GO:0006629]; proteolysis [GO:0006508]; regulation of lipid metabolic process [GO:0019216],cytosol [GO:0005829]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; peptidase activity [GO:0008233],GO:0003824; GO:0005739; GO:0005829; GO:0006629; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; cytosol; lipid metabolic process; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_03900,FUN_015654-T1,Peve_00010482,Pocillopora_meandrina_HIv1___RNAseq.g22169.t1,three_way,51.41033333333333,FUN_015654-T1,Q6AYJ1,RECQ1_RAT,,ATP-dependent DNA helicase Q1 (EC 5.6.2.4) (DNA 3'-5' helicase Q1) (DNA-dependent ATPase Q1) (RecQ protein-like 1),Rattus norvegicus (Rat),35.9,78.0,7.6e-06,53.1,sp|Q6AYJ1|RECQ1_RAT ATP-dependent DNA helicase Q1 OS=Rattus norvegicus OX=10116 GN=Recql PE=1 SV=1,GO:0000724; GO:0003678; GO:0005524; GO:0005634; GO:0005694; GO:0005737; GO:0006260; GO:0009378; GO:0016887; GO:0031297; GO:0036121; GO:0043138; GO:0046872; GO:1990814,DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297],chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; double-stranded DNA helicase activity [GO:0036121]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; chromosome; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_03901,FUN_015655-T1,Peve_00044112,Pocillopora_meandrina_HIv1___RNAseq.g28702.t1,three_way,56.23833333333334,FUN_015655-T1,Q55GU0,,,,,38.7,212.0,5.2e-23,111.3,sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0267514 PE=3 SV=1,,,,,,
OG_03902,FUN_015939-T1,Peve_00040603,Pocillopora_meandrina_HIv1___RNAseq.g22316.t1,three_way,72.592,FUN_015939-T1,Q9NWM8,FKB14_HUMAN,,Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (22 kDa FK506-binding protein) (22 kDa FKBP) (FKBP-22) (FK506-binding protein 14) (FKBP-14) (Rotamase),Homo sapiens (Human),44.0,218.0,4.200000000000001e-36,152.9,sp|Q9NWM8|FKB14_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP14 OS=Homo sapiens OX=9606 GN=FKBP14 PE=1 SV=1,GO:0003755; GO:0005509; GO:0005788,,endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0016853; GO:0140096,"catalytic activity; isomerase activity; catalytic activity, acting on a protein"
OG_03903,FUN_015977-T1,Peve_00032728,Pocillopora_meandrina_HIv1___RNAseq.g21409.t1,three_way,72.505,,,,,,,,,,,,,,,,,
OG_03904,FUN_015978-T1,Peve_00024021,Pocillopora_meandrina_HIv1___RNAseq.g21408.t2,three_way,79.68833333333333,FUN_015978-T1,P40939,ECHA_HUMAN,,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (MLCL AT) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]",Homo sapiens (Human),57.7,766.0,5.7e-253,875.2,"sp|P40939|ECHA_HUMAN Trifunctional enzyme subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=HADHA PE=1 SV=2",GO:0003857; GO:0003985; GO:0004300; GO:0005739; GO:0005743; GO:0006635; GO:0016507; GO:0016509; GO:0032868; GO:0035965; GO:0042645; GO:0052816; GO:0070403,cardiolipin acyl-chain remodeling [GO:0035965]; fatty acid beta-oxidation [GO:0006635]; response to insulin [GO:0032868],mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; NAD+ binding [GO:0070403],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0016740; GO:0016787; GO:0016829; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; transferase activity; hydrolase activity; lyase activity; organelle
OG_03905,FUN_015980-T1,Peve_00024016,Pocillopora_meandrina_HIv1___RNAseq.g21406.t1,three_way,72.376,FUN_015980-T1,Q8BKD6,R144B_MOUSE,,E3 ubiquitin-protein ligase RNF144B (EC 2.3.2.31) (IBR domain-containing protein 2) (RING finger protein 144B),Mus musculus (Mouse),45.8,264.0,3.6000000000000002e-65,250.0,sp|Q8BKD6|R144B_MOUSE E3 ubiquitin-protein ligase RNF144B OS=Mus musculus OX=10090 GN=Rnf144b PE=2 SV=2,GO:0004842; GO:0005737; GO:0006511; GO:0006915; GO:0008270; GO:0016567; GO:0031966; GO:0043066,apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_03906,FUN_015982-T1,Peve_00024012,Pocillopora_meandrina_HIv1___RNAseq.g21404.t2,three_way,57.955,FUN_015982-T1,Q00174,LAMA_DROME,,Laminin subunit alpha (Laminin A chain),Drosophila melanogaster (Fruit fly),29.8,729.0,2.6e-88,330.1,sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2,GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711,"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]",axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021],extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048856; GO:0098542,immune system process; structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism
OG_03907,FUN_015983-T2,Peve_00024011,Pocillopora_meandrina_HIv1___RNAseq.g21403.t1,three_way,53.04383333333333,FUN_015983-T2,Q99575,POP1_HUMAN,,Ribonucleases P/MRP protein subunit POP1 (hPOP1),Homo sapiens (Human),29.6,1024.0,4.0000000000000003e-104,380.9,sp|Q99575|POP1_HUMAN Ribonucleases P/MRP protein subunit POP1 OS=Homo sapiens OX=9606 GN=POP1 PE=1 SV=2,GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005615; GO:0005654; GO:0005655; GO:0005730; GO:0008033; GO:0016078; GO:0030681; GO:0033204,tRNA 5'-leader removal [GO:0001682]; tRNA decay [GO:0016078]; tRNA processing [GO:0008033],extracellular space [GO:0005615]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172],ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005615; GO:0005654; GO:0005730; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; extracellular space; nucleoplasm; nucleolus; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_03908,FUN_015984-T1,Peve_00024010,Pocillopora_meandrina_HIv1___RNAseq.g21402.t1,three_way,68.71833333333333,FUN_015984-T1,Q9WTL7,LYPA2_MOUSE,,Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase 2) (Lysophospholipase II) (LPL-II) (LysoPLA II) (mLyso II) (Palmitoyl-protein hydrolase) (EC 3.1.2.22),Mus musculus (Mouse),52.0,229.0,5.7e-64,245.7,sp|Q9WTL7|LYPA2_MOUSE Acyl-protein thioesterase 2 OS=Mus musculus OX=10090 GN=Lypla2 PE=1 SV=1,GO:0002084; GO:0004622; GO:0005654; GO:0005737; GO:0005795; GO:0005829; GO:0006631; GO:0008474; GO:0046464; GO:1905344,acylglycerol catabolic process [GO:0046464]; fatty acid metabolic process [GO:0006631]; prostaglandin catabolic process [GO:1905344]; protein depalmitoylation [GO:0002084],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleoplasm [GO:0005654],lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474],GO:0003824; GO:0005654; GO:0005829; GO:0006629; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; nucleoplasm; cytosol; lipid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03909,FUN_015985-T1,Peve_00024008,Pocillopora_meandrina_HIv1___RNAseq.g21401.t1,three_way,57.967666666666666,,,,,,,,,,,,,,,,,
OG_03910,FUN_015986-T1,Peve_00024004,Pocillopora_meandrina_HIv1___RNAseq.g21398.t1,three_way,64.2585,,,,,,,,,,,,,,,,,
OG_03911,FUN_015990-T1,Peve_00023998,Pocillopora_meandrina_HIv1___RNAseq.g21387.t1,three_way,69.50233333333334,FUN_015990-T1,Q5BIM1,,,,,25.3,490.0,3.2e-30,135.2,sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1,,,,,,
OG_03912,FUN_015993-T1,Peve_00023996,Pocillopora_meandrina_HIv1___RNAseq.g21382.t1,three_way,74.39133333333334,FUN_015993-T1,Q08AE8,SPIR1_HUMAN,,Protein spire homolog 1 (Spir-1),Homo sapiens (Human),29.2,627.0,3.7e-48,194.5,sp|Q08AE8|SPIR1_HUMAN Protein spire homolog 1 OS=Homo sapiens OX=9606 GN=SPIRE1 PE=1 SV=3,GO:0003779; GO:0005654; GO:0005741; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0008017; GO:0015031; GO:0016192; GO:0030036; GO:0030659; GO:0036089; GO:0040038; GO:0045010; GO:0045087; GO:0046907; GO:0048193; GO:0048471; GO:0051295; GO:0051639; GO:0070649; GO:0090141; GO:2000781,actin cytoskeleton organization [GO:0030036]; actin filament network formation [GO:0051639]; actin nucleation [GO:0045010]; cleavage furrow formation [GO:0036089]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; Golgi vesicle transport [GO:0048193]; innate immune response [GO:0045087]; intracellular transport [GO:0046907]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of mitochondrial fission [GO:0090141]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],actin binding [GO:0003779]; microtubule binding [GO:0008017],GO:0000910; GO:0002376; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016192; GO:0022414; GO:0043226; GO:0061024; GO:0098542,cytokinesis; immune system process; nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; reproductive process; organelle; membrane organization; defense response to other organism
OG_03913,FUN_015994-T1,Peve_00023995,Pocillopora_meandrina_HIv1___RNAseq.g21381.t1,three_way,89.52166666666666,FUN_015994-T1,Q9ULC3,RAB23_HUMAN,,Ras-related protein Rab-23 (EC 3.6.5.2),Homo sapiens (Human),67.2,232.0,1.1e-80,301.2,sp|Q9ULC3|RAB23_HUMAN Ras-related protein Rab-23 OS=Homo sapiens OX=9606 GN=RAB23 PE=1 SV=1,GO:0000045; GO:0003924; GO:0005525; GO:0005737; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0006968; GO:0010008; GO:0012505; GO:0030054; GO:0030670; GO:0036064; GO:0042308; GO:0045335; GO:0046039; GO:0060271; GO:0097094,autophagosome assembly [GO:0000045]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; craniofacial suture morphogenesis [GO:0097094]; GTP metabolic process [GO:0046039]; intracellular protein transport [GO:0006886]; negative regulation of protein import into nucleus [GO:0042308],autophagosome [GO:0005776]; cell junction [GO:0030054]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endosome membrane [GO:0010008]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005773; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0006886; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0055086; GO:1901135,catalytic activity; GTPase activity; vacuole; microtubule organizing center; cytosol; plasma membrane; cilium; intracellular protein transport; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_03914,FUN_015998-T1,Peve_00023991,Pocillopora_meandrina_HIv1___RNAseq.g21377.t2,three_way,83.981,FUN_015998-T1,Q00944,,,,,41.0,1143.0,8.4e-229,795.4,sp|Q00944|FAK1_CHICK Focal adhesion kinase 1 OS=Gallus gallus OX=9031 GN=PTK2 PE=1 SV=2,,,,,,
OG_03915,FUN_016001-T1,Peve_00004543,Pocillopora_meandrina_HIv1___RNAseq.g21372.t1,three_way,70.03,FUN_016001-T1,Q8N6T3,ARFG1_HUMAN,,ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 1) (ADP-ribosylation factor 1 GTPase-activating protein) (ARF1 GAP) (ARF1-directed GTPase-activating protein),Homo sapiens (Human),47.5,318.0,2.6000000000000004e-57,224.6,sp|Q8N6T3|ARFG1_HUMAN ADP-ribosylation factor GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=ARFGAP1 PE=1 SV=2,GO:0000139; GO:0005096; GO:0005829; GO:0008270; GO:0015031; GO:0016192; GO:0030100; GO:0032012; GO:0045202,protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; Golgi membrane [GO:0000139]; synapse [GO:0045202],GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005829; GO:0016192; GO:0098772,cytosol; vesicle-mediated transport; molecular function regulator activity
OG_03916,FUN_016002-T1,Peve_00004542,Pocillopora_meandrina_HIv1___RNAseq.g21371.t1,three_way,80.09833333333333,FUN_016002-T1,Q9D7A8,,,,,43.2,273.0,7.999999999999999e-53,208.8,sp|Q9D7A8|ARMC1_MOUSE Armadillo repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Armc1 PE=1 SV=1,,,,,,
OG_03917,FUN_016003-T1,Peve_00004541,Pocillopora_meandrina_HIv1___RNAseq.g21370.t1,three_way,63.619666666666674,FUN_016003-T1,Q08BD8,,,,,39.7,302.0,1.2e-20,102.4,sp|Q08BD8|MTRF2_DANRE Mitochondrial fission regulator 2 OS=Danio rerio OX=7955 GN=mtfr2 PE=2 SV=1,,,,,,
OG_03918,FUN_016014-T1,Peve_00004540,Pocillopora_meandrina_HIv1___RNAseq.g21369.t1,three_way,67.8095,FUN_016014-T1,B2RX88,CSPP1_MOUSE,,Centrosome and spindle pole associated protein 1,Mus musculus (Mouse),29.2,1240.0,2.1e-09,66.6,sp|B2RX88|CSPP1_MOUSE Centrosome and spindle pole associated protein 1 OS=Mus musculus OX=10090 GN=Cspp1 PE=1 SV=2,GO:0000922; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005874; GO:0005929; GO:0032467; GO:0034451; GO:0036064; GO:0051781,positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922],,GO:0005654; GO:0005815; GO:0005929; GO:0043226,nucleoplasm; microtubule organizing center; cilium; organelle
OG_03919,FUN_016017-T1,Peve_00004545,Pocillopora_meandrina_HIv1___TS.g26118.t2,three_way,74.83916666666667,FUN_016017-T1,Q9QZB0,RGS17_MOUSE,,Regulator of G-protein signaling 17 (RGS17) (Regulator of Gz-selective protein signaling 2),Mus musculus (Mouse),49.4,89.0,2.6e-18,93.6,sp|Q9QZB0|RGS17_MOUSE Regulator of G-protein signaling 17 OS=Mus musculus OX=10090 GN=Rgs17 PE=1 SV=1,GO:0001975; GO:0005096; GO:0005634; GO:0005737; GO:0007186; GO:0009968; GO:0016020; GO:0043005; GO:0045202,G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of signal transduction [GO:0009968]; response to amphetamine [GO:0001975],cytoplasm [GO:0005737]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202],GTPase activator activity [GO:0005096],GO:0005634; GO:0043226; GO:0098772,nucleus; organelle; molecular function regulator activity
OG_03920,FUN_016018-T1,Peve_00012864,Pocillopora_meandrina_HIv1___RNAseq.g21366.t1,three_way,47.949666666666666,,,,,,,,,,,,,,,,,
OG_03921,FUN_016025-T1,Peve_00033607,Pocillopora_meandrina_HIv1___RNAseq.g22273.t1,three_way,56.42033333333333,,,,,,,,,,,,,,,,,
OG_03922,FUN_016031-T1,Peve_00033606,Pocillopora_meandrina_HIv1___RNAseq.g22274.t1,three_way,88.53866666666666,FUN_016031-T1,Q5BKL0,,,,,74.8,385.0,4.6e-171,602.1,sp|Q5BKL0|HPPD_XENTR 4-hydroxyphenylpyruvate dioxygenase OS=Xenopus tropicalis OX=8364 GN=hpd PE=2 SV=1,,,,,,
OG_03923,FUN_016033-T1,Peve_00011813,Pocillopora_meandrina_HIv1___RNAseq.g21653.t1,three_way,71.436,FUN_016033-T1,P31422,GRM3_RAT,,Metabotropic glutamate receptor 3 (mGluR3),Rattus norvegicus (Rat),38.0,839.0,6.400000000000001e-158,559.7,sp|P31422|GRM3_RAT Metabotropic glutamate receptor 3 OS=Rattus norvegicus OX=10116 GN=Grm3 PE=1 SV=1,GO:0001641; GO:0005246; GO:0005886; GO:0007216; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0050804; GO:0051966; GO:0097110; GO:0097449; GO:0098978; GO:0099170,"cellular response to stress [GO:0033554]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of synaptic transmission, glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]",astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110],GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772,plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity
OG_03924,FUN_016036-T1,Peve_00011811,Pocillopora_meandrina_HIv1___RNAseq.g21652.t1,three_way,47.251000000000005,,,,,,,,,,,,,,,,,
OG_03925,FUN_016037-T1,Peve_00011810,Pocillopora_meandrina_HIv1___RNAseq.g21651.t1,three_way,74.29166666666667,FUN_016037-T1,F6ZDS4,TPR_MOUSE,,Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein),Mus musculus (Mouse),40.7,1012.0,4.0000000000000014e-74,282.7,sp|F6ZDS4|TPR_MOUSE Nucleoprotein TPR OS=Mus musculus OX=10090 GN=Tpr PE=1 SV=1,GO:0000122; GO:0000775; GO:0003682; GO:0003729; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006913; GO:0007094; GO:0010965; GO:0015031; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein transport [GO:0015031]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056],GO:0003723; GO:0005198; GO:0005635; GO:0006355; GO:0006913; GO:0043226,RNA binding; structural molecule activity; nuclear envelope; regulation of DNA-templated transcription; nucleocytoplasmic transport; organelle
OG_03925,FUN_016037-T1,Peve_00011810,Pocillopora_meandrina_HIv1___RNAseq.g21651.t1,three_way,74.29166666666667,FUN_016037-T1,F6ZDS4,TPR_MOUSE,,Nucleoprotein TPR (NPC-associated intranuclear protein) (Translocated promoter region and nuclear basket protein),Mus musculus (Mouse),34.5,145.0,1.9e-07,61.2,sp|F6ZDS4|TPR_MOUSE Nucleoprotein TPR OS=Mus musculus OX=10090 GN=Tpr PE=1 SV=1,GO:0000122; GO:0000775; GO:0003682; GO:0003729; GO:0005635; GO:0005643; GO:0005737; GO:0005868; GO:0006404; GO:0006405; GO:0006913; GO:0007094; GO:0010965; GO:0015031; GO:0017056; GO:0031072; GO:0031453; GO:0031965; GO:0031990; GO:0034399; GO:0034605; GO:0035457; GO:0042307; GO:0042405; GO:0042803; GO:0044615; GO:0045947; GO:0046827; GO:0046832; GO:0051019; GO:0051301; GO:0070849; GO:0072686; GO:0090267; GO:0090316; GO:1901673,cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nucleocytoplasmic transport [GO:0006913]; positive regulation of heterochromatin formation [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein transport [GO:0015031]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]",chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056],GO:0003723; GO:0005198; GO:0005635; GO:0006355; GO:0006913; GO:0043226,RNA binding; structural molecule activity; nuclear envelope; regulation of DNA-templated transcription; nucleocytoplasmic transport; organelle
OG_03926,FUN_016038-T1,Peve_00011807,Pocillopora_meandrina_HIv1___RNAseq.g21648.t2,three_way,64.21833333333333,FUN_016038-T1,Q8TDN4,CABL1_HUMAN,,CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1),Homo sapiens (Human),43.4,295.0,2.7e-61,237.7,sp|Q8TDN4|CABL1_HUMAN CDK5 and ABL1 enzyme substrate 1 OS=Homo sapiens OX=9606 GN=CABLES1 PE=1 SV=2,GO:0005634; GO:0005829; GO:0007399; GO:0051301; GO:0051726,cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726],cytosol [GO:0005829]; nucleus [GO:0005634],,GO:0005634; GO:0005829; GO:0043226; GO:0048856,nucleus; cytosol; organelle; anatomical structure development
OG_03927,FUN_016042-T1,Peve_00011805,Pocillopora_meandrina_HIv1___RNAseq.g21646.t1,three_way,79.87966666666667,FUN_016042-T1,A2VDP2,PCMD1_BOVIN,,Protein-L-isoaspartate O-methyltransferase domain-containing protein 1,Bos taurus (Bovine),58.8,255.0,6.599999999999998e-82,305.4,sp|A2VDP2|PCMD1_BOVIN Protein-L-isoaspartate O-methyltransferase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PCMTD1 PE=2 SV=1,GO:0004719; GO:0005737; GO:0016020; GO:0016567; GO:0031466; GO:1990756,protein ubiquitination [GO:0016567],Cul5-RING ubiquitin ligase complex [GO:0031466]; cytoplasm [GO:0005737]; membrane [GO:0016020],protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0003824; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_03928,FUN_016043-T1,Peve_00011803,Pocillopora_meandrina_HIv1___RNAseq.g21644.t1,three_way,70.11666666666666,,,,,,,,,,,,,,,,,
OG_03929,FUN_016044-T1,Peve_00011802,Pocillopora_meandrina_HIv1___RNAseq.g21643.t1,three_way,75.492,,,,,,,,,,,,,,,,,
OG_03930,FUN_016045-T2,Peve_00011796,Pocillopora_meandrina_HIv1___RNAseq.g21638.t1,three_way,82.58033333333333,FUN_016045-T2,Q9V6X7,OFUT1_DROME,,GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1),Drosophila melanogaster (Fruit fly),46.1,380.0,1.5e-94,347.8,sp|Q9V6X7|OFUT1_DROME GDP-fucose protein O-fucosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=O-fut1 PE=1 SV=1,GO:0005112; GO:0005788; GO:0006004; GO:0007219; GO:0036066; GO:0045165; GO:0045747; GO:0045807; GO:0046922,cell fate commitment [GO:0045165]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066],endoplasmic reticulum lumen [GO:0005788],Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922],GO:0003824; GO:0005975; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_03931,FUN_016047-T2,Peve_00011791,Pocillopora_meandrina_HIv1___RNAseq.g21637.t1,three_way,75.40733333333333,FUN_016047-T2,O43272,PROD_HUMAN,,"Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Proline oxidase 2) (p53-induced gene 6 protein)",Homo sapiens (Human),49.1,556.0,4.5e-144,513.1,"sp|O43272|PROD_HUMAN Proline dehydrogenase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PRODH PE=1 SV=4",GO:0004657; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0006560; GO:0006562; GO:0008631; GO:0010133; GO:0019470; GO:0043231; GO:0071949; GO:1903376,4-hydroxyproline catabolic process [GO:0019470]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376],intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657],GO:0003824; GO:0005654; GO:0005739; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_03932,FUN_016048-T1,Peve_00011790,Pocillopora_meandrina_HIv1___RNAseq.g26043.t1,three_way,52.87083333333334,,,,,,,,,,,,,,,,,
OG_03933,FUN_016049-T1,Peve_00011814,Pocillopora_meandrina_HIv1___RNAseq.g21636.t1,three_way,52.112,,,,,,,,,,,,,,,,,
OG_03934,FUN_016050-T1,Peve_00011794,Pocillopora_meandrina_HIv1___RNAseq.g21635.t1,three_way,66.26,,,,,,,,,,,,,,,,,
OG_03935,FUN_016052-T1,Peve_00034142,Pocillopora_meandrina_HIv1___RNAseq.g21628.t1,three_way,77.55666666666667,FUN_016052-T1,Q06726,,,,,39.2,342.0,8.2e-61,235.7,sp|Q06726|NR2F5_DANRE Nuclear receptor subfamily 2 group F member 5 OS=Danio rerio OX=7955 GN=nr2f5 PE=2 SV=1,,,,,,
OG_03936,FUN_016053-T1,Peve_00034141,Pocillopora_meandrina_HIv1___RNAseq.g21629.t1,three_way,79.90766666666667,FUN_016053-T1,P07314,GGT1_RAT,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Rattus norvegicus (Rat),44.8,556.0,6.6e-127,456.1,sp|P07314|GGT1_RAT Glutathione hydrolase 1 proenzyme OS=Rattus norvegicus OX=10116 GN=Ggt1 PE=1 SV=4,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982],aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_03937,FUN_016054-T1,Peve_00037117,Pocillopora_meandrina_HIv1___RNAseq.g21630.t1,three_way,76.58383333333333,,,,,,,,,,,,,,,,,
OG_03938,FUN_016055-T1,Peve_00011789,Pocillopora_meandrina_HIv1___RNAseq.g21631.t1,three_way,71.45683333333334,FUN_016055-T1,Q8IYT8,ULK2_HUMAN,,Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2),Homo sapiens (Human),34.9,1096.0,7e-132,473.4,sp|Q8IYT8|ULK2_HUMAN Serine/threonine-protein kinase ULK2 OS=Homo sapiens OX=9606 GN=ULK2 PE=1 SV=3,GO:0000045; GO:0000407; GO:0000423; GO:0004674; GO:0005524; GO:0005737; GO:0005776; GO:0005829; GO:0006914; GO:0007165; GO:0007411; GO:0008104; GO:0010506; GO:0030659; GO:0034045; GO:0034727; GO:0042594; GO:0046777; GO:0048668; GO:0048671; GO:0048675; GO:0061709; GO:0106310; GO:0160038,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon extension [GO:0048675]; axon guidance [GO:0007411]; collateral sprouting [GO:0048668]; mitophagy [GO:0000423]; negative regulation of collateral sprouting [GO:0048671]; piecemeal microautophagy of the nucleus [GO:0034727]; protein autophosphorylation [GO:0046777]; protein localization [GO:0008104]; regulation of autophagy [GO:0010506]; response to starvation [GO:0042594]; reticulophagy [GO:0061709]; signal transduction [GO:0007165]; somatic sensory system development [GO:0160038],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03939,FUN_016071-T1,Peve_00021918,Pocillopora_meandrina_HIv1___RNAseq.g21619.t1,three_way,78.3115,FUN_016071-T1,Q8JHJ2,,,,,64.9,470.0,1.8e-177,624.0,sp|Q8JHJ2|DDX55_DANRE ATP-dependent RNA helicase DDX55 OS=Danio rerio OX=7955 GN=ddx55 PE=2 SV=2,,,,,,
OG_03940,FUN_016075-T1,Peve_00021919,Pocillopora_meandrina_HIv1___RNAseq.g21617.t1,three_way,62.84066666666667,FUN_016075-T1,Q43470,,,,,64.7,238.0,7.3e-72,271.9,sp|Q43470|1433B_HORVU 14-3-3-like protein B OS=Hordeum vulgare OX=4513 PE=2 SV=1,,,,,,
OG_03941,FUN_016076-T1,Peve_00021921,Pocillopora_meandrina_HIv1___RNAseq.g21616.t1,three_way,70.497,FUN_016076-T1,Q9C9C6,,,,,49.4,180.0,1.2e-34,147.9,sp|Q9C9C6|RL62_ARATH Large ribosomal subunit protein eL6y OS=Arabidopsis thaliana OX=3702 GN=RPL6B PE=2 SV=1,,,,,,
OG_03942,FUN_016077-T1,Peve_00021922,Pocillopora_meandrina_HIv1___RNAseq.g21615.t1,three_way,81.17833333333333,FUN_016077-T1,Q9V3D2,,,,,63.3,349.0,6.9e-134,478.4,sp|Q9V3D2|HEM6_DROME Oxygen-dependent coproporphyrinogen-III oxidase OS=Drosophila melanogaster OX=7227 GN=Coprox PE=2 SV=1,,,,,,
OG_03943,FUN_016078-T1,Peve_00021923,Pocillopora_meandrina_HIv1___RNAseq.g21614.t1,three_way,69.4695,FUN_016078-T1,P16388,KCNA1_MOUSE,,Potassium voltage-gated channel subfamily A member 1 (MBK1) (MKI) (Voltage-gated potassium channel subunit Kv1.1),Mus musculus (Mouse),49.0,396.0,4.9e-75,283.5,sp|P16388|KCNA1_MOUSE Potassium voltage-gated channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Kcna1 PE=1 SV=1,GO:0001964; GO:0005251; GO:0005783; GO:0005829; GO:0005886; GO:0006937; GO:0007405; GO:0007420; GO:0008076; GO:0009986; GO:0010644; GO:0010960; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030424; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0070161; GO:0071286; GO:0071805; GO:0086011; GO:0097718,brain development [GO:0007420]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; membrane repolarization during action potential [GO:0086011]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],anchoring junction [GO:0070161]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; juxtaparanode region of axon [GO:0044224]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; protein-containing complex assembly
OG_03944,FUN_016081-T1,Peve_00021927,Pocillopora_meandrina_HIv1___RNAseq.g21612.t1,three_way,72.43566666666666,,,,,,,,,,,,,,,,,
OG_03945,FUN_016082-T1,Peve_00021929,Pocillopora_meandrina_HIv1___RNAseq.g21611.t1,three_way,89.665,FUN_016082-T1,Q8CCB4,,,,,60.6,830.0,1.8000000000000002e-273,943.3,sp|Q8CCB4|VPS53_MOUSE Vacuolar protein sorting-associated protein 53 homolog OS=Mus musculus OX=10090 GN=Vps53 PE=1 SV=1,,,,,,
OG_03946,FUN_016083-T1,Peve_00021930,Pocillopora_meandrina_HIv1___RNAseq.g21608.t1,three_way,63.108,FUN_016083-T1,Q503L9,NXN_DANRE,,Nucleoredoxin (EC 1.8.1.8),Danio rerio (Zebrafish) (Brachydanio rerio),44.6,413.0,5.8e-95,349.4,sp|Q503L9|NXN_DANRE Nucleoredoxin OS=Danio rerio OX=7955 GN=nxn PE=2 SV=1,GO:0004791; GO:0005634; GO:0005829; GO:0016055; GO:0030154; GO:0030178; GO:0031397; GO:0072359,cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634],thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005634; GO:0005829; GO:0016209; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; antioxidant activity; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_03947,FUN_016085-T1,Peve_00034972,Pocillopora_meandrina_HIv1___RNAseq.g21607.t1,three_way,82.75983333333333,FUN_016085-T1,Q6NYY9,VMP1_DANRE,,Vacuole membrane protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),60.9,396.0,7.5e-121,435.6,sp|Q6NYY9|VMP1_DANRE Vacuole membrane protein 1 OS=Danio rerio OX=7955 GN=vmp1 PE=2 SV=1,GO:0000045; GO:0005774; GO:0005783; GO:0005789; GO:0005886; GO:0006914; GO:0007030; GO:0012505; GO:0016020; GO:0017128; GO:0033116; GO:0042953,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; lipoprotein transport [GO:0042953],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774],phospholipid scramblase activity [GO:0017128],GO:0005215; GO:0005783; GO:0005886; GO:0006914; GO:0043226,transporter activity; endoplasmic reticulum; plasma membrane; autophagy; organelle
OG_03948,FUN_016087-T1,Peve_00010774,Pocillopora_meandrina_HIv1___RNAseq.g21606.t1,three_way,69.82266666666666,FUN_016087-T1,Q92667,AKAP1_HUMAN,,"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84)",Homo sapiens (Human),36.7,316.0,8.2e-45,183.0,"sp|Q92667|AKAP1_HUMAN A-kinase anchor protein 1, mitochondrial OS=Homo sapiens OX=9606 GN=AKAP1 PE=1 SV=1",GO:0003723; GO:0005739; GO:0005741; GO:0005829; GO:0006915; GO:0016020; GO:0034237; GO:0140374,antiviral innate immune response [GO:0140374]; apoptotic process [GO:0006915],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],protein kinase A regulatory subunit binding [GO:0034237]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005739; GO:0005829; GO:0012501; GO:0043226; GO:0098542,immune system process; RNA binding; mitochondrion; cytosol; programmed cell death; organelle; defense response to other organism
OG_03949,FUN_016088-T1,Peve_00010756,Pocillopora_meandrina_HIv1___RNAseq.g21605.t1,three_way,64.84400000000001,FUN_016088-T1,A6NFN9,,,,,31.8,466.0,7.399999999999999e-56,220.3,sp|A6NFN9|ANKUB_HUMAN Protein ANKUB1 OS=Homo sapiens OX=9606 GN=ANKUB1 PE=2 SV=3,,,,,,
OG_03950,FUN_016089-T1,Peve_00013364,Pocillopora_meandrina_HIv1___RNAseq.g21562.t1,three_way,69.75566666666667,FUN_016089-T1,Q4V9Y5,,,,,40.3,201.0,9.1e-34,146.4,sp|Q4V9Y5|CRLD2_XENTR Cysteine-rich secretory protein LCCL domain-containing 2 OS=Xenopus tropicalis OX=8364 GN=crispld2 PE=2 SV=1,,,,,,
OG_03951,FUN_016090-T1,Peve_00013365,Pocillopora_meandrina_HIv1___RNAseq.g21564.t1,three_way,74.69583333333334,FUN_016090-T1,Q9UDW3,ZMAT5_HUMAN,,Zinc finger matrin-type protein 5 (U11/U12 small nuclear ribonucleoprotein 20 kDa protein) (U11/U12 snRNP 20 kDa protein) (U11/U12-20K),Homo sapiens (Human),42.0,174.0,1.4e-31,137.5,sp|Q9UDW3|ZMAT5_HUMAN Zinc finger matrin-type protein 5 OS=Homo sapiens OX=9606 GN=ZMAT5 PE=1 SV=1,GO:0005654; GO:0005689; GO:0006397; GO:0008270; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nucleoplasm [GO:0005654]; U12-type spliceosomal complex [GO:0005689],zinc ion binding [GO:0008270],GO:0005654; GO:0016071,nucleoplasm; mRNA metabolic process
OG_03952,FUN_016091-T1,Peve_00013366,Pocillopora_meandrina_HIv1___RNAseq.g21574.t1,three_way,91.33766666666666,FUN_016091-T1,P63085,MK01_MOUSE,,Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2),Mus musculus (Mouse),85.7,349.0,1.0999999999999996e-177,624.0,sp|P63085|MK01_MOUSE Mitogen-activated protein kinase 1 OS=Mus musculus OX=10090 GN=Mapk1 PE=1 SV=3,GO:0000165; GO:0001784; GO:0004672; GO:0004674; GO:0004707; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005770; GO:0005794; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0005901; GO:0005925; GO:0006351; GO:0006915; GO:0006974; GO:0007173; GO:0007507; GO:0008286; GO:0008353; GO:0009887; GO:0010759; GO:0014032; GO:0014044; GO:0016301; GO:0018105; GO:0018107; GO:0019858; GO:0019902; GO:0030278; GO:0030521; GO:0030641; GO:0030878; GO:0031143; GO:0031647; GO:0031663; GO:0032206; GO:0032496; GO:0032872; GO:0033598; GO:0034198; GO:0035094; GO:0036064; GO:0038133; GO:0042473; GO:0042552; GO:0042802; GO:0043330; GO:0045542; GO:0045596; GO:0048009; GO:0048538; GO:0050847; GO:0050852; GO:0050853; GO:0051090; GO:0051403; GO:0051493; GO:0060020; GO:0060291; GO:0060324; GO:0060425; GO:0060440; GO:0060716; GO:0061308; GO:0061514; GO:0070371; GO:0070849; GO:0071356; GO:0072584; GO:0072686; GO:0090170; GO:0106310; GO:0120041; GO:2000641,androgen receptor signaling pathway [GO:0030521]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cellular response to amino acid starvation [GO:0034198]; cellular response to tumor necrosis factor [GO:0071356]; cytosine metabolic process [GO:0019858]; DNA damage response [GO:0006974]; DNA-templated transcription [GO:0006351]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-34-mediated signaling pathway [GO:0061514]; labyrinthine layer blood vessel development [GO:0060716]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; MAPK cascade [GO:0000165]; myelination [GO:0042552]; negative regulation of cell differentiation [GO:0045596]; neural crest cell development [GO:0014032]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of telomere maintenance [GO:0032206]; progesterone receptor signaling pathway [GO:0050847]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; Schwann cell development [GO:0014044]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440],caveola [GO:0005901]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; MAP kinase activity [GO:0004707]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005768; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0012501; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0055086; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; mitochondrion; endosome; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein"
OG_03953,FUN_016093-T1,Peve_00018223,Pocillopora_meandrina_HIv1___RNAseq.g21576.t1,three_way,55.824333333333335,,,,,,,,,,,,,,,,,
OG_03954,FUN_016097-T1,Peve_00010777,Pocillopora_meandrina_HIv1___TS.g26331.t1,three_way,46.02,,,,,,,,,,,,,,,,,
OG_03955,FUN_016100-T1,Peve_00010771,Pocillopora_meandrina_HIv1___RNAseq.g21590.t1,three_way,83.7185,FUN_016100-T1,Q13948,,,,,48.2,676.0,4.2e-151,536.6,sp|Q13948|CASP_HUMAN Protein CASP OS=Homo sapiens OX=9606 GN=CUX1 PE=1 SV=2,,,,,,
OG_03956,FUN_016101-T1,Peve_00010770,Pocillopora_meandrina_HIv1___RNAseq.g21591.t1,three_way,72.2,FUN_016101-T1,Q9W704,,,,,35.9,234.0,6.9e-30,132.5,sp|Q9W704|RIPA_XENLA RPA-interacting protein A OS=Xenopus laevis OX=8355 GN=rpain-a PE=1 SV=1,,,,,,
OG_03957,FUN_016102-T1,Peve_00010769,Pocillopora_meandrina_HIv1___RNAseq.g21592.t1,three_way,72.49366666666667,FUN_016102-T1,Q62985,SH2B1_RAT,,SH2B adapter protein 1 (FceRI gamma-chain-interacting protein SH2-B) (SH2 domain-containing protein 1B) (SH2-B PH domain-containing signaling mediator 1),Rattus norvegicus (Rat),39.9,358.0,1.1e-52,209.5,sp|Q62985|SH2B1_RAT SH2B adapter protein 1 OS=Rattus norvegicus OX=10116 GN=Sh2b1 PE=1 SV=1,GO:0005068; GO:0005634; GO:0005737; GO:0005886; GO:0030032; GO:0035556; GO:0045840; GO:0048870; GO:0060391; GO:2000278,cell motility [GO:0048870]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of SMAD protein signal transduction [GO:0060391]; regulation of DNA biosynthetic process [GO:2000278],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0005634; GO:0005886; GO:0043226; GO:0048870; GO:0060090,nucleus; plasma membrane; organelle; cell motility; molecular adaptor activity
OG_03958,FUN_016103-T1,Peve_00010768,Pocillopora_meandrina_HIv1___RNAseq.g21593.t1,three_way,67.107,FUN_016103-T1,O95721,SNP29_HUMAN,,Synaptosomal-associated protein 29 (SNAP-29) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29),Homo sapiens (Human),30.6,255.0,2.2e-21,104.4,sp|O95721|SNP29_HUMAN Synaptosomal-associated protein 29 OS=Homo sapiens OX=9606 GN=SNAP29 PE=1 SV=1,GO:0000139; GO:0000421; GO:0005484; GO:0005737; GO:0005739; GO:0005776; GO:0005813; GO:0005829; GO:0005886; GO:0006887; GO:0006903; GO:0015031; GO:0016082; GO:0016240; GO:0019905; GO:0020018; GO:0031201; GO:0031629; GO:0035577; GO:0060271; GO:0061025; GO:0097352; GO:0098793,autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; membrane fusion [GO:0061025]; protein transport [GO:0015031]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle targeting [GO:0006903],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; SNARE complex [GO:0031201],SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905],GO:0005739; GO:0005773; GO:0005815; GO:0005829; GO:0005886; GO:0016192; GO:0043226; GO:0044782; GO:0060090; GO:0061024; GO:0065003,mitochondrion; vacuole; microtubule organizing center; cytosol; plasma membrane; vesicle-mediated transport; organelle; cilium organization; molecular adaptor activity; membrane organization; protein-containing complex assembly
OG_03959,FUN_016104-T1,Peve_00010767,Pocillopora_meandrina_HIv1___RNAseq.g21594.t1,three_way,76.85283333333332,FUN_016104-T1,Q9H3C7,,,,,65.9,355.0,1.6e-133,478.0,sp|Q9H3C7|GGNB2_HUMAN Gametogenetin-binding protein 2 OS=Homo sapiens OX=9606 GN=GGNBP2 PE=1 SV=1,,,,,,
OG_03960,FUN_016106-T1,Peve_00010760,Pocillopora_meandrina_HIv1___TS.g26345.t1,three_way,78.27083333333333,FUN_016106-T1,P07314,GGT1_RAT,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Rattus norvegicus (Rat),45.9,536.0,3.6e-125,450.3,sp|P07314|GGT1_RAT Glutathione hydrolase 1 proenzyme OS=Rattus norvegicus OX=10116 GN=Ggt1 PE=1 SV=4,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982],aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_03961,FUN_016109-T1,Peve_00013354,Pocillopora_meandrina_HIv1___RNAseq.g21558.t1,three_way,89.81033333333333,FUN_016109-T1,O43709,,,,,62.1,282.0,2.9e-98,359.8,sp|O43709|BUD23_HUMAN 18S rRNA (guanine-N(7))-methyltransferase OS=Homo sapiens OX=9606 GN=BUD23 PE=1 SV=2,,,,,,
OG_03962,FUN_016111-T1,Peve_00013359,Pocillopora_meandrina_HIv1___RNAseq.g21553.t2,three_way,68.24533333333333,FUN_016111-T1,Q8WXX7,,,,,35.2,162.0,1.2e-07,60.5,sp|Q8WXX7|AUTS2_HUMAN Autism susceptibility gene 2 protein OS=Homo sapiens OX=9606 GN=AUTS2 PE=1 SV=1,,,,,,
OG_03963,FUN_016112-T1,Peve_00013360,Pocillopora_meandrina_HIv1___RNAseq.g21551.t1,three_way,44.34066666666666,,,,,,,,,,,,,,,,,
OG_03964,FUN_016113-T1,Peve_00013363,Pocillopora_meandrina_HIv1___RNAseq.g21560.t1,three_way,46.34166666666667,,,,,,,,,,,,,,,,,
OG_03965,FUN_016114-T1,Peve_00013353,Pocillopora_meandrina_HIv1___RNAseq.g21557.t1,three_way,59.141666666666666,FUN_016114-T1,B8F7S3,,,,,51.5,66.0,2.1e-13,78.2,sp|B8F7S3|DNAJ_GLAP5 Chaperone protein DnaJ OS=Glaesserella parasuis serovar 5 (strain SH0165) OX=557723 GN=dnaJ PE=3 SV=1,,,,,,
OG_03966,FUN_016115-T1,Peve_00013352,Pocillopora_meandrina_HIv1___RNAseq.g21556.t1,three_way,63.22466666666667,FUN_016115-T1,Q9H9H4,VP37B_HUMAN,,Vacuolar protein sorting-associated protein 37B (hVps37B) (ESCRT-I complex subunit VPS37B),Homo sapiens (Human),36.6,82.0,2.4e-06,53.1,sp|Q9H9H4|VP37B_HUMAN Vacuolar protein sorting-associated protein 37B OS=Homo sapiens OX=9606 GN=VPS37B PE=1 SV=1,GO:0000813; GO:0005737; GO:0005768; GO:0005886; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0019076; GO:0030496; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043328; GO:0048306; GO:0070062; GO:0090148; GO:1903774,macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306],GO:0005768; GO:0005886; GO:0006886; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; plasma membrane; intracellular protein transport; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_03967,FUN_016116-T1,Peve_00013351,Pocillopora_meandrina_HIv1___TS.g26292.t1a,three_way,59.283,FUN_016116-T1,Q01097,NMDE2_MOUSE,,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B)",Mus musculus (Mouse),22.8,689.0,2.1e-31,139.0,"sp|Q01097|NMDE2_MOUSE Glutamate receptor ionotropic, NMDA 2B OS=Mus musculus OX=10090 GN=Grin2b PE=1 SV=3",GO:0001662; GO:0001701; GO:0001964; GO:0001967; GO:0004972; GO:0005261; GO:0005262; GO:0005764; GO:0005770; GO:0005789; GO:0005856; GO:0005886; GO:0006812; GO:0006816; GO:0007268; GO:0007423; GO:0007611; GO:0007612; GO:0007613; GO:0008021; GO:0008270; GO:0009986; GO:0014069; GO:0016020; GO:0016595; GO:0017146; GO:0022849; GO:0030425; GO:0030658; GO:0035235; GO:0042596; GO:0042734; GO:0043005; GO:0045202; GO:0045211; GO:0045471; GO:0048167; GO:0048168; GO:0048266; GO:0050966; GO:0051290; GO:0051968; GO:0060078; GO:0060079; GO:0060291; GO:0097060; GO:0097553; GO:0098655; GO:0098794; GO:0098839; GO:0098978; GO:0141161; GO:1902951; GO:1904062; GO:2000463,"behavioral fear response [GO:0001662]; behavioral response to pain [GO:0048266]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; excitatory postsynaptic potential [GO:0060079]; fear response [GO:0042596]; in utero embryonic development [GO:0001701]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; negative regulation of dendritic spine maintenance [GO:1902951]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein heterotetramerization [GO:0051290]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of synaptic plasticity [GO:0048167]; response to ethanol [GO:0045471]; sensory organ development [GO:0007423]; startle response [GO:0001964]; suckling behavior [GO:0001967]",cell surface [GO:0009986]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021]; transport vesicle membrane [GO:0030658],calcium channel activity [GO:0005262]; glutamate binding [GO:0016595]; glutamate-gated calcium ion channel activity [GO:0022849]; monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; zinc ion binding [GO:0008270],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005856; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0060089; GO:0065003,transporter activity; lysosome; endosome; vacuole; cytoskeleton; plasma membrane; signaling; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly
OG_03968,FUN_016122-T1,Peve_00013455,Pocillopora_meandrina_HIv1___RNAseq.g21534.t1,three_way,49.625,,,,,,,,,,,,,,,,,
OG_03969,FUN_016123-T1,Peve_00013454,Pocillopora_meandrina_HIv1___RNAseq.g21533.t1,three_way,88.006,FUN_016123-T1,Q9YHZ6,,,,,47.3,566.0,1.3e-150,534.6,sp|Q9YHZ6|CDC45_XENLA Cell division control protein 45 homolog OS=Xenopus laevis OX=8355 GN=cdc45 PE=1 SV=2,,,,,,
OG_03970,FUN_016124-T1,Peve_00013453,Pocillopora_meandrina_HIv1___RNAseq.g21251.t1a,three_way,41.071333333333335,FUN_016124-T1,Q60774,,,,,30.0,273.0,3.3e-23,110.5,sp|Q60774|TM45A_MOUSE Transmembrane protein 45A OS=Mus musculus OX=10090 GN=Tmem45a PE=2 SV=1,,,,,,
OG_03971,FUN_016125-T1,Peve_00013452,Pocillopora_meandrina_HIv1___RNAseq.g21531.t1,three_way,80.723,FUN_016125-T1,Q8VI36,PAXI_MOUSE,,Paxillin,Mus musculus (Mouse),52.0,471.0,3.8e-133,476.5,sp|Q8VI36|PAXI_MOUSE Paxillin OS=Mus musculus OX=10090 GN=Pxn PE=1 SV=1,GO:0005078; GO:0005856; GO:0005925; GO:0005938; GO:0007010; GO:0007179; GO:0007229; GO:0008360; GO:0016477; GO:0030027; GO:0030032; GO:0030159; GO:0031252; GO:0031663; GO:0034446; GO:0038191; GO:0045766; GO:0046872; GO:0048041; GO:0048754; GO:0051435; GO:1900026,branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of angiogenesis [GO:0045766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179],cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027],BH4 domain binding [GO:0051435]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; neuropilin binding [GO:0038191]; signaling receptor complex adaptor activity [GO:0030159],GO:0005856; GO:0007010; GO:0007155; GO:0034330; GO:0043226; GO:0048870; GO:0060090,cytoskeleton; cytoskeleton organization; cell adhesion; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_03972,FUN_016126-T1,Peve_00013450,Pocillopora_meandrina_HIv1___RNAseq.g21529.t1,three_way,54.19866666666667,,,,,,,,,,,,,,,,,
OG_03973,FUN_016127-T1,Peve_00013451,Pocillopora_meandrina_HIv1___RNAseq.g21530.t1,three_way,82.134,FUN_016127-T1,Q5U3N0,,,,,47.0,168.0,1.1e-35,151.4,sp|Q5U3N0|PKHA8_DANRE Pleckstrin homology domain-containing family A member 8 OS=Danio rerio OX=7955 GN=plekha8 PE=2 SV=1,,,,,,
OG_03974,FUN_016128-T1,Peve_00013447,Pocillopora_meandrina_HIv1___RNAseq.g21528.t1,three_way,56.35066666666667,,,,,,,,,,,,,,,,,
OG_03975,FUN_016129-T1,Peve_00013443,Pocillopora_meandrina_HIv1___TS.g26226.t1,three_way,44.653,,,,,,,,,,,,,,,,,
OG_03976,FUN_016130-T1,Peve_00022572,Pocillopora_meandrina_HIv1___RNAseq.g21959.t1,three_way,68.79966666666667,FUN_016130-T1,A3KCL7,OXDD_PIG,,D-aspartate oxidase (DASOX) (DASPO) (DDO) (EC 1.4.3.1),Sus scrofa (Pig),40.6,342.0,3.8e-63,243.4,sp|A3KCL7|OXDD_PIG D-aspartate oxidase OS=Sus scrofa OX=9823 GN=DDO PE=1 SV=2,GO:0005737; GO:0005777; GO:0005782; GO:0005829; GO:0006531; GO:0007320; GO:0007625; GO:0008445; GO:0010646; GO:0019478; GO:0042445; GO:0047821; GO:0050877; GO:0071949,aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insemination [GO:0007320]; nervous system process [GO:0050877]; regulation of cell communication [GO:0010646],cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],D-aspartate oxidase activity [GO:0008445]; D-glutamate oxidase activity [GO:0047821]; FAD binding [GO:0071949],GO:0003824; GO:0005777; GO:0005829; GO:0006520; GO:0016491; GO:0022414; GO:0043226; GO:0050877,catalytic activity; peroxisome; cytosol; amino acid metabolic process; oxidoreductase activity; reproductive process; organelle; nervous system process
OG_03977,FUN_016131-T1,Peve_00022577,Pocillopora_meandrina_HIv1___RNAseq.g22028.t1,three_way,72.21333333333334,FUN_016131-T1,Q2KIY5,,,,,49.0,531.0,7e-144,512.3,sp|Q2KIY5|PLBL2_BOVIN Putative phospholipase B-like 2 OS=Bos taurus OX=9913 GN=PLBD2 PE=2 SV=1,,,,,,
OG_03978,FUN_016132-T1,Peve_00022580,Pocillopora_meandrina_HIv1___RNAseq.g22029.t1,three_way,56.699000000000005,FUN_016132-T1,Q8N4B1,SESQ1_HUMAN,,Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase-interacting protein A) (IPIP27A) (PH domain-containing endocytic trafficking adaptor 1),Homo sapiens (Human),45.7,127.0,1.2e-30,135.6,sp|Q8N4B1|SESQ1_HUMAN Sesquipedalian-1 OS=Homo sapiens OX=9606 GN=PHETA1 PE=1 SV=1,GO:0001881; GO:0005769; GO:0005802; GO:0005829; GO:0007032; GO:0030136; GO:0042147; GO:0042803; GO:0055037,"endosome organization [GO:0007032]; receptor recycling [GO:0001881]; retrograde transport, endosome to Golgi [GO:0042147]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],protein homodimerization activity [GO:0042803],GO:0005768; GO:0005829; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_03979,FUN_016137-T1,Peve_00022581,Pocillopora_meandrina_HIv1___RNAseq.g22030.t1,three_way,83.41883333333334,FUN_016137-T1,Q810B6,ANFY1_MOUSE,,Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif),Mus musculus (Mouse),49.1,1329.0,3.3e-253,876.7,sp|Q810B6|ANFY1_MOUSE Rabankyrin-5 OS=Mus musculus OX=10090 GN=Ankfy1 PE=1 SV=2,GO:0005769; GO:0005829; GO:0006897; GO:0008270; GO:0010008; GO:0030904; GO:0031267; GO:0034058; GO:0042147; GO:0044354; GO:0048549; GO:0090160; GO:1901981,"endocytosis [GO:0006897]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; macropinosome [GO:0044354]; retromer complex [GO:0030904],phosphatidylinositol phosphate binding [GO:1901981]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0005768; GO:0005829; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; cytosol; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_03980,FUN_016138-T1,Peve_00022583,Pocillopora_meandrina_HIv1___RNAseq.g22031.t2,three_way,68.26350000000001,FUN_016138-T1,Q9ER33,CNGA3_RAT,,Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3) (Gustatory cyclic nucleotide-gated cation channel) (CNGgust),Rattus norvegicus (Rat),42.4,224.0,1.1999999999999999e-41,172.2,sp|Q9ER33|CNGA3_RAT Cyclic nucleotide-gated channel alpha-3 OS=Rattus norvegicus OX=10116 GN=Cnga3 PE=1 SV=1,GO:0001750; GO:0005221; GO:0005222; GO:0005223; GO:0005886; GO:0006812; GO:0006814; GO:0017022; GO:0017071; GO:0030425; GO:0030553; GO:0032026; GO:0034220; GO:0043025; GO:0043194; GO:0043204; GO:0044877; GO:0045296; GO:0046549; GO:0051591; GO:0051899; GO:0060041; GO:0097386; GO:0098655; GO:0098659; GO:0120199; GO:1902495,inorganic cation import across plasma membrane [GO:0098659]; membrane depolarization [GO:0051899]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; response to cAMP [GO:0051591]; response to magnesium ion [GO:0032026]; retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; sodium ion transport [GO:0006814],axon initial segment [GO:0043194]; cone photoreceptor outer segment [GO:0120199]; dendrite [GO:0030425]; glial cell projection [GO:0097386]; intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transmembrane transporter complex [GO:1902495],cadherin binding [GO:0045296]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; intracellularly cyclic nucleotide-activated monoatomic cation channel activity [GO:0005221]; myosin binding [GO:0017022]; protein-containing complex binding [GO:0044877],GO:0005215; GO:0005886; GO:0008092; GO:0048856; GO:0055085,transporter activity; plasma membrane; cytoskeletal protein binding; anatomical structure development; transmembrane transport
OG_03981,FUN_016140-T1,Peve_00022584,Pocillopora_meandrina_HIv1___RNAseq.g22032.t2,three_way,82.32233333333333,FUN_016140-T1,Q13247,SRSF6_HUMAN,,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",Homo sapiens (Human),62.1,182.0,6.6e-61,235.7,sp|Q13247|SRSF6_HUMAN Serine/arginine-rich splicing factor 6 OS=Homo sapiens OX=9606 GN=SRSF6 PE=1 SV=2,GO:0000380; GO:0000381; GO:0000398; GO:0003723; GO:0005654; GO:0006376; GO:0010837; GO:0016607; GO:0032868; GO:0036002; GO:0045617; GO:0048025; GO:0060501; GO:0061041; GO:2000675,"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of keratinocyte proliferation [GO:0010837]; regulation of wound healing [GO:0061041]; response to insulin [GO:0032868]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_03982,FUN_016141-T1,Peve_00013437,Pocillopora_meandrina_HIv1___TS.g26796.t1c,three_way,79.88266666666667,FUN_016141-T1,O14578,,,,,35.7,1950.0,1.9e-239,831.6,sp|O14578|CTRO_HUMAN Citron Rho-interacting kinase OS=Homo sapiens OX=9606 GN=CIT PE=1 SV=2,,,,,,
OG_03983,FUN_016148-T1,Peve_00013425,Pocillopora_meandrina_HIv1___RNAseq.g22092.t1,three_way,82.95133333333334,FUN_016148-T1,P79987,HIRA_CHICK,,Protein HIRA (cHIRA) (TUP1-like enhancer of split protein 1),Gallus gallus (Chicken),44.1,1049.0,7.2e-216,752.3,sp|P79987|HIRA_CHICK Protein HIRA OS=Gallus gallus OX=9031 GN=HIRA PE=1 SV=2,GO:0000417; GO:0000785; GO:0005634; GO:0006338; GO:0006351; GO:0006355,chromatin remodeling [GO:0006338]; DNA-templated transcription [GO:0006351]; regulation of DNA-templated transcription [GO:0006355],chromatin [GO:0000785]; HIR complex [GO:0000417]; nucleus [GO:0005634],,GO:0005634; GO:0006325; GO:0006351; GO:0006355; GO:0043226,nucleus; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; organelle
OG_03984,FUN_016149-T1,Peve_00013423,Pocillopora_meandrina_HIv1___RNAseq.g22093.t1,three_way,80.72766666666666,,,,,,,,,,,,,,,,,
OG_03985,FUN_016150-T1,Peve_00013422,Pocillopora_meandrina_HIv1___RNAseq.g22094.t1,three_way,87.48066666666666,,,,,,,,,,,,,,,,,
OG_03986,FUN_016151-T3,Peve_00022570,Pocillopora_meandrina_HIv1___RNAseq.g21228.t1,three_way,51.66783333333333,FUN_016151-T3,Q5SW75,SSH2_MOUSE,,Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (mSSH-2L),Mus musculus (Mouse),48.9,509.0,4.7e-124,448.0,sp|Q5SW75|SSH2_MOUSE Protein phosphatase Slingshot homolog 2 OS=Mus musculus OX=10090 GN=Ssh2 PE=1 SV=2,GO:0001669; GO:0003779; GO:0004722; GO:0004725; GO:0005856; GO:0005925; GO:0007283; GO:0030154; GO:0030837,cell differentiation [GO:0030154]; negative regulation of actin filament polymerization [GO:0030837]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925],actin binding [GO:0003779]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005856; GO:0008092; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; cytoskeleton; cytoskeletal protein binding; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_03987,FUN_016152-T1,Peve_00022569,Pocillopora_meandrina_HIv1___RNAseq.g21229.t1,three_way,62.593833333333336,FUN_016152-T1,Q3U487,HECD3_MOUSE,,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),Mus musculus (Mouse),47.1,425.0,5.6e-104,380.9,sp|Q3U487|HECD3_MOUSE E3 ubiquitin-protein ligase HECTD3 OS=Mus musculus OX=10090 GN=Hectd3 PE=1 SV=2,GO:0004842; GO:0016567; GO:0019905; GO:0043161; GO:0048471,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],perinuclear region of cytoplasm [GO:0048471],syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03988,FUN_016154-T1,Peve_00004478,Pocillopora_meandrina_HIv1___RNAseq.g21231.t1,three_way,69.62266666666667,,,,,,,,,,,,,,,,,
OG_03989,FUN_016156-T1,Peve_00022567,Pocillopora_meandrina_HIv1___RNAseq.g21232.t1,three_way,67.495,FUN_016156-T1,Q6GQN8,MECR_DANRE,,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial (EC 1.3.1.104) (2-enoyl thioester reductase)",Danio rerio (Zebrafish) (Brachydanio rerio),47.7,130.0,7.1e-31,134.8,"sp|Q6GQN8|MECR_DANRE Enoyl-[acyl-carrier-protein] reductase, mitochondrial OS=Danio rerio OX=7955 GN=mecr PE=2 SV=2",GO:0005739; GO:0006631; GO:0006633; GO:0141148,fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631],mitochondrion [GO:0005739],enoyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0141148],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle
OG_03990,FUN_016158-T1,Peve_00022563,Pocillopora_meandrina_HIv1___RNAseq.g21233.t1,three_way,67.15366666666667,FUN_016158-T1,G3UYX5,,,,,31.1,775.0,2.5e-103,379.4,sp|G3UYX5|RGS22_MOUSE Regulator of G-protein signaling 22 OS=Mus musculus OX=10090 GN=Rgs22 PE=1 SV=1,,,,,,
OG_03991,FUN_016163-T1,Peve_00022617,Pocillopora_meandrina_HIv1___RNAseq.g21016.t1,three_way,65.033,FUN_016163-T1,Q9ULI0,ATD2B_HUMAN,,ATPase family AAA domain-containing protein 2B,Homo sapiens (Human),42.8,1254.0,1.0999999999999999e-249,865.1,sp|Q9ULI0|ATD2B_HUMAN ATPase family AAA domain-containing protein 2B OS=Homo sapiens OX=9606 GN=ATAD2B PE=1 SV=4,GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0016887; GO:0042393; GO:0045815; GO:0070577,nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; transcription initiation-coupled chromatin remodeling [GO:0045815],nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577],GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016787; GO:0042393; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; chromatin organization; hydrolase activity; histone binding; organelle; protein-containing complex assembly
OG_03992,FUN_016166-T1,Peve_00022615,Pocillopora_meandrina_HIv1___RNAseq.g21019.t1,three_way,80.89733333333334,FUN_016166-T1,Q8AY73,,,,,60.6,968.0,0.0,1147.1,sp|Q8AY73|XPO2_ORENI Exportin-2 OS=Oreochromis niloticus OX=8128 GN=cse1l PE=2 SV=1,,,,,,
OG_03993,FUN_016167-T1,Peve_00009494,Pocillopora_meandrina_HIv1___RNAseq.g22349.t1,three_way,58.57066666666667,FUN_016167-T1,Q9P0Z9,SOX_HUMAN,,Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase),Homo sapiens (Human),45.3,380.0,1.5e-95,351.3,sp|Q9P0Z9|SOX_HUMAN Peroxisomal sarcosine oxidase OS=Homo sapiens OX=9606 GN=PIPOX PE=1 SV=2,GO:0005777; GO:0005782; GO:0005829; GO:0006554; GO:0008115; GO:0033514; GO:0050031; GO:0050660,L-lysine catabolic process to acetyl-CoA via L-pipecolate [GO:0033514]; lysine catabolic process [GO:0006554],cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],flavin adenine dinucleotide binding [GO:0050660]; L-pipecolate oxidase activity [GO:0050031]; sarcosine oxidase activity [GO:0008115],GO:0003824; GO:0005777; GO:0005829; GO:0006520; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; peroxisome; cytosol; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_03994,FUN_016262-T1,Peve_00019444,Pocillopora_meandrina_HIv1___RNAseq.g11083.t1,three_way,70.785,,,,,,,,,,,,,,,,,
OG_03995,FUN_016279-T1,Peve_00003394,Pocillopora_meandrina_HIv1___RNAseq.g406.t1,three_way,53.544,,,,,,,,,,,,,,,,,
OG_03996,FUN_016280-T2,Peve_00003392,Pocillopora_meandrina_HIv1___RNAseq.g403.t1,three_way,76.21483333333333,FUN_016280-T2,P70627,FOLH1_RAT,,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen homolog) (Pteroylpoly-gamma-glutamate carboxypeptidase),Rattus norvegicus (Rat),42.5,742.0,6.9e-166,585.9,sp|P70627|FOLH1_RAT Glutamate carboxypeptidase 2 OS=Rattus norvegicus OX=10116 GN=Folh1 PE=1 SV=1,GO:0004180; GO:0004181; GO:0005886; GO:0006508; GO:0006760; GO:0008233; GO:0009986; GO:0016020; GO:0016805; GO:0030163; GO:0043065; GO:0046872; GO:1904492; GO:1904493,folic acid-containing compound metabolic process [GO:0006760]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cell surface [GO:0009986]; membrane [GO:0016020]; plasma membrane [GO:0005886],Ac-Asp-Glu binding [GO:1904492]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallocarboxypeptidase activity [GO:0004181]; peptidase activity [GO:0008233]; tetrahydrofolyl-poly(glutamate) polymer binding [GO:1904493],GO:0003824; GO:0005886; GO:0006575; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; plasma membrane; modified amino acid metabolic process; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_03997,FUN_016284-T1,Peve_00024280,Pocillopora_meandrina_HIv1___RNAseq.g401.t2,three_way,83.84983333333334,FUN_016284-T1,Q61084,M3K3_MOUSE,,Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3),Mus musculus (Mouse),43.4,677.0,4.9000000000000005e-123,443.4,sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus OX=10090 GN=Map3k3 PE=1 SV=1,GO:0001568; GO:0004672; GO:0004709; GO:0005524; GO:0035556; GO:0043123; GO:0046872; GO:0106310; GO:1900745,blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745],,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_03998,FUN_016286-T1,Peve_00027223,Pocillopora_meandrina_HIv1___RNAseq.g400.t1,three_way,87.92383333333333,FUN_016286-T1,O46470,,,,,56.8,458.0,9e-137,488.4,sp|O46470|RGS7_BOVIN Regulator of G-protein signaling 7 OS=Bos taurus OX=9913 GN=RGS7 PE=1 SV=1,,,,,,
OG_03999,FUN_016288-T1,Peve_00010631,Pocillopora_meandrina_HIv1___RNAseq.g397.t1,three_way,75.145,FUN_016288-T1,Q9Z315,,,,,40.3,769.0,9.7e-115,416.0,sp|Q9Z315|SNUT1_MOUSE U4/U6.U5 tri-snRNP-associated protein 1 OS=Mus musculus OX=10090 GN=Sart1 PE=1 SV=1,,,,,,
OG_04000,FUN_016294-T1,Peve_00001309,Pocillopora_meandrina_HIv1___RNAseq.g23519.t1b,three_way,61.464,,,,,,,,,,,,,,,,,
OG_04001,FUN_016296-T1,Peve_00043168,Pocillopora_meandrina_HIv1___RNAseq.g503.t1,three_way,73.475,FUN_016296-T1,Q99758,ABCA3_HUMAN,,Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ABC-C transporter) (ATP-binding cassette sub-family A member 3) (ATP-binding cassette transporter 3) (ATP-binding cassette 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form],Homo sapiens (Human),35.3,1952.0,2.1e-296,1020.8,sp|Q99758|ABCA3_HUMAN Phospholipid-transporting ATPase ABCA3 OS=Homo sapiens OX=9606 GN=ABCA3 PE=1 SV=2,GO:0005319; GO:0005524; GO:0005615; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0009410; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140,lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019],GO:0003824; GO:0005215; GO:0005615; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; extracellular space; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_04002,FUN_016297-T1,Peve_00002880,Pocillopora_meandrina_HIv1___RNAseq.g9883.t1,three_way,94.22166666666666,FUN_016297-T1,P35224,,,,,57.2,711.0,3.1e-203,709.9,sp|P35224|CTNB_URECA Catenin beta OS=Urechis caupo OX=6431 PE=2 SV=1,,,,,,
OG_04003,FUN_016299-T1,Peve_00025246,Pocillopora_meandrina_HIv1___RNAseq.g9888.t1,three_way,47.610166666666665,FUN_016299-T1,Q64337,SQSTM_MOUSE,,Sequestosome-1 (STONE14) (Ubiquitin-binding protein p62),Mus musculus (Mouse),47.7,44.0,4.8e-06,55.5,sp|Q64337|SQSTM_MOUSE Sequestosome-1 OS=Mus musculus OX=10090 GN=Sqstm1 PE=1 SV=1,GO:0000122; GO:0000407; GO:0000423; GO:0000425; GO:0000932; GO:0001659; GO:0002376; GO:0002931; GO:0003712; GO:0005080; GO:0005739; GO:0005770; GO:0005776; GO:0005783; GO:0005829; GO:0006366; GO:0006606; GO:0006914; GO:0006915; GO:0007032; GO:0008270; GO:0010508; GO:0016235; GO:0016236; GO:0016605; GO:0030017; GO:0030154; GO:0030163; GO:0030674; GO:0031397; GO:0031625; GO:0034144; GO:0035255; GO:0035591; GO:0035973; GO:0038023; GO:0042169; GO:0042802; GO:0043122; GO:0043130; GO:0043232; GO:0044753; GO:0044754; GO:0044877; GO:0061635; GO:0070342; GO:0070530; GO:0071211; GO:0097009; GO:0097225; GO:0097413; GO:0098780; GO:0098978; GO:0110076; GO:0140036; GO:0140311; GO:0140693; GO:0140694; GO:1900273; GO:1903078; GO:1905719,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; membraneless organelle assembly [GO:0140694]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pexophagy [GO:0000425]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; intracellular membraneless organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225],identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; transcription coregulator activity [GO:0003712]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0002376; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005829; GO:0006351; GO:0006355; GO:0006886; GO:0006913; GO:0006914; GO:0012501; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0060089; GO:0060090; GO:0140110; GO:0140313,immune system process; mitochondrion; lysosome; endosome; vacuole; endoplasmic reticulum; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; autophagy; programmed cell death; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity; molecular adaptor activity; transcription regulator activity; molecular sequestering activity
OG_04004,FUN_016302-T1,Peve_00032295,Pocillopora_meandrina_HIv1___RNAseq.g10043.t1,three_way,79.83366666666666,FUN_016302-T1,Q9UIU6,,,,,70.9,179.0,4.1e-71,269.6,sp|Q9UIU6|SIX4_HUMAN Homeobox protein SIX4 OS=Homo sapiens OX=9606 GN=SIX4 PE=1 SV=2,,,,,,
OG_04005,FUN_016304-T1,Peve_00032294,Pocillopora_meandrina_HIv1___RNAseq.g10041.t1,three_way,94.68466666666669,FUN_016304-T1,O42406,,,,,86.9,191.0,7.2e-98,358.2,sp|O42406|SIX3_CHICK Homeobox protein SIX3 OS=Gallus gallus OX=9031 GN=SIX3 PE=1 SV=2,,,,,,
OG_04006,FUN_016305-T1,Peve_00032293,Pocillopora_meandrina_HIv1___RNAseq.g10040.t1,three_way,94.53566666666669,FUN_016305-T1,Q6NZ04,SIX1B_DANRE,,Homeobox protein six1b (Homeobox protein six1a) (Sine oculis homeobox homolog 1a) (Sine oculis homeobox homolog 1b),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,285.0,6.9e-92,338.6,sp|Q6NZ04|SIX1B_DANRE Homeobox protein six1b OS=Danio rerio OX=7955 GN=six1b PE=1 SV=1,GO:0000978; GO:0000981; GO:0002074; GO:0005634; GO:0005667; GO:0005737; GO:0006357; GO:0006915; GO:0014857; GO:0021984; GO:0043282; GO:0048741; GO:0048839; GO:0048935; GO:0051146,adenohypophysis development [GO:0021984]; apoptotic process [GO:0006915]; chordate pharyngeal muscle development [GO:0043282]; extraocular skeletal muscle development [GO:0002074]; inner ear development [GO:0048839]; peripheral nervous system neuron development [GO:0048935]; regulation of skeletal muscle cell proliferation [GO:0014857]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle fiber development [GO:0048741]; striated muscle cell differentiation [GO:0051146],cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04007,FUN_016306-T1,Peve_00032291,Pocillopora_meandrina_HIv1___RNAseq.g10039.t1,three_way,79.79733333333333,FUN_016306-T1,Q27350,SO_DROME,,Protein sine oculis,Drosophila melanogaster (Fruit fly),63.4,186.0,2.2e-62,240.7,sp|Q27350|SO_DROME Protein sine oculis OS=Drosophila melanogaster OX=7227 GN=so PE=2 SV=1,GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001744; GO:0001745; GO:0001746; GO:0005634; GO:0005667; GO:0006357; GO:0007283; GO:0007623; GO:0008347; GO:0009649; GO:0035271; GO:0043565; GO:0045944; GO:0048749,Bolwig's organ morphogenesis [GO:0001746]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; entrainment of circadian clock [GO:0009649]; glial cell migration [GO:0008347]; insect visual primordium formation [GO:0001744]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; ring gland development [GO:0035271]; spermatogenesis [GO:0007283],nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04008,FUN_016308-T1,Peve_00032290,Pocillopora_meandrina_HIv1___RNAseq.g10037.t1,three_way,81.12333333333333,,,,,,,,,,,,,,,,,
OG_04009,FUN_016309-T1,Peve_00032289,Pocillopora_meandrina_HIv1___RNAseq.g10036.t1,three_way,69.13433333333334,FUN_016309-T1,Q90WM5,,,,,34.7,265.0,1.7999999999999997e-24,115.2,sp|Q90WM5|DMRT3_TAKRU Doublesex- and mab-3-related transcription factor 3 OS=Takifugu rubripes OX=31033 GN=dmrt3 PE=2 SV=2,,,,,,
OG_04010,FUN_016311-T1,Peve_00032324,Pocillopora_meandrina_HIv1___RNAseq.g10035.t1,three_way,78.09949999999999,FUN_016311-T1,Q76L87,,,,,37.8,259.0,3.8e-27,124.0,sp|Q76L87|DMTA2_ORYLA Doublesex- and mab-3-related transcription factor A2 OS=Oryzias latipes OX=8090 GN=dmrta2 PE=3 SV=1,,,,,,
OG_04011,FUN_016313-T2,Peve_00002513,Pocillopora_meandrina_HIv1___RNAseq.g9698.t1,three_way,65.3485,FUN_016313-T2,Q6GMG6,,,,,40.4,446.0,3.2e-86,320.5,"sp|Q6GMG6|S5A3B_DANRE Solute carrier family 52, riboflavin transporter, member 3-B OS=Danio rerio OX=7955 GN=slc52a3b PE=2 SV=1",,,,,,
OG_04012,FUN_016314-T1,Peve_00024695,Pocillopora_meandrina_HIv1___RNAseq.g9699.t1b,three_way,84.1865,FUN_016314-T1,Q6TUG0,,,,,63.0,357.0,9.999999999999998e-128,458.0,sp|Q6TUG0|DJB11_RAT DnaJ homolog subfamily B member 11 OS=Rattus norvegicus OX=10116 GN=Dnajb11 PE=2 SV=1,,,,,,
OG_04013,FUN_016316-T1,Peve_00024694,Pocillopora_meandrina_HIv1___RNAseq.g9705.t1,three_way,71.514,FUN_016316-T1,Q80UJ7,RB3GP_MOUSE,,Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP),Mus musculus (Mouse),43.6,1103.0,1.8e-239,830.9,sp|Q80UJ7|RB3GP_MOUSE Rab3 GTPase-activating protein catalytic subunit OS=Mus musculus OX=10090 GN=Rab3gap1 PE=1 SV=4,GO:0005085; GO:0005096; GO:0005737; GO:0005801; GO:0010628; GO:0010807; GO:0031267; GO:0032483; GO:0032991; GO:0034389; GO:0043547; GO:0048172; GO:0048489; GO:0050821; GO:0060079; GO:0061646; GO:0071782; GO:0097051; GO:0098794; GO:1903061; GO:1903233; GO:1903373; GO:2000786,establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; excitatory postsynaptic potential [GO:0060079]; lipid droplet organization [GO:0034389]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of endoplasmic reticulum tubular network organization [GO:1903373]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization [GO:0061646]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein lipidation [GO:1903061]; protein stabilization [GO:0050821]; regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903233]; regulation of Rab protein signal transduction [GO:0032483]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807]; synaptic vesicle transport [GO:0048489],cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; endoplasmic reticulum tubular network [GO:0071782]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0043226; GO:0098772,organelle; molecular function regulator activity
OG_04014,FUN_016317-T1,Peve_00002510,Pocillopora_meandrina_HIv1___RNAseq.g9706.t1,three_way,79.41633333333333,FUN_016317-T1,A1L0Y2,,,,,34.2,199.0,7.7e-22,105.5,sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1,,,,,,
OG_04015,FUN_016319-T2,Peve_00000584,Pocillopora_meandrina_HIv1___RNAseq.g9709.t1,three_way,76.87366666666667,FUN_016319-T2,Q2M3R5,S35G1_HUMAN,,Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20),Homo sapiens (Human),37.8,225.0,3.0000000000000003e-31,137.1,sp|Q2M3R5|S35G1_HUMAN Solute carrier family 35 member G1 OS=Homo sapiens OX=9606 GN=SLC35G1 PE=1 SV=1,GO:0005789; GO:0005886; GO:0051480; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],,GO:0005886; GO:0055085,plasma membrane; transmembrane transport
OG_04016,FUN_016320-T1,Peve_00000581,Pocillopora_meandrina_HIv1___RNAseq.g9711.t1,three_way,50.35866666666666,FUN_016320-T1,E7F6T8,UBP37_DANRE,,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),Danio rerio (Zebrafish) (Brachydanio rerio),36.6,361.0,7e-47,191.0,sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1,GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0021551; GO:0031647; GO:0035871; GO:0051301; GO:0071108; GO:1904888,cell division [GO:0051301]; central nervous system morphogenesis [GO:0021551]; cranial skeletal system development [GO:1904888]; G1/S transition of mitotic cell cycle [GO:0000082]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04016,FUN_016320-T1,Peve_00000581,Pocillopora_meandrina_HIv1___RNAseq.g9711.t1,three_way,50.35866666666666,FUN_016320-T1,E7F6T8,UBP37_DANRE,,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),Danio rerio (Zebrafish) (Brachydanio rerio),47.1,70.0,3e-13,79.3,sp|E7F6T8|UBP37_DANRE Ubiquitin carboxyl-terminal hydrolase 37 OS=Danio rerio OX=7955 GN=usp37 PE=2 SV=1,GO:0000082; GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0021551; GO:0031647; GO:0035871; GO:0051301; GO:0071108; GO:1904888,cell division [GO:0051301]; central nervous system morphogenesis [GO:0021551]; cranial skeletal system development [GO:1904888]; G1/S transition of mitotic cell cycle [GO:0000082]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04017,FUN_016322-T1,Peve_00000647,Pocillopora_meandrina_HIv1___RNAseq.g26417.t1,three_way,67.65366666666667,FUN_016322-T1,Q9R062,,,,,27.5,273.0,3.8e-19,97.4,sp|Q9R062|GLYG_MOUSE Glycogenin-1 OS=Mus musculus OX=10090 GN=Gyg1 PE=1 SV=3,,,,,,
OG_04018,FUN_016323-T1,Peve_00028007,Pocillopora_meandrina_HIv1___RNAseq.g9689.t1,three_way,80.98466666666667,FUN_016323-T1,Q5R5L3,,,,,45.0,800.0,9.5e-203,708.4,sp|Q5R5L3|DJC10_PONAB DnaJ homolog subfamily C member 10 OS=Pongo abelii OX=9601 GN=DNAJC10 PE=2 SV=1,,,,,,
OG_04019,FUN_016324-T1,Peve_00009565,Pocillopora_meandrina_HIv1___TS.g23223.t1,three_way,71.28433333333334,,,,,,,,,,,,,,,,,
OG_04020,FUN_016325-T1,Peve_00032381,Pocillopora_meandrina_HIv1___RNAseq.g9684.t1,three_way,69.31866666666667,,,,,,,,,,,,,,,,,
OG_04021,FUN_016326-T1,Peve_00032379,Pocillopora_meandrina_HIv1___RNAseq.g9683.t1,three_way,81.121,FUN_016326-T1,Q9I9N1,,,,,45.5,112.0,1.4e-14,80.5,sp|Q9I9N1|DAP1A_DANRE Death-associated protein 1 homolog OS=Danio rerio OX=7955 GN=dap PE=1 SV=1,,,,,,
OG_04022,FUN_016327-T1,Peve_00032378,Pocillopora_meandrina_HIv1___RNAseq.g9682.t1,three_way,50.593,,,,,,,,,,,,,,,,,
OG_04023,FUN_016329-T1,Peve_00032382,Pocillopora_meandrina_HIv1___RNAseq.g9858.t1b,three_way,87.74166666666666,FUN_016329-T1,Q96EZ8,MCRS1_HUMAN,,Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2),Homo sapiens (Human),53.9,410.0,8.7e-113,408.7,sp|Q96EZ8|MCRS1_HUMAN Microspherule protein 1 OS=Homo sapiens OX=9606 GN=MCRS1 PE=1 SV=1,GO:0000123; GO:0000723; GO:0002151; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0008266; GO:0010521; GO:0016604; GO:0030425; GO:0031011; GO:0033044; GO:0034046; GO:0036211; GO:0043204; GO:0044545; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0051726; GO:0060382; GO:0071339; GO:1904357; GO:1904507; GO:1904751,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204],G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226; GO:0098772,RNA binding; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle; molecular function regulator activity
OG_04024,FUN_016330-T1,Peve_00032370,Pocillopora_meandrina_HIv1___RNAseq.g9857.t2,three_way,82.74833333333333,FUN_016330-T1,Q9NRC6,SPTN5_HUMAN,,"Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)",Homo sapiens (Human),28.1,3578.0,0.0,1392.1,"sp|Q9NRC6|SPTN5_HUMAN Spectrin beta chain, non-erythrocytic 5 OS=Homo sapiens OX=9606 GN=SPTBN5 PE=1 SV=2",GO:0002046; GO:0003779; GO:0005737; GO:0005829; GO:0005875; GO:0005886; GO:0007030; GO:0007041; GO:0008091; GO:0016020; GO:0019894; GO:0030036; GO:0030054; GO:0030507; GO:0030864; GO:0032029; GO:0032391; GO:0034452; GO:0042802; GO:0042995; GO:0045179; GO:0045505; GO:0051015; GO:0051693; GO:0097381,actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041],apical cortex [GO:0045179]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule associated complex [GO:0005875]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; plasma membrane [GO:0005886]; spectrin [GO:0008091],actin binding [GO:0003779]; actin filament binding [GO:0051015]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; opsin binding [GO:0002046]; spectrin binding [GO:0030507],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_04025,FUN_016332-T1,Peve_00044544,Pocillopora_meandrina_HIv1___RNAseq.g9841.t1,three_way,43.75183333333334,,,,,,,,,,,,,,,,,
OG_04026,FUN_016333-T1,Peve_00044546,Pocillopora_meandrina_HIv1___TS.g23374.t1,three_way,71.42983333333333,FUN_016333-T1,P35869,AHR_HUMAN,,Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76),Homo sapiens (Human),40.4,381.0,7.4e-62,240.4,sp|P35869|AHR_HUMAN Aryl hydrocarbon receptor OS=Homo sapiens OX=9606 GN=AHR PE=1 SV=2,GO:0000785; GO:0000976; GO:0000981; GO:0000987; GO:0001094; GO:0001223; GO:0001568; GO:0002819; GO:0002841; GO:0003677; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006805; GO:0006915; GO:0009410; GO:0009636; GO:0010468; GO:0017025; GO:0030888; GO:0032922; GO:0032991; GO:0034751; GO:0034752; GO:0034753; GO:0042803; GO:0045892; GO:0045893; GO:0045944; GO:0046982; GO:0050728; GO:0051879; GO:0061629; GO:0070888; GO:0071219; GO:0071320; GO:1904322; GO:1904613; GO:1990837,"apoptotic process [GO:0006915]; blood vessel development [GO:0001568]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; cellular response to molecule of bacterial origin [GO:0071219]; circadian regulation of gene expression [GO:0032922]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of inflammatory response [GO:0050728]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell proliferation [GO:0030888]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; xenobiotic metabolic process [GO:0006805]",aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic aryl hydrocarbon receptor complex [GO:0034752]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; TBP-class protein binding [GO:0017025]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_04027,FUN_016334-T1,Peve_00044548,Pocillopora_meandrina_HIv1___RNAseq.g9843.t1,three_way,85.18666666666667,FUN_016334-T1,P60467,,,,,59.6,89.0,2.3e-18,93.2,sp|P60467|SC61B_CANLF Protein transport protein Sec61 subunit beta OS=Canis lupus familiaris OX=9615 GN=SEC61B PE=1 SV=2,,,,,,
OG_04028,FUN_016336-T1,Peve_00027345,Pocillopora_meandrina_HIv1___RNAseq.g19162.t1,three_way,38.645,,,,,,,,,,,,,,,,,
OG_04029,FUN_016337-T1,Peve_00044566,Pocillopora_meandrina_HIv1___RNAseq.g9732.t1,three_way,81.75833333333334,,,,,,,,,,,,,,,,,
OG_04030,FUN_016338-T1,Peve_00044573,Pocillopora_meandrina_HIv1___RNAseq.g9726.t1,three_way,78.57166666666667,FUN_016338-T1,Q6NWF4,,,,,59.3,177.0,7.1e-61,235.0,sp|Q6NWF4|VPS25_DANRE Vacuolar protein-sorting-associated protein 25 OS=Danio rerio OX=7955 GN=vps25 PE=2 SV=2,,,,,,
OG_04031,FUN_016339-T1,Peve_00044575,Pocillopora_meandrina_HIv1___RNAseq.g9729.t1,three_way,89.3255,FUN_016339-T1,Q9CQ19,MYL9_MOUSE,,"Myosin regulatory light polypeptide 9 (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9)",Mus musculus (Mouse),73.4,169.0,2.0000000000000007e-65,250.0,sp|Q9CQ19|MYL9_MOUSE Myosin regulatory light polypeptide 9 OS=Mus musculus OX=10090 GN=Myl9 PE=1 SV=3,GO:0001725; GO:0005200; GO:0005509; GO:0005938; GO:0016460; GO:0030018; GO:0032036; GO:0043149,stress fiber assembly [GO:0043149],cell cortex [GO:0005938]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0007010; GO:0008092,structural molecule activity; cytoskeleton organization; cytoskeletal protein binding
OG_04032,FUN_016340-T1,Peve_00044576,Pocillopora_meandrina_HIv1___RNAseq.g9730.t1,three_way,73.72266666666667,FUN_016340-T1,Q6P7A2,UBE4A_RAT,,Ubiquitin conjugation factor E4 A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 A),Rattus norvegicus (Rat),39.6,1095.0,2.2e-194,681.0,sp|Q6P7A2|UBE4A_RAT Ubiquitin conjugation factor E4 A OS=Rattus norvegicus OX=10116 GN=Ube4a PE=2 SV=1,GO:0000151; GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0034450; GO:0036503; GO:0061630,ERAD pathway [GO:0036503]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_04033,FUN_016341-T1,Peve_00044577,Pocillopora_meandrina_HIv1___RNAseq.g9731.t1,three_way,85.63799999999999,FUN_016341-T1,Q5ZKX6,UBE2F_CHICK,,NEDD8-conjugating enzyme UBE2F (EC 2.3.2.34) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F),Gallus gallus (Chicken),60.9,184.0,1.2e-62,241.1,sp|Q5ZKX6|UBE2F_CHICK NEDD8-conjugating enzyme UBE2F OS=Gallus gallus OX=9031 GN=UBE2F PE=2 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0045116; GO:0061654; GO:0061663,protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 ligase activity [GO:0061663]; NEDD8 transferase activity [GO:0019788],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04034,FUN_016342-T1,Peve_00044580,Pocillopora_meandrina_HIv1___RNAseq.g9725.t1,three_way,65.89516666666667,FUN_016342-T1,Q9USQ7,,,,,38.4,578.0,3.8e-99,364.0,sp|Q9USQ7|DPH6_SCHPO Diphthine--ammonia ligase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=mug71 PE=1 SV=1,,,,,,
OG_04035,FUN_016343-T1,Peve_00044581,Pocillopora_meandrina_HIv1___RNAseq.g9724.t1,three_way,79.218,FUN_016343-T1,Q28DS0,,,,,49.7,342.0,5.4e-94,345.9,sp|Q28DS0|SAE1_XENTR SUMO-activating enzyme subunit 1 OS=Xenopus tropicalis OX=8364 GN=sae1 PE=2 SV=1,,,,,,
OG_04036,FUN_016344-T1,Peve_00004330,Pocillopora_meandrina_HIv1___RNAseq.g9849.t1,three_way,55.79433333333333,FUN_016344-T1,Q28GL6,,,,,30.6,281.0,2.7e-14,80.9,sp|Q28GL6|S7A6O_XENTR Probable RNA polymerase II nuclear localization protein SLC7A6OS OS=Xenopus tropicalis OX=8364 GN=slc7a6os PE=2 SV=1,,,,,,
OG_04037,FUN_016345-T1,Peve_00004334,Pocillopora_meandrina_HIv1___TS.g23380.t1,three_way,66.87283333333333,FUN_016345-T1,P63252,KCNJ2_HUMAN,,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",Homo sapiens (Human),42.7,328.0,8.2e-70,265.8,sp|P63252|KCNJ2_HUMAN Inward rectifier potassium channel 2 OS=Homo sapiens OX=9606 GN=KCNJ2 PE=1 SV=1,GO:0005242; GO:0005546; GO:0005886; GO:0006813; GO:0008076; GO:0014704; GO:0014861; GO:0015693; GO:0016020; GO:0030007; GO:0030315; GO:0034765; GO:0042802; GO:0043025; GO:0043197; GO:0045211; GO:0051289; GO:0055119; GO:0060075; GO:0060306; GO:0071260; GO:0071805; GO:0086002; GO:0086004; GO:0086008; GO:0086011; GO:0086012; GO:0086013; GO:0086091; GO:0090076; GO:0098978; GO:1901381; GO:1990573,cardiac muscle cell action potential involved in contraction [GO:0086002]; cellular response to mechanical stimulus [GO:0071260]; intracellular potassium ion homeostasis [GO:0030007]; magnesium ion transport [GO:0015693]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; membrane repolarization during action potential [GO:0086011]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of resting membrane potential [GO:0060075]; regulation of skeletal muscle contraction via regulation of action potential [GO:0014861]; relaxation of cardiac muscle [GO:0055119]; relaxation of skeletal muscle [GO:0090076],dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; intercalated disc [GO:0014704]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076],"identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization [GO:0086008]",GO:0003012; GO:0005215; GO:0005886; GO:0008289; GO:0055085; GO:0065003,muscle system process; transporter activity; plasma membrane; lipid binding; transmembrane transport; protein-containing complex assembly
OG_04038,FUN_016346-T2,Peve_00004339,Pocillopora_meandrina_HIv1___TS.g23215.t1,three_way,85.454,FUN_016346-T2,Q6NW96,SP9_DANRE,,Transcription factor Sp9,Danio rerio (Zebrafish) (Brachydanio rerio),39.6,341.0,1.2999999999999998e-43,178.7,sp|Q6NW96|SP9_DANRE Transcription factor Sp9 OS=Danio rerio OX=7955 GN=sp9 PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008270; GO:0030326; GO:0035118; GO:0045743,embryonic limb morphogenesis [GO:0030326]; embryonic pectoral fin morphogenesis [GO:0035118]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04039,FUN_016347-T1,Peve_00004355,Pocillopora_meandrina_HIv1___RNAseq.g9679.t1,three_way,82.813,FUN_016347-T1,Q9JHX2,,,,,31.5,321.0,1.9e-18,95.1,sp|Q9JHX2|SP5_MOUSE Transcription factor Sp5 OS=Mus musculus OX=10090 GN=Sp5 PE=2 SV=1,,,,,,
OG_04040,FUN_016349-T1,Peve_00004360,Pocillopora_meandrina_HIv1___RNAseq.g9678.t1,three_way,89.957,FUN_016349-T1,Q7ZU42,,,,,75.0,388.0,1.4e-166,587.4,sp|Q7ZU42|OLA1_DANRE Obg-like ATPase 1 OS=Danio rerio OX=7955 GN=ola1 PE=2 SV=1,,,,,,
OG_04041,FUN_016350-T1,Peve_00004331,Pocillopora_meandrina_HIv1___RNAseq.16312_t,three_way,70.639,FUN_016350-T1,Q90WR8,SP3_CHICK,,Transcription factor Sp3,Gallus gallus (Chicken),48.7,117.0,7.9e-20,100.1,sp|Q90WR8|SP3_CHICK Transcription factor Sp3 OS=Gallus gallus OX=9031 GN=SP3 PE=1 SV=1,GO:0000978; GO:0000981; GO:0001227; GO:0001503; GO:0001779; GO:0001889; GO:0002318; GO:0003682; GO:0005829; GO:0006357; GO:0008270; GO:0016605; GO:0017053; GO:0030183; GO:0030217; GO:0030219; GO:0030224; GO:0030324; GO:0030851; GO:0043353; GO:0045944; GO:0048596; GO:0048706; GO:0060216; GO:0061629,B cell differentiation [GO:0030183]; definitive hemopoiesis [GO:0060216]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic skeletal system development [GO:0048706]; enucleate erythrocyte differentiation [GO:0043353]; granulocyte differentiation [GO:0030851]; liver development [GO:0001889]; lung development [GO:0030324]; megakaryocyte differentiation [GO:0030219]; monocyte differentiation [GO:0030224]; myeloid progenitor cell differentiation [GO:0002318]; natural killer cell differentiation [GO:0001779]; ossification [GO:0001503]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; T cell differentiation [GO:0030217],cytosol [GO:0005829]; PML body [GO:0016605]; transcription repressor complex [GO:0017053],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04042,FUN_016351-T1,Peve_00004332,Pocillopora_meandrina_HIv1___RNAseq.g9676.t1,three_way,80.54966666666667,FUN_016351-T1,Q6ZMI0,PPR21_HUMAN,,Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (Ferry endosomal RAB5 effector complex subunit 2) (Fy-2) (KLRAQ motif-containing protein 1),Homo sapiens (Human),40.8,787.0,5.8e-136,486.5,sp|Q6ZMI0|PPR21_HUMAN Protein phosphatase 1 regulatory subunit 21 OS=Homo sapiens OX=9606 GN=PPP1R21 PE=1 SV=1,GO:0003723; GO:0005769; GO:0016020,,early endosome [GO:0005769]; membrane [GO:0016020],RNA binding [GO:0003723],GO:0003723; GO:0005768; GO:0031410; GO:0043226,RNA binding; endosome; cytoplasmic vesicle; organelle
OG_04043,FUN_016352-T1,Peve_00004333,Pocillopora_meandrina_HIv1___RNAseq.g9675.t1,three_way,65.38916666666667,FUN_016352-T1,Q8CI75,DI3L2_MOUSE,,DIS3-like exonuclease 2 (EC 3.1.13.-),Mus musculus (Mouse),48.3,818.0,3.1e-212,740.7,sp|Q8CI75|DI3L2_MOUSE DIS3-like exonuclease 2 OS=Mus musculus OX=10090 GN=Dis3l2 PE=1 SV=1,GO:0000175; GO:0000278; GO:0000287; GO:0000932; GO:0000956; GO:0004540; GO:0005737; GO:0005829; GO:0008266; GO:0008285; GO:0010587; GO:0019827; GO:0051301; GO:0051306; GO:1990074,cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid separation [GO:0051306]; negative regulation of cell population proliferation [GO:0008285]; nuclear-transcribed mRNA catabolic process [GO:0000956]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; stem cell population maintenance [GO:0019827],cytoplasm [GO:0005737]; cytosol [GO:0005829]; P-body [GO:0000932],3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; poly(U) RNA binding [GO:0008266]; RNA nuclease activity [GO:0004540],GO:0000278; GO:0003723; GO:0003824; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"mitotic cell cycle; RNA binding; catalytic activity; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_04044,FUN_016353-T1,Peve_00004336,Pocillopora_meandrina_HIv1___RNAseq.g9674.t1,three_way,74.80966666666667,FUN_016353-T1,B5XBI1,,,,,63.4,123.0,2.7e-34,147.1,sp|B5XBI1|IF43A_SALSA Intraflagellar transport protein 43 homolog A OS=Salmo salar OX=8030 GN=ift43a PE=2 SV=1,,,,,,
OG_04045,FUN_016357-T1,Peve_00004337,Pocillopora_meandrina_HIv1___RNAseq.g9673.t1,three_way,68.83566666666667,FUN_016357-T1,Q8NBP0,,,,,36.6,470.0,3.1e-84,314.3,sp|Q8NBP0|TTC13_HUMAN Tetratricopeptide repeat protein 13 OS=Homo sapiens OX=9606 GN=TTC13 PE=1 SV=3,,,,,,
OG_04046,FUN_016360-T1,Peve_00004338,Pocillopora_meandrina_HIv1___RNAseq.g9672.t1,three_way,64.9715,FUN_016360-T1,Q9Y6R0,NUMBL_HUMAN,,Numb-like protein (Numb-related protein) (Numb-R),Homo sapiens (Human),58.1,160.0,1e-46,189.5,sp|Q9Y6R0|NUMBL_HUMAN Numb-like protein OS=Homo sapiens OX=9606 GN=NUMBL PE=1 SV=1,GO:0005737; GO:0007399; GO:0007409; GO:0019221; GO:0019538; GO:0021670; GO:0021849; GO:0034332; GO:0050769; GO:0050775; GO:0098978; GO:0150052,adherens junction organization [GO:0034332]; axonogenesis [GO:0007409]; cytokine-mediated signaling pathway [GO:0019221]; lateral ventricle development [GO:0021670]; nervous system development [GO:0007399]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neurogenesis [GO:0050769]; protein metabolic process [GO:0019538]; regulation of postsynapse assembly [GO:0150052],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978],,GO:0034330; GO:0048856,cell junction organization; anatomical structure development
OG_04047,FUN_016361-T1,Peve_00004340,Pocillopora_meandrina_HIv1___RNAseq.g9671.t1,three_way,68.96966666666667,FUN_016361-T1,P56962,STX17_HUMAN,,Syntaxin-17,Homo sapiens (Human),33.8,272.0,8.5e-27,122.5,sp|P56962|STX17_HUMAN Syntaxin-17 OS=Homo sapiens OX=9606 GN=STX17 PE=1 SV=2,GO:0000149; GO:0000421; GO:0005484; GO:0005739; GO:0005776; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006886; GO:0006887; GO:0006888; GO:0006906; GO:0007030; GO:0012505; GO:0012507; GO:0016240; GO:0019901; GO:0019903; GO:0030134; GO:0030868; GO:0031201; GO:0033116; GO:0034497; GO:0044233; GO:0048278; GO:0061909; GO:0097111; GO:0097352; GO:0120281,autophagosome maturation [GO:0097352]; autophagosome membrane docking [GO:0016240]; autophagosome-lysosome fusion [GO:0061909]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein localization to phagophore assembly site [GO:0034497]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],autolysosome membrane [GO:0120281]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum membrane [GO:0030868]; SNARE complex [GO:0031201],protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149],GO:0005739; GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090; GO:0061024,mitochondrion; vacuole; cytosol; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization
OG_04048,FUN_016362-T1,Peve_00004341,Pocillopora_meandrina_HIv1___RNAseq.g9604.t1,three_way,75.83800000000001,FUN_016362-T1,Q9D1Q6,ERP44_MOUSE,,Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4),Mus musculus (Mouse),47.8,427.0,4.6e-111,402.9,sp|Q9D1Q6|ERP44_MOUSE Endoplasmic reticulum resident protein 44 OS=Mus musculus OX=10090 GN=Erp44 PE=1 SV=1,GO:0003756; GO:0005788; GO:0005789; GO:0005793; GO:0006457; GO:0006986; GO:0009100; GO:0009986; GO:0034976,glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793],protein disulfide isomerase activity [GO:0003756],GO:0003824; GO:0006457; GO:0016853; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; protein folding; isomerase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04049,FUN_016365-T1,Peve_00004342,Pocillopora_meandrina_HIv1___RNAseq.g9605.t1,three_way,60.6625,FUN_016365-T1,Q58D84,,,,,40.3,72.0,1.4e-09,67.0,sp|Q58D84|FSTL1_BOVIN Follistatin-related protein 1 OS=Bos taurus OX=9913 GN=FSTL1 PE=2 SV=1,,,,,,
OG_04050,FUN_016368-T2,Peve_00004346,Pocillopora_meandrina_HIv1___RNAseq.g9681.t1,three_way,71.802,FUN_016368-T2,Q8NEV4,MYO3A_HUMAN,,Myosin-IIIa (EC 2.7.11.1),Homo sapiens (Human),49.4,1096.0,9.1e-305,1048.1,sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2,GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310,cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003774; GO:0003824; GO:0008092; GO:0016740; GO:0016787; GO:0016853; GO:0050877; GO:0140096; GO:0140657,"cytoskeletal motor activity; catalytic activity; cytoskeletal protein binding; transferase activity; hydrolase activity; isomerase activity; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_04051,FUN_016370-T1,Peve_00022928,Pocillopora_meandrina_HIv1___RNAseq.g20804.t1,three_way,58.012,FUN_016370-T1,Q9CQM0,,,,,36.2,207.0,3e-34,146.7,sp|Q9CQM0|NICN1_MOUSE Nicolin-1 OS=Mus musculus OX=10090 GN=Nicn1 PE=1 SV=1,,,,,,
OG_04052,FUN_016371-T1,Peve_00022927,Pocillopora_meandrina_HIv1___RNAseq.g9747.t1,three_way,64.89166666666667,FUN_016371-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),56.4,133.0,4.6e-27,123.2,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04053,FUN_016372-T1,Peve_00022926,Pocillopora_meandrina_HIv1___RNAseq.g9746.t1,three_way,60.034666666666666,FUN_016372-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,181.0,1.5e-16,88.2,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04054,FUN_016373-T1,Peve_00022923,Pocillopora_meandrina_HIv1___RNAseq.g9745.t1,three_way,73.565,FUN_016373-T1,P42587,,,,,58.7,75.0,4.2e-17,89.7,sp|P42587|HNK2_XENLA Homeobox protein XENK-2 OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_04055,FUN_016374-T1,Peve_00022922,Pocillopora_meandrina_HIv1___RNAseq.g9744.t1,three_way,74.13233333333334,FUN_016374-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,207.0,5.3e-32,139.4,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04056,FUN_016375-T1,Peve_00022921,Pocillopora_meandrina_HIv1___RNAseq.16382_t,three_way,83.09666666666666,FUN_016375-T1,Q90481,NX22A_DANRE,,Homeobox protein Nkx-2.2a (Homeobox protein NK-2 homolog B-A),Danio rerio (Zebrafish) (Brachydanio rerio),65.5,87.0,8.3e-25,115.5,sp|Q90481|NX22A_DANRE Homeobox protein Nkx-2.2a OS=Danio rerio OX=7955 GN=nkx2.2a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0008045; GO:0008347; GO:0014044; GO:0021508; GO:0021514; GO:0021529; GO:0021530; GO:0030154; GO:0031018; GO:0033504; GO:0045893,cell differentiation [GO:0030154]; endocrine pancreas development [GO:0031018]; floor plate development [GO:0033504]; floor plate formation [GO:0021508]; glial cell migration [GO:0008347]; motor neuron axon guidance [GO:0008045]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Schwann cell development [GO:0014044]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; spinal cord oligodendrocyte cell fate specification [GO:0021530]; ventral spinal cord interneuron differentiation [GO:0021514],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04057,FUN_016377-T1,Peve_00022920,Pocillopora_meandrina_HIv1___RNAseq.g9741.t1,three_way,46.54933333333334,FUN_016377-T1,Q03372,HMSH_DROME,,Muscle segmentation homeobox (Protein drop) (Protein msh),Drosophila melanogaster (Fruit fly),36.9,111.0,7e-08,59.3,sp|Q03372|HMSH_DROME Muscle segmentation homeobox OS=Drosophila melanogaster OX=7227 GN=Dr PE=1 SV=2,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007389; GO:0007398; GO:0007400; GO:0007417; GO:0007419; GO:0007420; GO:0007450; GO:0007476; GO:0007485; GO:0007517; GO:0009953; GO:0010629; GO:0021782; GO:0035222; GO:0035309; GO:0042659; GO:0043565; GO:0048598,"brain development [GO:0007420]; central nervous system development [GO:0007417]; dorsal/ventral pattern formation [GO:0009953]; dorsal/ventral pattern formation, imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic morphogenesis [GO:0048598]; glial cell development [GO:0021782]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing morphogenesis [GO:0007476]; muscle organ development [GO:0007517]; negative regulation of gene expression [GO:0010629]; neuroblast fate determination [GO:0007400]; pattern specification process [GO:0007389]; regulation of cell fate specification [GO:0042659]; regulation of transcription by RNA polymerase II [GO:0006357]; ventral cord development [GO:0007419]; wing and notum subfield formation [GO:0035309]; wing disc pattern formation [GO:0035222]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04058,FUN_016378-T1,Peve_00022919,Pocillopora_meandrina_HIv1___RNAseq.g9740.t1,three_way,68.21633333333332,FUN_016378-T1,Q03358,MSX2_MOUSE,,Homeobox protein MSX-2 (Homeobox protein Hox-8-1),Mus musculus (Mouse),45.5,99.0,2e-14,80.9,sp|Q03358|MSX2_MOUSE Homeobox protein MSX-2 OS=Mus musculus OX=10090 GN=Msx2 PE=1 SV=2,GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0001227; GO:0001503; GO:0001649; GO:0002063; GO:0002076; GO:0003148; GO:0003151; GO:0003198; GO:0003416; GO:0003677; GO:0005654; GO:0005667; GO:0005829; GO:0008285; GO:0009952; GO:0016607; GO:0023019; GO:0030326; GO:0030509; GO:0030513; GO:0035115; GO:0035116; GO:0035313; GO:0035880; GO:0042060; GO:0042476; GO:0042733; GO:0042981; GO:0043066; GO:0043565; GO:0045599; GO:0045617; GO:0045669; GO:0045892; GO:0048863; GO:0051216; GO:0051795; GO:0060346; GO:0060349; GO:0060364; GO:0060444; GO:0061180; GO:0061311; GO:0070166; GO:0071363; GO:0071392; GO:0090427; GO:0097152; GO:2001055,"activation of meiosis [GO:0090427]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; bone morphogenesis [GO:0060349]; bone trabecula formation [GO:0060346]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cartilage development [GO:0051216]; cell surface receptor signaling pathway involved in heart development [GO:0061311]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; chondrocyte development [GO:0002063]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic nail plate morphogenesis [GO:0035880]; enamel mineralization [GO:0070166]; endochondral bone growth [GO:0003416]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; frontal suture morphogenesis [GO:0060364]; mammary gland epithelium development [GO:0061180]; mesenchymal cell apoptotic process [GO:0097152]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast development [GO:0002076]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of timing of catagen [GO:0051795]; regulation of apoptotic process [GO:0042981]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]",cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005654; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleoplasm; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; wound healing; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04059,FUN_016379-T1,Peve_00022918,Pocillopora_meandrina_HIv1___RNAseq.g9739.t1,three_way,48.443333333333335,FUN_016379-T1,P02836,HMEN_DROME,,Segmentation polarity homeobox protein engrailed,Drosophila melanogaster (Fruit fly),42.7,96.0,4.6e-09,63.2,sp|P02836|HMEN_DROME Segmentation polarity homeobox protein engrailed OS=Drosophila melanogaster OX=7227 GN=en PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0007367; GO:0007386; GO:0007388; GO:0007400; GO:0007411; GO:0007418; GO:0007472; GO:0007474; GO:0007487; GO:0008406; GO:0010468; GO:0010629; GO:0035215; GO:0035224; GO:0035277; GO:0035288; GO:0035289; GO:0035290; GO:0043524; GO:0043565; GO:0045944; GO:0048099; GO:0048100,"analia development [GO:0007487]; anterior head segmentation [GO:0035288]; anterior/posterior lineage restriction, imaginal disc [GO:0048099]; axon guidance [GO:0007411]; compartment pattern specification [GO:0007386]; genital disc anterior/posterior pattern formation [GO:0035224]; genital disc development [GO:0035215]; gonad development [GO:0008406]; imaginal disc-derived wing vein specification [GO:0007474]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroblast fate determination [GO:0007400]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior compartment specification [GO:0007388]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; segment polarity determination [GO:0007367]; spiracle morphogenesis, open tracheal system [GO:0035277]; trunk segmentation [GO:0035290]; ventral midline development [GO:0007418]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04060,FUN_016380-T1,Peve_00022917,Pocillopora_meandrina_HIv1___RNAseq.g9748.t1,three_way,68.51766666666667,FUN_016380-T1,Q9JJZ8,CNGA3_MOUSE,,Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3) (Gustatory cyclic nucleotide-gated cation channel) (CNGgust),Mus musculus (Mouse),45.3,521.0,7.5e-117,422.9,sp|Q9JJZ8|CNGA3_MOUSE Cyclic nucleotide-gated channel alpha-3 OS=Mus musculus OX=10090 GN=Cnga3 PE=1 SV=2,GO:0001750; GO:0005221; GO:0005262; GO:0005272; GO:0005886; GO:0007601; GO:0030553; GO:0046549; GO:0060041; GO:0120199,retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; visual perception [GO:0007601],cone photoreceptor outer segment [GO:0120199]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; cGMP binding [GO:0030553]; intracellularly cyclic nucleotide-activated monoatomic cation channel activity [GO:0005221]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0048856; GO:0050877,transporter activity; plasma membrane; anatomical structure development; nervous system process
OG_04061,FUN_016381-T1,Peve_00022915,Pocillopora_meandrina_HIv1___RNAseq.g9749.t1,three_way,68.01166666666667,,,,,,,,,,,,,,,,,
OG_04062,FUN_016382-T1,Peve_00022906,Pocillopora_meandrina_HIv1___RNAseq.g9735.t1,three_way,83.83333333333333,FUN_016382-T1,Q3MHX1,,,,,50.0,200.0,4.0000000000000005e-49,196.1,sp|Q3MHX1|COMD7_BOVIN COMM domain-containing protein 7 OS=Bos taurus OX=9913 GN=COMMD7 PE=2 SV=1,,,,,,
OG_04063,FUN_016383-T1,Peve_00022908,Pocillopora_meandrina_HIv1___RNAseq.g9736.t1,three_way,80.03683333333333,FUN_016383-T1,A6QQL9,,,,,56.7,120.0,9.2e-25,114.4,sp|A6QQL9|SRP14_BOVIN Signal recognition particle 14 kDa protein OS=Bos taurus OX=9913 GN=SRP14 PE=3 SV=1,,,,,,
OG_04064,FUN_016385-T1,Peve_00022914,Pocillopora_meandrina_HIv1___RNAseq.g9738.t1,three_way,70.09116666666667,FUN_016385-T1,Q15061,WDR43_HUMAN,,WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog),Homo sapiens (Human),40.4,599.0,7.9e-112,406.0,sp|Q15061|WDR43_HUMAN WD repeat-containing protein 43 OS=Homo sapiens OX=9606 GN=WDR43 PE=1 SV=3,GO:0000462; GO:0000785; GO:0000993; GO:0001650; GO:0003711; GO:0003723; GO:0005654; GO:0005730; GO:0032040; GO:0034243; GO:0042274; GO:0045943; GO:2000036; GO:2000234,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; ribosomal small subunit biogenesis [GO:0042274]",chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040],RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; transcription elongation factor activity [GO:0003711],GO:0003723; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0140110,RNA binding; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04065,FUN_016386-T1,Peve_00030460,Pocillopora_meandrina_HIv1___RNAseq.g15065.t1,three_way,69.083,FUN_016386-T1,Q9UBD5,ORC3_HUMAN,,Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo),Homo sapiens (Human),40.6,729.0,7.2e-149,529.3,sp|Q9UBD5|ORC3_HUMAN Origin recognition complex subunit 3 OS=Homo sapiens OX=9606 GN=ORC3 PE=1 SV=1,GO:0000781; GO:0000785; GO:0000808; GO:0003688; GO:0005634; GO:0005654; GO:0005656; GO:0005664; GO:0006260; GO:0006270; GO:0006275; GO:0014009; GO:0016604; GO:0031261; GO:0061351,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; glial cell proliferation [GO:0014009]; neural precursor cell proliferation [GO:0061351]; regulation of DNA replication [GO:0006275],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA replication preinitiation complex [GO:0031261]; nuclear body [GO:0016604]; nuclear origin of replication recognition complex [GO:0005664]; nuclear pre-replicative complex [GO:0005656]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]",DNA replication origin binding [GO:0003688],GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA replication; organelle
OG_04066,FUN_016387-T1,Peve_00022900,Pocillopora_meandrina_HIv1___RNAseq.g9768.t1,three_way,79.809,FUN_016387-T1,O15229,KMO_HUMAN,,Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase),Homo sapiens (Human),57.1,417.0,7.7e-141,501.9,sp|O15229|KMO_HUMAN Kynurenine 3-monooxygenase OS=Homo sapiens OX=9606 GN=KMO PE=1 SV=2,GO:0004502; GO:0005615; GO:0005739; GO:0005741; GO:0005829; GO:0006569; GO:0009651; GO:0016174; GO:0019674; GO:0019805; GO:0034276; GO:0034354; GO:0043420; GO:0050660; GO:0070189; GO:0071222; GO:0071347; GO:0071949; GO:0097052; GO:1903296,"'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; kynurenic acid biosynthetic process [GO:0034276]; kynurenine metabolic process [GO:0070189]; L-kynurenine metabolic process [GO:0097052]; L-tryptophan catabolic process [GO:0006569]; NAD metabolic process [GO:0019674]; positive regulation of glutamate secretion, neurotransmission [GO:1903296]; quinolinate biosynthetic process [GO:0019805]; response to salt stress [GO:0009651]",cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase H2O2-forming activity [GO:0016174],GO:0003824; GO:0005615; GO:0005739; GO:0005829; GO:0006520; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; mitochondrion; cytosol; amino acid metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_04067,FUN_016388-T1,Peve_00033767,Pocillopora_meandrina_HIv1___RNAseq.g9766.t1,three_way,44.09583333333333,,,,,,,,,,,,,,,,,
OG_04068,FUN_016389-T1,Peve_00033768,Pocillopora_meandrina_HIv1___RNAseq.g9765.t1,three_way,65.33466666666666,FUN_016389-T1,Q6DGB6,DAA19_DANRE,,Dynein axonemal assembly factor 19 (Coiled-coil domain-containing protein 103) (Protein schmalhans),Danio rerio (Zebrafish) (Brachydanio rerio),48.0,200.0,2.7e-41,170.2,sp|Q6DGB6|DAA19_DANRE Dynein axonemal assembly factor 19 OS=Danio rerio OX=7955 GN=dnaaf19 PE=1 SV=1,GO:0001947; GO:0003143; GO:0003146; GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007368; GO:0031514; GO:0036157; GO:0036159; GO:0060271; GO:0070286; GO:0090660,axonemal dynein complex assembly [GO:0070286]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159],axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],,GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0050877; GO:0065003,extracellular region; cilium; microtubule-based movement; organelle; cilium organization; nervous system process; protein-containing complex assembly
OG_04069,FUN_016390-T1,Peve_00033769,Pocillopora_meandrina_HIv1___RNAseq.g9763.t1,three_way,61.38616666666667,,,,,,,,,,,,,,,,,
OG_04070,FUN_016391-T1,Peve_00006410,Pocillopora_meandrina_HIv1___RNAseq.g9753.t1,three_way,64.212,,,,,,,,,,,,,,,,,
OG_04071,FUN_016392-T1,Peve_00006407,Pocillopora_meandrina_HIv1___RNAseq.g9755.t1,three_way,95.59666666666666,FUN_016392-T1,Q7ZVN5,SRP54_DANRE,,Signal recognition particle subunit SRP54 (EC 3.6.5.4) (Signal recognition particle 54 kDa protein),Danio rerio (Zebrafish) (Brachydanio rerio),87.5,497.0,2.2e-250,865.9,sp|Q7ZVN5|SRP54_DANRE Signal recognition particle subunit SRP54 OS=Danio rerio OX=7955 GN=srp54 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005783; GO:0005786; GO:0005829; GO:0006616; GO:0008312; GO:0016607; GO:0016887; GO:0030593; GO:0030851; GO:0030942; GO:0031017,"exocrine pancreas development [GO:0031017]; granulocyte differentiation [GO:0030851]; neutrophil chemotaxis [GO:0030593]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]","cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear speck [GO:0016607]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]",7S RNA binding [GO:0008312]; ATP hydrolysis activity [GO:0016887]; endoplasmic reticulum signal peptide binding [GO:0030942]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0002376; GO:0003723; GO:0003824; GO:0003924; GO:0005783; GO:0005829; GO:0006886; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0055085,immune system process; RNA binding; catalytic activity; GTPase activity; endoplasmic reticulum; cytosol; intracellular protein transport; hydrolase activity; cell differentiation; organelle; anatomical structure development; cell motility; transmembrane transport
OG_04072,FUN_016393-T1,Peve_00006406,Pocillopora_meandrina_HIv1___RNAseq.g9756.t1,three_way,90.81433333333334,FUN_016393-T1,Q3T087,,,,,81.8,176.0,2.5e-82,306.2,sp|Q3T087|RL11_BOVIN Large ribosomal subunit protein uL5 OS=Bos taurus OX=9913 GN=RPL11 PE=2 SV=3,,,,,,
OG_04073,FUN_016396-T1,Peve_00006415,Pocillopora_meandrina_HIv1___RNAseq.g9761.t1,three_way,59.46566666666667,FUN_016396-T1,Q9NXE8,CWC25_HUMAN,,Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25),Homo sapiens (Human),58.0,143.0,1.2e-36,156.0,sp|Q9NXE8|CWC25_HUMAN Pre-mRNA-splicing factor CWC25 homolog OS=Homo sapiens OX=9606 GN=CWC25 PE=1 SV=1,GO:0000398; GO:0005634; GO:0005654; GO:0005684; GO:0016607; GO:0071006,"mRNA splicing, via spliceosome [GO:0000398]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type spliceosomal complex [GO:0005684],,GO:0005634; GO:0005654; GO:0016071; GO:0043226,nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_04074,FUN_016397-T1,Peve_00006409,Pocillopora_meandrina_HIv1___RNAseq.g9762.t1,three_way,64.79966666666667,FUN_016397-T1,Q8UVC1,INVS_DANRE,,Inversin,Danio rerio (Zebrafish) (Brachydanio rerio),57.1,56.0,3e-09,65.9,sp|Q8UVC1|INVS_DANRE Inversin OS=Danio rerio OX=7955 GN=invs PE=2 SV=1,GO:0001736; GO:0001822; GO:0001947; GO:0005516; GO:0005737; GO:0005856; GO:0005929; GO:0010171; GO:0016055; GO:0035844; GO:0036372; GO:0060027; GO:0072114; GO:0072116; GO:1904108,body morphogenesis [GO:0010171]; cloaca development [GO:0035844]; convergent extension involved in gastrulation [GO:0060027]; establishment of planar polarity [GO:0001736]; heart looping [GO:0001947]; kidney development [GO:0001822]; opsin transport [GO:0036372]; pronephros formation [GO:0072116]; pronephros morphogenesis [GO:0072114]; protein localization to ciliary inversin compartment [GO:1904108]; Wnt signaling pathway [GO:0016055],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],calmodulin binding [GO:0005516],GO:0005856; GO:0005929; GO:0043226; GO:0048856,cytoskeleton; cilium; organelle; anatomical structure development
OG_04075,FUN_016400-T1,Peve_00006411,Pocillopora_meandrina_HIv1___RNAseq.g9752.t1,three_way,83.30466666666666,FUN_016400-T1,Q6NUP7,PP4R4_HUMAN,,Serine/threonine-protein phosphatase 4 regulatory subunit 4,Homo sapiens (Human),46.8,667.0,3.4e-166,587.0,sp|Q6NUP7|PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PPP4R4 PE=1 SV=1,GO:0001835; GO:0004864; GO:0004865; GO:0005737; GO:0005829; GO:0005929; GO:0008287; GO:0019888; GO:0036064; GO:0043231,blastocyst hatching [GO:0001835],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase complex [GO:0008287],protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],GO:0005815; GO:0005829; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; cilium; organelle; molecular function regulator activity
OG_04076,FUN_016401-T1,Peve_00006412,Pocillopora_meandrina_HIv1___RNAseq.g9751.t1,three_way,88.60033333333332,FUN_016401-T1,Q7RYW6,,,,,62.5,333.0,7.300000000000001e-118,425.2,sp|Q7RYW6|CYSK_NEUCR Cysteine synthase 1 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=cys-17 PE=3 SV=1,,,,,,
OG_04077,FUN_016402-T1,Peve_00028063,Pocillopora_meandrina_HIv1___RNAseq.g9780.t1,three_way,62.028666666666666,FUN_016402-T1,Q9Y2I7,FYV1_HUMAN,,1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase) (Serine-protein kinase PIKFYVE) (EC 2.7.11.1),Homo sapiens (Human),31.1,2630.0,2.5e-294,1014.2,sp|Q9Y2I7|FYV1_HUMAN 1-phosphatidylinositol 3-phosphate 5-kinase OS=Homo sapiens OX=9606 GN=PIKFYVE PE=1 SV=3,GO:0000139; GO:0000285; GO:0004674; GO:0005524; GO:0005829; GO:0006612; GO:0006661; GO:0008270; GO:0010008; GO:0012506; GO:0016308; GO:0019065; GO:0019886; GO:0030593; GO:0030670; GO:0031410; GO:0031901; GO:0031902; GO:0032438; GO:0034504; GO:0035556; GO:0036289; GO:0042147; GO:0043813; GO:0045121; GO:0052810; GO:0090382; GO:0090385; GO:0106310; GO:1903100; GO:1903426; GO:1904562; GO:2000785,"1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process [GO:1903100]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular signal transduction [GO:0035556]; melanosome organization [GO:0032438]; neutrophil chemotaxis [GO:0030593]; peptidyl-serine autophosphorylation [GO:0036289]; phagosome maturation [GO:0090382]; phagosome-lysosome fusion [GO:0090385]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to nucleus [GO:0034504]; protein targeting to membrane [GO:0006612]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of autophagosome assembly [GO:2000785]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; retrograde transport, endosome to Golgi [GO:0042147]",cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; vesicle membrane [GO:0012506],"1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005829; GO:0006629; GO:0016192; GO:0016740; GO:0016787; GO:0031410; GO:0043226; GO:0048870; GO:0061024; GO:0140096,"immune system process; catalytic activity; cytosol; lipid metabolic process; vesicle-mediated transport; transferase activity; hydrolase activity; cytoplasmic vesicle; organelle; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_04078,FUN_016408-T1,Peve_00018205,Pocillopora_meandrina_HIv1___TS.g23317.t1,three_way,74.89666666666666,FUN_016408-T1,Q98TY9,,,,,63.8,469.0,2.1e-170,600.1,sp|Q98TY9|AKT1_XENLA RAC-alpha serine/threonine-protein kinase OS=Xenopus laevis OX=8355 GN=akt1 PE=2 SV=1,,,,,,
OG_04079,FUN_016409-T1,Peve_00018211,Pocillopora_meandrina_HIv1___TS.g23318.t2,three_way,80.886,FUN_016409-T1,Q5RBS1,NDUF5_PONAB,,"Arginine-hydroxylase NDUFAF5, mitochondrial (EC 1.-.-.-) (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5) (Putative methyltransferase NDUFAF5) (EC 2.1.1.-)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),62.6,294.0,3.2e-107,389.8,"sp|Q5RBS1|NDUF5_PONAB Arginine-hydroxylase NDUFAF5, mitochondrial OS=Pongo abelii OX=9601 GN=NDUFAF5 PE=2 SV=1",GO:0004497; GO:0005739; GO:0008757; GO:0032259; GO:0032981; GO:0099617,methylation [GO:0032259]; mitochondrial respiratory chain complex I assembly [GO:0032981],matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrion [GO:0005739],monooxygenase activity [GO:0004497]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0005739; GO:0016491; GO:0016740; GO:0043226; GO:0065003,catalytic activity; mitochondrion; oxidoreductase activity; transferase activity; organelle; protein-containing complex assembly
OG_04080,FUN_016410-T1,Peve_00018210,Pocillopora_meandrina_HIv1___RNAseq.g9784.t1,three_way,70.55316666666667,,,,,,,,,,,,,,,,,
OG_04081,FUN_016412-T1,Peve_00019839,Pocillopora_meandrina_HIv1___RNAseq.g9785.t2,three_way,70.61433333333333,FUN_016412-T1,O88350,,,,,57.3,178.0,5.100000000000001e-59,228.8,sp|O88350|RBBP9_RAT Serine hydrolase RBBP9 OS=Rattus norvegicus OX=10116 GN=Rbbp9 PE=1 SV=2,,,,,,
OG_04082,FUN_016418-T1,Peve_00023003,Pocillopora_meandrina_HIv1___RNAseq.g9800.t1,three_way,48.49066666666666,,,,,,,,,,,,,,,,,
OG_04083,FUN_016419-T1,Peve_00023004,Pocillopora_meandrina_HIv1___RNAseq.g9801.t1,three_way,61.829,,,,,,,,,,,,,,,,,
OG_04084,FUN_016420-T1,Peve_00023005,Pocillopora_meandrina_HIv1___RNAseq.g9802.t1,three_way,65.45266666666666,FUN_016420-T1,Q9CR88,,,,,43.0,93.0,4.4e-16,85.9,sp|Q9CR88|RT14_MOUSE Small ribosomal subunit protein uS14m OS=Mus musculus OX=10090 GN=Mrps14 PE=1 SV=1,,,,,,
OG_04085,FUN_016421-T1,Peve_00023006,Pocillopora_meandrina_HIv1___RNAseq.g9803.t1,three_way,72.968,FUN_016421-T1,Q9P2G1,AKIB1_HUMAN,,Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31),Homo sapiens (Human),50.3,746.0,6.800000000000001e-211,735.7,sp|Q9P2G1|AKIB1_HUMAN Ankyrin repeat and IBR domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKIB1 PE=1 SV=3,GO:0000151; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0061630,protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04086,FUN_016422-T1,Peve_00004363,Pocillopora_meandrina_HIv1___RNAseq.g9804.t1,three_way,88.40866666666666,FUN_016422-T1,P62490,,,,,67.1,207.0,2e-70,266.9,sp|P62490|RB11A_CANLF Ras-related protein Rab-11A OS=Canis lupus familiaris OX=9615 GN=RAB11A PE=2 SV=3,,,,,,
OG_04087,FUN_016423-T1,Peve_00004362,Pocillopora_meandrina_HIv1___RNAseq.g9805.t1,three_way,60.657833333333336,FUN_016423-T1,Q7ZWE3,LARP7_DANRE,,La-related protein 7 (La ribonucleoprotein domain family member 7),Danio rerio (Zebrafish) (Brachydanio rerio),31.0,568.0,1.3e-52,209.1,sp|Q7ZWE3|LARP7_DANRE La-related protein 7 OS=Danio rerio OX=7955 GN=larp7 PE=2 SV=1,GO:0000494; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0008380; GO:0017070; GO:0030154; GO:0048024; GO:0060043; GO:0061026; GO:0097322; GO:1904871; GO:1905382; GO:1990438; GO:1990904,"box C/D sno(s)RNA 3'-end processing [GO:0000494]; cardiac muscle tissue regeneration [GO:0061026]; cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U6 2'-O-snRNA methylation [GO:1990438]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],7SK snRNA binding [GO:0097322]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0016073; GO:0022414; GO:0030154; GO:0043226; GO:0048856,RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; snRNA metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development
OG_04088,FUN_016425-T1,Peve_00004359,Pocillopora_meandrina_HIv1___TS.g23342.t4,three_way,52.22683333333333,,,,,,,,,,,,,,,,,
OG_04089,FUN_016428-T1,Peve_00004356,Pocillopora_meandrina_HIv1___RNAseq.g9809.t1,three_way,74.45816666666666,FUN_016428-T1,Q15147,,,,,38.6,1257.0,9.2e-231,802.4,"sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3",,,,,,
OG_04090,FUN_016429-T1,Peve_00004354,Pocillopora_meandrina_HIv1___RNAseq.g9810.t1,three_way,71.03866666666667,FUN_016429-T1,Q642M9,,,,,44.1,331.0,4.8e-79,296.2,"sp|Q642M9|DHDH_DANRE Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase OS=Danio rerio OX=7955 GN=dhdh PE=2 SV=2",,,,,,
OG_04091,FUN_016430-T1,Peve_00004353,Pocillopora_meandrina_HIv1___RNAseq.g9811.t1,three_way,63.04533333333333,,,,,,,,,,,,,,,,,
OG_04092,FUN_016432-T1,Peve_00004351,Pocillopora_meandrina_HIv1___RNAseq.g9813.t3,three_way,72.73966666666666,FUN_016432-T1,P10894,PLCB1_BOVIN,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-beta-1) (PLC-beta-1)",Bos taurus (Bovine),58.2,490.0,5.7e-156,553.1,"sp|P10894|PLCB1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 OS=Bos taurus OX=9913 GN=PLCB1 PE=1 SV=1",GO:0004435; GO:0005096; GO:0005509; GO:0005516; GO:0005546; GO:0005737; GO:0005829; GO:0007186; GO:0007613; GO:0016042; GO:0016607; GO:0019899; GO:0031965; GO:0035722; GO:0035723; GO:0046330; GO:0046488; GO:0048015; GO:0051209; GO:0070498,G protein-coupled receptor signaling pathway [GO:0007186]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; lipid catabolic process [GO:0016042]; memory [GO:0007613]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of JNK cascade [GO:0046330]; release of sequestered calcium ion into cytosol [GO:0051209],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607],"calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]",GO:0003824; GO:0005829; GO:0006629; GO:0008289; GO:0016787; GO:0043226; GO:0050877; GO:0055085; GO:0098772,catalytic activity; cytosol; lipid metabolic process; lipid binding; hydrolase activity; organelle; nervous system process; transmembrane transport; molecular function regulator activity
OG_04093,FUN_016433-T1,Peve_00002890,Pocillopora_meandrina_HIv1___TS.g23394.t1,three_way,89.05133333333333,FUN_016433-T1,Q15542,TAF5_HUMAN,,Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100),Homo sapiens (Human),49.0,467.0,1.1e-100,369.0,sp|Q15542|TAF5_HUMAN Transcription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3,GO:0000124; GO:0000785; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006352; GO:0006357; GO:0006367; GO:0015629; GO:0016251; GO:0033276; GO:0042789; GO:0042802; GO:0045893; GO:0051123; GO:0060261,DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276],identical protein binding [GO:0042802]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0005634; GO:0005654; GO:0005856; GO:0006351; GO:0006355; GO:0016071; GO:0043226; GO:0065003; GO:0140223,nucleus; nucleoplasm; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; organelle; protein-containing complex assembly; general transcription initiation factor activity
OG_04094,FUN_016434-T1,Peve_00030461,Pocillopora_meandrina_HIv1___RNAseq.g9861.t1,three_way,81.31916666666666,FUN_016434-T1,B0S6T2,S15A2_DANRE,,Solute carrier family 15 member 2 (Peptide transporter 2) (PEPT2),Danio rerio (Zebrafish) (Brachydanio rerio),42.3,678.0,1.6999999999999998e-137,491.5,sp|B0S6T2|S15A2_DANRE Solute carrier family 15 member 2 OS=Danio rerio OX=7955 GN=slc15a2 PE=1 SV=1,GO:0001878; GO:0005886; GO:0015031; GO:0015333; GO:0015835; GO:0016324; GO:0030670; GO:0042937; GO:0045087; GO:0070424; GO:0071916; GO:0140206; GO:0140207,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; peptidoglycan transport [GO:0015835]; protein transport [GO:0015031]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; response to yeast [GO:0001878]; tripeptide import across plasma membrane [GO:0140207]",apical plasma membrane [GO:0016324]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886],dipeptide transmembrane transporter activity [GO:0071916]; peptide:proton symporter activity [GO:0015333]; tripeptide transmembrane transporter activity [GO:0042937],GO:0002376; GO:0005215; GO:0005886; GO:0055085; GO:0098542,immune system process; transporter activity; plasma membrane; transmembrane transport; defense response to other organism
OG_04095,FUN_016435-T1,Peve_00002885,Pocillopora_meandrina_HIv1___RNAseq.g9383.t1,three_way,76.45933333333333,,,,,,,,,,,,,,,,,
OG_04096,FUN_016436-T1,Peve_00002886,Pocillopora_meandrina_HIv1___TS.g23399.t2,three_way,66.57249999999999,FUN_016436-T1,P05455,LA_HUMAN,,Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B),Homo sapiens (Human),46.4,196.0,2.2e-38,160.6,sp|P05455|LA_HUMAN Lupus La protein OS=Homo sapiens OX=9606 GN=SSB PE=1 SV=2,GO:0000049; GO:0000781; GO:0001682; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006409; GO:0008033; GO:0008266; GO:0008334; GO:0010494; GO:0042780; GO:0045727; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904,histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; positive regulation of translation [GO:0045727]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]",mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005829; GO:0006399; GO:0006913; GO:0016071; GO:0043226,RNA binding; nucleus; cytosol; tRNA metabolic process; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_04097,FUN_016439-T1,Peve_00013822,Pocillopora_meandrina_HIv1___RNAseq.g9838.t1,three_way,64.92133333333334,FUN_016439-T1,O54928,SOCS5_MOUSE,,Suppressor of cytokine signaling 5 (SOCS-5) (Cytokine-inducible SH2-containing protein 5),Mus musculus (Mouse),47.5,219.0,2.9e-47,191.0,sp|O54928|SOCS5_MOUSE Suppressor of cytokine signaling 5 OS=Mus musculus OX=10090 GN=Socs5 PE=1 SV=2,GO:0005154; GO:0005737; GO:0007173; GO:0007175; GO:0007259; GO:0009968; GO:0016567; GO:0019210; GO:0019221; GO:0030971; GO:0032436; GO:0032715; GO:0035556; GO:0045627; GO:0045629; GO:0050728; GO:0071404; GO:0071638; GO:0097699; GO:1904988,cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; intracellular signal transduction [GO:0035556]; negative regulation of endothelial cell activation [GO:1904988]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of signal transduction [GO:0009968]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; protein ubiquitination [GO:0016567]; vascular endothelial cell response to fluid shear stress [GO:0097699],cytoplasm [GO:0005737],epidermal growth factor receptor binding [GO:0005154]; kinase inhibitor activity [GO:0019210]; receptor tyrosine kinase binding [GO:0030971],GO:0098772,molecular function regulator activity
OG_04098,FUN_016444-T1,Peve_00032931,Pocillopora_meandrina_HIv1___RNAseq.g9837.t1,three_way,85.07733333333333,FUN_016444-T1,Q02253,,,,,66.7,529.0,8.9e-205,714.5,"sp|Q02253|MMSA_RAT Methylmalonate-semialdehyde/malonate-semialdehyde dehydrogenase [acylating], mitochondrial OS=Rattus norvegicus OX=10116 GN=Aldh6a1 PE=1 SV=1",,,,,,
OG_04099,FUN_016445-T1,Peve_00032930,Pocillopora_meandrina_HIv1___RNAseq.g9836.t1,three_way,92.40566666666666,FUN_016445-T1,Q5NVP8,,,,,67.9,112.0,1e-36,154.1,sp|Q5NVP8|LIN52_PONAB Protein lin-52 homolog OS=Pongo abelii OX=9601 GN=LIN52 PE=3 SV=1,,,,,,
OG_04100,FUN_016446-T1,Peve_00032929,Pocillopora_meandrina_HIv1___RNAseq.g9835.t1,three_way,65.06700000000001,FUN_016446-T1,Q920N1,CMA1A_MOUSE,,Ciliary microtubule associated protein 1A (Outer dense fiber of sperm tails protein 3) (Outer dense fiber protein 3) (Sperm tail protein SHIPPO 1),Mus musculus (Mouse),42.8,236.0,4.9e-46,186.0,sp|Q920N1|CMA1A_MOUSE Ciliary microtubule associated protein 1A OS=Mus musculus OX=10090 GN=Cimap1a PE=1 SV=2,GO:0001520; GO:0005737; GO:0007283; GO:0030154; GO:0030317; GO:0036126,cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0030154; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; cell differentiation; organelle; cell motility
OG_04101,FUN_016452-T1,Peve_00016427,Pocillopora_meandrina_HIv1___RNAseq.g9832.t1,three_way,79.55466666666666,FUN_016452-T1,Q8TD10,MIPO1_HUMAN,,Mirror-image polydactyly gene 1 protein,Homo sapiens (Human),26.7,322.0,5.4e-17,90.5,sp|Q8TD10|MIPO1_HUMAN Mirror-image polydactyly gene 1 protein OS=Homo sapiens OX=9606 GN=MIPOL1 PE=1 SV=1,GO:0005634; GO:0042802,,nucleus [GO:0005634],identical protein binding [GO:0042802],GO:0005634; GO:0043226,nucleus; organelle
OG_04102,FUN_016453-T1,Peve_00040136,Pocillopora_meandrina_HIv1___RNAseq.g97.t1,three_way,59.23416666666667,FUN_016453-T1,Q0VF49,,,,,25.1,355.0,6.7e-07,58.5,sp|Q0VF49|K2012_HUMAN Uncharacterized protein KIAA2012 OS=Homo sapiens OX=9606 GN=KIAA2012 PE=1 SV=2,,,,,,
OG_04103,FUN_016454-T1,Peve_00040139,Pocillopora_meandrina_HIv1___RNAseq.g98.t1,three_way,77.08683333333333,FUN_016454-T1,Q6DJM7,CDK14_XENLA,,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14),Xenopus laevis (African clawed frog),56.3,421.0,1.8e-121,437.6,sp|Q6DJM7|CDK14_XENLA Cyclin-dependent kinase 14 OS=Xenopus laevis OX=8355 GN=cdk14 PE=2 SV=1,GO:0000086; GO:0000308; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0016055; GO:0030332; GO:0051301; GO:0060828; GO:0106310; GO:1901987,cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle phase transition [GO:1901987]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytoplasmic cyclin-dependent protein kinase holoenzyme complex [GO:0000308]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04104,FUN_016468-T1,Peve_00015302,Pocillopora_meandrina_HIv1___RNAseq.g10226.t1,three_way,73.41266666666667,FUN_016468-T1,Q5ZHT1,ACD11_CHICK,,Acyl-CoA dehydrogenase family member 11 (ACAD-11) (EC 1.3.8.-),Gallus gallus (Chicken),58.0,769.0,2.4e-243,843.2,sp|Q5ZHT1|ACD11_CHICK Acyl-CoA dehydrogenase family member 11 OS=Gallus gallus OX=9031 GN=ACAD11 PE=2 SV=1,GO:0003995; GO:0005737; GO:0005739; GO:0005777; GO:0031966; GO:0033539; GO:0050660,fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539],cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; peroxisome [GO:0005777],acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; oxidoreductase activity; organelle
OG_04105,FUN_016469-T1,Peve_00015303,Pocillopora_meandrina_HIv1___RNAseq.g100.t1,three_way,99.05466666666666,FUN_016469-T1,Q17QC5,AP2S1_BOVIN,,AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin),Bos taurus (Bovine),92.3,142.0,1.4e-69,263.5,sp|Q17QC5|AP2S1_BOVIN AP-2 complex subunit sigma OS=Bos taurus OX=9913 GN=AP2S1 PE=2 SV=1,GO:0006886; GO:0016192; GO:0030122; GO:0035615; GO:0043231; GO:0072583,clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],AP-2 adaptor complex [GO:0030122]; intracellular membrane-bounded organelle [GO:0043231],clathrin adaptor activity [GO:0035615],GO:0006886; GO:0016192; GO:0043226; GO:0060090,intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity
OG_04106,FUN_016470-T1,Peve_00015304,Pocillopora_meandrina_HIv1___RNAseq.g101.t1,three_way,67.28366666666666,FUN_016470-T1,Q6P4F7,RHGBA_HUMAN,,Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A),Homo sapiens (Human),37.3,260.0,1.6999999999999996e-31,139.0,sp|Q6P4F7|RHGBA_HUMAN Rho GTPase-activating protein 11A OS=Homo sapiens OX=9606 GN=ARHGAP11A PE=1 SV=2,GO:0005096; GO:0005634; GO:0005829; GO:0007165; GO:0043547; GO:0051056,positive regulation of GTPase activity [GO:0043547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleus [GO:0005634],GTPase activator activity [GO:0005096],GO:0005634; GO:0005829; GO:0043226; GO:0098772,nucleus; cytosol; organelle; molecular function regulator activity
OG_04107,FUN_016472-T1,Peve_00015305,Pocillopora_meandrina_HIv1___TS.g6873.t1,three_way,61.89483333333333,FUN_016472-T1,A4IJ06,GRP1_XENTR,,RAS guanyl-releasing protein 1,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),44.0,234.0,1.6e-47,191.4,sp|A4IJ06|GRP1_XENTR RAS guanyl-releasing protein 1 OS=Xenopus tropicalis OX=8364 GN=rasgrp1 PE=2 SV=1,GO:0000139; GO:0005085; GO:0005509; GO:0005789; GO:0005829; GO:0005886; GO:0007264; GO:0008270; GO:0030154,cell differentiation [GO:0030154]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270],GO:0005829; GO:0005886; GO:0030154; GO:0098772,cytosol; plasma membrane; cell differentiation; molecular function regulator activity
OG_04108,FUN_016473-T1,Peve_00015306,Pocillopora_meandrina_HIv1___RNAseq.g145.t1,three_way,60.1465,FUN_016473-T1,A7MB54,HLX_BOVIN,,H2.0-like homeobox protein (Homeobox protein HLX1),Bos taurus (Bovine),81.0,58.0,5e-21,102.8,sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1,GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679,embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0002376; GO:0003677; GO:0005634; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04109,FUN_016475-T1,Peve_00040144,Pocillopora_meandrina_HIv1___RNAseq.g10194.t1,three_way,66.4755,FUN_016475-T1,P0C5Y8,ALS2_RAT,,Alsin (Amyotrophic lateral sclerosis 2 protein homolog),Rattus norvegicus (Rat),30.6,1765.0,3.8e-188,661.0,sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1,GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072,"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267],GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0016192; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,nucleus; endosome; microtubule organizing center; cytosol; vesicle-mediated transport; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_04110,FUN_016476-T2,Peve_00024208,Pocillopora_meandrina_HIv1___RNAseq.g10193.t1,three_way,69.1025,FUN_016476-T2,P90666,,,,,48.6,638.0,6.4e-165,583.2,sp|P90666|TXND3_HELCR Thioredoxin domain-containing protein 3 homolog OS=Heliocidaris crassispina OX=1043166 GN=NME8 PE=1 SV=1,,,,,,
OG_04111,FUN_016484-T1,Peve_00005880,Pocillopora_meandrina_HIv1___RNAseq.g99.t1,three_way,81.93266666666666,FUN_016484-T1,Q9IA79,,,,,53.2,231.0,4.7e-65,249.2,sp|Q9IA79|BI1_PAROL Probable Bax inhibitor 1 OS=Paralichthys olivaceus OX=8255 GN=tmbim6 PE=2 SV=1,,,,,,
OG_04112,FUN_016487-T1,Peve_00001328,Pocillopora_meandrina_HIv1___RNAseq.g9628.t1,three_way,64.712,FUN_016487-T1,Q28ET4,VENT1_XENTR,,Homeobox protein vent1 (Vent-1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),35.8,137.0,9.6e-12,72.0,sp|Q28ET4|VENT1_XENTR Homeobox protein vent1 OS=Xenopus tropicalis OX=8364 GN=vent1 PE=2 SV=1,GO:0000122; GO:0000981; GO:0001707; GO:0005634; GO:0030509; GO:0043565; GO:0045892; GO:0048264,BMP signaling pathway [GO:0030509]; determination of ventral identity [GO:0048264]; mesoderm formation [GO:0001707]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04113,FUN_016489-T1,Peve_00001327,Pocillopora_meandrina_HIv1___RNAseq.g9629.t1,three_way,83.481,FUN_016489-T1,Q8R5L3,,,,,52.2,596.0,7.399999999999999e-171,602.1,sp|Q8R5L3|VPS39_MOUSE Vam6/Vps39-like protein OS=Mus musculus OX=10090 GN=Vps39 PE=1 SV=1,,,,,,
OG_04114,FUN_016490-T1,Peve_00001326,Pocillopora_meandrina_HIv1___RNAseq.g9508.t1,three_way,62.83783333333333,FUN_016490-T1,Q505F5,,,,,40.5,333.0,1.1e-45,186.0,sp|Q505F5|LRC47_MOUSE Leucine-rich repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Lrrc47 PE=1 SV=1,,,,,,
OG_04115,FUN_016491-T1,Peve_00024202,Pocillopora_meandrina_HIv1___RNAseq.g9195.t1,three_way,72.09166666666667,FUN_016491-T1,P31006,,,,,54.1,185.0,5.899999999999999e-53,208.8,sp|P31006|KGUA_PIG Guanylate kinase OS=Sus scrofa OX=9823 GN=GUK1 PE=1 SV=2,,,,,,
OG_04116,FUN_016492-T1,Peve_00042752,Pocillopora_meandrina_HIv1___RNAseq.g179.t1,three_way,63.57866666666666,FUN_016492-T1,Q8L706,,,,,24.4,312.0,1.1e-15,87.4,sp|Q8L706|SYT5_ARATH Synaptotagmin-5 OS=Arabidopsis thaliana OX=3702 GN=SYT5 PE=2 SV=1,,,,,,
OG_04117,FUN_016493-T1,Peve_00042754,Pocillopora_meandrina_HIv1___RNAseq.g178.t1,three_way,75.77766666666666,FUN_016493-T1,P54357,,,,,44.8,145.0,1.8e-29,130.6,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_04118,FUN_016494-T1,Peve_00042755,Pocillopora_meandrina_HIv1___TS.g6942.t1,three_way,83.782,FUN_016494-T1,Q9UT00,,,,,22.7,519.0,8.7e-20,100.9,sp|Q9UT00|YKH3_SCHPO Uncharacterized protein PYUK71.03c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAPYUK71.03c PE=1 SV=1,,,,,,
OG_04119,FUN_016495-T1,Peve_00042759,Pocillopora_meandrina_HIv1___RNAseq.g176.t1,three_way,53.5725,,,,,,,,,,,,,,,,,
OG_04120,FUN_016496-T1,Peve_00010548,Pocillopora_meandrina_HIv1___RNAseq.g175.t1,three_way,69.93133333333333,FUN_016496-T1,Q5RFE6,,,,,48.9,474.0,3.5e-128,459.9,sp|Q5RFE6|THNS2_PONAB Threonine synthase-like 2 OS=Pongo abelii OX=9601 GN=THNSL2 PE=2 SV=1,,,,,,
OG_04121,FUN_016502-T1,Peve_00002862,Pocillopora_meandrina_HIv1___RNAseq.g26039.t1,three_way,58.61033333333333,,,,,,,,,,,,,,,,,
OG_04122,FUN_016503-T1,Peve_00016813,Pocillopora_meandrina_HIv1___RNAseq.g9722.t1,three_way,69.429,FUN_016503-T1,Q32LQ4,,,,,58.3,336.0,3.3e-117,422.9,sp|Q32LQ4|BHMT1_DANRE Betaine--homocysteine S-methyltransferase 1 OS=Danio rerio OX=7955 GN=bhmt PE=2 SV=1,,,,,,
OG_04123,FUN_016504-T1,Peve_00016812,Pocillopora_meandrina_HIv1___RNAseq.g9720.t1,three_way,88.1275,FUN_016504-T1,Q9Y2X3,NOP58_HUMAN,,Nucleolar protein 58 (Nucleolar protein 5),Homo sapiens (Human),71.5,445.0,1.6e-174,614.0,sp|Q9Y2X3|NOP58_HUMAN Nucleolar protein 58 OS=Homo sapiens OX=9606 GN=NOP58 PE=1 SV=1,GO:0001094; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005829; GO:0006364; GO:0015030; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0048254; GO:0051117; GO:0070761,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; snoRNA localization [GO:0048254],box C/D methylation guide snoRNP complex [GO:0031428]; Cajal body [GO:0015030]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732],ATPase binding [GO:0051117]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; TFIID-class transcription factor complex binding [GO:0001094],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0043226,RNA binding; nucleoplasm; nucleolus; cytosol; organelle
OG_04124,FUN_016506-T1,Peve_00016809,Pocillopora_meandrina_HIv1___RNAseq.g9719.t1,three_way,60.988,FUN_016506-T1,Q6AX80,,,,,35.9,434.0,5.4e-76,286.6,sp|Q6AX80|ENPP4_XENLA Bis(5'-adenosyl)-triphosphatase enpp4 OS=Xenopus laevis OX=8355 GN=enpp4 PE=2 SV=1,,,,,,
OG_04125,FUN_016508-T1,Peve_00042768,Pocillopora_meandrina_HIv1___TS.g23255.t1,three_way,68.21666666666667,FUN_016508-T1,Q6PUF4,,,,,41.6,267.0,2.1e-49,197.6,sp|Q6PUF4|DHI1L_CHICK Hydroxysteroid 11-beta-dehydrogenase 1-like protein OS=Gallus gallus OX=9031 GN=HSD11B1L PE=2 SV=1,,,,,,
OG_04126,FUN_016561-T1,Peve_00041653,Pocillopora_meandrina_HIv1___RNAseq.g27970.t1,three_way,87.91766666666666,,,,,,,,,,,,,,,,,
OG_04127,FUN_016571-T1,Peve_00042779,Pocillopora_meandrina_HIv1___RNAseq.g9716.t1,three_way,78.609,FUN_016571-T1,Q9D4B2,ODAD4_MOUSE,,Outer dynein arm-docking complex subunit 4 (Tetratricopeptide repeat protein 25) (TPR repeat protein 25),Mus musculus (Mouse),50.6,482.0,3.1e-126,453.8,sp|Q9D4B2|ODAD4_MOUSE Outer dynein arm-docking complex subunit 4 OS=Mus musculus OX=10090 GN=Odad4 PE=1 SV=3,GO:0003341; GO:0005576; GO:0005930; GO:0007420; GO:0007507; GO:0030324; GO:0036158; GO:0060287; GO:0090660; GO:0097728; GO:0097729; GO:0120197; GO:0120228; GO:0120229,brain development [GO:0007420]; cerebrospinal fluid circulation [GO:0090660]; cilium movement [GO:0003341]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; heart development [GO:0007507]; lung development [GO:0030324]; mucociliary clearance [GO:0120197]; outer dynein arm assembly [GO:0036158]; protein localization to motile cilium [GO:0120229],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; outer dynein arm docking complex [GO:0120228],,GO:0003016; GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0048856; GO:0050877; GO:0065003,respiratory system process; extracellular region; cilium; microtubule-based movement; organelle; anatomical structure development; nervous system process; protein-containing complex assembly
OG_04128,FUN_016572-T1,Peve_00042784,Pocillopora_meandrina_HIv1___RNAseq.g9715.t1,three_way,90.504,FUN_016572-T1,Q6NRF4,,,,,62.2,347.0,3.1e-107,389.8,sp|Q6NRF4|CCY1B_XENLA Cyclin-Y-like protein 1-B OS=Xenopus laevis OX=8355 GN=ccnyl1-b PE=2 SV=1,,,,,,
OG_04129,FUN_016578-T1,Peve_00002516,Pocillopora_meandrina_HIv1___RNAseq.g9694.t1,three_way,71.17683333333333,FUN_016578-T1,Q8K4Q6,NEIL1_MOUSE,,Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (Nei homolog 1) (NEH1) (Nei-like protein 1),Mus musculus (Mouse),49.5,307.0,1.9e-80,301.2,sp|Q8K4Q6|NEIL1_MOUSE Endonuclease 8-like 1 OS=Mus musculus OX=10090 GN=Neil1 PE=2 SV=3,GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0006281; GO:0006284; GO:0006979; GO:0008270; GO:0016829; GO:0019104; GO:0140078,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; response to oxidative stress [GO:0006979],centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; lyase activity [GO:0016829]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0006281; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; microtubule organizing center; DNA repair; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_04130,FUN_016580-T1,Peve_00002515,Pocillopora_meandrina_HIv1___RNAseq.g9696.t1,three_way,53.467,,,,,,,,,,,,,,,,,
OG_04131,FUN_016583-T1,Peve_00016678,Pocillopora_meandrina_HIv1___RNAseq.g418.t1,three_way,41.5285,,,,,,,,,,,,,,,,,
OG_04132,FUN_016586-T1,Peve_00015488,Pocillopora_meandrina_HIv1___RNAseq.g471.t1,three_way,72.66883333333334,FUN_016586-T1,Q08CH3,,,,,37.6,540.0,7.2e-91,336.3,sp|Q08CH3|MPND_DANRE MPN domain-containing protein OS=Danio rerio OX=7955 GN=mpnd PE=2 SV=1,,,,,,
OG_04133,FUN_016587-T1,Peve_00000800,Pocillopora_meandrina_HIv1___RNAseq.g2974.t1,three_way,65.638,FUN_016587-T1,Q92900,RENT1_HUMAN,,Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1),Homo sapiens (Human),38.4,440.0,3.6e-69,265.8,sp|Q92900|RENT1_HUMAN Regulator of nonsense transcripts 1 OS=Homo sapiens OX=9606 GN=UPF1 PE=1 SV=2,GO:0000184; GO:0000781; GO:0000785; GO:0000932; GO:0000956; GO:0003682; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006260; GO:0006281; GO:0006406; GO:0006449; GO:0008270; GO:0016887; GO:0032201; GO:0032204; GO:0035145; GO:0036121; GO:0042162; GO:0044530; GO:0044770; GO:0044877; GO:0048471; GO:0061014; GO:0061158; GO:0071044; GO:0071222; GO:0071347; GO:1905746,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded DNA helicase activity [GO:0036121]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006913; GO:0016071; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA replication; DNA repair; nucleocytoplasmic transport; mRNA metabolic process; hydrolase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04134,FUN_016588-T1,Peve_00000798,Pocillopora_meandrina_HIv1___RNAseq.g2973.t1,three_way,71.725,,,,,,,,,,,,,,,,,
OG_04135,FUN_016589-T1,Peve_00005993,Pocillopora_meandrina_HIv1___RNAseq.g470.t1,three_way,71.651,FUN_016589-T1,F4K2M8,,,,,26.1,138.0,2.1e-09,65.5,sp|F4K2M8|JMJ31_ARATH Lysine-specific demethylase JMJ31 OS=Arabidopsis thaliana OX=3702 GN=JMJ31 PE=2 SV=1,,,,,,
OG_04136,FUN_016590-T1,Peve_00015491,Pocillopora_meandrina_HIv1___RNAseq.g473.t1,three_way,79.526,FUN_016590-T1,Q9NWM8,FKB14_HUMAN,,Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (22 kDa FK506-binding protein) (22 kDa FKBP) (FKBP-22) (FK506-binding protein 14) (FKBP-14) (Rotamase),Homo sapiens (Human),33.7,187.0,2.7e-24,113.6,sp|Q9NWM8|FKB14_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP14 OS=Homo sapiens OX=9606 GN=FKBP14 PE=1 SV=1,GO:0003755; GO:0005509; GO:0005788,,endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0016853; GO:0140096,"catalytic activity; isomerase activity; catalytic activity, acting on a protein"
OG_04137,FUN_016591-T1,Peve_00005997,Pocillopora_meandrina_HIv1___RNAseq.g474.t1,three_way,70.59733333333334,FUN_016591-T1,Q4KLE6,,,,,47.7,241.0,2.6e-61,236.9,sp|Q4KLE6|NT1AB_XENLA N-terminal Xaa-Pro-Lys N-methyltransferase 1-B OS=Xenopus laevis OX=8355 GN=ntmt1-b PE=2 SV=1,,,,,,
OG_04138,FUN_016592-T1,Peve_00005996,Pocillopora_meandrina_HIv1___RNAseq.g475.t1,three_way,82.95,FUN_016592-T1,D3ZY60,PKHA8_RAT,,Pleckstrin homology domain-containing family A member 8 (PH domain-containing family A member 8) (Phosphatidylinositol-four-phosphate adapter protein 2) (FAPP-2) (Phosphoinositol 4-phosphate adapter protein 2),Rattus norvegicus (Rat),39.0,546.0,2.4e-96,354.4,sp|D3ZY60|PKHA8_RAT Pleckstrin homology domain-containing family A member 8 OS=Rattus norvegicus OX=10116 GN=Plekha8 PE=1 SV=1,GO:0005654; GO:0005802; GO:0005829; GO:0006869; GO:0015031; GO:0016020; GO:0017089; GO:0035621; GO:0035627; GO:0042802; GO:0051861; GO:0070273; GO:0097001; GO:0120009; GO:1902387; GO:1902388,ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031],cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802],ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transfer activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transfer activity [GO:0017089]; identical protein binding [GO:0042802]; phosphatidylinositol-4-phosphate binding [GO:0070273],GO:0005215; GO:0005654; GO:0005829; GO:0008289; GO:0061024,transporter activity; nucleoplasm; cytosol; lipid binding; membrane organization
OG_04139,FUN_016594-T1,Peve_00005995,Pocillopora_meandrina_HIv1___TS.g7238.t1,three_way,73.7675,,,,,,,,,,,,,,,,,
OG_04140,FUN_016595-T1,Peve_00005991,Pocillopora_meandrina_HIv1___RNAseq.g477.t1,three_way,56.781666666666666,FUN_016595-T1,O17185,SUP9_CAEEL,,Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38),Caenorhabditis elegans,29.1,230.0,1.3e-23,112.1,sp|O17185|SUP9_CAEEL Two pore potassium channel protein sup-9 OS=Caenorhabditis elegans OX=6239 GN=sup-9 PE=1 SV=2,GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0036195; GO:0055120; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937],muscle cell projection membrane [GO:0036195]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120],outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_04141,FUN_016596-T1,Peve_00033776,Pocillopora_meandrina_HIv1___RNAseq.g481.t1,three_way,74.769,FUN_016596-T1,O46385,,,,,34.0,1119.0,3.3e-163,578.6,sp|O46385|SVIL_BOVIN Supervillin OS=Bos taurus OX=9913 GN=SVIL PE=1 SV=2,,,,,,
OG_04142,FUN_016599-T1,Peve_00003402,Pocillopora_meandrina_HIv1___RNAseq.g414.t2,three_way,67.56366666666666,,,,,,,,,,,,,,,,,
OG_04143,FUN_016604-T1,Peve_00003404,Pocillopora_meandrina_HIv1___RNAseq.g416.t1,three_way,93.88866666666668,FUN_016604-T1,Q5ZMV3,,,,,76.9,108.0,2.8e-43,176.4,sp|Q5ZMV3|NC2B_CHICK Protein Dr1 OS=Gallus gallus OX=9031 GN=DR1 PE=2 SV=1,,,,,,
OG_04144,FUN_016605-T1,Peve_00044543,Pocillopora_meandrina_HIv1___RNAseq.g9626.t1,three_way,81.345,FUN_016605-T1,Q7SXP8,,,,,52.2,295.0,1.4e-88,327.8,sp|Q7SXP8|GMPAB_DANRE Mannose-1-phosphate guanylyltransferase regulatory subunit alpha-B OS=Danio rerio OX=7955 GN=gmppab PE=2 SV=1,,,,,,
OG_04145,FUN_016607-T1,Peve_00010246,Pocillopora_meandrina_HIv1___RNAseq.g9625.t1,three_way,82.545,FUN_016607-T1,Q6AYD3,PA2G4_RAT,,Proliferation-associated protein 2G4,Rattus norvegicus (Rat),62.8,288.0,7.3e-106,385.2,sp|Q6AYD3|PA2G4_RAT Proliferation-associated protein 2G4 OS=Rattus norvegicus OX=10116 GN=Pa2g4 PE=1 SV=1,GO:0003676; GO:0003714; GO:0003723; GO:0005634; GO:0005730; GO:0005737; GO:0006364; GO:0006417; GO:0031625; GO:0043066; GO:0045597; GO:0045892; GO:1990904,negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005634; GO:0005730; GO:0006355; GO:0043226; GO:0060090; GO:0140110,RNA binding; nucleus; nucleolus; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_04146,FUN_016608-T1,Peve_00010249,Pocillopora_meandrina_HIv1___RNAseq.g9623.t1b,three_way,79.465,FUN_016608-T1,P58465,,,,,63.3,270.0,1.5e-89,330.9,sp|P58465|CTDSL_MOUSE CTD small phosphatase-like protein OS=Mus musculus OX=10090 GN=Ctdspl PE=2 SV=3,,,,,,
OG_04147,FUN_016609-T2,Peve_00010250,Pocillopora_meandrina_HIv1___RNAseq.g9614.t1,three_way,73.77483333333333,FUN_016609-T2,Q9EQD2,NPFF2_RAT,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor),Rattus norvegicus (Rat),35.0,303.0,4.8e-38,160.2,sp|Q9EQD2|NPFF2_RAT Neuropeptide FF receptor 2 OS=Rattus norvegicus OX=10116 GN=Npffr2 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_04148,FUN_016611-T1,Peve_00010247,Pocillopora_meandrina_HIv1___RNAseq.g9616.t1,three_way,64.97283333333333,FUN_016611-T1,O46606,DDHD1_BOVIN,,Phospholipase DDHD1 (EC 3.1.1.111) (EC 3.1.1.32) (DDHD domain-containing protein 1) (Phosphatidic acid-preferring phospholipase A1) (PA-PLA1) (EC 3.1.1.118) (Phospholipid sn-1 acylhydrolase),Bos taurus (Bovine),35.9,434.0,1.5e-56,221.9,sp|O46606|DDHD1_BOVIN Phospholipase DDHD1 OS=Bos taurus OX=9913 GN=DDHD1 PE=1 SV=1,GO:0004620; GO:0005737; GO:0008970; GO:0046488; GO:0046872,phosphatidylinositol metabolic process [GO:0046488],cytoplasm [GO:0005737],metal ion binding [GO:0046872]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_04149,FUN_016612-T1,Peve_00010248,Pocillopora_meandrina_HIv1___TS.g23153.t1,three_way,49.34766666666667,,,,,,,,,,,,,,,,,
OG_04150,FUN_016614-T1,Peve_00024466,Pocillopora_meandrina_HIv1___RNAseq.g9617.t1,three_way,81.786,FUN_016614-T1,Q96LR5,UB2E2_HUMAN,,Ubiquitin-conjugating enzyme E2 E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E2) (UbcH8) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2),Homo sapiens (Human),71.1,190.0,2.3000000000000002e-74,280.4,sp|Q96LR5|UB2E2_HUMAN Ubiquitin-conjugating enzyme E2 E2 OS=Homo sapiens OX=9606 GN=UBE2E2 PE=1 SV=1,GO:0004842; GO:0005524; GO:0005634; GO:0006513; GO:0006974; GO:0032020; GO:0042296; GO:0061631; GO:0070534; GO:0070936; GO:0070979; GO:1900087,DNA damage response [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513],nucleus [GO:0005634],ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04151,FUN_016615-T1,Peve_00024469,Pocillopora_meandrina_HIv1___RNAseq.g9618.t1,three_way,80.89766666666667,FUN_016615-T1,Q2T9X7,UB2E3_BOVIN,,Ubiquitin-conjugating enzyme E2 E3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E3) (Ubiquitin carrier protein E3) (Ubiquitin-protein ligase E3),Bos taurus (Bovine),89.1,147.0,2.7e-76,286.2,sp|Q2T9X7|UB2E3_BOVIN Ubiquitin-conjugating enzyme E2 E3 OS=Bos taurus OX=9913 GN=UBE2E3 PE=2 SV=1,GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0061631; GO:0070534; GO:0070936; GO:0070979,protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04152,FUN_016616-T1,Peve_00008566,Pocillopora_meandrina_HIv1___RNAseq.g9620.t1,three_way,88.02466666666666,FUN_016616-T1,Q6DFS6,CHM2A_XENTR,,Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),69.7,221.0,1.1e-57,224.6,sp|Q6DFS6|CHM2A_XENTR Charged multivesicular body protein 2a OS=Xenopus tropicalis OX=8364 GN=chmp2a PE=2 SV=1,GO:0005635; GO:0007034; GO:0010458; GO:0015031; GO:0031468; GO:0031902,exit from mitosis [GO:0010458]; nuclear membrane reassembly [GO:0031468]; protein transport [GO:0015031]; vacuolar transport [GO:0007034],late endosome membrane [GO:0031902]; nuclear envelope [GO:0005635],,GO:0005635; GO:0061024,nuclear envelope; membrane organization
OG_04153,FUN_016617-T1,Peve_00008570,Pocillopora_meandrina_HIv1___RNAseq.g9622.t1,three_way,68.09433333333334,FUN_016617-T1,P18293,ANPRA_MOUSE,,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),Mus musculus (Mouse),32.4,786.0,9.3e-99,362.8,sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2,GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0007168; GO:0008217; GO:0010753; GO:0016020; GO:0016941; GO:0017046; GO:0019934; GO:0042417; GO:0043235; GO:0048662; GO:0097746; GO:1990620,blood vessel diameter maintenance [GO:0097746]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217],ANPR-A receptor complex [GO:1990620]; membrane [GO:0016020]; receptor complex [GO:0043235],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672],GO:0003013; GO:0003824; GO:0009975; GO:0016740; GO:0016829; GO:0060089; GO:0140096,"circulatory system process; catalytic activity; cyclase activity; transferase activity; lyase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_04154,FUN_016621-T1,Peve_00005682,Pocillopora_meandrina_HIv1___RNAseq.g9611.t1,three_way,71.54566666666666,FUN_016621-T1,Q99615,DNJC7_HUMAN,,DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2),Homo sapiens (Human),55.3,414.0,1.4999999999999998e-127,458.0,sp|Q99615|DNJC7_HUMAN DnaJ homolog subfamily C member 7 OS=Homo sapiens OX=9606 GN=DNAJC7 PE=1 SV=2,GO:0001671; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006457; GO:0016020; GO:0031072; GO:0051085; GO:0070062; GO:1900034,chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072],GO:0005654; GO:0005829; GO:0005856; GO:0006457; GO:0043226; GO:0098772,nucleoplasm; cytosol; cytoskeleton; protein folding; organelle; molecular function regulator activity
OG_04155,FUN_016622-T1,Peve_00011211,Pocillopora_meandrina_HIv1___RNAseq.g9609.t1,three_way,83.40233333333333,FUN_016622-T1,P36975,,,,,51.5,202.0,4.2e-49,196.1,sp|P36975|SNP25_DROME Synaptosomal-associated protein 25 OS=Drosophila melanogaster OX=7227 GN=Snap25 PE=2 SV=1,,,,,,
OG_04156,FUN_016623-T1,Peve_00026347,Pocillopora_meandrina_HIv1___RNAseq.g9627.t1,three_way,60.69583333333333,FUN_016623-T1,P97718,ADA1A_MOUSE,,Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor),Mus musculus (Mouse),24.1,316.0,5.3e-23,110.2,sp|P97718|ADA1A_MOUSE Alpha-1A adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1a PE=1 SV=3,GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007512; GO:0008217; GO:0010507; GO:0010613; GO:0016020; GO:0019229; GO:0031965; GO:0035024; GO:0035265; GO:0043410; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0071875; GO:0097195; GO:0150099,adrenergic receptor signaling pathway [GO:0071875]; adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982],GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0060089,circulatory system process; nucleus; nucleoplasm; cytosol; plasma membrane; signaling; organelle; anatomical structure development; molecular transducer activity
OG_04157,FUN_016625-T1,Peve_00020325,Pocillopora_meandrina_HIv1___RNAseq.g148.t1,three_way,74.75966666666666,FUN_016625-T1,A0A8V1ABE9,DSD1_CHICK,,D-serine dehydratase (EC 4.3.1.18) (D-serine deaminase),Gallus gallus (Chicken),46.1,310.0,9e-77,288.5,sp|A0A8V1ABE9|DSD1_CHICK D-serine dehydratase OS=Gallus gallus OX=9031 GN=DSD PE=1 SV=1,GO:0005737; GO:0008270; GO:0008721; GO:0030170; GO:0030425; GO:0036088,D-serine catabolic process [GO:0036088],cytoplasm [GO:0005737]; dendrite [GO:0030425],D-serine ammonia-lyase activity [GO:0008721]; pyridoxal phosphate binding [GO:0030170]; zinc ion binding [GO:0008270],GO:0003824; GO:0006520; GO:0016829,catalytic activity; amino acid metabolic process; lyase activity
OG_04158,FUN_016635-T1,Peve_00020323,Pocillopora_meandrina_HIv1___RNAseq.g104.t1,three_way,85.525,FUN_016635-T1,A5PKH3,,,,,68.4,415.0,2.5e-178,626.3,sp|A5PKH3|FAAA_BOVIN Fumarylacetoacetase OS=Bos taurus OX=9913 GN=FAH PE=2 SV=1,,,,,,
OG_04159,FUN_016636-T2,Peve_00026358,Pocillopora_meandrina_HIv1___RNAseq.g103.t1,three_way,71.86316666666667,FUN_016636-T2,O46680,TGFR1_BOVIN,,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),Bos taurus (Bovine),56.6,486.0,9e-146,518.5,sp|O46680|TGFR1_BOVIN TGF-beta receptor type-1 OS=Bos taurus OX=9913 GN=TGFBR1 PE=2 SV=1,GO:0001938; GO:0005025; GO:0005524; GO:0005634; GO:0005768; GO:0005886; GO:0005923; GO:0006915; GO:0007179; GO:0007399; GO:0007507; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0016020; GO:0016361; GO:0032924; GO:0035556; GO:0042118; GO:0045121; GO:0045893; GO:0046332; GO:0046872; GO:0048179; GO:0048185; GO:0048762; GO:0050431; GO:0060317; GO:0071363; GO:0071560; GO:0101023,activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; endothelial cell activation [GO:0042118]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; mesenchymal cell differentiation [GO:0048762]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gene expression [GO:0010628]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vascular endothelial cell proliferation [GO:0101023],activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type I [GO:0005025]",GO:0003824; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0012501; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; programmed cell death; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_04160,FUN_016638-T1,Peve_00026352,Pocillopora_meandrina_HIv1___RNAseq.g102.t1,three_way,61.59666666666666,FUN_016638-T1,Q62136,,,,,27.0,1183.0,6.6999999999999995e-90,333.6,sp|Q62136|PTN21_MOUSE Tyrosine-protein phosphatase non-receptor type 21 OS=Mus musculus OX=10090 GN=Ptpn21 PE=1 SV=1,,,,,,
OG_04161,FUN_016639-T1,Peve_00001325,Pocillopora_meandrina_HIv1___RNAseq.g10191.t1,three_way,64.88383333333333,FUN_016639-T1,O70249,OGG1_RAT,,N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)],Rattus norvegicus (Rat),47.5,335.0,6.7e-84,312.4,sp|O70249|OGG1_RAT N-glycosylase/DNA lyase OS=Rattus norvegicus OX=10116 GN=Ogg1 PE=2 SV=1,GO:0000978; GO:0003677; GO:0003684; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006285; GO:0006289; GO:0006355; GO:0006974; GO:0006979; GO:0008017; GO:0008534; GO:0009314; GO:0009410; GO:0009416; GO:0016363; GO:0016607; GO:0019104; GO:0019899; GO:0032355; GO:0032357; GO:0032991; GO:0034039; GO:0034614; GO:0043066; GO:0044029; GO:0045471; GO:0045944; GO:0051593; GO:0071276; GO:0140078; GO:1901291,"base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair [GO:0006289]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314]; response to xenobiotic stimulus [GO:0009410]",mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],"8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; enzyme binding [GO:0019899]; microtubule binding [GO:0008017]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006325; GO:0006355; GO:0008092; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; chromatin organization; regulation of DNA-templated transcription; cytoskeletal protein binding; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_04162,FUN_016640-T1,Peve_00042751,Pocillopora_meandrina_HIv1___TS.g6976.t1,three_way,78.45166666666667,FUN_016640-T1,Q86XK2,FBX11_HUMAN,,F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1),Homo sapiens (Human),39.9,286.0,3.6999999999999997e-54,214.9,sp|Q86XK2|FBX11_HUMAN F-box only protein 11 OS=Homo sapiens OX=9606 GN=FBXO11 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0036211; GO:0042981; GO:0043161; GO:1990756,negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0050877; GO:0060090; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; transferase activity; protein catabolic process; organelle; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_04163,FUN_016642-T1,Peve_00042750,Pocillopora_meandrina_HIv1___RNAseq.g209.t1,three_way,69.53533333333333,FUN_016642-T1,Q5ZHV5,JMJD4_CHICK,,2-oxoglutarate and iron-dependent oxygenase JMJD4 (EC 1.14.11.-) (JmjC domain-containing protein 4) (Jumonji domain-containing protein 4) (Lysyl-hydroxylase JMJD4),Gallus gallus (Chicken),54.8,325.0,8.5e-110,398.7,sp|Q5ZHV5|JMJD4_CHICK 2-oxoglutarate and iron-dependent oxygenase JMJD4 OS=Gallus gallus OX=9031 GN=JMJD4 PE=2 SV=1,GO:0005634; GO:0005737; GO:0016706; GO:0018126; GO:0043565; GO:0045905; GO:0046872; GO:0106156,positive regulation of translational termination [GO:0045905]; protein hydroxylation [GO:0018126],cytoplasm [GO:0005737]; nucleus [GO:0005634],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; peptidyl-lysine 4-dioxygenase activity [GO:0106156]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0003824; GO:0005634; GO:0016491; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_04164,FUN_016645-T1,Peve_00042746,Pocillopora_meandrina_HIv1___TS.g6967.t1,three_way,90.44333333333331,FUN_016645-T1,Q6P632,NAA20_XENTR,,N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),74.2,178.0,3.9e-76,285.8,sp|Q6P632|NAA20_XENTR N-alpha-acetyltransferase 20 OS=Xenopus tropicalis OX=8364 GN=naa20 PE=2 SV=1,GO:0005634; GO:0005737; GO:0006474; GO:0017190; GO:0017192; GO:0018002; GO:0120518,N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-glutamine acetylation [GO:0017192]; N-terminal protein amino acid acetylation [GO:0006474],cytoplasm [GO:0005737]; nucleus [GO:0005634],protein N-terminal-methionine acetyltransferase activity [GO:0120518],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_04165,FUN_016646-T1,Peve_00042745,Pocillopora_meandrina_HIv1___RNAseq.g199.t1,three_way,51.387166666666666,FUN_016646-T1,P30173,,,,,42.1,378.0,2.2e-80,302.4,sp|P30173|ACT13_SOLTU Actin-101 OS=Solanum tuberosum OX=4113 GN=AC101 PE=3 SV=1,,,,,,
OG_04166,FUN_016647-T2,Peve_00042744,Pocillopora_meandrina_HIv1___RNAseq.g198.t1,three_way,70.97566666666667,FUN_016647-T2,Q8TBE0,BAHD1_HUMAN,,Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1),Homo sapiens (Human),50.0,194.0,2.6e-45,185.3,sp|Q8TBE0|BAHD1_HUMAN Bromo adjacent homology domain-containing 1 protein OS=Homo sapiens OX=9606 GN=BAHD1 PE=1 SV=2,GO:0000976; GO:0003682; GO:0005654; GO:0005677; GO:0005694; GO:0031507; GO:0045892,heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892],chromatin silencing complex [GO:0005677]; chromosome [GO:0005694]; nucleoplasm [GO:0005654],chromatin binding [GO:0003682]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0043226,DNA binding; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; organelle
OG_04167,FUN_016648-T1,Peve_00042742,Pocillopora_meandrina_HIv1___RNAseq.g197.t1,three_way,86.58166666666666,FUN_016648-T1,A8QCE4,,,,,45.3,64.0,6.8e-15,83.6,sp|A8QCE4|LST2_BRUMA Lateral signaling target protein 2 homolog OS=Brugia malayi OX=6279 GN=Bm5439 PE=3 SV=1,,,,,,
OG_04168,FUN_016649-T1,Peve_00042740,Pocillopora_meandrina_HIv1___TS.g6963.t1,three_way,75.31400000000001,FUN_016649-T1,Q8TDX6,,,,,47.3,427.0,4.4e-103,376.7,sp|Q8TDX6|CGAT1_HUMAN Chondroitin sulfate N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=CSGALNACT1 PE=1 SV=2,,,,,,
OG_04169,FUN_016650-T1,Peve_00042739,Pocillopora_meandrina_HIv1___RNAseq.g195.t1,three_way,37.1615,,,,,,,,,,,,,,,,,
OG_04170,FUN_016651-T1,Peve_00042780,Pocillopora_meandrina_HIv1___TS.g6961.t1,three_way,81.653,FUN_016651-T1,Q6TMK4,POXA_DICDI,,Peroxinectin A (EC 1.11.1.7),Dictyostelium discoideum (Social amoeba),34.7,521.0,3.3e-86,322.0,sp|Q6TMK4|POXA_DICDI Peroxinectin A OS=Dictyostelium discoideum OX=44689 GN=poxA PE=1 SV=1,GO:0004447; GO:0004601; GO:0005576; GO:0005783; GO:0006955; GO:0006979; GO:0020037; GO:0036393; GO:0042742; GO:0042744; GO:0140825,defense response to bacterium [GO:0042742]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; response to oxidative stress [GO:0006979],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; lactoperoxidase activity [GO:0140825]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393],GO:0002376; GO:0003824; GO:0005576; GO:0005783; GO:0016209; GO:0016491; GO:0043226,immune system process; catalytic activity; extracellular region; endoplasmic reticulum; antioxidant activity; oxidoreductase activity; organelle
OG_04171,FUN_016652-T1,Peve_00042777,Pocillopora_meandrina_HIv1___RNAseq.22127_t,three_way,89.431,FUN_016652-T1,Q2KIA2,TR112_BOVIN,,Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog),Bos taurus (Bovine),61.8,123.0,2.2e-37,156.4,sp|Q2KIA2|TR112_BOVIN Multifunctional methyltransferase subunit TRM112-like protein OS=Bos taurus OX=9913 GN=TRMT112 PE=2 SV=1,GO:0000470; GO:0005634; GO:0005654; GO:0005737; GO:0018364; GO:0030490; GO:0031167; GO:0043528; GO:0045815; GO:0046982; GO:0048471; GO:0070476; GO:0141106; GO:2000234,maturation of LSU-rRNA [GO:0000470]; maturation of SSU-rRNA [GO:0030490]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; rRNA methylation [GO:0031167]; transcription initiation-coupled chromatin remodeling [GO:0045815],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA (m2G10) methyltransferase complex [GO:0043528],protein heterodimerization activity [GO:0046982]; tRNA methyltransferase activator activity [GO:0141106],GO:0005634; GO:0005654; GO:0006325; GO:0043226; GO:0098772,nucleus; nucleoplasm; chromatin organization; organelle; molecular function regulator activity
OG_04172,FUN_016653-T1,Peve_00042772,Pocillopora_meandrina_HIv1___RNAseq.g192.t1,three_way,87.89933333333333,FUN_016653-T1,Q2KI54,,,,,49.4,650.0,1.4000000000000001e-167,591.3,sp|Q2KI54|ARMC8_BOVIN Armadillo repeat-containing protein 8 OS=Bos taurus OX=9913 GN=ARMC8 PE=2 SV=1,,,,,,
OG_04173,FUN_016657-T1,Peve_00020507,Pocillopora_meandrina_HIv1___RNAseq.g25312.t1a,three_way,54.83766666666666,FUN_016657-T1,Q5E9Q3,,,,,46.7,165.0,1.2e-34,149.1,sp|Q5E9Q3|MITOK_BOVIN Mitochondrial potassium channel OS=Bos taurus OX=9913 GN=CCDC51 PE=2 SV=1,,,,,,
OG_04174,FUN_016658-T1,Peve_00001663,Pocillopora_meandrina_HIv1___RNAseq.g25313.t1,three_way,70.49633333333333,FUN_016658-T1,Q924L1,,,,,29.2,274.0,3.6e-29,130.6,sp|Q924L1|LTMD1_MOUSE LETM1 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Letmd1 PE=1 SV=1,,,,,,
OG_04175,FUN_016660-T2,Peve_00032318,Pocillopora_meandrina_HIv1___RNAseq.g10087.t1,three_way,86.16333333333333,FUN_016660-T2,Q92047,,,,,58.3,223.0,3.4000000000000004e-74,279.6,sp|Q92047|PIMT_DANRE Protein-L-isoaspartate(D-aspartate) O-methyltransferase OS=Danio rerio OX=7955 GN=pcmt PE=2 SV=3,,,,,,
OG_04176,FUN_016661-T1,Peve_00032319,Pocillopora_meandrina_HIv1___RNAseq.g10086.t1,three_way,55.61933333333333,FUN_016661-T1,Q5RCI5,CSKMT_PONAB,,"Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial (CS-KMT) (EC 2.1.1.-) (Methyltransferase-like protein 12, mitochondrial)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),33.2,208.0,1.4e-17,91.7,"sp|Q5RCI5|CSKMT_PONAB Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial OS=Pongo abelii OX=9601 GN=CSKMT PE=2 SV=1",GO:0005739; GO:0006479; GO:0016278; GO:0016279; GO:0018023; GO:0018026; GO:0018027,peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; protein methylation [GO:0006479],mitochondrion [GO:0005739],lysine N-methyltransferase activity [GO:0016278]; protein-lysine N-methyltransferase activity [GO:0016279],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04177,FUN_016662-T1,Peve_00032320,Pocillopora_meandrina_HIv1___RNAseq.g10085.t1,three_way,61.4985,FUN_016662-T1,P98088,MUC5A_HUMAN,,"Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM)",Homo sapiens (Human),29.1,998.0,1.2e-119,433.3,sp|P98088|MUC5A_HUMAN Mucin-5AC OS=Homo sapiens OX=9606 GN=MUC5AC PE=1 SV=4,GO:0005201; GO:0005615; GO:0005796; GO:0005886; GO:0031012; GO:0046872; GO:0070062; GO:0070701,,extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; plasma membrane [GO:0005886],extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872],GO:0005198; GO:0005615; GO:0005886; GO:0030312; GO:0031012; GO:0043226,structural molecule activity; extracellular space; plasma membrane; external encapsulating structure; extracellular matrix; organelle
OG_04178,FUN_016668-T1,Peve_00002514,Pocillopora_meandrina_HIv1___RNAseq.g9697.t1,three_way,79.70833333333333,FUN_016668-T1,A0JNI5,CLASR_BOVIN,,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16)",Bos taurus (Bovine),51.1,309.0,1.2e-50,202.6,sp|A0JNI5|CLASR_BOVIN CLK4-associating serine/arginine rich protein OS=Bos taurus OX=9913 GN=CLASRP PE=2 SV=1,GO:0005634; GO:0006397; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nucleus [GO:0005634],,GO:0005634; GO:0016071; GO:0043226,nucleus; mRNA metabolic process; organelle
OG_04179,FUN_016671-T1,Peve_00034246,Pocillopora_meandrina_HIv1___TS.g7272.t1b,three_way,52.63633333333333,FUN_016671-T1,Q28C74,,,,,26.6,992.0,1.1e-15,87.4,"sp|Q28C74|LPPRC_XENTR Leucine-rich PPR motif-containing protein, mitochondrial OS=Xenopus tropicalis OX=8364 GN=lrpprc PE=2 SV=1",,,,,,
OG_04180,FUN_016676-T1,Peve_00013936,Pocillopora_meandrina_HIv1___RNAseq.g504.t1,three_way,57.66266666666667,FUN_016676-T1,Q96L42,,,,,50.7,213.0,2.9e-55,218.8,sp|Q96L42|KCNH8_HUMAN Voltage-gated delayed rectifier potassium channel KCNH8 OS=Homo sapiens OX=9606 GN=KCNH8 PE=1 SV=2,,,,,,
OG_04181,FUN_016677-T1,Peve_00035082,Pocillopora_meandrina_HIv1___RNAseq.g388.t3,three_way,77.881,FUN_016677-T1,A2RUC4,TYW5_HUMAN,,tRNA wybutosine-synthesizing protein 5 (hTYW5) (tRNA yW-synthesizing protein 5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase),Homo sapiens (Human),64.9,302.0,2.2e-116,420.2,sp|A2RUC4|TYW5_HUMAN tRNA wybutosine-synthesizing protein 5 OS=Homo sapiens OX=9606 GN=TYW5 PE=1 SV=1,GO:0000049; GO:0005506; GO:0005737; GO:0031591; GO:0042803; GO:0102524,wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],iron ion binding [GO:0005506]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity [GO:0102524],GO:0003723; GO:0003824; GO:0006399; GO:0016491; GO:0140098; GO:1901135,"RNA binding; catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_04182,FUN_016698-T1,Peve_00034243,Pocillopora_meandrina_HIv1___RNAseq.g389.t1,three_way,57.97016666666666,FUN_016698-T1,P35409,,,,,46.2,834.0,2.1e-129,464.9,sp|P35409|GLHR_ANTEL Probable glycoprotein hormone G-protein coupled receptor OS=Anthopleura elegantissima OX=6110 PE=2 SV=1,,,,,,
OG_04183,FUN_016701-T1,Peve_00004837,Pocillopora_meandrina_HIv1___RNAseq.g279.t1,three_way,55.42366666666667,,,,,,,,,,,,,,,,,
OG_04184,FUN_016703-T1,Peve_00004830,Pocillopora_meandrina_HIv1___RNAseq.g278.t1,three_way,63.02016666666667,FUN_016703-T1,P22121,,,,,36.0,111.0,5.8e-12,72.0,sp|P22121|HSF_KLULA Heat shock transcription factor OS=Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) OX=284590 GN=HSF PE=1 SV=1,,,,,,
OG_04185,FUN_016705-T1,Peve_00004831,Pocillopora_meandrina_HIv1___RNAseq.g281.t1,three_way,77.65433333333333,FUN_016705-T1,Q9SB50,,,,,48.3,292.0,1.1e-71,271.6,sp|Q9SB50|AP4M_ARATH AP-4 complex subunit mu OS=Arabidopsis thaliana OX=3702 GN=AP4M PE=2 SV=1,,,,,,
OG_04186,FUN_016706-T1,Peve_00034244,Pocillopora_meandrina_HIv1___RNAseq.g282.t2,three_way,70.44399999999999,FUN_016706-T1,Q8VDM6,HNRL1_MOUSE,,Heterogeneous nuclear ribonucleoprotein U-like protein 1,Mus musculus (Mouse),50.9,399.0,8.3e-112,406.4,sp|Q8VDM6|HNRL1_MOUSE Heterogeneous nuclear ribonucleoprotein U-like protein 1 OS=Mus musculus OX=10090 GN=Hnrnpul1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0005654; GO:0019899; GO:0045202; GO:1990904,,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],enzyme binding [GO:0019899]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0043226,RNA binding; nucleus; nucleoplasm; organelle
OG_04187,FUN_016708-T1,Peve_00024196,Pocillopora_meandrina_HIv1___RNAseq.g277.t1,three_way,80.69266666666667,FUN_016708-T1,Q1RMM1,,,,,48.7,431.0,1.1e-91,338.6,sp|Q1RMM1|ZC3HF_BOVIN Zinc finger CCCH domain-containing protein 15 OS=Bos taurus OX=9913 GN=ZC3H15 PE=2 SV=1,,,,,,
OG_04188,FUN_016709-T1,Peve_00024195,Pocillopora_meandrina_HIv1___RNAseq.g276.t1,three_way,51.529833333333336,FUN_016709-T1,P79763,,,,,33.7,543.0,6e-73,277.3,sp|P79763|FSHR_CHICK Follicle-stimulating hormone receptor OS=Gallus gallus OX=9031 GN=FSHR PE=2 SV=1,,,,,,
OG_04189,FUN_016710-T1,Peve_00024194,Pocillopora_meandrina_HIv1___RNAseq.g275.t1,three_way,50.513666666666666,,,,,,,,,,,,,,,,,
OG_04190,FUN_016711-T1,Peve_00024193,Pocillopora_meandrina_HIv1___RNAseq.g274.t1,three_way,81.8285,FUN_016711-T1,Q9BGI1,,,,,59.1,171.0,2e-55,216.9,"sp|Q9BGI1|PRDX5_BOVIN Peroxiredoxin-5, mitochondrial OS=Bos taurus OX=9913 GN=PRDX5 PE=2 SV=2",,,,,,
OG_04191,FUN_016712-T1,Peve_00024209,Pocillopora_meandrina_HIv1___RNAseq.g273.t1,three_way,78.60933333333334,FUN_016712-T1,Q7ZUZ0,,,,,47.5,181.0,4.1e-40,166.0,sp|Q7ZUZ0|CSN8_DANRE COP9 signalosome complex subunit 8 OS=Danio rerio OX=7955 GN=cops8 PE=2 SV=1,,,,,,
OG_04192,FUN_016714-T1,Peve_00014666,Pocillopora_meandrina_HIv1___RNAseq.g244.t1,three_way,51.332,,,,,,,,,,,,,,,,,
OG_04193,FUN_016717-T1,Peve_00014667,Pocillopora_meandrina_HIv1___RNAseq.g226.t1,three_way,70.61533333333334,,,,,,,,,,,,,,,,,
OG_04194,FUN_016718-T1,Peve_00014674,Pocillopora_meandrina_HIv1___RNAseq.g231.t1,three_way,57.21833333333333,FUN_016718-T1,Q7F0J0,,,,,30.4,138.0,2.1e-12,75.1,sp|Q7F0J0|CML13_ORYSJ Probable calcium-binding protein CML13 OS=Oryza sativa subsp. japonica OX=39947 GN=CML13 PE=2 SV=1,,,,,,
OG_04195,FUN_016720-T1,Peve_00014673,Pocillopora_meandrina_HIv1___RNAseq.g230.t1,three_way,61.32066666666666,FUN_016720-T1,Q64729,TGFR1_MOUSE,,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),Mus musculus (Mouse),38.4,487.0,5.7e-74,280.0,sp|Q64729|TGFR1_MOUSE TGF-beta receptor type-1 OS=Mus musculus OX=10090 GN=Tgfbr1 PE=1 SV=1,GO:0001501; GO:0001525; GO:0001701; GO:0001822; GO:0001824; GO:0001935; GO:0001937; GO:0001938; GO:0002088; GO:0003222; GO:0003223; GO:0005024; GO:0005025; GO:0005102; GO:0005114; GO:0005524; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005901; GO:0005923; GO:0005929; GO:0006915; GO:0007179; GO:0007507; GO:0008354; GO:0008584; GO:0009791; GO:0009952; GO:0009986; GO:0010468; GO:0010628; GO:0010717; GO:0010718; GO:0016020; GO:0030199; GO:0030307; GO:0030335; GO:0030336; GO:0031396; GO:0031625; GO:0032331; GO:0032924; GO:0035556; GO:0036446; GO:0042118; GO:0043065; GO:0043066; GO:0043542; GO:0045121; GO:0045893; GO:0046332; GO:0046847; GO:0046872; GO:0048538; GO:0048663; GO:0048701; GO:0048705; GO:0048762; GO:0048844; GO:0050431; GO:0051491; GO:0051496; GO:0051897; GO:0060017; GO:0060021; GO:0060037; GO:0060043; GO:0060317; GO:0060391; GO:0060395; GO:0060412; GO:0060978; GO:0060982; GO:0061450; GO:0070021; GO:0070411; GO:0070723; GO:0071560; GO:1901203; GO:1902462; GO:1904018; GO:1905007; GO:1905075; GO:1905223; GO:2001235; GO:2001237,activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; SMAD protein signal transduction [GO:0060395]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; trophoblast cell migration [GO:0061450]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],bicellular tight junction [GO:0005923]; caveola [GO:0005901]; cell surface [GO:0009986]; cilium [GO:0005929]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transforming growth factor beta ligand-receptor complex [GO:0070021],"ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005634; GO:0005654; GO:0005768; GO:0005886; GO:0005929; GO:0006355; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; nucleoplasm; endosome; plasma membrane; cilium; regulation of DNA-templated transcription; programmed cell death; transferase activity; reproductive process; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_04196,FUN_016722-T1,Peve_00014668,Pocillopora_meandrina_HIv1___RNAseq.g227.t1,three_way,81.29,FUN_016722-T1,P48630,,,,,50.0,372.0,8.000000000000002e-104,378.6,"sp|P48630|FD6E1_SOYBN Omega-6 fatty acid desaturase, endoplasmic reticulum isozyme 1 OS=Glycine max OX=3847 GN=FAD2-1 PE=2 SV=1",,,,,,
OG_04197,FUN_016724-T1,Peve_00014678,Pocillopora_meandrina_HIv1___RNAseq.g232.t1,three_way,75.45816666666667,,,,,,,,,,,,,,,,,
OG_04198,FUN_016725-T1,Peve_00014679,Pocillopora_meandrina_HIv1___RNAseq.g233.t1,three_way,87.47433333333333,FUN_016725-T1,Q5FWL3,,,,,62.7,324.0,7.7e-119,428.3,sp|Q5FWL3|RNF41_XENLA E3 ubiquitin-protein ligase NRDP1 OS=Xenopus laevis OX=8355 GN=rnf41 PE=2 SV=1,,,,,,
OG_04199,FUN_016732-T1,Peve_00014684,Pocillopora_meandrina_HIv1___RNAseq.g234.t1,three_way,56.1385,,,,,,,,,,,,,,,,,
OG_04200,FUN_016733-T1,Peve_00014686,Pocillopora_meandrina_HIv1___RNAseq.g235.t1,three_way,72.43933333333334,,,,,,,,,,,,,,,,,
OG_04201,FUN_016741-T1,Peve_00007364,Pocillopora_meandrina_HIv1___RNAseq.g236.t1,three_way,66.80833333333334,FUN_016741-T1,P84039,,,,,45.1,401.0,6.4e-103,375.9,sp|P84039|ENPP5_RAT Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Rattus norvegicus OX=10116 GN=Enpp5 PE=1 SV=2,,,,,,
OG_04202,FUN_016744-T1,Peve_00025013,Pocillopora_meandrina_HIv1___RNAseq.g9954.t1,three_way,80.80783333333333,FUN_016744-T1,Q9P2K3,RCOR3_HUMAN,,REST corepressor 3,Homo sapiens (Human),45.4,443.0,7.8e-93,342.8,sp|Q9P2K3|RCOR3_HUMAN REST corepressor 3 OS=Homo sapiens OX=9606 GN=RCOR3 PE=1 SV=2,GO:0000118; GO:0003714; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0045892,negative regulation of DNA-templated transcription [GO:0045892]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],transcription corepressor activity [GO:0003714],GO:0005654; GO:0005829; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; cytosol; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_04203,FUN_016745-T1,Peve_00028266,Pocillopora_meandrina_HIv1___RNAseq.g9953.t2,three_way,74.95666666666666,FUN_016745-T1,Q2T9V8,DTD1_BOVIN,,D-aminoacyl-tRNA deacylase 1 (DTD) (EC 3.1.1.96) (DNA-unwinding element-binding protein B) (DUE-B) (Gly-tRNA(Ala) deacylase),Bos taurus (Bovine),69.6,148.0,2.6e-56,219.9,sp|Q2T9V8|DTD1_BOVIN D-aminoacyl-tRNA deacylase 1 OS=Bos taurus OX=9913 GN=DTD1 PE=2 SV=1,GO:0000049; GO:0003677; GO:0005634; GO:0005737; GO:0006260; GO:0006399; GO:0046872; GO:0051500,DNA replication [GO:0006260]; tRNA metabolic process [GO:0006399],cytoplasm [GO:0005737]; nucleus [GO:0005634],D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0006260; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; DNA replication; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_04204,FUN_016759-T1,Peve_00003676,Pocillopora_meandrina_HIv1___RNAseq.g14956.t1,three_way,68.49566666666666,FUN_016759-T1,Q2QUN2,,,,,25.6,629.0,2.7e-41,172.6,sp|Q2QUN2|LAC24_ORYSJ Laccase-24 OS=Oryza sativa subsp. japonica OX=39947 GN=LAC24 PE=2 SV=1,,,,,,
OG_04205,FUN_016777-T1,Peve_00032303,Pocillopora_meandrina_HIv1___RNAseq.g10047.t1,three_way,85.97500000000001,FUN_016777-T1,Q86SR1,GLT10_HUMAN,,Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10),Homo sapiens (Human),41.8,584.0,1.1e-123,445.3,sp|Q86SR1|GLT10_HUMAN Polypeptide N-acetylgalactosaminyltransferase 10 OS=Homo sapiens OX=9606 GN=GALNT10 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04206,FUN_016778-T1,Peve_00032302,Pocillopora_meandrina_HIv1___RNAseq.g10030.t1,three_way,69.55216666666666,FUN_016778-T1,Q5TYQ8,,,,,28.0,640.0,5.1e-21,104.4,sp|Q5TYQ8|ZC3HE_DANRE Zinc finger CCCH domain-containing protein 14 OS=Danio rerio OX=7955 GN=zc3h14 PE=2 SV=1,,,,,,
OG_04207,FUN_016779-T1,Peve_00032301,Pocillopora_meandrina_HIv1___RNAseq.g10031.t1,three_way,80.821,FUN_016779-T1,Q8BTW9,PAK4_MOUSE,,Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4),Mus musculus (Mouse),45.4,597.0,1.4e-119,431.4,sp|Q8BTW9|PAK4_MOUSE Serine/threonine-protein kinase PAK 4 OS=Mus musculus OX=10090 GN=Pak4 PE=1 SV=1,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0006915; GO:0045766; GO:0060996; GO:0106310; GO:2000352,apoptotic process [GO:0006915]; dendritic spine development [GO:0060996]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766],cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0012501; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; programmed cell death; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04208,FUN_016787-T2,Peve_00032299,Pocillopora_meandrina_HIv1___RNAseq.g10046.t2,three_way,57.35933333333333,,,,,,,,,,,,,,,,,
OG_04209,FUN_016791-T1,Peve_00032297,Pocillopora_meandrina_HIv1___RNAseq.g10045.t1,three_way,78.91866666666667,FUN_016791-T1,Q65X23,,,,,26.7,292.0,1.5e-14,83.6,sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica OX=39947 GN=WNK2 PE=2 SV=1,,,,,,
OG_04210,FUN_016797-T1,Peve_00018601,Pocillopora_meandrina_HIv1___RNAseq.g241.t1,three_way,81.34166666666667,FUN_016797-T1,Q8TF09,DLRB2_HUMAN,,"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2)",Homo sapiens (Human),58.7,92.0,3.599999999999999e-24,112.8,sp|Q8TF09|DLRB2_HUMAN Dynein light chain roadblock-type 2 OS=Homo sapiens OX=9606 GN=DYNLRB2 PE=1 SV=1,GO:0003777; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005929; GO:0007018; GO:0045505; GO:0097542,microtubule-based movement [GO:0007018],centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874],dynein intermediate chain binding [GO:0045505]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0005929; GO:0007018; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cilium; microtubule-based movement; isomerase activity; organelle; ATP-dependent activity
OG_04211,FUN_016798-T1,Peve_00023973,Pocillopora_meandrina_HIv1___RNAseq.g242.t1,three_way,87.46816666666666,FUN_016798-T1,Q9Y2E4,,,,,56.7,1558.0,0.0,1701.0,sp|Q9Y2E4|DIP2C_HUMAN Disco-interacting protein 2 homolog C OS=Homo sapiens OX=9606 GN=DIP2C PE=1 SV=2,,,,,,
OG_04212,FUN_016801-T1,Peve_00018618,Pocillopora_meandrina_HIv1___RNAseq.g243.t1,three_way,58.68683333333333,FUN_016801-T1,Q7Z5N4,SDK1_HUMAN,,Protein sidekick-1,Homo sapiens (Human),25.9,942.0,8.3e-57,224.2,sp|Q7Z5N4|SDK1_HUMAN Protein sidekick-1 OS=Homo sapiens OX=9606 GN=SDK1 PE=1 SV=3,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998,behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_04213,FUN_016850-T1,Peve_00018595,Pocillopora_meandrina_HIv1___RNAseq.g15658.t1,three_way,64.21766666666667,,,,,,,,,,,,,,,,,
OG_04214,FUN_016851-T1,Peve_00020504,Pocillopora_meandrina_HIv1___RNAseq.g9942.t1,three_way,81.00866666666666,FUN_016851-T1,D3YVL2,CFA70_MOUSE,,Cilia- and flagella-associated protein 70 (Tetratricopeptide repeat protein 18) (TPR repeat protein 18),Mus musculus (Mouse),42.5,1149.0,6.8e-239,828.9,sp|D3YVL2|CFA70_MOUSE Cilia- and flagella-associated protein 70 OS=Mus musculus OX=10090 GN=Cfap70 PE=1 SV=2,GO:0000902; GO:0002177; GO:0003341; GO:0005737; GO:0005930; GO:0007338; GO:0008104; GO:0010467; GO:0030317; GO:0031514; GO:0036126; GO:0036157; GO:0044782; GO:0048872; GO:0060271; GO:0065003; GO:0098727; GO:0120316; GO:1905198,cell morphogenesis [GO:0000902]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; gene expression [GO:0010467]; homeostasis of number of cells [GO:0048872]; maintenance of cell number [GO:0098727]; manchette assembly [GO:1905198]; protein localization [GO:0008104]; protein-containing complex assembly [GO:0065003]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316],axoneme [GO:0005930]; cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0065003,cilium; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility; protein-containing complex assembly
OG_04215,FUN_016868-T1,Peve_00020503,Pocillopora_meandrina_HIv1___RNAseq.g9928.t1,three_way,70.04816666666666,FUN_016868-T1,Q9P2K8,E2AK4_HUMAN,,eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein),Homo sapiens (Human),38.7,1721.0,1.3999999999999998e-256,888.3,sp|Q9P2K8|E2AK4_HUMAN eIF-2-alpha kinase GCN2 OS=Homo sapiens OX=9606 GN=EIF2AK4 PE=1 SV=3,GO:0000049; GO:0000077; GO:0002230; GO:0002250; GO:0002286; GO:0002821; GO:0004674; GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006446; GO:0006468; GO:0007612; GO:0007616; GO:0010998; GO:0019081; GO:0022626; GO:0032057; GO:0032792; GO:0034198; GO:0034644; GO:0044828; GO:0045665; GO:0045947; GO:0046777; GO:0051607; GO:0060259; GO:0070417; GO:0071264; GO:0106310; GO:0140469; GO:1900273; GO:1990138,adaptive immune response [GO:0002250]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; GCN2-mediated signaling [GO:0140469]; learning [GO:0007612]; long-term memory [GO:0007616]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of CREB transcription factor activity [GO:0032792]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translational initiation [GO:0045947]; negative regulation of translational initiation in response to stress [GO:0032057]; neuron projection extension [GO:1990138]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of translational initiation in response to starvation [GO:0071264]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of feeding behavior [GO:0060259]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; T cell activation involved in immune response [GO:0002286]; viral translation [GO:0019081],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634],ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tRNA binding [GO:0000049],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0005840; GO:0006355; GO:0016740; GO:0043226; GO:0050877; GO:0140096,"immune system process; RNA binding; catalytic activity; nucleus; cytosol; ribosome; regulation of DNA-templated transcription; transferase activity; organelle; nervous system process; catalytic activity, acting on a protein"
OG_04216,FUN_016963-T1,Peve_00025249,Pocillopora_meandrina_HIv1___RNAseq.g9910.t1,three_way,65.054,,,,,,,,,,,,,,,,,
OG_04217,FUN_016964-T1,Peve_00025247,Pocillopora_meandrina_HIv1___RNAseq.g9909.t1,three_way,65.26533333333333,FUN_016964-T1,P24540,,,,,60.2,98.0,9.2e-26,117.5,sp|P24540|ACYP1_PIG Acylphosphatase-1 OS=Sus scrofa OX=9823 GN=ACYP1 PE=1 SV=2,,,,,,
OG_04218,FUN_016968-T1,Peve_00025295,Pocillopora_meandrina_HIv1___RNAseq.g9906.t1,three_way,69.24583333333334,FUN_016968-T1,O13046,,,,,38.1,1161.0,8.099999999999999e-200,699.1,sp|O13046|WDHD1_XENLA WD repeat and HMG-box DNA-binding protein 1 OS=Xenopus laevis OX=8355 GN=wdhd1 PE=1 SV=1,,,,,,
OG_04219,FUN_016970-T1,Peve_00025293,Pocillopora_meandrina_HIv1___RNAseq.g9903.t2,three_way,56.20816666666666,,,,,,,,,,,,,,,,,
OG_04220,FUN_016979-T1,Peve_00025290,Pocillopora_meandrina_HIv1___RNAseq.g9902.t2,three_way,75.31333333333333,FUN_016979-T1,G3UYX5,,,,,20.5,1227.0,1.4e-16,90.5,sp|G3UYX5|RGS22_MOUSE Regulator of G-protein signaling 22 OS=Mus musculus OX=10090 GN=Rgs22 PE=1 SV=1,,,,,,
OG_04221,FUN_016981-T1,Peve_00025289,Pocillopora_meandrina_HIv1___RNAseq.g9901.t1,three_way,58.73716666666667,FUN_016981-T1,P70585,,,,,28.4,278.0,1.3e-21,105.9,sp|P70585|GPR19_RAT Probable G-protein coupled receptor 19 OS=Rattus norvegicus OX=10116 GN=Gpr19 PE=2 SV=2,,,,,,
OG_04222,FUN_016983-T1,Peve_00025280,Pocillopora_meandrina_HIv1___RNAseq.g9900.t1,three_way,72.02816666666666,FUN_016983-T1,Q9P203,,,,,37.0,667.0,2.6e-109,397.9,sp|Q9P203|BTBD7_HUMAN BTB/POZ domain-containing protein 7 OS=Homo sapiens OX=9606 GN=BTBD7 PE=1 SV=3,,,,,,
OG_04223,FUN_016984-T1,Peve_00025278,Pocillopora_meandrina_HIv1___TS.g23429.t1,three_way,66.937,FUN_016984-T1,Q96GW7,,,,,31.6,133.0,2.6e-11,71.6,sp|Q96GW7|PGCB_HUMAN Brevican core protein OS=Homo sapiens OX=9606 GN=BCAN PE=1 SV=2,,,,,,
OG_04224,FUN_016988-T1,Peve_00025276,Pocillopora_meandrina_HIv1___RNAseq.g9895.t1,three_way,70.32283333333334,FUN_016988-T1,Q8CJ69,BMPER_MOUSE,,BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (mCV2),Mus musculus (Mouse),37.7,446.0,2.6e-92,340.9,sp|Q8CJ69|BMPER_MOUSE BMP-binding endothelial regulator protein OS=Mus musculus OX=10090 GN=Bmper PE=1 SV=1,GO:0001657; GO:0002043; GO:0005576; GO:0005615; GO:0010594; GO:0030509; GO:0030514; GO:0032880; GO:0042118; GO:0048839; GO:0060391; GO:0060395; GO:0062023; GO:0070374; GO:1903672,blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization [GO:0032880]; SMAD protein signal transduction [GO:0060395]; ureteric bud development [GO:0001657],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615],,GO:0005576; GO:0005615; GO:0048856,extracellular region; extracellular space; anatomical structure development
OG_04225,FUN_016992-T1,Peve_00025272,Pocillopora_meandrina_HIv1___RNAseq.g9893.t1,three_way,59.312333333333335,FUN_016992-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),28.0,318.0,1.2999999999999998e-24,115.5,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_04226,FUN_017004-T1,Peve_00025258,Pocillopora_meandrina_HIv1___RNAseq.g9892.t1,three_way,79.81666666666666,FUN_017004-T1,Q9TTF0,,,,,43.8,393.0,4.0000000000000004e-82,306.6,sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2,,,,,,
OG_04227,FUN_017022-T1,Peve_00018298,Pocillopora_meandrina_HIv1___RNAseq.g20360.t1,three_way,58.69716666666667,FUN_017022-T1,Q8BV79,,,,,28.2,2731.0,2.9e-254,881.7,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_04228,FUN_017222-T1,Peve_00030970,Pocillopora_meandrina_HIv1___RNAseq.g6117.t1,three_way,82.93966666666667,,,,,,,,,,,,,,,,,
OG_04229,FUN_017639-T1,Peve_00027957,Pocillopora_meandrina_HIv1___RNAseq.g7551.t1,three_way,54.09033333333333,,,,,,,,,,,,,,,,,
OG_04230,FUN_017693-T1,Peve_00030752,Pocillopora_meandrina_HIv1___RNAseq.g23495.t1,three_way,47.43216666666667,,,,,,,,,,,,,,,,,
OG_04231,FUN_017708-T1,Peve_00026625,Pocillopora_meandrina_HIv1___RNAseq.g24801.t1,three_way,60.646,FUN_017708-T1,P0DXC0,,,,,51.6,337.0,7.8e-93,342.0,sp|P0DXC0|CGLR3_STYPI Cyclic GMP-AMP synthase-like receptor 3 OS=Stylophora pistillata OX=50429 PE=1 SV=1,,,,,,
OG_04232,FUN_017709-T1,Peve_00022746,Pocillopora_meandrina_HIv1___RNAseq.g19535.t1,three_way,68.68633333333334,FUN_017709-T1,Q12931,TRAP1_HUMAN,,"Heat shock protein 75 kDa, mitochondrial (HSP 75) (Heat shock protein family C member 5) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)",Homo sapiens (Human),50.5,661.0,7.7999999999999985e-177,622.1,"sp|Q12931|TRAP1_HUMAN Heat shock protein 75 kDa, mitochondrial OS=Homo sapiens OX=9606 GN=TRAP1 PE=1 SV=3",GO:0003723; GO:0005164; GO:0005524; GO:0005654; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0006457; GO:0009386; GO:0016020; GO:0016887; GO:0019901; GO:0051082; GO:0061077; GO:0140662; GO:1901856; GO:1903427; GO:1903751,chaperone-mediated protein folding [GO:0061077]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; protein folding [GO:0006457]; translational attenuation [GO:0009386],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; tumor necrosis factor receptor binding [GO:0005164]; unfolded protein binding [GO:0051082],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0140657,RNA binding; catalytic activity; nucleoplasm; mitochondrion; protein folding; hydrolase activity; organelle; protein folding chaperone; ATP-dependent activity
OG_04233,FUN_017710-T1,Peve_00005948,Pocillopora_meandrina_HIv1___RNAseq.g25375.t1,three_way,60.20766666666667,FUN_017710-T1,P0DXC0,,,,,43.8,336.0,8.8e-67,256.5,sp|P0DXC0|CGLR3_STYPI Cyclic GMP-AMP synthase-like receptor 3 OS=Stylophora pistillata OX=50429 PE=1 SV=1,,,,,,
OG_04234,FUN_017711-T1,Peve_00005949,Pocillopora_meandrina_HIv1___RNAseq.g25376.t1,three_way,94.96333333333334,FUN_017711-T1,Q2HJH0,,,,,87.2,86.0,3e-37,155.6,sp|Q2HJH0|LSM5_BOVIN U6 snRNA-associated Sm-like protein LSm5 OS=Bos taurus OX=9913 GN=LSM5 PE=3 SV=3,,,,,,
OG_04235,FUN_017756-T1,Peve_00030017,Pocillopora_meandrina_HIv1___RNAseq.g15152.t1,three_way,86.29766666666667,FUN_017756-T1,Q3ZBG9,,,,,63.9,233.0,3.8e-92,339.3,sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1,,,,,,
OG_04236,FUN_017757-T1,Peve_00033745,Pocillopora_meandrina_HIv1___RNAseq.g426.t1,three_way,66.6565,FUN_017757-T1,Q5SS90,,,,,34.7,245.0,5.6e-26,119.8,sp|Q5SS90|CG057_MOUSE Uncharacterized protein C7orf57 homolog OS=Mus musculus OX=10090 GN=Gm11992 PE=1 SV=1,,,,,,
OG_04237,FUN_017758-T1,Peve_00040794,Pocillopora_meandrina_HIv1___RNAseq.g432.t3,three_way,65.21266666666666,FUN_017758-T1,Q9I8C7,,,,,33.0,485.0,1e-67,259.2,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_04238,FUN_017759-T1,Peve_00023800,Pocillopora_meandrina_HIv1___RNAseq.g438.t1,three_way,59.74,FUN_017759-T1,Q63207,FA10_RAT,,Coagulation factor X (EC 3.4.21.6) (Stuart factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain],Rattus norvegicus (Rat),39.7,242.0,1.1e-44,184.1,sp|Q63207|FA10_RAT Coagulation factor X OS=Rattus norvegicus OX=10116 GN=F10 PE=1 SV=1,GO:0004252; GO:0005509; GO:0005543; GO:0005615; GO:0006508; GO:0007596; GO:0032008,blood coagulation [GO:0007596]; positive regulation of TOR signaling [GO:0032008]; proteolysis [GO:0006508],extracellular space [GO:0005615],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005615; GO:0008289; GO:0016787; GO:0140096,"catalytic activity; extracellular space; lipid binding; hydrolase activity; catalytic activity, acting on a protein"
OG_04239,FUN_017760-T1,Peve_00037315,Pocillopora_meandrina_HIv1___RNAseq.g439.t1,three_way,80.33866666666667,,,,,,,,,,,,,,,,,
OG_04240,FUN_017761-T1,Peve_00003284,Pocillopora_meandrina_HIv1___RNAseq.g440.t1,three_way,66.74333333333334,FUN_017761-T1,Q8C1A9,,,,,42.5,457.0,1.5e-98,361.3,sp|Q8C1A9|ABD18_MOUSE Protein ABHD18 OS=Mus musculus OX=10090 GN=Abhd18 PE=2 SV=1,,,,,,
OG_04241,FUN_017762-T1,Peve_00003285,Pocillopora_meandrina_HIv1___RNAseq.g441.t1,three_way,80.27833333333334,FUN_017762-T1,Q8BPM2,,,,,46.1,857.0,7.6e-203,708.8,sp|Q8BPM2|M4K5_MOUSE Mitogen-activated protein kinase kinase kinase kinase 5 OS=Mus musculus OX=10090 GN=Map4k5 PE=1 SV=2,,,,,,
OG_04242,FUN_017764-T1,Peve_00027372,Pocillopora_meandrina_HIv1___RNAseq.g445.t1,three_way,65.001,FUN_017764-T1,Q6L8Q7,PDE12_HUMAN,,"2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)",Homo sapiens (Human),42.1,589.0,1.3e-113,411.8,"sp|Q6L8Q7|PDE12_HUMAN 2',5'-phosphodiesterase 12 OS=Homo sapiens OX=9606 GN=PDE12 PE=1 SV=2",GO:0000175; GO:0000288; GO:0000958; GO:0004527; GO:0004535; GO:0005739; GO:0005759; GO:0005829; GO:0006397; GO:0034611; GO:0035457; GO:0044528; GO:0045070; GO:0046872; GO:0051607; GO:0071346; GO:0071359; GO:0090304; GO:0140374,"antiviral innate immune response [GO:0140374]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to type II interferon [GO:0071346]; defense response to virus [GO:0051607]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nucleic acid metabolic process [GO:0090304]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528]",cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],3'-5'-RNA exonuclease activity [GO:0000175]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; oligoribonucleotidase activity [GO:0034611]; poly(A)-specific ribonuclease activity [GO:0004535],GO:0002376; GO:0003824; GO:0005739; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0098542; GO:0140098,"immune system process; catalytic activity; mitochondrion; cytosol; mRNA metabolic process; hydrolase activity; organelle; defense response to other organism; catalytic activity, acting on RNA"
OG_04243,FUN_017765-T1,Peve_00003282,Pocillopora_meandrina_HIv1___RNAseq.g446.t1,three_way,79.75516666666667,FUN_017765-T1,Q5RD44,B3A2_PONAB,,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Solute carrier family 4 member 2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),43.1,1043.0,1.9e-207,724.5,sp|Q5RD44|B3A2_PONAB Anion exchange protein 2 OS=Pongo abelii OX=9601 GN=SLC4A2 PE=2 SV=2,GO:0016323; GO:0016324; GO:0030316; GO:0032956; GO:0043377; GO:0045124; GO:0051453; GO:0140900; GO:2000565,"negative regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043377]; negative regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000565]; osteoclast differentiation [GO:0030316]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of bone resorption [GO:0045124]; regulation of intracellular pH [GO:0051453]",apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323],chloride:bicarbonate antiporter activity [GO:0140900],GO:0005215; GO:0030154,transporter activity; cell differentiation
OG_04244,FUN_017766-T1,Peve_00035953,Pocillopora_meandrina_HIv1___RNAseq.g462.t1,three_way,86.78283333333333,FUN_017766-T1,P19517,,,,,56.8,405.0,1.8e-114,414.5,sp|P19517|CACB1_RABIT Voltage-dependent L-type calcium channel subunit beta-1 OS=Oryctolagus cuniculus OX=9986 GN=CACNB1 PE=1 SV=1,,,,,,
OG_04245,FUN_017767-T1,Peve_00014745,Pocillopora_meandrina_HIv1___RNAseq.g460.t1,three_way,69.89833333333333,,,,,,,,,,,,,,,,,
OG_04246,FUN_017768-T1,Peve_00008289,Pocillopora_meandrina_HIv1___RNAseq.g461.t1,three_way,94.55683333333332,FUN_017768-T1,P51665,PSMD7_HUMAN,,26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40),Homo sapiens (Human),79.5,273.0,5.9999999999999985e-127,455.3,sp|P51665|PSMD7_HUMAN 26S proteasome non-ATPase regulatory subunit 7 OS=Homo sapiens OX=9606 GN=PSMD7 PE=1 SV=2,GO:0000502; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0005838; GO:0016020; GO:0034774; GO:0042803; GO:0043161; GO:0070062; GO:1904813,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774],protein homodimerization activity [GO:0042803],GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,extracellular region; nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_04247,FUN_017773-T1,Peve_00016058,Pocillopora_meandrina_HIv1___RNAseq.g448.t1,three_way,76.1215,FUN_017773-T1,P48746,,,,,41.1,915.0,2.4e-182,641.0,sp|P48746|B3A2_RABIT Anion exchange protein 2 OS=Oryctolagus cuniculus OX=9986 GN=SLC4A2 PE=1 SV=1,,,,,,
OG_04248,FUN_017774-T1,Peve_00006871,Pocillopora_meandrina_HIv1___TS.g7223.t1,three_way,82.89733333333334,FUN_017774-T1,O14653,,,,,52.1,213.0,7.2e-57,221.9,sp|O14653|GOSR2_HUMAN Golgi SNAP receptor complex member 2 OS=Homo sapiens OX=9606 GN=GOSR2 PE=1 SV=2,,,,,,
OG_04249,FUN_017777-T1,Peve_00006865,Pocillopora_meandrina_HIv1___RNAseq.g9511.t1,three_way,83.44666666666667,FUN_017777-T1,Q6IMK3,,,,,38.7,168.0,6.9e-33,142.1,sp|Q6IMK3|DJC27_DANRE DnaJ homolog subfamily C member 27 OS=Danio rerio OX=7955 GN=dnajc27 PE=2 SV=1,,,,,,
OG_04250,FUN_017780-T1,Peve_00029909,Pocillopora_meandrina_HIv1___RNAseq.g9514.t1,three_way,48.56066666666667,,,,,,,,,,,,,,,,,
OG_04251,FUN_017781-T1,Peve_00029908,Pocillopora_meandrina_HIv1___RNAseq.g9515.t1,three_way,87.17483333333334,FUN_017781-T1,P63017,HSP7C_MOUSE,,Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8),Mus musculus (Mouse),79.9,646.0,5.9e-296,1017.7,sp|P63017|HSP7C_MOUSE Heat shock cognate 71 kDa protein OS=Mus musculus OX=10090 GN=Hspa8 PE=1 SV=1,GO:0000082; GO:0000398; GO:0000974; GO:0001786; GO:0001822; GO:0001916; GO:0001917; GO:0003723; GO:0005524; GO:0005634; GO:0005681; GO:0005730; GO:0005737; GO:0005765; GO:0005770; GO:0005776; GO:0005829; GO:0005874; GO:0005882; GO:0006457; GO:0006606; GO:0007519; GO:0008021; GO:0009410; GO:0009986; GO:0010045; GO:0010667; GO:0014069; GO:0014823; GO:0016887; GO:0019899; GO:0021549; GO:0030674; GO:0030900; GO:0031686; GO:0031906; GO:0032355; GO:0032570; GO:0032984; GO:0034605; GO:0042026; GO:0042277; GO:0042470; GO:0042594; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0043209; GO:0043531; GO:0044743; GO:0044788; GO:0044829; GO:0044849; GO:0045471; GO:0045862; GO:0045892; GO:0048026; GO:0048471; GO:0050766; GO:0051082; GO:0051085; GO:0051726; GO:0061077; GO:0061635; GO:0061684; GO:0061738; GO:0061740; GO:0070062; GO:0070301; GO:0071276; GO:0072318; GO:0097214; GO:0098684; GO:0098690; GO:0098793; GO:0098880; GO:0098978; GO:0099175; GO:0099634; GO:0140662; GO:1904592; GO:1904593; GO:1904764; GO:1990832; GO:1990833; GO:1990834; GO:1990836; GO:1990904,"cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cerebellum development [GO:0021549]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; chaperone-mediated protein folding [GO:0061077]; clathrin coat disassembly [GO:0072318]; estrous cycle [GO:0044849]; forebrain development [GO:0030900]; G1/S transition of mitotic cell cycle [GO:0000082]; kidney development [GO:0001822]; late endosomal microautophagy [GO:0061738]; maintenance of postsynaptic specialization structure [GO:0098880]; modulation by host of viral process [GO:0044788]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of lysosomal membrane permeability [GO:0097214]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein refolding [GO:1904592]; positive regulation of proteolysis [GO:0045862]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein folding [GO:0006457]; protein import into nucleus [GO:0006606]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; protein transmembrane import into intracellular organelle [GO:0044743]; protein-containing complex disassembly [GO:0032984]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of protein complex stability [GO:0061635]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to nickel cation [GO:0010045]; response to odorant [GO:1990834]; response to progesterone [GO:0032570]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle tissue development [GO:0007519]; slow axonal transport [GO:1990832]",autophagosome [GO:0005776]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; glycinergic synapse [GO:0098690]; intermediate filament [GO:0005882]; late endosome [GO:0005770]; late endosome lumen [GO:0031906]; lysosomal matrix [GO:1990836]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; postsynaptic density [GO:0014069]; postsynaptic specialization membrane [GO:0099634]; presynapse [GO:0098793]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195],A1 adenosine receptor binding [GO:0031686]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; clathrin-uncoating ATPase activity [GO:1990833]; enzyme binding [GO:0019899]; peptide binding [GO:0042277]; phosphatidylserine binding [GO:0001786]; prostaglandin binding [GO:1904593]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082],GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0005768; GO:0005773; GO:0005829; GO:0006355; GO:0006457; GO:0006886; GO:0006913; GO:0006914; GO:0007018; GO:0008289; GO:0016071; GO:0016787; GO:0022414; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0044183; GO:0048856; GO:0055085; GO:0060090; GO:0061024; GO:0140657,RNA binding; catalytic activity; nucleus; nucleolus; endosome; vacuole; cytosol; regulation of DNA-templated transcription; protein folding; intracellular protein transport; nucleocytoplasmic transport; autophagy; microtubule-based movement; lipid binding; mRNA metabolic process; hydrolase activity; reproductive process; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; protein folding chaperone; anatomical structure development; transmembrane transport; molecular adaptor activity; membrane organization; ATP-dependent activity
OG_04252,FUN_017782-T1,Peve_00029910,Pocillopora_meandrina_HIv1___TS.g23048.t1,three_way,68.84083333333334,FUN_017782-T1,P77952,,,,,33.3,129.0,1.6e-06,55.8,sp|P77952|GLSA_STRGR L-glutamine:scyllo-inosose aminotransferase OS=Streptomyces griseus OX=1911 GN=stsC PE=1 SV=1,,,,,,
OG_04253,FUN_017783-T1,Peve_00034178,Pocillopora_meandrina_HIv1___RNAseq.g9517.t1,three_way,78.19766666666666,FUN_017783-T1,F1P4W9,,,,,36.7,1737.0,0.0,1172.9,sp|F1P4W9|CFA65_CHICK Cilia- and flagella-associated protein 65 OS=Gallus gallus OX=9031 GN=CFAP65 PE=2 SV=2,,,,,,
OG_04254,FUN_017784-T1,Peve_00040540,Pocillopora_meandrina_HIv1___RNAseq.g9518.t1,three_way,64.44666666666666,FUN_017784-T1,P29351,,,,,35.2,105.0,2.7e-10,67.0,sp|P29351|PTN6_MOUSE Tyrosine-protein phosphatase non-receptor type 6 OS=Mus musculus OX=10090 GN=Ptpn6 PE=1 SV=2,,,,,,
OG_04255,FUN_017786-T1,Peve_00040532,Pocillopora_meandrina_HIv1___RNAseq.g9521.t1,three_way,78.56866666666667,FUN_017786-T1,A0A455ZMR3,,,,,31.7,322.0,3.8e-35,150.2,sp|A0A455ZMR3|PPZD_METMF 2-oxoglutarate-Fe(II) type oxidoreductase ppzD OS=Metarhizium majus (strain ARSEF 297) OX=1276143 GN=ppzD PE=1 SV=1,,,,,,
OG_04256,FUN_017787-T1,Peve_00040530,Pocillopora_meandrina_HIv1___RNAseq.g9522.t1,three_way,41.8165,FUN_017787-T1,Q5VT06,CE350_HUMAN,,Centrosome-associated protein 350 (Cep350) (Centrosome-associated protein of 350 kDa),Homo sapiens (Human),39.4,66.0,1.1e-06,56.2,sp|Q5VT06|CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens OX=9606 GN=CEP350 PE=1 SV=1,GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0008017; GO:0016020; GO:0034453; GO:0036064; GO:0043231; GO:0071539; GO:1905515,microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0043226; GO:0044782,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_04257,FUN_017788-T1,Peve_00040544,Pocillopora_meandrina_HIv1___RNAseq.g9523.t1,three_way,55.71866666666666,,,,,,,,,,,,,,,,,
OG_04258,FUN_017800-T1,Peve_00040758,Pocillopora_meandrina_HIv1___RNAseq.g9529.t1,three_way,80.79866666666666,FUN_017800-T1,Q32LC9,,,,,65.8,237.0,4e-99,362.8,sp|Q32LC9|ZN330_BOVIN Zinc finger protein 330 OS=Bos taurus OX=9913 GN=ZNF330 PE=2 SV=1,,,,,,
OG_04259,FUN_017803-T1,Peve_00040753,Pocillopora_meandrina_HIv1___RNAseq.g9532.t1,three_way,84.562,,,,,,,,,,,,,,,,,
OG_04260,FUN_017806-T1,Peve_00040748,Pocillopora_meandrina_HIv1___RNAseq.g9534.t1,three_way,60.276333333333326,FUN_017806-T1,Q5ZJH7,,,,,46.4,211.0,5.8e-50,199.9,sp|Q5ZJH7|CNPD1_CHICK Protein CNPPD1 OS=Gallus gallus OX=9031 GN=CNPPD1 PE=2 SV=1,,,,,,
OG_04261,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,54.0,767.0,3.7e-223,777.3,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_04261,FUN_017807-T1,Peve_00040756,Pocillopora_meandrina_HIv1___RNAseq.g9535.t2,three_way,73.905,FUN_017807-T1,Q80TE4,,,,,38.5,78.0,0.002,47.4,sp|Q80TE4|SI1L2_MOUSE Signal-induced proliferation-associated 1-like protein 2 OS=Mus musculus OX=10090 GN=Sipa1l2 PE=1 SV=3,,,,,,
OG_04262,FUN_017808-T1,Peve_00023910,Pocillopora_meandrina_HIv1___RNAseq.g9554.t1,three_way,86.70083333333334,FUN_017808-T1,Q8WUB8,,,,,40.8,473.0,2.2e-89,331.3,sp|Q8WUB8|PHF10_HUMAN PHD finger protein 10 OS=Homo sapiens OX=9606 GN=PHF10 PE=1 SV=3,,,,,,
OG_04263,FUN_017810-T1,Peve_00040992,Pocillopora_meandrina_HIv1___RNAseq.g9553.t2,three_way,80.04366666666667,FUN_017810-T1,P54366,,,,,85.5,55.0,3.1e-20,100.1,sp|P54366|GSC_DROME Homeobox protein goosecoid OS=Drosophila melanogaster OX=7227 GN=Gsc PE=2 SV=2,,,,,,
OG_04264,FUN_017814-T1,Peve_00006860,Pocillopora_meandrina_HIv1___RNAseq.g9542.t1,three_way,84.417,FUN_017814-T1,Q91029,WNT1_CHICK,,Protein Wnt-1,Gallus gallus (Chicken),51.2,283.0,2.4e-87,323.6,sp|Q91029|WNT1_CHICK Protein Wnt-1 OS=Gallus gallus OX=9031 GN=WNT1 PE=1 SV=3,GO:0005102; GO:0005576; GO:0006915; GO:0009953; GO:0016055; GO:0030509; GO:0031334; GO:0048263,apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; positive regulation of protein-containing complex assembly [GO:0031334]; Wnt signaling pathway [GO:0016055],extracellular region [GO:0005576],signaling receptor binding [GO:0005102],GO:0005576; GO:0012501,extracellular region; programmed cell death
OG_04265,FUN_017815-T1,Peve_00006859,Pocillopora_meandrina_HIv1___RNAseq.g9541.t1,three_way,67.37566666666666,FUN_017815-T1,P22727,WNT6_MOUSE,,Protein Wnt-6,Mus musculus (Mouse),41.3,366.0,3e-82,307.0,sp|P22727|WNT6_MOUSE Protein Wnt-6 OS=Mus musculus OX=10090 GN=Wnt6 PE=1 SV=2,GO:0001658; GO:0005102; GO:0005576; GO:0005788; GO:0007165; GO:0007267; GO:0009798; GO:0009887; GO:0009986; GO:0010628; GO:0016055; GO:0031012; GO:0042475; GO:0045893; GO:0060684; GO:0070172; GO:0072079; GO:0072080,animal organ morphogenesis [GO:0009887]; axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell signaling [GO:0007267]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule development [GO:0072080]; nephron tubule formation [GO:0072079]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],signaling receptor binding [GO:0005102],GO:0005576; GO:0006355; GO:0023052; GO:0030312; GO:0031012; GO:0048856,extracellular region; regulation of DNA-templated transcription; signaling; external encapsulating structure; extracellular matrix; anatomical structure development
OG_04266,FUN_017816-T1,Peve_00006857,Pocillopora_meandrina_HIv1___RNAseq.g9540.t1,three_way,72.20233333333334,FUN_017816-T1,Q2LMP1,WNT3A_CHICK,,Protein Wnt-3a,Gallus gallus (Chicken),41.7,314.0,2.3000000000000002e-71,270.8,sp|Q2LMP1|WNT3A_CHICK Protein Wnt-3a OS=Gallus gallus OX=9031 GN=WNT3A PE=1 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0005640; GO:0005783; GO:0005829; GO:0005886; GO:0009953; GO:0010628; GO:0010831; GO:0030182; GO:0030509; GO:0035108; GO:0040036; GO:0042472; GO:0045165; GO:0045663; GO:0045743; GO:0045944; GO:0048263; GO:0050679; GO:0060070; GO:0060173; GO:0060828; GO:0061303; GO:0090263,BMP signaling pathway [GO:0030509]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cornea development in camera-type eye [GO:0061303]; determination of dorsal identity [GO:0048263]; dorsal/ventral pattern formation [GO:0009953]; inner ear morphogenesis [GO:0042472]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0005783; GO:0005829; GO:0005886; GO:0006355; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; endoplasmic reticulum; cytosol; plasma membrane; regulation of DNA-templated transcription; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_04267,FUN_017818-T1,Peve_00033195,Pocillopora_meandrina_HIv1___RNAseq.g9537.t1,three_way,63.40233333333333,,,,,,,,,,,,,,,,,
OG_04268,FUN_017820-T1,Peve_00040747,Pocillopora_meandrina_HIv1___RNAseq.g9536.t1,three_way,81.93033333333334,,,,,,,,,,,,,,,,,
OG_04269,FUN_017827-T1,Peve_00032668,Pocillopora_meandrina_HIv1___TS.g23180.t1,three_way,68.87883333333333,FUN_017827-T1,Q6NVP8,FUT8_XENTR,,"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)",Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),41.7,434.0,3.2e-91,337.0,"sp|Q6NVP8|FUT8_XENTR Alpha-(1,6)-fucosyltransferase OS=Xenopus tropicalis OX=8364 GN=fut8 PE=2 SV=1",GO:0008424; GO:0017124; GO:0018279; GO:0032580; GO:0046368,GDP-L-fucose metabolic process [GO:0046368]; protein N-linked glycosylation via asparagine [GO:0018279],Golgi cisterna membrane [GO:0032580],glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124],GO:0003824; GO:0009101; GO:0016740; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04270,FUN_017828-T1,Peve_00032669,Pocillopora_meandrina_HIv1___RNAseq.g9643.t1,three_way,84.98966666666666,FUN_017828-T1,P52162,,,,,65.5,139.0,1.8e-38,160.6,sp|P52162|MAX_CHICK Protein max OS=Gallus gallus OX=9031 GN=MAX PE=3 SV=1,,,,,,
OG_04271,FUN_017829-T1,Peve_00029495,Pocillopora_meandrina_HIv1___RNAseq.g9642.t1,three_way,83.37966666666667,FUN_017829-T1,Q9NES8,,,,,59.1,477.0,9.1e-164,578.2,sp|Q9NES8|PPP5_CAEEL Serine/threonine-protein phosphatase 5 OS=Caenorhabditis elegans OX=6239 GN=pph-5 PE=1 SV=2,,,,,,
OG_04272,FUN_017831-T1,Peve_00029496,Pocillopora_meandrina_HIv1___TS.g23177.t1,three_way,86.089,,,,,,,,,,,,,,,,,
OG_04273,FUN_017832-T1,Peve_00009486,Pocillopora_meandrina_HIv1___RNAseq.g9637.t3,three_way,63.501,FUN_017832-T1,Q28EW0,TM87A_XENTR,,Transmembrane protein 87A (Elkin1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),53.1,388.0,5.7e-112,406.8,sp|Q28EW0|TM87A_XENTR Transmembrane protein 87A OS=Xenopus tropicalis OX=8364 GN=tmem87a PE=2 SV=1,GO:0000139; GO:0005886; GO:0032580; GO:0050976; GO:0071260,cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_04274,FUN_017833-T1,Peve_00009485,Pocillopora_meandrina_HIv1___TS.g23172.t1,three_way,56.76433333333333,FUN_017833-T1,Q9D844,,,,,33.3,192.0,2.5e-16,87.4,sp|Q9D844|DNJC4_MOUSE DnaJ homolog subfamily C member 4 OS=Mus musculus OX=10090 GN=Dnajc4 PE=2 SV=2,,,,,,
OG_04275,FUN_017834-T1,Peve_00009484,Pocillopora_meandrina_HIv1___RNAseq.g9635.t1,three_way,60.010333333333335,FUN_017834-T1,Q9H3U7,,,,,30.4,214.0,7e-14,80.9,sp|Q9H3U7|SMOC2_HUMAN SPARC-related modular calcium-binding protein 2 OS=Homo sapiens OX=9606 GN=SMOC2 PE=1 SV=2,,,,,,
OG_04276,FUN_017835-T1,Peve_00027711,Pocillopora_meandrina_HIv1___RNAseq.g9593.t1,three_way,65.258,FUN_017835-T1,E1C1L6,ENTP5_CHICK,,Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5),Gallus gallus (Chicken),47.1,380.0,1e-88,328.6,sp|E1C1L6|ENTP5_CHICK Ectonucleoside triphosphate diphosphohydrolase 5 OS=Gallus gallus OX=9031 GN=ENTPD5 PE=3 SV=1,GO:0004382; GO:0005576; GO:0005783; GO:0006011; GO:0006256; GO:0006487; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003,'de novo' post-translational protein folding [GO:0051084]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-alpha-D-glucose metabolic process [GO:0006011],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],ADP phosphatase activity [GO:0043262]; CDP phosphatase activity [GO:0036384]; GDP phosphatase activity [GO:0004382]; IDP phosphatase activity [GO:1990003]; UDP phosphatase activity [GO:0045134],GO:0003824; GO:0005576; GO:0005783; GO:0006457; GO:0009101; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; extracellular region; endoplasmic reticulum; protein folding; glycoprotein biosynthetic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04277,FUN_017837-T1,Peve_00027713,Pocillopora_meandrina_HIv1___TS.g23127.t1,three_way,42.539,,,,,,,,,,,,,,,,,
OG_04278,FUN_017839-T1,Peve_00011466,Pocillopora_meandrina_HIv1___RNAseq.g9632.t1,three_way,66.87983333333334,FUN_017839-T1,Q9BYW2,,,,,31.0,1246.0,5.6e-130,467.2,sp|Q9BYW2|SETD2_HUMAN Histone-lysine N-methyltransferase SETD2 OS=Homo sapiens OX=9606 GN=SETD2 PE=1 SV=3,,,,,,
OG_04279,FUN_017840-T1,Peve_00011468,Pocillopora_meandrina_HIv1___RNAseq.g9633.t1,three_way,76.64583333333333,FUN_017840-T1,F4JYJ3,,,,,35.1,225.0,6.599999999999998e-29,129.8,sp|F4JYJ3|SFH11_ARATH Phosphatidylinositol/phosphatidylcholine transfer protein SFH11 OS=Arabidopsis thaliana OX=3702 GN=SFH11 PE=3 SV=1,,,,,,
OG_04280,FUN_017841-T1,Peve_00016638,Pocillopora_meandrina_HIv1___RNAseq.g9589.t1,three_way,64.23916666666666,,,,,,,,,,,,,,,,,
OG_04281,FUN_017843-T1,Peve_00018632,Pocillopora_meandrina_HIv1___RNAseq.g9587.t3,three_way,50.5255,,,,,,,,,,,,,,,,,
OG_04282,FUN_017845-T1,Peve_00018633,Pocillopora_meandrina_HIv1___RNAseq.g9586.t1,three_way,63.23116666666667,,,,,,,,,,,,,,,,,
OG_04283,FUN_017846-T1,Peve_00018628,Pocillopora_meandrina_HIv1___RNAseq.g9585.t1,three_way,60.34483333333333,,,,,,,,,,,,,,,,,
OG_04284,FUN_017847-T1,Peve_00013268,Pocillopora_meandrina_HIv1___RNAseq.g9584.t1b,three_way,70.75,,,,,,,,,,,,,,,,,
OG_04285,FUN_017848-T2,Peve_00013267,Pocillopora_meandrina_HIv1___RNAseq.g9584.t1a,three_way,68.80566666666667,FUN_017848-T2,Q09328,MGT5A_HUMAN,,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]",Homo sapiens (Human),37.0,873.0,6.1e-166,586.3,"sp|Q09328|MGT5A_HUMAN Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Homo sapiens OX=9606 GN=MGAT5 PE=1 SV=1",GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1904894,positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]",GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04286,FUN_017849-T1,Peve_00013266,Pocillopora_meandrina_HIv1___RNAseq.g9583.t1,three_way,76.97,FUN_017849-T1,P57788,,,,,32.0,419.0,1.8e-52,208.4,sp|P57788|MOT4_CHICK Monocarboxylate transporter 4 OS=Gallus gallus OX=9031 GN=SLC16A3 PE=2 SV=2,,,,,,
OG_04287,FUN_017850-T1,Peve_00019991,Pocillopora_meandrina_HIv1___RNAseq.g9582.t1,three_way,53.20133333333334,FUN_017850-T1,C5FWH1,,,,,34.9,146.0,8.9e-14,79.7,sp|C5FWH1|LIS1_ARTOC Nuclear distribution protein PAC1 OS=Arthroderma otae (strain ATCC MYA-4605 / CBS 113480) OX=554155 GN=PAC1 PE=3 SV=1,,,,,,
OG_04288,FUN_017851-T1,Peve_00019990,Pocillopora_meandrina_HIv1___RNAseq.g9581.t1,three_way,70.00766666666667,FUN_017851-T1,Q9CXL1,,,,,54.8,155.0,8.7e-44,177.9,sp|Q9CXL1|TM50A_MOUSE Transmembrane protein 50A OS=Mus musculus OX=10090 GN=Tmem50a PE=1 SV=1,,,,,,
OG_04289,FUN_017852-T1,Peve_00019989,Pocillopora_meandrina_HIv1___RNAseq.g9580.t1,three_way,97.72366666666667,FUN_017852-T1,O73817,,,,,79.5,205.0,1.4e-94,347.1,sp|O73817|PSB3_ONCMY Proteasome subunit beta type-3 OS=Oncorhynchus mykiss OX=8022 GN=psmb3 PE=2 SV=1,,,,,,
OG_04290,FUN_017853-T1,Peve_00019994,Pocillopora_meandrina_HIv1___RNAseq.g9579.t1,three_way,69.11966666666667,FUN_017853-T1,Q5RCR9,CPPED_PONAB,,Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),30.1,286.0,6.6e-33,142.9,sp|Q5RCR9|CPPED_PONAB Serine/threonine-protein phosphatase CPPED1 OS=Pongo abelii OX=9601 GN=CPPED1 PE=2 SV=1,GO:0004722; GO:0005737; GO:0046872,,cytoplasm [GO:0005737],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_04291,FUN_017854-T1,Peve_00019169,Pocillopora_meandrina_HIv1___RNAseq.g20298.t1,three_way,61.41483333333333,FUN_017854-T1,P09875,UD2B1_RAT,,UDP-glucuronosyltransferase 2B1 (UDPGT 2B1) (UGT2B1) (EC 2.4.1.17) (UDPGTr-2),Rattus norvegicus (Rat),34.3,505.0,7.5e-76,286.2,sp|P09875|UD2B1_RAT UDP-glucuronosyltransferase 2B1 OS=Rattus norvegicus OX=10116 GN=Ugt2b1 PE=1 SV=1,GO:0005789; GO:0006805; GO:0008210; GO:0015020; GO:0032496; GO:0070980; GO:0071361; GO:0071378; GO:0071385; GO:0071394,biphenyl catabolic process [GO:0070980]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to growth hormone stimulus [GO:0071378]; cellular response to testosterone stimulus [GO:0071394]; estrogen metabolic process [GO:0008210]; response to lipopolysaccharide [GO:0032496]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],glucuronosyltransferase activity [GO:0015020],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_04292,FUN_017858-T1,Peve_00032944,Pocillopora_meandrina_HIv1___RNAseq.g9575.t1,three_way,75.3595,FUN_017858-T1,Q9GLM4,,,,,46.3,428.0,1.5e-111,404.8,sp|Q9GLM4|TENS1_BOVIN Tensin-1 OS=Bos taurus OX=9913 GN=TNS1 PE=2 SV=2,,,,,,
OG_04293,FUN_017859-T1,Peve_00014752,Pocillopora_meandrina_HIv1___RNAseq.g9574.t2,three_way,59.749500000000005,FUN_017859-T1,Q04205,,,,,47.0,285.0,3.1e-68,261.9,sp|Q04205|TENS1_CHICK Tensin-1 OS=Gallus gallus OX=9031 GN=TNS1 PE=1 SV=3,,,,,,
OG_04294,FUN_017860-T1,Peve_00016057,Pocillopora_meandrina_HIv1___RNAseq.g9573.t1,three_way,35.627,,,,,,,,,,,,,,,,,
OG_04295,FUN_017861-T1,Peve_00016056,Pocillopora_meandrina_HIv1___RNAseq.g9572.t1,three_way,71.73,FUN_017861-T1,Q803R5,,,,,50.6,778.0,7.900000000000001e-224,778.5,sp|Q803R5|CMTR1_DANRE Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 OS=Danio rerio OX=7955 GN=cmtr1 PE=2 SV=1,,,,,,
OG_04296,FUN_017862-T1,Peve_00016055,Pocillopora_meandrina_HIv1___RNAseq.g9571.t1,three_way,53.224,,,,,,,,,,,,,,,,,
OG_04297,FUN_017864-T1,Peve_00018760,Pocillopora_meandrina_HIv1___RNAseq.g9560.t1,three_way,71.19116666666666,FUN_017864-T1,Q9VM21,,,,,27.0,629.0,9.8e-54,213.4,sp|Q9VM21|GUDU_DROME Armadillo repeat-containing protein gudu OS=Drosophila melanogaster OX=7227 GN=gudu PE=2 SV=1,,,,,,
OG_04298,FUN_017867-T1,Peve_00020408,Pocillopora_meandrina_HIv1___RNAseq.g9557.t1,three_way,69.84466666666667,FUN_017867-T1,P80205,OTX1_MOUSE,,Homeobox protein OTX1 (Orthodenticle homolog 1),Mus musculus (Mouse),68.5,89.0,1.4e-26,121.3,sp|P80205|OTX1_MOUSE Homeobox protein OTX1 OS=Mus musculus OX=10090 GN=Otx1 PE=2 SV=1,GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0009952; GO:0022037; GO:0030900; GO:0030901; GO:0042472; GO:0048852,anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; forebrain development [GO:0030900]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_04299,FUN_017868-T1,Peve_00020409,Pocillopora_meandrina_HIv1___RNAseq.g9556.t1,three_way,92.76516666666666,FUN_017868-T1,Q6DKN2,,,,,73.3,86.0,6.7e-28,125.6,sp|Q6DKN2|OTX2B_XENLA Homeobox protein OTX2-B OS=Xenopus laevis OX=8355 GN=otx2-b PE=2 SV=1,,,,,,
OG_04300,FUN_017869-T1,Peve_00023912,Pocillopora_meandrina_HIv1___RNAseq.g9555.t1,three_way,85.59933333333333,FUN_017869-T1,P80205,OTX1_MOUSE,,Homeobox protein OTX1 (Orthodenticle homolog 1),Mus musculus (Mouse),69.2,91.0,2.4e-26,120.6,sp|P80205|OTX1_MOUSE Homeobox protein OTX1 OS=Mus musculus OX=10090 GN=Otx1 PE=2 SV=1,GO:0000978; GO:0001228; GO:0005634; GO:0006357; GO:0009952; GO:0022037; GO:0030900; GO:0030901; GO:0042472; GO:0048852,anterior/posterior pattern specification [GO:0009952]; diencephalon morphogenesis [GO:0048852]; forebrain development [GO:0030900]; inner ear morphogenesis [GO:0042472]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_04301,FUN_017873-T1,Peve_00025703,Pocillopora_meandrina_HIv1___RNAseq.g354.t1,three_way,56.943666666666665,FUN_017873-T1,Q28HT3,,,,,43.9,98.0,2e-16,87.8,sp|Q28HT3|FOXI2_XENTR Forkhead box protein I2 OS=Xenopus tropicalis OX=8364 GN=foxi2 PE=2 SV=1,,,,,,
OG_04302,FUN_017878-T1,Peve_00021114,Pocillopora_meandrina_HIv1___TS.g7116.t1,three_way,74.763,FUN_017878-T1,P97259,,,,,45.1,587.0,8.600000000000001e-145,515.4,"sp|P97259|MGT5A_CRIGR Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Cricetulus griseus OX=10029 GN=MGAT5 PE=1 SV=1",,,,,,
OG_04303,FUN_017881-T1,Peve_00001915,Pocillopora_meandrina_HIv1___RNAseq.g9851.t1,three_way,79.504,,,,,,,,,,,,,,,,,
OG_04304,FUN_017889-T1,Peve_00001917,Pocillopora_meandrina_HIv1___RNAseq.g9667.t1,three_way,53.98566666666667,FUN_017889-T1,Q90X67,,,,,33.7,184.0,1.3e-19,97.8,sp|Q90X67|SOCS3_CHICK Suppressor of cytokine signaling 3 OS=Gallus gallus OX=9031 GN=SOCS3 PE=2 SV=1,,,,,,
OG_04305,FUN_017890-T1,Peve_00019164,Pocillopora_meandrina_HIv1___RNAseq.g9666.t1,three_way,81.693,FUN_017890-T1,Q5EAB6,PMGT1_BOVIN,,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)",Bos taurus (Bovine),52.1,657.0,1.9e-201,703.7,"sp|Q5EAB6|PMGT1_BOVIN Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Bos taurus OX=9913 GN=POMGNT1 PE=2 SV=1",GO:0000139; GO:0006493; GO:0008375; GO:0016020; GO:0016266; GO:0030145; GO:0030246; GO:0047223,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi membrane [GO:0000139]; membrane [GO:0016020],"acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]",GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04306,FUN_017891-T1,Peve_00019165,Pocillopora_meandrina_HIv1___TS.g23200.t2,three_way,53.3605,,,,,,,,,,,,,,,,,
OG_04307,FUN_017893-T1,Peve_00019166,Pocillopora_meandrina_HIv1___RNAseq.g9662.t1,three_way,63.02966666666666,FUN_017893-T1,Q8WZA1,PMGT1_HUMAN,,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2) (GnT I.2)",Homo sapiens (Human),43.1,613.0,2.5e-150,533.9,"sp|Q8WZA1|PMGT1_HUMAN Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=POMGNT1 PE=1 SV=2",GO:0000139; GO:0006493; GO:0007605; GO:0008375; GO:0010467; GO:0016020; GO:0016266; GO:0021542; GO:0030145; GO:0030246; GO:0035269; GO:0042552; GO:0047223; GO:0051674; GO:0071711; GO:0150103,basement membrane organization [GO:0071711]; dentate gyrus development [GO:0021542]; gene expression [GO:0010467]; localization of cell [GO:0051674]; myelination [GO:0042552]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269]; reactive gliosis [GO:0150103]; sensory perception of sound [GO:0007605],Golgi membrane [GO:0000139]; membrane [GO:0016020],"acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]",GO:0003824; GO:0006954; GO:0009101; GO:0016740; GO:0030198; GO:0048856; GO:0050877; GO:0140096; GO:1901135,"catalytic activity; inflammatory response; glycoprotein biosynthetic process; transferase activity; extracellular matrix organization; anatomical structure development; nervous system process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04308,FUN_017896-T1,Peve_00000236,Pocillopora_meandrina_HIv1___RNAseq.g344.t1,three_way,55.95933333333333,,,,,,,,,,,,,,,,,
OG_04309,FUN_017897-T1,Peve_00000237,Pocillopora_meandrina_HIv1___RNAseq.g343.t1,three_way,80.214,FUN_017897-T1,Q6AXJ9,,,,,63.9,352.0,1.4e-126,454.1,sp|Q6AXJ9|CDKL1_DANRE Cyclin-dependent kinase-like 1 OS=Danio rerio OX=7955 GN=cdkl1 PE=2 SV=1,,,,,,
OG_04310,FUN_017898-T2,Peve_00000239,Pocillopora_meandrina_HIv1___TS.g7103.t2,three_way,74.87016666666666,FUN_017898-T2,Q14123,PDE1C_HUMAN,,"Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (EC 3.1.4.17) (Hcam3)",Homo sapiens (Human),43.9,442.0,8.6e-100,365.9,"sp|Q14123|PDE1C_HUMAN Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C OS=Homo sapiens OX=9606 GN=PDE1C PE=1 SV=1",GO:0004115; GO:0004117; GO:0005516; GO:0005764; GO:0005829; GO:0019933; GO:0043025; GO:0046872; GO:0047555; GO:0048101,cAMP-mediated signaling [GO:0019933],cytosol [GO:0005829]; lysosome [GO:0005764]; neuronal cell body [GO:0043025],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calmodulin binding [GO:0005516]; calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004117]; metal ion binding [GO:0046872]",GO:0003824; GO:0005764; GO:0005773; GO:0005829; GO:0016787; GO:0043226,catalytic activity; lysosome; vacuole; cytosol; hydrolase activity; organelle
OG_04311,FUN_017899-T1,Peve_00000241,Pocillopora_meandrina_HIv1___RNAseq.g341.t1,three_way,85.13083333333333,FUN_017899-T1,Q8ND07,,,,,40.7,477.0,4.6e-76,287.0,sp|Q8ND07|BBOF1_HUMAN Basal body-orientation factor 1 OS=Homo sapiens OX=9606 GN=BBOF1 PE=1 SV=3,,,,,,
OG_04312,FUN_017900-T1,Peve_00000242,Pocillopora_meandrina_HIv1___RNAseq.g340.t1,three_way,70.87316666666666,FUN_017900-T1,Q3ZBV1,,,,,45.4,359.0,1.3e-66,255.0,sp|Q3ZBV1|IST1_BOVIN IST1 homolog OS=Bos taurus OX=9913 GN=IST1 PE=2 SV=1,,,,,,
OG_04313,FUN_017901-T1,Peve_00000244,Pocillopora_meandrina_HIv1___RNAseq.g335.t1,three_way,71.97016666666667,FUN_017901-T1,A7J1T0,M313B_XENLA,,Mitogen-activated protein kinase kinase kinase 13-B (EC 2.7.11.25),Xenopus laevis (African clawed frog),67.4,387.0,1.3e-155,551.6,sp|A7J1T0|M313B_XENLA Mitogen-activated protein kinase kinase kinase 13-B OS=Xenopus laevis OX=8355 GN=map3k13-b PE=2 SV=1,GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0007254; GO:0016020; GO:0060255; GO:0080090; GO:0106310,JNK cascade [GO:0007254]; regulation of macromolecule metabolic process [GO:0060255]; regulation of primary metabolic process [GO:0080090],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04314,FUN_017902-T1,Peve_00025079,Pocillopora_meandrina_HIv1___RNAseq.g336.t1,three_way,54.62016666666666,FUN_017902-T1,Q9HBW9,AGRL4_HUMAN,,"Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)",Homo sapiens (Human),25.4,268.0,1.3e-09,67.8,sp|Q9HBW9|AGRL4_HUMAN Adhesion G protein-coupled receptor L4 OS=Homo sapiens OX=9606 GN=ADGRL4 PE=1 SV=3,GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0031410,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0031410; GO:0043226; GO:0060089,plasma membrane; cytoplasmic vesicle; organelle; molecular transducer activity
OG_04315,FUN_017915-T1,Peve_00017903,Pocillopora_meandrina_HIv1___RNAseq.g332.t1,three_way,82.63666666666667,FUN_017915-T1,P07814,SYEP_HUMAN,,Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)],Homo sapiens (Human),58.0,1343.0,0.0,1438.3,sp|P07814|SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens OX=9606 GN=EPRS1 PE=1 SV=5,GO:0004818; GO:0004827; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006418; GO:0006424; GO:0006433; GO:0008270; GO:0016020; GO:0017101; GO:0017148; GO:0032869; GO:0035613; GO:0042802; GO:0042803; GO:0051020; GO:0071346; GO:0097452; GO:0140212; GO:1990904,cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005829; GO:0005886; GO:0006399; GO:0006520; GO:0016874; GO:0140098,"RNA binding; catalytic activity; cytosol; plasma membrane; tRNA metabolic process; amino acid metabolic process; ligase activity; catalytic activity, acting on RNA"
OG_04316,FUN_017916-T1,Peve_00025080,Pocillopora_meandrina_HIv1___RNAseq.g333.t1,three_way,82.00933333333333,FUN_017916-T1,Q9D8U2,,,,,57.2,250.0,1.1e-70,268.1,sp|Q9D8U2|TM41A_MOUSE Transmembrane protein 41A OS=Mus musculus OX=10090 GN=Tmem41a PE=2 SV=1,,,,,,
OG_04317,FUN_017917-T1,Peve_00013070,Pocillopora_meandrina_HIv1___RNAseq.g329.t1,three_way,70.42633333333333,FUN_017917-T1,Q9DAJ5,,,,,51.1,92.0,3.9e-20,99.4,sp|Q9DAJ5|DLRB2_MOUSE Dynein light chain roadblock-type 2 OS=Mus musculus OX=10090 GN=Dynlrb2 PE=1 SV=1,,,,,,
OG_04318,FUN_017918-T1,Peve_00013068,Pocillopora_meandrina_HIv1___RNAseq.g326.t1,three_way,47.547,,,,,,,,,,,,,,,,,
OG_04319,FUN_017919-T1,Peve_00005940,Pocillopora_meandrina_HIv1___RNAseq.g312.t1,three_way,45.6825,FUN_017919-T1,O88488,PTPRQ_RAT,,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.36) (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Protein-tyrosine phosphatase receptor-type expressed by glomerular mesangial cells protein 1) (rPTP-GMC1) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q),Rattus norvegicus (Rat),26.4,1078.0,1.7e-50,203.8,sp|O88488|PTPRQ_RAT Phosphatidylinositol phosphatase PTPRQ OS=Rattus norvegicus OX=10116 GN=Ptprq PE=1 SV=1,GO:0002244; GO:0004439; GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0032421; GO:0034485; GO:0042472; GO:0043235; GO:0043813; GO:0045598; GO:0050885; GO:0050910; GO:0052629; GO:0060116; GO:0120044,detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; receptor complex [GO:0043235]; stereocilium base [GO:0120044]; stereocilium bundle [GO:0032421],"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]",GO:0003824; GO:0016787; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; hydrolase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_04320,FUN_017921-T1,Peve_00005937,Pocillopora_meandrina_HIv1___RNAseq.g311.t1,three_way,63.10266666666666,FUN_017921-T1,Q9JJN0,POLH_MOUSE,,DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein homolog),Mus musculus (Mouse),39.7,653.0,6.100000000000001e-118,426.4,sp|Q9JJN0|POLH_MOUSE DNA polymerase eta OS=Mus musculus OX=10090 GN=Polh PE=1 SV=1,GO:0000731; GO:0003684; GO:0003887; GO:0005654; GO:0005829; GO:0006260; GO:0006290; GO:0006301; GO:0008270; GO:0071494,cellular response to UV-C [GO:0071494]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; postreplication repair [GO:0006301]; pyrimidine dimer repair [GO:0006290],cytosol [GO:0005829]; nucleoplasm [GO:0005654],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0016740; GO:0140097,"DNA binding; catalytic activity; nucleoplasm; cytosol; DNA replication; DNA repair; transferase activity; catalytic activity, acting on DNA"
OG_04321,FUN_017923-T1,Peve_00015799,Pocillopora_meandrina_HIv1___TS.g7057.t1,three_way,91.55833333333334,FUN_017923-T1,P63154,,,,,71.1,682.0,3e-184,646.7,sp|P63154|CRNL1_MOUSE Crooked neck-like protein 1 OS=Mus musculus OX=10090 GN=Crnkl1 PE=1 SV=1,,,,,,
OG_04322,FUN_017924-T1,Peve_00035877,Pocillopora_meandrina_HIv1___TS.g7056.t1,three_way,80.122,FUN_017924-T1,Q1JQD7,MOCS1_BOVIN,,"Molybdenum cofactor biosynthesis protein 1 [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]",Bos taurus (Bovine),70.1,344.0,6e-142,505.4,sp|Q1JQD7|MOCS1_BOVIN Molybdenum cofactor biosynthesis protein 1 OS=Bos taurus OX=9913 GN=MOCS1 PE=2 SV=2,GO:0005525; GO:0006777; GO:0046872; GO:0051539; GO:0061798; GO:0061799,Mo-molybdopterin cofactor biosynthetic process [GO:0006777],,"4 iron, 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]",GO:0003824; GO:0016829,catalytic activity; lyase activity
OG_04323,FUN_017925-T1,Peve_00001606,Pocillopora_meandrina_HIv1___RNAseq.g289.t1,three_way,96.3535,FUN_017925-T1,P30883,,,,,94.6,443.0,1.2e-250,866.7,sp|P30883|TBB4_XENLA Tubulin beta-4 chain OS=Xenopus laevis OX=8355 GN=tubb4 PE=1 SV=1,,,,,,
OG_04324,FUN_017926-T2,Peve_00001604,Pocillopora_meandrina_HIv1___RNAseq.g288.t1,three_way,71.02733333333333,FUN_017926-T2,Q7TNC6,KI26B_MOUSE,,Kinesin-like protein KIF26B,Mus musculus (Mouse),39.8,814.0,1.3e-130,469.9,sp|Q7TNC6|KI26B_MOUSE Kinesin-like protein KIF26B OS=Mus musculus OX=10090 GN=Kif26b PE=1 SV=3,GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017; GO:0022409; GO:0030010; GO:0072092,establishment of cell polarity [GO:0030010]; microtubule-based movement [GO:0007018]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092],cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0007018; GO:0007163; GO:0008092; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule-based movement; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_04325,FUN_017927-T2,Peve_00001600,Pocillopora_meandrina_HIv1___TS.g7049.t1,three_way,73.92666666666668,FUN_017927-T2,A0A8V0ZB02,TM63B_CHICK,,Mechanosensitive cation channel TMEM63B (Transmembrane protein 63B),Gallus gallus (Chicken),39.6,700.0,1.6e-133,478.4,sp|A0A8V0ZB02|TM63B_CHICK Mechanosensitive cation channel TMEM63B OS=Gallus gallus OX=9031 GN=TMEM63B PE=3 SV=1,GO:0005227; GO:0005765; GO:0005886; GO:0007605; GO:0015629; GO:0017128; GO:0031901; GO:0036335; GO:0042756; GO:0120019; GO:0140135; GO:0140338; GO:0160069; GO:1990760,drinking behavior [GO:0042756]; intestinal stem cell homeostasis [GO:0036335]; sensory perception of sound [GO:0007605]; surfactant secretion [GO:0160069],actin cytoskeleton [GO:0015629]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],calcium-activated cation channel activity [GO:0005227]; mechanosensitive monoatomic cation channel activity [GO:0140135]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; phosphatidylcholine transfer activity [GO:0120019]; phospholipid scramblase activity [GO:0017128]; sphingomyelin transfer activity [GO:0140338],GO:0005215; GO:0005856; GO:0005886; GO:0043226; GO:0050877; GO:0060089; GO:0098772; GO:0140299,transporter activity; cytoskeleton; plasma membrane; organelle; nervous system process; molecular transducer activity; molecular function regulator activity; molecular sensor activity
OG_04326,FUN_017929-T1,Peve_00001599,Pocillopora_meandrina_HIv1___RNAseq.g283.t1,three_way,89.11483333333334,FUN_017929-T1,O75165,DJC13_HUMAN,,DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8),Homo sapiens (Human),66.3,1643.0,0.0,2240.3,sp|O75165|DJC13_HUMAN DnaJ homolog subfamily C member 13 OS=Homo sapiens OX=9606 GN=DNAJC13 PE=1 SV=5,GO:0001649; GO:0005765; GO:0005829; GO:0005886; GO:0006898; GO:0007032; GO:0010008; GO:0015031; GO:0016020; GO:0030667; GO:0031901; GO:0035577; GO:0043231; GO:0070062; GO:1902954; GO:2000641,endosome organization [GO:0007032]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667],,GO:0005829; GO:0005886; GO:0016192; GO:0030154; GO:0043226,cytosol; plasma membrane; vesicle-mediated transport; cell differentiation; organelle
OG_04327,FUN_017932-T1,Peve_00001593,Pocillopora_meandrina_HIv1___RNAseq.g393.t1,three_way,94.81666666666666,FUN_017932-T1,Q99JY9,ARP3_MOUSE,,Actin-related protein 3 (Actin-like protein 3),Mus musculus (Mouse),83.7,418.0,3.9e-216,751.9,sp|Q99JY9|ARP3_MOUSE Actin-related protein 3 OS=Mus musculus OX=10090 GN=Actr3 PE=1 SV=3,GO:0000139; GO:0001726; GO:0005200; GO:0005524; GO:0005634; GO:0005737; GO:0005884; GO:0005885; GO:0005903; GO:0005911; GO:0007163; GO:0007283; GO:0008356; GO:0010592; GO:0010763; GO:0016344; GO:0030027; GO:0030056; GO:0030517; GO:0030838; GO:0032355; GO:0033206; GO:0034314; GO:0035861; GO:0035984; GO:0043519; GO:0045666; GO:0045944; GO:0048471; GO:0048708; GO:0048711; GO:0051015; GO:0051117; GO:0051321; GO:0051491; GO:0051653; GO:0051965; GO:0060076; GO:0060271; GO:0061003; GO:0061825; GO:0061828; GO:0061830; GO:0061831; GO:0061832; GO:0061843; GO:0061851; GO:0071346; GO:0071347; GO:0071356; GO:0071364; GO:0071503; GO:0071560; GO:0090314; GO:0098794; GO:0098974; GO:0098978; GO:1903078; GO:1904171; GO:1905835; GO:1905837,Arp2/3 complex-mediated actin nucleation [GO:0034314]; astrocyte differentiation [GO:0048708]; asymmetric cell division [GO:0008356]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to pyrimidine ribonucleotide [GO:1905835]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to trichostatin A [GO:0035984]; cellular response to triterpenoid [GO:1905837]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic cell cycle [GO:0051321]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; negative regulation of axon extension [GO:0030517]; negative regulation of bleb assembly [GO:1904171]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of myosin II filament organization [GO:0043519]; response to estradiol [GO:0032355]; response to heparin [GO:0071503]; Sertoli cell barrier remodeling [GO:0061843]; spermatogenesis [GO:0007283]; spindle localization [GO:0051653],actin filament [GO:0005884]; apical ectoplasmic specialization [GO:0061831]; apical tubulobulbar complex [GO:0061828]; Arp2/3 protein complex [GO:0005885]; basal ectoplasmic specialization [GO:0061832]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; concave side of sperm head [GO:0061830]; cytoplasm [GO:0005737]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; hemidesmosome [GO:0030056]; lamellipodium [GO:0030027]; leading edge of lamellipodium [GO:0061851]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; podosome core [GO:0061825]; postsynapse [GO:0098794]; ruffle [GO:0001726]; site of double-strand break [GO:0035861],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; structural constituent of cytoskeleton [GO:0005200],GO:0000910; GO:0005198; GO:0005634; GO:0006355; GO:0007010; GO:0007018; GO:0007163; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0044782,cytokinesis; structural molecule activity; nucleus; regulation of DNA-templated transcription; cytoskeleton organization; microtubule-based movement; establishment or maintenance of cell polarity; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; cilium organization
OG_04328,FUN_017935-T1,Peve_00001592,Pocillopora_meandrina_HIv1___RNAseq.g394.t1,three_way,57.60066666666667,,,,,,,,,,,,,,,,,
OG_04329,FUN_017936-T1,Peve_00001591,Pocillopora_meandrina_HIv1___RNAseq.g395.t1,three_way,80.378,FUN_017936-T1,Q9GKS9,,,,,39.4,797.0,9.999999999999998e-128,459.1,sp|Q9GKS9|DZAN1_MACFA Double zinc ribbon and ankyrin repeat-containing protein 1 OS=Macaca fascicularis OX=9541 GN=DZANK1 PE=2 SV=3,,,,,,
OG_04330,FUN_017938-T1,Peve_00001589,Pocillopora_meandrina_HIv1___RNAseq.g218.t1,three_way,75.231,FUN_017938-T1,Q7TPM9,,,,,34.7,507.0,4.4e-71,270.8,sp|Q7TPM9|MTMRA_MOUSE Myotubularin-related protein 10 OS=Mus musculus OX=10090 GN=Mtmr10 PE=1 SV=2,,,,,,
OG_04331,FUN_017939-T1,Peve_00001588,Pocillopora_meandrina_HIv1___RNAseq.g219.t1,three_way,53.27133333333334,FUN_017939-T1,Q6P0D7,,,,,42.1,449.0,7.2e-89,330.1,sp|Q6P0D7|MPP7_DANRE MAGUK p55 subfamily member 7 OS=Danio rerio OX=7955 GN=mpp7 PE=1 SV=1,,,,,,
OG_04332,FUN_017940-T1,Peve_00001587,Pocillopora_meandrina_HIv1___RNAseq.g220.t1,three_way,56.76766666666667,,,,,,,,,,,,,,,,,
OG_04333,FUN_017941-T1,Peve_00001585,Pocillopora_meandrina_HIv1___RNAseq.g221.t1,three_way,68.06433333333334,FUN_017941-T1,Q5R5J7,,,,,35.6,331.0,2.4e-51,204.1,sp|Q5R5J7|TBCC_PONAB Tubulin-specific chaperone C OS=Pongo abelii OX=9601 GN=TBCC PE=2 SV=1,,,,,,
OG_04334,FUN_017946-T1,Peve_00001582,Pocillopora_meandrina_HIv1___TS.g6988.t2,three_way,85.60566666666666,FUN_017946-T1,A7SGZ5,,,,,70.4,216.0,1.4e-84,313.9,sp|A7SGZ5|EIF3K_NEMVE Eukaryotic translation initiation factor 3 subunit K OS=Nematostella vectensis OX=45351 GN=v1g170558 PE=3 SV=1,,,,,,
OG_04335,FUN_017947-T1,Peve_00000380,Pocillopora_meandrina_HIv1___RNAseq.g25233.t1,three_way,66.458,FUN_017947-T1,F1M0Z1,TRIO_RAT,,Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein),Rattus norvegicus (Rat),44.3,314.0,2.2e-69,265.8,sp|F1M0Z1|TRIO_RAT Triple functional domain protein OS=Rattus norvegicus OX=10116 GN=Trio PE=1 SV=4,GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310,axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170],cell projection [GO:0042995]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04336,FUN_017948-T1,Peve_00000381,Pocillopora_meandrina_HIv1___RNAseq.g25232.t1,three_way,82.87233333333333,,,,,,,,,,,,,,,,,
OG_04337,FUN_017950-T1,Peve_00000377,Pocillopora_meandrina_HIv1___RNAseq.g25230.t1,three_way,61.35916666666667,FUN_017950-T1,Q8T689,,,,,26.9,583.0,8.299999999999999e-46,188.0,sp|Q8T689|ABCG4_DICDI ABC transporter G family member 4 OS=Dictyostelium discoideum OX=44689 GN=abcG4 PE=3 SV=1,,,,,,
OG_04338,FUN_017952-T1,Peve_00001586,Pocillopora_meandrina_HIv1___RNAseq.g224.t1,three_way,96.399,FUN_017952-T1,Q7T1R4,,,,,91.5,117.0,8.8e-61,235.3,sp|Q7T1R4|FOXA2_XENTR Forkhead box protein A2 OS=Xenopus tropicalis OX=8364 GN=foxa2 PE=2 SV=1,,,,,,
OG_04339,FUN_017954-T1,Peve_00001595,Pocillopora_meandrina_HIv1___RNAseq.g225.t1,three_way,76.9835,FUN_017954-T1,A7MB54,HLX_BOVIN,,H2.0-like homeobox protein (Homeobox protein HLX1),Bos taurus (Bovine),41.2,177.0,2.1e-22,107.5,sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1,GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679,embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0002376; GO:0003677; GO:0005634; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04340,FUN_017955-T1,Peve_00000384,Pocillopora_meandrina_HIv1___RNAseq.g25234.t1,three_way,69.41033333333334,FUN_017955-T1,Q6GLK6,,,,,52.1,530.0,4.1e-155,549.7,"sp|Q6GLK6|ACSF3_XENLA Malonate--CoA ligase ACSF3, mitochondrial OS=Xenopus laevis OX=8355 GN=acsf3 PE=2 SV=1",,,,,,
OG_04341,FUN_017958-T1,Peve_00000385,Pocillopora_meandrina_HIv1___RNAseq.g25238.t1,three_way,52.00333333333333,FUN_017958-T1,Q6L9W6,B4GN3_HUMAN,,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",Homo sapiens (Human),38.5,327.0,5.7e-66,253.8,"sp|Q6L9W6|B4GN3_HUMAN Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Homo sapiens OX=9606 GN=B4GALNT3 PE=1 SV=2",GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231,,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0005794; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; transferase activity; organelle
OG_04342,FUN_017959-T1,Peve_00000387,Pocillopora_meandrina_HIv1___RNAseq.g25237.t1,three_way,74.73633333333333,FUN_017959-T1,Q9H8Y8,,,,,65.2,282.0,9e-101,368.6,sp|Q9H8Y8|GORS2_HUMAN Golgi reassembly-stacking protein 2 OS=Homo sapiens OX=9606 GN=GORASP2 PE=1 SV=3,,,,,,
OG_04343,FUN_017964-T1,Peve_00000391,Pocillopora_meandrina_HIv1___TS.g25524.t1,three_way,75.0295,FUN_017964-T1,O00409,FOXN3_HUMAN,,Forkhead box protein N3 (Checkpoint suppressor 1),Homo sapiens (Human),44.8,281.0,4.799999999999999e-53,210.3,sp|O00409|FOXN3_HUMAN Forkhead box protein N3 OS=Homo sapiens OX=9606 GN=FOXN3 PE=1 SV=1,GO:0000785; GO:0000981; GO:0000987; GO:0003700; GO:0005634; GO:0006355; GO:0007095; GO:0045892; GO:0097094,craniofacial suture morphogenesis [GO:0097094]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],chromatin [GO:0000785]; nucleus [GO:0005634],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04344,FUN_017966-T1,Peve_00000393,Pocillopora_meandrina_HIv1___RNAseq.g25246.t1,three_way,76.61133333333333,FUN_017966-T1,Q4R7Z7,,,,,40.5,365.0,4.4e-54,213.4,sp|Q4R7Z7|SPT17_MACFA Spermatogenesis-associated protein 17 OS=Macaca fascicularis OX=9541 GN=SPATA17 PE=2 SV=1,,,,,,
OG_04345,FUN_017967-T1,Peve_00000394,Pocillopora_meandrina_HIv1___RNAseq.g25247.t1,three_way,83.32000000000001,FUN_017967-T1,Q0IID7,DUS10_BOVIN,,Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48),Bos taurus (Bovine),40.2,323.0,1.2e-64,248.4,sp|Q0IID7|DUS10_BOVIN Dual specificity protein phosphatase 10 OS=Bos taurus OX=9913 GN=DUSP10 PE=2 SV=1,GO:0002819; GO:0004722; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008330; GO:0008432; GO:0010633; GO:0017017; GO:0032496; GO:0032873; GO:0033549; GO:0033550; GO:0045591; GO:0046329; GO:0048273; GO:0048709; GO:0050680; GO:0051403; GO:0060266; GO:0070373; GO:0090335; GO:1903753; GO:1905042,negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelium regeneration [GO:1905042]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; negative regulation of stress-activated MAPK cascade [GO:0032873]; oligodendrocyte differentiation [GO:0048709]; positive regulation of regulatory T cell differentiation [GO:0045591]; regulation of adaptive immune response [GO:0002819]; regulation of brown fat cell differentiation [GO:0090335]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],JUN kinase binding [GO:0008432]; MAP kinase phosphatase activity [GO:0033549]; MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0030154; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; cell differentiation; catalytic activity, acting on a protein"
OG_04346,FUN_017970-T1,Peve_00000395,Pocillopora_meandrina_HIv1___TS.g25528.t2,three_way,63.346833333333336,FUN_017970-T1,Q9VM21,,,,,33.0,624.0,2.1999999999999997e-53,212.2,sp|Q9VM21|GUDU_DROME Armadillo repeat-containing protein gudu OS=Drosophila melanogaster OX=7227 GN=gudu PE=2 SV=1,,,,,,
OG_04347,FUN_017973-T1,Peve_00026630,Pocillopora_meandrina_HIv1___RNAseq.g25290.t1,three_way,46.385,,,,,,,,,,,,,,,,,
OG_04348,FUN_017974-T1,Peve_00027236,Pocillopora_meandrina_HIv1___RNAseq.g25289.t1,three_way,57.09133333333333,,,,,,,,,,,,,,,,,
OG_04349,FUN_017985-T2,Peve_00027237,Pocillopora_meandrina_HIv1___RNAseq.g25287.t1,three_way,41.04616666666666,,,,,,,,,,,,,,,,,
OG_04350,FUN_017986-T1,Peve_00004549,Pocillopora_meandrina_HIv1___RNAseq.g25273.t2,three_way,67.53116666666666,FUN_017986-T1,Q9GZT9,,,,,54.3,208.0,4.6e-62,240.0,sp|Q9GZT9|EGLN1_HUMAN Egl nine homolog 1 OS=Homo sapiens OX=9606 GN=EGLN1 PE=1 SV=1,,,,,,
OG_04351,FUN_017990-T1,Peve_00037470,Pocillopora_meandrina_HIv1___RNAseq.g25285.t1,three_way,80.066,FUN_017990-T1,Q16665,,,,,40.2,388.0,3.2e-77,291.2,sp|Q16665|HIF1A_HUMAN Hypoxia-inducible factor 1-alpha OS=Homo sapiens OX=9606 GN=HIF1A PE=1 SV=1,,,,,,
OG_04352,FUN_017991-T1,Peve_00004551,Pocillopora_meandrina_HIv1___RNAseq.g25286.t1,three_way,75.641,FUN_017991-T1,Q2KI24,,,,,62.5,240.0,2.7e-85,316.6,sp|Q2KI24|MTHSD_BOVIN Methenyltetrahydrofolate synthase domain-containing protein OS=Bos taurus OX=9913 GN=MTHFSD PE=2 SV=1,,,,,,
OG_04353,FUN_018000-T1,Peve_00044834,Pocillopora_meandrina_HIv1___RNAseq.29588_t,three_way,55.3835,FUN_018000-T1,Q8IXF0,NPAS3_HUMAN,,Neuronal PAS domain-containing protein 3 (Neuronal PAS3) (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12) (bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6),Homo sapiens (Human),40.8,424.0,9.4e-76,287.0,sp|Q8IXF0|NPAS3_HUMAN Neuronal PAS domain-containing protein 3 OS=Homo sapiens OX=9606 GN=NPAS3 PE=1 SV=1,GO:0000785; GO:0000977; GO:0000981; GO:0005654; GO:0006357; GO:0045893; GO:0046982,positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005654; GO:0006355; GO:0140110,DNA binding; nucleoplasm; regulation of DNA-templated transcription; transcription regulator activity
OG_04354,FUN_018004-T1,Peve_00015727,Pocillopora_meandrina_HIv1___RNAseq.g25251.t1,three_way,57.72966666666667,FUN_018004-T1,Q9JI78,NGLY1_MOUSE,,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (mPNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase),Mus musculus (Mouse),41.8,509.0,2.6e-100,367.5,sp|Q9JI78|NGLY1_MOUSE Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Mus musculus OX=10090 GN=Ngly1 PE=1 SV=2,GO:0000224; GO:0005634; GO:0005737; GO:0006516; GO:0046872; GO:0062023,glycoprotein catabolic process [GO:0006516],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; nucleus [GO:0005634],metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224],GO:0003824; GO:0005634; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; nucleus; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_04355,FUN_018005-T1,Peve_00015726,Pocillopora_meandrina_HIv1___RNAseq.g25259.t1,three_way,82.79083333333334,FUN_018005-T1,A7E2Z2,,,,,48.1,736.0,9e-189,661.8,sp|A7E2Z2|EZH1_BOVIN Histone-lysine N-methyltransferase EZH1 OS=Bos taurus OX=9913 GN=EZH1 PE=2 SV=2,,,,,,
OG_04356,FUN_018006-T1,Peve_00015728,Pocillopora_meandrina_HIv1___RNAseq.g25258.t1,three_way,74.419,FUN_018006-T1,O43264,ZW10_HUMAN,,Centromere/kinetochore protein zw10 homolog,Homo sapiens (Human),38.4,787.0,2.2e-143,511.1,sp|O43264|ZW10_HUMAN Centromere/kinetochore protein zw10 homolog OS=Homo sapiens OX=9606 GN=ZW10 PE=1 SV=3,GO:0000070; GO:0000132; GO:0000776; GO:0000922; GO:0005634; GO:0005783; GO:0005789; GO:0005811; GO:0005828; GO:0005829; GO:0006888; GO:0006890; GO:0007030; GO:0007080; GO:0007094; GO:0007096; GO:0015031; GO:0016020; GO:0019237; GO:0034501; GO:0051301; GO:0051321; GO:0051988; GO:0065003; GO:0070939; GO:1990423,"cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922],centromeric DNA binding [GO:0019237],GO:0003677; GO:0005634; GO:0005783; GO:0005811; GO:0005829; GO:0007010; GO:0007059; GO:0016192; GO:0022414; GO:0043226; GO:0065003,DNA binding; nucleus; endoplasmic reticulum; lipid droplet; cytosol; cytoskeleton organization; chromosome segregation; vesicle-mediated transport; reproductive process; organelle; protein-containing complex assembly
OG_04357,FUN_018007-T1,Peve_00015729,Pocillopora_meandrina_HIv1___RNAseq.g25257.t1,three_way,73.35633333333334,FUN_018007-T1,E7FCP8,NAGS_DANRE,,"N-acetylglutamate synthase, mitochondrial (EC 2.3.1.1) [Cleaved into: N-acetylglutamate synthase, mature form (NAGS-M); N-acetylglutamate synthase, conserved domain form (NAGS-C)]",Danio rerio (Zebrafish) (Brachydanio rerio),41.3,453.0,7.5e-89,329.3,"sp|E7FCP8|NAGS_DANRE N-acetylglutamate synthase, mitochondrial OS=Danio rerio OX=7955 GN=nags PE=1 SV=1",GO:0000050; GO:0004042; GO:0005759; GO:0006526; GO:0006536; GO:0034618,glutamate metabolic process [GO:0006536]; L-arginine biosynthetic process [GO:0006526]; urea cycle [GO:0000050],mitochondrial matrix [GO:0005759],arginine binding [GO:0034618]; L-glutamate N-acetyltransferase activity [GO:0004042],GO:0003824; GO:0006520; GO:0016740; GO:0071941,catalytic activity; amino acid metabolic process; transferase activity; nitrogen cycle metabolic process
OG_04358,FUN_018008-T1,Peve_00018955,Pocillopora_meandrina_HIv1___RNAseq.g25256.t1,three_way,90.871,FUN_018008-T1,P31327,CPSM_HUMAN,,"Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I)",Homo sapiens (Human),66.8,1481.0,0.0,2053.5,"sp|P31327|CPSM_HUMAN Carbamoyl-phosphate synthase [ammonia], mitochondrial OS=Homo sapiens OX=9606 GN=CPS1 PE=1 SV=2",GO:0000050; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0005886; GO:0006207; GO:0006541; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019240; GO:0019433; GO:0030955; GO:0032094; GO:0032496; GO:0032991; GO:0036094; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0046872; GO:0050667; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; midgut development [GO:0007494]; monoatomic anion homeostasis [GO:0055081]; nitric oxide metabolic process [GO:0046209]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; endopeptidase activity [GO:0004175]; glutamate binding [GO:0016595]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; phospholipid binding [GO:0005543]; potassium ion binding [GO:0030955]; protein-containing complex binding [GO:0044877]; small molecule binding [GO:0036094],GO:0003013; GO:0003824; GO:0005730; GO:0005739; GO:0005886; GO:0006520; GO:0006629; GO:0006790; GO:0008289; GO:0016787; GO:0016874; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0071941; GO:0140096,"circulatory system process; catalytic activity; nucleolus; mitochondrion; plasma membrane; amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; lipid binding; hydrolase activity; ligase activity; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; nitrogen cycle metabolic process; catalytic activity, acting on a protein"
OG_04359,FUN_018010-T1,Peve_00000404,Pocillopora_meandrina_HIv1___RNAseq.g25255.t4,three_way,81.14033333333334,FUN_018010-T1,A2CG49,,,,,35.3,3036.0,0.0,1707.6,sp|A2CG49|KALRN_MOUSE Kalirin OS=Mus musculus OX=10090 GN=Kalrn PE=1 SV=1,,,,,,
OG_04360,FUN_018011-T1,Peve_00000403,Pocillopora_meandrina_HIv1___RNAseq.g25254.t1,three_way,62.35866666666666,,,,,,,,,,,,,,,,,
OG_04361,FUN_018012-T1,Peve_00000401,Pocillopora_meandrina_HIv1___RNAseq.g25253.t1,three_way,51.12533333333333,,,,,,,,,,,,,,,,,
OG_04362,FUN_018013-T1,Peve_00000400,Pocillopora_meandrina_HIv1___RNAseq.g25252.t1,three_way,77.03966666666666,FUN_018013-T1,Q9JI78,NGLY1_MOUSE,,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (mPNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase),Mus musculus (Mouse),44.5,636.0,1.2e-146,521.9,sp|Q9JI78|NGLY1_MOUSE Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase OS=Mus musculus OX=10090 GN=Ngly1 PE=1 SV=2,GO:0000224; GO:0005634; GO:0005737; GO:0006516; GO:0046872; GO:0062023,glycoprotein catabolic process [GO:0006516],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; nucleus [GO:0005634],metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224],GO:0003824; GO:0005634; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; nucleus; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_04363,FUN_018014-T1,Peve_00000399,Pocillopora_meandrina_HIv1___RNAseq.g25260.t2,three_way,70.6505,FUN_018014-T1,Q5QM84,TPC1_ORYSJ,,Two pore calcium channel protein 1 (OsTPC1) (Voltage-dependent calcium channel protein TPC1),Oryza sativa subsp. japonica (Rice),24.1,439.0,2.1e-22,110.2,sp|Q5QM84|TPC1_ORYSJ Two pore calcium channel protein 1 OS=Oryza sativa subsp. japonica OX=39947 GN=TPC1 PE=1 SV=2,GO:0000325; GO:0005245; GO:0005509; GO:0005774; GO:0006816; GO:0006952; GO:0034702,calcium ion transport [GO:0006816]; defense response [GO:0006952],monoatomic ion channel complex [GO:0034702]; plant-type vacuole [GO:0000325]; vacuolar membrane [GO:0005774],calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005773; GO:0043226,transporter activity; vacuole; organelle
OG_04364,FUN_018017-T1,Peve_00026632,Pocillopora_meandrina_HIv1___RNAseq.g25291.t1,three_way,96.487,FUN_018017-T1,Q5ZHW4,RAB5B_CHICK,,Ras-related protein Rab-5B (EC 3.6.5.2),Gallus gallus (Chicken),90.2,153.0,3.8e-75,282.3,sp|Q5ZHW4|RAB5B_CHICK Ras-related protein Rab-5B OS=Gallus gallus OX=9031 GN=RAB5B PE=2 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005886; GO:0006886; GO:0006897; GO:0012505; GO:0019003; GO:0030139; GO:0031901,endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005886; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0098772,catalytic activity; GTPase activity; endosome; plasma membrane; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_04365,FUN_018018-T2,Peve_00026633,Pocillopora_meandrina_HIv1___RNAseq.g25292.t1,three_way,78.64166666666667,FUN_018018-T2,P30260,CDC27_HUMAN,,Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC),Homo sapiens (Human),51.0,843.0,4.8e-117,423.7,sp|P30260|CDC27_HUMAN Cell division cycle protein 27 homolog OS=Homo sapiens OX=9606 GN=CDC27 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005680; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0007091; GO:0007346; GO:0016567; GO:0019903; GO:0031145; GO:0031175; GO:0051301; GO:0051445; GO:0070936; GO:0070979; GO:0072686; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; neuron projection development [GO:0031175]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],protein phosphatase binding [GO:0019903],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; microtubule organizing center; cytosol; protein catabolic process; organelle
OG_04366,FUN_018019-T1,Peve_00026634,Pocillopora_meandrina_HIv1___RNAseq.29613_t,three_way,80.27433333333333,FUN_018019-T1,Q9I3S3,,,,,66.9,314.0,3.5000000000000005e-125,449.5,sp|Q9I3S3|GBUA_PSEAE Guanidinobutyrase OS=Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) OX=208964 GN=gbuA PE=1 SV=1,,,,,,
OG_04367,FUN_018023-T1,Peve_00005730,Pocillopora_meandrina_HIv1___RNAseq.g25298.t1,three_way,70.57966666666667,FUN_018023-T1,Q9WU06,AVIL_RAT,,Advillin (Peripheral nervous system villin-like protein) (Pervin),Rattus norvegicus (Rat),40.0,834.0,9e-156,552.4,sp|Q9WU06|AVIL_RAT Advillin OS=Rattus norvegicus OX=10116 GN=Avil PE=2 SV=2,GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480,actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005856; GO:0008092; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeletal protein binding; lipid binding; organelle; cilium organization; anatomical structure development
OG_04368,FUN_018026-T1,Peve_00005737,Pocillopora_meandrina_HIv1___RNAseq.g25300.t1,three_way,69.16366666666667,FUN_018026-T1,Q9Z0W3,,,,,33.6,1163.0,8.8e-181,636.0,sp|Q9Z0W3|NU160_MOUSE Nuclear pore complex protein Nup160 OS=Mus musculus OX=10090 GN=Nup160 PE=1 SV=2,,,,,,
OG_04369,FUN_018027-T1,Peve_00005736,Pocillopora_meandrina_HIv1___TS.g25576.t2,three_way,66.2555,FUN_018027-T1,A5D7P8,SOSB2_BOVIN,,SOSS complex subunit B2 (Nucleic acid-binding protein 1) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2A) (Sensor of single-strand DNA complex subunit B2) (Sensor of ssDNA subunit B2) (SOSS-B2) (Single-stranded DNA-binding protein 2),Bos taurus (Bovine),54.7,139.0,6.3e-40,166.0,sp|A5D7P8|SOSB2_BOVIN SOSS complex subunit B2 OS=Bos taurus OX=9913 GN=NABP1 PE=2 SV=1,GO:0000724; GO:0003677; GO:0010212; GO:0044818; GO:0070876,double-strand break repair via homologous recombination [GO:0000724]; mitotic G2/M transition checkpoint [GO:0044818]; response to ionizing radiation [GO:0010212],SOSS complex [GO:0070876],DNA binding [GO:0003677],GO:0003677; GO:0006281; GO:0006310,DNA binding; DNA repair; DNA recombination
OG_04370,FUN_018029-T1,Peve_00017615,Pocillopora_meandrina_HIv1___RNAseq.g25340.t1,three_way,59.88433333333333,FUN_018029-T1,Q9ULJ8,,,,,25.1,1213.0,1.4999999999999999e-40,170.2,sp|Q9ULJ8|NEB1_HUMAN Neurabin-1 OS=Homo sapiens OX=9606 GN=PPP1R9A PE=1 SV=2,,,,,,
OG_04371,FUN_018030-T1,Peve_00017616,Pocillopora_meandrina_HIv1___RNAseq.g25339.t1,three_way,71.04333333333334,FUN_018030-T1,P59054,CSRN1_MOUSE,,Cysteine/serine-rich nuclear protein 1 (CSRNP-1) (Axin-1 up-regulated gene 1 protein) (TGF-beta-induced apoptosis protein 3) (TAIP-3),Mus musculus (Mouse),35.6,222.0,4.2e-30,132.9,sp|P59054|CSRN1_MOUSE Cysteine/serine-rich nuclear protein 1 OS=Mus musculus OX=10090 GN=Csrnp1 PE=2 SV=1,GO:0001228; GO:0003700; GO:0005634; GO:0006355; GO:0006915; GO:0009791; GO:0043565; GO:0045944; GO:0048008; GO:0048705; GO:0060021; GO:0060325,apoptotic process [GO:0006915]; face morphogenesis [GO:0060325]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of DNA-templated transcription [GO:0006355]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; transcription regulator activity
OG_04372,FUN_018031-T1,Peve_00025689,Pocillopora_meandrina_HIv1___RNAseq.g25357.t1,three_way,55.23,FUN_018031-T1,O35206,COFA1_MOUSE,,Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV)],Mus musculus (Mouse),35.1,239.0,3.9999999999999994e-28,127.5,sp|O35206|COFA1_MOUSE Collagen alpha-1(XV) chain OS=Mus musculus OX=10090 GN=Col15a1 PE=1 SV=2,GO:0005581; GO:0005604; GO:0005615; GO:0005783; GO:0007155; GO:0062023,cell adhesion [GO:0007155],basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],,GO:0005615; GO:0005783; GO:0007155; GO:0030312; GO:0031012; GO:0043226,extracellular space; endoplasmic reticulum; cell adhesion; external encapsulating structure; extracellular matrix; organelle
OG_04373,FUN_018033-T1,Peve_00020008,Pocillopora_meandrina_HIv1___TS.g25636.t1,three_way,60.77283333333334,,,,,,,,,,,,,,,,,
OG_04374,FUN_018035-T2,Peve_00020009,Pocillopora_meandrina_HIv1___RNAseq.g25361.t2,three_way,68.1825,FUN_018035-T2,Q6P121,,,,,35.6,303.0,6e-37,156.8,sp|Q6P121|HYCCI_DANRE Hyccin OS=Danio rerio OX=7955 GN=hycc1 PE=2 SV=1,,,,,,
OG_04375,FUN_018040-T1,Peve_00020010,Pocillopora_meandrina_HIv1___RNAseq.g25362.t1,three_way,68.87333333333333,FUN_018040-T1,Q3TBW2,,,,,39.0,159.0,7.8e-23,108.6,sp|Q3TBW2|RM10_MOUSE Large ribosomal subunit protein uL10m OS=Mus musculus OX=10090 GN=Mrpl10 PE=1 SV=2,,,,,,
OG_04376,FUN_018042-T1,Peve_00021780,Pocillopora_meandrina_HIv1___RNAseq.g25354.t1,three_way,62.6125,FUN_018042-T1,P25931,,,,,24.0,263.0,3.1e-06,54.7,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_04377,FUN_018043-T1,Peve_00021781,Pocillopora_meandrina_HIv1___RNAseq.g25353.t1,three_way,53.90766666666666,FUN_018043-T1,C3ZQF9,,,,,28.6,318.0,6e-25,116.7,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_04378,FUN_018044-T1,Peve_00021778,Pocillopora_meandrina_HIv1___RNAseq.g25351.t1,three_way,82.307,FUN_018044-T1,Q3ZCH9,,,,,61.7,248.0,2e-88,327.0,sp|Q3ZCH9|HDHD2_BOVIN Haloacid dehalogenase-like hydrolase domain-containing protein 2 OS=Bos taurus OX=9913 GN=HDHD2 PE=2 SV=1,,,,,,
OG_04379,FUN_018045-T1,Peve_00021776,Pocillopora_meandrina_HIv1___RNAseq.g25350.t1,three_way,76.90433333333333,FUN_018045-T1,Q99741,CDC6_HUMAN,,Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6),Homo sapiens (Human),42.7,571.0,9.5e-109,395.6,sp|Q99741|CDC6_HUMAN Cell division control protein 6 homolog OS=Homo sapiens OX=9606 GN=CDC6 PE=1 SV=1,GO:0000076; GO:0000079; GO:0000166; GO:0000922; GO:0003682; GO:0003688; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006270; GO:0007089; GO:0008156; GO:0008285; GO:0016887; GO:0030071; GO:0032467; GO:0033314; GO:0045171; GO:0048146; GO:0051233; GO:0051301; GO:0051984; GO:0072686; GO:0120283; GO:1904117; GO:1904385,cell division [GO:0051301]; cellular response to angiotensin [GO:1904385]; cellular response to vasopressin [GO:1904117]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; mitotic DNA replication checkpoint signaling [GO:0033314]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of cytokinesis [GO:0032467]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; traversing start control point of mitotic cell cycle [GO:0007089],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; nucleotide binding [GO:0000166]; protein serine/threonine kinase binding [GO:0120283],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226,DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle
OG_04380,FUN_018046-T1,Peve_00021796,Pocillopora_meandrina_HIv1___RNAseq.g25349.t2,three_way,79.40316666666666,FUN_018046-T1,C3YZ51,,,,,67.8,410.0,3e-144,513.1,sp|C3YZ51|UBA5_BRAFL Ubiquitin-like modifier-activating enzyme 5 OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_113714 PE=3 SV=1,,,,,,
OG_04381,FUN_018086-T1,Peve_00021774,Pocillopora_meandrina_HIv1___RNAseq.g25348.t1,three_way,67.76233333333333,FUN_018086-T1,A0JM23,,,,,37.7,1131.0,2.1e-142,508.4,sp|A0JM23|NPHP3_XENTR Nephrocystin-3 OS=Xenopus tropicalis OX=8364 GN=nphp3 PE=2 SV=2,,,,,,
OG_04382,FUN_018087-T1,Peve_00034413,Pocillopora_meandrina_HIv1___RNAseq.g25347.t1,three_way,75.51383333333334,FUN_018087-T1,Q90673,,,,,49.4,166.0,7.5e-46,185.3,"sp|Q90673|PRLD1_CHICK PRELI domain-containing protein 1, mitochondrial OS=Gallus gallus OX=9031 GN=PRELID1 PE=2 SV=1",,,,,,
OG_04383,FUN_018089-T1,Peve_00034409,Pocillopora_meandrina_HIv1___RNAseq.g25344.t1,three_way,74.77966666666667,FUN_018089-T1,A6QQX9,TM163_BOVIN,,Transmembrane protein 163,Bos taurus (Bovine),35.8,215.0,2.7e-29,130.6,sp|A6QQX9|TM163_BOVIN Transmembrane protein 163 OS=Bos taurus OX=9913 GN=TMEM163 PE=2 SV=1,GO:0005765; GO:0005886; GO:0008270; GO:0030672; GO:0031901; GO:0031902; GO:0042552; GO:0140882,myelination [GO:0042552]; zinc export across plasma membrane [GO:0140882],early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],zinc ion binding [GO:0008270],GO:0005886; GO:0055085,plasma membrane; transmembrane transport
OG_04384,FUN_018090-T1,Peve_00017613,Pocillopora_meandrina_HIv1___RNAseq.g25343.t1,three_way,84.46766666666666,FUN_018090-T1,Q64521,GPDM_MOUSE,,"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (Protein TISP38)",Mus musculus (Mouse),62.2,717.0,1.6999999999999998e-259,896.7,"sp|Q64521|GPDM_MOUSE Glycerol-3-phosphate dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Gpd2 PE=1 SV=2",GO:0004368; GO:0005509; GO:0005739; GO:0005743; GO:0006072; GO:0006094; GO:0006127; GO:0019563; GO:0035264; GO:0043010,camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerol-3-phosphate shuttle [GO:0006127]; multicellular organism growth [GO:0035264],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368],GO:0003824; GO:0005739; GO:0005975; GO:0016491; GO:0043226; GO:0048856; GO:0055086; GO:1901135,catalytic activity; mitochondrion; carbohydrate metabolic process; oxidoreductase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04385,FUN_018091-T1,Peve_00001666,Pocillopora_meandrina_HIv1___TS.g25577.t1,three_way,73.79583333333333,FUN_018091-T1,Q6ZS30,,,,,36.6,2500.0,0.0,1536.9,sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3,,,,,,
OG_04386,FUN_018124-T1,Peve_00001655,Pocillopora_meandrina_HIv1___RNAseq.g25306.t1,three_way,75.08200000000001,FUN_018124-T1,Q28ES4,,,,,39.0,492.0,4.8e-84,313.5,sp|Q28ES4|S22FL_XENTR Solute carrier family 22 member 15-like OS=Xenopus tropicalis OX=8364 GN=slc22a15b PE=2 SV=1,,,,,,
OG_04387,FUN_018138-T1,Peve_00001660,Pocillopora_meandrina_HIv1___RNAseq.g25310.t1,three_way,71.25666666666666,FUN_018138-T1,Q9Y6B7,AP4B1_HUMAN,,AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin),Homo sapiens (Human),38.5,748.0,2.7000000000000003e-133,477.6,sp|Q9Y6B7|AP4B1_HUMAN AP-4 complex subunit beta-1 OS=Homo sapiens OX=9606 GN=AP4B1 PE=1 SV=2,GO:0005802; GO:0005829; GO:0006605; GO:0006886; GO:0008104; GO:0016192; GO:0030124; GO:0030131; GO:0030276; GO:0031904; GO:0032588; GO:0061938; GO:0098541,intracellular protein transport [GO:0006886]; protein localization [GO:0008104]; protein localization to somatodendritic compartment [GO:0061938]; protein targeting [GO:0006605]; vesicle-mediated transport [GO:0016192],AP-4 adaptor complex [GO:0030124]; clathrin adaptor complex [GO:0030131]; cytoplasmic side of trans-Golgi network transport vesicle membrane [GO:0098541]; cytosol [GO:0005829]; endosome lumen [GO:0031904]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],clathrin binding [GO:0030276],GO:0005829; GO:0006886; GO:0016192,cytosol; intracellular protein transport; vesicle-mediated transport
OG_04388,FUN_018139-T1,Peve_00020505,Pocillopora_meandrina_HIv1___RNAseq.g25311.t1,three_way,78.628,FUN_018139-T1,O88597,BECN1_MOUSE,,Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) [Cleaved into: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa],Mus musculus (Mouse),66.1,348.0,2.6e-72,273.9,sp|O88597|BECN1_MOUSE Beclin-1 OS=Mus musculus OX=10090 GN=Becn1 PE=1 SV=3,GO:0000045; GO:0000423; GO:0001525; GO:0001666; GO:0002753; GO:0005737; GO:0005776; GO:0005789; GO:0005802; GO:0005829; GO:0005856; GO:0006622; GO:0006914; GO:0006915; GO:0007040; GO:0007080; GO:0007254; GO:0007623; GO:0008285; GO:0009410; GO:0010008; GO:0010040; GO:0010288; GO:0010506; GO:0010507; GO:0010508; GO:0010613; GO:0016020; GO:0016236; GO:0016241; GO:0016604; GO:0019901; GO:0030425; GO:0030674; GO:0031410; GO:0031625; GO:0032465; GO:0032473; GO:0032801; GO:0032991; GO:0033197; GO:0034198; GO:0035032; GO:0036092; GO:0038066; GO:0042149; GO:0042802; GO:0043066; GO:0043069; GO:0043548; GO:0043652; GO:0045022; GO:0045335; GO:0048666; GO:0050435; GO:0051020; GO:0051301; GO:0051607; GO:0051707; GO:0060395; GO:0062029; GO:0065003; GO:0070301; GO:0071275; GO:0071280; GO:0071364; GO:0090650; GO:0097352; GO:0098780; GO:1902425; GO:1902902; GO:1905672; GO:2000786; GO:2001244,amyloid-beta metabolic process [GO:0050435]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular response to aluminum ion [GO:0071275]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxygen-glucose deprivation [GO:0090650]; circadian rhythm [GO:0007623]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; engulfment of apoptotic cell [GO:0043652]; JNK cascade [GO:0007254]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of lysosome organization [GO:1905672]; negative regulation of programmed cell death [GO:0043069]; neuron development [GO:0048666]; p38MAPK cascade [GO:0038066]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of stress granule assembly [GO:0062029]; protein targeting to lysosome [GO:0006622]; protein-containing complex assembly [GO:0065003]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to mitochondrial depolarisation [GO:0098780]; response to other organism [GO:0051707]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; SMAD protein signal transduction [GO:0060395],"autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; membrane [GO:0016020]; nuclear body [GO:0016604]; phagocytic vesicle [GO:0045335]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802]",GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625],GO:0002376; GO:0005773; GO:0005829; GO:0005856; GO:0006629; GO:0006886; GO:0006914; GO:0007040; GO:0012501; GO:0016192; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003,immune system process; vacuole; cytosol; cytoskeleton; lipid metabolic process; intracellular protein transport; autophagy; lysosome organization; programmed cell death; vesicle-mediated transport; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly
OG_04389,FUN_018387-T1,Peve_00032316,Pocillopora_meandrina_HIv1___RNAseq.g10089.t1,three_way,82.45,FUN_018387-T1,P05412,JUN_HUMAN,,Transcription factor Jun (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (Transcription factor AP-1 subunit Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39),Homo sapiens (Human),35.2,375.0,2.3e-31,137.9,sp|P05412|JUN_HUMAN Transcription factor Jun OS=Homo sapiens OX=9606 GN=JUN PE=1 SV=2,GO:0000122; GO:0000228; GO:0000785; GO:0000791; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0001774; GO:0001889; GO:0001938; GO:0003151; GO:0003677; GO:0003682; GO:0003700; GO:0003723; GO:0005096; GO:0005634; GO:0005654; GO:0005667; GO:0006357; GO:0006915; GO:0007179; GO:0007254; GO:0008283; GO:0008285; GO:0009410; GO:0010634; GO:0017053; GO:0019046; GO:0019899; GO:0030224; GO:0031103; GO:0031625; GO:0034976; GO:0035026; GO:0035497; GO:0035976; GO:0035994; GO:0042127; GO:0042802; GO:0043065; GO:0043392; GO:0043524; GO:0043922; GO:0043923; GO:0044389; GO:0045892; GO:0045893; GO:0045944; GO:0048146; GO:0048545; GO:0051726; GO:0060395; GO:0061029; GO:0061629; GO:0070374; GO:0070412; GO:0071277; GO:0072740; GO:0090575; GO:0140296; GO:0140467; GO:1902895; GO:1904707; GO:1990837; GO:2000144,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; axon regeneration [GO:0031103]; cell population proliferation [GO:0008283]; cellular response to anisomycin [GO:0072740]; cellular response to calcium ion [GO:0071277]; eyelid development in camera-type eye [GO:0061029]; integrated stress response signaling [GO:0140467]; JNK cascade [GO:0007254]; leading edge cell differentiation [GO:0035026]; liver development [GO:0001889]; microglial cell activation [GO:0001774]; monocyte differentiation [GO:0030224]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; release from viral latency [GO:0019046]; response to endoplasmic reticulum stress [GO:0034976]; response to muscle stretch [GO:0035994]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179],chromatin [GO:0000785]; euchromatin [GO:0000791]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription factor AP-1 complex [GO:0035976]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053],"cAMP response element binding [GO:0035497]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]",GO:0000228; GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140110,nuclear chromosome; immune system process; DNA binding; RNA binding; nucleus; nucleoplasm; chromosome; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_04390,FUN_018389-T1,Peve_00032312,Pocillopora_meandrina_HIv1___RNAseq.g10090.t1,three_way,51.62566666666667,,,,,,,,,,,,,,,,,
OG_04391,FUN_018391-T1,Peve_00032315,Pocillopora_meandrina_HIv1___RNAseq.g10091.t1,three_way,68.91016666666667,FUN_018391-T1,Q8BGF8,S35D3_MOUSE,,Solute carrier family 35 member D3 (Fringe connection-like protein 1),Mus musculus (Mouse),33.0,294.0,4.3e-34,147.1,sp|Q8BGF8|S35D3_MOUSE Solute carrier family 35 member D3 OS=Mus musculus OX=10090 GN=Slc35d3 PE=1 SV=1,GO:0005460; GO:0005769; GO:0005783; GO:0005789; GO:0010508; GO:0015786; GO:0030672; GO:0030674; GO:0031901; GO:0032527; GO:0060155; GO:0070863; GO:0097009,energy homeostasis [GO:0097009]; platelet dense granule organization [GO:0060155]; positive regulation of autophagy [GO:0010508]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; UDP-glucose transmembrane transport [GO:0015786],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; synaptic vesicle membrane [GO:0030672],protein-macromolecule adaptor activity [GO:0030674]; UDP-glucose transmembrane transporter activity [GO:0005460],GO:0005215; GO:0005768; GO:0005783; GO:0006886; GO:0031410; GO:0043226; GO:0055085; GO:0060090,transporter activity; endosome; endoplasmic reticulum; intracellular protein transport; cytoplasmic vesicle; organelle; transmembrane transport; molecular adaptor activity
OG_04392,FUN_018392-T1,Peve_00031705,Pocillopora_meandrina_HIv1___RNAseq.g10095.t1,three_way,82.48366666666666,FUN_018392-T1,F1MMV1,,,,,46.6,573.0,3.9e-142,506.5,sp|F1MMV1|EFHB_BOVIN EF-hand domain-containing family member B OS=Bos taurus OX=9913 GN=EFHB PE=1 SV=3,,,,,,
OG_04393,FUN_018395-T1,Peve_00031706,Pocillopora_meandrina_HIv1___RNAseq.16757_t,three_way,77.64733333333334,,,,,,,,,,,,,,,,,
OG_04394,FUN_018397-T1,Peve_00031707,Pocillopora_meandrina_HIv1___RNAseq.g10093.t1,three_way,92.263,FUN_018397-T1,O35819,,,,,45.6,294.0,3.2000000000000003e-28,127.1,sp|O35819|KLF6_RAT Krueppel-like factor 6 OS=Rattus norvegicus OX=10116 GN=Klf6 PE=2 SV=2,,,,,,
OG_04395,FUN_018398-T1,Peve_00032288,Pocillopora_meandrina_HIv1___TS.g23627.t2,three_way,73.27966666666667,FUN_018398-T1,P70168,IMB1_MOUSE,,Importin subunit beta-1 (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) (SCG),Mus musculus (Mouse),64.6,878.0,0.0,1105.5,sp|P70168|IMB1_MOUSE Importin subunit beta-1 OS=Mus musculus OX=10090 GN=Kpnb1 PE=1 SV=2,GO:0005654; GO:0005829; GO:0006404; GO:0006606; GO:0006607; GO:0006610; GO:0007079; GO:0007080; GO:0010494; GO:0019904; GO:0030953; GO:0031267; GO:0031965; GO:0032991; GO:0040001; GO:0042564; GO:0051879; GO:0061608; GO:0061676; GO:0071782; GO:0090307,astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610]; RNA import into nucleus [GO:0006404],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; NLS-dependent protein nuclear import complex [GO:0042564]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],Hsp90 protein binding [GO:0051879]; importin-alpha family protein binding [GO:0061676]; nuclear import signal receptor activity [GO:0061608]; protein domain specific binding [GO:0019904]; small GTPase binding [GO:0031267],GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0007010; GO:0007018; GO:0043226; GO:0140104,nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; cytoskeleton organization; microtubule-based movement; organelle; molecular carrier activity
OG_04396,FUN_018401-T1,Peve_00031702,Pocillopora_meandrina_HIv1___RNAseq.g10160.t1,three_way,68.175,FUN_018401-T1,Q6DIM3,TBD_XENTR,,Tubulin delta chain (Delta-tubulin),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),31.4,255.0,1.5e-26,122.5,sp|Q6DIM3|TBD_XENTR Tubulin delta chain OS=Xenopus tropicalis OX=8364 GN=tubd1 PE=2 SV=1,GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005814; GO:0005874; GO:0005929; GO:0007017; GO:0030030; GO:0045880,cell projection organization [GO:0030030]; microtubule-based process [GO:0007017]; positive regulation of smoothened signaling pathway [GO:0045880],centriole [GO:0005814]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634],GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005634; GO:0005929; GO:0043226,structural molecule activity; nucleus; cilium; organelle
OG_04397,FUN_018402-T1,Peve_00033494,Pocillopora_meandrina_HIv1___RNAseq.16819_t,three_way,58.857,FUN_018402-T1,Q8BVT6,,,,,27.0,429.0,2.6e-26,122.1,sp|Q8BVT6|PP2D1_MOUSE Protein phosphatase 2C-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pp2d1 PE=2 SV=1,,,,,,
OG_04398,FUN_018403-T1,Peve_00033495,Pocillopora_meandrina_HIv1___RNAseq.g10162.t1,three_way,77.55466666666666,FUN_018403-T1,Q28811,,,,,61.2,485.0,7.3000000000000005e-180,631.7,sp|Q28811|PHR_POTTR Deoxyribodipyrimidine photo-lyase OS=Potorous tridactylus OX=9310 GN=PHR PE=2 SV=1,,,,,,
OG_04399,FUN_018404-T1,Peve_00031698,Pocillopora_meandrina_HIv1___RNAseq.g10163.t1,three_way,62.86966666666667,FUN_018404-T1,Q5S006,LRRK2_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-),Mus musculus (Mouse),31.9,138.0,7.2e-09,64.7,sp|Q5S006|LRRK2_MOUSE Leucine-rich repeat serine/threonine-protein kinase 2 OS=Mus musculus OX=10090 GN=Lrrk2 PE=1 SV=2,GO:0000139; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0005096; GO:0005524; GO:0005525; GO:0005654; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0007005; GO:0007029; GO:0007030; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031410; GO:0031647; GO:0031965; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034614; GO:0035556; GO:0035564; GO:0035641; GO:0035751; GO:0036064; GO:0036465; GO:0036479; GO:0040012; GO:0042802; GO:0042803; GO:0043068; GO:0043195; GO:0043204; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045335; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; multivesicular body, internal vesicle [GO:0097487]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; nucleoplasm; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04400,FUN_018405-T1,Peve_00031697,Pocillopora_meandrina_HIv1___RNAseq.g10164.t1,three_way,90.36766666666666,FUN_018405-T1,Q5JU00,DRC5_HUMAN,,Dynein regulatory complex subunit 5 (T-complex-associated testis-expressed protein 1) (Tcte-1),Homo sapiens (Human),54.5,264.0,6.3000000000000016e-87,322.8,sp|Q5JU00|DRC5_HUMAN Dynein regulatory complex subunit 5 OS=Homo sapiens OX=9606 GN=TCTE1 PE=1 SV=1,GO:0005737; GO:0005856; GO:0007018; GO:0030317; GO:0036126,flagellated sperm motility [GO:0030317]; microtubule-based movement [GO:0007018],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126],,GO:0005856; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cytoskeleton; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_04401,FUN_018412-T1,Peve_00031696,Pocillopora_meandrina_HIv1___TS.g23694.t2,three_way,59.120666666666665,FUN_018412-T1,P28648,CD63_RAT,,CD63 antigen (Mast cell antigen AD1) (CD antigen CD63),Rattus norvegicus (Rat),36.8,242.0,2.3e-35,150.6,sp|P28648|CD63_RAT CD63 antigen OS=Rattus norvegicus OX=10116 GN=Cd63 PE=1 SV=2,GO:0002092; GO:0005615; GO:0005654; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0007160; GO:0009986; GO:0010008; GO:0010633; GO:0015031; GO:0016477; GO:0030855; GO:0031902; GO:0031904; GO:0032585; GO:0032991; GO:0035646; GO:0042470; GO:0043473; GO:0044877; GO:0045785; GO:0045807; GO:0048757; GO:0050931; GO:0070062; GO:0097487; GO:1900746; GO:1901379; GO:2001046,cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment cell differentiation [GO:0050931]; pigment granule maturation [GO:0048757]; pigmentation [GO:0043473]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],"cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body, internal vesicle [GO:0097487]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]",protein-containing complex binding [GO:0044877],GO:0005615; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0007155; GO:0030154; GO:0031410; GO:0043226; GO:0048870,extracellular space; nucleoplasm; lysosome; endosome; vacuole; plasma membrane; cell adhesion; cell differentiation; cytoplasmic vesicle; organelle; cell motility
OG_04402,FUN_018414-T1,Peve_00031694,Pocillopora_meandrina_HIv1___TS.g23697.t1,three_way,70.86200000000001,FUN_018414-T1,Q5ZID6,5NT3A_CHICK,,Cytosolic 5'-nucleotidase 3A (EC 3.1.3.5) (7-methylguanosine phosphate-specific 5'-nucleotidase) (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3) (Cytosolic 5'-nucleotidase III) (cN-III) (Pyrimidine 5'-nucleotidase 1) (P5'N-1) (P5N-1) (PN-I),Gallus gallus (Chicken),38.2,325.0,3.8000000000000003e-57,223.4,sp|Q5ZID6|5NT3A_CHICK Cytosolic 5'-nucleotidase 3A OS=Gallus gallus OX=9031 GN=NT5C3A PE=1 SV=3,GO:0000166; GO:0000287; GO:0005737; GO:0005783; GO:0005829; GO:0006248; GO:0008253; GO:0016604; GO:0016740,CMP catabolic process [GO:0006248],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear body [GO:0016604],5'-nucleotidase activity [GO:0008253]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; transferase activity [GO:0016740],GO:0003824; GO:0005783; GO:0005829; GO:0016740; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; endoplasmic reticulum; cytosol; transferase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04403,FUN_018416-T1,Peve_00031691,Pocillopora_meandrina_HIv1___RNAseq.g10170.t1,three_way,54.97866666666667,FUN_018416-T1,Q49A88,CCD14_HUMAN,,Coiled-coil domain-containing protein 14,Homo sapiens (Human),29.7,229.0,3.1e-18,95.5,sp|Q49A88|CCD14_HUMAN Coiled-coil domain-containing protein 14 OS=Homo sapiens OX=9606 GN=CCDC14 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005929; GO:0015630; GO:0021762; GO:0034451; GO:0036064; GO:0071539,protein localization to centrosome [GO:0071539]; substantia nigra development [GO:0021762],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630],,GO:0005815; GO:0005856; GO:0005929; GO:0043226; GO:0048856,microtubule organizing center; cytoskeleton; cilium; organelle; anatomical structure development
OG_04404,FUN_018418-T2,Peve_00031690,Pocillopora_meandrina_HIv1___RNAseq.g10175.t1,three_way,54.339,,,,,,,,,,,,,,,,,
OG_04405,FUN_018423-T1,Peve_00031689,Pocillopora_meandrina_HIv1___RNAseq.g10176.t1,three_way,63.1915,,,,,,,,,,,,,,,,,
OG_04406,FUN_018424-T1,Peve_00031688,Pocillopora_meandrina_HIv1___RNAseq.g10173.t1,three_way,88.72733333333333,FUN_018424-T1,P24156,,,,,76.4,271.0,1.7e-111,403.7,sp|P24156|PHB1_DROME Prohibitin 1 OS=Drosophila melanogaster OX=7227 GN=Phb1 PE=2 SV=2,,,,,,
OG_04407,FUN_018425-T1,Peve_00031687,Pocillopora_meandrina_HIv1___RNAseq.g10172.t1,three_way,90.69833333333332,FUN_018425-T1,Q9GT45,,,,,81.4,113.0,5.400000000000001e-44,178.3,sp|Q9GT45|RS26_ANOGA Small ribosomal subunit protein eS26 OS=Anopheles gambiae OX=7165 GN=RpS26 PE=3 SV=2,,,,,,
OG_04408,FUN_018426-T1,Peve_00031692,Pocillopora_meandrina_HIv1___TS.g23699.t1,three_way,67.75733333333334,,,,,,,,,,,,,,,,,
OG_04409,FUN_018428-T1,Peve_00007315,Pocillopora_meandrina_HIv1___TS.g23705.t3,three_way,65.60566666666666,FUN_018428-T1,P97321,SEPR_MOUSE,,"Prolyl endopeptidase FAP (EC 3.4.21.26) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]",Mus musculus (Mouse),35.3,787.0,7.4e-134,479.6,sp|P97321|SEPR_MOUSE Prolyl endopeptidase FAP OS=Mus musculus OX=10090 GN=Fap PE=1 SV=1,GO:0001525; GO:0002020; GO:0004252; GO:0005178; GO:0005615; GO:0005886; GO:0006508; GO:0007155; GO:0008233; GO:0008236; GO:0008239; GO:0009986; GO:0010710; GO:0010716; GO:0031258; GO:0032587; GO:0042803; GO:0043542; GO:0045177; GO:0045178; GO:0051603; GO:0051726; GO:0060244; GO:0070161; GO:0097325; GO:1900119; GO:1902362; GO:1903054; GO:1905368,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; melanocyte apoptotic process [GO:1902362]; melanocyte proliferation [GO:0097325]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of extracellular matrix organization [GO:1903054]; positive regulation of execution phase of apoptosis [GO:1900119]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cell cycle [GO:0051726]; regulation of collagen catabolic process [GO:0010710],anchoring junction [GO:0070161]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; extracellular space [GO:0005615]; lamellipodium membrane [GO:0031258]; peptidase complex [GO:1905368]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],dipeptidyl-peptidase activity [GO:0008239]; integrin binding [GO:0005178]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005615; GO:0005886; GO:0007155; GO:0012501; GO:0016787; GO:0048870; GO:0140096,"catalytic activity; extracellular space; plasma membrane; cell adhesion; programmed cell death; hydrolase activity; cell motility; catalytic activity, acting on a protein"
OG_04410,FUN_018429-T1,Peve_00007316,Pocillopora_meandrina_HIv1___RNAseq.g10178.t1,three_way,79.36266666666667,FUN_018429-T1,P20664,,,,,57.6,399.0,1.9e-133,477.2,sp|P20664|PRI1_MOUSE DNA primase small subunit OS=Mus musculus OX=10090 GN=Prim1 PE=1 SV=1,,,,,,
OG_04411,FUN_018479-T1,Peve_00000366,Pocillopora_meandrina_HIv1___TS.g480.t1,three_way,45.37416666666667,,,,,,,,,,,,,,,,,
OG_04412,FUN_018519-T1,Peve_00007317,Pocillopora_meandrina_HIv1___TS.g23707.t1,three_way,53.989333333333335,FUN_018519-T1,Q0Z7W6,TMX1_BOVIN,,Thioredoxin-related transmembrane protein 1 (Protein disulfide-isomerase TMX1) (EC 5.3.4.1) (Thioredoxin domain-containing protein 1),Bos taurus (Bovine),40.5,195.0,6.1e-43,176.0,sp|Q0Z7W6|TMX1_BOVIN Thioredoxin-related transmembrane protein 1 OS=Bos taurus OX=9913 GN=TMX1 PE=2 SV=1,GO:0003756; GO:0004857; GO:0005576; GO:0005789; GO:0010868; GO:0012505; GO:0015035; GO:0015036; GO:0031966; GO:0034976; GO:0044233; GO:0051924; GO:0090331; GO:1904294,negative regulation of platelet aggregation [GO:0090331]; negative regulation of triglyceride biosynthetic process [GO:0010868]; positive regulation of ERAD pathway [GO:1904294]; regulation of calcium ion transport [GO:0051924]; response to endoplasmic reticulum stress [GO:0034976],endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966],disulfide oxidoreductase activity [GO:0015036]; enzyme inhibitor activity [GO:0004857]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],GO:0003824; GO:0005576; GO:0016491; GO:0016853; GO:0098772; GO:0140096,"catalytic activity; extracellular region; oxidoreductase activity; isomerase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04413,FUN_018520-T1,Peve_00007308,Pocillopora_meandrina_HIv1___RNAseq.g10180.t1,three_way,53.64433333333333,,,,,,,,,,,,,,,,,
OG_04414,FUN_018521-T1,Peve_00007312,Pocillopora_meandrina_HIv1___RNAseq.g10181.t1,three_way,76.60266666666666,FUN_018521-T1,Q90ZA1,PARN_XENLA,,Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease) (parn-A),Xenopus laevis (African clawed frog),46.5,563.0,2.5e-139,497.3,sp|Q90ZA1|PARN_XENLA Poly(A)-specific ribonuclease PARN OS=Xenopus laevis OX=8355 GN=parn PE=1 SV=1,GO:0000175; GO:0000289; GO:0003723; GO:0004535; GO:0005634; GO:0005737; GO:0043169; GO:0046872; GO:0051321; GO:1990431; GO:1990432,meiotic cell cycle [GO:0051321]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; priRNA 3'-end processing [GO:1990431]; siRNA 3'-end processing [GO:1990432],cytoplasm [GO:0005737]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; reproductive process; organelle; catalytic activity, acting on RNA"
OG_04415,FUN_018522-T1,Peve_00007314,Pocillopora_meandrina_HIv1___RNAseq.g10182.t2,three_way,59.49766666666667,,,,,,,,,,,,,,,,,
OG_04416,FUN_018523-T1,Peve_00038651,Pocillopora_meandrina_HIv1___RNAseq.g10183.t1,three_way,87.47866666666667,FUN_018523-T1,Q9NZN3,EHD3_HUMAN,,EH domain-containing protein 3 (PAST homolog 3),Homo sapiens (Human),63.8,536.0,4.8e-198,692.2,sp|Q9NZN3|EHD3_HUMAN EH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=EHD3 PE=1 SV=2,GO:0001881; GO:0003676; GO:0005509; GO:0005524; GO:0005525; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0005925; GO:0006897; GO:0010008; GO:0015031; GO:0020018; GO:0030139; GO:0032456; GO:0034498; GO:0048471; GO:0051260; GO:0055038; GO:0055117; GO:0060271; GO:0072659; GO:0086036; GO:0090160; GO:1903358; GO:1903779,cilium assembly [GO:0060271]; early endosome to Golgi transport [GO:0034498]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; Golgi to lysosome transport [GO:0090160]; protein homooligomerization [GO:0051260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; receptor recycling [GO:0001881]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell membrane potential [GO:0086036]; regulation of cardiac muscle contraction [GO:0055117]; regulation of Golgi organization [GO:1903358],ciliary pocket membrane [GO:0020018]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676],GO:0005634; GO:0005768; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0044782; GO:0065003; GO:0072659,nucleus; endosome; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; cilium organization; protein-containing complex assembly; protein localization to plasma membrane
OG_04417,FUN_018525-T1,Peve_00039210,Pocillopora_meandrina_HIv1___RNAseq.g10001.t1,three_way,54.96333333333333,,,,,,,,,,,,,,,,,
OG_04418,FUN_018526-T1,Peve_00039209,Pocillopora_meandrina_HIv1___TS.g23531.t1,three_way,63.84433333333334,,,,,,,,,,,,,,,,,
OG_04419,FUN_018527-T1,Peve_00039208,Pocillopora_meandrina_HIv1___RNAseq.g9997.t1,three_way,66.57966666666667,,,,,,,,,,,,,,,,,
OG_04420,FUN_018529-T2,Peve_00039204,Pocillopora_meandrina_HIv1___RNAseq.g9995.t1,three_way,74.336,FUN_018529-T2,O15460,P4HA2_HUMAN,,"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)",Homo sapiens (Human),41.8,538.0,9.7e-114,412.1,sp|O15460|P4HA2_HUMAN Prolyl 4-hydroxylase subunit alpha-2 OS=Homo sapiens OX=9606 GN=P4HA2 PE=1 SV=1,GO:0004656; GO:0005506; GO:0005654; GO:0005783; GO:0005788; GO:0005829; GO:0009055; GO:0031418; GO:0043231,,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656],GO:0003824; GO:0005654; GO:0005783; GO:0005829; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; endoplasmic reticulum; cytosol; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_04421,FUN_018530-T2,Peve_00039202,Pocillopora_meandrina_HIv1___RNAseq.g9980.t1,three_way,91.0425,FUN_018530-T2,Q01082,SPTB2_HUMAN,,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",Homo sapiens (Human),49.4,2310.0,0.0,2035.0,"sp|Q01082|SPTB2_HUMAN Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTBN1 PE=1 SV=2",GO:0000281; GO:0003723; GO:0003779; GO:0005200; GO:0005516; GO:0005543; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0007009; GO:0007417; GO:0008091; GO:0014069; GO:0014731; GO:0021556; GO:0030036; GO:0030054; GO:0030506; GO:0030673; GO:0030864; GO:0031430; GO:0032437; GO:0032743; GO:0042995; GO:0043001; GO:0045296; GO:0051015; GO:0051020; GO:0051693; GO:0060390; GO:0070062; GO:0071709; GO:0072659; GO:0098978; GO:1903076; GO:1903078,actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; central nervous system development [GO:0007417]; central nervous system formation [GO:0021556]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],axolemma [GO:0030673]; cell junction [GO:0030054]; cell projection [GO:0042995]; cortical actin cytoskeleton [GO:0030864]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200],GO:0000910; GO:0003723; GO:0005198; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0008289; GO:0016192; GO:0043226; GO:0048856; GO:0061024; GO:0072659,cytokinesis; RNA binding; structural molecule activity; nucleolus; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; organelle; anatomical structure development; membrane organization; protein localization to plasma membrane
OG_04422,FUN_018531-T1,Peve_00039201,Pocillopora_meandrina_HIv1___RNAseq.g9981.t1,three_way,73.98216666666667,FUN_018531-T1,Q9H9S5,FKRP_HUMAN,,Ribitol 5-phosphate transferase FKRP (EC 2.7.8.-) (Fukutin-related protein) (Ribitol-5-phosphate transferase),Homo sapiens (Human),44.4,522.0,2.4e-120,434.1,sp|Q9H9S5|FKRP_HUMAN Ribitol 5-phosphate transferase FKRP OS=Homo sapiens OX=9606 GN=FKRP PE=1 SV=1,GO:0000139; GO:0001701; GO:0001764; GO:0002162; GO:0003007; GO:0003016; GO:0005615; GO:0005654; GO:0005791; GO:0005794; GO:0005829; GO:0006096; GO:0006600; GO:0006629; GO:0006936; GO:0006954; GO:0007420; GO:0007628; GO:0009410; GO:0010001; GO:0014823; GO:0016485; GO:0016780; GO:0017038; GO:0019321; GO:0019519; GO:0030282; GO:0035269; GO:0035437; GO:0036058; GO:0038026; GO:0042383; GO:0042802; GO:0043010; GO:0043236; GO:0043403; GO:0043491; GO:0046872; GO:0050905; GO:0051262; GO:0051384; GO:0051674; GO:0060539; GO:0061448; GO:0071711; GO:0072592; GO:0097305; GO:0097709; GO:0098528; GO:0098723,adult walking behavior [GO:0007628]; basement membrane organization [GO:0071711]; bone mineralization [GO:0030282]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; connective tissue development [GO:0061448]; connective tissue replacement [GO:0097709]; creatine metabolic process [GO:0006600]; diaphragm development [GO:0060539]; filtration diaphragm assembly [GO:0036058]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; localization of cell [GO:0051674]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; muscle contraction [GO:0006936]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; oxygen metabolic process [GO:0072592]; pentitol metabolic process [GO:0019519]; pentose metabolic process [GO:0019321]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; protein import [GO:0017038]; protein O-linked mannosylation [GO:0035269]; protein processing [GO:0016485]; protein tetramerization [GO:0051262]; reelin-mediated signaling pathway [GO:0038026]; respiratory system process [GO:0003016]; response to activity [GO:0014823]; response to alcohol [GO:0097305]; response to glucocorticoid [GO:0051384]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle fiber differentiation [GO:0098528]; skeletal muscle tissue regeneration [GO:0043403],cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; skeletal muscle myofibril [GO:0098723],"dystroglycan binding [GO:0002162]; identical protein binding [GO:0042802]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",GO:0003012; GO:0003016; GO:0003824; GO:0005615; GO:0005654; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0006575; GO:0006629; GO:0006954; GO:0009101; GO:0016740; GO:0030154; GO:0030198; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0051604; GO:0055086; GO:0065003; GO:1901135,muscle system process; respiratory system process; catalytic activity; extracellular space; nucleoplasm; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; modified amino acid metabolic process; lipid metabolic process; inflammatory response; glycoprotein biosynthetic process; transferase activity; cell differentiation; extracellular matrix organization; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; protein maturation; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_04423,FUN_018532-T1,Peve_00039214,Pocillopora_meandrina_HIv1___RNAseq.g9982.t1,three_way,57.187333333333335,,,,,,,,,,,,,,,,,
OG_04424,FUN_018533-T1,Peve_00006704,Pocillopora_meandrina_HIv1___RNAseq.g9983.t1,three_way,70.3825,FUN_018533-T1,Q8BVT6,,,,,28.1,424.0,2.4e-32,141.7,sp|Q8BVT6|PP2D1_MOUSE Protein phosphatase 2C-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pp2d1 PE=2 SV=1,,,,,,
OG_04425,FUN_018536-T1,Peve_00006701,Pocillopora_meandrina_HIv1___RNAseq.g9988.t1,three_way,84.17433333333334,FUN_018536-T1,Q0P5W1,VPS8_MOUSE,,Vacuolar protein sorting-associated protein 8 homolog,Mus musculus (Mouse),43.1,1398.0,0.0,1083.2,sp|Q0P5W1|VPS8_MOUSE Vacuolar protein sorting-associated protein 8 homolog OS=Mus musculus OX=10090 GN=Vps8 PE=1 SV=1,GO:0005769; GO:0006623; GO:0008270; GO:0033263; GO:0034058,endosomal vesicle fusion [GO:0034058]; protein targeting to vacuole [GO:0006623],CORVET complex [GO:0033263]; early endosome [GO:0005769],zinc ion binding [GO:0008270],GO:0005768; GO:0006886; GO:0031410; GO:0043226; GO:0061024,endosome; intracellular protein transport; cytoplasmic vesicle; organelle; membrane organization
OG_04426,FUN_018540-T1,Peve_00006702,Pocillopora_meandrina_HIv1___RNAseq.g9993.t1,three_way,69.65,FUN_018540-T1,O57460,TLL1_DANRE,,Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein),Danio rerio (Zebrafish) (Brachydanio rerio),37.6,109.0,4.2e-11,71.6,sp|O57460|TLL1_DANRE Dorsal-ventral patterning tolloid-like protein 1 OS=Danio rerio OX=7955 GN=tll1 PE=2 SV=1,GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264,blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular region [GO:0005576]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_04427,FUN_018550-T1,Peve_00032304,Pocillopora_meandrina_HIv1___RNAseq.g10049.t1,three_way,68.13333333333334,FUN_018550-T1,Q5BLD8,,,,,33.1,166.0,2.1e-17,90.9,sp|Q5BLD8|MT21A_DANRE Protein N-lysine methyltransferase METTL21A OS=Danio rerio OX=7955 GN=mettl21a PE=2 SV=1,,,,,,
OG_04428,FUN_018593-T1,Peve_00043161,Pocillopora_meandrina_HIv1___RNAseq.g10066.t1,three_way,45.1855,FUN_018593-T1,P98088,MUC5A_HUMAN,,"Mucin-5AC (MUC-5AC) (Gastric mucin) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM)",Homo sapiens (Human),27.1,1204.0,2e-102,375.9,sp|P98088|MUC5A_HUMAN Mucin-5AC OS=Homo sapiens OX=9606 GN=MUC5AC PE=1 SV=4,GO:0005201; GO:0005615; GO:0005796; GO:0005886; GO:0031012; GO:0046872; GO:0070062; GO:0070701,,extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; mucus layer [GO:0070701]; plasma membrane [GO:0005886],extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872],GO:0005198; GO:0005615; GO:0005886; GO:0030312; GO:0031012; GO:0043226,structural molecule activity; extracellular space; plasma membrane; external encapsulating structure; extracellular matrix; organelle
OG_04429,FUN_018595-T1,Peve_00043160,Pocillopora_meandrina_HIv1___RNAseq.g10034.t1,three_way,63.91766666666667,FUN_018595-T1,Q766D5,,,,,39.2,176.0,1.5e-28,128.6,sp|Q766D5|B4GN4_MOUSE N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=B4galnt4 PE=2 SV=1,,,,,,
OG_04430,FUN_018596-T1,Peve_00043163,Pocillopora_meandrina_HIv1___RNAseq.g501.t1,three_way,71.55466666666666,,,,,,,,,,,,,,,,,
OG_04431,FUN_018598-T1,Peve_00043164,Pocillopora_meandrina_HIv1___RNAseq.g502.t1,three_way,68.94316666666667,FUN_018598-T1,Q7TQC7,,,,,26.4,538.0,1.9e-18,95.5,sp|Q7TQC7|GPTC2_MOUSE G patch domain-containing protein 2 OS=Mus musculus OX=10090 GN=Gpatch2 PE=1 SV=2,,,,,,
OG_04432,FUN_018599-T1,Peve_00043159,Pocillopora_meandrina_HIv1___RNAseq.g10033.t1,three_way,85.14233333333334,FUN_018599-T1,F1MKX4,,,,,48.8,1856.0,0.0,1741.9,sp|F1MKX4|PSME4_BOVIN Proteasome activator complex subunit 4 OS=Bos taurus OX=9913 GN=PSME4 PE=1 SV=1,,,,,,
OG_04433,FUN_018604-T1,Peve_00002871,Pocillopora_meandrina_HIv1___RNAseq.g9881.t1,three_way,76.601,FUN_018604-T1,Q7TN73,CASD1_MOUSE,,N-acetylneuraminate (7)9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (CAS1 protein) (Cas1p) (Sialate O-acetyltransferase) (SOAT),Mus musculus (Mouse),41.1,794.0,1.2e-163,578.6,sp|Q7TN73|CASD1_MOUSE N-acetylneuraminate (7)9-O-acetyltransferase OS=Mus musculus OX=10090 GN=Casd1 PE=2 SV=1,GO:0000139; GO:0005975; GO:0047186,carbohydrate metabolic process [GO:0005975],Golgi membrane [GO:0000139],N-acetylneuraminate 9-O-acetyltransferase activity [GO:0047186],GO:0003824; GO:0005975; GO:0016740,catalytic activity; carbohydrate metabolic process; transferase activity
OG_04434,FUN_018790-T1,Peve_00013151,Pocillopora_meandrina_HIv1___RNAseq.g14712.t1,three_way,68.35233333333333,,,,,,,,,,,,,,,,,
OG_04435,FUN_018802-T1,Peve_00013887,Pocillopora_meandrina_HIv1___RNAseq.g9880.t1,three_way,68.601,,,,,,,,,,,,,,,,,
OG_04436,FUN_018806-T1,Peve_00035781,Pocillopora_meandrina_HIv1___TS.g23409.t1,three_way,74.02616666666667,FUN_018806-T1,P97411,,,,,37.4,604.0,6.7e-85,316.6,sp|P97411|ICA69_MOUSE Islet cell autoantigen 1 OS=Mus musculus OX=10090 GN=Ica1 PE=1 SV=3,,,,,,
OG_04437,FUN_018822-T1,Peve_00035783,Pocillopora_meandrina_HIv1___RNAseq.g9871.t1,three_way,38.3045,FUN_018822-T1,Q9Y2C9,TLR6_HUMAN,,Toll-like receptor 6 (CD antigen CD286),Homo sapiens (Human),36.5,148.0,1.2e-13,79.7,sp|Q9Y2C9|TLR6_HUMAN Toll-like receptor 6 OS=Homo sapiens OX=9606 GN=TLR6 PE=1 SV=2,GO:0001540; GO:0001774; GO:0002224; GO:0002755; GO:0004888; GO:0005102; GO:0005794; GO:0005886; GO:0006954; GO:0006955; GO:0007165; GO:0007250; GO:0010628; GO:0030670; GO:0032717; GO:0032720; GO:0032731; GO:0032755; GO:0034136; GO:0035355; GO:0035663; GO:0035666; GO:0038023; GO:0038124; GO:0042496; GO:0042498; GO:0042742; GO:0042802; GO:0043032; GO:0043123; GO:0043235; GO:0043507; GO:0045087; GO:0045121; GO:0045429; GO:0046209; GO:0046982; GO:0050729; GO:0061809; GO:0071723; GO:0071726; GO:0140052; GO:1900017; GO:1900227; GO:1903428; GO:1904646; GO:2001238,activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide metabolic process [GO:0046209]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355],"amyloid-beta binding [GO:0001540]; diacyl lipopeptide binding [GO:0042498]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_04438,FUN_018824-T1,Peve_00035784,Pocillopora_meandrina_HIv1___RNAseq.g9870.t1,three_way,86.71033333333334,FUN_018824-T1,P11586,C1TC_HUMAN,,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) (Epididymis secretory sperm binding protein) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]",Homo sapiens (Human),69.7,935.0,0.0,1325.1,"sp|P11586|C1TC_HUMAN C-1-tetrahydrofolate synthase, cytoplasmic OS=Homo sapiens OX=9606 GN=MTHFD1 PE=1 SV=4",GO:0001780; GO:0001843; GO:0004329; GO:0004477; GO:0004486; GO:0004487; GO:0004488; GO:0005524; GO:0005739; GO:0005829; GO:0006164; GO:0006555; GO:0007507; GO:0009086; GO:0009152; GO:0009257; GO:0016020; GO:0019346; GO:0035999; GO:0046655; GO:0048702; GO:0048703; GO:0061053; GO:0070062,10-formyltetrahydrofolate biosynthetic process [GO:0009257]; embryonic neurocranium morphogenesis [GO:0048702]; embryonic viscerocranium morphogenesis [GO:0048703]; folic acid metabolic process [GO:0046655]; heart development [GO:0007507]; methionine biosynthetic process [GO:0009086]; methionine metabolic process [GO:0006555]; neural tube closure [GO:0001843]; neutrophil homeostasis [GO:0001780]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleotide biosynthetic process [GO:0009152]; somite development [GO:0061053]; tetrahydrofolate interconversion [GO:0035999]; transsulfuration [GO:0019346],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486],GO:0002376; GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0006575; GO:0006790; GO:0016491; GO:0016787; GO:0016874; GO:0043226; GO:0048856; GO:0055086; GO:1901135,immune system process; catalytic activity; mitochondrion; cytosol; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; hydrolase activity; ligase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04439,FUN_018835-T2,Peve_00035787,Pocillopora_meandrina_HIv1___RNAseq.g9856.t1,three_way,77.22033333333333,FUN_018835-T2,Q9C0G6,DYH6_HUMAN,,Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6),Homo sapiens (Human),37.1,4337.0,0.0,2654.0,sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_04440,FUN_018842-T1,Peve_00035790,Pocillopora_meandrina_HIv1___RNAseq.g9855.t1,three_way,61.89533333333333,FUN_018842-T1,Q5U4Q0,,,,,31.7,221.0,1.2e-12,76.6,sp|Q5U4Q0|WAC_XENTR WW domain-containing adapter protein with coiled-coil OS=Xenopus tropicalis OX=8364 GN=wac PE=2 SV=1,,,,,,
OG_04441,FUN_018860-T1,Peve_00035792,Pocillopora_meandrina_HIv1___RNAseq.g372.t1,three_way,82.41166666666666,FUN_018860-T1,Q8NHU2,,,,,47.4,1233.0,0.0,1116.7,sp|Q8NHU2|CFA61_HUMAN Cilia- and flagella-associated protein 61 OS=Homo sapiens OX=9606 GN=CFAP61 PE=1 SV=3,,,,,,
OG_04442,FUN_018863-T1,Peve_00039216,Pocillopora_meandrina_HIv1___RNAseq.g7457.t1,three_way,62.373,,,,,,,,,,,,,,,,,
OG_04443,FUN_018864-T3,Peve_00035796,Pocillopora_meandrina_HIv1___RNAseq.g371.t1,three_way,60.120666666666665,FUN_018864-T3,G3V928,LRP1_RAT,,Prolow-density lipoprotein receptor-related protein 1 (LRP-1) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)],Rattus norvegicus (Rat),36.6,3344.0,4.5e-259,897.9,sp|G3V928|LRP1_RAT Prolow-density lipoprotein receptor-related protein 1 OS=Rattus norvegicus OX=10116 GN=Lrp1 PE=1 SV=1,GO:0002020; GO:0002265; GO:0003279; GO:0005102; GO:0005509; GO:0005634; GO:0005768; GO:0005769; GO:0005794; GO:0005815; GO:0005886; GO:0005905; GO:0006898; GO:0006909; GO:0007041; GO:0007167; GO:0007204; GO:0008203; GO:0009897; GO:0010629; GO:0010812; GO:0010875; GO:0010951; GO:0010976; GO:0010977; GO:0014912; GO:0015026; GO:0016020; GO:0016323; GO:0016964; GO:0021987; GO:0030136; GO:0030178; GO:0030425; GO:0030512; GO:0031623; GO:0032050; GO:0032370; GO:0032374; GO:0032376; GO:0032593; GO:0032956; GO:0034185; GO:0035774; GO:0035909; GO:0038024; GO:0043025; GO:0043066; GO:0043235; GO:0043277; GO:0043524; GO:0044295; GO:0044877; GO:0045177; GO:0045773; GO:0045807; GO:0048691; GO:0048694; GO:0050766; GO:0051222; GO:0051481; GO:0051895; GO:0060392; GO:0060976; GO:0061642; GO:0062136; GO:0070374; GO:0097242; GO:0098839; GO:0098978; GO:0099149; GO:0120283; GO:0150093; GO:0150094; GO:0150104; GO:1900149; GO:1900223; GO:1903078; GO:1904109; GO:1904300; GO:1904646; GO:1904754; GO:1905109; GO:1905167; GO:2000343; GO:2000587,amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta clearance by transcytosis [GO:0150093]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cellular response to amyloid-beta [GO:1904646]; cerebral cortex development [GO:0021987]; chemoattraction of axon [GO:0061642]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; enzyme-linked receptor protein signaling pathway [GO:0007167]; lysosomal transport [GO:0007041]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway [GO:0030178]; phagocytosis [GO:0006909]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of axon extension [GO:0045773]; positive regulation of axon extension involved in regeneration [GO:0048691]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol import [GO:1904109]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of collateral sprouting of injured axon [GO:0048694]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; positive regulation of Schwann cell migration [GO:1900149]; positive regulation of transcytosis [GO:1904300]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of pulmonary blood vessel remodeling [GO:1905109]; transport across blood-brain barrier [GO:0150104],apical part of cell [GO:0045177]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; low-density lipoprotein receptor complex [GO:0062136]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235],alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; coreceptor activity [GO:0015026]; protease binding [GO:0002020]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102],GO:0002376; GO:0003013; GO:0005634; GO:0005768; GO:0005794; GO:0005815; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0060089,immune system process; circulatory system process; nucleus; endosome; Golgi apparatus; microtubule organizing center; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; molecular transducer activity
OG_04444,FUN_018865-T1,Peve_00035798,Pocillopora_meandrina_HIv1___RNAseq.g368.t1,three_way,68.708,FUN_018865-T1,Q1LZ78,NTPCR_BOVIN,,Cancer-related nucleoside-triphosphatase homolog (NTPase) (EC 3.6.1.15) (Nucleoside triphosphate phosphohydrolase),Bos taurus (Bovine),47.9,190.0,3.5e-42,172.9,sp|Q1LZ78|NTPCR_BOVIN Cancer-related nucleoside-triphosphatase homolog OS=Bos taurus OX=9913 GN=NTPCR PE=2 SV=1,GO:0003924; GO:0005524; GO:0016887; GO:0017111; GO:0043273,,,ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CTPase activity [GO:0043273]; GTPase activity [GO:0003924]; ribonucleoside triphosphate phosphatase activity [GO:0017111],GO:0003824; GO:0003924; GO:0016787,catalytic activity; GTPase activity; hydrolase activity
OG_04445,FUN_018866-T1,Peve_00035799,Pocillopora_meandrina_HIv1___RNAseq.g369.t1,three_way,72.44133333333333,FUN_018866-T1,Q6INV3,,,,,56.3,71.0,2.7e-16,87.0,sp|Q6INV3|LRC57_XENLA Leucine-rich repeat-containing protein 57 OS=Xenopus laevis OX=8355 GN=lrrc57 PE=2 SV=1,,,,,,
OG_04446,FUN_018867-T1,Peve_00038302,Pocillopora_meandrina_HIv1___RNAseq.g3784.t1,three_way,49.116166666666665,,,,,,,,,,,,,,,,,
OG_04447,FUN_018948-T1,Peve_00035804,Pocillopora_meandrina_HIv1___RNAseq.g366.t1,three_way,49.209500000000006,FUN_018948-T1,P51954,NEK1_MOUSE,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1),Mus musculus (Mouse),41.7,266.0,6.8e-57,223.8,sp|P51954|NEK1_MOUSE Serine/threonine-protein kinase Nek1 OS=Mus musculus OX=10090 GN=Nek1 PE=1 SV=2,GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0007283; GO:0010212; GO:0030030; GO:0035264; GO:0046872; GO:0051301; GO:0071889; GO:0106310; GO:2000001,cell division [GO:0051301]; cell projection organization [GO:0030030]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04448,FUN_018972-T1,Peve_00009847,Pocillopora_meandrina_HIv1___RNAseq.g873.t1,three_way,55.61633333333334,,,,,,,,,,,,,,,,,
OG_04449,FUN_019015-T1,Peve_00035805,Pocillopora_meandrina_HIv1___RNAseq.g384.t1,three_way,68.97266666666667,FUN_019015-T1,Q03336,RGN_RAT,,Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30),Rattus norvegicus (Rat),49.3,134.0,6.5e-34,145.6,sp|Q03336|RGN_RAT Regucalcin OS=Rattus norvegicus OX=10116 GN=Rgn PE=1 SV=3,GO:0001822; GO:0001889; GO:0004341; GO:0005509; GO:0005634; GO:0005737; GO:0006874; GO:0007283; GO:0008270; GO:0010558; GO:0010867; GO:0010907; GO:0019853; GO:0030234; GO:0032781; GO:0043066; GO:0045019; GO:0045723; GO:0050680; GO:0050848; GO:0097421; GO:1901318; GO:1902679; GO:1903011; GO:1903052; GO:1903625; GO:2000279,intracellular calcium ion homeostasis [GO:0006874]; kidney development [GO:0001822]; L-ascorbic acid biosynthetic process [GO:0019853]; liver development [GO:0001889]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone development [GO:1903011]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA catabolic process [GO:1903625]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of flagellated sperm motility [GO:1901318]; negative regulation of macromolecule biosynthetic process [GO:0010558]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of RNA biosynthetic process [GO:1902679]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of calcium-mediated signaling [GO:0050848]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005975; GO:0006766; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; carbohydrate metabolic process; vitamin metabolic process; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity
OG_04450,FUN_019023-T1,Peve_00009450,Pocillopora_meandrina_HIv1___RNAseq.g9987.t1,three_way,68.78166666666667,,,,,,,,,,,,,,,,,
OG_04451,FUN_019128-T1,Peve_00024578,Pocillopora_meandrina_HIv1___RNAseq.g25384.t1b,three_way,61.328833333333336,,,,,,,,,,,,,,,,,
OG_04452,FUN_019129-T1,Peve_00024582,Pocillopora_meandrina_HIv1___RNAseq.g25384.t1a,three_way,50.742666666666665,,,,,,,,,,,,,,,,,
OG_04453,FUN_019130-T1,Peve_00024581,Pocillopora_meandrina_HIv1___TS.g25658.t1a,three_way,46.42666666666667,,,,,,,,,,,,,,,,,
OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04455,FUN_019138-T1,Peve_00032880,Pocillopora_meandrina_HIv1___TS.g25655.t1,three_way,66.97116666666666,FUN_019138-T1,Q80YE7,DAPK1_MOUSE,,Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1),Mus musculus (Mouse),33.5,319.0,3.5e-42,173.7,sp|Q80YE7|DAPK1_MOUSE Death-associated protein kinase 1 OS=Mus musculus OX=10090 GN=Dapk1 PE=1 SV=3,GO:0002357; GO:0002834; GO:0004672; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010508; GO:0014069; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0043065; GO:0043066; GO:0071346; GO:0071447; GO:0097190; GO:0098978; GO:0106310; GO:1902042; GO:1904094; GO:1990722; GO:2000310,apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to type II interferon [GO:0071346]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagic cell death [GO:1904094]; positive regulation of autophagy [GO:0010508]; protein phosphorylation [GO:0006468]; regulation of NMDA receptor activity [GO:2000310]; regulation of response to tumor cell [GO:0002834],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DAPK1-calmodulin complex [GO:1990722]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; syntaxin-1 binding [GO:0017075],GO:0003824; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04456,FUN_019139-T1,Peve_00032879,Pocillopora_meandrina_HIv1___RNAseq.g25379.t1,three_way,83.4905,FUN_019139-T1,P37287,PIGA_HUMAN,,Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A),Homo sapiens (Human),64.6,424.0,6.1e-154,545.4,sp|P37287|PIGA_HUMAN Phosphatidylinositol N-acetylglucosaminyltransferase subunit A OS=Homo sapiens OX=9606 GN=PIGA PE=1 SV=1,GO:0000506; GO:0005789; GO:0006506; GO:0008194; GO:0016020; GO:0017176; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; membrane [GO:0016020],phosphatidylinositol N-acetylglucosaminyltransferase activity [GO:0017176]; UDP-glycosyltransferase activity [GO:0008194],GO:0003824; GO:0006629; GO:0016740; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_04457,FUN_019141-T1,Peve_00024881,Pocillopora_meandrina_HIv1___RNAseq.g25378.t1,three_way,55.14266666666666,FUN_019141-T1,P15535,,,,,44.9,294.0,1.3e-67,258.5,"sp|P15535|B4GT1_MOUSE Beta-1,4-galactosyltransferase 1 OS=Mus musculus OX=10090 GN=B4galt1 PE=1 SV=1",,,,,,
OG_04458,FUN_019330-T1,Peve_00032905,Pocillopora_meandrina_HIv1___RNAseq.g19534.t1,three_way,82.16766666666666,FUN_019330-T1,Q8VXY7,,,,,26.4,390.0,3.3e-19,97.8,sp|Q8VXY7|ENT1_ARATH Equilibrative nucleotide transporter 1 OS=Arabidopsis thaliana OX=3702 GN=ENT1 PE=1 SV=1,,,,,,
OG_04459,FUN_019331-T1,Peve_00032903,Pocillopora_meandrina_HIv1___RNAseq.g20800.t1,three_way,84.01033333333334,FUN_019331-T1,O18373,,,,,64.6,305.0,4.4e-116,419.1,"sp|O18373|SPS1_DROME Inactive selenide, water dikinase-like protein OS=Drosophila melanogaster OX=7227 GN=Sps1 PE=2 SV=1",,,,,,
OG_04460,FUN_019334-T1,Peve_00040309,Pocillopora_meandrina_HIv1___RNAseq.g20765.t1,three_way,75.1505,FUN_019334-T1,Q3TIT8,SPX3_MOUSE,,Sugar phosphate exchanger 3 (Solute carrier family 37 member 3),Mus musculus (Mouse),50.9,477.0,6.6e-120,432.6,sp|Q3TIT8|SPX3_MOUSE Sugar phosphate exchanger 3 OS=Mus musculus OX=10090 GN=Slc37a3 PE=1 SV=1,GO:0005765; GO:0005789; GO:0006855; GO:0042910,xenobiotic transmembrane transport [GO:0006855],endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765],xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_04461,FUN_019335-T1,Peve_00040303,Pocillopora_meandrina_HIv1___RNAseq.g20809.t1,three_way,61.97033333333333,,,,,,,,,,,,,,,,,
OG_04462,FUN_019341-T1,Peve_00032918,Pocillopora_meandrina_HIv1___RNAseq.g20861.t1,three_way,61.333333333333336,FUN_019341-T1,Q8NHV4,NEDD1_HUMAN,,Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1),Homo sapiens (Human),34.3,697.0,4.2e-98,360.5,sp|Q8NHV4|NEDD1_HUMAN Protein NEDD1 OS=Homo sapiens OX=9606 GN=NEDD1 PE=1 SV=1,GO:0000242; GO:0000278; GO:0000922; GO:0001650; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007020; GO:0036064; GO:0043015; GO:0045177; GO:0051301,cell division [GO:0051301]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278],apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922],gamma-tubulin binding [GO:0043015],GO:0000278; GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0043226,mitotic cell cycle; nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_04463,FUN_019342-T1,Peve_00032901,Pocillopora_meandrina_HIv1___RNAseq.g20862.t1,three_way,54.33,FUN_019342-T1,Q01071,ESMD_DROME,,Enhancer of split mdelta protein (E(spl)mdelta) (HLH-mdelta) (Split locus enhancer protein mC),Drosophila melanogaster (Fruit fly),36.6,123.0,2e-12,74.3,sp|Q01071|ESMD_DROME Enhancer of split mdelta protein OS=Drosophila melanogaster OX=7227 GN=E(spl)mdelta-HLH PE=1 SV=1,GO:0000122; GO:0000978; GO:0005634; GO:0007219; GO:0007525; GO:0043565; GO:0045466; GO:0046983; GO:0048052; GO:0050767; GO:1902692; GO:1990837,negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; R1/R6 cell differentiation [GO:0048052]; R7 cell differentiation [GO:0045466]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; somatic muscle development [GO:0007525],nucleus [GO:0005634],protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development
OG_04464,FUN_019346-T1,Peve_00032914,Pocillopora_meandrina_HIv1___RNAseq.g20864.t1,three_way,58.6805,FUN_019346-T1,Q80XP9,WNK3_MOUSE,,Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3),Mus musculus (Mouse),68.5,378.0,6e-143,510.8,sp|Q80XP9|WNK3_MOUSE Serine/threonine-protein kinase WNK3 OS=Mus musculus OX=10090 GN=Wnk3 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005912; GO:0005923; GO:0006884; GO:0007231; GO:0010765; GO:0010800; GO:0035633; GO:0043066; GO:0044325; GO:0050801; GO:0051928; GO:0070294; GO:0071474; GO:0072659; GO:0090188; GO:0090279; GO:0106310; GO:0140693; GO:0140694; GO:0141109; GO:1903077; GO:1903078; GO:1904062; GO:2000651,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; maintenance of blood-brain barrier [GO:0035633]; membraneless organelle assembly [GO:0140694]; monoatomic ion homeostasis [GO:0050801]; negative regulation of apoptotic process [GO:0043066]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; osmosensory signaling pathway [GO:0007231]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to plasma membrane [GO:0072659]; regulation of calcium ion import [GO:0090279]; regulation of monoatomic cation transmembrane transport [GO:1904062]; renal sodium ion absorption [GO:0070294],adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; transmembrane transporter binding [GO:0044325]; transporter activator activity [GO:0141109],GO:0003014; GO:0003824; GO:0016740; GO:0060090; GO:0072659; GO:0098772; GO:0140096,"renal system process; catalytic activity; transferase activity; molecular adaptor activity; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04465,FUN_019382-T1,Peve_00031766,Pocillopora_meandrina_HIv1___RNAseq.g23704.t1,three_way,75.74716666666667,,,,,,,,,,,,,,,,,
OG_04466,FUN_019399-T1,Peve_00002021,Pocillopora_meandrina_HIv1___RNAseq.g6611.t1,three_way,70.861,FUN_019399-T1,Q2KJC3,MPEG1_BOVIN,,"Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Perforin-2) (P-2) [Cleaved into: Macrophage-expressed gene 1 protein, processed form]",Bos taurus (Bovine),38.2,688.0,1.1e-136,488.8,sp|Q2KJC3|MPEG1_BOVIN Macrophage-expressed gene 1 protein OS=Bos taurus OX=9913 GN=MPEG1 PE=2 SV=2,GO:0002250; GO:0002468; GO:0002478; GO:0022829; GO:0030670; GO:0031410; GO:0042590; GO:0042742; GO:0045335; GO:0050829; GO:0050830; GO:0061474; GO:0140367,adaptive immune response [GO:0002250]; antibacterial innate immune response [GO:0140367]; antigen processing and presentation of exogenous peptide antigen [GO:0002478]; antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendritic cell antigen processing and presentation [GO:0002468],cytoplasmic vesicle [GO:0031410]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; phagolysosome membrane [GO:0061474],wide pore channel activity [GO:0022829],GO:0002376; GO:0005215; GO:0031410; GO:0043226; GO:0098542,immune system process; transporter activity; cytoplasmic vesicle; organelle; defense response to other organism
OG_04467,FUN_019433-T2,Peve_00018458,Pocillopora_meandrina_HIv1___RNAseq.g20865.t1,three_way,64.422,FUN_019433-T2,O70244,,,,,30.3,379.0,7.000000000000002e-44,179.9,sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2,,,,,,
OG_04468,FUN_019560-T1,Peve_00032909,Pocillopora_meandrina_HIv1___RNAseq.g20816.t1,three_way,74.66783333333333,FUN_019560-T1,Q90941,,,,,38.3,1523.0,1.2e-280,968.4,sp|Q90941|PB1_CHICK Protein polybromo-1 OS=Gallus gallus OX=9031 GN=PBRM1 PE=1 SV=1,,,,,,
OG_04469,FUN_020835-T1,Peve_00010927,Pocillopora_meandrina_HIv1___RNAseq.g20757.t2,three_way,70.56066666666666,,,,,,,,,,,,,,,,,
OG_04470,FUN_020838-T1,Peve_00041429,Pocillopora_meandrina_HIv1___RNAseq.g20756.t1,three_way,72.166,FUN_020838-T1,E9Q634,MYO1E_MOUSE,,Unconventional myosin-Ie (Unconventional myosin 1E),Mus musculus (Mouse),41.5,697.0,1.0999999999999999e-148,529.3,sp|E9Q634|MYO1E_MOUSE Unconventional myosin-Ie OS=Mus musculus OX=10090 GN=Myo1e PE=1 SV=1,GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005903; GO:0005912; GO:0006897; GO:0016459; GO:0016887; GO:0030097; GO:0032836; GO:0035091; GO:0035166; GO:0045334; GO:0048008; GO:0051015; GO:0072015,endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091],GO:0003014; GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856,renal system process; cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development
OG_04471,FUN_020851-T1,Peve_00032912,Pocillopora_meandrina_HIv1___RNAseq.g20810.t1,three_way,76.60133333333333,FUN_020851-T1,B5X5D0,,,,,44.2,104.0,1e-20,100.9,sp|B5X5D0|PIRC1_SALSA Piercer of microtubule wall 1 protein OS=Salmo salar OX=8030 GN=pierce1 PE=2 SV=1,,,,,,
OG_04472,FUN_020852-T1,Peve_00032913,Pocillopora_meandrina_HIv1___RNAseq.g20811.t1,three_way,76.23033333333333,FUN_020852-T1,Q00PJ7,,,,,62.8,288.0,2.5e-108,393.3,sp|Q00PJ7|CAZA2_ATEAB F-actin-capping protein subunit alpha-2 OS=Atelerix albiventris OX=9368 GN=CAPZA2 PE=3 SV=1,,,,,,
OG_04473,FUN_020853-T1,Peve_00032915,Pocillopora_meandrina_HIv1___RNAseq.g20812.t1,three_way,73.17133333333334,FUN_020853-T1,Q3MII6,TBC25_HUMAN,,TBC1 domain family member 25,Homo sapiens (Human),34.2,626.0,1.3000000000000001e-89,332.0,sp|Q3MII6|TBC25_HUMAN TBC1 domain family member 25 OS=Homo sapiens OX=9606 GN=TBC1D25 PE=1 SV=2,GO:0005096; GO:0005776; GO:0006914; GO:0031410; GO:1901096,autophagy [GO:0006914]; regulation of autophagosome maturation [GO:1901096],autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410],GTPase activator activity [GO:0005096],GO:0005773; GO:0006914; GO:0031410; GO:0043226; GO:0098772,vacuole; autophagy; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_04474,FUN_020855-T1,Peve_00032916,Pocillopora_meandrina_HIv1___RNAseq.g20813.t1,three_way,66.00766666666667,,,,,,,,,,,,,,,,,
OG_04475,FUN_020917-T1,Peve_00041316,Pocillopora_meandrina_HIv1___RNAseq.g6156.t1,three_way,40.312333333333335,,,,,,,,,,,,,,,,,
OG_04476,FUN_020920-T1,Peve_00017285,Pocillopora_meandrina_HIv1___RNAseq.g15907.t1a,three_way,47.4085,FUN_020920-T1,O95450,,,,,28.7,905.0,8.1e-97,356.7,sp|O95450|ATS2_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 2 OS=Homo sapiens OX=9606 GN=ADAMTS2 PE=1 SV=2,,,,,,
OG_04477,FUN_021107-T1,Peve_00008862,Pocillopora_meandrina_HIv1___RNAseq.g4370.t1,three_way,74.41733333333333,FUN_021107-T1,Q5FVN8,,,,,34.2,325.0,2.8e-38,161.4,"sp|Q5FVN8|WSDU1_RAT WD repeat, SAM and U-box domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Wdsub1 PE=2 SV=1",,,,,,
OG_04478,FUN_021108-T1,Peve_00008861,Pocillopora_meandrina_HIv1___RNAseq.g4371.t1,three_way,84.41233333333334,FUN_021108-T1,Q15119,PDK2_HUMAN,,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)",Homo sapiens (Human),50.9,385.0,7.8e-108,392.1,"sp|Q15119|PDK2_HUMAN [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial OS=Homo sapiens OX=9606 GN=PDK2 PE=1 SV=2",GO:0004672; GO:0004740; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006006; GO:0006111; GO:0006885; GO:0008286; GO:0010510; GO:0010565; GO:0010906; GO:0031670; GO:0034614; GO:0042593; GO:0042803; GO:0045254; GO:0050848; GO:0072332,cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of ketone metabolic process [GO:0010565]; regulation of pH [GO:0006885],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254],ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0005975; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; mitochondrion; cytosol; carbohydrate metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04479,FUN_021449-T1,Peve_00025992,Pocillopora_meandrina_HIv1___RNAseq.g2971.t1,three_way,68.957,FUN_021449-T1,Q13416,ORC2_HUMAN,,Origin recognition complex subunit 2,Homo sapiens (Human),43.0,505.0,6.2e-99,362.8,sp|Q13416|ORC2_HUMAN Origin recognition complex subunit 2 OS=Homo sapiens OX=9606 GN=ORC2 PE=1 SV=2,GO:0000122; GO:0000781; GO:0000792; GO:0000808; GO:0000939; GO:0003688; GO:0005634; GO:0005654; GO:0005664; GO:0005813; GO:0006270; GO:0016020,DNA replication initiation [GO:0006270]; negative regulation of transcription by RNA polymerase II [GO:0000122],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; inner kinetochore [GO:0000939]; membrane [GO:0016020]; nuclear origin of replication recognition complex [GO:0005664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; origin recognition complex [GO:0000808]",DNA replication origin binding [GO:0003688],GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; microtubule organizing center; regulation of DNA-templated transcription; organelle
OG_04480,FUN_021451-T1,Peve_00016702,Pocillopora_meandrina_HIv1___RNAseq.g2924.t1,three_way,77.19016666666667,FUN_021451-T1,Q8R0S1,ATF7_MOUSE,,Cyclic AMP-dependent transcription factor ATF-7 (cAMP-dependent transcription factor ATF-7) (Activating transcription factor 7) (Transcription factor ATF-A),Mus musculus (Mouse),36.8,419.0,9.7e-51,202.6,sp|Q8R0S1|ATF7_MOUSE Cyclic AMP-dependent transcription factor ATF-7 OS=Mus musculus OX=10090 GN=Atf7 PE=1 SV=1,GO:0000781; GO:0001701; GO:0001889; GO:0002244; GO:0003677; GO:0003700; GO:0005654; GO:0007507; GO:0008270; GO:0038066; GO:0097284,heart development [GO:0007507]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; p38MAPK cascade [GO:0038066],"chromosome, telomeric region [GO:0000781]; nucleoplasm [GO:0005654]",DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0012501; GO:0030154; GO:0048856; GO:0140110,DNA binding; nucleoplasm; programmed cell death; cell differentiation; anatomical structure development; transcription regulator activity
OG_04481,FUN_021458-T1,Peve_00010329,Pocillopora_meandrina_HIv1___RNAseq.g2933.t1,three_way,50.342666666666666,,,,,,,,,,,,,,,,,
OG_04482,FUN_021463-T2,Peve_00016699,Pocillopora_meandrina_HIv1___RNAseq.g2972.t1,three_way,77.39433333333334,FUN_021463-T2,Q9XWB9,,,,,32.7,165.0,7.6e-16,85.9,sp|Q9XWB9|BAT36_CAEEL BTB and MATH domain-containing protein 36 OS=Caenorhabditis elegans OX=6239 GN=bath-36 PE=4 SV=1,,,,,,
OG_04483,FUN_021466-T1,Peve_00010332,Pocillopora_meandrina_HIv1___RNAseq.g2936.t1,three_way,68.288,,,,,,,,,,,,,,,,,
OG_04484,FUN_021473-T1,Peve_00002680,Pocillopora_meandrina_HIv1___RNAseq.g2937.t1,three_way,63.3845,FUN_021473-T1,Q3UHB8,,,,,29.0,335.0,3.1e-11,72.0,sp|Q3UHB8|CC177_MOUSE Coiled-coil domain-containing protein 177 OS=Mus musculus OX=10090 GN=Ccdc177 PE=1 SV=1,,,,,,
OG_04485,FUN_021478-T1,Peve_00013249,Pocillopora_meandrina_HIv1___RNAseq.g9417.t1,three_way,57.57933333333333,FUN_021478-T1,P51046,,,,,24.3,301.0,9.8e-15,82.8,sp|P51046|MR1AA_DANRE Melatonin receptor type 1A-A OS=Danio rerio OX=7955 GN=mtnr1aa PE=2 SV=2,,,,,,
OG_04486,FUN_021479-T1,Peve_00013215,Pocillopora_meandrina_HIv1___RNAseq.g9419.t1,three_way,44.461333333333336,,,,,,,,,,,,,,,,,
OG_04487,FUN_021608-T1,Peve_00002684,Pocillopora_meandrina_HIv1___RNAseq.g2921.t1,three_way,51.73733333333333,FUN_021608-T1,A0JPF9,ISPD_DANRE,,D-ribitol-5-phosphate cytidylyltransferase (EC 2.7.7.40) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein) (Isoprenoid synthase domain-containing protein),Danio rerio (Zebrafish) (Brachydanio rerio),46.1,323.0,1e-73,278.9,sp|A0JPF9|ISPD_DANRE D-ribitol-5-phosphate cytidylyltransferase OS=Danio rerio OX=7955 GN=crppa PE=2 SV=2,GO:0005829; GO:0008299; GO:0035269; GO:0042803; GO:0047349; GO:0048854; GO:0055001; GO:0060049; GO:0070567,brain morphogenesis [GO:0048854]; isoprenoid biosynthetic process [GO:0008299]; muscle cell development [GO:0055001]; protein O-linked mannosylation [GO:0035269]; regulation of protein glycosylation [GO:0060049],cytosol [GO:0005829],cytidylyltransferase activity [GO:0070567]; D-ribitol-5-phosphate cytidylyltransferase activity [GO:0047349]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006629; GO:0009101; GO:0016740; GO:0048856; GO:1901135,catalytic activity; cytosol; lipid metabolic process; glycoprotein biosynthetic process; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_04488,FUN_021610-T1,Peve_00002673,Pocillopora_meandrina_HIv1___RNAseq.g2919.t1,three_way,82.09833333333333,FUN_021610-T1,Q07537,GALT1_BOVIN,,Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form],Bos taurus (Bovine),47.5,556.0,7.3e-141,502.3,sp|Q07537|GALT1_BOVIN Polypeptide N-acetylgalactosaminyltransferase 1 OS=Bos taurus OX=9913 GN=GALNT1 PE=1 SV=1,GO:0004653; GO:0005576; GO:0005794; GO:0006493; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471,protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005576; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; extracellular region; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04489,FUN_021612-T1,Peve_00021567,Pocillopora_meandrina_HIv1___RNAseq.g4223.t1,three_way,65.06666666666666,FUN_021612-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),35.3,439.0,6.1e-64,246.5,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_04490,FUN_021819-T1,Peve_00036137,Pocillopora_meandrina_HIv1___TS.g20331.t1a,three_way,68.62833333333333,,,,,,,,,,,,,,,,,
OG_04491,FUN_021922-T1,Peve_00016338,Pocillopora_meandrina_HIv1___RNAseq.g2917.t1,three_way,68.88416666666666,,,,,,,,,,,,,,,,,
OG_04492,FUN_021923-T1,Peve_00016339,Pocillopora_meandrina_HIv1___RNAseq.g2916.t1a,three_way,59.88366666666666,FUN_021923-T1,Q9CPS6,,,,,43.3,67.0,9.4e-10,64.3,sp|Q9CPS6|HINT3_MOUSE Adenosine 5'-monophosphoramidase HINT3 OS=Mus musculus OX=10090 GN=Hint3 PE=1 SV=1,,,,,,
OG_04493,FUN_021925-T2,Peve_00023939,Pocillopora_meandrina_HIv1___RNAseq.g2916.t1c,three_way,63.59733333333333,FUN_021925-T2,A0JMM9,,,,,37.1,132.0,5.3e-20,99.4,sp|A0JMM9|GGACA_DANRE Gamma-glutamylaminecyclotransferase A OS=Danio rerio OX=7955 GN=ggact.1 PE=2 SV=1,,,,,,
OG_04494,FUN_021926-T1,Peve_00000368,Pocillopora_meandrina_HIv1___RNAseq.g2915.t1,three_way,72.39533333333334,,,,,,,,,,,,,,,,,
OG_04495,FUN_021927-T1,Peve_00000369,Pocillopora_meandrina_HIv1___RNAseq.g2914.t1,three_way,67.16066666666667,,,,,,,,,,,,,,,,,
OG_04496,FUN_021928-T1,Peve_00023935,Pocillopora_meandrina_HIv1___RNAseq.g2913.t1,three_way,79.017,FUN_021928-T1,O81884,,,,,44.3,316.0,7.099999999999999e-70,265.8,sp|O81884|GALDH_ARATH L-galactose dehydrogenase OS=Arabidopsis thaliana OX=3702 GN=LGALDH PE=1 SV=1,,,,,,
OG_04497,FUN_021932-T1,Peve_00023933,Pocillopora_meandrina_HIv1___RNAseq.g2963.t1,three_way,94.748,FUN_021932-T1,Q13616,CUL1_HUMAN,,Cullin-1 (CUL-1),Homo sapiens (Human),78.6,776.0,0.0,1172.1,sp|Q13616|CUL1_HUMAN Cullin-1 OS=Homo sapiens OX=9606 GN=CUL1 PE=1 SV=2,GO:0000082; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006513; GO:0008283; GO:0009887; GO:0016567; GO:0019005; GO:0030674; GO:0031146; GO:0031461; GO:0031625; GO:0043123; GO:0043161; GO:0070936; GO:0097193; GO:0160072; GO:1990452,animal organ morphogenesis [GO:0009887]; cell population proliferation [GO:0008283]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; plasma membrane [GO:0005886]; SCF ubiquitin ligase complex [GO:0019005],protein-macromolecule adaptor activity [GO:0030674]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0030163; GO:0043226; GO:0060090,nucleus; nucleoplasm; cytosol; plasma membrane; protein catabolic process; organelle; molecular adaptor activity
OG_04498,FUN_021934-T1,Peve_00023932,Pocillopora_meandrina_HIv1___RNAseq.g2962.t1,three_way,57.409666666666666,,,,,,,,,,,,,,,,,
OG_04499,FUN_021937-T1,Peve_00023931,Pocillopora_meandrina_HIv1___RNAseq.g2961.t1,three_way,82.98416666666667,FUN_021937-T1,P50549,ETV1_HUMAN,,ETS translocation variant 1 (Ets-related protein 81),Homo sapiens (Human),35.8,477.0,1.3e-58,228.8,sp|P50549|ETV1_HUMAN ETS translocation variant 1 OS=Homo sapiens OX=9606 GN=ETV1 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0006357; GO:0006366; GO:0007411; GO:0007517; GO:0007638; GO:0030154; GO:0045944; GO:0048935; GO:1990837,axon guidance [GO:0007411]; cell differentiation [GO:0030154]; mechanosensory behavior [GO:0007638]; muscle organ development [GO:0007517]; peripheral nervous system neuron development [GO:0048935]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04500,FUN_021938-T1,Peve_00023930,Pocillopora_meandrina_HIv1___RNAseq.g2960.t2,three_way,73.7475,FUN_021938-T1,Q4W5Z4,DNM3A_CHICK,,DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (Cysteine methyltransferase DNMT3A) (EC 2.1.1.-),Gallus gallus (Chicken),47.0,651.0,6.4e-174,612.5,sp|Q4W5Z4|DNM3A_CHICK DNA (cytosine-5)-methyltransferase 3A OS=Gallus gallus OX=9031 GN=DNMT3A PE=2 SV=1,GO:0000791; GO:0001046; GO:0003886; GO:0005634; GO:0005737; GO:0008270; GO:0009408; GO:0016363; GO:0032259; GO:0044027; GO:0045892; GO:0071774; GO:0106363,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; response to fibroblast growth factor [GO:0071774]; response to heat [GO:0009408],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear matrix [GO:0016363]; nucleus [GO:0005634],core promoter sequence-specific DNA binding [GO:0001046]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; protein-cysteine methyltransferase activity [GO:0106363]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0140096; GO:0140097,"DNA binding; catalytic activity; nucleus; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_04501,FUN_021939-T1,Peve_00022544,Pocillopora_meandrina_HIv1___RNAseq.g12977.t2,three_way,61.04866666666667,FUN_021939-T1,Q5M888,,,,,43.1,404.0,8.3e-83,308.9,sp|Q5M888|CG025_RAT UPF0415 protein C7orf25 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1,,,,,,
OG_04502,FUN_021996-T1,Peve_00019249,Pocillopora_meandrina_HIv1___RNAseq.g108.t1,three_way,70.58833333333334,,,,,,,,,,,,,,,,,
OG_04503,FUN_022013-T1,Peve_00042673,Pocillopora_meandrina_HIv1___RNAseq.g3139.t1,three_way,74.30833333333334,FUN_022013-T1,Q05360,,,,,43.6,676.0,1.9e-149,531.2,sp|Q05360|WHITE_LUCCU Protein white OS=Lucilia cuprina OX=7375 GN=W PE=2 SV=2,,,,,,
OG_04504,FUN_022016-T1,Peve_00042666,Pocillopora_meandrina_HIv1___RNAseq.g3182.t2,three_way,75.399,FUN_022016-T1,P07228,,,,,38.2,808.0,2.6e-144,514.2,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_04505,FUN_022017-T1,Peve_00030675,Pocillopora_meandrina_HIv1___RNAseq.g3183.t1,three_way,89.45066666666666,FUN_022017-T1,Q0II68,,,,,67.9,336.0,3.7e-151,535.8,sp|Q0II68|ACMSD_BOVIN 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase OS=Bos taurus OX=9913 GN=ACMSD PE=2 SV=1,,,,,,
OG_04506,FUN_022030-T1,Peve_00036252,Pocillopora_meandrina_HIv1___RNAseq.g3188.t1,three_way,85.19900000000001,FUN_022030-T1,Q9Z1G4,VPP1_MOUSE,,V-type proton ATPase 116 kDa subunit a 1 (V-ATPase 116 kDa subunit a 1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1),Mus musculus (Mouse),63.4,855.0,9.9e-307,1053.9,sp|Q9Z1G4|VPP1_MOUSE V-type proton ATPase 116 kDa subunit a 1 OS=Mus musculus OX=10090 GN=Atp6v0a1 PE=1 SV=3,GO:0000220; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0016241; GO:0016607; GO:0030665; GO:0030672; GO:0042470; GO:0046961; GO:0048471; GO:0051117; GO:0097401,regulation of macroautophagy [GO:0016241]; synaptic vesicle lumen acidification [GO:0097401],"clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]","ATPase binding [GO:0051117]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0005794; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0055085; GO:0140657,transporter activity; Golgi apparatus; cytosol; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_04507,FUN_022031-T1,Peve_00036254,Pocillopora_meandrina_HIv1___RNAseq.g3190.t1,three_way,65.41766666666666,FUN_022031-T1,Q86A72,,,,,24.7,178.0,1.5e-07,60.1,sp|Q86A72|Y4781_DICDI Recoverin family protein DDB_G0274781 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0274781 PE=3 SV=1,,,,,,
OG_04508,FUN_022036-T1,Peve_00019003,Pocillopora_meandrina_HIv1___RNAseq.g9285.t1,three_way,61.077333333333335,,,,,,,,,,,,,,,,,
OG_04509,FUN_022038-T1,Peve_00016622,Pocillopora_meandrina_HIv1___RNAseq.g9268.t1,three_way,65.09233333333333,FUN_022038-T1,Q568B7,,,,,53.4,425.0,7.300000000000001e-125,448.7,sp|Q568B7|QTMAN_DANRE tRNA-queuosine alpha-mannosyltransferase OS=Danio rerio OX=7955 GN=gtdc1 PE=2 SV=2,,,,,,
OG_04510,FUN_022042-T1,Peve_00006664,Pocillopora_meandrina_HIv1___RNAseq.g9275.t1,three_way,80.45416666666667,FUN_022042-T1,Q9CYL5,,,,,49.0,145.0,2.7e-33,144.4,sp|Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr2 PE=1 SV=3,,,,,,
OG_04511,FUN_022043-T1,Peve_00004576,Pocillopora_meandrina_HIv1___RNAseq.g9277.t1,three_way,83.28766666666667,FUN_022043-T1,Q9BZE4,GTPB4_HUMAN,,GTP-binding protein 4 (Chronic renal failure gene protein) (GTP-binding protein NGB) (Nucleolar GTP-binding protein 1),Homo sapiens (Human),58.0,638.0,2.2e-202,706.8,sp|Q9BZE4|GTPB4_HUMAN GTP-binding protein 4 OS=Homo sapiens OX=9606 GN=GTPBP4 PE=1 SV=3,GO:0000463; GO:0001649; GO:0003723; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008156; GO:0008285; GO:0010972; GO:0016020; GO:0022408; GO:0030336; GO:0031397; GO:0031965; GO:0042273; GO:0048471; GO:0050821; GO:1990275,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of DNA replication [GO:0008156]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; ribosomal large subunit biogenesis [GO:0042273]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; preribosome binding [GO:1990275]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016787; GO:0030154; GO:0043226,RNA binding; catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; cytosol; hydrolase activity; cell differentiation; organelle
OG_04512,FUN_022044-T1,Peve_00007834,Pocillopora_meandrina_HIv1___RNAseq.g9290.t1,three_way,72.45516666666667,FUN_022044-T1,Q5T2R2,DPS1_HUMAN,,All trans-polyprenyl-diphosphate synthase PDSS1 (All-trans-decaprenyl-diphosphate synthase subunit 1) (EC 2.5.1.91) (Decaprenyl pyrophosphate synthase subunit 1) (Decaprenyl-diphosphate synthase subunit 1) (Solanesyl-diphosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1),Homo sapiens (Human),57.9,323.0,3e-102,373.6,sp|Q5T2R2|DPS1_HUMAN All trans-polyprenyl-diphosphate synthase PDSS1 OS=Homo sapiens OX=9606 GN=PDSS1 PE=1 SV=1,GO:0004659; GO:0005739; GO:0005759; GO:0006744; GO:0008299; GO:0032476; GO:0032478; GO:0046872; GO:0046982; GO:0052923; GO:0097269; GO:0110142,isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],heterotetrameric polyprenyl diphosphate synthase complex [GO:0032478]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; polyprenyl diphosphate synthase complex [GO:0032476]; ubiquinone biosynthesis complex [GO:0110142],all-trans-decaprenyl-diphosphate synthase activity [GO:0097269]; all-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific) activity [GO:0052923]; metal ion binding [GO:0046872]; prenyltransferase activity [GO:0004659]; protein heterodimerization activity [GO:0046982],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_04513,FUN_022046-T1,Peve_00007833,Pocillopora_meandrina_HIv1___RNAseq.g9288.t1,three_way,85.22166666666666,FUN_022046-T1,Q8WVP7,LMBR1_HUMAN,,Limb region 1 protein homolog (Differentiation-related gene 14 protein),Homo sapiens (Human),51.5,464.0,4.400000000000001e-118,426.4,sp|Q8WVP7|LMBR1_HUMAN Limb region 1 protein homolog OS=Homo sapiens OX=9606 GN=LMBR1 PE=1 SV=1,GO:0004888; GO:0005886; GO:0007165; GO:0042733,embryonic digit morphogenesis [GO:0042733]; signal transduction [GO:0007165],plasma membrane [GO:0005886],transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_04514,FUN_022047-T1,Peve_00017133,Pocillopora_meandrina_HIv1___RNAseq.g4597.t1,three_way,56.1085,FUN_022047-T1,Q8JZM8,,,,,27.0,852.0,8.8e-68,261.5,sp|Q8JZM8|MUC4_MOUSE Mucin-4 OS=Mus musculus OX=10090 GN=Muc4 PE=2 SV=2,,,,,,
OG_04515,FUN_022048-T1,Peve_00017132,Pocillopora_meandrina_HIv1___RNAseq.g4598.t1,three_way,56.047666666666665,FUN_022048-T1,Q7TN88,,,,,27.8,1834.0,3.2e-182,642.5,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_04516,FUN_022049-T1,Peve_00032394,Pocillopora_meandrina_HIv1___RNAseq.g4599.t1,three_way,67.69266666666667,FUN_022049-T1,Q9C098,DCLK3_HUMAN,,Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3),Homo sapiens (Human),59.1,269.0,1.9999999999999998e-91,338.6,sp|Q9C098|DCLK3_HUMAN Serine/threonine-protein kinase DCLK3 OS=Homo sapiens OX=9606 GN=DCLK3 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0034504; GO:0106310,protein localization to nucleus [GO:0034504],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04517,FUN_022051-T1,Peve_00014023,Pocillopora_meandrina_HIv1___RNAseq.g4603.t1,three_way,64.20333333333333,,,,,,,,,,,,,,,,,
OG_04518,FUN_022052-T1,Peve_00014024,Pocillopora_meandrina_HIv1___TS.g22020.t1b,three_way,85.33466666666666,FUN_022052-T1,A1DWM3,,,,,41.0,592.0,4e-107,390.2,sp|A1DWM3|MFSD6_PIG Major facilitator superfamily domain-containing protein 6 OS=Sus scrofa OX=9823 GN=MFSD6 PE=2 SV=1,,,,,,
OG_04519,FUN_022053-T1,Peve_00014931,Pocillopora_meandrina_HIv1___TS.g22020.t1a,three_way,47.467333333333336,FUN_022053-T1,Q6P135,,,,,29.6,152.0,8.4e-08,59.3,sp|Q6P135|TMUB1_DANRE Transmembrane and ubiquitin-like domain-containing protein 1 OS=Danio rerio OX=7955 GN=tmub1 PE=2 SV=1,,,,,,
OG_04520,FUN_022054-T1,Peve_00014935,Pocillopora_meandrina_HIv1___TS.g22021.t1,three_way,85.77199999999999,FUN_022054-T1,A7RHL5,,,,,85.4,82.0,1.3000000000000001e-33,143.3,sp|A7RHL5|COSA_NEMVE Costars family protein v1g158749 OS=Nematostella vectensis OX=45351 GN=v1g158749 PE=3 SV=1,,,,,,
OG_04521,FUN_022055-T1,Peve_00014937,Pocillopora_meandrina_HIv1___RNAseq.g4606.t1,three_way,77.94066666666666,FUN_022055-T1,Q9BVL4,SELO_HUMAN,,"Protein adenylyltransferase SelO, mitochondrial (EC 2.7.7.-) (EC 2.7.7.108) (Selenoprotein O) (SelO)",Homo sapiens (Human),55.3,631.0,1.3999999999999999e-191,671.0,"sp|Q9BVL4|SELO_HUMAN Protein adenylyltransferase SelO, mitochondrial OS=Homo sapiens OX=9606 GN=SELENOO PE=1 SV=3",GO:0005524; GO:0005694; GO:0005739; GO:0018117; GO:0046872; GO:0070733,protein adenylylation [GO:0018117],chromosome [GO:0005694]; mitochondrion [GO:0005739],AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],GO:0003824; GO:0005694; GO:0005739; GO:0016740; GO:0043226,catalytic activity; chromosome; mitochondrion; transferase activity; organelle
OG_04522,FUN_022056-T1,Peve_00014019,Pocillopora_meandrina_HIv1___RNAseq.g4607.t1,three_way,71.81,FUN_022056-T1,P0C8Z0,,,,,36.7,120.0,4.4e-14,79.3,sp|P0C8Z0|Y8359_ORYSI Uncharacterized protein OsI_027940 OS=Oryza sativa subsp. indica OX=39946 GN=OsI_027940 PE=1 SV=2,,,,,,
OG_04523,FUN_022057-T1,Peve_00014939,Pocillopora_meandrina_HIv1___RNAseq.g4608.t1,three_way,86.64366666666668,FUN_022057-T1,M0RDU0,,,,,37.1,350.0,4.3e-50,199.9,sp|M0RDU0|HAP40_RAT 40-kDa huntingtin-associated protein OS=Rattus norvegicus OX=10116 GN=F8a1 PE=1 SV=1,,,,,,
OG_04524,FUN_022059-T1,Peve_00014932,Pocillopora_meandrina_HIv1___RNAseq.g4610.t1,three_way,48.778,FUN_022059-T1,Q9NVV4,PAPD1_HUMAN,,"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)",Homo sapiens (Human),35.3,292.0,4.3e-40,167.9,"sp|Q9NVV4|PAPD1_HUMAN Poly(A) RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=MTPAP PE=1 SV=1",GO:0000287; GO:0000965; GO:0002134; GO:0003723; GO:0005524; GO:0005654; GO:0005739; GO:0006397; GO:0030145; GO:0031123; GO:0042802; GO:0042803; GO:0043231; GO:0071044; GO:1990817,histone mRNA catabolic process [GO:0071044]; mitochondrial RNA 3'-end processing [GO:0000965]; mRNA processing [GO:0006397]; RNA 3'-end processing [GO:0031123],intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; poly(A) RNA polymerase activity [GO:1990817]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; UTP binding [GO:0002134],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0016071; GO:0016740; GO:0043226; GO:0140053,RNA binding; catalytic activity; nucleoplasm; mitochondrion; mRNA metabolic process; transferase activity; organelle; mitochondrial gene expression
OG_04525,FUN_022066-T1,Peve_00012093,Pocillopora_meandrina_HIv1___RNAseq.g4616.t1,three_way,73.00566666666667,FUN_022066-T1,Q32L53,LFG1_BOVIN,,Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit),Bos taurus (Bovine),43.7,222.0,1.4e-38,161.8,sp|Q32L53|LFG1_BOVIN Protein lifeguard 1 OS=Bos taurus OX=9913 GN=GRINA PE=2 SV=1,GO:0005262; GO:0005783; GO:0005794; GO:0016020; GO:0043524; GO:0097190; GO:1902042,apoptotic signaling pathway [GO:0097190]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524],endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],calcium channel activity [GO:0005262],GO:0005215; GO:0005783; GO:0005794; GO:0043226,transporter activity; endoplasmic reticulum; Golgi apparatus; organelle
OG_04526,FUN_022067-T1,Peve_00012095,Pocillopora_meandrina_HIv1___RNAseq.g4618.t1,three_way,80.96883333333334,FUN_022067-T1,Q86X95,CIR1_HUMAN,,Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor) (Recepin),Homo sapiens (Human),54.5,134.0,2.9e-30,134.0,sp|Q86X95|CIR1_HUMAN Corepressor interacting with RBPJ 1 OS=Homo sapiens OX=9606 GN=CIR1 PE=1 SV=1,GO:0000122; GO:0001701; GO:0003714; GO:0005634; GO:0005737; GO:0005813; GO:0006397; GO:0008380; GO:0016607; GO:0019901; GO:0032991; GO:0042826; GO:0044877; GO:0045892,in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; RNA splicing [GO:0008380],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005815; GO:0006355; GO:0016071; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; microtubule organizing center; regulation of DNA-templated transcription; mRNA metabolic process; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_04527,FUN_022071-T1,Peve_00012099,Pocillopora_meandrina_HIv1___RNAseq.g4619.t1,three_way,95.92566666666669,FUN_022071-T1,P11833,,,,,91.9,445.0,4.0000000000000005e-243,841.6,sp|P11833|TBB_PARLI Tubulin beta chain OS=Paracentrotus lividus OX=7656 PE=2 SV=1,,,,,,
OG_04528,FUN_022072-T1,Peve_00025462,Pocillopora_meandrina_HIv1___RNAseq.g4582.t1,three_way,69.28633333333333,FUN_022072-T1,Q1MTN8,,,,,29.9,324.0,1.3e-27,125.6,sp|Q1MTN8|ACL4_SCHPO Probable assembly chaperone of rpl4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC16D10.01c PE=3 SV=2,,,,,,
OG_04529,FUN_022073-T1,Peve_00012101,Pocillopora_meandrina_HIv1___RNAseq.g4581.t1,three_way,60.477,FUN_022073-T1,P58557,,,,,36.4,162.0,2.6e-19,97.1,sp|P58557|YBEY_HUMAN Endoribonuclease YbeY OS=Homo sapiens OX=9606 GN=YBEY PE=1 SV=2,,,,,,
OG_04530,FUN_022074-T1,Peve_00038289,Pocillopora_meandrina_HIv1___RNAseq.g4562.t1,three_way,49.9445,,,,,,,,,,,,,,,,,
OG_04531,FUN_022075-T1,Peve_00038290,Pocillopora_meandrina_HIv1___RNAseq.g9321.t1,three_way,59.58166666666667,,,,,,,,,,,,,,,,,
OG_04532,FUN_022076-T1,Peve_00038277,Pocillopora_meandrina_HIv1___RNAseq.g9325.t1,three_way,82.528,FUN_022076-T1,B2GUE2,,,,,35.5,338.0,2.8e-25,117.9,sp|B2GUE2|LRRF2_XENTR Leucine-rich repeat flightless-interacting protein 2 OS=Xenopus tropicalis OX=8364 GN=lrrfip2 PE=2 SV=1,,,,,,
OG_04533,FUN_022079-T1,Peve_00038279,Pocillopora_meandrina_HIv1___TS.g19620.t1,three_way,56.668,FUN_022079-T1,Q3TZ87,MARH9_MOUSE,,E3 ubiquitin-protein ligase MARCHF9 (EC 2.3.2.27) (Membrane-associated RING finger protein 9) (Membrane-associated RING-CH protein IX) (MARCH-IX) (RING-type E3 ubiquitin transferase MARCHF9),Mus musculus (Mouse),33.2,187.0,1.4e-21,105.5,sp|Q3TZ87|MARH9_MOUSE E3 ubiquitin-protein ligase MARCHF9 OS=Mus musculus OX=10090 GN=Marchf9 PE=2 SV=1,GO:0000139; GO:0004842; GO:0005765; GO:0005795; GO:0005802; GO:0008270; GO:0016567,protein ubiquitination [GO:0016567],Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lysosomal membrane [GO:0005765]; trans-Golgi network [GO:0005802],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04534,FUN_022086-T1,Peve_00038282,Pocillopora_meandrina_HIv1___RNAseq.g9328.t1,three_way,60.606,FUN_022086-T1,Q6GN40,,,,,26.0,169.0,6e-14,79.7,sp|Q6GN40|CNPY3_XENLA Protein canopy homolog 3 OS=Xenopus laevis OX=8355 GN=cnpy3 PE=2 SV=2,,,,,,
OG_04535,FUN_022087-T1,Peve_00038283,Pocillopora_meandrina_HIv1___RNAseq.g9329.t1,three_way,74.059,,,,,,,,,,,,,,,,,
OG_04536,FUN_022092-T1,Peve_00038684,Pocillopora_meandrina_HIv1___RNAseq.g4111.t1,three_way,48.881,,,,,,,,,,,,,,,,,
OG_04537,FUN_022093-T1,Peve_00038681,Pocillopora_meandrina_HIv1___RNAseq.g4110.t1,three_way,51.9395,FUN_022093-T1,P47984,ZP2_FELCA,,Zona pellucida sperm-binding protein 2 (Zona pellucida glycoprotein 2) (Zp-2) (Zona pellucida protein A) [Cleaved into: Processed zona pellucida sperm-binding protein 2],Felis catus (Cat) (Felis silvestris catus),26.6,316.0,4.2e-21,104.0,sp|P47984|ZP2_FELCA Zona pellucida sperm-binding protein 2 OS=Felis catus OX=9685 GN=ZP2 PE=2 SV=1,GO:0005576; GO:0005771; GO:0005783; GO:0005886; GO:0007339; GO:0032190; GO:0035804; GO:0035805; GO:0060468; GO:0062023,binding of sperm to zona pellucida [GO:0007339]; prevention of polyspermy [GO:0060468],collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886],acrosin binding [GO:0032190]; structural constituent of egg coat [GO:0035804],GO:0005198; GO:0005576; GO:0005768; GO:0005783; GO:0005886; GO:0030312; GO:0031012; GO:0031410; GO:0043226,structural molecule activity; extracellular region; endosome; endoplasmic reticulum; plasma membrane; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle
OG_04538,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_04539,FUN_022096-T1,Peve_00038680,Pocillopora_meandrina_HIv1___RNAseq.g4123.t1,three_way,44.281,,,,,,,,,,,,,,,,,
OG_04540,FUN_022097-T1,Peve_00038679,Pocillopora_meandrina_HIv1___RNAseq.g4107.t1,three_way,79.26,FUN_022097-T1,A8MV24,,,,,47.5,141.0,3e-29,129.8,sp|A8MV24|SPMA1_HUMAN Sperm microtubule associated protein 1 OS=Homo sapiens OX=9606 GN=SPMAP1 PE=1 SV=1,,,,,,
OG_04541,FUN_022098-T1,Peve_00038678,Pocillopora_meandrina_HIv1___RNAseq.g4106.t1,three_way,67.46583333333334,FUN_022098-T1,Q9IA31,,,,,31.5,523.0,6.9e-32,141.4,sp|Q9IA31|GLI3_CHICK Transcriptional activator GLI3 (Fragment) OS=Gallus gallus OX=9031 GN=GLI3 PE=1 SV=1,,,,,,
OG_04542,FUN_022103-T1,Peve_00009716,Pocillopora_meandrina_HIv1___RNAseq.g4105.t1,three_way,85.40766666666667,FUN_022103-T1,A6H779,FBXL2_BOVIN,,F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2),Bos taurus (Bovine),69.6,102.0,2.1e-37,158.3,sp|A6H779|FBXL2_BOVIN F-box/LRR-repeat protein 2 OS=Bos taurus OX=9913 GN=FBXL2 PE=2 SV=1,GO:0005516; GO:0006513; GO:0010506; GO:0016020; GO:0016567; GO:0019005; GO:0019903; GO:0031146; GO:0036312; GO:0044830; GO:0050727; GO:0051896; GO:1900226; GO:1990756,modulation by host of viral RNA genome replication [GO:0044830]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],membrane [GO:0016020]; SCF ubiquitin ligase complex [GO:0019005],calmodulin binding [GO:0005516]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; protein phosphatase binding [GO:0019903]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_04543,FUN_022104-T2,Peve_00009726,Pocillopora_meandrina_HIv1___RNAseq.g4104.t1,three_way,90.09683333333334,FUN_022104-T2,Q9JHD2,KAT2A_MOUSE,,Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (MmGCN5) (Histone glutaryltransferase KAT2A) (EC 2.3.1.-) (Histone succinyltransferase KAT2A) (EC 2.3.1.-) (Lysine acetyltransferase 2A),Mus musculus (Mouse),63.9,758.0,4.4999999999999997e-293,1008.4,sp|Q9JHD2|KAT2A_MOUSE Histone acetyltransferase KAT2A OS=Mus musculus OX=10090 GN=Kat2a PE=1 SV=2,GO:0000122; GO:0000123; GO:0000124; GO:0001701; GO:0001756; GO:0001819; GO:0001843; GO:0003682; GO:0003713; GO:0004402; GO:0005634; GO:0005654; GO:0005813; GO:0006094; GO:0006282; GO:0006355; GO:0006357; GO:0007399; GO:0007507; GO:0007616; GO:0008080; GO:0010484; GO:0016407; GO:0019903; GO:0021537; GO:0022037; GO:0030901; GO:0031346; GO:0031647; GO:0031667; GO:0033276; GO:0035264; GO:0042826; GO:0043484; GO:0043992; GO:0043993; GO:0043997; GO:0045252; GO:0045589; GO:0045721; GO:0045722; GO:0045893; GO:0045944; GO:0045995; GO:0046600; GO:0048144; GO:0048167; GO:0048312; GO:0050863; GO:0051302; GO:0051726; GO:0060173; GO:0061035; GO:0071356; GO:0072686; GO:0106078; GO:0106227; GO:0106229; GO:0140297; GO:0140672; GO:1903010; GO:1990090; GO:2000036; GO:2000727,cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; fibroblast proliferation [GO:0048144]; gluconeogenesis [GO:0006094]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular distribution of mitochondria [GO:0048312]; limb development [GO:0060173]; long-term memory [GO:0007616]; metencephalon development [GO:0022037]; midbrain development [GO:0030901]; multicellular organism growth [GO:0035264]; negative regulation of centriole replication [GO:0046600]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural tube closure [GO:0001843]; peptidyl-lysine glutarylation [GO:0106227]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell projection organization [GO:0031346]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of bone development [GO:1903010]; regulation of cartilage development [GO:0061035]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of RNA splicing [GO:0043484]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell activation [GO:0050863]; regulation of transcription by RNA polymerase II [GO:0006357]; response to nutrient levels [GO:0031667]; somitogenesis [GO:0001756]; telencephalon development [GO:0021537],ATAC complex [GO:0140672]; centrosome [GO:0005813]; histone acetyltransferase complex [GO:0000123]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone deacetylase binding [GO:0042826]; histone glutaryltransferase activity [GO:0106229]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K9 acetyltransferase activity [GO:0043992]; histone H4K12 acetyltransferase activity [GO:0043997]; histone succinyltransferase activity [GO:0106078]; N-acetyltransferase activity [GO:0008080]; protein phosphatase binding [GO:0019903]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005975; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; carbohydrate metabolic process; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_04544,FUN_022106-T1,Peve_00025701,Pocillopora_meandrina_HIv1___RNAseq.g9229.t1,three_way,68.26433333333333,FUN_022106-T1,Q5E9J9,,,,,39.2,375.0,1.3e-70,268.5,sp|Q5E9J9|STRAA_BOVIN STE20-related kinase adapter protein alpha OS=Bos taurus OX=9913 GN=STRADA PE=2 SV=1,,,,,,
OG_04545,FUN_022110-T1,Peve_00020403,Pocillopora_meandrina_HIv1___RNAseq.g9226.t1,three_way,64.77066666666667,FUN_022110-T1,Q9FN03,,,,,33.7,347.0,2.7e-51,204.9,sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1,,,,,,
OG_04546,FUN_022112-T1,Peve_00036606,Pocillopora_meandrina_HIv1___RNAseq.g4778.t1,three_way,74.535,FUN_022112-T1,Q8IZD6,S22AF_HUMAN,,Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1),Homo sapiens (Human),34.7,435.0,2.5000000000000002e-58,228.0,sp|Q8IZD6|S22AF_HUMAN Solute carrier family 22 member 15 OS=Homo sapiens OX=9606 GN=SLC22A15 PE=1 SV=1,GO:0005886; GO:0006811; GO:0006865; GO:0015199,amino acid transport [GO:0006865]; monoatomic ion transport [GO:0006811],plasma membrane [GO:0005886],amino-acid betaine transmembrane transporter activity [GO:0015199],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_04547,FUN_022170-T1,Peve_00036602,Pocillopora_meandrina_HIv1___RNAseq.g4779.t1,three_way,50.17433333333334,FUN_022170-T1,B8UU78,,,,,90.7,1117.0,0.0,1992.2,sp|B8UU78|ELP_ACRMI EGF and laminin G domain-containing protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_04548,FUN_022174-T1,Peve_00036601,Pocillopora_meandrina_HIv1___RNAseq.g4782.t1,three_way,67.46216666666666,FUN_022174-T1,O42370,,,,,39.8,181.0,7.100000000000002e-22,105.5,sp|O42370|HXD3A_DANRE Homeobox protein Hox-D3a OS=Danio rerio OX=7955 GN=hoxd3a PE=2 SV=2,,,,,,
OG_04549,FUN_022175-T1,Peve_00036598,Pocillopora_meandrina_HIv1___RNAseq.g4783.t1,three_way,69.11966666666667,,,,,,,,,,,,,,,,,
OG_04550,FUN_022178-T1,Peve_00036596,Pocillopora_meandrina_HIv1___RNAseq.g4784.t1,three_way,69.363,FUN_022178-T1,P07548,DFD_DROME,,Homeotic protein deformed,Drosophila melanogaster (Fruit fly),68.6,70.0,4.6e-19,96.3,sp|P07548|DFD_DROME Homeotic protein deformed OS=Drosophila melanogaster OX=7227 GN=Dfd PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0007380; GO:0009952; GO:0010468; GO:0035289; GO:0043025; GO:0043565; GO:0045944; GO:0060090; GO:0060322; GO:0060323; GO:0140297; GO:1902339; GO:1990403,"anterior/posterior pattern specification [GO:0009952]; embryonic brain development [GO:1990403]; head development [GO:0060322]; head morphogenesis [GO:0060323]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior head segmentation [GO:0035289]; regulation of gene expression [GO:0010468]; specification of segmental identity, head [GO:0007380]",neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; molecular adaptor activity [GO:0060090]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_04551,FUN_022179-T1,Peve_00036595,Pocillopora_meandrina_HIv1___RNAseq.g4785.t1,three_way,75.04833333333333,FUN_022179-T1,P09070,,,,,54.7,106.0,6.2e-23,108.6,sp|P09070|HXB4_XENLA Homeobox protein Hox-B4 OS=Xenopus laevis OX=8355 GN=hoxb4 PE=2 SV=1,,,,,,
OG_04552,FUN_022180-T1,Peve_00036610,Pocillopora_meandrina_HIv1___RNAseq.g4787.t1,three_way,75.57533333333333,FUN_022180-T1,Q03828,,,,,55.9,102.0,8.7e-20,99.0,sp|Q03828|EVX2_HUMAN Homeobox even-skipped homolog protein 2 OS=Homo sapiens OX=9606 GN=EVX2 PE=1 SV=2,,,,,,
OG_04553,FUN_022183-T1,Peve_00036603,Pocillopora_meandrina_HIv1___RNAseq.g4789.t1,three_way,67.36933333333333,FUN_022183-T1,Q5E9T4,TPK1_BOVIN,,Thiamine pyrophosphokinase 1 (EC 2.7.6.-),Bos taurus (Bovine),49.1,230.0,3.7e-60,233.0,sp|Q5E9T4|TPK1_BOVIN Thiamine pyrophosphokinase 1 OS=Bos taurus OX=9913 GN=TPK1 PE=2 SV=1,GO:0004788; GO:0005524; GO:0006772; GO:0009229; GO:0016301; GO:0030975; GO:0141200,thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772],,ATP binding [GO:0005524]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; UTP thiamine diphosphokinase activity [GO:0141200],GO:0003824; GO:0006766; GO:0006790; GO:0016740,catalytic activity; vitamin metabolic process; sulfur compound metabolic process; transferase activity
OG_04554,FUN_022185-T2,Peve_00014941,Pocillopora_meandrina_HIv1___RNAseq.g4790.t1,three_way,68.66233333333334,FUN_022185-T2,P34147,,,,,27.5,632.0,8.3e-64,246.5,sp|P34147|RACA_DICDI Rho-related protein racA OS=Dictyostelium discoideum OX=44689 GN=racA PE=1 SV=2,,,,,,
OG_04555,FUN_022186-T1,Peve_00018623,Pocillopora_meandrina_HIv1___RNAseq.g4791.t1,three_way,75.88,FUN_022186-T1,O08539,BIN1_MOUSE,,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Bridging integrator 1) (SH3 domain-containing protein 9),Mus musculus (Mouse),31.9,593.0,2e-57,224.9,sp|O08539|BIN1_MOUSE Myc box-dependent-interacting protein 1 OS=Mus musculus OX=10090 GN=Bin1 PE=1 SV=1,GO:0000122; GO:0005634; GO:0005635; GO:0005768; GO:0005874; GO:0010564; GO:0019828; GO:0030018; GO:0030100; GO:0030315; GO:0030424; GO:0030425; GO:0030838; GO:0031674; GO:0031982; GO:0032496; GO:0033268; GO:0033292; GO:0035591; GO:0042692; GO:0043065; GO:0043194; GO:0045202; GO:0045664; GO:0048156; GO:0048488; GO:0048711; GO:0051647; GO:0060987; GO:0060988; GO:0086091; GO:0090571; GO:0098793; GO:0098794; GO:0098978; GO:1901380; GO:1902430; GO:1903946; GO:1904878,lipid tube assembly [GO:0060988]; muscle cell differentiation [GO:0042692]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell cycle process [GO:0010564]; regulation of endocytosis [GO:0030100]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; response to lipopolysaccharide [GO:0032496]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292],axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; microtubule [GO:0005874]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; RNA polymerase II transcription repressor complex [GO:0090571]; synapse [GO:0045202]; T-tubule [GO:0030315]; vesicle [GO:0031982]; Z disc [GO:0030018],aspartic-type endopeptidase inhibitor activity [GO:0019828]; signaling adaptor activity [GO:0035591]; tau protein binding [GO:0048156],GO:0005634; GO:0005635; GO:0005768; GO:0006355; GO:0008092; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0065003; GO:0098772,nucleus; nuclear envelope; endosome; regulation of DNA-templated transcription; cytoskeletal protein binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; protein-containing complex assembly; molecular function regulator activity
OG_04556,FUN_022187-T1,Peve_00038022,Pocillopora_meandrina_HIv1___RNAseq.g4792.t1,three_way,81.82866666666666,FUN_022187-T1,Q91YJ2,SNX4_MOUSE,,Sorting nexin-4,Mus musculus (Mouse),42.4,425.0,1.8e-91,337.8,sp|Q91YJ2|SNX4_MOUSE Sorting nexin-4 OS=Mus musculus OX=10090 GN=Snx4 PE=1 SV=1,GO:0005154; GO:0005158; GO:0005769; GO:0005868; GO:0005886; GO:0015031; GO:0031201; GO:0031901; GO:0032266; GO:0032456; GO:0035091; GO:0098830; GO:1903595; GO:1990459; GO:1990460; GO:2000786,endocytic recycling [GO:0032456]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031],cytoplasmic dynein complex [GO:0005868]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; presynaptic endosome [GO:0098830]; SNARE complex [GO:0031201],epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; transferrin receptor binding [GO:1990459],GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_04557,FUN_022195-T1,Peve_00038012,Pocillopora_meandrina_HIv1___RNAseq.g4794.t1,three_way,95.207,FUN_022195-T1,P24495,,,,,85.8,233.0,5.6000000000000014e-111,401.7,sp|P24495|PSA2_XENLA Proteasome subunit alpha type-2 OS=Xenopus laevis OX=8355 GN=psma2 PE=2 SV=2,,,,,,
OG_04558,FUN_022197-T1,Peve_00021103,Pocillopora_meandrina_HIv1___RNAseq.g4796.t1,three_way,90.381,FUN_022197-T1,P15178,,,,,69.7,476.0,1.2e-194,681.0,"sp|P15178|SYDC_RAT Aspartate--tRNA ligase, cytoplasmic OS=Rattus norvegicus OX=10116 GN=Dars1 PE=1 SV=1",,,,,,
OG_04559,FUN_022198-T1,Peve_00038010,Pocillopora_meandrina_HIv1___RNAseq.g4797.t1,three_way,68.02633333333333,,,,,,,,,,,,,,,,,
OG_04560,FUN_022199-T1,Peve_00041449,Pocillopora_meandrina_HIv1___RNAseq.g4798.t1,three_way,67.538,,,,,,,,,,,,,,,,,
OG_04561,FUN_022200-T1,Peve_00041448,Pocillopora_meandrina_HIv1___TS.g22211.t1,three_way,99.00466666666668,FUN_022200-T1,Q7Z1B8,,,,,84.8,66.0,5.099999999999998e-25,114.4,sp|Q7Z1B8|S61G1_GRYOR Protein transport protein Sec61 subunit gamma OS=Gryllotalpa orientalis OX=213494 GN=SEC61G PE=3 SV=1,,,,,,
OG_04562,FUN_022202-T1,Peve_00041446,Pocillopora_meandrina_HIv1___RNAseq.g4799.t1,three_way,83.59866666666667,FUN_022202-T1,P10181,ROUGH_DROME,,Homeobox protein rough,Drosophila melanogaster (Fruit fly),63.8,80.0,5.7e-20,99.4,sp|P10181|ROUGH_DROME Homeobox protein rough OS=Drosophila melanogaster OX=7227 GN=ro PE=2 SV=4,GO:0000977; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007463; GO:0007601; GO:0042067; GO:0045944; GO:0048054,establishment of ommatidial planar polarity [GO:0042067]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R2/R5 cell differentiation [GO:0048054]; R2/R5 cell fate commitment [GO:0007463]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0007163; GO:0030154; GO:0043226; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; cell differentiation; organelle; nervous system process; transcription regulator activity
OG_04563,FUN_022204-T1,Peve_00041452,Pocillopora_meandrina_HIv1___TS.g22213.t2,three_way,62.89816666666666,FUN_022204-T1,Q92626,PXDN_HUMAN,,Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment],Homo sapiens (Human),28.5,270.0,2.3000000000000003e-22,109.4,sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0002376; GO:0003824; GO:0005198; GO:0005576; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003; GO:0098772,immune system process; catalytic activity; structural molecule activity; extracellular region; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_04564,FUN_022206-T1,Peve_00008604,Pocillopora_meandrina_HIv1___RNAseq.g4803.t1,three_way,63.762,FUN_022206-T1,Q80X71,T106B_MOUSE,,Transmembrane protein 106B,Mus musculus (Mouse),31.3,198.0,5.4e-20,99.8,sp|Q80X71|T106B_MOUSE Transmembrane protein 106B OS=Mus musculus OX=10090 GN=Tmem106b PE=1 SV=1,GO:0005764; GO:0005765; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0031902; GO:0032418; GO:0048813; GO:0051117; GO:0070050; GO:1900006; GO:1905146; GO:1905671,dendrite morphogenesis [GO:0048813]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; neuron cellular homeostasis [GO:0070050]; positive regulation of dendrite development [GO:1900006]; regulation of lysosome organization [GO:1905671],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],ATPase binding [GO:0051117],GO:0005764; GO:0005773; GO:0005886; GO:0007040; GO:0030163; GO:0043226,lysosome; vacuole; plasma membrane; lysosome organization; protein catabolic process; organelle
OG_04565,FUN_022208-T1,Peve_00008602,Pocillopora_meandrina_HIv1___RNAseq.g4802.t1,three_way,72.70933333333333,FUN_022208-T1,A4QBI8,,,,,39.6,101.0,5.1e-13,75.9,sp|A4QBI8|RL16_CORGB Large ribosomal subunit protein uL16 OS=Corynebacterium glutamicum (strain R) OX=340322 GN=rplP PE=3 SV=1,,,,,,
OG_04566,FUN_022209-T1,Peve_00008601,Pocillopora_meandrina_HIv1___RNAseq.g4801.t1,three_way,46.54666666666667,FUN_022209-T1,Q7KM13,,,,,52.7,91.0,2.1e-14,81.3,sp|Q7KM13|HEY_DROME Hairy/enhancer-of-split related with YRPW motif protein OS=Drosophila melanogaster OX=7227 GN=Hey PE=2 SV=1,,,,,,
OG_04567,FUN_022210-T1,Peve_00008600,Pocillopora_meandrina_HIv1___RNAseq.g4765.t1,three_way,84.062,FUN_022210-T1,Q8HYI9,,,,,45.7,138.0,1.9e-30,133.7,sp|Q8HYI9|PFD5_BOVIN Prefoldin subunit 5 OS=Bos taurus OX=9913 GN=PFDN5 PE=2 SV=1,,,,,,
OG_04568,FUN_022212-T1,Peve_00008597,Pocillopora_meandrina_HIv1___RNAseq.g4763.t1,three_way,72.44316666666667,FUN_022212-T1,Q14554,PDIA5_HUMAN,,Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein),Homo sapiens (Human),38.8,405.0,1.2e-71,272.7,sp|Q14554|PDIA5_HUMAN Protein disulfide-isomerase A5 OS=Homo sapiens OX=9606 GN=PDIA5 PE=1 SV=1,GO:0003756; GO:0005783; GO:0005788; GO:0005789; GO:0006457; GO:0015035; GO:0016491; GO:0022900,electron transport chain [GO:0022900]; protein folding [GO:0006457],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],oxidoreductase activity [GO:0016491]; protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],GO:0003824; GO:0005783; GO:0006091; GO:0006457; GO:0016491; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; generation of precursor metabolites and energy; protein folding; oxidoreductase activity; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_04569,FUN_022214-T1,Peve_00008606,Pocillopora_meandrina_HIv1___RNAseq.g4762.t1,three_way,80.757,FUN_022214-T1,Q0D2E8,,,,,49.6,544.0,3e-147,523.5,sp|Q0D2E8|RFT1_XENTR Man(5)GlcNAc(2)-PP-dolichol translocation protein RFT1 OS=Xenopus tropicalis OX=8364 GN=rft1 PE=2 SV=1,,,,,,
OG_04570,FUN_022215-T1,Peve_00008605,Pocillopora_meandrina_HIv1___RNAseq.g4761.t1,three_way,63.72266666666667,,,,,,,,,,,,,,,,,
OG_04571,FUN_022218-T1,Peve_00028321,Pocillopora_meandrina_HIv1___RNAseq.g4733.t1c,three_way,83.12133333333334,FUN_022218-T1,Q6QN10,,,,,66.3,181.0,2.9999999999999997e-47,189.9,sp|Q6QN10|NACA_CHILA Nascent polypeptide-associated complex subunit alpha OS=Chinchilla lanigera OX=34839 PE=2 SV=1,,,,,,
OG_04572,FUN_022220-T1,Peve_00033928,Pocillopora_meandrina_HIv1___RNAseq.g4737.t1,three_way,78.52833333333334,FUN_022220-T1,A7SG73,NADC_NEMVE,,Nicotinate-nucleotide pyrophosphorylase [carboxylating] (EC 2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]) (QAPRTase),Nematostella vectensis (Starlet sea anemone),60.9,289.0,1.3e-95,350.9,sp|A7SG73|NADC_NEMVE Nicotinate-nucleotide pyrophosphorylase [carboxylating] (Fragment) OS=Nematostella vectensis OX=45351 GN=qprt PE=3 SV=1,GO:0004514; GO:0005737; GO:0009435; GO:0034213,NAD biosynthetic process [GO:0009435]; quinolinate catabolic process [GO:0034213],cytoplasm [GO:0005737],nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514],GO:0003824; GO:0016740; GO:0055086,catalytic activity; transferase activity; nucleobase-containing small molecule metabolic process
OG_04573,FUN_022221-T1,Peve_00033927,Pocillopora_meandrina_HIv1___RNAseq.g4738.t1,three_way,56.5145,FUN_022221-T1,Q3V2A7,QRIC2_MOUSE,,Glutamine-rich protein 2,Mus musculus (Mouse),29.7,353.0,6.5e-34,147.5,sp|Q3V2A7|QRIC2_MOUSE Glutamine-rich protein 2 OS=Mus musculus OX=10090 GN=Qrich2 PE=2 SV=1,GO:0005634; GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059,cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleus; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_04574,FUN_022224-T1,Peve_00008148,Pocillopora_meandrina_HIv1___RNAseq.g4744.t1,three_way,83.988,,,,,,,,,,,,,,,,,
OG_04575,FUN_022225-T1,Peve_00008146,Pocillopora_meandrina_HIv1___RNAseq.g4746.t1b,three_way,48.185,FUN_022225-T1,P35448,,,,,39.9,158.0,7.7e-07,57.8,sp|P35448|TSP1_XENLA Thrombospondin-1 OS=Xenopus laevis OX=8355 GN=thbs1 PE=2 SV=1,,,,,,
OG_04576,FUN_022235-T2,Peve_00012432,Pocillopora_meandrina_HIv1___RNAseq.g4750.t1,three_way,76.53366666666666,FUN_022235-T2,Q0VCA7,OXSM_BOVIN,,"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase)",Bos taurus (Bovine),53.0,423.0,5.4000000000000006e-126,452.6,"sp|Q0VCA7|OXSM_BOVIN 3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial OS=Bos taurus OX=9913 GN=OXSM PE=2 SV=1",GO:0004315; GO:0005739; GO:0006633,fatty acid biosynthetic process [GO:0006633],mitochondrion [GO:0005739],3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_04577,FUN_022239-T1,Peve_00029745,Pocillopora_meandrina_HIv1___RNAseq.g4755.t1,three_way,65.46666666666667,,,,,,,,,,,,,,,,,
OG_04578,FUN_022241-T1,Peve_00037422,Pocillopora_meandrina_HIv1___RNAseq.g4756.t1,three_way,81.13533333333334,FUN_022241-T1,B8JKD7,RPA2_DANRE,,DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6),Danio rerio (Zebrafish) (Brachydanio rerio),56.1,1131.0,0.0,1315.1,sp|B8JKD7|RPA2_DANRE DNA-directed RNA polymerase I subunit RPA2 OS=Danio rerio OX=7955 GN=polr1b PE=3 SV=1,GO:0000428; GO:0003677; GO:0003899; GO:0005694; GO:0005730; GO:0005739; GO:0006351; GO:0008270; GO:0014029; GO:0032549,DNA-templated transcription [GO:0006351]; neural crest formation [GO:0014029],chromosome [GO:0005694]; DNA-directed RNA polymerase complex [GO:0000428]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; ribonucleoside binding [GO:0032549]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005694; GO:0005730; GO:0005739; GO:0006351; GO:0016740; GO:0030154; GO:0043226; GO:0140098,"DNA binding; catalytic activity; chromosome; nucleolus; mitochondrion; DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_04579,FUN_022242-T1,Peve_00037424,Pocillopora_meandrina_HIv1___TS.g22171.t1,three_way,87.71433333333333,FUN_022242-T1,E7F590,VPS41_DANRE,,Vacuolar protein sorting-associated protein 41 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),53.6,823.0,8.099999999999999e-251,868.2,sp|E7F590|VPS41_DANRE Vacuolar protein sorting-associated protein 41 homolog OS=Danio rerio OX=7955 GN=vps41 PE=1 SV=1,GO:0005765; GO:0005770; GO:0005794; GO:0005829; GO:0006623; GO:0008270; GO:0008333; GO:0009267; GO:0016236; GO:0030136; GO:0030897; GO:0031901; GO:0031902; GO:0034058,cellular response to starvation [GO:0009267]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; macroautophagy [GO:0016236]; protein targeting to vacuole [GO:0006623],clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765],zinc ion binding [GO:0008270],GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; Golgi apparatus; cytosol; intracellular protein transport; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_04580,FUN_022243-T2,Peve_00037426,Pocillopora_meandrina_HIv1___RNAseq.g4758.t1,three_way,80.60083333333333,FUN_022243-T2,Q9H2F5,,,,,46.3,555.0,5.4e-117,423.3,sp|Q9H2F5|EPC1_HUMAN Enhancer of polycomb homolog 1 OS=Homo sapiens OX=9606 GN=EPC1 PE=1 SV=1,,,,,,
OG_04581,FUN_022244-T1,Peve_00037427,Pocillopora_meandrina_HIv1___RNAseq.g4759.t1,three_way,49.892,,,,,,,,,,,,,,,,,
OG_04582,FUN_022245-T1,Peve_00037428,Pocillopora_meandrina_HIv1___RNAseq.g4760.t1,three_way,54.247166666666665,FUN_022245-T1,Q96DN6,MBD6_HUMAN,,Methyl-CpG-binding domain protein 6 (Methyl-CpG-binding protein MBD6),Homo sapiens (Human),41.4,99.0,6.5e-16,88.6,sp|Q96DN6|MBD6_HUMAN Methyl-CpG-binding domain protein 6 OS=Homo sapiens OX=9606 GN=MBD6 PE=1 SV=2,GO:0001650; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0010369,,chromocenter [GO:0010369]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0005654; GO:0005694; GO:0043226,nucleus; nucleoplasm; chromosome; organelle
OG_04583,FUN_022248-T1,Peve_00021274,Pocillopora_meandrina_HIv1___RNAseq.g4731.t1,three_way,77.724,FUN_022248-T1,P50171,,,,,54.1,259.0,1.3e-68,261.2,sp|P50171|DHB8_MOUSE (3R)-3-hydroxyacyl-CoA dehydrogenase OS=Mus musculus OX=10090 GN=Hsd17b8 PE=1 SV=2,,,,,,
OG_04584,FUN_022249-T1,Peve_00021283,Pocillopora_meandrina_HIv1___RNAseq.g4723.t1,three_way,79.9,FUN_022249-T1,Q1ECX4,TLK2_DANRE,,Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (PKU-alpha) (Tousled-like kinase 2),Danio rerio (Zebrafish) (Brachydanio rerio),51.9,697.0,1.7e-174,614.4,sp|Q1ECX4|TLK2_DANRE Serine/threonine-protein kinase tousled-like 2 OS=Danio rerio OX=7955 GN=tlk2 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0035556; GO:0048471; GO:0106310,chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556],cytoskeleton [GO:0005856]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005856; GO:0007059; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytoskeleton; chromosome segregation; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04585,FUN_022251-T1,Peve_00021288,Pocillopora_meandrina_HIv1___RNAseq.g4724.t1,three_way,52.4535,FUN_022251-T1,P35969,,,,,30.3,511.0,3.2e-49,198.7,sp|P35969|VGFR1_MOUSE Vascular endothelial growth factor receptor 1 OS=Mus musculus OX=10090 GN=Flt1 PE=1 SV=1,,,,,,
OG_04586,FUN_022256-T1,Peve_00021275,Pocillopora_meandrina_HIv1___TS.g22138.t1,three_way,45.06,,,,,,,,,,,,,,,,,
OG_04587,FUN_022259-T1,Peve_00043995,Pocillopora_meandrina_HIv1___RNAseq.g4721.t1,three_way,56.8915,,,,,,,,,,,,,,,,,
OG_04588,FUN_022260-T1,Peve_00043990,Pocillopora_meandrina_HIv1___RNAseq.g4718.t1,three_way,93.872,FUN_022260-T1,P61209,,,,,95.0,179.0,3.3e-95,349.0,sp|P61209|ARF1_DROME ADP-ribosylation factor 1 OS=Drosophila melanogaster OX=7227 GN=Arf1 PE=1 SV=2,,,,,,
OG_04589,FUN_022261-T1,Peve_00043989,Pocillopora_meandrina_HIv1___RNAseq.g4717.t1,three_way,64.07733333333333,,,,,,,,,,,,,,,,,
OG_04590,FUN_022265-T1,Peve_00043988,Pocillopora_meandrina_HIv1___RNAseq.g4716.t1,three_way,60.199,FUN_022265-T1,Q9BU76,,,,,46.3,134.0,3.5e-28,127.1,sp|Q9BU76|MMTA2_HUMAN Multiple myeloma tumor-associated protein 2 OS=Homo sapiens OX=9606 GN=MMTAG2 PE=1 SV=1,,,,,,
OG_04591,FUN_022266-T1,Peve_00044000,Pocillopora_meandrina_HIv1___RNAseq.g4715.t1,three_way,77.09633333333333,FUN_022266-T1,Q13319,CD5R2_HUMAN,,Cyclin-dependent kinase 5 activator 2 (CDK5 activator 2) (Cyclin-dependent kinase 5 regulatory subunit 2) (p39) (p39I),Homo sapiens (Human),50.7,148.0,6e-41,169.5,sp|Q13319|CD5R2_HUMAN Cyclin-dependent kinase 5 activator 2 OS=Homo sapiens OX=9606 GN=CDK5R2 PE=1 SV=1,GO:0000079; GO:0000307; GO:0001764; GO:0003779; GO:0005737; GO:0005886; GO:0007411; GO:0007420; GO:0008289; GO:0016020; GO:0016533; GO:0019901; GO:0021549; GO:0021722; GO:0021766; GO:0021819; GO:0030426; GO:0043005; GO:0045956; GO:0051493; GO:0061575; GO:0098793,axon guidance [GO:0007411]; brain development [GO:0007420]; cerebellum development [GO:0021549]; hippocampus development [GO:0021766]; layer formation in cerebral cortex [GO:0021819]; neuron migration [GO:0001764]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of cytoskeleton organization [GO:0051493]; superior olivary nucleus maturation [GO:0021722],cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533],actin binding [GO:0003779]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901],GO:0005886; GO:0008092; GO:0008289; GO:0048856; GO:0048870; GO:0098772,plasma membrane; cytoskeletal protein binding; lipid binding; anatomical structure development; cell motility; molecular function regulator activity
OG_04592,FUN_022267-T1,Peve_00043987,Pocillopora_meandrina_HIv1___RNAseq.g4714.t2,three_way,76.18966666666667,FUN_022267-T1,Q63357,MYO1D_RAT,,Unconventional myosin-Id (Myosin heavy chain myr 4),Rattus norvegicus (Rat),52.1,637.0,3e-186,653.3,sp|Q63357|MYO1D_RAT Unconventional myosin-Id OS=Rattus norvegicus OX=10116 GN=Myo1d PE=1 SV=3,GO:0000146; GO:0005516; GO:0005524; GO:0005737; GO:0005768; GO:0005769; GO:0005886; GO:0005902; GO:0005903; GO:0005938; GO:0006897; GO:0007015; GO:0015031; GO:0015629; GO:0016323; GO:0016459; GO:0019904; GO:0030048; GO:0030424; GO:0030673; GO:0030900; GO:0031410; GO:0043005; GO:0043025; GO:0043204; GO:0043209; GO:0044853; GO:0048306; GO:0051015; GO:0061502; GO:0097440,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; early endosome to recycling endosome transport [GO:0061502]; endocytosis [GO:0006897]; forebrain development [GO:0030900]; protein transport [GO:0015031],actin cytoskeleton [GO:0015629]; apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; protein domain specific binding [GO:0019904],GO:0003774; GO:0003824; GO:0005768; GO:0005856; GO:0005886; GO:0008092; GO:0016192; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytoskeleton; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_04593,FUN_022271-T1,Peve_00007683,Pocillopora_meandrina_HIv1___RNAseq.g4712.t1,three_way,56.11566666666666,FUN_022271-T1,Q5F479,,,,,25.6,679.0,7.7e-41,171.4,sp|Q5F479|S11IP_CHICK Serine/threonine-protein kinase 11-interacting protein OS=Gallus gallus OX=9031 GN=STK11IP PE=2 SV=1,,,,,,
OG_04594,FUN_022278-T1,Peve_00022094,Pocillopora_meandrina_HIv1___RNAseq.g4704.t1,three_way,78.5305,FUN_022278-T1,Q08CH6,CATIP_DANRE,,Ciliogenesis-associated TTC17-interacting protein,Danio rerio (Zebrafish) (Brachydanio rerio),43.1,341.0,9.5e-73,275.4,sp|Q08CH6|CATIP_DANRE Ciliogenesis-associated TTC17-interacting protein OS=Danio rerio OX=7955 GN=catip PE=1 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0060271; GO:0061371,actin filament polymerization [GO:0030041]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005856; GO:0005886; GO:0043226; GO:0044782; GO:0065003,nucleus; cytoskeleton; plasma membrane; organelle; cilium organization; protein-containing complex assembly
OG_04595,FUN_022279-T1,Peve_00022093,Pocillopora_meandrina_HIv1___RNAseq.g4703.t2,three_way,75.602,FUN_022279-T1,Q7ZWS1,DUS3L_XENLA,,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.89) (mRNA-dihydrouridine synthase DUS3L) (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like),Xenopus laevis (African clawed frog),54.4,634.0,7.399999999999998e-190,665.2,sp|Q7ZWS1|DUS3L_XENLA tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like OS=Xenopus laevis OX=8355 GN=dus3l PE=2 SV=1,GO:0002943; GO:0003723; GO:0006397; GO:0006417; GO:0008270; GO:0017150; GO:0050660; GO:0102265; GO:0106414,mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; tRNA dihydrouridine synthesis [GO:0002943],,flavin adenine dinucleotide binding [GO:0050660]; mRNA dihydrouridine synthase activity [GO:0106414]; RNA binding [GO:0003723]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine47 synthase activity [GO:0102265]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0006399; GO:0016071; GO:0016491; GO:0140098,"RNA binding; catalytic activity; tRNA metabolic process; mRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA"
OG_04596,FUN_022280-T1,Peve_00022092,Pocillopora_meandrina_HIv1___RNAseq.g4702.t1,three_way,79.605,FUN_022280-T1,Q0V9W6,,,,,40.9,423.0,5.6e-88,326.2,sp|Q0V9W6|BTBD6_XENTR BTB/POZ domain-containing protein 6 OS=Xenopus tropicalis OX=8364 GN=btbd6 PE=2 SV=2,,,,,,
OG_04597,FUN_022282-T1,Peve_00027183,Pocillopora_meandrina_HIv1___RNAseq.g4699.t1,three_way,41.48266666666667,FUN_022282-T1,Q9Y6R4,M3K4_HUMAN,,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),Homo sapiens (Human),37.2,261.0,9.6e-40,167.5,sp|Q9Y6R4|M3K4_HUMAN Mitogen-activated protein kinase kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP3K4 PE=1 SV=2,GO:0000165; GO:0001890; GO:0004709; GO:0005524; GO:0005737; GO:0010225; GO:0010468; GO:0019100; GO:0032206; GO:0035556; GO:0038066; GO:0043507; GO:0046872; GO:0048471; GO:0060718; GO:0106310; GO:1900745,chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; MAPK cascade [GO:0000165]; p38MAPK cascade [GO:0038066]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomere maintenance [GO:0032206]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_04598,FUN_022283-T1,Peve_00029268,Pocillopora_meandrina_HIv1___RNAseq.g4698.t1,three_way,63.41,,,,,,,,,,,,,,,,,
OG_04599,FUN_022284-T1,Peve_00028966,Pocillopora_meandrina_HIv1___RNAseq.g4697.t1,three_way,77.41933333333333,FUN_022284-T1,Q8N0Z2,,,,,52.5,101.0,1.3e-21,104.0,sp|Q8N0Z2|ABRA_HUMAN Actin-binding Rho-activating protein OS=Homo sapiens OX=9606 GN=ABRA PE=1 SV=1,,,,,,
OG_04600,FUN_022285-T1,Peve_00003591,Pocillopora_meandrina_HIv1___RNAseq.g4696.t1,three_way,62.73716666666667,FUN_022285-T1,A7MB54,HLX_BOVIN,,H2.0-like homeobox protein (Homeobox protein HLX1),Bos taurus (Bovine),69.0,58.0,3.8e-17,90.1,sp|A7MB54|HLX_BOVIN H2.0-like homeobox protein OS=Bos taurus OX=9913 GN=HLX PE=2 SV=1,GO:0000981; GO:0001889; GO:0005634; GO:0007519; GO:0035265; GO:0043565; GO:0045063; GO:0045064; GO:0045627; GO:0045629; GO:0046622; GO:0048484; GO:0048557; GO:0050673; GO:0050679,embryonic digestive tract morphogenesis [GO:0048557]; enteric nervous system development [GO:0048484]; epithelial cell proliferation [GO:0050673]; liver development [GO:0001889]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; organ growth [GO:0035265]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of organ growth [GO:0046622]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; skeletal muscle tissue development [GO:0007519]; T-helper 1 cell differentiation [GO:0045063]; T-helper 2 cell differentiation [GO:0045064],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0002376; GO:0003677; GO:0005634; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04601,FUN_022288-T1,Peve_00003595,Pocillopora_meandrina_HIv1___RNAseq.g4695.t1,three_way,67.76066666666667,FUN_022288-T1,Q9Z340,PARD3_RAT,,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (Atypical PKC-specific-binding protein) (ASBP),Rattus norvegicus (Rat),32.5,805.0,1.7e-76,289.7,sp|Q9Z340|PARD3_RAT Partitioning defective 3 homolog OS=Rattus norvegicus OX=10116 GN=Pard3 PE=1 SV=1,GO:0000226; GO:0002092; GO:0003383; GO:0005546; GO:0005547; GO:0005737; GO:0005819; GO:0005911; GO:0005912; GO:0005923; GO:0005938; GO:0006612; GO:0007155; GO:0008104; GO:0010801; GO:0012505; GO:0016324; GO:0019903; GO:0022011; GO:0030010; GO:0030054; GO:0031643; GO:0032266; GO:0032970; GO:0032991; GO:0033269; GO:0035091; GO:0042802; GO:0043025; GO:0043219; GO:0043220; GO:0043296; GO:0044295; GO:0044319; GO:0045197; GO:0051301; GO:0051642; GO:0051660; GO:0060341; GO:0070830; GO:0090162; GO:0120157,"apical constriction [GO:0003383]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome localization [GO:0051642]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; positive regulation of receptor internalization [GO:0002092]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; regulation of actin filament-based process [GO:0032970]; regulation of cellular localization [GO:0060341]; wound healing, spreading of cells [GO:0044319]",adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; lateral loop [GO:0043219]; neuronal cell body [GO:0043025]; PAR polarity complex [GO:0120157]; protein-containing complex [GO:0032991]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]",GO:0007010; GO:0007155; GO:0007163; GO:0008289; GO:0034330; GO:0043226; GO:0048870,cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell junction organization; organelle; cell motility
OG_04602,FUN_022291-T1,Peve_00003683,Pocillopora_meandrina_HIv1___RNAseq.g4693.t1,three_way,60.70033333333333,,,,,,,,,,,,,,,,,
OG_04603,FUN_022292-T1,Peve_00003687,Pocillopora_meandrina_HIv1___RNAseq.g4692.t1,three_way,84.67733333333334,FUN_022292-T1,Q9BUZ4,TRAF4_HUMAN,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),Homo sapiens (Human),34.6,315.0,7.4e-50,199.1,sp|Q9BUZ4|TRAF4_HUMAN TNF receptor-associated factor 4 OS=Homo sapiens OX=9606 GN=TRAF4 PE=1 SV=1,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007166; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0035591; GO:0042802; GO:0042981; GO:0043122; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism
OG_04604,FUN_022293-T1,Peve_00003688,Pocillopora_meandrina_HIv1___RNAseq.g4691.t1,three_way,65.73366666666666,,,,,,,,,,,,,,,,,
OG_04605,FUN_022295-T1,Peve_00003689,Pocillopora_meandrina_HIv1___RNAseq.g4689.t1,three_way,77.32466666666667,FUN_022295-T1,Q6P5U8,,,,,35.1,535.0,8e-40,166.8,sp|Q6P5U8|CC148_MOUSE Coiled-coil domain-containing protein 148 OS=Mus musculus OX=10090 GN=Ccdc148 PE=2 SV=1,,,,,,
OG_04606,FUN_022296-T1,Peve_00003691,Pocillopora_meandrina_HIv1___RNAseq.g4665.t1,three_way,63.23733333333333,FUN_022296-T1,Q5U4U4,,,,,31.4,574.0,6.7e-65,250.0,sp|Q5U4U4|DONS_XENLA Protein downstream neighbor of son homolog OS=Xenopus laevis OX=8355 GN=donson PE=1 SV=1,,,,,,
OG_04607,FUN_022297-T1,Peve_00021643,Pocillopora_meandrina_HIv1___RNAseq.g4620.t1,three_way,54.49733333333333,FUN_022297-T1,Q6AXX1,,,,,37.6,178.0,1.2e-23,112.1,sp|Q6AXX1|SLNL1_RAT Schlafen-like protein 1 OS=Rattus norvegicus OX=10116 GN=Slfnl1 PE=2 SV=1,,,,,,
OG_04608,FUN_022298-T1,Peve_00003685,Pocillopora_meandrina_HIv1___RNAseq.g4621.t1b,three_way,70.31033333333333,,,,,,,,,,,,,,,,,
OG_04609,FUN_022305-T1,Peve_00003816,Pocillopora_meandrina_HIv1___RNAseq.g3971.t1,three_way,36.00233333333333,,,,,,,,,,,,,,,,,
OG_04610,FUN_022307-T1,Peve_00021671,Pocillopora_meandrina_HIv1___RNAseq.g4623.t1,three_way,86.57633333333334,FUN_022307-T1,Q8VEE0,,,,,65.1,212.0,1.0000000000000001e-75,284.6,sp|Q8VEE0|RPE_MOUSE Ribulose-phosphate 3-epimerase OS=Mus musculus OX=10090 GN=Rpe PE=1 SV=1,,,,,,
OG_04611,FUN_022308-T1,Peve_00021683,Pocillopora_meandrina_HIv1___RNAseq.g4624.t1,three_way,85.60266666666666,FUN_022308-T1,Q3TZZ7,ESYT2_MOUSE,,Extended synaptotagmin-2 (E-Syt2),Mus musculus (Mouse),35.6,793.0,2.9e-132,474.2,sp|Q3TZZ7|ESYT2_MOUSE Extended synaptotagmin-2 OS=Mus musculus OX=10090 GN=Esyt2 PE=1 SV=1,GO:0005509; GO:0005789; GO:0005829; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0044232; GO:0061817; GO:0140268,endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232],calcium ion binding [GO:0005509]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0008289; GO:0016192,cytosol; lipid binding; vesicle-mediated transport
OG_04612,FUN_022309-T1,Peve_00021685,Pocillopora_meandrina_HIv1___RNAseq.g4625.t1,three_way,73.5495,FUN_022309-T1,P08003,PDIA4_MOUSE,,Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72),Mus musculus (Mouse),55.8,591.0,2.7e-192,673.3,sp|P08003|PDIA4_MOUSE Protein disulfide-isomerase A4 OS=Mus musculus OX=10090 GN=Pdia4 PE=1 SV=3,GO:0003756; GO:0005178; GO:0005783; GO:0005788; GO:0009986; GO:0034663; GO:0042470; GO:0061077; GO:0070527; GO:0072378,"blood coagulation, fibrin clot formation [GO:0072378]; chaperone-mediated protein folding [GO:0061077]; platelet aggregation [GO:0070527]",cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470],integrin binding [GO:0005178]; protein disulfide isomerase activity [GO:0003756],GO:0003824; GO:0005783; GO:0007155; GO:0016853; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; endoplasmic reticulum; cell adhesion; isomerase activity; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_04613,FUN_022311-T1,Peve_00021687,Pocillopora_meandrina_HIv1___RNAseq.g4627.t1,three_way,77.60866666666666,FUN_022311-T1,Q8N983,,,,,46.7,122.0,4.6e-26,119.0,sp|Q8N983|RM43_HUMAN Large ribosomal subunit protein mL43 OS=Homo sapiens OX=9606 GN=MRPL43 PE=1 SV=1,,,,,,
OG_04614,FUN_022312-T1,Peve_00021688,Pocillopora_meandrina_HIv1___RNAseq.g4629.t1,three_way,45.843,,,,,,,,,,,,,,,,,
OG_04615,FUN_022314-T1,Peve_00021691,Pocillopora_meandrina_HIv1___TS.g22047.t1,three_way,61.79866666666667,,,,,,,,,,,,,,,,,
OG_04616,FUN_022315-T1,Peve_00021692,Pocillopora_meandrina_HIv1___RNAseq.g4632.t1,three_way,88.54166666666667,FUN_022315-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),67.0,218.0,3.2e-15,83.6,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_04617,FUN_022316-T1,Peve_00021693,Pocillopora_meandrina_HIv1___RNAseq.g4633.t1,three_way,36.72766666666666,,,,,,,,,,,,,,,,,
OG_04618,FUN_022319-T1,Peve_00021701,Pocillopora_meandrina_HIv1___TS.g22054.t1,three_way,56.806333333333335,,,,,,,,,,,,,,,,,
OG_04619,FUN_022321-T1,Peve_00021706,Pocillopora_meandrina_HIv1___RNAseq.g4642.t1,three_way,52.955333333333336,,,,,,,,,,,,,,,,,
OG_04620,FUN_022322-T1,Peve_00021644,Pocillopora_meandrina_HIv1___RNAseq.g4643.t1,three_way,86.02233333333332,,,,,,,,,,,,,,,,,
OG_04621,FUN_022323-T1,Peve_00021645,Pocillopora_meandrina_HIv1___RNAseq.g4644.t1,three_way,86.14483333333334,,,,,,,,,,,,,,,,,
OG_04622,FUN_022327-T1,Peve_00021647,Pocillopora_meandrina_HIv1___RNAseq.g4647.t1,three_way,94.488,FUN_022327-T1,O08810,,,,,79.7,973.0,0.0,1565.8,sp|O08810|U5S1_MOUSE 116 kDa U5 small nuclear ribonucleoprotein component OS=Mus musculus OX=10090 GN=Eftud2 PE=1 SV=1,,,,,,
OG_04623,FUN_022328-T1,Peve_00021648,Pocillopora_meandrina_HIv1___RNAseq.g4648.t1,three_way,72.99766666666666,FUN_022328-T1,Q8IY37,DHX37_HUMAN,,Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37),Homo sapiens (Human),55.4,939.0,5.7e-289,995.3,sp|Q8IY37|DHX37_HUMAN Probable ATP-dependent RNA helicase DHX37 OS=Homo sapiens OX=9606 GN=DHX37 PE=1 SV=1,GO:0000462; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0007420; GO:0016887; GO:0031965; GO:0032040; GO:0034511; GO:0042254; GO:0042255; GO:0042274; GO:2000020,"brain development [GO:0007420]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of male gonad development [GO:2000020]; ribosomal small subunit biogenesis [GO:0042274]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254]",cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; U3 snoRNA binding [GO:0034511],GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0016787; GO:0016853; GO:0042254; GO:0043226; GO:0048856; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleoplasm; nucleolus; hydrolase activity; isomerase activity; ribosome biogenesis; organelle; anatomical structure development; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04624,FUN_022332-T1,Peve_00028602,Pocillopora_meandrina_HIv1___RNAseq.g4651.t2,three_way,52.3965,FUN_022332-T1,P26008,,,,,27.8,994.0,3.3000000000000003e-81,305.1,sp|P26008|ITAV_CHICK Integrin alpha-V OS=Gallus gallus OX=9031 GN=ITGAV PE=2 SV=1,,,,,,
OG_04625,FUN_022333-T1,Peve_00028601,Pocillopora_meandrina_HIv1___RNAseq.g4652.t1,three_way,61.93866666666667,FUN_022333-T1,Q92609,TBCD5_HUMAN,,TBC1 domain family member 5,Homo sapiens (Human),37.5,610.0,3.2e-104,381.3,sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1,GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:1905394,"autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]",autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904],AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394],GO:0005773; GO:0005794; GO:0005829; GO:0006914; GO:0016192; GO:0043226; GO:0098772,vacuole; Golgi apparatus; cytosol; autophagy; vesicle-mediated transport; organelle; molecular function regulator activity
OG_04626,FUN_022334-T2,Peve_00028599,Pocillopora_meandrina_HIv1___RNAseq.g4653.t1,three_way,68.03833333333333,FUN_022334-T2,Q149M9,,,,,31.2,944.0,1.1e-108,397.1,sp|Q149M9|NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=NWD1 PE=1 SV=3,,,,,,
OG_04627,FUN_022340-T1,Peve_00028608,Pocillopora_meandrina_HIv1___RNAseq.g4654.t1,three_way,62.08733333333333,FUN_022340-T1,Q63258,ITA7_RAT,,Integrin alpha-7 (H36-alpha7) [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form],Rattus norvegicus (Rat),27.7,1149.0,3.1e-87,325.1,sp|Q63258|ITA7_RAT Integrin alpha-7 OS=Rattus norvegicus OX=10116 GN=Itga7 PE=1 SV=2,GO:0005178; GO:0005737; GO:0005927; GO:0007155; GO:0007229; GO:0007519; GO:0008305; GO:0008360; GO:0009897; GO:0009986; GO:0016477; GO:0031594; GO:0033627; GO:0034113; GO:0034677; GO:0035987; GO:0042383; GO:0043236; GO:0044877; GO:0046872; GO:0048514; GO:0050839; GO:0050900; GO:0098609,blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; endodermal cell differentiation [GO:0035987]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; regulation of cell shape [GO:0008360]; skeletal muscle tissue development [GO:0007519],cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; integrin alpha7-beta1 complex [GO:0034677]; integrin complex [GO:0008305]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383],cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877],GO:0002376; GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0048870,immune system process; plasma membrane; cell adhesion; cell differentiation; anatomical structure development; cell motility
OG_04628,FUN_022341-T1,Peve_00028605,Pocillopora_meandrina_HIv1___RNAseq.g4655.t1,three_way,55.89933333333333,FUN_022341-T1,O70445,BARD1_MOUSE,,BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1),Mus musculus (Mouse),27.9,816.0,4.8e-45,184.5,sp|O70445|BARD1_MOUSE BRCA1-associated RING domain protein 1 OS=Mus musculus OX=10090 GN=Bard1 PE=2 SV=1,GO:0000152; GO:0003723; GO:0004842; GO:0005634; GO:0005737; GO:0006281; GO:0006282; GO:0006974; GO:0008270; GO:0016607; GO:0031436; GO:0035825; GO:0036464; GO:0042325; GO:0042803; GO:0043065; GO:0043066; GO:0044818; GO:0045787; GO:0046826; GO:0046982; GO:0070531; GO:0070532; GO:0070533; GO:0071479; GO:0085020; GO:0110025; GO:2000001,cellular response to ionizing radiation [GO:0071479]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; homologous recombination [GO:0035825]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein export from nucleus [GO:0046826]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell cycle [GO:0045787]; protein K6-linked ubiquitination [GO:0085020]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of phosphorylation [GO:0042325],BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nuclear ubiquitin ligase complex [GO:0000152]; nucleus [GO:0005634],protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04629,FUN_022342-T1,Peve_00028600,Pocillopora_meandrina_HIv1___RNAseq.g4656.t1,three_way,74.125,,,,,,,,,,,,,,,,,
OG_04630,FUN_022343-T1,Peve_00028597,Pocillopora_meandrina_HIv1___RNAseq.g4657.t1,three_way,58.79733333333333,,,,,,,,,,,,,,,,,
OG_04631,FUN_022344-T1,Peve_00018541,Pocillopora_meandrina_HIv1___TS.g22072.t1,three_way,53.583333333333336,FUN_022344-T1,Q3USZ8,,,,,32.1,358.0,3.1e-40,167.5,sp|Q3USZ8|DIK2A_MOUSE Divergent protein kinase domain 2A OS=Mus musculus OX=10090 GN=Dipk2a PE=1 SV=2,,,,,,
OG_04632,FUN_022345-T1,Peve_00018540,Pocillopora_meandrina_HIv1___RNAseq.g4659.t1,three_way,72.2795,FUN_022345-T1,Q5R9X9,,,,,39.2,332.0,1.7e-45,185.7,sp|Q5R9X9|3BP5L_PONAB SH3 domain-binding protein 5-like OS=Pongo abelii OX=9601 GN=SH3BP5L PE=2 SV=1,,,,,,
OG_04633,FUN_022346-T1,Peve_00018538,Pocillopora_meandrina_HIv1___RNAseq.g4661.t1,three_way,98.06033333333332,FUN_022346-T1,Q3T057,RL23_BOVIN,,Large ribosomal subunit protein uL14 (60S ribosomal protein L23),Bos taurus (Bovine),92.1,139.0,2.1e-68,259.6,sp|Q3T057|RL23_BOVIN Large ribosomal subunit protein uL14 OS=Bos taurus OX=9913 GN=RPL23 PE=2 SV=2,GO:0000122; GO:0001223; GO:0003735; GO:0005654; GO:0005730; GO:0006412; GO:0008284; GO:0010628; GO:0022625; GO:0031625; GO:0032986; GO:0045202; GO:0050821; GO:0070180; GO:0070314; GO:0072717; GO:1901798; GO:1903450; GO:1990948; GO:2000059,cellular response to actinomycin D [GO:0072717]; G1 to G0 transition [GO:0070314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; regulation of G1 to G0 transition [GO:1903450]; translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202],large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005198; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0098772,RNA binding; structural molecule activity; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_04634,FUN_022354-T1,Peve_00021995,Pocillopora_meandrina_HIv1___RNAseq.g4584.t1,three_way,73.46366666666667,FUN_022354-T1,Q8LQJ9,,,,,52.9,592.0,1e-161,572.0,"sp|Q8LQJ9|FTSH4_ORYSJ ATP-dependent zinc metalloprotease FTSH 4, mitochondrial OS=Oryza sativa subsp. japonica OX=39947 GN=FTSH4 PE=3 SV=1",,,,,,
OG_04635,FUN_022357-T1,Peve_00021682,Pocillopora_meandrina_HIv1___RNAseq.g4585.t1,three_way,74.13533333333334,FUN_022357-T1,P55011,S12A2_HUMAN,,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (hNKCC1),Homo sapiens (Human),45.9,1014.0,4e-238,826.2,sp|P55011|S12A2_HUMAN Solute carrier family 12 member 2 OS=Homo sapiens OX=9606 GN=SLC12A2 PE=1 SV=1,GO:0005886; GO:0006811; GO:0006883; GO:0006884; GO:0006972; GO:0007214; GO:0008511; GO:0008519; GO:0009925; GO:0010818; GO:0015079; GO:0015377; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0019901; GO:0030007; GO:0030321; GO:0030644; GO:0030659; GO:0031253; GO:0035633; GO:0035725; GO:0035865; GO:0042995; GO:0043005; GO:0043025; GO:0044297; GO:0044298; GO:0045795; GO:0046873; GO:0051087; GO:0051879; GO:0055064; GO:0055075; GO:0055078; GO:0061044; GO:0070062; GO:0070634; GO:0071944; GO:0072488; GO:0098658; GO:0098659; GO:0098719; GO:0150003; GO:0150104; GO:1902476; GO:1903561; GO:1904450; GO:1904464; GO:1990573; GO:1990869,ammonium transmembrane transport [GO:0072488]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; cellular response to potassium ion [GO:0035865]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hyperosmotic response [GO:0006972]; inorganic anion import across plasma membrane [GO:0098658]; inorganic cation import across plasma membrane [GO:0098659]; intracellular chloride ion homeostasis [GO:0030644]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of blood-brain barrier [GO:0035633]; monoatomic ion transport [GO:0006811]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of cell volume [GO:0045795]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; T cell chemotaxis [GO:0010818]; transepithelial ammonium transport [GO:0070634]; transepithelial chloride transport [GO:0030321]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell body membrane [GO:0044298]; cell periphery [GO:0071944]; cell projection [GO:0042995]; cell projection membrane [GO:0031253]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],ammonium channel activity [GO:0008519]; chloride:monoatomic cation symporter activity [GO:0015377]; Hsp90 protein binding [GO:0051879]; metal ion transmembrane transporter activity [GO:0046873]; potassium ion transmembrane transporter activity [GO:0015079]; protein kinase binding [GO:0019901]; protein-folding chaperone binding [GO:0051087]; sodium:potassium:chloride symporter activity [GO:0008511],GO:0002376; GO:0003013; GO:0005215; GO:0005886; GO:0023052; GO:0043226; GO:0048870; GO:0055085,immune system process; circulatory system process; transporter activity; plasma membrane; signaling; organelle; cell motility; transmembrane transport
OG_04636,FUN_022359-T1,Peve_00021994,Pocillopora_meandrina_HIv1___TS.g22004.t1,three_way,71.571,FUN_022359-T1,Q9Y238,DLEC1_HUMAN,,Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1),Homo sapiens (Human),34.6,1713.0,1.3999999999999998e-264,914.8,sp|Q9Y238|DLEC1_HUMAN Deleted in lung and esophageal cancer protein 1 OS=Homo sapiens OX=9606 GN=DLEC1 PE=1 SV=2,GO:0002357; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0008285; GO:0015631; GO:0030154; GO:0043014; GO:0048487,cell differentiation [GO:0030154]; defense response to tumor cell [GO:0002357]; negative regulation of cell population proliferation [GO:0008285]; spermatogenesis [GO:0007283],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829],alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; tubulin binding [GO:0015631],GO:0005829; GO:0005929; GO:0008092; GO:0022414; GO:0030154; GO:0043226,cytosol; cilium; cytoskeletal protein binding; reproductive process; cell differentiation; organelle
OG_04637,FUN_022363-T1,Peve_00021993,Pocillopora_meandrina_HIv1___RNAseq.g4594.t1,three_way,86.07533333333333,FUN_022363-T1,Q7Z5J8,,,,,48.0,1367.0,3.1e-212,740.7,sp|Q7Z5J8|ANKAR_HUMAN Ankyrin and armadillo repeat-containing protein OS=Homo sapiens OX=9606 GN=ANKAR PE=1 SV=3,,,,,,
OG_04638,FUN_022364-T3,Peve_00021992,Pocillopora_meandrina_HIv1___RNAseq.g4595.t2,three_way,67.867,FUN_022364-T3,P18461,,,,,32.1,808.0,7.1e-87,323.6,sp|P18461|FGFR2_CHICK Fibroblast growth factor receptor 2 OS=Gallus gallus OX=9031 GN=FGFR2 PE=2 SV=1,,,,,,
OG_04639,FUN_022365-T1,Peve_00021988,Pocillopora_meandrina_HIv1___TS.g22011.t1,three_way,64.79716666666667,FUN_022365-T1,A2RRU4,SCAP_RAT,,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),Rattus norvegicus (Rat),35.1,1375.0,2.5e-147,525.0,sp|A2RRU4|SCAP_RAT Sterol regulatory element-binding protein cleavage-activating protein OS=Rattus norvegicus OX=10116 GN=Scap PE=2 SV=1,GO:0000139; GO:0001666; GO:0005789; GO:0006629; GO:0006955; GO:0008203; GO:0012507; GO:0019217; GO:0032868; GO:0032933; GO:0032934; GO:0032936; GO:0032991; GO:0033552; GO:0042304; GO:0044877; GO:0045540; GO:0045542; GO:0090110,cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; lipid metabolic process [GO:0006629]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to vitamin B3 [GO:0033552]; SREBP signaling pathway [GO:0032933],endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; protein-containing complex [GO:0032991]; SREBP-SCAP complex [GO:0032936],protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934],GO:0002376; GO:0006629; GO:0008289,immune system process; lipid metabolic process; lipid binding
OG_04640,FUN_022366-T1,Peve_00001649,Pocillopora_meandrina_HIv1___RNAseq.g9291.t1,three_way,48.586666666666666,,,,,,,,,,,,,,,,,
OG_04641,FUN_022367-T1,Peve_00013238,Pocillopora_meandrina_HIv1___TS.g19588.t1,three_way,84.17866666666667,FUN_022367-T1,P53603,,,,,60.6,543.0,4.5e-188,659.1,sp|P53603|FTCD_PIG Formimidoyltransferase-cyclodeaminase OS=Sus scrofa OX=9823 GN=FTCD PE=1 SV=1,,,,,,
OG_04642,FUN_022368-T1,Peve_00013237,Pocillopora_meandrina_HIv1___RNAseq.g9293.t2,three_way,55.12766666666666,FUN_022368-T1,B2GV47,,,,,31.2,523.0,1.9000000000000001e-66,255.8,sp|B2GV47|RADX_RAT RPA-related protein RADX OS=Rattus norvegicus OX=10116 GN=Radx PE=2 SV=1,,,,,,
OG_04643,FUN_022369-T1,Peve_00013236,Pocillopora_meandrina_HIv1___RNAseq.g9295.t1,three_way,77.29733333333333,FUN_022369-T1,Q8NCL4,GALT6_HUMAN,,Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6),Homo sapiens (Human),52.4,450.0,6.6e-132,472.6,sp|Q8NCL4|GALT6_HUMAN Polypeptide N-acetylgalactosaminyltransferase 6 OS=Homo sapiens OX=9606 GN=GALNT6 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0018243; GO:0030246; GO:0046872; GO:0048471,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via threonine [GO:0018243],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04644,FUN_022371-T1,Peve_00013234,Pocillopora_meandrina_HIv1___RNAseq.g9296.t1,three_way,87.35,FUN_022371-T1,Q6WV17,GALT5_DROME,,Polypeptide N-acetylgalactosaminyltransferase 5 (pp-GaNTase 5) (EC 2.4.1.41) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5),Drosophila melanogaster (Fruit fly),52.9,442.0,3.5e-128,460.3,sp|Q6WV17|GALT5_DROME Polypeptide N-acetylgalactosaminyltransferase 5 OS=Drosophila melanogaster OX=7227 GN=Pgant5 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0005795; GO:0006493; GO:0012505; GO:0030246; GO:0046872,protein O-linked glycosylation [GO:0006493],endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04645,FUN_022375-T1,Peve_00013232,Pocillopora_meandrina_HIv1___RNAseq.g9298.t2,three_way,64.13066666666667,,,,,,,,,,,,,,,,,
OG_04646,FUN_022378-T1,Peve_00013226,Pocillopora_meandrina_HIv1___RNAseq.g9303.t1,three_way,49.90833333333334,,,,,,,,,,,,,,,,,
OG_04647,FUN_022379-T1,Peve_00013225,Pocillopora_meandrina_HIv1___RNAseq.g9304.t1,three_way,65.24716666666666,FUN_022379-T1,Q13439,,,,,31.5,124.0,1.8e-06,57.0,sp|Q13439|GOGA4_HUMAN Golgin subfamily A member 4 OS=Homo sapiens OX=9606 GN=GOLGA4 PE=1 SV=1,,,,,,
OG_04648,FUN_022381-T1,Peve_00013224,Pocillopora_meandrina_HIv1___RNAseq.g9305.t1,three_way,76.63933333333333,FUN_022381-T1,A7E3Q8,PLST_BOVIN,,Plastin-3 (T-plastin),Bos taurus (Bovine),48.8,619.0,4.5e-160,566.2,sp|A7E3Q8|PLST_BOVIN Plastin-3 OS=Bos taurus OX=9913 GN=PLS3 PE=2 SV=1,GO:0005509; GO:0005737; GO:0005884; GO:0032432; GO:0051015; GO:0051017; GO:0051639,actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639],actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737],actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0008092,cytoskeletal protein binding
OG_04649,FUN_022382-T1,Peve_00013222,Pocillopora_meandrina_HIv1___RNAseq.g9307.t1,three_way,66.057,FUN_022382-T1,O93366,,,,,50.0,76.0,4.7e-14,79.7,sp|O93366|TLX1_CHICK T-cell leukemia homeobox protein 1 OS=Gallus gallus OX=9031 GN=TLX1 PE=2 SV=1,,,,,,
OG_04650,FUN_022383-T1,Peve_00013221,Pocillopora_meandrina_HIv1___RNAseq.g9308.t1,three_way,67.081,FUN_022383-T1,P20009,DLL_DROME,,Homeotic protein distal-less (Protein brista),Drosophila melanogaster (Fruit fly),47.1,174.0,6.900000000000001e-28,125.9,sp|P20009|DLL_DROME Homeotic protein distal-less OS=Drosophila melanogaster OX=7227 GN=Dll PE=2 SV=3,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007449; GO:0007469; GO:0007479; GO:0007480; GO:0007485; GO:0007487; GO:0008587; GO:0010092; GO:0010629; GO:0016319; GO:0030154; GO:0035114; GO:0035215; GO:0045893; GO:0048264; GO:0048728,"analia development [GO:0007487]; antennal development [GO:0007469]; cell differentiation [GO:0030154]; determination of ventral identity [GO:0048264]; genital disc development [GO:0035215]; imaginal disc-derived appendage morphogenesis [GO:0035114]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived male genitalia development [GO:0007485]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc proximal/distal pattern formation [GO:0007479]; mushroom body development [GO:0016319]; negative regulation of gene expression [GO:0010629]; positive regulation of DNA-templated transcription [GO:0045893]; proboscis development [GO:0048728]; proximal/distal pattern formation, imaginal disc [GO:0007449]; regulation of transcription by RNA polymerase II [GO:0006357]; specification of animal organ identity [GO:0010092]",nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04651,FUN_022386-T3,Peve_00037603,Pocillopora_meandrina_HIv1___RNAseq.g9310.t1,three_way,63.92666666666666,FUN_022386-T3,B8V7S0,,,,,48.6,251.0,2.8e-62,241.5,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_04652,FUN_022389-T1,Peve_00037602,Pocillopora_meandrina_HIv1___TS.g19607.t1,three_way,66.46,FUN_022389-T1,D3Z2X2,DNHD1_MOUSE,,Dynein heavy chain domain-containing protein 1 (Coiled-coil domain-containing protein 35) (Dynein heavy chain domain 1-like protein),Mus musculus (Mouse),22.8,4456.0,4.5e-257,891.3,sp|D3Z2X2|DNHD1_MOUSE Dynein heavy chain domain-containing protein 1 OS=Mus musculus OX=10090 GN=Dnhd1 PE=1 SV=3,GO:0005524; GO:0008569; GO:0030286; GO:0030317; GO:0036126; GO:0045505; GO:0051959; GO:0120316,flagellated sperm motility [GO:0030317]; sperm flagellum assembly [GO:0120316],dynein complex [GO:0030286]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; isomerase activity; reproductive process; organelle; cilium organization; cell motility; ATP-dependent activity
OG_04653,FUN_022390-T1,Peve_00037601,Pocillopora_meandrina_HIv1___RNAseq.g9313.t2,three_way,66.70333333333333,FUN_022390-T1,Q6AY46,TRM61_RAT,,tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (EC 2.1.1.220) (mRNA methyladenosine-N(1)-methyltransferase catalytic subunit TRMT61A) (EC 2.1.1.-) (tRNA(m1A58)-methyltransferase subunit TRMT61A) (tRNA(m1A58)MTase subunit TRMT61A),Rattus norvegicus (Rat),58.3,252.0,3.1e-85,317.0,sp|Q6AY46|TRM61_RAT tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A OS=Rattus norvegicus OX=10116 GN=Trmt61a PE=2 SV=1,GO:0005634; GO:0006397; GO:0030488; GO:0031515; GO:0061953; GO:0160107,mRNA processing [GO:0006397]; tRNA methylation [GO:0030488],nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515],mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine(58)-N1)-methyltransferase activity [GO:0160107],GO:0003824; GO:0005634; GO:0006399; GO:0016071; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; tRNA metabolic process; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_04654,FUN_022393-T1,Peve_00037599,Pocillopora_meandrina_HIv1___TS.g19612.t1,three_way,78.64883333333333,FUN_022393-T1,P63080,GBRB3_MOUSE,,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3),Mus musculus (Mouse),37.8,463.0,6.3e-77,289.7,sp|P63080|GBRB3_MOUSE Gamma-aminobutyric acid receptor subunit beta-3 OS=Mus musculus OX=10090 GN=Gabrb3 PE=1 SV=1,GO:0004890; GO:0005216; GO:0005886; GO:0007214; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030659; GO:0034707; GO:0035176; GO:0035640; GO:0042747; GO:0042802; GO:0043197; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]",cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; monoatomic ion channel activity [GO:0005216]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0022414; GO:0023052; GO:0034330; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; reproductive process; signaling; cell junction organization; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_04655,FUN_022395-T1,Peve_00037598,Pocillopora_meandrina_HIv1___RNAseq.g9318.t1,three_way,95.205,FUN_022395-T1,P48643,TCPE_HUMAN,,T-complex protein 1 subunit epsilon (TCP-1-epsilon) (EC 3.6.1.-) (CCT-epsilon) (Chaperonin containing T-complex polypeptide 1 subunit 5),Homo sapiens (Human),78.8,533.0,1.0000000000000002e-248,860.5,sp|P48643|TCPE_HUMAN T-complex protein 1 subunit epsilon OS=Homo sapiens OX=9606 GN=CCT5 PE=1 SV=1,GO:0003730; GO:0005524; GO:0005813; GO:0005829; GO:0005832; GO:0005874; GO:0006457; GO:0007339; GO:0009615; GO:0016887; GO:0031681; GO:0032212; GO:0044183; GO:0044297; GO:0048027; GO:0048487; GO:0050821; GO:0051082; GO:0051086; GO:0061077; GO:0070062; GO:0140662; GO:1904871; GO:1904874,binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein folding [GO:0061077]; positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615],cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein folding chaperone [GO:0044183]; unfolded protein binding [GO:0051082],GO:0003723; GO:0003824; GO:0005815; GO:0005829; GO:0006457; GO:0008092; GO:0016787; GO:0043226; GO:0044183; GO:0140657,RNA binding; catalytic activity; microtubule organizing center; cytosol; protein folding; cytoskeletal protein binding; hydrolase activity; organelle; protein folding chaperone; ATP-dependent activity
OG_04656,FUN_022396-T1,Peve_00037596,Pocillopora_meandrina_HIv1___RNAseq.g9319.t1b,three_way,72.51733333333334,,,,,,,,,,,,,,,,,
OG_04657,FUN_022397-T1,Peve_00037595,Pocillopora_meandrina_HIv1___RNAseq.g9319.t1a,three_way,71.057,,,,,,,,,,,,,,,,,
OG_04658,FUN_022398-T1,Peve_00037594,Pocillopora_meandrina_HIv1___RNAseq.g9320.t1,three_way,62.90333333333333,FUN_022398-T1,Q66KD6,,,,,39.7,194.0,1.3e-34,147.9,sp|Q66KD6|PHOP2_XENTR Probable phosphatase phospho2 OS=Xenopus tropicalis OX=8364 GN=phospho2 PE=2 SV=1,,,,,,
OG_04659,FUN_022401-T1,Peve_00037592,Pocillopora_meandrina_HIv1___RNAseq.g4560.t1,three_way,53.783,FUN_022401-T1,P96738,,,,,30.1,259.0,3e-25,118.6,sp|P96738|CAPA_BACSU PGA biosynthesis protein CapA OS=Bacillus subtilis (strain 168) OX=224308 GN=capA PE=3 SV=1,,,,,,
OG_04660,FUN_022403-T2,Peve_00037588,Pocillopora_meandrina_HIv1___RNAseq.g4547.t1,three_way,80.267,FUN_022403-T2,Q0VFZ6,CF210_HUMAN,,Cilia- and flagella- associated protein 210 (Coiled-coil domain-containing protein 173),Homo sapiens (Human),30.4,529.0,3.1e-35,151.4,sp|Q0VFZ6|CF210_HUMAN Cilia- and flagella- associated protein 210 OS=Homo sapiens OX=9606 GN=CFAP210 PE=1 SV=2,GO:0005879; GO:0030317; GO:0036126; GO:0160112,flagellated sperm motility [GO:0030317],axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_04661,FUN_022406-T1,Peve_00037585,Pocillopora_meandrina_HIv1___TS.g21958.t2,three_way,79.75416666666666,FUN_022406-T1,Q8BXK8,AGAP1_MOUSE,,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 (AGAP-1) (Centaurin-gamma-2) (Cnt-g2)",Mus musculus (Mouse),46.3,525.0,1e-111,405.6,"sp|Q8BXK8|AGAP1_MOUSE Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 OS=Mus musculus OX=10090 GN=Agap1 PE=1 SV=1",GO:0003924; GO:0005096; GO:0005525; GO:0005829; GO:0008270; GO:0015031,protein transport [GO:0015031],cytosol [GO:0005829],GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270],GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0098772,catalytic activity; GTPase activity; cytosol; hydrolase activity; molecular function regulator activity
OG_04662,FUN_022408-T1,Peve_00037583,Pocillopora_meandrina_HIv1___RNAseq.g4541.t1,three_way,68.21366666666667,FUN_022408-T1,F1QJX5,UBR3_DANRE,,E3 ubiquitin-protein ligase ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase ubr3),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,844.0,4.4e-125,451.1,sp|F1QJX5|UBR3_DANRE E3 ubiquitin-protein ligase ubr3 OS=Danio rerio OX=7955 GN=ubr3 PE=2 SV=2,GO:0000151; GO:0005737; GO:0008270; GO:0016567; GO:0048592; GO:0061630; GO:0071596,eye morphogenesis [GO:0048592]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04663,FUN_022411-T1,Peve_00037636,Pocillopora_meandrina_HIv1___TS.g21954.t1,three_way,56.841166666666666,FUN_022411-T1,Q5R802,,,,,36.3,353.0,1.9e-48,196.1,sp|Q5R802|KANL2_PONAB KAT8 regulatory NSL complex subunit 2 OS=Pongo abelii OX=9601 GN=KANSL2 PE=2 SV=1,,,,,,
OG_04664,FUN_022412-T1,Peve_00037635,Pocillopora_meandrina_HIv1___RNAseq.18822_t,three_way,91.77833333333334,FUN_022412-T1,Q15382,,,,,70.5,156.0,5.100000000000001e-59,228.8,sp|Q15382|RHEB_HUMAN GTP-binding protein Rheb OS=Homo sapiens OX=9606 GN=RHEB PE=1 SV=1,,,,,,
OG_04665,FUN_022413-T1,Peve_00037634,Pocillopora_meandrina_HIv1___RNAseq.g4538.t1,three_way,77.59166666666667,FUN_022413-T1,Q9Y2B0,CNPY2_HUMAN,,Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4),Homo sapiens (Human),43.0,165.0,6.8e-36,152.1,sp|Q9Y2B0|CNPY2_HUMAN Protein canopy homolog 2 OS=Homo sapiens OX=9606 GN=CNPY2 PE=1 SV=1,GO:0005783; GO:0010629; GO:0010988,negative regulation of gene expression [GO:0010629]; regulation of low-density lipoprotein particle clearance [GO:0010988],endoplasmic reticulum [GO:0005783],,GO:0005783; GO:0043226,endoplasmic reticulum; organelle
OG_04666,FUN_022414-T1,Peve_00037631,Pocillopora_meandrina_HIv1___RNAseq.g4357.t1,three_way,37.86366666666667,,,,,,,,,,,,,,,,,
OG_04667,FUN_022419-T1,Peve_00037625,Pocillopora_meandrina_HIv1___RNAseq.g4351.t2,three_way,41.7235,FUN_022419-T1,B2LT64,TLR2_GIRCA,,Toll-like receptor 2 (CD antigen CD282),Giraffa camelopardalis (Giraffe),32.1,134.0,7.3e-13,77.0,sp|B2LT64|TLR2_GIRCA Toll-like receptor 2 OS=Giraffa camelopardalis OX=9894 GN=TLR2 PE=3 SV=1,GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0042497; GO:0043235; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727,cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; transmembrane signaling receptor activity [GO:0004888]; triacyl lipopeptide binding [GO:0042497]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_04668,FUN_022424-T1,Peve_00037614,Pocillopora_meandrina_HIv1___RNAseq.g4350.t1,three_way,87.994,FUN_022424-T1,P41250,GARS_HUMAN,,Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1),Homo sapiens (Human),62.3,673.0,6.6e-253,874.8,sp|P41250|GARS_HUMAN Glycine--tRNA ligase OS=Homo sapiens OX=9606 GN=GARS1 PE=1 SV=3,GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006418; GO:0015966; GO:0030141; GO:0030424; GO:0042802; GO:0046983; GO:0070062; GO:0070150; GO:0141192,diadenosine tetraphosphate biosynthetic process [GO:0015966]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141],ATP binding [GO:0005524]; ATP:ATP adenylyltransferase activity [GO:0141192]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983],GO:0003824; GO:0005739; GO:0005829; GO:0006399; GO:0006520; GO:0016740; GO:0016787; GO:0016874; GO:0031410; GO:0043226; GO:0055086; GO:0140098,"catalytic activity; mitochondrion; cytosol; tRNA metabolic process; amino acid metabolic process; transferase activity; hydrolase activity; ligase activity; cytoplasmic vesicle; organelle; nucleobase-containing small molecule metabolic process; catalytic activity, acting on RNA"
OG_04669,FUN_022425-T1,Peve_00037613,Pocillopora_meandrina_HIv1___RNAseq.g4349.t1,three_way,66.758,,,,,,,,,,,,,,,,,
OG_04670,FUN_022428-T1,Peve_00037611,Pocillopora_meandrina_HIv1___RNAseq.g4345.t1,three_way,59.46366666666667,FUN_022428-T1,Q9VCX3,,,,,31.2,253.0,4.2e-31,136.7,sp|Q9VCX3|RM45_DROME Large ribosomal subunit protein mL45 OS=Drosophila melanogaster OX=7227 GN=mRpL45 PE=2 SV=1,,,,,,
OG_04671,FUN_022429-T1,Peve_00037610,Pocillopora_meandrina_HIv1___TS.g21752.t1,three_way,84.66583333333334,FUN_022429-T1,Q5ZLT7,,,,,58.7,421.0,3.5e-135,483.0,sp|Q5ZLT7|5MP2_CHICK eIF5-mimic protein 2 OS=Gallus gallus OX=9031 GN=BZW1 PE=2 SV=1,,,,,,
OG_04672,FUN_022430-T1,Peve_00037605,Pocillopora_meandrina_HIv1___RNAseq.g4343.t1,three_way,55.87566666666667,FUN_022430-T1,P07106,,,,,46.6,131.0,5.1e-28,127.5,sp|P07106|ACBD5_BOVIN Acyl-CoA-binding domain-containing protein 5 OS=Bos taurus OX=9913 GN=ACBD5 PE=2 SV=2,,,,,,
OG_04673,FUN_022435-T1,Peve_00037620,Pocillopora_meandrina_HIv1___RNAseq.g4340.t1,three_way,53.306666666666665,,,,,,,,,,,,,,,,,
OG_04674,FUN_022436-T1,Peve_00037615,Pocillopora_meandrina_HIv1___RNAseq.g4337.t1,three_way,61.0185,FUN_022436-T1,Q0IIH8,,,,,44.9,463.0,6e-104,379.4,sp|Q0IIH8|MINY3_BOVIN Ubiquitin carboxyl-terminal hydrolase MINDY-3 OS=Bos taurus OX=9913 GN=MINDY3 PE=2 SV=1,,,,,,
OG_04675,FUN_022437-T1,Peve_00017892,Pocillopora_meandrina_HIv1___RNAseq.g4335.t1,three_way,81.93833333333333,FUN_022437-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),42.7,450.0,4.5e-92,340.1,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_04676,FUN_022441-T1,Peve_00017898,Pocillopora_meandrina_HIv1___RNAseq.g4334.t1,three_way,57.25933333333334,,,,,,,,,,,,,,,,,
OG_04677,FUN_022446-T1,Peve_00037587,Pocillopora_meandrina_HIv1___RNAseq.g4330.t1,three_way,71.33800000000001,FUN_022446-T1,Q29496,CP3AO_SHEEP,,Cytochrome P450 3A24 (EC 1.14.14.1) (CYPIIIA24),Ovis aries (Sheep),38.8,485.0,1.4999999999999999e-92,341.7,sp|Q29496|CP3AO_SHEEP Cytochrome P450 3A24 OS=Ovis aries OX=9940 GN=CYP3A24 PE=2 SV=1,GO:0004497; GO:0005506; GO:0005789; GO:0008202; GO:0016712; GO:0020037; GO:0050649; GO:0070989,oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; testosterone 6-beta-hydroxylase activity [GO:0050649]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_04678,FUN_022450-T1,Peve_00009225,Pocillopora_meandrina_HIv1___RNAseq.g4325.t1,three_way,62.3975,FUN_022450-T1,Q5RDB4,,,,,39.0,249.0,4.2e-48,193.7,sp|Q5RDB4|NEMP1_PONAB Nuclear envelope integral membrane protein 1 OS=Pongo abelii OX=9601 GN=NEMP1 PE=2 SV=1,,,,,,
OG_04679,FUN_022452-T1,Peve_00009229,Pocillopora_meandrina_HIv1___RNAseq.g4320.t1,three_way,51.78233333333333,FUN_022452-T1,B2LT64,TLR2_GIRCA,,Toll-like receptor 2 (CD antigen CD282),Giraffa camelopardalis (Giraffe),30.2,199.0,2.2e-17,92.0,sp|B2LT64|TLR2_GIRCA Toll-like receptor 2 OS=Giraffa camelopardalis OX=9894 GN=TLR2 PE=3 SV=1,GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0042497; GO:0043235; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727,cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; transmembrane signaling receptor activity [GO:0004888]; triacyl lipopeptide binding [GO:0042497]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_04680,FUN_022460-T1,Peve_00005135,Pocillopora_meandrina_HIv1___RNAseq.g4118.t1,three_way,71.59633333333333,,,,,,,,,,,,,,,,,
OG_04681,FUN_022471-T1,Peve_00021891,Pocillopora_meandrina_HIv1___RNAseq.g4309.t2,three_way,76.20733333333334,,,,,,,,,,,,,,,,,
OG_04682,FUN_022473-T2,Peve_00020969,Pocillopora_meandrina_HIv1___RNAseq.g4307.t1,three_way,65.6105,,,,,,,,,,,,,,,,,
OG_04683,FUN_022474-T1,Peve_00020970,Pocillopora_meandrina_HIv1___RNAseq.g4306.t1,three_way,54.81516666666667,,,,,,,,,,,,,,,,,
OG_04684,FUN_022475-T1,Peve_00020972,Pocillopora_meandrina_HIv1___RNAseq.g4305.t1,three_way,57.77916666666667,,,,,,,,,,,,,,,,,
OG_04685,FUN_022476-T1,Peve_00020971,Pocillopora_meandrina_HIv1___RNAseq.g4304.t1,three_way,48.067,,,,,,,,,,,,,,,,,
OG_04686,FUN_022477-T1,Peve_00002918,Pocillopora_meandrina_HIv1___RNAseq.g4303.t1,three_way,85.38066666666667,FUN_022477-T1,Q32L53,LFG1_BOVIN,,Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit),Bos taurus (Bovine),46.4,220.0,5.999999999999998e-47,189.1,sp|Q32L53|LFG1_BOVIN Protein lifeguard 1 OS=Bos taurus OX=9913 GN=GRINA PE=2 SV=1,GO:0005262; GO:0005783; GO:0005794; GO:0016020; GO:0043524; GO:0097190; GO:1902042,apoptotic signaling pathway [GO:0097190]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of neuron apoptotic process [GO:0043524],endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],calcium channel activity [GO:0005262],GO:0005215; GO:0005783; GO:0005794; GO:0043226,transporter activity; endoplasmic reticulum; Golgi apparatus; organelle
OG_04687,FUN_022478-T1,Peve_00002929,Pocillopora_meandrina_HIv1___RNAseq.g4301.t1,three_way,36.67283333333333,,,,,,,,,,,,,,,,,
OG_04688,FUN_022479-T1,Peve_00002930,Pocillopora_meandrina_HIv1___RNAseq.g4300.t2,three_way,75.41633333333333,FUN_022479-T1,P52624,UPP1_MOUSE,,Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3),Mus musculus (Mouse),50.2,285.0,6.900000000000001e-78,292.4,sp|P52624|UPP1_MOUSE Uridine phosphorylase 1 OS=Mus musculus OX=10090 GN=Upp1 PE=1 SV=2,GO:0004850; GO:0005654; GO:0005829; GO:0006218; GO:0006220; GO:0006248; GO:0006249; GO:0009032; GO:0042149; GO:0042802; GO:0044206; GO:0046050; GO:0046074; GO:0046079; GO:0046108; GO:0047847,cellular response to glucose starvation [GO:0042149]; CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dTMP catabolic process [GO:0046074]; dUMP catabolic process [GO:0046079]; pyrimidine nucleotide metabolic process [GO:0006220]; UMP catabolic process [GO:0046050]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218]; uridine metabolic process [GO:0046108],cytosol [GO:0005829]; nucleoplasm [GO:0005654],deoxyuridine phosphorylase activity [GO:0047847]; identical protein binding [GO:0042802]; thymidine phosphorylase activity [GO:0009032]; uridine phosphorylase activity [GO:0004850],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04689,FUN_022480-T1,Peve_00002919,Pocillopora_meandrina_HIv1___RNAseq.g4299.t1,three_way,73.78766666666667,FUN_022480-T1,Q9UH92,MLX_HUMAN,,Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4),Homo sapiens (Human),61.2,188.0,1.8e-56,220.7,sp|Q9UH92|MLX_HUMAN Max-like protein X OS=Homo sapiens OX=9606 GN=MLX PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0031965; GO:0042803; GO:0045892; GO:0045944; GO:0046982; GO:0061629; GO:1990837,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_04690,FUN_022481-T1,Peve_00002920,Pocillopora_meandrina_HIv1___RNAseq.g4298.t1,three_way,71.46483333333333,FUN_022481-T1,Q99MZ8,LASP1_RAT,,LIM and SH3 domain protein 1 (LASP-1),Rattus norvegicus (Rat),56.1,264.0,1.0999999999999999e-53,211.5,sp|Q99MZ8|LASP1_RAT LIM and SH3 domain protein 1 OS=Rattus norvegicus OX=10116 GN=Lasp1 PE=1 SV=1,GO:0005737; GO:0005925; GO:0006811; GO:0015075; GO:0030864; GO:0046872; GO:0051015; GO:0098794,monoatomic ion transport [GO:0006811],cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; postsynapse [GO:0098794],actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; monoatomic ion transmembrane transporter activity [GO:0015075],GO:0005215; GO:0005856; GO:0008092; GO:0043226,transporter activity; cytoskeleton; cytoskeletal protein binding; organelle
OG_04691,FUN_022482-T1,Peve_00002923,Pocillopora_meandrina_HIv1___RNAseq.g4296.t1,three_way,79.319,FUN_022482-T1,O14929,HAT1_HUMAN,,Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1),Homo sapiens (Human),48.1,401.0,2.5e-106,387.1,sp|O14929|HAT1_HUMAN Histone acetyltransferase type B catalytic subunit OS=Homo sapiens OX=9606 GN=HAT1 PE=1 SV=2,GO:0000781; GO:0000785; GO:0004402; GO:0005634; GO:0005654; GO:0005739; GO:0006334; GO:0006475; GO:0010485; GO:0016363; GO:0031509; GO:0032991; GO:0042393; GO:0043997; GO:0051276,chromosome organization [GO:0051276]; internal protein amino acid acetylation [GO:0006475]; nucleosome assembly [GO:0006334]; subtelomeric heterochromatin formation [GO:0031509],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K12 acetyltransferase activity [GO:0043997],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006325; GO:0016740; GO:0042393; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; chromatin organization; transferase activity; histone binding; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_04692,FUN_022484-T1,Peve_00002924,Pocillopora_meandrina_HIv1___RNAseq.g4295.t1,three_way,86.47083333333333,FUN_022484-T1,Q8VID6,PDE11_RAT,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)",Rattus norvegicus (Rat),47.6,930.0,9.3e-242,838.2,"sp|Q8VID6|PDE11_RAT Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Rattus norvegicus OX=10116 GN=Pde11a PE=1 SV=1",GO:0004115; GO:0004118; GO:0005829; GO:0010754; GO:0019933; GO:0030553; GO:0043204; GO:0046872; GO:0047555; GO:0141162,cAMP-mediated signaling [GO:0019933]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754],cytosol [GO:0005829]; perikaryon [GO:0043204],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787,catalytic activity; cytosol; hydrolase activity
OG_04693,FUN_022485-T1,Peve_00002925,Pocillopora_meandrina_HIv1___RNAseq.g4293.t1,three_way,88.12733333333333,,,,,,,,,,,,,,,,,
OG_04694,FUN_022486-T1,Peve_00002926,Pocillopora_meandrina_HIv1___RNAseq.g4292.t1,three_way,75.504,FUN_022486-T1,P15882,CHIN_HUMAN,,N-chimaerin (A-chimaerin) (Alpha-chimerin) (N-chimerin) (NC) (Rho GTPase-activating protein 2),Homo sapiens (Human),55.8,457.0,7e-142,505.4,sp|P15882|CHIN_HUMAN N-chimaerin OS=Homo sapiens OX=9606 GN=CHN1 PE=1 SV=3,GO:0005096; GO:0005829; GO:0008045; GO:0008270; GO:0046875; GO:0048013; GO:0050770; GO:0051056,ephrin receptor signaling pathway [GO:0048013]; motor neuron axon guidance [GO:0008045]; regulation of axonogenesis [GO:0050770]; regulation of small GTPase mediated signal transduction [GO:0051056],cytosol [GO:0005829],ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_04695,FUN_022487-T1,Peve_00002927,Pocillopora_meandrina_HIv1___RNAseq.g4290.t1,three_way,61.783,,,,,,,,,,,,,,,,,
OG_04696,FUN_022491-T2,Peve_00043031,Pocillopora_meandrina_HIv1___RNAseq.g4280.t1,three_way,80.142,FUN_022491-T2,O15178,,,,,55.1,372.0,3.5e-97,356.7,sp|O15178|TBXT_HUMAN T-box transcription factor T OS=Homo sapiens OX=9606 GN=TBXT PE=1 SV=1,,,,,,
OG_04697,FUN_022494-T1,Peve_00043030,Pocillopora_meandrina_HIv1___TS.18734_t,three_way,69.23266666666666,,,,,,,,,,,,,,,,,
OG_04698,FUN_022495-T1,Peve_00043033,Pocillopora_meandrina_HIv1___TS.g21687.t1,three_way,47.8575,,,,,,,,,,,,,,,,,
OG_04699,FUN_022499-T1,Peve_00033031,Pocillopora_meandrina_HIv1___RNAseq.g4275.t1,three_way,69.74766666666667,FUN_022499-T1,A4IH82,,,,,29.7,290.0,3.3e-22,107.8,sp|A4IH82|3BP5L_XENTR SH3 domain-binding protein 5-like OS=Xenopus tropicalis OX=8364 GN=sh3bp5l PE=2 SV=1,,,,,,
OG_04700,FUN_022500-T1,Peve_00032397,Pocillopora_meandrina_HIv1___RNAseq.g4274.t2,three_way,58.830666666666666,,,,,,,,,,,,,,,,,
OG_04701,FUN_022501-T1,Peve_00002457,Pocillopora_meandrina_HIv1___RNAseq.g4267.t1,three_way,63.63316666666667,FUN_022501-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),34.8,744.0,1.6000000000000002e-125,451.8,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_04702,FUN_022502-T1,Peve_00002455,Pocillopora_meandrina_HIv1___RNAseq.g4266.t1,three_way,72.781,FUN_022502-T1,Q6PF21,,,,,52.6,919.0,1e-272,941.0,"sp|Q6PF21|SYMC_XENLA Methionine--tRNA ligase, cytoplasmic OS=Xenopus laevis OX=8355 GN=mars1 PE=2 SV=1",,,,,,
OG_04703,FUN_022503-T1,Peve_00002454,Pocillopora_meandrina_HIv1___RNAseq.g4265.t1,three_way,71.45716666666667,FUN_022503-T1,Q8VD33,,,,,43.5,315.0,1.2e-19,99.0,sp|Q8VD33|SGTB_MOUSE Small glutamine-rich tetratricopeptide repeat-containing protein beta OS=Mus musculus OX=10090 GN=Sgtb PE=1 SV=1,,,,,,
OG_04704,FUN_022505-T1,Peve_00002453,Pocillopora_meandrina_HIv1___RNAseq.g4264.t1,three_way,59.093,,,,,,,,,,,,,,,,,
OG_04705,FUN_022506-T1,Peve_00002460,Pocillopora_meandrina_HIv1___RNAseq.g4262.t1,three_way,76.27033333333334,FUN_022506-T1,P58742,AAAS_MOUSE,,Aladin (Adracalin),Mus musculus (Mouse),41.0,493.0,3.7e-115,416.8,sp|P58742|AAAS_MOUSE Aladin OS=Mus musculus OX=10090 GN=Aaas PE=1 SV=1,GO:0000922; GO:0001578; GO:0005635; GO:0005643; GO:0005654; GO:0005813; GO:0005829; GO:0006749; GO:0006913; GO:0006979; GO:0007612; GO:0009566; GO:0015031; GO:0031965; GO:0035264; GO:0051028; GO:0072686; GO:0090307,fertilization [GO:0009566]; glutathione metabolic process [GO:0006749]; learning [GO:0007612]; microtubule bundle formation [GO:0001578]; mitotic spindle assembly [GO:0090307]; mRNA transport [GO:0051028]; multicellular organism growth [GO:0035264]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; response to oxidative stress [GO:0006979],centrosome [GO:0005813]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],,GO:0005635; GO:0005654; GO:0005815; GO:0005829; GO:0006575; GO:0006790; GO:0006913; GO:0007010; GO:0022414; GO:0043226; GO:0050877,nuclear envelope; nucleoplasm; microtubule organizing center; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; organelle; nervous system process
OG_04706,FUN_022507-T1,Peve_00002459,Pocillopora_meandrina_HIv1___RNAseq.g4261.t1,three_way,67.73566666666666,FUN_022507-T1,F1QDI9,,,,,65.5,640.0,6.4e-248,858.6,sp|F1QDI9|MCM9_DANRE DNA helicase MCM9 OS=Danio rerio OX=7955 GN=mcm9 PE=3 SV=2,,,,,,
OG_04707,FUN_022509-T1,Peve_00031525,Pocillopora_meandrina_HIv1___RNAseq.g4259.t1,three_way,82.23083333333334,FUN_022509-T1,Q810A7,DDX42_MOUSE,,ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42),Mus musculus (Mouse),59.9,731.0,1.4e-227,790.8,sp|Q810A7|DDX42_MOUSE ATP-dependent RNA helicase DDX42 OS=Mus musculus OX=10090 GN=Ddx42 PE=1 SV=3,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0008104; GO:0016607; GO:0016887; GO:0042981; GO:0071004; GO:1903241,protein localization [GO:0008104]; regulation of apoptotic process [GO:0042981]; U2-type prespliceosome assembly [GO:1903241],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type prespliceosome [GO:0071004],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0065003; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; cytosol; hydrolase activity; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04708,FUN_022512-T3,Peve_00029626,Pocillopora_meandrina_HIv1___RNAseq.g4258.t2,three_way,80.24166666666667,FUN_022512-T3,P49282,NRAM2_MOUSE,,Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2),Mus musculus (Mouse),65.1,504.0,1.1e-179,631.3,sp|P49282|NRAM2_MOUSE Natural resistance-associated macrophage protein 2 OS=Mus musculus OX=10090 GN=Slc11a2 PE=1 SV=2,GO:0005375; GO:0005381; GO:0005384; GO:0005634; GO:0005741; GO:0005765; GO:0005768; GO:0005769; GO:0005794; GO:0005886; GO:0005903; GO:0006778; GO:0006779; GO:0006783; GO:0006824; GO:0006826; GO:0007611; GO:0009986; GO:0010039; GO:0012505; GO:0015078; GO:0015086; GO:0015087; GO:0015093; GO:0015094; GO:0015295; GO:0016324; GO:0031526; GO:0031901; GO:0031902; GO:0033212; GO:0045178; GO:0046870; GO:0048471; GO:0048813; GO:0048821; GO:0051649; GO:0055037; GO:0055038; GO:0060586; GO:0070574; GO:0070826; GO:1902600; GO:1903561,cadmium ion transmembrane transport [GO:0070574]; cobalt ion transport [GO:0006824]; dendrite morphogenesis [GO:0048813]; erythrocyte development [GO:0048821]; establishment of localization in cell [GO:0051649]; heme biosynthetic process [GO:0006783]; iron import into cell [GO:0033212]; iron ion transport [GO:0006826]; learning or memory [GO:0007611]; multicellular organismal-level iron ion homeostasis [GO:0060586]; porphyrin-containing compound biosynthetic process [GO:0006779]; porphyrin-containing compound metabolic process [GO:0006778]; proton transmembrane transport [GO:1902600]; response to iron ion [GO:0010039],apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; endosome [GO:0005768]; extracellular vesicle [GO:1903561]; Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; paraferritin complex [GO:0070826]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],cadmium ion binding [GO:0046870]; cadmium ion transmembrane transporter activity [GO:0015086]; cobalt ion transmembrane transporter activity [GO:0015087]; copper ion transmembrane transporter activity [GO:0005375]; ferrous iron transmembrane transporter activity [GO:0015093]; iron ion transmembrane transporter activity [GO:0005381]; lead ion transmembrane transporter activity [GO:0015094]; manganese ion transmembrane transporter activity [GO:0005384]; proton transmembrane transporter activity [GO:0015078]; solute:proton symporter activity [GO:0015295],GO:0005215; GO:0005634; GO:0005768; GO:0005794; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085,transporter activity; nucleus; endosome; Golgi apparatus; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_04709,FUN_022513-T1,Peve_00029618,Pocillopora_meandrina_HIv1___RNAseq.g4256.t1,three_way,61.22516666666667,FUN_022513-T1,Q8K2X2,,,,,63.7,146.0,8.400000000000001e-48,192.6,sp|Q8K2X2|RBM48_MOUSE RNA-binding protein 48 OS=Mus musculus OX=10090 GN=Rbm48 PE=2 SV=2,,,,,,
OG_04710,FUN_022517-T1,Peve_00029619,Pocillopora_meandrina_HIv1___RNAseq.g4255.t1,three_way,77.4915,FUN_022517-T1,A6X919,D19L1_MOUSE,,Protein C-mannosyl-transferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1),Mus musculus (Mouse),47.7,677.0,1.4e-171,604.7,sp|A6X919|D19L1_MOUSE Protein C-mannosyl-transferase DPY19L1 OS=Mus musculus OX=10090 GN=Dpy19l1 PE=1 SV=1,GO:0000030; GO:0005789; GO:0018103,protein C-linked glycosylation [GO:0018103],endoplasmic reticulum membrane [GO:0005789],mannosyltransferase activity [GO:0000030],GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_04711,FUN_022518-T1,Peve_00030465,Pocillopora_meandrina_HIv1___TS.g21661.t1,three_way,66.89816666666665,FUN_022518-T1,Q99996,AKAP9_HUMAN,,A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao),Homo sapiens (Human),36.4,291.0,1.9e-34,152.1,sp|Q99996|AKAP9_HUMAN A-kinase anchor protein 9 OS=Homo sapiens OX=9606 GN=AKAP9 PE=1 SV=4,GO:0003677; GO:0005102; GO:0005794; GO:0005795; GO:0005801; GO:0005813; GO:0005829; GO:0005856; GO:0007020; GO:0007165; GO:0007268; GO:0008076; GO:0015459; GO:0031116; GO:0031503; GO:0034237; GO:0034705; GO:0043025; GO:0043231; GO:0044307; GO:0044325; GO:0051602; GO:0051661; GO:0060090; GO:0060306; GO:0060307; GO:0071320; GO:0086091; GO:0097060; GO:0098909; GO:0098978; GO:0099104; GO:0099147; GO:1903358,cellular response to cAMP [GO:0071320]; chemical synaptic transmission [GO:0007268]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of Golgi organization [GO:1903358]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of membrane repolarization [GO:0060306]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165],centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; potassium channel complex [GO:0034705]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076],DNA binding [GO:0003677]; molecular adaptor activity [GO:0060090]; potassium channel activator activity [GO:0099104]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325],GO:0003677; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0023052; GO:0043226; GO:0060090; GO:0098772,DNA binding; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; signaling; organelle; molecular adaptor activity; molecular function regulator activity
OG_04712,FUN_022519-T1,Peve_00026444,Pocillopora_meandrina_HIv1___RNAseq.g4252.t1,three_way,93.754,FUN_022519-T1,F6XBL2,,,,,71.0,414.0,4.3000000000000005e-162,572.4,sp|F6XBL2|PSD11_XENTR 26S proteasome non-ATPase regulatory subunit 11 OS=Xenopus tropicalis OX=8364 GN=psmd11 PE=3 SV=2,,,,,,
OG_04713,FUN_022520-T1,Peve_00026443,Pocillopora_meandrina_HIv1___RNAseq.g4251.t1,three_way,57.53933333333333,,,,,,,,,,,,,,,,,
OG_04714,FUN_022525-T1,Peve_00020800,Pocillopora_meandrina_HIv1___RNAseq.g4522.t1,three_way,52.60116666666667,,,,,,,,,,,,,,,,,
OG_04715,FUN_022527-T1,Peve_00020803,Pocillopora_meandrina_HIv1___RNAseq.g4524.t2,three_way,62.5415,FUN_022527-T1,Q9NYL2,M3K20_HUMAN,,Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase 7) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK),Homo sapiens (Human),50.5,533.0,3.2e-135,484.2,sp|Q9NYL2|M3K20_HUMAN Mitogen-activated protein kinase kinase kinase 20 OS=Homo sapiens OX=9606 GN=MAP3K20 PE=1 SV=3,GO:0000077; GO:0000165; GO:0000287; GO:0003723; GO:0004674; GO:0004706; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007010; GO:0007059; GO:0007254; GO:0008219; GO:0019887; GO:0030071; GO:0030154; GO:0030295; GO:0031098; GO:0038066; GO:0042733; GO:0043022; GO:0043065; GO:0043068; GO:0046777; GO:0051403; GO:0060173; GO:0070181; GO:0070269; GO:0070303; GO:0071480; GO:0071493; GO:0106310; GO:0140469; GO:0170011; GO:1902010; GO:1904291,cell death [GO:0008219]; cell differentiation [GO:0030154]; cellular response to gamma radiation [GO:0071480]; cellular response to UV-B [GO:0071493]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; DNA damage checkpoint signaling [GO:0000077]; embryonic digit morphogenesis [GO:0042733]; GCN2-mediated signaling [GO:0140469]; inflammatory response [GO:0006954]; JNK cascade [GO:0007254]; limb development [GO:0060173]; MAPK cascade [GO:0000165]; negative regulation of stress-activated protein kinase signaling cascade [GO:0070303]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; p38MAPK cascade [GO:0038066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of mitotic DNA damage checkpoint [GO:1904291]; positive regulation of programmed cell death [GO:0043068]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; pyroptotic inflammatory response [GO:0070269]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; stress-activated MAPK cascade [GO:0051403]; stress-activated protein kinase signaling cascade [GO:0031098],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; JUN kinase kinase kinase activity [GO:0004706]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activator activity [GO:0030295]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; stalled ribosome sensor activity [GO:0170011],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006954; GO:0007010; GO:0007059; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140096; GO:0140299,"RNA binding; catalytic activity; nucleus; cytosol; inflammatory response; cytoskeleton organization; chromosome segregation; transferase activity; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein; molecular sensor activity"
OG_04716,FUN_022538-T1,Peve_00043570,Pocillopora_meandrina_HIv1___RNAseq.g4146.t1,three_way,41.83383333333333,,,,,,,,,,,,,,,,,
OG_04717,FUN_022539-T2,Peve_00025372,Pocillopora_meandrina_HIv1___RNAseq.g4147.t1,three_way,68.20566666666667,,,,,,,,,,,,,,,,,
OG_04718,FUN_022540-T1,Peve_00029315,Pocillopora_meandrina_HIv1___TS.g21550.t3,three_way,86.79216666666667,FUN_022540-T1,P30626,SORCN_HUMAN,,Sorcin (22 kDa protein) (CP-22) (CP22) (V19),Homo sapiens (Human),63.8,196.0,5.699999999999999e-69,261.9,sp|P30626|SORCN_HUMAN Sorcin OS=Homo sapiens OX=9606 GN=SRI PE=1 SV=1,GO:0002020; GO:0005102; GO:0005246; GO:0005509; GO:0005654; GO:0005737; GO:0005789; GO:0005829; GO:0006816; GO:0007165; GO:0010459; GO:0010649; GO:0010880; GO:0016020; GO:0016529; GO:0030018; GO:0030315; GO:0033017; GO:0042802; GO:0044325; GO:0046982; GO:0051281; GO:0051924; GO:0055118; GO:0061178; GO:0070062; GO:0086004; GO:0140297; GO:0140311; GO:0140416; GO:1901077; GO:1901844,calcium ion transport [GO:0006816]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling [GO:0010649]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of relaxation of muscle [GO:1901077]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; T-tubule [GO:0030315]; Z disc [GO:0030018],calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; signaling receptor binding [GO:0005102]; transcription regulator inhibitor activity [GO:0140416]; transmembrane transporter binding [GO:0044325],GO:0005654; GO:0005783; GO:0005829; GO:0043226; GO:0098772; GO:0140313,nucleoplasm; endoplasmic reticulum; cytosol; organelle; molecular function regulator activity; molecular sequestering activity
OG_04719,FUN_022545-T1,Peve_00003430,Pocillopora_meandrina_HIv1___RNAseq.g4154.t1,three_way,65.10566666666666,FUN_022545-T1,Q7T3E6,,,,,44.2,226.0,4.7e-45,183.3,sp|Q7T3E6|BMI1B_DANRE Polycomb complex protein BMI-1-B OS=Danio rerio OX=7955 GN=bmi1b PE=2 SV=1,,,,,,
OG_04720,FUN_022569-T1,Peve_00000937,Pocillopora_meandrina_HIv1___RNAseq.g4156.t1,three_way,73.66833333333334,,,,,,,,,,,,,,,,,
OG_04721,FUN_022578-T1,Peve_00020592,Pocillopora_meandrina_HIv1___RNAseq.g4435.t1,three_way,84.55266666666667,FUN_022578-T1,Q9JLI7,SPAG6_MOUSE,,Sperm-associated antigen 6 (Axoneme central apparatus protein) (Protein PF16 homolog),Mus musculus (Mouse),87.9,506.0,1.2e-81,305.4,sp|Q9JLI7|SPAG6_MOUSE Sperm-associated antigen 6 OS=Mus musculus OX=10090 GN=Spag6 PE=1 SV=1,GO:0001669; GO:0002177; GO:0003351; GO:0003356; GO:0005576; GO:0005829; GO:0005874; GO:0005930; GO:0006931; GO:0007283; GO:0007288; GO:0008017; GO:0008104; GO:0010761; GO:0021591; GO:0030317; GO:0031410; GO:0043149; GO:0043583; GO:0044458; GO:0045198; GO:0046847; GO:0051301; GO:0051649; GO:0090175; GO:0090660; GO:0097228; GO:0120197; GO:0120249; GO:1905515; GO:1990138; GO:1990716,"cell division [GO:0051301]; cerebrospinal fluid circulation [GO:0090660]; ear development [GO:0043583]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of localization in cell [GO:0051649]; fibroblast migration [GO:0010761]; filopodium assembly [GO:0046847]; flagellated sperm motility [GO:0030317]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; neuron projection extension [GO:1990138]; non-motile cilium assembly [GO:1905515]; protein localization [GO:0008104]; regulation of cilium beat frequency [GO:0003356]; regulation of establishment of planar polarity [GO:0090175]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283]; stress fiber assembly [GO:0043149]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; ventricular system development [GO:0021591]",acrosomal vesicle [GO:0001669]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; lateral wall of outer hair cell [GO:0120249]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm principal piece [GO:0097228],microtubule binding [GO:0008017],GO:0003016; GO:0005576; GO:0005829; GO:0007010; GO:0007018; GO:0007155; GO:0007163; GO:0008092; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877,respiratory system process; extracellular region; cytosol; cytoskeleton organization; microtubule-based movement; cell adhesion; establishment or maintenance of cell polarity; cytoskeletal protein binding; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; cell motility; nervous system process
OG_04722,FUN_022580-T1,Peve_00020261,Pocillopora_meandrina_HIv1___RNAseq.g4432.t1,three_way,74.89066666666666,FUN_022580-T1,Q5F3W2,,,,,42.0,205.0,8.4e-46,185.3,sp|Q5F3W2|INSI2_CHICK Insulin-induced gene 2 protein OS=Gallus gallus OX=9031 GN=INSIG2 PE=2 SV=2,,,,,,
OG_04723,FUN_022586-T1,Peve_00020593,Pocillopora_meandrina_HIv1___RNAseq.g4434.t2,three_way,67.00133333333333,FUN_022586-T1,Q9BE31,,,,,29.9,632.0,8e-77,289.7,sp|Q9BE31|RHG12_MACFA Rho GTPase-activating protein 12 OS=Macaca fascicularis OX=9541 GN=ARHGAP12 PE=2 SV=1,,,,,,
OG_04724,FUN_022589-T1,Peve_00020263,Pocillopora_meandrina_HIv1___RNAseq.g4431.t1,three_way,80.9065,FUN_022589-T1,O70172,,,,,50.9,450.0,7.000000000000002e-110,399.1,sp|O70172|PI42A_MOUSE Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha OS=Mus musculus OX=10090 GN=Pip4k2a PE=1 SV=1,,,,,,
OG_04725,FUN_022590-T1,Peve_00020264,Pocillopora_meandrina_HIv1___RNAseq.g4430.t1,three_way,67.37833333333333,FUN_022590-T1,Q64368,DAZL_MOUSE,,Deleted in azoospermia-like (DAZ-like autosomal) (Deleted in azoospermia-like 1),Mus musculus (Mouse),37.4,139.0,2e-15,84.0,sp|Q64368|DAZL_MOUSE Deleted in azoospermia-like OS=Mus musculus OX=10090 GN=Dazl PE=1 SV=1,GO:0001556; GO:0003730; GO:0005634; GO:0005737; GO:0005840; GO:0007147; GO:0007281; GO:0007283; GO:0008494; GO:0032991; GO:0042802; GO:0045836; GO:0045948,female meiosis II [GO:0007147]; germ cell development [GO:0007281]; oocyte maturation [GO:0001556]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of translational initiation [GO:0045948]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribosome [GO:0005840],identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; translation activator activity [GO:0008494],GO:0003723; GO:0005634; GO:0005840; GO:0022414; GO:0043226; GO:0045182; GO:0048856; GO:0140013,RNA binding; nucleus; ribosome; reproductive process; organelle; translation regulator activity; anatomical structure development; meiotic nuclear division
OG_04726,FUN_022591-T1,Peve_00020266,Pocillopora_meandrina_HIv1___RNAseq.g4429.t1,three_way,89.74766666666666,FUN_022591-T1,E2RG47,STT3B_CANLF,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18),Canis lupus familiaris (Dog) (Canis familiaris),69.7,700.0,4.4e-276,951.8,sp|E2RG47|STT3B_CANLF Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B OS=Canis lupus familiaris OX=9615 GN=STT3B PE=1 SV=1,GO:0004579; GO:0006516; GO:0006986; GO:0008250; GO:0018279; GO:0036503; GO:0043686; GO:0043687; GO:0046872; GO:0160227,co-translational protein modification [GO:0043686]; ERAD pathway [GO:0036503]; glycoprotein catabolic process [GO:0006516]; post-translational protein modification [GO:0043687]; protein N-linked glycosylation via asparagine [GO:0018279]; response to unfolded protein [GO:0006986],oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex B [GO:0160227],dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872],GO:0003824; GO:0009101; GO:0016740; GO:0030163; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; protein catabolic process; carbohydrate derivative metabolic process
OG_04727,FUN_022593-T1,Peve_00020267,Pocillopora_meandrina_HIv1___RNAseq.g4428.t2,three_way,75.349,,,,,,,,,,,,,,,,,
OG_04728,FUN_022594-T1,Peve_00020268,Pocillopora_meandrina_HIv1___RNAseq.g4427.t1,three_way,86.208,FUN_022594-T1,Q969G3,SMCE1_HUMAN,,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57),Homo sapiens (Human),52.9,240.0,5.8e-47,189.5,sp|Q969G3|SMCE1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 OS=Homo sapiens OX=9606 GN=SMARCE1 PE=1 SV=2,GO:0000228; GO:0000776; GO:0000785; GO:0003677; GO:0003682; GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0008080; GO:0016363; GO:0016514; GO:0016586; GO:0016922; GO:0022008; GO:0030071; GO:0032991; GO:0035060; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:1902459; GO:2000045; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],GO:0000228; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0060090; GO:0140110,nuclear chromosome; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_04729,FUN_022596-T1,Peve_00020269,Pocillopora_meandrina_HIv1___RNAseq.g4426.t1,three_way,59.531,FUN_022596-T1,Q91559,,,,,29.8,352.0,2.9e-30,134.4,sp|Q91559|5HT7R_XENLA 5-hydroxytryptamine receptor 7 OS=Xenopus laevis OX=8355 GN=htr7 PE=2 SV=1,,,,,,
OG_04730,FUN_022598-T1,Peve_00006977,Pocillopora_meandrina_HIv1___RNAseq.g4425.t1,three_way,65.40233333333333,FUN_022598-T1,Q5R4Q6,5HT2A_PONPY,,5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A),Pongo pygmaeus (Bornean orangutan),28.8,323.0,9.5e-26,119.4,sp|Q5R4Q6|5HT2A_PONPY 5-hydroxytryptamine receptor 2A OS=Pongo pygmaeus OX=9600 GN=HTR2A PE=2 SV=1,GO:0004993; GO:0005901; GO:0007187; GO:0007208; GO:0007210; GO:0007268; GO:0009410; GO:0030424; GO:0030425; GO:0030594; GO:0031410; GO:0051209; GO:0098793; GO:0099589,"chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; serotonin receptor signaling pathway [GO:0007210]",axon [GO:0030424]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; presynapse [GO:0098793],G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594]; serotonin receptor activity [GO:0099589],GO:0023052; GO:0031410; GO:0043226; GO:0055085; GO:0060089,signaling; cytoplasmic vesicle; organelle; transmembrane transport; molecular transducer activity
OG_04731,FUN_022599-T1,Peve_00012273,Pocillopora_meandrina_HIv1___RNAseq.g4424.t2,three_way,83.4855,FUN_022599-T1,F1LZW6,S2513_RAT,,"Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial (Solute carrier family 25 member 13)",Rattus norvegicus (Rat),51.9,671.0,7.100000000000001e-186,652.1,"sp|F1LZW6|S2513_RAT Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial OS=Rattus norvegicus OX=10116 GN=Slc25a13 PE=3 SV=4",GO:0000514; GO:0000515; GO:0005313; GO:0005509; GO:0005739; GO:0005743; GO:0006094; GO:0006754; GO:0015172; GO:0015183; GO:0015810; GO:0015813; GO:0042802; GO:0043490; GO:0045333; GO:0051592,aspartate transmembrane transport [GO:0015810]; ATP biosynthetic process [GO:0006754]; cellular respiration [GO:0045333]; gluconeogenesis [GO:0006094]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; response to calcium ion [GO:0051592],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],"3-sulfino-L-alanine: proton, glutamate antiporter activity [GO:0000514]; acidic amino acid transmembrane transporter activity [GO:0015172]; aspartate:glutamate, proton antiporter activity [GO:0000515]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]",GO:0005215; GO:0005739; GO:0005975; GO:0006091; GO:0043226; GO:0055085; GO:0055086; GO:1901135,transporter activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04732,FUN_022601-T1,Peve_00012225,Pocillopora_meandrina_HIv1___RNAseq.g4422.t1,three_way,65.245,FUN_022601-T1,Q498E7,SMAL1_XENLA,,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (EC 3.6.4.-) (HepA-related protein) (Sucrose nonfermenting protein 2-like 1),Xenopus laevis (African clawed frog),56.2,571.0,1.2e-174,615.1,sp|Q498E7|SMAL1_XENLA SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 OS=Xenopus laevis OX=8355 GN=smarcal1 PE=2 SV=1,GO:0004386; GO:0005524; GO:0005634; GO:0006281; GO:0006357; GO:0016787; GO:0031297; GO:0036310; GO:0043596,DNA repair [GO:0006281]; regulation of transcription by RNA polymerase II [GO:0006357]; replication fork processing [GO:0031297],nuclear replication fork [GO:0043596]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_04733,FUN_022602-T1,Peve_00012234,Pocillopora_meandrina_HIv1___RNAseq.g4421.t1,three_way,70.62083333333334,FUN_022602-T1,Q91VY9,,,,,38.8,477.0,4.4e-81,303.1,sp|Q91VY9|ZN622_MOUSE Cytoplasmic 60S subunit biogenesis factor ZNF622 OS=Mus musculus OX=10090 GN=Znf622 PE=1 SV=1,,,,,,
OG_04734,FUN_022603-T1,Peve_00012244,Pocillopora_meandrina_HIv1___RNAseq.g4420.t1,three_way,66.55866666666667,FUN_022603-T1,C0QT62,,,,,37.2,261.0,1.1e-32,142.1,sp|C0QT62|Y079_PERMH Probable transcriptional regulatory protein PERMA_0079 OS=Persephonella marina (strain DSM 14350 / EX-H1) OX=123214 GN=PERMA_0079 PE=3 SV=1,,,,,,
OG_04735,FUN_022604-T1,Peve_00012247,Pocillopora_meandrina_HIv1___RNAseq.g4419.t1,three_way,56.8415,FUN_022604-T1,Q8VCH8,,,,,36.6,514.0,1.1e-42,176.0,sp|Q8VCH8|UBXN4_MOUSE UBX domain-containing protein 4 OS=Mus musculus OX=10090 GN=Ubxn4 PE=1 SV=1,,,,,,
OG_04736,FUN_022610-T1,Peve_00012255,Pocillopora_meandrina_HIv1___TS.g21808.t1,three_way,50.32066666666667,,,,,,,,,,,,,,,,,
OG_04737,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_04738,FUN_022614-T1,Peve_00012265,Pocillopora_meandrina_HIv1___RNAseq.g4396.t1,three_way,66.271,,,,,,,,,,,,,,,,,
OG_04739,FUN_022615-T1,Peve_00012268,Pocillopora_meandrina_HIv1___RNAseq.g4395.t1,three_way,62.804,FUN_022615-T1,P79691,SHH_CARAU,,Sonic hedgehog protein (SHHA) (EC 3.1.-.-) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) [Cleaved into: Sonic hedgehog protein A N-product (Shh N-terminal processed signaling domains) (ShhNp) (Sonic hedgehog protein N-product) (ShhN)],Carassius auratus (Goldfish),44.2,398.0,9.4e-82,305.4,sp|P79691|SHH_CARAU Sonic hedgehog protein OS=Carassius auratus OX=7957 GN=shha PE=3 SV=3,GO:0000139; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005789; GO:0005886; GO:0007224; GO:0007267; GO:0007389; GO:0008233; GO:0009888; GO:0010468; GO:0016539; GO:0016540; GO:0030182; GO:0035295; GO:0042127; GO:0045880; GO:0048468; GO:0048513; GO:0048709; GO:0050793; GO:0097264; GO:0140853,animal organ development [GO:0048513]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; neuron differentiation [GO:0030182]; oligodendrocyte differentiation [GO:0048709]; pattern specification process [GO:0007389]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of cell population proliferation [GO:0042127]; regulation of developmental process [GO:0050793]; regulation of gene expression [GO:0010468]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224]; tissue development [GO:0009888]; tube development [GO:0035295],endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233],GO:0003824; GO:0005615; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0030154; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; transferase activity; hydrolase activity; signaling; cell differentiation; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_04740,FUN_022616-T1,Peve_00012270,Pocillopora_meandrina_HIv1___RNAseq.g4394.t1,three_way,75.47166666666666,FUN_022616-T1,Q8N865,SMIP4_HUMAN,,Sperm-associated microtubule inner protein 4,Homo sapiens (Human),43.2,183.0,1.6999999999999996e-31,137.9,sp|Q8N865|SMIP4_HUMAN Sperm-associated microtubule inner protein 4 OS=Homo sapiens OX=9606 GN=SPMIP4 PE=1 SV=3,GO:0005737; GO:0005813; GO:0031514,,centrosome [GO:0005813]; cytoplasm [GO:0005737]; motile cilium [GO:0031514],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_04741,FUN_022617-T1,Peve_00012269,Pocillopora_meandrina_HIv1___RNAseq.g4392.t1,three_way,77.53916666666667,,,,,,,,,,,,,,,,,
OG_04742,FUN_022619-T1,Peve_00012271,Pocillopora_meandrina_HIv1___TS.g21800.t2,three_way,49.095333333333336,FUN_022619-T1,A8QMS7,,,,,33.0,282.0,6.9e-33,142.5,sp|A8QMS7|MYD88_TAKRU Myeloid differentiation primary response protein MyD88 OS=Takifugu rubripes OX=31033 GN=myd88 PE=2 SV=1,,,,,,
OG_04743,FUN_022622-T1,Peve_00012274,Pocillopora_meandrina_HIv1___RNAseq.g4388.t1,three_way,79.17566666666667,FUN_022622-T1,Q58EB4,,,,,64.5,242.0,7.4e-80,298.5,"sp|Q58EB4|HIBCH_DANRE 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial OS=Danio rerio OX=7955 GN=hibch PE=2 SV=1",,,,,,
OG_04744,FUN_022625-T1,Peve_00012278,Pocillopora_meandrina_HIv1___RNAseq.g4387.t1,three_way,69.70766666666667,FUN_022625-T1,P04179,SODM_HUMAN,,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)",Homo sapiens (Human),61.6,216.0,3e-77,289.7,"sp|P04179|SODM_HUMAN Superoxide dismutase [Mn], mitochondrial OS=Homo sapiens OX=9606 GN=SOD2 PE=1 SV=3",GO:0000303; GO:0001666; GO:0001836; GO:0001889; GO:0003032; GO:0003069; GO:0003677; GO:0004784; GO:0005739; GO:0005759; GO:0006357; GO:0006749; GO:0006801; GO:0007507; GO:0007626; GO:0008217; GO:0008285; GO:0008630; GO:0008631; GO:0009410; GO:0009791; GO:0010042; GO:0010043; GO:0010269; GO:0010332; GO:0010729; GO:0014823; GO:0019430; GO:0019825; GO:0019899; GO:0022904; GO:0030097; GO:0030145; GO:0030335; GO:0032364; GO:0032496; GO:0033591; GO:0034021; GO:0034599; GO:0035900; GO:0035902; GO:0042542; GO:0042554; GO:0042645; GO:0042802; GO:0043524; GO:0045429; GO:0045599; GO:0046686; GO:0048147; GO:0048666; GO:0048678; GO:0048773; GO:0050665; GO:0051289; GO:0051602; GO:0051881; GO:0055093; GO:0060586; GO:0070062; GO:0071000; GO:0071361; GO:1902176; GO:1902631; GO:1904706; GO:1905461; GO:1905932,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0003069]; cellular response to ethanol [GO:0071361]; cellular response to oxidative stress [GO:0034599]; detection of oxygen [GO:0003032]; erythrophore differentiation [GO:0048773]; glutathione metabolic process [GO:0006749]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; hydrogen peroxide biosynthetic process [GO:0050665]; intracellular oxygen homeostasis [GO:0032364]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; liver development [GO:0001889]; locomotory behavior [GO:0007626]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of membrane hyperpolarization [GO:1902631]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron development [GO:0048666]; positive regulation of cell migration [GO:0030335]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905932]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; regulation of blood pressure [GO:0008217]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; respiratory electron transport chain [GO:0022904]; response to activity [GO:0014823]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to electrical stimulus [GO:0051602]; response to gamma radiation [GO:0010332]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to isolation stress [GO:0035900]; response to L-ascorbic acid [GO:0033591]; response to lipopolysaccharide [GO:0032496]; response to magnetism [GO:0071000]; response to manganese ion [GO:0010042]; response to selenium ion [GO:0010269]; response to silicon dioxide [GO:0034021]; response to superoxide [GO:0000303]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801],extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739],DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784],GO:0003013; GO:0003677; GO:0003824; GO:0005739; GO:0006091; GO:0006355; GO:0006575; GO:0006790; GO:0007005; GO:0016209; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098754,circulatory system process; DNA binding; catalytic activity; mitochondrion; generation of precursor metabolites and energy; regulation of DNA-templated transcription; modified amino acid metabolic process; sulfur compound metabolic process; mitochondrion organization; antioxidant activity; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; detoxification
OG_04745,FUN_022626-T1,Peve_00012279,Pocillopora_meandrina_HIv1___RNAseq.g4386.t1,three_way,75.93066666666667,FUN_022626-T1,Q5U3U0,,,,,52.9,291.0,3.4e-89,329.7,sp|Q5U3U0|PHYD1_DANRE Phytanoyl-CoA dioxygenase domain-containing protein 1 OS=Danio rerio OX=7955 GN=phyhd1 PE=2 SV=1,,,,,,
OG_04746,FUN_022627-T1,Peve_00012280,Pocillopora_meandrina_HIv1___RNAseq.g4385.t1,three_way,74.43166666666667,FUN_022627-T1,Q13485,SMAD4_HUMAN,,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),Homo sapiens (Human),52.7,220.0,2.4e-51,205.7,sp|Q13485|SMAD4_HUMAN Mothers against decapentaplegic homolog 4 OS=Homo sapiens OX=9606 GN=SMAD4 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001222; GO:0001223; GO:0001228; GO:0001541; GO:0001649; GO:0001658; GO:0001666; GO:0001701; GO:0001702; GO:0001837; GO:0003148; GO:0003161; GO:0003190; GO:0003198; GO:0003220; GO:0003251; GO:0003360; GO:0003682; GO:0003700; GO:0005518; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005813; GO:0005829; GO:0006351; GO:0006355; GO:0006357; GO:0006366; GO:0006879; GO:0007179; GO:0007283; GO:0007338; GO:0007411; GO:0008283; GO:0008285; GO:0009653; GO:0010614; GO:0010628; GO:0010631; GO:0010666; GO:0010718; GO:0014033; GO:0014898; GO:0030154; GO:0030308; GO:0030325; GO:0030509; GO:0030511; GO:0031005; GO:0032444; GO:0032525; GO:0032909; GO:0032924; GO:0033686; GO:0035556; GO:0036064; GO:0036302; GO:0042118; GO:0042177; GO:0042733; GO:0042802; GO:0042803; GO:0043199; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0046872; GO:0046881; GO:0048382; GO:0048589; GO:0048665; GO:0048733; GO:0048859; GO:0051797; GO:0060065; GO:0060391; GO:0060395; GO:0060412; GO:0060956; GO:0061040; GO:0061629; GO:0062009; GO:0070102; GO:0070371; GO:0070373; GO:0070411; GO:0070412; GO:0071141; GO:0071144; GO:0071333; GO:0071559; GO:0071560; GO:0071773; GO:0072133; GO:0072134; GO:0072520; GO:0090090; GO:0097191; GO:1901203; GO:1902895; GO:1905305,activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412],activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04747,FUN_022630-T1,Peve_00012283,Pocillopora_meandrina_HIv1___RNAseq.g2910.t1,three_way,68.43933333333334,FUN_022630-T1,P07228,,,,,38.2,815.0,1.2e-144,515.4,sp|P07228|ITB1_CHICK Integrin beta-1 OS=Gallus gallus OX=9031 GN=ITGB1 PE=1 SV=1,,,,,,
OG_04748,FUN_022631-T1,Peve_00012222,Pocillopora_meandrina_HIv1___RNAseq.g2907.t1,three_way,61.568000000000005,FUN_022631-T1,C3ZQF9,,,,,31.4,322.0,7.4e-33,143.3,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_04749,FUN_022632-T1,Peve_00012223,Pocillopora_meandrina_HIv1___RNAseq.g2906.t1,three_way,91.81466666666668,FUN_022632-T1,Q2NKW0,BL1S1_BOVIN,,Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC-1 subunit 1) (Protein acetyltransferase BLOC1S1) (EC 2.3.1.-),Bos taurus (Bovine),61.9,118.0,2.7000000000000004e-32,139.4,sp|Q2NKW0|BL1S1_BOVIN Biogenesis of lysosome-related organelles complex 1 subunit 1 OS=Bos taurus OX=9913 GN=BLOC1S1 PE=2 SV=1,GO:0005758; GO:0005759; GO:0005765; GO:0005829; GO:0008089; GO:0009060; GO:0016197; GO:0018394; GO:0031083; GO:0031175; GO:0032418; GO:0048490; GO:0061733; GO:0099078; GO:1904115,aerobic respiration [GO:0009060]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; neuron projection development [GO:0031175]; peptidyl-lysine acetylation [GO:0018394],axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759],protein-lysine-acetyltransferase activity [GO:0061733],GO:0003824; GO:0005829; GO:0006091; GO:0007018; GO:0016192; GO:0016740; GO:0140096,"catalytic activity; cytosol; generation of precursor metabolites and energy; microtubule-based movement; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_04750,FUN_022634-T1,Peve_00012928,Pocillopora_meandrina_HIv1___RNAseq.g9361.t1,three_way,87.668,FUN_022634-T1,Q7Z4L5,TT21B_HUMAN,,Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog),Homo sapiens (Human),54.7,1309.0,0.0,1412.5,sp|Q7Z4L5|TT21B_HUMAN Tetratricopeptide repeat protein 21B OS=Homo sapiens OX=9606 GN=TTC21B PE=1 SV=2,GO:0003682; GO:0005737; GO:0005856; GO:0005929; GO:0006357; GO:0007224; GO:0008589; GO:0010628; GO:0021591; GO:0021702; GO:0021798; GO:0030991; GO:0035721; GO:0060020; GO:0060271; GO:0061512; GO:0090263; GO:0097499; GO:0097542; GO:1903999; GO:1905799,Bergmann glial cell differentiation [GO:0060020]; cerebellar Purkinje cell differentiation [GO:0021702]; cilium assembly [GO:0060271]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; negative regulation of eating behavior [GO:1903999]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; protein localization to cilium [GO:0061512]; protein localization to non-motile cilium [GO:0097499]; regulation of intraciliary retrograde transport [GO:1905799]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591],ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991],chromatin binding [GO:0003682],GO:0005856; GO:0005929; GO:0006355; GO:0007018; GO:0030154; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cilium; regulation of DNA-templated transcription; microtubule-based movement; cell differentiation; organelle; cilium organization; anatomical structure development
OG_04751,FUN_022635-T1,Peve_00027026,Pocillopora_meandrina_HIv1___RNAseq.g9362.t1,three_way,80.95233333333333,FUN_022635-T1,Q8R344,,,,,58.0,162.0,1.2e-38,161.0,sp|Q8R344|CCD12_MOUSE Coiled-coil domain-containing protein 12 OS=Mus musculus OX=10090 GN=Ccdc12 PE=1 SV=2,,,,,,
OG_04752,FUN_022636-T1,Peve_00012919,Pocillopora_meandrina_HIv1___RNAseq.g9363.t1,three_way,57.05,,,,,,,,,,,,,,,,,
OG_04753,FUN_022637-T1,Peve_00020783,Pocillopora_meandrina_HIv1___RNAseq.g9364.t1,three_way,62.15833333333333,FUN_022637-T1,Q6DJM2,TAM41_XENLA,,"Phosphatidate cytidylyltransferase, mitochondrial (EC 2.7.7.41) (CDP-diacylglycerol synthase) (CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 homolog) (TAM41)",Xenopus laevis (African clawed frog),47.4,323.0,3.6e-75,283.5,"sp|Q6DJM2|TAM41_XENLA Phosphatidate cytidylyltransferase, mitochondrial OS=Xenopus laevis OX=8355 GN=tamm41 PE=2 SV=1",GO:0004605; GO:0005739; GO:0005743; GO:0016024; GO:0032049,cardiolipin biosynthetic process [GO:0032049]; CDP-diacylglycerol biosynthetic process [GO:0016024],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],phosphatidate cytidylyltransferase activity [GO:0004605],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_04754,FUN_022639-T1,Peve_00022141,Pocillopora_meandrina_HIv1___RNAseq.g9366.t2,three_way,68.227,FUN_022639-T1,Q9H330,,,,,37.4,854.0,4.5e-129,463.8,sp|Q9H330|TM245_HUMAN Transmembrane protein 245 OS=Homo sapiens OX=9606 GN=TMEM245 PE=1 SV=3,,,,,,
OG_04755,FUN_022640-T1,Peve_00022140,Pocillopora_meandrina_HIv1___RNAseq.g9367.t1,three_way,76.032,FUN_022640-T1,P49356,FNTB_HUMAN,,Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta),Homo sapiens (Human),54.6,388.0,6.6e-122,438.7,sp|P49356|FNTB_HUMAN Protein farnesyltransferase subunit beta OS=Homo sapiens OX=9606 GN=FNTB PE=1 SV=1,GO:0004660; GO:0005829; GO:0005875; GO:0005965; GO:0006629; GO:0008270; GO:0008284; GO:0010698; GO:0018343; GO:0019899; GO:0042277; GO:0045787; GO:0060632,lipid metabolic process [GO:0006629]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; protein farnesylation [GO:0018343]; regulation of microtubule-based movement [GO:0060632],cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; protein farnesyltransferase complex [GO:0005965],acetyltransferase activator activity [GO:0010698]; enzyme binding [GO:0019899]; peptide binding [GO:0042277]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006629; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04756,FUN_022642-T1,Peve_00044337,Pocillopora_meandrina_HIv1___RNAseq.g9369.t1,three_way,57.92616666666667,FUN_022642-T1,Q14517,,,,,26.9,334.0,2.4e-19,100.1,sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2,,,,,,
OG_04757,FUN_022644-T2,Peve_00044335,Pocillopora_meandrina_HIv1___RNAseq.g9376.t1,three_way,70.68516666666667,FUN_022644-T2,Q9UNS1,TIM_HUMAN,,Protein timeless homolog (hTIM),Homo sapiens (Human),42.1,1053.0,1.1e-205,718.8,sp|Q9UNS1|TIM_HUMAN Protein timeless homolog OS=Homo sapiens OX=9606 GN=TIMELESS PE=1 SV=2,GO:0000076; GO:0000785; GO:0002009; GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006974; GO:0007623; GO:0008047; GO:0009582; GO:0030324; GO:0031297; GO:0031298; GO:0035861; GO:0042752; GO:0042802; GO:0043111; GO:0044770; GO:0045892; GO:0048754; GO:0051301; GO:0072711; GO:0072719; GO:1904976; GO:1905168; GO:2000781,branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork processing [GO:0031297],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; site of double-strand break [GO:0035861],DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802],GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006355; GO:0043226; GO:0048856; GO:0098772,DNA binding; nucleus; nucleoplasm; DNA repair; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular function regulator activity
OG_04758,FUN_022647-T1,Peve_00036577,Pocillopora_meandrina_HIv1___RNAseq.g4454.t1,three_way,72.587,FUN_022647-T1,Q15434,,,,,61.2,232.0,9.8e-69,262.7,"sp|Q15434|RBMS2_HUMAN RNA-binding motif, single-stranded-interacting protein 2 OS=Homo sapiens OX=9606 GN=RBMS2 PE=1 SV=1",,,,,,
OG_04759,FUN_022649-T1,Peve_00019793,Pocillopora_meandrina_HIv1___RNAseq.g4450.t2,three_way,87.07466666666667,FUN_022649-T1,Q6ZWH5,NEK10_HUMAN,,Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10),Homo sapiens (Human),45.7,1046.0,4.3e-211,736.5,sp|Q6ZWH5|NEK10_HUMAN Serine/threonine-protein kinase Nek10 OS=Homo sapiens OX=9606 GN=NEK10 PE=1 SV=3,GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0006468; GO:0031954; GO:0043406; GO:0046872; GO:0070372; GO:0106310; GO:0120197; GO:1902749; GO:1902911,mucociliary clearance [GO:0120197]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein autophosphorylation [GO:0031954]; protein phosphorylation [GO:0006468]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of ERK1 and ERK2 cascade [GO:0070372],extracellular region [GO:0005576]; protein kinase complex [GO:1902911],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003016; GO:0003824; GO:0005576; GO:0007018; GO:0016740; GO:0140096,"respiratory system process; catalytic activity; extracellular region; microtubule-based movement; transferase activity; catalytic activity, acting on a protein"
OG_04760,FUN_022656-T1,Peve_00019498,Pocillopora_meandrina_HIv1___RNAseq.g21258.t1,three_way,47.02216666666666,,,,,,,,,,,,,,,,,
OG_04761,FUN_022659-T1,Peve_00020231,Pocillopora_meandrina_HIv1___RNAseq.g3028.t1,three_way,39.47416666666667,,,,,,,,,,,,,,,,,
OG_04762,FUN_022662-T1,Peve_00027940,Pocillopora_meandrina_HIv1___RNAseq.g3157.t1b,three_way,84.34933333333333,FUN_022662-T1,Q5ZLC8,,,,,47.4,137.0,1.4e-25,120.2,sp|Q5ZLC8|ANR52_CHICK Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Gallus gallus OX=9031 GN=ANKRD52 PE=2 SV=1,,,,,,
OG_04763,FUN_022663-T1,Peve_00027941,Pocillopora_meandrina_HIv1___RNAseq.g3155.t1,three_way,91.83666666666667,FUN_022663-T1,Q7YRA3,,,,,61.3,238.0,4.8e-81,302.4,sp|Q7YRA3|EXOS4_BOVIN Exosome complex component RRP41 OS=Bos taurus OX=9913 GN=EXOSC4 PE=2 SV=3,,,,,,
OG_04764,FUN_022664-T2,Peve_00027942,Pocillopora_meandrina_HIv1___RNAseq.g3154.t1,three_way,68.32866666666666,FUN_022664-T2,O19094,OCTC_BOVIN,,Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137),Bos taurus (Bovine),42.1,598.0,9.4e-137,488.8,sp|O19094|OCTC_BOVIN Peroxisomal carnitine O-octanoyltransferase OS=Bos taurus OX=9913 GN=CROT PE=1 SV=1,GO:0005777; GO:0006091; GO:0006631; GO:0006635; GO:0008458; GO:0009437; GO:0015936; GO:0051791,carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791],peroxisome [GO:0005777],carnitine O-octanoyltransferase activity [GO:0008458],GO:0003824; GO:0005777; GO:0006091; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; peroxisome; generation of precursor metabolites and energy; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_04765,FUN_022665-T1,Peve_00036260,Pocillopora_meandrina_HIv1___RNAseq.g3193.t1,three_way,60.42666666666667,,,,,,,,,,,,,,,,,
OG_04766,FUN_022667-T1,Peve_00036259,Pocillopora_meandrina_HIv1___RNAseq.g3192.t1,three_way,73.93866666666668,FUN_022667-T1,P05123,,,,,41.6,317.0,5.5e-64,246.1,sp|P05123|KCRM_CANLF Creatine kinase M-type OS=Canis lupus familiaris OX=9615 GN=CKM PE=1 SV=3,,,,,,
OG_04767,FUN_022668-T2,Peve_00036258,Pocillopora_meandrina_HIv1___RNAseq.g3191.t1,three_way,66.714,FUN_022668-T2,Q61263,SOAT1_MOUSE,,Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1),Mus musculus (Mouse),42.1,523.0,9.4e-109,395.6,sp|Q61263|SOAT1_MOUSE Sterol O-acyltransferase 1 OS=Mus musculus OX=10090 GN=Soat1 PE=1 SV=2,GO:0000062; GO:0004772; GO:0005789; GO:0008203; GO:0010742; GO:0010878; GO:0015485; GO:0016020; GO:0033344; GO:0034379; GO:0034736; GO:0042632; GO:0042986,cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; macrophage derived foam cell differentiation [GO:0010742]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; very-low-density lipoprotein particle assembly [GO:0034379],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],cholesterol binding [GO:0015485]; cholesterol O-acyltransferase activity [GO:0034736]; fatty-acyl-CoA binding [GO:0000062]; sterol O-acyltransferase activity [GO:0004772],GO:0003824; GO:0006629; GO:0008289; GO:0016740; GO:0030154; GO:0065003,catalytic activity; lipid metabolic process; lipid binding; transferase activity; cell differentiation; protein-containing complex assembly
OG_04768,FUN_022670-T1,Peve_00003746,Pocillopora_meandrina_HIv1___RNAseq.g4535.t1,three_way,78.69650000000001,FUN_022670-T1,Q05096,MYO1B_RAT,,Unconventional myosin-Ib (Myosin I alpha) (MMI-alpha) (MMIa) (Myosin heavy chain myr 1),Rattus norvegicus (Rat),57.9,1094.0,2.4e-300,1033.1,sp|Q05096|MYO1B_RAT Unconventional myosin-Ib OS=Rattus norvegicus OX=10116 GN=Myo1b PE=1 SV=1,GO:0000146; GO:0003774; GO:0003779; GO:0005516; GO:0005524; GO:0005546; GO:0005547; GO:0005737; GO:0005769; GO:0005884; GO:0005886; GO:0005902; GO:0005903; GO:0006892; GO:0006897; GO:0007015; GO:0007399; GO:0010008; GO:0015629; GO:0016459; GO:0030048; GO:0030175; GO:0032588; GO:0033572; GO:0045177; GO:0048471; GO:0051015; GO:0051017; GO:0071944,actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; microvillus [GO:0005902]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0003774; GO:0003824; GO:0005768; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0016192; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_04769,FUN_022671-T1,Peve_00010104,Pocillopora_meandrina_HIv1___RNAseq.g4534.t1,three_way,94.68966666666668,FUN_022671-T1,Q00535,CDK5_HUMAN,,Cyclin-dependent kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Cyclin-dependent-like kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit),Homo sapiens (Human),84.4,237.0,2.1e-121,436.4,sp|Q00535|CDK5_HUMAN Cyclin-dependent kinase 5 OS=Homo sapiens OX=9606 GN=CDK5 PE=1 SV=3,GO:0000226; GO:0000307; GO:0001764; GO:0001963; GO:0002039; GO:0004672; GO:0004674; GO:0004693; GO:0005176; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0006886; GO:0007160; GO:0007268; GO:0007409; GO:0007416; GO:0007519; GO:0008045; GO:0008542; GO:0014044; GO:0014069; GO:0016020; GO:0016079; GO:0016241; GO:0016301; GO:0016533; GO:0019233; GO:0021697; GO:0021766; GO:0021819; GO:0021954; GO:0022038; GO:0030027; GO:0030036; GO:0030054; GO:0030175; GO:0030182; GO:0030334; GO:0030424; GO:0030425; GO:0030426; GO:0030517; GO:0030549; GO:0031175; GO:0031397; GO:0031594; GO:0031914; GO:0032801; GO:0035249; GO:0035418; GO:0042981; GO:0043005; GO:0043025; GO:0043113; GO:0043125; GO:0043204; GO:0043525; GO:0045786; GO:0045861; GO:0045892; GO:0045956; GO:0046826; GO:0048148; GO:0048156; GO:0048167; GO:0048488; GO:0048489; GO:0048511; GO:0048675; GO:0048709; GO:0048813; GO:0050321; GO:0051301; GO:0051402; GO:0051726; GO:0051879; GO:0051966; GO:0060079; GO:0061001; GO:0070509; GO:0090314; GO:0098793; GO:0099533; GO:0106310; GO:1901987; GO:1903076; GO:1903234; GO:1903421; GO:1904646,"actin cytoskeleton organization [GO:0030036]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell division [GO:0051301]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex formation [GO:0021697]; chemical synaptic transmission [GO:0007268]; corpus callosum development [GO:0022038]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; hippocampus development [GO:0021766]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; microtubule cytoskeleton organization [GO:0000226]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of calcium ion-dependent exocytosis of neurotransmitter [GO:1903234]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of presynaptic cytosolic calcium concentration [GO:0099533]; positive regulation of protein targeting to membrane [GO:0090314]; protein localization to synapse [GO:0035418]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell cycle phase transition [GO:1901987]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of macroautophagy [GO:0016241]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle recycling [GO:1903421]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle transport [GO:0048489]; visual learning [GO:0008542]",axon [GO:0030424]; cell junction [GO:0030054]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533],acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0007010; GO:0007155; GO:0008092; GO:0012501; GO:0016192; GO:0016740; GO:0023052; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; programmed cell death; vesicle-mediated transport; transferase activity; signaling; cell differentiation; cell junction organization; organelle; anatomical structure development; cell motility; nervous system process; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04770,FUN_022672-T1,Peve_00010103,Pocillopora_meandrina_HIv1___RNAseq.g4533.t1,three_way,50.85366666666666,,,,,,,,,,,,,,,,,
OG_04771,FUN_022673-T1,Peve_00010102,Pocillopora_meandrina_HIv1___RNAseq.g4124.t2,three_way,59.6315,FUN_022673-T1,Q3U821,,,,,33.9,785.0,7.1e-103,376.7,sp|Q3U821|WDR75_MOUSE WD repeat-containing protein 75 OS=Mus musculus OX=10090 GN=Wdr75 PE=1 SV=1,,,,,,
OG_04772,FUN_022675-T1,Peve_00020610,Pocillopora_meandrina_HIv1___RNAseq.g4127.t1,three_way,92.3255,FUN_022675-T1,Q0III3,DC1I2_BOVIN,,"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)",Bos taurus (Bovine),64.9,507.0,1.1e-195,684.5,sp|Q0III3|DC1I2_BOVIN Cytoplasmic dynein 1 intermediate chain 2 OS=Bos taurus OX=9913 GN=DYNC1I2 PE=1 SV=1,GO:0005737; GO:0005868; GO:0005874; GO:0010970; GO:0031982; GO:0045503; GO:0045504,transport along microtubule [GO:0010970],cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; vesicle [GO:0031982],dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503],GO:0007018; GO:0043226,microtubule-based movement; organelle
OG_04773,FUN_022677-T1,Peve_00018002,Pocillopora_meandrina_HIv1___RNAseq.g4842.t1,three_way,82.19733333333333,FUN_022677-T1,B0G143,,,,,44.4,306.0,1.9e-69,264.2,sp|B0G143|UCPB_DICDI Mitochondrial substrate carrier family protein ucpB OS=Dictyostelium discoideum OX=44689 GN=ucpB PE=3 SV=1,,,,,,
OG_04774,FUN_022678-T1,Peve_00018003,Pocillopora_meandrina_HIv1___RNAseq.g4841.t1,three_way,59.595666666666666,FUN_022678-T1,Q91175,,,,,25.1,323.0,3.9e-15,84.3,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_04775,FUN_022679-T1,Peve_00018004,Pocillopora_meandrina_HIv1___RNAseq.g4840.t1,three_way,62.58166666666666,FUN_022679-T1,Q9UKJ3,,,,,46.6,223.0,1.2e-49,199.5,sp|Q9UKJ3|GPTC8_HUMAN G patch domain-containing protein 8 OS=Homo sapiens OX=9606 GN=GPATCH8 PE=1 SV=2,,,,,,
OG_04776,FUN_022682-T1,Peve_00018005,Pocillopora_meandrina_HIv1___RNAseq.g4839.t1,three_way,89.59733333333334,FUN_022682-T1,Q9WUD8,,,,,67.6,176.0,4.5e-68,258.8,sp|Q9WUD8|FAIM1_MOUSE Fas apoptotic inhibitory molecule 1 OS=Mus musculus OX=10090 GN=Faim PE=1 SV=1,,,,,,
OG_04777,FUN_022683-T1,Peve_00018006,Pocillopora_meandrina_HIv1___RNAseq.g4838.t1,three_way,79.14633333333333,FUN_022683-T1,Q5RFD3,,,,,50.6,245.0,8.2e-65,248.4,sp|Q5RFD3|PSME3_PONAB Proteasome activator complex subunit 3 OS=Pongo abelii OX=9601 GN=PSME3 PE=2 SV=1,,,,,,
OG_04778,FUN_022684-T1,Peve_00019690,Pocillopora_meandrina_HIv1___TS.g22251.t2,three_way,75.05633333333333,FUN_022684-T1,O94880,PHF14_HUMAN,,PHD finger protein 14,Homo sapiens (Human),48.8,291.0,4.8e-73,276.6,sp|O94880|PHF14_HUMAN PHD finger protein 14 OS=Homo sapiens OX=9606 GN=PHF14 PE=1 SV=3,GO:0000122; GO:0000785; GO:0002314; GO:0005634; GO:0005694; GO:0005737; GO:0008270; GO:0008285; GO:0010463; GO:0042393; GO:0048286; GO:0060916; GO:0072201; GO:0140566; GO:2000584; GO:2000791,germinal center B cell differentiation [GO:0002314]; lung alveolus development [GO:0048286]; mesenchymal cell proliferation [GO:0010463]; mesenchymal cell proliferation involved in lung development [GO:0060916]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122],chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634],histone binding [GO:0042393]; histone reader activity [GO:0140566]; zinc ion binding [GO:0008270],GO:0002376; GO:0005634; GO:0005694; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0048856; GO:0060090,immune system process; nucleus; chromosome; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; anatomical structure development; molecular adaptor activity
OG_04779,FUN_022688-T1,Peve_00045105,Pocillopora_meandrina_HIv1___RNAseq.19135_t,three_way,60.34033333333333,FUN_022688-T1,Q4ZQC6,,,,,55.3,123.0,3.1e-34,146.7,sp|Q4ZQC6|MSRB_PSEU2 Peptide methionine sulfoxide reductase MsrB OS=Pseudomonas syringae pv. syringae (strain B728a) OX=205918 GN=msrB PE=3 SV=1,,,,,,
OG_04780,FUN_022689-T1,Peve_00045106,Pocillopora_meandrina_HIv1___RNAseq.g4835.t1,three_way,78.04266666666666,FUN_022689-T1,Q8NKE2,,,,,44.2,278.0,4.999999999999999e-62,239.6,"sp|Q8NKE2|AOX_CRYNH Alternative oxidase, mitochondrial OS=Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) OX=235443 GN=AOX1 PE=3 SV=2",,,,,,
OG_04781,FUN_022692-T1,Peve_00045099,Pocillopora_meandrina_HIv1___RNAseq.g4833.t1,three_way,72.29033333333334,FUN_022692-T1,Q9P959,,,,,51.5,239.0,8.7e-65,248.8,"sp|Q9P959|AOX_EMENI Alternative oxidase, mitochondrial OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=alxA PE=3 SV=2",,,,,,
OG_04782,FUN_022693-T1,Peve_00045100,Pocillopora_meandrina_HIv1___RNAseq.g4832.t1,three_way,44.72983333333333,,,,,,,,,,,,,,,,,
OG_04783,FUN_022694-T1,Peve_00045101,Pocillopora_meandrina_HIv1___RNAseq.g4831.t1,three_way,58.6035,,,,,,,,,,,,,,,,,
OG_04784,FUN_022696-T1,Peve_00045102,Pocillopora_meandrina_HIv1___TS.g22242.t1,three_way,67.26566666666666,,,,,,,,,,,,,,,,,
OG_04785,FUN_022697-T1,Peve_00045103,Pocillopora_meandrina_HIv1___RNAseq.g4828.t1,three_way,67.73633333333333,FUN_022697-T1,Q9XJ54,,,,,53.3,120.0,8.5e-26,117.9,sp|Q9XJ54|NTF2_ORYSJ Nuclear transport factor 2 OS=Oryza sativa subsp. japonica OX=39947 GN=NTF2 PE=2 SV=1,,,,,,
OG_04786,FUN_022700-T1,Peve_00018683,Pocillopora_meandrina_HIv1___RNAseq.g4826.t1,three_way,70.454,FUN_022700-T1,Q9NS86,LANC2_HUMAN,,LanC-like protein 2 (Testis-specific adriamycin sensitivity protein),Homo sapiens (Human),49.2,386.0,2.1e-89,330.9,sp|Q9NS86|LANC2_HUMAN LanC-like protein 2 OS=Homo sapiens OX=9606 GN=LANCL2 PE=1 SV=1,GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0005975; GO:0009789; GO:0010314; GO:0030864; GO:0031179; GO:0032266; GO:0045892; GO:0070273,carbohydrate metabolic process [GO:0005975]; negative regulation of DNA-templated transcription [GO:0045892]; peptide modification [GO:0031179]; positive regulation of abscisic acid-activated signaling pathway [GO:0009789],cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314],GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005975; GO:0006355; GO:0008289; GO:0043226,nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; carbohydrate metabolic process; regulation of DNA-templated transcription; lipid binding; organelle
OG_04787,FUN_022701-T1,Peve_00018684,Pocillopora_meandrina_HIv1___RNAseq.g4825.t2,three_way,38.749,FUN_022701-T1,Q9NRH1,,,,,35.9,103.0,2.7e-07,57.4,sp|Q9NRH1|YAE1_HUMAN Protein YAE1 homolog OS=Homo sapiens OX=9606 GN=YAE1 PE=1 SV=1,,,,,,
OG_04788,FUN_022702-T1,Peve_00018685,Pocillopora_meandrina_HIv1___TS.g22237.t2,three_way,74.7355,FUN_022702-T1,Q3MJK5,CDK12_RAT,,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (Protein kinase for splicing component)",Rattus norvegicus (Rat),77.8,334.0,3.2e-159,564.3,sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus OX=10116 GN=Cdk12 PE=1 SV=1,GO:0002944; GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0006366; GO:0006397; GO:0008024; GO:0008353; GO:0008380; GO:0016607; GO:0019901; GO:0019908; GO:0030332; GO:0032968; GO:0043405; GO:0043484; GO:0045944; GO:0106310; GO:2000737,mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],cyclin K-CDK12 complex [GO:0002944]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04789,FUN_022703-T1,Peve_00018677,Pocillopora_meandrina_HIv1___RNAseq.g4823.t1,three_way,91.9455,FUN_022703-T1,P11233,RALA_HUMAN,,Ras-related protein Ral-A (EC 3.6.5.2),Homo sapiens (Human),81.1,185.0,4.5e-77,288.9,sp|P11233|RALA_HUMAN Ras-related protein Ral-A OS=Homo sapiens OX=9606 GN=RALA PE=1 SV=1,GO:0001843; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005886; GO:0005925; GO:0006887; GO:0006935; GO:0007165; GO:0007265; GO:0009986; GO:0017022; GO:0017157; GO:0019003; GO:0030659; GO:0031623; GO:0031625; GO:0031755; GO:0032154; GO:0032956; GO:0045742; GO:0051117; GO:0051301; GO:0051491; GO:0051665; GO:0070062; GO:0072655; GO:0090141; GO:0090543; GO:0097060; GO:0098685; GO:0099149,cell division [GO:0051301]; chemotaxis [GO:0006935]; establishment of protein localization to mitochondrion [GO:0072655]; exocytosis [GO:0006887]; membrane raft localization [GO:0051665]; neural tube closure [GO:0001843]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of mitochondrial fission [GO:0090141]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of exocytosis [GO:0017157]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; signal transduction [GO:0007165],cell surface [GO:0009986]; cleavage furrow [GO:0032154]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060],ATPase binding [GO:0051117]; Edg-2 lysophosphatidic acid receptor binding [GO:0031755]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0003924; GO:0005739; GO:0005886; GO:0008092; GO:0016192; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; mitochondrion; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; organelle; molecular function regulator activity
OG_04790,FUN_022704-T1,Peve_00018678,Pocillopora_meandrina_HIv1___RNAseq.g4822.t1,three_way,73.40866666666666,FUN_022704-T1,F6NXI9,TRNT1_DANRE,,"CCA tRNA nucleotidyltransferase 1, mitochondrial (EC 2.7.7.72)",Danio rerio (Zebrafish) (Brachydanio rerio),44.8,411.0,1.1e-98,361.7,"sp|F6NXI9|TRNT1_DANRE CCA tRNA nucleotidyltransferase 1, mitochondrial OS=Danio rerio OX=7955 GN=trnt1 PE=2 SV=1",GO:0000049; GO:0001654; GO:0001680; GO:0001966; GO:0004810; GO:0005524; GO:0005634; GO:0005739; GO:0007632; GO:0008033; GO:0046872; GO:0160016; GO:1990180,eye development [GO:0001654]; mitochondrial tRNA 3'-end processing [GO:1990180]; thigmotaxis [GO:0001966]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033]; visual behavior [GO:0007632],mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; CCA tRNA nucleotidyltransferase activity [GO:0004810]; CCACCA tRNA nucleotidyltransferase activity [GO:0160016]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0006399; GO:0016740; GO:0043226; GO:0048856; GO:0140053; GO:0140098,"RNA binding; catalytic activity; nucleus; mitochondrion; tRNA metabolic process; transferase activity; organelle; anatomical structure development; mitochondrial gene expression; catalytic activity, acting on RNA"
OG_04791,FUN_022707-T1,Peve_00006887,Pocillopora_meandrina_HIv1___RNAseq.g4819.t1a,three_way,61.56366666666667,FUN_022707-T1,O60294,TYW4_HUMAN,,tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase),Homo sapiens (Human),32.6,242.0,5.8e-26,119.4,sp|O60294|TYW4_HUMAN tRNA wybutosine-synthesizing protein 4 OS=Homo sapiens OX=9606 GN=LCMT2 PE=1 SV=3,GO:0005737; GO:0006400; GO:0008175; GO:0030488; GO:0031591,tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],tRNA methyltransferase activity [GO:0008175],GO:0003824; GO:0006399; GO:0016740; GO:0140098; GO:1901135,"catalytic activity; tRNA metabolic process; transferase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_04792,FUN_022708-T1,Peve_00006883,Pocillopora_meandrina_HIv1___RNAseq.g4815.t1,three_way,78.88033333333333,FUN_022708-T1,P59101,,,,,45.4,108.0,5.2e-15,82.4,sp|P59101|SCX_CHICK Basic helix-loop-helix transcription factor scleraxis OS=Gallus gallus OX=9031 GN=SCX PE=2 SV=1,,,,,,
OG_04793,FUN_022709-T1,Peve_00006884,Pocillopora_meandrina_HIv1___RNAseq.g4816.t1,three_way,59.685833333333335,FUN_022709-T1,Q32PV5,TCF21_DANRE,,Transcription factor 21 (TCF-21) (Capsulin) (Epicardin) (MyoRa2),Danio rerio (Zebrafish) (Brachydanio rerio),38.7,111.0,5.4e-06,52.8,sp|Q32PV5|TCF21_DANRE Transcription factor 21 OS=Danio rerio OX=7955 GN=tcf21 PE=2 SV=1,GO:0000122; GO:0000977; GO:0000981; GO:0001227; GO:0001228; GO:0001657; GO:0001658; GO:0001763; GO:0001822; GO:0001944; GO:0005634; GO:0006357; GO:0007519; GO:0007530; GO:0014707; GO:0030855; GO:0032502; GO:0032835; GO:0045944; GO:0046983; GO:0048286; GO:0048536; GO:0048557; GO:0048608; GO:0048732; GO:0060008; GO:0060021; GO:0060425; GO:0060426; GO:0060435; GO:0060539; GO:0060541; GO:0060766; GO:0060840; GO:0070888; GO:0072162; GO:0072277,artery development [GO:0060840]; branching involved in ureteric bud morphogenesis [GO:0001658]; branchiomeric skeletal muscle development [GO:0014707]; bronchiole development [GO:0060435]; developmental process [GO:0032502]; diaphragm development [GO:0060539]; embryonic digestive tract morphogenesis [GO:0048557]; epithelial cell differentiation [GO:0030855]; gland development [GO:0048732]; glomerulus development [GO:0032835]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; metanephric glomerular capillary formation [GO:0072277]; metanephric mesenchymal cell differentiation [GO:0072162]; morphogenesis of a branching structure [GO:0001763]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; reproductive structure development [GO:0048608]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; Sertoli cell differentiation [GO:0060008]; sex determination [GO:0007530]; skeletal muscle tissue development [GO:0007519]; spleen development [GO:0048536]; ureteric bud development [GO:0001657]; vasculature development [GO:0001944],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04794,FUN_022710-T1,Peve_00006885,Pocillopora_meandrina_HIv1___RNAseq.g4817.t1,three_way,81.13166666666666,FUN_022710-T1,Q3T904,ATG9A_BOVIN,,Autophagy-related protein 9A (APG9-like 1) (Autophagy protein 9),Bos taurus (Bovine),54.5,462.0,1.2e-152,541.6,sp|Q3T904|ATG9A_BOVIN Autophagy-related protein 9A OS=Bos taurus OX=9913 GN=ATG9A PE=2 SV=1,GO:0000045; GO:0000139; GO:0000407; GO:0000421; GO:0000423; GO:0005739; GO:0005776; GO:0005789; GO:0005794; GO:0005802; GO:0017128; GO:0031902; GO:0031966; GO:0034045; GO:0034497; GO:0034727; GO:0055038; GO:0060349; GO:0061709; GO:0097300,autophagosome assembly [GO:0000045]; bone morphogenesis [GO:0060349]; mitophagy [GO:0000423]; piecemeal microautophagy of the nucleus [GO:0034727]; programmed necrotic cell death [GO:0097300]; protein localization to phagophore assembly site [GO:0034497]; reticulophagy [GO:0061709],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802],phospholipid scramblase activity [GO:0017128],GO:0005215; GO:0005739; GO:0005773; GO:0005794; GO:0006914; GO:0012501; GO:0043226,transporter activity; mitochondrion; vacuole; Golgi apparatus; autophagy; programmed cell death; organelle
OG_04795,FUN_022711-T1,Peve_00006886,Pocillopora_meandrina_HIv1___TS.g22231.t1,three_way,42.857,,,,,,,,,,,,,,,,,
OG_04796,FUN_022715-T1,Peve_00016563,Pocillopora_meandrina_HIv1___RNAseq.g3160.t1,three_way,74.70833333333333,FUN_022715-T1,O88794,,,,,52.1,234.0,1.4e-65,251.1,sp|O88794|PNPO_RAT Pyridoxine-5'-phosphate oxidase OS=Rattus norvegicus OX=10116 GN=Pnpo PE=1 SV=1,,,,,,
OG_04797,FUN_022716-T1,Peve_00016561,Pocillopora_meandrina_HIv1___RNAseq.g3161.t1,three_way,88.14033333333333,FUN_022716-T1,A7RG82,,,,,77.2,338.0,3.5e-154,545.8,sp|A7RG82|CLP1_NEMVE Protein CLP1 homolog OS=Nematostella vectensis OX=45351 GN=v1g236308 PE=3 SV=1,,,,,,
OG_04798,FUN_022717-T2,Peve_00016559,Pocillopora_meandrina_HIv1___TS.g18265.t1a,three_way,70.595,,,,,,,,,,,,,,,,,
OG_04799,FUN_022718-T3,Peve_00016555,Pocillopora_meandrina_HIv1___TS.g18265.t1b,three_way,60.96783333333333,FUN_022718-T3,O43897,,,,,30.5,734.0,2.8e-96,355.5,sp|O43897|TLL1_HUMAN Tolloid-like protein 1 OS=Homo sapiens OX=9606 GN=TLL1 PE=1 SV=1,,,,,,
OG_04800,FUN_022722-T1,Peve_00009025,Pocillopora_meandrina_HIv1___RNAseq.g3194.t1,three_way,77.942,FUN_022722-T1,Q9WU78,PDC6I_MOUSE,,Programmed cell death 6-interacting protein (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (E2F1-inducible protein) (Eig2),Mus musculus (Mouse),48.1,722.0,3.4e-174,613.6,sp|Q9WU78|PDC6I_MOUSE Programmed cell death 6-interacting protein OS=Mus musculus OX=10090 GN=Pdcd6ip PE=1 SV=3,GO:0000281; GO:0000915; GO:0005813; GO:0005829; GO:0005923; GO:0006915; GO:0015031; GO:0016236; GO:0017124; GO:0042470; GO:0042641; GO:0042802; GO:0043209; GO:0045199; GO:0046983; GO:0070062; GO:0070830; GO:0090543; GO:0090559; GO:0097734,actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; extracellular exosome biogenesis [GO:0097734]; macroautophagy [GO:0016236]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mitotic cytokinesis [GO:0000281]; protein transport [GO:0015031]; regulation of membrane permeability [GO:0090559],actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; melanosome [GO:0042470]; myelin sheath [GO:0043209],identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; SH3 domain binding [GO:0017124],GO:0000910; GO:0005815; GO:0005829; GO:0006914; GO:0007010; GO:0007163; GO:0012501; GO:0031410; GO:0034330; GO:0043226,cytokinesis; microtubule organizing center; cytosol; autophagy; cytoskeleton organization; establishment or maintenance of cell polarity; programmed cell death; cytoplasmic vesicle; cell junction organization; organelle
OG_04801,FUN_022758-T1,Peve_00027945,Pocillopora_meandrina_HIv1___RNAseq.g3153.t1,three_way,64.09166666666667,,,,,,,,,,,,,,,,,
OG_04802,FUN_022761-T1,Peve_00006882,Pocillopora_meandrina_HIv1___RNAseq.g4814.t1,three_way,80.2745,,,,,,,,,,,,,,,,,
OG_04803,FUN_022762-T1,Peve_00006888,Pocillopora_meandrina_HIv1___RNAseq.g4810.t1,three_way,52.281666666666666,,,,,,,,,,,,,,,,,
OG_04804,FUN_022763-T1,Peve_00006881,Pocillopora_meandrina_HIv1___RNAseq.g4809.t1,three_way,71.97783333333334,FUN_022763-T1,Q96RJ6,FER3L_HUMAN,,Fer3-like protein (Basic helix-loop-helix protein N-twist) (Class A basic helix-loop-helix protein 31) (bHLHa31) (Nephew of atonal 3) (Neuronal twist),Homo sapiens (Human),46.4,56.0,7.9e-07,55.1,sp|Q96RJ6|FER3L_HUMAN Fer3-like protein OS=Homo sapiens OX=9606 GN=FERD3L PE=1 SV=1,GO:0000785; GO:0000977; GO:0000981; GO:0001227; GO:0005634; GO:0006357; GO:0032502; GO:0033504; GO:0045892; GO:0046983; GO:0048468; GO:0050767; GO:1904338; GO:1990837,cell development [GO:0048468]; developmental process [GO:0032502]; floor plate development [GO:0033504]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_04805,FUN_022764-T1,Peve_00014654,Pocillopora_meandrina_HIv1___RNAseq.g4808.t1,three_way,73.40683333333334,FUN_022764-T1,Q6QHK4,FIGLA_HUMAN,,Factor in the germline alpha (FIGalpha) (Class C basic helix-loop-helix protein 8) (bHLHc8) (Folliculogenesis-specific basic helix-loop-helix protein) (Transcription factor FIGa),Homo sapiens (Human),45.3,64.0,1.6e-08,61.2,sp|Q6QHK4|FIGLA_HUMAN Factor in the germline alpha OS=Homo sapiens OX=9606 GN=FIGLA PE=1 SV=2,GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005667; GO:0006357; GO:0032502; GO:0043425; GO:0046983; GO:0048599; GO:1990837,developmental process [GO:0032502]; oocyte development [GO:0048599]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; transcription regulator activity
OG_04806,FUN_022765-T1,Peve_00014656,Pocillopora_meandrina_HIv1___RNAseq.g4805.t1,three_way,83.05433333333333,FUN_022765-T1,P13903,,,,,77.5,89.0,1.1e-31,137.5,sp|P13903|TWIST_XENLA Twist-related protein OS=Xenopus laevis OX=8355 GN=twist1 PE=2 SV=1,,,,,,
OG_04807,FUN_022766-T1,Peve_00014657,Pocillopora_meandrina_HIv1___RNAseq.g4730.t1,three_way,58.63033333333333,,,,,,,,,,,,,,,,,
OG_04808,FUN_022767-T1,Peve_00014658,Pocillopora_meandrina_HIv1___RNAseq.g4729.t1,three_way,73.63166666666666,FUN_022767-T1,Q7ZX22,WDR24_XENLA,,GATOR2 complex protein WDR24 (EC 2.3.2.27),Xenopus laevis (African clawed frog),38.4,799.0,4.6e-160,566.6,sp|Q7ZX22|WDR24_XENLA GATOR2 complex protein WDR24 OS=Xenopus laevis OX=8355 GN=wdr24 PE=2 SV=1,GO:0005765; GO:0005774; GO:0005829; GO:0006914; GO:0008270; GO:0016239; GO:0031669; GO:0034198; GO:0061630; GO:0061700; GO:0085020; GO:1904263,autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; protein K6-linked ubiquitination [GO:0085020],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006914; GO:0016740; GO:0140096,"catalytic activity; cytosol; autophagy; transferase activity; catalytic activity, acting on a protein"
OG_04809,FUN_022771-T1,Peve_00043386,Pocillopora_meandrina_HIv1___RNAseq.g4766.t1,three_way,62.87,FUN_022771-T1,P49442,,,,,39.7,393.0,1.5e-66,255.0,sp|P49442|INPP_MOUSE Inositol polyphosphate 1-phosphatase OS=Mus musculus OX=10090 GN=Inpp1 PE=1 SV=2,,,,,,
OG_04810,FUN_022772-T1,Peve_00043388,Pocillopora_meandrina_HIv1___RNAseq.g4767.t1,three_way,97.277,FUN_022772-T1,P23258,TBG1_HUMAN,,Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1),Homo sapiens (Human),81.6,451.0,5.9e-221,768.1,sp|P23258|TBG1_HUMAN Tubulin gamma-1 chain OS=Homo sapiens OX=9606 GN=TUBG1 PE=1 SV=2,GO:0000070; GO:0000212; GO:0000226; GO:0000242; GO:0000278; GO:0000794; GO:0000930; GO:0000931; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005827; GO:0005829; GO:0005881; GO:0007020; GO:0007052; GO:0031122; GO:0031252; GO:0036064; GO:0042802; GO:0043005; GO:0045177; GO:0055037; GO:0097730; GO:0140490; GO:1990498,cytoplasmic microtubule organization [GO:0031122]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052],apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; gamma-tubulin ring complex [GO:0000931]; mitotic spindle microtubule [GO:1990498]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819],GTP binding [GO:0005525]; identical protein binding [GO:0042802]; microtubule nucleator activity [GO:0140490]; structural constituent of cytoskeleton [GO:0005200],GO:0000228; GO:0000278; GO:0005198; GO:0005634; GO:0005694; GO:0005768; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0007059; GO:0022414; GO:0031410; GO:0043226,nuclear chromosome; mitotic cell cycle; structural molecule activity; nucleus; chromosome; endosome; microtubule organizing center; cytosol; cilium; cytoskeleton organization; chromosome segregation; reproductive process; cytoplasmic vesicle; organelle
OG_04811,FUN_022775-T1,Peve_00043390,Pocillopora_meandrina_HIv1___RNAseq.g4768.t1,three_way,88.94066666666666,FUN_022775-T1,F1R4U0,TXTPB_DANRE,,"Tricarboxylate transport protein B, mitochondrial (Citrate transport protein B) (Solute carrier family 25 member 1b)",Danio rerio (Zebrafish) (Brachydanio rerio),64.8,307.0,8.1e-116,418.3,"sp|F1R4U0|TXTPB_DANRE Tricarboxylate transport protein B, mitochondrial OS=Danio rerio OX=7955 GN=slc25a1b PE=3 SV=2",GO:0005739; GO:0005743; GO:0006843; GO:0007528; GO:0015142; GO:0015297; GO:0071913,mitochondrial citrate transmembrane transport [GO:0006843]; neuromuscular junction development [GO:0007528],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],antiporter activity [GO:0015297]; citrate secondary active transmembrane transporter activity [GO:0071913]; tricarboxylic acid transmembrane transporter activity [GO:0015142],GO:0005215; GO:0005739; GO:0034330; GO:0043226; GO:0055085,transporter activity; mitochondrion; cell junction organization; organelle; transmembrane transport
OG_04812,FUN_022776-T1,Peve_00043391,Pocillopora_meandrina_HIv1___RNAseq.g4769.t1,three_way,74.15733333333334,FUN_022776-T1,Q63ZL2,,,,,35.4,212.0,3.8000000000000005e-28,126.3,sp|Q63ZL2|HOP2_XENLA Homologous-pairing protein 2 homolog OS=Xenopus laevis OX=8355 GN=psmc3ip PE=2 SV=1,,,,,,
OG_04813,FUN_022777-T1,Peve_00021164,Pocillopora_meandrina_HIv1___RNAseq.g4771.t1,three_way,52.269,,,,,,,,,,,,,,,,,
OG_04814,FUN_022778-T1,Peve_00021168,Pocillopora_meandrina_HIv1___RNAseq.g4772.t1,three_way,76.42866666666667,,,,,,,,,,,,,,,,,
OG_04815,FUN_022787-T1,Peve_00030606,Pocillopora_meandrina_HIv1___TS.g22189.t1,three_way,80.07866666666666,FUN_022787-T1,Q95R48,,,,,30.0,397.0,2.1e-48,194.5,sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2,,,,,,
OG_04816,FUN_022797-T1,Peve_00024723,Pocillopora_meandrina_HIv1___TS.g9662.t2,three_way,93.94933333333334,FUN_022797-T1,P36876,,,,,76.0,441.0,2.8e-204,712.6,sp|P36876|2ABA_RAT Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform OS=Rattus norvegicus OX=10116 GN=Ppp2r2a PE=2 SV=1,,,,,,
OG_04817,FUN_022803-T1,Peve_00024730,Pocillopora_meandrina_HIv1___RNAseq.g3482.t1,three_way,64.24266666666666,,,,,,,,,,,,,,,,,
OG_04818,FUN_022804-T1,Peve_00024731,Pocillopora_meandrina_HIv1___RNAseq.g3480.t1,three_way,66.91633333333334,FUN_022804-T1,Q9NQZ5,STAR7_HUMAN,,"StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7) (StARD7)",Homo sapiens (Human),44.1,247.0,7.6000000000000005e-59,229.2,"sp|Q9NQZ5|STAR7_HUMAN StAR-related lipid transfer protein 7, mitochondrial OS=Homo sapiens OX=9606 GN=STARD7 PE=1 SV=2",GO:0001773; GO:0005576; GO:0005739; GO:0005741; GO:0006744; GO:0006954; GO:0008289; GO:0042092; GO:0061436; GO:0120013; GO:0120197; GO:0140104,establishment of skin barrier [GO:0061436]; inflammatory response [GO:0006954]; mucociliary clearance [GO:0120197]; myeloid dendritic cell activation [GO:0001773]; type 2 immune response [GO:0042092]; ubiquinone biosynthetic process [GO:0006744],extracellular region [GO:0005576]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; lipid transfer activity [GO:0120013]; molecular carrier activity [GO:0140104],GO:0002376; GO:0003016; GO:0005215; GO:0005576; GO:0005739; GO:0006954; GO:0007018; GO:0008289; GO:0043226; GO:0048856; GO:0140104,immune system process; respiratory system process; transporter activity; extracellular region; mitochondrion; inflammatory response; microtubule-based movement; lipid binding; organelle; anatomical structure development; molecular carrier activity
OG_04819,FUN_022805-T1,Peve_00018106,Pocillopora_meandrina_HIv1___RNAseq.g3479.t1,three_way,60.698,,,,,,,,,,,,,,,,,
OG_04820,FUN_022809-T1,Peve_00031625,Pocillopora_meandrina_HIv1___RNAseq.g3471.t1,three_way,41.729,,,,,,,,,,,,,,,,,
OG_04821,FUN_022810-T1,Peve_00031624,Pocillopora_meandrina_HIv1___RNAseq.g3470.t1,three_way,49.74966666666666,,,,,,,,,,,,,,,,,
OG_04822,FUN_022812-T1,Peve_00031630,Pocillopora_meandrina_HIv1___RNAseq.g3465.t1,three_way,78.11,FUN_022812-T1,P00504,,,,,54.6,368.0,1e-114,414.8,"sp|P00504|AATC_CHICK Aspartate aminotransferase, cytoplasmic OS=Gallus gallus OX=9031 GN=GOT1 PE=1 SV=3",,,,,,
OG_04823,FUN_022813-T1,Peve_00031629,Pocillopora_meandrina_HIv1___RNAseq.g3464.t1,three_way,84.17833333333333,FUN_022813-T1,Q6NRM7,,,,,45.2,221.0,3.6e-35,149.8,sp|Q6NRM7|CHMP3_XENLA Charged multivesicular body protein 3 OS=Xenopus laevis OX=8355 GN=chmp3 PE=2 SV=3,,,,,,
OG_04824,FUN_022815-T1,Peve_00017628,Pocillopora_meandrina_HIv1___RNAseq.g3454.t1,three_way,55.73433333333333,,,,,,,,,,,,,,,,,
OG_04825,FUN_022817-T1,Peve_00014997,Pocillopora_meandrina_HIv1___TS.g9632.t1,three_way,48.804,,,,,,,,,,,,,,,,,
OG_04826,FUN_022818-T1,Peve_00031617,Pocillopora_meandrina_HIv1___RNAseq.g3463.t1,three_way,77.29366666666667,FUN_022818-T1,Q8CDU6,,,,,63.1,640.0,1.2000000000000001e-238,827.8,sp|Q8CDU6|HECD2_MOUSE Probable E3 ubiquitin-protein ligase HECTD2 OS=Mus musculus OX=10090 GN=Hectd2 PE=1 SV=2,,,,,,
OG_04827,FUN_022821-T1,Peve_00016085,Pocillopora_meandrina_HIv1___RNAseq.g3443.t1,three_way,74.968,FUN_022821-T1,B3S3D5,,,,,72.1,104.0,1.5e-34,148.3,sp|B3S3D5|DDRGK_TRIAD DDRGK domain-containing protein 1 OS=Trichoplax adhaerens OX=10228 GN=TRIADDRAFT_58679 PE=3 SV=1,,,,,,
OG_04828,FUN_022822-T1,Peve_00016082,Pocillopora_meandrina_HIv1___RNAseq.g3441.t1,three_way,81.581,FUN_022822-T1,P77475,,,,,28.9,159.0,2e-14,80.5,sp|P77475|YQAB_ECOLI Fructose-1-phosphate phosphatase YqaB OS=Escherichia coli (strain K12) OX=83333 GN=yqaB PE=1 SV=1,,,,,,
OG_04829,FUN_022823-T1,Peve_00027665,Pocillopora_meandrina_HIv1___RNAseq.g3439.t1,three_way,69.43183333333333,FUN_022823-T1,A8MU46,SMTL1_HUMAN,,Smoothelin-like protein 1,Homo sapiens (Human),49.5,101.0,9.6e-22,106.7,sp|A8MU46|SMTL1_HUMAN Smoothelin-like protein 1 OS=Homo sapiens OX=9606 GN=SMTNL1 PE=1 SV=2,GO:0005516; GO:0005523; GO:0005634; GO:0005737; GO:0008157; GO:0009410; GO:0014823; GO:0031430; GO:0031674; GO:0042310; GO:0043292; GO:0045892; GO:0045907; GO:0048644; GO:0051401; GO:0097718,muscle organ morphogenesis [GO:0048644]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of vasoconstriction [GO:0045907]; response to activity [GO:0014823]; response to xenobiotic stimulus [GO:0009410]; vasoconstriction [GO:0042310],contractile muscle fiber [GO:0043292]; cytoplasm [GO:0005737]; I band [GO:0031674]; M band [GO:0031430]; nucleus [GO:0005634],calmodulin binding [GO:0005516]; CH domain binding [GO:0051401]; disordered domain specific binding [GO:0097718]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523],GO:0003013; GO:0005634; GO:0006355; GO:0008092; GO:0043226,circulatory system process; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; organelle
OG_04830,FUN_022824-T1,Peve_00030469,Pocillopora_meandrina_HIv1___RNAseq.g3440.t1,three_way,97.61033333333332,FUN_022824-T1,B2RW38,CFA58_MOUSE,,Cilia- and flagella-associated protein 58,Mus musculus (Mouse),69.4,788.0,3.3999999999999996e-177,623.6,sp|B2RW38|CFA58_MOUSE Cilia- and flagella-associated protein 58 OS=Mus musculus OX=10090 GN=Cfap58 PE=1 SV=1,GO:0005737; GO:0005813; GO:0007219; GO:0007288; GO:0030317; GO:0036126; GO:0060271; GO:0097225; GO:0120229; GO:0120316; GO:0120317,cilium assembly [GO:0060271]; flagellated sperm motility [GO:0030317]; Notch signaling pathway [GO:0007219]; protein localization to motile cilium [GO:0120229]; sperm axoneme assembly [GO:0007288]; sperm flagellum assembly [GO:0120316]; sperm mitochondrial sheath assembly [GO:0120317],centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225],,GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_04831,FUN_022825-T1,Peve_00028904,Pocillopora_meandrina_HIv1___RNAseq.g3433.t1,three_way,66.04366666666667,FUN_022825-T1,O43156,TTI1_HUMAN,,TELO2-interacting protein 1 homolog (Protein SMG10),Homo sapiens (Human),33.4,1144.0,2.5e-172,607.8,sp|O43156|TTI1_HUMAN TELO2-interacting protein 1 homolog OS=Homo sapiens OX=9606 GN=TTI1 PE=1 SV=3,GO:0005634; GO:0005737; GO:0031931; GO:0031932; GO:0032006; GO:0050821; GO:0110078; GO:2000003,positive regulation of DNA damage checkpoint [GO:2000003]; protein stabilization [GO:0050821]; regulation of TOR signaling [GO:0032006],cytoplasm [GO:0005737]; nucleus [GO:0005634]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; TTT Hsp90 cochaperone complex [GO:0110078],,GO:0005634; GO:0043226,nucleus; organelle
OG_04832,FUN_022826-T1,Peve_00028899,Pocillopora_meandrina_HIv1___RNAseq.g3432.t1,three_way,71.25966666666666,FUN_022826-T1,Q7Z6M1,RABEK_HUMAN,,Rab9 effector protein with kelch motifs (40 kDa Rab9 effector protein) (p40),Homo sapiens (Human),46.3,218.0,1.1e-57,225.3,sp|Q7Z6M1|RABEK_HUMAN Rab9 effector protein with kelch motifs OS=Homo sapiens OX=9606 GN=RABEPK PE=1 SV=1,GO:0005768; GO:0005829; GO:0006898; GO:0006904; GO:0010008; GO:0030133; GO:0032588; GO:0043231,receptor-mediated endocytosis [GO:0006898]; vesicle docking involved in exocytosis [GO:0006904],cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133],,GO:0005768; GO:0005829; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_04833,FUN_022827-T1,Peve_00028898,Pocillopora_meandrina_HIv1___RNAseq.g3431.t1,three_way,84.11833333333334,FUN_022827-T1,Q0IJ33,,,,,54.4,362.0,6.2e-117,422.2,sp|Q0IJ33|TM129_XENTR E3 ubiquitin-protein ligase TM129 OS=Xenopus tropicalis OX=8364 GN=tmem129 PE=2 SV=1,,,,,,
OG_04834,FUN_022832-T1,Peve_00028897,Pocillopora_meandrina_HIv1___RNAseq.g3430.t1,three_way,80.637,FUN_022832-T1,Q8WXB1,MT21A_HUMAN,,Protein N-lysine methyltransferase METTL21A (EC 2.1.1.-) (HSPA lysine methyltransferase) (HSPA-KMT) (Hepatocellular carcinoma-associated antigen 557b) (Methyltransferase-like protein 21A),Homo sapiens (Human),53.4,161.0,2.2e-38,160.2,sp|Q8WXB1|MT21A_HUMAN Protein N-lysine methyltransferase METTL21A OS=Homo sapiens OX=9606 GN=METTL21A PE=1 SV=2,GO:0005654; GO:0005829; GO:0006479; GO:0008276; GO:0016279; GO:0030544; GO:0031072; GO:0032991; GO:0051117; GO:1903645,negative regulation of chaperone-mediated protein folding [GO:1903645]; protein methylation [GO:0006479],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],ATPase binding [GO:0051117]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; protein methyltransferase activity [GO:0008276]; protein-lysine N-methyltransferase activity [GO:0016279],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_04835,FUN_022833-T1,Peve_00028896,Pocillopora_meandrina_HIv1___RNAseq.g3429.t1,three_way,83.13033333333334,FUN_022833-T1,Q969Q5,RAB24_HUMAN,,Ras-related protein Rab-24 (EC 3.6.5.2),Homo sapiens (Human),69.6,171.0,4.8e-66,252.3,sp|Q969Q5|RAB24_HUMAN Ras-related protein Rab-24 OS=Homo sapiens OX=9606 GN=RAB24 PE=1 SV=1,GO:0000421; GO:0001556; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0008608; GO:0012505; GO:0030139; GO:0030667; GO:0048471; GO:0140013,attachment of spindle microtubules to kinetochore [GO:0008608]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; meiotic nuclear division [GO:0140013]; oocyte maturation [GO:0001556],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle [GO:0005819],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0098772; GO:0140013,catalytic activity; GTPase activity; mitochondrion; endosome; vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity; meiotic nuclear division
OG_04836,FUN_022834-T1,Peve_00028894,Pocillopora_meandrina_HIv1___RNAseq.g3426.t1,three_way,70.747,FUN_022834-T1,P57775,,,,,34.0,391.0,1.3e-56,221.9,sp|P57775|FBXW4_HUMAN F-box/WD repeat-containing protein 4 OS=Homo sapiens OX=9606 GN=FBXW4 PE=1 SV=1,,,,,,
OG_04837,FUN_022835-T1,Peve_00020479,Pocillopora_meandrina_HIv1___TS.g9598.t1,three_way,64.63833333333334,,,,,,,,,,,,,,,,,
OG_04838,FUN_022837-T1,Peve_00028887,Pocillopora_meandrina_HIv1___RNAseq.g3399.t1,three_way,45.176,,,,,,,,,,,,,,,,,
OG_04839,FUN_022838-T1,Peve_00028886,Pocillopora_meandrina_HIv1___RNAseq.g3398.t1,three_way,65.971,,,,,,,,,,,,,,,,,
OG_04840,FUN_022844-T1,Peve_00028885,Pocillopora_meandrina_HIv1___TS.g9571.t1,three_way,74.77733333333333,,,,,,,,,,,,,,,,,
OG_04841,FUN_022850-T2,Peve_00028882,Pocillopora_meandrina_HIv1___RNAseq.g3395.t1,three_way,55.903,FUN_022850-T2,Q9I8N6,CSF1R_DANRE,,Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms homolog),Danio rerio (Zebrafish) (Brachydanio rerio),27.4,431.0,2.4e-30,135.6,sp|Q9I8N6|CSF1R_DANRE Macrophage colony-stimulating factor 1 receptor OS=Danio rerio OX=7955 GN=csf1r PE=2 SV=1,GO:0002383; GO:0005011; GO:0005524; GO:0005886; GO:0006629; GO:0006954; GO:0007169; GO:0008284; GO:0010759; GO:0014004; GO:0014005; GO:0016477; GO:0019838; GO:0019955; GO:0030100; GO:0030316; GO:0030318; GO:0030335; GO:0031641; GO:0036035; GO:0036179; GO:0036269; GO:0042481; GO:0043235; GO:0043408; GO:0043473; GO:0045087; GO:0048066; GO:0048070; GO:0048246; GO:0050936; GO:0050938; GO:0061075; GO:0097324; GO:1990682; GO:2001204,cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; developmental pigmentation [GO:0048066]; immune response in brain or nervous system [GO:0002383]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipid metabolic process [GO:0006629]; macrophage chemotaxis [GO:0048246]; melanocyte differentiation [GO:0030318]; melanocyte migration [GO:0097324]; microglia development [GO:0014005]; microglia differentiation [GO:0014004]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast maturation [GO:0036179]; pigmentation [GO:0043473]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neural retina development [GO:0061075]; regulation of developmental pigmentation [GO:0048070]; regulation of endocytosis [GO:0030100]; regulation of MAPK cascade [GO:0043408]; regulation of myelination [GO:0031641]; regulation of odontogenesis [GO:0042481]; regulation of osteoclast development [GO:2001204]; regulation of xanthophore differentiation [GO:0050938]; swimming behavior [GO:0036269]; xanthophore differentiation [GO:0050936],CSF1-CSF1R complex [GO:1990682]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; macrophage colony-stimulating factor receptor activity [GO:0005011],GO:0002376; GO:0003824; GO:0005886; GO:0006629; GO:0006954; GO:0016740; GO:0030154; GO:0048856; GO:0048870; GO:0060089; GO:0098542; GO:0140096,"immune system process; catalytic activity; plasma membrane; lipid metabolic process; inflammatory response; transferase activity; cell differentiation; anatomical structure development; cell motility; molecular transducer activity; defense response to other organism; catalytic activity, acting on a protein"
OG_04842,FUN_022851-T1,Peve_00028879,Pocillopora_meandrina_HIv1___RNAseq.g3394.t1,three_way,79.718,FUN_022851-T1,Q62302,,,,,54.8,199.0,2.3999999999999997e-46,186.8,sp|Q62302|TX261_MOUSE Protein TEX261 OS=Mus musculus OX=10090 GN=Tex261 PE=2 SV=1,,,,,,
OG_04843,FUN_022852-T1,Peve_00028878,Pocillopora_meandrina_HIv1___RNAseq.g3393.t1,three_way,64.0195,FUN_022852-T1,Q5ZJS6,,,,,34.9,129.0,1.5e-07,57.4,sp|Q5ZJS6|PAIP2_CHICK Polyadenylate-binding protein-interacting protein 2 OS=Gallus gallus OX=9031 GN=PAIP2 PE=2 SV=1,,,,,,
OG_04844,FUN_022854-T1,Peve_00004028,Pocillopora_meandrina_HIv1___RNAseq.g3391.t1,three_way,84.87066666666666,FUN_022854-T1,Q91175,,,,,27.4,325.0,8.5e-18,92.8,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_04845,FUN_022855-T1,Peve_00004027,Pocillopora_meandrina_HIv1___RNAseq.g3390.t1,three_way,86.75766666666667,FUN_022855-T1,P0AF49,,,,,51.4,138.0,8.000000000000001e-39,161.4,sp|P0AF49|YJBQ_ECO57 UPF0047 protein YjbQ OS=Escherichia coli O157:H7 OX=83334 GN=yjbQ PE=3 SV=1,,,,,,
OG_04846,FUN_022856-T1,Peve_00004026,Pocillopora_meandrina_HIv1___RNAseq.g3389.t1,three_way,83.74,FUN_022856-T1,A2TLM1,,,,,67.5,194.0,8.9e-66,251.5,sp|A2TLM1|RPIA_PIG Ribose-5-phosphate isomerase OS=Sus scrofa OX=9823 GN=RPIA PE=2 SV=1,,,,,,
OG_04847,FUN_022857-T1,Peve_00004025,Pocillopora_meandrina_HIv1___TS.g9560.t1,three_way,73.97733333333333,FUN_022857-T1,Q75Z89,5HT2A_BOVIN,,5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A),Bos taurus (Bovine),28.6,318.0,4.5e-26,120.2,sp|Q75Z89|5HT2A_BOVIN 5-hydroxytryptamine receptor 2A OS=Bos taurus OX=9913 GN=HTR2A PE=2 SV=1,GO:0001587; GO:0004993; GO:0005886; GO:0005901; GO:0006096; GO:0006874; GO:0007187; GO:0007208; GO:0007210; GO:0007268; GO:0009410; GO:0010513; GO:0030296; GO:0030424; GO:0030425; GO:0030594; GO:0031410; GO:0042802; GO:0044380; GO:0045600; GO:0045821; GO:0051209; GO:0051378; GO:0070374; GO:0071886; GO:0098666; GO:0098793; GO:0099589,"chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; glycolytic process [GO:0006096]; intracellular calcium ion homeostasis [GO:0006874]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of glycolytic process [GO:0045821]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein localization to cytoskeleton [GO:0044380]; release of sequestered calcium ion into cytosol [GO:0051209]; response to xenobiotic stimulus [GO:0009410]; serotonin receptor signaling pathway [GO:0007210]",axon [GO:0030424]; caveola [GO:0005901]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; G protein-coupled serotonin receptor complex [GO:0098666]; plasma membrane [GO:0005886]; presynapse [GO:0098793],"1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; G protein-coupled serotonin receptor activity [GO:0004993]; Gq/11-coupled serotonin receptor activity [GO:0001587]; identical protein binding [GO:0042802]; neurotransmitter receptor activity [GO:0030594]; protein tyrosine kinase activator activity [GO:0030296]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589]",GO:0005886; GO:0005975; GO:0006091; GO:0023052; GO:0031410; GO:0043226; GO:0055085; GO:0055086; GO:0060089; GO:0098772; GO:1901135,plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; signaling; cytoplasmic vesicle; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process; molecular transducer activity; molecular function regulator activity; carbohydrate derivative metabolic process
OG_04848,FUN_022858-T1,Peve_00004024,Pocillopora_meandrina_HIv1___RNAseq.g3387.t1,three_way,56.8245,,,,,,,,,,,,,,,,,
OG_04849,FUN_022861-T1,Peve_00025611,Pocillopora_meandrina_HIv1___RNAseq.g3605.t1,three_way,79.88833333333334,FUN_022861-T1,O55003,BNIP3_MOUSE,,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,Mus musculus (Mouse),33.5,188.0,1.5e-15,84.3,sp|O55003|BNIP3_MOUSE BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 OS=Mus musculus OX=10090 GN=Bnip3 PE=1 SV=1,GO:0000423; GO:0001666; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005739; GO:0005741; GO:0005789; GO:0006915; GO:0009617; GO:0010637; GO:0010659; GO:0010666; GO:0010917; GO:0014069; GO:0016239; GO:0021987; GO:0030425; GO:0031966; GO:0035694; GO:0042802; GO:0042803; GO:0043065; GO:0043069; GO:0043243; GO:0043653; GO:0045837; GO:0046902; GO:0048102; GO:0048678; GO:0048709; GO:0050873; GO:0051020; GO:0051402; GO:0051561; GO:0051607; GO:0055093; GO:0061709; GO:0070301; GO:0071260; GO:0071279; GO:0071456; GO:0072593; GO:0090141; GO:0090200; GO:0090649; GO:0097193; GO:0097345; GO:0140506; GO:0140507; GO:0140580; GO:1902109; GO:1903599; GO:1990144,apoptotic process [GO:0006915]; autophagic cell death [GO:0048102]; brown fat cell differentiation [GO:0050873]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to cobalt ion [GO:0071279]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial protein catabolic process [GO:0035694]; mitophagy [GO:0000423]; negative regulation of membrane potential [GO:0045837]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of programmed cell death [GO:0043069]; neuron apoptotic process [GO:0051402]; oligodendrocyte differentiation [GO:0048709]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane permeability [GO:0046902]; response to axon injury [GO:0048678]; response to bacterium [GO:0009617]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to oxygen-glucose deprivation [GO:0090649]; reticulophagy [GO:0061709],cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; mitochondrion autophagosome adaptor activity [GO:0140580]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0005635; GO:0005654; GO:0005739; GO:0006914; GO:0007005; GO:0012501; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0061024,nucleus; nuclear envelope; nucleoplasm; mitochondrion; autophagy; mitochondrion organization; programmed cell death; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; membrane organization
OG_04850,FUN_022862-T1,Peve_00025610,Pocillopora_meandrina_HIv1___RNAseq.g3606.t1,three_way,84.90033333333334,FUN_022862-T1,Q5EA43,SFXN2_BOVIN,,Sideroflexin-2,Bos taurus (Bovine),60.2,314.0,9.8e-106,384.8,sp|Q5EA43|SFXN2_BOVIN Sideroflexin-2 OS=Bos taurus OX=9913 GN=SFXN2 PE=2 SV=2,GO:0005739; GO:0005741; GO:0005743; GO:0015075; GO:0022857; GO:0140300; GO:1990542,mitochondrial transmembrane transport [GO:1990542]; serine import into mitochondrion [GO:0140300],mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],monoatomic ion transmembrane transporter activity [GO:0015075]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_04851,FUN_022863-T1,Peve_00025604,Pocillopora_meandrina_HIv1___RNAseq.g3607.t1,three_way,83.18433333333333,FUN_022863-T1,Q5F450,PAN2_CHICK,,PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2),Gallus gallus (Chicken),51.1,1129.0,0.0,1086.6,sp|Q5F450|PAN2_CHICK PAN2-PAN3 deadenylation complex catalytic subunit PAN2 OS=Gallus gallus OX=9031 GN=PAN2 PE=2 SV=1,GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872,mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535],GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_04852,FUN_022864-T1,Peve_00025619,Pocillopora_meandrina_HIv1___TS.g9783.t1,three_way,69.89,FUN_022864-T1,Q9BSG0,,,,,43.6,165.0,7.2e-38,158.7,sp|Q9BSG0|PADC1_HUMAN Protease-associated domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PRADC1 PE=1 SV=1,,,,,,
OG_04853,FUN_022865-T1,Peve_00025617,Pocillopora_meandrina_HIv1___RNAseq.g3609.t1,three_way,84.65799999999999,FUN_022865-T1,Q7T321,KCMF1_DANRE,,E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27),Danio rerio (Zebrafish) (Brachydanio rerio),62.8,333.0,2.6e-92,340.5,sp|Q7T321|KCMF1_DANRE E3 ubiquitin-protein ligase KCMF1 OS=Danio rerio OX=7955 GN=kcmf1 PE=2 SV=1,GO:0005764; GO:0005770; GO:0005886; GO:0008270; GO:0016740; GO:0045202; GO:0070534; GO:0099536; GO:0141191,negative regulation of HRI-mediated signaling [GO:0141191]; protein K63-linked ubiquitination [GO:0070534]; synaptic signaling [GO:0099536],late endosome [GO:0005770]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; synapse [GO:0045202],transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0016740; GO:0023052; GO:0031410; GO:0043226,catalytic activity; lysosome; endosome; vacuole; plasma membrane; transferase activity; signaling; cytoplasmic vesicle; organelle
OG_04854,FUN_022868-T1,Peve_00012303,Pocillopora_meandrina_HIv1___RNAseq.g3613.t1,three_way,73.38633333333333,FUN_022868-T1,Q804R0,LBX2_DANRE,,Transcription factor LBX2 (Ladybird homeobox 2) (Ladybird homeobox protein homolog 2),Danio rerio (Zebrafish) (Brachydanio rerio),46.3,177.0,4.2e-30,132.9,sp|Q804R0|LBX2_DANRE Transcription factor LBX2 OS=Danio rerio OX=7955 GN=lbx2 PE=1 SV=1,GO:0000578; GO:0000981; GO:0005634; GO:0006357; GO:0042692; GO:0048920; GO:0048922; GO:0055001; GO:0060828; GO:1904105; GO:1990837; GO:2000052,embryonic axis specification [GO:0000578]; muscle cell development [GO:0055001]; muscle cell differentiation [GO:0042692]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; posterior lateral line neuromast deposition [GO:0048922]; posterior lateral line neuromast primordium migration [GO:0048920]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_04855,FUN_022869-T2,Peve_00012301,Pocillopora_meandrina_HIv1___TS.g9788.t2,three_way,79.94416666666667,FUN_022869-T2,Q6AXU1,,,,,39.4,348.0,1.1e-66,256.1,sp|Q6AXU1|BTBDG_RAT BTB/POZ domain-containing protein 16 OS=Rattus norvegicus OX=10116 GN=Btbd16 PE=2 SV=1,,,,,,
OG_04856,FUN_022870-T1,Peve_00012300,Pocillopora_meandrina_HIv1___RNAseq.g3615.t1,three_way,81.07966666666667,FUN_022870-T1,P70061,,,,,67.0,106.0,5.3e-32,139.4,sp|P70061|NKX32_XENLA Homeobox protein Nkx-3.2 OS=Xenopus laevis OX=8355 GN=nkx3-2 PE=2 SV=1,,,,,,
OG_04857,FUN_022871-T1,Peve_00012299,Pocillopora_meandrina_HIv1___RNAseq.g3616.t1,three_way,89.286,FUN_022871-T1,Q90788,NKX25_CHICK,,Homeobox protein Nkx-2.5 (cNKx-2.5) (Homeobox protein NK-2 homolog E),Gallus gallus (Chicken),52.2,159.0,1.2e-33,145.2,sp|Q90788|NKX25_CHICK Homeobox protein Nkx-2.5 OS=Gallus gallus OX=9031 GN=NKX-2.5 PE=2 SV=1,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0001570; GO:0001947; GO:0003148; GO:0003166; GO:0003168; GO:0003211; GO:0003221; GO:0003222; GO:0003228; GO:0003278; GO:0003285; GO:0003342; GO:0003350; GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0006366; GO:0007512; GO:0010628; GO:0010667; GO:0010765; GO:0010832; GO:0030097; GO:0030154; GO:0030855; GO:0030878; GO:0032991; GO:0032993; GO:0042803; GO:0045666; GO:0045823; GO:0048536; GO:0050673; GO:0050679; GO:0051891; GO:0055005; GO:0055117; GO:0060037; GO:0060038; GO:0060043; GO:0060048; GO:0060261; GO:0060347; GO:0060412; GO:0060413; GO:0060928; GO:0060929; GO:0060971; GO:0061629; GO:0071772; GO:0090090; GO:1903779; GO:1904019; GO:1904036; GO:1990664,adult heart development [GO:0007512]; apoptotic process involved in heart morphogenesis [GO:0003278]; atrial cardiac muscle tissue development [GO:0003228]; atrial septum morphogenesis [GO:0060413]; atrioventricular node cell development [GO:0060928]; atrioventricular node cell fate commitment [GO:0060929]; bundle of His development [GO:0003166]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle contraction [GO:0060048]; cardiac ventricle formation [GO:0003211]; cell differentiation [GO:0030154]; embryonic heart tube left/right pattern formation [GO:0060971]; epithelial cell apoptotic process [GO:1904019]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; heart trabecula formation [GO:0060347]; hemopoiesis [GO:0030097]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal system development [GO:0060037]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of heart contraction [GO:0045823]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of sodium ion transport [GO:0010765]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; proepicardium development [GO:0003342]; pulmonary myocardium development [GO:0003350]; Purkinje myocyte differentiation [GO:0003168]; regulation of cardiac conduction [GO:1903779]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cardiac muscle contraction [GO:0055117]; regulation of transcription by RNA polymerase II [GO:0006357]; response to BMP [GO:0071772]; right ventricular cardiac muscle tissue morphogenesis [GO:0003221]; septum secundum development [GO:0003285]; spleen development [GO:0048536]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasculogenesis [GO:0001570]; ventricular cardiac myofibril assembly [GO:0055005]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],cytosol [GO:0005829]; Nkx-2.5 complex [GO:1990664]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0007010; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,muscle system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04858,FUN_022873-T1,Peve_00012298,Pocillopora_meandrina_HIv1___RNAseq.g3617.t1,three_way,80.57066666666667,FUN_022873-T1,P13297,MSX1_MOUSE,,Homeobox protein MSX-1 (Homeobox protein Hox-7) (Hox-7.1) (Msh homeobox 1-like protein),Mus musculus (Mouse),65.8,149.0,1e-41,171.8,sp|P13297|MSX1_MOUSE Homeobox protein MSX-1 OS=Mus musculus OX=10090 GN=Msx1 PE=1 SV=4,GO:0000122; GO:0000902; GO:0000976; GO:0000977; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001701; GO:0001837; GO:0002039; GO:0003007; GO:0003198; GO:0005634; GO:0005654; GO:0005667; GO:0006366; GO:0007507; GO:0007517; GO:0008285; GO:0009952; GO:0010463; GO:0010629; GO:0021983; GO:0023019; GO:0030308; GO:0030326; GO:0030509; GO:0030513; GO:0030900; GO:0030901; GO:0034399; GO:0034504; GO:0035115; GO:0035116; GO:0035880; GO:0042474; GO:0042475; GO:0042476; GO:0042481; GO:0042482; GO:0042733; GO:0043066; GO:0043565; GO:0043584; GO:0045787; GO:0045892; GO:0045944; GO:0048839; GO:0048863; GO:0050821; GO:0051154; GO:0060021; GO:0060325; GO:0060349; GO:0060536; GO:0061180; GO:0061311; GO:0071316; GO:0090427; GO:0097152; GO:1901330; GO:1902255; GO:2001055,activation of meiosis [GO:0090427]; anterior/posterior pattern specification [GO:0009952]; BMP signaling pathway [GO:0030509]; bone morphogenesis [GO:0060349]; cartilage morphogenesis [GO:0060536]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway involved in heart development [GO:0061311]; cellular response to nicotine [GO:0071316]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic nail plate morphogenesis [GO:0035880]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; inner ear development [GO:0048839]; mammary gland epithelium development [GO:0061180]; mesenchymal cell apoptotic process [GO:0097152]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; muscle organ development [GO:0007517]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of odontoblast differentiation [GO:1901330]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nose development [GO:0043584]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; pituitary gland development [GO:0021983]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell cycle [GO:0045787]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of mesenchymal cell apoptotic process [GO:2001055]; positive regulation of odontogenesis [GO:0042482]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; regulation of odontogenesis [GO:0042481]; roof of mouth development [GO:0060021]; signal transduction involved in regulation of gene expression [GO:0023019]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366],nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; p53 binding [GO:0002039]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04859,FUN_022876-T1,Peve_00012294,Pocillopora_meandrina_HIv1___RNAseq.g3619.t2,three_way,78.97766666666666,FUN_022876-T1,Q5SNQ7,,,,,44.6,489.0,2e-115,417.9,sp|Q5SNQ7|SRAC1_DANRE Protein SERAC1 OS=Danio rerio OX=7955 GN=serac1 PE=3 SV=1,,,,,,
OG_04860,FUN_022877-T1,Peve_00012293,Pocillopora_meandrina_HIv1___RNAseq.g3620.t1,three_way,78.91933333333333,FUN_022877-T1,Q9BRF8,CPPED_HUMAN,,Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1),Homo sapiens (Human),48.3,294.0,1.3e-80,301.2,sp|Q9BRF8|CPPED_HUMAN Serine/threonine-protein phosphatase CPPED1 OS=Homo sapiens OX=9606 GN=CPPED1 PE=1 SV=3,GO:0004722; GO:0005576; GO:0005829; GO:0005886; GO:0035578; GO:0046872,,azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005576; GO:0005829; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular region; cytosol; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_04861,FUN_022878-T1,Peve_00012292,Pocillopora_meandrina_HIv1___RNAseq.g3621.t1,three_way,69.06,,,,,,,,,,,,,,,,,
OG_04862,FUN_022879-T1,Peve_00012290,Pocillopora_meandrina_HIv1___RNAseq.g3622.t1,three_way,61.50833333333333,,,,,,,,,,,,,,,,,
OG_04863,FUN_022883-T1,Peve_00001738,Pocillopora_meandrina_HIv1___RNAseq.g3685.t1,three_way,72.18866666666668,FUN_022883-T1,P48442,CASR_RAT,,Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR),Rattus norvegicus (Rat),31.3,878.0,1.7e-126,455.7,sp|P48442|CASR_RAT Extracellular calcium-sensing receptor OS=Rattus norvegicus OX=10116 GN=Casr PE=1 SV=1,GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; vasodilation [GO:0042311],apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0005886; GO:0048856; GO:0055085; GO:0060089,circulatory system process; plasma membrane; anatomical structure development; transmembrane transport; molecular transducer activity
OG_04864,FUN_022888-T1,Peve_00001730,Pocillopora_meandrina_HIv1___RNAseq.g3687.t1,three_way,82.29666666666667,FUN_022888-T1,Q8TCE6,,,,,48.3,263.0,1.1e-72,275.0,sp|Q8TCE6|DEN10_HUMAN DENN domain-containing protein 10 OS=Homo sapiens OX=9606 GN=DENND10 PE=1 SV=1,,,,,,
OG_04865,FUN_022890-T1,Peve_00001724,Pocillopora_meandrina_HIv1___RNAseq.g3688.t1,three_way,77.9365,FUN_022890-T1,Q14147,DHX34_HUMAN,,Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34) (DExH-box helicase 34),Homo sapiens (Human),53.8,1013.0,2.4e-288,993.0,sp|Q14147|DHX34_HUMAN Probable ATP-dependent RNA helicase DHX34 OS=Homo sapiens OX=9606 GN=DHX34 PE=1 SV=2,GO:0000956; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0016020; GO:0016887; GO:0042327; GO:0044877; GO:2000623,"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of phosphorylation [GO:0042327]",membrane [GO:0016020],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0016071; GO:0016787; GO:0016853; GO:0140098; GO:0140657,"RNA binding; catalytic activity; mRNA metabolic process; hydrolase activity; isomerase activity; catalytic activity, acting on RNA; ATP-dependent activity"
OG_04866,FUN_022891-T1,Peve_00001723,Pocillopora_meandrina_HIv1___RNAseq.g3689.t1,three_way,64.56,FUN_022891-T1,G4WMX4,,,,,31.4,296.0,1.2e-22,109.0,sp|G4WMX4|RYAR_TRICA RYamide receptor OS=Tribolium castaneum OX=7070 GN=RYa-R PE=2 SV=1,,,,,,
OG_04867,FUN_022892-T1,Peve_00001721,Pocillopora_meandrina_HIv1___RNAseq.g3691.t1,three_way,78.155,FUN_022892-T1,P43141,,,,,27.1,328.0,1.5e-19,98.6,sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1,,,,,,
OG_04868,FUN_022895-T1,Peve_00001718,Pocillopora_meandrina_HIv1___RNAseq.g3694.t1,three_way,68.29366666666667,FUN_022895-T1,F1RD85,LOX3A_DANRE,,Lysyl oxidase homolog 3A (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3A),Danio rerio (Zebrafish) (Brachydanio rerio),39.7,715.0,1.4e-142,508.4,sp|F1RD85|LOX3A_DANRE Lysyl oxidase homolog 3A OS=Danio rerio OX=7955 GN=loxl3a PE=2 SV=1,GO:0001968; GO:0004720; GO:0005507; GO:0005615; GO:0005634; GO:0005737; GO:0006954; GO:0016020; GO:0018057; GO:0021510; GO:0030199; GO:0030324; GO:0060021; GO:0061053; GO:0062023; GO:1905590; GO:2000329; GO:2001046,collagen fibril organization [GO:0030199]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0006954; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; nucleus; inflammatory response; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04869,FUN_022896-T1,Peve_00001719,Pocillopora_meandrina_HIv1___RNAseq.g3697.t1,three_way,53.845,,,,,,,,,,,,,,,,,
OG_04870,FUN_022897-T1,Peve_00001717,Pocillopora_meandrina_HIv1___RNAseq.g3698.t1,three_way,60.53266666666666,FUN_022897-T1,Q0VCR4,PPR3C_BOVIN,,Protein phosphatase 1 regulatory subunit 3C (Protein phosphatase 1 regulatory subunit 5) (PP1 subunit R5) (Protein targeting to glycogen) (PTG),Bos taurus (Bovine),35.8,176.0,3e-26,120.2,sp|Q0VCR4|PPR3C_BOVIN Protein phosphatase 1 regulatory subunit 3C OS=Bos taurus OX=9913 GN=PPP1R3C PE=2 SV=1,GO:0000164; GO:0005829; GO:0005977; GO:0005978; GO:0005979; GO:0008157; GO:0019903; GO:0060090; GO:2001069,glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; regulation of glycogen biosynthetic process [GO:0005979],cytosol [GO:0005829]; protein phosphatase type 1 complex [GO:0000164],glycogen binding [GO:2001069]; molecular adaptor activity [GO:0060090]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase binding [GO:0019903],GO:0005829; GO:0005975; GO:0006091; GO:0060090,cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; molecular adaptor activity
OG_04871,FUN_022899-T1,Peve_00001716,Pocillopora_meandrina_HIv1___RNAseq.g3699.t1,three_way,85.126,FUN_022899-T1,Q99LZ3,,,,,53.1,179.0,8.599999999999999e-49,194.9,sp|Q99LZ3|SLD5_MOUSE DNA replication complex GINS protein SLD5 OS=Mus musculus OX=10090 GN=Gins4 PE=1 SV=1,,,,,,
OG_04872,FUN_022900-T1,Peve_00001844,Pocillopora_meandrina_HIv1___TS.g9874.t2,three_way,78.98066666666666,FUN_022900-T1,P14735,IDE_HUMAN,,Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin),Homo sapiens (Human),57.6,531.0,2.7e-191,669.8,sp|P14735|IDE_HUMAN Insulin-degrading enzyme OS=Homo sapiens OX=9606 GN=IDE PE=1 SV=4,GO:0001540; GO:0001618; GO:0004175; GO:0004222; GO:0005524; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0008270; GO:0008286; GO:0009897; GO:0009986; GO:0010815; GO:0010992; GO:0016323; GO:0016887; GO:0019885; GO:0030163; GO:0031597; GO:0031626; GO:0032092; GO:0042277; GO:0042447; GO:0042802; GO:0042803; GO:0043171; GO:0043559; GO:0044877; GO:0045732; GO:0045861; GO:0050435; GO:0051603; GO:0070062; GO:0097242; GO:0150094; GO:1901142; GO:1901143; GO:1903715,amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-endorphin binding [GO:0031626]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270],GO:0001618; GO:0002376; GO:0003824; GO:0005615; GO:0005634; GO:0005739; GO:0005777; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"virus receptor activity; immune system process; catalytic activity; extracellular space; nucleus; mitochondrion; peroxisome; cytosol; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_04873,FUN_022902-T1,Peve_00001843,Pocillopora_meandrina_HIv1___RNAseq.g3701.t1,three_way,79.475,FUN_022902-T1,Q2KIG5,THAS_BOVIN,,Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),Bos taurus (Bovine),36.2,116.0,1.9e-13,78.6,sp|Q2KIG5|THAS_BOVIN Thromboxane-A synthase OS=Bos taurus OX=9913 GN=TBXAS1 PE=2 SV=1,GO:0001516; GO:0004497; GO:0004796; GO:0005506; GO:0005789; GO:0006690; GO:0016705; GO:0020037; GO:0036134; GO:0106256,icosanoid metabolic process [GO:0006690]; prostaglandin biosynthetic process [GO:0001516],endoplasmic reticulum membrane [GO:0005789],"12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; thromboxane-A synthase activity [GO:0004796]",GO:0003824; GO:0006629; GO:0016491; GO:0016829; GO:0016853,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity; isomerase activity
OG_04874,FUN_022903-T1,Peve_00001842,Pocillopora_meandrina_HIv1___RNAseq.g3702.t1,three_way,81.031,FUN_022903-T1,Q6ZQN7,SO4C1_HUMAN,,Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (OATP-H) (Organic anion transporter M1) (OATP-M1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20),Homo sapiens (Human),35.1,615.0,6.1e-111,403.3,sp|Q6ZQN7|SO4C1_HUMAN Solute carrier organic anion transporter family member 4C1 OS=Homo sapiens OX=9606 GN=SLCO4C1 PE=1 SV=1,GO:0005886; GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0016323; GO:0030154; GO:0035577; GO:0035579; GO:0043252; GO:0070062,cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283],azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347],GO:0005215; GO:0005886; GO:0022414; GO:0030154; GO:0043226,transporter activity; plasma membrane; reproductive process; cell differentiation; organelle
OG_04875,FUN_022906-T1,Peve_00001841,Pocillopora_meandrina_HIv1___RNAseq.g3703.t1,three_way,76.03683333333333,,,,,,,,,,,,,,,,,
OG_04876,FUN_022907-T1,Peve_00001835,Pocillopora_meandrina_HIv1___RNAseq.g3704.t2,three_way,64.9645,FUN_022907-T1,Q5TFE4,,,,,37.9,390.0,1.9e-70,268.1,sp|Q5TFE4|NT5D1_HUMAN 5'-nucleotidase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NT5DC1 PE=1 SV=1,,,,,,
OG_04877,FUN_022908-T1,Peve_00001834,Pocillopora_meandrina_HIv1___RNAseq.g3705.t1,three_way,83.53733333333334,FUN_022908-T1,Q08DA5,,,,,59.4,360.0,8.9e-119,428.3,sp|Q08DA5|PANK3_BOVIN Pantothenate kinase 3 OS=Bos taurus OX=9913 GN=PANK3 PE=2 SV=1,,,,,,
OG_04878,FUN_022909-T1,Peve_00001833,Pocillopora_meandrina_HIv1___RNAseq.g3706.t1,three_way,71.17616666666667,FUN_022909-T1,A2RSY1,KANL3_MOUSE,,KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog),Mus musculus (Mouse),49.6,516.0,4.3e-134,480.7,sp|A2RSY1|KANL3_MOUSE KAT8 regulatory NSL complex subunit 3 OS=Mus musculus OX=10090 GN=Kansl3 PE=1 SV=1,GO:0000123; GO:0000922; GO:0005654; GO:0005739; GO:0006325; GO:0044545; GO:0045893; GO:0051011; GO:0090307; GO:1903108,chromatin organization [GO:0006325]; mitotic spindle assembly [GO:0090307]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitochondrial transcription [GO:1903108],histone acetyltransferase complex [GO:0000123]; mitochondrion [GO:0005739]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],microtubule minus-end binding [GO:0051011],GO:0005654; GO:0005739; GO:0006325; GO:0006355; GO:0007010; GO:0008092; GO:0043226,nucleoplasm; mitochondrion; chromatin organization; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_04879,FUN_022913-T1,Peve_00038541,Pocillopora_meandrina_HIv1___RNAseq.g3709.t1,three_way,75.51899999999999,FUN_022913-T1,Q5M990,,,,,44.1,179.0,4.1e-37,156.4,sp|Q5M990|TTC33_XENLA Tetratricopeptide repeat protein 33 OS=Xenopus laevis OX=8355 GN=ttc33 PE=2 SV=1,,,,,,
OG_04880,FUN_022914-T1,Peve_00001826,Pocillopora_meandrina_HIv1___RNAseq.g3710.t1,three_way,80.40933333333334,FUN_022914-T1,Q63028,ADDA_RAT,,Alpha-adducin (Erythrocyte adducin subunit alpha),Rattus norvegicus (Rat),47.2,375.0,3.7e-87,323.9,sp|Q63028|ADDA_RAT Alpha-adducin OS=Rattus norvegicus OX=10116 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0005200; GO:0005516; GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006811; GO:0006884; GO:0007010; GO:0008290; GO:0014069; GO:0016020; GO:0020027; GO:0030218; GO:0030425; GO:0030507; GO:0030837; GO:0035264; GO:0042608; GO:0042803; GO:0043197; GO:0045202; GO:0045766; GO:0045807; GO:0046982; GO:0046983; GO:0048471; GO:0048873; GO:0051015; GO:0051016; GO:0051017; GO:0061629; GO:0071277; GO:0071300; GO:1903142; GO:1903393,actin filament bundle assembly [GO:0051017]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; cellular response to retinoic acid [GO:0071300]; cytoskeleton organization [GO:0007010]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; monoatomic ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endocytosis [GO:0045807]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],actin filament binding [GO:0051015]; calmodulin binding [GO:0005516]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; T cell receptor binding [GO:0042608],GO:0005198; GO:0005634; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; nucleus; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_04881,FUN_022915-T1,Peve_00001787,Pocillopora_meandrina_HIv1___RNAseq.g3711.t1,three_way,84.37066666666666,FUN_022915-T1,P55036,PSMD4_HUMAN,,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein),Homo sapiens (Human),60.6,383.0,1.1e-98,361.7,sp|P55036|PSMD4_HUMAN 26S proteasome non-ATPase regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PSMD4 PE=1 SV=1,GO:0000502; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0022624; GO:0031593; GO:0042802; GO:0043161; GO:0060090,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226; GO:0060090,RNA binding; nucleus; nucleoplasm; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_04882,FUN_022916-T1,Peve_00001780,Pocillopora_meandrina_HIv1___RNAseq.g3712.t1,three_way,72.08516666666667,,,,,,,,,,,,,,,,,
OG_04883,FUN_022917-T1,Peve_00001769,Pocillopora_meandrina_HIv1___RNAseq.g3713.t1,three_way,76.55633333333334,FUN_022917-T1,Q5VZQ5,,,,,33.1,148.0,1e-11,71.6,sp|Q5VZQ5|TEX36_HUMAN Testis-expressed protein 36 OS=Homo sapiens OX=9606 GN=TEX36 PE=1 SV=1,,,,,,
OG_04884,FUN_022918-T1,Peve_00001740,Pocillopora_meandrina_HIv1___RNAseq.g3714.t1,three_way,73.348,FUN_022918-T1,O94903,,,,,58.6,239.0,4.2e-77,289.3,sp|O94903|PLPHP_HUMAN Pyridoxal phosphate homeostasis protein OS=Homo sapiens OX=9606 GN=PLPBP PE=1 SV=1,,,,,,
OG_04885,FUN_022922-T1,Peve_00008665,Pocillopora_meandrina_HIv1___RNAseq.g3726.t1,three_way,68.77866666666667,FUN_022922-T1,Q58A42,DD3_DICDI,,Protein DD3-3,Dictyostelium discoideum (Social amoeba),33.6,661.0,3e-82,307.8,sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_04886,FUN_022926-T1,Peve_00008664,Pocillopora_meandrina_HIv1___RNAseq.g3725.t1,three_way,76.998,FUN_022926-T1,Q9UBJ2,ABCD2_HUMAN,,ATP-binding cassette sub-family D member 2 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR),Homo sapiens (Human),58.7,717.0,1.5e-234,813.9,sp|Q9UBJ2|ABCD2_HUMAN ATP-binding cassette sub-family D member 2 OS=Homo sapiens OX=9606 GN=ABCD2 PE=1 SV=1,GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0005829; GO:0006635; GO:0006636; GO:0007031; GO:0009617; GO:0015605; GO:0015910; GO:0015932; GO:0016887; GO:0032000; GO:0036109; GO:0042626; GO:0042759; GO:0042760; GO:0042803; GO:0042887; GO:0043217; GO:0043651; GO:0046982; GO:0047617; GO:0140359; GO:1900016; GO:1901570; GO:1901682; GO:1903427; GO:1990535; GO:2001280,alpha-linolenic acid metabolic process [GO:0036109]; fatty acid beta-oxidation [GO:0006635]; fatty acid derivative biosynthetic process [GO:1901570]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid import into peroxisome [GO:0015910]; myelin maintenance [GO:0043217]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; neuron projection maintenance [GO:1990535]; peroxisome organization [GO:0007031]; positive regulation of fatty acid beta-oxidation [GO:0032000]; positive regulation of unsaturated fatty acid biosynthetic process [GO:2001280]; response to bacterium [GO:0009617]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038],cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type transporter activity [GO:0140359]; amide transmembrane transporter activity [GO:0042887]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; fatty acyl-CoA hydrolase activity [GO:0047617]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; nucleobase-containing compound transmembrane transporter activity [GO:0015932]; organophosphate ester transmembrane transporter activity [GO:0015605]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sulfur compound transmembrane transporter activity [GO:1901682],GO:0003824; GO:0005215; GO:0005777; GO:0005829; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; peroxisome; cytosol; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
OG_04887,FUN_022928-T1,Peve_00004269,Pocillopora_meandrina_HIv1___RNAseq.g3731.t1,three_way,63.60333333333333,FUN_022928-T1,Q6NZC7,S23IP_MOUSE,,SEC23-interacting protein,Mus musculus (Mouse),46.8,763.0,2.5e-179,630.9,sp|Q6NZC7|S23IP_MOUSE SEC23-interacting protein OS=Mus musculus OX=10090 GN=Sec23ip PE=1 SV=2,GO:0001675; GO:0005801; GO:0007286; GO:0007338; GO:0012507; GO:0046872; GO:0048471; GO:0070971; GO:0097038,acrosome assembly [GO:0001675]; single fertilization [GO:0007338]; spermatid development [GO:0007286],cis-Golgi network [GO:0005801]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471],metal ion binding [GO:0046872],GO:0022414; GO:0043226; GO:0048856,reproductive process; organelle; anatomical structure development
OG_04888,FUN_022929-T1,Peve_00032134,Pocillopora_meandrina_HIv1___RNAseq.g3730.t1,three_way,53.774166666666666,FUN_022929-T1,Q1LVZ2,MARH2_DANRE,,E3 ubiquitin-protein ligase MARCHF2 (EC 2.3.2.27) (Membrane-associated RING finger protein 2) (Membrane-associated RING-CH protein II) (MARCH-II) (RING finger protein 172) (RING-type E3 ubiquitin transferase MARCHF2),Danio rerio (Zebrafish) (Brachydanio rerio),46.9,81.0,8.7e-15,82.4,sp|Q1LVZ2|MARH2_DANRE E3 ubiquitin-protein ligase MARCHF2 OS=Danio rerio OX=7955 GN=marchf2 PE=2 SV=1,GO:0000139; GO:0004842; GO:0005765; GO:0005783; GO:0005789; GO:0005886; GO:0006897; GO:0008270; GO:0010008; GO:0016567; GO:0030097; GO:0031410; GO:0061630,endocytosis [GO:0006897]; hemopoiesis [GO:0030097]; protein ubiquitination [GO:0016567],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005783; GO:0005886; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endoplasmic reticulum; plasma membrane; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_04889,FUN_022930-T1,Peve_00032135,Pocillopora_meandrina_HIv1___RNAseq.g3729.t1,three_way,70.59166666666667,,,,,,,,,,,,,,,,,
OG_04890,FUN_022933-T1,Peve_00016029,Pocillopora_meandrina_HIv1___RNAseq.g3734.t1,three_way,55.45366666666667,,,,,,,,,,,,,,,,,
OG_04891,FUN_022934-T1,Peve_00031537,Pocillopora_meandrina_HIv1___RNAseq.g3733.t1,three_way,81.226,FUN_022934-T1,A2RRW4,,,,,28.0,286.0,1.9e-12,74.7,sp|A2RRW4|CMI2B_DANRE Ciliary microtubule inner protein 2B OS=Danio rerio OX=7955 GN=cimip2b PE=2 SV=1,,,,,,
OG_04892,FUN_022936-T1,Peve_00016028,Pocillopora_meandrina_HIv1___RNAseq.g3735.t1,three_way,71.89616666666666,FUN_022936-T1,Q5M8W9,,,,,59.0,290.0,4.5e-99,362.8,"sp|Q5M8W9|HOGA1_XENTR 4-hydroxy-2-oxoglutarate aldolase, mitochondrial OS=Xenopus tropicalis OX=8364 GN=hoga1 PE=2 SV=2",,,,,,
OG_04893,FUN_022937-T1,Peve_00026752,Pocillopora_meandrina_HIv1___RNAseq.g3737.t1,three_way,87.12,FUN_022937-T1,P67827,KC1A_BOVIN,,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),Bos taurus (Bovine),87.7,277.0,5.1000000000000005e-145,515.4,sp|P67827|KC1A_BOVIN Casein kinase I isoform alpha OS=Bos taurus OX=9913 GN=CSNK1A1 PE=1 SV=1,GO:0000139; GO:0000776; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007165; GO:0016055; GO:0016607; GO:0018105; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1900226,cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04894,FUN_022938-T1,Peve_00026754,Pocillopora_meandrina_HIv1___RNAseq.g3738.t1,three_way,80.67833333333333,FUN_022938-T1,Q9HAN9,NMNA1_HUMAN,,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide-nucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1),Homo sapiens (Human),53.8,251.0,1.9e-71,270.4,sp|Q9HAN9|NMNA1_HUMAN Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 OS=Homo sapiens OX=9606 GN=NMNAT1 PE=1 SV=1,GO:0000309; GO:0000785; GO:0004515; GO:0005524; GO:0005634; GO:0005654; GO:0009165; GO:0009435; GO:0009611; GO:0016604; GO:0042802; GO:0043410; GO:0043524; GO:0045892; GO:0140768; GO:1902511; GO:1990535; GO:1990966,ATP generation from poly-ADP-D-ribose [GO:1990966]; NAD biosynthetic process [GO:0009435]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; neuron projection maintenance [GO:1990535]; nucleotide biosynthetic process [GO:0009165]; positive regulation of MAPK cascade [GO:0043410]; response to wounding [GO:0009611],chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0043226; GO:0055086; GO:0060090; GO:1901135,catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; organelle; nucleobase-containing small molecule metabolic process; molecular adaptor activity; carbohydrate derivative metabolic process
OG_04895,FUN_022939-T1,Peve_00026755,Pocillopora_meandrina_HIv1___RNAseq.g3742.t1,three_way,61.73183333333333,FUN_022939-T1,A8WG21,,,,,39.9,153.0,2.9e-19,97.1,sp|A8WG21|SNXAB_DANRE Sorting nexin-10B OS=Danio rerio OX=7955 GN=snx10b PE=2 SV=1,,,,,,
OG_04896,FUN_022940-T1,Peve_00001686,Pocillopora_meandrina_HIv1___RNAseq.g3744.t1,three_way,83.253,FUN_022940-T1,Q9JJX8,,,,,59.5,375.0,1.9000000000000007e-130,467.2,sp|Q9JJX8|ST32B_MOUSE Serine/threonine-protein kinase 32B OS=Mus musculus OX=10090 GN=Stk32b PE=2 SV=2,,,,,,
OG_04897,FUN_022941-T1,Peve_00001690,Pocillopora_meandrina_HIv1___RNAseq.g3745.t1,three_way,72.69833333333334,FUN_022941-T1,Q9HDY1,,,,,24.5,575.0,2.9e-24,115.2,sp|Q9HDY1|ASE1_SCHPO Anaphase spindle elongation protein 1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=ase1 PE=1 SV=1,,,,,,
OG_04898,FUN_022942-T2,Peve_00001683,Pocillopora_meandrina_HIv1___RNAseq.g3746.t1,three_way,53.5425,FUN_022942-T2,Q76NI1,KNDC1_HUMAN,,Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Cerebral protein 9) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2),Homo sapiens (Human),29.4,901.0,7e-79,298.5,sp|Q76NI1|KNDC1_HUMAN Kinase non-catalytic C-lobe domain-containing protein 1 OS=Homo sapiens OX=9606 GN=KNDC1 PE=1 SV=2,GO:0001934; GO:0005085; GO:0007264; GO:0021707; GO:0030425; GO:0032045; GO:0043025; GO:0043204; GO:0048814; GO:0050773,cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase-mediated signal transduction [GO:0007264],dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0030154; GO:0098772,cell differentiation; molecular function regulator activity
OG_04899,FUN_022944-T1,Peve_00015104,Pocillopora_meandrina_HIv1___RNAseq.g3747.t2,three_way,69.95933333333333,FUN_022944-T1,Q8BRU6,VMAT2_MOUSE,,Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2) (Vesicular monoamine transporter 2),Mus musculus (Mouse),48.6,247.0,1.4e-60,234.6,sp|Q8BRU6|VMAT2_MOUSE Synaptic vesicular amine transporter OS=Mus musculus OX=10090 GN=Slc18a2 PE=1 SV=1,GO:0001975; GO:0002552; GO:0002553; GO:0005813; GO:0007626; GO:0009636; GO:0009791; GO:0015311; GO:0030424; GO:0030425; GO:0030667; GO:0030672; GO:0042910; GO:0051610; GO:0051615; GO:0098691; GO:0098700; GO:0099123,histamine secretion by mast cell [GO:0002553]; histamine uptake [GO:0051615]; locomotory behavior [GO:0007626]; neurotransmitter loading into synaptic vesicle [GO:0098700]; post-embryonic development [GO:0009791]; response to amphetamine [GO:0001975]; response to toxic substance [GO:0009636]; serotonin secretion by mast cell [GO:0002552]; serotonin uptake [GO:0051610]; somato-dendritic dopamine secretion [GO:0099123],axon [GO:0030424]; centrosome [GO:0005813]; dendrite [GO:0030425]; dopaminergic synapse [GO:0098691]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672],monoamine:proton antiporter activity [GO:0015311]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005815,transporter activity; microtubule organizing center
OG_04900,FUN_022945-T1,Peve_00015105,Pocillopora_meandrina_HIv1___RNAseq.g3748.t1,three_way,90.02333333333334,FUN_022945-T1,E7FDB3,,,,,59.2,76.0,2e-20,100.9,sp|E7FDB3|NANO1_DANRE Nanos homolog 1 OS=Danio rerio OX=7955 GN=nanos1 PE=3 SV=1,,,,,,
OG_04901,FUN_022946-T1,Peve_00015106,Pocillopora_meandrina_HIv1___RNAseq.g3749.t1a,three_way,71.6855,FUN_022946-T1,Q5RA03,SHOT1_PONAB,,Shootin-1 (Shootin1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.6,289.0,2e-21,105.5,sp|Q5RA03|SHOT1_PONAB Shootin-1 OS=Pongo abelii OX=9601 GN=SHTN1 PE=2 SV=2,GO:0005875; GO:0006930; GO:0007265; GO:0007409; GO:0015630; GO:0030027; GO:0030175; GO:0030424; GO:0030426; GO:0031252; GO:0032488; GO:0038007; GO:0043204; GO:0044295; GO:0045773; GO:0048471; GO:0048812; GO:0051015; GO:0060327; GO:0061163; GO:0061573; GO:2000114; GO:2001224,"actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration, cell extension [GO:0006930]",axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471],actin filament binding [GO:0051015],GO:0005856; GO:0008092; GO:0043226,cytoskeleton; cytoskeletal protein binding; organelle
OG_04902,FUN_022948-T1,Peve_00005141,Pocillopora_meandrina_HIv1___RNAseq.g3749.t1b,three_way,55.449,FUN_022948-T1,O16374,GALT1_CAEEL,,"Beta-1,4-galactosyltransferase galt-1 (EC 2.4.1.-)",Caenorhabditis elegans,26.7,303.0,1.7e-26,121.7,"sp|O16374|GALT1_CAEEL Beta-1,4-galactosyltransferase galt-1 OS=Caenorhabditis elegans OX=6239 GN=galt-1 PE=1 SV=4",GO:0003831; GO:0005737; GO:0006491; GO:0016757; GO:0032580; GO:0035250; GO:0042125; GO:0043229; GO:0046872; GO:0070085,glycosylation [GO:0070085]; N-glycan processing [GO:0006491]; protein galactosylation [GO:0042125],cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; intracellular organelle [GO:0043229],"beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; glycosyltransferase activity [GO:0016757]; metal ion binding [GO:0046872]; UDP-galactosyltransferase activity [GO:0035250]",GO:0003824; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_04903,FUN_022949-T1,Peve_00005144,Pocillopora_meandrina_HIv1___TS.g9923.t1,three_way,70.34633333333333,FUN_022949-T1,Q9JIP0,TRPV5_RAT,,Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transporter 2) (CaT2) (Epithelial calcium channel 1) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3),Rattus norvegicus (Rat),27.3,598.0,1.4999999999999998e-43,179.5,sp|Q9JIP0|TRPV5_RAT Transient receptor potential cation channel subfamily V member 5 OS=Rattus norvegicus OX=10116 GN=Trpv5 PE=1 SV=1,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0016324; GO:0034704; GO:0035809; GO:0046872; GO:0051289; GO:0055074; GO:0060402; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; protein homotetramerization [GO:0051289]; regulation of urine volume [GO:0035809],apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0003014; GO:0005215; GO:0005886; GO:0055085; GO:0065003,renal system process; transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_04904,FUN_022950-T1,Peve_00005145,Pocillopora_meandrina_HIv1___TS.g9924.t1,three_way,66.84333333333333,FUN_022950-T1,Q86V86,PIM3_HUMAN,,Serine/threonine-protein kinase pim-3 (EC 2.7.11.1),Homo sapiens (Human),42.4,255.0,2.2999999999999997e-53,211.1,sp|Q86V86|PIM3_HUMAN Serine/threonine-protein kinase pim-3 OS=Homo sapiens OX=9606 GN=PIM3 PE=1 SV=3,GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007346; GO:0043066; GO:0061179; GO:0106310; GO:1904322,apoptotic process [GO:0006915]; cellular response to forskolin [GO:1904322]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005829; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; cytosol; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_04905,FUN_022951-T1,Peve_00001408,Pocillopora_meandrina_HIv1___TS.g9408.t1,three_way,68.699,,,,,,,,,,,,,,,,,
OG_04906,FUN_022955-T1,Peve_00001405,Pocillopora_meandrina_HIv1___RNAseq.17404_t,three_way,60.97516666666667,FUN_022955-T1,Q8CGI1,,,,,56.6,76.0,3.5e-19,99.0,sp|Q8CGI1|F193A_MOUSE Protein FAM193A OS=Mus musculus OX=10090 GN=Fam193a PE=1 SV=2,,,,,,
OG_04907,FUN_022957-T1,Peve_00001411,Pocillopora_meandrina_HIv1___RNAseq.g3772.t1,three_way,78.32566666666666,FUN_022957-T1,Q28BS5,,,,,41.9,148.0,1.9e-25,117.9,sp|Q28BS5|FOXF1_XENTR Forkhead box protein F1 OS=Xenopus tropicalis OX=8364 GN=foxf1 PE=2 SV=1,,,,,,
OG_04908,FUN_022958-T1,Peve_00030518,Pocillopora_meandrina_HIv1___RNAseq.g3771.t1,three_way,66.259,,,,,,,,,,,,,,,,,
OG_04909,FUN_022959-T1,Peve_00018879,Pocillopora_meandrina_HIv1___RNAseq.g3769.t1c,three_way,42.45766666666667,FUN_022959-T1,P22455,FGFR4_HUMAN,,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334),Homo sapiens (Human),27.8,198.0,5.4e-08,60.5,sp|P22455|FGFR4_HUMAN Fibroblast growth factor receptor 4 OS=Homo sapiens OX=9606 GN=FGFR4 PE=1 SV=2,GO:0005007; GO:0005524; GO:0005576; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0008201; GO:0008284; GO:0008543; GO:0010628; GO:0010715; GO:0016477; GO:0017134; GO:0018108; GO:0019216; GO:0030133; GO:0042593; GO:0042632; GO:0043085; GO:0043235; GO:0045862; GO:0046777; GO:0055062; GO:0070374; GO:0070857; GO:2000573,cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216],endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201],GO:0003824; GO:0005576; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; extracellular region; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_04910,FUN_022960-T1,Peve_00011908,Pocillopora_meandrina_HIv1___RNAseq.g3769.t1a,three_way,65.96483333333333,FUN_022960-T1,P41596,,,,,28.2,358.0,1.7e-21,105.5,sp|P41596|DOPR1_DROME Dopamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=Dop1R1 PE=2 SV=2,,,,,,
OG_04911,FUN_022963-T1,Peve_00011891,Pocillopora_meandrina_HIv1___RNAseq.g3767.t1,three_way,65.58466666666666,FUN_022963-T1,P29275,AA2BR_HUMAN,,Adenosine receptor A2b,Homo sapiens (Human),30.9,304.0,7e-20,99.8,sp|P29275|AA2BR_HUMAN Adenosine receptor A2b OS=Homo sapiens OX=9606 GN=ADORA2B PE=1 SV=1,GO:0001609; GO:0002882; GO:0004930; GO:0005886; GO:0007186; GO:0007189; GO:0007190; GO:0010575; GO:0010753; GO:0019934; GO:0032722; GO:0032755; GO:0042311; GO:0043303; GO:0043306; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171,activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; relaxation of vascular associated smooth muscle [GO:0060087]; vasodilation [GO:0042311],glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685],G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930],GO:0002376; GO:0003012; GO:0003013; GO:0005886; GO:0016192; GO:0060089,immune system process; muscle system process; circulatory system process; plasma membrane; vesicle-mediated transport; molecular transducer activity
OG_04912,FUN_022965-T1,Peve_00011899,Pocillopora_meandrina_HIv1___RNAseq.g3764.t1,three_way,81.05166666666666,FUN_022965-T1,Q6NTV9,,,,,55.1,98.0,1.2e-22,107.5,sp|Q6NTV9|NHP2_XENLA H/ACA ribonucleoprotein complex subunit 2-like protein OS=Xenopus laevis OX=8355 GN=nhp2 PE=2 SV=1,,,,,,
OG_04913,FUN_022966-T1,Peve_00011900,Pocillopora_meandrina_HIv1___RNAseq.g3763.t1,three_way,73.11233333333334,,,,,,,,,,,,,,,,,
OG_04914,FUN_022968-T1,Peve_00011901,Pocillopora_meandrina_HIv1___RNAseq.g3762.t1,three_way,74.65283333333333,FUN_022968-T1,Q14185,,,,,47.2,1635.0,0.0,1488.4,sp|Q14185|DOCK1_HUMAN Dedicator of cytokinesis protein 1 OS=Homo sapiens OX=9606 GN=DOCK1 PE=1 SV=2,,,,,,
OG_04915,FUN_022969-T1,Peve_00011904,Pocillopora_meandrina_HIv1___RNAseq.g3761.t1,three_way,71.649,FUN_022969-T1,P17124,,,,,30.7,332.0,2.2e-29,131.3,sp|P17124|HRH2_CANLF Histamine H2 receptor OS=Canis lupus familiaris OX=9615 GN=HRH2 PE=1 SV=1,,,,,,
OG_04916,FUN_022970-T1,Peve_00011906,Pocillopora_meandrina_HIv1___RNAseq.17380_t,three_way,66.845,FUN_022970-T1,Q9QYC0,ADDA_MOUSE,,Alpha-adducin (Erythrocyte adducin subunit alpha),Mus musculus (Mouse),34.7,395.0,3.5e-58,227.6,sp|Q9QYC0|ADDA_MOUSE Alpha-adducin OS=Mus musculus OX=10090 GN=Add1 PE=1 SV=2,GO:0000902; GO:0001701; GO:0003779; GO:0005200; GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0005912; GO:0006884; GO:0016020; GO:0016604; GO:0020027; GO:0030218; GO:0035264; GO:0045202; GO:0048873; GO:0071277; GO:1903142; GO:1903393,cell morphogenesis [GO:0000902]; cell volume homeostasis [GO:0006884]; cellular response to calcium ion [GO:0071277]; erythrocyte differentiation [GO:0030218]; hemoglobin metabolic process [GO:0020027]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; multicellular organism growth [GO:0035264]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of establishment of endothelial barrier [GO:1903142],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; membrane [GO:0016020]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; synapse [GO:0045202],actin binding [GO:0003779]; calmodulin binding [GO:0005516]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005856; GO:0005886; GO:0008092; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_04917,FUN_022971-T1,Peve_00011907,Pocillopora_meandrina_HIv1___RNAseq.g3757.t1,three_way,63.9935,FUN_022971-T1,A9ULG4,AUP1_XENTR,,Lipid droplet-regulating VLDL assembly factor AUP1 (Ancient ubiquitous protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),35.3,306.0,6.1e-41,169.5,sp|A9ULG4|AUP1_XENTR Lipid droplet-regulating VLDL assembly factor AUP1 OS=Xenopus tropicalis OX=8364 GN=aup1 PE=2 SV=1,GO:0005789; GO:0005811; GO:0034389; GO:0036503; GO:0043130; GO:0140042; GO:1990044,ERAD pathway [GO:0036503]; lipid droplet formation [GO:0140042]; lipid droplet organization [GO:0034389]; protein localization to lipid droplet [GO:1990044],endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811],ubiquitin binding [GO:0043130],GO:0005811; GO:0030163; GO:0043226,lipid droplet; protein catabolic process; organelle
OG_04918,FUN_022975-T1,Peve_00011910,Pocillopora_meandrina_HIv1___RNAseq.g3756.t1,three_way,72.659,FUN_022975-T1,Q20591,VA0E_CAEEL,,V-type proton ATPase subunit e (V-ATPase subunit e) (Vacuolar proton pump subunit e),Caenorhabditis elegans,45.2,73.0,2.4e-14,79.3,sp|Q20591|VA0E_CAEEL V-type proton ATPase subunit e OS=Caenorhabditis elegans OX=6239 GN=vha-17 PE=1 SV=2,GO:0009792; GO:0010172; GO:0016324; GO:0033179; GO:0033181; GO:0043296; GO:0046961; GO:0055085; GO:0060142,embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; regulation of syncytium formation by plasma membrane fusion [GO:0060142]; transmembrane transport [GO:0055085],"apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V0 domain [GO:0033179]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0048856; GO:0055085; GO:0140657,transporter activity; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_04919,FUN_022976-T1,Peve_00011912,Pocillopora_meandrina_HIv1___RNAseq.g3755.t1,three_way,63.82566666666666,,,,,,,,,,,,,,,,,
OG_04920,FUN_022978-T1,Peve_00027960,Pocillopora_meandrina_HIv1___RNAseq.g3754.t1,three_way,71.34933333333333,FUN_022978-T1,Q28FF3,,,,,41.1,436.0,3.3e-92,340.5,sp|Q28FF3|S49A3_XENTR Solute carrier family 49 member A3 OS=Xenopus tropicalis OX=8364 GN=slc49a3 PE=2 SV=2,,,,,,
OG_04921,FUN_022979-T1,Peve_00035533,Pocillopora_meandrina_HIv1___RNAseq.g3753.t1,three_way,73.28333333333333,,,,,,,,,,,,,,,,,
OG_04922,FUN_022980-T1,Peve_00043402,Pocillopora_meandrina_HIv1___RNAseq.g3752.t1,three_way,86.49766666666666,FUN_022980-T1,O00567,NOP56_HUMAN,,Nucleolar protein 56 (Nucleolar protein 5A),Homo sapiens (Human),69.4,431.0,3.2000000000000003e-170,599.7,sp|O00567|NOP56_HUMAN Nucleolar protein 56 OS=Homo sapiens OX=9606 GN=NOP56 PE=1 SV=4,GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005732; GO:0005737; GO:0006364; GO:0016020; GO:0030515; GO:0031428; GO:0032040; GO:0042274; GO:0045296; GO:0070761; GO:1990226,ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],box C/D methylation guide snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small-subunit processome [GO:0032040]; sno(s)RNA-containing ribonucleoprotein complex [GO:0005732],cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515],GO:0003723; GO:0005654; GO:0005730; GO:0043226,RNA binding; nucleoplasm; nucleolus; organelle
OG_04923,FUN_022981-T1,Peve_00043401,Pocillopora_meandrina_HIv1___RNAseq.g3751.t1,three_way,84.266,FUN_022981-T1,Q6GLT8,,,,,64.8,287.0,5.1e-114,412.1,"sp|Q6GLT8|FAHD2_XENLA Oxaloacetate tautomerase fahd2, mitochondrial OS=Xenopus laevis OX=8355 GN=fahd2 PE=2 SV=1",,,,,,
OG_04924,FUN_022988-T1,Peve_00043399,Pocillopora_meandrina_HIv1___RNAseq.g3782.t1,three_way,75.88300000000001,FUN_022988-T1,Q27245,,,,,48.8,461.0,2.1999999999999998e-112,407.5,sp|Q27245|YH24_CAEEL Putative aminopeptidase W07G4.4 OS=Caenorhabditis elegans OX=6239 GN=lap-2 PE=3 SV=1,,,,,,
OG_04925,FUN_022989-T1,Peve_00043398,Pocillopora_meandrina_HIv1___RNAseq.17408_t,three_way,75.91316666666667,FUN_022989-T1,Q8AVJ1,,,,,39.4,208.0,9.2e-32,139.0,sp|Q8AVJ1|PRR5_XENLA Proline-rich protein 5 OS=Xenopus laevis OX=8355 GN=prr5 PE=2 SV=1,,,,,,
OG_04926,FUN_022990-T1,Peve_00043397,Pocillopora_meandrina_HIv1___RNAseq.g3786.t1,three_way,90.48633333333332,FUN_022990-T1,Q5EAE3,,,,,57.6,245.0,2.4e-69,263.5,sp|Q5EAE3|UBTD2_BOVIN Ubiquitin domain-containing protein 2 OS=Bos taurus OX=9913 GN=UBTD2 PE=2 SV=1,,,,,,
OG_04927,FUN_022991-T1,Peve_00043406,Pocillopora_meandrina_HIv1___RNAseq.g3788.t2,three_way,68.32766666666667,FUN_022991-T1,Q3B7T1,EDRF1_HUMAN,,Erythroid differentiation-related factor 1,Homo sapiens (Human),38.7,1219.0,1e-200,702.2,sp|Q3B7T1|EDRF1_HUMAN Erythroid differentiation-related factor 1 OS=Homo sapiens OX=9606 GN=EDRF1 PE=1 SV=1,GO:0005634; GO:0045893,positive regulation of DNA-templated transcription [GO:0045893],nucleus [GO:0005634],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_04928,FUN_022993-T1,Peve_00043404,Pocillopora_meandrina_HIv1___RNAseq.g3789.t1,three_way,71.83366666666667,,,,,,,,,,,,,,,,,
OG_04929,FUN_022996-T2,Peve_00006906,Pocillopora_meandrina_HIv1___RNAseq.17418_t,three_way,53.84466666666667,FUN_022996-T2,Q8BTU7,,,,,30.2,400.0,1.5999999999999998e-41,171.8,sp|Q8BTU7|RCCD1_MOUSE RCC1 domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rccd1 PE=2 SV=2,,,,,,
OG_04930,FUN_022997-T1,Peve_00006903,Pocillopora_meandrina_HIv1___RNAseq.g3793.t1,three_way,49.0015,,,,,,,,,,,,,,,,,
OG_04931,FUN_022998-T1,Peve_00006898,Pocillopora_meandrina_HIv1___RNAseq.g3792.t1,three_way,50.482,,,,,,,,,,,,,,,,,
OG_04932,FUN_023000-T1,Peve_00024659,Pocillopora_meandrina_HIv1___RNAseq.g3813.t1,three_way,53.00183333333333,FUN_023000-T1,Q90Z00,FGR1A_DANRE,,Fibroblast growth factor receptor 1-A (FGFR-1-A) (bFGF-R-1-A) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1-A),Danio rerio (Zebrafish) (Brachydanio rerio),37.9,804.0,7.2e-136,486.5,sp|Q90Z00|FGR1A_DANRE Fibroblast growth factor receptor 1-A OS=Danio rerio OX=7955 GN=fgfr1a PE=1 SV=2,GO:0001889; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007498; GO:0008201; GO:0008284; GO:0008543; GO:0009953; GO:0017134; GO:0021535; GO:0021628; GO:0031101; GO:0031410; GO:0033339; GO:0036342; GO:0042664; GO:0043235; GO:0043410; GO:0043589; GO:0045471; GO:0045597; GO:0048738; GO:0048916; GO:0051216; GO:0060249; GO:0071699,anatomical structure homeostasis [GO:0060249]; cardiac muscle tissue development [GO:0048738]; cartilage development [GO:0051216]; cell migration in hindbrain [GO:0021535]; dorsal/ventral pattern formation [GO:0009953]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fin regeneration [GO:0031101]; liver development [GO:0001889]; mesoderm development [GO:0007498]; negative regulation of endodermal cell fate specification [GO:0042664]; olfactory nerve formation [GO:0021628]; olfactory placode morphogenesis [GO:0071699]; pectoral fin development [GO:0033339]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line development [GO:0048916]; response to ethanol [GO:0045471]; skin morphogenesis [GO:0043589],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_04933,FUN_023003-T1,Peve_00009969,Pocillopora_meandrina_HIv1___RNAseq.g3815.t1,three_way,63.2335,FUN_023003-T1,A9UMP7,ENO4_XENLA,,Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),Xenopus laevis (African clawed frog),27.5,462.0,7.399999999999999e-43,176.8,sp|A9UMP7|ENO4_XENLA Enolase 4 OS=Xenopus laevis OX=8355 GN=eno4 PE=2 SV=2,GO:0000015; GO:0000287; GO:0004634; GO:0006096,glycolytic process [GO:0006096],phosphopyruvate hydratase complex [GO:0000015],magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634],GO:0003824; GO:0005975; GO:0006091; GO:0016829; GO:0055086; GO:1901135,catalytic activity; carbohydrate metabolic process; generation of precursor metabolites and energy; lyase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04934,FUN_023005-T1,Peve_00010020,Pocillopora_meandrina_HIv1___TS.g9991.t1,three_way,69.04316666666666,FUN_023005-T1,Q80YS5,,,,,31.4,468.0,6.6e-10,67.0,sp|Q80YS5|LRC27_MOUSE Leucine-rich repeat-containing protein 27 OS=Mus musculus OX=10090 GN=Lrrc27 PE=2 SV=1,,,,,,
OG_04935,FUN_023006-T1,Peve_00010033,Pocillopora_meandrina_HIv1___RNAseq.g3819.t1,three_way,89.79050000000001,FUN_023006-T1,Q9Y297,FBW1A_HUMAN,,F-box/WD repeat-containing protein 1A (E3RSIkappaB) (Epididymis tissue protein Li 2a) (F-box and WD repeats protein beta-TrCP) (pIkappaBalpha-E3 receptor subunit),Homo sapiens (Human),76.5,213.0,2.4e-98,360.9,sp|Q9Y297|FBW1A_HUMAN F-box/WD repeat-containing protein 1A OS=Homo sapiens OX=9606 GN=BTRC PE=1 SV=1,GO:0000122; GO:0000209; GO:0005654; GO:0005737; GO:0005829; GO:0006470; GO:0006511; GO:0007165; GO:0008013; GO:0016055; GO:0016567; GO:0016874; GO:0019005; GO:0031146; GO:0031648; GO:0033598; GO:0038061; GO:0042752; GO:0042753; GO:0043122; GO:0043161; GO:0045309; GO:0045862; GO:0045879; GO:0045893; GO:0046983; GO:0048511; GO:0050860; GO:0051726; GO:0060444; GO:0060828; GO:0061136; GO:0061630; GO:0070936; GO:1904668; GO:1990756; GO:1990757,branching involved in mammary gland duct morphogenesis [GO:0060444]; mammary gland epithelial cell proliferation [GO:0033598]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of circadian rhythm [GO:0042752]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005],beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0016740; GO:0016874; GO:0030163; GO:0060090; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; transferase activity; ligase activity; protein catabolic process; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04936,FUN_023007-T1,Peve_00009984,Pocillopora_meandrina_HIv1___RNAseq.g3820.t1,three_way,51.1705,,,,,,,,,,,,,,,,,
OG_04937,FUN_023008-T1,Peve_00009991,Pocillopora_meandrina_HIv1___RNAseq.g3821.t1,three_way,76.93366666666667,FUN_023008-T1,O13067,,,,,36.1,757.0,6.9e-94,346.7,sp|O13067|CND2_XENLA Condensin complex subunit 2 OS=Xenopus laevis OX=8355 GN=ncaph PE=1 SV=1,,,,,,
OG_04938,FUN_023010-T1,Peve_00010013,Pocillopora_meandrina_HIv1___TS.g9998.t1,three_way,66.16799999999999,FUN_023010-T1,A8WHR0,,,,,34.1,501.0,4.2e-74,280.4,sp|A8WHR0|DCA17_DANRE DDB1- and CUL4-associated factor 17 OS=Danio rerio OX=7955 GN=dcaf17 PE=3 SV=1,,,,,,
OG_04939,FUN_023011-T1,Peve_00010014,Pocillopora_meandrina_HIv1___RNAseq.g3825.t1,three_way,91.88166666666667,FUN_023011-T1,Q3ZBL0,RUXG_BOVIN,,Small nuclear ribonucleoprotein G (snRNP-G) (Sm protein G) (Sm-G) (SmG),Bos taurus (Bovine),77.6,49.0,3.7e-16,85.5,sp|Q3ZBL0|RUXG_BOVIN Small nuclear ribonucleoprotein G OS=Bos taurus OX=9913 GN=SNRPG PE=3 SV=1,GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005683; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0034709; GO:0034719; GO:0043186; GO:0046540; GO:0071004; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; P granule [GO:0043186]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; U7 snRNP [GO:0005683],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_04940,FUN_023013-T1,Peve_00010016,Pocillopora_meandrina_HIv1___RNAseq.g3827.t1,three_way,86.635,FUN_023013-T1,Q5E9S2,,,,,61.7,94.0,3.4e-20,100.1,sp|Q5E9S2|NFYA_BOVIN Nuclear transcription factor Y subunit alpha OS=Bos taurus OX=9913 GN=NFYA PE=2 SV=1,,,,,,
OG_04941,FUN_023015-T1,Peve_00010017,Pocillopora_meandrina_HIv1___RNAseq.17453_t,three_way,39.771166666666666,,,,,,,,,,,,,,,,,
OG_04942,FUN_023017-T1,Peve_00010018,Pocillopora_meandrina_HIv1___RNAseq.g3833.t1,three_way,60.31033333333333,FUN_023017-T1,Q1PSW8,LIN41_MOUSE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Mus musculus (Mouse),21.1,313.0,9.5e-09,63.2,sp|Q1PSW8|LIN41_MOUSE E3 ubiquitin-protein ligase TRIM71 OS=Mus musculus OX=10090 GN=Trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637,3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04943,FUN_023019-T1,Peve_00010019,Pocillopora_meandrina_HIv1___RNAseq.g3834.t1,three_way,76.95366666666666,FUN_023019-T1,Q9D0B6,,,,,52.8,142.0,1e-41,171.0,sp|Q9D0B6|PBDC1_MOUSE Protein PBDC1 OS=Mus musculus OX=10090 GN=Pbdc1 PE=1 SV=1,,,,,,
OG_04944,FUN_023023-T1,Peve_00010022,Pocillopora_meandrina_HIv1___RNAseq.g3837.t1,three_way,74.59233333333333,FUN_023023-T1,Q91175,,,,,31.2,333.0,6e-37,156.4,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_04945,FUN_023026-T1,Peve_00008496,Pocillopora_meandrina_HIv1___RNAseq.g3849.t1b,three_way,70.80616666666666,FUN_023026-T1,Q86WZ0,,,,,29.6,635.0,2.2e-72,275.8,sp|Q86WZ0|HEAT4_HUMAN HEAT repeat-containing protein 4 OS=Homo sapiens OX=9606 GN=HEATR4 PE=1 SV=2,,,,,,
OG_04946,FUN_023033-T1,Peve_00008499,Pocillopora_meandrina_HIv1___RNAseq.g3855.t2,three_way,61.9305,FUN_023033-T1,O14924,,,,,29.3,1289.0,6.6e-108,394.4,sp|O14924|RGS12_HUMAN Regulator of G-protein signaling 12 OS=Homo sapiens OX=9606 GN=RGS12 PE=1 SV=1,,,,,,
OG_04947,FUN_023036-T1,Peve_00008501,Pocillopora_meandrina_HIv1___RNAseq.g3856.t1,three_way,49.26266666666667,,,,,,,,,,,,,,,,,
OG_04948,FUN_023038-T1,Peve_00008502,Pocillopora_meandrina_HIv1___RNAseq.17481_t,three_way,82.503,,,,,,,,,,,,,,,,,
OG_04949,FUN_023039-T1,Peve_00008503,Pocillopora_meandrina_HIv1___RNAseq.g3858.t1,three_way,73.10366666666667,FUN_023039-T1,B5FYQ0,ARL3_TAEGU,,ADP-ribosylation factor-like protein 3,Taeniopygia guttata (Zebra finch) (Poephila guttata),70.2,181.0,1.6e-68,260.4,sp|B5FYQ0|ARL3_TAEGU ADP-ribosylation factor-like protein 3 OS=Taeniopygia guttata OX=59729 GN=ARL3 PE=2 SV=1,GO:0000139; GO:0000281; GO:0000287; GO:0001822; GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005876; GO:0005881; GO:0005929; GO:0005930; GO:0006893; GO:0007224; GO:0007264; GO:0008017; GO:0015031; GO:0019003; GO:0030496; GO:0032391; GO:0036064; GO:0042073; GO:0042461; GO:0060271; GO:1903441,cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; mitotic cytokinesis [GO:0000281]; photoreceptor cell development [GO:0042461]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; small GTPase-mediated signal transduction [GO:0007264]; smoothened signaling pathway [GO:0007224],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; spindle microtubule [GO:0005876],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017],GO:0000910; GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005929; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0043226; GO:0044782; GO:0048856,cytokinesis; catalytic activity; GTPase activity; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; cilium; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; organelle; cilium organization; anatomical structure development
OG_04950,FUN_023040-T1,Peve_00008504,Pocillopora_meandrina_HIv1___RNAseq.g3859.t1,three_way,86.40083333333334,FUN_023040-T1,Q28479,IDH3B_MACFA,,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),57.6,337.0,1.3e-112,407.9,"sp|Q28479|IDH3B_MACFA Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial OS=Macaca fascicularis OX=9541 GN=IDH3B PE=2 SV=2",GO:0000287; GO:0005739; GO:0006099; GO:0006102; GO:0016616; GO:0051287,isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],mitochondrion [GO:0005739],"magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_04951,FUN_023041-T1,Peve_00008505,Pocillopora_meandrina_HIv1___RNAseq.g3860.t1,three_way,73.58200000000001,FUN_023041-T1,P40692,MLH1_HUMAN,,DNA mismatch repair protein Mlh1 (MutL protein homolog 1),Homo sapiens (Human),53.6,813.0,1.3e-236,820.8,sp|P40692|MLH1_HUMAN DNA mismatch repair protein Mlh1 OS=Homo sapiens OX=9606 GN=MLH1 PE=1 SV=1,GO:0000289; GO:0000712; GO:0000795; GO:0001673; GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005712; GO:0005715; GO:0006298; GO:0006303; GO:0007060; GO:0007129; GO:0007283; GO:0008047; GO:0008630; GO:0009617; GO:0016020; GO:0016321; GO:0016446; GO:0016887; GO:0019899; GO:0032137; GO:0032389; GO:0043060; GO:0045141; GO:0045190; GO:0045950; GO:0048298; GO:0048304; GO:0048477; GO:0051257; GO:0140664,double-strand break repair via nonhomologous end joining [GO:0006303]; female meiosis chromosome segregation [GO:0016321]; homologous chromosome pairing at meiosis [GO:0007129]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; isotype switching [GO:0045190]; male meiosis chromosome segregation [GO:0007060]; meiotic metaphase I homologous chromosome alignment [GO:0043060]; meiotic spindle midzone assembly [GO:0051257]; meiotic telomere clustering [GO:0045141]; mismatch repair [GO:0006298]; negative regulation of mitotic recombination [GO:0045950]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oogenesis [GO:0048477]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; resolution of meiotic recombination intermediates [GO:0000712]; response to bacterium [GO:0009617]; somatic hypermutation of immunoglobulin genes [GO:0016446]; spermatogenesis [GO:0007283],chiasma [GO:0005712]; chromosome [GO:0005694]; late recombination nodule [GO:0005715]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; guanine/thymine mispair binding [GO:0032137],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0007059; GO:0016071; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; DNA repair; DNA recombination; chromosome segregation; mRNA metabolic process; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_04952,FUN_023042-T1,Peve_00008506,Pocillopora_meandrina_HIv1___RNAseq.g3861.t1,three_way,76.38366666666667,,,,,,,,,,,,,,,,,
OG_04953,FUN_023043-T1,Peve_00008509,Pocillopora_meandrina_HIv1___RNAseq.g3862.t1,three_way,69.66266666666667,FUN_023043-T1,Q6DCF2,,,,,35.5,991.0,7.2e-163,576.2,sp|Q6DCF2|MMS19_XENLA MMS19 nucleotide excision repair protein homolog OS=Xenopus laevis OX=8355 GN=mms19 PE=2 SV=1,,,,,,
OG_04954,FUN_023044-T1,Peve_00008510,Pocillopora_meandrina_HIv1___TS.g10041.t2,three_way,72.67383333333333,FUN_023044-T1,Q01085,TIAR_HUMAN,,Nucleolysin TIAR (TIA-1-related protein),Homo sapiens (Human),41.0,373.0,1e-67,258.8,sp|Q01085|TIAR_HUMAN Nucleolysin TIAR OS=Homo sapiens OX=9606 GN=TIAL1 PE=1 SV=1,GO:0003677; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005829; GO:0006357; GO:0006915; GO:0006952; GO:0008285; GO:0010494; GO:0035332; GO:0044194; GO:0140517; GO:2000637,apoptotic process [GO:0006915]; defense response [GO:0006952]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of hippo signaling [GO:0035332]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; regulation of transcription by RNA polymerase II [GO:0006357],cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; protein-RNA adaptor activity [GO:0140517]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0005829; GO:0006355; GO:0012501; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; nucleoplasm; lysosome; vacuole; cytosol; regulation of DNA-templated transcription; programmed cell death; organelle; molecular adaptor activity
OG_04955,FUN_023045-T1,Peve_00008511,Pocillopora_meandrina_HIv1___TS.g10042.t2c,three_way,82.148,FUN_023045-T1,P45954,ACDSB_HUMAN,,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)",Homo sapiens (Human),63.8,376.0,7.7e-143,508.4,"sp|P45954|ACDSB_HUMAN Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADSB PE=1 SV=1",GO:0003853; GO:0003995; GO:0005739; GO:0005759; GO:0006550; GO:0006631; GO:0016937; GO:0042802; GO:0050660,fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; short-chain 2-methyl fatty acyl-CoA dehydrogenase activity [GO:0003853]; short-chain fatty acyl-CoA dehydrogenase activity [GO:0016937],GO:0003824; GO:0005739; GO:0006520; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; lipid metabolic process; oxidoreductase activity; organelle
OG_04956,FUN_023046-T1,Peve_00008513,Pocillopora_meandrina_HIv1___TS.g10042.t2a,three_way,84.98833333333333,FUN_023046-T1,Q9HD40,SPCS_HUMAN,,O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Liver-pancreas antigen) (LP) (SLA-p35) (SLA/LP autoantigen) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (Soluble liver antigen) (SLA) (UGA suppressor tRNA-associated protein) (tRNA(Ser/Sec)-associated antigenic protein),Homo sapiens (Human),62.7,469.0,1.6e-168,594.0,sp|Q9HD40|SPCS_HUMAN O-phosphoseryl-tRNA(Sec) selenium transferase OS=Homo sapiens OX=9606 GN=SEPSECS PE=1 SV=2,GO:0000049; GO:0001514; GO:0001717; GO:0005634; GO:0005737; GO:0005829; GO:0098621,conversion of seryl-tRNAsec to selenocys-tRNAsec [GO:0001717]; selenocysteine incorporation [GO:0001514],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],O-phosphoseryl-tRNA(Sec) selenium transferase activity [GO:0098621]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; cytosol; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_04957,FUN_023047-T1,Peve_00008514,Pocillopora_meandrina_HIv1___RNAseq.g3871.t1,three_way,45.82666666666667,FUN_023047-T1,Q6NUJ5,PWP2B_HUMAN,,PWWP domain-containing protein 2B,Homo sapiens (Human),48.9,92.0,3.3e-17,91.7,sp|Q6NUJ5|PWP2B_HUMAN PWWP domain-containing protein 2B OS=Homo sapiens OX=9606 GN=PWWP2B PE=1 SV=3,GO:0005634; GO:0005654; GO:0006338; GO:0032968; GO:0120161; GO:0120325,chromatin remodeling [GO:0006338]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of cold-induced thermogenesis [GO:0120161],nucleoplasm [GO:0005654]; nucleus [GO:0005634],NuRD complex binding [GO:0120325],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_04958,FUN_023048-T1,Peve_00008515,Pocillopora_meandrina_HIv1___RNAseq.g3872.t1,three_way,85.48266666666667,FUN_023048-T1,Q4R7T7,,,,,51.6,475.0,7.999999999999999e-141,501.9,sp|Q4R7T7|TBD_MACFA Tubulin delta chain OS=Macaca fascicularis OX=9541 GN=TUBD1 PE=2 SV=1,,,,,,
OG_04959,FUN_023050-T1,Peve_00008516,Pocillopora_meandrina_HIv1___RNAseq.g3873.t1,three_way,85.382,FUN_023050-T1,Q7M760,ZRAN1_MOUSE,,Ubiquitin thioesterase Zranb1 (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1),Mus musculus (Mouse),46.4,724.0,1.2e-185,651.4,sp|Q7M760|ZRAN1_MOUSE Ubiquitin thioesterase Zranb1 OS=Mus musculus OX=10090 GN=Zranb1 PE=2 SV=1,GO:0004843; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0007010; GO:0008270; GO:0016055; GO:0016477; GO:0022604; GO:0030177; GO:0035523; GO:0070530; GO:0070536; GO:0071947; GO:1990168,cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K63-linked deubiquitination [GO:0070536]; regulation of cell morphogenesis [GO:0022604]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0007010; GO:0016787; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton organization; hydrolase activity; organelle; cell motility; catalytic activity, acting on a protein"
OG_04960,FUN_023051-T1,Peve_00008518,Pocillopora_meandrina_HIv1___TS.g10046.t1,three_way,59.464666666666666,FUN_023051-T1,Q99ME2,,,,,28.8,1022.0,2.5e-109,398.7,sp|Q99ME2|WDR6_MOUSE tRNA (34-2'-O)-methyltransferase regulator WDR6 OS=Mus musculus OX=10090 GN=Wdr6 PE=1 SV=1,,,,,,
OG_04961,FUN_023053-T1,Peve_00027088,Pocillopora_meandrina_HIv1___RNAseq.g13314.t1,three_way,61.67966666666666,,,,,,,,,,,,,,,,,
OG_04962,FUN_023054-T2,Peve_00008519,Pocillopora_meandrina_HIv1___RNAseq.g3877.t1,three_way,70.94933333333334,FUN_023054-T2,Q9BPW9,DHRS9_HUMAN,,Dehydrogenase/reductase SDR family member 9 (EC 1.1.1.209) (EC 1.1.1.53) (3-alpha hydroxysteroid dehydrogenase) (3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Retinol dehydrogenase 15) (EC 1.1.1.105) (Short chain dehydrogenase/reductase family 9C member 4) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase) (RDH-TBE),Homo sapiens (Human),45.9,305.0,1.2e-66,255.0,sp|Q9BPW9|DHRS9_HUMAN Dehydrogenase/reductase SDR family member 9 OS=Homo sapiens OX=9606 GN=DHRS9 PE=1 SV=1,GO:0004022; GO:0004745; GO:0005789; GO:0008202; GO:0008209; GO:0016491; GO:0016854; GO:0030855; GO:0042448; GO:0042572; GO:0042904; GO:0043231; GO:0047023; GO:0047035; GO:0047044,9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"alcohol dehydrogenase (NAD+) activity [GO:0004022]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; oxidoreductase activity [GO:0016491]; racemase and epimerase activity [GO:0016854]; testosterone dehydrogenase (NAD+) activity [GO:0047035]",GO:0003824; GO:0006629; GO:0016491; GO:0016853; GO:0030154; GO:0043226,catalytic activity; lipid metabolic process; oxidoreductase activity; isomerase activity; cell differentiation; organelle
OG_04963,FUN_023062-T1,Peve_00024671,Pocillopora_meandrina_HIv1___RNAseq.g3881.t1,three_way,72.876,,,,,,,,,,,,,,,,,
OG_04964,FUN_023063-T1,Peve_00024670,Pocillopora_meandrina_HIv1___RNAseq.g3882.t1,three_way,80.55416666666666,FUN_023063-T1,Q66L33,,,,,68.8,192.0,2.0000000000000002e-75,283.9,sp|Q66L33|MK16A_XENLA Protein MAK16 homolog A OS=Xenopus laevis OX=8355 GN=mak16-a PE=2 SV=1,,,,,,
OG_04965,FUN_023064-T1,Peve_00024668,Pocillopora_meandrina_HIv1___RNAseq.g3883.t1,three_way,87.05566666666667,FUN_023064-T1,P43249,,,,,62.2,566.0,1.8e-203,710.3,sp|P43249|GRK5_BOVIN G protein-coupled receptor kinase 5 OS=Bos taurus OX=9913 GN=GRK5 PE=1 SV=1,,,,,,
OG_04966,FUN_023066-T1,Peve_00024667,Pocillopora_meandrina_HIv1___RNAseq.g3884.t2,three_way,87.49933333333333,FUN_023066-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),46.5,2103.0,0.0,1895.2,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_04967,FUN_023071-T1,Peve_00024666,Pocillopora_meandrina_HIv1___RNAseq.g3885.t1,three_way,75.79416666666665,FUN_023071-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),47.7,1884.0,0.0,1799.3,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_04968,FUN_023073-T1,Peve_00014063,Pocillopora_meandrina_HIv1___RNAseq.g1646.t2,three_way,77.28333333333333,FUN_023073-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),42.4,2171.0,0.0,1587.8,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_04969,FUN_023074-T1,Peve_00014065,Pocillopora_meandrina_HIv1___RNAseq.g1647.t1,three_way,71.61066666666666,FUN_023074-T1,Q8NBF2,,,,,51.1,704.0,3.9e-195,682.9,sp|Q8NBF2|NHLC2_HUMAN NHL repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=NHLRC2 PE=1 SV=1,,,,,,
OG_04970,FUN_023076-T1,Peve_00001942,Pocillopora_meandrina_HIv1___RNAseq.g1652.t1,three_way,73.28766666666667,FUN_023076-T1,Q5ZKD5,,,,,42.4,1270.0,1.4e-269,931.0,sp|Q5ZKD5|RRP12_CHICK RRP12-like protein OS=Gallus gallus OX=9031 GN=RRP12 PE=2 SV=1,,,,,,
OG_04971,FUN_023078-T1,Peve_00001941,Pocillopora_meandrina_HIv1___RNAseq.g1653.t1,three_way,54.835,FUN_023078-T1,Q98982,,,,,26.8,336.0,8.899999999999999e-24,112.8,sp|Q98982|NK1R_AQUCT Substance-P receptor OS=Aquarana catesbeiana OX=8400 GN=TACR1 PE=2 SV=1,,,,,,
OG_04972,FUN_023079-T1,Peve_00038939,Pocillopora_meandrina_HIv1___RNAseq.g1654.t1,three_way,68.149,FUN_023079-T1,Q09326,MGAT2_RAT,,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)",Rattus norvegicus (Rat),42.2,417.0,1.4e-95,351.7,"sp|Q09326|MGAT2_RAT Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Rattus norvegicus OX=10116 GN=Mgat2 PE=1 SV=1",GO:0000139; GO:0005795; GO:0006487; GO:0008455; GO:0009312; GO:0015934; GO:0018279; GO:0030145; GO:0030246; GO:0042803; GO:0098556,oligosaccharide biosynthetic process [GO:0009312]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; large ribosomal subunit [GO:0015934],"alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0008455]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]",GO:0003824; GO:0005975; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04973,FUN_023080-T1,Peve_00038940,Pocillopora_meandrina_HIv1___RNAseq.g1655.t1,three_way,72.83166666666666,FUN_023080-T1,Q28EX9,UBCP1_XENTR,,Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),65.9,232.0,9e-83,308.1,sp|Q28EX9|UBCP1_XENTR Ubiquitin-like domain-containing CTD phosphatase 1 OS=Xenopus tropicalis OX=8364 GN=ublcp1 PE=2 SV=1,GO:0004722; GO:0005634; GO:0046872; GO:0090364,regulation of proteasome assembly [GO:0090364],nucleus [GO:0005634],metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_04974,FUN_023081-T1,Peve_00038942,Pocillopora_meandrina_HIv1___RNAseq.g1656.t1,three_way,77.20400000000001,,,,,,,,,,,,,,,,,
OG_04975,FUN_023083-T1,Peve_00001935,Pocillopora_meandrina_HIv1___RNAseq.g1659.t1,three_way,45.626,FUN_023083-T1,G4WMX4,,,,,26.9,335.0,6.6e-24,113.2,sp|G4WMX4|RYAR_TRICA RYamide receptor OS=Tribolium castaneum OX=7070 GN=RYa-R PE=2 SV=1,,,,,,
OG_04976,FUN_023085-T1,Peve_00027837,Pocillopora_meandrina_HIv1___RNAseq.g1661.t1,three_way,55.247166666666665,FUN_023085-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),30.7,313.0,4.7e-31,137.1,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_04977,FUN_023086-T1,Peve_00037477,Pocillopora_meandrina_HIv1___TS.g4174.t3,three_way,63.9085,FUN_023086-T1,Q9Y251,HPSE_HUMAN,,Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit],Homo sapiens (Human),40.4,498.0,6.6e-93,342.8,sp|Q9Y251|HPSE_HUMAN Heparanase OS=Homo sapiens OX=9606 GN=HPSE PE=1 SV=2,GO:0004566; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005765; GO:0006029; GO:0007160; GO:0010575; GO:0030194; GO:0030200; GO:0030202; GO:0030305; GO:0031012; GO:0033690; GO:0035580; GO:0043202; GO:0043231; GO:0045121; GO:0045545; GO:0046677; GO:0051797; GO:0051798; GO:0051897; GO:0060055; GO:0061028; GO:0061042; GO:0071806,angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; establishment of endothelial barrier [GO:0061028]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; positive regulation of blood coagulation [GO:0030194]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein transmembrane transport [GO:0071806]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; response to antibiotic [GO:0046677]; vascular wound healing [GO:0061042],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580],beta-glucuronidase activity [GO:0004566]; heparanase activity [GO:0030305]; syndecan binding [GO:0045545],GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0007155; GO:0016787; GO:0030163; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0055085; GO:1901135,catalytic activity; extracellular region; extracellular space; nucleus; nucleoplasm; lysosome; vacuole; cell adhesion; hydrolase activity; protein catabolic process; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; transmembrane transport; carbohydrate derivative metabolic process
OG_04978,FUN_023097-T1,Peve_00006987,Pocillopora_meandrina_HIv1___RNAseq.g1671.t1,three_way,63.32366666666667,FUN_023097-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),43.6,140.0,6.5e-25,116.3,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_04979,FUN_023099-T1,Peve_00006979,Pocillopora_meandrina_HIv1___TS.g4182.t1,three_way,64.4485,FUN_023099-T1,P55115,,,,,34.9,278.0,7e-41,171.0,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_04980,FUN_023100-T1,Peve_00006982,Pocillopora_meandrina_HIv1___RNAseq.g1675.t1,three_way,70.84949999999999,FUN_023100-T1,Q32L68,,,,,52.3,109.0,1.1e-22,109.4,sp|Q32L68|HM20B_BOVIN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related OS=Bos taurus OX=9913 GN=HMG20B PE=2 SV=1,,,,,,
OG_04981,FUN_023108-T1,Peve_00038931,Pocillopora_meandrina_HIv1___RNAseq.g1687.t1,three_way,51.39366666666667,FUN_023108-T1,Q9JME2,CHSTB_MOUSE,,Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1),Mus musculus (Mouse),37.0,265.0,1.1e-43,178.7,sp|Q9JME2|CHSTB_MOUSE Carbohydrate sulfotransferase 11 OS=Mus musculus OX=10090 GN=Chst11 PE=2 SV=1,GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050650; GO:0050654; GO:0050659; GO:0051216,apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; chondroitin sulfate proteoglycan metabolic process [GO:0050654]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179],Golgi membrane [GO:0000139],chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005975; GO:0009101; GO:0012501; GO:0016740; GO:0048856; GO:1901135,catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; programmed cell death; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_04982,FUN_023109-T1,Peve_00001973,Pocillopora_meandrina_HIv1___RNAseq.g1688.t1,three_way,60.158,FUN_023109-T1,Q5VV63,ATRN1_HUMAN,,Attractin-like protein 1,Homo sapiens (Human),32.3,1320.0,4.1e-183,643.7,sp|Q5VV63|ATRN1_HUMAN Attractin-like protein 1 OS=Homo sapiens OX=9606 GN=ATRNL1 PE=1 SV=2,GO:0005112; GO:0007186; GO:0016020; GO:0030246,G protein-coupled receptor signaling pathway [GO:0007186],membrane [GO:0016020],carbohydrate binding [GO:0030246]; Notch binding [GO:0005112],,
OG_04983,FUN_023110-T1,Peve_00000494,Pocillopora_meandrina_HIv1___RNAseq.g1701.t2,three_way,63.913,FUN_023110-T1,Q8IUR6,,,,,61.0,59.0,2e-11,71.6,sp|Q8IUR6|CRERF_HUMAN CREB3 regulatory factor OS=Homo sapiens OX=9606 GN=CREBRF PE=1 SV=2,,,,,,
OG_04984,FUN_023111-T1,Peve_00045023,Pocillopora_meandrina_HIv1___RNAseq.g1700.t1,three_way,62.512,FUN_023111-T1,A7MB10,,,,,36.0,1929.0,1.9e-291,1004.2,sp|A7MB10|RRP5_BOVIN Protein RRP5 homolog OS=Bos taurus OX=9913 GN=PDCD11 PE=2 SV=1,,,,,,
OG_04985,FUN_023112-T1,Peve_00045022,Pocillopora_meandrina_HIv1___RNAseq.g1699.t1,three_way,49.251,,,,,,,,,,,,,,,,,
OG_04986,FUN_023113-T1,Peve_00045019,Pocillopora_meandrina_HIv1___RNAseq.g1698.t1,three_way,71.10633333333334,FUN_023113-T1,Q5ZJN2,RB11A_CHICK,,Ras-related protein Rab-11A (EC 3.6.5.2),Gallus gallus (Chicken),52.4,233.0,3.8e-62,239.6,sp|Q5ZJN2|RB11A_CHICK Ras-related protein Rab-11A OS=Gallus gallus OX=9031 GN=RAB11A PE=2 SV=1,GO:0000139; GO:0003924; GO:0003925; GO:0005525; GO:0005794; GO:0006887; GO:0030133; GO:0030666; GO:0032154; GO:0032402; GO:0032588; GO:0045335; GO:0055038; GO:0061512; GO:0098837; GO:0098887; GO:1902017; GO:1902954; GO:1904779; GO:2001135,"exocytosis [GO:0006887]; melanosome transport [GO:0032402]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of early endosome to recycling endosome transport [GO:1902954]; regulation of endocytic recycling [GO:2001135]; regulation of protein localization to centrosome [GO:1904779]",cleavage furrow [GO:0032154]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; transport vesicle [GO:0030133],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005794; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0072659; GO:0098772,catalytic activity; GTPase activity; endosome; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; protein localization to plasma membrane; molecular function regulator activity
OG_04987,FUN_023115-T1,Peve_00045026,Pocillopora_meandrina_HIv1___RNAseq.g1697.t1,three_way,82.82133333333333,,,,,,,,,,,,,,,,,
OG_04988,FUN_023118-T1,Peve_00045010,Pocillopora_meandrina_HIv1___RNAseq.g1695.t1,three_way,60.8045,FUN_023118-T1,Q80UN9,MOD5_MOUSE,,tRNA dimethylallyltransferase (EC 2.5.1.75) (Isopentenyl-diphosphate:tRNA isopentenyltransferase) (IPP transferase) (IPPT) (tRNA isopentenyltransferase) (IPTase),Mus musculus (Mouse),39.0,516.0,1.6e-92,341.7,sp|Q80UN9|MOD5_MOUSE tRNA dimethylallyltransferase OS=Mus musculus OX=10090 GN=Trit1 PE=1 SV=2,GO:0005524; GO:0005634; GO:0005739; GO:0006400; GO:0008270; GO:0052381; GO:0070900,mitochondrial tRNA modification [GO:0070900]; tRNA modification [GO:0006400],mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; tRNA dimethylallyltransferase activity [GO:0052381]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005739; GO:0006399; GO:0016740; GO:0043226; GO:0140053; GO:0140098,"catalytic activity; nucleus; mitochondrion; tRNA metabolic process; transferase activity; organelle; mitochondrial gene expression; catalytic activity, acting on RNA"
OG_04989,FUN_023119-T1,Peve_00021102,Pocillopora_meandrina_HIv1___RNAseq.g1692.t1,three_way,61.756166666666665,FUN_023119-T1,Q92547,TOPB1_HUMAN,,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),Homo sapiens (Human),33.8,1669.0,2e-207,724.9,sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens OX=9606 GN=TOPBP1 PE=1 SV=3,GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166,broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212],actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922],chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0000228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0005856; GO:0005886; GO:0006281; GO:0006310; GO:0043226; GO:0060090; GO:0098772,nuclear chromosome; DNA binding; nucleus; nucleoplasm; chromosome; microtubule organizing center; cytoskeleton; plasma membrane; DNA repair; DNA recombination; organelle; molecular adaptor activity; molecular function regulator activity
OG_04990,FUN_023120-T1,Peve_00021101,Pocillopora_meandrina_HIv1___RNAseq.g1691.t1,three_way,66.651,,,,,,,,,,,,,,,,,
OG_04991,FUN_023121-T1,Peve_00021100,Pocillopora_meandrina_HIv1___RNAseq.g1690.t1,three_way,75.82333333333334,FUN_023121-T1,Q4VBI7,STX18_DANRE,,Syntaxin-18,Danio rerio (Zebrafish) (Brachydanio rerio),56.5,322.0,4.9000000000000004e-86,319.3,sp|Q4VBI7|STX18_DANRE Syntaxin-18 OS=Danio rerio OX=7955 GN=stx18 PE=2 SV=1,GO:0005484; GO:0005783; GO:0005789; GO:0006886; GO:0006890; GO:0031201,"intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SNARE complex [GO:0031201],SNAP receptor activity [GO:0005484],GO:0005783; GO:0006886; GO:0016192; GO:0043226; GO:0060090,endoplasmic reticulum; intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity
OG_04992,FUN_023122-T1,Peve_00021098,Pocillopora_meandrina_HIv1___RNAseq.g1689.t1,three_way,60.922666666666665,FUN_023122-T1,Q9VY86,,,,,61.6,151.0,2.1e-52,206.8,sp|Q9VY86|TM2D2_DROME TM2 domain-containing protein amaretto OS=Drosophila melanogaster OX=7227 GN=amrt PE=2 SV=3,,,,,,
OG_04993,FUN_023123-T1,Peve_00028445,Pocillopora_meandrina_HIv1___RNAseq.g1762.t1,three_way,56.01433333333333,,,,,,,,,,,,,,,,,
OG_04994,FUN_023126-T1,Peve_00025716,Pocillopora_meandrina_HIv1___RNAseq.g1765.t1,three_way,50.372,FUN_023126-T1,Q9JKF4,CLC6A_MOUSE,,C-type lectin domain family 6 member A (C-type lectin superfamily member 10) (Dendritic cell-associated C-type lectin 2) (DC-associated C-type lectin 2) (Dectin-2),Mus musculus (Mouse),28.7,136.0,1.4e-11,71.6,sp|Q9JKF4|CLC6A_MOUSE C-type lectin domain family 6 member A OS=Mus musculus OX=10090 GN=Clec6a PE=1 SV=1,GO:0001819; GO:0001878; GO:0001879; GO:0002223; GO:0002250; GO:0005509; GO:0005537; GO:0005886; GO:0030246; GO:0038187; GO:0043123; GO:0045087; GO:0050832; GO:0061760; GO:1902533; GO:2000318,adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; defense response to fungus [GO:0050832]; detection of yeast [GO:0001879]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production [GO:0001819]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of T-helper 17 type immune response [GO:2000318]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; D-mannose binding [GO:0005537]; pattern recognition receptor activity [GO:0038187],GO:0002376; GO:0005886; GO:0060089; GO:0098542,immune system process; plasma membrane; molecular transducer activity; defense response to other organism
OG_04995,FUN_023127-T1,Peve_00011778,Pocillopora_meandrina_HIv1___RNAseq.g1757.t1,three_way,70.8965,FUN_023127-T1,P42859,,,,,34.8,3196.0,0.0,1587.0,sp|P42859|HD_MOUSE Huntingtin OS=Mus musculus OX=10090 GN=Htt PE=1 SV=2,,,,,,
OG_04996,FUN_023129-T1,Peve_00011777,Pocillopora_meandrina_HIv1___RNAseq.g1756.t1,three_way,68.69866666666667,,,,,,,,,,,,,,,,,
OG_04997,FUN_023132-T1,Peve_00008526,Pocillopora_meandrina_HIv1___RNAseq.g1755.t1,three_way,43.72866666666667,FUN_023132-T1,O16264,,,,,38.7,75.0,4.9e-09,62.4,sp|O16264|PEBPH_CAEEL Phosphatidylethanolamine-binding protein homolog F40A3.3 OS=Caenorhabditis elegans OX=6239 GN=F40A3.3 PE=3 SV=1,,,,,,
OG_04998,FUN_023133-T1,Peve_00008525,Pocillopora_meandrina_HIv1___RNAseq.g1754.t1,three_way,68.886,FUN_023133-T1,Q9EPZ8,,,,,36.0,663.0,6.6e-106,386.3,sp|Q9EPZ8|RN103_RAT E3 ubiquitin-protein ligase RNF103 OS=Rattus norvegicus OX=10116 GN=Rnf103 PE=2 SV=1,,,,,,
OG_04999,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05000,FUN_023136-T1,Peve_00008523,Pocillopora_meandrina_HIv1___RNAseq.g1752.t1,three_way,64.003,,,,,,,,,,,,,,,,,
OG_05001,FUN_023137-T1,Peve_00008522,Pocillopora_meandrina_HIv1___RNAseq.g1751.t1,three_way,83.42833333333333,FUN_023137-T1,Q9Z2X8,KEAP1_MOUSE,,Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2),Mus musculus (Mouse),32.2,391.0,2.2e-55,218.4,sp|Q9Z2X8|KEAP1_MOUSE Kelch-like ECH-associated protein 1 OS=Mus musculus OX=10090 GN=Keap1 PE=1 SV=1,GO:0000122; GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006355; GO:0006511; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0032991; GO:0034451; GO:0034599; GO:0042802; GO:0043161; GO:0045604; GO:0061629; GO:0071353; GO:0097718; GO:0140416; GO:1902883; GO:1990756,cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511],actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005783; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleoplasm; endoplasmic reticulum; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_05002,FUN_023138-T1,Peve_00042474,Pocillopora_meandrina_HIv1___RNAseq.g1750.t1,three_way,71.85766666666667,,,,,,,,,,,,,,,,,
OG_05003,FUN_023139-T1,Peve_00042477,Pocillopora_meandrina_HIv1___RNAseq.g1749.t1,three_way,49.72316666666666,FUN_023139-T1,P70399,TP53B_MOUSE,,TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),Mus musculus (Mouse),27.4,559.0,4.8e-43,179.1,sp|P70399|TP53B_MOUSE TP53-binding protein 1 OS=Mus musculus OX=10090 GN=Tp53bp1 PE=1 SV=3,GO:0000776; GO:0000781; GO:0002039; GO:0003684; GO:0003712; GO:0005634; GO:0005657; GO:0005737; GO:0006281; GO:0006303; GO:0006355; GO:0006974; GO:0016604; GO:0035064; GO:0035861; GO:0042162; GO:0043565; GO:0045830; GO:0045944; GO:0051260; GO:0061629; GO:0061649; GO:0071481; GO:0097680; GO:0140005; GO:0140941; GO:1990166; GO:1990391; GO:2000042,cellular response to X-ray [GO:0071481]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of isotype switching [GO:0045830]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; protein localization to site of double-strand break [GO:1990166]; regulation of DNA-templated transcription [GO:0006355],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",damaged DNA binding [GO:0003684]; histone H4K20me methyltransferase activity [GO:0140941]; histone H4K20me2 reader activity [GO:0140005]; methylated histone binding [GO:0035064]; p53 binding [GO:0002039]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; telomeric DNA binding [GO:0042162]; transcription coregulator activity [GO:0003712]; ubiquitin-modified histone reader activity [GO:0061649],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; DNA repair; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_05004,FUN_023140-T1,Peve_00042480,Pocillopora_meandrina_HIv1___RNAseq.g1748.t1,three_way,90.46233333333332,FUN_023140-T1,Q9YGD2,,,,,79.1,292.0,6.5e-136,485.0,"sp|Q9YGD2|SUCA_COLLI Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (Fragment) OS=Columba livia OX=8932 GN=SUCLG1 PE=1 SV=1",,,,,,
OG_05005,FUN_023153-T1,Peve_00014158,Pocillopora_meandrina_HIv1___RNAseq.g17694.t1,three_way,72.7995,FUN_023153-T1,Q9Y2H2,SAC2_HUMAN,,Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2),Homo sapiens (Human),48.1,774.0,2e-204,714.5,sp|Q9Y2H2|SAC2_HUMAN Phosphatidylinositide phosphatase SAC2 OS=Homo sapiens OX=9606 GN=INPP5F PE=1 SV=3,GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0043231; GO:0043491; GO:0043812; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135,adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135],axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037],inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803],GO:0003012; GO:0003824; GO:0005768; GO:0006629; GO:0016192; GO:0016787; GO:0031410; GO:0043226,muscle system process; catalytic activity; endosome; lipid metabolic process; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_05006,FUN_023156-T1,Peve_00017446,Pocillopora_meandrina_HIv1___RNAseq.g12683.t1,three_way,83.89033333333333,FUN_023156-T1,Q8VC12,,,,,73.1,439.0,8.5e-185,647.9,sp|Q8VC12|HUTU_MOUSE Urocanate hydratase OS=Mus musculus OX=10090 GN=Uroc1 PE=1 SV=2,,,,,,
OG_05007,FUN_023157-T1,Peve_00017447,Pocillopora_meandrina_HIv1___RNAseq.g12682.t1,three_way,76.46433333333333,FUN_023157-T1,A7YWP4,HUTH_BOVIN,,Histidine ammonia-lyase (Histidase) (EC 4.3.1.3),Bos taurus (Bovine),62.6,642.0,4.4e-222,772.3,sp|A7YWP4|HUTH_BOVIN Histidine ammonia-lyase OS=Bos taurus OX=9913 GN=HAL PE=2 SV=1,GO:0004397; GO:0005737; GO:0006548; GO:0019556; GO:0019557,L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557],cytoplasm [GO:0005737],histidine ammonia-lyase activity [GO:0004397],GO:0003824; GO:0006520; GO:0016829,catalytic activity; amino acid metabolic process; lyase activity
OG_05008,FUN_023159-T1,Peve_00018798,Pocillopora_meandrina_HIv1___RNAseq.g640.t1,three_way,86.96466666666667,FUN_023159-T1,O00909,ARF1_DICDI,,ADP-ribosylation factor 1 (EC 3.6.5.2),Dictyostelium discoideum (Social amoeba),82.2,180.0,4.5e-84,312.0,sp|O00909|ARF1_DICDI ADP-ribosylation factor 1 OS=Dictyostelium discoideum OX=44689 GN=arfA PE=1 SV=3,GO:0000281; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0045335; GO:0048471; GO:0051489; GO:0140220,intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; regulation of filopodium assembly [GO:0051489]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; pathogen-containing vacuole [GO:0140220]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0000910; GO:0003824; GO:0003924; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226,cytokinesis; catalytic activity; GTPase activity; Golgi apparatus; cytosol; plasma membrane; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_05009,FUN_023160-T2,Peve_00018797,Pocillopora_meandrina_HIv1___RNAseq.g641.t1,three_way,62.85266666666667,,,,,,,,,,,,,,,,,
OG_05010,FUN_023162-T1,Peve_00018796,Pocillopora_meandrina_HIv1___TS.g25340.t2b,three_way,66.74266666666666,FUN_023162-T1,Q6BEA2,PRS27_RAT,,Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin),Rattus norvegicus (Rat),41.8,256.0,1.7e-54,214.5,sp|Q6BEA2|PRS27_RAT Serine protease 27 OS=Rattus norvegicus OX=10116 GN=Prss27 PE=2 SV=1,GO:0004252; GO:0005576; GO:0005886; GO:0006508,proteolysis [GO:0006508],extracellular region [GO:0005576]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_05011,FUN_023163-T1,Peve_00018795,Pocillopora_meandrina_HIv1___TS.g25340.t2c,three_way,74.67866666666667,FUN_023163-T1,Q8K4G5,ABLM1_MOUSE,,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1),Mus musculus (Mouse),48.6,253.0,8.9e-78,292.0,sp|Q8K4G5|ABLM1_MOUSE Actin-binding LIM protein 1 OS=Mus musculus OX=10090 GN=Ablim1 PE=1 SV=1,GO:0001725; GO:0003779; GO:0005737; GO:0006366; GO:0007010; GO:0007411; GO:0014069; GO:0015629; GO:0030027; GO:0030032; GO:0045944; GO:0046872; GO:0060271,axon guidance [GO:0007411]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription by RNA polymerase II [GO:0006366],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; postsynaptic density [GO:0014069]; stress fiber [GO:0001725],actin binding [GO:0003779]; metal ion binding [GO:0046872],GO:0005856; GO:0006351; GO:0006355; GO:0007010; GO:0008092; GO:0043226; GO:0044782,cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_05012,FUN_023164-T1,Peve_00018800,Pocillopora_meandrina_HIv1___TS.g25341.t1b,three_way,66.82433333333334,,,,,,,,,,,,,,,,,
OG_05013,FUN_023172-T1,Peve_00009974,Pocillopora_meandrina_HIv1___TS.g25349.t1,three_way,75.821,,,,,,,,,,,,,,,,,
OG_05014,FUN_023173-T1,Peve_00009976,Pocillopora_meandrina_HIv1___TS.g25350.t1,three_way,83.18433333333333,FUN_023173-T1,O93309,SMC3_XENLA,,Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3),Xenopus laevis (African clawed frog),50.2,630.0,2.6e-150,533.9,sp|O93309|SMC3_XENLA Structural maintenance of chromosomes protein 3 OS=Xenopus laevis OX=8355 GN=smc3 PE=1 SV=2,GO:0000775; GO:0000785; GO:0003690; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0007064; GO:0016887; GO:0030892; GO:0030893; GO:0051301; GO:0051321,cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; regulation of DNA replication [GO:0006275],"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0022414; GO:0043226,DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; reproductive process; organelle
OG_05015,FUN_023177-T1,Peve_00009975,Pocillopora_meandrina_HIv1___RNAseq.g656.t1,three_way,61.85766666666667,FUN_023177-T1,Q9LJR3,SPA3_ARATH,,Protein SPA1-RELATED 3,Arabidopsis thaliana (Mouse-ear cress),24.5,143.0,4.2e-06,53.9,sp|Q9LJR3|SPA3_ARATH Protein SPA1-RELATED 3 OS=Arabidopsis thaliana OX=3702 GN=SPA3 PE=1 SV=1,GO:0004672; GO:0005524; GO:0005634; GO:0009585; GO:0009640; GO:0042802,"photomorphogenesis [GO:0009640]; red, far-red light phototransduction [GO:0009585]",nucleus [GO:0005634],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05016,FUN_023178-T1,Peve_00009977,Pocillopora_meandrina_HIv1___RNAseq.g659.t2,three_way,55.161,FUN_023178-T1,Q8WY21,SORC1_HUMAN,,VPS10 domain-containing receptor SorCS1 (hSorCS),Homo sapiens (Human),28.4,989.0,4.4e-95,351.3,sp|Q8WY21|SORC1_HUMAN VPS10 domain-containing receptor SorCS1 OS=Homo sapiens OX=9606 GN=SORCS1 PE=1 SV=3,GO:0005794; GO:0006892; GO:0007218; GO:0008188; GO:0016020,neuropeptide signaling pathway [GO:0007218]; post-Golgi vesicle-mediated transport [GO:0006892],Golgi apparatus [GO:0005794]; membrane [GO:0016020],neuropeptide receptor activity [GO:0008188],GO:0005794; GO:0016192; GO:0043226; GO:0060089,Golgi apparatus; vesicle-mediated transport; organelle; molecular transducer activity
OG_05017,FUN_023180-T1,Peve_00009979,Pocillopora_meandrina_HIv1___RNAseq.g661.t1,three_way,65.57166666666666,FUN_023180-T1,Q2NL37,BCCIP_BOVIN,,BRCA2 and CDKN1A-interacting protein,Bos taurus (Bovine),30.5,272.0,2.3e-30,134.4,sp|Q2NL37|BCCIP_BOVIN BRCA2 and CDKN1A-interacting protein OS=Bos taurus OX=9913 GN=BCCIP PE=2 SV=1,GO:0000226; GO:0005634; GO:0005737; GO:0005813; GO:0005814; GO:0006281; GO:0007052; GO:0034453; GO:0090307; GO:0097431,DNA repair [GO:0006281]; microtubule anchoring [GO:0034453]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634],,GO:0005634; GO:0005815; GO:0006281; GO:0007010; GO:0043226,nucleus; microtubule organizing center; DNA repair; cytoskeleton organization; organelle
OG_05018,FUN_023181-T1,Peve_00009980,Pocillopora_meandrina_HIv1___RNAseq.g662.t1,three_way,72.565,FUN_023181-T1,Q8R0X2,,,,,46.7,225.0,3.5999999999999986e-55,216.5,sp|Q8R0X2|CACL1_MOUSE CDK2-associated and cullin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cacul1 PE=2 SV=1,,,,,,
OG_05019,FUN_023182-T1,Peve_00009981,Pocillopora_meandrina_HIv1___RNAseq.g663.t1,three_way,81.25466666666667,FUN_023182-T1,Q58CW5,,,,,33.8,293.0,2.4e-40,167.5,sp|Q58CW5|SERC2_BOVIN Serine incorporator 2 OS=Bos taurus OX=9913 GN=SERINC2 PE=2 SV=1,,,,,,
OG_05020,FUN_023183-T1,Peve_00009982,Pocillopora_meandrina_HIv1___RNAseq.g664.t1,three_way,89.54533333333333,FUN_023183-T1,Q7Z7H5,TMED4_HUMAN,,Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3),Homo sapiens (Human),75.1,213.0,5.4999999999999995e-92,338.6,sp|Q7Z7H5|TMED4_HUMAN Transmembrane emp24 domain-containing protein 4 OS=Homo sapiens OX=9606 GN=TMED4 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005793; GO:0005794; GO:0006886; GO:0006888; GO:0007030; GO:0030134; GO:0043123,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794],,GO:0005783; GO:0005794; GO:0006886; GO:0016192; GO:0031410; GO:0043226,endoplasmic reticulum; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_05021,FUN_023184-T1,Peve_00027670,Pocillopora_meandrina_HIv1___RNAseq.g665.t1,three_way,47.4835,,,,,,,,,,,,,,,,,
OG_05022,FUN_023185-T1,Peve_00027669,Pocillopora_meandrina_HIv1___RNAseq.g667.t1,three_way,92.11933333333332,FUN_023185-T1,Q29RL1,CF206_BOVIN,,Cilia- and flagella-associated protein 206,Bos taurus (Bovine),60.4,627.0,1e-207,724.5,sp|Q29RL1|CF206_BOVIN Cilia- and flagella-associated protein 206 OS=Bos taurus OX=9913 GN=CFAP206 PE=2 SV=2,GO:0001534; GO:0003341; GO:0003356; GO:0005930; GO:0007288; GO:0031514; GO:0035082; GO:0036064; GO:1901317,axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; regulation of cilium beat frequency [GO:0003356]; regulation of flagellated sperm motility [GO:1901317]; sperm axoneme assembly [GO:0007288],axoneme [GO:0005930]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514]; radial spoke [GO:0001534],,GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226,microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle
OG_05023,FUN_023186-T1,Peve_00009988,Pocillopora_meandrina_HIv1___RNAseq.g668.t1,three_way,64.46583333333334,FUN_023186-T1,Q6NXT6,TAPT1_HUMAN,,Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor),Homo sapiens (Human),52.5,503.0,7.099999999999999e-135,482.6,sp|Q6NXT6|TAPT1_HUMAN Transmembrane anterior posterior transformation protein 1 homolog OS=Homo sapiens OX=9606 GN=TAPT1 PE=1 SV=1,GO:0001503; GO:0005654; GO:0005789; GO:0005813; GO:0005829; GO:0014032; GO:0016020; GO:0016520; GO:0030030; GO:0036064; GO:0045724; GO:0048706; GO:0051216; GO:0061036; GO:1903012,cartilage development [GO:0051216]; cell projection organization [GO:0030030]; embryonic skeletal system development [GO:0048706]; neural crest cell development [GO:0014032]; ossification [GO:0001503]; positive regulation of bone development [GO:1903012]; positive regulation of cartilage development [GO:0061036]; positive regulation of cilium assembly [GO:0045724],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleoplasm [GO:0005654],growth hormone-releasing hormone receptor activity [GO:0016520],GO:0005654; GO:0005815; GO:0005829; GO:0048856; GO:0060089,nucleoplasm; microtubule organizing center; cytosol; anatomical structure development; molecular transducer activity
OG_05024,FUN_023187-T1,Peve_00009989,Pocillopora_meandrina_HIv1___RNAseq.g669.t1,three_way,73.152,FUN_023187-T1,F1Q8J0,RNPC3_DANRE,,RNA-binding region-containing protein 3 (RNA-binding protein 40),Danio rerio (Zebrafish) (Brachydanio rerio),44.0,489.0,1.1999999999999999e-75,285.4,sp|F1Q8J0|RNPC3_DANRE RNA-binding region-containing protein 3 OS=Danio rerio OX=7955 GN=rnpc3 PE=2 SV=1,GO:0000398; GO:0001889; GO:0005689; GO:0030626; GO:0031016; GO:0048565; GO:0097157,"digestive tract development [GO:0048565]; liver development [GO:0001889]; mRNA splicing, via spliceosome [GO:0000398]; pancreas development [GO:0031016]",U12-type spliceosomal complex [GO:0005689],pre-mRNA intronic binding [GO:0097157]; U12 snRNA binding [GO:0030626],GO:0003723; GO:0016071; GO:0048856,RNA binding; mRNA metabolic process; anatomical structure development
OG_05025,FUN_023188-T1,Peve_00009990,Pocillopora_meandrina_HIv1___RNAseq.g670.t1,three_way,70.7675,,,,,,,,,,,,,,,,,
OG_05026,FUN_023189-T1,Peve_00009992,Pocillopora_meandrina_HIv1___TS.g25367.t1,three_way,58.125,FUN_023189-T1,O43490,,,,,27.2,751.0,1.8e-53,212.6,sp|O43490|PROM1_HUMAN Prominin-1 OS=Homo sapiens OX=9606 GN=PROM1 PE=1 SV=1,,,,,,
OG_05027,FUN_023190-T1,Peve_00009995,Pocillopora_meandrina_HIv1___RNAseq.g672.t1,three_way,70.11833333333333,,,,,,,,,,,,,,,,,
OG_05028,FUN_023192-T1,Peve_00009996,Pocillopora_meandrina_HIv1___RNAseq.27898_t,three_way,78.95266666666667,FUN_023192-T1,O17185,SUP9_CAEEL,,Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38),Caenorhabditis elegans,36.6,238.0,3.2000000000000005e-33,143.7,sp|O17185|SUP9_CAEEL Two pore potassium channel protein sup-9 OS=Caenorhabditis elegans OX=6239 GN=sup-9 PE=1 SV=2,GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0036195; GO:0055120; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937],muscle cell projection membrane [GO:0036195]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120],outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05029,FUN_023194-T1,Peve_00027171,Pocillopora_meandrina_HIv1___RNAseq.g674.t1,three_way,56.34633333333333,FUN_023194-T1,Q76EC5,,,,,37.2,172.0,7.8e-24,112.1,sp|Q76EC5|CHST9_MOUSE Carbohydrate sulfotransferase 9 OS=Mus musculus OX=10090 GN=Chst9 PE=2 SV=1,,,,,,
OG_05030,FUN_023202-T1,Peve_00010001,Pocillopora_meandrina_HIv1___RNAseq.g680.t1,three_way,51.176,FUN_023202-T1,Q9Z0R0,,,,,46.0,339.0,2.0000000000000002e-82,308.5,sp|Q9Z0R0|HASP_MOUSE Serine/threonine-protein kinase haspin OS=Mus musculus OX=10090 GN=Haspin PE=1 SV=3,,,,,,
OG_05031,FUN_023205-T1,Peve_00010002,Pocillopora_meandrina_HIv1___RNAseq.g681.t2,three_way,61.8175,FUN_023205-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),41.3,150.0,3.5e-26,119.8,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_05032,FUN_023211-T1,Peve_00010008,Pocillopora_meandrina_HIv1___RNAseq.g688.t1,three_way,82.62133333333334,FUN_023211-T1,Q6IND7,,,,,42.0,300.0,1e-63,245.4,sp|Q6IND7|LR2BP_XENLA LRP2-binding protein OS=Xenopus laevis OX=8355 GN=lrp2bp PE=2 SV=1,,,,,,
OG_05033,FUN_023213-T1,Peve_00010009,Pocillopora_meandrina_HIv1___RNAseq.g689.t1,three_way,68.199,FUN_023213-T1,Q8IUR5,,,,,44.5,456.0,6e-86,320.9,sp|Q8IUR5|TMTC1_HUMAN Protein O-mannosyl-transferase TMTC1 OS=Homo sapiens OX=9606 GN=TMTC1 PE=1 SV=3,,,,,,
OG_05034,FUN_023215-T1,Peve_00029821,Pocillopora_meandrina_HIv1___RNAseq.g690.t1,three_way,75.65683333333334,FUN_023215-T1,Q75W95,,,,,43.3,224.0,6.5e-31,136.0,sp|Q75W95|NKX11_DANRE NK1 transcription factor-related protein 1 OS=Danio rerio OX=7955 GN=nkx1.2lb PE=2 SV=1,,,,,,
OG_05035,FUN_023216-T1,Peve_00029820,Pocillopora_meandrina_HIv1___RNAseq.g691.t1,three_way,77.107,FUN_023216-T1,Q90XN9,,,,,68.3,126.0,2e-36,154.1,sp|Q90XN9|HMX3B_ORYLA Homeobox protein HMX3-B OS=Oryzias latipes OX=8090 GN=hmx3b PE=2 SV=1,,,,,,
OG_05036,FUN_023217-T1,Peve_00029819,Pocillopora_meandrina_HIv1___RNAseq.g693.t1,three_way,81.623,FUN_023217-T1,Q9FR44,,,,,55.5,256.0,2.4e-78,293.5,sp|Q9FR44|PEAM1_ARATH Phosphoethanolamine N-methyltransferase 1 OS=Arabidopsis thaliana OX=3702 GN=NMT1 PE=1 SV=1,,,,,,
OG_05037,FUN_023219-T1,Peve_00029815,Pocillopora_meandrina_HIv1___RNAseq.g695.t1,three_way,62.362,FUN_023219-T1,P53454,,,,,31.2,327.0,5.3e-29,130.6,sp|P53454|DRD5L_TAKRU D(5)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=dl PE=3 SV=1,,,,,,
OG_05038,FUN_023220-T1,Peve_00029814,Pocillopora_meandrina_HIv1___RNAseq.g696.t1,three_way,81.45,FUN_023220-T1,Q8K2C8,GPAT4_MOUSE,,Glycerol-3-phosphate acyltransferase 4 (GPAT4) (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta) (Testis spermatogenesis apoptosis-related protein 7),Mus musculus (Mouse),50.9,432.0,5.8e-122,439.1,sp|Q8K2C8|GPAT4_MOUSE Glycerol-3-phosphate acyltransferase 4 OS=Mus musculus OX=10090 GN=Gpat4 PE=1 SV=1,GO:0002071; GO:0004366; GO:0005783; GO:0005789; GO:0006631; GO:0006637; GO:0006641; GO:0006656; GO:0007595; GO:0008610; GO:0016024; GO:0019432; GO:0030879; GO:0040014; GO:0046339,acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; mammary gland development [GO:0030879]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],glycerol-3-phosphate O-acyltransferase activity [GO:0004366],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0048856; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_05039,FUN_023223-T1,Peve_00029812,Pocillopora_meandrina_HIv1___RNAseq.g707.t1,three_way,76.11533333333334,FUN_023223-T1,P19087,GNAT2_HUMAN,,Guanine nucleotide-binding protein G(t) subunit alpha-2 (Transducin alpha-2 chain),Homo sapiens (Human),39.1,353.0,4.700000000000002e-72,273.1,sp|P19087|GNAT2_HUMAN Guanine nucleotide-binding protein G(t) subunit alpha-2 OS=Homo sapiens OX=9606 GN=GNAT2 PE=1 SV=4,GO:0000902; GO:0001580; GO:0001664; GO:0001750; GO:0001917; GO:0003924; GO:0005525; GO:0005737; GO:0005834; GO:0005886; GO:0007186; GO:0007188; GO:0007204; GO:0007601; GO:0007602; GO:0007632; GO:0008020; GO:0008104; GO:0009411; GO:0010467; GO:0031683; GO:0042417; GO:0042622; GO:0045202; GO:0046549; GO:0046872; GO:0048771; GO:0048877; GO:0050908; GO:0051938; GO:0060221; GO:0097719; GO:0120302; GO:0150103; GO:1904390,adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; background adaptation [GO:0120302]; cell morphogenesis [GO:0000902]; cone retinal bipolar cell differentiation [GO:1904390]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; detection of light stimulus involved in visual perception [GO:0050908]; dopamine metabolic process [GO:0042417]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; homeostasis of number of retina cells [GO:0048877]; L-glutamate import [GO:0051938]; neural tissue regeneration [GO:0097719]; phototransduction [GO:0007602]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein localization [GO:0008104]; reactive gliosis [GO:0150103]; response to UV [GO:0009411]; retinal cone cell development [GO:0046549]; retinal rod cell differentiation [GO:0060221]; tissue remodeling [GO:0048771]; visual behavior [GO:0007632]; visual perception [GO:0007601],cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; photoreceptor outer segment membrane [GO:0042622]; plasma membrane [GO:0005886]; synapse [GO:0045202],G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0003824; GO:0003924; GO:0005886; GO:0006954; GO:0016787; GO:0030154; GO:0048856; GO:0050877; GO:0060089,catalytic activity; GTPase activity; plasma membrane; inflammatory response; hydrolase activity; cell differentiation; anatomical structure development; nervous system process; molecular transducer activity
OG_05040,FUN_023224-T1,Peve_00029811,Pocillopora_meandrina_HIv1___RNAseq.g708.t1,three_way,94.295,FUN_023224-T1,Q5ZJK8,,,,,81.7,531.0,3.7e-254,878.6,sp|Q5ZJK8|TCPH_CHICK T-complex protein 1 subunit eta OS=Gallus gallus OX=9031 GN=CCT7 PE=1 SV=1,,,,,,
OG_05041,FUN_023225-T1,Peve_00029810,Pocillopora_meandrina_HIv1___RNAseq.g709.t1,three_way,77.67733333333334,FUN_023225-T1,Q9Y227,ENTP4_HUMAN,,Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.15) (EC 3.6.1.6) (Golgi UDPase) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase) (EC 3.6.1.42),Homo sapiens (Human),48.0,533.0,1.7e-135,484.6,sp|Q9Y227|ENTP4_HUMAN Ectonucleoside triphosphate diphosphohydrolase 4 OS=Homo sapiens OX=9606 GN=ENTPD4 PE=1 SV=1,GO:0000139; GO:0000421; GO:0003924; GO:0004382; GO:0005765; GO:0005794; GO:0006256; GO:0016020; GO:0017110; GO:0017111; GO:0031410; GO:0034656; GO:0036384; GO:0043273; GO:0045134; GO:0046036; GO:0046712,CTP metabolic process [GO:0046036]; GDP catabolic process [GO:0046712]; nucleobase-containing small molecule catabolic process [GO:0034656]; UDP catabolic process [GO:0006256],autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134],GO:0003824; GO:0003924; GO:0005794; GO:0016787; GO:0031410; GO:0043226; GO:0055086; GO:1901135,catalytic activity; GTPase activity; Golgi apparatus; hydrolase activity; cytoplasmic vesicle; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05042,FUN_023226-T1,Peve_00029805,Pocillopora_meandrina_HIv1___TS.g25414.t1,three_way,82.15833333333333,FUN_023226-T1,A1A4R8,,,,,53.7,294.0,9.999999999999999e-85,315.8,sp|A1A4R8|CDC23_BOVIN Cell division cycle protein 23 homolog OS=Bos taurus OX=9913 GN=CDC23 PE=2 SV=1,,,,,,
OG_05043,FUN_023227-T1,Peve_00029804,Pocillopora_meandrina_HIv1___RNAseq.g717.t1,three_way,76.54016666666666,FUN_023227-T1,Q8NB25,F184A_HUMAN,,Protein FAM184A,Homo sapiens (Human),26.8,1100.0,2.1e-22,109.8,sp|Q8NB25|F184A_HUMAN Protein FAM184A OS=Homo sapiens OX=9606 GN=FAM184A PE=1 SV=3,GO:0000932; GO:0005615; GO:0005829; GO:0034451; GO:0036064; GO:0043231,,centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; P-body [GO:0000932],,GO:0005615; GO:0005815; GO:0005829; GO:0043226,extracellular space; microtubule organizing center; cytosol; organelle
OG_05044,FUN_023228-T1,Peve_00029803,Pocillopora_meandrina_HIv1___RNAseq.g718.t1,three_way,84.18599999999999,FUN_023228-T1,Q5U4F6,DC2I2_MOUSE,,Cytoplasmic dynein 2 intermediate chain 2 (Dynein 2 intermediate chain 2) (WD repeat-containing protein 34),Mus musculus (Mouse),45.9,492.0,1.2e-121,438.3,sp|Q5U4F6|DC2I2_MOUSE Cytoplasmic dynein 2 intermediate chain 2 OS=Mus musculus OX=10090 GN=Dync2i2 PE=1 SV=3,GO:0005730; GO:0005813; GO:0005814; GO:0005829; GO:0005868; GO:0005929; GO:0005930; GO:0016604; GO:0030175; GO:0031965; GO:0035721; GO:0036064; GO:0045503; GO:0060271,cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721],axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; filopodium [GO:0030175]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730],dynein light chain binding [GO:0045503],GO:0005730; GO:0005815; GO:0005829; GO:0005929; GO:0007018; GO:0043226; GO:0044782,nucleolus; microtubule organizing center; cytosol; cilium; microtubule-based movement; organelle; cilium organization
OG_05045,FUN_023231-T1,Peve_00029854,Pocillopora_meandrina_HIv1___RNAseq.g17040.t1,three_way,64.61666666666667,FUN_023231-T1,Q9WU56,PUS1_MOUSE,,Pseudouridylate synthase 1 homolog (EC 5.4.99.-) (tRNA pseudouridine synthase 1) (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I),Mus musculus (Mouse),44.1,338.0,8.4e-74,279.3,sp|Q9WU56|PUS1_MOUSE Pseudouridylate synthase 1 homolog OS=Mus musculus OX=10090 GN=Pus1 PE=1 SV=2,GO:0000049; GO:0002153; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005730; GO:0005739; GO:0006397; GO:0008380; GO:0009982; GO:0031119; GO:0045944; GO:0106029; GO:0160147; GO:1990481,mRNA processing [GO:0006397]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA splicing [GO:0008380]; tRNA pseudouridine synthesis [GO:0031119],mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],chromatin binding [GO:0003682]; pseudouridine synthase activity [GO:0009982]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; tRNA pseudouridine(38-40) synthase activity [GO:0160147],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006355; GO:0006399; GO:0016071; GO:0016853; GO:0043226; GO:0060090; GO:0140098; GO:0140110,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; regulation of DNA-templated transcription; tRNA metabolic process; mRNA metabolic process; isomerase activity; organelle; molecular adaptor activity; catalytic activity, acting on RNA; transcription regulator activity"
OG_05046,FUN_023233-T1,Peve_00029853,Pocillopora_meandrina_HIv1___RNAseq.g727.t1,three_way,79.16716666666666,FUN_023233-T1,Q08DG6,,,,,57.5,219.0,3.8e-65,249.6,sp|Q08DG6|COX15_BOVIN Heme A synthase COX15 OS=Bos taurus OX=9913 GN=COX15 PE=2 SV=1,,,,,,
OG_05047,FUN_023236-T1,Peve_00029852,Pocillopora_meandrina_HIv1___TS.g16967.t1,three_way,66.868,FUN_023236-T1,Q8AW42,,,,,44.2,353.0,1.7e-70,268.1,sp|Q8AW42|S39AD_DANRE Zinc transporter ZIP13 OS=Danio rerio OX=7955 GN=slc39a13 PE=2 SV=1,,,,,,
OG_05048,FUN_023237-T1,Peve_00029851,Pocillopora_meandrina_HIv1___RNAseq.g17389.t1,three_way,74.06716666666667,FUN_023237-T1,B9FHF3,DJB6_ORYSJ,,DnaJ protein ERDJ3B (Chaperone protein dnaJ B6) (OsDjB6) (Endoplasmic reticulum dnaJ domain-containing protein 3B) (OsERdj3B),Oryza sativa subsp. japonica (Rice),47.3,55.0,6.4e-09,64.3,sp|B9FHF3|DJB6_ORYSJ DnaJ protein ERDJ3B OS=Oryza sativa subsp. japonica OX=39947 GN=ERDJ3B PE=1 SV=1,GO:0005737; GO:0005788; GO:0042026; GO:0051082; GO:0051087,protein refolding [GO:0042026],cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788],protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0006457,protein folding
OG_05049,FUN_023239-T1,Peve_00029850,Pocillopora_meandrina_HIv1___RNAseq.g17390.t1,three_way,93.638,FUN_023239-T1,Q6DCT2,,,,,58.7,688.0,1.9999999999999998e-218,760.4,sp|Q6DCT2|ARMD3_XENLA Armadillo-like helical domain-containing protein 3 OS=Xenopus laevis OX=8355 GN=armh3 PE=2 SV=2,,,,,,
OG_05050,FUN_023240-T1,Peve_00029849,Pocillopora_meandrina_HIv1___RNAseq.g17391.t1,three_way,69.214,FUN_023240-T1,Q6Y685,TACC1_MOUSE,,Transforming acidic coiled-coil-containing protein 1,Mus musculus (Mouse),43.0,193.0,1.1e-29,133.3,sp|Q6Y685|TACC1_MOUSE Transforming acidic coiled-coil-containing protein 1 OS=Mus musculus OX=10090 GN=Tacc1 PE=1 SV=1,GO:0000226; GO:0003713; GO:0005634; GO:0005737; GO:0005813; GO:0007052; GO:0008283; GO:0019904; GO:0021987; GO:0022008; GO:0022027; GO:0030331; GO:0030496; GO:0032886; GO:0035259; GO:0042974; GO:0042975; GO:0046965; GO:0046966; GO:0051301,cell division [GO:0051301]; cell population proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; regulation of microtubule-based process [GO:0032886],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634],nuclear estrogen receptor binding [GO:0030331]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005815; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; microtubule organizing center; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_05051,FUN_023247-T1,Peve_00019237,Pocillopora_meandrina_HIv1___RNAseq.g17396.t1,three_way,62.26833333333333,FUN_023247-T1,P56407,,,,,64.5,76.0,6.2e-19,95.9,sp|P56407|HM09_CAEEL Homeobox protein ceh-9 OS=Caenorhabditis elegans OX=6239 GN=ceh-9 PE=3 SV=2,,,,,,
OG_05052,FUN_023248-T1,Peve_00019246,Pocillopora_meandrina_HIv1___RNAseq.g17397.t1,three_way,77.48166666666667,FUN_023248-T1,Q5ZIZ2,SMYD5_CHICK,,Protein-lysine N-trimethyltransferase SMYD5 (EC 2.1.1.-) (SET and MYND domain-containing protein 5) ([histone H3]-lysine20 N-trimethyltransferase SMYD5) (EC 2.1.1.372) ([histone H4]-lysine36 N-trimethyltransferase SMYD5) (EC 2.1.1.359),Gallus gallus (Chicken),55.4,381.0,2.8000000000000008e-118,426.8,sp|Q5ZIZ2|SMYD5_CHICK Protein-lysine N-trimethyltransferase SMYD5 OS=Gallus gallus OX=9031 GN=SMYD5 PE=2 SV=1,GO:0005737; GO:0008270; GO:0016279; GO:0032259; GO:0042799; GO:0045814; GO:0140943; GO:0140955; GO:1900249; GO:2000035; GO:2000736,"methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of cytoplasmic translational elongation [GO:1900249]; regulation of stem cell differentiation [GO:2000736]; regulation of stem cell division [GO:2000035]",cytoplasm [GO:0005737],histone H3K36 trimethyltransferase activity [GO:0140955]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 trimethyltransferase activity [GO:0140943]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270],GO:0003824; GO:0006325; GO:0016740; GO:0140096,"catalytic activity; chromatin organization; transferase activity; catalytic activity, acting on a protein"
OG_05053,FUN_023249-T1,Peve_00019252,Pocillopora_meandrina_HIv1___TS.g16979.t2,three_way,58.003,,,,,,,,,,,,,,,,,
OG_05054,FUN_023250-T1,Peve_00019253,Pocillopora_meandrina_HIv1___RNAseq.g17400.t1,three_way,95.03433333333334,FUN_023250-T1,Q9GR88,,,,,85.8,431.0,4.2e-216,751.9,sp|Q9GR88|ERF1_POLMI Eukaryotic peptide chain release factor subunit 1 OS=Polyandrocarpa misakiensis OX=7723 GN=ERF1 PE=2 SV=1,,,,,,
OG_05055,FUN_023251-T1,Peve_00019255,Pocillopora_meandrina_HIv1___RNAseq.g1743.t1,three_way,82.61816666666667,FUN_023251-T1,Q6PCJ1,DCTN1_XENLA,,Dynactin subunit 1,Xenopus laevis (African clawed frog),41.7,763.0,1.9e-112,409.1,sp|Q6PCJ1|DCTN1_XENLA Dynactin subunit 1 OS=Xenopus laevis OX=8355 GN=dctn1 PE=2 SV=1,GO:0000132; GO:0000776; GO:0000922; GO:0005813; GO:0005814; GO:0005874; GO:0005875; GO:0005938; GO:0007097; GO:0008017; GO:0030286; GO:0030424; GO:0031122; GO:0035371; GO:0051301; GO:0060236; GO:0090316; GO:0099738,cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122]; establishment of mitotic spindle orientation [GO:0000132]; nuclear migration [GO:0007097]; positive regulation of intracellular protein transport [GO:0090316]; regulation of mitotic spindle organization [GO:0060236],axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; dynein complex [GO:0030286]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_05056,FUN_023252-T1,Peve_00019257,Pocillopora_meandrina_HIv1___RNAseq.g1747.t1,three_way,87.91333333333333,FUN_023252-T1,Q155U0,,,,,55.4,819.0,1.3e-228,794.3,sp|Q155U0|VPS51_DANRE Vacuolar protein sorting-associated protein 51 homolog OS=Danio rerio OX=7955 GN=vps51 PE=2 SV=1,,,,,,
OG_05057,FUN_023254-T1,Peve_00019258,Pocillopora_meandrina_HIv1___TS.g25271.t1,three_way,66.88033333333334,FUN_023254-T1,Q924H0,,,,,30.0,317.0,1.4e-25,118.6,sp|Q924H0|NPFF2_MOUSE Neuropeptide FF receptor 2 OS=Mus musculus OX=10090 GN=Npffr2 PE=2 SV=2,,,,,,
OG_05058,FUN_023255-T1,Peve_00019259,Pocillopora_meandrina_HIv1___RNAseq.g571.t1,three_way,52.29533333333333,,,,,,,,,,,,,,,,,
OG_05059,FUN_023256-T1,Peve_00019260,Pocillopora_meandrina_HIv1___TS.g25273.t1,three_way,37.922666666666665,,,,,,,,,,,,,,,,,
OG_05060,FUN_023257-T1,Peve_00019264,Pocillopora_meandrina_HIv1___RNAseq.g573.t1,three_way,65.63666666666667,FUN_023257-T1,Q9BT09,CNPY3_HUMAN,,Protein canopy homolog 3 (CTG repeat protein 4a) (Expanded repeat-domain protein CAG/CTG 5) (Protein associated with TLR4) (Trinucleotide repeat-containing gene 5 protein),Homo sapiens (Human),40.1,182.0,2.1e-34,148.3,sp|Q9BT09|CNPY3_HUMAN Protein canopy homolog 3 OS=Homo sapiens OX=9606 GN=CNPY3 PE=1 SV=1,GO:0005102; GO:0005788; GO:0045087,innate immune response [GO:0045087],endoplasmic reticulum lumen [GO:0005788],signaling receptor binding [GO:0005102],GO:0002376; GO:0098542,immune system process; defense response to other organism
OG_05061,FUN_023258-T1,Peve_00019265,Pocillopora_meandrina_HIv1___RNAseq.g29203.t1,three_way,59.568333333333335,FUN_023258-T1,Q057J1,,,,,53.5,71.0,4.5e-13,75.9,sp|Q057J1|RL27_BUCCC Large ribosomal subunit protein bL27 OS=Buchnera aphidicola subsp. Cinara cedri (strain Cc) OX=372461 GN=rpmA PE=3 SV=1,,,,,,
OG_05062,FUN_023259-T1,Peve_00019266,Pocillopora_meandrina_HIv1___RNAseq.g574.t1,three_way,69.79666666666667,,,,,,,,,,,,,,,,,
OG_05063,FUN_023260-T1,Peve_00019268,Pocillopora_meandrina_HIv1___RNAseq.g578.t1,three_way,89.18833333333333,FUN_023260-T1,Q9W676,,,,,61.8,382.0,2.4e-114,413.7,sp|Q9W676|LDB2_CHICK LIM domain-binding protein 2 OS=Gallus gallus OX=9031 GN=LDB2 PE=2 SV=1,,,,,,
OG_05064,FUN_023262-T2,Peve_00019267,Pocillopora_meandrina_HIv1___RNAseq.g576.t2,three_way,62.084,FUN_023262-T2,A4IG62,SUV3_DANRE,,"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)",Danio rerio (Zebrafish) (Brachydanio rerio),45.3,583.0,4.8e-149,530.0,"sp|A4IG62|SUV3_DANRE ATP-dependent RNA helicase SUPV3L1, mitochondrial OS=Danio rerio OX=7955 GN=supv3l1 PE=2 SV=1",GO:0000958; GO:0000962; GO:0000965; GO:0001889; GO:0003677; GO:0003678; GO:0003724; GO:0003725; GO:0005524; GO:0005634; GO:0005739; GO:0005759; GO:0006310; GO:0006401; GO:0007005; GO:0016887; GO:0030307; GO:0034458; GO:0035945; GO:0035946; GO:0042645; GO:0043066; GO:0045025; GO:2000827,DNA recombination [GO:0006310]; liver development [GO:0001889]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA surveillance [GO:0035946]; mitochondrial ncRNA surveillance [GO:0035945]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA surveillance [GO:2000827]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell growth [GO:0030307]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; RNA catabolic process [GO:0006401],mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0006310; GO:0007005; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0140053; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; DNA recombination; mitochondrion organization; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; anatomical structure development; mitochondrial gene expression; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05065,FUN_023268-T1,Peve_00018794,Pocillopora_meandrina_HIv1___TS.g17377.t1b,three_way,60.35533333333333,FUN_023268-T1,Q96N46,,,,,35.8,433.0,8.1e-59,230.3,sp|Q96N46|TTC14_HUMAN Tetratricopeptide repeat protein 14 OS=Homo sapiens OX=9606 GN=TTC14 PE=1 SV=1,,,,,,
OG_05066,FUN_023269-T1,Peve_00019482,Pocillopora_meandrina_HIv1___TS.g17377.t1a,three_way,74.93916666666667,FUN_023269-T1,Q9PVF8,CTNA1_DANRE,,Catenin alpha-1 (Alpha E-catenin),Danio rerio (Zebrafish) (Brachydanio rerio),23.7,628.0,5.3e-38,162.2,sp|Q9PVF8|CTNA1_DANRE Catenin alpha-1 OS=Danio rerio OX=7955 GN=ctnna1 PE=1 SV=1,GO:0001894; GO:0005198; GO:0005634; GO:0005902; GO:0005911; GO:0005912; GO:0005938; GO:0008013; GO:0015629; GO:0016342; GO:0016477; GO:0034334; GO:0043009; GO:0045296; GO:0051015; GO:0098609,adherens junction maintenance [GO:0034334]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; chordate embryonic development [GO:0043009]; tissue homeostasis [GO:0001894],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; microvillus [GO:0005902]; nucleus [GO:0005634],actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198],GO:0005198; GO:0005634; GO:0005856; GO:0007155; GO:0008092; GO:0034330; GO:0043226; GO:0048856; GO:0048870,structural molecule activity; nucleus; cytoskeleton; cell adhesion; cytoskeletal protein binding; cell junction organization; organelle; anatomical structure development; cell motility
OG_05067,FUN_023270-T1,Peve_00019480,Pocillopora_meandrina_HIv1___RNAseq.g17805.t1,three_way,80.59366666666666,FUN_023270-T1,Q63ZH8,,,,,32.8,137.0,1.2e-18,94.4,sp|Q63ZH8|F136A_XENLA Protein FAM136A OS=Xenopus laevis OX=8355 GN=fam136a PE=2 SV=1,,,,,,
OG_05068,FUN_023271-T1,Peve_00019479,Pocillopora_meandrina_HIv1___RNAseq.g17804.t1,three_way,65.41499999999999,,,,,,,,,,,,,,,,,
OG_05069,FUN_023272-T1,Peve_00031864,Pocillopora_meandrina_HIv1___RNAseq.g17803.t1,three_way,64.60916666666667,FUN_023272-T1,Q9Z1Z1,E2AK3_RAT,,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (Protein tyrosine kinase EIF2AK3) (EC 2.7.10.2),Rattus norvegicus (Rat),35.6,1035.0,9.7e-144,512.7,sp|Q9Z1Z1|E2AK3_RAT Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Rattus norvegicus OX=10116 GN=Eif2ak3 PE=1 SV=1,GO:0001501; GO:0001503; GO:0001525; GO:0002063; GO:0004672; GO:0004674; GO:0004694; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005789; GO:0006412; GO:0006446; GO:0006983; GO:0007029; GO:0007595; GO:0009967; GO:0010575; GO:0010628; GO:0010629; GO:0017148; GO:0019217; GO:0019722; GO:0019899; GO:0019903; GO:0030282; GO:0030968; GO:0031016; GO:0031018; GO:0031642; GO:0032055; GO:0032933; GO:0034198; GO:0034976; GO:0036499; GO:0036503; GO:0042149; GO:0042802; GO:0043066; GO:0044233; GO:0044322; GO:0045444; GO:0045943; GO:0048009; GO:0048471; GO:0051787; GO:0051879; GO:0060734; GO:0070059; GO:0070417; GO:0106310; GO:1900182; GO:1902010; GO:1902235; GO:1902237; GO:1903788; GO:1990737,angiogenesis [GO:0001525]; bone mineralization [GO:0030282]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid starvation [GO:0034198]; cellular response to cold [GO:0070417]; cellular response to glucose starvation [GO:0042149]; chondrocyte development [GO:0002063]; endocrine pancreas development [GO:0031018]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; fat cell differentiation [GO:0045444]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; lactation [GO:0007595]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of myelination [GO:0031642]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; negative regulation of translation in response to stress [GO:0032055]; ossification [GO:0001503]; pancreas development [GO:0031016]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gene expression [GO:0010628]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:0060734]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235]; regulation of fatty acid metabolic process [GO:0019217]; regulation of translational initiation [GO:0006446]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; skeletal system development [GO:0001501]; SREBP signaling pathway [GO:0032933]; translation [GO:0006412],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005783; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05070,FUN_023276-T1,Peve_00041312,Pocillopora_meandrina_HIv1___RNAseq.g17800.t1,three_way,81.05266666666667,FUN_023276-T1,Q6AYQ8,FAHD1_RAT,,"Oxaloacetate tautomerase FAHD1, mitochondrial (EC 5.3.2.2) (Acylpyruvase FAHD1) (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112)",Rattus norvegicus (Rat),53.5,215.0,5.4999999999999994e-68,258.8,"sp|Q6AYQ8|FAHD1_RAT Oxaloacetate tautomerase FAHD1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Fahd1 PE=1 SV=1",GO:0005654; GO:0005739; GO:0005829; GO:0006090; GO:0006107; GO:0008948; GO:0018773; GO:0034545; GO:0046872; GO:0047621; GO:0050163,oxaloacetate metabolic process [GO:0006107]; pyruvate metabolic process [GO:0006090],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]; oxaloacetate tautomerase activity [GO:0050163],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016787; GO:0016829; GO:0016853; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; cytosol; hydrolase activity; lyase activity; isomerase activity; organelle
OG_05071,FUN_023293-T1,Peve_00003652,Pocillopora_meandrina_HIv1___RNAseq.g23035.t1,three_way,68.382,,,,,,,,,,,,,,,,,
OG_05072,FUN_023298-T1,Peve_00041305,Pocillopora_meandrina_HIv1___RNAseq.g17780.t1,three_way,76.65966666666667,FUN_023298-T1,Q5XIH9,HPDL_RAT,,4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) (EC 1.13.11.46) (Glyoxalase domain-containing protein 1),Rattus norvegicus (Rat),32.8,390.0,1.4e-48,195.3,sp|Q5XIH9|HPDL_RAT 4-hydroxyphenylpyruvate dioxygenase-like protein OS=Rattus norvegicus OX=10116 GN=Hpdl PE=2 SV=1,GO:0003868; GO:0005739; GO:0009072; GO:0046872; GO:0050585,aromatic amino acid metabolic process [GO:0009072],mitochondrion [GO:0005739],4-hydroxymandelate synthase activity [GO:0050585]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; organelle
OG_05073,FUN_023299-T2,Peve_00041307,Pocillopora_meandrina_HIv1___RNAseq.g17779.t1,three_way,85.93666666666667,FUN_023299-T2,Q5E9M8,,,,,70.0,210.0,2.5e-82,306.6,sp|Q5E9M8|SFXN1_BOVIN Sideroflexin-1 OS=Bos taurus OX=9913 GN=SFXN1 PE=2 SV=3,,,,,,
OG_05074,FUN_023300-T1,Peve_00041309,Pocillopora_meandrina_HIv1___RNAseq.g17778.t1,three_way,86.52966666666667,FUN_023300-T1,Q3ZCF5,,,,,75.7,276.0,3.2e-128,459.5,"sp|Q3ZCF5|OAT_BOVIN Ornithine aminotransferase, mitochondrial OS=Bos taurus OX=9913 GN=OAT PE=2 SV=1",,,,,,
OG_05075,FUN_023301-T1,Peve_00041311,Pocillopora_meandrina_HIv1___RNAseq.g17777.t1,three_way,77.84916666666666,FUN_023301-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),31.5,371.0,1.6e-38,162.5,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_05076,FUN_023305-T1,Peve_00041313,Pocillopora_meandrina_HIv1___RNAseq.g17776.t1,three_way,83.91333333333333,FUN_023305-T1,P29702,FNTA_BOVIN,,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha),Bos taurus (Bovine),67.0,279.0,1.1e-39,165.2,sp|P29702|FNTA_BOVIN Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha OS=Bos taurus OX=9913 GN=FNTA PE=2 SV=2,GO:0004660; GO:0004661; GO:0004662; GO:0005737; GO:0005953; GO:0005965; GO:0007323; GO:0018343; GO:0018344,peptide pheromone maturation [GO:0007323]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344],CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; protein farnesyltransferase complex [GO:0005965],CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661],GO:0003824; GO:0016740; GO:0051604; GO:0140096,"catalytic activity; transferase activity; protein maturation; catalytic activity, acting on a protein"
OG_05077,FUN_023306-T1,Peve_00041314,Pocillopora_meandrina_HIv1___RNAseq.g17775.t2,three_way,73.69766666666666,FUN_023306-T1,Q9H008,,,,,58.0,257.0,3.1e-84,313.2,sp|Q9H008|LHPP_HUMAN Phospholysine phosphohistidine inorganic pyrophosphate phosphatase OS=Homo sapiens OX=9606 GN=LHPP PE=1 SV=2,,,,,,
OG_05078,FUN_023307-T1,Peve_00041315,Pocillopora_meandrina_HIv1___RNAseq.g17774.t1,three_way,62.178,FUN_023307-T1,Q9QXT1,,,,,36.0,86.0,3.4e-10,67.4,sp|Q9QXT1|DAPP1_MOUSE Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide OS=Mus musculus OX=10090 GN=Dapp1 PE=1 SV=1,,,,,,
OG_05079,FUN_023308-T1,Peve_00041319,Pocillopora_meandrina_HIv1___RNAseq.g17773.t1,three_way,65.986,FUN_023308-T1,Q80YG3,,,,,38.9,378.0,3.6e-73,276.9,sp|Q80YG3|KLDC1_MOUSE Kelch domain-containing protein 1 OS=Mus musculus OX=10090 GN=Klhdc1 PE=2 SV=1,,,,,,
OG_05080,FUN_023309-T1,Peve_00041320,Pocillopora_meandrina_HIv1___RNAseq.g17772.t1,three_way,73.30616666666667,FUN_023309-T1,P52732,KIF11_HUMAN,,Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5) (TR-interacting protein 5) (TRIP-5),Homo sapiens (Human),51.0,755.0,1.2e-171,605.5,sp|P52732|KIF11_HUMAN Kinesin-like protein KIF11 OS=Homo sapiens OX=9606 GN=KIF11 PE=1 SV=2,GO:0000278; GO:0000922; GO:0003777; GO:0005524; GO:0005634; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007051; GO:0007052; GO:0007100; GO:0008017; GO:0008574; GO:0016020; GO:0019901; GO:0032991; GO:0036064; GO:0043231; GO:0046602; GO:0051231; GO:0051301; GO:0072686; GO:0090307,cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; spindle elongation [GO:0051231]; spindle organization [GO:0007051],ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle pole [GO:0000922],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein kinase binding [GO:0019901],GO:0000278; GO:0003774; GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0140657,mitotic cell cycle; cytoskeletal motor activity; catalytic activity; nucleus; microtubule organizing center; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; ATP-dependent activity
OG_05081,FUN_023311-T1,Peve_00011528,Pocillopora_meandrina_HIv1___RNAseq.g17770.t1,three_way,61.54116666666667,FUN_023311-T1,Q13332,,,,,29.5,742.0,1.2e-61,240.4,sp|Q13332|PTPRS_HUMAN Receptor-type tyrosine-protein phosphatase S OS=Homo sapiens OX=9606 GN=PTPRS PE=1 SV=3,,,,,,
OG_05082,FUN_023314-T1,Peve_00017882,Pocillopora_meandrina_HIv1___RNAseq.g17767.t1,three_way,79.65150000000001,FUN_023314-T1,P47870,GBRB2_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Homo sapiens (Human),40.5,321.0,5.9e-61,236.5,sp|P47870|GBRB2_HUMAN Gamma-aminobutyric acid receptor subunit beta-2 OS=Homo sapiens OX=9606 GN=GABRB2 PE=1 SV=2,GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0007268; GO:0022851; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0051932; GO:0060119; GO:0060384; GO:0070062; GO:0071420; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; organelle; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05083,FUN_023316-T2,Peve_00017883,Pocillopora_meandrina_HIv1___RNAseq.g17768.t1,three_way,78.326,FUN_023316-T2,P63138,GBRB2_RAT,,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) (GABAAR subunit beta-2),Rattus norvegicus (Rat),32.2,391.0,1.6000000000000002e-48,194.9,sp|P63138|GBRB2_RAT Gamma-aminobutyric acid receptor subunit beta-2 OS=Rattus norvegicus OX=10116 GN=Gabrb2 PE=1 SV=1,GO:0004890; GO:0005237; GO:0005254; GO:0005886; GO:0007214; GO:0030659; GO:0034707; GO:0043197; GO:0045211; GO:0048666; GO:0048787; GO:0051932; GO:0060119; GO:0060384; GO:0071420; GO:0090102; GO:0098978; GO:0098982; GO:0099507; GO:0099634; GO:1902476; GO:1902710; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; chloride transmembrane transport [GO:1902476]; cochlea development [GO:0090102]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; neuron development [GO:0048666]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA receptor complex [GO:1902710]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; presynaptic active zone membrane [GO:0048787],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; inhibitory extracellular ligand-gated monoatomic ion channel activity [GO:0005237]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; cell junction organization; anatomical structure development; transmembrane transport; molecular transducer activity
OG_05084,FUN_023319-T1,Peve_00017885,Pocillopora_meandrina_HIv1___RNAseq.g17823.t1,three_way,52.87566666666667,,,,,,,,,,,,,,,,,
OG_05085,FUN_023321-T1,Peve_00021498,Pocillopora_meandrina_HIv1___RNAseq.g17825.t1,three_way,50.699666666666666,FUN_023321-T1,Q8N264,RHG24_HUMAN,,Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP),Homo sapiens (Human),30.4,112.0,2.2e-08,62.0,sp|Q8N264|RHG24_HUMAN Rho GTPase-activating protein 24 OS=Homo sapiens OX=9606 GN=ARHGAP24 PE=1 SV=2,GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:1900028,"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]",adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925],GTPase activator activity [GO:0005096],GO:0005856; GO:0030154; GO:0043226; GO:0048870; GO:0098772,cytoskeleton; cell differentiation; organelle; cell motility; molecular function regulator activity
OG_05086,FUN_023322-T1,Peve_00004288,Pocillopora_meandrina_HIv1___RNAseq.g17831.t1,three_way,40.015166666666666,,,,,,,,,,,,,,,,,
OG_05087,FUN_023324-T2,Peve_00004283,Pocillopora_meandrina_HIv1___RNAseq.g17837.t1,three_way,49.6935,FUN_023324-T2,Q9D733,GP2_MOUSE,,Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2),Mus musculus (Mouse),35.4,164.0,5.600000000000001e-23,111.3,sp|Q9D733|GP2_MOUSE Pancreatic secretory granule membrane major glycoprotein GP2 OS=Mus musculus OX=10090 GN=Gp2 PE=1 SV=3,GO:0002412; GO:0003823; GO:0005615; GO:0005768; GO:0009897; GO:0016324; GO:0042589; GO:0045087; GO:0045121; GO:0051649,antigen transcytosis by M cells in mucosal-associated lymphoid tissue [GO:0002412]; establishment of localization in cell [GO:0051649]; innate immune response [GO:0045087],apical plasma membrane [GO:0016324]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; zymogen granule membrane [GO:0042589],antigen binding [GO:0003823],GO:0002376; GO:0005615; GO:0005768; GO:0016192; GO:0031410; GO:0043226; GO:0098542,immune system process; extracellular space; endosome; vesicle-mediated transport; cytoplasmic vesicle; organelle; defense response to other organism
OG_05088,FUN_023331-T1,Peve_00017388,Pocillopora_meandrina_HIv1___RNAseq.g17414.t1,three_way,53.624,FUN_023331-T1,Q91770,,,,,40.0,175.0,6.4e-19,95.9,sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1,,,,,,
OG_05089,FUN_023333-T1,Peve_00001908,Pocillopora_meandrina_HIv1___RNAseq.g17416.t2,three_way,65.74466666666667,FUN_023333-T1,Q969W1,ZDH16_HUMAN,,Palmitoyltransferase ZDHHC16 (EC 2.3.1.225) (Abl-philin 2) (Zinc finger DHHC domain-containing protein 16) (DHHC-16),Homo sapiens (Human),41.9,351.0,1.6e-51,204.9,sp|Q969W1|ZDH16_HUMAN Palmitoyltransferase ZDHHC16 OS=Homo sapiens OX=9606 GN=ZDHHC16 PE=1 SV=1,GO:0001654; GO:0005789; GO:0005794; GO:0006915; GO:0006974; GO:0007507; GO:0016409; GO:0018345; GO:0019706; GO:0021537; GO:0021899,apoptotic process [GO:0006915]; DNA damage response [GO:0006974]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment [GO:0021899]; heart development [GO:0007507]; protein palmitoylation [GO:0018345]; telencephalon development [GO:0021537],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0003824; GO:0005794; GO:0012501; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; programmed cell death; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05090,FUN_023334-T1,Peve_00001906,Pocillopora_meandrina_HIv1___RNAseq.g17417.t1,three_way,76.06566666666667,FUN_023334-T1,Q9HB40,,,,,53.6,379.0,2.3e-114,413.7,sp|Q9HB40|RISC_HUMAN Retinoid-inducible serine carboxypeptidase OS=Homo sapiens OX=9606 GN=SCPEP1 PE=1 SV=1,,,,,,
OG_05091,FUN_023336-T1,Peve_00001907,Pocillopora_meandrina_HIv1___RNAseq.g17418.t1,three_way,88.16199999999999,FUN_023336-T1,Q9NX55,HYPK_HUMAN,,Huntingtin-interacting protein K (Huntingtin yeast partner K),Homo sapiens (Human),59.6,104.0,1.5e-23,110.2,sp|Q9NX55|HYPK_HUMAN Huntingtin-interacting protein K OS=Homo sapiens OX=9606 GN=HYPK PE=1 SV=3,GO:0005634; GO:0005654; GO:0005737; GO:0015630; GO:0032991; GO:0043066; GO:0044183; GO:0050821,negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821],cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],protein folding chaperone [GO:0044183],GO:0005634; GO:0005654; GO:0005856; GO:0043226; GO:0044183,nucleus; nucleoplasm; cytoskeleton; organelle; protein folding chaperone
OG_05092,FUN_023338-T1,Peve_00001905,Pocillopora_meandrina_HIv1___RNAseq.g17419.t1,three_way,63.309333333333335,FUN_023338-T1,Q9HB40,,,,,47.1,408.0,6.6e-100,365.9,sp|Q9HB40|RISC_HUMAN Retinoid-inducible serine carboxypeptidase OS=Homo sapiens OX=9606 GN=SCPEP1 PE=1 SV=1,,,,,,
OG_05093,FUN_023339-T1,Peve_00001913,Pocillopora_meandrina_HIv1___RNAseq.g17420.t1,three_way,51.641666666666666,FUN_023339-T1,Q91ZV2,,,,,33.3,168.0,2.7e-14,82.0,"sp|Q91ZV2|DCBD2_RAT Discoidin, CUB and LCCL domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Dcbld2 PE=2 SV=1",,,,,,
OG_05094,FUN_023341-T1,Peve_00023294,Pocillopora_meandrina_HIv1___RNAseq.g17422.t2,three_way,63.56933333333334,FUN_023341-T1,O15066,KIF3B_HUMAN,,"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]",Homo sapiens (Human),28.9,557.0,1.3000000000000002e-44,183.7,sp|O15066|KIF3B_HUMAN Kinesin-like protein KIF3B OS=Homo sapiens OX=9606 GN=KIF3B PE=1 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016192; GO:0016887; GO:0016939; GO:0030425; GO:0030496; GO:0031267; GO:0032467; GO:0032839; GO:0036372; GO:0042073; GO:0043197; GO:0060271; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0098971; GO:0098978; GO:0120170; GO:1904115,anterograde axonal transport [GO:0008089]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; opsin transport [GO:0036372]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; vesicle-mediated transport [GO:0016192],axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_05095,FUN_023342-T1,Peve_00023292,Pocillopora_meandrina_HIv1___RNAseq.g17423.t1,three_way,64.36,,,,,,,,,,,,,,,,,
OG_05096,FUN_023343-T1,Peve_00023293,Pocillopora_meandrina_HIv1___RNAseq.g17424.t1,three_way,72.48533333333333,FUN_023343-T1,Q05AM5,,,,,45.9,854.0,2.9e-210,733.4,sp|Q05AM5|ELP2_DANRE Elongator complex protein 2 OS=Danio rerio OX=7955 GN=elp2 PE=2 SV=1,,,,,,
OG_05097,FUN_023345-T1,Peve_00035609,Pocillopora_meandrina_HIv1___RNAseq.g17425.t1,three_way,45.39233333333333,FUN_023345-T1,Q06615,,,,,58.5,65.0,2.9e-11,70.5,sp|Q06615|NOTO_XENLA Homeobox protein notochord OS=Xenopus laevis OX=8355 GN=noto PE=2 SV=1,,,,,,
OG_05098,FUN_023347-T1,Peve_00035620,Pocillopora_meandrina_HIv1___TS.g17007.t1,three_way,50.666,FUN_023347-T1,Q9EP86,,,,,29.2,308.0,1.4e-28,128.6,sp|Q9EP86|NPFF1_RAT Neuropeptide FF receptor 1 OS=Rattus norvegicus OX=10116 GN=Npffr1 PE=1 SV=1,,,,,,
OG_05099,FUN_023351-T1,Peve_00035607,Pocillopora_meandrina_HIv1___RNAseq.g17430.t1,three_way,83.50133333333333,FUN_023351-T1,Q802G6,MSB1A_DANRE,,Methionine-R-sulfoxide reductase B1-A (MsrB) (MsrB1-A) (EC 1.8.4.12) (EC 1.8.4.14) (Selenoprotein X-A) (SePR) (SelX-A),Danio rerio (Zebrafish) (Brachydanio rerio),58.6,99.0,5.799999999999998e-29,128.3,sp|Q802G6|MSB1A_DANRE Methionine-R-sulfoxide reductase B1-A OS=Danio rerio OX=7955 GN=msrb1 PE=2 SV=3,GO:0003779; GO:0005634; GO:0005737; GO:0005856; GO:0030041; GO:0030091; GO:0033743; GO:0033745; GO:0045087; GO:0046872,actin filament polymerization [GO:0030041]; innate immune response [GO:0045087]; protein repair [GO:0030091],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743],GO:0002376; GO:0003824; GO:0005634; GO:0005856; GO:0008092; GO:0016491; GO:0043226; GO:0065003; GO:0098542,immune system process; catalytic activity; nucleus; cytoskeleton; cytoskeletal protein binding; oxidoreductase activity; organelle; protein-containing complex assembly; defense response to other organism
OG_05100,FUN_023352-T1,Peve_00035608,Pocillopora_meandrina_HIv1___RNAseq.g17431.t1,three_way,88.21533333333333,FUN_023352-T1,Q8R367,,,,,42.9,161.0,3.8999999999999995e-28,126.7,sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1,,,,,,
OG_05101,FUN_023353-T1,Peve_00035612,Pocillopora_meandrina_HIv1___RNAseq.g17432.t1,three_way,75.67133333333334,FUN_023353-T1,Q8R367,,,,,35.9,195.0,6.6e-26,119.4,sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1,,,,,,
OG_05102,FUN_023356-T1,Peve_00035611,Pocillopora_meandrina_HIv1___RNAseq.g17434.t1,three_way,67.75233333333333,FUN_023356-T1,Q96A58,RERG_HUMAN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Homo sapiens (Human),40.6,180.0,8.8e-29,128.6,sp|Q96A58|RERG_HUMAN Ras-related and estrogen-regulated growth inhibitor OS=Homo sapiens OX=9606 GN=RERG PE=1 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007264; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear estrogen receptor binding [GO:0030331],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; nucleus; nucleoplasm; cytosol; plasma membrane; hydrolase activity; organelle; molecular function regulator activity
OG_05103,FUN_023358-T2,Peve_00005335,Pocillopora_meandrina_HIv1___TS.g17018.t1,three_way,80.87916666666666,FUN_023358-T2,Q96A58,RERG_HUMAN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Homo sapiens (Human),36.9,160.0,2.8e-28,127.1,sp|Q96A58|RERG_HUMAN Ras-related and estrogen-regulated growth inhibitor OS=Homo sapiens OX=9606 GN=RERG PE=1 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007264; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear estrogen receptor binding [GO:0030331],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; nucleus; nucleoplasm; cytosol; plasma membrane; hydrolase activity; organelle; molecular function regulator activity
OG_05104,FUN_023360-T1,Peve_00005336,Pocillopora_meandrina_HIv1___TS.g17019.t1,three_way,64.49333333333334,FUN_023360-T1,Q0VCJ7,RERG_BOVIN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Bos taurus (Bovine),38.9,193.0,1.6e-29,131.3,sp|Q0VCJ7|RERG_BOVIN Ras-related and estrogen-regulated growth inhibitor OS=Bos taurus OX=9913 GN=RERG PE=2 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005829; GO:0005886; GO:0008285; GO:0009725; GO:0019003; GO:0030308,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; nucleoplasm; cytosol; plasma membrane; hydrolase activity; molecular function regulator activity
OG_05105,FUN_023363-T1,Peve_00005341,Pocillopora_meandrina_HIv1___RNAseq.g17541.t1,three_way,60.940666666666665,FUN_023363-T1,Q24207,BOULE_DROME,,Protein boule,Drosophila melanogaster (Fruit fly),35.0,163.0,3.5e-13,76.6,sp|Q24207|BOULE_DROME Protein boule OS=Drosophila melanogaster OX=7227 GN=bol PE=1 SV=1,GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0006417; GO:0008315; GO:0008494; GO:0030154; GO:0043204; GO:0045924; GO:0045948; GO:0048137; GO:0070935,3'-UTR-mediated mRNA stabilization [GO:0070935]; cell differentiation [GO:0030154]; G2/MI transition of meiotic cell cycle [GO:0008315]; positive regulation of translational initiation [GO:0045948]; regulation of female receptivity [GO:0045924]; regulation of translation [GO:0006417]; spermatocyte division [GO:0048137],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perikaryon [GO:0043204],mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],GO:0003723; GO:0005634; GO:0022414; GO:0030154; GO:0043226; GO:0045182,RNA binding; nucleus; reproductive process; cell differentiation; organelle; translation regulator activity
OG_05106,FUN_023364-T2,Peve_00005343,Pocillopora_meandrina_HIv1___RNAseq.g17540.t1,three_way,47.92916666666667,,,,,,,,,,,,,,,,,
OG_05107,FUN_023365-T1,Peve_00005350,Pocillopora_meandrina_HIv1___TS.g17124.t1,three_way,78.19416666666667,FUN_023365-T1,Q15542,TAF5_HUMAN,,Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100),Homo sapiens (Human),27.4,361.0,1.6e-32,142.5,sp|Q15542|TAF5_HUMAN Transcription initiation factor TFIID subunit 5 OS=Homo sapiens OX=9606 GN=TAF5 PE=1 SV=3,GO:0000124; GO:0000785; GO:0005634; GO:0005654; GO:0005669; GO:0006282; GO:0006352; GO:0006357; GO:0006367; GO:0015629; GO:0016251; GO:0033276; GO:0042789; GO:0042802; GO:0045893; GO:0051123; GO:0060261,DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription initiation at RNA polymerase II promoter [GO:0006367],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276],identical protein binding [GO:0042802]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0005634; GO:0005654; GO:0005856; GO:0006351; GO:0006355; GO:0016071; GO:0043226; GO:0065003; GO:0140223,nucleus; nucleoplasm; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; organelle; protein-containing complex assembly; general transcription initiation factor activity
OG_05108,FUN_023367-T1,Peve_00005352,Pocillopora_meandrina_HIv1___TS.g17123.t1,three_way,73.227,FUN_023367-T1,Q91W97,HKDC1_MOUSE,,Hexokinase HKDC1 (EC 2.7.1.1) (Hexokinase domain-containing protein 1),Mus musculus (Mouse),46.1,447.0,1e-103,378.6,sp|Q91W97|HKDC1_MOUSE Hexokinase HKDC1 OS=Mus musculus OX=10090 GN=Hkdc1 PE=2 SV=1,GO:0001678; GO:0001917; GO:0004340; GO:0005524; GO:0005536; GO:0005739; GO:0006096; GO:0019318; GO:0031966; GO:0051156,glucose 6-phosphate metabolic process [GO:0051156]; glycolytic process [GO:0006096]; hexose metabolic process [GO:0019318]; intracellular glucose homeostasis [GO:0001678],mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; photoreceptor inner segment [GO:0001917],ATP binding [GO:0005524]; D-glucose binding [GO:0005536]; glucokinase activity [GO:0004340],GO:0003824; GO:0005739; GO:0005975; GO:0006091; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05109,FUN_023368-T1,Peve_00005353,Pocillopora_meandrina_HIv1___RNAseq.g17535.t1,three_way,80.16333333333333,FUN_023368-T1,Q12981,,,,,45.7,219.0,9.3e-42,171.8,sp|Q12981|SEC20_HUMAN Vesicle transport protein SEC20 OS=Homo sapiens OX=9606 GN=BNIP1 PE=1 SV=3,,,,,,
OG_05110,FUN_023369-T2,Peve_00005354,Pocillopora_meandrina_HIv1___TS.g17121.t2,three_way,69.55983333333333,FUN_023369-T2,O96028,NSD2_HUMAN,,Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.357) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein),Homo sapiens (Human),41.5,1229.0,2.6e-223,777.3,sp|O96028|NSD2_HUMAN Histone-lysine N-methyltransferase NSD2 OS=Homo sapiens OX=9606 GN=NSD2 PE=1 SV=1,GO:0000122; GO:0000785; GO:0003149; GO:0003289; GO:0003290; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006355; GO:0008270; GO:0032259; GO:0042799; GO:0043565; GO:0046975; GO:0048298; GO:0060348; GO:0070201; GO:0140938; GO:0140954; GO:0140955; GO:2001032,atrial septum primum morphogenesis [GO:0003289]; atrial septum secundum morphogenesis [GO:0003290]; bone development [GO:0060348]; double-strand break repair [GO:0006302]; membranous septum morphogenesis [GO:0003149]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of establishment of protein localization [GO:0070201],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K36 trimethyltransferase activity [GO:0140955]; histone H4K20 methyltransferase activity [GO:0042799]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05111,FUN_023370-T1,Peve_00005355,Pocillopora_meandrina_HIv1___RNAseq.g17532.t1,three_way,49.90916666666666,,,,,,,,,,,,,,,,,
OG_05112,FUN_023371-T1,Peve_00005356,Pocillopora_meandrina_HIv1___RNAseq.g17531.t1,three_way,86.89033333333333,FUN_023371-T1,Q8TD22,SFXN5_HUMAN,,Sideroflexin-5,Homo sapiens (Human),56.9,318.0,1.6e-103,377.5,sp|Q8TD22|SFXN5_HUMAN Sideroflexin-5 OS=Homo sapiens OX=9606 GN=SFXN5 PE=1 SV=1,GO:0005739; GO:0005743; GO:0006865; GO:0015075; GO:0015137; GO:0015746; GO:0120162; GO:1990542,amino acid transport [GO:0006865]; citrate transport [GO:0015746]; mitochondrial transmembrane transport [GO:1990542]; positive regulation of cold-induced thermogenesis [GO:0120162],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],citrate transmembrane transporter activity [GO:0015137]; monoatomic ion transmembrane transporter activity [GO:0015075],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_05113,FUN_023372-T1,Peve_00005358,Pocillopora_meandrina_HIv1___RNAseq.g17530.t1,three_way,85.00200000000001,FUN_023372-T1,Q14582,,,,,37.6,202.0,1.9e-13,77.4,sp|Q14582|MAD4_HUMAN Max dimerization protein 4 OS=Homo sapiens OX=9606 GN=MXD4 PE=1 SV=2,,,,,,
OG_05114,FUN_023373-T1,Peve_00005360,Pocillopora_meandrina_HIv1___RNAseq.g17529.t1,three_way,56.03366666666667,,,,,,,,,,,,,,,,,
OG_05115,FUN_023375-T1,Peve_00005363,Pocillopora_meandrina_HIv1___RNAseq.g17527.t1,three_way,81.29566666666666,FUN_023375-T1,Q804S6,,,,,49.5,105.0,7.6e-20,99.0,sp|Q804S6|EMX1_DANRE Homeobox protein EMX1 OS=Danio rerio OX=7955 GN=emx1 PE=2 SV=1,,,,,,
OG_05116,FUN_023376-T1,Peve_00005364,Pocillopora_meandrina_HIv1___RNAseq.g17526.t1,three_way,65.55333333333333,FUN_023376-T1,Q54PR9,CF60_DICDI,,Counting factor 60,Dictyostelium discoideum (Social amoeba),31.2,404.0,3.9e-42,174.1,sp|Q54PR9|CF60_DICDI Counting factor 60 OS=Dictyostelium discoideum OX=44689 GN=cf60 PE=1 SV=1,GO:0005576; GO:0016791; GO:0031158,negative regulation of aggregate size involved in sorocarp development [GO:0031158],extracellular region [GO:0005576],phosphatase activity [GO:0016791],GO:0003824; GO:0005576; GO:0016787,catalytic activity; extracellular region; hydrolase activity
OG_05117,FUN_023378-T1,Peve_00005367,Pocillopora_meandrina_HIv1___RNAseq.g17524.t1,three_way,84.52566666666667,FUN_023378-T1,Q6GLB9,,,,,40.1,192.0,1.6000000000000002e-23,110.9,sp|Q6GLB9|EMX1_XENTR Homeobox protein EMX1 OS=Xenopus tropicalis OX=8364 GN=emx1 PE=2 SV=1,,,,,,
OG_05118,FUN_023380-T1,Peve_00006487,Pocillopora_meandrina_HIv1___RNAseq.g17522.t2,three_way,55.57666666666667,FUN_023380-T1,P25291,,,,,41.4,133.0,1.5e-20,104.0,sp|P25291|GP2_CANLF Pancreatic secretory granule membrane major glycoprotein GP2 OS=Canis lupus familiaris OX=9615 GN=GP2 PE=1 SV=1,,,,,,
OG_05119,FUN_023381-T1,Peve_00030697,Pocillopora_meandrina_HIv1___RNAseq.g17515.t1,three_way,64.44500000000001,FUN_023381-T1,Q7ZWG6,PCFT_DANRE,,Proton-coupled folate transporter (Solute carrier family 46 member 1),Danio rerio (Zebrafish) (Brachydanio rerio),32.7,428.0,4.3e-52,207.2,sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1,GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085,transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05120,FUN_023382-T1,Peve_00014629,Pocillopora_meandrina_HIv1___RNAseq.g17514.t1,three_way,70.77666666666667,FUN_023382-T1,Q7ZWG6,PCFT_DANRE,,Proton-coupled folate transporter (Solute carrier family 46 member 1),Danio rerio (Zebrafish) (Brachydanio rerio),27.7,411.0,1.6e-37,158.7,sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1,GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085,transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05121,FUN_023383-T1,Peve_00015212,Pocillopora_meandrina_HIv1___TS.g17098.t2,three_way,73.90266666666666,FUN_023383-T1,Q26534,,,,,53.8,314.0,1.4e-95,351.7,sp|Q26534|CATL_SCHMA Cathepsin L OS=Schistosoma mansoni OX=6183 GN=CL1 PE=2 SV=1,,,,,,
OG_05122,FUN_023385-T1,Peve_00004634,Pocillopora_meandrina_HIv1___RNAseq.g17451.t1,three_way,50.331,FUN_023385-T1,Q923Y9,,,,,29.6,297.0,2e-22,108.2,sp|Q923Y9|TAAR1_RAT Trace amine-associated receptor 1 OS=Rattus norvegicus OX=10116 GN=Taar1 PE=2 SV=1,,,,,,
OG_05123,FUN_023386-T1,Peve_00004633,Pocillopora_meandrina_HIv1___RNAseq.g17450.t1,three_way,75.50966666666666,FUN_023386-T1,Q8R367,,,,,33.6,137.0,4.7e-16,85.9,sp|Q8R367|RERG_MOUSE Ras-related and estrogen-regulated growth inhibitor OS=Mus musculus OX=10090 GN=Rerg PE=2 SV=1,,,,,,
OG_05124,FUN_023388-T1,Peve_00038655,Pocillopora_meandrina_HIv1___TS.g17146.t1,three_way,77.67366666666666,FUN_023388-T1,H9D1R1,,,,,53.0,151.0,1.9e-38,162.9,sp|H9D1R1|TXD12_EPICO Thioredoxin domain-containing protein 12 OS=Epinephelus coioides OX=94232 GN=Txndc12 PE=1 SV=1,,,,,,
OG_05125,FUN_023389-T1,Peve_00038656,Pocillopora_meandrina_HIv1___RNAseq.g17561.t1,three_way,51.303666666666665,FUN_023389-T1,Q5I0C4,,,,,39.1,202.0,6.5e-32,139.8,sp|Q5I0C4|ABHEA_RAT Protein ABHD14A OS=Rattus norvegicus OX=10116 GN=Abhd14a PE=2 SV=1,,,,,,
OG_05126,FUN_023390-T1,Peve_00038658,Pocillopora_meandrina_HIv1___TS.g17148.t1,three_way,86.79466666666667,FUN_023390-T1,Q9W7R6,,,,,67.5,83.0,1.5e-26,121.3,sp|Q9W7R6|SOX14_CHICK Transcription factor SOX-14 OS=Gallus gallus OX=9031 GN=SOX14 PE=2 SV=1,,,,,,
OG_05127,FUN_023392-T1,Peve_00038659,Pocillopora_meandrina_HIv1___RNAseq.g17625.t2,three_way,55.8355,FUN_023392-T1,Q96LW4,PRIPO_HUMAN,,DNA-directed primase/polymerase protein (hPrimpol1) (EC 2.7.7.102) (EC 2.7.7.7) (Coiled-coil domain-containing protein 111),Homo sapiens (Human),42.4,507.0,8.4e-97,356.3,sp|Q96LW4|PRIPO_HUMAN DNA-directed primase/polymerase protein OS=Homo sapiens OX=9606 GN=PRIMPOL PE=1 SV=3,GO:0000428; GO:0003682; GO:0003887; GO:0003899; GO:0005634; GO:0005657; GO:0005739; GO:0005759; GO:0006264; GO:0006269; GO:0008270; GO:0009411; GO:0019985; GO:0030145; GO:0031297; GO:0042276; GO:0043504; GO:0062176,"DNA replication, synthesis of primer [GO:0006269]; error-prone translesion synthesis [GO:0042276]; mitochondrial DNA repair [GO:0043504]; mitochondrial DNA replication [GO:0006264]; R-loop processing [GO:0062176]; replication fork processing [GO:0031297]; response to UV [GO:0009411]; translesion synthesis [GO:0019985]",DNA-directed RNA polymerase complex [GO:0000428]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; replication fork [GO:0005657],chromatin binding [GO:0003682]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-directed RNA polymerase activity [GO:0003899]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005739; GO:0006260; GO:0006281; GO:0006325; GO:0016740; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; mitochondrion; DNA replication; DNA repair; chromatin organization; transferase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_05128,FUN_023393-T2,Peve_00038660,Pocillopora_meandrina_HIv1___RNAseq.g17626.t1,three_way,95.275,FUN_023393-T2,O43143,DHX15_HUMAN,,ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15) (Splicing factor Prp43) (hPrp43),Homo sapiens (Human),81.6,674.0,0.0,1121.3,sp|O43143|DHX15_HUMAN ATP-dependent RNA helicase DHX15 OS=Homo sapiens OX=9606 GN=DHX15 PE=1 SV=2,GO:0000398; GO:0003723; GO:0003724; GO:0003725; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005689; GO:0005730; GO:0006397; GO:0008186; GO:0008380; GO:0009636; GO:0016607; GO:0016887; GO:0042742; GO:0043123; GO:0043279; GO:0051607; GO:0140374,"antiviral innate immune response [GO:0140374]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380]",nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]",GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0098542; GO:0140098; GO:0140657,"immune system process; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05129,FUN_023394-T2,Peve_00038661,Pocillopora_meandrina_HIv1___RNAseq.g17627.t1,three_way,62.523,FUN_023394-T2,P10746,HEM4_HUMAN,,Uroporphyrinogen-III synthase (UROIIIS) (UROS) (EC 4.2.1.75) (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase),Homo sapiens (Human),36.3,262.0,2.3e-39,164.1,sp|P10746|HEM4_HUMAN Uroporphyrinogen-III synthase OS=Homo sapiens OX=9606 GN=Mgu PE=1 SV=1,GO:0004852; GO:0005542; GO:0005739; GO:0005829; GO:0006780; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0048034; GO:0070541; GO:0071243; GO:0071418,cellular response to amine stimulus [GO:0071418]; cellular response to arsenic-containing substance [GO:0071243]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to platinum ion [GO:0070541]; uroporphyrinogen III biosynthetic process [GO:0006780],cytosol [GO:0005829]; mitochondrion [GO:0005739],folic acid binding [GO:0005542]; uroporphyrinogen-III synthase activity [GO:0004852],GO:0003824; GO:0005739; GO:0005829; GO:0016829; GO:0043226,catalytic activity; mitochondrion; cytosol; lyase activity; organelle
OG_05130,FUN_023398-T1,Peve_00004631,Pocillopora_meandrina_HIv1___RNAseq.g17445.t1,three_way,65.884,FUN_023398-T1,Q9BW72,,,,,47.9,71.0,1.4e-12,74.3,"sp|Q9BW72|HIG2A_HUMAN HIG1 domain family member 2A, mitochondrial OS=Homo sapiens OX=9606 GN=HIGD2A PE=1 SV=1",,,,,,
OG_05131,FUN_023399-T1,Peve_00004637,Pocillopora_meandrina_HIv1___RNAseq.g17446.t1,three_way,47.458,,,,,,,,,,,,,,,,,
OG_05132,FUN_023401-T1,Peve_00004630,Pocillopora_meandrina_HIv1___RNAseq.g17449.t1,three_way,62.9805,FUN_023401-T1,P47747,,,,,32.1,290.0,6.1e-26,119.8,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_05133,FUN_023402-T1,Peve_00038654,Pocillopora_meandrina_HIv1___RNAseq.g17559.t1,three_way,90.449,FUN_023402-T1,Q3ZCH0,HSPA9_BOVIN,,"Stress-70 protein, mitochondrial (EC 3.6.4.10) (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9)",Bos taurus (Bovine),78.8,660.0,3.6e-295,1015.4,"sp|Q3ZCH0|HSPA9_BOVIN Stress-70 protein, mitochondrial OS=Bos taurus OX=9913 GN=HSPA9 PE=2 SV=1",GO:0005524; GO:0005730; GO:0005737; GO:0005739; GO:0005759; GO:0006611; GO:0016226; GO:0016887; GO:0030218; GO:0031072; GO:0031625; GO:0036444; GO:0042026; GO:0042645; GO:0043065; GO:0044183; GO:0045646; GO:0045647; GO:0051082; GO:0051085; GO:0140662; GO:1902037; GO:1903707,calcium import into the mitochondrion [GO:0036444]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; positive regulation of apoptotic process [GO:0043065]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; protein folding chaperone [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],GO:0003824; GO:0005730; GO:0005739; GO:0006457; GO:0006886; GO:0006913; GO:0016787; GO:0030154; GO:0043226; GO:0044183; GO:0055085; GO:0140657,catalytic activity; nucleolus; mitochondrion; protein folding; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; cell differentiation; organelle; protein folding chaperone; transmembrane transport; ATP-dependent activity
OG_05134,FUN_023405-T1,Peve_00016099,Pocillopora_meandrina_HIv1___RNAseq.g17555.t1,three_way,68.52166666666666,,,,,,,,,,,,,,,,,
OG_05135,FUN_023406-T1,Peve_00016101,Pocillopora_meandrina_HIv1___RNAseq.g17553.t1,three_way,88.30066666666667,FUN_023406-T1,P24844,MYL9_HUMAN,,"Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)",Homo sapiens (Human),59.1,171.0,2.5e-52,206.5,sp|P24844|MYL9_HUMAN Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4,GO:0001725; GO:0005200; GO:0005509; GO:0005737; GO:0005829; GO:0005859; GO:0005938; GO:0006937; GO:0008307; GO:0016460; GO:0030016; GO:0030018; GO:0030239; GO:0032036; GO:0043149; GO:0070527,myofibril assembly [GO:0030239]; platelet aggregation [GO:0070527]; regulation of muscle contraction [GO:0006937]; stress fiber assembly [GO:0043149],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307],GO:0005198; GO:0005829; GO:0007010; GO:0007155; GO:0008092; GO:0043226,structural molecule activity; cytosol; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; organelle
OG_05136,FUN_023407-T1,Peve_00016102,Pocillopora_meandrina_HIv1___RNAseq.g17552.t1,three_way,89.46416666666667,FUN_023407-T1,P24032,,,,,63.5,170.0,1.6e-54,213.8,"sp|P24032|MLRN_CHICK Myosin regulatory light chain 2, smooth muscle minor isoform OS=Gallus gallus OX=9031 PE=1 SV=2",,,,,,
OG_05137,FUN_023408-T1,Peve_00016095,Pocillopora_meandrina_HIv1___RNAseq.g17551.t1,three_way,72.24833333333333,FUN_023408-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),32.9,286.0,1.6e-26,121.3,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_05138,FUN_023410-T1,Peve_00017394,Pocillopora_meandrina_HIv1___RNAseq.g17575.t1,three_way,54.03783333333333,FUN_023410-T1,Q1LYG0,,,,,34.5,313.0,3.9e-50,201.8,sp|Q1LYG0|SPD2A_DANRE SH3 and PX domain-containing protein 2A OS=Danio rerio OX=7955 GN=sh3pxd2a PE=3 SV=2,,,,,,
OG_05139,FUN_023415-T1,Peve_00017405,Pocillopora_meandrina_HIv1___RNAseq.g17586.t1,three_way,77.27233333333334,FUN_023415-T1,Q5SWK7,RN145_MOUSE,,RING finger protein 145 (EC 2.3.2.27),Mus musculus (Mouse),27.9,584.0,2.3e-46,188.3,sp|Q5SWK7|RN145_MOUSE RING finger protein 145 OS=Mus musculus OX=10090 GN=Rnf145 PE=1 SV=1,GO:0005789; GO:0008270; GO:0016740,,endoplasmic reticulum membrane [GO:0005789],transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_05140,FUN_023416-T1,Peve_00017406,Pocillopora_meandrina_HIv1___RNAseq.g17587.t2,three_way,86.484,FUN_023416-T1,Q9UHX1,,,,,45.5,569.0,4.5e-115,416.8,sp|Q9UHX1|PUF60_HUMAN Poly(U)-binding-splicing factor PUF60 OS=Homo sapiens OX=9606 GN=PUF60 PE=1 SV=1,,,,,,
OG_05141,FUN_023417-T1,Peve_00017409,Pocillopora_meandrina_HIv1___RNAseq.g17588.t1,three_way,80.30666666666667,FUN_023417-T1,Q28ID3,,,,,62.9,318.0,4.4e-114,412.5,sp|Q28ID3|GLRX3_XENTR Glutaredoxin-3 OS=Xenopus tropicalis OX=8364 GN=glrx3 PE=2 SV=2,,,,,,
OG_05142,FUN_023418-T1,Peve_00019270,Pocillopora_meandrina_HIv1___RNAseq.g579.t1,three_way,56.60016666666667,FUN_023418-T1,Q5ZJR9,,,,,27.2,383.0,7.6e-21,103.6,sp|Q5ZJR9|TAF1B_CHICK TATA box-binding protein-associated factor RNA polymerase I subunit B OS=Gallus gallus OX=9031 GN=TAF1B PE=2 SV=2,,,,,,
OG_05143,FUN_023419-T2,Peve_00019272,Pocillopora_meandrina_HIv1___RNAseq.g580.t1,three_way,70.67533333333334,FUN_023419-T2,Q8N9I5,FADS6_HUMAN,,Fatty acid desaturase 6 (EC 1.14.19.-),Homo sapiens (Human),45.8,330.0,2.4e-77,290.8,sp|Q8N9I5|FADS6_HUMAN Fatty acid desaturase 6 OS=Homo sapiens OX=9606 GN=FADS6 PE=1 SV=2,GO:0006629; GO:0006633; GO:0016020; GO:0016717,fatty acid biosynthetic process [GO:0006633]; lipid metabolic process [GO:0006629],membrane [GO:0016020],"oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO:0016717]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_05144,FUN_023420-T1,Peve_00019213,Pocillopora_meandrina_HIv1___RNAseq.g581.t1,three_way,86.11033333333333,FUN_023420-T1,Q5ZIG2,SLU7_CHICK,,Pre-mRNA-splicing factor SLU7,Gallus gallus (Chicken),65.2,543.0,4.1e-181,636.0,sp|Q5ZIG2|SLU7_CHICK Pre-mRNA-splicing factor SLU7 OS=Gallus gallus OX=9031 GN=SLU7 PE=2 SV=1,GO:0000398; GO:0005681; GO:0005737; GO:0008270; GO:0008380; GO:0016607; GO:0030628,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681],pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270],GO:0003723; GO:0016071; GO:0043226,RNA binding; mRNA metabolic process; organelle
OG_05145,FUN_023421-T1,Peve_00019214,Pocillopora_meandrina_HIv1___RNAseq.g582.t1,three_way,76.22699999999999,FUN_023421-T1,Q12907,,,,,46.8,333.0,2.3e-78,293.9,sp|Q12907|LMAN2_HUMAN Vesicular integral-membrane protein VIP36 OS=Homo sapiens OX=9606 GN=LMAN2 PE=1 SV=1,,,,,,
OG_05146,FUN_023423-T1,Peve_00019215,Pocillopora_meandrina_HIv1___RNAseq.g583.t1,three_way,90.14433333333334,FUN_023423-T1,Q5R416,CTNA2_PONAB,,Catenin alpha-2 (Alpha N-catenin),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),41.2,1200.0,2.9000000000000003e-214,747.3,sp|Q5R416|CTNA2_PONAB Catenin alpha-2 OS=Pongo abelii OX=9601 GN=CTNNA2 PE=2 SV=3,GO:0005198; GO:0005634; GO:0005737; GO:0005912; GO:0007409; GO:0008013; GO:0010975; GO:0015629; GO:0016342; GO:0021942; GO:0030424; GO:0034316; GO:0045296; GO:0048813; GO:0048854; GO:0051015; GO:0051823; GO:0060134; GO:0098609; GO:2001222,axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of neuron migration [GO:2001222]; regulation of neuron projection development [GO:0010975]; regulation of synapse structural plasticity [GO:0051823],actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; catenin complex [GO:0016342]; cytoplasm [GO:0005737]; nucleus [GO:0005634],actin filament binding [GO:0051015]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; structural molecule activity [GO:0005198],GO:0005198; GO:0005634; GO:0005856; GO:0007155; GO:0008092; GO:0043226; GO:0048870,structural molecule activity; nucleus; cytoskeleton; cell adhesion; cytoskeletal protein binding; organelle; cell motility
OG_05147,FUN_023426-T1,Peve_00019216,Pocillopora_meandrina_HIv1___RNAseq.g584.t1,three_way,75.90066666666667,FUN_023426-T1,Q6P4Q7,CNNM4_HUMAN,,Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4),Homo sapiens (Human),52.5,537.0,1.7e-155,550.8,sp|Q6P4Q7|CNNM4_HUMAN Metal transporter CNNM4 OS=Homo sapiens OX=9606 GN=CNNM4 PE=1 SV=3,GO:0005886; GO:0007601; GO:0010960; GO:0015081; GO:0015095; GO:0015693; GO:0016323; GO:0030003; GO:0032991; GO:0070166,enamel mineralization [GO:0070166]; intracellular monoatomic cation homeostasis [GO:0030003]; magnesium ion homeostasis [GO:0010960]; magnesium ion transport [GO:0015693]; visual perception [GO:0007601],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],magnesium ion transmembrane transporter activity [GO:0015095]; sodium ion transmembrane transporter activity [GO:0015081],GO:0005215; GO:0005886; GO:0048856; GO:0050877,transporter activity; plasma membrane; anatomical structure development; nervous system process
OG_05148,FUN_023427-T1,Peve_00019217,Pocillopora_meandrina_HIv1___TS.g25286.t1,three_way,69.96566666666666,FUN_023427-T1,P47747,,,,,32.2,292.0,8.000000000000001e-29,129.4,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_05149,FUN_023431-T1,Peve_00019220,Pocillopora_meandrina_HIv1___RNAseq.g563.t1,three_way,61.802166666666665,FUN_023431-T1,O13076,,,,,23.0,309.0,6e-08,60.1,sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1,,,,,,
OG_05150,FUN_023433-T1,Peve_00019225,Pocillopora_meandrina_HIv1___TS.g25287.t1,three_way,71.47266666666667,FUN_023433-T1,Q9UBG0,MRC2_HUMAN,,C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280),Homo sapiens (Human),32.6,132.0,8.5e-14,80.5,sp|Q9UBG0|MRC2_HUMAN C-type mannose receptor 2 OS=Homo sapiens OX=9606 GN=MRC2 PE=1 SV=2,GO:0001649; GO:0005518; GO:0005925; GO:0006897; GO:0016020; GO:0030246; GO:0030574; GO:0038023,collagen catabolic process [GO:0030574]; endocytosis [GO:0006897]; osteoblast differentiation [GO:0001649],focal adhesion [GO:0005925]; membrane [GO:0016020],carbohydrate binding [GO:0030246]; collagen binding [GO:0005518]; signaling receptor activity [GO:0038023],GO:0016192; GO:0030154; GO:0060089,vesicle-mediated transport; cell differentiation; molecular transducer activity
OG_05151,FUN_023434-T1,Peve_00019227,Pocillopora_meandrina_HIv1___RNAseq.g550.t1,three_way,80.48166666666667,FUN_023434-T1,Q7L273,KCTD9_HUMAN,,BTB/POZ domain-containing protein KCTD9,Homo sapiens (Human),53.6,235.0,1.4000000000000001e-59,231.9,sp|Q7L273|KCTD9_HUMAN BTB/POZ domain-containing protein KCTD9 OS=Homo sapiens OX=9606 GN=KCTD9 PE=1 SV=1,GO:0016567; GO:0035556; GO:0042802; GO:0051260; GO:0097602,intracellular signal transduction [GO:0035556]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567],,cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802],GO:0065003,protein-containing complex assembly
OG_05152,FUN_023435-T1,Peve_00019228,Pocillopora_meandrina_HIv1___RNAseq.g549.t1a,three_way,81.44566666666667,FUN_023435-T1,Q9NQW7,XPP1_HUMAN,,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",Homo sapiens (Human),56.8,620.0,1.9e-203,710.3,sp|Q9NQW7|XPP1_HUMAN Xaa-Pro aminopeptidase 1 OS=Homo sapiens OX=9606 GN=XPNPEP1 PE=1 SV=3,GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006; GO:0070062,bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05153,FUN_023437-T1,Peve_00011119,Pocillopora_meandrina_HIv1___RNAseq.g17830.t1,three_way,67.552,,,,,,,,,,,,,,,,,
OG_05154,FUN_023441-T1,Peve_00019234,Pocillopora_meandrina_HIv1___RNAseq.g17618.t1b,three_way,79.646,FUN_023441-T1,Q9P2U8,VGLU2_HUMAN,,Vesicular glutamate transporter 2 (VGluT2) (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6),Homo sapiens (Human),41.8,407.0,9.4e-82,305.4,sp|Q9P2U8|VGLU2_HUMAN Vesicular glutamate transporter 2 OS=Homo sapiens OX=9606 GN=SLC17A6 PE=1 SV=1,GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0006811; GO:0006817; GO:0015386; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0051938; GO:0055062; GO:0060076; GO:0098700; GO:0140788; GO:1990384,"hyaloid vascular plexus regression [GO:1990384]; L-glutamate import [GO:0051938]; monoatomic ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]",chloride channel complex [GO:0034707]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamate uniporter activity [GO:0140788]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0005886; GO:0023052,transporter activity; plasma membrane; signaling
OG_05155,FUN_023442-T1,Peve_00019240,Pocillopora_meandrina_HIv1___RNAseq.g17640.t2,three_way,86.21766666666667,FUN_023442-T1,I6LDA6,,,,,61.0,520.0,2.4e-183,643.3,"sp|I6LDA6|GPMI_ONCVO 2,3-bisphosphoglycerate-independent phosphoglycerate mutase OS=Onchocerca volvulus OX=6282 GN=ipgm-1 PE=1 SV=1",,,,,,
OG_05156,FUN_023445-T1,Peve_00019243,Pocillopora_meandrina_HIv1___TS.g17221.t1,three_way,64.31433333333334,FUN_023445-T1,Q8WW35,DYT2B_HUMAN,,Dynein light chain Tctex-type protein 2B (Tctex1 domain-containing protein 2),Homo sapiens (Human),41.2,114.0,1.8e-19,97.4,sp|Q8WW35|DYT2B_HUMAN Dynein light chain Tctex-type protein 2B OS=Homo sapiens OX=9606 GN=DYNLT2B PE=1 SV=2,GO:0005737; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0045505; GO:0060271; GO:0120293; GO:1902017; GO:1905799,cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; microtubule-based movement [GO:0007018]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein axonemal particle [GO:0120293],dynein intermediate chain binding [GO:0045505],GO:0005929; GO:0007018; GO:0043226; GO:0044782,cilium; microtubule-based movement; organelle; cilium organization
OG_05157,FUN_023446-T1,Peve_00019244,Pocillopora_meandrina_HIv1___RNAseq.g17636.t1,three_way,73.13333333333333,FUN_023446-T1,Q708S6,ASI1C_DANRE,,"Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3)",Danio rerio (Zebrafish) (Brachydanio rerio),32.2,457.0,5.9999999999999996e-55,216.9,sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1,GO:0005261; GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128,cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725],dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05158,FUN_023447-T1,Peve_00019245,Pocillopora_meandrina_HIv1___RNAseq.g17633.t1,three_way,62.09233333333333,FUN_023447-T1,Q708S6,ASI1C_DANRE,,"Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3)",Danio rerio (Zebrafish) (Brachydanio rerio),26.3,457.0,1.1e-37,159.5,sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1,GO:0005261; GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128,cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725],dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05159,FUN_023449-T1,Peve_00037222,Pocillopora_meandrina_HIv1___RNAseq.g17631.t2,three_way,40.68716666666667,,,,,,,,,,,,,,,,,
OG_05160,FUN_023450-T1,Peve_00037237,Pocillopora_meandrina_HIv1___RNAseq.g17630.t1,three_way,87.68333333333334,FUN_023450-T1,Q9JI08,,,,,42.9,254.0,5.1999999999999996e-46,186.0,sp|Q9JI08|BIN3_MOUSE Bridging integrator 3 OS=Mus musculus OX=10090 GN=Bin3 PE=1 SV=1,,,,,,
OG_05161,FUN_023459-T1,Peve_00037224,Pocillopora_meandrina_HIv1___RNAseq.g17544.t1,three_way,95.354,FUN_023459-T1,O75643,U520_HUMAN,,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),Homo sapiens (Human),74.1,2143.0,0.0,3215.6,sp|O75643|U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens OX=9606 GN=SNRNP200 PE=1 SV=2,GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005886; GO:0005929; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013,"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]",catalytic step 2 spliceosome [GO:0071013]; cilium [GO:0005929]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005886; GO:0005929; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0065003; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; plasma membrane; cilium; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; protein-containing complex assembly; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05162,FUN_023460-T1,Peve_00004663,Pocillopora_meandrina_HIv1___RNAseq.g17545.t1,three_way,66.0435,FUN_023460-T1,P30937,SSR4_RAT,,Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R),Rattus norvegicus (Rat),26.8,284.0,1.2e-17,92.4,sp|P30937|SSR4_RAT Somatostatin receptor type 4 OS=Rattus norvegicus OX=10116 GN=Sstr4 PE=1 SV=1,GO:0004994; GO:0005886; GO:0007218; GO:0016477; GO:0030900; GO:0042923; GO:0043005; GO:0070374; GO:0071385; GO:0090238; GO:0106072,cell migration [GO:0016477]; cellular response to glucocorticoid stimulus [GO:0071385]; forebrain development [GO:0030900]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; neuropeptide signaling pathway [GO:0007218]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],neuron projection [GO:0043005]; plasma membrane [GO:0005886],neuropeptide binding [GO:0042923]; somatostatin receptor activity [GO:0004994],GO:0005886; GO:0048856; GO:0048870; GO:0060089,plasma membrane; anatomical structure development; cell motility; molecular transducer activity
OG_05163,FUN_023461-T1,Peve_00004657,Pocillopora_meandrina_HIv1___RNAseq.g17546.t1,three_way,73.69733333333333,FUN_023461-T1,G3M4F8,,,,,34.4,323.0,4.200000000000001e-36,153.7,sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1,,,,,,
OG_05164,FUN_023465-T1,Peve_00004659,Pocillopora_meandrina_HIv1___RNAseq.g17548.t1,three_way,69.85166666666666,FUN_023465-T1,Q9VCZ3,OCTB1_DROME,,Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R),Drosophila melanogaster (Fruit fly),31.4,341.0,8.3e-36,152.5,sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1,GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410],membrane [GO:0016020]; plasma membrane [GO:0005886],adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_05165,FUN_023489-T1,Peve_00017466,Pocillopora_meandrina_HIv1___RNAseq.g544.t1,three_way,67.37633333333333,FUN_023489-T1,P56484,,,,,25.7,319.0,2.9e-16,87.8,sp|P56484|CCR8_MOUSE C-C chemokine receptor type 8 OS=Mus musculus OX=10090 GN=Ccr8 PE=2 SV=1,,,,,,
OG_05166,FUN_023493-T1,Peve_00017463,Pocillopora_meandrina_HIv1___RNAseq.g543.t1,three_way,62.046,FUN_023493-T1,Q6DHN0,,,,,31.0,261.0,5.1e-27,123.2,sp|Q6DHN0|TMM53_DANRE Transmembrane protein 53 OS=Danio rerio OX=7955 GN=tmem53 PE=2 SV=1,,,,,,
OG_05167,FUN_023494-T1,Peve_00017462,Pocillopora_meandrina_HIv1___RNAseq.g542.t1,three_way,88.889,FUN_023494-T1,P51157,RAB28_HUMAN,,Ras-related protein Rab-28 (EC 3.6.5.2),Homo sapiens (Human),59.4,224.0,2.6e-73,276.6,sp|P51157|RAB28_HUMAN Ras-related protein Rab-28 OS=Homo sapiens OX=9606 GN=RAB28 PE=1 SV=2,GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005886; GO:0006886; GO:0012505; GO:0019003; GO:0035253; GO:0036064,intracellular protein transport [GO:0006886],ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005815; GO:0005886; GO:0006886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; microtubule organizing center; plasma membrane; intracellular protein transport; hydrolase activity; molecular function regulator activity
OG_05168,FUN_023496-T1,Peve_00017460,Pocillopora_meandrina_HIv1___TS.g25241.t1,three_way,76.61966666666666,FUN_023496-T1,Q9UMX1,,,,,51.2,449.0,2.1e-133,477.2,sp|Q9UMX1|SUFU_HUMAN Suppressor of fused homolog OS=Homo sapiens OX=9606 GN=SUFU PE=1 SV=2,,,,,,
OG_05169,FUN_023497-T1,Peve_00017459,Pocillopora_meandrina_HIv1___RNAseq.g539.t1,three_way,83.72433333333333,FUN_023497-T1,Q7T292,,,,,56.8,301.0,4.9e-98,359.4,sp|Q7T292|MFRN2_DANRE Mitoferrin-2 OS=Danio rerio OX=7955 GN=slc25a28 PE=2 SV=1,,,,,,
OG_05170,FUN_023498-T1,Peve_00017458,Pocillopora_meandrina_HIv1___RNAseq.g538.t1,three_way,71.93366666666667,FUN_023498-T1,Q9DAM9,FANK1_MOUSE,,Fibronectin type 3 and ankyrin repeat domains 1 protein (Germ cell-specific gene 1 protein) (GSG1),Mus musculus (Mouse),40.9,149.0,1.5999999999999999e-24,115.2,sp|Q9DAM9|FANK1_MOUSE Fibronectin type 3 and ankyrin repeat domains 1 protein OS=Mus musculus OX=10090 GN=Fank1 PE=1 SV=1,GO:0000785; GO:0005634; GO:0005654; GO:0005829; GO:0005929; GO:0036064; GO:0045893; GO:0051091; GO:0097546,positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893],chromatin [GO:0000785]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0006355; GO:0043226,nucleus; nucleoplasm; microtubule organizing center; cytosol; cilium; regulation of DNA-templated transcription; organelle
OG_05171,FUN_023499-T1,Peve_00017457,Pocillopora_meandrina_HIv1___RNAseq.g537.t1,three_way,81.41233333333334,FUN_023499-T1,Q8K1X1,WDR11_MOUSE,,WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2),Mus musculus (Mouse),43.1,1285.0,1.3e-299,1030.8,sp|Q8K1X1|WDR11_MOUSE WD repeat-containing protein 11 OS=Mus musculus OX=10090 GN=Wdr11 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005802; GO:0005929; GO:0005930; GO:0006886; GO:0007507; GO:0008589; GO:0031410; GO:0035264; GO:0036064; GO:0060271; GO:0060322; GO:0099041,cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041],axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802],,GO:0005634; GO:0005815; GO:0005929; GO:0006886; GO:0031410; GO:0043226; GO:0044782; GO:0048856,nucleus; microtubule organizing center; cilium; intracellular protein transport; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development
OG_05172,FUN_023500-T1,Peve_00017455,Pocillopora_meandrina_HIv1___RNAseq.g536.t1,three_way,69.905,FUN_023500-T1,Q28GF4,,,,,42.2,64.0,5.4e-06,52.0,sp|Q28GF4|SMIM8_XENTR Small integral membrane protein 8 OS=Xenopus tropicalis OX=8364 GN=smim8 PE=3 SV=1,,,,,,
OG_05173,FUN_023501-T1,Peve_00017454,Pocillopora_meandrina_HIv1___RNAseq.g534.t1,three_way,56.98533333333334,,,,,,,,,,,,,,,,,
OG_05174,FUN_023502-T1,Peve_00017448,Pocillopora_meandrina_HIv1___RNAseq.g533.t1,three_way,74.54433333333333,FUN_023502-T1,Q8IVU9,,,,,31.0,213.0,2e-18,94.7,sp|Q8IVU9|CBCO1_HUMAN Ciliary-associated calcium-binding coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=CABCOCO1 PE=1 SV=1,,,,,,
OG_05175,FUN_023503-T1,Peve_00017430,Pocillopora_meandrina_HIv1___RNAseq.g531.t2,three_way,72.32416666666667,FUN_023503-T1,Q3UUG6,TBC24_MOUSE,,TBC1 domain family member 24,Mus musculus (Mouse),28.8,539.0,1.3e-52,209.1,sp|Q3UUG6|TBC24_MOUSE TBC1 domain family member 24 OS=Mus musculus OX=10090 GN=Tbc1d24 PE=1 SV=2,GO:0005096; GO:0005886; GO:0016358; GO:0030659; GO:0031175; GO:0031594; GO:0034599; GO:0043195; GO:0048488; GO:0050775; GO:0061564; GO:1900408; GO:2000463; GO:2001224,axon development [GO:0061564]; cellular response to oxidative stress [GO:0034599]; dendrite development [GO:0016358]; negative regulation of cellular response to oxidative stress [GO:1900408]; neuron projection development [GO:0031175]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron migration [GO:2001224]; synaptic vesicle endocytosis [GO:0048488],cytoplasmic vesicle membrane [GO:0030659]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195],GTPase activator activity [GO:0005096],GO:0005886; GO:0016192; GO:0048856; GO:0098772,plasma membrane; vesicle-mediated transport; anatomical structure development; molecular function regulator activity
OG_05176,FUN_023504-T1,Peve_00005821,Pocillopora_meandrina_HIv1___RNAseq.g569.t1,three_way,45.79283333333333,FUN_023504-T1,Q8WZ42,TITIN_HUMAN,,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),Homo sapiens (Human),24.7,527.0,2.8e-18,95.1,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,GO:0000794; GO:0002020; GO:0003009; GO:0003300; GO:0004672; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0045214; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733,cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433],GO:0000228; GO:0003012; GO:0003824; GO:0005198; GO:0005576; GO:0005694; GO:0005829; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"nuclear chromosome; muscle system process; catalytic activity; structural molecule activity; extracellular region; chromosome; cytosol; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05177,FUN_023507-T1,Peve_00005822,Pocillopora_meandrina_HIv1___RNAseq.g568.t1,three_way,58.58383333333333,,,,,,,,,,,,,,,,,
OG_05178,FUN_023509-T1,Peve_00018237,Pocillopora_meandrina_HIv1___RNAseq.g567.t1,three_way,69.6595,FUN_023509-T1,Q60554,NKX61_MESAU,,Homeobox protein Nkx-6.1 (Homeobox protein NK-6 homolog A),Mesocricetus auratus (Golden hamster),67.6,108.0,1.9e-31,137.5,sp|Q60554|NKX61_MESAU Homeobox protein Nkx-6.1 OS=Mesocricetus auratus OX=10036 GN=NKX6-1 PE=1 SV=1,GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0010255; GO:0031016; GO:0044342; GO:0045944; GO:0061629; GO:0072560; GO:2000078,glucose mediated signaling pathway [GO:0010255]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type B pancreatic cell development [GO:2000078]; type B pancreatic cell maturation [GO:0072560]; type B pancreatic cell proliferation [GO:0044342],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05179,FUN_023512-T1,Peve_00009068,Pocillopora_meandrina_HIv1___TS.g9737.t1,three_way,70.70433333333332,FUN_023512-T1,P47747,,,,,36.1,263.0,1e-27,125.9,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_05180,FUN_023513-T1,Peve_00009065,Pocillopora_meandrina_HIv1___RNAseq.g3559.t1,three_way,63.098000000000006,FUN_023513-T1,Q76MS7,,,,,32.8,311.0,2.7000000000000004e-32,141.0,sp|Q76MS7|HRH2_GORGO Histamine H2 receptor OS=Gorilla gorilla gorilla OX=9595 GN=HRH2 PE=3 SV=1,,,,,,
OG_05181,FUN_023522-T1,Peve_00009063,Pocillopora_meandrina_HIv1___RNAseq.g3599.t1,three_way,72.77533333333334,FUN_023522-T1,Q8BH74,,,,,43.7,948.0,3.4e-215,750.0,sp|Q8BH74|NU107_MOUSE Nuclear pore complex protein Nup107 OS=Mus musculus OX=10090 GN=Nup107 PE=1 SV=1,,,,,,
OG_05182,FUN_023523-T1,Peve_00009062,Pocillopora_meandrina_HIv1___RNAseq.g3600.t2,three_way,64.48166666666667,FUN_023523-T1,Q4SQ06,,,,,35.9,78.0,1e-06,54.3,sp|Q4SQ06|NOP16_TETNG Nucleolar protein 16 OS=Tetraodon nigroviridis OX=99883 GN=nop16 PE=3 SV=1,,,,,,
OG_05183,FUN_023529-T1,Peve_00044316,Pocillopora_meandrina_HIv1___TS.g7657.t1,three_way,73.594,,,,,,,,,,,,,,,,,
OG_05184,FUN_023550-T1,Peve_00041532,Pocillopora_meandrina_HIv1___RNAseq.g11206.t1a,three_way,67.22466666666666,FUN_023550-T1,Q5SSH8,NEUFC_MOUSE,,Neuferricin (Cytochrome b5 domain-containing protein 2),Mus musculus (Mouse),43.9,223.0,2.5000000000000002e-58,227.3,sp|Q5SSH8|NEUFC_MOUSE Neuferricin OS=Mus musculus OX=10090 GN=Cyb5d2 PE=1 SV=1,GO:0005576; GO:0020037; GO:0030182; GO:0045666,neuron differentiation [GO:0030182]; positive regulation of neuron differentiation [GO:0045666],extracellular region [GO:0005576],heme binding [GO:0020037],GO:0005576; GO:0030154,extracellular region; cell differentiation
OG_05185,FUN_023551-T1,Peve_00009052,Pocillopora_meandrina_HIv1___RNAseq.g3556.t1,three_way,81.81566666666666,FUN_023551-T1,Q4R4Q3,,,,,32.7,297.0,1.1e-40,168.7,sp|Q4R4Q3|NDRG1_MACFA Protein NDRG1 OS=Macaca fascicularis OX=9541 GN=Ndrg1 PE=2 SV=1,,,,,,
OG_05186,FUN_023552-T1,Peve_00009071,Pocillopora_meandrina_HIv1___RNAseq.g3591.t2,three_way,74.04033333333334,FUN_023552-T1,Q9NXH9,TRM1_HUMAN,,"tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA methyltransferase 1) (hTRM1) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase)",Homo sapiens (Human),51.0,590.0,4.2e-163,576.2,sp|Q9NXH9|TRM1_HUMAN tRNA (guanine(26)-N(2))-dimethyltransferase OS=Homo sapiens OX=9606 GN=TRMT1 PE=1 SV=1,GO:0000049; GO:0002940; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0006400; GO:0008270; GO:0160104,tRNA modification [GO:0006400]; tRNA N2-guanine methylation [GO:0002940],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; tRNA (guanine(26)-N2)-dimethyltransferase activity [GO:0160104]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_05187,FUN_023553-T1,Peve_00009074,Pocillopora_meandrina_HIv1___RNAseq.g3589.t1,three_way,89.21216666666666,FUN_023553-T1,Q8NE35,CPEB3_HUMAN,,Cytoplasmic polyadenylation element-binding protein 3 (CPE-BP3) (CPE-binding protein 3) (hCPEB-3),Homo sapiens (Human),70.5,369.0,1.6e-146,521.2,sp|Q8NE35|CPEB3_HUMAN Cytoplasmic polyadenylation element-binding protein 3 OS=Homo sapiens OX=9606 GN=CPEB3 PE=1 SV=2,GO:0000122; GO:0000900; GO:0003723; GO:0003730; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0007616; GO:0008135; GO:0014069; GO:0017148; GO:0030014; GO:0030425; GO:0030496; GO:0035613; GO:0035925; GO:0043005; GO:0043022; GO:0045202; GO:0045727; GO:0048167; GO:0060213; GO:0060998; GO:0060999; GO:0061158; GO:0071230; GO:0097440; GO:1900153; GO:1900248; GO:2000766,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; long-term memory [GO:0007616]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of cytoplasmic translational elongation [GO:1900248]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translation [GO:0045727]; regulation of dendritic spine development [GO:0060998]; regulation of synaptic plasticity [GO:0048167]",apical dendrite [GO:0097440]; CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synapse [GO:0045202],"mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA regulatory element binding translation repressor activity [GO:0000900]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; translation factor activity, RNA binding [GO:0008135]",GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0045182; GO:0050877,RNA binding; nucleus; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; translation regulator activity; nervous system process
OG_05188,FUN_023554-T1,Peve_00024945,Pocillopora_meandrina_HIv1___RNAseq.g3590.t1,three_way,88.87966666666667,FUN_023554-T1,Q6GM44,,,,,63.3,275.0,7.8e-104,378.3,sp|Q6GM44|MARH5_XENLA E3 ubiquitin-protein ligase MARCHF5 OS=Xenopus laevis OX=8355 GN=marchf5 PE=2 SV=1,,,,,,
OG_05189,FUN_023555-T1,Peve_00009058,Pocillopora_meandrina_HIv1___RNAseq.g3555.t1,three_way,64.18966666666667,FUN_023555-T1,Q9UIF7,MUTYH_HUMAN,,Adenine DNA glycosylase (EC 3.2.2.31) (MutY homolog) (hMYH),Homo sapiens (Human),47.7,472.0,1.2e-110,401.7,sp|Q9UIF7|MUTYH_HUMAN Adenine DNA glycosylase OS=Homo sapiens OX=9606 GN=MUTYH PE=1 SV=1,GO:0000701; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006284; GO:0006298; GO:0019104; GO:0032357; GO:0032407; GO:0034039; GO:0035485; GO:0045007; GO:0046872; GO:0051539; GO:0060546,base-excision repair [GO:0006284]; depurination [GO:0045007]; DNA repair [GO:0006281]; mismatch repair [GO:0006298]; negative regulation of necroptotic process [GO:0060546],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; adenine/guanine mispair binding [GO:0035485]; DNA N-glycosylase activity [GO:0019104]; metal ion binding [GO:0046872]; MutSalpha complex binding [GO:0032407]; oxidized purine DNA binding [GO:0032357]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_05190,FUN_023556-T1,Peve_00037254,Pocillopora_meandrina_HIv1___RNAseq.g521.t1,three_way,64.69166666666666,FUN_023556-T1,Q9NYF3,,,,,25.5,318.0,2.4e-07,58.2,sp|Q9NYF3|FA53C_HUMAN Protein FAM53C OS=Homo sapiens OX=9606 GN=FAM53C PE=1 SV=1,,,,,,
OG_05191,FUN_023557-T1,Peve_00037255,Pocillopora_meandrina_HIv1___RNAseq.g520.t1,three_way,63.37466666666667,FUN_023557-T1,Q5TEA3,,,,,35.3,1191.0,5.8e-204,713.0,sp|Q5TEA3|DAAF9_HUMAN Dynein axonemal assembly factor 9 OS=Homo sapiens OX=9606 GN=DNAAF9 PE=1 SV=1,,,,,,
OG_05192,FUN_023558-T1,Peve_00037258,Pocillopora_meandrina_HIv1___RNAseq.g519.t1,three_way,71.653,FUN_023558-T1,P29419,,,,,46.3,67.0,8.1e-07,53.9,"sp|P29419|ATP5I_RAT ATP synthase F(0) complex subunit e, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5me PE=1 SV=3",,,,,,
OG_05193,FUN_023559-T1,Peve_00037259,Pocillopora_meandrina_HIv1___RNAseq.g518.t1,three_way,85.97,FUN_023559-T1,Q3T000,YKT6_BOVIN,,Synaptobrevin homolog YKT6 (EC 2.3.1.-),Bos taurus (Bovine),62.6,187.0,1.7e-59,230.7,sp|Q3T000|YKT6_BOVIN Synaptobrevin homolog YKT6 OS=Bos taurus OX=9913 GN=YKT6 PE=2 SV=1,GO:0000139; GO:0005484; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006888; GO:0006903; GO:0006904; GO:0015031; GO:0019706; GO:0030659,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903],cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],protein-cysteine S-palmitoyltransferase activity [GO:0019706]; SNAP receptor activity [GO:0005484],GO:0003824; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0016192; GO:0016740; GO:0043226; GO:0060090; GO:0140096,"catalytic activity; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; vesicle-mediated transport; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein"
OG_05194,FUN_023565-T2,Peve_00037262,Pocillopora_meandrina_HIv1___RNAseq.g514.t1,three_way,79.68733333333333,FUN_023565-T2,Q14642,,,,,45.9,386.0,2e-98,360.9,sp|Q14642|I5P1_HUMAN Inositol polyphosphate-5-phosphatase A OS=Homo sapiens OX=9606 GN=INPP5A PE=1 SV=1,,,,,,
OG_05195,FUN_023567-T1,Peve_00017440,Pocillopora_meandrina_HIv1___RNAseq.g565.t1,three_way,51.30566666666667,FUN_023567-T1,Q708S6,ASI1C_DANRE,,"Acid-sensing ion channel 1C (ASIC1-C) (Acid-sensing ion channel 1.3-C) (Amiloride-sensitive cation channel 2-C, neuronal-C) (ZASIC1.3)",Danio rerio (Zebrafish) (Brachydanio rerio),30.0,483.0,4.1999999999999996e-47,190.7,sp|Q708S6|ASI1C_DANRE Acid-sensing ion channel 1C OS=Danio rerio OX=7955 GN=asic1c PE=1 SV=1,GO:0005261; GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128,cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725],dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05196,FUN_023575-T1,Peve_00009070,Pocillopora_meandrina_HIv1___RNAseq.g3562.t1,three_way,75.99383333333334,FUN_023575-T1,Q298P4,PDE6_DROPS,,"cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35)",Drosophila pseudoobscura pseudoobscura (Fruit fly),56.5,749.0,1.2e-241,837.8,"sp|Q298P4|PDE6_DROPS cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=Pde6 PE=3 SV=3",GO:0005886; GO:0007165; GO:0016020; GO:0046068; GO:0046872; GO:0047555,cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165],membrane [GO:0016020]; plasma membrane [GO:0005886],"3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]",GO:0003824; GO:0005886; GO:0016787; GO:0055086; GO:1901135,catalytic activity; plasma membrane; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05197,FUN_023577-T1,Peve_00035415,Pocillopora_meandrina_HIv1___TS.g9740.t1,three_way,64.30766666666666,FUN_023577-T1,E1BGQ2,ZCHC4_BOVIN,,rRNA N(6)-adenosine-methyltransferase ZCCHC4 (EC 2.1.1.-) (Zinc finger CCHC domain-containing protein 4),Bos taurus (Bovine),48.2,498.0,3.4e-86,320.5,sp|E1BGQ2|ZCHC4_BOVIN rRNA N(6)-adenosine-methyltransferase ZCCHC4 OS=Bos taurus OX=9913 GN=ZCCHC4 PE=3 SV=1,GO:0003676; GO:0005730; GO:0005737; GO:0008270; GO:0008988; GO:0031167; GO:0045727; GO:1904047,positive regulation of translation [GO:0045727]; rRNA methylation [GO:0031167],cytoplasm [GO:0005737]; nucleolus [GO:0005730],nucleic acid binding [GO:0003676]; rRNA (adenine-N6-)-methyltransferase activity [GO:0008988]; S-adenosyl-L-methionine binding [GO:1904047]; zinc ion binding [GO:0008270],GO:0003824; GO:0005730; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleolus; transferase activity; organelle; catalytic activity, acting on RNA"
OG_05198,FUN_023578-T1,Peve_00035142,Pocillopora_meandrina_HIv1___RNAseq.g3534.t2,three_way,64.644,FUN_023578-T1,O95786,RIGI_HUMAN,,Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),Homo sapiens (Human),35.5,716.0,2.1e-106,388.7,sp|O95786|RIGI_HUMAN Antiviral innate immune response receptor RIG-I OS=Homo sapiens OX=9606 GN=RIGI PE=1 SV=2,GO:0002230; GO:0002735; GO:0002753; GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005923; GO:0008270; GO:0009597; GO:0009615; GO:0010467; GO:0010628; GO:0015629; GO:0016887; GO:0030334; GO:0031625; GO:0032587; GO:0032725; GO:0032727; GO:0032728; GO:0032755; GO:0032757; GO:0032760; GO:0034344; GO:0038187; GO:0039529; GO:0042802; GO:0043330; GO:0045087; GO:0045944; GO:0051607; GO:0060760; GO:0071360; GO:0140374; GO:1990904,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; gene expression [GO:0010467]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; ruffle membrane [GO:0032587],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005829; GO:0005856; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; cytosol; cytoskeleton; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; molecular transducer activity; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05199,FUN_023579-T1,Peve_00035155,Pocillopora_meandrina_HIv1___RNAseq.g3533.t1,three_way,74.84533333333333,FUN_023579-T1,Q9BST9,RTKN_HUMAN,,Rhotekin,Homo sapiens (Human),30.6,438.0,3.7e-48,194.1,sp|Q9BST9|RTKN_HUMAN Rhotekin OS=Homo sapiens OX=9606 GN=RTKN PE=1 SV=2,GO:0000281; GO:0000915; GO:0005095; GO:0005525; GO:0005826; GO:0005829; GO:0006915; GO:0007165; GO:0007266; GO:0031106; GO:0031267; GO:0042981,actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; mitotic cytokinesis [GO:0000281]; regulation of apoptotic process [GO:0042981]; Rho protein signal transduction [GO:0007266]; septin ring organization [GO:0031106]; signal transduction [GO:0007165],actomyosin contractile ring [GO:0005826]; cytosol [GO:0005829],GTP binding [GO:0005525]; GTPase inhibitor activity [GO:0005095]; small GTPase binding [GO:0031267],GO:0000910; GO:0005829; GO:0007010; GO:0012501; GO:0098772,cytokinesis; cytosol; cytoskeleton organization; programmed cell death; molecular function regulator activity
OG_05200,FUN_023581-T1,Peve_00035146,Pocillopora_meandrina_HIv1___RNAseq.g3529.t1,three_way,51.781333333333336,,,,,,,,,,,,,,,,,
OG_05201,FUN_023582-T1,Peve_00035145,Pocillopora_meandrina_HIv1___RNAseq.g3528.t1,three_way,65.47666666666666,FUN_023582-T1,Q91770,,,,,56.1,82.0,6.3e-16,85.9,sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1,,,,,,
OG_05202,FUN_023586-T1,Peve_00039436,Pocillopora_meandrina_HIv1___RNAseq.g3307.t1,three_way,72.94,,,,,,,,,,,,,,,,,
OG_05203,FUN_023587-T1,Peve_00012774,Pocillopora_meandrina_HIv1___RNAseq.g17843.t1,three_way,73.40833333333333,FUN_023587-T1,Q6DIF4,WDR1_XENTR,,WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),50.6,607.0,1.3e-172,607.8,sp|Q6DIF4|WDR1_XENTR WD repeat-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=wdr1 PE=2 SV=1,GO:0003779; GO:0005634; GO:0005737; GO:0005884; GO:0005886; GO:0030043; GO:0051015,actin filament fragmentation [GO:0030043],actin filament [GO:0005884]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],actin binding [GO:0003779]; actin filament binding [GO:0051015],GO:0005634; GO:0005886; GO:0008092; GO:0043226,nucleus; plasma membrane; cytoskeletal protein binding; organelle
OG_05204,FUN_023588-T1,Peve_00028963,Pocillopora_meandrina_HIv1___TS.g17411.t1,three_way,68.98,FUN_023588-T1,Q5ZK33,LETM1_CHICK,,Mitochondrial proton/calcium exchanger protein (Electroneutral mitochondrial K(+)/H(+)exchanger) (KHE) (Leucine zipper-EF-hand-containing transmembrane protein 1),Gallus gallus (Chicken),40.7,644.0,2.9999999999999997e-105,384.4,sp|Q5ZK33|LETM1_CHICK Mitochondrial proton/calcium exchanger protein OS=Gallus gallus OX=9031 GN=LETM1 PE=2 SV=1,GO:0005509; GO:0005739; GO:0005743; GO:0006813; GO:0006816; GO:0006851; GO:0007005; GO:0007007; GO:0015369; GO:0034214; GO:0043022; GO:0051260; GO:0051560; GO:0099093,calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrion organization [GO:0007005]; potassium ion transport [GO:0006813]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022],GO:0005215; GO:0005739; GO:0007005; GO:0043226; GO:0055085; GO:0061024; GO:0065003,transporter activity; mitochondrion; mitochondrion organization; organelle; transmembrane transport; membrane organization; protein-containing complex assembly
OG_05205,FUN_023589-T1,Peve_00028962,Pocillopora_meandrina_HIv1___RNAseq.g17840.t1,three_way,69.53,FUN_023589-T1,Q1ZZH1,,,,,37.3,823.0,6.8e-149,529.6,sp|Q1ZZH1|GRM3_MACFA Metabotropic glutamate receptor 3 OS=Macaca fascicularis OX=9541 GN=GRM3 PE=2 SV=1,,,,,,
OG_05206,FUN_023590-T1,Peve_00026477,Pocillopora_meandrina_HIv1___RNAseq.16918_t,three_way,48.98133333333333,,,,,,,,,,,,,,,,,
OG_05207,FUN_023591-T1,Peve_00023917,Pocillopora_meandrina_HIv1___RNAseq.g3310.t1,three_way,53.26583333333333,FUN_023591-T1,A7Z035,EPN4_BOVIN,,Clathrin interactor 1 (Epsin-4),Bos taurus (Bovine),38.2,626.0,8.3e-77,289.7,sp|A7Z035|EPN4_BOVIN Clathrin interactor 1 OS=Bos taurus OX=9913 GN=CLINT1 PE=2 SV=1,GO:0005543; GO:0005654; GO:0005768; GO:0005798; GO:0005802; GO:0005886; GO:0006897; GO:0030125; GO:0030276; GO:0048471,endocytosis [GO:0006897],clathrin vesicle coat [GO:0030125]; endosome [GO:0005768]; Golgi-associated vesicle [GO:0005798]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],clathrin binding [GO:0030276]; phospholipid binding [GO:0005543],GO:0005654; GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; endosome; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_05208,FUN_023592-T1,Peve_00023919,Pocillopora_meandrina_HIv1___RNAseq.g3311.t1,three_way,44.60383333333333,FUN_023592-T1,E9PVX6,KI67_MOUSE,,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog),Mus musculus (Mouse),42.2,135.0,5.7e-18,95.9,sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1,GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072089; GO:0072574; GO:0140693; GO:1902275; GO:1990705,cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088]; stem cell proliferation [GO:0072089],"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0007059; GO:0022414; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; chromosome; nucleolus; chromosome segregation; reproductive process; organelle; molecular adaptor activity
OG_05209,FUN_023593-T1,Peve_00039448,Pocillopora_meandrina_HIv1___RNAseq.g3313.t1,three_way,77.99266666666666,FUN_023593-T1,Q6PIW4,FIGL1_HUMAN,,Fidgetin-like protein 1 (EC 3.6.4.-),Homo sapiens (Human),45.8,718.0,3.7e-150,533.5,sp|Q6PIW4|FIGL1_HUMAN Fidgetin-like protein 1 OS=Homo sapiens OX=9606 GN=FIGNL1 PE=1 SV=2,GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0070062; GO:0071479; GO:2001243,ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule severing ATPase activity [GO:0008568],GO:0000228; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0055086; GO:0140013; GO:0140096; GO:0140657; GO:1901135,"nuclear chromosome; catalytic activity; nucleus; nucleoplasm; chromosome; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; nucleobase-containing small molecule metabolic process; meiotic nuclear division; catalytic activity, acting on a protein; ATP-dependent activity; carbohydrate derivative metabolic process"
OG_05210,FUN_023597-T1,Peve_00039446,Pocillopora_meandrina_HIv1___RNAseq.g19748.t1,three_way,71.65633333333334,FUN_023597-T1,P08217,CEL2A_HUMAN,,Chymotrypsin-like elastase family member 2A (EC 3.4.21.71) (Elastase-2A),Homo sapiens (Human),39.5,210.0,6.7e-31,135.6,sp|P08217|CEL2A_HUMAN Chymotrypsin-like elastase family member 2A OS=Homo sapiens OX=9606 GN=CELA2A PE=1 SV=1,GO:0004175; GO:0004252; GO:0005576; GO:0005615; GO:0005829; GO:0006508; GO:0017171; GO:0032868; GO:0036457; GO:0050796; GO:0090330; GO:1901143,insulin catabolic process [GO:1901143]; proteolysis [GO:0006508]; regulation of insulin secretion [GO:0050796]; regulation of platelet aggregation [GO:0090330]; response to insulin [GO:0032868],cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; keratohyalin granule [GO:0036457],endopeptidase activity [GO:0004175]; serine hydrolase activity [GO:0017171]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005615; GO:0005829; GO:0016787; GO:0030163; GO:0140096,"catalytic activity; extracellular region; extracellular space; cytosol; hydrolase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_05211,FUN_023616-T1,Peve_00018311,Pocillopora_meandrina_HIv1___RNAseq.g3518.t1,three_way,47.42466666666667,FUN_023616-T1,Q9CYL5,,,,,38.6,140.0,6.5e-21,104.4,sp|Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr2 PE=1 SV=3,,,,,,
OG_05212,FUN_023619-T1,Peve_00018316,Pocillopora_meandrina_HIv1___RNAseq.g3522.t2,three_way,51.43366666666667,,,,,,,,,,,,,,,,,
OG_05213,FUN_023620-T1,Peve_00018315,Pocillopora_meandrina_HIv1___RNAseq.g3523.t1,three_way,43.61633333333333,,,,,,,,,,,,,,,,,
OG_05214,FUN_023621-T1,Peve_00010901,Pocillopora_meandrina_HIv1___RNAseq.g3524.t1,three_way,81.48,FUN_023621-T1,Q969X5,ERGI1_HUMAN,,Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32),Homo sapiens (Human),58.6,227.0,1.9000000000000002e-74,280.4,sp|Q969X5|ERGI1_HUMAN Endoplasmic reticulum-Golgi intermediate compartment protein 1 OS=Homo sapiens OX=9606 GN=ERGIC1 PE=1 SV=1,GO:0000139; GO:0005654; GO:0005783; GO:0005789; GO:0005793; GO:0006888; GO:0006890; GO:0016020; GO:0030134; GO:0033116; GO:0043231,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005783; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; endoplasmic reticulum; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_05215,FUN_023623-T1,Peve_00010900,Pocillopora_meandrina_HIv1___RNAseq.g3525.t1,three_way,73.34016666666666,FUN_023623-T1,Q90W58,,,,,46.8,308.0,4.4e-68,260.0,sp|Q90W58|DUS1B_XENLA Dual specificity protein phosphatase 1-B OS=Xenopus laevis OX=8355 GN=dusp1-b PE=2 SV=1,,,,,,
OG_05216,FUN_023625-T1,Peve_00010903,Pocillopora_meandrina_HIv1___RNAseq.g3527.t1,three_way,62.84083333333333,FUN_023625-T1,A2AAY5,SPD2B_MOUSE,,SH3 and PX domain-containing protein 2B (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains),Mus musculus (Mouse),42.8,442.0,2.3e-99,365.5,sp|A2AAY5|SPD2B_MOUSE SH3 and PX domain-containing protein 2B OS=Mus musculus OX=10090 GN=Sh3pxd2b PE=1 SV=1,GO:0001501; GO:0001654; GO:0002051; GO:0002102; GO:0005737; GO:0006801; GO:0007507; GO:0010314; GO:0010628; GO:0032266; GO:0040018; GO:0042169; GO:0042995; GO:0045600; GO:0048705; GO:0051496; GO:0060348; GO:0060378; GO:0060612; GO:0070161; GO:0070273; GO:0071800; GO:0072657; GO:0080025; GO:1904179; GO:1904888,adipose tissue development [GO:0060612]; bone development [GO:0060348]; cranial skeletal system development [GO:1904888]; eye development [GO:0001654]; heart development [GO:0007507]; osteoblast fate commitment [GO:0002051]; podosome assembly [GO:0071800]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to membrane [GO:0072657]; regulation of brood size [GO:0060378]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; superoxide metabolic process [GO:0006801],anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; podosome [GO:0002102],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; SH2 domain binding [GO:0042169]",GO:0008289; GO:0022414; GO:0043226; GO:0048856; GO:0065003,lipid binding; reproductive process; organelle; anatomical structure development; protein-containing complex assembly
OG_05217,FUN_023627-T2,Peve_00037251,Pocillopora_meandrina_HIv1___RNAseq.g523.t1,three_way,55.51683333333334,FUN_023627-T2,Q9JIC3,,,,,30.6,1016.0,8.3e-114,412.9,sp|Q9JIC3|DCR1A_MOUSE DNA cross-link repair 1A protein OS=Mus musculus OX=10090 GN=Dclre1a PE=1 SV=2,,,,,,
OG_05218,FUN_023629-T1,Peve_00037249,Pocillopora_meandrina_HIv1___RNAseq.g525.t1,three_way,84.83833333333334,FUN_023629-T1,P34118,,,,,49.9,853.0,7.3e-193,675.6,sp|P34118|MVPA_DICDI Major vault protein alpha OS=Dictyostelium discoideum OX=44689 GN=mvpA PE=1 SV=1,,,,,,
OG_05219,FUN_023631-T1,Peve_00017456,Pocillopora_meandrina_HIv1___RNAseq.g526.t1,three_way,75.54283333333333,FUN_023631-T1,P57073,SOX8_HUMAN,,Transcription factor SOX-8,Homo sapiens (Human),59.1,110.0,6.7e-28,126.7,sp|P57073|SOX8_HUMAN Transcription factor SOX-8 OS=Homo sapiens OX=9606 GN=SOX8 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001649; GO:0001701; GO:0001755; GO:0002009; GO:0003677; GO:0005634; GO:0005667; GO:0005737; GO:0007165; GO:0007283; GO:0007422; GO:0008584; GO:0010628; GO:0010817; GO:0014015; GO:0014032; GO:0033690; GO:0035914; GO:0043066; GO:0045165; GO:0045444; GO:0045662; GO:0045892; GO:0045893; GO:0045944; GO:0046533; GO:0048469; GO:0048484; GO:0048709; GO:0060009; GO:0060018; GO:0060041; GO:0060221; GO:0060612; GO:0061138; GO:0072034; GO:0072197; GO:0072289; GO:0090184; GO:0090190; GO:0140297; GO:1990837,adipose tissue development [GO:0060612]; astrocyte fate commitment [GO:0060018]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; enteric nervous system development [GO:0048484]; fat cell differentiation [GO:0045444]; in utero embryonic development [GO:0001701]; male gonad development [GO:0008584]; metanephric nephron tubule formation [GO:0072289]; morphogenesis of a branching epithelium [GO:0061138]; morphogenesis of an epithelium [GO:0002009]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell development [GO:0014032]; neural crest cell migration [GO:0001755]; oligodendrocyte differentiation [GO:0048709]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of gliogenesis [GO:0014015]; positive regulation of kidney development [GO:0090184]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hormone levels [GO:0010817]; renal vesicle induction [GO:0072034]; retina development in camera-type eye [GO:0060041]; retinal rod cell differentiation [GO:0060221]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; spermatogenesis [GO:0007283]; ureter morphogenesis [GO:0072197],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_05220,FUN_023632-T1,Peve_00017477,Pocillopora_meandrina_HIv1___RNAseq.g527.t1,three_way,59.04733333333333,,,,,,,,,,,,,,,,,
OG_05221,FUN_023633-T1,Peve_00027834,Pocillopora_meandrina_HIv1___RNAseq.g17808.t1,three_way,84.26366666666667,FUN_023633-T1,Q5ZKJ5,,,,,58.5,491.0,2.5e-161,570.9,sp|Q5ZKJ5|MF13A_CHICK Transmembrane protein 180 OS=Gallus gallus OX=9031 GN=MFSD13A PE=2 SV=1,,,,,,
OG_05222,FUN_023634-T1,Peve_00027833,Pocillopora_meandrina_HIv1___RNAseq.g17811.t1,three_way,78.49183333333333,FUN_023634-T1,Q98TX3,,,,,45.7,438.0,1.4e-94,348.2,sp|Q98TX3|PDCD4_CHICK Programmed cell death protein 4 OS=Gallus gallus OX=9031 GN=PDCD4 PE=2 SV=1,,,,,,
OG_05223,FUN_023635-T1,Peve_00027832,Pocillopora_meandrina_HIv1___RNAseq.g17812.t1,three_way,82.328,FUN_023635-T1,A0A1L8GXY4,,,,,37.3,1717.0,8.1e-300,1031.9,sp|A0A1L8GXY4|CFA43_XENLA Cilia- and flagella-associated protein 43 OS=Xenopus laevis OX=8355 GN=cfap43 PE=2 SV=1,,,,,,
OG_05224,FUN_023636-T1,Peve_00027831,Pocillopora_meandrina_HIv1___RNAseq.g17813.t1,three_way,85.25933333333333,,,,,,,,,,,,,,,,,
OG_05225,FUN_023638-T1,Peve_00027830,Pocillopora_meandrina_HIv1___RNAseq.g17814.t1a,three_way,68.096,FUN_023638-T1,Q975N4,,,,,30.1,349.0,1.4000000000000001e-33,145.2,sp|Q975N4|METE_SULTO Methionine synthase OS=Sulfurisphaera tokodaii (strain DSM 16993 / JCM 10545 / NBRC 100140 / 7) OX=273063 GN=metE PE=3 SV=1,,,,,,
OG_05226,FUN_023639-T1,Peve_00027828,Pocillopora_meandrina_HIv1___RNAseq.g17814.t1c,three_way,45.796,,,,,,,,,,,,,,,,,
OG_05227,FUN_023640-T1,Peve_00036926,Pocillopora_meandrina_HIv1___TS.g15365.t1,three_way,62.085,FUN_023640-T1,A3KNJ3,FXI3A_DANRE,,Forkhead box protein I3-A,Danio rerio (Zebrafish) (Brachydanio rerio),35.0,140.0,7.5e-16,85.5,sp|A3KNJ3|FXI3A_DANRE Forkhead box protein I3-A OS=Danio rerio OX=7955 GN=foxi3a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0009913; GO:0009957; GO:0030154; GO:0050891; GO:0062236,anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; epidermal cell differentiation [GO:0009913]; epidermal cell fate specification [GO:0009957]; ionocyte differentiation [GO:0062236]; multicellular organismal-level water homeostasis [GO:0050891]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_05228,FUN_023641-T1,Peve_00027827,Pocillopora_meandrina_HIv1___RNAseq.g17817.t2,three_way,57.86066666666667,FUN_023641-T1,Q9H7T0,,,,,21.3,709.0,1.4e-27,127.1,sp|Q9H7T0|CTSRB_HUMAN Cation channel sperm-associated auxiliary subunit beta OS=Homo sapiens OX=9606 GN=CATSPERB PE=1 SV=2,,,,,,
OG_05229,FUN_023642-T1,Peve_00027826,Pocillopora_meandrina_HIv1___RNAseq.g17815.t1,three_way,79.919,FUN_023642-T1,P06798,,,,,55.1,107.0,5.1e-20,99.8,sp|P06798|HXA4_MOUSE Homeobox protein Hox-A4 OS=Mus musculus OX=10090 GN=Hoxa4 PE=2 SV=4,,,,,,
OG_05230,FUN_023643-T1,Peve_00027825,Pocillopora_meandrina_HIv1___RNAseq.g17818.t1,three_way,90.502,FUN_023643-T1,Q9DAA6,EXOS1_MOUSE,,Exosome complex component CSL4 (Exosome component 1),Mus musculus (Mouse),64.6,147.0,2.7000000000000004e-44,179.9,sp|Q9DAA6|EXOS1_MOUSE Exosome complex component CSL4 OS=Mus musculus OX=10090 GN=Exosc1 PE=1 SV=1,GO:0000176; GO:0000177; GO:0000178; GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0101019,RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364],cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleus [GO:0005634],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0043226,RNA binding; nucleus; nucleolus; cytosol; organelle
OG_05231,FUN_023644-T1,Peve_00027824,Pocillopora_meandrina_HIv1___RNAseq.g17819.t1,three_way,74.502,,,,,,,,,,,,,,,,,
OG_05232,FUN_023647-T1,Peve_00027823,Pocillopora_meandrina_HIv1___RNAseq.23947_t,three_way,76.041,FUN_023647-T1,Q6PCJ9,,,,,50.9,287.0,2.7e-78,293.5,sp|Q6PCJ9|PPT2A_XENLA Lysosomal thioesterase PPT2-A OS=Xenopus laevis OX=8355 GN=ppt2-a PE=2 SV=1,,,,,,
OG_05233,FUN_023648-T1,Peve_00027822,Pocillopora_meandrina_HIv1___TS.g17390.t1,three_way,77.26466666666667,FUN_023648-T1,B0I564,FANCI_CHICK,,Fanconi anemia group I protein,Gallus gallus (Chicken),44.9,1333.0,0.0,1077.4,sp|B0I564|FANCI_CHICK Fanconi anemia group I protein OS=Gallus gallus OX=9031 GN=FANCI PE=1 SV=1,GO:0005654; GO:0006281,DNA repair [GO:0006281],nucleoplasm [GO:0005654],,GO:0005654; GO:0006281,nucleoplasm; DNA repair
OG_05234,FUN_023649-T1,Peve_00027829,Pocillopora_meandrina_HIv1___RNAseq.g19794.t1,three_way,56.414,FUN_023649-T1,O96790,,,,,33.2,277.0,5.8e-27,123.2,sp|O96790|DPGN_DIPMA Serine protease inhibitor dipetalogastin (Fragment) OS=Dipetalogaster maximus OX=72496 PE=1 SV=2,,,,,,
OG_05235,FUN_023671-T1,Peve_00012777,Pocillopora_meandrina_HIv1___RNAseq.g17761.t1,three_way,50.331833333333336,,,,,,,,,,,,,,,,,
OG_05236,FUN_023672-T1,Peve_00012772,Pocillopora_meandrina_HIv1___RNAseq.g17760.t1,three_way,65.943,FUN_023672-T1,B3CQD1,,,,,51.4,358.0,5.9999999999999996e-92,339.3,sp|B3CQD1|RF1_ORITI Peptide chain release factor 1 OS=Orientia tsutsugamushi (strain Ikeda) OX=334380 GN=prfA PE=3 SV=1,,,,,,
OG_05237,FUN_023673-T1,Peve_00012773,Pocillopora_meandrina_HIv1___RNAseq.g17758.t1,three_way,59.16866666666667,FUN_023673-T1,A0A2B4RP11,,,,,24.7,393.0,1.1e-16,89.7,sp|A0A2B4RP11|CGLR1_STYPI Cyclic GMP-AMP synthase-like receptor 1 OS=Stylophora pistillata OX=50429 GN=cGLR1 PE=1 SV=1,,,,,,
OG_05238,FUN_023675-T1,Peve_00012771,Pocillopora_meandrina_HIv1___RNAseq.g17757.t1,three_way,66.28833333333333,FUN_023675-T1,Q5XI46,PAAT_RAT,,ATPase PAAT (EC 3.6.1.-) (Protein associated with ABC transporters) (PAAT),Rattus norvegicus (Rat),28.2,216.0,2.6e-10,68.2,sp|Q5XI46|PAAT_RAT ATPase PAAT OS=Rattus norvegicus OX=10116 GN=Paat PE=2 SV=1,GO:0005737; GO:0005739; GO:0016887; GO:0042802,,cytoplasm [GO:0005737]; mitochondrion [GO:0005739],ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802],GO:0003824; GO:0005739; GO:0016787; GO:0043226,catalytic activity; mitochondrion; hydrolase activity; organelle
OG_05239,FUN_023676-T1,Peve_00020274,Pocillopora_meandrina_HIv1___RNAseq.g17755.t1,three_way,66.76166666666667,FUN_023676-T1,G1T7U7,,,,,48.8,326.0,2.5e-83,310.5,sp|G1T7U7|NAAA_RABIT N-acylethanolamine-hydrolyzing acid amidase OS=Oryctolagus cuniculus OX=9986 GN=NAAA PE=1 SV=2,,,,,,
OG_05240,FUN_023681-T1,Peve_00020273,Pocillopora_meandrina_HIv1___RNAseq.g17754.t1,three_way,63.02466666666666,FUN_023681-T1,Q923Y6,,,,,26.4,295.0,4.2e-09,63.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_05241,FUN_023682-T1,Peve_00014139,Pocillopora_meandrina_HIv1___RNAseq.g17753.t1,three_way,78.52883333333334,FUN_023682-T1,A7SK48,EIF3A_NEMVE,,Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10),Nematostella vectensis (Starlet sea anemone),73.3,786.0,8.7e-296,1018.1,sp|A7SK48|EIF3A_NEMVE Eukaryotic translation initiation factor 3 subunit A OS=Nematostella vectensis OX=45351 GN=v1g190699 PE=3 SV=2,GO:0001732; GO:0002188; GO:0003729; GO:0003743; GO:0016282; GO:0033290; GO:0043614; GO:0071540; GO:0071541,formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188],"eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]",mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_05242,FUN_023683-T2,Peve_00014143,Pocillopora_meandrina_HIv1___RNAseq.g17734.t1,three_way,51.321,,,,,,,,,,,,,,,,,
OG_05243,FUN_023688-T1,Peve_00014148,Pocillopora_meandrina_HIv1___RNAseq.g17729.t1,three_way,65.41066666666667,FUN_023688-T1,Q0IJ20,,,,,46.7,225.0,3.3e-58,227.6,sp|Q0IJ20|RN145_XENTR RING finger protein 145 OS=Xenopus tropicalis OX=8364 GN=rnf145 PE=2 SV=1,,,,,,
OG_05244,FUN_023689-T1,Peve_00014149,Pocillopora_meandrina_HIv1___RNAseq.g17728.t1,three_way,68.89233333333334,FUN_023689-T1,F6S215,,,,,25.8,979.0,3.2e-75,285.0,sp|F6S215|AP5B1_XENTR AP-5 complex subunit beta-1 OS=Xenopus tropicalis OX=8364 GN=ap5b1 PE=3 SV=1,,,,,,
OG_05245,FUN_023691-T1,Peve_00014150,Pocillopora_meandrina_HIv1___RNAseq.g17727.t1,three_way,36.65,,,,,,,,,,,,,,,,,
OG_05246,FUN_023692-T1,Peve_00014152,Pocillopora_meandrina_HIv1___RNAseq.g17721.t1,three_way,88.26066666666667,FUN_023692-T1,Q4VC33,MAEA_MOUSE,,E3 ubiquitin-protein transferase MAEA (EC 2.3.2.27) (Erythroblast macrophage protein) (Macrophage erythroblast attacher),Mus musculus (Mouse),51.8,388.0,2.7000000000000004e-110,400.2,sp|Q4VC33|MAEA_MOUSE E3 ubiquitin-protein transferase MAEA OS=Mus musculus OX=10090 GN=Maea PE=1 SV=1,GO:0000151; GO:0003779; GO:0005654; GO:0005819; GO:0005826; GO:0005886; GO:0007010; GO:0007155; GO:0008270; GO:0015629; GO:0016363; GO:0033033; GO:0043161; GO:0043249; GO:0048821; GO:0048822; GO:0051301; GO:0061630,cell adhesion [GO:0007155]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte development [GO:0048821]; erythrocyte maturation [GO:0043249]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],actin cytoskeleton [GO:0015629]; actomyosin contractile ring [GO:0005826]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005856; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleoplasm; cytoskeleton; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; transferase activity; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05247,FUN_023693-T1,Peve_00014155,Pocillopora_meandrina_HIv1___RNAseq.g17720.t1,three_way,64.13166666666666,FUN_023693-T1,Q5YCC5,,,,,29.7,660.0,6.2e-79,297.0,sp|Q5YCC5|TMC7_CHICK Transmembrane channel-like protein 7 OS=Gallus gallus OX=9031 GN=Tmc7 PE=2 SV=1,,,,,,
OG_05248,FUN_023694-T1,Peve_00017435,Pocillopora_meandrina_HIv1___RNAseq.g17612.t1,three_way,85.42266666666667,FUN_023694-T1,Q28G26,P4K2B_XENTR,,Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),61.3,434.0,4.4e-152,539.3,sp|Q28G26|P4K2B_XENTR Phosphatidylinositol 4-kinase type 2-beta OS=Xenopus tropicalis OX=8364 GN=pi4k2b PE=2 SV=1,GO:0000139; GO:0004430; GO:0005524; GO:0005789; GO:0005829; GO:0005886; GO:0031901; GO:0046854,phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016740,catalytic activity; cytosol; plasma membrane; lipid metabolic process; transferase activity
OG_05249,FUN_023696-T1,Peve_00017427,Pocillopora_meandrina_HIv1___RNAseq.g17601.t1,three_way,48.01816666666667,,,,,,,,,,,,,,,,,
OG_05250,FUN_023697-T1,Peve_00017421,Pocillopora_meandrina_HIv1___RNAseq.g17597.t1,three_way,43.47883333333333,FUN_023697-T1,B3EWZ2,,,,,96.7,214.0,2.8e-117,422.5,sp|B3EWZ2|USOM8_ACRMI Uncharacterized skeletal organic matrix protein 8 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05251,FUN_023698-T1,Peve_00017419,Pocillopora_meandrina_HIv1___RNAseq.g17595.t2a,three_way,87.464,FUN_023698-T1,Q01890,,,,,61.8,170.0,1.2e-59,231.1,sp|Q01890|YPT1_PHYIN Ras-like GTP-binding protein YPT1 OS=Phytophthora infestans OX=4787 GN=YPT1 PE=3 SV=1,,,,,,
OG_05252,FUN_023700-T1,Peve_00017416,Pocillopora_meandrina_HIv1___RNAseq.g17595.t2b,three_way,81.831,FUN_023700-T1,O14776,TCRG1_HUMAN,,Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150),Homo sapiens (Human),60.9,274.0,1.7000000000000001e-65,251.1,sp|O14776|TCRG1_HUMAN Transcription elongation regulator 1 OS=Homo sapiens OX=9606 GN=TCERG1 PE=1 SV=2,GO:0000122; GO:0003711; GO:0003712; GO:0003713; GO:0003714; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032968; GO:0034244; GO:0042802; GO:0044390; GO:0045944; GO:0061629; GO:0070063,mRNA processing [GO:0006397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription elongation factor activity [GO:0003711]; ubiquitin-like protein conjugating enzyme binding [GO:0044390],GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0140110,RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_05253,FUN_023701-T1,Peve_00017415,Pocillopora_meandrina_HIv1___RNAseq.g17594.t1,three_way,79.94866666666667,FUN_023701-T1,Q8IYX7,SAXO1_HUMAN,,Stabilizer of axonemal microtubules 1,Homo sapiens (Human),21.5,498.0,2.4e-12,75.1,sp|Q8IYX7|SAXO1_HUMAN Stabilizer of axonemal microtubules 1 OS=Homo sapiens OX=9606 GN=SAXO1 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005856; GO:0005879; GO:0008017; GO:0009631; GO:0030030; GO:0031514; GO:0036064; GO:0036126; GO:0045724; GO:0050821; GO:0070417,cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821],axonemal microtubule [GO:0005879]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],microtubule binding [GO:0008017],GO:0005815; GO:0005856; GO:0005929; GO:0008092; GO:0043226,microtubule organizing center; cytoskeleton; cilium; cytoskeletal protein binding; organelle
OG_05254,FUN_023702-T1,Peve_00017411,Pocillopora_meandrina_HIv1___RNAseq.g17589.t1,three_way,69.48033333333333,FUN_023702-T1,Q3KP44,ANR55_HUMAN,,Ankyrin repeat domain-containing protein 55,Homo sapiens (Human),25.1,259.0,1.5e-16,89.0,sp|Q3KP44|ANR55_HUMAN Ankyrin repeat domain-containing protein 55 OS=Homo sapiens OX=9606 GN=ANKRD55 PE=1 SV=3,,,,,,
OG_05255,FUN_023758-T1,Peve_00044463,Pocillopora_meandrina_HIv1___RNAseq.g3496.t2,three_way,86.88133333333333,FUN_023758-T1,Q3T0Z7,,,,,59.3,226.0,2.7e-76,286.6,sp|Q3T0Z7|DHPR_BOVIN Dihydropteridine reductase OS=Bos taurus OX=9913 GN=QDPR PE=2 SV=1,,,,,,
OG_05256,FUN_023759-T1,Peve_00044461,Pocillopora_meandrina_HIv1___RNAseq.g3497.t1,three_way,51.79566666666666,FUN_023759-T1,E7FBY6,AGRA2_DANRE,,Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124),Danio rerio (Zebrafish) (Brachydanio rerio),26.0,889.0,4.7e-66,255.4,sp|E7FBY6|AGRA2_DANRE Adhesion G protein-coupled receptor A2 OS=Danio rerio OX=7955 GN=adgra2 PE=1 SV=2,GO:0001525; GO:0004930; GO:0005886; GO:0007399; GO:0060070; GO:1990909,angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; nervous system development [GO:0007399],plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0048856; GO:0060089,plasma membrane; anatomical structure development; molecular transducer activity
OG_05257,FUN_023760-T1,Peve_00040584,Pocillopora_meandrina_HIv1___RNAseq.g3498.t1,three_way,71.76966666666667,FUN_023760-T1,Q8BTQ0,PCGF3_MOUSE,,Polycomb group RING finger protein 3 (RING finger protein 3A),Mus musculus (Mouse),40.6,244.0,1.3e-41,171.4,sp|Q8BTQ0|PCGF3_MOUSE Polycomb group RING finger protein 3 OS=Mus musculus OX=10090 GN=PcgF3 PE=1 SV=1,GO:0005654; GO:0008270; GO:0031519; GO:0060816; GO:0140862,random inactivation of X chromosome [GO:0060816],nucleoplasm [GO:0005654]; PcG protein complex [GO:0031519],histone H2AK119 ubiquitin ligase activity [GO:0140862]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006325; GO:0016740; GO:0140096,"catalytic activity; nucleoplasm; chromatin organization; transferase activity; catalytic activity, acting on a protein"
OG_05258,FUN_023762-T1,Peve_00044465,Pocillopora_meandrina_HIv1___TS.g9665.t1,three_way,75.69,FUN_023762-T1,P00727,AMPL_BOVIN,,Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (LAP) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase),Bos taurus (Bovine),60.9,294.0,8.999999999999999e-96,351.7,sp|P00727|AMPL_BOVIN Cytosol aminopeptidase OS=Bos taurus OX=9913 GN=LAP3 PE=1 SV=3,GO:0004180; GO:0005737; GO:0005739; GO:0006508; GO:0008233; GO:0016805; GO:0030145; GO:0070006; GO:0097718,proteolysis [GO:0006508],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; disordered domain specific binding [GO:0097718]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05259,FUN_023765-T1,Peve_00030839,Pocillopora_meandrina_HIv1___TS.g9692.t1a,three_way,65.00833333333333,FUN_023765-T1,P17453,,,,,32.3,473.0,4.500000000000001e-65,250.4,sp|P17453|BPI_BOVIN Bactericidal permeability-increasing protein OS=Bos taurus OX=9913 GN=BPI PE=2 SV=2,,,,,,
OG_05260,FUN_023768-T1,Peve_00030842,Pocillopora_meandrina_HIv1___TS.g9692.t1b,three_way,52.268,FUN_023768-T1,B3EWZ8,,,,,31.8,154.0,3.7e-11,72.0,sp|B3EWZ8|ECT_ACRMI Ectin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05261,FUN_023772-T1,Peve_00039442,Pocillopora_meandrina_HIv1___RNAseq.g3603.t1,three_way,71.67933333333333,FUN_023772-T1,Q4JIM5,ABL2_MOUSE,,Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG),Mus musculus (Mouse),40.5,74.0,4.7e-08,60.8,sp|Q4JIM5|ABL2_MOUSE Tyrosine-protein kinase ABL2 OS=Mus musculus OX=10090 GN=Abl2 PE=1 SV=1,GO:0000287; GO:0001843; GO:0001891; GO:0002118; GO:0004713; GO:0004715; GO:0005524; GO:0006468; GO:0006909; GO:0006930; GO:0007015; GO:0007173; GO:0007200; GO:0007204; GO:0007249; GO:0007266; GO:0007612; GO:0007628; GO:0008104; GO:0008542; GO:0009791; GO:0010976; GO:0015629; GO:0016322; GO:0018108; GO:0021587; GO:0022408; GO:0030027; GO:0030036; GO:0030145; GO:0030182; GO:0031223; GO:0031410; GO:0032729; GO:0032743; GO:0035024; GO:0035264; GO:0035640; GO:0043123; GO:0043197; GO:0046632; GO:0048008; GO:0048813; GO:0050885; GO:0051017; GO:0051649; GO:0060020; GO:0060074; GO:0060563; GO:0070374; GO:0072359; GO:0097062; GO:0098609; GO:0098794; GO:0098978; GO:1903053; GO:1903905; GO:1904157; GO:2000096; GO:2000352; GO:2000406,"actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; adult walking behavior [GO:0007628]; aggressive behavior [GO:0002118]; alpha-beta T cell differentiation [GO:0046632]; auditory behavior [GO:0031223]; Bergmann glial cell differentiation [GO:0060020]; canonical NF-kappaB signal transduction [GO:0007249]; cell-cell adhesion [GO:0098609]; cerebellum morphogenesis [GO:0021587]; circulatory system development [GO:0072359]; dendrite morphogenesis [GO:0048813]; dendritic spine maintenance [GO:0097062]; DN4 thymocyte differentiation [GO:1904157]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of localization in cell [GO:0051649]; exploration behavior [GO:0035640]; learning [GO:0007612]; multicellular organism growth [GO:0035264]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of Rho protein signal transduction [GO:0035024]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuron differentiation [GO:0030182]; neuron remodeling [GO:0016322]; peptidyl-tyrosine phosphorylation [GO:0018108]; phagocytosis [GO:0006909]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell migration [GO:2000406]; positive regulation of type II interferon production [GO:0032729]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; regulation of extracellular matrix organization [GO:1903053]; Rho protein signal transduction [GO:0007266]; substrate-dependent cell migration, cell extension [GO:0006930]; synapse maturation [GO:0060074]; visual learning [GO:0008542]",actin cytoskeleton [GO:0015629]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; phagocytic cup [GO:0001891]; postsynapse [GO:0098794],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713],GO:0002376; GO:0003824; GO:0005856; GO:0007010; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"immune system process; catalytic activity; cytoskeleton; cytoskeleton organization; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05262,FUN_023774-T1,Peve_00036451,Pocillopora_meandrina_HIv1___RNAseq.g24245.t1,three_way,66.79066666666667,FUN_023774-T1,Q8BXN7,PPM1K_MOUSE,,Protein phosphatase Mn(2+)-dependent 1K (Branched-chain alpha-ketoacid dehydrogenase phosphatase) (BCKDH) (BDP) (EC 3.1.3.16) (Protein phosphatase 2C family member) (Protein phosphatase 2C isoform kappa) (PP2C-kappa) ([3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring)]-phosphatase) (EC 3.1.3.52),Mus musculus (Mouse),42.5,358.0,5.8e-70,266.2,sp|Q8BXN7|PPM1K_MOUSE Protein phosphatase Mn(2+)-dependent 1K OS=Mus musculus OX=10090 GN=Ppm1k PE=1 SV=1,GO:0004722; GO:0005739; GO:0005759; GO:0009083; GO:0030145; GO:0047385; GO:1902108,branched-chain amino acid catabolic process [GO:0009083]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],[3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase activity [GO:0047385]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005739; GO:0006520; GO:0007005; GO:0016787; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; mitochondrion; amino acid metabolic process; mitochondrion organization; hydrolase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_05263,FUN_023790-T1,Peve_00039437,Pocillopora_meandrina_HIv1___RNAseq.g3306.t1,three_way,84.11133333333333,FUN_023790-T1,Q1L8X9,VGLU3_DANRE,,Vesicular glutamate transporter 3 (VGluT3) (Solute carrier family 17 member 8),Danio rerio (Zebrafish) (Brachydanio rerio),43.0,449.0,1.9e-105,384.4,sp|Q1L8X9|VGLU3_DANRE Vesicular glutamate transporter 3 OS=Danio rerio OX=7955 GN=slc17a8 PE=3 SV=2,GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0015813; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0050957; GO:0051631; GO:0051938; GO:0051951; GO:0055062; GO:0060005; GO:0060076; GO:0098700; GO:0140788,"equilibrioception [GO:0050957]; L-glutamate import [GO:0051938]; L-glutamate transmembrane transport [GO:0015813]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; positive regulation of glutamate uptake involved in transmission of nerve impulse [GO:0051951]; regulation of acetylcholine uptake [GO:0051631]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]; vestibular reflex [GO:0060005]",chloride channel complex [GO:0034707]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamate uniporter activity [GO:0140788]; neurotransmitter transmembrane transporter activity [GO:0005326]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport
OG_05264,FUN_023791-T1,Peve_00039443,Pocillopora_meandrina_HIv1___RNAseq.g3557.t1,three_way,48.73533333333333,,,,,,,,,,,,,,,,,
OG_05265,FUN_023795-T1,Peve_00039445,Pocillopora_meandrina_HIv1___RNAseq.g5766.t1,three_way,90.22266666666668,FUN_023795-T1,Q91VN6,DDX41_MOUSE,,Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41),Mus musculus (Mouse),76.5,548.0,1.1e-243,844.0,sp|Q91VN6|DDX41_MOUSE Probable ATP-dependent RNA helicase DDX41 OS=Mus musculus OX=10090 GN=Ddx41 PE=1 SV=2,GO:0000398; GO:0003677; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005783; GO:0005829; GO:0008270; GO:0008283; GO:0016887; GO:0030154; GO:0035458; GO:0045944; GO:0051607; GO:0071013; GO:0140896,"cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; cGAS/STING signaling pathway [GO:0140896]; defense response to virus [GO:0051607]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005783; GO:0005829; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; endoplasmic reticulum; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05266,FUN_023798-T1,Peve_00039438,Pocillopora_meandrina_HIv1___RNAseq.g3305.t1,three_way,83.62333333333333,FUN_023798-T1,P54886,P5CS_HUMAN,,Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)],Homo sapiens (Human),59.2,777.0,1e-249,864.4,sp|P54886|P5CS_HUMAN Delta-1-pyrroline-5-carboxylate synthase OS=Homo sapiens OX=9606 GN=ALDH18A1 PE=1 SV=2,GO:0003723; GO:0004349; GO:0004350; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006536; GO:0006561; GO:0006592; GO:0009266; GO:0019240; GO:0042802; GO:0055129,citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561]; response to temperature stimulus [GO:0009266],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0006520; GO:0016491; GO:0016740; GO:0043226,RNA binding; catalytic activity; mitochondrion; amino acid metabolic process; oxidoreductase activity; transferase activity; organelle
OG_05267,FUN_023801-T1,Peve_00035150,Pocillopora_meandrina_HIv1___RNAseq.g17839.t1,three_way,70.28433333333334,FUN_023801-T1,F1R4Y7,,,,,28.7,421.0,1.3e-35,152.5,sp|F1R4Y7|CEP83_DANRE Centrosomal protein of 83 kDa OS=Danio rerio OX=7955 GN=cep83 PE=3 SV=2,,,,,,
OG_05268,FUN_023921-T1,Peve_00026572,Pocillopora_meandrina_HIv1___TS.g27910.t1,three_way,65.93933333333332,,,,,,,,,,,,,,,,,
OG_05269,FUN_023922-T1,Peve_00017665,Pocillopora_meandrina_HIv1___TS.g28130.t1a,three_way,66.8095,FUN_023922-T1,Q3UMC0,AFG2A_MOUSE,,ATPase family gene 2 protein homolog A (EC 3.6.4.10) (AFG2 AAA ATPase homolog A) (Ribosome biogenesis protein SPATA5) (Spermatogenesis-associated factor protein) (Spermatogenesis-associated protein 5),Mus musculus (Mouse),47.8,856.0,3.2e-207,723.4,sp|Q3UMC0|AFG2A_MOUSE ATPase family gene 2 protein homolog A OS=Mus musculus OX=10090 GN=Afg2a PE=1 SV=2,GO:0005524; GO:0005737; GO:0005739; GO:0005819; GO:0005829; GO:0007283; GO:0007420; GO:0016887; GO:0030154; GO:0042273; GO:1990275,brain development [GO:0007420]; cell differentiation [GO:0030154]; ribosomal large subunit biogenesis [GO:0042273]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; spindle [GO:0005819],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856,catalytic activity; mitochondrion; cytosol; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development
OG_05270,FUN_023923-T1,Peve_00010790,Pocillopora_meandrina_HIv1___RNAseq.g18865.t1,three_way,53.831,FUN_023923-T1,P59672,ANS1A_MOUSE,,Ankyrin repeat and SAM domain-containing protein 1A (Odin),Mus musculus (Mouse),30.1,133.0,2.6e-08,60.8,sp|P59672|ANS1A_MOUSE Ankyrin repeat and SAM domain-containing protein 1A OS=Mus musculus OX=10090 GN=Anks1a PE=1 SV=3,GO:0005737; GO:0006929; GO:0016322; GO:0043005; GO:0046875; GO:0048013; GO:1901187; GO:2000059,ephrin receptor signaling pathway [GO:0048013]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron remodeling [GO:0016322]; regulation of ephrin receptor signaling pathway [GO:1901187]; substrate-dependent cell migration [GO:0006929],cytoplasm [GO:0005737]; neuron projection [GO:0043005],ephrin receptor binding [GO:0046875],GO:0048870,cell motility
OG_05271,FUN_023924-T1,Peve_00026568,Pocillopora_meandrina_HIv1___RNAseq.g18866.t1,three_way,53.82933333333333,,,,,,,,,,,,,,,,,
OG_05272,FUN_023925-T1,Peve_00026567,Pocillopora_meandrina_HIv1___RNAseq.g18510.t1,three_way,82.92366666666666,FUN_023925-T1,P61085,UBE2K_BOVIN,,Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase),Bos taurus (Bovine),69.2,201.0,1.2e-74,280.8,sp|P61085|UBE2K_BOVIN Ubiquitin-conjugating enzyme E2 K OS=Bos taurus OX=9913 GN=UBE2K PE=1 SV=3,GO:0000209; GO:0004842; GO:0005524; GO:0005634; GO:0005737; GO:0031625; GO:0061631; GO:0070936,protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05273,FUN_023927-T1,Peve_00026566,Pocillopora_meandrina_HIv1___TS.g27906.t1b,three_way,44.959,,,,,,,,,,,,,,,,,
OG_05274,FUN_023928-T1,Peve_00026565,Pocillopora_meandrina_HIv1___TS.g27906.t1a,three_way,36.54933333333333,FUN_023928-T1,Q3V2Q8,N42L1_MOUSE,,NEDD4-binding protein 2-like 1,Mus musculus (Mouse),51.4,175.0,3.6999999999999997e-41,172.2,sp|Q3V2Q8|N42L1_MOUSE NEDD4-binding protein 2-like 1 OS=Mus musculus OX=10090 GN=N4bp2l1 PE=1 SV=1,,,,,,
OG_05275,FUN_023933-T1,Peve_00017668,Pocillopora_meandrina_HIv1___TS.g28130.t1b,three_way,81.382,FUN_023933-T1,Q6P0U0,,,,,51.3,398.0,7.3e-117,422.2,sp|Q6P0U0|NAGA_DANRE N-acetylglucosamine-6-phosphate deacetylase OS=Danio rerio OX=7955 GN=amdhd2 PE=2 SV=1,,,,,,
OG_05276,FUN_023934-T1,Peve_00017662,Pocillopora_meandrina_HIv1___RNAseq.g18854.t1,three_way,58.2855,,,,,,,,,,,,,,,,,
OG_05277,FUN_023935-T1,Peve_00017663,Pocillopora_meandrina_HIv1___RNAseq.g18855.t1,three_way,79.559,FUN_023935-T1,Q91X58,ZFN2B_MOUSE,,AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein),Mus musculus (Mouse),63.0,135.0,4.5e-51,203.0,sp|Q91X58|ZFN2B_MOUSE AN1-type zinc finger protein 2B OS=Mus musculus OX=10090 GN=Zfand2b PE=1 SV=1,GO:0000502; GO:0005783; GO:0005789; GO:0006616; GO:0008270; GO:0016020; GO:0031593; GO:0036435; GO:0043130; GO:0043161; GO:0043567; GO:0045047,"proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane, translocation [GO:0006616]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; proteasome complex [GO:0000502],K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270],GO:0005783; GO:0006886; GO:0030163; GO:0043226; GO:0055085,endoplasmic reticulum; intracellular protein transport; protein catabolic process; organelle; transmembrane transport
OG_05278,FUN_023936-T1,Peve_00023219,Pocillopora_meandrina_HIv1___RNAseq.g18856.t1,three_way,83.582,,,,,,,,,,,,,,,,,
OG_05279,FUN_023937-T1,Peve_00023220,Pocillopora_meandrina_HIv1___RNAseq.g18857.t1,three_way,73.68016666666666,FUN_023937-T1,Q6DGG0,PPID_RAT,,Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D),Rattus norvegicus (Rat),55.4,379.0,2.9999999999999998e-114,413.3,sp|Q6DGG0|PPID_RAT Peptidyl-prolyl cis-trans isomerase D OS=Rattus norvegicus OX=10116 GN=Ppid PE=1 SV=3,GO:0000122; GO:0003755; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006457; GO:0006915; GO:0006979; GO:0008134; GO:0015031; GO:0016018; GO:0019899; GO:0030331; GO:0030544; GO:0031072; GO:0034389; GO:0043065; GO:0043066; GO:0045070; GO:0050714; GO:0051879; GO:0051881; GO:0061077; GO:0065003; GO:0071492,apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of mitochondrial membrane potential [GO:0051881]; response to oxidative stress [GO:0006979],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; nuclear estrogen receptor binding [GO:0030331]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006355; GO:0006457; GO:0012501; GO:0016853; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; regulation of DNA-templated transcription; protein folding; programmed cell death; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_05280,FUN_023942-T1,Peve_00023221,Pocillopora_meandrina_HIv1___RNAseq.g18858.t1,three_way,53.260666666666665,,,,,,,,,,,,,,,,,
OG_05281,FUN_023943-T2,Peve_00023222,Pocillopora_meandrina_HIv1___RNAseq.g18860.t1,three_way,70.39283333333333,FUN_023943-T2,Q9JHI7,EXOS9_MOUSE,,Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75),Mus musculus (Mouse),48.0,452.0,3.4e-104,380.2,sp|Q9JHI7|EXOS9_MOUSE Exosome complex component RRP45 OS=Mus musculus OX=10090 GN=Exosc9 PE=1 SV=1,GO:0000176; GO:0000177; GO:0000178; GO:0000228; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0030307; GO:0035925; GO:0045944; GO:0061629; GO:0071028; GO:0071035; GO:0101019,nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364],cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear chromosome [GO:0000228]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0000228; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006355; GO:0016071; GO:0043226,nuclear chromosome; RNA binding; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_05282,FUN_023944-T1,Peve_00010788,Pocillopora_meandrina_HIv1___RNAseq.g18862.t1,three_way,57.44716666666667,FUN_023944-T1,Q32L31,HMGB3_BOVIN,,High mobility group protein B3,Bos taurus (Bovine),41.3,172.0,2.3000000000000003e-28,127.1,sp|Q32L31|HMGB3_BOVIN High mobility group protein B3 OS=Bos taurus OX=9913 GN=HMGB3 PE=2 SV=2,GO:0000400; GO:0003690; GO:0005634; GO:0005694; GO:0005737; GO:0006310; GO:0008301; GO:0032392; GO:0045087,DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087],chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA binding, bending [GO:0008301]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]",GO:0002376; GO:0003677; GO:0005634; GO:0005694; GO:0006310; GO:0043226; GO:0098542,immune system process; DNA binding; nucleus; chromosome; DNA recombination; organelle; defense response to other organism
OG_05283,FUN_023945-T1,Peve_00010787,Pocillopora_meandrina_HIv1___RNAseq.g18863.t1,three_way,91.15233333333332,FUN_023945-T1,Q6NYV5,SP30L_DANRE,,Histone deacetylase complex subunit SAP30L (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like),Danio rerio (Zebrafish) (Brachydanio rerio),62.1,174.0,1.5e-54,213.8,sp|Q6NYV5|SP30L_DANRE Histone deacetylase complex subunit SAP30L OS=Danio rerio OX=7955 GN=sap30l PE=1 SV=1,GO:0000118; GO:0000122; GO:0001947; GO:0003677; GO:0003712; GO:0005730; GO:0006355; GO:0008270; GO:0010314; GO:0031491; GO:0032266; GO:0042393; GO:0044378; GO:0070273,heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355],histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; histone binding [GO:0042393]; non-sequence-specific DNA binding, bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005730; GO:0006355; GO:0008289; GO:0042393; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleolus; regulation of DNA-templated transcription; lipid binding; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_05284,FUN_023947-T1,Peve_00016131,Pocillopora_meandrina_HIv1___RNAseq.g18527.t1,three_way,70.57366666666667,FUN_023947-T1,O35828,,,,,39.7,941.0,3.3e-191,670.2,sp|O35828|CORO7_RAT Coronin-7 OS=Rattus norvegicus OX=10116 GN=Coro7 PE=1 SV=2,,,,,,
OG_05285,FUN_023948-T1,Peve_00016130,Pocillopora_meandrina_HIv1___RNAseq.g18526.t1,three_way,94.61833333333334,FUN_023948-T1,Q176V0,,,,,94.0,83.0,2.8e-37,155.6,sp|Q176V0|UFM1_AEDAE Ubiquitin-fold modifier 1 OS=Aedes aegypti OX=7159 GN=AAEL006251 PE=3 SV=1,,,,,,
OG_05286,FUN_023949-T1,Peve_00016150,Pocillopora_meandrina_HIv1___RNAseq.2014_t,three_way,80.2065,FUN_023949-T1,P51830,,,,,39.3,1189.0,3.8999999999999997e-205,716.8,sp|P51830|ADCY9_MOUSE Adenylate cyclase type 9 OS=Mus musculus OX=10090 GN=Adcy9 PE=1 SV=1,,,,,,
OG_05287,FUN_023950-T1,Peve_00017994,Pocillopora_meandrina_HIv1___RNAseq.g18524.t1a,three_way,76.55283333333334,FUN_023950-T1,Q92793,CBP_HUMAN,,CREB-binding protein (Histone lysine acetyltransferase CREBBP) (EC 2.3.1.48) (Protein lactyltransferas CREBBP) (EC 2.3.1.-) (Protein-lysine acetyltransferase CREBBP) (EC 2.3.1.-),Homo sapiens (Human),41.9,2186.0,0.0,1193.7,sp|Q92793|CBP_HUMAN CREB-binding protein OS=Homo sapiens OX=9606 GN=CREBBP PE=1 SV=3,GO:0000122; GO:0000123; GO:0000785; GO:0001223; GO:0001666; GO:0002039; GO:0002223; GO:0003682; GO:0003684; GO:0003713; GO:0003714; GO:0004402; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0005829; GO:0006355; GO:0006473; GO:0007165; GO:0007249; GO:0008270; GO:0008589; GO:0016407; GO:0016479; GO:0016604; GO:0018076; GO:0030511; GO:0031490; GO:0031648; GO:0031669; GO:0034644; GO:0042592; GO:0042733; GO:0043426; GO:0043993; GO:0044017; GO:0045893; GO:0045944; GO:0048156; GO:0048511; GO:0061629; GO:0061733; GO:0065003; GO:0120300; GO:0140297; GO:1900034; GO:1900182; GO:1905168,canonical NF-kappaB signal transduction [GO:0007249]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; embryonic digit morphogenesis [GO:0042733]; homeostatic process [GO:0042592]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of DNA-templated transcription [GO:0006355]; regulation of smoothened signaling pathway [GO:0008589]; response to hypoxia [GO:0001666]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],acetyltransferase activity [GO:0016407]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; MRF binding [GO:0043426]; p53 binding [GO:0002039]; peptide lactyltransferase (CoA-dependent) activity [GO:0120300]; protein-lysine-acetyltransferase activity [GO:0061733]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0008092; GO:0016740; GO:0043226; GO:0051604; GO:0060090; GO:0065003; GO:0140096; GO:0140110,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; organelle; protein maturation; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein; transcription regulator activity"
OG_05288,FUN_023952-T1,Peve_00017998,Pocillopora_meandrina_HIv1___RNAseq.g18523.t1,three_way,45.82333333333333,,,,,,,,,,,,,,,,,
OG_05289,FUN_023954-T1,Peve_00016132,Pocillopora_meandrina_HIv1___RNAseq.g18528.t1,three_way,73.87133333333334,,,,,,,,,,,,,,,,,
OG_05290,FUN_023956-T1,Peve_00017997,Pocillopora_meandrina_HIv1___RNAseq.g18522.t1,three_way,84.48,FUN_023956-T1,O60271,,,,,49.1,642.0,1.4e-149,531.2,sp|O60271|JIP4_HUMAN C-Jun-amino-terminal kinase-interacting protein 4 OS=Homo sapiens OX=9606 GN=SPAG9 PE=1 SV=4,,,,,,
OG_05291,FUN_023958-T1,Peve_00017996,Pocillopora_meandrina_HIv1___RNAseq.g18521.t1,three_way,58.741,,,,,,,,,,,,,,,,,
OG_05292,FUN_023959-T1,Peve_00017995,Pocillopora_meandrina_HIv1___RNAseq.g18520.t1,three_way,96.22633333333332,FUN_023959-T1,Q5XGI0,PRPS2_XENTR,,Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),81.8,318.0,5.6e-146,518.5,sp|Q5XGI0|PRPS2_XENTR Ribose-phosphate pyrophosphokinase 2 OS=Xenopus tropicalis OX=8364 GN=prps2 PE=2 SV=1,GO:0000287; GO:0004749; GO:0005524; GO:0006015; GO:0009156; GO:0009165; GO:0016301; GO:0042803,5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156],,ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749],GO:0003824; GO:0016740; GO:0055086; GO:1901135,catalytic activity; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05293,FUN_023961-T1,Peve_00013173,Pocillopora_meandrina_HIv1___RNAseq.g18587.t1,three_way,57.663,FUN_023961-T1,Q91285,FGFR1_PLEWA,,Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (PFR1),Pleurodeles waltl (Iberian ribbed newt),48.3,300.0,1.1999999999999999e-75,286.2,sp|Q91285|FGFR1_PLEWA Fibroblast growth factor receptor 1 OS=Pleurodeles waltl OX=8319 GN=FGFR1 PE=2 SV=1,GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0008284; GO:0010604; GO:0017134; GO:0030154; GO:0031410; GO:0043235; GO:0045597; GO:0048513; GO:0080090,animal organ development [GO:0048513]; cell differentiation [GO:0030154]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of macromolecule metabolic process [GO:0010604]; regulation of primary metabolic process [GO:0080090],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_05294,FUN_023962-T1,Peve_00043985,Pocillopora_meandrina_HIv1___RNAseq.g18585.t1,three_way,84.302,,,,,,,,,,,,,,,,,
OG_05295,FUN_023963-T1,Peve_00043986,Pocillopora_meandrina_HIv1___RNAseq.g18584.t1,three_way,76.16533333333334,FUN_023963-T1,P22770,,,,,29.2,506.0,4.1e-61,237.3,sp|P22770|ACHA7_CHICK Neuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1,,,,,,
OG_05296,FUN_023964-T2,Peve_00043975,Pocillopora_meandrina_HIv1___RNAseq.g18583.t1,three_way,68.576,FUN_023964-T2,P17644,ACH2_DROME,,Acetylcholine receptor subunit alpha-like 2 (Nicotinic acetylcholine receptor alpha 2),Drosophila melanogaster (Fruit fly),30.6,366.0,5.7999999999999986e-55,216.9,sp|P17644|ACH2_DROME Acetylcholine receptor subunit alpha-like 2 OS=Drosophila melanogaster OX=7227 GN=nAChRalpha2 PE=2 SV=1,GO:0004888; GO:0005231; GO:0005886; GO:0005892; GO:0007268; GO:0007271; GO:0022848; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0098655; GO:1904315,"chemical synaptic transmission [GO:0007268]; monoatomic cation transmembrane transport [GO:0098655]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; excitatory extracellular ligand-gated monoatomic ion channel activity [GO:0005231]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_05297,FUN_023965-T1,Peve_00043977,Pocillopora_meandrina_HIv1___RNAseq.g18582.t2,three_way,65.41683333333333,FUN_023965-T1,Q9I8C7,,,,,37.3,322.0,3.5000000000000005e-57,224.2,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_05298,FUN_023967-T1,Peve_00043976,Pocillopora_meandrina_HIv1___RNAseq.g18581.t1,three_way,51.779,,,,,,,,,,,,,,,,,
OG_05299,FUN_023969-T1,Peve_00043982,Pocillopora_meandrina_HIv1___RNAseq.g18532.t2,three_way,60.025333333333336,FUN_023969-T1,Q5FVB0,,,,,34.9,401.0,1.6e-51,205.3,sp|Q5FVB0|ATX10_XENTR Ataxin-10 OS=Xenopus tropicalis OX=8364 GN=atxn10 PE=2 SV=1,,,,,,
OG_05300,FUN_023970-T1,Peve_00025471,Pocillopora_meandrina_HIv1___TS.g27927.t1a,three_way,49.32233333333333,FUN_023970-T1,Q9R0W9,ACHA6_MOUSE,,Neuronal acetylcholine receptor subunit alpha-6,Mus musculus (Mouse),31.3,332.0,1.1e-41,172.9,sp|Q9R0W9|ACHA6_MOUSE Neuronal acetylcholine receptor subunit alpha-6 OS=Mus musculus OX=10090 GN=Chrna6 PE=1 SV=2,GO:0004888; GO:0005892; GO:0014059; GO:0022848; GO:0034703; GO:0035095; GO:0042734; GO:0045211; GO:0051899; GO:0098691; GO:0098878; GO:0099171,behavioral response to nicotine [GO:0035095]; membrane depolarization [GO:0051899]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of dopamine secretion [GO:0014059],acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dopaminergic synapse [GO:0098691]; neurotransmitter receptor complex [GO:0098878]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888],GO:0005215; GO:0060089,transporter activity; molecular transducer activity
OG_05301,FUN_023971-T1,Peve_00025477,Pocillopora_meandrina_HIv1___RNAseq.g18534.t1,three_way,57.55416666666667,FUN_023971-T1,P15384,,,,,33.7,395.0,9.300000000000001e-57,222.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_05302,FUN_023972-T1,Peve_00025484,Pocillopora_meandrina_HIv1___RNAseq.g18530.t1,three_way,91.074,FUN_023972-T1,Q8K2G4,BBS7_MOUSE,,BBSome complex member BBS7 (BBS2-like protein 1) (Bardet-Biedl syndrome 7 protein homolog),Mus musculus (Mouse),68.9,718.0,1.8e-293,1009.6,sp|Q8K2G4|BBS7_MOUSE BBSome complex member BBS7 OS=Mus musculus OX=10090 GN=Bbs7 PE=1 SV=1,GO:0001654; GO:0001750; GO:0005634; GO:0005813; GO:0005930; GO:0006357; GO:0007224; GO:0007420; GO:0007507; GO:0008104; GO:0015031; GO:0016020; GO:0032436; GO:0034451; GO:0034464; GO:0036064; GO:0045444; GO:0060170; GO:0060173; GO:0060271; GO:0061629; GO:1903929; GO:1905515,brain development [GO:0007420]; cilium assembly [GO:0060271]; eye development [GO:0001654]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; limb development [GO:0060173]; non-motile cilium assembly [GO:1905515]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; primary palate development [GO:1903929]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224],axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; membrane [GO:0016020]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0005634; GO:0005815; GO:0006355; GO:0030154; GO:0043226; GO:0044782; GO:0048856,nucleus; microtubule organizing center; regulation of DNA-templated transcription; cell differentiation; organelle; cilium organization; anatomical structure development
OG_05303,FUN_023974-T2,Peve_00002583,Pocillopora_meandrina_HIv1___RNAseq.g19437.t1,three_way,55.776333333333326,FUN_023974-T2,P98069,,,,,30.9,282.0,2e-35,152.1,sp|P98069|BMPH_STRPU Bone morphogenetic protein 1 homolog OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_05304,FUN_023976-T1,Peve_00020879,Pocillopora_meandrina_HIv1___RNAseq.g19436.t1,three_way,62.5495,FUN_023976-T1,Q9HBW9,AGRL4_HUMAN,,"Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)",Homo sapiens (Human),37.6,93.0,1.4e-08,65.1,sp|Q9HBW9|AGRL4_HUMAN Adhesion G protein-coupled receptor L4 OS=Homo sapiens OX=9606 GN=ADGRL4 PE=1 SV=3,GO:0004930; GO:0005509; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020; GO:0031410,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],cytoplasmic vesicle [GO:0031410]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0031410; GO:0043226; GO:0060089,plasma membrane; cytoplasmic vesicle; organelle; molecular transducer activity
OG_05305,FUN_023978-T1,Peve_00020874,Pocillopora_meandrina_HIv1___RNAseq.g19435.t1,three_way,47.72816666666667,,,,,,,,,,,,,,,,,
OG_05306,FUN_023979-T1,Peve_00020872,Pocillopora_meandrina_HIv1___RNAseq.g19434.t1,three_way,54.052166666666665,,,,,,,,,,,,,,,,,
OG_05307,FUN_023981-T1,Peve_00020886,Pocillopora_meandrina_HIv1___RNAseq.g19442.t1,three_way,77.2305,FUN_023981-T1,P21440,MDR3_MOUSE,,Phosphatidylcholine translocator ABCB4 (EC 7.6.2.1) (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 2) (Multidrug resistance protein 3) (P-glycoprotein 2) (P-glycoprotein 3),Mus musculus (Mouse),52.3,1273.0,0.0,1234.6,sp|P21440|MDR3_MOUSE Phosphatidylcholine translocator ABCB4 OS=Mus musculus OX=10090 GN=Abcb4 PE=1 SV=2,GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005925; GO:0016020; GO:0016324; GO:0016887; GO:0030136; GO:0032376; GO:0032782; GO:0042626; GO:0045121; GO:0045332; GO:0046581; GO:0055088; GO:0061092; GO:0090554; GO:0140359; GO:1901557; GO:1903413; GO:2001140,bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557],apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; phosphatidylcholine floppase activity [GO:0090554],GO:0003824; GO:0005215; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleoplasm; cytosol; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; membrane organization; ATP-dependent activity
OG_05308,FUN_023982-T1,Peve_00020888,Pocillopora_meandrina_HIv1___RNAseq.g19411.t1,three_way,76.62366666666667,FUN_023982-T1,Q8N264,RHG24_HUMAN,,Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP),Homo sapiens (Human),47.5,341.0,3.3e-91,337.0,sp|Q8N264|RHG24_HUMAN Rho GTPase-activating protein 24 OS=Homo sapiens OX=9606 GN=ARHGAP24 PE=1 SV=2,GO:0001525; GO:0005096; GO:0005737; GO:0005856; GO:0005912; GO:0005925; GO:0007165; GO:0030154; GO:0035021; GO:0035313; GO:0042995; GO:1900028,"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of Rac protein signal transduction [GO:0035021]; negative regulation of ruffle assembly [GO:1900028]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]",adherens junction [GO:0005912]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925],GTPase activator activity [GO:0005096],GO:0005856; GO:0030154; GO:0043226; GO:0048870; GO:0098772,cytoskeleton; cell differentiation; organelle; cell motility; molecular function regulator activity
OG_05309,FUN_023983-T1,Peve_00020889,Pocillopora_meandrina_HIv1___RNAseq.g19410.t1,three_way,79.52850000000001,FUN_023983-T1,Q5R754,CDKL2_PONAB,,Cyclin-dependent kinase-like 2 (EC 2.7.11.22),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),66.5,328.0,2.6e-132,474.2,sp|Q5R754|CDKL2_PONAB Cyclin-dependent kinase-like 2 OS=Pongo abelii OX=9601 GN=CDKL2 PE=2 SV=1,GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0106310,,cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05310,FUN_023985-T1,Peve_00020893,Pocillopora_meandrina_HIv1___RNAseq.g19365.t1,three_way,71.53066666666666,FUN_023985-T1,Q9H598,VIAAT_HUMAN,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter) (hVIAAT),Homo sapiens (Human),33.6,411.0,8.900000000000002e-57,222.6,sp|Q9H598|VIAAT_HUMAN Vesicular inhibitory amino acid transporter OS=Homo sapiens OX=9606 GN=SLC32A1 PE=1 SV=2,GO:0001762; GO:0005886; GO:0006811; GO:0007269; GO:0008021; GO:0009986; GO:0015171; GO:0015185; GO:0015187; GO:0015495; GO:0015812; GO:0015816; GO:0021766; GO:0030425; GO:0030672; GO:0043005; GO:0044292; GO:0044306; GO:0044316; GO:0048786; GO:0051286; GO:0051939; GO:0060077; GO:0061202; GO:0098700; GO:0098793; GO:0098982; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; hippocampus development [GO:0021766]; monoatomic ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; neurotransmitter secretion [GO:0007269],cell surface [GO:0009986]; cell tip [GO:0051286]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cone cell pedicle [GO:0044316]; dendrite [GO:0030425]; dendrite terminus [GO:0044292]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],amino acid transmembrane transporter activity [GO:0015171]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; gamma-aminobutyric acid:proton symporter activity [GO:0015495]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0005886; GO:0031410; GO:0043226; GO:0048856,transporter activity; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development
OG_05311,FUN_023988-T1,Peve_00020894,Pocillopora_meandrina_HIv1___RNAseq.g19364.t1,three_way,63.86633333333334,,,,,,,,,,,,,,,,,
OG_05312,FUN_023991-T1,Peve_00020895,Pocillopora_meandrina_HIv1___RNAseq.g19363.t1,three_way,36.39533333333333,,,,,,,,,,,,,,,,,
OG_05313,FUN_023992-T2,Peve_00040851,Pocillopora_meandrina_HIv1___RNAseq.g19361.t1,three_way,34.8195,,,,,,,,,,,,,,,,,
OG_05314,FUN_023999-T1,Peve_00034191,Pocillopora_meandrina_HIv1___RNAseq.g19353.t1,three_way,71.23733333333334,FUN_023999-T1,Q3USF0,,,,,34.5,264.0,2.6e-31,137.9,"sp|Q3USF0|B3GN6_MOUSE Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase OS=Mus musculus OX=10090 GN=B3gnt6 PE=2 SV=2",,,,,,
OG_05315,FUN_024000-T1,Peve_00034190,Pocillopora_meandrina_HIv1___RNAseq.g19352.t1,three_way,67.46066666666667,FUN_024000-T1,Q5E9U6,,,,,44.0,368.0,1.3e-87,324.7,sp|Q5E9U6|WNT16_BOVIN Protein Wnt-16 OS=Bos taurus OX=9913 GN=WNT16 PE=2 SV=1,,,,,,
OG_05316,FUN_024001-T1,Peve_00034187,Pocillopora_meandrina_HIv1___RNAseq.g19350.t1,three_way,77.74116666666666,FUN_024001-T1,P15056,BRAF_HUMAN,,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),Homo sapiens (Human),47.0,743.0,1.8999999999999998e-173,610.9,sp|P15056|BRAF_HUMAN Serine/threonine-protein kinase B-raf OS=Homo sapiens OX=9606 GN=BRAF PE=1 SV=4,GO:0000165; GO:0002318; GO:0004672; GO:0004674; GO:0004708; GO:0004709; GO:0005509; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005929; GO:0006468; GO:0007173; GO:0008270; GO:0008542; GO:0009887; GO:0010628; GO:0010764; GO:0010828; GO:0016079; GO:0030878; GO:0033077; GO:0033138; GO:0034446; GO:0034451; GO:0035019; GO:0036064; GO:0042127; GO:0042802; GO:0043005; GO:0043066; GO:0043149; GO:0043231; GO:0043367; GO:0043369; GO:0043524; GO:0044297; GO:0045580; GO:0048538; GO:0048680; GO:0050772; GO:0050852; GO:0051496; GO:0060291; GO:0060323; GO:0060324; GO:0070371; GO:0070374; GO:0071277; GO:0071466; GO:0072577; GO:0090150; GO:0097110; GO:0098793; GO:0098794; GO:0098978; GO:0099170; GO:0106310; GO:1900026; GO:2000301; GO:2000352,"animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive, alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to xenobiotic stimulus [GO:0071466]; endothelial cell apoptotic process [GO:0072577]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; somatic stem cell population maintenance [GO:0035019]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic vesicle exocytosis [GO:0016079]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; visual learning [GO:0008542]",cell body [GO:0044297]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; scaffold protein binding [GO:0097110]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0007155; GO:0012501; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; cell adhesion; programmed cell death; vesicle-mediated transport; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05317,FUN_024002-T1,Peve_00034192,Pocillopora_meandrina_HIv1___RNAseq.g19348.t1,three_way,47.63516666666667,FUN_024002-T1,A4D0V7,CPED1_HUMAN,,Cadherin-like and PC-esterase domain-containing protein 1,Homo sapiens (Human),33.3,771.0,3.9e-108,394.4,sp|A4D0V7|CPED1_HUMAN Cadherin-like and PC-esterase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CPED1 PE=1 SV=1,GO:0005783,,endoplasmic reticulum [GO:0005783],,GO:0005783; GO:0043226,endoplasmic reticulum; organelle
OG_05318,FUN_024003-T1,Peve_00040409,Pocillopora_meandrina_HIv1___RNAseq.g19347.t2,three_way,68.49716666666667,,,,,,,,,,,,,,,,,
OG_05319,FUN_024004-T3,Peve_00040410,Pocillopora_meandrina_HIv1___RNAseq.g19346.t1,three_way,63.36033333333334,,,,,,,,,,,,,,,,,
OG_05320,FUN_024005-T1,Peve_00040411,Pocillopora_meandrina_HIv1___RNAseq.g19345.t1,three_way,78.31733333333334,FUN_024005-T1,Q68EH9,CRBN_DANRE,,Protein cereblon (zcrbn),Danio rerio (Zebrafish) (Brachydanio rerio),48.4,382.0,3.4e-97,356.7,sp|Q68EH9|CRBN_DANRE Protein cereblon OS=Danio rerio OX=7955 GN=crbn PE=1 SV=1,GO:0000151; GO:0005634; GO:0005737; GO:0008283; GO:0016567; GO:0031464; GO:0033333; GO:0035118; GO:0043161; GO:0046872; GO:0060173; GO:0071599; GO:0071600,cell population proliferation [GO:0008283]; embryonic pectoral fin morphogenesis [GO:0035118]; fin development [GO:0033333]; limb development [GO:0060173]; otic vesicle development [GO:0071599]; otic vesicle morphogenesis [GO:0071600]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],metal ion binding [GO:0046872],GO:0005634; GO:0030163; GO:0043226; GO:0048856,nucleus; protein catabolic process; organelle; anatomical structure development
OG_05321,FUN_024010-T1,Peve_00042605,Pocillopora_meandrina_HIv1___RNAseq.g7352.t1,three_way,64.49566666666666,,,,,,,,,,,,,,,,,
OG_05322,FUN_024011-T1,Peve_00040413,Pocillopora_meandrina_HIv1___RNAseq.g19343.t1,three_way,89.23066666666666,FUN_024011-T1,Q5ZMV7,,,,,70.6,313.0,3.3e-138,492.7,sp|Q5ZMV7|WDR82_CHICK WD repeat-containing protein 82 OS=Gallus gallus OX=9031 GN=WDR82 PE=2 SV=1,,,,,,
OG_05323,FUN_024015-T1,Peve_00040419,Pocillopora_meandrina_HIv1___RNAseq.g19286.t1,three_way,70.89716666666666,FUN_024015-T1,Q6ZR37,PKHG7_HUMAN,,Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7),Homo sapiens (Human),35.4,540.0,1.8e-73,279.3,sp|Q6ZR37|PKHG7_HUMAN Pleckstrin homology domain-containing family G member 7 OS=Homo sapiens OX=9606 GN=PLEKHG7 PE=1 SV=2,GO:0005085; GO:0007266,Rho protein signal transduction [GO:0007266],,guanyl-nucleotide exchange factor activity [GO:0005085],GO:0098772,molecular function regulator activity
OG_05324,FUN_024016-T1,Peve_00034897,Pocillopora_meandrina_HIv1___RNAseq.g19285.t1,three_way,78.09433333333332,FUN_024016-T1,Q9NRM2,,,,,52.8,386.0,2.4e-115,417.2,sp|Q9NRM2|ZN277_HUMAN Zinc finger protein 277 OS=Homo sapiens OX=9606 GN=ZNF277 PE=1 SV=2,,,,,,
OG_05325,FUN_024017-T1,Peve_00023794,Pocillopora_meandrina_HIv1___RNAseq.g19284.t1,three_way,80.70366666666666,FUN_024017-T1,F6UA42,,,,,57.2,797.0,4.3e-248,859.0,sp|F6UA42|UHRF1_XENTR E3 ubiquitin-protein ligase UHRF1 OS=Xenopus tropicalis OX=8364 GN=uhrf1 PE=3 SV=2,,,,,,
OG_05326,FUN_024018-T1,Peve_00023795,Pocillopora_meandrina_HIv1___RNAseq.g19283.t1,three_way,81.60583333333334,FUN_024018-T1,Q96T37,RBM15_HUMAN,,RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),Homo sapiens (Human),35.3,835.0,2.1e-99,365.2,sp|Q96T37|RBM15_HUMAN RNA-binding protein 15 OS=Homo sapiens OX=9606 GN=RBM15 PE=1 SV=2,GO:0000381; GO:0001510; GO:0001569; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0007221; GO:0009048; GO:0016607; GO:0031965; GO:0036396; GO:0038163; GO:0045638; GO:0045652; GO:0048536; GO:0060412; GO:0060674,"branching involved in blood vessel morphogenesis [GO:0001569]; dosage compensation by inactivation of X chromosome [GO:0009048]; negative regulation of myeloid cell differentiation [GO:0045638]; placenta blood vessel development [GO:0060674]; positive regulation of transcription of Notch receptor target [GO:0007221]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of megakaryocyte differentiation [GO:0045652]; RNA methylation [GO:0001510]; spleen development [GO:0048536]; thrombopoietin-mediated signaling pathway [GO:0038163]; ventricular septum morphogenesis [GO:0060412]",nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0048856,RNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development
OG_05327,FUN_024025-T1,Peve_00023796,Pocillopora_meandrina_HIv1___RNAseq.g19282.t1,three_way,89.24733333333333,FUN_024025-T1,Q6AZW1,,,,,66.2,74.0,9.6e-20,98.2,sp|Q6AZW1|KISHB_DANRE Protein kish-B OS=Danio rerio OX=7955 GN=tmem167b PE=3 SV=1,,,,,,
OG_05328,FUN_024026-T1,Peve_00024951,Pocillopora_meandrina_HIv1___RNAseq.g19281.t1,three_way,75.564,FUN_024026-T1,Q5S1U6,,,,,41.0,390.0,1.3e-78,295.0,sp|Q5S1U6|IFRD1_PIG Interferon-related developmental regulator 1 OS=Sus scrofa OX=9823 GN=IFRD1 PE=2 SV=1,,,,,,
OG_05329,FUN_024032-T1,Peve_00020332,Pocillopora_meandrina_HIv1___RNAseq.g19275.t1,three_way,51.3095,FUN_024032-T1,Q6A548,TERT_CANLF,,Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit),Canis lupus familiaris (Dog) (Canis familiaris),32.1,831.0,2.7e-107,392.1,sp|Q6A548|TERT_CANLF Telomerase reverse transcriptase OS=Canis lupus familiaris OX=9615 GN=TERT PE=2 SV=1,GO:0000333; GO:0000781; GO:0003720; GO:0005697; GO:0005730; GO:0005737; GO:0007004; GO:0016605; GO:0042162; GO:0046872; GO:0070034,telomere maintenance via telomerase [GO:0007004],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; PML body [GO:0016605]; telomerase catalytic core complex [GO:0000333]; telomerase holoenzyme complex [GO:0005697]",metal ion binding [GO:0046872]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005730; GO:0016740; GO:0032200; GO:0043226; GO:0140097,"DNA binding; RNA binding; catalytic activity; nucleolus; transferase activity; telomere organization; organelle; catalytic activity, acting on DNA"
OG_05330,FUN_024034-T1,Peve_00020334,Pocillopora_meandrina_HIv1___RNAseq.g19276.t1,three_way,96.28633333333332,FUN_024034-T1,P30676,,,,,85.9,354.0,2e-176,619.8,sp|P30676|GNAI_PATPE Guanine nucleotide-binding protein G(i) subunit alpha OS=Patiria pectinifera OX=7594 PE=1 SV=3,,,,,,
OG_05331,FUN_024037-T1,Peve_00020333,Pocillopora_meandrina_HIv1___RNAseq.g19274.t1,three_way,74.21233333333333,FUN_024037-T1,O00462,MANBA_HUMAN,,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase),Homo sapiens (Human),47.2,885.0,1.1999999999999998e-243,844.3,sp|O00462|MANBA_HUMAN Beta-mannosidase OS=Homo sapiens OX=9606 GN=MANBA PE=1 SV=3,GO:0004567; GO:0005886; GO:0006516; GO:0009313; GO:0035577; GO:0036211; GO:0043202; GO:0043231,glycoprotein catabolic process [GO:0006516]; oligosaccharide catabolic process [GO:0009313]; protein modification process [GO:0036211],azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886],beta-mannosidase activity [GO:0004567],GO:0003824; GO:0005886; GO:0005975; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; plasma membrane; carbohydrate metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_05332,FUN_024041-T2,Peve_00020339,Pocillopora_meandrina_HIv1___RNAseq.g19271.t1,three_way,87.892,FUN_024041-T2,P11024,NNTM_BOVIN,,"NAD(P) transhydrogenase, mitochondrial (EC 7.1.1.1) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)",Bos taurus (Bovine),63.4,1036.0,0.0,1258.0,"sp|P11024|NNTM_BOVIN NAD(P) transhydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=NNT PE=1 SV=3",GO:0005743; GO:0006740; GO:0008750; GO:0016491; GO:0050661; GO:0072593,NADPH regeneration [GO:0006740]; reactive oxygen species metabolic process [GO:0072593],mitochondrial inner membrane [GO:0005743],NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; proton-translocating NAD(P)+ transhydrogenase activity [GO:0008750],GO:0003824; GO:0005215; GO:0006091; GO:0016491; GO:0055086,catalytic activity; transporter activity; generation of precursor metabolites and energy; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_05333,FUN_024043-T1,Peve_00020342,Pocillopora_meandrina_HIv1___RNAseq.g19269.t1,three_way,88.07966666666667,FUN_024043-T1,Q5T0T0,MARH8_HUMAN,,E3 ubiquitin-protein ligase MARCHF8 (EC 2.3.2.27) (Cellular modulator of immune recognition) (c-MIR) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII) (MARCH-VIII) (RING finger protein 178) (RING-type E3 ubiquitin transferase MARCHF8),Homo sapiens (Human),59.5,237.0,4.300000000000001e-74,279.3,sp|Q5T0T0|MARH8_HUMAN E3 ubiquitin-protein ligase MARCHF8 OS=Homo sapiens OX=9606 GN=MARCHF8 PE=1 SV=1,GO:0000139; GO:0000209; GO:0002250; GO:0002495; GO:0004842; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005789; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0042287; GO:0061630,adaptive immune response [GO:0002250]; antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"immune system process; catalytic activity; lysosome; endosome; vacuole; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05334,FUN_024044-T4,Peve_00020349,Pocillopora_meandrina_HIv1___RNAseq.g19263.t1,three_way,44.71333333333334,,,,,,,,,,,,,,,,,
OG_05335,FUN_024047-T1,Peve_00020347,Pocillopora_meandrina_HIv1___RNAseq.g19265.t1,three_way,76.87566666666666,FUN_024047-T1,Q99MB5,,,,,60.5,124.0,1.3000000000000002e-44,180.6,sp|Q99MB5|LMO3_RAT LIM domain only protein 3 OS=Rattus norvegicus OX=10116 GN=Lmo3 PE=2 SV=2,,,,,,
OG_05336,FUN_024051-T1,Peve_00020343,Pocillopora_meandrina_HIv1___RNAseq.g19268.t1a,three_way,33.204166666666666,,,,,,,,,,,,,,,,,
OG_05337,FUN_024053-T1,Peve_00000160,Pocillopora_meandrina_HIv1___RNAseq.g19257.t2,three_way,68.68216666666666,FUN_024053-T1,Q8CIQ7,DOCK3_MOUSE,,Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP),Mus musculus (Mouse),42.0,1682.0,0.0,1276.5,sp|Q8CIQ7|DOCK3_MOUSE Dedicator of cytokinesis protein 3 OS=Mus musculus OX=10090 GN=Dock3 PE=1 SV=1,GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007264; GO:0017124,small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; cytosol [GO:0005829],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_05338,FUN_024054-T1,Peve_00000164,Pocillopora_meandrina_HIv1___RNAseq.g19258.t1,three_way,82.41566666666667,FUN_024054-T1,Q80T69,RSBN1_MOUSE,,Lysine-specific demethylase 9 (KDM9) (EC 1.14.11.-) (Round spermatid basic protein 1) (Rosbin),Mus musculus (Mouse),56.1,271.0,1e-81,305.4,sp|Q80T69|RSBN1_MOUSE Lysine-specific demethylase 9 OS=Mus musculus OX=10090 GN=Rsbn1 PE=1 SV=3,GO:0005634; GO:0035575; GO:0046872,,nucleus [GO:0005634],histone H4K20 demethylase activity [GO:0035575]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_05339,FUN_024055-T1,Peve_00000165,Pocillopora_meandrina_HIv1___TS.g28634.t1,three_way,68.473,FUN_024055-T1,P25723,TLD_DROME,,Dorsal-ventral patterning protein tolloid (EC 3.4.24.-),Drosophila melanogaster (Fruit fly),44.7,76.0,4.8e-06,53.1,sp|P25723|TLD_DROME Dorsal-ventral patterning protein tolloid OS=Drosophila melanogaster OX=7227 GN=tld PE=2 SV=2,GO:0004222; GO:0005509; GO:0005518; GO:0005615; GO:0006508; GO:0007313; GO:0007378; GO:0008270; GO:0008586; GO:0009953; GO:0016485; GO:0030513; GO:0032927; GO:0045464,"amnioserosa formation [GO:0007378]; dorsal/ventral pattern formation [GO:0009953]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maternal specification of dorsal/ventral axis, oocyte, soma encoded [GO:0007313]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485]; proteolysis [GO:0006508]; R8 cell fate specification [GO:0045464]",extracellular space [GO:0005615],calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0022414; GO:0051604; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; reproductive process; protein maturation; catalytic activity, acting on a protein"
OG_05340,FUN_024063-T1,Peve_00000155,Pocillopora_meandrina_HIv1___RNAseq.g19256.t1,three_way,75.40483333333333,FUN_024063-T1,Q9P241,AT10D_HUMAN,,Phospholipid-transporting ATPase VD (EC 7.6.2.1) (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D),Homo sapiens (Human),43.6,1316.0,3.4e-279,963.0,sp|Q9P241|AT10D_HUMAN Phospholipid-transporting ATPase VD OS=Homo sapiens OX=9606 GN=ATP10D PE=1 SV=3,GO:0000287; GO:0005524; GO:0005654; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0016020; GO:0016887; GO:0034220; GO:0045332; GO:0140326; GO:0140351; GO:1990531,monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; glycosylceramide flippase activity [GO:0140351]; magnesium ion binding [GO:0000287],GO:0003824; GO:0005215; GO:0005654; GO:0005783; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleoplasm; endoplasmic reticulum; plasma membrane; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
OG_05341,FUN_024067-T1,Peve_00000150,Pocillopora_meandrina_HIv1___RNAseq.g19254.t1,three_way,69.05799999999999,FUN_024067-T1,Q54RA4,,,,,34.9,352.0,9.9e-50,198.7,sp|Q54RA4|Y3291_DICDI Probable iron/ascorbate oxidoreductase DDB_G0283291 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0283291 PE=3 SV=1,,,,,,
OG_05342,FUN_024071-T1,Peve_00014630,Pocillopora_meandrina_HIv1___RNAseq.23622_t,three_way,47.72133333333333,,,,,,,,,,,,,,,,,
OG_05343,FUN_024074-T1,Peve_00000137,Pocillopora_meandrina_HIv1___RNAseq.g19216.t1,three_way,88.08233333333334,FUN_024074-T1,Q3UGF1,,,,,63.3,1342.0,0.0,1771.9,sp|Q3UGF1|WDR19_MOUSE WD repeat-containing protein 19 OS=Mus musculus OX=10090 GN=Wdr19 PE=1 SV=1,,,,,,
OG_05344,FUN_024075-T1,Peve_00000135,Pocillopora_meandrina_HIv1___TS.g28590.t2,three_way,90.34133333333334,FUN_024075-T1,Q3T0T7,SAR1B_BOVIN,,Small COPII coat GTPase SAR1B (EC 3.6.5.2),Bos taurus (Bovine),71.3,195.0,4.5e-82,305.8,sp|Q3T0T7|SAR1B_BOVIN Small COPII coat GTPase SAR1B OS=Bos taurus OX=9913 GN=SAR1B PE=2 SV=1,GO:0003400; GO:0003924; GO:0003925; GO:0005525; GO:0005765; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0016050; GO:0030127; GO:0032368; GO:0032580; GO:0042953; GO:0046872; GO:0048208; GO:0055088; GO:0061024; GO:0070971; GO:0090110; GO:0140353; GO:0140785; GO:1904262; GO:1990253,cellular response to leucine starvation [GO:1990253]; COPII vesicle coating [GO:0048208]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lipid export from cell [GO:0140353]; lipid homeostasis [GO:0055088]; lipoprotein transport [GO:0042953]; membrane organization [GO:0061024]; negative regulation of TORC1 signaling [GO:1904262]; regulation of COPII vesicle coating [GO:0003400]; regulation of lipid transport [GO:0032368]; vesicle organization [GO:0016050],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765],amino acid sensor activity [GO:0140785]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0003824; GO:0003924; GO:0005829; GO:0006886; GO:0016192; GO:0016787; GO:0061024; GO:0065003; GO:0098772; GO:0140299,catalytic activity; GTPase activity; cytosol; intracellular protein transport; vesicle-mediated transport; hydrolase activity; membrane organization; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_05345,FUN_024077-T1,Peve_00000134,Pocillopora_meandrina_HIv1___RNAseq.g19214.t1,three_way,52.69133333333333,FUN_024077-T1,Q63447,,,,,26.6,301.0,5.6e-14,80.1,sp|Q63447|NPY4R_RAT Neuropeptide Y receptor type 4 OS=Rattus norvegicus OX=10116 GN=Npy4r PE=2 SV=1,,,,,,
OG_05346,FUN_024106-T1,Peve_00000192,Pocillopora_meandrina_HIv1___RNAseq.g19200.t1,three_way,44.25,,,,,,,,,,,,,,,,,
OG_05347,FUN_024110-T1,Peve_00000187,Pocillopora_meandrina_HIv1___RNAseq.g19190.t1,three_way,60.88066666666666,FUN_024110-T1,P30874,SSR2_HUMAN,,Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SST2) (SRIF-1),Homo sapiens (Human),23.1,337.0,2e-13,78.6,sp|P30874|SSR2_HUMAN Somatostatin receptor type 2 OS=Homo sapiens OX=9606 GN=SSTR2 PE=1 SV=1,GO:0004994; GO:0005654; GO:0005829; GO:0005886; GO:0007187; GO:0007193; GO:0007218; GO:0008285; GO:0030165; GO:0042923; GO:0043005; GO:0071385; GO:0071392,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cellular response to estradiol stimulus [GO:0071392]; cellular response to glucocorticoid stimulus [GO:0071385]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]",cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],neuropeptide binding [GO:0042923]; PDZ domain binding [GO:0030165]; somatostatin receptor activity [GO:0004994],GO:0005654; GO:0005829; GO:0005886; GO:0060089,nucleoplasm; cytosol; plasma membrane; molecular transducer activity
OG_05348,FUN_024111-T1,Peve_00000186,Pocillopora_meandrina_HIv1___RNAseq.g19189.t1,three_way,75.39166666666667,FUN_024111-T1,O00408,PDE2A_HUMAN,,"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)",Homo sapiens (Human),45.4,868.0,9.700000000000001e-196,685.3,"sp|O00408|PDE2A_HUMAN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Homo sapiens OX=9606 GN=PDE2A PE=1 SV=1",GO:0000122; GO:0000287; GO:0003170; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0008270; GO:0010628; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030224; GO:0030552; GO:0030553; GO:0030911; GO:0035904; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071320; GO:0071321; GO:0071466; GO:0071560; GO:0097011; GO:0097060; GO:0106072; GO:1904613,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; ventricular septum development [GO:0003281]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]",GO:0003013; GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:1901135,circulatory system process; catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05349,FUN_024112-T1,Peve_00000185,Pocillopora_meandrina_HIv1___RNAseq.g19188.t1,three_way,63.54033333333333,FUN_024112-T1,Q804X9,,,,,29.4,316.0,3e-33,144.1,sp|Q804X9|OPN4A_GADMO Melanopsin-A OS=Gadus morhua OX=8049 GN=opn4a PE=2 SV=1,,,,,,
OG_05350,FUN_024113-T1,Peve_00000184,Pocillopora_meandrina_HIv1___RNAseq.g19187.t1,three_way,78.90166666666667,FUN_024113-T1,Q9UI95,MD2L2_HUMAN,,Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2) (REV7 homolog) (hREV7),Homo sapiens (Human),55.6,160.0,4.5e-44,179.1,sp|Q9UI95|MD2L2_HUMAN Mitotic spindle assembly checkpoint protein MAD2B OS=Homo sapiens OX=9606 GN=MAD2L2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0001558; GO:0002208; GO:0003714; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005819; GO:0006302; GO:0007015; GO:0007094; GO:0008432; GO:0010719; GO:0010944; GO:0016035; GO:0033138; GO:0035861; GO:0042177; GO:0042276; GO:0042772; GO:0043247; GO:0045830; GO:0045893; GO:0051301; GO:0061629; GO:0090090; GO:1904667; GO:2000042; GO:2000048; GO:2001034,"actin filament organization [GO:0007015]; cell division [GO:0051301]; DNA damage response, signal transduction resulting in transcription [GO:0042772]; double-strand break repair [GO:0006302]; error-prone translesion synthesis [GO:0042276]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of cell growth [GO:0001558]; somatic diversification of immunoglobulins involved in immune response [GO:0002208]; telomere maintenance in response to DNA damage [GO:0043247]",chromatin [GO:0000785]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; zeta DNA polymerase complex [GO:0016035],JUN kinase binding [GO:0008432]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006355; GO:0032200; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; nucleoplasm; chromosome; DNA repair; regulation of DNA-templated transcription; telomere organization; organelle; molecular adaptor activity; transcription regulator activity
OG_05351,FUN_024121-T1,Peve_00000177,Pocillopora_meandrina_HIv1___RNAseq.g19176.t1,three_way,46.95433333333333,,,,,,,,,,,,,,,,,
OG_05352,FUN_024123-T1,Peve_00000175,Pocillopora_meandrina_HIv1___RNAseq.g19173.t1,three_way,69.35583333333332,FUN_024123-T1,A8MY62,,,,,33.6,330.0,6.3e-47,190.3,sp|A8MY62|BLML_HUMAN Putative beta-lactamase-like 1 OS=Homo sapiens OX=9606 GN=LACTBL1 PE=1 SV=2,,,,,,
OG_05353,FUN_024124-T1,Peve_00000162,Pocillopora_meandrina_HIv1___RNAseq.g19172.t1,three_way,87.20466666666667,FUN_024124-T1,Q9Y603,,,,,37.1,62.0,8e-08,58.9,sp|Q9Y603|ETV7_HUMAN Transcription factor ETV7 OS=Homo sapiens OX=9606 GN=ETV7 PE=1 SV=1,,,,,,
OG_05354,FUN_024126-T1,Peve_00000142,Pocillopora_meandrina_HIv1___RNAseq.g19899.t1,three_way,63.01416666666667,FUN_024126-T1,A6QQL0,S15A4_BOVIN,,Solute carrier family 15 member 4 (Peptide/histidine transporter 1),Bos taurus (Bovine),30.3,545.0,1.1999999999999999e-54,216.1,sp|A6QQL0|S15A4_BOVIN Solute carrier family 15 member 4 OS=Bos taurus OX=9913 GN=SLC15A4 PE=2 SV=2,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_05355,FUN_024127-T1,Peve_00000138,Pocillopora_meandrina_HIv1___RNAseq.g19898.t1,three_way,68.97566666666667,FUN_024127-T1,Q8N5I4,DHRSX_HUMAN,,Polyprenol dehydrogenase (EC 1.1.1.441) (DHRSXY) (Dehydrogenase/reductase SDR family member on chromosome X) (Dolichal reductase),Homo sapiens (Human),44.9,321.0,1.2e-74,281.6,sp|Q8N5I4|DHRSX_HUMAN Polyprenol dehydrogenase OS=Homo sapiens OX=9606 GN=DHRSX PE=1 SV=2,GO:0005576; GO:0005811; GO:0010508; GO:0019408; GO:0160196; GO:0160197,dolichol biosynthetic process [GO:0019408]; positive regulation of autophagy [GO:0010508],extracellular region [GO:0005576]; lipid droplet [GO:0005811],dolichal reductase [NAD(P)+] activity [GO:0160197]; polyprenol dehydrogenase activity [GO:0160196],GO:0003824; GO:0005576; GO:0005811; GO:0016491; GO:0043226,catalytic activity; extracellular region; lipid droplet; oxidoreductase activity; organelle
OG_05356,FUN_024129-T1,Peve_00005110,Pocillopora_meandrina_HIv1___RNAseq.g19897.t1,three_way,72.21683333333333,FUN_024129-T1,F1MDL2,,,,,35.2,899.0,1.6e-142,508.4,sp|F1MDL2|INTU_BOVIN Protein inturned OS=Bos taurus OX=9913 GN=INTU PE=3 SV=2,,,,,,
OG_05357,FUN_024130-T1,Peve_00010978,Pocillopora_meandrina_HIv1___RNAseq.g19883.t1,three_way,89.545,FUN_024130-T1,Q6ZWB6,,,,,44.8,281.0,2e-56,220.7,sp|Q6ZWB6|KCTD8_HUMAN BTB/POZ domain-containing protein KCTD8 OS=Homo sapiens OX=9606 GN=KCTD8 PE=1 SV=1,,,,,,
OG_05358,FUN_024132-T1,Peve_00010979,Pocillopora_meandrina_HIv1___RNAseq.g19882.t1,three_way,64.038,FUN_024132-T1,P79942,,,,,44.9,325.0,1.5e-64,248.1,sp|P79942|NOCT_XENLA Nocturnin OS=Xenopus laevis OX=8355 GN=noct PE=2 SV=1,,,,,,
OG_05359,FUN_024133-T1,Peve_00010980,Pocillopora_meandrina_HIv1___RNAseq.g19881.t1,three_way,63.13883333333333,FUN_024133-T1,Q14108,,,,,33.2,476.0,2.6000000000000007e-71,271.2,sp|Q14108|SCRB2_HUMAN Lysosome membrane protein 2 OS=Homo sapiens OX=9606 GN=SCARB2 PE=1 SV=2,,,,,,
OG_05360,FUN_024135-T1,Peve_00036826,Pocillopora_meandrina_HIv1___RNAseq.g19871.t1,three_way,47.9855,FUN_024135-T1,B0BN56,,,,,45.3,106.0,8.5e-18,93.2,sp|B0BN56|RT31_RAT Small ribosomal subunit protein mS31 OS=Rattus norvegicus OX=10116 GN=Mrps31 PE=2 SV=1,,,,,,
OG_05361,FUN_024136-T1,Peve_00020658,Pocillopora_meandrina_HIv1___RNAseq.g19872.t1,three_way,70.992,FUN_024136-T1,A7SNN5,PLK4_NEMVE,,Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4),Nematostella vectensis (Starlet sea anemone),55.1,1013.0,1.3999999999999998e-280,967.2,sp|A7SNN5|PLK4_NEMVE Serine/threonine-protein kinase PLK4 OS=Nematostella vectensis OX=45351 GN=v1g246408 PE=3 SV=1,GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005814; GO:0106310,,centriole [GO:0005814]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05362,FUN_024140-T1,Peve_00036827,Pocillopora_meandrina_HIv1___RNAseq.g19870.t1,three_way,70.87366666666667,FUN_024140-T1,Q96IZ5,,,,,33.3,381.0,5.6e-48,193.4,sp|Q96IZ5|RBM41_HUMAN RNA-binding protein 41 OS=Homo sapiens OX=9606 GN=RBM41 PE=1 SV=2,,,,,,
OG_05363,FUN_024144-T1,Peve_00036832,Pocillopora_meandrina_HIv1___RNAseq.g19865.t1,three_way,39.884166666666665,,,,,,,,,,,,,,,,,
OG_05364,FUN_024151-T1,Peve_00036839,Pocillopora_meandrina_HIv1___RNAseq.g19861.t1,three_way,80.388,FUN_024151-T1,Q9I9K7,TBX20_DANRE,,T-box transcription factor TBX20 (T-box protein 20) (H15-related T-box transcription factor hrT),Danio rerio (Zebrafish) (Brachydanio rerio),50.2,408.0,9.6e-95,348.6,sp|Q9I9K7|TBX20_DANRE T-box transcription factor TBX20 OS=Danio rerio OX=7955 GN=tbx20 PE=2 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001525; GO:0001568; GO:0001570; GO:0001708; GO:0001947; GO:0003313; GO:0005634; GO:0006357; GO:0007507; GO:0035050; GO:0035162; GO:0035844; GO:0045892; GO:0045893; GO:0060038; GO:0060043,angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cardiac muscle cell proliferation [GO:0060038]; cell fate specification [GO:0001708]; cloaca development [GO:0035844]; embryonic heart tube development [GO:0035050]; embryonic hemopoiesis [GO:0035162]; heart development [GO:0007507]; heart looping [GO:0001947]; heart rudiment development [GO:0003313]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of transcription by RNA polymerase II [GO:0006357]; vasculogenesis [GO:0001570],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05365,FUN_024152-T1,Peve_00036840,Pocillopora_meandrina_HIv1___RNAseq.g19849.t1,three_way,82.19433333333333,FUN_024152-T1,Q6PBL0,,,,,61.7,128.0,3.4e-33,142.5,sp|Q6PBL0|TIM16_DANRE Mitochondrial import inner membrane translocase subunit tim16 OS=Danio rerio OX=7955 GN=pam16 PE=2 SV=1,,,,,,
OG_05366,FUN_024155-T1,Peve_00034622,Pocillopora_meandrina_HIv1___RNAseq.g19853.t1,three_way,62.59933333333333,FUN_024155-T1,Q5U405,TMPSD_MOUSE,,Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease),Mus musculus (Mouse),26.8,272.0,2.7e-21,104.8,sp|Q5U405|TMPSD_MOUSE Transmembrane protease serine 13 OS=Mus musculus OX=10090 GN=Tmprss13 PE=2 SV=2,GO:0004252; GO:0005576; GO:0005737; GO:0005886; GO:0006508; GO:0061436,establishment of skin barrier [GO:0061436]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0048856; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_05367,FUN_024160-T1,Peve_00012381,Pocillopora_meandrina_HIv1___RNAseq.g19854.t1,three_way,64.70983333333334,FUN_024160-T1,P98070,,,,,34.9,284.0,6.5e-45,184.5,sp|P98070|BMP1_XENLA Bone morphogenetic protein 1 OS=Xenopus laevis OX=8355 GN=bmp1 PE=1 SV=1,,,,,,
OG_05368,FUN_024162-T1,Peve_00012380,Pocillopora_meandrina_HIv1___RNAseq.g19856.t2,three_way,67.17133333333334,FUN_024162-T1,Q20201,,,,,64.5,76.0,8.000000000000001e-23,109.0,sp|Q20201|SOX3_CAEEL Transcription factor sox-3 OS=Caenorhabditis elegans OX=6239 GN=sox-3 PE=2 SV=1,,,,,,
OG_05369,FUN_024171-T1,Peve_00010867,Pocillopora_meandrina_HIv1___RNAseq.g13459.t1,three_way,71.43766666666666,,,,,,,,,,,,,,,,,
OG_05370,FUN_024172-T1,Peve_00010868,Pocillopora_meandrina_HIv1___RNAseq.g13458.t1,three_way,63.120666666666665,,,,,,,,,,,,,,,,,
OG_05371,FUN_024173-T1,Peve_00010869,Pocillopora_meandrina_HIv1___RNAseq.g13457.t1,three_way,74.04,FUN_024173-T1,Q2UPB1,,,,,24.9,454.0,1.8e-29,132.1,sp|Q2UPB1|ACLC_ASPOR Cytochrome P450 monooxygenase aclC OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) OX=510516 GN=aclC PE=3 SV=1,,,,,,
OG_05372,FUN_024174-T1,Peve_00031891,Pocillopora_meandrina_HIv1___RNAseq.g18891.t1,three_way,67.8785,FUN_024174-T1,Q9P2B7,,,,,29.6,230.0,3.4e-09,63.9,sp|Q9P2B7|CFA97_HUMAN Cilia- and flagella-associated protein 97 OS=Homo sapiens OX=9606 GN=CFAP97 PE=1 SV=2,,,,,,
OG_05373,FUN_024176-T1,Peve_00005152,Pocillopora_meandrina_HIv1___RNAseq.g18889.t1,three_way,53.38816666666667,FUN_024176-T1,P62597,,,,,25.5,368.0,7.5e-19,97.1,sp|P62597|POTE1_CHICK Protection of telomeres protein 1 OS=Gallus gallus OX=9031 GN=POT1 PE=1 SV=1,,,,,,
OG_05374,FUN_024187-T1,Peve_00013614,Pocillopora_meandrina_HIv1___RNAseq.g18887.t1,three_way,88.22666666666666,FUN_024187-T1,Q921G7,ETFD_MOUSE,,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)",Mus musculus (Mouse),75.3,595.0,1.9e-280,966.1,"sp|Q921G7|ETFD_MOUSE Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial OS=Mus musculus OX=10090 GN=Etfdh PE=1 SV=1",GO:0004174; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006979; GO:0009055; GO:0016020; GO:0016491; GO:0017133; GO:0033539; GO:0046872; GO:0048039; GO:0051539,fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; response to oxidative stress [GO:0006979],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; ubiquinone binding [GO:0048039]",GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0006629; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; cytosol; lipid metabolic process; oxidoreductase activity; organelle
OG_05375,FUN_024188-T1,Peve_00013618,Pocillopora_meandrina_HIv1___RNAseq.g18884.t1,three_way,43.766,,,,,,,,,,,,,,,,,
OG_05376,FUN_024192-T1,Peve_00018693,Pocillopora_meandrina_HIv1___RNAseq.g18883.t1,three_way,75.952,FUN_024192-T1,Q921D9,GRHL1_MOUSE,,Grainyhead-like protein 1 homolog (Transcription factor CP2-like 2) (Transcription factor LBP-32),Mus musculus (Mouse),33.3,93.0,6.4e-10,65.5,sp|Q921D9|GRHL1_MOUSE Grainyhead-like protein 1 homolog OS=Mus musculus OX=10090 GN=Grhl1 PE=1 SV=1,GO:0000976; GO:0000978; GO:0001228; GO:0002934; GO:0003700; GO:0005634; GO:0005654; GO:0006355; GO:0008544; GO:0031490; GO:0042803; GO:0043565; GO:0045616; GO:0045944; GO:0061436; GO:0140297,desmosome organization [GO:0002934]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of keratinocyte differentiation [GO:0045616],nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0034330; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell junction organization; organelle; anatomical structure development; transcription regulator activity
OG_05377,FUN_024194-T1,Peve_00018695,Pocillopora_meandrina_HIv1___RNAseq.g18881.t1,three_way,60.04266666666667,FUN_024194-T1,O75330,HMMR_HUMAN,,Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168),Homo sapiens (Human),45.3,148.0,1.2e-20,103.6,sp|O75330|HMMR_HUMAN Hyaluronan mediated motility receptor OS=Homo sapiens OX=9606 GN=HMMR PE=1 SV=2,GO:0005540; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005886; GO:0006898; GO:0009986; GO:0015630; GO:0016020; GO:0030214; GO:0038024,hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],cell surface [GO:0009986]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819],cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540],GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0016192; GO:0038024; GO:0043226; GO:1901135,microtubule organizing center; cytosol; cytoskeleton; plasma membrane; vesicle-mediated transport; cargo receptor activity; organelle; carbohydrate derivative metabolic process
OG_05378,FUN_024195-T1,Peve_00018698,Pocillopora_meandrina_HIv1___RNAseq.g18880.t1,three_way,77.08933333333333,FUN_024195-T1,Q96NL6,SCLT1_HUMAN,,Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1),Homo sapiens (Human),27.6,613.0,2.3999999999999998e-54,215.3,sp|Q96NL6|SCLT1_HUMAN Sodium channel and clathrin linker 1 OS=Homo sapiens OX=9606 GN=SCLT1 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005829; GO:0015630; GO:0017080; GO:0030276; GO:0036064; GO:0045162; GO:0060271; GO:0071439; GO:0097539,cilium assembly [GO:0060271]; clustering of voltage-gated sodium channels [GO:0045162],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; clathrin complex [GO:0071439]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630],clathrin binding [GO:0030276]; sodium channel regulator activity [GO:0017080],GO:0005815; GO:0005829; GO:0005856; GO:0043226; GO:0044782; GO:0061024; GO:0098772,microtubule organizing center; cytosol; cytoskeleton; organelle; cilium organization; membrane organization; molecular function regulator activity
OG_05379,FUN_024196-T1,Peve_00018699,Pocillopora_meandrina_HIv1___TS.g28463.t1,three_way,51.997,,,,,,,,,,,,,,,,,
OG_05380,FUN_024197-T1,Peve_00025330,Pocillopora_meandrina_HIv1___RNAseq.g3316.t1,three_way,57.18566666666667,FUN_024197-T1,Q6PBQ2,,,,,33.5,388.0,6.1e-54,213.4,sp|Q6PBQ2|CHMP7_DANRE Charged multivesicular body protein 7 OS=Danio rerio OX=7955 GN=chmp7 PE=2 SV=1,,,,,,
OG_05381,FUN_024198-T1,Peve_00031881,Pocillopora_meandrina_HIv1___RNAseq.g18899.t1,three_way,47.24066666666667,,,,,,,,,,,,,,,,,
OG_05382,FUN_024199-T1,Peve_00031882,Pocillopora_meandrina_HIv1___RNAseq.g18898.t1,three_way,95.62316666666666,FUN_024199-T1,A5WWB0,,,,,75.2,375.0,3.8e-162,572.4,sp|A5WWB0|UBP46_DANRE Ubiquitin carboxyl-terminal hydrolase 46 OS=Danio rerio OX=7955 GN=usp46 PE=3 SV=2,,,,,,
OG_05383,FUN_024200-T1,Peve_00031883,Pocillopora_meandrina_HIv1___RNAseq.g18897.t1,three_way,88.11166666666666,FUN_024200-T1,Q9VCA9,,,,,67.6,105.0,2.5e-37,156.0,sp|Q9VCA9|SPCS3_DROME Signal peptidase complex subunit 3 OS=Drosophila melanogaster OX=7227 GN=Spase22-23 PE=2 SV=1,,,,,,
OG_05384,FUN_024201-T1,Peve_00031885,Pocillopora_meandrina_HIv1___RNAseq.g18895.t1,three_way,52.33616666666667,FUN_024201-T1,Q5RG49,,,,,28.2,1294.0,6.1e-121,437.2,sp|Q5RG49|ACSF4_DANRE Beta-alanine-activating enzyme OS=Danio rerio OX=7955 GN=aasdh PE=3 SV=1,,,,,,
OG_05385,FUN_024206-T1,Peve_00031875,Pocillopora_meandrina_HIv1___RNAseq.g18903.t1,three_way,91.63933333333333,FUN_024206-T1,P61221,ABCE1_HUMAN,,ATP-binding cassette sub-family E member 1 (EC 3.6.5.-) (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I),Homo sapiens (Human),81.8,598.0,6e-290,997.7,sp|P61221|ABCE1_HUMAN ATP-binding cassette sub-family E member 1 OS=Homo sapiens OX=9606 GN=ABCE1 PE=1 SV=1,GO:0003924; GO:0005506; GO:0005524; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006413; GO:0006415; GO:0006417; GO:0016020; GO:0016887; GO:0017111; GO:0022626; GO:0032790; GO:0043024; GO:0043273; GO:0051539; GO:0060698; GO:0060702; GO:0072344,negative regulation of endoribonuclease activity [GO:0060702]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; translational initiation [GO:0006413]; translational termination [GO:0006415],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CTPase activity [GO:0043273]; endoribonuclease inhibitor activity [GO:0060698]; GTPase activity [GO:0003924]; iron ion binding [GO:0005506]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]",GO:0003824; GO:0003924; GO:0005739; GO:0005829; GO:0005840; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; mitochondrion; cytosol; ribosome; hydrolase activity; organelle; molecular function regulator activity
OG_05386,FUN_024207-T1,Peve_00031874,Pocillopora_meandrina_HIv1___RNAseq.g18904.t1,three_way,54.37766666666667,,,,,,,,,,,,,,,,,
OG_05387,FUN_024208-T1,Peve_00031873,Pocillopora_meandrina_HIv1___RNAseq.g18905.t1b,three_way,71.887,FUN_024208-T1,O09167,RL21_MOUSE,,Large ribosomal subunit protein eL21 (60S ribosomal protein L21),Mus musculus (Mouse),65.0,160.0,4.7e-52,206.1,sp|O09167|RL21_MOUSE Large ribosomal subunit protein eL21 OS=Mus musculus OX=10090 GN=Rpl21 PE=1 SV=4,GO:0002181; GO:0003735; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098794,cytoplasmic translation [GO:0002181],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; postsynapse [GO:0098794]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005783; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; endoplasmic reticulum; cytosol; ribosome; organelle
OG_05388,FUN_024214-T1,Peve_00031909,Pocillopora_meandrina_HIv1___RNAseq.g18908.t1,three_way,69.09233333333334,,,,,,,,,,,,,,,,,
OG_05389,FUN_024215-T1,Peve_00031908,Pocillopora_meandrina_HIv1___RNAseq.g18907.t1,three_way,81.43066666666667,FUN_024215-T1,Q06AB3,,,,,58.7,225.0,2.6e-76,286.6,sp|Q06AB3|UCHL3_PIG Ubiquitin carboxyl-terminal hydrolase isozyme L3 OS=Sus scrofa OX=9823 GN=UCHL3 PE=2 SV=1,,,,,,
OG_05390,FUN_024216-T1,Peve_00031907,Pocillopora_meandrina_HIv1___RNAseq.g18909.t1,three_way,78.90966666666667,FUN_024216-T1,Q5F452,MTMR8_CHICK,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR8 (EC 3.1.3.95) (Myotubularin-related protein 8) (Phosphatidylinositol-3-phosphate phosphatase)",Gallus gallus (Chicken),55.8,543.0,1.6e-188,661.0,"sp|Q5F452|MTMR8_CHICK Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR8 OS=Gallus gallus OX=9031 GN=MTMR8 PE=2 SV=1",GO:0004438; GO:0005635; GO:0005737; GO:0046856; GO:0052629; GO:0106018,phosphatidylinositol dephosphorylation [GO:0046856],cytoplasm [GO:0005737]; nuclear envelope [GO:0005635],"phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO:0106018]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]",GO:0003824; GO:0005635; GO:0006629; GO:0016787,catalytic activity; nuclear envelope; lipid metabolic process; hydrolase activity
OG_05391,FUN_024217-T1,Peve_00031902,Pocillopora_meandrina_HIv1___RNAseq.g18910.t1,three_way,65.40866666666666,FUN_024217-T1,Q8R332,NUP58_MOUSE,,Nucleoporin p58/p45 (58 kDa nucleoporin) (Nucleoporin-like protein 1),Mus musculus (Mouse),44.6,350.0,5.4e-38,160.6,sp|Q8R332|NUP58_MOUSE Nucleoporin p58/p45 OS=Mus musculus OX=10090 GN=Nup58 PE=1 SV=1,GO:0005635; GO:0005643; GO:0006913; GO:0008139; GO:0015031; GO:0017056; GO:0031965; GO:0042306; GO:0042802; GO:0044877; GO:0051028,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031]; regulation of protein import into nucleus [GO:0042306],nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643],identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; protein-containing complex binding [GO:0044877]; structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0006913,structural molecule activity; nuclear envelope; nucleocytoplasmic transport
OG_05392,FUN_024218-T1,Peve_00031898,Pocillopora_meandrina_HIv1___RNAseq.g18911.t1,three_way,58.434,FUN_024218-T1,Q9H6E4,,,,,39.4,165.0,2.6e-31,137.1,sp|Q9H6E4|CC134_HUMAN Coiled-coil domain-containing protein 134 OS=Homo sapiens OX=9606 GN=CCDC134 PE=1 SV=1,,,,,,
OG_05393,FUN_024219-T1,Peve_00031897,Pocillopora_meandrina_HIv1___RNAseq.g18912.t1,three_way,71.5065,FUN_024219-T1,Q5RED7,AGK_PONAB,,"Acylglycerol kinase, mitochondrial (EC 2.7.1.107) (EC 2.7.1.138) (EC 2.7.1.94) (Multiple substrate lipid kinase) (MuLK) (Multi-substrate lipid kinase)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),37.0,405.0,6.5e-67,256.1,"sp|Q5RED7|AGK_PONAB Acylglycerol kinase, mitochondrial OS=Pongo abelii OX=9601 GN=AGK PE=2 SV=1",GO:0001729; GO:0004143; GO:0005524; GO:0005743; GO:0005758; GO:0017050; GO:0031966; GO:0042721; GO:0045039; GO:0046486; GO:0046512; GO:0046513; GO:0046834; GO:0047620,ceramide biosynthetic process [GO:0046513]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; protein insertion into mitochondrial inner membrane [GO:0045039]; sphingosine biosynthetic process [GO:0046512],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721],acylglycerol kinase activity [GO:0047620]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; ceramide kinase activity [GO:0001729]; D-erythro-sphingosine kinase activity [GO:0017050],GO:0003824; GO:0006629; GO:0007005; GO:0016740; GO:0061024,catalytic activity; lipid metabolic process; mitochondrion organization; transferase activity; membrane organization
OG_05394,FUN_024220-T1,Peve_00031896,Pocillopora_meandrina_HIv1___RNAseq.g18913.t1,three_way,90.01333333333334,FUN_024220-T1,Q99612,,,,,90.0,90.0,6.5e-17,89.4,sp|Q99612|KLF6_HUMAN Krueppel-like factor 6 OS=Homo sapiens OX=9606 GN=KLF6 PE=1 SV=3,,,,,,
OG_05395,FUN_024222-T1,Peve_00031895,Pocillopora_meandrina_HIv1___RNAseq.g18914.t1,three_way,77.07900000000001,FUN_024222-T1,Q13887,KLF5_HUMAN,,Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2),Homo sapiens (Human),38.6,166.0,5.3e-19,96.7,sp|Q13887|KLF5_HUMAN Krueppel-like factor 5 OS=Homo sapiens OX=9606 GN=KLF5 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0008270; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0060576; GO:0061586; GO:1901653; GO:1990830; GO:1990837,angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816],chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005654; GO:0005794; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleoplasm; Golgi apparatus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05396,FUN_024223-T1,Peve_00031888,Pocillopora_meandrina_HIv1___RNAseq.g18916.t1,three_way,89.404,FUN_024223-T1,P49596,,,,,62.5,309.0,1.6e-113,410.6,sp|P49596|PP2C2_CAEEL Probable protein phosphatase 2C T23F11.1 OS=Caenorhabditis elegans OX=6239 GN=ppm-2 PE=3 SV=2,,,,,,
OG_05397,FUN_024224-T1,Peve_00031887,Pocillopora_meandrina_HIv1___TS.g28304.t1,three_way,65.771,FUN_024224-T1,O60343,TBCD4_HUMAN,,TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160),Homo sapiens (Human),33.6,1274.0,8.199999999999999e-148,526.6,sp|O60343|TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens OX=9606 GN=TBC1D4 PE=1 SV=2,GO:0005096; GO:0005794; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869,cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],GTPase activator activity [GO:0005096],GO:0005794; GO:0005829; GO:0016192; GO:0043226; GO:0098772,Golgi apparatus; cytosol; vesicle-mediated transport; organelle; molecular function regulator activity
OG_05398,FUN_024327-T2,Peve_00016300,Pocillopora_meandrina_HIv1___RNAseq.g18921.t1,three_way,43.888,FUN_024327-T2,O60494,CUBN_HUMAN,,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Homo sapiens (Human),38.0,108.0,1.7e-11,71.6,sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5,GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_05399,FUN_024328-T1,Peve_00016318,Pocillopora_meandrina_HIv1___RNAseq.g18924.t1,three_way,71.84100000000001,FUN_024328-T1,Q21565,,,,,49.4,419.0,7.6e-111,402.5,sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2,,,,,,
OG_05400,FUN_024330-T1,Peve_00016319,Pocillopora_meandrina_HIv1___RNAseq.g18926.t1,three_way,76.277,FUN_024330-T1,O89023,TPP1_MOUSE,,Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I),Mus musculus (Mouse),50.2,562.0,2.3e-155,550.4,sp|O89023|TPP1_MOUSE Tripeptidyl-peptidase 1 OS=Mus musculus OX=10090 GN=Tpp1 PE=1 SV=2,GO:0004175; GO:0004252; GO:0005739; GO:0005764; GO:0005794; GO:0006508; GO:0007040; GO:0007399; GO:0008233; GO:0008236; GO:0008240; GO:0030855; GO:0035727; GO:0042470; GO:0043171; GO:0045121; GO:0045453; GO:0046872; GO:0050885; GO:0055037; GO:0070198; GO:0120146; GO:1905146,"bone resorption [GO:0045453]; epithelial cell differentiation [GO:0030855]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; peptide catabolic process [GO:0043171]; protein localization to chromosome, telomeric region [GO:0070198]; proteolysis [GO:0006508]",Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; recycling endosome [GO:0055037],endopeptidase activity [GO:0004175]; lysophosphatidic acid binding [GO:0035727]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; sulfatide binding [GO:0120146]; tripeptidyl-peptidase activity [GO:0008240],GO:0003824; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0007040; GO:0008289; GO:0016787; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"catalytic activity; mitochondrion; lysosome; endosome; vacuole; Golgi apparatus; lysosome organization; lipid binding; hydrolase activity; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_05401,FUN_024332-T1,Peve_00016315,Pocillopora_meandrina_HIv1___RNAseq.g18928.t1,three_way,91.02566666666668,FUN_024332-T1,A7S3J7,,,,,82.1,263.0,2.4e-123,443.0,sp|A7S3J7|RS3A_NEMVE Small ribosomal subunit protein eS1 OS=Nematostella vectensis OX=45351 GN=v1g242621 PE=3 SV=1,,,,,,
OG_05402,FUN_024333-T1,Peve_00016310,Pocillopora_meandrina_HIv1___RNAseq.g18942.t1,three_way,73.826,FUN_024333-T1,Q8BFR4,,,,,53.1,490.0,1.6e-153,544.3,sp|Q8BFR4|GNS_MOUSE N-acetylglucosamine-6-sulfatase OS=Mus musculus OX=10090 GN=Gns PE=1 SV=1,,,,,,
OG_05403,FUN_024334-T1,Peve_00016307,Pocillopora_meandrina_HIv1___RNAseq.g18941.t1,three_way,70.359,FUN_024334-T1,Q99MK9,,,,,38.3,313.0,2e-57,224.9,sp|Q99MK9|RASF1_MOUSE Ras association domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rassf1 PE=1 SV=1,,,,,,
OG_05404,FUN_024335-T1,Peve_00016306,Pocillopora_meandrina_HIv1___TS.g28328.t1c,three_way,80.27,FUN_024335-T1,O75896,TUSC2_HUMAN,,Tumor suppressor candidate 2 (Fusion 1 protein) (Fus-1 protein) (PDGFA-associated protein 2),Homo sapiens (Human),55.6,72.0,2.7e-17,89.4,sp|O75896|TUSC2_HUMAN Tumor suppressor candidate 2 OS=Homo sapiens OX=9606 GN=TUSC2 PE=1 SV=3,GO:0001779; GO:0005739; GO:0006909; GO:0006954; GO:0032700; GO:0032733; GO:0048469; GO:0051881; GO:0070945; GO:2000377,cell maturation [GO:0048469]; inflammatory response [GO:0006954]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377],mitochondrion [GO:0005739],,GO:0002376; GO:0005739; GO:0006954; GO:0016192; GO:0030154; GO:0043226; GO:0098542,immune system process; mitochondrion; inflammatory response; vesicle-mediated transport; cell differentiation; organelle; defense response to other organism
OG_05405,FUN_024336-T1,Peve_00013120,Pocillopora_meandrina_HIv1___RNAseq.g18939.t1,three_way,39.82233333333333,,,,,,,,,,,,,,,,,
OG_05406,FUN_024337-T1,Peve_00013124,Pocillopora_meandrina_HIv1___RNAseq.g18938.t1,three_way,65.52933333333333,FUN_024337-T1,O14059,,,,,42.9,280.0,7.1e-61,235.7,sp|O14059|HIS9_SCHPO Probable histidinol-phosphatase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPCC1672.01 PE=3 SV=1,,,,,,
OG_05407,FUN_024339-T1,Peve_00016804,Pocillopora_meandrina_HIv1___RNAseq.g18936.t1,three_way,66.383,FUN_024339-T1,Q96H96,COQ2_HUMAN,,"4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase)",Homo sapiens (Human),66.2,305.0,3.4e-116,419.9,"sp|Q96H96|COQ2_HUMAN 4-hydroxybenzoate polyprenyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=COQ2 PE=1 SV=2",GO:0004659; GO:0005739; GO:0005743; GO:0006071; GO:0006744; GO:0008299; GO:0008412; GO:0031314,glycerol metabolic process [GO:0006071]; isoprenoid biosynthetic process [GO:0008299]; ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],4-hydroxybenzoate polyprenyltransferase activity [GO:0008412]; prenyltransferase activity [GO:0004659],GO:0003824; GO:0005739; GO:0005975; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lipid metabolic process; transferase activity; organelle
OG_05408,FUN_024342-T1,Peve_00016807,Pocillopora_meandrina_HIv1___RNAseq.g18932.t1,three_way,79.807,FUN_024342-T1,P53348,,,,,53.5,114.0,7.6e-30,131.7,sp|P53348|BTG1_BOVIN Protein BTG1 OS=Bos taurus OX=9913 GN=BTG1 PE=2 SV=2,,,,,,
OG_05409,FUN_024343-T1,Peve_00016806,Pocillopora_meandrina_HIv1___RNAseq.g18931.t1,three_way,80.135,FUN_024343-T1,Q6BRB4,,,,,37.3,83.0,3.1e-06,53.9,sp|Q6BRB4|NHP6_DEBHA Non-histone chromosomal protein 6 OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) OX=284592 GN=NHP6 PE=3 SV=1,,,,,,
OG_05410,FUN_024344-T1,Peve_00016805,Pocillopora_meandrina_HIv1___RNAseq.g18930.t1,three_way,83.4915,FUN_024344-T1,F1QN74,,,,,50.1,435.0,4.5e-125,449.5,sp|F1QN74|ZMY10_DANRE Zinc finger MYND domain-containing protein 10 OS=Danio rerio OX=7955 GN=zmynd10 PE=2 SV=1,,,,,,
OG_05411,FUN_024348-T1,Peve_00021946,Pocillopora_meandrina_HIv1___RNAseq.g18670.t1,three_way,69.60533333333333,FUN_024348-T1,A9LIW2,,,,,30.1,615.0,8.1e-64,246.5,sp|A9LIW2|CSC1L_BRAJU CSC1-like protein ERD4 OS=Brassica juncea OX=3707 GN=ERD4 PE=3 SV=2,,,,,,
OG_05412,FUN_024349-T1,Peve_00021947,Pocillopora_meandrina_HIv1___RNAseq.g18671.t1,three_way,34.297666666666665,,,,,,,,,,,,,,,,,
OG_05413,FUN_024350-T1,Peve_00021948,Pocillopora_meandrina_HIv1___RNAseq.g18672.t1,three_way,54.338166666666666,FUN_024350-T1,Q01804,OTUD4_HUMAN,,OTU domain-containing protein 4 (EC 3.4.19.12) (HIV-1-induced protein HIN-1),Homo sapiens (Human),46.7,285.0,7.4e-66,254.2,sp|Q01804|OTUD4_HUMAN OTU domain-containing protein 4 OS=Homo sapiens OX=9606 GN=OTUD4 PE=1 SV=4,GO:0003723; GO:0004843; GO:0005634; GO:0005737; GO:0005829; GO:0006307; GO:0006508; GO:0034122; GO:0035871; GO:0060090; GO:0061578; GO:0070536; GO:0071108; GO:0140374; GO:1903093; GO:2000660,antiviral innate immune response [GO:0140374]; DNA alkylation repair [GO:0006307]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of protein K48-linked deubiquitination [GO:1903093],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578]; molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0016787; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; RNA binding; catalytic activity; nucleus; cytosol; DNA repair; hydrolase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_05414,FUN_024351-T1,Peve_00024494,Pocillopora_meandrina_HIv1___RNAseq.g18673.t1,three_way,45.65566666666666,,,,,,,,,,,,,,,,,
OG_05415,FUN_024353-T1,Peve_00024188,Pocillopora_meandrina_HIv1___RNAseq.g18689.t1,three_way,83.83233333333334,FUN_024353-T1,A6NFE3,,,,,36.8,117.0,2.2e-15,83.2,sp|A6NFE3|EFC10_HUMAN EF-hand calcium-binding domain-containing protein 10 OS=Homo sapiens OX=9606 GN=EFCAB10 PE=1 SV=2,,,,,,
OG_05416,FUN_024354-T1,Peve_00024185,Pocillopora_meandrina_HIv1___RNAseq.g18690.t1,three_way,66.696,FUN_024354-T1,Q5I0M0,SETMR_RAT,,Histone-lysine N-methyltransferase SETMAR (EC 2.1.1.357) (SET domain and mariner transposase fusion protein homolog),Rattus norvegicus (Rat),46.7,289.0,3.1000000000000003e-66,253.4,sp|Q5I0M0|SETMR_RAT Histone-lysine N-methyltransferase SETMAR OS=Rattus norvegicus OX=10116 GN=Setmar PE=2 SV=1,GO:0000014; GO:0000729; GO:0000793; GO:0003677; GO:0003690; GO:0003697; GO:0004519; GO:0005634; GO:0006303; GO:0006308; GO:0008270; GO:0008283; GO:0015074; GO:0031297; GO:0032259; GO:0035861; GO:0042054; GO:0042800; GO:0042803; GO:0044547; GO:0044774; GO:0045814; GO:0045892; GO:0046975; GO:0140954; GO:2001034; GO:2001251,"cell population proliferation [GO:0008283]; DNA catabolic process [GO:0006308]; DNA double-strand break processing [GO:0000729]; DNA integration [GO:0015074]; double-strand break repair via nonhomologous end joining [GO:0006303]; methylation [GO:0032259]; mitotic DNA integrity checkpoint signaling [GO:0044774]; negative regulation of chromosome organization [GO:2001251]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; replication fork processing [GO:0031297]",condensed chromosome [GO:0000793]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H3K4 methyltransferase activity [GO:0042800]; histone methyltransferase activity [GO:0042054]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0043226; GO:0140096; GO:0140097,"DNA binding; catalytic activity; nucleus; chromosome; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_05417,FUN_024355-T1,Peve_00024184,Pocillopora_meandrina_HIv1___RNAseq.g18691.t1,three_way,67.9895,,,,,,,,,,,,,,,,,
OG_05418,FUN_024357-T1,Peve_00024183,Pocillopora_meandrina_HIv1___RNAseq.g18694.t1,three_way,60.891,,,,,,,,,,,,,,,,,
OG_05419,FUN_024363-T1,Peve_00029255,Pocillopora_meandrina_HIv1___RNAseq.g18650.t1,three_way,74.098,,,,,,,,,,,,,,,,,
OG_05420,FUN_024365-T1,Peve_00034596,Pocillopora_meandrina_HIv1___RNAseq.g15262.t1,three_way,59.11716666666667,,,,,,,,,,,,,,,,,
OG_05421,FUN_024366-T1,Peve_00003582,Pocillopora_meandrina_HIv1___RNAseq.g18651.t1,three_way,82.84366666666666,FUN_024366-T1,Q6P1S4,,,,,66.0,658.0,4.4e-255,882.1,"sp|Q6P1S4|SYRC_XENTR Arginine--tRNA ligase, cytoplasmic OS=Xenopus tropicalis OX=8364 GN=rars1 PE=2 SV=1",,,,,,
OG_05422,FUN_024367-T1,Peve_00003572,Pocillopora_meandrina_HIv1___RNAseq.g18652.t1,three_way,79.83883333333333,FUN_024367-T1,Q8BM85,,,,,51.3,905.0,2.2e-245,850.1,sp|Q8BM85|TBCK_MOUSE TBC domain-containing protein kinase-like protein OS=Mus musculus OX=10090 GN=Tbck PE=1 SV=2,,,,,,
OG_05423,FUN_024368-T1,Peve_00003573,Pocillopora_meandrina_HIv1___RNAseq.g19083.t1,three_way,88.05250000000001,FUN_024368-T1,Q9Y496,KIF3A_HUMAN,,Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A),Homo sapiens (Human),71.0,648.0,6.800000000000001e-216,751.9,sp|Q9Y496|KIF3A_HUMAN Kinesin-like protein KIF3A OS=Homo sapiens OX=9606 GN=KIF3A PE=1 SV=4,GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0006996; GO:0008017; GO:0008089; GO:0008574; GO:0010457; GO:0015031; GO:0015630; GO:0016887; GO:0016939; GO:0019903; GO:0030507; GO:0031267; GO:0034454; GO:0060271; GO:0070062; GO:0072383; GO:0097542; GO:1902414; GO:1904115,anterograde axonal transport [GO:0008089]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; organelle organization [GO:0006996]; plus-end-directed vesicle transport along microtubule [GO:0072383]; protein localization to cell junction [GO:1902414]; protein transport [GO:0015031],axon cytoplasm [GO:1904115]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; protein phosphatase binding [GO:0019903]; small GTPase binding [GO:0031267]; spectrin binding [GO:0030507],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_05424,FUN_024369-T1,Peve_00003574,Pocillopora_meandrina_HIv1___RNAseq.g19084.t1,three_way,59.029,,,,,,,,,,,,,,,,,
OG_05425,FUN_024370-T1,Peve_00003575,Pocillopora_meandrina_HIv1___RNAseq.g19085.t1,three_way,79.644,FUN_024370-T1,Q02040,AK17A_HUMAN,,"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)",Homo sapiens (Human),58.5,275.0,1.9e-87,324.7,sp|Q02040|AK17A_HUMAN A-kinase anchor protein 17A OS=Homo sapiens OX=9606 GN=AKAP17A PE=1 SV=2,GO:0003723; GO:0005634; GO:0005681; GO:0005829; GO:0006355; GO:0006397; GO:0007165; GO:0008380; GO:0016607; GO:0042113; GO:0043484; GO:0051018,B cell activation [GO:0042113]; mRNA processing [GO:0006397]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; signal transduction [GO:0007165],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],protein kinase A binding [GO:0051018]; RNA binding [GO:0003723],GO:0002376; GO:0003723; GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0043226,immune system process; RNA binding; nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_05426,FUN_024371-T1,Peve_00003576,Pocillopora_meandrina_HIv1___RNAseq.g19086.t1,three_way,85.09433333333334,FUN_024371-T1,Q80UU9,PGRC2_MOUSE,,Membrane-associated progesterone receptor component 2,Mus musculus (Mouse),61.1,131.0,5.5e-37,155.6,sp|Q80UU9|PGRC2_MOUSE Membrane-associated progesterone receptor component 2 OS=Mus musculus OX=10090 GN=Pgrmc2 PE=1 SV=2,GO:0005496; GO:0005576; GO:0005635; GO:0005783; GO:0015232; GO:0015886; GO:0016020; GO:0020037; GO:0045202; GO:0060612; GO:0098978,adipose tissue development [GO:0060612]; heme transport [GO:0015886],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; synapse [GO:0045202],heme binding [GO:0020037]; heme transmembrane transporter activity [GO:0015232]; steroid binding [GO:0005496],GO:0005215; GO:0005576; GO:0005635; GO:0005783; GO:0008289; GO:0043226; GO:0048856,transporter activity; extracellular region; nuclear envelope; endoplasmic reticulum; lipid binding; organelle; anatomical structure development
OG_05427,FUN_024372-T1,Peve_00018876,Pocillopora_meandrina_HIv1___RNAseq.g18588.t1,three_way,75.26633333333334,FUN_024372-T1,Q6ZV65,FA47E_HUMAN,,Protein FAM47E,Homo sapiens (Human),29.6,361.0,8.7e-28,126.3,sp|Q6ZV65|FA47E_HUMAN Protein FAM47E OS=Homo sapiens OX=9606 GN=FAM47E PE=1 SV=3,GO:0000785; GO:0005634; GO:0005737; GO:0008047; GO:0045815; GO:0071168,protein localization to chromatin [GO:0071168]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],enzyme activator activity [GO:0008047],GO:0005634; GO:0006325; GO:0043226; GO:0098772,nucleus; chromatin organization; organelle; molecular function regulator activity
OG_05428,FUN_024373-T1,Peve_00020237,Pocillopora_meandrina_HIv1___RNAseq.g18595.t1,three_way,71.70833333333333,FUN_024373-T1,A0JMY5,,,,,42.7,560.0,4.7999999999999995e-92,340.1,sp|A0JMY5|NFXL1_XENLA NF-X1-type zinc finger protein NFXL1 OS=Xenopus laevis OX=8355 GN=nfxl1 PE=2 SV=1,,,,,,
OG_05429,FUN_024375-T1,Peve_00020238,Pocillopora_meandrina_HIv1___RNAseq.g18600.t1,three_way,67.935,,,,,,,,,,,,,,,,,
OG_05430,FUN_024376-T1,Peve_00020239,Pocillopora_meandrina_HIv1___RNAseq.g18601.t1,three_way,98.059,FUN_024376-T1,Q3T169,RS3_BOVIN,,Small ribosomal subunit protein uS3 (EC 4.2.99.18) (40S ribosomal protein S3),Bos taurus (Bovine),90.4,239.0,1.4e-120,433.7,sp|Q3T169|RS3_BOVIN Small ribosomal subunit protein uS3 OS=Bos taurus OX=9913 GN=RPS3 PE=2 SV=1,GO:0003677; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005743; GO:0005819; GO:0006281; GO:0006412; GO:0006417; GO:0006915; GO:0022627; GO:0051301; GO:0140078; GO:1990904; GO:2001235,apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; regulation of translation [GO:0006417]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003677; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005730; GO:0006281; GO:0012501; GO:0016829; GO:0043226; GO:0140097,"DNA binding; RNA binding; catalytic activity; structural molecule activity; nucleus; nucleolus; DNA repair; programmed cell death; lyase activity; organelle; catalytic activity, acting on DNA"
OG_05431,FUN_024377-T1,Peve_00020232,Pocillopora_meandrina_HIv1___RNAseq.g18602.t1,three_way,62.677,,,,,,,,,,,,,,,,,
OG_05432,FUN_024378-T1,Peve_00020233,Pocillopora_meandrina_HIv1___RNAseq.g18603.t1,three_way,84.493,FUN_024378-T1,P94598,,,,,60.0,440.0,7.3e-161,568.5,sp|P94598|DHE3_BACTN Glutamate dehydrogenase OS=Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50) OX=226186 GN=gdhA PE=3 SV=2,,,,,,
OG_05433,FUN_024382-T1,Peve_00021903,Pocillopora_meandrina_HIv1___RNAseq.g18604.t1,three_way,82.13216666666666,FUN_024382-T1,Q5E9N5,CLPB_BOVIN,,"Mitochondrial disaggregase (EC 3.6.1.-) (Suppressor of potassium transport defect 3) [Cleaved into: Mitochondrial disaggregase, cleaved form]",Bos taurus (Bovine),57.9,534.0,1.3e-179,630.9,sp|Q5E9N5|CLPB_BOVIN Mitochondrial disaggregase OS=Bos taurus OX=9913 GN=CLPB PE=2 SV=1,GO:0005524; GO:0005737; GO:0005739; GO:0005758; GO:0016887; GO:0034605,cellular response to heat [GO:0034605],cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005739; GO:0016787; GO:0043226,catalytic activity; mitochondrion; hydrolase activity; organelle
OG_05434,FUN_024384-T1,Peve_00021902,Pocillopora_meandrina_HIv1___RNAseq.g18617.t2,three_way,54.318333333333335,,,,,,,,,,,,,,,,,
OG_05435,FUN_024385-T1,Peve_00021901,Pocillopora_meandrina_HIv1___RNAseq.g18618.t1,three_way,80.53566666666667,FUN_024385-T1,Q0P4F7,ACSF2_DANRE,,"Medium-chain acyl-CoA ligase ACSF2, mitochondrial (EC 6.2.1.2)",Danio rerio (Zebrafish) (Brachydanio rerio),53.8,561.0,9.5e-179,628.2,"sp|Q0P4F7|ACSF2_DANRE Medium-chain acyl-CoA ligase ACSF2, mitochondrial OS=Danio rerio OX=7955 GN=acsf2 PE=2 SV=1",GO:0005524; GO:0005739; GO:0006631; GO:0031956,fatty acid metabolic process [GO:0006631],mitochondrion [GO:0005739],ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956],GO:0003824; GO:0005739; GO:0006629; GO:0016874; GO:0043226; GO:0140657,catalytic activity; mitochondrion; lipid metabolic process; ligase activity; organelle; ATP-dependent activity
OG_05436,FUN_024389-T1,Peve_00018044,Pocillopora_meandrina_HIv1___RNAseq.g18620.t1,three_way,74.58266666666667,FUN_024389-T1,O70433,,,,,39.0,269.0,1.3e-68,262.3,sp|O70433|FHL2_MOUSE Four and a half LIM domains protein 2 OS=Mus musculus OX=10090 GN=Fhl2 PE=1 SV=1,,,,,,
OG_05437,FUN_024390-T2,Peve_00018042,Pocillopora_meandrina_HIv1___RNAseq.g18621.t1,three_way,74.62266666666667,FUN_024390-T2,Q80VL3,,,,,50.8,413.0,3e-126,454.1,sp|Q80VL3|PRIC3_MOUSE Prickle planar cell polarity protein 3 OS=Mus musculus OX=10090 GN=Prickle3 PE=1 SV=1,,,,,,
OG_05438,FUN_024391-T1,Peve_00005020,Pocillopora_meandrina_HIv1___RNAseq.g18622.t2,three_way,84.50533333333333,FUN_024391-T1,Q90YH9,,,,,43.8,418.0,1.2e-97,358.2,sp|Q90YH9|TES_CHICK Testin OS=Gallus gallus OX=9031 GN=TES PE=2 SV=1,,,,,,
OG_05439,FUN_024392-T1,Peve_00005022,Pocillopora_meandrina_HIv1___TS.g28013.t1,three_way,38.70916666666667,,,,,,,,,,,,,,,,,
OG_05440,FUN_024393-T1,Peve_00005016,Pocillopora_meandrina_HIv1___RNAseq.g18624.t1,three_way,66.556,FUN_024393-T1,P42674,,,,,48.3,201.0,1.4e-44,182.2,sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1,,,,,,
OG_05441,FUN_024394-T1,Peve_00005019,Pocillopora_meandrina_HIv1___RNAseq.g18627.t1,three_way,70.47866666666667,FUN_024394-T1,Q8UW76,TBX20_CHICK,,T-box transcription factor TBX20 (T-box protein 20) (cTbx20),Gallus gallus (Chicken),48.6,294.0,3.4e-67,256.9,sp|Q8UW76|TBX20_CHICK T-box transcription factor TBX20 OS=Gallus gallus OX=9031 GN=TBX20 PE=2 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001569; GO:0001708; GO:0001947; GO:0003148; GO:0003175; GO:0003180; GO:0003193; GO:0003207; GO:0003215; GO:0003272; GO:0003344; GO:0005634; GO:0005737; GO:0006357; GO:0006936; GO:0008015; GO:0009953; GO:0010628; GO:0010629; GO:0010718; GO:0014031; GO:0021524; GO:0030335; GO:0030513; GO:0035922; GO:0036302; GO:0036306; GO:0055008; GO:0060045; GO:0060392; GO:0060413; GO:0060577; GO:0060973; GO:0061629; GO:0097475; GO:2000793,aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; mesenchymal cell development [GO:0014031]; motor neuron migration [GO:0097475]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; regulation of transcription by RNA polymerase II [GO:0006357]; tricuspid valve development [GO:0003175]; visceral motor neuron differentiation [GO:0021524],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003013; GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; circulatory system process; DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_05442,FUN_024395-T1,Peve_00005021,Pocillopora_meandrina_HIv1___RNAseq.g18630.t1,three_way,66.315,FUN_024395-T1,P57102,HAND2_DANRE,,"Heart- and neural crest derivatives-expressed protein 2 (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)",Danio rerio (Zebrafish) (Brachydanio rerio),43.6,140.0,1.8e-16,87.4,sp|P57102|HAND2_DANRE Heart- and neural crest derivatives-expressed protein 2 OS=Danio rerio OX=7955 GN=hand2 PE=2 SV=1,GO:0000977; GO:0000981; GO:0001947; GO:0003007; GO:0003142; GO:0003144; GO:0003342; GO:0003357; GO:0005634; GO:0006357; GO:0007507; GO:0010002; GO:0030859; GO:0030878; GO:0035051; GO:0035118; GO:0046983; GO:0048485; GO:0048703; GO:0055007; GO:0060047; GO:0071908; GO:0072015,cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart development [GO:0007507]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; podocyte development [GO:0072015]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; regulation of transcription by RNA polymerase II [GO:0006357]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003013; GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,circulatory system process; DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05443,FUN_024398-T2,Peve_00021812,Pocillopora_meandrina_HIv1___RNAseq.g18631.t1,three_way,82.838,FUN_024398-T2,Q66GS9,CP135_HUMAN,,Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4),Homo sapiens (Human),37.8,566.0,6.9e-91,337.4,sp|Q66GS9|CP135_HUMAN Centrosomal protein of 135 kDa OS=Homo sapiens OX=9606 GN=CEP135 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008017; GO:0010457; GO:0015631; GO:0042802; GO:0042803; GO:1902857; GO:1904951,centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829],identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631],GO:0005815; GO:0005829; GO:0008092; GO:0043226,microtubule organizing center; cytosol; cytoskeletal protein binding; organelle
OG_05444,FUN_024399-T1,Peve_00021813,Pocillopora_meandrina_HIv1___RNAseq.g18632.t1,three_way,82.354,FUN_024399-T1,Q9QZN3,,,,,52.8,267.0,1.5e-81,304.3,sp|Q9QZN3|FBX8_MOUSE F-box only protein 8 OS=Mus musculus OX=10090 GN=Fbxo8 PE=2 SV=2,,,,,,
OG_05445,FUN_024401-T1,Peve_00033232,Pocillopora_meandrina_HIv1___RNAseq.g18633.t1,three_way,75.52233333333334,FUN_024401-T1,P20595,GCYB1_RAT,,Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit),Rattus norvegicus (Rat),46.0,620.0,2.1e-138,494.6,sp|P20595|GCYB1_RAT Guanylate cyclase soluble subunit beta-1 OS=Rattus norvegicus OX=10116 GN=Gucy1b1 PE=1 SV=2,GO:0004383; GO:0005525; GO:0005829; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0032991; GO:0038060; GO:0044877; GO:0046872; GO:0051879; GO:0070026; GO:0070482; GO:0071732; GO:0098831; GO:0098978,cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482],"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone cytoplasmic component [GO:0098831]; protein-containing complex [GO:0032991]",GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005829; GO:0009975; GO:0016829; GO:0055086; GO:1901135,catalytic activity; cytosol; cyclase activity; lyase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05446,FUN_024402-T1,Peve_00007147,Pocillopora_meandrina_HIv1___RNAseq.g18634.t1,three_way,78.25166666666667,FUN_024402-T1,O54865,,,,,51.5,532.0,1.4e-146,521.2,sp|O54865|GCYB1_MOUSE Guanylate cyclase soluble subunit beta-1 OS=Mus musculus OX=10090 GN=Gucy1b1 PE=1 SV=1,,,,,,
OG_05447,FUN_024403-T1,Peve_00029253,Pocillopora_meandrina_HIv1___RNAseq.g18701.t1,three_way,61.388666666666666,FUN_024403-T1,Q8JZQ5,,,,,36.9,699.0,3.3e-131,470.7,sp|Q8JZQ5|AOC1_MOUSE Diamine oxidase [copper-containing] OS=Mus musculus OX=10090 GN=Aoc1 PE=2 SV=1,,,,,,
OG_05448,FUN_024405-T1,Peve_00004238,Pocillopora_meandrina_HIv1___TS.g28034.t1,three_way,55.29616666666666,FUN_024405-T1,O62809,,,,,26.2,328.0,1.4e-10,68.9,sp|O62809|OX2R_PIG Orexin receptor type 2 OS=Sus scrofa OX=9823 GN=HCRTR2 PE=2 SV=2,,,,,,
OG_05449,FUN_024407-T1,Peve_00029248,Pocillopora_meandrina_HIv1___RNAseq.g18642.t1,three_way,46.429,,,,,,,,,,,,,,,,,
OG_05450,FUN_024408-T1,Peve_00015478,Pocillopora_meandrina_HIv1___TS.g28030.t1,three_way,67.57766666666666,FUN_024408-T1,Q8I719,KGP_PLAF7,,cGMP-dependent protein kinase (EC 2.7.11.12) (PfPKG),Plasmodium falciparum (isolate 3D7),26.9,245.0,7.8e-13,77.4,sp|Q8I719|KGP_PLAF7 cGMP-dependent protein kinase OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=PKG PE=1 SV=1,GO:0004691; GO:0004692; GO:0005524; GO:0005737; GO:0005783; GO:0005789; GO:0005952; GO:0006468; GO:0007165; GO:0007276; GO:0019898; GO:0030553; GO:0046872; GO:0106310,gamete generation [GO:0007276]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],cAMP-dependent protein kinase complex [GO:0005952]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898],ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005783; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_05451,FUN_024409-T1,Peve_00015479,Pocillopora_meandrina_HIv1___TS.g28029.t1b,three_way,67.058,,,,,,,,,,,,,,,,,
OG_05452,FUN_024410-T1,Peve_00015480,Pocillopora_meandrina_HIv1___TS.g28029.t1a,three_way,83.57366666666667,,,,,,,,,,,,,,,,,
OG_05453,FUN_024411-T1,Peve_00011775,Pocillopora_meandrina_HIv1___RNAseq.g18636.t1,three_way,77.30883333333334,FUN_024411-T1,Q7T163,KDISB_DANRE,,Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B),Danio rerio (Zebrafish) (Brachydanio rerio),35.3,893.0,4.4e-141,504.6,sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3,GO:0005770; GO:0007399; GO:0019887; GO:0030165; GO:0031902; GO:0038180,nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399],late endosome [GO:0005770]; late endosome membrane [GO:0031902],PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887],GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0098772,endosome; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_05454,FUN_024412-T1,Peve_00007146,Pocillopora_meandrina_HIv1___RNAseq.g18635.t1,three_way,68.411,FUN_024412-T1,Q6ZQ58,,,,,38.2,878.0,1.9e-105,385.6,sp|Q6ZQ58|LARP1_MOUSE La-related protein 1 OS=Mus musculus OX=10090 GN=Larp1 PE=1 SV=3,,,,,,
OG_05455,FUN_024413-T1,Peve_00029254,Pocillopora_meandrina_HIv1___TS.g28094.t1,three_way,72.38216666666666,FUN_024413-T1,Q08874,MITF_MOUSE,,Microphthalmia-associated transcription factor,Mus musculus (Mouse),41.5,366.0,1.1e-46,189.1,sp|Q08874|MITF_MOUSE Microphthalmia-associated transcription factor OS=Mus musculus OX=10090 GN=Mitf PE=1 SV=4,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0006357; GO:0010468; GO:0010628; GO:0016055; GO:0030154; GO:0030316; GO:0030318; GO:0030336; GO:0032991; GO:0042127; GO:0043010; GO:0043066; GO:0043473; GO:0043565; GO:0045165; GO:0045670; GO:0045893; GO:0045944; GO:0046849; GO:0046983; GO:0065003; GO:0070888; GO:1902362; GO:2000144,bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; melanocyte apoptotic process [GO:1902362]; melanocyte differentiation [GO:0030318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; pigmentation [GO:0043473]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_05456,FUN_024414-T1,Peve_00027663,Pocillopora_meandrina_HIv1___RNAseq.g18703.t1,three_way,84.054,FUN_024414-T1,O02691,HCD2_BOVIN,,3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-estradiol 17-dehydrogenase) (EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))) (EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase) (EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH),Bos taurus (Bovine),64.1,256.0,7.3e-88,325.1,sp|O02691|HCD2_BOVIN 3-hydroxyacyl-CoA dehydrogenase type-2 OS=Bos taurus OX=9913 GN=HSD17B10 PE=1 SV=3,GO:0000049; GO:0003857; GO:0004303; GO:0005739; GO:0006550; GO:0006631; GO:0006635; GO:0006699; GO:0008207; GO:0008209; GO:0008210; GO:0008709; GO:0030283; GO:0030678; GO:0042645; GO:0044594; GO:0047015; GO:0047035; GO:0047044; GO:0051289; GO:0062173; GO:0070901; GO:0097745; GO:0106281; GO:0106282; GO:0106283; GO:1990180,androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; protein homotetramerization [GO:0051289],mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739],"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity [GO:0106281]; cholate 7-alpha-dehydrogenase (NAD+) activity [GO:0008709]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)+] activity [GO:0030283]; tRNA binding [GO:0000049]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283]",GO:0003723; GO:0003824; GO:0005739; GO:0006399; GO:0006520; GO:0006629; GO:0016491; GO:0043226; GO:0065003; GO:0140053,RNA binding; catalytic activity; mitochondrion; tRNA metabolic process; amino acid metabolic process; lipid metabolic process; oxidoreductase activity; organelle; protein-containing complex assembly; mitochondrial gene expression
OG_05457,FUN_024418-T1,Peve_00029260,Pocillopora_meandrina_HIv1___RNAseq.g18720.t1,three_way,74.32566666666666,FUN_024418-T1,Q98SN7,,,,,55.1,345.0,5e-110,399.4,sp|Q98SN7|WNT2B_CHICK Protein Wnt-2b OS=Gallus gallus OX=9031 GN=WNT2B PE=1 SV=1,,,,,,
OG_05458,FUN_024419-T1,Peve_00029262,Pocillopora_meandrina_HIv1___RNAseq.g18719.t1,three_way,91.95566666666666,FUN_024419-T1,A7S641,,,,,83.4,536.0,3.9e-264,911.8,sp|A7S641|ST7_NEMVE Protein ST7 homolog OS=Nematostella vectensis OX=45351 GN=v1g243132 PE=3 SV=1,,,,,,
OG_05459,FUN_024431-T1,Peve_00004166,Pocillopora_meandrina_HIv1___RNAseq.g18717.t1,three_way,46.351333333333336,,,,,,,,,,,,,,,,,
OG_05460,FUN_024439-T1,Peve_00004162,Pocillopora_meandrina_HIv1___RNAseq.g18714.t1,three_way,80.35366666666667,FUN_024439-T1,Q9Z206,ARHG8_MOUSE,,Neuroepithelial cell-transforming gene 1 protein (Rho guanine nucleotide exchange factor 8),Mus musculus (Mouse),45.5,444.0,1.8000000000000002e-104,381.3,sp|Q9Z206|ARHG8_MOUSE Neuroepithelial cell-transforming gene 1 protein OS=Mus musculus OX=10090 GN=Net1 PE=1 SV=2,GO:0005085; GO:0005634; GO:0005737; GO:0005886; GO:0031267; GO:0035556; GO:0043065; GO:0043547; GO:0051451; GO:0070301; GO:0071479; GO:1900026,cellular response to hydrogen peroxide [GO:0070301]; cellular response to ionizing radiation [GO:0071479]; intracellular signal transduction [GO:0035556]; myoblast migration [GO:0051451]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005634; GO:0005886; GO:0043226; GO:0048870; GO:0098772,nucleus; plasma membrane; organelle; cell motility; molecular function regulator activity
OG_05461,FUN_024444-T1,Peve_00025480,Pocillopora_meandrina_HIv1___RNAseq.g18709.t1,three_way,69.896,FUN_024444-T1,Q08BL7,,,,,41.6,507.0,2e-95,351.3,sp|Q08BL7|GLCTK_DANRE Glycerate kinase OS=Danio rerio OX=7955 GN=glyctk PE=2 SV=1,,,,,,
OG_05462,FUN_024445-T1,Peve_00025478,Pocillopora_meandrina_HIv1___RNAseq.g18708.t1,three_way,87.55799999999999,FUN_024445-T1,Q14643,,,,,59.9,2841.0,0.0,3137.1,"sp|Q14643|ITPR1_HUMAN Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1 OS=Homo sapiens OX=9606 GN=ITPR1 PE=1 SV=3",,,,,,
OG_05463,FUN_024446-T1,Peve_00025476,Pocillopora_meandrina_HIv1___RNAseq.g18707.t1,three_way,64.72083333333333,FUN_024446-T1,Q4KLI2,TM10A_RAT,,tRNA methyltransferase 10 homolog A (EC 2.1.1.221) (RNA (guanine-9-)-methyltransferase domain-containing protein 2) (tRNA (guanine(9)-N(1))-methyltransferase TRMT10A),Rattus norvegicus (Rat),57.9,178.0,2.4e-55,217.6,sp|Q4KLI2|TM10A_RAT tRNA methyltransferase 10 homolog A OS=Rattus norvegicus OX=10116 GN=Trmt10a PE=1 SV=1,GO:0000049; GO:0002939; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0010960; GO:0030488; GO:0052905,magnesium ion homeostasis [GO:0010960]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],tRNA (guanosine(9)-N1)-methyltransferase activity [GO:0052905]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_05464,FUN_024447-T1,Peve_00025475,Pocillopora_meandrina_HIv1___TS.g28098.t1,three_way,82.643,FUN_024447-T1,Q9CQ79,,,,,47.0,202.0,9.5e-52,204.9,sp|Q9CQ79|TXND9_MOUSE Thioredoxin domain-containing protein 9 OS=Mus musculus OX=10090 GN=Txndc9 PE=1 SV=1,,,,,,
OG_05465,FUN_024448-T1,Peve_00025474,Pocillopora_meandrina_HIv1___RNAseq.g18705.t1,three_way,56.5495,FUN_024448-T1,Q96RY5,,,,,49.1,228.0,3.2e-52,208.8,sp|Q96RY5|CRML_HUMAN Protein cramped-like OS=Homo sapiens OX=9606 GN=CRAMP1 PE=1 SV=3,,,,,,
OG_05466,FUN_024449-T1,Peve_00025473,Pocillopora_meandrina_HIv1___RNAseq.g18704.t1,three_way,77.344,FUN_024449-T1,Q9Z0U4,GABR1_RAT,,Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1),Rattus norvegicus (Rat),36.2,712.0,3.8e-111,404.1,sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2,GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932]",axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021],extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982],GO:0005615; GO:0005886; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0060089,extracellular space; plasma membrane; signaling; cell differentiation; cytoplasmic vesicle; organelle; molecular transducer activity
OG_05467,FUN_024450-T1,Peve_00025472,Pocillopora_meandrina_HIv1___RNAseq.g18853.t1,three_way,86.50233333333333,FUN_024450-T1,P51790,CLCN3_HUMAN,,H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3),Homo sapiens (Human),61.5,808.0,1.8e-281,969.9,sp|P51790|CLCN3_HUMAN H(+)/Cl(-) exchange transporter 3 OS=Homo sapiens OX=9606 GN=CLCN3 PE=1 SV=2,GO:0000139; GO:0005247; GO:0005254; GO:0005524; GO:0005765; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0006885; GO:0006911; GO:0008021; GO:0008344; GO:0009897; GO:0009986; GO:0010008; GO:0012506; GO:0015297; GO:0016020; GO:0030141; GO:0030165; GO:0030672; GO:0031410; GO:0031901; GO:0031902; GO:0032587; GO:0035249; GO:0042581; GO:0043231; GO:0043679; GO:0045335; GO:0045494; GO:0045794; GO:0048388; GO:0051932; GO:0055037; GO:0062158; GO:0072320; GO:0097401; GO:0098978; GO:0098982; GO:1902476; GO:1903428,"adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; endosomal lumen acidification [GO:0048388]; negative regulation of cell volume [GO:0045794]; phagocytosis, engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; regulation of pH [GO:0006885]; synaptic transmission, GABAergic [GO:0051932]; synaptic transmission, glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401]",axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; vesicle membrane [GO:0012506],antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride:proton antiporter activity [GO:0062158]; PDZ domain binding [GO:0030165]; voltage-gated chloride channel activity [GO:0005247]; volume-sensitive chloride channel activity [GO:0072320],GO:0005215; GO:0005768; GO:0005794; GO:0005886; GO:0023052; GO:0031410; GO:0043226; GO:0055085; GO:0061024,transporter activity; endosome; Golgi apparatus; plasma membrane; signaling; cytoplasmic vesicle; organelle; transmembrane transport; membrane organization
OG_05468,FUN_024451-T1,Peve_00003482,Pocillopora_meandrina_HIv1___RNAseq.g18852.t1,three_way,84.42533333333333,FUN_024451-T1,Q6P5I8,,,,,47.8,228.0,1.8e-45,184.1,sp|Q6P5I8|YIPF5_DANRE Protein YIPF5 OS=Danio rerio OX=7955 GN=yipf5 PE=2 SV=1,,,,,,
OG_05469,FUN_024452-T1,Peve_00010318,Pocillopora_meandrina_HIv1___TS.g27970.t1,three_way,82.02633333333333,FUN_024452-T1,Q9SVG0,,,,,34.9,415.0,2.3e-51,204.5,sp|Q9SVG0|AVT3C_ARATH Amino acid transporter AVT3C OS=Arabidopsis thaliana OX=3702 GN=AVT3C PE=1 SV=1,,,,,,
OG_05470,FUN_024453-T1,Peve_00010317,Pocillopora_meandrina_HIv1___RNAseq.g18578.t1,three_way,82.89666666666666,FUN_024453-T1,Q3SYR7,,,,,65.0,177.0,1.7e-59,230.3,sp|Q3SYR7|RL9_BOVIN Large ribosomal subunit protein uL6 OS=Bos taurus OX=9913 GN=RPL9 PE=2 SV=1,,,,,,
OG_05471,FUN_024454-T1,Peve_00010316,Pocillopora_meandrina_HIv1___RNAseq.g18577.t1,three_way,67.4025,FUN_024454-T1,Q5DTZ6,,,,,45.4,273.0,1.5e-58,228.4,sp|Q5DTZ6|RN150_MOUSE RING finger protein 150 OS=Mus musculus OX=10090 GN=Rnf150 PE=2 SV=2,,,,,,
OG_05472,FUN_024455-T1,Peve_00010314,Pocillopora_meandrina_HIv1___RNAseq.g18575.t1,three_way,42.60583333333333,,,,,,,,,,,,,,,,,
OG_05473,FUN_024456-T1,Peve_00010312,Pocillopora_meandrina_HIv1___RNAseq.g18574.t1,three_way,77.98883333333333,FUN_024456-T1,A7S6A1,,,,,59.2,903.0,2.2e-272,939.9,sp|A7S6A1|U518_NEMVE FHIP family protein v1g243165 OS=Nematostella vectensis OX=45351 GN=v1g243165 PE=3 SV=1,,,,,,
OG_05474,FUN_024457-T1,Peve_00010311,Pocillopora_meandrina_HIv1___TS.g27964.t1,three_way,63.876,FUN_024457-T1,Q9H8H3,TMT1A_HUMAN,,Thiol S-methyltransferase TMT1A (EC 2.1.1.9) (Methyltransferase-like protein 7A) (N6-adenosine-methyltransferase TMT1A) (EC 2.1.1.348) (Protein AAM-B) (Thiol methyltransferase 1A),Homo sapiens (Human),40.7,216.0,1.1e-40,168.3,sp|Q9H8H3|TMT1A_HUMAN Thiol S-methyltransferase TMT1A OS=Homo sapiens OX=9606 GN=TMT1A PE=1 SV=1,GO:0001649; GO:0001734; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0008168; GO:0008173; GO:0016020; GO:0018708; GO:0032259; GO:0042476; GO:0180035; GO:1904724,lncRNA processing [GO:0180035]; methylation [GO:0032259]; odontogenesis [GO:0042476]; osteoblast differentiation [GO:0001649],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; tertiary granule lumen [GO:1904724],methyltransferase activity [GO:0008168]; mRNA m(6)A methyltransferase activity [GO:0001734]; RNA methyltransferase activity [GO:0008173]; thiol S-methyltransferase activity [GO:0018708],GO:0003824; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0016740; GO:0030154; GO:0043226; GO:0140098,"catalytic activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; transferase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_05475,FUN_024460-T1,Peve_00032923,Pocillopora_meandrina_HIv1___RNAseq.g14859.t1,three_way,88.63699999999999,FUN_024460-T1,Q2M389,WASC4_HUMAN,,WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP),Homo sapiens (Human),64.5,920.0,0.0,1206.8,sp|Q2M389|WASC4_HUMAN WASH complex subunit 4 OS=Homo sapiens OX=9606 GN=WASHC4 PE=1 SV=2,GO:0005654; GO:0005768; GO:0007032; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0050890; GO:0050905; GO:0061635; GO:0071203; GO:0140591; GO:0140894,cognition [GO:0050890]; endolysosomal toll-like receptor signaling pathway [GO:0140894]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; neuromuscular process [GO:0050905]; nuclear envelope budding [GO:0140591]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of protein complex stability [GO:0061635],early endosome membrane [GO:0031901]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203],,GO:0002376; GO:0005654; GO:0005768; GO:0006913; GO:0016192; GO:0031410; GO:0043226; GO:0050877,immune system process; nucleoplasm; endosome; nucleocytoplasmic transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; nervous system process
OG_05476,FUN_024466-T1,Peve_00026420,Pocillopora_meandrina_HIv1___RNAseq.g18562.t1,three_way,72.03833333333334,FUN_024466-T1,J7GQ11,,,,,35.2,495.0,1e-70,270.0,sp|J7GQ11|TYRDC_LEVBR L-tyrosine decarboxylase OS=Levilactobacillus brevis OX=1580 GN=tdc PE=1 SV=1,,,,,,
OG_05477,FUN_024467-T1,Peve_00026395,Pocillopora_meandrina_HIv1___RNAseq.g18560.t1,three_way,49.363166666666665,,,,,,,,,,,,,,,,,
OG_05478,FUN_024472-T1,Peve_00041386,Pocillopora_meandrina_HIv1___RNAseq.g29213.t1,three_way,48.294,,,,,,,,,,,,,,,,,
OG_05479,FUN_024473-T1,Peve_00002830,Pocillopora_meandrina_HIv1___RNAseq.g18567.t1,three_way,52.34666666666666,FUN_024473-T1,P97460,NPAS2_MOUSE,,Neuronal PAS domain-containing protein 2 (Neuronal PAS2),Mus musculus (Mouse),34.6,413.0,1.1999999999999999e-46,190.7,sp|P97460|NPAS2_MOUSE Neuronal PAS domain-containing protein 2 OS=Mus musculus OX=10090 GN=Npas2 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006974; GO:0007623; GO:0009410; GO:0032922; GO:0042745; GO:0042752; GO:0045475; GO:0045739; GO:0045893; GO:0045944; GO:0046872; GO:0046983; GO:0051775; GO:2000987,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; circadian sleep/wake cycle [GO:0042745]; DNA damage response [GO:0006974]; locomotor rhythm [GO:0045475]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; response to redox state [GO:0051775]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_05480,FUN_024476-T1,Peve_00002831,Pocillopora_meandrina_HIv1___RNAseq.g18568.t1,three_way,62.83433333333333,FUN_024476-T1,Q6NRD3,SH3R1_XENLA,,E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (xPOSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1),Xenopus laevis (African clawed frog),39.7,514.0,1.3e-79,298.9,sp|Q6NRD3|SH3R1_XENLA E3 ubiquitin-protein ligase SH3RF1 OS=Xenopus laevis OX=8355 GN=sh3rf1 PE=1 SV=1,GO:0001764; GO:0005078; GO:0005794; GO:0005829; GO:0008270; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043370; GO:0046330; GO:0048471; GO:0051865; GO:0061630; GO:2000564,"negative regulation of apoptotic process [GO:0043066]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471],MAP-kinase scaffold activity [GO:0005078]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0005829; GO:0016740; GO:0043226; GO:0048870; GO:0060090; GO:0140096,"catalytic activity; Golgi apparatus; cytosol; transferase activity; organelle; cell motility; molecular adaptor activity; catalytic activity, acting on a protein"
OG_05481,FUN_024477-T1,Peve_00002832,Pocillopora_meandrina_HIv1___RNAseq.g18569.t1,three_way,56.37466666666667,,,,,,,,,,,,,,,,,
OG_05482,FUN_024478-T1,Peve_00024796,Pocillopora_meandrina_HIv1___RNAseq.g18570.t1,three_way,65.79466666666667,,,,,,,,,,,,,,,,,
OG_05483,FUN_024480-T1,Peve_00024797,Pocillopora_meandrina_HIv1___RNAseq.g19065.t1,three_way,76.45266666666667,FUN_024480-T1,Q0DAE4,,,,,49.5,95.0,1.5e-18,93.6,sp|Q0DAE4|GRXC8_ORYSJ Glutaredoxin-C8 OS=Oryza sativa subsp. japonica OX=39947 GN=GRXC8 PE=2 SV=2,,,,,,
OG_05484,FUN_024481-T1,Peve_00016898,Pocillopora_meandrina_HIv1___RNAseq.g19066.t2,three_way,65.00099999999999,FUN_024481-T1,Q92870,APBB2_HUMAN,,Amyloid beta precursor protein binding family B member 2 (Amyloid-beta (A4) precursor protein-binding family B member 2) (Protein Fe65-like 1),Homo sapiens (Human),36.6,331.0,3.8e-55,218.8,sp|Q92870|APBB2_HUMAN Amyloid beta precursor protein binding family B member 2 OS=Homo sapiens OX=9606 GN=APBB2 PE=1 SV=3,GO:0000122; GO:0001540; GO:0001764; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0006355; GO:0006939; GO:0007411; GO:0016020; GO:0030027; GO:0030198; GO:0030426; GO:0035556; GO:0036438; GO:0043065; GO:0043066; GO:0045202; GO:0045944; GO:0050808; GO:0060090; GO:1901988,axon guidance [GO:0007411]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; maintenance of lens transparency [GO:0036438]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle phase transition [GO:1901988]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; smooth muscle contraction [GO:0006939]; synapse organization [GO:0050808],cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; synapse [GO:0045202],amyloid-beta binding [GO:0001540]; molecular adaptor activity [GO:0060090],GO:0003012; GO:0005634; GO:0005768; GO:0005783; GO:0005794; GO:0006355; GO:0030198; GO:0031410; GO:0034330; GO:0043226; GO:0048870; GO:0060090,muscle system process; nucleus; endosome; endoplasmic reticulum; Golgi apparatus; regulation of DNA-templated transcription; extracellular matrix organization; cytoplasmic vesicle; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_05485,FUN_024482-T1,Peve_00010582,Pocillopora_meandrina_HIv1___RNAseq.g19067.t1,three_way,60.68966666666667,,,,,,,,,,,,,,,,,
OG_05486,FUN_024483-T1,Peve_00010585,Pocillopora_meandrina_HIv1___RNAseq.g19068.t1,three_way,49.94483333333333,FUN_024483-T1,Q9UHB7,,,,,27.0,248.0,1.4e-13,80.5,sp|Q9UHB7|AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1,,,,,,
OG_05487,FUN_024484-T1,Peve_00010584,Pocillopora_meandrina_HIv1___RNAseq.g19069.t1,three_way,93.02366666666668,FUN_024484-T1,Q8QG64,RBX1_SALSA,,E3 ubiquitin-protein ligase RBX1 (EC 2.3.2.27) (EC 2.3.2.32) (Hyperosmotic protein 21) (sHOP21) (RING-box protein 1) (Rbx1),Salmo salar (Atlantic salmon),92.4,105.0,9.999999999999999e-55,213.8,sp|Q8QG64|RBX1_SALSA E3 ubiquitin-protein ligase RBX1 OS=Salmo salar OX=8030 GN=rbx1 PE=2 SV=2,GO:0004842; GO:0005634; GO:0005737; GO:0006513; GO:0008270; GO:0016567; GO:0019005; GO:0031146; GO:0031463; GO:0031464; GO:0031465; GO:0031467; GO:0043161; GO:0045116; GO:0061663; GO:0160240,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; RNA polymerase II transcription initiation surveillance [GO:0160240]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],NEDD8 ligase activity [GO:0061663]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_05488,FUN_024485-T1,Peve_00010581,Pocillopora_meandrina_HIv1___RNAseq.g19070.t1,three_way,78.75466666666667,,,,,,,,,,,,,,,,,
OG_05489,FUN_024487-T1,Peve_00042022,Pocillopora_meandrina_HIv1___RNAseq.g18539.t1,three_way,70.27733333333333,FUN_024487-T1,A2BGL3,,,,,31.5,111.0,1.6e-08,60.8,sp|A2BGL3|WSCD2_DANRE Sialate:O-sulfotransferase 2 OS=Danio rerio OX=7955 GN=wscd2 PE=3 SV=1,,,,,,
OG_05490,FUN_024521-T1,Peve_00042014,Pocillopora_meandrina_HIv1___RNAseq.g18540.t1,three_way,87.92333333333333,,,,,,,,,,,,,,,,,
OG_05491,FUN_024523-T1,Peve_00034557,Pocillopora_meandrina_HIv1___RNAseq.g18541.t1,three_way,83.11133333333333,,,,,,,,,,,,,,,,,
OG_05492,FUN_024524-T1,Peve_00034558,Pocillopora_meandrina_HIv1___RNAseq.g18542.t1,three_way,74.3655,FUN_024524-T1,Q96PY6,NEK1_HUMAN,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55),Homo sapiens (Human),32.6,1424.0,3.4000000000000003e-128,461.5,sp|Q96PY6|NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens OX=9606 GN=NEK1 PE=1 SV=2,GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310,cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_05493,FUN_024525-T1,Peve_00015355,Pocillopora_meandrina_HIv1___RNAseq.g18543.t1,three_way,64.36533333333333,FUN_024525-T1,Q08DR9,SPDLY_BOVIN,,Protein Spindly (Coiled-coil domain-containing protein 99) (Spindle apparatus coiled-coil domain-containing protein 1),Bos taurus (Bovine),30.0,227.0,5e-19,97.8,sp|Q08DR9|SPDLY_BOVIN Protein Spindly OS=Bos taurus OX=9913 GN=SPDL1 PE=2 SV=1,GO:0000132; GO:0000922; GO:0000940; GO:0005634; GO:0005737; GO:0005813; GO:0007080; GO:0007094; GO:0016477; GO:0034501; GO:0043515; GO:0051301,cell division [GO:0051301]; cell migration [GO:0016477]; establishment of mitotic spindle orientation [GO:0000132]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle pole [GO:0000922],kinetochore binding [GO:0043515],GO:0005634; GO:0005815; GO:0007010; GO:0043226; GO:0048870,nucleus; microtubule organizing center; cytoskeleton organization; organelle; cell motility
OG_05494,FUN_024526-T1,Peve_00015356,Pocillopora_meandrina_HIv1___RNAseq.g18544.t1,three_way,81.946,FUN_024526-T1,B3RXR7,GUF1_TRIAD,,"Translation factor GUF1 homolog, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1 homolog) (Ribosomal back-translocase)",Trichoplax adhaerens (Trichoplax reptans),64.5,605.0,5.600000000000001e-236,818.5,"sp|B3RXR7|GUF1_TRIAD Translation factor GUF1 homolog, mitochondrial OS=Trichoplax adhaerens OX=10228 GN=TRIADDRAFT_56304 PE=3 SV=1",GO:0003924; GO:0005525; GO:0005739; GO:0005743; GO:0005759; GO:0006412; GO:0045727; GO:0097177,positive regulation of translation [GO:0045727]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitochondrial ribosome binding [GO:0097177],GO:0003824; GO:0003924; GO:0005739; GO:0016787; GO:0043226,catalytic activity; GTPase activity; mitochondrion; hydrolase activity; organelle
OG_05495,FUN_024527-T1,Peve_00015359,Pocillopora_meandrina_HIv1___RNAseq.g18551.t1,three_way,73.2285,FUN_024527-T1,Q99LB6,,,,,47.7,306.0,2.7e-76,287.0,sp|Q99LB6|MAT2B_MOUSE Methionine adenosyltransferase 2 subunit beta OS=Mus musculus OX=10090 GN=Mat2b PE=1 SV=1,,,,,,
OG_05496,FUN_024555-T2,Peve_00039518,Pocillopora_meandrina_HIv1___RNAseq.g18654.t1,three_way,73.77483333333333,FUN_024555-T2,P46061,,,,,53.4,590.0,8.2e-95,349.4,sp|P46061|RAGP1_MOUSE Ran GTPase-activating protein 1 OS=Mus musculus OX=10090 GN=Rangap1 PE=1 SV=2,,,,,,
OG_05497,FUN_024556-T1,Peve_00039499,Pocillopora_meandrina_HIv1___RNAseq.g18655.t1,three_way,76.91333333333333,FUN_024556-T1,Q9GKT2,,,,,52.6,310.0,6.9e-100,365.5,sp|Q9GKT2|FXDC2_MACFA Fatty acid hydroxylase domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=FAXDC2 PE=2 SV=1,,,,,,
OG_05498,FUN_024557-T1,Peve_00039513,Pocillopora_meandrina_HIv1___RNAseq.g18656.t1,three_way,51.671,,,,,,,,,,,,,,,,,
OG_05499,FUN_024558-T1,Peve_00039515,Pocillopora_meandrina_HIv1___RNAseq.g18657.t1,three_way,76.14133333333334,FUN_024558-T1,Q9Y673,ALG5_HUMAN,,Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog),Homo sapiens (Human),56.7,321.0,5.2e-102,372.5,sp|Q9Y673|ALG5_HUMAN Dolichyl-phosphate beta-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG5 PE=1 SV=1,GO:0004581; GO:0005789; GO:0006487; GO:0006488; GO:0007368; GO:0016020; GO:0018279; GO:0098556,determination of left/right symmetry [GO:0007368]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],dolichyl-phosphate beta-glucosyltransferase activity [GO:0004581],GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_05500,FUN_024559-T1,Peve_00039516,Pocillopora_meandrina_HIv1___RNAseq.g18658.t1,three_way,92.67866666666669,FUN_024559-T1,P70340,SMAD1_MOUSE,,Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (Dwarfin-A) (Dwf-A) (Mothers-against-DPP-related 1) (Mad-related protein 1) (mMad1) (SMAD family member 1) (SMAD 1) (Smad1),Mus musculus (Mouse),70.4,467.0,2.5e-184,646.4,sp|P70340|SMAD1_MOUSE Mothers against decapentaplegic homolog 1 OS=Mus musculus OX=10090 GN=Smad1 PE=1 SV=2,GO:0000165; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001649; GO:0001657; GO:0001673; GO:0001710; GO:0002051; GO:0003700; GO:0005634; GO:0005637; GO:0005654; GO:0005667; GO:0005737; GO:0006351; GO:0006357; GO:0006366; GO:0006879; GO:0006954; GO:0007179; GO:0007276; GO:0008283; GO:0008285; GO:0009880; GO:0010628; GO:0017151; GO:0019901; GO:0030509; GO:0030901; GO:0030902; GO:0031625; GO:0032991; GO:0042592; GO:0042802; GO:0043565; GO:0045669; GO:0045944; GO:0046872; GO:0048863; GO:0051148; GO:0051216; GO:0060038; GO:0060348; GO:0060395; GO:0061036; GO:0070410; GO:0070411; GO:0070878; GO:0071142; GO:0071144; GO:1902895; GO:1903672,BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle cell proliferation [GO:0060038]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; DNA-templated transcription [GO:0006351]; embryonic pattern specification [GO:0009880]; gamete generation [GO:0007276]; hindbrain development [GO:0030902]; homeostatic process [GO:0042592]; inflammatory response [GO:0006954]; intracellular iron ion homeostasis [GO:0006879]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; midbrain development [GO:0030901]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle cell differentiation [GO:0051148]; osteoblast differentiation [GO:0001649]; osteoblast fate commitment [GO:0002051]; positive regulation of cartilage development [GO:0061036]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],chromatin [GO:0000785]; cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; male germ cell nucleus [GO:0001673]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667],"co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; ubiquitin protein ligase binding [GO:0031625]",GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0006954; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; RNA binding; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; inflammatory response; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05501,FUN_024564-T1,Peve_00009968,Pocillopora_meandrina_HIv1___RNAseq.g18662.t1,three_way,88.02933333333334,,,,,,,,,,,,,,,,,
OG_05502,FUN_024566-T1,Peve_00009964,Pocillopora_meandrina_HIv1___RNAseq.g19087.t1,three_way,94.32233333333332,FUN_024566-T1,P81436,OGT1_RABIT,,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT),Oryctolagus cuniculus (Rabbit),77.1,1013.0,5.300000000000002e-211,736.1,sp|P81436|OGT1_RABIT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit OS=Oryctolagus cuniculus OX=9986 GN=OGT PE=1 SV=2,GO:0000123; GO:0005547; GO:0005634; GO:0005737; GO:0005886; GO:0006110; GO:0006111; GO:0006325; GO:0006493; GO:0006915; GO:0016485; GO:0017122; GO:0031397; GO:0032922; GO:0045944; GO:0071333; GO:0097363; GO:0160076; GO:1904263,apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; negative regulation of non-canonical inflammasome complex assembly [GO:0160076]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein N-acetylglucosaminyltransferase complex [GO:0017122],"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein O-acetylglucosaminyltransferase activity [GO:0097363]",GO:0003824; GO:0005634; GO:0005886; GO:0006325; GO:0006355; GO:0008289; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; nucleus; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid binding; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_05503,FUN_024567-T1,Peve_00036070,Pocillopora_meandrina_HIv1___RNAseq.g19088.t1,three_way,78.1325,FUN_024567-T1,Q8WXW3,PIBF1_HUMAN,,Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90),Homo sapiens (Human),39.1,713.0,3.8000000000000003e-119,430.6,sp|Q8WXW3|PIBF1_HUMAN Progesterone-induced-blocking factor 1 OS=Homo sapiens OX=9606 GN=PIBF1 PE=1 SV=2,GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0036064; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515,activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],interleukin-4 receptor binding [GO:0005136],GO:0002376; GO:0005615; GO:0005634; GO:0005815; GO:0007010; GO:0043226; GO:0044782,immune system process; extracellular space; nucleus; microtubule organizing center; cytoskeleton organization; organelle; cilium organization
OG_05504,FUN_024574-T1,Peve_00026364,Pocillopora_meandrina_HIv1___RNAseq.g23152.t1,three_way,48.51866666666667,,,,,,,,,,,,,,,,,
OG_05505,FUN_024577-T1,Peve_00007643,Pocillopora_meandrina_HIv1___TS.g28491.t1,three_way,74.36816666666667,FUN_024577-T1,Q2LD37,BLTP1_HUMAN,,Bridge-like lipid transfer protein family member 1 (Fragile site-associated protein),Homo sapiens (Human),29.4,5271.0,0.0,1751.9,sp|Q2LD37|BLTP1_HUMAN Bridge-like lipid transfer protein family member 1 OS=Homo sapiens OX=9606 GN=BLTP1 PE=1 SV=2,GO:0001558; GO:0005634; GO:0005789; GO:0005886; GO:0006909; GO:0016020; GO:0016197; GO:0030856; GO:0031966; GO:0032456; GO:0048488; GO:0098793; GO:0120009; GO:0140268; GO:1904121,endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intermembrane lipid transfer [GO:0120009]; phagocytosis [GO:0006909]; regulation of cell growth [GO:0001558]; regulation of epithelial cell differentiation [GO:0030856]; synaptic vesicle endocytosis [GO:0048488],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793],phosphatidylethanolamine transfer activity [GO:1904121],GO:0005215; GO:0005634; GO:0005886; GO:0016192; GO:0043226; GO:0061024,transporter activity; nucleus; plasma membrane; vesicle-mediated transport; organelle; membrane organization
OG_05506,FUN_024587-T1,Peve_00037917,Pocillopora_meandrina_HIv1___RNAseq.2717_t,three_way,63.268,,,,,,,,,,,,,,,,,
OG_05507,FUN_024588-T1,Peve_00007644,Pocillopora_meandrina_HIv1___RNAseq.g19109.t1,three_way,76.148,FUN_024588-T1,P42785,PCP_HUMAN,,Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP),Homo sapiens (Human),59.5,444.0,2.2e-157,557.0,sp|P42785|PCP_HUMAN Lysosomal Pro-X carboxypeptidase OS=Homo sapiens OX=9606 GN=PRCP PE=1 SV=1,GO:0002003; GO:0002155; GO:0002353; GO:0003085; GO:0004181; GO:0004185; GO:0005886; GO:0008239; GO:0035577; GO:0042593; GO:0043231; GO:0043535; GO:0045178; GO:0060055; GO:0070062; GO:0097009; GO:0101003; GO:2000377,angiogenesis involved in wound healing [GO:0060055]; angiotensin maturation [GO:0002003]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; negative regulation of systemic arterial blood pressure [GO:0003085]; plasma kallikrein-kinin cascade [GO:0002353]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of thyroid hormone receptor signaling pathway [GO:0002155],azurophil granule membrane [GO:0035577]; basal part of cell [GO:0045178]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],dipeptidyl-peptidase activity [GO:0008239]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185],GO:0003824; GO:0005886; GO:0006954; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; inflammatory response; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_05508,FUN_024589-T1,Peve_00007645,Pocillopora_meandrina_HIv1___RNAseq.g19110.t1,three_way,77.43599999999999,FUN_024589-T1,Q96EY1,DNJA3_HUMAN,,"DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)",Homo sapiens (Human),42.7,424.0,7.7e-85,315.8,"sp|Q96EY1|DNJA3_HUMAN DnaJ homolog subfamily A member 3, mitochondrial OS=Homo sapiens OX=9606 GN=DNAJA3 PE=1 SV=2",GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0008270; GO:0008285; GO:0009408; GO:0009898; GO:0019901; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043231; GO:0044877; GO:0045211; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0061629; GO:0071340; GO:0090398; GO:0106137; GO:0140297,activation-induced cell death of T cells [GO:0006924]; cellular senescence [GO:0090398]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to type II interferon [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase-mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; type II interferon receptor binding [GO:0005133]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0002376; GO:0005634; GO:0005739; GO:0005829; GO:0006260; GO:0006355; GO:0006457; GO:0007005; GO:0012501; GO:0030154; GO:0034330; GO:0043226; GO:0098772,immune system process; nucleus; mitochondrion; cytosol; DNA replication; regulation of DNA-templated transcription; protein folding; mitochondrion organization; programmed cell death; cell differentiation; cell junction organization; organelle; molecular function regulator activity
OG_05509,FUN_024592-T1,Peve_00037916,Pocillopora_meandrina_HIv1___RNAseq.g19122.t1,three_way,65.791,FUN_024592-T1,Q2KIK0,,,,,38.3,397.0,1.2e-68,261.9,sp|Q2KIK0|SGT1_BOVIN Protein SGT1 homolog OS=Bos taurus OX=9913 GN=SUGT1 PE=2 SV=1,,,,,,
OG_05510,FUN_024593-T1,Peve_00037920,Pocillopora_meandrina_HIv1___RNAseq.g19123.t1,three_way,88.745,,,,,,,,,,,,,,,,,
OG_05511,FUN_024594-T1,Peve_00037923,Pocillopora_meandrina_HIv1___RNAseq.g19124.t1,three_way,73.8495,FUN_024594-T1,Q8R0F3,SUMF1_MOUSE,,Formylglycine-generating enzyme (FGE) (EC 1.8.3.7) (C-alpha-formylglycine-generating enzyme 1) (Sulfatase-modifying factor 1),Mus musculus (Mouse),69.0,281.0,4.5e-123,442.6,sp|Q8R0F3|SUMF1_MOUSE Formylglycine-generating enzyme OS=Mus musculus OX=10090 GN=Sumf1 PE=1 SV=2,GO:0005783; GO:0005788; GO:0018158; GO:0042802; GO:0043687; GO:0120147; GO:1903135,post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],cupric ion binding [GO:1903135]; formylglycine-generating oxidase activity [GO:0120147]; identical protein binding [GO:0042802],GO:0003824; GO:0005783; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; oxidoreductase activity; organelle
OG_05512,FUN_024595-T1,Peve_00037919,Pocillopora_meandrina_HIv1___RNAseq.g19128.t1,three_way,50.955666666666666,,,,,,,,,,,,,,,,,
OG_05513,FUN_024596-T1,Peve_00037922,Pocillopora_meandrina_HIv1___TS.g28511.t1,three_way,92.383,FUN_024596-T1,P60122,,,,,86.6,456.0,2.1000000000000002e-223,776.2,sp|P60122|RUVB1_MOUSE RuvB-like 1 OS=Mus musculus OX=10090 GN=Ruvbl1 PE=1 SV=1,,,,,,
OG_05514,FUN_024614-T1,Peve_00041134,Pocillopora_meandrina_HIv1___RNAseq.g19147.t1,three_way,72.74433333333333,FUN_024614-T1,B3EWZ9,HEPHL_ACRMI,,Hephaestin-like protein (EC 1.-.-.-),Acropora millepora (Staghorn coral) (Heteropora millepora),96.7,1114.0,0.0,2249.2,sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491,copper ion transport [GO:0006825]; iron ion transport [GO:0006826],plasma membrane [GO:0005886],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005886; GO:0016491,catalytic activity; plasma membrane; oxidoreductase activity
OG_05515,FUN_024615-T2,Peve_00041137,Pocillopora_meandrina_HIv1___RNAseq.g19148.t1,three_way,76.7845,FUN_024615-T2,Q8N8Q9,,,,,64.3,297.0,2.4e-106,387.1,sp|Q8N8Q9|NIPA2_HUMAN Magnesium transporter NIPA2 OS=Homo sapiens OX=9606 GN=NIPA2 PE=1 SV=1,,,,,,
OG_05516,FUN_024616-T1,Peve_00041138,Pocillopora_meandrina_HIv1___RNAseq.g19149.t1,three_way,62.02,FUN_024616-T1,B6CZ61,,,,,49.4,170.0,8.9e-38,158.3,sp|B6CZ61|LRC51_RAT Leucine-rich repeat-containing protein 51 OS=Rattus norvegicus OX=10116 GN=Lrrc51 PE=2 SV=1,,,,,,
OG_05517,FUN_024617-T1,Peve_00041139,Pocillopora_meandrina_HIv1___RNAseq.g19150.t1,three_way,79.05566666666667,FUN_024617-T1,Q2TA01,,,,,42.7,143.0,3e-17,89.7,sp|Q2TA01|TM216_BOVIN Transmembrane protein 216 OS=Bos taurus OX=9913 GN=TMEM216 PE=2 SV=2,,,,,,
OG_05518,FUN_024618-T1,Peve_00027329,Pocillopora_meandrina_HIv1___RNAseq.g19153.t1,three_way,82.87033333333333,FUN_024618-T1,Q9VJ79,PDE11_DROME,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11) (PDE11)",Drosophila melanogaster (Fruit fly),51.3,915.0,3.4e-254,879.4,"sp|Q9VJ79|PDE11_DROME Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 OS=Drosophila melanogaster OX=7227 GN=Pde11 PE=1 SV=4",GO:0004115; GO:0005829; GO:0019933; GO:0046058; GO:0046068; GO:0046872; GO:0047555,cAMP metabolic process [GO:0046058]; cAMP-mediated signaling [GO:0019933]; cGMP metabolic process [GO:0046068],cytosol [GO:0005829],"3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05519,FUN_024619-T1,Peve_00027330,Pocillopora_meandrina_HIv1___RNAseq.g19154.t1,three_way,62.20733333333333,,,,,,,,,,,,,,,,,
OG_05520,FUN_024620-T1,Peve_00027337,Pocillopora_meandrina_HIv1___RNAseq.g19155.t1,three_way,66.53033333333333,,,,,,,,,,,,,,,,,
OG_05521,FUN_024621-T1,Peve_00027338,Pocillopora_meandrina_HIv1___TS.g28539.t1,three_way,62.588,,,,,,,,,,,,,,,,,
OG_05522,FUN_024625-T1,Peve_00012720,Pocillopora_meandrina_HIv1___TS.g28341.t1,three_way,37.063,,,,,,,,,,,,,,,,,
OG_05523,FUN_024629-T1,Peve_00012710,Pocillopora_meandrina_HIv1___RNAseq.g18959.t1,three_way,61.03916666666667,,,,,,,,,,,,,,,,,
OG_05524,FUN_024632-T1,Peve_00012707,Pocillopora_meandrina_HIv1___RNAseq.g18962.t1,three_way,81.95866666666667,FUN_024632-T1,P07742,,,,,75.2,793.0,0.0,1231.5,sp|P07742|RIR1_MOUSE Ribonucleoside-diphosphate reductase large subunit OS=Mus musculus OX=10090 GN=Rrm1 PE=1 SV=2,,,,,,
OG_05525,FUN_024633-T1,Peve_00012726,Pocillopora_meandrina_HIv1___RNAseq.g18963.t1,three_way,42.951166666666666,,,,,,,,,,,,,,,,,
OG_05526,FUN_024661-T1,Peve_00012719,Pocillopora_meandrina_HIv1___RNAseq.g18964.t1,three_way,69.191,FUN_024661-T1,Q74GW7,,,,,36.1,249.0,1.3e-35,153.7,sp|Q74GW7|TTCA_GEOSL tRNA-cytidine(32) 2-sulfurtransferase OS=Geobacter sulfurreducens (strain ATCC 51573 / DSM 12127 / PCA) OX=243231 GN=ttcA PE=3 SV=2,,,,,,
OG_05527,FUN_024669-T1,Peve_00033882,Pocillopora_meandrina_HIv1___RNAseq.g18965.t1,three_way,75.67533333333334,,,,,,,,,,,,,,,,,
OG_05528,FUN_024671-T1,Peve_00032976,Pocillopora_meandrina_HIv1___RNAseq.g18966.t1,three_way,60.04133333333333,FUN_024671-T1,Q5BK09,,,,,25.9,263.0,2.8e-13,77.4,sp|Q5BK09|DRAM2_RAT DNA damage-regulated autophagy modulator protein 2 OS=Rattus norvegicus OX=10116 GN=Dram2 PE=2 SV=1,,,,,,
OG_05529,FUN_024672-T1,Peve_00027344,Pocillopora_meandrina_HIv1___RNAseq.g19161.t1,three_way,74.23133333333334,,,,,,,,,,,,,,,,,
OG_05530,FUN_024677-T1,Peve_00012721,Pocillopora_meandrina_HIv1___RNAseq.g18952.t1,three_way,50.53216666666667,FUN_024677-T1,Q6ZVD7,STOX1_HUMAN,,Storkhead-box protein 1 (Winged-helix domain-containing protein),Homo sapiens (Human),39.2,158.0,6.199999999999999e-24,114.4,sp|Q6ZVD7|STOX1_HUMAN Storkhead-box protein 1 OS=Homo sapiens OX=9606 GN=STOX1 PE=1 SV=2,GO:0000977; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0006357; GO:0010468; GO:0010628; GO:0010629; GO:0010800; GO:0010821; GO:0010971; GO:0033138; GO:0048839; GO:0051301; GO:0051881; GO:0051897; GO:0071500; GO:1900087; GO:1901858; GO:1902882; GO:1904031; GO:1904120,cell division [GO:0051301]; cellular response to nitrosative stress [GO:0071500]; inner ear development [GO:0048839]; negative regulation of gene expression [GO:0010629]; positive regulation of cyclin-dependent protein kinase activity [GO:1904031]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of otic vesicle morphogenesis [GO:1904120]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of gene expression [GO:0010468]; regulation of mitochondrial DNA metabolic process [GO:1901858]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of mitochondrion organization [GO:0010821]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription by RNA polymerase II [GO:0006357],cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977],GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05531,FUN_024682-T1,Peve_00012723,Pocillopora_meandrina_HIv1___RNAseq.g18950.t1,three_way,76.55683333333333,FUN_024682-T1,Q17QB7,RAB30_BOVIN,,Ras-related protein Rab-30 (EC 3.6.5.2),Bos taurus (Bovine),53.8,184.0,3.1e-55,216.5,sp|Q17QB7|RAB30_BOVIN Ras-related protein Rab-30 OS=Bos taurus OX=9913 GN=RAB30 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005801; GO:0005802; GO:0007030; GO:0016020; GO:0016192; GO:0031985; GO:0032482,Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; vesicle-mediated transport; hydrolase activity; organelle
OG_05532,FUN_024704-T1,Peve_00045230,Pocillopora_meandrina_HIv1___TS.g1559.t2,three_way,38.1355,,,,,,,,,,,,,,,,,
OG_05533,FUN_024719-T1,Peve_00012704,Pocillopora_meandrina_HIv1___RNAseq.g18947.t1,three_way,64.05266666666667,FUN_024719-T1,A7MBB3,,,,,31.4,175.0,8.8e-10,65.9,sp|A7MBB3|T150B_BOVIN Modulator of macroautophagy TMEM150B OS=Bos taurus OX=9913 GN=TMEM150B PE=2 SV=1,,,,,,
OG_05534,FUN_024722-T1,Peve_00012713,Pocillopora_meandrina_HIv1___RNAseq.g18944.t1,three_way,60.545,FUN_024722-T1,P49219,,,,,24.4,365.0,7.6e-21,103.2,sp|P49219|MTR1C_XENLA Melatonin receptor type 1C OS=Xenopus laevis OX=8355 GN=mtnr1c PE=2 SV=1,,,,,,
OG_05535,FUN_024724-T1,Peve_00012714,Pocillopora_meandrina_HIv1___RNAseq.g18835.t1,three_way,82.242,FUN_024724-T1,Q9EPW0,INP4A_MOUSE,,"Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Inositol polyphosphate 4-phosphatase-1) (4-Ptase-1) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66)",Mus musculus (Mouse),37.1,911.0,3.5e-154,547.4,sp|Q9EPW0|INP4A_MOUSE Inositol polyphosphate-4-phosphatase type I A OS=Mus musculus OX=10090 GN=Inpp4a PE=1 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0006798; GO:0014069; GO:0016316; GO:0017161; GO:0031901; GO:0052828; GO:0055038; GO:0098978; GO:0099072,polyphosphate catabolic process [GO:0006798]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; recycling endosome membrane [GO:0055038],"inositol-1,3,4-trisphosphate 4-phosphatase activity [GO:0017161]; inositol-3,4-bisphosphate 4-phosphatase activity [GO:0052828]; phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity [GO:0016316]",GO:0003824; GO:0005634; GO:0005886; GO:0016787; GO:0043226,catalytic activity; nucleus; plasma membrane; hydrolase activity; organelle
OG_05536,FUN_024725-T1,Peve_00012715,Pocillopora_meandrina_HIv1___RNAseq.g18836.t1,three_way,72.26233333333333,FUN_024725-T1,Q9UBS8,RNF14_HUMAN,,E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.31) (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14),Homo sapiens (Human),47.6,479.0,1.7e-127,457.6,sp|Q9UBS8|RNF14_HUMAN E3 ubiquitin-protein ligase RNF14 OS=Homo sapiens OX=9606 GN=RNF14 PE=1 SV=1,GO:0000151; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006355; GO:0006357; GO:0006511; GO:0007165; GO:0008270; GO:0016567; GO:0019787; GO:0022626; GO:0030521; GO:0031624; GO:0045893; GO:0050681; GO:0060765; GO:0060828; GO:0061630; GO:0072344; GO:0085020; GO:0160127,androgen receptor signaling pathway [GO:0030521]; positive regulation of DNA-templated transcription [GO:0045893]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; protein-RNA covalent cross-linking repair [GO:0160127]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; rescue of stalled ribosome [GO:0072344]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein transferase activity [GO:0019787]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005840; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; ribosome; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_05537,FUN_024726-T1,Peve_00029154,Pocillopora_meandrina_HIv1___RNAseq.g18837.t1,three_way,72.15833333333333,FUN_024726-T1,A0A1J6KGJ9,,,,,30.6,563.0,1e-55,219.5,sp|A0A1J6KGJ9|JAR4_NICAT Jasmonoyl--L-amino acid synthetase JAR4 OS=Nicotiana attenuata OX=49451 GN=JAR4 PE=1 SV=1,,,,,,
OG_05538,FUN_024740-T1,Peve_00026310,Pocillopora_meandrina_HIv1___RNAseq.g18838.t1,three_way,80.97633333333333,FUN_024740-T1,O15067,PUR4_HUMAN,,Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase) (Phosphoribosylformylglycineamide amidotransferase),Homo sapiens (Human),58.8,1323.0,0.0,1520.8,sp|O15067|PUR4_HUMAN Phosphoribosylformylglycinamidine synthase OS=Homo sapiens OX=9606 GN=PFAS PE=1 SV=4,GO:0004642; GO:0005524; GO:0005737; GO:0005829; GO:0006164; GO:0006177; GO:0006189; GO:0006541; GO:0009168; GO:0009410; GO:0044208; GO:0046872; GO:0070062; GO:0097065; GO:0097294,'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to xenobiotic stimulus [GO:0009410],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642],GO:0003824; GO:0005829; GO:0006520; GO:0016874; GO:0043226; GO:0048856; GO:0055086; GO:1901135,catalytic activity; cytosol; amino acid metabolic process; ligase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05539,FUN_024741-T1,Peve_00026308,Pocillopora_meandrina_HIv1___RNAseq.g18839.t1,three_way,45.45766666666667,FUN_024741-T1,Q8NB91,FANCB_HUMAN,,Fanconi anemia group B protein (Protein FACB) (Fanconi anemia-associated polypeptide of 95 kDa) (FAAP95),Homo sapiens (Human),20.2,643.0,3.7e-10,68.6,sp|Q8NB91|FANCB_HUMAN Fanconi anemia group B protein OS=Homo sapiens OX=9606 GN=FANCB PE=1 SV=1,GO:0000785; GO:0005654; GO:0005829; GO:0036297; GO:0043240; GO:1905168; GO:1990414; GO:2000042,interstrand cross-link repair [GO:0036297]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829; GO:0006281; GO:0006310,nucleoplasm; cytosol; DNA repair; DNA recombination
OG_05540,FUN_024742-T1,Peve_00005934,Pocillopora_meandrina_HIv1___TS.g28230.t1,three_way,61.432,FUN_024742-T1,Q865W2,,,,,26.7,217.0,2e-10,69.3,sp|Q865W2|TRI50_PIG E3 ubiquitin-protein ligase TRIM50 OS=Sus scrofa OX=9823 GN=TRIM50 PE=2 SV=1,,,,,,
OG_05541,FUN_024743-T1,Peve_00005932,Pocillopora_meandrina_HIv1___RNAseq.g18843.t1,three_way,49.214666666666666,FUN_024743-T1,A6NEQ2,,,,,56.5,46.0,4.8e-07,57.0,sp|A6NEQ2|F181B_HUMAN Protein FAM181B OS=Homo sapiens OX=9606 GN=FAM181B PE=1 SV=1,,,,,,
OG_05542,FUN_024748-T1,Peve_00005930,Pocillopora_meandrina_HIv1___RNAseq.g18844.t2,three_way,45.1395,,,,,,,,,,,,,,,,,
OG_05543,FUN_024749-T1,Peve_00005929,Pocillopora_meandrina_HIv1___RNAseq.g18845.t1,three_way,56.452666666666666,,,,,,,,,,,,,,,,,
OG_05544,FUN_024750-T3,Peve_00005936,Pocillopora_meandrina_HIv1___RNAseq.g18846.t1,three_way,49.522333333333336,FUN_024750-T3,Q6NTV6,,,,,43.7,1158.0,2.8e-127,458.8,sp|Q6NTV6|INF2_XENLA Inverted formin-2 OS=Xenopus laevis OX=8355 GN=inf2 PE=2 SV=1,,,,,,
OG_05545,FUN_024751-T1,Peve_00005927,Pocillopora_meandrina_HIv1___RNAseq.g18851.t1,three_way,90.225,FUN_024751-T1,A2AF53,,,,,53.0,351.0,3.1e-102,373.2,sp|A2AF53|T185A_MOUSE Transmembrane protein 185A OS=Mus musculus OX=10090 GN=Tmem185a PE=1 SV=1,,,,,,
OG_05546,FUN_024753-T1,Peve_00041145,Pocillopora_meandrina_HIv1___RNAseq.g18834.t1,three_way,70.904,,,,,,,,,,,,,,,,,
OG_05547,FUN_024754-T1,Peve_00041144,Pocillopora_meandrina_HIv1___RNAseq.g18833.t1,three_way,62.28083333333333,FUN_024754-T1,Q9NXR5,,,,,41.9,93.0,3.5e-12,73.9,sp|Q9NXR5|ANR10_HUMAN Ankyrin repeat domain-containing protein 10 OS=Homo sapiens OX=9606 GN=ANKRD10 PE=1 SV=2,,,,,,
OG_05548,FUN_024755-T1,Peve_00041143,Pocillopora_meandrina_HIv1___RNAseq.2312_t,three_way,71.259,FUN_024755-T1,P22304,IDS_HUMAN,,Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain],Homo sapiens (Human),52.4,510.0,3.2e-146,520.0,sp|P22304|IDS_HUMAN Iduronate 2-sulfatase OS=Homo sapiens OX=9606 GN=IDS PE=1 SV=1,GO:0004423; GO:0005509; GO:0005737; GO:0005764; GO:0006027; GO:0030200; GO:0030209; GO:0043202,dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200],cytoplasm [GO:0005737]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],calcium ion binding [GO:0005509]; iduronate-2-sulfatase activity [GO:0004423],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_05549,FUN_024756-T1,Peve_00027351,Pocillopora_meandrina_HIv1___RNAseq.g18828.t1,three_way,51.74283333333333,FUN_024756-T1,Q9P0M2,AKA7G_HUMAN,,A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma),Homo sapiens (Human),39.0,205.0,7.9e-36,153.3,sp|Q9P0M2|AKA7G_HUMAN A-kinase anchor protein 7 isoform gamma OS=Homo sapiens OX=9606 GN=AKAP7 PE=1 SV=2,GO:0000166; GO:0005634; GO:0005829; GO:0019901; GO:0032991; GO:0034237; GO:0050804; GO:0051018; GO:0098686,modulation of chemical synaptic transmission [GO:0050804],cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901],GO:0005634; GO:0005829; GO:0043226,nucleus; cytosol; organelle
OG_05550,FUN_024757-T1,Peve_00027332,Pocillopora_meandrina_HIv1___RNAseq.g18827.t1,three_way,63.693000000000005,FUN_024757-T1,Q5XIB4,UFSP2_RAT,,Ufm1-specific protease 2 (UfSP2) (EC 3.4.22.-),Rattus norvegicus (Rat),47.7,434.0,3.8e-106,387.1,sp|Q5XIB4|UFSP2_RAT Ufm1-specific protease 2 OS=Rattus norvegicus OX=10116 GN=Ufsp2 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005783; GO:0006508; GO:0032649; GO:0032790; GO:0033146; GO:0071567; GO:0072344; GO:1903051,negative regulation of proteolysis involved in protein catabolic process [GO:1903051]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of type II interferon production [GO:0032649]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634],deUFMylase activity [GO:0071567],GO:0003824; GO:0005634; GO:0005783; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05551,FUN_024758-T1,Peve_00027326,Pocillopora_meandrina_HIv1___RNAseq.g18826.t1,three_way,87.74933333333333,,,,,,,,,,,,,,,,,
OG_05552,FUN_024760-T1,Peve_00020486,Pocillopora_meandrina_HIv1___RNAseq.g18824.t1,three_way,64.475,,,,,,,,,,,,,,,,,
OG_05553,FUN_024761-T1,Peve_00025825,Pocillopora_meandrina_HIv1___RNAseq.g18823.t1,three_way,89.74166666666666,FUN_024761-T1,P49459,UBE2A_HUMAN,,Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (hHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A),Homo sapiens (Human),94.0,149.0,1.8e-78,293.1,sp|P49459|UBE2A_HUMAN Ubiquitin-conjugating enzyme E2 A OS=Homo sapiens OX=9606 GN=UBE2A PE=1 SV=2,GO:0000086; GO:0000209; GO:0000785; GO:0004842; GO:0005524; GO:0005654; GO:0005764; GO:0005770; GO:0005829; GO:0006281; GO:0006301; GO:0006338; GO:0006511; GO:0009411; GO:0031625; GO:0033503; GO:0043130; GO:0043161; GO:0061631; GO:0070936; GO:0070979; GO:1901526,chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of mitophagy [GO:1901526]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; response to UV [GO:0009411]; ubiquitin-dependent protein catabolic process [GO:0006511],chromatin [GO:0000785]; cytosol [GO:0005829]; HULC complex [GO:0033503]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; lysosome; endosome; vacuole; cytosol; DNA repair; chromatin organization; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05554,FUN_024762-T1,Peve_00020489,Pocillopora_meandrina_HIv1___RNAseq.g18822.t1,three_way,75.65866666666666,FUN_024762-T1,Q5U3V7,,,,,46.3,341.0,4.3e-72,273.1,sp|Q5U3V7|S2543_DANRE Solute carrier family 25 member 43 OS=Danio rerio OX=7955 GN=slc25a43 PE=2 SV=1,,,,,,
OG_05555,FUN_024763-T1,Peve_00020490,Pocillopora_meandrina_HIv1___TS.g28209.t1,three_way,90.23433333333334,FUN_024763-T1,O49447,ADT3_ARATH,,"ADP,ATP carrier protein 3, mitochondrial (ADP/ATP translocase 3) (Adenine nucleotide translocator 3) (ANT 3)",Arabidopsis thaliana (Mouse-ear cress),60.0,305.0,7e-96,352.1,"sp|O49447|ADT3_ARATH ADP,ATP carrier protein 3, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=AAC3 PE=1 SV=1",GO:0005471; GO:0005739; GO:0005743; GO:0005886; GO:0009941; GO:0015865; GO:0016020; GO:0140021; GO:1990544,mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; purine nucleotide transport [GO:0015865],chloroplast envelope [GO:0009941]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],ATP:ADP antiporter activity [GO:0005471],GO:0005215; GO:0005739; GO:0005886; GO:0043226; GO:0055085,transporter activity; mitochondrion; plasma membrane; organelle; transmembrane transport
OG_05556,FUN_024770-T1,Peve_00003488,Pocillopora_meandrina_HIv1___RNAseq.g18819.t1,three_way,69.99166666666666,FUN_024770-T1,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),33.2,918.0,1.8e-116,422.9,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_05557,FUN_024775-T1,Peve_00033053,Pocillopora_meandrina_HIv1___RNAseq.g18815.t1,three_way,70.15433333333333,FUN_024775-T1,Q92629,,,,,40.8,265.0,5.7e-49,196.1,sp|Q92629|SGCD_HUMAN Delta-sarcoglycan OS=Homo sapiens OX=9606 GN=SGCD PE=1 SV=2,,,,,,
OG_05558,FUN_024776-T1,Peve_00036224,Pocillopora_meandrina_HIv1___RNAseq.g18814.t1,three_way,89.42866666666667,FUN_024776-T1,Q8BTV1,TUSC3_MOUSE,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 (Oligosaccharyl transferase subunit TUSC3) (Magnesium uptake/transporter TUSC3) (Protein N33) (Tumor suppressor candidate 3),Mus musculus (Mouse),65.9,299.0,8.100000000000001e-124,444.9,sp|Q8BTV1|TUSC3_MOUSE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit TUSC3 OS=Mus musculus OX=10090 GN=Tusc3 PE=1 SV=1,GO:0005739; GO:0008250; GO:0015693; GO:0018279; GO:0050890; GO:0062062,cognition [GO:0050890]; magnesium ion transport [GO:0015693]; protein N-linked glycosylation via asparagine [GO:0018279],mitochondrion [GO:0005739]; oligosaccharyltransferase complex [GO:0008250],oligosaccharyltransferase complex binding [GO:0062062],GO:0005739; GO:0009101; GO:0043226; GO:0050877; GO:1901135,mitochondrion; glycoprotein biosynthetic process; organelle; nervous system process; carbohydrate derivative metabolic process
OG_05559,FUN_024777-T1,Peve_00029133,Pocillopora_meandrina_HIv1___RNAseq.g18813.t1,three_way,71.3975,FUN_024777-T1,Q5T8P6,RBM26_HUMAN,,RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26),Homo sapiens (Human),31.9,1043.0,1e-47,193.7,sp|Q5T8P6|RBM26_HUMAN RNA-binding protein 26 OS=Homo sapiens OX=9606 GN=RBM26 PE=1 SV=3,GO:0003723; GO:0005634; GO:0008270,,nucleus [GO:0005634],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005634; GO:0043226,RNA binding; nucleus; organelle
OG_05560,FUN_024778-T1,Peve_00016140,Pocillopora_meandrina_HIv1___RNAseq.g18804.t1,three_way,93.01066666666668,FUN_024778-T1,Q91ZW3,,,,,72.6,999.0,0.0,1404.0,sp|Q91ZW3|SMCA5_MOUSE SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 OS=Mus musculus OX=10090 GN=Smarca5 PE=1 SV=1,,,,,,
OG_05561,FUN_024780-T1,Peve_00015072,Pocillopora_meandrina_HIv1___RNAseq.g18803.t1,three_way,84.27633333333333,FUN_024780-T1,Q9CXV9,DCNL5_MOUSE,,DCN1-like protein 5 (DCNL5) (DCUN1 domain-containing protein 5) (Defective in cullin neddylation protein 1-like protein 5) (Squamous cell carcinoma-related oncogene 5),Mus musculus (Mouse),51.8,168.0,1.3e-42,174.5,sp|Q9CXV9|DCNL5_MOUSE DCN1-like protein 5 OS=Mus musculus OX=10090 GN=Dcun1d5 PE=1 SV=1,GO:0001558; GO:0005634; GO:0005737; GO:0005819; GO:0006974; GO:0097602; GO:2000434; GO:2000436,DNA damage response [GO:0006974]; positive regulation of protein neddylation [GO:2000436]; regulation of cell growth [GO:0001558]; regulation of protein neddylation [GO:2000434],cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819],cullin family protein binding [GO:0097602],GO:0005634; GO:0043226,nucleus; organelle
OG_05562,FUN_024781-T1,Peve_00015076,Pocillopora_meandrina_HIv1___TS.g28189.t2,three_way,75.94966666666666,FUN_024781-T1,Q5F3U9,,,,,42.0,1148.0,3.5999999999999997e-242,840.1,sp|Q5F3U9|PDS5B_CHICK Sister chromatid cohesion protein PDS5 homolog B OS=Gallus gallus OX=9031 GN=PDS5B PE=2 SV=3,,,,,,
OG_05563,FUN_024783-T1,Peve_00007043,Pocillopora_meandrina_HIv1___TS.g28188.t1,three_way,49.95166666666667,FUN_024783-T1,Q3U481,MFS12_MOUSE,,Major facilitator superfamily domain-containing protein 12 (Protein grizzled),Mus musculus (Mouse),32.5,206.0,9e-19,96.7,sp|Q3U481|MFS12_MOUSE Major facilitator superfamily domain-containing protein 12 OS=Mus musculus OX=10090 GN=Mfsd12 PE=1 SV=1,GO:0005764; GO:0005765; GO:0005770; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; cytoplasmic vesicle; organelle; transmembrane transport
OG_05564,FUN_024784-T1,Peve_00007038,Pocillopora_meandrina_HIv1___RNAseq.g18796.t1,three_way,47.03666666666667,FUN_024784-T1,Q923Y3,,,,,23.4,295.0,8.3e-06,52.8,sp|Q923Y3|TAA8B_RAT Trace amine-associated receptor 8b OS=Rattus norvegicus OX=10116 GN=Taar8b PE=3 SV=1,,,,,,
OG_05565,FUN_024794-T1,Peve_00007040,Pocillopora_meandrina_HIv1___RNAseq.2280_t,three_way,39.91566666666667,FUN_024794-T1,P79121,,,,,26.6,177.0,1.8e-13,77.8,sp|P79121|TIMP3_BOVIN Metalloproteinase inhibitor 3 OS=Bos taurus OX=9913 GN=TIMP3 PE=2 SV=1,,,,,,
OG_05566,FUN_024796-T1,Peve_00007042,Pocillopora_meandrina_HIv1___RNAseq.g18794.t1,three_way,55.33416666666667,,,,,,,,,,,,,,,,,
OG_05567,FUN_024797-T1,Peve_00026090,Pocillopora_meandrina_HIv1___RNAseq.g18789.t1,three_way,78.34133333333334,FUN_024797-T1,Q6NUT3,MFS12_HUMAN,,Major facilitator superfamily domain-containing protein 12,Homo sapiens (Human),32.6,482.0,4.4e-71,270.4,sp|Q6NUT3|MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens OX=9606 GN=MFSD12 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05568,FUN_024804-T1,Peve_00026081,Pocillopora_meandrina_HIv1___RNAseq.g18778.t2,three_way,85.261,FUN_024804-T1,Q64332,SYN2_MOUSE,,Synapsin-2 (Synapsin II),Mus musculus (Mouse),58.6,326.0,4.6e-111,402.9,sp|Q64332|SYN2_MOUSE Synapsin-2 OS=Mus musculus OX=10090 GN=Syn2 PE=1 SV=2,GO:0005524; GO:0005886; GO:0007269; GO:0014069; GO:0017156; GO:0030672; GO:0031201; GO:0042802; GO:0043209; GO:0045202; GO:0097091; GO:0098685; GO:0098978; GO:0099504,calcium-ion regulated exocytosis [GO:0017156]; neurotransmitter secretion [GO:0007269]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle cycle [GO:0099504],glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],ATP binding [GO:0005524]; identical protein binding [GO:0042802],GO:0005886; GO:0016192; GO:0043226,plasma membrane; vesicle-mediated transport; organelle
OG_05569,FUN_024811-T1,Peve_00026080,Pocillopora_meandrina_HIv1___RNAseq.g18777.t1,three_way,37.74783333333333,,,,,,,,,,,,,,,,,
OG_05570,FUN_024812-T1,Peve_00026078,Pocillopora_meandrina_HIv1___RNAseq.g18775.t1,three_way,37.9165,,,,,,,,,,,,,,,,,
OG_05571,FUN_024814-T1,Peve_00026077,Pocillopora_meandrina_HIv1___RNAseq.g18773.t1,three_way,88.77166666666666,FUN_024814-T1,Q4GZT3,PKD2_BOVIN,,Polycystin-2 (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2),Bos taurus (Bovine),54.5,751.0,1.4999999999999999e-215,751.1,sp|Q4GZT3|PKD2_BOVIN Polycystin-2 OS=Bos taurus OX=9913 GN=PKD2 PE=2 SV=1,GO:0002133; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005929; GO:0006813; GO:0006814; GO:0006816; GO:0007166; GO:0015271; GO:0016020; GO:0016323; GO:0030659; GO:0034703; GO:0050982; GO:0051209; GO:0051262; GO:0051290; GO:0051371; GO:0060170; GO:0070062; GO:0070588; GO:0071277; GO:0071805; GO:0098662; GO:0140494,calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; detection of mechanical stimulus [GO:0050982]; inorganic cation transmembrane transport [GO:0098662]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; release of sequestered calcium ion into cytosol [GO:0051209]; sodium ion transport [GO:0006814],basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; migrasome [GO:0140494]; plasma membrane [GO:0005886]; polycystin complex [GO:0002133],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0008092; GO:0043226; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; Golgi apparatus; plasma membrane; cilium; cytoskeletal protein binding; organelle; transmembrane transport; protein-containing complex assembly
OG_05572,FUN_024815-T1,Peve_00026076,Pocillopora_meandrina_HIv1___RNAseq.g18772.t1,three_way,69.34433333333334,FUN_024815-T1,Q96PE2,ARHGH_HUMAN,,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),Homo sapiens (Human),40.1,1066.0,9.2e-179,630.2,sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056,actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0007010; GO:0098772,cytosol; cytoskeleton organization; molecular function regulator activity
OG_05573,FUN_024861-T1,Peve_00026074,Pocillopora_meandrina_HIv1___RNAseq.g18770.t1,three_way,57.13,FUN_024861-T1,Q8NEG2,,,,,29.7,182.0,2.8e-08,60.8,sp|Q8NEG2|CG057_HUMAN Uncharacterized protein C7orf57 OS=Homo sapiens OX=9606 GN=C7orf57 PE=1 SV=3,,,,,,
OG_05574,FUN_024863-T1,Peve_00026086,Pocillopora_meandrina_HIv1___TS.g28157.t1,three_way,75.19033333333333,FUN_024863-T1,Q9NVM9,INT13_HUMAN,,Integrator complex subunit 13 (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Protein asunder homolog) (Sarcoma antigen NY-SAR-95),Homo sapiens (Human),42.6,698.0,1.3000000000000002e-145,518.5,sp|Q9NVM9|INT13_HUMAN Integrator complex subunit 13 OS=Homo sapiens OX=9606 GN=INTS13 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005737; GO:0007052; GO:0007346; GO:0016180; GO:0016604; GO:0030317; GO:0032039; GO:0034243; GO:0043231; GO:0051301; GO:0051642; GO:0080154; GO:0090435; GO:0140297; GO:0160232; GO:0160240,cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA processing [GO:0016180],cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA-binding transcription factor binding [GO:0140297],GO:0005634; GO:0005654; GO:0006355; GO:0007010; GO:0007018; GO:0016073; GO:0022414; GO:0043226; GO:0048870,nucleus; nucleoplasm; regulation of DNA-templated transcription; cytoskeleton organization; microtubule-based movement; snRNA metabolic process; reproductive process; organelle; cell motility
OG_05575,FUN_024865-T1,Peve_00016133,Pocillopora_meandrina_HIv1___RNAseq.g18765.t1,three_way,72.15233333333333,FUN_024865-T1,Q9WV52,PLEK2_MOUSE,,Pleckstrin-2,Mus musculus (Mouse),32.3,378.0,2.5e-47,191.0,sp|Q9WV52|PLEK2_MOUSE Pleckstrin-2 OS=Mus musculus OX=10090 GN=Plek2 PE=1 SV=1,GO:0005737; GO:0005856; GO:0005886; GO:0016020; GO:0030036; GO:0031258; GO:0031346; GO:0032266; GO:0035556; GO:0043325; GO:0080025; GO:0120034,actin cytoskeleton organization [GO:0030036]; intracellular signal transduction [GO:0035556]; positive regulation of cell projection organization [GO:0031346]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; plasma membrane [GO:0005886],"phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]",GO:0005856; GO:0005886; GO:0007010; GO:0008289; GO:0043226,cytoskeleton; plasma membrane; cytoskeleton organization; lipid binding; organelle
OG_05576,FUN_024871-T1,Peve_00016134,Pocillopora_meandrina_HIv1___RNAseq.g18750.t1,three_way,55.18966666666667,FUN_024871-T1,P39022,,,,,68.3,161.0,3.8e-60,233.8,sp|P39022|RAD52_CHICK DNA repair protein RAD52 homolog OS=Gallus gallus OX=9031 GN=RAD52 PE=2 SV=1,,,,,,
OG_05577,FUN_024872-T1,Peve_00016135,Pocillopora_meandrina_HIv1___RNAseq.g18749.t1,three_way,59.77783333333333,FUN_024872-T1,Q9D8N6,,,,,32.5,169.0,1.5e-15,84.7,sp|Q9D8N6|LIN37_MOUSE Protein lin-37 homolog OS=Mus musculus OX=10090 GN=Lin37 PE=1 SV=1,,,,,,
OG_05578,FUN_024891-T1,Peve_00008003,Pocillopora_meandrina_HIv1___RNAseq.g19789.t1,three_way,93.80933333333331,FUN_024891-T1,P52046,,,,,32.8,235.0,1.5999999999999999e-24,114.8,sp|P52046|CRT_CLOAB Short-chain-enoyl-CoA hydratase OS=Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / IAM 19013 / LMG 5710 / NBRC 13948 / NRRL B-527 / VKM B-1787 / 2291 / W) OX=272562 GN=crt PE=1 SV=1,,,,,,
OG_05579,FUN_024900-T1,Peve_00016136,Pocillopora_meandrina_HIv1___RNAseq.g18747.t1a,three_way,92.683,FUN_024900-T1,A0A1B0GTI8,,,,,32.9,170.0,4.6000000000000015e-22,106.3,sp|A0A1B0GTI8|TM272_HUMAN Transmembrane protein 272 OS=Homo sapiens OX=9606 GN=TMEM272 PE=2 SV=3,,,,,,
OG_05580,FUN_024901-T2,Peve_00016138,Pocillopora_meandrina_HIv1___RNAseq.g18747.t1b,three_way,57.15083333333333,FUN_024901-T2,O54853,KCNH6_RAT,,Voltage-gated inwardly rectifying potassium channel KCNH6 (Ether-a-go-go-related gene potassium channel 2) (ERG-2) (Eag-related protein 2) (Ether-a-go-go-related protein 2) (Potassium voltage-gated channel subfamily H member 6) (Voltage-gated potassium channel subunit Kv11.2),Rattus norvegicus (Rat),47.5,461.0,8.4e-106,386.0,sp|O54853|KCNH6_RAT Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Rattus norvegicus OX=10116 GN=Kcnh6 PE=1 SV=1,GO:0005242; GO:0005249; GO:0005267; GO:0005886; GO:0006813; GO:0034702; GO:0044877; GO:0060307; GO:0071805; GO:0086013; GO:0086091,membrane repolarization during cardiac muscle cell action potential [GO:0086013]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307],monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05581,FUN_024905-T1,Peve_00016139,Pocillopora_meandrina_HIv1___RNAseq.g18746.t1,three_way,52.13,FUN_024905-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),36.1,280.0,9.9e-38,160.2,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_05582,FUN_024906-T1,Peve_00038387,Pocillopora_meandrina_HIv1___RNAseq.g19419.t1,three_way,66.53216666666667,FUN_024906-T1,P23359,BMP7_MOUSE,,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1),Mus musculus (Mouse),24.3,382.0,1.2e-30,135.6,sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2,GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0036305; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312,allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; vesicle [GO:0031982],BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005615; GO:0006355; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell adhesion; programmed cell death; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05583,FUN_024907-T1,Peve_00020896,Pocillopora_meandrina_HIv1___RNAseq.g19418.t1,three_way,77.17183333333334,FUN_024907-T1,Q8BTS4,,,,,53.7,404.0,1.4e-120,434.9,sp|Q8BTS4|NUP54_MOUSE Nuclear pore complex protein Nup54 OS=Mus musculus OX=10090 GN=Nup54 PE=1 SV=1,,,,,,
OG_05584,FUN_024912-T1,Peve_00020857,Pocillopora_meandrina_HIv1___RNAseq.g19413.t1,three_way,77.491,FUN_024912-T1,P32320,CDD_HUMAN,,Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase),Homo sapiens (Human),52.2,134.0,1.2e-32,141.0,sp|P32320|CDD_HUMAN Cytidine deaminase OS=Homo sapiens OX=9606 GN=CDA PE=1 SV=2,GO:0001882; GO:0004126; GO:0005576; GO:0005829; GO:0007166; GO:0008270; GO:0008655; GO:0009972; GO:0019858; GO:0030308; GO:0034774; GO:0042802; GO:0042803; GO:0044206; GO:0045980; GO:0046898; GO:0071217; GO:1904724; GO:1904813,cell surface receptor signaling pathway [GO:0007166]; cellular response to external biotic stimulus [GO:0071217]; cytidine deamination [GO:0009972]; cytosine metabolic process [GO:0019858]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; pyrimidine-containing compound salvage [GO:0008655]; response to cycloheximide [GO:0046898]; UMP salvage [GO:0044206],cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724],cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; extracellular region; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05585,FUN_024916-T1,Peve_00007311,Pocillopora_meandrina_HIv1___RNAseq.g22868.t1,three_way,51.687666666666665,,,,,,,,,,,,,,,,,
OG_05586,FUN_024942-T1,Peve_00038386,Pocillopora_meandrina_HIv1___RNAseq.g19445.t1,three_way,68.45700000000001,FUN_024942-T1,A8MXD5,GRCR1_HUMAN,,Glutaredoxin domain-containing cysteine-rich protein 1,Homo sapiens (Human),35.3,190.0,2.1e-28,127.5,sp|A8MXD5|GRCR1_HUMAN Glutaredoxin domain-containing cysteine-rich protein 1 OS=Homo sapiens OX=9606 GN=GRXCR1 PE=1 SV=1,GO:0005902; GO:0006887; GO:0007009; GO:0007605; GO:0032420; GO:0051592; GO:0051649; GO:0060088; GO:0060091; GO:0060118; GO:0060119; GO:0060122; GO:0070588; GO:0090102; GO:1905144,auditory receptor cell stereocilium organization [GO:0060088]; calcium ion transmembrane transport [GO:0070588]; cochlea development [GO:0090102]; establishment of localization in cell [GO:0051649]; exocytosis [GO:0006887]; inner ear receptor cell development [GO:0060119]; inner ear receptor cell stereocilium organization [GO:0060122]; plasma membrane organization [GO:0007009]; response to acetylcholine [GO:1905144]; response to calcium ion [GO:0051592]; sensory perception of sound [GO:0007605]; vestibular receptor cell development [GO:0060118],kinocilium [GO:0060091]; microvillus [GO:0005902]; stereocilium [GO:0032420],,GO:0005929; GO:0016192; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0061024,cilium; vesicle-mediated transport; organelle; anatomical structure development; nervous system process; transmembrane transport; membrane organization
OG_05587,FUN_024944-T1,Peve_00038384,Pocillopora_meandrina_HIv1___RNAseq.g19542.t1,three_way,72.11733333333333,FUN_024944-T1,A1L1R5,,,,,38.1,636.0,9.2e-106,386.0,sp|A1L1R5|PTPC1_DANRE Protein tyrosine phosphatase domain-containing protein 1 OS=Danio rerio OX=7955 GN=ptpdc1 PE=2 SV=1,,,,,,
OG_05588,FUN_025031-T1,Peve_00004654,Pocillopora_meandrina_HIv1___TS.g28790.t2,three_way,69.56233333333333,FUN_025031-T1,Q6R1L1,,,,,55.9,195.0,5.1999999999999996e-46,186.4,sp|Q6R1L1|TAF7_CRIGR Transcription initiation factor TFIID subunit 7 OS=Cricetulus griseus OX=10029 GN=TAF7 PE=1 SV=1,,,,,,
OG_05589,FUN_025035-T1,Peve_00038379,Pocillopora_meandrina_HIv1___RNAseq.g19423.t1,three_way,84.7295,FUN_025035-T1,Q6DCE3,ZNT9_XENLA,,"Proton-coupled zinc antiporter SLC30A9, mitochondrial (Solute carrier family 30 member 9) (Zinc transporter 9) (ZnT-9)",Xenopus laevis (African clawed frog),48.4,517.0,2.8e-121,437.2,"sp|Q6DCE3|ZNT9_XENLA Proton-coupled zinc antiporter SLC30A9, mitochondrial OS=Xenopus laevis OX=8355 GN=slc30a9 PE=2 SV=1",GO:0005385; GO:0005634; GO:0005783; GO:0006829; GO:0006882; GO:0010821; GO:0015297; GO:0031410; GO:0031966,intracellular zinc ion homeostasis [GO:0006882]; regulation of mitochondrion organization [GO:0010821]; zinc ion transport [GO:0006829],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634],antiporter activity [GO:0015297]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005634; GO:0005783; GO:0031410; GO:0043226,transporter activity; nucleus; endoplasmic reticulum; cytoplasmic vesicle; organelle
OG_05590,FUN_025062-T1,Peve_00039601,Pocillopora_meandrina_HIv1___RNAseq.g19541.t1,three_way,62.935,,,,,,,,,,,,,,,,,
OG_05591,FUN_025097-T1,Peve_00028154,Pocillopora_meandrina_HIv1___RNAseq.g18137.t1,three_way,68.95116666666667,FUN_025097-T1,Q9UBU9,NXF1_HUMAN,,Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP),Homo sapiens (Human),43.6,583.0,2.3e-117,424.5,sp|Q9UBU9|NXF1_HUMAN Nuclear RNA export factor 1 OS=Homo sapiens OX=9606 GN=NXF1 PE=1 SV=1,GO:0003723; GO:0003729; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006406; GO:0010494; GO:0015031; GO:0016607; GO:0016973; GO:0042272; GO:0042405,mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear RNA export factor complex [GO:0042272]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006913; GO:0043226,RNA binding; nucleus; nucleoplasm; cytosol; nucleocytoplasmic transport; organelle
OG_05592,FUN_025098-T1,Peve_00038381,Pocillopora_meandrina_HIv1___RNAseq.g19422.t1,three_way,89.146,FUN_025098-T1,P63082,VATL_MOUSE,,V-type proton ATPase 16 kDa proteolipid subunit c (V-ATPase 16 kDa proteolipid subunit c) (PL16) (Vacuolar proton pump 16 kDa proteolipid subunit c),Mus musculus (Mouse),86.2,152.0,6e-61,235.0,sp|P63082|VATL_MOUSE V-type proton ATPase 16 kDa proteolipid subunit c OS=Mus musculus OX=10090 GN=Atp6v0c PE=1 SV=1,GO:0000220; GO:0007035; GO:0007042; GO:0008553; GO:0016471; GO:0030177; GO:0030665; GO:0030672; GO:0031625; GO:0033176; GO:0033179; GO:0046961; GO:0097401,lysosomal lumen acidification [GO:0007042]; positive regulation of Wnt signaling pathway [GO:0030177]; synaptic vesicle lumen acidification [GO:0097401]; vacuolar acidification [GO:0007035],"clathrin-coated vesicle membrane [GO:0030665]; proton-transporting V-type ATPase complex [GO:0033176]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]","P-type proton-exporting transporter activity [GO:0008553]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ubiquitin protein ligase binding [GO:0031625]",GO:0005215; GO:0055085; GO:0140657,transporter activity; transmembrane transport; ATP-dependent activity
OG_05593,FUN_025100-T1,Peve_00038383,Pocillopora_meandrina_HIv1___RNAseq.g19443.t1,three_way,68.198,FUN_025100-T1,Q8C8U0,,,,,33.6,961.0,3.5e-107,391.0,sp|Q8C8U0|LIPB1_MOUSE Liprin-beta-1 OS=Mus musculus OX=10090 GN=Ppfibp1 PE=1 SV=3,,,,,,
OG_05594,FUN_025108-T1,Peve_00038376,Pocillopora_meandrina_HIv1___RNAseq.g19430.t1,three_way,83.12366666666667,FUN_025108-T1,P41252,SYIC_HUMAN,,"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)",Homo sapiens (Human),62.5,1157.0,0.0,1500.3,"sp|P41252|SYIC_HUMAN Isoleucine--tRNA ligase, cytoplasmic OS=Homo sapiens OX=9606 GN=IARS1 PE=1 SV=2",GO:0000049; GO:0001649; GO:0002161; GO:0004822; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006418; GO:0006428; GO:0016020; GO:0017101; GO:0051020; GO:0070062,isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654],aminoacyl-tRNA deacylase activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005654; GO:0005829; GO:0006399; GO:0006520; GO:0016874; GO:0030154; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; cytosol; tRNA metabolic process; amino acid metabolic process; ligase activity; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_05595,FUN_025109-T1,Peve_00038375,Pocillopora_meandrina_HIv1___RNAseq.g19429.t1,three_way,81.03466666666667,FUN_025109-T1,P23935,,,,,54.4,114.0,4.2e-27,122.1,sp|P23935|NDUA5_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 OS=Bos taurus OX=9913 GN=NDUFA5 PE=1 SV=3,,,,,,
OG_05596,FUN_025110-T1,Peve_00038374,Pocillopora_meandrina_HIv1___RNAseq.g19428.t1,three_way,40.1995,,,,,,,,,,,,,,,,,
OG_05597,FUN_025113-T1,Peve_00038373,Pocillopora_meandrina_HIv1___RNAseq.g19427.t1,three_way,60.751333333333335,FUN_025113-T1,B7FF09,,,,,31.2,474.0,1.7e-40,168.7,sp|B7FF09|WDY_DROWI WD repeat-containing protein on Y chromosome OS=Drosophila willistoni OX=7260 GN=WDY PE=4 SV=1,,,,,,
OG_05598,FUN_025116-T1,Peve_00038372,Pocillopora_meandrina_HIv1___RNAseq.g19426.t1,three_way,74.80733333333333,FUN_025116-T1,Q5C9L6,CNMT_THLFG,,(S)-coclaurine N-methyltransferase (TfCNMT) (EC 2.1.1.140),Thalictrum flavum subsp. glaucum (Yellow meadow rue),38.8,317.0,2.2e-63,244.2,sp|Q5C9L6|CNMT_THLFG (S)-coclaurine N-methyltransferase OS=Thalictrum flavum subsp. glaucum OX=150095 GN=fCNMT PE=1 SV=1,GO:0005737; GO:0030794; GO:0032259,methylation [GO:0032259],cytoplasm [GO:0005737],(S)-coclaurine-N-methyltransferase activity [GO:0030794],GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_05599,FUN_025140-T1,Peve_00020870,Pocillopora_meandrina_HIv1___RNAseq.g19432.t1,three_way,82.82633333333334,FUN_025140-T1,Q14135,,,,,29.6,287.0,6.5e-11,69.3,sp|Q14135|VGLL4_HUMAN Transcription cofactor vestigial-like protein 4 OS=Homo sapiens OX=9606 GN=VGLL4 PE=1 SV=5,,,,,,
OG_05600,FUN_025144-T2,Peve_00020871,Pocillopora_meandrina_HIv1___RNAseq.g19433.t2,three_way,60.54366666666667,FUN_025144-T2,O75665,OFD1_HUMAN,,Centriole and centriolar satellite protein OFD1 (Oral-facial-digital syndrome 1 protein) (Protein 71-7A),Homo sapiens (Human),35.2,355.0,3.8e-40,167.9,sp|O75665|OFD1_HUMAN Centriole and centriolar satellite protein OFD1 OS=Homo sapiens OX=9606 GN=OFD1 PE=1 SV=1,GO:0005576; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0010172; GO:0016020; GO:0031514; GO:0034451; GO:0035082; GO:0036064; GO:0042802; GO:0043014; GO:0043015; GO:0060090; GO:0060271; GO:0060287; GO:2000314,axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000314],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; motile cilium [GO:0031514]; nucleus [GO:0005634],alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],GO:0005576; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0043226; GO:0044782; GO:0060090,extracellular region; nucleus; microtubule organizing center; cytosol; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; organelle; cilium organization; molecular adaptor activity
OG_05601,FUN_025233-T1,Peve_00034838,Pocillopora_meandrina_HIv1___RNAseq.g13605.t1,three_way,74.29116666666667,FUN_025233-T1,P49916,DNLI3_HUMAN,,DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3),Homo sapiens (Human),56.4,922.0,2.1e-265,916.8,sp|P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2,GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006273; GO:0006284; GO:0006287; GO:0006302; GO:0007005; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681,"base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]",DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006310; GO:0007005; GO:0016874; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; DNA recombination; mitochondrion organization; ligase activity; organelle; catalytic activity, acting on DNA"
OG_05602,FUN_025259-T1,Peve_00031195,Pocillopora_meandrina_HIv1___TS.g2586.t1,three_way,76.54266666666668,FUN_025259-T1,Q8NCX0,,,,,27.3,956.0,1.9e-10,70.1,sp|Q8NCX0|CC150_HUMAN Coiled-coil domain-containing protein 150 OS=Homo sapiens OX=9606 GN=CCDC150 PE=1 SV=2,,,,,,
OG_05603,FUN_025260-T1,Peve_00031287,Pocillopora_meandrina_HIv1___RNAseq.g13591.t1,three_way,87.201,FUN_025260-T1,Q5W041,ARMC3_HUMAN,,Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1),Homo sapiens (Human),51.8,871.0,3.1e-103,377.9,sp|Q5W041|ARMC3_HUMAN Armadillo repeat-containing protein 3 OS=Homo sapiens OX=9606 GN=ARMC3 PE=1 SV=2,GO:0007286; GO:0030317; GO:0034517; GO:0070062,flagellated sperm motility [GO:0030317]; ribophagy [GO:0034517]; spermatid development [GO:0007286],extracellular exosome [GO:0070062],,GO:0006914; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,autophagy; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_05604,FUN_025261-T1,Peve_00014013,Pocillopora_meandrina_HIv1___RNAseq.g13588.t1,three_way,47.211666666666666,,,,,,,,,,,,,,,,,
OG_05605,FUN_025263-T1,Peve_00014011,Pocillopora_meandrina_HIv1___RNAseq.g13585.t1,three_way,79.685,FUN_025263-T1,Q12962,TAF10_HUMAN,,Transcription initiation factor TFIID subunit 10 (STAF28) (Transcription initiation factor TFIID 30 kDa subunit) (TAF(II)30) (TAFII-30) (TAFII30),Homo sapiens (Human),68.4,117.0,2e-40,166.8,sp|Q12962|TAF10_HUMAN Transcription initiation factor TFIID subunit 10 OS=Homo sapiens OX=9606 GN=TAF10 PE=1 SV=1,GO:0000082; GO:0000124; GO:0001673; GO:0001756; GO:0001892; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005737; GO:0006282; GO:0006338; GO:0006352; GO:0006355; GO:0006357; GO:0006366; GO:0006367; GO:0006915; GO:0016251; GO:0019899; GO:0030331; GO:0033276; GO:0035264; GO:0036285; GO:0042789; GO:0042802; GO:0043484; GO:0045893; GO:0048371; GO:0048471; GO:0051123; GO:0060173; GO:0060261; GO:0070063; GO:0070365; GO:0097550; GO:1905069; GO:1990841,allantois development [GO:1905069]; apoptotic process [GO:0006915]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; embryonic placenta development [GO:0001892]; G1/S transition of mitotic cell cycle [GO:0000082]; hepatocyte differentiation [GO:0070365]; lateral mesodermal cell differentiation [GO:0048371]; limb development [GO:0060173]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organism growth [GO:0035264]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; SAGA complex assembly [GO:0036285]; somitogenesis [GO:0001756]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SAGA complex [GO:0000124]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; transcription preinitiation complex [GO:0097550],DNA binding [GO:0003677]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; nuclear estrogen receptor binding [GO:0030331]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase binding [GO:0070063]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006351; GO:0006355; GO:0012501; GO:0016071; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0140223,DNA binding; nucleus; nucleoplasm; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; mRNA metabolic process; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; general transcription initiation factor activity
OG_05606,FUN_025266-T1,Peve_00030516,Pocillopora_meandrina_HIv1___RNAseq.g13584.t1,three_way,92.62,FUN_025266-T1,O70475,,,,,71.9,481.0,2.8e-197,689.5,sp|O70475|UGDH_MOUSE UDP-glucose 6-dehydrogenase OS=Mus musculus OX=10090 GN=Ugdh PE=1 SV=1,,,,,,
OG_05607,FUN_025290-T1,Peve_00040964,Pocillopora_meandrina_HIv1___TS.g2613.t1,three_way,52.95733333333334,,,,,,,,,,,,,,,,,
OG_05608,FUN_025291-T1,Peve_00040962,Pocillopora_meandrina_HIv1___RNAseq.g13475.t1,three_way,54.800666666666665,,,,,,,,,,,,,,,,,
OG_05609,FUN_025294-T1,Peve_00040955,Pocillopora_meandrina_HIv1___RNAseq.g13469.t1,three_way,53.38583333333333,,,,,,,,,,,,,,,,,
OG_05610,FUN_025295-T1,Peve_00040954,Pocillopora_meandrina_HIv1___RNAseq.g13468.t1,three_way,62.326,,,,,,,,,,,,,,,,,
OG_05611,FUN_025296-T1,Peve_00001926,Pocillopora_meandrina_HIv1___RNAseq.g11490.t1,three_way,45.81016666666667,,,,,,,,,,,,,,,,,
OG_05612,FUN_025297-T1,Peve_00040951,Pocillopora_meandrina_HIv1___TS.g2463.t1,three_way,68.94166666666666,,,,,,,,,,,,,,,,,
OG_05613,FUN_025299-T1,Peve_00040950,Pocillopora_meandrina_HIv1___RNAseq.g13465.t1,three_way,63.21666666666667,,,,,,,,,,,,,,,,,
OG_05614,FUN_025302-T1,Peve_00040947,Pocillopora_meandrina_HIv1___RNAseq.g13462.t1,three_way,63.404,FUN_025302-T1,Q08DT6,,,,,55.0,109.0,1.1e-22,108.2,sp|Q08DT6|RM47_BOVIN Large ribosomal subunit protein uL29m OS=Bos taurus OX=9913 GN=MRPL47 PE=2 SV=1,,,,,,
OG_05615,FUN_025303-T1,Peve_00040953,Pocillopora_meandrina_HIv1___TS.g2457.t1,three_way,67.70566666666667,FUN_025303-T1,Q08AW4,,,,,50.0,242.0,8.900000000000001e-67,256.5,sp|Q08AW4|PKHM3_XENLA Pleckstrin homology domain-containing family M member 3 OS=Xenopus laevis OX=8355 GN=plekhm3 PE=2 SV=1,,,,,,
OG_05616,FUN_025304-T1,Peve_00040949,Pocillopora_meandrina_HIv1___RNAseq.g13460.t1,three_way,85.93833333333333,FUN_025304-T1,Q9I7S6,,,,,53.0,372.0,3.1e-112,407.1,"sp|Q9I7S6|PDE9A_DROME High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A OS=Drosophila melanogaster OX=7227 GN=Pde9 PE=2 SV=2",,,,,,
OG_05617,FUN_025306-T1,Peve_00027097,Pocillopora_meandrina_HIv1___RNAseq.g13454.t1,three_way,78.10933333333332,FUN_025306-T1,Q95R48,,,,,28.5,396.0,5.8e-38,159.8,sp|Q95R48|OCTL_DROME Organic cation transporter-like protein OS=Drosophila melanogaster OX=7227 GN=Orct2 PE=2 SV=2,,,,,,
OG_05618,FUN_025308-T1,Peve_00027048,Pocillopora_meandrina_HIv1___RNAseq.g13453.t1,three_way,61.894,,,,,,,,,,,,,,,,,
OG_05619,FUN_025309-T1,Peve_00027055,Pocillopora_meandrina_HIv1___RNAseq.g13452.t2,three_way,92.745,FUN_025309-T1,Q9XT54,,,,,80.8,146.0,2.0000000000000002e-66,253.1,"sp|Q9XT54|PDE6D_CANLF Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta OS=Canis lupus familiaris OX=9615 GN=PDE6D PE=2 SV=1",,,,,,
OG_05620,FUN_025310-T1,Peve_00027063,Pocillopora_meandrina_HIv1___RNAseq.g13451.t1,three_way,53.777,,,,,,,,,,,,,,,,,
OG_05621,FUN_025314-T1,Peve_00027075,Pocillopora_meandrina_HIv1___RNAseq.g13449.t1,three_way,74.45566666666667,FUN_025314-T1,Q5U458,DJC11_MOUSE,,DnaJ homolog subfamily C member 11,Mus musculus (Mouse),47.5,558.0,2e-135,484.2,sp|Q5U458|DJC11_MOUSE DnaJ homolog subfamily C member 11 OS=Mus musculus OX=10090 GN=Dnajc11 PE=1 SV=2,GO:0001401; GO:0005739; GO:0005743; GO:0016607; GO:0042407; GO:0061617,cristae formation [GO:0042407],MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; SAM complex [GO:0001401],,GO:0005739; GO:0007005; GO:0043226; GO:0061024,mitochondrion; mitochondrion organization; organelle; membrane organization
OG_05622,FUN_025315-T1,Peve_00027083,Pocillopora_meandrina_HIv1___RNAseq.g13448.t1,three_way,79.72466666666666,FUN_025315-T1,P30038,AL4A1_HUMAN,,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)",Homo sapiens (Human),55.4,552.0,1.2e-183,644.4,"sp|P30038|AL4A1_HUMAN Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ALDH4A1 PE=1 SV=3",GO:0003842; GO:0004029; GO:0005739; GO:0005759; GO:0005829; GO:0006560; GO:0006562; GO:0009055; GO:0010133; GO:0019470; GO:0042802,4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_05623,FUN_025317-T1,Peve_00027085,Pocillopora_meandrina_HIv1___RNAseq.g13426.t1,three_way,77.72999999999999,FUN_025317-T1,Q92685,ALG3_HUMAN,,"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein)",Homo sapiens (Human),57.3,403.0,6.1e-119,429.1,"sp|Q92685|ALG3_HUMAN Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase OS=Homo sapiens OX=9606 GN=ALG3 PE=1 SV=1",GO:0000033; GO:0005783; GO:0005789; GO:0006486; GO:0006487; GO:0006488; GO:0052925; GO:0098553,dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553],"alpha-1,3-mannosyltransferase activity [GO:0000033]; dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity [GO:0052925]",GO:0003824; GO:0005783; GO:0006486; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; protein glycosylation; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_05624,FUN_025318-T1,Peve_00027086,Pocillopora_meandrina_HIv1___RNAseq.14712_t,three_way,59.059000000000005,,,,,,,,,,,,,,,,,
OG_05625,FUN_025319-T1,Peve_00027087,Pocillopora_meandrina_HIv1___RNAseq.g13424.t1,three_way,92.1145,FUN_025319-T1,P67827,KC1A_BOVIN,,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),Bos taurus (Bovine),92.5,280.0,1.9e-152,540.0,sp|P67827|KC1A_BOVIN Casein kinase I isoform alpha OS=Bos taurus OX=9913 GN=CSNK1A1 PE=1 SV=1,GO:0000139; GO:0000776; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005819; GO:0006468; GO:0007165; GO:0016055; GO:0016607; GO:0018105; GO:0036064; GO:0045104; GO:0051301; GO:0090090; GO:0106310; GO:1900226,cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; kinetochore [GO:0000776]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spindle [GO:0005819],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05626,FUN_025321-T1,Peve_00027089,Pocillopora_meandrina_HIv1___RNAseq.g13423.t1,three_way,58.5,,,,,,,,,,,,,,,,,
OG_05627,FUN_025322-T1,Peve_00027091,Pocillopora_meandrina_HIv1___RNAseq.g13422.t1,three_way,87.86033333333333,FUN_025322-T1,Q6PAX2,,,,,62.0,574.0,2.0000000000000003e-165,583.9,sp|Q6PAX2|ATD3B_XENLA ATPase family AAA domain-containing protein 3-B OS=Xenopus laevis OX=8355 GN=atad3-b PE=2 SV=1,,,,,,
OG_05628,FUN_025323-T1,Peve_00027092,Pocillopora_meandrina_HIv1___RNAseq.g13421.t1,three_way,91.80316666666668,FUN_025323-T1,P63026,VAMP2_BOVIN,,Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2),Bos taurus (Bovine),87.5,32.0,3.6e-07,55.8,sp|P63026|VAMP2_BOVIN Vesicle-associated membrane protein 2 OS=Bos taurus OX=9913 GN=VAMP2 PE=1 SV=2,GO:0005484; GO:0005765; GO:0005886; GO:0005901; GO:0006906; GO:0007165; GO:0016079; GO:0017004; GO:0017075; GO:0019905; GO:0030672; GO:0031201; GO:0031580; GO:0031982; GO:0035493; GO:0042311; GO:0048488; GO:1902259,cytochrome complex assembly [GO:0017004]; membrane raft distribution [GO:0031580]; regulation of delayed rectifier potassium channel activity [GO:1902259]; signal transduction [GO:0007165]; SNARE complex assembly [GO:0035493]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; vasodilation [GO:0042311]; vesicle fusion [GO:0006906],caveola [GO:0005901]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; vesicle [GO:0031982],SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075],GO:0003013; GO:0005886; GO:0016192; GO:0043226; GO:0060090; GO:0061024; GO:0065003,circulatory system process; plasma membrane; vesicle-mediated transport; organelle; molecular adaptor activity; membrane organization; protein-containing complex assembly
OG_05629,FUN_025324-T1,Peve_00027096,Pocillopora_meandrina_HIv1___RNAseq.g13420.t1,three_way,68.96249999999999,FUN_025324-T1,Q9Y6Y1,CMTA1_HUMAN,,Calmodulin-binding transcription activator 1,Homo sapiens (Human),29.5,1137.0,2.1e-90,335.9,sp|Q9Y6Y1|CMTA1_HUMAN Calmodulin-binding transcription activator 1 OS=Homo sapiens OX=9606 GN=CAMTA1 PE=1 SV=4,GO:0003690; GO:0003712; GO:0005634; GO:0005737; GO:0006357; GO:0043565; GO:0045944; GO:0050885; GO:0070886,neuromuscular process controlling balance [GO:0050885]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712],GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; nervous system process; molecular adaptor activity; transcription regulator activity
OG_05630,FUN_025325-T1,Peve_00027073,Pocillopora_meandrina_HIv1___RNAseq.g13419.t1,three_way,77.61399999999999,FUN_025325-T1,Q02360,,,,,49.5,107.0,1.9e-22,108.2,sp|Q02360|FOXL1_DROME Fork head domain-containing protein L1 OS=Drosophila melanogaster OX=7227 GN=FoxL1 PE=1 SV=2,,,,,,
OG_05631,FUN_025328-T1,Peve_00027062,Pocillopora_meandrina_HIv1___RNAseq.g13406.t1,three_way,70.02683333333333,FUN_025328-T1,Q9H3D4,,,,,34.9,272.0,1.2e-35,152.5,sp|Q9H3D4|P63_HUMAN Tumor protein 63 OS=Homo sapiens OX=9606 GN=TP63 PE=1 SV=1,,,,,,
OG_05632,FUN_025330-T1,Peve_00027061,Pocillopora_meandrina_HIv1___RNAseq.g13405.t1,three_way,58.849,,,,,,,,,,,,,,,,,
OG_05633,FUN_025331-T1,Peve_00027057,Pocillopora_meandrina_HIv1___RNAseq.g13404.t2,three_way,84.81166666666667,FUN_025331-T1,Q5F499,OPA1_CHICK,,"Dynamin-like GTPase OPA1, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like GTPase OPA1, long form (L-OPA1); Dynamin-like GTPase OPA1, short form (S-OPA1)]",Gallus gallus (Chicken),53.5,939.0,5.1999999999999995e-264,912.1,"sp|Q5F499|OPA1_CHICK Dynamin-like GTPase OPA1, mitochondrial OS=Gallus gallus OX=9031 GN=OPA1 PE=2 SV=1",GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005743; GO:0005758; GO:0005874; GO:0006897; GO:0006915; GO:0008017; GO:0008053; GO:0016559; GO:0031966; GO:0032740; GO:0046039; GO:0046872; GO:0048312; GO:0070300; GO:0097749; GO:0140523; GO:0180020; GO:1901612; GO:1990627; GO:2000330,apoptotic process [GO:0006915]; endocytosis [GO:0006897]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrial inner membrane fusion [GO:1990627]; peroxisome fission [GO:0016559]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330],cytoplasm [GO:0005737]; microtubule [GO:0005874]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966],cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; membrane bending activity [GO:0180020]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300],GO:0003824; GO:0003924; GO:0007005; GO:0008092; GO:0008289; GO:0012501; GO:0016192; GO:0016787; GO:0055086; GO:0061024; GO:1901135,catalytic activity; GTPase activity; mitochondrion organization; cytoskeletal protein binding; lipid binding; programmed cell death; vesicle-mediated transport; hydrolase activity; nucleobase-containing small molecule metabolic process; membrane organization; carbohydrate derivative metabolic process
OG_05634,FUN_025333-T1,Peve_00027056,Pocillopora_meandrina_HIv1___TS.g2396.t1,three_way,44.92166666666667,,,,,,,,,,,,,,,,,
OG_05635,FUN_025334-T1,Peve_00027054,Pocillopora_meandrina_HIv1___RNAseq.g13401.t1,three_way,57.558,,,,,,,,,,,,,,,,,
OG_05636,FUN_025335-T1,Peve_00027053,Pocillopora_meandrina_HIv1___RNAseq.g13400.t1,three_way,76.48966666666666,FUN_025335-T1,Q5ZK62,ACAP2_CHICK,,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)",Gallus gallus (Chicken),42.7,858.0,2.3e-170,600.9,"sp|Q5ZK62|ACAP2_CHICK Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ACAP2 PE=2 SV=1",GO:0005096; GO:0005886; GO:0008270; GO:0010008; GO:0032456; GO:1990090,cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456],endosome membrane [GO:0010008]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005886; GO:0016192; GO:0098772,plasma membrane; vesicle-mediated transport; molecular function regulator activity
OG_05637,FUN_025338-T2,Peve_00000776,Pocillopora_meandrina_HIv1___RNAseq.g24106.t1,three_way,62.506,,,,,,,,,,,,,,,,,
OG_05638,FUN_025342-T1,Peve_00027052,Pocillopora_meandrina_HIv1___RNAseq.g13380.t1,three_way,69.806,FUN_025342-T1,Q7RYI0,,,,,42.1,57.0,4.4e-06,52.4,sp|Q7RYI0|MIC10_NEUCR MICOS complex subunit mic10 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=mic10 PE=3 SV=1,,,,,,
OG_05639,FUN_025343-T1,Peve_00027051,Pocillopora_meandrina_HIv1___RNAseq.g13379.t1,three_way,83.50133333333333,FUN_025343-T1,P13732,,,,,66.7,93.0,9.900000000000001e-30,130.6,sp|P13732|RL22_TRIGR Large ribosomal subunit protein eL22 OS=Tripneustes gratilla OX=7673 GN=RPL22 PE=2 SV=1,,,,,,
OG_05640,FUN_025348-T1,Peve_00004327,Pocillopora_meandrina_HIv1___TS.g2360.t1a,three_way,40.693666666666665,,,,,,,,,,,,,,,,,
OG_05641,FUN_025350-T1,Peve_00004325,Pocillopora_meandrina_HIv1___RNAseq.g13374.t1,three_way,91.94633333333331,FUN_025350-T1,Q5RKQ0,,,,,63.2,204.0,2.8e-71,270.4,sp|Q5RKQ0|SPF27_DANRE Pre-mRNA-splicing factor SPF27 OS=Danio rerio OX=7955 GN=bcas2 PE=2 SV=1,,,,,,
OG_05642,FUN_025360-T2,Peve_00040525,Pocillopora_meandrina_HIv1___TS.g2350.t1,three_way,61.20066666666667,FUN_025360-T2,P54001,,,,,41.7,511.0,1.2e-100,368.6,sp|P54001|P4HA1_RAT Prolyl 4-hydroxylase subunit alpha-1 OS=Rattus norvegicus OX=10116 GN=P4ha1 PE=2 SV=2,,,,,,
OG_05643,FUN_025361-T1,Peve_00040526,Pocillopora_meandrina_HIv1___RNAseq.14643_t,three_way,74.309,FUN_025361-T1,P10160,,,,,69.3,153.0,2.4e-57,223.0,sp|P10160|IF5A1_RABIT Eukaryotic translation initiation factor 5A-1 OS=Oryctolagus cuniculus OX=9986 GN=EIF5A PE=1 SV=2,,,,,,
OG_05644,FUN_025362-T1,Peve_00040527,Pocillopora_meandrina_HIv1___RNAseq.g13347.t1,three_way,93.85966666666668,FUN_025362-T1,Q5PQN7,,,,,68.9,190.0,6.3e-62,238.8,sp|Q5PQN7|LZIC_RAT Protein LZIC OS=Rattus norvegicus OX=10116 GN=Lzic PE=2 SV=1,,,,,,
OG_05645,FUN_025363-T1,Peve_00040516,Pocillopora_meandrina_HIv1___RNAseq.g13346.t1,three_way,65.52933333333334,FUN_025363-T1,Q9ER65,CSTN2_MOUSE,,Calsyntenin-2,Mus musculus (Mouse),27.8,856.0,4.6e-77,291.2,sp|Q9ER65|CSTN2_MOUSE Calsyntenin-2 OS=Mus musculus OX=10090 GN=Clstn2 PE=1 SV=2,GO:0000139; GO:0005509; GO:0005789; GO:0007156; GO:0008306; GO:0009986; GO:0014069; GO:0030425; GO:0045211; GO:0050806; GO:0051965; GO:0098839; GO:0098978; GO:1904862,associative learning [GO:0008306]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inhibitory synapse assembly [GO:1904862]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806],cell surface [GO:0009986]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211],calcium ion binding [GO:0005509],GO:0007155; GO:0034330; GO:0043226; GO:0050877,cell adhesion; cell junction organization; organelle; nervous system process
OG_05646,FUN_025364-T1,Peve_00040517,Pocillopora_meandrina_HIv1___RNAseq.g13345.t1,three_way,58.62533333333333,FUN_025364-T1,Q54PR9,CF60_DICDI,,Counting factor 60,Dictyostelium discoideum (Social amoeba),25.8,414.0,3.9e-21,104.4,sp|Q54PR9|CF60_DICDI Counting factor 60 OS=Dictyostelium discoideum OX=44689 GN=cf60 PE=1 SV=1,GO:0005576; GO:0016791; GO:0031158,negative regulation of aggregate size involved in sorocarp development [GO:0031158],extracellular region [GO:0005576],phosphatase activity [GO:0016791],GO:0003824; GO:0005576; GO:0016787,catalytic activity; extracellular region; hydrolase activity
OG_05647,FUN_025365-T1,Peve_00040518,Pocillopora_meandrina_HIv1___RNAseq.g13333.t1,three_way,68.1275,FUN_025365-T1,Q62504,MINT_MOUSE,,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),Mus musculus (Mouse),40.8,610.0,6.4e-84,314.3,sp|Q62504|MINT_MOUSE Msx2-interacting protein OS=Mus musculus OX=10090 GN=Spen PE=1 SV=2,GO:0003697; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0007219; GO:0045892; GO:0045893; GO:0060816,negative regulation of DNA-templated transcription [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; random inactivation of X chromosome [GO:0060816],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; RNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_05647,FUN_025365-T1,Peve_00040518,Pocillopora_meandrina_HIv1___RNAseq.g13333.t1,three_way,68.1275,FUN_025365-T1,Q62504,MINT_MOUSE,,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),Mus musculus (Mouse),61.2,188.0,5.7e-56,221.5,sp|Q62504|MINT_MOUSE Msx2-interacting protein OS=Mus musculus OX=10090 GN=Spen PE=1 SV=2,GO:0003697; GO:0003700; GO:0003714; GO:0003723; GO:0005634; GO:0007219; GO:0045892; GO:0045893; GO:0060816,negative regulation of DNA-templated transcription [GO:0045892]; Notch signaling pathway [GO:0007219]; positive regulation of DNA-templated transcription [GO:0045893]; random inactivation of X chromosome [GO:0060816],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; RNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_05648,FUN_025368-T1,Peve_00040520,Pocillopora_meandrina_HIv1___RNAseq.g13331.t1,three_way,95.874,FUN_025368-T1,Q6PH57,,,,,91.4,339.0,2.9e-140,499.6,sp|Q6PH57|GBB1_DANRE Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 OS=Danio rerio OX=7955 GN=gnb1 PE=2 SV=1,,,,,,
OG_05649,FUN_025372-T1,Peve_00040522,Pocillopora_meandrina_HIv1___RNAseq.g13329.t1,three_way,85.562,FUN_025372-T1,Q92997,DVL3_HUMAN,,Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3),Homo sapiens (Human),61.0,485.0,3.2e-124,447.2,sp|Q92997|DVL3_HUMAN Segment polarity protein dishevelled homolog DVL-3 OS=Homo sapiens OX=9606 GN=DVL3 PE=1 SV=2,GO:0000785; GO:0002020; GO:0005102; GO:0005109; GO:0005829; GO:0008013; GO:0009410; GO:0031267; GO:0032880; GO:0032956; GO:0035556; GO:0035567; GO:0043547; GO:0045893; GO:0045944; GO:0046330; GO:0050821; GO:0060070; GO:0060071; GO:0150012,"canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein localization [GO:0032880]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",chromatin [GO:0000785]; cytosol [GO:0005829],beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267],GO:0005829; GO:0006355,cytosol; regulation of DNA-templated transcription
OG_05650,FUN_025373-T1,Peve_00040523,Pocillopora_meandrina_HIv1___RNAseq.g13328.t1,three_way,60.128166666666665,FUN_025373-T1,A1L0Y2,,,,,39.5,1520.0,7.3e-307,1055.0,sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1,,,,,,
OG_05651,FUN_025392-T1,Peve_00031005,Pocillopora_meandrina_HIv1___RNAseq.g13301.t1,three_way,65.45566666666666,FUN_025392-T1,Q98943,,,,,29.5,434.0,2.5e-45,184.5,sp|Q98943|CASP2_CHICK Caspase-2 OS=Gallus gallus OX=9031 GN=CASP2 PE=2 SV=2,,,,,,
OG_05652,FUN_025393-T1,Peve_00031004,Pocillopora_meandrina_HIv1___RNAseq.g13303.t1,three_way,60.83166666666666,FUN_025393-T1,Q9NH13,,,,,29.0,352.0,1.2e-32,142.9,sp|Q9NH13|RP43_RIFPA Exoskeleton protein RP43 OS=Riftia pachyptila OX=6426 PE=1 SV=1,,,,,,
OG_05653,FUN_025394-T1,Peve_00017051,Pocillopora_meandrina_HIv1___RNAseq.g13304.t1,three_way,67.56833333333333,,,,,,,,,,,,,,,,,
OG_05654,FUN_025403-T1,Peve_00026689,Pocillopora_meandrina_HIv1___RNAseq.g13308.t1,three_way,71.69633333333334,FUN_025403-T1,Q7SXN5,DNM1L_DANRE,,Dynamin-1-like protein (EC 3.6.5.5),Danio rerio (Zebrafish) (Brachydanio rerio),21.1,701.0,1.2e-07,60.1,sp|Q7SXN5|DNM1L_DANRE Dynamin-1-like protein OS=Danio rerio OX=7955 GN=dnm1l PE=2 SV=1,GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0008017; GO:0008289; GO:0016020; GO:0016559; GO:0030672; GO:0042803; GO:0043653; GO:0048312; GO:0048511; GO:0051259,endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; rhythmic process [GO:0048511],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0065003,catalytic activity; GTPase activity; mitochondrion; peroxisome; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; protein-containing complex assembly
OG_05655,FUN_025410-T1,Peve_00017348,Pocillopora_meandrina_HIv1___RNAseq.14602_t,three_way,53.36533333333333,,,,,,,,,,,,,,,,,
OG_05656,FUN_025411-T1,Peve_00017349,Pocillopora_meandrina_HIv1___RNAseq.g13310.t1,three_way,63.414,FUN_025411-T1,C3ZQF9,,,,,24.0,313.0,5e-17,90.1,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_05657,FUN_025412-T1,Peve_00030580,Pocillopora_meandrina_HIv1___RNAseq.g13312.t1,three_way,88.07566666666666,FUN_025412-T1,Q3MHN0,PSB6_BOVIN,,Proteasome subunit beta type-6 (EC 3.4.25.1),Bos taurus (Bovine),69.7,208.0,1.3e-83,310.8,sp|Q3MHN0|PSB6_BOVIN Proteasome subunit beta type-6 OS=Bos taurus OX=9913 GN=PSMB6 PE=1 SV=1,GO:0004175; GO:0004298; GO:0005634; GO:0005829; GO:0005839; GO:0019774; GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]",endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_05658,FUN_025425-T1,Peve_00030588,Pocillopora_meandrina_HIv1___RNAseq.g13315.t1,three_way,80.68633333333334,,,,,,,,,,,,,,,,,
OG_05659,FUN_025426-T1,Peve_00030587,Pocillopora_meandrina_HIv1___RNAseq.g13320.t1,three_way,57.10866666666667,FUN_025426-T1,Q3U4G3,XXLT1_MOUSE,,"Xyloside xylosyltransferase 1 (EC 2.4.2.62) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)",Mus musculus (Mouse),42.8,306.0,1e-73,278.9,sp|Q3U4G3|XXLT1_MOUSE Xyloside xylosyltransferase 1 OS=Mus musculus OX=10090 GN=Xxylt1 PE=1 SV=2,GO:0000287; GO:0005789; GO:0016266; GO:0030145; GO:0035252; GO:0140560,O-glycan processing [GO:0016266],endoplasmic reticulum membrane [GO:0005789],"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; UDP-xylosyltransferase activity [GO:0035252]; xylosyl alpha-1,3-xylosyltransferase activity [GO:0140560]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_05660,FUN_025427-T1,Peve_00030586,Pocillopora_meandrina_HIv1___RNAseq.g13321.t1,three_way,62.47633333333333,FUN_025427-T1,P82649,,,,,46.5,282.0,7.1e-64,245.7,sp|P82649|RT22_BOVIN Small ribosomal subunit protein mS22 OS=Bos taurus OX=9913 GN=MRPS22 PE=1 SV=2,,,,,,
OG_05661,FUN_025430-T2,Peve_00030583,Pocillopora_meandrina_HIv1___RNAseq.g13324.t1,three_way,80.823,FUN_025430-T2,Q3ZBV2,DD19A_BOVIN,,ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DEAD box protein 19A),Bos taurus (Bovine),64.6,418.0,8.7e-162,571.6,sp|Q3ZBV2|DD19A_BOVIN ATP-dependent RNA helicase DDX19A OS=Bos taurus OX=9913 GN=DDX19A PE=2 SV=1,GO:0003724; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0010494; GO:0016887; GO:0016973,poly(A)+ mRNA export from nucleus [GO:0016973],cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006913; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleocytoplasmic transport; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05662,FUN_025431-T1,Peve_00034116,Pocillopora_meandrina_HIv1___RNAseq.g13326.t1,three_way,68.45533333333333,FUN_025431-T1,A0A0R4IB93,UBP48_DANRE,,Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Ubiquitin specific peptidase 48),Danio rerio (Zebrafish) (Brachydanio rerio),41.9,1141.0,1.6999999999999996e-242,840.9,sp|A0A0R4IB93|UBP48_DANRE Ubiquitin carboxyl-terminal hydrolase 48 OS=Danio rerio OX=7955 GN=usp48 PE=3 SV=1,GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006508; GO:0016579; GO:0031647; GO:1904888,cranial skeletal system development [GO:1904888]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_05663,FUN_025432-T1,Peve_00029489,Pocillopora_meandrina_HIv1___RNAseq.g13327.t1,three_way,51.88183333333333,,,,,,,,,,,,,,,,,
OG_05664,FUN_025438-T1,Peve_00029483,Pocillopora_meandrina_HIv1___RNAseq.g13296.t1,three_way,38.040333333333336,,,,,,,,,,,,,,,,,
OG_05665,FUN_025439-T1,Peve_00029480,Pocillopora_meandrina_HIv1___RNAseq.g13295.t1,three_way,42.21083333333333,FUN_025439-T1,P14780,MMP9_HUMAN,,Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9],Homo sapiens (Human),49.1,57.0,1.6e-08,62.8,sp|P14780|MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens OX=9606 GN=MMP9 PE=1 SV=3,GO:0001501; GO:0001934; GO:0004175; GO:0004222; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0006915; GO:0007566; GO:0008233; GO:0008237; GO:0008270; GO:0016477; GO:0022617; GO:0030198; GO:0030225; GO:0030574; GO:0035987; GO:0042802; GO:0043065; GO:0043066; GO:0043388; GO:0045742; GO:0048013; GO:0051549; GO:0062023; GO:0070062; GO:0071222; GO:0071492; GO:0090200; GO:0150077; GO:1900122; GO:1904645; GO:1904707; GO:1904724; GO:1904813; GO:2000697; GO:2001243; GO:2001258,apoptotic process [GO:0006915]; cell migration [GO:0016477]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; macrophage differentiation [GO:0030225]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501],collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724],collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0012501; GO:0016787; GO:0022414; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; extracellular space; programmed cell death; hydrolase activity; reproductive process; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_05666,FUN_025441-T1,Peve_00029478,Pocillopora_meandrina_HIv1___RNAseq.g13294.t1,three_way,72.48916666666666,FUN_025441-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),45.7,361.0,2.8e-94,349.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_05667,FUN_025443-T1,Peve_00029492,Pocillopora_meandrina_HIv1___RNAseq.g13293.t1,three_way,70.4805,FUN_025443-T1,Q68LP1,MIB2_RAT,,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Rattus norvegicus (Rat),42.2,1067.0,4.8e-146,520.4,sp|Q68LP1|MIB2_RAT E3 ubiquitin-protein ligase MIB2 OS=Rattus norvegicus OX=10116 GN=Mib2 PE=1 SV=2,GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005886; GO:0007219; GO:0008270; GO:0016567; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation protein catabolic process at postsynapse [GO:0140252],cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005886; GO:0008092; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; plasma membrane; cytoskeletal protein binding; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05668,FUN_025458-T1,Peve_00034350,Pocillopora_meandrina_HIv1___RNAseq.g13247.t1,three_way,91.296,FUN_025458-T1,Q6DFH9,,,,,71.7,180.0,1.4e-80,300.4,sp|Q6DFH9|NIP7_XENLA 60S ribosome subunit biogenesis protein NIP7 homolog OS=Xenopus laevis OX=8355 GN=nip7 PE=2 SV=1,,,,,,
OG_05669,FUN_025459-T1,Peve_00005466,Pocillopora_meandrina_HIv1___RNAseq.g13245.t1,three_way,94.06666666666666,FUN_025459-T1,Q2KJ93,CDC42_BOVIN,,Cell division control protein 42 homolog (EC 3.6.5.2),Bos taurus (Bovine),90.6,191.0,9e-99,360.9,sp|Q2KJ93|CDC42_BOVIN Cell division control protein 42 homolog OS=Bos taurus OX=9913 GN=CDC42 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005813; GO:0005886; GO:0006897; GO:0006911; GO:0007015; GO:0007165; GO:0007264; GO:0016020; GO:0019901; GO:0030010; GO:0030425; GO:0030496; GO:0031258; GO:0032467; GO:0034329; GO:0045198; GO:0048549; GO:0051233; GO:0051489; GO:0051491; GO:0051988; GO:0060997; GO:0072686; GO:1900026,"actin filament organization [GO:0007015]; cell junction assembly [GO:0034329]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of pinocytosis [GO:0048549]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005815; GO:0005886; GO:0007163; GO:0016192; GO:0016787; GO:0030154; GO:0034330; GO:0043226; GO:0061024; GO:0098772,catalytic activity; GTPase activity; microtubule organizing center; plasma membrane; establishment or maintenance of cell polarity; vesicle-mediated transport; hydrolase activity; cell differentiation; cell junction organization; organelle; membrane organization; molecular function regulator activity
OG_05670,FUN_025463-T1,Peve_00043840,Pocillopora_meandrina_HIv1___RNAseq.g13243.t1,three_way,97.54233333333332,FUN_025463-T1,Q5E9F9,PRS7_BOVIN,,26S proteasome regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2),Bos taurus (Bovine),92.2,434.0,7.399999999999999e-234,810.8,sp|Q5E9F9|PRS7_BOVIN 26S proteasome regulatory subunit 7 OS=Bos taurus OX=9913 GN=PSMC2 PE=2 SV=3,GO:0000502; GO:0000932; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0008540; GO:0016887; GO:0022624; GO:0036402; GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proteasome-activating activity [GO:0036402],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0016853; GO:0030163; GO:0043226; GO:0140657,catalytic activity; nucleus; cytosol; hydrolase activity; isomerase activity; protein catabolic process; organelle; ATP-dependent activity
OG_05671,FUN_025464-T1,Peve_00043839,Pocillopora_meandrina_HIv1___RNAseq.g13242.t1,three_way,70.53633333333333,FUN_025464-T1,P60763,RAC3_HUMAN,,Ras-related C3 botulinum toxin substrate 3 (EC 3.6.5.2) (p21-Rac3),Homo sapiens (Human),39.2,153.0,6.8e-23,111.7,sp|P60763|RAC3_HUMAN Ras-related C3 botulinum toxin substrate 3 OS=Homo sapiens OX=9606 GN=RAC3 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005789; GO:0005829; GO:0005856; GO:0005886; GO:0007015; GO:0007163; GO:0008045; GO:0008360; GO:0012505; GO:0014041; GO:0016055; GO:0016601; GO:0019901; GO:0021894; GO:0030027; GO:0030031; GO:0030036; GO:0030426; GO:0030865; GO:0031410; GO:0031941; GO:0032956; GO:0033630; GO:0035556; GO:0043005; GO:0043020; GO:0043025; GO:0045730; GO:0048306; GO:0048471; GO:0048873; GO:0050885; GO:0051932; GO:0060326; GO:0070062; GO:0071944; GO:0098794; GO:0098974; GO:0098978; GO:0150052; GO:1900026; GO:1902622,"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; cell chemotaxis [GO:0060326]; cell projection assembly [GO:0030031]; cerebral cortex GABAergic interneuron development [GO:0021894]; cortical cytoskeleton organization [GO:0030865]; establishment or maintenance of cell polarity [GO:0007163]; homeostasis of number of cells within a tissue [GO:0048873]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic actin cytoskeleton organization [GO:0098974]; Rac protein signal transduction [GO:0016601]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360]; regulation of neuron maturation [GO:0014041]; regulation of neutrophil migration [GO:1902622]; regulation of postsynapse assembly [GO:0150052]; respiratory burst [GO:0045730]; synaptic transmission, GABAergic [GO:0051932]; Wnt signaling pathway [GO:0016055]",cell periphery [GO:0071944]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; NADPH oxidase complex [GO:0043020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],calcium-dependent protein binding [GO:0048306]; G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0016787; GO:0023052; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0098772,catalytic activity; GTPase activity; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; hydrolase activity; signaling; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; nervous system process; molecular function regulator activity
OG_05672,FUN_025466-T1,Peve_00043837,Pocillopora_meandrina_HIv1___RNAseq.g13240.t1,three_way,86.86633333333333,FUN_025466-T1,Q8VDJ3,,,,,52.2,1291.0,0.0,1320.8,sp|Q8VDJ3|VIGLN_MOUSE Vigilin OS=Mus musculus OX=10090 GN=Hdlbp PE=1 SV=1,,,,,,
OG_05673,FUN_025503-T1,Peve_00016401,Pocillopora_meandrina_HIv1___RNAseq.g13229.t1,three_way,45.6685,,,,,,,,,,,,,,,,,
OG_05674,FUN_025504-T1,Peve_00040926,Pocillopora_meandrina_HIv1___RNAseq.g13217.t1,three_way,54.756166666666665,FUN_025504-T1,Q90X46,GP161_DANRE,,G-protein coupled receptor 161,Danio rerio (Zebrafish) (Brachydanio rerio),42.3,196.0,3.5e-33,144.8,sp|Q90X46|GP161_DANRE G-protein coupled receptor 161 OS=Danio rerio OX=7955 GN=gpr161 PE=2 SV=2,GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0007368; GO:0051924; GO:0055037; GO:0060170; GO:1901621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; determination of left/right symmetry [GO:0007368]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; regulation of calcium ion transport [GO:0051924],ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037],G protein-coupled receptor activity [GO:0004930],GO:0005768; GO:0005929; GO:0031410; GO:0043226; GO:0060089,endosome; cilium; cytoplasmic vesicle; organelle; molecular transducer activity
OG_05675,FUN_025505-T1,Peve_00040925,Pocillopora_meandrina_HIv1___RNAseq.g13216.t1,three_way,38.21266666666666,,,,,,,,,,,,,,,,,
OG_05676,FUN_025507-T1,Peve_00036821,Pocillopora_meandrina_HIv1___RNAseq.g13214.t1,three_way,61.089,FUN_025507-T1,P17124,,,,,30.4,280.0,6.5e-16,86.3,sp|P17124|HRH2_CANLF Histamine H2 receptor OS=Canis lupus familiaris OX=9615 GN=HRH2 PE=1 SV=1,,,,,,
OG_05677,FUN_025510-T1,Peve_00002253,Pocillopora_meandrina_HIv1___RNAseq.g13213.t1,three_way,72.42949999999999,,,,,,,,,,,,,,,,,
OG_05678,FUN_025511-T1,Peve_00002249,Pocillopora_meandrina_HIv1___RNAseq.g13212.t1,three_way,56.655,FUN_025511-T1,Q8TCQ1,MARH1_HUMAN,,E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING finger protein 171) (RING-type E3 ubiquitin transferase MARCHF1),Homo sapiens (Human),28.2,206.0,7.7e-14,79.7,sp|Q8TCQ1|MARH1_HUMAN E3 ubiquitin-protein ligase MARCHF1 OS=Homo sapiens OX=9606 GN=MARCHF1 PE=1 SV=1,GO:0000209; GO:0002495; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0043231; GO:0061630,antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"immune system process; catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05679,FUN_025516-T1,Peve_00002247,Pocillopora_meandrina_HIv1___RNAseq.g13210.t1,three_way,89.46916666666667,,,,,,,,,,,,,,,,,
OG_05680,FUN_025517-T1,Peve_00020632,Pocillopora_meandrina_HIv1___RNAseq.14497_t,three_way,51.73233333333334,,,,,,,,,,,,,,,,,
OG_05681,FUN_025518-T1,Peve_00031512,Pocillopora_meandrina_HIv1___RNAseq.g13207.t1,three_way,87.27499999999999,FUN_025518-T1,O95140,,,,,51.6,744.0,3.3999999999999997e-205,716.5,sp|O95140|MFN2_HUMAN Mitofusin-2 OS=Homo sapiens OX=9606 GN=MFN2 PE=1 SV=3,,,,,,
OG_05682,FUN_025519-T1,Peve_00024297,Pocillopora_meandrina_HIv1___RNAseq.g13206.t1,three_way,45.24616666666667,,,,,,,,,,,,,,,,,
OG_05683,FUN_025520-T1,Peve_00024301,Pocillopora_meandrina_HIv1___RNAseq.g13205.t1,three_way,68.23033333333333,,,,,,,,,,,,,,,,,
OG_05684,FUN_025527-T1,Peve_00009002,Pocillopora_meandrina_HIv1___RNAseq.g23047.t1,three_way,85.454,FUN_025527-T1,Q9D2N4,DTNA_MOUSE,,Dystrobrevin alpha (DTN-A) (Alpha-dystrobrevin),Mus musculus (Mouse),46.0,554.0,2.5e-117,424.1,sp|Q9D2N4|DTNA_MOUSE Dystrobrevin alpha OS=Mus musculus OX=10090 GN=Dtna PE=1 SV=2,GO:0005737; GO:0008270; GO:0016014; GO:0032991; GO:0042383; GO:0045202,,cytoplasm [GO:0005737]; dystrobrevin complex [GO:0016014]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202],zinc ion binding [GO:0008270],GO:0005886,plasma membrane
OG_05685,FUN_025530-T1,Peve_00009476,Pocillopora_meandrina_HIv1___TS.g2807.t1,three_way,91.53566666666669,FUN_025530-T1,Q5U395,,,,,73.8,244.0,2.7000000000000002e-104,379.8,sp|Q5U395|CNEPA_DANRE CTD nuclear envelope phosphatase 1A OS=Danio rerio OX=7955 GN=ctdnep1a PE=2 SV=1,,,,,,
OG_05686,FUN_025531-T1,Peve_00009475,Pocillopora_meandrina_HIv1___RNAseq.g13803.t1,three_way,43.56766666666667,,,,,,,,,,,,,,,,,
OG_05687,FUN_025538-T1,Peve_00013052,Pocillopora_meandrina_HIv1___RNAseq.g13802.t1,three_way,63.76133333333333,FUN_025538-T1,Q3SYU1,NOC2L_BOVIN,,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),Bos taurus (Bovine),39.7,491.0,3.2e-107,391.0,sp|Q3SYU1|NOC2L_BOVIN Nucleolar complex protein 2 homolog OS=Bos taurus OX=9913 GN=NOC2L PE=2 SV=1,GO:0000122; GO:0003714; GO:0005654; GO:0005730; GO:0006915; GO:0030690; GO:0030691; GO:0042273; GO:0042393,apoptotic process [GO:0006915]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273],Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005654; GO:0005730; GO:0006355; GO:0012501; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleoplasm; nucleolus; regulation of DNA-templated transcription; programmed cell death; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_05688,FUN_025539-T1,Peve_00013053,Pocillopora_meandrina_HIv1___RNAseq.g13801.t1,three_way,63.6775,FUN_025539-T1,O75381,PEX14_HUMAN,,Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14),Homo sapiens (Human),31.0,261.0,1.1e-16,89.4,sp|O75381|PEX14_HUMAN Peroxisomal membrane protein PEX14 OS=Homo sapiens OX=9606 GN=PEX14 PE=1 SV=1,GO:0001650; GO:0003714; GO:0005102; GO:0005634; GO:0005777; GO:0005778; GO:0005829; GO:0007031; GO:0008017; GO:0008320; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0030674; GO:0032091; GO:0032991; GO:0034453; GO:0034614; GO:0036250; GO:0042802; GO:0043433; GO:0044721; GO:0045892; GO:0048487; GO:0065003; GO:1990429,"cellular response to reactive oxygen species [GO:0034614]; microtubule anchoring [GO:0034453]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein binding [GO:0032091]; peroxisome organization [GO:0007031]; peroxisome transport along microtubule [GO:0036250]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein-containing complex assembly [GO:0065003]",cytosol [GO:0005829]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleus [GO:0005634]; peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein transmembrane transporter activity [GO:0008320]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714],GO:0005215; GO:0005634; GO:0005777; GO:0005829; GO:0006355; GO:0006886; GO:0007010; GO:0007018; GO:0007031; GO:0008092; GO:0043226; GO:0055085; GO:0060090; GO:0065003; GO:0140110,transporter activity; nucleus; peroxisome; cytosol; regulation of DNA-templated transcription; intracellular protein transport; cytoskeleton organization; microtubule-based movement; peroxisome organization; cytoskeletal protein binding; organelle; transmembrane transport; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_05689,FUN_025540-T1,Peve_00032949,Pocillopora_meandrina_HIv1___RNAseq.g13800.t1,three_way,84.76633333333334,FUN_025540-T1,Q8IZ02,,,,,41.1,190.0,9.7e-23,109.4,sp|Q8IZ02|LRC34_HUMAN Leucine-rich repeat-containing protein 34 OS=Homo sapiens OX=9606 GN=LRRC34 PE=1 SV=3,,,,,,
OG_05690,FUN_025541-T1,Peve_00032959,Pocillopora_meandrina_HIv1___RNAseq.g13799.t1,three_way,49.872166666666665,,,,,,,,,,,,,,,,,
OG_05691,FUN_025542-T1,Peve_00032958,Pocillopora_meandrina_HIv1___RNAseq.g13798.t1,three_way,69.249,,,,,,,,,,,,,,,,,
OG_05692,FUN_025543-T1,Peve_00002302,Pocillopora_meandrina_HIv1___RNAseq.g13797.t1,three_way,76.96466666666667,FUN_025543-T1,A2A825,CPLN2_MOUSE,,Ciliogenesis and planar polarity effector 2 (REM2- and Rab-like small GTPase 1),Mus musculus (Mouse),54.1,181.0,2.7e-55,216.5,sp|A2A825|CPLN2_MOUSE Ciliogenesis and planar polarity effector 2 OS=Mus musculus OX=10090 GN=Cplane2 PE=1 SV=1,GO:0003274; GO:0003924; GO:0005525; GO:0005737; GO:0005814; GO:0006887; GO:0007224; GO:0008104; GO:0008589; GO:0015031; GO:0016485; GO:0017157; GO:0031338; GO:0035082; GO:0035869; GO:0036064; GO:0060173; GO:0060271; GO:0097546; GO:1904888,axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cranial skeletal system development [GO:1904888]; endocardial cushion fusion [GO:0003274]; exocytosis [GO:0006887]; limb development [GO:0060173]; protein localization [GO:0008104]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of smoothened signaling pathway [GO:0008589]; regulation of vesicle fusion [GO:0031338]; smoothened signaling pathway [GO:0007224],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005815; GO:0007010; GO:0007155; GO:0016192; GO:0016787; GO:0043226; GO:0044782; GO:0048856; GO:0051604,catalytic activity; GTPase activity; microtubule organizing center; cytoskeleton organization; cell adhesion; vesicle-mediated transport; hydrolase activity; organelle; cilium organization; anatomical structure development; protein maturation
OG_05693,FUN_025544-T1,Peve_00032952,Pocillopora_meandrina_HIv1___TS.g2798.t1,three_way,69.56033333333333,FUN_025544-T1,O60308,CE104_HUMAN,,Centrosomal protein of 104 kDa (Cep104),Homo sapiens (Human),38.5,925.0,9.3e-159,562.4,sp|O60308|CE104_HUMAN Centrosomal protein of 104 kDa OS=Homo sapiens OX=9606 GN=CEP104 PE=1 SV=1,GO:0000922; GO:0005737; GO:0005813; GO:0005814; GO:0005929,,centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; spindle pole [GO:0000922],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_05694,FUN_025545-T1,Peve_00002304,Pocillopora_meandrina_HIv1___RNAseq.g13791.t1,three_way,43.73166666666666,,,,,,,,,,,,,,,,,
OG_05695,FUN_025556-T1,Peve_00017520,Pocillopora_meandrina_HIv1___RNAseq.g13790.t1,three_way,77.30333333333333,FUN_025556-T1,Q5SRE5,NU188_HUMAN,,Nucleoporin NUP188 (hNup188),Homo sapiens (Human),37.0,1762.0,5.6e-296,1019.2,sp|Q5SRE5|NU188_HUMAN Nucleoporin NUP188 OS=Homo sapiens OX=9606 GN=NUP188 PE=1 SV=1,GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006606; GO:0006913; GO:0016020; GO:0017056; GO:0044611; GO:0051028,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005829; GO:0006886; GO:0006913,structural molecule activity; nuclear envelope; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_05696,FUN_025557-T1,Peve_00019810,Pocillopora_meandrina_HIv1___RNAseq.g13789.t1,three_way,60.382333333333335,FUN_025557-T1,Q5XXP2,OPN4_PHOSU,,Melanopsin (Opsin-4),Phodopus sungorus (Striped hairy-footed hamster) (Djungarian hamster),32.0,309.0,4e-36,153.7,sp|Q5XXP2|OPN4_PHOSU Melanopsin OS=Phodopus sungorus OX=10044 GN=OPN4 PE=2 SV=1,GO:0005502; GO:0005886; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016020; GO:0030424; GO:0030425; GO:0042752; GO:0043204; GO:0048511; GO:1990384,hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020],GO:0005886; GO:0008289; GO:0050877; GO:0060089,plasma membrane; lipid binding; nervous system process; molecular transducer activity
OG_05697,FUN_025558-T1,Peve_00019821,Pocillopora_meandrina_HIv1___RNAseq.g13788.t2b,three_way,70.39066666666666,FUN_025558-T1,Q5T0D9,TPRGL_HUMAN,,Tumor protein p63-regulated gene 1-like protein (Mossy fiber terminal-associated vertebrate-specific presynaptic protein) (Protein FAM79A),Homo sapiens (Human),35.0,226.0,2.8e-35,150.6,sp|Q5T0D9|TPRGL_HUMAN Tumor protein p63-regulated gene 1-like protein OS=Homo sapiens OX=9606 GN=TPRG1L PE=1 SV=1,GO:0005516; GO:0005737; GO:0008021; GO:0016081; GO:0030672; GO:0033173; GO:0042802; GO:0044305; GO:0048786; GO:0050805; GO:0051966; GO:0070062,"calcineurin-NFAT signaling cascade [GO:0033173]; negative regulation of synaptic transmission [GO:0050805]; regulation of synaptic transmission, glutamatergic [GO:0051966]; synaptic vesicle docking [GO:0016081]",calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; presynaptic active zone [GO:0048786]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],calmodulin binding [GO:0005516]; identical protein binding [GO:0042802],GO:0031410; GO:0043226,cytoplasmic vesicle; organelle
OG_05698,FUN_025561-T1,Peve_00019806,Pocillopora_meandrina_HIv1___TS.g2789.t1,three_way,87.92233333333333,FUN_025561-T1,Q6VFT7,FOXL2_BOVIN,,Forkhead box protein L2,Bos taurus (Bovine),89.7,107.0,1.9e-52,207.6,sp|Q6VFT7|FOXL2_BOVIN Forkhead box protein L2 OS=Bos taurus OX=9913 GN=FOXL2 PE=2 SV=1,GO:0000978; GO:0000981; GO:0001541; GO:0002074; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0006309; GO:0006357; GO:0009653; GO:0019101; GO:0030154; GO:0031624; GO:0043028; GO:0043065; GO:0045892; GO:0045893; GO:0045944; GO:0048048; GO:0060014; GO:0090543,anatomical structure morphogenesis [GO:0009653]; apoptotic DNA fragmentation [GO:0006309]; cell differentiation [GO:0030154]; embryonic eye morphogenesis [GO:0048048]; extraocular skeletal muscle development [GO:0002074]; female somatic sex determination [GO:0019101]; granulosa cell differentiation [GO:0060014]; negative regulation of DNA-templated transcription [GO:0045892]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],Flemming body [GO:0090543]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"cysteine-type endopeptidase regulator activity involved in apoptotic process [GO:0043028]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin conjugating enzyme binding [GO:0031624]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_05699,FUN_025564-T2,Peve_00019809,Pocillopora_meandrina_HIv1___TS.g2787.t2,three_way,71.04416666666667,FUN_025564-T2,O35142,COPB2_RAT,,Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102),Rattus norvegicus (Rat),74.7,875.0,0.0,1131.3,sp|O35142|COPB2_RAT Coatomer subunit beta' OS=Rattus norvegicus OX=10116 GN=Copb2 PE=1 SV=3,GO:0000139; GO:0005080; GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0006888; GO:0006890; GO:0006891; GO:0030126,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],protein kinase C binding [GO:0005080]; structural molecule activity [GO:0005198],GO:0005198; GO:0005794; GO:0005829; GO:0006886; GO:0016192; GO:0043226,structural molecule activity; Golgi apparatus; cytosol; intracellular protein transport; vesicle-mediated transport; organelle
OG_05700,FUN_025570-T2,Peve_00033327,Pocillopora_meandrina_HIv1___RNAseq.g13774.t1,three_way,69.50533333333334,FUN_025570-T2,P63080,GBRB3_MOUSE,,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3),Mus musculus (Mouse),36.5,430.0,7.8e-74,279.3,sp|P63080|GBRB3_MOUSE Gamma-aminobutyric acid receptor subunit beta-3 OS=Mus musculus OX=10090 GN=Gabrb3 PE=1 SV=1,GO:0004890; GO:0005216; GO:0005886; GO:0007214; GO:0007399; GO:0007420; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030659; GO:0034707; GO:0035176; GO:0035640; GO:0042747; GO:0042802; GO:0043197; GO:0048666; GO:0051932; GO:0060021; GO:0060022; GO:0060077; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"brain development [GO:0007420]; cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuron development [GO:0048666]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]",cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; monoatomic ion channel activity [GO:0005216]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0022414; GO:0023052; GO:0034330; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; reproductive process; signaling; cell junction organization; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_05701,FUN_025571-T1,Peve_00001252,Pocillopora_meandrina_HIv1___TS.g2769.t1,three_way,65.26633333333334,FUN_025571-T1,Q7ZUC2,CAB45_DANRE,,45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,159.0,6.8e-20,99.0,sp|Q7ZUC2|CAB45_DANRE 45 kDa calcium-binding protein OS=Danio rerio OX=7955 GN=sdf4 PE=2 SV=1,GO:0002040; GO:0005509; GO:0005783; GO:0005796; GO:0017156,calcium-ion regulated exocytosis [GO:0017156]; sprouting angiogenesis [GO:0002040],endoplasmic reticulum [GO:0005783]; Golgi lumen [GO:0005796],calcium ion binding [GO:0005509],GO:0005783; GO:0016192; GO:0043226,endoplasmic reticulum; vesicle-mediated transport; organelle
OG_05702,FUN_025572-T1,Peve_00001254,Pocillopora_meandrina_HIv1___RNAseq.g13766.t1,three_way,87.75500000000001,FUN_025572-T1,Q9P2S5,WRP73_HUMAN,,WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene),Homo sapiens (Human),60.9,443.0,3.9e-166,585.9,sp|Q9P2S5|WRP73_HUMAN WD repeat-containing protein WRAP73 OS=Homo sapiens OX=9606 GN=WRAP73 PE=1 SV=1,GO:0005737; GO:0005813; GO:0005814; GO:0005815; GO:0030030; GO:0034451; GO:0036064; GO:0090307; GO:1902857; GO:1990811,cell projection organization [GO:0030030]; mitotic spindle assembly [GO:0090307]; positive regulation of non-motile cilium assembly [GO:1902857],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; MWP complex [GO:1990811],,GO:0005815; GO:0007010; GO:0043226,microtubule organizing center; cytoskeleton organization; organelle
OG_05703,FUN_025573-T1,Peve_00001256,Pocillopora_meandrina_HIv1___RNAseq.g13765.t2,three_way,53.1625,,,,,,,,,,,,,,,,,
OG_05704,FUN_025577-T1,Peve_00001263,Pocillopora_meandrina_HIv1___RNAseq.g13761.t1,three_way,75.097,FUN_025577-T1,P30437,,,,,36.5,419.0,8.600000000000001e-73,275.8,"sp|P30437|CP17A_ONCMY Steroid 17-alpha-hydroxylase/17,20 lyase OS=Oncorhynchus mykiss OX=8022 GN=cyp17a1 PE=2 SV=1",,,,,,
OG_05705,FUN_025578-T1,Peve_00022365,Pocillopora_meandrina_HIv1___RNAseq.g13760.t1,three_way,91.371,FUN_025578-T1,Q2TA03,UB2J2_BOVIN,,Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J2),Bos taurus (Bovine),60.8,250.0,3.4e-76,286.2,sp|Q2TA03|UB2J2_BOVIN Ubiquitin-conjugating enzyme E2 J2 OS=Bos taurus OX=9913 GN=UBE2J2 PE=2 SV=1,GO:0000209; GO:0005524; GO:0005634; GO:0005783; GO:0005789; GO:0006986; GO:0036503; GO:0061631; GO:0085020,ERAD pathway [GO:0036503]; protein K6-linked ubiquitination [GO:0085020]; protein polyubiquitination [GO:0000209]; response to unfolded protein [GO:0006986],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0005783; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_05706,FUN_025579-T1,Peve_00022366,Pocillopora_meandrina_HIv1___RNAseq.g13759.t1,three_way,85.93933333333334,FUN_025579-T1,Q9CZ04,CSN7A_MOUSE,,COP9 signalosome complex subunit 7a (SGN7a) (Signalosome subunit 7a) (JAB1-containing signalosome subunit 7a),Mus musculus (Mouse),48.7,271.0,6.5e-66,252.3,sp|Q9CZ04|CSN7A_MOUSE COP9 signalosome complex subunit 7a OS=Mus musculus OX=10090 GN=Cops7a PE=1 SV=2,GO:0000338; GO:0005654; GO:0005829; GO:0008180; GO:0010387,COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338],COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829; GO:0065003,nucleoplasm; cytosol; protein-containing complex assembly
OG_05707,FUN_025580-T1,Peve_00010640,Pocillopora_meandrina_HIv1___RNAseq.g13742.t1,three_way,70.19,FUN_025580-T1,B1AUE5,PEX10_MOUSE,,Peroxisome biogenesis factor 10 (EC 2.3.2.27) (Peroxin-10) (Peroxisomal biogenesis factor 10) (Peroxisome assembly protein 10),Mus musculus (Mouse),43.1,313.0,1.7e-62,241.5,sp|B1AUE5|PEX10_MOUSE Peroxisome biogenesis factor 10 OS=Mus musculus OX=10090 GN=Pex10 PE=2 SV=1,GO:0000209; GO:0005777; GO:0005778; GO:0008270; GO:0016562; GO:0034614; GO:0061630,"cellular response to reactive oxygen species [GO:0034614]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein polyubiquitination [GO:0000209]",peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005777; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; peroxisome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05708,FUN_025581-T1,Peve_00010643,Pocillopora_meandrina_HIv1___RNAseq.g13741.t1,three_way,99.04733333333331,FUN_025581-T1,P62147,,,,,99.1,117.0,7.6e-29,128.3,sp|P62147|CALM1_BRAFL Calmodulin-1 OS=Branchiostoma floridae OX=7739 PE=2 SV=2,,,,,,
OG_05709,FUN_025584-T2,Peve_00032137,Pocillopora_meandrina_HIv1___RNAseq.g13737.t1,three_way,82.64366666666666,FUN_025584-T2,P41041,,,,,56.0,50.0,3.3e-09,63.2,sp|P41041|CALM_PNECA Calmodulin OS=Pneumocystis carinii OX=4754 PE=3 SV=1,,,,,,
OG_05710,FUN_025585-T1,Peve_00038692,Pocillopora_meandrina_HIv1___TS.g2735.t1,three_way,75.33333333333333,,,,,,,,,,,,,,,,,
OG_05711,FUN_025595-T1,Peve_00037558,Pocillopora_meandrina_HIv1___RNAseq.g13622.t1,three_way,49.812666666666665,FUN_025595-T1,Q07912,ACK1_HUMAN,,Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2),Homo sapiens (Human),46.8,438.0,1.4e-106,389.4,sp|Q07912|ACK1_HUMAN Activated CDC42 kinase 1 OS=Homo sapiens OX=9606 GN=TNK2 PE=1 SV=3,GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005095; GO:0005154; GO:0005524; GO:0005634; GO:0005737; GO:0005768; GO:0005829; GO:0005886; GO:0005905; GO:0005912; GO:0006897; GO:0007166; GO:0007264; GO:0016020; GO:0016310; GO:0030136; GO:0030659; GO:0031625; GO:0042802; GO:0043231; GO:0046872; GO:0048471; GO:0050699; GO:0050731; GO:0070436; GO:0097268; GO:0106310; GO:2000369,cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; phosphorylation [GO:0016310]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of clathrin-dependent endocytosis [GO:2000369]; small GTPase-mediated signal transduction [GO:0007264],adherens junction [GO:0005912]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; Grb2-EGFR complex [GO:0070436]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; GTPase inhibitor activity [GO:0005095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699],GO:0003824; GO:0005634; GO:0005768; GO:0005829; GO:0005886; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; endosome; cytosol; plasma membrane; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05712,FUN_025596-T1,Peve_00037559,Pocillopora_meandrina_HIv1___RNAseq.g23150.t1,three_way,86.92,FUN_025596-T1,Q6NS26,,,,,65.8,549.0,1.3e-214,747.3,sp|Q6NS26|CDKAL_XENLA Threonylcarbamoyladenosine tRNA methylthiotransferase OS=Xenopus laevis OX=8355 GN=cdkal1 PE=2 SV=1,,,,,,
OG_05713,FUN_025598-T1,Peve_00041095,Pocillopora_meandrina_HIv1___RNAseq.g23146.t1,three_way,72.71566666666666,FUN_025598-T1,B2RQR8,ECE2_MOUSE,,Endothelin-converting enzyme 2 (ECE-2) (EC 3.4.24.71),Mus musculus (Mouse),41.2,639.0,5.8e-142,506.1,sp|B2RQR8|ECE2_MOUSE Endothelin-converting enzyme 2 OS=Mus musculus OX=10090 GN=Ece2 PE=1 SV=1,GO:0000139; GO:0004222; GO:0005802; GO:0016486; GO:0030658; GO:0046872,peptide hormone processing [GO:0016486],Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_05714,FUN_025599-T1,Peve_00006553,Pocillopora_meandrina_HIv1___RNAseq.g23142.t1,three_way,79.949,FUN_025599-T1,A9UMS3,,,,,63.0,284.0,5.999999999999999e-93,342.0,sp|A9UMS3|PHB2_XENTR Prohibitin-2 OS=Xenopus tropicalis OX=8364 GN=phb2 PE=2 SV=1,,,,,,
OG_05715,FUN_025600-T1,Peve_00006554,Pocillopora_meandrina_HIv1___RNAseq.g23141.t1,three_way,73.26283333333333,FUN_025600-T1,A1A4J7,,,,,31.7,819.0,5.300000000000001e-100,367.1,sp|A1A4J7|SMG8_BOVIN Nonsense-mediated mRNA decay factor SMG8 OS=Bos taurus OX=9913 GN=SMG8 PE=2 SV=2,,,,,,
OG_05716,FUN_025604-T1,Peve_00006549,Pocillopora_meandrina_HIv1___RNAseq.g23137.t1,three_way,68.401,FUN_025604-T1,P29274,AA2AR_HUMAN,,Adenosine receptor A2a,Homo sapiens (Human),29.1,313.0,7.5e-17,90.5,sp|P29274|AA2AR_HUMAN Adenosine receptor A2a OS=Homo sapiens OX=9606 GN=ADORA2A PE=1 SV=2,GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005882; GO:0005886; GO:0006355; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007188; GO:0007189; GO:0007200; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0008289; GO:0009410; GO:0014049; GO:0014057; GO:0014061; GO:0014074; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0042311; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0070374; GO:0097190; GO:0098978; GO:0099171; GO:1900273; GO:2001235,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of calcium ion transport [GO:0051924]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]",asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734],alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802],GO:0003013; GO:0003014; GO:0005886; GO:0006355; GO:0006954; GO:0008092; GO:0008289; GO:0012501; GO:0016192; GO:0023052; GO:0048856; GO:0050877; GO:0060089,circulatory system process; renal system process; plasma membrane; regulation of DNA-templated transcription; inflammatory response; cytoskeletal protein binding; lipid binding; programmed cell death; vesicle-mediated transport; signaling; anatomical structure development; nervous system process; molecular transducer activity
OG_05717,FUN_025607-T1,Peve_00033139,Pocillopora_meandrina_HIv1___RNAseq.g23132.t1,three_way,41.1535,FUN_025607-T1,P29319,,,,,33.2,386.0,5.0000000000000005e-48,194.1,sp|P29319|EPHA3_MOUSE Ephrin type-A receptor 3 OS=Mus musculus OX=10090 GN=Epha3 PE=1 SV=1,,,,,,
OG_05718,FUN_025610-T1,Peve_00009537,Pocillopora_meandrina_HIv1___RNAseq.g23128.t1,three_way,58.688833333333335,FUN_025610-T1,Q07497,,,,,34.9,935.0,3.7e-147,523.9,sp|Q07497|EPHB5_CHICK Ephrin type-B receptor 5 OS=Gallus gallus OX=9031 GN=EPHB5 PE=2 SV=1,,,,,,
OG_05719,FUN_025624-T1,Peve_00009538,Pocillopora_meandrina_HIv1___RNAseq.g23127.t1,three_way,56.78766666666667,,,,,,,,,,,,,,,,,
OG_05720,FUN_025626-T1,Peve_00023243,Pocillopora_meandrina_HIv1___RNAseq.g23126.t2a,three_way,80.867,FUN_025626-T1,Q9H0R3,TM222_HUMAN,,Transmembrane protein 222,Homo sapiens (Human),70.8,161.0,3.9e-64,245.7,sp|Q9H0R3|TM222_HUMAN Transmembrane protein 222 OS=Homo sapiens OX=9606 GN=TMEM222 PE=1 SV=2,GO:0016020; GO:0030425,,dendrite [GO:0030425]; membrane [GO:0016020],,,
OG_05721,FUN_025629-T1,Peve_00032155,Pocillopora_meandrina_HIv1___TS.g16003.t1,three_way,70.9745,FUN_025629-T1,A2AP18,,,,,46.6,736.0,4.500000000000001e-186,652.9,"sp|A2AP18|PLCH2_MOUSE 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 OS=Mus musculus OX=10090 GN=Plch2 PE=1 SV=2",,,,,,
OG_05722,FUN_025641-T1,Peve_00041903,Pocillopora_meandrina_HIv1___RNAseq.g23108.t1,three_way,52.76533333333333,FUN_025641-T1,Q59E83,NPR22_CAEEL,,Neuropeptide receptor 22,Caenorhabditis elegans,24.8,315.0,2.2e-12,75.1,sp|Q59E83|NPR22_CAEEL Neuropeptide receptor 22 OS=Caenorhabditis elegans OX=6239 GN=npr-22 PE=2 SV=1,GO:0005886; GO:0007218; GO:0008188; GO:0008340; GO:0040013; GO:1901046; GO:2000252,determination of adult lifespan [GO:0008340]; negative regulation of feeding behavior [GO:2000252]; negative regulation of locomotion [GO:0040013]; neuropeptide signaling pathway [GO:0007218]; positive regulation of egg-laying behavior [GO:1901046],plasma membrane [GO:0005886],neuropeptide receptor activity [GO:0008188],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_05723,FUN_025642-T1,Peve_00039651,Pocillopora_meandrina_HIv1___RNAseq.g23097.t1,three_way,81.889,FUN_025642-T1,Q5I598,MTHR_BOVIN,,Methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.53),Bos taurus (Bovine),63.3,602.0,5.7e-238,825.1,sp|Q5I598|MTHR_BOVIN Methylenetetrahydrofolate reductase (NADPH) OS=Bos taurus OX=9913 GN=MTHFR PE=2 SV=1,GO:0004489; GO:0009086; GO:0035999; GO:0071949; GO:0106313,methionine biosynthetic process [GO:0009086]; tetrahydrofolate interconversion [GO:0035999],,FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methylenetetrahydrofolate reductase (NADPH) activity [GO:0106313],GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0016491,catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity
OG_05724,FUN_025643-T1,Peve_00002527,Pocillopora_meandrina_HIv1___TS.g15983.t1,three_way,64.00683333333333,FUN_025643-T1,Q04637,IF4G1_HUMAN,,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),Homo sapiens (Human),39.4,1020.0,1.2e-159,566.2,sp|Q04637|IF4G1_HUMAN Eukaryotic translation initiation factor 4 gamma 1 OS=Homo sapiens OX=9606 GN=EIF4G1 PE=1 SV=4,GO:0001662; GO:0002191; GO:0003723; GO:0003729; GO:0003743; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0006413; GO:0006446; GO:0008135; GO:0008190; GO:0010494; GO:0010507; GO:0016020; GO:0016281; GO:0030182; GO:0030307; GO:0031369; GO:0031669; GO:0035278; GO:0036493; GO:0045666; GO:0051247; GO:0060090; GO:0080135; GO:0097009; GO:1900087; GO:1904377; GO:1905537; GO:1905606; GO:1905612,behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; translation [GO:0006412]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; ribosome [GO:0005840],"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]",GO:0003723; GO:0005634; GO:0005829; GO:0005840; GO:0030154; GO:0031047; GO:0043226; GO:0060090,RNA binding; nucleus; cytosol; ribosome; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity
OG_05725,FUN_025644-T1,Peve_00002563,Pocillopora_meandrina_HIv1___RNAseq.g23094.t1,three_way,55.178,,,,,,,,,,,,,,,,,
OG_05726,FUN_025649-T1,Peve_00039652,Pocillopora_meandrina_HIv1___RNAseq.g23087.t2c,three_way,52.45816666666667,,,,,,,,,,,,,,,,,
OG_05727,FUN_025650-T1,Peve_00002528,Pocillopora_meandrina_HIv1___RNAseq.g23087.t2a,three_way,85.454,,,,,,,,,,,,,,,,,
OG_05728,FUN_025651-T1,Peve_00002530,Pocillopora_meandrina_HIv1___RNAseq.g23086.t1,three_way,78.245,FUN_025651-T1,Q9Z1L0,PK3CB_RAT,,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1)",Rattus norvegicus (Rat),46.3,1059.0,4.4e-264,912.5,"sp|Q9Z1L0|PK3CB_RAT Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform OS=Rattus norvegicus OX=10116 GN=Pik3cb PE=2 SV=1",GO:0001935; GO:0001952; GO:0002931; GO:0003376; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005942; GO:0005943; GO:0006874; GO:0006897; GO:0006914; GO:0007156; GO:0010595; GO:0010628; GO:0016303; GO:0016477; GO:0030168; GO:0031526; GO:0033031; GO:0035005; GO:0035022; GO:0036092; GO:0040016; GO:0042267; GO:0043409; GO:0043491; GO:0043560; GO:0045429; GO:0046854; GO:0046934; GO:0048015; GO:0051898; GO:0060055; GO:0106310; GO:1900747; GO:1903298; GO:1903671,angiogenesis involved in wound healing [GO:0060055]; autophagy [GO:0006914]; cell migration [GO:0016477]; embryonic cleavage [GO:0040016]; endocytosis [GO:0006897]; endothelial cell proliferation [GO:0001935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intracellular calcium ion homeostasis [GO:0006874]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; platelet activation [GO:0030168]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cell-matrix adhesion [GO:0001952]; response to ischemia [GO:0002931]; sphingosine-1-phosphate receptor signaling pathway [GO:0003376],"brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]","1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity [GO:0046934]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; protein serine kinase activity [GO:0106310]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006629; GO:0006914; GO:0007155; GO:0016192; GO:0016740; GO:0043226; GO:0048870; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; lipid metabolic process; autophagy; cell adhesion; vesicle-mediated transport; transferase activity; organelle; cell motility; defense response to other organism; catalytic activity, acting on a protein"
OG_05729,FUN_025654-T1,Peve_00002534,Pocillopora_meandrina_HIv1___RNAseq.g23083.t1,three_way,64.02466666666666,FUN_025654-T1,A4IH36,,,,,33.0,203.0,3.6e-23,110.5,sp|A4IH36|ADIPL_XENTR Adipolin OS=Xenopus tropicalis OX=8364 GN=c1qtnf12 PE=2 SV=1,,,,,,
OG_05730,FUN_025656-T1,Peve_00042177,Pocillopora_meandrina_HIv1___RNAseq.g23077.t1,three_way,71.13966666666667,FUN_025656-T1,Q96LK0,,,,,39.9,158.0,9.6e-25,114.8,sp|Q96LK0|CEP19_HUMAN Centrosomal protein of 19 kDa OS=Homo sapiens OX=9606 GN=CEP19 PE=1 SV=2,,,,,,
OG_05731,FUN_025657-T1,Peve_00042176,Pocillopora_meandrina_HIv1___RNAseq.g23075.t1,three_way,71.07683333333333,FUN_025657-T1,P17863,,,,,33.1,341.0,1.1e-45,186.4,sp|P17863|SKI_AVIES Transforming protein Ski OS=Avian erythroblastosis virus (strain Sloan-Kettering) OX=11862 GN=V-SKI PE=1 SV=1,,,,,,
OG_05732,FUN_025658-T1,Peve_00042175,Pocillopora_meandrina_HIv1___RNAseq.g23074.t1,three_way,65.081,FUN_025658-T1,Q8C033,ARHGA_MOUSE,,Rho guanine nucleotide exchange factor 10,Mus musculus (Mouse),34.0,920.0,1.1e-133,479.9,sp|Q8C033|ARHGA_MOUSE Rho guanine nucleotide exchange factor 10 OS=Mus musculus OX=10090 GN=Arhgef10 PE=1 SV=2,GO:0005085; GO:0005813; GO:0019894; GO:0022011; GO:0035025; GO:0051298; GO:0051496; GO:0090307,centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496],centrosome [GO:0005813],guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894],GO:0005815; GO:0007010; GO:0008092; GO:0098772,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; molecular function regulator activity
OG_05733,FUN_025659-T1,Peve_00042174,Pocillopora_meandrina_HIv1___RNAseq.g23073.t1,three_way,72.82333333333334,,,,,,,,,,,,,,,,,
OG_05734,FUN_025660-T1,Peve_00042171,Pocillopora_meandrina_HIv1___RNAseq.g23068.t1,three_way,78.61866666666667,FUN_025660-T1,B0DOB4,NPHP4_XENLA,,Nephrocystin-4,Xenopus laevis (African clawed frog),41.9,1048.0,1.8e-222,774.2,sp|B0DOB4|NPHP4_XENLA Nephrocystin-4 OS=Xenopus laevis OX=8355 GN=nphp4 PE=2 SV=1,GO:0005737; GO:0035869; GO:0036064; GO:0090090; GO:0097546; GO:0097730; GO:1904491,negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein localization to ciliary transition zone [GO:1904491],ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_05735,FUN_025661-T1,Peve_00042170,Pocillopora_meandrina_HIv1___RNAseq.g23064.t1,three_way,97.34233333333331,FUN_025661-T1,Q5ZMP6,,,,,81.8,439.0,1.4e-211,736.9,sp|Q5ZMP6|AP2M1_CHICK AP-2 complex subunit mu OS=Gallus gallus OX=9031 GN=AP2M1 PE=2 SV=1,,,,,,
OG_05736,FUN_025662-T1,Peve_00042169,Pocillopora_meandrina_HIv1___RNAseq.g23063.t1,three_way,85.11566666666667,FUN_025662-T1,P39656,OST48_HUMAN,,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit),Homo sapiens (Human),69.1,414.0,8.6e-169,594.7,sp|P39656|OST48_HUMAN Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit OS=Homo sapiens OX=9606 GN=DDOST PE=1 SV=4,GO:0005783; GO:0005789; GO:0005886; GO:0006486; GO:0006487; GO:0008047; GO:0008250; GO:0016020; GO:0018279; GO:0031647; GO:0034097; GO:0035577; GO:0042110; GO:0043231; GO:0160226; GO:0160227,protein glycosylation [GO:0006486]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; regulation of protein stability [GO:0031647]; response to cytokine [GO:0034097]; T cell activation [GO:0042110],azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; oligosaccharyltransferase complex [GO:0008250]; oligosaccharyltransferase complex A [GO:0160226]; oligosaccharyltransferase complex B [GO:0160227]; plasma membrane [GO:0005886],enzyme activator activity [GO:0008047],GO:0002376; GO:0005783; GO:0005886; GO:0006486; GO:0009101; GO:0043226; GO:0098772; GO:1901135,immune system process; endoplasmic reticulum; plasma membrane; protein glycosylation; glycoprotein biosynthetic process; organelle; molecular function regulator activity; carbohydrate derivative metabolic process
OG_05737,FUN_025663-T1,Peve_00042168,Pocillopora_meandrina_HIv1___RNAseq.g23062.t1,three_way,73.4105,FUN_025663-T1,Q9UPW0,FOXJ3_HUMAN,,Forkhead box protein J3,Homo sapiens (Human),43.9,321.0,8.1e-57,223.0,sp|Q9UPW0|FOXJ3_HUMAN Forkhead box protein J3 OS=Homo sapiens OX=9606 GN=FOXJ3 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0007141; GO:0007283; GO:0030154; GO:0043565; GO:0045944; GO:1990837,cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; meiotic nuclear division; transcription regulator activity
OG_05738,FUN_025665-T1,Peve_00042167,Pocillopora_meandrina_HIv1___TS.g15949.t1,three_way,38.97733333333333,,,,,,,,,,,,,,,,,
OG_05739,FUN_025666-T1,Peve_00042166,Pocillopora_meandrina_HIv1___RNAseq.g23061.t1,three_way,80.65366666666667,FUN_025666-T1,Q5E9Q4,NECP2_BOVIN,,Adaptin ear-binding coat-associated protein 2 (NECAP endocytosis-associated protein 2) (NECAP-2),Bos taurus (Bovine),48.3,269.0,4.7e-66,252.7,sp|Q5E9Q4|NECP2_BOVIN Adaptin ear-binding coat-associated protein 2 OS=Bos taurus OX=9913 GN=NECAP2 PE=2 SV=1,GO:0005886; GO:0006897; GO:0015031; GO:0016192; GO:0030125,endocytosis [GO:0006897]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],clathrin vesicle coat [GO:0030125]; plasma membrane [GO:0005886],,GO:0005886; GO:0016192,plasma membrane; vesicle-mediated transport
OG_05740,FUN_025667-T2,Peve_00042165,Pocillopora_meandrina_HIv1___RNAseq.g23060.t1,three_way,41.132,,,,,,,,,,,,,,,,,
OG_05741,FUN_025668-T1,Peve_00042161,Pocillopora_meandrina_HIv1___RNAseq.g23059.t1,three_way,84.68433333333333,,,,,,,,,,,,,,,,,
OG_05742,FUN_025669-T1,Peve_00042197,Pocillopora_meandrina_HIv1___RNAseq.g23058.t1,three_way,85.04666666666667,FUN_025669-T1,Q567I9,,,,,67.1,164.0,1.3e-62,240.7,sp|Q567I9|CB5D1_DANRE Cytochrome b5 domain-containing protein 1 OS=Danio rerio OX=7955 GN=cyb5d1 PE=2 SV=1,,,,,,
OG_05743,FUN_025670-T1,Peve_00042194,Pocillopora_meandrina_HIv1___TS.g15944.t1,three_way,81.551,FUN_025670-T1,O09012,PEX5_MOUSE,,Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (PXR1P) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1),Mus musculus (Mouse),47.9,645.0,2.2e-117,424.5,sp|O09012|PEX5_MOUSE Peroxisomal targeting signal 1 receptor OS=Mus musculus OX=10090 GN=Pex5 PE=1 SV=2,GO:0000038; GO:0000268; GO:0000425; GO:0001764; GO:0005052; GO:0005739; GO:0005777; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006629; GO:0006635; GO:0007005; GO:0007006; GO:0007029; GO:0007031; GO:0016020; GO:0016558; GO:0016560; GO:0016562; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0034614; GO:0040018; GO:0044721; GO:0045046; GO:0048468; GO:0050905; GO:0140597,"cell development [GO:0048468]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629]; mitochondrial membrane organization [GO:0007006]; mitochondrion organization [GO:0007005]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid metabolic process [GO:0000038]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome membrane targeting sequence binding [GO:0033328]; peroxisome targeting sequence binding [GO:0000268]; protein carrier chaperone [GO:0140597]; small GTPase binding [GO:0031267],GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0006629; GO:0006886; GO:0006914; GO:0007005; GO:0007031; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0055085; GO:0061024; GO:0140104,mitochondrion; peroxisome; Golgi apparatus; cytosol; lipid metabolic process; intracellular protein transport; autophagy; mitochondrion organization; peroxisome organization; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process; transmembrane transport; membrane organization; molecular carrier activity
OG_05744,FUN_025671-T1,Peve_00042192,Pocillopora_meandrina_HIv1___RNAseq.g23056.t1,three_way,56.519,FUN_025671-T1,B1AZ99,OTUD3_MOUSE,,OTU domain-containing protein 3 (EC 3.4.19.12),Mus musculus (Mouse),46.0,285.0,4.8e-56,220.3,sp|B1AZ99|OTUD3_MOUSE OTU domain-containing protein 3 OS=Mus musculus OX=10090 GN=Otud3 PE=1 SV=1,GO:0004843; GO:0005634; GO:0005737; GO:0006508; GO:0031669; GO:0035871; GO:0044313; GO:0050821; GO:0051898; GO:0071108; GO:1990167,cellular response to nutrient levels [GO:0031669]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K48-linked deubiquitination [GO:0071108]; protein K6-linked deubiquitination [GO:0044313]; protein stabilization [GO:0050821]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05745,FUN_025672-T1,Peve_00042189,Pocillopora_meandrina_HIv1___RNAseq.g23055.t1,three_way,85.41666666666667,FUN_025672-T1,Q7F0J0,,,,,45.2,146.0,7.6e-31,135.6,sp|Q7F0J0|CML13_ORYSJ Probable calcium-binding protein CML13 OS=Oryza sativa subsp. japonica OX=39947 GN=CML13 PE=2 SV=1,,,,,,
OG_05746,FUN_025673-T1,Peve_00023389,Pocillopora_meandrina_HIv1___RNAseq.g1882.t1,three_way,79.89666666666666,FUN_025673-T1,C3YWU0,FUCO_BRAFL,,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),Branchiostoma floridae (Florida lancelet) (Amphioxus),62.1,449.0,3.8e-180,632.5,sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2,GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139,fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],extracellular region [GO:0005576]; lysosome [GO:0005764],alpha-L-fucosidase activity [GO:0004560],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0005975; GO:0016787; GO:0043226; GO:1901135,catalytic activity; extracellular region; lysosome; vacuole; carbohydrate metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_05747,FUN_025677-T1,Peve_00000461,Pocillopora_meandrina_HIv1___RNAseq.g13121.t1,three_way,68.10233333333333,FUN_025677-T1,Q21565,,,,,49.5,416.0,2.0000000000000002e-104,381.3,sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2,,,,,,
OG_05748,FUN_025680-T1,Peve_00000465,Pocillopora_meandrina_HIv1___RNAseq.g13116.t1,three_way,73.074,FUN_025680-T1,P49338,,,,,57.1,347.0,9.599999999999999e-115,414.8,sp|P49338|WNT4_XENLA Protein Wnt-4 OS=Xenopus laevis OX=8355 GN=wnt4 PE=2 SV=1,,,,,,
OG_05749,FUN_025681-T1,Peve_00000455,Pocillopora_meandrina_HIv1___RNAseq.g13115.t1,three_way,68.22683333333333,FUN_025681-T1,P98064,,,,,39.3,690.0,1.6e-137,491.5,sp|P98064|MASP1_MOUSE Mannan-binding lectin serine protease 1 OS=Mus musculus OX=10090 GN=Masp1 PE=1 SV=2,,,,,,
OG_05750,FUN_025682-T1,Peve_00000456,Pocillopora_meandrina_HIv1___TS.g2103.t1,three_way,67.785,FUN_025682-T1,Q3UQ28,PXDN_MOUSE,,Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Mus musculus (Mouse),38.9,742.0,5.6000000000000005e-126,454.1,sp|Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus musculus OX=10090 GN=Pxdn PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0003824; GO:0005198; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003,catalytic activity; structural molecule activity; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly
OG_05751,FUN_025683-T2,Peve_00000457,Pocillopora_meandrina_HIv1___RNAseq.g13113.t1,three_way,56.72566666666667,FUN_025683-T2,O57460,TLL1_DANRE,,Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein),Danio rerio (Zebrafish) (Brachydanio rerio),34.0,141.0,1.2e-16,89.7,sp|O57460|TLL1_DANRE Dorsal-ventral patterning tolloid-like protein 1 OS=Danio rerio OX=7955 GN=tll1 PE=2 SV=1,GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264,blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular region [GO:0005576]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_05752,FUN_025684-T1,Peve_00000458,Pocillopora_meandrina_HIv1___RNAseq.g13117.t1,three_way,62.62833333333333,,,,,,,,,,,,,,,,,
OG_05753,FUN_025686-T1,Peve_00022755,Pocillopora_meandrina_HIv1___RNAseq.g13112.t1,three_way,71.20066666666666,FUN_025686-T1,O76075,,,,,35.7,328.0,1.5999999999999999e-55,218.0,sp|O76075|DFFB_HUMAN DNA fragmentation factor subunit beta OS=Homo sapiens OX=9606 GN=DFFB PE=1 SV=1,,,,,,
OG_05754,FUN_025689-T1,Peve_00005582,Pocillopora_meandrina_HIv1___RNAseq.g13163.t2a,three_way,81.69233333333334,FUN_025689-T1,P58058,,,,,53.0,389.0,1.3999999999999999e-112,407.9,sp|P58058|NADK_MOUSE NAD kinase OS=Mus musculus OX=10090 GN=Nadk PE=1 SV=2,,,,,,
OG_05755,FUN_025690-T1,Peve_00005581,Pocillopora_meandrina_HIv1___RNAseq.g13163.t2b,three_way,57.99366666666667,,,,,,,,,,,,,,,,,
OG_05756,FUN_025691-T3,Peve_00005580,Pocillopora_meandrina_HIv1___RNAseq.g13162.t1,three_way,70.04033333333334,FUN_025691-T3,Q66GQ5,RWA3_ARATH,,Protein REDUCED WALL ACETYLATION 3 (EC 2.3.1.-),Arabidopsis thaliana (Mouse-ear cress),40.8,519.0,2e-95,351.3,sp|Q66GQ5|RWA3_ARATH Protein REDUCED WALL ACETYLATION 3 OS=Arabidopsis thaliana OX=3702 GN=RWA3 PE=1 SV=1,GO:0000139; GO:0005794; GO:0009834; GO:0016491; GO:0016740; GO:0045491; GO:0045492; GO:1990937,plant-type secondary cell wall biogenesis [GO:0009834]; xylan acetylation [GO:1990937]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740],GO:0003824; GO:0005794; GO:0005975; GO:0016491; GO:0016740; GO:0043226; GO:0071554,catalytic activity; Golgi apparatus; carbohydrate metabolic process; oxidoreductase activity; transferase activity; organelle; cell wall organization or biogenesis
OG_05757,FUN_025692-T1,Peve_00005578,Pocillopora_meandrina_HIv1___RNAseq.g13161.t2,three_way,54.39333333333333,,,,,,,,,,,,,,,,,
OG_05758,FUN_025699-T1,Peve_00004691,Pocillopora_meandrina_HIv1___RNAseq.g13830.t1,three_way,83.33416666666666,FUN_025699-T1,P38166,,,,,42.3,137.0,5e-23,109.4,sp|P38166|SFT2_YEAST Protein transport protein SFT2 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=SFT2 PE=1 SV=1,,,,,,
OG_05759,FUN_025700-T1,Peve_00004692,Pocillopora_meandrina_HIv1___RNAseq.g13829.t1,three_way,50.16833333333334,FUN_025700-T1,P13116,,,,,38.1,97.0,4.7e-06,55.5,sp|P13116|SRC2_XENLA Tyrosine-protein kinase Src-2 OS=Xenopus laevis OX=8355 GN=src-b PE=2 SV=3,,,,,,
OG_05760,FUN_025701-T1,Peve_00026329,Pocillopora_meandrina_HIv1___RNAseq.g13828.t1,three_way,85.17516666666667,FUN_025701-T1,Q8K268,,,,,58.7,715.0,2.7e-228,793.1,sp|Q8K268|ABCF3_MOUSE ATP-binding cassette sub-family F member 3 OS=Mus musculus OX=10090 GN=Abcf3 PE=1 SV=1,,,,,,
OG_05761,FUN_025702-T1,Peve_00004694,Pocillopora_meandrina_HIv1___RNAseq.g13827.t1,three_way,44.88766666666667,FUN_025702-T1,Q08D19,,,,,43.6,110.0,8.7e-14,80.1,sp|Q08D19|GOLI4_XENTR Golgi integral membrane protein 4 OS=Xenopus tropicalis OX=8364 GN=golim4 PE=2 SV=2,,,,,,
OG_05762,FUN_025716-T1,Peve_00001130,Pocillopora_meandrina_HIv1___RNAseq.g10446.t1,three_way,60.85233333333333,,,,,,,,,,,,,,,,,
OG_05763,FUN_025720-T1,Peve_00014084,Pocillopora_meandrina_HIv1___RNAseq.g10451.t1,three_way,60.96366666666667,,,,,,,,,,,,,,,,,
OG_05764,FUN_025722-T1,Peve_00014085,Pocillopora_meandrina_HIv1___RNAseq.g10452.t1,three_way,58.814,FUN_025722-T1,A8MY62,,,,,29.3,447.0,1.5e-46,188.7,sp|A8MY62|BLML_HUMAN Putative beta-lactamase-like 1 OS=Homo sapiens OX=9606 GN=LACTBL1 PE=1 SV=2,,,,,,
OG_05765,FUN_025723-T1,Peve_00001126,Pocillopora_meandrina_HIv1___RNAseq.g10454.t2,three_way,89.69200000000001,FUN_025723-T1,Q14566,MCM6_HUMAN,,DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM),Homo sapiens (Human),70.7,808.0,0.0,1134.0,sp|Q14566|MCM6_HUMAN DNA replication licensing factor MCM6 OS=Homo sapiens OX=9606 GN=MCM6 PE=1 SV=1,GO:0000727; GO:0000781; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0042802; GO:0071162; GO:1902969,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; double-strand break repair via break-induced replication [GO:0000727]; mitotic DNA replication [GO:1902969]; regulation of DNA-templated DNA replication initiation [GO:0030174],"chromosome, telomeric region [GO:0000781]; CMG complex [GO:0071162]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_05766,FUN_025724-T1,Peve_00001160,Pocillopora_meandrina_HIv1___RNAseq.g10456.t1,three_way,61.71366666666667,FUN_025724-T1,Q5NUA6,NF2L2_BOVIN,,"Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2)",Bos taurus (Bovine),43.4,122.0,1e-17,93.2,sp|Q5NUA6|NF2L2_BOVIN Nuclear factor erythroid 2-related factor 2 OS=Bos taurus OX=9913 GN=NFE2L2 PE=2 SV=2,GO:0000976; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005737; GO:0005829; GO:0006357; GO:0010499; GO:0016567; GO:0034599; GO:0043161; GO:0043565; GO:0045088; GO:0045454; GO:0045944; GO:0071498; GO:0110076,cell redox homeostasis [GO:0045454]; cellular response to fluid shear stress [GO:0071498]; cellular response to oxidative stress [GO:0034599]; negative regulation of ferroptosis [GO:0110076]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of innate immune response [GO:0045088]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; transcription regulator activity
OG_05767,FUN_025725-T1,Peve_00001159,Pocillopora_meandrina_HIv1___RNAseq.g10457.t1,three_way,72.23316666666668,FUN_025725-T1,Q9NZI7,UBIP1_HUMAN,,Upstream-binding protein 1 (Transcription factor LBP-1),Homo sapiens (Human),36.7,586.0,8.2e-89,329.3,sp|Q9NZI7|UBIP1_HUMAN Upstream-binding protein 1 OS=Homo sapiens OX=9606 GN=UBP1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0032897; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; negative regulation of viral transcription [GO:0032897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_05768,FUN_025726-T1,Peve_00014086,Pocillopora_meandrina_HIv1___RNAseq.g10439.t1,three_way,90.70733333333334,FUN_025726-T1,Q6DHC1,RB18B_DANRE,,Ras-related protein Rab-18-B (EC 3.6.5.2),Danio rerio (Zebrafish) (Brachydanio rerio),75.0,204.0,3.8999999999999998e-84,312.4,sp|Q6DHC1|RB18B_DANRE Ras-related protein Rab-18-B OS=Danio rerio OX=7955 GN=rab18b PE=2 SV=1,GO:0001654; GO:0003924; GO:0005525; GO:0005789; GO:0005794; GO:0005811; GO:0006886; GO:0007420; GO:0012505; GO:0016324; GO:0033106; GO:0034389; GO:0043009,brain development [GO:0007420]; chordate embryonic development [GO:0043009]; eye development [GO:0001654]; intracellular protein transport [GO:0006886]; lipid droplet organization [GO:0034389],apical plasma membrane [GO:0016324]; cis-Golgi network membrane [GO:0033106]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lipid droplet [GO:0005811],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005794; GO:0005811; GO:0006886; GO:0016787; GO:0043226; GO:0048856,catalytic activity; GTPase activity; Golgi apparatus; lipid droplet; intracellular protein transport; hydrolase activity; organelle; anatomical structure development
OG_05769,FUN_025728-T1,Peve_00024169,Pocillopora_meandrina_HIv1___RNAseq.g10438.t1,three_way,70.458,FUN_025728-T1,Q8WZA2,RPGF4_HUMAN,,Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII),Homo sapiens (Human),49.9,351.0,4.2e-105,382.9,sp|Q8WZA2|RPGF4_HUMAN Rap guanine nucleotide exchange factor 4 OS=Homo sapiens OX=9606 GN=RAPGEF4 PE=1 SV=1,GO:0002250; GO:0005085; GO:0005829; GO:0005886; GO:0007186; GO:0007189; GO:0007265; GO:0016020; GO:0017156; GO:0017157; GO:0030073; GO:0030552; GO:0030674; GO:0031267; GO:0032024; GO:0050796; GO:0098686; GO:0098693,adaptive immune response [GO:0002250]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcium-ion regulated exocytosis [GO:0017156]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin secretion [GO:0030073]; positive regulation of insulin secretion [GO:0032024]; Ras protein signal transduction [GO:0007265]; regulation of exocytosis [GO:0017157]; regulation of insulin secretion [GO:0050796]; regulation of synaptic vesicle cycle [GO:0098693],cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; membrane [GO:0016020]; plasma membrane [GO:0005886],cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-macromolecule adaptor activity [GO:0030674]; small GTPase binding [GO:0031267],GO:0002376; GO:0005829; GO:0005886; GO:0016192; GO:0060090; GO:0098772,immune system process; cytosol; plasma membrane; vesicle-mediated transport; molecular adaptor activity; molecular function regulator activity
OG_05770,FUN_025730-T1,Peve_00035630,Pocillopora_meandrina_HIv1___RNAseq.g10436.t1,three_way,81.93766666666667,FUN_025730-T1,A5D8W1,CFA69_HUMAN,,Cilia- and flagella-associated protein 69,Homo sapiens (Human),40.2,895.0,9.3e-194,678.7,sp|A5D8W1|CFA69_HUMAN Cilia- and flagella-associated protein 69 OS=Homo sapiens OX=9606 GN=CFAP69 PE=1 SV=3,GO:0005737; GO:0007288; GO:0007608; GO:0030317; GO:0042048; GO:0097225; GO:0097730; GO:1902093; GO:1905516; GO:1990834,flagellated sperm motility [GO:0030317]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sperm axoneme assembly [GO:0007288],cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225],,GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_05771,FUN_025733-T1,Peve_00013276,Pocillopora_meandrina_HIv1___RNAseq.g10433.t1,three_way,81.46533333333333,FUN_025733-T1,Q8TCB7,METL6_HUMAN,,tRNA N(3)-cytidine methyltransferase METTL6 (EC 2.1.1.-) (Methyltransferase-like protein 6) (hMETTL6),Homo sapiens (Human),58.5,260.0,5.8e-88,325.5,sp|Q8TCB7|METL6_HUMAN tRNA N(3)-cytidine methyltransferase METTL6 OS=Homo sapiens OX=9606 GN=METTL6 PE=1 SV=2,GO:0005634; GO:0005737; GO:0006400; GO:0019899; GO:0030488; GO:0052735,tRNA methylation [GO:0030488]; tRNA modification [GO:0006400],cytoplasm [GO:0005737]; nucleus [GO:0005634],enzyme binding [GO:0019899]; tRNA (cytidine-3-)-methyltransferase activity [GO:0052735],GO:0003824; GO:0005634; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_05772,FUN_025734-T1,Peve_00013274,Pocillopora_meandrina_HIv1___TS.g13847.t1,three_way,69.05016666666667,FUN_025734-T1,Q68DK7,MSL1_HUMAN,,Male-specific lethal 1 homolog (MSL-1) (Male-specific lethal 1-like 1) (MSL1-like 1) (Male-specific lethal-1 homolog 1),Homo sapiens (Human),39.4,127.0,1.1e-14,82.8,sp|Q68DK7|MSL1_HUMAN Male-specific lethal 1 homolog OS=Homo sapiens OX=9606 GN=MSL1 PE=1 SV=3,GO:0005634; GO:0005654; GO:0006338; GO:0016607; GO:0030674; GO:0045893; GO:0072487,chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893],MSL complex [GO:0072487]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],protein-macromolecule adaptor activity [GO:0030674],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0060090,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_05773,FUN_025736-T1,Peve_00013270,Pocillopora_meandrina_HIv1___RNAseq.g10430.t1,three_way,64.86883333333334,,,,,,,,,,,,,,,,,
OG_05774,FUN_025737-T1,Peve_00008541,Pocillopora_meandrina_HIv1___RNAseq.g10429.t1,three_way,55.18066666666667,FUN_025737-T1,Q5T7P8,SYT6_HUMAN,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Homo sapiens (Human),33.6,125.0,8.9e-12,73.6,sp|Q5T7P8|SYT6_HUMAN Synaptotagmin-6 OS=Homo sapiens OX=9606 GN=SYT6 PE=1 SV=3,GO:0000149; GO:0005829; GO:0005886; GO:0007268; GO:0009898; GO:0016020; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0046872; GO:0060478; GO:0061891; GO:0070382; GO:0097038,acrosomal vesicle exocytosis [GO:0060478]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion sensor activity [GO:0061891]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005829; GO:0005886; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0098772; GO:0140299,cytosol; plasma membrane; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_05775,FUN_025738-T1,Peve_00008539,Pocillopora_meandrina_HIv1___RNAseq.g30315.t1,three_way,59.97833333333333,,,,,,,,,,,,,,,,,
OG_05776,FUN_025745-T1,Peve_00008538,Pocillopora_meandrina_HIv1___TS.g13844.t2,three_way,50.434333333333335,FUN_025745-T1,Q86XL3,ANKL2_HUMAN,,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),Homo sapiens (Human),28.6,889.0,7.4e-84,313.5,sp|Q86XL3|ANKL2_HUMAN Ankyrin repeat and LEM domain-containing protein 2 OS=Homo sapiens OX=9606 GN=ANKLE2 PE=1 SV=4,GO:0004860; GO:0005783; GO:0005789; GO:0007084; GO:0007417; GO:0016020; GO:0019888; GO:0042326; GO:0043066; GO:0050790; GO:0051301; GO:0051721,cell division [GO:0051301]; central nervous system development [GO:0007417]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphorylation [GO:0042326]; regulation of catalytic activity [GO:0050790],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],protein kinase inhibitor activity [GO:0004860]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888],GO:0005783; GO:0043226; GO:0048856; GO:0061024; GO:0098772,endoplasmic reticulum; organelle; anatomical structure development; membrane organization; molecular function regulator activity
OG_05777,FUN_025746-T1,Peve_00008534,Pocillopora_meandrina_HIv1___RNAseq.g10426.t1,three_way,57.30083333333333,FUN_025746-T1,Q6P132,,,,,40.8,152.0,1.9999999999999998e-32,142.9,sp|Q6P132|TXB1B_DANRE Tax1-binding protein 1 homolog B OS=Danio rerio OX=7955 GN=tax1bp1b PE=2 SV=3,,,,,,
OG_05778,FUN_025748-T1,Peve_00014397,Pocillopora_meandrina_HIv1___RNAseq.g10413.t1,three_way,92.053,FUN_025748-T1,Q66KB0,,,,,76.1,222.0,9.1e-102,371.3,sp|Q66KB0|UBE2Z_XENTR Ubiquitin-conjugating enzyme E2 Z OS=Xenopus tropicalis OX=8364 GN=ube2z PE=2 SV=2,,,,,,
OG_05779,FUN_025750-T1,Peve_00007726,Pocillopora_meandrina_HIv1___RNAseq.g10411.t1,three_way,86.325,FUN_025750-T1,O57656,,,,,52.3,392.0,2.2e-107,390.6,"sp|O57656|GPDA_TAKRU Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic OS=Takifugu rubripes OX=31033 GN=gpd1 PE=3 SV=1",,,,,,
OG_05780,FUN_025751-T1,Peve_00007731,Pocillopora_meandrina_HIv1___RNAseq.g10407.t1,three_way,81.0305,FUN_025751-T1,A2A935,PRD16_MOUSE,,Histone-lysine N-methyltransferase PRDM16 (EC 2.1.1.367) (PR domain zinc finger protein 16) (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1),Mus musculus (Mouse),24.8,298.0,1.1e-20,103.2,sp|A2A935|PRD16_MOUSE Histone-lysine N-methyltransferase PRDM16 OS=Mus musculus OX=10090 GN=Prdm16 PE=1 SV=1,GO:0000122; GO:0001228; GO:0003713; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0008270; GO:0017053; GO:0019827; GO:0022008; GO:0030512; GO:0030853; GO:0032259; GO:0035019; GO:0043457; GO:0043565; GO:0043586; GO:0045892; GO:0045893; GO:0046332; GO:0046974; GO:0050872; GO:0050873; GO:0060021; GO:0070828; GO:0090336; GO:0120162; GO:0140947; GO:0140948,brown fat cell differentiation [GO:0050873]; heterochromatin organization [GO:0070828]; methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neurogenesis [GO:0022008]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cellular respiration [GO:0043457]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; stem cell population maintenance [GO:0019827]; tongue development [GO:0043586]; white fat cell differentiation [GO:0050872],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9 monomethyltransferase activity [GO:0140948]; histone H3K9me2 methyltransferase activity [GO:0140947]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_05781,FUN_025755-T1,Peve_00040610,Pocillopora_meandrina_HIv1___RNAseq.g10416.t1,three_way,76.434,FUN_025755-T1,A7T1N0,TMP2L_NEMVE,,Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2),Nematostella vectensis (Starlet sea anemone),60.0,1583.0,0.0,1838.2,sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1,GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604,calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725],plasma membrane [GO:0005886],ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872],GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0055085,catalytic activity; transporter activity; plasma membrane; hydrolase activity; transmembrane transport
OG_05782,FUN_025756-T1,Peve_00040609,Pocillopora_meandrina_HIv1___RNAseq.26310_t,three_way,71.92066666666666,FUN_025756-T1,Q91ZS8,RED1_MOUSE,,Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase),Mus musculus (Mouse),46.2,643.0,3.6e-145,516.9,sp|Q91ZS8|RED1_MOUSE Double-stranded RNA-specific editase 1 OS=Mus musculus OX=10090 GN=Adarb1 PE=1 SV=1,GO:0003723; GO:0003725; GO:0003726; GO:0004000; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0007274; GO:0008285; GO:0021610; GO:0021618; GO:0021965; GO:0030336; GO:0035264; GO:0044387; GO:0045070; GO:0045202; GO:0046872; GO:0050884; GO:0051726; GO:0060384; GO:0060415; GO:0061744; GO:0097049,adenosine to inosine editing [GO:0006382]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202],adenosine deaminase activity [GO:0004000]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0012501; GO:0016071; GO:0016787; GO:0023052; GO:0043226; GO:0050877,RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; programmed cell death; mRNA metabolic process; hydrolase activity; signaling; organelle; nervous system process
OG_05783,FUN_025757-T1,Peve_00029936,Pocillopora_meandrina_HIv1___RNAseq.g10418.t1,three_way,73.75783333333334,FUN_025757-T1,Q5R4D6,LEO1_PONAB,,RNA polymerase-associated protein LEO1,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),67.6,256.0,2.5000000000000002e-89,330.9,sp|Q5R4D6|LEO1_PONAB RNA polymerase-associated protein LEO1 OS=Pongo abelii OX=9601 GN=LEO1 PE=2 SV=1,GO:0001711; GO:0006368; GO:0016055; GO:0016593; GO:0019827; GO:0031124; GO:0032968; GO:0045638; GO:1990269,endodermal cell fate commitment [GO:0001711]; mRNA 3'-end processing [GO:0031124]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593],RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269],GO:0006355; GO:0016071,regulation of DNA-templated transcription; mRNA metabolic process
OG_05784,FUN_025758-T1,Peve_00040618,Pocillopora_meandrina_HIv1___RNAseq.g10419.t1,three_way,66.84783333333333,FUN_025758-T1,Q3TVI4,,,,,39.1,169.0,3.4e-16,87.4,sp|Q3TVI4|HEXI2_MOUSE Protein HEXIM2 OS=Mus musculus OX=10090 GN=Hexim2 PE=1 SV=1,,,,,,
OG_05785,FUN_025760-T1,Peve_00041463,Pocillopora_meandrina_HIv1___RNAseq.g10421.t1,three_way,74.163,FUN_025760-T1,Q566I1,,,,,31.3,518.0,1.4e-47,193.0,sp|Q566I1|IN80D_XENLA INO80 complex subunit D OS=Xenopus laevis OX=8355 GN=ino80d PE=2 SV=1,,,,,,
OG_05786,FUN_025762-T1,Peve_00041464,Pocillopora_meandrina_HIv1___RNAseq.g10422.t1,three_way,66.92333333333333,FUN_025762-T1,Q6PFM4,,,,,42.4,361.0,1.4e-61,238.4,sp|Q6PFM4|LNPB_DANRE Endoplasmic reticulum junction formation protein lunapark-B OS=Danio rerio OX=7955 GN=lnpkb PE=2 SV=2,,,,,,
OG_05787,FUN_025764-T1,Peve_00016581,Pocillopora_meandrina_HIv1___RNAseq.g10375.t1,three_way,50.89866666666666,,,,,,,,,,,,,,,,,
OG_05788,FUN_025765-T1,Peve_00031421,Pocillopora_meandrina_HIv1___RNAseq.g10374.t1,three_way,82.512,FUN_025765-T1,P78383,S35B1_HUMAN,,Solute carrier family 35 member B1 (ATP/ADP exchanger ER) (AXER) (Endoplasmic reticulum ATP/ADP translocase) (UDP-galactose transporter-related protein 1) (UGTrel1),Homo sapiens (Human),59.9,317.0,2.9000000000000003e-100,366.7,sp|P78383|S35B1_HUMAN Solute carrier family 35 member B1 OS=Homo sapiens OX=9606 GN=SLC35B1 PE=1 SV=1,GO:0000139; GO:0005459; GO:0005460; GO:0005471; GO:0005654; GO:0005783; GO:0005789; GO:0043231; GO:0072334,UDP-galactose transmembrane transport [GO:0072334],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],ATP:ADP antiporter activity [GO:0005471]; UDP-galactose transmembrane transporter activity [GO:0005459]; UDP-glucose transmembrane transporter activity [GO:0005460],GO:0005215; GO:0005654; GO:0005783; GO:0043226; GO:0055085,transporter activity; nucleoplasm; endoplasmic reticulum; organelle; transmembrane transport
OG_05789,FUN_025767-T1,Peve_00021328,Pocillopora_meandrina_HIv1___RNAseq.g10372.t1,three_way,75.75,FUN_025767-T1,P31508,,,,,64.9,37.0,9.2e-06,52.4,sp|P31508|ESCA_APIME Escargot/snail protein homolog (Fragment) OS=Apis mellifera OX=7460 PE=3 SV=1,,,,,,
OG_05790,FUN_025768-T1,Peve_00021329,Pocillopora_meandrina_HIv1___RNAseq.g10371.t1,three_way,68.259,FUN_025768-T1,Q6GL69,,,,,49.5,192.0,2.9e-44,180.3,sp|Q6GL69|MK67I_XENTR MKI67 FHA domain-interacting nucleolar phosphoprotein-like OS=Xenopus tropicalis OX=8364 GN=nifk PE=2 SV=1,,,,,,
OG_05791,FUN_025771-T1,Peve_00016587,Pocillopora_meandrina_HIv1___RNAseq.g10367.t1,three_way,68.582,FUN_025771-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),53.1,130.0,1.7000000000000002e-32,140.6,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_05792,FUN_025772-T1,Peve_00016588,Pocillopora_meandrina_HIv1___RNAseq.g10366.t1,three_way,47.3045,FUN_025772-T1,Q3TBV4,KCNK6_MOUSE,,Potassium channel subfamily K member 6,Mus musculus (Mouse),28.9,149.0,1.5e-10,68.6,sp|Q3TBV4|KCNK6_MOUSE Potassium channel subfamily K member 6 OS=Mus musculus OX=10090 GN=Kcnk6 PE=1 SV=1,GO:0003073; GO:0003085; GO:0005267; GO:0005765; GO:0031902; GO:0046872; GO:0060075; GO:0062196; GO:1900227,negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; regulation of lysosome size [GO:0062196]; regulation of resting membrane potential [GO:0060075]; regulation of systemic arterial blood pressure [GO:0003073],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765],metal ion binding [GO:0046872]; potassium channel activity [GO:0005267],GO:0005215,transporter activity
OG_05793,FUN_025774-T1,Peve_00016582,Pocillopora_meandrina_HIv1___RNAseq.g10364.t1,three_way,67.209,FUN_025774-T1,Q66IB8,,,,,55.5,119.0,2.6000000000000006e-33,142.9,sp|Q66IB8|CB076_DANRE UPF0538 protein C2orf76 homolog OS=Danio rerio OX=7955 GN=zgc:101851 PE=2 SV=1,,,,,,
OG_05794,FUN_025775-T1,Peve_00012555,Pocillopora_meandrina_HIv1___RNAseq.g10363.t1,three_way,91.0985,FUN_025775-T1,P79145,,,,,50.4,254.0,2.7e-39,164.1,sp|P79145|CREM_CANLF cAMP-responsive element modulator OS=Canis lupus familiaris OX=9615 GN=CREM PE=2 SV=2,,,,,,
OG_05795,FUN_025777-T1,Peve_00009655,Pocillopora_meandrina_HIv1___TS.g13775.t1,three_way,73.476,FUN_025777-T1,Q5I0I9,,,,,63.1,157.0,2.8e-57,223.4,"sp|Q5I0I9|CQ10B_RAT Coenzyme Q-binding protein COQ10 homolog B, mitochondrial OS=Rattus norvegicus OX=10116 GN=Coq10b PE=2 SV=2",,,,,,
OG_05796,FUN_025778-T1,Peve_00009659,Pocillopora_meandrina_HIv1___RNAseq.g10360.t1,three_way,63.86666666666667,,,,,,,,,,,,,,,,,
OG_05797,FUN_025780-T1,Peve_00009651,Pocillopora_meandrina_HIv1___RNAseq.g10358.t1,three_way,87.72200000000001,FUN_025780-T1,P18687,,,,,71.6,556.0,2.2e-220,766.5,"sp|P18687|CH60_CRIGR 60 kDa heat shock protein, mitochondrial OS=Cricetulus griseus OX=10029 GN=HSPD1 PE=2 SV=1",,,,,,
OG_05798,FUN_025782-T1,Peve_00009656,Pocillopora_meandrina_HIv1___RNAseq.g10389.t1,three_way,90.97166666666666,FUN_025782-T1,Q9U505,,,,,57.1,168.0,8.099999999999998e-35,148.3,"sp|Q9U505|AT5G_MANSE ATP synthase lipid-binding protein, mitochondrial OS=Manduca sexta OX=7130 PE=2 SV=1",,,,,,
OG_05799,FUN_025784-T1,Peve_00003062,Pocillopora_meandrina_HIv1___TS.g13806.t1,three_way,71.1365,FUN_025784-T1,Q80TG1,KANL1_MOUSE,,KAT8 regulatory NSL complex subunit 1 (NSL complex protein NSL1) (Non-specific lethal 1 homolog),Mus musculus (Mouse),27.1,535.0,5e-21,105.1,sp|Q80TG1|KANL1_MOUSE KAT8 regulatory NSL complex subunit 1 OS=Mus musculus OX=10090 GN=Kansl1 PE=1 SV=1,GO:0000123; GO:0000776; GO:0005739; GO:0006325; GO:0044545; GO:0045893; GO:0071339; GO:1903108,chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitochondrial transcription [GO:1903108],histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545],,GO:0005739; GO:0006325; GO:0006355; GO:0043226,mitochondrion; chromatin organization; regulation of DNA-templated transcription; organelle
OG_05800,FUN_025786-T1,Peve_00003054,Pocillopora_meandrina_HIv1___RNAseq.g10392.t1,three_way,81.36866666666667,FUN_025786-T1,Q8VHI3,OFUT2_MOUSE,,GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2),Mus musculus (Mouse),56.2,390.0,3.2000000000000008e-130,467.2,sp|Q8VHI3|OFUT2_MOUSE GDP-fucose protein O-fucosyltransferase 2 OS=Mus musculus OX=10090 GN=Pofut2 PE=1 SV=1,GO:0001707; GO:0005789; GO:0005794; GO:0006004; GO:0008417; GO:0010468; GO:0010717; GO:0036065; GO:0036066; GO:0046922; GO:0051046; GO:1903334,fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; mesoderm formation [GO:0001707]; positive regulation of protein folding [GO:1903334]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922],GO:0003824; GO:0005794; GO:0005975; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_05801,FUN_025790-T1,Peve_00021009,Pocillopora_meandrina_HIv1___RNAseq.g10399.t1,three_way,79.69133333333333,FUN_025790-T1,Q9PTG6,,,,,35.9,362.0,4.2e-45,183.7,sp|Q9PTG6|DCTN2_CHICK Dynactin subunit 2 OS=Gallus gallus OX=9031 GN=DCTN2 PE=2 SV=1,,,,,,
OG_05802,FUN_025792-T1,Peve_00021008,Pocillopora_meandrina_HIv1___RNAseq.g10401.t1,three_way,63.68466666666667,FUN_025792-T1,P68254,1433T_MOUSE,,14-3-3 protein theta (14-3-3 protein tau),Mus musculus (Mouse),62.0,237.0,1.1e-72,274.6,sp|P68254|1433T_MOUSE 14-3-3 protein theta OS=Mus musculus OX=10090 GN=Ywhaq PE=1 SV=1,GO:0005634; GO:0005829; GO:0006605; GO:0007165; GO:0007264; GO:0019904; GO:0032991; GO:0034766; GO:0042802; GO:0044325; GO:0045202; GO:0045892; GO:0071889,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monoatomic ion transmembrane transport [GO:0034766]; protein targeting [GO:0006605]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; synapse [GO:0045202],14-3-3 protein binding [GO:0071889]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; transmembrane transporter binding [GO:0044325],GO:0005634; GO:0005829; GO:0006355; GO:0043226,nucleus; cytosol; regulation of DNA-templated transcription; organelle
OG_05803,FUN_025793-T1,Peve_00021012,Pocillopora_meandrina_HIv1___RNAseq.g10402.t1,three_way,55.269666666666666,FUN_025793-T1,Q6R3M4,POLI_MOUSE,,DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B),Mus musculus (Mouse),40.9,541.0,1.2e-94,349.0,sp|Q6R3M4|POLI_MOUSE DNA polymerase iota OS=Mus musculus OX=10090 GN=Poli PE=1 SV=1,GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0019985; GO:0046872; GO:0071494,cellular response to UV-C [GO:0071494]; DNA replication [GO:0006260]; translesion synthesis [GO:0019985],nucleus [GO:0005634],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_05804,FUN_025798-T1,Peve_00017924,Pocillopora_meandrina_HIv1___RNAseq.g10383.t1,three_way,63.96233333333333,FUN_025798-T1,P0CB42,ALKB1_MOUSE,,Nucleic acid dioxygenase ALKBH1 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 1) (Alpha-ketoglutarate-dependent dioxygenase ABH1) (DNA 6mA demethylase) (DNA N6-methyl adenine demethylase ALKBH1) (EC 1.14.11.51) (DNA lyase ABH1) (EC 4.2.99.18) (DNA oxidative demethylase ALKBH1) (EC 1.14.11.33) (mRNA N(3)-methylcytidine demethylase) (EC 1.14.11.-) (tRNA N1-methyl adenine demethylase) (EC 1.14.11.-),Mus musculus (Mouse),41.8,275.0,7.2e-58,226.1,sp|P0CB42|ALKB1_MOUSE Nucleic acid dioxygenase ALKBH1 OS=Mus musculus OX=10090 GN=Alkbh1 PE=1 SV=1,GO:0000049; GO:0000791; GO:0001701; GO:0001764; GO:0001890; GO:0002101; GO:0005654; GO:0005739; GO:0005783; GO:0006281; GO:0006446; GO:0006448; GO:0008198; GO:0010468; GO:0016706; GO:0030154; GO:0031175; GO:0035513; GO:0035515; GO:0035516; GO:0042056; GO:0042245; GO:0043524; GO:0048589; GO:0070129; GO:0140078; GO:0141131; GO:0141137; GO:1990983; GO:1990984,"cell differentiation [GO:0030154]; developmental growth [GO:0048589]; DNA repair [GO:0006281]; in utero embryonic development [GO:0001701]; negative regulation of neuron apoptotic process [GO:0043524]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; oxidative RNA demethylation [GO:0035513]; placenta development [GO:0001890]; positive regulation of gene expression, epigenetic [GO:0141137]; regulation of gene expression [GO:0010468]; regulation of mitochondrial translation [GO:0070129]; regulation of translational elongation [GO:0006448]; regulation of translational initiation [GO:0006446]; regulation of translational initiation by tRNA modification [GO:1990983]; RNA repair [GO:0042245]; tRNA wobble cytosine modification [GO:0002101]",endoplasmic reticulum [GO:0005783]; euchromatin [GO:0000791]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; broad specificity oxidative DNA demethylase activity [GO:0035516]; chemoattractant activity [GO:0042056]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA N6-methyladenine demethylase activity [GO:0141131]; ferrous iron binding [GO:0008198]; oxidative RNA demethylase activity [GO:0035515]; tRNA binding [GO:0000049]; tRNA demethylase activity [GO:1990984],GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0005783; GO:0006281; GO:0006325; GO:0006399; GO:0016491; GO:0016829; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772; GO:0140097; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; mitochondrion; endoplasmic reticulum; DNA repair; chromatin organization; tRNA metabolic process; oxidoreductase activity; lyase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_05805,FUN_025800-T1,Peve_00017926,Pocillopora_meandrina_HIv1___RNAseq.g10386.t2,three_way,84.613,FUN_025800-T1,Q8VDT1,,,,,52.0,666.0,8.599999999999999e-189,661.8,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_05806,FUN_025802-T1,Peve_00017927,Pocillopora_meandrina_HIv1___RNAseq.g10356.t1,three_way,86.251,FUN_025802-T1,Q7ZVY5,,,,,65.5,469.0,2.6000000000000003e-184,646.4,"sp|Q7ZVY5|CISY_DANRE Citrate synthase, mitochondrial OS=Danio rerio OX=7955 GN=cs PE=2 SV=1",,,,,,
OG_05807,FUN_025803-T1,Peve_00017929,Pocillopora_meandrina_HIv1___RNAseq.g10355.t1,three_way,75.95183333333334,FUN_025803-T1,Q9LI61,,,,,28.9,284.0,7.3e-13,76.3,sp|Q9LI61|AVT6A_ARATH Amino acid transporter AVT6A OS=Arabidopsis thaliana OX=3702 GN=AVT6A PE=2 SV=1,,,,,,
OG_05808,FUN_025806-T1,Peve_00017932,Pocillopora_meandrina_HIv1___RNAseq.g10347.t1,three_way,73.36699999999999,FUN_025806-T1,Q95245,,,,,44.4,169.0,4.999999999999999e-32,139.0,sp|Q95245|CY561_PIG Transmembrane ascorbate-dependent reductase CYB561 OS=Sus scrofa OX=9823 GN=CYB561 PE=2 SV=1,,,,,,
OG_05809,FUN_025809-T2,Peve_00017944,Pocillopora_meandrina_HIv1___TS.g19642.t2,three_way,56.2395,FUN_025809-T2,Q08EN7,,,,,29.7,286.0,1.6e-26,122.5,sp|Q08EN7|ZCPW2_MOUSE Zinc finger CW-type PWWP domain protein 2 homolog OS=Mus musculus OX=10090 GN=Zcwpw2 PE=2 SV=2,,,,,,
OG_05810,FUN_025810-T1,Peve_00002517,Pocillopora_meandrina_HIv1___RNAseq.g9333.t1,three_way,83.25233333333333,FUN_025810-T1,Q9Y6W3,CAN7_HUMAN,,Calpain-7 (EC 3.4.22.-) (PalB homolog) (PalBH),Homo sapiens (Human),52.7,522.0,7.499999999999999e-143,508.8,sp|Q9Y6W3|CAN7_HUMAN Calpain-7 OS=Homo sapiens OX=9606 GN=CAPN7 PE=1 SV=1,GO:0004175; GO:0004197; GO:0004198; GO:0005634; GO:0005813; GO:0005829; GO:0006508; GO:0010634; GO:0070062; GO:0090541; GO:0097264,positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264],centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; MIT domain binding [GO:0090541],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05811,FUN_025813-T1,Peve_00002522,Pocillopora_meandrina_HIv1___RNAseq.g9335.t1,three_way,47.96866666666666,,,,,,,,,,,,,,,,,
OG_05812,FUN_025814-T1,Peve_00002523,Pocillopora_meandrina_HIv1___RNAseq.g9336.t1,three_way,66.91966666666667,FUN_025814-T1,O15520,FGF10_HUMAN,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Homo sapiens (Human),32.0,122.0,1.2e-12,74.7,sp|O15520|FGF10_HUMAN Fibroblast growth factor 10 OS=Homo sapiens OX=9606 GN=FGF10 PE=1 SV=1,GO:0000132; GO:0001525; GO:0001656; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005104; GO:0005111; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007368; GO:0007431; GO:0008083; GO:0008201; GO:0008284; GO:0008543; GO:0008589; GO:0009880; GO:0009986; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0022008; GO:0030036; GO:0030334; GO:0030538; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032781; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0042056; GO:0042060; GO:0042246; GO:0042475; GO:0042693; GO:0043410; GO:0043616; GO:0045739; GO:0045747; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048536; GO:0048538; GO:0048557; GO:0048754; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050731; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060054; GO:0060174; GO:0060428; GO:0060430; GO:0060436; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; lung epithelium development [GO:0060428]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; metanephros morphogenesis [GO:0003338]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; neurogenesis [GO:0022008]; odontogenesis of dentin-containing tooth [GO:0042475]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of ATP-dependent activity [GO:0032781]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland development [GO:0007431]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0005576; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular region; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05813,FUN_025815-T1,Peve_00002524,Pocillopora_meandrina_HIv1___RNAseq.g9337.t1,three_way,46.56366666666667,FUN_025815-T1,O35565,FGF10_MOUSE,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Mus musculus (Mouse),32.5,126.0,2e-11,71.2,sp|O35565|FGF10_MOUSE Fibroblast growth factor 10 OS=Mus musculus OX=10090 GN=Fgf10 PE=2 SV=1,GO:0000132; GO:0000278; GO:0001525; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005111; GO:0005615; GO:0005634; GO:0005886; GO:0006935; GO:0007267; GO:0007368; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008544; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010468; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030036; GO:0030177; GO:0030324; GO:0030538; GO:0030855; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0035108; GO:0035265; GO:0042056; GO:0042060; GO:0042246; GO:0042472; GO:0042475; GO:0042693; GO:0043616; GO:0045739; GO:0045747; GO:0045893; GO:0045931; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048286; GO:0048514; GO:0048536; GO:0048538; GO:0048557; GO:0048565; GO:0048566; GO:0048645; GO:0048730; GO:0048752; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060173; GO:0060174; GO:0060425; GO:0060428; GO:0060430; GO:0060436; GO:0060441; GO:0060445; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060541; GO:0060594; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in salivary gland morphogenesis [GO:0060445]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; inner ear morphogenesis [GO:0042472]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mammary gland specification [GO:0060594]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros morphogenesis [GO:0003338]; mitotic cell cycle [GO:0000278]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; positive regulation of Wnt signaling pathway [GO:0030177]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of gene expression [GO:0010468]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; respiratory system development [GO:0060541]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland morphogenesis [GO:0007435]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; semicircular canal morphogenesis [GO:0048752]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0000278; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05814,FUN_025820-T1,Peve_00033995,Pocillopora_meandrina_HIv1___RNAseq.g9340.t1,three_way,77.072,FUN_025820-T1,A7RHG8,,,,,52.2,429.0,1.1e-131,471.5,sp|A7RHG8|WDR12_NEMVE Ribosome biogenesis protein WDR12 homolog (Fragment) OS=Nematostella vectensis OX=45351 GN=v1g82024 PE=3 SV=1,,,,,,
OG_05815,FUN_025821-T1,Peve_00036285,Pocillopora_meandrina_HIv1___RNAseq.g9341.t1,three_way,70.9975,FUN_025821-T1,Q9TUI4,,,,,51.1,924.0,2.8e-231,803.5,sp|Q9TUI4|KCNH2_PIG Voltage-gated inwardly rectifying potassium channel KCNH2 OS=Sus scrofa OX=9823 GN=KCNH2 PE=2 SV=2,,,,,,
OG_05816,FUN_025823-T1,Peve_00036294,Pocillopora_meandrina_HIv1___RNAseq.g9342.t1,three_way,86.49533333333333,FUN_025823-T1,Q2TCH3,ACLY_SHEEP,,ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (Citrate cleavage enzyme),Ovis aries (Sheep),69.7,1104.0,0.0,1583.2,sp|Q2TCH3|ACLY_SHEEP ATP-citrate synthase OS=Ovis aries OX=9940 GN=ACLY PE=2 SV=1,GO:0003878; GO:0005524; GO:0005829; GO:0006085; GO:0006101; GO:0006633; GO:0008610; GO:0046872,acetyl-CoA biosynthetic process [GO:0006085]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610],cytosol [GO:0005829],ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; metal ion binding [GO:0046872],GO:0003824; GO:0005829; GO:0006629; GO:0006790; GO:0016740; GO:0055086,catalytic activity; cytosol; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process
OG_05817,FUN_025824-T1,Peve_00036284,Pocillopora_meandrina_HIv1___RNAseq.g9344.t1,three_way,88.77216666666666,FUN_025824-T1,Q9GM70,,,,,50.4,282.0,9e-78,292.0,sp|Q9GM70|ST17A_RABIT Serine/threonine-protein kinase 17A OS=Oryctolagus cuniculus OX=9986 GN=STK17A PE=2 SV=1,,,,,,
OG_05818,FUN_025825-T2,Peve_00036287,Pocillopora_meandrina_HIv1___RNAseq.g9345.t1,three_way,78.706,FUN_025825-T2,P54513,,,,,32.3,195.0,9.9e-15,83.6,sp|P54513|YQHO_BACSU Uncharacterized protein YqhO OS=Bacillus subtilis (strain 168) OX=224308 GN=yqhO PE=3 SV=1,,,,,,
OG_05819,FUN_025826-T1,Peve_00036290,Pocillopora_meandrina_HIv1___RNAseq.g9346.t1,three_way,60.5495,FUN_025826-T1,B8V7Q1,,,,,39.9,3257.0,0.0,2112.0,sp|B8V7Q1|PCDL_ACRMI Protocadherin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05820,FUN_025835-T1,Peve_00028303,Pocillopora_meandrina_HIv1___RNAseq.g9347.t1,three_way,68.652,FUN_025835-T1,P08684,CP3A4_HUMAN,,"Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)",Homo sapiens (Human),36.3,482.0,3.3000000000000003e-78,293.9,sp|P08684|CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens OX=9606 GN=CYP3A4 PE=1 SV=4,GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006629; GO:0006706; GO:0006805; GO:0008202; GO:0008203; GO:0008209; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016098; GO:0016491; GO:0019825; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0042759; GO:0043231; GO:0046222; GO:0050591; GO:0050649; GO:0062181; GO:0062187; GO:0062188; GO:0062189; GO:0070576; GO:0070989; GO:0101020; GO:0101021; GO:0102320,aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; androgen metabolic process [GO:0008209]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"1,8-cineole 2-exo-monooxygenase activity [GO:0102320]; 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; quinine 3-monooxygenase activity [GO:0050591]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491; GO:0043226,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity; organelle
OG_05821,FUN_025836-T1,Peve_00028304,Pocillopora_meandrina_HIv1___RNAseq.g10325.t1b,three_way,67.41033333333334,FUN_025836-T1,Q9DBC0,SELO_MOUSE,,"Protein adenylyltransferase SelO, mitochondrial (EC 2.7.7.-) (EC 2.7.7.108) (Selenoprotein O) (SelO)",Mus musculus (Mouse),46.7,642.0,4.1e-148,526.6,"sp|Q9DBC0|SELO_MOUSE Protein adenylyltransferase SelO, mitochondrial OS=Mus musculus OX=10090 GN=Selenoo PE=1 SV=4",GO:0005524; GO:0005694; GO:0005739; GO:0046872; GO:0070733,,chromosome [GO:0005694]; mitochondrion [GO:0005739],AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],GO:0003824; GO:0005694; GO:0005739; GO:0016740; GO:0043226,catalytic activity; chromosome; mitochondrion; transferase activity; organelle
OG_05822,FUN_025838-T1,Peve_00028309,Pocillopora_meandrina_HIv1___RNAseq.g10332.t1,three_way,68.98100000000001,FUN_025838-T1,Q14957,NMDE3_HUMAN,,"Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C)",Homo sapiens (Human),25.0,472.0,4.799999999999998e-41,171.4,"sp|Q14957|NMDE3_HUMAN Glutamate receptor ionotropic, NMDA 2C OS=Homo sapiens OX=9606 GN=GRIN2C PE=1 SV=3",GO:0004972; GO:0005261; GO:0005789; GO:0005886; GO:0007215; GO:0007420; GO:0009611; GO:0017146; GO:0033058; GO:0035235; GO:0035249; GO:0042177; GO:0045211; GO:0048167; GO:0048168; GO:0050885; GO:0051968; GO:0060079; GO:0060291; GO:0097553; GO:0098655; GO:0098839; GO:0098976; GO:0098978; GO:1903539; GO:1904062; GO:1904315; GO:2000463,"brain development [GO:0007420]; calcium ion transmembrane import into cytosol [GO:0097553]; directional locomotion [GO:0033058]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; glutamate receptor signaling pathway [GO:0007215]; ionotropic glutamate receptor signaling pathway [GO:0035235]; long-term synaptic potentiation [GO:0060291]; monoatomic cation transmembrane transport [GO:0098655]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process controlling balance [GO:0050885]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; protein localization to postsynaptic membrane [GO:1903539]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to wounding [GO:0009611]; synaptic transmission, glutamatergic [GO:0035249]",endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211],monoatomic cation channel activity [GO:0005261]; NMDA glutamate receptor activity [GO:0004972]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_05823,FUN_025840-T1,Peve_00028313,Pocillopora_meandrina_HIv1___RNAseq.g10336.t1,three_way,94.462,FUN_025840-T1,Q5ZLC5,ATPB_CHICK,,"ATP synthase F(1) complex catalytic subunit beta, mitochondrial (EC 7.1.2.2) (ATP synthase F1 subunit beta)",Gallus gallus (Chicken),91.4,466.0,4.6e-241,835.1,"sp|Q5ZLC5|ATPB_CHICK ATP synthase F(1) complex catalytic subunit beta, mitochondrial OS=Gallus gallus OX=9031 GN=ATP5F1B PE=1 SV=1",GO:0001525; GO:0005524; GO:0005739; GO:0005743; GO:0015986; GO:0016887; GO:0042776; GO:0045259; GO:0046933,angiogenesis [GO:0001525]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]",GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; transporter activity; mitochondrion; hydrolase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05824,FUN_025841-T1,Peve_00028314,Pocillopora_meandrina_HIv1___RNAseq.g10337.t1,three_way,68.842,FUN_025841-T1,Q921L8,GLT11_MOUSE,,Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11),Mus musculus (Mouse),52.4,553.0,7.5e-165,582.0,sp|Q921L8|GLT11_MOUSE Polypeptide N-acetylgalactosaminyltransferase 11 OS=Mus musculus OX=10090 GN=Galnt11 PE=1 SV=1,GO:0000139; GO:0004653; GO:0005112; GO:0007220; GO:0007368; GO:0008593; GO:0018243; GO:0030246; GO:0046872; GO:0060271; GO:0061314,cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; Notch receptor processing [GO:0007220]; Notch signaling involved in heart development [GO:0061314]; protein O-linked glycosylation via threonine [GO:0018243]; regulation of Notch signaling pathway [GO:0008593],Golgi membrane [GO:0000139],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; Notch binding [GO:0005112]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0016740; GO:0044782; GO:0140096,"catalytic activity; transferase activity; cilium organization; catalytic activity, acting on a protein"
OG_05825,FUN_025842-T1,Peve_00028315,Pocillopora_meandrina_HIv1___TS.g13751.t1,three_way,74.87866666666667,FUN_025842-T1,Q91WG5,AAKG2_MOUSE,,5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2),Mus musculus (Mouse),61.1,314.0,5.6e-108,392.9,sp|Q91WG5|AAKG2_MOUSE 5'-AMP-activated protein kinase subunit gamma-2 OS=Mus musculus OX=10090 GN=Prkag2 PE=1 SV=2,GO:0004679; GO:0004862; GO:0005524; GO:0005654; GO:0005829; GO:0005977; GO:0006110; GO:0006633; GO:0008607; GO:0016208; GO:0019217; GO:0019887; GO:0019901; GO:0030295; GO:0031588; GO:0031669; GO:0035556; GO:0043531,cellular response to nutrient levels [GO:0031669]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; regulation of fatty acid metabolic process [GO:0019217]; regulation of glycolytic process [GO:0006110],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588],ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887],GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0006629; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; lipid metabolic process; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_05826,FUN_025843-T1,Peve_00028316,Pocillopora_meandrina_HIv1___RNAseq.g10339.t1,three_way,66.52566666666667,,,,,,,,,,,,,,,,,
OG_05827,FUN_025844-T1,Peve_00028317,Pocillopora_meandrina_HIv1___RNAseq.g10340.t2a,three_way,92.42766666666668,FUN_025844-T1,Q60HG1,,,,,68.5,771.0,6e-298,1024.6,sp|Q60HG1|ERCC3_MACFA General transcription and DNA repair factor IIH helicase/translocase subunit XPB OS=Macaca fascicularis OX=9541 GN=ERCC3 PE=2 SV=1,,,,,,
OG_05828,FUN_025845-T1,Peve_00012183,Pocillopora_meandrina_HIv1___RNAseq.g10340.t2b,three_way,73.04216666666667,FUN_025845-T1,P42768,WASP_HUMAN,,Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp),Homo sapiens (Human),38.9,293.0,2.1000000000000005e-44,181.8,sp|P42768|WASP_HUMAN Actin nucleation-promoting factor WAS OS=Homo sapiens OX=9606 GN=WAS PE=1 SV=4,GO:0002625; GO:0003779; GO:0005634; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0006952; GO:0006955; GO:0007596; GO:0008064; GO:0008154; GO:0008544; GO:0010591; GO:0012506; GO:0015629; GO:0016197; GO:0017124; GO:0019901; GO:0030041; GO:0030048; GO:0030695; GO:0031267; GO:0032488; GO:0035861; GO:0042110; GO:0042802; GO:0043274; GO:0045335; GO:0045944; GO:0051492; GO:0051497; GO:0065003; GO:0070062; GO:0071346; GO:1905168; GO:2000146,actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to type II interferon [GO:0071346]; defense response [GO:0006952]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506],actin binding [GO:0003779]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267],GO:0002376; GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0048856; GO:0065003; GO:0098772,immune system process; nucleus; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_05829,FUN_025847-T1,Peve_00012182,Pocillopora_meandrina_HIv1___TS.g13754.t1,three_way,63.074,FUN_025847-T1,Q9NZA1,CLIC5_HUMAN,,Chloride intracellular channel protein 5 (Glutaredoxin-like oxidoreductase CLIC5) (EC 1.8.-.-),Homo sapiens (Human),34.1,223.0,1.5e-20,101.3,sp|Q9NZA1|CLIC5_HUMAN Chloride intracellular channel protein 5 OS=Homo sapiens OX=9606 GN=CLIC5 PE=1 SV=3,GO:0005254; GO:0005739; GO:0005794; GO:0005813; GO:0005938; GO:0006821; GO:0007565; GO:0007601; GO:0007605; GO:0015629; GO:0016324; GO:0016491; GO:0032420; GO:0034707; GO:0070062,chloride transport [GO:0006821]; female pregnancy [GO:0007565]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; stereocilium [GO:0032420],chloride channel activity [GO:0005254]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005215; GO:0005739; GO:0005794; GO:0005815; GO:0005856; GO:0016491; GO:0022414; GO:0043226; GO:0050877,catalytic activity; transporter activity; mitochondrion; Golgi apparatus; microtubule organizing center; cytoskeleton; oxidoreductase activity; reproductive process; organelle; nervous system process
OG_05830,FUN_025848-T1,Peve_00012181,Pocillopora_meandrina_HIv1___RNAseq.g10342.t1,three_way,86.345,FUN_025848-T1,Q96KE9,,,,,38.5,429.0,6.8e-73,276.2,sp|Q96KE9|BTBD6_HUMAN BTB/POZ domain-containing protein 6 OS=Homo sapiens OX=9606 GN=BTBD6 PE=1 SV=4,,,,,,
OG_05831,FUN_025871-T1,Peve_00012180,Pocillopora_meandrina_HIv1___RNAseq.g10343.t1,three_way,78.87733333333334,FUN_025871-T1,Q9Y5Z0,BACE2_HUMAN,,Beta-secretase 2 (EC 3.4.23.45) (Aspartic-like protease 56 kDa) (Aspartyl protease 1) (ASP1) (Asp 1) (Beta-site amyloid precursor protein cleaving enzyme 2) (Beta-site APP cleaving enzyme 2) (Down region aspartic protease) (DRAP) (Memapsin-1) (Membrane-associated aspartic protease 1) (Theta-secretase),Homo sapiens (Human),33.6,307.0,2.9999999999999998e-36,154.5,sp|Q9Y5Z0|BACE2_HUMAN Beta-secretase 2 OS=Homo sapiens OX=9606 GN=BACE2 PE=1 SV=1,GO:0004190; GO:0005768; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006508; GO:0006509; GO:0016020; GO:0016485; GO:0016486; GO:0032438; GO:0033162; GO:0042593; GO:0042985; GO:0050435,amyloid-beta metabolic process [GO:0050435]; glucose homeostasis [GO:0042593]; melanosome organization [GO:0032438]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; proteolysis [GO:0006508],endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],aspartic-type endopeptidase activity [GO:0004190],GO:0003824; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_05832,FUN_025872-T1,Peve_00012178,Pocillopora_meandrina_HIv1___TS.g13757.t1,three_way,81.34966666666666,FUN_025872-T1,Q148G4,,,,,60.3,282.0,6.100000000000002e-104,378.6,sp|Q148G4|TATD1_BOVIN Deoxyribonuclease TATDN1 OS=Bos taurus OX=9913 GN=TATDN1 PE=2 SV=1,,,,,,
OG_05833,FUN_025877-T1,Peve_00006434,Pocillopora_meandrina_HIv1___RNAseq.g9351.t1c,three_way,59.905,FUN_025877-T1,Q91ZV7,PLDX1_MOUSE,,Plexin domain-containing protein 1 (Tumor endothelial marker 7),Mus musculus (Mouse),38.3,295.0,4.2e-53,210.3,sp|Q91ZV7|PLDX1_MOUSE Plexin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Plxdc1 PE=1 SV=2,GO:0005576; GO:0005737; GO:0005886; GO:0005923; GO:0021510; GO:0030425; GO:0043025; GO:0043235,spinal cord development [GO:0021510],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],,GO:0005576; GO:0005886; GO:0048856,extracellular region; plasma membrane; anatomical structure development
OG_05834,FUN_025878-T1,Peve_00006435,Pocillopora_meandrina_HIv1___RNAseq.g3176.t1,three_way,82.42066666666666,FUN_025878-T1,Q61753,,,,,53.8,463.0,7.0000000000000014e-130,465.7,sp|Q61753|SERA_MOUSE D-3-phosphoglycerate dehydrogenase OS=Mus musculus OX=10090 GN=Phgdh PE=1 SV=3,,,,,,
OG_05835,FUN_025879-T1,Peve_00006436,Pocillopora_meandrina_HIv1___RNAseq.g3178.t1,three_way,64.36766666666666,,,,,,,,,,,,,,,,,
OG_05836,FUN_025881-T1,Peve_00018905,Pocillopora_meandrina_HIv1___RNAseq.g10520.t1,three_way,82.03883333333333,FUN_025881-T1,Q3ZBT6,TRA2B_BOVIN,,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",Bos taurus (Bovine),59.6,141.0,7.8e-43,175.6,sp|Q3ZBT6|TRA2B_BOVIN Transformer-2 protein homolog beta OS=Bos taurus OX=9913 GN=TRA2B PE=2 SV=1,GO:0000381; GO:0003723; GO:0003729; GO:0005634; GO:0005681; GO:0006397; GO:0008380; GO:0043484; GO:0048026,"mRNA processing [GO:0006397]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]",nucleus [GO:0005634]; spliceosomal complex [GO:0005681],mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_05837,FUN_025883-T1,Peve_00018900,Pocillopora_meandrina_HIv1___TS.g13938.t2,three_way,66.98766666666667,,,,,,,,,,,,,,,,,
OG_05838,FUN_025884-T1,Peve_00018894,Pocillopora_meandrina_HIv1___RNAseq.g10516.t1b,three_way,71.66166666666666,,,,,,,,,,,,,,,,,
OG_05839,FUN_025885-T1,Peve_00018893,Pocillopora_meandrina_HIv1___RNAseq.g10515.t1,three_way,81.218,FUN_025885-T1,P49914,MTHFS_HUMAN,,"5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase)",Homo sapiens (Human),54.7,190.0,3.9e-54,213.0,sp|P49914|MTHFS_HUMAN 5-formyltetrahydrofolate cyclo-ligase OS=Homo sapiens OX=9606 GN=MTHFS PE=1 SV=2,GO:0005524; GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006536; GO:0009396; GO:0015942; GO:0030272; GO:0035999; GO:0046653; GO:0046655; GO:0046657; GO:0046872,folic acid catabolic process [GO:0046657]; folic acid metabolic process [GO:0046655]; folic acid-containing compound biosynthetic process [GO:0009396]; formate metabolic process [GO:0015942]; glutamate metabolic process [GO:0006536]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; folic acid binding [GO:0005542]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0006575; GO:0006766; GO:0016874; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; modified amino acid metabolic process; vitamin metabolic process; ligase activity; organelle
OG_05840,FUN_025888-T1,Peve_00018908,Pocillopora_meandrina_HIv1___RNAseq.g25928.t1,three_way,65.47316666666667,,,,,,,,,,,,,,,,,
OG_05841,FUN_025889-T1,Peve_00024284,Pocillopora_meandrina_HIv1___RNAseq.g10542.t1,three_way,53.60116666666666,FUN_025889-T1,Q5ZM41,,,,,29.0,728.0,7.4e-64,247.3,sp|Q5ZM41|TEX10_CHICK Testis-expressed protein 10 homolog OS=Gallus gallus OX=9031 GN=TEX10 PE=2 SV=1,,,,,,
OG_05842,FUN_025911-T2,Peve_00018892,Pocillopora_meandrina_HIv1___RNAseq.g10543.t1,three_way,87.18599999999999,FUN_025911-T2,Q9Y4A5,TRRAP_HUMAN,,Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog),Homo sapiens (Human),57.4,3490.0,0.0,3867.8,sp|Q9Y4A5|TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens OX=9606 GN=TRRAP PE=1 SV=3,GO:0000124; GO:0000786; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006282; GO:0006355; GO:0006357; GO:0033276; GO:0035267; GO:0042981; GO:0043484; GO:0045893; GO:0051726; GO:0140861; GO:1905168; GO:2000779,DNA repair-dependent chromatin remodeling [GO:0140861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357],Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276],transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0005794; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; Golgi apparatus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_05843,FUN_025912-T1,Peve_00021822,Pocillopora_meandrina_HIv1___RNAseq.g10544.t1,three_way,78.68233333333333,FUN_025912-T1,Q4V8D7,,,,,61.3,287.0,4.1e-107,389.4,sp|Q4V8D7|F221A_RAT Protein FAM221A OS=Rattus norvegicus OX=10116 GN=Fam221a PE=2 SV=2,,,,,,
OG_05844,FUN_025913-T1,Peve_00010174,Pocillopora_meandrina_HIv1___RNAseq.g10545.t1,three_way,67.16866666666667,FUN_025913-T1,Q8NEG5,,,,,38.3,384.0,5.6e-76,287.0,sp|Q8NEG5|ZSWM2_HUMAN E3 ubiquitin-protein ligase ZSWIM2 OS=Homo sapiens OX=9606 GN=ZSWIM2 PE=1 SV=2,,,,,,
OG_05845,FUN_025914-T1,Peve_00010173,Pocillopora_meandrina_HIv1___TS.g13966.t1,three_way,69.57366666666667,,,,,,,,,,,,,,,,,
OG_05846,FUN_025915-T1,Peve_00010172,Pocillopora_meandrina_HIv1___RNAseq.g10468.t1,three_way,86.59700000000001,FUN_025915-T1,Q6DDF0,,,,,41.7,489.0,1.6999999999999998e-96,354.8,sp|Q6DDF0|WDR37_XENLA WD repeat-containing protein 37 OS=Xenopus laevis OX=8355 GN=wdr37 PE=2 SV=1,,,,,,
OG_05847,FUN_025916-T1,Peve_00010171,Pocillopora_meandrina_HIv1___TS.g13883.t1,three_way,63.434333333333335,,,,,,,,,,,,,,,,,
OG_05848,FUN_025917-T1,Peve_00001158,Pocillopora_meandrina_HIv1___RNAseq.g10466.t1,three_way,67.06833333333333,FUN_025917-T1,Q8C6G1,CF410_MOUSE,,Cilia- and flagella-associated protein 410,Mus musculus (Mouse),38.9,265.0,4.6e-38,159.8,sp|Q8C6G1|CF410_MOUSE Cilia- and flagella-associated protein 410 OS=Mus musculus OX=10090 GN=Cfap410 PE=1 SV=1,GO:0001750; GO:0005654; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006974; GO:0007010; GO:0007224; GO:0008360; GO:0032391; GO:0036064; GO:0060271; GO:0097733,cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; DNA damage response [GO:0006974]; regulation of cell shape [GO:0008360]; smoothened signaling pathway [GO:0007224],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor cell cilium [GO:0097733]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886],,GO:0005654; GO:0005739; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007010; GO:0043226; GO:0044782,nucleoplasm; mitochondrion; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; cilium; cytoskeleton organization; organelle; cilium organization
OG_05849,FUN_025921-T2,Peve_00028582,Pocillopora_meandrina_HIv1___RNAseq.g3140.t1,three_way,66.67733333333334,FUN_025921-T2,Q924Y0,,,,,28.8,392.0,3.3e-45,184.1,sp|Q924Y0|BODG_MOUSE Gamma-butyrobetaine dioxygenase OS=Mus musculus OX=10090 GN=Bbox1 PE=1 SV=1,,,,,,
OG_05850,FUN_025923-T1,Peve_00018907,Pocillopora_meandrina_HIv1___TS.g13940.t2,three_way,74.94983333333333,FUN_025923-T1,A1A5K2,CLA1B_XENLA,,CLIP-associating protein 1-B (Cytoplasmic linker-associated protein 1-B) (Protein Orbit homolog) (Xorbit) (Xorbit/CLASP),Xenopus laevis (African clawed frog),42.2,756.0,1.2e-134,482.3,sp|A1A5K2|CLA1B_XENLA CLIP-associating protein 1-B OS=Xenopus laevis OX=8355 GN=clasp1b PE=1 SV=1,GO:0000776; GO:0005794; GO:0005813; GO:0005815; GO:0005876; GO:0005881; GO:0007020; GO:0008017; GO:0031023; GO:0031110; GO:0034453; GO:0040001; GO:0043515; GO:0045180; GO:0051301; GO:0072686; GO:0090307; GO:1902903,cell division [GO:0051301]; establishment of mitotic spindle localization [GO:0040001]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of supramolecular fiber organization [GO:1902903],basal cortex [GO:0045180]; centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; spindle microtubule [GO:0005876],kinetochore binding [GO:0043515]; microtubule binding [GO:0008017],GO:0005794; GO:0005815; GO:0007010; GO:0008092; GO:0043226,Golgi apparatus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_05851,FUN_025924-T1,Peve_00027741,Pocillopora_meandrina_HIv1___RNAseq.g10523.t1,three_way,81.66433333333333,FUN_025924-T1,Q80TV8,CLAP1_MOUSE,,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1),Mus musculus (Mouse),41.3,726.0,1.1e-131,472.2,sp|Q80TV8|CLAP1_MOUSE CLIP-associating protein 1 OS=Mus musculus OX=10090 GN=Clasp1 PE=1 SV=2,GO:0000776; GO:0005794; GO:0005813; GO:0005819; GO:0005874; GO:0005938; GO:0007020; GO:0007026; GO:0008017; GO:0015630; GO:0016477; GO:0030010; GO:0031023; GO:0034453; GO:0051294; GO:0051301,cell division [GO:0051301]; cell migration [GO:0016477]; establishment of cell polarity [GO:0030010]; establishment of spindle orientation [GO:0051294]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; negative regulation of microtubule depolymerization [GO:0007026],cell cortex [GO:0005938]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005794; GO:0005815; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0043226; GO:0048870,Golgi apparatus; microtubule organizing center; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; organelle; cell motility
OG_05852,FUN_025925-T1,Peve_00034317,Pocillopora_meandrina_HIv1___RNAseq.g10524.t1,three_way,79.89450000000001,FUN_025925-T1,A6IPG1,,,,,66.2,225.0,7.6e-65,248.4,sp|A6IPG1|EF1B_RAT Elongation factor 1-beta OS=Rattus norvegicus OX=10116 GN=Eef1b2 PE=1 SV=1,,,,,,
OG_05853,FUN_025926-T1,Peve_00027735,Pocillopora_meandrina_HIv1___RNAseq.g10525.t1,three_way,70.25033333333333,FUN_025926-T1,Q28I29,,,,,39.1,179.0,4.3e-28,125.9,sp|Q28I29|DTWD1_XENTR tRNA-uridine aminocarboxypropyltransferase 1 OS=Xenopus tropicalis OX=8364 GN=dtwd1 PE=2 SV=1,,,,,,
OG_05854,FUN_025929-T1,Peve_00027749,Pocillopora_meandrina_HIv1___RNAseq.g10531.t1,three_way,67.36683333333333,FUN_025929-T1,Q6NUT3,MFS12_HUMAN,,Major facilitator superfamily domain-containing protein 12,Homo sapiens (Human),33.6,529.0,5.6e-76,287.0,sp|Q6NUT3|MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens OX=9606 GN=MFSD12 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_05855,FUN_025934-T1,Peve_00027751,Pocillopora_meandrina_HIv1___RNAseq.g10534.t1,three_way,60.88033333333333,FUN_025934-T1,Q6BZG7,KAPR_DEBHA,,cAMP-dependent protein kinase regulatory subunit (PKA regulatory subunit),Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) (Yeast) (Torulaspora hansenii),25.1,215.0,2.8e-06,55.1,sp|Q6BZG7|KAPR_DEBHA cAMP-dependent protein kinase regulatory subunit OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) OX=284592 GN=PKAR PE=3 SV=2,GO:0000785; GO:0004862; GO:0005634; GO:0005829; GO:0005886; GO:0005952; GO:0006995; GO:0007189; GO:0010603; GO:0030552; GO:0034236; GO:0042149; GO:0042802; GO:0045944; GO:0046580; GO:0046827; GO:0097271,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to glucose starvation [GO:0042149]; cellular response to nitrogen starvation [GO:0006995]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to bud neck [GO:0097271]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603],cAMP-dependent protein kinase complex [GO:0005952]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; identical protein binding [GO:0042802]; protein kinase A catalytic subunit binding [GO:0034236],GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0098772,nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_05856,FUN_025935-T1,Peve_00027752,Pocillopora_meandrina_HIv1___RNAseq.g13629.t2,three_way,63.209,FUN_025935-T1,Q4PZA2,ECE1_MOUSE,,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),Mus musculus (Mouse),35.1,701.0,2.4e-126,454.5,sp|Q4PZA2|ECE1_MOUSE Endothelin-converting enzyme 1 OS=Mus musculus OX=10090 GN=Ece1 PE=1 SV=1,GO:0001921; GO:0004222; GO:0005768; GO:0005794; GO:0007411; GO:0008270; GO:0009897; GO:0009986; GO:0010467; GO:0010814; GO:0010815; GO:0010816; GO:0016486; GO:0031175; GO:0033093; GO:0034959; GO:0035050; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0060385; GO:0097492; GO:1902287,axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492],cell surface [GO:0009986]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Weibel-Palade body [GO:0033093],metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005794; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; endosome; Golgi apparatus; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_05857,FUN_025940-T1,Peve_00027756,Pocillopora_meandrina_HIv1___RNAseq.g10537.t1a,three_way,54.245666666666665,,,,,,,,,,,,,,,,,
OG_05858,FUN_025943-T1,Peve_00003741,Pocillopora_meandrina_HIv1___RNAseq.g10538.t1,three_way,71.72466666666666,FUN_025943-T1,B2RZ86,,,,,31.3,355.0,1.8000000000000002e-28,128.3,sp|B2RZ86|CCD89_RAT Coiled-coil domain-containing protein 89 OS=Rattus norvegicus OX=10116 GN=Ccdc89 PE=2 SV=2,,,,,,
OG_05859,FUN_025962-T1,Peve_00015811,Pocillopora_meandrina_HIv1___RNAseq.26407_t,three_way,53.32666666666667,FUN_025962-T1,O17185,SUP9_CAEEL,,Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38),Caenorhabditis elegans,28.4,257.0,1.3e-22,108.6,sp|O17185|SUP9_CAEEL Two pore potassium channel protein sup-9 OS=Caenorhabditis elegans OX=6239 GN=sup-9 PE=1 SV=2,GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0036195; GO:0055120; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937],muscle cell projection membrane [GO:0036195]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120],outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_05860,FUN_025963-T1,Peve_00015816,Pocillopora_meandrina_HIv1___RNAseq.g10514.t1,three_way,62.4445,,,,,,,,,,,,,,,,,
OG_05861,FUN_025968-T1,Peve_00015812,Pocillopora_meandrina_HIv1___RNAseq.g10513.t1,three_way,76.54333333333334,FUN_025968-T1,Q8IZ52,CHSS2_HUMAN,,Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2),Homo sapiens (Human),31.2,794.0,3.2e-100,367.9,sp|Q8IZ52|CHSS2_HUMAN Chondroitin sulfate synthase 2 OS=Homo sapiens OX=9606 GN=CHPF PE=1 SV=2,GO:0000139; GO:0005759; GO:0005829; GO:0032580; GO:0046872; GO:0047238; GO:0050510; GO:0050650,chondroitin sulfate proteoglycan biosynthetic process [GO:0050650],cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; mitochondrial matrix [GO:0005759],glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510],GO:0003824; GO:0005829; GO:0009101; GO:0016740; GO:1901135,catalytic activity; cytosol; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_05862,FUN_025969-T1,Peve_00002916,Pocillopora_meandrina_HIv1___RNAseq.g10512.t2a,three_way,60.004,,,,,,,,,,,,,,,,,
OG_05863,FUN_025970-T1,Peve_00002912,Pocillopora_meandrina_HIv1___RNAseq.g10511.t1,three_way,65.593,FUN_025970-T1,Q6XYQ8,SYT10_HUMAN,,Synaptotagmin-10 (Synaptotagmin X) (SytX),Homo sapiens (Human),44.2,113.0,7e-19,95.9,sp|Q6XYQ8|SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens OX=9606 GN=SYT10 PE=1 SV=1,GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0006887; GO:0007268; GO:0007608; GO:0016192; GO:0017158; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0061891; GO:0070382; GO:0098793; GO:0098978,chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192],exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658],"calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]",GO:0005886; GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0050877; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; nervous system process; molecular function regulator activity; molecular sensor activity
OG_05864,FUN_025971-T1,Peve_00002910,Pocillopora_meandrina_HIv1___RNAseq.g10510.t1,three_way,71.926,FUN_025971-T1,Q6XYQ8,SYT10_HUMAN,,Synaptotagmin-10 (Synaptotagmin X) (SytX),Homo sapiens (Human),34.1,229.0,9.9e-28,125.2,sp|Q6XYQ8|SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens OX=9606 GN=SYT10 PE=1 SV=1,GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0006887; GO:0007268; GO:0007608; GO:0016192; GO:0017158; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0061891; GO:0070382; GO:0098793; GO:0098978,chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192],exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658],"calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]",GO:0005886; GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0050877; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; nervous system process; molecular function regulator activity; molecular sensor activity
OG_05865,FUN_025974-T1,Peve_00002327,Pocillopora_meandrina_HIv1___RNAseq.g10508.t1,three_way,78.03366666666666,,,,,,,,,,,,,,,,,
OG_05866,FUN_025975-T1,Peve_00002326,Pocillopora_meandrina_HIv1___RNAseq.g10507.t1,three_way,57.90466666666666,,,,,,,,,,,,,,,,,
OG_05867,FUN_025976-T1,Peve_00002325,Pocillopora_meandrina_HIv1___RNAseq.g10506.t1,three_way,64.18716666666667,FUN_025976-T1,Q13873,BMPR2_HUMAN,,Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II),Homo sapiens (Human),38.1,494.0,1.9e-88,328.2,sp|Q13873|BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens OX=9606 GN=BMPR2 PE=1 SV=2,GO:0001568; GO:0001649; GO:0001707; GO:0001893; GO:0001935; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0005024; GO:0005524; GO:0005615; GO:0005654; GO:0005886; GO:0005901; GO:0005905; GO:0005912; GO:0007178; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010628; GO:0010634; GO:0014069; GO:0014916; GO:0016324; GO:0016362; GO:0019838; GO:0030154; GO:0030166; GO:0030308; GO:0030424; GO:0030425; GO:0030501; GO:0030509; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048662; GO:0048842; GO:0048863; GO:0051148; GO:0060173; GO:0060350; GO:0060391; GO:0060412; GO:0060413; GO:0060426; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782,anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lung vasculature development [GO:0060426]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; stem cell differentiation [GO:0048863]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235],"activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta receptor activity [GO:0005024]",GO:0003013; GO:0003824; GO:0005615; GO:0005654; GO:0005886; GO:0006355; GO:0009101; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140096; GO:1901135,"circulatory system process; catalytic activity; extracellular space; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; glycoprotein biosynthetic process; programmed cell death; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_05868,FUN_025977-T1,Peve_00002324,Pocillopora_meandrina_HIv1___RNAseq.g10505.t1,three_way,91.186,FUN_025977-T1,P43450,,,,,76.2,294.0,7.8e-134,478.0,sp|P43450|CDK2_CARAU Cyclin-dependent kinase 2 OS=Carassius auratus OX=7957 GN=cdk2 PE=1 SV=1,,,,,,
OG_05869,FUN_025978-T1,Peve_00002323,Pocillopora_meandrina_HIv1___RNAseq.g10504.t2,three_way,75.62133333333334,FUN_025978-T1,O93479,,,,,54.7,422.0,1.9999999999999998e-122,440.7,sp|O93479|ORC4_XENLA Origin recognition complex subunit 4 OS=Xenopus laevis OX=8355 GN=orc4 PE=2 SV=1,,,,,,
OG_05870,FUN_025985-T1,Peve_00002331,Pocillopora_meandrina_HIv1___RNAseq.g10502.t1,three_way,56.960166666666666,,,,,,,,,,,,,,,,,
OG_05871,FUN_025986-T1,Peve_00002322,Pocillopora_meandrina_HIv1___TS.g13918.t1,three_way,61.095,FUN_025986-T1,Q8K2A1,,,,,50.5,186.0,1e-43,179.1,sp|Q8K2A1|GULP1_MOUSE PTB domain-containing engulfment adapter protein 1 OS=Mus musculus OX=10090 GN=Gulp1 PE=1 SV=1,,,,,,
OG_05872,FUN_026014-T1,Peve_00004062,Pocillopora_meandrina_HIv1___RNAseq.g10490.t1,three_way,68.83616666666667,FUN_026014-T1,Q61122,,,,,30.6,317.0,1.0999999999999998e-24,116.3,sp|Q61122|NAB1_MOUSE NGFI-A-binding protein 1 OS=Mus musculus OX=10090 GN=Nab1 PE=1 SV=2,,,,,,
OG_05873,FUN_026015-T1,Peve_00004071,Pocillopora_meandrina_HIv1___RNAseq.g10491.t1,three_way,88.20066666666666,FUN_026015-T1,B0G143,,,,,47.0,298.0,1.8e-72,274.2,sp|B0G143|UCPB_DICDI Mitochondrial substrate carrier family protein ucpB OS=Dictyostelium discoideum OX=44689 GN=ucpB PE=3 SV=1,,,,,,
OG_05874,FUN_026023-T1,Peve_00026728,Pocillopora_meandrina_HIv1___RNAseq.g10495.t1,three_way,61.43916666666667,FUN_026023-T1,Q91717,,,,,31.0,277.0,2.3e-26,123.6,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_05875,FUN_026024-T1,Peve_00026729,Pocillopora_meandrina_HIv1___RNAseq.g10496.t1,three_way,59.858,FUN_026024-T1,O46392,,,,,37.0,216.0,5.4e-35,152.1,sp|O46392|CO1A2_CANLF Collagen alpha-2(I) chain OS=Canis lupus familiaris OX=9615 GN=COL1A2 PE=2 SV=2,,,,,,
OG_05876,FUN_026025-T1,Peve_00026725,Pocillopora_meandrina_HIv1___RNAseq.g10478.t1,three_way,86.32866666666666,FUN_026025-T1,Q8N0X2,SPG16_HUMAN,,Sperm-associated antigen 16 protein (Pf20 protein homolog),Homo sapiens (Human),40.9,362.0,5.5e-70,266.9,sp|Q8N0X2|SPG16_HUMAN Sperm-associated antigen 16 protein OS=Homo sapiens OX=9606 GN=SPAG16 PE=1 SV=2,GO:0005576; GO:0005930; GO:0007288; GO:0035082; GO:0036126; GO:0060271; GO:0090660; GO:0120197; GO:1990716,axoneme assembly [GO:0035082]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; mucociliary clearance [GO:0120197]; sperm axoneme assembly [GO:0007288],axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126],,GO:0003016; GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0050877,respiratory system process; extracellular region; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; nervous system process
OG_05877,FUN_026027-T1,Peve_00026727,Pocillopora_meandrina_HIv1___RNAseq.g10474.t1,three_way,56.87566666666667,FUN_026027-T1,P32442,MEOX1_MOUSE,,Homeobox protein MOX-1 (Mesenchyme homeobox 1),Mus musculus (Mouse),78.8,66.0,1.8e-23,110.9,sp|P32442|MEOX1_MOUSE Homeobox protein MOX-1 OS=Mus musculus OX=10090 GN=Meox1 PE=1 SV=1,GO:0000978; GO:0001228; GO:0001757; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0043565; GO:0045944; GO:0060218; GO:0061053; GO:0061056; GO:0071837,hematopoietic stem cell differentiation [GO:0060218]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sclerotome development [GO:0061056]; somite development [GO:0061053]; somite specification [GO:0001757],cytoplasm [GO:0005737]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; HMG box domain binding [GO:0071837]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05878,FUN_026029-T1,Peve_00003815,Pocillopora_meandrina_HIv1___RNAseq.26365_t,three_way,69.68616666666667,FUN_026029-T1,F1Q4R9,MEOX1_DANRE,,Homeobox protein MOX-1 (Mesenchyme homeobox 1) (Protein choker),Danio rerio (Zebrafish) (Brachydanio rerio),89.1,55.0,6.3e-20,99.4,sp|F1Q4R9|MEOX1_DANRE Homeobox protein MOX-1 OS=Danio rerio OX=7955 GN=meox1 PE=2 SV=1,GO:0000978; GO:0000981; GO:0001501; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0030097; GO:0043565; GO:0045944; GO:0048066; GO:0055001; GO:0060218; GO:0061053; GO:0061056,developmental pigmentation [GO:0048066]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; muscle cell development [GO:0055001]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; skeletal system development [GO:0001501]; somite development [GO:0061053],cytoplasm [GO:0005737]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_05879,FUN_026032-T1,Peve_00003809,Pocillopora_meandrina_HIv1___RNAseq.g10470.t1,three_way,63.20466666666667,FUN_026032-T1,P05205,HP1_DROME,,Heterochromatin protein 1 (HP1) (Non-histone chromosomal protein C1A9 antigen),Drosophila melanogaster (Fruit fly),49.7,191.0,4.3e-25,116.3,sp|P05205|HP1_DROME Heterochromatin protein 1 OS=Drosophila melanogaster OX=7227 GN=Su(var)205 PE=1 SV=2,GO:0000182; GO:0000278; GO:0000723; GO:0000775; GO:0000779; GO:0000781; GO:0000791; GO:0000792; GO:0000793; GO:0003682; GO:0003696; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005694; GO:0005700; GO:0005701; GO:0005703; GO:0005721; GO:0006355; GO:0010369; GO:0030544; GO:0030674; GO:0031507; GO:0031508; GO:0035064; GO:0042393; GO:0044877; GO:0045892; GO:0045893; GO:0045944; GO:0051276; GO:0070063; GO:0099122; GO:0141006; GO:0141194; GO:1905632; GO:1905634; GO:1905646,chromosome organization [GO:0051276]; heterochromatin formation [GO:0031507]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-templated transcription [GO:0045892]; pericentric heterochromatin formation [GO:0031508]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of FACT complex assembly [GO:1905646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to euchromatin [GO:1905632]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization to chromatin [GO:1905634]; siRNA-mediated heterochromatin formation [GO:0141194]; telomere maintenance [GO:0000723]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],"chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; chromosome, telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; condensed chromosome, centromeric region [GO:0000779]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; polytene chromosome [GO:0005700]; polytene chromosome chromocenter [GO:0005701]; polytene chromosome puff [GO:0005703]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; methylated histone binding [GO:0035064]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; rDNA binding [GO:0000182]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II C-terminal domain binding [GO:0099122]; satellite DNA binding [GO:0003696],GO:0000278; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0031047; GO:0032200; GO:0042393; GO:0043226; GO:0060090,mitotic cell cycle; DNA binding; RNA binding; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; regulatory ncRNA-mediated gene silencing; telomere organization; histone binding; organelle; molecular adaptor activity
OG_05880,FUN_026033-T1,Peve_00003810,Pocillopora_meandrina_HIv1___RNAseq.g10469.t1,three_way,72.66566666666667,FUN_026033-T1,Q8BP00,IQCB1_MOUSE,,IQ calmodulin-binding motif-containing protein 1,Mus musculus (Mouse),32.5,569.0,6.2e-74,280.0,sp|Q8BP00|IQCB1_MOUSE IQ calmodulin-binding motif-containing protein 1 OS=Mus musculus OX=10090 GN=Iqcb1 PE=1 SV=2,GO:0001750; GO:0005516; GO:0005737; GO:0005813; GO:0019899; GO:0030674; GO:0032391; GO:0045494; GO:0048496; GO:0060271; GO:0061824; GO:0062063,cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494],centrosome [GO:0005813]; cytoplasm [GO:0005737]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750],BBSome binding [GO:0062063]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; protein-macromolecule adaptor activity [GO:0030674],GO:0005815; GO:0044782; GO:0060090,microtubule organizing center; cilium organization; molecular adaptor activity
OG_05881,FUN_026034-T1,Peve_00022184,Pocillopora_meandrina_HIv1___RNAseq.g10547.t1,three_way,87.94766666666666,FUN_026034-T1,P29074,PTN4_HUMAN,,Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1),Homo sapiens (Human),43.1,929.0,2e-217,757.3,sp|P29074|PTN4_HUMAN Tyrosine-protein phosphatase non-receptor type 4 OS=Homo sapiens OX=9606 GN=PTPN4 PE=1 SV=1,GO:0004725; GO:0004726; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0006470; GO:0008092; GO:0009898; GO:0035254,protein dephosphorylation [GO:0006470],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],cytoskeletal protein binding [GO:0008092]; glutamate receptor binding [GO:0035254]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005654; GO:0005829; GO:0005856; GO:0008092; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; cytoskeleton; cytoskeletal protein binding; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05882,FUN_026035-T1,Peve_00022186,Pocillopora_meandrina_HIv1___TS.g13968.t3,three_way,87.66533333333334,FUN_026035-T1,Q5ZKI4,,,,,58.3,604.0,6.5000000000000004e-186,652.1,sp|Q5ZKI4|CCD93_CHICK Coiled-coil domain-containing protein 93 OS=Gallus gallus OX=9031 GN=CCDC93 PE=2 SV=1,,,,,,
OG_05883,FUN_026036-T1,Peve_00022187,Pocillopora_meandrina_HIv1___RNAseq.g10549.t1,three_way,71.13533333333334,,,,,,,,,,,,,,,,,
OG_05884,FUN_026037-T1,Peve_00025183,Pocillopora_meandrina_HIv1___RNAseq.g10550.t1,three_way,71.07133333333333,FUN_026037-T1,P47727,CBR1_RAT,,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)",Rattus norvegicus (Rat),45.3,278.0,2.3e-66,253.8,sp|P47727|CBR1_RAT Carbonyl reductase [NADPH] 1 OS=Rattus norvegicus OX=10116 GN=Cbr1 PE=1 SV=2,GO:0001542; GO:0004090; GO:0005737; GO:0005902; GO:0006706; GO:0006805; GO:0008211; GO:0016616; GO:0016655; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0047020; GO:0047021; GO:0050221; GO:0160163; GO:1905344; GO:2000379,epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; microvillus [GO:0005902],"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E2 9-reductase activity [GO:0050221]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163]",GO:0003824; GO:0006629; GO:0006766; GO:0016491; GO:0022414; GO:0030154,catalytic activity; lipid metabolic process; vitamin metabolic process; oxidoreductase activity; reproductive process; cell differentiation
OG_05885,FUN_026038-T1,Peve_00022188,Pocillopora_meandrina_HIv1___RNAseq.g10551.t1,three_way,73.833,FUN_026038-T1,A0JMH2,,,,,40.4,292.0,2.7000000000000008e-59,230.3,sp|A0JMH2|CB069_DANRE Mitochondrial protein C2orf69 homolog OS=Danio rerio OX=7955 GN=zgc:153521 PE=2 SV=1,,,,,,
OG_05886,FUN_026049-T1,Peve_00022189,Pocillopora_meandrina_HIv1___TS.g13972.t1,three_way,66.42933333333333,FUN_026049-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),35.0,537.0,5.4e-80,300.1,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_05887,FUN_026051-T1,Peve_00022190,Pocillopora_meandrina_HIv1___RNAseq.g10553.t1,three_way,59.20016666666667,FUN_026051-T1,Q8NFZ3,,,,,33.3,631.0,7.6e-91,336.3,"sp|Q8NFZ3|NLGNY_HUMAN Neuroligin-4, Y-linked OS=Homo sapiens OX=9606 GN=NLGN4Y PE=1 SV=1",,,,,,
OG_05888,FUN_026052-T1,Peve_00022191,Pocillopora_meandrina_HIv1___RNAseq.g10554.t1,three_way,94.17266666666669,,,,,,,,,,,,,,,,,
OG_05889,FUN_026053-T1,Peve_00017807,Pocillopora_meandrina_HIv1___RNAseq.g10555.t1,three_way,95.15933333333334,FUN_026053-T1,Q96GM5,SMRD1_HUMAN,,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 (60 kDa BRG-1/Brm-associated factor subunit A) (BRG1-associated factor 60A) (BAF60A) (SWI/SNF complex 60 kDa subunit),Homo sapiens (Human),74.5,388.0,1.2999999999999998e-173,610.9,sp|Q96GM5|SMRD1_HUMAN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 OS=Homo sapiens OX=9606 GN=SMARCD1 PE=1 SV=2,GO:0000776; GO:0000785; GO:0003682; GO:0003712; GO:0003713; GO:0005102; GO:0005634; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0008284; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0035060; GO:0043231; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045815; GO:0060090; GO:0070316; GO:0071398; GO:0071564; GO:0071565; GO:0140288; GO:1902459; GO:2000045; GO:2000781; GO:2000819,cellular response to fatty acid [GO:0071398]; chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815],brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514],chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_05890,FUN_026054-T1,Peve_00017806,Pocillopora_meandrina_HIv1___RNAseq.g10556.t1,three_way,44.381166666666665,,,,,,,,,,,,,,,,,
OG_05891,FUN_026057-T1,Peve_00022193,Pocillopora_meandrina_HIv1___RNAseq.g10569.t1,three_way,81.50766666666667,FUN_026057-T1,Q66I12,CCD47_DANRE,,PAT complex subunit CCDC47 (Coiled-coil domain-containing protein 47),Danio rerio (Zebrafish) (Brachydanio rerio),44.5,321.0,3.9e-74,280.4,sp|Q66I12|CCD47_DANRE PAT complex subunit CCDC47 OS=Danio rerio OX=7955 GN=ccdc47 PE=2 SV=1,GO:0005509; GO:0005783; GO:0005789; GO:0030867; GO:0032469; GO:0043022; GO:0044183; GO:0045048; GO:0160063; GO:0160064,endoplasmic reticulum calcium ion homeostasis [GO:0032469]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; protein insertion into ER membrane [GO:0045048],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; multi-pass translocon complex [GO:0160064]; rough endoplasmic reticulum membrane [GO:0030867],calcium ion binding [GO:0005509]; protein folding chaperone [GO:0044183]; ribosome binding [GO:0043022],GO:0005783; GO:0043226; GO:0044183,endoplasmic reticulum; organelle; protein folding chaperone
OG_05892,FUN_026058-T1,Peve_00022194,Pocillopora_meandrina_HIv1___RNAseq.g10568.t1,three_way,87.0575,FUN_026058-T1,Q9BUQ8,,,,,74.4,575.0,3.3e-256,885.9,sp|Q9BUQ8|DDX23_HUMAN Probable ATP-dependent RNA helicase DDX23 OS=Homo sapiens OX=9606 GN=DDX23 PE=1 SV=3,,,,,,
OG_05893,FUN_026062-T1,Peve_00005309,Pocillopora_meandrina_HIv1___RNAseq.g5411.t1,three_way,83.498,,,,,,,,,,,,,,,,,
OG_05894,FUN_026070-T1,Peve_00010394,Pocillopora_meandrina_HIv1___RNAseq.g10565.t1,three_way,76.21583333333334,FUN_026070-T1,Q80U56,,,,,43.2,236.0,1.9e-48,194.1,sp|Q80U56|AVL9_MOUSE Late secretory pathway protein AVL9 homolog OS=Mus musculus OX=10090 GN=Avl9 PE=1 SV=2,,,,,,
OG_05895,FUN_026071-T1,Peve_00010393,Pocillopora_meandrina_HIv1___TS.g13984.t1,three_way,67.47733333333333,FUN_026071-T1,O82333,,,,,27.7,573.0,9e-47,189.9,sp|O82333|GH31_ARATH Probable indole-3-acetic acid-amido synthetase GH3.1 OS=Arabidopsis thaliana OX=3702 GN=GH3.1 PE=2 SV=1,,,,,,
OG_05896,FUN_026072-T1,Peve_00010389,Pocillopora_meandrina_HIv1___RNAseq.g10563.t1c,three_way,70.632,FUN_026072-T1,O19998,,,,,50.7,207.0,4.7e-52,207.6,sp|O19998|HO_RHOVL Heme oxygenase OS=Rhodella violacea OX=2801 GN=pbsA PE=3 SV=1,,,,,,
OG_05897,FUN_026073-T1,Peve_00002028,Pocillopora_meandrina_HIv1___RNAseq.g10563.t1a,three_way,88.83766666666666,FUN_026073-T1,Q5F495,,,,,81.9,204.0,3.4000000000000003e-100,365.9,sp|Q5F495|PHOCN_CHICK MOB-like protein phocein OS=Gallus gallus OX=9031 GN=MOB4 PE=2 SV=1,,,,,,
OG_05898,FUN_026074-T1,Peve_00002027,Pocillopora_meandrina_HIv1___RNAseq.g10562.t1,three_way,77.955,FUN_026074-T1,Q7TNE1,SUCHY_MOUSE,,Succinyl-CoA:glutarate CoA-transferase (EC 2.8.3.-) (Dicarboxyl-CoA:dicarboxylic acid coenzyme A transferase SUGCT) (Succinate--hydroxymethylglutarate CoA-transferase) (EC 2.8.3.13),Mus musculus (Mouse),65.4,237.0,5.4e-88,325.9,sp|Q7TNE1|SUCHY_MOUSE Succinyl-CoA:glutarate CoA-transferase OS=Mus musculus OX=10090 GN=Sugct PE=1 SV=2,GO:0005739; GO:0047369,,mitochondrion [GO:0005739],succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369],GO:0003824; GO:0005739; GO:0016740; GO:0043226,catalytic activity; mitochondrion; transferase activity; organelle
OG_05899,FUN_026076-T1,Peve_00002022,Pocillopora_meandrina_HIv1___RNAseq.g10561.t1,three_way,58.79216666666667,FUN_026076-T1,Q9NVE5,,,,,35.0,1254.0,1.6e-196,688.3,sp|Q9NVE5|UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens OX=9606 GN=USP40 PE=1 SV=3,,,,,,
OG_05900,FUN_026078-T1,Peve_00016849,Pocillopora_meandrina_HIv1___RNAseq.g10560.t1,three_way,71.18333333333334,FUN_026078-T1,Q9D1Z3,ACKMT_MOUSE,,ATP synthase subunit C lysine N-methyltransferase (EC 2.1.1.-) (Protein N-lysine methyltransferase FAM173B) (mFam173b),Mus musculus (Mouse),53.5,187.0,2.9e-50,199.9,sp|Q9D1Z3|ACKMT_MOUSE ATP synthase subunit C lysine N-methyltransferase OS=Mus musculus OX=10090 GN=Atpsckmt PE=1 SV=1,GO:0005739; GO:0016279; GO:0018022; GO:0018023; GO:0030061; GO:1904058; GO:1905273; GO:1905706,"peptidyl-lysine methylation [GO:0018022]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; positive regulation of sensory perception of pain [GO:1904058]; regulation of mitochondrial ATP synthesis coupled proton transport [GO:1905706]",mitochondrial crista [GO:0030061]; mitochondrion [GO:0005739],protein-lysine N-methyltransferase activity [GO:0016279],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_05901,FUN_026079-T1,Peve_00016850,Pocillopora_meandrina_HIv1___RNAseq.g10559.t1,three_way,85.88933333333334,FUN_026079-T1,Q3ZBL4,LZTL1_BOVIN,,Leucine zipper transcription factor-like protein 1,Bos taurus (Bovine),52.5,303.0,2.4e-77,290.4,sp|Q3ZBL4|LZTL1_BOVIN Leucine zipper transcription factor-like protein 1 OS=Bos taurus OX=9913 GN=LZTFL1 PE=2 SV=1,GO:0002177; GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0030317; GO:0042802; GO:0044877; GO:1903565; GO:1903568,flagellated sperm motility [GO:0030317]; negative regulation of protein localization to ciliary membrane [GO:1903568]; negative regulation of protein localization to cilium [GO:1903565]; spermatogenesis [GO:0007283],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177],identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877],GO:0005829; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cytosol; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_05902,FUN_026081-T1,Peve_00004132,Pocillopora_meandrina_HIv1___RNAseq.g10570.t1,three_way,97.37833333333332,FUN_026081-T1,Q96KC2,,,,,79.0,176.0,5.6e-79,295.0,sp|Q96KC2|ARL5B_HUMAN ADP-ribosylation factor-like protein 5B OS=Homo sapiens OX=9606 GN=ARL5B PE=1 SV=1,,,,,,
OG_05903,FUN_026088-T1,Peve_00004126,Pocillopora_meandrina_HIv1___RNAseq.g10571.t1,three_way,73.563,FUN_026088-T1,Q5FVG2,E41L5_RAT,,Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5),Rattus norvegicus (Rat),47.5,358.0,2.8e-86,321.6,sp|Q5FVG2|E41L5_RAT Band 4.1-like protein 5 OS=Rattus norvegicus OX=10116 GN=Epb41l5 PE=1 SV=2,GO:0000902; GO:0001701; GO:0001756; GO:0001837; GO:0001839; GO:0001917; GO:0001954; GO:0003382; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007498; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0030036; GO:0031032; GO:0031252; GO:0032525; GO:0032587; GO:0048318; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560,"actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis [GO:0000902]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]",adherens junction [GO:0005912]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904],GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0048870,nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; cell motility
OG_05904,FUN_026090-T1,Peve_00004127,Pocillopora_meandrina_HIv1___TS.g13992.t1,three_way,76.80466666666666,FUN_026090-T1,Q08D64,ABCB6_XENTR,,ATP-binding cassette sub-family B member 6 (ABC-type heme transporter ABCB6) (EC 7.6.2.5),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),55.9,755.0,4.1e-234,812.8,sp|Q08D64|ABCB6_XENTR ATP-binding cassette sub-family B member 6 OS=Xenopus tropicalis OX=8364 GN=abcb6 PE=2 SV=1,GO:0000139; GO:0005524; GO:0005739; GO:0005741; GO:0005765; GO:0005789; GO:0005794; GO:0005886; GO:0006778; GO:0006878; GO:0015439; GO:0016887; GO:0031901; GO:0031902; GO:0032585; GO:0033013; GO:0033162; GO:0035351; GO:0036020; GO:0042168; GO:0046906; GO:0070062; GO:0098849; GO:0140359; GO:1903232,cellular detoxification of cadmium ion [GO:0098849]; heme metabolic process [GO:0042168]; heme transmembrane transport [GO:0035351]; intracellular copper ion homeostasis [GO:0006878]; melanosome assembly [GO:1903232]; porphyrin-containing compound metabolic process [GO:0006778]; tetrapyrrole metabolic process [GO:0033013],early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome membrane [GO:0033162]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type heme transporter activity [GO:0015439]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; tetrapyrrole binding [GO:0046906],GO:0003824; GO:0005215; GO:0005739; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0098754; GO:0140657,catalytic activity; transporter activity; mitochondrion; Golgi apparatus; plasma membrane; hydrolase activity; organelle; transmembrane transport; detoxification; ATP-dependent activity
OG_05905,FUN_026091-T1,Peve_00017829,Pocillopora_meandrina_HIv1___RNAseq.g10573.t1,three_way,33.376,,,,,,,,,,,,,,,,,
OG_05906,FUN_026093-T1,Peve_00036299,Pocillopora_meandrina_HIv1___RNAseq.g10574.t1a,three_way,64.66183333333333,FUN_026093-T1,Q9Y6M1,IF2B2_HUMAN,,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),Homo sapiens (Human),30.0,474.0,8.6e-34,146.4,sp|Q9Y6M1|IF2B2_HUMAN Insulin-like growth factor 2 mRNA-binding protein 2 OS=Homo sapiens OX=9606 GN=IGF2BP2 PE=1 SV=2,GO:0000932; GO:0001817; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0007399; GO:0009653; GO:0010494; GO:0017148; GO:0043489; GO:0045182; GO:0048027; GO:0051028; GO:0070934; GO:0097009; GO:0106106; GO:1990247,anatomical structure morphogenesis [GO:0009653]; cold-induced thermogenesis [GO:0106106]; CRD-mediated mRNA stabilization [GO:0070934]; energy homeostasis [GO:0097009]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; nervous system development [GO:0007399]; regulation of cytokine production [GO:0001817]; RNA stabilization [GO:0043489],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723]; translation regulator activity [GO:0045182],GO:0003723; GO:0005634; GO:0005829; GO:0005856; GO:0043226; GO:0045182; GO:0048856; GO:0060090,RNA binding; nucleus; cytosol; cytoskeleton; organelle; translation regulator activity; anatomical structure development; molecular adaptor activity
OG_05907,FUN_026096-T1,Peve_00013339,Pocillopora_meandrina_HIv1___RNAseq.g10574.t1b,three_way,84.50033333333333,FUN_026096-T1,P19891,,,,,60.1,564.0,4.6e-196,685.6,sp|P19891|ASNS_CRIGR Asparagine synthetase [glutamine-hydrolyzing] OS=Cricetulus griseus OX=10029 GN=ASNS PE=2 SV=2,,,,,,
OG_05908,FUN_026097-T1,Peve_00013340,Pocillopora_meandrina_HIv1___RNAseq.g10575.t1,three_way,60.32333333333333,FUN_026097-T1,A1DWM3,,,,,26.4,648.0,3.7e-48,194.5,sp|A1DWM3|MFSD6_PIG Major facilitator superfamily domain-containing protein 6 OS=Sus scrofa OX=9823 GN=MFSD6 PE=2 SV=1,,,,,,
OG_05909,FUN_026100-T1,Peve_00013337,Pocillopora_meandrina_HIv1___RNAseq.g10578.t1,three_way,53.79516666666667,FUN_026100-T1,Q6ZSS7,MFSD6_HUMAN,,Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog),Homo sapiens (Human),46.2,106.0,1.0000000000000001e-23,114.0,sp|Q6ZSS7|MFSD6_HUMAN Major facilitator superfamily domain-containing protein 6 OS=Homo sapiens OX=9606 GN=MFSD6 PE=1 SV=2,GO:0005886; GO:0016020; GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I [GO:0042590],membrane [GO:0016020]; plasma membrane [GO:0005886],,GO:0002376; GO:0005886,immune system process; plasma membrane
OG_05910,FUN_026101-T1,Peve_00013338,Pocillopora_meandrina_HIv1___RNAseq.g10579.t1,three_way,87.09166666666667,FUN_026101-T1,Q96JG6,,,,,51.6,965.0,9.3e-269,927.9,sp|Q96JG6|VPS50_HUMAN Syndetin OS=Homo sapiens OX=9606 GN=VPS50 PE=1 SV=3,,,,,,
OG_05911,FUN_026102-T1,Peve_00013333,Pocillopora_meandrina_HIv1___RNAseq.g10577.t1,three_way,60.9305,FUN_026102-T1,Q1LUQ4,,,,,21.8,611.0,7.400000000000001e-22,107.1,sp|Q1LUQ4|MFD6A_DANRE Major facilitator superfamily domain-containing protein 6-A OS=Danio rerio OX=7955 GN=mfsd6a PE=3 SV=1,,,,,,
OG_05912,FUN_026103-T1,Peve_00044189,Pocillopora_meandrina_HIv1___RNAseq.g10325.t1a,three_way,77.14266666666667,FUN_026103-T1,Q2TA12,,,,,45.4,207.0,1.9e-44,181.0,sp|Q2TA12|RM02_BOVIN Large ribosomal subunit protein uL2m OS=Bos taurus OX=9913 GN=MRPL2 PE=1 SV=2,,,,,,
OG_05913,FUN_026104-T1,Peve_00044188,Pocillopora_meandrina_HIv1___RNAseq.g10324.t1,three_way,89.33133333333333,FUN_026104-T1,P15690,,,,,68.5,695.0,7.7e-284,977.6,"sp|P15690|NDUS1_BOVIN NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS1 PE=1 SV=1",,,,,,
OG_05914,FUN_026106-T1,Peve_00044187,Pocillopora_meandrina_HIv1___RNAseq.g10323.t1,three_way,77.17033333333333,FUN_026106-T1,Q9UL51,HCN2_HUMAN,,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2),Homo sapiens (Human),55.8,258.0,1.8e-72,274.6,sp|Q9UL51|HCN2_HUMAN Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 OS=Homo sapiens OX=9606 GN=HCN2 PE=1 SV=3,GO:0003254; GO:0005222; GO:0005248; GO:0005249; GO:0005886; GO:0007267; GO:0008076; GO:0009410; GO:0030165; GO:0030424; GO:0030425; GO:0030552; GO:0032590; GO:0035725; GO:0042391; GO:0042802; GO:0043025; GO:0043198; GO:0044877; GO:0060090; GO:0071320; GO:0071321; GO:0071805; GO:0072488; GO:0086012; GO:0098719; GO:0098855; GO:1904045; GO:1990573,ammonium transmembrane transport [GO:0072488]; cell-cell signaling [GO:0007267]; cellular response to aldosterone [GO:1904045]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; membrane depolarization during cardiac muscle cell action potential [GO:0086012]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; regulation of membrane depolarization [GO:0003254]; regulation of membrane potential [GO:0042391]; response to xenobiotic stimulus [GO:0009410]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725],axon [GO:0030424]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; dendritic shaft [GO:0043198]; HCN channel complex [GO:0098855]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076],cAMP binding [GO:0030552]; identical protein binding [GO:0042802]; intracellularly cAMP-activated cation channel activity [GO:0005222]; molecular adaptor activity [GO:0060090]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060090,transporter activity; plasma membrane; signaling; transmembrane transport; molecular adaptor activity
OG_05915,FUN_026107-T1,Peve_00044186,Pocillopora_meandrina_HIv1___RNAseq.g10322.t1,three_way,90.69366666666669,FUN_026107-T1,P22033,MUTA_HUMAN,,"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)",Homo sapiens (Human),74.7,732.0,0.0,1115.5,"sp|P22033|MUTA_HUMAN Methylmalonyl-CoA mutase, mitochondrial OS=Homo sapiens OX=9606 GN=MMUT PE=1 SV=4",GO:0003924; GO:0004494; GO:0005737; GO:0005739; GO:0005759; GO:0009791; GO:0019678; GO:0031419; GO:0042802; GO:0042803; GO:0043547; GO:0046872; GO:0050667; GO:0072341; GO:1901290,"homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791]; propionate metabolic process, methylmalonyl pathway [GO:0019678]; succinyl-CoA biosynthetic process [GO:1901290]",cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0006520; GO:0006629; GO:0006790; GO:0016787; GO:0016853; GO:0043226; GO:0055086,catalytic activity; GTPase activity; mitochondrion; amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; hydrolase activity; isomerase activity; organelle; nucleobase-containing small molecule metabolic process
OG_05916,FUN_026108-T1,Peve_00014996,Pocillopora_meandrina_HIv1___RNAseq.g10317.t1,three_way,87.78083333333333,FUN_026108-T1,Q9HD67,MYO10_HUMAN,,Unconventional myosin-X (Unconventional myosin-10),Homo sapiens (Human),45.4,2065.0,0.0,1582.8,sp|Q9HD67|MYO10_HUMAN Unconventional myosin-X OS=Homo sapiens OX=9606 GN=MYO10 PE=1 SV=3,GO:0000146; GO:0001726; GO:0005516; GO:0005524; GO:0005547; GO:0005730; GO:0005829; GO:0005886; GO:0005938; GO:0007165; GO:0008360; GO:0016459; GO:0022409; GO:0030027; GO:0030175; GO:0030507; GO:0030705; GO:0031527; GO:0032433; GO:0043005; GO:0043025; GO:0051015; GO:0051489; GO:0060002,cytoskeleton-dependent intracellular transport [GO:0030705]; positive regulation of cell-cell adhesion [GO:0022409]; regulation of cell shape [GO:0008360]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165],cell cortex [GO:0005938]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; plus-end directed microfilament motor activity [GO:0060002]; spectrin binding [GO:0030507]",GO:0003774; GO:0003824; GO:0005730; GO:0005829; GO:0005886; GO:0008092; GO:0008289; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleolus; cytosol; plasma membrane; cytoskeletal protein binding; lipid binding; isomerase activity; organelle; ATP-dependent activity
OG_05917,FUN_026112-T1,Peve_00014998,Pocillopora_meandrina_HIv1___TS.g13728.t1,three_way,36.16533333333333,,,,,,,,,,,,,,,,,
OG_05918,FUN_026113-T1,Peve_00013996,Pocillopora_meandrina_HIv1___RNAseq.g10315.t1,three_way,80.111,FUN_026113-T1,Q642F4,,,,,39.4,307.0,4.7e-54,213.0,sp|Q642F4|SC22A_RAT Vesicle-trafficking protein SEC22a OS=Rattus norvegicus OX=10116 GN=Sec22a PE=2 SV=1,,,,,,
OG_05919,FUN_026115-T1,Peve_00013997,Pocillopora_meandrina_HIv1___RNAseq.20147_t,three_way,55.01466666666666,,,,,,,,,,,,,,,,,
OG_05920,FUN_026136-T1,Peve_00029016,Pocillopora_meandrina_HIv1___RNAseq.g6100.t1,three_way,47.75216666666667,,,,,,,,,,,,,,,,,
OG_05921,FUN_026144-T1,Peve_00014870,Pocillopora_meandrina_HIv1___RNAseq.g3241.t1,three_way,80.867,FUN_026144-T1,Q4G0U5,PCDP1_HUMAN,,Cilia- and flagella-associated protein 221 (Primary ciliary dyskinesia protein 1),Homo sapiens (Human),36.6,848.0,1.2e-140,502.3,sp|Q4G0U5|PCDP1_HUMAN Cilia- and flagella-associated protein 221 OS=Homo sapiens OX=9606 GN=CFAP221 PE=1 SV=2,GO:0002177; GO:0005516; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0036126; GO:0044458; GO:0051649; GO:0060271; GO:0090660; GO:0097386; GO:0097729; GO:0120197; GO:0120316,cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; motile cilium assembly [GO:0044458]; mucociliary clearance [GO:0120197]; sperm flagellum assembly [GO:0120316],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; manchette [GO:0002177]; sperm flagellum [GO:0036126],calmodulin binding [GO:0005516],GO:0003016; GO:0005576; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0050877,respiratory system process; extracellular region; cilium; microtubule-based movement; reproductive process; organelle; cilium organization; nervous system process
OG_05922,FUN_026145-T1,Peve_00014871,Pocillopora_meandrina_HIv1___RNAseq.g3240.t1,three_way,90.387,FUN_026145-T1,Q2KJA2,,,,,72.2,540.0,1.7e-233,810.1,sp|Q2KJA2|ABCF2_BOVIN ATP-binding cassette sub-family F member 2 OS=Bos taurus OX=9913 GN=ABCF2 PE=2 SV=1,,,,,,
OG_05923,FUN_026146-T1,Peve_00014873,Pocillopora_meandrina_HIv1___RNAseq.g3230.t1,three_way,58.29633333333334,,,,,,,,,,,,,,,,,
OG_05924,FUN_026147-T1,Peve_00014874,Pocillopora_meandrina_HIv1___RNAseq.g3231.t1,three_way,62.565,FUN_026147-T1,Q24K03,,,,,39.3,336.0,1.8e-52,208.0,sp|Q24K03|THUM1_BOVIN THUMP domain-containing protein 1 OS=Bos taurus OX=9913 GN=THUMPD1 PE=2 SV=1,,,,,,
OG_05925,FUN_026148-T1,Peve_00014875,Pocillopora_meandrina_HIv1___RNAseq.g3232.t1,three_way,87.95866666666667,FUN_026148-T1,Q64261,CDK6_MOUSE,,Cyclin-dependent kinase 6 (EC 2.7.11.22) (CR2 protein kinase) (CRK2) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE),Mus musculus (Mouse),68.0,222.0,6.7e-85,315.1,sp|Q64261|CDK6_MOUSE Cyclin-dependent kinase 6 OS=Mus musculus OX=10090 GN=Cdk6 PE=1 SV=2,GO:0000082; GO:0000122; GO:0001726; GO:0001954; GO:0002244; GO:0003323; GO:0004693; GO:0005524; GO:0005654; GO:0005813; GO:0005829; GO:0006974; GO:0007219; GO:0009615; GO:0010628; GO:0016301; GO:0030097; GO:0030332; GO:0033077; GO:0042063; GO:0043697; GO:0045646; GO:0045656; GO:0045668; GO:0045786; GO:0048146; GO:0050680; GO:0051301; GO:0060218; GO:0097131; GO:0097132; GO:0097133; GO:0098770; GO:0106310; GO:1902036; GO:2000773,cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; DNA damage response [GO:0006974]; G1/S transition of mitotic cell cycle [GO:0000082]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; regulation of erythrocyte differentiation [GO:0045646]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],centrosome [GO:0005813]; cyclin D1-CDK6 complex [GO:0097131]; cyclin D2-CDK6 complex [GO:0097132]; cyclin D3-CDK6 complex [GO:0097133]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ruffle [GO:0001726],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310],GO:0002376; GO:0003824; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0016740; GO:0030154; GO:0048856; GO:0140096,"immune system process; catalytic activity; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; transferase activity; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_05926,FUN_026150-T1,Peve_00020731,Pocillopora_meandrina_HIv1___RNAseq.g3216.t1,three_way,83.78333333333333,FUN_026150-T1,Q9UJ83,HACL1_HUMAN,,2-hydroxyacyl-CoA lyase 1 (EC 4.1.2.63) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2),Homo sapiens (Human),60.0,578.0,2.3e-206,719.9,sp|Q9UJ83|HACL1_HUMAN 2-hydroxyacyl-CoA lyase 1 OS=Homo sapiens OX=9606 GN=HACL1 PE=1 SV=2,GO:0000287; GO:0001561; GO:0005524; GO:0005654; GO:0005777; GO:0005782; GO:0005829; GO:0006625; GO:0006631; GO:0016830; GO:0030976; GO:0042802; GO:0043231; GO:0097089; GO:0106359; GO:0106376; GO:1903512,fatty acid alpha-oxidation [GO:0001561]; fatty acid metabolic process [GO:0006631]; methyl-branched fatty acid metabolic process [GO:0097089]; phytanic acid metabolic process [GO:1903512]; protein targeting to peroxisome [GO:0006625],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],2-hydroxyacyl-CoA lyase activity [GO:0106359]; 2-hydroxyphytanoyl-CoA lyase activity [GO:0106376]; ATP binding [GO:0005524]; carbon-carbon lyase activity [GO:0016830]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0005654; GO:0005777; GO:0005829; GO:0006629; GO:0016829; GO:0043226,catalytic activity; nucleoplasm; peroxisome; cytosol; lipid metabolic process; lyase activity; organelle
OG_05927,FUN_026151-T1,Peve_00000906,Pocillopora_meandrina_HIv1___RNAseq.g3215.t1,three_way,73.916,FUN_026151-T1,Q6DG99,,,,,37.7,159.0,8.7e-18,92.8,sp|Q6DG99|KCTD6_DANRE BTB/POZ domain-containing protein KCTD6 OS=Danio rerio OX=7955 GN=kctd6 PE=2 SV=1,,,,,,
OG_05928,FUN_026154-T1,Peve_00000925,Pocillopora_meandrina_HIv1___RNAseq.g3213.t1,three_way,86.743,FUN_026154-T1,O60921,HUS1_HUMAN,,Checkpoint protein HUS1 (hHUS1),Homo sapiens (Human),53.2,282.0,1.7e-82,307.4,sp|O60921|HUS1_HUMAN Checkpoint protein HUS1 OS=Homo sapiens OX=9606 GN=HUS1 PE=1 SV=1,GO:0000077; GO:0000723; GO:0000724; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006289; GO:0006974; GO:0009411; GO:0009792; GO:0030896; GO:0031573; GO:0033314; GO:0035861; GO:0044778; GO:0071479,cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; embryo development ending in birth or egg hatching [GO:0009792]; meiotic DNA integrity checkpoint signaling [GO:0044778]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; response to UV [GO:0009411]; telomere maintenance [GO:0000723],checkpoint clamp complex [GO:0030896]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],,GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006310; GO:0022414; GO:0032200; GO:0043226; GO:0048856,nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; DNA recombination; reproductive process; telomere organization; organelle; anatomical structure development
OG_05929,FUN_026155-T1,Peve_00023054,Pocillopora_meandrina_HIv1___RNAseq.g3212.t1,three_way,75.10733333333333,FUN_026155-T1,P54357,,,,,43.2,146.0,6.300000000000001e-28,125.2,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_05930,FUN_026156-T1,Peve_00023049,Pocillopora_meandrina_HIv1___RNAseq.g3211.t1,three_way,81.222,FUN_026156-T1,P54357,,,,,55.3,150.0,1e-41,171.0,sp|P54357|MLC2_DROME Myosin-2 essential light chain OS=Drosophila melanogaster OX=7227 GN=Mlc-c PE=1 SV=1,,,,,,
OG_05931,FUN_026158-T1,Peve_00023048,Pocillopora_meandrina_HIv1___RNAseq.g3210.t2,three_way,71.991,FUN_026158-T1,Q12999,,,,,41.4,215.0,1.4e-37,157.9,sp|Q12999|TSN31_HUMAN Tetraspanin-31 OS=Homo sapiens OX=9606 GN=TSPAN31 PE=1 SV=1,,,,,,
OG_05932,FUN_026160-T1,Peve_00006894,Pocillopora_meandrina_HIv1___TS.g18306.t1,three_way,66.21466666666667,FUN_026160-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),35.0,563.0,1.2e-85,318.9,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_05933,FUN_026161-T1,Peve_00006892,Pocillopora_meandrina_HIv1___RNAseq.g3202.t1,three_way,65.80033333333333,FUN_026161-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),33.2,564.0,2.8e-82,307.8,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_05934,FUN_026162-T1,Peve_00006896,Pocillopora_meandrina_HIv1___RNAseq.g3201.t1,three_way,64.434,FUN_026162-T1,Q5RAP8,,,,,35.1,211.0,1.4000000000000002e-23,111.3,sp|Q5RAP8|TSN31_PONAB Tetraspanin-31 OS=Pongo abelii OX=9601 GN=TSPAN31 PE=2 SV=1,,,,,,
OG_05935,FUN_026165-T1,Peve_00008133,Pocillopora_meandrina_HIv1___RNAseq.g3173.t1,three_way,63.327666666666666,FUN_026165-T1,Q5NU32,AOFA_HORSE,,Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A),Equus caballus (Horse),37.2,468.0,2.9e-77,290.8,sp|Q5NU32|AOFA_HORSE Amine oxidase [flavin-containing] A OS=Equus caballus OX=9796 GN=MAOA PE=2 SV=1,GO:0005739; GO:0005741; GO:0006584; GO:0008131; GO:0050660; GO:0097621,catecholamine metabolic process [GO:0006584],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_05936,FUN_026166-T1,Peve_00008132,Pocillopora_meandrina_HIv1___RNAseq.g3195.t1,three_way,97.83466666666666,FUN_026166-T1,P62194,,,,,91.0,400.0,1.9e-205,716.5,sp|P62194|PRS8_BOVIN 26S proteasome regulatory subunit 8 OS=Bos taurus OX=9913 GN=PSMC5 PE=2 SV=1,,,,,,
OG_05937,FUN_026167-T1,Peve_00008134,Pocillopora_meandrina_HIv1___RNAseq.g3196.t1,three_way,63.132333333333335,,,,,,,,,,,,,,,,,
OG_05938,FUN_026173-T1,Peve_00039168,Pocillopora_meandrina_HIv1___RNAseq.g3177.t1,three_way,35.60133333333333,FUN_026173-T1,P24668,MPRD_MOUSE,,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),Mus musculus (Mouse),51.8,56.0,7e-07,56.2,sp|P24668|MPRD_MOUSE Cation-dependent mannose-6-phosphate receptor OS=Mus musculus OX=10090 GN=M6pr PE=1 SV=1,GO:0005765; GO:0005768; GO:0005770; GO:0005794; GO:0006622; GO:0006886; GO:0007041; GO:0019904; GO:0033299; GO:0048471; GO:1905394,intracellular protein transport [GO:0006886]; lysosomal transport [GO:0007041]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471],protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394],GO:0005768; GO:0005794; GO:0006886; GO:0031410; GO:0043226,endosome; Golgi apparatus; intracellular protein transport; cytoplasmic vesicle; organelle
OG_05939,FUN_026176-T1,Peve_00039165,Pocillopora_meandrina_HIv1___TS.g18147.t1,three_way,42.05466666666667,,,,,,,,,,,,,,,,,
OG_05940,FUN_026177-T2,Peve_00012697,Pocillopora_meandrina_HIv1___RNAseq.g3032.t1,three_way,74.30799999999999,FUN_026177-T2,P83038,HDAC4_CHICK,,Histone deacetylase 4 (HD4) (EC 3.5.1.98),Gallus gallus (Chicken),58.6,486.0,8e-161,569.7,sp|P83038|HDAC4_CHICK Histone deacetylase 4 OS=Gallus gallus OX=9031 GN=HDAC4 PE=2 SV=1,GO:0000118; GO:0000122; GO:0004407; GO:0006325; GO:0006954; GO:0007399; GO:0030183; GO:0040029; GO:0042113; GO:0045843; GO:0045892; GO:0046872; GO:0140297; GO:0141221,B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; chromatin organization [GO:0006325]; epigenetic regulation of gene expression [GO:0040029]; inflammatory response [GO:0006954]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399],histone deacetylase complex [GO:0000118],"DNA-binding transcription factor binding [GO:0140297]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; metal ion binding [GO:0046872]",GO:0002376; GO:0003824; GO:0006325; GO:0006355; GO:0006954; GO:0016787; GO:0030154; GO:0048856; GO:0140096,"immune system process; catalytic activity; chromatin organization; regulation of DNA-templated transcription; inflammatory response; hydrolase activity; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_05941,FUN_026178-T1,Peve_00012696,Pocillopora_meandrina_HIv1___TS.g18149.t1,three_way,56.303,,,,,,,,,,,,,,,,,
OG_05942,FUN_026179-T1,Peve_00012698,Pocillopora_meandrina_HIv1___RNAseq.g3034.t1,three_way,82.133,FUN_026179-T1,O02695,,,,,58.0,440.0,8.500000000000001e-133,476.1,sp|O02695|PTPR2_MACNE Receptor-type tyrosine-protein phosphatase N2 OS=Macaca nemestrina OX=9545 GN=PTPRN2 PE=2 SV=1,,,,,,
OG_05943,FUN_026181-T1,Peve_00022313,Pocillopora_meandrina_HIv1___RNAseq.g3036.t1,three_way,74.56566666666667,FUN_026181-T1,Q9H0H5,RGAP1_HUMAN,,Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4),Homo sapiens (Human),42.3,636.0,4.8e-117,423.3,sp|Q9H0H5|RGAP1_HUMAN Rac GTPase-activating protein 1 OS=Homo sapiens OX=9606 GN=RACGAP1 PE=1 SV=1,GO:0000281; GO:0000915; GO:0001669; GO:0005096; GO:0005547; GO:0005634; GO:0005654; GO:0005739; GO:0005819; GO:0005829; GO:0005874; GO:0006811; GO:0007266; GO:0007283; GO:0007405; GO:0008017; GO:0008270; GO:0009898; GO:0019901; GO:0030218; GO:0030496; GO:0030674; GO:0032154; GO:0032467; GO:0043014; GO:0043015; GO:0045995; GO:0048487; GO:0051056; GO:0051233; GO:0051256; GO:0051988; GO:0070062; GO:0072686; GO:0090543; GO:0097149; GO:1902358,actomyosin contractile ring assembly [GO:0000915]; erythrocyte differentiation [GO:0030218]; mitotic cytokinesis [GO:0000281]; mitotic spindle midzone assembly [GO:0051256]; monoatomic ion transport [GO:0006811]; neuroblast proliferation [GO:0007405]; positive regulation of cytokinesis [GO:0032467]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of embryonic development [GO:0045995]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; sulfate transmembrane transport [GO:1902358],acrosomal vesicle [GO:0001669]; centralspindlin complex [GO:0097149]; cleavage furrow [GO:0032154]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle midzone [GO:0051233],"alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270]",GO:0000910; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0007010; GO:0008092; GO:0008289; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0055085; GO:0060090; GO:0098772,cytokinesis; nucleus; nucleoplasm; mitochondrion; cytosol; cytoskeleton organization; cytoskeletal protein binding; lipid binding; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; transmembrane transport; molecular adaptor activity; molecular function regulator activity
OG_05944,FUN_026182-T1,Peve_00022314,Pocillopora_meandrina_HIv1___RNAseq.g3037.t1,three_way,64.16,,,,,,,,,,,,,,,,,
OG_05945,FUN_026188-T1,Peve_00007220,Pocillopora_meandrina_HIv1___RNAseq.g9603.t1,three_way,49.890166666666666,,,,,,,,,,,,,,,,,
OG_05946,FUN_026192-T1,Peve_00009453,Pocillopora_meandrina_HIv1___RNAseq.g3041.t1,three_way,80.75266666666667,FUN_026192-T1,Q99L13,,,,,61.1,303.0,4.6e-103,375.9,"sp|Q99L13|3HIDH_MOUSE 3-hydroxyisobutyrate dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Hibadh PE=1 SV=1",,,,,,
OG_05947,FUN_026194-T1,Peve_00016690,Pocillopora_meandrina_HIv1___TS.g18158.t1,three_way,54.12983333333333,,,,,,,,,,,,,,,,,
OG_05948,FUN_026198-T1,Peve_00010239,Pocillopora_meandrina_HIv1___RNAseq.g3043.t1,three_way,75.10766666666666,FUN_026198-T1,O75431,MTX2_HUMAN,,Metaxin-2 (Mitochondrial outer membrane import complex protein 2),Homo sapiens (Human),38.3,188.0,5.2e-30,132.5,sp|O75431|MTX2_HUMAN Metaxin-2 OS=Homo sapiens OX=9606 GN=MTX2 PE=1 SV=1,GO:0001401; GO:0005730; GO:0005737; GO:0005739; GO:0005741; GO:0006839; GO:0007005; GO:0007007; GO:0045040; GO:0140275,inner mitochondrial membrane organization [GO:0007007]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; protein insertion into mitochondrial outer membrane [GO:0045040],cytoplasm [GO:0005737]; MIB complex [GO:0140275]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; SAM complex [GO:0001401],,GO:0005730; GO:0005739; GO:0007005; GO:0043226; GO:0061024,nucleolus; mitochondrion; mitochondrion organization; organelle; membrane organization
OG_05949,FUN_026199-T1,Peve_00010232,Pocillopora_meandrina_HIv1___RNAseq.g3044.t1,three_way,45.858,,,,,,,,,,,,,,,,,
OG_05950,FUN_026200-T1,Peve_00044664,Pocillopora_meandrina_HIv1___RNAseq.g3045.t1,three_way,58.144,FUN_026200-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),47.4,342.0,3.6e-107,392.1,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_05951,FUN_026211-T1,Peve_00044665,Pocillopora_meandrina_HIv1___RNAseq.g3049.t1,three_way,49.01616666666666,FUN_026211-T1,A2AX52,CO6A4_MOUSE,,Collagen alpha-4(VI) chain,Mus musculus (Mouse),24.8,1256.0,9.1e-63,246.1,sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2,GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991],collagen binding [GO:0005518],GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_05952,FUN_026214-T1,Peve_00004859,Pocillopora_meandrina_HIv1___TS.g18166.t1,three_way,63.017,FUN_026214-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,371.0,3.5e-20,102.4,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_05953,FUN_026233-T1,Peve_00000059,Pocillopora_meandrina_HIv1___TS.g25199.t1,three_way,59.2455,,,,,,,,,,,,,,,,,
OG_05954,FUN_026297-T1,Peve_00030617,Pocillopora_meandrina_HIv1___TS.g18167.t1,three_way,62.13683333333333,FUN_026297-T1,Q28824,MYLK_BOVIN,,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",Bos taurus (Bovine),43.7,332.0,4.0000000000000003e-75,284.3,"sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1",GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872,tonic smooth muscle contraction [GO:0014820],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725],actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687],GO:0003012; GO:0003824; GO:0008092; GO:0016740; GO:0140096,"muscle system process; catalytic activity; cytoskeletal protein binding; transferase activity; catalytic activity, acting on a protein"
OG_05955,FUN_026298-T1,Peve_00030620,Pocillopora_meandrina_HIv1___RNAseq.g3053.t1,three_way,82.72766666666666,FUN_026298-T1,Q13617,,,,,50.9,748.0,3.7e-225,782.7,sp|Q13617|CUL2_HUMAN Cullin-2 OS=Homo sapiens OX=9606 GN=CUL2 PE=1 SV=2,,,,,,
OG_05956,FUN_026300-T1,Peve_00030624,Pocillopora_meandrina_HIv1___RNAseq.g3055.t1,three_way,48.91783333333333,,,,,,,,,,,,,,,,,
OG_05957,FUN_026303-T1,Peve_00017107,Pocillopora_meandrina_HIv1___RNAseq.g3057.t1,three_way,75.509,FUN_026303-T1,Q9PRL8,,,,,69.2,78.0,2.2e-25,115.9,sp|Q9PRL8|ACBP_CHICK Acyl-CoA-binding protein OS=Gallus gallus OX=9031 GN=DBI PE=1 SV=1,,,,,,
OG_05958,FUN_026305-T1,Peve_00025709,Pocillopora_meandrina_HIv1___RNAseq.g3058.t1,three_way,89.43866666666666,FUN_026305-T1,P21613,,,,,58.8,972.0,2.4e-239,830.5,sp|P21613|KINH_DORPE Kinesin heavy chain OS=Doryteuthis pealeii OX=1051067 PE=1 SV=1,,,,,,
OG_05959,FUN_026306-T1,Peve_00025710,Pocillopora_meandrina_HIv1___RNAseq.g3061.t1,three_way,81.67766666666667,FUN_026306-T1,P40757,,,,,57.9,375.0,1.6000000000000004e-130,467.6,"sp|P40757|ALN_AQUCT Allantoinase, mitochondrial OS=Aquarana catesbeiana OX=8400 GN=ALN PE=1 SV=1",,,,,,
OG_05960,FUN_026307-T1,Peve_00024349,Pocillopora_meandrina_HIv1___RNAseq.g3062.t1,three_way,70.94866666666667,FUN_026307-T1,P34410,,,,,30.6,284.0,3.8e-26,120.6,sp|P34410|TWK7_CAEEL TWiK family of potassium channels protein 7 OS=Caenorhabditis elegans OX=6239 GN=twk-7 PE=3 SV=3,,,,,,
OG_05961,FUN_026308-T1,Peve_00023863,Pocillopora_meandrina_HIv1___RNAseq.g3063.t1,three_way,52.47083333333333,,,,,,,,,,,,,,,,,
OG_05962,FUN_026309-T1,Peve_00036856,Pocillopora_meandrina_HIv1___RNAseq.g3064.t1,three_way,88.59666666666666,FUN_026309-T1,Q6X1Y6,ASIC3_MOUSE,,Acid-sensing ion channel 3 (ASIC3) (Amiloride-sensitive cation channel 3) (Dorsal root ASIC) (DRASIC),Mus musculus (Mouse),31.1,453.0,2.4e-56,222.2,sp|Q6X1Y6|ASIC3_MOUSE Acid-sensing ion channel 3 OS=Mus musculus OX=10090 GN=Asic3 PE=1 SV=2,GO:0005261; GO:0005737; GO:0005886; GO:0006812; GO:0006814; GO:0009408; GO:0009612; GO:0010447; GO:0015280; GO:0034220; GO:0042931; GO:0050907; GO:0050915; GO:0050961; GO:0050965; GO:0050966; GO:0050968; GO:0050974; GO:0051649; GO:0051899; GO:0160125,detection of chemical stimulus involved in sensory perception [GO:0050907]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception [GO:0050961]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; establishment of localization in cell [GO:0051649]; membrane depolarization [GO:0051899]; monoatomic cation transport [GO:0006812]; monoatomic ion transmembrane transport [GO:0034220]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; response to mechanical stimulus [GO:0009612]; sensory perception of sour taste [GO:0050915]; sodium ion transport [GO:0006814],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],enterobactin transmembrane transporter activity [GO:0042931]; ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated sodium channel activity [GO:0160125],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_05963,FUN_026310-T1,Peve_00036855,Pocillopora_meandrina_HIv1___RNAseq.g3065.t1,three_way,55.12266666666667,FUN_026310-T1,A0A1L8F5J9,NMDZ1_XENLA,,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",Xenopus laevis (African clawed frog),26.6,549.0,1.2e-49,199.9,"sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1",GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839,calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725],neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_05964,FUN_026364-T1,Peve_00004982,Pocillopora_meandrina_HIv1___RNAseq.g3115.t1,three_way,43.937,,,,,,,,,,,,,,,,,
OG_05965,FUN_026366-T1,Peve_00004983,Pocillopora_meandrina_HIv1___RNAseq.g3117.t1,three_way,74.71266666666666,,,,,,,,,,,,,,,,,
OG_05966,FUN_026369-T2,Peve_00027912,Pocillopora_meandrina_HIv1___RNAseq.g3119.t1,three_way,54.78633333333333,FUN_026369-T2,Q9H8Y5,ANKZ1_HUMAN,,tRNA endonuclease ANKZF1 (EC 3.1.-.-) (Ankyrin repeat and zinc finger domain-containing protein 1) (Zinc finger protein 744),Homo sapiens (Human),36.6,711.0,4.3e-67,257.7,sp|Q9H8Y5|ANKZ1_HUMAN tRNA endonuclease ANKZF1 OS=Homo sapiens OX=9606 GN=ANKZF1 PE=1 SV=1,GO:0004521; GO:0005737; GO:0006515; GO:0008270; GO:0016020; GO:0036503; GO:0070301; GO:0072344; GO:0140101,cellular response to hydrogen peroxide [GO:0070301]; ERAD pathway [GO:0036503]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; rescue of stalled ribosome [GO:0072344],cytoplasm [GO:0005737]; membrane [GO:0016020],"catalytic activity, acting on a tRNA [GO:0140101]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270]",GO:0003824; GO:0030163; GO:0140098,"catalytic activity; protein catabolic process; catalytic activity, acting on RNA"
OG_05967,FUN_026374-T1,Peve_00021083,Pocillopora_meandrina_HIv1___RNAseq.g290.t1,three_way,60.242,FUN_026374-T1,Q9NZB8,,,,,44.6,231.0,2.6e-43,177.2,sp|Q9NZB8|MOCS1_HUMAN Molybdenum cofactor biosynthesis protein 1 OS=Homo sapiens OX=9606 GN=MOCS1 PE=1 SV=3,,,,,,
OG_05968,FUN_026375-T1,Peve_00010505,Pocillopora_meandrina_HIv1___RNAseq.g2959.t1,three_way,60.9335,,,,,,,,,,,,,,,,,
OG_05969,FUN_026377-T1,Peve_00021079,Pocillopora_meandrina_HIv1___RNAseq.g2957.t2,three_way,62.79133333333333,FUN_026377-T1,Q3SZA2,,,,,59.6,47.0,1.7e-07,56.2,sp|Q3SZA2|FMC1_BOVIN Protein FMC1 homolog OS=Bos taurus OX=9913 GN=FMC1 PE=3 SV=1,,,,,,
OG_05970,FUN_026378-T1,Peve_00010508,Pocillopora_meandrina_HIv1___RNAseq.g2958.t1,three_way,69.759,FUN_026378-T1,P78318,IGBP1_HUMAN,,Immunoglobulin-binding protein 1 (B-cell signal transduction molecule alpha 4) (Protein alpha-4) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit) (Renal carcinoma antigen NY-REN-16),Homo sapiens (Human),32.3,291.0,3.4e-30,133.7,sp|P78318|IGBP1_HUMAN Immunoglobulin-binding protein 1 OS=Homo sapiens OX=9606 GN=IGBP1 PE=1 SV=1,GO:0000122; GO:0005737; GO:0005829; GO:0007165; GO:0019888; GO:0032873; GO:0034612; GO:0035303; GO:0035556; GO:0042113; GO:0051721; GO:0060632; GO:0070555,B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of dephosphorylation [GO:0035303]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829],protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888],GO:0002376; GO:0005829; GO:0006355; GO:0098772,immune system process; cytosol; regulation of DNA-templated transcription; molecular function regulator activity
OG_05971,FUN_026385-T1,Peve_00010504,Pocillopora_meandrina_HIv1___RNAseq.g2955.t1,three_way,77.00399999999999,FUN_026385-T1,Q27960,NPT2B_BOVIN,,Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2),Bos taurus (Bovine),56.3,545.0,5.3e-150,532.7,sp|Q27960|NPT2B_BOVIN Sodium-dependent phosphate transport protein 2B OS=Bos taurus OX=9913 GN=SLC34A2 PE=1 SV=1,GO:0005436; GO:0005903; GO:0006817; GO:0016020; GO:0016324; GO:0030643; GO:0031402; GO:0031982; GO:0042301; GO:0044341,intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transport [GO:0006817]; sodium-dependent phosphate transport [GO:0044341],apical plasma membrane [GO:0016324]; brush border [GO:0005903]; membrane [GO:0016020]; vesicle [GO:0031982],phosphate ion binding [GO:0042301]; sodium ion binding [GO:0031402]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0043226,transporter activity; organelle
OG_05972,FUN_026388-T1,Peve_00032419,Pocillopora_meandrina_HIv1___RNAseq.g2952.t1,three_way,95.50233333333334,FUN_026388-T1,Q9D1K2,,,,,70.7,116.0,7.8e-43,174.5,sp|Q9D1K2|VATF_MOUSE V-type proton ATPase subunit F OS=Mus musculus OX=10090 GN=Atp6v1f PE=1 SV=2,,,,,,
OG_05973,FUN_026389-T1,Peve_00032417,Pocillopora_meandrina_HIv1___RNAseq.g2951.t1,three_way,65.594,FUN_026389-T1,Q54UT2,DGK_DICDI,,Deoxyguanosine kinase (dGK) (EC 2.7.1.113) (DddGK),Dictyostelium discoideum (Social amoeba),46.5,217.0,9e-51,202.2,sp|Q54UT2|DGK_DICDI Deoxyguanosine kinase OS=Dictyostelium discoideum OX=44689 GN=dgk PE=1 SV=2,GO:0004138; GO:0005524; GO:0005737; GO:0005739; GO:0006120; GO:0006180; GO:0045271,"deoxyguanosine salvage [GO:0006180]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]",cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271],ATP binding [GO:0005524]; deoxyguanosine kinase activity [GO:0004138],GO:0003824; GO:0005739; GO:0006091; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; generation of precursor metabolites and energy; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05974,FUN_026394-T1,Peve_00032420,Pocillopora_meandrina_HIv1___RNAseq.g2941.t1,three_way,86.70166666666667,FUN_026394-T1,Q01583,DGK1_DROME,,Diacylglycerol kinase 1 (DAG kinase 1) (DGK 1) (Diglyceride kinase 1) (EC 2.7.1.107),Drosophila melanogaster (Fruit fly),39.6,450.0,3.8e-71,270.4,sp|Q01583|DGK1_DROME Diacylglycerol kinase 1 OS=Drosophila melanogaster OX=7227 GN=Dgk PE=2 SV=5,GO:0004143; GO:0005509; GO:0005524; GO:0005886; GO:0006654; GO:0007200; GO:0008270; GO:0035556; GO:0046339,diacylglycerol metabolic process [GO:0046339]; intracellular signal transduction [GO:0035556]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0006629; GO:0016740,catalytic activity; plasma membrane; lipid metabolic process; transferase activity
OG_05975,FUN_026395-T1,Peve_00028957,Pocillopora_meandrina_HIv1___RNAseq.g2940.t1,three_way,69.13300000000001,FUN_026395-T1,A7S1H9,,,,,55.6,90.0,2.5e-21,102.8,"sp|A7S1H9|SDHF3_NEMVE Succinate dehydrogenase assembly factor 3, mitochondrial OS=Nematostella vectensis OX=45351 GN=acn9 PE=3 SV=1",,,,,,
OG_05976,FUN_026399-T1,Peve_00028956,Pocillopora_meandrina_HIv1___TS.g18054.t2,three_way,70.44033333333333,FUN_026399-T1,P02720,,,,,49.0,206.0,3.5e-53,209.9,sp|P02720|PPCT_BOVIN Phosphatidylcholine transfer protein OS=Bos taurus OX=9913 GN=PCTP PE=1 SV=1,,,,,,
OG_05977,FUN_026406-T1,Peve_00000795,Pocillopora_meandrina_HIv1___RNAseq.g2938.t1,three_way,71.30283333333334,,,,,,,,,,,,,,,,,
OG_05978,FUN_026408-T1,Peve_00000791,Pocillopora_meandrina_HIv1___RNAseq.g2975.t1,three_way,72.372,,,,,,,,,,,,,,,,,
OG_05979,FUN_026410-T1,Peve_00000792,Pocillopora_meandrina_HIv1___TS.g18090.t2,three_way,66.82866666666666,,,,,,,,,,,,,,,,,
OG_05980,FUN_026411-T1,Peve_00006098,Pocillopora_meandrina_HIv1___RNAseq.g2984.t1,three_way,76.715,,,,,,,,,,,,,,,,,
OG_05981,FUN_026412-T1,Peve_00006099,Pocillopora_meandrina_HIv1___RNAseq.g2985.t1,three_way,75.33266666666667,,,,,,,,,,,,,,,,,
OG_05982,FUN_026413-T1,Peve_00006097,Pocillopora_meandrina_HIv1___RNAseq.g2986.t1,three_way,57.643,,,,,,,,,,,,,,,,,
OG_05983,FUN_026415-T1,Peve_00006089,Pocillopora_meandrina_HIv1___RNAseq.g3014.t1,three_way,79.76233333333333,FUN_026415-T1,Q9EPR4,S23A2_MOUSE,,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2),Mus musculus (Mouse),54.1,549.0,1.1e-163,578.2,sp|Q9EPR4|S23A2_MOUSE Solute carrier family 23 member 2 OS=Mus musculus OX=10090 GN=Slc23a2 PE=1 SV=2,GO:0005737; GO:0006979; GO:0007155; GO:0008015; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0071361; GO:1903861,blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229],GO:0003013; GO:0005215; GO:0005975; GO:0007155; GO:0055085,circulatory system process; transporter activity; carbohydrate metabolic process; cell adhesion; transmembrane transport
OG_05984,FUN_026422-T1,Peve_00015944,Pocillopora_meandrina_HIv1___RNAseq.g3019.t1,three_way,70.0415,FUN_026422-T1,A8WFS8,,,,,44.0,298.0,2.9e-73,276.9,sp|A8WFS8|PGAP3_DANRE GPI-specific phospholipase A2-like PGAP3 OS=Danio rerio OX=7955 GN=pgap3 PE=2 SV=1,,,,,,
OG_05985,FUN_026471-T1,Peve_00030192,Pocillopora_meandrina_HIv1___RNAseq.g4186.t1,three_way,66.35833333333333,FUN_026471-T1,F4JZ24,,,,,31.6,177.0,5e-17,90.5,sp|F4JZ24|P4H10_ARATH Probable prolyl 4-hydroxylase 10 OS=Arabidopsis thaliana OX=3702 GN=P4H10 PE=3 SV=1,,,,,,
OG_05986,FUN_026472-T1,Peve_00002340,Pocillopora_meandrina_HIv1___TS.g21592.t2,three_way,76.41433333333333,FUN_026472-T1,Q8K3I9,,,,,36.6,306.0,1.1e-27,125.9,sp|Q8K3I9|GLCI1_MOUSE Glucocorticoid-induced transcript 1 protein OS=Mus musculus OX=10090 GN=Glcci1 PE=1 SV=1,,,,,,
OG_05987,FUN_026473-T1,Peve_00002338,Pocillopora_meandrina_HIv1___RNAseq.g4184.t1,three_way,47.833,,,,,,,,,,,,,,,,,
OG_05988,FUN_026474-T1,Peve_00002337,Pocillopora_meandrina_HIv1___RNAseq.g4183.t1,three_way,68.71333333333334,FUN_026474-T1,P35244,RFA3_HUMAN,,Replication protein A 14 kDa subunit (RP-A p14) (Replication factor A protein 3) (RF-A protein 3),Homo sapiens (Human),38.3,107.0,2.6e-13,76.3,sp|P35244|RFA3_HUMAN Replication protein A 14 kDa subunit OS=Homo sapiens OX=9606 GN=RPA3 PE=1 SV=1,GO:0000723; GO:0000724; GO:0003684; GO:0003697; GO:0005654; GO:0005662; GO:0006260; GO:0006281; GO:0006284; GO:0006289; GO:0006298; GO:0007346; GO:0035861; GO:0042127,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; regulation of cell population proliferation [GO:0042127]; regulation of mitotic cell cycle [GO:0007346]; telomere maintenance [GO:0000723],DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861],damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0005654; GO:0006260; GO:0006281; GO:0006310; GO:0032200,DNA binding; nucleoplasm; DNA replication; DNA repair; DNA recombination; telomere organization
OG_05989,FUN_026475-T1,Peve_00002335,Pocillopora_meandrina_HIv1___RNAseq.g4182.t1,three_way,75.23366666666666,FUN_026475-T1,Q802U2,MIOS_DANRE,,GATOR2 complex protein MIOS,Danio rerio (Zebrafish) (Brachydanio rerio),45.1,443.0,7.2e-107,389.0,sp|Q802U2|MIOS_DANRE GATOR2 complex protein MIOS OS=Danio rerio OX=7955 GN=mios PE=2 SV=1,GO:0005737; GO:0005765; GO:0008270; GO:0031669; GO:0034198; GO:0060047; GO:0060841; GO:0061700; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; heart contraction [GO:0060047]; positive regulation of TORC1 signaling [GO:1904263]; venous blood vessel development [GO:0060841],cytoplasm [GO:0005737]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765],zinc ion binding [GO:0008270],GO:0003013; GO:0048856,circulatory system process; anatomical structure development
OG_05990,FUN_026477-T1,Peve_00002334,Pocillopora_meandrina_HIv1___RNAseq.g4181.t1,three_way,66.879,,,,,,,,,,,,,,,,,
OG_05991,FUN_026480-T1,Peve_00002343,Pocillopora_meandrina_HIv1___RNAseq.g4178.t1,three_way,72.6325,FUN_026480-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),31.4,408.0,9.999999999999999e-54,212.6,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_05992,FUN_026481-T1,Peve_00002333,Pocillopora_meandrina_HIv1___RNAseq.g4177.t1,three_way,82.02083333333333,FUN_026481-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),34.3,414.0,6.6e-58,226.5,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_05993,FUN_026482-T1,Peve_00002332,Pocillopora_meandrina_HIv1___RNAseq.g4176.t1,three_way,69.22866666666667,FUN_026482-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),30.8,402.0,2.2999999999999998e-55,218.0,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_05994,FUN_026483-T1,Peve_00022078,Pocillopora_meandrina_HIv1___RNAseq.g4175.t1,three_way,67.52216666666666,FUN_026483-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),30.5,436.0,1.3e-41,172.6,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_05995,FUN_026484-T1,Peve_00022075,Pocillopora_meandrina_HIv1___RNAseq.g4174.t1,three_way,66.93066666666667,FUN_026484-T1,Q8N5B7,CERS5_HUMAN,,Ceramide synthase 5 (CerS5) (LAG1 longevity assurance homolog 5) (Sphingoid base N-palmitoyltransferase CERS5) (EC 2.3.1.291) (Sphingosine N-acyltransferase CERS5) (EC 2.3.1.24),Homo sapiens (Human),41.5,347.0,8.999999999999999e-71,268.9,sp|Q8N5B7|CERS5_HUMAN Ceramide synthase 5 OS=Homo sapiens OX=9606 GN=CERS5 PE=1 SV=1,GO:0003677; GO:0005789; GO:0014003; GO:0030148; GO:0046513; GO:0050291,ceramide biosynthetic process [GO:0046513]; oligodendrocyte development [GO:0014003]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum membrane [GO:0005789],DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291],GO:0003677; GO:0003824; GO:0006629; GO:0016740; GO:0048856,DNA binding; catalytic activity; lipid metabolic process; transferase activity; anatomical structure development
OG_05996,FUN_026485-T1,Peve_00030055,Pocillopora_meandrina_HIv1___RNAseq.g4173.t1,three_way,93.52966666666669,FUN_026485-T1,Q9CZQ9,,,,,78.2,335.0,3.5e-154,545.8,sp|Q9CZQ9|BBS5_MOUSE BBSome complex member BBS5 OS=Mus musculus OX=10090 GN=Bbs5 PE=1 SV=1,,,,,,
OG_05997,FUN_026486-T1,Peve_00037221,Pocillopora_meandrina_HIv1___RNAseq.g4172.t1,three_way,92.45966666666668,FUN_026486-T1,Q8N138,ORML3_HUMAN,,ORM1-like protein 3,Homo sapiens (Human),59.0,144.0,3.2e-46,186.0,sp|Q8N138|ORML3_HUMAN ORM1-like protein 3 OS=Homo sapiens OX=9606 GN=ORMDL3 PE=1 SV=1,GO:0002903; GO:0005783; GO:0005789; GO:0005886; GO:0006672; GO:0006686; GO:0006940; GO:0010508; GO:0017059; GO:0030148; GO:0030667; GO:0035579; GO:0042552; GO:0061744; GO:0090156; GO:1900060; GO:1900182,ceramide metabolic process [GO:0006672]; intracellular sphingolipid homeostasis [GO:0090156]; motor behavior [GO:0061744]; myelination [GO:0042552]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of ceramide biosynthetic process [GO:1900060]; positive regulation of autophagy [GO:0010508]; positive regulation of protein localization to nucleus [GO:1900182]; regulation of smooth muscle contraction [GO:0006940]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; serine palmitoyltransferase complex [GO:0017059]; specific granule membrane [GO:0035579],,GO:0005783; GO:0005886; GO:0006629; GO:0043226,endoplasmic reticulum; plasma membrane; lipid metabolic process; organelle
OG_05998,FUN_026487-T1,Peve_00037220,Pocillopora_meandrina_HIv1___RNAseq.g4189.t1,three_way,92.38083333333331,FUN_026487-T1,P24844,MYL9_HUMAN,,"Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)",Homo sapiens (Human),73.8,172.0,7.2999999999999984e-68,258.1,sp|P24844|MYL9_HUMAN Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4,GO:0001725; GO:0005200; GO:0005509; GO:0005737; GO:0005829; GO:0005859; GO:0005938; GO:0006937; GO:0008307; GO:0016460; GO:0030016; GO:0030018; GO:0030239; GO:0032036; GO:0043149; GO:0070527,myofibril assembly [GO:0030239]; platelet aggregation [GO:0070527]; regulation of muscle contraction [GO:0006937]; stress fiber assembly [GO:0043149],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307],GO:0005198; GO:0005829; GO:0007010; GO:0007155; GO:0008092; GO:0043226,structural molecule activity; cytosol; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; organelle
OG_05999,FUN_026488-T1,Peve_00030554,Pocillopora_meandrina_HIv1___RNAseq.g4190.t1,three_way,72.27866666666667,,,,,,,,,,,,,,,,,
OG_06000,FUN_026489-T1,Peve_00002086,Pocillopora_meandrina_HIv1___TS.g21598.t2,three_way,57.582,FUN_026489-T1,Q9BUL9,,,,,37.9,87.0,2.8e-09,63.9,sp|Q9BUL9|RPP25_HUMAN Ribonuclease P protein subunit p25 OS=Homo sapiens OX=9606 GN=RPP25 PE=1 SV=1,,,,,,
OG_06001,FUN_026490-T1,Peve_00002095,Pocillopora_meandrina_HIv1___RNAseq.g4192.t1,three_way,88.14433333333334,FUN_026490-T1,O57683,,,,,77.7,1266.0,0.0,1677.9,sp|O57683|SF3B1_XENLA Splicing factor 3B subunit 1 OS=Xenopus laevis OX=8355 GN=sf3b1 PE=2 SV=1,,,,,,
OG_06002,FUN_026491-T1,Peve_00032989,Pocillopora_meandrina_HIv1___RNAseq.g4193.t1,three_way,81.38333333333334,FUN_026491-T1,E1B836,ENKUR_BOVIN,,Enkurin,Bos taurus (Bovine),51.8,249.0,8.1e-66,251.9,sp|E1B836|ENKUR_BOVIN Enkurin OS=Bos taurus OX=9913 GN=ENKUR PE=1 SV=2,GO:0001669; GO:0005516; GO:0005879; GO:0017124; GO:0030317; GO:0036126; GO:0061966; GO:0097228; GO:0097728; GO:0160112,establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317],9+0 motile cilium [GO:0097728]; acrosomal vesicle [GO:0001669]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228],calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124],GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_06003,FUN_026492-T1,Peve_00032990,Pocillopora_meandrina_HIv1___RNAseq.g4194.t1,three_way,63.86033333333334,,,,,,,,,,,,,,,,,
OG_06004,FUN_026494-T1,Peve_00004180,Pocillopora_meandrina_HIv1___RNAseq.g4199.t1,three_way,63.488,FUN_026494-T1,Q71M21,,,,,28.2,1343.0,2.3e-88,329.7,sp|Q71M21|RH21B_XENLA Rho GTPase-activating protein 21-B OS=Xenopus laevis OX=8355 GN=arhgap21-b PE=2 SV=1,,,,,,
OG_06005,FUN_026501-T1,Peve_00004184,Pocillopora_meandrina_HIv1___TS.g21607.t1,three_way,44.153333333333336,FUN_026501-T1,Q9VTT0,SEM5C_DROME,,Semaphorin 5c,Drosophila melanogaster (Fruit fly),27.1,630.0,1.7e-51,206.1,sp|Q9VTT0|SEM5C_DROME Semaphorin 5c OS=Drosophila melanogaster OX=7227 GN=Sema5c PE=1 SV=3,GO:0001700; GO:0005768; GO:0005886; GO:0007411; GO:0016324; GO:0016328; GO:0030215; GO:0030335; GO:0042048; GO:0045499; GO:0048036; GO:0071526,axon guidance [GO:0007411]; central complex development [GO:0048036]; embryonic development via the syncytial blastoderm [GO:0001700]; olfactory behavior [GO:0042048]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526],apical plasma membrane [GO:0016324]; endosome [GO:0005768]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215],GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0048018; GO:0048856; GO:0098772,endosome; plasma membrane; cytoplasmic vesicle; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06006,FUN_026511-T1,Peve_00034433,Pocillopora_meandrina_HIv1___RNAseq.g4202.t1,three_way,85.81833333333333,FUN_026511-T1,Q9H269,VPS16_HUMAN,,Vacuolar protein sorting-associated protein 16 homolog (hVPS16),Homo sapiens (Human),48.9,630.0,2.5e-166,587.0,sp|Q9H269|VPS16_HUMAN Vacuolar protein sorting-associated protein 16 homolog OS=Homo sapiens OX=9606 GN=VPS16 PE=1 SV=2,GO:0003779; GO:0005764; GO:0005765; GO:0005768; GO:0005769; GO:0005770; GO:0005776; GO:0006886; GO:0008333; GO:0010008; GO:0016197; GO:0030136; GO:0030424; GO:0030897; GO:0031902; GO:0033263; GO:0034058; GO:0035542; GO:0042144; GO:0043025; GO:0051015; GO:0055037; GO:0097352; GO:0098793,"autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion, non-autophagic [GO:0042144]",autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; presynapse [GO:0098793]; recycling endosome [GO:0055037],actin binding [GO:0003779]; actin filament binding [GO:0051015],GO:0005764; GO:0005768; GO:0005773; GO:0006886; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0061024,lysosome; endosome; vacuole; intracellular protein transport; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_06007,FUN_026527-T1,Peve_00021565,Pocillopora_meandrina_HIv1___RNAseq.g4205.t1,three_way,58.59633333333333,,,,,,,,,,,,,,,,,
OG_06008,FUN_026528-T1,Peve_00040219,Pocillopora_meandrina_HIv1___RNAseq.g4218.t1,three_way,81.22200000000001,FUN_026528-T1,Q08DM8,,,,,59.9,212.0,1.3e-67,257.7,sp|Q08DM8|TSN_BOVIN Translin OS=Bos taurus OX=9913 GN=TSN PE=2 SV=1,,,,,,
OG_06009,FUN_026529-T1,Peve_00021569,Pocillopora_meandrina_HIv1___RNAseq.g4217.t1,three_way,74.87133333333334,FUN_026529-T1,Q9JIT1,,,,,47.4,369.0,1.4000000000000001e-89,331.3,sp|Q9JIT1|RNF32_MOUSE RING finger protein 32 OS=Mus musculus OX=10090 GN=Rnf32 PE=1 SV=1,,,,,,
OG_06010,FUN_026532-T1,Peve_00021566,Pocillopora_meandrina_HIv1___RNAseq.g4216.t1,three_way,63.30566666666667,,,,,,,,,,,,,,,,,
OG_06011,FUN_026537-T1,Peve_00034458,Pocillopora_meandrina_HIv1___RNAseq.18533_t,three_way,67.80466666666666,,,,,,,,,,,,,,,,,
OG_06012,FUN_026539-T1,Peve_00002363,Pocillopora_meandrina_HIv1___RNAseq.g4243.t1,three_way,67.683,,,,,,,,,,,,,,,,,
OG_06013,FUN_026540-T1,Peve_00021545,Pocillopora_meandrina_HIv1___RNAseq.g4242.t1,three_way,66.76066666666667,FUN_026540-T1,Q1LWZ0,CLXN_DANRE,,Calaxin (EF-hand calcium-binding domain-containing protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),52.5,181.0,7.400000000000001e-48,192.2,sp|Q1LWZ0|CLXN_DANRE Calaxin OS=Danio rerio OX=7955 GN=clxn PE=2 SV=2,GO:0003341; GO:0005509; GO:0005737; GO:0005856; GO:0005929; GO:0009966; GO:0036126; GO:0036158,cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; regulation of signal transduction [GO:0009966],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126],calcium ion binding [GO:0005509],GO:0005856; GO:0005929; GO:0007018; GO:0043226; GO:0065003,cytoskeleton; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_06014,FUN_026541-T1,Peve_00020321,Pocillopora_meandrina_HIv1___RNAseq.g4240.t1,three_way,62.72516666666667,FUN_026541-T1,P55197,AF10_HUMAN,,Protein AF-10 (ALL1-fused gene from chromosome 10 protein),Homo sapiens (Human),78.8,184.0,1.1999999999999999e-90,336.3,sp|P55197|AF10_HUMAN Protein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0031491; GO:0032991; GO:0042393; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; histone binding; organelle
OG_06014,FUN_026541-T1,Peve_00020321,Pocillopora_meandrina_HIv1___RNAseq.g4240.t1,three_way,62.72516666666667,FUN_026541-T1,P55197,AF10_HUMAN,,Protein AF-10 (ALL1-fused gene from chromosome 10 protein),Homo sapiens (Human),46.3,67.0,7.8e-10,67.8,sp|P55197|AF10_HUMAN Protein AF-10 OS=Homo sapiens OX=9606 GN=MLLT10 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0006357; GO:0008270; GO:0031491; GO:0032991; GO:0042393; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; histone binding; organelle
OG_06015,FUN_026542-T1,Peve_00020320,Pocillopora_meandrina_HIv1___RNAseq.g4239.t1,three_way,82.803,FUN_026542-T1,Q8BHN5,,,,,39.6,493.0,2.8000000000000003e-80,300.8,sp|Q8BHN5|RBM45_MOUSE RNA-binding protein 45 OS=Mus musculus OX=10090 GN=Rbm45 PE=1 SV=1,,,,,,
OG_06016,FUN_026543-T1,Peve_00020319,Pocillopora_meandrina_HIv1___RNAseq.g4238.t1,three_way,56.20633333333333,,,,,,,,,,,,,,,,,
OG_06017,FUN_026545-T1,Peve_00002360,Pocillopora_meandrina_HIv1___RNAseq.g4236.t1,three_way,91.02066666666668,FUN_026545-T1,Q7ZSX3,PTF1A_DANRE,,Pancreas transcription factor 1 subunit alpha (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48),Danio rerio (Zebrafish) (Brachydanio rerio),66.7,102.0,9.8e-28,124.4,sp|Q7ZSX3|PTF1A_DANRE Pancreas transcription factor 1 subunit alpha OS=Danio rerio OX=7955 GN=ptf1a PE=2 SV=1,GO:0000977; GO:0000981; GO:0003677; GO:0003700; GO:0005634; GO:0005667; GO:0005737; GO:0006355; GO:0006357; GO:0009887; GO:0009888; GO:0030154; GO:0030902; GO:0031016; GO:0031017; GO:0032502; GO:0035881; GO:0043565; GO:0045893; GO:0046983; GO:0048384; GO:0048666; GO:0048699,amacrine cell differentiation [GO:0035881]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; developmental process [GO:0032502]; exocrine pancreas development [GO:0031017]; generation of neurons [GO:0048699]; hindbrain development [GO:0030902]; neuron development [GO:0048666]; pancreas development [GO:0031016]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; tissue development [GO:0009888],cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06018,FUN_026546-T1,Peve_00033713,Pocillopora_meandrina_HIv1___RNAseq.g4237.t1,three_way,64.72766666666666,FUN_026546-T1,Q96KC8,DNJC1_HUMAN,,DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1),Homo sapiens (Human),40.8,525.0,4.4e-84,313.5,sp|Q96KC8|DNJC1_HUMAN DnaJ homolog subfamily C member 1 OS=Homo sapiens OX=9606 GN=DNAJC1 PE=1 SV=1,GO:0001671; GO:0003677; GO:0005783; GO:0005789; GO:0005886; GO:0006417; GO:0006457; GO:0012505; GO:0016020; GO:0031965; GO:0045861; GO:0050708; GO:0051087,negative regulation of proteolysis [GO:0045861]; protein folding [GO:0006457]; regulation of protein secretion [GO:0050708]; regulation of translation [GO:0006417],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],ATPase activator activity [GO:0001671]; DNA binding [GO:0003677]; protein-folding chaperone binding [GO:0051087],GO:0003677; GO:0005783; GO:0005886; GO:0006457; GO:0043226; GO:0098772,DNA binding; endoplasmic reticulum; plasma membrane; protein folding; organelle; molecular function regulator activity
OG_06019,FUN_026547-T1,Peve_00002361,Pocillopora_meandrina_HIv1___RNAseq.g4233.t1,three_way,71.54266666666666,,,,,,,,,,,,,,,,,
OG_06020,FUN_026548-T1,Peve_00002362,Pocillopora_meandrina_HIv1___RNAseq.g4232.t1,three_way,67.98133333333332,FUN_026548-T1,Q8IYJ2,CJ067_HUMAN,,"Uncharacterized protein C10orf67, mitochondrial",Homo sapiens (Human),25.5,216.0,5.9e-14,80.9,"sp|Q8IYJ2|CJ067_HUMAN Uncharacterized protein C10orf67, mitochondrial OS=Homo sapiens OX=9606 GN=C10orf67 PE=1 SV=3",GO:0005739,,mitochondrion [GO:0005739],,GO:0005739; GO:0043226,mitochondrion; organelle
OG_06021,FUN_026556-T3,Peve_00043079,Pocillopora_meandrina_HIv1___RNAseq.g4518.t1,three_way,60.15483333333333,,,,,,,,,,,,,,,,,
OG_06022,FUN_026564-T1,Peve_00043274,Pocillopora_meandrina_HIv1___RNAseq.g4519.t1,three_way,45.92583333333333,FUN_026564-T1,Q9DD78,,,,,32.7,107.0,3.3e-12,75.1,sp|Q9DD78|TLR21_CHICK Toll-like receptor 2 type-1 OS=Gallus gallus OX=9031 GN=TLR2-1 PE=2 SV=1,,,,,,
OG_06023,FUN_026579-T1,Peve_00040668,Pocillopora_meandrina_HIv1___RNAseq.g30115.t1,three_way,59.54333333333334,FUN_026579-T1,Q5R868,,,,,28.9,377.0,1.6e-29,132.1,sp|Q5R868|PGAP4_PONAB GPI-N-acetylgalactosamine transferase PGAP4 OS=Pongo abelii OX=9601 GN=PGAP4 PE=2 SV=1,,,,,,
OG_06024,FUN_026582-T1,Peve_00006460,Pocillopora_meandrina_HIv1___RNAseq.g4513.t1,three_way,81.87833333333333,FUN_026582-T1,Q8TAQ2,SMRC2_HUMAN,,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),Homo sapiens (Human),51.1,991.0,1.4e-241,837.8,sp|Q8TAQ2|SMRC2_HUMAN SWI/SNF complex subunit SMARCC2 OS=Homo sapiens OX=9606 GN=SMARCC2 PE=1 SV=1,GO:0000776; GO:0000785; GO:0003713; GO:0005654; GO:0006337; GO:0006338; GO:0006357; GO:0007399; GO:0016363; GO:0016514; GO:0016586; GO:0030071; GO:0032991; GO:0035060; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045892; GO:0045893; GO:0070316; GO:0071564; GO:0071565; GO:0140092; GO:2000045; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of cell differentiation [GO:0045597]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357],bBAF complex [GO:0140092]; brahma complex [GO:0035060]; chromatin [GO:0000785]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514],histone binding [GO:0042393]; transcription coactivator activity [GO:0003713],GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06025,FUN_026584-T1,Peve_00006456,Pocillopora_meandrina_HIv1___TS.g21923.t1,three_way,41.721,,,,,,,,,,,,,,,,,
OG_06026,FUN_026585-T1,Peve_00006457,Pocillopora_meandrina_HIv1___TS.g21922.t2,three_way,56.837,,,,,,,,,,,,,,,,,
OG_06027,FUN_026586-T1,Peve_00006458,Pocillopora_meandrina_HIv1___RNAseq.g4506.t1,three_way,78.36933333333333,,,,,,,,,,,,,,,,,
OG_06028,FUN_026589-T1,Peve_00043907,Pocillopora_meandrina_HIv1___TS.g21913.t2,three_way,75.30533333333334,FUN_026589-T1,F8WLE0,,,,,39.4,864.0,1.9e-152,541.6,sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1,,,,,,
OG_06029,FUN_026590-T1,Peve_00043908,Pocillopora_meandrina_HIv1___RNAseq.g4497.t1,three_way,58.6655,FUN_026590-T1,A4D1E9,GTPBA_HUMAN,,GTP-binding protein 10 (Protein obg homolog 2) (ObgH2),Homo sapiens (Human),46.9,286.0,1.5e-65,252.3,sp|A4D1E9|GTPBA_HUMAN GTP-binding protein 10 OS=Homo sapiens OX=9606 GN=GTPBP10 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003924; GO:0005525; GO:0005694; GO:0005730; GO:0005739; GO:0042254,ribosome biogenesis [GO:0042254],chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0003924; GO:0005694; GO:0005730; GO:0005739; GO:0016787; GO:0042254; GO:0043226,RNA binding; catalytic activity; GTPase activity; chromosome; nucleolus; mitochondrion; hydrolase activity; ribosome biogenesis; organelle
OG_06030,FUN_026591-T1,Peve_00035407,Pocillopora_meandrina_HIv1___RNAseq.g4496.t1,three_way,59.29,,,,,,,,,,,,,,,,,
OG_06031,FUN_026597-T1,Peve_00035402,Pocillopora_meandrina_HIv1___RNAseq.g4485.t1,three_way,53.672666666666665,,,,,,,,,,,,,,,,,
OG_06032,FUN_026617-T1,Peve_00043915,Pocillopora_meandrina_HIv1___RNAseq.g4482.t1,three_way,86.23883333333333,FUN_026617-T1,A0A8I5ZNK2,OXSR1_RAT,,Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein),Rattus norvegicus (Rat),54.0,522.0,8.8e-151,535.0,sp|A0A8I5ZNK2|OXSR1_RAT Serine/threonine-protein kinase OSR1 OS=Rattus norvegicus OX=10116 GN=Oxsr1 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006884; GO:0006979; GO:0007165; GO:0007231; GO:0009410; GO:0010820; GO:0019901; GO:0035556; GO:0038116; GO:0038146; GO:0042802; GO:0070294; GO:0071474; GO:0071476; GO:1901380; GO:1990869,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; negative regulation of potassium ion transmembrane transport [GO:1901380]; osmosensory signaling pathway [GO:0007231]; positive regulation of T cell chemotaxis [GO:0010820]; renal sodium ion absorption [GO:0070294]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674],GO:0003014; GO:0003824; GO:0005829; GO:0016740; GO:0140096,"renal system process; catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_06033,FUN_026619-T1,Peve_00043889,Pocillopora_meandrina_HIv1___RNAseq.g4478.t1a,three_way,66.35766666666667,FUN_026619-T1,Q8BHC4,,,,,46.8,222.0,1.7e-51,204.1,sp|Q8BHC4|DCAKD_MOUSE Dephospho-CoA kinase domain-containing protein OS=Mus musculus OX=10090 GN=Dcakd PE=1 SV=1,,,,,,
OG_06034,FUN_026626-T1,Peve_00030694,Pocillopora_meandrina_HIv1___RNAseq.g4478.t1b,three_way,49.834833333333336,FUN_026626-T1,P23785,GRN_RAT,,Progranulin (PGRN) (Acrogranin) (Epithelin precursor) (Granulin precursor) (Proepithelin) (PEPI) [Cleaved into: Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Epithelin-2) (Granulin B); Granulin-4 (Epithelin-1) (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)],Rattus norvegicus (Rat),31.6,510.0,1.9e-62,243.0,sp|P23785|GRN_RAT Progranulin OS=Rattus norvegicus OX=10116 GN=Grn PE=1 SV=3,GO:0001834; GO:0001835; GO:0002265; GO:0002282; GO:0005125; GO:0005576; GO:0005615; GO:0005764; GO:0005765; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0007040; GO:0007041; GO:0007042; GO:0007566; GO:0008284; GO:0010595; GO:0010976; GO:0016020; GO:0030335; GO:0031982; GO:0032355; GO:0035641; GO:0035988; GO:0043524; GO:0043525; GO:0045202; GO:0045766; GO:0045824; GO:0048488; GO:0048680; GO:0050673; GO:0050679; GO:0050727; GO:0050728; GO:0050821; GO:0051087; GO:0060041; GO:0060179; GO:0060266; GO:0060999; GO:0061351; GO:0098793; GO:0098978; GO:0099558; GO:0106016; GO:0150053; GO:1900426; GO:1902564; GO:1903334; GO:1903979; GO:1904075; GO:1905146; GO:1905247; GO:1905671; GO:1905673,astrocyte activation involved in immune response [GO:0002265]; blastocyst hatching [GO:0001835]; chondrocyte proliferation [GO:0035988]; embryo implantation [GO:0007566]; epithelial cell proliferation [GO:0050673]; locomotory exploration behavior [GO:0035641]; lysosomal lumen acidification [GO:0007042]; lysosomal protein catabolic process [GO:1905146]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; maintenance of synapse structure [GO:0099558]; male mating behavior [GO:0060179]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neural precursor cell proliferation [GO:0061351]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein folding [GO:1903334]; positive regulation of trophectodermal cell proliferation [GO:1904075]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; regulation of lysosome organization [GO:1905671]; response to estradiol [GO:0032355]; retina development in camera-type eye [GO:0060041]; synaptic vesicle endocytosis [GO:0048488]; trophectodermal cell proliferation [GO:0001834],cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982],cytokine activity [GO:0005125]; protein-folding chaperone binding [GO:0051087],GO:0002376; GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0007040; GO:0016192; GO:0022414; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048018; GO:0048856; GO:0098772,immune system process; extracellular region; extracellular space; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; lysosome organization; vesicle-mediated transport; reproductive process; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06035,FUN_026628-T1,Peve_00030693,Pocillopora_meandrina_HIv1___RNAseq.g4477.t1,three_way,52.323,FUN_026628-T1,Q86VD9,PIGZ_HUMAN,,"GPI alpha-1,2-mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein) (PIG-Z) (SMP3 homolog) (hSMP3)",Homo sapiens (Human),34.0,556.0,2.2e-66,255.0,"sp|Q86VD9|PIGZ_HUMAN GPI alpha-1,2-mannosyltransferase 4 OS=Homo sapiens OX=9606 GN=PIGZ PE=1 SV=4",GO:0000026; GO:0000030; GO:0005783; GO:0005789; GO:0006506,GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],"alpha-1,2-mannosyltransferase activity [GO:0000026]; mannosyltransferase activity [GO:0000030]",GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_06036,FUN_026629-T1,Peve_00042470,Pocillopora_meandrina_HIv1___RNAseq.g4472.t1,three_way,77.261,,,,,,,,,,,,,,,,,
OG_06037,FUN_026672-T1,Peve_00042468,Pocillopora_meandrina_HIv1___RNAseq.g4471.t1,three_way,65.003,,,,,,,,,,,,,,,,,
OG_06038,FUN_026685-T1,Peve_00036589,Pocillopora_meandrina_HIv1___RNAseq.g4459.t1,three_way,71.81433333333334,FUN_026685-T1,Q8IYE1,CCD13_HUMAN,,Coiled-coil domain-containing protein 13,Homo sapiens (Human),29.4,697.0,4.1e-46,188.0,sp|Q8IYE1|CCD13_HUMAN Coiled-coil domain-containing protein 13 OS=Homo sapiens OX=9606 GN=CCDC13 PE=1 SV=2,GO:0005737; GO:0005813; GO:0006974; GO:0031122; GO:0034451; GO:0042995; GO:1905515,cytoplasmic microtubule organization [GO:0031122]; DNA damage response [GO:0006974]; non-motile cilium assembly [GO:1905515],cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytoplasm [GO:0005737],,GO:0005815; GO:0007010; GO:0044782,microtubule organizing center; cytoskeleton organization; cilium organization
OG_06039,FUN_026686-T1,Peve_00036588,Pocillopora_meandrina_HIv1___RNAseq.g4458.t1,three_way,77.316,FUN_026686-T1,Q91ZR4,NEK8_MOUSE,,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8),Mus musculus (Mouse),53.2,710.0,1.2e-204,714.5,sp|Q91ZR4|NEK8_MOUSE Serine/threonine-protein kinase Nek8 OS=Mus musculus OX=10090 GN=Nek8 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0005929; GO:0007368; GO:0007507; GO:0009887; GO:0035330; GO:0046872; GO:0097543; GO:0097546; GO:0106310,animal organ morphogenesis [GO:0009887]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; regulation of hippo signaling [GO:0035330],centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary inversin compartment [GO:0097543]; cilium [GO:0005929]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005815; GO:0005929; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06040,FUN_026703-T1,Peve_00018531,Pocillopora_meandrina_HIv1___RNAseq.g9386.t1,three_way,68.91433333333333,,,,,,,,,,,,,,,,,
OG_06041,FUN_026704-T1,Peve_00018530,Pocillopora_meandrina_HIv1___RNAseq.g9385.t2,three_way,58.49566666666667,,,,,,,,,,,,,,,,,
OG_06042,FUN_026705-T1,Peve_00018528,Pocillopora_meandrina_HIv1___RNAseq.g9382.t1,three_way,63.395,FUN_026705-T1,Q1LUQ4,,,,,23.4,559.0,4.5e-32,141.0,sp|Q1LUQ4|MFD6A_DANRE Major facilitator superfamily domain-containing protein 6-A OS=Danio rerio OX=7955 GN=mfsd6a PE=3 SV=1,,,,,,
OG_06043,FUN_026708-T1,Peve_00018526,Pocillopora_meandrina_HIv1___RNAseq.g9381.t1,three_way,91.74133333333332,FUN_026708-T1,Q9VVI9,,,,,50.0,220.0,2.3e-45,183.7,sp|Q9VVI9|CHMP5_DROME Charged multivesicular body protein 5 OS=Drosophila melanogaster OX=7227 GN=Vps60 PE=1 SV=2,,,,,,
OG_06044,FUN_026709-T1,Peve_00018525,Pocillopora_meandrina_HIv1___RNAseq.g9380.t1,three_way,64.574,,,,,,,,,,,,,,,,,
OG_06045,FUN_026713-T1,Peve_00018520,Pocillopora_meandrina_HIv1___TS.g19667.t2,three_way,92.40666666666668,FUN_026713-T1,Q2KJ46,,,,,65.5,472.0,4.3e-169,595.9,sp|Q2KJ46|PSMD3_BOVIN 26S proteasome non-ATPase regulatory subunit 3 OS=Bos taurus OX=9913 GN=PSMD3 PE=2 SV=1,,,,,,
OG_06046,FUN_026714-T1,Peve_00018519,Pocillopora_meandrina_HIv1___RNAseq.g9373.t1,three_way,56.48,FUN_026714-T1,Q96EW2,,,,,42.0,138.0,4.4e-20,99.4,sp|Q96EW2|HBAP1_HUMAN HSPB1-associated protein 1 OS=Homo sapiens OX=9606 GN=HSPBAP1 PE=1 SV=1,,,,,,
OG_06047,FUN_026715-T1,Peve_00018524,Pocillopora_meandrina_HIv1___TS.g19669.t1,three_way,89.792,,,,,,,,,,,,,,,,,
OG_06048,FUN_026718-T1,Peve_00044326,Pocillopora_meandrina_HIv1___RNAseq.g9375.t1b,three_way,81.01533333333333,FUN_026718-T1,Q6DEJ5,,,,,48.4,401.0,6.4e-108,392.5,sp|Q6DEJ5|AASD1_DANRE Alanyl-tRNA editing protein Aarsd1 OS=Danio rerio OX=7955 GN=aarsd1 PE=2 SV=1,,,,,,
OG_06049,FUN_026721-T1,Peve_00018533,Pocillopora_meandrina_HIv1___RNAseq.g9388.t1,three_way,45.75816666666667,,,,,,,,,,,,,,,,,
OG_06050,FUN_026723-T1,Peve_00018534,Pocillopora_meandrina_HIv1___RNAseq.g9389.t1b,three_way,43.464,,,,,,,,,,,,,,,,,
OG_06051,FUN_026725-T2,Peve_00018535,Pocillopora_meandrina_HIv1___RNAseq.g9389.t1a,three_way,47.534,,,,,,,,,,,,,,,,,
OG_06052,FUN_026728-T1,Peve_00021678,Pocillopora_meandrina_HIv1___RNAseq.g9394.t1,three_way,53.815,,,,,,,,,,,,,,,,,
OG_06053,FUN_026732-T1,Peve_00021672,Pocillopora_meandrina_HIv1___RNAseq.g9404.t1,three_way,84.143,FUN_026732-T1,Q1LUQ4,,,,,28.4,612.0,2.9e-62,241.1,sp|Q1LUQ4|MFD6A_DANRE Major facilitator superfamily domain-containing protein 6-A OS=Danio rerio OX=7955 GN=mfsd6a PE=3 SV=1,,,,,,
OG_06054,FUN_026733-T1,Peve_00021670,Pocillopora_meandrina_HIv1___RNAseq.g9406.t1,three_way,88.12866666666666,FUN_026733-T1,A1DWM3,,,,,31.6,610.0,1.5e-71,271.9,sp|A1DWM3|MFSD6_PIG Major facilitator superfamily domain-containing protein 6 OS=Sus scrofa OX=9823 GN=MFSD6 PE=2 SV=1,,,,,,
OG_06055,FUN_026738-T1,Peve_00021667,Pocillopora_meandrina_HIv1___RNAseq.g9410.t1,three_way,56.565,FUN_026738-T1,A1DWM3,,,,,32.0,341.0,2.2e-42,175.6,sp|A1DWM3|MFSD6_PIG Major facilitator superfamily domain-containing protein 6 OS=Sus scrofa OX=9823 GN=MFSD6 PE=2 SV=1,,,,,,
OG_06056,FUN_026739-T2,Peve_00021666,Pocillopora_meandrina_HIv1___RNAseq.g9411.t1,three_way,70.781,FUN_026739-T2,P42232,STA5B_MOUSE,,Signal transducer and activator of transcription 5B,Mus musculus (Mouse),32.8,729.0,1e-96,356.3,sp|P42232|STA5B_MOUSE Signal transducer and activator of transcription 5B OS=Mus musculus OX=10090 GN=Stat5b PE=1 SV=1,GO:0000278; GO:0000978; GO:0001228; GO:0001553; GO:0001779; GO:0001787; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0006366; GO:0007259; GO:0007548; GO:0007565; GO:0007595; GO:0008283; GO:0008284; GO:0019218; GO:0019221; GO:0019530; GO:0019915; GO:0030098; GO:0030155; GO:0030183; GO:0030218; GO:0030856; GO:0032355; GO:0032743; GO:0032819; GO:0032825; GO:0033028; GO:0033033; GO:0033077; GO:0035259; GO:0038162; GO:0040014; GO:0040018; GO:0042104; GO:0042267; GO:0042448; GO:0042492; GO:0042803; GO:0043029; GO:0045579; GO:0045588; GO:0045621; GO:0045647; GO:0045648; GO:0045931; GO:0045944; GO:0045954; GO:0046543; GO:0046544; GO:0046983; GO:0048541; GO:0050729; GO:0050798; GO:0060397; GO:0070669; GO:0070670; GO:0070672; GO:0071363; GO:0071364; GO:0097531,activated T cell proliferation [GO:0050798]; B cell differentiation [GO:0030183]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; erythrocyte differentiation [GO:0030218]; erythropoietin-mediated signaling pathway [GO:0038162]; female pregnancy [GO:0007565]; gamma-delta T cell differentiation [GO:0042492]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; luteinization [GO:0001553]; lymphocyte differentiation [GO:0030098]; mast cell migration [GO:0097531]; mitotic cell cycle [GO:0000278]; myeloid cell apoptotic process [GO:0033028]; natural killer cell differentiation [GO:0001779]; natural killer cell mediated cytotoxicity [GO:0042267]; natural killer cell proliferation [GO:0001787]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of myeloid cell apoptotic process [GO:0033033]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; nuclear glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0000278; GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0006629; GO:0006790; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0098542; GO:0140110,mitotic cell cycle; immune system process; DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; lipid metabolic process; sulfur compound metabolic process; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility; defense response to other organism; transcription regulator activity
OG_06057,FUN_026741-T2,Peve_00006716,Pocillopora_meandrina_HIv1___RNAseq.g9416.t1,three_way,57.72766666666666,FUN_026741-T2,Q8BKN6,,,,,53.6,261.0,1.3000000000000001e-71,271.6,sp|Q8BKN6|HS3SA_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 OS=Mus musculus OX=10090 GN=Hs3st3a1 PE=2 SV=1,,,,,,
OG_06058,FUN_026758-T1,Peve_00011338,Pocillopora_meandrina_HIv1___RNAseq.g9118.t1,three_way,49.97033333333333,,,,,,,,,,,,,,,,,
OG_06059,FUN_026820-T1,Peve_00021665,Pocillopora_meandrina_HIv1___TS.g2806.t1,three_way,59.154,FUN_026820-T1,Q8BSL4,,,,,39.0,349.0,4.1e-70,266.5,sp|Q8BSL4|HS3S5_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 5 OS=Mus musculus OX=10090 GN=Hs3st5 PE=2 SV=1,,,,,,
OG_06060,FUN_026826-T1,Peve_00021661,Pocillopora_meandrina_HIv1___RNAseq.g2905.t1,three_way,81.5875,FUN_026826-T1,Q6PHS6,,,,,41.4,950.0,6.9e-205,715.7,sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1,,,,,,
OG_06061,FUN_026850-T1,Peve_00040338,Pocillopora_meandrina_HIv1___RNAseq.g27108.t1,three_way,78.967,,,,,,,,,,,,,,,,,
OG_06062,FUN_026858-T1,Peve_00039692,Pocillopora_meandrina_HIv1___TS.g14248.t1,three_way,42.34816666666667,,,,,,,,,,,,,,,,,
OG_06063,FUN_026896-T1,Peve_00021663,Pocillopora_meandrina_HIv1___RNAseq.g2819.t1,three_way,56.90566666666667,,,,,,,,,,,,,,,,,
OG_06064,FUN_026897-T1,Peve_00021662,Pocillopora_meandrina_HIv1___RNAseq.g2818.t1,three_way,84.28133333333334,FUN_026897-T1,P34275,,,,,52.0,392.0,4.8e-116,419.5,sp|P34275|IVD_CAEEL Probable acyl-CoA dehydrogenase 6 OS=Caenorhabditis elegans OX=6239 GN=acdh-6 PE=3 SV=2,,,,,,
OG_06065,FUN_026899-T1,Peve_00021656,Pocillopora_meandrina_HIv1___RNAseq.g9422.t1,three_way,59.486,FUN_026899-T1,Q5C9Z4,NOM1_HUMAN,,Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog),Homo sapiens (Human),48.6,664.0,3.3e-126,454.1,sp|Q5C9Z4|NOM1_HUMAN Nucleolar MIF4G domain-containing protein 1 OS=Homo sapiens OX=9606 GN=NOM1 PE=1 SV=1,GO:0003723; GO:0005730; GO:0042274; GO:0048820,hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274],nucleolus [GO:0005730],RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0043226,RNA binding; nucleolus; organelle
OG_06066,FUN_026909-T1,Peve_00021653,Pocillopora_meandrina_HIv1___TS.g19726.t1,three_way,61.72833333333333,FUN_026909-T1,Q66J01,,,,,30.8,910.0,4e-101,370.9,sp|Q66J01|PGAP1_XENLA GPI inositol-deacylase OS=Xenopus laevis OX=8355 GN=pgap1 PE=2 SV=1,,,,,,
OG_06067,FUN_026913-T1,Peve_00021652,Pocillopora_meandrina_HIv1___TS.g19727.t2,three_way,92.013,FUN_026913-T1,Q5PPI9,TTLL1_RAT,,Polyglutamylase complex subunit TTLL1 (EC 6.3.2.-) (Tubulin polyglutamylase TTLL1) (Tubulin polyglutamylase complex subunit 3) (PGs3) (Tubulin--tyrosine ligase-like protein 1),Rattus norvegicus (Rat),71.4,420.0,5.1e-187,655.2,sp|Q5PPI9|TTLL1_RAT Polyglutamylase complex subunit TTLL1 OS=Rattus norvegicus OX=10116 GN=Ttll1 PE=2 SV=1,GO:0000226; GO:0002395; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0007288; GO:0015631; GO:0021702; GO:0030317; GO:0031514; GO:0035082; GO:0036064; GO:0036211; GO:0046872; GO:0070740; GO:0106438; GO:0120197; GO:0120222,axoneme assembly [GO:0035082]; cerebellar Purkinje cell differentiation [GO:0021702]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; immune response in nasopharyngeal-associated lymphoid tissue [GO:0002395]; microtubule cytoskeleton organization [GO:0000226]; mucociliary clearance [GO:0120197]; protein modification process [GO:0036211]; regulation of blastocyst development [GO:0120222]; sperm axoneme assembly [GO:0007288],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; microtubule [GO:0005874]; motile cilium [GO:0031514],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0002376; GO:0003016; GO:0003824; GO:0005576; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016874; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0140096,"immune system process; respiratory system process; catalytic activity; extracellular region; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; ligase activity; reproductive process; cell differentiation; organelle; cell motility; catalytic activity, acting on a protein"
OG_06068,FUN_026916-T1,Peve_00014703,Pocillopora_meandrina_HIv1___RNAseq.g11017.t1,three_way,54.9965,,,,,,,,,,,,,,,,,
OG_06069,FUN_026917-T1,Peve_00013239,Pocillopora_meandrina_HIv1___RNAseq.g9415.t2,three_way,55.821,FUN_026917-T1,A2VD33,,,,,42.9,825.0,2.5e-193,677.2,sp|A2VD33|MOCOS_DANRE Molybdenum cofactor sulfurase OS=Danio rerio OX=7955 GN=mocos PE=2 SV=2,,,,,,
OG_06070,FUN_026918-T1,Peve_00013241,Pocillopora_meandrina_HIv1___TS.g19711.t1,three_way,50.77583333333333,FUN_026918-T1,Q96NB3,,,,,29.6,328.0,8.3e-19,95.9,sp|Q96NB3|ZN830_HUMAN Zinc finger protein 830 OS=Homo sapiens OX=9606 GN=ZNF830 PE=1 SV=2,,,,,,
OG_06071,FUN_026976-T1,Peve_00013247,Pocillopora_meandrina_HIv1___TS.g17924.t2,three_way,66.8675,FUN_026976-T1,Q9NZ56,FMN2_HUMAN,,Formin-2,Homo sapiens (Human),40.8,449.0,2e-89,331.6,sp|Q9NZ56|FMN2_HUMAN Formin-2 OS=Homo sapiens OX=9606 GN=FMN2 PE=1 SV=4,GO:0003779; GO:0005634; GO:0005730; GO:0005783; GO:0005789; GO:0005819; GO:0005829; GO:0005886; GO:0005902; GO:0005938; GO:0006974; GO:0015031; GO:0015629; GO:0016192; GO:0016477; GO:0030036; GO:0030659; GO:0035556; GO:0040038; GO:0042177; GO:0043066; GO:0046907; GO:0048471; GO:0048477; GO:0051295; GO:0051758; GO:0070649; GO:0071456; GO:2000781,actin cytoskeleton organization [GO:0030036]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole in meiosis I anaphase [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0005730; GO:0005783; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0022414; GO:0043226; GO:0048856; GO:0048870,cytokinesis; nucleus; nucleolus; endoplasmic reticulum; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; reproductive process; organelle; anatomical structure development; cell motility
OG_06072,FUN_026981-T1,Peve_00013217,Pocillopora_meandrina_HIv1___RNAseq.g9421.t1,three_way,51.642,,,,,,,,,,,,,,,,,
OG_06073,FUN_026982-T1,Peve_00013216,Pocillopora_meandrina_HIv1___RNAseq.g9420.t1,three_way,84.08966666666667,FUN_026982-T1,P31335,,,,,70.9,587.0,3.5e-250,865.5,sp|P31335|PUR9_CHICK Bifunctional purine biosynthesis protein ATIC OS=Gallus gallus OX=9031 GN=ATIC PE=1 SV=1,,,,,,
OG_06074,FUN_026983-T1,Peve_00013214,Pocillopora_meandrina_HIv1___RNAseq.g9418.t1,three_way,73.671,FUN_026983-T1,Q6ZQ18,,,,,39.6,818.0,8e-149,529.3,sp|Q6ZQ18|EFR3B_MOUSE Protein EFR3 homolog B OS=Mus musculus OX=10090 GN=Efr3b PE=1 SV=2,,,,,,
OG_06075,FUN_026985-T2,Peve_00012932,Pocillopora_meandrina_HIv1___RNAseq.g4367.t1,three_way,58.64566666666666,,,,,,,,,,,,,,,,,
OG_06076,FUN_026986-T1,Peve_00012933,Pocillopora_meandrina_HIv1___RNAseq.g4368.t1,three_way,86.65316666666666,,,,,,,,,,,,,,,,,
OG_06077,FUN_026988-T1,Peve_00012934,Pocillopora_meandrina_HIv1___RNAseq.g4369.t1,three_way,61.893,,,,,,,,,,,,,,,,,
OG_06078,FUN_026989-T1,Peve_00012936,Pocillopora_meandrina_HIv1___RNAseq.g10353.t1,three_way,77.742,FUN_026989-T1,Q6UW02,,,,,30.3,472.0,2.6e-70,267.7,sp|Q6UW02|CP20A_HUMAN Cytochrome P450 20A1 OS=Homo sapiens OX=9606 GN=CYP20A1 PE=1 SV=1,,,,,,
OG_06079,FUN_027044-T1,Peve_00025954,Pocillopora_meandrina_HIv1___TS.g12881.t1,three_way,61.001,,,,,,,,,,,,,,,,,
OG_06080,FUN_027065-T1,Peve_00012227,Pocillopora_meandrina_HIv1___RNAseq.g2816.t1,three_way,66.86916666666667,FUN_027065-T1,A2AG06,MEIOC_MOUSE,,Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein),Mus musculus (Mouse),46.5,114.0,4.8e-14,80.9,sp|A2AG06|MEIOC_MOUSE Meiosis-specific coiled-coil domain-containing protein MEIOC OS=Mus musculus OX=10090 GN=Meioc PE=1 SV=1,GO:0005634; GO:0005737; GO:0006302; GO:0007130; GO:0007141; GO:0007144; GO:0007283; GO:0007286; GO:0048255; GO:0048599; GO:0051310; GO:0051729; GO:0070192,"chromosome organization involved in meiotic cell cycle [GO:0070192]; double-strand break repair [GO:0006302]; female meiosis I [GO:0007144]; germline cell cycle switching, mitotic to meiotic cell cycle [GO:0051729]; male meiosis I [GO:0007141]; metaphase chromosome alignment [GO:0051310]; mRNA stabilization [GO:0048255]; oocyte development [GO:0048599]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]",cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0006281; GO:0022414; GO:0043226; GO:0048856; GO:0140013,nucleus; DNA repair; reproductive process; organelle; anatomical structure development; meiotic nuclear division
OG_06081,FUN_027066-T1,Peve_00012226,Pocillopora_meandrina_HIv1___RNAseq.g2817.t2,three_way,73.43866666666666,FUN_027066-T1,Q504M2,,,,,38.7,460.0,2.9e-72,274.2,"sp|Q504M2|PDP2_MOUSE [Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial OS=Mus musculus OX=10090 GN=Pdp2 PE=1 SV=1",,,,,,
OG_06082,FUN_027067-T1,Peve_00012228,Pocillopora_meandrina_HIv1___RNAseq.g2815.t1,three_way,77.89,FUN_027067-T1,Q6DHC3,,,,,51.8,336.0,2.1e-90,334.0,sp|Q6DHC3|S2540_DANRE Mitochondrial glutathione transporter SLC25A40 OS=Danio rerio OX=7955 GN=slc25a40 PE=2 SV=1,,,,,,
OG_06083,FUN_027071-T1,Peve_00012230,Pocillopora_meandrina_HIv1___RNAseq.23069_t,three_way,84.827,FUN_027071-T1,Q1L8G7,,,,,40.0,210.0,3.4e-36,153.3,sp|Q1L8G7|GATD1_DANRE GATA zinc finger domain-containing protein 1 OS=Danio rerio OX=7955 GN=gatad1 PE=2 SV=1,,,,,,
OG_06084,FUN_027072-T1,Peve_00012231,Pocillopora_meandrina_HIv1___RNAseq.g2813.t1,three_way,68.39233333333333,FUN_027072-T1,P26797,,,,,38.5,91.0,5.9e-11,69.3,sp|P26797|HM19_CAEEL Homeobox protein ceh-19 OS=Caenorhabditis elegans OX=6239 GN=ceh-19 PE=2 SV=2,,,,,,
OG_06085,FUN_027075-T1,Peve_00012235,Pocillopora_meandrina_HIv1___RNAseq.g2812.t1,three_way,70.49183333333333,FUN_027075-T1,Q14549,,,,,69.1,97.0,4.5000000000000004e-30,132.9,sp|Q14549|GBX1_HUMAN Homeobox protein GBX-1 OS=Homo sapiens OX=9606 GN=GBX1 PE=1 SV=2,,,,,,
OG_06086,FUN_027084-T1,Peve_00013218,Pocillopora_meandrina_HIv1___RNAseq.g2808.t1,three_way,82.44433333333333,FUN_027084-T1,Q3ZBR6,,,,,77.6,49.0,1.5e-13,77.0,sp|Q3ZBR6|SEM1_BOVIN 26S proteasome complex subunit SEM1 OS=Bos taurus OX=9913 GN=SEM1 PE=3 SV=1,,,,,,
OG_06087,FUN_027086-T1,Peve_00012245,Pocillopora_meandrina_HIv1___TS.g17920.t1,three_way,91.32083333333333,FUN_027086-T1,Q14562,DHX8_HUMAN,,ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1),Homo sapiens (Human),75.5,1179.0,0.0,1576.2,sp|Q14562|DHX8_HUMAN ATP-dependent RNA helicase DHX8 OS=Homo sapiens OX=9606 GN=DHX8 PE=1 SV=1,GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0008186; GO:0008380; GO:0016604; GO:0016887; GO:0042802; GO:0071007; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]",GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06088,FUN_027087-T1,Peve_00012239,Pocillopora_meandrina_HIv1___RNAseq.g24966.t1,three_way,81.16233333333334,FUN_027087-T1,E9Q3T6,PRD14_MOUSE,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Mus musculus (Mouse),53.8,234.0,2.2e-67,257.7,sp|E9Q3T6|PRD14_MOUSE PR domain zinc finger protein 14 OS=Mus musculus OX=10090 GN=Prdm14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0032259; GO:0040029; GO:0040037; GO:0045814; GO:0048873; GO:0060818; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of gene expression [GO:0010468]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_06089,FUN_027127-T1,Peve_00039622,Pocillopora_meandrina_HIv1___RNAseq.g15332.t1,three_way,58.584833333333336,FUN_027127-T1,Q8K245,UVRAG_MOUSE,,UV radiation resistance-associated protein,Mus musculus (Mouse),43.1,450.0,5.2e-84,313.9,sp|Q8K245|UVRAG_MOUSE UV radiation resistance-associated protein OS=Mus musculus OX=10090 GN=Uvrag PE=1 SV=2,GO:0000149; GO:0000421; GO:0000775; GO:0005764; GO:0005769; GO:0005770; GO:0005783; GO:0005813; GO:0006281; GO:0006890; GO:0007051; GO:0007059; GO:0007098; GO:0010506; GO:0017124; GO:0030496; GO:0032465; GO:0032801; GO:0032991; GO:0035032; GO:0035493; GO:0036092; GO:0045335; GO:0046718; GO:0051684; GO:0070418; GO:0097352; GO:0097680,"autophagosome maturation [GO:0097352]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; maintenance of Golgi location [GO:0051684]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; SNARE complex assembly [GO:0035493]; spindle organization [GO:0007051]; symbiont entry into host cell [GO:0046718]","autophagosome membrane [GO:0000421]; centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; DNA-dependent protein kinase complex [GO:0070418]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; lysosome [GO:0005764]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; protein-containing complex [GO:0032991]",SH3 domain binding [GO:0017124]; SNARE binding [GO:0000149],GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005815; GO:0006281; GO:0006629; GO:0007010; GO:0007059; GO:0016192; GO:0031410; GO:0043226; GO:0065003,lysosome; endosome; vacuole; endoplasmic reticulum; microtubule organizing center; DNA repair; lipid metabolic process; cytoskeleton organization; chromosome segregation; vesicle-mediated transport; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_06090,FUN_027128-T1,Peve_00039620,Pocillopora_meandrina_HIv1___TS.g10360.t2,three_way,69.8775,FUN_027128-T1,O60244,MED14_HUMAN,,Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150),Homo sapiens (Human),36.0,1532.0,7.500000000000001e-225,782.7,sp|O60244|MED14_HUMAN Mediator of RNA polymerase II transcription subunit 14 OS=Homo sapiens OX=9606 GN=MED14 PE=1 SV=2,GO:0003712; GO:0003713; GO:0005634; GO:0005654; GO:0006357; GO:0016020; GO:0016592; GO:0032968; GO:0035019; GO:0042809; GO:0045893; GO:0045944; GO:0051123; GO:0060261; GO:0070847,positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; somatic stem cell population maintenance [GO:0035019],core mediator complex [GO:0070847]; mediator complex [GO:0016592]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],nuclear vitamin D receptor binding [GO:0042809]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_06091,FUN_027213-T1,Peve_00039610,Pocillopora_meandrina_HIv1___RNAseq.g15326.t1,three_way,61.34866666666667,,,,,,,,,,,,,,,,,
OG_06092,FUN_027218-T1,Peve_00018289,Pocillopora_meandrina_HIv1___RNAseq.g15249.t1,three_way,69.15166666666667,FUN_027218-T1,Q8IW92,,,,,43.8,665.0,4.3e-148,526.6,sp|Q8IW92|GLBL2_HUMAN Beta-galactosidase-1-like protein 2 OS=Homo sapiens OX=9606 GN=GLB1L2 PE=1 SV=1,,,,,,
OG_06093,FUN_027219-T1,Peve_00018290,Pocillopora_meandrina_HIv1___RNAseq.g15895.t1,three_way,83.92083333333333,FUN_027219-T1,Q95LR0,,,,,55.3,721.0,6.3e-205,715.7,sp|Q95LR0|CFA91_MACFA Cilia- and flagella-associated protein 91 OS=Macaca fascicularis OX=9541 GN=CFAP91 PE=2 SV=3,,,,,,
OG_06094,FUN_027220-T1,Peve_00018291,Pocillopora_meandrina_HIv1___RNAseq.g15896.t1,three_way,89.22933333333333,FUN_027220-T1,Q4R5Y0,,,,,52.7,112.0,4.3e-29,129.0,sp|Q4R5Y0|CFA68_MACFA Cilia- and flagella-associated protein 68 OS=Macaca fascicularis OX=9541 GN=CFAP68 PE=2 SV=1,,,,,,
OG_06095,FUN_027269-T1,Peve_00034309,Pocillopora_meandrina_HIv1___RNAseq.g4020.t1,three_way,51.61,,,,,,,,,,,,,,,,,
OG_06096,FUN_027270-T1,Peve_00018292,Pocillopora_meandrina_HIv1___TS.g10917.t1,three_way,87.52583333333334,FUN_027270-T1,Q80W99,CTSR3_MOUSE,,Cation channel sperm-associated protein 3 (CatSper3),Mus musculus (Mouse),34.5,383.0,1.4e-53,211.8,sp|Q80W99|CTSR3_MOUSE Cation channel sperm-associated protein 3 OS=Mus musculus OX=10090 GN=Catsper3 PE=1 SV=2,GO:0001669; GO:0005245; GO:0005783; GO:0006814; GO:0030317; GO:0031514; GO:0036128; GO:0048240; GO:0051649,establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; sodium ion transport [GO:0006814]; sperm capacitation [GO:0048240],acrosomal vesicle [GO:0001669]; CatSper complex [GO:0036128]; endoplasmic reticulum [GO:0005783]; motile cilium [GO:0031514],voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005783; GO:0005929; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0048870,transporter activity; endoplasmic reticulum; cilium; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cell motility
OG_06097,FUN_027479-T1,Peve_00029219,Pocillopora_meandrina_HIv1___RNAseq.g6737.t1,three_way,69.85133333333333,,,,,,,,,,,,,,,,,
OG_06098,FUN_027734-T1,Peve_00036493,Pocillopora_meandrina_HIv1___RNAseq.g13905.t1,three_way,66.03566666666666,FUN_027734-T1,Q86YF9,DZIP1_HUMAN,,Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1),Homo sapiens (Human),28.4,334.0,1.3e-27,127.1,sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0043231; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140706; GO:1903566,ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0060090,nucleus; nucleoplasm; microtubule organizing center; cytosol; reproductive process; organelle; cilium organization; anatomical structure development; molecular adaptor activity
OG_06099,FUN_027735-T1,Peve_00036492,Pocillopora_meandrina_HIv1___RNAseq.g13904.t1,three_way,70.82816666666666,FUN_027735-T1,O94888,UBXN7_HUMAN,,UBX domain-containing protein 7,Homo sapiens (Human),41.6,500.0,1e-93,345.5,sp|O94888|UBXN7_HUMAN UBX domain-containing protein 7 OS=Homo sapiens OX=9606 GN=UBXN7 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005829; GO:0031625; GO:0034098; GO:0043130; GO:0043161; GO:0061629,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005654; GO:0005829; GO:0030163; GO:0043226,nucleus; nucleoplasm; cytosol; protein catabolic process; organelle
OG_06100,FUN_027736-T1,Peve_00036491,Pocillopora_meandrina_HIv1___RNAseq.g13903.t1,three_way,88.12533333333333,FUN_027736-T1,Q8WYA0,IFT81_HUMAN,,Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1),Homo sapiens (Human),55.2,677.0,1.5e-180,634.4,sp|Q8WYA0|IFT81_HUMAN Intraflagellar transport protein 81 homolog OS=Homo sapiens OX=9606 GN=IFT81 PE=1 SV=1,GO:0005737; GO:0005813; GO:0005814; GO:0005929; GO:0007283; GO:0008589; GO:0015631; GO:0030992; GO:0031514; GO:0035720; GO:0035735; GO:0036064; GO:0042073; GO:0060271; GO:0097225; GO:0097228; GO:0097542; GO:0120316,cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of smoothened signaling pathway [GO:0008589]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228],tubulin binding [GO:0015631],GO:0005815; GO:0005929; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0044782,microtubule organizing center; cilium; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; cilium organization
OG_06101,FUN_027779-T1,Peve_00034984,Pocillopora_meandrina_HIv1___RNAseq.g12667.t1,three_way,61.244166666666665,FUN_027779-T1,Q7Z408,CSMD2_HUMAN,,CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2),Homo sapiens (Human),23.2,921.0,4.8e-24,116.7,sp|Q7Z408|CSMD2_HUMAN CUB and sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CSMD2 PE=1 SV=2,GO:0097107; GO:0098839; GO:0098978; GO:0099562,maintenance of postsynaptic density structure [GO:0099562]; postsynaptic density assembly [GO:0097107],glutamatergic synapse [GO:0098978]; postsynaptic density membrane [GO:0098839],,GO:0034330,cell junction organization
OG_06102,FUN_027803-T1,Peve_00036490,Pocillopora_meandrina_HIv1___RNAseq.g13902.t1,three_way,71.5315,FUN_027803-T1,Q6DFJ3,,,,,34.9,149.0,9.3e-19,94.7,sp|Q6DFJ3|FUD1B_XENLA FUN14 domain-containing protein 1B OS=Xenopus laevis OX=8355 GN=fundc1-b PE=2 SV=1,,,,,,
OG_06103,FUN_027804-T1,Peve_00036486,Pocillopora_meandrina_HIv1___RNAseq.g13899.t1,three_way,84.46000000000001,FUN_027804-T1,Q9U9L2,,,,,82.8,250.0,9.3e-123,441.0,sp|Q9U9L2|RL8_ANOGA Large ribosomal subunit protein uL2 OS=Anopheles gambiae OX=7165 GN=RpL8 PE=2 SV=2,,,,,,
OG_06104,FUN_027805-T1,Peve_00036485,Pocillopora_meandrina_HIv1___RNAseq.g13898.t1,three_way,81.17733333333334,FUN_027805-T1,Q8BHJ5,TBL1R_MOUSE,,F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1),Mus musculus (Mouse),58.4,514.0,4.8e-120,433.0,sp|Q8BHJ5|TBL1R_MOUSE F-box-like/WD repeat-containing protein TBL1XR1 OS=Mus musculus OX=10090 GN=Tbl1xr1 PE=1 SV=1,GO:0000118; GO:0000122; GO:0000976; GO:0001835; GO:0002021; GO:0003677; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0008013; GO:0010468; GO:0016042; GO:0017053; GO:0035264; GO:0042393; GO:0043161; GO:0045892; GO:0045944; GO:0050872; GO:0060612; GO:0060613; GO:0072686; GO:0090207; GO:0090263,adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; chromatin organization [GO:0006325]; fat pad development [GO:0060613]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872],histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0006629; GO:0030154; GO:0030163; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; cell differentiation; protein catabolic process; histone binding; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_06105,FUN_027806-T1,Peve_00036481,Pocillopora_meandrina_HIv1___RNAseq.g13895.t1,three_way,70.82966666666667,,,,,,,,,,,,,,,,,
OG_06106,FUN_027808-T2,Peve_00036480,Pocillopora_meandrina_HIv1___RNAseq.g13894.t1,three_way,79.88533333333334,FUN_027808-T2,P21333,FLNA_HUMAN,,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),Homo sapiens (Human),27.6,1675.0,4.7e-140,501.1,sp|P21333|FLNA_HUMAN Filamin-A OS=Homo sapiens OX=9606 GN=FLNA PE=1 SV=4,GO:0001664; GO:0002102; GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0007195; GO:0007597; GO:0010572; GO:0015459; GO:0015629; GO:0016020; GO:0016479; GO:0019900; GO:0021943; GO:0021987; GO:0030018; GO:0030036; GO:0030334; GO:0030426; GO:0030863; GO:0031267; GO:0031523; GO:0032233; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0042789; GO:0042803; GO:0043066; GO:0043113; GO:0043123; GO:0043198; GO:0043204; GO:0043433; GO:0044319; GO:0044325; GO:0045184; GO:0045296; GO:0046332; GO:0048471; GO:0050821; GO:0051015; GO:0051020; GO:0051209; GO:0051764; GO:0060271; GO:0070062; GO:0070527; GO:0071526; GO:0072659; GO:0090042; GO:0090307; GO:0097368; GO:0097440; GO:0098794; GO:0098978; GO:0140297; GO:0140311; GO:1900026; GO:1901381; GO:1902396; GO:1905000; GO:1905031; GO:1990779; GO:2000179; GO:2001046; GO:2001224,"actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; blood coagulation, intrinsic pathway [GO:0007597]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]",actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; Z disc [GO:0030018],actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325],GO:0003723; GO:0005576; GO:0005634; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0006351; GO:0006355; GO:0007010; GO:0007155; GO:0008092; GO:0016071; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0051604; GO:0055085; GO:0072659; GO:0098772; GO:0140313,RNA binding; extracellular region; nucleus; nucleolus; cytosol; cytoskeleton; plasma membrane; DNA-templated transcription; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; mRNA metabolic process; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein maturation; transmembrane transport; protein localization to plasma membrane; molecular function regulator activity; molecular sequestering activity
OG_06107,FUN_027811-T1,Peve_00036479,Pocillopora_meandrina_HIv1___RNAseq.g13893.t1,three_way,68.13966666666667,,,,,,,,,,,,,,,,,
OG_06108,FUN_027813-T1,Peve_00036478,Pocillopora_meandrina_HIv1___RNAseq.g13891.t1,three_way,60.12866666666667,,,,,,,,,,,,,,,,,
OG_06109,FUN_027814-T1,Peve_00036499,Pocillopora_meandrina_HIv1___RNAseq.g13890.t1,three_way,84.264,FUN_027814-T1,O00571,DDX3X_HUMAN,,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2)",Homo sapiens (Human),71.5,425.0,1.6999999999999996e-177,623.6,sp|O00571|DDX3X_HUMAN ATP-dependent RNA helicase DDX3X OS=Homo sapiens OX=9606 GN=DDX3X PE=1 SV=3,GO:0002753; GO:0003677; GO:0003678; GO:0003723; GO:0003724; GO:0003729; GO:0003924; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006413; GO:0007059; GO:0007276; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010628; GO:0010629; GO:0016055; GO:0016887; GO:0017111; GO:0017148; GO:0030027; GO:0030154; GO:0030307; GO:0030308; GO:0031252; GO:0031333; GO:0031369; GO:0032481; GO:0032727; GO:0032728; GO:0033592; GO:0034063; GO:0034157; GO:0034161; GO:0034774; GO:0035556; GO:0035591; GO:0035613; GO:0036493; GO:0042256; GO:0043015; GO:0043024; GO:0043065; GO:0043066; GO:0043186; GO:0043273; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0055088; GO:0070062; GO:0070131; GO:0071243; GO:0071470; GO:0071651; GO:0072559; GO:0090263; GO:0097193; GO:0098586; GO:1900087; GO:1900227; GO:1901223; GO:1901224; GO:1902042; GO:1902523; GO:1903608; GO:1904813; GO:2001243,cell differentiation [GO:0030154]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytosolic ribosome assembly [GO:0042256]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; gamete generation [GO:0007276]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lipid homeostasis [GO:0055088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; positive regulation of translational initiation [GO:0045948]; positive regulation of type I interferon production [GO:0032481]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; stress granule assembly [GO:0034063]; translational initiation [GO:0006413]; Wnt signaling pathway [GO:0016055],cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634]; P granule [GO:0043186]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; eukaryotic initiation factor 4E binding [GO:0008190]; gamma-tubulin binding [GO:0043015]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; signaling adaptor activity [GO:0035591]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; GTPase activity; extracellular region; nucleus; mitochondrion; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06110,FUN_027815-T1,Peve_00036487,Pocillopora_meandrina_HIv1___RNAseq.g13889.t2,three_way,90.976,FUN_027815-T1,Q23356,MIG15_CAEEL,,Serine/threonine-protein kinase mig-15 (EC 2.7.11.1) (Abnormal cell migration protein 15),Caenorhabditis elegans,44.9,1094.0,1.7e-240,833.9,sp|Q23356|MIG15_CAEEL Serine/threonine-protein kinase mig-15 OS=Caenorhabditis elegans OX=6239 GN=mig-15 PE=2 SV=3,GO:0000165; GO:0002119; GO:0004674; GO:0005524; GO:0005737; GO:0010171; GO:0022414; GO:0030334; GO:0032228; GO:0033563; GO:0043408; GO:0048812; GO:0106310,"body morphogenesis [GO:0010171]; dorsal/ventral axon guidance [GO:0033563]; MAPK cascade [GO:0000165]; nematode larval development [GO:0002119]; neuron projection morphogenesis [GO:0048812]; regulation of cell migration [GO:0030334]; regulation of MAPK cascade [GO:0043408]; regulation of synaptic transmission, GABAergic [GO:0032228]; reproductive process [GO:0022414]",cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; transferase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_06111,FUN_027817-T1,Peve_00042678,Pocillopora_meandrina_HIv1___TS.g22877.t1b,three_way,64.28866666666667,,,,,,,,,,,,,,,,,
OG_06112,FUN_027829-T1,Peve_00020555,Pocillopora_meandrina_HIv1___RNAseq.g13866.t1,three_way,85.965,FUN_027829-T1,Q8BXG3,IFT57_MOUSE,,Intraflagellar transport protein 57 homolog (HIP1-interacting protein),Mus musculus (Mouse),59.2,223.0,1.3e-70,268.5,sp|Q8BXG3|IFT57_MOUSE Intraflagellar transport protein 57 homolog OS=Mus musculus OX=10090 GN=Ift57 PE=1 SV=1,GO:0001843; GO:0001947; GO:0003677; GO:0005794; GO:0005813; GO:0005929; GO:0005930; GO:0006915; GO:0007224; GO:0010839; GO:0030992; GO:0032391; GO:0035720; GO:0036064; GO:0042073; GO:0042981; GO:0043616; GO:0044292; GO:0044458; GO:0060271; GO:0060972; GO:0097546; GO:1905515,apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; keratinocyte proliferation [GO:0043616]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of keratinocyte proliferation [GO:0010839]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; photoreceptor connecting cilium [GO:0032391],DNA binding [GO:0003677],GO:0003677; GO:0005794; GO:0005815; GO:0005929; GO:0007018; GO:0012501; GO:0043226; GO:0044782,DNA binding; Golgi apparatus; microtubule organizing center; cilium; microtubule-based movement; programmed cell death; organelle; cilium organization
OG_06113,FUN_027830-T1,Peve_00020554,Pocillopora_meandrina_HIv1___RNAseq.g13867.t1,three_way,75.69233333333334,FUN_027830-T1,O00233,PSMD9_HUMAN,,26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27),Homo sapiens (Human),49.5,206.0,1.6999999999999996e-47,190.7,sp|O00233|PSMD9_HUMAN 26S proteasome non-ATPase regulatory subunit 9 OS=Homo sapiens OX=9606 GN=PSMD9 PE=1 SV=3,GO:0003713; GO:0005634; GO:0005737; GO:0005829; GO:0005838; GO:0006511; GO:0032024; GO:0043425; GO:0045893; GO:0046676; GO:0070682,negative regulation of insulin secretion [GO:0046676]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion [GO:0032024]; proteasome regulatory particle assembly [GO:0070682]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome regulatory particle [GO:0005838],bHLH transcription factor binding [GO:0043425]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005829; GO:0006355; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_06114,FUN_027831-T1,Peve_00020551,Pocillopora_meandrina_HIv1___RNAseq.g13868.t1,three_way,74.62966666666667,FUN_027831-T1,Q9H892,,,,,27.8,753.0,8.2e-63,243.4,sp|Q9H892|TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens OX=9606 GN=TTC12 PE=1 SV=2,,,,,,
OG_06115,FUN_027832-T1,Peve_00020550,Pocillopora_meandrina_HIv1___TS.g11651.t1a,three_way,84.66816666666666,FUN_027832-T1,Q6NRH1,,,,,58.3,408.0,3.2e-139,496.5,sp|Q6NRH1|DCAF8_XENLA DDB1- and CUL4-associated factor 8 OS=Xenopus laevis OX=8355 GN=dcaf8 PE=2 SV=1,,,,,,
OG_06116,FUN_027847-T1,Peve_00020549,Pocillopora_meandrina_HIv1___TS.g11651.t1b,three_way,53.05566666666667,FUN_027847-T1,P57052,RBM11_HUMAN,,Splicing regulator RBM11 (RNA-binding motif protein 11),Homo sapiens (Human),61.7,94.0,6.400000000000001e-23,109.0,sp|P57052|RBM11_HUMAN Splicing regulator RBM11 OS=Homo sapiens OX=9606 GN=RBM11 PE=1 SV=1,GO:0000381; GO:0003727; GO:0005634; GO:0005654; GO:0006397; GO:0008266; GO:0008380; GO:0016607; GO:0030154; GO:0034599; GO:0042803,"cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],poly(U) RNA binding [GO:0008266]; protein homodimerization activity [GO:0042803]; single-stranded RNA binding [GO:0003727],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0030154; GO:0043226,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; cell differentiation; organelle
OG_06117,FUN_027848-T1,Peve_00023422,Pocillopora_meandrina_HIv1___RNAseq.g29757.t1,three_way,50.14816666666667,,,,,,,,,,,,,,,,,
OG_06118,FUN_027849-T2,Peve_00024334,Pocillopora_meandrina_HIv1___RNAseq.g13871.t1,three_way,64.28016666666666,FUN_027849-T2,Q9QZS7,,,,,24.7,522.0,3.9e-26,122.5,sp|Q9QZS7|NPHN_MOUSE Nephrin OS=Mus musculus OX=10090 GN=Nphs1 PE=1 SV=2,,,,,,
OG_06119,FUN_027850-T1,Peve_00024333,Pocillopora_meandrina_HIv1___TS.g11653.t1,three_way,77.86916666666667,,,,,,,,,,,,,,,,,
OG_06120,FUN_027852-T2,Peve_00031657,Pocillopora_meandrina_HIv1___TS.g11671.t1,three_way,59.174166666666665,,,,,,,,,,,,,,,,,
OG_06121,FUN_027853-T1,Peve_00020102,Pocillopora_meandrina_HIv1___RNAseq.g13886.t1,three_way,89.03033333333333,FUN_027853-T1,Q8CI04,,,,,48.8,818.0,1.5e-211,737.6,sp|Q8CI04|COG3_MOUSE Conserved oligomeric Golgi complex subunit 3 OS=Mus musculus OX=10090 GN=Cog3 PE=1 SV=3,,,,,,
OG_06122,FUN_027899-T1,Peve_00020103,Pocillopora_meandrina_HIv1___RNAseq.g13885.t1,three_way,50.3325,,,,,,,,,,,,,,,,,
OG_06123,FUN_027900-T1,Peve_00020104,Pocillopora_meandrina_HIv1___RNAseq.g13884.t1,three_way,58.21116666666667,FUN_027900-T1,B2RYR0,RN168_RAT,,E3 ubiquitin-protein ligase RNF168 (EC 2.3.2.27) (RING finger protein 168) (RING-type E3 ubiquitin transferase RNF168),Rattus norvegicus (Rat),47.5,122.0,2.4e-30,134.4,sp|B2RYR0|RN168_RAT E3 ubiquitin-protein ligase RNF168 OS=Rattus norvegicus OX=10116 GN=Rnf168 PE=1 SV=1,GO:0000151; GO:0003682; GO:0004842; GO:0005634; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0016567; GO:0031491; GO:0032880; GO:0032991; GO:0034244; GO:0034644; GO:0035861; GO:0040029; GO:0042393; GO:0043130; GO:0045190; GO:0045739; GO:0070530; GO:0070534; GO:0097680; GO:0140852; GO:0140858; GO:0140861; GO:1990391,cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; regulation of protein localization [GO:0032880]; response to ionizing radiation [GO:0010212]; ubiquitin-dependent protein catabolic process [GO:0006511],DNA repair complex [GO:1990391]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151],chromatin binding [GO:0003682]; histone binding [GO:0042393]; histone H2AK15 ubiquitin ligase activity [GO:0140858]; histone ubiquitin ligase activity [GO:0140852]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; nucleosome binding [GO:0031491]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_06124,FUN_027902-T1,Peve_00020105,Pocillopora_meandrina_HIv1___RNAseq.g13882.t1,three_way,48.062,,,,,,,,,,,,,,,,,
OG_06125,FUN_027903-T1,Peve_00020107,Pocillopora_meandrina_HIv1___RNAseq.g13881.t1,three_way,48.315666666666665,FUN_027903-T1,O75487,GPC4_HUMAN,,Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4],Homo sapiens (Human),33.5,507.0,6.5e-73,276.6,sp|O75487|GPC4_HUMAN Glypican-4 OS=Homo sapiens OX=9606 GN=GPC4 PE=1 SV=4,GO:0005634; GO:0005796; GO:0005886; GO:0009897; GO:0009966; GO:0009986; GO:0015026; GO:0016055; GO:0016477; GO:0043202; GO:0045202; GO:0070062; GO:0098696; GO:0098978; GO:0099560; GO:1905606,cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of presynapse assembly [GO:1905606]; regulation of signal transduction [GO:0009966]; synaptic membrane adhesion [GO:0099560]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synapse [GO:0045202],coreceptor activity [GO:0015026],GO:0005634; GO:0005886; GO:0007155; GO:0043226; GO:0048870; GO:0060089,nucleus; plasma membrane; cell adhesion; organelle; cell motility; molecular transducer activity
OG_06126,FUN_027923-T1,Peve_00020108,Pocillopora_meandrina_HIv1___RNAseq.g13880.t1,three_way,62.48633333333333,FUN_027923-T1,Q2KHV4,,,,,42.6,298.0,1.5e-61,238.0,"sp|Q2KHV4|PARL_BOVIN Presenilin-associated rhomboid-like protein, mitochondrial OS=Bos taurus OX=9913 GN=PARL PE=2 SV=1",,,,,,
OG_06127,FUN_027928-T4,Peve_00020552,Pocillopora_meandrina_HIv1___TS.g11659.t1,three_way,46.897,FUN_027928-T4,Q9UBM8,MGT4C_HUMAN,,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-acetylglucosaminyltransferase IV homolog) (hGnT-IV-H) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GlcNAc-T IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)",Homo sapiens (Human),21.7,387.0,5e-18,94.0,"sp|Q9UBM8|MGT4C_HUMAN Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Homo sapiens OX=9606 GN=MGAT4C PE=2 SV=2",GO:0000139; GO:0006487; GO:0008375; GO:0008454; GO:0019082; GO:0046872,protein N-linked glycosylation [GO:0006487]; viral protein processing [GO:0019082],Golgi membrane [GO:0000139],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]",GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06128,FUN_027932-T1,Peve_00020113,Pocillopora_meandrina_HIv1___RNAseq.g13876.t1,three_way,75.51033333333334,FUN_027932-T1,P49848,TAF6_HUMAN,,Transcription initiation factor TFIID subunit 6 (RNA polymerase II TBP-associated factor subunit E) (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70) (Transcription initiation factor TFIID 80 kDa subunit) (TAF(II)80) (TAFII-80) (TAFII80),Homo sapiens (Human),53.7,456.0,1.8e-142,507.7,sp|P49848|TAF6_HUMAN Transcription initiation factor TFIID subunit 6 OS=Homo sapiens OX=9606 GN=TAF6 PE=1 SV=1,GO:0000124; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0006915; GO:0008285; GO:0016251; GO:0017162; GO:0032991; GO:0033276; GO:0042789; GO:0043065; GO:0045786; GO:0045893; GO:0046695; GO:0046982; GO:0051123; GO:0060261; GO:0071339; GO:2001244,apoptotic process [GO:0006915]; DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276],aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0012501; GO:0016071; GO:0043226; GO:0060090; GO:0065003; GO:0140110; GO:0140223,DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; mRNA metabolic process; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity; general transcription initiation factor activity
OG_06129,FUN_027933-T1,Peve_00020114,Pocillopora_meandrina_HIv1___RNAseq.g13875.t1,three_way,72.51966666666667,,,,,,,,,,,,,,,,,
OG_06130,FUN_027934-T1,Peve_00020115,Pocillopora_meandrina_HIv1___RNAseq.g13874.t1,three_way,86.42533333333334,FUN_027934-T1,Q32TG3,,,,,53.9,707.0,2.1e-228,793.5,sp|Q32TG3|EFHC2_CHICK EF-hand domain-containing family member C2 OS=Gallus gallus OX=9031 GN=EFHC2 PE=2 SV=1,,,,,,
OG_06131,FUN_027935-T1,Peve_00023144,Pocillopora_meandrina_HIv1___RNAseq.g14027.t1,three_way,83.12183333333333,,,,,,,,,,,,,,,,,
OG_06132,FUN_027938-T2,Peve_00032459,Pocillopora_meandrina_HIv1___RNAseq.g14030.t1,three_way,71.97066666666667,,,,,,,,,,,,,,,,,
OG_06133,FUN_027939-T1,Peve_00023148,Pocillopora_meandrina_HIv1___RNAseq.g14031.t1,three_way,77.95766666666667,FUN_027939-T1,Q18120,TWK18_CAEEL,,TWiK family of potassium channels protein 18,Caenorhabditis elegans,35.9,192.0,7.4e-23,109.8,sp|Q18120|TWK18_CAEEL TWiK family of potassium channels protein 18 OS=Caenorhabditis elegans OX=6239 GN=twk-18 PE=1 SV=2,GO:0005886; GO:0006813; GO:0006936; GO:0015271; GO:0016020; GO:0022841; GO:0040011; GO:0071805,locomotion [GO:0040011]; muscle contraction [GO:0006936]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813],membrane [GO:0016020]; plasma membrane [GO:0005886],outward rectifier potassium channel activity [GO:0015271]; potassium ion leak channel activity [GO:0022841],GO:0003012; GO:0005215; GO:0005886; GO:0055085,muscle system process; transporter activity; plasma membrane; transmembrane transport
OG_06134,FUN_027944-T2,Peve_00023150,Pocillopora_meandrina_HIv1___TS.g11810.t1,three_way,50.5155,,,,,,,,,,,,,,,,,
OG_06135,FUN_027946-T1,Peve_00034208,Pocillopora_meandrina_HIv1___RNAseq.g14033.t1,three_way,60.9715,FUN_027946-T1,Q0V9T8,,,,,63.8,229.0,9.999999999999999e-87,322.4,sp|Q0V9T8|BIVM_XENTR Basic immunoglobulin-like variable motif-containing protein OS=Xenopus tropicalis OX=8364 GN=bivm PE=2 SV=1,,,,,,
OG_06136,FUN_027947-T1,Peve_00034209,Pocillopora_meandrina_HIv1___RNAseq.g14034.t1,three_way,76.312,,,,,,,,,,,,,,,,,
OG_06137,FUN_027950-T1,Peve_00021880,Pocillopora_meandrina_HIv1___RNAseq.g14040.t1,three_way,82.44316666666667,FUN_027950-T1,Q58EK3,,,,,36.9,306.0,1.3e-53,211.8,sp|Q58EK3|PLCX3_DANRE PI-PLC X domain-containing protein 3 OS=Danio rerio OX=7955 GN=plcxd3 PE=2 SV=1,,,,,,
OG_06138,FUN_027960-T1,Peve_00017205,Pocillopora_meandrina_HIv1___RNAseq.g14049.t1,three_way,88.88733333333333,,,,,,,,,,,,,,,,,
OG_06139,FUN_027961-T1,Peve_00021881,Pocillopora_meandrina_HIv1___RNAseq.g14050.t1,three_way,83.93933333333334,FUN_027961-T1,P47791,,,,,60.3,461.0,1.9e-158,560.5,"sp|P47791|GSHR_MOUSE Glutathione reductase, mitochondrial OS=Mus musculus OX=10090 GN=Gsr PE=1 SV=3",,,,,,
OG_06140,FUN_027962-T1,Peve_00031346,Pocillopora_meandrina_HIv1___RNAseq.g14048.t1,three_way,72.3915,FUN_027962-T1,Q8NBM4,UBAC2_HUMAN,,Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1),Homo sapiens (Human),32.7,367.0,5.2e-39,163.3,sp|Q8NBM4|UBAC2_HUMAN Ubiquitin-associated domain-containing protein 2 OS=Homo sapiens OX=9606 GN=UBAC2 PE=1 SV=1,GO:0004252; GO:0005783; GO:0005789; GO:0016055; GO:0070972; GO:0090090; GO:1904153,"negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein localization to endoplasmic reticulum [GO:0070972]; Wnt signaling pathway [GO:0016055]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005783; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06141,FUN_027963-T1,Peve_00031347,Pocillopora_meandrina_HIv1___RNAseq.g14047.t1,three_way,67.17033333333333,FUN_027963-T1,P16333,NCK1_HUMAN,,SH2/SH3 adapter protein NCK1 (Cytoplasmic protein NCK1) (NCK adapter protein 1) (Nck-1) (SH2/SH3 adapter protein NCK-alpha),Homo sapiens (Human),41.3,380.0,7e-76,285.8,sp|P16333|NCK1_HUMAN SH2/SH3 adapter protein NCK1 OS=Homo sapiens OX=9606 GN=NCK1 PE=1 SV=1,GO:0000122; GO:0000164; GO:0004860; GO:0005102; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0005911; GO:0006930; GO:0007015; GO:0007172; GO:0008093; GO:0010976; GO:0012506; GO:0016477; GO:0019904; GO:0030032; GO:0030159; GO:0030334; GO:0030674; GO:0030838; GO:0030971; GO:0034976; GO:0035591; GO:0036491; GO:0036493; GO:0042102; GO:0042110; GO:0045296; GO:0045944; GO:0046627; GO:0046875; GO:0048013; GO:0050860; GO:0071074; GO:0140311; GO:0140374; GO:0140693; GO:1902237; GO:1903676; GO:1903679; GO:1903898,"actin filament organization [GO:0007015]; antiviral innate immune response [GO:0140374]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036491]; response to endoplasmic reticulum stress [GO:0034976]; signal complex assembly [GO:0007172]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]",cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506],cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; molecular condensate scaffold activity [GO:0140693]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein sequestering activity [GO:0140311]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159],GO:0002376; GO:0005634; GO:0005783; GO:0005829; GO:0005840; GO:0005886; GO:0006355; GO:0043226; GO:0048870; GO:0060090; GO:0065003; GO:0098542; GO:0098772; GO:0140313,immune system process; nucleus; endoplasmic reticulum; cytosol; ribosome; plasma membrane; regulation of DNA-templated transcription; organelle; cell motility; molecular adaptor activity; protein-containing complex assembly; defense response to other organism; molecular function regulator activity; molecular sequestering activity
OG_06142,FUN_027968-T1,Peve_00031355,Pocillopora_meandrina_HIv1___RNAseq.g14051.t1,three_way,49.82666666666667,FUN_027968-T1,O70137,,,,,41.6,89.0,8.6e-07,55.8,sp|O70137|ALX3_MOUSE Homeobox protein aristaless-like 3 OS=Mus musculus OX=10090 GN=Alx3 PE=2 SV=1,,,,,,
OG_06143,FUN_027969-T1,Peve_00031356,Pocillopora_meandrina_HIv1___RNAseq.g14052.t1,three_way,45.65766666666666,,,,,,,,,,,,,,,,,
OG_06144,FUN_027971-T1,Peve_00031357,Pocillopora_meandrina_HIv1___RNAseq.g14053.t1,three_way,64.43966666666667,FUN_027971-T1,Q7PCJ9,,,,,47.6,168.0,1.4e-37,157.5,sp|Q7PCJ9|SAT2_PIG Thialysine N-epsilon-acetyltransferase OS=Sus scrofa OX=9823 GN=SAT2 PE=2 SV=1,,,,,,
OG_06145,FUN_027975-T1,Peve_00031359,Pocillopora_meandrina_HIv1___RNAseq.g14056.t1,three_way,65.946,,,,,,,,,,,,,,,,,
OG_06146,FUN_027976-T1,Peve_00031360,Pocillopora_meandrina_HIv1___RNAseq.g14057.t1,three_way,82.28966666666666,FUN_027976-T1,Q9NRX2,RM17_HUMAN,,"Large ribosomal subunit protein bL17m (39S ribosomal protein L17, mitochondrial) (L17mt) (MRP-L17) (LYST-interacting protein 2)",Homo sapiens (Human),46.8,111.0,8e-22,105.1,sp|Q9NRX2|RM17_HUMAN Large ribosomal subunit protein bL17m OS=Homo sapiens OX=9606 GN=MRPL17 PE=1 SV=1,GO:0003735; GO:0005739; GO:0005743; GO:0005762; GO:0019904; GO:0032543,mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739],protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735],GO:0005198; GO:0005739; GO:0043226,structural molecule activity; mitochondrion; organelle
OG_06147,FUN_027977-T1,Peve_00031366,Pocillopora_meandrina_HIv1___RNAseq.g14058.t1,three_way,74.97666666666666,FUN_027977-T1,Q9Z2F6,,,,,44.0,175.0,4.200000000000001e-33,143.7,sp|Q9Z2F6|BCL3_MOUSE B-cell lymphoma 3 protein homolog OS=Mus musculus OX=10090 GN=Bcl3 PE=1 SV=2,,,,,,
OG_06148,FUN_027979-T1,Peve_00034899,Pocillopora_meandrina_HIv1___RNAseq.g14060.t1,three_way,65.74916666666667,,,,,,,,,,,,,,,,,
OG_06149,FUN_027981-T1,Peve_00036295,Pocillopora_meandrina_HIv1___RNAseq.g14061.t1,three_way,57.874,FUN_027981-T1,P20749,BCL3_HUMAN,,B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3),Homo sapiens (Human),41.5,200.0,9.7e-21,102.8,sp|P20749|BCL3_HUMAN B-cell lymphoma 3 protein OS=Homo sapiens OX=9606 GN=BCL3 PE=1 SV=2,GO:0002268; GO:0002315; GO:0002455; GO:0002467; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0006974; GO:0007249; GO:0009615; GO:0010225; GO:0019730; GO:0030198; GO:0030330; GO:0030496; GO:0030674; GO:0032088; GO:0032717; GO:0032720; GO:0032729; GO:0032733; GO:0032991; GO:0032996; GO:0033257; GO:0036064; GO:0042088; GO:0042742; GO:0042771; GO:0042826; GO:0042832; GO:0042981; GO:0043066; GO:0043231; GO:0045064; GO:0045727; GO:0045892; GO:0045893; GO:0045944; GO:0046426; GO:0048471; GO:0048536; GO:0051101; GO:0070231; GO:0070233; GO:0140297; GO:1901222,"antimicrobial humoral response [GO:0019730]; canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of type II interferon production [GO:0032729]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T cell apoptotic process [GO:0070231]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]",Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991],DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0006886; GO:0006913; GO:0012501; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0140110,immune system process; nucleus; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; programmed cell death; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; transcription regulator activity
OG_06150,FUN_027982-T1,Peve_00033314,Pocillopora_meandrina_HIv1___RNAseq.g14062.t1,three_way,57.83766666666667,FUN_027982-T1,O88623,UBP2_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2),Mus musculus (Mouse),50.1,385.0,1.6e-96,355.1,sp|O88623|UBP2_MOUSE Ubiquitin carboxyl-terminal hydrolase 2 OS=Mus musculus OX=10090 GN=Usp2 PE=1 SV=3,GO:0000122; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0005938; GO:0006508; GO:0007517; GO:0016020; GO:0016579; GO:0030332; GO:0031625; GO:0032922; GO:0042802; GO:0043153; GO:0045475; GO:0045931; GO:0046872; GO:0048471; GO:0048512; GO:0050821; GO:0051926,circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508],cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],cyclin binding [GO:0030332]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06151,FUN_027983-T1,Peve_00033313,Pocillopora_meandrina_HIv1___RNAseq.g14010.t1,three_way,75.17066666666666,FUN_027983-T1,O53901,,,,,27.8,320.0,8.5e-29,129.4,sp|O53901|PKS5_MYCTU Mycocerosic acid synthase-like polyketide synthase OS=Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) OX=83332 GN=pks5 PE=1 SV=2,,,,,,
OG_06152,FUN_027984-T2,Peve_00011299,Pocillopora_meandrina_HIv1___RNAseq.g13864.t1,three_way,75.97583333333333,,,,,,,,,,,,,,,,,
OG_06153,FUN_027986-T1,Peve_00036755,Pocillopora_meandrina_HIv1___RNAseq.g14026.t1,three_way,85.17533333333333,,,,,,,,,,,,,,,,,
OG_06154,FUN_027987-T1,Peve_00023127,Pocillopora_meandrina_HIv1___RNAseq.g14022.t1,three_way,64.95433333333334,,,,,,,,,,,,,,,,,
OG_06155,FUN_027992-T1,Peve_00023124,Pocillopora_meandrina_HIv1___RNAseq.g14020.t1,three_way,64.479,,,,,,,,,,,,,,,,,
OG_06156,FUN_027997-T2,Peve_00023116,Pocillopora_meandrina_HIv1___TS.g11842.t1,three_way,83.45866666666667,,,,,,,,,,,,,,,,,
OG_06157,FUN_028000-T1,Peve_00023138,Pocillopora_meandrina_HIv1___RNAseq.g14071.t1,three_way,85.642,FUN_028000-T1,Q80W32,DRC9_MOUSE,,Dynein regulatory complex protein 9 (IQ domain-containing protein G),Mus musculus (Mouse),40.1,357.0,2.6999999999999998e-62,240.7,sp|Q80W32|DRC9_MOUSE Dynein regulatory complex protein 9 OS=Mus musculus OX=10090 GN=Iqcg PE=1 SV=1,GO:0002177; GO:0005516; GO:0005737; GO:0005829; GO:0007286; GO:0007288; GO:0015629; GO:0030544; GO:0031514; GO:0036126,sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],calmodulin binding [GO:0005516]; Hsp70 protein binding [GO:0030544],GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0022414; GO:0043226; GO:0048856,cytosol; cytoskeleton; cilium; cytoskeleton organization; reproductive process; organelle; anatomical structure development
OG_06158,FUN_028002-T1,Peve_00033369,Pocillopora_meandrina_HIv1___RNAseq.g14073.t1,three_way,57.124500000000005,FUN_028002-T1,Q9WVT6,,,,,36.8,280.0,4.2999999999999996e-46,187.6,sp|Q9WVT6|CAH14_MOUSE Carbonic anhydrase 14 OS=Mus musculus OX=10090 GN=Ca14 PE=1 SV=1,,,,,,
OG_06159,FUN_028004-T1,Peve_00040470,Pocillopora_meandrina_HIv1___TS.g11853.t1,three_way,85.94933333333333,FUN_028004-T1,Q8JZZ6,,,,,68.4,193.0,2.6e-76,286.6,sp|Q8JZZ6|AMERL_MOUSE AMMECR1-like protein OS=Mus musculus OX=10090 GN=Ammecr1l PE=1 SV=1,,,,,,
OG_06160,FUN_028005-T1,Peve_00032127,Pocillopora_meandrina_HIv1___RNAseq.g14075.t1,three_way,71.60433333333333,FUN_028005-T1,Q28678,ICLN_RABIT,,"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln))",Oryctolagus cuniculus (Rabbit),42.4,236.0,4.5e-35,149.4,sp|Q28678|ICLN_RABIT Methylosome subunit pICln OS=Oryctolagus cuniculus OX=9986 GN=CLNS1A PE=2 SV=2,GO:0000387; GO:0005634; GO:0005681; GO:0005829; GO:0005856; GO:0005886; GO:0006821; GO:0006884; GO:0034709; GO:0034715; GO:0045292,"cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; mRNA cis splicing, via spliceosome [GO:0045292]; spliceosomal snRNP assembly [GO:0000387]",cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681],,GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0016071; GO:0043226; GO:0065003,nucleus; cytosol; cytoskeleton; plasma membrane; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06161,FUN_028007-T1,Peve_00040331,Pocillopora_meandrina_HIv1___TS.g11855.t1,three_way,82.549,FUN_028007-T1,Q923S8,PANK4_RAT,,4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (rPanK4),Rattus norvegicus (Rat),57.3,640.0,9.4e-209,728.0,sp|Q923S8|PANK4_RAT 4'-phosphopantetheine phosphatase OS=Rattus norvegicus OX=10116 GN=Pank4 PE=1 SV=1,GO:0004594; GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0016791; GO:0046872,coenzyme A biosynthetic process [GO:0015937],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pantothenate kinase activity [GO:0004594]; phosphatase activity [GO:0016791],GO:0003824; GO:0005634; GO:0005829; GO:0006790; GO:0016740; GO:0016787; GO:0043226; GO:0055086,catalytic activity; nucleus; cytosol; sulfur compound metabolic process; transferase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_06162,FUN_028008-T1,Peve_00008115,Pocillopora_meandrina_HIv1___RNAseq.g14077.t1,three_way,56.86366666666667,FUN_028008-T1,D8VNS7,,,,,46.8,231.0,2.2e-52,208.8,sp|D8VNS7|FCNV1_CERRY Ryncolin-1 OS=Cerberus rynchops OX=46267 PE=1 SV=1,,,,,,
OG_06163,FUN_028014-T1,Peve_00008114,Pocillopora_meandrina_HIv1___RNAseq.g14103.t1,three_way,86.13066666666667,FUN_028014-T1,Q66HG5,,,,,64.5,639.0,2e-238,826.6,sp|Q66HG5|TM9S2_RAT Transmembrane 9 superfamily member 2 OS=Rattus norvegicus OX=10116 GN=Tm9sf2 PE=2 SV=1,,,,,,
OG_06164,FUN_028015-T1,Peve_00036494,Pocillopora_meandrina_HIv1___RNAseq.g13906.t1,three_way,79.2535,FUN_028015-T1,Q13217,DNJC3_HUMAN,,"DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)",Homo sapiens (Human),37.9,472.0,1e-77,292.4,sp|Q13217|DNJC3_HUMAN DnaJ homolog subfamily C member 3 OS=Homo sapiens OX=9606 GN=DNAJC3 PE=1 SV=1,GO:0004860; GO:0005576; GO:0005737; GO:0005783; GO:0005788; GO:0005829; GO:0006986; GO:0016020; GO:0019901; GO:0034975; GO:0035578; GO:0036494; GO:0043066; GO:0051087; GO:0051603; GO:0051607; GO:0051787; GO:0070062; GO:0070417; GO:1902010; GO:1903561; GO:1903912,cellular response to cold [GO:0070417]; defense response to virus [GO:0051607]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; proteolysis involved in protein catabolic process [GO:0051603]; response to unfolded protein [GO:0006986],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; membrane [GO:0016020],misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein-folding chaperone binding [GO:0051087],GO:0005576; GO:0005783; GO:0005829; GO:0006457; GO:0043226; GO:0098772,extracellular region; endoplasmic reticulum; cytosol; protein folding; organelle; molecular function regulator activity
OG_06165,FUN_028016-T1,Peve_00036498,Pocillopora_meandrina_HIv1___TS.g11693.t1,three_way,59.587,FUN_028016-T1,P23416,GLRA2_HUMAN,,Glycine receptor subunit alpha-2,Homo sapiens (Human),36.1,449.0,4.7e-67,256.9,sp|P23416|GLRA2_HUMAN Glycine receptor subunit alpha-2 OS=Homo sapiens OX=9606 GN=GLRA2 PE=1 SV=1,GO:0004888; GO:0005886; GO:0007218; GO:0016594; GO:0016934; GO:0022852; GO:0034220; GO:0034707; GO:0042995; GO:0043231; GO:0046872; GO:0050804; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0098982; GO:0099634; GO:1902476; GO:1904315,cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic ion transmembrane transport [GO:0034220]; neuropeptide signaling pathway [GO:0007218],cell projection [GO:0042995]; chloride channel complex [GO:0034707]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0060089,transporter activity; plasma membrane; organelle; transmembrane transport; molecular transducer activity
OG_06166,FUN_028019-T1,Peve_00036500,Pocillopora_meandrina_HIv1___RNAseq.g13910.t1,three_way,60.98683333333333,FUN_028019-T1,Q6DCD5,TMTC2_XENLA,,Protein O-mannosyl-transferase tmtc2 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 2) (Transmembrane and tetratricopeptide repeat-containing 2),Xenopus laevis (African clawed frog),36.7,581.0,5.800000000000001e-86,320.5,sp|Q6DCD5|TMTC2_XENLA Protein O-mannosyl-transferase tmtc2 OS=Xenopus laevis OX=8355 GN=tmtc2 PE=2 SV=1,GO:0000030; GO:0004169; GO:0005789; GO:0035269,protein O-linked mannosylation [GO:0035269],endoplasmic reticulum membrane [GO:0005789],dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030],GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06167,FUN_028020-T1,Peve_00036501,Pocillopora_meandrina_HIv1___RNAseq.g13911.t1,three_way,68.68566666666666,FUN_028020-T1,Q6NME7,TEN1_ARATH,,CST complex subunit TEN1 (Protein MERISTEM DISORGANIZATION 1) (Protein telomeric pathways with STN1 homolog),Arabidopsis thaliana (Mouse-ear cress),30.5,95.0,2.1e-06,53.5,sp|Q6NME7|TEN1_ARATH CST complex subunit TEN1 OS=Arabidopsis thaliana OX=3702 GN=TEN1 PE=1 SV=1,GO:0000723; GO:0000781; GO:0003697; GO:0009408; GO:0010521; GO:0019827; GO:0044183; GO:0048367; GO:1990879,response to heat [GO:0009408]; shoot system development [GO:0048367]; stem cell population maintenance [GO:0019827]; telomere maintenance [GO:0000723],"chromosome, telomeric region [GO:0000781]; CST complex [GO:1990879]",protein folding chaperone [GO:0044183]; single-stranded DNA binding [GO:0003697]; telomerase inhibitor activity [GO:0010521],GO:0003677; GO:0032200; GO:0044183; GO:0048856; GO:0098772,DNA binding; telomere organization; protein folding chaperone; anatomical structure development; molecular function regulator activity
OG_06168,FUN_028021-T1,Peve_00036502,Pocillopora_meandrina_HIv1___RNAseq.g13912.t1,three_way,65.23266666666666,FUN_028021-T1,A8XKV0,,,,,37.1,245.0,3.3e-40,166.8,sp|A8XKV0|BCA1_CAEBR Beta carbonic anhydrase 1 OS=Caenorhabditis briggsae OX=6238 GN=bca-1 PE=3 SV=2,,,,,,
OG_06169,FUN_028022-T1,Peve_00010821,Pocillopora_meandrina_HIv1___RNAseq.g13913.t1,three_way,64.496,FUN_028022-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),32.9,434.0,7.499999999999999e-62,239.6,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_06170,FUN_028023-T1,Peve_00010826,Pocillopora_meandrina_HIv1___RNAseq.g13914.t1,three_way,48.07233333333333,,,,,,,,,,,,,,,,,
OG_06171,FUN_028024-T1,Peve_00010827,Pocillopora_meandrina_HIv1___RNAseq.g13915.t1,three_way,86.50533333333333,,,,,,,,,,,,,,,,,
OG_06172,FUN_028025-T1,Peve_00011627,Pocillopora_meandrina_HIv1___RNAseq.g2942.t1,three_way,44.946333333333335,,,,,,,,,,,,,,,,,
OG_06173,FUN_028028-T1,Peve_00044200,Pocillopora_meandrina_HIv1___RNAseq.g13931.t1,three_way,54.44433333333333,,,,,,,,,,,,,,,,,
OG_06174,FUN_028030-T1,Peve_00044201,Pocillopora_meandrina_HIv1___RNAseq.g13933.t1,three_way,44.60566666666666,,,,,,,,,,,,,,,,,
OG_06175,FUN_028032-T1,Peve_00020106,Pocillopora_meandrina_HIv1___RNAseq.g13935.t1,three_way,50.176,,,,,,,,,,,,,,,,,
OG_06176,FUN_028039-T1,Peve_00020116,Pocillopora_meandrina_HIv1___RNAseq.g13937.t1,three_way,86.83566666666667,FUN_028039-T1,Q9VCA2,,,,,36.3,521.0,4.5e-84,313.5,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_06177,FUN_028040-T1,Peve_00020094,Pocillopora_meandrina_HIv1___RNAseq.g13938.t1,three_way,66.845,,,,,,,,,,,,,,,,,
OG_06178,FUN_028041-T1,Peve_00020095,Pocillopora_meandrina_HIv1___RNAseq.g13939.t1,three_way,79.764,FUN_028041-T1,P70097,,,,,41.4,157.0,1.7999999999999997e-24,114.0,"sp|P70097|C560_CRIGR Succinate dehydrogenase cytochrome b560 subunit, mitochondrial OS=Cricetulus griseus OX=10029 GN=SDHC PE=2 SV=1",,,,,,
OG_06179,FUN_028042-T1,Peve_00020097,Pocillopora_meandrina_HIv1___RNAseq.g15391.t1,three_way,65.06816666666667,FUN_028042-T1,Q568J8,,,,,41.3,104.0,2.5e-07,55.8,sp|Q568J8|TM256_DANRE Transmembrane protein 256 OS=Danio rerio OX=7955 GN=tmem256 PE=3 SV=1,,,,,,
OG_06180,FUN_028087-T1,Peve_00031647,Pocillopora_meandrina_HIv1___RNAseq.g16564.t1,three_way,92.40866666666666,FUN_028087-T1,Q969V4,TEKT1_HUMAN,,Tektin-1,Homo sapiens (Human),42.3,388.0,5.2e-79,296.6,sp|Q969V4|TEKT1_HUMAN Tektin-1 OS=Homo sapiens OX=9606 GN=TEKT1 PE=1 SV=1,GO:0005634; GO:0005879; GO:0015630; GO:0030317; GO:0036126; GO:0060271; GO:0060294; GO:0160111,cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005856; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,nucleus; cytoskeleton; cilium; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_06181,FUN_028088-T1,Peve_00031660,Pocillopora_meandrina_HIv1___TS.g11574.t1,three_way,88.21483333333333,FUN_028088-T1,P18907,,,,,76.6,988.0,0.0,1502.3,sp|P18907|AT1A1_HORSE Sodium/potassium-transporting ATPase subunit alpha-1 OS=Equus caballus OX=9796 GN=ATP1A1 PE=3 SV=1,,,,,,
OG_06182,FUN_028092-T1,Peve_00031646,Pocillopora_meandrina_HIv1___RNAseq.g16567.t1,three_way,76.8695,FUN_028092-T1,Q5F364,MRP1_CHICK,,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),Gallus gallus (Chicken),53.1,1353.0,0.0,1347.0,sp|Q5F364|MRP1_CHICK Multidrug resistance-associated protein 1 OS=Gallus gallus OX=9031 GN=ABCC1 PE=2 SV=1,GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729,cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908],basolateral plasma membrane [GO:0016323],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; glutathione transmembrane transporter activity [GO:0034634],GO:0003824; GO:0005215; GO:0016787; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; transmembrane transport; ATP-dependent activity
OG_06183,FUN_028093-T1,Peve_00022235,Pocillopora_meandrina_HIv1___RNAseq.g15583.t1,three_way,71.7505,FUN_028093-T1,Q6DDH6,,,,,27.4,394.0,2.4e-21,105.9,sp|Q6DDH6|SP13A_XENLA Histone deacetylase complex subunit SAP130-A OS=Xenopus laevis OX=8355 GN=sap130-a PE=2 SV=1,,,,,,
OG_06184,FUN_028094-T1,Peve_00026159,Pocillopora_meandrina_HIv1___RNAseq.g15582.t1,three_way,90.60566666666666,,,,,,,,,,,,,,,,,
OG_06185,FUN_028095-T1,Peve_00004891,Pocillopora_meandrina_HIv1___RNAseq.g15581.t1,three_way,83.67366666666666,FUN_028095-T1,Q9CQ49,NCBP2_MOUSE,,Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (NCBP 20 kDa subunit) (CBP20),Mus musculus (Mouse),80.0,140.0,1.2e-61,237.3,sp|Q9CQ49|NCBP2_MOUSE Nuclear cap-binding protein subunit 2 OS=Mus musculus OX=10090 GN=Ncbp2 PE=1 SV=1,GO:0000184; GO:0000340; GO:0000380; GO:0000398; GO:0002191; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005846; GO:0006406; GO:0006408; GO:0006446; GO:0008334; GO:0008380; GO:0017069; GO:0031053; GO:0031124; GO:0031442; GO:0032968; GO:0035195; GO:0036064; GO:0042789; GO:0045292; GO:0046833,"alternative mRNA splicing, via spliceosome [GO:0000380]; cap-dependent translational initiation [GO:0002191]; histone mRNA metabolic process [GO:0008334]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription by RNA polymerase II [GO:0042789]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; primary miRNA processing [GO:0031053]; regulation of translational initiation [GO:0006446]; RNA splicing [GO:0008380]; snRNA export from nucleus [GO:0006408]",ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear cap binding complex [GO:0005846]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069],GO:0003723; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006351; GO:0006355; GO:0006913; GO:0016071; GO:0031047; GO:0043226,RNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; nucleocytoplasmic transport; mRNA metabolic process; regulatory ncRNA-mediated gene silencing; organelle
OG_06186,FUN_028098-T1,Peve_00026162,Pocillopora_meandrina_HIv1___RNAseq.g15579.t1b,three_way,70.61933333333333,FUN_028098-T1,Q08D62,,,,,33.1,350.0,9e-46,186.4,sp|Q08D62|MAEL_XENTR Protein maelstrom homolog OS=Xenopus tropicalis OX=8364 GN=mael PE=2 SV=1,,,,,,
OG_06187,FUN_028099-T2,Peve_00004894,Pocillopora_meandrina_HIv1___RNAseq.g15574.t1,three_way,79.82566666666666,FUN_028099-T2,Q7ZUW2,,,,,57.3,913.0,4.6e-213,743.0,sp|Q7ZUW2|HYOU1_DANRE Hypoxia up-regulated protein 1 OS=Danio rerio OX=7955 GN=hyou1 PE=2 SV=1,,,,,,
OG_06188,FUN_028103-T1,Peve_00032588,Pocillopora_meandrina_HIv1___RNAseq.g15573.t1,three_way,47.289,,,,,,,,,,,,,,,,,
OG_06189,FUN_028104-T1,Peve_00004896,Pocillopora_meandrina_HIv1___RNAseq.g15572.t1,three_way,86.157,FUN_028104-T1,Q6XBT4,,,,,36.7,343.0,4.1e-42,173.7,sp|Q6XBT4|USF1_BOVIN Upstream stimulatory factor 1 OS=Bos taurus OX=9913 GN=USF1 PE=2 SV=1,,,,,,
OG_06190,FUN_028105-T1,Peve_00004887,Pocillopora_meandrina_HIv1___RNAseq.g15571.t1,three_way,74.17699999999999,FUN_028105-T1,Q86UT8,CATAC_HUMAN,,Centrosomal AT-AC splicing factor (Coiled-coil domain-containing protein 84),Homo sapiens (Human),33.2,355.0,3.3e-44,180.6,sp|Q86UT8|CATAC_HUMAN Centrosomal AT-AC splicing factor OS=Homo sapiens OX=9606 GN=CENATAC PE=1 SV=1,GO:0000398; GO:0005737; GO:0005813; GO:0010826; GO:0042176; GO:0051304,"chromosome separation [GO:0051304]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of centrosome duplication [GO:0010826]; regulation of protein catabolic process [GO:0042176]",centrosome [GO:0005813]; cytoplasm [GO:0005737],,GO:0005815; GO:0016071,microtubule organizing center; mRNA metabolic process
OG_06191,FUN_028111-T1,Peve_00019693,Pocillopora_meandrina_HIv1___RNAseq.g15567.t1,three_way,64.035,,,,,,,,,,,,,,,,,
OG_06192,FUN_028114-T1,Peve_00019695,Pocillopora_meandrina_HIv1___RNAseq.g15565.t1,three_way,50.1775,FUN_028114-T1,P56182,RRP1_HUMAN,,Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein),Homo sapiens (Human),33.4,347.0,2.3e-47,191.8,sp|P56182|RRP1_HUMAN Ribosomal RNA processing protein 1 homolog A OS=Homo sapiens OX=9606 GN=RRP1 PE=1 SV=1,GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0006364; GO:0030688,rRNA processing [GO:0006364],"chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome, small subunit precursor [GO:0030688]",RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0043226,RNA binding; nucleus; chromosome; nucleolus; organelle
OG_06193,FUN_028115-T1,Peve_00030850,Pocillopora_meandrina_HIv1___RNAseq.g15564.t1,three_way,78.04,FUN_028115-T1,A1A4P5,,,,,54.7,137.0,1.4e-32,141.0,sp|A1A4P5|PFD2_BOVIN Prefoldin subunit 2 OS=Bos taurus OX=9913 GN=PFDN2 PE=2 SV=1,,,,,,
OG_06194,FUN_028116-T1,Peve_00030851,Pocillopora_meandrina_HIv1___RNAseq.g15563.t1,three_way,44.718833333333336,,,,,,,,,,,,,,,,,
OG_06195,FUN_028120-T1,Peve_00033839,Pocillopora_meandrina_HIv1___TS.g10588.t1b,three_way,59.40266666666667,,,,,,,,,,,,,,,,,
OG_06196,FUN_028121-T1,Peve_00035340,Pocillopora_meandrina_HIv1___RNAseq.g15559.t1,three_way,58.269333333333336,FUN_028121-T1,Q503F2,BARX1_DANRE,,Homeobox protein BarH-like 1 (BarH-class homeodomain transcription factor 4),Danio rerio (Zebrafish) (Brachydanio rerio),56.3,87.0,8.2e-19,95.1,sp|Q503F2|BARX1_DANRE Homeobox protein BarH-like 1 OS=Danio rerio OX=7955 GN=barx1 PE=2 SV=2,GO:0000977; GO:0000981; GO:0002053; GO:0005634; GO:0006357; GO:0051216; GO:0060037,cartilage development [GO:0051216]; pharyngeal system development [GO:0060037]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_06197,FUN_028122-T1,Peve_00004261,Pocillopora_meandrina_HIv1___RNAseq.g15557.t2,three_way,43.58133333333333,FUN_028122-T1,P36335,,,,,26.3,598.0,1.3e-35,152.9,sp|P36335|NCA12_XENLA Neural cell adhesion molecule 1-B OS=Xenopus laevis OX=8355 GN=ncam1-b PE=2 SV=1,,,,,,
OG_06198,FUN_028130-T1,Peve_00004260,Pocillopora_meandrina_HIv1___RNAseq.g15556.t1,three_way,59.60266666666666,FUN_028130-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),26.8,276.0,4.9e-14,81.6,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_06199,FUN_028133-T1,Peve_00004264,Pocillopora_meandrina_HIv1___RNAseq.g15555.t1,three_way,47.007000000000005,FUN_028133-T1,A2AJ76,HMCN2_MOUSE,,Hemicentin-2,Mus musculus (Mouse),22.6,495.0,5.8e-18,94.4,sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0030054; GO:0032154; GO:0062023,,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],calcium ion binding [GO:0005509],GO:0005576; GO:0030312; GO:0031012,extracellular region; external encapsulating structure; extracellular matrix
OG_06200,FUN_028134-T1,Peve_00004262,Pocillopora_meandrina_HIv1___RNAseq.g15554.t1,three_way,46.048,FUN_028134-T1,Q8WZ42,TITIN_HUMAN,,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),Homo sapiens (Human),25.8,267.0,3.5e-11,70.9,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,GO:0000794; GO:0002020; GO:0003009; GO:0003300; GO:0004672; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0045214; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733,cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433],GO:0000228; GO:0003012; GO:0003824; GO:0005198; GO:0005576; GO:0005694; GO:0005829; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"nuclear chromosome; muscle system process; catalytic activity; structural molecule activity; extracellular region; chromosome; cytosol; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06201,FUN_028135-T1,Peve_00004259,Pocillopora_meandrina_HIv1___RNAseq.g15553.t1,three_way,87.28,FUN_028135-T1,P53619,COPD_BOVIN,,Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP),Bos taurus (Bovine),59.6,512.0,5.2e-170,599.0,sp|P53619|COPD_BOVIN Coatomer subunit delta OS=Bos taurus OX=9913 GN=ARCN1 PE=1 SV=1,GO:0000139; GO:0005783; GO:0006888; GO:0006890; GO:0006891; GO:0008344; GO:0015031; GO:0021691; GO:0030126; GO:0043473; GO:0051645,"adult locomotory behavior [GO:0008344]; cerebellar Purkinje cell layer maturation [GO:0021691]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; intra-Golgi vesicle-mediated transport [GO:0006891]; pigmentation [GO:0043473]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",COPI vesicle coat [GO:0030126]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139],,GO:0005783; GO:0016192; GO:0043226,endoplasmic reticulum; vesicle-mediated transport; organelle
OG_06202,FUN_028138-T1,Peve_00042833,Pocillopora_meandrina_HIv1___RNAseq.g15552.t1,three_way,60.35533333333333,FUN_028138-T1,Q6DRI7,DDX51_DANRE,,ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51),Danio rerio (Zebrafish) (Brachydanio rerio),46.6,528.0,1.1e-125,452.2,sp|Q6DRI7|DDX51_DANRE ATP-dependent RNA helicase DDX51 OS=Danio rerio OX=7955 GN=ddx51 PE=2 SV=1,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0016887,rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleolus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06203,FUN_028139-T1,Peve_00025714,Pocillopora_meandrina_HIv1___RNAseq.g16451.t1,three_way,81.30433333333333,FUN_028139-T1,A1L3P4,SL9A6_MOUSE,,Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Sodium/hydrogen exchanger) (Solute carrier family 9 member 6),Mus musculus (Mouse),55.7,587.0,3.3e-153,543.5,sp|A1L3P4|SL9A6_MOUSE Sodium/hydrogen exchanger 6 OS=Mus musculus OX=10090 GN=Slc9a6 PE=1 SV=1,GO:0005739; GO:0005768; GO:0005769; GO:0005770; GO:0005886; GO:0015385; GO:0015386; GO:0030010; GO:0030425; GO:0031410; GO:0031547; GO:0031901; GO:0031902; GO:0043679; GO:0044308; GO:0045202; GO:0048675; GO:0048812; GO:0050808; GO:0051386; GO:0051453; GO:0055037; GO:0055038; GO:0060996; GO:0097484; GO:0098685; GO:0098978; GO:0099072; GO:1902600,axon extension [GO:0048675]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; dendrite extension [GO:0097484]; dendritic spine development [GO:0060996]; establishment of cell polarity [GO:0030010]; neuron projection morphogenesis [GO:0048812]; proton transmembrane transport [GO:1902600]; regulation of intracellular pH [GO:0051453]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; synapse organization [GO:0050808],axon terminus [GO:0043679]; axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202],potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005739; GO:0005768; GO:0005886; GO:0007163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0055085,transporter activity; mitochondrion; endosome; plasma membrane; establishment or maintenance of cell polarity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; transmembrane transport
OG_06204,FUN_028140-T1,Peve_00037731,Pocillopora_meandrina_HIv1___RNAseq.g16455.t1,three_way,89.77433333333333,,,,,,,,,,,,,,,,,
OG_06205,FUN_028141-T1,Peve_00037718,Pocillopora_meandrina_HIv1___RNAseq.g16456.t1,three_way,57.817,,,,,,,,,,,,,,,,,
OG_06206,FUN_028142-T1,Peve_00037719,Pocillopora_meandrina_HIv1___RNAseq.g16428.t1,three_way,69.77866666666667,FUN_028142-T1,Q53RE8,,,,,50.8,65.0,6.8e-11,68.9,sp|Q53RE8|ANR39_HUMAN Ankyrin repeat domain-containing protein 39 OS=Homo sapiens OX=9606 GN=ANKRD39 PE=1 SV=1,,,,,,
OG_06207,FUN_028143-T1,Peve_00037720,Pocillopora_meandrina_HIv1___TS.g11444.t1,three_way,74.73266666666667,FUN_028143-T1,Q5SZT7,NKAPL_MOUSE,,NKAP-like protein,Mus musculus (Mouse),72.4,123.0,4.9e-41,169.9,sp|Q5SZT7|NKAPL_MOUSE NKAP-like protein OS=Mus musculus OX=10090 GN=Nkapl PE=1 SV=1,GO:0003682; GO:0005634; GO:0007283; GO:0030154,cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],nucleus [GO:0005634],chromatin binding [GO:0003682],GO:0005634; GO:0022414; GO:0030154; GO:0043226,nucleus; reproductive process; cell differentiation; organelle
OG_06208,FUN_028145-T1,Peve_00037725,Pocillopora_meandrina_HIv1___RNAseq.g16425.t1,three_way,84.72733333333333,FUN_028145-T1,A0JPE9,,,,,53.0,513.0,8.6e-160,565.1,sp|A0JPE9|GLPK5_DANRE Glycerol kinase 5 OS=Danio rerio OX=7955 GN=gk5 PE=2 SV=2,,,,,,
OG_06209,FUN_028148-T1,Peve_00017303,Pocillopora_meandrina_HIv1___RNAseq.g15549.t1,three_way,81.402,FUN_028148-T1,Q9UI14,PRAF1_HUMAN,,Prenylated Rab acceptor protein 1 (PRA1 family protein 1),Homo sapiens (Human),47.2,125.0,2.5e-26,120.2,sp|Q9UI14|PRAF1_HUMAN Prenylated Rab acceptor protein 1 OS=Homo sapiens OX=9606 GN=RABAC1 PE=1 SV=1,GO:0005794; GO:0005886; GO:0008021; GO:0016020; GO:0042802; GO:0051020; GO:0070064; GO:0098978,,glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021],GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064],GO:0005794; GO:0005886; GO:0031410; GO:0043226,Golgi apparatus; plasma membrane; cytoplasmic vesicle; organelle
OG_06210,FUN_028149-T1,Peve_00042831,Pocillopora_meandrina_HIv1___RNAseq.g15550.t1,three_way,87.651,FUN_028149-T1,Q641Y2,NDUS2_RAT,,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 7.1.1.2) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",Rattus norvegicus (Rat),81.5,417.0,3.2e-206,719.2,"sp|Q641Y2|NDUS2_RAT NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial OS=Rattus norvegicus OX=10116 GN=Ndufs2 PE=1 SV=1",GO:0005739; GO:0005743; GO:0006120; GO:0008137; GO:0019826; GO:0022008; GO:0031625; GO:0032981; GO:0042063; GO:0042775; GO:0045271; GO:0046872; GO:0048038; GO:0051287; GO:0051539; GO:0061351; GO:0071453,"cellular response to oxygen levels [GO:0071453]; gliogenesis [GO:0042063]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neural precursor cell proliferation [GO:0061351]; neurogenesis [GO:0022008]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; oxygen sensor activity [GO:0019826]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]",GO:0005215; GO:0005739; GO:0006091; GO:0030154; GO:0043226; GO:0065003; GO:0098772; GO:0140299,transporter activity; mitochondrion; generation of precursor metabolites and energy; cell differentiation; organelle; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_06211,FUN_028150-T1,Peve_00042832,Pocillopora_meandrina_HIv1___RNAseq.g15551.t1,three_way,65.80033333333333,FUN_028150-T1,Q68J42,LIPS_PIG,,Hormone-sensitive lipase (HSL) (EC 3.1.1.79) (Monoacylglycerol lipase LIPE) (EC 3.1.1.23) (Retinyl ester hydrolase) (REH),Sus scrofa (Pig),33.3,816.0,3.4e-115,417.5,sp|Q68J42|LIPS_PIG Hormone-sensitive lipase OS=Sus scrofa OX=9823 GN=LIPE PE=2 SV=1,GO:0004771; GO:0004806; GO:0005634; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0005901; GO:0006361; GO:0006363; GO:0008203; GO:0016020; GO:0016042; GO:0019433; GO:0042134; GO:0046340; GO:0046485; GO:0047372; GO:0047376; GO:0050253; GO:0120516,cholesterol metabolic process [GO:0008203]; diacylglycerol catabolic process [GO:0046340]; ether lipid metabolic process [GO:0046485]; lipid catabolic process [GO:0016042]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation at RNA polymerase I promoter [GO:0006361]; triglyceride catabolic process [GO:0019433],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],"all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diacylglycerol lipase activity [GO:0120516]; monoacylglycerol lipase activity [GO:0047372]; retinyl-palmitate esterase activity [GO:0050253]; rRNA primary transcript binding [GO:0042134]; sterol ester esterase activity [GO:0004771]; triacylglycerol lipase activity [GO:0004806]",GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016787; GO:0043226,RNA binding; catalytic activity; nucleus; mitochondrion; lipid droplet; cytosol; lipid metabolic process; hydrolase activity; organelle
OG_06212,FUN_028151-T1,Peve_00037724,Pocillopora_meandrina_HIv1___RNAseq.g16452.t1,three_way,82.02066666666667,FUN_028151-T1,Q9TTF0,,,,,43.1,415.0,1.5e-82,308.1,sp|Q9TTF0|NR2E3_BOVIN Photoreceptor-specific nuclear receptor OS=Bos taurus OX=9913 GN=NR2E3 PE=1 SV=2,,,,,,
OG_06213,FUN_028152-T1,Peve_00037717,Pocillopora_meandrina_HIv1___TS.g11460.t1,three_way,57.332,,,,,,,,,,,,,,,,,
OG_06214,FUN_028155-T1,Peve_00031152,Pocillopora_meandrina_HIv1___RNAseq.g16459.t1,three_way,39.693000000000005,,,,,,,,,,,,,,,,,
OG_06215,FUN_028156-T1,Peve_00027512,Pocillopora_meandrina_HIv1___RNAseq.g16461.t1,three_way,34.681666666666665,,,,,,,,,,,,,,,,,
OG_06216,FUN_028157-T1,Peve_00010295,Pocillopora_meandrina_HIv1___RNAseq.g16467.t1,three_way,45.73066666666666,,,,,,,,,,,,,,,,,
OG_06217,FUN_028158-T1,Peve_00024808,Pocillopora_meandrina_HIv1___RNAseq.g16501.t1,three_way,79.09966666666666,FUN_028158-T1,Q9Y5P8,,,,,48.1,459.0,2.1e-120,434.1,sp|Q9Y5P8|P2R3B_HUMAN Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta OS=Homo sapiens OX=9606 GN=PPP2R3B PE=1 SV=2,,,,,,
OG_06218,FUN_028160-T1,Peve_00000617,Pocillopora_meandrina_HIv1___RNAseq.g29828.t1,three_way,77.55183333333333,,,,,,,,,,,,,,,,,
OG_06219,FUN_028162-T1,Peve_00018136,Pocillopora_meandrina_HIv1___RNAseq.g16500.t1,three_way,57.34316666666667,FUN_028162-T1,Q96T23,RSF1_HUMAN,,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),Homo sapiens (Human),42.2,154.0,6.7e-24,114.0,sp|Q96T23|RSF1_HUMAN Remodeling and spacing factor 1 OS=Homo sapiens OX=9606 GN=RSF1 PE=1 SV=2,GO:0005634; GO:0005654; GO:0006325; GO:0006334; GO:0006338; GO:0006352; GO:0006355; GO:0008270; GO:0031213; GO:0042393; GO:0043392; GO:0045892; GO:0045893; GO:0050434; GO:0140751,chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA-templated transcription initiation [GO:0006352]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of viral transcription [GO:0050434]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSF complex [GO:0031213],histone binding [GO:0042393]; histone octamer slider activity [GO:0140751]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0065003; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; protein-containing complex assembly; catalytic activity, acting on DNA; ATP-dependent activity"
OG_06220,FUN_028163-T1,Peve_00018135,Pocillopora_meandrina_HIv1___RNAseq.g16498.t1,three_way,74.717,FUN_028163-T1,Q6ZHE5,DCYD1_ORYSJ,,"D-cysteine desulfhydrase 1, mitochondrial (OsDCD1) (EC 4.4.1.15) (OsD-CDes1) (D-CDes1)",Oryza sativa subsp. japonica (Rice),42.2,346.0,5.6e-76,286.2,"sp|Q6ZHE5|DCYD1_ORYSJ D-cysteine desulfhydrase 1, mitochondrial OS=Oryza sativa subsp. japonica OX=39947 GN=DCD1 PE=1 SV=2",GO:0005739; GO:0019148; GO:0042802; GO:0042803,,mitochondrion [GO:0005739],D-cysteine desulfhydrase activity [GO:0019148]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005739; GO:0016829; GO:0043226,catalytic activity; mitochondrion; lyase activity; organelle
OG_06221,FUN_028164-T1,Peve_00044586,Pocillopora_meandrina_HIv1___TS.g11490.t1,three_way,71.51433333333334,,,,,,,,,,,,,,,,,
OG_06222,FUN_028166-T1,Peve_00044585,Pocillopora_meandrina_HIv1___RNAseq.g16474.t1,three_way,55.586666666666666,FUN_028166-T1,Q6AI12,,,,,49.2,59.0,3.6e-10,67.0,sp|Q6AI12|ANR40_HUMAN Ankyrin repeat domain-containing protein 40 OS=Homo sapiens OX=9606 GN=ANKRD40 PE=1 SV=2,,,,,,
OG_06223,FUN_028167-T1,Peve_00029326,Pocillopora_meandrina_HIv1___RNAseq.g16473.t1,three_way,78.41499999999999,FUN_028167-T1,Q8VDI9,,,,,56.0,563.0,3.4e-184,646.4,"sp|Q8VDI9|ALG9_MOUSE Alpha-1,2-mannosyltransferase ALG9 OS=Mus musculus OX=10090 GN=Alg9 PE=2 SV=1",,,,,,
OG_06224,FUN_028169-T1,Peve_00044583,Pocillopora_meandrina_HIv1___RNAseq.g16471.t1,three_way,73.55933333333333,FUN_028169-T1,Q5ZJP7,,,,,43.8,153.0,4.2e-23,110.2,sp|Q5ZJP7|KCTD7_CHICK BTB/POZ domain-containing protein KCTD7 OS=Gallus gallus OX=9031 GN=KCTD7 PE=2 SV=1,,,,,,
OG_06225,FUN_028170-T1,Peve_00044582,Pocillopora_meandrina_HIv1___RNAseq.g16470.t1,three_way,67.04516666666666,,,,,,,,,,,,,,,,,
OG_06226,FUN_028172-T1,Peve_00020832,Pocillopora_meandrina_HIv1___RNAseq.g16468.t1,three_way,88.88433333333333,FUN_028172-T1,Q8WW35,DYT2B_HUMAN,,Dynein light chain Tctex-type protein 2B (Tctex1 domain-containing protein 2),Homo sapiens (Human),61.2,116.0,7.4e-38,157.9,sp|Q8WW35|DYT2B_HUMAN Dynein light chain Tctex-type protein 2B OS=Homo sapiens OX=9606 GN=DYNLT2B PE=1 SV=2,GO:0005737; GO:0005868; GO:0005929; GO:0007018; GO:0035721; GO:0045505; GO:0060271; GO:0120293; GO:1902017; GO:1905799,cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; microtubule-based movement [GO:0007018]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein axonemal particle [GO:0120293],dynein intermediate chain binding [GO:0045505],GO:0005929; GO:0007018; GO:0043226; GO:0044782,cilium; microtubule-based movement; organelle; cilium organization
OG_06227,FUN_028173-T1,Peve_00024812,Pocillopora_meandrina_HIv1___RNAseq.g16502.t1,three_way,60.945166666666665,FUN_028173-T1,P50534,MSL2_DROME,,E3 ubiquitin-protein ligase msl-2 (EC 2.3.2.27) (Protein male-specific lethal-2),Drosophila melanogaster (Fruit fly),40.9,88.0,2.8e-11,71.2,sp|P50534|MSL2_DROME E3 ubiquitin-protein ligase msl-2 OS=Drosophila melanogaster OX=7227 GN=msl-2 PE=1 SV=2,GO:0000209; GO:0000228; GO:0000805; GO:0003677; GO:0003682; GO:0005694; GO:0007549; GO:0008270; GO:0009047; GO:0016456; GO:0016567; GO:0046536; GO:0061630; GO:0071168; GO:0072487; GO:0106222; GO:0140463; GO:0140517; GO:0140693; GO:0141054; GO:1990837,dosage compensation by hyperactivation of X chromosome [GO:0009047]; protein localization to chromatin [GO:0071168]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; sex-chromosome dosage compensation [GO:0007549],"chromosome [GO:0005694]; dosage compensation complex [GO:0046536]; MSL complex [GO:0072487]; nuclear chromosome [GO:0000228]; X chromosome [GO:0000805]; X chromosome located dosage compensation complex, transcription activating [GO:0016456]",chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; histone H2B ubiquitin ligase activity [GO:0141054]; lncRNA binding [GO:0106222]; molecular condensate scaffold activity [GO:0140693]; protein-RNA adaptor activity [GO:0140517]; sequence-specific double-stranded DNA binding [GO:1990837]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0000228; GO:0003677; GO:0003723; GO:0003824; GO:0005694; GO:0006325; GO:0016740; GO:0043226; GO:0060090; GO:0140096,"nuclear chromosome; DNA binding; RNA binding; catalytic activity; chromosome; chromatin organization; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein"
OG_06228,FUN_028174-T1,Peve_00024810,Pocillopora_meandrina_HIv1___RNAseq.g16503.t1,three_way,89.96966666666667,FUN_028174-T1,P79384,,,,,77.6,510.0,8.2e-238,824.3,"sp|P79384|PCCB_PIG Propionyl-CoA carboxylase beta chain, mitochondrial OS=Sus scrofa OX=9823 GN=PCCB PE=1 SV=1",,,,,,
OG_06229,FUN_028179-T1,Peve_00001294,Pocillopora_meandrina_HIv1___RNAseq.g16508.t1,three_way,69.56766666666667,,,,,,,,,,,,,,,,,
OG_06230,FUN_028180-T1,Peve_00001282,Pocillopora_meandrina_HIv1___RNAseq.g16511.t1,three_way,66.941,FUN_028180-T1,Q8BLN6,UNC80_MOUSE,,Protein unc-80 homolog (mUNC-80),Mus musculus (Mouse),29.5,3133.0,7.3e-307,1056.2,sp|Q8BLN6|UNC80_MOUSE Protein unc-80 homolog OS=Mus musculus OX=10090 GN=Unc80 PE=1 SV=3,GO:0005886; GO:0030425; GO:0034706,,dendrite [GO:0030425]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706],,GO:0005886,plasma membrane
OG_06231,FUN_028181-T1,Peve_00001286,Pocillopora_meandrina_HIv1___RNAseq.g16512.t1,three_way,90.78883333333332,FUN_028181-T1,Q5F418,,,,,69.3,987.0,0.0,1213.4,sp|Q5F418|PSMD1_CHICK 26S proteasome non-ATPase regulatory subunit 1 OS=Gallus gallus OX=9031 GN=PSMD1 PE=2 SV=1,,,,,,
OG_06232,FUN_028185-T1,Peve_00001293,Pocillopora_meandrina_HIv1___TS.g11524.t1,three_way,76.6565,FUN_028185-T1,Q86YW9,MD12L_HUMAN,,Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like),Homo sapiens (Human),39.9,1865.0,0.0,1122.5,sp|Q86YW9|MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens OX=9606 GN=MED12L PE=1 SV=2,GO:0003713; GO:0008013; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592],beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713],GO:0006355; GO:0060090; GO:0140110,regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_06233,FUN_028186-T1,Peve_00001295,Pocillopora_meandrina_HIv1___RNAseq.g16516.t1,three_way,89.27566666666667,FUN_028186-T1,Q9YI37,,,,,67.5,416.0,2.5e-163,576.6,"sp|Q9YI37|SUCB1_COLLI Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (Fragment) OS=Columba livia OX=8932 GN=SUCLA2 PE=1 SV=1",,,,,,
OG_06234,FUN_028187-T1,Peve_00000861,Pocillopora_meandrina_HIv1___RNAseq.g16542.t1,three_way,56.39333333333333,FUN_028187-T1,Q9YH85,,,,,27.1,284.0,4.2e-15,84.0,sp|Q9YH85|TECTA_CHICK Alpha-tectorin OS=Gallus gallus OX=9031 GN=TECTA PE=1 SV=1,,,,,,
OG_06235,FUN_028191-T1,Peve_00001300,Pocillopora_meandrina_HIv1___RNAseq.g16519.t1,three_way,59.74283333333334,FUN_028191-T1,Q5UNS8,,,,,28.1,352.0,4.5000000000000003e-23,110.9,sp|Q5UNS8|YR665_MIMIV Uncharacterized protein R665 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R665 PE=4 SV=1,,,,,,
OG_06236,FUN_028192-T1,Peve_00001297,Pocillopora_meandrina_HIv1___TS.g11527.t1,three_way,50.75,FUN_028192-T1,Q91X17,UROM_MOUSE,,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",Mus musculus (Mouse),37.5,144.0,6.5e-21,104.0,sp|Q91X17|UROM_MOUSE Uromodulin OS=Mus musculus OX=10090 GN=Umod PE=1 SV=1,GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033554; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266,antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to stress [GO:0033554]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509]; IgG binding [GO:0019864],GO:0002376; GO:0003014; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007155; GO:0012501; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0061024; GO:0098542,immune system process; renal system process; extracellular space; endoplasmic reticulum; plasma membrane; cilium; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; cell adhesion; programmed cell death; protein catabolic process; organelle; anatomical structure development; cell motility; transmembrane transport; membrane organization; defense response to other organism
OG_06237,FUN_028193-T1,Peve_00000868,Pocillopora_meandrina_HIv1___RNAseq.g16538.t1,three_way,88.00966666666666,FUN_028193-T1,O00303,EIF3F_HUMAN,,Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47),Homo sapiens (Human),53.0,268.0,6.2e-80,298.9,sp|O00303|EIF3F_HUMAN Eukaryotic translation initiation factor 3 subunit F OS=Homo sapiens OX=9606 GN=EIF3F PE=1 SV=1,GO:0001732; GO:0003743; GO:0004843; GO:0005829; GO:0005852; GO:0006413; GO:0006508; GO:0016020; GO:0016282; GO:0031369; GO:0033290; GO:0042802; GO:0045202; GO:0071541; GO:0075522; GO:0140492,formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; proteolysis [GO:0006508]; translational initiation [GO:0006413],"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; synapse [GO:0045202]",cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; metal-dependent deubiquitinase activity [GO:0140492]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369],GO:0003824; GO:0005829; GO:0016787; GO:0065003; GO:0140096,"catalytic activity; cytosol; hydrolase activity; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_06238,FUN_028198-T1,Peve_00010298,Pocillopora_meandrina_HIv1___RNAseq.g15536.t1,three_way,74.60466666666666,FUN_028198-T1,Q5F2N2,OFUT4_ORYLA,,GDP-fucose protein O-fucosyltransferase 4 (EC 2.4.1.221) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11),Oryzias latipes (Japanese rice fish) (Japanese killifish),41.8,421.0,2.3e-98,360.9,sp|Q5F2N2|OFUT4_ORYLA GDP-fucose protein O-fucosyltransferase 4 OS=Oryzias latipes OX=8090 GN=fut11 PE=2 SV=1,GO:0000139; GO:0005783; GO:0005789; GO:0036065; GO:0046920; GO:0046922; GO:0050714,fucosylation [GO:0036065]; positive regulation of protein secretion [GO:0050714],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],alpha-(1->3)-fucosyltransferase activity [GO:0046920]; peptide-O-fucosyltransferase activity [GO:0046922],GO:0003824; GO:0005783; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06239,FUN_028199-T1,Peve_00010300,Pocillopora_meandrina_HIv1___RNAseq.g15535.t1,three_way,53.30166666666666,,,,,,,,,,,,,,,,,
OG_06240,FUN_028200-T1,Peve_00010301,Pocillopora_meandrina_HIv1___RNAseq.g15534.t1,three_way,97.70033333333332,FUN_028200-T1,Q3T030,,,,,81.6,419.0,2.9e-187,656.0,sp|Q3T030|PRS6B_BOVIN 26S proteasome regulatory subunit 6B OS=Bos taurus OX=9913 GN=PSMC4 PE=2 SV=1,,,,,,
OG_06241,FUN_028229-T1,Peve_00015265,Pocillopora_meandrina_HIv1___TS.g10556.t1,three_way,86.2135,FUN_028229-T1,Q9H172,ABCG4_HUMAN,,ATP-binding cassette sub-family G member 4 (EC 7.6.2.-),Homo sapiens (Human),58.5,602.0,8.9e-191,668.3,sp|Q9H172|ABCG4_HUMAN ATP-binding cassette sub-family G member 4 OS=Homo sapiens OX=9606 GN=ABCG4 PE=1 SV=2,GO:0005524; GO:0005886; GO:0006355; GO:0010008; GO:0010875; GO:0016887; GO:0031410; GO:0033344; GO:0034041; GO:0042632; GO:0042802; GO:0042803; GO:0045542; GO:0046982; GO:0055085; GO:0071403; GO:1990830,cellular response to high density lipoprotein particle stimulus [GO:0071403]; cellular response to leukemia inhibitory factor [GO:1990830]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of cholesterol efflux [GO:0010875]; regulation of DNA-templated transcription [GO:0006355]; transmembrane transport [GO:0055085],cytoplasmic vesicle [GO:0031410]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],ABC-type sterol transporter activity [GO:0034041]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005215; GO:0005886; GO:0006355; GO:0016787; GO:0031410; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_06242,FUN_028232-T1,Peve_00018561,Pocillopora_meandrina_HIv1___RNAseq.g15526.t1,three_way,81.03166666666667,FUN_028232-T1,Q96KN3,,,,,45.9,407.0,1.1e-76,289.3,sp|Q96KN3|PKNX2_HUMAN Homeobox protein PKNOX2 OS=Homo sapiens OX=9606 GN=PKNOX2 PE=1 SV=2,,,,,,
OG_06243,FUN_028234-T1,Peve_00015262,Pocillopora_meandrina_HIv1___TS.g29893.t1,three_way,62.39333333333333,,,,,,,,,,,,,,,,,
OG_06244,FUN_028236-T1,Peve_00015260,Pocillopora_meandrina_HIv1___TS.g10553.t1,three_way,56.52033333333333,,,,,,,,,,,,,,,,,
OG_06245,FUN_028240-T1,Peve_00019541,Pocillopora_meandrina_HIv1___RNAseq.g15523.t1,three_way,73.03533333333334,FUN_028240-T1,O18638,,,,,35.4,274.0,1.1e-44,181.8,sp|O18638|OAF_DROVI Out at first protein OS=Drosophila virilis OX=7244 GN=oaf PE=3 SV=1,,,,,,
OG_06246,FUN_028241-T1,Peve_00019542,Pocillopora_meandrina_HIv1___RNAseq.g15522.t1,three_way,71.78316666666666,FUN_028241-T1,Q155Q3,DIXC1_HUMAN,,Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1),Homo sapiens (Human),41.1,725.0,4.900000000000001e-71,270.8,sp|Q155Q3|DIXC1_HUMAN Dixin OS=Homo sapiens OX=9606 GN=DIXDC1 PE=1 SV=2,GO:0001725; GO:0003779; GO:0005829; GO:0005925; GO:0019904; GO:0021799; GO:0021869; GO:0030177; GO:0032956; GO:0043015; GO:0045665; GO:0060070; GO:0070507; GO:0098794; GO:0098885; GO:0098978,canonical Wnt signaling pathway [GO:0060070]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; modification of postsynaptic actin cytoskeleton [GO:0098885]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; stress fiber [GO:0001725],actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; protein domain specific binding [GO:0019904],GO:0005829; GO:0008092; GO:0034330; GO:0048870,cytosol; cytoskeletal protein binding; cell junction organization; cell motility
OG_06247,FUN_028242-T1,Peve_00027191,Pocillopora_meandrina_HIv1___RNAseq.g15521.t1,three_way,72.64866666666667,FUN_028242-T1,Q8IS64,,,,,37.3,697.0,2.4e-131,471.1,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_06248,FUN_028245-T1,Peve_00017263,Pocillopora_meandrina_HIv1___RNAseq.g15520.t1,three_way,57.244,FUN_028245-T1,Q6L9W6,B4GN3_HUMAN,,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",Homo sapiens (Human),30.7,322.0,2.9e-42,174.9,"sp|Q6L9W6|B4GN3_HUMAN Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Homo sapiens OX=9606 GN=B4GALNT3 PE=1 SV=2",GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231,,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0005794; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; transferase activity; organelle
OG_06249,FUN_028246-T1,Peve_00017262,Pocillopora_meandrina_HIv1___RNAseq.g15519.t1,three_way,56.01233333333333,FUN_028246-T1,Q6L8F3,S39A6_DANRE,,Zinc transporter ZIP6 (Estrogen-regulated protein LIV-1) (Solute carrier family 39 member 6) (Zrt- and Irt-like protein 6) (ZIP-6),Danio rerio (Zebrafish) (Brachydanio rerio),39.9,163.0,1.7000000000000002e-27,124.8,sp|Q6L8F3|S39A6_DANRE Zinc transporter ZIP6 OS=Danio rerio OX=7955 GN=slc39a6 PE=2 SV=1,GO:0001837; GO:0005385; GO:0005886; GO:0006829; GO:0006882; GO:0030003; GO:0033077; GO:0042074; GO:0045121; GO:0050852; GO:0071578; GO:0140410,cell migration involved in gastrulation [GO:0042074]; epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transport [GO:0006829],membrane raft [GO:0045121]; plasma membrane [GO:0005886],monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385],GO:0002376; GO:0005215; GO:0005886; GO:0030154; GO:0048870; GO:0055085,immune system process; transporter activity; plasma membrane; cell differentiation; cell motility; transmembrane transport
OG_06250,FUN_028247-T1,Peve_00017261,Pocillopora_meandrina_HIv1___RNAseq.g15518.t1,three_way,77.46416666666667,,,,,,,,,,,,,,,,,
OG_06251,FUN_028249-T1,Peve_00017260,Pocillopora_meandrina_HIv1___RNAseq.g15517.t1,three_way,63.967333333333336,,,,,,,,,,,,,,,,,
OG_06252,FUN_028250-T1,Peve_00017259,Pocillopora_meandrina_HIv1___RNAseq.g15516.t1,three_way,59.79533333333333,FUN_028250-T1,Q9DGD1,,,,,37.2,242.0,1.7e-37,158.3,"sp|Q9DGD1|MGT4C_CHICK Alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase OS=Gallus gallus OX=9031 GN=MGAT4C PE=1 SV=1",,,,,,
OG_06253,FUN_028251-T1,Peve_00017265,Pocillopora_meandrina_HIv1___RNAseq.g15514.t1,three_way,89.22233333333334,FUN_028251-T1,Q6IR61,,,,,68.8,269.0,1.1e-109,398.3,sp|Q6IR61|NIT2A_XENLA Omega-amidase NIT2-A OS=Xenopus laevis OX=8355 GN=nit2a PE=2 SV=1,,,,,,
OG_06254,FUN_028262-T1,Peve_00017258,Pocillopora_meandrina_HIv1___RNAseq.g15513.t1,three_way,84.51566666666666,FUN_028262-T1,Q8AYC9,CHK1_CHICK,,Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Checkpoint kinase-1),Gallus gallus (Chicken),55.6,473.0,4.4e-147,522.7,sp|Q8AYC9|CHK1_CHICK Serine/threonine-protein kinase Chk1 OS=Gallus gallus OX=9031 GN=CHEK1 PE=1 SV=1,GO:0000077; GO:0000785; GO:0000794; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0006281; GO:0006338; GO:0006974; GO:0007095; GO:0010569; GO:0018107; GO:0035402; GO:0042770; GO:0045814; GO:0045839; GO:0046602; GO:0106310,"chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of mitotic nuclear division [GO:0045839]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mitotic centrosome separation [GO:0046602]; signal transduction in response to DNA damage [GO:0042770]",centrosome [GO:0005813]; chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone H3T11 kinase activity [GO:0035402]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000228; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0006281; GO:0006325; GO:0016740; GO:0043226; GO:0140096,"nuclear chromosome; catalytic activity; nucleus; nucleoplasm; chromosome; microtubule organizing center; DNA repair; chromatin organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06255,FUN_028269-T1,Peve_00013158,Pocillopora_meandrina_HIv1___TS.g10539.t1b,three_way,69.86733333333333,,,,,,,,,,,,,,,,,
OG_06256,FUN_028272-T1,Peve_00005744,Pocillopora_meandrina_HIv1___RNAseq.g15508.t1,three_way,60.34533333333333,,,,,,,,,,,,,,,,,
OG_06257,FUN_028275-T1,Peve_00000871,Pocillopora_meandrina_HIv1___RNAseq.g29777.t1,three_way,56.74166666666667,FUN_028275-T1,P49961,ENTP1_HUMAN,,Ectonucleoside triphosphate diphosphohydrolase 1 (EC 3.6.1.5) (ATP diphosphohydrolase) (ATP-DPH) (ATPDase) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (Nucleoside triphosphate diphosphohydrolase 1) (NTPDase1) (CD antigen CD39),Homo sapiens (Human),30.6,418.0,3e-43,177.6,sp|P49961|ENTP1_HUMAN Ectonucleoside triphosphate diphosphohydrolase 1 OS=Homo sapiens OX=9606 GN=ENTPD1 PE=1 SV=1,GO:0003924; GO:0004050; GO:0004382; GO:0005524; GO:0005604; GO:0005886; GO:0005901; GO:0007155; GO:0007186; GO:0007596; GO:0009134; GO:0009897; GO:0016020; GO:0016887; GO:0017110; GO:0017111; GO:0036384; GO:0043262; GO:0043273; GO:0045134; GO:0046032; GO:0070062; GO:0070527; GO:0103023; GO:1990003,ADP catabolic process [GO:0046032]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; G protein-coupled receptor signaling pathway [GO:0007186]; nucleoside diphosphate catabolic process [GO:0009134]; platelet aggregation [GO:0070527],basement membrane [GO:0005604]; caveola [GO:0005901]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886],ADP phosphatase activity [GO:0043262]; apyrase activity [GO:0004050]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; CDP phosphatase activity [GO:0036384]; CTPase activity [GO:0043273]; GDP phosphatase activity [GO:0004382]; GTPase activity [GO:0003924]; IDP phosphatase activity [GO:1990003]; ITPase activity [GO:0103023]; nucleoside diphosphate phosphatase activity [GO:0017110]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; UDP phosphatase activity [GO:0045134],GO:0003824; GO:0003924; GO:0005886; GO:0007155; GO:0016787; GO:0030312; GO:0031012; GO:0043226; GO:0055086; GO:1901135,catalytic activity; GTPase activity; plasma membrane; cell adhesion; hydrolase activity; external encapsulating structure; extracellular matrix; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_06258,FUN_028276-T1,Peve_00018995,Pocillopora_meandrina_HIv1___RNAseq.g15501.t1,three_way,50.34283333333333,,,,,,,,,,,,,,,,,
OG_06259,FUN_028277-T1,Peve_00018996,Pocillopora_meandrina_HIv1___RNAseq.g15500.t2,three_way,61.196,,,,,,,,,,,,,,,,,
OG_06260,FUN_028278-T1,Peve_00003675,Pocillopora_meandrina_HIv1___RNAseq.g15498.t1,three_way,51.95133333333333,,,,,,,,,,,,,,,,,
OG_06261,FUN_028279-T1,Peve_00003674,Pocillopora_meandrina_HIv1___RNAseq.g15496.t1,three_way,60.25483333333333,FUN_028279-T1,Q1L8I0,,,,,35.2,687.0,2.8e-90,334.7,sp|Q1L8I0|PUS7L_DANRE Pseudouridylate synthase PUS7L OS=Danio rerio OX=7955 GN=pus7l PE=2 SV=1,,,,,,
OG_06262,FUN_028287-T1,Peve_00003672,Pocillopora_meandrina_HIv1___RNAseq.g15495.t1,three_way,73.47366666666667,FUN_028287-T1,Q8K1K9,HINFP_MOUSE,,Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein),Mus musculus (Mouse),50.1,413.0,4.2e-106,386.7,sp|Q8K1K9|HINFP_MOUSE Histone H4 transcription factor OS=Mus musculus OX=10090 GN=Hinfp PE=2 SV=3,GO:0000077; GO:0000082; GO:0000122; GO:0000976; GO:0000978; GO:0001227; GO:0001228; GO:0001701; GO:0003677; GO:0003682; GO:0003700; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0008270; GO:0010628; GO:0010629; GO:0015030; GO:0019899; GO:0042393; GO:0044843; GO:0045184; GO:0045445; GO:0045892; GO:0045893,cell cycle G1/S phase transition [GO:0044843]; DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; DNA-templated transcription [GO:0006351]; establishment of protein localization [GO:0045184]; G1/S transition of mitotic cell cycle [GO:0000082]; in utero embryonic development [GO:0001701]; myoblast differentiation [GO:0045445]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; regulation of DNA-templated transcription [GO:0006355],Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; anatomical structure development; transcription regulator activity
OG_06263,FUN_028288-T1,Peve_00003669,Pocillopora_meandrina_HIv1___RNAseq.g15491.t1,three_way,75.29166666666667,FUN_028288-T1,P69849,NOMO3_HUMAN,,BOS complex subunit NOMO3 (Nodal modulator 3) (pM5 protein 3),Homo sapiens (Human),42.8,1171.0,1.2e-286,987.6,sp|P69849|NOMO3_HUMAN BOS complex subunit NOMO3 OS=Homo sapiens OX=9606 GN=NOMO3 PE=1 SV=2,GO:0003140; GO:0005789; GO:0030246; GO:0043022; GO:0160063; GO:0160064; GO:1900108,determination of left/right asymmetry in lateral mesoderm [GO:0003140]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; negative regulation of nodal signaling pathway [GO:1900108],endoplasmic reticulum membrane [GO:0005789]; multi-pass translocon complex [GO:0160064],carbohydrate binding [GO:0030246]; ribosome binding [GO:0043022],,
OG_06264,FUN_028291-T1,Peve_00000712,Pocillopora_meandrina_HIv1___RNAseq.g15537.t1,three_way,68.49083333333334,,,,,,,,,,,,,,,,,
OG_06265,FUN_028292-T1,Peve_00000715,Pocillopora_meandrina_HIv1___TS.g10566.t1,three_way,67.17266666666667,FUN_028292-T1,Q5QD04,TAAR9_MOUSE,,Trace amine-associated receptor 9 (TaR-9) (Trace amine receptor 9) (mTaar9),Mus musculus (Mouse),31.6,307.0,4.400000000000001e-28,127.1,sp|Q5QD04|TAAR9_MOUSE Trace amine-associated receptor 9 OS=Mus musculus OX=10090 GN=Taar9 PE=1 SV=1,GO:0001594; GO:0005886; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],trace-amine receptor activity [GO:0001594],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_06266,FUN_028293-T1,Peve_00000716,Pocillopora_meandrina_HIv1___TS.g10567.t1,three_way,55.41733333333333,FUN_028293-T1,G5EBF1,SAX3_CAEEL,,Protein sax-3 (Sensory axon guidance 3),Caenorhabditis elegans,24.9,887.0,4.3e-42,175.6,sp|G5EBF1|SAX3_CAEEL Protein sax-3 OS=Caenorhabditis elegans OX=6239 GN=sax-3 PE=2 SV=1,GO:0001764; GO:0005829; GO:0005886; GO:0007411; GO:0008046; GO:0030424; GO:0033563; GO:0035385; GO:0097374; GO:0098609; GO:1905489,axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; dorsal/ventral axon guidance [GO:0033563]; neuron migration [GO:0001764]; regulation of sensory neuron axon guidance [GO:1905489]; Roundabout signaling pathway [GO:0035385]; sensory neuron axon guidance [GO:0097374],axon [GO:0030424]; cytosol [GO:0005829]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046],GO:0005829; GO:0005886; GO:0007155; GO:0048870; GO:0060089,cytosol; plasma membrane; cell adhesion; cell motility; molecular transducer activity
OG_06267,FUN_028298-T1,Peve_00000717,Pocillopora_meandrina_HIv1___TS.g10568.t1,three_way,85.25066666666667,FUN_028298-T1,Q9NYG2,,,,,35.7,258.0,8.9e-38,158.7,sp|Q9NYG2|ZDHC3_HUMAN Palmitoyltransferase ZDHHC3 OS=Homo sapiens OX=9606 GN=ZDHHC3 PE=1 SV=2,,,,,,
OG_06268,FUN_028299-T1,Peve_00000718,Pocillopora_meandrina_HIv1___RNAseq.g15542.t2,three_way,70.94366666666667,,,,,,,,,,,,,,,,,
OG_06269,FUN_028300-T1,Peve_00000713,Pocillopora_meandrina_HIv1___RNAseq.g15543.t1,three_way,84.12116666666667,FUN_028300-T1,Q80Z96,,,,,42.7,461.0,2.0999999999999998e-94,347.8,sp|Q80Z96|VANG1_MOUSE Vang-like protein 1 OS=Mus musculus OX=10090 GN=Vangl1 PE=1 SV=2,,,,,,
OG_06270,FUN_028301-T1,Peve_00000714,Pocillopora_meandrina_HIv1___TS.g10572.t1,three_way,51.42816666666666,FUN_028301-T1,D3ZSP7,TTC3_RAT,,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D),Rattus norvegicus (Rat),27.5,741.0,7.4e-62,241.5,sp|D3ZSP7|TTC3_RAT E3 ubiquitin-protein ligase TTC3 OS=Rattus norvegicus OX=10116 GN=Ttc3 PE=3 SV=3,GO:0004842; GO:0005634; GO:0005773; GO:0005794; GO:0006511; GO:0008270; GO:0030517; GO:0045665; GO:0070936,negative regulation of axon extension [GO:0030517]; negative regulation of neuron differentiation [GO:0045665]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; vacuole [GO:0005773],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005773; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vacuole; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06271,FUN_028303-T1,Peve_00027867,Pocillopora_meandrina_HIv1___RNAseq.g15547.t1,three_way,85.15633333333334,FUN_028303-T1,Q32LN4,CFA45_BOVIN,,Cilia- and flagella-associated protein 45,Bos taurus (Bovine),35.3,547.0,1e-17,93.2,sp|Q32LN4|CFA45_BOVIN Cilia- and flagella-associated protein 45 OS=Bos taurus OX=9913 GN=CFAP45 PE=1 SV=2,GO:0005576; GO:0005879; GO:0016208; GO:0030317; GO:0036126; GO:0060287; GO:0060296; GO:0061966; GO:0090660; GO:0097728; GO:0160112,cerebrospinal fluid circulation [GO:0090660]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; establishment of left/right asymmetry [GO:0061966]; flagellated sperm motility [GO:0030317]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],9+0 motile cilium [GO:0097728]; axonemal B tubule inner sheath [GO:0160112]; axonemal microtubule [GO:0005879]; extracellular region [GO:0005576]; sperm flagellum [GO:0036126],AMP binding [GO:0016208],GO:0005576; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0050877,extracellular region; cilium; microtubule-based movement; reproductive process; organelle; cell motility; nervous system process
OG_06272,FUN_028304-T1,Peve_00027868,Pocillopora_meandrina_HIv1___RNAseq.g15548.t1,three_way,58.65733333333333,FUN_028304-T1,Q9BZE1,RM37_HUMAN,,"Large ribosomal subunit protein mL37 (39S ribosomal protein L2, mitochondrial) (L2mt) (MRP-L2) (39S ribosomal protein L37, mitochondrial) (L37mt) (MRP-L37)",Homo sapiens (Human),29.1,327.0,5.3e-30,133.3,sp|Q9BZE1|RM37_HUMAN Large ribosomal subunit protein mL37 OS=Homo sapiens OX=9606 GN=MRPL37 PE=1 SV=2,GO:0003723; GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0006412; GO:0032543,mitochondrial translation [GO:0032543]; translation [GO:0006412],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005739; GO:0005840; GO:0043226,RNA binding; structural molecule activity; mitochondrion; ribosome; organelle
OG_06273,FUN_028309-T1,Peve_00037726,Pocillopora_meandrina_HIv1___RNAseq.g16424.t1,three_way,73.845,FUN_028309-T1,O15550,KDM6A_HUMAN,,Lysine-specific demethylase 6A (EC 1.14.11.68) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein) ([histone H3]-trimethyl-L-lysine(27) demethylase 6A),Homo sapiens (Human),40.4,1012.0,2.5e-115,418.3,sp|O15550|KDM6A_HUMAN Lysine-specific demethylase 6A OS=Homo sapiens OX=9606 GN=KDM6A PE=1 SV=2,GO:0000978; GO:0005634; GO:0005654; GO:0006338; GO:0007507; GO:0010468; GO:0031490; GO:0032452; GO:0035097; GO:0044666; GO:0046872; GO:0071558,chromatin remodeling [GO:0006338]; heart development [GO:0007507]; regulation of gene expression [GO:0010468],histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016491; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; oxidoreductase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06274,FUN_028311-T1,Peve_00037729,Pocillopora_meandrina_HIv1___RNAseq.g16423.t1,three_way,51.885,,,,,,,,,,,,,,,,,
OG_06275,FUN_028312-T1,Peve_00025176,Pocillopora_meandrina_HIv1___RNAseq.g16422.t1,three_way,50.10016666666667,FUN_028312-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),47.0,304.0,1.7e-73,279.3,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_06276,FUN_028315-T1,Peve_00040903,Pocillopora_meandrina_HIv1___TS.g11411.t1,three_way,55.938,FUN_028315-T1,P16092,FGFR1_MOUSE,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Mus musculus (Mouse),45.8,286.0,1.1e-67,259.2,sp|P16092|FGFR1_MOUSE Fibroblast growth factor receptor 1 OS=Mus musculus OX=10090 GN=Fgfr1 PE=1 SV=2,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0005007; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010966; GO:0010976; GO:0017134; GO:0021769; GO:0021847; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042803; GO:0043235; GO:0043536; GO:0043583; GO:0045666; GO:0045787; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0060979; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cementum mineralization [GO:0071529]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_06277,FUN_028316-T1,Peve_00040892,Pocillopora_meandrina_HIv1___RNAseq.g16390.t1,three_way,51.38133333333333,FUN_028316-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),41.5,325.0,2.4e-68,261.9,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_06278,FUN_028437-T1,Peve_00018283,Pocillopora_meandrina_HIv1___RNAseq.g8009.t1,three_way,77.03933333333333,,,,,,,,,,,,,,,,,
OG_06279,FUN_028447-T1,Peve_00026233,Pocillopora_meandrina_HIv1___RNAseq.g16195.t1,three_way,59.692,FUN_028447-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),40.3,573.0,9.700000000000001e-117,423.7,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_06280,FUN_028449-T1,Peve_00031080,Pocillopora_meandrina_HIv1___TS.g11207.t1,three_way,39.0405,FUN_028449-T1,Q62718,NTRI_RAT,,Neurotrimin (GP65),Rattus norvegicus (Rat),31.4,204.0,2.4e-18,95.9,sp|Q62718|NTRI_RAT Neurotrimin OS=Rattus norvegicus OX=10116 GN=Ntm PE=1 SV=1,GO:0005615; GO:0007155; GO:0009986; GO:0010976; GO:0010977; GO:0021549; GO:0030424; GO:0032355; GO:0042802; GO:0048471; GO:0048787; GO:0060076; GO:0060253; GO:0071392; GO:0098552; GO:0098686; GO:0098839; GO:1900149,cell adhesion [GO:0007155]; cellular response to estradiol stimulus [GO:0071392]; cerebellum development [GO:0021549]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of neuron projection development [GO:0010977]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Schwann cell migration [GO:1900149]; response to estradiol [GO:0032355],axon [GO:0030424]; cell surface [GO:0009986]; excitatory synapse [GO:0060076]; extracellular space [GO:0005615]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density membrane [GO:0098839]; presynaptic active zone membrane [GO:0048787]; side of membrane [GO:0098552],identical protein binding [GO:0042802],GO:0005615; GO:0007155; GO:0048856,extracellular space; cell adhesion; anatomical structure development
OG_06281,FUN_028450-T1,Peve_00002378,Pocillopora_meandrina_HIv1___RNAseq.g16191.t1,three_way,41.13883333333333,FUN_028450-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),28.0,168.0,1.3e-08,62.8,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_06282,FUN_028452-T1,Peve_00003099,Pocillopora_meandrina_HIv1___RNAseq.g16134.t1,three_way,56.43066666666667,FUN_028452-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),45.5,308.0,6.7000000000000004e-74,279.6,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_06283,FUN_028468-T1,Peve_00036785,Pocillopora_meandrina_HIv1___RNAseq.g16127.t1,three_way,61.769666666666666,FUN_028468-T1,Q17LW0,,,,,35.2,577.0,2.8e-92,340.9,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_06284,FUN_028470-T1,Peve_00036788,Pocillopora_meandrina_HIv1___RNAseq.g16126.t1,three_way,85.66233333333334,FUN_028470-T1,Q17LW0,,,,,59.3,1107.0,1.4e-292,1007.3,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_06285,FUN_028472-T1,Peve_00036790,Pocillopora_meandrina_HIv1___RNAseq.g16124.t1,three_way,53.61833333333333,,,,,,,,,,,,,,,,,
OG_06286,FUN_028473-T1,Peve_00023657,Pocillopora_meandrina_HIv1___RNAseq.g16117.t1,three_way,88.432,FUN_028473-T1,O60573,IF4E2_HUMAN,,Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (Eukaryotic translation initiation factor 4E homologous protein) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP) (mRNA cap-binding protein 4EHP) (h4EHP) (mRNA cap-binding protein type 3),Homo sapiens (Human),76.0,179.0,2.2e-80,300.4,sp|O60573|IF4E2_HUMAN Eukaryotic translation initiation factor 4E type 2 OS=Homo sapiens OX=9606 GN=EIF4E2 PE=1 SV=1,GO:0000339; GO:0000340; GO:0000932; GO:0003723; GO:0003743; GO:0005737; GO:0005829; GO:0006413; GO:0008135; GO:0016281; GO:0017148; GO:0031625; GO:0035278; GO:0045947; GO:0060339; GO:0072344; GO:0098808,miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; rescue of stalled ribosome [GO:0072344]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; P-body [GO:0000932],"mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]",GO:0003723; GO:0005829; GO:0031047; GO:0043226,RNA binding; cytosol; regulatory ncRNA-mediated gene silencing; organelle
OG_06287,FUN_028477-T1,Peve_00039732,Pocillopora_meandrina_HIv1___RNAseq.6804_t,three_way,81.0705,FUN_028477-T1,Q9H3P2,NELFA_HUMAN,,Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 protein),Homo sapiens (Human),41.4,534.0,1.4e-61,238.8,sp|Q9H3P2|NELFA_HUMAN Negative elongation factor A OS=Homo sapiens OX=9606 GN=NELFA PE=1 SV=3,GO:0003682; GO:0005634; GO:0005654; GO:0005829; GO:0016604; GO:0032021; GO:0034244; GO:0045944; GO:0060090,negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytosol [GO:0005829]; NELF complex [GO:0032021]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; molecular adaptor activity [GO:0060090],GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0060090,nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity
OG_06288,FUN_028482-T1,Peve_00039731,Pocillopora_meandrina_HIv1___RNAseq.11963_t,three_way,70.764,FUN_028482-T1,Q9NYR8,,,,,45.3,287.0,1.1e-60,235.0,sp|Q9NYR8|RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens OX=9606 GN=RDH8 PE=1 SV=1,,,,,,
OG_06289,FUN_028484-T1,Peve_00023662,Pocillopora_meandrina_HIv1___RNAseq.g16115.t1,three_way,73.85666666666667,FUN_028484-T1,Q9NYR8,,,,,33.7,264.0,2.2e-31,137.9,sp|Q9NYR8|RDH8_HUMAN Retinol dehydrogenase 8 OS=Homo sapiens OX=9606 GN=RDH8 PE=1 SV=1,,,,,,
OG_06290,FUN_028485-T1,Peve_00023655,Pocillopora_meandrina_HIv1___RNAseq.g16086.t1,three_way,82.86200000000001,FUN_028485-T1,Q5ZIV5,PDC10_CHICK,,Programmed cell death protein 10,Gallus gallus (Chicken),38.9,185.0,3.6000000000000003e-22,107.1,sp|Q5ZIV5|PDC10_CHICK Programmed cell death protein 10 OS=Gallus gallus OX=9031 GN=PDCD10 PE=2 SV=1,GO:0000139; GO:0001525; GO:0005829; GO:0005886; GO:0008284; GO:0010628; GO:0010629; GO:0019901; GO:0030335; GO:0032874; GO:0036481; GO:0042803; GO:0043066; GO:0044319; GO:0045747; GO:0050821; GO:0051683; GO:0090051; GO:0090168; GO:0090316; GO:0090443; GO:1903588; GO:1990830,"angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of gene expression [GO:0010629]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein stabilization [GO:0050821]; wound healing, spreading of cells [GO:0044319]",cytosol [GO:0005829]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901],GO:0005829; GO:0005886; GO:0048870,cytosol; plasma membrane; cell motility
OG_06291,FUN_028486-T1,Peve_00039740,Pocillopora_meandrina_HIv1___TS.g11105.t3a,three_way,50.81666666666667,FUN_028486-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),33.2,368.0,2.2e-41,172.6,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_06292,FUN_028487-T1,Peve_00039741,Pocillopora_meandrina_HIv1___TS.g11105.t3b,three_way,64.85216666666666,FUN_028487-T1,Q9GP15,,,,,44.3,70.0,3.3e-13,78.2,sp|Q9GP15|IRCPI_IXORI Kunitz-type anticoagulant protein Ir-CPI OS=Ixodes ricinus OX=34613 GN=CPI PE=2 SV=1,,,,,,
OG_06293,FUN_028491-T1,Peve_00015137,Pocillopora_meandrina_HIv1___RNAseq.g20858.t1,three_way,70.98166666666667,FUN_028491-T1,Q6P4R8,NFRKB_HUMAN,,Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G),Homo sapiens (Human),75.4,167.0,3.6999999999999996e-68,260.4,sp|Q6P4R8|NFRKB_HUMAN Nuclear factor related to kappa-B-binding protein OS=Homo sapiens OX=9606 GN=NFRKB PE=1 SV=2,GO:0000723; GO:0002020; GO:0003677; GO:0005634; GO:0005654; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0031011; GO:0033044; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:1904507,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],Ino80 complex [GO:0031011]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; protease binding [GO:0002020],GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle
OG_06294,FUN_028494-T1,Peve_00015135,Pocillopora_meandrina_HIv1___RNAseq.g16087.t1,three_way,73.79483333333333,FUN_028494-T1,Q96MW5,COG8_HUMAN,,Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8),Homo sapiens (Human),53.1,499.0,7.300000000000001e-145,515.8,sp|Q96MW5|COG8_HUMAN Conserved oligomeric Golgi complex subunit 8 OS=Homo sapiens OX=9606 GN=COG8 PE=1 SV=2,GO:0000139; GO:0000301; GO:0005794; GO:0006891; GO:0007030; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0070085,"glycosylation [GO:0070085]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588],,GO:0005794; GO:0016192; GO:0043226,Golgi apparatus; vesicle-mediated transport; organelle
OG_06295,FUN_028495-T1,Peve_00019600,Pocillopora_meandrina_HIv1___RNAseq.g16122.t1,three_way,80.23233333333333,FUN_028495-T1,Q9CQ92,FIS1_MOUSE,,Mitochondrial fission 1 protein (FIS1 homolog) (Tetratricopeptide repeat protein 11) (TPR repeat protein 11),Mus musculus (Mouse),46.9,147.0,1.1e-32,141.0,sp|Q9CQ92|FIS1_MOUSE Mitochondrial fission 1 protein OS=Mus musculus OX=10090 GN=Fis1 PE=1 SV=1,GO:0000266; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0006626; GO:0006915; GO:0007005; GO:0016559; GO:0032991; GO:0042802; GO:1903579; GO:2000192; GO:2001244,apoptotic process [GO:0006915]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; negative regulation of ATP metabolic process [GO:1903579]; negative regulation of fatty acid transport [GO:2000192]; peroxisome fission [GO:0016559]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; protein targeting to mitochondrion [GO:0006626],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],identical protein binding [GO:0042802],GO:0005739; GO:0005777; GO:0007005; GO:0012501; GO:0043226,mitochondrion; peroxisome; mitochondrion organization; programmed cell death; organelle
OG_06296,FUN_028496-T1,Peve_00015133,Pocillopora_meandrina_HIv1___RNAseq.g15240.t1,three_way,36.889,,,,,,,,,,,,,,,,,
OG_06297,FUN_028497-T1,Peve_00019601,Pocillopora_meandrina_HIv1___RNAseq.g15239.t1,three_way,51.07533333333333,,,,,,,,,,,,,,,,,
OG_06298,FUN_028498-T2,Peve_00019598,Pocillopora_meandrina_HIv1___RNAseq.g15238.t2,three_way,79.519,FUN_028498-T2,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),35.8,617.0,9.999999999999999e-98,360.1,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_06299,FUN_028503-T1,Peve_00029191,Pocillopora_meandrina_HIv1___RNAseq.g15905.t1,three_way,96.94266666666668,FUN_028503-T1,F2Z4H3,,,,,84.7,150.0,6.9e-70,264.6,"sp|F2Z4H3|RPAB3_BOVIN DNA-directed RNA polymerases I, II, and III subunit RPABC3 OS=Bos taurus OX=9913 GN=POLR2H PE=1 SV=1",,,,,,
OG_06300,FUN_028505-T1,Peve_00022933,Pocillopora_meandrina_HIv1___RNAseq.g15900.t1b,three_way,61.44466666666667,FUN_028505-T1,P49288,,,,,25.1,271.0,1.2e-09,65.5,sp|P49288|MTR1C_CHICK Melatonin receptor type 1C OS=Gallus gallus OX=9031 PE=2 SV=1,,,,,,
OG_06301,FUN_028506-T1,Peve_00029711,Pocillopora_meandrina_HIv1___RNAseq.g15898.t1,three_way,64.91666666666667,,,,,,,,,,,,,,,,,
OG_06302,FUN_028508-T1,Peve_00008106,Pocillopora_meandrina_HIv1___RNAseq.g14114.t1,three_way,92.56366666666666,FUN_028508-T1,Q66HB3,IFT80_RAT,,Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56),Rattus norvegicus (Rat),63.8,763.0,3.9e-310,1065.1,sp|Q66HB3|IFT80_RAT Intraflagellar transport protein 80 homolog OS=Rattus norvegicus OX=10116 GN=Ift80 PE=2 SV=1,GO:0001501; GO:0001503; GO:0001649; GO:0001958; GO:0002062; GO:0003417; GO:0003418; GO:0005737; GO:0005813; GO:0005929; GO:0006915; GO:0007163; GO:0007224; GO:0007249; GO:0008283; GO:0008543; GO:0009888; GO:0010467; GO:0010498; GO:0010839; GO:0016567; GO:0021510; GO:0030316; GO:0030992; GO:0033687; GO:0035264; GO:0035567; GO:0035630; GO:0036064; GO:0042476; GO:0043491; GO:0043616; GO:0044691; GO:0044782; GO:0048863; GO:0050821; GO:0051216; GO:0060173; GO:0060271; GO:0060348; GO:0060349; GO:0061975; GO:0071895; GO:0072089; GO:0097500; GO:0097731; GO:1902140; GO:1905515; GO:1990079; GO:2000051,apoptotic process [GO:0006915]; articular cartilage development [GO:0061975]; bone development [GO:0060348]; bone mineralization involved in bone maturation [GO:0035630]; bone morphogenesis [GO:0060349]; canonical NF-kappaB signal transduction [GO:0007249]; cartilage development [GO:0051216]; cartilage homeostasis [GO:1990079]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; endochondral ossification [GO:0001958]; establishment or maintenance of cell polarity [GO:0007163]; fibroblast growth factor receptor signaling pathway [GO:0008543]; gene expression [GO:0010467]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage development [GO:0003417]; keratinocyte proliferation [GO:0043616]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-canonical Wnt signaling pathway [GO:0035567]; non-motile cilium assembly [GO:1905515]; odontoblast differentiation [GO:0071895]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; receptor localization to non-motile cilium [GO:0097500]; response to inositol [GO:1902140]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spinal cord development [GO:0021510]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; tissue development [GO:0009888]; tooth eruption [GO:0044691],9+0 non-motile cilium [GO:0097731]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992],,GO:0005815; GO:0005929; GO:0007163; GO:0012501; GO:0030154; GO:0030163; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; establishment or maintenance of cell polarity; programmed cell death; cell differentiation; protein catabolic process; organelle; cilium organization; anatomical structure development
OG_06303,FUN_028509-T1,Peve_00008104,Pocillopora_meandrina_HIv1___RNAseq.g14115.t1,three_way,77.53633333333333,FUN_028509-T1,Q96LI9,,,,,44.6,258.0,1.0999999999999999e-53,211.8,sp|Q96LI9|CX058_HUMAN Uncharacterized protein CXorf58 OS=Homo sapiens OX=9606 GN=CXorf58 PE=1 SV=2,,,,,,
OG_06304,FUN_028510-T1,Peve_00008103,Pocillopora_meandrina_HIv1___TS.g11897.t1,three_way,78.13066666666667,FUN_028510-T1,Q96RQ3,MCCA_HUMAN,,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)",Homo sapiens (Human),60.7,687.0,8.1e-238,824.7,"sp|Q96RQ3|MCCA_HUMAN Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial OS=Homo sapiens OX=9606 GN=MCCC1 PE=1 SV=3",GO:0004075; GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0005829; GO:0006552; GO:0006768; GO:0009083; GO:0009374; GO:0046872; GO:1905202,biotin metabolic process [GO:0006768]; branched-chain amino acid catabolic process [GO:0009083]; L-leucine catabolic process [GO:0006552],cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0006790; GO:0016874; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; sulfur compound metabolic process; ligase activity; organelle
OG_06305,FUN_028511-T1,Peve_00008102,Pocillopora_meandrina_HIv1___RNAseq.g14117.t1,three_way,72.03616666666667,FUN_028511-T1,Q6GLC9,FMR1_XENTR,,Fragile X messenger ribonucleoprotein 1 homolog (XtFmrp),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.6,377.0,2e-87,324.7,sp|Q6GLC9|FMR1_XENTR Fragile X messenger ribonucleoprotein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fmr1 PE=2 SV=1,GO:0000381; GO:0000775; GO:0002092; GO:0002151; GO:0003682; GO:0003723; GO:0003729; GO:0003730; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0006281; GO:0006397; GO:0006406; GO:0007215; GO:0007399; GO:0008017; GO:0008266; GO:0008380; GO:0010369; GO:0010494; GO:0010629; GO:0014069; GO:0017148; GO:0030371; GO:0030424; GO:0030425; GO:0030426; GO:0032433; GO:0033592; GO:0034046; GO:0034063; GO:0035195; GO:0035197; GO:0035198; GO:0035613; GO:0036464; GO:0042734; GO:0042803; GO:0042995; GO:0043005; GO:0043197; GO:0043204; GO:0043232; GO:0043488; GO:0043679; GO:0045202; GO:0045211; GO:0045727; GO:0045947; GO:0046928; GO:0046982; GO:0048027; GO:0048471; GO:0051028; GO:0051489; GO:0051491; GO:0060538; GO:0060965; GO:0060998; GO:0060999; GO:0070840; GO:0071598; GO:0097386; GO:0098793; GO:0098794; GO:0098908; GO:0140006; GO:0140693; GO:0140694; GO:1900453; GO:1901386; GO:1901800; GO:1902737; GO:1990247; GO:1990812; GO:1990825; GO:1990904; GO:2000301; GO:2000637; GO:2000766,"DNA repair [GO:0006281]; glutamate receptor signaling pathway [GO:0007215]; membraneless organelle assembly [GO:0140694]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of miRNA-mediated gene silencing [GO:0060965]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; nervous system development [GO:0007399]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of receptor internalization [GO:0002092]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of mRNA stability [GO:0043488]; regulation of neuronal action potential [GO:0098908]; regulation of neurotransmitter secretion [GO:0046928]; RNA splicing [GO:0008380]; skeletal muscle organ development [GO:0060538]; stress granule assembly [GO:0034063]","axon [GO:0030424]; axon terminus [GO:0043679]; cell projection [GO:0042995]; chromocenter [GO:0010369]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; dendritic filopodium [GO:1902737]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; growth cone filopodium [GO:1990812]; intracellular membraneless organelle [GO:0043232]; neuron projection [GO:0043005]; neuronal ribonucleoprotein granule [GO:0071598]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]",chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; G-quadruplex RNA binding [GO:0002151]; histone H3 reader activity [GO:0140006]; microtubule binding [GO:0008017]; miRNA binding [GO:0035198]; molecular condensate scaffold activity [GO:0140693]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; sequence-specific mRNA binding [GO:1990825]; siRNA binding [GO:0035197]; translation repressor activity [GO:0030371],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006913; GO:0008092; GO:0016071; GO:0016853; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0060090; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; nucleocytoplasmic transport; cytoskeletal protein binding; mRNA metabolic process; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; molecular adaptor activity; catalytic activity, acting on RNA"
OG_06306,FUN_028512-T1,Peve_00008099,Pocillopora_meandrina_HIv1___RNAseq.g14118.t1,three_way,39.94833333333333,,,,,,,,,,,,,,,,,
OG_06307,FUN_028513-T1,Peve_00008089,Pocillopora_meandrina_HIv1___TS.g11902.t2,three_way,40.3635,,,,,,,,,,,,,,,,,
OG_06308,FUN_028547-T1,Peve_00012988,Pocillopora_meandrina_HIv1___RNAseq.g16675.t1,three_way,72.68233333333333,FUN_028547-T1,Q9CR50,ZN363_MOUSE,,RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363),Mus musculus (Mouse),55.2,241.0,1.9e-82,307.4,sp|Q9CR50|ZN363_MOUSE RING finger and CHY zinc finger domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rchy1 PE=1 SV=1,GO:0000151; GO:0002039; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0051865; GO:0061630; GO:0072344,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06309,FUN_028548-T1,Peve_00000559,Pocillopora_meandrina_HIv1___RNAseq.g17190.t1,three_way,72.73383333333334,FUN_028548-T1,Q8BHG1,NRDC_MOUSE,,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase),Mus musculus (Mouse),50.4,942.0,3.7e-279,962.6,sp|Q8BHG1|NRDC_MOUSE Nardilysin OS=Mus musculus OX=10090 GN=Nrdc PE=1 SV=1,GO:0004222; GO:0005739; GO:0006508; GO:0008233; GO:0030425; GO:0031643; GO:0046872; GO:0050772; GO:0051044; GO:0120163,negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of axonogenesis [GO:0050772]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; proteolysis [GO:0006508],dendrite [GO:0030425]; mitochondrion [GO:0005739],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06310,FUN_028549-T1,Peve_00000746,Pocillopora_meandrina_HIv1___RNAseq.g6218.t1,three_way,56.03633333333333,FUN_028549-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),30.5,285.0,4.8e-29,131.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_06311,FUN_028551-T1,Peve_00000748,Pocillopora_meandrina_HIv1___RNAseq.g9165.t1,three_way,77.50166666666667,FUN_028551-T1,Q63ZK1,,,,,69.5,105.0,1.4e-39,164.1,sp|Q63ZK1|MI40B_XENLA Mitochondrial intermembrane space import and assembly protein 40-B OS=Xenopus laevis OX=8355 GN=chchd4-b PE=2 SV=1,,,,,,
OG_06312,FUN_028552-T1,Peve_00000749,Pocillopora_meandrina_HIv1___RNAseq.g9164.t1,three_way,47.18,,,,,,,,,,,,,,,,,
OG_06313,FUN_028553-T1,Peve_00000750,Pocillopora_meandrina_HIv1___TS.g15553.t2,three_way,74.64583333333333,FUN_028553-T1,A2AT37,RENT2_MOUSE,,Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog) (Upf2),Mus musculus (Mouse),48.4,1041.0,5e-267,922.5,sp|A2AT37|RENT2_MOUSE Regulator of nonsense transcripts 2 OS=Mus musculus OX=10090 GN=Upf2 PE=1 SV=1,GO:0000184; GO:0001889; GO:0003723; GO:0005737; GO:0005829; GO:0006986; GO:0031100; GO:0035145; GO:0036464; GO:0042162; GO:0048471,"animal organ regeneration [GO:0031100]; liver development [GO:0001889]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; response to unfolded protein [GO:0006986]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; perinuclear region of cytoplasm [GO:0048471],RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0005829; GO:0016071; GO:0043226; GO:0048856,DNA binding; RNA binding; cytosol; mRNA metabolic process; organelle; anatomical structure development
OG_06314,FUN_028554-T1,Peve_00002501,Pocillopora_meandrina_HIv1___RNAseq.g20706.t2,three_way,70.67833333333333,FUN_028554-T1,A8MWY0,ELAP2_HUMAN,,Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 (Estrogen-induced gene 121-like protein) (hEIG121L),Homo sapiens (Human),35.5,1029.0,1.2e-176,622.1,sp|A8MWY0|ELAP2_HUMAN Endosome/lysosome-associated apoptosis and autophagy regulator family member 2 OS=Homo sapiens OX=9606 GN=ELAPOR2 PE=1 SV=2,GO:0005886; GO:0016020; GO:0030513; GO:0045684; GO:0051961; GO:0070700,negative regulation of nervous system development [GO:0051961]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of epidermis development [GO:0045684],membrane [GO:0016020]; plasma membrane [GO:0005886],BMP receptor binding [GO:0070700],GO:0005886,plasma membrane
OG_06315,FUN_028641-T1,Peve_00027118,Pocillopora_meandrina_HIv1___RNAseq.g28135.t1,three_way,62.84,FUN_028641-T1,P15043,RECQ_ECOLI,,ATP-dependent DNA helicase RecQ (EC 5.6.2.4) (DNA 3'-5' helicase RecQ),Escherichia coli (strain K12),31.0,145.0,1.2e-11,72.0,sp|P15043|RECQ_ECOLI ATP-dependent DNA helicase RecQ OS=Escherichia coli (strain K12) OX=83333 GN=recQ PE=1 SV=5,GO:0003677; GO:0003678; GO:0005524; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0006310; GO:0006974; GO:0008094; GO:0008270; GO:0009378; GO:0009432; GO:0016887; GO:0017116; GO:0017117; GO:0030894; GO:0043138; GO:0043590; GO:0046914; GO:0140640,DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; SOS response [GO:0009432],bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; replisome [GO:0030894]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117],"3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; four-way junction helicase activity [GO:0009378]; single-stranded DNA helicase activity [GO:0017116]; transition metal ion binding [GO:0046914]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005694; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; chromosome; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_06316,FUN_028658-T1,Peve_00027144,Pocillopora_meandrina_HIv1___TS.g27058.t1,three_way,39.778333333333336,,,,,,,,,,,,,,,,,
OG_06317,FUN_028677-T1,Peve_00015451,Pocillopora_meandrina_HIv1___RNAseq.g24439.t1,three_way,58.61033333333333,,,,,,,,,,,,,,,,,
OG_06318,FUN_028794-T1,Peve_00000751,Pocillopora_meandrina_HIv1___RNAseq.g20732.t1,three_way,77.11333333333333,FUN_028794-T1,Q9W352,,,,,39.9,313.0,1.9e-21,104.8,sp|Q9W352|CXXC1_DROME CXXC-type zinc finger protein 1 OS=Drosophila melanogaster OX=7227 GN=Cfp1 PE=1 SV=1,,,,,,
OG_06319,FUN_028795-T1,Peve_00000745,Pocillopora_meandrina_HIv1___RNAseq.g20731.t1,three_way,70.815,FUN_028795-T1,P52756,RBM5_HUMAN,,RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9),Homo sapiens (Human),39.6,768.0,1.8e-75,285.8,sp|P52756|RBM5_HUMAN RNA-binding protein 5 OS=Homo sapiens OX=9606 GN=RBM5 PE=1 SV=2,GO:0000245; GO:0000381; GO:0000398; GO:0003677; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005829; GO:0006396; GO:0006915; GO:0008270; GO:0008285; GO:0043065; GO:0043231,"apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA processing [GO:0006396]; spliceosomal complex assembly [GO:0000245]",cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],DNA binding [GO:0003677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0012501; GO:0016071; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; cytosol; programmed cell death; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06320,FUN_028803-T1,Peve_00018546,Pocillopora_meandrina_HIv1___RNAseq.g20705.t1,three_way,75.81733333333334,FUN_028803-T1,Q6P4A8,PLBL1_HUMAN,,Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C],Homo sapiens (Human),51.0,529.0,1.9e-146,520.8,sp|Q6P4A8|PLBL1_HUMAN Phospholipase B-like 1 OS=Homo sapiens OX=9606 GN=PLBD1 PE=1 SV=2,GO:0004620; GO:0005576; GO:0005615; GO:0005764; GO:0005829; GO:0009395,phospholipid catabolic process [GO:0009395],cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764],phospholipase activity [GO:0004620],GO:0003824; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005829; GO:0006629; GO:0016787; GO:0043226,catalytic activity; extracellular region; extracellular space; lysosome; vacuole; cytosol; lipid metabolic process; hydrolase activity; organelle
OG_06321,FUN_028816-T2,Peve_00000752,Pocillopora_meandrina_HIv1___RNAseq.g6229.t1,three_way,66.25733333333334,,,,,,,,,,,,,,,,,
OG_06322,FUN_028819-T1,Peve_00031680,Pocillopora_meandrina_HIv1___RNAseq.g20707.t1,three_way,83.64516666666667,FUN_028819-T1,Q3U2S4,OTUD5_MOUSE,,OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA),Mus musculus (Mouse),44.3,447.0,2.4e-87,324.3,sp|Q3U2S4|OTUD5_MOUSE OTU domain-containing protein 5 OS=Mus musculus OX=10090 GN=Otud5 PE=1 SV=2,GO:0004843; GO:0005634; GO:0014033; GO:0016579; GO:0031647; GO:0032496; GO:0032700; GO:0043161; GO:0043374; GO:0061578; GO:0070536; GO:0071108; GO:0072540; GO:0101005; GO:1990380; GO:2000316,"CD8-positive, alpha-beta T cell differentiation [GO:0043374]; negative regulation of interleukin-17 production [GO:0032700]; neural crest cell differentiation [GO:0014033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein stability [GO:0031647]; regulation of T-helper 17 type immune response [GO:2000316]; response to lipopolysaccharide [GO:0032496]; T-helper 17 cell lineage commitment [GO:0072540]",nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578],GO:0002376; GO:0003824; GO:0005634; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; hydrolase activity; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_06323,FUN_028831-T1,Peve_00024573,Pocillopora_meandrina_HIv1___RNAseq.g20708.t1,three_way,60.382666666666665,FUN_028831-T1,Q9NVH0,EXD2_HUMAN,,Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (3'-5' exoribonuclease EXD2) (EC 3.1.13.-) (Exonuclease 3'-5' domain-like-containing protein 2),Homo sapiens (Human),34.2,669.0,3.8e-100,367.5,sp|Q9NVH0|EXD2_HUMAN Exonuclease 3'-5' domain-containing protein 2 OS=Homo sapiens OX=9606 GN=EXD2 PE=1 SV=2,GO:0000175; GO:0000287; GO:0000724; GO:0000729; GO:0003676; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005759; GO:0006302; GO:0008296; GO:0008310; GO:0008408; GO:0030145; GO:0031297; GO:0042803; GO:0045111; GO:0090304; GO:0090734,DNA double-strand break processing [GO:0000729]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; nucleic acid metabolic process [GO:0090304]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; intermediate filament cytoskeleton [GO:0045111]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; single-stranded DNA 3'-5' DNA exonuclease activity [GO:0008310],GO:0003824; GO:0005634; GO:0005739; GO:0005856; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; mitochondrion; cytoskeleton; DNA repair; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_06324,FUN_028842-T1,Peve_00021443,Pocillopora_meandrina_HIv1___TS.g27739.t1b,three_way,93.753,FUN_028842-T1,Q32PE9,,,,,82.3,96.0,7.499999999999998e-41,167.5,sp|Q32PE9|LSM3_BOVIN U6 snRNA-associated Sm-like protein LSm3 OS=Bos taurus OX=9913 GN=LSM3 PE=3 SV=3,,,,,,
OG_06325,FUN_028843-T1,Peve_00024571,Pocillopora_meandrina_HIv1___RNAseq.g20712.t1,three_way,79.26683333333334,FUN_028843-T1,Q32M08,DUS4L_MOUSE,,tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like (EC 1.3.1.90) (tRNA-dihydrouridine synthase 4-like),Mus musculus (Mouse),60.2,299.0,5e-110,399.1,sp|Q32M08|DUS4L_MOUSE tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like OS=Mus musculus OX=10090 GN=Dus4l PE=2 SV=1,GO:0002943; GO:0050660; GO:0102266; GO:0102267,tRNA dihydrouridine synthesis [GO:0002943],,flavin adenine dinucleotide binding [GO:0050660]; tRNA-dihydrouridine20a synthase activity [GO:0102266]; tRNA-dihydrouridine20b synthase activity [GO:0102267],GO:0003824; GO:0006399; GO:0016491; GO:0140098,"catalytic activity; tRNA metabolic process; oxidoreductase activity; catalytic activity, acting on RNA"
OG_06326,FUN_028846-T1,Peve_00024569,Pocillopora_meandrina_HIv1___RNAseq.g12799.t1,three_way,61.40933333333333,FUN_028846-T1,Q99999,G3ST1_HUMAN,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Homo sapiens (Human),32.0,394.0,1.4e-48,195.3,sp|Q99999|G3ST1_HUMAN Galactosylceramide sulfotransferase OS=Homo sapiens OX=9606 GN=GAL3ST1 PE=1 SV=1,GO:0000139; GO:0001733; GO:0005886; GO:0006487; GO:0006665; GO:0006681; GO:0006682; GO:0006688; GO:0007283; GO:0008146; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665],Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886],galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005886; GO:0006629; GO:0009101; GO:0016740; GO:0022414; GO:1901135,catalytic activity; plasma membrane; lipid metabolic process; glycoprotein biosynthetic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_06327,FUN_028847-T1,Peve_00044608,Pocillopora_meandrina_HIv1___RNAseq.g12800.t1,three_way,69.94233333333334,,,,,,,,,,,,,,,,,
OG_06328,FUN_028848-T1,Peve_00044606,Pocillopora_meandrina_HIv1___RNAseq.g12798.t1,three_way,76.77366666666667,FUN_028848-T1,Q96M69,,,,,40.2,331.0,8.4e-66,253.4,sp|Q96M69|LRGUK_HUMAN Leucine-rich repeat and guanylate kinase domain-containing protein OS=Homo sapiens OX=9606 GN=LRGUK PE=1 SV=1,,,,,,
OG_06329,FUN_028877-T1,Peve_00044602,Pocillopora_meandrina_HIv1___RNAseq.g12808.t1,three_way,91.02266666666668,FUN_028877-T1,Q28FE4,,,,,80.5,113.0,2.1e-56,219.9,sp|Q28FE4|MORN5_XENTR MORN repeat-containing protein 5 OS=Xenopus tropicalis OX=8364 GN=morn5 PE=2 SV=1,,,,,,
OG_06330,FUN_028886-T1,Peve_00044601,Pocillopora_meandrina_HIv1___RNAseq.g12807.t1,three_way,57.31466666666667,,,,,,,,,,,,,,,,,
OG_06331,FUN_028887-T1,Peve_00044600,Pocillopora_meandrina_HIv1___RNAseq.g12804.t1,three_way,83.86333333333333,FUN_028887-T1,Q9NQX0,,,,,33.8,352.0,5.2e-52,206.8,sp|Q9NQX0|PRDM6_HUMAN Putative histone-lysine N-methyltransferase PRDM6 OS=Homo sapiens OX=9606 GN=PRDM6 PE=1 SV=2,,,,,,
OG_06332,FUN_028889-T2,Peve_00044599,Pocillopora_meandrina_HIv1___RNAseq.g12803.t1,three_way,74.40866666666666,,,,,,,,,,,,,,,,,
OG_06333,FUN_028891-T1,Peve_00044598,Pocillopora_meandrina_HIv1___RNAseq.g12802.t1,three_way,56.90533333333333,,,,,,,,,,,,,,,,,
OG_06334,FUN_028892-T3,Peve_00044597,Pocillopora_meandrina_HIv1___TS.g9140.t1,three_way,64.58333333333334,FUN_028892-T3,Q32LL6,,,,,53.2,111.0,3.0000000000000003e-30,133.3,sp|Q32LL6|MORN5_BOVIN MORN repeat-containing protein 5 OS=Bos taurus OX=9913 GN=MORN5 PE=2 SV=1,,,,,,
OG_06335,FUN_028893-T2,Peve_00044596,Pocillopora_meandrina_HIv1___RNAseq.g25694.t1,three_way,63.66133333333333,FUN_028893-T2,Q93890,,,,,36.8,323.0,1.4e-47,191.8,sp|Q93890|SRF3_CAEEL UDP-galactose/UDP-N-acetylglucosamine transporter srf-3 OS=Caenorhabditis elegans OX=6239 GN=srf-3 PE=1 SV=5,,,,,,
OG_06336,FUN_028894-T1,Peve_00044594,Pocillopora_meandrina_HIv1___RNAseq.g25693.t1,three_way,71.78116666666666,FUN_028894-T1,Q58DA6,S35A2_BOVIN,,UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT),Bos taurus (Bovine),52.1,286.0,8.9e-69,261.9,sp|Q58DA6|S35A2_BOVIN UDP-galactose translocator OS=Bos taurus OX=9913 GN=SLC35A2 PE=2 SV=1,GO:0000139; GO:0005459; GO:0015297; GO:0072334,UDP-galactose transmembrane transport [GO:0072334],Golgi membrane [GO:0000139],antiporter activity [GO:0015297]; UDP-galactose transmembrane transporter activity [GO:0005459],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_06337,FUN_028896-T1,Peve_00031964,Pocillopora_meandrina_HIv1___RNAseq.g25673.t1,three_way,77.62133333333333,FUN_028896-T1,Q6PF45,VIAAT_XENLA,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter) (xVIAAT),Xenopus laevis (African clawed frog),31.2,455.0,2.2999999999999998e-55,218.0,sp|Q6PF45|VIAAT_XENLA Vesicular inhibitory amino acid transporter OS=Xenopus laevis OX=8355 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0003333; GO:0005774; GO:0006836; GO:0008021; GO:0015179; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,amino acid transmembrane transport [GO:0003333]; beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021]; vacuolar membrane [GO:0005774],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799]; L-amino acid transmembrane transporter activity [GO:0015179],GO:0005215; GO:0031410; GO:0043226; GO:0055085,transporter activity; cytoplasmic vesicle; organelle; transmembrane transport
OG_06338,FUN_028897-T1,Peve_00027290,Pocillopora_meandrina_HIv1___RNAseq.g25674.t1,three_way,93.493,FUN_028897-T1,A8WIP6,CDK20_DANRE,,Cyclin-dependent kinase 20 (EC 2.7.11.22) (Cell cycle-related kinase) (Cell division protein kinase 20),Danio rerio (Zebrafish) (Brachydanio rerio),79.6,334.0,1.2e-152,540.8,sp|A8WIP6|CDK20_DANRE Cyclin-dependent kinase 20 OS=Danio rerio OX=7955 GN=cdk20 PE=2 SV=1,GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0051301; GO:0060271; GO:0106310,cell division [GO:0051301]; cilium assembly [GO:0060271],cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; cilium; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_06339,FUN_028898-T1,Peve_00029314,Pocillopora_meandrina_HIv1___RNAseq.13303_t,three_way,80.672,FUN_028898-T1,Q89B32,,,,,22.1,231.0,6.2e-11,70.1,"sp|Q89B32|EPMB_BUCBP L-lysine 2,3-aminomutase OS=Buchnera aphidicola subsp. Baizongia pistaciae (strain Bp) OX=224915 GN=epmB PE=3 SV=1",,,,,,
OG_06340,FUN_028905-T1,Peve_00042688,Pocillopora_meandrina_HIv1___RNAseq.g25682.t1,three_way,65.59266666666667,,,,,,,,,,,,,,,,,
OG_06341,FUN_028906-T1,Peve_00031963,Pocillopora_meandrina_HIv1___RNAseq.g25670.t1,three_way,85.42666666666668,FUN_028906-T1,O00429,DNM1L_HUMAN,,Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1),Homo sapiens (Human),60.5,770.0,7.5e-242,838.2,sp|O00429|DNM1L_HUMAN Dynamin-1-like protein OS=Homo sapiens OX=9606 GN=DNM1L PE=1 SV=2,GO:0000266; GO:0003924; GO:0005096; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005783; GO:0005789; GO:0005794; GO:0005829; GO:0005874; GO:0005903; GO:0005905; GO:0006816; GO:0006897; GO:0007005; GO:0008017; GO:0008289; GO:0010468; GO:0016020; GO:0016559; GO:0030672; GO:0030742; GO:0031267; GO:0031625; GO:0032991; GO:0042802; GO:0042803; GO:0043231; GO:0043653; GO:0048312; GO:0048471; GO:0048511; GO:0050714; GO:0051259; GO:0060047; GO:0070585; GO:0090023; GO:0090141; GO:0090149; GO:0160040; GO:1900063; GO:1901524; GO:1903578,calcium ion transport [GO:0006816]; endocytosis [GO:0006897]; heart contraction [GO:0060047]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial membrane fission [GO:0090149]; mitochondrion organization [GO:0007005]; mitocytosis [GO:0160040]; peroxisome fission [GO:0016559]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein secretion [GO:0050714]; protein complex oligomerization [GO:0051259]; protein localization to mitochondrion [GO:0070585]; regulation of ATP metabolic process [GO:1903578]; regulation of gene expression [GO:0010468]; regulation of mitophagy [GO:1901524]; regulation of peroxisome organization [GO:1900063]; rhythmic process [GO:0048511],brush border [GO:0005903]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625],GO:0003013; GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005783; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0061024; GO:0065003; GO:0098772,circulatory system process; catalytic activity; GTPase activity; mitochondrion; peroxisome; endoplasmic reticulum; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; membrane organization; protein-containing complex assembly; molecular function regulator activity
OG_06342,FUN_028907-T1,Peve_00031954,Pocillopora_meandrina_HIv1___RNAseq.g25671.t1,three_way,81.73166666666667,FUN_028907-T1,P48728,GCST_HUMAN,,"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)",Homo sapiens (Human),59.4,374.0,2.6e-119,430.3,"sp|P48728|GCST_HUMAN Aminomethyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=AMT PE=1 SV=1",GO:0004047; GO:0005654; GO:0005739; GO:0005759; GO:0005960; GO:0006546; GO:0008483; GO:0019464,glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464],glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483],GO:0003824; GO:0005654; GO:0005739; GO:0006520; GO:0016740; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; amino acid metabolic process; transferase activity; organelle
OG_06343,FUN_028908-T1,Peve_00031952,Pocillopora_meandrina_HIv1___TS.g27739.t1a,three_way,69.60266666666666,FUN_028908-T1,Q8K4F6,NSUN5_MOUSE,,28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein homolog),Mus musculus (Mouse),49.7,429.0,2.5e-109,397.5,sp|Q8K4F6|NSUN5_MOUSE 28S rRNA (cytosine-C(5))-methyltransferase OS=Mus musculus OX=10090 GN=Nsun5 PE=1 SV=2,GO:0003723; GO:0005654; GO:0005730; GO:0009383; GO:0014003; GO:0021987; GO:0022038; GO:0031641; GO:0045727; GO:0050890; GO:0070475,cerebral cortex development [GO:0021987]; cognition [GO:0050890]; corpus callosum development [GO:0022038]; oligodendrocyte development [GO:0014003]; positive regulation of translation [GO:0045727]; regulation of myelination [GO:0031641]; rRNA base methylation [GO:0070475],nucleolus [GO:0005730]; nucleoplasm [GO:0005654],RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383],GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0016740; GO:0043226; GO:0048856; GO:0050877; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; nucleolus; transferase activity; organelle; anatomical structure development; nervous system process; catalytic activity, acting on RNA"
OG_06344,FUN_028909-T1,Peve_00041428,Pocillopora_meandrina_HIv1___RNAseq.g20758.t1,three_way,59.083,,,,,,,,,,,,,,,,,
OG_06345,FUN_028911-T1,Peve_00010926,Pocillopora_meandrina_HIv1___RNAseq.g20753.t1,three_way,75.914,FUN_028911-T1,Q13569,TDG_HUMAN,,G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG),Homo sapiens (Human),54.4,193.0,2.0999999999999998e-55,217.2,sp|Q13569|TDG_HUMAN G/T mismatch-specific thymine DNA glycosylase OS=Homo sapiens OX=9606 GN=TDG PE=1 SV=2,GO:0000122; GO:0000287; GO:0003676; GO:0003677; GO:0003684; GO:0003690; GO:0003712; GO:0004844; GO:0005080; GO:0005524; GO:0005634; GO:0005654; GO:0005886; GO:0006284; GO:0006285; GO:0008263; GO:0016605; GO:0019104; GO:0019904; GO:0030983; GO:0031402; GO:0031404; GO:0032183; GO:0040029; GO:0043739; GO:0045008; GO:0045995; GO:0140297; GO:0141016; GO:0141167,"base-excision repair [GO:0006284]; base-excision repair, AP site formation [GO:0006285]; chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; depyrimidination [GO:0045008]; epigenetic regulation of gene expression [GO:0040029]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of embryonic development [GO:0045995]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605],ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; G/T mismatch-specific thymine-DNA glycosylase activity [GO:0141016]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; nucleic acid binding [GO:0003676]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; uracil DNA N-glycosylase activity [GO:0004844],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0043226; GO:0055086; GO:0060090; GO:0140097; GO:0140110; GO:1901135,"DNA binding; catalytic activity; nucleus; nucleoplasm; plasma membrane; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity; carbohydrate derivative metabolic process"
OG_06346,FUN_028912-T1,Peve_00041442,Pocillopora_meandrina_HIv1___RNAseq.g22342.t1,three_way,75.41166666666666,FUN_028912-T1,Q96DF8,ESS2_HUMAN,,Splicing factor ESS-2 homolog (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H) (DGS-H) (Protein ES2),Homo sapiens (Human),39.3,458.0,2.7e-72,274.2,sp|Q96DF8|ESS2_HUMAN Splicing factor ESS-2 homolog OS=Homo sapiens OX=9606 GN=ESS2 PE=1 SV=1,GO:0000398; GO:0005634; GO:0007399; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; nervous system development [GO:0007399]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634],,GO:0005634; GO:0016071; GO:0043226; GO:0048856,nucleus; mRNA metabolic process; organelle; anatomical structure development
OG_06347,FUN_028913-T1,Peve_00028026,Pocillopora_meandrina_HIv1___RNAseq.g20741.t2a,three_way,84.06333333333333,FUN_028913-T1,Q8IV35,,,,,40.4,1045.0,5.2e-223,776.2,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_06348,FUN_028918-T1,Peve_00028028,Pocillopora_meandrina_HIv1___TS.g9367.t1,three_way,84.30666666666667,FUN_028918-T1,A7RX26,HUTI_NEMVE,,Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1 homolog),Nematostella vectensis (Starlet sea anemone),71.0,317.0,6.6e-131,468.4,sp|A7RX26|HUTI_NEMVE Probable imidazolonepropionase OS=Nematostella vectensis OX=45351 GN=amdhd1 PE=3 SV=1,GO:0005737; GO:0006548; GO:0019556; GO:0019557; GO:0046872; GO:0050480,L-histidine catabolic process [GO:0006548]; L-histidine catabolic process to glutamate and formamide [GO:0019556]; L-histidine catabolic process to glutamate and formate [GO:0019557],cytoplasm [GO:0005737],imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872],GO:0003824; GO:0006520; GO:0016787,catalytic activity; amino acid metabolic process; hydrolase activity
OG_06349,FUN_028919-T1,Peve_00028034,Pocillopora_meandrina_HIv1___RNAseq.g20741.t2b,three_way,74.77233333333334,FUN_028919-T1,Q28107,FA5_BOVIN,,Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain],Bos taurus (Bovine),36.2,160.0,5e-24,112.5,sp|Q28107|FA5_BOVIN Coagulation factor V OS=Bos taurus OX=9913 GN=F5 PE=1 SV=1,GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091,blood circulation [GO:0008015]; blood coagulation [GO:0007596],extracellular region [GO:0005576]; platelet alpha granule [GO:0031091],copper ion binding [GO:0005507],GO:0003013; GO:0005576; GO:0031410; GO:0043226,circulatory system process; extracellular region; cytoplasmic vesicle; organelle
OG_06350,FUN_028924-T1,Peve_00028042,Pocillopora_meandrina_HIv1___TS.g9385.t1,three_way,55.74633333333333,FUN_028924-T1,Q9UI42,CBPA4_HUMAN,,Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3),Homo sapiens (Human),34.3,405.0,3.9e-73,276.9,sp|Q9UI42|CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens OX=9606 GN=CPA4 PE=1 SV=2,GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0042447; GO:0043171,hormone catabolic process [GO:0042447]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_06351,FUN_028927-T1,Peve_00028043,Pocillopora_meandrina_HIv1___RNAseq.g25556.t1,three_way,63.5355,FUN_028927-T1,Q6NU95,,,,,47.6,391.0,1.4e-25,119.0,sp|Q6NU95|RPAP3_XENLA RNA polymerase II-associated protein 3 OS=Xenopus laevis OX=8355 GN=rpap3 PE=2 SV=1,,,,,,
OG_06352,FUN_028939-T1,Peve_00026871,Pocillopora_meandrina_HIv1___TS.g9025.t1,three_way,60.138,FUN_028939-T1,P16305,,,,,34.0,418.0,2.2e-52,208.0,sp|P16305|GBRA6_MOUSE Gamma-aminobutyric acid receptor subunit alpha-6 OS=Mus musculus OX=10090 GN=Gabra6 PE=1 SV=3,,,,,,
OG_06353,FUN_028946-T1,Peve_00026868,Pocillopora_meandrina_HIv1___RNAseq.g25583.t1,three_way,40.32216666666666,,,,,,,,,,,,,,,,,
OG_06354,FUN_028947-T1,Peve_00026866,Pocillopora_meandrina_HIv1___RNAseq.g25582.t1,three_way,71.633,FUN_028947-T1,Q9NSA2,KCND1_HUMAN,,A-type voltage-gated potassium channel KCND1 (Potassium voltage-gated channel subfamily D member 1) (Shal-type potassium channel KCND1) (Voltage-gated potassium channel subunit Kv4.1),Homo sapiens (Human),39.5,390.0,6.4e-67,256.1,sp|Q9NSA2|KCND1_HUMAN A-type voltage-gated potassium channel KCND1 OS=Homo sapiens OX=9606 GN=KCND1 PE=1 SV=2,GO:0001508; GO:0005250; GO:0005886; GO:0008076; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260],dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_06355,FUN_028950-T1,Peve_00026877,Pocillopora_meandrina_HIv1___RNAseq.g25581.t1,three_way,65.13466666666667,FUN_028950-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),33.6,450.0,1.2e-56,222.2,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06356,FUN_028952-T1,Peve_00026876,Pocillopora_meandrina_HIv1___RNAseq.g25580.t1,three_way,78.66766666666666,FUN_028952-T1,P59995,,,,,41.8,383.0,6.1e-72,273.1,sp|P59995|KCND2_RABIT A-type voltage-gated potassium channel KCND2 OS=Oryctolagus cuniculus OX=9986 GN=KCND2 PE=2 SV=1,,,,,,
OG_06357,FUN_028953-T1,Peve_00025108,Pocillopora_meandrina_HIv1___RNAseq.g25579.t1,three_way,77.653,FUN_028953-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),43.3,395.0,4.900000000000001e-71,270.0,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06358,FUN_028960-T1,Peve_00029298,Pocillopora_meandrina_HIv1___RNAseq.g25590.t1,three_way,79.48733333333334,FUN_028960-T1,A7RT29,,,,,72.5,91.0,1.5e-32,139.8,sp|A7RT29|LTOR5_NEMVE Ragulator complex protein LAMTOR5 homolog OS=Nematostella vectensis OX=45351 GN=v1g226489 PE=3 SV=1,,,,,,
OG_06359,FUN_028961-T1,Peve_00029299,Pocillopora_meandrina_HIv1___TS.g8998.t1,three_way,54.599,,,,,,,,,,,,,,,,,
OG_06360,FUN_028963-T1,Peve_00025110,Pocillopora_meandrina_HIv1___RNAseq.g25566.t1,three_way,55.882666666666665,,,,,,,,,,,,,,,,,
OG_06361,FUN_028965-T1,Peve_00020162,Pocillopora_meandrina_HIv1___RNAseq.g25571.t1,three_way,72.39466666666667,FUN_028965-T1,Q9Y2M2,SSUH2_HUMAN,,Protein SSUH2 homolog (Protein ssu-2 homolog),Homo sapiens (Human),38.1,357.0,7.200000000000001e-44,179.5,sp|Q9Y2M2|SSUH2_HUMAN Protein SSUH2 homolog OS=Homo sapiens OX=9606 GN=SSUH2 PE=1 SV=2,GO:0005634; GO:0005737; GO:0031072; GO:0042476; GO:0051082,odontogenesis [GO:0042476],cytoplasm [GO:0005737]; nucleus [GO:0005634],heat shock protein binding [GO:0031072]; unfolded protein binding [GO:0051082],GO:0005634; GO:0043226,nucleus; organelle
OG_06362,FUN_028966-T1,Peve_00020164,Pocillopora_meandrina_HIv1___RNAseq.g25572.t1,three_way,56.937333333333335,,,,,,,,,,,,,,,,,
OG_06363,FUN_028967-T1,Peve_00031101,Pocillopora_meandrina_HIv1___RNAseq.g25573.t1,three_way,48.36216666666667,,,,,,,,,,,,,,,,,
OG_06364,FUN_028968-T1,Peve_00029303,Pocillopora_meandrina_HIv1___RNAseq.g25575.t1,three_way,71.739,FUN_028968-T1,O97725,,,,,53.4,133.0,5.799999999999999e-31,135.2,sp|O97725|NDUAC_BOVIN NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 OS=Bos taurus OX=9913 GN=NDUFA12 PE=1 SV=1,,,,,,
OG_06365,FUN_028969-T1,Peve_00029302,Pocillopora_meandrina_HIv1___TS.g9014.t1a,three_way,92.622,FUN_028969-T1,Q69ZQ2,ISY1_MOUSE,,Pre-mRNA-splicing factor ISY1 homolog,Mus musculus (Mouse),65.4,286.0,9.2e-92,338.2,sp|Q69ZQ2|ISY1_MOUSE Pre-mRNA-splicing factor ISY1 homolog OS=Mus musculus OX=10090 GN=Isy1 PE=1 SV=2,GO:0000350; GO:0000398; GO:0005634; GO:0071006; GO:0071013,"generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006],,GO:0005634; GO:0016071; GO:0043226; GO:0065003,nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06366,FUN_028970-T1,Peve_00006113,Pocillopora_meandrina_HIv1___RNAseq.g25636.t1,three_way,82.70400000000001,FUN_028970-T1,P13195,HEM1_RAT,,"5-aminolevulinate synthase, non-specific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)",Rattus norvegicus (Rat),52.0,611.0,1.8e-169,597.4,"sp|P13195|HEM1_RAT 5-aminolevulinate synthase, non-specific, mitochondrial OS=Rattus norvegicus OX=10116 GN=Alas1 PE=2 SV=2",GO:0001666; GO:0003870; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0009410; GO:0009635; GO:0010045; GO:0030170; GO:0031667; GO:0032025; GO:0032869; GO:0034698; GO:0042541; GO:0042802; GO:0045471; GO:0048034; GO:0048821; GO:0051591; GO:0070541; GO:1903412,cellular response to insulin stimulus [GO:0032869]; erythrocyte development [GO:0048821]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412]; response to cAMP [GO:0051591]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to nickel cation [GO:0010045]; response to nutrient levels [GO:0031667]; response to platinum ion [GO:0070541]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleoplasm; mitochondrion; cytosol; transferase activity; organelle; anatomical structure development
OG_06367,FUN_028971-T1,Peve_00006112,Pocillopora_meandrina_HIv1___RNAseq.g25601.t1,three_way,69.34566666666667,FUN_028971-T1,Q80TM9,NISCH_MOUSE,,Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor I-1-like protein) (Imidazoline-1 receptor) (I1R),Mus musculus (Mouse),25.1,343.0,6e-15,85.5,sp|Q80TM9|NISCH_MOUSE Nischarin OS=Mus musculus OX=10090 GN=Nisch PE=1 SV=2,GO:0005178; GO:0005654; GO:0005769; GO:0005829; GO:0005886; GO:0006915; GO:0015630; GO:0016601; GO:0030036; GO:0030336; GO:0035091; GO:0042802; GO:0045171; GO:0055037,actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; negative regulation of cell migration [GO:0030336]; Rac protein signal transduction [GO:0016601],cytosol [GO:0005829]; early endosome [GO:0005769]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091],GO:0005654; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008289; GO:0012501; GO:0031410; GO:0043226,nucleoplasm; endosome; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; lipid binding; programmed cell death; cytoplasmic vesicle; organelle
OG_06368,FUN_028972-T1,Peve_00016206,Pocillopora_meandrina_HIv1___RNAseq.g25602.t1,three_way,75.99566666666666,FUN_028972-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),30.6,402.0,1.2e-51,205.7,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_06369,FUN_028973-T1,Peve_00031293,Pocillopora_meandrina_HIv1___RNAseq.g25606.t1,three_way,43.651833333333336,,,,,,,,,,,,,,,,,
OG_06370,FUN_028974-T1,Peve_00031294,Pocillopora_meandrina_HIv1___RNAseq.g25605.t1,three_way,66.13433333333333,FUN_028974-T1,Q921L7,,,,,43.7,293.0,5.9e-61,236.1,sp|Q921L7|HEMK1_MOUSE MTRF1L release factor glutamine methyltransferase OS=Mus musculus OX=10090 GN=Hemk1 PE=2 SV=2,,,,,,
OG_06371,FUN_028976-T1,Peve_00016207,Pocillopora_meandrina_HIv1___RNAseq.g25603.t1,three_way,67.631,FUN_028976-T1,Q8IXL7,MSRB3_HUMAN,,Methionine-R-sulfoxide reductase B3 (MsrB3) (EC 1.8.4.12) (EC 1.8.4.14),Homo sapiens (Human),57.7,137.0,7.799999999999999e-46,184.9,sp|Q8IXL7|MSRB3_HUMAN Methionine-R-sulfoxide reductase B3 OS=Homo sapiens OX=9606 GN=MSRB3 PE=1 SV=2,GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006979; GO:0008270; GO:0030091; GO:0033743; GO:0033745,protein repair [GO:0030091]; response to oxidative stress [GO:0006979],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0005783; GO:0005829; GO:0016491; GO:0043226,catalytic activity; mitochondrion; endoplasmic reticulum; cytosol; oxidoreductase activity; organelle
OG_06372,FUN_028977-T1,Peve_00014804,Pocillopora_meandrina_HIv1___RNAseq.g25607.t1,three_way,64.57616666666667,FUN_028977-T1,Q3UG20,KMT2E_MOUSE,,Inactive histone-lysine N-methyltransferase 2E (Inactive lysine N-methyltransferase 2E) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog),Mus musculus (Mouse),30.4,460.0,1e-47,194.1,sp|Q3UG20|KMT2E_MOUSE Inactive histone-lysine N-methyltransferase 2E OS=Mus musculus OX=10090 GN=Kmt2e PE=1 SV=2,GO:0000791; GO:0002446; GO:0003713; GO:0005737; GO:0005813; GO:0008270; GO:0016607; GO:0019899; GO:0030218; GO:0032991; GO:0035064; GO:0040029; GO:0042119; GO:0042800; GO:0045893; GO:0048384; GO:1900087,epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; retinoic acid receptor signaling pathway [GO:0048384],centrosome [GO:0005813]; cytoplasm [GO:0005737]; euchromatin [GO:0000791]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],enzyme binding [GO:0019899]; histone H3K4 methyltransferase activity [GO:0042800]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005815; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"immune system process; catalytic activity; microtubule organizing center; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_06373,FUN_028978-T1,Peve_00029291,Pocillopora_meandrina_HIv1___RNAseq.g25600.t1,three_way,57.49583333333333,FUN_028978-T1,P35331,,,,,29.0,978.0,1.4e-95,352.8,sp|P35331|NRCAM_CHICK Neuronal cell adhesion molecule OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06374,FUN_028979-T1,Peve_00015447,Pocillopora_meandrina_HIv1___TS.g9074.t2,three_way,83.00766666666667,FUN_028979-T1,Q803T2,,,,,52.2,795.0,2.6e-221,770.0,sp|Q803T2|STRP1_DANRE Striatin-interacting protein 1 homolog OS=Danio rerio OX=7955 GN=strip1 PE=1 SV=1,,,,,,
OG_06375,FUN_028980-T1,Peve_00015446,Pocillopora_meandrina_HIv1___RNAseq.g25620.t1,three_way,72.642,FUN_028980-T1,Q9UHQ4,BAP29_HUMAN,,B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29),Homo sapiens (Human),47.0,168.0,9.6e-32,138.7,sp|Q9UHQ4|BAP29_HUMAN B-cell receptor-associated protein 29 OS=Homo sapiens OX=9606 GN=BCAP29 PE=1 SV=2,GO:0001649; GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0016020; GO:0070973,apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],,GO:0006886; GO:0012501; GO:0016192; GO:0030154,intracellular protein transport; programmed cell death; vesicle-mediated transport; cell differentiation
OG_06376,FUN_028981-T1,Peve_00014491,Pocillopora_meandrina_HIv1___RNAseq.g25619.t1,three_way,69.54766666666667,FUN_028981-T1,A7WM73,HEXO1_ARATH,,Beta-hexosaminidase 1 (EC 3.2.1.52) (Beta-GlcNAcase 1) (Beta-N-acetylhexosaminidase 1) (Beta-hexosaminidase 2) (AtHEX2) (N-acetyl-beta-glucosaminidase 1),Arabidopsis thaliana (Mouse-ear cress),27.5,534.0,4.1e-45,184.1,sp|A7WM73|HEXO1_ARATH Beta-hexosaminidase 1 OS=Arabidopsis thaliana OX=3702 GN=HEXO1 PE=1 SV=1,GO:0000325; GO:0004563; GO:0005773; GO:0005975; GO:0015929; GO:0099503,carbohydrate metabolic process [GO:0005975],plant-type vacuole [GO:0000325]; secretory vesicle [GO:0099503]; vacuole [GO:0005773],beta-N-acetylhexosaminidase activity [GO:0004563]; hexosaminidase activity [GO:0015929],GO:0003824; GO:0005773; GO:0005975; GO:0016787; GO:0031410; GO:0043226,catalytic activity; vacuole; carbohydrate metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_06377,FUN_028983-T1,Peve_00034516,Pocillopora_meandrina_HIv1___RNAseq.g25617.t1,three_way,89.974,FUN_028983-T1,Q99JI4,,,,,69.9,389.0,1.1999999999999998e-153,544.3,sp|Q99JI4|PSMD6_MOUSE 26S proteasome non-ATPase regulatory subunit 6 OS=Mus musculus OX=10090 GN=Psmd6 PE=1 SV=1,,,,,,
OG_06378,FUN_028984-T1,Peve_00034530,Pocillopora_meandrina_HIv1___RNAseq.g25616.t1,three_way,82.81966666666666,FUN_028984-T1,Q9BU79,,,,,53.1,98.0,8.100000000000001e-28,124.4,sp|Q9BU79|TM243_HUMAN Transmembrane protein 243 OS=Homo sapiens OX=9606 GN=TMEM243 PE=1 SV=1,,,,,,
OG_06379,FUN_028985-T1,Peve_00026496,Pocillopora_meandrina_HIv1___RNAseq.g25615.t1,three_way,82.04266666666666,FUN_028985-T1,Q96I99,SUCB2_HUMAN,,"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG)",Homo sapiens (Human),65.5,411.0,8.199999999999999e-148,525.0,"sp|Q96I99|SUCB2_HUMAN Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial OS=Homo sapiens OX=9606 GN=SUCLG2 PE=1 SV=2",GO:0000287; GO:0004776; GO:0005524; GO:0005525; GO:0005739; GO:0005759; GO:0005886; GO:0006099; GO:0006104; GO:0006105; GO:0019003; GO:0042709; GO:0044877; GO:0045244; GO:1901289,succinate metabolic process [GO:0006105]; succinyl-CoA catabolic process [GO:1901289]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; succinate-CoA ligase complex [GO:0042709]; succinate-CoA ligase complex (GDP-forming) [GO:0045244],ATP binding [GO:0005524]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877]; succinate-CoA ligase (GDP-forming) activity [GO:0004776],GO:0003824; GO:0005739; GO:0005886; GO:0006790; GO:0016874; GO:0043226; GO:0055086,catalytic activity; mitochondrion; plasma membrane; sulfur compound metabolic process; ligase activity; organelle; nucleobase-containing small molecule metabolic process
OG_06380,FUN_028987-T1,Peve_00034521,Pocillopora_meandrina_HIv1___TS.g9080.t1a,three_way,71.96766666666667,FUN_028987-T1,P48052,CBPA2_HUMAN,,Carboxypeptidase A2 (EC 3.4.17.15),Homo sapiens (Human),41.3,409.0,2.6e-87,323.9,sp|P48052|CBPA2_HUMAN Carboxypeptidase A2 OS=Homo sapiens OX=9606 GN=CPA2 PE=1 SV=3,GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270,protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508],extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773],carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; vacuole; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_06381,FUN_028993-T1,Peve_00034527,Pocillopora_meandrina_HIv1___TS.g9080.t1b,three_way,53.91833333333334,FUN_028993-T1,A2AVA0,SVEP1_MOUSE,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)",Mus musculus (Mouse),33.5,191.0,1e-20,102.4,"sp|A2AVA0|SVEP1_MOUSE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Mus musculus OX=10090 GN=Svep1 PE=1 SV=1",GO:0001945; GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0016477; GO:0031012; GO:0036303; GO:0045906; GO:0048014; GO:0090136; GO:0098640; GO:0120193,cell migration [GO:0016477]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0007155; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell adhesion; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; cell motility; cell adhesion mediator activity
OG_06382,FUN_028994-T1,Peve_00034531,Pocillopora_meandrina_HIv1___RNAseq.g25641.t1,three_way,71.23533333333333,FUN_028994-T1,Q9UI42,CBPA4_HUMAN,,Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3),Homo sapiens (Human),39.8,402.0,5.9000000000000005e-87,322.8,sp|Q9UI42|CBPA4_HUMAN Carboxypeptidase A4 OS=Homo sapiens OX=9606 GN=CPA4 PE=1 SV=2,GO:0004181; GO:0005615; GO:0006508; GO:0008270; GO:0042447; GO:0043171,hormone catabolic process [GO:0042447]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_06383,FUN_029007-T1,Peve_00025770,Pocillopora_meandrina_HIv1___RNAseq.g25642.t1,three_way,63.09433333333333,FUN_029007-T1,Q8N4T0,CBPA6_HUMAN,,Carboxypeptidase A6 (EC 3.4.17.-),Homo sapiens (Human),33.4,404.0,1.7e-60,235.0,sp|Q8N4T0|CBPA6_HUMAN Carboxypeptidase A6 OS=Homo sapiens OX=9606 GN=CPA6 PE=1 SV=2,GO:0004181; GO:0005615; GO:0006508; GO:0008270,proteolysis [GO:0006508],extracellular space [GO:0005615],metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_06384,FUN_029014-T1,Peve_00003118,Pocillopora_meandrina_HIv1___TS.g9087.t1,three_way,52.617,FUN_029014-T1,B8VIW9,,,,,40.2,1040.0,3.3e-188,660.6,sp|B8VIW9|FP_ACRMI Fibronectin type III domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_06385,FUN_029018-T1,Peve_00028035,Pocillopora_meandrina_HIv1___TS.g9259.t2,three_way,56.882666666666665,FUN_029018-T1,Q6IC98,GRAM4_HUMAN,,GRAM domain-containing protein 4 (Death-inducing protein),Homo sapiens (Human),33.6,429.0,2.2e-54,215.3,sp|Q6IC98|GRAM4_HUMAN GRAM domain-containing protein 4 OS=Homo sapiens OX=9606 GN=GRAMD4 PE=1 SV=1,GO:0005739; GO:0005789; GO:0006915; GO:0031966; GO:0034164; GO:0043065,apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of apoptotic process [GO:0043065],endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],,GO:0005739; GO:0012501; GO:0043226,mitochondrion; programmed cell death; organelle
OG_06386,FUN_029019-T1,Peve_00028036,Pocillopora_meandrina_HIv1___RNAseq.g25813.t1,three_way,75.201,FUN_029019-T1,Q8TCT0,CERK1_HUMAN,,Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4),Homo sapiens (Human),33.9,481.0,2.3e-80,301.2,sp|Q8TCT0|CERK1_HUMAN Ceramide kinase OS=Homo sapiens OX=9606 GN=CERK PE=1 SV=1,GO:0000287; GO:0001729; GO:0005524; GO:0005737; GO:0005886; GO:0006672; GO:0006688; GO:0016020,ceramide metabolic process [GO:0006672]; glycosphingolipid biosynthetic process [GO:0006688],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ceramide kinase activity [GO:0001729]; magnesium ion binding [GO:0000287],GO:0003824; GO:0005886; GO:0006629; GO:0016740; GO:1901135,catalytic activity; plasma membrane; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_06387,FUN_029028-T1,Peve_00003122,Pocillopora_meandrina_HIv1___TS.g9269.t1,three_way,58.06966666666667,FUN_029028-T1,Q923Y9,,,,,24.7,292.0,1.9e-06,55.1,sp|Q923Y9|TAAR1_RAT Trace amine-associated receptor 1 OS=Rattus norvegicus OX=10116 GN=Taar1 PE=2 SV=1,,,,,,
OG_06388,FUN_029031-T1,Peve_00003119,Pocillopora_meandrina_HIv1___RNAseq.g20773.t1,three_way,58.98433333333333,,,,,,,,,,,,,,,,,
OG_06389,FUN_029032-T2,Peve_00006767,Pocillopora_meandrina_HIv1___RNAseq.g20772.t1,three_way,92.37233333333332,FUN_029032-T2,Q9C0G6,DYH6_HUMAN,,Dynein axonemal heavy chain 6 (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6),Homo sapiens (Human),66.1,4022.0,0.0,5300.7,sp|Q9C0G6|DYH6_HUMAN Dynein axonemal heavy chain 6 OS=Homo sapiens OX=9606 GN=DNAH6 PE=1 SV=3,GO:0005524; GO:0005874; GO:0005930; GO:0008569; GO:0016887; GO:0030286; GO:0045505; GO:0051959; GO:0060294; GO:0097729,cilium movement involved in cell motility [GO:0060294],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_06390,FUN_029038-T1,Peve_00006770,Pocillopora_meandrina_HIv1___TS.g27794.t1,three_way,80.09283333333333,FUN_029038-T1,Q9Z0V2,KCND2_MOUSE,,A-type voltage-gated potassium channel KCND2 (Potassium voltage-gated channel subfamily D member 2) (Voltage-gated potassium channel subunit Kv4.2),Mus musculus (Mouse),43.0,377.0,4.4e-77,290.0,sp|Q9Z0V2|KCND2_MOUSE A-type voltage-gated potassium channel KCND2 OS=Mus musculus OX=10090 GN=Kcnd2 PE=1 SV=1,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0005901; GO:0006936; GO:0008016; GO:0008076; GO:0016020; GO:0019228; GO:0019233; GO:0030315; GO:0030425; GO:0032809; GO:0042383; GO:0043025; GO:0043197; GO:0043204; GO:0044853; GO:0045211; GO:0045475; GO:0046872; GO:0051260; GO:0070161; GO:0071193; GO:0071456; GO:0071805; GO:0086001; GO:0086009; GO:0098978; GO:0098982; GO:0099634; GO:1905030,action potential [GO:0001508]; cardiac muscle cell action potential [GO:0086001]; cellular response to hypoxia [GO:0071456]; locomotor rhythm [GO:0045475]; membrane repolarization [GO:0086009]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; sensory perception of pain [GO:0019233],anchoring junction [GO:0070161]; caveola [GO:0005901]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Kv4.2-KChIP2 channel complex [GO:0071193]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated potassium channel activity [GO:0005249],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0065003,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06391,FUN_029039-T1,Peve_00026016,Pocillopora_meandrina_HIv1___RNAseq.g20770.t1,three_way,84.69016666666666,FUN_029039-T1,Q924M5,,,,,31.8,233.0,2.4e-13,77.8,sp|Q924M5|BOLL_MOUSE Protein boule-like OS=Mus musculus OX=10090 GN=Boll PE=1 SV=3,,,,,,
OG_06392,FUN_029040-T1,Peve_00026015,Pocillopora_meandrina_HIv1___RNAseq.g20769.t1,three_way,90.76433333333334,FUN_029040-T1,P17971,KCNAL_DROME,,Potassium voltage-gated channel protein Shal (Shaker cognate l) (Shal2),Drosophila melanogaster (Fruit fly),57.2,568.0,1.8000000000000004e-164,580.9,sp|P17971|KCNAL_DROME Potassium voltage-gated channel protein Shal OS=Drosophila melanogaster OX=7227 GN=Shal PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006813; GO:0007268; GO:0008076; GO:0008306; GO:0016020; GO:0030425; GO:0043204; GO:0045202; GO:0051260; GO:0071805,action potential [GO:0001508]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06393,FUN_029041-T1,Peve_00026017,Pocillopora_meandrina_HIv1___RNAseq.g20768.t1,three_way,78.406,,,,,,,,,,,,,,,,,
OG_06394,FUN_029045-T1,Peve_00024363,Pocillopora_meandrina_HIv1___RNAseq.g20806.t1,three_way,66.928,FUN_029045-T1,P21266,GSTM3_HUMAN,,Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3),Homo sapiens (Human),56.2,210.0,1.7e-66,253.8,sp|P21266|GSTM3_HUMAN Glutathione S-transferase Mu 3 OS=Homo sapiens OX=9606 GN=GSTM3 PE=1 SV=3,GO:0004364; GO:0005634; GO:0005737; GO:0005829; GO:0006749; GO:0008065; GO:0018916; GO:0019899; GO:0035686; GO:0042178; GO:0042802; GO:0042803; GO:0043295; GO:0043627; GO:0045171; GO:0070062; GO:0070458,cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686],enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016740; GO:0043226; GO:0048856; GO:0098754,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle; anatomical structure development; detoxification
OG_06395,FUN_029056-T1,Peve_00040055,Pocillopora_meandrina_HIv1___RNAseq.g25438.t1,three_way,34.492,,,,,,,,,,,,,,,,,
OG_06396,FUN_029057-T1,Peve_00040058,Pocillopora_meandrina_HIv1___TS.g8868.t1,three_way,44.50083333333333,,,,,,,,,,,,,,,,,
OG_06397,FUN_029058-T1,Peve_00040067,Pocillopora_meandrina_HIv1___RNAseq.g25430.t1,three_way,34.364333333333335,,,,,,,,,,,,,,,,,
OG_06398,FUN_029059-T2,Peve_00002500,Pocillopora_meandrina_HIv1___RNAseq.g25824.t1,three_way,47.455333333333336,FUN_029059-T2,Q6PJN8,,,,,34.8,267.0,4.9e-39,164.1,sp|Q6PJN8|DALD3_MOUSE DALR anticodon-binding domain-containing protein 3 OS=Mus musculus OX=10090 GN=Dalrd3 PE=2 SV=1,,,,,,
OG_06399,FUN_029060-T1,Peve_00043259,Pocillopora_meandrina_HIv1___RNAseq.g25811.t1,three_way,84.07766666666667,FUN_029060-T1,A8E657,AASS_BOVIN,,"Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)]",Bos taurus (Bovine),52.2,900.0,1e-272,941.0,"sp|A8E657|AASS_BOVIN Alpha-aminoadipic semialdehyde synthase, mitochondrial OS=Bos taurus OX=9913 GN=AASS PE=2 SV=1",GO:0004753; GO:0005737; GO:0005739; GO:0006554; GO:0019878; GO:0033512; GO:0047130; GO:0047131,L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],"saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+, L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]",GO:0003824; GO:0005739; GO:0006520; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; mitochondrion; amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_06400,FUN_029061-T1,Peve_00043258,Pocillopora_meandrina_HIv1___RNAseq.g25810.t1,three_way,65.944,FUN_029061-T1,A8MTJ6,FOXI3_HUMAN,,Forkhead box protein I3,Homo sapiens (Human),42.1,145.0,1.6e-20,101.7,sp|A8MTJ6|FOXI3_HUMAN Forkhead box protein I3 OS=Homo sapiens OX=9606 GN=FOXI3 PE=1 SV=3,GO:0000978; GO:0000981; GO:0001942; GO:0005634; GO:0006357; GO:0009653; GO:0009957; GO:0030154; GO:0042475; GO:0048538; GO:0060017; GO:0060037; GO:1905040,anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; epidermal cell fate specification [GO:0009957]; hair follicle development [GO:0001942]; odontogenesis of dentin-containing tooth [GO:0042475]; otic placode development [GO:1905040]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; regulation of transcription by RNA polymerase II [GO:0006357]; thymus development [GO:0048538],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06401,FUN_029062-T1,Peve_00043257,Pocillopora_meandrina_HIv1___RNAseq.g25809.t1,three_way,72.04133333333333,FUN_029062-T1,Q02360,,,,,47.4,114.0,6.8e-21,104.0,sp|Q02360|FOXL1_DROME Fork head domain-containing protein L1 OS=Drosophila melanogaster OX=7227 GN=FoxL1 PE=1 SV=2,,,,,,
OG_06402,FUN_029064-T1,Peve_00043254,Pocillopora_meandrina_HIv1___RNAseq.g25803.t1,three_way,63.13433333333333,,,,,,,,,,,,,,,,,
OG_06403,FUN_029065-T1,Peve_00043255,Pocillopora_meandrina_HIv1___RNAseq.g25804.t1,three_way,71.726,,,,,,,,,,,,,,,,,
OG_06404,FUN_029078-T1,Peve_00042919,Pocillopora_meandrina_HIv1___RNAseq.g25462.t1,three_way,70.93966666666667,FUN_029078-T1,Q5RCU3,NAPEP_PONAB,,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),50.0,346.0,7.099999999999999e-105,382.1,sp|Q5RCU3|NAPEP_PONAB N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Pongo abelii OX=9601 GN=NAPEPLD PE=2 SV=1,GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0031901; GO:0048874; GO:0050729; GO:0070290; GO:0070291; GO:0070292; GO:0090336,host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; temperature homeostasis [GO:0001659],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654],N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270],GO:0003824; GO:0005635; GO:0005654; GO:0005768; GO:0005794; GO:0006629; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nuclear envelope; nucleoplasm; endosome; Golgi apparatus; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_06405,FUN_029079-T1,Peve_00012859,Pocillopora_meandrina_HIv1___RNAseq.g25850.t1,three_way,44.321333333333335,,,,,,,,,,,,,,,,,
OG_06406,FUN_029080-T1,Peve_00012860,Pocillopora_meandrina_HIv1___RNAseq.g25461.t1,three_way,67.50433333333334,FUN_029080-T1,Q6IQ20,NAPEP_HUMAN,,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54),Homo sapiens (Human),54.1,344.0,7.000000000000002e-110,398.7,sp|Q6IQ20|NAPEP_HUMAN N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Homo sapiens OX=9606 GN=NAPEPLD PE=1 SV=2,GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0030868; GO:0031901; GO:0032052; GO:0035900; GO:0042622; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0098686; GO:1903999,host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; temperature homeostasis [GO:0001659],cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; smooth endoplasmic reticulum membrane [GO:0030868],bile acid binding [GO:0032052]; identical protein binding [GO:0042802]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270],GO:0003824; GO:0005635; GO:0005654; GO:0005768; GO:0005794; GO:0006629; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nuclear envelope; nucleoplasm; endosome; Golgi apparatus; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_06407,FUN_029081-T1,Peve_00012861,Pocillopora_meandrina_HIv1___RNAseq.g25460.t1,three_way,36.51533333333333,,,,,,,,,,,,,,,,,
OG_06408,FUN_029085-T1,Peve_00042925,Pocillopora_meandrina_HIv1___RNAseq.g25453.t1,three_way,37.96333333333333,,,,,,,,,,,,,,,,,
OG_06409,FUN_029091-T1,Peve_00033472,Pocillopora_meandrina_HIv1___RNAseq.g25753.t1,three_way,63.12366666666667,FUN_029091-T1,Q8R4U0,STAB2_MOUSE,,"Stabilin-2 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) [Cleaved into: Short form stabilin-2]",Mus musculus (Mouse),35.9,2141.0,2.6e-153,545.8,sp|Q8R4U0|STAB2_MOUSE Stabilin-2 OS=Mus musculus OX=10090 GN=Stab2 PE=1 SV=1,GO:0005041; GO:0005044; GO:0005509; GO:0005540; GO:0005829; GO:0006897; GO:0006898; GO:0007155; GO:0009897; GO:0030169; GO:0030214; GO:0038024; GO:0050830,cell adhesion [GO:0007155]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897]; hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],cytosol [GO:0005829]; external side of plasma membrane [GO:0009897],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044],GO:0005829; GO:0007155; GO:0016192; GO:0038024; GO:1901135,cytosol; cell adhesion; vesicle-mediated transport; cargo receptor activity; carbohydrate derivative metabolic process
OG_06410,FUN_029093-T1,Peve_00007821,Pocillopora_meandrina_HIv1___TS.g9197.t1,three_way,87.07566666666666,FUN_029093-T1,Q6GNL7,AL1L1_XENLA,,Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1),Xenopus laevis (African clawed frog),64.4,634.0,9.2e-244,844.3,sp|Q6GNL7|AL1L1_XENLA Cytosolic 10-formyltetrahydrofolate dehydrogenase OS=Xenopus laevis OX=8355 GN=aldh1l1 PE=2 SV=1,GO:0004029; GO:0005829; GO:0006730; GO:0006740; GO:0009058; GO:0009258; GO:0016155,10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730],cytosol [GO:0005829],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155],GO:0003824; GO:0005829; GO:0006091; GO:0006575; GO:0016491; GO:0055086,catalytic activity; cytosol; generation of precursor metabolites and energy; modified amino acid metabolic process; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_06411,FUN_029094-T1,Peve_00033474,Pocillopora_meandrina_HIv1___RNAseq.g25750.t1,three_way,77.252,FUN_029094-T1,Q8N468,,,,,33.0,479.0,7.7e-58,226.5,sp|Q8N468|MFD4A_HUMAN Major facilitator superfamily domain-containing protein 4A OS=Homo sapiens OX=9606 GN=MFSD4A PE=1 SV=3,,,,,,
OG_06412,FUN_029095-T1,Peve_00007830,Pocillopora_meandrina_HIv1___RNAseq.g25749.t1,three_way,83.04316666666666,FUN_029095-T1,Q6PDC8,,,,,35.7,487.0,2.5000000000000003e-67,258.1,sp|Q6PDC8|MFD4A_MOUSE Major facilitator superfamily domain-containing protein 4A OS=Mus musculus OX=10090 GN=Mfsd4a PE=2 SV=2,,,,,,
OG_06413,FUN_029096-T1,Peve_00038071,Pocillopora_meandrina_HIv1___RNAseq.g25748.t1,three_way,91.14066666666666,FUN_029096-T1,Q6PDC8,,,,,32.1,480.0,1.1999999999999998e-53,212.6,sp|Q6PDC8|MFD4A_MOUSE Major facilitator superfamily domain-containing protein 4A OS=Mus musculus OX=10090 GN=Mfsd4a PE=2 SV=2,,,,,,
OG_06414,FUN_029097-T1,Peve_00038060,Pocillopora_meandrina_HIv1___RNAseq.g25747.t1,three_way,61.98233333333333,FUN_029097-T1,P41970,ELK3_HUMAN,,ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2),Homo sapiens (Human),63.2,87.0,1.5e-23,111.3,sp|P41970|ELK3_HUMAN ETS domain-containing protein Elk-3 OS=Homo sapiens OX=9606 GN=ELK3 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060],chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0030154; GO:0042060; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; cell differentiation; wound healing; organelle; transcription regulator activity
OG_06415,FUN_029098-T1,Peve_00038059,Pocillopora_meandrina_HIv1___RNAseq.g25745.t1,three_way,75.214,FUN_029098-T1,Q9QUQ5,TRPC4_MOUSE,,Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel Trp4) (Receptor-activated cation channel TRP4),Mus musculus (Mouse),33.1,708.0,3e-95,351.3,sp|Q9QUQ5|TRPC4_MOUSE Short transient receptor potential channel 4 OS=Mus musculus OX=10090 GN=Trpc4 PE=1 SV=1,GO:0005886; GO:0005901; GO:0005911; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0032991; GO:0034704; GO:0045121; GO:0045296; GO:0048709; GO:0070509; GO:0070679,calcium ion import [GO:0070509]; gamma-aminobutyric acid secretion [GO:0014051]; oligodendrocyte differentiation [GO:0048709],basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],"beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0005215; GO:0005856; GO:0005886; GO:0030154; GO:0043226,transporter activity; cytoskeleton; plasma membrane; cell differentiation; organelle
OG_06416,FUN_029099-T1,Peve_00038062,Pocillopora_meandrina_HIv1___RNAseq.g25485.t1,three_way,55.33266666666667,FUN_029099-T1,P20105,E74EA_DROME,,Ecdysone-induced protein 74EF isoform A (ETS-related protein E74A),Drosophila melanogaster (Fruit fly),52.4,105.0,3.5e-21,103.6,sp|P20105|E74EA_DROME Ecdysone-induced protein 74EF isoform A OS=Drosophila melanogaster OX=7227 GN=Eip74EF PE=2 SV=2,GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0006914; GO:0030154; GO:0040034; GO:0043565; GO:0045944; GO:0048102; GO:0048477,"autophagic cell death [GO:0048102]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development, heterochronic [GO:0040034]; regulation of transcription by RNA polymerase II [GO:0006357]",nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0006914; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; autophagy; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06417,FUN_029104-T1,Peve_00038072,Pocillopora_meandrina_HIv1___TS.g8929.t1,three_way,65.834,FUN_029104-T1,P41970,ELK3_HUMAN,,ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2),Homo sapiens (Human),60.0,85.0,1.5000000000000002e-22,107.8,sp|P41970|ELK3_HUMAN ETS domain-containing protein Elk-3 OS=Homo sapiens OX=9606 GN=ELK3 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060],chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0030154; GO:0042060; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; cell differentiation; wound healing; organelle; transcription regulator activity
OG_06418,FUN_029105-T1,Peve_00029018,Pocillopora_meandrina_HIv1___RNAseq.g25494.t1,three_way,84.80216666666666,FUN_029105-T1,Q6GP04,,,,,50.3,1768.0,0.0,1569.7,sp|Q6GP04|MON2_XENLA Protein MON2 homolog OS=Xenopus laevis OX=8355 GN=mon2 PE=2 SV=1,,,,,,
OG_06419,FUN_029107-T1,Peve_00017657,Pocillopora_meandrina_HIv1___RNAseq.g25464.t1,three_way,96.55666666666669,FUN_029107-T1,Q5E987,,,,,80.9,241.0,2.4e-109,396.4,sp|Q5E987|PSA5_BOVIN Proteasome subunit alpha type-5 OS=Bos taurus OX=9913 GN=PSMA5 PE=1 SV=1,,,,,,
OG_06420,FUN_029108-T1,Peve_00017655,Pocillopora_meandrina_HIv1___RNAseq.g25465.t1,three_way,91.391,FUN_029108-T1,Q3SZ71,MPPB_BOVIN,,Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP),Bos taurus (Bovine),69.1,469.0,1.3000000000000004e-186,654.1,sp|Q3SZ71|MPPB_BOVIN Mitochondrial-processing peptidase subunit beta OS=Bos taurus OX=9913 GN=PMPCB PE=2 SV=1,GO:0004222; GO:0005739; GO:0005759; GO:0006627; GO:0046872,protein processing involved in protein targeting to mitochondrion [GO:0006627],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_06421,FUN_029110-T1,Peve_00004670,Pocillopora_meandrina_HIv1___RNAseq.g25754.t1,three_way,87.27333333333334,FUN_029110-T1,Q99LW6,,,,,52.4,143.0,9.8e-29,127.9,sp|Q99LW6|YAF2_MOUSE YY1-associated factor 2 OS=Mus musculus OX=10090 GN=Yaf2 PE=1 SV=1,,,,,,
OG_06422,FUN_029111-T1,Peve_00004671,Pocillopora_meandrina_HIv1___TS.g9201.t1,three_way,50.54466666666666,FUN_029111-T1,Q9NS91,RAD18_HUMAN,,E3 ubiquitin-protein ligase RAD18 (EC 2.3.2.27) (Postreplication repair protein RAD18) (hHR18) (hRAD18) (RING finger protein 73) (RING-type E3 ubiquitin transferase RAD18),Homo sapiens (Human),32.9,523.0,3.7e-56,221.1,sp|Q9NS91|RAD18_HUMAN E3 ubiquitin-protein ligase RAD18 OS=Homo sapiens OX=9606 GN=RAD18 PE=1 SV=2,GO:0000403; GO:0003684; GO:0003697; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0006301; GO:0006513; GO:0006974; GO:0008270; GO:0016604; GO:0031593; GO:0031625; GO:0035861; GO:0042405; GO:0042802; GO:0044877; GO:0051865; GO:0051984; GO:0061630; GO:0097505,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; positive regulation of chromosome segregation [GO:0051984]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad6-Rad18 complex [GO:0097505]; replication fork [GO:0005657]; site of double-strand break [GO:0035861],damaged DNA binding [GO:0003684]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein-containing complex binding [GO:0044877]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; Y-form DNA binding [GO:0000403]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0016740; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06423,FUN_029112-T1,Peve_00013128,Pocillopora_meandrina_HIv1___RNAseq.g25756.t1,three_way,93.785,FUN_029112-T1,O60830,TI17B_HUMAN,,Mitochondrial import inner membrane translocase subunit Tim17-B,Homo sapiens (Human),66.5,167.0,3.3e-55,216.1,sp|O60830|TI17B_HUMAN Mitochondrial import inner membrane translocase subunit Tim17-B OS=Homo sapiens OX=9606 GN=TIMM17B PE=1 SV=1,GO:0005739; GO:0005743; GO:0005744; GO:0006626; GO:0006886; GO:0008320; GO:0030150,intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; protein targeting to mitochondrion [GO:0006626],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744],protein transmembrane transporter activity [GO:0008320],GO:0005215; GO:0005739; GO:0006886; GO:0043226; GO:0055085,transporter activity; mitochondrion; intracellular protein transport; organelle; transmembrane transport
OG_06424,FUN_029113-T1,Peve_00013129,Pocillopora_meandrina_HIv1___RNAseq.g25757.t1,three_way,79.15533333333333,FUN_029113-T1,A7RK30,,,,,66.5,364.0,2.7e-136,486.5,sp|A7RK30|QORL2_NEMVE Quinone oxidoreductase-like protein 2 homolog OS=Nematostella vectensis OX=45351 GN=v1g238856 PE=3 SV=1,,,,,,
OG_06425,FUN_029114-T1,Peve_00013130,Pocillopora_meandrina_HIv1___RNAseq.g25758.t1,three_way,83.05566666666667,FUN_029114-T1,P18294,,,,,61.8,1211.0,0.0,1511.1,"sp|P18294|KCRF_STRPU Creatine kinase, flagellar OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1",,,,,,
OG_06426,FUN_029115-T1,Peve_00013132,Pocillopora_meandrina_HIv1___RNAseq.g25772.t1,three_way,35.194,,,,,,,,,,,,,,,,,
OG_06427,FUN_029117-T1,Peve_00013133,Pocillopora_meandrina_HIv1___RNAseq.g25773.t1,three_way,89.271,FUN_029117-T1,Q6NYH1,IF122_DANRE,,Intraflagellar transport protein 122 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),70.9,1191.0,0.0,1824.3,sp|Q6NYH1|IF122_DANRE Intraflagellar transport protein 122 homolog OS=Danio rerio OX=7955 GN=ift122 PE=2 SV=1,GO:0001823; GO:0005737; GO:0005929; GO:0007507; GO:0008589; GO:0008594; GO:0030991; GO:0032402; GO:0035721; GO:0036064; GO:0036372; GO:0042073; GO:0045494; GO:0045879; GO:0048593; GO:0060271; GO:0061512; GO:0097730; GO:1905515,camera-type eye morphogenesis [GO:0048593]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; melanosome transport [GO:0032402]; mesonephros development [GO:0001823]; negative regulation of smoothened signaling pathway [GO:0045879]; non-motile cilium assembly [GO:1905515]; opsin transport [GO:0036372]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; regulation of smoothened signaling pathway [GO:0008589],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730],,GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_06428,FUN_029119-T1,Peve_00024538,Pocillopora_meandrina_HIv1___RNAseq.g25774.t1,three_way,82.585,FUN_029119-T1,C4R7Z3,C9MT_KOMPG,,Sphingolipid C9-methyltransferase (C-9-MT) (EC 2.1.1.317),Komagataella phaffii (strain GS115 / ATCC 20864) (Yeast) (Pichia pastoris),54.4,377.0,3.3e-115,416.8,sp|C4R7Z3|C9MT_KOMPG Sphingolipid C9-methyltransferase OS=Komagataella phaffii (strain GS115 / ATCC 20864) OX=644223 GN=PAS_chr4_0465 PE=1 SV=1,GO:0006665; GO:0008168; GO:0016020; GO:0032259,methylation [GO:0032259]; sphingolipid metabolic process [GO:0006665],membrane [GO:0016020],methyltransferase activity [GO:0008168],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_06429,FUN_029122-T1,Peve_00016285,Pocillopora_meandrina_HIv1___RNAseq.g25777.t1,three_way,63.29733333333333,FUN_029122-T1,C5FP68,,,,,30.2,202.0,2.1e-24,116.3,sp|C5FP68|SCONB_ARTOC Probable E3 ubiquitin ligase complex SCF subunit sconB OS=Arthroderma otae (strain ATCC MYA-4605 / CBS 113480) OX=554155 GN=sconB PE=3 SV=1,,,,,,
OG_06430,FUN_029123-T1,Peve_00016284,Pocillopora_meandrina_HIv1___RNAseq.g25776.t1,three_way,95.471,FUN_029123-T1,P62833,RAP1A_BOVIN,,Ras-related protein Rap-1A (EC 3.6.5.2) (GTP-binding protein smg p21A),Bos taurus (Bovine),89.1,184.0,7.299999999999999e-90,331.3,sp|P62833|RAP1A_BOVIN Ras-related protein Rap-1A OS=Bos taurus OX=9913 GN=RAP1A PE=1 SV=1,GO:0003924; GO:0003925; GO:0005085; GO:0005525; GO:0005737; GO:0005769; GO:0005770; GO:0005886; GO:0007399; GO:0010976; GO:0016079; GO:0019003; GO:0030054; GO:0031267; GO:0032045; GO:0032486; GO:0038180; GO:0043005; GO:0043547; GO:0044877; GO:0045860; GO:0048471; GO:0061028; GO:0070161; GO:0070374; GO:0071320; GO:0072659; GO:0097225; GO:0098696; GO:0098793; GO:0098978; GO:1901888; GO:1990090; GO:2000301; GO:2001214,cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of endothelial barrier [GO:0061028]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vasculogenesis [GO:2001214]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; synaptic vesicle exocytosis [GO:0016079],anchoring junction [GO:0070161]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; late endosome [GO:0005770]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; sperm midpiece [GO:0097225],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex binding [GO:0044877]; small GTPase binding [GO:0031267],GO:0003824; GO:0003924; GO:0005768; GO:0005886; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0072659; GO:0098772,catalytic activity; GTPase activity; endosome; plasma membrane; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; protein localization to plasma membrane; molecular function regulator activity
OG_06431,FUN_029125-T1,Peve_00024870,Pocillopora_meandrina_HIv1___RNAseq.g25775.t1,three_way,64.52616666666667,FUN_029125-T1,A4IHD2,,,,,50.8,846.0,7.7e-237,822.4,sp|A4IHD2|ARIP4_XENTR Helicase ARIP4 OS=Xenopus tropicalis OX=8364 GN=rad54l2 PE=2 SV=1,,,,,,
OG_06432,FUN_029126-T1,Peve_00004666,Pocillopora_meandrina_HIv1___RNAseq.g25778.t1,three_way,79.85533333333333,FUN_029126-T1,Q67ER4,R113A_BOVIN,,E3 ubiquitin-protein ligase RNF113A (EC 2.3.2.27) (RING finger protein 113A) (Zinc finger protein 183),Bos taurus (Bovine),54.4,318.0,1.6e-92,340.9,sp|Q67ER4|R113A_BOVIN E3 ubiquitin-protein ligase RNF113A OS=Bos taurus OX=9913 GN=RNF113A PE=2 SV=1,GO:0000398; GO:0005634; GO:0005684; GO:0006281; GO:0008270; GO:0016567; GO:0016607; GO:0034247; GO:0061630; GO:0070100; GO:0071005,"DNA repair [GO:0006281]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247]",nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006281; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA repair; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06433,FUN_029127-T1,Peve_00004665,Pocillopora_meandrina_HIv1___RNAseq.g25779.t1,three_way,50.135333333333335,,,,,,,,,,,,,,,,,
OG_06434,FUN_029128-T1,Peve_00004674,Pocillopora_meandrina_HIv1___RNAseq.g25780.t1,three_way,76.54333333333334,FUN_029128-T1,I6V1W0,,,,,40.1,409.0,1.2e-79,298.9,sp|I6V1W0|BMBL_DANRE Protein brambleberry OS=Danio rerio OX=7955 GN=bmb PE=2 SV=1,,,,,,
OG_06435,FUN_029129-T1,Peve_00004668,Pocillopora_meandrina_HIv1___TS.g9227.t1,three_way,79.41,,,,,,,,,,,,,,,,,
OG_06436,FUN_029130-T1,Peve_00033155,Pocillopora_meandrina_HIv1___RNAseq.g25785.t1,three_way,48.33016666666666,,,,,,,,,,,,,,,,,
OG_06437,FUN_029132-T1,Peve_00042112,Pocillopora_meandrina_HIv1___RNAseq.g25787.t1,three_way,41.67366666666667,,,,,,,,,,,,,,,,,
OG_06438,FUN_029139-T1,Peve_00041022,Pocillopora_meandrina_HIv1___TS.g9187.t2,three_way,76.01066666666667,FUN_029139-T1,Q9H1D0,TRPV6_HUMAN,,Transient receptor potential cation channel subfamily V member 6 (TrpV6) (CaT-like) (CaT-L) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2),Homo sapiens (Human),27.6,566.0,5.5e-48,194.1,sp|Q9H1D0|TRPV6_HUMAN Transient receptor potential cation channel subfamily V member 6 OS=Homo sapiens OX=9606 GN=TRPV6 PE=1 SV=3,GO:0005262; GO:0005516; GO:0005886; GO:0006816; GO:0017158; GO:0034704; GO:0035898; GO:0042802; GO:0046872; GO:0051592; GO:0055074; GO:0070588; GO:0098703,calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; regulation of calcium ion-dependent exocytosis [GO:0017158]; response to calcium ion [GO:0051592],calcium channel complex [GO:0034704]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06439,FUN_029142-T1,Peve_00029530,Pocillopora_meandrina_HIv1___RNAseq.g27965.t1,three_way,74.99333333333334,FUN_029142-T1,Q8K4Z4,,,,,25.3,324.0,7e-19,97.1,sp|Q8K4Z4|ADRB2_CAVPO Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1,,,,,,
OG_06440,FUN_029144-T1,Peve_00000512,Pocillopora_meandrina_HIv1___RNAseq.g25729.t1,three_way,75.978,FUN_029144-T1,Q14BN4,,,,,59.9,289.0,1.6e-89,332.4,sp|Q14BN4|SLMAP_HUMAN Sarcolemmal membrane-associated protein OS=Homo sapiens OX=9606 GN=SLMAP PE=1 SV=1,,,,,,
OG_06441,FUN_029145-T1,Peve_00000511,Pocillopora_meandrina_HIv1___RNAseq.g25730.t1,three_way,65.79666666666667,,,,,,,,,,,,,,,,,
OG_06442,FUN_029149-T1,Peve_00000508,Pocillopora_meandrina_HIv1___RNAseq.g25732.t1,three_way,83.18866666666666,FUN_029149-T1,Q62717,,,,,54.3,1182.0,0.0,1248.0,sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1,,,,,,
OG_06443,FUN_029154-T1,Peve_00041026,Pocillopora_meandrina_HIv1___RNAseq.g25735.t1,three_way,90.00566666666667,FUN_029154-T1,Q86XH1,,,,,57.3,820.0,1.7000000000000002e-218,760.8,sp|Q86XH1|DRC11_HUMAN Dynein regulatory complex protein 11 OS=Homo sapiens OX=9606 GN=IQCA1 PE=1 SV=1,,,,,,
OG_06444,FUN_029155-T1,Peve_00041031,Pocillopora_meandrina_HIv1___RNAseq.g25739.t1,three_way,86.88166666666667,FUN_029155-T1,A8Y5T1,,,,,42.2,161.0,3.5e-27,122.9,sp|A8Y5T1|CF276_DANRE Protein CFAP276 OS=Danio rerio OX=7955 GN=cfap276 PE=3 SV=1,,,,,,
OG_06445,FUN_029156-T1,Peve_00041032,Pocillopora_meandrina_HIv1___RNAseq.g25738.t1,three_way,72.0625,FUN_029156-T1,Q6DEZ2,,,,,32.0,977.0,4.3e-129,464.2,sp|Q6DEZ2|F120A_XENTR Constitutive coactivator of PPAR-gamma-like protein 1 homolog OS=Xenopus tropicalis OX=8364 GN=fam120a PE=2 SV=1,,,,,,
OG_06446,FUN_029165-T1,Peve_00003759,Pocillopora_meandrina_HIv1___RNAseq.g25482.t1,three_way,60.49966666666667,FUN_029165-T1,Q91035,SHH_CHICK,,Sonic hedgehog protein (SHH) (EC 3.1.-.-) (Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains) (ShhNC) [Cleaved into: Sonic hedgehog protein N-product (ShhN) (Shh N-terminal processed signaling domains) (ShhNp)],Gallus gallus (Chicken),43.2,410.0,3e-83,310.5,sp|Q91035|SHH_CHICK Sonic hedgehog protein OS=Gallus gallus OX=9031 GN=SHH PE=1 SV=1,GO:0000139; GO:0001708; GO:0001709; GO:0001895; GO:0003406; GO:0003408; GO:0003430; GO:0005113; GO:0005509; GO:0005576; GO:0005615; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0008270; GO:0009880; GO:0009888; GO:0009949; GO:0009951; GO:0009952; GO:0010468; GO:0010628; GO:0016015; GO:0016539; GO:0016540; GO:0021508; GO:0021513; GO:0021631; GO:0023052; GO:0030326; GO:0030514; GO:0032526; GO:0042733; GO:0043066; GO:0045880; GO:0048709; GO:0048877; GO:0060059; GO:0060573; GO:0060591; GO:0060785; GO:0060786; GO:0061075; GO:0071679; GO:0090269; GO:0097190; GO:0097264; GO:0140853; GO:2000177,anterior/posterior pattern specification [GO:0009952]; apoptotic signaling pathway [GO:0097190]; cell fate determination [GO:0001709]; cell fate specification [GO:0001708]; cell fate specification involved in pattern specification [GO:0060573]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; commissural neuron axon guidance [GO:0071679]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; fibroblast growth factor production [GO:0090269]; floor plate formation [GO:0021508]; growth plate cartilage chondrocyte growth [GO:0003430]; homeostasis of number of retina cells [GO:0048877]; intein-mediated protein splicing [GO:0016539]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; oligodendrocyte differentiation [GO:0048709]; optic cup formation involved in camera-type eye development [GO:0003408]; optic nerve morphogenesis [GO:0021631]; polarity specification of anterior/posterior axis [GO:0009949]; polarity specification of dorsal/ventral axis [GO:0009951]; positive regulation of gene expression [GO:0010628]; positive regulation of neural retina development [GO:0061075]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of cell differentiation involved in tissue homeostasis [GO:0060786]; regulation of gene expression [GO:0010468]; regulation of neural precursor cell proliferation [GO:2000177]; response to retinoic acid [GO:0032526]; retina homeostasis [GO:0001895]; retinal pigment epithelium development [GO:0003406]; self proteolysis [GO:0097264]; signaling [GO:0023052]; smoothened signaling pathway [GO:0007224]; spinal cord dorsal/ventral patterning [GO:0021513]; tissue development [GO:0009888],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; extracellular region; extracellular space; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; hydrolase activity; signaling; cell differentiation; organelle; receptor ligand activity; anatomical structure development; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06447,FUN_029166-T1,Peve_00027805,Pocillopora_meandrina_HIv1___RNAseq.g25481.t1,three_way,75.72866666666667,FUN_029166-T1,P50395,GDIB_HUMAN,,Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2),Homo sapiens (Human),62.2,442.0,6.8e-166,585.1,sp|P50395|GDIB_HUMAN Rab GDP dissociation inhibitor beta OS=Homo sapiens OX=9606 GN=GDI2 PE=1 SV=2,GO:0003723; GO:0005093; GO:0005096; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0007165; GO:0007264; GO:0015031; GO:0016020; GO:0016192; GO:0031267; GO:0031982; GO:0034774; GO:0035578; GO:0045202; GO:0070062; GO:1902018; GO:1903565,negative regulation of cilium assembly [GO:1902018]; negative regulation of protein localization to cilium [GO:1903565]; protein transport [GO:0015031]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; vesicle-mediated transport [GO:0016192],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0003723; GO:0005576; GO:0005794; GO:0005829; GO:0016192; GO:0043226; GO:0098772,RNA binding; extracellular region; Golgi apparatus; cytosol; vesicle-mediated transport; organelle; molecular function regulator activity
OG_06448,FUN_029167-T1,Peve_00000513,Pocillopora_meandrina_HIv1___RNAseq.g25650.t1,three_way,55.28533333333333,,,,,,,,,,,,,,,,,
OG_06449,FUN_029169-T1,Peve_00042458,Pocillopora_meandrina_HIv1___RNAseq.g25480.t1,three_way,80.11266666666667,FUN_029169-T1,Q5RA02,,,,,50.7,515.0,3.8e-144,513.1,sp|Q5RA02|XPOT_PONAB Exportin-T OS=Pongo abelii OX=9601 GN=XPOT PE=2 SV=1,,,,,,
OG_06450,FUN_029170-T1,Peve_00042457,Pocillopora_meandrina_HIv1___RNAseq.g25479.t1,three_way,70.12,FUN_029170-T1,P40580,,,,,26.6,229.0,3.1e-06,54.3,sp|P40580|BZRD_YEAST Benzil reductase ((S)-benzoin forming) IRC24 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=IRC24 PE=1 SV=1,,,,,,
OG_06451,FUN_029171-T1,Peve_00042456,Pocillopora_meandrina_HIv1___RNAseq.g25478.t1,three_way,65.962,FUN_029171-T1,Q9UHD2,TBK1_HUMAN,,Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1),Homo sapiens (Human),42.0,628.0,2.1e-125,451.4,sp|Q9UHD2|TBK1_HUMAN Serine/threonine-protein kinase TBK1 OS=Homo sapiens OX=9606 GN=TBK1 PE=1 SV=1,GO:0002218; GO:0002753; GO:0003676; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0006954; GO:0007249; GO:0009615; GO:0010508; GO:0010629; GO:0016236; GO:0016239; GO:0018105; GO:0018107; GO:0019903; GO:0032479; GO:0032481; GO:0032727; GO:0032728; GO:0034142; GO:0042802; GO:0043123; GO:0043231; GO:0044565; GO:0045087; GO:0045944; GO:0050830; GO:0051219; GO:0051607; GO:0060337; GO:0060340; GO:0061470; GO:0061629; GO:0106310; GO:0140374; GO:0140896; GO:1902554; GO:1904262; GO:1904263; GO:1904417; GO:1904515,activation of innate immune response [GO:0002218]; antiviral innate immune response [GO:0140374]; canonical NF-kappaB signal transduction [GO:0007249]; cGAS/STING signaling pathway [GO:0140896]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; dendritic cell proliferation [GO:0044565]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macroautophagy [GO:0016236]; negative regulation of gene expression [GO:0010629]; negative regulation of TORC1 signaling [GO:1904262]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of type I interferon production [GO:0032479]; response to virus [GO:0009615]; T follicular helper cell differentiation [GO:0061470]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; serine/threonine protein kinase complex [GO:1902554],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein phosphatase binding [GO:0019903]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0002376; GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0006914; GO:0006954; GO:0016740; GO:0030154; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; autophagy; inflammatory response; transferase activity; cell differentiation; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_06452,FUN_029173-T1,Peve_00015170,Pocillopora_meandrina_HIv1___RNAseq.g25496.t1,three_way,85.54066666666667,FUN_029173-T1,Q3T003,,,,,65.9,176.0,1.4e-69,263.8,sp|Q3T003|RL18A_BOVIN Large ribosomal subunit protein eL20 OS=Bos taurus OX=9913 GN=RPL18A PE=1 SV=1,,,,,,
OG_06453,FUN_029174-T1,Peve_00015171,Pocillopora_meandrina_HIv1___TS.g8934.t1,three_way,64.79366666666667,FUN_029174-T1,Q62277,SYPH_MOUSE,,Synaptophysin (BM89 antigen) (Major synaptic vesicle protein p38),Mus musculus (Mouse),30.8,240.0,2.2000000000000004e-28,127.5,sp|Q62277|SYPH_MOUSE Synaptophysin OS=Mus musculus OX=10090 GN=Syp PE=1 SV=2,GO:0006897; GO:0007268; GO:0008021; GO:0010807; GO:0015485; GO:0016020; GO:0017075; GO:0030672; GO:0031594; GO:0042169; GO:0042734; GO:0042802; GO:0043005; GO:0043195; GO:0044306; GO:0045202; GO:0048169; GO:0048172; GO:0048471; GO:0048786; GO:0050804; GO:0060076; GO:0060203; GO:0098685; GO:0098793; GO:2000474,chemical synaptic transmission [GO:0007268]; endocytosis [GO:0006897]; modulation of chemical synaptic transmission [GO:0050804]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of opioid receptor signaling pathway [GO:2000474]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle priming [GO:0010807],clathrin-sculpted glutamate transport vesicle membrane [GO:0060203]; excitatory synapse [GO:0060076]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195],cholesterol binding [GO:0015485]; identical protein binding [GO:0042802]; SH2 domain binding [GO:0042169]; syntaxin-1 binding [GO:0017075],GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226,lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle
OG_06454,FUN_029175-T1,Peve_00015172,Pocillopora_meandrina_HIv1___RNAseq.g25499.t1,three_way,65.24666666666667,FUN_029175-T1,B2GUB3,TTLL3_XENTR,,Tubulin tyrosine ligase 3 (EC 6.3.2.-) (Tubulin--tyrosine ligase protein 3),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),49.2,659.0,3.6e-156,554.3,sp|B2GUB3|TTLL3_XENTR Tubulin tyrosine ligase 3 OS=Xenopus tropicalis OX=8364 GN=ttll3 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005874; GO:0018094; GO:0031514; GO:0046872; GO:0070736,protein polyglycylation [GO:0018094],cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glycine ligase activity, initiating [GO:0070736]",GO:0003824; GO:0005929; GO:0016874; GO:0043226; GO:0140096,"catalytic activity; cilium; ligase activity; organelle; catalytic activity, acting on a protein"
OG_06455,FUN_029177-T1,Peve_00031203,Pocillopora_meandrina_HIv1___TS.g8937.t1,three_way,73.50366666666666,FUN_029177-T1,Q9DC53,,,,,63.0,519.0,6.399999999999999e-190,665.2,sp|Q9DC53|CPNE8_MOUSE Copine-8 OS=Mus musculus OX=10090 GN=Cpne8 PE=2 SV=3,,,,,,
OG_06456,FUN_029185-T1,Peve_00031209,Pocillopora_meandrina_HIv1___RNAseq.g25504.t1,three_way,67.281,FUN_029185-T1,Q96LD8,SENP8_HUMAN,,"Sentrin-specific protease 8 (EC 3.4.22.-) (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8)",Homo sapiens (Human),49.5,212.0,4.5e-51,202.6,sp|Q96LD8|SENP8_HUMAN Sentrin-specific protease 8 OS=Homo sapiens OX=9606 GN=SENP8 PE=1 SV=1,GO:0000338; GO:0005829; GO:0006508; GO:0008234; GO:0016579; GO:0019784; GO:0043687,post-translational protein modification [GO:0043687]; protein deneddylation [GO:0000338]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cytosol [GO:0005829],cysteine-type peptidase activity [GO:0008234]; deNEDDylase activity [GO:0019784],GO:0003824; GO:0005829; GO:0016787; GO:0140096,"catalytic activity; cytosol; hydrolase activity; catalytic activity, acting on a protein"
OG_06457,FUN_029186-T1,Peve_00031210,Pocillopora_meandrina_HIv1___RNAseq.g25503.t1,three_way,70.64266666666667,FUN_029186-T1,Q8R4I1,ATX7_MOUSE,,Ataxin-7 (Spinocerebellar ataxia type 7 protein homolog),Mus musculus (Mouse),32.3,470.0,2.7e-26,122.5,sp|Q8R4I1|ATX7_MOUSE Ataxin-7 OS=Mus musculus OX=10090 GN=Atxn7 PE=1 SV=2,GO:0000124; GO:0003682; GO:0005634; GO:0005730; GO:0005737; GO:0005856; GO:0006282; GO:0006357; GO:0006366; GO:0016363; GO:0033276; GO:0043484; GO:0043569; GO:0045893; GO:0045944; GO:0048009,insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],chromatin binding [GO:0003682],GO:0005634; GO:0005730; GO:0005856; GO:0006351; GO:0006355; GO:0043226,nucleus; nucleolus; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; organelle
OG_06458,FUN_029187-T1,Peve_00031211,Pocillopora_meandrina_HIv1___RNAseq.g25505.t1,three_way,77.81533333333333,FUN_029187-T1,Q63481,RAB7L_RAT,,Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29),Rattus norvegicus (Rat),52.6,209.0,3e-57,223.4,sp|Q63481|RAB7L_RAT Ras-related protein Rab-7L1 OS=Rattus norvegicus OX=10116 GN=Rab29 PE=1 SV=1,GO:0000139; GO:0001921; GO:0003924; GO:0005525; GO:0005654; GO:0005737; GO:0005739; GO:0005769; GO:0005773; GO:0005794; GO:0005801; GO:0005802; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0007030; GO:0007416; GO:0009617; GO:0010977; GO:0012505; GO:0019003; GO:0019894; GO:0030154; GO:0031267; GO:0031965; GO:0031982; GO:0032438; GO:0042110; GO:0042147; GO:0042470; GO:0044788; GO:0048471; GO:0050862; GO:0055037; GO:0060271; GO:0070840; GO:0072657; GO:0090316; GO:0097708; GO:1903441; GO:1905279; GO:1990748,"cell differentiation [GO:0030154]; cellular detoxification [GO:1990748]; cilium assembly [GO:0060271]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; mitochondrion organization [GO:0007005]; modulation by host of viral process [GO:0044788]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to ciliary membrane [GO:1903441]; protein localization to membrane [GO:0072657]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; response to bacterium [GO:0009617]; retrograde transport, endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]",cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; vacuole [GO:0005773]; vesicle [GO:0031982],dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; small GTPase binding [GO:0031267],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005739; GO:0005768; GO:0005773; GO:0005794; GO:0005829; GO:0005856; GO:0005886; GO:0006886; GO:0007005; GO:0008092; GO:0016192; GO:0016787; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0044782; GO:0098754,immune system process; catalytic activity; GTPase activity; nucleoplasm; mitochondrion; endosome; vacuole; Golgi apparatus; cytosol; cytoskeleton; plasma membrane; intracellular protein transport; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; cilium organization; detoxification
OG_06459,FUN_029188-T1,Peve_00031212,Pocillopora_meandrina_HIv1___RNAseq.g25507.t1,three_way,58.37133333333333,FUN_029188-T1,P70677,,,,,38.7,261.0,3.5e-43,177.2,sp|P70677|CASP3_MOUSE Caspase-3 OS=Mus musculus OX=10090 GN=Casp3 PE=1 SV=1,,,,,,
OG_06460,FUN_029191-T1,Peve_00032837,Pocillopora_meandrina_HIv1___RNAseq.g25515.t1,three_way,68.01266666666666,FUN_029191-T1,A7SNN9,,,,,60.1,341.0,1.6e-117,424.1,sp|A7SNN9|QNG1_NEMVE Queuosine 5'-phosphate N-glycosylase/hydrolase OS=Nematostella vectensis OX=45351 GN=v1g230591 PE=3 SV=1,,,,,,
OG_06461,FUN_029192-T1,Peve_00028753,Pocillopora_meandrina_HIv1___RNAseq.g25516.t1,three_way,63.91766666666667,,,,,,,,,,,,,,,,,
OG_06462,FUN_029193-T1,Peve_00032838,Pocillopora_meandrina_HIv1___RNAseq.g25517.t1,three_way,55.414,FUN_029193-T1,Q1RMZ1,SAMTR_HUMAN,,S-adenosylmethionine sensor upstream of mTORC1 (Probable methyltransferase BMT2 homolog) (EC 2.1.1.-),Homo sapiens (Human),38.7,411.0,3.7e-70,266.9,sp|Q1RMZ1|SAMTR_HUMAN S-adenosylmethionine sensor upstream of mTORC1 OS=Homo sapiens OX=9606 GN=SAMTOR PE=1 SV=1,GO:0005829; GO:0008168; GO:0032259; GO:0034198; GO:0044877; GO:0061431; GO:1903432; GO:1904047; GO:1904262; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to methionine [GO:0061431]; methylation [GO:0032259]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TORC1 signaling [GO:1904263]; regulation of TORC1 signaling [GO:1903432],cytosol [GO:0005829],methyltransferase activity [GO:0008168]; protein-containing complex binding [GO:0044877]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0005829; GO:0016740,catalytic activity; cytosol; transferase activity
OG_06463,FUN_029194-T1,Peve_00032836,Pocillopora_meandrina_HIv1___RNAseq.g25518.t1,three_way,49.035,,,,,,,,,,,,,,,,,
OG_06464,FUN_029195-T1,Peve_00025427,Pocillopora_meandrina_HIv1___RNAseq.g25521.t1,three_way,69.22866666666667,,,,,,,,,,,,,,,,,
OG_06465,FUN_029196-T1,Peve_00004309,Pocillopora_meandrina_HIv1___RNAseq.g25522.t1,three_way,39.9695,FUN_029196-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),29.6,213.0,2.1e-13,79.3,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_06466,FUN_029197-T1,Peve_00004308,Pocillopora_meandrina_HIv1___RNAseq.g25524.t1,three_way,73.50966666666666,FUN_029197-T1,P0AGF8,,,,,30.2,235.0,9.5e-21,102.1,sp|P0AGF8|TDCB_ECO57 L-threonine dehydratase catabolic TdcB OS=Escherichia coli O157:H7 OX=83334 GN=tdcB PE=3 SV=1,,,,,,
OG_06467,FUN_029198-T1,Peve_00004307,Pocillopora_meandrina_HIv1___RNAseq.g25525.t1,three_way,50.453833333333336,,,,,,,,,,,,,,,,,
OG_06468,FUN_029199-T1,Peve_00004306,Pocillopora_meandrina_HIv1___RNAseq.g25526.t1,three_way,87.316,FUN_029199-T1,P55735,SEC13_HUMAN,,Protein SEC13 homolog (GATOR2 complex protein SEC13) (SEC13-like protein 1) (SEC13-related protein),Homo sapiens (Human),76.3,308.0,1.4e-98,360.9,sp|P55735|SEC13_HUMAN Protein SEC13 homolog OS=Homo sapiens OX=9606 GN=SEC13 PE=1 SV=3,GO:0005198; GO:0005635; GO:0005643; GO:0005654; GO:0005765; GO:0005789; GO:0005829; GO:0006606; GO:0006886; GO:0006913; GO:0012507; GO:0030127; GO:0031080; GO:0031669; GO:0032008; GO:0032527; GO:0042802; GO:0043231; GO:0051028; GO:0061700; GO:0070062; GO:0090110; GO:0090114; GO:1904262; GO:1904263,cellular response to nutrient levels [GO:0031669]; COPII-coated vesicle budding [GO:0090114]; COPII-coated vesicle cargo loading [GO:0090110]; intracellular protein transport [GO:0006886]; mRNA transport [GO:0051028]; negative regulation of TORC1 signaling [GO:1904262]; nucleocytoplasmic transport [GO:0006913]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein import into nucleus [GO:0006606],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654],identical protein binding [GO:0042802]; structural molecule activity [GO:0005198],GO:0005198; GO:0005635; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0061024,structural molecule activity; nuclear envelope; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; membrane organization
OG_06469,FUN_029208-T1,Peve_00013633,Pocillopora_meandrina_HIv1___RNAseq.g25538.t1,three_way,48.8415,,,,,,,,,,,,,,,,,
OG_06470,FUN_029211-T1,Peve_00024515,Pocillopora_meandrina_HIv1___RNAseq.g25545.t1,three_way,61.35433333333333,,,,,,,,,,,,,,,,,
OG_06471,FUN_029230-T1,Peve_00045062,Pocillopora_meandrina_HIv1___RNAseq.g25548.t1,three_way,60.20133333333334,FUN_029230-T1,Q5QD14,TAAR5_MOUSE,,Trace amine-associated receptor 5 (TaR-5) (Trace amine receptor 5) (mTaar5) (Trimethylamine receptor),Mus musculus (Mouse),28.8,285.0,9.9e-13,75.9,sp|Q5QD14|TAAR5_MOUSE Trace amine-associated receptor 5 OS=Mus musculus OX=10090 GN=Taar5 PE=1 SV=1,GO:0001594; GO:0005886; GO:0007166; GO:0007189; GO:0007606; GO:0007617; GO:0035176; GO:0050890; GO:1990081,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cognition [GO:0050890]; mating behavior [GO:0007617]; sensory perception of chemical stimulus [GO:0007606]; social behavior [GO:0035176],plasma membrane [GO:0005886],trace-amine receptor activity [GO:0001594]; trimethylamine receptor activity [GO:1990081],GO:0005886; GO:0022414; GO:0050877; GO:0060089,plasma membrane; reproductive process; nervous system process; molecular transducer activity
OG_06472,FUN_029234-T1,Peve_00045061,Pocillopora_meandrina_HIv1___RNAseq.g25553.t1,three_way,64.42733333333334,FUN_029234-T1,O15427,MOT4_HUMAN,,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),Homo sapiens (Human),27.4,398.0,5.9999999999999996e-40,166.8,sp|O15427|MOT4_HUMAN Monocarboxylate transporter 4 OS=Homo sapiens OX=9606 GN=SLC16A3 PE=1 SV=1,GO:0003723; GO:0005886; GO:0008028; GO:0015650; GO:0015718; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0031965; GO:0035873; GO:0035879; GO:0042867; GO:0050833; GO:1901475,lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate catabolic process [GO:0042867]; pyruvate transmembrane transport [GO:1901475],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],lactate:proton symporter activity [GO:0015650]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; pyruvate transmembrane transporter activity [GO:0050833]; RNA binding [GO:0003723],GO:0003723; GO:0005215; GO:0005886; GO:0055085,RNA binding; transporter activity; plasma membrane; transmembrane transport
OG_06473,FUN_029239-T1,Peve_00013754,Pocillopora_meandrina_HIv1___RNAseq.g25411.t1,three_way,73.07666666666667,FUN_029239-T1,Q5R9S8,,,,,37.6,226.0,8.300000000000001e-38,158.7,sp|Q5R9S8|TMM43_PONAB Transmembrane protein 43 OS=Pongo abelii OX=9601 GN=TMEM43 PE=2 SV=1,,,,,,
OG_06474,FUN_029241-T1,Peve_00013753,Pocillopora_meandrina_HIv1___RNAseq.g25410.t1,three_way,73.27116666666666,FUN_029241-T1,Q9D8P7,,,,,39.5,119.0,5.8e-17,88.6,sp|Q9D8P7|TF3C6_MOUSE General transcription factor 3C polypeptide 6 OS=Mus musculus OX=10090 GN=Gtf3c6 PE=2 SV=1,,,,,,
OG_06475,FUN_029242-T1,Peve_00013752,Pocillopora_meandrina_HIv1___RNAseq.g25409.t1,three_way,68.66733333333333,,,,,,,,,,,,,,,,,
OG_06476,FUN_029243-T1,Peve_00013751,Pocillopora_meandrina_HIv1___TS.g8847.t1a,three_way,61.89633333333333,,,,,,,,,,,,,,,,,
OG_06477,FUN_029244-T1,Peve_00013750,Pocillopora_meandrina_HIv1___TS.g8847.t1b,three_way,82.03566666666667,FUN_029244-T1,A2RUV5,,,,,60.9,727.0,4.4e-259,896.0,sp|A2RUV5|HFM1_XENTR Probable ATP-dependent DNA helicase HFM1 OS=Xenopus tropicalis OX=8364 GN=hfm1 PE=2 SV=1,,,,,,
OG_06478,FUN_029246-T1,Peve_00013747,Pocillopora_meandrina_HIv1___RNAseq.g25404.t1,three_way,78.42166666666667,FUN_029246-T1,Q9Y2I9,TBC30_HUMAN,,TBC1 domain family member 30,Homo sapiens (Human),49.0,569.0,8.899999999999999e-139,496.1,sp|Q9Y2I9|TBC30_HUMAN TBC1 domain family member 30 OS=Homo sapiens OX=9606 GN=TBC1D30 PE=1 SV=2,GO:0005096; GO:0005829; GO:0005886; GO:0005929; GO:0016604; GO:0031267; GO:0036064; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; nuclear body [GO:0016604]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; plasma membrane; cilium; organelle; molecular function regulator activity
OG_06479,FUN_029247-T1,Peve_00013745,Pocillopora_meandrina_HIv1___TS.g9395.t1,three_way,61.76716666666667,FUN_029247-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),37.3,496.0,4.5e-84,314.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_06480,FUN_029250-T1,Peve_00024382,Pocillopora_meandrina_HIv1___TS.g9401.t1,three_way,59.02816666666666,FUN_029250-T1,Q8IZF6,AGRG4_HUMAN,,"Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112) [Cleaved into: Adhesion G-protein coupled receptor G4, N-terminal fragment (ADGRG4 N-terminal fragment); Adhesion G-protein coupled receptor G4, C-terminal fragment (ADGRG4 C-terminal fragment)]",Homo sapiens (Human),26.0,665.0,5.0999999999999985e-55,218.4,sp|Q8IZF6|AGRG4_HUMAN Adhesion G-protein coupled receptor G4 OS=Homo sapiens OX=9606 GN=ADGRG4 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0016020,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_06481,FUN_029252-T1,Peve_00024381,Pocillopora_meandrina_HIv1___RNAseq.g15018.t1,three_way,65.63983333333334,FUN_029252-T1,Q3UGP8,,,,,44.5,465.0,1.6999999999999998e-92,341.3,"sp|Q3UGP8|AG10B_MOUSE Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase OS=Mus musculus OX=10090 GN=Alg10b PE=1 SV=1",,,,,,
OG_06482,FUN_029254-T1,Peve_00024374,Pocillopora_meandrina_HIv1___RNAseq.g15019.t1,three_way,65.14966666666666,,,,,,,,,,,,,,,,,
OG_06483,FUN_029255-T1,Peve_00024372,Pocillopora_meandrina_HIv1___RNAseq.g15020.t1,three_way,52.675,,,,,,,,,,,,,,,,,
OG_06484,FUN_029258-T1,Peve_00024383,Pocillopora_meandrina_HIv1___RNAseq.g15028.t1,three_way,87.08666666666666,FUN_029258-T1,A7RX34,,,,,68.6,207.0,3.3e-71,269.6,sp|A7RX34|THOC7_NEMVE THO complex subunit 7 homolog OS=Nematostella vectensis OX=45351 GN=thoc7 PE=3 SV=1,,,,,,
OG_06485,FUN_029259-T1,Peve_00024365,Pocillopora_meandrina_HIv1___RNAseq.g15031.t1b,three_way,71.01783333333333,FUN_029259-T1,Q6DN90,IQEC1_HUMAN,,IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2),Homo sapiens (Human),42.1,447.0,1.1e-74,283.1,sp|Q6DN90|IQEC1_HUMAN IQ motif and SEC7 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IQSEC1 PE=1 SV=1,GO:0005085; GO:0005654; GO:0005813; GO:0005829; GO:0008021; GO:0008289; GO:0014069; GO:0016020; GO:0030036; GO:0032012; GO:0043231; GO:0051549; GO:0060996; GO:0120183,actin cytoskeleton organization [GO:0030036]; dendritic spine development [GO:0060996]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of keratinocyte migration [GO:0051549]; regulation of ARF protein signal transduction [GO:0032012],centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085]; lipid binding [GO:0008289],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_06486,FUN_029260-T1,Peve_00024369,Pocillopora_meandrina_HIv1___RNAseq.g15032.t1,three_way,74.517,FUN_029260-T1,Q13905,,,,,47.8,335.0,2.1000000000000002e-73,279.3,sp|Q13905|RPGF1_HUMAN Rap guanine nucleotide exchange factor 1 OS=Homo sapiens OX=9606 GN=RAPGEF1 PE=1 SV=3,,,,,,
OG_06487,FUN_029261-T1,Peve_00024370,Pocillopora_meandrina_HIv1___RNAseq.g15021.t1,three_way,68.45433333333334,FUN_029261-T1,F1QZ15,,,,,40.9,164.0,3.1e-32,139.8,sp|F1QZ15|TPRKB_DANRE EKC/KEOPS complex subunit TPRKB OS=Danio rerio OX=7955 GN=tprkb PE=2 SV=1,,,,,,
OG_06488,FUN_029262-T1,Peve_00030746,Pocillopora_meandrina_HIv1___RNAseq.g15033.t1,three_way,67.793,FUN_029262-T1,Q9Y222,DMTF1_HUMAN,,Cyclin-D-binding Myb-like transcription factor 1 (hDMTF1) (Cyclin-D-interacting Myb-like protein 1) (hDMP1),Homo sapiens (Human),40.9,599.0,2e-107,391.7,sp|Q9Y222|DMTF1_HUMAN Cyclin-D-binding Myb-like transcription factor 1 OS=Homo sapiens OX=9606 GN=DMTF1 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006357,regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_06489,FUN_029264-T1,Peve_00030745,Pocillopora_meandrina_HIv1___RNAseq.g15034.t1,three_way,71.40766666666667,,,,,,,,,,,,,,,,,
OG_06490,FUN_029267-T1,Peve_00030744,Pocillopora_meandrina_HIv1___RNAseq.g15043.t2,three_way,58.678333333333335,,,,,,,,,,,,,,,,,
OG_06491,FUN_029269-T1,Peve_00002504,Pocillopora_meandrina_HIv1___RNAseq.g25417.t1,three_way,91.27916666666668,FUN_029269-T1,P08110,,,,,69.4,779.0,1.7e-282,973.4,sp|P08110|ENPL_CHICK Endoplasmin OS=Gallus gallus OX=9031 GN=HSP90B1 PE=1 SV=1,,,,,,
OG_06492,FUN_029270-T2,Peve_00002499,Pocillopora_meandrina_HIv1___RNAseq.g25416.t1,three_way,76.03433333333332,FUN_029270-T2,Q5XH36,,,,,47.4,308.0,2.5e-70,267.7,sp|Q5XH36|CRE2A_XENLA Cysteine-rich with EGF-like domain protein 2-A OS=Xenopus laevis OX=8355 GN=creld2-a PE=2 SV=1,,,,,,
OG_06493,FUN_029273-T1,Peve_00030749,Pocillopora_meandrina_HIv1___RNAseq.g25414.t1,three_way,44.414,,,,,,,,,,,,,,,,,
OG_06494,FUN_029275-T1,Peve_00030743,Pocillopora_meandrina_HIv1___RNAseq.g15044.t1,three_way,76.801,FUN_029275-T1,Q9SLX0,,,,,29.3,188.0,5.7e-16,86.7,sp|Q9SLX0|IMA1B_ORYSJ Importin subunit alpha-1b OS=Oryza sativa subsp. japonica OX=39947 GN=Os05g0155601 PE=1 SV=2,,,,,,
OG_06495,FUN_029276-T1,Peve_00030742,Pocillopora_meandrina_HIv1___RNAseq.g15045.t1,three_way,92.86866666666668,FUN_029276-T1,Q28I85,,,,,74.1,54.0,4.6e-16,87.4,sp|Q28I85|POC1A_XENTR POC1 centriolar protein homolog A OS=Xenopus tropicalis OX=8364 GN=poc1a PE=2 SV=1,,,,,,
OG_06496,FUN_029277-T1,Peve_00030739,Pocillopora_meandrina_HIv1___RNAseq.g25413.t1,three_way,84.80083333333334,FUN_029277-T1,Q16829,DUS7_HUMAN,,Dual specificity protein phosphatase 7 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST2),Homo sapiens (Human),44.7,358.0,9e-73,275.4,sp|Q16829|DUS7_HUMAN Dual specificity protein phosphatase 7 OS=Homo sapiens OX=9606 GN=DUSP7 PE=1 SV=4,GO:0000165; GO:0004722; GO:0004725; GO:0005654; GO:0005737; GO:0005829; GO:0007165; GO:0008138; GO:0008330; GO:0017017; GO:0033550; GO:0035335; GO:0043407; GO:0070371; GO:0070373,ERK1 and ERK2 cascade [GO:0070371]; MAPK cascade [GO:0000165]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of MAP kinase activity [GO:0043407]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],MAP kinase tyrosine phosphatase activity [GO:0033550]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; catalytic activity, acting on a protein"
OG_06497,FUN_029286-T1,Peve_00018583,Pocillopora_meandrina_HIv1___RNAseq.g16621.t1,three_way,73.06333333333333,,,,,,,,,,,,,,,,,
OG_06498,FUN_029288-T1,Peve_00036556,Pocillopora_meandrina_HIv1___RNAseq.g11161.t1,three_way,72.14083333333333,FUN_029288-T1,A8EZG1,,,,,38.9,478.0,1.0000000000000001e-82,308.9,sp|A8EZG1|MUTS_RICCK DNA mismatch repair protein MutS OS=Rickettsia canadensis (strain McKiel) OX=293613 GN=mutS PE=3 SV=1,,,,,,
OG_06499,FUN_029290-T1,Peve_00036558,Pocillopora_meandrina_HIv1___RNAseq.g11162.t1,three_way,72.6425,FUN_029290-T1,O95602,RPA1_HUMAN,,DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194),Homo sapiens (Human),50.1,1092.0,2e-264,913.7,sp|O95602|RPA1_HUMAN DNA-directed RNA polymerase I subunit RPA1 OS=Homo sapiens OX=9606 GN=POLR1A PE=1 SV=2,GO:0000287; GO:0000785; GO:0003677; GO:0003682; GO:0003899; GO:0005654; GO:0005694; GO:0005736; GO:0005739; GO:0006360; GO:0008270; GO:0071667; GO:1904750,negative regulation of protein localization to nucleolus [GO:1904750]; transcription by RNA polymerase I [GO:0006360],chromatin [GO:0000785]; chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005694; GO:0005739; GO:0006351; GO:0016740; GO:0043226; GO:0140098,"DNA binding; catalytic activity; nucleoplasm; chromosome; mitochondrion; DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on RNA"
OG_06500,FUN_029291-T1,Peve_00036559,Pocillopora_meandrina_HIv1___RNAseq.g11686.t1,three_way,61.11266666666666,FUN_029291-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),44.3,300.0,2.1e-68,263.1,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_06501,FUN_029295-T1,Peve_00040802,Pocillopora_meandrina_HIv1___TS.g18469.t1,three_way,60.07966666666667,FUN_029295-T1,A2VDD2,,,,,35.9,184.0,6.6e-20,99.0,sp|A2VDD2|DYL5B_XENLA Dynein light chain Tctex-type 5-B (Fragment) OS=Xenopus laevis OX=8355 GN=Dynlt5-b PE=2 SV=1,,,,,,
OG_06502,FUN_029296-T1,Peve_00040801,Pocillopora_meandrina_HIv1___RNAseq.g12593.t1,three_way,55.744,FUN_029296-T1,Q8TE60,,,,,30.5,1022.0,6.6e-110,401.0,sp|Q8TE60|ATS18_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Homo sapiens OX=9606 GN=ADAMTS18 PE=1 SV=3,,,,,,
OG_06503,FUN_029297-T1,Peve_00040797,Pocillopora_meandrina_HIv1___RNAseq.g12591.t1,three_way,79.32433333333333,FUN_029297-T1,Q8BMN4,,,,,44.2,602.0,5.3e-151,536.2,sp|Q8BMN4|LMLN_MOUSE Leishmanolysin-like peptidase OS=Mus musculus OX=10090 GN=Lmln PE=2 SV=1,,,,,,
OG_06504,FUN_029298-T1,Peve_00040798,Pocillopora_meandrina_HIv1___TS.g18465.t1,three_way,65.23166666666667,,,,,,,,,,,,,,,,,
OG_06505,FUN_029299-T1,Peve_00040810,Pocillopora_meandrina_HIv1___RNAseq.g12587.t1,three_way,89.47666666666666,FUN_029299-T1,Q90511,,,,,60.5,357.0,3.9e-116,419.5,sp|Q90511|EI2BB_TAKRU Translation initiation factor eIF2B subunit beta OS=Takifugu rubripes OX=31033 GN=eif2b2 PE=3 SV=1,,,,,,
OG_06506,FUN_029300-T2,Peve_00040809,Pocillopora_meandrina_HIv1___RNAseq.g12586.t1,three_way,47.71066666666667,FUN_029300-T2,Q3SZD5,,,,,32.8,244.0,4.5e-29,131.3,sp|Q3SZD5|DCA15_BOVIN DDB1- and CUL4-associated factor 15 OS=Bos taurus OX=9913 GN=DCAF15 PE=2 SV=1,,,,,,
OG_06507,FUN_029301-T1,Peve_00040808,Pocillopora_meandrina_HIv1___RNAseq.g12585.t1,three_way,51.386,FUN_029301-T1,Q01974,ROR2_HUMAN,,"Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)",Homo sapiens (Human),27.3,264.0,1.5e-16,90.5,sp|Q01974|ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens OX=9606 GN=ROR2 PE=1 SV=2,GO:0004714; GO:0005524; GO:0005886; GO:0007165; GO:0007169; GO:0015026; GO:0016055; GO:0017147; GO:0030335; GO:0030424; GO:0030669; GO:0031435; GO:0043235; GO:0046872,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; positive regulation of cell migration [GO:0030335]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; clathrin-coated endocytic vesicle membrane [GO:0030669]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; metal ion binding [GO:0046872]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0016740; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; transferase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_06508,FUN_029305-T1,Peve_00040807,Pocillopora_meandrina_HIv1___RNAseq.g12584.t1,three_way,70.46983333333334,FUN_029305-T1,P51049,,,,,27.9,315.0,5.7e-28,126.7,sp|P51049|MR1BB_DANRE Melatonin receptor type 1B-B OS=Danio rerio OX=7955 GN=mtnr1bb PE=2 SV=2,,,,,,
OG_06509,FUN_029306-T2,Peve_00040799,Pocillopora_meandrina_HIv1___RNAseq.g12583.t1,three_way,74.93816666666666,FUN_029306-T2,O55164,MPDZ_RAT,,Multiple PDZ domain protein (Multi-PDZ domain protein 1),Rattus norvegicus (Rat),35.8,2259.0,2.8e-304,1047.0,sp|O55164|MPDZ_RAT Multiple PDZ domain protein OS=Rattus norvegicus OX=10116 GN=Mpdz PE=1 SV=1,GO:0005737; GO:0005886; GO:0005923; GO:0006886; GO:0007155; GO:0012505; GO:0014069; GO:0016324; GO:0016327; GO:0016358; GO:0030425; GO:0031410; GO:0035003; GO:0035556; GO:0042552; GO:0043220; GO:0045177; GO:0045202; GO:0098978; GO:0120192,cell adhesion [GO:0007155]; dendrite development [GO:0016358]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; myelination [GO:0042552]; tight junction assembly [GO:0120192],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schmidt-Lanterman incisure [GO:0043220]; subapical complex [GO:0035003]; synapse [GO:0045202],,GO:0005886; GO:0006886; GO:0007155; GO:0031410; GO:0034330; GO:0043226; GO:0048856,plasma membrane; intracellular protein transport; cell adhesion; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development
OG_06510,FUN_029307-T1,Peve_00035000,Pocillopora_meandrina_HIv1___RNAseq.g12580.t1,three_way,72.083,FUN_029307-T1,Q9H867,,,,,44.6,224.0,7.799999999999999e-46,185.3,sp|Q9H867|MT21D_HUMAN Protein N-lysine methyltransferase METTL21D OS=Homo sapiens OX=9606 GN=VCPKMT PE=1 SV=2,,,,,,
OG_06511,FUN_029308-T1,Peve_00038266,Pocillopora_meandrina_HIv1___RNAseq.g12581.t1,three_way,73.26783333333334,FUN_029308-T1,P14314,GLU2B_HUMAN,,Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH),Homo sapiens (Human),42.0,512.0,3.2999999999999996e-53,211.1,sp|P14314|GLU2B_HUMAN Glucosidase 2 subunit beta OS=Homo sapiens OX=9606 GN=PRKCSH PE=1 SV=2,GO:0001889; GO:0005080; GO:0005509; GO:0005783; GO:0005788; GO:0006491; GO:0017177; GO:0035556; GO:0043231; GO:0044325; GO:0051219,intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; N-glycan processing [GO:0006491],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular membrane-bounded organelle [GO:0043231],calcium ion binding [GO:0005509]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; transmembrane transporter binding [GO:0044325],GO:0005783; GO:0009101; GO:0043226; GO:0048856; GO:1901135,endoplasmic reticulum; glycoprotein biosynthetic process; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_06512,FUN_029309-T1,Peve_00038265,Pocillopora_meandrina_HIv1___RNAseq.g12582.t1,three_way,42.67516666666667,FUN_029309-T1,Q921R4,,,,,33.1,314.0,2.9999999999999998e-36,155.6,sp|Q921R4|DJC14_MOUSE DnaJ homolog subfamily C member 14 OS=Mus musculus OX=10090 GN=Dnajc14 PE=2 SV=2,,,,,,
OG_06513,FUN_029310-T1,Peve_00038264,Pocillopora_meandrina_HIv1___RNAseq.g12579.t1,three_way,89.39833333333333,FUN_029310-T1,O00139,KIF2A_HUMAN,,Kinesin-like protein KIF2A (Kinesin-2) (hK2),Homo sapiens (Human),53.7,709.0,1.3e-187,657.9,sp|O00139|KIF2A_HUMAN Kinesin-like protein KIF2A OS=Homo sapiens OX=9606 GN=KIF2A PE=1 SV=3,GO:0000226; GO:0000922; GO:0003774; GO:0003777; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0007018; GO:0007019; GO:0007052; GO:0007399; GO:0008017; GO:0016020; GO:0016604; GO:0016887; GO:0030154; GO:0030334; GO:0036064; GO:0051301; GO:0072686; GO:0090307; GO:0120103,cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule cytoskeleton organization [GO:0000226]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399]; regulation of cell migration [GO:0030334],centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle [GO:0005819]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; cytoskeletal motor activity [GO:0003774]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005654; GO:0005730; GO:0005815; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleoplasm; nucleolus; microtubule organizing center; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; cell differentiation; organelle; anatomical structure development; ATP-dependent activity
OG_06514,FUN_029313-T1,Peve_00038263,Pocillopora_meandrina_HIv1___RNAseq.g12578.t1,three_way,48.20866666666667,FUN_029313-T1,Q8R5I0,,,,,28.7,251.0,6.3e-20,99.8,sp|Q8R5I0|KCNKF_RAT Potassium channel subfamily K member 15 OS=Rattus norvegicus OX=10116 GN=Kcnk15 PE=2 SV=1,,,,,,
OG_06515,FUN_029315-T1,Peve_00038260,Pocillopora_meandrina_HIv1___RNAseq.g12576.t1,three_way,59.641666666666666,FUN_029315-T1,Q6RI86,TRPA1_RAT,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Rattus norvegicus (Rat),28.2,181.0,5e-07,57.0,sp|Q6RI86|TRPA1_RAT Transient receptor potential cation channel subfamily A member 1 OS=Rattus norvegicus OX=10116 GN=Trpa1 PE=1 SV=2,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_06516,FUN_029317-T1,Peve_00038259,Pocillopora_meandrina_HIv1___RNAseq.g12575.t1,three_way,56.52,FUN_029317-T1,Q8IY67,,,,,37.9,269.0,1.4e-40,169.9,sp|Q8IY67|RAVR1_HUMAN Ribonucleoprotein PTB-binding 1 OS=Homo sapiens OX=9606 GN=RAVER1 PE=1 SV=1,,,,,,
OG_06517,FUN_029319-T1,Peve_00038249,Pocillopora_meandrina_HIv1___RNAseq.g11687.t1,three_way,77.53966666666666,FUN_029319-T1,Q8AVP1,,,,,58.6,297.0,7.8e-97,355.1,sp|Q8AVP1|RPF1_XENLA Ribosome production factor 1 OS=Xenopus laevis OX=8355 GN=rpf1 PE=2 SV=1,,,,,,
OG_06518,FUN_029320-T1,Peve_00038248,Pocillopora_meandrina_HIv1___RNAseq.g17366.t1,three_way,41.22833333333333,,,,,,,,,,,,,,,,,
OG_06519,FUN_029326-T2,Peve_00031600,Pocillopora_meandrina_HIv1___RNAseq.g11792.t1a,three_way,80.827,FUN_029326-T2,A4Q9F0,TTLL7_MOUSE,,Tubulin polyglutamylase TTLL7 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 7) (mTTLL7),Mus musculus (Mouse),48.4,798.0,2.5e-211,736.9,sp|A4Q9F0|TTLL7_MOUSE Tubulin polyglutamylase TTLL7 OS=Mus musculus OX=10090 GN=Ttll7 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005874; GO:0007399; GO:0018095; GO:0030154; GO:0030425; GO:0036064; GO:0043014; GO:0043204; GO:0046872; GO:0048487; GO:0070740; GO:0097731; GO:0106437; GO:0106438,cell differentiation [GO:0030154]; nervous system development [GO:0007399]; protein polyglutamylation [GO:0018095],9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; microtubule [GO:0005874]; perikaryon [GO:0043204],"alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005815; GO:0005929; GO:0008092; GO:0016874; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; microtubule organizing center; cilium; cytoskeletal protein binding; ligase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06520,FUN_029330-T1,Peve_00010682,Pocillopora_meandrina_HIv1___TS.g2875.t1,three_way,40.08233333333333,FUN_029330-T1,Q9VC47,TOK_DROME,,Protein tolkin (EC 3.4.24.-) (Tolloid-related protein) (Tolloid-related protein 1),Drosophila melanogaster (Fruit fly),26.6,218.0,6.4e-11,70.1,sp|Q9VC47|TOK_DROME Protein tolkin OS=Drosophila melanogaster OX=7227 GN=tok PE=1 SV=1,GO:0004222; GO:0005509; GO:0005615; GO:0007411; GO:0007415; GO:0008045; GO:0008270; GO:0008586; GO:0009953; GO:0016485; GO:0030424; GO:0030513; GO:0032927; GO:0043204,axon guidance [GO:0007411]; defasciculation of motor neuron axon [GO:0007415]; dorsal/ventral pattern formation [GO:0009953]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; motor neuron axon guidance [GO:0008045]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of BMP signaling pathway [GO:0030513]; protein processing [GO:0016485],axon [GO:0030424]; extracellular space [GO:0005615]; perikaryon [GO:0043204],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_06521,FUN_029337-T1,Peve_00023376,Pocillopora_meandrina_HIv1___RNAseq.g17303.t1,three_way,76.86833333333334,FUN_029337-T1,Q5ZLN0,,,,,59.5,608.0,8.6e-57,223.8,sp|Q5ZLN0|LRC40_CHICK Leucine-rich repeat-containing protein 40 OS=Gallus gallus OX=9031 GN=LRRC40 PE=2 SV=1,,,,,,
OG_06522,FUN_029339-T1,Peve_00023361,Pocillopora_meandrina_HIv1___RNAseq.g17301.t1,three_way,61.434333333333335,FUN_029339-T1,Q01973,ROR1_HUMAN,,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",Homo sapiens (Human),31.6,773.0,1.1000000000000001e-118,429.1,sp|Q01973|ROR1_HUMAN Inactive tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens OX=9606 GN=ROR1 PE=1 SV=2,GO:0001725; GO:0004714; GO:0005524; GO:0005737; GO:0005886; GO:0007169; GO:0007605; GO:0008283; GO:0009986; GO:0014002; GO:0015026; GO:0017147; GO:0030424; GO:0038023; GO:0042813; GO:0043123; GO:0043235; GO:0043679; GO:0048839; GO:0051092,astrocyte development [GO:0014002]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; inner ear development [GO:0048839]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0006355; GO:0016740; GO:0048856; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; anatomical structure development; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_06523,FUN_029340-T1,Peve_00023362,Pocillopora_meandrina_HIv1___RNAseq.g17300.t2,three_way,70.36116666666666,FUN_029340-T1,Q99KY4,GAK_MOUSE,,Cyclin-G-associated kinase (EC 2.7.11.1) (DnaJ homolog subfamily C member 26),Mus musculus (Mouse),37.7,1476.0,1e-239,832.0,sp|Q99KY4|GAK_MOUSE Cyclin-G-associated kinase OS=Mus musculus OX=10090 GN=Gak PE=1 SV=2,GO:0002064; GO:0004674; GO:0005524; GO:0005794; GO:0005925; GO:0007029; GO:0007030; GO:0009913; GO:0010977; GO:0030136; GO:0030216; GO:0031982; GO:0035622; GO:0046907; GO:0048471; GO:0048853; GO:0048863; GO:0060563; GO:0061351; GO:0061436; GO:0072318; GO:0072583; GO:0106310; GO:1905443; GO:2000179,clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; epidermal cell differentiation [GO:0009913]; epithelial cell development [GO:0002064]; establishment of skin barrier [GO:0061436]; forebrain morphogenesis [GO:0048853]; Golgi organization [GO:0007030]; intracellular transport [GO:0046907]; intrahepatic bile duct development [GO:0035622]; keratinocyte differentiation [GO:0030216]; negative regulation of neuron projection development [GO:0010977]; neural precursor cell proliferation [GO:0061351]; neuroepithelial cell differentiation [GO:0060563]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of clathrin coat assembly [GO:1905443]; stem cell differentiation [GO:0048863],clathrin-coated vesicle [GO:0030136]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005794; GO:0016192; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; vesicle-mediated transport; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06524,FUN_029341-T1,Peve_00023364,Pocillopora_meandrina_HIv1___TS.g3062.t1,three_way,68.22483333333334,,,,,,,,,,,,,,,,,
OG_06525,FUN_029343-T1,Peve_00023373,Pocillopora_meandrina_HIv1___RNAseq.g17296.t1,three_way,74.304,FUN_029343-T1,Q3ZBN6,GA45A_BOVIN,,Growth arrest and DNA damage-inducible protein GADD45 alpha,Bos taurus (Bovine),38.4,112.0,6.2e-10,65.5,sp|Q3ZBN6|GA45A_BOVIN Growth arrest and DNA damage-inducible protein GADD45 alpha OS=Bos taurus OX=9913 GN=GADD45A PE=2 SV=1,GO:0000122; GO:0005634; GO:0005737; GO:0016607; GO:0019900; GO:0042770; GO:0042803; GO:0043065; GO:0043537; GO:0046330; GO:0046982; GO:0051726; GO:0071260; GO:0071479; GO:1900745; GO:2000379,cellular response to ionizing radiation [GO:0071479]; cellular response to mechanical stimulus [GO:0071260]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; regulation of cell cycle [GO:0051726]; signal transduction in response to DNA damage [GO:0042770],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_06526,FUN_029345-T1,Peve_00023375,Pocillopora_meandrina_HIv1___RNAseq.g17294.t1,three_way,65.33866666666667,FUN_029345-T1,Q6PB03,PLD3_XENLA,,5'-3' exonuclease PLD3 (EC 3.1.16.1) (Choline phosphatase 3) (Phosphatidylcholine-hydrolyzing phospholipase D3) (Phospholipase D3) (PLD 3),Xenopus laevis (African clawed frog),48.3,445.0,6.4e-117,422.5,sp|Q6PB03|PLD3_XENLA 5'-3' exonuclease PLD3 OS=Xenopus laevis OX=8355 GN=pld3 PE=2 SV=1,GO:0000139; GO:0002376; GO:0005789; GO:0006954; GO:0014902; GO:0031901; GO:0031902; GO:0043202; GO:0045145; GO:1900015,immune system process [GO:0002376]; inflammatory response [GO:0006954]; myotube differentiation [GO:0014902]; regulation of cytokine production involved in inflammatory response [GO:1900015],early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; lysosomal lumen [GO:0043202],single-stranded DNA 5'-3' DNA exonuclease activity [GO:0045145],GO:0002376; GO:0003824; GO:0006954; GO:0016787; GO:0030154; GO:0140097,"immune system process; catalytic activity; inflammatory response; hydrolase activity; cell differentiation; catalytic activity, acting on DNA"
OG_06527,FUN_029356-T1,Peve_00023383,Pocillopora_meandrina_HIv1___RNAseq.g17292.t1,three_way,73.16533333333334,FUN_029356-T1,Q15397,,,,,44.1,424.0,5.2e-92,339.7,sp|Q15397|PUM3_HUMAN Pumilio homolog 3 OS=Homo sapiens OX=9606 GN=PUM3 PE=1 SV=3,,,,,,
OG_06528,FUN_029357-T1,Peve_00023328,Pocillopora_meandrina_HIv1___RNAseq.g17291.t1,three_way,87.65433333333334,FUN_029357-T1,Q9UIJ7,KAD3_HUMAN,,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (Adenylate kinase 3 alpha-like 1) (Adenylate kinase isozyme 3)",Homo sapiens (Human),57.9,209.0,2.1e-67,256.9,"sp|Q9UIJ7|KAD3_HUMAN GTP:AMP phosphotransferase AK3, mitochondrial OS=Homo sapiens OX=9606 GN=AK3 PE=1 SV=4",GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005759; GO:0006172; GO:0007596; GO:0009142; GO:0016874; GO:0046033; GO:0046039; GO:0046041; GO:0046051; GO:0046899,ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; blood coagulation [GO:0007596]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; nucleoside triphosphate biosynthetic process [GO:0009142]; UTP metabolic process [GO:0046051],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; ligase activity [GO:0016874]; nucleoside triphosphate adenylate kinase activity [GO:0046899],GO:0003824; GO:0005739; GO:0016740; GO:0016874; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; transferase activity; ligase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_06529,FUN_029359-T1,Peve_00023331,Pocillopora_meandrina_HIv1___RNAseq.g17289.t1,three_way,79.39766666666667,FUN_029359-T1,Q802T2,,,,,53.4,489.0,4.5e-139,496.1,"sp|Q802T2|ALG6_CHICK Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Gallus gallus OX=9031 GN=ALG6 PE=2 SV=1",,,,,,
OG_06530,FUN_029360-T1,Peve_00044526,Pocillopora_meandrina_HIv1___RNAseq.g17132.t3,three_way,79.10799999999999,FUN_029360-T1,B2GV50,RFX2_RAT,,DNA-binding protein RFX2 (Regulatory factor X 2),Rattus norvegicus (Rat),57.0,604.0,1.9e-176,620.9,sp|B2GV50|RFX2_RAT DNA-binding protein RFX2 OS=Rattus norvegicus OX=10116 GN=Rfx2 PE=1 SV=1,GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0001675; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007286; GO:0045944; GO:0060271; GO:1990830; GO:1990837,acrosome assembly [GO:0001675]; cellular response to leukemia inhibitory factor [GO:1990830]; cilium assembly [GO:0060271]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; organelle; cilium organization; anatomical structure development; transcription regulator activity
OG_06531,FUN_029367-T1,Peve_00044527,Pocillopora_meandrina_HIv1___TS.g2904.t1,three_way,50.9045,,,,,,,,,,,,,,,,,
OG_06532,FUN_029392-T1,Peve_00044524,Pocillopora_meandrina_HIv1___TS.g2905.t4c,three_way,42.15233333333333,,,,,,,,,,,,,,,,,
OG_06533,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,55.2,87.0,8.5e-18,94.4,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06533,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,56.2,48.0,2e-06,56.6,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06534,FUN_029394-T1,Peve_00044522,Pocillopora_meandrina_HIv1___RNAseq.g17136.t1,three_way,79.3645,FUN_029394-T1,P12532,KCRU_HUMAN,,"Creatine kinase U-type, mitochondrial (EC 2.7.3.2) (Acidic-type mitochondrial creatine kinase) (Mia-CK) (Ubiquitous mitochondrial creatine kinase) (U-MtCK)",Homo sapiens (Human),68.9,415.0,1.7000000000000002e-158,560.5,"sp|P12532|KCRU_HUMAN Creatine kinase U-type, mitochondrial OS=Homo sapiens OX=9606 GN=CKMT1A PE=1 SV=1",GO:0004111; GO:0005524; GO:0005739; GO:0005743; GO:0046314,phosphocreatine biosynthetic process [GO:0046314],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; creatine kinase activity [GO:0004111],GO:0003824; GO:0005739; GO:0006575; GO:0016740; GO:0043226,catalytic activity; mitochondrion; modified amino acid metabolic process; transferase activity; organelle
OG_06535,FUN_029395-T2,Peve_00044521,Pocillopora_meandrina_HIv1___RNAseq.g17137.t1,three_way,87.53966666666668,FUN_029395-T2,Q9TTK8,,,,,74.2,388.0,8.3e-166,584.7,"sp|Q9TTK8|KCRU_BOVIN Creatine kinase U-type, mitochondrial OS=Bos taurus OX=9913 GN=CKMT1 PE=1 SV=1",,,,,,
OG_06536,FUN_029396-T1,Peve_00044520,Pocillopora_meandrina_HIv1___RNAseq.g17138.t1,three_way,63.98033333333333,FUN_029396-T1,Q7SZC5,,,,,32.8,673.0,7.2e-84,313.2,sp|Q7SZC5|NDC1_DANRE Nucleoporin NDC1 OS=Danio rerio OX=7955 GN=ndc1 PE=2 SV=1,,,,,,
OG_06537,FUN_029397-T1,Peve_00044519,Pocillopora_meandrina_HIv1___RNAseq.g17139.t1,three_way,75.86833333333334,FUN_029397-T1,Q5ZL00,EMC1_CHICK,,ER membrane protein complex subunit 1,Gallus gallus (Chicken),39.0,1036.0,1e-185,652.1,sp|Q5ZL00|EMC1_CHICK ER membrane protein complex subunit 1 OS=Gallus gallus OX=9031 GN=EMC1 PE=2 SV=1,GO:0005789; GO:0016020; GO:0045050; GO:0071816; GO:0072546,protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],,,
OG_06538,FUN_029400-T1,Peve_00044529,Pocillopora_meandrina_HIv1___RNAseq.g17141.t1,three_way,71.86333333333333,FUN_029400-T1,Q7T3H9,,,,,41.9,265.0,5.600000000000001e-59,229.2,sp|Q7T3H9|HYI_DANRE Putative hydroxypyruvate isomerase OS=Danio rerio OX=7955 GN=hyi PE=2 SV=2,,,,,,
OG_06539,FUN_029401-T1,Peve_00044530,Pocillopora_meandrina_HIv1___RNAseq.g17142.t1,three_way,73.958,,,,,,,,,,,,,,,,,
OG_06540,FUN_029404-T2,Peve_00044518,Pocillopora_meandrina_HIv1___RNAseq.g17143.t1,three_way,73.2395,FUN_029404-T2,Q5ZLX5,,,,,66.9,136.0,1.8e-50,200.7,sp|Q5ZLX5|ZRAB2_CHICK Zinc finger Ran-binding domain-containing protein 2 OS=Gallus gallus OX=9031 GN=ZRANB2 PE=2 SV=1,,,,,,
OG_06541,FUN_029405-T1,Peve_00035059,Pocillopora_meandrina_HIv1___RNAseq.g17144.t1,three_way,85.84700000000001,FUN_029405-T1,Q3MHG1,SPTC1_BOVIN,,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),Bos taurus (Bovine),57.5,463.0,4.2e-156,552.7,sp|Q3MHG1|SPTC1_BOVIN Serine palmitoyltransferase 1 OS=Bos taurus OX=9913 GN=SPTLC1 PE=2 SV=1,GO:0004758; GO:0005783; GO:0005789; GO:0006665; GO:0017059; GO:0030170; GO:0046512; GO:0046513; GO:1904649,ceramide biosynthetic process [GO:0046513]; regulation of fat cell apoptotic process [GO:1904649]; sphingolipid metabolic process [GO:0006665]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; serine palmitoyltransferase complex [GO:0017059],pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_06542,FUN_029410-T1,Peve_00004978,Pocillopora_meandrina_HIv1___RNAseq.g19537.t1,three_way,82.68033333333334,FUN_029410-T1,Q3T0P6,PGK1_BOVIN,,Phosphoglycerate kinase 1 (EC 2.7.11.1) (EC 2.7.2.3),Bos taurus (Bovine),69.6,411.0,1.9e-162,573.5,sp|Q3T0P6|PGK1_BOVIN Phosphoglycerate kinase 1 OS=Bos taurus OX=9913 GN=PGK1 PE=2 SV=3,GO:0004618; GO:0004674; GO:0005524; GO:0005615; GO:0005759; GO:0005829; GO:0006094; GO:0006096; GO:0016525; GO:0030855; GO:0031639; GO:0043531; GO:0044325; GO:0045121; GO:0046872; GO:0047134; GO:0061621; GO:0071456; GO:0106310; GO:0160218,canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0160218]; negative regulation of angiogenesis [GO:0016525]; plasminogen activation [GO:0031639],cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; mitochondrial matrix [GO:0005759],ADP binding [GO:0043531]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoglycerate kinase activity [GO:0004618]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-disulfide reductase [NAD(P)H] activity [GO:0047134]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005615; GO:0005829; GO:0005975; GO:0006091; GO:0016491; GO:0016740; GO:0030154; GO:0051604; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; extracellular space; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; transferase activity; cell differentiation; protein maturation; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06543,FUN_029412-T1,Peve_00028187,Pocillopora_meandrina_HIv1___TS.g2914.t1,three_way,80.83733333333333,FUN_029412-T1,Q9HBH9,,,,,65.3,242.0,6.9e-94,345.5,sp|Q9HBH9|MKNK2_HUMAN MAP kinase-interacting serine/threonine-protein kinase 2 OS=Homo sapiens OX=9606 GN=MKNK2 PE=1 SV=3,,,,,,
OG_06544,FUN_029413-T1,Peve_00028192,Pocillopora_meandrina_HIv1___RNAseq.g17146.t1,three_way,87.61466666666666,FUN_029413-T1,Q2KHZ9,GCDH_BOVIN,,"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)",Bos taurus (Bovine),74.9,398.0,2.8000000000000004e-180,632.9,"sp|Q2KHZ9|GCDH_BOVIN Glutaryl-CoA dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=GCDH PE=2 SV=1",GO:0000062; GO:0004361; GO:0005759; GO:0006568; GO:0033539; GO:0046949; GO:0050660,fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; L-tryptophan metabolic process [GO:0006568],mitochondrial matrix [GO:0005759],fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361],GO:0003824; GO:0006520; GO:0006629; GO:0006790; GO:0008289; GO:0016491; GO:0055086,catalytic activity; amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; lipid binding; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_06545,FUN_029414-T3,Peve_00018038,Pocillopora_meandrina_HIv1___RNAseq.g17125.t1,three_way,87.62133333333334,FUN_029414-T3,Q9CZU3,MTREX_MOUSE,,Exosome RNA helicase MTR4 (EC 3.6.4.13) (ATP-dependent helicase SKIV2L2) (Superkiller viralicidic activity 2-like 2) (TRAMP-like complex helicase),Mus musculus (Mouse),70.0,1040.0,0.0,1463.0,sp|Q9CZU3|MTREX_MOUSE Exosome RNA helicase MTR4 OS=Mus musculus OX=10090 GN=Mtrex PE=1 SV=1,GO:0000176; GO:0000460; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0006397; GO:0006401; GO:0006974; GO:0008380; GO:0016607; GO:0016887; GO:0031499; GO:0071013,DNA damage response [GO:0006974]; maturation of 5.8S rRNA [GO:0000460]; mRNA processing [GO:0006397]; RNA catabolic process [GO:0006401]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],catalytic step 2 spliceosome [GO:0071013]; nuclear exosome (RNase complex) [GO:0000176]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_06546,FUN_029418-T1,Peve_00018039,Pocillopora_meandrina_HIv1___RNAseq.g17183.t1,three_way,76.90733333333334,FUN_029418-T1,P05630,ATPD_BOVIN,,"ATP synthase F(1) complex subunit delta, mitochondrial (ATP synthase F1 subunit delta) (F-ATPase delta subunit)",Bos taurus (Bovine),48.2,164.0,8.999999999999999e-31,134.8,"sp|P05630|ATPD_BOVIN ATP synthase F(1) complex subunit delta, mitochondrial OS=Bos taurus OX=9913 GN=ATP5F1D PE=1 SV=2",GO:0005198; GO:0005739; GO:0005740; GO:0005743; GO:0009060; GO:0015078; GO:0015986; GO:0033615; GO:0042776; GO:0045259; GO:0046933; GO:1902600,aerobic respiration [GO:0009060]; mitochondrial proton-transporting ATP synthase complex assembly [GO:0033615]; proton motive force-driven ATP synthesis [GO:0015986]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; proton transmembrane transport [GO:1902600],mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259],"proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; structural molecule activity [GO:0005198]",GO:0003824; GO:0005198; GO:0005215; GO:0005739; GO:0006091; GO:0016874; GO:0043226; GO:0055085; GO:0055086; GO:0065003; GO:1901135,catalytic activity; structural molecule activity; transporter activity; mitochondrion; generation of precursor metabolites and energy; ligase activity; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_06547,FUN_029419-T1,Peve_00018040,Pocillopora_meandrina_HIv1___RNAseq.g17182.t1,three_way,85.85033333333334,FUN_029419-T1,Q9PTS2,,,,,57.6,356.0,1.5e-118,427.6,sp|Q9PTS2|DCUP_DANRE Uroporphyrinogen decarboxylase OS=Danio rerio OX=7955 GN=urod PE=1 SV=1,,,,,,
OG_06548,FUN_029420-T1,Peve_00005725,Pocillopora_meandrina_HIv1___RNAseq.g17181.t1,three_way,45.06466666666667,FUN_029420-T1,Q1LZF8,CLCC1_BOVIN,,Chloride channel CLIC-like protein 1 (ER anion channel 1) (ERAC1),Bos taurus (Bovine),24.9,478.0,1.2e-19,99.4,sp|Q1LZF8|CLCC1_BOVIN Chloride channel CLIC-like protein 1 OS=Bos taurus OX=9913 GN=CLCC1 PE=2 SV=1,GO:0005254; GO:0005783; GO:0005789; GO:0016020; GO:0032469; GO:0034707; GO:0044233,endoplasmic reticulum calcium ion homeostasis [GO:0032469],chloride channel complex [GO:0034707]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233],chloride channel activity [GO:0005254],GO:0005215; GO:0005783; GO:0043226,transporter activity; endoplasmic reticulum; organelle
OG_06549,FUN_029421-T1,Peve_00005727,Pocillopora_meandrina_HIv1___RNAseq.g17180.t1,three_way,63.6955,,,,,,,,,,,,,,,,,
OG_06550,FUN_029422-T1,Peve_00005721,Pocillopora_meandrina_HIv1___RNAseq.g17177.t2,three_way,42.010666666666665,,,,,,,,,,,,,,,,,
OG_06551,FUN_029423-T1,Peve_00015936,Pocillopora_meandrina_HIv1___RNAseq.g17176.t1,three_way,50.726333333333336,,,,,,,,,,,,,,,,,
OG_06552,FUN_029426-T1,Peve_00039469,Pocillopora_meandrina_HIv1___RNAseq.g17174.t1,three_way,59.09,FUN_029426-T1,Q5H8A4,PIGG_HUMAN,,"GPI ethanolamine phosphate transferase 2, catalytic subunit (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G)",Homo sapiens (Human),36.9,1045.0,9.6e-171,602.4,"sp|Q5H8A4|PIGG_HUMAN GPI ethanolamine phosphate transferase 2, catalytic subunit OS=Homo sapiens OX=9606 GN=PIGG PE=1 SV=1",GO:0005783; GO:0005789; GO:0006506; GO:0016020; GO:0016740; GO:0016780; GO:0051267,GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],"CP2 mannose-ethanolamine phosphotransferase activity [GO:0051267]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; transferase activity [GO:0016740]",GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_06553,FUN_029428-T1,Peve_00039462,Pocillopora_meandrina_HIv1___RNAseq.g17173.t1,three_way,68.539,,,,,,,,,,,,,,,,,
OG_06554,FUN_029431-T1,Peve_00039461,Pocillopora_meandrina_HIv1___RNAseq.g17172.t1,three_way,70.55433333333333,,,,,,,,,,,,,,,,,
OG_06555,FUN_029434-T1,Peve_00039460,Pocillopora_meandrina_HIv1___RNAseq.g17170.t1,three_way,82.005,FUN_029434-T1,Q2TA24,VATO_BOVIN,,V-type proton ATPase 21 kDa proteolipid subunit c'' (V-ATPase 21 kDa proteolipid subunit c'') (Vacuolar proton pump 21 kDa proteolipid subunit c''),Bos taurus (Bovine),62.9,197.0,5.8e-62,238.8,sp|Q2TA24|VATO_BOVIN V-type proton ATPase 21 kDa proteolipid subunit c'' OS=Bos taurus OX=9913 GN=ATP6V0B PE=1 SV=1,GO:0000220; GO:0005768; GO:0016020; GO:0030665; GO:0045851; GO:0046961; GO:1902600,pH reduction [GO:0045851]; proton transmembrane transport [GO:1902600],"clathrin-coated vesicle membrane [GO:0030665]; endosome [GO:0005768]; membrane [GO:0016020]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0005768; GO:0031410; GO:0043226; GO:0055085; GO:0140657,transporter activity; endosome; cytoplasmic vesicle; organelle; transmembrane transport; ATP-dependent activity
OG_06556,FUN_029438-T1,Peve_00028188,Pocillopora_meandrina_HIv1___RNAseq.g17152.t1,three_way,76.8055,FUN_029438-T1,Q8IZF0,NALCN_HUMAN,,Sodium leak channel NALCN (CanIon) (Sodium leak channel non-selective protein) (Voltage gated channel-like protein 1),Homo sapiens (Human),41.8,1604.0,0.0,1137.9,sp|Q8IZF0|NALCN_HUMAN Sodium leak channel NALCN OS=Homo sapiens OX=9606 GN=NALCN PE=1 SV=1,GO:0005248; GO:0005261; GO:0005272; GO:0005886; GO:0022840; GO:0032224; GO:0032230; GO:0034220; GO:0034702; GO:0035725; GO:0060075; GO:0070588; GO:0071805,"calcium ion transmembrane transport [GO:0070588]; monoatomic ion transmembrane transport [GO:0034220]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; potassium ion transmembrane transport [GO:0071805]; regulation of resting membrane potential [GO:0060075]; sodium ion transmembrane transport [GO:0035725]",monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],leak channel activity [GO:0022840]; monoatomic cation channel activity [GO:0005261]; sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06557,FUN_029439-T1,Peve_00028189,Pocillopora_meandrina_HIv1___RNAseq.g17153.t1,three_way,82.17283333333333,FUN_029439-T1,Q91X83,,,,,67.5,381.0,1.1e-154,547.7,sp|Q91X83|METK1_MOUSE S-adenosylmethionine synthase isoform type-1 OS=Mus musculus OX=10090 GN=Mat1a PE=1 SV=1,,,,,,
OG_06558,FUN_029440-T1,Peve_00028190,Pocillopora_meandrina_HIv1___RNAseq.g17154.t1,three_way,63.96833333333333,FUN_029440-T1,Q8TDY2,,,,,32.0,596.0,2.7e-76,288.9,sp|Q8TDY2|RBCC1_HUMAN RB1-inducible coiled-coil protein 1 OS=Homo sapiens OX=9606 GN=RB1CC1 PE=1 SV=3,,,,,,
OG_06559,FUN_029442-T1,Peve_00028191,Pocillopora_meandrina_HIv1___RNAseq.g17155.t1,three_way,58.567,FUN_029442-T1,Q2KIL7,,,,,33.9,236.0,1.5000000000000002e-22,108.2,sp|Q2KIL7|R3HD4_BOVIN R3H domain-containing protein 4 OS=Bos taurus OX=9913 GN=R3HDM4 PE=2 SV=1,,,,,,
OG_06560,FUN_029443-T1,Peve_00034541,Pocillopora_meandrina_HIv1___RNAseq.g17168.t1,three_way,63.576,FUN_029443-T1,Q92179,,,,,26.6,331.0,1.7e-20,102.1,sp|Q92179|CHST3_CHICK Carbohydrate sulfotransferase 3 OS=Gallus gallus OX=9031 GN=CHST3 PE=1 SV=1,,,,,,
OG_06561,FUN_029445-T1,Peve_00025077,Pocillopora_meandrina_HIv1___RNAseq.g17165.t1,three_way,60.66566666666667,FUN_029445-T1,Q6IQH6,,,,,34.5,232.0,2.4e-29,131.0,sp|Q6IQH6|PLPR1_DANRE Phospholipid phosphatase-related protein type 1 OS=Danio rerio OX=7955 GN=plppr1 PE=2 SV=1,,,,,,
OG_06562,FUN_029451-T1,Peve_00018719,Pocillopora_meandrina_HIv1___RNAseq.g17159.t1,three_way,61.97333333333333,FUN_029451-T1,Q61469,,,,,38.3,256.0,1.1e-40,168.7,sp|Q61469|PLPP1_MOUSE Phospholipid phosphatase 1 OS=Mus musculus OX=10090 GN=Plpp1 PE=1 SV=1,,,,,,
OG_06563,FUN_029452-T1,Peve_00021753,Pocillopora_meandrina_HIv1___RNAseq.g17158.t1,three_way,67.24433333333333,,,,,,,,,,,,,,,,,
OG_06564,FUN_029453-T1,Peve_00021752,Pocillopora_meandrina_HIv1___RNAseq.g17157.t1,three_way,84.16833333333334,FUN_029453-T1,Q9UBC2,EP15R_HUMAN,,Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R),Homo sapiens (Human),53.5,409.0,2.3999999999999998e-105,384.8,sp|Q9UBC2|EP15R_HUMAN Epidermal growth factor receptor substrate 15-like 1 OS=Homo sapiens OX=9606 GN=EPS15L1 PE=1 SV=1,GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006897; GO:0016020; GO:0016197; GO:0030132; GO:0045296; GO:0048488; GO:0098793,endocytosis [GO:0006897]; endosomal transport [GO:0016197]; synaptic vesicle endocytosis [GO:0048488],clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509],GO:0005634; GO:0005829; GO:0005886; GO:0016192; GO:0043226,nucleus; cytosol; plasma membrane; vesicle-mediated transport; organelle
OG_06565,FUN_029472-T1,Peve_00017121,Pocillopora_meandrina_HIv1___RNAseq.g17126.t1,three_way,60.79366666666667,FUN_029472-T1,Q92179,,,,,24.9,354.0,2.8e-17,91.3,sp|Q92179|CHST3_CHICK Carbohydrate sulfotransferase 3 OS=Gallus gallus OX=9031 GN=CHST3 PE=1 SV=1,,,,,,
OG_06566,FUN_029473-T1,Peve_00028195,Pocillopora_meandrina_HIv1___RNAseq.g17147.t1,three_way,66.37633333333333,FUN_029473-T1,Q8IWX8,CHERP_HUMAN,,Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6),Homo sapiens (Human),43.1,933.0,6.6e-63,243.8,sp|Q8IWX8|CHERP_HUMAN Calcium homeostasis endoplasmic reticulum protein OS=Homo sapiens OX=9606 GN=CHERP PE=1 SV=3,GO:0003723; GO:0005654; GO:0005737; GO:0006396; GO:0006874; GO:0007399; GO:0008285; GO:0016020; GO:0033017; GO:0044325; GO:0048471; GO:0051209; GO:0070886,intracellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396],cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017],RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325],GO:0003723; GO:0005654; GO:0048856; GO:0055085,RNA binding; nucleoplasm; anatomical structure development; transmembrane transport
OG_06567,FUN_029474-T1,Peve_00028201,Pocillopora_meandrina_HIv1___RNAseq.g17148.t1,three_way,64.5595,,,,,,,,,,,,,,,,,
OG_06568,FUN_029475-T1,Peve_00028203,Pocillopora_meandrina_HIv1___RNAseq.g17149.t1,three_way,80.37583333333333,FUN_029475-T1,Q5F3F5,,,,,45.8,690.0,1.3e-158,561.6,sp|Q5F3F5|LMBD2_CHICK G-protein coupled receptor-associated protein LMBRD2 OS=Gallus gallus OX=9031 GN=LMBRD2 PE=2 SV=1,,,,,,
OG_06569,FUN_029476-T1,Peve_00028204,Pocillopora_meandrina_HIv1___RNAseq.g17150.t1,three_way,62.744166666666665,,,,,,,,,,,,,,,,,
OG_06570,FUN_029479-T1,Peve_00017246,Pocillopora_meandrina_HIv1___RNAseq.g17127.t1,three_way,56.412333333333336,FUN_029479-T1,O88199,,,,,24.6,338.0,1.5e-19,98.6,sp|O88199|CHST3_MOUSE Carbohydrate sulfotransferase 3 OS=Mus musculus OX=10090 GN=Chst3 PE=1 SV=1,,,,,,
OG_06571,FUN_029484-T1,Peve_00017245,Pocillopora_meandrina_HIv1___RNAseq.g17128.t1,three_way,64.353,FUN_029484-T1,Q8NEA6,GLIS3_HUMAN,,Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515),Homo sapiens (Human),64.3,70.0,4.8e-23,110.9,sp|Q8NEA6|GLIS3_HUMAN Zinc finger protein GLIS3 OS=Homo sapiens OX=9606 GN=GLIS3 PE=1 SV=5,GO:0000122; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0006357; GO:0006366; GO:0008270; GO:0045944,negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_06572,FUN_029487-T1,Peve_00017244,Pocillopora_meandrina_HIv1___RNAseq.g17129.t1,three_way,53.333666666666666,FUN_029487-T1,Q0V9Y8,,,,,32.0,331.0,1.5e-32,142.1,sp|Q0V9Y8|LRC42_XENTR Leucine-rich repeat-containing protein 42 OS=Xenopus tropicalis OX=8364 GN=lrrc42 PE=2 SV=2,,,,,,
OG_06573,FUN_029518-T1,Peve_00008555,Pocillopora_meandrina_HIv1___RNAseq.g17117.t1,three_way,79.40516666666666,FUN_029518-T1,Q00438,,,,,47.7,558.0,2.7e-132,473.8,sp|Q00438|PTBP1_RAT Polypyrimidine tract-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Ptbp1 PE=1 SV=2,,,,,,
OG_06574,FUN_029519-T1,Peve_00022876,Pocillopora_meandrina_HIv1___TS.g2888.t1,three_way,93.70616666666666,FUN_029519-T1,Q9JHU4,DYHC1_MOUSE,,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",Mus musculus (Mouse),73.3,4665.0,0.0,6825.7,sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2,GO:0003341; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0008569; GO:0016887; GO:0030175; GO:0030286; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1905832,cell division [GO:0051301]; cilium movement [GO:0003341]; establishment of spindle localization [GO:0051293]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; filopodium [GO:0030175]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0016787; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; hydrolase activity; isomerase activity; ATP-dependent activity
OG_06575,FUN_029520-T1,Peve_00028644,Pocillopora_meandrina_HIv1___RNAseq.g17115.t1,three_way,95.12166666666668,FUN_029520-T1,Q8MQI6,,,,,74.4,82.0,6.9e-32,137.5,sp|Q8MQI6|ELOF1_DROME Transcription elongation factor 1 homolog OS=Drosophila melanogaster OX=7227 GN=CG40228 PE=3 SV=1,,,,,,
OG_06576,FUN_029521-T2,Peve_00028580,Pocillopora_meandrina_HIv1___RNAseq.g17111.t1,three_way,61.62799999999999,FUN_029521-T2,P0DN10,,,,,63.5,52.0,2.7e-14,83.6,sp|P0DN10|VKT6_ANEVI U-actitoxin-Avd3i OS=Anemonia viridis OX=51769 PE=3 SV=1,,,,,,
OG_06577,FUN_029524-T1,Peve_00010676,Pocillopora_meandrina_HIv1___RNAseq.g17110.t1,three_way,64.472,,,,,,,,,,,,,,,,,
OG_06578,FUN_029525-T1,Peve_00010677,Pocillopora_meandrina_HIv1___RNAseq.g17107.t1,three_way,53.90266666666667,FUN_029525-T1,A8Y5U1,,,,,35.4,285.0,9.9e-41,168.7,sp|A8Y5U1|RIMC1_DANRE RAB7A-interacting MON1-CCZ1 complex subunit 1 OS=Danio rerio OX=7955 GN=rimoc1 PE=2 SV=1,,,,,,
OG_06579,FUN_029536-T1,Peve_00023332,Pocillopora_meandrina_HIv1___RNAseq.g17287.t1,three_way,88.79033333333334,,,,,,,,,,,,,,,,,
OG_06580,FUN_029537-T1,Peve_00023333,Pocillopora_meandrina_HIv1___RNAseq.g17286.t1,three_way,66.61766666666666,FUN_029537-T1,Q4R4T9,,,,,37.9,311.0,5.8e-36,153.7,sp|Q4R4T9|RANB3_MACFA Ran-binding protein 3 OS=Macaca fascicularis OX=9541 GN=RANBP3 PE=2 SV=1,,,,,,
OG_06581,FUN_029538-T1,Peve_00012818,Pocillopora_meandrina_HIv1___RNAseq.g2589.t1,three_way,73.36083333333333,,,,,,,,,,,,,,,,,
OG_06582,FUN_029550-T1,Peve_00023351,Pocillopora_meandrina_HIv1___RNAseq.g17268.t1,three_way,83.60266666666666,FUN_029550-T1,O62742,,,,,65.4,540.0,9.5e-207,721.1,sp|O62742|SCP2_RABIT Sterol carrier protein 2 OS=Oryctolagus cuniculus OX=9986 GN=SCP2 PE=1 SV=1,,,,,,
OG_06583,FUN_029554-T1,Peve_00023354,Pocillopora_meandrina_HIv1___RNAseq.g17263.t1,three_way,73.25566666666667,FUN_029554-T1,Q6NRK1,ADIPA_XENLA,,Afadin- and alpha-actinin-binding protein A (ADIP-A) (Afadin DIL domain-interacting protein A) (SSX2-interacting protein A) (XSSX2IP),Xenopus laevis (African clawed frog),33.5,424.0,5.9e-51,203.8,sp|Q6NRK1|ADIPA_XENLA Afadin- and alpha-actinin-binding protein A OS=Xenopus laevis OX=8355 GN=ssx2ip-a PE=1 SV=1,GO:0005737; GO:0005874; GO:0005912; GO:0007098; GO:0007155; GO:0034451; GO:0035735; GO:0036064; GO:0051011,cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; intraciliary transport involved in cilium assembly [GO:0035735],adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874],microtubule minus-end binding [GO:0051011],GO:0005815; GO:0007018; GO:0007155; GO:0008092,microtubule organizing center; microtubule-based movement; cell adhesion; cytoskeletal protein binding
OG_06584,FUN_029556-T1,Peve_00023360,Pocillopora_meandrina_HIv1___TS.g3028.t1,three_way,49.354,,,,,,,,,,,,,,,,,
OG_06585,FUN_029557-T1,Peve_00044890,Pocillopora_meandrina_HIv1___RNAseq.g17260.t1,three_way,94.77716666666667,FUN_029557-T1,Q8BFY9,,,,,75.1,897.0,0.0,1327.4,sp|Q8BFY9|TNPO1_MOUSE Transportin-1 OS=Mus musculus OX=10090 GN=Tnpo1 PE=1 SV=2,,,,,,
OG_06586,FUN_029567-T1,Peve_00018825,Pocillopora_meandrina_HIv1___RNAseq.g17258.t1,three_way,57.566,FUN_029567-T1,P58307,,,,,28.8,340.0,2.2000000000000004e-28,128.6,sp|P58307|OX1R_MOUSE Orexin/Hypocretin receptor type 1 OS=Mus musculus OX=10090 GN=Hcrtr1 PE=2 SV=3,,,,,,
OG_06587,FUN_029568-T1,Peve_00037904,Pocillopora_meandrina_HIv1___RNAseq.g17257.t1,three_way,76.67266666666667,,,,,,,,,,,,,,,,,
OG_06588,FUN_029570-T1,Peve_00018824,Pocillopora_meandrina_HIv1___RNAseq.g17256.t1,three_way,51.34166666666667,,,,,,,,,,,,,,,,,
OG_06589,FUN_029571-T1,Peve_00018823,Pocillopora_meandrina_HIv1___RNAseq.g17253.t1b,three_way,42.12166666666667,,,,,,,,,,,,,,,,,
OG_06590,FUN_029616-T1,Peve_00037897,Pocillopora_meandrina_HIv1___RNAseq.28516_t,three_way,77.36733333333333,FUN_029616-T1,D4ACN8,,,,,47.0,134.0,1.9e-26,120.2,sp|D4ACN8|PLRKT_RAT Plasminogen receptor (KT) OS=Rattus norvegicus OX=10116 GN=Plgrkt PE=1 SV=1,,,,,,
OG_06591,FUN_029639-T1,Peve_00037896,Pocillopora_meandrina_HIv1___RNAseq.g17203.t2,three_way,75.95783333333334,FUN_029639-T1,Q3SZZ0,,,,,63.1,249.0,3.3e-95,349.7,sp|Q3SZZ0|BRX1_BOVIN Ribosome biogenesis protein BRX1 homolog OS=Bos taurus OX=9913 GN=BRIX1 PE=2 SV=1,,,,,,
OG_06592,FUN_029640-T1,Peve_00037895,Pocillopora_meandrina_HIv1___RNAseq.g17204.t1,three_way,61.37616666666666,FUN_029640-T1,A2ARV4,LRP2_MOUSE,,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),Mus musculus (Mouse),38.1,428.0,4.3e-50,201.4,sp|A2ARV4|LRP2_MOUSE Low-density lipoprotein receptor-related protein 2 OS=Mus musculus OX=10090 GN=Lrp2 PE=1 SV=1,GO:0001822; GO:0001843; GO:0003139; GO:0003148; GO:0003151; GO:0003223; GO:0003281; GO:0005509; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005903; GO:0005905; GO:0006898; GO:0007507; GO:0007605; GO:0008283; GO:0008584; GO:0009897; GO:0010467; GO:0015031; GO:0016020; GO:0016324; GO:0017124; GO:0030001; GO:0030139; GO:0030424; GO:0030425; GO:0030514; GO:0030900; GO:0031526; GO:0031904; GO:0034311; GO:0035904; GO:0042359; GO:0043066; GO:0043235; GO:0043491; GO:0044321; GO:0045177; GO:0050769; GO:0051087; GO:0060068; GO:0060976; GO:0060982; GO:0061156; GO:0070447; GO:0140058; GO:1904447; GO:1904888,aorta development [GO:0035904]; cell population proliferation [GO:0008283]; coronary artery morphogenesis [GO:0060982]; coronary vasculature development [GO:0060976]; cranial skeletal system development [GO:1904888]; diol metabolic process [GO:0034311]; folate import across plasma membrane [GO:1904447]; forebrain development [GO:0030900]; gene expression [GO:0010467]; heart development [GO:0007507]; kidney development [GO:0001822]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; protein transport [GO:0015031]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to leptin [GO:0044321]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum development [GO:0003281]; vitamin D metabolic process [GO:0042359],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; protein-folding chaperone binding [GO:0051087]; SH3 domain binding [GO:0017124],GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006629; GO:0016192; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085,endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; lipid metabolic process; vesicle-mediated transport; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_06593,FUN_029641-T1,Peve_00037891,Pocillopora_meandrina_HIv1___TS.g2973.t1,three_way,92.316,FUN_029641-T1,B7Z0W9,OTOP_DROME,,Proton channel OtopLc (Otopetrin-Lc) (DmOtopLc),Drosophila melanogaster (Fruit fly),23.8,499.0,1.4e-12,76.3,sp|B7Z0W9|OTOP_DROME Proton channel OtopLc OS=Drosophila melanogaster OX=7227 GN=OtopLc PE=3 SV=2,GO:0005886; GO:0015252; GO:0016020; GO:1902600,proton transmembrane transport [GO:1902600],membrane [GO:0016020]; plasma membrane [GO:0005886],proton channel activity [GO:0015252],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_06594,FUN_029642-T1,Peve_00037886,Pocillopora_meandrina_HIv1___RNAseq.g17206.t1,three_way,42.014,,,,,,,,,,,,,,,,,
OG_06595,FUN_029644-T1,Peve_00038767,Pocillopora_meandrina_HIv1___RNAseq.g17207.t1,three_way,82.503,FUN_029644-T1,Q92113,,,,,43.0,498.0,3.1000000000000003e-119,430.3,"sp|Q92113|CP17A_SQUAC Steroid 17-alpha-hydroxylase/17,20 lyase OS=Squalus acanthias OX=7797 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_06596,FUN_029662-T1,Peve_00038766,Pocillopora_meandrina_HIv1___RNAseq.g17208.t1,three_way,48.72233333333333,,,,,,,,,,,,,,,,,
OG_06597,FUN_029670-T1,Peve_00038768,Pocillopora_meandrina_HIv1___RNAseq.g17307.t1,three_way,67.54366666666667,FUN_029670-T1,Q90YI8,,,,,49.1,116.0,7.8e-19,95.1,sp|Q90YI8|TAL1_TAKRU T-cell acute lymphocytic leukemia protein 1 OS=Takifugu rubripes OX=31033 GN=tal1 PE=2 SV=1,,,,,,
OG_06598,FUN_029671-T2,Peve_00038757,Pocillopora_meandrina_HIv1___RNAseq.g17306.t1,three_way,45.8935,FUN_029671-T2,Q8N3J2,METL4_HUMAN,,N(6)-adenine-specific methyltransferase METTL4 (Methyltransferase-like protein 4) (N(6)-adenine-specific DNA methyltransferase METTL4) (EC 2.1.1.72) (snRNA (2'-O-methyladenosine-N(6)-)-methyltransferase METTL4) (EC 2.1.1.-),Homo sapiens (Human),28.4,507.0,6.9e-56,219.9,sp|Q8N3J2|METL4_HUMAN N(6)-adenine-specific methyltransferase METTL4 OS=Homo sapiens OX=9606 GN=METTL4 PE=1 SV=3,GO:0003676; GO:0005634; GO:0005759; GO:0005829; GO:0008173; GO:0009007; GO:0032259; GO:0036396; GO:0043484; GO:0045814; GO:0090296; GO:0106347; GO:0120049; GO:1903108; GO:1990204,"methylation [GO:0032259]; negative regulation of gene expression, epigenetic [GO:0045814]; regulation of mitochondrial DNA replication [GO:0090296]; regulation of mitochondrial transcription [GO:1903108]; regulation of RNA splicing [GO:0043484]; snRNA (adenine-N6)-methylation [GO:0120049]",cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],nucleic acid binding [GO:0003676]; RNA methyltransferase activity [GO:0008173]; site-specific DNA-methyltransferase (adenine-specific) activity [GO:0009007]; U2 snRNA 2'-O-methyladenosine m6 methyltransferase activity [GO:0106347],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006355; GO:0016073; GO:0016740; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; cytosol; chromatin organization; regulation of DNA-templated transcription; snRNA metabolic process; transferase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_06599,FUN_029673-T1,Peve_00038759,Pocillopora_meandrina_HIv1___RNAseq.g17212.t1,three_way,61.962,FUN_029673-T1,O88572,LRP6_MOUSE,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Mus musculus (Mouse),38.7,310.0,4.200000000000001e-58,228.0,sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1,GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043065; GO:0045121; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0110135; GO:1990963; GO:2000051; GO:2000648,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005768; GO:0005783; GO:0005886; GO:0006355; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0048870; GO:0060089,transporter activity; endosome; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_06600,FUN_029706-T1,Peve_00018722,Pocillopora_meandrina_HIv1___RNAseq.g17309.t1,three_way,68.622,FUN_029706-T1,P27792,,,,,53.7,95.0,1.1e-19,97.8,sp|P27792|LYL1_MOUSE Protein lyl-1 OS=Mus musculus OX=10090 GN=Lyl1 PE=2 SV=2,,,,,,
OG_06601,FUN_029708-T1,Peve_00020456,Pocillopora_meandrina_HIv1___RNAseq.g17310.t1,three_way,74.966,FUN_029708-T1,Q7ZW86,,,,,47.2,462.0,8.399999999999999e-95,349.0,sp|Q7ZW86|CWC27_DANRE Spliceosome-associated protein CWC27 homolog OS=Danio rerio OX=7955 GN=cwc27 PE=2 SV=1,,,,,,
OG_06602,FUN_029709-T1,Peve_00020457,Pocillopora_meandrina_HIv1___RNAseq.g17311.t1,three_way,71.462,FUN_029709-T1,P11182,ODB2_HUMAN,,"Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (EC 2.3.1.168) (52 kDa mitochondrial autoantigen of primary biliary cirrhosis) (Branched chain 2-oxo-acid dehydrogenase complex component E2) (BCOADC-E2) (Branched-chain alpha-keto acid dehydrogenase complex component E2) (BCKAD-E2) (BCKADE2) (BCKDH-E2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)",Homo sapiens (Human),50.4,528.0,1.1e-135,485.0,"sp|P11182|ODB2_HUMAN Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial OS=Homo sapiens OX=9606 GN=DBT PE=1 SV=4",GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0009083; GO:0015630; GO:0016407; GO:0016747; GO:0031405; GO:0031625; GO:0042645; GO:0043754; GO:0045252; GO:0160157,branched-chain amino acid catabolic process [GO:0009083],branched-chain alpha-ketoacid dehydrogenase complex [GO:0160157]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; oxoglutarate dehydrogenase complex [GO:0045252],"acetyltransferase activity [GO:0016407]; acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625]",GO:0003824; GO:0005739; GO:0005829; GO:0005856; GO:0006520; GO:0008289; GO:0016740; GO:0043226,catalytic activity; mitochondrion; cytosol; cytoskeleton; amino acid metabolic process; lipid binding; transferase activity; organelle
OG_06603,FUN_029710-T1,Peve_00018724,Pocillopora_meandrina_HIv1___RNAseq.g17312.t1,three_way,68.5275,FUN_029710-T1,Q8N9Q2,SR1IP_HUMAN,,Protein SREK1IP1 (SFRS12-interacting protein 1) (SREK1-interacting protein 1) (Splicing regulatory protein of 18 kDa) (p18SRP),Homo sapiens (Human),75.7,37.0,1.6e-11,70.9,sp|Q8N9Q2|SR1IP_HUMAN Protein SREK1IP1 OS=Homo sapiens OX=9606 GN=SREK1IP1 PE=1 SV=1,GO:0003676; GO:0006397; GO:0008270; GO:0008380,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],,nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0016071,mRNA metabolic process
OG_06604,FUN_029731-T1,Peve_00020200,Pocillopora_meandrina_HIv1___RNAseq.g16841.t1,three_way,41.393,,,,,,,,,,,,,,,,,
OG_06605,FUN_029753-T1,Peve_00031236,Pocillopora_meandrina_HIv1___RNAseq.g17314.t1,three_way,79.57516666666666,FUN_029753-T1,Q5U2Z0,,,,,57.1,205.0,1.3999999999999998e-29,131.7,sp|Q5U2Z0|ZN367_RAT Zinc finger protein 367 OS=Rattus norvegicus OX=10116 GN=Znf367 PE=2 SV=1,,,,,,
OG_06606,FUN_029754-T1,Peve_00019513,Pocillopora_meandrina_HIv1___RNAseq.g17315.t1,three_way,73.25083333333333,FUN_029754-T1,D3ZYR1,FCHO2_RAT,,F-BAR domain only protein 2,Rattus norvegicus (Rat),35.2,1026.0,1.2e-117,426.0,sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1,GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793,clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]",GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0065003; GO:0072659,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; protein-containing complex assembly; protein localization to plasma membrane
OG_06607,FUN_029756-T1,Peve_00019493,Pocillopora_meandrina_HIv1___RNAseq.g17316.t1,three_way,54.69416666666667,,,,,,,,,,,,,,,,,
OG_06608,FUN_029758-T1,Peve_00019497,Pocillopora_meandrina_HIv1___TS.g3083.t1,three_way,75.64366666666666,FUN_029758-T1,O75694,NU155_HUMAN,,Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155),Homo sapiens (Human),46.4,1399.0,0.0,1191.4,sp|O75694|NU155_HUMAN Nuclear pore complex protein Nup155 OS=Homo sapiens OX=9606 GN=NUP155 PE=1 SV=1,GO:0000972; GO:0005635; GO:0005643; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006913; GO:0006998; GO:0016020; GO:0017056; GO:0031965; GO:0035196; GO:0036228; GO:0044611; GO:0086014,atrial cardiac muscle cell action potential [GO:0086014]; miRNA processing [GO:0035196]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; RNA export from nucleus [GO:0006405]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005829; GO:0006886; GO:0006913; GO:0061024,structural molecule activity; nuclear envelope; cytosol; intracellular protein transport; nucleocytoplasmic transport; membrane organization
OG_06609,FUN_029759-T1,Peve_00019499,Pocillopora_meandrina_HIv1___RNAseq.g17321.t1,three_way,95.305,FUN_029759-T1,Q9QYK7,RNF11_MOUSE,,RING finger protein 11 (NEDD4 WW domain-binding protein 2) (Sid 1669),Mus musculus (Mouse),62.2,156.0,3.2e-45,182.6,sp|Q9QYK7|RNF11_MOUSE RING finger protein 11 OS=Mus musculus OX=10090 GN=Rnf11 PE=1 SV=1,GO:0000151; GO:0005634; GO:0005769; GO:0006511; GO:0008270; GO:0051865; GO:0055037; GO:0061630,protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],early endosome [GO:0005769]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005768; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_06610,FUN_029760-T1,Peve_00019501,Pocillopora_meandrina_HIv1___RNAseq.g17234.t1,three_way,80.53166666666667,FUN_029760-T1,Q8NBS3,,,,,44.5,815.0,1.7000000000000001e-178,627.9,sp|Q8NBS3|S4A11_HUMAN Solute carrier family 4 member 11 OS=Homo sapiens OX=9606 GN=SLC4A11 PE=1 SV=3,,,,,,
OG_06611,FUN_029761-T1,Peve_00019503,Pocillopora_meandrina_HIv1___RNAseq.g17322.t1,three_way,61.18983333333333,FUN_029761-T1,Q8NC51,SERB1_HUMAN,,SERPINE1 mRNA-binding protein 1 (PAI1 RNA-binding protein 1) (PAI-RBP1) (Plasminogen activator inhibitor 1 RNA-binding protein),Homo sapiens (Human),31.6,152.0,5e-06,53.9,sp|Q8NC51|SERB1_HUMAN SERPINE1 mRNA-binding protein 1 OS=Homo sapiens OX=9606 GN=SERBP1 PE=1 SV=2,GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0016020; GO:0017148; GO:0030371; GO:0030578; GO:0032183; GO:0043022; GO:0043488; GO:0045296; GO:0048471; GO:0061770; GO:0070062; GO:0141014,negative regulation of translation [GO:0017148]; PML body organization [GO:0030578]; regulation of mRNA stability [GO:0043488]; ribosome hibernation [GO:0141014],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; SUMO binding [GO:0032183]; translation elongation factor binding [GO:0061770]; translation repressor activity [GO:0030371],GO:0003723; GO:0005634; GO:0005829; GO:0043226; GO:0045182,RNA binding; nucleus; cytosol; organelle; translation regulator activity
OG_06612,FUN_029763-T1,Peve_00019504,Pocillopora_meandrina_HIv1___RNAseq.g17323.t1,three_way,61.1925,FUN_029763-T1,Q6PCS4,,,,,36.2,716.0,2.9e-92,342.0,sp|Q6PCS4|RHG29_DANRE Rho GTPase-activating protein 29 OS=Danio rerio OX=7955 GN=arhgap29 PE=2 SV=1,,,,,,
OG_06613,FUN_029767-T1,Peve_00019505,Pocillopora_meandrina_HIv1___RNAseq.g17324.t1,three_way,60.8995,,,,,,,,,,,,,,,,,
OG_06614,FUN_029768-T1,Peve_00024890,Pocillopora_meandrina_HIv1___RNAseq.g17325.t1,three_way,45.82833333333333,,,,,,,,,,,,,,,,,
OG_06615,FUN_029771-T1,Peve_00042908,Pocillopora_meandrina_HIv1___RNAseq.g5152.t1,three_way,51.961666666666666,,,,,,,,,,,,,,,,,
OG_06616,FUN_029772-T1,Peve_00013611,Pocillopora_meandrina_HIv1___RNAseq.g17328.t1a,three_way,49.64566666666666,FUN_029772-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),21.8,458.0,5e-18,94.7,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06617,FUN_029836-T1,Peve_00044415,Pocillopora_meandrina_HIv1___RNAseq.g11737.t1,three_way,81.02133333333333,,,,,,,,,,,,,,,,,
OG_06618,FUN_029878-T1,Peve_00013604,Pocillopora_meandrina_HIv1___RNAseq.g17334.t2,three_way,50.275,FUN_029878-T1,Q2VL90,C163A_PIG,,Scavenger receptor cysteine-rich type 1 protein M130 (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)],Sus scrofa (Pig),38.9,149.0,8.8e-21,103.2,sp|Q2VL90|C163A_PIG Scavenger receptor cysteine-rich type 1 protein M130 OS=Sus scrofa OX=9823 GN=CD163 PE=1 SV=1,GO:0001618; GO:0005576; GO:0006953; GO:0009897,acute-phase response [GO:0006953],external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576],virus receptor activity [GO:0001618],GO:0001618; GO:0005576; GO:0006954,virus receptor activity; extracellular region; inflammatory response
OG_06619,FUN_029880-T1,Peve_00013607,Pocillopora_meandrina_HIv1___RNAseq.28643_t,three_way,53.984,FUN_029880-T1,P13497,BMP1_HUMAN,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Homo sapiens (Human),25.2,540.0,1.5e-30,136.0,sp|P13497|BMP1_HUMAN Bone morphogenetic protein 1 OS=Homo sapiens OX=9606 GN=BMP1 PE=1 SV=2,GO:0001501; GO:0001502; GO:0001503; GO:0004222; GO:0004252; GO:0005125; GO:0005509; GO:0005576; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030154; GO:0030199; GO:0031982; GO:0042802; GO:0061036,cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; dorsal/ventral pattern formation [GO:0009953]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; protein processing [GO:0016485]; proteolysis [GO:0006508]; skeletal system development [GO:0001501],extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0030198; GO:0043226; GO:0048018; GO:0048856; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; extracellular region; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; extracellular matrix organization; organelle; receptor ligand activity; anatomical structure development; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06620,FUN_029881-T1,Peve_00008451,Pocillopora_meandrina_HIv1___TS.g3099.t1,three_way,53.879333333333335,,,,,,,,,,,,,,,,,
OG_06621,FUN_029882-T1,Peve_00024289,Pocillopora_meandrina_HIv1___RNAseq.g17341.t1,three_way,72.087,FUN_029882-T1,Q9BT73,,,,,34.5,119.0,2.2e-13,76.6,sp|Q9BT73|PSMG3_HUMAN Proteasome assembly chaperone 3 OS=Homo sapiens OX=9606 GN=PSMG3 PE=1 SV=1,,,,,,
OG_06622,FUN_029891-T1,Peve_00008454,Pocillopora_meandrina_HIv1___RNAseq.g17343.t1,three_way,56.2075,FUN_029891-T1,O15146,,,,,37.1,318.0,1.7e-61,239.2,"sp|O15146|MUSK_HUMAN Muscle, skeletal receptor tyrosine-protein kinase OS=Homo sapiens OX=9606 GN=MUSK PE=1 SV=1",,,,,,
OG_06623,FUN_030045-T1,Peve_00008453,Pocillopora_meandrina_HIv1___RNAseq.g17344.t1,three_way,83.89533333333333,FUN_030045-T1,Q5PPX5,,,,,45.9,257.0,1.7e-61,237.7,sp|Q5PPX5|RN170_XENLA E3 ubiquitin-protein ligase RNF170 OS=Xenopus laevis OX=8355 GN=rnf170 PE=2 SV=1,,,,,,
OG_06624,FUN_030046-T1,Peve_00008452,Pocillopora_meandrina_HIv1___RNAseq.g17345.t1,three_way,89.0,FUN_030046-T1,Q1JPX3,,,,,66.2,497.0,2.4e-196,686.4,sp|Q1JPX3|SYFA_DANRE Phenylalanine--tRNA ligase alpha subunit OS=Danio rerio OX=7955 GN=farsa PE=2 SV=2,,,,,,
OG_06625,FUN_030048-T1,Peve_00008446,Pocillopora_meandrina_HIv1___RNAseq.g17347.t1,three_way,81.524,FUN_030048-T1,Q5RBL0,,,,,58.5,229.0,6.200000000000001e-73,275.8,sp|Q5RBL0|YIPF1_PONAB Protein YIPF1 OS=Pongo abelii OX=9601 GN=YIPF1 PE=2 SV=1,,,,,,
OG_06626,FUN_030056-T1,Peve_00040199,Pocillopora_meandrina_HIv1___RNAseq.g17348.t1,three_way,57.199666666666666,,,,,,,,,,,,,,,,,
OG_06627,FUN_030057-T1,Peve_00027775,Pocillopora_meandrina_HIv1___RNAseq.g17349.t1,three_way,71.34366666666666,FUN_030057-T1,Q19425,,,,,43.3,536.0,1.2e-109,398.7,sp|Q19425|S38A9_CAEEL Sodium-coupled neutral amino acid transporter 9 homolog OS=Caenorhabditis elegans OX=6239 GN=F13H10.3 PE=3 SV=2,,,,,,
OG_06628,FUN_030068-T1,Peve_00043526,Pocillopora_meandrina_HIv1___TS.g3111.t1,three_way,61.681333333333335,FUN_030068-T1,O42490,,,,,25.8,306.0,3.6e-10,67.4,sp|O42490|OPSP_PETMA Pineal opsin OS=Petromyzon marinus OX=7757 PE=1 SV=1,,,,,,
OG_06629,FUN_030077-T1,Peve_00011133,Pocillopora_meandrina_HIv1___RNAseq.g20157.t1,three_way,65.86500000000001,,,,,,,,,,,,,,,,,
OG_06630,FUN_030078-T1,Peve_00018131,Pocillopora_meandrina_HIv1___RNAseq.g20156.t1,three_way,75.601,,,,,,,,,,,,,,,,,
OG_06631,FUN_030133-T1,Peve_00008753,Pocillopora_meandrina_HIv1___TS.g14870.t1,three_way,47.67916666666667,,,,,,,,,,,,,,,,,
OG_06632,FUN_030140-T1,Peve_00027504,Pocillopora_meandrina_HIv1___RNAseq.g11469.t1,three_way,91.03816666666668,,,,,,,,,,,,,,,,,
OG_06633,FUN_030179-T1,Peve_00004644,Pocillopora_meandrina_HIv1___TS.g3115.t1,three_way,73.66666666666667,FUN_030179-T1,P30975,,,,,25.2,301.0,4.5e-14,80.9,sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2,,,,,,
OG_06634,FUN_030182-T1,Peve_00004650,Pocillopora_meandrina_HIv1___RNAseq.g17358.t1,three_way,61.07183333333333,FUN_030182-T1,Q6ZNA5,,,,,30.9,330.0,1.2e-40,169.1,sp|Q6ZNA5|FRRS1_HUMAN Ferric-chelate reductase 1 OS=Homo sapiens OX=9606 GN=FRRS1 PE=1 SV=2,,,,,,
OG_06635,FUN_030183-T1,Peve_00004642,Pocillopora_meandrina_HIv1___RNAseq.g17361.t1,three_way,86.83633333333333,FUN_030183-T1,Q4ZIN3,MBRL_HUMAN,,Membralin (Transmembrane protein 259),Homo sapiens (Human),57.5,454.0,1.4999999999999998e-127,458.0,sp|Q4ZIN3|MBRL_HUMAN Membralin OS=Homo sapiens OX=9606 GN=TMEM259 PE=1 SV=1,GO:0005783; GO:0005789; GO:0034976; GO:1904294,positive regulation of ERAD pathway [GO:1904294]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0005783; GO:0043226,endoplasmic reticulum; organelle
OG_06636,FUN_030184-T1,Peve_00004643,Pocillopora_meandrina_HIv1___TS.g3120.t1,three_way,72.65866666666666,FUN_030184-T1,O64411,,,,,40.5,481.0,3.3e-94,347.1,sp|O64411|PAO1_MAIZE Polyamine oxidase 1 OS=Zea mays OX=4577 GN=MPAO1 PE=1 SV=1,,,,,,
OG_06637,FUN_030185-T1,Peve_00000773,Pocillopora_meandrina_HIv1___RNAseq.g23592.t1,three_way,64.50933333333333,,,,,,,,,,,,,,,,,
OG_06638,FUN_030186-T1,Peve_00028242,Pocillopora_meandrina_HIv1___RNAseq.g19719.t1,three_way,82.053,FUN_030186-T1,P49582,,,,,40.4,337.0,1.3e-73,278.5,sp|P49582|ACHA7_MOUSE Neuronal acetylcholine receptor subunit alpha-7 OS=Mus musculus OX=10090 GN=Chrna7 PE=1 SV=1,,,,,,
OG_06639,FUN_030196-T1,Peve_00004645,Pocillopora_meandrina_HIv1___RNAseq.g17363.t1,three_way,66.36449999999999,FUN_030196-T1,Q8BH88,,,,,31.6,554.0,1.5e-64,248.8,sp|Q8BH88|DEP1B_MOUSE DEP domain-containing protein 1B OS=Mus musculus OX=10090 GN=Depdc1b PE=2 SV=1,,,,,,
OG_06640,FUN_030199-T1,Peve_00004646,Pocillopora_meandrina_HIv1___TS.g3122.t1,three_way,57.19833333333333,FUN_030199-T1,Q767J3,,,,,46.7,261.0,3.1999999999999998e-62,240.7,sp|Q767J3|DNAS1_CANLF Deoxyribonuclease-1 OS=Canis lupus familiaris OX=9615 GN=DNASE1 PE=1 SV=1,,,,,,
OG_06641,FUN_030202-T1,Peve_00017913,Pocillopora_meandrina_HIv1___RNAseq.g17365.t1,three_way,75.41716666666666,FUN_030202-T1,Q96SU4,OSBL9_HUMAN,,Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9),Homo sapiens (Human),43.4,491.0,4.6e-91,336.7,sp|Q96SU4|OSBL9_HUMAN Oxysterol-binding protein-related protein 9 OS=Homo sapiens OX=9606 GN=OSBPL9 PE=1 SV=2,GO:0005794; GO:0005829; GO:0006699; GO:0016020; GO:0031902; GO:0032934; GO:0043231; GO:0120015,bile acid biosynthetic process [GO:0006699],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020],sterol binding [GO:0032934]; sterol transfer activity [GO:0120015],GO:0005215; GO:0005794; GO:0005829; GO:0006629; GO:0008289; GO:0043226,transporter activity; Golgi apparatus; cytosol; lipid metabolic process; lipid binding; organelle
OG_06642,FUN_030643-T1,Peve_00006240,Pocillopora_meandrina_HIv1___RNAseq.g21086.t1,three_way,75.03066666666666,FUN_030643-T1,P52493,,,,,33.6,143.0,3.3e-19,96.3,sp|P52493|UBC2_NEUCR Ubiquitin-conjugating enzyme E2 2 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=mus-8 PE=3 SV=4,,,,,,
OG_06643,FUN_030655-T1,Peve_00043685,Pocillopora_meandrina_HIv1___RNAseq.g30310.t1,three_way,62.553666666666665,FUN_030655-T1,Q80T85,DCAF5_MOUSE,,DDB1- and CUL4-associated factor 5 (WD repeat-containing protein 22),Mus musculus (Mouse),49.2,445.0,8.699999999999999e-107,389.4,sp|Q80T85|DCAF5_MOUSE DDB1- and CUL4-associated factor 5 OS=Mus musculus OX=10090 GN=Dcaf5 PE=1 SV=2,GO:0005739; GO:0016567; GO:0080008,protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; mitochondrion [GO:0005739],,GO:0005739; GO:0043226,mitochondrion; organelle
OG_06644,FUN_030656-T1,Peve_00043684,Pocillopora_meandrina_HIv1___RNAseq.g30311.t1,three_way,88.95683333333334,FUN_030656-T1,Q0V9S9,,,,,55.0,789.0,1.4e-246,854.0,sp|Q0V9S9|DRC7_XENTR Dynein regulatory complex subunit 7 OS=Xenopus tropicalis OX=8364 GN=drc7 PE=2 SV=1,,,,,,
OG_06645,FUN_030659-T1,Peve_00043646,Pocillopora_meandrina_HIv1___RNAseq.g6200.t1,three_way,64.83266666666667,FUN_030659-T1,Q8N806,,,,,45.6,412.0,1.6e-95,351.3,sp|Q8N806|UBR7_HUMAN Putative E3 ubiquitin-protein ligase UBR7 OS=Homo sapiens OX=9606 GN=UBR7 PE=1 SV=2,,,,,,
OG_06646,FUN_030662-T1,Peve_00043683,Pocillopora_meandrina_HIv1___RNAseq.g6189.t1,three_way,65.17066666666666,,,,,,,,,,,,,,,,,
OG_06647,FUN_030663-T1,Peve_00043681,Pocillopora_meandrina_HIv1___RNAseq.g30304.t1,three_way,83.89,FUN_030663-T1,P20650,PPM1A_RAT,,Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA),Rattus norvegicus (Rat),54.7,369.0,2.6e-114,413.7,sp|P20650|PPM1A_RAT Protein phosphatase 1A OS=Rattus norvegicus OX=10116 GN=Ppm1a PE=1 SV=1,GO:0000287; GO:0004721; GO:0004722; GO:0005634; GO:0005829; GO:0006470; GO:0006499; GO:0006611; GO:0016020; GO:0030145; GO:0030512; GO:0030514; GO:0033192; GO:0043005; GO:0043122; GO:0043124; GO:0044325; GO:0045893; GO:0046827; GO:0070412; GO:0071560; GO:0090263; GO:1901223,cellular response to transforming growth factor beta stimulus [GO:0071560]; N-terminal protein myristoylation [GO:0006499]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein export from nucleus [GO:0046827]; protein dephosphorylation [GO:0006470]; protein export from nucleus [GO:0006611]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634],calmodulin-dependent protein phosphatase activity [GO:0033192]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; R-SMAD binding [GO:0070412]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_06648,FUN_030668-T1,Peve_00009122,Pocillopora_meandrina_HIv1___RNAseq.g6204.t1,three_way,79.862,,,,,,,,,,,,,,,,,
OG_06649,FUN_030670-T1,Peve_00028183,Pocillopora_meandrina_HIv1___RNAseq.g30312.t1,three_way,72.44566666666667,,,,,,,,,,,,,,,,,
OG_06650,FUN_030671-T1,Peve_00028182,Pocillopora_meandrina_HIv1___RNAseq.g30313.t1,three_way,75.83566666666667,FUN_030671-T1,Q9Y6R9,CCD61_HUMAN,,Centrosomal protein CCDC61 (Coiled-coil domain-containing protein 61) (VFL3 homolog),Homo sapiens (Human),47.6,296.0,1.5e-58,228.8,sp|Q9Y6R9|CCD61_HUMAN Centrosomal protein CCDC61 OS=Homo sapiens OX=9606 GN=CCDC61 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005815; GO:0008017; GO:0030030; GO:0034451; GO:0036064; GO:0042802; GO:0090307; GO:0098534; GO:0120103,cell projection organization [GO:0030030]; centriole assembly [GO:0098534]; mitotic spindle assembly [GO:0090307],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],identical protein binding [GO:0042802]; microtubule binding [GO:0008017],GO:0005815; GO:0007010; GO:0008092,microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding
OG_06651,FUN_030672-T1,Peve_00028178,Pocillopora_meandrina_HIv1___RNAseq.g30294.t1,three_way,67.33333333333333,FUN_030672-T1,P55345,ANM2_HUMAN,,Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2),Homo sapiens (Human),46.5,409.0,6.200000000000001e-106,386.0,sp|P55345|ANM2_HUMAN Protein arginine N-methyltransferase 2 OS=Homo sapiens OX=9606 GN=PRMT2 PE=1 SV=1,GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0007165; GO:0016274; GO:0030331; GO:0032088; GO:0033142; GO:0035242; GO:0042054; GO:0042803; GO:0042974; GO:0042975; GO:0043065; GO:0044877; GO:0045892; GO:0045893; GO:0046966; GO:0048588; GO:0050681; GO:0060765; GO:0140592; GO:0140938; GO:2000134,chromatin remodeling [GO:0006338]; developmental cell growth [GO:0048588]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; protein methylation [GO:0006479]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone H3 methyltransferase activity [GO:0140938]; histone H3R8 methyltransferase activity [GO:0140592]; histone methyltransferase activity [GO:0042054]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear progesterone receptor binding [GO:0033142]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear thyroid hormone receptor binding [GO:0046966]; peroxisome proliferator activated receptor binding [GO:0042975]; protein homodimerization activity [GO:0042803]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_06652,FUN_030673-T1,Peve_00028169,Pocillopora_meandrina_HIv1___RNAseq.g30328.t1,three_way,63.029,FUN_030673-T1,Q28C69,,,,,49.0,239.0,3.9e-60,233.0,sp|Q28C69|ENOPH_XENTR Enolase-phosphatase E1 OS=Xenopus tropicalis OX=8364 GN=enoph1 PE=2 SV=1,,,,,,
OG_06653,FUN_030678-T1,Peve_00028161,Pocillopora_meandrina_HIv1___RNAseq.g6203.t1,three_way,43.779,,,,,,,,,,,,,,,,,
OG_06654,FUN_030679-T1,Peve_00028159,Pocillopora_meandrina_HIv1___RNAseq.g30326.t1,three_way,92.19966666666669,FUN_030679-T1,Q7TN83,SYT16_MOUSE,,Synaptotagmin-16 (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein),Mus musculus (Mouse),44.2,303.0,5.6e-64,246.5,sp|Q7TN83|SYT16_MOUSE Synaptotagmin-16 OS=Mus musculus OX=10090 GN=Syt16 PE=1 SV=1,GO:0005543; GO:0016020; GO:0042802,,membrane [GO:0016020],identical protein binding [GO:0042802]; phospholipid binding [GO:0005543],GO:0008289,lipid binding
OG_06655,FUN_030682-T1,Peve_00038787,Pocillopora_meandrina_HIv1___RNAseq.g30284.t1,three_way,56.81,FUN_030682-T1,Q8UWA5,,,,,38.4,268.0,3.9999999999999995e-42,173.3,sp|Q8UWA5|CAH2_PSEHK Carbonic anhydrase 2 OS=Pseudaspius hakonensis OX=3004147 GN=ca2 PE=2 SV=3,,,,,,
OG_06656,FUN_030742-T1,Peve_00043627,Pocillopora_meandrina_HIv1___RNAseq.g30286.t1,three_way,81.203,FUN_030742-T1,Q9DAG5,STPG4_MOUSE,,Protein STPG4 (Gonad-specific expression gene protein) (GSE) (Sperm-tail PG-rich repeat-containing protein 4),Mus musculus (Mouse),38.7,243.0,3.5000000000000004e-32,140.2,sp|Q9DAG5|STPG4_MOUSE Protein STPG4 OS=Mus musculus OX=10090 GN=Stpg4 PE=1 SV=1,GO:0001673; GO:0001674; GO:0001939; GO:0001940; GO:0003682; GO:0005654; GO:0005737; GO:0042393; GO:0042585; GO:0044727; GO:0072529,epigenetic programing of male pronucleus [GO:0044727]; pyrimidine-containing compound catabolic process [GO:0072529],cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; female pronucleus [GO:0001939]; germinal vesicle [GO:0042585]; male germ cell nucleus [GO:0001673]; male pronucleus [GO:0001940]; nucleoplasm [GO:0005654],chromatin binding [GO:0003682]; histone binding [GO:0042393],GO:0005634; GO:0005654; GO:0006325; GO:0042393; GO:0043226,nucleus; nucleoplasm; chromatin organization; histone binding; organelle
OG_06657,FUN_030873-T1,Peve_00043626,Pocillopora_meandrina_HIv1___RNAseq.g30288.t1,three_way,63.519333333333336,,,,,,,,,,,,,,,,,
OG_06658,FUN_030874-T1,Peve_00043625,Pocillopora_meandrina_HIv1___RNAseq.g30289.t1,three_way,83.54933333333334,FUN_030874-T1,Q9P2D3,HTR5B_HUMAN,,HEAT repeat-containing protein 5B,Homo sapiens (Human),50.9,2060.0,0.0,1933.7,sp|Q9P2D3|HTR5B_HUMAN HEAT repeat-containing protein 5B OS=Homo sapiens OX=9606 GN=HEATR5B PE=1 SV=2,GO:0005654; GO:0005794; GO:0005829; GO:0006897; GO:0008104; GO:0015031; GO:0016020; GO:0030136; GO:0030139; GO:0042147; GO:0043231; GO:0048471,"endocytosis [GO:0006897]; protein localization [GO:0008104]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],,GO:0005654; GO:0005794; GO:0005829; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; Golgi apparatus; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06659,FUN_030875-T1,Peve_00043622,Pocillopora_meandrina_HIv1___RNAseq.g30291.t1,three_way,73.61166666666666,FUN_030875-T1,Q6DC39,DESI2_DANRE,,Deubiquitinase DESI2 (EC 3.4.19.12) (Desumoylating isopeptidase 2) (DeSI-2) (PPPDE peptidase domain-containing protein 1) (Palmitoyl protein thioesterase DESI2) (EC 3.1.2.22) (Protein FAM152A) (S-depalmitoylase DESI2),Danio rerio (Zebrafish) (Brachydanio rerio),53.5,157.0,8.8e-51,201.4,sp|Q6DC39|DESI2_DANRE Deubiquitinase DESI2 OS=Danio rerio OX=7955 GN=desi2 PE=2 SV=1,GO:0004843; GO:0005737; GO:0006508; GO:0008474; GO:0052816; GO:0060027; GO:0101005,convergent extension involved in gastrulation [GO:0060027]; proteolysis [GO:0006508],cytoplasm [GO:0005737],cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; palmitoyl-(protein) hydrolase activity [GO:0008474],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_06660,FUN_030876-T1,Peve_00043621,Pocillopora_meandrina_HIv1___RNAseq.g30292.t1,three_way,68.59583333333333,FUN_030876-T1,Q96F63,,,,,38.8,289.0,4.3e-33,143.3,sp|Q96F63|CCD97_HUMAN Coiled-coil domain-containing protein 97 OS=Homo sapiens OX=9606 GN=CCDC97 PE=1 SV=1,,,,,,
OG_06661,FUN_030880-T1,Peve_00043612,Pocillopora_meandrina_HIv1___RNAseq.g30296.t1,three_way,70.443,,,,,,,,,,,,,,,,,
OG_06662,FUN_030881-T1,Peve_00043611,Pocillopora_meandrina_HIv1___RNAseq.g30297.t1,three_way,90.43266666666666,FUN_030881-T1,A6H7B5,,,,,59.6,413.0,1.8e-139,497.3,sp|A6H7B5|CSN3_BOVIN COP9 signalosome complex subunit 3 OS=Bos taurus OX=9913 GN=COPS3 PE=2 SV=1,,,,,,
OG_06663,FUN_031054-T1,Peve_00028185,Pocillopora_meandrina_HIv1___RNAseq.g30322.t1,three_way,84.973,FUN_031054-T1,Q8CIB5,FERM2_MOUSE,,Fermitin family homolog 2 (Kindlin-2) (Pleckstrin homology domain-containing family C member 1),Mus musculus (Mouse),47.4,694.0,4.1000000000000004e-170,599.7,sp|Q8CIB5|FERM2_MOUSE Fermitin family homolog 2 OS=Mus musculus OX=10090 GN=Fermt2 PE=1 SV=1,GO:0001725; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005912; GO:0005925; GO:0005938; GO:0007160; GO:0007179; GO:0007229; GO:0008360; GO:0009898; GO:0009986; GO:0010718; GO:0016055; GO:0031258; GO:0031674; GO:0033622; GO:0033625; GO:0034334; GO:0034446; GO:0034713; GO:0035025; GO:0043116; GO:0043539; GO:0045599; GO:0045669; GO:0046332; GO:0048041; GO:0051015; GO:0051496; GO:0051894; GO:0051897; GO:0060173; GO:0070374; GO:0072657; GO:0120283; GO:1900026; GO:1900182; GO:1902414; GO:1902462; GO:1903691,"adherens junction maintenance [GO:0034334]; cell-matrix adhesion [GO:0007160]; focal adhesion assembly [GO:0048041]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; limb development [GO:0060173]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of vascular permeability [GO:0043116]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of integrin activation [GO:0033625]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of wound healing, spreading of epidermal cells [GO:1903691]; protein localization to cell junction [GO:1902414]; protein localization to membrane [GO:0072657]; regulation of cell shape [GO:0008360]; substrate adhesion-dependent cell spreading [GO:0034446]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055]",adherens junction [GO:0005912]; cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; I band [GO:0031674]; lamellipodium membrane [GO:0031258]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; stress fiber [GO:0001725],"actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; SMAD binding [GO:0046332]; type I transforming growth factor beta receptor binding [GO:0034713]",GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0007155; GO:0008092; GO:0008289; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,circulatory system process; nucleus; nucleoplasm; cytosol; cell adhesion; cytoskeletal protein binding; lipid binding; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_06664,FUN_031056-T1,Peve_00028186,Pocillopora_meandrina_HIv1___RNAseq.g30325.t1a,three_way,64.37166666666667,FUN_031056-T1,Q8R0G9,NU133_MOUSE,,Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133),Mus musculus (Mouse),36.7,1120.0,3e-178,627.5,sp|Q8R0G9|NU133_MOUSE Nuclear pore complex protein Nup133 OS=Mus musculus OX=10090 GN=Nup133 PE=1 SV=2,GO:0000776; GO:0005635; GO:0005643; GO:0006406; GO:0006913; GO:0006999; GO:0015031; GO:0017056; GO:0021915; GO:0022008; GO:0031080; GO:0031965; GO:0048339; GO:0061053; GO:0072006,mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; paraxial mesoderm development [GO:0048339]; protein transport [GO:0015031]; somite development [GO:0061053],kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0006913; GO:0030154; GO:0043226; GO:0048856,structural molecule activity; nuclear envelope; nucleocytoplasmic transport; cell differentiation; organelle; anatomical structure development
OG_06665,FUN_031057-T1,Peve_00028131,Pocillopora_meandrina_HIv1___RNAseq.g30324.t1,three_way,60.543,FUN_031057-T1,P56873,,,,,36.3,171.0,2.2e-18,93.6,sp|P56873|ZNRD2_MOUSE Protein ZNRD2 OS=Mus musculus OX=10090 GN=Znrd2 PE=1 SV=1,,,,,,
OG_06666,FUN_031062-T1,Peve_00013554,Pocillopora_meandrina_HIv1___RNAseq.g5923.t1,three_way,85.05166666666668,FUN_031062-T1,P51824,,,,,54.8,186.0,1.2e-52,208.0,sp|P51824|ARF1_SOLTU ADP-ribosylation factor 1 OS=Solanum tuberosum OX=4113 PE=2 SV=2,,,,,,
OG_06667,FUN_031066-T1,Peve_00013555,Pocillopora_meandrina_HIv1___RNAseq.g5922.t1,three_way,79.245,FUN_031066-T1,Q7TSU0,,,,,52.1,121.0,5.5e-31,135.6,sp|Q7TSU0|C1D_CRIGR Nuclear nucleic acid-binding protein C1D OS=Cricetulus griseus OX=10029 GN=C1D PE=2 SV=1,,,,,,
OG_06668,FUN_031067-T1,Peve_00028134,Pocillopora_meandrina_HIv1___RNAseq.g30320.t1,three_way,70.354,FUN_031067-T1,O89043,,,,,41.5,619.0,1.5e-126,454.9,sp|O89043|DPOA2_RAT DNA polymerase alpha subunit B OS=Rattus norvegicus OX=10116 GN=Pola2 PE=1 SV=2,,,,,,
OG_06669,FUN_031068-T1,Peve_00028133,Pocillopora_meandrina_HIv1___RNAseq.g30321.t1,three_way,84.0175,FUN_031068-T1,P05094,,,,,65.8,876.0,0.0,1176.4,sp|P05094|ACTN1_CHICK Alpha-actinin-1 OS=Gallus gallus OX=9031 GN=ACTN1 PE=1 SV=3,,,,,,
OG_06670,FUN_031070-T1,Peve_00025081,Pocillopora_meandrina_HIv1___RNAseq.g6195.t1,three_way,68.65666666666667,FUN_031070-T1,Q93VC9,,,,,40.9,320.0,1.6e-60,234.6,sp|Q93VC9|CATB2_ARATH Cathepsin B-like protease 2 OS=Arabidopsis thaliana OX=3702 GN=CATHB2 PE=2 SV=1,,,,,,
OG_06671,FUN_031071-T1,Peve_00043181,Pocillopora_meandrina_HIv1___RNAseq.g11212.t1,three_way,58.844166666666666,FUN_031071-T1,Q4LBB6,OCTB3_DROME,,Octopamine receptor beta-3R (DmOct-beta-3R),Drosophila melanogaster (Fruit fly),28.4,229.0,1.7e-11,72.0,sp|Q4LBB6|OCTB3_DROME Octopamine receptor beta-3R OS=Drosophila melanogaster OX=7227 GN=Octbeta3R PE=2 SV=4,GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0016020; GO:0043410; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of MAPK cascade [GO:0043410],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_06672,FUN_031075-T1,Peve_00028138,Pocillopora_meandrina_HIv1___RNAseq.g30319.t1,three_way,66.64233333333333,FUN_031075-T1,P56965,DDAH1_BOVIN,,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)",Bos taurus (Bovine),46.1,269.0,2e-57,224.2,"sp|P56965|DDAH1_BOVIN N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 OS=Bos taurus OX=9913 GN=DDAH1 PE=1 SV=3",GO:0000052; GO:0006525; GO:0006809; GO:0008270; GO:0016403; GO:0016597; GO:0017014; GO:0045429,arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein nitrosylation [GO:0017014],,amino acid binding [GO:0016597]; dimethylargininase activity [GO:0016403]; zinc ion binding [GO:0008270],GO:0003824; GO:0006520; GO:0016787,catalytic activity; amino acid metabolic process; hydrolase activity
OG_06673,FUN_031076-T1,Peve_00028143,Pocillopora_meandrina_HIv1___RNAseq.g30318.t1,three_way,70.30116666666667,FUN_031076-T1,Q14919,NC2A_HUMAN,,Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha),Homo sapiens (Human),77.4,93.0,4.2e-34,146.4,sp|Q14919|NC2A_HUMAN Dr1-associated corepressor OS=Homo sapiens OX=9606 GN=DRAP1 PE=1 SV=3,GO:0000122; GO:0001046; GO:0001091; GO:0005634; GO:0006366; GO:0016251; GO:0017025; GO:0017054; GO:0042802; GO:0046982; GO:0090575,negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366],negative cofactor 2 complex [GO:0017054]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],core promoter sequence-specific DNA binding [GO:0001046]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; TBP-class protein binding [GO:0017025],GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0043226; GO:0140223,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; organelle; general transcription initiation factor activity
OG_06674,FUN_031077-T3,Peve_00028144,Pocillopora_meandrina_HIv1___RNAseq.g30317.t1,three_way,76.78383333333333,FUN_031077-T3,Q3V2A7,QRIC2_MOUSE,,Glutamine-rich protein 2,Mus musculus (Mouse),31.8,337.0,1.4e-27,126.7,sp|Q3V2A7|QRIC2_MOUSE Glutamine-rich protein 2 OS=Mus musculus OX=10090 GN=Qrich2 PE=2 SV=1,GO:0005634; GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059,cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleus; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_06675,FUN_031078-T1,Peve_00028145,Pocillopora_meandrina_HIv1___RNAseq.g30316.t1,three_way,77.07333333333334,FUN_031078-T1,Q7L8A9,VASH1_HUMAN,,Tubulinyl-Tyr carboxypeptidase 1 (EC 3.4.17.17) (Tubulin carboxypeptidase 1) (Tyrosine carboxypeptidase 1) (TTCP 1) (Vasohibin-1),Homo sapiens (Human),50.2,273.0,1.2e-74,281.6,sp|Q7L8A9|VASH1_HUMAN Tubulinyl-Tyr carboxypeptidase 1 OS=Homo sapiens OX=9606 GN=VASH1 PE=1 SV=1,GO:0001525; GO:0001937; GO:0003779; GO:0004181; GO:0005615; GO:0005737; GO:0005783; GO:0006508; GO:0009611; GO:0016525; GO:0043537; GO:0045177; GO:0045765; GO:0051726; GO:0060716; GO:0106423; GO:1901491; GO:2000772,angiogenesis [GO:0001525]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of lymphangiogenesis [GO:1901491]; proteolysis [GO:0006508]; regulation of angiogenesis [GO:0045765]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; response to wounding [GO:0009611],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],actin binding [GO:0003779]; metallocarboxypeptidase activity [GO:0004181]; tubulin-tyrosine carboxypeptidase [GO:0106423],GO:0003824; GO:0005615; GO:0005783; GO:0008092; GO:0016787; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; endoplasmic reticulum; cytoskeletal protein binding; hydrolase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_06676,FUN_031079-T1,Peve_00028146,Pocillopora_meandrina_HIv1___RNAseq.27627_t,three_way,61.867666666666665,,,,,,,,,,,,,,,,,
OG_06677,FUN_031080-T1,Peve_00032684,Pocillopora_meandrina_HIv1___TS.g24407.t2,three_way,79.01866666666668,FUN_031080-T1,Q3U1C6,,,,,56.9,267.0,1.0000000000000001e-82,308.1,sp|Q3U1C6|TATD3_MOUSE Putative deoxyribonuclease TATDN3 OS=Mus musculus OX=10090 GN=Tatdn3 PE=1 SV=1,,,,,,
OG_06678,FUN_031081-T1,Peve_00031208,Pocillopora_meandrina_HIv1___RNAseq.g25502.t1,three_way,48.558,,,,,,,,,,,,,,,,,
OG_06679,FUN_031085-T1,Peve_00025083,Pocillopora_meandrina_HIv1___RNAseq.g5957.t1,three_way,74.02966666666667,FUN_031085-T1,Q6PB93,GALT2_MOUSE,,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],Mus musculus (Mouse),51.6,580.0,2.8e-175,616.7,sp|Q6PB93|GALT2_MOUSE Polypeptide N-acetylgalactosaminyltransferase 2 OS=Mus musculus OX=10090 GN=Galnt2 PE=1 SV=1,GO:0002639; GO:0004653; GO:0005576; GO:0005796; GO:0006493; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0051604,O-glycan processing [GO:0016266]; positive regulation of immunoglobulin production [GO:0002639]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005576; GO:0009101; GO:0016740; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; extracellular region; glycoprotein biosynthetic process; transferase activity; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06680,FUN_031176-T1,Peve_00016087,Pocillopora_meandrina_HIv1___TS.g23938.t1b,three_way,56.30883333333333,,,,,,,,,,,,,,,,,
OG_06681,FUN_031184-T1,Peve_00016090,Pocillopora_meandrina_HIv1___RNAseq.g5221.t1,three_way,48.904,,,,,,,,,,,,,,,,,
OG_06682,FUN_031185-T1,Peve_00041866,Pocillopora_meandrina_HIv1___RNAseq.g5216.t1,three_way,46.915,,,,,,,,,,,,,,,,,
OG_06683,FUN_031186-T1,Peve_00041875,Pocillopora_meandrina_HIv1___RNAseq.g5214.t1,three_way,69.12466666666667,FUN_031186-T1,P25500,,,,,64.8,491.0,5.8e-181,636.0,sp|P25500|PAPOA_BOVIN Poly(A) polymerase alpha OS=Bos taurus OX=9913 GN=PAPOLA PE=1 SV=3,,,,,,
OG_06684,FUN_031195-T1,Peve_00043774,Pocillopora_meandrina_HIv1___RNAseq.g19340.t1,three_way,73.738,,,,,,,,,,,,,,,,,
OG_06685,FUN_031206-T1,Peve_00041864,Pocillopora_meandrina_HIv1___RNAseq.g5212.t1,three_way,67.21766666666666,,,,,,,,,,,,,,,,,
OG_06686,FUN_031212-T1,Peve_00041872,Pocillopora_meandrina_HIv1___RNAseq.g5200.t1,three_way,90.47633333333332,FUN_031212-T1,P36954,RPB9_HUMAN,,DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II subunit I) (RNA polymerase II 14.5 kDa subunit) (RPB14.5),Homo sapiens (Human),79.2,125.0,3.3e-55,216.1,sp|P36954|RPB9_HUMAN DNA-directed RNA polymerase II subunit RPB9 OS=Homo sapiens OX=9606 GN=POLR2I PE=1 SV=1,GO:0001193; GO:0003676; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005730; GO:0006283; GO:0006366; GO:0006367; GO:0008270,maintenance of transcriptional fidelity during transcription elongation by RNA polymerase II [GO:0001193]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],"nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]",DNA-directed RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006351; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on RNA"
OG_06687,FUN_031214-T1,Peve_00041871,Pocillopora_meandrina_HIv1___RNAseq.g5201.t1,three_way,62.63333333333333,FUN_031214-T1,Q6DBY9,CHST1_DANRE,,Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST),Danio rerio (Zebrafish) (Brachydanio rerio),27.0,371.0,2.3e-21,104.8,sp|Q6DBY9|CHST1_DANRE Carbohydrate sulfotransferase 1 OS=Danio rerio OX=7955 GN=chst1 PE=2 SV=2,GO:0000139; GO:0001517; GO:0005975; GO:0006044; GO:0042339; GO:0045130,carbohydrate metabolic process [GO:0005975]; keratan sulfate proteoglycan metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044],Golgi membrane [GO:0000139],keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517],GO:0003824; GO:0005975; GO:0016740; GO:1901135,catalytic activity; carbohydrate metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_06688,FUN_031220-T1,Peve_00032142,Pocillopora_meandrina_HIv1___RNAseq.g5199.t1,three_way,54.43183333333333,,,,,,,,,,,,,,,,,
OG_06689,FUN_031221-T1,Peve_00043066,Pocillopora_meandrina_HIv1___RNAseq.g5197.t1,three_way,64.83466666666666,FUN_031221-T1,P51901,,,,,29.0,635.0,6.1e-63,245.0,sp|P51901|ANXA6_CHICK Annexin A6 OS=Gallus gallus OX=9031 GN=ANXA6 PE=2 SV=1,,,,,,
OG_06690,FUN_031234-T1,Peve_00040979,Pocillopora_meandrina_HIv1___RNAseq.g22662.t1,three_way,68.60033333333334,FUN_031234-T1,Q9ULQ1,,,,,45.7,750.0,3.3e-152,540.4,sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3,,,,,,
OG_06691,FUN_031236-T1,Peve_00043063,Pocillopora_meandrina_HIv1___RNAseq.g5195.t1,three_way,57.85166666666667,FUN_031236-T1,Q8NA75,,,,,33.1,278.0,1.9e-39,164.9,sp|Q8NA75|DC4L2_HUMAN DDB1- and CUL4-associated factor 4-like protein 2 OS=Homo sapiens OX=9606 GN=DCAF4L2 PE=1 SV=1,,,,,,
OG_06692,FUN_031240-T1,Peve_00043069,Pocillopora_meandrina_HIv1___RNAseq.g5193.t1,three_way,67.849,FUN_031240-T1,P42335,,,,,50.9,399.0,9.1e-107,389.0,sp|P42335|IP3KB_RAT Inositol-trisphosphate 3-kinase B OS=Rattus norvegicus OX=10116 GN=Itpkb PE=1 SV=3,,,,,,
OG_06693,FUN_031241-T1,Peve_00043067,Pocillopora_meandrina_HIv1___RNAseq.g5192.t1,three_way,56.55766666666667,,,,,,,,,,,,,,,,,
OG_06694,FUN_031242-T1,Peve_00043062,Pocillopora_meandrina_HIv1___RNAseq.g5191.t1,three_way,62.47316666666666,FUN_031242-T1,A0A0G2L7I0,SPRTN_DANRE,,DNA-dependent metalloprotease SPRTN (EC 3.4.24.-) (Protein with SprT-like domain at the N terminus) (Spartan),Danio rerio (Zebrafish) (Brachydanio rerio),60.6,279.0,7.3e-94,345.9,sp|A0A0G2L7I0|SPRTN_DANRE DNA-dependent metalloprotease SPRTN OS=Danio rerio OX=7955 GN=sprtn PE=3 SV=1,GO:0000785; GO:0003690; GO:0003697; GO:0004222; GO:0005634; GO:0006508; GO:0006974; GO:0008270; GO:0016540; GO:0031593; GO:0106300,DNA damage response [GO:0006974]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508],chromatin [GO:0000785]; nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; metalloendopeptidase activity [GO:0004222]; polyubiquitin modification-dependent protein binding [GO:0031593]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_06695,FUN_031246-T1,Peve_00015903,Pocillopora_meandrina_HIv1___RNAseq.g5189.t1,three_way,78.97766666666666,FUN_031246-T1,Q5RE51,DEGS1_PONAB,,Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Degenerative spermatocyte homolog 1) (Dihydroceramide desaturase-1) (Retinol isomerase) (EC 5.2.1.-),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),57.9,316.0,2.2e-113,410.2,sp|Q5RE51|DEGS1_PONAB Sphingolipid delta(4)-desaturase DES1 OS=Pongo abelii OX=9601 GN=DEGS1 PE=2 SV=1,GO:0005789; GO:0006633; GO:0016859; GO:0031966; GO:0042284; GO:0043217; GO:0046513; GO:0050251,ceramide biosynthetic process [GO:0046513]; fatty acid biosynthetic process [GO:0006633]; myelin maintenance [GO:0043217],endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966],cis-trans isomerase activity [GO:0016859]; retinol isomerase activity [GO:0050251]; sphingolipid delta-4 desaturase activity [GO:0042284],GO:0003824; GO:0006629; GO:0016491; GO:0016853; GO:0061024,catalytic activity; lipid metabolic process; oxidoreductase activity; isomerase activity; membrane organization
OG_06696,FUN_031251-T1,Peve_00015904,Pocillopora_meandrina_HIv1___RNAseq.g5188.t1,three_way,77.20766666666667,FUN_031251-T1,Q9D0L4,,,,,54.6,476.0,2.2e-147,523.9,sp|Q9D0L4|ADCK1_MOUSE AarF domain-containing protein kinase 1 OS=Mus musculus OX=10090 GN=Adck1 PE=1 SV=1,,,,,,
OG_06697,FUN_031252-T1,Peve_00015905,Pocillopora_meandrina_HIv1___RNAseq.g5183.t1,three_way,69.73966666666666,FUN_031252-T1,O15033,AREL1_HUMAN,,Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1),Homo sapiens (Human),45.2,814.0,7.6e-194,679.1,sp|O15033|AREL1_HUMAN Apoptosis-resistant E3 ubiquitin protein ligase 1 OS=Homo sapiens OX=9606 GN=AREL1 PE=1 SV=3,GO:0004842; GO:0005737; GO:0005829; GO:0006511; GO:0006915; GO:0016567; GO:0043066; GO:0050727; GO:0061630; GO:0070979; GO:1990390,apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; protein K11-linked ubiquitination [GO:0070979]; protein K33-linked ubiquitination [GO:1990390]; protein ubiquitination [GO:0016567]; regulation of inflammatory response [GO:0050727]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005829; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; cytosol; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_06698,FUN_031263-T1,Peve_00001470,Pocillopora_meandrina_HIv1___RNAseq.g5187.t1,three_way,67.0335,,,,,,,,,,,,,,,,,
OG_06699,FUN_031265-T1,Peve_00001471,Pocillopora_meandrina_HIv1___RNAseq.g5186.t1,three_way,80.76033333333334,FUN_031265-T1,Q4I963,,,,,34.0,150.0,3.9e-17,89.4,sp|Q4I963|COFI_GIBZE Cofilin OS=Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) OX=229533 GN=COF1 PE=3 SV=2,,,,,,
OG_06700,FUN_031267-T1,Peve_00036736,Pocillopora_meandrina_HIv1___RNAseq.11406_t,three_way,69.776,FUN_031267-T1,P20072,,,,,40.6,313.0,1.1e-60,237.3,sp|P20072|ANXA7_BOVIN Annexin A7 OS=Bos taurus OX=9913 GN=ANXA7 PE=1 SV=2,,,,,,
OG_06701,FUN_031268-T1,Peve_00036751,Pocillopora_meandrina_HIv1___RNAseq.g5181.t2,three_way,67.62816666666666,FUN_031268-T1,Q9UBV2,SE1L1_HUMAN,,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),Homo sapiens (Human),62.3,579.0,1.3e-73,279.6,sp|Q9UBV2|SE1L1_HUMAN Protein sel-1 homolog 1 OS=Homo sapiens OX=9606 GN=SEL1L PE=1 SV=3,GO:0000836; GO:0000839; GO:0005783; GO:0005789; GO:0006641; GO:0007219; GO:0009306; GO:0030970; GO:0036503; GO:0036513; GO:0050821,"ERAD pathway [GO:0036503]; Notch signaling pathway [GO:0007219]; protein secretion [GO:0009306]; protein stabilization [GO:0050821]; retrograde protein transport, ER to cytosol [GO:0030970]; triglyceride metabolic process [GO:0006641]",Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Hrd1p ubiquitin ligase complex [GO:0000836]; Hrd1p ubiquitin ligase ERAD-L complex [GO:0000839],,GO:0005783; GO:0006629; GO:0006886; GO:0030163; GO:0043226,endoplasmic reticulum; lipid metabolic process; intracellular protein transport; protein catabolic process; organelle
OG_06702,FUN_031269-T1,Peve_00036737,Pocillopora_meandrina_HIv1___TS.g23896.t1,three_way,69.62383333333334,FUN_031269-T1,Q3T906,GNPTA_HUMAN,,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta],Homo sapiens (Human),39.7,1334.0,1e-257,891.7,sp|Q3T906|GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens OX=9606 GN=GNPTAB PE=1 SV=1,GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0033299; GO:0046835,carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976],GO:0003824; GO:0005794; GO:0005975; GO:0007040; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; carbohydrate metabolic process; lysosome organization; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_06703,FUN_031274-T1,Peve_00036739,Pocillopora_meandrina_HIv1___TS.g23895.t1,three_way,65.17633333333333,FUN_031274-T1,Q09470,KCNA1_HUMAN,,Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1),Homo sapiens (Human),40.3,385.0,2.9e-73,277.3,sp|Q09470|KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens OX=9606 GN=KCNA1 PE=1 SV=2,GO:0001508; GO:0001964; GO:0005249; GO:0005251; GO:0005783; GO:0005829; GO:0005886; GO:0006937; GO:0007405; GO:0008076; GO:0009986; GO:0010644; GO:0010960; GO:0016020; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0070161; GO:0071286; GO:0071805; GO:0086011; GO:0097718,action potential [GO:0001508]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; membrane repolarization during action potential [GO:0086011]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],anchoring junction [GO:0070161]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; protein-containing complex assembly
OG_06704,FUN_031275-T1,Peve_00036740,Pocillopora_meandrina_HIv1___TS.g23894.t1,three_way,74.68383333333334,FUN_031275-T1,Q6ZUK4,,,,,31.6,225.0,1.4e-21,105.5,sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1,,,,,,
OG_06705,FUN_031276-T1,Peve_00036741,Pocillopora_meandrina_HIv1___RNAseq.g5175.t1,three_way,49.56583333333333,FUN_031276-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),47.1,70.0,5.9e-10,67.8,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_06706,FUN_031286-T1,Peve_00036747,Pocillopora_meandrina_HIv1___RNAseq.g5173.t1,three_way,73.2735,FUN_031286-T1,Q8CHB8,TTLL5_MOUSE,,Tubulin polyglutamylase TTLL5 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 5),Mus musculus (Mouse),44.1,870.0,1.4999999999999998e-189,665.2,sp|Q8CHB8|TTLL5_MOUSE Tubulin polyglutamylase TTLL5 OS=Mus musculus OX=10090 GN=Ttll5 PE=1 SV=3,GO:0005524; GO:0005634; GO:0005737; GO:0005874; GO:0005929; GO:0007283; GO:0007288; GO:0009566; GO:0030317; GO:0036064; GO:0036211; GO:0046872; GO:0060041; GO:0070740; GO:0097731; GO:0106437; GO:0106438,fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211]; retina development in camera-type eye [GO:0060041]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283],9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005634; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0016874; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; ligase activity; reproductive process; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_06707,FUN_031287-T1,Peve_00036748,Pocillopora_meandrina_HIv1___RNAseq.g5172.t1,three_way,87.3345,FUN_031287-T1,Q8BFX3,,,,,64.2,653.0,1.1999999999999999e-235,817.4,sp|Q8BFX3|KCTD3_MOUSE BTB/POZ domain-containing protein KCTD3 OS=Mus musculus OX=10090 GN=Kctd3 PE=1 SV=1,,,,,,
OG_06708,FUN_031289-T1,Peve_00026529,Pocillopora_meandrina_HIv1___RNAseq.g5169.t1,three_way,74.811,FUN_031289-T1,Q96L93,KI16B_HUMAN,,Kinesin-like protein KIF16B (Sorting nexin-23),Homo sapiens (Human),58.3,599.0,8.2e-179,629.8,sp|Q96L93|KI16B_HUMAN Kinesin-like protein KIF16B OS=Homo sapiens OX=9606 GN=KIF16B PE=1 SV=2,GO:0001704; GO:0001919; GO:0005524; GO:0005547; GO:0005737; GO:0005768; GO:0005769; GO:0005819; GO:0005829; GO:0005871; GO:0005874; GO:0006895; GO:0007173; GO:0007492; GO:0008017; GO:0008543; GO:0008574; GO:0016887; GO:0031901; GO:0032266; GO:0032801; GO:0043325; GO:0045022; GO:0047496; GO:0080025,early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; spindle [GO:0005819],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; plus-end-directed microtubule motor activity [GO:0008574]",GO:0003774; GO:0003824; GO:0005768; GO:0005829; GO:0007018; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; cytosol; microtubule-based movement; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_06709,FUN_031291-T1,Peve_00026523,Pocillopora_meandrina_HIv1___TS.g23886.t1b,three_way,51.8035,FUN_031291-T1,Q5SY80,CTSRE_HUMAN,,Cation channel sperm-associated auxiliary subunit epsilon (CatSper-epsilon) (CatSperepsilon),Homo sapiens (Human),23.7,670.0,1.2e-35,153.3,sp|Q5SY80|CTSRE_HUMAN Cation channel sperm-associated auxiliary subunit epsilon OS=Homo sapiens OX=9606 GN=CATSPERE PE=1 SV=1,GO:0030317; GO:0036128; GO:0048240; GO:0097228,flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240],CatSper complex [GO:0036128]; sperm principal piece [GO:0097228],,GO:0007018; GO:0022414; GO:0048870,microtubule-based movement; reproductive process; cell motility
OG_06710,FUN_031297-T1,Peve_00026518,Pocillopora_meandrina_HIv1___RNAseq.g5161.t1,three_way,35.85066666666667,,,,,,,,,,,,,,,,,
OG_06711,FUN_031299-T1,Peve_00026517,Pocillopora_meandrina_HIv1___TS.g23878.t1,three_way,71.31383333333333,FUN_031299-T1,Q20JQ7,SC4AB_DANRE,,Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b),Danio rerio (Zebrafish) (Brachydanio rerio),37.8,1295.0,2.4e-184,647.9,sp|Q20JQ7|SC4AB_DANRE Sodium channel protein type 4 subunit alpha B OS=Danio rerio OX=7955 GN=scn4ab PE=2 SV=1,GO:0001518; GO:0005248; GO:0019228; GO:0030424; GO:0086010,membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228],axon [GO:0030424]; voltage-gated sodium channel complex [GO:0001518],voltage-gated sodium channel activity [GO:0005248],GO:0005215,transporter activity
OG_06712,FUN_031304-T1,Peve_00026516,Pocillopora_meandrina_HIv1___TS.g23876.t1,three_way,80.76050000000001,FUN_031304-T1,Q2XVR6,SC4AB_TAKRU,,Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b),Takifugu rubripes (Japanese pufferfish) (Fugu rubripes),36.0,1773.0,3.2e-262,907.1,sp|Q2XVR6|SC4AB_TAKRU Sodium channel protein type 4 subunit alpha B OS=Takifugu rubripes OX=31033 GN=scn4ab PE=3 SV=1,GO:0001518; GO:0005248; GO:0019228; GO:0086010,membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228],voltage-gated sodium channel complex [GO:0001518],voltage-gated sodium channel activity [GO:0005248],GO:0005215,transporter activity
OG_06713,FUN_031306-T1,Peve_00026515,Pocillopora_meandrina_HIv1___RNAseq.11376_t,three_way,53.790333333333336,,,,,,,,,,,,,,,,,
OG_06714,FUN_031307-T1,Peve_00026514,Pocillopora_meandrina_HIv1___TS.g23874.t1,three_way,75.132,FUN_031307-T1,Q9CWG8,NDUF7_MOUSE,,"Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)",Mus musculus (Mouse),50.9,407.0,7.8e-106,385.6,"sp|Q9CWG8|NDUF7_MOUSE Protein arginine methyltransferase NDUFAF7, mitochondrial OS=Mus musculus OX=10090 GN=Ndufaf7 PE=1 SV=4",GO:0005739; GO:0019899; GO:0019918; GO:0032981; GO:0035243,"mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation, to symmetrical-dimethyl arginine [GO:0019918]",mitochondrion [GO:0005739],enzyme binding [GO:0019899]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_06715,FUN_031465-T1,Peve_00026560,Pocillopora_meandrina_HIv1___RNAseq.g5151.t1,three_way,70.29766666666667,FUN_031465-T1,Q8VYR2,,,,,33.4,287.0,5.599999999999998e-29,129.8,sp|Q8VYR2|NUDT9_ARATH Nudix hydrolase 9 OS=Arabidopsis thaliana OX=3702 GN=NUDT9 PE=2 SV=1,,,,,,
OG_06716,FUN_031466-T1,Peve_00026559,Pocillopora_meandrina_HIv1___RNAseq.g5146.t1,three_way,90.51,FUN_031466-T1,Q2KIU7,,,,,53.2,278.0,5.9e-83,308.9,sp|Q2KIU7|RSPH9_BOVIN Radial spoke head protein 9 homolog OS=Bos taurus OX=9913 GN=RSPH9 PE=2 SV=1,,,,,,
OG_06717,FUN_031467-T1,Peve_00026558,Pocillopora_meandrina_HIv1___RNAseq.g5084.t2,three_way,78.09566666666667,FUN_031467-T1,Q5RDQ2,PALS1_PONAB,,Protein PALS1 (MAGUK p55 subfamily member 5) (Protein associated with Lin-7 1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),46.4,576.0,2.3e-140,501.5,sp|Q5RDQ2|PALS1_PONAB Protein PALS1 OS=Pongo abelii OX=9601 GN=PALS1 PE=2 SV=1,GO:0005524; GO:0005794; GO:0005912; GO:0005923; GO:0016324; GO:0017015; GO:0021954; GO:0021987; GO:0030424; GO:0043204,central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; bicellular tight junction [GO:0005923]; Golgi apparatus [GO:0005794]; perikaryon [GO:0043204],ATP binding [GO:0005524],GO:0005794; GO:0043226; GO:0048856,Golgi apparatus; organelle; anatomical structure development
OG_06718,FUN_031469-T1,Peve_00026553,Pocillopora_meandrina_HIv1___RNAseq.g5083.t1,three_way,63.895,,,,,,,,,,,,,,,,,
OG_06719,FUN_031470-T1,Peve_00026552,Pocillopora_meandrina_HIv1___RNAseq.g5082.t1,three_way,68.5885,FUN_031470-T1,Q9JLC8,,,,,30.2,4722.0,0.0,1872.1,sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2,,,,,,
OG_06720,FUN_031471-T1,Peve_00026551,Pocillopora_meandrina_HIv1___RNAseq.g5081.t1,three_way,81.32666666666667,FUN_031471-T1,P97376,,,,,43.9,214.0,1.7e-44,181.0,sp|P97376|FRG1_MOUSE Protein FRG1 OS=Mus musculus OX=10090 GN=Frg1 PE=1 SV=2,,,,,,
OG_06721,FUN_031472-T1,Peve_00026549,Pocillopora_meandrina_HIv1___RNAseq.g5080.t1,three_way,65.82266666666666,FUN_031472-T1,Q5F4B8,,,,,30.9,444.0,3.9e-40,167.5,sp|Q5F4B8|S46A3_CHICK Lysosomal proton-coupled steroid conjugate and bile acid symporter SLC46A3 OS=Gallus gallus OX=9031 GN=SLC46A3 PE=2 SV=1,,,,,,
OG_06722,FUN_031477-T1,Peve_00026545,Pocillopora_meandrina_HIv1___RNAseq.g5079.t1,three_way,55.821,FUN_031477-T1,Q5FYA8,ARSH_HUMAN,,Arylsulfatase H (ASH) (EC 3.1.6.-),Homo sapiens (Human),29.7,536.0,5.5e-48,193.7,sp|Q5FYA8|ARSH_HUMAN Arylsulfatase H OS=Homo sapiens OX=9606 GN=ARSH PE=2 SV=1,GO:0004065; GO:0005788; GO:0016020; GO:0046872,,endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872],GO:0003824; GO:0016787,catalytic activity; hydrolase activity
OG_06723,FUN_031489-T1,Peve_00026539,Pocillopora_meandrina_HIv1___RNAseq.g5078.t1,three_way,87.43599999999999,FUN_031489-T1,O82018,,,,,70.5,146.0,1.3e-29,131.0,sp|O82018|CALM_MOUSC Calmodulin OS=Mougeotia scalaris OX=13158 PE=2 SV=3,,,,,,
OG_06724,FUN_031493-T1,Peve_00026536,Pocillopora_meandrina_HIv1___RNAseq.g5092.t1,three_way,89.652,FUN_031493-T1,A4QNE6,,,,,72.3,354.0,2.9e-159,562.8,sp|A4QNE6|DAA10_XENTR Dynein axonemal assembly factor 10 OS=Xenopus tropicalis OX=8364 GN=dnaaf10 PE=2 SV=1,,,,,,
OG_06725,FUN_031497-T1,Peve_00044299,Pocillopora_meandrina_HIv1___RNAseq.g5099.t1,three_way,61.17183333333333,FUN_031497-T1,Q5T197,DCST1_HUMAN,,E3 ubiquitin-protein ligase DCST1 (EC 2.3.2.27) (DC-STAMP domain-containing protein 1) (RING-type E3 ubiquitin transferase),Homo sapiens (Human),26.0,338.0,8.3e-13,77.8,sp|Q5T197|DCST1_HUMAN E3 ubiquitin-protein ligase DCST1 OS=Homo sapiens OX=9606 GN=DCST1 PE=1 SV=1,GO:0002080; GO:0005886; GO:0006511; GO:0007342; GO:0008270; GO:0016567; GO:0035036; GO:0045087; GO:0060339; GO:0061630,fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein ubiquitination [GO:0016567]; sperm-egg recognition [GO:0035036]; ubiquitin-dependent protein catabolic process [GO:0006511],acrosomal membrane [GO:0002080]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005886; GO:0016740; GO:0022414; GO:0061024; GO:0098542; GO:0140096,"immune system process; catalytic activity; plasma membrane; transferase activity; reproductive process; membrane organization; defense response to other organism; catalytic activity, acting on a protein"
OG_06726,FUN_031499-T1,Peve_00026541,Pocillopora_meandrina_HIv1___RNAseq.g5100.t1,three_way,66.92466666666667,FUN_031499-T1,Q0VFR9,,,,,41.0,641.0,2e-118,427.9,sp|Q0VFR9|MED17_XENTR Mediator of RNA polymerase II transcription subunit 17 OS=Xenopus tropicalis OX=8364 GN=med17 PE=2 SV=1,,,,,,
OG_06727,FUN_031500-T1,Peve_00044287,Pocillopora_meandrina_HIv1___RNAseq.g5103.t1,three_way,70.925,FUN_031500-T1,Q9VCZ3,OCTB1_DROME,,Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R),Drosophila melanogaster (Fruit fly),25.6,309.0,9.6e-13,76.6,sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1,GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410],membrane [GO:0016020]; plasma membrane [GO:0005886],adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_06728,FUN_031501-T1,Peve_00044288,Pocillopora_meandrina_HIv1___RNAseq.g5104.t1,three_way,66.48166666666667,FUN_031501-T1,O58320,,,,,47.3,292.0,1e-60,235.3,sp|O58320|GYAR_PYRHO Glyoxylate reductase OS=Pyrococcus horikoshii (strain ATCC 700860 / DSM 12428 / JCM 9974 / NBRC 100139 / OT-3) OX=70601 GN=gyaR PE=1 SV=2,,,,,,
OG_06729,FUN_031505-T1,Peve_00004810,Pocillopora_meandrina_HIv1___TS.g23831.t2,three_way,48.518166666666666,FUN_031505-T1,Q6L4L4,SIZ1_ORYSJ,,E3 SUMO-protein ligase SIZ1 (EC 2.3.2.-) (E3 SUMO-protein transferase SIZ1),Oryza sativa subsp. japonica (Rice),33.0,109.0,6e-10,66.6,sp|Q6L4L4|SIZ1_ORYSJ E3 SUMO-protein ligase SIZ1 OS=Oryza sativa subsp. japonica OX=39947 GN=SIZ1 PE=1 SV=1,GO:0000785; GO:0005634; GO:0008270; GO:0016925; GO:0061665,protein sumoylation [GO:0016925],chromatin [GO:0000785]; nucleus [GO:0005634],SUMO ligase activity [GO:0061665]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06730,FUN_031507-T1,Peve_00004813,Pocillopora_meandrina_HIv1___RNAseq.g5114.t1,three_way,62.814,FUN_031507-T1,H3ZPL1,,,,,29.4,394.0,3.1e-48,194.1,sp|H3ZPL1|ARAT1_THELN Aromatic-amino-acid aminotransferase 1 OS=Thermococcus litoralis (strain ATCC 51850 / DSM 5473 / JCM 8560 / NS-C) OX=523849 GN=OCC_04335 PE=1 SV=1,,,,,,
OG_06731,FUN_031508-T1,Peve_00004814,Pocillopora_meandrina_HIv1___RNAseq.g5115.t1,three_way,90.06433333333334,FUN_031508-T1,Q86TJ2,TAD2B_HUMAN,,Transcriptional adapter 2-beta (ADA2-like protein beta) (ADA2-beta),Homo sapiens (Human),45.8,432.0,9.7e-101,368.6,sp|Q86TJ2|TAD2B_HUMAN Transcriptional adapter 2-beta OS=Homo sapiens OX=9606 GN=TADA2B PE=1 SV=2,GO:0000124; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0006282; GO:0006338; GO:0006357; GO:0008270; GO:0043484; GO:0045893; GO:0070461,chromatin remodeling [GO:0006338]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; SAGA-type complex [GO:0070461],chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_06732,FUN_031509-T1,Peve_00004815,Pocillopora_meandrina_HIv1___TS.g23836.t1,three_way,71.6965,FUN_031509-T1,A7SIM4,HAP2_NEMVE,,Hapless 2 (Generative cell specific 1),Nematostella vectensis (Starlet sea anemone),51.4,905.0,3.5e-260,899.4,sp|A7SIM4|HAP2_NEMVE Hapless 2 OS=Nematostella vectensis OX=45351 GN=HAP2 PE=1 SV=1,GO:0005886; GO:0007338; GO:0008289,single fertilization [GO:0007338],plasma membrane [GO:0005886],lipid binding [GO:0008289],GO:0005886; GO:0008289; GO:0022414,plasma membrane; lipid binding; reproductive process
OG_06733,FUN_031517-T2,Peve_00045249,Pocillopora_meandrina_HIv1___TS.g23839.t1,three_way,57.293,FUN_031517-T2,Q8NBJ9,SIDT2_HUMAN,,SID1 transmembrane family member 2,Homo sapiens (Human),23.9,440.0,5.2e-15,84.7,sp|Q8NBJ9|SIDT2_HUMAN SID1 transmembrane family member 2 OS=Homo sapiens OX=9606 GN=SIDT2 PE=1 SV=2,GO:0000902; GO:0003323; GO:0003677; GO:0003725; GO:0005764; GO:0005765; GO:0005886; GO:0006401; GO:0009749; GO:0035612; GO:0035650; GO:0042593; GO:0044342; GO:0050658; GO:0051032; GO:0051033; GO:0061178,cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342],lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032]; RNA transmembrane transporter activity [GO:0051033],GO:0003677; GO:0003723; GO:0005215; GO:0005764; GO:0005773; GO:0005886; GO:0043226; GO:0048856,DNA binding; RNA binding; transporter activity; lysosome; vacuole; plasma membrane; organelle; anatomical structure development
OG_06734,FUN_031518-T1,Peve_00045248,Pocillopora_meandrina_HIv1___RNAseq.g5120.t1,three_way,47.7075,FUN_031518-T1,D0PRN3,,,,,27.2,463.0,3.3000000000000003e-34,148.3,sp|D0PRN3|NRX3A_CHICK Neurexin-3 OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06735,FUN_031519-T1,Peve_00045247,Pocillopora_meandrina_HIv1___RNAseq.g5126.t1,three_way,70.90833333333333,,,,,,,,,,,,,,,,,
OG_06736,FUN_031523-T1,Peve_00045246,Pocillopora_meandrina_HIv1___RNAseq.g5128.t1,three_way,77.84,FUN_031523-T1,Q5RF14,,,,,51.4,693.0,1.8e-197,690.6,sp|Q5RF14|MIPEP_PONAB Mitochondrial intermediate peptidase OS=Pongo abelii OX=9601 GN=MIPEP PE=2 SV=1,,,,,,
OG_06737,FUN_031524-T1,Peve_00022781,Pocillopora_meandrina_HIv1___RNAseq.g5130.t1,three_way,58.0995,FUN_031524-T1,Q4KLN4,GLE1_RAT,,mRNA export factor GLE1 (GLE1 RNA export mediator) (GLE1-like protein) (Nucleoporin GLE1),Rattus norvegicus (Rat),41.9,329.0,2.3e-70,268.5,sp|Q4KLN4|GLE1_RAT mRNA export factor GLE1 OS=Rattus norvegicus OX=10116 GN=Gle1 PE=2 SV=1,GO:0000822; GO:0005543; GO:0005635; GO:0005737; GO:0005813; GO:0005814; GO:0015031; GO:0016973; GO:0031369; GO:0036064; GO:0042802; GO:0044614,poly(A)+ mRNA export from nucleus [GO:0016973]; protein transport [GO:0015031],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear pore cytoplasmic filaments [GO:0044614],identical protein binding [GO:0042802]; inositol hexakisphosphate binding [GO:0000822]; phospholipid binding [GO:0005543]; translation initiation factor binding [GO:0031369],GO:0005635; GO:0005815; GO:0006913; GO:0008289; GO:0043226,nuclear envelope; microtubule organizing center; nucleocytoplasmic transport; lipid binding; organelle
OG_06738,FUN_031525-T1,Peve_00022761,Pocillopora_meandrina_HIv1___TS.g23851.t1,three_way,69.21566666666666,FUN_031525-T1,O75445,USH2A_HUMAN,,Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein),Homo sapiens (Human),31.2,5403.0,0.0,2352.8,sp|O75445|USH2A_HUMAN Usherin OS=Homo sapiens OX=9606 GN=USH2A PE=1 SV=3,GO:0001917; GO:0002141; GO:0002142; GO:0005518; GO:0005576; GO:0005604; GO:0005737; GO:0007601; GO:0007605; GO:0016324; GO:0017022; GO:0032391; GO:0032421; GO:0035315; GO:0036064; GO:0042491; GO:0042802; GO:0045184; GO:0045494; GO:0048496; GO:0050953; GO:0051649; GO:0060113; GO:0060171; GO:1990075; GO:1990696,establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; hair cell differentiation [GO:0035315]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear receptor cell differentiation [GO:0060113]; maintenance of animal organ identity [GO:0048496]; photoreceptor cell maintenance [GO:0045494]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium bundle [GO:0032421]; stereocilium membrane [GO:0060171]; USH2 complex [GO:1990696],collagen binding [GO:0005518]; identical protein binding [GO:0042802]; myosin binding [GO:0017022],GO:0005576; GO:0005815; GO:0008092; GO:0030154; GO:0030312; GO:0031012; GO:0050877,extracellular region; microtubule organizing center; cytoskeletal protein binding; cell differentiation; external encapsulating structure; extracellular matrix; nervous system process
OG_06739,FUN_031526-T1,Peve_00022762,Pocillopora_meandrina_HIv1___RNAseq.g5133.t1,three_way,69.272,FUN_031526-T1,Q99N57,RAF1_MOUSE,,RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1),Mus musculus (Mouse),31.8,283.0,3.3e-28,127.9,sp|Q99N57|RAF1_MOUSE RAF proto-oncogene serine/threonine-protein kinase OS=Mus musculus OX=10090 GN=Raf1 PE=1 SV=2,GO:0000165; GO:0001678; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0008270; GO:0008285; GO:0008286; GO:0008625; GO:0010856; GO:0014044; GO:0030154; GO:0030878; GO:0031143; GO:0031267; GO:0031333; GO:0035019; GO:0035556; GO:0035773; GO:0035994; GO:0038133; GO:0042552; GO:0042802; GO:0043410; GO:0044342; GO:0045104; GO:0045944; GO:0048009; GO:0048011; GO:0048538; GO:0060324; GO:0071550; GO:0106310; GO:1902042,cell differentiation [GO:0030154]; death-inducing signaling complex assembly [GO:0071550]; ERBB2-ERBB3 signaling pathway [GO:0038133]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; face development [GO:0060324]; insulin receptor signaling pathway [GO:0008286]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular glucose homeostasis [GO:0001678]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; myelination [GO:0042552]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to muscle stretch [GO:0035994]; Schwann cell development [GO:0014044]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; type B pancreatic cell proliferation [GO:0044342],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],adenylate cyclase activator activity [GO:0010856]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005739; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0007010; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"catalytic activity; nucleus; mitochondrion; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; transferase activity; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06740,FUN_031528-T2,Peve_00022765,Pocillopora_meandrina_HIv1___RNAseq.g5137.t1,three_way,65.17133333333334,FUN_031528-T2,Q54H46,DRKA_DICDI,,Probable serine/threonine-protein kinase drkA (EC 2.7.11.1) (Receptor-like kinase 1) (Receptor-like kinase A) (Vesicle-associated receptor tyrosine kinase-like protein 1),Dictyostelium discoideum (Social amoeba),28.8,302.0,9.3e-27,123.2,sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum OX=44689 GN=drkA PE=3 SV=1,GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0097677; GO:0097696; GO:0106310,cell surface receptor signaling pathway via STAT [GO:0097696]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; STAT family protein binding [GO:0097677],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_06741,FUN_031540-T1,Peve_00022767,Pocillopora_meandrina_HIv1___RNAseq.g5140.t2,three_way,78.98833333333333,FUN_031540-T1,Q0KK59,UNC79_MOUSE,,Protein unc-79 homolog,Mus musculus (Mouse),28.5,2723.0,7.2e-267,922.9,sp|Q0KK59|UNC79_MOUSE Protein unc-79 homolog OS=Mus musculus OX=10090 GN=Unc79 PE=1 SV=1,GO:0001967; GO:0005886; GO:0030534; GO:0035264; GO:0048149,adult behavior [GO:0030534]; behavioral response to ethanol [GO:0048149]; multicellular organism growth [GO:0035264]; suckling behavior [GO:0001967],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_06742,FUN_031548-T1,Peve_00022768,Pocillopora_meandrina_HIv1___RNAseq.g5141.t1,three_way,49.17633333333333,FUN_031548-T1,A3KMW7,,,,,26.0,519.0,1.2e-11,73.6,sp|A3KMW7|MAP10_BOVIN Microtubule-associated protein 10 OS=Bos taurus OX=9913 GN=MAP10 PE=2 SV=1,,,,,,
OG_06743,FUN_031549-T1,Peve_00022771,Pocillopora_meandrina_HIv1___RNAseq.g5142.t1,three_way,79.50266666666667,FUN_031549-T1,Q5F480,ITPK1_CHICK,,"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)",Gallus gallus (Chicken),42.8,320.0,4.6e-77,289.7,sp|Q5F480|ITPK1_CHICK Inositol-tetrakisphosphate 1-kinase OS=Gallus gallus OX=9031 GN=ITPK1 PE=2 SV=1,GO:0000287; GO:0000825; GO:0005524; GO:0016853; GO:0032957; GO:0047325; GO:0052725; GO:0052726; GO:0052835; GO:0070266,inositol trisphosphate metabolic process [GO:0032957]; necroptotic process [GO:0070266],,"ATP binding [GO:0005524]; inositol-1,3,4,5-tetrakisphosphate 6-kinase activity [GO:0000825]; inositol-1,3,4-trisphosphate 5-kinase activity [GO:0052726]; inositol-1,3,4-trisphosphate 6-kinase activity [GO:0052725]; inositol-3,4,5,6-tetrakisphosphate 1-kinase activity [GO:0047325]; inositol-3,4,6-trisphosphate 1-kinase activity [GO:0052835]; isomerase activity [GO:0016853]; magnesium ion binding [GO:0000287]",GO:0003824; GO:0012501; GO:0016740; GO:0016853,catalytic activity; programmed cell death; transferase activity; isomerase activity
OG_06744,FUN_031550-T1,Peve_00022772,Pocillopora_meandrina_HIv1___RNAseq.g5143.t1,three_way,67.64183333333334,,,,,,,,,,,,,,,,,
OG_06745,FUN_031552-T1,Peve_00022775,Pocillopora_meandrina_HIv1___TS.g23806.t2,three_way,57.309,,,,,,,,,,,,,,,,,
OG_06746,FUN_031553-T1,Peve_00022777,Pocillopora_meandrina_HIv1___TS.g23807.t1,three_way,61.806333333333335,,,,,,,,,,,,,,,,,
OG_06747,FUN_031556-T1,Peve_00022778,Pocillopora_meandrina_HIv1___RNAseq.g5088.t1,three_way,56.9495,FUN_031556-T1,Q6DD45,ZCHC8_XENLA,,Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8),Xenopus laevis (African clawed frog),35.5,389.0,7.999999999999999e-53,209.9,sp|Q6DD45|ZCHC8_XENLA Zinc finger CCHC domain-containing protein 8 OS=Xenopus laevis OX=8355 GN=zcchc8 PE=2 SV=1,GO:0003723; GO:0005654; GO:0006396; GO:0008270; GO:0031124; GO:0071013,mRNA 3'-end processing [GO:0031124]; RNA processing [GO:0006396],catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005654; GO:0016071,RNA binding; nucleoplasm; mRNA metabolic process
OG_06748,FUN_031557-T1,Peve_00022779,Pocillopora_meandrina_HIv1___RNAseq.g5089.t1,three_way,81.36666666666666,FUN_031557-T1,Q8BH75,RNF41_MOUSE,,E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1),Mus musculus (Mouse),34.5,197.0,6.9e-21,102.8,sp|Q8BH75|RNF41_MOUSE E3 ubiquitin-protein ligase NRDP1 OS=Mus musculus OX=10090 GN=Rnf41 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005128; GO:0005135; GO:0006914; GO:0008270; GO:0008285; GO:0010498; GO:0019904; GO:0030336; GO:0030971; GO:0031267; GO:0042802; GO:0043408; GO:0045619; GO:0045637; GO:0045732; GO:0048471; GO:0051865; GO:0051896; GO:0061630; GO:0071782; GO:0097191; GO:1901525; GO:2000379,autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471],erythropoietin receptor binding [GO:0005128]; identical protein binding [GO:0042802]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; receptor tyrosine kinase binding [GO:0030971]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0006914; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; autophagy; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_06749,FUN_031558-T1,Peve_00022782,Pocillopora_meandrina_HIv1___RNAseq.g5091.t1,three_way,75.19633333333334,FUN_031558-T1,Q6PBX9,,,,,40.2,179.0,2.4999999999999998e-31,137.1,sp|Q6PBX9|REEP5_DANRE Receptor expression-enhancing protein 5 OS=Danio rerio OX=7955 GN=reep5 PE=1 SV=1,,,,,,
OG_06750,FUN_031559-T1,Peve_00032865,Pocillopora_meandrina_HIv1___RNAseq.g5076.t1,three_way,48.826166666666666,FUN_031559-T1,Q8WXE1,ATRIP_HUMAN,,ATR-interacting protein (ATM and Rad3-related-interacting protein),Homo sapiens (Human),30.7,153.0,1.1e-07,60.8,sp|Q8WXE1|ATRIP_HUMAN ATR-interacting protein OS=Homo sapiens OX=9606 GN=ATRIP PE=1 SV=1,GO:0000077; GO:0005634; GO:0005654; GO:0006139; GO:0006281; GO:0070310; GO:0070530; GO:2000779,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; nucleobase-containing compound metabolic process [GO:0006139]; regulation of double-strand break repair [GO:2000779],ATR-ATRIP complex [GO:0070310]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530],GO:0005634; GO:0005654; GO:0006281; GO:0043226,nucleus; nucleoplasm; DNA repair; organelle
OG_06751,FUN_031560-T1,Peve_00032864,Pocillopora_meandrina_HIv1___TS.g23795.t1,three_way,47.11333333333334,FUN_031560-T1,B1H349,,,,,42.6,68.0,1.3e-06,57.4,sp|B1H349|SOX6_XENTR Transcription factor Sox-6 OS=Xenopus tropicalis OX=8364 GN=sox6 PE=2 SV=1,,,,,,
OG_06752,FUN_031561-T1,Peve_00025442,Pocillopora_meandrina_HIv1___RNAseq.g5074.t2,three_way,66.97466666666666,FUN_031561-T1,Q8TCS8,PNPT1_HUMAN,,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)",Homo sapiens (Human),44.5,366.0,1e-83,312.0,"sp|Q8TCS8|PNPT1_HUMAN Polyribonucleotide nucleotidyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PNPT1 PE=1 SV=2",GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0005840; GO:0006397; GO:0006401; GO:0006402; GO:0007005; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042802; GO:0043457; GO:0045025; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0071042; GO:0097222; GO:0097421; GO:2000627; GO:2000772,cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion organization [GO:0007005]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; rRNA import into mitochondrion [GO:0035928],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosome [GO:0005840],3'-5'-RNA exonuclease activity [GO:0000175]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0005829; GO:0005840; GO:0007005; GO:0016071; GO:0016740; GO:0016787; GO:0043226; GO:0048856; GO:0055085; GO:0065003; GO:0140053; GO:0140098,"RNA binding; catalytic activity; mitochondrion; cytosol; ribosome; mitochondrion organization; mRNA metabolic process; transferase activity; hydrolase activity; organelle; anatomical structure development; transmembrane transport; protein-containing complex assembly; mitochondrial gene expression; catalytic activity, acting on RNA"
OG_06753,FUN_031564-T1,Peve_00021506,Pocillopora_meandrina_HIv1___RNAseq.g5073.t1,three_way,72.53333333333333,FUN_031564-T1,Q8TBA6,GOGA5_HUMAN,,Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein),Homo sapiens (Human),36.0,745.0,2.7e-63,245.0,sp|Q8TBA6|GOGA5_HUMAN Golgin subfamily A member 5 OS=Homo sapiens OX=9606 GN=GOLGA5 PE=1 SV=3,GO:0000139; GO:0000301; GO:0005794; GO:0005801; GO:0007030; GO:0016020; GO:0030133; GO:0031267; GO:0031985; GO:0042803; GO:0048193,"Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",cis-Golgi network [GO:0005801]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133],protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],GO:0005794; GO:0016192; GO:0031410; GO:0043226,Golgi apparatus; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06754,FUN_031565-T1,Peve_00021513,Pocillopora_meandrina_HIv1___RNAseq.g5072.t1,three_way,87.24600000000001,FUN_031565-T1,Q01728,,,,,54.5,932.0,1.8e-266,920.2,sp|Q01728|NAC1_RAT Sodium/calcium exchanger 1 OS=Rattus norvegicus OX=10116 GN=Slc8a1 PE=1 SV=3,,,,,,
OG_06755,FUN_031566-T1,Peve_00021501,Pocillopora_meandrina_HIv1___RNAseq.g5071.t1,three_way,88.431,FUN_031566-T1,Q9H115,,,,,61.9,281.0,5.2e-98,359.0,sp|Q9H115|SNAB_HUMAN Beta-soluble NSF attachment protein OS=Homo sapiens OX=9606 GN=NAPB PE=1 SV=2,,,,,,
OG_06756,FUN_031567-T1,Peve_00021502,Pocillopora_meandrina_HIv1___TS.g23790.t1,three_way,75.33816666666667,FUN_031567-T1,Q86UY6,NAA40_HUMAN,,N-alpha-acetyltransferase 40 (EC 2.3.1.257) (N-acetyltransferase 11) (N-alpha-acetyltransferase D) (NatD) (hNatD) (Protein acetyltransferase 1),Homo sapiens (Human),56.2,217.0,9.4e-63,241.5,sp|Q86UY6|NAA40_HUMAN N-alpha-acetyltransferase 40 OS=Homo sapiens OX=9606 GN=NAA40 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0010485; GO:0034451; GO:0043998; GO:1990189,lipid metabolic process [GO:0006629],centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone H2A acetyltransferase activity [GO:0043998]; histone H4 acetyltransferase activity [GO:0010485]; protein N-terminal-serine acetyltransferase activity [GO:1990189],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; lipid metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06757,FUN_031570-T1,Peve_00021507,Pocillopora_meandrina_HIv1___RNAseq.g5065.t1,three_way,57.521,FUN_031570-T1,D4A218,,,,,32.0,303.0,1.1e-26,122.5,sp|D4A218|DMRT3_RAT Doublesex and mab-3 related transcription factor 3 OS=Rattus norvegicus OX=10116 GN=Dmrt3 PE=3 SV=1,,,,,,
OG_06758,FUN_031589-T1,Peve_00021514,Pocillopora_meandrina_HIv1___RNAseq.g5069.t1,three_way,86.82000000000001,FUN_031589-T1,Q561L1,,,,,61.0,438.0,3.8e-161,569.3,sp|Q561L1|PUA1A_XENLA Adenylosuccinate synthetase isozyme 1 A OS=Xenopus laevis OX=8355 GN=adss1-a PE=2 SV=1,,,,,,
OG_06759,FUN_031590-T1,Peve_00012525,Pocillopora_meandrina_HIv1___RNAseq.g5062.t1,three_way,79.86133333333333,FUN_031590-T1,Q86VP3,PACS2_HUMAN,,Phosphofurin acidic cluster sorting protein 2 (PACS-2) (PACS1-like protein),Homo sapiens (Human),37.8,886.0,1.1e-132,475.7,sp|Q86VP3|PACS2_HUMAN Phosphofurin acidic cluster sorting protein 2 OS=Homo sapiens OX=9606 GN=PACS2 PE=1 SV=3,GO:0000045; GO:0005739; GO:0005783; GO:0006915; GO:0032469; GO:0034497; GO:0044325; GO:0072659; GO:1990456,apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659],endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],transmembrane transporter binding [GO:0044325],GO:0005739; GO:0005783; GO:0012501; GO:0043226; GO:0072659,mitochondrion; endoplasmic reticulum; programmed cell death; organelle; protein localization to plasma membrane
OG_06760,FUN_031591-T1,Peve_00012524,Pocillopora_meandrina_HIv1___RNAseq.g5061.t1,three_way,48.54716666666667,FUN_031591-T1,P40564,,,,,56.9,51.0,6.8e-10,66.2,sp|P40564|DJP1_YEAST DnaJ-like protein 1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=DJP1 PE=1 SV=1,,,,,,
OG_06761,FUN_031592-T1,Peve_00012523,Pocillopora_meandrina_HIv1___RNAseq.g5060.t1,three_way,68.10383333333334,FUN_031592-T1,P41823,,,,,25.5,165.0,2.3e-09,64.3,sp|P41823|SY65_APLCA Synaptotagmin-1 OS=Aplysia californica OX=6500 GN=SYT1 PE=1 SV=2,,,,,,
OG_06762,FUN_031593-T1,Peve_00012522,Pocillopora_meandrina_HIv1___RNAseq.g5059.t1,three_way,61.513,,,,,,,,,,,,,,,,,
OG_06763,FUN_031595-T1,Peve_00012520,Pocillopora_meandrina_HIv1___RNAseq.g5058.t1,three_way,67.68833333333333,FUN_031595-T1,A2CG63,ARI4B_MOUSE,,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Histone deacetylase complex subunit SAP180),Mus musculus (Mouse),27.0,562.0,3e-13,79.0,sp|A2CG63|ARI4B_MOUSE AT-rich interactive domain-containing protein 4B OS=Mus musculus OX=10090 GN=Arid4b PE=1 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006366; GO:0007283; GO:0030336; GO:0030512; GO:0045944; GO:0070822; GO:0071514; GO:0097368; GO:1902455; GO:1902459,chromatin organization [GO:0006325]; establishment of Sertoli cell barrier [GO:0097368]; genomic imprinting [GO:0071514]; negative regulation of cell migration [GO:0030336]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005739; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0022414; GO:0043226; GO:0048856,DNA binding; nucleus; mitochondrion; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development
OG_06764,FUN_031596-T1,Peve_00012519,Pocillopora_meandrina_HIv1___RNAseq.g5057.t1,three_way,58.190333333333335,FUN_031596-T1,P42696,,,,,40.8,314.0,1.3000000000000002e-44,181.8,sp|P42696|RBM34_HUMAN RNA-binding protein 34 OS=Homo sapiens OX=9606 GN=RBM34 PE=1 SV=2,,,,,,
OG_06765,FUN_031597-T1,Peve_00012517,Pocillopora_meandrina_HIv1___RNAseq.g5995.t1,three_way,76.125,,,,,,,,,,,,,,,,,
OG_06766,FUN_031605-T1,Peve_00012514,Pocillopora_meandrina_HIv1___RNAseq.g5989.t1,three_way,84.85766666666667,FUN_031605-T1,Q6PB93,GALT2_MOUSE,,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],Mus musculus (Mouse),62.1,493.0,2.3e-192,673.3,sp|Q6PB93|GALT2_MOUSE Polypeptide N-acetylgalactosaminyltransferase 2 OS=Mus musculus OX=10090 GN=Galnt2 PE=1 SV=1,GO:0002639; GO:0004653; GO:0005576; GO:0005796; GO:0006493; GO:0016266; GO:0018242; GO:0018243; GO:0030145; GO:0030246; GO:0032580; GO:0048471; GO:0051604,O-glycan processing [GO:0016266]; positive regulation of immunoglobulin production [GO:0002639]; protein maturation [GO:0051604]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; perinuclear region of cytoplasm [GO:0048471],carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005576; GO:0009101; GO:0016740; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; extracellular region; glycoprotein biosynthetic process; transferase activity; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_06767,FUN_031606-T1,Peve_00012513,Pocillopora_meandrina_HIv1___RNAseq.g5968.t1,three_way,73.351,FUN_031606-T1,Q9HBF4,ZFYV1_HUMAN,,Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1),Homo sapiens (Human),53.5,708.0,2.8e-217,756.5,sp|Q9HBF4|ZFYV1_HUMAN Zinc finger FYVE domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZFYVE1 PE=1 SV=1,GO:0000407; GO:0005545; GO:0005547; GO:0005739; GO:0005776; GO:0005783; GO:0005789; GO:0005794; GO:0005795; GO:0005811; GO:0008270; GO:0009267; GO:0016236; GO:0032266; GO:0043325; GO:0044233; GO:0044829; GO:0048471; GO:0097629; GO:0140042; GO:1990462,cellular response to starvation [GO:0009267]; lipid droplet formation [GO:0140042]; macroautophagy [GO:0016236]; positive regulation by host of viral genome replication [GO:0044829],autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of omegasome membrane [GO:0097629]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407],"1-phosphatidylinositol binding [GO:0005545]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270]",GO:0005739; GO:0005773; GO:0005783; GO:0005794; GO:0005811; GO:0006914; GO:0008289; GO:0043226,mitochondrion; vacuole; endoplasmic reticulum; Golgi apparatus; lipid droplet; autophagy; lipid binding; organelle
OG_06768,FUN_031608-T1,Peve_00012512,Pocillopora_meandrina_HIv1___RNAseq.g5967.t1,three_way,78.76383333333334,FUN_031608-T1,Q92541,RTF1_HUMAN,,RNA polymerase-associated protein RTF1 homolog,Homo sapiens (Human),48.1,349.0,1e-80,302.4,sp|Q92541|RTF1_HUMAN RNA polymerase-associated protein RTF1 homolog OS=Homo sapiens OX=9606 GN=RTF1 PE=1 SV=4,GO:0000122; GO:0001711; GO:0001832; GO:0003697; GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0006368; GO:0016055; GO:0016593; GO:0019827,blastocyst growth [GO:0001832]; chromatin organization [GO:0006325]; endodermal cell fate commitment [GO:0001711]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368]; Wnt signaling pathway [GO:0016055],Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0043226,DNA binding; RNA binding; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; organelle
OG_06769,FUN_031627-T1,Peve_00019757,Pocillopora_meandrina_HIv1___RNAseq.g5964.t1,three_way,88.16233333333334,,,,,,,,,,,,,,,,,
OG_06770,FUN_031633-T1,Peve_00012499,Pocillopora_meandrina_HIv1___RNAseq.g5960.t1,three_way,82.72833333333334,FUN_031633-T1,A0A3Q7ZPG5,S39A9_MICUN,,Zinc transporter ZIP9 (ZIP-9) (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9),Micropogonias undulatus (Atlantic croaker),59.5,316.0,4.9000000000000004e-86,319.3,sp|A0A3Q7ZPG5|S39A9_MICUN Zinc transporter ZIP9 OS=Micropogonias undulatus OX=29154 GN=slc39a9 PE=1 SV=1,GO:0004930; GO:0005385; GO:0005497; GO:0005634; GO:0005739; GO:0005794; GO:0005886; GO:0006882; GO:0048471; GO:0071577,intracellular zinc ion homeostasis [GO:0006882]; zinc ion transmembrane transport [GO:0071577],Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],androgen binding [GO:0005497]; G protein-coupled receptor activity [GO:0004930]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005634; GO:0005739; GO:0005794; GO:0005886; GO:0043226; GO:0055085; GO:0060089,transporter activity; nucleus; mitochondrion; Golgi apparatus; plasma membrane; organelle; transmembrane transport; molecular transducer activity
OG_06771,FUN_031635-T1,Peve_00032682,Pocillopora_meandrina_HIv1___RNAseq.g5688.t1,three_way,60.882666666666665,FUN_031635-T1,Q9DBY8,NVL_MOUSE,,Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein),Mus musculus (Mouse),44.8,562.0,1.9e-102,374.8,sp|Q9DBY8|NVL_MOUSE Nuclear valosin-containing protein-like OS=Mus musculus OX=10090 GN=Nvl PE=1 SV=1,GO:0000176; GO:0005524; GO:0005634; GO:0005654; GO:0005697; GO:0005730; GO:0006364; GO:0016887; GO:0032092; GO:0032206; GO:0042254; GO:0042273; GO:1904749; GO:1905323; GO:1990275,positive regulation of protein binding [GO:0032092]; positive regulation of telomere maintenance [GO:0032206]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364]; telomerase holoenzyme complex assembly [GO:1905323],nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; preribosome binding [GO:1990275],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0042254; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; ribosome biogenesis; organelle; protein-containing complex assembly
OG_06772,FUN_031637-T1,Peve_00032681,Pocillopora_meandrina_HIv1___RNAseq.g5689.t1,three_way,76.88733333333333,FUN_031637-T1,Q5HZE0,S2529_RAT,,Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29),Rattus norvegicus (Rat),52.4,288.0,1.7e-80,300.8,sp|Q5HZE0|S2529_RAT Mitochondrial basic amino acids transporter OS=Rattus norvegicus OX=10116 GN=Slc25a29 PE=2 SV=1,GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0015174; GO:0015227; GO:0015822; GO:0089709; GO:1903401; GO:1903826; GO:1990575,L-arginine transmembrane transport [GO:1903826]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity L-arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_06773,FUN_031638-T1,Peve_00032680,Pocillopora_meandrina_HIv1___TS.g24410.t3a,three_way,91.53766666666668,FUN_031638-T1,P25490,TYY1_HUMAN,,Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1),Homo sapiens (Human),88.5,113.0,4.1e-58,226.5,sp|P25490|TYY1_HUMAN Transcriptional repressor protein YY1 OS=Homo sapiens OX=9606 GN=YY1 PE=1 SV=2,GO:0000122; GO:0000400; GO:0000723; GO:0000724; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0000987; GO:0001217; GO:0001227; GO:0001228; GO:0003677; GO:0003682; GO:0003723; GO:0005634; GO:0005654; GO:0005667; GO:0005677; GO:0006275; GO:0006282; GO:0006338; GO:0006357; GO:0006403; GO:0006974; GO:0007283; GO:0008270; GO:0009952; GO:0010225; GO:0010628; GO:0010629; GO:0016363; GO:0030183; GO:0031011; GO:0031519; GO:0032688; GO:0033044; GO:0034644; GO:0034696; GO:0045739; GO:0045893; GO:0045944; GO:0045995; GO:0046332; GO:0048593; GO:0051726; GO:0060382; GO:0061052; GO:0071347; GO:0071707; GO:0140297; GO:1902894; GO:1904507; GO:1990837,anterior/posterior pattern specification [GO:0009952]; B cell differentiation [GO:0030183]; camera-type eye morphogenesis [GO:0048593]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; immunoglobulin heavy chain V-D-J recombination [GO:0071707]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283]; telomere maintenance [GO:0000723],chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; Ino80 complex [GO:0031011]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0032200; GO:0043226; GO:0140110,immune system process; DNA binding; RNA binding; nucleus; nucleoplasm; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; telomere organization; organelle; transcription regulator activity
OG_06774,FUN_031639-T1,Peve_00032679,Pocillopora_meandrina_HIv1___TS.g24410.t3b,three_way,82.65466666666667,FUN_031639-T1,Q6NWD4,TIM50_DANRE,,Mitochondrial import inner membrane translocase subunit TIM50,Danio rerio (Zebrafish) (Brachydanio rerio),50.0,268.0,1.1e-68,261.9,sp|Q6NWD4|TIM50_DANRE Mitochondrial import inner membrane translocase subunit TIM50 OS=Danio rerio OX=7955 GN=timm50 PE=2 SV=2,GO:0004722; GO:0004725; GO:0005743; GO:0005744; GO:0006470; GO:0006915; GO:0007006; GO:0030150,apoptotic process [GO:0006915]; mitochondrial membrane organization [GO:0007006]; protein dephosphorylation [GO:0006470]; protein import into mitochondrial matrix [GO:0030150],mitochondrial inner membrane [GO:0005743]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744],protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0007005; GO:0012501; GO:0016787; GO:0055085; GO:0061024; GO:0140096,"catalytic activity; mitochondrion organization; programmed cell death; hydrolase activity; transmembrane transport; membrane organization; catalytic activity, acting on a protein"
OG_06775,FUN_031641-T1,Peve_00032677,Pocillopora_meandrina_HIv1___TS.g24411.t1,three_way,53.80883333333333,FUN_031641-T1,P18168,SERR_DROME,,Protein serrate (Protein beaded),Drosophila melanogaster (Fruit fly),31.2,337.0,1.0000000000000001e-34,149.8,sp|P18168|SERR_DROME Protein serrate OS=Drosophila melanogaster OX=7227 GN=Ser PE=1 SV=3,GO:0005112; GO:0005509; GO:0005886; GO:0007219; GO:0007423; GO:0007435; GO:0007436; GO:0007476; GO:0007480; GO:0008587; GO:0009986; GO:0014009; GO:0016324; GO:0016330; GO:0030673; GO:0030718; GO:0035017; GO:0035167; GO:0035204; GO:0035214; GO:0036011; GO:0042688; GO:0043208; GO:0045179; GO:0046331; GO:0048018; GO:0048100; GO:0048749,compound eye development [GO:0048749]; crystal cell differentiation [GO:0042688]; cuticle pattern formation [GO:0035017]; eye-antennal disc development [GO:0035214]; germ-line stem cell population maintenance [GO:0030718]; glial cell proliferation [GO:0014009]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; larval lymph gland hemopoiesis [GO:0035167]; larval salivary gland morphogenesis [GO:0007436]; lateral inhibition [GO:0046331]; negative regulation of lamellocyte differentiation [GO:0035204]; Notch signaling pathway [GO:0007219]; salivary gland morphogenesis [GO:0007435]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; wing disc anterior/posterior pattern formation [GO:0048100],apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axolemma [GO:0030673]; cell surface [GO:0009986]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; glycosphingolipid binding [GO:0043208]; Notch binding [GO:0005112]; receptor ligand activity [GO:0048018],GO:0000278; GO:0002376; GO:0005886; GO:0008289; GO:0023052; GO:0030154; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; immune system process; plasma membrane; lipid binding; signaling; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_06776,FUN_031642-T1,Peve_00032678,Pocillopora_meandrina_HIv1___RNAseq.g5693.t1,three_way,79.11933333333333,FUN_031642-T1,Q16975,,,,,57.8,742.0,1.7e-248,860.1,sp|Q16975|KPC2_APLCA Calcium-independent protein kinase C OS=Aplysia californica OX=6500 GN=PRKC2 PE=1 SV=1,,,,,,
OG_06777,FUN_031643-T1,Peve_00043580,Pocillopora_meandrina_HIv1___RNAseq.g5686.t1,three_way,83.8815,FUN_031643-T1,Q14738,2A5D_HUMAN,,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta),Homo sapiens (Human),65.9,548.0,3.3e-205,716.1,sp|Q14738|2A5D_HUMAN Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform OS=Homo sapiens OX=9606 GN=PPP2R5D PE=1 SV=1,GO:0000159; GO:0005634; GO:0005654; GO:0005829; GO:0007165; GO:0007399; GO:0019888; GO:0051177; GO:0072542,meiotic sister chromatid cohesion [GO:0051177]; nervous system development [GO:0007399]; signal transduction [GO:0007165],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159],protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888],GO:0005634; GO:0005654; GO:0005829; GO:0043226; GO:0048856; GO:0098772,nucleus; nucleoplasm; cytosol; organelle; anatomical structure development; molecular function regulator activity
OG_06778,FUN_031644-T1,Peve_00043582,Pocillopora_meandrina_HIv1___RNAseq.g5685.t1,three_way,76.86,FUN_031644-T1,Q3EBF7,SLD2_ARATH,,Delta(8)-fatty-acid desaturase 2 (EC 1.14.19.29) (Delta(8)-sphingolipid desaturase 2) (Sphingoid long-chain base desaturase 2) (Sphingoid LCB desaturase 2) (Sphingolipid 8-(E/Z)-desaturase 2),Arabidopsis thaliana (Mouse-ear cress),41.9,451.0,8.5e-100,365.5,sp|Q3EBF7|SLD2_ARATH Delta(8)-fatty-acid desaturase 2 OS=Arabidopsis thaliana OX=3702 GN=SLD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0030148; GO:0046872; GO:0052631; GO:0070417,cellular response to cold [GO:0070417]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],metal ion binding [GO:0046872]; sphingolipid 8-(E/Z)-desaturase activity [GO:0052631],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle
OG_06779,FUN_031646-T1,Peve_00043571,Pocillopora_meandrina_HIv1___RNAseq.g5683.t1,three_way,65.723,FUN_031646-T1,A6H7B1,,,,,54.9,144.0,2.7e-34,146.4,sp|A6H7B1|TOM20_BOVIN Mitochondrial import receptor subunit TOM20 homolog OS=Bos taurus OX=9913 GN=TOMM20 PE=2 SV=1,,,,,,
OG_06780,FUN_031647-T1,Peve_00043573,Pocillopora_meandrina_HIv1___RNAseq.g5682.t1,three_way,73.94383333333333,FUN_031647-T1,A0A1L8G016,,,,,52.6,485.0,1e-89,332.0,sp|A0A1L8G016|DAA11_XENLA Dynein axonemal assembly factor 11 OS=Xenopus laevis OX=8355 GN=dnaaf11 PE=3 SV=1,,,,,,
OG_06781,FUN_031648-T1,Peve_00043574,Pocillopora_meandrina_HIv1___RNAseq.g5681.t1,three_way,93.75783333333334,FUN_031648-T1,Q6PD03,2A5A_MOUSE,,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha),Mus musculus (Mouse),75.4,443.0,6.199999999999999e-189,661.8,sp|Q6PD03|2A5A_MOUSE Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform OS=Mus musculus OX=10090 GN=Ppp2r5a PE=1 SV=1,GO:0000159; GO:0000775; GO:0005634; GO:0005813; GO:0005829; GO:0005886; GO:0007165; GO:0019210; GO:0019900; GO:0030018; GO:0031430; GO:0072542; GO:1903077,negative regulation of protein localization to plasma membrane [GO:1903077]; signal transduction [GO:0007165],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; M band [GO:0031430]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]",kinase binding [GO:0019900]; kinase inhibitor activity [GO:0019210]; protein phosphatase activator activity [GO:0072542],GO:0005634; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; plasma membrane; organelle; molecular function regulator activity
OG_06782,FUN_031649-T1,Peve_00043575,Pocillopora_meandrina_HIv1___TS.g24400.t2a,three_way,66.82783333333333,FUN_031649-T1,Q96PN7,TREF1_HUMAN,,Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132),Homo sapiens (Human),29.4,486.0,4.0000000000000004e-39,165.6,sp|Q96PN7|TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens OX=9606 GN=TRERF1 PE=1 SV=1,GO:0000118; GO:0001223; GO:0001650; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0008270; GO:0033142; GO:0045892; GO:0045893; GO:0045944; GO:0050847; GO:0071393,cellular response to progesterone stimulus [GO:0071393]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; nuclear progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_06783,FUN_031650-T1,Peve_00043578,Pocillopora_meandrina_HIv1___TS.g24400.t2b,three_way,70.58166666666666,FUN_031650-T1,Q5R5D8,BODG_PONAB,,"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),35.3,380.0,3e-73,277.3,sp|Q5R5D8|BODG_PONAB Gamma-butyrobetaine dioxygenase OS=Pongo abelii OX=9601 GN=BBOX1 PE=2 SV=1,GO:0005506; GO:0005739; GO:0008270; GO:0008336; GO:0045329,carnitine biosynthetic process [GO:0045329],mitochondrion [GO:0005739],gamma-butyrobetaine dioxygenase activity [GO:0008336]; iron ion binding [GO:0005506]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_06784,FUN_031651-T1,Peve_00017754,Pocillopora_meandrina_HIv1___RNAseq.g5677.t1,three_way,75.48266666666667,FUN_031651-T1,Q9NQX3,GEPH_HUMAN,,Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)],Homo sapiens (Human),46.9,721.0,2.5e-174,614.4,sp|Q9NQX3|GEPH_HUMAN Gephyrin OS=Homo sapiens OX=9606 GN=GPHN PE=1 SV=1,GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0006777; GO:0007416; GO:0007529; GO:0008940; GO:0009898; GO:0010038; GO:0014069; GO:0030425; GO:0030674; GO:0032324; GO:0042802; GO:0043197; GO:0043546; GO:0045184; GO:0045211; GO:0046872; GO:0060077; GO:0061598; GO:0061599; GO:0072579; GO:0097060; GO:0097112; GO:0098690; GO:0098982; GO:0099091; GO:0099572; GO:0099645,establishment of protein localization [GO:0045184]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; response to metal ion [GO:0010038]; synapse assembly [GO:0007416],"cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization, intracellular component [GO:0099091]; synaptic membrane [GO:0097060]",ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; protein-macromolecule adaptor activity [GO:0030674]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005856; GO:0005886; GO:0016491; GO:0016740; GO:0034330; GO:0043226; GO:0060090,catalytic activity; cytosol; cytoskeleton; plasma membrane; oxidoreductase activity; transferase activity; cell junction organization; organelle; molecular adaptor activity
OG_06785,FUN_031652-T1,Peve_00017753,Pocillopora_meandrina_HIv1___RNAseq.g5676.t1,three_way,63.12333333333333,FUN_031652-T1,Q642T7,,,,,48.6,366.0,1.9e-91,338.2,sp|Q642T7|UTP25_XENTR U3 small nucleolar RNA-associated protein 25 homolog OS=Xenopus tropicalis OX=8364 GN=utp25 PE=2 SV=1,,,,,,
OG_06786,FUN_031653-T1,Peve_00017752,Pocillopora_meandrina_HIv1___RNAseq.g5674.t1a,three_way,77.49199999999999,FUN_031653-T1,A7RIT9,3HAO_NEMVE,,"3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6) (3-hydroxyanthranilate oxygenase) (3-HAO) (3-hydroxyanthranilic acid dioxygenase) (HAD)",Nematostella vectensis (Starlet sea anemone),59.1,274.0,5.1e-96,352.4,"sp|A7RIT9|3HAO_NEMVE 3-hydroxyanthranilate 3,4-dioxygenase OS=Nematostella vectensis OX=45351 GN=v1g178517 PE=3 SV=1",GO:0000334; GO:0005737; GO:0006569; GO:0008198; GO:0019805; GO:0034354; GO:0043420; GO:0046874,'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-tryptophan catabolic process [GO:0006569]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874],cytoplasm [GO:0005737],"3-hydroxyanthranilate 3,4-dioxygenase activity [GO:0000334]; ferrous iron binding [GO:0008198]",GO:0003824; GO:0006520; GO:0016491; GO:0055086,catalytic activity; amino acid metabolic process; oxidoreductase activity; nucleobase-containing small molecule metabolic process
OG_06787,FUN_031665-T2,Peve_00015111,Pocillopora_meandrina_HIv1___RNAseq.g5666.t1,three_way,79.292,FUN_031665-T2,Q86TV6,TTC7B_HUMAN,,Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1),Homo sapiens (Human),41.4,751.0,1.1e-137,492.3,sp|Q86TV6|TTC7B_HUMAN Tetratricopeptide repeat protein 7B OS=Homo sapiens OX=9606 GN=TTC7B PE=1 SV=3,GO:0005829; GO:0005886; GO:0046854; GO:0072659,phosphatidylinositol phosphate biosynthetic process [GO:0046854]; protein localization to plasma membrane [GO:0072659],cytosol [GO:0005829]; plasma membrane [GO:0005886],,GO:0005829; GO:0005886; GO:0006629; GO:0072659,cytosol; plasma membrane; lipid metabolic process; protein localization to plasma membrane
OG_06788,FUN_031666-T1,Peve_00015110,Pocillopora_meandrina_HIv1___RNAseq.g5665.t4,three_way,79.61233333333334,FUN_031666-T1,Q0IUU4,CML2_ORYSJ,,Putative calmodulin-like protein 2,Oryza sativa subsp. japonica (Rice),44.1,143.0,2.1e-29,130.2,sp|Q0IUU4|CML2_ORYSJ Putative calmodulin-like protein 2 OS=Oryza sativa subsp. japonica OX=39947 GN=CML2 PE=3 SV=2,GO:0005509; GO:0005737; GO:0016020; GO:0030234,,cytoplasm [GO:0005737]; membrane [GO:0016020],calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234],GO:0098772,molecular function regulator activity
OG_06789,FUN_031667-T1,Peve_00015108,Pocillopora_meandrina_HIv1___TS.g24371.t1,three_way,87.50266666666667,FUN_031667-T1,P0DH95,,,,,73.0,74.0,5.5999999999999996e-24,112.1,sp|P0DH95|CALM1_ARATH Calmodulin-1 OS=Arabidopsis thaliana OX=3702 GN=CAM1 PE=1 SV=1,,,,,,
OG_06790,FUN_031669-T1,Peve_00026337,Pocillopora_meandrina_HIv1___RNAseq.g5726.t1,three_way,88.93966666666667,,,,,,,,,,,,,,,,,
OG_06791,FUN_031672-T1,Peve_00012839,Pocillopora_meandrina_HIv1___RNAseq.g5743.t1,three_way,61.50066666666667,FUN_031672-T1,Q91Y77,,,,,29.3,433.0,4.3e-36,154.1,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_06792,FUN_031678-T1,Peve_00012833,Pocillopora_meandrina_HIv1___RNAseq.g5745.t1,three_way,69.84783333333333,FUN_031678-T1,Q5R4I2,RNF8_PONAB,,E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),29.4,446.0,2.1e-21,105.5,sp|Q5R4I2|RNF8_PONAB E3 ubiquitin-protein ligase RNF8 OS=Pongo abelii OX=9601 GN=RNF8 PE=2 SV=1,GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168,cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_06793,FUN_031679-T1,Peve_00012832,Pocillopora_meandrina_HIv1___TS.g24464.t2,three_way,82.46733333333333,FUN_031679-T1,A6NFT4,,,,,25.1,315.0,9.2e-10,66.2,sp|A6NFT4|CFA73_HUMAN Cilia- and flagella-associated protein 73 OS=Homo sapiens OX=9606 GN=CFAP73 PE=1 SV=3,,,,,,
OG_06794,FUN_031681-T1,Peve_00012830,Pocillopora_meandrina_HIv1___RNAseq.g5749.t1,three_way,56.66333333333333,,,,,,,,,,,,,,,,,
OG_06795,FUN_031683-T1,Peve_00013837,Pocillopora_meandrina_HIv1___RNAseq.g5779.t1,three_way,56.06166666666667,FUN_031683-T1,Q17QR6,,,,,26.9,402.0,1.8e-23,112.1,sp|Q17QR6|MOT13_BOVIN Monocarboxylate transporter 13 OS=Bos taurus OX=9913 GN=SLC16A13 PE=2 SV=1,,,,,,
OG_06796,FUN_031684-T1,Peve_00013836,Pocillopora_meandrina_HIv1___RNAseq.g5778.t1,three_way,57.97633333333333,,,,,,,,,,,,,,,,,
OG_06797,FUN_031685-T1,Peve_00013839,Pocillopora_meandrina_HIv1___RNAseq.g5777.t1,three_way,70.694,FUN_031685-T1,Q9H7D7,,,,,59.9,509.0,6.8999999999999986e-192,671.8,sp|Q9H7D7|WDR26_HUMAN WD repeat-containing protein 26 OS=Homo sapiens OX=9606 GN=WDR26 PE=1 SV=3,,,,,,
OG_06798,FUN_031686-T1,Peve_00013838,Pocillopora_meandrina_HIv1___RNAseq.g5776.t1,three_way,76.2835,FUN_031686-T1,Q9D2G2,ODO2_MOUSE,,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K)",Mus musculus (Mouse),73.2,396.0,8.5e-127,455.3,"sp|Q9D2G2|ODO2_MOUSE Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial OS=Mus musculus OX=10090 GN=Dlst PE=1 SV=1",GO:0004149; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006103; GO:0006104; GO:0016746; GO:0033512; GO:0043209; GO:0045252; GO:0160167,2-oxoglutarate metabolic process [GO:0006103]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxoadipate dehydrogenase complex [GO:0160167]; oxoglutarate dehydrogenase complex [GO:0045252],acyltransferase activity [GO:0016746]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006520; GO:0006790; GO:0016740; GO:0043226; GO:0055086; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein"
OG_06799,FUN_031687-T1,Peve_00021456,Pocillopora_meandrina_HIv1___RNAseq.g5769.t1,three_way,58.85433333333334,FUN_031687-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),28.0,440.0,4.8e-42,173.7,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_06800,FUN_031688-T1,Peve_00008190,Pocillopora_meandrina_HIv1___RNAseq.g5768.t1,three_way,65.605,FUN_031688-T1,Q15582,BGH3_HUMAN,,Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP),Homo sapiens (Human),27.7,629.0,1.4999999999999999e-53,212.6,sp|Q15582|BGH3_HUMAN Transforming growth factor-beta-induced protein ig-h3 OS=Homo sapiens OX=9606 GN=TGFBI PE=1 SV=1,GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005802; GO:0005886; GO:0007155; GO:0007162; GO:0007601; GO:0008283; GO:0030198; GO:0031012; GO:0042802; GO:0050839; GO:0050840; GO:0062023; GO:0070062,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; visual perception [GO:0007601],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178],GO:0005198; GO:0005576; GO:0005615; GO:0005886; GO:0007155; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; extracellular region; extracellular space; plasma membrane; cell adhesion; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_06801,FUN_031696-T1,Peve_00008196,Pocillopora_meandrina_HIv1___RNAseq.g5767.t1,three_way,78.851,,,,,,,,,,,,,,,,,
OG_06802,FUN_031697-T1,Peve_00008197,Pocillopora_meandrina_HIv1___TS.g24481.t1a,three_way,57.38466666666667,,,,,,,,,,,,,,,,,
OG_06803,FUN_031698-T1,Peve_00008191,Pocillopora_meandrina_HIv1___TS.g24481.t1b,three_way,82.58383333333333,FUN_031698-T1,Q5BIN6,,,,,50.0,164.0,1.1e-39,164.5,sp|Q5BIN6|CNIH1_BOVIN Protein cornichon homolog 1 OS=Bos taurus OX=9913 GN=CNIH1 PE=2 SV=1,,,,,,
OG_06804,FUN_031699-T1,Peve_00008192,Pocillopora_meandrina_HIv1___RNAseq.g5763.t1,three_way,69.65766666666667,FUN_031699-T1,O60234,,,,,60.0,75.0,2.2e-20,99.8,sp|O60234|GMFG_HUMAN Glia maturation factor gamma OS=Homo sapiens OX=9606 GN=GMFG PE=1 SV=1,,,,,,
OG_06805,FUN_031703-T1,Peve_00018219,Pocillopora_meandrina_HIv1___RNAseq.g5760.t1,three_way,62.979,FUN_031703-T1,Q9H1A4,APC1_HUMAN,,Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein),Homo sapiens (Human),31.9,1180.0,1.5e-145,518.8,sp|Q9H1A4|APC1_HUMAN Anaphase-promoting complex subunit 1 OS=Homo sapiens OX=9606 GN=ANAPC1 PE=1 SV=1,GO:0005654; GO:0005680; GO:0005829; GO:0007091; GO:0007346; GO:0031145; GO:0051301; GO:0051445; GO:0060090; GO:0070936; GO:0070979; GO:0141198,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; regulation of meiotic cell cycle [GO:0051445]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],molecular adaptor activity [GO:0060090],GO:0005654; GO:0005829; GO:0030163; GO:0060090,nucleoplasm; cytosol; protein catabolic process; molecular adaptor activity
OG_06806,FUN_031705-T1,Peve_00018220,Pocillopora_meandrina_HIv1___TS.g24476.t1a,three_way,84.14866666666667,FUN_031705-T1,A7YWS7,,,,,56.9,524.0,9.7e-180,631.3,sp|A7YWS7|DPOE2_BOVIN DNA polymerase epsilon subunit 2 OS=Bos taurus OX=9913 GN=POLE2 PE=2 SV=1,,,,,,
OG_06807,FUN_031706-T1,Peve_00022014,Pocillopora_meandrina_HIv1___TS.g24476.t1b,three_way,67.46533333333333,,,,,,,,,,,,,,,,,
OG_06808,FUN_031707-T2,Peve_00022016,Pocillopora_meandrina_HIv1___RNAseq.g5757.t1,three_way,66.85733333333333,FUN_031707-T2,Q2T9W2,THUM3_BOVIN,,tRNA (guanine(6)-N(2))-methyltransferase THUMP3 (EC 2.1.1.256) (THUMP domain-containing protein 3) (tRNA(Trp) (guanine(7)-N(2))-methyltransferase THUMP3) (EC 2.1.1.-),Bos taurus (Bovine),43.7,462.0,3.4e-96,353.6,sp|Q2T9W2|THUM3_BOVIN tRNA (guanine(6)-N(2))-methyltransferase THUMP3 OS=Bos taurus OX=9913 GN=THUMPD3 PE=2 SV=1,GO:0000049; GO:0005737; GO:0016423; GO:0030488,tRNA methylation [GO:0030488],cytoplasm [GO:0005737],tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0006399; GO:0016740; GO:0140098,"RNA binding; catalytic activity; tRNA metabolic process; transferase activity; catalytic activity, acting on RNA"
OG_06809,FUN_031708-T1,Peve_00002669,Pocillopora_meandrina_HIv1___RNAseq.g5756.t1,three_way,77.23333333333333,FUN_031708-T1,P26642,,,,,62.6,436.0,1.7000000000000001e-134,480.7,sp|P26642|EF1GA_XENLA Elongation factor 1-gamma-A OS=Xenopus laevis OX=8355 GN=eef1g-a PE=1 SV=1,,,,,,
OG_06810,FUN_031709-T1,Peve_00002668,Pocillopora_meandrina_HIv1___RNAseq.g5755.t1,three_way,78.13916666666667,FUN_031709-T1,O75909,CCNK_HUMAN,,Cyclin-K,Homo sapiens (Human),61.2,237.0,2.2e-81,304.7,sp|O75909|CCNK_HUMAN Cyclin-K OS=Homo sapiens OX=9606 GN=CCNK PE=1 SV=2,GO:0000079; GO:0002944; GO:0002945; GO:0004693; GO:0005634; GO:0005654; GO:0006366; GO:0006974; GO:0008024; GO:0008353; GO:0009966; GO:0019901; GO:0032786; GO:0032968; GO:0044828; GO:0045944; GO:0051301; GO:0061575,"cell division [GO:0051301]; DNA damage response [GO:0006974]; negative regulation by host of viral genome replication [GO:0044828]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of signal transduction [GO:0009966]; transcription by RNA polymerase II [GO:0006366]",cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06811,FUN_031711-T1,Peve_00002662,Pocillopora_meandrina_HIv1___RNAseq.g5753.t1a,three_way,72.13733333333333,FUN_031711-T1,Q5RGU1,COQ8A_DANRE,,"Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)",Danio rerio (Zebrafish) (Brachydanio rerio),57.9,494.0,3.7e-159,563.1,"sp|Q5RGU1|COQ8A_DANRE Atypical kinase COQ8A, mitochondrial OS=Danio rerio OX=7955 GN=coq8a PE=2 SV=2",GO:0004672; GO:0005524; GO:0005739; GO:0006744; GO:0016301; GO:0016310; GO:0031966; GO:0043531,phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744],mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672],GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06812,FUN_031712-T1,Peve_00002661,Pocillopora_meandrina_HIv1___RNAseq.g5450.t1,three_way,83.29866666666666,FUN_031712-T1,M9PH32,,,,,46.4,69.0,3.2e-08,62.0,sp|M9PH32|MEI26_DROME Protein meiotic P26 OS=Drosophila melanogaster OX=7227 GN=mei-P26 PE=1 SV=1,,,,,,
OG_06813,FUN_031713-T1,Peve_00002672,Pocillopora_meandrina_HIv1___RNAseq.g5451.t1,three_way,71.65333333333334,,,,,,,,,,,,,,,,,
OG_06814,FUN_031714-T1,Peve_00025698,Pocillopora_meandrina_HIv1___RNAseq.g5452.t1,three_way,40.220666666666666,FUN_031714-T1,P16581,LYAM2_HUMAN,,E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E),Homo sapiens (Human),25.8,260.0,2.1e-11,72.4,sp|P16581|LYAM2_HUMAN E-selectin OS=Homo sapiens OX=9606 GN=SELE PE=1 SV=1,GO:0002092; GO:0002523; GO:0002687; GO:0004888; GO:0005615; GO:0005886; GO:0005901; GO:0005905; GO:0006954; GO:0007157; GO:0007159; GO:0007200; GO:0009897; GO:0019722; GO:0030029; GO:0030863; GO:0032496; GO:0033691; GO:0034097; GO:0034612; GO:0043274; GO:0045121; GO:0046872; GO:0048471; GO:0050727; GO:0050901; GO:0070492; GO:0070555; GO:1903238,actin filament-based process [GO:0030029]; calcium-mediated signaling [GO:0019722]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte migration involved in inflammatory response [GO:0002523]; leukocyte tethering or rolling [GO:0050901]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of receptor internalization [GO:0002092]; regulation of inflammatory response [GO:0050727]; response to cytokine [GO:0034097]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612],caveola [GO:0005901]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],metal ion binding [GO:0046872]; oligosaccharide binding [GO:0070492]; phospholipase binding [GO:0043274]; sialic acid binding [GO:0033691]; transmembrane signaling receptor activity [GO:0004888],GO:0002376; GO:0005615; GO:0005856; GO:0005886; GO:0006954; GO:0007155; GO:0043226; GO:0048870; GO:0060089,immune system process; extracellular space; cytoskeleton; plasma membrane; inflammatory response; cell adhesion; organelle; cell motility; molecular transducer activity
OG_06815,FUN_031715-T1,Peve_00039096,Pocillopora_meandrina_HIv1___RNAseq.g5460.t1,three_way,86.92166666666667,FUN_031715-T1,Q4V8K5,BROX_RAT,,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),Rattus norvegicus (Rat),49.5,384.0,5.9e-103,375.9,sp|Q4V8K5|BROX_RAT BRO1 domain-containing protein BROX OS=Rattus norvegicus OX=10116 GN=Brox PE=2 SV=1,GO:0005635; GO:0007084; GO:0031965,mitotic nuclear membrane reassembly [GO:0007084],nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965],,GO:0005635; GO:0061024,nuclear envelope; membrane organization
OG_06816,FUN_031719-T1,Peve_00039098,Pocillopora_meandrina_HIv1___RNAseq.g5470.t1,three_way,77.35166666666666,FUN_031719-T1,P80025,PERL_BOVIN,,Lactoperoxidase (LPO) (EC 1.11.1.7),Bos taurus (Bovine),35.0,448.0,4.4e-55,217.2,sp|P80025|PERL_BOVIN Lactoperoxidase OS=Bos taurus OX=9913 GN=LPO PE=1 SV=1,GO:0001580; GO:0004601; GO:0005509; GO:0005615; GO:0005737; GO:0006979; GO:0016323; GO:0019731; GO:0020037; GO:0036393; GO:0042742; GO:0042744; GO:0140825,antibacterial humoral response [GO:0019731]; defense response to bacterium [GO:0042742]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; peroxidase activity [GO:0004601]; thiocyanate peroxidase activity [GO:0036393],GO:0002376; GO:0003824; GO:0005615; GO:0016209; GO:0016491; GO:0098542,immune system process; catalytic activity; extracellular space; antioxidant activity; oxidoreductase activity; defense response to other organism
OG_06817,FUN_031723-T1,Peve_00040627,Pocillopora_meandrina_HIv1___RNAseq.g5482.t1,three_way,60.10466666666667,FUN_031723-T1,Q8BH86,,,,,37.3,510.0,3.3e-76,287.3,"sp|Q8BH86|GLUCM_MOUSE D-glutamate cyclase, mitochondrial OS=Mus musculus OX=10090 GN=Dglucy PE=1 SV=1",,,,,,
OG_06818,FUN_031724-T1,Peve_00000894,Pocillopora_meandrina_HIv1___TS.g24210.t1,three_way,56.0895,FUN_031724-T1,Q9P219,DAPLE_HUMAN,,Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues) (hDaple) (Hook-related protein 2) (HkRP2),Homo sapiens (Human),35.4,432.0,7.8e-60,235.3,sp|Q9P219|DAPLE_HUMAN Protein Daple OS=Homo sapiens OX=9606 GN=CCDC88C PE=1 SV=3,GO:0001578; GO:0001965; GO:0003383; GO:0005085; GO:0005109; GO:0005576; GO:0005737; GO:0005813; GO:0007026; GO:0007264; GO:0008017; GO:0030054; GO:0030165; GO:0030705; GO:0031122; GO:0031648; GO:0035567; GO:0042802; GO:0043296; GO:0044782; GO:0046330; GO:0046983; GO:0051959; GO:0060071; GO:0090090; GO:0120197; GO:1902691,"apical constriction [GO:0003383]; cilium organization [GO:0044782]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule bundle formation [GO:0001578]; mucociliary clearance [GO:0120197]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of microtubule depolymerization [GO:0007026]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of JNK cascade [GO:0046330]; protein destabilization [GO:0031648]; respiratory basal cell differentiation [GO:1902691]; small GTPase-mediated signal transduction [GO:0007264]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",apical junction complex [GO:0043296]; cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular region [GO:0005576],dynein light intermediate chain binding [GO:0051959]; frizzled binding [GO:0005109]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; PDZ domain binding [GO:0030165]; protein dimerization activity [GO:0046983],GO:0003016; GO:0005576; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0030154; GO:0044782; GO:0098772,respiratory system process; extracellular region; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; cell differentiation; cilium organization; molecular function regulator activity
OG_06819,FUN_031725-T1,Peve_00040632,Pocillopora_meandrina_HIv1___RNAseq.g5493.t1,three_way,86.41283333333334,FUN_031725-T1,Q6P2K6,P4R3A_MOUSE,,Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1),Mus musculus (Mouse),62.4,675.0,1.2e-239,830.9,sp|Q6P2K6|P4R3A_MOUSE Serine/threonine-protein phosphatase 4 regulatory subunit 3A OS=Mus musculus OX=10090 GN=Ppp4r3a PE=1 SV=1,GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006094; GO:0016607; GO:0019888; GO:0030289; GO:0045722,gluconeogenesis [GO:0006094]; positive regulation of gluconeogenesis [GO:0045722],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289],protein phosphatase regulator activity [GO:0019888],GO:0005634; GO:0005815; GO:0005829; GO:0005975; GO:0043226; GO:0098772,nucleus; microtubule organizing center; cytosol; carbohydrate metabolic process; organelle; molecular function regulator activity
OG_06820,FUN_031726-T1,Peve_00040633,Pocillopora_meandrina_HIv1___RNAseq.g5506.t1,three_way,64.57666666666667,FUN_031726-T1,Q3ZC62,,,,,34.1,179.0,1.8000000000000001e-22,108.6,sp|Q3ZC62|CFA36_BOVIN Cilia- and flagella-associated protein 36 OS=Bos taurus OX=9913 GN=CFAP36 PE=2 SV=1,,,,,,
OG_06821,FUN_031731-T1,Peve_00029895,Pocillopora_meandrina_HIv1___RNAseq.g5508.t1,three_way,58.312,FUN_031731-T1,Q6IUR5,NENF_RAT,,Neudesin (Neuron-derived neurotrophic factor) (SCIRP10-related protein) (Spinal cord injury-related protein 10),Rattus norvegicus (Rat),44.3,106.0,1.2e-22,107.8,sp|Q6IUR5|NENF_RAT Neudesin OS=Rattus norvegicus OX=10116 GN=Nenf PE=1 SV=1,GO:0000165; GO:0005615; GO:0005739; GO:0005783; GO:0008083; GO:0012505; GO:0016020; GO:0032099; GO:0043410; GO:0046872,MAPK cascade [GO:0000165]; negative regulation of appetite [GO:0032099]; positive regulation of MAPK cascade [GO:0043410],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739],growth factor activity [GO:0008083]; metal ion binding [GO:0046872],GO:0005615; GO:0005739; GO:0005783; GO:0043226; GO:0048018; GO:0098772,extracellular space; mitochondrion; endoplasmic reticulum; organelle; receptor ligand activity; molecular function regulator activity
OG_06822,FUN_031732-T1,Peve_00029894,Pocillopora_meandrina_HIv1___RNAseq.g5509.t1,three_way,63.61333333333334,FUN_031732-T1,Q56P03,EAPP_HUMAN,,E2F-associated phosphoprotein (EAPP),Homo sapiens (Human),39.8,249.0,2e-37,157.5,sp|Q56P03|EAPP_HUMAN E2F-associated phosphoprotein OS=Homo sapiens OX=9606 GN=EAPP PE=1 SV=4,GO:0005634; GO:0005654; GO:0005737; GO:0008284; GO:0016607; GO:0032968; GO:0034244,negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0006355; GO:0043226,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle
OG_06823,FUN_031733-T1,Peve_00029893,Pocillopora_meandrina_HIv1___RNAseq.g5510.t1,three_way,68.32266666666666,FUN_031733-T1,Q3UDE2,,,,,24.0,492.0,1.4000000000000002e-23,113.2,sp|Q3UDE2|TTL12_MOUSE Tubulin--tyrosine ligase-like protein 12 OS=Mus musculus OX=10090 GN=Ttll12 PE=1 SV=1,,,,,,
OG_06824,FUN_031734-T1,Peve_00043416,Pocillopora_meandrina_HIv1___RNAseq.g5511.t1,three_way,50.765,FUN_031734-T1,Q60HG2,TOR1A_MACFA,,Torsin-1A (Dystonia 1 protein) (Torsin ATPase 1) (EC 3.6.4.-) (Torsin family 1 member A),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),40.1,284.0,9.500000000000001e-58,226.5,sp|Q60HG2|TOR1A_MACFA Torsin-1A OS=Macaca fascicularis OX=9541 GN=TOR1A PE=2 SV=1,GO:0000338; GO:0005524; GO:0005635; GO:0005788; GO:0005789; GO:0005856; GO:0006998; GO:0007155; GO:0008021; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0036503; GO:0042802; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051085; GO:0051584; GO:0061077; GO:0071763; GO:0140662; GO:1900244; GO:2000008,"cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ERAD pathway [GO:0036503]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]",cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; growth cone [GO:0030426]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894],GO:0003824; GO:0005635; GO:0005856; GO:0007010; GO:0007155; GO:0008092; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0044183; GO:0048870; GO:0061024; GO:0140657,catalytic activity; nuclear envelope; cytoskeleton; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; protein folding chaperone; cell motility; membrane organization; ATP-dependent activity
OG_06825,FUN_031735-T1,Peve_00043415,Pocillopora_meandrina_HIv1___RNAseq.g5512.t1c,three_way,69.34566666666667,FUN_031735-T1,Q5E9D6,,,,,39.0,205.0,4.6e-36,152.9,sp|Q5E9D6|HDHD3_BOVIN Haloacid dehalogenase-like hydrolase domain-containing protein 3 OS=Bos taurus OX=9913 GN=HDHD3 PE=2 SV=1,,,,,,
OG_06826,FUN_031736-T1,Peve_00043414,Pocillopora_meandrina_HIv1___RNAseq.g5512.t1a,three_way,84.65166666666667,FUN_031736-T1,Q2NKU6,DPY30_BOVIN,,Protein dpy-30 homolog (Dpy-30-like protein) (Dpy-30L),Bos taurus (Bovine),62.5,96.0,2.1e-26,119.8,sp|Q2NKU6|DPY30_BOVIN Protein dpy-30 homolog OS=Bos taurus OX=9913 GN=DPY30 PE=3 SV=1,GO:0005634; GO:0005802; GO:0016197; GO:0035097; GO:0042803; GO:0044666; GO:0045815; GO:0048188; GO:0071339,endosomal transport [GO:0016197]; transcription initiation-coupled chromatin remodeling [GO:0045815],histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; trans-Golgi network [GO:0005802],protein homodimerization activity [GO:0042803],GO:0005634; GO:0006325; GO:0016192; GO:0043226,nucleus; chromatin organization; vesicle-mediated transport; organelle
OG_06827,FUN_031738-T1,Peve_00043413,Pocillopora_meandrina_HIv1___RNAseq.g5513.t1,three_way,87.03966666666666,FUN_031738-T1,Q6P8X1,SNX6_MOUSE,,"Sorting nexin-6 [Cleaved into: Sorting nexin-6, N-terminally processed]",Mus musculus (Mouse),65.9,396.0,6.2e-142,505.4,sp|Q6P8X1|SNX6_MOUSE Sorting nexin-6 OS=Mus musculus OX=10090 GN=Snx6 PE=1 SV=2,GO:0005634; GO:0005764; GO:0005829; GO:0006886; GO:0030512; GO:0030904; GO:0031901; GO:0034452; GO:0034713; GO:0035091; GO:0042147; GO:0042803; GO:0043524; GO:0045892; GO:0071364; GO:0097422; GO:0098842; GO:0098978; GO:0099072; GO:1904646,"cellular response to amyloid-beta [GO:1904646]; cellular response to epidermal growth factor stimulus [GO:0071364]; intracellular protein transport [GO:0006886]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; lysosome [GO:0005764]; nucleus [GO:0005634]; postsynaptic early endosome [GO:0098842]; retromer complex [GO:0030904]; tubular endosome [GO:0097422],dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006355; GO:0006886; GO:0008092; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleus; lysosome; endosome; vacuole; cytosol; regulation of DNA-templated transcription; intracellular protein transport; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06828,FUN_031739-T1,Peve_00043412,Pocillopora_meandrina_HIv1___RNAseq.g5514.t1,three_way,71.18233333333333,,,,,,,,,,,,,,,,,
OG_06829,FUN_031741-T1,Peve_00043410,Pocillopora_meandrina_HIv1___RNAseq.g5525.t1,three_way,83.86366666666667,FUN_031741-T1,Q80X82,,,,,50.7,1142.0,2.8e-291,1003.0,sp|Q80X82|SYMPK_MOUSE Symplekin OS=Mus musculus OX=10090 GN=Sympk PE=1 SV=2,,,,,,
OG_06830,FUN_031742-T1,Peve_00043409,Pocillopora_meandrina_HIv1___RNAseq.g5526.t1,three_way,96.30366666666669,FUN_031742-T1,P36404,ARL2_HUMAN,,ADP-ribosylation factor-like protein 2,Homo sapiens (Human),81.5,162.0,7.5e-76,284.6,sp|P36404|ARL2_HUMAN ADP-ribosylation factor-like protein 2 OS=Homo sapiens OX=9606 GN=ARL2 PE=1 SV=4,GO:0003924; GO:0005525; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005813; GO:0005829; GO:0006110; GO:0006457; GO:0007098; GO:0010811; GO:0015630; GO:0016328; GO:0019003; GO:0031113; GO:0031116; GO:0034260; GO:0036064; GO:0051457; GO:0070830; GO:1903715,bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; protein folding [GO:0006457]; regulation of aerobic respiration [GO:1903715]; regulation of glycolytic process [GO:0006110]; regulation of microtubule polymerization [GO:0031113],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005815; GO:0005829; GO:0005856; GO:0006457; GO:0016787; GO:0034330; GO:0043226,catalytic activity; GTPase activity; nucleus; nucleoplasm; nucleolus; mitochondrion; microtubule organizing center; cytosol; cytoskeleton; protein folding; hydrolase activity; cell junction organization; organelle
OG_06831,FUN_031743-T1,Peve_00028289,Pocillopora_meandrina_HIv1___RNAseq.g5527.t1,three_way,46.6595,,,,,,,,,,,,,,,,,
OG_06832,FUN_031748-T1,Peve_00045071,Pocillopora_meandrina_HIv1___RNAseq.g5531.t1,three_way,67.169,,,,,,,,,,,,,,,,,
OG_06833,FUN_031750-T1,Peve_00023211,Pocillopora_meandrina_HIv1___RNAseq.g5533.t1,three_way,71.87083333333334,FUN_031750-T1,Q0VAA2,,,,,45.1,82.0,3.1e-10,68.2,sp|Q0VAA2|LR74A_HUMAN Leucine-rich repeat-containing protein 74A OS=Homo sapiens OX=9606 GN=LRRC74A PE=1 SV=2,,,,,,
OG_06834,FUN_031752-T1,Peve_00023214,Pocillopora_meandrina_HIv1___RNAseq.g5535.t1,three_way,68.37466666666667,,,,,,,,,,,,,,,,,
OG_06835,FUN_031753-T1,Peve_00023213,Pocillopora_meandrina_HIv1___RNAseq.g5536.t1,three_way,55.97633333333333,,,,,,,,,,,,,,,,,
OG_06836,FUN_031754-T1,Peve_00023210,Pocillopora_meandrina_HIv1___RNAseq.g5542.t1,three_way,70.37316666666666,FUN_031754-T1,Q8R9T6,,,,,32.9,246.0,1.1e-20,104.0,sp|Q8R9T6|PKN1_CALS4 Probable serine/threonine-protein kinase Sps1 OS=Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) OX=273068 GN=sps1 PE=3 SV=1,,,,,,
OG_06837,FUN_031756-T1,Peve_00010432,Pocillopora_meandrina_HIv1___RNAseq.11794_t,three_way,33.38433333333333,,,,,,,,,,,,,,,,,
OG_06838,FUN_031757-T1,Peve_00010422,Pocillopora_meandrina_HIv1___RNAseq.g5545.t1,three_way,77.33833333333334,FUN_031757-T1,Q92485,ASM3B_HUMAN,,Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-),Homo sapiens (Human),46.1,414.0,6.3e-117,422.5,sp|Q92485|ASM3B_HUMAN Acid sphingomyelinase-like phosphodiesterase 3b OS=Homo sapiens OX=9606 GN=SMPDL3B PE=1 SV=2,GO:0004767; GO:0005615; GO:0005886; GO:0006685; GO:0006954; GO:0008081; GO:0008270; GO:0016798; GO:0034122; GO:0045087; GO:0046466; GO:0050728; GO:0070062; GO:0098552,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],"hydrolase activity, acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005615; GO:0005886; GO:0006629; GO:0006954; GO:0016787; GO:0043226; GO:0098542,immune system process; catalytic activity; extracellular space; plasma membrane; lipid metabolic process; inflammatory response; hydrolase activity; organelle; defense response to other organism
OG_06839,FUN_031779-T1,Peve_00026557,Pocillopora_meandrina_HIv1___RNAseq.g5548.t1a,three_way,38.97683333333333,,,,,,,,,,,,,,,,,
OG_06840,FUN_031780-T1,Peve_00010423,Pocillopora_meandrina_HIv1___RNAseq.g5563.t1,three_way,75.46933333333334,FUN_031780-T1,P29176,,,,,50.0,76.0,3.8e-10,66.2,sp|P29176|FOSX_MSVFR Transforming protein v-Fos/v-Fox OS=FBR murine osteosarcoma virus OX=353765 GN=FOS-FOX PE=3 SV=1,,,,,,
OG_06841,FUN_031781-T1,Peve_00010425,Pocillopora_meandrina_HIv1___TS.g24284.t1,three_way,64.70833333333333,,,,,,,,,,,,,,,,,
OG_06842,FUN_031782-T1,Peve_00010427,Pocillopora_meandrina_HIv1___RNAseq.g5565.t1,three_way,65.31783333333333,FUN_031782-T1,P29176,,,,,44.2,77.0,1.2e-06,55.1,sp|P29176|FOSX_MSVFR Transforming protein v-Fos/v-Fox OS=FBR murine osteosarcoma virus OX=353765 GN=FOS-FOX PE=3 SV=1,,,,,,
OG_06843,FUN_031783-T1,Peve_00010428,Pocillopora_meandrina_HIv1___RNAseq.g5566.t1,three_way,57.474,,,,,,,,,,,,,,,,,
OG_06844,FUN_031784-T1,Peve_00010429,Pocillopora_meandrina_HIv1___TS.g24287.t1,three_way,83.68866666666666,FUN_031784-T1,Q9ULT8,HECD1_HUMAN,,E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1),Homo sapiens (Human),52.0,2736.0,0.0,2536.5,sp|Q9ULT8|HECD1_HUMAN E3 ubiquitin-protein ligase HECTD1 OS=Homo sapiens OX=9606 GN=HECTD1 PE=1 SV=4,GO:0003170; GO:0003281; GO:0006511; GO:0016567; GO:0032436; GO:0035904; GO:0046872; GO:0061630,aorta development [GO:0035904]; heart valve development [GO:0003170]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281],,metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_06845,FUN_031786-T1,Peve_00037108,Pocillopora_meandrina_HIv1___RNAseq.g29845.t1,three_way,63.76533333333334,FUN_031786-T1,P0DXB5,,,,,23.8,320.0,1.5e-06,56.2,sp|P0DXB5|CGLR_CTEFE Cyclic GMP-AMP synthase-like receptor OS=Ctenocephalides felis OX=7515 GN=cGLR PE=1 SV=1,,,,,,
OG_06846,FUN_031787-T1,Peve_00019324,Pocillopora_meandrina_HIv1___RNAseq.g5568.t1,three_way,65.77866666666667,FUN_031787-T1,A7Z026,,,,,44.6,294.0,6.300000000000001e-65,250.4,sp|A7Z026|PPR37_BOVIN Protein phosphatase 1 regulatory subunit 37 OS=Bos taurus OX=9913 GN=PPP1R37 PE=2 SV=1,,,,,,
OG_06847,FUN_031788-T1,Peve_00019329,Pocillopora_meandrina_HIv1___RNAseq.g5570.t1,three_way,65.31133333333334,,,,,,,,,,,,,,,,,
OG_06848,FUN_031789-T1,Peve_00019327,Pocillopora_meandrina_HIv1___RNAseq.g5569.t1,three_way,58.21266666666667,,,,,,,,,,,,,,,,,
OG_06849,FUN_031790-T1,Peve_00019330,Pocillopora_meandrina_HIv1___TS.g24291.t1,three_way,72.05833333333334,,,,,,,,,,,,,,,,,
OG_06850,FUN_031791-T1,Peve_00019321,Pocillopora_meandrina_HIv1___RNAseq.g5572.t1,three_way,73.44166666666666,FUN_031791-T1,K7VCB9,,,,,43.1,232.0,1e-38,161.8,sp|K7VCB9|THIM_MAIZE Hydroxyethylthiazole kinase OS=Zea mays OX=4577 GN=THIM PE=1 SV=1,,,,,,
OG_06851,FUN_031800-T1,Peve_00019322,Pocillopora_meandrina_HIv1___RNAseq.g5573.t1,three_way,74.092,FUN_031800-T1,Q99986,VRK1_HUMAN,,Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1),Homo sapiens (Human),53.3,336.0,1.4e-101,371.3,sp|Q99986|VRK1_HUMAN Serine/threonine-protein kinase VRK1 OS=Homo sapiens OX=9606 GN=VRK1 PE=1 SV=1,GO:0000785; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005829; GO:0006338; GO:0006468; GO:0006974; GO:0007077; GO:0007165; GO:0015030; GO:0016301; GO:0019901; GO:0030576; GO:0031175; GO:0031492; GO:0035175; GO:0042393; GO:0046777; GO:0051301; GO:0072354; GO:0090166; GO:0106310; GO:0120187; GO:0141003; GO:2001222,Cajal body organization [GO:0030576]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; Golgi disassembly [GO:0090166]; mitotic nuclear membrane disassembly [GO:0007077]; neuron projection development [GO:0031175]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of neuron migration [GO:2001222]; signal transduction [GO:0007165],Cajal body [GO:0015030]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone binding [GO:0042393]; histone H2AX kinase activity [GO:0141003]; histone H3S10 kinase activity [GO:0035175]; histone H3T3 kinase activity [GO:0072354]; kinase activity [GO:0016301]; nucleosomal DNA binding [GO:0031492]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0016740; GO:0042393; GO:0043226; GO:0061024; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; transferase activity; histone binding; organelle; membrane organization; catalytic activity, acting on a protein"
OG_06852,FUN_031801-T1,Peve_00019325,Pocillopora_meandrina_HIv1___RNAseq.g5575.t1,three_way,84.17933333333333,FUN_031801-T1,Q4V8V1,,,,,45.0,271.0,2.2e-57,224.6,sp|Q4V8V1|BM1LA_DANRE Breast cancer metastasis-suppressor 1-like protein-A OS=Danio rerio OX=7955 GN=brms1la PE=2 SV=1,,,,,,
OG_06853,FUN_031802-T1,Peve_00030270,Pocillopora_meandrina_HIv1___RNAseq.g5589.t1,three_way,72.05866666666667,FUN_031802-T1,Q0V9J5,,,,,66.4,107.0,1.7e-35,150.6,sp|Q0V9J5|EIF1A_XENTR Probable RNA-binding protein EIF1AD OS=Xenopus tropicalis OX=8364 GN=eif1ad PE=2 SV=1,,,,,,
OG_06854,FUN_031819-T1,Peve_00030275,Pocillopora_meandrina_HIv1___RNAseq.g5595.t1,three_way,82.48433333333334,FUN_031819-T1,Q2YDI0,,,,,60.6,142.0,4.199999999999999e-43,175.6,sp|Q2YDI0|RM11_BOVIN Large ribosomal subunit protein uL11m OS=Bos taurus OX=9913 GN=MRPL11 PE=1 SV=2,,,,,,
OG_06855,FUN_031831-T1,Peve_00030276,Pocillopora_meandrina_HIv1___RNAseq.g5596.t1,three_way,53.513,,,,,,,,,,,,,,,,,
OG_06856,FUN_031834-T1,Peve_00030278,Pocillopora_meandrina_HIv1___TS.g24318.t1,three_way,70.685,FUN_031834-T1,Q29RY4,RNZ1_BOVIN,,Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1),Bos taurus (Bovine),47.7,329.0,4e-78,293.1,sp|Q29RY4|RNZ1_BOVIN Zinc phosphodiesterase ELAC protein 1 OS=Bos taurus OX=9913 GN=ELAC1 PE=2 SV=1,GO:0004549; GO:0005634; GO:0005654; GO:0005829; GO:0042780; GO:0042781; GO:0046872; GO:0072344,rescue of stalled ribosome [GO:0072344]; tRNA 3'-end processing [GO:0042780],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872]; tRNA-specific ribonuclease activity [GO:0004549],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; nucleus; nucleoplasm; cytosol; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_06857,FUN_031838-T1,Peve_00030279,Pocillopora_meandrina_HIv1___RNAseq.g5598.t1,three_way,67.74966666666667,FUN_031838-T1,Q3UJB0,,,,,70.4,540.0,9.5e-162,572.4,sp|Q3UJB0|SF3B2_MOUSE Splicing factor 3B subunit 2 OS=Mus musculus OX=10090 GN=Sf3b2 PE=2 SV=1,,,,,,
OG_06858,FUN_031848-T1,Peve_00030290,Pocillopora_meandrina_HIv1___RNAseq.g5607.t1,three_way,63.642,FUN_031848-T1,A6QNR1,,,,,44.3,219.0,1.2e-29,131.7,sp|A6QNR1|RRP36_BOVIN Ribosomal RNA processing protein 36 homolog OS=Bos taurus OX=9913 GN=RRP36 PE=2 SV=1,,,,,,
OG_06859,FUN_031849-T1,Peve_00030292,Pocillopora_meandrina_HIv1___RNAseq.g5608.t1,three_way,82.18233333333333,FUN_031849-T1,Q8BX37,,,,,55.5,402.0,4.6e-141,502.7,sp|Q8BX37|ACP7_MOUSE Acid phosphatase type 7 OS=Mus musculus OX=10090 GN=Acp7 PE=2 SV=2,,,,,,
OG_06860,FUN_031851-T1,Peve_00030297,Pocillopora_meandrina_HIv1___RNAseq.g5613.t1,three_way,88.85733333333333,FUN_031851-T1,P51153,RAB13_HUMAN,,Ras-related protein Rab-13 (EC 3.6.5.2) (Cell growth-inhibiting gene 4 protein),Homo sapiens (Human),59.9,182.0,1.8e-60,233.8,sp|P51153|RAB13_HUMAN Ras-related protein Rab-13 OS=Homo sapiens OX=9606 GN=RAB13 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005768; GO:0005802; GO:0005829; GO:0005886; GO:0005923; GO:0006887; GO:0006893; GO:0008021; GO:0010737; GO:0015031; GO:0016197; GO:0016328; GO:0030027; GO:0030054; GO:0030139; GO:0030140; GO:0030866; GO:0031175; GO:0031410; GO:0032456; GO:0032593; GO:0032869; GO:0035767; GO:0043005; GO:0044795; GO:0055037; GO:0055038; GO:0070062; GO:0070830; GO:0072659; GO:0097368; GO:1902463,bicellular tight junction assembly [GO:0070830]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endothelial cell chemotaxis [GO:0035767]; establishment of Sertoli cell barrier [GO:0097368]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuron projection development [GO:0031175]; protein kinase A signaling [GO:0010737]; protein localization to cell leading edge [GO:1902463]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; trans-Golgi network to recycling endosome transport [GO:0044795],bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; insulin-responsive compartment [GO:0032593]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005829; GO:0005886; GO:0007010; GO:0016192; GO:0016787; GO:0022414; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0072659,catalytic activity; GTPase activity; endosome; cytosol; plasma membrane; cytoskeleton organization; vesicle-mediated transport; hydrolase activity; reproductive process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; protein localization to plasma membrane
OG_06861,FUN_031852-T2,Peve_00030298,Pocillopora_meandrina_HIv1___RNAseq.g5614.t1,three_way,88.76,FUN_031852-T2,P62861,RS30_HUMAN,,Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein (FAU ubiquitin like and ribosomal protein S30 fusion) [Cleaved into: Ubiquitin-like protein FUBI; Small ribosomal subunit protein eS30 (40S ribosomal protein S30)],Homo sapiens (Human),66.9,133.0,1.9e-39,163.3,sp|P62861|RS30_HUMAN Ubiquitin-like FUBI-ribosomal protein eS30 fusion protein OS=Homo sapiens OX=9606 GN=FAU PE=1 SV=2,GO:0002181; GO:0002227; GO:0003723; GO:0003735; GO:0005615; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006412; GO:0015935; GO:0016567; GO:0019731; GO:0019941; GO:0022626; GO:0022627; GO:0031386; GO:0031625; GO:0050830; GO:0061844,antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytoplasmic translation [GO:0002181]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response in mucosa [GO:0002227]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small ribosomal subunit [GO:0015935],protein tag activity [GO:0031386]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625],GO:0002181; GO:0002376; GO:0003723; GO:0005198; GO:0005615; GO:0005634; GO:0005654; GO:0005829; GO:0005840; GO:0031386; GO:0043226; GO:0098542,cytoplasmic translation; immune system process; RNA binding; structural molecule activity; extracellular space; nucleus; nucleoplasm; cytosol; ribosome; protein tag activity; organelle; defense response to other organism
OG_06862,FUN_031854-T1,Peve_00038987,Pocillopora_meandrina_HIv1___RNAseq.g5616.t1,three_way,84.778,FUN_031854-T1,O70333,,,,,71.8,78.0,3.9e-27,122.1,sp|O70333|CRIPT_MOUSE Cysteine-rich PDZ-binding protein OS=Mus musculus OX=10090 GN=Cript PE=1 SV=1,,,,,,
OG_06863,FUN_031856-T1,Peve_00011072,Pocillopora_meandrina_HIv1___RNAseq.g5630.t1,three_way,86.09033333333333,FUN_031856-T1,P13255,GNMT_RAT,,Glycine N-methyltransferase (EC 2.1.1.20) (Folate-binding protein),Rattus norvegicus (Rat),55.3,309.0,1.1e-88,328.2,sp|P13255|GNMT_RAT Glycine N-methyltransferase OS=Rattus norvegicus OX=10116 GN=Gnmt PE=1 SV=2,GO:0005542; GO:0005829; GO:0005977; GO:0006111; GO:0006544; GO:0006555; GO:0006730; GO:0008757; GO:0016594; GO:0017174; GO:0032259; GO:0034708; GO:0042802; GO:0046498; GO:0046500; GO:0051289; GO:0098603; GO:1901052; GO:1904047,glycine metabolic process [GO:0006544]; glycogen metabolic process [GO:0005977]; methionine metabolic process [GO:0006555]; methylation [GO:0032259]; one-carbon metabolic process [GO:0006730]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; S-adenosylhomocysteine metabolic process [GO:0046498]; S-adenosylmethionine metabolic process [GO:0046500]; sarcosine metabolic process [GO:1901052],cytosol [GO:0005829]; methyltransferase complex [GO:0034708],folic acid binding [GO:0005542]; glycine binding [GO:0016594]; glycine N-methyltransferase activity [GO:0017174]; identical protein binding [GO:0042802]; S-adenosyl-L-methionine binding [GO:1904047]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; selenol Se-methyltransferase activity [GO:0098603],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0006520; GO:0006575; GO:0006790; GO:0016740; GO:0055086; GO:0065003; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_06864,FUN_031860-T1,Peve_00011073,Pocillopora_meandrina_HIv1___RNAseq.g5631.t4,three_way,80.47416666666668,FUN_031860-T1,Q86UA1,,,,,44.6,579.0,9.1e-144,512.3,sp|Q86UA1|PRP39_HUMAN Pre-mRNA-processing factor 39 OS=Homo sapiens OX=9606 GN=PRPF39 PE=1 SV=3,,,,,,
OG_06865,FUN_031861-T1,Peve_00010192,Pocillopora_meandrina_HIv1___RNAseq.g5632.t1,three_way,58.57866666666666,,,,,,,,,,,,,,,,,
OG_06866,FUN_031862-T1,Peve_00011064,Pocillopora_meandrina_HIv1___RNAseq.g5635.t1,three_way,61.84783333333333,,,,,,,,,,,,,,,,,
OG_06867,FUN_031863-T1,Peve_00011065,Pocillopora_meandrina_HIv1___RNAseq.g5636.t1,three_way,61.019666666666666,,,,,,,,,,,,,,,,,
OG_06868,FUN_031868-T1,Peve_00010189,Pocillopora_meandrina_HIv1___RNAseq.g5646.t1b,three_way,72.2535,FUN_031868-T1,P50748,KNTC1_HUMAN,,Kinetochore-associated protein 1 (Rough deal homolog) (HsROD) (Rod) (hRod),Homo sapiens (Human),32.2,2261.0,3.3999999999999998e-301,1036.9,sp|P50748|KNTC1_HUMAN Kinetochore-associated protein 1 OS=Homo sapiens OX=9606 GN=KNTC1 PE=1 SV=1,GO:0000070; GO:0000922; GO:0005634; GO:0005737; GO:0005828; GO:0005829; GO:0005886; GO:0007094; GO:0007096; GO:0015629; GO:0031267; GO:0051301; GO:0051988; GO:0065003; GO:1903394; GO:1990423,cell division [GO:0051301]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore involved in kinetochore assembly [GO:1903394]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RZZ complex [GO:1990423]; spindle pole [GO:0000922],small GTPase binding [GO:0031267],GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0007059; GO:0043226; GO:0065003,nucleus; cytosol; cytoskeleton; plasma membrane; chromosome segregation; organelle; protein-containing complex assembly
OG_06869,FUN_031869-T1,Peve_00010191,Pocillopora_meandrina_HIv1___RNAseq.g5647.t1,three_way,60.89966666666667,,,,,,,,,,,,,,,,,
OG_06870,FUN_031870-T1,Peve_00012646,Pocillopora_meandrina_HIv1___RNAseq.g5648.t1,three_way,69.29950000000001,FUN_031870-T1,Q9CYK2,QPCT_MOUSE,,Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (Glutaminyl-tRNA cyclotransferase),Mus musculus (Mouse),41.0,351.0,6.8999999999999995e-68,259.2,sp|Q9CYK2|QPCT_MOUSE Glutaminyl-peptide cyclotransferase OS=Mus musculus OX=10090 GN=Qpct PE=1 SV=2,GO:0005576; GO:0008270; GO:0016603; GO:0017186,"peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase [GO:0017186]",extracellular region [GO:0005576],glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0016740; GO:0140096,"catalytic activity; extracellular region; transferase activity; catalytic activity, acting on a protein"
OG_06871,FUN_031874-T1,Peve_00012650,Pocillopora_meandrina_HIv1___RNAseq.g5445.t1b,three_way,69.66433333333333,FUN_031874-T1,A5D6U8,ACP7_DANRE,,Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form),Danio rerio (Zebrafish) (Brachydanio rerio),57.7,414.0,1.5e-144,514.2,sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1,GO:0003993; GO:0005576; GO:0046872,,extracellular region [GO:0005576],acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0016787,catalytic activity; extracellular region; hydrolase activity
OG_06872,FUN_031875-T1,Peve_00012649,Pocillopora_meandrina_HIv1___RNAseq.g5445.t1a,three_way,81.16000000000001,FUN_031875-T1,Q8BHN3,GANAB_MOUSE,,Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha),Mus musculus (Mouse),53.7,916.0,5.7e-300,1031.6,sp|Q8BHN3|GANAB_MOUSE Neutral alpha-glucosidase AB OS=Mus musculus OX=10090 GN=Ganab PE=1 SV=1,GO:0005783; GO:0005794; GO:0005975; GO:0006491; GO:0015926; GO:0017177; GO:0030246; GO:0033919; GO:0042470; GO:0106407,carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491],endoplasmic reticulum [GO:0005783]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470],"carbohydrate binding [GO:0030246]; Glc2Man9GlcNAc2 oligosaccharide glucosidase activity [GO:0106407]; glucan 1,3-alpha-glucosidase activity [GO:0033919]; glucosidase activity [GO:0015926]",GO:0003824; GO:0005783; GO:0005794; GO:0005975; GO:0009101; GO:0016787; GO:0031410; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; glycoprotein biosynthetic process; hydrolase activity; cytoplasmic vesicle; organelle; carbohydrate derivative metabolic process
OG_06873,FUN_031876-T1,Peve_00012647,Pocillopora_meandrina_HIv1___RNAseq.g5446.t1,three_way,98.995,FUN_031876-T1,P63099,CANB1_BOVIN,,Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1),Bos taurus (Bovine),88.2,170.0,7.999999999999999e-83,307.8,sp|P63099|CANB1_BOVIN Calcineurin subunit B type 1 OS=Bos taurus OX=9913 GN=PPP3R1 PE=1 SV=2,GO:0005509; GO:0005829; GO:0005955; GO:0008597; GO:0019902; GO:0033173; GO:0042383,calcineurin-NFAT signaling cascade [GO:0033173],calcineurin complex [GO:0005955]; cytosol [GO:0005829]; sarcolemma [GO:0042383],calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine phosphatase regulator activity [GO:0008597]; phosphatase binding [GO:0019902],GO:0005829; GO:0005886; GO:0098772,cytosol; plasma membrane; molecular function regulator activity
OG_06874,FUN_031877-T1,Peve_00012644,Pocillopora_meandrina_HIv1___RNAseq.g5447.t1,three_way,82.98033333333333,FUN_031877-T1,Q9VT65,CANB_DROME,,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],Drosophila melanogaster (Fruit fly),40.7,685.0,5.4e-154,546.2,sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2,GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; membrane [GO:0016020],calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198],GO:0003824; GO:0016787; GO:0048870; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_06875,FUN_031878-T1,Peve_00031835,Pocillopora_meandrina_HIv1___TS.g24761.t1,three_way,73.57633333333334,FUN_031878-T1,Q05973,,,,,36.1,1564.0,1.8000000000000003e-248,861.3,sp|Q05973|SCN1_HETBL Sodium channel protein 1 brain OS=Heterololigo bleekeri OX=1423826 PE=2 SV=1,,,,,,
OG_06876,FUN_031888-T1,Peve_00031832,Pocillopora_meandrina_HIv1___RNAseq.g6051.t1,three_way,66.68083333333333,FUN_031888-T1,P23913,,,,,45.3,417.0,4.9e-103,376.7,sp|P23913|LBR_CHICK Delta(14)-sterol reductase LBR OS=Gallus gallus OX=9031 GN=LBR PE=1 SV=1,,,,,,
OG_06877,FUN_031894-T1,Peve_00031826,Pocillopora_meandrina_HIv1___RNAseq.g6060.t1,three_way,53.31966666666666,,,,,,,,,,,,,,,,,
OG_06878,FUN_031896-T2,Peve_00013255,Pocillopora_meandrina_HIv1___RNAseq.g17917.t1,three_way,66.58333333333333,FUN_031896-T2,Q5HZE0,S2529_RAT,,Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29),Rattus norvegicus (Rat),41.3,286.0,2.9e-51,203.8,sp|Q5HZE0|S2529_RAT Mitochondrial basic amino acids transporter OS=Rattus norvegicus OX=10116 GN=Slc25a29 PE=2 SV=1,GO:0005289; GO:0005292; GO:0005739; GO:0005743; GO:0015174; GO:0015227; GO:0015822; GO:0089709; GO:1903401; GO:1903826; GO:1990575,L-arginine transmembrane transport [GO:1903826]; L-histidine transmembrane transport [GO:0089709]; L-lysine transmembrane transport [GO:1903401]; mitochondrial L-ornithine transmembrane transport [GO:1990575]; ornithine transport [GO:0015822],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],basic amino acid transmembrane transporter activity [GO:0015174]; high-affinity L-arginine transmembrane transporter activity [GO:0005289]; high-affinity lysine transmembrane transporter activity [GO:0005292]; O-acyl-L-carnitine transmembrane transporter activity [GO:0015227],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_06879,FUN_031898-T1,Peve_00013256,Pocillopora_meandrina_HIv1___RNAseq.g17916.t1,three_way,81.25366666666666,FUN_031898-T1,Q9EQT3,RHOU_MOUSE,,Rho-related GTP-binding protein RhoU (Rho GTPase-like protein ARHU) (Wnt-1 responsive Cdc42 homolog 1) (WRCH-1),Mus musculus (Mouse),59.9,177.0,7.100000000000002e-57,221.9,sp|Q9EQT3|RHOU_MOUSE Rho-related GTP-binding protein RhoU OS=Mus musculus OX=10090 GN=Rhou PE=2 SV=1,GO:0000082; GO:0000139; GO:0002102; GO:0003924; GO:0005525; GO:0005886; GO:0005925; GO:0007010; GO:0008360; GO:0016601; GO:0030036; GO:0042995; GO:0046872,actin cytoskeleton organization [GO:0030036]; cytoskeleton organization [GO:0007010]; G1/S transition of mitotic cell cycle [GO:0000082]; Rac protein signal transduction [GO:0016601]; regulation of cell shape [GO:0008360],cell projection [GO:0042995]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; podosome [GO:0002102],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872],GO:0003824; GO:0003924; GO:0005886; GO:0007010; GO:0016787; GO:0043226,catalytic activity; GTPase activity; plasma membrane; cytoskeleton organization; hydrolase activity; organelle
OG_06880,FUN_031900-T1,Peve_00037707,Pocillopora_meandrina_HIv1___RNAseq.21387_t,three_way,70.62066666666666,FUN_031900-T1,Q00168,,,,,39.0,264.0,1.4e-53,211.5,sp|Q00168|KCC2A_DROME Calcium/calmodulin-dependent protein kinase type II alpha chain OS=Drosophila melanogaster OX=7227 GN=CaMKII PE=1 SV=1,,,,,,
OG_06881,FUN_031902-T1,Peve_00037703,Pocillopora_meandrina_HIv1___RNAseq.g30039.t1,three_way,69.01516666666666,FUN_031902-T1,Q8N9M1,,,,,36.5,241.0,4.0000000000000004e-23,110.5,sp|Q8N9M1|CS047_HUMAN Uncharacterized protein C19orf47 OS=Homo sapiens OX=9606 GN=C19orf47 PE=1 SV=1,,,,,,
OG_06882,FUN_031903-T1,Peve_00037702,Pocillopora_meandrina_HIv1___RNAseq.g30040.t1,three_way,82.041,FUN_031903-T1,Q7ZXY0,,,,,73.9,506.0,4.6e-220,765.4,sp|Q7ZXY0|INO1A_XENLA Inositol-3-phosphate synthase 1-A OS=Xenopus laevis OX=8355 GN=isyna1-a PE=2 SV=1,,,,,,
OG_06883,FUN_031904-T1,Peve_00037700,Pocillopora_meandrina_HIv1___RNAseq.g30041.t1,three_way,62.568666666666665,,,,,,,,,,,,,,,,,
OG_06884,FUN_031907-T1,Peve_00037699,Pocillopora_meandrina_HIv1___RNAseq.g30042.t1,three_way,82.0565,,,,,,,,,,,,,,,,,
OG_06885,FUN_031908-T1,Peve_00037696,Pocillopora_meandrina_HIv1___RNAseq.g30045.t1,three_way,57.48116666666667,FUN_031908-T1,Q9Z2E9,,,,,45.7,221.0,1.5e-52,209.1,sp|Q9Z2E9|BSCL2_MOUSE Seipin OS=Mus musculus OX=10090 GN=Bscl2 PE=1 SV=2,,,,,,
OG_06886,FUN_031920-T1,Peve_00040655,Pocillopora_meandrina_HIv1___RNAseq.g30047.t1,three_way,68.389,FUN_031920-T1,Q07326,PIGF_HUMAN,,"GPI ethanolamine phosphate transferase, stabilizing subunit (GPI ethanolamine phosphate transferase 2, stabilizing subunit) (GPI ethanolamine phosphate transferase 3, stabilizing subunit) (GPI11 homolog) (Phosphatidylinositol-glycan biosynthesis class F protein) (PIG-F)",Homo sapiens (Human),38.3,162.0,4.8e-24,112.8,"sp|Q07326|PIGF_HUMAN GPI ethanolamine phosphate transferase, stabilizing subunit OS=Homo sapiens OX=9606 GN=PIGF PE=1 SV=1",GO:0004307; GO:0005789; GO:0006506,GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum membrane [GO:0005789],ethanolaminephosphotransferase activity [GO:0004307],GO:0003824; GO:0006629; GO:0016740; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_06887,FUN_031921-T1,Peve_00040661,Pocillopora_meandrina_HIv1___RNAseq.g30046.t1,three_way,57.22266666666666,FUN_031921-T1,Q3LU38,,,,,36.1,183.0,3.9e-15,83.6,sp|Q3LU38|PROP1_ALOBE Homeobox protein prophet of Pit-1 OS=Alouatta belzebul OX=30590 GN=PROP1 PE=3 SV=1,,,,,,
OG_06888,FUN_031925-T1,Peve_00004245,Pocillopora_meandrina_HIv1___TS.g21220.t1,three_way,43.71983333333333,,,,,,,,,,,,,,,,,
OG_06889,FUN_031927-T1,Peve_00004242,Pocillopora_meandrina_HIv1___RNAseq.g18295.t1,three_way,59.02133333333333,FUN_031927-T1,Q9C907,,,,,36.2,257.0,4.8e-40,166.4,sp|Q9C907|GDPD5_ARATH Glycerophosphodiester phosphodiesterase GDPD5 OS=Arabidopsis thaliana OX=3702 GN=GDPD5 PE=2 SV=1,,,,,,
OG_06890,FUN_031929-T1,Peve_00004239,Pocillopora_meandrina_HIv1___RNAseq.g18236.t1,three_way,51.3345,FUN_031929-T1,A0A061IR73,,,,,46.3,749.0,3.1e-175,617.5,sp|A0A061IR73|PEX6_CRIGR Peroxisomal ATPase PEX6 OS=Cricetulus griseus OX=10029 GN=PEX6 PE=3 SV=1,,,,,,
OG_06891,FUN_031930-T1,Peve_00004237,Pocillopora_meandrina_HIv1___RNAseq.g18237.t1,three_way,54.86833333333333,,,,,,,,,,,,,,,,,
OG_06892,FUN_031931-T1,Peve_00004235,Pocillopora_meandrina_HIv1___RNAseq.g18238.t1,three_way,59.82666666666667,FUN_031931-T1,Q498L0,,,,,51.9,104.0,1.7000000000000002e-22,110.2,sp|Q498L0|C170B_XENLA Centrosomal protein of 170 kDa protein B OS=Xenopus laevis OX=8355 GN=cep170b PE=2 SV=1,,,,,,
OG_06893,FUN_031934-T1,Peve_00035174,Pocillopora_meandrina_HIv1___RNAseq.g18219.t1,three_way,62.78816666666666,FUN_031934-T1,Q9DAZ9,ANCHR_MOUSE,,Abscission/NoCut checkpoint regulator (ANCHR) (Zinc finger FYVE domain-containing protein 19),Mus musculus (Mouse),27.1,414.0,1.2e-30,135.6,sp|Q9DAZ9|ANCHR_MOUSE Abscission/NoCut checkpoint regulator OS=Mus musculus OX=10090 GN=Zfyve19 PE=1 SV=2,GO:0005737; GO:0005813; GO:0008270; GO:0030496; GO:0032154; GO:0032266; GO:0032466; GO:0044878; GO:0061952; GO:0090543,midbody abscission [GO:0061952]; mitotic cytokinesis checkpoint signaling [GO:0044878]; negative regulation of cytokinesis [GO:0032466],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496],phosphatidylinositol-3-phosphate binding [GO:0032266]; zinc ion binding [GO:0008270],GO:0005815; GO:0008289; GO:0061024,microtubule organizing center; lipid binding; membrane organization
OG_06894,FUN_031935-T1,Peve_00035173,Pocillopora_meandrina_HIv1___TS.g21206.t1,three_way,72.281,,,,,,,,,,,,,,,,,
OG_06895,FUN_031937-T1,Peve_00024805,Pocillopora_meandrina_HIv1___RNAseq.g18211.t1,three_way,52.65616666666666,,,,,,,,,,,,,,,,,
OG_06896,FUN_031938-T1,Peve_00024799,Pocillopora_meandrina_HIv1___RNAseq.g18210.t1,three_way,53.64366666666667,,,,,,,,,,,,,,,,,
OG_06897,FUN_031939-T1,Peve_00024800,Pocillopora_meandrina_HIv1___RNAseq.g18209.t1,three_way,83.44266666666667,FUN_031939-T1,Q9NRN9,,,,,64.9,205.0,1.4000000000000001e-74,280.8,sp|Q9NRN9|METL5_HUMAN rRNA N(6)-adenosine-methyltransferase METTL5 OS=Homo sapiens OX=9606 GN=METTL5 PE=1 SV=1,,,,,,
OG_06898,FUN_031940-T1,Peve_00024801,Pocillopora_meandrina_HIv1___RNAseq.g18208.t1,three_way,59.729,,,,,,,,,,,,,,,,,
OG_06899,FUN_031942-T1,Peve_00031841,Pocillopora_meandrina_HIv1___RNAseq.g18206.t1,three_way,81.319,FUN_031942-T1,Q9UKY4,,,,,52.4,687.0,1.1e-208,728.0,sp|Q9UKY4|POMT2_HUMAN Protein O-mannosyl-transferase 2 OS=Homo sapiens OX=9606 GN=POMT2 PE=1 SV=2,,,,,,
OG_06900,FUN_031943-T1,Peve_00031842,Pocillopora_meandrina_HIv1___RNAseq.g18205.t1,three_way,68.272,,,,,,,,,,,,,,,,,
OG_06901,FUN_031944-T1,Peve_00031843,Pocillopora_meandrina_HIv1___RNAseq.g18204.t2,three_way,92.98266666666666,FUN_031944-T1,Q7ZT47,PSF1_XENLA,,DNA replication complex GINS protein PSF1 (GINS complex subunit 1),Xenopus laevis (African clawed frog),59.0,195.0,4.900000000000001e-65,248.8,sp|Q7ZT47|PSF1_XENLA DNA replication complex GINS protein PSF1 OS=Xenopus laevis OX=8355 GN=gins1 PE=1 SV=1,GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902983,DNA replication [GO:0006260]; DNA strand elongation involved in mitotic DNA replication [GO:1902983],CMG complex [GO:0071162]; GINS complex [GO:0000811],chromatin binding [GO:0003682],GO:0006260,DNA replication
OG_06902,FUN_031945-T1,Peve_00031844,Pocillopora_meandrina_HIv1___RNAseq.g6066.t1,three_way,66.55733333333333,FUN_031945-T1,Q08C93,ABD12_DANRE,,Lysophosphatidylserine lipase ABHD12 (EC 3.1.-.-) (2-arachidonoylglycerol hydrolase ABHD12) (Abhydrolase domain-containing protein 12) (Monoacylglycerol lipase ABHD12) (EC 3.1.1.23) (Oxidized phosphatidylserine lipase ABHD12) (EC 3.1.-.-),Danio rerio (Zebrafish) (Brachydanio rerio),41.7,326.0,4e-63,243.4,sp|Q08C93|ABD12_DANRE Lysophosphatidylserine lipase ABHD12 OS=Danio rerio OX=7955 GN=abhd12 PE=2 SV=1,GO:0004620; GO:0004622; GO:0005789; GO:0006660; GO:0009395; GO:0010842; GO:0016020; GO:0036269; GO:0042552; GO:0043010; GO:0046464; GO:0047372; GO:0048899; GO:0048919; GO:0052651,acylglycerol catabolic process [GO:0046464]; anterior lateral line development [GO:0048899]; camera-type eye development [GO:0043010]; monoacylglycerol catabolic process [GO:0052651]; myelination [GO:0042552]; phosphatidylserine catabolic process [GO:0006660]; phospholipid catabolic process [GO:0009395]; posterior lateral line neuromast development [GO:0048919]; retina layer formation [GO:0010842]; swimming behavior [GO:0036269],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],lysophospholipase activity [GO:0004622]; monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620],GO:0003824; GO:0006575; GO:0006629; GO:0016787; GO:0048856,catalytic activity; modified amino acid metabolic process; lipid metabolic process; hydrolase activity; anatomical structure development
OG_06903,FUN_031949-T1,Peve_00031822,Pocillopora_meandrina_HIv1___RNAseq.g6063.t2,three_way,64.09533333333334,FUN_031949-T1,P81439,,,,,40.1,187.0,5.8e-32,141.7,sp|P81439|EQSTC_ACTEQ Equistatin OS=Actinia equina OX=6106 PE=1 SV=2,,,,,,
OG_06904,FUN_031950-T1,Peve_00031823,Pocillopora_meandrina_HIv1___RNAseq.g6062.t1,three_way,97.722,FUN_031950-T1,P48601,,,,,94.3,334.0,2e-178,626.3,sp|P48601|PRS4_DROME 26S proteasome regulatory subunit 4 OS=Drosophila melanogaster OX=7227 GN=Rpt2 PE=1 SV=2,,,,,,
OG_06905,FUN_031953-T1,Peve_00013254,Pocillopora_meandrina_HIv1___TS.g20904.t2,three_way,78.99966666666667,FUN_031953-T1,Q9WVL0,,,,,62.3,212.0,8.000000000000001e-72,271.6,sp|Q9WVL0|MAAI_MOUSE Maleylacetoacetate isomerase OS=Mus musculus OX=10090 GN=Gstz1 PE=1 SV=1,,,,,,
OG_06906,FUN_031954-T1,Peve_00013253,Pocillopora_meandrina_HIv1___RNAseq.g30201.t1,three_way,52.73033333333333,,,,,,,,,,,,,,,,,
OG_06907,FUN_031957-T1,Peve_00013252,Pocillopora_meandrina_HIv1___TS.g22498.t1,three_way,61.96216666666666,,,,,,,,,,,,,,,,,
OG_06908,FUN_031966-T1,Peve_00043673,Pocillopora_meandrina_HIv1___RNAseq.g30203.t1,three_way,76.01766666666667,FUN_031966-T1,Q8UWA5,,,,,36.9,274.0,3.3e-36,153.7,sp|Q8UWA5|CAH2_PSEHK Carbonic anhydrase 2 OS=Pseudaspius hakonensis OX=3004147 GN=ca2 PE=2 SV=3,,,,,,
OG_06909,FUN_031967-T1,Peve_00013260,Pocillopora_meandrina_HIv1___RNAseq.g17806.t1,three_way,83.551,FUN_031967-T1,Q95M17,CHIA_BOVIN,,Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04),Bos taurus (Bovine),46.4,390.0,4.4e-91,336.7,sp|Q95M17|CHIA_BOVIN Acidic mammalian chitinase OS=Bos taurus OX=9913 GN=CHIA PE=1 SV=1,GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0008843; GO:0032722,apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005975; GO:0012501; GO:0016787; GO:1901135,immune system process; catalytic activity; extracellular region; extracellular space; carbohydrate metabolic process; programmed cell death; hydrolase activity; carbohydrate derivative metabolic process
OG_06910,FUN_031970-T1,Peve_00043666,Pocillopora_meandrina_HIv1___RNAseq.g30204.t1,three_way,57.15116666666666,FUN_031970-T1,Q96J02,,,,,37.4,270.0,1.6e-43,180.3,sp|Q96J02|ITCH_HUMAN E3 ubiquitin-protein ligase Itchy homolog OS=Homo sapiens OX=9606 GN=ITCH PE=1 SV=2,,,,,,
OG_06911,FUN_031971-T1,Peve_00043665,Pocillopora_meandrina_HIv1___RNAseq.g30205.t1,three_way,62.97566666666667,,,,,,,,,,,,,,,,,
OG_06912,FUN_031972-T1,Peve_00043663,Pocillopora_meandrina_HIv1___TS.g22502.t1,three_way,81.21033333333332,FUN_031972-T1,C6EUD4,,,,,58.3,338.0,4.9000000000000003e-110,399.4,sp|C6EUD4|APSCT_FASHE Succinyl-CoA:acetate/propanoyl-CoA:succinate CoA transferase OS=Fasciola hepatica OX=6192 PE=1 SV=1,,,,,,
OG_06913,FUN_031974-T2,Peve_00043636,Pocillopora_meandrina_HIv1___TS.g22504.t1,three_way,69.29716666666667,FUN_031974-T2,Q866F4,,,,,31.2,818.0,1.2e-97,360.5,sp|Q866F4|ADCYA_RABIT Adenylate cyclase type 10 OS=Oryctolagus cuniculus OX=9986 GN=ADCY10 PE=2 SV=1,,,,,,
OG_06914,FUN_031975-T1,Peve_00043634,Pocillopora_meandrina_HIv1___RNAseq.27566_t,three_way,90.708,FUN_031975-T1,P14408,FUMH_RAT,,"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)",Rattus norvegicus (Rat),75.9,469.0,6.6e-210,731.5,"sp|P14408|FUMH_RAT Fumarate hydratase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Fh PE=1 SV=2",GO:0000050; GO:0000821; GO:0004333; GO:0005634; GO:0005694; GO:0005739; GO:0005759; GO:0005829; GO:0006099; GO:0006106; GO:0006108; GO:0006281; GO:0006525; GO:0006974; GO:0048873; GO:0120162; GO:2001034,arginine metabolic process [GO:0006525]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050],chromosome [GO:0005694]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634],fumarate hydratase activity [GO:0004333],GO:0003824; GO:0005634; GO:0005694; GO:0005739; GO:0005829; GO:0006281; GO:0006520; GO:0016829; GO:0043226; GO:0071941,catalytic activity; nucleus; chromosome; mitochondrion; cytosol; DNA repair; amino acid metabolic process; lyase activity; organelle; nitrogen cycle metabolic process
OG_06915,FUN_031976-T1,Peve_00043633,Pocillopora_meandrina_HIv1___RNAseq.g30254.t1,three_way,69.245,FUN_031976-T1,Q54CI5,,,,,40.9,154.0,3.3e-23,109.8,sp|Q54CI5|DPH4_DICDI DPH4 homolog OS=Dictyostelium discoideum OX=44689 GN=dph4 PE=3 SV=1,,,,,,
OG_06916,FUN_031977-T1,Peve_00043632,Pocillopora_meandrina_HIv1___RNAseq.g30255.t1,three_way,74.21633333333334,FUN_031977-T1,Q5SPH9,,,,,48.8,123.0,8.300000000000001e-27,122.1,sp|Q5SPH9|RT10_DANRE Small ribosomal subunit protein uS10m OS=Danio rerio OX=7955 GN=mrps10 PE=3 SV=1,,,,,,
OG_06917,FUN_031981-T1,Peve_00028816,Pocillopora_meandrina_HIv1___RNAseq.g30256.t2,three_way,80.43633333333334,FUN_031981-T1,A7RZW4,DPP3_NEMVE,,Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III),Nematostella vectensis (Starlet sea anemone),69.4,731.0,1.7e-302,1039.6,sp|A7RZW4|DPP3_NEMVE Dipeptidyl peptidase 3 OS=Nematostella vectensis OX=45351 GN=dpp3 PE=3 SV=1,GO:0004177; GO:0005737; GO:0006508; GO:0008235; GO:0008239; GO:0046872,proteolysis [GO:0006508],cytoplasm [GO:0005737],aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metalloexopeptidase activity [GO:0008235],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_06918,FUN_031982-T1,Peve_00028815,Pocillopora_meandrina_HIv1___RNAseq.g30257.t1,three_way,64.92633333333333,FUN_031982-T1,Q2KIU2,PMVK_BOVIN,,Phosphomevalonate kinase (PMKase) (EC 2.7.4.2),Bos taurus (Bovine),54.8,188.0,5.4e-54,212.2,sp|Q2KIU2|PMVK_BOVIN Phosphomevalonate kinase OS=Bos taurus OX=9913 GN=PMVK PE=2 SV=3,GO:0004631; GO:0005524; GO:0005829; GO:0006695; GO:0019287,"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]",cytosol [GO:0005829],ATP binding [GO:0005524]; phosphomevalonate kinase activity [GO:0004631],GO:0003824; GO:0005829; GO:0006629; GO:0006790; GO:0016740; GO:0055086,catalytic activity; cytosol; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process
OG_06919,FUN_031983-T1,Peve_00028814,Pocillopora_meandrina_HIv1___RNAseq.g30258.t1,three_way,74.83933333333334,FUN_031983-T1,Q8NBN7,RDH13_HUMAN,,Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3),Homo sapiens (Human),55.7,298.0,1e-85,318.2,sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2,GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650,eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226; GO:0048856,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle; anatomical structure development
OG_06920,FUN_032004-T1,Peve_00028811,Pocillopora_meandrina_HIv1___TS.g22558.t1,three_way,74.84166666666667,FUN_032004-T1,Q5ZME2,,,,,69.8,331.0,8.9e-126,451.4,"sp|Q5ZME2|MDHC_CHICK Malate dehydrogenase, cytoplasmic OS=Gallus gallus OX=9031 GN=MDH1 PE=2 SV=1",,,,,,
OG_06921,FUN_032007-T1,Peve_00028808,Pocillopora_meandrina_HIv1___RNAseq.g30263.t1,three_way,64.71766666666667,FUN_032007-T1,Q49LS8,,,,,26.6,387.0,1.9e-25,118.6,sp|Q49LS8|XKR6_TETNG XK-related protein 6 OS=Tetraodon nigroviridis OX=99883 GN=xkr6 PE=2 SV=1,,,,,,
OG_06922,FUN_032012-T1,Peve_00028791,Pocillopora_meandrina_HIv1___RNAseq.g30267.t1,three_way,74.29599999999999,FUN_032012-T1,Q20191,,,,,44.3,228.0,1.5e-45,185.7,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_06923,FUN_032013-T1,Peve_00028828,Pocillopora_meandrina_HIv1___RNAseq.g30268.t1,three_way,59.529,FUN_032013-T1,Q49LS6,,,,,25.3,359.0,1.5e-12,76.3,sp|Q49LS6|XKR9_TETNG XK-related protein 9 OS=Tetraodon nigroviridis OX=99883 GN=xkr9 PE=2 SV=1,,,,,,
OG_06924,FUN_032014-T1,Peve_00041128,Pocillopora_meandrina_HIv1___RNAseq.g30270.t1,three_way,57.59433333333333,FUN_032014-T1,P14824,ANXA6_MOUSE,,Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70),Mus musculus (Mouse),25.3,292.0,1.3e-17,92.0,sp|P14824|ANXA6_MOUSE Annexin A6 OS=Mus musculus OX=10090 GN=Anxa6 PE=1 SV=3,GO:0005509; GO:0005525; GO:0005544; GO:0005739; GO:0005765; GO:0005829; GO:0006816; GO:0006937; GO:0015276; GO:0015485; GO:0016020; GO:0031902; GO:0042470; GO:0042802; GO:0048306; GO:0048471; GO:0051560; GO:0062023; GO:0097190,apoptotic signaling pathway [GO:0097190]; calcium ion transport [GO:0006816]; mitochondrial calcium ion homeostasis [GO:0051560]; regulation of muscle contraction [GO:0006937],collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cholesterol binding [GO:0015485]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; ligand-gated monoatomic ion channel activity [GO:0015276],GO:0005215; GO:0005739; GO:0005829; GO:0008289; GO:0031410; GO:0043226,transporter activity; mitochondrion; cytosol; lipid binding; cytoplasmic vesicle; organelle
OG_06925,FUN_032015-T1,Peve_00041126,Pocillopora_meandrina_HIv1___RNAseq.g30271.t1,three_way,95.74166666666667,FUN_032015-T1,Q9BXW4,,,,,72.9,118.0,2.5e-41,169.5,sp|Q9BXW4|MLP3C_HUMAN Microtubule-associated protein 1 light chain 3 gamma OS=Homo sapiens OX=9606 GN=MAP1LC3C PE=1 SV=1,,,,,,
OG_06926,FUN_032016-T2,Peve_00041123,Pocillopora_meandrina_HIv1___RNAseq.27584_t,three_way,52.10083333333333,FUN_032016-T2,Q1G7G9,TALD3_CHICK,,TALPID3 protein,Gallus gallus (Chicken),25.3,663.0,1.1000000000000002e-28,131.3,sp|Q1G7G9|TALD3_CHICK TALPID3 protein OS=Gallus gallus OX=9031 GN=TALPID3 PE=2 SV=2,GO:0005737; GO:0005813; GO:0005814; GO:0007224; GO:0036064; GO:0044458; GO:0051642; GO:0060271,centrosome localization [GO:0051642]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458]; smoothened signaling pathway [GO:0007224],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737],,GO:0005815; GO:0043226; GO:0044782,microtubule organizing center; organelle; cilium organization
OG_06927,FUN_032017-T1,Peve_00041122,Pocillopora_meandrina_HIv1___RNAseq.g30275.t1,three_way,62.1695,FUN_032017-T1,E1C760,,,,,38.0,737.0,2.5e-117,424.5,sp|E1C760|UVSSA_CHICK UV-stimulated scaffold protein A OS=Gallus gallus OX=9031 GN=UVSSA PE=3 SV=1,,,,,,
OG_06928,FUN_032018-T1,Peve_00041130,Pocillopora_meandrina_HIv1___RNAseq.g30276.t1,three_way,85.556,,,,,,,,,,,,,,,,,
OG_06929,FUN_032019-T1,Peve_00041125,Pocillopora_meandrina_HIv1___TS.g22573.t1,three_way,74.76366666666667,FUN_032019-T1,Q55E31,RB32B_DICDI,,Ras-related protein Rab-32B,Dictyostelium discoideum (Social amoeba),61.0,182.0,6.3999999999999996e-62,238.8,sp|Q55E31|RB32B_DICDI Ras-related protein Rab-32B OS=Dictyostelium discoideum OX=44689 GN=rab32B PE=3 SV=1,GO:0003924; GO:0005525; GO:0005802; GO:0006886; GO:0012505; GO:0016192; GO:0031982; GO:0032438,intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; vesicle-mediated transport [GO:0016192],endomembrane system [GO:0012505]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0006886; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; intracellular protein transport; vesicle-mediated transport; hydrolase activity; organelle
OG_06930,FUN_032021-T1,Peve_00041120,Pocillopora_meandrina_HIv1___RNAseq.g25906.t1,three_way,45.036,,,,,,,,,,,,,,,,,
OG_06931,FUN_032022-T1,Peve_00029553,Pocillopora_meandrina_HIv1___RNAseq.g5694.t1,three_way,65.54733333333333,FUN_032022-T1,O43854,EDIL3_HUMAN,,EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1),Homo sapiens (Human),32.5,114.0,1.9e-06,56.6,sp|O43854|EDIL3_HUMAN EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Homo sapiens OX=9606 GN=EDIL3 PE=1 SV=1,GO:0005178; GO:0005509; GO:0005576; GO:0007155; GO:0010811; GO:0062023; GO:0070062; GO:1903561,cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811],collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561],calcium ion binding [GO:0005509]; integrin binding [GO:0005178],GO:0005576; GO:0007155; GO:0043226,extracellular region; cell adhesion; organelle
OG_06932,FUN_032024-T1,Peve_00001041,Pocillopora_meandrina_HIv1___RNAseq.g5695.t1,three_way,95.975,FUN_032024-T1,Q3SZF8,SMD2_BOVIN,,Small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2),Bos taurus (Bovine),89.0,118.0,5.1e-52,204.9,sp|Q3SZF8|SMD2_BOVIN Small nuclear ribonucleoprotein Sm D2 OS=Bos taurus OX=9913 GN=SNRPD2 PE=3 SV=1,GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005689; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06933,FUN_032025-T1,Peve_00001044,Pocillopora_meandrina_HIv1___RNAseq.g5696.t1a,three_way,85.64333333333333,FUN_032025-T1,Q5U5C5,PRP31_XENLA,,U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31),Xenopus laevis (African clawed frog),62.3,496.0,2.4e-156,553.5,sp|Q5U5C5|PRP31_XENLA U4/U6 small nuclear ribonucleoprotein Prp31 OS=Xenopus laevis OX=8355 GN=prpf31 PE=2 SV=1,GO:0000244; GO:0000398; GO:0005634; GO:0005687; GO:0005690; GO:0015030; GO:0016607; GO:0030622; GO:0046540; GO:0071005; GO:0071011; GO:0071339; GO:0097526,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]",Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690],U4atac snRNA binding [GO:0030622],GO:0003723; GO:0005634; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_06934,FUN_032038-T1,Peve_00013548,Pocillopora_meandrina_HIv1___RNAseq.g5928.t1b,three_way,59.332,,,,,,,,,,,,,,,,,
OG_06935,FUN_032040-T1,Peve_00013552,Pocillopora_meandrina_HIv1___RNAseq.g5930.t1,three_way,82.90566666666666,FUN_032040-T1,Q6PA06,ATLA2_MOUSE,,Atlastin-2 (EC 3.6.5.-),Mus musculus (Mouse),61.0,490.0,2.9e-179,629.8,sp|Q6PA06|ATLA2_MOUSE Atlastin-2 OS=Mus musculus OX=10090 GN=Atl2 PE=1 SV=1,GO:0005525; GO:0016320; GO:0071346; GO:0098826; GO:0140523; GO:1990809,cellular response to type II interferon [GO:0071346]; endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum tubular network membrane organization [GO:1990809],endoplasmic reticulum tubular network membrane [GO:0098826],GTP binding [GO:0005525]; GTPase-dependent fusogenic activity [GO:0140523],GO:0003824; GO:0003924; GO:0016787; GO:0061024,catalytic activity; GTPase activity; hydrolase activity; membrane organization
OG_06936,FUN_032043-T1,Peve_00013570,Pocillopora_meandrina_HIv1___RNAseq.g5943.t1,three_way,65.27933333333333,FUN_032043-T1,Q99N87,,,,,51.2,215.0,7.9999999999999985e-56,219.2,sp|Q99N87|RT05_MOUSE Small ribosomal subunit protein uS5m OS=Mus musculus OX=10090 GN=Mrps5 PE=1 SV=1,,,,,,
OG_06937,FUN_032044-T1,Peve_00013568,Pocillopora_meandrina_HIv1___RNAseq.g5941.t1,three_way,84.47583333333333,FUN_032044-T1,Q91ZR5,CTSR1_MOUSE,,Cation channel sperm-associated protein 1 (CatSper1),Mus musculus (Mouse),47.8,205.0,5.4e-22,106.7,sp|Q91ZR5|CTSR1_MOUSE Cation channel sperm-associated protein 1 OS=Mus musculus OX=10090 GN=Catsper1 PE=1 SV=1,GO:0005227; GO:0005245; GO:0005886; GO:0006816; GO:0007283; GO:0007342; GO:0030154; GO:0030317; GO:0036128; GO:0051924; GO:0060296; GO:0097228,calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; regulation of calcium ion transport [GO:0051924]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; spermatogenesis [GO:0007283],CatSper complex [GO:0036128]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228],calcium-activated cation channel activity [GO:0005227]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005886; GO:0007018; GO:0022414; GO:0030154; GO:0048870; GO:0061024,transporter activity; plasma membrane; microtubule-based movement; reproductive process; cell differentiation; cell motility; membrane organization
OG_06938,FUN_032045-T1,Peve_00013564,Pocillopora_meandrina_HIv1___RNAseq.g5935.t1,three_way,48.15616666666666,FUN_032045-T1,Q4JL91,IPPK_DANRE,,"Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase) (InsP5 2-kinase)",Danio rerio (Zebrafish) (Brachydanio rerio),24.6,605.0,6.7e-42,173.7,sp|Q4JL91|IPPK_DANRE Inositol-pentakisphosphate 2-kinase OS=Danio rerio OX=7955 GN=ippk PE=1 SV=3,GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005813; GO:0007368; GO:0032402; GO:0032958; GO:0035299; GO:0036064; GO:0060287,determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; inositol phosphate biosynthetic process [GO:0032958]; melanosome transport [GO:0032402],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634],"ATP binding [GO:0005524]; inositol-1,3,4,5,6-pentakisphosphate 2-kinase activity [GO:0035299]",GO:0003824; GO:0005576; GO:0005634; GO:0005815; GO:0007018; GO:0016740; GO:0043226,catalytic activity; extracellular region; nucleus; microtubule organizing center; microtubule-based movement; transferase activity; organelle
OG_06939,FUN_032048-T1,Peve_00013563,Pocillopora_meandrina_HIv1___RNAseq.g5934.t1,three_way,88.20733333333334,FUN_032048-T1,Q9XTL9,,,,,70.2,831.0,0.0,1236.1,sp|Q9XTL9|PYG_DROME Glycogen phosphorylase OS=Drosophila melanogaster OX=7227 GN=Glyp PE=2 SV=2,,,,,,
OG_06940,FUN_032050-T1,Peve_00012447,Pocillopora_meandrina_HIv1___RNAseq.g6024.t1,three_way,83.42633333333333,FUN_032050-T1,Q9P1Q0,,,,,43.1,988.0,2.9e-204,713.8,sp|Q9P1Q0|VPS54_HUMAN Vacuolar protein sorting-associated protein 54 OS=Homo sapiens OX=9606 GN=VPS54 PE=1 SV=2,,,,,,
OG_06941,FUN_032051-T1,Peve_00012446,Pocillopora_meandrina_HIv1___RNAseq.g6025.t1,three_way,90.203,FUN_032051-T1,Q91918,,,,,83.3,335.0,2.3000000000000003e-158,559.7,sp|Q91918|RA51A_XENLA DNA repair protein RAD51 homolog A OS=Xenopus laevis OX=8355 GN=rad51-a PE=2 SV=1,,,,,,
OG_06942,FUN_032052-T1,Peve_00012445,Pocillopora_meandrina_HIv1___RNAseq.g6026.t1,three_way,72.548,FUN_032052-T1,Q96NT5,,,,,28.5,445.0,2.6e-38,161.4,sp|Q96NT5|PCFT_HUMAN Proton-coupled folate transporter OS=Homo sapiens OX=9606 GN=SLC46A1 PE=1 SV=1,,,,,,
OG_06943,FUN_032053-T1,Peve_00012451,Pocillopora_meandrina_HIv1___RNAseq.g6027.t1,three_way,65.46633333333334,FUN_032053-T1,Q68DK2,ZFY26_HUMAN,,Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein) (FYVE-CENT) (Spastizin),Homo sapiens (Human),31.7,1223.0,2.8e-168,595.9,sp|Q68DK2|ZFY26_HUMAN Zinc finger FYVE domain-containing protein 26 OS=Homo sapiens OX=9606 GN=ZFYVE26 PE=1 SV=4,GO:0000281; GO:0000724; GO:0005764; GO:0005765; GO:0005769; GO:0005770; GO:0005813; GO:0007040; GO:0008270; GO:0019901; GO:0030496; GO:0032266; GO:0032465; GO:1905037,autophagosome organization [GO:1905037]; double-strand break repair via homologous recombination [GO:0000724]; lysosome organization [GO:0007040]; mitotic cytokinesis [GO:0000281]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; midbody [GO:0030496],phosphatidylinositol-3-phosphate binding [GO:0032266]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270],GO:0000910; GO:0005764; GO:0005768; GO:0005773; GO:0005815; GO:0006281; GO:0006310; GO:0007040; GO:0008289; GO:0031410; GO:0043226,cytokinesis; lysosome; endosome; vacuole; microtubule organizing center; DNA repair; DNA recombination; lysosome organization; lipid binding; cytoplasmic vesicle; organelle
OG_06944,FUN_032054-T1,Peve_00012450,Pocillopora_meandrina_HIv1___RNAseq.g6019.t1,three_way,66.74666666666667,,,,,,,,,,,,,,,,,
OG_06945,FUN_032055-T1,Peve_00012449,Pocillopora_meandrina_HIv1___RNAseq.g6020.t1,three_way,62.906666666666666,,,,,,,,,,,,,,,,,
OG_06946,FUN_032056-T1,Peve_00011274,Pocillopora_meandrina_HIv1___RNAseq.g6021.t1,three_way,60.78183333333333,,,,,,,,,,,,,,,,,
OG_06947,FUN_032057-T1,Peve_00011276,Pocillopora_meandrina_HIv1___RNAseq.g6013.t1,three_way,64.61149999999999,,,,,,,,,,,,,,,,,
OG_06948,FUN_032061-T2,Peve_00040453,Pocillopora_meandrina_HIv1___RNAseq.g6047.t1,three_way,65.65933333333334,FUN_032061-T2,P39428,TRAF1_MOUSE,,TNF receptor-associated factor 1,Mus musculus (Mouse),31.4,264.0,1.1e-27,125.9,sp|P39428|TRAF1_MOUSE TNF receptor-associated factor 1 OS=Mus musculus OX=10090 GN=Traf1 PE=1 SV=2,GO:0005164; GO:0005737; GO:0006915; GO:0007165; GO:0008270; GO:0031625; GO:0031996; GO:0042802; GO:2001236,apoptotic process [GO:0006915]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; signal transduction [GO:0007165],cytoplasm [GO:0005737],identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0012501,programmed cell death
OG_06949,FUN_032062-T1,Peve_00008200,Pocillopora_meandrina_HIv1___RNAseq.g6046.t1,three_way,65.52866666666667,FUN_032062-T1,O00463,TRAF5_HUMAN,,TNF receptor-associated factor 5 (RING finger protein 84),Homo sapiens (Human),30.1,173.0,5.8e-13,77.0,sp|O00463|TRAF5_HUMAN TNF receptor-associated factor 5 OS=Homo sapiens OX=9606 GN=TRAF5 PE=1 SV=2,GO:0005164; GO:0005737; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0007166; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0023035; GO:0031625; GO:0031996; GO:0033209; GO:0035591; GO:0035631; GO:0042802; GO:0042981; GO:0043122; GO:0043123; GO:0048255; GO:0051092; GO:0061630; GO:0097400,apoptotic process [GO:0006915]; CD40 signaling pathway [GO:0023035]; cell surface receptor signaling pathway [GO:0007166]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829],identical protein binding [GO:0042802]; signaling adaptor activity [GO:0035591]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0006355; GO:0012501; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; regulation of DNA-templated transcription; programmed cell death; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_06950,FUN_032063-T1,Peve_00024739,Pocillopora_meandrina_HIv1___RNAseq.g6045.t1,three_way,41.4025,,,,,,,,,,,,,,,,,
OG_06951,FUN_032064-T1,Peve_00024743,Pocillopora_meandrina_HIv1___RNAseq.g6044.t3,three_way,55.462,FUN_032064-T1,Q28DL4,TRAF6_XENTR,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),25.1,346.0,2.8e-20,101.3,sp|Q28DL4|TRAF6_XENTR TNF receptor-associated factor 6 OS=Xenopus tropicalis OX=8364 GN=traf6 PE=2 SV=1,GO:0004842; GO:0005164; GO:0005634; GO:0005811; GO:0005938; GO:0008270; GO:0019222; GO:0042981; GO:0043122; GO:0070534; GO:0141124,intracellular signaling cassette [GO:0141124]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of metabolic process [GO:0019222],cell cortex [GO:0005938]; lipid droplet [GO:0005811]; nucleus [GO:0005634],tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005811; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; lipid droplet; transferase activity; organelle; catalytic activity, acting on a protein"
OG_06952,FUN_032065-T1,Peve_00024742,Pocillopora_meandrina_HIv1___RNAseq.g6040.t1,three_way,67.569,FUN_032065-T1,Q63HM2,,,,,39.0,1229.0,1.2e-228,795.0,sp|Q63HM2|PCX4_HUMAN Pecanex-like protein 4 OS=Homo sapiens OX=9606 GN=PCNX4 PE=1 SV=4,,,,,,
OG_06953,FUN_032067-T1,Peve_00024741,Pocillopora_meandrina_HIv1___RNAseq.g6039.t1,three_way,74.31583333333334,FUN_032067-T1,Q8N128,,,,,48.1,52.0,4e-10,67.0,sp|Q8N128|F177A_HUMAN Protein FAM177A1 OS=Homo sapiens OX=9606 GN=FAM177A1 PE=1 SV=1,,,,,,
OG_06954,FUN_032069-T1,Peve_00024738,Pocillopora_meandrina_HIv1___RNAseq.g6018.t1,three_way,64.7885,,,,,,,,,,,,,,,,,
OG_06955,FUN_032074-T1,Peve_00018829,Pocillopora_meandrina_HIv1___RNAseq.g6016.t1,three_way,67.94316666666667,FUN_032074-T1,P78504,JAG1_HUMAN,,Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339),Homo sapiens (Human),41.2,204.0,9.5e-42,174.5,sp|P78504|JAG1_HUMAN Protein jagged-1 OS=Homo sapiens OX=9606 GN=JAG1 PE=1 SV=3,GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737,angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; molecular adaptor activity [GO:0060090]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198],GO:0002376; GO:0005198; GO:0005576; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0048018; GO:0048856; GO:0060090; GO:0098772,immune system process; structural molecule activity; extracellular region; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; receptor ligand activity; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_06956,FUN_032081-T1,Peve_00039910,Pocillopora_meandrina_HIv1___RNAseq.g5227.t1,three_way,79.99466666666666,FUN_032081-T1,Q5RE98,AOFB_PONAB,,Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),47.7,486.0,1.1000000000000001e-130,468.4,sp|Q5RE98|AOFB_PONAB Amine oxidase [flavin-containing] B OS=Pongo abelii OX=9601 GN=MAOB PE=2 SV=3,GO:0005739; GO:0005741; GO:0008131; GO:0050660; GO:0097621,,mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary methylamine oxidase activity [GO:0008131],GO:0003824; GO:0005739; GO:0016491; GO:0043226,catalytic activity; mitochondrion; oxidoreductase activity; organelle
OG_06957,FUN_032082-T1,Peve_00039909,Pocillopora_meandrina_HIv1___RNAseq.g5228.t1,three_way,70.91216666666666,FUN_032082-T1,Q6UWX4,,,,,47.1,605.0,4.7e-163,576.2,sp|Q6UWX4|HIPL2_HUMAN HHIP-like protein 2 OS=Homo sapiens OX=9606 GN=HHIPL2 PE=1 SV=1,,,,,,
OG_06958,FUN_032087-T1,Peve_00026034,Pocillopora_meandrina_HIv1___RNAseq.g5298.t1,three_way,38.37983333333334,,,,,,,,,,,,,,,,,
OG_06959,FUN_032088-T1,Peve_00026033,Pocillopora_meandrina_HIv1___RNAseq.g5297.t1,three_way,66.52333333333334,FUN_032088-T1,Q5RBF1,SIR2_PONAB,,NAD-dependent protein deacetylase sirtuin-2 (EC 2.3.1.286) (NAD-dependent protein defatty-acylase sirtuin-2) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),59.6,297.0,1.9e-105,384.0,sp|Q5RBF1|SIR2_PONAB NAD-dependent protein deacetylase sirtuin-2 OS=Pongo abelii OX=9601 GN=SIRT2 PE=1 SV=1,GO:0000122; GO:0000792; GO:0003682; GO:0004407; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006476; GO:0010507; GO:0010801; GO:0016042; GO:0022011; GO:0030426; GO:0030496; GO:0031641; GO:0032436; GO:0033010; GO:0033270; GO:0033558; GO:0034599; GO:0034979; GO:0034983; GO:0040029; GO:0042177; GO:0042903; GO:0043161; GO:0043204; GO:0043209; GO:0043219; GO:0043220; GO:0043388; GO:0044224; GO:0045599; GO:0045836; GO:0045944; GO:0046872; GO:0046970; GO:0048471; GO:0051301; GO:0051726; GO:0051781; GO:0051987; GO:0061433; GO:0070403; GO:0070446; GO:0071456; GO:0071872; GO:0072686; GO:0072687; GO:0090042; GO:0097386; GO:0140773; GO:0140774; GO:1900119; GO:1900195; GO:2000378,cell division [GO:0051301]; cellular response to caloric restriction [GO:0061433]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; epigenetic regulation of gene expression [GO:0040029]; lipid catabolic process [GO:0016042]; myelination in peripheral nervous system [GO:0022011]; negative regulation of autophagy [GO:0010507]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of cell division [GO:0051781]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of oocyte maturation [GO:1900195]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; regulation of myelination [GO:0031641]; tubulin deacetylation [GO:0090042],centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; heterochromatin [GO:0000792]; juxtaparanode region of axon [GO:0044224]; lateral loop [GO:0043219]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819],"chromatin binding [GO:0003682]; histone deacetylase activity [GO:0004407]; histone H4K16 deacetylase activity, NAD-dependent [GO:0046970]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; protein lysine deacetylase activity [GO:0033558]; tubulin deacetylase activity [GO:0042903]",GO:0003824; GO:0005634; GO:0005694; GO:0005815; GO:0005829; GO:0005886; GO:0006325; GO:0006355; GO:0006629; GO:0016740; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; microtubule organizing center; cytosol; plasma membrane; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_06960,FUN_032089-T1,Peve_00012817,Pocillopora_meandrina_HIv1___RNAseq.g2588.t1,three_way,67.0965,,,,,,,,,,,,,,,,,
OG_06961,FUN_032091-T1,Peve_00012819,Pocillopora_meandrina_HIv1___RNAseq.g5277.t1,three_way,71.29066666666667,FUN_032091-T1,Q00IB7,,,,,40.9,952.0,1.5e-190,668.7,sp|Q00IB7|PKHH1_DANRE Pleckstrin homology domain-containing family H member 1 OS=Danio rerio OX=7955 GN=plekhh1 PE=2 SV=1,,,,,,
OG_06962,FUN_032092-T1,Peve_00012820,Pocillopora_meandrina_HIv1___RNAseq.g5276.t1,three_way,74.64983333333333,,,,,,,,,,,,,,,,,
OG_06963,FUN_032093-T1,Peve_00019993,Pocillopora_meandrina_HIv1___TS.g23987.t2,three_way,67.63983333333334,,,,,,,,,,,,,,,,,
OG_06964,FUN_032095-T1,Peve_00012823,Pocillopora_meandrina_HIv1___RNAseq.g5274.t1,three_way,65.23833333333333,,,,,,,,,,,,,,,,,
OG_06965,FUN_032097-T1,Peve_00035672,Pocillopora_meandrina_HIv1___RNAseq.g5267.t1,three_way,74.00183333333334,,,,,,,,,,,,,,,,,
OG_06966,FUN_032098-T1,Peve_00035667,Pocillopora_meandrina_HIv1___RNAseq.g5302.t1,three_way,77.37366666666667,FUN_032098-T1,Q9Y256,FACE2_HUMAN,,CAAX prenyl protease 2 (EC 3.4.26.1) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) (hRCE1),Homo sapiens (Human),47.3,292.0,1.5e-65,251.1,sp|Q9Y256|FACE2_HUMAN CAAX prenyl protease 2 OS=Homo sapiens OX=9606 GN=RCE1 PE=1 SV=1,GO:0000165; GO:0004175; GO:0004197; GO:0004222; GO:0005789; GO:0005829; GO:0005886; GO:0008238; GO:0016020; GO:0018342; GO:0071586,CAAX-box protein processing [GO:0071586]; MAPK cascade [GO:0000165]; protein prenylation [GO:0018342],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; cytosol; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_06967,FUN_032099-T1,Peve_00035662,Pocillopora_meandrina_HIv1___RNAseq.g5303.t1,three_way,74.34366666666666,FUN_032099-T1,P98192,GNPAT_MOUSE,,Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase),Mus musculus (Mouse),36.0,659.0,1.3e-94,349.0,sp|P98192|GNPAT_MOUSE Dihydroxyacetone phosphate acyltransferase OS=Mus musculus OX=10090 GN=Gnpat PE=1 SV=1,GO:0003824; GO:0005777; GO:0005778; GO:0005782; GO:0006650; GO:0007416; GO:0008611; GO:0016287; GO:0021587; GO:0030054; GO:0030913; GO:0042552; GO:0061024,cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; synapse assembly [GO:0007416],cell junction [GO:0030054]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],catalytic activity [GO:0003824]; glycerone-phosphate O-acyltransferase activity [GO:0016287],GO:0003824; GO:0005777; GO:0006629; GO:0016740; GO:0034330; GO:0043226; GO:0061024,catalytic activity; peroxisome; lipid metabolic process; transferase activity; cell junction organization; organelle; membrane organization
OG_06968,FUN_032101-T1,Peve_00018056,Pocillopora_meandrina_HIv1___RNAseq.g5996.t1b,three_way,72.21733333333333,FUN_032101-T1,Q05B60,,,,,39.9,213.0,8.999999999999998e-41,168.7,sp|Q05B60|NUD14_BOVIN Uridine diphosphate glucose pyrophosphatase NUDT14 OS=Bos taurus OX=9913 GN=NUDT14 PE=2 SV=1,,,,,,
OG_06969,FUN_032102-T1,Peve_00011283,Pocillopora_meandrina_HIv1___RNAseq.g5997.t1,three_way,73.34833333333333,FUN_032102-T1,Q9DFZ4,,,,,58.5,106.0,2.1e-34,146.4,sp|Q9DFZ4|CHUR_XENLA Protein Churchill OS=Xenopus laevis OX=8355 GN=churc1 PE=3 SV=1,,,,,,
OG_06970,FUN_032103-T1,Peve_00011281,Pocillopora_meandrina_HIv1___RNAseq.g5999.t1,three_way,81.78566666666667,,,,,,,,,,,,,,,,,
OG_06971,FUN_032104-T1,Peve_00011277,Pocillopora_meandrina_HIv1___RNAseq.g6000.t1,three_way,72.7205,FUN_032104-T1,Q8IWV8,UBR2_HUMAN,,E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II),Homo sapiens (Human),42.3,1795.0,0.0,1350.1,sp|Q8IWV8|UBR2_HUMAN E3 ubiquitin-protein ligase UBR2 OS=Homo sapiens OX=9606 GN=UBR2 PE=1 SV=1,GO:0000151; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0007131; GO:0007140; GO:0007141; GO:0007283; GO:0008270; GO:0010526; GO:0016567; GO:0031507; GO:0032007; GO:0043161; GO:0050862; GO:0061630; GO:0070534; GO:0070728; GO:0071233; GO:0071596; GO:0141053,cellular response to L-leucine [GO:0071233]; heterochromatin formation [GO:0031507]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; positive regulation of T cell receptor signaling pathway [GO:0050862]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],histone H2A ubiquitin ligase activity [GO:0141053]; L-leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0006310; GO:0006325; GO:0016740; GO:0022414; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"catalytic activity; nucleus; cytosol; DNA recombination; chromatin organization; transferase activity; reproductive process; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_06972,FUN_032106-T1,Peve_00030222,Pocillopora_meandrina_HIv1___RNAseq.g5395.t1,three_way,94.85066666666668,FUN_032106-T1,P53451,,,,,75.0,539.0,3.9e-224,778.9,sp|P53451|TCPD_TAKRU T-complex protein 1 subunit delta OS=Takifugu rubripes OX=31033 GN=cct4 PE=2 SV=1,,,,,,
OG_06973,FUN_032108-T1,Peve_00030224,Pocillopora_meandrina_HIv1___RNAseq.g5393.t1,three_way,58.33233333333333,FUN_032108-T1,Q8IWX5,SGPP2_HUMAN,,Sphingosine-1-phosphate phosphatase 2 (SPPase2) (Spp2) (hSPP2) (EC 3.1.3.-) (Sphingosine-1-phosphatase 2),Homo sapiens (Human),34.5,403.0,2.3e-56,221.1,sp|Q8IWX5|SGPP2_HUMAN Sphingosine-1-phosphate phosphatase 2 OS=Homo sapiens OX=9606 GN=SGPP2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0006670; GO:0030149; GO:0042392; GO:0046839; GO:0061469; GO:0070780,phospholipid dephosphorylation [GO:0046839]; regulation of type B pancreatic cell proliferation [GO:0061469]; sphingolipid catabolic process [GO:0030149]; sphingosine metabolic process [GO:0006670],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],dihydrosphingosine-1-phosphate phosphatase activity [GO:0070780]; sphingosine-1-phosphate phosphatase activity [GO:0042392],GO:0003824; GO:0005783; GO:0006629; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; hydrolase activity; organelle
OG_06974,FUN_032109-T1,Peve_00030225,Pocillopora_meandrina_HIv1___RNAseq.g5392.t1,three_way,77.26299999999999,FUN_032109-T1,F1RAX8,,,,,55.6,444.0,2.5e-134,480.3,"sp|F1RAX8|COQ6_DANRE Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial OS=Danio rerio OX=7955 GN=coq6 PE=2 SV=1",,,,,,
OG_06975,FUN_032110-T1,Peve_00030226,Pocillopora_meandrina_HIv1___RNAseq.g5391.t1,three_way,85.20466666666667,FUN_032110-T1,Q8K4M5,COMD1_MOUSE,,COMM domain-containing protein 1 (Protein Murr1),Mus musculus (Mouse),46.2,182.0,1.9e-40,167.2,sp|Q8K4M5|COMD1_MOUSE COMM domain-containing protein 1 OS=Mus musculus OX=10090 GN=Commd1 PE=1 SV=2,GO:0005507; GO:0005546; GO:0005547; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0006289; GO:0006878; GO:0006893; GO:0010008; GO:0015031; GO:0019871; GO:0031398; GO:0031462; GO:0031648; GO:0032088; GO:0032434; GO:0034383; GO:0034394; GO:0042632; GO:0042803; GO:0043325; GO:0048227; GO:0050750; GO:0055037; GO:0055070; GO:0070300; GO:0080025; GO:0097006; GO:1902072; GO:1902306; GO:1904109; GO:1905751; GO:2000009; GO:2000010,cholesterol homeostasis [GO:0042632]; copper ion homeostasis [GO:0055070]; Golgi to plasma membrane transport [GO:0006893]; intracellular copper ion homeostasis [GO:0006878]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of hypoxia-inducible factor-1alpha signaling pathway [GO:1902072]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; nucleotide-excision repair [GO:0006289]; plasma membrane to endosome transport [GO:0048227]; positive regulation of cholesterol import [GO:1904109]; positive regulation of endosome to plasma membrane protein transport [GO:1905751]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein ubiquitination [GO:0031398]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein transport [GO:0015031]; regulation of plasma lipoprotein particle levels [GO:0097006]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; recycling endosome [GO:0055037],"copper ion binding [GO:0005507]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; sodium channel inhibitor activity [GO:0019871]",GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0006281; GO:0006355; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772,nucleus; nucleoplasm; endosome; cytosol; DNA repair; regulation of DNA-templated transcription; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_06976,FUN_032111-T1,Peve_00030228,Pocillopora_meandrina_HIv1___RNAseq.g5390.t1,three_way,72.92066666666666,FUN_032111-T1,A6H630,ARMT1_MOUSE,,Damage-control phosphatase ARMT1 (EC 3.1.3.-) (Acidic residue methyltransferase 1) (Protein-glutamate O-methyltransferase) (EC 2.1.1.-) (Sugar phosphate phosphatase ARMT1),Mus musculus (Mouse),46.2,439.0,2.3e-105,384.0,sp|A6H630|ARMT1_MOUSE Damage-control phosphatase ARMT1 OS=Mus musculus OX=10090 GN=Armt1 PE=1 SV=1,GO:0006974; GO:0008757; GO:0008983; GO:0019899; GO:0032259; GO:0046872; GO:0051998; GO:0097023; GO:0103026,DNA damage response [GO:0006974]; methylation [GO:0032259],,enzyme binding [GO:0019899]; fructose 6-phosphate aldolase activity [GO:0097023]; fructose-1-phosphatase activity [GO:0103026]; metal ion binding [GO:0046872]; protein carboxyl O-methyltransferase activity [GO:0051998]; protein-glutamate O-methyltransferase activity [GO:0008983]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],GO:0003824; GO:0016740; GO:0016787; GO:0016829; GO:0140096,"catalytic activity; transferase activity; hydrolase activity; lyase activity; catalytic activity, acting on a protein"
OG_06977,FUN_032112-T1,Peve_00030229,Pocillopora_meandrina_HIv1___RNAseq.g5389.t1,three_way,58.21633333333333,FUN_032112-T1,Q93015,NAA80_HUMAN,,N-alpha-acetyltransferase 80 (HsNAAA80) (EC 2.3.1.-) (N-acetyltransferase 6) (Protein fusion-2) (Protein fus-2),Homo sapiens (Human),39.3,117.0,2e-17,91.3,sp|Q93015|NAA80_HUMAN N-alpha-acetyltransferase 80 OS=Homo sapiens OX=9606 GN=NAA80 PE=1 SV=2,GO:0004596; GO:0005737; GO:0005829; GO:0006473; GO:0008064; GO:0008080; GO:0017190; GO:0018002; GO:0030047; GO:1905502,actin modification [GO:0030047]; N-terminal peptidyl-aspartic acid acetylation [GO:0017190]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; protein acetylation [GO:0006473]; regulation of actin polymerization or depolymerization [GO:0008064],cytoplasm [GO:0005737]; cytosol [GO:0005829],acetyl-CoA binding [GO:1905502]; N-acetyltransferase activity [GO:0008080]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596],GO:0003824; GO:0005829; GO:0007010; GO:0016740; GO:0051604; GO:0140096,"catalytic activity; cytosol; cytoskeleton organization; transferase activity; protein maturation; catalytic activity, acting on a protein"
OG_06978,FUN_032113-T1,Peve_00030230,Pocillopora_meandrina_HIv1___RNAseq.g5388.t1,three_way,75.95,,,,,,,,,,,,,,,,,
OG_06979,FUN_032115-T1,Peve_00030231,Pocillopora_meandrina_HIv1___RNAseq.g5383.t1,three_way,75.76333333333334,,,,,,,,,,,,,,,,,
OG_06980,FUN_032117-T1,Peve_00030232,Pocillopora_meandrina_HIv1___TS.g24094.t1,three_way,95.08266666666668,FUN_032117-T1,Q80U96,XPO1_RAT,,Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog),Rattus norvegicus (Rat),78.0,1074.0,0.0,1682.5,sp|Q80U96|XPO1_RAT Exportin-1 OS=Rattus norvegicus OX=10116 GN=Xpo1 PE=1 SV=1,GO:0000054; GO:0000055; GO:0000056; GO:0000122; GO:0000776; GO:0003723; GO:0005049; GO:0005634; GO:0005642; GO:0005730; GO:0005737; GO:0005829; GO:0006406; GO:0006611; GO:0006913; GO:0009410; GO:0010824; GO:0015030; GO:0019904; GO:0031267; GO:0031965; GO:0032434; GO:0032991; GO:0034504; GO:0042176; GO:0042254; GO:0046825; GO:0071401; GO:0140297; GO:1902075; GO:1990904,cellular response to salt [GO:1902075]; cellular response to triglyceride [GO:0071401]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to xenobiotic stimulus [GO:0009410]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; ribosome biogenesis [GO:0042254],annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],DNA-binding transcription factor binding [GO:0140297]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0003723; GO:0005634; GO:0005730; GO:0005829; GO:0006355; GO:0006886; GO:0006913; GO:0042254; GO:0043226; GO:0140104,RNA binding; nucleus; nucleolus; cytosol; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; ribosome biogenesis; organelle; molecular carrier activity
OG_06981,FUN_032118-T1,Peve_00030238,Pocillopora_meandrina_HIv1___RNAseq.g5380.t1,three_way,76.23633333333333,FUN_032118-T1,Q5ZL91,INT7_CHICK,,Integrator complex subunit 7 (Int7),Gallus gallus (Chicken),45.5,927.0,3.2e-212,740.3,sp|Q5ZL91|INT7_CHICK Integrator complex subunit 7 OS=Gallus gallus OX=9031 GN=INTS7 PE=2 SV=1,GO:0005634; GO:0005694; GO:0005737; GO:0006974; GO:0032039; GO:0034472; GO:0160232; GO:0160240,DNA damage response [GO:0006974]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472],chromosome [GO:0005694]; cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634],,GO:0005634; GO:0005694; GO:0016073; GO:0043226,nucleus; chromosome; snRNA metabolic process; organelle
OG_06982,FUN_032121-T1,Peve_00030242,Pocillopora_meandrina_HIv1___RNAseq.g5376.t1,three_way,84.77116666666667,FUN_032121-T1,Q6P3N5,,,,,56.6,136.0,1.1e-40,167.5,sp|Q6P3N5|CNIH4_XENTR Protein cornichon homolog 4 OS=Xenopus tropicalis OX=8364 GN=cnih4 PE=2 SV=1,,,,,,
OG_06983,FUN_032122-T1,Peve_00030243,Pocillopora_meandrina_HIv1___RNAseq.g5375.t1,three_way,72.13333333333333,FUN_032122-T1,Q8CB59,,,,,32.7,446.0,1.4e-46,189.5,sp|Q8CB59|F161B_MOUSE Protein FAM161B OS=Mus musculus OX=10090 GN=Fam161b PE=1 SV=1,,,,,,
OG_06984,FUN_032123-T1,Peve_00040721,Pocillopora_meandrina_HIv1___RNAseq.g5374.t1,three_way,85.32833333333333,FUN_032123-T1,Q8K4B0,MTA1_MOUSE,,Metastasis-associated protein MTA1,Mus musculus (Mouse),52.5,571.0,9.999999999999999e-153,542.3,sp|Q8K4B0|MTA1_MOUSE Metastasis-associated protein MTA1 OS=Mus musculus OX=10090 GN=Mta1 PE=1 SV=1,GO:0000978; GO:0003682; GO:0003713; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005874; GO:0006302; GO:0006338; GO:0008270; GO:0010212; GO:0016581; GO:0032922; GO:0042659; GO:0043153; GO:0043161; GO:0045475; GO:0045814; GO:0045892; GO:0045893; GO:1902499; GO:2000736,"chromatin remodeling [GO:0006338]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell fate specification [GO:0042659]; regulation of stem cell differentiation [GO:2000736]; response to ionizing radiation [GO:0010212]",cytoplasm [GO:0005737]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581],chromatin binding [GO:0003682]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005635; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0030163; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nuclear envelope; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; protein catabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_06985,FUN_032124-T1,Peve_00040714,Pocillopora_meandrina_HIv1___TS.g24079.t3,three_way,68.271,FUN_032124-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),24.2,715.0,4.2e-45,184.9,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_06986,FUN_032125-T1,Peve_00040713,Pocillopora_meandrina_HIv1___RNAseq.g5366.t1,three_way,78.05966666666667,FUN_032125-T1,Q6DF57,,,,,46.3,95.0,4e-16,85.9,sp|Q6DF57|GPT11_XENTR G patch domain-containing protein 11 OS=Xenopus tropicalis OX=8364 GN=gpatch11 PE=2 SV=1,,,,,,
OG_06987,FUN_032128-T1,Peve_00040717,Pocillopora_meandrina_HIv1___RNAseq.g5363.t1,three_way,49.11266666666667,,,,,,,,,,,,,,,,,
OG_06988,FUN_032129-T1,Peve_00040715,Pocillopora_meandrina_HIv1___RNAseq.g5362.t1,three_way,64.65516666666666,FUN_032129-T1,Q9BWU0,NADAP_HUMAN,,Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein),Homo sapiens (Human),37.0,637.0,3.2e-87,324.3,sp|Q9BWU0|NADAP_HUMAN Kanadaptin OS=Homo sapiens OX=9606 GN=SLC4A1AP PE=1 SV=2,GO:0003729; GO:0005654; GO:0005737; GO:0005886; GO:0043231,,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],mRNA binding [GO:0003729],GO:0003723; GO:0005654; GO:0005886; GO:0043226,RNA binding; nucleoplasm; plasma membrane; organelle
OG_06989,FUN_032130-T1,Peve_00040711,Pocillopora_meandrina_HIv1___RNAseq.g5361.t1,three_way,79.16666666666667,FUN_032130-T1,Q6PBM1,GLRX5_DANRE,,"Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)",Danio rerio (Zebrafish) (Brachydanio rerio),68.1,113.0,4e-43,175.6,"sp|Q6PBM1|GLRX5_DANRE Glutaredoxin-related protein 5, mitochondrial OS=Danio rerio OX=7955 GN=glrx5 PE=2 SV=1",GO:0005737; GO:0005739; GO:0005759; GO:0016226; GO:0030097; GO:0046872; GO:0051537,hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]",GO:0005739; GO:0043226; GO:0048856,mitochondrion; organelle; anatomical structure development
OG_06990,FUN_032132-T1,Peve_00033983,Pocillopora_meandrina_HIv1___RNAseq.g5359.t1,three_way,84.06133333333334,FUN_032132-T1,Q94515,,,,,65.1,315.0,2.7e-127,456.4,sp|Q94515|DEGS1_DROME Sphingolipid delta(4)-desaturase DES1 OS=Drosophila melanogaster OX=7227 GN=ifc PE=1 SV=1,,,,,,
OG_06991,FUN_032133-T1,Peve_00029139,Pocillopora_meandrina_HIv1___RNAseq.g5353.t1,three_way,78.61566666666667,FUN_032133-T1,Q9ULQ1,,,,,28.8,552.0,2.7000000000000004e-44,181.8,sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3,,,,,,
OG_06992,FUN_032137-T1,Peve_00007914,Pocillopora_meandrina_HIv1___RNAseq.g5357.t1,three_way,65.0305,FUN_032137-T1,Q3MIT2,PUS10_HUMAN,,tRNA pseudouridine synthase Pus10 (Hup10) (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase),Homo sapiens (Human),46.1,347.0,1.3e-77,291.6,sp|Q3MIT2|PUS10_HUMAN tRNA pseudouridine synthase Pus10 OS=Homo sapiens OX=9606 GN=PUS10 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005739; GO:0009982; GO:0031053; GO:0031119; GO:0046872; GO:0070878; GO:0106029; GO:0160148,primary miRNA processing [GO:0031053]; tRNA pseudouridine synthesis [GO:0031119],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; pseudouridine synthase activity [GO:0009982]; tRNA pseudouridine synthase activity [GO:0106029]; tRNA pseudouridine(55) synthase activity [GO:0160148],GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0006399; GO:0016853; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mitochondrion; tRNA metabolic process; isomerase activity; organelle; catalytic activity, acting on RNA"
OG_06993,FUN_032139-T1,Peve_00007913,Pocillopora_meandrina_HIv1___TS.g24062.t1,three_way,49.26766666666666,,,,,,,,,,,,,,,,,
OG_06994,FUN_032140-T1,Peve_00007911,Pocillopora_meandrina_HIv1___RNAseq.g5348.t1,three_way,58.658,FUN_032140-T1,A8WJ42,,,,,38.7,124.0,1.7e-17,90.9,"sp|A8WJ42|COA8_CAEBR COA8 family protein CBG23705, mitochondrial OS=Caenorhabditis briggsae OX=6238 GN=CBG23705 PE=3 SV=1",,,,,,
OG_06995,FUN_032143-T1,Peve_00007909,Pocillopora_meandrina_HIv1___RNAseq.g5346.t1,three_way,75.438,FUN_032143-T1,Q9H0R1,AP5M1_HUMAN,,AP-5 complex subunit mu-1 (Adaptor-related protein complex 5 subunit mu-1) (Mu5) (Mu-2-related death-inducing protein) (MuD) (Putative HIV-1 infection-related protein),Homo sapiens (Human),34.8,515.0,1.2e-78,295.4,sp|Q9H0R1|AP5M1_HUMAN AP-5 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP5M1 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0016020; GO:0016192; GO:0016197; GO:0030119; GO:0031902; GO:0044599,endosomal transport [GO:0016197]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],AP-5 adaptor complex [GO:0044599]; AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],,GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_06996,FUN_032145-T1,Peve_00007916,Pocillopora_meandrina_HIv1___TS.g24057.t1,three_way,48.8235,,,,,,,,,,,,,,,,,
OG_06997,FUN_032146-T1,Peve_00007915,Pocillopora_meandrina_HIv1___RNAseq.g5343.t1,three_way,60.750166666666665,,,,,,,,,,,,,,,,,
OG_06998,FUN_032147-T1,Peve_00007908,Pocillopora_meandrina_HIv1___RNAseq.g5342.t1,three_way,65.17866666666666,FUN_032147-T1,Q3U435,MMP25_MOUSE,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-),Mus musculus (Mouse),37.3,566.0,7.6e-77,289.7,sp|Q3U435|MMP25_MOUSE Matrix metalloproteinase-25 OS=Mus musculus OX=10090 GN=Mmp25 PE=2 SV=1,GO:0004222; GO:0005886; GO:0006508; GO:0008270; GO:0009986; GO:0016504; GO:0031012; GO:0060022; GO:0098552,hard palate development [GO:0060022]; proteolysis [GO:0006508],cell surface [GO:0009986]; extracellular matrix [GO:0031012]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],metalloendopeptidase activity [GO:0004222]; peptidase activator activity [GO:0016504]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030312; GO:0031012; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; external encapsulating structure; extracellular matrix; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06999,FUN_032148-T1,Peve_00033080,Pocillopora_meandrina_HIv1___RNAseq.g5341.t1,three_way,65.70083333333334,FUN_032148-T1,P79227,,,,,34.9,392.0,9.5e-50,199.5,sp|P79227|MMP12_RABIT Macrophage metalloelastase OS=Oryctolagus cuniculus OX=9986 GN=MMP12 PE=2 SV=1,,,,,,
OG_07000,FUN_032151-T1,Peve_00003236,Pocillopora_meandrina_HIv1___RNAseq.g5328.t1,three_way,63.626333333333335,FUN_032151-T1,Q9NPA2,MMP25_HUMAN,,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP),Homo sapiens (Human),36.2,384.0,6.7e-56,219.9,sp|Q9NPA2|MMP25_HUMAN Matrix metalloproteinase-25 OS=Homo sapiens OX=9606 GN=MMP25 PE=1 SV=1,GO:0004222; GO:0005615; GO:0005886; GO:0006508; GO:0006954; GO:0008270; GO:0016020; GO:0030198; GO:0030574; GO:0031012; GO:0035579; GO:0060022; GO:0098552,collagen catabolic process [GO:0030574]; extracellular matrix organization [GO:0030198]; hard palate development [GO:0060022]; inflammatory response [GO:0006954]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; specific granule membrane [GO:0035579],metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0006954; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0140096,"catalytic activity; extracellular space; plasma membrane; inflammatory response; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; catalytic activity, acting on a protein"
OG_07001,FUN_032153-T1,Peve_00022296,Pocillopora_meandrina_HIv1___RNAseq.g5327.t1,three_way,78.09466666666667,FUN_032153-T1,A7S7Z9,ZFPL1_NEMVE,,Zinc finger protein-like 1 homolog,Nematostella vectensis (Starlet sea anemone),49.2,331.0,2.7e-82,307.0,sp|A7S7Z9|ZFPL1_NEMVE Zinc finger protein-like 1 homolog OS=Nematostella vectensis OX=45351 GN=zfpl1 PE=3 SV=1,GO:0005794; GO:0008270; GO:0016020,,Golgi apparatus [GO:0005794]; membrane [GO:0016020],zinc ion binding [GO:0008270],GO:0005794; GO:0043226,Golgi apparatus; organelle
OG_07002,FUN_032154-T1,Peve_00003238,Pocillopora_meandrina_HIv1___RNAseq.g5326.t1,three_way,41.39083333333333,,,,,,,,,,,,,,,,,
OG_07003,FUN_032155-T1,Peve_00003240,Pocillopora_meandrina_HIv1___RNAseq.g5324.t1,three_way,81.494,FUN_032155-T1,Q80U44,,,,,40.9,88.0,2.1e-14,80.9,sp|Q80U44|ZFY16_MOUSE Zinc finger FYVE domain-containing protein 16 OS=Mus musculus OX=10090 GN=Zfyve16 PE=1 SV=2,,,,,,
OG_07004,FUN_032156-T1,Peve_00003241,Pocillopora_meandrina_HIv1___RNAseq.g5323.t1,three_way,54.30733333333333,,,,,,,,,,,,,,,,,
OG_07005,FUN_032157-T1,Peve_00003243,Pocillopora_meandrina_HIv1___RNAseq.11552_t,three_way,70.325,,,,,,,,,,,,,,,,,
OG_07006,FUN_032158-T1,Peve_00013926,Pocillopora_meandrina_HIv1___RNAseq.g5321.t1,three_way,75.96416666666667,FUN_032158-T1,Q9EPI9,KCNH5_RAT,,Voltage-gated delayed rectifier potassium channel KCNH5 (Ether-a-go-go potassium channel 2) (rEAG2) (Potassium voltage-gated channel subfamily H member 5) (Voltage-gated potassium channel subunit Kv10.2),Rattus norvegicus (Rat),44.8,757.0,1.3e-182,641.7,sp|Q9EPI9|KCNH5_RAT Voltage-gated delayed rectifier potassium channel KCNH5 OS=Rattus norvegicus OX=10116 GN=Kcnh5 PE=2 SV=1,GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0006813; GO:0008076; GO:0009986; GO:0010389; GO:0042391; GO:0044325; GO:0044877; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of membrane potential [GO:0042391],cell surface [GO:0009986]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076],calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_07007,FUN_032160-T1,Peve_00005389,Pocillopora_meandrina_HIv1___RNAseq.g5308.t1,three_way,84.28083333333333,FUN_032160-T1,Q9BX10,GTPB2_HUMAN,,GTP-binding protein 2,Homo sapiens (Human),61.1,535.0,2.7e-191,669.8,sp|Q9BX10|GTPB2_HUMAN GTP-binding protein 2 OS=Homo sapiens OX=9606 GN=GTPBP2 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005576; GO:0006414; GO:0031093; GO:0042802; GO:0070966; GO:0072344; GO:1904678,"nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; rescue of stalled ribosome [GO:0072344]; translational elongation [GO:0006414]",extracellular region [GO:0005576]; platelet alpha granule lumen [GO:0031093],alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802],GO:0003723; GO:0003824; GO:0003924; GO:0005576; GO:0016071; GO:0016787,RNA binding; catalytic activity; GTPase activity; extracellular region; mRNA metabolic process; hydrolase activity
OG_07008,FUN_032161-T2,Peve_00038630,Pocillopora_meandrina_HIv1___RNAseq.g5312.t1,three_way,57.96933333333333,,,,,,,,,,,,,,,,,
OG_07009,FUN_032162-T1,Peve_00038631,Pocillopora_meandrina_HIv1___RNAseq.g5313.t1,three_way,99.18466666666669,FUN_032162-T1,Q6GQL2,PP1B_XENLA,,Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (EC 3.1.3.16),Xenopus laevis (African clawed frog),94.5,325.0,3.300000000000001e-186,652.1,sp|Q6GQL2|PP1B_XENLA Serine/threonine-protein phosphatase PP1-beta catalytic subunit OS=Xenopus laevis OX=8355 GN=ppp1cb PE=2 SV=1,GO:0004722; GO:0005634; GO:0005737; GO:0005977; GO:0030155; GO:0032922; GO:0042752; GO:0046872; GO:0050115; GO:0051301; GO:0072357,cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752],cytoplasm [GO:0005737]; nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357],metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005975; GO:0006091; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; carbohydrate metabolic process; generation of precursor metabolites and energy; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07010,FUN_032163-T1,Peve_00038632,Pocillopora_meandrina_HIv1___RNAseq.g5314.t1,three_way,95.89,FUN_032163-T1,Q561P5,MCM5_XENTR,,DNA replication licensing factor mcm5 (EC 3.6.4.12),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),72.9,735.0,0.0,1084.7,sp|Q561P5|MCM5_XENTR DNA replication licensing factor mcm5 OS=Xenopus tropicalis OX=8364 GN=mcm5 PE=2 SV=1,GO:0000785; GO:0003688; GO:0004386; GO:0005524; GO:0006270; GO:0016887; GO:0030174; GO:0042555; GO:0044786; GO:0071162,cell cycle DNA replication [GO:0044786]; DNA replication initiation [GO:0006270]; regulation of DNA-templated DNA replication initiation [GO:0030174],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA replication origin binding [GO:0003688]; helicase activity [GO:0004386],GO:0003677; GO:0003824; GO:0006260; GO:0016787; GO:0016853; GO:0140657,DNA binding; catalytic activity; DNA replication; hydrolase activity; isomerase activity; ATP-dependent activity
OG_07011,FUN_032164-T1,Peve_00038633,Pocillopora_meandrina_HIv1___RNAseq.g5317.t1,three_way,79.22566666666667,FUN_032164-T1,O73930,,,,,64.1,103.0,3.8e-33,142.1,sp|O73930|PHS_CHICK Pterin-4-alpha-carbinolamine dehydratase OS=Gallus gallus OX=9031 GN=PCBD1 PE=2 SV=3,,,,,,
OG_07012,FUN_032165-T1,Peve_00013928,Pocillopora_meandrina_HIv1___RNAseq.g5318.t1,three_way,78.37766666666666,FUN_032165-T1,Q2JVA4,GLMU_SYNJA,,Bifunctional protein GlmU [Includes: UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (N-acetylglucosamine-1-phosphate uridyltransferase); Glucosamine-1-phosphate N-acetyltransferase (EC 2.3.1.157)],Synechococcus sp. (strain JA-3-3Ab) (Cyanobacteria bacterium Yellowstone A-Prime),39.7,136.0,1.7e-18,94.0,sp|Q2JVA4|GLMU_SYNJA Bifunctional protein GlmU OS=Synechococcus sp. (strain JA-3-3Ab) OX=321327 GN=glmU PE=3 SV=1,GO:0000287; GO:0000902; GO:0003977; GO:0005737; GO:0006048; GO:0008360; GO:0009245; GO:0009252; GO:0016020; GO:0019134; GO:0031470; GO:0043886; GO:0071555,cell morphogenesis [GO:0000902]; cell wall organization [GO:0071555]; lipid A biosynthetic process [GO:0009245]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],carboxysome [GO:0031470]; cytoplasm [GO:0005737]; membrane [GO:0016020],glucosamine-1-phosphate N-acetyltransferase activity [GO:0019134]; magnesium ion binding [GO:0000287]; structural constituent of carboxysome shell [GO:0043886]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977],GO:0003824; GO:0005198; GO:0006629; GO:0016740; GO:0043226; GO:0055086; GO:0071554; GO:1901135,catalytic activity; structural molecule activity; lipid metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process; cell wall organization or biogenesis; carbohydrate derivative metabolic process
OG_07013,FUN_032166-T1,Peve_00038634,Pocillopora_meandrina_HIv1___RNAseq.g5319.t2,three_way,83.15083333333334,FUN_032166-T1,Q6DFF9,,,,,47.4,610.0,1.9e-158,560.8,sp|Q6DFF9|MABP1_XENLA Mitogen-activated protein kinase-binding protein 1 OS=Xenopus laevis OX=8355 GN=mapkbp1 PE=2 SV=1,,,,,,
OG_07014,FUN_032167-T1,Peve_00012811,Pocillopora_meandrina_HIv1___RNAseq.g5306.t1,three_way,90.62433333333334,FUN_032167-T1,P18074,ERCC2_HUMAN,,General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 5.6.2.3) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA 5'-3' helicase XPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein),Homo sapiens (Human),72.6,731.0,0.0,1078.9,sp|P18074|ERCC2_HUMAN General transcription and DNA repair factor IIH helicase subunit XPD OS=Homo sapiens OX=9606 GN=ERCC2 PE=1 SV=1,GO:0000439; GO:0000462; GO:0001666; GO:0001701; GO:0003678; GO:0003684; GO:0005524; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0005737; GO:0005819; GO:0005829; GO:0006283; GO:0006289; GO:0006357; GO:0006362; GO:0006366; GO:0006367; GO:0006915; GO:0006979; GO:0007059; GO:0008340; GO:0009650; GO:0009791; GO:0016887; GO:0021510; GO:0030198; GO:0030282; GO:0030674; GO:0032289; GO:0035264; GO:0035315; GO:0040016; GO:0043139; GO:0043249; GO:0045951; GO:0046872; GO:0048009; GO:0048568; GO:0048820; GO:0051539; GO:0060218; GO:0070516; GO:0071425; GO:0071817; GO:0072332; GO:1901990,"apoptotic process [GO:0006915]; bone mineralization [GO:0030282]; central nervous system myelin formation [GO:0032289]; chromosome segregation [GO:0007059]; determination of adult lifespan [GO:0008340]; embryonic cleavage [GO:0040016]; embryonic organ development [GO:0048568]; erythrocyte maturation [GO:0043249]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; hair follicle maturation [GO:0048820]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; in utero embryonic development [GO:0001701]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; positive regulation of mitotic recombination [GO:0045951]; post-embryonic development [GO:0009791]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; spinal cord development [GO:0021510]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase I [GO:0006362]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]",CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006351; GO:0006355; GO:0007059; GO:0012501; GO:0016787; GO:0016853; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; chromosome segregation; programmed cell death; hydrolase activity; isomerase activity; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07015,FUN_032191-T1,Peve_00020048,Pocillopora_meandrina_HIv1___RNAseq.g24664.t1,three_way,75.42333333333333,FUN_032191-T1,Q0V9A9,,,,,59.2,284.0,1.1e-90,334.7,sp|Q0V9A9|LACB2_XENTR Endoribonuclease LACTB2 OS=Xenopus tropicalis OX=8364 GN=lactb2 PE=2 SV=1,,,,,,
OG_07016,FUN_032192-T1,Peve_00020047,Pocillopora_meandrina_HIv1___RNAseq.g24665.t1,three_way,77.12066666666666,,,,,,,,,,,,,,,,,
OG_07017,FUN_032193-T1,Peve_00020046,Pocillopora_meandrina_HIv1___RNAseq.g24666.t1,three_way,76.88433333333333,FUN_032193-T1,Q6P0I8,,,,,41.4,268.0,5.9e-56,219.2,sp|Q6P0I8|EXOS6_DANRE Exosome complex component MTR3 OS=Danio rerio OX=7955 GN=exosc6 PE=2 SV=2,,,,,,
OG_07018,FUN_032194-T1,Peve_00017482,Pocillopora_meandrina_HIv1___RNAseq.g24398.t1,three_way,85.27199999999999,FUN_032194-T1,P48506,GSH1_HUMAN,,Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase),Homo sapiens (Human),62.3,628.0,4.5e-227,788.9,sp|P48506|GSH1_HUMAN Glutamate--cysteine ligase catalytic subunit OS=Homo sapiens OX=9606 GN=GCLC PE=1 SV=2,GO:0000287; GO:0004357; GO:0005524; GO:0005739; GO:0005829; GO:0006534; GO:0006536; GO:0006750; GO:0006979; GO:0007584; GO:0009408; GO:0009410; GO:0009725; GO:0014823; GO:0016595; GO:0017109; GO:0019852; GO:0031397; GO:0032436; GO:0032869; GO:0035729; GO:0043066; GO:0043524; GO:0043531; GO:0044344; GO:0044752; GO:0044877; GO:0045454; GO:0045892; GO:0046685; GO:0046686; GO:0051409; GO:0051900; GO:0070555; GO:0071260; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1901029; GO:2000490; GO:2001237,blood vessel diameter maintenance [GO:0097746]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; mitochondrion [GO:0005739],ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein-containing complex binding [GO:0044877],GO:0003013; GO:0003824; GO:0005739; GO:0005829; GO:0005975; GO:0006355; GO:0006520; GO:0006575; GO:0006790; GO:0007005; GO:0016874; GO:0043226; GO:0061024,circulatory system process; catalytic activity; mitochondrion; cytosol; carbohydrate metabolic process; regulation of DNA-templated transcription; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; mitochondrion organization; ligase activity; organelle; membrane organization
OG_07019,FUN_032195-T1,Peve_00017484,Pocillopora_meandrina_HIv1___RNAseq.g24403.t1,three_way,73.50766666666667,FUN_032195-T1,Q6YJI5,,,,,48.1,445.0,3.1e-113,410.2,sp|Q6YJI5|TRM11_CHICK tRNA (guanine(10)-N(2))-methyltransferase TRMT11 OS=Gallus gallus OX=9031 GN=TRMT11 PE=2 SV=1,,,,,,
OG_07020,FUN_032196-T1,Peve_00017487,Pocillopora_meandrina_HIv1___RNAseq.g24408.t1,three_way,64.211,FUN_032196-T1,D3ZAT9,,,,,33.5,239.0,5.8e-38,159.5,sp|D3ZAT9|FAXC_RAT Failed axon connections homolog OS=Rattus norvegicus OX=10116 GN=Faxc PE=3 SV=1,,,,,,
OG_07021,FUN_032200-T2,Peve_00017491,Pocillopora_meandrina_HIv1___RNAseq.g24414.t1,three_way,73.51166666666667,FUN_032200-T2,Q6DDS9,XRCC5_XENLA,,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (Ku80),Xenopus laevis (African clawed frog),38.2,744.0,6.100000000000001e-130,466.5,sp|Q6DDS9|XRCC5_XENLA X-ray repair cross-complementing protein 5 OS=Xenopus laevis OX=8355 GN=xrcc5.L PE=1 SV=1,GO:0000723; GO:0003678; GO:0003684; GO:0003690; GO:0005524; GO:0006303; GO:0006310; GO:0016787; GO:0042162; GO:0043564,DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; telomere maintenance [GO:0000723],Ku70:Ku80 complex [GO:0043564],ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; hydrolase activity [GO:0016787]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0032200; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA repair; DNA recombination; hydrolase activity; isomerase activity; telomere organization; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07022,FUN_032201-T1,Peve_00017492,Pocillopora_meandrina_HIv1___RNAseq.g24415.t1,three_way,62.11133333333333,,,,,,,,,,,,,,,,,
OG_07023,FUN_032204-T1,Peve_00013799,Pocillopora_meandrina_HIv1___RNAseq.g24269.t1,three_way,60.29666666666667,FUN_032204-T1,Q9UBU6,,,,,33.3,201.0,1.1e-22,109.0,sp|Q9UBU6|FA8A1_HUMAN Protein FAM8A1 OS=Homo sapiens OX=9606 GN=FAM8A1 PE=1 SV=1,,,,,,
OG_07024,FUN_032215-T1,Peve_00015531,Pocillopora_meandrina_HIv1___RNAseq.g24275.t1,three_way,85.61,FUN_032215-T1,Q8BYK6,YTHD3_MOUSE,,YTH domain-containing family protein 3,Mus musculus (Mouse),37.8,614.0,2.1e-84,314.7,sp|Q8BYK6|YTHD3_MOUSE YTH domain-containing family protein 3 OS=Mus musculus OX=10090 GN=Ythdf3 PE=1 SV=2,GO:0000932; GO:0003723; GO:0005737; GO:0005829; GO:0010494; GO:0034063; GO:0043022; GO:0043488; GO:0045727; GO:0060339; GO:0061157; GO:0070925; GO:1901163; GO:1990247,mRNA destabilization [GO:0061157]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; organelle assembly [GO:0070925]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488]; regulation of trophoblast cell migration [GO:1901163]; stress granule assembly [GO:0034063],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932],N6-methyladenosine-containing RNA reader activity [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0043226; GO:0060090,RNA binding; cytosol; organelle; molecular adaptor activity
OG_07025,FUN_032217-T1,Peve_00015500,Pocillopora_meandrina_HIv1___RNAseq.g24278.t1,three_way,88.01366666666667,,,,,,,,,,,,,,,,,
OG_07026,FUN_032218-T1,Peve_00015505,Pocillopora_meandrina_HIv1___RNAseq.g24279.t1,three_way,81.62233333333333,FUN_032218-T1,Q5F477,,,,,37.9,285.0,3.4e-45,183.7,sp|Q5F477|LDAH_CHICK Lipid droplet-associated hydrolase OS=Gallus gallus OX=9031 GN=LDAH PE=2 SV=2,,,,,,
OG_07027,FUN_032219-T1,Peve_00015512,Pocillopora_meandrina_HIv1___RNAseq.g24280.t1,three_way,65.81,FUN_032219-T1,A3KP40,,,,,24.7,461.0,2.2e-09,65.5,sp|A3KP40|CH034_DANRE Uncharacterized protein C8orf34 homolog OS=Danio rerio OX=7955 GN=zgc:162928 PE=2 SV=1,,,,,,
OG_07028,FUN_032220-T1,Peve_00015518,Pocillopora_meandrina_HIv1___RNAseq.g24281.t1,three_way,76.94216666666667,FUN_032220-T1,P08461,,,,,60.7,443.0,2.7e-132,473.8,"sp|P08461|ODP2_RAT Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial OS=Rattus norvegicus OX=10116 GN=Dlat PE=1 SV=3",,,,,,
OG_07029,FUN_032221-T1,Peve_00015532,Pocillopora_meandrina_HIv1___RNAseq.g24282.t1,three_way,58.141666666666666,FUN_032221-T1,Q9W6I0,,,,,46.7,169.0,1e-40,168.7,sp|Q9W6I0|UQCC1_XENLA Ubiquinol-cytochrome-c reductase complex assembly factor 1 OS=Xenopus laevis OX=8355 GN=uqcc1 PE=2 SV=1,,,,,,
OG_07030,FUN_032222-T1,Peve_00015538,Pocillopora_meandrina_HIv1___RNAseq.g24283.t1,three_way,63.73566666666667,FUN_032222-T1,Q8BVA5,LDAH_MOUSE,,Lipid droplet-associated hydrolase (EC 3.1.1.13) (Lipid droplet-associated serine hydrolase) (mLDAH),Mus musculus (Mouse),39.9,288.0,2.1e-50,201.1,sp|Q8BVA5|LDAH_MOUSE Lipid droplet-associated hydrolase OS=Mus musculus OX=10090 GN=Ldah PE=1 SV=1,GO:0004771; GO:0005783; GO:0005811; GO:0019915; GO:0035356; GO:0042632; GO:0090077; GO:0160077,cholesterol homeostasis [GO:0042632]; foam cell differentiation [GO:0090077]; intracellular triglyceride homeostasis [GO:0035356]; lipid droplet fusion [GO:0160077]; lipid storage [GO:0019915],endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811],sterol ester esterase activity [GO:0004771],GO:0003824; GO:0005783; GO:0005811; GO:0016787; GO:0030154; GO:0043226,catalytic activity; endoplasmic reticulum; lipid droplet; hydrolase activity; cell differentiation; organelle
OG_07031,FUN_032223-T1,Peve_00015541,Pocillopora_meandrina_HIv1___RNAseq.g24284.t1,three_way,70.46133333333333,FUN_032223-T1,C3ZQF9,,,,,30.2,305.0,1.9e-25,118.2,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_07032,FUN_032224-T1,Peve_00020126,Pocillopora_meandrina_HIv1___RNAseq.g24826.t1,three_way,76.53466666666667,FUN_032224-T1,Q99JL1,SPEF1_MOUSE,,Sperm flagellar protein 1 (Calponin-homology and microtubule-associated protein),Mus musculus (Mouse),36.4,305.0,1.5e-41,171.8,sp|Q99JL1|SPEF1_MOUSE Sperm flagellar protein 1 OS=Mus musculus OX=10090 GN=Spef1 PE=1 SV=1,GO:0001578; GO:0001725; GO:0003341; GO:0003779; GO:0005737; GO:0005874; GO:0005902; GO:0005930; GO:0007026; GO:0008017; GO:0016323; GO:0016324; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0031514; GO:0046847; GO:0097542; GO:0097729; GO:1904158; GO:1990716; GO:2000095,"axonemal central apparatus assembly [GO:1904158]; cell migration [GO:0016477]; cilium movement [GO:0003341]; filopodium assembly [GO:0046847]; lamellipodium assembly [GO:0030032]; microtubule bundle formation [GO:0001578]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000095]",9+2 motile cilium [GO:0097729]; apical plasma membrane [GO:0016324]; axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; basolateral plasma membrane [GO:0016323]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microtubule [GO:0005874]; microvillus [GO:0005902]; motile cilium [GO:0031514]; stress fiber [GO:0001725],actin binding [GO:0003779]; microtubule binding [GO:0008017],GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0043226; GO:0048870,cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; organelle; cell motility
OG_07033,FUN_032225-T1,Peve_00043436,Pocillopora_meandrina_HIv1___RNAseq.g24827.t1,three_way,72.54,FUN_032225-T1,Q5HZI9,S2551_MOUSE,,Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 (Mitochondrial NAD(+) transporter SLC25A51) (Mitochondrial carrier triple repeat protein 1) (Solute carrier family 25 member 51),Mus musculus (Mouse),51.1,266.0,4.2e-74,279.6,sp|Q5HZI9|S2551_MOUSE Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51 OS=Mus musculus OX=10090 GN=Slc25a51 PE=1 SV=1,GO:0005739; GO:0005743; GO:0006741; GO:0008514; GO:0019646; GO:0051724; GO:1990549,aerobic electron transport chain [GO:0019646]; mitochondrial NAD transmembrane transport [GO:1990549]; NADP biosynthetic process [GO:0006741],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],NAD transmembrane transporter activity [GO:0051724]; organic anion transmembrane transporter activity [GO:0008514],GO:0005215; GO:0005739; GO:0006091; GO:0043226; GO:0055085; GO:0055086,transporter activity; mitochondrion; generation of precursor metabolites and energy; organelle; transmembrane transport; nucleobase-containing small molecule metabolic process
OG_07034,FUN_032228-T1,Peve_00024039,Pocillopora_meandrina_HIv1___RNAseq.g24830.t1,three_way,54.98133333333333,,,,,,,,,,,,,,,,,
OG_07035,FUN_032229-T1,Peve_00027503,Pocillopora_meandrina_HIv1___RNAseq.g24831.t1,three_way,71.70400000000001,FUN_032229-T1,Q66GV0,,,,,49.1,175.0,1.7e-41,170.6,sp|Q66GV0|MPV17_XENLA Mitochondrial inner membrane protein Mpv17 OS=Xenopus laevis OX=8355 GN=mpv17 PE=2 SV=2,,,,,,
OG_07036,FUN_032231-T1,Peve_00043435,Pocillopora_meandrina_HIv1___RNAseq.g24834.t1,three_way,85.91533333333334,FUN_032231-T1,Q2KIN6,,,,,40.7,172.0,1.9e-35,150.6,sp|Q2KIN6|MPV17_BOVIN Mitochondrial inner membrane protein Mpv17 OS=Bos taurus OX=9913 GN=MPV17 PE=2 SV=1,,,,,,
OG_07037,FUN_032232-T1,Peve_00043437,Pocillopora_meandrina_HIv1___RNAseq.g24836.t1,three_way,68.60266666666666,FUN_032232-T1,Q6DG22,ADA_DANRE,,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),Danio rerio (Zebrafish) (Brachydanio rerio),48.0,350.0,3.3e-91,336.7,sp|Q6DG22|ADA_DANRE Adenosine deaminase OS=Danio rerio OX=7955 GN=ada PE=2 SV=2,GO:0004000; GO:0005764; GO:0005829; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0009897; GO:0042110; GO:0043103; GO:0046103; GO:0046936; GO:0060169; GO:0060205; GO:0070161,adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; T cell activation [GO:0042110],anchoring junction [GO:0070161]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764],2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07038,FUN_032233-T1,Peve_00012061,Pocillopora_meandrina_HIv1___RNAseq.g24837.t1,three_way,53.79233333333333,,,,,,,,,,,,,,,,,
OG_07039,FUN_032235-T1,Peve_00043486,Pocillopora_meandrina_HIv1___RNAseq.g24841.t1,three_way,59.83833333333334,,,,,,,,,,,,,,,,,
OG_07040,FUN_032238-T1,Peve_00019317,Pocillopora_meandrina_HIv1___RNAseq.g24859.t1,three_way,72.69616666666667,FUN_032238-T1,Q9NRA2,S17A5_HUMAN,,Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular excitatory amino acid transporter) (VEAT),Homo sapiens (Human),49.6,466.0,1e-123,445.3,sp|Q9NRA2|S17A5_HUMAN Sialin OS=Homo sapiens OX=9606 GN=SLC17A5 PE=1 SV=2,GO:0005351; GO:0005764; GO:0005765; GO:0005829; GO:0005886; GO:0006811; GO:0006820; GO:0006865; GO:0009617; GO:0015136; GO:0015538; GO:0015739; GO:0016020; GO:0016323; GO:0016324; GO:0030672; GO:0042880; GO:0098700; GO:0098978,amino acid transport [GO:0006865]; monoatomic anion transport [GO:0006820]; monoatomic ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],carbohydrate:proton symporter activity [GO:0005351]; D-glucuronate transmembrane transporter activity [GO:0042880]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538],GO:0005215; GO:0005764; GO:0005773; GO:0005829; GO:0005886; GO:0043226,transporter activity; lysosome; vacuole; cytosol; plasma membrane; organelle
OG_07041,FUN_032240-T1,Peve_00023299,Pocillopora_meandrina_HIv1___RNAseq.g24847.t1,three_way,68.45100000000001,FUN_032240-T1,P51029,,,,,41.0,317.0,2.7e-66,253.8,sp|P51029|WNT8B_DANRE Protein Wnt-8b OS=Danio rerio OX=7955 GN=wnt8b PE=2 SV=1,,,,,,
OG_07042,FUN_032241-T1,Peve_00023301,Pocillopora_meandrina_HIv1___TS.g12785.t1,three_way,77.97733333333333,FUN_032241-T1,Q9JLT4,TRXR2_MOUSE,,"Thioredoxin reductase 2, mitochondrial (EC 1.8.1.9) (Thioredoxin reductase TR3)",Mus musculus (Mouse),64.1,493.0,1.2e-193,677.6,"sp|Q9JLT4|TRXR2_MOUSE Thioredoxin reductase 2, mitochondrial OS=Mus musculus OX=10090 GN=Txnrd2 PE=1 SV=4",GO:0000305; GO:0004791; GO:0005739; GO:0007507; GO:0030097; GO:0042803; GO:0045454; GO:0050660,cell redox homeostasis [GO:0045454]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; response to oxygen radical [GO:0000305],mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; thioredoxin-disulfide reductase (NADPH) activity [GO:0004791],GO:0003824; GO:0005739; GO:0016209; GO:0016491; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; antioxidant activity; oxidoreductase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07043,FUN_032245-T1,Peve_00012762,Pocillopora_meandrina_HIv1___TS.g12783.t1,three_way,92.19866666666668,FUN_032245-T1,P92208,JNK_DROME,,Stress-activated protein kinase JNK (dJNK) (EC 2.7.11.24) (Protein basket),Drosophila melanogaster (Fruit fly),71.2,354.0,1.2e-151,537.7,sp|P92208|JNK_DROME Stress-activated protein kinase JNK OS=Drosophila melanogaster OX=7227 GN=bsk PE=1 SV=1,GO:0004672; GO:0004674; GO:0004705; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006979; GO:0007254; GO:0007391; GO:0007395; GO:0007411; GO:0007616; GO:0008284; GO:0009408; GO:0010508; GO:0010628; GO:0016319; GO:0019731; GO:0030424; GO:0030425; GO:0030707; GO:0033209; GO:0034599; GO:0034614; GO:0035006; GO:0035313; GO:0042060; GO:0043065; GO:0043068; GO:0043652; GO:0046529; GO:0046843; GO:0046844; GO:0048010; GO:0048615; GO:0048666; GO:0048674; GO:0048675; GO:0048803; GO:0048812; GO:0050829; GO:0061057; GO:0071243; GO:0071276; GO:0071907; GO:0071963; GO:0106310; GO:0140255; GO:1903688; GO:1903689; GO:1904801,"antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; defense response to Gram-negative bacterium [GO:0050829]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; follicle cell of egg chamber development [GO:0030707]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; JNK cascade [GO:0007254]; long-term memory [GO:0007616]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; peptidoglycan recognition protein signaling pathway [GO:0061057]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; positive regulation of programmed cell death [GO:0043068]; regulation of cellular response to phosphate starvation [GO:0140255]; regulation of wound healing, spreading of epidermal cells [GO:1903689]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing, spreading of epidermal cells [GO:0035313]",axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0007163; GO:0016740; GO:0022414; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0061024; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; establishment or maintenance of cell polarity; transferase activity; reproductive process; wound healing; organelle; anatomical structure development; cell motility; nervous system process; membrane organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07044,FUN_032246-T1,Peve_00036312,Pocillopora_meandrina_HIv1___RNAseq.g24842.t1,three_way,59.7065,,,,,,,,,,,,,,,,,
OG_07045,FUN_032247-T1,Peve_00036304,Pocillopora_meandrina_HIv1___RNAseq.g24869.t1,three_way,75.44666666666667,FUN_032247-T1,Q5PQN1,HERC4_RAT,,Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4),Rattus norvegicus (Rat),48.8,1069.0,3.5000000000000003e-274,946.0,sp|Q5PQN1|HERC4_RAT Probable E3 ubiquitin-protein ligase HERC4 OS=Rattus norvegicus OX=10116 GN=Herc4 PE=2 SV=1,GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630,cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0140096,"catalytic activity; cytosol; transferase activity; reproductive process; cell differentiation; catalytic activity, acting on a protein"
OG_07046,FUN_032249-T1,Peve_00042108,Pocillopora_meandrina_HIv1___TS.g12806.t2,three_way,79.56116666666667,FUN_032249-T1,Q4H4B6,SCRIB_DANRE,,Protein scribble homolog (Scribble1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,938.0,2.3e-130,468.8,sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1,GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887,"activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944]",adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793],protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0005886; GO:0006886; GO:0007010; GO:0007155; GO:0007163; GO:0012501; GO:0016192; GO:0043226; GO:0048856; GO:0048870; GO:0072659,plasma membrane; intracellular protein transport; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; programmed cell death; vesicle-mediated transport; organelle; anatomical structure development; cell motility; protein localization to plasma membrane
OG_07047,FUN_032252-T1,Peve_00042110,Pocillopora_meandrina_HIv1___RNAseq.g24907.t1a,three_way,67.65599999999999,FUN_032252-T1,Q92539,LPIN2_HUMAN,,Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2),Homo sapiens (Human),37.9,927.0,2.1e-129,464.9,sp|Q92539|LPIN2_HUMAN Phosphatidate phosphatase LPIN2 OS=Homo sapiens OX=9606 GN=LPIN2 PE=1 SV=1,GO:0003713; GO:0005634; GO:0005789; GO:0005829; GO:0006629; GO:0008195; GO:0009062; GO:0019432; GO:0032869; GO:0045944,cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0006629; GO:0016787; GO:0043226; GO:0060090; GO:0140110,catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; lipid metabolic process; hydrolase activity; organelle; molecular adaptor activity; transcription regulator activity
OG_07048,FUN_032253-T1,Peve_00014265,Pocillopora_meandrina_HIv1___RNAseq.g24907.t1c,three_way,69.48400000000001,FUN_032253-T1,Q1LY51,,,,,29.0,544.0,4.2e-30,134.0,sp|Q1LY51|ZN704_DANRE Zinc finger protein 704 OS=Danio rerio OX=7955 GN=znf704 PE=3 SV=2,,,,,,
OG_07049,FUN_032255-T1,Peve_00014264,Pocillopora_meandrina_HIv1___RNAseq.g24905.t1,three_way,70.49433333333333,FUN_032255-T1,O43909,EXTL3_HUMAN,,Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3),Homo sapiens (Human),46.1,855.0,2.3e-207,723.8,sp|O43909|EXTL3_HUMAN Exostosin-like 3 OS=Homo sapiens OX=9606 GN=EXTL3 PE=1 SV=1,GO:0000287; GO:0001888; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006486; GO:0010838; GO:0015012; GO:0016500; GO:0016757; GO:0030307; GO:0045617; GO:0050728; GO:0051897; GO:0106015; GO:1900016; GO:2000972,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of inflammatory response [GO:0050728]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of keratinocyte differentiation [GO:0045617]; positive regulation of cell growth [GO:0030307]; positive regulation of detection of glucose [GO:2000972]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein glycosylation [GO:0006486],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886],glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity [GO:0001888]; glycosyltransferase activity [GO:0016757]; magnesium ion binding [GO:0000287]; protein-hormone receptor activity [GO:0016500],GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0005886; GO:0006486; GO:0009101; GO:0016740; GO:0043226; GO:0060089; GO:1901135,catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; plasma membrane; protein glycosylation; glycoprotein biosynthetic process; transferase activity; organelle; molecular transducer activity; carbohydrate derivative metabolic process
OG_07050,FUN_032270-T1,Peve_00014263,Pocillopora_meandrina_HIv1___RNAseq.g24972.t1,three_way,76.632,,,,,,,,,,,,,,,,,
OG_07051,FUN_032271-T1,Peve_00030007,Pocillopora_meandrina_HIv1___RNAseq.g24973.t1,three_way,77.01566666666666,FUN_032271-T1,A5PJJ7,,,,,49.8,301.0,1.9e-82,307.8,sp|A5PJJ7|S16C6_BOVIN Short-chain dehydrogenase/reductase family 16C member 6 OS=Bos taurus OX=9913 GN=SDR16C6 PE=2 SV=1,,,,,,
OG_07052,FUN_032274-T1,Peve_00011763,Pocillopora_meandrina_HIv1___RNAseq.g24974.t1,three_way,68.399,FUN_032274-T1,A8E7N9,,,,,31.6,370.0,2.9e-44,181.0,sp|A8E7N9|GDF6B_DANRE Growth/differentiation factor 6-B OS=Danio rerio OX=7955 GN=gdf6b PE=2 SV=1,,,,,,
OG_07053,FUN_032276-T1,Peve_00011761,Pocillopora_meandrina_HIv1___RNAseq.g24976.t1,three_way,83.19833333333334,FUN_032276-T1,Q8QZZ8,RAB38_MOUSE,,Ras-related protein Rab-38 (EC 3.6.5.2),Mus musculus (Mouse),70.5,129.0,3.4e-52,205.7,sp|Q8QZZ8|RAB38_MOUSE Ras-related protein Rab-38 OS=Mus musculus OX=10090 GN=Rab38 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005739; GO:0005764; GO:0005769; GO:0005802; GO:0005886; GO:0007005; GO:0015031; GO:0016192; GO:0030670; GO:0030742; GO:0033162; GO:0035646; GO:0035650; GO:0035651; GO:0036461; GO:0042470; GO:0044233; GO:0044297; GO:0045335; GO:0048023; GO:0048471; GO:0060155; GO:0072657; GO:0090383; GO:1903232; GO:1904377; GO:2001247,endosome to melanosome transport [GO:0035646]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome acidification [GO:0090383]; platelet dense granule organization [GO:0060155]; positive regulation of melanin biosynthetic process [GO:0048023]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; positive regulation of protein localization to cell periphery [GO:1904377]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],cell body [GO:0044297]; early endosome [GO:0005769]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0007005; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; mitochondrion; lysosome; endosome; vacuole; plasma membrane; mitochondrion organization; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_07054,FUN_032277-T1,Peve_00011760,Pocillopora_meandrina_HIv1___RNAseq.g24977.t1,three_way,65.527,FUN_032277-T1,P00129,,,,,54.4,90.0,1.1e-19,97.4,sp|P00129|QCR7_BOVIN Cytochrome b-c1 complex subunit 7 OS=Bos taurus OX=9913 GN=UQCRB PE=1 SV=3,,,,,,
OG_07055,FUN_032278-T1,Peve_00011758,Pocillopora_meandrina_HIv1___RNAseq.g24978.t1,three_way,81.38966666666667,FUN_032278-T1,Q8N584,,,,,40.9,587.0,4.1e-121,436.8,sp|Q8N584|TT39C_HUMAN Tetratricopeptide repeat protein 39C OS=Homo sapiens OX=9606 GN=TTC39C PE=1 SV=2,,,,,,
OG_07056,FUN_032281-T1,Peve_00015549,Pocillopora_meandrina_HIv1___RNAseq.g24293.t1,three_way,73.47583333333333,FUN_032281-T1,P13264,GLSK_RAT,,"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) [Cleaved into: Glutaminase kidney isoform, mitochondrial 68 kDa chain; Glutaminase kidney isoform, mitochondrial 65 kDa chain]",Rattus norvegicus (Rat),52.4,517.0,1.8000000000000002e-158,560.8,"sp|P13264|GLSK_RAT Glutaminase kidney isoform, mitochondrial OS=Rattus norvegicus OX=10116 GN=Gls PE=1 SV=2",GO:0001967; GO:0002087; GO:0004359; GO:0005739; GO:0005759; GO:0005829; GO:0006537; GO:0006543; GO:0007268; GO:0045202; GO:0051289; GO:0090461,chemical synaptic transmission [GO:0007268]; glutamate biosynthetic process [GO:0006537]; glutamine catabolic process [GO:0006543]; intracellular glutamate homeostasis [GO:0090461]; protein homotetramerization [GO:0051289]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; suckling behavior [GO:0001967],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202],glutaminase activity [GO:0004359],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016787; GO:0023052; GO:0043226; GO:0050877; GO:0065003,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; hydrolase activity; signaling; organelle; nervous system process; protein-containing complex assembly
OG_07057,FUN_032282-T1,Peve_00015548,Pocillopora_meandrina_HIv1___RNAseq.g24294.t1,three_way,60.5455,FUN_032282-T1,Q0IJ01,,,,,26.5,567.0,1.5e-33,146.0,sp|Q0IJ01|ZWILC_XENTR Protein zwilch homolog OS=Xenopus tropicalis OX=8364 GN=zwilch PE=2 SV=1,,,,,,
OG_07058,FUN_032284-T1,Peve_00015547,Pocillopora_meandrina_HIv1___RNAseq.g24296.t2,three_way,84.13550000000001,FUN_032284-T1,A4IFE9,TM9S1_BOVIN,,Transmembrane 9 superfamily member 1,Bos taurus (Bovine),67.6,571.0,7.5e-229,794.7,sp|A4IFE9|TM9S1_BOVIN Transmembrane 9 superfamily member 1 OS=Bos taurus OX=9913 GN=TM9SF1 PE=2 SV=1,GO:0000421; GO:0005765; GO:0006914; GO:0016020; GO:0031410; GO:0072657,autophagy [GO:0006914]; protein localization to membrane [GO:0072657],autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],,GO:0006914; GO:0031410; GO:0043226,autophagy; cytoplasmic vesicle; organelle
OG_07059,FUN_032285-T1,Peve_00015515,Pocillopora_meandrina_HIv1___RNAseq.g3787.t1,three_way,65.661,FUN_032285-T1,P26186,,,,,39.3,168.0,1.8e-27,124.0,sp|P26186|MGMT_CRIGR Methylated-DNA--protein-cysteine methyltransferase OS=Cricetulus griseus OX=10029 GN=MGMT PE=2 SV=1,,,,,,
OG_07060,FUN_032286-T1,Peve_00015514,Pocillopora_meandrina_HIv1___RNAseq.g24297.t1,three_way,82.484,FUN_032286-T1,Q28HF8,NTCP7_XENTR,,Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),66.1,339.0,5.8e-120,432.2,sp|Q28HF8|NTCP7_XENTR Sodium/bile acid cotransporter 7 OS=Xenopus tropicalis OX=8364 GN=slc10a7 PE=2 SV=1,GO:0000139; GO:0005789; GO:0005886; GO:0006814; GO:0015293,sodium ion transport [GO:0006814],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],symporter activity [GO:0015293],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_07061,FUN_032287-T1,Peve_00015513,Pocillopora_meandrina_HIv1___RNAseq.g24298.t1,three_way,80.58466666666666,FUN_032287-T1,O60942,MCE1_HUMAN,,mRNA-capping enzyme (HCAP1) (HCE) [Includes: mRNA 5'-triphosphate monophosphatase (EC 3.6.1.74) (mRNA 5'-phosphatase); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)],Homo sapiens (Human),49.5,566.0,5.900000000000001e-162,572.4,sp|O60942|MCE1_HUMAN mRNA-capping enzyme OS=Homo sapiens OX=9606 GN=RNGTT PE=1 SV=1,GO:0004484; GO:0004651; GO:0004721; GO:0005524; GO:0005525; GO:0005634; GO:0005654; GO:0006370; GO:0006396; GO:0008192; GO:0050355; GO:0140818,7-methylguanosine mRNA capping [GO:0006370]; RNA processing [GO:0006396],nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; GTP binding [GO:0005525]; inorganic triphosphate phosphatase activity [GO:0050355]; mRNA 5'-triphosphate monophosphatase activity [GO:0140818]; mRNA guanylyltransferase activity [GO:0004484]; phosphoprotein phosphatase activity [GO:0004721]; polynucleotide 5'-phosphatase activity [GO:0004651]; RNA guanylyltransferase activity [GO:0008192],GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016740; GO:0016787; GO:0043226; GO:0140096; GO:0140098,"catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_07062,FUN_032288-T1,Peve_00015511,Pocillopora_meandrina_HIv1___RNAseq.g24311.t1,three_way,76.559,FUN_032288-T1,Q6P5E8,DGKQ_MOUSE,,Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (EC 2.7.1.93) (Diglyceride kinase theta) (DGK-theta),Mus musculus (Mouse),40.0,879.0,2.1e-185,651.0,sp|Q6P5E8|DGKQ_MOUSE Diacylglycerol kinase theta OS=Mus musculus OX=10090 GN=Dgkq PE=1 SV=1,GO:0004143; GO:0004697; GO:0005524; GO:0005730; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006111; GO:0006357; GO:0006654; GO:0007173; GO:0007189; GO:0007200; GO:0008270; GO:0010628; GO:0010629; GO:0012506; GO:0016363; GO:0016607; GO:0030297; GO:0030971; GO:0043274; GO:0046339; GO:0046834; GO:0047649; GO:0051591; GO:0070493; GO:0090037; GO:0090181; GO:0098793; GO:0098794; GO:0098978; GO:0140297; GO:1900242; GO:1903413; GO:1903432; GO:2000064; GO:2000182,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to bile acid [GO:1903413]; diacylglycerol metabolic process [GO:0046339]; epidermal growth factor receptor signaling pathway [GO:0007173]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of gene expression [GO:0010628]; positive regulation of protein kinase C signaling [GO:0090037]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506],alkylglycerol kinase activity [GO:0047649]; ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; DNA-binding transcription factor binding [GO:0140297]; phospholipase binding [GO:0043274]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; zinc ion binding [GO:0008270],GO:0003824; GO:0005730; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleolus; endosome; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07063,FUN_032289-T1,Peve_00015510,Pocillopora_meandrina_HIv1___TS.g12261.t1,three_way,71.52666666666667,FUN_032289-T1,Q54SR7,FKBP2_DICDI,,FK506-binding protein 2 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase),Dictyostelium discoideum (Social amoeba),50.8,132.0,2.3e-30,133.7,sp|Q54SR7|FKBP2_DICDI FK506-binding protein 2 OS=Dictyostelium discoideum OX=44689 GN=fkbp2 PE=3 SV=1,GO:0003755; GO:0005783; GO:0061077,chaperone-mediated protein folding [GO:0061077],endoplasmic reticulum [GO:0005783],peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0005783; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_07064,FUN_032290-T1,Peve_00015509,Pocillopora_meandrina_HIv1___RNAseq.g24318.t1,three_way,80.926,FUN_032290-T1,Q9BV90,SNR25_HUMAN,,U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein),Homo sapiens (Human),56.0,134.0,9.9e-35,147.9,sp|Q9BV90|SNR25_HUMAN U11/U12 small nuclear ribonucleoprotein 25 kDa protein OS=Homo sapiens OX=9606 GN=SNRNP25 PE=1 SV=1,GO:0000398; GO:0005634; GO:0005654; GO:0005689; GO:0005829; GO:0008380; GO:0045171,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689],,GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0043226,nucleus; nucleoplasm; cytosol; mRNA metabolic process; organelle
OG_07065,FUN_032291-T1,Peve_00015504,Pocillopora_meandrina_HIv1___RNAseq.g24890.t1,three_way,78.677,FUN_032291-T1,Q9WU84,,,,,56.0,248.0,4.9e-79,295.8,sp|Q9WU84|CCS_MOUSE Copper chaperone for superoxide dismutase OS=Mus musculus OX=10090 GN=Ccs PE=1 SV=1,,,,,,
OG_07066,FUN_032299-T1,Peve_00020128,Pocillopora_meandrina_HIv1___RNAseq.g24900.t1,three_way,50.632333333333335,FUN_032299-T1,Q3ZT31,SNX25_MOUSE,,Sorting nexin-25,Mus musculus (Mouse),27.2,125.0,1.3e-07,60.8,sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3,GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091,negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801],endosome [GO:0005768]; endosome membrane [GO:0010008],phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005768; GO:0008289; GO:0031410; GO:0043226,endosome; lipid binding; cytoplasmic vesicle; organelle
OG_07067,FUN_032301-T1,Peve_00005298,Pocillopora_meandrina_HIv1___RNAseq.g24895.t1,three_way,63.05066666666667,FUN_032301-T1,Q642J4,,,,,41.1,316.0,1.7999999999999996e-68,261.2,sp|Q642J4|IMPCT_DANRE Protein IMPACT OS=Danio rerio OX=7955 GN=impact PE=2 SV=1,,,,,,
OG_07068,FUN_032303-T1,Peve_00029763,Pocillopora_meandrina_HIv1___RNAseq.g24894.t1,three_way,68.74666666666667,FUN_032303-T1,Q5ZK95,,,,,41.2,131.0,7.4e-16,85.1,sp|Q5ZK95|CCD43_CHICK Coiled-coil domain-containing protein 43 OS=Gallus gallus OX=9031 GN=CCDC43 PE=2 SV=1,,,,,,
OG_07069,FUN_032304-T1,Peve_00029762,Pocillopora_meandrina_HIv1___RNAseq.g24893.t1,three_way,84.42699999999999,FUN_032304-T1,Q99470,,,,,60.9,115.0,4.5e-38,158.7,sp|Q99470|SDF2_HUMAN Stromal cell-derived factor 2 OS=Homo sapiens OX=9606 GN=SDF2 PE=1 SV=2,,,,,,
OG_07070,FUN_032305-T1,Peve_00027302,Pocillopora_meandrina_HIv1___RNAseq.g24891.t1,three_way,48.758833333333335,,,,,,,,,,,,,,,,,
OG_07071,FUN_032307-T1,Peve_00001538,Pocillopora_meandrina_HIv1___RNAseq.g24762.t2,three_way,70.71366666666667,FUN_032307-T1,Q3U0J8,,,,,48.1,480.0,9.9e-126,452.6,sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2,,,,,,
OG_07072,FUN_032308-T1,Peve_00001539,Pocillopora_meandrina_HIv1___RNAseq.g24763.t1,three_way,65.20216666666667,FUN_032308-T1,Q3B8Q1,DDX21_RAT,,Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu),Rattus norvegicus (Rat),49.4,579.0,2.2e-147,524.2,sp|Q3B8Q1|DDX21_RAT Nucleolar RNA helicase 2 OS=Rattus norvegicus OX=10116 GN=Ddx21 PE=2 SV=1,GO:0002735; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006364; GO:0006366; GO:0009615; GO:0016887; GO:0019843; GO:0030515; GO:0035198; GO:0042802; GO:0043123; GO:0043330; GO:0045087; GO:0045945; GO:0051607; GO:0062176; GO:0097322; GO:0110016,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of transcription by RNA polymerase III [GO:0045945]; R-loop processing [GO:0062176]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; rRNA processing [GO:0006364]; transcription by RNA polymerase II [GO:0006366],B-WICH complex [GO:0110016]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],7SK snRNA binding [GO:0097322]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724]; rRNA binding [GO:0019843]; snoRNA binding [GO:0030515],GO:0002376; GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0098542; GO:0140098; GO:0140657,"immune system process; RNA binding; catalytic activity; nucleoplasm; nucleolus; mitochondrion; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_07073,FUN_032309-T1,Peve_00009101,Pocillopora_meandrina_HIv1___RNAseq.g24764.t1,three_way,78.17133333333334,FUN_032309-T1,A7RZS0,BL1S2_NEMVE,,Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC-1 subunit 2),Nematostella vectensis (Starlet sea anemone),53.8,104.0,2.7e-21,103.2,sp|A7RZS0|BL1S2_NEMVE Biogenesis of lysosome-related organelles complex 1 subunit 2 OS=Nematostella vectensis OX=45351 GN=bloc1s2 PE=3 SV=1,GO:0000930; GO:0005765; GO:0005813; GO:0016197; GO:0031083; GO:0032418; GO:0043015; GO:0099078,endosomal transport [GO:0016197]; lysosome localization [GO:0032418],BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; centrosome [GO:0005813]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765],gamma-tubulin binding [GO:0043015],GO:0005815; GO:0008092; GO:0016192,microtubule organizing center; cytoskeletal protein binding; vesicle-mediated transport
OG_07074,FUN_032310-T1,Peve_00001530,Pocillopora_meandrina_HIv1___RNAseq.g24765.t1,three_way,78.05033333333333,FUN_032310-T1,Q6GPV5,,,,,48.7,156.0,3.2e-35,149.4,sp|Q6GPV5|RN181_XENLA E3 ubiquitin-protein ligase RNF181 OS=Xenopus laevis OX=8355 GN=rnf181 PE=2 SV=1,,,,,,
OG_07075,FUN_032312-T1,Peve_00002566,Pocillopora_meandrina_HIv1___RNAseq.g24785.t1,three_way,58.21183333333333,,,,,,,,,,,,,,,,,
OG_07076,FUN_032313-T1,Peve_00002570,Pocillopora_meandrina_HIv1___RNAseq.g24766.t1,three_way,78.20966666666666,FUN_032313-T1,Q99729,ROAA_HUMAN,,Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (APOBEC1-binding protein 1) (ABBP-1),Homo sapiens (Human),46.6,193.0,2.4e-43,177.6,sp|Q99729|ROAA_HUMAN Heterogeneous nuclear ribonucleoprotein A/B OS=Homo sapiens OX=9606 GN=HNRNPAB PE=1 SV=2,GO:0000785; GO:0001837; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0010468; GO:0016556; GO:0030425; GO:0044877; GO:0045293; GO:0045893; GO:0071230; GO:0071598; GO:0090575; GO:0141166; GO:1904580; GO:1990837; GO:1990904; GO:2000623,"cellular response to amino acid stimulus [GO:0071230]; chromosomal 5-methylcytosine DNA demethylation pathway [GO:0141166]; epithelial to mesenchymal transition [GO:0001837]; mRNA modification [GO:0016556]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mRNA editing complex [GO:0045293]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription regulator complex [GO:0090575],mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0030154; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; organelle
OG_07077,FUN_032314-T1,Peve_00031926,Pocillopora_meandrina_HIv1___RNAseq.g24787.t1,three_way,73.028,FUN_032314-T1,P83205,CATB_SHEEP,,Cathepsin B (EC 3.4.22.1) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain],Ovis aries (Sheep),56.0,336.0,2.5e-107,390.2,sp|P83205|CATB_SHEEP Cathepsin B OS=Ovis aries OX=9940 GN=CTSB PE=1 SV=2,GO:0004175; GO:0004197; GO:0005518; GO:0005615; GO:0005764; GO:0006590; GO:0009897; GO:0016324; GO:0030574; GO:0030855; GO:0042470; GO:0043394; GO:0046697; GO:0046718; GO:0048471; GO:0051603; GO:0097067; GO:1904090,cellular response to thyroid hormone stimulus [GO:0097067]; collagen catabolic process [GO:0030574]; decidualization [GO:0046697]; epithelial cell differentiation [GO:0030855]; proteolysis involved in protein catabolic process [GO:0051603]; symbiont entry into host cell [GO:0046718]; thyroid hormone generation [GO:0006590],apical plasma membrane [GO:0016324]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; peptidase inhibitor complex [GO:1904090]; perinuclear region of cytoplasm [GO:0048471],collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; proteoglycan binding [GO:0043394],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0006575; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; modified amino acid metabolic process; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07078,FUN_032315-T1,Peve_00002571,Pocillopora_meandrina_HIv1___TS.g12729.t1,three_way,79.40783333333333,FUN_032315-T1,O14730,RIOK3_HUMAN,,Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog),Homo sapiens (Human),56.2,470.0,6.699999999999999e-141,502.3,sp|O14730|RIOK3_HUMAN Serine/threonine-protein kinase RIO3 OS=Homo sapiens OX=9606 GN=RIOK3 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005829; GO:0007059; GO:0030490; GO:0030688; GO:0031333; GO:0032728; GO:0039534; GO:0043124; GO:0045087; GO:0045089; GO:0046872; GO:0051607; GO:0071359; GO:0089720; GO:0098586; GO:0106310; GO:1990786,cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; chromosome segregation [GO:0007059]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728],"cytosol [GO:0005829]; preribosome, small subunit precursor [GO:0030688]",ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005829; GO:0007059; GO:0016740; GO:0098542; GO:0140096,"immune system process; catalytic activity; cytosol; chromosome segregation; transferase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07079,FUN_032317-T1,Peve_00031925,Pocillopora_meandrina_HIv1___RNAseq.g24788.t1,three_way,48.4895,FUN_032317-T1,Q3ULM6,,,,,29.3,300.0,2.1e-30,135.6,sp|Q3ULM6|USPL1_MOUSE SUMO-specific isopeptidase USPL1 OS=Mus musculus OX=10090 GN=Uspl1 PE=2 SV=2,,,,,,
OG_07080,FUN_032322-T1,Peve_00010337,Pocillopora_meandrina_HIv1___RNAseq.g24794.t1,three_way,64.49116666666667,FUN_032322-T1,Q24488,ROR1_DROME,,Tyrosine-protein kinase transmembrane receptor Ror (dRor) (EC 2.7.10.1),Drosophila melanogaster (Fruit fly),45.1,297.0,8.8e-72,273.1,sp|Q24488|ROR1_DROME Tyrosine-protein kinase transmembrane receptor Ror OS=Drosophila melanogaster OX=7227 GN=Ror PE=1 SV=1,GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006468; GO:0007169; GO:0007417; GO:0016020; GO:0017147; GO:0030424; GO:0043235,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; central nervous system development [GO:0007417]; protein phosphorylation [GO:0006468],axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0016740; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; transferase activity; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_07081,FUN_032323-T1,Peve_00017288,Pocillopora_meandrina_HIv1___RNAseq.g24797.t1,three_way,83.84383333333334,FUN_032323-T1,O60763,USO1_HUMAN,,General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein),Homo sapiens (Human),57.8,765.0,2.2e-236,820.5,sp|O60763|USO1_HUMAN General vesicular transport factor p115 OS=Homo sapiens OX=9606 GN=USO1 PE=1 SV=2,GO:0000139; GO:0001650; GO:0003723; GO:0005783; GO:0005794; GO:0005795; GO:0005815; GO:0005829; GO:0006886; GO:0006888; GO:0007264; GO:0012507; GO:0016020; GO:0030133; GO:0032252; GO:0045056; GO:0045296; GO:0048211; GO:0048280; GO:0048471; GO:0061025; GO:1900076,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; regulation of cellular response to insulin stimulus [GO:1900076]; secretory granule localization [GO:0032252]; small GTPase-mediated signal transduction [GO:0007264]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133],cadherin binding [GO:0045296]; RNA binding [GO:0003723],GO:0003723; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0061024,RNA binding; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_07082,FUN_032325-T1,Peve_00017290,Pocillopora_meandrina_HIv1___RNAseq.g24798.t1,three_way,74.93133333333334,,,,,,,,,,,,,,,,,
OG_07083,FUN_032326-T1,Peve_00017292,Pocillopora_meandrina_HIv1___RNAseq.g24799.t1,three_way,83.26566666666666,FUN_032326-T1,P09917,LOX5_HUMAN,,Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34),Homo sapiens (Human),30.8,681.0,1.1e-82,309.3,sp|P09917|LOX5_HUMAN Polyunsaturated fatty acid 5-lipoxygenase OS=Homo sapiens OX=9606 GN=ALOX5 PE=1 SV=2,GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016491; GO:0016525; GO:0016701; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301,arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426],cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774],"arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701]",GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005635; GO:0005654; GO:0005829; GO:0006629; GO:0016491; GO:0016787; GO:0048870,immune system process; catalytic activity; extracellular region; extracellular space; nuclear envelope; nucleoplasm; cytosol; lipid metabolic process; oxidoreductase activity; hydrolase activity; cell motility
OG_07084,FUN_032336-T1,Peve_00027885,Pocillopora_meandrina_HIv1___TS.g12755.t1,three_way,60.60433333333334,,,,,,,,,,,,,,,,,
OG_07085,FUN_032342-T1,Peve_00043848,Pocillopora_meandrina_HIv1___RNAseq.g24825.t1,three_way,44.547666666666665,FUN_032342-T1,Q6R5N8,TLR13_MOUSE,,Toll-like receptor 13,Mus musculus (Mouse),33.1,130.0,5.8e-15,84.3,sp|Q6R5N8|TLR13_MOUSE Toll-like receptor 13 OS=Mus musculus OX=10090 GN=Tlr13 PE=1 SV=1,GO:0002755; GO:0005737; GO:0005768; GO:0006954; GO:0009615; GO:0010008; GO:0019843; GO:0034178; GO:0042802; GO:0043408; GO:0045087; GO:0061809,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178],cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008],"identical protein binding [GO:0042802]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; rRNA binding [GO:0019843]",GO:0002376; GO:0003723; GO:0003824; GO:0005768; GO:0006954; GO:0016787; GO:0031410; GO:0043226; GO:0098542,immune system process; RNA binding; catalytic activity; endosome; inflammatory response; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism
OG_07086,FUN_032343-T1,Peve_00043851,Pocillopora_meandrina_HIv1___RNAseq.g29795.t1,three_way,70.73383333333334,FUN_032343-T1,Q9VCA2,,,,,31.8,528.0,2.4e-61,238.0,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_07087,FUN_032344-T1,Peve_00021401,Pocillopora_meandrina_HIv1___RNAseq.g29796.t1,three_way,74.12733333333334,FUN_032344-T1,Q9H3R1,,,,,40.3,749.0,4.3000000000000005e-161,570.1,sp|Q9H3R1|NDST4_HUMAN Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 OS=Homo sapiens OX=9606 GN=NDST4 PE=1 SV=1,,,,,,
OG_07088,FUN_032345-T1,Peve_00021405,Pocillopora_meandrina_HIv1___RNAseq.g29797.t2,three_way,70.41966666666667,FUN_032345-T1,Q9V3L1,NDST_DROME,,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)],Drosophila melanogaster (Fruit fly),46.3,901.0,9.6e-236,818.1,sp|Q9V3L1|NDST_DROME Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase OS=Drosophila melanogaster OX=7227 GN=sfl PE=1 SV=1,GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008543; GO:0008587; GO:0015012; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140,"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]",endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139],deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate N-sulfotransferase activity [GO:0015016],GO:0003824; GO:0005783; GO:0005794; GO:0006790; GO:0009101; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; hydrolase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_07089,FUN_032346-T1,Peve_00021402,Pocillopora_meandrina_HIv1___RNAseq.g29798.t1,three_way,92.105,FUN_032346-T1,O04438,,,,,58.8,68.0,9e-18,90.5,sp|O04438|SRP09_MAIZE Signal recognition particle 9 kDa protein OS=Zea mays OX=4577 GN=SRP9 PE=3 SV=1,,,,,,
OG_07090,FUN_032347-T1,Peve_00032203,Pocillopora_meandrina_HIv1___RNAseq.g29799.t1,three_way,82.527,,,,,,,,,,,,,,,,,
OG_07091,FUN_032348-T1,Peve_00012753,Pocillopora_meandrina_HIv1___TS.g25052.t1,three_way,72.73100000000001,FUN_032348-T1,Q9PT60,,,,,44.5,263.0,4.7e-52,207.2,sp|Q9PT60|RBP1A_XENLA RalA-binding protein 1-A OS=Xenopus laevis OX=8355 GN=ralbp1-a PE=1 SV=3,,,,,,
OG_07092,FUN_032349-T1,Peve_00012757,Pocillopora_meandrina_HIv1___RNAseq.g29801.t1,three_way,87.25633333333333,FUN_032349-T1,Q5XHC1,,,,,53.7,296.0,1.2e-84,314.7,sp|Q5XHC1|CFA96_XENLA Cilia-and flagella-associated protein 96 OS=Xenopus laevis OX=8355 GN=cfap96.L PE=2 SV=1,,,,,,
OG_07093,FUN_032350-T1,Peve_00012758,Pocillopora_meandrina_HIv1___RNAseq.g29802.t1,three_way,54.929,FUN_032350-T1,Q5BJT4,TXD15_RAT,,Thioredoxin domain-containing protein 15,Rattus norvegicus (Rat),40.4,198.0,3.2e-29,130.6,sp|Q5BJT4|TXD15_RAT Thioredoxin domain-containing protein 15 OS=Rattus norvegicus OX=10116 GN=Txndc15 PE=2 SV=1,GO:0005929; GO:0045880; GO:0060170; GO:0060271,cilium assembly [GO:0060271]; positive regulation of smoothened signaling pathway [GO:0045880],ciliary membrane [GO:0060170]; cilium [GO:0005929],,GO:0005929; GO:0043226; GO:0044782,cilium; organelle; cilium organization
OG_07094,FUN_032352-T1,Peve_00024032,Pocillopora_meandrina_HIv1___RNAseq.g29803.t2,three_way,59.69416666666667,FUN_032352-T1,P15535,,,,,44.9,265.0,1.6e-63,245.0,"sp|P15535|B4GT1_MOUSE Beta-1,4-galactosyltransferase 1 OS=Mus musculus OX=10090 GN=B4galt1 PE=1 SV=1",,,,,,
OG_07095,FUN_032353-T1,Peve_00026256,Pocillopora_meandrina_HIv1___RNAseq.g29804.t1,three_way,66.072,FUN_032353-T1,Q8BL06,,,,,55.3,342.0,2.5e-110,401.7,sp|Q8BL06|UBP54_MOUSE Ubiquitin carboxyl-terminal hydrolase 54 OS=Mus musculus OX=10090 GN=Usp54 PE=1 SV=2,,,,,,
OG_07096,FUN_032354-T1,Peve_00026257,Pocillopora_meandrina_HIv1___TS.g25057.t4,three_way,83.02083333333333,,,,,,,,,,,,,,,,,
OG_07097,FUN_032355-T1,Peve_00001953,Pocillopora_meandrina_HIv1___RNAseq.g29813.t1,three_way,45.463833333333326,FUN_032355-T1,Q640K1,,,,,28.7,680.0,1.2e-66,256.1,sp|Q640K1|NCDN_XENLA Neurochondrin OS=Xenopus laevis OX=8355 GN=ncdn PE=2 SV=1,,,,,,
OG_07098,FUN_032356-T1,Peve_00001943,Pocillopora_meandrina_HIv1___RNAseq.g29814.t1,three_way,72.94966666666667,FUN_032356-T1,O95876,FRITZ_HUMAN,,WD repeat-containing and planar cell polarity effector protein fritz homolog (hFRTZ) (Bardet-Biedl syndrome 15 protein) (WD repeat-containing and planar cell polarity effector protein),Homo sapiens (Human),42.2,720.0,3.6e-153,543.5,sp|O95876|FRITZ_HUMAN WD repeat-containing and planar cell polarity effector protein fritz homolog OS=Homo sapiens OX=9606 GN=WDPCP PE=1 SV=2,GO:0001736; GO:0001822; GO:0002093; GO:0005886; GO:0005929; GO:0005930; GO:0007224; GO:0007399; GO:0010762; GO:0016476; GO:0021915; GO:0032185; GO:0032880; GO:0035091; GO:0042073; GO:0042733; GO:0043010; GO:0043587; GO:0044782; GO:0045184; GO:0051893; GO:0055123; GO:0060021; GO:0060271; GO:0060541; GO:0072359; GO:0090521; GO:0097541; GO:1900027; GO:1902017; GO:2000114,auditory receptor cell morphogenesis [GO:0002093]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; cilium organization [GO:0044782]; circulatory system development [GO:0072359]; digestive system development [GO:0055123]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; establishment of protein localization [GO:0045184]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; nervous system development [GO:0007399]; neural tube development [GO:0021915]; podocyte cell migration [GO:0090521]; regulation of cilium assembly [GO:1902017]; regulation of embryonic cell shape [GO:0016476]; regulation of establishment of cell polarity [GO:2000114]; regulation of fibroblast migration [GO:0010762]; regulation of focal adhesion assembly [GO:0051893]; regulation of protein localization [GO:0032880]; regulation of ruffle assembly [GO:1900027]; respiratory system development [GO:0060541]; roof of mouth development [GO:0060021]; septin cytoskeleton organization [GO:0032185]; smoothened signaling pathway [GO:0007224]; tongue morphogenesis [GO:0043587],axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; cilium [GO:0005929]; plasma membrane [GO:0005886],phosphatidylinositol binding [GO:0035091],GO:0005886; GO:0005929; GO:0007010; GO:0007018; GO:0008289; GO:0043226; GO:0044782; GO:0048856; GO:0048870,plasma membrane; cilium; cytoskeleton organization; microtubule-based movement; lipid binding; organelle; cilium organization; anatomical structure development; cell motility
OG_07099,FUN_032357-T1,Peve_00045034,Pocillopora_meandrina_HIv1___RNAseq.g29816.t1,three_way,87.85333333333334,FUN_032357-T1,Q9QXT1,,,,,51.1,235.0,1.1e-67,258.1,sp|Q9QXT1|DAPP1_MOUSE Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide OS=Mus musculus OX=10090 GN=Dapp1 PE=1 SV=1,,,,,,
OG_07100,FUN_032358-T1,Peve_00045036,Pocillopora_meandrina_HIv1___RNAseq.g29817.t1,three_way,81.91766666666666,FUN_032358-T1,P50749,RASF2_HUMAN,,Ras association domain-containing protein 2,Homo sapiens (Human),32.1,302.0,4.6e-34,147.1,sp|P50749|RASF2_HUMAN Ras association domain-containing protein 2 OS=Homo sapiens OX=9606 GN=RASSF2 PE=1 SV=1,GO:0000776; GO:0001501; GO:0001503; GO:0004672; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0007165; GO:0007249; GO:0031954; GO:0032991; GO:0033137; GO:0043065; GO:0045667; GO:0045670; GO:0045860; GO:0046330; GO:0046849; GO:0048872; GO:0050821; GO:1901222; GO:1901223,bone remodeling [GO:0046849]; canonical NF-kappaB signal transduction [GO:0007249]; homeostasis of number of cells [GO:0048872]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; ossification [GO:0001503]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase activity [GO:0045860]; protein stabilization [GO:0050821]; regulation of non-canonical NF-kappaB signal transduction [GO:1901222]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoclast differentiation [GO:0045670]; signal transduction [GO:0007165]; skeletal system development [GO:0001501],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],protein kinase activity [GO:0004672],GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; plasma membrane; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07101,FUN_032361-T1,Peve_00045028,Pocillopora_meandrina_HIv1___RNAseq.g29818.t1,three_way,57.91883333333333,FUN_032361-T1,Q8C3S2,,,,,33.1,1162.0,1.7e-147,525.4,sp|Q8C3S2|TNG6_MOUSE Transport and Golgi organization protein 6 homolog OS=Mus musculus OX=10090 GN=Tango6 PE=1 SV=1,,,,,,
OG_07102,FUN_032363-T1,Peve_00045030,Pocillopora_meandrina_HIv1___RNAseq.g29819.t1,three_way,59.871500000000005,FUN_032363-T1,Q6N021,TET2_HUMAN,,Methylcytosine dioxygenase TET2 (EC 1.14.11.80),Homo sapiens (Human),32.8,825.0,5.8e-99,364.4,sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3,GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579; GO:0141167,"chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]",chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0009101; GO:0016491; GO:0030154; GO:0043226; GO:0140097; GO:1901135,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; glycoprotein biosynthetic process; oxidoreductase activity; cell differentiation; organelle; catalytic activity, acting on DNA; carbohydrate derivative metabolic process"
OG_07103,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_07104,FUN_032371-T1,Peve_00036465,Pocillopora_meandrina_HIv1___RNAseq.g24259.t1,three_way,67.01666666666667,FUN_032371-T1,Q04786,,,,,38.5,881.0,3.5e-156,553.9,sp|Q04786|HEX_VIBVL Beta-hexosaminidase OS=Vibrio vulnificus OX=672 GN=hex PE=3 SV=1,,,,,,
OG_07105,FUN_032372-T1,Peve_00036459,Pocillopora_meandrina_HIv1___TS.g12198.t1,three_way,80.77066666666667,FUN_032372-T1,Q04786,,,,,38.7,863.0,5.8e-153,543.1,sp|Q04786|HEX_VIBVL Beta-hexosaminidase OS=Vibrio vulnificus OX=672 GN=hex PE=3 SV=1,,,,,,
OG_07106,FUN_032374-T1,Peve_00036458,Pocillopora_meandrina_HIv1___RNAseq.g24256.t1,three_way,62.577333333333335,FUN_032374-T1,Q04786,,,,,35.2,685.0,6.6e-104,379.8,sp|Q04786|HEX_VIBVL Beta-hexosaminidase OS=Vibrio vulnificus OX=672 GN=hex PE=3 SV=1,,,,,,
OG_07107,FUN_032377-T1,Peve_00041775,Pocillopora_meandrina_HIv1___RNAseq.g24363.t1,three_way,75.99600000000001,FUN_032377-T1,Q3SX30,,,,,27.7,285.0,4.5e-20,100.1,sp|Q3SX30|PSMF1_BOVIN Proteasome inhibitor PI31 subunit OS=Bos taurus OX=9913 GN=PSMF1 PE=2 SV=2,,,,,,
OG_07108,FUN_032378-T1,Peve_00041776,Pocillopora_meandrina_HIv1___RNAseq.7604_t,three_way,89.479,FUN_032378-T1,Q5R7J8,TP4A1_PONAB,,Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),64.7,167.0,1.4000000000000001e-59,230.7,sp|Q5R7J8|TP4A1_PONAB Protein tyrosine phosphatase type IVA 1 OS=Pongo abelii OX=9601 GN=PTP4A1 PE=2 SV=1,GO:0004725; GO:0005634; GO:0005769; GO:0005783; GO:0005819; GO:0005886,,early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819],protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005634; GO:0005768; GO:0005783; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; endoplasmic reticulum; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07109,FUN_032379-T1,Peve_00041779,Pocillopora_meandrina_HIv1___TS.g12307.t1,three_way,82.202,FUN_032379-T1,Q66I21,,,,,63.8,442.0,3.4e-165,582.8,sp|Q66I21|AL8A1_DANRE 2-aminomuconic semialdehyde dehydrogenase OS=Danio rerio OX=7955 GN=aldh8a1 PE=2 SV=1,,,,,,
OG_07110,FUN_032381-T1,Peve_00041787,Pocillopora_meandrina_HIv1___RNAseq.g24369.t2,three_way,58.79066666666667,FUN_032381-T1,Q0VGT4,ZGRF1_MOUSE,,5'-3' DNA helicase ZGRF1 (EC 5.6.2.3) (GRF-type zinc finger domain-containing protein 1),Mus musculus (Mouse),49.1,846.0,3.2e-210,734.2,sp|Q0VGT4|ZGRF1_MOUSE 5'-3' DNA helicase ZGRF1 OS=Mus musculus OX=10090 GN=Zgrf1 PE=1 SV=2,GO:0000725; GO:0005524; GO:0005634; GO:0008270; GO:0016787; GO:0043139,recombinational repair [GO:0000725],nucleus [GO:0005634],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07111,FUN_032384-T1,Peve_00041789,Pocillopora_meandrina_HIv1___RNAseq.g24371.t1,three_way,71.52466666666666,FUN_032384-T1,Q92113,,,,,35.0,472.0,2.7e-81,304.3,"sp|Q92113|CP17A_SQUAC Steroid 17-alpha-hydroxylase/17,20 lyase OS=Squalus acanthias OX=7797 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_07112,FUN_032385-T1,Peve_00007850,Pocillopora_meandrina_HIv1___RNAseq.g29733.t1,three_way,82.91166666666666,FUN_032385-T1,P52649,,,,,54.6,467.0,1.3e-138,494.6,sp|P52649|CY24B_PIG NADPH oxidase 2 OS=Sus scrofa OX=9823 GN=CYBB PE=2 SV=3,,,,,,
OG_07113,FUN_032386-T1,Peve_00032594,Pocillopora_meandrina_HIv1___RNAseq.g29750.t1,three_way,46.69566666666667,FUN_032386-T1,Q5ZI22,NUP42_CHICK,,Nucleoporin NUP42 (Nucleoporin-like protein 2),Gallus gallus (Chicken),28.6,259.0,9.2e-15,82.8,sp|Q5ZI22|NUP42_CHICK Nucleoporin NUP42 OS=Gallus gallus OX=9031 GN=NUP42 PE=2 SV=1,GO:0005049; GO:0005643; GO:0008270; GO:0015031; GO:0031965; GO:0051028,mRNA transport [GO:0051028]; protein transport [GO:0015031],nuclear membrane [GO:0031965]; nuclear pore [GO:0005643],nuclear export signal receptor activity [GO:0005049]; zinc ion binding [GO:0008270],GO:0140104,molecular carrier activity
OG_07114,FUN_032389-T1,Peve_00034319,Pocillopora_meandrina_HIv1___TS.g24989.t1,three_way,81.11766666666666,FUN_032389-T1,Q54MZ4,,,,,44.4,304.0,5.9e-64,246.1,sp|Q54MZ4|MCFB_DICDI Mitochondrial substrate carrier family protein B OS=Dictyostelium discoideum OX=44689 GN=mcfB PE=3 SV=1,,,,,,
OG_07115,FUN_032391-T1,Peve_00023249,Pocillopora_meandrina_HIv1___TS.g24987.t1,three_way,61.20033333333333,,,,,,,,,,,,,,,,,
OG_07116,FUN_032392-T1,Peve_00023247,Pocillopora_meandrina_HIv1___RNAseq.g29740.t1,three_way,68.81316666666666,FUN_032392-T1,Q641M3,,,,,38.8,134.0,3.6e-23,109.4,sp|Q641M3|TMM18_DANRE Transmembrane protein 18 OS=Danio rerio OX=7955 GN=tmem18 PE=2 SV=1,,,,,,
OG_07117,FUN_032394-T1,Peve_00018856,Pocillopora_meandrina_HIv1___RNAseq.g29832.t1,three_way,75.89816666666667,FUN_032394-T1,P40123,CAP2_HUMAN,,Adenylyl cyclase-associated protein 2 (CAP 2),Homo sapiens (Human),40.3,467.0,2.3e-79,297.7,sp|P40123|CAP2_HUMAN Adenylyl cyclase-associated protein 2 OS=Homo sapiens OX=9606 GN=CAP2 PE=1 SV=1,GO:0000902; GO:0003779; GO:0005737; GO:0005886; GO:0007015; GO:0007163; GO:0007165; GO:0007190; GO:0008179; GO:0014069; GO:0019933; GO:0042802; GO:0099140,actin filament organization [GO:0007015]; activation of adenylate cyclase activity [GO:0007190]; cAMP-mediated signaling [GO:0019933]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; presynaptic actin cytoskeleton organization [GO:0099140]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; identical protein binding [GO:0042802],GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0043226,plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; organelle
OG_07118,FUN_032395-T1,Peve_00036447,Pocillopora_meandrina_HIv1___RNAseq.g29833.t1,three_way,64.09349999999999,FUN_032395-T1,Q76LC6,RBM24_DANRE,,RNA-binding protein 24 (RNA-binding motif protein 24) (RNA-binding protein SEB-4),Danio rerio (Zebrafish) (Brachydanio rerio),61.8,89.0,7.2e-27,122.5,sp|Q76LC6|RBM24_DANRE RNA-binding protein 24 OS=Danio rerio OX=7955 GN=rbm24 PE=2 SV=1,GO:0000381; GO:0001654; GO:0001756; GO:0001947; GO:0003228; GO:0003723; GO:0003730; GO:0005634; GO:0005737; GO:0005829; GO:0006397; GO:0006974; GO:0007519; GO:0008380; GO:0010830; GO:0010831; GO:0035315; GO:0035925; GO:0043488; GO:0045663; GO:0048255; GO:0048702; GO:0060297; GO:0060298; GO:0061157; GO:0061158; GO:0071599; GO:0072359; GO:0097157; GO:1902811; GO:1905870; GO:1990715; GO:1990825; GO:2000738; GO:2000766,"3'-UTR-mediated mRNA destabilization [GO:0061158]; atrial cardiac muscle tissue development [GO:0003228]; circulatory system development [GO:0072359]; DNA damage response [GO:0006974]; embryonic neurocranium morphogenesis [GO:0048702]; eye development [GO:0001654]; hair cell differentiation [GO:0035315]; heart looping [GO:0001947]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cytoplasmic translation [GO:2000766]; otic vesicle development [GO:0071599]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of skeletal muscle fiber differentiation [GO:1902811]; positive regulation of stem cell differentiation [GO:2000738]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA stability [GO:0043488]; regulation of myotube differentiation [GO:0010830]; regulation of sarcomere organization [GO:0060297]; RNA splicing [GO:0008380]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0030154; GO:0043226; GO:0048856,RNA binding; nucleus; cytosol; mRNA metabolic process; cell differentiation; organelle; anatomical structure development
OG_07119,FUN_032403-T1,Peve_00013358,Pocillopora_meandrina_HIv1___RNAseq.g29838.t1,three_way,44.5025,FUN_032403-T1,Q9QXX0,JAG1_MOUSE,,Protein jagged-1 (Jagged1) (CD antigen CD339),Mus musculus (Mouse),48.2,56.0,4.7e-07,57.0,sp|Q9QXX0|JAG1_MOUSE Protein jagged-1 OS=Mus musculus OX=10090 GN=Jag1 PE=1 SV=1,GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003184; GO:0003215; GO:0005112; GO:0005509; GO:0005543; GO:0005886; GO:0005912; GO:0007219; GO:0009887; GO:0016324; GO:0022408; GO:0030182; GO:0030336; GO:0032495; GO:0035909; GO:0042491; GO:0043010; GO:0045177; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0048839; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737,animal organ morphogenesis [GO:0009887]; aorta morphogenesis [GO:0035909]; blood vessel remodeling [GO:0001974]; camera-type eye development [GO:0043010]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear development [GO:0048839]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation [GO:0050678]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; molecular adaptor activity [GO:0060090]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543],GO:0002376; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0048856; GO:0060090,immune system process; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; anatomical structure development; molecular adaptor activity
OG_07120,FUN_032405-T1,Peve_00009164,Pocillopora_meandrina_HIv1___RNAseq.g29839.t1,three_way,82.7025,FUN_032405-T1,Q6GNS3,,,,,57.4,509.0,6.3000000000000005e-168,592.0,sp|Q6GNS3|NMD3_XENLA 60S ribosomal export protein NMD3 OS=Xenopus laevis OX=8355 GN=nmd3 PE=2 SV=1,,,,,,
OG_07121,FUN_032420-T1,Peve_00041753,Pocillopora_meandrina_HIv1___RNAseq.g24395.t1,three_way,71.22583333333333,,,,,,,,,,,,,,,,,
OG_07122,FUN_032421-T1,Peve_00009160,Pocillopora_meandrina_HIv1___RNAseq.g29847.t1,three_way,76.65833333333333,FUN_032421-T1,Q6DEY1,,,,,33.8,240.0,8.100000000000001e-28,125.6,sp|Q6DEY1|SPF30_XENTR Survival of motor neuron-related-splicing factor 30 OS=Xenopus tropicalis OX=8364 GN=smndc1 PE=2 SV=1,,,,,,
OG_07123,FUN_032422-T1,Peve_00009161,Pocillopora_meandrina_HIv1___RNAseq.g21126.t1,three_way,56.91133333333333,,,,,,,,,,,,,,,,,
OG_07124,FUN_032423-T1,Peve_00009162,Pocillopora_meandrina_HIv1___RNAseq.g29841.t1,three_way,74.066,FUN_032423-T1,Q8N3Y7,RDHE2_HUMAN,,Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5),Homo sapiens (Human),43.0,284.0,2.1e-62,240.7,sp|Q8N3Y7|RDHE2_HUMAN Epidermal retinol dehydrogenase 2 OS=Homo sapiens OX=9606 GN=SDR16C5 PE=1 SV=2,GO:0000122; GO:0000785; GO:0003714; GO:0004745; GO:0005634; GO:0005789; GO:0005811; GO:0017053; GO:0042572; GO:0042574; GO:0043616; GO:0045814; GO:0061629; GO:0140297,"keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]",chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005811; GO:0006325; GO:0006355; GO:0006629; GO:0016491; GO:0043226; GO:0060090; GO:0140110,catalytic activity; nucleus; lipid droplet; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; oxidoreductase activity; organelle; molecular adaptor activity; transcription regulator activity
OG_07125,FUN_032425-T1,Peve_00007852,Pocillopora_meandrina_HIv1___RNAseq.g29732.t1,three_way,72.82133333333334,FUN_032425-T1,Q90YB1,,,,,48.1,909.0,1.2000000000000002e-246,854.4,sp|Q90YB1|DNLI4_CHICK DNA ligase 4 OS=Gallus gallus OX=9031 GN=LIG4 PE=2 SV=2,,,,,,
OG_07126,FUN_032426-T1,Peve_00007846,Pocillopora_meandrina_HIv1___TS.g24984.t1,three_way,72.67033333333333,FUN_032426-T1,Q9CPV7,ZDHC6_MOUSE,,Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Stearoyltransferase ZDHHC6) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 6) (DHHC-6),Mus musculus (Mouse),41.0,161.0,6.6e-23,109.0,sp|Q9CPV7|ZDHC6_MOUSE Palmitoyltransferase ZDHHC6 OS=Mus musculus OX=10090 GN=Zdhhc6 PE=1 SV=1,GO:0005783; GO:0005789; GO:0010636; GO:0016409; GO:0018345; GO:0019706; GO:0140438; GO:0140439,positive regulation of mitochondrial fusion [GO:0010636]; protein palmitoylation [GO:0018345]; protein stearoylation [GO:0140438],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439],GO:0003824; GO:0005783; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07127,FUN_032427-T1,Peve_00027370,Pocillopora_meandrina_HIv1___RNAseq.g24120.t1,three_way,71.50633333333333,FUN_032427-T1,Q5U2W5,,,,,53.6,806.0,3e-171,604.0,sp|Q5U2W5|TBL3_RAT Transducin beta-like protein 3 OS=Rattus norvegicus OX=10116 GN=Tbl3 PE=2 SV=1,,,,,,
OG_07128,FUN_032428-T1,Peve_00007849,Pocillopora_meandrina_HIv1___RNAseq.g24119.t1,three_way,84.269,FUN_032428-T1,P14148,RL7_MOUSE,,Large ribosomal subunit protein uL30 (60S ribosomal protein L7),Mus musculus (Mouse),78.3,180.0,4.8e-79,295.8,sp|P14148|RL7_MOUSE Large ribosomal subunit protein uL30 OS=Mus musculus OX=10090 GN=Rpl7 PE=1 SV=2,GO:0000463; GO:0002181; GO:0003677; GO:0003729; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0006412; GO:0022625; GO:0042802; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242; GO:1990904,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation [GO:0006412]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202],DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003677; GO:0003723; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; DNA binding; RNA binding; structural molecule activity; cytosol; ribosome; organelle
OG_07129,FUN_032429-T1,Peve_00027369,Pocillopora_meandrina_HIv1___RNAseq.g24121.t1,three_way,86.55766666666666,FUN_032429-T1,O95847,UCP4_HUMAN,,Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27),Homo sapiens (Human),60.4,303.0,4.3e-103,375.9,sp|O95847|UCP4_HUMAN Mitochondrial uncoupling protein 4 OS=Homo sapiens OX=9606 GN=SLC25A27 PE=1 SV=1,GO:0005739; GO:0005743; GO:0008284; GO:0009409; GO:0010917; GO:0015078; GO:0015108; GO:0022857; GO:0031966; GO:0035356; GO:0042803; GO:0043025; GO:0043524; GO:0045177; GO:0046324; GO:0048839; GO:0051562,inner ear development [GO:0048839]; intracellular triglyceride homeostasis [GO:0035356]; negative regulation of mitochondrial calcium ion concentration [GO:0051562]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; regulation of D-glucose import [GO:0046324]; response to cold [GO:0009409],apical part of cell [GO:0045177]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025],chloride transmembrane transporter activity [GO:0015108]; protein homodimerization activity [GO:0042803]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005739; GO:0043226; GO:0048856,transporter activity; mitochondrion; organelle; anatomical structure development
OG_07130,FUN_032431-T1,Peve_00038720,Pocillopora_meandrina_HIv1___TS.g12074.t1,three_way,81.645,FUN_032431-T1,Q61749,,,,,59.4,377.0,1e-115,418.7,sp|Q61749|EI2BD_MOUSE Translation initiation factor eIF2B subunit delta OS=Mus musculus OX=10090 GN=Eif2b4 PE=1 SV=2,,,,,,
OG_07131,FUN_032432-T1,Peve_00038723,Pocillopora_meandrina_HIv1___RNAseq.g24125.t1,three_way,82.28133333333334,FUN_032432-T1,Q7ZWG6,PCFT_DANRE,,Proton-coupled folate transporter (Solute carrier family 46 member 1),Danio rerio (Zebrafish) (Brachydanio rerio),32.3,431.0,5.6e-52,206.8,sp|Q7ZWG6|PCFT_DANRE Proton-coupled folate transporter OS=Danio rerio OX=7955 GN=slc46a1 PE=2 SV=1,GO:0005542; GO:0005768; GO:0005886; GO:0010008; GO:0015293; GO:0015350; GO:0016323; GO:0016324; GO:0022857; GO:0055085,transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endosome [GO:0005768]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; methotrexate transmembrane transporter activity [GO:0015350]; symporter activity [GO:0015293]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_07132,FUN_032433-T1,Peve_00038721,Pocillopora_meandrina_HIv1___RNAseq.g20796.t1b,three_way,50.24216666666667,FUN_032433-T1,Q12789,TF3C1_HUMAN,,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),Homo sapiens (Human),25.0,1605.0,2.7e-101,372.9,sp|Q12789|TF3C1_HUMAN General transcription factor 3C polypeptide 1 OS=Homo sapiens OX=9606 GN=GTF3C1 PE=1 SV=4,GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0005730; GO:0006383; GO:0006384; GO:0009303; GO:0009304; GO:0016020; GO:0042791; GO:0042797; GO:1990904,5S class rRNA transcription by RNA polymerase III [GO:0042791]; rRNA transcription [GO:0009303]; transcription by RNA polymerase III [GO:0006383]; transcription initiation at RNA polymerase III promoter [GO:0006384]; tRNA transcription [GO:0009304]; tRNA transcription by RNA polymerase III [GO:0042797],membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; transcription factor TFIIIC complex [GO:0000127],DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995],GO:0003677; GO:0005654; GO:0005730; GO:0006351; GO:0006399; GO:0043226; GO:0140223,DNA binding; nucleoplasm; nucleolus; DNA-templated transcription; tRNA metabolic process; organelle; general transcription initiation factor activity
OG_07133,FUN_032435-T1,Peve_00020056,Pocillopora_meandrina_HIv1___RNAseq.g24659.t1,three_way,54.922666666666665,FUN_032435-T1,Q91X17,UROM_MOUSE,,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",Mus musculus (Mouse),46.6,118.0,4.0000000000000004e-23,110.5,sp|Q91X17|UROM_MOUSE Uromodulin OS=Mus musculus OX=10090 GN=Umod PE=1 SV=1,GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033554; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266,antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to stress [GO:0033554]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509]; IgG binding [GO:0019864],GO:0002376; GO:0003014; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007155; GO:0012501; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0061024; GO:0098542,immune system process; renal system process; extracellular space; endoplasmic reticulum; plasma membrane; cilium; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; cell adhesion; programmed cell death; protein catabolic process; organelle; anatomical structure development; cell motility; transmembrane transport; membrane organization; defense response to other organism
OG_07134,FUN_032459-T1,Peve_00009149,Pocillopora_meandrina_HIv1___RNAseq.g24151.t1,three_way,75.24633333333333,,,,,,,,,,,,,,,,,
OG_07135,FUN_032460-T1,Peve_00009148,Pocillopora_meandrina_HIv1___RNAseq.g24152.t1,three_way,86.11133333333333,FUN_032460-T1,P29410,,,,,72.2,216.0,4e-89,329.3,"sp|P29410|KAD2_RAT Adenylate kinase 2, mitochondrial OS=Rattus norvegicus OX=10116 GN=Ak2 PE=2 SV=2",,,,,,
OG_07136,FUN_032461-T1,Peve_00009147,Pocillopora_meandrina_HIv1___RNAseq.g24160.t1,three_way,52.884,FUN_032461-T1,G5ECX0,LPLT2_CAEEL,,Latrophilin-like protein LAT-2,Caenorhabditis elegans,35.2,369.0,3.4e-52,208.0,sp|G5ECX0|LPLT2_CAEEL Latrophilin-like protein LAT-2 OS=Caenorhabditis elegans OX=6239 GN=lat-2 PE=2 SV=1,GO:0004175; GO:0004930; GO:0005886; GO:0007166; GO:0030246; GO:0097264,cell surface receptor signaling pathway [GO:0007166]; self proteolysis [GO:0097264],plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930],GO:0003824; GO:0005886; GO:0016787; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_07137,FUN_032463-T1,Peve_00009181,Pocillopora_meandrina_HIv1___TS.g12109.t1,three_way,56.84433333333333,,,,,,,,,,,,,,,,,
OG_07138,FUN_032464-T1,Peve_00009180,Pocillopora_meandrina_HIv1___TS.g12111.t1,three_way,65.44783333333334,FUN_032464-T1,E1BB03,ZRAB3_BOVIN,,DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)],Bos taurus (Bovine),45.5,521.0,7.4999999999999995e-115,416.0,sp|E1BB03|ZRAB3_BOVIN DNA annealing helicase and endonuclease ZRANB3 OS=Bos taurus OX=9913 GN=ZRANB3 PE=3 SV=3,GO:0004386; GO:0004520; GO:0005524; GO:0006281; GO:0006974; GO:0008270; GO:0009411; GO:0031297; GO:0036310; GO:0043596; GO:0070530,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; replication fork processing [GO:0031297]; response to UV [GO:0009411],nuclear replication fork [GO:0043596],ATP binding [GO:0005524]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA endonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0006281; GO:0016853; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA repair; isomerase activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07139,FUN_032467-T1,Peve_00009179,Pocillopora_meandrina_HIv1___RNAseq.g24169.t1,three_way,67.812,,,,,,,,,,,,,,,,,
OG_07140,FUN_032468-T1,Peve_00006862,Pocillopora_meandrina_HIv1___TS.g12113.t1,three_way,56.82333333333333,FUN_032468-T1,C3ZQF9,,,,,30.1,292.0,9.6e-25,115.5,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_07141,FUN_032469-T1,Peve_00009178,Pocillopora_meandrina_HIv1___RNAseq.g24170.t1,three_way,60.356,,,,,,,,,,,,,,,,,
OG_07142,FUN_032470-T1,Peve_00009176,Pocillopora_meandrina_HIv1___RNAseq.g24172.t1,three_way,42.879,,,,,,,,,,,,,,,,,
OG_07143,FUN_032471-T1,Peve_00009175,Pocillopora_meandrina_HIv1___RNAseq.g24174.t1,three_way,40.74066666666667,,,,,,,,,,,,,,,,,
OG_07144,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_07145,FUN_032477-T1,Peve_00041760,Pocillopora_meandrina_HIv1___RNAseq.g24343.t1,three_way,81.312,FUN_032477-T1,Q6DGE9,UN45B_DANRE,,Protein unc-45 homolog B (Unc-45B) (UNC45-related protein),Danio rerio (Zebrafish) (Brachydanio rerio),36.6,929.0,1.9e-165,584.7,sp|Q6DGE9|UN45B_DANRE Protein unc-45 homolog B OS=Danio rerio OX=7955 GN=unc45b PE=1 SV=2,GO:0002088; GO:0005737; GO:0007519; GO:0030018; GO:0030239; GO:0031672; GO:0048471; GO:0048738; GO:0051879; GO:0055001; GO:0055002; GO:0060538; GO:0061077,cardiac muscle tissue development [GO:0048738]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle cell development [GO:0055001]; myofibril assembly [GO:0030239]; skeletal muscle organ development [GO:0060538]; skeletal muscle tissue development [GO:0007519]; striated muscle cell development [GO:0055002],A band [GO:0031672]; cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018],Hsp90 protein binding [GO:0051879],GO:0007010; GO:0048856,cytoskeleton organization; anatomical structure development
OG_07146,FUN_032479-T1,Peve_00041757,Pocillopora_meandrina_HIv1___RNAseq.g24342.t1,three_way,65.62533333333333,,,,,,,,,,,,,,,,,
OG_07147,FUN_032482-T1,Peve_00045320,Pocillopora_meandrina_HIv1___RNAseq.g24339.t1,three_way,75.098,FUN_032482-T1,Q866A2,,,,,39.7,312.0,4.7e-52,206.5,sp|Q866A2|ACHA7_MACMU Neuronal acetylcholine receptor subunit alpha-7 OS=Macaca mulatta OX=9544 GN=CHRNA7 PE=2 SV=1,,,,,,
OG_07148,FUN_032489-T1,Peve_00045330,Pocillopora_meandrina_HIv1___RNAseq.g24337.t1,three_way,74.5735,FUN_032489-T1,O76387,,,,,37.8,196.0,2.9e-27,123.6,sp|O76387|PTH2_CAEEL Probable peptidyl-tRNA hydrolase 2 OS=Caenorhabditis elegans OX=6239 GN=C24G6.8 PE=3 SV=1,,,,,,
OG_07149,FUN_032502-T1,Peve_00042406,Pocillopora_meandrina_HIv1___RNAseq.g24323.t1,three_way,42.0895,,,,,,,,,,,,,,,,,
OG_07150,FUN_032503-T1,Peve_00042404,Pocillopora_meandrina_HIv1___TS.g12263.t1,three_way,58.67733333333334,FUN_032503-T1,Q20191,,,,,47.1,204.0,5.400000000000001e-44,181.0,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_07151,FUN_032520-T1,Peve_00000679,Pocillopora_meandrina_HIv1___RNAseq.g24739.t1,three_way,55.748,,,,,,,,,,,,,,,,,
OG_07152,FUN_032525-T1,Peve_00000684,Pocillopora_meandrina_HIv1___RNAseq.g24736.t1b,three_way,45.146166666666666,,,,,,,,,,,,,,,,,
OG_07153,FUN_032526-T1,Peve_00000682,Pocillopora_meandrina_HIv1___RNAseq.g24734.t1,three_way,53.52583333333333,,,,,,,,,,,,,,,,,
OG_07154,FUN_032533-T1,Peve_00000693,Pocillopora_meandrina_HIv1___RNAseq.g24729.t1,three_way,83.166,FUN_032533-T1,Q55CD9,,,,,47.7,413.0,1.2e-101,371.7,sp|Q55CD9|NDH_DICDI Probable NADH dehydrogenase OS=Dictyostelium discoideum OX=44689 GN=DDB_G0270104 PE=3 SV=2,,,,,,
OG_07155,FUN_032535-T1,Peve_00000696,Pocillopora_meandrina_HIv1___RNAseq.g24726.t1,three_way,79.178,FUN_032535-T1,Q8K4L0,,,,,50.9,807.0,2.5000000000000007e-201,703.7,sp|Q8K4L0|DDX54_MOUSE ATP-dependent RNA helicase DDX54 OS=Mus musculus OX=10090 GN=Ddx54 PE=1 SV=1,,,,,,
OG_07156,FUN_032537-T1,Peve_00029251,Pocillopora_meandrina_HIv1___RNAseq.g18699.t1,three_way,53.31433333333334,FUN_032537-T1,Q13585,MTR1L_HUMAN,,Melatonin-related receptor (G protein-coupled receptor 50) (H9) [Cleaved into: C-terminal domain],Homo sapiens (Human),24.8,303.0,6.5e-11,70.1,sp|Q13585|MTR1L_HUMAN Melatonin-related receptor OS=Homo sapiens OX=9606 GN=GPR50 PE=1 SV=3,GO:0004930; GO:0005654; GO:0005886; GO:0007186; GO:0007267; GO:0008502; GO:0014069,cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186],nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],G protein-coupled receptor activity [GO:0004930]; melatonin receptor activity [GO:0008502],GO:0005654; GO:0005886; GO:0023052; GO:0043226; GO:0060089,nucleoplasm; plasma membrane; signaling; organelle; molecular transducer activity
OG_07157,FUN_032542-T1,Peve_00000698,Pocillopora_meandrina_HIv1___TS.g12666.t1,three_way,53.22266666666667,FUN_032542-T1,Q6P4Y6,,,,,31.6,465.0,2.0000000000000003e-48,195.7,sp|Q6P4Y6|IRS1_XENTR Insulin receptor substrate 1 OS=Xenopus tropicalis OX=8364 GN=irs1 PE=2 SV=1,,,,,,
OG_07158,FUN_032568-T1,Peve_00000699,Pocillopora_meandrina_HIv1___RNAseq.g24716.t1b,three_way,85.37066666666666,FUN_032568-T1,F1M8G0,,,,,33.0,764.0,2.5e-102,374.4,sp|F1M8G0|PHTF1_RAT Protein PHTF1 OS=Rattus norvegicus OX=10116 GN=Phtf1 PE=1 SV=1,,,,,,
OG_07159,FUN_032569-T1,Peve_00000700,Pocillopora_meandrina_HIv1___RNAseq.g24716.t1a,three_way,75.09,FUN_032569-T1,Q5FWL4,EST2A_XENLA,,Extended synaptotagmin-2-A (E-Syt2-A),Xenopus laevis (African clawed frog),28.4,855.0,1.4000000000000001e-89,332.4,sp|Q5FWL4|EST2A_XENLA Extended synaptotagmin-2-A OS=Xenopus laevis OX=8355 GN=esyt2-a PE=2 SV=1,GO:0005509; GO:0005544; GO:0005789; GO:0006869; GO:0006897; GO:0008429; GO:0009898; GO:0031210; GO:0035091; GO:0044232; GO:0061817; GO:0140268,endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; organelle membrane contact site [GO:0044232],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091],GO:0008289; GO:0016192,lipid binding; vesicle-mediated transport
OG_07160,FUN_032571-T1,Peve_00000701,Pocillopora_meandrina_HIv1___RNAseq.g24714.t1,three_way,68.33,FUN_032571-T1,O95497,VNN1_HUMAN,,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1),Homo sapiens (Human),45.2,496.0,7.1e-112,406.0,sp|O95497|VNN1_HUMAN Pantetheinase OS=Homo sapiens OX=9606 GN=VNN1 PE=1 SV=2,GO:0002526; GO:0002544; GO:0005576; GO:0005886; GO:0006954; GO:0006979; GO:0015938; GO:0015939; GO:0016020; GO:0017159; GO:0033089; GO:0035577; GO:0045087; GO:0098552; GO:0098609; GO:1902177,acute inflammatory response [GO:0002526]; cell-cell adhesion [GO:0098609]; chronic inflammatory response [GO:0002544]; coenzyme A catabolic process [GO:0015938]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pantothenate metabolic process [GO:0015939]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of T cell differentiation in thymus [GO:0033089]; response to oxidative stress [GO:0006979],azurophil granule membrane [GO:0035577]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],pantetheine hydrolase activity [GO:0017159],GO:0002376; GO:0003824; GO:0005576; GO:0005886; GO:0006575; GO:0006790; GO:0006954; GO:0007155; GO:0016787; GO:0055086; GO:0098542,immune system process; catalytic activity; extracellular region; plasma membrane; modified amino acid metabolic process; sulfur compound metabolic process; inflammatory response; cell adhesion; hydrolase activity; nucleobase-containing small molecule metabolic process; defense response to other organism
OG_07161,FUN_032573-T1,Peve_00020057,Pocillopora_meandrina_HIv1___RNAseq.g24657.t1,three_way,46.22766666666666,FUN_032573-T1,Q90876,,,,,34.0,153.0,5.600000000000001e-23,109.4,sp|Q90876|IRF1_CHICK Interferon regulatory factor 1 OS=Gallus gallus OX=9031 GN=IRF1 PE=2 SV=1,,,,,,
OG_07162,FUN_032574-T1,Peve_00020059,Pocillopora_meandrina_HIv1___RNAseq.g24656.t1,three_way,65.90716666666667,FUN_032574-T1,P23906,,,,,51.3,117.0,2.4e-35,150.6,sp|P23906|IRF2_MOUSE Interferon regulatory factor 2 OS=Mus musculus OX=10090 GN=Irf2 PE=1 SV=1,,,,,,
OG_07163,FUN_032580-T1,Peve_00020061,Pocillopora_meandrina_HIv1___RNAseq.g24653.t1,three_way,70.88866666666667,FUN_032580-T1,Q6DIV2,,,,,43.3,457.0,2.1e-114,414.1,sp|Q6DIV2|TTC38_XENTR Tetratricopeptide repeat protein 38 OS=Xenopus tropicalis OX=8364 GN=ttc38 PE=2 SV=1,,,,,,
OG_07164,FUN_032581-T1,Peve_00018742,Pocillopora_meandrina_HIv1___RNAseq.g24647.t1,three_way,91.33833333333334,FUN_032581-T1,A7MBJ5,,,,,69.8,1242.0,0.0,1598.6,sp|A7MBJ5|CAND1_BOVIN Cullin-associated NEDD8-dissociated protein 1 OS=Bos taurus OX=9913 GN=CAND1 PE=2 SV=1,,,,,,
OG_07165,FUN_032583-T1,Peve_00026847,Pocillopora_meandrina_HIv1___RNAseq.g24648.t1,three_way,42.123333333333335,,,,,,,,,,,,,,,,,
OG_07166,FUN_032584-T1,Peve_00024132,Pocillopora_meandrina_HIv1___TS.g12593.t1,three_way,79.44666666666666,FUN_032584-T1,A3KPN8,,,,,50.9,456.0,4.1e-137,489.6,sp|A3KPN8|TTC38_DANRE Tetratricopeptide repeat protein 38 OS=Danio rerio OX=7955 GN=ttc38 PE=3 SV=1,,,,,,
OG_07167,FUN_032602-T1,Peve_00001527,Pocillopora_meandrina_HIv1___RNAseq.g24628.t1,three_way,85.47983333333333,FUN_032602-T1,Q9Y2J2,E41L3_HUMAN,,"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]",Homo sapiens (Human),51.7,348.0,4e-95,349.7,sp|Q9Y2J2|E41L3_HUMAN Band 4.1-like protein 3 OS=Homo sapiens OX=9606 GN=EPB41L3 PE=1 SV=2,GO:0002175; GO:0003779; GO:0005200; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005929; GO:0006915; GO:0008360; GO:0030054; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0036064; GO:0043217; GO:0044224; GO:0048812; GO:0071205; GO:0072659; GO:0098696; GO:0098794; GO:0098978; GO:0106006,actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696],cell junction [GO:0030054]; cell-cell junction [GO:0005911]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],actin binding [GO:0003779]; cytoskeletal protein-membrane anchor activity [GO:0106006]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007010; GO:0008092; GO:0012501; GO:0034330; GO:0043226; GO:0060090; GO:0061024; GO:0072659,structural molecule activity; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeleton organization; cytoskeletal protein binding; programmed cell death; cell junction organization; organelle; molecular adaptor activity; membrane organization; protein localization to plasma membrane
OG_07168,FUN_032603-T1,Peve_00001522,Pocillopora_meandrina_HIv1___RNAseq.g24627.t1,three_way,61.717666666666666,FUN_032603-T1,Q8NFZ3,,,,,34.2,588.0,2.8e-77,291.2,"sp|Q8NFZ3|NLGNY_HUMAN Neuroligin-4, Y-linked OS=Homo sapiens OX=9606 GN=NLGN4Y PE=1 SV=1",,,,,,
OG_07169,FUN_032604-T1,Peve_00021803,Pocillopora_meandrina_HIv1___RNAseq.g24617.t1,three_way,56.25416666666666,FUN_032604-T1,Q17895,,,,,83.3,30.0,5.8e-06,53.9,sp|Q17895|MNM2_CAEEL Zinc finger protein mnm-2 OS=Caenorhabditis elegans OX=6239 GN=mnm-2 PE=1 SV=2,,,,,,
OG_07170,FUN_032605-T1,Peve_00028661,Pocillopora_meandrina_HIv1___RNAseq.g24618.t1,three_way,77.81633333333333,FUN_032605-T1,Q13535,,,,,40.7,2731.0,0.0,1912.9,sp|Q13535|ATR_HUMAN Serine/threonine-protein kinase ATR OS=Homo sapiens OX=9606 GN=ATR PE=1 SV=3,,,,,,
OG_07171,FUN_032607-T1,Peve_00030641,Pocillopora_meandrina_HIv1___RNAseq.g29785.t1,three_way,97.002,FUN_032607-T1,O00487,PSDE_HUMAN,,26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1),Homo sapiens (Human),89.8,265.0,1e-135,484.2,sp|O00487|PSDE_HUMAN 26S proteasome non-ATPase regulatory subunit 14 OS=Homo sapiens OX=9606 GN=PSMD14 PE=1 SV=1,GO:0000502; GO:0000724; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006303; GO:0006511; GO:0008237; GO:0008541; GO:0016579; GO:0022624; GO:0031597; GO:0034774; GO:0043161; GO:0045471; GO:0046872; GO:0061133; GO:0061136; GO:0061578; GO:0070536; GO:0070628; GO:0140492; GO:1904813,double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; regulation of proteasomal protein catabolic process [GO:0061136]; response to ethanol [GO:0045471]; ubiquitin-dependent protein catabolic process [GO:0006511],"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, lid subcomplex [GO:0008541]; secretory granule lumen [GO:0034774]",endopeptidase activator activity [GO:0061133]; K63-linked deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metal-dependent deubiquitinase activity [GO:0140492]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628],GO:0003824; GO:0005576; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; extracellular region; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07172,FUN_032609-T1,Peve_00030642,Pocillopora_meandrina_HIv1___RNAseq.g29786.t1,three_way,72.363,FUN_032609-T1,P52272,HNRPM_HUMAN,,Heterogeneous nuclear ribonucleoprotein M (hnRNP M),Homo sapiens (Human),36.5,255.0,1.0000000000000001e-34,149.4,sp|P52272|HNRPM_HUMAN Heterogeneous nuclear ribonucleoprotein M OS=Homo sapiens OX=9606 GN=HNRNPM PE=1 SV=3,GO:0000380; GO:0000398; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005681; GO:0005730; GO:0016020; GO:0016363; GO:0019904; GO:0042382; GO:0045202; GO:0062023; GO:0070062; GO:0071013,"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; spliceosomal complex [GO:0005681]; synapse [GO:0045202],mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; nucleolus; mRNA metabolic process; organelle
OG_07173,FUN_032611-T1,Peve_00026810,Pocillopora_meandrina_HIv1___RNAseq.g29794.t1,three_way,66.65333333333334,FUN_032611-T1,P23359,BMP7_MOUSE,,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1),Mus musculus (Mouse),42.2,393.0,4.2e-78,293.5,sp|P23359|BMP7_MOUSE Bone morphogenetic protein 7 OS=Mus musculus OX=10090 GN=Bmp7 PE=1 SV=2,GO:0001649; GO:0001654; GO:0001657; GO:0001707; GO:0001822; GO:0003272; GO:0003344; GO:0005125; GO:0005615; GO:0007389; GO:0007411; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008285; GO:0009880; GO:0009887; GO:0010628; GO:0010718; GO:0021502; GO:0030326; GO:0030501; GO:0030509; GO:0030855; GO:0030858; GO:0030902; GO:0031982; GO:0032355; GO:0033280; GO:0034116; GO:0035239; GO:0036305; GO:0042475; GO:0043065; GO:0043434; GO:0043539; GO:0045665; GO:0045666; GO:0045669; GO:0045746; GO:0045839; GO:0045892; GO:0045893; GO:0045944; GO:0048468; GO:0048593; GO:0048596; GO:0048646; GO:0048738; GO:0048754; GO:0048762; GO:0048812; GO:0050768; GO:0051216; GO:0060037; GO:0060272; GO:0060391; GO:0060411; GO:0060445; GO:0060485; GO:0060686; GO:0060687; GO:0060710; GO:0061384; GO:0070487; GO:0070700; GO:0072040; GO:0072125; GO:0072133; GO:0072134; GO:0072136; GO:0090336; GO:1900006; GO:1900106; GO:1901145; GO:1905069; GO:1905312,allantois development [GO:1905069]; ameloblast differentiation [GO:0036305]; anatomical structure formation involved in morphogenesis [GO:0048646]; animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cell development [GO:0048468]; cell population proliferation [GO:0008283]; chorio-allantoic fusion [GO:0060710]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; eye development [GO:0001654]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:1901145]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; monocyte aggregation [GO:0070487]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of prostatic bud formation [GO:0060686]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; vesicle [GO:0031982],BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005615; GO:0006355; GO:0007155; GO:0012501; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell adhesion; programmed cell death; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_07174,FUN_032613-T1,Peve_00026811,Pocillopora_meandrina_HIv1___RNAseq.g29793.t1,three_way,59.45166666666667,,,,,,,,,,,,,,,,,
OG_07175,FUN_032614-T1,Peve_00026809,Pocillopora_meandrina_HIv1___RNAseq.g29792.t1,three_way,69.88433333333333,,,,,,,,,,,,,,,,,
OG_07176,FUN_032616-T1,Peve_00033688,Pocillopora_meandrina_HIv1___RNAseq.g29791.t1,three_way,53.149,FUN_032616-T1,Q17QK8,,,,,39.5,261.0,9.6e-43,175.3,sp|Q17QK8|SPRE_BOVIN Sepiapterin reductase OS=Bos taurus OX=9913 GN=SPR PE=2 SV=1,,,,,,
OG_07177,FUN_032628-T1,Peve_00033703,Pocillopora_meandrina_HIv1___RNAseq.g29789.t1,three_way,82.41583333333334,FUN_032628-T1,Q9EQW7,KI13A_MOUSE,,Kinesin-like protein KIF13A,Mus musculus (Mouse),47.9,1454.0,0.0,1170.6,sp|Q9EQW7|KI13A_MOUSE Kinesin-like protein KIF13A OS=Mus musculus OX=10090 GN=Kif13a PE=1 SV=1,GO:0000139; GO:0003777; GO:0005524; GO:0005813; GO:0005874; GO:0006886; GO:0008017; GO:0008333; GO:0010008; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383,cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459],centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0006886; GO:0007018; GO:0008092; GO:0016192; GO:0016853; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; protein localization to plasma membrane; ATP-dependent activity
OG_07178,FUN_032629-T1,Peve_00033684,Pocillopora_meandrina_HIv1___RNAseq.g24118.t1,three_way,65.04233333333333,FUN_032629-T1,Q91175,,,,,32.9,316.0,2.3000000000000002e-33,144.4,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_07179,FUN_032632-T1,Peve_00033689,Pocillopora_meandrina_HIv1___RNAseq.g24117.t1,three_way,60.99433333333333,FUN_032632-T1,Q5ZIJ9,,,,,45.3,1029.0,1.5e-112,409.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_07180,FUN_032633-T1,Peve_00033698,Pocillopora_meandrina_HIv1___RNAseq.g24116.t1,three_way,50.065666666666665,,,,,,,,,,,,,,,,,
OG_07181,FUN_032636-T1,Peve_00033699,Pocillopora_meandrina_HIv1___TS.g12060.t1,three_way,41.117,,,,,,,,,,,,,,,,,
OG_07182,FUN_032637-T1,Peve_00033700,Pocillopora_meandrina_HIv1___RNAseq.g24114.t1,three_way,72.59783333333333,FUN_032637-T1,Q9QYI4,,,,,42.2,384.0,3.8e-69,263.5,sp|Q9QYI4|DJB12_MOUSE DnaJ homolog subfamily B member 12 OS=Mus musculus OX=10090 GN=Dnajb12 PE=1 SV=2,,,,,,
OG_07183,FUN_032641-T1,Peve_00015953,Pocillopora_meandrina_HIv1___RNAseq.g24113.t1,three_way,69.64766666666667,FUN_032641-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),31.4,2239.0,9.5e-255,882.9,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_07184,FUN_032644-T1,Peve_00008492,Pocillopora_meandrina_HIv1___RNAseq.g3844.t2,three_way,66.17416666666666,,,,,,,,,,,,,,,,,
OG_07185,FUN_032676-T1,Peve_00015960,Pocillopora_meandrina_HIv1___RNAseq.g24112.t1,three_way,78.02799999999999,FUN_032676-T1,Q4KMZ8,NKAI1_HUMAN,,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 1) (Protein FAM77C),Homo sapiens (Human),45.9,205.0,1.6e-45,184.1,sp|Q4KMZ8|NKAI1_HUMAN Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 OS=Homo sapiens OX=9606 GN=NKAIN1 PE=2 SV=3,GO:0002028; GO:0005886; GO:0051117,regulation of sodium ion transport [GO:0002028],plasma membrane [GO:0005886],ATPase binding [GO:0051117],GO:0005886,plasma membrane
OG_07186,FUN_032677-T1,Peve_00015961,Pocillopora_meandrina_HIv1___RNAseq.g24111.t1,three_way,50.2185,FUN_032677-T1,Q9D361,,,,,41.7,151.0,6.1e-15,83.6,sp|Q9D361|SNR48_MOUSE U11/U12 small nuclear ribonucleoprotein 48 kDa protein OS=Mus musculus OX=10090 GN=Snrnp48 PE=2 SV=2,,,,,,
OG_07187,FUN_032678-T1,Peve_00015962,Pocillopora_meandrina_HIv1___RNAseq.g24110.t1,three_way,84.3185,FUN_032678-T1,Q9BRI3,ZNT2_HUMAN,,Proton-coupled zinc antiporter SLC30A2 (Solute carrier family 30 member 2) (Zinc transporter 2) (ZnT-2),Homo sapiens (Human),48.8,299.0,5.2e-77,290.0,sp|Q9BRI3|ZNT2_HUMAN Proton-coupled zinc antiporter SLC30A2 OS=Homo sapiens OX=9606 GN=SLC30A2 PE=1 SV=2,GO:0005385; GO:0005737; GO:0005743; GO:0005765; GO:0005770; GO:0005886; GO:0006882; GO:0010008; GO:0010043; GO:0030658; GO:0042589; GO:0042802; GO:0043231; GO:0046872; GO:0062111; GO:0071577; GO:0099503; GO:0140826; GO:0140882; GO:0140914; GO:0140915; GO:0140916; GO:0140917,intracellular zinc ion homeostasis [GO:0006882]; response to zinc ion [GO:0010043]; zinc export across plasma membrane [GO:0140882]; zinc ion import into lysosome [GO:0140916]; zinc ion import into mitochondrion [GO:0140917]; zinc ion import into organelle [GO:0062111]; zinc ion import into secretory vesicle [GO:0140914]; zinc ion import into zymogen granule [GO:0140915]; zinc ion transmembrane transport [GO:0071577],cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; secretory vesicle [GO:0099503]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_07188,FUN_032679-T1,Peve_00015963,Pocillopora_meandrina_HIv1___RNAseq.g24109.t1,three_way,79.57666666666667,FUN_032679-T1,A4L9J0,MIP_RABIT,,Lens fiber major intrinsic protein (Aquaporin-0),Oryctolagus cuniculus (Rabbit),39.3,229.0,3.4e-33,143.7,sp|A4L9J0|MIP_RABIT Lens fiber major intrinsic protein OS=Oryctolagus cuniculus OX=9986 GN=MIP PE=2 SV=1,GO:0002088; GO:0005212; GO:0005516; GO:0005886; GO:0006833; GO:0007601; GO:0015250; GO:0016324; GO:0034109; GO:0036438; GO:0070161; GO:0098631; GO:1990349,gap junction-mediated intercellular transport [GO:1990349]; homotypic cell-cell adhesion [GO:0034109]; lens development in camera-type eye [GO:0002088]; maintenance of lens transparency [GO:0036438]; visual perception [GO:0007601]; water transport [GO:0006833],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],calmodulin binding [GO:0005516]; cell adhesion mediator activity [GO:0098631]; structural constituent of eye lens [GO:0005212]; water channel activity [GO:0015250],GO:0005198; GO:0005215; GO:0005886; GO:0007155; GO:0048856; GO:0050877; GO:0098631,structural molecule activity; transporter activity; plasma membrane; cell adhesion; anatomical structure development; nervous system process; cell adhesion mediator activity
OG_07189,FUN_032681-T1,Peve_00015965,Pocillopora_meandrina_HIv1___TS.g12051.t1,three_way,86.97266666666667,FUN_032681-T1,Q9VQX4,,,,,62.7,542.0,8.799999999999999e-200,698.0,sp|Q9VQX4|PNCB_DROME Nicotinate phosphoribosyltransferase OS=Drosophila melanogaster OX=7227 GN=Naprt PE=2 SV=2,,,,,,
OG_07190,FUN_032683-T1,Peve_00015966,Pocillopora_meandrina_HIv1___RNAseq.g24105.t1,three_way,78.53933333333333,FUN_032683-T1,P38060,HMGCL_MOUSE,,"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)",Mus musculus (Mouse),71.4,105.0,2.3e-38,159.5,"sp|P38060|HMGCL_MOUSE Hydroxymethylglutaryl-CoA lyase, mitochondrial OS=Mus musculus OX=10090 GN=Hmgcl PE=1 SV=2",GO:0000287; GO:0004419; GO:0005198; GO:0005739; GO:0005743; GO:0005759; GO:0005777; GO:0007005; GO:0030145; GO:0032991; GO:0046872; GO:0046951,ketone body biosynthetic process [GO:0046951]; mitochondrion organization [GO:0007005],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991],hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198],GO:0003824; GO:0005198; GO:0005739; GO:0005777; GO:0006091; GO:0006629; GO:0007005; GO:0016829; GO:0043226,catalytic activity; structural molecule activity; mitochondrion; peroxisome; generation of precursor metabolites and energy; lipid metabolic process; mitochondrion organization; lyase activity; organelle
OG_07191,FUN_032685-T1,Peve_00029545,Pocillopora_meandrina_HIv1___RNAseq.g24103.t1,three_way,77.26916666666666,FUN_032685-T1,P70297,STAM1_MOUSE,,Signal transducing adapter molecule 1 (STAM-1),Mus musculus (Mouse),39.9,544.0,1.3e-75,285.4,sp|P70297|STAM1_MOUSE Signal transducing adapter molecule 1 OS=Mus musculus OX=10090 GN=Stam PE=1 SV=3,GO:0005829; GO:0015031; GO:0031901; GO:0033565; GO:0035091; GO:0043130; GO:0044389; GO:1903543; GO:1903551,positive regulation of exosomal secretion [GO:1903543]; protein transport [GO:0015031]; regulation of extracellular exosome assembly [GO:1903551],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565],phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; ubiquitin-like protein ligase binding [GO:0044389],GO:0005829; GO:0008289,cytosol; lipid binding
OG_07192,FUN_032690-T1,Peve_00006289,Pocillopora_meandrina_HIv1___RNAseq.g24100.t1,three_way,67.0185,FUN_032690-T1,Q9CPZ8,,,,,53.3,90.0,3.8e-21,102.4,sp|Q9CPZ8|COXM1_MOUSE COX assembly mitochondrial protein homolog OS=Mus musculus OX=10090 GN=Cmc1 PE=1 SV=1,,,,,,
OG_07193,FUN_032691-T1,Peve_00032993,Pocillopora_meandrina_HIv1___TS.g12044.t1,three_way,49.66816666666666,,,,,,,,,,,,,,,,,
OG_07194,FUN_032692-T1,Peve_00017799,Pocillopora_meandrina_HIv1___RNAseq.g5050.t1,three_way,78.03866666666667,FUN_032692-T1,Q8IWA6,,,,,28.3,173.0,2.3e-08,62.8,sp|Q8IWA6|CCD60_HUMAN Coiled-coil domain-containing protein 60 OS=Homo sapiens OX=9606 GN=CCDC60 PE=1 SV=2,,,,,,
OG_07195,FUN_032699-T1,Peve_00006288,Pocillopora_meandrina_HIv1___RNAseq.g29941.t1,three_way,87.00933333333333,FUN_032699-T1,Q8CJG0,AGO2_MOUSE,,Protein argonaute-2 (Argonaute2) (mAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Piwi/argonaute family protein meIF2C2) (Protein slicer),Mus musculus (Mouse),68.1,846.0,0.0,1192.9,sp|Q8CJG0|AGO2_MOUSE Protein argonaute-2 OS=Mus musculus OX=10090 GN=Ago2 PE=1 SV=3,GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0009791; GO:0010467; GO:0010586; GO:0010628; GO:0016442; GO:0030154; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0033962; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035925; GO:0043489; GO:0045727; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0090128; GO:0090624; GO:0090625; GO:0098794; GO:0098808; GO:0098978; GO:1900153; GO:1901165; GO:1990904,"cell differentiation [GO:0030154]; gene expression [GO:0010467]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of translational initiation [GO:0045947]; P-body assembly [GO:0033962]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of synapse maturation [GO:0090128]; regulatory ncRNA-mediated gene silencing [GO:0031047]; RISC complex assembly [GO:0070922]; RNA stabilization [GO:0043489]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578],"core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016787; GO:0030154; GO:0031047; GO:0043226; GO:0065003; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; protein-containing complex assembly; catalytic activity, acting on RNA"
OG_07196,FUN_032703-T1,Peve_00014080,Pocillopora_meandrina_HIv1___TS.g25192.t1,three_way,89.64,FUN_032703-T1,Q5ZMM5,,,,,61.1,72.0,3.7e-16,85.1,sp|Q5ZMM5|ZN706_CHICK Zinc finger protein 706 OS=Gallus gallus OX=9031 GN=ZNF706 PE=3 SV=1,,,,,,
OG_07197,FUN_032704-T1,Peve_00014081,Pocillopora_meandrina_HIv1___RNAseq.g29945.t1,three_way,85.25633333333333,FUN_032704-T1,Q7ZUX6,,,,,60.3,302.0,1e-96,354.8,sp|Q7ZUX6|DOHH_DANRE Deoxyhypusine hydroxylase OS=Danio rerio OX=7955 GN=dohh PE=2 SV=1,,,,,,
OG_07198,FUN_032706-T1,Peve_00029923,Pocillopora_meandrina_HIv1___RNAseq.g29870.t1,three_way,82.68833333333333,FUN_032706-T1,Q63ZI0,,,,,51.8,257.0,2.8e-65,250.4,sp|Q63ZI0|KCNK9_XENLA Potassium channel subfamily K member 9 OS=Xenopus laevis OX=8355 GN=kcnk9 PE=2 SV=1,,,,,,
OG_07199,FUN_032708-T1,Peve_00029922,Pocillopora_meandrina_HIv1___RNAseq.g29872.t1,three_way,49.76916666666667,,,,,,,,,,,,,,,,,
OG_07200,FUN_032709-T2,Peve_00029921,Pocillopora_meandrina_HIv1___RNAseq.g29873.t1,three_way,77.85433333333333,FUN_032709-T2,F1QB54,PABPA_DANRE,,Polyadenylate-binding protein 1A (PABP-1A) (Poly(A)-binding protein 1A),Danio rerio (Zebrafish) (Brachydanio rerio),58.9,628.0,1.1e-187,657.9,sp|F1QB54|PABPA_DANRE Polyadenylate-binding protein 1A OS=Danio rerio OX=7955 GN=pabpc1a PE=1 SV=1,GO:0003730; GO:0005634; GO:0005829; GO:0006397; GO:0006412; GO:0006417; GO:0007507; GO:0008143; GO:0008266; GO:0010494; GO:1990904,heart development [GO:0007507]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; translation [GO:0006412],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0048856,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; anatomical structure development
OG_07201,FUN_032734-T1,Peve_00029920,Pocillopora_meandrina_HIv1___RNAseq.g29874.t1,three_way,43.718,,,,,,,,,,,,,,,,,
OG_07202,FUN_032737-T1,Peve_00029919,Pocillopora_meandrina_HIv1___RNAseq.g29875.t1,three_way,74.34933333333333,FUN_032737-T1,A7SPE8,,,,,41.0,117.0,3.5e-17,89.4,sp|A7SPE8|BL1S5_NEMVE Biogenesis of lysosome-related organelles complex 1 subunit 5 OS=Nematostella vectensis OX=45351 GN=bloc1s5 PE=3 SV=1,,,,,,
OG_07203,FUN_032738-T1,Peve_00029918,Pocillopora_meandrina_HIv1___RNAseq.g29876.t1,three_way,86.90433333333334,FUN_032738-T1,P49739,,,,,65.5,823.0,6e-285,981.5,sp|P49739|MCM3M_XENLA Maternal DNA replication licensing factor mcm3 OS=Xenopus laevis OX=8355 GN=mmcm3 PE=1 SV=2,,,,,,
OG_07204,FUN_032744-T1,Peve_00029914,Pocillopora_meandrina_HIv1___RNAseq.g29879.t1,three_way,57.566,FUN_032744-T1,Q9VCZ3,OCTB1_DROME,,Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R),Drosophila melanogaster (Fruit fly),24.7,299.0,5.5e-17,90.1,sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1,GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410],membrane [GO:0016020]; plasma membrane [GO:0005886],adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_07205,FUN_032745-T1,Peve_00029929,Pocillopora_meandrina_HIv1___RNAseq.g29880.t1,three_way,55.068333333333335,FUN_032745-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),29.8,540.0,7.7e-54,213.8,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_07206,FUN_032747-T1,Peve_00006280,Pocillopora_meandrina_HIv1___RNAseq.g29883.t1,three_way,65.71983333333333,FUN_032747-T1,Q8CJG0,AGO2_MOUSE,,Protein argonaute-2 (Argonaute2) (mAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (Piwi/argonaute family protein meIF2C2) (Protein slicer),Mus musculus (Mouse),49.0,851.0,2.2e-220,767.3,sp|Q8CJG0|AGO2_MOUSE Protein argonaute-2 OS=Mus musculus OX=10090 GN=Ago2 PE=1 SV=3,GO:0000340; GO:0000932; GO:0000993; GO:0001046; GO:0003723; GO:0003725; GO:0003727; GO:0003729; GO:0004521; GO:0005634; GO:0005737; GO:0005829; GO:0009791; GO:0010467; GO:0010586; GO:0010628; GO:0016442; GO:0030154; GO:0030422; GO:0030425; GO:0031047; GO:0031054; GO:0033962; GO:0035196; GO:0035197; GO:0035198; GO:0035278; GO:0035279; GO:0035925; GO:0043489; GO:0045727; GO:0045766; GO:0045944; GO:0045947; GO:0046872; GO:0060213; GO:0070062; GO:0070551; GO:0070578; GO:0070922; GO:0090128; GO:0090624; GO:0090625; GO:0098794; GO:0098808; GO:0098978; GO:1900153; GO:1901165; GO:1990904,"cell differentiation [GO:0030154]; gene expression [GO:0010467]; miRNA metabolic process [GO:0010586]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; miRNA-mediated gene silencing by mRNA destabilization [GO:0035279]; negative regulation of translational initiation [GO:0045947]; P-body assembly [GO:0033962]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; regulation of synapse maturation [GO:0090128]; regulatory ncRNA-mediated gene silencing [GO:0031047]; RISC complex assembly [GO:0070922]; RNA stabilization [GO:0043489]; siRNA processing [GO:0030422]; siRNA-mediated gene silencing by mRNA destabilization [GO:0090625]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynapse [GO:0098794]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578],"core promoter sequence-specific DNA binding [GO:0001046]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity, cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity, cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016787; GO:0030154; GO:0031047; GO:0043226; GO:0065003; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; protein-containing complex assembly; catalytic activity, acting on RNA"
OG_07207,FUN_032750-T1,Peve_00029924,Pocillopora_meandrina_HIv1___RNAseq.g29869.t1,three_way,91.93033333333334,FUN_032750-T1,Q91YR7,PRP6_MOUSE,,Pre-mRNA-processing factor 6 (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein),Mus musculus (Mouse),75.3,938.0,1.4e-200,701.4,sp|Q91YR7|PRP6_MOUSE Pre-mRNA-processing factor 6 OS=Mus musculus OX=10090 GN=Prpf6 PE=1 SV=1,GO:0000244; GO:0000398; GO:0003713; GO:0003723; GO:0005634; GO:0005682; GO:0005813; GO:0005829; GO:0006403; GO:0016607; GO:0030674; GO:0036064; GO:0042802; GO:0043021; GO:0045944; GO:0046540; GO:0050681; GO:0071005; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],identical protein binding [GO:0042802]; nuclear androgen receptor binding [GO:0050681]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0005634; GO:0005815; GO:0005829; GO:0006355; GO:0016071; GO:0043226; GO:0060090; GO:0065003; GO:0140110,RNA binding; nucleus; microtubule organizing center; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_07208,FUN_032751-T1,Peve_00029925,Pocillopora_meandrina_HIv1___RNAseq.g29868.t1,three_way,43.476333333333336,,,,,,,,,,,,,,,,,
OG_07209,FUN_032752-T2,Peve_00023813,Pocillopora_meandrina_HIv1___TS.g25116.t1,three_way,46.43383333333333,FUN_032752-T2,F1R983,,,,,50.5,97.0,2.5e-19,99.0,sp|F1R983|CTIP_DANRE DNA endonuclease RBBP8 OS=Danio rerio OX=7955 GN=rbbp8 PE=2 SV=1,,,,,,
OG_07210,FUN_032753-T1,Peve_00023819,Pocillopora_meandrina_HIv1___RNAseq.g29865.t1,three_way,75.09366666666666,,,,,,,,,,,,,,,,,
OG_07211,FUN_032755-T1,Peve_00023820,Pocillopora_meandrina_HIv1___RNAseq.g29864.t1,three_way,82.49766666666667,FUN_032755-T1,Q62825,,,,,43.2,750.0,3.3e-160,567.0,sp|Q62825|EXOC3_RAT Exocyst complex component 3 OS=Rattus norvegicus OX=10116 GN=Exoc3 PE=1 SV=1,,,,,,
OG_07212,FUN_032760-T1,Peve_00023814,Pocillopora_meandrina_HIv1___RNAseq.g29862.t1,three_way,41.60766666666667,,,,,,,,,,,,,,,,,
OG_07213,FUN_032772-T1,Peve_00017712,Pocillopora_meandrina_HIv1___RNAseq.g29730.t1,three_way,60.71333333333333,,,,,,,,,,,,,,,,,
OG_07214,FUN_032773-T1,Peve_00017713,Pocillopora_meandrina_HIv1___RNAseq.g29729.t1,three_way,95.40066666666668,FUN_032773-T1,Q26630,IDLC_STRPU,,"33 kDa inner dynein arm light chain, axonemal (p33)",Strongylocentrotus purpuratus (Purple sea urchin),74.3,249.0,3e-86,319.7,"sp|Q26630|IDLC_STRPU 33 kDa inner dynein arm light chain, axonemal OS=Strongylocentrotus purpuratus OX=7668 PE=1 SV=1",GO:0005930; GO:0030286; GO:0045504; GO:0097546,,axoneme [GO:0005930]; ciliary base [GO:0097546]; dynein complex [GO:0030286],dynein heavy chain binding [GO:0045504],,
OG_07215,FUN_032774-T1,Peve_00010354,Pocillopora_meandrina_HIv1___RNAseq.g29728.t1,three_way,61.269333333333336,,,,,,,,,,,,,,,,,
OG_07216,FUN_032781-T1,Peve_00010377,Pocillopora_meandrina_HIv1___RNAseq.g29726.t1,three_way,78.02833333333334,FUN_032781-T1,Q6Y1H2,HACD2_HUMAN,,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B),Homo sapiens (Human),56.5,207.0,3.5e-67,256.1,sp|Q6Y1H2|HACD2_HUMAN Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 OS=Homo sapiens OX=9606 GN=HACD2 PE=1 SV=1,GO:0005783; GO:0005789; GO:0018812; GO:0019899; GO:0030148; GO:0030497; GO:0035338; GO:0042761; GO:0102158,fatty acid elongation [GO:0030497]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enzyme binding [GO:0019899]; very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity [GO:0102158],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016829; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; lyase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07217,FUN_032782-T1,Peve_00010376,Pocillopora_meandrina_HIv1___RNAseq.g29725.t1,three_way,79.18933333333334,FUN_032782-T1,Q6A4L1,,,,,45.0,702.0,3.4e-154,547.0,sp|Q6A4L1|S12A8_XENLA Solute carrier family 12 member 8 OS=Xenopus laevis OX=8355 GN=slc12a8 PE=2 SV=1,,,,,,
OG_07218,FUN_032790-T1,Peve_00010373,Pocillopora_meandrina_HIv1___RNAseq.g29721.t1,three_way,55.391333333333336,FUN_032790-T1,Q68LP1,MIB2_RAT,,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Rattus norvegicus (Rat),38.8,456.0,1.6e-83,312.8,sp|Q68LP1|MIB2_RAT E3 ubiquitin-protein ligase MIB2 OS=Rattus norvegicus OX=10116 GN=Mib2 PE=1 SV=2,GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005886; GO:0007219; GO:0008270; GO:0016567; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation protein catabolic process at postsynapse [GO:0140252],cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005886; GO:0008092; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; plasma membrane; cytoskeletal protein binding; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07219,FUN_032794-T1,Peve_00010370,Pocillopora_meandrina_HIv1___RNAseq.g29714.t1,three_way,65.03266666666667,FUN_032794-T1,O77715,,,,,27.3,194.0,6.5e-09,63.2,sp|O77715|ADA2B_DIDVI Alpha-2B adrenergic receptor (Fragment) OS=Didelphis virginiana OX=9267 GN=ADRA2B PE=3 SV=1,,,,,,
OG_07220,FUN_032813-T1,Peve_00010364,Pocillopora_meandrina_HIv1___TS.g24962.t1,three_way,46.85066666666666,FUN_032813-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),40.7,327.0,6.7e-59,230.7,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_07221,FUN_032814-T1,Peve_00014511,Pocillopora_meandrina_HIv1___RNAseq.g29708.t1,three_way,72.67099999999999,FUN_032814-T1,A7SCH8,KYNU_NEMVE,,Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase),Nematostella vectensis (Starlet sea anemone),58.9,472.0,1.2e-166,587.8,sp|A7SCH8|KYNU_NEMVE Kynureninase OS=Nematostella vectensis OX=45351 GN=kynu PE=3 SV=1,GO:0005737; GO:0019441; GO:0019805; GO:0030170; GO:0030429; GO:0034354; GO:0043420; GO:0097053,'de novo' NAD biosynthetic process from L-tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; L-tryptophan catabolic process to kynurenine [GO:0019441]; quinolinate biosynthetic process [GO:0019805],cytoplasm [GO:0005737],kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0006520; GO:0016787; GO:0055086,catalytic activity; amino acid metabolic process; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_07222,FUN_032815-T1,Peve_00014570,Pocillopora_meandrina_HIv1___RNAseq.g29707.t1,three_way,69.17233333333334,FUN_032815-T1,Q5HYM0,ZC12B_HUMAN,,Probable ribonuclease ZC3H12B (EC 3.1.-.-) (MCP-induced protein 2) (Zinc finger CCCH domain-containing protein 12B),Homo sapiens (Human),59.1,220.0,8.099999999999998e-69,263.1,sp|Q5HYM0|ZC12B_HUMAN Probable ribonuclease ZC3H12B OS=Homo sapiens OX=9606 GN=ZC3H12B PE=1 SV=3,GO:0003729; GO:0004521; GO:0005634; GO:0008270; GO:0036464,,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; organelle; catalytic activity, acting on RNA"
OG_07223,FUN_032817-T1,Peve_00014521,Pocillopora_meandrina_HIv1___RNAseq.g29683.t2,three_way,71.64333333333333,FUN_032817-T1,Q8K0Q5,,,,,40.2,540.0,1.3e-92,342.4,sp|Q8K0Q5|RHG18_MOUSE Rho GTPase-activating protein 18 OS=Mus musculus OX=10090 GN=Arhgap18 PE=1 SV=1,,,,,,
OG_07224,FUN_032825-T1,Peve_00014525,Pocillopora_meandrina_HIv1___TS.g24937.t1a,three_way,59.772,FUN_032825-T1,A1ZAY1,DLISH_DROME,,SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains),Drosophila melanogaster (Fruit fly),55.6,63.0,2.3e-14,81.6,sp|A1ZAY1|DLISH_DROME SH3 domain-containing protein Dlish OS=Drosophila melanogaster OX=7227 GN=Dlish PE=1 SV=1,GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219,establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251],apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219],cadherin binding [GO:0045296],GO:0005929; GO:0007163; GO:0043226,cilium; establishment or maintenance of cell polarity; organelle
OG_07225,FUN_032831-T1,Peve_00014559,Pocillopora_meandrina_HIv1___RNAseq.g24970.t1,three_way,43.674,FUN_032831-T1,Q9Y4W2,LAS1L_HUMAN,,Ribosomal biogenesis protein LAS1L (Endoribonuclease LAS1L) (EC 3.1.-.-) (Protein LAS1 homolog),Homo sapiens (Human),39.9,148.0,3.1e-21,104.8,sp|Q9Y4W2|LAS1L_HUMAN Ribosomal biogenesis protein LAS1L OS=Homo sapiens OX=9606 GN=LAS1L PE=1 SV=2,GO:0000460; GO:0000470; GO:0003723; GO:0004519; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0016020; GO:0071339; GO:0090730,maturation of 5.8S rRNA [GO:0000460]; maturation of LSU-rRNA [GO:0000470]; rRNA processing [GO:0006364],Las1 complex [GO:0090730]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],endonuclease activity [GO:0004519]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0043226,RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; organelle
OG_07226,FUN_032832-T1,Peve_00014560,Pocillopora_meandrina_HIv1___RNAseq.g24969.t3,three_way,68.74916666666667,FUN_032832-T1,Q66I22,,,,,48.1,270.0,3.4e-62,241.5,sp|Q66I22|SRRT_DANRE Serrate RNA effector molecule homolog OS=Danio rerio OX=7955 GN=srrt PE=2 SV=1,,,,,,
OG_07226,FUN_032832-T1,Peve_00014560,Pocillopora_meandrina_HIv1___RNAseq.g24969.t3,three_way,68.74916666666667,FUN_032832-T1,Q66I22,,,,,35.9,78.0,3.8e-05,52.0,sp|Q66I22|SRRT_DANRE Serrate RNA effector molecule homolog OS=Danio rerio OX=7955 GN=srrt PE=2 SV=1,,,,,,
OG_07227,FUN_032873-T1,Peve_00014572,Pocillopora_meandrina_HIv1___RNAseq.28951_t,three_way,71.659,FUN_032873-T1,Q1H0D2,,,,,42.9,503.0,3.1e-107,390.6,sp|Q1H0D2|SELO_METFK Protein nucleotidyltransferase YdiU OS=Methylobacillus flagellatus (strain ATCC 51484 / DSM 6875 / VKM B-1610 / KT) OX=265072 GN=ydiU PE=3 SV=1,,,,,,
OG_07228,FUN_032874-T1,Peve_00014576,Pocillopora_meandrina_HIv1___RNAseq.g29697.t1,three_way,84.13433333333333,FUN_032874-T1,Q9H3K2,GHITM_HUMAN,,Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5),Homo sapiens (Human),50.6,265.0,1.6000000000000001e-74,281.2,sp|Q9H3K2|GHITM_HUMAN Growth hormone-inducible transmembrane protein OS=Homo sapiens OX=9606 GN=GHITM PE=1 SV=2,GO:0005262; GO:0005739; GO:0005743; GO:0005789; GO:0006816; GO:0006851; GO:0006915; GO:0007007; GO:0015369; GO:0031966; GO:0070062; GO:0090201; GO:0099093; GO:0140141; GO:1905448,apoptotic process [GO:0006915]; calcium export from the mitochondrion [GO:0099093]; calcium ion transport [GO:0006816]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial potassium ion transmembrane transport [GO:0140141]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of mitochondrial ATP synthesis coupled electron transport [GO:1905448],endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],calcium channel activity [GO:0005262]; calcium:proton antiporter activity [GO:0015369],GO:0005215; GO:0005739; GO:0007005; GO:0012501; GO:0043226; GO:0055085; GO:0061024,transporter activity; mitochondrion; mitochondrion organization; programmed cell death; organelle; transmembrane transport; membrane organization
OG_07229,FUN_032885-T1,Peve_00001722,Pocillopora_meandrina_HIv1___RNAseq.g29858.t1,three_way,52.5095,,,,,,,,,,,,,,,,,
OG_07230,FUN_032903-T1,Peve_00014524,Pocillopora_meandrina_HIv1___TS.g12933.t1a,three_way,88.37766666666667,FUN_032903-T1,Q5XIT9,MCCB_RAT,,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)",Rattus norvegicus (Rat),76.9,541.0,1.6e-249,863.2,"sp|Q5XIT9|MCCB_RAT Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial OS=Rattus norvegicus OX=10116 GN=Mccc2 PE=2 SV=1",GO:0004485; GO:0005524; GO:0005739; GO:0005759; GO:0006552; GO:0015936; GO:1905202,coenzyme A metabolic process [GO:0015936]; L-leucine catabolic process [GO:0006552],methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485],GO:0003824; GO:0005739; GO:0006520; GO:0006790; GO:0016874; GO:0043226; GO:0055086,catalytic activity; mitochondrion; amino acid metabolic process; sulfur compound metabolic process; ligase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07231,FUN_032904-T2,Peve_00014527,Pocillopora_meandrina_HIv1___RNAseq.g24993.t1,three_way,55.487,,,,,,,,,,,,,,,,,
OG_07232,FUN_032905-T1,Peve_00014528,Pocillopora_meandrina_HIv1___RNAseq.g24990.t2,three_way,70.00566666666667,,,,,,,,,,,,,,,,,
OG_07233,FUN_032906-T1,Peve_00014529,Pocillopora_meandrina_HIv1___RNAseq.g24991.t1,three_way,83.96633333333334,FUN_032906-T1,Q14671,,,,,46.1,1272.0,9e-53,210.7,sp|Q14671|PUM1_HUMAN Pumilio homolog 1 OS=Homo sapiens OX=9606 GN=PUM1 PE=1 SV=3,,,,,,
OG_07234,FUN_032907-T1,Peve_00014530,Pocillopora_meandrina_HIv1___RNAseq.g24992.t1,three_way,79.497,FUN_032907-T1,Q5PQ53,PEF1_XENLA,,Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1),Xenopus laevis (African clawed frog),49.1,165.0,3.699999999999999e-43,176.4,sp|Q5PQ53|PEF1_XENLA Peflin OS=Xenopus laevis OX=8355 GN=pef1 PE=1 SV=1,GO:0005509; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0031463; GO:0048208; GO:0048306; GO:1902527; GO:1990756,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527],COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; endoplasmic reticulum [GO:0005783],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0065003,endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_07235,FUN_032908-T1,Peve_00014533,Pocillopora_meandrina_HIv1___RNAseq.g24988.t1,three_way,75.6895,FUN_032908-T1,Q9JKP8,,,,,42.9,105.0,2.1e-16,86.7,sp|Q9JKP8|CHRC1_MOUSE Chromatin accessibility complex protein 1 OS=Mus musculus OX=10090 GN=Chrac1 PE=1 SV=1,,,,,,
OG_07236,FUN_032909-T1,Peve_00014534,Pocillopora_meandrina_HIv1___TS.g12926.t1,three_way,60.93333333333333,,,,,,,,,,,,,,,,,
OG_07237,FUN_032910-T1,Peve_00014535,Pocillopora_meandrina_HIv1___TS.g12925.t1,three_way,45.20733333333333,,,,,,,,,,,,,,,,,
OG_07238,FUN_032958-T1,Peve_00014537,Pocillopora_meandrina_HIv1___RNAseq.g24985.t1,three_way,92.142,FUN_032958-T1,Q16204,CCDC6_HUMAN,,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),Homo sapiens (Human),66.4,369.0,7.5e-39,162.9,sp|Q16204|CCDC6_HUMAN Coiled-coil domain-containing protein 6 OS=Homo sapiens OX=9606 GN=CCDC6 PE=1 SV=2,GO:0005200; GO:0005829; GO:0005856; GO:0017124; GO:0042802,,cytoskeleton [GO:0005856]; cytosol [GO:0005829],identical protein binding [GO:0042802]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005829; GO:0005856; GO:0043226,structural molecule activity; cytosol; cytoskeleton; organelle
OG_07239,FUN_032960-T1,Peve_00015577,Pocillopora_meandrina_HIv1___RNAseq.g24902.t1,three_way,69.48333333333333,FUN_032960-T1,P07099,HYEP_HUMAN,,Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH),Homo sapiens (Human),46.5,428.0,8.2e-106,385.6,sp|P07099|HYEP_HUMAN Epoxide hydrolase 1 OS=Homo sapiens OX=9606 GN=EPHX1 PE=1 SV=1,GO:0004301; GO:0005789; GO:0006805; GO:0008142; GO:0009636; GO:0019369; GO:0033961; GO:0097176; GO:0120253,arachidonate metabolic process [GO:0019369]; epoxide metabolic process [GO:0097176]; hydrocarbon catabolic process [GO:0120253]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142],GO:0003824; GO:0006629; GO:0008289; GO:0016787,catalytic activity; lipid metabolic process; lipid binding; hydrolase activity
OG_07240,FUN_032970-T1,Peve_00015579,Pocillopora_meandrina_HIv1___RNAseq.g24965.t1,three_way,86.36466666666666,FUN_032970-T1,P86884,,,,,77.8,374.0,5e-178,625.2,sp|P86884|ADHX_SCYCA Alcohol dehydrogenase class-3 OS=Scyliorhinus canicula OX=7830 PE=1 SV=1,,,,,,
OG_07241,FUN_032971-T1,Peve_00017817,Pocillopora_meandrina_HIv1___RNAseq.g29687.t1,three_way,75.51633333333334,FUN_032971-T1,Q8IX29,,,,,52.3,214.0,1.3e-58,228.4,sp|Q8IX29|FBX16_HUMAN F-box only protein 16 OS=Homo sapiens OX=9606 GN=FBXO16 PE=1 SV=1,,,,,,
OG_07242,FUN_032972-T1,Peve_00017816,Pocillopora_meandrina_HIv1___TS.g24940.t1,three_way,69.297,FUN_032972-T1,Q680A5,,,,,48.4,335.0,1.9e-86,320.9,sp|Q680A5|KPRS4_ARATH Ribose-phosphate pyrophosphokinase 4 OS=Arabidopsis thaliana OX=3702 GN=PRS4 PE=1 SV=2,,,,,,
OG_07243,FUN_032973-T1,Peve_00015586,Pocillopora_meandrina_HIv1___RNAseq.g29689.t1,three_way,85.39766666666667,FUN_032973-T1,Q4QRK0,MAP11_DANRE,,Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1),Danio rerio (Zebrafish) (Brachydanio rerio),68.7,380.0,8.099999999999999e-160,564.7,sp|Q4QRK0|MAP11_DANRE Methionine aminopeptidase 1 OS=Danio rerio OX=7955 GN=metap1 PE=2 SV=2,GO:0004239; GO:0005829; GO:0006882; GO:0008270; GO:0016485; GO:0022626; GO:0070006,intracellular zinc ion homeostasis [GO:0006882]; protein processing [GO:0016485],cytosol [GO:0005829]; cytosolic ribosome [GO:0022626],initiator methionyl aminopeptidase activity [GO:0004239]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005840; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; cytosol; ribosome; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_07244,FUN_032974-T1,Peve_00017818,Pocillopora_meandrina_HIv1___RNAseq.g29686.t1,three_way,48.894,,,,,,,,,,,,,,,,,
OG_07245,FUN_032975-T1,Peve_00014556,Pocillopora_meandrina_HIv1___RNAseq.g24981.t1,three_way,41.4585,,,,,,,,,,,,,,,,,
OG_07246,FUN_032980-T2,Peve_00014554,Pocillopora_meandrina_HIv1___RNAseq.g24982.t1,three_way,79.0795,FUN_032980-T2,Q9R1D7,,,,,49.7,1820.0,0.0,1533.5,sp|Q9R1D7|GBF1_CRIGR Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 OS=Cricetulus griseus OX=10029 GN=GBF1 PE=1 SV=1,,,,,,
OG_07247,FUN_032981-T1,Peve_00014553,Pocillopora_meandrina_HIv1___RNAseq.g24984.t1,three_way,51.269666666666666,FUN_032981-T1,Q7TT16,,,,,35.3,232.0,9.9e-28,125.6,sp|Q7TT16|IPMK_MOUSE Inositol polyphosphate multikinase OS=Mus musculus OX=10090 GN=Ipmk PE=1 SV=1,,,,,,
OG_07248,FUN_032987-T2,Peve_00014549,Pocillopora_meandrina_HIv1___RNAseq.g24997.t1,three_way,40.58166666666667,,,,,,,,,,,,,,,,,
OG_07249,FUN_032988-T2,Peve_00014547,Pocillopora_meandrina_HIv1___RNAseq.8254_t,three_way,56.93683333333333,FUN_032988-T2,Q8IWU6,SULF1_HUMAN,,Extracellular sulfatase Sulf-1 (hSulf-1) (Arylsulfatase) (EC 3.1.6.1) (N-acetylglucosamine-6-sulfatase) (EC 3.1.6.14) [Cleaved into: Extracellular sulfatase Sulf-2 secreted form],Homo sapiens (Human),39.1,844.0,2.4e-151,538.1,sp|Q8IWU6|SULF1_HUMAN Extracellular sulfatase Sulf-1 OS=Homo sapiens OX=9606 GN=SULF1 PE=1 SV=1,GO:0001822; GO:0001937; GO:0002063; GO:0003094; GO:0004065; GO:0005509; GO:0005539; GO:0005615; GO:0005783; GO:0005795; GO:0005886; GO:0006915; GO:0008449; GO:0009986; GO:0010575; GO:0014846; GO:0016525; GO:0030177; GO:0030201; GO:0030336; GO:0030513; GO:0032836; GO:0035860; GO:0040036; GO:0040037; GO:0045121; GO:0048010; GO:0048706; GO:0051216; GO:0060348; GO:0060384; GO:0060686,apoptotic process [GO:0006915]; bone development [GO:0060348]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; embryonic skeletal system development [GO:0048706]; esophagus smooth muscle contraction [GO:0014846]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; heparan sulfate proteoglycan metabolic process [GO:0030201]; innervation [GO:0060384]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of prostatic bud formation [GO:0060686]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi stack [GO:0005795]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539]; N-acetylglucosamine-6-sulfatase activity [GO:0008449],GO:0003012; GO:0003014; GO:0003824; GO:0005615; GO:0005783; GO:0005886; GO:0012501; GO:0016787; GO:0030198; GO:0043226; GO:0048856; GO:1901135,muscle system process; renal system process; catalytic activity; extracellular space; endoplasmic reticulum; plasma membrane; programmed cell death; hydrolase activity; extracellular matrix organization; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_07250,FUN_032992-T1,Peve_00014540,Pocillopora_meandrina_HIv1___RNAseq.g24473.t1,three_way,73.003,FUN_032992-T1,Q8RCT3,,,,,57.0,302.0,2.5e-88,328.2,sp|Q8RCT3|PSUG_CALS4 Pseudouridine-5'-phosphate glycosidase OS=Caldanaerobacter subterraneus subsp. tengcongensis (strain DSM 15242 / JCM 11007 / NBRC 100824 / MB4) OX=273068 GN=psuG PE=3 SV=1,,,,,,
OG_07251,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,1e-115,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_07252,FUN_033014-T1,Peve_00015570,Pocillopora_meandrina_HIv1___TS.g12407.t1,three_way,65.45333333333333,FUN_033014-T1,Q9BIM7,,,,,48.6,70.0,2.8e-08,62.4,sp|Q9BIM7|MIC8_TOXGO Micronemal protein 8 OS=Toxoplasma gondii OX=5811 GN=MIC8 PE=1 SV=1,,,,,,
OG_07253,FUN_033016-T1,Peve_00015569,Pocillopora_meandrina_HIv1___RNAseq.g24465.t1,three_way,50.23716666666667,FUN_033016-T1,Q20911,,,,,32.7,107.0,1.5e-06,56.6,sp|Q20911|CUBN_CAEEL Cubilin homolog OS=Caenorhabditis elegans OX=6239 GN=cubn-1 PE=1 SV=4,,,,,,
OG_07254,FUN_033020-T1,Peve_00020848,Pocillopora_meandrina_HIv1___RNAseq.g24458.t1,three_way,61.12266666666667,FUN_033020-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),32.5,271.0,1.0999999999999998e-24,116.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_07255,FUN_033022-T1,Peve_00017508,Pocillopora_meandrina_HIv1___RNAseq.g24456.t1,three_way,78.04766666666666,FUN_033022-T1,Q99835,SMO_HUMAN,,Protein smoothened (Protein Gx),Homo sapiens (Human),48.7,435.0,2.7000000000000003e-126,453.8,sp|Q99835|SMO_HUMAN Protein smoothened OS=Homo sapiens OX=9606 GN=SMO PE=1 SV=1,GO:0000122; GO:0001570; GO:0001649; GO:0001701; GO:0001708; GO:0001755; GO:0001933; GO:0001947; GO:0002052; GO:0002053; GO:0003140; GO:0003323; GO:0004862; GO:0004930; GO:0005113; GO:0005770; GO:0005783; GO:0005793; GO:0005794; GO:0005814; GO:0005886; GO:0005929; GO:0006606; GO:0006915; GO:0007224; GO:0007371; GO:0007389; GO:0007405; GO:0007417; GO:0007494; GO:0008142; GO:0009952; GO:0010467; GO:0010628; GO:0010629; GO:0021513; GO:0021542; GO:0021696; GO:0021794; GO:0021904; GO:0021953; GO:0021987; GO:0030335; GO:0030425; GO:0030666; GO:0030857; GO:0031069; GO:0034236; GO:0035264; GO:0040018; GO:0042307; GO:0042475; GO:0043066; GO:0043231; GO:0043392; GO:0045880; GO:0045944; GO:0046622; GO:0048143; GO:0048741; GO:0048745; GO:0048853; GO:0048873; GO:0050673; GO:0050679; GO:0050821; GO:0051451; GO:0051799; GO:0060170; GO:0060242; GO:0060413; GO:0060644; GO:0060684; GO:0061053; GO:0061113; GO:0070062; GO:0070986; GO:0071397; GO:0071542; GO:0071679; GO:0072285; GO:0090190; GO:0097542; GO:0097731; GO:0140311; GO:1902140; GO:1904672; GO:2000826,anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; atrial septum morphogenesis [GO:0060413]; cell fate specification [GO:0001708]; cellular response to cholesterol [GO:0071397]; central nervous system development [GO:0007417]; central nervous system neuron differentiation [GO:0021953]; cerebellar cortex morphogenesis [GO:0021696]; cerebral cortex development [GO:0021987]; commissural neuron axon guidance [GO:0071679]; contact inhibition [GO:0060242]; dentate gyrus development [GO:0021542]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; epithelial cell proliferation [GO:0050673]; epithelial-mesenchymal cell signaling [GO:0060684]; forebrain morphogenesis [GO:0048853]; gene expression [GO:0010467]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mammary gland epithelial cell differentiation [GO:0060644]; mesenchymal to epithelial transition involved in metanephric renal vesicle formation [GO:0072285]; midgut development [GO:0007494]; multicellular organism growth [GO:0035264]; myoblast migration [GO:0051451]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA binding [GO:0043392]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of hair follicle development [GO:0051799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pancreas morphogenesis [GO:0061113]; pattern specification process [GO:0007389]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of organ growth [GO:0046622]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of heart morphogenesis [GO:2000826]; regulation of somatic stem cell population maintenance [GO:1904672]; response to inositol [GO:1902140]; skeletal muscle fiber development [GO:0048741]; smooth muscle tissue development [GO:0048745]; smoothened signaling pathway [GO:0007224]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; thalamus development [GO:0021794]; type B pancreatic cell development [GO:0003323]; vasculogenesis [GO:0001570]; ventral midline determination [GO:0007371],9+0 non-motile cilium [GO:0097731]; centriole [GO:0005814]; ciliary membrane [GO:0060170]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite [GO:0030425]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; plasma membrane [GO:0005886],cAMP-dependent protein kinase inhibitor activity [GO:0004862]; G protein-coupled receptor activity [GO:0004930]; oxysterol binding [GO:0008142]; patched binding [GO:0005113]; protein kinase A catalytic subunit binding [GO:0034236]; protein sequestering activity [GO:0140311],GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0005929; GO:0006355; GO:0006886; GO:0006913; GO:0008289; GO:0012501; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0098772; GO:0140313,endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; cilium; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; lipid binding; programmed cell death; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; molecular function regulator activity; molecular sequestering activity
OG_07256,FUN_033023-T1,Peve_00017506,Pocillopora_meandrina_HIv1___RNAseq.g24455.t1,three_way,46.03516666666667,FUN_033023-T1,Q0P4I1,,,,,32.3,235.0,4.2e-23,111.3,sp|Q0P4I1|CEP44_XENTR Centrosomal protein of 44 kDa OS=Xenopus tropicalis OX=8364 GN=cep44 PE=2 SV=1,,,,,,
OG_07257,FUN_033025-T1,Peve_00017504,Pocillopora_meandrina_HIv1___RNAseq.g24453.t1,three_way,59.50533333333333,,,,,,,,,,,,,,,,,
OG_07258,FUN_033035-T1,Peve_00017503,Pocillopora_meandrina_HIv1___RNAseq.g24452.t1,three_way,61.70483333333333,,,,,,,,,,,,,,,,,
OG_07259,FUN_033036-T1,Peve_00017502,Pocillopora_meandrina_HIv1___RNAseq.g24450.t1,three_way,76.906,FUN_033036-T1,Q96QG7,,,,,53.2,329.0,2.6e-101,370.2,sp|Q96QG7|MTMR9_HUMAN Myotubularin-related protein 9 OS=Homo sapiens OX=9606 GN=MTMR9 PE=1 SV=1,,,,,,
OG_07260,FUN_033037-T1,Peve_00001493,Pocillopora_meandrina_HIv1___RNAseq.g24449.t1,three_way,85.58766666666668,FUN_033037-T1,Q3SZ13,UQCC2_BOVIN,,Ubiquinol-cytochrome c reductase complex assembly factor 2 (Mitochondrial nucleoid factor 1) (Mitochondrial protein M19),Bos taurus (Bovine),37.3,118.0,5.8e-14,78.6,sp|Q3SZ13|UQCC2_BOVIN Ubiquinol-cytochrome c reductase complex assembly factor 2 OS=Bos taurus OX=9913 GN=UQCC2 PE=2 SV=1,GO:0002082; GO:0005739; GO:0005743; GO:0005758; GO:0005759; GO:0016604; GO:0034551; GO:0042645; GO:0050796; GO:0070131; GO:2001014,mitochondrial respiratory chain complex III assembly [GO:0034551]; positive regulation of mitochondrial translation [GO:0070131]; regulation of insulin secretion [GO:0050796]; regulation of oxidative phosphorylation [GO:0002082]; regulation of skeletal muscle cell differentiation [GO:2001014],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nuclear body [GO:0016604],,GO:0005739; GO:0043226; GO:0065003,mitochondrion; organelle; protein-containing complex assembly
OG_07261,FUN_033038-T1,Peve_00017501,Pocillopora_meandrina_HIv1___RNAseq.g24448.t1,three_way,84.66233333333334,FUN_033038-T1,Q5ZM55,,,,,46.0,624.0,7.899999999999999e-83,309.7,sp|Q5ZM55|FEM1B_CHICK Protein fem-1 homolog B OS=Gallus gallus OX=9031 GN=FEM1B PE=2 SV=1,,,,,,
OG_07262,FUN_033039-T1,Peve_00017500,Pocillopora_meandrina_HIv1___RNAseq.g24445.t1,three_way,64.32033333333334,FUN_033039-T1,O94766,,,,,45.2,303.0,1.9e-65,251.1,sp|O94766|B3GA3_HUMAN Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 OS=Homo sapiens OX=9606 GN=B3GAT3 PE=1 SV=2,,,,,,
OG_07263,FUN_033040-T1,Peve_00017499,Pocillopora_meandrina_HIv1___RNAseq.g24444.t1,three_way,60.882333333333335,FUN_033040-T1,O94766,,,,,46.2,301.0,1.2e-65,251.9,sp|O94766|B3GA3_HUMAN Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 OS=Homo sapiens OX=9606 GN=B3GAT3 PE=1 SV=2,,,,,,
OG_07264,FUN_033047-T1,Peve_00020149,Pocillopora_meandrina_HIv1___RNAseq.g24182.t1,three_way,58.319,FUN_033047-T1,Q09596,,,,,32.5,212.0,1.9e-20,100.9,sp|Q09596|GST5_CAEEL Probable glutathione S-transferase 5 OS=Caenorhabditis elegans OX=6239 GN=gst-5 PE=1 SV=1,,,,,,
OG_07265,FUN_033056-T1,Peve_00024296,Pocillopora_meandrina_HIv1___RNAseq.g25129.t1,three_way,51.20366666666667,FUN_033056-T1,Q9UGM3,,,,,54.1,218.0,8e-62,239.6,sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,,,,,,
OG_07266,FUN_033114-T1,Peve_00019518,Pocillopora_meandrina_HIv1___RNAseq.g24261.t1,three_way,54.964666666666666,FUN_033114-T1,Q1EG27,MYO3B_MOUSE,,Myosin-IIIb (EC 2.7.11.1),Mus musculus (Mouse),33.6,769.0,3.6e-116,421.4,sp|Q1EG27|MYO3B_MOUSE Myosin-IIIb OS=Mus musculus OX=10090 GN=Myo3b PE=1 SV=2,GO:0000146; GO:0001750; GO:0001917; GO:0003779; GO:0004674; GO:0005524; GO:0005829; GO:0007601; GO:0007605; GO:0016459; GO:0030832; GO:0032426; GO:0032433; GO:0051491; GO:0060088; GO:0090103; GO:0106310,auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytosol [GO:0005829]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003774; GO:0003824; GO:0005829; GO:0008092; GO:0016740; GO:0016853; GO:0050877; GO:0140096; GO:0140657,"cytoskeletal motor activity; catalytic activity; cytosol; cytoskeletal protein binding; transferase activity; isomerase activity; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07267,FUN_033115-T1,Peve_00034200,Pocillopora_meandrina_HIv1___RNAseq.g29761.t1,three_way,71.55166666666666,,,,,,,,,,,,,,,,,
OG_07268,FUN_033119-T1,Peve_00013204,Pocillopora_meandrina_HIv1___TS.g25013.t2,three_way,69.678,FUN_033119-T1,Q9R1R2,TRIM3_MOUSE,,Tripartite motif-containing protein 3 (EC 2.3.2.27) (RING finger protein 22) (RING finger protein HAC1),Mus musculus (Mouse),23.2,482.0,3.9e-23,111.7,sp|Q9R1R2|TRIM3_MOUSE Tripartite motif-containing protein 3 OS=Mus musculus OX=10090 GN=Trim3 PE=1 SV=1,GO:0004842; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0016567; GO:0030425; GO:0034141; GO:0042802; GO:0061351; GO:0061630; GO:0070534,neural precursor cell proliferation [GO:0061351]; positive regulation of toll-like receptor 3 signaling pathway [GO:0034141]; protein K63-linked ubiquitination [GO:0070534]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07269,FUN_033125-T1,Peve_00043512,Pocillopora_meandrina_HIv1___RNAseq.g29766.t1,three_way,79.22233333333334,FUN_033125-T1,Q91616,,,,,56.5,62.0,8.7e-08,58.5,sp|Q91616|NDF1_XENLA Neurogenic differentiation factor 1 OS=Xenopus laevis OX=8355 GN=neurod1 PE=1 SV=1,,,,,,
OG_07270,FUN_033126-T1,Peve_00043509,Pocillopora_meandrina_HIv1___RNAseq.g29765.t1,three_way,88.98233333333334,FUN_033126-T1,O14802,RPC1_HUMAN,,DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160),Homo sapiens (Human),69.2,1391.0,0.0,1951.8,sp|O14802|RPC1_HUMAN DNA-directed RNA polymerase III subunit RPC1 OS=Homo sapiens OX=9606 GN=POLR3A PE=1 SV=2,GO:0000287; GO:0003677; GO:0003682; GO:0003899; GO:0005634; GO:0005654; GO:0005666; GO:0005737; GO:0005739; GO:0005829; GO:0006351; GO:0008270; GO:0016020; GO:0032728; GO:0042797; GO:0045087; GO:0051607; GO:0071667,defense response to virus [GO:0051607]; DNA-templated transcription [GO:0006351]; innate immune response [GO:0045087]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0006351; GO:0006399; GO:0016740; GO:0043226; GO:0098542; GO:0140098,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; DNA-templated transcription; tRNA metabolic process; transferase activity; organelle; defense response to other organism; catalytic activity, acting on RNA"
OG_07271,FUN_033127-T1,Peve_00043508,Pocillopora_meandrina_HIv1___RNAseq.g29764.t1,three_way,64.51100000000001,FUN_033127-T1,P0C152,MKS3_RAT,,Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67),Rattus norvegicus (Rat),39.0,1006.0,3.6e-183,643.7,sp|P0C152|MKS3_RAT Meckelin OS=Rattus norvegicus OX=10116 GN=Tmem67 PE=1 SV=1,GO:0001822; GO:0005789; GO:0005813; GO:0005930; GO:0007368; GO:0007507; GO:0010826; GO:0030659; GO:0031005; GO:0035567; GO:0035845; GO:0035869; GO:0036038; GO:0036503; GO:0048754; GO:0051082; GO:0051787; GO:0060170; GO:0060271; GO:0060322; GO:0060441; GO:1902857; GO:1904294,branching morphogenesis of an epithelial tube [GO:0048754]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERAD pathway [GO:0036503]; head development [GO:0060322]; heart development [GO:0007507]; kidney development [GO:0001822]; negative regulation of centrosome duplication [GO:0010826]; non-canonical Wnt signaling pathway [GO:0035567]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of non-motile cilium assembly [GO:1902857],axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; MKS complex [GO:0036038],filamin binding [GO:0031005]; misfolded protein binding [GO:0051787]; unfolded protein binding [GO:0051082],GO:0005815; GO:0008092; GO:0030163; GO:0044782; GO:0048856,microtubule organizing center; cytoskeletal protein binding; protein catabolic process; cilium organization; anatomical structure development
OG_07272,FUN_033210-T1,Peve_00043517,Pocillopora_meandrina_HIv1___RNAseq.g29763.t1,three_way,93.34833333333331,FUN_033210-T1,P63328,PP2BA_MOUSE,,Protein phosphatase 3 catalytic subunit alpha (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin A alpha) (Calmodulin-dependent calcineurin A subunit alpha isoform) (CNA alpha) (Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform),Mus musculus (Mouse),80.6,407.0,2.1e-201,703.0,sp|P63328|PP2BA_MOUSE Protein phosphatase 3 catalytic subunit alpha OS=Mus musculus OX=10090 GN=Ppp3ca PE=1 SV=1,GO:0000082; GO:0004721; GO:0004723; GO:0005516; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0005955; GO:0006470; GO:0006606; GO:0006816; GO:0008287; GO:0008544; GO:0009898; GO:0010613; GO:0010628; GO:0010629; GO:0014883; GO:0014898; GO:0019722; GO:0023057; GO:0030018; GO:0030216; GO:0030335; GO:0033173; GO:0033192; GO:0033555; GO:0042104; GO:0042383; GO:0043197; GO:0045669; GO:0045672; GO:0045807; GO:0045944; GO:0046872; GO:0046878; GO:0046983; GO:0048741; GO:0048813; GO:0050774; GO:0050804; GO:0051117; GO:0051592; GO:0060079; GO:0061006; GO:0070886; GO:0090193; GO:0097205; GO:0098685; GO:0098978; GO:0099170; GO:0110062; GO:1903244; GO:1905205; GO:1905665; GO:1905949,calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy in response to stress [GO:0014898]; dendrite morphogenesis [GO:0048813]; epidermis development [GO:0008544]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; keratinocyte differentiation [GO:0030216]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of angiotensin-activated signaling pathway [GO:0110062]; negative regulation of calcium ion import across plasma membrane [GO:1905949]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of gene expression [GO:0010629]; negative regulation of signaling [GO:0023057]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endocytosis [GO:0045807]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of saliva secretion [GO:0046878]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; regulation of cell proliferation involved in kidney morphogenesis [GO:0061006]; renal filtration [GO:0097205]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883],calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein serine/threonine phosphatase complex [GO:0008287]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; Z disc [GO:0030018],ATPase binding [GO:0051117]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein dimerization activity [GO:0046983],GO:0003012; GO:0003014; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006355; GO:0006886; GO:0006913; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"muscle system process; renal system process; catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07273,FUN_033212-T1,Peve_00043513,Pocillopora_meandrina_HIv1___RNAseq.g29767.t1,three_way,73.36633333333333,FUN_033212-T1,Q99NA2,ATOH8_MOUSE,,Transcription factor Atoh8 (Helix-loop-helix protein mATH-6) (mATH6) (Okadin) (Protein atonal homolog 8),Mus musculus (Mouse),47.4,116.0,4.5e-17,89.4,sp|Q99NA2|ATOH8_MOUSE Transcription factor Atoh8 OS=Mus musculus OX=10090 GN=Atoh8 PE=1 SV=1,GO:0001704; GO:0001937; GO:0003700; GO:0005634; GO:0005737; GO:0007399; GO:0008134; GO:0010595; GO:0010629; GO:0016607; GO:0030154; GO:0035148; GO:0045603; GO:0045892; GO:0045893; GO:0046983; GO:0051450; GO:0060391; GO:0070888; GO:0140297; GO:1902895,cell differentiation [GO:0030154]; formation of primary germ layer [GO:0001704]; myoblast proliferation [GO:0051450]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; tube formation [GO:0035148],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; transcription factor binding [GO:0008134],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07274,FUN_033213-T1,Peve_00009683,Pocillopora_meandrina_HIv1___RNAseq.g29768.t1,three_way,69.78466666666667,FUN_033213-T1,Q923Z4,,,,,49.3,67.0,3.7e-07,56.6,sp|Q923Z4|FER3L_MOUSE Fer3-like protein OS=Mus musculus OX=10090 GN=Ferd3l PE=1 SV=1,,,,,,
OG_07275,FUN_033214-T1,Peve_00009684,Pocillopora_meandrina_HIv1___RNAseq.g29769.t1,three_way,77.82566666666666,FUN_033214-T1,Q60715,P4HA1_MOUSE,,"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)",Mus musculus (Mouse),43.3,515.0,6.6e-123,442.6,sp|Q60715|P4HA1_MOUSE Prolyl 4-hydroxylase subunit alpha-1 OS=Mus musculus OX=10090 GN=P4ha1 PE=1 SV=2,GO:0004656; GO:0005506; GO:0005739; GO:0005788; GO:0016222; GO:0030199; GO:0031418; GO:0042802,collagen fibril organization [GO:0030199],endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222],identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656],GO:0003824; GO:0005739; GO:0016491; GO:0030198; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; oxidoreductase activity; extracellular matrix organization; organelle; catalytic activity, acting on a protein"
OG_07276,FUN_033215-T1,Peve_00009678,Pocillopora_meandrina_HIv1___TS.g25021.t1,three_way,66.55533333333334,FUN_033215-T1,P54001,,,,,40.2,510.0,9.1e-98,359.0,sp|P54001|P4HA1_RAT Prolyl 4-hydroxylase subunit alpha-1 OS=Rattus norvegicus OX=10116 GN=P4ha1 PE=2 SV=2,,,,,,
OG_07277,FUN_033216-T1,Peve_00009679,Pocillopora_meandrina_HIv1___RNAseq.g29771.t1,three_way,82.727,FUN_033216-T1,Q3T078,,,,,35.2,307.0,6e-34,146.4,sp|Q3T078|ENKD1_BOVIN Enkurin domain-containing protein 1 OS=Bos taurus OX=9913 GN=ENKD1 PE=2 SV=1,,,,,,
OG_07278,FUN_033217-T1,Peve_00009680,Pocillopora_meandrina_HIv1___RNAseq.g29772.t1,three_way,57.77166666666667,,,,,,,,,,,,,,,,,
OG_07279,FUN_033219-T1,Peve_00009681,Pocillopora_meandrina_HIv1___RNAseq.g29773.t1,three_way,60.311,FUN_033219-T1,Q9H2A3,,,,,51.6,62.0,1.2e-07,58.5,sp|Q9H2A3|NGN2_HUMAN Neurogenin-2 OS=Homo sapiens OX=9606 GN=NEUROG2 PE=1 SV=2,,,,,,
OG_07280,FUN_033223-T1,Peve_00021001,Pocillopora_meandrina_HIv1___RNAseq.g29776.t1,three_way,67.0795,,,,,,,,,,,,,,,,,
OG_07281,FUN_033488-T1,Peve_00033737,Pocillopora_meandrina_HIv1___RNAseq.g12099.t1,three_way,71.806,FUN_033488-T1,Q60848,HELLS_MOUSE,,Lymphocyte-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein),Mus musculus (Mouse),50.1,807.0,3.8e-200,699.9,sp|Q60848|HELLS_MOUSE Lymphocyte-specific helicase OS=Mus musculus OX=10090 GN=Hells PE=1 SV=2,GO:0000775; GO:0001655; GO:0001822; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005721; GO:0006338; GO:0006346; GO:0006915; GO:0016787; GO:0030098; GO:0031507; GO:0031508; GO:0043066; GO:0044027; GO:0046651; GO:0051301; GO:0141119; GO:1990830; GO:2001243,apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin remodeling [GO:0006338]; chromosomal DNA methylation maintenance following DNA replication [GO:0141119]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; heterochromatin formation [GO:0031507]; kidney development [GO:0001822]; lymphocyte differentiation [GO:0030098]; lymphocyte proliferation [GO:0046651]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; pericentric heterochromatin formation [GO:0031508]; urogenital system development [GO:0001655],"chromosome, centromeric region [GO:0000775]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]",ATP binding [GO:0005524]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787],GO:0002376; GO:0003824; GO:0005634; GO:0006325; GO:0012501; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0048856; GO:0140657,immune system process; catalytic activity; nucleus; chromatin organization; programmed cell death; hydrolase activity; isomerase activity; cell differentiation; organelle; anatomical structure development; ATP-dependent activity
OG_07282,FUN_033509-T1,Peve_00009172,Pocillopora_meandrina_HIv1___RNAseq.g24179.t1,three_way,62.28966666666666,FUN_033509-T1,P14942,GSTA4_RAT,,Glutathione S-transferase alpha-4 (EC 2.5.1.18) (GST 8-8) (GST A4-4) (GST K) (Glutathione S-transferase Yk) (GST Yk),Rattus norvegicus (Rat),30.8,211.0,1.5e-17,91.3,sp|P14942|GSTA4_RAT Glutathione S-transferase alpha-4 OS=Rattus norvegicus OX=10116 GN=Gsta4 PE=1 SV=2,GO:0004364; GO:0005739; GO:0005829; GO:0006749; GO:0006805; GO:0009635; GO:0010043; GO:0015643; GO:0035094; GO:0042802; GO:0042803; GO:0071285,cellular response to lithium ion [GO:0071285]; glutathione metabolic process [GO:0006749]; response to herbicide [GO:0009635]; response to nicotine [GO:0035094]; response to zinc ion [GO:0010043]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; mitochondrion [GO:0005739],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643],GO:0003824; GO:0005739; GO:0005829; GO:0006575; GO:0006790; GO:0016740; GO:0043226,catalytic activity; mitochondrion; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle
OG_07283,FUN_033510-T1,Peve_00041772,Pocillopora_meandrina_HIv1___RNAseq.g24351.t1,three_way,50.45783333333333,FUN_033510-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),39.7,343.0,3.3e-68,261.5,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_07284,FUN_033608-T1,Peve_00041752,Pocillopora_meandrina_HIv1___RNAseq.g24385.t1,three_way,81.65133333333334,FUN_033608-T1,Q9QUR6,,,,,66.5,708.0,4.9e-299,1028.1,sp|Q9QUR6|PPCE_MOUSE Prolyl endopeptidase OS=Mus musculus OX=10090 GN=Prep PE=1 SV=1,,,,,,
OG_07285,FUN_033611-T1,Peve_00007851,Pocillopora_meandrina_HIv1___TS.g24988.t1b,three_way,76.69316666666667,FUN_033611-T1,Q80TP3,UBR5_MOUSE,,"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog)",Mus musculus (Mouse),42.4,2918.0,0.0,1864.0,sp|Q80TP3|UBR5_MOUSE E3 ubiquitin-protein ligase UBR5 OS=Mus musculus OX=10090 GN=Ubr5 PE=1 SV=2,GO:0003723; GO:0005634; GO:0005737; GO:0006281; GO:0006974; GO:0008270; GO:0010628; GO:0031647; GO:0032700; GO:0032991; GO:0033696; GO:0043130; GO:0045879; GO:0048471; GO:0050847; GO:0061630; GO:0071596; GO:0071629; GO:0071630; GO:0140861; GO:0141198,cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smoothened signaling pathway [GO:0045879]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of gene expression [GO:0010628]; progesterone receptor signaling pathway [GO:0050847]; protein branched polyubiquitination [GO:0141198]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_07286,FUN_033666-T1,Peve_00006805,Pocillopora_meandrina_HIv1___RNAseq.g28824.t1,three_way,56.083,,,,,,,,,,,,,,,,,
OG_07287,FUN_033668-T1,Peve_00006804,Pocillopora_meandrina_HIv1___RNAseq.g28825.t1,three_way,80.98966666666666,FUN_033668-T1,O70579,,,,,61.8,204.0,3.6e-63,243.0,sp|O70579|PM34_MOUSE Peroxisomal membrane protein PMP34 OS=Mus musculus OX=10090 GN=Slc25a17 PE=1 SV=1,,,,,,
OG_07288,FUN_033669-T1,Peve_00006803,Pocillopora_meandrina_HIv1___RNAseq.g28826.t1,three_way,71.8855,,,,,,,,,,,,,,,,,
OG_07289,FUN_033670-T1,Peve_00037062,Pocillopora_meandrina_HIv1___RNAseq.g28727.t1,three_way,77.678,,,,,,,,,,,,,,,,,
OG_07290,FUN_033671-T1,Peve_00037059,Pocillopora_meandrina_HIv1___RNAseq.g28729.t1,three_way,39.33133333333333,FUN_033671-T1,A2APV2,,,,,42.6,237.0,1.1e-43,179.9,sp|A2APV2|FMNL2_MOUSE Formin-like protein 2 OS=Mus musculus OX=10090 GN=Fmnl2 PE=1 SV=2,,,,,,
OG_07291,FUN_033672-T1,Peve_00037093,Pocillopora_meandrina_HIv1___RNAseq.g25923.t1,three_way,75.25266666666667,FUN_033672-T1,O05218,,,,,36.4,549.0,6.5e-89,329.7,sp|O05218|YWRD_BACSU Glutathione hydrolase-like YwrD proenzyme OS=Bacillus subtilis (strain 168) OX=224308 GN=ywrD PE=1 SV=1,,,,,,
OG_07292,FUN_033674-T1,Peve_00006807,Pocillopora_meandrina_HIv1___RNAseq.g28846.t1,three_way,76.976,FUN_033674-T1,Q728Q5,,,,,30.7,205.0,5.0999999999999995e-24,112.8,sp|Q728Q5|AZOR_NITV2 FMN-dependent NADH:quinone oxidoreductase OS=Nitratidesulfovibrio vulgaris (strain ATCC 29579 / DSM 644 / CCUG 34227 / NCIMB 8303 / VKM B-1760 / Hildenborough) OX=882 GN=azoR PE=3 SV=1,,,,,,
OG_07293,FUN_033675-T1,Peve_00006808,Pocillopora_meandrina_HIv1___TS.g8603.t2,three_way,61.733,FUN_033675-T1,Q8R1N4,,,,,33.3,360.0,2.1e-53,211.1,sp|Q8R1N4|NUDC3_MOUSE NudC domain-containing protein 3 OS=Mus musculus OX=10090 GN=Nudcd3 PE=1 SV=3,,,,,,
OG_07294,FUN_033676-T1,Peve_00002018,Pocillopora_meandrina_HIv1___RNAseq.g6612.t1,three_way,56.45333333333333,,,,,,,,,,,,,,,,,
OG_07295,FUN_033677-T2,Peve_00025912,Pocillopora_meandrina_HIv1___TS.g18594.t1,three_way,73.50366666666666,FUN_033677-T2,P0C6B8,,,,,25.9,1080.0,2.6e-74,282.3,"sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1",,,,,,
OG_07296,FUN_033680-T1,Peve_00025920,Pocillopora_meandrina_HIv1___RNAseq.g25844.t1,three_way,85.704,,,,,,,,,,,,,,,,,
OG_07297,FUN_033681-T1,Peve_00042855,Pocillopora_meandrina_HIv1___RNAseq.g25845.t3,three_way,71.65066666666667,FUN_033681-T1,Q80TT2,BAIP3_MOUSE,,BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3) (Baiap3),Mus musculus (Mouse),32.6,1060.0,1.9e-154,548.5,sp|Q80TT2|BAIP3_MOUSE BAI1-associated protein 3 OS=Mus musculus OX=10090 GN=Baiap3 PE=1 SV=4,GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0050795; GO:0050804; GO:0055038; GO:0098793; GO:0098982; GO:1905413; GO:1990502,"dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of behavior [GO:0050795]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005829; GO:0005886; GO:0008289; GO:0016192,cytosol; plasma membrane; lipid binding; vesicle-mediated transport
OG_07298,FUN_033683-T1,Peve_00042857,Pocillopora_meandrina_HIv1___RNAseq.g25846.t1,three_way,70.0405,FUN_033683-T1,Q6ZUK4,,,,,26.1,387.0,2.9e-23,111.3,sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1,,,,,,
OG_07299,FUN_033684-T1,Peve_00042858,Pocillopora_meandrina_HIv1___RNAseq.g25847.t1,three_way,79.03466666666667,,,,,,,,,,,,,,,,,
OG_07300,FUN_033685-T1,Peve_00042859,Pocillopora_meandrina_HIv1___RNAseq.g6845.t1,three_way,63.208666666666666,,,,,,,,,,,,,,,,,
OG_07301,FUN_033687-T1,Peve_00030755,Pocillopora_meandrina_HIv1___RNAseq.g28834.t1,three_way,70.18366666666667,FUN_033687-T1,P48441,IDUA_MOUSE,,Alpha-L-iduronidase (EC 3.2.1.76),Mus musculus (Mouse),44.5,613.0,6.9e-159,562.8,sp|P48441|IDUA_MOUSE Alpha-L-iduronidase OS=Mus musculus OX=10090 GN=Idua PE=1 SV=2,GO:0000902; GO:0003940; GO:0005615; GO:0005764; GO:0005975; GO:0006027; GO:0007040; GO:0007613; GO:0007626; GO:0007628; GO:0008344; GO:0008542; GO:0030198; GO:0030200; GO:0030209; GO:0030211; GO:0035108; GO:0043202; GO:0045780; GO:0048705; GO:0048878; GO:0060348; GO:0061037; GO:0090341; GO:0120158; GO:1990079,adult locomotory behavior [GO:0008344]; adult walking behavior [GO:0007628]; bone development [GO:0060348]; carbohydrate metabolic process [GO:0005975]; cartilage homeostasis [GO:1990079]; cell morphogenesis [GO:0000902]; chemical homeostasis [GO:0048878]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; extracellular matrix organization [GO:0030198]; glycosaminoglycan catabolic process [GO:0006027]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan catabolic process [GO:0030211]; limb morphogenesis [GO:0035108]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; memory [GO:0007613]; negative regulation of cartilage development [GO:0061037]; negative regulation of secretion of lysosomal enzymes [GO:0090341]; positive regulation of bone resorption [GO:0045780]; positive regulation of collagen catabolic process [GO:0120158]; skeletal system morphogenesis [GO:0048705]; visual learning [GO:0008542],extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],L-iduronidase activity [GO:0003940],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005975; GO:0007040; GO:0016787; GO:0030163; GO:0030198; GO:0043226; GO:0048856; GO:0050877; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; carbohydrate metabolic process; lysosome organization; hydrolase activity; protein catabolic process; extracellular matrix organization; organelle; anatomical structure development; nervous system process; carbohydrate derivative metabolic process
OG_07302,FUN_033688-T1,Peve_00010874,Pocillopora_meandrina_HIv1___TS.g18604.t2,three_way,85.6255,,,,,,,,,,,,,,,,,
OG_07303,FUN_033689-T1,Peve_00010871,Pocillopora_meandrina_HIv1___TS.g21813.t1,three_way,59.508,FUN_033689-T1,Q62867,GGH_RAT,,Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase),Rattus norvegicus (Rat),39.4,322.0,1.9000000000000001e-59,231.1,sp|Q62867|GGH_RAT Gamma-glutamyl hydrolase OS=Rattus norvegicus OX=10116 GN=Ggh PE=1 SV=1,GO:0005615; GO:0005764; GO:0005773; GO:0009410; GO:0010043; GO:0032868; GO:0034722; GO:0042470; GO:0045471; GO:0046900,response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900],extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773],gamma-glutamyl-peptidase activity [GO:0034722],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0006575; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; modified amino acid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07304,FUN_033690-T1,Peve_00010870,Pocillopora_meandrina_HIv1___RNAseq.g25853.t1,three_way,71.70283333333333,,,,,,,,,,,,,,,,,
OG_07305,FUN_033691-T1,Peve_00010865,Pocillopora_meandrina_HIv1___RNAseq.g25877.t1,three_way,90.88,FUN_033691-T1,A7SMR1,EIF3D_NEMVE,,Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7),Nematostella vectensis (Starlet sea anemone),76.6,475.0,2.6e-211,736.1,sp|A7SMR1|EIF3D_NEMVE Eukaryotic translation initiation factor 3 subunit D OS=Nematostella vectensis OX=45351 GN=v1g235689 PE=3 SV=1,GO:0001732; GO:0002191; GO:0003743; GO:0005852; GO:0006413; GO:0016282; GO:0033290; GO:0098808,cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852],mRNA cap binding [GO:0098808]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_07306,FUN_033692-T1,Peve_00010864,Pocillopora_meandrina_HIv1___RNAseq.g25878.t1,three_way,73.286,FUN_033692-T1,P36366,,,,,26.0,520.0,6.599999999999998e-41,170.2,sp|P36366|FMO2_CAVPO Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Cavia porcellus OX=10141 GN=FMO2 PE=2 SV=2,,,,,,
OG_07307,FUN_033693-T1,Peve_00042850,Pocillopora_meandrina_HIv1___RNAseq.g25880.t1,three_way,93.79566666666668,FUN_033693-T1,Q5ZL16,WIPI3_CHICK,,WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45B),Gallus gallus (Chicken),78.4,342.0,5.4e-163,575.1,sp|Q5ZL16|WIPI3_CHICK WD repeat domain phosphoinositide-interacting protein 3 OS=Gallus gallus OX=9031 GN=WDR45B PE=2 SV=1,GO:0000045; GO:0000407; GO:0000422; GO:0000425; GO:0005764; GO:0005829; GO:0009267; GO:0030674; GO:0032266; GO:0034045; GO:0034497; GO:0044804; GO:0061723; GO:0080025,autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; glycophagy [GO:0061723]; nucleophagy [GO:0044804]; pexophagy [GO:0000425]; protein localization to phagophore assembly site [GO:0034497],cytosol [GO:0005829]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein-macromolecule adaptor activity [GO:0030674]",GO:0005764; GO:0005773; GO:0005829; GO:0005975; GO:0006091; GO:0006914; GO:0008289; GO:0043226; GO:0060090,lysosome; vacuole; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; autophagy; lipid binding; organelle; molecular adaptor activity
OG_07308,FUN_033694-T1,Peve_00042849,Pocillopora_meandrina_HIv1___RNAseq.g25879.t1,three_way,83.94766666666666,FUN_033694-T1,A8E4L1,,,,,55.4,65.0,5.1e-16,84.7,sp|A8E4L1|COX19_BOVIN Cytochrome c oxidase assembly protein COX19 OS=Bos taurus OX=9913 GN=COX19 PE=3 SV=1,,,,,,
OG_07309,FUN_033695-T1,Peve_00042861,Pocillopora_meandrina_HIv1___RNAseq.g25901.t1,three_way,82.69466666666666,FUN_033695-T1,Q8K4Y7,CANT1_RAT,,Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog),Rattus norvegicus (Rat),53.5,340.0,5.9e-103,375.9,sp|Q8K4Y7|CANT1_RAT Soluble calcium-activated nucleotidase 1 OS=Rattus norvegicus OX=10116 GN=Cant1 PE=1 SV=1,GO:0004382; GO:0005509; GO:0005789; GO:0016020; GO:0030166; GO:0032580; GO:0042803; GO:0043262; GO:0045134,proteoglycan biosynthetic process [GO:0030166],endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020],ADP phosphatase activity [GO:0043262]; calcium ion binding [GO:0005509]; GDP phosphatase activity [GO:0004382]; protein homodimerization activity [GO:0042803]; UDP phosphatase activity [GO:0045134],GO:0003824; GO:0009101; GO:0016787; GO:1901135,catalytic activity; glycoprotein biosynthetic process; hydrolase activity; carbohydrate derivative metabolic process
OG_07310,FUN_033698-T1,Peve_00027578,Pocillopora_meandrina_HIv1___TS.g8559.t1,three_way,66.93816666666667,,,,,,,,,,,,,,,,,
OG_07311,FUN_033700-T1,Peve_00027581,Pocillopora_meandrina_HIv1___RNAseq.g28769.t1,three_way,83.841,FUN_033700-T1,Q2HZX7,FUZZY_XENTR,,Protein fuzzy homolog (Xfy),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),47.5,417.0,1.1e-107,391.7,sp|Q2HZX7|FUZZY_XENTR Protein fuzzy homolog OS=Xenopus tropicalis OX=8364 GN=fuz PE=1 SV=1,GO:0001736; GO:0001843; GO:0005737; GO:0005856; GO:0008589; GO:0010172; GO:0015031; GO:0016192; GO:0042995; GO:0048704; GO:0060271,cilium assembly [GO:0060271]; embryonic body morphogenesis [GO:0010172]; embryonic skeletal system morphogenesis [GO:0048704]; establishment of planar polarity [GO:0001736]; neural tube closure [GO:0001843]; protein transport [GO:0015031]; regulation of smoothened signaling pathway [GO:0008589]; vesicle-mediated transport [GO:0016192],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],,GO:0005856; GO:0016192; GO:0043226; GO:0044782,cytoskeleton; vesicle-mediated transport; organelle; cilium organization
OG_07312,FUN_033703-T1,Peve_00027582,Pocillopora_meandrina_HIv1___RNAseq.g28765.t1,three_way,58.368833333333335,FUN_033703-T1,Q6GP15,,,,,32.4,463.0,5.3e-51,203.4,sp|Q6GP15|MED25_XENLA Mediator of RNA polymerase II transcription subunit 25 OS=Xenopus laevis OX=8355 GN=med25 PE=2 SV=1,,,,,,
OG_07313,FUN_033704-T1,Peve_00032797,Pocillopora_meandrina_HIv1___RNAseq.g3999.t1,three_way,55.599,FUN_033704-T1,A0A2B4RNI3,,,,,54.9,692.0,1e-200,701.4,sp|A0A2B4RNI3|CGLR2_STYPI Cyclic GMP-AMP synthase-like receptor 2 OS=Stylophora pistillata OX=50429 GN=cGLR2 PE=1 SV=1,,,,,,
OG_07314,FUN_033706-T1,Peve_00042860,Pocillopora_meandrina_HIv1___RNAseq.g25900.t1,three_way,65.661,FUN_033706-T1,P07992,ERCC1_HUMAN,,DNA excision repair protein ERCC-1,Homo sapiens (Human),65.2,198.0,5.100000000000001e-74,279.6,sp|P07992|ERCC1_HUMAN DNA excision repair protein ERCC-1 OS=Homo sapiens OX=9606 GN=ERCC1 PE=1 SV=1,GO:0000109; GO:0000110; GO:0000720; GO:0000781; GO:0001094; GO:0003684; GO:0003697; GO:0005654; GO:0005737; GO:0006281; GO:0006289; GO:0006303; GO:0006312; GO:0006949; GO:0006979; GO:0007283; GO:0008283; GO:0008340; GO:0008584; GO:0009650; GO:0010165; GO:0032205; GO:0035166; GO:0035264; GO:0036297; GO:0045190; GO:0048009; GO:0048477; GO:0060261; GO:0061819; GO:0070522; GO:0070914; GO:0090399; GO:0090656; GO:1904431; GO:1905765; GO:1990841,cell population proliferation [GO:0008283]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interstrand cross-link repair [GO:0036297]; isotype switching [GO:0045190]; male gonad development [GO:0008584]; mitotic recombination [GO:0006312]; multicellular organism growth [GO:0035264]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of telomere maintenance [GO:0032205]; nucleotide-excision repair [GO:0006289]; oogenesis [GO:0048477]; positive regulation of t-circle formation [GO:1904431]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; post-embryonic hemopoiesis [GO:0035166]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; syncytium formation [GO:0006949]; t-circle formation [GO:0090656]; telomeric DNA-containing double minutes formation [GO:0061819]; UV protection [GO:0009650]; UV-damage excision repair [GO:0070914],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; ERCC4-ERCC1 complex [GO:0070522]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 1 complex [GO:0000110]",damaged DNA binding [GO:0003684]; promoter-specific chromatin binding [GO:1990841]; single-stranded DNA binding [GO:0003697]; TFIID-class transcription factor complex binding [GO:0001094],GO:0002376; GO:0003677; GO:0005654; GO:0006281; GO:0006310; GO:0006355; GO:0022414; GO:0032200; GO:0048856,immune system process; DNA binding; nucleoplasm; DNA repair; DNA recombination; regulation of DNA-templated transcription; reproductive process; telomere organization; anatomical structure development
OG_07315,FUN_033707-T1,Peve_00042846,Pocillopora_meandrina_HIv1___TS.g18650.t1,three_way,55.01383333333333,FUN_033707-T1,Q6S5C2,GNPTG_MOUSE,,N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (M6PR domain-containing protein 1) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma),Mus musculus (Mouse),40.2,276.0,7.9e-49,196.1,sp|Q6S5C2|GNPTG_MOUSE N-acetylglucosamine-1-phosphotransferase subunit gamma OS=Mus musculus OX=10090 GN=Gnptg PE=1 SV=1,GO:0005576; GO:0005794; GO:0042803; GO:0046835,carbohydrate phosphorylation [GO:0046835],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],protein homodimerization activity [GO:0042803],GO:0005576; GO:0005794; GO:0005975; GO:0043226,extracellular region; Golgi apparatus; carbohydrate metabolic process; organelle
OG_07316,FUN_033709-T1,Peve_00007404,Pocillopora_meandrina_HIv1___RNAseq.g25897.t1,three_way,55.0075,FUN_033709-T1,Q5I012,S38AA_MOUSE,,Solute carrier family 38 member 10 (Amino acid transporter SLC38A10),Mus musculus (Mouse),35.4,554.0,6.7e-76,287.0,sp|Q5I012|S38AA_MOUSE Solute carrier family 38 member 10 OS=Mus musculus OX=10090 GN=Slc38a10 PE=1 SV=2,GO:0005794; GO:0006865; GO:0016020; GO:0060348,amino acid transport [GO:0006865]; bone development [GO:0060348],Golgi apparatus [GO:0005794]; membrane [GO:0016020],,GO:0005794; GO:0043226; GO:0048856,Golgi apparatus; organelle; anatomical structure development
OG_07317,FUN_033710-T1,Peve_00014635,Pocillopora_meandrina_HIv1___RNAseq.g25890.t1,three_way,79.785,FUN_033710-T1,P53369,8ODP_RAT,,"Oxidized purine nucleoside triphosphate hydrolase (EC 3.6.1.56) (2-hydroxy-dATP diphosphatase) (7,8-dihydro-8-oxoguanine triphosphatase) (8-oxo-dGTPase) (Methylated purine nucleoside triphosphate hydrolase) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1)",Rattus norvegicus (Rat),61.4,153.0,6.1e-53,208.4,sp|P53369|8ODP_RAT Oxidized purine nucleoside triphosphate hydrolase OS=Rattus norvegicus OX=10116 GN=Nudt1 PE=1 SV=1,GO:0001669; GO:0005615; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0006152; GO:0008413; GO:0008584; GO:0008828; GO:0016818; GO:0030515; GO:0031965; GO:0035539; GO:0042262; GO:0046686; GO:0046872; GO:0047693; GO:0106377; GO:0106378; GO:0106431; GO:0106433,DNA protection [GO:0042262]; male gonad development [GO:0008584]; purine nucleoside catabolic process [GO:0006152]; response to cadmium ion [GO:0046686],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634],"2-hydroxy-ATP hydrolase activity [GO:0106377]; 2-hydroxy-dATP hydrolase activity [GO:0106378]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; dATP diphosphatase activity [GO:0008828]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872]; N6-methyl-(d)ATP hydrolase activity [GO:0106431]; O6-methyl-dGTP hydrolase activity [GO:0106433]; snoRNA binding [GO:0030515]",GO:0003723; GO:0003824; GO:0005615; GO:0005634; GO:0005739; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0055086; GO:1901135,RNA binding; catalytic activity; extracellular space; nucleus; mitochondrion; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07318,FUN_033711-T1,Peve_00014636,Pocillopora_meandrina_HIv1___RNAseq.g28838.t1,three_way,71.58500000000001,FUN_033711-T1,O00418,EF2K_HUMAN,,Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase),Homo sapiens (Human),45.3,695.0,2.2e-155,550.8,sp|O00418|EF2K_HUMAN Eukaryotic elongation factor 2 kinase OS=Homo sapiens OX=9606 GN=EEF2K PE=1 SV=2,GO:0002931; GO:0004672; GO:0004686; GO:0005509; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006414; GO:0008135; GO:0014069; GO:0031037; GO:0032869; GO:0043066; GO:0043197; GO:0045807; GO:0046777; GO:0051965; GO:0061003; GO:0071277; GO:0071320; GO:0071454; GO:0098978; GO:0140245; GO:1990416; GO:1990637,cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; myosin II filament disassembly [GO:0031037]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of translation at postsynapse [GO:0140245]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637]; translational elongation [GO:0006414],cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069],"ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; protein kinase activity [GO:0004672]; translation factor activity, RNA binding [GO:0008135]",GO:0003824; GO:0005829; GO:0007010; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07319,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),34.7,404.0,4.399999999999998e-47,191.8,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07319,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),36.6,243.0,1.1e-37,160.6,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07320,FUN_033713-T1,Peve_00017867,Pocillopora_meandrina_HIv1___RNAseq.g28833.t1,three_way,70.459,FUN_033713-T1,A7E3W5,SNG2_BOVIN,,Synaptogyrin-2 (Cellugyrin),Bos taurus (Bovine),40.1,222.0,3.2e-39,163.3,sp|A7E3W5|SNG2_BOVIN Synaptogyrin-2 OS=Bos taurus OX=9913 GN=SYNGR2 PE=2 SV=1,GO:0030672; GO:0031594; GO:0045055; GO:0048499,regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499],neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672],,GO:0016192; GO:0061024,vesicle-mediated transport; membrane organization
OG_07321,FUN_033714-T1,Peve_00017869,Pocillopora_meandrina_HIv1___RNAseq.g28832.t1,three_way,41.261,,,,,,,,,,,,,,,,,
OG_07322,FUN_033715-T1,Peve_00017870,Pocillopora_meandrina_HIv1___RNAseq.g22319.t1,three_way,70.41133333333333,FUN_033715-T1,Q9ZNT0,VPS4_ARATH,,Protein SUPPRESSOR OF K(+) TRANSPORT GROWTH DEFECT 1 (AtSKD1) (EC 3.6.4.6) (Protein VACUOLAR PROTEIN SORTING 4),Arabidopsis thaliana (Mouse-ear cress),47.0,330.0,2.0000000000000003e-74,281.2,sp|Q9ZNT0|VPS4_ARATH Protein SUPPRESSOR OF K(+) TRANSPORT GROWTH DEFECT 1 OS=Arabidopsis thaliana OX=3702 GN=SKD1 PE=1 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005771; GO:0005777; GO:0007032; GO:0007033; GO:0009506; GO:0010091; GO:0015031; GO:0016192; GO:0016887; GO:0032585; GO:0055075; GO:0055078,endosome organization [GO:0007032]; potassium ion homeostasis [GO:0055075]; protein transport [GO:0015031]; sodium ion homeostasis [GO:0055078]; trichome branching [GO:0010091]; vacuole organization [GO:0007033]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasmodesma [GO:0009506],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005634; GO:0005768; GO:0005777; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nucleus; endosome; peroxisome; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_07323,FUN_033717-T1,Peve_00017865,Pocillopora_meandrina_HIv1___RNAseq.g25848.t1,three_way,68.39483333333334,FUN_033717-T1,Q8CHU3,EPN2_MOUSE,,Epsin-2 (EPS-15-interacting protein 2) (Intersectin-EH-binding protein 2) (Ibp2),Mus musculus (Mouse),47.6,361.0,7.300000000000001e-74,279.6,sp|Q8CHU3|EPN2_MOUSE Epsin-2 OS=Mus musculus OX=10090 GN=Epn2 PE=1 SV=1,GO:0001701; GO:0005737; GO:0006897; GO:0007219; GO:0008289; GO:0048568,embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; in utero embryonic development [GO:0001701]; Notch signaling pathway [GO:0007219],cytoplasm [GO:0005737],lipid binding [GO:0008289],GO:0008289; GO:0016192; GO:0048856,lipid binding; vesicle-mediated transport; anatomical structure development
OG_07324,FUN_033718-T1,Peve_00027571,Pocillopora_meandrina_HIv1___RNAseq.g25637.t1,three_way,64.38233333333334,,,,,,,,,,,,,,,,,
OG_07325,FUN_033719-T1,Peve_00027616,Pocillopora_meandrina_HIv1___RNAseq.g28865.t1,three_way,70.01366666666667,FUN_033719-T1,Q8TBP0,,,,,47.6,464.0,1.4e-120,435.3,sp|Q8TBP0|TBC16_HUMAN TBC1 domain family member 16 OS=Homo sapiens OX=9606 GN=TBC1D16 PE=1 SV=1,,,,,,
OG_07326,FUN_033720-T1,Peve_00027572,Pocillopora_meandrina_HIv1___RNAseq.g25888.t1,three_way,75.48283333333333,FUN_033720-T1,Q8VDL4,ADPGK_MOUSE,,ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147),Mus musculus (Mouse),32.2,428.0,2.5e-49,198.0,sp|Q8VDL4|ADPGK_MOUSE ADP-dependent glucokinase OS=Mus musculus OX=10090 GN=Adpgk PE=1 SV=2,GO:0005576; GO:0006006; GO:0006096; GO:0043843; GO:0046872,glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096],extracellular region [GO:0005576],ADP-specific glucokinase activity [GO:0043843]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0005975; GO:0006091; GO:0016740; GO:0055086; GO:1901135,catalytic activity; extracellular region; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07327,FUN_033721-T1,Peve_00027574,Pocillopora_meandrina_HIv1___RNAseq.g23690.t2,three_way,54.64266666666667,FUN_033721-T1,Q9CWB7,,,,,60.0,85.0,4.6e-24,112.1,sp|Q9CWB7|YD286_MOUSE Glutaredoxin-like protein C5orf63 homolog OS=Mus musculus OX=10090 PE=1 SV=1,,,,,,
OG_07328,FUN_033729-T1,Peve_00027613,Pocillopora_meandrina_HIv1___RNAseq.g28785.t3,three_way,68.036,FUN_033729-T1,Q9H0J4,QRIC2_HUMAN,,Glutamine-rich protein 2,Homo sapiens (Human),32.9,395.0,4.1e-45,184.5,sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1,GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059,cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_07329,FUN_033730-T1,Peve_00027615,Pocillopora_meandrina_HIv1___RNAseq.g28784.t1,three_way,68.86500000000001,FUN_033730-T1,Q96RR1,PEO1_HUMAN,,"Twinkle mtDNA helicase (EC 5.6.2.3) (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase) (Twinkle protein, mitochondrial)",Homo sapiens (Human),40.6,611.0,5.2e-118,426.8,sp|Q96RR1|PEO1_HUMAN Twinkle mtDNA helicase OS=Homo sapiens OX=9606 GN=TWNK PE=1 SV=1,GO:0000262; GO:0002020; GO:0003678; GO:0003697; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006261; GO:0006264; GO:0006390; GO:0008289; GO:0016887; GO:0034214; GO:0042645; GO:0042802; GO:0043139,DNA-templated DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; protein hexamerization [GO:0034214],mitochondrial chromosome [GO:0000262]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005694; GO:0005739; GO:0006260; GO:0006351; GO:0008289; GO:0016787; GO:0016853; GO:0043226; GO:0065003; GO:0140097; GO:0140657,"DNA binding; catalytic activity; chromosome; mitochondrion; DNA replication; DNA-templated transcription; lipid binding; hydrolase activity; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07330,FUN_033731-T1,Peve_00027617,Pocillopora_meandrina_HIv1___RNAseq.g28783.t1,three_way,63.181666666666665,FUN_033731-T1,Q6PHG8,,,,,40.0,170.0,1.7e-30,134.4,sp|Q6PHG8|RPA43_DANRE DNA-directed RNA polymerase I subunit RPA43 OS=Danio rerio OX=7955 GN=polr1f PE=2 SV=2,,,,,,
OG_07331,FUN_033732-T1,Peve_00027618,Pocillopora_meandrina_HIv1___RNAseq.g28782.t1,three_way,52.22166666666666,FUN_033732-T1,B3EWY8,,,,,96.7,391.0,2.9e-136,486.5,sp|B3EWY8|SAAR2_ACRMI Skeletal aspartic acid-rich protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_07332,FUN_033735-T1,Peve_00017779,Pocillopora_meandrina_HIv1___RNAseq.g7857.t1,three_way,53.07566666666667,,,,,,,,,,,,,,,,,
OG_07333,FUN_033736-T1,Peve_00027622,Pocillopora_meandrina_HIv1___RNAseq.g28776.t2,three_way,80.22166666666666,FUN_033736-T1,Q8AVR2,,,,,48.8,201.0,3.5e-40,166.4,sp|Q8AVR2|FGOP2_XENLA FGFR1 oncogene partner 2 homolog OS=Xenopus laevis OX=8355 GN=fgfr1op2 PE=2 SV=1,,,,,,
OG_07334,FUN_033738-T1,Peve_00027592,Pocillopora_meandrina_HIv1___RNAseq.g28761.t1,three_way,77.64833333333334,FUN_033738-T1,Q3ZBH3,,,,,37.7,244.0,3e-46,186.8,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_07335,FUN_033739-T1,Peve_00027591,Pocillopora_meandrina_HIv1___TS.g2617.t1,three_way,42.981,,,,,,,,,,,,,,,,,
OG_07336,FUN_033740-T1,Peve_00027590,Pocillopora_meandrina_HIv1___TS.g8552.t1c,three_way,74.79316666666666,FUN_033740-T1,Q3ZBH3,,,,,33.3,192.0,1.9e-26,120.9,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_07337,FUN_033741-T1,Peve_00027596,Pocillopora_meandrina_HIv1___RNAseq.g26636.t1,three_way,45.35183333333333,FUN_033741-T1,Q16322,KCA10_HUMAN,,Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8),Homo sapiens (Human),31.0,116.0,4.5e-06,54.3,sp|Q16322|KCA10_HUMAN Potassium voltage-gated channel subfamily A member 10 OS=Homo sapiens OX=9606 GN=KCNA10 PE=1 SV=2,GO:0001508; GO:0005221; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0016020; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260],membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; intracellularly cyclic nucleotide-activated monoatomic cation channel activity [GO:0005221]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_07338,FUN_033743-T1,Peve_00027600,Pocillopora_meandrina_HIv1___RNAseq.g28759.t1,three_way,72.24666666666667,FUN_033743-T1,P25931,,,,,27.6,293.0,2e-17,91.7,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_07339,FUN_033744-T1,Peve_00004928,Pocillopora_meandrina_HIv1___RNAseq.g28756.t1,three_way,54.52616666666667,FUN_033744-T1,O61735,,,,,28.5,362.0,1.4e-35,152.5,sp|O61735|CLOCK_DROME Circadian locomoter output cycles protein kaput OS=Drosophila melanogaster OX=7227 GN=Clk PE=1 SV=3,,,,,,
OG_07340,FUN_033745-T1,Peve_00004929,Pocillopora_meandrina_HIv1___RNAseq.g28757.t1,three_way,54.01,FUN_033745-T1,Q8QGQ6,CLOCK_CHICK,,Circadian locomoter output cycles protein kaput,Gallus gallus (Chicken),37.6,367.0,2.7000000000000002e-58,228.0,sp|Q8QGQ6|CLOCK_CHICK Circadian locomoter output cycles protein kaput OS=Gallus gallus OX=9031 GN=CLOCK PE=1 SV=2,GO:0000978; GO:0000981; GO:0003677; GO:0005634; GO:0005829; GO:0006357; GO:0006473; GO:0006974; GO:0032922; GO:0046983; GO:0051775; GO:0070888; GO:1990513,circadian regulation of gene expression [GO:0032922]; DNA damage response [GO:0006974]; protein acetylation [GO:0006473]; regulation of transcription by RNA polymerase II [GO:0006357]; response to redox state [GO:0051775],CLOCK-BMAL transcription complex [GO:1990513]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07341,FUN_033746-T1,Peve_00004930,Pocillopora_meandrina_HIv1___RNAseq.g16445.t1,three_way,68.84733333333334,,,,,,,,,,,,,,,,,
OG_07342,FUN_033747-T1,Peve_00004931,Pocillopora_meandrina_HIv1___RNAseq.g28755.t1,three_way,74.33666666666667,FUN_033747-T1,Q9DCK3,,,,,40.9,220.0,1.4e-37,157.9,sp|Q9DCK3|TSN4_MOUSE Tetraspanin-4 OS=Mus musculus OX=10090 GN=Tspan4 PE=1 SV=1,,,,,,
OG_07343,FUN_033748-T1,Peve_00004932,Pocillopora_meandrina_HIv1___RNAseq.g28754.t1,three_way,36.10916666666667,,,,,,,,,,,,,,,,,
OG_07344,FUN_033751-T1,Peve_00004933,Pocillopora_meandrina_HIv1___TS.g8542.t1,three_way,79.90966666666667,FUN_033751-T1,O95461,,,,,60.2,689.0,6.4e-254,878.2,sp|O95461|LARG1_HUMAN Xylosyl- and glucuronyltransferase LARGE1 OS=Homo sapiens OX=9606 GN=LARGE1 PE=1 SV=1,,,,,,
OG_07345,FUN_033752-T1,Peve_00004934,Pocillopora_meandrina_HIv1___RNAseq.g28752.t1,three_way,78.085,FUN_033752-T1,Q9JI85,NUCB2_RAT,,Nucleobindin-2 (DNA-binding protein NEFA) (Prepronesfatin) [Cleaved into: Nesfatin-1],Rattus norvegicus (Rat),51.0,304.0,4.3e-50,200.3,sp|Q9JI85|NUCB2_RAT Nucleobindin-2 OS=Rattus norvegicus OX=10116 GN=Nucb2 PE=1 SV=1,GO:0001965; GO:0003677; GO:0005085; GO:0005164; GO:0005509; GO:0005615; GO:0005634; GO:0005640; GO:0005737; GO:0005783; GO:0005793; GO:0005797; GO:0007264; GO:0009749; GO:0032099; GO:0042594; GO:0044752; GO:0045599; GO:0046321; GO:0046627; GO:0070093; GO:0141162; GO:1901142; GO:1990680; GO:2000845,insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085]; tumor necrosis factor receptor binding [GO:0005164],GO:0003677; GO:0005615; GO:0005634; GO:0005783; GO:0043226; GO:0098772,DNA binding; extracellular space; nucleus; endoplasmic reticulum; organelle; molecular function regulator activity
OG_07346,FUN_033753-T1,Peve_00004935,Pocillopora_meandrina_HIv1___RNAseq.g28751.t1,three_way,71.35733333333333,FUN_033753-T1,Q8MPM1,,,,,51.9,362.0,3.4e-99,363.2,sp|Q8MPM1|GELS2_LUMTE Gelsolin-like protein 2 OS=Lumbricus terrestris OX=6398 GN=gelsolin PE=1 SV=1,,,,,,
OG_07347,FUN_033754-T1,Peve_00004912,Pocillopora_meandrina_HIv1___TS.g8539.t2,three_way,70.884,FUN_033754-T1,Q7JQD3,GELS1_LUMTE,,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),Lumbricus terrestris (Common earthworm),48.5,371.0,5.8e-94,345.9,sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1,GO:0003779; GO:0005509; GO:0005737; GO:0015629; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0005856; GO:0008092; GO:0043226; GO:0065003,cytoskeleton; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_07348,FUN_033755-T1,Peve_00004913,Pocillopora_meandrina_HIv1___RNAseq.g28749.t2,three_way,76.47383333333333,FUN_033755-T1,P15384,,,,,58.7,392.0,9.1e-108,392.1,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_07349,FUN_033756-T1,Peve_00004915,Pocillopora_meandrina_HIv1___RNAseq.g28747.t1,three_way,85.5945,FUN_033756-T1,Q13136,LIPA1_HUMAN,,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),Homo sapiens (Human),45.4,1218.0,1.3e-187,658.7,sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1,GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077,cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444],,GO:0005829; GO:0007010; GO:0007155; GO:0034330; GO:0043226,cytosol; cytoskeleton organization; cell adhesion; cell junction organization; organelle
OG_07350,FUN_033757-T1,Peve_00004916,Pocillopora_meandrina_HIv1___RNAseq.g28746.t2,three_way,69.06666666666666,FUN_033757-T1,Q8IYG6,LRC56_HUMAN,,Leucine-rich repeat-containing protein 56,Homo sapiens (Human),35.6,413.0,1.5e-30,136.0,sp|Q8IYG6|LRC56_HUMAN Leucine-rich repeat-containing protein 56 OS=Homo sapiens OX=9606 GN=LRRC56 PE=1 SV=1,GO:0005929; GO:0030030,cell projection organization [GO:0030030],cilium [GO:0005929],,GO:0005929; GO:0043226,cilium; organelle
OG_07351,FUN_033759-T1,Peve_00009253,Pocillopora_meandrina_HIv1___RNAseq.g28744.t1,three_way,61.443,FUN_033759-T1,Q28005,LSHR_BOVIN,,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LSH-R),Bos taurus (Bovine),36.1,498.0,3.2000000000000003e-80,301.6,sp|Q28005|LSHR_BOVIN Lutropin-choriogonadotropic hormone receptor OS=Bos taurus OX=9913 GN=LHCGR PE=2 SV=1,GO:0001541; GO:0004964; GO:0005886; GO:0007189; GO:0007200; GO:0008528; GO:0008584; GO:0009755; GO:0022602; GO:0042700; GO:0071373,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to luteinizing hormone stimulus [GO:0071373]; hormone-mediated signaling pathway [GO:0009755]; luteinizing hormone signaling pathway [GO:0042700]; male gonad development [GO:0008584]; ovarian follicle development [GO:0001541]; ovulation cycle process [GO:0022602]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; luteinizing hormone receptor activity [GO:0004964],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_07352,FUN_033760-T2,Peve_00009251,Pocillopora_meandrina_HIv1___TS.g8526.t2,three_way,62.784333333333336,FUN_033760-T2,Q1E3S4,,,,,31.7,183.0,2e-13,78.2,sp|Q1E3S4|FES1_COCIM Hsp70 nucleotide exchange factor FES1 OS=Coccidioides immitis (strain RS) OX=246410 GN=FES1 PE=3 SV=2,,,,,,
OG_07353,FUN_033761-T1,Peve_00009250,Pocillopora_meandrina_HIv1___RNAseq.g28736.t1,three_way,73.48766666666667,FUN_033761-T1,Q2HJ55,,,,,49.7,437.0,2e-117,424.1,sp|Q2HJ55|SAM50_BOVIN Sorting and assembly machinery component 50 homolog OS=Bos taurus OX=9913 GN=SAMM50 PE=2 SV=1,,,,,,
OG_07354,FUN_033762-T1,Peve_00009249,Pocillopora_meandrina_HIv1___TS.g8524.t1,three_way,86.10033333333332,FUN_033762-T1,Q9VFC8,GYS_DROME,,Glycogen [starch] synthase (EC 2.4.1.11) (Glycogen synthase),Drosophila melanogaster (Fruit fly),60.9,627.0,8e-232,804.7,sp|Q9VFC8|GYS_DROME Glycogen [starch] synthase OS=Drosophila melanogaster OX=7227 GN=Glys PE=1 SV=2,GO:0004373; GO:0005737; GO:0005776; GO:0005829; GO:0005978; GO:0009267; GO:0009744; GO:0031410; GO:0071329,cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; response to sucrose [GO:0009744],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829],"alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity [GO:0004373]",GO:0003824; GO:0005773; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0031410; GO:0043226,catalytic activity; vacuole; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; cytoplasmic vesicle; organelle
OG_07355,FUN_033763-T1,Peve_00009255,Pocillopora_meandrina_HIv1___RNAseq.g28734.t1,three_way,65.53633333333333,FUN_033763-T1,Q6NRZ1,,,,,29.8,1444.0,1.4e-132,476.1,sp|Q6NRZ1|BLT3B_XENLA Bridge-like lipid transfer protein family member 3B OS=Xenopus laevis OX=8355 GN=bltp3b PE=2 SV=1,,,,,,
OG_07356,FUN_033764-T1,Peve_00009254,Pocillopora_meandrina_HIv1___RNAseq.g28733.t1,three_way,74.24483333333333,FUN_033764-T1,Q8INF0,GCY8E_DROME,,Soluble guanylate cyclase 88E (EC 4.6.1.2),Drosophila melanogaster (Fruit fly),52.7,609.0,2.7e-178,627.1,sp|Q8INF0|GCY8E_DROME Soluble guanylate cyclase 88E OS=Drosophila melanogaster OX=7227 GN=Gyc88E PE=1 SV=4,GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482,cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302],"guanylate cyclase complex, soluble [GO:0008074]",carbon monoxide binding [GO:0070025]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0009975; GO:0016787; GO:0016829; GO:0098772; GO:0140299,catalytic activity; GTPase activity; cyclase activity; hydrolase activity; lyase activity; molecular function regulator activity; molecular sensor activity
OG_07357,FUN_033767-T1,Peve_00005709,Pocillopora_meandrina_HIv1___RNAseq.g25936.t1,three_way,59.3455,,,,,,,,,,,,,,,,,
OG_07358,FUN_033769-T1,Peve_00006493,Pocillopora_meandrina_HIv1___RNAseq.g26662.t1,three_way,67.60866666666666,FUN_033769-T1,Q6B9X6,VWKA_DICDI,,Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase),Dictyostelium discoideum (Social amoeba),35.0,137.0,1.1e-14,82.4,sp|Q6B9X6|VWKA_DICDI Alpha-protein kinase vwkA OS=Dictyostelium discoideum OX=44689 GN=vwkA PE=1 SV=1,GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006971; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177; GO:0106310,contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288],contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005773; GO:0005829; GO:0007010; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"cytokinesis; catalytic activity; vacuole; cytosol; cytoskeleton organization; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07359,FUN_033770-T1,Peve_00006489,Pocillopora_meandrina_HIv1___RNAseq.g26661.t1,three_way,47.22,FUN_033770-T1,P10733,,,,,27.9,204.0,1.2e-17,92.4,sp|P10733|SEVE_DICDI Severin OS=Dictyostelium discoideum OX=44689 GN=sevA PE=1 SV=1,,,,,,
OG_07360,FUN_033771-T1,Peve_00006491,Pocillopora_meandrina_HIv1___RNAseq.g26660.t1,three_way,47.66133333333333,FUN_033771-T1,Q7JQD3,GELS1_LUMTE,,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),Lumbricus terrestris (Common earthworm),34.7,340.0,7.799999999999999e-49,196.1,sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1,GO:0003779; GO:0005509; GO:0005737; GO:0015629; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0005856; GO:0008092; GO:0043226; GO:0065003,cytoskeleton; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_07361,FUN_033773-T1,Peve_00005280,Pocillopora_meandrina_HIv1___RNAseq.g26658.t2,three_way,82.50433333333334,FUN_033773-T1,B9EJ86,OSBL8_MOUSE,,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),Mus musculus (Mouse),46.7,803.0,3.8e-197,689.9,sp|B9EJ86|OSBL8_MOUSE Oxysterol-binding protein-related protein 8 OS=Mus musculus OX=10090 GN=Osbpl8 PE=1 SV=1,GO:0001786; GO:0005789; GO:0015485; GO:0015914; GO:0030336; GO:0031965; GO:0045444; GO:0046326; GO:0046628; GO:0051897; GO:0070273; GO:0070328; GO:0090204; GO:0140343,fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; phospholipid transport [GO:0015914]; positive regulation of D-glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein localization to nuclear pore [GO:0090204]; triglyceride homeostasis [GO:0070328],endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965],cholesterol binding [GO:0015485]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phosphatidylserine transfer activity [GO:0140343],GO:0005215; GO:0008289; GO:0030154,transporter activity; lipid binding; cell differentiation
OG_07362,FUN_033774-T1,Peve_00005278,Pocillopora_meandrina_HIv1___RNAseq.g26656.t1,three_way,62.04566666666667,,,,,,,,,,,,,,,,,
OG_07363,FUN_033775-T1,Peve_00005277,Pocillopora_meandrina_HIv1___RNAseq.g26655.t1,three_way,73.41866666666667,FUN_033775-T1,Q64127,TIF1A_MOUSE,,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase Trim24) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24),Mus musculus (Mouse),28.5,1018.0,1.7e-86,322.4,sp|Q64127|TIF1A_MOUSE Transcription intermediary factor 1-alpha OS=Mus musculus OX=10090 GN=Trim24 PE=1 SV=1,GO:0000791; GO:0001673; GO:0002039; GO:0003682; GO:0003713; GO:0004672; GO:0004842; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0008270; GO:0010628; GO:0016567; GO:0016922; GO:0030163; GO:0031647; GO:0034056; GO:0042981; GO:0043434; GO:0043565; GO:0045892; GO:0045893; GO:0050673; GO:0050680; GO:0055074; GO:0061630; GO:0070562; GO:0070577; GO:0071391; GO:1901796,calcium ion homeostasis [GO:0055074]; cellular response to estrogen stimulus [GO:0071391]; epithelial cell proliferation [GO:0050673]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of vitamin D receptor signaling pathway [GO:0070562]; response to peptide hormone [GO:0043434],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726],chromatin binding [GO:0003682]; estrogen response element binding [GO:0034056]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_07364,FUN_033776-T1,Peve_00005287,Pocillopora_meandrina_HIv1___RNAseq.g26654.t1,three_way,88.918,FUN_033776-T1,P47830,,,,,77.0,148.0,7.8e-42,171.4,sp|P47830|RL27A_XENLA Large ribosomal subunit protein uL15 OS=Xenopus laevis OX=8355 GN=rpl27a PE=2 SV=2,,,,,,
OG_07365,FUN_033777-T1,Peve_00005283,Pocillopora_meandrina_HIv1___RNAseq.g26653.t1,three_way,63.86333333333334,FUN_033777-T1,P35790,CHKA_HUMAN,,Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82),Homo sapiens (Human),42.2,372.0,1.8e-79,297.7,sp|P35790|CHKA_HUMAN Choline kinase alpha OS=Homo sapiens OX=9606 GN=CHKA PE=1 SV=3,GO:0004103; GO:0004104; GO:0004305; GO:0004713; GO:0005524; GO:0005737; GO:0005811; GO:0005829; GO:0006629; GO:0006646; GO:0006656; GO:0006657; GO:0006869; GO:0042149; GO:0042803; GO:1905691,CDP-choline pathway [GO:0006657]; cellular response to glucose starvation [GO:0042149]; lipid droplet disassembly [GO:1905691]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811],ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; cholinesterase activity [GO:0004104]; ethanolamine kinase activity [GO:0004305]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07366,FUN_033778-T1,Peve_00025001,Pocillopora_meandrina_HIv1___RNAseq.g26651.t1,three_way,74.63816666666666,FUN_033778-T1,O00327,BMAL1_HUMAN,,Basic helix-loop-helix ARNT-like protein 1 (Aryl hydrocarbon receptor nuclear translocator-like protein 1) (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5) (bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3),Homo sapiens (Human),43.1,634.0,9.999999999999999e-123,442.2,sp|O00327|BMAL1_HUMAN Basic helix-loop-helix ARNT-like protein 1 OS=Homo sapiens OX=9606 GN=BMAL1 PE=1 SV=2,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0003677; GO:0003712; GO:0005634; GO:0005654; GO:0006355; GO:0006357; GO:0007283; GO:0007623; GO:0016605; GO:0017162; GO:0032007; GO:0032922; GO:0033391; GO:0034751; GO:0042634; GO:0042753; GO:0043161; GO:0043231; GO:0043565; GO:0045599; GO:0045892; GO:0045893; GO:0045944; GO:0046983; GO:0050767; GO:0050796; GO:0051726; GO:0051775; GO:0051879; GO:0070888; GO:0090263; GO:0090403; GO:0097009; GO:0120163; GO:0140297; GO:1901985; GO:1990513; GO:1990837; GO:2000074; GO:2000323; GO:2000772; GO:2001016,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; energy homeostasis [GO:0097009]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of nuclear receptor-mediated glucocorticoid signaling pathway [GO:2000323]; negative regulation of TOR signaling [GO:0032007]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein acetylation [GO:1901985]; positive regulation of skeletal muscle cell differentiation [GO:2001016]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell cycle [GO:0051726]; regulation of cellular senescence [GO:2000772]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair cycle [GO:0042634]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell development [GO:2000074]; response to redox state [GO:0051775]; spermatogenesis [GO:0007283],aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; chromatoid body [GO:0033391]; CLOCK-BMAL transcription complex [GO:1990513]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],"aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; Hsp90 protein binding [GO:0051879]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030163; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; protein catabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_07367,FUN_033784-T1,Peve_00014252,Pocillopora_meandrina_HIv1___RNAseq.g26641.t2,three_way,77.84533333333333,FUN_033784-T1,Q2TBN5,,,,,49.2,189.0,1.6999999999999998e-43,177.6,sp|Q2TBN5|COMD9_BOVIN COMM domain-containing protein 9 OS=Bos taurus OX=9913 GN=COMMD9 PE=2 SV=1,,,,,,
OG_07368,FUN_033785-T1,Peve_00014251,Pocillopora_meandrina_HIv1___RNAseq.18346_t,three_way,74.81,FUN_033785-T1,Q4R4W5,IDI1_MACFA,,Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) (IPPI1),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),57.0,221.0,2.9e-72,273.1,sp|Q4R4W5|IDI1_MACFA Isopentenyl-diphosphate Delta-isomerase 1 OS=Macaca fascicularis OX=9541 GN=IDI1 PE=2 SV=2,GO:0004452; GO:0005777; GO:0006695; GO:0009240; GO:0046872; GO:0050992,cholesterol biosynthetic process [GO:0006695]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240],peroxisome [GO:0005777],isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; metal ion binding [GO:0046872],GO:0003824; GO:0005777; GO:0006629; GO:0016853; GO:0043226,catalytic activity; peroxisome; lipid metabolic process; isomerase activity; organelle
OG_07369,FUN_033786-T1,Peve_00014256,Pocillopora_meandrina_HIv1___RNAseq.g26643.t1,three_way,63.952333333333335,,,,,,,,,,,,,,,,,
OG_07370,FUN_033787-T1,Peve_00014255,Pocillopora_meandrina_HIv1___RNAseq.g26644.t1,three_way,95.845,FUN_033787-T1,Q9DE27,,,,,85.8,466.0,1.3e-223,776.9,sp|Q9DE27|RUVB2_XENLA RuvB-like 2 OS=Xenopus laevis OX=8355 GN=ruvbl2 PE=2 SV=1,,,,,,
OG_07371,FUN_033788-T1,Peve_00018801,Pocillopora_meandrina_HIv1___RNAseq.g26645.t1,three_way,76.75766666666667,FUN_033788-T1,O15457,MSH4_HUMAN,,MutS protein homolog 4 (hMSH4),Homo sapiens (Human),45.6,439.0,4e-90,333.2,sp|O15457|MSH4_HUMAN MutS protein homolog 4 OS=Homo sapiens OX=9606 GN=MSH4 PE=1 SV=2,GO:0000795; GO:0001541; GO:0003677; GO:0003690; GO:0005524; GO:0005634; GO:0005694; GO:0005713; GO:0006298; GO:0007129; GO:0007131; GO:0007283; GO:0007292; GO:0030983; GO:0140664,female gamete generation [GO:0007292]; homologous chromosome pairing at meiosis [GO:0007129]; mismatch repair [GO:0006298]; ovarian follicle development [GO:0001541]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283],chromosome [GO:0005694]; nucleus [GO:0005634]; recombination nodule [GO:0005713]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; mismatched DNA binding [GO:0030983],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0006310; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; chromosome; DNA repair; DNA recombination; reproductive process; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_07372,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,43.9,214.0,1.7e-40,169.9,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07372,FUN_033792-T1,Peve_00029691,Pocillopora_meandrina_HIv1___RNAseq.g26638.t2,three_way,43.8095,FUN_033792-T1,Q9P1Y6,,,,,30.4,171.0,0.00058,48.5,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_07373,FUN_033793-T2,Peve_00029690,Pocillopora_meandrina_HIv1___RNAseq.g26316.t1,three_way,63.531666666666666,,,,,,,,,,,,,,,,,
OG_07374,FUN_033796-T1,Peve_00029689,Pocillopora_meandrina_HIv1___RNAseq.g26321.t1,three_way,45.691,,,,,,,,,,,,,,,,,
OG_07375,FUN_033797-T1,Peve_00029703,Pocillopora_meandrina_HIv1___RNAseq.g26319.t1,three_way,67.2325,FUN_033797-T1,O95071,,,,,39.0,318.0,1.5e-52,211.1,sp|O95071|UBR5_HUMAN E3 ubiquitin-protein ligase UBR5 OS=Homo sapiens OX=9606 GN=UBR5 PE=1 SV=2,,,,,,
OG_07376,FUN_033798-T1,Peve_00029699,Pocillopora_meandrina_HIv1___TS.g19067.t1,three_way,72.4535,FUN_033798-T1,Q8R0S4,CACB4_MOUSE,,Voltage-dependent L-type calcium channel subunit beta-4 (CAB4) (Calcium channel voltage-dependent subunit beta 4),Mus musculus (Mouse),47.8,251.0,2.2999999999999998e-55,218.0,sp|Q8R0S4|CACB4_MOUSE Voltage-dependent L-type calcium channel subunit beta-4 OS=Mus musculus OX=10090 GN=Cacnb4 PE=1 SV=2,GO:0005245; GO:0005886; GO:0005891; GO:0006816; GO:0007214; GO:0007528; GO:0007628; GO:0008285; GO:0008331; GO:0014051; GO:0016607; GO:0019227; GO:0019901; GO:0035249; GO:0042391; GO:0046058; GO:0048536; GO:0048538; GO:0048541; GO:0050852; GO:0050877; GO:0050908; GO:0055001; GO:0098793; GO:0098978; GO:0099626; GO:1904751; GO:1990830; GO:2000134; GO:2000300,"adult walking behavior [GO:0007628]; calcium ion transport [GO:0006816]; cAMP metabolic process [GO:0046058]; cellular response to leukemia inhibitory factor [GO:1990830]; detection of light stimulus involved in visual perception [GO:0050908]; gamma-aminobutyric acid secretion [GO:0014051]; gamma-aminobutyric acid signaling pathway [GO:0007214]; muscle cell development [GO:0055001]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; nervous system process [GO:0050877]; neuromuscular junction development [GO:0007528]; neuronal action potential propagation [GO:0019227]; Peyer's patch development [GO:0048541]; positive regulation of protein localization to nucleolus [GO:1904751]; regulation of membrane potential [GO:0042391]; regulation of synaptic vesicle exocytosis [GO:2000300]; spleen development [GO:0048536]; synaptic transmission, glutamatergic [GO:0035249]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]",glutamatergic synapse [GO:0098978]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; voltage-gated calcium channel complex [GO:0005891],high voltage-gated calcium channel activity [GO:0008331]; protein kinase binding [GO:0019901]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels [GO:0099626],GO:0002376; GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:1901135,immune system process; transporter activity; plasma membrane; signaling; cell junction organization; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07377,FUN_033799-T2,Peve_00007573,Pocillopora_meandrina_HIv1___RNAseq.g26317.t1,three_way,61.620666666666665,,,,,,,,,,,,,,,,,
OG_07378,FUN_033800-T1,Peve_00007584,Pocillopora_meandrina_HIv1___RNAseq.g26322.t1,three_way,43.99316666666667,,,,,,,,,,,,,,,,,
OG_07379,FUN_033801-T1,Peve_00009709,Pocillopora_meandrina_HIv1___RNAseq.g26326.t1,three_way,35.447,,,,,,,,,,,,,,,,,
OG_07380,FUN_033802-T1,Peve_00009708,Pocillopora_meandrina_HIv1___RNAseq.g26325.t1,three_way,55.423,FUN_033802-T1,Q7ZVS9,MYCB_DANRE,,Transcriptional regulator Myc-B (c-Myc-B),Danio rerio (Zebrafish) (Brachydanio rerio),37.0,100.0,2.2e-10,68.2,sp|Q7ZVS9|MYCB_DANRE Transcriptional regulator Myc-B OS=Danio rerio OX=7955 GN=mycb PE=2 SV=1,GO:0000122; GO:0000978; GO:0000981; GO:0002244; GO:0005634; GO:0006357; GO:0008284; GO:0042246; GO:0045944; GO:0046983; GO:0060216,definitive hemopoiesis [GO:0060216]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; tissue regeneration [GO:0042246],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07381,FUN_033803-T1,Peve_00009714,Pocillopora_meandrina_HIv1___RNAseq.g26324.t1,three_way,73.78666666666666,FUN_033803-T1,P01108,,,,,27.5,415.0,2.2e-16,88.2,sp|P01108|MYC_MOUSE Myc proto-oncogene protein OS=Mus musculus OX=10090 GN=Myc PE=1 SV=2,,,,,,
OG_07382,FUN_033804-T1,Peve_00009713,Pocillopora_meandrina_HIv1___RNAseq.g26323.t1,three_way,76.55666666666666,FUN_033804-T1,Q90341,,,,,52.7,91.0,6.4e-15,83.2,sp|Q90341|MYC1_CYPCA Transcriptional regulator Myc-1 OS=Cyprinus carpio OX=7962 GN=myca PE=3 SV=1,,,,,,
OG_07383,FUN_033809-T1,Peve_00033385,Pocillopora_meandrina_HIv1___TS.g19094.t1,three_way,82.90566666666666,FUN_033809-T1,Q9W6H5,UBC9A_DANRE,,SUMO-conjugating enzyme UBC9-A (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9-A) (SUMO-protein ligase A) (Ubiquitin carrier protein 9-A) (Ubiquitin carrier protein I-A) (Ubiquitin-conjugating enzyme E2 I-A) (Ubiquitin-protein ligase I-A),Danio rerio (Zebrafish) (Brachydanio rerio),54.2,153.0,1.7e-48,193.7,sp|Q9W6H5|UBC9A_DANRE SUMO-conjugating enzyme UBC9-A OS=Danio rerio OX=7955 GN=ube2ia PE=1 SV=1,GO:0001947; GO:0005524; GO:0005634; GO:0007059; GO:0007088; GO:0016925; GO:0019789; GO:0031099; GO:0036306; GO:0051301; GO:0060216; GO:0061484; GO:0061656,cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; hematopoietic stem cell homeostasis [GO:0061484]; protein sumoylation [GO:0016925]; regeneration [GO:0031099]; regulation of mitotic nuclear division [GO:0007088],nucleus [GO:0005634],ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]; SUMO transferase activity [GO:0019789],GO:0003824; GO:0005634; GO:0007059; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; chromosome segregation; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07384,FUN_033810-T1,Peve_00028712,Pocillopora_meandrina_HIv1___RNAseq.g26344.t1,three_way,76.18866666666666,FUN_033810-T1,Q7T2D4,,,,,43.4,371.0,2.5e-77,290.8,sp|Q7T2D4|ERGI2_DANRE Endoplasmic reticulum-Golgi intermediate compartment protein 2 OS=Danio rerio OX=7955 GN=ergic2 PE=2 SV=1,,,,,,
OG_07385,FUN_033812-T1,Peve_00028718,Pocillopora_meandrina_HIv1___RNAseq.g26345.t1,three_way,82.21633333333334,FUN_033812-T1,Q9C040,TRIM2_HUMAN,,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2),Homo sapiens (Human),28.2,550.0,1.4000000000000001e-59,232.6,sp|Q9C040|TRIM2_HUMAN Tripartite motif-containing protein 2 OS=Homo sapiens OX=9606 GN=TRIM2 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],cytoplasm [GO:0005737],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_07386,FUN_033813-T1,Peve_00028719,Pocillopora_meandrina_HIv1___RNAseq.g26346.t1,three_way,86.456,FUN_033813-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,533.0,2.9e-60,235.0,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07387,FUN_033814-T1,Peve_00028720,Pocillopora_meandrina_HIv1___RNAseq.g26347.t1,three_way,89.28699999999999,,,,,,,,,,,,,,,,,
OG_07388,FUN_033815-T1,Peve_00028731,Pocillopora_meandrina_HIv1___RNAseq.g26348.t1,three_way,86.71966666666667,FUN_033815-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),32.6,552.0,5.8e-72,273.9,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07389,FUN_033818-T1,Peve_00028736,Pocillopora_meandrina_HIv1___RNAseq.g26354.t1,three_way,55.74516666666667,FUN_033818-T1,B3EWY6,,,,,96.4,386.0,1.3e-160,567.4,sp|B3EWY6|SAAR1_ACRMI Skeletal aspartic acid-rich protein 1 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_07390,FUN_033819-T1,Peve_00028739,Pocillopora_meandrina_HIv1___RNAseq.g26353.t1,three_way,66.712,FUN_033819-T1,Q9GZZ6,,,,,30.9,433.0,7.5e-59,229.6,sp|Q9GZZ6|ACH10_HUMAN Neuronal acetylcholine receptor subunit alpha-10 OS=Homo sapiens OX=9606 GN=CHRNA10 PE=1 SV=1,,,,,,
OG_07391,FUN_033820-T1,Peve_00028743,Pocillopora_meandrina_HIv1___RNAseq.g26352.t1,three_way,71.83,FUN_033820-T1,Q80VW5,WHRN_MOUSE,,Whirlin,Mus musculus (Mouse),32.1,324.0,3.8e-36,154.5,sp|Q80VW5|WHRN_MOUSE Whirlin OS=Mus musculus OX=10090 GN=Whrn PE=1 SV=3,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005829; GO:0005884; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032421; GO:0032426; GO:0036064; GO:0042802; GO:0043005; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005829; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; cytosol; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_07392,FUN_033822-T1,Peve_00028749,Pocillopora_meandrina_HIv1___RNAseq.g26351.t1,three_way,76.16866666666667,FUN_033822-T1,Q9H6K1,,,,,60.7,140.0,2.5e-44,180.3,sp|Q9H6K1|ILRUN_HUMAN Protein ILRUN OS=Homo sapiens OX=9606 GN=ILRUN PE=1 SV=2,,,,,,
OG_07393,FUN_033823-T1,Peve_00028748,Pocillopora_meandrina_HIv1___RNAseq.g26350.t1,three_way,70.8005,,,,,,,,,,,,,,,,,
OG_07394,FUN_033824-T1,Peve_00028770,Pocillopora_meandrina_HIv1___RNAseq.g26355.t1,three_way,53.976,,,,,,,,,,,,,,,,,
OG_07395,FUN_033834-T1,Peve_00028775,Pocillopora_meandrina_HIv1___RNAseq.g26359.t1,three_way,52.308,FUN_033834-T1,Q6L9W6,B4GN3_HUMAN,,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",Homo sapiens (Human),32.0,328.0,2e-52,208.8,"sp|Q6L9W6|B4GN3_HUMAN Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Homo sapiens OX=9606 GN=B4GALNT3 PE=1 SV=2",GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231,,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0005794; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; transferase activity; organelle
OG_07396,FUN_033835-T1,Peve_00028776,Pocillopora_meandrina_HIv1___TS.g19113.t1,three_way,58.552,,,,,,,,,,,,,,,,,
OG_07397,FUN_033836-T1,Peve_00013463,Pocillopora_meandrina_HIv1___RNAseq.g26363.t1,three_way,68.35566666666666,FUN_033836-T1,Q8H1F7,,,,,35.8,288.0,1.3e-35,151.8,sp|Q8H1F7|IPK_ARATH Isopentenyl phosphate kinase OS=Arabidopsis thaliana OX=3702 GN=IPK PE=1 SV=1,,,,,,
OG_07398,FUN_033837-T1,Peve_00013462,Pocillopora_meandrina_HIv1___RNAseq.g26364.t1,three_way,77.89933333333333,FUN_033837-T1,P24844,MYL9_HUMAN,,"Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)",Homo sapiens (Human),39.9,163.0,1.1e-31,137.9,sp|P24844|MYL9_HUMAN Myosin regulatory light polypeptide 9 OS=Homo sapiens OX=9606 GN=MYL9 PE=1 SV=4,GO:0001725; GO:0005200; GO:0005509; GO:0005737; GO:0005829; GO:0005859; GO:0005938; GO:0006937; GO:0008307; GO:0016460; GO:0030016; GO:0030018; GO:0030239; GO:0032036; GO:0043149; GO:0070527,myofibril assembly [GO:0030239]; platelet aggregation [GO:0070527]; regulation of muscle contraction [GO:0006937]; stress fiber assembly [GO:0043149],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; myosin II complex [GO:0016460]; stress fiber [GO:0001725]; Z disc [GO:0030018],calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307],GO:0005198; GO:0005829; GO:0007010; GO:0007155; GO:0008092; GO:0043226,structural molecule activity; cytosol; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; organelle
OG_07399,FUN_033838-T1,Peve_00013461,Pocillopora_meandrina_HIv1___TS.g19118.t1,three_way,55.586,,,,,,,,,,,,,,,,,
OG_07400,FUN_033839-T1,Peve_00016490,Pocillopora_meandrina_HIv1___RNAseq.g26367.t1,three_way,53.79466666666666,,,,,,,,,,,,,,,,,
OG_07401,FUN_033841-T1,Peve_00013535,Pocillopora_meandrina_HIv1___RNAseq.g26142.t1,three_way,86.34633333333333,FUN_033841-T1,Q9V9S7,,,,,46.9,81.0,3e-13,77.8,sp|Q9V9S7|SYDE_DROME Rho GTPase-activating protein 100F OS=Drosophila melanogaster OX=7227 GN=RhoGAP100F PE=1 SV=2,,,,,,
OG_07402,FUN_033843-T1,Peve_00013534,Pocillopora_meandrina_HIv1___RNAseq.g26141.t1,three_way,90.93266666666668,FUN_033843-T1,Q6P6Z0,,,,,68.4,1095.0,0.0,1486.5,sp|Q6P6Z0|DDB1_XENLA DNA damage-binding protein 1 OS=Xenopus laevis OX=8355 GN=ddb1 PE=2 SV=1,,,,,,
OG_07403,FUN_033845-T1,Peve_00039879,Pocillopora_meandrina_HIv1___RNAseq.g26135.t1,three_way,74.83,FUN_033845-T1,P50430,,,,,43.8,525.0,6.2e-118,426.0,sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2,,,,,,
OG_07404,FUN_033855-T1,Peve_00039888,Pocillopora_meandrina_HIv1___RNAseq.g28422.t1,three_way,68.755,FUN_033855-T1,O75581,LRP6_HUMAN,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Homo sapiens (Human),46.7,1685.0,2.9e-254,880.6,sp|O75581|LRP6_HUMAN Low-density lipoprotein receptor-related protein 6 OS=Homo sapiens OX=9606 GN=LRP6 PE=1 SV=2,GO:0005041; GO:0005102; GO:0005109; GO:0005576; GO:0005783; GO:0005886; GO:0006897; GO:0007204; GO:0007268; GO:0007399; GO:0009986; GO:0014029; GO:0014033; GO:0015026; GO:0016055; GO:0017147; GO:0019210; GO:0019534; GO:0030291; GO:0031410; GO:0031901; GO:0034392; GO:0042802; GO:0042803; GO:0042813; GO:0043025; GO:0043434; GO:0045121; GO:0045202; GO:0045787; GO:0045893; GO:0045944; GO:0060070; GO:0071397; GO:0071542; GO:0072659; GO:0098609; GO:1904948; GO:1990851; GO:1990909,canonical Wnt signaling pathway [GO:0060070]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; chemical synaptic transmission [GO:0007268]; dopaminergic neuron differentiation [GO:0071542]; endocytosis [GO:0006897]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; nervous system development [GO:0007399]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; response to peptide hormone [GO:0043434]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851],coreceptor activity [GO:0015026]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase inhibitor activity [GO:0030291]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005576; GO:0005783; GO:0005886; GO:0006355; GO:0007155; GO:0016192; GO:0023052; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0060089; GO:0072659; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; cell adhesion; vesicle-mediated transport; signaling; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; molecular transducer activity; protein localization to plasma membrane; molecular function regulator activity
OG_07405,FUN_033856-T2,Peve_00043300,Pocillopora_meandrina_HIv1___TS.g8205.t2,three_way,77.4,FUN_033856-T2,Q96KP4,CNDP2_HUMAN,,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) (Threonyl dipeptidase),Homo sapiens (Human),65.4,474.0,6.799999999999999e-188,658.3,sp|Q96KP4|CNDP2_HUMAN Cytosolic non-specific dipeptidase OS=Homo sapiens OX=9606 GN=CNDP2 PE=1 SV=2,GO:0004180; GO:0005654; GO:0005829; GO:0006508; GO:0016805; GO:0046872; GO:0070062; GO:0070573,proteolysis [GO:0006508],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573],GO:0003824; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07406,FUN_033859-T1,Peve_00043297,Pocillopora_meandrina_HIv1___RNAseq.g28418.t1,three_way,86.258,FUN_033859-T1,Q3MHW9,,,,,57.1,303.0,4.4e-100,365.9,sp|Q3MHW9|NB5R1_BOVIN NADH-cytochrome b5 reductase 1 OS=Bos taurus OX=9913 GN=CYB5R1 PE=2 SV=1,,,,,,
OG_07407,FUN_033860-T1,Peve_00043298,Pocillopora_meandrina_HIv1___RNAseq.20855_t,three_way,71.87700000000001,,,,,,,,,,,,,,,,,
OG_07408,FUN_033861-T1,Peve_00043296,Pocillopora_meandrina_HIv1___RNAseq.g28415.t1,three_way,63.10766666666667,FUN_033861-T1,Q95JR6,,,,,28.8,295.0,3.5e-27,124.8,sp|Q95JR6|CNBD2_MACFA Cyclic nucleotide-binding domain-containing protein 2 OS=Macaca fascicularis OX=9541 GN=CNBD2 PE=2 SV=1,,,,,,
OG_07409,FUN_033862-T1,Peve_00043295,Pocillopora_meandrina_HIv1___RNAseq.g28416.t1,three_way,77.74766666666666,,,,,,,,,,,,,,,,,
OG_07410,FUN_033863-T1,Peve_00043293,Pocillopora_meandrina_HIv1___RNAseq.g28414.t1,three_way,64.51266666666666,FUN_033863-T1,Q96SL1,DIRC2_HUMAN,,Solute carrier family 49 member 4 (Disrupted in renal cancer protein 2) (Disrupted in renal carcinoma protein 2),Homo sapiens (Human),37.1,418.0,1e-62,242.3,sp|Q96SL1|DIRC2_HUMAN Solute carrier family 49 member 4 OS=Homo sapiens OX=9606 GN=SLC49A4 PE=1 SV=1,GO:0005765; GO:0016020; GO:0022857; GO:0031923; GO:0043231,pyridoxine transport [GO:0031923],intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],transmembrane transporter activity [GO:0022857],GO:0005215; GO:0043226,transporter activity; organelle
OG_07411,FUN_033864-T1,Peve_00043326,Pocillopora_meandrina_HIv1___RNAseq.g28413.t1,three_way,80.2635,FUN_033864-T1,Q86YS7,C2CD5_HUMAN,,C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa),Homo sapiens (Human),45.1,1041.0,6.3e-250,865.5,sp|Q86YS7|C2CD5_HUMAN C2 domain-containing protein 5 OS=Homo sapiens OX=9606 GN=C2CD5 PE=1 SV=1,GO:0005509; GO:0005544; GO:0005829; GO:0005886; GO:0005938; GO:0008286; GO:0010828; GO:0030659; GO:0031340; GO:0032587; GO:0034451; GO:0065002; GO:0072659; GO:0090314,insulin receptor signaling pathway [GO:0008286]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of D-glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340]; protein localization to plasma membrane [GO:0072659],cell cortex [GO:0005938]; centriolar satellite [GO:0034451]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544],GO:0005829; GO:0005886; GO:0006886; GO:0008289; GO:0055085; GO:0072659,cytosol; plasma membrane; intracellular protein transport; lipid binding; transmembrane transport; protein localization to plasma membrane
OG_07412,FUN_033869-T1,Peve_00043323,Pocillopora_meandrina_HIv1___RNAseq.g28411.t1,three_way,74.63466666666667,FUN_033869-T1,Q56R14,TRI33_XENLA,,E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33),Xenopus laevis (African clawed frog),27.3,341.0,5.9000000000000005e-37,157.5,sp|Q56R14|TRI33_XENLA E3 ubiquitin-protein ligase TRIM33 OS=Xenopus laevis OX=8355 GN=trim33 PE=1 SV=1,GO:0000785; GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740,protein ubiquitination [GO:0016567],chromatin [GO:0000785]; nucleus [GO:0005634],DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0016740; GO:0043226,DNA binding; catalytic activity; nucleus; transferase activity; organelle
OG_07413,FUN_033871-T1,Peve_00043321,Pocillopora_meandrina_HIv1___RNAseq.g28410.t2,three_way,61.42316666666667,FUN_033871-T1,Q54PQ4,GEFA_DICDI,,Ras guanine nucleotide exchange factor A (Aimless) (RasGEF domain-containing protein A),Dictyostelium discoideum (Social amoeba),35.0,214.0,6.6e-24,114.8,sp|Q54PQ4|GEFA_DICDI Ras guanine nucleotide exchange factor A OS=Dictyostelium discoideum OX=44689 GN=gefA PE=1 SV=1,GO:0000165; GO:0004860; GO:0005085; GO:0005829; GO:0005886; GO:0007265; GO:0010628; GO:0010856; GO:0030250; GO:0030295; GO:0030587; GO:0031152; GO:0043327; GO:0046579; GO:0051602; GO:0051897; GO:1903665; GO:1905742,aggregation involved in sorocarp development [GO:0031152]; chemotaxis to cAMP [GO:0043327]; MAPK cascade [GO:0000165]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; response to electrical stimulus [GO:0051602]; sorocarp development [GO:0030587],cytosol [GO:0005829]; plasma membrane [GO:0005886]; Ras guanyl-nucleotide exchange factor complex [GO:1905742],adenylate cyclase activator activity [GO:0010856]; guanyl-nucleotide exchange factor activity [GO:0005085]; guanylate cyclase activator activity [GO:0030250]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860],GO:0005829; GO:0005886; GO:0048856; GO:0098772,cytosol; plasma membrane; anatomical structure development; molecular function regulator activity
OG_07414,FUN_033872-T1,Peve_00043319,Pocillopora_meandrina_HIv1___RNAseq.g28409.t1,three_way,53.156,,,,,,,,,,,,,,,,,
OG_07415,FUN_033873-T1,Peve_00043318,Pocillopora_meandrina_HIv1___RNAseq.g28408.t1,three_way,82.103,,,,,,,,,,,,,,,,,
OG_07416,FUN_033874-T1,Peve_00043316,Pocillopora_meandrina_HIv1___RNAseq.g28405.t1,three_way,78.36116666666666,,,,,,,,,,,,,,,,,
OG_07417,FUN_033875-T1,Peve_00043311,Pocillopora_meandrina_HIv1___RNAseq.g28403.t1,three_way,86.92433333333334,FUN_033875-T1,Q5F408,SYCC_CHICK,,"Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)",Gallus gallus (Chicken),61.5,442.0,8.9e-137,488.4,"sp|Q5F408|SYCC_CHICK Cysteine--tRNA ligase, cytoplasmic OS=Gallus gallus OX=9031 GN=CARS1 PE=2 SV=1",GO:0000049; GO:0004817; GO:0005524; GO:0005737; GO:0006423; GO:0046872,cysteinyl-tRNA aminoacylation [GO:0006423],cytoplasm [GO:0005737],ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0006399; GO:0006520; GO:0016874; GO:0140098,"RNA binding; catalytic activity; tRNA metabolic process; amino acid metabolic process; ligase activity; catalytic activity, acting on RNA"
OG_07418,FUN_033878-T1,Peve_00043310,Pocillopora_meandrina_HIv1___RNAseq.g28402.t1,three_way,78.19333333333333,FUN_033878-T1,Q5U4K5,,,,,58.3,252.0,7.9e-75,282.0,sp|Q5U4K5|TM41B_XENLA Transmembrane protein 41B OS=Xenopus laevis OX=8355 GN=tmem41b PE=2 SV=1,,,,,,
OG_07419,FUN_033880-T1,Peve_00043309,Pocillopora_meandrina_HIv1___RNAseq.g28401.t1,three_way,84.31566666666667,FUN_033880-T1,Q66II8,,,,,67.6,225.0,2.1e-77,290.8,sp|Q66II8|RU17_XENTR U1 small nuclear ribonucleoprotein 70 kDa OS=Xenopus tropicalis OX=8364 GN=snrnp70 PE=2 SV=1,,,,,,
OG_07420,FUN_033882-T1,Peve_00043308,Pocillopora_meandrina_HIv1___RNAseq.g28395.t1,three_way,83.125,FUN_033882-T1,P08510,,,,,61.8,395.0,1.9e-120,434.5,sp|P08510|KCNAS_DROME Potassium voltage-gated channel protein Shaker OS=Drosophila melanogaster OX=7227 GN=Sh PE=1 SV=3,,,,,,
OG_07421,FUN_033883-T1,Peve_00043307,Pocillopora_meandrina_HIv1___RNAseq.g28394.t1,three_way,75.87733333333333,FUN_033883-T1,P28739,,,,,55.2,377.0,4.1e-107,390.6,sp|P28739|KLPA_EMENI Kinesin-like protein klpA OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=klpA PE=2 SV=3,,,,,,
OG_07422,FUN_033884-T1,Peve_00043305,Pocillopora_meandrina_HIv1___RNAseq.g28393.t1,three_way,52.554,,,,,,,,,,,,,,,,,
OG_07423,FUN_033885-T1,Peve_00043302,Pocillopora_meandrina_HIv1___TS.g8173.t1,three_way,71.79350000000001,FUN_033885-T1,Q9NTG7,,,,,62.2,270.0,7.9e-100,365.9,"sp|Q9NTG7|SIR3_HUMAN NAD-dependent protein deacetylase sirtuin-3, mitochondrial OS=Homo sapiens OX=9606 GN=SIRT3 PE=1 SV=2",,,,,,
OG_07424,FUN_033886-T1,Peve_00043301,Pocillopora_meandrina_HIv1___RNAseq.20826_t,three_way,52.64116666666667,FUN_033886-T1,Q6ZQ03,,,,,35.6,219.0,1.8000000000000002e-28,129.4,sp|Q6ZQ03|FNBP4_MOUSE Formin-binding protein 4 OS=Mus musculus OX=10090 GN=Fnbp4 PE=1 SV=2,,,,,,
OG_07424,FUN_033886-T1,Peve_00043301,Pocillopora_meandrina_HIv1___RNAseq.20826_t,three_way,52.64116666666667,FUN_033886-T1,Q6ZQ03,,,,,52.8,36.0,0.0003,48.9,sp|Q6ZQ03|FNBP4_MOUSE Formin-binding protein 4 OS=Mus musculus OX=10090 GN=Fnbp4 PE=1 SV=2,,,,,,
OG_07425,FUN_033890-T1,Peve_00035943,Pocillopora_meandrina_HIv1___RNAseq.g28382.t1,three_way,42.425,,,,,,,,,,,,,,,,,
OG_07426,FUN_033906-T1,Peve_00039887,Pocillopora_meandrina_HIv1___TS.g8165.t1a,three_way,38.5305,FUN_033906-T1,Q704V6,TLR6_BOVIN,,Toll-like receptor 6 (CD antigen CD286),Bos taurus (Bovine),37.8,111.0,1.4e-16,89.0,sp|Q704V6|TLR6_BOVIN Toll-like receptor 6 OS=Bos taurus OX=9913 GN=TLR6 PE=2 SV=1,GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0032731; GO:0035355; GO:0035663; GO:0038023; GO:0042802; GO:0045087; GO:0045121; GO:0061809; GO:0071723; GO:0071726; GO:1900227,cellular response to diacyl bacterial lipopeptide [GO:0071726]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; toll-like receptor signaling pathway [GO:0002224],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355],"identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; signaling receptor activity [GO:0038023]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_07427,FUN_033911-T1,Peve_00035948,Pocillopora_meandrina_HIv1___RNAseq.g28376.t1,three_way,39.52483333333333,,,,,,,,,,,,,,,,,
OG_07428,FUN_033913-T1,Peve_00032110,Pocillopora_meandrina_HIv1___RNAseq.g28372.t2,three_way,56.92033333333333,FUN_033913-T1,Q5R4A6,,,,,31.1,344.0,9.1e-40,166.8,sp|Q5R4A6|AMZ2_PONAB Archaemetzincin-2 OS=Pongo abelii OX=9601 GN=AMZ2 PE=2 SV=1,,,,,,
OG_07429,FUN_033915-T1,Peve_00022636,Pocillopora_meandrina_HIv1___RNAseq.g26598.t1,three_way,74.89316666666667,FUN_033915-T1,E7EY42,PTSS2_DANRE,,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),Danio rerio (Zebrafish) (Brachydanio rerio),61.7,366.0,2.1e-146,520.4,sp|E7EY42|PTSS2_DANRE Phosphatidylserine synthase 2 OS=Danio rerio OX=7955 GN=ptdss2 PE=3 SV=1,GO:0005789; GO:0006659; GO:0106245,phosphatidylserine biosynthetic process [GO:0006659],endoplasmic reticulum membrane [GO:0005789],L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO:0106245],GO:0003824; GO:0006575; GO:0006629; GO:0016740,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity
OG_07430,FUN_033917-T1,Peve_00022631,Pocillopora_meandrina_HIv1___TS.g19347.t2a,three_way,44.82383333333333,,,,,,,,,,,,,,,,,
OG_07431,FUN_033919-T1,Peve_00022630,Pocillopora_meandrina_HIv1___RNAseq.g26196.t1,three_way,46.1855,,,,,,,,,,,,,,,,,
OG_07432,FUN_033920-T1,Peve_00022629,Pocillopora_meandrina_HIv1___RNAseq.g26595.t1,three_way,69.64033333333333,,,,,,,,,,,,,,,,,
OG_07433,FUN_033921-T1,Peve_00022625,Pocillopora_meandrina_HIv1___RNAseq.g26594.t1,three_way,72.53766666666667,FUN_033921-T1,Q8IUH5,ZDH17_HUMAN,,Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Acyltransferase ZDHHC17) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 17) (DHHC17) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17),Homo sapiens (Human),50.0,564.0,7.8e-130,465.7,sp|Q8IUH5|ZDH17_HUMAN Palmitoyltransferase ZDHHC17 OS=Homo sapiens OX=9606 GN=ZDHHC17 PE=1 SV=2,GO:0000139; GO:0005102; GO:0005794; GO:0007409; GO:0016409; GO:0018345; GO:0019705; GO:0019706; GO:0030660; GO:0042734; GO:0042802; GO:0042953; GO:0042995; GO:0043067; GO:0043123; GO:0043231; GO:0051386; GO:0070372; GO:0098978; GO:0098987; GO:0140240; GO:0140439; GO:0150051,"axonogenesis [GO:0007409]; lipoprotein transport [GO:0042953]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; protein palmitoylation [GO:0018345]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of modification of synapse structure, modulating synaptic transmission [GO:0098987]; regulation of neurotrophin TRK receptor signaling pathway [GO:0051386]; regulation of programmed cell death [GO:0043067]",cell projection [GO:0042995]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; intracellular membrane-bounded organelle [GO:0043231]; perforant pathway to dendrate granule cell synapse [GO:0140240]; postsynaptic Golgi apparatus [GO:0150051]; presynaptic membrane [GO:0042734],identical protein binding [GO:0042802]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07434,FUN_033922-T1,Peve_00022624,Pocillopora_meandrina_HIv1___RNAseq.g26592.t1,three_way,71.24166666666666,FUN_033922-T1,Q6GP17,KT5BA_XENLA,,Histone-lysine N-methyltransferase KMT5B-A (Lysine-specific methyltransferase 5B-A) (Suppressor of variegation 4-20 homolog 1-A) (Su(var)4-20 homolog 1-A) (Suv4-20h1-A) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361),Xenopus laevis (African clawed frog),59.9,269.0,1.7e-93,344.7,sp|Q6GP17|KT5BA_XENLA Histone-lysine N-methyltransferase KMT5B-A OS=Xenopus laevis OX=8355 GN=kmt5b-a PE=2 SV=1,GO:0003682; GO:0005634; GO:0005694; GO:0006281; GO:0007517; GO:0032259; GO:0042799; GO:0045830; GO:0046872; GO:0140941; GO:0140944; GO:1904047; GO:2001034,DNA repair [GO:0006281]; methylation [GO:0032259]; muscle organ development [GO:0007517]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830],chromosome [GO:0005694]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941]; metal ion binding [GO:0046872]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; chromosome; DNA repair; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07435,FUN_033924-T1,Peve_00022623,Pocillopora_meandrina_HIv1___RNAseq.g26586.t2,three_way,66.44966666666667,FUN_033924-T1,Q14444,CAPR1_HUMAN,,Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105),Homo sapiens (Human),38.3,180.0,4.2e-27,123.2,sp|Q14444|CAPR1_HUMAN Caprin-1 OS=Homo sapiens OX=9606 GN=CAPRIN1 PE=1 SV=2,GO:0000932; GO:0003723; GO:0003729; GO:0005524; GO:0005737; GO:0005829; GO:0007416; GO:0008298; GO:0010494; GO:0016020; GO:0017148; GO:0030027; GO:0030425; GO:0031252; GO:0035591; GO:0043232; GO:0045202; GO:0048699; GO:0050775; GO:0061003; GO:0062029; GO:0106288; GO:0140677; GO:0140693; GO:0140694,generation of neurons [GO:0048699]; intracellular mRNA localization [GO:0008298]; membraneless organelle assembly [GO:0140694]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of stress granule assembly [GO:0062029]; regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0106288]; synapse assembly [GO:0007416],cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membraneless organelle [GO:0043232]; lamellipodium [GO:0030027]; membrane [GO:0016020]; P-body [GO:0000932]; synapse [GO:0045202],ATP binding [GO:0005524]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; signaling adaptor activity [GO:0035591],GO:0003723; GO:0005829; GO:0030154; GO:0034330; GO:0043226; GO:0060090; GO:0098772,RNA binding; cytosol; cell differentiation; cell junction organization; organelle; molecular adaptor activity; molecular function regulator activity
OG_07436,FUN_033926-T1,Peve_00022622,Pocillopora_meandrina_HIv1___TS.g19337.t1,three_way,74.93,,,,,,,,,,,,,,,,,
OG_07437,FUN_033927-T1,Peve_00022641,Pocillopora_meandrina_HIv1___RNAseq.g26588.t2,three_way,72.48533333333333,FUN_033927-T1,Q8IZU3,SYCP3_HUMAN,,Synaptonemal complex protein 3 (SCP-3),Homo sapiens (Human),41.9,167.0,1e-25,118.6,sp|Q8IZU3|SYCP3_HUMAN Synaptonemal complex protein 3 OS=Homo sapiens OX=9606 GN=SYCP3 PE=1 SV=1,GO:0000775; GO:0000795; GO:0000800; GO:0003677; GO:0005634; GO:0007141; GO:0007286; GO:0035092; GO:0051301; GO:0051321,cell division [GO:0051301]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; sperm DNA condensation [GO:0035092]; spermatid development [GO:0007286],"chromosome, centromeric region [GO:0000775]; lateral element [GO:0000800]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]",DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0006325; GO:0022414; GO:0043226; GO:0048856; GO:0140013,DNA binding; nucleus; chromatin organization; reproductive process; organelle; anatomical structure development; meiotic nuclear division
OG_07438,FUN_033928-T1,Peve_00022640,Pocillopora_meandrina_HIv1___RNAseq.g26589.t1,three_way,76.85166666666666,FUN_033928-T1,A6H8T2,,,,,34.0,712.0,1.4e-110,402.1,sp|A6H8T2|DNAI7_DANRE Dynein axonemal intermediate chain 7 OS=Danio rerio OX=7955 GN=dnai7 PE=2 SV=2,,,,,,
OG_07439,FUN_033929-T1,Peve_00022639,Pocillopora_meandrina_HIv1___TS.g19340.t1,three_way,41.10216666666667,,,,,,,,,,,,,,,,,
OG_07440,FUN_033932-T1,Peve_00020979,Pocillopora_meandrina_HIv1___RNAseq.g26584.t1,three_way,60.418,,,,,,,,,,,,,,,,,
OG_07441,FUN_033933-T1,Peve_00020980,Pocillopora_meandrina_HIv1___RNAseq.g26583.t1,three_way,86.51866666666666,FUN_033933-T1,Q15915,ZIC1_HUMAN,,Zinc finger protein ZIC 1 (Zinc finger protein 201) (Zinc finger protein of the cerebellum 1),Homo sapiens (Human),37.8,249.0,1.7e-36,155.2,sp|Q15915|ZIC1_HUMAN Zinc finger protein ZIC 1 OS=Homo sapiens OX=9606 GN=ZIC1 PE=1 SV=2,GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007389; GO:0007417; GO:0007420; GO:0007628; GO:0008270; GO:0008589; GO:0010467; GO:0021510; GO:0021766; GO:0021772; GO:0030154; GO:0042307; GO:0042472; GO:0045893; GO:0098727; GO:1990837,adult walking behavior [GO:0007628]; brain development [GO:0007420]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; inner ear morphogenesis [GO:0042472]; maintenance of cell number [GO:0098727]; olfactory bulb development [GO:0021772]; pattern specification process [GO:0007389]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07442,FUN_033934-T1,Peve_00020984,Pocillopora_meandrina_HIv1___RNAseq.g26581.t1,three_way,92.2815,FUN_033934-T1,Q9IB89,,,,,45.0,169.0,3.2000000000000005e-33,144.4,sp|Q9IB89|ZIC5_XENLA Zinc finger protein ZIC 5 OS=Xenopus laevis OX=8355 GN=zic5 PE=2 SV=1,,,,,,
OG_07443,FUN_033935-T1,Peve_00020986,Pocillopora_meandrina_HIv1___RNAseq.g26580.t1,three_way,84.01316666666666,FUN_033935-T1,Q6DJQ6,,,,,35.6,281.0,6.4e-32,140.2,sp|Q6DJQ6|ZIC3_XENTR Zinc finger protein ZIC 3 OS=Xenopus tropicalis OX=8364 GN=zic3 PE=2 SV=1,,,,,,
OG_07444,FUN_033936-T1,Peve_00020989,Pocillopora_meandrina_HIv1___RNAseq.g26579.t1,three_way,66.17033333333333,FUN_033936-T1,Q9IB89,,,,,50.6,83.0,2.4e-20,101.7,sp|Q9IB89|ZIC5_XENLA Zinc finger protein ZIC 5 OS=Xenopus laevis OX=8355 GN=zic5 PE=2 SV=1,,,,,,
OG_07445,FUN_033937-T1,Peve_00020988,Pocillopora_meandrina_HIv1___RNAseq.g26578.t1,three_way,78.66766666666666,FUN_033937-T1,A7SK27,,,,,56.0,350.0,1.4e-113,411.0,sp|A7SK27|EKI_NEMVE Probable ethanolamine kinase OS=Nematostella vectensis OX=45351 GN=etnk PE=3 SV=1,,,,,,
OG_07446,FUN_033938-T1,Peve_00020990,Pocillopora_meandrina_HIv1___RNAseq.g26577.t1,three_way,71.27083333333333,FUN_033938-T1,A7E2M3,,,,,35.3,187.0,1.4e-19,98.2,sp|A7E2M3|EMC10_DANRE ER membrane protein complex subunit 10 OS=Danio rerio OX=7955 GN=emc10 PE=2 SV=1,,,,,,
OG_07447,FUN_033939-T1,Peve_00020991,Pocillopora_meandrina_HIv1___RNAseq.g26576.t1,three_way,38.9615,,,,,,,,,,,,,,,,,
OG_07448,FUN_033942-T1,Peve_00020994,Pocillopora_meandrina_HIv1___RNAseq.g26574.t1,three_way,64.84833333333333,FUN_033942-T1,P48733,,,,,43.3,127.0,1.1000000000000002e-28,131.3,sp|P48733|UROM_BOVIN Uromodulin OS=Bos taurus OX=9913 GN=UMOD PE=2 SV=1,,,,,,
OG_07449,FUN_033943-T1,Peve_00020995,Pocillopora_meandrina_HIv1___RNAseq.g26573.t1,three_way,65.91733333333333,FUN_033943-T1,Q8WVB3,,,,,40.2,460.0,1.3e-86,322.0,sp|Q8WVB3|HEXD_HUMAN Hexosaminidase D OS=Homo sapiens OX=9606 GN=HEXD PE=1 SV=3,,,,,,
OG_07450,FUN_033944-T1,Peve_00039782,Pocillopora_meandrina_HIv1___RNAseq.g26571.t1,three_way,77.19666666666666,FUN_033944-T1,Q96FG2,,,,,50.7,268.0,3.5e-72,273.9,sp|Q96FG2|ELMD3_HUMAN ELMO domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ELMOD3 PE=1 SV=2,,,,,,
OG_07451,FUN_033945-T1,Peve_00039783,Pocillopora_meandrina_HIv1___RNAseq.g26570.t1,three_way,53.059,,,,,,,,,,,,,,,,,
OG_07452,FUN_033947-T1,Peve_00039784,Pocillopora_meandrina_HIv1___TS.g19318.t2,three_way,67.47200000000001,FUN_033947-T1,P29775,,,,,48.1,81.0,2.5e-14,81.3,sp|P29775|ETS4_DROME DNA-binding protein D-ETS-4 OS=Drosophila melanogaster OX=7227 GN=Ets98B PE=2 SV=3,,,,,,
OG_07453,FUN_033948-T2,Peve_00039785,Pocillopora_meandrina_HIv1___RNAseq.g26569.t1,three_way,56.28533333333333,,,,,,,,,,,,,,,,,
OG_07454,FUN_033950-T1,Peve_00036244,Pocillopora_meandrina_HIv1___RNAseq.g28347.t1,three_way,68.354,FUN_033950-T1,Q6DDY9,,,,,50.6,170.0,3.5e-41,169.9,sp|Q6DDY9|RT07_XENLA Small ribosomal subunit protein uS7m OS=Xenopus laevis OX=8355 GN=mrps7 PE=2 SV=1,,,,,,
OG_07455,FUN_033951-T1,Peve_00032117,Pocillopora_meandrina_HIv1___RNAseq.g28360.t1,three_way,65.717,,,,,,,,,,,,,,,,,
OG_07456,FUN_033957-T1,Peve_00022635,Pocillopora_meandrina_HIv1___RNAseq.g26599.t1,three_way,75.81933333333333,FUN_033957-T1,Q8BGS7,CEPT1_MOUSE,,Choline/ethanolaminephosphotransferase 1 (mCEPT1) (EC 2.7.8.1) (EC 2.7.8.2) (1-alkenyl-2-acylglycerol choline phosphotransferase) (EC 2.7.8.22),Mus musculus (Mouse),49.7,364.0,4.2e-100,366.3,sp|Q8BGS7|CEPT1_MOUSE Choline/ethanolaminephosphotransferase 1 OS=Mus musculus OX=10090 GN=Cept1 PE=1 SV=1,GO:0004142; GO:0004307; GO:0005789; GO:0006646; GO:0006656; GO:0016780; GO:0031965; GO:0046872; GO:0047359,phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646],endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965],"1-alkenyl-2-acylglycerol choline phosphotransferase activity [GO:0047359]; diacylglycerol cholinephosphotransferase activity [GO:0004142]; ethanolaminephosphotransferase activity [GO:0004307]; metal ion binding [GO:0046872]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_07457,FUN_033958-T1,Peve_00022633,Pocillopora_meandrina_HIv1___RNAseq.g26600.t1,three_way,70.71616666666667,FUN_033958-T1,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),32.6,972.0,1.4e-144,516.2,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_07458,FUN_033959-T1,Peve_00022634,Pocillopora_meandrina_HIv1___RNAseq.g26601.t1,three_way,52.78833333333333,FUN_033959-T1,Q21109,ENDOU_CAEEL,,Endoribonuclease endu-1 (EC 4.6.1.-) (Poly(U)-specific endoribonuclease homolog) (Uridylate-specific endoribonuclease homolog),Caenorhabditis elegans,31.6,158.0,2.9e-11,70.9,sp|Q21109|ENDOU_CAEEL Endoribonuclease endu-1 OS=Caenorhabditis elegans OX=6239 GN=endu-1 PE=1 SV=1,GO:0003723; GO:0004521; GO:0005576; GO:0016829; GO:0046872,,extracellular region [GO:0005576],lyase activity [GO:0016829]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521],GO:0003723; GO:0003824; GO:0005576; GO:0016829; GO:0140098,"RNA binding; catalytic activity; extracellular region; lyase activity; catalytic activity, acting on RNA"
OG_07459,FUN_033963-T1,Peve_00015226,Pocillopora_meandrina_HIv1___RNAseq.g28555.t1,three_way,45.479,,,,,,,,,,,,,,,,,
OG_07460,FUN_033964-T1,Peve_00015231,Pocillopora_meandrina_HIv1___RNAseq.g28554.t1,three_way,63.715,,,,,,,,,,,,,,,,,
OG_07461,FUN_033965-T1,Peve_00015234,Pocillopora_meandrina_HIv1___RNAseq.g28552.t1,three_way,61.097,FUN_033965-T1,Q24155,TRUNK_DROME,,Protein trunk,Drosophila melanogaster (Fruit fly),31.5,197.0,8e-18,92.0,sp|Q24155|TRUNK_DROME Protein trunk OS=Drosophila melanogaster OX=7227 GN=trk PE=3 SV=1,GO:0005102; GO:0005122; GO:0005615; GO:0007362; GO:0008293; GO:0030297; GO:0048018,terminal region determination [GO:0007362]; torso signaling pathway [GO:0008293],extracellular space [GO:0005615],receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; torso binding [GO:0005122]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297],GO:0005615; GO:0048018; GO:0098772,extracellular space; receptor ligand activity; molecular function regulator activity
OG_07462,FUN_033966-T1,Peve_00015215,Pocillopora_meandrina_HIv1___RNAseq.g28551.t1,three_way,59.46483333333333,FUN_033966-T1,P48547,KCNC1_HUMAN,,Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4),Homo sapiens (Human),50.1,467.0,2.5e-111,405.6,sp|P48547|KCNC1_HUMAN Voltage-gated potassium channel KCNC1 OS=Homo sapiens OX=9606 GN=KCNC1 PE=1 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030673; GO:0032590; GO:0032809; GO:0035864; GO:0042734; GO:0043679; GO:0044305; GO:0044325; GO:0045211; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1901381; GO:1990089,action potential [GO:0001508]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636],axolemma [GO:0030673]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0008092; GO:0048856; GO:0055085; GO:0065003,transporter activity; plasma membrane; cytoskeletal protein binding; anatomical structure development; transmembrane transport; protein-containing complex assembly
OG_07463,FUN_033967-T1,Peve_00015216,Pocillopora_meandrina_HIv1___RNAseq.g28550.t1,three_way,70.581,FUN_033967-T1,Q5XG58,,,,,46.2,379.0,1.2e-89,331.6,sp|Q5XG58|ELP4_XENLA Elongator complex protein 4 OS=Xenopus laevis OX=8355 GN=elp4 PE=2 SV=1,,,,,,
OG_07464,FUN_033968-T1,Peve_00015220,Pocillopora_meandrina_HIv1___RNAseq.g28549.t1,three_way,90.424,FUN_033968-T1,Q9Y2H1,ST38L_HUMAN,,Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2),Homo sapiens (Human),71.3,442.0,1.3e-188,660.6,sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens OX=9606 GN=STK38L PE=1 SV=3,GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0010507; GO:0015629; GO:0016020; GO:0035556; GO:0051128; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005829; GO:0005856; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07465,FUN_033969-T1,Peve_00015221,Pocillopora_meandrina_HIv1___TS.g8334.t2,three_way,84.03933333333333,FUN_033969-T1,Q32NG4,,,,,59.5,210.0,5.899999999999999e-70,265.4,sp|Q32NG4|GALD1_XENLA Glutamine amidotransferase-like class 1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=gatd1 PE=2 SV=1,,,,,,
OG_07466,FUN_033970-T2,Peve_00015222,Pocillopora_meandrina_HIv1___RNAseq.g26371.t1,three_way,71.7745,FUN_033970-T2,Q4V7B1,,,,,32.9,639.0,3.7e-56,221.5,sp|Q4V7B1|CF20D_RAT Protein CFAP20DC OS=Rattus norvegicus OX=10116 GN=Cfap20dc PE=2 SV=1,,,,,,
OG_07467,FUN_033971-T3,Peve_00015223,Pocillopora_meandrina_HIv1___RNAseq.g26370.t1,three_way,66.31200000000001,FUN_033971-T3,Q5E9H2,,,,,39.4,419.0,1.4e-85,318.5,sp|Q5E9H2|1A1L1_BOVIN 1-aminocyclopropane-1-carboxylate synthase-like protein 1 OS=Bos taurus OX=9913 GN=ACCS PE=2 SV=1,,,,,,
OG_07468,FUN_033978-T1,Peve_00004849,Pocillopora_meandrina_HIv1___RNAseq.g26112.t1,three_way,70.29166666666667,FUN_033978-T1,Q1LVW0,,,,,36.9,895.0,1.8e-163,578.2,sp|Q1LVW0|ABT3A_DANRE Ankyrin repeat- and BTB/POZ domain-containing protein 3-A OS=Danio rerio OX=7955 GN=abtb3a PE=3 SV=2,,,,,,
OG_07469,FUN_033979-T1,Peve_00004846,Pocillopora_meandrina_HIv1___RNAseq.g26111.t1,three_way,80.1855,FUN_033979-T1,O70247,,,,,40.7,570.0,5.3000000000000004e-111,403.3,sp|O70247|SC5A6_RAT Sodium-dependent multivitamin transporter OS=Rattus norvegicus OX=10116 GN=Slc5a6 PE=1 SV=1,,,,,,
OG_07470,FUN_033980-T1,Peve_00004847,Pocillopora_meandrina_HIv1___RNAseq.g26110.t1,three_way,64.06066666666666,FUN_033980-T1,Q1EHB4,SC5AC_HUMAN,,Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12),Homo sapiens (Human),34.5,560.0,3.3e-86,320.9,sp|Q1EHB4|SC5AC_HUMAN Sodium-coupled monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC5A12 PE=1 SV=2,GO:0005343; GO:0005654; GO:0005886; GO:0006811; GO:0006814; GO:0015129; GO:0015293; GO:0015718; GO:0016324; GO:0070062; GO:0140161,monoatomic ion transport [GO:0006811]; monocarboxylic acid transport [GO:0015718]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; organic acid:sodium symporter activity [GO:0005343]; symporter activity [GO:0015293],GO:0005215; GO:0005654; GO:0005886; GO:0043226,transporter activity; nucleoplasm; plasma membrane; organelle
OG_07471,FUN_033981-T1,Peve_00004845,Pocillopora_meandrina_HIv1___RNAseq.g26109.t1,three_way,70.14966666666666,FUN_033981-T1,A7S4N4,,,,,30.2,378.0,5.1e-38,160.2,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_07472,FUN_033982-T1,Peve_00004843,Pocillopora_meandrina_HIv1___TS.g18856.t1,three_way,49.4835,,,,,,,,,,,,,,,,,
OG_07473,FUN_033988-T1,Peve_00031324,Pocillopora_meandrina_HIv1___RNAseq.g26103.t1,three_way,92.09933333333332,FUN_033988-T1,Q9BV81,EMC6_HUMAN,,ER membrane protein complex subunit 6 (Transmembrane protein 93),Homo sapiens (Human),60.7,89.0,1.0000000000000001e-23,110.5,sp|Q9BV81|EMC6_HUMAN ER membrane protein complex subunit 6 OS=Homo sapiens OX=9606 GN=EMC6 PE=1 SV=1,GO:0000045; GO:0005789; GO:0016020; GO:0045050; GO:0071816; GO:0072546; GO:1903349,autophagosome assembly [GO:0000045]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],EMC complex [GO:0072546]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; omegasome membrane [GO:1903349],,,
OG_07474,FUN_033989-T1,Peve_00004922,Pocillopora_meandrina_HIv1___RNAseq.g26102.t1,three_way,69.42083333333333,FUN_033989-T1,E9Q2Z1,CECR2_MOUSE,,Chromatin remodeling regulator CECR2 (Cat eye syndrome critical region protein 2 homolog),Mus musculus (Mouse),46.8,571.0,1.8e-84,316.2,sp|E9Q2Z1|CECR2_MOUSE Chromatin remodeling regulator CECR2 OS=Mus musculus OX=10090 GN=Cecr2 PE=1 SV=1,GO:0000791; GO:0001842; GO:0001843; GO:0005634; GO:0006338; GO:0007338; GO:0021915; GO:0031010; GO:0060122; GO:0090102; GO:0090537; GO:0097194; GO:0140658,chromatin remodeling [GO:0006338]; cochlea development [GO:0090102]; execution phase of apoptosis [GO:0097194]; inner ear receptor cell stereocilium organization [GO:0060122]; neural fold formation [GO:0001842]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; single fertilization [GO:0007338],CERF complex [GO:0090537]; euchromatin [GO:0000791]; ISWI-type complex [GO:0031010]; nucleus [GO:0005634],ATP-dependent chromatin remodeler activity [GO:0140658],GO:0003824; GO:0005634; GO:0006325; GO:0022414; GO:0043226; GO:0048856; GO:0140097; GO:0140657,"catalytic activity; nucleus; chromatin organization; reproductive process; organelle; anatomical structure development; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07475,FUN_033996-T1,Peve_00027604,Pocillopora_meandrina_HIv1___RNAseq.g26097.t1,three_way,52.35683333333333,FUN_033996-T1,P42291,,,,,25.0,308.0,4.9e-09,63.5,sp|P42291|DRD1C_XENLA D(1C) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd1c PE=2 SV=1,,,,,,
OG_07476,FUN_033998-T2,Peve_00000499,Pocillopora_meandrina_HIv1___RNAseq.g26093.t2,three_way,69.55316666666667,FUN_033998-T2,Q8CDK2,,,,,49.7,734.0,1.8e-192,674.9,sp|Q8CDK2|CBPC2_MOUSE Cytosolic carboxypeptidase 2 OS=Mus musculus OX=10090 GN=Agbl2 PE=1 SV=1,,,,,,
OG_07477,FUN_033999-T1,Peve_00044495,Pocillopora_meandrina_HIv1___RNAseq.g9828.t1,three_way,84.30799999999999,FUN_033999-T1,Q9F234,,,,,29.2,854.0,2.3e-86,322.0,sp|Q9F234|AGL2_BACTQ Alpha-glucosidase 2 OS=Bacillus thermoamyloliquefaciens OX=1425 PE=3 SV=1,,,,,,
OG_07478,FUN_034000-T1,Peve_00034177,Pocillopora_meandrina_HIv1___RNAseq.g9829.t1,three_way,70.24966666666667,,,,,,,,,,,,,,,,,
OG_07479,FUN_034003-T1,Peve_00000507,Pocillopora_meandrina_HIv1___RNAseq.g26092.t1,three_way,53.3595,,,,,,,,,,,,,,,,,
OG_07480,FUN_034004-T2,Peve_00000506,Pocillopora_meandrina_HIv1___RNAseq.g26091.t1,three_way,60.98133333333333,FUN_034004-T2,Q553Y0,P2XC_DICDI,,P2X receptor C (P2XC),Dictyostelium discoideum (Social amoeba),26.9,376.0,5.4e-19,96.7,sp|Q553Y0|P2XC_DICDI P2X receptor C OS=Dictyostelium discoideum OX=44689 GN=p2xC PE=3 SV=1,GO:0031164; GO:0035381; GO:0050848; GO:0070588; GO:0071476; GO:0140417,calcium ion transmembrane transport [GO:0070588]; cellular hypotonic response [GO:0071476]; regulation of calcium-mediated signaling [GO:0050848],contractile vacuolar membrane [GO:0031164],ATP-gated ion channel activity [GO:0035381]; intracellularly ATP-gated calcium channel activity [GO:0140417],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_07481,FUN_034006-T1,Peve_00006676,Pocillopora_meandrina_HIv1___RNAseq.g26090.t1,three_way,87.93166666666667,FUN_034006-T1,Q4R8N2,,,,,59.9,491.0,4.6e-155,549.3,sp|Q4R8N2|LIN9_MACFA Protein lin-9 homolog OS=Macaca fascicularis OX=9541 GN=LIN9 PE=2 SV=1,,,,,,
OG_07482,FUN_034007-T2,Peve_00005925,Pocillopora_meandrina_HIv1___RNAseq.g26089.t1,three_way,79.04933333333334,FUN_034007-T2,Q5QQ57,XYLT1_PANTR,,Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I),Pan troglodytes (Chimpanzee),44.2,745.0,1.5e-184,647.9,sp|Q5QQ57|XYLT1_PANTR Xylosyltransferase 1 OS=Pan troglodytes OX=9598 GN=XYLT1 PE=2 SV=1,GO:0000137; GO:0000139; GO:0005615; GO:0015012; GO:0030158; GO:0030166; GO:0043931; GO:0046872; GO:0048706; GO:0050650,chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; embryonic skeletal system development [GO:0048706]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; ossification involved in bone maturation [GO:0043931]; proteoglycan biosynthetic process [GO:0030166],extracellular space [GO:0005615]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139],metal ion binding [GO:0046872]; protein xylosyltransferase activity [GO:0030158],GO:0003824; GO:0005615; GO:0009101; GO:0016740; GO:0048856; GO:0140096; GO:1901135,"catalytic activity; extracellular space; glycoprotein biosynthetic process; transferase activity; anatomical structure development; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_07483,FUN_034008-T1,Peve_00033154,Pocillopora_meandrina_HIv1___RNAseq.g26086.t1,three_way,63.45133333333334,FUN_034008-T1,P46023,,,,,46.7,347.0,3.7e-84,314.7,sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_07484,FUN_034010-T1,Peve_00030670,Pocillopora_meandrina_HIv1___RNAseq.g26085.t1,three_way,72.63733333333333,FUN_034010-T1,Q9Y2V2,CHSP1_HUMAN,,Calcium-regulated heat-stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24),Homo sapiens (Human),55.4,130.0,8.4e-31,134.8,sp|Q9Y2V2|CHSP1_HUMAN Calcium-regulated heat-stable protein 1 OS=Homo sapiens OX=9606 GN=CARHSP1 PE=1 SV=2,GO:0000177; GO:0000932; GO:0003730; GO:0005737; GO:0005829; GO:0019902; GO:0035556; GO:0043186; GO:0043488,intracellular signal transduction [GO:0035556]; regulation of mRNA stability [GO:0043488],cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932],mRNA 3'-UTR binding [GO:0003730]; phosphatase binding [GO:0019902],GO:0003723; GO:0005829; GO:0043226,RNA binding; cytosol; organelle
OG_07485,FUN_034011-T1,Peve_00007017,Pocillopora_meandrina_HIv1___RNAseq.g26084.t1,three_way,51.6635,FUN_034011-T1,Q8TEQ0,,,,,30.1,1078.0,2.6e-94,348.6,sp|Q8TEQ0|SNX29_HUMAN Sorting nexin-29 OS=Homo sapiens OX=9606 GN=SNX29 PE=1 SV=3,,,,,,
OG_07486,FUN_034012-T1,Peve_00007016,Pocillopora_meandrina_HIv1___TS.g18832.t1,three_way,67.49216666666666,FUN_034012-T1,B1AQJ2,UBP36_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 36 (EC 2.3.2.-) (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36),Mus musculus (Mouse),50.0,470.0,3.3e-123,444.5,sp|B1AQJ2|UBP36_MOUSE Ubiquitin carboxyl-terminal hydrolase 36 OS=Mus musculus OX=10090 GN=Usp36 PE=1 SV=1,GO:0003723; GO:0004843; GO:0005730; GO:0005737; GO:0006325; GO:0006508; GO:0007000; GO:0016242; GO:0016579; GO:0016607; GO:0016740; GO:0031647; GO:0050821; GO:0140936; GO:1990380; GO:2000232,chromatin organization [GO:0006325]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730],cysteine-type deubiquitinase activity [GO:0004843]; histone H2B deubiquitinase activity [GO:0140936]; K48-linked deubiquitinase activity [GO:1990380]; RNA binding [GO:0003723]; transferase activity [GO:0016740],GO:0003723; GO:0003824; GO:0005730; GO:0006325; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleolus; chromatin organization; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07487,FUN_034013-T1,Peve_00007013,Pocillopora_meandrina_HIv1___TS.g18830.t1,three_way,57.79133333333333,,,,,,,,,,,,,,,,,
OG_07488,FUN_034015-T1,Peve_00007012,Pocillopora_meandrina_HIv1___RNAseq.g26080.t1,three_way,77.31,FUN_034015-T1,A5PK16,CCNF_BOVIN,,Cyclin-F,Bos taurus (Bovine),40.1,619.0,3.5e-119,430.6,sp|A5PK16|CCNF_BOVIN Cyclin-F OS=Bos taurus OX=9913 GN=CCNF PE=2 SV=1,GO:0000082; GO:0000307; GO:0005634; GO:0005737; GO:0005814; GO:0005815; GO:0010826; GO:0016538; GO:0016567; GO:0019005; GO:0031146; GO:0048471; GO:0051301; GO:0051726,cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of centrosome duplication [GO:0010826]; protein ubiquitination [GO:0016567]; regulation of cell cycle [GO:0051726]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],centriole [GO:0005814]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538],GO:0005634; GO:0005815; GO:0030163; GO:0043226; GO:0098772,nucleus; microtubule organizing center; protein catabolic process; organelle; molecular function regulator activity
OG_07489,FUN_034016-T1,Peve_00034969,Pocillopora_meandrina_HIv1___RNAseq.g26078.t1,three_way,63.12616666666667,,,,,,,,,,,,,,,,,
OG_07490,FUN_034017-T1,Peve_00007018,Pocillopora_meandrina_HIv1___RNAseq.g26077.t1,three_way,88.351,FUN_034017-T1,Q0VCN3,IFT27_BOVIN,,Intraflagellar transport protein 27 homolog (IFT27) (Putative GTP-binding protein RAY-like) (Rab-like protein 4),Bos taurus (Bovine),53.0,185.0,8.5e-54,211.5,sp|Q0VCN3|IFT27_BOVIN Intraflagellar transport protein 27 homolog OS=Bos taurus OX=9913 GN=IFT27 PE=2 SV=1,GO:0000139; GO:0001822; GO:0003924; GO:0005525; GO:0005737; GO:0005794; GO:0005929; GO:0006886; GO:0007224; GO:0007283; GO:0016192; GO:0030154; GO:0030992; GO:0036126; GO:0042073,cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; vesicle-mediated transport [GO:0016192],cilium [GO:0005929]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intraciliary transport particle B [GO:0030992]; sperm flagellum [GO:0036126],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005794; GO:0005929; GO:0006886; GO:0007018; GO:0016192; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856,catalytic activity; GTPase activity; Golgi apparatus; cilium; intracellular protein transport; microtubule-based movement; vesicle-mediated transport; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development
OG_07491,FUN_034018-T1,Peve_00024700,Pocillopora_meandrina_HIv1___RNAseq.g26076.t1,three_way,64.037,FUN_034018-T1,Q9Z2E3,,,,,35.4,401.0,2.3e-51,206.5,sp|Q9Z2E3|ERN2_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Mus musculus OX=10090 GN=Ern2 PE=2 SV=2,,,,,,
OG_07492,FUN_034019-T1,Peve_00024699,Pocillopora_meandrina_HIv1___RNAseq.g26013.t1,three_way,68.39866666666667,FUN_034019-T1,Q8NBH2,,,,,24.8,428.0,2.2e-25,119.4,sp|Q8NBH2|KY_HUMAN Kyphoscoliosis peptidase OS=Homo sapiens OX=9606 GN=KY PE=1 SV=3,,,,,,
OG_07493,FUN_034021-T3,Peve_00024697,Pocillopora_meandrina_HIv1___RNAseq.g26019.t1,three_way,71.889,FUN_034021-T3,Q5ZHN9,,,,,47.5,480.0,1.2999999999999999e-120,434.9,"sp|Q5ZHN9|PGPS1_CHICK CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial OS=Gallus gallus OX=9031 GN=PGS1 PE=2 SV=1",,,,,,
OG_07494,FUN_034022-T1,Peve_00034126,Pocillopora_meandrina_HIv1___RNAseq.g26020.t1,three_way,90.51583333333332,FUN_034022-T1,Q16960,,,,,77.4,518.0,4.3e-251,868.6,"sp|Q16960|DYI3_HELCR Dynein intermediate chain 3, ciliary OS=Heliocidaris crassispina OX=1043166 PE=2 SV=1",,,,,,
OG_07495,FUN_034026-T1,Peve_00034136,Pocillopora_meandrina_HIv1___RNAseq.g25924.t1,three_way,61.47733333333333,FUN_034026-T1,Q3ZBH3,,,,,35.5,242.0,6.9999999999999995e-40,165.6,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_07496,FUN_034028-T1,Peve_00043490,Pocillopora_meandrina_HIv1___RNAseq.g16571.t1,three_way,51.52466666666667,,,,,,,,,,,,,,,,,
OG_07497,FUN_034029-T1,Peve_00031756,Pocillopora_meandrina_HIv1___RNAseq.g26024.t1,three_way,90.55533333333334,FUN_034029-T1,Q99873,ANM1_HUMAN,,Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1) (Interferon receptor 1-bound protein 4),Homo sapiens (Human),66.6,359.0,1.9999999999999997e-142,506.9,sp|Q99873|ANM1_HUMAN Protein arginine N-methyltransferase 1 OS=Homo sapiens OX=9606 GN=PRMT1 PE=1 SV=3,GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0005765; GO:0005829; GO:0006338; GO:0006355; GO:0006479; GO:0006974; GO:0007166; GO:0008168; GO:0008170; GO:0008276; GO:0008284; GO:0008327; GO:0008380; GO:0016274; GO:0018216; GO:0019082; GO:0019899; GO:0030510; GO:0031175; GO:0034709; GO:0035241; GO:0035242; GO:0042054; GO:0042802; GO:0044020; GO:0045648; GO:0045652; GO:0045653; GO:0045727; GO:0046329; GO:0046985; GO:0048273; GO:0048738; GO:0051260; GO:0061431; GO:0106080; GO:1900745; GO:1904047; GO:1904263; GO:1905168,cardiac muscle tissue development [GO:0048738]; cell surface receptor signaling pathway [GO:0007166]; cellular response to methionine [GO:0061431]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; in utero embryonic development [GO:0001701]; negative regulation of JNK cascade [GO:0046329]; negative regulation of megakaryocyte differentiation [GO:0045653]; neuron projection development [GO:0031175]; peptidyl-arginine methylation [GO:0018216]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hemoglobin biosynthetic process [GO:0046985]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of translation [GO:0045727]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of BMP signaling pathway [GO:0030510]; regulation of DNA-templated transcription [GO:0006355]; regulation of megakaryocyte differentiation [GO:0045652]; RNA splicing [GO:0008380]; viral protein processing [GO:0019082],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],enzyme binding [GO:0019899]; GATOR1 complex binding [GO:0106080]; histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; mitogen-activated protein kinase p38 binding [GO:0048273]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; RNA binding [GO:0003723]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0065003; GO:0140096,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_07498,FUN_034034-T1,Peve_00019783,Pocillopora_meandrina_HIv1___RNAseq.g26094.t1,three_way,69.25983333333333,FUN_034034-T1,Q6P859,,,,,47.1,187.0,9.3e-41,168.7,sp|Q6P859|GPTC4_XENTR G patch domain-containing protein 4 OS=Xenopus tropicalis OX=8364 GN=gpatch4 PE=2 SV=1,,,,,,
OG_07499,FUN_034036-T1,Peve_00019782,Pocillopora_meandrina_HIv1___RNAseq.g26045.t1b,three_way,76.29766666666667,FUN_034036-T1,Q95L46,,,,,39.6,793.0,4.7e-143,510.0,sp|Q95L46|IF4G2_BOVIN Eukaryotic translation initiation factor 4 gamma 2 OS=Bos taurus OX=9913 GN=EIF4G2 PE=2 SV=2,,,,,,
OG_07500,FUN_034039-T1,Peve_00023160,Pocillopora_meandrina_HIv1___RNAseq.17737_t,three_way,94.59466666666668,FUN_034039-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),80.3,188.0,1.6999999999999999e-84,313.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_07501,FUN_034040-T1,Peve_00023161,Pocillopora_meandrina_HIv1___RNAseq.g26044.t1,three_way,41.32083333333333,FUN_034040-T1,Q6NU13,,,,,50.7,73.0,1.1e-06,56.2,sp|Q6NU13|SPT2_XENLA Protein SPT2 homolog OS=Xenopus laevis OX=8355 GN=spty2d1 PE=2 SV=1,,,,,,
OG_07502,FUN_034042-T1,Peve_00023162,Pocillopora_meandrina_HIv1___RNAseq.g26042.t1,three_way,74.04383333333334,FUN_034042-T1,Q9H0F5,,,,,39.1,207.0,1.7000000000000003e-28,128.6,sp|Q9H0F5|RNF38_HUMAN E3 ubiquitin-protein ligase RNF38 OS=Homo sapiens OX=9606 GN=RNF38 PE=1 SV=4,,,,,,
OG_07503,FUN_034043-T1,Peve_00023163,Pocillopora_meandrina_HIv1___RNAseq.g26041.t1,three_way,35.382666666666665,,,,,,,,,,,,,,,,,
OG_07504,FUN_034045-T3,Peve_00038328,Pocillopora_meandrina_HIv1___TS.g18788.t1,three_way,74.62866666666666,FUN_034045-T3,M0R2J8,DCDC1_HUMAN,,Doublecortin domain-containing protein 1 (Doublecortin domain-containing 5 protein),Homo sapiens (Human),30.7,1578.0,5.9999999999999995e-174,614.0,sp|M0R2J8|DCDC1_HUMAN Doublecortin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=DCDC1 PE=1 SV=1,GO:0005737; GO:0005874; GO:0008017; GO:0030246; GO:0030496; GO:0035556; GO:0051301; GO:0072686; GO:0090543; GO:1902412,cell division [GO:0051301]; intracellular signal transduction [GO:0035556]; regulation of mitotic cytokinesis [GO:1902412],cytoplasm [GO:0005737]; Flemming body [GO:0090543]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle [GO:0072686],carbohydrate binding [GO:0030246]; microtubule binding [GO:0008017],GO:0008092; GO:0043226,cytoskeletal protein binding; organelle
OG_07505,FUN_034047-T1,Peve_00022953,Pocillopora_meandrina_HIv1___RNAseq.g26036.t1,three_way,59.839,FUN_034047-T1,Q1LV46,,,,,45.2,199.0,1.0000000000000001e-44,181.8,sp|Q1LV46|ABHEA_DANRE Protein ABHD14A OS=Danio rerio OX=7955 GN=abhd14a PE=2 SV=1,,,,,,
OG_07506,FUN_034048-T1,Peve_00022954,Pocillopora_meandrina_HIv1___RNAseq.g26035.t1,three_way,53.06433333333334,FUN_034048-T1,Q1LV46,,,,,37.9,198.0,3.2e-35,150.2,sp|Q1LV46|ABHEA_DANRE Protein ABHD14A OS=Danio rerio OX=7955 GN=abhd14a PE=2 SV=1,,,,,,
OG_07507,FUN_034049-T1,Peve_00022955,Pocillopora_meandrina_HIv1___RNAseq.g26034.t2,three_way,61.748,FUN_034049-T1,Q9JIH2,NUP50_MOUSE,,Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50),Mus musculus (Mouse),30.3,478.0,2.7e-38,161.0,sp|Q9JIH2|NUP50_MOUSE Nuclear pore complex protein Nup50 OS=Mus musculus OX=10090 GN=Nup50 PE=1 SV=3,GO:0001841; GO:0005635; GO:0005643; GO:0005654; GO:0006913; GO:0015031; GO:0031965; GO:0051028; GO:1990904,mRNA transport [GO:0051028]; neural tube formation [GO:0001841]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904],,GO:0005635; GO:0005654; GO:0006913,nuclear envelope; nucleoplasm; nucleocytoplasmic transport
OG_07508,FUN_034050-T2,Peve_00022956,Pocillopora_meandrina_HIv1___TS.g18783.t1,three_way,73.61983333333333,FUN_034050-T2,Q22516,CHD3_CAEEL,,Chromodomain-helicase-DNA-binding protein 3 homolog (CHD-3) (EC 3.6.4.-),Caenorhabditis elegans,46.0,63.0,6.7e-12,73.6,sp|Q22516|CHD3_CAEEL Chromodomain-helicase-DNA-binding protein 3 homolog OS=Caenorhabditis elegans OX=6239 GN=chd-3 PE=2 SV=2,GO:0000118; GO:0000785; GO:0001709; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0005634; GO:0006338; GO:0008270; GO:0016581; GO:0016887; GO:0040027; GO:0042393; GO:0046580; GO:0140658,cell fate determination [GO:0001709]; chromatin remodeling [GO:0006338]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of vulval development [GO:0040027],chromatin [GO:0000785]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; NuRD complex [GO:0016581],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; histone binding [GO:0042393]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006325; GO:0016787; GO:0016853; GO:0042393; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; chromatin organization; hydrolase activity; isomerase activity; histone binding; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07509,FUN_034051-T1,Peve_00009941,Pocillopora_meandrina_HIv1___RNAseq.g26031.t1,three_way,79.378,FUN_034051-T1,O93257,XRCC6_CHICK,,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP/AP lyase Ku70) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (DNA repair protein XRCC6) (Ku autoantigen protein p70 homolog) (Ku70),Gallus gallus (Chicken),46.8,583.0,2.6e-147,523.9,sp|O93257|XRCC6_CHICK X-ray repair cross-complementing protein 5 OS=Gallus gallus OX=9031 GN=XRCC6 PE=2 SV=1,GO:0000723; GO:0003678; GO:0003684; GO:0003723; GO:0005524; GO:0005654; GO:0005694; GO:0006303; GO:0006310; GO:0016787; GO:0042162; GO:0043564; GO:0045892; GO:0051575; GO:0070419; GO:0071480; GO:1990904,cellular response to gamma radiation [GO:0071480]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of DNA-templated transcription [GO:0045892]; telomere maintenance [GO:0000723],chromosome [GO:0005694]; Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904],5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; hydrolase activity [GO:0016787]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0003824; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0006355; GO:0016787; GO:0016829; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleoplasm; chromosome; DNA repair; DNA recombination; regulation of DNA-templated transcription; hydrolase activity; lyase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07510,FUN_034052-T1,Peve_00009942,Pocillopora_meandrina_HIv1___RNAseq.g26030.t1,three_way,36.97683333333333,,,,,,,,,,,,,,,,,
OG_07511,FUN_034054-T1,Peve_00009943,Pocillopora_meandrina_HIv1___RNAseq.g26029.t1,three_way,82.816,FUN_034054-T1,Q9I829,,,,,52.2,385.0,3.7999999999999997e-90,333.6,sp|Q9I829|KCNA1_ONCMY Shaker-related potassium channel tsha2 OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1,,,,,,
OG_07512,FUN_034055-T1,Peve_00015322,Pocillopora_meandrina_HIv1___RNAseq.g26028.t2,three_way,81.44633333333333,FUN_034055-T1,O08873,MADD_RAT,,MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP),Rattus norvegicus (Rat),38.5,1719.0,1.8e-285,984.2,sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1,GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236,anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483],axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0007018; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; microtubule-based movement; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_07513,FUN_034057-T1,Peve_00031736,Pocillopora_meandrina_HIv1___TS.g18777.t1,three_way,76.52566666666667,FUN_034057-T1,Q3ZBH3,,,,,40.9,242.0,5.6e-45,182.6,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_07514,FUN_034059-T1,Peve_00031737,Pocillopora_meandrina_HIv1___RNAseq.g26048.t1,three_way,65.53866666666667,FUN_034059-T1,Q3ZCC3,TRAF6_BOVIN,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Bos taurus (Bovine),40.0,490.0,3.3e-95,350.5,sp|Q3ZCC3|TRAF6_BOVIN TNF receptor-associated factor 6 OS=Bos taurus OX=9913 GN=TRAF6 PE=2 SV=1,GO:0000045; GO:0000122; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002753; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005938; GO:0006974; GO:0007249; GO:0008270; GO:0009898; GO:0019886; GO:0023035; GO:0030316; GO:0031624; GO:0031663; GO:0031666; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0033209; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0038061; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0045087; GO:0045453; GO:0045672; GO:0045944; GO:0046330; GO:0048471; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070498; GO:0070534; GO:0097400; GO:0098696; GO:0098978; GO:0140374; GO:0141198; GO:1904996,antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; DNA damage response [GO:0006974]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0005829; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; cytosol; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07515,FUN_034083-T1,Peve_00037081,Pocillopora_meandrina_HIv1___RNAseq.g26053.t1,three_way,67.07933333333332,,,,,,,,,,,,,,,,,
OG_07516,FUN_034084-T1,Peve_00037080,Pocillopora_meandrina_HIv1___RNAseq.g26054.t2,three_way,74.45100000000001,FUN_034084-T1,P07607,,,,,71.9,299.0,1.9000000000000007e-130,466.8,sp|P07607|TYSY_MOUSE Thymidylate synthase OS=Mus musculus OX=10090 GN=Tyms PE=1 SV=1,,,,,,
OG_07517,FUN_034085-T1,Peve_00023949,Pocillopora_meandrina_HIv1___RNAseq.g26055.t1,three_way,85.14366666666666,FUN_034085-T1,Q91V16,,,,,71.6,81.0,1.9999999999999998e-26,119.4,sp|Q91V16|ETFR1_MOUSE Electron transfer flavoprotein regulatory factor 1 OS=Mus musculus OX=10090 GN=Etfrf1 PE=1 SV=1,,,,,,
OG_07518,FUN_034086-T1,Peve_00037076,Pocillopora_meandrina_HIv1___RNAseq.g26057.t1,three_way,75.915,FUN_034086-T1,Q2S1V4,,,,,52.2,469.0,6e-134,479.2,sp|Q2S1V4|TNAA_SALRD Tryptophanase OS=Salinibacter ruber (strain DSM 13855 / M31) OX=309807 GN=tnaA PE=3 SV=1,,,,,,
OG_07519,FUN_034088-T1,Peve_00037071,Pocillopora_meandrina_HIv1___RNAseq.g26059.t1,three_way,77.17566666666667,FUN_034088-T1,Q4V920,PACN1_DANRE,,Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1),Danio rerio (Zebrafish) (Brachydanio rerio),36.1,449.0,4.1e-70,266.9,sp|Q4V920|PACN1_DANRE Protein kinase C and casein kinase substrate in neurons protein 1 OS=Danio rerio OX=7955 GN=pacsin1b PE=1 SV=1,GO:0005543; GO:0005737; GO:0005768; GO:0005829; GO:0006897; GO:0007010; GO:0007015; GO:0030100; GO:0030659; GO:0032587; GO:0043005; GO:0045202; GO:0048812; GO:0060088; GO:0060271; GO:0097320; GO:1900006,actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006]; regulation of endocytosis [GO:0030100],cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endosome [GO:0005768]; neuron projection [GO:0043005]; ruffle membrane [GO:0032587]; synapse [GO:0045202],phospholipid binding [GO:0005543],GO:0005768; GO:0005829; GO:0007010; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0044782; GO:0061024,endosome; cytosol; cytoskeleton organization; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; cilium organization; membrane organization
OG_07520,FUN_034090-T1,Peve_00037070,Pocillopora_meandrina_HIv1___RNAseq.g26061.t1,three_way,75.31133333333334,FUN_034090-T1,Q9I9H8,,,,,36.6,1258.0,6.200000000000001e-146,520.4,sp|Q9I9H8|APAF_DANRE Apoptotic protease-activating factor 1 OS=Danio rerio OX=7955 GN=apaf1 PE=2 SV=1,,,,,,
OG_07521,FUN_034091-T1,Peve_00037069,Pocillopora_meandrina_HIv1___RNAseq.g26062.t1,three_way,83.5495,FUN_034091-T1,Q9VWG3,,,,,62.3,154.0,1.1e-44,181.0,sp|Q9VWG3|RS10B_DROME Small ribosomal subunit protein eS10B OS=Drosophila melanogaster OX=7227 GN=RpS10b PE=1 SV=2,,,,,,
OG_07522,FUN_034092-T1,Peve_00037068,Pocillopora_meandrina_HIv1___RNAseq.g26064.t1,three_way,61.58783333333333,,,,,,,,,,,,,,,,,
OG_07523,FUN_034093-T1,Peve_00037067,Pocillopora_meandrina_HIv1___RNAseq.g26065.t1,three_way,65.31416666666668,FUN_034093-T1,Q641G4,,,,,38.5,642.0,2.6e-94,347.8,sp|Q641G4|CNDH2_XENLA Condensin-2 complex subunit H2 OS=Xenopus laevis OX=8355 GN=ncaph2 PE=1 SV=1,,,,,,
OG_07524,FUN_034094-T1,Peve_00014895,Pocillopora_meandrina_HIv1___RNAseq.g26066.t1,three_way,67.27116666666667,FUN_034094-T1,Q5ZKZ9,,,,,34.3,866.0,3.7e-118,427.6,sp|Q5ZKZ9|LMF2_CHICK Lipase maturation factor 2 OS=Gallus gallus OX=9031 GN=LMF2 PE=2 SV=2,,,,,,
OG_07525,FUN_034095-T1,Peve_00006471,Pocillopora_meandrina_HIv1___TS.g18816.t1a,three_way,78.403,FUN_034095-T1,Q0P4Y8,,,,,47.8,670.0,7e-167,589.0,sp|Q0P4Y8|LMF2_XENTR Lipase maturation factor 2 OS=Xenopus tropicalis OX=8364 GN=lmf2 PE=2 SV=1,,,,,,
OG_07526,FUN_034096-T1,Peve_00006468,Pocillopora_meandrina_HIv1___TS.g18816.t1b,three_way,49.18933333333333,FUN_034096-T1,E7F211,TTC17_DANRE,,Tetratricopeptide repeat protein 17 (TPR repeat protein 17),Danio rerio (Zebrafish) (Brachydanio rerio),26.7,1249.0,1.1e-72,276.9,sp|E7F211|TTC17_DANRE Tetratricopeptide repeat protein 17 OS=Danio rerio OX=7955 GN=ttc17 PE=3 SV=1,GO:0005737; GO:0005886; GO:0015629; GO:0030041; GO:0044782; GO:0061371,actin filament polymerization [GO:0030041]; cilium organization [GO:0044782]; determination of heart left/right asymmetry [GO:0061371],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005856; GO:0005886; GO:0043226; GO:0044782; GO:0065003,cytoskeleton; plasma membrane; organelle; cilium organization; protein-containing complex assembly
OG_07527,FUN_034097-T1,Peve_00031185,Pocillopora_meandrina_HIv1___RNAseq.g26069.t1,three_way,81.34366666666666,FUN_034097-T1,Q5PP32,,,,,32.9,383.0,1.7e-34,148.3,sp|Q5PP32|WTR25_ARATH WAT1-related protein At3g45870 OS=Arabidopsis thaliana OX=3702 GN=At3g45870 PE=2 SV=1,,,,,,
OG_07528,FUN_034098-T1,Peve_00042343,Pocillopora_meandrina_HIv1___RNAseq.g26070.t1,three_way,59.001,FUN_034098-T1,Q9NQ36,SCUB2_HUMAN,,"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You)",Homo sapiens (Human),41.2,85.0,1.9e-12,75.9,"sp|Q9NQ36|SCUB2_HUMAN Signal peptide, CUB and EGF-like domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SCUBE2 PE=1 SV=3",GO:0005509; GO:0005576; GO:0005615; GO:0007165; GO:0008289; GO:0009986,signal transduction [GO:0007165],cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; lipid binding [GO:0008289],GO:0005576; GO:0005615; GO:0008289,extracellular region; extracellular space; lipid binding
OG_07529,FUN_034101-T1,Peve_00042339,Pocillopora_meandrina_HIv1___RNAseq.g26072.t1,three_way,59.225,,,,,,,,,,,,,,,,,
OG_07530,FUN_034102-T1,Peve_00042340,Pocillopora_meandrina_HIv1___RNAseq.g26012.t1,three_way,92.093,FUN_034102-T1,B5X277,,,,,77.8,117.0,1.8e-50,199.9,sp|B5X277|MTNB_SALSA Methylthioribulose-1-phosphate dehydratase OS=Salmo salar OX=8030 GN=apip PE=2 SV=1,,,,,,
OG_07531,FUN_034107-T1,Peve_00035269,Pocillopora_meandrina_HIv1___RNAseq.g25964.t2,three_way,76.35033333333332,FUN_034107-T1,B5X4E0,,,,,33.2,289.0,2.6e-39,164.1,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_07532,FUN_034108-T1,Peve_00035268,Pocillopora_meandrina_HIv1___RNAseq.g25963.t1,three_way,83.90533333333333,FUN_034108-T1,P17972,KCNAW_DROME,,Potassium voltage-gated channel protein Shaw (Shaw2),Drosophila melanogaster (Fruit fly),49.9,433.0,1.8e-110,401.4,sp|P17972|KCNAW_DROME Potassium voltage-gated channel protein Shaw OS=Drosophila melanogaster OX=7227 GN=Shaw PE=2 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0022843; GO:0030431; GO:0032590; GO:0032809; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; sleep [GO:0030431],axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_07533,FUN_034109-T1,Peve_00034853,Pocillopora_meandrina_HIv1___RNAseq.g25962.t1,three_way,67.35366666666667,FUN_034109-T1,P55265,DSRAD_HUMAN,,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),Homo sapiens (Human),33.4,739.0,5.6e-90,334.0,sp|P55265|DSRAD_HUMAN Double-stranded RNA-specific adenosine deaminase OS=Homo sapiens OX=9606 GN=ADAR PE=1 SV=4,GO:0001649; GO:0002244; GO:0002566; GO:0003677; GO:0003723; GO:0003725; GO:0003726; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0006382; GO:0006396; GO:0006397; GO:0006606; GO:0006611; GO:0008251; GO:0009615; GO:0016020; GO:0016553; GO:0030218; GO:0031054; GO:0035455; GO:0044387; GO:0044530; GO:0045070; GO:0045087; GO:0046872; GO:0051607; GO:0060216; GO:0060339; GO:0061484; GO:0070922; GO:0097284; GO:0098586; GO:1900369; GO:1903944,adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; hepatocyte apoptotic process [GO:0097284]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of post-transcriptional gene silencing by regulatory ncRNA [GO:1900369]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RISC complex assembly [GO:0070922]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530],DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0006886; GO:0006913; GO:0012501; GO:0016071; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098542; GO:0140098,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; intracellular protein transport; nucleocytoplasmic transport; programmed cell death; mRNA metabolic process; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA"
OG_07534,FUN_034110-T1,Peve_00034861,Pocillopora_meandrina_HIv1___RNAseq.g25961.t1,three_way,65.22083333333333,,,,,,,,,,,,,,,,,
OG_07535,FUN_034111-T1,Peve_00034867,Pocillopora_meandrina_HIv1___TS.g18705.t1a,three_way,76.7515,FUN_034111-T1,Q0P5H9,TTC5_BOVIN,,Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Protein Strap),Bos taurus (Bovine),50.7,302.0,4.8e-81,302.8,sp|Q0P5H9|TTC5_BOVIN Tetratricopeptide repeat protein 5 OS=Bos taurus OX=9913 GN=TTC5 PE=2 SV=1,GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006281; GO:0006974; GO:0009267; GO:0031410,cellular response to starvation [GO:0009267]; DNA damage response [GO:0006974]; DNA repair [GO:0006281],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634],,GO:0005634; GO:0005739; GO:0005829; GO:0006281; GO:0031410; GO:0043226,nucleus; mitochondrion; cytosol; DNA repair; cytoplasmic vesicle; organelle
OG_07536,FUN_034112-T1,Peve_00034854,Pocillopora_meandrina_HIv1___RNAseq.g25957.t1,three_way,95.99733333333332,FUN_034112-T1,P61211,,,,,86.2,181.0,9.1e-85,314.3,sp|P61211|ARL1_MOUSE ADP-ribosylation factor-like protein 1 OS=Mus musculus OX=10090 GN=Arl1 PE=1 SV=1,,,,,,
OG_07537,FUN_034113-T1,Peve_00034855,Pocillopora_meandrina_HIv1___RNAseq.g25956.t1,three_way,76.55533333333334,FUN_034113-T1,Q178L7,,,,,58.6,116.0,4.899999999999999e-31,135.6,"sp|Q178L7|SDHF2_AEDAE Succinate dehydrogenase assembly factor 2, mitochondrial OS=Aedes aegypti OX=7159 GN=AAEL005866 PE=3 SV=1",,,,,,
OG_07538,FUN_034114-T1,Peve_00034856,Pocillopora_meandrina_HIv1___RNAseq.g25955.t1,three_way,88.02533333333334,FUN_034114-T1,O54747,DPOD1_RAT,,DNA polymerase delta catalytic subunit (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-),Rattus norvegicus (Rat),65.3,1059.0,0.0,1419.8,sp|O54747|DPOD1_RAT DNA polymerase delta catalytic subunit OS=Rattus norvegicus OX=10116 GN=Pold1 PE=2 SV=1,GO:0000109; GO:0000166; GO:0000731; GO:0000781; GO:0003677; GO:0003682; GO:0003684; GO:0003887; GO:0005634; GO:0006260; GO:0006261; GO:0006287; GO:0006297; GO:0008270; GO:0008296; GO:0008408; GO:0019899; GO:0034644; GO:0043625; GO:0045004; GO:0051539; GO:0055089; GO:0070987; GO:0071897,"base-excision repair, gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair, DNA gap filling [GO:0006297]","chromosome, telomeric region [GO:0000781]; delta DNA polymerase complex [GO:0043625]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]","3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; enzyme binding [GO:0019899]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016740; GO:0016787; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; transferase activity; hydrolase activity; organelle; catalytic activity, acting on DNA"
OG_07539,FUN_034120-T1,Peve_00039587,Pocillopora_meandrina_HIv1___RNAseq.g25948.t2,three_way,82.97233333333334,FUN_034120-T1,A0A0G2K047,ACSS3_RAT,,"Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 3) (Acyl-CoA synthetase short-chain family member 3) (Propionate--CoA ligase) (EC 6.2.1.17)",Rattus norvegicus (Rat),54.1,625.0,2.0000000000000002e-212,740.3,"sp|A0A0G2K047|ACSS3_RAT Acyl-CoA synthetase short-chain family member 3, mitochondrial OS=Rattus norvegicus OX=10116 GN=Acss3 PE=1 SV=1",GO:0003987; GO:0005524; GO:0005759; GO:0006629; GO:0031956; GO:0050218,lipid metabolic process [GO:0006629],mitochondrial matrix [GO:0005759],acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; propionate-CoA ligase activity [GO:0050218],GO:0003824; GO:0006629; GO:0016874; GO:0140657,catalytic activity; lipid metabolic process; ligase activity; ATP-dependent activity
OG_07540,FUN_034121-T1,Peve_00039586,Pocillopora_meandrina_HIv1___RNAseq.g25946.t1,three_way,61.15633333333333,FUN_034121-T1,Q5FVF4,,,,,34.1,460.0,1.1000000000000004e-59,232.6,sp|Q5FVF4|TM7S3_RAT Transmembrane 7 superfamily member 3 OS=Rattus norvegicus OX=10116 GN=Tm7sf3 PE=2 SV=1,,,,,,
OG_07541,FUN_034122-T1,Peve_00039585,Pocillopora_meandrina_HIv1___RNAseq.g25947.t1,three_way,51.35716666666666,FUN_034122-T1,Q8BUR3,FOXJ3_MOUSE,,Forkhead box protein J3,Mus musculus (Mouse),44.5,155.0,4.5000000000000003e-23,110.9,sp|Q8BUR3|FOXJ3_MOUSE Forkhead box protein J3 OS=Mus musculus OX=10090 GN=Foxj3 PE=1 SV=1,GO:0001228; GO:0005634; GO:0007141; GO:0007283; GO:0030154; GO:1990837,cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; spermatogenesis [GO:0007283],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0022414; GO:0030154; GO:0043226; GO:0140013; GO:0140110,DNA binding; nucleus; reproductive process; cell differentiation; organelle; meiotic nuclear division; transcription regulator activity
OG_07542,FUN_034123-T1,Peve_00039584,Pocillopora_meandrina_HIv1___TS.g18693.t1,three_way,50.32483333333333,FUN_034123-T1,Q9NSA2,KCND1_HUMAN,,A-type voltage-gated potassium channel KCND1 (Potassium voltage-gated channel subfamily D member 1) (Shal-type potassium channel KCND1) (Voltage-gated potassium channel subunit Kv4.1),Homo sapiens (Human),44.4,376.0,1.7e-73,279.3,sp|Q9NSA2|KCND1_HUMAN A-type voltage-gated potassium channel KCND1 OS=Homo sapiens OX=9606 GN=KCND1 PE=1 SV=2,GO:0001508; GO:0005250; GO:0005886; GO:0008076; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260],dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_07543,FUN_034124-T1,Peve_00006391,Pocillopora_meandrina_HIv1___RNAseq.g25944.t1,three_way,74.825,FUN_034124-T1,Q9NZV8,KCND2_HUMAN,,A-type voltage-gated potassium channel KCND2 (Potassium voltage-gated channel subfamily D member 2) (Voltage-gated potassium channel subunit Kv4.2),Homo sapiens (Human),41.2,279.0,9.3e-45,182.2,sp|Q9NZV8|KCND2_HUMAN A-type voltage-gated potassium channel KCND2 OS=Homo sapiens OX=9606 GN=KCND2 PE=1 SV=2,GO:0001508; GO:0005249; GO:0005250; GO:0005886; GO:0006936; GO:0007268; GO:0008016; GO:0008076; GO:0019228; GO:0019233; GO:0032809; GO:0043025; GO:0043197; GO:0043204; GO:0044853; GO:0045211; GO:0045475; GO:0046872; GO:0051260; GO:0070161; GO:0071193; GO:0071456; GO:0071805; GO:0086009; GO:0098978; GO:0098982; GO:0099634; GO:1905030,action potential [GO:0001508]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; locomotor rhythm [GO:0045475]; membrane repolarization [GO:0086009]; muscle contraction [GO:0006936]; neuronal action potential [GO:0019228]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of heart contraction [GO:0008016]; sensory perception of pain [GO:0019233],anchoring junction [GO:0070161]; dendritic spine [GO:0043197]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Kv4.2-KChIP2 channel complex [GO:0071193]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030]; voltage-gated potassium channel activity [GO:0005249],GO:0003012; GO:0005215; GO:0005886; GO:0023052; GO:0050877; GO:0055085; GO:0065003,muscle system process; transporter activity; plasma membrane; signaling; nervous system process; transmembrane transport; protein-containing complex assembly
OG_07544,FUN_034125-T1,Peve_00006390,Pocillopora_meandrina_HIv1___RNAseq.g25943.t1,three_way,55.485,FUN_034125-T1,P61168,,,,,31.7,205.0,6.5e-13,76.6,sp|P61168|DRD2_MOUSE D(2) dopamine receptor OS=Mus musculus OX=10090 GN=Drd2 PE=1 SV=2,,,,,,
OG_07545,FUN_034126-T1,Peve_00006389,Pocillopora_meandrina_HIv1___RNAseq.g25942.t1,three_way,44.913,,,,,,,,,,,,,,,,,
OG_07546,FUN_034128-T1,Peve_00006388,Pocillopora_meandrina_HIv1___RNAseq.g25941.t1,three_way,73.77066666666667,FUN_034128-T1,Q9JJK3,,,,,43.3,381.0,4.2e-79,296.6,sp|Q9JJK3|PEX3_CRILO Peroxisomal biogenesis factor 3 OS=Cricetulus longicaudatus OX=10030 GN=PEX3 PE=2 SV=1,,,,,,
OG_07547,FUN_034129-T1,Peve_00006387,Pocillopora_meandrina_HIv1___RNAseq.g25940.t1,three_way,75.964,FUN_034129-T1,O02703,BAX_BOVIN,,Apoptosis regulator BAX,Bos taurus (Bovine),37.1,140.0,9.6e-19,95.1,sp|O02703|BAX_BOVIN Apoptosis regulator BAX OS=Bos taurus OX=9913 GN=BAX PE=2 SV=1,GO:0001783; GO:0001836; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005757; GO:0005783; GO:0005789; GO:0005829; GO:0008053; GO:0008289; GO:0008630; GO:0008637; GO:0009636; GO:0010248; GO:0010917; GO:0015267; GO:0031334; GO:0032091; GO:0032976; GO:0042803; GO:0042981; GO:0043065; GO:0043525; GO:0043653; GO:0046930; GO:0051434; GO:0051881; GO:0090200; GO:0097136; GO:0097144; GO:0097190; GO:0097192; GO:0097193; GO:2001244,apoptotic mitochondrial changes [GO:0008637]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of protein binding [GO:0032091]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of apoptotic process [GO:0042981]; regulation of mitochondrial membrane potential [GO:0051881]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to toxic substance [GO:0009636],BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930],BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005634; GO:0005739; GO:0005783; GO:0005829; GO:0007005; GO:0008289; GO:0012501; GO:0043226; GO:0055085,transporter activity; nucleus; mitochondrion; endoplasmic reticulum; cytosol; mitochondrion organization; lipid binding; programmed cell death; organelle; transmembrane transport
OG_07548,FUN_034130-T1,Peve_00006386,Pocillopora_meandrina_HIv1___RNAseq.g26664.t1,three_way,57.29133333333333,,,,,,,,,,,,,,,,,
OG_07549,FUN_034131-T1,Peve_00006385,Pocillopora_meandrina_HIv1___RNAseq.g26665.t1,three_way,67.411,FUN_034131-T1,Q9ZE48,RL28_RICPR,,Large ribosomal subunit protein bL28 (50S ribosomal protein L28),Rickettsia prowazekii (strain Madrid E),31.0,87.0,7.7e-06,52.0,sp|Q9ZE48|RL28_RICPR Large ribosomal subunit protein bL28 OS=Rickettsia prowazekii (strain Madrid E) OX=272947 GN=rpmB PE=3 SV=1,GO:0003735; GO:0005840; GO:0006412; GO:1990904,translation [GO:0006412],ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840],structural constituent of ribosome [GO:0003735],GO:0005198; GO:0005840; GO:0043226,structural molecule activity; ribosome; organelle
OG_07550,FUN_034132-T1,Peve_00006384,Pocillopora_meandrina_HIv1___RNAseq.g7012.t1,three_way,59.236666666666665,FUN_034132-T1,A0A2B4RP11,,,,,53.8,372.0,1.1e-103,378.3,sp|A0A2B4RP11|CGLR1_STYPI Cyclic GMP-AMP synthase-like receptor 1 OS=Stylophora pistillata OX=50429 GN=cGLR1 PE=1 SV=1,,,,,,
OG_07551,FUN_034135-T1,Peve_00006366,Pocillopora_meandrina_HIv1___TS.g19061.t1b,three_way,58.830333333333336,,,,,,,,,,,,,,,,,
OG_07552,FUN_034143-T1,Peve_00018766,Pocillopora_meandrina_HIv1___RNAseq.g26306.t1,three_way,76.9615,FUN_034143-T1,Q03168,,,,,61.2,335.0,1.4e-113,411.0,sp|Q03168|ASPP_AEDAE Lysosomal aspartic protease OS=Aedes aegypti OX=7159 GN=AAEL006169 PE=1 SV=2,,,,,,
OG_07553,FUN_034144-T1,Peve_00018769,Pocillopora_meandrina_HIv1___RNAseq.g26305.t1,three_way,57.939,FUN_034144-T1,Q9UPZ3,HPS5_HUMAN,,BLOC-2 complex member HPS5 (Alpha-integrin-binding protein 63) (Hermansky-Pudlak syndrome 5 protein) (Ruby-eye protein 2 homolog) (Ru2),Homo sapiens (Human),32.0,425.0,2.9e-54,216.1,sp|Q9UPZ3|HPS5_HUMAN BLOC-2 complex member HPS5 OS=Homo sapiens OX=9606 GN=HPS5 PE=1 SV=2,GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232,blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155],BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769],,GO:0005768; GO:0005829; GO:0031410; GO:0043226,endosome; cytosol; cytoplasmic vesicle; organelle
OG_07554,FUN_034149-T1,Peve_00026010,Pocillopora_meandrina_HIv1___TS.g23718.t1b,three_way,50.663833333333336,,,,,,,,,,,,,,,,,
OG_07555,FUN_034159-T1,Peve_00018778,Pocillopora_meandrina_HIv1___RNAseq.g26287.t1,three_way,78.49566666666666,FUN_034159-T1,Q8CFE4,SCYL2_MOUSE,,SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa),Mus musculus (Mouse),55.5,600.0,1.7e-193,677.9,sp|Q8CFE4|SCYL2_MOUSE SCY1-like protein 2 OS=Mus musculus OX=10090 GN=Scyl2 PE=1 SV=1,GO:0004672; GO:0005102; GO:0005524; GO:0005794; GO:0007420; GO:0008333; GO:0010008; GO:0021860; GO:0030136; GO:0031623; GO:0072583; GO:0090090,brain development [GO:0007420]; clathrin-dependent endocytosis [GO:0072583]; endosome to lysosome transport [GO:0008333]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; pyramidal neuron development [GO:0021860]; receptor internalization [GO:0031623],clathrin-coated vesicle [GO:0030136]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005794; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; Golgi apparatus; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07556,FUN_034160-T1,Peve_00018779,Pocillopora_meandrina_HIv1___RNAseq.g26286.t1,three_way,47.58283333333333,FUN_034160-T1,O17645,HST2_CAEEL,,Heparan sulfate 2-O-sulfotransferase hst-2 (Heparan sulfotransferase 2) (EC 2.8.2.-) (HS2ST1 homolog),Caenorhabditis elegans,26.5,230.0,5.2e-07,58.2,sp|O17645|HST2_CAEEL Heparan sulfate 2-O-sulfotransferase hst-2 OS=Caenorhabditis elegans OX=6239 GN=hst-2 PE=1 SV=2,GO:0000139; GO:0004394; GO:0005794; GO:0015012; GO:0030334; GO:0040018; GO:1902667,heparan sulfate proteoglycan biosynthetic process [GO:0015012]; positive regulation of multicellular organism growth [GO:0040018]; regulation of axon guidance [GO:1902667]; regulation of cell migration [GO:0030334],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],heparan sulfate 2-sulfotransferase activity [GO:0004394],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_07557,FUN_034162-T1,Peve_00039725,Pocillopora_meandrina_HIv1___RNAseq.g26285.t1,three_way,67.07516666666666,FUN_034162-T1,Q9TRY0,,,,,48.3,402.0,1.3e-98,361.7,sp|Q9TRY0|FKBP4_BOVIN Peptidyl-prolyl cis-trans isomerase FKBP4 OS=Bos taurus OX=9913 GN=FKBP4 PE=1 SV=4,,,,,,
OG_07558,FUN_034167-T1,Peve_00039722,Pocillopora_meandrina_HIv1___RNAseq.g26282.t1,three_way,58.50483333333333,FUN_034167-T1,Q9CR48,DRAM2_MOUSE,,DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77),Mus musculus (Mouse),40.2,239.0,5.1e-36,152.9,sp|Q9CR48|DRAM2_MOUSE DNA damage-regulated autophagy modulator protein 2 OS=Mus musculus OX=10090 GN=Dram2 PE=2 SV=1,GO:0001917; GO:0005764; GO:0005765; GO:0005794; GO:0006914; GO:0006915; GO:0007601; GO:0008283; GO:0010087; GO:0010506; GO:0016324; GO:0045494; GO:0060041,apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell population proliferation [GO:0008283]; phloem or xylem histogenesis [GO:0010087]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917],,GO:0005764; GO:0005773; GO:0005794; GO:0006914; GO:0012501; GO:0043226; GO:0048856; GO:0050877,lysosome; vacuole; Golgi apparatus; autophagy; programmed cell death; organelle; anatomical structure development; nervous system process
OG_07559,FUN_034173-T1,Peve_00006812,Pocillopora_meandrina_HIv1___RNAseq.g26278.t1,three_way,85.85433333333333,FUN_034173-T1,Q6UPE0,CHDH_RAT,,"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)",Rattus norvegicus (Rat),63.8,450.0,6.7e-177,621.7,"sp|Q6UPE0|CHDH_RAT Choline dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Chdh PE=1 SV=1",GO:0005743; GO:0008812; GO:0019285; GO:0050660,glycine betaine biosynthetic process from choline [GO:0019285],mitochondrial inner membrane [GO:0005743],choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660],GO:0003824; GO:0006575; GO:0016491,catalytic activity; modified amino acid metabolic process; oxidoreductase activity
OG_07560,FUN_034174-T1,Peve_00006815,Pocillopora_meandrina_HIv1___RNAseq.g26277.t1,three_way,48.913,,,,,,,,,,,,,,,,,
OG_07561,FUN_034204-T1,Peve_00027540,Pocillopora_meandrina_HIv1___RNAseq.g26173.t1,three_way,63.34916666666667,FUN_034204-T1,Q8C9V1,TB10C_MOUSE,,Carabin (TBC1 domain family member 10C),Mus musculus (Mouse),28.3,371.0,1.2e-33,146.4,sp|Q8C9V1|TB10C_MOUSE Carabin OS=Mus musculus OX=10090 GN=Tbc1d10c PE=1 SV=1,GO:0005096; GO:0005829; GO:0031527; GO:0033173; GO:0042113; GO:0042147; GO:0050869; GO:0070371; GO:0070373; GO:0070885,"B cell activation [GO:0042113]; calcineurin-NFAT signaling cascade [GO:0033173]; ERK1 and ERK2 cascade [GO:0070371]; negative regulation of B cell activation [GO:0050869]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; filopodium membrane [GO:0031527],GTPase activator activity [GO:0005096],GO:0002376; GO:0005829; GO:0016192; GO:0098772,immune system process; cytosol; vesicle-mediated transport; molecular function regulator activity
OG_07562,FUN_034205-T1,Peve_00027539,Pocillopora_meandrina_HIv1___TS.g18923.t1,three_way,65.39233333333334,FUN_034205-T1,A6NJV1,CMI2C_HUMAN,,Ciliary microtubule inner protein 2C,Homo sapiens (Human),39.5,129.0,1.8e-17,90.9,sp|A6NJV1|CMI2C_HUMAN Ciliary microtubule inner protein 2C OS=Homo sapiens OX=9606 GN=CIMIP2C PE=1 SV=1,GO:0005634; GO:0005879; GO:0030317; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleus; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_07563,FUN_034209-T1,Peve_00027534,Pocillopora_meandrina_HIv1___RNAseq.g26169.t1,three_way,56.48,,,,,,,,,,,,,,,,,
OG_07564,FUN_034211-T1,Peve_00027535,Pocillopora_meandrina_HIv1___RNAseq.g26168.t1,three_way,46.269333333333336,,,,,,,,,,,,,,,,,
OG_07565,FUN_034214-T1,Peve_00027532,Pocillopora_meandrina_HIv1___RNAseq.g26163.t1,three_way,52.1425,,,,,,,,,,,,,,,,,
OG_07566,FUN_034216-T1,Peve_00027530,Pocillopora_meandrina_HIv1___RNAseq.g26161.t1,three_way,74.85666666666667,,,,,,,,,,,,,,,,,
OG_07567,FUN_034229-T1,Peve_00040765,Pocillopora_meandrina_HIv1___RNAseq.g28437.t1,three_way,83.228,FUN_034229-T1,Q8IWQ3,BRSK2_HUMAN,,Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A),Homo sapiens (Human),50.3,650.0,3.5e-169,596.7,sp|Q8IWQ3|BRSK2_HUMAN Serine/threonine-protein kinase BRSK2 OS=Homo sapiens OX=9606 GN=BRSK2 PE=1 SV=3,GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0019901; GO:0021953; GO:0030010; GO:0030036; GO:0030182; GO:0036503; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0106310; GO:0150034; GO:1904152; GO:2000807,"actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell division [GO:0051301]; central nervous system neuron differentiation [GO:0021953]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005783; GO:0005815; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endoplasmic reticulum; microtubule organizing center; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07568,FUN_034230-T1,Peve_00000636,Pocillopora_meandrina_HIv1___RNAseq.g28438.t1,three_way,78.84533333333333,FUN_034230-T1,P32780,TF2H1_HUMAN,,General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit) (BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit),Homo sapiens (Human),42.3,549.0,9e-112,405.6,sp|P32780|TF2H1_HUMAN General transcription factor IIH subunit 1 OS=Homo sapiens OX=9606 GN=GTF2H1 PE=1 SV=1,GO:0000079; GO:0000439; GO:0003682; GO:0005654; GO:0005675; GO:0006281; GO:0006289; GO:0006360; GO:0006366; GO:0006367; GO:0009755; GO:0045893; GO:0046966,DNA repair [GO:0006281]; hormone-mediated signaling pathway [GO:0009755]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675],chromatin binding [GO:0003682]; nuclear thyroid hormone receptor binding [GO:0046966],GO:0005654; GO:0006281; GO:0006351; GO:0006355,nucleoplasm; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription
OG_07569,FUN_034231-T1,Peve_00000637,Pocillopora_meandrina_HIv1___RNAseq.g28439.t1,three_way,80.96333333333334,FUN_034231-T1,Q8VI63,,,,,46.2,212.0,1.0999999999999999e-47,191.4,sp|Q8VI63|MOB2_MOUSE MOB kinase activator 2 OS=Mus musculus OX=10090 GN=Mob2 PE=1 SV=1,,,,,,
OG_07570,FUN_034232-T1,Peve_00000638,Pocillopora_meandrina_HIv1___RNAseq.g28440.t1,three_way,77.614,FUN_034232-T1,Q7ZXF5,FACR1_XENLA,,Fatty acyl-CoA reductase 1 (Far1) (EC 1.2.1.84),Xenopus laevis (African clawed frog),46.0,506.0,1e-133,478.4,sp|Q7ZXF5|FACR1_XENLA Fatty acyl-CoA reductase 1 OS=Xenopus laevis OX=8355 GN=far1 PE=2 SV=1,GO:0005777; GO:0005778; GO:0008611; GO:0010025; GO:0035336; GO:0080019; GO:0102965,ether lipid biosynthetic process [GO:0008611]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; wax biosynthetic process [GO:0010025],peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],alcohol-forming long-chain fatty acyl-CoA reductase activity [GO:0102965]; alcohol-forming very long-chain fatty acyl-CoA reductase activity [GO:0080019],GO:0003824; GO:0005777; GO:0006629; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; peroxisome; lipid metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07571,FUN_034238-T1,Peve_00022637,Pocillopora_meandrina_HIv1___TS.g19354.t1,three_way,70.52716666666667,FUN_034238-T1,A0NLY7,ISAHY_ROSAI,,Isatin hydrolase (EC 3.5.2.20) (Isatin amidohydrolase) (Isatin hydrolase isoform b) (IH-b),Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) (Stappia aggregata),32.5,209.0,7.6e-25,115.9,sp|A0NLY7|ISAHY_ROSAI Isatin hydrolase OS=Roseibium aggregatum (strain ATCC 25650 / DSM 13394 / JCM 20685 / NBRC 16684 / NCIMB 2208 / IAM 12614 / B1) OX=384765 GN=SIAM614_09648 PE=1 SV=1,GO:0004061; GO:0016812; GO:0019441; GO:0030145,L-tryptophan catabolic process to kynurenine [GO:0019441],,"arylformamidase activity [GO:0004061]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO:0016812]; manganese ion binding [GO:0030145]",GO:0003824; GO:0006520; GO:0016787,catalytic activity; amino acid metabolic process; hydrolase activity
OG_07572,FUN_034244-T1,Peve_00036914,Pocillopora_meandrina_HIv1___TS.g19363.t1,three_way,41.717333333333336,,,,,,,,,,,,,,,,,
OG_07573,FUN_034245-T1,Peve_00003830,Pocillopora_meandrina_HIv1___RNAseq.g26610.t1c,three_way,49.638666666666666,FUN_034245-T1,P07949,RET_HUMAN,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Homo sapiens (Human),40.5,328.0,3.6e-57,224.6,sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens OX=9606 GN=RET PE=1 SV=3,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0010008; GO:0010628; GO:0010976; GO:0030155; GO:0030335; GO:0030424; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:0160144; GO:2001241,axon guidance [GO:0007411]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; posterior midgut development [GO:0007497]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; signal transduction [GO:0007165]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"immune system process; catalytic activity; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_07574,FUN_034251-T1,Peve_00031516,Pocillopora_meandrina_HIv1___RNAseq.g26612.t1,three_way,40.29966666666667,FUN_034251-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),26.9,324.0,4e-19,97.8,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_07575,FUN_034253-T1,Peve_00007814,Pocillopora_meandrina_HIv1___RNAseq.g26631.t1,three_way,51.3935,FUN_034253-T1,Q91288,FGFR4_PLEWA,,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (PFR4),Pleurodeles waltl (Iberian ribbed newt),31.6,626.0,1.5e-67,259.2,sp|Q91288|FGFR4_PLEWA Fibroblast growth factor receptor 4 OS=Pleurodeles waltl OX=8319 GN=FGFR4 PE=2 SV=1,GO:0005007; GO:0005524; GO:0005768; GO:0005783; GO:0005886; GO:0008284; GO:0017134; GO:0043235; GO:0070374; GO:0070857,positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of bile acid biosynthetic process [GO:0070857],endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007],GO:0003824; GO:0005768; GO:0005783; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0060089; GO:0140096,"catalytic activity; endosome; endoplasmic reticulum; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; molecular transducer activity; catalytic activity, acting on a protein"
OG_07576,FUN_034255-T1,Peve_00011313,Pocillopora_meandrina_HIv1___TS.g19379.t1,three_way,47.93416666666666,,,,,,,,,,,,,,,,,
OG_07577,FUN_034258-T1,Peve_00009313,Pocillopora_meandrina_HIv1___RNAseq.g26618.t1,three_way,57.11,FUN_034258-T1,A0A386CAB9,NLRP1_DANRE,,"NACHT, LRR and PYD domains-containing protein 1 homolog (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1, C-terminus (NLRP1-CT); NACHT, LRR and PYD domains-containing protein 1, N-terminus (NLRP1-NT)]",Danio rerio (Zebrafish) (Brachydanio rerio),23.4,402.0,5e-16,88.6,"sp|A0A386CAB9|NLRP1_DANRE NACHT, LRR and PYD domains-containing protein 1 homolog OS=Danio rerio OX=7955 GN=nlrp1 PE=1 SV=1",GO:0002221; GO:0005524; GO:0005737; GO:0006508; GO:0006954; GO:0008233; GO:0012501; GO:0032731; GO:0042981; GO:0045087; GO:0050729; GO:0061702; GO:0072558,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; programmed cell death [GO:0012501]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981],canonical inflammasome complex [GO:0061702]; cytoplasm [GO:0005737]; NLRP1 inflammasome complex [GO:0072558],ATP binding [GO:0005524]; peptidase activity [GO:0008233],GO:0002376; GO:0003824; GO:0006954; GO:0012501; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; inflammatory response; programmed cell death; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07578,FUN_034259-T1,Peve_00009314,Pocillopora_meandrina_HIv1___RNAseq.g26619.t1,three_way,51.376333333333335,,,,,,,,,,,,,,,,,
OG_07579,FUN_034260-T1,Peve_00009311,Pocillopora_meandrina_HIv1___RNAseq.g26620.t1,three_way,74.869,FUN_034260-T1,Q9H2X6,HIPK2_HUMAN,,Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1),Homo sapiens (Human),49.5,662.0,4.4e-159,563.9,sp|Q9H2X6|HIPK2_HUMAN Homeodomain-interacting protein kinase 2 OS=Homo sapiens OX=9606 GN=HIPK2 PE=1 SV=2,GO:0000122; GO:0001654; GO:0003016; GO:0003713; GO:0003714; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0006468; GO:0007179; GO:0007224; GO:0007628; GO:0008283; GO:0008284; GO:0009952; GO:0010467; GO:0010494; GO:0010842; GO:0016604; GO:0016605; GO:0018105; GO:0030182; GO:0030218; GO:0030330; GO:0030511; GO:0030514; GO:0030578; GO:0030878; GO:0040029; GO:0042771; GO:0043524; GO:0045766; GO:0045944; GO:0046330; GO:0046332; GO:0046790; GO:0048596; GO:0050882; GO:0051402; GO:0051726; GO:0060059; GO:0060235; GO:0060395; GO:0060425; GO:0061072; GO:0061629; GO:0071456; GO:0090575; GO:0097193; GO:0106310; GO:1901796; GO:2000059,"adult walking behavior [GO:0007628]; anterior/posterior pattern specification [GO:0009952]; cell population proliferation [GO:0008283]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; epigenetic regulation of gene expression [GO:0040029]; erythrocyte differentiation [GO:0030218]; eye development [GO:0001654]; gene expression [GO:0010467]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; iris morphogenesis [GO:0061072]; lens induction in camera-type eye [GO:0060235]; lung morphogenesis [GO:0060425]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; peptidyl-serine phosphorylation [GO:0018105]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of JNK cascade [GO:0046330]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of signal transduction by p53 class mediator [GO:1901796]; respiratory system process [GO:0003016]; retina layer formation [GO:0010842]; SMAD protein signal transduction [GO:0060395]; smoothened signaling pathway [GO:0007224]; thyroid gland development [GO:0030878]; transforming growth factor beta receptor signaling pathway [GO:0007179]; voluntary musculoskeletal movement [GO:0050882]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; RNA polymerase II transcription regulator complex [GO:0090575],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; virion binding [GO:0046790],GO:0003016; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0012501; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140096; GO:0140110,"respiratory system process; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; programmed cell death; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_07580,FUN_034263-T1,Peve_00039351,Pocillopora_meandrina_HIv1___TS.g19376.t1,three_way,59.382,FUN_034263-T1,Q6INA9,,,,,36.2,318.0,1.2999999999999998e-47,193.4,sp|Q6INA9|SETB1_XENLA Histone-lysine N-methyltransferase SETDB1 OS=Xenopus laevis OX=8355 GN=setdb1 PE=2 SV=1,,,,,,
OG_07581,FUN_034265-T2,Peve_00039352,Pocillopora_meandrina_HIv1___RNAseq.g26635.t1,three_way,82.47233333333334,FUN_034265-T2,O15992,,,,,76.4,700.0,0.0,1118.6,sp|O15992|KARG_ANTJA Arginine kinase OS=Anthopleura japonica OX=67755 PE=1 SV=1,,,,,,
OG_07582,FUN_034275-T1,Peve_00026012,Pocillopora_meandrina_HIv1___RNAseq.g26314.t1,three_way,81.416,FUN_034275-T1,A7RLE5,DNPH1_NEMVE,,Putative 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-),Nematostella vectensis (Starlet sea anemone),66.0,144.0,8.199999999999999e-49,194.5,sp|A7RLE5|DNPH1_NEMVE Putative 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 OS=Nematostella vectensis OX=45351 GN=v1g160099 PE=3 SV=1,GO:0005634; GO:0005737; GO:0009116; GO:0009117; GO:0009159; GO:0030307; GO:0070694,deoxyribonucleoside monophosphate catabolic process [GO:0009159]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]; positive regulation of cell growth [GO:0030307],cytoplasm [GO:0005737]; nucleus [GO:0005634],5-hydroxymethyl-dUMP N-hydrolase activity [GO:0070694],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07583,FUN_034276-T1,Peve_00035852,Pocillopora_meandrina_HIv1___RNAseq.g26313.t1,three_way,81.86433333333333,FUN_034276-T1,Q8BGC4,PTGR3_MOUSE,,Prostaglandin reductase-3 (PTGR-3) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 2),Mus musculus (Mouse),53.3,349.0,8.2e-107,388.7,sp|Q8BGC4|PTGR3_MOUSE Prostaglandin reductase-3 OS=Mus musculus OX=10090 GN=Ptgr3 PE=1 SV=1,GO:0005739; GO:0005777; GO:0006629; GO:0008270; GO:0045599; GO:0047522,lipid metabolic process [GO:0006629]; negative regulation of fat cell differentiation [GO:0045599],mitochondrion [GO:0005739]; peroxisome [GO:0005777],15-oxoprostaglandin 13-oxidase [NAD(P)+] activity [GO:0047522]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; oxidoreductase activity; organelle
OG_07584,FUN_034278-T1,Peve_00012564,Pocillopora_meandrina_HIv1___RNAseq.g28525.t1,three_way,80.85883333333334,FUN_034278-T1,Q0VCK5,AP2A2_BOVIN,,AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit),Bos taurus (Bovine),67.1,952.0,0.0,1247.6,sp|Q0VCK5|AP2A2_BOVIN AP-2 complex subunit alpha-2 OS=Bos taurus OX=9913 GN=AP2A2 PE=1 SV=1,GO:0006886; GO:0008289; GO:0019901; GO:0030122; GO:0035615; GO:0048268; GO:0048488; GO:0072583; GO:0097718; GO:0098793,clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488],AP-2 adaptor complex [GO:0030122]; presynapse [GO:0098793],clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; protein kinase binding [GO:0019901],GO:0006886; GO:0008289; GO:0016192; GO:0060090; GO:0065003,intracellular protein transport; lipid binding; vesicle-mediated transport; molecular adaptor activity; protein-containing complex assembly
OG_07585,FUN_034281-T2,Peve_00014404,Pocillopora_meandrina_HIv1___RNAseq.g28521.t1,three_way,93.60633333333334,FUN_034281-T2,Q98TR7,,,,,82.7,139.0,1.5e-61,236.9,sp|Q98TR7|RS16_HETFO Small ribosomal subunit protein uS9 OS=Heteropneustes fossilis OX=93621 GN=rps16 PE=2 SV=1,,,,,,
OG_07586,FUN_034282-T1,Peve_00013944,Pocillopora_meandrina_HIv1___RNAseq.g28519.t1,three_way,57.317,,,,,,,,,,,,,,,,,
OG_07587,FUN_034284-T1,Peve_00013969,Pocillopora_meandrina_HIv1___RNAseq.g28518.t1,three_way,86.07033333333334,FUN_034284-T1,O35841,,,,,47.1,505.0,3.4e-111,403.7,sp|O35841|API5_MOUSE Apoptosis inhibitor 5 OS=Mus musculus OX=10090 GN=Api5 PE=1 SV=2,,,,,,
OG_07588,FUN_034291-T1,Peve_00013954,Pocillopora_meandrina_HIv1___RNAseq.g28511.t1,three_way,73.35566666666666,,,,,,,,,,,,,,,,,
OG_07589,FUN_034292-T1,Peve_00013953,Pocillopora_meandrina_HIv1___RNAseq.g28510.t2b,three_way,59.324333333333335,,,,,,,,,,,,,,,,,
OG_07590,FUN_034294-T1,Peve_00013952,Pocillopora_meandrina_HIv1___RNAseq.g28509.t1,three_way,53.21816666666667,,,,,,,,,,,,,,,,,
OG_07591,FUN_034295-T1,Peve_00013951,Pocillopora_meandrina_HIv1___RNAseq.g28508.t1,three_way,79.80283333333334,,,,,,,,,,,,,,,,,
OG_07592,FUN_034297-T1,Peve_00013947,Pocillopora_meandrina_HIv1___RNAseq.g28506.t1,three_way,74.32883333333334,,,,,,,,,,,,,,,,,
OG_07593,FUN_034298-T1,Peve_00013945,Pocillopora_meandrina_HIv1___RNAseq.g28503.t1,three_way,77.514,FUN_034298-T1,P28285,,,,,30.0,217.0,3.3e-14,80.9,sp|P28285|5HT2A_DROME 5-hydroxytryptamine receptor 2A OS=Drosophila melanogaster OX=7227 GN=5-HT1A PE=2 SV=2,,,,,,
OG_07594,FUN_034300-T1,Peve_00013958,Pocillopora_meandrina_HIv1___RNAseq.g28501.t1,three_way,80.99333333333334,FUN_034300-T1,Q86WG5,MTMRD_HUMAN,,Myotubularin-related protein 13 (Inactive phosphatidylinositol 3-phosphatase 13) (SET-binding factor 2),Homo sapiens (Human),39.3,2002.0,0.0,1303.1,sp|Q86WG5|MTMRD_HUMAN Myotubularin-related protein 13 OS=Homo sapiens OX=9606 GN=SBF2 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005774; GO:0005829; GO:0006914; GO:0010008; GO:0016020; GO:0019208; GO:0019902; GO:0030424; GO:0035091; GO:0042552; GO:0042802; GO:0048471,autophagy [GO:0006914]; myelination [GO:0042552],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; vacuolar membrane [GO:0005774],guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; phosphatase binding [GO:0019902]; phosphatase regulator activity [GO:0019208]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006914; GO:0008289; GO:0098772,cytosol; autophagy; lipid binding; molecular function regulator activity
OG_07595,FUN_034301-T1,Peve_00019147,Pocillopora_meandrina_HIv1___RNAseq.g28498.t1,three_way,69.90066666666667,FUN_034301-T1,Q803M5,,,,,33.4,392.0,1.2e-47,192.6,sp|Q803M5|SAAL1_DANRE Protein saal1 OS=Danio rerio OX=7955 GN=saal1 PE=2 SV=2,,,,,,
OG_07596,FUN_034303-T1,Peve_00019148,Pocillopora_meandrina_HIv1___RNAseq.g28500.t1,three_way,76.81366666666666,FUN_034303-T1,Q15256,,,,,35.3,544.0,8.4e-69,263.1,sp|Q15256|PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens OX=9606 GN=PTPRR PE=1 SV=2,,,,,,
OG_07597,FUN_034305-T1,Peve_00011309,Pocillopora_meandrina_HIv1___RNAseq.g28496.t1,three_way,63.1735,FUN_034305-T1,Q96CN9,GCC1_HUMAN,,GRIP and coiled-coil domain-containing protein 1 (Golgi coiled-coil protein 1),Homo sapiens (Human),28.7,791.0,3.6e-50,201.4,sp|Q96CN9|GCC1_HUMAN GRIP and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GCC1 PE=1 SV=1,GO:0000138; GO:0000139; GO:0005794; GO:0005829; GO:0031267,,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138],small GTPase binding [GO:0031267],GO:0005794; GO:0005829; GO:0043226,Golgi apparatus; cytosol; organelle
OG_07598,FUN_034312-T1,Peve_00011305,Pocillopora_meandrina_HIv1___RNAseq.g28493.t1,three_way,91.465,FUN_034312-T1,Q9VSF3,UBC2M_DROME,,Nedd8-conjugating enzyme UbcE2M (EC 2.3.2.34) (Nedd8 carrier protein),Drosophila melanogaster (Fruit fly),74.9,179.0,1.4e-77,290.4,sp|Q9VSF3|UBC2M_DROME Nedd8-conjugating enzyme UbcE2M OS=Drosophila melanogaster OX=7227 GN=UbcE2M PE=1 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0019788; GO:0036211; GO:0045116; GO:0045879; GO:0061059; GO:0061654,negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of peptidoglycan recognition protein signaling pathway [GO:0061059]; protein modification process [GO:0036211]; protein neddylation [GO:0045116],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; NEDD8 conjugating enzyme activity [GO:0061654]; NEDD8 transferase activity [GO:0019788],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07599,FUN_034313-T1,Peve_00011307,Pocillopora_meandrina_HIv1___RNAseq.g28492.t1,three_way,82.53633333333333,FUN_034313-T1,A7SLW1,BCAT_NEMVE,,Branched-chain-amino-acid aminotransferase (EC 2.6.1.42),Nematostella vectensis (Starlet sea anemone),65.7,385.0,5.8e-156,552.0,sp|A7SLW1|BCAT_NEMVE Branched-chain-amino-acid aminotransferase OS=Nematostella vectensis OX=45351 GN=v1g246094 PE=3 SV=1,GO:0004084; GO:0005739; GO:0009098; GO:0009099; GO:0052654; GO:0052655; GO:0052656,L-leucine biosynthetic process [GO:0009098]; L-valine biosynthetic process [GO:0009099],mitochondrion [GO:0005739],branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine-2-oxoglutarate transaminase activity [GO:0052656]; L-leucine-2-oxoglutarate transaminase activity [GO:0052654]; L-valine-2-oxoglutarate transaminase activity [GO:0052655],GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; organelle
OG_07600,FUN_034314-T1,Peve_00027985,Pocillopora_meandrina_HIv1___RNAseq.g28491.t2,three_way,44.29716666666666,FUN_034314-T1,O15945,ARNT_DROME,,Aryl hydrocarbon receptor nuclear translocator homolog (dARNT) (Hypoxia-inducible factor 1-beta) (Protein tango),Drosophila melanogaster (Fruit fly),24.8,367.0,3.3e-21,105.1,sp|O15945|ARNT_DROME Aryl hydrocarbon receptor nuclear translocator homolog OS=Drosophila melanogaster OX=7227 GN=tgo PE=1 SV=3,GO:0000122; GO:0000978; GO:0000981; GO:0001228; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0006357; GO:0007417; GO:0007420; GO:0008286; GO:0008347; GO:0016348; GO:0017022; GO:0032869; GO:0032991; GO:0034751; GO:0043565; GO:0045676; GO:0045944; GO:0046982; GO:0048477; GO:0048736; GO:0071456; GO:0090575,appendage development [GO:0048736]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; insulin receptor signaling pathway [GO:0008286]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_07601,FUN_034316-T1,Peve_00025514,Pocillopora_meandrina_HIv1___RNAseq.g28488.t1,three_way,64.57783333333333,,,,,,,,,,,,,,,,,
OG_07602,FUN_034319-T1,Peve_00016715,Pocillopora_meandrina_HIv1___RNAseq.g28486.t1,three_way,86.86533333333334,FUN_034319-T1,Q501I9,,,,,33.9,445.0,1.6000000000000004e-59,231.9,sp|Q501I9|DIRC2_XENTR Solute carrier family 49 member 4 homolog OS=Xenopus tropicalis OX=8364 GN=slc49a4 PE=2 SV=1,,,,,,
OG_07603,FUN_034320-T1,Peve_00040329,Pocillopora_meandrina_HIv1___TS.g8270.t1,three_way,45.431,,,,,,,,,,,,,,,,,
OG_07604,FUN_034321-T1,Peve_00025493,Pocillopora_meandrina_HIv1___RNAseq.g28483.t1,three_way,79.57433333333333,FUN_034321-T1,Q66H95,,,,,39.6,450.0,5.7e-87,323.2,sp|Q66H95|DIRC2_RAT Solute carrier family 49 member 4 OS=Rattus norvegicus OX=10116 GN=Slc49a4 PE=2 SV=1,,,,,,
OG_07605,FUN_034322-T1,Peve_00015003,Pocillopora_meandrina_HIv1___RNAseq.g28482.t1,three_way,81.48233333333333,FUN_034322-T1,Q14008,,,,,45.2,2083.0,0.0,1544.3,sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3,,,,,,
OG_07606,FUN_034323-T1,Peve_00015002,Pocillopora_meandrina_HIv1___RNAseq.g28481.t1,three_way,65.10766666666666,FUN_034323-T1,Q3UR85,MYRF_MOUSE,,"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]",Mus musculus (Mouse),54.0,404.0,1.5e-117,425.6,sp|Q3UR85|MYRF_MOUSE Myelin regulatory factor OS=Mus musculus OX=10090 GN=Myrf PE=1 SV=2,GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0005794; GO:0005829; GO:0006357; GO:0008233; GO:0014003; GO:0016540; GO:0022010; GO:0031643; GO:0032286; GO:0035902; GO:0042220; GO:0043565; GO:0045893; GO:0048709; GO:0048714,central nervous system myelin maintenance [GO:0032286]; central nervous system myelination [GO:0022010]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein autoprocessing [GO:0016540]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cocaine [GO:0042220]; response to immobilization stress [GO:0035902],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; peptidase activity [GO:0008233]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0061024; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein maturation; membrane organization; catalytic activity, acting on a protein; transcription regulator activity"
OG_07607,FUN_034324-T1,Peve_00013956,Pocillopora_meandrina_HIv1___TS.g8265.t1,three_way,50.318333333333335,,,,,,,,,,,,,,,,,
OG_07608,FUN_034327-T1,Peve_00019143,Pocillopora_meandrina_HIv1___RNAseq.g28477.t1,three_way,46.769666666666666,,,,,,,,,,,,,,,,,
OG_07609,FUN_034331-T1,Peve_00019133,Pocillopora_meandrina_HIv1___TS.g8256.t1,three_way,43.48883333333333,,,,,,,,,,,,,,,,,
OG_07610,FUN_034332-T1,Peve_00019132,Pocillopora_meandrina_HIv1___RNAseq.g28470.t1,three_way,44.45016666666667,,,,,,,,,,,,,,,,,
OG_07611,FUN_034333-T1,Peve_00019134,Pocillopora_meandrina_HIv1___RNAseq.g28458.t2,three_way,68.18866666666666,FUN_034333-T1,Q7ZWY2,,,,,47.7,281.0,4.799999999999999e-75,282.7,sp|Q7ZWY2|PIHD1_XENLA PIH1 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=pih1d1 PE=2 SV=1,,,,,,
OG_07612,FUN_034334-T1,Peve_00019131,Pocillopora_meandrina_HIv1___RNAseq.g28457.t2,three_way,78.18466666666667,FUN_034334-T1,Q8BHR8,,,,,51.1,262.0,1.0000000000000001e-71,271.6,sp|Q8BHR8|CSTP1_MOUSE Centriolar satellite-associated tubulin polyglutamylase complex regulator 1 OS=Mus musculus OX=10090 GN=Cstpp1 PE=1 SV=1,,,,,,
OG_07613,FUN_034338-T1,Peve_00004393,Pocillopora_meandrina_HIv1___RNAseq.g26118.t1,three_way,82.06266666666666,FUN_034338-T1,A7SPX9,,,,,54.1,377.0,2.7e-115,416.8,sp|A7SPX9|EIF3M_NEMVE Eukaryotic translation initiation factor 3 subunit M OS=Nematostella vectensis OX=45351 GN=v1g192238 PE=3 SV=1,,,,,,
OG_07614,FUN_034339-T3,Peve_00004388,Pocillopora_meandrina_HIv1___RNAseq.g26117.t1,three_way,86.5475,FUN_034339-T3,Q9H0A0,,,,,66.6,1002.0,0.0,1347.8,sp|Q9H0A0|NAT10_HUMAN RNA cytidine acetyltransferase OS=Homo sapiens OX=9606 GN=NAT10 PE=1 SV=2,,,,,,
OG_07615,FUN_034340-T1,Peve_00004387,Pocillopora_meandrina_HIv1___RNAseq.g26119.t1,three_way,76.25116666666666,FUN_034340-T1,Q8BH18,,,,,52.8,415.0,3e-123,443.7,sp|Q8BH18|TM117_MOUSE Transmembrane protein 117 OS=Mus musculus OX=10090 GN=Tmem117 PE=1 SV=1,,,,,,
OG_07616,FUN_034341-T1,Peve_00004386,Pocillopora_meandrina_HIv1___RNAseq.g26120.t2,three_way,96.96133333333331,FUN_034341-T1,P04464,,,,,51.4,144.0,1.4e-35,150.6,sp|P04464|CALM_WHEAT Calmodulin OS=Triticum aestivum OX=4565 PE=1 SV=3,,,,,,
OG_07617,FUN_034343-T1,Peve_00004385,Pocillopora_meandrina_HIv1___RNAseq.g26121.t1,three_way,79.68666666666667,FUN_034343-T1,Q68RJ7,,,,,30.5,203.0,7.7e-22,105.9,sp|Q68RJ7|ACH92_ONCMY Neuronal acetylcholine receptor subunit alpha-9-II OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1,,,,,,
OG_07618,FUN_034346-T1,Peve_00004383,Pocillopora_meandrina_HIv1___RNAseq.g26123.t1,three_way,81.891,FUN_034346-T1,P04464,,,,,56.0,116.0,2.4e-29,130.2,sp|P04464|CALM_WHEAT Calmodulin OS=Triticum aestivum OX=4565 PE=1 SV=3,,,,,,
OG_07619,FUN_034359-T1,Peve_00026451,Pocillopora_meandrina_HIv1___RNAseq.g26125.t2,three_way,53.81183333333333,FUN_034359-T1,Q7Z6G8,ANS1B_HUMAN,,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),Homo sapiens (Human),37.4,417.0,4.7e-65,251.9,sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2,GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013,ephrin receptor signaling pathway [GO:0048013],Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ephrin receptor binding [GO:0046875],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0043226,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; organelle
OG_07619,FUN_034359-T1,Peve_00026451,Pocillopora_meandrina_HIv1___RNAseq.g26125.t2,three_way,53.81183333333333,FUN_034359-T1,Q7Z6G8,ANS1B_HUMAN,,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),Homo sapiens (Human),56.3,158.0,7.6e-15,85.1,sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2,GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013,ephrin receptor signaling pathway [GO:0048013],Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ephrin receptor binding [GO:0046875],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0043226,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; organelle
OG_07620,FUN_034361-T1,Peve_00036161,Pocillopora_meandrina_HIv1___TS.g18876.t2,three_way,81.43766666666667,FUN_034361-T1,B5X4E0,,,,,58.0,319.0,1.3e-92,341.3,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_07621,FUN_034366-T1,Peve_00036160,Pocillopora_meandrina_HIv1___RNAseq.g26129.t1,three_way,55.84466666666667,,,,,,,,,,,,,,,,,
OG_07622,FUN_034367-T1,Peve_00036158,Pocillopora_meandrina_HIv1___RNAseq.g26130.t1,three_way,71.85166666666667,FUN_034367-T1,Q6IV56,,,,,34.6,243.0,5.799999999999999e-31,136.0,sp|Q6IV56|RN141_DANRE RING finger protein 141 OS=Danio rerio OX=7955 GN=rnf141 PE=2 SV=2,,,,,,
OG_07623,FUN_034368-T1,Peve_00036157,Pocillopora_meandrina_HIv1___RNAseq.g26131.t2,three_way,72.677,FUN_034368-T1,Q9TW28,,,,,31.6,269.0,1.9e-30,135.6,sp|Q9TW28|MYOM_DICDI Myosin-M heavy chain OS=Dictyostelium discoideum OX=44689 GN=myoM PE=1 SV=1,,,,,,
OG_07624,FUN_034370-T1,Peve_00036156,Pocillopora_meandrina_HIv1___TS.g18881.t2,three_way,70.096,FUN_034370-T1,Q4QQM4,,,,,30.7,176.0,1.7e-10,67.8,sp|Q4QQM4|P5I11_MOUSE Tumor protein p53-inducible protein 11 OS=Mus musculus OX=10090 GN=Trp53i11 PE=1 SV=1,,,,,,
OG_07625,FUN_034371-T1,Peve_00036159,Pocillopora_meandrina_HIv1___TS.g18910.t1,three_way,44.22016666666666,,,,,,,,,,,,,,,,,
OG_07626,FUN_034372-T1,Peve_00027170,Pocillopora_meandrina_HIv1___TS.g18909.t1,three_way,77.589,FUN_034372-T1,B4G9L6,,,,,66.9,263.0,2.6e-99,363.6,sp|B4G9L6|KRR1_DROPE KRR1 small subunit processome component homolog OS=Drosophila persimilis OX=7234 GN=dbe PE=3 SV=1,,,,,,
OG_07627,FUN_034375-T1,Peve_00027169,Pocillopora_meandrina_HIv1___RNAseq.g26155.t1,three_way,86.971,FUN_034375-T1,Q2YDE3,GOT1B_BOVIN,,Vesicle transport protein GOT1B (Golgi transport 1 homolog B),Bos taurus (Bovine),67.1,140.0,2e-47,189.9,sp|Q2YDE3|GOT1B_BOVIN Vesicle transport protein GOT1B OS=Bos taurus OX=9913 GN=GOLT1B PE=2 SV=1,GO:0000139; GO:0005783; GO:0005829; GO:0006888; GO:0015031; GO:0016020; GO:0042147,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; membrane [GO:0016020],,GO:0005783; GO:0005829; GO:0016192; GO:0043226,endoplasmic reticulum; cytosol; vesicle-mediated transport; organelle
OG_07628,FUN_034376-T1,Peve_00027168,Pocillopora_meandrina_HIv1___RNAseq.g26154.t1,three_way,68.84483333333333,FUN_034376-T1,E7FAG6,AMR1A_DANRE,,Activating molecule in BECN1-regulated autophagy protein 1A,Danio rerio (Zebrafish) (Brachydanio rerio),26.3,954.0,1.9e-61,238.8,sp|E7FAG6|AMR1A_DANRE Activating molecule in BECN1-regulated autophagy protein 1A OS=Danio rerio OX=7955 GN=ambra1a PE=2 SV=2,GO:0000045; GO:0000209; GO:0000423; GO:0005634; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0005856; GO:0005925; GO:0006914; GO:0007626; GO:0008406; GO:0031410; GO:0043009; GO:0043231; GO:0045591; GO:0048741; GO:0072542; GO:0080008; GO:1901526; GO:1904544; GO:1990756; GO:2000045,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; chordate embryonic development [GO:0043009]; gonad development [GO:0008406]; locomotory behavior [GO:0007626]; mitophagy [GO:0000423]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitophagy [GO:1901526]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein polyubiquitination [GO:0000209]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; skeletal muscle fiber development [GO:0048741],autophagosome [GO:0005776]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634],protein phosphatase activator activity [GO:0072542]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0005856; GO:0006914; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; mitochondrion; vacuole; endoplasmic reticulum; cytosol; cytoskeleton; autophagy; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_07629,FUN_034379-T1,Peve_00027166,Pocillopora_meandrina_HIv1___RNAseq.g26152.t1,three_way,68.00166666666667,FUN_034379-T1,Q86TZ1,,,,,49.0,206.0,4.2e-56,222.6,sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1,,,,,,
OG_07630,FUN_034382-T1,Peve_00027165,Pocillopora_meandrina_HIv1___RNAseq.g26151.t3,three_way,63.092,FUN_034382-T1,Q15723,ELF2_HUMAN,,ETS-related transcription factor Elf-2 (E74-like factor 2) (New ETS-related factor),Homo sapiens (Human),61.7,94.0,5.3e-27,123.6,sp|Q15723|ELF2_HUMAN ETS-related transcription factor Elf-2 OS=Homo sapiens OX=9606 GN=ELF2 PE=1 SV=2,GO:0000785; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016604; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:1990837,cell differentiation [GO:0030154]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_07631,FUN_034387-T1,Peve_00027164,Pocillopora_meandrina_HIv1___TS.g18900.t1,three_way,70.562,FUN_034387-T1,Q95K73,ELOV4_MACFA,,Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),52.3,279.0,3e-77,290.0,sp|Q95K73|ELOV4_MACFA Very long chain fatty acid elongase 4 OS=Macaca fascicularis OX=9541 GN=ELOVL4 PE=2 SV=1,GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0030148; GO:0034625; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, monounsaturated fatty acid [GO:0034625]; fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07632,FUN_034388-T1,Peve_00027163,Pocillopora_meandrina_HIv1___RNAseq.g26149.t2,three_way,73.248,FUN_034388-T1,Q9EQC4,ELOV4_MOUSE,,Very long chain fatty acid elongase 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Elongation of very long chain fatty acids protein 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),Mus musculus (Mouse),44.2,258.0,3.2e-57,223.4,sp|Q9EQC4|ELOV4_MOUSE Very long chain fatty acid elongase 4 OS=Mus musculus OX=10090 GN=Elovl4 PE=1 SV=2,GO:0005783; GO:0005789; GO:0006636; GO:0009922; GO:0019367; GO:0034626; GO:0035338; GO:0042761,"fatty acid elongation, polyunsaturated fatty acid [GO:0034626]; fatty acid elongation, saturated fatty acid [GO:0019367]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],fatty acid elongase activity [GO:0009922],GO:0003824; GO:0005783; GO:0006629; GO:0006790; GO:0016740; GO:0043226; GO:0055086,catalytic activity; endoplasmic reticulum; lipid metabolic process; sulfur compound metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07633,FUN_034391-T1,Peve_00002468,Pocillopora_meandrina_HIv1___TS.g18897.t1,three_way,58.58133333333333,,,,,,,,,,,,,,,,,
OG_07634,FUN_034392-T1,Peve_00002464,Pocillopora_meandrina_HIv1___RNAseq.g26115.t1,three_way,42.51433333333333,,,,,,,,,,,,,,,,,
OG_07635,FUN_034393-T1,Peve_00002463,Pocillopora_meandrina_HIv1___RNAseq.g26669.t1,three_way,75.402,,,,,,,,,,,,,,,,,
OG_07636,FUN_034395-T1,Peve_00002462,Pocillopora_meandrina_HIv1___RNAseq.g26668.t1,three_way,63.63366666666666,,,,,,,,,,,,,,,,,
OG_07637,FUN_034396-T1,Peve_00002461,Pocillopora_meandrina_HIv1___RNAseq.g26667.t1,three_way,87.09,,,,,,,,,,,,,,,,,
OG_07638,FUN_034397-T1,Peve_00002472,Pocillopora_meandrina_HIv1___RNAseq.g28581.t1,three_way,61.739,FUN_034397-T1,Q20191,,,,,45.7,188.0,3.3e-39,163.7,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_07639,FUN_034399-T1,Peve_00002471,Pocillopora_meandrina_HIv1___RNAseq.g28580.t1,three_way,85.80316666666667,FUN_034399-T1,Q9EPL8,IPO7_MOUSE,,Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7),Mus musculus (Mouse),55.4,1040.0,2.1e-311,1069.7,sp|Q9EPL8|IPO7_MOUSE Importin-7 OS=Mus musculus OX=10090 GN=Ipo7 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006606; GO:0031267; GO:0042393; GO:0045087; GO:0045668; GO:0046332; GO:1900182; GO:1901331,innate immune response [GO:0045087]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of protein localization to nucleus [GO:1900182]; protein import into nucleus [GO:0006606],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone binding [GO:0042393]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267],GO:0002376; GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0042393; GO:0043226; GO:0098542,immune system process; nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; histone binding; organelle; defense response to other organism
OG_07640,FUN_034418-T1,Peve_00033057,Pocillopora_meandrina_HIv1___RNAseq.g28578.t1,three_way,49.98766666666667,FUN_034418-T1,Q766D5,,,,,39.9,323.0,1.6e-68,262.3,sp|Q766D5|B4GN4_MOUSE N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=B4galnt4 PE=2 SV=1,,,,,,
OG_07641,FUN_034420-T1,Peve_00021291,Pocillopora_meandrina_HIv1___RNAseq.g28575.t1,three_way,76.00066666666666,FUN_034420-T1,Q32LP4,S4A10_BOVIN,,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),Bos taurus (Bovine),48.4,1093.0,1.6000000000000002e-273,944.1,sp|Q32LP4|S4A10_BOVIN Sodium-driven chloride bicarbonate exchanger OS=Bos taurus OX=9913 GN=SLC4A10 PE=2 SV=1,GO:0005452; GO:0005886; GO:0007601; GO:0008509; GO:0008510; GO:0015701; GO:0016323; GO:0016324; GO:0030425; GO:0036477; GO:0043025; GO:0043204; GO:0043679; GO:0045202; GO:0048172; GO:0051453; GO:0055085; GO:0098794; GO:0098982,bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; transmembrane transport [GO:0055085]; visual perception [GO:0007601],apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; dendrite [GO:0030425]; GABA-ergic synapse [GO:0098982]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; somatodendritic compartment [GO:0036477]; synapse [GO:0045202],monoatomic anion transmembrane transporter activity [GO:0008509]; sodium:bicarbonate symporter activity [GO:0008510]; solute:inorganic anion antiporter activity [GO:0005452],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_07642,FUN_034421-T1,Peve_00038701,Pocillopora_meandrina_HIv1___RNAseq.g28564.t1,three_way,82.62766666666667,FUN_034421-T1,Q3MHQ7,,,,,47.0,230.0,2.9e-47,190.3,sp|Q3MHQ7|TM86A_BOVIN Lysoplasmalogenase TMEM86A OS=Bos taurus OX=9913 GN=TMEM86A PE=2 SV=1,,,,,,
OG_07643,FUN_034422-T1,Peve_00038700,Pocillopora_meandrina_HIv1___RNAseq.g28563.t1,three_way,91.19266666666668,FUN_034422-T1,Q6DEU9,CTR9_XENTR,,RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),77.7,896.0,0.0,1350.1,sp|Q6DEU9|CTR9_XENTR RNA polymerase-associated protein CTR9 homolog OS=Xenopus tropicalis OX=8364 GN=ctr9 PE=2 SV=1,GO:0000122; GO:0000791; GO:0001711; GO:0006368; GO:0016593; GO:0016607; GO:0019827; GO:0045638,endodermal cell fate commitment [GO:0001711]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; stem cell population maintenance [GO:0019827]; transcription elongation by RNA polymerase II [GO:0006368],Cdc73/Paf1 complex [GO:0016593]; euchromatin [GO:0000791]; nuclear speck [GO:0016607],,GO:0006355; GO:0043226,regulation of DNA-templated transcription; organelle
OG_07644,FUN_034423-T1,Peve_00010896,Pocillopora_meandrina_HIv1___RNAseq.g28847.t1,three_way,41.70183333333333,FUN_034423-T1,Q10057,PDI1_SCHPO,,Putative protein disulfide-isomerase C1F5.02 (EC 5.3.4.1),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),32.3,195.0,3.4e-18,95.5,sp|Q10057|PDI1_SCHPO Putative protein disulfide-isomerase C1F5.02 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC1F5.02 PE=3 SV=1,GO:0003756; GO:0005783; GO:0005788; GO:0006457; GO:0015035; GO:0034975; GO:0034976,protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],protein disulfide isomerase activity [GO:0003756]; protein-disulfide reductase activity [GO:0015035],GO:0003824; GO:0005783; GO:0006457; GO:0016491; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; protein folding; oxidoreductase activity; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_07645,FUN_034460-T1,Peve_00025955,Pocillopora_meandrina_HIv1___RNAseq.g25842.t2,three_way,66.28216666666667,FUN_034460-T1,Q8QGX4,PRKDC_CHICK,,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1),Gallus gallus (Chicken),40.0,1500.0,3.2e-308,1059.7,sp|Q8QGX4|PRKDC_CHICK DNA-dependent protein kinase catalytic subunit OS=Gallus gallus OX=9031 GN=PRKDC PE=2 SV=1,GO:0000723; GO:0000724; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0008630; GO:0031571; GO:0033152; GO:0035979; GO:0042254; GO:0070419; GO:0106310,double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; ribosome biogenesis [GO:0042254]; telomere maintenance [GO:0000723],nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016740; GO:0032200; GO:0042254; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; transferase activity; telomere organization; ribosome biogenesis; organelle; catalytic activity, acting on a protein"
OG_07646,FUN_034478-T1,Peve_00025950,Pocillopora_meandrina_HIv1___RNAseq.g25831.t1,three_way,75.27966666666666,FUN_034478-T1,Q9CPQ3,,,,,55.1,98.0,1.2e-16,87.4,sp|Q9CPQ3|TOM22_MOUSE Mitochondrial import receptor subunit TOM22 homolog OS=Mus musculus OX=10090 GN=Tomm22 PE=1 SV=3,,,,,,
OG_07647,FUN_034479-T1,Peve_00025909,Pocillopora_meandrina_HIv1___TS.g8626.t2,three_way,75.47233333333334,FUN_034479-T1,Q00004,,,,,49.1,581.0,2.2e-151,537.3,sp|Q00004|SRP68_CANLF Signal recognition particle subunit SRP68 OS=Canis lupus familiaris OX=9615 GN=SRP68 PE=1 SV=1,,,,,,
OG_07648,FUN_034480-T1,Peve_00008656,Pocillopora_meandrina_HIv1___RNAseq.g25905.t1,three_way,72.97983333333333,,,,,,,,,,,,,,,,,
OG_07649,FUN_034481-T1,Peve_00010882,Pocillopora_meandrina_HIv1___RNAseq.g28844.t1,three_way,80.02866666666667,FUN_034481-T1,P80147,GABT_PIG,,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)",Sus scrofa (Pig),53.6,459.0,4.2e-148,526.2,"sp|P80147|GABT_PIG 4-aminobutyrate aminotransferase, mitochondrial OS=Sus scrofa OX=9823 GN=ABAT PE=1 SV=2",GO:0005739; GO:0005759; GO:0005829; GO:0009450; GO:0030170; GO:0032144; GO:0032145; GO:0034386; GO:0042802; GO:0042803; GO:0046872; GO:0047298; GO:0050877; GO:0051537,gamma-aminobutyric acid catabolic process [GO:0009450]; nervous system process [GO:0050877],4-aminobutyrate transaminase complex [GO:0032144]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016740; GO:0043226; GO:0050877,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; transferase activity; organelle; nervous system process
OG_07650,FUN_034483-T1,Peve_00038716,Pocillopora_meandrina_HIv1___RNAseq.g16114.t1,three_way,74.1005,FUN_034483-T1,Q0P595,SIR7_BOVIN,,NAD-dependent protein deacetylase sirtuin-7 (EC 2.3.1.286) (NAD-dependent protein deacylase sirtuin-7) (EC 2.3.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7),Bos taurus (Bovine),58.2,328.0,1.5e-101,371.3,sp|Q0P595|SIR7_BOVIN NAD-dependent protein deacetylase sirtuin-7 OS=Bos taurus OX=9913 GN=SIRT7 PE=2 SV=1,GO:0000122; GO:0000785; GO:0001649; GO:0003682; GO:0005634; GO:0005654; GO:0005730; GO:0005731; GO:0005737; GO:0006281; GO:0006357; GO:0006476; GO:0007129; GO:0009303; GO:0010526; GO:0010821; GO:0031397; GO:0034979; GO:0035861; GO:0036055; GO:0045722; GO:0045943; GO:0046825; GO:0046872; GO:0061697; GO:0061698; GO:0062176; GO:0070403; GO:0097372; GO:0106230; GO:0106231; GO:0140861; GO:1901836; GO:2000234,DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; homologous chromosome pairing at meiosis [GO:0007129]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein deacetylation [GO:0006476]; protein deglutarylation [GO:0061698]; protein depropionylation [GO:0106230]; R-loop processing [GO:0062176]; regulation of mitochondrion organization [GO:0010821]; regulation of protein export from nucleus [GO:0046825]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901836]; rRNA transcription [GO:0009303]; transposable element silencing [GO:0010526],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleolus organizer region [GO:0005731]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],"chromatin binding [GO:0003682]; histone H3K18 deacetylase activity, NAD-dependent [GO:0097372]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; NAD-dependent protein-lysine depropionylase activity [GO:0106231]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-succinyllysine desuccinylase activity [GO:0036055]",GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006325; GO:0006351; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_07651,FUN_034485-T1,Peve_00043241,Pocillopora_meandrina_HIv1___RNAseq.g28572.t1,three_way,72.51733333333333,FUN_034485-T1,Q9VCY8,,,,,58.4,298.0,8.3e-99,362.5,sp|Q9VCY8|ADRL_DROME Adiponectin receptor protein OS=Drosophila melanogaster OX=7227 GN=AdipoR PE=1 SV=2,,,,,,
OG_07652,FUN_034486-T1,Peve_00043236,Pocillopora_meandrina_HIv1___RNAseq.g28569.t1,three_way,78.29433333333334,FUN_034486-T1,Q13613,,,,,45.0,387.0,6.2e-98,360.5,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_07653,FUN_034487-T1,Peve_00043237,Pocillopora_meandrina_HIv1___TS.g8352.t1,three_way,80.419,FUN_034487-T1,Q5XIG6,GALK2_RAT,,N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2),Rattus norvegicus (Rat),61.1,442.0,2.8999999999999998e-151,536.6,sp|Q5XIG6|GALK2_RAT N-acetylgalactosamine kinase OS=Rattus norvegicus OX=10116 GN=Galk2 PE=2 SV=1,GO:0004335; GO:0005524; GO:0005829; GO:0006012; GO:0033858,galactose metabolic process [GO:0006012],cytosol [GO:0005829],ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; N-acetylgalactosamine kinase activity [GO:0033858],GO:0003824; GO:0005829; GO:0005975; GO:0016740,catalytic activity; cytosol; carbohydrate metabolic process; transferase activity
OG_07654,FUN_034488-T1,Peve_00043238,Pocillopora_meandrina_HIv1___RNAseq.g28567.t1,three_way,95.15633333333334,FUN_034488-T1,Q8JFQ2,,,,,74.8,131.0,6.7e-58,224.9,sp|Q8JFQ2|RBTN1_DANRE Rhombotin-1 OS=Danio rerio OX=7955 GN=lmo1 PE=2 SV=1,,,,,,
OG_07655,FUN_034489-T1,Peve_00043240,Pocillopora_meandrina_HIv1___RNAseq.g28566.t1,three_way,65.82883333333334,FUN_034489-T1,Q9Y3B9,,,,,36.4,214.0,3.8e-22,106.7,sp|Q9Y3B9|RRP15_HUMAN RRP15-like protein OS=Homo sapiens OX=9606 GN=RRP15 PE=1 SV=2,,,,,,
OG_07656,FUN_034598-T1,Peve_00038719,Pocillopora_meandrina_HIv1___TS.g8610.t1,three_way,51.57266666666667,,,,,,,,,,,,,,,,,
OG_07657,FUN_034599-T1,Peve_00039728,Pocillopora_meandrina_HIv1___RNAseq.g25886.t1,three_way,67.98116666666667,FUN_034599-T1,E1BZR9,,,,,41.2,466.0,4.099999999999999e-96,354.0,sp|E1BZR9|TCPR1_CHICK Tectonin beta-propeller repeat-containing protein 1 OS=Gallus gallus OX=9031 GN=TECPR1 PE=3 SV=1,,,,,,
OG_07658,FUN_034602-T1,Peve_00039727,Pocillopora_meandrina_HIv1___RNAseq.g25885.t1,three_way,43.3945,,,,,,,,,,,,,,,,,
OG_07659,FUN_034604-T1,Peve_00037084,Pocillopora_meandrina_HIv1___TS.g18635.t1,three_way,65.48566666666666,FUN_034604-T1,Q90XE6,KLF1_DANRE,,Kruppel-like factor 1 (Erythroid krueppel-like transcription factor) (Kruppel-like factor d),Danio rerio (Zebrafish) (Brachydanio rerio),80.0,80.0,5.7e-08,59.7,sp|Q90XE6|KLF1_DANRE Kruppel-like factor 1 OS=Danio rerio OX=7955 GN=klf1 PE=2 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005634; GO:0005829; GO:0006357; GO:0008270; GO:0010628; GO:0010725; GO:0031100; GO:0043565; GO:0043697; GO:0045214; GO:0055007; GO:0060038; GO:0060319,animal organ regeneration [GO:0031100]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; cell dedifferentiation [GO:0043697]; positive regulation of gene expression [GO:0010628]; primitive erythrocyte differentiation [GO:0060319]; regulation of primitive erythrocyte differentiation [GO:0010725]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0007010; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07660,FUN_034607-T1,Peve_00037082,Pocillopora_meandrina_HIv1___RNAseq.g25882.t1,three_way,89.60166666666667,FUN_034607-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),30.1,409.0,2.3999999999999997e-46,188.0,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_07661,FUN_034712-T2,Peve_00037083,Pocillopora_meandrina_HIv1___TS.g18658.t2,three_way,85.44166666666666,FUN_034712-T2,Q3SX41,,,,,67.1,234.0,2.8e-84,313.9,sp|Q3SX41|LC7L3_BOVIN Luc7-like protein 3 OS=Bos taurus OX=9913 GN=LUC7L3 PE=2 SV=1,,,,,,
OG_07662,FUN_034715-T1,Peve_00014894,Pocillopora_meandrina_HIv1___RNAseq.g28726.t1,three_way,68.227,FUN_034715-T1,P31399,,,,,34.0,144.0,3.6e-21,102.8,"sp|P31399|ATP5H_RAT ATP synthase peripheral stalk subunit d, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5pd PE=1 SV=3",,,,,,
OG_07663,FUN_034717-T1,Peve_00014893,Pocillopora_meandrina_HIv1___RNAseq.g28725.t1,three_way,59.878,FUN_034717-T1,Q91754,GCKR_XENLA,,Glucokinase regulatory protein (GKRP) (Glucokinase regulator),Xenopus laevis (African clawed frog),39.5,582.0,8.800000000000001e-111,402.5,sp|Q91754|GCKR_XENLA Glucokinase regulatory protein OS=Xenopus laevis OX=8355 GN=gckr PE=1 SV=1,GO:0001678; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0009750; GO:0019210; GO:0019899; GO:0030246; GO:0033132; GO:0034504; GO:0070095; GO:0141089; GO:1901135,carbohydrate derivative metabolic process [GO:1901135]; intracellular glucose homeostasis [GO:0001678]; negative regulation of glucokinase activity [GO:0033132]; protein localization to nucleus [GO:0034504]; response to fructose [GO:0009750],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],carbohydrate binding [GO:0030246]; enzyme binding [GO:0019899]; fructose-6-phosphate binding [GO:0070095]; glucose sensor activity [GO:0141089]; kinase inhibitor activity [GO:0019210],GO:0005654; GO:0005739; GO:0005829; GO:0043226; GO:0098772; GO:0140299; GO:1901135,nucleoplasm; mitochondrion; cytosol; organelle; molecular function regulator activity; molecular sensor activity; carbohydrate derivative metabolic process
OG_07664,FUN_034718-T1,Peve_00033270,Pocillopora_meandrina_HIv1___RNAseq.g28724.t1,three_way,70.42683333333333,FUN_034718-T1,Q6NUQ1,RINT1_HUMAN,,RAD50-interacting protein 1 (RAD50 interactor 1) (HsRINT-1) (RINT-1),Homo sapiens (Human),38.7,771.0,2e-149,531.2,sp|Q6NUQ1|RINT1_HUMAN RAD50-interacting protein 1 OS=Homo sapiens OX=9606 GN=RINT1 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005829; GO:0006888; GO:0006890; GO:0007095; GO:0015031; GO:0060628; GO:0070939,"endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0005783; GO:0005829; GO:0016192; GO:0043226,endoplasmic reticulum; cytosol; vesicle-mediated transport; organelle
OG_07665,FUN_034720-T1,Peve_00033269,Pocillopora_meandrina_HIv1___RNAseq.g28723.t1,three_way,62.28366666666667,FUN_034720-T1,P82094,TMF1_HUMAN,,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),Homo sapiens (Human),40.1,685.0,2.9e-43,179.1,sp|P82094|TMF1_HUMAN TATA element modulatory factor OS=Homo sapiens OX=9606 GN=TMF1 PE=1 SV=2,GO:0000139; GO:0001675; GO:0001819; GO:0003677; GO:0003713; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0007289; GO:0010629; GO:0030317; GO:0030521; GO:0032275; GO:0033327; GO:0042742; GO:0045944; GO:0050681; GO:0061136; GO:1904019; GO:1904036; GO:2000845,acrosome assembly [GO:0001675]; androgen receptor signaling pathway [GO:0030521]; defense response to bacterium [GO:0042742]; epithelial cell apoptotic process [GO:1904019]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of proteasomal protein catabolic process [GO:0061136]; spermatid nucleus differentiation [GO:0007289],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],DNA binding [GO:0003677]; nuclear androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006355; GO:0007018; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048870; GO:0060090; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; regulation of DNA-templated transcription; microtubule-based movement; programmed cell death; reproductive process; cell differentiation; organelle; cell motility; molecular adaptor activity; transcription regulator activity
OG_07666,FUN_034721-T1,Peve_00033268,Pocillopora_meandrina_HIv1___RNAseq.g28722.t1,three_way,61.17733333333334,,,,,,,,,,,,,,,,,
OG_07667,FUN_034722-T1,Peve_00033266,Pocillopora_meandrina_HIv1___RNAseq.g28721.t1,three_way,40.38783333333333,,,,,,,,,,,,,,,,,
OG_07668,FUN_034723-T1,Peve_00033265,Pocillopora_meandrina_HIv1___TS.g8510.t1,three_way,76.84766666666667,,,,,,,,,,,,,,,,,
OG_07669,FUN_034724-T1,Peve_00033264,Pocillopora_meandrina_HIv1___RNAseq.g28719.t1,three_way,89.57333333333334,FUN_034724-T1,P39023,RL3_HUMAN,,Large ribosomal subunit protein uL3 (60S ribosomal protein L3) (HIV-1 TAR RNA-binding protein B) (TARBP-B),Homo sapiens (Human),72.8,397.0,2.4e-170,599.7,sp|P39023|RL3_HUMAN Large ribosomal subunit protein uL3 OS=Homo sapiens OX=9606 GN=RPL3 PE=1 SV=2,GO:0002181; GO:0003723; GO:0003735; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005925; GO:0006412; GO:0022625; GO:0022626; GO:0032991; GO:0070062; GO:0071353,cellular response to interleukin-4 [GO:0071353]; cytoplasmic translation [GO:0002181]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198; GO:0005634; GO:0005730; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; RNA binding; structural molecule activity; nucleus; nucleolus; cytosol; ribosome; organelle
OG_07670,FUN_034727-T1,Peve_00033249,Pocillopora_meandrina_HIv1___RNAseq.g28714.t1,three_way,89.599,FUN_034727-T1,Q93009,UBP7_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7),Homo sapiens (Human),59.7,1090.0,0.0,1328.5,sp|Q93009|UBP7_HUMAN Ubiquitin carboxyl-terminal hydrolase 7 OS=Homo sapiens OX=9606 GN=USP7 PE=1 SV=2,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006283; GO:0006307; GO:0006508; GO:0016567; GO:0016579; GO:0016604; GO:0016605; GO:0031647; GO:0032088; GO:0032435; GO:0032991; GO:0035520; GO:0042752; GO:0044027; GO:0045721; GO:0048511; GO:0050821; GO:0051090; GO:0070203; GO:0075342; GO:0101005; GO:1901796; GO:1904262; GO:1904353; GO:1905279; GO:1990380,"DNA alkylation repair [GO:0006307]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of TORC1 signaling [GO:1904262]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of establishment of protein localization to telomere [GO:0070203]; regulation of protein stability [GO:0031647]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of telomere capping [GO:1904353]; rhythmic process [GO:0048511]; symbiont-mediated disruption of host cell PML body [GO:0075342]; transcription-coupled nucleotide-excision repair [GO:0006283]",chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; deubiquitinase activity [GO:0101005]; K48-linked deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07671,FUN_034738-T1,Peve_00010863,Pocillopora_meandrina_HIv1___RNAseq.g25891.t1,three_way,58.40533333333333,,,,,,,,,,,,,,,,,
OG_07672,FUN_034779-T1,Peve_00043699,Pocillopora_meandrina_HIv1___RNAseq.g6184.t1,three_way,61.442,FUN_034779-T1,Q6P3X3,,,,,35.9,830.0,6.2999999999999996e-136,486.5,sp|Q6P3X3|TTC27_HUMAN Tetratricopeptide repeat protein 27 OS=Homo sapiens OX=9606 GN=TTC27 PE=1 SV=1,,,,,,
OG_07673,FUN_034780-T1,Peve_00029729,Pocillopora_meandrina_HIv1___RNAseq.g12275.t1,three_way,82.57533333333333,FUN_034780-T1,Q9Y4W6,AFG32_HUMAN,,Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein),Homo sapiens (Human),68.9,637.0,6.099999999999999e-247,855.1,sp|Q9Y4W6|AFG32_HUMAN Mitochondrial inner membrane m-AAA protease component AFG3L2 OS=Homo sapiens OX=9606 GN=AFG3L2 PE=1 SV=2,GO:0004176; GO:0004222; GO:0005524; GO:0005739; GO:0005743; GO:0005745; GO:0006508; GO:0007409; GO:0007528; GO:0008053; GO:0008237; GO:0008270; GO:0016485; GO:0016540; GO:0016887; GO:0021675; GO:0030163; GO:0033619; GO:0034982; GO:0036444; GO:0040014; GO:0042407; GO:0042552; GO:0051082; GO:0051560; GO:0051604; GO:0055001; GO:0060013; GO:0072753; GO:0110097; GO:0141164,axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cellular response to glutathione [GO:0072753]; cristae formation [GO:0042407]; membrane protein proteolysis [GO:0033619]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; mitochondrial protein quality control [GO:0141164]; muscle cell development [GO:0055001]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of calcium import into the mitochondrion [GO:0110097]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0003824; GO:0005739; GO:0007005; GO:0016787; GO:0030163; GO:0034330; GO:0043226; GO:0048856; GO:0051604; GO:0055085; GO:0061024; GO:0140096; GO:0140657,"catalytic activity; mitochondrion; mitochondrion organization; hydrolase activity; protein catabolic process; cell junction organization; organelle; anatomical structure development; protein maturation; transmembrane transport; membrane organization; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07674,FUN_034781-T1,Peve_00029730,Pocillopora_meandrina_HIv1___RNAseq.g12276.t1,three_way,58.02466666666667,FUN_034781-T1,Q6DIJ4,UBP10_XENTR,,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),43.1,485.0,6.800000000000001e-100,366.7,sp|Q6DIJ4|UBP10_XENTR Ubiquitin carboxyl-terminal hydrolase 10 OS=Xenopus tropicalis OX=8364 GN=usp10 PE=2 SV=1,GO:0002039; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0006281; GO:0006508; GO:0006914; GO:0006974; GO:0010506; GO:0016579; GO:0030330; GO:0043124; GO:0044325; GO:0062030; GO:0071347; GO:0072344,"autophagy [GO:0006914]; cellular response to interleukin-1 [GO:0071347]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of stress granule assembly [GO:0062030]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of autophagy [GO:0010506]; rescue of stalled ribosome [GO:0072344]",cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; p53 binding [GO:0002039]; transmembrane transporter binding [GO:0044325],GO:0003824; GO:0005634; GO:0005768; GO:0006281; GO:0006914; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; endosome; DNA repair; autophagy; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_07675,FUN_034783-T1,Peve_00029734,Pocillopora_meandrina_HIv1___RNAseq.g12279.t1,three_way,75.0925,FUN_034783-T1,Q8TF05,,,,,43.2,940.0,1.9e-171,604.7,sp|Q8TF05|PP4R1_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 1 OS=Homo sapiens OX=9606 GN=PPP4R1 PE=1 SV=1,,,,,,
OG_07676,FUN_034785-T1,Peve_00029735,Pocillopora_meandrina_HIv1___RNAseq.g12280.t2,three_way,53.20216666666666,FUN_034785-T1,O08699,PGDH_RAT,,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)",Rattus norvegicus (Rat),39.5,205.0,1.4e-37,157.9,sp|O08699|PGDH_RAT 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Rattus norvegicus OX=10116 GN=Hpgd PE=1 SV=2,GO:0001822; GO:0004957; GO:0005615; GO:0005654; GO:0005737; GO:0005829; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016323; GO:0016404; GO:0016616; GO:0030728; GO:0032355; GO:0032496; GO:0042802; GO:0043065; GO:0045471; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1904707; GO:1905828,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654],"15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E receptor activity [GO:0004957]",GO:0003824; GO:0005615; GO:0005654; GO:0005829; GO:0006629; GO:0016491; GO:0022414; GO:0048856; GO:0060089,catalytic activity; extracellular space; nucleoplasm; cytosol; lipid metabolic process; oxidoreductase activity; reproductive process; anatomical structure development; molecular transducer activity
OG_07677,FUN_034795-T1,Peve_00007519,Pocillopora_meandrina_HIv1___RNAseq.g12295.t1,three_way,68.32300000000001,FUN_034795-T1,Q5RFU0,,,,,42.2,500.0,3.2999999999999996e-114,413.7,sp|Q5RFU0|SIAE_PONAB Sialate O-acetylesterase OS=Pongo abelii OX=9601 GN=SIAE PE=2 SV=1,,,,,,
OG_07678,FUN_034796-T1,Peve_00007518,Pocillopora_meandrina_HIv1___RNAseq.g12296.t1,three_way,97.267,FUN_034796-T1,Q60779,DRC4_MOUSE,,Dynein regulatory complex subunit 4 (Growth arrest-specific protein 11) (GAS-11) (Growth arrest-specific protein 8) (GAS-8),Mus musculus (Mouse),52.8,462.0,1.3e-114,414.8,sp|Q60779|DRC4_MOUSE Dynein regulatory complex subunit 4 OS=Mus musculus OX=10090 GN=Gas8 PE=1 SV=2,GO:0003351; GO:0005576; GO:0005737; GO:0005794; GO:0005829; GO:0005874; GO:0005886; GO:0005930; GO:0007368; GO:0007420; GO:0008017; GO:0008104; GO:0015630; GO:0030317; GO:0031267; GO:0031514; GO:0035082; GO:0036064; GO:0036126; GO:0045880; GO:0051649; GO:0097386; GO:0097729; GO:1903566; GO:1904526,axoneme assembly [GO:0035082]; brain development [GO:0007420]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; protein localization [GO:0008104]; regulation of microtubule binding [GO:1904526],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sperm flagellum [GO:0036126],microtubule binding [GO:0008017]; small GTPase binding [GO:0031267],GO:0005576; GO:0005794; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0048856; GO:0048870,extracellular region; Golgi apparatus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; anatomical structure development; cell motility
OG_07679,FUN_034797-T1,Peve_00007517,Pocillopora_meandrina_HIv1___RNAseq.g12297.t1,three_way,79.21333333333334,FUN_034797-T1,D3ZDI6,MYLIP_RAT,,E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP),Rattus norvegicus (Rat),43.0,440.0,5.1e-96,353.2,sp|D3ZDI6|MYLIP_RAT E3 ubiquitin-protein ligase MYLIP OS=Rattus norvegicus OX=10116 GN=Mylip PE=2 SV=1,GO:0004842; GO:0005737; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0008270; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0061630,cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886],cytoskeletal protein binding [GO:0008092]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07680,FUN_034798-T1,Peve_00007516,Pocillopora_meandrina_HIv1___RNAseq.g12298.t1,three_way,81.09333333333333,FUN_034798-T1,Q09470,KCNA1_HUMAN,,Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1),Homo sapiens (Human),52.4,336.0,1.3000000000000001e-71,271.9,sp|Q09470|KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens OX=9606 GN=KCNA1 PE=1 SV=2,GO:0001508; GO:0001964; GO:0005249; GO:0005251; GO:0005783; GO:0005829; GO:0005886; GO:0006937; GO:0007405; GO:0008076; GO:0009986; GO:0010644; GO:0010960; GO:0016020; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0070161; GO:0071286; GO:0071805; GO:0086011; GO:0097718,action potential [GO:0001508]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; membrane repolarization during action potential [GO:0086011]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],anchoring junction [GO:0070161]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; protein-containing complex assembly
OG_07681,FUN_034799-T1,Peve_00007557,Pocillopora_meandrina_HIv1___RNAseq.g12300.t1,three_way,88.019,FUN_034799-T1,O14744,,,,,58.5,626.0,8.5e-215,748.0,sp|O14744|ANM5_HUMAN Protein arginine N-methyltransferase 5 OS=Homo sapiens OX=9606 GN=PRMT5 PE=1 SV=4,,,,,,
OG_07682,FUN_034800-T1,Peve_00007556,Pocillopora_meandrina_HIv1___RNAseq.g12301.t1,three_way,60.461666666666666,FUN_034800-T1,Q2T9V7,,,,,52.7,55.0,9.8e-11,67.0,"sp|Q2T9V7|PREY_BOVIN Protein preY, mitochondrial OS=Bos taurus OX=9913 GN=PREY PE=3 SV=1",,,,,,
OG_07683,FUN_034801-T1,Peve_00007555,Pocillopora_meandrina_HIv1___RNAseq.g12302.t1,three_way,39.9515,,,,,,,,,,,,,,,,,
OG_07684,FUN_034803-T1,Peve_00007553,Pocillopora_meandrina_HIv1___RNAseq.g12304.t1,three_way,77.09400000000001,FUN_034803-T1,Q4R4P4,FA2H_MACFA,,Fatty acid 2-hydroxylase (EC 1.14.18.-) (Fatty acid alpha-hydroxylase),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),45.3,364.0,2.4e-84,313.9,sp|Q4R4P4|FA2H_MACFA Fatty acid 2-hydroxylase OS=Macaca fascicularis OX=9541 GN=FA2H PE=2 SV=1,GO:0005506; GO:0005789; GO:0006633; GO:0006679; GO:0006682; GO:0016020; GO:0020037; GO:0044857; GO:0046513; GO:0061436; GO:0080132; GO:0120520,ceramide biosynthetic process [GO:0046513]; establishment of skin barrier [GO:0061436]; fatty acid biosynthetic process [GO:0006633]; galactosylceramide biosynthetic process [GO:0006682]; glucosylceramide biosynthetic process [GO:0006679]; plasma membrane raft organization [GO:0044857],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],fatty acid 2-hydroxylase activity [GO:0080132]; free fatty acid 2-hydroxylase activity [GO:0120520]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0048856; GO:0061024; GO:1901135,catalytic activity; lipid metabolic process; oxidoreductase activity; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_07685,FUN_034805-T1,Peve_00007538,Pocillopora_meandrina_HIv1___RNAseq.g12305.t1,three_way,80.764,FUN_034805-T1,P21894,,,,,53.6,623.0,2.3000000000000004e-180,633.6,"sp|P21894|SYAC_BOMMO Alanine--tRNA ligase, cytoplasmic OS=Bombyx mori OX=7091 PE=1 SV=1",,,,,,
OG_07686,FUN_034807-T1,Peve_00007533,Pocillopora_meandrina_HIv1___RNAseq.g12306.t1,three_way,71.20566666666667,FUN_034807-T1,Q08BG1,,,,,39.2,400.0,4.3e-80,300.1,sp|Q08BG1|TMPPE_DANRE Transmembrane protein with metallophosphoesterase domain OS=Danio rerio OX=7955 GN=tmppe PE=2 SV=1,,,,,,
OG_07687,FUN_034808-T1,Peve_00034936,Pocillopora_meandrina_HIv1___RNAseq.g12307.t1,three_way,87.922,FUN_034808-T1,Q5R4A0,UBA3_PONAB,,NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),68.8,432.0,2.3e-185,649.8,sp|Q5R4A0|UBA3_PONAB NEDD8-activating enzyme E1 catalytic subunit OS=Pongo abelii OX=9601 GN=UBA3 PE=2 SV=2,GO:0005524; GO:0005634; GO:0005737; GO:0007113; GO:0019781; GO:0032991; GO:0042802; GO:0045116; GO:0046982; GO:0051726,endomitotic cell cycle [GO:0007113]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726],cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; protein heterodimerization activity [GO:0046982],GO:0000278; GO:0003824; GO:0005634; GO:0016874; GO:0043226; GO:0140096; GO:0140657,"mitotic cell cycle; catalytic activity; nucleus; ligase activity; organelle; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07688,FUN_034810-T1,Peve_00007544,Pocillopora_meandrina_HIv1___RNAseq.g12309.t1,three_way,62.55050000000001,FUN_034810-T1,B8ARK7,SRT1_ORYSI,,NAD-dependent protein deacetylase SRT1 (EC 2.3.1.286) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (OsSIRT1),Oryza sativa subsp. indica (Rice),35.6,323.0,2.5e-46,188.0,sp|B8ARK7|SRT1_ORYSI NAD-dependent protein deacetylase SRT1 OS=Oryza sativa subsp. indica OX=39946 GN=SRT1 PE=1 SV=2,GO:0000122; GO:0003714; GO:0005634; GO:0017136; GO:0046872; GO:0070403,negative regulation of transcription by RNA polymerase II [GO:0000122],nucleus [GO:0005634],"histone deacetylase activity, NAD-dependent [GO:0017136]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; transcription corepressor activity [GO:0003714]",GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_07689,FUN_034812-T1,Peve_00003622,Pocillopora_meandrina_HIv1___TS.g3642.t1,three_way,57.64416666666666,FUN_034812-T1,Q9BQ04,RBM4B_HUMAN,,RNA-binding protein 4B (RNA-binding motif protein 30) (RNA-binding motif protein 4B) (RNA-binding protein 30),Homo sapiens (Human),48.0,75.0,5.9e-13,75.9,sp|Q9BQ04|RBM4B_HUMAN RNA-binding protein 4B OS=Homo sapiens OX=9606 GN=RBM4B PE=1 SV=1,GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006397; GO:0006417; GO:0007623; GO:0008270; GO:0008380; GO:0010628; GO:0016607; GO:0032922; GO:0032991; GO:0043153,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; mRNA processing [GO:0006397]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0016071; GO:0043226,RNA binding; nucleoplasm; nucleolus; cytosol; mRNA metabolic process; organelle
OG_07690,FUN_034813-T1,Peve_00003621,Pocillopora_meandrina_HIv1___RNAseq.g12312.t1,three_way,91.71466666666667,FUN_034813-T1,Q3ZCF2,,,,,56.1,132.0,9.7e-37,154.5,sp|Q3ZCF2|MED10_BOVIN Mediator of RNA polymerase II transcription subunit 10 OS=Bos taurus OX=9913 GN=MED10 PE=2 SV=1,,,,,,
OG_07691,FUN_034815-T1,Peve_00003618,Pocillopora_meandrina_HIv1___RNAseq.g12314.t1,three_way,85.67166666666667,FUN_034815-T1,Q922L6,,,,,58.0,564.0,1.3000000000000001e-201,704.1,sp|Q922L6|NELFD_MOUSE Negative elongation factor D OS=Mus musculus OX=10090 GN=Nelfcd PE=1 SV=2,,,,,,
OG_07692,FUN_034819-T1,Peve_00041509,Pocillopora_meandrina_HIv1___RNAseq.g27216.t1,three_way,74.395,FUN_034819-T1,Q9R088,,,,,47.5,204.0,1.1e-52,208.4,"sp|Q9R088|KITM_MOUSE Thymidine kinase 2, mitochondrial OS=Mus musculus OX=10090 GN=Tk2 PE=1 SV=2",,,,,,
OG_07693,FUN_034821-T1,Peve_00040559,Pocillopora_meandrina_HIv1___RNAseq.g27215.t1b,three_way,71.47466666666666,FUN_034821-T1,Q96AQ8,MCUR1_HUMAN,,"Mitochondrial calcium uniporter regulator 1 (MCU regulator 1) (Coiled-coil domain-containing protein 90A, mitochondrial)",Homo sapiens (Human),37.8,193.0,1.1e-22,108.6,sp|Q96AQ8|MCUR1_HUMAN Mitochondrial calcium uniporter regulator 1 OS=Homo sapiens OX=9606 GN=MCUR1 PE=1 SV=1,GO:0005739; GO:0005743; GO:0006851; GO:0036444; GO:0051561; GO:0070509,calcium import into the mitochondrion [GO:0036444]; calcium ion import [GO:0070509]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],,GO:0005739; GO:0043226; GO:0055085,mitochondrion; organelle; transmembrane transport
OG_07694,FUN_034822-T1,Peve_00040546,Pocillopora_meandrina_HIv1___RNAseq.g27205.t1,three_way,72.92,FUN_034822-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),32.0,294.0,1.1e-26,122.1,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_07695,FUN_034828-T1,Peve_00040552,Pocillopora_meandrina_HIv1___RNAseq.g27178.t1,three_way,86.10566666666666,FUN_034828-T1,P05202,AATM_MOUSE,,"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)",Mus musculus (Mouse),70.4,406.0,6.100000000000001e-180,631.7,"sp|P05202|AATM_MOUSE Aspartate aminotransferase, mitochondrial OS=Mus musculus OX=10090 GN=Got2 PE=1 SV=1",GO:0004069; GO:0005739; GO:0005743; GO:0005759; GO:0005886; GO:0006103; GO:0006107; GO:0006531; GO:0006532; GO:0006533; GO:0006536; GO:0006538; GO:0015908; GO:0016212; GO:0019550; GO:0030170; GO:0043209; GO:0043490; GO:0045471,2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; fatty acid transport [GO:0015908]; glutamate catabolic process [GO:0006538]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; malate-aspartate shuttle [GO:0043490]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0005886; GO:0006520; GO:0016740; GO:0043226; GO:0055086,catalytic activity; mitochondrion; plasma membrane; amino acid metabolic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process
OG_07696,FUN_034829-T1,Peve_00040555,Pocillopora_meandrina_HIv1___RNAseq.g27179.t1,three_way,62.16466666666667,,,,,,,,,,,,,,,,,
OG_07697,FUN_034830-T1,Peve_00022084,Pocillopora_meandrina_HIv1___RNAseq.g27180.t1,three_way,46.66733333333333,,,,,,,,,,,,,,,,,
OG_07698,FUN_034832-T1,Peve_00006740,Pocillopora_meandrina_HIv1___TS.g14528.t1,three_way,88.521,FUN_034832-T1,O35242,,,,,46.1,921.0,1.3e-227,791.2,sp|O35242|FAN_MOUSE Protein FAN OS=Mus musculus OX=10090 GN=Nsmaf PE=1 SV=2,,,,,,
OG_07699,FUN_034833-T1,Peve_00010451,Pocillopora_meandrina_HIv1___RNAseq.g27185.t1,three_way,51.098,,,,,,,,,,,,,,,,,
OG_07700,FUN_034834-T1,Peve_00010452,Pocillopora_meandrina_HIv1___RNAseq.g27184.t1,three_way,72.52166666666666,FUN_034834-T1,Q7TT47,,,,,53.2,637.0,7.000000000000001e-182,639.0,sp|Q7TT47|SPG7_RAT Mitochondrial inner membrane m-AAA protease component paraplegin OS=Rattus norvegicus OX=10116 GN=Spg7 PE=2 SV=2,,,,,,
OG_07701,FUN_034835-T1,Peve_00007812,Pocillopora_meandrina_HIv1___RNAseq.g27183.t1,three_way,81.74166666666667,FUN_034835-T1,Q8N4L2,PP4P2_HUMAN,,"Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 2 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase II) (Transmembrane protein 55A)",Homo sapiens (Human),49.7,197.0,3.5e-48,193.4,"sp|Q8N4L2|PP4P2_HUMAN Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase OS=Homo sapiens OX=9606 GN=PIP4P2 PE=1 SV=1",GO:0005765; GO:0005886; GO:0030670; GO:0031902; GO:0034597; GO:0046856; GO:0050765,negative regulation of phagocytosis [GO:0050765]; phosphatidylinositol dephosphorylation [GO:0046856],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886],"phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO:0034597]",GO:0003824; GO:0005886; GO:0006629; GO:0016787,catalytic activity; plasma membrane; lipid metabolic process; hydrolase activity
OG_07702,FUN_034836-T1,Peve_00010453,Pocillopora_meandrina_HIv1___RNAseq.g27186.t1,three_way,80.12466666666667,FUN_034836-T1,Q69YN4,VIR_HUMAN,,Protein virilizer homolog,Homo sapiens (Human),33.3,1962.0,5.5e-217,756.9,sp|Q69YN4|VIR_HUMAN Protein virilizer homolog OS=Homo sapiens OX=9606 GN=VIRMA PE=1 SV=2,GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006397; GO:0008380; GO:0016604; GO:0016607; GO:0036396,mRNA processing [GO:0006397]; RNA splicing [GO:0008380],cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; cytosol; mRNA metabolic process; organelle
OG_07703,FUN_034837-T1,Peve_00010449,Pocillopora_meandrina_HIv1___RNAseq.g27187.t1,three_way,85.81433333333334,FUN_034837-T1,Q6IWL4,TRAF6_DANRE,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Danio rerio (Zebrafish) (Brachydanio rerio),29.9,157.0,1.4e-08,62.0,sp|Q6IWL4|TRAF6_DANRE TNF receptor-associated factor 6 OS=Danio rerio OX=7955 GN=traf6 PE=1 SV=2,GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0008270; GO:0009615; GO:0009617; GO:0009898; GO:0031663; GO:0035591; GO:0038061; GO:0042981; GO:0043122; GO:0045087; GO:0045893; GO:0061630; GO:0070534; GO:0098978,innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of DNA-templated transcription [GO:0045893]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; response to bacterium [GO:0009617]; response to virus [GO:0009615],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634],signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_07704,FUN_034842-T1,Peve_00037379,Pocillopora_meandrina_HIv1___RNAseq.g27193.t1,three_way,74.40350000000001,FUN_034842-T1,Q7TMC8,FCSK_MOUSE,,L-fucose kinase (Fucokinase) (EC 2.7.1.52),Mus musculus (Mouse),43.7,1102.0,5.899999999999998e-243,842.4,sp|Q7TMC8|FCSK_MOUSE L-fucose kinase OS=Mus musculus OX=10090 GN=Fcsk PE=1 SV=1,GO:0005524; GO:0005829; GO:0042352; GO:0046835; GO:0050201,carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352],cytosol [GO:0005829],ATP binding [GO:0005524]; fucokinase activity [GO:0050201],GO:0003824; GO:0005829; GO:0005975; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07705,FUN_034843-T1,Peve_00037378,Pocillopora_meandrina_HIv1___RNAseq.g27195.t1,three_way,68.62916666666666,FUN_034843-T1,A5D8S5,SH3R1_DANRE,,E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),39.0,77.0,6.6e-06,53.9,sp|A5D8S5|SH3R1_DANRE E3 ubiquitin-protein ligase SH3RF1 OS=Danio rerio OX=7955 GN=sh3rf1 PE=2 SV=2,GO:0001764; GO:0005078; GO:0005794; GO:0008270; GO:0016567; GO:0030027; GO:0032436; GO:0043066; GO:0043370; GO:0046330; GO:0048471; GO:0051865; GO:0061630; GO:2000564,"negative regulation of apoptotic process [GO:0043066]; neuron migration [GO:0001764]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043370]; regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000564]",Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471],MAP-kinase scaffold activity [GO:0005078]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005794; GO:0016740; GO:0043226; GO:0048870; GO:0060090; GO:0140096,"catalytic activity; Golgi apparatus; transferase activity; organelle; cell motility; molecular adaptor activity; catalytic activity, acting on a protein"
OG_07706,FUN_034848-T1,Peve_00037381,Pocillopora_meandrina_HIv1___RNAseq.g27197.t1,three_way,73.5195,FUN_034848-T1,A6NE52,WDR97_HUMAN,,WD repeat-containing protein 97,Homo sapiens (Human),27.0,677.0,3.9e-70,268.9,sp|A6NE52|WDR97_HUMAN WD repeat-containing protein 97 OS=Homo sapiens OX=9606 GN=WDR97 PE=1 SV=2,,,,,,
OG_07707,FUN_034849-T1,Peve_00037374,Pocillopora_meandrina_HIv1___RNAseq.g12146.t1,three_way,54.702333333333335,FUN_034849-T1,Q5ZMS4,,,,,46.5,157.0,1.1e-37,159.8,sp|Q5ZMS4|NCOA7_CHICK Nuclear receptor coactivator 7 OS=Gallus gallus OX=9031 GN=NCOA7 PE=2 SV=1,,,,,,
OG_07708,FUN_034851-T1,Peve_00008087,Pocillopora_meandrina_HIv1___RNAseq.g12149.t1,three_way,84.26383333333334,FUN_034851-T1,Q6DIV6,VIAAT_XENTR,,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),34.7,360.0,2.4e-51,204.5,sp|Q6DIV6|VIAAT_XENTR Vesicular inhibitory amino acid transporter OS=Xenopus tropicalis OX=8364 GN=slc32a1 PE=2 SV=1,GO:0001762; GO:0006836; GO:0008021; GO:0015185; GO:0015187; GO:0015812; GO:0015816; GO:0030659; GO:0042995; GO:0051939; GO:0098793; GO:0140799; GO:0140800,beta-alanine transport [GO:0001762]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid transport [GO:0015812]; glycine transport [GO:0015816]; neurotransmitter transport [GO:0006836],cell projection [GO:0042995]; cytoplasmic vesicle membrane [GO:0030659]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:proton antiporter activity [GO:0140800]; glycine transmembrane transporter activity [GO:0015187]; glycine:proton antiporter activity [GO:0140799],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_07709,FUN_034854-T1,Peve_00008081,Pocillopora_meandrina_HIv1___RNAseq.g12153.t1,three_way,83.84633333333333,FUN_034854-T1,P08574,CY1_HUMAN,,"Cytochrome c1, heme protein, mitochondrial (EC 7.1.1.8) (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1)",Homo sapiens (Human),62.9,213.0,1.2e-76,287.7,"sp|P08574|CY1_HUMAN Cytochrome c1, heme protein, mitochondrial OS=Homo sapiens OX=9606 GN=CYC1 PE=1 SV=3",GO:0005634; GO:0005739; GO:0005743; GO:0006122; GO:0008121; GO:0016020; GO:0020037; GO:0033762; GO:0045275; GO:0045333; GO:0046872,"cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; response to glucagon [GO:0033762]",membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; respiratory chain complex III [GO:0045275],heme binding [GO:0020037]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121],GO:0005215; GO:0005634; GO:0005739; GO:0006091; GO:0043226,transporter activity; nucleus; mitochondrion; generation of precursor metabolites and energy; organelle
OG_07710,FUN_034856-T1,Peve_00008083,Pocillopora_meandrina_HIv1___TS.g3494.t2,three_way,93.22233333333334,FUN_034856-T1,Q6DJE4,CPSF5_XENLA,,Cleavage and polyadenylation specificity factor subunit 5 (Nudix hydrolase 21),Xenopus laevis (African clawed frog),83.1,195.0,4e-94,345.5,sp|Q6DJE4|CPSF5_XENLA Cleavage and polyadenylation specificity factor subunit 5 OS=Xenopus laevis OX=8355 GN=nudt21 PE=2 SV=1,GO:0003729; GO:0005634; GO:0005737; GO:0005849; GO:0006397; GO:0010608; GO:0030154; GO:0031124; GO:0035925; GO:0042382; GO:0042802; GO:0051290; GO:0110104; GO:0180010; GO:2000738; GO:2000975,"cell differentiation [GO:0030154]; co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA 3'-end processing [GO:0031124]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; post-transcriptional regulation of gene expression [GO:0010608]; protein heterotetramerization [GO:0051290]",cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382],identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729],GO:0003723; GO:0005634; GO:0016071; GO:0030154; GO:0043226; GO:0065003,RNA binding; nucleus; mRNA metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_07711,FUN_034859-T1,Peve_00008084,Pocillopora_meandrina_HIv1___RNAseq.g12156.t1,three_way,75.80933333333333,FUN_034859-T1,Q80V03,,,,,50.4,538.0,3.3e-152,540.0,sp|Q80V03|ADCK5_MOUSE Uncharacterized aarF domain-containing protein kinase 5 OS=Mus musculus OX=10090 GN=Adck5 PE=2 SV=2,,,,,,
OG_07712,FUN_034861-T1,Peve_00044993,Pocillopora_meandrina_HIv1___TS.g14489.t1,three_way,57.678666666666665,FUN_034861-T1,P51473,,,,,25.9,317.0,4.7e-20,100.5,sp|P51473|OPSV_XENLA Violet-sensitive opsin OS=Xenopus laevis OX=8355 PE=1 SV=1,,,,,,
OG_07713,FUN_034865-T1,Peve_00005779,Pocillopora_meandrina_HIv1___RNAseq.g27145.t1,three_way,97.222,FUN_034865-T1,Q641G7,,,,,88.7,168.0,1.3e-77,290.4,sp|Q641G7|ARPC4_XENLA Actin-related protein 2/3 complex subunit 4 OS=Xenopus laevis OX=8355 GN=arpc4 PE=1 SV=1,,,,,,
OG_07714,FUN_034867-T1,Peve_00005778,Pocillopora_meandrina_HIv1___RNAseq.g27146.t1,three_way,75.34383333333334,FUN_034867-T1,Q28193,FURIN_BOVIN,,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Trans Golgi network protease furin),Bos taurus (Bovine),49.8,616.0,5.7e-165,582.8,sp|Q28193|FURIN_BOVIN Furin OS=Bos taurus OX=9913 GN=FURIN PE=1 SV=1,GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0008201; GO:0010008; GO:0016486; GO:0046872; GO:0140447; GO:1904399,cytokine precursor processing [GO:0140447]; peptide hormone processing [GO:0016486],endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_07715,FUN_034869-T1,Peve_00042509,Pocillopora_meandrina_HIv1___TS.g14495.t1c,three_way,59.291,,,,,,,,,,,,,,,,,
OG_07716,FUN_034870-T1,Peve_00005769,Pocillopora_meandrina_HIv1___RNAseq.g27159.t1,three_way,54.551,FUN_034870-T1,Q91Y77,,,,,29.8,423.0,2.3e-49,198.7,sp|Q91Y77|MOT10_RAT Monocarboxylate transporter 10 OS=Rattus norvegicus OX=10116 GN=Slc16a10 PE=1 SV=2,,,,,,
OG_07717,FUN_034871-T1,Peve_00005768,Pocillopora_meandrina_HIv1___RNAseq.g27160.t1,three_way,85.68666666666667,FUN_034871-T1,Q5RDE7,NFS1_PONAB,,Cysteine desulfurase (EC 2.8.1.7),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),74.5,432.0,4.7e-191,668.7,sp|Q5RDE7|NFS1_PONAB Cysteine desulfurase OS=Pongo abelii OX=9601 GN=NFS1 PE=2 SV=1,GO:0005634; GO:0005739; GO:0005813; GO:0005829; GO:0006777; GO:0030170; GO:0031071; GO:0042803; GO:0044571; GO:0044572; GO:0046872; GO:0051536; GO:0099128,[2Fe-2S] cluster assembly [GO:0044571]; [4Fe-4S] cluster assembly [GO:0044572]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],centrosome [GO:0005813]; cytosol [GO:0005829]; mitochondrial [2Fe-2S] assembly complex [GO:0099128]; mitochondrion [GO:0005739]; nucleus [GO:0005634],cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0005829; GO:0016740; GO:0043226,catalytic activity; nucleus; mitochondrion; microtubule organizing center; cytosol; transferase activity; organelle
OG_07718,FUN_034873-T1,Peve_00005762,Pocillopora_meandrina_HIv1___RNAseq.g27162.t1,three_way,90.15966666666668,FUN_034873-T1,A1L3F5,,,,,44.8,724.0,1.6e-163,577.8,sp|A1L3F5|CMIP_XENLA C-Maf-inducing protein OS=Xenopus laevis OX=8355 GN=cmip PE=2 SV=2,,,,,,
OG_07719,FUN_034874-T1,Peve_00005761,Pocillopora_meandrina_HIv1___RNAseq.g27163.t1,three_way,71.02033333333334,FUN_034874-T1,P00172,,,,,52.7,131.0,2.2000000000000002e-30,133.3,sp|P00172|CYB5_PIG Cytochrome b5 OS=Sus scrofa OX=9823 GN=CYB5A PE=1 SV=3,,,,,,
OG_07720,FUN_034875-T1,Peve_00005784,Pocillopora_meandrina_HIv1___RNAseq.g27164.t1b,three_way,85.19866666666667,FUN_034875-T1,Q8QZR1,ATTY_MOUSE,,Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase),Mus musculus (Mouse),53.7,408.0,7.9e-140,498.4,sp|Q8QZR1|ATTY_MOUSE Tyrosine aminotransferase OS=Mus musculus OX=10090 GN=Tat PE=1 SV=1,GO:0004838; GO:0005739; GO:0006103; GO:0006536; GO:0006559; GO:0006572; GO:0006979; GO:0009058; GO:0016597; GO:0030170; GO:0042802; GO:0046689; GO:0071548,2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to dexamethasone [GO:0071548]; response to mercury ion [GO:0046689]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572],mitochondrion [GO:0005739],amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-tyrosine-2-oxoglutarate transaminase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; organelle
OG_07721,FUN_034877-T1,Peve_00005697,Pocillopora_meandrina_HIv1___TS.g14510.t1,three_way,45.81933333333333,,,,,,,,,,,,,,,,,
OG_07722,FUN_034878-T1,Peve_00005698,Pocillopora_meandrina_HIv1___TS.g14511.t1,three_way,82.43299999999999,FUN_034878-T1,Q8NDA8,,,,,34.0,1657.0,1.1e-290,1001.5,sp|Q8NDA8|MROH1_HUMAN Maestro heat-like repeat-containing protein family member 1 OS=Homo sapiens OX=9606 GN=MROH1 PE=1 SV=3,,,,,,
OG_07723,FUN_034880-T1,Peve_00005696,Pocillopora_meandrina_HIv1___RNAseq.g27166.t1,three_way,80.42966666666666,FUN_034880-T1,Q0VC84,C1GLT_BOVIN,,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)",Bos taurus (Bovine),47.3,332.0,1.3999999999999998e-82,308.1,sp|Q0VC84|C1GLT_BOVIN Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 OS=Bos taurus OX=9913 GN=C1GALT1 PE=2 SV=1,GO:0000166; GO:0001525; GO:0001822; GO:0006486; GO:0016020; GO:0016263; GO:0030154; GO:0046872,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; kidney development [GO:0001822]; protein glycosylation [GO:0006486],membrane [GO:0016020],glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO:0016263]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166],GO:0003824; GO:0006486; GO:0016740; GO:0030154; GO:0048856; GO:0140096,"catalytic activity; protein glycosylation; transferase activity; cell differentiation; anatomical structure development; catalytic activity, acting on a protein"
OG_07724,FUN_034882-T1,Peve_00011622,Pocillopora_meandrina_HIv1___RNAseq.g27168.t1,three_way,66.23566666666667,FUN_034882-T1,Q9CY64,BIEA_MOUSE,,Biliverdin reductase A (BVR A) (EC 1.3.1.24) (Biliverdin-IX alpha-reductase),Mus musculus (Mouse),34.7,294.0,4.7000000000000005e-38,159.8,sp|Q9CY64|BIEA_MOUSE Biliverdin reductase A OS=Mus musculus OX=10090 GN=Blvra PE=1 SV=1,GO:0000166; GO:0004074; GO:0005829; GO:0006631; GO:0006641; GO:0006935; GO:0006954; GO:0006979; GO:0008270; GO:0010467; GO:0032094; GO:0032496; GO:0034440; GO:0038178; GO:0042167; GO:0042440; GO:0106276; GO:0106277; GO:0160025; GO:1905237,chemotaxis [GO:0006935]; complement component C5a signaling pathway [GO:0038178]; fatty acid metabolic process [GO:0006631]; gene expression [GO:0010467]; heme catabolic process [GO:0042167]; inflammatory response [GO:0006954]; lipid oxidation [GO:0034440]; pigment metabolic process [GO:0042440]; response to cyclosporin A [GO:1905237]; response to food [GO:0032094]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; sensory perception of itch [GO:0160025]; triglyceride metabolic process [GO:0006641],cytosol [GO:0005829],biliberdin reductase (NAD+) activity [GO:0106276]; biliverdin reductase (NADP+) activity [GO:0106277]; biliverdin reductase [NAD(P)+] activity [GO:0004074]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005829; GO:0006629; GO:0006954; GO:0016491; GO:0050877,immune system process; catalytic activity; cytosol; lipid metabolic process; inflammatory response; oxidoreductase activity; nervous system process
OG_07725,FUN_034884-T1,Peve_00011623,Pocillopora_meandrina_HIv1___TS.g14516.t1,three_way,73.757,FUN_034884-T1,Q97MV3,,,,,41.7,72.0,3.9e-08,59.3,sp|Q97MV3|MSRA_CLOAB Peptide methionine sulfoxide reductase MsrA OS=Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / IAM 19013 / LMG 5710 / NBRC 13948 / NRRL B-527 / VKM B-1787 / 2291 / W) OX=272562 GN=msrA PE=3 SV=1,,,,,,
OG_07726,FUN_034887-T1,Peve_00009321,Pocillopora_meandrina_HIv1___RNAseq.g27811.t1,three_way,76.001,FUN_034887-T1,Q5U4I3,,,,,37.3,324.0,1.4e-54,214.9,sp|Q5U4I3|CCDB1_XENLA Cyclin-D1-binding protein 1 homolog OS=Xenopus laevis OX=8355 GN=ccndbp1 PE=2 SV=2,,,,,,
OG_07727,FUN_034888-T1,Peve_00023804,Pocillopora_meandrina_HIv1___RNAseq.g27810.t1,three_way,82.89466666666667,FUN_034888-T1,A7RRG3,AKTIP_NEMVE,,Protein AKTIP homolog (Fused toes protein homolog),Nematostella vectensis (Starlet sea anemone),69.6,306.0,1e-120,434.5,sp|A7RRG3|AKTIP_NEMVE Protein AKTIP homolog OS=Nematostella vectensis OX=45351 GN=v1g232160 PE=3 SV=1,,,,,,
OG_07728,FUN_034889-T1,Peve_00037341,Pocillopora_meandrina_HIv1___RNAseq.g27809.t1,three_way,78.04,FUN_034889-T1,Q6P1X6,,,,,54.9,175.0,1.5e-52,207.6,sp|Q6P1X6|CH082_HUMAN UPF0598 protein C8orf82 OS=Homo sapiens OX=9606 GN=C8orf82 PE=1 SV=2,,,,,,
OG_07729,FUN_034890-T1,Peve_00037340,Pocillopora_meandrina_HIv1___TS.g15152.t1,three_way,81.66833333333334,FUN_034890-T1,O61585,,,,,55.5,714.0,5.000000000000001e-80,300.4,sp|O61585|KTNB1_STRPU Katanin p80 WD40 repeat-containing subunit B1 OS=Strongylocentrotus purpuratus OX=7668 GN=KATNB1 PE=1 SV=1,,,,,,
OG_07730,FUN_034891-T1,Peve_00037339,Pocillopora_meandrina_HIv1___TS.g15151.t2,three_way,94.67133333333334,FUN_034891-T1,Q13951,,,,,57.1,170.0,1.1e-48,194.5,sp|Q13951|PEBB_HUMAN Core-binding factor subunit beta OS=Homo sapiens OX=9606 GN=CBFB PE=1 SV=2,,,,,,
OG_07731,FUN_034892-T1,Peve_00037338,Pocillopora_meandrina_HIv1___TS.g15150.t1,three_way,61.52,,,,,,,,,,,,,,,,,
OG_07732,FUN_034893-T1,Peve_00037337,Pocillopora_meandrina_HIv1___RNAseq.g27805.t1,three_way,60.900333333333336,FUN_034893-T1,Q8R4E9,CDT1_MOUSE,,DNA replication factor Cdt1 (Double parked homolog) (DUP) (Retroviral insertion site 2 protein),Mus musculus (Mouse),32.5,449.0,1.2e-50,203.0,sp|Q8R4E9|CDT1_MOUSE DNA replication factor Cdt1 OS=Mus musculus OX=10090 GN=Cdt1 PE=1 SV=1,GO:0000076; GO:0000776; GO:0003677; GO:0003682; GO:0005634; GO:0016604; GO:0030174; GO:0033262; GO:0051315; GO:0071163; GO:0072708; GO:2000104; GO:2000105,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; DNA replication checkpoint signaling [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; negative regulation of DNA-templated DNA replication [GO:2000104]; positive regulation of DNA-templated DNA replication [GO:2000105]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708],kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0043226; GO:0065003,DNA binding; nucleus; organelle; protein-containing complex assembly
OG_07733,FUN_034894-T1,Peve_00030258,Pocillopora_meandrina_HIv1___RNAseq.g27804.t1,three_way,78.94566666666667,FUN_034894-T1,Q62737,CY24A_RAT,,Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox) (p22phox),Rattus norvegicus (Rat),52.1,140.0,2.1000000000000006e-33,143.7,sp|Q62737|CY24A_RAT Cytochrome b-245 light chain OS=Rattus norvegicus OX=10116 GN=Cyba PE=1 SV=3,GO:0001666; GO:0001725; GO:0001938; GO:0003106; GO:0005737; GO:0005768; GO:0005886; GO:0005925; GO:0006801; GO:0006954; GO:0009055; GO:0009410; GO:0014823; GO:0014895; GO:0016175; GO:0016324; GO:0017004; GO:0017124; GO:0020037; GO:0030307; GO:0030425; GO:0031667; GO:0032755; GO:0032760; GO:0032930; GO:0034137; GO:0042554; GO:0043020; GO:0043025; GO:0045087; GO:0045730; GO:0045777; GO:0046872; GO:0046982; GO:0048661; GO:0050665; GO:0050766; GO:0051279; GO:0051649; GO:0070254; GO:0070257; GO:0070555; GO:0071260; GO:0071333; GO:0071356; GO:0071480; GO:0072593; GO:0097038; GO:1900426; GO:1903428; GO:1904044; GO:1904385; GO:1904628; GO:1904845,cellular response to angiotensin [GO:1904385]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose stimulus [GO:0071333]; cellular response to L-glutamine [GO:1904845]; cellular response to mechanical stimulus [GO:0071260]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to tumor necrosis factor [GO:0071356]; cytochrome complex assembly [GO:0017004]; establishment of localization in cell [GO:0051649]; hydrogen peroxide biosynthetic process [GO:0050665]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of glomerular filtration by angiotensin [GO:0003106]; positive regulation of blood pressure [GO:0045777]; positive regulation of cell growth [GO:0030307]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mucus secretion [GO:0070257]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of toll-like receptor 2 signaling pathway [GO:0034137]; positive regulation of tumor necrosis factor production [GO:0032760]; reactive oxygen species metabolic process [GO:0072593]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; respiratory burst [GO:0045730]; response to activity [GO:0014823]; response to aldosterone [GO:1904044]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; smooth muscle hypertrophy [GO:0014895]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801],apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; focal adhesion [GO:0005925]; NADPH oxidase complex [GO:0043020]; neuronal cell body [GO:0043025]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; stress fiber [GO:0001725],electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; SH3 domain binding [GO:0017124]; superoxide-generating NAD(P)H oxidase activity [GO:0016175],GO:0002376; GO:0003012; GO:0003824; GO:0005768; GO:0005886; GO:0006954; GO:0016491; GO:0031410; GO:0043226; GO:0050886; GO:0065003; GO:0098542,immune system process; muscle system process; catalytic activity; endosome; plasma membrane; inflammatory response; oxidoreductase activity; cytoplasmic vesicle; organelle; endocrine process; protein-containing complex assembly; defense response to other organism
OG_07734,FUN_034896-T1,Peve_00037331,Pocillopora_meandrina_HIv1___RNAseq.g27802.t1,three_way,54.4095,,,,,,,,,,,,,,,,,
OG_07735,FUN_034912-T1,Peve_00039143,Pocillopora_meandrina_HIv1___RNAseq.g14669.t1,three_way,80.86066666666667,FUN_034912-T1,A5D6U8,ACP7_DANRE,,Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form),Danio rerio (Zebrafish) (Brachydanio rerio),45.3,426.0,1.1e-94,348.6,sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1,GO:0003993; GO:0005576; GO:0046872,,extracellular region [GO:0005576],acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0016787,catalytic activity; extracellular region; hydrolase activity
OG_07736,FUN_034913-T1,Peve_00039132,Pocillopora_meandrina_HIv1___RNAseq.g12143.t1,three_way,89.33033333333333,FUN_034913-T1,Q21305,SOX2_CAEEL,,Transcription factor sox-2,Caenorhabditis elegans,71.1,90.0,2.6e-30,134.0,sp|Q21305|SOX2_CAEEL Transcription factor sox-2 OS=Caenorhabditis elegans OX=6239 GN=sox-2 PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0005634; GO:0007420; GO:0030182; GO:0036498; GO:0045944; GO:0048665,brain development [GO:0007420]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07737,FUN_034914-T1,Peve_00009290,Pocillopora_meandrina_HIv1___RNAseq.g27121.t1,three_way,69.19466666666666,FUN_034914-T1,B5X4H8,,,,,41.4,452.0,1.5e-80,301.6,sp|B5X4H8|RFT2_SALSA Riboflavin transporter 2 OS=Salmo salar OX=8030 GN=rft2 PE=2 SV=1,,,,,,
OG_07738,FUN_034917-T1,Peve_00039135,Pocillopora_meandrina_HIv1___RNAseq.g12141.t1,three_way,71.13166666666666,,,,,,,,,,,,,,,,,
OG_07739,FUN_034918-T1,Peve_00039136,Pocillopora_meandrina_HIv1___RNAseq.g12140.t1,three_way,67.611,FUN_034918-T1,Q15650,,,,,50.0,438.0,1.4e-109,398.3,sp|Q15650|TRIP4_HUMAN Activating signal cointegrator 1 OS=Homo sapiens OX=9606 GN=TRIP4 PE=1 SV=4,,,,,,
OG_07740,FUN_034919-T1,Peve_00039137,Pocillopora_meandrina_HIv1___TS.g3478.t2,three_way,88.44266666666667,FUN_034919-T1,Q5R7R6,COG4_PONAB,,Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),53.4,761.0,1.5e-213,744.2,sp|Q5R7R6|COG4_PONAB Conserved oligomeric Golgi complex subunit 4 OS=Pongo abelii OX=9601 GN=COG4 PE=2 SV=1,GO:0000139; GO:0005829; GO:0006890; GO:0007030; GO:0015031; GO:0017119,"Golgi organization [GO:0007030]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119],,GO:0005829; GO:0016192,cytosol; vesicle-mediated transport
OG_07741,FUN_034920-T1,Peve_00039139,Pocillopora_meandrina_HIv1___RNAseq.g12138.t1,three_way,54.01583333333333,FUN_034920-T1,Q8CGC6,,,,,34.2,929.0,3.6e-76,288.1,sp|Q8CGC6|RBM28_MOUSE RNA-binding protein 28 OS=Mus musculus OX=10090 GN=Rbm28 PE=1 SV=4,,,,,,
OG_07742,FUN_034925-T1,Peve_00009317,Pocillopora_meandrina_HIv1___RNAseq.g27813.t1,three_way,63.78083333333333,FUN_034925-T1,P29119,,,,,41.9,558.0,2.1e-121,438.0,sp|P29119|FURI1_XENLA Furin-1 OS=Xenopus laevis OX=8355 GN=furin PE=2 SV=1,,,,,,
OG_07743,FUN_034928-T1,Peve_00018021,Pocillopora_meandrina_HIv1___RNAseq.g27820.t1,three_way,73.23,FUN_034928-T1,P47747,,,,,26.3,270.0,1.1e-06,56.6,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_07744,FUN_034931-T1,Peve_00018022,Pocillopora_meandrina_HIv1___TS.g15166.t1a,three_way,46.51616666666666,FUN_034931-T1,F1NPG5,,,,,49.1,110.0,2.4e-24,114.8,sp|F1NPG5|CENPT_CHICK Centromere protein T OS=Gallus gallus OX=9031 GN=CENPT PE=1 SV=2,,,,,,
OG_07745,FUN_034933-T1,Peve_00018027,Pocillopora_meandrina_HIv1___RNAseq.10949_t,three_way,79.33566666666667,FUN_034933-T1,O75177,CREST_HUMAN,,Calcium-responsive transactivator (SS18-like protein 1) (SYT homolog 1),Homo sapiens (Human),44.8,154.0,2.3e-20,101.3,sp|O75177|CREST_HUMAN Calcium-responsive transactivator OS=Homo sapiens OX=9606 GN=SS18L1 PE=1 SV=2,GO:0000776; GO:0003713; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0016358; GO:0045893; GO:0045944; GO:0050775; GO:0071565,chromatin organization [GO:0006325]; dendrite development [GO:0016358]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytosol [GO:0005829]; kinetochore [GO:0000776]; nBAF complex [GO:0071565]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription coactivator activity [GO:0003713],GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; cytosol; chromatin organization; regulation of DNA-templated transcription; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_07746,FUN_034935-T1,Peve_00018031,Pocillopora_meandrina_HIv1___RNAseq.g27829.t1,three_way,62.48333333333333,FUN_034935-T1,A0A8M2,L14AA_XENLA,,Protein LSM14 homolog A-A (RNA-associated protein 55A-A) (RAP55A-A) (xRAP55) (xRAP55A),Xenopus laevis (African clawed frog),34.3,426.0,8.7e-45,183.0,sp|A0A8M2|L14AA_XENLA Protein LSM14 homolog A-A OS=Xenopus laevis OX=8355 GN=lsm14a-a PE=1 SV=1,GO:0000932; GO:0003723; GO:0003729; GO:0005737; GO:0010494; GO:0017148; GO:0017151; GO:0032991; GO:0033962; GO:0034063; GO:1990904,negative regulation of translation [GO:0017148]; P-body assembly [GO:0033962]; stress granule assembly [GO:0034063],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],DEAD/H-box RNA helicase binding [GO:0017151]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0043226,RNA binding; organelle
OG_07747,FUN_034936-T1,Peve_00018032,Pocillopora_meandrina_HIv1___RNAseq.g27830.t1,three_way,67.77,FUN_034936-T1,Q75QN2,INT8_HUMAN,,Integrator complex subunit 8 (Int8) (Protein kaonashi-1),Homo sapiens (Human),29.4,1071.0,1.8e-108,395.6,sp|Q75QN2|INT8_HUMAN Integrator complex subunit 8 OS=Homo sapiens OX=9606 GN=INTS8 PE=1 SV=1,GO:0000785; GO:0005634; GO:0005654; GO:0016180; GO:0032039; GO:0034243; GO:0034472; GO:0071168; GO:0160232; GO:0160240,protein localization to chromatin [GO:0071168]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],chromatin [GO:0000785]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0005634; GO:0005654; GO:0006355; GO:0016073; GO:0043226,nucleus; nucleoplasm; regulation of DNA-templated transcription; snRNA metabolic process; organelle
OG_07748,FUN_034937-T1,Peve_00018033,Pocillopora_meandrina_HIv1___RNAseq.g27831.t1,three_way,59.422666666666665,FUN_034937-T1,Q7Z614,SNX20_HUMAN,,Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1) (SLIC-1),Homo sapiens (Human),34.4,224.0,2.3e-17,91.3,sp|Q7Z614|SNX20_HUMAN Sorting nexin-20 OS=Homo sapiens OX=9606 GN=SNX20 PE=1 SV=1,GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266; GO:1901981,protein transport [GO:0015031],early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005654; GO:0005886; GO:0008289,nucleoplasm; plasma membrane; lipid binding
OG_07749,FUN_034938-T1,Peve_00036685,Pocillopora_meandrina_HIv1___RNAseq.g27832.t1,three_way,69.10716666666667,FUN_034938-T1,Q7Z614,SNX20_HUMAN,,Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1) (SLIC-1),Homo sapiens (Human),35.0,246.0,3.5000000000000005e-22,107.1,sp|Q7Z614|SNX20_HUMAN Sorting nexin-20 OS=Homo sapiens OX=9606 GN=SNX20 PE=1 SV=1,GO:0005546; GO:0005654; GO:0005886; GO:0015031; GO:0031901; GO:0032266; GO:1901981,protein transport [GO:0015031],early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005654; GO:0005886; GO:0008289,nucleoplasm; plasma membrane; lipid binding
OG_07750,FUN_034940-T1,Peve_00028340,Pocillopora_meandrina_HIv1___RNAseq.g12178.t1,three_way,72.15266666666666,FUN_034940-T1,Q0MQE9,,,,,47.4,95.0,3e-18,92.8,sp|Q0MQE9|NDUB9_GORGO NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 OS=Gorilla gorilla gorilla OX=9595 GN=NDUFB9 PE=2 SV=3,,,,,,
OG_07751,FUN_034941-T1,Peve_00028352,Pocillopora_meandrina_HIv1___RNAseq.g12180.t1,three_way,86.32333333333334,FUN_034941-T1,Q3KQF4,,,,,48.4,124.0,2.1e-29,131.3,sp|Q3KQF4|LRC69_XENLA Leucine-rich repeat-containing protein 69 OS=Xenopus laevis OX=8355 GN=lrrc69 PE=2 SV=1,,,,,,
OG_07752,FUN_034942-T1,Peve_00028348,Pocillopora_meandrina_HIv1___RNAseq.g12181.t1,three_way,62.79666666666667,FUN_034942-T1,Q91WE2,,,,,50.6,164.0,6.1e-31,136.0,sp|Q91WE2|PIP30_MOUSE PSME3-interacting protein OS=Mus musculus OX=10090 GN=Psme3ip1 PE=1 SV=1,,,,,,
OG_07753,FUN_034945-T1,Peve_00036658,Pocillopora_meandrina_HIv1___RNAseq.g27858.t1,three_way,59.49966666666667,,,,,,,,,,,,,,,,,
OG_07754,FUN_034946-T1,Peve_00036664,Pocillopora_meandrina_HIv1___RNAseq.g27857.t1,three_way,50.61566666666667,FUN_034946-T1,Q4R366,MRPP3_MACFA,,Mitochondrial ribonuclease P catalytic subunit (EC 3.1.26.5) (Mitochondrial ribonuclease P protein 3) (Mitochondrial RNase P protein 3),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),23.9,414.0,2.8e-19,98.2,sp|Q4R366|MRPP3_MACFA Mitochondrial ribonuclease P catalytic subunit OS=Macaca fascicularis OX=9541 GN=PRORP PE=2 SV=2,GO:0001682; GO:0004526; GO:0030678; GO:0046872; GO:0097745,mitochondrial tRNA 5'-end processing [GO:0097745]; tRNA 5'-leader removal [GO:0001682],mitochondrial ribonuclease P complex [GO:0030678],metal ion binding [GO:0046872]; ribonuclease P activity [GO:0004526],GO:0003824; GO:0006399; GO:0016787; GO:0140053; GO:0140098,"catalytic activity; tRNA metabolic process; hydrolase activity; mitochondrial gene expression; catalytic activity, acting on RNA"
OG_07755,FUN_034948-T1,Peve_00036666,Pocillopora_meandrina_HIv1___RNAseq.g27856.t1,three_way,75.81233333333334,FUN_034948-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),27.8,539.0,1.2e-56,223.0,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07756,FUN_034949-T1,Peve_00036668,Pocillopora_meandrina_HIv1___RNAseq.g27855.t1,three_way,73.09133333333334,FUN_034949-T1,Q6E2N3,TRI33_DANRE,,E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33),Danio rerio (Zebrafish) (Brachydanio rerio),25.4,323.0,9.1e-25,116.7,sp|Q6E2N3|TRI33_DANRE E3 ubiquitin-protein ligase TRIM33 OS=Danio rerio OX=7955 GN=trim33 PE=2 SV=1,GO:0000785; GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266,developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation by RNA polymerase II [GO:0034243],chromatin [GO:0000785]; nucleus [GO:0005634],DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0048870,immune system process; DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; anatomical structure development; cell motility
OG_07757,FUN_034950-T1,Peve_00036669,Pocillopora_meandrina_HIv1___TS.g15196.t1,three_way,81.33766666666666,FUN_034950-T1,Q1LU86,CBAR1_DANRE,,CBY1-interacting BAR domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),41.6,219.0,6.2e-40,166.0,sp|Q1LU86|CBAR1_DANRE CBY1-interacting BAR domain-containing protein 1 OS=Danio rerio OX=7955 GN=cibar1 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005929; GO:0007007; GO:0007283; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0097227; GO:0097546,cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of smoothened signaling pathway [GO:0045880]; spermatogenesis [GO:0007283],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; sperm annulus [GO:0097227],,GO:0005634; GO:0005815; GO:0005929; GO:0007005; GO:0022414; GO:0043226; GO:0044782; GO:0061024,nucleus; microtubule organizing center; cilium; mitochondrion organization; reproductive process; organelle; cilium organization; membrane organization
OG_07758,FUN_034951-T1,Peve_00036670,Pocillopora_meandrina_HIv1___RNAseq.g27851.t1,three_way,76.332,FUN_034951-T1,Q9H490,,,,,43.1,429.0,7.6e-88,325.9,sp|Q9H490|PIGU_HUMAN GPI-anchor transamidase component PIGU OS=Homo sapiens OX=9606 GN=PIGU PE=1 SV=3,,,,,,
OG_07759,FUN_034953-T1,Peve_00036672,Pocillopora_meandrina_HIv1___TS.g15182.t2,three_way,75.75533333333334,FUN_034953-T1,Q944H0,,,,,50.2,488.0,3.1e-143,510.0,sp|Q944H0|PEAM2_ARATH Phosphoethanolamine N-methyltransferase 2 OS=Arabidopsis thaliana OX=3702 GN=NMT2 PE=1 SV=2,,,,,,
OG_07760,FUN_034954-T1,Peve_00036673,Pocillopora_meandrina_HIv1___RNAseq.g27838.t1,three_way,81.57233333333333,FUN_034954-T1,Q9NXC2,GFOD1_HUMAN,,Glucose-fructose oxidoreductase domain-containing protein 1 (Gfo/Idh/MocA-like oxidoreductase domain-containing protein 1),Homo sapiens (Human),45.3,371.0,7.8e-92,339.0,sp|Q9NXC2|GFOD1_HUMAN Glucose-fructose oxidoreductase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=GFOD1 PE=1 SV=1,GO:0000166; GO:0005576; GO:0016491; GO:0042802,,extracellular region [GO:0005576],identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005576; GO:0016491,catalytic activity; extracellular region; oxidoreductase activity
OG_07761,FUN_034955-T1,Peve_00036678,Pocillopora_meandrina_HIv1___RNAseq.g27837.t1,three_way,88.89633333333333,FUN_034955-T1,Q75WB5,,,,,64.3,1304.0,0.0,1668.7,sp|Q75WB5|OPLA_BOVIN 5-oxoprolinase OS=Bos taurus OX=9913 GN=OPLAH PE=1 SV=2,,,,,,
OG_07762,FUN_034956-T1,Peve_00036680,Pocillopora_meandrina_HIv1___RNAseq.g27836.t1,three_way,74.127,FUN_034956-T1,P39949,CCNE1_RAT,,G1/S-specific cyclin-E1,Rattus norvegicus (Rat),51.8,311.0,1.5e-85,318.2,sp|P39949|CCNE1_RAT G1/S-specific cyclin-E1 OS=Rattus norvegicus OX=10116 GN=Ccne1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0001547; GO:0001889; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0006270; GO:0007129; GO:0009410; GO:0014074; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0031100; GO:0031670; GO:0032355; GO:0032570; GO:0032880; GO:0033197; GO:0034097; GO:0044877; GO:0045471; GO:0045597; GO:0048545; GO:0051301; GO:0051412; GO:0051597; GO:0051726; GO:0070192; GO:0097134; GO:1900087; GO:1902462,animal organ regeneration [GO:0031100]; antral ovarian follicle growth [GO:0001547]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to progesterone [GO:0032570]; response to purine-containing compound [GO:0014074]; response to steroid hormone [GO:0048545]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016740; GO:0022414; GO:0032200; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; transferase activity; reproductive process; telomere organization; organelle; anatomical structure development; molecular function regulator activity
OG_07763,FUN_034957-T1,Peve_00036683,Pocillopora_meandrina_HIv1___RNAseq.g27834.t1,three_way,81.576,FUN_034957-T1,Q1NZ26,,,,,46.5,273.0,1.4e-65,251.1,"sp|Q1NZ26|YSMU_CAEEL Uncharacterized protein F13E9.13, mitochondrial OS=Caenorhabditis elegans OX=6239 GN=F13E9.13 PE=3 SV=1",,,,,,
OG_07764,FUN_034958-T1,Peve_00036684,Pocillopora_meandrina_HIv1___RNAseq.g27833.t1,three_way,75.85683333333333,FUN_034958-T1,Q8IXH6,T53I2_HUMAN,,Tumor protein p53-inducible nuclear protein 2 (Diabetes and obesity-regulated gene) (p53-inducible protein U) (PIG-U),Homo sapiens (Human),47.5,80.0,5.2e-12,72.8,sp|Q8IXH6|T53I2_HUMAN Tumor protein p53-inducible nuclear protein 2 OS=Homo sapiens OX=9606 GN=TP53INP2 PE=1 SV=2,GO:0000045; GO:0001649; GO:0001894; GO:0005634; GO:0005776; GO:0005829; GO:0006511; GO:0008104; GO:0016605; GO:0031410; GO:0043130; GO:0045893; GO:1903828,autophagosome assembly [GO:0000045]; negative regulation of protein localization [GO:1903828]; osteoblast differentiation [GO:0001649]; positive regulation of DNA-templated transcription [GO:0045893]; protein localization [GO:0008104]; tissue homeostasis [GO:0001894]; ubiquitin-dependent protein catabolic process [GO:0006511],autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605],ubiquitin binding [GO:0043130],GO:0005634; GO:0005773; GO:0005829; GO:0006355; GO:0030154; GO:0031410; GO:0043226,nucleus; vacuole; cytosol; regulation of DNA-templated transcription; cell differentiation; cytoplasmic vesicle; organelle
OG_07765,FUN_034960-T1,Peve_00028346,Pocillopora_meandrina_HIv1___RNAseq.g12176.t1,three_way,53.46833333333333,,,,,,,,,,,,,,,,,
OG_07766,FUN_034961-T1,Peve_00028347,Pocillopora_meandrina_HIv1___RNAseq.g12173.t1,three_way,58.9135,FUN_034961-T1,P0C7T6,ATX1L_MOUSE,,Ataxin-1-like (Brother of ataxin-1),Mus musculus (Mouse),46.0,150.0,1.8e-30,135.6,sp|P0C7T6|ATX1L_MOUSE Ataxin-1-like OS=Mus musculus OX=10090 GN=Atxn1l PE=1 SV=1,GO:0000122; GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006366; GO:0007420; GO:0007612; GO:0007613; GO:0030198; GO:0030425; GO:0031208; GO:0035176; GO:0048286; GO:1902035,brain development [GO:0007420]; extracellular matrix organization [GO:0030198]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; social behavior [GO:0035176]; transcription by RNA polymerase II [GO:0006366],dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; POZ domain binding [GO:0031208]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005654; GO:0005730; GO:0006351; GO:0006355; GO:0030198; GO:0043226; GO:0048856; GO:0050877,DNA binding; RNA binding; nucleoplasm; nucleolus; DNA-templated transcription; regulation of DNA-templated transcription; extracellular matrix organization; organelle; anatomical structure development; nervous system process
OG_07767,FUN_034962-T1,Peve_00028349,Pocillopora_meandrina_HIv1___RNAseq.g12172.t1,three_way,90.49,FUN_034962-T1,Q9P2T1,GMPR2_HUMAN,,GMP reductase 2 (GMPR 2) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2),Homo sapiens (Human),71.5,347.0,2.7e-146,519.6,sp|Q9P2T1|GMPR2_HUMAN GMP reductase 2 OS=Homo sapiens OX=9606 GN=GMPR2 PE=1 SV=1,GO:0003920; GO:0005829; GO:0006144; GO:0046037; GO:0046872; GO:1902560,GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144],cytosol [GO:0005829]; GMP reductase complex [GO:1902560],GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872],GO:0003824; GO:0005829; GO:0016491; GO:0055086; GO:1901135,catalytic activity; cytosol; oxidoreductase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_07768,FUN_034963-T1,Peve_00028350,Pocillopora_meandrina_HIv1___TS.g3511.t1,three_way,62.328,FUN_034963-T1,Q9D5D8,,,,,27.8,503.0,6.9e-36,153.3,sp|Q9D5D8|CDYL2_MOUSE Chromodomain Y-like protein 2 OS=Mus musculus OX=10090 GN=Cdyl2 PE=1 SV=1,,,,,,
OG_07769,FUN_034972-T1,Peve_00028365,Pocillopora_meandrina_HIv1___RNAseq.g12164.t1,three_way,71.28216666666667,FUN_034972-T1,Q91820,AURAA_XENLA,,Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265),Xenopus laevis (African clawed frog),63.3,341.0,1.5e-121,437.6,sp|Q91820|AURAA_XENLA Aurora kinase A-A OS=Xenopus laevis OX=8355 GN=aurka-a PE=1 SV=1,GO:0000212; GO:0000776; GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005876; GO:0007052; GO:0007100; GO:0008017; GO:0018105; GO:0019894; GO:0032133; GO:0032465; GO:0046777; GO:0051233; GO:0051301; GO:0090307; GO:0106310,cell division [GO:0051301]; meiotic spindle organization [GO:0000212]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; chromosome passenger complex [GO:0032133]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; nucleus [GO:0005634]; spindle microtubule [GO:0005876]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],ATP binding [GO:0005524]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0007010; GO:0008092; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_07770,FUN_034973-T1,Peve_00028364,Pocillopora_meandrina_HIv1___RNAseq.g12163.t1,three_way,69.25200000000001,FUN_034973-T1,Q9D8B6,F210B_MOUSE,,"Protein FAM210B, mitochondrial",Mus musculus (Mouse),43.1,144.0,1.3e-20,101.3,"sp|Q9D8B6|F210B_MOUSE Protein FAM210B, mitochondrial OS=Mus musculus OX=10090 GN=Fam210b PE=1 SV=3",GO:0005739; GO:0005741; GO:0006954; GO:0016020; GO:0030218; GO:0043249; GO:0043588; GO:0045648; GO:0048536; GO:0071392; GO:0072593,cellular response to estradiol stimulus [GO:0071392]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; inflammatory response [GO:0006954]; positive regulation of erythrocyte differentiation [GO:0045648]; reactive oxygen species metabolic process [GO:0072593]; skin development [GO:0043588]; spleen development [GO:0048536],membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],,GO:0005739; GO:0006954; GO:0030154; GO:0043226; GO:0048856,mitochondrion; inflammatory response; cell differentiation; organelle; anatomical structure development
OG_07771,FUN_034974-T1,Peve_00028360,Pocillopora_meandrina_HIv1___RNAseq.g12162.t1,three_way,65.07733333333333,FUN_034974-T1,Q8K4T5,DUS19_MOUSE,,Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1),Mus musculus (Mouse),43.9,198.0,3.4e-40,166.4,sp|Q8K4T5|DUS19_MOUSE Dual specificity protein phosphatase 19 OS=Mus musculus OX=10090 GN=Dusp19 PE=2 SV=1,GO:0004722; GO:0004725; GO:0004860; GO:0005078; GO:0005737; GO:0007254; GO:0008138; GO:0008330; GO:0008579; GO:0030295; GO:0031434; GO:0031435; GO:0043409; GO:0043410; GO:0046329; GO:0046330,JNK cascade [GO:0007254]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410],cytoplasm [GO:0005737],JUN kinase phosphatase activity [GO:0008579]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase activator activity [GO:0030295]; protein kinase inhibitor activity [GO:0004860]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein tyrosine/threonine phosphatase activity [GO:0008330],GO:0003824; GO:0016787; GO:0060090; GO:0098772; GO:0140096,"catalytic activity; hydrolase activity; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07772,FUN_034983-T1,Peve_00009294,Pocillopora_meandrina_HIv1___RNAseq.g12158.t1,three_way,52.6345,FUN_034983-T1,A2A259,PK2L1_MOUSE,,Polycystin-2-like protein 1 (Polycystin-2L1) (Polycystic kidney disease 2-like 1 protein) (Polycystin-2 homolog),Mus musculus (Mouse),25.5,509.0,4.6e-40,168.7,sp|A2A259|PK2L1_MOUSE Polycystin-2-like protein 1 OS=Mus musculus OX=10090 GN=Pkd2l1 PE=1 SV=1,GO:0001581; GO:0005227; GO:0005261; GO:0005262; GO:0005272; GO:0005509; GO:0005783; GO:0005829; GO:0005886; GO:0006812; GO:0007224; GO:0009415; GO:0015269; GO:0015629; GO:0031410; GO:0034703; GO:0034704; GO:0042802; GO:0043235; GO:0044325; GO:0050912; GO:0051262; GO:0051289; GO:0051371; GO:0060170; GO:0071467; GO:0071468; GO:0097730; GO:0098662; GO:0160128; GO:1990760,cellular response to acidic pH [GO:0071468]; cellular response to pH [GO:0071467]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; detection of chemical stimulus involved in sensory perception of taste [GO:0050912]; inorganic cation transmembrane transport [GO:0098662]; monoatomic cation transport [GO:0006812]; protein homotetramerization [GO:0051289]; protein tetramerization [GO:0051262]; response to water [GO:0009415]; smoothened signaling pathway [GO:0007224],actin cytoskeleton [GO:0015629]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; ciliary membrane [GO:0060170]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; calcium-activated potassium channel activity [GO:0015269]; identical protein binding [GO:0042802]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; pH-gated monoatomic ion channel activity [GO:0160128]; sodium channel activity [GO:0005272]; transmembrane transporter binding [GO:0044325],GO:0005215; GO:0005783; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0008092; GO:0031410; GO:0043226; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,transporter activity; endoplasmic reticulum; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeletal protein binding; cytoplasmic vesicle; organelle; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_07773,FUN_034984-T1,Peve_00009292,Pocillopora_meandrina_HIv1___TS.g14469.t2,three_way,75.10966666666667,FUN_034984-T1,Q502K2,SAMH1_DANRE,,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-),Danio rerio (Zebrafish) (Brachydanio rerio),57.7,480.0,3.3e-162,573.2,sp|Q502K2|SAMH1_DANRE Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 OS=Danio rerio OX=7955 GN=samhd1 PE=2 SV=2,GO:0000724; GO:0003676; GO:0003697; GO:0003723; GO:0005525; GO:0005634; GO:0006203; GO:0006974; GO:0008270; GO:0008832; GO:0009264; GO:0016446; GO:0016793; GO:0032567; GO:0035861; GO:0036269; GO:0045087; GO:0045088; GO:0045540; GO:0046061; GO:0051289; GO:0051607; GO:0060339; GO:0106375; GO:0110025,dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA damage response [GO:0006974]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; swimming behavior [GO:0036269],nucleus [GO:0005634]; site of double-strand break [GO:0035861],deoxynucleoside triphosphate hydrolase activity [GO:0106375]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0055086; GO:0065003; GO:0098542; GO:1901135,immune system process; DNA binding; RNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; defense response to other organism; carbohydrate derivative metabolic process
OG_07774,FUN_034986-T1,Peve_00009289,Pocillopora_meandrina_HIv1___RNAseq.g27118.t1,three_way,87.63316666666667,FUN_034986-T1,Q9BUN8,DERL1_HUMAN,,Derlin-1 (Degradation in endoplasmic reticulum protein 1) (DERtrin-1) (Der1-like protein 1),Homo sapiens (Human),61.0,249.0,1.3e-81,304.3,sp|Q9BUN8|DERL1_HUMAN Derlin-1 OS=Homo sapiens OX=9606 GN=DERL1 PE=1 SV=1,GO:0002020; GO:0005047; GO:0005769; GO:0005770; GO:0005783; GO:0005789; GO:0006986; GO:0016020; GO:0030968; GO:0030970; GO:0031398; GO:0031625; GO:0031648; GO:0036502; GO:0036503; GO:0036513; GO:0038023; GO:0042288; GO:0042802; GO:0043161; GO:0044322; GO:0044877; GO:0045184; GO:0051117; GO:0071218; GO:1990381,"cellular response to misfolded protein [GO:0071218]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]",Derlin-1 retrotranslocation complex [GO:0036513]; Derlin-1-VIMP complex [GO:0036502]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; late endosome [GO:0005770]; membrane [GO:0016020],ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; MHC class I protein binding [GO:0042288]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; signal recognition particle binding [GO:0005047]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381],GO:0005768; GO:0005783; GO:0006886; GO:0030163; GO:0031410; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; intracellular protein transport; protein catabolic process; cytoplasmic vesicle; organelle; molecular transducer activity
OG_07775,FUN_034990-T1,Peve_00024609,Pocillopora_meandrina_HIv1___RNAseq.g12120.t1,three_way,92.32533333333332,FUN_034990-T1,O08654,,,,,63.1,295.0,1.8e-106,387.1,sp|O08654|PHAF1_RAT Phagosome assembly factor 1 OS=Rattus norvegicus OX=10116 GN=Phaf1 PE=2 SV=1,,,,,,
OG_07776,FUN_034991-T1,Peve_00024608,Pocillopora_meandrina_HIv1___RNAseq.g12121.t1,three_way,73.899,FUN_034991-T1,Q148V7,,,,,40.7,1181.0,1.8e-226,787.7,sp|Q148V7|RELCH_MOUSE RAB11-binding protein RELCH OS=Mus musculus OX=10090 GN=Relch PE=1 SV=1,,,,,,
OG_07777,FUN_034993-T1,Peve_00024607,Pocillopora_meandrina_HIv1___RNAseq.g12122.t1,three_way,65.4765,FUN_034993-T1,Q90WY6,ADA2C_DANRE,,Alpha-2C adrenergic receptor (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR),Danio rerio (Zebrafish) (Brachydanio rerio),29.2,233.0,3.5e-14,80.9,sp|Q90WY6|ADA2C_DANRE Alpha-2C adrenergic receptor OS=Danio rerio OX=7955 GN=adra2c PE=3 SV=1,GO:0004938; GO:0005886; GO:0006940; GO:0007186; GO:0019229; GO:0030168; GO:0051379; GO:0071881,adenylate cyclase-inhibiting adrenergic receptor signaling pathway [GO:0071881]; G protein-coupled receptor signaling pathway [GO:0007186]; platelet activation [GO:0030168]; regulation of smooth muscle contraction [GO:0006940]; regulation of vasoconstriction [GO:0019229],plasma membrane [GO:0005886],alpha2-adrenergic receptor activity [GO:0004938]; epinephrine binding [GO:0051379],GO:0003013; GO:0005886; GO:0060089,circulatory system process; plasma membrane; molecular transducer activity
OG_07778,FUN_034994-T1,Peve_00024604,Pocillopora_meandrina_HIv1___TS.g3464.t1,three_way,66.411,FUN_034994-T1,O02667,,,,,24.4,308.0,6.8e-18,93.2,sp|O02667|AA3R_RABIT Adenosine receptor A3 OS=Oryctolagus cuniculus OX=9986 GN=ADORA3 PE=2 SV=1,,,,,,
OG_07779,FUN_034996-T1,Peve_00024602,Pocillopora_meandrina_HIv1___RNAseq.g12126.t1,three_way,68.37866666666666,FUN_034996-T1,Q923X6,,,,,27.8,299.0,3.7e-18,94.0,sp|Q923X6|TAA7E_RAT Trace amine-associated receptor 7e OS=Rattus norvegicus OX=10116 GN=Taar7e PE=3 SV=1,,,,,,
OG_07780,FUN_034997-T1,Peve_00024600,Pocillopora_meandrina_HIv1___RNAseq.g4153.t1,three_way,61.30266666666667,FUN_034997-T1,Q8K4Z4,,,,,28.7,310.0,2e-22,108.2,sp|Q8K4Z4|ADRB2_CAVPO Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1,,,,,,
OG_07781,FUN_034998-T1,Peve_00024599,Pocillopora_meandrina_HIv1___RNAseq.g12127.t1,three_way,52.55766666666667,FUN_034998-T1,P14316,IRF2_HUMAN,,Interferon regulatory factor 2 (IRF-2),Homo sapiens (Human),48.2,110.0,5.3e-27,124.0,sp|P14316|IRF2_HUMAN Interferon regulatory factor 2 OS=Homo sapiens OX=9606 GN=IRF2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001228; GO:0002376; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0005925; GO:0006355; GO:0006357; GO:0008283; GO:0045944; GO:0051607; GO:1990837,cell population proliferation [GO:0008283]; defense response to virus [GO:0051607]; immune system process [GO:0002376]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0140110,immune system process; DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07782,FUN_035002-T1,Peve_00024598,Pocillopora_meandrina_HIv1___RNAseq.g12128.t1,three_way,74.33966666666667,FUN_035002-T1,Q9NRW4,,,,,54.7,172.0,8e-51,201.8,sp|Q9NRW4|DUS22_HUMAN Dual specificity protein phosphatase 22 OS=Homo sapiens OX=9606 GN=DUSP22 PE=1 SV=1,,,,,,
OG_07783,FUN_035003-T1,Peve_00024597,Pocillopora_meandrina_HIv1___RNAseq.g12129.t1,three_way,63.208333333333336,FUN_035003-T1,P23819,,,,,30.4,874.0,3.8e-97,357.8,sp|P23819|GRIA2_MOUSE Glutamate receptor 2 OS=Mus musculus OX=10090 GN=Gria2 PE=1 SV=3,,,,,,
OG_07784,FUN_035004-T2,Peve_00024592,Pocillopora_meandrina_HIv1___RNAseq.g12131.t1,three_way,65.9825,FUN_035004-T2,Q6DFQ7,TM198_XENTR,,Transmembrane protein 198,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),21.0,205.0,6.7e-09,63.2,sp|Q6DFQ7|TM198_XENTR Transmembrane protein 198 OS=Xenopus tropicalis OX=8364 GN=tmem198 PE=1 SV=1,GO:0005886; GO:0012506; GO:0016055; GO:0031410,Wnt signaling pathway [GO:0016055],cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506],,GO:0005886; GO:0031410; GO:0043226,plasma membrane; cytoplasmic vesicle; organelle
OG_07785,FUN_035006-T1,Peve_00024591,Pocillopora_meandrina_HIv1___RNAseq.g12132.t1,three_way,87.31233333333333,FUN_035006-T1,Q32P85,,,,,84.9,93.0,5.999999999999998e-39,162.2,sp|Q32P85|DLRB2_BOVIN Dynein light chain roadblock-type 2 OS=Bos taurus OX=9913 GN=DYNLRB2 PE=3 SV=1,,,,,,
OG_07786,FUN_035007-T1,Peve_00024588,Pocillopora_meandrina_HIv1___RNAseq.g12133.t1,three_way,76.595,FUN_035007-T1,O60268,,,,,33.6,110.0,4.3e-10,65.5,sp|O60268|K0513_HUMAN Uncharacterized protein KIAA0513 OS=Homo sapiens OX=9606 GN=KIAA0513 PE=1 SV=1,,,,,,
OG_07787,FUN_035008-T1,Peve_00024587,Pocillopora_meandrina_HIv1___RNAseq.g12134.t1,three_way,76.40066666666667,FUN_035008-T1,Q9VCA2,,,,,32.9,538.0,3.9e-72,273.9,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_07788,FUN_035009-T1,Peve_00024586,Pocillopora_meandrina_HIv1___RNAseq.g27786.t1,three_way,91.84933333333332,FUN_035009-T1,P19387,RPB3_HUMAN,,DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II 33 kDa polypeptide) (RPB33) (DNA-directed RNA polymerase II subunit C) (RPB31),Homo sapiens (Human),77.3,278.0,7.900000000000001e-125,448.0,sp|P19387|RPB3_HUMAN DNA-directed RNA polymerase II subunit RPB3 OS=Homo sapiens OX=9606 GN=POLR2C PE=1 SV=2,GO:0003677; GO:0003899; GO:0005634; GO:0005654; GO:0005665; GO:0005829; GO:0006366; GO:0046983,transcription by RNA polymerase II [GO:0006366],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II, core complex [GO:0005665]",DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0016740; GO:0043226; GO:0140098,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on RNA"
OG_07789,FUN_035010-T1,Peve_00024585,Pocillopora_meandrina_HIv1___RNAseq.g27785.t1,three_way,66.97333333333333,FUN_035010-T1,Q95044,,,,,57.8,147.0,8.999999999999998e-41,167.9,sp|Q95044|UBE2C_SPISO Ubiquitin-conjugating enzyme E2 C OS=Spisula solidissima OX=6584 GN=UBE2C PE=1 SV=1,,,,,,
OG_07790,FUN_035011-T1,Peve_00024584,Pocillopora_meandrina_HIv1___RNAseq.g27784.t1,three_way,86.16116666666666,FUN_035011-T1,A1L252,RANB9_DANRE,,Ran-binding protein 9 (RanBP9),Danio rerio (Zebrafish) (Brachydanio rerio),57.7,503.0,5.9e-155,548.9,sp|A1L252|RANB9_DANRE Ran-binding protein 9 OS=Danio rerio OX=7955 GN=ranbp9 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005886; GO:0007010; GO:0060041,cytoskeleton organization [GO:0007010]; retina development in camera-type eye [GO:0060041],cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],,GO:0005634; GO:0005886; GO:0007010; GO:0043226; GO:0048856,nucleus; plasma membrane; cytoskeleton organization; organelle; anatomical structure development
OG_07791,FUN_035012-T1,Peve_00024655,Pocillopora_meandrina_HIv1___RNAseq.g27783.t1,three_way,78.43166666666667,FUN_035012-T1,Q8BXA5,,,,,50.3,537.0,6.9e-157,555.4,sp|Q8BXA5|CLP1L_MOUSE Lipid scramblase CLPTM1L OS=Mus musculus OX=10090 GN=Clptm1l PE=1 SV=1,,,,,,
OG_07792,FUN_035013-T1,Peve_00024652,Pocillopora_meandrina_HIv1___RNAseq.g27781.t1,three_way,80.01333333333334,FUN_035013-T1,Q9GV16,,,,,54.1,386.0,2.4e-119,430.3,sp|Q9GV16|EGCSE_CYANO Endoglycoceramidase OS=Cyanea nozakii OX=135523 PE=1 SV=1,,,,,,
OG_07793,FUN_035020-T1,Peve_00024635,Pocillopora_meandrina_HIv1___RNAseq.g27768.t1,three_way,45.82483333333333,FUN_035020-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),36.2,149.0,5.9e-19,97.1,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_07794,FUN_035021-T1,Peve_00024634,Pocillopora_meandrina_HIv1___RNAseq.g27767.t1,three_way,74.369,FUN_035021-T1,P47033,PRY3_YEAST,,Cell wall protein PRY3 (Pathogenesis-related protein 3),Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast),36.5,148.0,3e-16,87.4,sp|P47033|PRY3_YEAST Cell wall protein PRY3 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PRY3 PE=1 SV=1,GO:0000747; GO:0005615; GO:0009277; GO:0015908; GO:0015918; GO:0019953; GO:0071944; GO:0098552,conjugation with cellular fusion [GO:0000747]; fatty acid transport [GO:0015908]; sexual reproduction [GO:0019953]; sterol transport [GO:0015918],cell periphery [GO:0071944]; extracellular space [GO:0005615]; fungal-type cell wall [GO:0009277]; side of membrane [GO:0098552],,GO:0005615; GO:0005618; GO:0022414; GO:0030312,extracellular space; cell wall; reproductive process; external encapsulating structure
OG_07795,FUN_035024-T1,Peve_00024631,Pocillopora_meandrina_HIv1___RNAseq.g27765.t1,three_way,67.5,,,,,,,,,,,,,,,,,
OG_07796,FUN_035028-T1,Peve_00024629,Pocillopora_meandrina_HIv1___RNAseq.g27762.t1,three_way,45.4505,FUN_035028-T1,G3CJR9,VA5_DIPMA,,Salivary antigen-5 (DMAV),Dipetalogaster maximus (Blood-sucking bug),34.7,121.0,1.5e-08,62.8,sp|G3CJR9|VA5_DIPMA Salivary antigen-5 OS=Dipetalogaster maximus OX=72496 PE=1 SV=1,GO:0005615; GO:0006801; GO:0008201; GO:0016209; GO:0035893; GO:0090729; GO:1903135; GO:1904399,superoxide metabolic process [GO:0006801]; suppression of platelet aggregation in another organism [GO:0035893],extracellular space [GO:0005615],antioxidant activity [GO:0016209]; cupric ion binding [GO:1903135]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; toxin activity [GO:0090729],GO:0005615; GO:0016209; GO:0090729,extracellular space; antioxidant activity; toxin activity
OG_07797,FUN_035032-T1,Peve_00024626,Pocillopora_meandrina_HIv1___RNAseq.g27760.t1,three_way,96.02833333333334,FUN_035032-T1,P68399,CSK21_BOVIN,,Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1),Bos taurus (Bovine),89.2,269.0,4.8e-146,518.5,sp|P68399|CSK21_BOVIN Casein kinase II subunit alpha OS=Bos taurus OX=9913 GN=CSNK2A1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005634; GO:0005829; GO:0005956; GO:0006302; GO:0006915; GO:0008284; GO:0016055; GO:0030177; GO:0030307; GO:0045732; GO:0048511; GO:0051726; GO:0106310; GO:1905337; GO:1905818; GO:2000042; GO:2001234,apoptotic process [GO:0006915]; double-strand break repair [GO:0006302]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; positive regulation of aggrephagy [GO:1905337]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase CK2 complex [GO:0005956],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; DNA repair; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07798,FUN_035033-T1,Peve_00024625,Pocillopora_meandrina_HIv1___RNAseq.g27759.t1,three_way,65.54933333333334,,,,,,,,,,,,,,,,,
OG_07799,FUN_035034-T1,Peve_00024624,Pocillopora_meandrina_HIv1___RNAseq.g27758.t1,three_way,74.63333333333333,FUN_035034-T1,Q3SZ84,,,,,59.0,78.0,1.1e-19,97.4,sp|Q3SZ84|BOLA3_BOVIN BolA-like protein 3 OS=Bos taurus OX=9913 GN=BOLA3 PE=3 SV=1,,,,,,
OG_07800,FUN_035035-T1,Peve_00024623,Pocillopora_meandrina_HIv1___RNAseq.g27757.t1,three_way,67.09666666666666,FUN_035035-T1,Q6NRQ1,,,,,39.6,470.0,1.8e-101,371.3,"sp|Q6NRQ1|B3GL2_XENLA UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 OS=Xenopus laevis OX=8355 GN=b3galnt2 PE=2 SV=1",,,,,,
OG_07801,FUN_035036-T1,Peve_00024636,Pocillopora_meandrina_HIv1___RNAseq.g27754.t1,three_way,63.75233333333333,FUN_035036-T1,Q9VKA4,,,,,27.3,538.0,1e-52,209.9,sp|Q9VKA4|Y1760_DROME Probable G-protein coupled receptor CG31760 OS=Drosophila melanogaster OX=7227 GN=CG31760 PE=1 SV=3,,,,,,
OG_07802,FUN_035038-T1,Peve_00044749,Pocillopora_meandrina_HIv1___RNAseq.g27752.t1,three_way,86.15366666666667,FUN_035038-T1,Q3ZBY3,CALB2_BOVIN,,Calretinin (CR),Bos taurus (Bovine),45.5,244.0,2.4e-51,204.1,sp|Q3ZBY3|CALB2_BOVIN Calretinin OS=Bos taurus OX=9913 GN=CALB2 PE=2 SV=1,GO:0005509; GO:0005634; GO:0005829; GO:0006874; GO:0030425; GO:0043195; GO:0044293; GO:0045202; GO:0048167; GO:0098688; GO:0099534; GO:0099536,intracellular calcium ion homeostasis [GO:0006874]; regulation of synaptic plasticity [GO:0048167]; synaptic signaling [GO:0099536],cytosol [GO:0005829]; dendriole [GO:0044293]; dendrite [GO:0030425]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; synapse [GO:0045202]; terminal bouton [GO:0043195],calcium ion binding [GO:0005509]; calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534],GO:0005634; GO:0005829; GO:0023052; GO:0043226,nucleus; cytosol; signaling; organelle
OG_07803,FUN_035039-T1,Peve_00044750,Pocillopora_meandrina_HIv1___TS.g15093.t1,three_way,84.09616666666668,FUN_035039-T1,Q96GQ7,,,,,59.6,287.0,5.999999999999999e-84,312.4,sp|Q96GQ7|DDX27_HUMAN Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens OX=9606 GN=DDX27 PE=1 SV=3,,,,,,
OG_07804,FUN_035041-T1,Peve_00044751,Pocillopora_meandrina_HIv1___RNAseq.g27747.t1,three_way,77.77466666666666,FUN_035041-T1,Q9NXG6,,,,,35.4,373.0,5.1e-57,223.4,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_07805,FUN_035042-T1,Peve_00044753,Pocillopora_meandrina_HIv1___RNAseq.g27744.t1,three_way,66.28966666666666,FUN_035042-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),32.0,338.0,3.8e-41,170.6,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_07806,FUN_035044-T2,Peve_00044754,Pocillopora_meandrina_HIv1___RNAseq.g27745.t1,three_way,63.242,FUN_035044-T2,P0DOX0,,,,,32.3,486.0,1.3e-70,268.9,sp|P0DOX0|C27C1_AQUCT Cytochrome P450 27C1 OS=Aquarana catesbeiana OX=8400 GN=cyp27c1 PE=1 SV=1,,,,,,
OG_07807,FUN_035052-T1,Peve_00011121,Pocillopora_meandrina_HIv1___RNAseq.g27741.t1,three_way,68.56233333333333,FUN_035052-T1,Q9C2L8,,,,,29.8,168.0,2.7e-14,80.5,sp|Q9C2L8|RAB7_NEUCR Ypt/Rab-type GTPase Rab7 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=gtp-14 PE=3 SV=1,,,,,,
OG_07808,FUN_035053-T1,Peve_00011120,Pocillopora_meandrina_HIv1___RNAseq.g27740.t1,three_way,70.04766666666667,FUN_035053-T1,Q09930,DIRA_CAEEL,,GTP-binding protein drn-1 (Di-Ras/Rig/Noey2 Ras-like protein homolog),Caenorhabditis elegans,38.6,127.0,8.6e-19,95.1,sp|Q09930|DIRA_CAEEL GTP-binding protein drn-1 (Fragment) OS=Caenorhabditis elegans OX=6239 GN=drn-1 PE=1 SV=3,GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0019003,signal transduction [GO:0007165],plasma membrane [GO:0005886],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005886; GO:0016787,catalytic activity; GTPase activity; plasma membrane; hydrolase activity
OG_07809,FUN_035054-T2,Peve_00001113,Pocillopora_meandrina_HIv1___RNAseq.g27738.t1,three_way,87.29066666666667,FUN_035054-T2,Q8BLA8,TRPA1_MOUSE,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor),Mus musculus (Mouse),25.6,1076.0,1.2e-49,200.3,sp|Q8BLA8|TRPA1_MOUSE Transient receptor potential cation channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Trpa1 PE=1 SV=1,GO:0005216; GO:0005245; GO:0005262; GO:0005886; GO:0006816; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016020; GO:0016324; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042542; GO:0042802; GO:0046872; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0050974; GO:0051289; GO:0070301; GO:0070417; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transport [GO:0006816]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception [GO:0050974]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to hydrogen peroxide [GO:0042542]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; metal ion binding [GO:0046872]; monoatomic ion channel activity [GO:0005216]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_07810,FUN_035057-T1,Peve_00001111,Pocillopora_meandrina_HIv1___RNAseq.g27737.t1,three_way,76.10633333333334,FUN_035057-T1,Q96S44,PRPK_HUMAN,,EKC/KEOPS complex subunit TP53RK (EC 3.6.-.-) (Atypical serine/threonine protein kinase TP53RK) (Nori-2) (TP53-regulating kinase) (EC 2.7.11.1) (p53-related protein kinase),Homo sapiens (Human),60.1,218.0,1.5e-66,254.2,sp|Q96S44|PRPK_HUMAN EKC/KEOPS complex subunit TP53RK OS=Homo sapiens OX=9606 GN=TP53RK PE=1 SV=2,GO:0000408; GO:0002039; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006468; GO:0008033; GO:0016787; GO:0070525; GO:0106310; GO:1901796,protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525],cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006399; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; tRNA metabolic process; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_07811,FUN_035058-T1,Peve_00001885,Pocillopora_meandrina_HIv1___RNAseq.g27736.t1,three_way,68.96166666666667,FUN_035058-T1,Q8WNV7,,,,,54.6,282.0,8.5e-74,278.5,sp|Q8WNV7|DHRS4_PIG Dehydrogenase/reductase SDR family member 4 OS=Sus scrofa OX=9823 GN=DHRS4 PE=1 SV=2,,,,,,
OG_07812,FUN_035060-T1,Peve_00026574,Pocillopora_meandrina_HIv1___TS.g15080.t1,three_way,75.726,FUN_035060-T1,Q99L04,,,,,51.1,323.0,2.9000000000000004e-80,300.4,sp|Q99L04|DHRS1_MOUSE Dehydrogenase/reductase SDR family member 1 OS=Mus musculus OX=10090 GN=Dhrs1 PE=1 SV=1,,,,,,
OG_07813,FUN_035061-T1,Peve_00025324,Pocillopora_meandrina_HIv1___RNAseq.g22114.t1,three_way,61.75866666666667,,,,,,,,,,,,,,,,,
OG_07814,FUN_035065-T1,Peve_00002212,Pocillopora_meandrina_HIv1___RNAseq.g27725.t1,three_way,77.09883333333333,FUN_035065-T1,F1QB30,AMFR_DANRE,,E3 ubiquitin-protein ligase AMFR (EC 2.3.2.36) (Autocrine motility factor receptor) (AMF receptor),Danio rerio (Zebrafish) (Brachydanio rerio),50.1,535.0,1.3e-141,505.0,sp|F1QB30|AMFR_DANRE E3 ubiquitin-protein ligase AMFR OS=Danio rerio OX=7955 GN=amfra PE=1 SV=1,GO:0000151; GO:0000209; GO:0005783; GO:0005789; GO:0005829; GO:0006511; GO:0008270; GO:0030968; GO:0034976; GO:0043130; GO:0061630; GO:0070936,endoplasmic reticulum unfolded protein response [GO:0030968]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ubiquitin ligase complex [GO:0000151],ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005783; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07815,FUN_035067-T1,Peve_00002216,Pocillopora_meandrina_HIv1___RNAseq.g27723.t1,three_way,72.051,FUN_035067-T1,A6QQV6,ANM7_BOVIN,,Protein arginine N-methyltransferase 7 (EC 2.1.1.321) (Histone-arginine N-methyltransferase PRMT7) ([Myelin basic protein]-arginine N-methyltransferase PRMT7),Bos taurus (Bovine),41.5,725.0,4.5e-159,563.1,sp|A6QQV6|ANM7_BOVIN Protein arginine N-methyltransferase 7 OS=Bos taurus OX=9913 GN=PRMT7 PE=2 SV=1,GO:0000387; GO:0005634; GO:0005829; GO:0006338; GO:0006355; GO:0016274; GO:0018216; GO:0035241; GO:0035243; GO:0042054; GO:0044020; GO:0071514,chromatin remodeling [GO:0006338]; genomic imprinting [GO:0071514]; peptidyl-arginine methylation [GO:0018216]; regulation of DNA-templated transcription [GO:0006355]; spliceosomal snRNP assembly [GO:0000387],cytosol [GO:0005829]; nucleus [GO:0005634],histone H4R3 methyltransferase activity [GO:0044020]; histone methyltransferase activity [GO:0042054]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_07816,FUN_035068-T1,Peve_00026040,Pocillopora_meandrina_HIv1___RNAseq.g27722.t1,three_way,68.704,FUN_035068-T1,Q5U403,MVD1_DANRE,,Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase),Danio rerio (Zebrafish) (Brachydanio rerio),54.7,391.0,7.4e-119,428.7,sp|Q5U403|MVD1_DANRE Diphosphomevalonate decarboxylase OS=Danio rerio OX=7955 GN=mvd PE=2 SV=1,GO:0003334; GO:0004163; GO:0005524; GO:0005829; GO:0006695; GO:0019287; GO:0045765,"cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process, mevalonate pathway [GO:0019287]; keratinocyte development [GO:0003334]; regulation of angiogenesis [GO:0045765]",cytosol [GO:0005829],ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163],GO:0003824; GO:0005829; GO:0006629; GO:0006790; GO:0016829; GO:0048856; GO:0055086,catalytic activity; cytosol; lipid metabolic process; sulfur compound metabolic process; lyase activity; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_07817,FUN_035069-T1,Peve_00026039,Pocillopora_meandrina_HIv1___RNAseq.g27720.t1,three_way,65.01733333333334,FUN_035069-T1,Q6DEL1,S38A7_DANRE,,Sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7),Danio rerio (Zebrafish) (Brachydanio rerio),41.4,406.0,1.6e-80,301.6,sp|Q6DEL1|S38A7_DANRE Sodium-coupled neutral amino acid transporter 7 OS=Danio rerio OX=7955 GN=slc38a7 PE=2 SV=1,GO:0003333; GO:0005765; GO:0006867; GO:0006868; GO:0015182; GO:0015186; GO:0016020; GO:0030424; GO:0140901; GO:0140902,amino acid transmembrane transport [GO:0003333]; asparagine transport [GO:0006867]; glutamine transport [GO:0006868],axon [GO:0030424]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],L-asparagine transmembrane transporter activity [GO:0015182]; L-asparagine:sodium symporter activity [GO:0140901]; L-glutamine transmembrane transporter activity [GO:0015186]; L-glutamine:sodium symporter activity [GO:0140902],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_07818,FUN_035070-T1,Peve_00031377,Pocillopora_meandrina_HIv1___RNAseq.g27719.t1,three_way,82.29666666666667,FUN_035070-T1,Q7ZT01,PSF3_XENLA,,DNA replication complex GINS protein PSF3 (GINS complex subunit 3),Xenopus laevis (African clawed frog),43.1,197.0,9.3e-49,194.9,sp|Q7ZT01|PSF3_XENLA DNA replication complex GINS protein PSF3 OS=Xenopus laevis OX=8355 GN=gins3 PE=1 SV=1,GO:0000811; GO:0003682; GO:0006260; GO:0071162; GO:1902975,DNA replication [GO:0006260]; mitotic DNA replication initiation [GO:1902975],CMG complex [GO:0071162]; GINS complex [GO:0000811],chromatin binding [GO:0003682],GO:0006260,DNA replication
OG_07819,FUN_035071-T1,Peve_00031378,Pocillopora_meandrina_HIv1___RNAseq.g27718.t1a,three_way,94.78266666666669,FUN_035071-T1,Q8I7Z2,,,,,73.0,111.0,7.4e-40,164.5,sp|Q8I7Z2|DAD1_ARAVE Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 OS=Araneus ventricosus OX=182803 GN=DAD1 PE=2 SV=1,,,,,,
OG_07820,FUN_035088-T1,Peve_00037967,Pocillopora_meandrina_HIv1___TS.g15056.t2,three_way,81.78233333333334,FUN_035088-T1,Q92508,PIEZ1_HUMAN,,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),Homo sapiens (Human),32.0,2582.0,4.8e-312,1072.8,sp|Q92508|PIEZ1_HUMAN Piezo-type mechanosensitive ion channel component 1 OS=Homo sapiens OX=9606 GN=PIEZO1 PE=1 SV=4,GO:0005261; GO:0005783; GO:0005789; GO:0005886; GO:0006812; GO:0008381; GO:0010831; GO:0031258; GO:0032420; GO:0032437; GO:0033116; GO:0033625; GO:0033634; GO:0042391; GO:0050982; GO:0071260; GO:0140135,cellular response to mechanical stimulus [GO:0071260]; detection of mechanical stimulus [GO:0050982]; monoatomic cation transport [GO:0006812]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of integrin activation [GO:0033625]; positive regulation of myotube differentiation [GO:0010831]; regulation of membrane potential [GO:0042391],cuticular plate [GO:0032437]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; stereocilium [GO:0032420],mechanosensitive monoatomic cation channel activity [GO:0140135]; mechanosensitive monoatomic ion channel activity [GO:0008381]; monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005783; GO:0005886; GO:0043226,transporter activity; endoplasmic reticulum; plasma membrane; organelle
OG_07821,FUN_035089-T1,Peve_00037966,Pocillopora_meandrina_HIv1___RNAseq.g27710.t1,three_way,58.702,FUN_035089-T1,O54991,CNTP1_MOUSE,,Contactin-associated protein 1 (Caspr) (Caspr1) (MHDNIV) (NCP1) (Neurexin IV) (Neurexin-4) (Paranodin),Mus musculus (Mouse),30.4,593.0,2.3000000000000002e-74,282.0,sp|O54991|CNTP1_MOUSE Contactin-associated protein 1 OS=Mus musculus OX=10090 GN=Cntnap1 PE=1 SV=2,GO:0002175; GO:0005886; GO:0005918; GO:0007005; GO:0007010; GO:0007155; GO:0007409; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0031175; GO:0033010; GO:0033270; GO:0042552; GO:0043209; GO:0048812; GO:0050884; GO:0050885; GO:0050905; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227,"axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]",glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; septate junction [GO:0005918],SH3 domain binding [GO:0017124],GO:0005886; GO:0007005; GO:0007010; GO:0007155; GO:0034330; GO:0050877,plasma membrane; mitochondrion organization; cytoskeleton organization; cell adhesion; cell junction organization; nervous system process
OG_07822,FUN_035090-T2,Peve_00037965,Pocillopora_meandrina_HIv1___RNAseq.g27709.t1,three_way,52.48183333333333,FUN_035090-T2,Q0V8T6,CTP5A_RAT,,Contactin-associated protein like 5-1 (Cell recognition molecule Caspr5-1) (Cell recognition molecule Caspr5a) (Contactin-associated protein-like 5a),Rattus norvegicus (Rat),29.9,626.0,1.1e-68,263.1,sp|Q0V8T6|CTP5A_RAT Contactin-associated protein like 5-1 OS=Rattus norvegicus OX=10116 GN=Cntnap5a PE=2 SV=1,GO:0007155; GO:0016020; GO:0030054,cell adhesion [GO:0007155],cell junction [GO:0030054]; membrane [GO:0016020],,GO:0007155,cell adhesion
OG_07823,FUN_035093-T1,Peve_00005803,Pocillopora_meandrina_HIv1___RNAseq.g27701.t1,three_way,95.78933333333332,FUN_035093-T1,Q7PD79,,,,,76.3,384.0,1.1e-172,607.4,sp|Q7PD79|GNAS_ANOGA Guanine nucleotide-binding protein G(s) subunit alpha OS=Anopheles gambiae OX=7165 GN=G-s-alpha-60A PE=2 SV=1,,,,,,
OG_07824,FUN_035094-T1,Peve_00014774,Pocillopora_meandrina_HIv1___RNAseq.g27699.t1,three_way,62.495,FUN_035094-T1,Q92896,GSLG1_HUMAN,,Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1) (ESL-1) (Golgi sialoglycoprotein MG-160),Homo sapiens (Human),40.9,1085.0,6.1999999999999985e-251,869.0,sp|Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,GO:0000139; GO:0005102; GO:0005794; GO:0005815; GO:0005886; GO:0007179; GO:0010955; GO:0016020; GO:0016485; GO:0017134; GO:0030512; GO:0031012; GO:0032330; GO:0060349; GO:0070062,bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein processing [GO:0016485]; regulation of chondrocyte differentiation [GO:0032330]; transforming growth factor beta receptor signaling pathway [GO:0007179],extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886],fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102],GO:0005794; GO:0005815; GO:0005886; GO:0030312; GO:0031012; GO:0043226; GO:0051604,Golgi apparatus; microtubule organizing center; plasma membrane; external encapsulating structure; extracellular matrix; organelle; protein maturation
OG_07825,FUN_035121-T1,Peve_00005906,Pocillopora_meandrina_HIv1___RNAseq.g27643.t1,three_way,58.49466666666667,FUN_035121-T1,Q86HG9,,,,,32.5,246.0,1.0000000000000001e-24,116.3,sp|Q86HG9|Y9871_DICDI Probable serine/threonine-protein kinase DDB_G0271682 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0271682 PE=3 SV=2,,,,,,
OG_07826,FUN_035122-T1,Peve_00005905,Pocillopora_meandrina_HIv1___RNAseq.g27642.t1,three_way,59.37683333333334,FUN_035122-T1,Q7T6X2,,,,,32.0,278.0,2.7e-20,102.1,sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R826 PE=3 SV=2,,,,,,
OG_07827,FUN_035129-T1,Peve_00005904,Pocillopora_meandrina_HIv1___RNAseq.g27641.t1,three_way,89.21533333333333,,,,,,,,,,,,,,,,,
OG_07828,FUN_035130-T3,Peve_00005902,Pocillopora_meandrina_HIv1___TS.g14990.t1,three_way,58.65316666666666,FUN_035130-T3,Q8TEP8,,,,,32.3,871.0,3.2e-116,422.5,sp|Q8TEP8|CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens OX=9606 GN=CEP192 PE=1 SV=3,,,,,,
OG_07829,FUN_035131-T3,Peve_00005900,Pocillopora_meandrina_HIv1___RNAseq.g27639.t1,three_way,66.834,FUN_035131-T3,A6H603,NWD1_MOUSE,,NACHT domain- and WD repeat-containing protein 1,Mus musculus (Mouse),29.1,983.0,1.9e-97,359.8,sp|A6H603|NWD1_MOUSE NACHT domain- and WD repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Nwd1 PE=2 SV=2,GO:0005524; GO:0005730; GO:0005829; GO:0010628; GO:0032088,negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of gene expression [GO:0010628],cytosol [GO:0005829]; nucleolus [GO:0005730],ATP binding [GO:0005524],GO:0005730; GO:0005829; GO:0006355; GO:0043226,nucleolus; cytosol; regulation of DNA-templated transcription; organelle
OG_07830,FUN_035135-T1,Peve_00030331,Pocillopora_meandrina_HIv1___RNAseq.g27638.t1a,three_way,53.556,,,,,,,,,,,,,,,,,
OG_07831,FUN_035151-T1,Peve_00030330,Pocillopora_meandrina_HIv1___TS.g14987.t1,three_way,73.245,FUN_035151-T1,Q8VCX2,,,,,53.8,277.0,4.7e-75,283.1,sp|Q8VCX2|S35C2_MOUSE Solute carrier family 35 member C2 OS=Mus musculus OX=10090 GN=Slc35c2 PE=1 SV=1,,,,,,
OG_07832,FUN_035154-T1,Peve_00006880,Pocillopora_meandrina_HIv1___RNAseq.g27634.t1,three_way,56.06466666666667,FUN_035154-T1,Q9UKV3,,,,,30.4,280.0,5e-24,114.8,sp|Q9UKV3|ACINU_HUMAN Apoptotic chromatin condensation inducer in the nucleus OS=Homo sapiens OX=9606 GN=ACIN1 PE=1 SV=2,,,,,,
OG_07833,FUN_035158-T1,Peve_00003080,Pocillopora_meandrina_HIv1___TS.g14947.t1b,three_way,56.551,,,,,,,,,,,,,,,,,
OG_07834,FUN_035159-T1,Peve_00006321,Pocillopora_meandrina_HIv1___RNAseq.g27599.t1,three_way,55.585,,,,,,,,,,,,,,,,,
OG_07835,FUN_035161-T1,Peve_00006324,Pocillopora_meandrina_HIv1___RNAseq.11026_t,three_way,61.05166666666667,FUN_035161-T1,Q923Y6,,,,,26.7,330.0,9.8e-13,75.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_07836,FUN_035166-T1,Peve_00036194,Pocillopora_meandrina_HIv1___RNAseq.g27915.t1,three_way,52.95516666666667,FUN_035166-T1,Q29477,TRFL_CAPHI,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-),Capra hircus (Goat),35.5,366.0,2.5e-42,174.5,sp|Q29477|TRFL_CAPHI Lactotransferrin OS=Capra hircus OX=9925 GN=LTF PE=1 SV=1,GO:0001503; GO:0001817; GO:0002227; GO:0005615; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0008236; GO:0019731; GO:0019732; GO:0031665; GO:0032680; GO:0033690; GO:0042581; GO:0043066; GO:0045669; GO:0046872; GO:0055037; GO:0060349; GO:1900159; GO:1900229; GO:1902732; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; bone morphogenesis [GO:0060349]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule [GO:0042581],metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236],GO:0002376; GO:0003824; GO:0005615; GO:0005768; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; endosome; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_07837,FUN_035168-T1,Peve_00036178,Pocillopora_meandrina_HIv1___RNAseq.g27917.t1,three_way,73.896,FUN_035168-T1,Q9BZ19,,,,,35.8,176.0,2.1e-21,105.1,sp|Q9BZ19|ANR60_HUMAN Ankyrin repeat domain-containing protein 60 OS=Homo sapiens OX=9606 GN=ANKRD60 PE=1 SV=3,,,,,,
OG_07838,FUN_035169-T1,Peve_00036181,Pocillopora_meandrina_HIv1___RNAseq.g27918.t1,three_way,87.309,FUN_035169-T1,Q9JK84,,,,,54.5,299.0,5.5e-80,299.3,sp|Q9JK84|PAR6G_MOUSE Partitioning defective 6 homolog gamma OS=Mus musculus OX=10090 GN=Pard6g PE=2 SV=1,,,,,,
OG_07839,FUN_035170-T1,Peve_00036182,Pocillopora_meandrina_HIv1___RNAseq.g27919.t1,three_way,79.174,FUN_035170-T1,F1QWW8,KDSR_DANRE,,3-dehydrosphinganine reductase (EC 1.1.1.102),Danio rerio (Zebrafish) (Brachydanio rerio),47.5,324.0,4.8e-76,286.2,sp|F1QWW8|KDSR_DANRE 3-dehydrosphinganine reductase OS=Danio rerio OX=7955 GN=kdsr PE=1 SV=2,GO:0005789; GO:0006666; GO:0006686; GO:0030148; GO:0030220; GO:0047560; GO:0070402; GO:0090156; GO:0090520,3-keto-sphinganine metabolic process [GO:0006666]; intracellular sphingolipid homeostasis [GO:0090156]; platelet formation [GO:0030220]; sphingolipid biosynthetic process [GO:0030148]; sphingolipid mediated signaling pathway [GO:0090520]; sphingomyelin biosynthetic process [GO:0006686],endoplasmic reticulum membrane [GO:0005789],3-dehydrosphinganine reductase activity [GO:0047560]; NADPH binding [GO:0070402],GO:0003824; GO:0006629; GO:0016491; GO:0030154,catalytic activity; lipid metabolic process; oxidoreductase activity; cell differentiation
OG_07840,FUN_035171-T1,Peve_00036183,Pocillopora_meandrina_HIv1___RNAseq.g27920.t1,three_way,64.12,,,,,,,,,,,,,,,,,
OG_07841,FUN_035174-T1,Peve_00036186,Pocillopora_meandrina_HIv1___RNAseq.g27927.t1,three_way,61.35166666666667,FUN_035174-T1,Q5RB37,,,,,38.1,561.0,1.4e-103,379.4,sp|Q5RB37|ITIH3_PONAB Inter-alpha-trypsin inhibitor heavy chain H3 OS=Pongo abelii OX=9601 GN=ITIH3 PE=2 SV=1,,,,,,
OG_07842,FUN_035177-T1,Peve_00036192,Pocillopora_meandrina_HIv1___RNAseq.g27936.t1,three_way,89.8475,FUN_035177-T1,Q14703,MBTP1_HUMAN,,Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1),Homo sapiens (Human),63.6,1006.0,0.0,1305.4,sp|Q14703|MBTP1_HUMAN Membrane-bound transcription factor site-1 protease OS=Homo sapiens OX=9606 GN=MBTPS1 PE=1 SV=1,GO:0000139; GO:0004252; GO:0005788; GO:0005789; GO:0005794; GO:0005795; GO:0006508; GO:0006606; GO:0007040; GO:0007095; GO:0008203; GO:0016485; GO:0030968; GO:0031293; GO:0034976; GO:0036500; GO:0045540; GO:0051604; GO:0060627,ATF6-mediated unfolded protein response [GO:0036500]; cholesterol metabolic process [GO:0008203]; endoplasmic reticulum unfolded protein response [GO:0030968]; lysosome organization [GO:0007040]; membrane protein intracellular domain proteolysis [GO:0031293]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein import into nucleus [GO:0006606]; protein maturation [GO:0051604]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of vesicle-mediated transport [GO:0060627]; response to endoplasmic reticulum stress [GO:0034976],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005794; GO:0006629; GO:0006886; GO:0006913; GO:0007040; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; Golgi apparatus; lipid metabolic process; intracellular protein transport; nucleocytoplasmic transport; lysosome organization; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_07843,FUN_035180-T1,Peve_00021485,Pocillopora_meandrina_HIv1___TS.g15289.t2,three_way,73.132,FUN_035180-T1,O88665,BRD7_MOUSE,,Bromodomain-containing protein 7 (75 kDa bromodomain protein),Mus musculus (Mouse),37.2,540.0,9.4e-80,299.7,sp|O88665|BRD7_MOUSE Bromodomain-containing protein 7 OS=Mus musculus OX=10090 GN=Brd7 PE=1 SV=1,GO:0000776; GO:0000785; GO:0000976; GO:0002039; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006357; GO:0016055; GO:0016363; GO:0016586; GO:0030071; GO:0042393; GO:0045582; GO:0045597; GO:0045663; GO:0045815; GO:0045892; GO:0070316; GO:0140015; GO:2000045; GO:2000134; GO:2000781; GO:2000819,chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of cell differentiation [GO:0045597]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of T cell differentiation [GO:0045582]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation-coupled chromatin remodeling [GO:0045815]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RSC-type complex [GO:0016586],histone binding [GO:0042393]; histone H3K14ac reader activity [GO:0140015]; p53 binding [GO:0002039]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_07844,FUN_035182-T1,Peve_00021488,Pocillopora_meandrina_HIv1___RNAseq.g27944.t1,three_way,78.65466666666667,FUN_035182-T1,Q8NBX0,,,,,49.1,424.0,1.2e-111,404.8,sp|Q8NBX0|SCPDL_HUMAN Saccharopine dehydrogenase-like oxidoreductase OS=Homo sapiens OX=9606 GN=SCCPDH PE=1 SV=1,,,,,,
OG_07845,FUN_035183-T1,Peve_00021486,Pocillopora_meandrina_HIv1___RNAseq.g27945.t1,three_way,68.04133333333333,FUN_035183-T1,Q9NXG6,,,,,34.9,352.0,7.499999999999998e-54,212.6,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_07846,FUN_035184-T1,Peve_00036894,Pocillopora_meandrina_HIv1___RNAseq.g27956.t1,three_way,61.53933333333333,,,,,,,,,,,,,,,,,
OG_07847,FUN_035185-T1,Peve_00036893,Pocillopora_meandrina_HIv1___RNAseq.g27955.t1,three_way,75.83783333333334,FUN_035185-T1,P07090,,,,,41.6,262.0,1.6e-43,177.9,sp|P07090|CALB2_CHICK Calretinin OS=Gallus gallus OX=9031 GN=CALB2 PE=2 SV=3,,,,,,
OG_07848,FUN_035190-T1,Peve_00044650,Pocillopora_meandrina_HIv1___RNAseq.g27958.t1,three_way,60.0245,,,,,,,,,,,,,,,,,
OG_07849,FUN_035191-T1,Peve_00044663,Pocillopora_meandrina_HIv1___RNAseq.g27959.t1,three_way,74.12833333333333,FUN_035191-T1,Q9VZF4,FBXW7_DROME,,F-box/WD repeat-containing protein 7 (F-box and WD-40 domain-containing protein 7) (Protein archipelago),Drosophila melanogaster (Fruit fly),28.8,198.0,1.8e-18,95.5,sp|Q9VZF4|FBXW7_DROME F-box/WD repeat-containing protein 7 OS=Drosophila melanogaster OX=7227 GN=ago PE=1 SV=1,GO:0005634; GO:0007088; GO:0007096; GO:0007419; GO:0016567; GO:0019005; GO:0030162; GO:0030332; GO:0031146; GO:0035147; GO:0042023; GO:0045571; GO:0045926; GO:0060253; GO:0060438; GO:0071456; GO:1900038; GO:1903146; GO:1990381,"branch fusion, open tracheal system [GO:0035147]; cellular response to hypoxia [GO:0071456]; DNA endoreduplication [GO:0042023]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; protein ubiquitination [GO:0016567]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of exit from mitosis [GO:0007096]; regulation of mitotic nuclear division [GO:0007088]; regulation of proteolysis [GO:0030162]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; trachea development [GO:0060438]; ventral cord development [GO:0007419]",nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; ubiquitin-specific protease binding [GO:1990381],GO:0005634; GO:0006260; GO:0030163; GO:0043226; GO:0048856,nucleus; DNA replication; protein catabolic process; organelle; anatomical structure development
OG_07850,FUN_035192-T1,Peve_00036908,Pocillopora_meandrina_HIv1___RNAseq.g27961.t1,three_way,54.408166666666666,,,,,,,,,,,,,,,,,
OG_07851,FUN_035194-T1,Peve_00016110,Pocillopora_meandrina_HIv1___RNAseq.g8466.t1,three_way,62.026,,,,,,,,,,,,,,,,,
OG_07852,FUN_035196-T1,Peve_00044655,Pocillopora_meandrina_HIv1___TS.g15307.t1,three_way,54.73116666666667,,,,,,,,,,,,,,,,,
OG_07853,FUN_035207-T1,Peve_00027696,Pocillopora_meandrina_HIv1___RNAseq.g27964.t1a,three_way,52.52433333333333,,,,,,,,,,,,,,,,,
OG_07854,FUN_035208-T1,Peve_00027694,Pocillopora_meandrina_HIv1___RNAseq.g27632.t1,three_way,78.51983333333334,FUN_035208-T1,Q21920,,,,,31.1,132.0,2.1e-08,61.6,sp|Q21920|ANKHM_CAEEL Ankyrin repeat and KH domain-containing protein mask-1 OS=Caenorhabditis elegans OX=6239 GN=mask-1 PE=3 SV=3,,,,,,
OG_07855,FUN_035210-T1,Peve_00027693,Pocillopora_meandrina_HIv1___RNAseq.g27630.t1,three_way,70.29866666666666,,,,,,,,,,,,,,,,,
OG_07856,FUN_035211-T1,Peve_00027692,Pocillopora_meandrina_HIv1___RNAseq.g27628.t1,three_way,61.5215,,,,,,,,,,,,,,,,,
OG_07857,FUN_035212-T1,Peve_00027689,Pocillopora_meandrina_HIv1___RNAseq.g27625.t1,three_way,88.569,FUN_035212-T1,Q6P4W8,,,,,63.3,425.0,6.1e-148,525.4,sp|Q6P4W8|PCH2_XENTR Pachytene checkpoint protein 2 homolog OS=Xenopus tropicalis OX=8364 GN=trip13 PE=2 SV=1,,,,,,
OG_07858,FUN_035213-T1,Peve_00027688,Pocillopora_meandrina_HIv1___RNAseq.g27624.t1,three_way,87.76233333333333,FUN_035213-T1,Q5RCP7,,,,,62.5,658.0,6.9e-252,871.3,sp|Q5RCP7|CEP76_PONAB Centrosomal protein of 76 kDa OS=Pongo abelii OX=9601 GN=CEP76 PE=2 SV=1,,,,,,
OG_07859,FUN_035214-T1,Peve_00027702,Pocillopora_meandrina_HIv1___RNAseq.g27840.t2,three_way,74.03666666666668,FUN_035214-T1,Q8RDT4,,,,,46.5,372.0,1e-88,328.6,sp|Q8RDT4|MEGL_FUSNN L-methionine gamma-lyase OS=Fusobacterium nucleatum subsp. nucleatum (strain ATCC 25586 / DSM 15643 / BCRC 10681 / CIP 101130 / JCM 8532 / KCTC 2640 / LMG 13131 / VPI 4355) OX=190304 GN=FN1419 PE=1 SV=1,,,,,,
OG_07860,FUN_035215-T1,Peve_00027695,Pocillopora_meandrina_HIv1___RNAseq.g27616.t1,three_way,57.300666666666665,,,,,,,,,,,,,,,,,
OG_07861,FUN_035216-T2,Peve_00035892,Pocillopora_meandrina_HIv1___RNAseq.g27615.t1,three_way,70.04816666666666,FUN_035216-T2,Q503Z8,IRX6A_DANRE,,Iroquois homeobox protein 6a,Danio rerio (Zebrafish) (Brachydanio rerio),47.6,233.0,1.9e-40,168.3,sp|Q503Z8|IRX6A_DANRE Iroquois homeobox protein 6a OS=Danio rerio OX=7955 GN=irx6a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0030182; GO:0048468,cell development [GO:0048468]; neuron differentiation [GO:0030182]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07862,FUN_035217-T1,Peve_00035882,Pocillopora_meandrina_HIv1___TS.g14965.t1,three_way,86.42566666666667,FUN_035217-T1,O43747,,,,,62.9,851.0,9.3e-281,967.6,sp|O43747|AP1G1_HUMAN AP-1 complex subunit gamma-1 OS=Homo sapiens OX=9606 GN=AP1G1 PE=1 SV=5,,,,,,
OG_07863,FUN_035220-T1,Peve_00035885,Pocillopora_meandrina_HIv1___RNAseq.g27612.t1,three_way,83.25133333333333,FUN_035220-T1,D3YXS5,,,,,37.8,932.0,1.3e-153,545.4,sp|D3YXS5|KIF28_MOUSE Kinesin-like protein KIF28 OS=Mus musculus OX=10090 GN=Kif28 PE=3 SV=1,,,,,,
OG_07864,FUN_035221-T1,Peve_00035886,Pocillopora_meandrina_HIv1___RNAseq.g27610.t1,three_way,84.449,FUN_035221-T1,Q6DE14,E2F4_XENLA,,Transcription factor E2F4 (E2F-4),Xenopus laevis (African clawed frog),54.9,368.0,1.1e-96,354.8,sp|Q6DE14|E2F4_XENLA Transcription factor E2F4 OS=Xenopus laevis OX=8355 GN=e2f4 PE=1 SV=1,GO:0000978; GO:0000981; GO:0003700; GO:0006357; GO:0044458; GO:0045944; GO:0046983; GO:0090575; GO:0098534; GO:1903251,centriole assembly [GO:0098534]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0006355; GO:0030154; GO:0044782; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; cilium organization; transcription regulator activity
OG_07865,FUN_035222-T1,Peve_00035887,Pocillopora_meandrina_HIv1___RNAseq.g27609.t1,three_way,55.40566666666666,FUN_035222-T1,Q501V0,KPSH1_DANRE,,Serine/threonine-protein kinase H1 homolog (EC 2.7.11.1),Danio rerio (Zebrafish) (Brachydanio rerio),66.9,323.0,4.8e-116,419.9,sp|Q501V0|KPSH1_DANRE Serine/threonine-protein kinase H1 homolog OS=Danio rerio OX=7955 GN=pskh1 PE=2 SV=2,GO:0004674; GO:0005524; GO:0005737; GO:0106310,,cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_07866,FUN_035224-T1,Peve_00035889,Pocillopora_meandrina_HIv1___RNAseq.g27608.t2,three_way,68.49266666666666,FUN_035224-T1,Q944S2,,,,,30.6,330.0,5.3000000000000005e-34,146.7,sp|Q944S2|GTS1_ARATH WD repeat-containing protein GTS1 OS=Arabidopsis thaliana OX=3702 GN=GTS1 PE=2 SV=1,,,,,,
OG_07867,FUN_035225-T1,Peve_00035891,Pocillopora_meandrina_HIv1___RNAseq.g27617.t1,three_way,54.354,FUN_035225-T1,B9EJI9,,,,,39.2,125.0,9.6e-17,88.2,sp|B9EJI9|T229A_MOUSE Transmembrane protein 229A OS=Mus musculus OX=10090 GN=Tmem229a PE=2 SV=1,,,,,,
OG_07868,FUN_035226-T1,Peve_00044870,Pocillopora_meandrina_HIv1___RNAseq.g27607.t1,three_way,72.06166666666667,FUN_035226-T1,Q5PR73,,,,,35.1,171.0,2e-22,108.2,sp|Q5PR73|DIRA2_MOUSE GTP-binding protein Di-Ras2 OS=Mus musculus OX=10090 GN=Diras2 PE=1 SV=1,,,,,,
OG_07869,FUN_035227-T1,Peve_00043182,Pocillopora_meandrina_HIv1___RNAseq.g27605.t1,three_way,65.062,,,,,,,,,,,,,,,,,
OG_07870,FUN_035228-T1,Peve_00026317,Pocillopora_meandrina_HIv1___RNAseq.g27602.t1,three_way,56.61966666666667,FUN_035228-T1,Q2YDQ5,,,,,52.0,50.0,1.1e-07,59.7,sp|Q2YDQ5|FBXL5_DANRE F-box/LRR-repeat protein 5 OS=Danio rerio OX=7955 GN=fbxl5 PE=2 SV=2,,,,,,
OG_07871,FUN_035229-T1,Peve_00026316,Pocillopora_meandrina_HIv1___RNAseq.g27626.t1,three_way,69.89033333333333,FUN_035229-T1,O75907,DGAT1_HUMAN,,Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (ACAT-related gene product 1) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase),Homo sapiens (Human),55.2,422.0,1.5e-131,471.1,sp|O75907|DGAT1_HUMAN Diacylglycerol O-acyltransferase 1 OS=Homo sapiens OX=9606 GN=DGAT1 PE=1 SV=2,GO:0003846; GO:0004144; GO:0005789; GO:0005886; GO:0006640; GO:0006641; GO:0016020; GO:0016746; GO:0019432; GO:0019915; GO:0034379; GO:0035336; GO:0035579; GO:0042802; GO:0046339; GO:0050252; GO:0055089,diacylglycerol metabolic process [GO:0046339]; fatty acid homeostasis [GO:0055089]; lipid storage [GO:0019915]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle assembly [GO:0034379],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],2-acylglycerol O-acyltransferase activity [GO:0003846]; acyltransferase activity [GO:0016746]; diacylglycerol O-acyltransferase activity [GO:0004144]; identical protein binding [GO:0042802]; retinol O-fatty-acyltransferase activity [GO:0050252],GO:0003824; GO:0005886; GO:0006629; GO:0006790; GO:0016740; GO:0055086; GO:0065003,catalytic activity; plasma membrane; lipid metabolic process; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; protein-containing complex assembly
OG_07872,FUN_035231-T1,Peve_00044486,Pocillopora_meandrina_HIv1___RNAseq.g27905.t1,three_way,73.57433333333333,,,,,,,,,,,,,,,,,
OG_07873,FUN_035233-T1,Peve_00044494,Pocillopora_meandrina_HIv1___RNAseq.g27904.t1,three_way,73.75433333333334,FUN_035233-T1,Q3T0C2,PGDH_BOVIN,,"15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Eicosanoid/docosanoid dehydrogenase [NAD(+)]) (EC 1.1.1.-, EC 1.1.1.232) (Prostaglandin dehydrogenase 1)",Bos taurus (Bovine),40.9,257.0,7.100000000000001e-48,192.2,sp|Q3T0C2|PGDH_BOVIN 15-hydroxyprostaglandin dehydrogenase [NAD(+)] OS=Bos taurus OX=9913 GN=HPGD PE=2 SV=1,GO:0004957; GO:0005737; GO:0006693; GO:0007179; GO:0007565; GO:0007567; GO:0016404; GO:0030728; GO:0045786; GO:0051287; GO:0070403; GO:0070493; GO:0097070; GO:1905828,ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; regulation of prostaglandin catabolic process [GO:1905828]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957],GO:0003824; GO:0006629; GO:0016491; GO:0022414; GO:0060089,catalytic activity; lipid metabolic process; oxidoreductase activity; reproductive process; molecular transducer activity
OG_07874,FUN_035235-T1,Peve_00007100,Pocillopora_meandrina_HIv1___RNAseq.g27902.t1,three_way,80.08733333333333,FUN_035235-T1,Q7TSH2,,,,,47.5,1092.0,1.6e-269,930.6,sp|Q7TSH2|KPBB_MOUSE Phosphorylase b kinase regulatory subunit beta OS=Mus musculus OX=10090 GN=Phkb PE=1 SV=1,,,,,,
OG_07875,FUN_035236-T2,Peve_00007099,Pocillopora_meandrina_HIv1___RNAseq.g27901.t1,three_way,49.373666666666665,FUN_035236-T2,Q96DY7,,,,,23.1,835.0,1.5e-25,119.8,sp|Q96DY7|MTBP_HUMAN Mdm2-binding protein OS=Homo sapiens OX=9606 GN=MTBP PE=1 SV=1,,,,,,
OG_07876,FUN_035237-T1,Peve_00007098,Pocillopora_meandrina_HIv1___RNAseq.g27900.t1,three_way,84.26833333333333,FUN_035237-T1,Q8NDH3,,,,,61.3,501.0,1.9e-180,633.6,sp|Q8NDH3|PEPL1_HUMAN Probable aminopeptidase NPEPL1 OS=Homo sapiens OX=9606 GN=NPEPL1 PE=1 SV=3,,,,,,
OG_07877,FUN_035239-T2,Peve_00042235,Pocillopora_meandrina_HIv1___RNAseq.g27898.t1,three_way,66.54466666666667,FUN_035239-T2,P54278,PMS2_HUMAN,,Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2),Homo sapiens (Human),48.0,891.0,7.499999999999999e-217,755.4,sp|P54278|PMS2_HUMAN Mismatch repair endonuclease PMS2 OS=Homo sapiens OX=9606 GN=PMS2 PE=1 SV=2,GO:0003677; GO:0004519; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0006298; GO:0009410; GO:0016446; GO:0016447; GO:0016887; GO:0032138; GO:0032389; GO:0048298; GO:0048304; GO:0140664,mismatch repair [GO:0006298]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; response to xenobiotic stimulus [GO:0009410]; somatic hypermutation of immunoglobulin genes [GO:0016446]; somatic recombination of immunoglobulin gene segments [GO:0016447],cytosol [GO:0005829]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_07878,FUN_035240-T1,Peve_00042231,Pocillopora_meandrina_HIv1___TS.g15237.t1,three_way,53.185,FUN_035240-T1,Q9CYL5,,,,,40.6,160.0,2.1e-25,117.9,sp|Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr2 PE=1 SV=3,,,,,,
OG_07879,FUN_035241-T1,Peve_00042230,Pocillopora_meandrina_HIv1___RNAseq.g27894.t1,three_way,72.514,FUN_035241-T1,P51452,DUS3_HUMAN,,Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR),Homo sapiens (Human),45.5,178.0,1.5e-36,154.5,sp|P51452|DUS3_HUMAN Dual specificity protein phosphatase 3 OS=Homo sapiens OX=9606 GN=DUSP3 PE=1 SV=1,GO:0001772; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0008092; GO:0008138; GO:0016311; GO:0016791; GO:0019901; GO:0030294; GO:0030336; GO:0030971; GO:0031514; GO:0033549; GO:0035335; GO:0042059; GO:0043409; GO:0045931; GO:0046329; GO:0050860; GO:0050868; GO:0050922; GO:0051893; GO:0070373; GO:0071364; GO:0120183; GO:1990782,cellular response to epidermal growth factor stimulus [GO:0071364]; dephosphorylation [GO:0016311]; negative regulation of cell migration [GO:0030336]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of JNK cascade [GO:0046329]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of focal adhesion assembly [GO:0051893],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; immunological synapse [GO:0001772]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cytoskeletal protein binding [GO:0008092]; MAP kinase phosphatase activity [GO:0033549]; phosphatase activity [GO:0016791]; protein kinase binding [GO:0019901]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; receptor signaling protein tyrosine kinase inhibitor activity [GO:0030294]; receptor tyrosine kinase binding [GO:0030971],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005929; GO:0008092; GO:0016787; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; cilium; cytoskeletal protein binding; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07880,FUN_035243-T1,Peve_00042228,Pocillopora_meandrina_HIv1___RNAseq.g27896.t1,three_way,91.40466666666669,FUN_035243-T1,Q6Q137,SEPT7_BOVIN,,Septin-7 (CDC10 protein homolog),Bos taurus (Bovine),67.9,330.0,2.2e-129,463.8,sp|Q6Q137|SEPT7_BOVIN Septin-7 OS=Bos taurus OX=9913 GN=SEPTIN7 PE=2 SV=2,GO:0000776; GO:0001725; GO:0003924; GO:0005525; GO:0005634; GO:0005819; GO:0005930; GO:0005940; GO:0007283; GO:0008104; GO:0015630; GO:0016476; GO:0030154; GO:0030496; GO:0031105; GO:0032153; GO:0032154; GO:0042802; GO:0060090; GO:0060271; GO:0061640; GO:0097227; GO:0097730; GO:1902857,cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; positive regulation of non-motile cilium assembly [GO:1902857]; protein localization [GO:0008104]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],axoneme [GO:0005930]; cell division site [GO:0032153]; cleavage furrow [GO:0032154]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; septin complex [GO:0031105]; septin ring [GO:0005940]; sperm annulus [GO:0097227]; spindle [GO:0005819]; stress fiber [GO:0001725],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],GO:0000910; GO:0003824; GO:0003924; GO:0005634; GO:0005856; GO:0005929; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0060090,cytokinesis; catalytic activity; GTPase activity; nucleus; cytoskeleton; cilium; hydrolase activity; reproductive process; cell differentiation; organelle; cilium organization; molecular adaptor activity
OG_07881,FUN_035244-T1,Peve_00042234,Pocillopora_meandrina_HIv1___RNAseq.g27892.t1b,three_way,69.50633333333333,FUN_035244-T1,O32210,,,,,44.7,262.0,5.5e-61,236.1,sp|O32210|GR_BACSU Glyoxal reductase OS=Bacillus subtilis (strain 168) OX=224308 GN=yvgN PE=1 SV=1,,,,,,
OG_07882,FUN_035257-T1,Peve_00032647,Pocillopora_meandrina_HIv1___RNAseq.g27885.t1,three_way,70.81866666666667,FUN_035257-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),43.3,1072.0,9.4e-262,904.8,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_07883,FUN_035260-T1,Peve_00032643,Pocillopora_meandrina_HIv1___RNAseq.g27881.t1,three_way,64.38783333333333,FUN_035260-T1,O88738,BIRC6_MOUSE,,Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),Mus musculus (Mouse),43.8,267.0,4.8e-62,241.9,sp|O88738|BIRC6_MOUSE Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Mus musculus OX=10090 GN=Birc6 PE=1 SV=2,GO:0000922; GO:0001890; GO:0004869; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0060712; GO:0061631; GO:0090543; GO:2001237,apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; placenta development [GO:0001890]; positive regulation of cell population proliferation [GO:0008284]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712],centrosome [GO:0005813]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802],cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005768; GO:0005815; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; endosome; microtubule organizing center; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07884,FUN_035261-T1,Peve_00032642,Pocillopora_meandrina_HIv1___TS.g15222.t2,three_way,64.01466666666667,,,,,,,,,,,,,,,,,
OG_07885,FUN_035262-T1,Peve_00032640,Pocillopora_meandrina_HIv1___RNAseq.g27878.t1,three_way,84.152,FUN_035262-T1,Q9CR96,,,,,51.1,139.0,5.5e-31,135.6,sp|Q9CR96|TM208_MOUSE Transmembrane protein 208 OS=Mus musculus OX=10090 GN=Tmem208 PE=2 SV=1,,,,,,
OG_07886,FUN_035264-T1,Peve_00032651,Pocillopora_meandrina_HIv1___RNAseq.g27869.t1,three_way,80.32,FUN_035264-T1,Q16698,,,,,64.3,319.0,1.4e-110,401.0,"sp|Q16698|DECR_HUMAN 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial OS=Homo sapiens OX=9606 GN=DECR1 PE=1 SV=1",,,,,,
OG_07887,FUN_035265-T1,Peve_00032654,Pocillopora_meandrina_HIv1___RNAseq.g27870.t1,three_way,70.16533333333334,FUN_035265-T1,Q2LKW6,NL1B1_MOUSE,,"NACHT, LRR and PYD domains-containing protein 1b allele 1 (EC 3.4.-.-) [Cleaved into: NACHT, LRR and PYD domains-containing protein 1b, C-terminus (Nlrp1b1-CT); NACHT, LRR and PYD domains-containing protein 1b, N-terminus (Nlrp1b1-NT)]",Mus musculus (Mouse),24.6,346.0,2.5e-09,65.9,"sp|Q2LKW6|NL1B1_MOUSE NACHT, LRR and PYD domains-containing protein 1b allele 1 OS=Mus musculus OX=10090 GN=Nlrp1b PE=1 SV=1",GO:0002221; GO:0005524; GO:0005737; GO:0006508; GO:0008233; GO:0012501; GO:0016020; GO:0030163; GO:0032731; GO:0042981; GO:0045087; GO:0050729; GO:0070269; GO:0072558,innate immune response [GO:0045087]; pattern recognition receptor signaling pathway [GO:0002221]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; programmed cell death [GO:0012501]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; pyroptotic inflammatory response [GO:0070269]; regulation of apoptotic process [GO:0042981],cytoplasm [GO:0005737]; membrane [GO:0016020]; NLRP1 inflammasome complex [GO:0072558],ATP binding [GO:0005524]; peptidase activity [GO:0008233],GO:0002376; GO:0003824; GO:0006954; GO:0012501; GO:0016787; GO:0030163; GO:0098542; GO:0140096,"immune system process; catalytic activity; inflammatory response; programmed cell death; hydrolase activity; protein catabolic process; defense response to other organism; catalytic activity, acting on a protein"
OG_07888,FUN_035266-T1,Peve_00032638,Pocillopora_meandrina_HIv1___RNAseq.g27875.t1,three_way,78.45100000000001,FUN_035266-T1,Q5R9K8,AR2BP_PONAB,,ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),59.0,134.0,6.6e-42,171.8,sp|Q5R9K8|AR2BP_PONAB ADP-ribosylation factor-like protein 2-binding protein OS=Pongo abelii OX=9601 GN=ARL2BP PE=2 SV=1,GO:0003713; GO:0005654; GO:0005758; GO:0005813; GO:0005819; GO:0005829; GO:0030496; GO:0036064; GO:0042531; GO:0051457,maintenance of protein location in nucleus [GO:0051457]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrial intermembrane space [GO:0005758]; nucleoplasm [GO:0005654]; spindle [GO:0005819],transcription coactivator activity [GO:0003713],GO:0005654; GO:0005815; GO:0005829; GO:0043226; GO:0060090; GO:0140110,nucleoplasm; microtubule organizing center; cytosol; organelle; molecular adaptor activity; transcription regulator activity
OG_07889,FUN_035267-T1,Peve_00032639,Pocillopora_meandrina_HIv1___RNAseq.g27876.t1,three_way,69.10499999999999,FUN_035267-T1,Q4R7K1,MCES_MACFA,,mRNA cap guanine-N(7) methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7))-methyltransferase) (mRNA cap methyltransferase),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),55.7,334.0,8e-103,375.9,sp|Q4R7K1|MCES_MACFA mRNA cap guanine-N(7) methyltransferase OS=Macaca fascicularis OX=9541 GN=RNMT PE=2 SV=1,GO:0003723; GO:0004482; GO:0005634; GO:0006370; GO:0160130,7-methylguanosine mRNA capping [GO:0006370],mRNA cap methyltransferase RNMT:RAMAC complex [GO:0160130]; nucleus [GO:0005634],mRNA 5'-cap (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_07890,FUN_035269-T1,Peve_00029229,Pocillopora_meandrina_HIv1___RNAseq.g27867.t1,three_way,75.15266666666666,FUN_035269-T1,Q9NUD7,,,,,23.3,356.0,2.7e-12,74.7,sp|Q9NUD7|CT096_HUMAN Uncharacterized protein C20orf96 OS=Homo sapiens OX=9606 GN=C20orf96 PE=1 SV=2,,,,,,
OG_07891,FUN_035270-T1,Peve_00029230,Pocillopora_meandrina_HIv1___RNAseq.g27866.t1,three_way,78.87733333333333,FUN_035270-T1,Q32KJ8,ARSI_RAT,,Arylsulfatase I (ASI) (EC 3.1.6.-),Rattus norvegicus (Rat),53.0,485.0,1.4e-154,547.7,sp|Q32KJ8|ARSI_RAT Arylsulfatase I OS=Rattus norvegicus OX=10116 GN=Arsi PE=2 SV=1,GO:0005576; GO:0005783; GO:0008484; GO:0046872,,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484],GO:0003824; GO:0005576; GO:0005783; GO:0016787; GO:0043226,catalytic activity; extracellular region; endoplasmic reticulum; hydrolase activity; organelle
OG_07892,FUN_035271-T1,Peve_00011446,Pocillopora_meandrina_HIv1___RNAseq.g27865.t1,three_way,85.66933333333333,FUN_035271-T1,P57709,AT2C1_BOVIN,,Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 7.2.2.10) (ATP-dependent Ca(2+) pump PMR1) (Ca(2+)/Mn(2+)-ATPase 2C1) (Secretory pathway Ca(2+)-transporting ATPase type 1) (SPCA1),Bos taurus (Bovine),63.0,698.0,9e-245,847.8,sp|P57709|AT2C1_BOVIN Calcium-transporting ATPase type 2C member 1 OS=Bos taurus OX=9913 GN=ATP2C1 PE=2 SV=1,GO:0000139; GO:0005388; GO:0005509; GO:0005524; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006816; GO:0006828; GO:0006874; GO:0008544; GO:0016339; GO:0016887; GO:0030026; GO:0030036; GO:0030145; GO:0032468; GO:0032472; GO:0032580; GO:0033106; GO:0042998; GO:0043123; GO:0070588; GO:0098629; GO:0140613,actin cytoskeleton organization [GO:0030036]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; intracellular calcium ion homeostasis [GO:0006874]; intracellular manganese ion homeostasis [GO:0030026]; manganese ion transport [GO:0006828]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of Golgi to plasma membrane protein transport [GO:0042998]; trans-Golgi network membrane organization [GO:0098629],cis-Golgi network membrane [GO:0033106]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; P-type calcium transporter activity [GO:0005388]; P-type manganese transporter activity [GO:0140613],GO:0003824; GO:0005215; GO:0005783; GO:0005794; GO:0005886; GO:0007010; GO:0007155; GO:0016787; GO:0043226; GO:0048856; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; endoplasmic reticulum; Golgi apparatus; plasma membrane; cytoskeleton organization; cell adhesion; hydrolase activity; organelle; anatomical structure development; transmembrane transport; membrane organization; ATP-dependent activity
OG_07893,FUN_035272-T1,Peve_00044991,Pocillopora_meandrina_HIv1___RNAseq.g27864.t1,three_way,73.48066666666666,FUN_035272-T1,Q6NRC9,,,,,41.0,1022.0,1.9e-99,365.5,sp|Q6NRC9|LRCC1_XENLA Leucine-rich repeat and coiled-coil domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=lrrcc1 PE=2 SV=1,,,,,,
OG_07894,FUN_035273-T1,Peve_00044990,Pocillopora_meandrina_HIv1___RNAseq.g27863.t1,three_way,88.18650000000001,FUN_035273-T1,O75351,VPS4B_HUMAN,,Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1),Homo sapiens (Human),76.4,437.0,5.299999999999999e-171,602.1,sp|O75351|VPS4B_HUMAN Vacuolar protein sorting-associated protein 4B OS=Homo sapiens OX=9606 GN=VPS4B PE=1 SV=2,GO:0000922; GO:0001525; GO:0001778; GO:0005524; GO:0005634; GO:0005643; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006813; GO:0006914; GO:0006997; GO:0007033; GO:0007080; GO:0010008; GO:0010824; GO:0010971; GO:0015031; GO:0016197; GO:0016236; GO:0016887; GO:0030301; GO:0030496; GO:0031468; GO:0031902; GO:0032510; GO:0033993; GO:0036258; GO:0039702; GO:0042802; GO:0042803; GO:0043162; GO:0044877; GO:0046761; GO:0051261; GO:0060070; GO:0060856; GO:0061738; GO:0061764; GO:0061952; GO:0070062; GO:0071985; GO:0090148; GO:0090543; GO:0090611; GO:0097352; GO:1901673; GO:1903542; GO:1903543; GO:1903724; GO:1904903; GO:1904949,angiogenesis [GO:0001525]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; canonical Wnt signaling pathway [GO:0060070]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ESCRT III complex disassembly [GO:1904903]; establishment of blood-brain barrier [GO:0060856]; late endosomal microautophagy [GO:0061738]; late endosome to lysosome transport via multivesicular body sorting pathway [GO:0061764]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; negative regulation of exosomal secretion [GO:1903542]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],ATPase complex [GO:1904949]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0006914; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0061024,catalytic activity; nucleus; endosome; microtubule organizing center; cytosol; plasma membrane; autophagy; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; membrane organization
OG_07895,FUN_035274-T1,Peve_00044989,Pocillopora_meandrina_HIv1___RNAseq.g27861.t1,three_way,96.17166666666668,FUN_035274-T1,Q6PGV1,VA0D1_DANRE,,V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (Vacuolar proton pump subunit d 1),Danio rerio (Zebrafish) (Brachydanio rerio),80.6,350.0,8.699999999999999e-172,604.4,sp|Q6PGV1|VA0D1_DANRE V-type proton ATPase subunit d 1 OS=Danio rerio OX=7955 GN=atp6v0d1 PE=1 SV=1,GO:0001947; GO:0003406; GO:0005765; GO:0005769; GO:0006879; GO:0007034; GO:0007035; GO:0008057; GO:0016471; GO:0032438; GO:0033179; GO:0033181; GO:0035675; GO:0036295; GO:0039022; GO:0045176; GO:0046688; GO:0046961; GO:0060041; GO:0060271; GO:0070986,apical protein localization [GO:0045176]; cellular response to increased oxygen levels [GO:0036295]; cilium assembly [GO:0060271]; eye pigment granule organization [GO:0008057]; heart looping [GO:0001947]; intracellular iron ion homeostasis [GO:0006879]; left/right axis specification [GO:0070986]; melanosome organization [GO:0032438]; neuromast hair cell development [GO:0035675]; pronephric duct development [GO:0039022]; response to copper ion [GO:0046688]; retina development in camera-type eye [GO:0060041]; retinal pigment epithelium development [GO:0003406]; vacuolar acidification [GO:0007035]; vacuolar transport [GO:0007034],"early endosome [GO:0005769]; lysosomal membrane [GO:0005765]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting V-type ATPase, V0 domain [GO:0033179]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]","proton-transporting ATPase activity, rotational mechanism [GO:0046961]",GO:0005215; GO:0005768; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0140657,transporter activity; endosome; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; ATP-dependent activity
OG_07896,FUN_035275-T1,Peve_00044988,Pocillopora_meandrina_HIv1___RNAseq.g27860.t1,three_way,93.55466666666666,FUN_035275-T1,Q9D600,,,,,59.8,179.0,7.3e-58,224.9,sp|Q9D600|PSF2_MOUSE DNA replication complex GINS protein PSF2 OS=Mus musculus OX=10090 GN=Gins2 PE=1 SV=1,,,,,,
OG_07897,FUN_035276-T1,Peve_00044995,Pocillopora_meandrina_HIv1___RNAseq.g27859.t1,three_way,66.694,,,,,,,,,,,,,,,,,
OG_07898,FUN_035279-T1,Peve_00001128,Pocillopora_meandrina_HIv1___RNAseq.g10444.t1,three_way,76.0005,FUN_035279-T1,Q9Z2W0,,,,,60.3,441.0,8.4e-151,535.0,sp|Q9Z2W0|DNPEP_MOUSE Aspartyl aminopeptidase OS=Mus musculus OX=10090 GN=Dnpep PE=1 SV=2,,,,,,
OG_07899,FUN_035293-T1,Peve_00008867,Pocillopora_meandrina_HIv1___RNAseq.g10157.t1,three_way,74.44466666666666,FUN_035293-T1,A0A3M6TIF0,,,,,66.0,426.0,1.7e-166,587.0,sp|A0A3M6TIF0|CGLR_POCDA Cyclic GMP-AMP synthase-like receptor OS=Pocillopora damicornis OX=46731 GN=cGLR PE=1 SV=1,,,,,,
OG_07900,FUN_035333-T1,Peve_00029728,Pocillopora_meandrina_HIv1___RNAseq.g12269.t1,three_way,60.7565,,,,,,,,,,,,,,,,,
OG_07901,FUN_035334-T1,Peve_00029726,Pocillopora_meandrina_HIv1___RNAseq.g12268.t1,three_way,71.4505,FUN_035334-T1,Q91175,,,,,33.0,345.0,9.8e-39,162.5,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_07902,FUN_035339-T1,Peve_00029658,Pocillopora_meandrina_HIv1___RNAseq.g12265.t1,three_way,70.72233333333334,FUN_035339-T1,B7ZBB8,PP13G_HUMAN,,Protein phosphatase 1 regulatory subunit 3G,Homo sapiens (Human),28.0,225.0,2e-09,64.3,sp|B7ZBB8|PP13G_HUMAN Protein phosphatase 1 regulatory subunit 3G OS=Homo sapiens OX=9606 GN=PPP1R3G PE=1 SV=1,GO:0000164; GO:0005978; GO:0005979; GO:0008157; GO:0042593; GO:0045725; GO:2001069,glucose homeostasis [GO:0042593]; glycogen biosynthetic process [GO:0005978]; positive regulation of glycogen biosynthetic process [GO:0045725]; regulation of glycogen biosynthetic process [GO:0005979],protein phosphatase type 1 complex [GO:0000164],glycogen binding [GO:2001069]; protein phosphatase 1 binding [GO:0008157],GO:0005975; GO:0006091,carbohydrate metabolic process; generation of precursor metabolites and energy
OG_07903,FUN_035340-T1,Peve_00029660,Pocillopora_meandrina_HIv1___RNAseq.g12264.t1,three_way,78.014,FUN_035340-T1,Q9VVY3,,,,,41.0,183.0,8.4e-24,112.1,sp|Q9VVY3|GBS76_DROME Glycogen-binding subunit 76A OS=Drosophila melanogaster OX=7227 GN=Gbs-76A PE=1 SV=1,,,,,,
OG_07904,FUN_035341-T1,Peve_00029661,Pocillopora_meandrina_HIv1___TS.g3597.t1,three_way,81.158,FUN_035341-T1,Q3URV1,BROMI_MOUSE,,Protein broad-minded (TBC1 domain family member 32),Mus musculus (Mouse),41.3,269.0,9.2e-49,195.3,sp|Q3URV1|BROMI_MOUSE Protein broad-minded OS=Mus musculus OX=10090 GN=Tbc1d32 PE=1 SV=2,GO:0001822; GO:0002088; GO:0003406; GO:0005737; GO:0005929; GO:0007224; GO:0007368; GO:0007507; GO:0021532; GO:0021915; GO:0035082; GO:0042733; GO:0043010; GO:0060021; GO:0060041; GO:0060271; GO:0060831; GO:0061512; GO:1905515,axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; neural tube development [GO:0021915]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retina development in camera-type eye [GO:0060041]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005929; GO:0007010; GO:0043226; GO:0044782; GO:0048856,cilium; cytoskeleton organization; organelle; cilium organization; anatomical structure development
OG_07905,FUN_035346-T1,Peve_00036057,Pocillopora_meandrina_HIv1___RNAseq.g12858.t1,three_way,36.35866666666666,,,,,,,,,,,,,,,,,
OG_07906,FUN_035349-T1,Peve_00032934,Pocillopora_meandrina_HIv1___RNAseq.g12261.t1,three_way,88.37633333333333,FUN_035349-T1,P11387,TOP1_HUMAN,,DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I),Homo sapiens (Human),67.5,511.0,6.8e-202,704.9,sp|P11387|TOP1_HUMAN DNA topoisomerase 1 OS=Homo sapiens OX=9606 GN=TOP1 PE=1 SV=2,GO:0000932; GO:0000978; GO:0001650; GO:0001651; GO:0001673; GO:0003677; GO:0003682; GO:0003690; GO:0003697; GO:0003723; GO:0003917; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006265; GO:0006338; GO:0007059; GO:0007623; GO:0008301; GO:0009266; GO:0009303; GO:0009410; GO:0010332; GO:0012501; GO:0018105; GO:0019904; GO:0031100; GO:0031490; GO:0032922; GO:0032993; GO:0040016; GO:0043204; GO:0044877; GO:0051591; GO:0071373; GO:0097100,animal organ regeneration [GO:0031100]; cellular response to luteinizing hormone stimulus [GO:0071373]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; programmed cell death [GO:0012501]; response to cAMP [GO:0051591]; response to gamma radiation [GO:0010332]; response to temperature stimulus [GO:0009266]; response to xenobiotic stimulus [GO:0009410]; rRNA transcription [GO:0009303],chromosome [GO:0005694]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993],"ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006260; GO:0006325; GO:0006351; GO:0007059; GO:0012501; GO:0016740; GO:0016853; GO:0043226; GO:0048856; GO:0140096; GO:0140097,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA replication; chromatin organization; DNA-templated transcription; chromosome segregation; programmed cell death; transferase activity; isomerase activity; organelle; anatomical structure development; catalytic activity, acting on a protein; catalytic activity, acting on DNA"
OG_07907,FUN_035351-T1,Peve_00016239,Pocillopora_meandrina_HIv1___RNAseq.g12260.t1,three_way,72.70233333333333,FUN_035351-T1,Q6XPZ3,PAG15_CANLF,,Lysosomal phospholipase A and acyltransferase (EC 2.3.1.-) (EC 3.1.1.32) (EC 3.1.1.4) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (EC 3.1.1.5) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2) (Phospholipase A2 group XV),Canis lupus familiaris (Dog) (Canis familiaris),40.4,394.0,2.4e-82,307.4,sp|Q6XPZ3|PAG15_CANLF Lysosomal phospholipase A and acyltransferase OS=Canis lupus familiaris OX=9615 GN=PLA2G15 PE=1 SV=1,GO:0004622; GO:0005615; GO:0005654; GO:0005764; GO:0006631; GO:0006650; GO:0006651; GO:0006658; GO:0006672; GO:0008270; GO:0008374; GO:0008970; GO:0016020; GO:0016411; GO:0034638; GO:0046338; GO:0046470; GO:0046471; GO:0047499,ceramide metabolic process [GO:0006672]; diacylglycerol biosynthetic process [GO:0006651]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine catabolic process [GO:0046338]; phosphatidylglycerol metabolic process [GO:0046471]; phosphatidylserine metabolic process [GO:0006658],extracellular space [GO:0005615]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654],acylglycerol O-acyltransferase activity [GO:0016411]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipase A1 activity [GO:0008970]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005654; GO:0005764; GO:0005773; GO:0006575; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; extracellular space; nucleoplasm; lysosome; vacuole; modified amino acid metabolic process; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_07908,FUN_035360-T1,Peve_00016223,Pocillopora_meandrina_HIv1___RNAseq.g12230.t1,three_way,43.8945,FUN_035360-T1,Q8CAS9,,,,,41.1,163.0,2.7e-25,118.6,sp|Q8CAS9|PARP9_MOUSE Protein mono-ADP-ribosyltransferase PARP9 OS=Mus musculus OX=10090 GN=Parp9 PE=1 SV=2,,,,,,
OG_07909,FUN_035364-T1,Peve_00016221,Pocillopora_meandrina_HIv1___RNAseq.g12229.t1,three_way,77.99666666666667,FUN_035364-T1,P49288,,,,,27.5,298.0,7.8e-29,129.4,sp|P49288|MTR1C_CHICK Melatonin receptor type 1C OS=Gallus gallus OX=9031 PE=2 SV=1,,,,,,
OG_07910,FUN_035368-T1,Peve_00016220,Pocillopora_meandrina_HIv1___TS.g3560.t1,three_way,68.399,FUN_035368-T1,P10611,,,,,35.0,451.0,5.5e-78,293.1,sp|P10611|CP4A4_RABIT Cytochrome P450 4A4 OS=Oryctolagus cuniculus OX=9986 GN=CYP4A4 PE=1 SV=3,,,,,,
OG_07911,FUN_035369-T1,Peve_00016219,Pocillopora_meandrina_HIv1___TS.g3559.t1,three_way,73.006,FUN_035369-T1,Q5ZIJ9,,,,,36.0,100.0,7e-11,70.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_07912,FUN_035371-T1,Peve_00016216,Pocillopora_meandrina_HIv1___RNAseq.g12225.t1,three_way,67.83666666666667,,,,,,,,,,,,,,,,,
OG_07913,FUN_035378-T1,Peve_00016215,Pocillopora_meandrina_HIv1___RNAseq.g12217.t1,three_way,76.479,FUN_035378-T1,O60675,MAFK_HUMAN,,Transcription factor MafK (Erythroid transcription factor NF-E2 p18 subunit),Homo sapiens (Human),47.4,57.0,2.3e-06,54.7,sp|O60675|MAFK_HUMAN Transcription factor MafK OS=Homo sapiens OX=9606 GN=MAFK PE=1 SV=1,GO:0000122; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0005654; GO:0006357; GO:0043565; GO:0090575,negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07914,FUN_035393-T1,Peve_00005174,Pocillopora_meandrina_HIv1___RNAseq.g12212.t1,three_way,60.65866666666667,,,,,,,,,,,,,,,,,
OG_07915,FUN_035395-T1,Peve_00005179,Pocillopora_meandrina_HIv1___RNAseq.g12211.t1,three_way,45.61,,,,,,,,,,,,,,,,,
OG_07916,FUN_035397-T1,Peve_00005178,Pocillopora_meandrina_HIv1___RNAseq.g12210.t1,three_way,59.64666666666667,,,,,,,,,,,,,,,,,
OG_07917,FUN_035401-T1,Peve_00002636,Pocillopora_meandrina_HIv1___TS.g3525.t1,three_way,60.43566666666666,FUN_035401-T1,Q8R0N9,ZDHC1_MOUSE,,Palmitoyltransferase ZDHHC1 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 1),Mus musculus (Mouse),49.4,267.0,2.7e-41,171.4,sp|Q8R0N9|ZDHC1_MOUSE Palmitoyltransferase ZDHHC1 OS=Mus musculus OX=10090 GN=Zdhhc1 PE=1 SV=2,GO:0002230; GO:0005789; GO:0005794; GO:0010008; GO:0016409; GO:0018230; GO:0019706; GO:0032461; GO:0140374; GO:1900227; GO:1905668,antiviral innate immune response [GO:0140374]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of protein localization to endosome [GO:1905668]; positive regulation of protein oligomerization [GO:0032461],endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0002376; GO:0003824; GO:0005794; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; Golgi apparatus; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_07918,FUN_035403-T1,Peve_00002640,Pocillopora_meandrina_HIv1___TS.g3526.t1,three_way,88.887,,,,,,,,,,,,,,,,,
OG_07919,FUN_035404-T1,Peve_00002644,Pocillopora_meandrina_HIv1___TS.g3527.t2,three_way,68.768,FUN_035404-T1,Q9WYX8,,,,,49.4,172.0,3.9e-43,176.4,sp|Q9WYX8|Y508_THEMA Uncharacterized protein TM_0508 OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=TM_0508 PE=3 SV=1,,,,,,
OG_07920,FUN_035405-T1,Peve_00002645,Pocillopora_meandrina_HIv1___RNAseq.g12189.t1,three_way,73.37433333333333,,,,,,,,,,,,,,,,,
OG_07921,FUN_035406-T1,Peve_00002646,Pocillopora_meandrina_HIv1___TS.g3529.t1,three_way,75.06933333333333,FUN_035406-T1,O43312,,,,,48.1,239.0,4.2e-60,234.2,sp|O43312|MTSS1_HUMAN Protein MTSS 1 OS=Homo sapiens OX=9606 GN=MTSS1 PE=1 SV=2,,,,,,
OG_07922,FUN_035408-T1,Peve_00018729,Pocillopora_meandrina_HIv1___RNAseq.g12195.t1,three_way,79.51133333333334,FUN_035408-T1,Q9Y3D0,CIA2B_HUMAN,,Cytosolic iron-sulfur assembly component 2B (MSS19-interacting protein of 18 kDa) (Mitotic spindle-associated MMXD complex subunit MIP18) (Protein FAM96B),Homo sapiens (Human),67.0,106.0,4.8e-33,144.1,sp|Q9Y3D0|CIA2B_HUMAN Cytosolic iron-sulfur assembly component 2B OS=Homo sapiens OX=9606 GN=CIAO2B PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0007059; GO:0030496; GO:0051604; GO:0071817; GO:0097361,chromosome segregation [GO:0007059]; protein maturation [GO:0051604],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic [4Fe-4S] assembly targeting complex [GO:0097361]; midbody [GO:0030496]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],,GO:0005634; GO:0005654; GO:0005829; GO:0007059; GO:0043226; GO:0051604,nucleus; nucleoplasm; cytosol; chromosome segregation; organelle; protein maturation
OG_07923,FUN_035409-T1,Peve_00039846,Pocillopora_meandrina_HIv1___RNAseq.g12196.t1,three_way,78.21966666666667,FUN_035409-T1,A2RT91,,,,,34.3,306.0,3.9e-42,174.9,sp|A2RT91|ANKAR_MOUSE Ankyrin and armadillo repeat-containing protein OS=Mus musculus OX=10090 GN=Ankar PE=2 SV=1,,,,,,
OG_07924,FUN_035411-T1,Peve_00039845,Pocillopora_meandrina_HIv1___RNAseq.g12198.t1,three_way,59.06466666666667,FUN_035411-T1,Q91175,,,,,25.6,328.0,2.6e-13,77.8,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_07925,FUN_035413-T1,Peve_00039843,Pocillopora_meandrina_HIv1___RNAseq.g27561.t1,three_way,72.32216666666666,FUN_035413-T1,Q9BVG8,,,,,62.9,383.0,8.400000000000001e-134,479.6,sp|Q9BVG8|KIFC3_HUMAN Kinesin-like protein KIFC3 OS=Homo sapiens OX=9606 GN=KIFC3 PE=1 SV=4,,,,,,
OG_07926,FUN_035414-T1,Peve_00039842,Pocillopora_meandrina_HIv1___RNAseq.g27562.t1,three_way,52.20816666666667,FUN_035414-T1,Q3SYV3,,,,,36.0,372.0,9.2e-58,226.1,sp|Q3SYV3|OXA1L_BOVIN Mitochondrial inner membrane protein OXA1L OS=Bos taurus OX=9913 GN=OXA1L PE=2 SV=1,,,,,,
OG_07927,FUN_035416-T1,Peve_00039836,Pocillopora_meandrina_HIv1___RNAseq.g27563.t1,three_way,75.12766666666667,,,,,,,,,,,,,,,,,
OG_07928,FUN_035417-T1,Peve_00039835,Pocillopora_meandrina_HIv1___RNAseq.10682_t,three_way,65.99,,,,,,,,,,,,,,,,,
OG_07929,FUN_035418-T1,Peve_00039851,Pocillopora_meandrina_HIv1___RNAseq.g27566.t1,three_way,69.55066666666667,FUN_035418-T1,B8AJ09,,,,,28.2,312.0,1.7e-16,88.6,"sp|B8AJ09|BASS4_ORYSI Probable sodium/metabolite cotransporter BASS4, chloroplastic OS=Oryza sativa subsp. indica OX=39946 GN=BASS4 PE=3 SV=1",,,,,,
OG_07930,FUN_035419-T1,Peve_00039850,Pocillopora_meandrina_HIv1___RNAseq.g27568.t1,three_way,74.39466666666667,FUN_035419-T1,Q54S12,,,,,36.3,485.0,5.1e-68,260.0,sp|Q54S12|TM104_DICDI Transmembrane protein 104 homolog OS=Dictyostelium discoideum OX=44689 GN=tmem104 PE=3 SV=1,,,,,,
OG_07931,FUN_035420-T1,Peve_00039844,Pocillopora_meandrina_HIv1___RNAseq.g27569.t2,three_way,58.379,FUN_035420-T1,O04469,,,,,30.5,203.0,1.1e-19,98.6,"sp|O04469|ECI1_ARATH Enoyl-CoA delta isomerase 1, peroxisomal OS=Arabidopsis thaliana OX=3702 GN=ECI1 PE=1 SV=1",,,,,,
OG_07932,FUN_035422-T1,Peve_00007637,Pocillopora_meandrina_HIv1___RNAseq.g27570.t1,three_way,46.10816666666667,,,,,,,,,,,,,,,,,
OG_07933,FUN_035426-T1,Peve_00007639,Pocillopora_meandrina_HIv1___RNAseq.g27573.t1,three_way,42.896,,,,,,,,,,,,,,,,,
OG_07934,FUN_035428-T1,Peve_00007632,Pocillopora_meandrina_HIv1___RNAseq.g27576.t1,three_way,53.50966666666667,,,,,,,,,,,,,,,,,
OG_07935,FUN_035439-T1,Peve_00037156,Pocillopora_meandrina_HIv1___RNAseq.g27578.t1,three_way,43.833333333333336,,,,,,,,,,,,,,,,,
OG_07936,FUN_035441-T1,Peve_00002177,Pocillopora_meandrina_HIv1___RNAseq.g27112.t1,three_way,63.269666666666666,FUN_035441-T1,Q5NA18,,,,,39.6,333.0,4.3e-58,226.9,sp|Q5NA18|MTP5_ORYSJ Metal tolerance protein 5 OS=Oryza sativa subsp. japonica OX=39947 GN=MTP5 PE=2 SV=1,,,,,,
OG_07937,FUN_035443-T1,Peve_00002173,Pocillopora_meandrina_HIv1___RNAseq.g9412.t1,three_way,74.024,,,,,,,,,,,,,,,,,
OG_07938,FUN_035444-T1,Peve_00002174,Pocillopora_meandrina_HIv1___RNAseq.g27111.t1,three_way,85.51933333333334,FUN_035444-T1,Q8BZZ3,WWP1_MOUSE,,NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase WWP1) (WW domain-containing protein 1),Mus musculus (Mouse),57.0,910.0,8.499999999999999e-234,811.6,sp|Q8BZZ3|WWP1_MOUSE NEDD4-like E3 ubiquitin-protein ligase WWP1 OS=Mus musculus OX=10090 GN=Wwp1 PE=1 SV=2,GO:0004842; GO:0005634; GO:0005829; GO:0005886; GO:0016567; GO:0030217; GO:0030324; GO:0043161; GO:0045892; GO:0061630; GO:0070161,lung development [GO:0030324]; negative regulation of DNA-templated transcription [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217],anchoring junction [GO:0070161]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07939,FUN_035448-T1,Peve_00012114,Pocillopora_meandrina_HIv1___TS.g14403.t1,three_way,63.81366666666667,,,,,,,,,,,,,,,,,
OG_07940,FUN_035449-T1,Peve_00012113,Pocillopora_meandrina_HIv1___RNAseq.g26981.t2,three_way,76.47,FUN_035449-T1,Q8MYF0,,,,,45.2,217.0,8.4e-49,195.3,sp|Q8MYF0|MG101_DICDI Mitochondrial genome maintenance protein mgm101 homolog OS=Dictyostelium discoideum OX=44689 GN=mgm101 PE=3 SV=1,,,,,,
OG_07941,FUN_035450-T2,Peve_00001658,Pocillopora_meandrina_HIv1___RNAseq.g25308.t1,three_way,52.35066666666667,FUN_035450-T2,A2BGU9,,,,,34.3,303.0,9.8e-42,172.2,sp|A2BGU9|SERHL_DANRE Serine hydrolase-like protein OS=Danio rerio OX=7955 GN=serhl PE=2 SV=1,,,,,,
OG_07942,FUN_035456-T1,Peve_00012138,Pocillopora_meandrina_HIv1___RNAseq.g26976.t1,three_way,62.52466666666667,FUN_035456-T1,F4KGU4,,,,,33.2,1498.0,1.7e-214,748.4,"sp|F4KGU4|DEAHC_ARATH ATP-dependent RNA helicase DEAH12, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=At5g10370 PE=3 SV=1",,,,,,
OG_07943,FUN_035457-T1,Peve_00012137,Pocillopora_meandrina_HIv1___TS.g14393.t2,three_way,86.11866666666667,FUN_035457-T1,Q8BYM7,RSH4A_MOUSE,,Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3),Mus musculus (Mouse),55.7,474.0,5.5e-114,412.9,sp|Q8BYM7|RSH4A_MOUSE Radial spoke head protein 4 homolog A OS=Mus musculus OX=10090 GN=Rsph4a PE=1 SV=2,GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005930; GO:0051649; GO:0060294; GO:0062177; GO:0097729; GO:0120221; GO:0120336; GO:0120337; GO:0120338,cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; maintenance of ciliary planar beating movement pattern [GO:0120221]; radial spoke assembly [GO:0062177],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 2 [GO:0120337]; radial spoke head 3 [GO:0120338],,GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0065003,extracellular region; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_07944,FUN_035462-T1,Peve_00012136,Pocillopora_meandrina_HIv1___RNAseq.g27041.t1,three_way,72.29833333333333,FUN_035462-T1,Q9SY73,PTALR_ARATH,,NADPH-dependent pterin aldehyde reductase (EC 1.1.1.-),Arabidopsis thaliana (Mouse-ear cress),45.1,224.0,2e-55,217.2,sp|Q9SY73|PTALR_ARATH NADPH-dependent pterin aldehyde reductase OS=Arabidopsis thaliana OX=3702 GN=At1g10310 PE=1 SV=1,GO:0005829; GO:0006760; GO:0016616,folic acid-containing compound metabolic process [GO:0006760],cytosol [GO:0005829],"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0005829; GO:0006575; GO:0016491,catalytic activity; cytosol; modified amino acid metabolic process; oxidoreductase activity
OG_07945,FUN_035465-T2,Peve_00012135,Pocillopora_meandrina_HIv1___TS.g14389.t1b,three_way,52.7335,FUN_035465-T2,Q0P5K4,TOX4_BOVIN,,TOX high mobility group box family member 4,Bos taurus (Bovine),41.4,58.0,1.9e-06,56.6,sp|Q0P5K4|TOX4_BOVIN TOX high mobility group box family member 4 OS=Bos taurus OX=9913 GN=TOX4 PE=2 SV=1,GO:0001111; GO:0005634; GO:0006357; GO:0031490; GO:0032968; GO:0072357,positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II promoter clearance [GO:0001111],nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357],chromatin DNA binding [GO:0031490],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_07945,FUN_035465-T2,Peve_00012135,Pocillopora_meandrina_HIv1___TS.g14389.t1b,three_way,52.7335,FUN_035465-T2,Q0P5K4,TOX4_BOVIN,,TOX high mobility group box family member 4,Bos taurus (Bovine),39.7,63.0,2.8e-05,52.8,sp|Q0P5K4|TOX4_BOVIN TOX high mobility group box family member 4 OS=Bos taurus OX=9913 GN=TOX4 PE=2 SV=1,GO:0001111; GO:0005634; GO:0006357; GO:0031490; GO:0032968; GO:0072357,positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II promoter clearance [GO:0001111],nucleus [GO:0005634]; PTW/PP1 phosphatase complex [GO:0072357],chromatin DNA binding [GO:0031490],GO:0003677; GO:0005634; GO:0006355; GO:0043226,DNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_07946,FUN_035466-T1,Peve_00012134,Pocillopora_meandrina_HIv1___RNAseq.g11796.t1,three_way,51.17766666666667,FUN_035466-T1,Q9JIL9,NBN_RAT,,Nibrin (Nijmegen breakage syndrome protein 1 homolog),Rattus norvegicus (Rat),26.3,753.0,1.1e-56,223.0,sp|Q9JIL9|NBN_RAT Nibrin OS=Rattus norvegicus OX=10116 GN=Nbn PE=1 SV=2,GO:0000077; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001701; GO:0001832; GO:0003684; GO:0005634; GO:0005657; GO:0005730; GO:0006302; GO:0007095; GO:0007405; GO:0008284; GO:0009410; GO:0016605; GO:0030870; GO:0031848; GO:0031860; GO:0032206; GO:0035861; GO:0042393; GO:0042405; GO:0043247; GO:0043539; GO:0045190; GO:0045665; GO:0046597; GO:0048145; GO:0050885; GO:0051321; GO:0062176; GO:0070533; GO:0090656; GO:0090737; GO:0097193; GO:0097681; GO:0110025; GO:0140031; GO:0140297; GO:0140463; GO:1904354; GO:1990166; GO:2000781,blastocyst growth [GO:0001832]; DNA damage checkpoint signaling [GO:0000077]; DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; host-mediated suppression of symbiont invasion [GO:0046597]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; isotype switching [GO:0045190]; meiotic cell cycle [GO:0051321]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of telomere capping [GO:1904354]; neuroblast proliferation [GO:0007405]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to site of double-strand break [GO:1990166]; R-loop processing [GO:0062176]; regulation of fibroblast proliferation [GO:0048145]; response to xenobiotic stimulus [GO:0009410]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomere maintenance via telomere trimming [GO:0090737]; telomeric 3' overhang formation [GO:0031860],"BRCA1-C complex [GO:0070533]; chromosome, telomeric region [GO:0000781]; Mre11 complex [GO:0030870]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",chromatin-protein adaptor activity [GO:0140463]; damaged DNA binding [GO:0003684]; DNA-binding transcription factor binding [GO:0140297]; histone binding [GO:0042393]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0002376; GO:0003677; GO:0005634; GO:0005730; GO:0006281; GO:0006310; GO:0006325; GO:0022414; GO:0032200; GO:0042393; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0098542; GO:0098772,immune system process; DNA binding; nucleus; nucleolus; DNA repair; DNA recombination; chromatin organization; reproductive process; telomere organization; histone binding; organelle; anatomical structure development; nervous system process; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_07947,FUN_035468-T1,Peve_00012132,Pocillopora_meandrina_HIv1___TS.g14397.t1,three_way,83.6845,FUN_035468-T1,Q8BH04,PCKGM_MOUSE,,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)",Mus musculus (Mouse),65.5,611.0,6.100000000000001e-248,858.2,"sp|Q8BH04|PCKGM_MOUSE Phosphoenolpyruvate carboxykinase [GTP], mitochondrial OS=Mus musculus OX=10090 GN=Pck2 PE=1 SV=1",GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0006090; GO:0006094; GO:0006107; GO:0030145; GO:0032024; GO:0032496; GO:0071333; GO:0071356; GO:0071548,cellular response to glucose stimulus [GO:0071333]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; pyruvate metabolic process [GO:0006090]; response to dexamethasone [GO:0071548]; response to lipopolysaccharide [GO:0032496],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],GTP binding [GO:0005525]; manganese ion binding [GO:0030145]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613],GO:0003824; GO:0005739; GO:0005975; GO:0016829; GO:0043226,catalytic activity; mitochondrion; carbohydrate metabolic process; lyase activity; organelle
OG_07948,FUN_035469-T1,Peve_00012131,Pocillopora_meandrina_HIv1___RNAseq.g27047.t1,three_way,52.6305,FUN_035469-T1,P17706,PTN2_HUMAN,,Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP),Homo sapiens (Human),52.8,307.0,2.0000000000000002e-82,308.1,sp|P17706|PTN2_HUMAN Tyrosine-protein phosphatase non-receptor type 2 OS=Homo sapiens OX=9606 GN=PTPN2 PE=1 SV=2,GO:0000122; GO:0004725; GO:0004726; GO:0005178; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005793; GO:0005829; GO:0005886; GO:0008285; GO:0008286; GO:0010804; GO:0010888; GO:0019901; GO:0019905; GO:0030183; GO:0030217; GO:0030218; GO:0030971; GO:0031904; GO:0035335; GO:0038020; GO:0042059; GO:0042532; GO:0042593; GO:0045650; GO:0045722; GO:0046426; GO:0046627; GO:0050728; GO:0050860; GO:0050922; GO:0060334; GO:0060336; GO:0060339; GO:0070104; GO:0070373; GO:0097677; GO:1902202; GO:1902206; GO:1902215; GO:1902227; GO:1902233; GO:1902237; GO:1903899; GO:2000587,B cell differentiation [GO:0030183]; erythrocyte differentiation [GO:0030218]; glucose homeostasis [GO:0042593]; insulin receptor recycling [GO:0038020]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemotaxis [GO:0050922]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of interleukin-2-mediated signaling pathway [GO:1902206]; negative regulation of interleukin-4-mediated signaling pathway [GO:1902215]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of positive thymic T cell selection [GO:1902233]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of PERK-mediated unfolded protein response [GO:1903899]; regulation of hepatocyte growth factor receptor signaling pathway [GO:1902202]; regulation of type II interferon-mediated signaling pathway [GO:0060334]; T cell differentiation [GO:0030217],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome lumen [GO:0031904]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],integrin binding [GO:0005178]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; STAT family protein binding [GO:0097677]; syntaxin binding [GO:0019905],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; endoplasmic reticulum; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_07949,FUN_035470-T1,Peve_00012129,Pocillopora_meandrina_HIv1___RNAseq.g27049.t1,three_way,76.12633333333333,FUN_035470-T1,Q1JPD3,,,,,62.9,496.0,8.699999999999999e-181,634.8,"sp|Q1JPD3|D2HDH_BOVIN D-2-hydroxyglutarate dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=D2HGDH PE=2 SV=2",,,,,,
OG_07950,FUN_035473-T1,Peve_00033973,Pocillopora_meandrina_HIv1___RNAseq.g26982.t1,three_way,62.86833333333333,FUN_035473-T1,A4ZNR5,NKD2L_DANRE,,Protein naked cuticle homolog 2-like (Naked-2-like) (Protein naked cuticle homolog 2-B) (Naked-2B),Danio rerio (Zebrafish) (Brachydanio rerio),30.5,236.0,1.9e-14,82.0,sp|A4ZNR5|NKD2L_DANRE Protein naked cuticle homolog 2-like OS=Danio rerio OX=7955 GN=nkd2l PE=2 SV=1,GO:0005509; GO:0005737; GO:0005886; GO:0016055; GO:0030178; GO:0090090,negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886,plasma membrane
OG_07951,FUN_035476-T1,Peve_00033971,Pocillopora_meandrina_HIv1___TS.g14334.t1b,three_way,75.7615,FUN_035476-T1,Q58EX7,PKHG4_HUMAN,,Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1),Homo sapiens (Human),31.9,906.0,1.4e-119,433.0,sp|Q58EX7|PKHG4_HUMAN Puratrophin-1 OS=Homo sapiens OX=9606 GN=PLEKHG4 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0005886; GO:0007411; GO:0019898; GO:0051056,axon guidance [GO:0007411]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0098772,cytosol; plasma membrane; molecular function regulator activity
OG_07952,FUN_035478-T1,Peve_00033970,Pocillopora_meandrina_HIv1___TS.g14339.t1,three_way,81.2215,FUN_035478-T1,P08487,,,,,46.2,825.0,3.7e-203,709.9,"sp|P08487|PLCG1_BOVIN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 OS=Bos taurus OX=9913 GN=PLCG1 PE=1 SV=1",,,,,,
OG_07953,FUN_035490-T1,Peve_00033965,Pocillopora_meandrina_HIv1___RNAseq.g26985.t1,three_way,91.537,,,,,,,,,,,,,,,,,
OG_07954,FUN_035494-T1,Peve_00033964,Pocillopora_meandrina_HIv1___RNAseq.g26989.t1,three_way,76.04083333333334,FUN_035494-T1,P52171,,,,,53.8,240.0,1.4e-69,265.4,sp|P52171|IMA1_XENLA Importin subunit alpha-1 OS=Xenopus laevis OX=8355 GN=kpna2 PE=1 SV=2,,,,,,
OG_07955,FUN_035498-T1,Peve_00033959,Pocillopora_meandrina_HIv1___RNAseq.g26992.t1,three_way,53.365833333333335,,,,,,,,,,,,,,,,,
OG_07956,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_07957,FUN_035504-T1,Peve_00039980,Pocillopora_meandrina_HIv1___RNAseq.g26996.t1,three_way,57.49133333333333,FUN_035504-T1,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),39.4,322.0,9.7e-57,223.8,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_07958,FUN_035508-T1,Peve_00039971,Pocillopora_meandrina_HIv1___TS.g14356.t2,three_way,47.306,FUN_035508-T1,Q9V5N8,,,,,34.5,592.0,2.5e-66,256.5,sp|Q9V5N8|STAN_DROME Protocadherin-like wing polarity protein stan OS=Drosophila melanogaster OX=7227 GN=stan PE=1 SV=4,,,,,,
OG_07959,FUN_035511-T1,Peve_00039974,Pocillopora_meandrina_HIv1___RNAseq.g26971.t1,three_way,78.77533333333332,FUN_035511-T1,Q99747,SNAG_HUMAN,,Gamma-soluble NSF attachment protein (SNAP-gamma) (N-ethylmaleimide-sensitive factor attachment protein gamma),Homo sapiens (Human),32.3,331.0,8.6e-28,125.9,sp|Q99747|SNAG_HUMAN Gamma-soluble NSF attachment protein OS=Homo sapiens OX=9606 GN=NAPG PE=1 SV=1,GO:0005483; GO:0005739; GO:0005765; GO:0005794; GO:0006886; GO:0006891; GO:0019905; GO:0031201; GO:0050821; GO:0061025; GO:0065003; GO:0070062,intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; protein stabilization [GO:0050821]; protein-containing complex assembly [GO:0065003],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; SNARE complex [GO:0031201],soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905],GO:0005739; GO:0005794; GO:0006886; GO:0016192; GO:0043226; GO:0060090; GO:0061024; GO:0065003,mitochondrion; Golgi apparatus; intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity; membrane organization; protein-containing complex assembly
OG_07960,FUN_035513-T1,Peve_00039975,Pocillopora_meandrina_HIv1___RNAseq.g26972.t1,three_way,86.628,FUN_035513-T1,Q0P5Y3,TPPP2_MOUSE,,Tubulin polymerization-promoting protein family member 2,Mus musculus (Mouse),45.7,164.0,1.1000000000000002e-28,127.9,sp|Q0P5Y3|TPPP2_MOUSE Tubulin polymerization-promoting protein family member 2 OS=Mus musculus OX=10090 GN=Tppp2 PE=2 SV=1,GO:0005829; GO:0007283; GO:0015631; GO:0030154; GO:0036126; GO:0046785; GO:1901317,cell differentiation [GO:0030154]; microtubule polymerization [GO:0046785]; regulation of flagellated sperm motility [GO:1901317]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; sperm flagellum [GO:0036126],tubulin binding [GO:0015631],GO:0005829; GO:0005929; GO:0007010; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0065003,cytosol; cilium; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; protein-containing complex assembly
OG_07961,FUN_035519-T1,Peve_00007927,Pocillopora_meandrina_HIv1___RNAseq.g26966.t1,three_way,53.88283333333334,FUN_035519-T1,A3KMR8,MAFA_DANRE,,Transcription factor MafAa (Somite Maf1) (SMaf1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,97.0,4.2e-09,63.2,sp|A3KMR8|MAFA_DANRE Transcription factor MafAa OS=Danio rerio OX=7955 GN=mafaa PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0043565,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07962,FUN_035522-T1,Peve_00007931,Pocillopora_meandrina_HIv1___TS.g14310.t1,three_way,48.43233333333333,FUN_035522-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),35.3,363.0,1.6000000000000002e-48,195.7,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_07963,FUN_035524-T1,Peve_00020842,Pocillopora_meandrina_HIv1___RNAseq.g26954.t1,three_way,73.49983333333333,FUN_035524-T1,O54975,XPP1_RAT,,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",Rattus norvegicus (Rat),44.4,626.0,4.6e-150,533.1,sp|O54975|XPP1_RAT Xaa-Pro aminopeptidase 1 OS=Rattus norvegicus OX=10116 GN=Xpnpep1 PE=1 SV=1,GO:0004177; GO:0005737; GO:0005829; GO:0006508; GO:0010815; GO:0030145; GO:0042803; GO:0043069; GO:0070006,bradykinin catabolic process [GO:0010815]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0016787; GO:0140096,"catalytic activity; cytosol; hydrolase activity; catalytic activity, acting on a protein"
OG_07964,FUN_035525-T1,Peve_00020841,Pocillopora_meandrina_HIv1___RNAseq.g27993.t1,three_way,77.325,FUN_035525-T1,Q5ZJX5,MEAK7_CHICK,,MTOR-associated protein MEAK7 (MEAK7) (TBC/LysM-associated domain-containing protein 1) (TLD domain-containing protein 1),Gallus gallus (Chicken),36.1,460.0,2.8e-77,290.8,sp|Q5ZJX5|MEAK7_CHICK MTOR-associated protein MEAK7 OS=Gallus gallus OX=9031 GN=MEAK7 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005765; GO:0006979; GO:0016020; GO:0030334; GO:0031667; GO:0031929; GO:0032868; GO:0042127; GO:0043200; GO:0150032,positive regulation of protein localization to lysosome [GO:0150032]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; response to amino acid [GO:0043200]; response to insulin [GO:0032868]; response to nutrient levels [GO:0031667]; response to oxidative stress [GO:0006979]; TOR signaling [GO:0031929],cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634],,GO:0005634; GO:0043226,nucleus; organelle
OG_07965,FUN_035527-T1,Peve_00021385,Pocillopora_meandrina_HIv1___RNAseq.g27994.t1,three_way,69.53316666666666,FUN_035527-T1,Q28IV8,,,,,39.9,298.0,1.5e-44,181.4,sp|Q28IV8|NGDN_XENTR Neuroguidin OS=Xenopus tropicalis OX=8364 GN=ngdn PE=2 SV=1,,,,,,
OG_07966,FUN_035535-T1,Peve_00021382,Pocillopora_meandrina_HIv1___RNAseq.g27998.t1,three_way,79.72866666666667,,,,,,,,,,,,,,,,,
OG_07967,FUN_035536-T1,Peve_00026593,Pocillopora_meandrina_HIv1___RNAseq.g27999.t1,three_way,59.93233333333333,FUN_035536-T1,Q9N121,,,,,56.3,126.0,8.6e-37,154.8,"sp|Q9N121|GCSH_RABIT Glycine cleavage system H protein, mitochondrial OS=Oryctolagus cuniculus OX=9986 GN=GCSH PE=2 SV=1",,,,,,
OG_07968,FUN_035537-T1,Peve_00026592,Pocillopora_meandrina_HIv1___RNAseq.g28000.t1,three_way,95.7,FUN_035537-T1,Q921M3,,,,,79.5,1222.0,0.0,2003.0,sp|Q921M3|SF3B3_MOUSE Splicing factor 3B subunit 3 OS=Mus musculus OX=10090 GN=Sf3b3 PE=1 SV=1,,,,,,
OG_07969,FUN_035539-T2,Peve_00017701,Pocillopora_meandrina_HIv1___RNAseq.g28001.t1,three_way,78.2765,FUN_035539-T2,Q761V0,SC6A5_MOUSE,,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),Mus musculus (Mouse),47.1,614.0,1.8e-157,557.8,sp|Q761V0|SC6A5_MOUSE Sodium- and chloride-dependent glycine transporter 2 OS=Mus musculus OX=10090 GN=Slc6a5 PE=1 SV=1,GO:0001504; GO:0005886; GO:0015375; GO:0046872; GO:0098690; GO:0098793; GO:0098810,neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504],glycinergic synapse [GO:0098690]; plasma membrane [GO:0005886]; presynapse [GO:0098793],glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_07970,FUN_035540-T1,Peve_00000028,Pocillopora_meandrina_HIv1___RNAseq.g28019.t1,three_way,53.44983333333334,FUN_035540-T1,A3KNJ3,FXI3A_DANRE,,Forkhead box protein I3-A,Danio rerio (Zebrafish) (Brachydanio rerio),34.5,119.0,4.6e-16,86.3,sp|A3KNJ3|FXI3A_DANRE Forkhead box protein I3-A OS=Danio rerio OX=7955 GN=foxi3a PE=2 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0009653; GO:0009913; GO:0009957; GO:0030154; GO:0050891; GO:0062236,anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; epidermal cell differentiation [GO:0009913]; epidermal cell fate specification [GO:0009957]; ionocyte differentiation [GO:0062236]; multicellular organismal-level water homeostasis [GO:0050891]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_07971,FUN_035544-T1,Peve_00036928,Pocillopora_meandrina_HIv1___RNAseq.g28003.t1,three_way,75.86166666666666,FUN_035544-T1,Q9NX74,,,,,52.0,431.0,2.6e-125,450.3,sp|Q9NX74|DUS2_HUMAN tRNA-dihydrouridine(20) synthase [NAD(P)+]-like OS=Homo sapiens OX=9606 GN=DUS2 PE=1 SV=1,,,,,,
OG_07972,FUN_035547-T1,Peve_00036924,Pocillopora_meandrina_HIv1___RNAseq.11135_t,three_way,45.327,,,,,,,,,,,,,,,,,
OG_07973,FUN_035549-T1,Peve_00036920,Pocillopora_meandrina_HIv1___TS.g15362.t1,three_way,72.92433333333334,,,,,,,,,,,,,,,,,
OG_07974,FUN_035551-T1,Peve_00036917,Pocillopora_meandrina_HIv1___TS.g15370.t1,three_way,68.17833333333333,FUN_035551-T1,G3M4F8,,,,,24.3,247.0,9e-11,68.9,sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1,,,,,,
OG_07975,FUN_035552-T1,Peve_00036916,Pocillopora_meandrina_HIv1___RNAseq.g28024.t1,three_way,68.95633333333333,FUN_035552-T1,Q7M767,UB2V2_RAT,,Ubiquitin-conjugating enzyme E2 variant 2 (Ubiquitin-conjugating enzyme variant MMS2),Rattus norvegicus (Rat),69.6,138.0,2.3e-51,203.0,sp|Q7M767|UB2V2_RAT Ubiquitin-conjugating enzyme E2 variant 2 OS=Rattus norvegicus OX=10116 GN=Ube2v2 PE=1 SV=3,GO:0000729; GO:0005634; GO:0006301; GO:0010976; GO:0031371; GO:0031372; GO:0032436; GO:0042275; GO:0043524; GO:0045739; GO:0051965; GO:0070534; GO:1902523; GO:2000781,DNA double-strand break processing [GO:0000729]; error-free postreplication DNA repair [GO:0042275]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; positive regulation of synapse assembly [GO:0051965]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534],nucleus [GO:0005634]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme complex [GO:0031371],,GO:0005634; GO:0006281; GO:0043226,nucleus; DNA repair; organelle
OG_07976,FUN_035554-T2,Peve_00036915,Pocillopora_meandrina_HIv1___TS.g15372.t1,three_way,93.07433333333334,FUN_035554-T2,Q8TE73,DYH5_HUMAN,,Dynein axonemal heavy chain 5 (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5),Homo sapiens (Human),67.4,4652.0,0.0,6165.9,sp|Q8TE73|DYH5_HUMAN Dynein axonemal heavy chain 5 OS=Homo sapiens OX=9606 GN=DNAH5 PE=1 SV=3,GO:0003341; GO:0003351; GO:0005524; GO:0005576; GO:0005737; GO:0005874; GO:0005930; GO:0007368; GO:0007507; GO:0008569; GO:0016887; GO:0021670; GO:0030317; GO:0031514; GO:0036157; GO:0036158; GO:0045505; GO:0051649; GO:0051959; GO:0060271; GO:0060294; GO:0097386; GO:0097728; GO:0097729,cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; outer dynein arm assembly [GO:0036158],9+0 motile cilium [GO:0097728]; 9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; hydrolase activity; isomerase activity; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_07977,FUN_035598-T2,Peve_00027482,Pocillopora_meandrina_HIv1___TS.g15377.t1,three_way,86.6325,FUN_035598-T2,Q92620,PRP16_HUMAN,,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38),Homo sapiens (Human),76.7,951.0,0.0,1411.7,sp|Q92620|PRP16_HUMAN Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 OS=Homo sapiens OX=9606 GN=DHX38 PE=1 SV=2,GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0016020; GO:0016887; GO:0034458; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_07978,FUN_035600-T1,Peve_00027480,Pocillopora_meandrina_HIv1___RNAseq.g28038.t1,three_way,84.73833333333333,FUN_035600-T1,Q9T043,,,,,54.9,133.0,1.4e-32,140.6,sp|Q9T043|RL142_ARATH Large ribosomal subunit protein eL14y OS=Arabidopsis thaliana OX=3702 GN=RPL14B PE=1 SV=1,,,,,,
OG_07979,FUN_035601-T1,Peve_00027479,Pocillopora_meandrina_HIv1___RNAseq.g28039.t1,three_way,66.077,,,,,,,,,,,,,,,,,
OG_07980,FUN_035602-T1,Peve_00027478,Pocillopora_meandrina_HIv1___RNAseq.g28040.t1,three_way,92.946,FUN_035602-T1,O60762,DPM1_HUMAN,,Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1),Homo sapiens (Human),81.5,238.0,3.2999999999999996e-114,412.5,sp|O60762|DPM1_HUMAN Dolichol-phosphate mannosyltransferase subunit 1 OS=Homo sapiens OX=9606 GN=DPM1 PE=1 SV=1,GO:0004169; GO:0004582; GO:0005537; GO:0005634; GO:0005783; GO:0005789; GO:0006488; GO:0006506; GO:0016020; GO:0018279; GO:0019348; GO:0019673; GO:0033185; GO:0035268; GO:0035269; GO:0043178; GO:0046872; GO:0070482; GO:0180047,dolichol metabolic process [GO:0019348]; dolichol phosphate mannose biosynthetic process [GO:0180047]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; GDP-mannose metabolic process [GO:0019673]; GPI anchor biosynthetic process [GO:0006506]; protein mannosylation [GO:0035268]; protein N-linked glycosylation via asparagine [GO:0018279]; protein O-linked mannosylation [GO:0035269]; response to oxygen levels [GO:0070482],dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nucleus [GO:0005634],alcohol binding [GO:0043178]; D-mannose binding [GO:0005537]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0005783; GO:0006629; GO:0009101; GO:0016740; GO:0043226; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; nucleus; endoplasmic reticulum; lipid metabolic process; glycoprotein biosynthetic process; transferase activity; organelle; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_07981,FUN_035603-T1,Peve_00027476,Pocillopora_meandrina_HIv1___RNAseq.g28041.t1,three_way,72.97933333333333,FUN_035603-T1,Q92556,ELMO1_HUMAN,,Engulfment and cell motility protein 1 (Protein ced-12 homolog),Homo sapiens (Human),43.4,726.0,1.6e-169,597.8,sp|Q92556|ELMO1_HUMAN Engulfment and cell motility protein 1 OS=Homo sapiens OX=9606 GN=ELMO1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870; GO:0098794; GO:0098978; GO:0150052,"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],SH3 domain binding [GO:0017124],GO:0005829; GO:0005886; GO:0007010; GO:0012501; GO:0048870; GO:0061024,cytosol; plasma membrane; cytoskeleton organization; programmed cell death; cell motility; membrane organization
OG_07982,FUN_035607-T2,Peve_00025644,Pocillopora_meandrina_HIv1___RNAseq.g28044.t1,three_way,64.08733333333333,,,,,,,,,,,,,,,,,
OG_07983,FUN_035608-T1,Peve_00031575,Pocillopora_meandrina_HIv1___RNAseq.g28045.t1,three_way,61.36366666666667,,,,,,,,,,,,,,,,,
OG_07984,FUN_035609-T1,Peve_00025646,Pocillopora_meandrina_HIv1___RNAseq.g28046.t1a,three_way,55.686166666666665,FUN_035609-T1,Q9JI13,SAS10_MOUSE,,Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (Crl-1) (Disrupter of silencing SAS10) (UTP3 homolog),Mus musculus (Mouse),33.1,360.0,9.1e-37,156.4,sp|Q9JI13|SAS10_MOUSE Something about silencing protein 10 OS=Mus musculus OX=10090 GN=Utp3 PE=1 SV=1,GO:0005634; GO:0005730; GO:0006325; GO:0007420; GO:0032040; GO:0042274,brain development [GO:0007420]; chromatin organization [GO:0006325]; ribosomal small subunit biogenesis [GO:0042274],nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040],,GO:0005634; GO:0005730; GO:0006325; GO:0043226; GO:0048856,nucleus; nucleolus; chromatin organization; organelle; anatomical structure development
OG_07985,FUN_035612-T1,Peve_00019611,Pocillopora_meandrina_HIv1___RNAseq.g28060.t1,three_way,40.537333333333336,,,,,,,,,,,,,,,,,
OG_07986,FUN_035613-T1,Peve_00029657,Pocillopora_meandrina_HIv1___RNAseq.g28081.t1,three_way,73.11133333333333,FUN_035613-T1,P53454,,,,,34.0,329.0,2e-36,154.8,sp|P53454|DRD5L_TAKRU D(5)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=dl PE=3 SV=1,,,,,,
OG_07987,FUN_035615-T1,Peve_00029654,Pocillopora_meandrina_HIv1___RNAseq.g28080.t1,three_way,72.06366666666666,FUN_035615-T1,P35404,,,,,33.6,348.0,1.1e-32,142.5,sp|P35404|5HT1B_DIDVI 5-hydroxytryptamine receptor 1B OS=Didelphis virginiana OX=9267 GN=HTR1B PE=2 SV=1,,,,,,
OG_07988,FUN_035618-T1,Peve_00029653,Pocillopora_meandrina_HIv1___TS.g15425.t1,three_way,87.45883333333333,FUN_035618-T1,Q9Y5B9,,,,,59.7,937.0,0.0,1174.5,sp|Q9Y5B9|SP16H_HUMAN FACT complex subunit SPT16 OS=Homo sapiens OX=9606 GN=SUPT16H PE=1 SV=1,,,,,,
OG_07989,FUN_035619-T1,Peve_00029652,Pocillopora_meandrina_HIv1___TS.g15424.t1,three_way,51.177,,,,,,,,,,,,,,,,,
OG_07990,FUN_035623-T1,Peve_00029665,Pocillopora_meandrina_HIv1___RNAseq.g28073.t1,three_way,67.64616666666666,,,,,,,,,,,,,,,,,
OG_07991,FUN_035626-T1,Peve_00029659,Pocillopora_meandrina_HIv1___RNAseq.g28070.t1,three_way,76.00266666666667,FUN_035626-T1,Q4R5X8,,,,,62.2,90.0,1.8000000000000002e-28,126.7,"sp|Q4R5X8|NDUS6_MACFA NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial OS=Macaca fascicularis OX=9541 GN=NDUFS6 PE=2 SV=1",,,,,,
OG_07992,FUN_035627-T1,Peve_00029656,Pocillopora_meandrina_HIv1___RNAseq.g28069.t1,three_way,82.09766666666667,FUN_035627-T1,P97762,,,,,67.2,122.0,1.3e-48,194.5,sp|P97762|RP9_MOUSE Retinitis pigmentosa 9 protein homolog OS=Mus musculus OX=10090 GN=rp9 PE=1 SV=1,,,,,,
OG_07993,FUN_035629-T1,Peve_00044824,Pocillopora_meandrina_HIv1___RNAseq.g28067.t1,three_way,75.19483333333334,FUN_035629-T1,Q9Y2L5,TPPC8_HUMAN,,Trafficking protein particle complex subunit 8 (Protein TRS85 homolog),Homo sapiens (Human),37.0,1516.0,1e-253,878.6,sp|Q9Y2L5|TPPC8_HUMAN Trafficking protein particle complex subunit 8 OS=Homo sapiens OX=9606 GN=TRAPPC8 PE=1 SV=2,GO:0005737; GO:0005829; GO:0006888; GO:0007030; GO:0030008; GO:0032964; GO:0048208; GO:0099022; GO:1990072,collagen biosynthetic process [GO:0032964]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; vesicle tethering [GO:0099022],cytoplasm [GO:0005737]; cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072],,GO:0005829; GO:0016192; GO:0065003,cytosol; vesicle-mediated transport; protein-containing complex assembly
OG_07994,FUN_035635-T1,Peve_00029724,Pocillopora_meandrina_HIv1___RNAseq.g28083.t1,three_way,77.435,FUN_035635-T1,P0C0T0,LITAF_RAT,,Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog (LPS-induced TNF-alpha factor homolog) (Estrogen-enhanced transcript protein 1) (Eet-1),Rattus norvegicus (Rat),50.0,100.0,6.000000000000002e-22,105.5,sp|P0C0T0|LITAF_RAT Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog OS=Rattus norvegicus OX=10116 GN=Litaf PE=2 SV=1,GO:0000139; GO:0000978; GO:0001228; GO:0001817; GO:0005576; GO:0005634; GO:0005765; GO:0005794; GO:0005886; GO:0008270; GO:0009898; GO:0010935; GO:0032496; GO:0042802; GO:0043123; GO:0045944; GO:0050699; GO:0071222; GO:0098559; GO:0098560; GO:0098574; GO:1901223,cellular response to lipopolysaccharide [GO:0071222]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytokine production [GO:0001817]; regulation of macrophage cytokine production [GO:0010935]; response to lipopolysaccharide [GO:0032496],cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of late endosome membrane [GO:0098560]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005576; GO:0005634; GO:0005794; GO:0005886; GO:0006355; GO:0043226; GO:0140110,DNA binding; extracellular region; nucleus; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_07995,FUN_035636-T1,Peve_00029723,Pocillopora_meandrina_HIv1___RNAseq.g28084.t1,three_way,75.15066666666667,FUN_035636-T1,Q96BZ9,,,,,47.6,380.0,1.6e-87,324.7,sp|Q96BZ9|TBC20_HUMAN TBC1 domain family member 20 OS=Homo sapiens OX=9606 GN=TBC1D20 PE=1 SV=1,,,,,,
OG_07996,FUN_035637-T1,Peve_00029721,Pocillopora_meandrina_HIv1___RNAseq.g28085.t1,three_way,59.298,,,,,,,,,,,,,,,,,
OG_07997,FUN_035638-T1,Peve_00029736,Pocillopora_meandrina_HIv1___RNAseq.g28087.t1,three_way,77.51633333333334,FUN_035638-T1,Q8GYM3,,,,,28.8,191.0,4.1e-20,100.5,sp|Q8GYM3|AUG4_ARATH AUGMIN subunit 4 OS=Arabidopsis thaliana OX=3702 GN=AUG4 PE=1 SV=1,,,,,,
OG_07998,FUN_035639-T1,Peve_00029727,Pocillopora_meandrina_HIv1___RNAseq.g28088.t1,three_way,57.65466666666666,,,,,,,,,,,,,,,,,
OG_07999,FUN_035640-T1,Peve_00020462,Pocillopora_meandrina_HIv1___RNAseq.g28090.t1,three_way,58.150333333333336,FUN_035640-T1,Q58L91,FA5V_OXYSU,,Venom prothrombin activator oscutarin-C non-catalytic subunit (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Oscutarin-C non-catalytic subunit heavy chain; Oscutarin-C non-catalytic subunit light chain],Oxyuranus scutellatus (Coastal taipan),40.5,163.0,8.3e-24,113.2,sp|Q58L91|FA5V_OXYSU Venom prothrombin activator oscutarin-C non-catalytic subunit OS=Oxyuranus scutellatus OX=8668 PE=1 SV=1,GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729,venom-mediated blood coagulation [GO:0044469],extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729],GO:0005576; GO:0005886; GO:0060089; GO:0090729; GO:0098772,extracellular region; plasma membrane; molecular transducer activity; toxin activity; molecular function regulator activity
OG_08000,FUN_035645-T1,Peve_00022823,Pocillopora_meandrina_HIv1___RNAseq.g12089.t1,three_way,63.82933333333334,FUN_035645-T1,Q94BV5,,,,,38.8,400.0,1.3e-72,276.2,sp|Q94BV5|GSXL4_ARATH Flavin-containing monooxygenase FMO GS-OX-like 4 OS=Arabidopsis thaliana OX=3702 GN=At1g62600 PE=2 SV=1,,,,,,
OG_08001,FUN_035647-T1,Peve_00022820,Pocillopora_meandrina_HIv1___RNAseq.g28097.t1,three_way,46.10966666666667,,,,,,,,,,,,,,,,,
OG_08002,FUN_035648-T1,Peve_00022818,Pocillopora_meandrina_HIv1___RNAseq.g28098.t1,three_way,65.012,FUN_035648-T1,P53668,LIMK1_MOUSE,,LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) (KIZ-1),Mus musculus (Mouse),32.9,210.0,5.1e-23,110.2,sp|P53668|LIMK1_MOUSE LIM domain kinase 1 OS=Mus musculus OX=10090 GN=Limk1 PE=1 SV=1,GO:0001673; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005856; GO:0005925; GO:0006468; GO:0016020; GO:0016607; GO:0030027; GO:0031072; GO:0031625; GO:0043005; GO:0043149; GO:0045773; GO:0046872; GO:0048675; GO:0051496; GO:0098794; GO:0098978; GO:0106310; GO:1990948,axon extension [GO:0048675]; positive regulation of axon extension [GO:0045773]; positive regulation of stress fiber assembly [GO:0051496]; protein phosphorylation [GO:0006468]; stress fiber assembly [GO:0043149],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; male germ cell nucleus [GO:0001673]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynapse [GO:0098794],ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; cytosol; cytoskeleton; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08003,FUN_035652-T1,Peve_00022825,Pocillopora_meandrina_HIv1___RNAseq.g28106.t1,three_way,72.28066666666666,FUN_035652-T1,Q80ZW0,,,,,30.1,335.0,1.1e-27,125.6,sp|Q80ZW0|STK35_MOUSE Serine/threonine-protein kinase 35 OS=Mus musculus OX=10090 GN=Stk35 PE=1 SV=3,,,,,,
OG_08004,FUN_035653-T1,Peve_00028212,Pocillopora_meandrina_HIv1___RNAseq.g28108.t1,three_way,78.766,FUN_035653-T1,Q568Z7,CIB2_RAT,,Calcium and integrin-binding family member 2,Rattus norvegicus (Rat),52.7,188.0,6.2e-54,213.0,sp|Q568Z7|CIB2_RAT Calcium and integrin-binding family member 2 OS=Rattus norvegicus OX=10116 GN=Cib2 PE=1 SV=1,GO:0000287; GO:0001750; GO:0001917; GO:0005178; GO:0005509; GO:0005737; GO:0005829; GO:0005927; GO:0007204; GO:0031594; GO:0032420; GO:0032437; GO:0042383; GO:0042803; GO:0044877; GO:0045494; GO:0055074; GO:0071318; GO:0071944,calcium ion homeostasis [GO:0055074]; cellular response to ATP [GO:0071318]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cytosolic calcium ion concentration [GO:0007204],cell periphery [GO:0071944]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; muscle tendon junction [GO:0005927]; neuromuscular junction [GO:0031594]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; sarcolemma [GO:0042383]; stereocilium [GO:0032420],calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0005829; GO:0005886,cytosol; plasma membrane
OG_08005,FUN_035654-T1,Peve_00028213,Pocillopora_meandrina_HIv1___RNAseq.g28110.t1,three_way,80.874,FUN_035654-T1,Q9H063,MAF1_HUMAN,,Repressor of RNA polymerase III transcription MAF1 homolog,Homo sapiens (Human),50.8,254.0,2.8e-63,243.4,sp|Q9H063|MAF1_HUMAN Repressor of RNA polymerase III transcription MAF1 homolog OS=Homo sapiens OX=9606 GN=MAF1 PE=1 SV=2,GO:0000994; GO:0001002; GO:0001003; GO:0001006; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0016479; GO:0016480; GO:0030424; GO:0030425; GO:0048471; GO:0050811; GO:0060077,negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; inhibitory synapse [GO:0060077]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],GABA receptor binding [GO:0050811]; RNA polymerase III core binding [GO:0000994]; RNA polymerase III type 1 promoter sequence-specific DNA binding [GO:0001002]; RNA polymerase III type 2 promoter sequence-specific DNA binding [GO:0001003]; RNA polymerase III type 3 promoter sequence-specific DNA binding [GO:0001006],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle
OG_08006,FUN_035655-T1,Peve_00030364,Pocillopora_meandrina_HIv1___RNAseq.g28111.t1,three_way,77.333,FUN_035655-T1,Q5F389,WWOX_CHICK,,WW domain-containing oxidoreductase (EC 1.1.1.-),Gallus gallus (Chicken),57.5,414.0,3.9e-110,399.8,sp|Q5F389|WWOX_CHICK WW domain-containing oxidoreductase OS=Gallus gallus OX=9031 GN=WWOX PE=2 SV=2,GO:0001649; GO:0003713; GO:0005739; GO:0005764; GO:0005794; GO:0005829; GO:0005886; GO:0005902; GO:0016055; GO:0016491; GO:0019899; GO:0030178; GO:0045944; GO:0048705; GO:0071560; GO:0072332; GO:0090575; GO:0097191; GO:2001241,cellular response to transforming growth factor beta stimulus [GO:0071560]; extrinsic apoptotic signaling pathway [GO:0097191]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system morphogenesis [GO:0048705]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575],enzyme binding [GO:0019899]; oxidoreductase activity [GO:0016491]; transcription coactivator activity [GO:0003713],GO:0003824; GO:0005739; GO:0005764; GO:0005773; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016491; GO:0030154; GO:0043226; GO:0060090; GO:0140110,catalytic activity; mitochondrion; lysosome; vacuole; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; oxidoreductase activity; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_08007,FUN_035656-T1,Peve_00038559,Pocillopora_meandrina_HIv1___TS.g15459.t1b,three_way,59.03066666666666,,,,,,,,,,,,,,,,,
OG_08008,FUN_035660-T1,Peve_00020774,Pocillopora_meandrina_HIv1___RNAseq.g28116.t1,three_way,60.16833333333333,,,,,,,,,,,,,,,,,
OG_08009,FUN_035662-T1,Peve_00019696,Pocillopora_meandrina_HIv1___RNAseq.g28118.t1,three_way,56.57933333333333,FUN_035662-T1,Q13637,,,,,29.6,199.0,7e-16,85.9,sp|Q13637|RAB32_HUMAN Ras-related protein Rab-32 OS=Homo sapiens OX=9606 GN=RAB32 PE=1 SV=3,,,,,,
OG_08010,FUN_035663-T1,Peve_00038557,Pocillopora_meandrina_HIv1___RNAseq.g28119.t3,three_way,87.50766666666667,FUN_035663-T1,O75081,MTG16_HUMAN,,Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein) (hMTG16) (Zinc finger MYND domain-containing protein 4),Homo sapiens (Human),42.8,549.0,6.600000000000001e-80,299.7,sp|O75081|MTG16_HUMAN Protein CBFA2T3 OS=Homo sapiens OX=9606 GN=CBFA2T3 PE=1 SV=2,GO:0000139; GO:0001666; GO:0003714; GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0008270; GO:0008285; GO:0030851; GO:0032436; GO:0045820; GO:0045892; GO:1903715,DNA-templated transcription [GO:0006351]; granulocyte differentiation [GO:0030851]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of glycolytic process [GO:0045820]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of aerobic respiration [GO:1903715]; response to hypoxia [GO:0001666],Golgi membrane [GO:0000139]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005730; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; nucleolus; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_08011,FUN_035664-T1,Peve_00029725,Pocillopora_meandrina_HIv1___RNAseq.g28120.t1,three_way,46.14533333333333,,,,,,,,,,,,,,,,,
OG_08012,FUN_035665-T1,Peve_00002788,Pocillopora_meandrina_HIv1___RNAseq.g28121.t1,three_way,70.55033333333334,FUN_035665-T1,Q9NRH2,,,,,66.7,330.0,4.4e-126,453.8,sp|Q9NRH2|SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=SNRK PE=1 SV=2,,,,,,
OG_08013,FUN_035667-T1,Peve_00002800,Pocillopora_meandrina_HIv1___RNAseq.g28123.t1,three_way,73.54066666666667,FUN_035667-T1,Q86V88,,,,,52.3,155.0,1.1e-44,181.0,sp|Q86V88|MGDP1_HUMAN Magnesium-dependent phosphatase 1 OS=Homo sapiens OX=9606 GN=MDP1 PE=1 SV=1,,,,,,
OG_08014,FUN_035668-T1,Peve_00002801,Pocillopora_meandrina_HIv1___TS.g15470.t1,three_way,83.02633333333334,,,,,,,,,,,,,,,,,
OG_08015,FUN_035669-T1,Peve_00002790,Pocillopora_meandrina_HIv1___RNAseq.g28126.t1,three_way,71.78333333333333,FUN_035669-T1,Q8TDM0,,,,,38.7,124.0,4.3e-14,79.7,sp|Q8TDM0|BCAS4_HUMAN Breast carcinoma-amplified sequence 4 OS=Homo sapiens OX=9606 GN=BCAS4 PE=1 SV=1,,,,,,
OG_08016,FUN_035670-T1,Peve_00002791,Pocillopora_meandrina_HIv1___RNAseq.g28127.t1,three_way,93.71433333333334,FUN_035670-T1,Q9PV94,,,,,77.2,149.0,1.9e-54,214.2,sp|Q9PV94|RSMB_CHICK Small nuclear ribonucleoprotein-associated protein B' OS=Gallus gallus OX=9031 GN=SNRPB PE=2 SV=1,,,,,,
OG_08017,FUN_035671-T1,Peve_00002792,Pocillopora_meandrina_HIv1___RNAseq.g28139.t1,three_way,83.45733333333334,FUN_035671-T1,Q561X0,,,,,57.4,122.0,3.5000000000000004e-32,139.0,sp|Q561X0|NEPR1_DANRE Nuclear envelope phosphatase-regulatory subunit 1 OS=Danio rerio OX=7955 GN=cnep1r1 PE=2 SV=1,,,,,,
OG_08018,FUN_035673-T1,Peve_00002793,Pocillopora_meandrina_HIv1___RNAseq.g28140.t1,three_way,79.00033333333333,,,,,,,,,,,,,,,,,
OG_08019,FUN_035674-T1,Peve_00002794,Pocillopora_meandrina_HIv1___RNAseq.g28141.t1,three_way,76.93833333333333,FUN_035674-T1,Q5JS54,PSMG4_HUMAN,,Proteasome assembly chaperone 4 (PAC-4) (hPAC4) (Proteasome chaperone homolog 4) (Pba4),Homo sapiens (Human),51.8,110.0,6.8e-25,114.8,sp|Q5JS54|PSMG4_HUMAN Proteasome assembly chaperone 4 OS=Homo sapiens OX=9606 GN=PSMG4 PE=1 SV=2,GO:0005829; GO:0032991; GO:0043248; GO:0044877,proteasome assembly [GO:0043248],cytosol [GO:0005829]; protein-containing complex [GO:0032991],protein-containing complex binding [GO:0044877],GO:0005829; GO:0065003,cytosol; protein-containing complex assembly
OG_08020,FUN_035675-T1,Peve_00002795,Pocillopora_meandrina_HIv1___RNAseq.g28142.t1,three_way,59.38916666666667,FUN_035675-T1,Q6NZL6,TONSL_MOUSE,,Tonsoku-like protein (Inhibitor of kappa B-related protein) (I-kappa-B-related protein) (IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2),Mus musculus (Mouse),29.1,1503.0,7.8e-97,357.5,sp|Q6NZL6|TONSL_MOUSE Tonsoku-like protein OS=Mus musculus OX=10090 GN=Tonsl PE=1 SV=2,GO:0000724; GO:0005737; GO:0031297; GO:0035861; GO:0042393; GO:0043596; GO:0140566,double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297],cytoplasm [GO:0005737]; nuclear replication fork [GO:0043596]; site of double-strand break [GO:0035861],histone binding [GO:0042393]; histone reader activity [GO:0140566],GO:0006281; GO:0006310; GO:0042393; GO:0060090,DNA repair; DNA recombination; histone binding; molecular adaptor activity
OG_08021,FUN_035676-T1,Peve_00002798,Pocillopora_meandrina_HIv1___RNAseq.g28143.t1,three_way,86.53333333333333,FUN_035676-T1,A0PJN4,U2QL1_MOUSE,,Ubiquitin-conjugating enzyme E2Q-like protein 1 (EC 2.3.2.23) (E2Q-like ubiquitin-conjugating enzyme 1),Mus musculus (Mouse),66.7,162.0,4.5e-58,226.1,sp|A0PJN4|U2QL1_MOUSE Ubiquitin-conjugating enzyme E2Q-like protein 1 OS=Mus musculus OX=10090 GN=Ube2ql1 PE=2 SV=2,GO:0005524; GO:0005634; GO:0016567; GO:0061631,protein ubiquitination [GO:0016567],nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08022,FUN_035677-T1,Peve_00002799,Pocillopora_meandrina_HIv1___RNAseq.g28144.t1,three_way,61.552,FUN_035677-T1,Q96I34,PP16A_HUMAN,,Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3),Homo sapiens (Human),37.7,371.0,1.2e-26,123.2,sp|Q96I34|PP16A_HUMAN Protein phosphatase 1 regulatory subunit 16A OS=Homo sapiens OX=9606 GN=PPP1R16A PE=1 SV=1,GO:0004857; GO:0005737; GO:0005886; GO:0017020,,cytoplasm [GO:0005737]; plasma membrane [GO:0005886],enzyme inhibitor activity [GO:0004857]; myosin phosphatase regulator activity [GO:0017020],GO:0005886; GO:0098772,plasma membrane; molecular function regulator activity
OG_08023,FUN_035678-T1,Peve_00033237,Pocillopora_meandrina_HIv1___TS.g15489.t1,three_way,88.24733333333333,FUN_035678-T1,A7SXZ6,OSGEP_NEMVE,,Probable tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein osgep) (tRNA threonylcarbamoyladenosine biosynthesis protein osgep),Nematostella vectensis (Starlet sea anemone),88.9,334.0,1.2e-175,617.1,sp|A7SXZ6|OSGEP_NEMVE Probable tRNA N6-adenosine threonylcarbamoyltransferase OS=Nematostella vectensis OX=45351 GN=osgep PE=3 SV=1,GO:0000408; GO:0002949; GO:0005634; GO:0005737; GO:0046872; GO:0061711,tRNA threonylcarbamoyladenosine modification [GO:0002949],cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634],metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711],GO:0003824; GO:0005634; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_08024,FUN_035679-T1,Peve_00025446,Pocillopora_meandrina_HIv1___RNAseq.g28146.t1,three_way,82.66166666666666,FUN_035679-T1,Q15024,EXOS7_HUMAN,,Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8),Homo sapiens (Human),60.1,291.0,4e-98,359.4,sp|Q15024|EXOS7_HUMAN Exosome complex component RRP42 OS=Homo sapiens OX=9606 GN=EXOSC7 PE=1 SV=3,GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006364; GO:0006396; GO:0006401; GO:0016075; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0071028; GO:0071035; GO:0071038; GO:0101019,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]",cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006399; GO:0016071; GO:0016073; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; tRNA metabolic process; mRNA metabolic process; snRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_08025,FUN_035680-T1,Peve_00025447,Pocillopora_meandrina_HIv1___RNAseq.g28147.t1,three_way,66.779,FUN_035680-T1,Q6J2U6,RN114_RAT,,E3 ubiquitin-protein ligase RNF114 (EC 2.3.2.27) (RING finger protein 114) (RING-type E3 ubiquitin transferase RNF114) (Zinc finger protein 313),Rattus norvegicus (Rat),44.8,203.0,2.4e-47,190.3,sp|Q6J2U6|RN114_RAT E3 ubiquitin-protein ligase RNF114 OS=Rattus norvegicus OX=10116 GN=Rnf114 PE=2 SV=1,GO:0000209; GO:0005634; GO:0005737; GO:0006511; GO:0007283; GO:0008270; GO:0030154; GO:0061630,cell differentiation [GO:0030154]; protein polyubiquitination [GO:0000209]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_08026,FUN_035681-T1,Peve_00025448,Pocillopora_meandrina_HIv1___RNAseq.g28148.t1,three_way,71.902,,,,,,,,,,,,,,,,,
OG_08027,FUN_035682-T1,Peve_00041297,Pocillopora_meandrina_HIv1___RNAseq.g28149.t1,three_way,75.479,FUN_035682-T1,Q8BJT9,,,,,56.2,560.0,2.7e-180,633.3,sp|Q8BJT9|EDEM2_MOUSE ER degradation-enhancing alpha-mannosidase-like protein 2 OS=Mus musculus OX=10090 GN=Edem2 PE=1 SV=1,,,,,,
OG_08028,FUN_035683-T1,Peve_00041296,Pocillopora_meandrina_HIv1___RNAseq.g11803.t1,three_way,70.305,FUN_035683-T1,P20456,IMPA1_BOVIN,,Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1),Bos taurus (Bovine),55.4,271.0,2.1e-80,300.4,sp|P20456|IMPA1_BOVIN Inositol monophosphatase 1 OS=Bos taurus OX=9913 GN=IMPA1 PE=1 SV=1,GO:0000287; GO:0004346; GO:0005737; GO:0006020; GO:0006021; GO:0007165; GO:0008877; GO:0008934; GO:0030145; GO:0031403; GO:0046854; GO:0047954; GO:0052832; GO:0052833; GO:0052834; GO:0103026,inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; signal transduction [GO:0007165],cytoplasm [GO:0005737],fructose-1-phosphatase activity [GO:0103026]; glucose-1-phosphatase activity [GO:0008877]; glucose-6-phosphatase activity [GO:0004346]; glycerol-2-phosphatase activity [GO:0047954]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_08029,FUN_035684-T1,Peve_00041295,Pocillopora_meandrina_HIv1___RNAseq.g11804.t1a,three_way,62.284333333333336,FUN_035684-T1,Q6GM78,ASGL1_XENLA,,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],Xenopus laevis (African clawed frog),43.1,269.0,2.8e-45,183.7,sp|Q6GM78|ASGL1_XENLA Isoaspartyl peptidase/L-asparaginase OS=Xenopus laevis OX=8355 GN=asrgl1 PE=2 SV=1,GO:0001917; GO:0004067; GO:0005737; GO:0006508; GO:0008798; GO:0033345,asparagine catabolic process via L-aspartate [GO:0033345]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917],asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798],GO:0003824; GO:0006520; GO:0016787; GO:0140096,"catalytic activity; amino acid metabolic process; hydrolase activity; catalytic activity, acting on a protein"
OG_08030,FUN_035688-T1,Peve_00041294,Pocillopora_meandrina_HIv1___RNAseq.g11804.t1b,three_way,57.10333333333333,,,,,,,,,,,,,,,,,
OG_08031,FUN_035689-T1,Peve_00041293,Pocillopora_meandrina_HIv1___RNAseq.g11805.t1,three_way,90.49,FUN_035689-T1,Q13884,SNTB1_HUMAN,,Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43),Homo sapiens (Human),47.2,527.0,2.4e-127,457.2,sp|Q13884|SNTB1_HUMAN Beta-1-syntrophin OS=Homo sapiens OX=9606 GN=SNTB1 PE=1 SV=3,GO:0003779; GO:0005198; GO:0005516; GO:0005737; GO:0005856; GO:0005886; GO:0005925; GO:0006936; GO:0016010; GO:0030165; GO:0032991; GO:0042383; GO:0045202,muscle contraction [GO:0006936],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystrophin-associated glycoprotein complex [GO:0016010]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202],actin binding [GO:0003779]; calmodulin binding [GO:0005516]; PDZ domain binding [GO:0030165]; structural molecule activity [GO:0005198],GO:0003012; GO:0005198; GO:0005856; GO:0005886; GO:0008092; GO:0043226,muscle system process; structural molecule activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle
OG_08032,FUN_035692-T1,Peve_00041299,Pocillopora_meandrina_HIv1___RNAseq.g11811.t1,three_way,77.73133333333334,FUN_035692-T1,Q6DGQ4,,,,,59.6,57.0,1.1e-10,68.6,sp|Q6DGQ4|CP087_DANRE UPF0547 protein C16orf87 homolog OS=Danio rerio OX=7955 GN=zgc:92818 PE=2 SV=1,,,,,,
OG_08033,FUN_035693-T1,Peve_00041290,Pocillopora_meandrina_HIv1___RNAseq.g11812.t1,three_way,82.895,FUN_035693-T1,Q6NYL5,ALAT2_DANRE,,Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2),Danio rerio (Zebrafish) (Brachydanio rerio),57.9,487.0,4.2000000000000006e-164,579.3,sp|Q6NYL5|ALAT2_DANRE Alanine aminotransferase 2-like OS=Danio rerio OX=7955 GN=gpt2l PE=2 SV=2,GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853,2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],,L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0006520; GO:0016740,catalytic activity; amino acid metabolic process; transferase activity
OG_08034,FUN_035694-T1,Peve_00033765,Pocillopora_meandrina_HIv1___RNAseq.g11819.t1,three_way,79.92699999999999,FUN_035694-T1,Q8BQM4,,,,,35.3,680.0,4.0999999999999996e-92,340.5,sp|Q8BQM4|HEAT3_MOUSE HEAT repeat-containing protein 3 OS=Mus musculus OX=10090 GN=Heatr3 PE=1 SV=1,,,,,,
OG_08035,FUN_035701-T1,Peve_00014072,Pocillopora_meandrina_HIv1___RNAseq.g11834.t1,three_way,65.56466666666667,FUN_035701-T1,Q8BGT5,,,,,45.4,460.0,2e-121,437.6,sp|Q8BGT5|ALAT2_MOUSE Alanine aminotransferase 2 OS=Mus musculus OX=10090 GN=Gpt2 PE=1 SV=1,,,,,,
OG_08036,FUN_035709-T1,Peve_00044090,Pocillopora_meandrina_HIv1___RNAseq.g11840.t1,three_way,42.494,,,,,,,,,,,,,,,,,
OG_08037,FUN_035714-T1,Peve_00044093,Pocillopora_meandrina_HIv1___RNAseq.g11845.t1,three_way,86.7495,FUN_035714-T1,Q6GL11,,,,,66.5,215.0,7.300000000000001e-65,248.4,sp|Q6GL11|CHM4B_XENTR Charged multivesicular body protein 4b OS=Xenopus tropicalis OX=8364 GN=chmp4b PE=2 SV=1,,,,,,
OG_08038,FUN_035715-T1,Peve_00044094,Pocillopora_meandrina_HIv1___RNAseq.g11846.t1,three_way,79.94233333333334,FUN_035715-T1,O95336,,,,,47.9,242.0,2.6e-58,226.9,sp|O95336|6PGL_HUMAN 6-phosphogluconolactonase OS=Homo sapiens OX=9606 GN=PGLS PE=1 SV=2,,,,,,
OG_08039,FUN_035716-T1,Peve_00044096,Pocillopora_meandrina_HIv1___RNAseq.g11847.t1,three_way,59.97466666666666,FUN_035716-T1,Q9NTZ6,,,,,46.7,75.0,6.8e-13,77.0,sp|Q9NTZ6|RBM12_HUMAN RNA-binding protein 12 OS=Homo sapiens OX=9606 GN=RBM12 PE=1 SV=1,,,,,,
OG_08040,FUN_035717-T1,Peve_00044097,Pocillopora_meandrina_HIv1___TS.g3184.t1,three_way,69.33633333333333,FUN_035717-T1,Q1LU86,CBAR1_DANRE,,CBY1-interacting BAR domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),33.9,245.0,1.3e-32,141.7,sp|Q1LU86|CBAR1_DANRE CBY1-interacting BAR domain-containing protein 1 OS=Danio rerio OX=7955 GN=cibar1 PE=2 SV=1,GO:0005634; GO:0005737; GO:0005743; GO:0005814; GO:0005929; GO:0007007; GO:0007283; GO:0035869; GO:0036064; GO:0045880; GO:0060271; GO:0097227; GO:0097546,cilium assembly [GO:0060271]; inner mitochondrial membrane organization [GO:0007007]; positive regulation of smoothened signaling pathway [GO:0045880]; spermatogenesis [GO:0007283],centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; sperm annulus [GO:0097227],,GO:0005634; GO:0005815; GO:0005929; GO:0007005; GO:0022414; GO:0043226; GO:0044782; GO:0061024,nucleus; microtubule organizing center; cilium; mitochondrion organization; reproductive process; organelle; cilium organization; membrane organization
OG_08041,FUN_035718-T1,Peve_00044098,Pocillopora_meandrina_HIv1___RNAseq.g11849.t1,three_way,49.524,,,,,,,,,,,,,,,,,
OG_08042,FUN_035719-T1,Peve_00044099,Pocillopora_meandrina_HIv1___RNAseq.g11850.t2,three_way,78.6335,FUN_035719-T1,Q3US41,,,,,38.6,681.0,3.3e-122,440.7,sp|Q3US41|ESRP1_MOUSE Epithelial splicing regulatory protein 1 OS=Mus musculus OX=10090 GN=Esrp1 PE=1 SV=2,,,,,,
OG_08043,FUN_035720-T1,Peve_00044100,Pocillopora_meandrina_HIv1___RNAseq.g11851.t1,three_way,80.81633333333333,FUN_035720-T1,E2RDZ6,,,,,67.2,265.0,2.5e-105,383.3,"sp|E2RDZ6|SIR5_CANLF NAD-dependent protein deacylase sirtuin-5, mitochondrial OS=Canis lupus familiaris OX=9615 GN=SIRT5 PE=3 SV=1",,,,,,
OG_08044,FUN_035722-T1,Peve_00044101,Pocillopora_meandrina_HIv1___RNAseq.g11852.t1,three_way,79.41966666666667,FUN_035722-T1,Q90WU3,,,,,58.5,306.0,7.4e-98,358.6,sp|Q90WU3|DDX1_CHICK ATP-dependent RNA helicase DDX1 OS=Gallus gallus OX=9031 GN=DDX1 PE=1 SV=1,,,,,,
OG_08045,FUN_035724-T1,Peve_00044102,Pocillopora_meandrina_HIv1___RNAseq.g2697.t1,three_way,72.28183333333334,,,,,,,,,,,,,,,,,
OG_08046,FUN_035734-T1,Peve_00044083,Pocillopora_meandrina_HIv1___RNAseq.g11861.t1,three_way,58.831,FUN_035734-T1,Q8C080,,,,,51.9,162.0,2.9e-41,171.0,sp|Q8C080|SNX16_MOUSE Sorting nexin-16 OS=Mus musculus OX=10090 GN=Snx16 PE=1 SV=2,,,,,,
OG_08047,FUN_035735-T1,Peve_00044084,Pocillopora_meandrina_HIv1___RNAseq.g11862.t1,three_way,61.315000000000005,FUN_035735-T1,P57769,SNX16_RAT,,Sorting nexin-16,Rattus norvegicus (Rat),44.3,149.0,4.9000000000000005e-27,124.0,sp|P57769|SNX16_RAT Sorting nexin-16 OS=Rattus norvegicus OX=10116 GN=Snx16 PE=1 SV=2,GO:0001881; GO:0005764; GO:0005769; GO:0005770; GO:0006622; GO:0008333; GO:0010008; GO:0031901; GO:0031902; GO:0035091; GO:0042802; GO:0045022,early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; protein targeting to lysosome [GO:0006622]; receptor recycling [GO:0001881],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosome [GO:0005764],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0005764; GO:0005768; GO:0005773; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,lysosome; endosome; vacuole; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_08048,FUN_035736-T1,Peve_00044086,Pocillopora_meandrina_HIv1___RNAseq.g11863.t1,three_way,69.81016666666667,FUN_035736-T1,Q8JFV8,,,,,53.8,342.0,2.6e-102,374.0,sp|Q8JFV8|VAT1_DANRE Synaptic vesicle membrane protein VAT-1 homolog OS=Danio rerio OX=7955 GN=vat1 PE=2 SV=1,,,,,,
OG_08049,FUN_035737-T1,Peve_00044088,Pocillopora_meandrina_HIv1___RNAseq.g11864.t1,three_way,77.52216666666666,FUN_035737-T1,Q8BYH8,CHD9_MOUSE,,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.-) (ATP-dependent helicase CHD9) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),Mus musculus (Mouse),43.2,2161.0,0.0,1496.1,sp|Q8BYH8|CHD9_MOUSE Chromodomain-helicase-DNA-binding protein 9 OS=Mus musculus OX=10090 GN=Chd9 PE=1 SV=2,GO:0003677; GO:0004386; GO:0005524; GO:0005654; GO:0005829; GO:0006325; GO:0016887,chromatin organization [GO:0006325],cytosol [GO:0005829]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; helicase activity [GO:0004386],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0140657,DNA binding; catalytic activity; nucleoplasm; cytosol; chromatin organization; hydrolase activity; isomerase activity; ATP-dependent activity
OG_08050,FUN_035738-T1,Peve_00026220,Pocillopora_meandrina_HIv1___TS.g3202.t2,three_way,93.476,FUN_035738-T1,Q05975,,,,,92.9,212.0,1.9000000000000002e-110,399.8,sp|Q05975|RAB2_LYMST Ras-related protein Rab-2 OS=Lymnaea stagnalis OX=6523 GN=RAB2 PE=2 SV=1,,,,,,
OG_08051,FUN_035742-T1,Peve_00026223,Pocillopora_meandrina_HIv1___RNAseq.g11866.t1,three_way,82.196,FUN_035742-T1,Q9W1Y1,,,,,43.8,130.0,5.1e-26,119.0,sp|Q9W1Y1|EMC89_DROME ER membrane protein complex subunit 8/9 homolog OS=Drosophila melanogaster OX=7227 GN=EMC8-9 PE=1 SV=1,,,,,,
OG_08052,FUN_035743-T1,Peve_00026224,Pocillopora_meandrina_HIv1___TS.g3204.t1,three_way,69.02166666666666,,,,,,,,,,,,,,,,,
OG_08053,FUN_035748-T1,Peve_00014368,Pocillopora_meandrina_HIv1___TS.g3212.t1,three_way,61.029833333333336,FUN_035748-T1,Q9P2E3,ZNFX1_HUMAN,,NFX1-type zinc finger-containing protein 1,Homo sapiens (Human),38.2,1862.0,1.3e-311,1071.2,sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2,GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0006325; GO:0016853; GO:0031047; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; chromatin organization; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; defense response to other organism; ATP-dependent activity
OG_08054,FUN_035749-T1,Peve_00016720,Pocillopora_meandrina_HIv1___RNAseq.g11875.t1,three_way,66.67133333333334,,,,,,,,,,,,,,,,,
OG_08055,FUN_035750-T1,Peve_00044196,Pocillopora_meandrina_HIv1___RNAseq.g11876.t1,three_way,69.98333333333333,FUN_035750-T1,Q9BQ70,TCF25_HUMAN,,Ribosome quality control complex subunit TCF25 (Nuclear localized protein 1) (Transcription factor 25) (TCF-25),Homo sapiens (Human),47.6,527.0,3.4e-132,473.8,sp|Q9BQ70|TCF25_HUMAN Ribosome quality control complex subunit TCF25 OS=Homo sapiens OX=9606 GN=TCF25 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005829; GO:0061945; GO:0072344; GO:1990112,regulation of protein K48-linked ubiquitination [GO:0061945]; rescue of stalled ribosome [GO:0072344],cytosol [GO:0005829]; nucleus [GO:0005634]; RQC complex [GO:1990112],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005829; GO:0043226,DNA binding; nucleus; cytosol; organelle
OG_08056,FUN_035751-T1,Peve_00044197,Pocillopora_meandrina_HIv1___RNAseq.g11877.t1,three_way,71.535,FUN_035751-T1,P54802,ANAG_HUMAN,,Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form],Homo sapiens (Human),50.3,708.0,3.1e-214,746.5,sp|P54802|ANAG_HUMAN Alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGLU PE=1 SV=2,GO:0001573; GO:0001774; GO:0001889; GO:0003158; GO:0003183; GO:0003220; GO:0004561; GO:0005764; GO:0006801; GO:0006914; GO:0007028; GO:0007030; GO:0007040; GO:0007399; GO:0008340; GO:0009611; GO:0014004; GO:0016020; GO:0016042; GO:0016485; GO:0021675; GO:0021680; GO:0030200; GO:0030202; GO:0030203; GO:0030534; GO:0031069; GO:0032496; GO:0032963; GO:0034142; GO:0034285; GO:0034599; GO:0035633; GO:0035640; GO:0035909; GO:0042445; GO:0042474; GO:0042982; GO:0043161; GO:0043202; GO:0045475; GO:0046548; GO:0048143; GO:0055013; GO:0060119; GO:0060173; GO:0060586; GO:0061744; GO:0070062; GO:0097696; GO:0099022; GO:1904389; GO:1904390,adult behavior [GO:0030534]; amyloid precursor protein metabolic process [GO:0042982]; aorta morphogenesis [GO:0035909]; astrocyte activation [GO:0048143]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to oxidative stress [GO:0034599]; cerebellar Purkinje cell layer development [GO:0021680]; collagen metabolic process [GO:0032963]; cone retinal bipolar cell differentiation [GO:1904390]; cytoplasm organization [GO:0007028]; determination of adult lifespan [GO:0008340]; endothelium development [GO:0003158]; exploration behavior [GO:0035640]; ganglioside metabolic process [GO:0001573]; glycosaminoglycan metabolic process [GO:0030203]; Golgi organization [GO:0007030]; hair follicle morphogenesis [GO:0031069]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; hormone metabolic process [GO:0042445]; inner ear receptor cell development [GO:0060119]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; limb development [GO:0060173]; lipid catabolic process [GO:0016042]; liver development [GO:0001889]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; maintenance of blood-brain barrier [GO:0035633]; microglia differentiation [GO:0014004]; microglial cell activation [GO:0001774]; middle ear morphogenesis [GO:0042474]; mitral valve morphogenesis [GO:0003183]; motor behavior [GO:0061744]; multicellular organismal-level iron ion homeostasis [GO:0060586]; nerve development [GO:0021675]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein processing [GO:0016485]; response to disaccharide [GO:0034285]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; rod bipolar cell differentiation [GO:1904389]; superoxide metabolic process [GO:0006801]; toll-like receptor 4 signaling pathway [GO:0034142]; vesicle tethering [GO:0099022],extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; membrane [GO:0016020],alpha-N-acetylglucosaminidase activity [GO:0004561],GO:0002376; GO:0003824; GO:0005764; GO:0005773; GO:0006629; GO:0006914; GO:0007040; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0051604; GO:1901135,immune system process; catalytic activity; lysosome; vacuole; lipid metabolic process; autophagy; lysosome organization; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; protein maturation; carbohydrate derivative metabolic process
OG_08057,FUN_035752-T1,Peve_00044203,Pocillopora_meandrina_HIv1___RNAseq.g11880.t1,three_way,86.57133333333333,FUN_035752-T1,Q64701,RBL1_MOUSE,,Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1),Mus musculus (Mouse),50.0,1056.0,2.6e-275,949.9,sp|Q64701|RBL1_MOUSE Retinoblastoma-like protein 1 OS=Mus musculus OX=10090 GN=Rbl1 PE=1 SV=3,GO:0000122; GO:0005634; GO:0005654; GO:0005667; GO:0006325; GO:0010629; GO:0051726; GO:1990841; GO:2000773,chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],promoter-specific chromatin binding [GO:1990841],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_08058,FUN_035753-T1,Peve_00044191,Pocillopora_meandrina_HIv1___RNAseq.g11881.t1,three_way,66.50783333333334,,,,,,,,,,,,,,,,,
OG_08059,FUN_035754-T1,Peve_00044192,Pocillopora_meandrina_HIv1___RNAseq.g11883.t1,three_way,63.23283333333333,FUN_035754-T1,Q5NDE7,PMGT2_XENLA,,"Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGnT2) (EC 2.4.1.312) (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2)",Xenopus laevis (African clawed frog),45.0,524.0,2.7e-140,500.4,"sp|Q5NDE7|PMGT2_XENLA Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 OS=Xenopus laevis OX=8355 GN=pomgnt2 PE=2 SV=1",GO:0001764; GO:0005783; GO:0005789; GO:0006493; GO:0008375; GO:0035269; GO:0097363,neuron migration [GO:0001764]; protein O-linked glycosylation [GO:0006493]; protein O-linked mannosylation [GO:0035269],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],acetylglucosaminyltransferase activity [GO:0008375]; protein O-acetylglucosaminyltransferase activity [GO:0097363],GO:0003824; GO:0005783; GO:0009101; GO:0016740; GO:0043226; GO:0048870; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; transferase activity; organelle; cell motility; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_08060,FUN_035756-T1,Peve_00033435,Pocillopora_meandrina_HIv1___RNAseq.g11887.t1,three_way,63.470666666666666,,,,,,,,,,,,,,,,,
OG_08061,FUN_035758-T1,Peve_00033436,Pocillopora_meandrina_HIv1___RNAseq.g11888.t1,three_way,71.446,FUN_035758-T1,Q9PVY8,,,,,68.4,155.0,1.1e-52,209.1,sp|Q9PVY8|FXC2B_XENLA Forkhead box protein C2-B OS=Xenopus laevis OX=8355 GN=foxc2-b PE=2 SV=2,,,,,,
OG_08062,FUN_035760-T1,Peve_00033437,Pocillopora_meandrina_HIv1___RNAseq.g11889.t1,three_way,60.47816666666667,FUN_035760-T1,O70220,,,,,63.1,103.0,6.9e-33,142.5,sp|O70220|FOXQ1_MOUSE Forkhead box protein Q1 OS=Mus musculus OX=10090 GN=Foxq1 PE=2 SV=3,,,,,,
OG_08063,FUN_035761-T1,Peve_00033438,Pocillopora_meandrina_HIv1___RNAseq.g11890.t1,three_way,66.28783333333334,FUN_035761-T1,O70220,,,,,66.0,94.0,2.7e-33,144.1,sp|O70220|FOXQ1_MOUSE Forkhead box protein Q1 OS=Mus musculus OX=10090 GN=Foxq1 PE=2 SV=3,,,,,,
OG_08064,FUN_035762-T1,Peve_00033439,Pocillopora_meandrina_HIv1___RNAseq.g11891.t1,three_way,71.21000000000001,,,,,,,,,,,,,,,,,
OG_08065,FUN_035765-T1,Peve_00033443,Pocillopora_meandrina_HIv1___RNAseq.g11894.t1,three_way,90.73666666666666,FUN_035765-T1,Q6GL41,MCM4_XENTR,,DNA replication licensing factor mcm4 (EC 3.6.4.12) (Minichromosome maintenance protein 4),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),68.7,836.0,0.0,1105.1,sp|Q6GL41|MCM4_XENTR DNA replication licensing factor mcm4 OS=Xenopus tropicalis OX=8364 GN=mcm4 PE=2 SV=1,GO:0000785; GO:0001878; GO:0003677; GO:0003678; GO:0003682; GO:0005524; GO:0006270; GO:0008270; GO:0016887; GO:0030174; GO:0042555; GO:0044786; GO:0071162,cell cycle DNA replication [GO:0044786]; DNA replication initiation [GO:0006270]; regulation of DNA-templated DNA replication initiation [GO:0030174]; response to yeast [GO:0001878],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0006260; GO:0016787; GO:0016853; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA replication; hydrolase activity; isomerase activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_08066,FUN_035767-T1,Peve_00033444,Pocillopora_meandrina_HIv1___RNAseq.g11895.t1,three_way,83.33766666666666,FUN_035767-T1,Q8VI75,,,,,41.1,443.0,5.400000000000001e-89,330.1,sp|Q8VI75|IPO4_MOUSE Importin-4 OS=Mus musculus OX=10090 GN=Ipo4 PE=1 SV=1,,,,,,
OG_08067,FUN_035770-T1,Peve_00027765,Pocillopora_meandrina_HIv1___RNAseq.g11896.t1,three_way,75.35533333333333,FUN_035770-T1,A2VDS1,SCLY_BOVIN,,Selenocysteine lyase (EC 4.4.1.16),Bos taurus (Bovine),57.0,407.0,1.3e-129,464.5,sp|A2VDS1|SCLY_BOVIN Selenocysteine lyase OS=Bos taurus OX=9913 GN=SCLY PE=2 SV=1,GO:0005829; GO:0009000; GO:0016740,,cytosol [GO:0005829],selenocysteine lyase activity [GO:0009000]; transferase activity [GO:0016740],GO:0003824; GO:0005829; GO:0016740; GO:0016829,catalytic activity; cytosol; transferase activity; lyase activity
OG_08068,FUN_035771-T1,Peve_00027766,Pocillopora_meandrina_HIv1___RNAseq.g11897.t1,three_way,82.68666666666667,FUN_035771-T1,Q3UHG7,,,,,48.2,421.0,1.2e-103,378.3,sp|Q3UHG7|DEN11_MOUSE DENN domain-containing protein 11 OS=Mus musculus OX=10090 GN=Dennd11 PE=2 SV=1,,,,,,
OG_08069,FUN_035773-T1,Peve_00027763,Pocillopora_meandrina_HIv1___RNAseq.g11898.t1,three_way,88.316,,,,,,,,,,,,,,,,,
OG_08070,FUN_035775-T1,Peve_00017724,Pocillopora_meandrina_HIv1___RNAseq.g11904.t1,three_way,71.4095,FUN_035775-T1,Q1LUT1,,,,,33.8,1359.0,3e-127,458.4,sp|Q1LUT1|EDC4_DANRE Enhancer of mRNA-decapping protein 4 OS=Danio rerio OX=7955 GN=edc4 PE=3 SV=1,,,,,,
OG_08071,FUN_035776-T1,Peve_00017723,Pocillopora_meandrina_HIv1___RNAseq.g11903.t1,three_way,63.2255,FUN_035776-T1,Q7TSG2,CTDP1_MOUSE,,RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),Mus musculus (Mouse),33.5,714.0,1.6e-88,328.9,sp|Q7TSG2|CTDP1_MOUSE RNA polymerase II subunit A C-terminal domain phosphatase OS=Mus musculus OX=10090 GN=Ctdp1 PE=1 SV=1,GO:0000922; GO:0001096; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0006470; GO:0008420; GO:0010458; GO:0030496; GO:0030957; GO:0032991; GO:0043923; GO:0051233; GO:0051301; GO:0061052,cell division [GO:0051301]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922],RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096],GO:0003824; GO:0005654; GO:0005815; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; microtubule organizing center; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08072,FUN_035777-T1,Peve_00017722,Pocillopora_meandrina_HIv1___RNAseq.g11902.t1,three_way,56.0365,FUN_035777-T1,Q68ED3,PAPD5_MOUSE,,Terminal nucleotidyltransferase 4B (Non-canonical poly(A) RNA polymerase PAPD5) (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal guanylyltransferase) (EC 2.7.7.-) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2),Mus musculus (Mouse),56.3,332.0,8.300000000000001e-100,366.3,sp|Q68ED3|PAPD5_MOUSE Terminal nucleotidyltransferase 4B OS=Mus musculus OX=10090 GN=Tent4b PE=1 SV=2,GO:0003677; GO:0003887; GO:0005524; GO:0005730; GO:0005737; GO:0006364; GO:0010587; GO:0031124; GO:0033500; GO:0046872; GO:0051301; GO:0060212; GO:0070568; GO:0071044; GO:0071051; GO:1905870; GO:1990817,carbohydrate homeostasis [GO:0033500]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA 3'-end processing [GO:0031124]; negative regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060212]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of 3'-UTR-mediated mRNA stabilization [GO:1905870]; rRNA processing [GO:0006364],cytoplasm [GO:0005737]; nucleolus [GO:0005730],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; guanylyltransferase activity [GO:0070568]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003677; GO:0003824; GO:0005730; GO:0016071; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleolus; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on DNA"
OG_08073,FUN_035778-T1,Peve_00027195,Pocillopora_meandrina_HIv1___RNAseq.g11901.t1,three_way,76.41,FUN_035778-T1,Q9BWW7,SCRT1_HUMAN,,Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (hScrt),Homo sapiens (Human),76.7,86.0,1.5e-16,88.2,sp|Q9BWW7|SCRT1_HUMAN Transcriptional repressor scratch 1 OS=Homo sapiens OX=9606 GN=SCRT1 PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0006355; GO:0008270; GO:0016604; GO:0043565; GO:1990837; GO:2001222,negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron migration [GO:2001222],nuclear body [GO:0016604],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0006355; GO:0043226; GO:0140110,DNA binding; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_08074,FUN_035779-T1,Peve_00027194,Pocillopora_meandrina_HIv1___RNAseq.g11900.t1,three_way,82.8665,FUN_035779-T1,Q9CWL8,CTBL1_MOUSE,,Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP),Mus musculus (Mouse),62.4,479.0,1.4e-168,594.3,sp|Q9CWL8|CTBL1_MOUSE Beta-catenin-like protein 1 OS=Mus musculus OX=10090 GN=Ctnnbl1 PE=1 SV=1,GO:0000398; GO:0000974; GO:0002250; GO:0005634; GO:0005654; GO:0005681; GO:0005813; GO:0005829; GO:0006915; GO:0016445; GO:0019899; GO:0043065,"adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of apoptotic process [GO:0043065]; somatic diversification of immunoglobulins [GO:0016445]",centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681],enzyme binding [GO:0019899],GO:0002376; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0012501; GO:0016071; GO:0043226,immune system process; nucleus; nucleoplasm; microtubule organizing center; cytosol; programmed cell death; mRNA metabolic process; organelle
OG_08075,FUN_035780-T1,Peve_00027193,Pocillopora_meandrina_HIv1___RNAseq.g11899.t1,three_way,76.77516666666666,FUN_035780-T1,Q2KHY5,,,,,34.8,135.0,1.4e-16,87.4,sp|Q2KHY5|FAP24_BOVIN Fanconi anemia core complex-associated protein 24 OS=Bos taurus OX=9913 GN=FAAP24 PE=2 SV=1,,,,,,
OG_08076,FUN_035800-T1,Peve_00015196,Pocillopora_meandrina_HIv1___RNAseq.g11910.t1a,three_way,62.337,FUN_035800-T1,O13076,,,,,29.1,313.0,8e-19,96.3,sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1,,,,,,
OG_08077,FUN_035801-T1,Peve_00017706,Pocillopora_meandrina_HIv1___TS.g3256.t1,three_way,56.76383333333334,,,,,,,,,,,,,,,,,
OG_08078,FUN_035802-T1,Peve_00017705,Pocillopora_meandrina_HIv1___RNAseq.g11918.t1,three_way,55.39816666666666,,,,,,,,,,,,,,,,,
OG_08079,FUN_035803-T1,Peve_00017711,Pocillopora_meandrina_HIv1___TS.g3258.t1,three_way,42.588,,,,,,,,,,,,,,,,,
OG_08080,FUN_035804-T1,Peve_00017708,Pocillopora_meandrina_HIv1___RNAseq.g11921.t1,three_way,69.93833333333333,FUN_035804-T1,Q8NCN5,,,,,39.3,819.0,1e-170,602.1,"sp|Q8NCN5|PDPR_HUMAN Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial OS=Homo sapiens OX=9606 GN=PDPR PE=1 SV=2",,,,,,
OG_08081,FUN_035805-T1,Peve_00033371,Pocillopora_meandrina_HIv1___RNAseq.g11922.t1,three_way,79.60766666666667,FUN_035805-T1,A5PLL7,PEDS1_HUMAN,,Plasmanylethanolamine desaturase 1 (EC 1.14.19.77) (Transmembrane protein 189),Homo sapiens (Human),61.3,238.0,6.7999999999999995e-84,312.0,sp|A5PLL7|PEDS1_HUMAN Plasmanylethanolamine desaturase 1 OS=Homo sapiens OX=9606 GN=PEDS1 PE=1 SV=3,GO:0005783; GO:0005789; GO:0006631; GO:0008611; GO:0050207,ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],plasmanylethanolamine desaturase activity [GO:0050207],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle
OG_08082,FUN_035806-T1,Peve_00021611,Pocillopora_meandrina_HIv1___RNAseq.g11923.t1,three_way,62.91633333333333,FUN_035806-T1,Q1GRQ3,,,,,30.4,181.0,4.2e-13,76.6,sp|Q1GRQ3|RRF_SPHAL Ribosome-recycling factor OS=Sphingopyxis alaskensis (strain DSM 13593 / LMG 18877 / RB2256) OX=317655 GN=frr PE=3 SV=1,,,,,,
OG_08083,FUN_035810-T1,Peve_00037792,Pocillopora_meandrina_HIv1___RNAseq.g11929.t1,three_way,63.96066666666667,FUN_035810-T1,O15943,CADN_DROME,,Neural-cadherin (Cadherin-N) (dN-cadherin),Drosophila melanogaster (Fruit fly),31.2,2035.0,2.2e-241,838.2,sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2,GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016020; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609,axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803],GO:0005886; GO:0007155; GO:0048856,plasma membrane; cell adhesion; anatomical structure development
OG_08084,FUN_035813-T1,Peve_00037805,Pocillopora_meandrina_HIv1___RNAseq.g11928.t1,three_way,74.87766666666667,FUN_035813-T1,Q969N2,PIGT_HUMAN,,GPI-anchor transamidase component PIGT (Phosphatidylinositol-glycan biosynthesis class T protein),Homo sapiens (Human),45.6,553.0,4.1e-142,506.5,sp|Q969N2|PIGT_HUMAN GPI-anchor transamidase component PIGT OS=Homo sapiens OX=9606 GN=PIGT PE=1 SV=1,GO:0005789; GO:0006506; GO:0016020; GO:0016255; GO:0030182; GO:0031410; GO:0034235; GO:0042765; GO:0051402; GO:0180046,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; GPI-anchor transamidase complex [GO:0042765]; membrane [GO:0016020],GPI anchor binding [GO:0034235],GO:0006629; GO:0008289; GO:0012501; GO:0030154; GO:0031410; GO:0043226; GO:0051604; GO:1901135,lipid metabolic process; lipid binding; programmed cell death; cell differentiation; cytoplasmic vesicle; organelle; protein maturation; carbohydrate derivative metabolic process
OG_08085,FUN_035816-T1,Peve_00037797,Pocillopora_meandrina_HIv1___RNAseq.g11927.t1,three_way,65.37283333333333,,,,,,,,,,,,,,,,,
OG_08086,FUN_035818-T1,Peve_00037796,Pocillopora_meandrina_HIv1___RNAseq.g11926.t1,three_way,85.777,FUN_035818-T1,Q6ZQ89,,,,,69.6,573.0,3.7e-215,749.2,sp|Q6ZQ89|MARH6_MOUSE E3 ubiquitin-protein ligase MARCHF6 OS=Mus musculus OX=10090 GN=Marchf6 PE=2 SV=2,,,,,,
OG_08087,FUN_035819-T1,Peve_00037795,Pocillopora_meandrina_HIv1___RNAseq.g11925.t1,three_way,66.42033333333333,FUN_035819-T1,Q9CVD2,ATX3_MOUSE,,Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1 homolog),Mus musculus (Mouse),53.3,152.0,9.399999999999999e-39,161.8,sp|Q9CVD2|ATX3_MOUSE Ataxin-3 OS=Mus musculus OX=10090 GN=Atxn3 PE=1 SV=2,GO:0000226; GO:0004843; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005759; GO:0005765; GO:0005789; GO:0005829; GO:0005886; GO:0006511; GO:0006515; GO:0010810; GO:0016363; GO:0030036; GO:0031625; GO:0031966; GO:0034198; GO:0034605; GO:0035520; GO:0035640; GO:0042405; GO:0042802; GO:0043161; GO:0045104; GO:0051117; GO:0061578; GO:0070536; GO:0071108; GO:0071218; GO:1904262; GO:1904294; GO:1904327; GO:1990380; GO:2000060,actin cytoskeleton organization [GO:0030036]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; exploration behavior [GO:0035640]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex [GO:1904327]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATPase binding [GO:0051117]; cysteine-type deubiquitinase activity [GO:0004843]; identical protein binding [GO:0042802]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0007010; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; plasma membrane; cytoskeleton organization; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_08088,FUN_035820-T1,Peve_00037798,Pocillopora_meandrina_HIv1___RNAseq.g11930.t1,three_way,77.11866666666667,FUN_035820-T1,P0C6T1,,,,,45.4,119.0,3.2000000000000003e-22,105.9,sp|P0C6T1|CTF8_RAT Chromosome transmission fidelity protein 8 homolog OS=Rattus norvegicus OX=10116 GN=Chtf8 PE=3 SV=1,,,,,,
OG_08089,FUN_035821-T1,Peve_00037800,Pocillopora_meandrina_HIv1___RNAseq.g11931.t1,three_way,74.61166666666666,FUN_035821-T1,A8DZE6,WTIP_DANRE,,Wilms tumor protein 1-interacting protein homolog (WT1-interacting protein homolog),Danio rerio (Zebrafish) (Brachydanio rerio),52.4,191.0,1.8e-56,220.7,sp|A8DZE6|WTIP_DANRE Wilms tumor protein 1-interacting protein homolog OS=Danio rerio OX=7955 GN=wtip PE=3 SV=1,GO:0000132; GO:0000932; GO:0001666; GO:0001947; GO:0003140; GO:0003714; GO:0005634; GO:0005667; GO:0005912; GO:0006355; GO:0007010; GO:0010882; GO:0014032; GO:0022604; GO:0035331; GO:0035844; GO:0036064; GO:0046872; GO:0060271; GO:0061032; GO:0061371,cilium assembly [GO:0060271]; cloaca development [GO:0035844]; cytoskeleton organization [GO:0007010]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; establishment of mitotic spindle orientation [GO:0000132]; heart looping [GO:0001947]; negative regulation of hippo signaling [GO:0035331]; neural crest cell development [GO:0014032]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cell morphogenesis [GO:0022604]; regulation of DNA-templated transcription [GO:0006355]; response to hypoxia [GO:0001666]; visceral serous pericardium development [GO:0061032],adherens junction [GO:0005912]; ciliary basal body [GO:0036064]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription regulator complex [GO:0005667],metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005815; GO:0006355; GO:0007010; GO:0043226; GO:0044782; GO:0048856; GO:0060090; GO:0140110,nucleus; microtubule organizing center; regulation of DNA-templated transcription; cytoskeleton organization; organelle; cilium organization; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_08090,FUN_035822-T1,Peve_00037801,Pocillopora_meandrina_HIv1___RNAseq.g11932.t1,three_way,75.45,FUN_035822-T1,Q6PJI9,WDR59_HUMAN,,GATOR2 complex protein WDR59 (WD repeat-containing protein 59),Homo sapiens (Human),39.0,885.0,8.999999999999999e-151,535.8,sp|Q6PJI9|WDR59_HUMAN GATOR2 complex protein WDR59 OS=Homo sapiens OX=9606 GN=WDR59 PE=1 SV=2,GO:0005765; GO:0005774; GO:0005829; GO:0008270; GO:0031669; GO:0034198; GO:0035591; GO:0035859; GO:0043231; GO:0061700; GO:1904262; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TORC1 signaling [GO:1904263],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]; vacuolar membrane [GO:0005774],signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270],GO:0005829; GO:0043226; GO:0060090,cytosol; organelle; molecular adaptor activity
OG_08091,FUN_035824-T1,Peve_00037802,Pocillopora_meandrina_HIv1___RNAseq.g11933.t1,three_way,90.67833333333334,FUN_035824-T1,P08239,,,,,72.6,354.0,3e-148,526.2,sp|P08239|GNAO_BOVIN Guanine nucleotide-binding protein G(o) subunit alpha OS=Bos taurus OX=9913 GN=GNAO1 PE=1 SV=4,,,,,,
OG_08092,FUN_035825-T1,Peve_00037803,Pocillopora_meandrina_HIv1___RNAseq.g11934.t1,three_way,85.167,FUN_035825-T1,Q80VY9,DHX33_MOUSE,,ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33),Mus musculus (Mouse),58.4,630.0,1.3e-219,764.2,sp|Q80VY9|DHX33_MOUSE ATP-dependent RNA helicase DHX33 OS=Mus musculus OX=10090 GN=Dhx33 PE=1 SV=1,GO:0000182; GO:0003724; GO:0003725; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006413; GO:0016887; GO:0032481; GO:0043023; GO:0043410; GO:0045943; GO:0051092; GO:0072559; GO:0140297; GO:1900227,positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of type I interferon production [GO:0032481]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; NLRP3 inflammasome complex [GO:0072559]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; double-stranded RNA binding [GO:0003725]; mRNA binding [GO:0003729]; rDNA binding [GO:0000182]; ribosomal large subunit binding [GO:0043023]; RNA helicase activity [GO:0003724],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08093,FUN_035828-T1,Peve_00002588,Pocillopora_meandrina_HIv1___RNAseq.g11936.t1,three_way,67.353,FUN_035828-T1,Q60751,IGF1R_MOUSE,,Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain],Mus musculus (Mouse),48.0,275.0,4.300000000000001e-71,271.6,sp|Q60751|IGF1R_MOUSE Insulin-like growth factor 1 receptor OS=Mus musculus OX=10090 GN=Igf1r PE=1 SV=3,GO:0000165; GO:0004713; GO:0005010; GO:0005198; GO:0005520; GO:0005524; GO:0005886; GO:0007420; GO:0008544; GO:0009887; GO:0016020; GO:0030238; GO:0030315; GO:0030325; GO:0030879; GO:0031017; GO:0032869; GO:0043235; GO:0043409; GO:0043410; GO:0043491; GO:0043548; GO:0043560; GO:0045840; GO:0045893; GO:0046777; GO:0048009; GO:0048639; GO:0051446; GO:0051897; GO:0051898; GO:0060740; GO:0071333; GO:0098794; GO:0098978; GO:0099170; GO:0120162; GO:0140014,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; brain development [GO:0007420]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; epidermis development [GO:0008544]; exocrine pancreas development [GO:0031017]; insulin-like growth factor receptor signaling pathway [GO:0048009]; male sex determination [GO:0030238]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; mitotic nuclear division [GO:0140014]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of meiotic cell cycle [GO:0051446]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; prostate gland epithelium morphogenesis [GO:0060740]; protein autophosphorylation [GO:0046777],glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235]; T-tubule [GO:0030315],ATP binding [GO:0005524]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor receptor activity [GO:0005010]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein tyrosine kinase activity [GO:0004713]; structural molecule activity [GO:0005198],GO:0003824; GO:0005198; GO:0005886; GO:0006355; GO:0016740; GO:0022414; GO:0048856; GO:0060089; GO:0140014; GO:0140096,"catalytic activity; structural molecule activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; reproductive process; anatomical structure development; molecular transducer activity; mitotic nuclear division; catalytic activity, acting on a protein"
OG_08094,FUN_035829-T1,Peve_00002595,Pocillopora_meandrina_HIv1___RNAseq.g11938.t1,three_way,39.348333333333336,,,,,,,,,,,,,,,,,
OG_08095,FUN_035833-T1,Peve_00002593,Pocillopora_meandrina_HIv1___RNAseq.g11963.t1,three_way,82.79166666666667,FUN_035833-T1,O74212,,,,,49.9,443.0,1.9999999999999999e-128,460.7,sp|O74212|D5FAD_MORAP Acyl-lipid (8-3)-desaturase OS=Mortierella alpina OX=64518 GN=DES1 PE=1 SV=1,,,,,,
OG_08096,FUN_035837-T1,Peve_00032517,Pocillopora_meandrina_HIv1___RNAseq.g11959.t1,three_way,60.47533333333333,FUN_035837-T1,Q16820,,,,,34.7,380.0,1.9e-53,213.0,sp|Q16820|MEP1B_HUMAN Meprin A subunit beta OS=Homo sapiens OX=9606 GN=MEP1B PE=1 SV=3,,,,,,
OG_08097,FUN_035839-T1,Peve_00032500,Pocillopora_meandrina_HIv1___RNAseq.g11958.t2,three_way,68.27866666666667,,,,,,,,,,,,,,,,,
OG_08098,FUN_035840-T1,Peve_00032502,Pocillopora_meandrina_HIv1___RNAseq.g11957.t1,three_way,76.54033333333332,FUN_035840-T1,P38532,HSF1_MOUSE,,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Mus musculus (Mouse),55.7,176.0,1.1e-44,182.6,sp|P38532|HSF1_MOUSE Heat shock factor protein 1 OS=Mus musculus OX=10090 GN=Hsf1 PE=1 SV=2,GO:0000122; GO:0000165; GO:0000776; GO:0000791; GO:0000792; GO:0000978; GO:0001162; GO:0001227; GO:0001228; GO:0001701; GO:0001892; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006281; GO:0006397; GO:0006952; GO:0007143; GO:0007283; GO:0007584; GO:0008283; GO:0009408; GO:0010628; GO:0010667; GO:0014823; GO:0016605; GO:0019901; GO:0031072; GO:0031333; GO:0031490; GO:0032496; GO:0032720; GO:0032991; GO:0033574; GO:0034605; GO:0034620; GO:0035865; GO:0040018; GO:0042802; GO:0043565; GO:0045120; GO:0045651; GO:0045931; GO:0045944; GO:0046982; GO:0048471; GO:0050673; GO:0050680; GO:0051028; GO:0051879; GO:0060136; GO:0061770; GO:0062029; GO:0065003; GO:0070301; GO:0071222; GO:0071276; GO:0071280; GO:0071392; GO:0071466; GO:0071480; GO:0072738; GO:0090084; GO:0090261; GO:0097165; GO:0097431; GO:0097677; GO:0098847; GO:0101031; GO:0120162; GO:0140296; GO:1900034; GO:1901652; GO:1902512; GO:1903936; GO:1904385; GO:1904843; GO:1904845; GO:1990841; GO:1990904; GO:1990910; GO:1990911; GO:2001033; GO:2001235,cell population proliferation [GO:0008283]; cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; epithelial cell proliferation [GO:0050673]; female meiotic nuclear division [GO:0007143]; in utero embryonic development [GO:0001701]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; response to activity [GO:0014823]; response to heat [GO:0009408]; response to hypobaric hypoxia [GO:1990910]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; pronucleus [GO:0045120]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; translation elongation factor binding [GO:0061770]",GO:0003677; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006355; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0065003; GO:0140013; GO:0140110,DNA binding; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; organelle; anatomical structure development; protein-containing complex assembly; meiotic nuclear division; transcription regulator activity
OG_08099,FUN_035843-T1,Peve_00032503,Pocillopora_meandrina_HIv1___RNAseq.g11956.t1,three_way,81.321,FUN_035843-T1,Q2YDM5,SMIP8_BOVIN,,"Sperm microtubule inner protein 8 (Testis, prostate and placenta-expressed protein)",Bos taurus (Bovine),35.1,188.0,9.6e-19,95.1,sp|Q2YDM5|SMIP8_BOVIN Sperm microtubule inner protein 8 OS=Bos taurus OX=9913 GN=SPMIP8 PE=1 SV=2,GO:0031514; GO:0160111,,axonemal A tubule inner sheath [GO:0160111]; motile cilium [GO:0031514],,GO:0005929; GO:0043226,cilium; organelle
OG_08100,FUN_035844-T1,Peve_00032504,Pocillopora_meandrina_HIv1___TS.g3294.t2,three_way,79.22566666666667,FUN_035844-T1,Q942L2,,,,,47.7,333.0,6e-88,325.9,sp|Q942L2|PDI22_ORYSJ Protein disulfide isomerase-like 2-2 OS=Oryza sativa subsp. japonica OX=39947 GN=PDIL2-2 PE=2 SV=1,,,,,,
OG_08101,FUN_035845-T1,Peve_00032505,Pocillopora_meandrina_HIv1___RNAseq.g11954.t1,three_way,74.447,FUN_035845-T1,A0JMQ0,,,,,61.0,623.0,8.5e-230,798.1,sp|A0JMQ0|BOP1_DANRE Ribosome biogenesis protein bop1 OS=Danio rerio OX=7955 GN=bop1 PE=2 SV=1,,,,,,
OG_08102,FUN_035847-T1,Peve_00032506,Pocillopora_meandrina_HIv1___RNAseq.g11953.t2,three_way,67.05083333333333,FUN_035847-T1,Q86VV8,RTTN_HUMAN,,Rotatin,Homo sapiens (Human),28.2,2362.0,1.5e-211,739.2,sp|Q86VV8|RTTN_HUMAN Rotatin OS=Homo sapiens OX=9606 GN=RTTN PE=1 SV=3,GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0007368; GO:0010457; GO:0032053; GO:0036064,centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737],,GO:0005815; GO:0043226; GO:0044782,microtubule organizing center; organelle; cilium organization
OG_08103,FUN_035849-T1,Peve_00032507,Pocillopora_meandrina_HIv1___RNAseq.g11952.t1,three_way,79.79733333333333,FUN_035849-T1,Q9VQ29,,,,,62.9,197.0,4.2e-70,266.2,"sp|Q9VQ29|UCRI_DROME Cytochrome b-c1 complex subunit Rieske, mitochondrial OS=Drosophila melanogaster OX=7227 GN=RFeSP PE=1 SV=3",,,,,,
OG_08104,FUN_035850-T1,Peve_00032508,Pocillopora_meandrina_HIv1___RNAseq.g11951.t1,three_way,80.12583333333333,,,,,,,,,,,,,,,,,
OG_08105,FUN_035852-T1,Peve_00032510,Pocillopora_meandrina_HIv1___RNAseq.g11950.t1,three_way,70.93616666666667,FUN_035852-T1,Q63185,E2AK1_RAT,,Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (Hemin-sensitive initiation factor 2-alpha kinase),Rattus norvegicus (Rat),33.4,626.0,4.1e-72,274.2,sp|Q63185|E2AK1_RAT Eukaryotic translation initiation factor 2-alpha kinase 1 OS=Rattus norvegicus OX=10116 GN=Eif2ak1 PE=1 SV=2,GO:0002526; GO:0004672; GO:0004694; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006417; GO:0006446; GO:0006909; GO:0008285; GO:0017148; GO:0020037; GO:0030225; GO:0042803; GO:0046501; GO:0046777; GO:0046984; GO:0046986; GO:0051649; GO:0060586; GO:0070585; GO:0106310; GO:0140467; GO:0140468; GO:1901526; GO:1990641,acute inflammatory response [GO:0002526]; establishment of localization in cell [GO:0051649]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; macrophage differentiation [GO:0030225]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hemoglobin biosynthetic process [GO:0046986]; negative regulation of translation [GO:0017148]; phagocytosis [GO:0006909]; positive regulation of mitophagy [GO:1901526]; protein autophosphorylation [GO:0046777]; protein localization to mitochondrion [GO:0070585]; protoporphyrinogen IX metabolic process [GO:0046501]; regulation of hemoglobin biosynthetic process [GO:0046984]; regulation of translation [GO:0006417]; regulation of translational initiation [GO:0006446]; response to iron ion starvation [GO:1990641],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; heme binding [GO:0020037]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005829; GO:0006954; GO:0016192; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; inflammatory response; vesicle-mediated transport; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_08106,FUN_035853-T1,Peve_00022799,Pocillopora_meandrina_HIv1___RNAseq.g11949.t1,three_way,50.63183333333333,FUN_035853-T1,Q6H601,RH22_ORYSJ,,DEAD-box ATP-dependent RNA helicase 22 (EC 3.6.4.13),Oryza sativa subsp. japonica (Rice),27.3,594.0,3.6e-37,157.9,sp|Q6H601|RH22_ORYSJ DEAD-box ATP-dependent RNA helicase 22 OS=Oryza sativa subsp. japonica OX=39947 GN=Os09g0383400 PE=2 SV=2,GO:0003724; GO:0003729; GO:0005524; GO:0009507; GO:0016887,,chloroplast [GO:0009507],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0009536; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; plastid; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08107,FUN_035857-T1,Peve_00032515,Pocillopora_meandrina_HIv1___TS.g3285.t1,three_way,57.440000000000005,FUN_035857-T1,O97860,,,,,39.8,319.0,5.3e-62,239.6,sp|O97860|PPA5_RABIT Tartrate-resistant acid phosphatase type 5 OS=Oryctolagus cuniculus OX=9986 GN=ACP5 PE=2 SV=1,,,,,,
OG_08108,FUN_035859-T2,Peve_00035389,Pocillopora_meandrina_HIv1___RNAseq.g11944.t1,three_way,59.82066666666666,FUN_035859-T2,Q8CHP0,ZC3H3_MOUSE,,Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor),Mus musculus (Mouse),54.4,169.0,1.6e-16,89.7,sp|Q8CHP0|ZC3H3_MOUSE Zinc finger CCCH domain-containing protein 3 OS=Mus musculus OX=10090 GN=Zc3h3 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005847; GO:0008270; GO:0031124; GO:0032927; GO:0046332; GO:0051028; GO:0070412,mRNA 3'-end processing [GO:0031124]; mRNA transport [GO:0051028]; positive regulation of activin receptor signaling pathway [GO:0032927],mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634],DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0016071; GO:0043226,DNA binding; nucleus; mRNA metabolic process; organelle
OG_08109,FUN_035862-T1,Peve_00045294,Pocillopora_meandrina_HIv1___RNAseq.g11941.t1,three_way,73.98133333333332,,,,,,,,,,,,,,,,,
OG_08110,FUN_035863-T1,Peve_00045295,Pocillopora_meandrina_HIv1___RNAseq.g11940.t1,three_way,67.611,,,,,,,,,,,,,,,,,
OG_08111,FUN_035864-T1,Peve_00042154,Pocillopora_meandrina_HIv1___RNAseq.g11966.t1,three_way,90.75366666666666,FUN_035864-T1,O60231,DHX16_HUMAN,,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),Homo sapiens (Human),62.5,1039.0,0.0,1148.7,sp|O60231|DHX16_HUMAN Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 OS=Homo sapiens OX=9606 GN=DHX16 PE=1 SV=2,GO:0000398; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0008380; GO:0016887; GO:0038187; GO:0043130; GO:0060090; GO:0071005; GO:0140374,"antiviral innate immune response [GO:0140374]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; molecular adaptor activity [GO:0060090]; pattern recognition receptor activity [GO:0038187]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; ubiquitin binding [GO:0043130],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0060090; GO:0098542; GO:0140098; GO:0140657,"immune system process; RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; molecular transducer activity; molecular adaptor activity; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08112,FUN_035865-T1,Peve_00012613,Pocillopora_meandrina_HIv1___RNAseq.g11977.t1,three_way,77.13466666666666,FUN_035865-T1,Q8TEL6,TP4AP_HUMAN,,Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS),Homo sapiens (Human),37.4,768.0,3.2e-131,470.7,sp|Q8TEL6|TP4AP_HUMAN Short transient receptor potential channel 4-associated protein OS=Homo sapiens OX=9606 GN=TRPC4AP PE=1 SV=2,GO:0005262; GO:0005829; GO:0005886; GO:0006511; GO:0016567; GO:0019902; GO:0031464; GO:0048471; GO:0048820; GO:0070588; GO:0080008; GO:0140627; GO:1990756,calcium ion transmembrane transport [GO:0070588]; hair follicle maturation [GO:0048820]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the C-end degron rule pathway [GO:0140627],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; phosphatase binding [GO:0019902]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005215; GO:0005829; GO:0005886; GO:0030163; GO:0055085; GO:0060090,transporter activity; cytosol; plasma membrane; protein catabolic process; transmembrane transport; molecular adaptor activity
OG_08113,FUN_035867-T1,Peve_00012616,Pocillopora_meandrina_HIv1___RNAseq.g11976.t1,three_way,85.703,FUN_035867-T1,Q642Q1,,,,,69.7,287.0,2e-117,423.7,sp|Q642Q1|SAE2A_XENLA SUMO-activating enzyme subunit 2-A OS=Xenopus laevis OX=8355 GN=uba2-a PE=2 SV=1,,,,,,
OG_08114,FUN_035868-T1,Peve_00012617,Pocillopora_meandrina_HIv1___RNAseq.g11975.t1,three_way,69.01,,,,,,,,,,,,,,,,,
OG_08115,FUN_035869-T1,Peve_00012618,Pocillopora_meandrina_HIv1___RNAseq.g11973.t1,three_way,53.684333333333335,FUN_035869-T1,Q8R1F9,,,,,30.0,360.0,5.4e-36,152.9,sp|Q8R1F9|RPP40_MOUSE Ribonuclease P protein subunit p40 OS=Mus musculus OX=10090 GN=Rpp40 PE=2 SV=2,,,,,,
OG_08116,FUN_035870-T1,Peve_00012619,Pocillopora_meandrina_HIv1___RNAseq.g11972.t1,three_way,63.05433333333333,,,,,,,,,,,,,,,,,
OG_08117,FUN_035871-T1,Peve_00012622,Pocillopora_meandrina_HIv1___RNAseq.g11971.t1,three_way,62.25533333333333,FUN_035871-T1,O35218,,,,,52.0,269.0,2.1e-71,271.9,sp|O35218|CPSF2_MOUSE Cleavage and polyadenylation specificity factor subunit 2 OS=Mus musculus OX=10090 GN=Cpsf2 PE=1 SV=1,,,,,,
OG_08118,FUN_035872-T1,Peve_00014418,Pocillopora_meandrina_HIv1___RNAseq.g11987.t1,three_way,91.452,FUN_035872-T1,Q10568,,,,,69.1,181.0,3.2e-69,262.7,sp|Q10568|CPSF2_BOVIN Cleavage and polyadenylation specificity factor subunit 2 OS=Bos taurus OX=9913 GN=CPSF2 PE=1 SV=1,,,,,,
OG_08119,FUN_035873-T1,Peve_00014419,Pocillopora_meandrina_HIv1___RNAseq.g11988.t1,three_way,39.23133333333333,,,,,,,,,,,,,,,,,
OG_08120,FUN_035877-T1,Peve_00014421,Pocillopora_meandrina_HIv1___TS.g3329.t1b,three_way,54.79466666666666,FUN_035877-T1,A5PLK6,RGSL_HUMAN,,Regulator of G-protein signaling protein-like,Homo sapiens (Human),24.2,636.0,4.1e-35,152.1,sp|A5PLK6|RGSL_HUMAN Regulator of G-protein signaling protein-like OS=Homo sapiens OX=9606 GN=RGSL1 PE=1 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_08121,FUN_035878-T1,Peve_00014423,Pocillopora_meandrina_HIv1___RNAseq.g11992.t1,three_way,81.17266666666667,FUN_035878-T1,Q01650,LAT1_HUMAN,,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),Homo sapiens (Human),47.3,412.0,9.6e-108,392.1,sp|Q01650|LAT1_HUMAN Large neutral amino acids transporter small subunit 1 OS=Homo sapiens OX=9606 GN=SLC7A5 PE=1 SV=2,GO:0002720; GO:0003333; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010507; GO:0010629; GO:0014850; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015297; GO:0015349; GO:0015804; GO:0015818; GO:0015820; GO:0015821; GO:0015823; GO:0015824; GO:0015827; GO:0015828; GO:0015829; GO:0016020; GO:0016323; GO:0016324; GO:0031528; GO:0032328; GO:0032729; GO:0032740; GO:0032753; GO:0042149; GO:0042605; GO:0042908; GO:0043231; GO:0055093; GO:0060252; GO:0070062; GO:0070327; GO:0071222; GO:0089718; GO:0097421; GO:0098591; GO:0150104; GO:1902024; GO:1903577; GO:1903801; GO:1904556; GO:1905460; GO:1905534; GO:1990184,alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; cellular response to glucose starvation [GO:0042149]; cellular response to L-arginine [GO:1903577]; cellular response to lipopolysaccharide [GO:0071222]; isoleucine transport [GO:0015818]; L-histidine transport [GO:1902024]; L-leucine import across plasma membrane [GO:1903801]; L-leucine transport [GO:0015820]; L-tryptophan transmembrane transport [GO:1904556]; liver regeneration [GO:0097421]; methionine transport [GO:0015821]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of L-leucine import across plasma membrane [GO:1905534]; positive regulation of type II interferon production [GO:0032729]; proline transport [GO:0015824]; response to hyperoxia [GO:0055093]; response to muscle activity [GO:0014850]; thyroid hormone transport [GO:0070327]; transport across blood-brain barrier [GO:0150104]; tryptophan transport [GO:0015827]; tyrosine transport [GO:0015828]; valine transport [GO:0015829]; xenobiotic transport [GO:0042908],amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349],GO:0003013; GO:0005215; GO:0005829; GO:0005886; GO:0043226; GO:0048856; GO:0055085,circulatory system process; transporter activity; cytosol; plasma membrane; organelle; anatomical structure development; transmembrane transport
OG_08122,FUN_035879-T1,Peve_00014424,Pocillopora_meandrina_HIv1___TS.g3332.t1,three_way,50.62166666666667,,,,,,,,,,,,,,,,,
OG_08123,FUN_035880-T1,Peve_00014425,Pocillopora_meandrina_HIv1___RNAseq.g11995.t1,three_way,83.295,FUN_035880-T1,Q9QXA6,BAT1_MOUSE,,"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",Mus musculus (Mouse),47.9,457.0,9.000000000000001e-117,422.2,"sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1",GO:0005886; GO:0015175; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009,L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_08124,FUN_035882-T1,Peve_00014426,Pocillopora_meandrina_HIv1___RNAseq.g11996.t1,three_way,76.97966666666666,FUN_035882-T1,Q9QXA6,BAT1_MOUSE,,"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",Mus musculus (Mouse),50.3,485.0,5.700000000000001e-124,446.0,"sp|Q9QXA6|BAT1_MOUSE b(0,+)-type amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a9 PE=1 SV=1",GO:0005886; GO:0015175; GO:0015184; GO:0015804; GO:0015811; GO:0016324; GO:0031526; GO:0042605; GO:0046982; GO:0180009,L-cystine transport [GO:0015811]; neutral amino acid transport [GO:0015804],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],broad specificity neutral L-amino acid:basic L-amino acid antiporter activity [GO:0180009]; L-cystine transmembrane transporter activity [GO:0015184]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; protein heterodimerization activity [GO:0046982],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_08125,FUN_035883-T1,Peve_00014427,Pocillopora_meandrina_HIv1___RNAseq.g11998.t1,three_way,92.58233333333334,FUN_035883-T1,O14662,STX16_HUMAN,,Syntaxin-16 (Syn16),Homo sapiens (Human),51.5,305.0,2.8e-73,276.9,sp|O14662|STX16_HUMAN Syntaxin-16 OS=Homo sapiens OX=9606 GN=STX16 PE=1 SV=3,GO:0000139; GO:0000149; GO:0005484; GO:0005737; GO:0005794; GO:0005802; GO:0005829; GO:0005925; GO:0006886; GO:0006906; GO:0012505; GO:0016020; GO:0019905; GO:0030672; GO:0031201; GO:0031985; GO:0032456; GO:0032588; GO:0042147; GO:0043231; GO:0048278; GO:0048471,"endocytic recycling [GO:0032456]; intracellular protein transport [GO:0006886]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005794; GO:0005829; GO:0006886; GO:0016192; GO:0043226; GO:0060090; GO:0061024,Golgi apparatus; cytosol; intracellular protein transport; vesicle-mediated transport; organelle; molecular adaptor activity; membrane organization
OG_08126,FUN_035885-T1,Peve_00029403,Pocillopora_meandrina_HIv1___TS.g3340.t1,three_way,58.976333333333336,FUN_035885-T1,P0C0T2,ANKS6_RAT,,Ankyrin repeat and SAM domain-containing protein 6 (Polycystic kidney disease protein 1) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6),Rattus norvegicus (Rat),30.4,717.0,2.1e-37,159.1,sp|P0C0T2|ANKS6_RAT Ankyrin repeat and SAM domain-containing protein 6 OS=Rattus norvegicus OX=10116 GN=Anks6 PE=1 SV=2,GO:0001701; GO:0001822; GO:0005737; GO:0007368; GO:0007507; GO:0042802; GO:0045087; GO:0097543,determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; kidney development [GO:0001822],ciliary inversin compartment [GO:0097543]; cytoplasm [GO:0005737],identical protein binding [GO:0042802],GO:0002376; GO:0048856; GO:0098542,immune system process; anatomical structure development; defense response to other organism
OG_08127,FUN_035886-T1,Peve_00029402,Pocillopora_meandrina_HIv1___RNAseq.g12004.t1,three_way,81.07366666666667,FUN_035886-T1,O75340,PDCD6_HUMAN,,Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2),Homo sapiens (Human),52.7,167.0,2.5e-50,199.9,sp|O75340|PDCD6_HUMAN Programmed cell death protein 6 OS=Homo sapiens OX=9606 GN=PDCD6 PE=1 SV=1,GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005783; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031410; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042802; GO:0042803; GO:0043065; GO:0043495; GO:0045766; GO:0046982; GO:0046983; GO:0048208; GO:0048306; GO:0048471; GO:0051592; GO:0051898; GO:0070062; GO:0070971; GO:0097190; GO:1902527; GO:1990756,angiogenesis [GO:0001525]; apoptotic signaling pathway [GO:0097190]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005654; GO:0005768; GO:0005783; GO:0005829; GO:0006886; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0065003,nucleus; nucleoplasm; endosome; endoplasmic reticulum; cytosol; intracellular protein transport; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_08128,FUN_035888-T1,Peve_00029401,Pocillopora_meandrina_HIv1___RNAseq.g12005.t1,three_way,90.43733333333331,FUN_035888-T1,P12815,PDCD6_MOUSE,,Programmed cell death protein 6 (ALG-257) (Apoptosis-linked gene 2 protein) (ALG-2) (PMP41),Mus musculus (Mouse),64.9,168.0,8.4e-67,254.6,sp|P12815|PDCD6_MOUSE Programmed cell death protein 6 OS=Mus musculus OX=10090 GN=Pdcd6 PE=1 SV=2,GO:0000287; GO:0001525; GO:0001938; GO:0005509; GO:0005634; GO:0005654; GO:0005737; GO:0005768; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0006915; GO:0010595; GO:0014029; GO:0014032; GO:0030127; GO:0030674; GO:0030948; GO:0031463; GO:0032007; GO:0034605; GO:0036324; GO:0042803; GO:0043065; GO:0043495; GO:0045766; GO:0046982; GO:0046983; GO:0048208; GO:0048306; GO:0048471; GO:0051592; GO:0051898; GO:0070971; GO:1902527; GO:1990756,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005654; GO:0005768; GO:0005829; GO:0006886; GO:0012501; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0065003,nucleus; nucleoplasm; endosome; cytosol; intracellular protein transport; programmed cell death; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_08129,FUN_035889-T1,Peve_00029399,Pocillopora_meandrina_HIv1___RNAseq.g12006.t1,three_way,87.087,FUN_035889-T1,Q9CZX9,,,,,53.7,190.0,4.2e-40,166.0,sp|Q9CZX9|EMC4_MOUSE ER membrane protein complex subunit 4 OS=Mus musculus OX=10090 GN=Emc4 PE=1 SV=1,,,,,,
OG_08130,FUN_035890-T2,Peve_00029398,Pocillopora_meandrina_HIv1___RNAseq.g12007.t1,three_way,73.41116666666667,FUN_035890-T2,Q8TEB1,DCA11_HUMAN,,DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23),Homo sapiens (Human),51.1,493.0,1.3e-147,524.6,sp|Q8TEB1|DCA11_HUMAN DDB1- and CUL4-associated factor 11 OS=Homo sapiens OX=9606 GN=DCAF11 PE=1 SV=1,GO:0003016; GO:0005654; GO:0006979; GO:0007613; GO:0010467; GO:0016567; GO:0035640; GO:0043161; GO:0050821; GO:0080008,exploration behavior [GO:0035640]; gene expression [GO:0010467]; memory [GO:0007613]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; respiratory system process [GO:0003016]; response to oxidative stress [GO:0006979],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; nucleoplasm [GO:0005654],,GO:0003016; GO:0005654; GO:0030163; GO:0050877,respiratory system process; nucleoplasm; protein catabolic process; nervous system process
OG_08131,FUN_035891-T1,Peve_00029395,Pocillopora_meandrina_HIv1___RNAseq.g12008.t1,three_way,81.82483333333333,FUN_035891-T1,Q9WUU6,,,,,68.0,325.0,9.9e-122,438.3,sp|Q9WUU6|HNF4G_MOUSE Hepatocyte nuclear factor 4-gamma OS=Mus musculus OX=10090 GN=Hnf4g PE=2 SV=2,,,,,,
OG_08132,FUN_035892-T1,Peve_00029394,Pocillopora_meandrina_HIv1___RNAseq.g12009.t1,three_way,77.4455,FUN_035892-T1,Q8BH79,,,,,42.9,631.0,1.1e-140,501.9,sp|Q8BH79|ANO10_MOUSE Anoctamin-10 OS=Mus musculus OX=10090 GN=Ano10 PE=1 SV=1,,,,,,
OG_08133,FUN_035894-T1,Peve_00029391,Pocillopora_meandrina_HIv1___RNAseq.g12010.t1,three_way,84.60600000000001,FUN_035894-T1,Q9NYG2,,,,,45.2,252.0,8.5e-50,198.7,sp|Q9NYG2|ZDHC3_HUMAN Palmitoyltransferase ZDHHC3 OS=Homo sapiens OX=9606 GN=ZDHHC3 PE=1 SV=2,,,,,,
OG_08134,FUN_035895-T1,Peve_00029390,Pocillopora_meandrina_HIv1___RNAseq.g12011.t1,three_way,74.62633333333333,FUN_035895-T1,Q1JPG1,,,,,37.2,470.0,1.4e-52,209.5,sp|Q1JPG1|RS10B_BOVIN Radial spoke head 10 homolog B OS=Bos taurus OX=9913 GN=RSPH10B PE=2 SV=2,,,,,,
OG_08135,FUN_035897-T1,Peve_00029404,Pocillopora_meandrina_HIv1___RNAseq.g12021.t1,three_way,83.846,FUN_035897-T1,P35285,RB22A_MOUSE,,Ras-related protein Rab-22A (Rab-22) (Rab-14),Mus musculus (Mouse),55.9,195.0,9.999999999999999e-54,211.5,sp|P35285|RB22A_MOUSE Ras-related protein Rab-22A OS=Mus musculus OX=10090 GN=Rab22a PE=1 SV=2,GO:0001726; GO:0003924; GO:0005525; GO:0005769; GO:0005770; GO:0005794; GO:0005886; GO:0006897; GO:0007032; GO:0010008; GO:0015031; GO:0015629; GO:0019003; GO:0030670; GO:0045335; GO:0097494,endocytosis [GO:0006897]; endosome organization [GO:0007032]; protein transport [GO:0015031]; regulation of vesicle size [GO:0097494],actin cytoskeleton [GO:0015629]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; ruffle [GO:0001726],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005794; GO:0005856; GO:0005886; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; endosome; Golgi apparatus; cytoskeleton; plasma membrane; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_08136,FUN_035898-T1,Peve_00029392,Pocillopora_meandrina_HIv1___RNAseq.g12022.t1,three_way,92.744,FUN_035898-T1,A2APC3,TTLL9_MOUSE,,Probable tubulin polyglutamylase TTLL9 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 9),Mus musculus (Mouse),68.2,444.0,1.6e-175,617.1,sp|A2APC3|TTLL9_MOUSE Probable tubulin polyglutamylase TTLL9 OS=Mus musculus OX=10090 GN=Ttll9 PE=1 SV=2,GO:0005524; GO:0005737; GO:0005874; GO:0030317; GO:0031514; GO:0036064; GO:0036211; GO:0046872; GO:0070740; GO:0106438,flagellated sperm motility [GO:0030317]; protein modification process [GO:0036211],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; motile cilium [GO:0031514],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005815; GO:0005929; GO:0007018; GO:0016874; GO:0022414; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; microtubule organizing center; cilium; microtubule-based movement; ligase activity; reproductive process; organelle; cell motility; catalytic activity, acting on a protein"
OG_08137,FUN_035899-T1,Peve_00006715,Pocillopora_meandrina_HIv1___RNAseq.g12023.t1,three_way,75.59100000000001,FUN_035899-T1,Q148L7,,,,,49.2,120.0,7.699999999999998e-25,114.8,sp|Q148L7|PDRG1_BOVIN p53 and DNA damage-regulated protein 1 OS=Bos taurus OX=9913 GN=PDRG1 PE=2 SV=1,,,,,,
OG_08138,FUN_035900-T1,Peve_00006713,Pocillopora_meandrina_HIv1___RNAseq.g12025.t1,three_way,79.64066666666668,,,,,,,,,,,,,,,,,
OG_08139,FUN_035901-T1,Peve_00006712,Pocillopora_meandrina_HIv1___RNAseq.g12026.t1,three_way,63.80683333333334,FUN_035901-T1,Q96H35,,,,,44.4,160.0,6.5e-30,132.1,sp|Q96H35|RBM18_HUMAN Probable RNA-binding protein 18 OS=Homo sapiens OX=9606 GN=RBM18 PE=1 SV=1,,,,,,
OG_08140,FUN_035902-T1,Peve_00006711,Pocillopora_meandrina_HIv1___TS.g3367.t1,three_way,85.12433333333334,FUN_035902-T1,Q9JJ94,SSNA1_MOUSE,,Microtubule nucleation factor SSNA1 (Sjoegren syndrome nuclear autoantigen 1 homolog),Mus musculus (Mouse),44.7,114.0,9e-12,71.2,sp|Q9JJ94|SSNA1_MOUSE Microtubule nucleation factor SSNA1 OS=Mus musculus OX=10090 GN=Ssna1 PE=1 SV=1,GO:0000226; GO:0005634; GO:0005813; GO:0005814; GO:0005886; GO:0005930; GO:0007020; GO:0007409; GO:0008017; GO:0030424; GO:0030496; GO:0031514; GO:0036064; GO:0042073; GO:0042802; GO:0043113; GO:0048675; GO:0051301; GO:0099512; GO:0140060,axon arborization [GO:0140060]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell division [GO:0051301]; intraciliary transport [GO:0042073]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; receptor clustering [GO:0043113],axon [GO:0030424]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; midbody [GO:0030496]; motile cilium [GO:0031514]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; supramolecular fiber [GO:0099512],identical protein binding [GO:0042802]; microtubule binding [GO:0008017],GO:0005634; GO:0005815; GO:0005886; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0043226,nucleus; microtubule organizing center; plasma membrane; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; organelle
OG_08141,FUN_035903-T1,Peve_00006709,Pocillopora_meandrina_HIv1___RNAseq.g12028.t1,three_way,63.929,FUN_035903-T1,Q3TQF0,FBX31_MOUSE,,F-box only protein 31,Mus musculus (Mouse),32.1,448.0,2.8e-57,224.2,sp|Q3TQF0|FBX31_MOUSE F-box only protein 31 OS=Mus musculus OX=10090 GN=Fbxo31 PE=1 SV=1,GO:0005737; GO:0006974; GO:0016567; GO:0019005; GO:0030332; GO:0031145; GO:0031146; GO:0031571; GO:0034599; GO:0043025; GO:0043161; GO:1990756,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cellular response to oxidative stress [GO:0034599]; DNA damage response [GO:0006974]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_08142,FUN_035907-T1,Peve_00006737,Pocillopora_meandrina_HIv1___RNAseq.g12031.t1,three_way,87.19116666666667,FUN_035907-T1,Q5RE09,DC1L2_PONAB,,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),51.2,477.0,2.9e-122,440.3,sp|Q5RE09|DC1L2_PONAB Cytoplasmic dynein 1 light intermediate chain 2 OS=Pongo abelii OX=9601 GN=DYNC1LI2 PE=2 SV=1,GO:0000226; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0007018; GO:0045504,microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874],ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504],GO:0005815; GO:0007010; GO:0007018,microtubule organizing center; cytoskeleton organization; microtubule-based movement
OG_08143,FUN_035908-T1,Peve_00006733,Pocillopora_meandrina_HIv1___TS.g3371.t1,three_way,92.83516666666668,,,,,,,,,,,,,,,,,
OG_08144,FUN_035913-T1,Peve_00006734,Pocillopora_meandrina_HIv1___RNAseq.g12035.t1,three_way,56.841,,,,,,,,,,,,,,,,,
OG_08145,FUN_035914-T1,Peve_00006728,Pocillopora_meandrina_HIv1___TS.g3385.t1,three_way,55.639,FUN_035914-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),29.7,1194.0,1.6e-96,356.3,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_08146,FUN_035915-T1,Peve_00006727,Pocillopora_meandrina_HIv1___RNAseq.24982_t,three_way,54.92366666666666,,,,,,,,,,,,,,,,,
OG_08147,FUN_035916-T1,Peve_00006726,Pocillopora_meandrina_HIv1___RNAseq.g12042.t1,three_way,65.44183333333334,,,,,,,,,,,,,,,,,
OG_08148,FUN_035917-T1,Peve_00006725,Pocillopora_meandrina_HIv1___TS.g3382.t1,three_way,58.83166666666667,FUN_035917-T1,Q3ZBF3,,,,,41.2,245.0,2.2e-49,197.6,sp|Q3ZBF3|RM38_BOVIN Large ribosomal subunit protein mL38 OS=Bos taurus OX=9913 GN=MRPL38 PE=1 SV=2,,,,,,
OG_08149,FUN_035919-T1,Peve_00006722,Pocillopora_meandrina_HIv1___RNAseq.g12040.t1b,three_way,71.68866666666666,,,,,,,,,,,,,,,,,
OG_08150,FUN_035921-T1,Peve_00006717,Pocillopora_meandrina_HIv1___TS.g3389.t1,three_way,59.95333333333333,,,,,,,,,,,,,,,,,
OG_08151,FUN_035923-T1,Peve_00006710,Pocillopora_meandrina_HIv1___RNAseq.g12052.t1,three_way,56.369166666666665,,,,,,,,,,,,,,,,,
OG_08152,FUN_035926-T1,Peve_00006729,Pocillopora_meandrina_HIv1___RNAseq.g12054.t1,three_way,74.99366666666667,FUN_035926-T1,A3KG59,P20D2_MOUSE,,Xaa-Arg dipeptidase (EC 3.4.13.4),Mus musculus (Mouse),49.6,399.0,6.3e-102,372.5,sp|A3KG59|P20D2_MOUSE Xaa-Arg dipeptidase OS=Mus musculus OX=10090 GN=Pm20d2 PE=1 SV=1,GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246,proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802],GO:0003824; GO:0005654; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; catalytic activity, acting on a protein"
OG_08153,FUN_035930-T1,Peve_00036624,Pocillopora_meandrina_HIv1___RNAseq.g12067.t1,three_way,73.38733333333333,FUN_035930-T1,Q6EDY6,CARL1_MOUSE,,"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (CARML1) (Leucine-rich repeat-containing protein 16A)",Mus musculus (Mouse),37.8,1029.0,9.8e-173,609.8,sp|Q6EDY6|CARL1_MOUSE F-actin-uncapping protein LRRC16A OS=Mus musculus OX=10090 GN=Carmil1 PE=1 SV=2,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007163; GO:0016477; GO:0016607; GO:0030027; GO:0030032; GO:0030335; GO:0030838; GO:0031529; GO:0031941; GO:0044351; GO:0044354; GO:0044877; GO:0045111; GO:0046415; GO:0051496; GO:0051638; GO:0051639; GO:1900026; GO:1902745; GO:2000813,actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886],protein-containing complex binding [GO:0044877],GO:0005634; GO:0005768; GO:0005829; GO:0005856; GO:0005886; GO:0007163; GO:0016192; GO:0031410; GO:0043226; GO:0048870,nucleus; endosome; cytosol; cytoskeleton; plasma membrane; establishment or maintenance of cell polarity; vesicle-mediated transport; cytoplasmic vesicle; organelle; cell motility
OG_08154,FUN_035931-T1,Peve_00036620,Pocillopora_meandrina_HIv1___RNAseq.25006_t,three_way,67.78866666666667,FUN_035931-T1,A4XU32,RRAAH_ECTM1,,Putative 4-hydroxy-4-methyl-2-oxoglutarate aldolase (HMG aldolase) (EC 4.1.3.17) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.112) (Regulator of ribonuclease activity homolog) (RraA-like protein),Ectopseudomonas mendocina (strain ymp) (Pseudomonas mendocina),55.7,158.0,1.6999999999999996e-47,190.7,sp|A4XU32|RRAAH_ECTM1 Putative 4-hydroxy-4-methyl-2-oxoglutarate aldolase OS=Ectopseudomonas mendocina (strain ymp) OX=399739 GN=Pmen_2087 PE=3 SV=1,GO:0008428; GO:0008948; GO:0046872; GO:0047443; GO:0051252,regulation of RNA metabolic process [GO:0051252],,4-hydroxy-4-methyl-2-oxoglutarate aldolase activity [GO:0047443]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]; ribonuclease inhibitor activity [GO:0008428],GO:0003824; GO:0016829; GO:0098772,catalytic activity; lyase activity; molecular function regulator activity
OG_08155,FUN_035933-T1,Peve_00036622,Pocillopora_meandrina_HIv1___RNAseq.g12069.t1,three_way,85.512,FUN_035933-T1,Q8HXG8,BCDO2_MACFA,,"Carotenoid-cleaving dioxygenase, mitochondrial (EC 1.13.11.-) (EC 1.13.11.71) (Beta-carotene dioxygenase 2)",Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),35.6,368.0,2.7e-56,220.7,"sp|Q8HXG8|BCDO2_MACFA Carotenoid-cleaving dioxygenase, mitochondrial OS=Macaca fascicularis OX=9541 GN=BCO2 PE=2 SV=2",GO:0003834; GO:0005739; GO:0010437; GO:0016119; GO:0016121; GO:0016124; GO:0016702; GO:0042574; GO:0046872; GO:0062172; GO:0102076; GO:1901176; GO:1901826,carotene catabolic process [GO:0016121]; carotene metabolic process [GO:0016119]; lutein catabolic process [GO:0062172]; lycopene catabolic process [GO:1901176]; retinal metabolic process [GO:0042574]; xanthophyll catabolic process [GO:0016124]; zeaxanthin catabolic process [GO:1901826],mitochondrion [GO:0005739],"9,10 (9', 10')-carotenoid-cleaving dioxygenase activity [GO:0010437]; beta,beta-carotene-9',10'-cleaving oxygenase activity [GO:0102076]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]",GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle
OG_08156,FUN_035934-T1,Peve_00036623,Pocillopora_meandrina_HIv1___RNAseq.g12071.t1,three_way,75.52133333333333,FUN_035934-T1,Q9Z2D5,,,,,23.1,303.0,5.2e-08,60.1,sp|Q9Z2D5|NPY2R_CAVPO Neuropeptide Y receptor type 2 OS=Cavia porcellus OX=10141 GN=NPY2R PE=3 SV=1,,,,,,
OG_08157,FUN_035935-T1,Peve_00036625,Pocillopora_meandrina_HIv1___RNAseq.g12072.t1,three_way,80.009,FUN_035935-T1,P23709,,,,,72.6,212.0,3.8e-87,322.8,"sp|P23709|NDUS3_BOVIN NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS3 PE=1 SV=1",,,,,,
OG_08158,FUN_035936-T1,Peve_00036627,Pocillopora_meandrina_HIv1___RNAseq.g12073.t1,three_way,53.47433333333333,FUN_035936-T1,Q4UB16,,,,,28.3,191.0,4.2e-12,73.2,sp|Q4UB16|RAB1_THEAN Ras-related protein Rab-1 OS=Theileria annulata OX=5874 GN=rab1 PE=3 SV=1,,,,,,
OG_08159,FUN_035940-T1,Peve_00036628,Pocillopora_meandrina_HIv1___RNAseq.g12074.t1,three_way,50.0505,FUN_035940-T1,Q86JC8,,,,,30.0,150.0,1.5e-06,54.7,sp|Q86JC8|RABH_DICDI Ras-related protein RabH OS=Dictyostelium discoideum OX=44689 GN=rabH PE=3 SV=1,,,,,,
OG_08160,FUN_035941-T1,Peve_00036629,Pocillopora_meandrina_HIv1___RNAseq.g12076.t1,three_way,64.244,FUN_035941-T1,P36861,,,,,37.7,175.0,9.3e-27,122.1,sp|P36861|YPTV2_VOLCA GTP-binding protein yptV2 OS=Volvox carteri OX=3067 GN=YPTV2 PE=3 SV=1,,,,,,
OG_08161,FUN_035942-T1,Peve_00036630,Pocillopora_meandrina_HIv1___RNAseq.g12075.t1,three_way,70.11566666666667,FUN_035942-T1,P36410,RAB14_DICDI,,Ras-related protein Rab-14 (EC 3.6.5.2) (Rab4-like GTPase),Dictyostelium discoideum (Social amoeba),37.9,169.0,2.2000000000000004e-28,127.1,sp|P36410|RAB14_DICDI Ras-related protein Rab-14 OS=Dictyostelium discoideum OX=44689 GN=rab14 PE=1 SV=2,GO:0003924; GO:0005525; GO:0005764; GO:0005765; GO:0005769; GO:0005802; GO:0005811; GO:0005829; GO:0006886; GO:0006895; GO:0006970; GO:0006971; GO:0012505; GO:0031164; GO:0032456; GO:0033298; GO:0042742; GO:0045335; GO:0048548; GO:0055037; GO:0062160; GO:0090382; GO:0140220; GO:1905364,contractile vacuole organization [GO:0033298]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; Golgi to endosome transport [GO:0006895]; hypotonic response [GO:0006971]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; regulation of endosomal vesicle fusion [GO:1905364]; regulation of pinocytosis [GO:0048548]; response to osmotic stress [GO:0006970],contractile vacuolar membrane [GO:0031164]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; pathogen-containing vacuole [GO:0140220]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; spongiome [GO:0062160]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005764; GO:0005768; GO:0005773; GO:0005811; GO:0005829; GO:0006886; GO:0016192; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; lysosome; endosome; vacuole; lipid droplet; cytosol; intracellular protein transport; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_08162,FUN_035943-T1,Peve_00036631,Pocillopora_meandrina_HIv1___RNAseq.g12354.t1,three_way,85.26533333333333,,,,,,,,,,,,,,,,,
OG_08163,FUN_035945-T1,Peve_00036633,Pocillopora_meandrina_HIv1___RNAseq.g12353.t1,three_way,72.697,FUN_035945-T1,Q5RJV0,,,,,44.9,243.0,8.8e-55,215.3,"sp|Q5RJV0|COQ9_XENTR Ubiquinone biosynthesis protein COQ9, mitochondrial OS=Xenopus tropicalis OX=8364 GN=coq9 PE=2 SV=1",,,,,,
OG_08164,FUN_035947-T1,Peve_00036635,Pocillopora_meandrina_HIv1___RNAseq.g12350.t1,three_way,62.132666666666665,FUN_035947-T1,Q99KW9,,,,,39.8,606.0,8.400000000000001e-111,402.5,sp|Q99KW9|TIP_MOUSE T-cell immunomodulatory protein OS=Mus musculus OX=10090 GN=Itfg1 PE=1 SV=2,,,,,,
OG_08165,FUN_035962-T1,Peve_00006624,Pocillopora_meandrina_HIv1___RNAseq.g12329.t1,three_way,87.42883333333333,FUN_035962-T1,Q9GYZ0,,,,,39.5,1065.0,2e-180,634.8,sp|Q9GYZ0|KIF15_STRPU Kinesin-like protein KIF15 OS=Strongylocentrotus purpuratus OX=7668 GN=KIF15 PE=1 SV=1,,,,,,
OG_08166,FUN_035965-T1,Peve_00006627,Pocillopora_meandrina_HIv1___RNAseq.g12331.t2,three_way,65.468,,,,,,,,,,,,,,,,,
OG_08167,FUN_035969-T1,Peve_00045085,Pocillopora_meandrina_HIv1___RNAseq.g12339.t1,three_way,87.10833333333333,FUN_035969-T1,Q6GR45,,,,,81.2,245.0,5.7e-114,411.8,sp|Q6GR45|IF6_XENLA Eukaryotic translation initiation factor 6 OS=Xenopus laevis OX=8355 GN=eif6 PE=2 SV=1,,,,,,
OG_08168,FUN_035972-T1,Peve_00006613,Pocillopora_meandrina_HIv1___RNAseq.g12338.t2,three_way,69.5,FUN_035972-T1,P0DOC8,,,,,43.1,204.0,5.9e-40,165.6,sp|P0DOC8|CF418_DANRE Cilia- and flagella-associated protein 418 OS=Danio rerio OX=7955 GN=cfap418 PE=1 SV=1,,,,,,
OG_08169,FUN_035973-T1,Peve_00006612,Pocillopora_meandrina_HIv1___RNAseq.g12337.t2,three_way,84.21,FUN_035973-T1,Q11136,PEPD_MOUSE,,Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase 4) (Peptidase D) (Proline dipeptidase) (Prolidase),Mus musculus (Mouse),65.2,492.0,1.3e-197,690.6,sp|Q11136|PEPD_MOUSE Xaa-Pro dipeptidase OS=Mus musculus OX=10090 GN=Pepd PE=1 SV=3,GO:0006508; GO:0008233; GO:0030145; GO:0030574; GO:0043069; GO:0070006; GO:0102009,collagen catabolic process [GO:0030574]; negative regulation of programmed cell death [GO:0043069]; proteolysis [GO:0006508],,manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; proline dipeptidase activity [GO:0102009],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_08170,FUN_035976-T1,Peve_00006611,Pocillopora_meandrina_HIv1___RNAseq.g12335.t1,three_way,78.89066666666666,FUN_035976-T1,Q8BVR6,,,,,56.2,489.0,3e-152,540.0,sp|Q8BVR6|RSPRY_MOUSE RING finger and SPRY domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rspry1 PE=1 SV=1,,,,,,
OG_08171,FUN_035978-T1,Peve_00045087,Pocillopora_meandrina_HIv1___RNAseq.g12340.t1,three_way,89.63966666666667,FUN_035978-T1,Q9Y2E8,SL9A8_HUMAN,,Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8),Homo sapiens (Human),56.9,568.0,1.0999999999999999e-166,588.2,sp|Q9Y2E8|SL9A8_HUMAN Sodium/hydrogen exchanger 8 OS=Homo sapiens OX=9606 GN=SLC9A8 PE=1 SV=4,GO:0000139; GO:0001669; GO:0001675; GO:0006811; GO:0015385; GO:0015386; GO:0016324; GO:0032585; GO:0032588; GO:0035725; GO:0051453; GO:0071805; GO:1902600; GO:1905526,acrosome assembly [GO:0001675]; monoatomic ion transport [GO:0006811]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of Golgi lumen acidification [GO:1905526]; regulation of intracellular pH [GO:0051453]; sodium ion transmembrane transport [GO:0035725],acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; multivesicular body membrane [GO:0032585]; trans-Golgi network membrane [GO:0032588],potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0022414; GO:0031410; GO:0043226; GO:0055085,transporter activity; reproductive process; cytoplasmic vesicle; organelle; transmembrane transport
OG_08172,FUN_035980-T1,Peve_00045080,Pocillopora_meandrina_HIv1___RNAseq.g12341.t1,three_way,43.156333333333336,,,,,,,,,,,,,,,,,
OG_08173,FUN_035981-T1,Peve_00045083,Pocillopora_meandrina_HIv1___RNAseq.g12342.t1,three_way,87.08966666666667,FUN_035981-T1,Q9QYJ0,,,,,57.3,410.0,3.3e-127,456.4,sp|Q9QYJ0|DNJA2_MOUSE DnaJ homolog subfamily A member 2 OS=Mus musculus OX=10090 GN=Dnaja2 PE=1 SV=1,,,,,,
OG_08174,FUN_035983-T1,Peve_00038194,Pocillopora_meandrina_HIv1___TS.g3681.t1,three_way,41.83016666666666,,,,,,,,,,,,,,,,,
OG_08175,FUN_035986-T1,Peve_00038193,Pocillopora_meandrina_HIv1___RNAseq.g12345.t1,three_way,50.869166666666665,,,,,,,,,,,,,,,,,
OG_08176,FUN_035998-T1,Peve_00041845,Pocillopora_meandrina_HIv1___RNAseq.g12328.t1b,three_way,73.96566666666666,FUN_035998-T1,Q5EAC2,GSHB_BOVIN,,Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase),Bos taurus (Bovine),44.9,472.0,1.8e-108,394.4,sp|Q5EAC2|GSHB_BOVIN Glutathione synthetase OS=Bos taurus OX=9913 GN=GSS PE=2 SV=1,GO:0000287; GO:0004363; GO:0005524; GO:0005829; GO:0042803; GO:0043295,,cytosol [GO:0005829],ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0016874,catalytic activity; cytosol; ligase activity
OG_08177,FUN_036000-T1,Peve_00041843,Pocillopora_meandrina_HIv1___RNAseq.g12328.t1a,three_way,77.74933333333334,FUN_036000-T1,Q93XX5,,,,,32.8,186.0,9e-18,92.8,sp|Q93XX5|Y5713_ARATH PI-PLC X domain-containing protein At5g67130 OS=Arabidopsis thaliana OX=3702 GN=At5g67130 PE=1 SV=1,,,,,,
OG_08178,FUN_036002-T1,Peve_00041842,Pocillopora_meandrina_HIv1___RNAseq.g12326.t1,three_way,67.96933333333334,FUN_036002-T1,O16099,,,,,43.3,506.0,4.3e-112,406.8,sp|O16099|MAL2_DROVI Maltase 2 OS=Drosophila virilis OX=7244 GN=Mal-B2 PE=3 SV=2,,,,,,
OG_08179,FUN_036003-T1,Peve_00041841,Pocillopora_meandrina_HIv1___RNAseq.g12325.t1,three_way,75.89933333333333,FUN_036003-T1,Q0VCJ8,METL9_BOVIN,,Protein-L-histidine N-pros-methyltransferase (EC 2.1.1.-) (Methyltransferase-like protein 9),Bos taurus (Bovine),51.5,262.0,1.7e-76,287.7,sp|Q0VCJ8|METL9_BOVIN Protein-L-histidine N-pros-methyltransferase OS=Bos taurus OX=9913 GN=METTL9 PE=2 SV=1,GO:0005739; GO:0005783; GO:0032259; GO:0106370,methylation [GO:0032259],endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],protein-L-histidine N-pros-methyltransferase activity [GO:0106370],GO:0003824; GO:0005739; GO:0005783; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; endoplasmic reticulum; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08180,FUN_036004-T1,Peve_00041840,Pocillopora_meandrina_HIv1___RNAseq.g12324.t1,three_way,77.76566666666666,FUN_036004-T1,Q6YI46,,,,,48.0,223.0,3e-49,197.2,sp|Q6YI46|TMM64_HUMAN Transmembrane protein 64 OS=Homo sapiens OX=9606 GN=TMEM64 PE=1 SV=2,,,,,,
OG_08181,FUN_036015-T1,Peve_00001714,Pocillopora_meandrina_HIv1___RNAseq.g12323.t1,three_way,70.30366666666667,FUN_036015-T1,Q9D1Q1,,,,,37.7,162.0,1.4e-15,84.3,sp|Q9D1Q1|MPH6_MOUSE M-phase phosphoprotein 6 OS=Mus musculus OX=10090 GN=Mphosph6 PE=1 SV=1,,,,,,
OG_08182,FUN_036018-T2,Peve_00024357,Pocillopora_meandrina_HIv1___RNAseq.g12321.t1,three_way,60.927,FUN_036018-T2,Q6ZN54,DEFI8_HUMAN,,Differentially expressed in FDCP 8 homolog (DEF-8),Homo sapiens (Human),51.8,380.0,3.6e-108,394.4,sp|Q6ZN54|DEFI8_HUMAN Differentially expressed in FDCP 8 homolog OS=Homo sapiens OX=9606 GN=DEF8 PE=1 SV=2,GO:0008270; GO:0032418; GO:0045780; GO:1900029,lysosome localization [GO:0032418]; positive regulation of bone resorption [GO:0045780]; positive regulation of ruffle assembly [GO:1900029],,zinc ion binding [GO:0008270],,
OG_08183,FUN_036020-T1,Peve_00024356,Pocillopora_meandrina_HIv1___TS.g3652.t1,three_way,70.24316666666667,FUN_036020-T1,Q54PH5,,,,,37.7,371.0,4.7999999999999997e-54,213.8,sp|Q54PH5|CWC2_DICDI Pre-mRNA-splicing factor cwc2 OS=Dictyostelium discoideum OX=44689 GN=cwc2 PE=3 SV=1,,,,,,
OG_08184,FUN_036021-T2,Peve_00001106,Pocillopora_meandrina_HIv1___RNAseq.g12317.t1,three_way,59.592,FUN_036021-T2,Q9HCD5,NCOA5_HUMAN,,Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA),Homo sapiens (Human),35.6,261.0,6.599999999999998e-29,131.0,sp|Q9HCD5|NCOA5_HUMAN Nuclear receptor coactivator 5 OS=Homo sapiens OX=9606 GN=NCOA5 PE=1 SV=2,GO:0000122; GO:0003682; GO:0003714; GO:0003723; GO:0005615; GO:0005654; GO:0008286; GO:0009966; GO:0015629; GO:0042593; GO:0046627,glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of signal transduction [GO:0009966],actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654],chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714],GO:0003723; GO:0005615; GO:0005654; GO:0005856; GO:0006355; GO:0043226; GO:0060090; GO:0140110,RNA binding; extracellular space; nucleoplasm; cytoskeleton; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_08185,FUN_036025-T1,Peve_00011111,Pocillopora_meandrina_HIv1___RNAseq.g27235.t1,three_way,81.50766666666667,FUN_036025-T1,F7B645,,,,,49.8,311.0,1e-83,311.6,sp|F7B645|TM231_XENTR Transmembrane protein 231 OS=Xenopus tropicalis OX=8364 GN=tmem231 PE=2 SV=1,,,,,,
OG_08186,FUN_036026-T1,Peve_00011110,Pocillopora_meandrina_HIv1___RNAseq.g27236.t1,three_way,53.73583333333333,FUN_036026-T1,Q9BUB4,,,,,36.3,529.0,4.8e-73,276.9,sp|Q9BUB4|ADAT1_HUMAN tRNA-specific adenosine deaminase 1 OS=Homo sapiens OX=9606 GN=ADAT1 PE=1 SV=1,,,,,,
OG_08187,FUN_036027-T1,Peve_00011108,Pocillopora_meandrina_HIv1___RNAseq.g27237.t1,three_way,96.29633333333334,FUN_036027-T1,P60519,,,,,75.9,116.0,3.2e-46,185.7,sp|P60519|GBRL2_BOVIN Gamma-aminobutyric acid receptor-associated protein-like 2 OS=Bos taurus OX=9913 GN=GABARAPL2 PE=1 SV=1,,,,,,
OG_08188,FUN_036028-T1,Peve_00011107,Pocillopora_meandrina_HIv1___RNAseq.g27238.t2,three_way,67.458,FUN_036028-T1,Q8N6M0,OTU6B_HUMAN,,Deubiquitinase OTUD6B (EC 3.4.19.12) (DUBA-5) (OTU domain-containing protein 6B),Homo sapiens (Human),51.6,281.0,5.5999999999999986e-68,259.2,sp|Q8N6M0|OTU6B_HUMAN Deubiquitinase OTUD6B OS=Homo sapiens OX=9606 GN=OTUD6B PE=1 SV=1,GO:0004843; GO:0006508; GO:0008283; GO:0016579; GO:0017148; GO:0043248; GO:0045727,cell population proliferation [GO:0008283]; negative regulation of translation [GO:0017148]; positive regulation of translation [GO:0045727]; proteasome assembly [GO:0043248]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],,cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0016787; GO:0065003; GO:0140096,"catalytic activity; hydrolase activity; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_08189,FUN_036029-T1,Peve_00011105,Pocillopora_meandrina_HIv1___RNAseq.g27239.t1,three_way,87.85733333333333,FUN_036029-T1,P37879,,,,,74.4,426.0,4e-195,682.2,sp|P37879|SYK_CRIGR Lysine--tRNA ligase OS=Cricetulus griseus OX=10029 GN=KARS1 PE=1 SV=1,,,,,,
OG_08190,FUN_036030-T1,Peve_00011104,Pocillopora_meandrina_HIv1___RNAseq.g27240.t1,three_way,78.177,FUN_036030-T1,Q6NRS2,,,,,60.0,180.0,2.9e-55,216.5,sp|Q6NRS2|S66A2_XENLA Solute carrier family 66 member 2 OS=Xenopus laevis OX=8355 GN=slc66a2 PE=2 SV=1,,,,,,
OG_08191,FUN_036031-T1,Peve_00011103,Pocillopora_meandrina_HIv1___RNAseq.g27241.t1,three_way,81.92866666666667,FUN_036031-T1,A5A779,PGTA_PIG,,Geranylgeranyl transferase type-2 subunit alpha (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha),Sus scrofa (Pig),51.5,305.0,3.7e-86,319.7,sp|A5A779|PGTA_PIG Geranylgeranyl transferase type-2 subunit alpha OS=Sus scrofa OX=9823 GN=RABGGTA PE=2 SV=1,GO:0004663; GO:0005737; GO:0005968; GO:0006888; GO:0008270; GO:0018344; GO:0031267,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein geranylgeranylation [GO:0018344],cytoplasm [GO:0005737]; Rab-protein geranylgeranyltransferase complex [GO:0005968],Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0003824; GO:0016192; GO:0016740; GO:0140096,"catalytic activity; vesicle-mediated transport; transferase activity; catalytic activity, acting on a protein"
OG_08192,FUN_036035-T1,Peve_00011097,Pocillopora_meandrina_HIv1___TS.g14605.t2,three_way,50.55033333333333,FUN_036035-T1,Q0V8S9,,,,,27.5,641.0,1.3e-62,243.4,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_08193,FUN_036036-T1,Peve_00011095,Pocillopora_meandrina_HIv1___RNAseq.g27261.t1,three_way,84.87933333333334,FUN_036036-T1,Q17QB7,RAB30_BOVIN,,Ras-related protein Rab-30 (EC 3.6.5.2),Bos taurus (Bovine),46.9,194.0,1.5e-44,181.0,sp|Q17QB7|RAB30_BOVIN Ras-related protein Rab-30 OS=Bos taurus OX=9913 GN=RAB30 PE=2 SV=1,GO:0003924; GO:0005525; GO:0005801; GO:0005802; GO:0007030; GO:0016020; GO:0016192; GO:0031985; GO:0032482,Golgi organization [GO:0007030]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],cis-Golgi network [GO:0005801]; Golgi cisterna [GO:0031985]; membrane [GO:0016020]; trans-Golgi network [GO:0005802],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016192; GO:0016787; GO:0043226,catalytic activity; GTPase activity; vesicle-mediated transport; hydrolase activity; organelle
OG_08194,FUN_036037-T1,Peve_00011093,Pocillopora_meandrina_HIv1___TS.g14608.t1,three_way,65.38533333333334,,,,,,,,,,,,,,,,,
OG_08195,FUN_036039-T1,Peve_00011116,Pocillopora_meandrina_HIv1___RNAseq.g27232.t1,three_way,63.887,FUN_036039-T1,O42430,,,,,33.9,487.0,2.1e-81,304.7,sp|O42430|CP1A1_LIMLI Cytochrome P450 1A1 OS=Limanda limanda OX=27771 GN=cyp1a1 PE=2 SV=1,,,,,,
OG_08196,FUN_036040-T1,Peve_00011088,Pocillopora_meandrina_HIv1___RNAseq.g27265.t1,three_way,59.95966666666666,FUN_036040-T1,Q9VD28,JMJD6_DROME,,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Jumonji domain-containing protein 6) (Phosphatidylserine receptor) (dPSR),Drosophila melanogaster (Fruit fly),27.5,291.0,4.3e-23,110.9,sp|Q9VD28|JMJD6_DROME Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 OS=Drosophila melanogaster OX=7227 GN=JMJD6 PE=2 SV=1,GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006909; GO:0018395; GO:0033746; GO:0033749; GO:0035212; GO:0043066; GO:0046329; GO:0046872; GO:0048512; GO:0070815; GO:0106140,cell competition in a multicellular organism [GO:0035212]; circadian behavior [GO:0048512]; negative regulation of apoptotic process [GO:0043066]; negative regulation of JNK cascade [GO:0046329]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone H3R2 demethylase activity [GO:0033746]; histone H4R3 demethylase activity [GO:0033749]; metal ion binding [GO:0046872]; P-TEFb complex binding [GO:0106140]; peptidyl-lysine 5-dioxygenase activity [GO:0070815],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016192; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; vesicle-mediated transport; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_08197,FUN_036041-T1,Peve_00011146,Pocillopora_meandrina_HIv1___RNAseq.g27345.t1,three_way,78.86766666666666,FUN_036041-T1,A0A0D1C8Z4,GRP1_MYCMD,,Glycine-rich RNA-binding protein 1,Mycosarcoma maydis (Corn smut fungus) (Ustilago maydis),44.7,85.0,1.1e-11,72.0,sp|A0A0D1C8Z4|GRP1_MYCMD Glycine-rich RNA-binding protein 1 OS=Mycosarcoma maydis OX=5270 GN=GRP1 PE=1 SV=1,GO:0003723; GO:0005768; GO:0051028,mRNA transport [GO:0051028],endosome [GO:0005768],RNA binding [GO:0003723],GO:0003723; GO:0005768; GO:0031410; GO:0043226,RNA binding; endosome; cytoplasmic vesicle; organelle
OG_08198,FUN_036042-T1,Peve_00011145,Pocillopora_meandrina_HIv1___RNAseq.g27346.t1,three_way,70.13033333333333,FUN_036042-T1,O00750,P3C2B_HUMAN,,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta),Homo sapiens (Human),40.2,1439.0,5.8e-287,989.2,sp|O00750|P3C2B_HUMAN Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta OS=Homo sapiens OX=9606 GN=PIK3C2B PE=1 SV=2,GO:0005524; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0009267; GO:0016303; GO:0016477; GO:0030139; GO:0031965; GO:0035005; GO:0035091; GO:0036092; GO:0043231; GO:0043491; GO:0048015; GO:1905037,autophagosome organization [GO:1905037]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091],GO:0003824; GO:0005654; GO:0005783; GO:0005829; GO:0005886; GO:0006629; GO:0008289; GO:0016740; GO:0031410; GO:0043226; GO:0048870,catalytic activity; nucleoplasm; endoplasmic reticulum; cytosol; plasma membrane; lipid metabolic process; lipid binding; transferase activity; cytoplasmic vesicle; organelle; cell motility
OG_08199,FUN_036043-T1,Peve_00011144,Pocillopora_meandrina_HIv1___RNAseq.g27347.t1,three_way,70.165,,,,,,,,,,,,,,,,,
OG_08200,FUN_036044-T1,Peve_00011142,Pocillopora_meandrina_HIv1___RNAseq.g27348.t1,three_way,84.868,FUN_036044-T1,F1QXM5,,,,,66.1,449.0,1e-178,627.9,"sp|F1QXM5|LDHD_DANRE Probable D-lactate dehydrogenase, mitochondrial OS=Danio rerio OX=7955 GN=ldhd PE=2 SV=1",,,,,,
OG_08201,FUN_036046-T1,Peve_00029868,Pocillopora_meandrina_HIv1___RNAseq.g27386.t1,three_way,42.30983333333333,FUN_036046-T1,Q6UB98,ANR12_HUMAN,,Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein),Homo sapiens (Human),36.3,113.0,2.4e-08,62.8,sp|Q6UB98|ANR12_HUMAN Ankyrin repeat domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ANKRD12 PE=1 SV=3,GO:0005654; GO:0005829,,cytosol [GO:0005829]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_08202,FUN_036047-T1,Peve_00029867,Pocillopora_meandrina_HIv1___RNAseq.g27387.t1,three_way,71.29666666666667,FUN_036047-T1,Q2HJ57,,,,,48.2,137.0,3.3e-29,129.4,sp|Q2HJ57|COTL1_BOVIN Coactosin-like protein OS=Bos taurus OX=9913 GN=COTL1 PE=2 SV=3,,,,,,
OG_08203,FUN_036054-T1,Peve_00029869,Pocillopora_meandrina_HIv1___RNAseq.g27392.t1,three_way,71.262,FUN_036054-T1,Q9NQP4,PFD4_HUMAN,,Prefoldin subunit 4 (Protein C-1),Homo sapiens (Human),60.2,133.0,6.200000000000001e-38,158.3,sp|Q9NQP4|PFD4_HUMAN Prefoldin subunit 4 OS=Homo sapiens OX=9606 GN=PFDN4 PE=1 SV=1,GO:0001540; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006457; GO:0016272; GO:0051082; GO:0051087; GO:0061077; GO:1905907,chaperone-mediated protein folding [GO:0061077]; negative regulation of amyloid fibril formation [GO:1905907]; protein folding [GO:0006457],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272],amyloid-beta binding [GO:0001540]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005634; GO:0005739; GO:0005829; GO:0006457; GO:0043226,nucleus; mitochondrion; cytosol; protein folding; organelle
OG_08204,FUN_036055-T1,Peve_00043184,Pocillopora_meandrina_HIv1___RNAseq.g27393.t1,three_way,66.97699999999999,FUN_036055-T1,Q3U2U7,MET17_MOUSE,,"Ribosome assembly protein METTL17, mitochondrial (Methyltransferase-like protein 17)",Mus musculus (Mouse),36.6,374.0,3.1e-62,241.1,"sp|Q3U2U7|MET17_MOUSE Ribosome assembly protein METTL17, mitochondrial OS=Mus musculus OX=10090 GN=Mettl17 PE=1 SV=2",GO:0005654; GO:0005739; GO:0005759; GO:0006412; GO:0008168; GO:0042274; GO:0046872; GO:0051539; GO:0097177; GO:0180026; GO:1904047,mitochondrial small ribosomal subunit assembly [GO:0180026]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; mitochondrial ribosome binding [GO:0097177]; S-adenosyl-L-methionine binding [GO:1904047]",GO:0003824; GO:0005654; GO:0005739; GO:0016740; GO:0043226; GO:0065003,catalytic activity; nucleoplasm; mitochondrion; transferase activity; organelle; protein-containing complex assembly
OG_08205,FUN_036057-T1,Peve_00043176,Pocillopora_meandrina_HIv1___TS.g14741.t1,three_way,64.9455,FUN_036057-T1,E2RYF8,,,,,34.8,594.0,1.8e-56,222.2,sp|E2RYF8|TPX2_PATPE Targeting protein for Xklp2 homolog OS=Patiria pectinifera OX=7594 GN=TPX2 PE=2 SV=1,,,,,,
OG_08206,FUN_036058-T1,Peve_00043177,Pocillopora_meandrina_HIv1___RNAseq.g27395.t1,three_way,62.19433333333333,,,,,,,,,,,,,,,,,
OG_08207,FUN_036059-T1,Peve_00043179,Pocillopora_meandrina_HIv1___RNAseq.g27396.t1,three_way,53.202,,,,,,,,,,,,,,,,,
OG_08208,FUN_036060-T1,Peve_00043178,Pocillopora_meandrina_HIv1___RNAseq.g27397.t1,three_way,74.72666666666666,FUN_036060-T1,Q9NXG6,,,,,36.3,383.0,1e-52,209.1,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_08209,FUN_036061-T1,Peve_00018987,Pocillopora_meandrina_HIv1___RNAseq.g27398.t1,three_way,52.07933333333333,FUN_036061-T1,Q864G9,,,,,23.4,274.0,2.8e-06,54.3,sp|Q864G9|MSHR_CEBAL Melanocyte-stimulating hormone receptor OS=Cebus albifrons OX=9514 GN=MC1R PE=3 SV=1,,,,,,
OG_08210,FUN_036065-T1,Peve_00004233,Pocillopora_meandrina_HIv1___RNAseq.g27402.t1,three_way,72.23566666666667,FUN_036065-T1,Q8BG58,P4HTM_MOUSE,,Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4),Mus musculus (Mouse),34.1,396.0,2.5e-56,221.1,sp|Q8BG58|P4HTM_MOUSE Transmembrane prolyl 4-hydroxylase OS=Mus musculus OX=10090 GN=P4htm PE=1 SV=1,GO:0005506; GO:0005509; GO:0005789; GO:0008270; GO:0016706; GO:0031418; GO:0045646; GO:0160082,regulation of erythrocyte differentiation [GO:0045646],endoplasmic reticulum membrane [GO:0005789],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; hypoxia-inducible factor-proline dioxygenase activity [GO:0160082]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; zinc ion binding [GO:0008270],GO:0003824; GO:0016491; GO:0140096,"catalytic activity; oxidoreductase activity; catalytic activity, acting on a protein"
OG_08211,FUN_036066-T1,Peve_00004232,Pocillopora_meandrina_HIv1___RNAseq.g27403.t2,three_way,60.70766666666667,FUN_036066-T1,Q9NXG6,,,,,38.4,367.0,7.499999999999999e-56,219.5,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_08212,FUN_036068-T3,Peve_00018977,Pocillopora_meandrina_HIv1___TS.g14754.t1,three_way,69.37833333333333,FUN_036068-T3,Q9NXG6,,,,,39.2,372.0,2.8e-58,227.6,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_08213,FUN_036069-T1,Peve_00018976,Pocillopora_meandrina_HIv1___RNAseq.g27405.t1,three_way,73.667,FUN_036069-T1,Q9NXG6,,,,,39.5,365.0,8.7e-65,249.2,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_08214,FUN_036070-T1,Peve_00018970,Pocillopora_meandrina_HIv1___RNAseq.g27410.t1,three_way,71.0545,FUN_036070-T1,Q8BG58,P4HTM_MOUSE,,Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4),Mus musculus (Mouse),38.3,376.0,3.9e-65,250.4,sp|Q8BG58|P4HTM_MOUSE Transmembrane prolyl 4-hydroxylase OS=Mus musculus OX=10090 GN=P4htm PE=1 SV=1,GO:0005506; GO:0005509; GO:0005789; GO:0008270; GO:0016706; GO:0031418; GO:0045646; GO:0160082,regulation of erythrocyte differentiation [GO:0045646],endoplasmic reticulum membrane [GO:0005789],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; hypoxia-inducible factor-proline dioxygenase activity [GO:0160082]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; zinc ion binding [GO:0008270],GO:0003824; GO:0016491; GO:0140096,"catalytic activity; oxidoreductase activity; catalytic activity, acting on a protein"
OG_08215,FUN_036073-T1,Peve_00018969,Pocillopora_meandrina_HIv1___TS.g14760.t2,three_way,77.22200000000001,FUN_036073-T1,Q17QH8,,,,,55.4,294.0,1.2e-86,321.2,sp|Q17QH8|D39U1_BOVIN Epimerase family protein SDR39U1 OS=Bos taurus OX=9913 GN=SDR39U1 PE=2 SV=1,,,,,,
OG_08216,FUN_036074-T3,Peve_00018966,Pocillopora_meandrina_HIv1___RNAseq.g27412.t1,three_way,78.726,FUN_036074-T3,Q8CG73,FTM_MOUSE,,Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein),Mus musculus (Mouse),37.4,1341.0,1.0999999999999998e-198,695.7,sp|Q8CG73|FTM_MOUSE Protein fantom OS=Mus musculus OX=10090 GN=Rpgrip1l PE=1 SV=2,GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0007420; GO:0008589; GO:0016607; GO:0021532; GO:0021537; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0035108; GO:0035115; GO:0035116; GO:0035869; GO:0036064; GO:0043010; GO:0043584; GO:0045744; GO:0060039; GO:0060271; GO:0060322; GO:0090102; GO:1905515,brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; telencephalon development [GO:0021537],axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886],thromboxane A2 receptor binding [GO:0031870],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007163; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytosol; plasma membrane; cilium; establishment or maintenance of cell polarity; organelle; cilium organization; anatomical structure development
OG_08217,FUN_036077-T1,Peve_00018989,Pocillopora_meandrina_HIv1___RNAseq.g27413.t1,three_way,66.047,,,,,,,,,,,,,,,,,
OG_08218,FUN_036079-T1,Peve_00018984,Pocillopora_meandrina_HIv1___RNAseq.g27415.t1,three_way,56.51533333333333,,,,,,,,,,,,,,,,,
OG_08219,FUN_036081-T1,Peve_00018988,Pocillopora_meandrina_HIv1___RNAseq.g27414.t1,three_way,75.69716666666666,,,,,,,,,,,,,,,,,
OG_08220,FUN_036082-T1,Peve_00018968,Pocillopora_meandrina_HIv1___RNAseq.g27416.t1,three_way,86.618,FUN_036082-T1,P56812,,,,,59.5,126.0,4.5000000000000004e-30,132.1,sp|P56812|PDCD5_MOUSE Programmed cell death protein 5 OS=Mus musculus OX=10090 GN=Pdcd5 PE=1 SV=3,,,,,,
OG_08221,FUN_036085-T1,Peve_00041355,Pocillopora_meandrina_HIv1___RNAseq.g27449.t1,three_way,82.33333333333333,FUN_036085-T1,Q6NX12,,,,,53.2,824.0,2.9e-247,856.3,sp|Q6NX12|NUP93_XENTR Nuclear pore complex protein Nup93 OS=Xenopus tropicalis OX=8364 GN=nup93 PE=2 SV=1,,,,,,
OG_08222,FUN_036093-T1,Peve_00032189,Pocillopora_meandrina_HIv1___RNAseq.g27441.t1,three_way,76.63133333333333,FUN_036093-T1,Q68DA7,FMN1_HUMAN,,Formin-1 (Limb deformity protein homolog),Homo sapiens (Human),33.3,471.0,1.5e-63,246.1,sp|Q68DA7|FMN1_HUMAN Formin-1 OS=Homo sapiens OX=9606 GN=FMN1 PE=1 SV=3,GO:0003779; GO:0005634; GO:0005789; GO:0005884; GO:0005886; GO:0005912; GO:0008017; GO:0030036; GO:0045010,actin cytoskeleton organization [GO:0030036]; actin nucleation [GO:0045010],actin filament [GO:0005884]; adherens junction [GO:0005912]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; plasma membrane [GO:0005886],actin binding [GO:0003779]; microtubule binding [GO:0008017],GO:0005634; GO:0005886; GO:0007010; GO:0008092; GO:0043226,nucleus; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08223,FUN_036094-T1,Peve_00032191,Pocillopora_meandrina_HIv1___RNAseq.g27440.t1,three_way,45.972,,,,,,,,,,,,,,,,,
OG_08224,FUN_036095-T1,Peve_00032192,Pocillopora_meandrina_HIv1___RNAseq.g27439.t1,three_way,90.405,FUN_036095-T1,Q9EQH3,VPS35_MOUSE,,Vacuolar protein sorting-associated protein 35 (Maternal-embryonic 3) (Vesicle protein sorting 35),Mus musculus (Mouse),69.9,800.0,0.0,1120.5,sp|Q9EQH3|VPS35_MOUSE Vacuolar protein sorting-associated protein 35 OS=Mus musculus OX=10090 GN=Vps35 PE=1 SV=1,GO:0005737; GO:0005739; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005829; GO:0006624; GO:0007040; GO:0010008; GO:0010628; GO:0010629; GO:0014069; GO:0016020; GO:0030904; GO:0030906; GO:0031648; GO:0031748; GO:0032456; GO:0032463; GO:0033365; GO:0036010; GO:0042147; GO:0043005; GO:0043025; GO:0043653; GO:0045056; GO:0045202; GO:0045732; GO:0048471; GO:0050728; GO:0050804; GO:0050882; GO:0060161; GO:0061357; GO:0090128; GO:0090141; GO:0090263; GO:0090326; GO:0097422; GO:0098691; GO:0098793; GO:0098794; GO:0098887; GO:0098978; GO:0099003; GO:0099073; GO:0099074; GO:0099639; GO:0150052; GO:1902823; GO:1902950; GO:1903181; GO:1903828; GO:1904377; GO:1905166; GO:2000331,"endocytic recycling [GO:0032456]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome vesicle-mediated transport [GO:0099074]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of protein homooligomerization [GO:0032463]; negative regulation of protein localization [GO:1903828]; neurotransmitter receptor transport, endosome to plasma membrane [GO:0099639]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to endosome [GO:0036010]; protein localization to organelle [GO:0033365]; regulation of dendritic spine maintenance [GO:1902950]; regulation of postsynapse assembly [GO:0150052]; regulation of synapse maturation [GO:0090128]; regulation of terminal button organization [GO:2000331]; retrograde transport, endosome to Golgi [GO:0042147]; transcytosis [GO:0045056]; vacuolar protein processing [GO:0006624]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; dopaminergic synapse [GO:0098691]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer, cargo-selective complex [GO:0030906]; synapse [GO:0045202]; tubular endosome [GO:0097422]",D1 dopamine receptor binding [GO:0031748],GO:0005739; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006886; GO:0007005; GO:0007040; GO:0016192; GO:0031410; GO:0043226; GO:0050877; GO:0051604; GO:0072659,mitochondrion; lysosome; endosome; vacuole; cytosol; intracellular protein transport; mitochondrion organization; lysosome organization; vesicle-mediated transport; cytoplasmic vesicle; organelle; nervous system process; protein maturation; protein localization to plasma membrane
OG_08225,FUN_036096-T1,Peve_00032193,Pocillopora_meandrina_HIv1___RNAseq.g27438.t1,three_way,74.27666666666667,FUN_036096-T1,Q9NP78,ABCB9_HUMAN,,ABC-type oligopeptide transporter ABCB9 (EC 7.4.2.6) (ATP-binding cassette sub-family B member 9) (ATP-binding cassette transporter 9) (ABC transporter 9 protein) (hABCB9) (TAP-like protein) (TAPL),Homo sapiens (Human),47.3,731.0,6.000000000000001e-181,636.0,sp|Q9NP78|ABCB9_HUMAN ABC-type oligopeptide transporter ABCB9 OS=Homo sapiens OX=9606 GN=ABCB9 PE=1 SV=1,GO:0005524; GO:0005764; GO:0005765; GO:0005789; GO:0006518; GO:0015031; GO:0015421; GO:0015440; GO:0015833; GO:0016020; GO:0016887; GO:0022857; GO:0042803; GO:0043231; GO:0055085,peptide metabolic process [GO:0006518]; peptide transport [GO:0015833]; protein transport [GO:0015031]; transmembrane transport [GO:0055085],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020],ABC-type oligopeptide transporter activity [GO:0015421]; ABC-type peptide transporter activity [GO:0015440]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857],GO:0003824; GO:0005215; GO:0005764; GO:0005773; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; lysosome; vacuole; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_08226,FUN_036097-T2,Peve_00032194,Pocillopora_meandrina_HIv1___RNAseq.g27437.t1,three_way,61.02516666666666,FUN_036097-T2,Q801E2,ANLN_XENLA,,Anillin,Xenopus laevis (African clawed frog),34.7,432.0,4.6e-56,221.5,sp|Q801E2|ANLN_XENLA Anillin OS=Xenopus laevis OX=8355 GN=anln PE=1 SV=1,GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005826; GO:0005938; GO:0031106; GO:0032059; GO:1904172,actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; septin ring organization [GO:0031106],actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; nucleus [GO:0005634],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0007010; GO:0008092; GO:0043226,cytokinesis; nucleus; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08227,FUN_036099-T1,Peve_00032195,Pocillopora_meandrina_HIv1___RNAseq.g27436.t1,three_way,72.92099999999999,FUN_036099-T1,Q66JZ4,,,,,33.3,475.0,4.2e-60,233.8,"sp|Q66JZ4|TCAIM_MOUSE T-cell activation inhibitor, mitochondrial OS=Mus musculus OX=10090 GN=TCAIM PE=1 SV=1",,,,,,
OG_08228,FUN_036100-T1,Peve_00032196,Pocillopora_meandrina_HIv1___RNAseq.g27435.t1,three_way,77.412,FUN_036100-T1,Q0P8I7,GMHD_CAMJE,,GDP-D-glycero-alpha-D-manno-heptose dehydrogenase (EC 1.1.98.-),Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168),41.3,310.0,2.6e-64,247.3,sp|Q0P8I7|GMHD_CAMJE GDP-D-glycero-alpha-D-manno-heptose dehydrogenase OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) OX=192222 GN=Cj1427c PE=1 SV=1,GO:0003978; GO:0016491; GO:0019003; GO:0042802; GO:0045227; GO:0051289; GO:0070404,capsule polysaccharide biosynthetic process [GO:0045227]; protein homotetramerization [GO:0051289],,GDP binding [GO:0019003]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491]; UDP-glucose 4-epimerase activity [GO:0003978],GO:0003824; GO:0005975; GO:0016491; GO:0016853; GO:0065003,catalytic activity; carbohydrate metabolic process; oxidoreductase activity; isomerase activity; protein-containing complex assembly
OG_08229,FUN_036101-T1,Peve_00032197,Pocillopora_meandrina_HIv1___RNAseq.g10817.t1,three_way,53.59666666666666,,,,,,,,,,,,,,,,,
OG_08230,FUN_036103-T1,Peve_00003702,Pocillopora_meandrina_HIv1___RNAseq.g27433.t1,three_way,73.634,FUN_036103-T1,P82160,,,,,38.8,147.0,1.8000000000000001e-22,107.8,"sp|P82160|MLE3_CHERA Myosin light chain 3, skeletal muscle isoform OS=Chelon ramada OX=30804 PE=1 SV=1",,,,,,
OG_08231,FUN_036106-T1,Peve_00003695,Pocillopora_meandrina_HIv1___RNAseq.g27429.t1,three_way,71.5815,FUN_036106-T1,Q68D86,C102B_HUMAN,,Coiled-coil domain-containing protein 102B,Homo sapiens (Human),37.2,390.0,5.6e-42,173.7,sp|Q68D86|C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens OX=9606 GN=CCDC102B PE=1 SV=4,GO:0005737; GO:0005814; GO:0010457; GO:0120283,centriole-centriole cohesion [GO:0010457],centriole [GO:0005814]; cytoplasm [GO:0005737],protein serine/threonine kinase binding [GO:0120283],GO:0043226,organelle
OG_08232,FUN_036108-T1,Peve_00003698,Pocillopora_meandrina_HIv1___RNAseq.g27428.t1,three_way,57.653666666666666,FUN_036108-T1,P25867,UBCD1_DROME,,Ubiquitin-conjugating enzyme E2-17 kDa (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D1) (Protein effete) (Ubiquitin carrier protein) (Ubiquitin-protein ligase),Drosophila melanogaster (Fruit fly),49.7,143.0,6.2e-36,153.3,sp|P25867|UBCD1_DROME Ubiquitin-conjugating enzyme E2-17 kDa OS=Drosophila melanogaster OX=7227 GN=eff PE=1 SV=1,GO:0000209; GO:0000278; GO:0001745; GO:0001751; GO:0005524; GO:0005634; GO:0005829; GO:0006511; GO:0007140; GO:0016322; GO:0016567; GO:0030718; GO:0031145; GO:0031625; GO:0031647; GO:0045676; GO:0045879; GO:0048132; GO:0051276; GO:0061057; GO:0061631; GO:0097039,anaphase-promoting complex-dependent catabolic process [GO:0031145]; chromosome organization [GO:0051276]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor cell differentiation [GO:0001751]; female germ-line stem cell asymmetric division [GO:0048132]; germ-line stem cell population maintenance [GO:0030718]; male meiotic nuclear division [GO:0007140]; mitotic cell cycle [GO:0000278]; negative regulation of smoothened signaling pathway [GO:0045879]; neuron remodeling [GO:0016322]; peptidoglycan recognition protein signaling pathway [GO:0061057]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of protein stability [GO:0031647]; regulation of R7 cell differentiation [GO:0045676]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625],GO:0000278; GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"mitotic cell cycle; immune system process; catalytic activity; nucleus; cytosol; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_08233,FUN_036109-T1,Peve_00003699,Pocillopora_meandrina_HIv1___RNAseq.g27427.t1,three_way,71.93266666666666,FUN_036109-T1,Q330K2,NDUF6_HUMAN,,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 (Putative phytoene synthase)",Homo sapiens (Human),51.8,301.0,2.4e-85,317.0,"sp|Q330K2|NDUF6_HUMAN NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 OS=Homo sapiens OX=9606 GN=NDUFAF6 PE=1 SV=2",GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0009058; GO:0032981,biosynthetic process [GO:0009058]; mitochondrial respiratory chain complex I assembly [GO:0032981],cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634],,GO:0005634; GO:0005739; GO:0043226; GO:0065003,nucleus; mitochondrion; organelle; protein-containing complex assembly
OG_08234,FUN_036110-T1,Peve_00032894,Pocillopora_meandrina_HIv1___RNAseq.g27426.t1,three_way,79.54533333333333,FUN_036110-T1,O35435,PYRD_MOUSE,,"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)",Mus musculus (Mouse),59.0,395.0,3.1e-125,449.9,"sp|O35435|PYRD_MOUSE Dihydroorotate dehydrogenase (quinone), mitochondrial OS=Mus musculus OX=10090 GN=Dhodh PE=1 SV=2",GO:0004151; GO:0004152; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006207; GO:0006225; GO:0044205; GO:0106430,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; UDP biosynthetic process [GO:0006225],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],dihydroorotase activity [GO:0004151]; dihydroorotate dehydrogenase (quinone) activity [GO:0106430]; dihydroorotate dehydrogenase activity [GO:0004152],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016491; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; mitochondrion; cytosol; oxidoreductase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08235,FUN_036114-T1,Peve_00029949,Pocillopora_meandrina_HIv1___RNAseq.g27425.t1,three_way,66.59783333333334,FUN_036114-T1,Q91XU0,,,,,59.3,467.0,4.2e-148,526.6,sp|Q91XU0|WRIP1_MOUSE ATPase WRNIP1 OS=Mus musculus OX=10090 GN=Wrnip1 PE=1 SV=2,,,,,,
OG_08236,FUN_036115-T1,Peve_00029948,Pocillopora_meandrina_HIv1___RNAseq.g27424.t1,three_way,79.33183333333334,FUN_036115-T1,A7S6Y0,,,,,68.9,151.0,1.1e-57,224.2,sp|A7S6Y0|SYS1_NEMVE Protein SYS1 homolog OS=Nematostella vectensis OX=45351 GN=sys1 PE=3 SV=1,,,,,,
OG_08237,FUN_036116-T1,Peve_00000283,Pocillopora_meandrina_HIv1___RNAseq.g27423.t1,three_way,63.0515,FUN_036116-T1,O34313,NTPES_BACSU,,"Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)]",Bacillus subtilis (strain 168),27.1,510.0,4.6e-36,154.8,sp|O34313|NTPES_BACSU Trifunctional nucleotide phosphoesterase protein YfkN OS=Bacillus subtilis (strain 168) OX=224308 GN=yfkN PE=1 SV=1,GO:0000166; GO:0005576; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872,nucleotide catabolic process [GO:0009166],extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288],"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]",GO:0003824; GO:0005576; GO:0016787; GO:0055086,catalytic activity; extracellular region; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_08238,FUN_036118-T1,Peve_00000287,Pocillopora_meandrina_HIv1___RNAseq.g27450.t1,three_way,76.68433333333334,,,,,,,,,,,,,,,,,
OG_08239,FUN_036119-T1,Peve_00000289,Pocillopora_meandrina_HIv1___RNAseq.g27453.t1,three_way,78.82766666666666,FUN_036119-T1,Q6Q0C0,TRAF7_HUMAN,,E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7),Homo sapiens (Human),37.1,523.0,1.3999999999999998e-41,172.6,sp|Q6Q0C0|TRAF7_HUMAN E3 ubiquitin-protein ligase TRAF7 OS=Homo sapiens OX=9606 GN=TRAF7 PE=1 SV=1,GO:0000151; GO:0004842; GO:0005634; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0035519; GO:0043231; GO:0043410; GO:0043525; GO:0061630; GO:0070372; GO:2000060; GO:2001235,apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372],cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005886; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_08240,FUN_036124-T1,Peve_00000288,Pocillopora_meandrina_HIv1___RNAseq.g27452.t1,three_way,65.2255,FUN_036124-T1,Q9UK23,NAGPA_HUMAN,,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase),Homo sapiens (Human),47.2,369.0,3.6e-90,334.0,sp|Q9UK23|NAGPA_HUMAN N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase OS=Homo sapiens OX=9606 GN=NAGPA PE=1 SV=2,GO:0003944; GO:0005975; GO:0006486; GO:0006622; GO:0007040; GO:0016020; GO:0032580; GO:0033299; GO:0036211,carbohydrate metabolic process [GO:0005975]; lysosome organization [GO:0007040]; protein glycosylation [GO:0006486]; protein modification process [GO:0036211]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020],N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity [GO:0003944],GO:0003824; GO:0005975; GO:0006486; GO:0006886; GO:0007040; GO:0016787,catalytic activity; carbohydrate metabolic process; protein glycosylation; intracellular protein transport; lysosome organization; hydrolase activity
OG_08241,FUN_036143-T1,Peve_00000292,Pocillopora_meandrina_HIv1___TS.g14803.t1,three_way,87.003,FUN_036143-T1,Q13885,TBB2A_HUMAN,,Tubulin beta-2A chain (Tubulin beta class IIa),Homo sapiens (Human),69.0,432.0,1.8e-185,650.2,sp|Q13885|TBB2A_HUMAN Tubulin beta-2A chain OS=Homo sapiens OX=9606 GN=TUBB2A PE=1 SV=1,GO:0000226; GO:0000278; GO:0001764; GO:0003924; GO:0005200; GO:0005525; GO:0005634; GO:0005737; GO:0005874; GO:0015630; GO:0021987; GO:0045171; GO:0046872; GO:0070062; GO:0072686; GO:1903561,cerebral cortex development [GO:0021987]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0003824; GO:0003924; GO:0005198; GO:0005634; GO:0005856; GO:0007010; GO:0016787; GO:0043226; GO:0048856; GO:0048870,mitotic cell cycle; catalytic activity; GTPase activity; structural molecule activity; nucleus; cytoskeleton; cytoskeleton organization; hydrolase activity; organelle; anatomical structure development; cell motility
OG_08242,FUN_036149-T1,Peve_00000295,Pocillopora_meandrina_HIv1___RNAseq.g27458.t1,three_way,66.75033333333333,FUN_036149-T1,Q6PIP5,,,,,34.3,601.0,4e-89,330.5,sp|Q6PIP5|NUDC1_MOUSE NudC domain-containing protein 1 OS=Mus musculus OX=10090 GN=Nudcd1 PE=1 SV=2,,,,,,
OG_08243,FUN_036150-T2,Peve_00000296,Pocillopora_meandrina_HIv1___RNAseq.g27459.t1,three_way,82.88,FUN_036150-T2,Q9NTJ5,SAC1_HUMAN,,Phosphatidylinositol-3-phosphatase SAC1 (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein),Homo sapiens (Human),56.5,591.0,2.1e-194,680.2,sp|Q9NTJ5|SAC1_HUMAN Phosphatidylinositol-3-phosphatase SAC1 OS=Homo sapiens OX=9606 GN=SACM1L PE=1 SV=2,GO:0000139; GO:0004438; GO:0005783; GO:0005789; GO:0005794; GO:0006661; GO:0016791; GO:0032281; GO:0034596; GO:0043812; GO:0046856; GO:0098967; GO:0098978; GO:0099003; GO:0140268,exocytic insertion of neurotransmitter receptor to postsynaptic membrane [GO:0098967]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; vesicle-mediated transport in synapse [GO:0099003],AMPA glutamate receptor complex [GO:0032281]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],phosphatase activity [GO:0016791]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812],GO:0003824; GO:0005783; GO:0005794; GO:0006629; GO:0016192; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; Golgi apparatus; lipid metabolic process; vesicle-mediated transport; hydrolase activity; organelle
OG_08244,FUN_036151-T1,Peve_00022380,Pocillopora_meandrina_HIv1___RNAseq.g27460.t1,three_way,91.05433333333332,FUN_036151-T1,Q9NQG5,RPR1B_HUMAN,,Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor),Homo sapiens (Human),53.8,325.0,9.1e-85,315.1,sp|Q9NQG5|RPR1B_HUMAN Regulation of nuclear pre-mRNA domain-containing protein 1B OS=Homo sapiens OX=9606 GN=RPRD1B PE=1 SV=1,GO:0000993; GO:0001111; GO:0005634; GO:0005654; GO:0008284; GO:0010564; GO:0031124; GO:0042802; GO:0045944; GO:0097550; GO:0099122,mRNA 3'-end processing [GO:0031124]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle process [GO:0010564]; RNA polymerase II promoter clearance [GO:0001111],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription preinitiation complex [GO:0097550],identical protein binding [GO:0042802]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II complex binding [GO:0000993],GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0043226,nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; organelle
OG_08245,FUN_036153-T1,Peve_00006918,Pocillopora_meandrina_HIv1___RNAseq.g27466.t1,three_way,71.90833333333333,FUN_036153-T1,P49895,IOD1_HUMAN,,Type I iodothyronine deiodinase (EC 1.21.99.3) (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase),Homo sapiens (Human),47.8,180.0,1.1e-40,168.3,sp|P49895|IOD1_HUMAN Type I iodothyronine deiodinase OS=Homo sapiens OX=9606 GN=DIO1 PE=1 SV=3,GO:0004800; GO:0005789; GO:0005886; GO:0006520; GO:0006590; GO:0008430; GO:0016323; GO:0033798; GO:0042403; GO:0042404; GO:0042446,amino acid metabolic process [GO:0006520]; hormone biosynthetic process [GO:0042446]; thyroid hormone catabolic process [GO:0042404]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403],basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],selenium binding [GO:0008430]; thyroxine 5'-deiodinase activity [GO:0004800]; thyroxine 5-deiodinase activity [GO:0033798],GO:0003824; GO:0005886; GO:0006520; GO:0006575; GO:0016491,catalytic activity; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity
OG_08246,FUN_036154-T1,Peve_00006919,Pocillopora_meandrina_HIv1___RNAseq.g27467.t1,three_way,72.82966666666667,FUN_036154-T1,P49899,,,,,48.1,185.0,7.1e-41,169.1,sp|P49899|IOD3_XENLA Thyroxine 5-deiodinase OS=Xenopus laevis OX=8355 GN=dio3 PE=1 SV=2,,,,,,
OG_08247,FUN_036155-T1,Peve_00006921,Pocillopora_meandrina_HIv1___RNAseq.g27468.t1,three_way,65.3335,FUN_036155-T1,P23944,ADA1D_RAT,,Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (RA42),Rattus norvegicus (Rat),34.2,339.0,1.7e-33,145.2,sp|P23944|ADA1D_RAT Alpha-1D adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adra1d PE=2 SV=2,GO:0001986; GO:0001994; GO:0004937; GO:0005886; GO:0007200; GO:0007204; GO:0007267; GO:0008217; GO:0042802; GO:0043410; GO:0045907; GO:0071880; GO:0150099,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; cell-cell signaling [GO:0007267]; negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001986]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of vasoconstriction [GO:0045907]; regulation of blood pressure [GO:0008217],plasma membrane [GO:0005886],alpha1-adrenergic receptor activity [GO:0004937]; identical protein binding [GO:0042802],GO:0003013; GO:0005886; GO:0023052; GO:0060089,circulatory system process; plasma membrane; signaling; molecular transducer activity
OG_08248,FUN_036156-T1,Peve_00043542,Pocillopora_meandrina_HIv1___RNAseq.g27469.t1,three_way,82.613,FUN_036156-T1,F1Q4S1,,,,,66.8,1110.0,0.0,1413.7,sp|F1Q4S1|ATP9B_DANRE Probable phospholipid-transporting ATPase IIB OS=Danio rerio OX=7955 GN=atp9b PE=3 SV=1,,,,,,
OG_08249,FUN_036158-T1,Peve_00039218,Pocillopora_meandrina_HIv1___RNAseq.g27493.t1,three_way,85.587,FUN_036158-T1,Q5PQY6,,,,,58.8,838.0,6.9e-268,924.9,"sp|Q5PQY6|LONP2_DANRE Lon protease homolog 2, peroxisomal OS=Danio rerio OX=7955 GN=lonp2 PE=2 SV=1",,,,,,
OG_08250,FUN_036159-T1,Peve_00039229,Pocillopora_meandrina_HIv1___RNAseq.g27494.t1,three_way,65.17816666666667,FUN_036159-T1,P0C2B7,,,,,41.4,70.0,1.2e-07,57.8,sp|P0C2B7|RM52_BOVIN Large ribosomal subunit protein mL52 OS=Bos taurus OX=9913 GN=MRPL52 PE=1 SV=1,,,,,,
OG_08251,FUN_036160-T1,Peve_00039232,Pocillopora_meandrina_HIv1___RNAseq.g27495.t1,three_way,53.35233333333333,FUN_036160-T1,Q1LZE9,,,,,33.4,317.0,2.7e-34,147.9,sp|Q1LZE9|PRS23_BOVIN Serine protease 23 OS=Bos taurus OX=9913 GN=PRSS23 PE=2 SV=1,,,,,,
OG_08252,FUN_036161-T1,Peve_00039217,Pocillopora_meandrina_HIv1___RNAseq.g27496.t1,three_way,49.679833333333335,FUN_036161-T1,Q9D6X6,,,,,31.2,346.0,1.5e-33,145.2,sp|Q9D6X6|PRS23_MOUSE Serine protease 23 OS=Mus musculus OX=10090 GN=Prss23 PE=2 SV=2,,,,,,
OG_08253,FUN_036163-T1,Peve_00027207,Pocillopora_meandrina_HIv1___RNAseq.g27497.t1,three_way,92.25,FUN_036163-T1,Q6NUD8,,,,,54.2,166.0,5.8e-36,152.1,sp|Q6NUD8|CHM1A_XENLA Charged multivesicular body protein 1a OS=Xenopus laevis OX=8355 GN=chmp1a PE=2 SV=1,,,,,,
OG_08254,FUN_036164-T1,Peve_00027211,Pocillopora_meandrina_HIv1___RNAseq.g27499.t1,three_way,89.75383333333333,FUN_036164-T1,Q5RC80,RBM39_PONAB,,RNA-binding protein 39 (RNA-binding motif protein 39),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),58.2,385.0,3.1e-117,423.7,sp|Q5RC80|RBM39_PONAB RNA-binding protein 39 OS=Pongo abelii OX=9601 GN=RBM39 PE=2 SV=1,GO:0003723; GO:0006397; GO:0008380; GO:0016607; GO:0032991; GO:0034451; GO:0048024; GO:0050733,"mRNA processing [GO:0006397]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]",centriolar satellite [GO:0034451]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; RS domain binding [GO:0050733],GO:0003723; GO:0016071; GO:0043226,RNA binding; mRNA metabolic process; organelle
OG_08255,FUN_036165-T1,Peve_00027201,Pocillopora_meandrina_HIv1___RNAseq.g27500.t1,three_way,70.53633333333333,FUN_036165-T1,C7G3A0,,,,,48.3,383.0,1e-99,365.2,sp|C7G3A0|MPPE1_CRIGR Metallophosphoesterase 1 OS=Cricetulus griseus OX=10029 GN=MPPE1 PE=2 SV=1,,,,,,
OG_08256,FUN_036166-T2,Peve_00027202,Pocillopora_meandrina_HIv1___RNAseq.g27501.t1,three_way,89.64366666666666,FUN_036166-T2,O93477,,,,,79.8,430.0,3.8e-206,718.8,sp|O93477|SAHHB_XENLA Adenosylhomocysteinase B OS=Xenopus laevis OX=8355 GN=ahcy-b PE=2 SV=1,,,,,,
OG_08257,FUN_036167-T1,Peve_00027204,Pocillopora_meandrina_HIv1___TS.g14851.t1,three_way,60.79866666666666,FUN_036167-T1,Q64093,S6A20_RAT,,Sodium- and chloride-dependent transporter XTRP3 (Sodium/imino-acid transporter 1) (Solute carrier family 6 member 20) (Transporter rB21A),Rattus norvegicus (Rat),35.0,577.0,1.6e-93,345.5,sp|Q64093|S6A20_RAT Sodium- and chloride-dependent transporter XTRP3 OS=Rattus norvegicus OX=10116 GN=Slc6a20 PE=2 SV=1,GO:0005298; GO:0005886; GO:0006865; GO:0015171; GO:0015175; GO:0015193; GO:0015199; GO:0015370; GO:0015816; GO:0015824; GO:0015838; GO:0016324; GO:0031526; GO:0035725; GO:0089718; GO:1903804; GO:1904271; GO:1905647,amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; amino-acid betaine transport [GO:0015838]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; L-proline import across plasma membrane [GO:1904271]; proline import across plasma membrane [GO:1905647]; proline transport [GO:0015824]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; amino-acid betaine transmembrane transporter activity [GO:0015199]; L-proline transmembrane transporter activity [GO:0015193]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; proline:sodium symporter activity [GO:0005298]; solute:sodium symporter activity [GO:0015370],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_08258,FUN_036169-T2,Peve_00027206,Pocillopora_meandrina_HIv1___TS.g14852.t1,three_way,74.27483333333333,FUN_036169-T2,Q9XS59,,,,,42.6,611.0,6.1e-141,503.1,sp|Q9XS59|S6A15_BOVIN Sodium-dependent neutral amino acid transporter B(0)AT2 OS=Bos taurus OX=9913 GN=SLC6A15 PE=2 SV=1,,,,,,
OG_08259,FUN_036171-T4,Peve_00027208,Pocillopora_meandrina_HIv1___RNAseq.g27504.t1,three_way,57.3255,FUN_036171-T4,Q7TN88,,,,,26.0,1910.0,4.8e-157,558.5,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08260,FUN_036172-T1,Peve_00027209,Pocillopora_meandrina_HIv1___RNAseq.g27505.t1,three_way,60.32333333333333,FUN_036172-T1,Q504M2,,,,,34.6,442.0,8.400000000000001e-57,223.0,"sp|Q504M2|PDP2_MOUSE [Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial OS=Mus musculus OX=10090 GN=Pdp2 PE=1 SV=1",,,,,,
OG_08261,FUN_036173-T1,Peve_00027210,Pocillopora_meandrina_HIv1___RNAseq.g27506.t1,three_way,82.76566666666666,FUN_036173-T1,Q00168,,,,,38.1,310.0,4.5999999999999995e-55,216.5,sp|Q00168|KCC2A_DROME Calcium/calmodulin-dependent protein kinase type II alpha chain OS=Drosophila melanogaster OX=7227 GN=CaMKII PE=1 SV=1,,,,,,
OG_08262,FUN_036174-T1,Peve_00027212,Pocillopora_meandrina_HIv1___RNAseq.g27507.t1,three_way,77.46166666666666,FUN_036174-T1,Q5ZKI0,KCC2D_CHICK,,Calcium/calmodulin-dependent protein kinase type II delta chain (CaM kinase II subunit delta) (CaM-kinase II delta chain) (CaMK-II subunit delta) (EC 2.7.11.17),Gallus gallus (Chicken),42.4,377.0,2.1000000000000002e-73,277.7,sp|Q5ZKI0|KCC2D_CHICK Calcium/calmodulin-dependent protein kinase type II delta chain OS=Gallus gallus OX=9031 GN=CAMK2D PE=2 SV=1,GO:0004683; GO:0005516; GO:0005524; GO:0005737; GO:0014069; GO:0043005; GO:0048168; GO:0106310; GO:1903076,regulation of neuronal synaptic plasticity [GO:0048168]; regulation of protein localization to plasma membrane [GO:1903076],cytoplasm [GO:0005737]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08263,FUN_036175-T1,Peve_00027214,Pocillopora_meandrina_HIv1___RNAseq.g27508.t1,three_way,81.739,FUN_036175-T1,Q64414,,,,,54.2,177.0,1.5e-45,184.1,sp|Q64414|APT_DIPCP Adenine phosphoribosyltransferase OS=Dipodillus campestris OX=41199 GN=APRT PE=3 SV=1,,,,,,
OG_08264,FUN_036176-T1,Peve_00027215,Pocillopora_meandrina_HIv1___RNAseq.g27510.t1,three_way,89.82000000000001,FUN_036176-T1,P28075,,,,,76.9,229.0,1.1e-97,357.8,sp|P28075|PSB5_RAT Proteasome subunit beta type-5 OS=Rattus norvegicus OX=10116 GN=Psmb5 PE=1 SV=3,,,,,,
OG_08265,FUN_036177-T1,Peve_00027216,Pocillopora_meandrina_HIv1___RNAseq.g27511.t1,three_way,55.68066666666667,,,,,,,,,,,,,,,,,
OG_08266,FUN_036178-T1,Peve_00027217,Pocillopora_meandrina_HIv1___RNAseq.g27512.t1,three_way,66.12366666666667,FUN_036178-T1,Q3ZBX6,,,,,42.9,282.0,2.9e-56,220.7,sp|Q3ZBX6|RM03_BOVIN Large ribosomal subunit protein uL3m OS=Bos taurus OX=9913 GN=MRPL3 PE=1 SV=1,,,,,,
OG_08267,FUN_036179-T1,Peve_00027218,Pocillopora_meandrina_HIv1___RNAseq.g27513.t1,three_way,49.457,FUN_036179-T1,O94763,,,,,33.3,249.0,4.4e-29,130.6,sp|O94763|RMP_HUMAN Unconventional prefoldin RPB5 interactor 1 OS=Homo sapiens OX=9606 GN=URI1 PE=1 SV=3,,,,,,
OG_08268,FUN_036180-T1,Peve_00015591,Pocillopora_meandrina_HIv1___RNAseq.g27514.t1,three_way,71.41016666666667,FUN_036180-T1,Q5R4M2,,,,,37.6,1344.0,2.1e-234,814.3,sp|Q5R4M2|ULK4_PONAB Serine/threonine-protein kinase ULK4 OS=Pongo abelii OX=9601 GN=ULK4 PE=2 SV=1,,,,,,
OG_08269,FUN_036181-T1,Peve_00015589,Pocillopora_meandrina_HIv1___RNAseq.10483_t,three_way,61.40083333333333,FUN_036181-T1,A9JTG5,HOIL1_DANRE,,RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.31) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) (Heme-oxidized IRP2 ubiquitin transferase 1 homolog),Danio rerio (Zebrafish) (Brachydanio rerio),38.2,610.0,1.3e-119,432.2,sp|A9JTG5|HOIL1_DANRE RanBP-type and C3HC4-type zinc finger-containing protein 1 OS=Danio rerio OX=7955 GN=rbck1 PE=2 SV=1,GO:0004842; GO:0008270; GO:0042742; GO:0043123; GO:0043130; GO:0043161; GO:0048701; GO:0071600; GO:0071797; GO:0097039,defense response to bacterium [GO:0042742]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039],LUBAC complex [GO:0071797],ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_08270,FUN_036182-T1,Peve_00015595,Pocillopora_meandrina_HIv1___RNAseq.g27379.t1,three_way,86.98400000000001,FUN_036182-T1,Q99P25,,,,,35.7,669.0,4.4e-106,387.1,sp|Q99P25|TXIP1_MOUSE Translin-associated factor X-interacting protein 1 OS=Mus musculus OX=10090 GN=Tsnaxip1 PE=1 SV=2,,,,,,
OG_08271,FUN_036183-T1,Peve_00015587,Pocillopora_meandrina_HIv1___RNAseq.g27377.t1,three_way,72.55316666666667,FUN_036183-T1,Q8R422,CD109_MOUSE,,CD109 antigen (GPI-anchored alpha-2 macroglobulin-related protein) (CD antigen CD109),Mus musculus (Mouse),33.9,1471.0,4.4000000000000005e-193,677.2,sp|Q8R422|CD109_MOUSE CD109 antigen OS=Mus musculus OX=10090 GN=Cd109 PE=1 SV=1,GO:0001942; GO:0004867; GO:0005615; GO:0005829; GO:0005886; GO:0010839; GO:0030512; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647,hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089],cytosol [GO:0005829]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005615; GO:0005829; GO:0005886; GO:0048856; GO:0098772,extracellular space; cytosol; plasma membrane; anatomical structure development; molecular function regulator activity
OG_08272,FUN_036187-T1,Peve_00035509,Pocillopora_meandrina_HIv1___RNAseq.g27375.t1,three_way,45.659666666666666,,,,,,,,,,,,,,,,,
OG_08273,FUN_036188-T1,Peve_00023186,Pocillopora_meandrina_HIv1___RNAseq.g27373.t1,three_way,65.388,FUN_036188-T1,Q28DF1,,,,,31.8,422.0,7.4e-29,129.8,sp|Q28DF1|HERP2_XENTR Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein OS=Xenopus tropicalis OX=8364 GN=herpud2 PE=2 SV=1,,,,,,
OG_08274,FUN_036189-T1,Peve_00038735,Pocillopora_meandrina_HIv1___RNAseq.g27372.t1,three_way,67.0075,FUN_036189-T1,P42674,,,,,42.8,208.0,8.1e-39,164.1,sp|P42674|BP10_PARLI Blastula protease 10 OS=Paracentrotus lividus OX=7656 GN=BP10 PE=2 SV=1,,,,,,
OG_08275,FUN_036192-T1,Peve_00011127,Pocillopora_meandrina_HIv1___RNAseq.g27369.t1,three_way,85.32933333333334,FUN_036192-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),37.9,536.0,3.7e-101,370.9,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08276,FUN_036193-T1,Peve_00011114,Pocillopora_meandrina_HIv1___RNAseq.g27368.t2,three_way,60.47933333333333,,,,,,,,,,,,,,,,,
OG_08277,FUN_036195-T1,Peve_00011109,Pocillopora_meandrina_HIv1___RNAseq.g27367.t1,three_way,72.57383333333334,FUN_036195-T1,Q3UMR0,ANR27_MOUSE,,Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein),Mus musculus (Mouse),42.3,787.0,1.6e-96,355.9,sp|Q3UMR0|ANR27_MOUSE Ankyrin repeat domain-containing protein 27 OS=Mus musculus OX=10090 GN=Ankrd27 PE=1 SV=2,GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0045022; GO:0048812; GO:0050775; GO:0097422,early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031],cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149],GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,lysosome; endosome; vacuole; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08278,FUN_036196-T1,Peve_00025812,Pocillopora_meandrina_HIv1___RNAseq.g27366.t1,three_way,85.65133333333334,FUN_036196-T1,Q3UMM4,CDK10_MOUSE,,Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10),Mus musculus (Mouse),65.4,358.0,4.4e-137,489.2,sp|Q3UMM4|CDK10_MOUSE Cyclin-dependent kinase 10 OS=Mus musculus OX=10090 GN=Cdk10 PE=1 SV=1,GO:0000307; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0007346; GO:0018107; GO:0030030; GO:0032956; GO:0036064; GO:0043410; GO:0097472; GO:0106310; GO:1902018; GO:1902749,cell projection organization [GO:0030030]; negative regulation of cilium assembly [GO:1902018]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of MAPK cascade [GO:0043410]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of mitotic cell cycle [GO:0007346],ciliary basal body [GO:0036064]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein kinase activity [GO:0097472]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08279,FUN_036200-T1,Peve_00011078,Pocillopora_meandrina_HIv1___RNAseq.g27365.t1,three_way,49.842666666666666,,,,,,,,,,,,,,,,,
OG_08280,FUN_036204-T1,Peve_00038740,Pocillopora_meandrina_HIv1___RNAseq.g27360.t1,three_way,76.42366666666666,FUN_036204-T1,Q08DZ2,PRP4K_BOVIN,,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 pre-mRNA-processing factor 4 homolog),Bos taurus (Bovine),64.4,469.0,1.3e-160,568.5,sp|Q08DZ2|PRP4K_BOVIN Serine/threonine-protein kinase PRP4 homolog OS=Bos taurus OX=9913 GN=PRP4K PE=2 SV=1,GO:0000244; GO:0000387; GO:0000776; GO:0004674; GO:0005524; GO:0005681; GO:0016607; GO:0045292; GO:0090266; GO:0106310,"mRNA cis splicing, via spliceosome [GO:0045292]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244]",kinetochore [GO:0000776]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016071; GO:0016740; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; mRNA metabolic process; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_08281,FUN_036205-T1,Peve_00038741,Pocillopora_meandrina_HIv1___RNAseq.g27357.t1,three_way,76.24883333333334,FUN_036205-T1,O88554,PARP2_MOUSE,,Poly [ADP-ribose] polymerase 2 (PARP-2) (mPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (DNA ADP-ribosyltransferase PARP2) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2) (Protein poly-ADP-ribosyltransferase PARP2) (EC 2.4.2.-),Mus musculus (Mouse),55.8,545.0,8.2e-169,595.5,sp|O88554|PARP2_MOUSE Poly [ADP-ribose] polymerase 2 OS=Mus musculus OX=10090 GN=Parp2 PE=1 SV=3,GO:0003682; GO:0003684; GO:0003950; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006284; GO:0016779; GO:0030592; GO:0031491; GO:0046697; GO:0061051; GO:0070212; GO:0070213; GO:0072572; GO:0090649; GO:0090734; GO:0097191; GO:0110088; GO:0140294; GO:0140805; GO:0140806; GO:0140807; GO:0140861; GO:0160004; GO:1990404,base-excision repair [GO:0006284]; decidualization [GO:0046697]; DNA ADP-ribosylation [GO:0030592]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; extrinsic apoptotic signaling pathway [GO:0097191]; hippocampal neuron apoptotic process [GO:0110088]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein auto-ADP-ribosylation [GO:0070213]; protein poly-ADP-ribosylation [GO:0070212]; response to oxygen-glucose deprivation [GO:0090649],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734],chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; poly-ADP-D-ribose binding [GO:0072572]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006325; GO:0012501; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; chromatin organization; programmed cell death; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08282,FUN_036206-T1,Peve_00038731,Pocillopora_meandrina_HIv1___TS.g14703.t1,three_way,37.79683333333333,,,,,,,,,,,,,,,,,
OG_08283,FUN_036207-T2,Peve_00038732,Pocillopora_meandrina_HIv1___RNAseq.g27355.t1,three_way,77.35466666666666,FUN_036207-T2,Q5RDW1,,,,,48.1,322.0,7.600000000000001e-80,298.9,sp|Q5RDW1|MTG2_PONAB Mitochondrial ribosome-associated GTPase 2 OS=Pongo abelii OX=9601 GN=MTG2 PE=2 SV=1,,,,,,
OG_08284,FUN_036208-T1,Peve_00038733,Pocillopora_meandrina_HIv1___RNAseq.g27354.t1,three_way,51.08383333333333,FUN_036208-T1,Q5F363,,,,,36.3,658.0,8.7e-114,414.1,sp|Q5F363|JARD2_CHICK Protein Jumonji OS=Gallus gallus OX=9031 GN=JARID2 PE=2 SV=1,,,,,,
OG_08285,FUN_036212-T1,Peve_00025926,Pocillopora_meandrina_HIv1___RNAseq.g27384.t1,three_way,79.80799999999999,FUN_036212-T1,Q96RK4,BBS4_HUMAN,,BBSome complex member BBS4 (Bardet-Biedl syndrome 4 protein),Homo sapiens (Human),38.6,451.0,2.1999999999999998e-75,284.6,sp|Q96RK4|BBS4_HUMAN BBSome complex member BBS4 OS=Homo sapiens OX=9606 GN=BBS4 PE=1 SV=2,GO:0000226; GO:0000242; GO:0000281; GO:0001750; GO:0001764; GO:0001782; GO:0001843; GO:0001895; GO:0001917; GO:0001947; GO:0003085; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007098; GO:0007286; GO:0007601; GO:0007608; GO:0010467; GO:0010629; GO:0015031; GO:0016055; GO:0016358; GO:0019216; GO:0021591; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0030674; GO:0030837; GO:0031514; GO:0032391; GO:0032402; GO:0032465; GO:0033365; GO:0034101; GO:0034451; GO:0034452; GO:0034454; GO:0034464; GO:0035176; GO:0035845; GO:0035869; GO:0036064; GO:0038108; GO:0040018; GO:0043014; GO:0045444; GO:0045494; GO:0045724; GO:0046548; GO:0046907; GO:0048487; GO:0048854; GO:0050893; GO:0051457; GO:0051492; GO:0060170; GO:0060271; GO:0060296; GO:0060324; GO:0060613; GO:0061512; GO:0061629; GO:0071539; GO:0097730; GO:0120316; GO:1902855; GO:1903546; GO:1905515,adult behavior [GO:0030534]; B cell homeostasis [GO:0001782]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; erythrocyte homeostasis [GO:0034101]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; gene expression [GO:0010467]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; sperm flagellum assembly [GO:0120316]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750],alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0000910; GO:0002376; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0008092; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0050877; GO:0060090,cytokinesis; immune system process; nucleus; microtubule organizing center; cytosol; cilium; cytoskeleton organization; cytoskeletal protein binding; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; cell motility; nervous system process; molecular adaptor activity
OG_08286,FUN_036221-T1,Peve_00025940,Pocillopora_meandrina_HIv1___RNAseq.g27543.t1,three_way,83.386,FUN_036221-T1,F1MM41,ZNRF1_BOVIN,,E3 ubiquitin-protein ligase ZNRF1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNRF1) (Zinc/RING finger protein 1),Bos taurus (Bovine),57.0,93.0,2.6e-26,120.2,sp|F1MM41|ZNRF1_BOVIN E3 ubiquitin-protein ligase ZNRF1 OS=Bos taurus OX=9913 GN=ZNRF1 PE=3 SV=2,GO:0004842; GO:0005737; GO:0005764; GO:0005768; GO:0005829; GO:0008270; GO:0016020; GO:0030672; GO:0034145; GO:0043161; GO:0043231; GO:0061630; GO:0070936; GO:0160177,positive regulation of autophagosome-lysosome fusion [GO:0160177]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; synaptic vesicle membrane [GO:0030672],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; lysosome; endosome; vacuole; cytosol; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_08287,FUN_036222-T1,Peve_00025942,Pocillopora_meandrina_HIv1___RNAseq.g27544.t1,three_way,56.418,FUN_036222-T1,Q8IZU8,,,,,33.9,921.0,1.2e-134,482.3,sp|Q8IZU8|DSEL_HUMAN Dermatan-sulfate epimerase-like protein OS=Homo sapiens OX=9606 GN=DSEL PE=1 SV=2,,,,,,
OG_08288,FUN_036223-T1,Peve_00025943,Pocillopora_meandrina_HIv1___RNAseq.g27546.t2,three_way,69.85516666666668,FUN_036223-T1,Q6GNG3,TMX3_XENLA,,Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3),Xenopus laevis (African clawed frog),34.3,429.0,2.3e-69,264.6,sp|Q6GNG3|TMX3_XENLA Protein disulfide-isomerase TMX3 OS=Xenopus laevis OX=8355 GN=tmx3 PE=2 SV=1,GO:0003756; GO:0005783; GO:0005789; GO:0009986,,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],protein disulfide isomerase activity [GO:0003756],GO:0003824; GO:0005783; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_08289,FUN_036224-T1,Peve_00025944,Pocillopora_meandrina_HIv1___RNAseq.g27547.t1,three_way,76.61933333333333,FUN_036224-T1,P41123,,,,,62.6,211.0,9e-68,258.1,sp|P41123|RL13_RAT Large ribosomal subunit protein eL13 OS=Rattus norvegicus OX=10116 GN=Rpl13 PE=1 SV=2,,,,,,
OG_08290,FUN_036225-T1,Peve_00025945,Pocillopora_meandrina_HIv1___RNAseq.g27548.t1,three_way,81.77766666666666,FUN_036225-T1,A0A8I3S9V6,RCAF1_CANLF,,GEL complex subunit OPTI (Obligate partner of TMCO1 insertase) (Rab5-interacting protein) (RIP5) (Respirasome Complex Assembly Factor 1) (RCAF1),Canis lupus familiaris (Dog) (Canis familiaris),55.5,128.0,6.6000000000000005e-34,145.2,sp|A0A8I3S9V6|RCAF1_CANLF GEL complex subunit OPTI OS=Canis lupus familiaris OX=9615 GN=RAB5IF PE=1 SV=1,GO:0005743; GO:0005789; GO:0097250; GO:0160063; GO:0160064,mitochondrial respirasome assembly [GO:0097250]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063],endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; multi-pass translocon complex [GO:0160064],,GO:0007005; GO:0065003,mitochondrion organization; protein-containing complex assembly
OG_08291,FUN_036229-T1,Peve_00032851,Pocillopora_meandrina_HIv1___RNAseq.g27550.t2,three_way,73.45533333333333,FUN_036229-T1,Q91X96,,,,,52.2,115.0,2.9e-31,136.0,sp|Q91X96|MSS4_MOUSE Guanine nucleotide exchange factor MSS4 OS=Mus musculus OX=10090 GN=Rabif PE=1 SV=1,,,,,,
OG_08292,FUN_036230-T1,Peve_00032846,Pocillopora_meandrina_HIv1___RNAseq.g27551.t1,three_way,66.83933333333333,FUN_036230-T1,Q8TB40,,,,,51.4,319.0,7.7e-96,352.1,sp|Q8TB40|ABHD4_HUMAN (Lyso)-N-acylphosphatidylethanolamine lipase OS=Homo sapiens OX=9606 GN=ABHD4 PE=1 SV=1,,,,,,
OG_08293,FUN_036231-T1,Peve_00032844,Pocillopora_meandrina_HIv1___RNAseq.g27552.t1,three_way,77.99933333333334,FUN_036231-T1,Q8WTS1,ABHD5_HUMAN,,1-acylglycerol-3-phosphate O-acyltransferase ABHD5 (EC 2.3.1.51) (Abhydrolase domain-containing protein 5) (Lipid droplet-binding protein CGI-58),Homo sapiens (Human),56.8,315.0,1.9000000000000002e-110,400.6,sp|Q8WTS1|ABHD5_HUMAN 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 OS=Homo sapiens OX=9606 GN=ABHD5 PE=1 SV=1,GO:0003841; GO:0005654; GO:0005739; GO:0005811; GO:0005829; GO:0006631; GO:0006654; GO:0010891; GO:0010898; GO:0030154; GO:0042171; GO:0043231; GO:0052689; GO:0055088; GO:0060229,cell differentiation [GO:0030154]; fatty acid metabolic process [GO:0006631]; lipid homeostasis [GO:0055088]; negative regulation of triglyceride storage [GO:0010891]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of triglyceride catabolic process [GO:0010898],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; carboxylic ester hydrolase activity [GO:0052689]; lipase activator activity [GO:0060229]; lysophosphatidic acid acyltransferase activity [GO:0042171],GO:0003824; GO:0005654; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0030154; GO:0043226; GO:0098772,catalytic activity; nucleoplasm; mitochondrion; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; cell differentiation; organelle; molecular function regulator activity
OG_08294,FUN_036232-T1,Peve_00015682,Pocillopora_meandrina_HIv1___RNAseq.g27553.t2,three_way,83.43166666666666,FUN_036232-T1,O75131,CPNE3_HUMAN,,Copine-3 (Copine III),Homo sapiens (Human),56.6,525.0,3.6e-177,622.9,sp|O75131|CPNE3_HUMAN Copine-3 OS=Homo sapiens OX=9606 GN=CPNE3 PE=1 SV=1,GO:0003723; GO:0004674; GO:0005544; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0005925; GO:0030054; GO:0030335; GO:0030971; GO:0035577; GO:0038128; GO:0046872; GO:0048306; GO:0070062; GO:0071277; GO:0071363,cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; positive regulation of cell migration [GO:0030335],azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0008289; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; plasma membrane; lipid binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08295,FUN_036233-T1,Peve_00015684,Pocillopora_meandrina_HIv1___RNAseq.g27555.t1,three_way,54.409333333333336,,,,,,,,,,,,,,,,,
OG_08296,FUN_036235-T1,Peve_00045139,Pocillopora_meandrina_HIv1___RNAseq.g27557.t1,three_way,86.43366666666667,FUN_036235-T1,Q6DDI6,,,,,47.9,1094.0,1.5e-283,977.2,sp|Q6DDI6|TBC31_XENLA TBC1 domain family member 31 OS=Xenopus laevis OX=8355 GN=tbc1d31 PE=2 SV=1,,,,,,
OG_08297,FUN_036246-T1,Peve_00042157,Pocillopora_meandrina_HIv1___RNAseq.g27581.t2,three_way,85.31133333333334,FUN_036246-T1,P08059,,,,,72.2,550.0,9.8e-239,827.4,sp|P08059|G6PI_PIG Glucose-6-phosphate isomerase OS=Sus scrofa OX=9823 GN=GPI PE=1 SV=3,,,,,,
OG_08298,FUN_036247-T1,Peve_00042155,Pocillopora_meandrina_HIv1___RNAseq.g27593.t1,three_way,84.28566666666666,FUN_036247-T1,Q8NDZ6,,,,,42.0,505.0,3.1e-103,377.1,sp|Q8NDZ6|T161B_HUMAN Transmembrane protein 161B OS=Homo sapiens OX=9606 GN=TMEM161B PE=1 SV=1,,,,,,
OG_08299,FUN_036248-T1,Peve_00045282,Pocillopora_meandrina_HIv1___TS.g14942.t1,three_way,59.625,,,,,,,,,,,,,,,,,
OG_08300,FUN_036249-T1,Peve_00045287,Pocillopora_meandrina_HIv1___RNAseq.g27590.t1,three_way,48.918,,,,,,,,,,,,,,,,,
OG_08301,FUN_036251-T1,Peve_00045290,Pocillopora_meandrina_HIv1___RNAseq.g27588.t1,three_way,74.035,FUN_036251-T1,P20042,IF2B_HUMAN,,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF2-beta),Homo sapiens (Human),85.7,168.0,3.3000000000000003e-80,300.1,sp|P20042|IF2B_HUMAN Eukaryotic translation initiation factor 2 subunit 2 OS=Homo sapiens OX=9606 GN=EIF2S2 PE=1 SV=2,GO:0001701; GO:0001731; GO:0002176; GO:0002183; GO:0003723; GO:0003729; GO:0003743; GO:0005737; GO:0005829; GO:0005850; GO:0006413; GO:0008135; GO:0008270; GO:0008584; GO:0031369; GO:0045202,cytoplasmic translational initiation [GO:0002183]; formation of translation preinitiation complex [GO:0001731]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; synapse [GO:0045202],"mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]",GO:0003723; GO:0005829; GO:0022414; GO:0048856; GO:0065003,RNA binding; cytosol; reproductive process; anatomical structure development; protein-containing complex assembly
OG_08302,FUN_036254-T1,Peve_00045291,Pocillopora_meandrina_HIv1___TS.g14938.t2,three_way,78.763,FUN_036254-T1,Q9UJX0,OSGI1_HUMAN,,"Oxidative stress-induced growth inhibitor 1 (EC 1.14.13.-) (Bone marrow stromal cell-derived growth inhibitor) (BMSC-derived growth inhibitor) (Ovary, kidney and liver protein 38) (huOKL38) (Pregnancy-induced growth inhibitor OKL38)",Homo sapiens (Human),42.5,480.0,3.2e-101,370.5,sp|Q9UJX0|OSGI1_HUMAN Oxidative stress-induced growth inhibitor 1 OS=Homo sapiens OX=9606 GN=OSGIN1 PE=1 SV=4,GO:0008083; GO:0030154; GO:0030308,cell differentiation [GO:0030154]; negative regulation of cell growth [GO:0030308],,growth factor activity [GO:0008083],GO:0030154; GO:0048018; GO:0098772,cell differentiation; receptor ligand activity; molecular function regulator activity
OG_08303,FUN_036255-T1,Peve_00045292,Pocillopora_meandrina_HIv1___TS.g14937.t1,three_way,66.72966666666667,FUN_036255-T1,Q8BYI6,PCAT2_MOUSE,,Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1),Mus musculus (Mouse),38.1,491.0,7.4e-84,312.8,sp|Q8BYI6|PCAT2_MOUSE Lysophosphatidylcholine acyltransferase 2 OS=Mus musculus OX=10090 GN=Lpcat2 PE=1 SV=1,GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005795; GO:0005811; GO:0005886; GO:0006663; GO:0016020; GO:0036151; GO:0047159; GO:0047184; GO:0047192; GO:0061024,membrane organization [GO:0061024]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; platelet activating factor biosynthetic process [GO:0006663],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0047159],GO:0003824; GO:0005783; GO:0005811; GO:0005886; GO:0006629; GO:0016740; GO:0043226; GO:0061024,catalytic activity; endoplasmic reticulum; lipid droplet; plasma membrane; lipid metabolic process; transferase activity; organelle; membrane organization
OG_08304,FUN_036258-T1,Peve_00032885,Pocillopora_meandrina_HIv1___RNAseq.g27585.t1,three_way,77.87166666666667,FUN_036258-T1,Q8BYI6,PCAT2_MOUSE,,Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkenylglycerophosphocholine O-acyltransferase) (EC 2.3.1.25) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1),Mus musculus (Mouse),48.2,475.0,1.2e-123,444.9,sp|Q8BYI6|PCAT2_MOUSE Lysophosphatidylcholine acyltransferase 2 OS=Mus musculus OX=10090 GN=Lpcat2 PE=1 SV=1,GO:0000139; GO:0003841; GO:0005509; GO:0005783; GO:0005789; GO:0005795; GO:0005811; GO:0005886; GO:0006663; GO:0016020; GO:0036151; GO:0047159; GO:0047184; GO:0047192; GO:0061024,membrane organization [GO:0061024]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; platelet activating factor biosynthetic process [GO:0006663],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; calcium ion binding [GO:0005509]; plasmalogen synthase activity [GO:0047159],GO:0003824; GO:0005783; GO:0005811; GO:0005886; GO:0006629; GO:0016740; GO:0043226; GO:0061024,catalytic activity; endoplasmic reticulum; lipid droplet; plasma membrane; lipid metabolic process; transferase activity; organelle; membrane organization
OG_08305,FUN_036260-T1,Peve_00012320,Pocillopora_meandrina_HIv1___RNAseq.g27582.t1,three_way,82.303,FUN_036260-T1,Q8WXH2,JPH3_HUMAN,,Junctophilin-3 (JP-3) (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein),Homo sapiens (Human),66.7,57.0,9.9e-20,99.4,sp|Q8WXH2|JPH3_HUMAN Junctophilin-3 OS=Homo sapiens OX=9606 GN=JPH3 PE=1 SV=2,GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0010880; GO:0010882; GO:0014701; GO:0016020; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060402,calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic plasticity [GO:0048167],endoplasmic reticulum membrane [GO:0005789]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886],,GO:0005886; GO:0050877; GO:0055085,plasma membrane; nervous system process; transmembrane transport
OG_08306,FUN_036263-T1,Peve_00031402,Pocillopora_meandrina_HIv1___TS.g3444.t1,three_way,50.59766666666667,,,,,,,,,,,,,,,,,
OG_08307,FUN_036264-T1,Peve_00009286,Pocillopora_meandrina_HIv1___RNAseq.g27055.t1,three_way,54.22983333333334,FUN_036264-T1,Q75QI0,,,,,45.5,178.0,1.9e-27,124.4,sp|Q75QI0|CFDP1_CHICK Craniofacial development protein 1 OS=Gallus gallus OX=9031 GN=CFDP1 PE=2 SV=1,,,,,,
OG_08308,FUN_036278-T1,Peve_00043324,Pocillopora_meandrina_HIv1___RNAseq.g2118.t1,three_way,57.734,,,,,,,,,,,,,,,,,
OG_08309,FUN_036334-T1,Peve_00031396,Pocillopora_meandrina_HIv1___RNAseq.g12103.t1,three_way,81.12233333333333,,,,,,,,,,,,,,,,,
OG_08310,FUN_036335-T1,Peve_00031401,Pocillopora_meandrina_HIv1___RNAseq.g12101.t1,three_way,84.46183333333333,FUN_036335-T1,A0A0R4IC37,,,,,53.9,778.0,5.1e-235,815.5,sp|A0A0R4IC37|CPSF1_DANRE Cleavage and polyadenylation specificity factor subunit 1 OS=Danio rerio OX=7955 GN=cpsf1 PE=3 SV=2,,,,,,
OG_08311,FUN_036338-T1,Peve_00031393,Pocillopora_meandrina_HIv1___RNAseq.g12116.t1,three_way,98.718,FUN_036338-T1,Q6PBJ2,CFA20_DANRE,,Cilia- and flagella-associated protein 20,Danio rerio (Zebrafish) (Brachydanio rerio),98.1,156.0,2.9999999999999996e-84,312.4,sp|Q6PBJ2|CFA20_DANRE Cilia- and flagella-associated protein 20 OS=Danio rerio OX=7955 GN=cfap20 PE=2 SV=1,GO:0001895; GO:0005634; GO:0005814; GO:0005879; GO:0005929; GO:0014807; GO:0018095; GO:0031514; GO:0036064; GO:0048570; GO:0060271; GO:0060296; GO:0061371; GO:0065001; GO:1901207; GO:2000147; GO:2000253,cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; notochord morphogenesis [GO:0048570]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of heart looping [GO:1901207]; regulation of somitogenesis [GO:0014807]; retina homeostasis [GO:0001895]; specification of axis polarity [GO:0065001],axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; motile cilium [GO:0031514]; nucleus [GO:0005634],,GO:0005634; GO:0005815; GO:0005929; GO:0043226; GO:0044782,nucleus; microtubule organizing center; cilium; organelle; cilium organization
OG_08312,FUN_036507-T1,Peve_00008825,Pocillopora_meandrina_HIv1___RNAseq.g27056.t1,three_way,63.563,FUN_036507-T1,Q149F1,,,,,48.7,417.0,2.3e-118,427.2,sp|Q149F1|RUSD2_MOUSE Pseudouridylate synthase RPUSD2 OS=Mus musculus OX=10090 GN=Rpusd2 PE=1 SV=2,,,,,,
OG_08313,FUN_036513-T1,Peve_00031408,Pocillopora_meandrina_HIv1___RNAseq.g27052.t1,three_way,58.79833333333333,FUN_036513-T1,A0A8I3PDQ1,CASL_CANLF,,Enhancer of filamentation 1 (CRK-associated substrate-related protein) (CAS-L) (Neural precursor cell expressed developmentally down-regulated protein 9) (NEDD-9) (p105),Canis lupus familiaris (Dog) (Canis familiaris),22.2,968.0,2.6e-26,122.5,sp|A0A8I3PDQ1|CASL_CANLF Enhancer of filamentation 1 OS=Canis lupus familiaris OX=9615 GN=NEDD9 PE=1 SV=1,GO:0000922; GO:0001772; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0005925; GO:0005938; GO:0007155; GO:0007169; GO:0007611; GO:0016323; GO:0016477; GO:0030027; GO:0030336; GO:0032956; GO:0036064; GO:0045672; GO:0051301; GO:0061523; GO:0072686; GO:0097021; GO:0140131; GO:1900026; GO:1902952; GO:1903829; GO:1990782; GO:2000522,cell adhesion [GO:0007155]; cell division [GO:0051301]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cilium disassembly [GO:0061523]; learning or memory [GO:0007611]; lymphocyte migration into lymphoid organs [GO:0097021]; negative regulation of cell migration [GO:0030336]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of immunological synapse formation [GO:2000522]; positive regulation of lymphocyte chemotaxis [GO:0140131]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein localization [GO:1903829]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of actin cytoskeleton organization [GO:0032956],basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0007155; GO:0043226; GO:0044782; GO:0048870; GO:0050877,immune system process; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; cell adhesion; organelle; cilium organization; cell motility; nervous system process
OG_08314,FUN_036524-T1,Peve_00031406,Pocillopora_meandrina_HIv1___RNAseq.g12097.t1,three_way,72.94333333333334,FUN_036524-T1,Q8NG66,NEK11_HUMAN,,Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11),Homo sapiens (Human),37.1,631.0,1.6e-98,361.7,sp|Q8NG66|NEK11_HUMAN Serine/threonine-protein kinase Nek11 OS=Homo sapiens OX=9606 GN=NEK11 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006468; GO:0031573; GO:0035556; GO:0046872; GO:0106310; GO:1901990,intracellular signal transduction [GO:0035556]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle phase transition [GO:1901990],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08315,FUN_036525-T1,Peve_00032571,Pocillopora_meandrina_HIv1___RNAseq.g6106.t1,three_way,67.44800000000001,,,,,,,,,,,,,,,,,
OG_08316,FUN_036541-T1,Peve_00013615,Pocillopora_meandrina_HIv1___RNAseq.g12094.t1,three_way,42.91,,,,,,,,,,,,,,,,,
OG_08317,FUN_036563-T1,Peve_00036100,Pocillopora_meandrina_HIv1___RNAseq.g12087.t1,three_way,71.88566666666667,FUN_036563-T1,Q9JHW1,CBPD_RAT,,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180),Rattus norvegicus (Rat),46.0,428.0,2.4e-108,394.0,sp|Q9JHW1|CBPD_RAT Carboxypeptidase D OS=Rattus norvegicus OX=10116 GN=Cpd PE=1 SV=2,GO:0004181; GO:0005615; GO:0005634; GO:0005802; GO:0005886; GO:0006508; GO:0006518; GO:0008270; GO:0016020; GO:0016485; GO:0044877; GO:0048471; GO:0051721; GO:0071352,cellular response to interleukin-2 [GO:0071352]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],metallocarboxypeptidase activity [GO:0004181]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005634; GO:0005886; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; extracellular space; nucleus; plasma membrane; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_08318,FUN_036742-T1,Peve_00018098,Pocillopora_meandrina_HIv1___RNAseq.g12110.t1,three_way,78.11333333333333,FUN_036742-T1,Q86U44,MTA70_HUMAN,,N(6)-adenosine-methyltransferase catalytic subunit METTL3 (EC 2.1.1.348) (Methyltransferase-like protein 3) (hMETTL3) (N(6)-adenosine-methyltransferase 70 kDa subunit) (MT-A70),Homo sapiens (Human),40.3,442.0,2.4000000000000003e-80,300.8,sp|Q86U44|MTA70_HUMAN N(6)-adenosine-methyltransferase catalytic subunit METTL3 OS=Homo sapiens OX=9606 GN=METTL3 PE=1 SV=2,GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006397; GO:0006974; GO:0007283; GO:0007623; GO:0008173; GO:0009048; GO:0016556; GO:0016604; GO:0016607; GO:0019827; GO:0021861; GO:0031053; GO:0034644; GO:0036396; GO:0042063; GO:0045087; GO:0045580; GO:0045727; GO:0045746; GO:0046982; GO:0048477; GO:0051445; GO:0060339; GO:0061157; GO:0098508; GO:1902036; GO:1903679; GO:1904047; GO:1990204,"cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; innate immune response [GO:0045087]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; oogenesis [GO:0048477]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of translation [GO:0045727]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006325; GO:0016071; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098542; GO:0140098,"immune system process; RNA binding; catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; chromatin organization; mRNA metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; defense response to other organism; catalytic activity, acting on RNA"
OG_08319,FUN_036746-T1,Peve_00018099,Pocillopora_meandrina_HIv1___TS.g3451.t1,three_way,67.292,FUN_036746-T1,Q29IC2,RIC8_DROPS,,Chaperone Ric-8 (Synembryn),Drosophila pseudoobscura pseudoobscura (Fruit fly),32.0,565.0,2.9e-63,244.6,sp|Q29IC2|RIC8_DROPS Chaperone Ric-8 OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=ric8a PE=3 SV=1,GO:0001965; GO:0005085; GO:0005737; GO:0005938; GO:0007163; GO:0007186; GO:0008104; GO:0008356; GO:0010004; GO:0040001; GO:0042995; GO:0050821; GO:0055057; GO:0098793,asymmetric cell division [GO:0008356]; establishment of mitotic spindle localization [GO:0040001]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation involving germ band extension [GO:0010004]; neuroblast division [GO:0055057]; protein localization [GO:0008104]; protein stabilization [GO:0050821],cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; presynapse [GO:0098793],G-protein alpha-subunit binding [GO:0001965]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0007010; GO:0007163; GO:0098772,cytoskeleton organization; establishment or maintenance of cell polarity; molecular function regulator activity
OG_08320,FUN_036747-T1,Peve_00018100,Pocillopora_meandrina_HIv1___RNAseq.g27116.t1,three_way,47.78366666666667,,,,,,,,,,,,,,,,,
OG_08321,FUN_036748-T1,Peve_00029513,Pocillopora_meandrina_HIv1___RNAseq.g12118.t1,three_way,83.22666666666667,FUN_036748-T1,Q5ZJ85,PRPF3_CHICK,,U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3),Gallus gallus (Chicken),52.0,696.0,1.8000000000000004e-165,584.3,sp|Q5ZJ85|PRPF3_CHICK U4/U6 small nuclear ribonucleoprotein Prp3 OS=Gallus gallus OX=9031 GN=PRPF3 PE=2 SV=1,GO:0000244; GO:0000398; GO:0005634; GO:0005681; GO:0016607; GO:0046540,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]",nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540],,GO:0005634; GO:0016071; GO:0043226; GO:0065003,nucleus; mRNA metabolic process; organelle; protein-containing complex assembly
OG_08322,FUN_036749-T2,Peve_00029514,Pocillopora_meandrina_HIv1___RNAseq.g12117.t1,three_way,82.16683333333333,FUN_036749-T2,A7RRJ0,FEN1_NEMVE,,Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1),Nematostella vectensis (Starlet sea anemone),77.7,382.0,9.000000000000002e-165,581.3,sp|A7RRJ0|FEN1_NEMVE Flap endonuclease 1 OS=Nematostella vectensis OX=45351 GN=FEN1 PE=3 SV=1,GO:0000287; GO:0003677; GO:0004523; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006284; GO:0008409; GO:0017108; GO:0030145; GO:0043137,"base-excision repair [GO:0006284]; DNA replication, removal of RNA primer [GO:0043137]",mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006281; GO:0016787; GO:0043226; GO:0140097; GO:0140098,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_08323,FUN_036750-T1,Peve_00036101,Pocillopora_meandrina_HIv1___RNAseq.g12086.t1,three_way,56.69133333333333,FUN_036750-T1,Q4R537,,,,,38.1,433.0,1.6000000000000001e-71,271.6,sp|Q4R537|NOB1_MACFA RNA-binding protein NOB1 OS=Macaca fascicularis OX=9541 GN=NOB1 PE=2 SV=1,,,,,,
OG_08324,FUN_036753-T1,Peve_00001060,Pocillopora_meandrina_HIv1___RNAseq.g12113.t1,three_way,78.39483333333332,FUN_036753-T1,Q2V2M9,FHOD3_HUMAN,,FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2),Homo sapiens (Human),42.2,1460.0,2.6e-214,747.7,sp|Q2V2M9|FHOD3_HUMAN FH1/FH2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=FHOD3 PE=1 SV=2,GO:0005737; GO:0005856; GO:0030018; GO:0030866; GO:0045214; GO:0051015; GO:0055003,cardiac myofibril assembly [GO:0055003]; cortical actin cytoskeleton organization [GO:0030866]; sarcomere organization [GO:0045214],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Z disc [GO:0030018],actin filament binding [GO:0051015],GO:0005856; GO:0007010; GO:0008092; GO:0043226,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08325,FUN_036755-T1,Peve_00027843,Pocillopora_meandrina_HIv1___RNAseq.g27068.t1,three_way,83.454,FUN_036755-T1,Q9CY50,,,,,53.3,197.0,9.4e-56,218.4,sp|Q9CY50|SSRA_MOUSE Translocon-associated protein subunit alpha OS=Mus musculus OX=10090 GN=Ssr1 PE=1 SV=1,,,,,,
OG_08326,FUN_036756-T1,Peve_00001059,Pocillopora_meandrina_HIv1___RNAseq.g27066.t1,three_way,84.369,FUN_036756-T1,Q08CH8,,,,,50.0,340.0,3.7e-95,349.7,sp|Q08CH8|ZTRF1_DANRE Zinc finger TRAF-type-containing protein 1 OS=Danio rerio OX=7955 GN=zftraf1 PE=2 SV=2,,,,,,
OG_08327,FUN_036757-T1,Peve_00001061,Pocillopora_meandrina_HIv1___RNAseq.g27065.t1,three_way,52.537333333333336,,,,,,,,,,,,,,,,,
OG_08328,FUN_036764-T1,Peve_00006972,Pocillopora_meandrina_HIv1___RNAseq.g10638.t1,three_way,53.79416666666667,,,,,,,,,,,,,,,,,
OG_08329,FUN_036767-T1,Peve_00006967,Pocillopora_meandrina_HIv1___RNAseq.g10634.t1,three_way,71.927,FUN_036767-T1,F1N2K1,,,,,39.2,452.0,1.3e-83,312.0,sp|F1N2K1|PCYOX_BOVIN Prenylcysteine oxidase 1 OS=Bos taurus OX=9913 GN=PCYOX1 PE=1 SV=2,,,,,,
OG_08330,FUN_036809-T1,Peve_00006528,Pocillopora_meandrina_HIv1___RNAseq.g10614.t1,three_way,83.708,FUN_036809-T1,Q7T0V2,,,,,53.3,122.0,2.4e-28,126.3,sp|Q7T0V2|LTR3A_XENLA Ragulator complex protein LAMTOR3-A OS=Xenopus laevis OX=8355 GN=lamtor3-a PE=2 SV=1,,,,,,
OG_08331,FUN_036817-T1,Peve_00006527,Pocillopora_meandrina_HIv1___RNAseq.g10617.t1,three_way,69.63,FUN_036817-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),31.5,2060.0,1.3e-224,782.3,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_08332,FUN_036826-T1,Peve_00006971,Pocillopora_meandrina_HIv1___TS.g13145.t5b,three_way,63.583666666666666,FUN_036826-T1,O15111,IKKA_HUMAN,,Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK-1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16),Homo sapiens (Human),35.9,754.0,3.9e-129,463.8,sp|O15111|IKKA_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Homo sapiens OX=9606 GN=CHUK PE=1 SV=2,GO:0003009; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008384; GO:0008385; GO:0009410; GO:0009615; GO:0009636; GO:0009653; GO:0009898; GO:0010034; GO:0032088; GO:0032727; GO:0033194; GO:0033209; GO:0034142; GO:0035631; GO:0038061; GO:0042803; GO:0043123; GO:0043200; GO:0044877; GO:0045087; GO:0045944; GO:0046982; GO:0051092; GO:0051146; GO:0061847; GO:0071356; GO:0097110; GO:0098586; GO:1990459,anatomical structure morphogenesis [GO:0009653]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to acetate [GO:0010034]; response to amino acid [GO:0043200]; response to cholecystokinin [GO:0061847]; response to hydroperoxide [GO:0033194]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle contraction [GO:0003009]; striated muscle cell differentiation [GO:0051146]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; transferrin receptor binding [GO:1990459],GO:0002376; GO:0003012; GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0006954; GO:0016740; GO:0030154; GO:0098542; GO:0140096,"immune system process; muscle system process; catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; inflammatory response; transferase activity; cell differentiation; defense response to other organism; catalytic activity, acting on a protein"
OG_08333,FUN_036827-T2,Peve_00006950,Pocillopora_meandrina_HIv1___RNAseq.g10630.t1,three_way,69.77466666666666,FUN_036827-T2,Q6TH47,,,,,45.8,367.0,2e-62,241.1,sp|Q6TH47|STBPA_DANRE STAM-binding protein-like A OS=Danio rerio OX=7955 GN=stambpa PE=2 SV=3,,,,,,
OG_08334,FUN_036829-T1,Peve_00006952,Pocillopora_meandrina_HIv1___TS.g13147.t1,three_way,73.91533333333334,FUN_036829-T1,Q9NYI0,PSD3_HUMAN,,PH and SEC7 domain-containing protein 3 (Epididymis tissue protein Li 20mP) (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 D) (Exchange factor for ARF6 D) (Hepatocellular carcinoma-associated antigen 67) (Pleckstrin homology and SEC7 domain-containing protein 3),Homo sapiens (Human),44.6,417.0,3.4e-91,337.8,sp|Q9NYI0|PSD3_HUMAN PH and SEC7 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=PSD3 PE=1 SV=2,GO:0005085; GO:0014069; GO:0032012; GO:0032587,regulation of ARF protein signal transduction [GO:0032012],postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0043226; GO:0098772,organelle; molecular function regulator activity
OG_08335,FUN_036831-T1,Peve_00006966,Pocillopora_meandrina_HIv1___RNAseq.g10632.t1,three_way,76.47966666666666,FUN_036831-T1,O95470,SGPL1_HUMAN,,Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase),Homo sapiens (Human),52.1,94.0,7.9e-25,114.4,sp|O95470|SGPL1_HUMAN Sphingosine-1-phosphate lyase 1 OS=Homo sapiens OX=9606 GN=SGPL1 PE=1 SV=3,GO:0001553; GO:0001570; GO:0001822; GO:0005783; GO:0005789; GO:0006631; GO:0006672; GO:0007283; GO:0008117; GO:0008209; GO:0008210; GO:0009791; GO:0010761; GO:0030097; GO:0030149; GO:0030170; GO:0033327; GO:0040014; GO:0048008; GO:0048705; GO:0060021; GO:0060325; GO:0097190,androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; vasculogenesis [GO:0001570],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117],GO:0003824; GO:0005783; GO:0006629; GO:0016829; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0048870,catalytic activity; endoplasmic reticulum; lipid metabolic process; lyase activity; reproductive process; cell differentiation; organelle; anatomical structure development; cell motility
OG_08336,FUN_036841-T1,Peve_00006959,Pocillopora_meandrina_HIv1___TS.g13168.t1,three_way,71.919,FUN_036841-T1,P80457,XDH_BOVIN,,Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)],Bos taurus (Bovine),33.5,1310.0,3.4e-197,690.6,sp|P80457|XDH_BOVIN Xanthine dehydrogenase/oxidase OS=Bos taurus OX=9913 GN=XDH PE=1 SV=4,GO:0002197; GO:0004854; GO:0004855; GO:0005506; GO:0005615; GO:0005777; GO:0009115; GO:0030151; GO:0042803; GO:0043546; GO:0050660; GO:0051537; GO:0071949,xanthine catabolic process [GO:0009115],extracellular space [GO:0005615]; peroxisome [GO:0005777]; xanthine dehydrogenase complex [GO:0002197],"2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]",GO:0003824; GO:0005615; GO:0005777; GO:0016491; GO:0043226; GO:0055086,catalytic activity; extracellular space; peroxisome; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_08337,FUN_036850-T1,Peve_00036530,Pocillopora_meandrina_HIv1___RNAseq.g10652.t1,three_way,46.763666666666666,,,,,,,,,,,,,,,,,
OG_08338,FUN_036852-T1,Peve_00036539,Pocillopora_meandrina_HIv1___RNAseq.g10654.t1,three_way,83.33333333333333,FUN_036852-T1,A0A7U2MMF3,ADHB_ASPFN,,Zinc-type alcohol dehydrogenase B (EC 1.1.1.1),Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167),27.4,296.0,3.4e-19,97.4,sp|A0A7U2MMF3|ADHB_ASPFN Zinc-type alcohol dehydrogenase B OS=Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) OX=332952 GN=adhB PE=1 SV=1,GO:0008270; GO:0016491,,,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_08339,FUN_036853-T1,Peve_00036532,Pocillopora_meandrina_HIv1___RNAseq.g10656.t1,three_way,73.08466666666666,FUN_036853-T1,P21765,,,,,43.4,143.0,7.7e-27,121.7,sp|P21765|GPX5_MOUSE Epididymal secretory glutathione peroxidase OS=Mus musculus OX=10090 GN=Gpx5 PE=2 SV=3,,,,,,
OG_08340,FUN_036857-T1,Peve_00001064,Pocillopora_meandrina_HIv1___RNAseq.g27062.t1,three_way,73.51566666666666,FUN_036857-T1,Q8BTI7,,,,,29.1,158.0,2.6e-07,58.9,sp|Q8BTI7|ANR52_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Mus musculus OX=10090 GN=Ankrd52 PE=1 SV=1,,,,,,
OG_08341,FUN_036858-T1,Peve_00001065,Pocillopora_meandrina_HIv1___RNAseq.g27061.t1,three_way,76.1845,FUN_036858-T1,P22412,,,,,50.9,369.0,1.1e-104,381.7,sp|P22412|DPEP1_PIG Dipeptidase 1 OS=Sus scrofa OX=9823 GN=DPEP1 PE=1 SV=1,,,,,,
OG_08342,FUN_036865-T1,Peve_00044052,Pocillopora_meandrina_HIv1___RNAseq.g28988.t1,three_way,35.233666666666664,,,,,,,,,,,,,,,,,
OG_08343,FUN_036868-T1,Peve_00004118,Pocillopora_meandrina_HIv1___RNAseq.g10621.t1,three_way,60.080666666666666,FUN_036868-T1,P46616,,,,,28.6,308.0,2.1e-10,68.2,sp|P46616|AA2AR_CAVPO Adenosine receptor A2a OS=Cavia porcellus OX=10141 GN=ADORA2A PE=2 SV=1,,,,,,
OG_08344,FUN_036870-T1,Peve_00004117,Pocillopora_meandrina_HIv1___RNAseq.g10622.t1,three_way,59.571666666666665,FUN_036870-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),23.8,298.0,1.7e-06,55.1,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_08345,FUN_036872-T1,Peve_00039758,Pocillopora_meandrina_HIv1___TS.g13142.t1,three_way,53.678333333333335,FUN_036872-T1,O08710,THYG_MOUSE,,Thyroglobulin (Tg),Mus musculus (Mouse),21.6,1359.0,7.8e-40,168.7,sp|O08710|THYG_MOUSE Thyroglobulin OS=Mus musculus OX=10090 GN=Tg PE=1 SV=3,GO:0005179; GO:0005615; GO:0006590; GO:0015705; GO:0030878; GO:0031641; GO:0042403; GO:0042446; GO:0042802,hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403],extracellular space [GO:0005615],hormone activity [GO:0005179]; identical protein binding [GO:0042802],GO:0005615; GO:0006575; GO:0048018; GO:0048856; GO:0098772,extracellular space; modified amino acid metabolic process; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_08346,FUN_036879-T1,Peve_00006949,Pocillopora_meandrina_HIv1___RNAseq.g10628.t1,three_way,88.30766666666666,FUN_036879-T1,Q27128,PAPSS_URECA,,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase (PAPS synthase) (PAPS synthetase) (PAPSS) (Sulfurylase kinase) (SK) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],Urechis caupo (Innkeeper worm) (Spoonworm),71.9,597.0,1.0999999999999999e-265,917.1,sp|Q27128|PAPSS_URECA Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase OS=Urechis caupo OX=6431 PE=1 SV=1,GO:0000103; GO:0004020; GO:0004781; GO:0005524; GO:0016779; GO:0050428,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process [GO:0050428]; sulfate assimilation [GO:0000103],,adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781],GO:0003824; GO:0006790; GO:0016740; GO:0055086; GO:1901135,catalytic activity; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08347,FUN_036881-T1,Peve_00006965,Pocillopora_meandrina_HIv1___TS.g13145.t5a,three_way,67.16199999999999,FUN_036881-T1,O94988,,,,,26.8,1111.0,2.2000000000000008e-59,232.6,sp|O94988|FA13A_HUMAN Protein FAM13A OS=Homo sapiens OX=9606 GN=FAM13A PE=1 SV=2,,,,,,
OG_08348,FUN_036882-T1,Peve_00018386,Pocillopora_meandrina_HIv1___RNAseq.g10797.t1,three_way,61.394666666666666,FUN_036882-T1,Q9H0R5,GBP3_HUMAN,,Guanylate-binding protein 3 (EC 3.6.5.-) (GTP-binding protein 3) (GBP-3) (Guanine nucleotide-binding protein 3),Homo sapiens (Human),26.4,405.0,1e-20,103.2,sp|Q9H0R5|GBP3_HUMAN Guanylate-binding protein 3 OS=Homo sapiens OX=9606 GN=GBP3 PE=1 SV=3,GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0031410; GO:0042742; GO:0042802; GO:0042803; GO:0048471; GO:0051607; GO:0051715; GO:0071222; GO:0071346; GO:0071347; GO:0071356; GO:0140639,cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; cytolysis in another organism [GO:0051715]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; positive regulation of pyroptotic inflammatory response [GO:0140639],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0031410; GO:0043226,catalytic activity; GTPase activity; cytosol; hydrolase activity; cytoplasmic vesicle; organelle
OG_08349,FUN_036888-T1,Peve_00018384,Pocillopora_meandrina_HIv1___RNAseq.g10793.t1,three_way,86.20466666666667,FUN_036888-T1,P82808,GFPT1_RAT,,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1),Rattus norvegicus (Rat),69.5,691.0,6.3e-272,937.9,sp|P82808|GFPT1_RAT Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 OS=Rattus norvegicus OX=10116 GN=Gfpt1 PE=1 SV=3,GO:0004360; GO:0006002; GO:0006042; GO:0006047; GO:0006048; GO:0006487; GO:0009744; GO:0016597; GO:0030246; GO:0032868; GO:0032869; GO:0032922; GO:0042802; GO:0045719; GO:0097367,cellular response to insulin stimulus [GO:0032869]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein N-linked glycosylation [GO:0006487]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],,amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; identical protein binding [GO:0042802],GO:0003824; GO:0009101; GO:0016740; GO:0055086; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08350,FUN_036889-T1,Peve_00018383,Pocillopora_meandrina_HIv1___RNAseq.g10792.t1,three_way,77.267,FUN_036889-T1,Q3SYV5,TSN33_BOVIN,,Tetraspanin-33 (Tspan-33),Bos taurus (Bovine),42.6,251.0,1e-55,218.4,sp|Q3SYV5|TSN33_BOVIN Tetraspanin-33 OS=Bos taurus OX=9913 GN=TSPAN33 PE=1 SV=1,GO:0005737; GO:0005886; GO:0005912; GO:0051604; GO:0072659,protein localization to plasma membrane [GO:0072659]; protein maturation [GO:0051604],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,GO:0005886; GO:0051604; GO:0072659,plasma membrane; protein maturation; protein localization to plasma membrane
OG_08351,FUN_036892-T1,Peve_00018381,Pocillopora_meandrina_HIv1___RNAseq.g10791.t1,three_way,49.0455,FUN_036892-T1,Q6P1Z5,,,,,37.6,282.0,9.5e-45,183.3,sp|Q6P1Z5|PED1A_MOUSE PC-esterase domain-containing protein 1A OS=Mus musculus OX=10090 GN=Pced1a PE=2 SV=2,,,,,,
OG_08352,FUN_036896-T1,Peve_00018377,Pocillopora_meandrina_HIv1___RNAseq.g10784.t1,three_way,81.105,FUN_036896-T1,Q5HZT9,,,,,48.0,323.0,9.8e-85,315.1,sp|Q5HZT9|DJC25_XENTR DnaJ homolog subfamily C member 25 OS=Xenopus tropicalis OX=8364 GN=dnajc25 PE=2 SV=1,,,,,,
OG_08353,FUN_036897-T1,Peve_00018373,Pocillopora_meandrina_HIv1___RNAseq.g10782.t1,three_way,84.62,FUN_036897-T1,Q9MYP6,,,,,53.5,256.0,1.8e-76,287.3,sp|Q9MYP6|DHB14_BOVIN L-fucose dehydrogenase OS=Bos taurus OX=9913 GN=HSD17B14 PE=2 SV=1,,,,,,
OG_08354,FUN_036898-T1,Peve_00018372,Pocillopora_meandrina_HIv1___RNAseq.g10780.t1,three_way,90.75833333333333,FUN_036898-T1,Q6XUZ5,,,,,79.5,409.0,2.4e-189,662.9,sp|Q6XUZ5|IDHC_SHEEP Isocitrate dehydrogenase [NADP] cytoplasmic OS=Ovis aries OX=9940 GN=IDH1 PE=2 SV=1,,,,,,
OG_08355,FUN_036899-T1,Peve_00018371,Pocillopora_meandrina_HIv1___RNAseq.g26703.t1,three_way,78.23133333333332,FUN_036899-T1,Q8VZ42,,,,,40.3,129.0,1.3e-25,117.5,sp|Q8VZ42|SAP11_ARATH Zinc finger AN1 and C2H2 domain-containing stress-associated protein 11 OS=Arabidopsis thaliana OX=3702 GN=SAP11 PE=2 SV=1,,,,,,
OG_08356,FUN_036900-T1,Peve_00018370,Pocillopora_meandrina_HIv1___RNAseq.g10779.t1,three_way,79.11716666666666,FUN_036900-T1,Q99PW8,KIF17_MOUSE,,Kinesin-like protein KIF17 (MmKIF17),Mus musculus (Mouse),42.7,1061.0,2.3e-197,690.6,sp|Q99PW8|KIF17_MOUSE Kinesin-like protein KIF17 OS=Mus musculus OX=10090 GN=Kif17 PE=1 SV=1,GO:0001750; GO:0001917; GO:0003777; GO:0005524; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0007017; GO:0008017; GO:0015031; GO:0015630; GO:0016192; GO:0031503; GO:0032391; GO:0032839; GO:0036064; GO:0042073; GO:0098794; GO:0098971; GO:1990075,anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; intraciliary transport [GO:0042073]; microtubule-based process [GO:0007017]; protein transport [GO:0015031]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007018; GO:0008092; GO:0016192; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; organelle; ATP-dependent activity
OG_08357,FUN_036902-T1,Peve_00018348,Pocillopora_meandrina_HIv1___TS.g22911.t1b,three_way,48.922666666666665,,,,,,,,,,,,,,,,,
OG_08358,FUN_036907-T1,Peve_00018423,Pocillopora_meandrina_HIv1___RNAseq.g10812.t1,three_way,90.18,FUN_036907-T1,P61962,DCAF7_HUMAN,,DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog),Homo sapiens (Human),88.8,338.0,2.6e-189,662.5,sp|P61962|DCAF7_HUMAN DDB1- and CUL4-associated factor 7 OS=Homo sapiens OX=9606 GN=DCAF7 PE=1 SV=1,GO:0005654; GO:0005737; GO:0005829; GO:0016363; GO:0016567; GO:0016604; GO:0030674; GO:0032991; GO:0080008,protein ubiquitination [GO:0016567],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],protein-macromolecule adaptor activity [GO:0030674],GO:0005654; GO:0005829; GO:0043226; GO:0060090,nucleoplasm; cytosol; organelle; molecular adaptor activity
OG_08359,FUN_036908-T1,Peve_00018421,Pocillopora_meandrina_HIv1___RNAseq.g10813.t1,three_way,70.3725,,,,,,,,,,,,,,,,,
OG_08360,FUN_036909-T1,Peve_00018420,Pocillopora_meandrina_HIv1___RNAseq.g10814.t1,three_way,80.27433333333333,,,,,,,,,,,,,,,,,
OG_08361,FUN_036910-T1,Peve_00018417,Pocillopora_meandrina_HIv1___RNAseq.g10815.t1,three_way,60.812666666666665,,,,,,,,,,,,,,,,,
OG_08362,FUN_036911-T1,Peve_00018411,Pocillopora_meandrina_HIv1___RNAseq.g10816.t1,three_way,73.75933333333333,FUN_036911-T1,P51614,,,,,32.5,292.0,1.1e-35,152.5,sp|P51614|CHIT3_VITVI Acidic endochitinase OS=Vitis vinifera OX=29760 GN=CHIT3 PE=2 SV=1,,,,,,
OG_08363,FUN_036912-T1,Peve_00018402,Pocillopora_meandrina_HIv1___RNAseq.g10818.t1,three_way,83.19500000000001,FUN_036912-T1,Q5ZLY5,,,,,72.2,223.0,1.2e-94,347.8,sp|Q5ZLY5|PKHF2_CHICK Pleckstrin homology domain-containing family F member 2 OS=Gallus gallus OX=9031 GN=PLEKHF2 PE=2 SV=1,,,,,,
OG_08364,FUN_036913-T1,Peve_00018400,Pocillopora_meandrina_HIv1___RNAseq.g10819.t1,three_way,58.561,,,,,,,,,,,,,,,,,
OG_08365,FUN_036917-T1,Peve_00018360,Pocillopora_meandrina_HIv1___TS.g13339.t1,three_way,60.458,FUN_036917-T1,Q6DJL7,,,,,32.4,238.0,1e-06,55.8,sp|Q6DJL7|BORA_XENLA Protein aurora borealis OS=Xenopus laevis OX=8355 GN=bora PE=2 SV=1,,,,,,
OG_08366,FUN_036918-T1,Peve_00018356,Pocillopora_meandrina_HIv1___RNAseq.g10823.t1,three_way,84.78133333333334,,,,,,,,,,,,,,,,,
OG_08367,FUN_036919-T1,Peve_00018354,Pocillopora_meandrina_HIv1___RNAseq.g10824.t1,three_way,88.945,FUN_036919-T1,Q8BWT1,THIM_MOUSE,,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)",Mus musculus (Mouse),65.7,394.0,5.2e-149,528.9,"sp|Q8BWT1|THIM_MOUSE 3-ketoacyl-CoA thiolase, mitochondrial OS=Mus musculus OX=10090 GN=Acaa2 PE=1 SV=3",GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005743; GO:0006635; GO:0016604; GO:0036064; GO:0047617; GO:0071456; GO:1901029; GO:1902109,cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029],ciliary basal body [GO:0036064]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear body [GO:0016604],acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA hydrolase activity [GO:0003986]; fatty acyl-CoA hydrolase activity [GO:0047617],GO:0003824; GO:0005739; GO:0005815; GO:0006629; GO:0007005; GO:0016740; GO:0016787; GO:0043226; GO:0061024,catalytic activity; mitochondrion; microtubule organizing center; lipid metabolic process; mitochondrion organization; transferase activity; hydrolase activity; organelle; membrane organization
OG_08368,FUN_036921-T1,Peve_00018424,Pocillopora_meandrina_HIv1___RNAseq.g10826.t1,three_way,86.99816666666666,FUN_036921-T1,Q6NV04,HACL2_DANRE,,2-hydroxyacyl-CoA lyase 2 (EC 4.1.2.-) (Acetolactate synthase-like protein) (IlvB-like protein),Danio rerio (Zebrafish) (Brachydanio rerio),70.3,609.0,1.1e-259,897.1,sp|Q6NV04|HACL2_DANRE 2-hydroxyacyl-CoA lyase 2 OS=Danio rerio OX=7955 GN=ilvbl PE=2 SV=1,GO:0000287; GO:0001561; GO:0003984; GO:0005789; GO:0005948; GO:0009097; GO:0009099; GO:0016829; GO:0030976; GO:0048701; GO:0050660,embryonic cranial skeleton morphogenesis [GO:0048701]; fatty acid alpha-oxidation [GO:0001561]; isoleucine biosynthetic process [GO:0009097]; L-valine biosynthetic process [GO:0009099],acetolactate synthase complex [GO:0005948]; endoplasmic reticulum membrane [GO:0005789],acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0006520; GO:0006629; GO:0016740; GO:0016829,catalytic activity; amino acid metabolic process; lipid metabolic process; transferase activity; lyase activity
OG_08369,FUN_036922-T1,Peve_00018419,Pocillopora_meandrina_HIv1___RNAseq.g10827.t3,three_way,57.46,,,,,,,,,,,,,,,,,
OG_08370,FUN_036923-T2,Peve_00026097,Pocillopora_meandrina_HIv1___RNAseq.g10834.t1,three_way,80.37633333333333,FUN_036923-T2,Q3UR70,,,,,41.3,855.0,6.4e-187,656.0,sp|Q3UR70|TGFA1_MOUSE Transforming growth factor-beta receptor-associated protein 1 OS=Mus musculus OX=10090 GN=Tgfbrap1 PE=1 SV=1,,,,,,
OG_08371,FUN_036924-T1,Peve_00026098,Pocillopora_meandrina_HIv1___RNAseq.g10835.t1,three_way,85.29133333333333,FUN_036924-T1,Q9D6Y9,GLGB_MOUSE,,"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)",Mus musculus (Mouse),64.1,674.0,6.4e-272,937.9,"sp|Q9D6Y9|GLGB_MOUSE 1,4-alpha-glucan-branching enzyme OS=Mus musculus OX=10090 GN=Gbe1 PE=1 SV=1",GO:0003844; GO:0004553; GO:0005829; GO:0005978; GO:0030246; GO:0043169; GO:0043524,glycogen biosynthetic process [GO:0005978]; negative regulation of neuron apoptotic process [GO:0043524],cytosol [GO:0005829],"1,4-alpha-glucan branching enzyme activity [GO:0003844]; carbohydrate binding [GO:0030246]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]",GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0016787,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; hydrolase activity
OG_08372,FUN_036925-T1,Peve_00040016,Pocillopora_meandrina_HIv1___TS.g13354.t1,three_way,76.31133333333334,FUN_036925-T1,Q91618,PMYT1_XENLA,,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase),Xenopus laevis (African clawed frog),38.5,550.0,3.8e-86,320.5,sp|Q91618|PMYT1_XENLA Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase OS=Xenopus laevis OX=8355 GN=pkmyt1 PE=1 SV=1,GO:0000139; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0007088; GO:0010972; GO:0046872; GO:0051321; GO:0106310; GO:0110031,meiotic cell cycle [GO:0051321]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of G2/MI transition of meiotic cell cycle [GO:0110031]; regulation of mitotic nuclear division [GO:0007088],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_08373,FUN_036934-T1,Peve_00040009,Pocillopora_meandrina_HIv1___RNAseq.g10839.t1,three_way,68.39766666666667,,,,,,,,,,,,,,,,,
OG_08374,FUN_036939-T1,Peve_00040037,Pocillopora_meandrina_HIv1___TS.g13373.t2,three_way,65.984,FUN_036939-T1,A0A2R8QF68,GRIK2_DANRE,,"Glutamate receptor ionotropic, kainate 2 (GluK2)",Danio rerio (Zebrafish) (Brachydanio rerio),26.9,878.0,3.2999999999999996e-90,334.7,"sp|A0A2R8QF68|GRIK2_DANRE Glutamate receptor ionotropic, kainate 2 OS=Danio rerio OX=7955 GN=grik2 PE=3 SV=1",GO:0005886; GO:0015277; GO:0022849; GO:0032983; GO:0035249; GO:0042734; GO:0050804; GO:0098839; GO:1904315,"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]",kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734],glutamate-gated calcium ion channel activity [GO:0022849]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0060089,transporter activity; plasma membrane; signaling; molecular transducer activity
OG_08375,FUN_036940-T1,Peve_00040036,Pocillopora_meandrina_HIv1___RNAseq.g10861.t1,three_way,62.068666666666665,,,,,,,,,,,,,,,,,
OG_08376,FUN_036942-T1,Peve_00040031,Pocillopora_meandrina_HIv1___TS.g13375.t1,three_way,66.2055,FUN_036942-T1,A6QQL0,S15A4_BOVIN,,Solute carrier family 15 member 4 (Peptide/histidine transporter 1),Bos taurus (Bovine),34.5,551.0,1.1e-80,302.4,sp|A6QQL0|S15A4_BOVIN Solute carrier family 15 member 4 OS=Bos taurus OX=9913 GN=SLC15A4 PE=2 SV=2,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015817; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0089708; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; histidine transport [GO:0015817]; innate immune response [GO:0045087]; L-histidine transmembrane export from vacuole [GO:0089708]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_08377,FUN_036954-T1,Peve_00040030,Pocillopora_meandrina_HIv1___RNAseq.g10864.t1,three_way,72.17399999999999,,,,,,,,,,,,,,,,,
OG_08378,FUN_036955-T1,Peve_00040029,Pocillopora_meandrina_HIv1___RNAseq.g10865.t1,three_way,80.931,FUN_036955-T1,Q9DFS6,IF4EA_DANRE,,Eukaryotic translation initiation factor 4E-1A (eIF4E-1A) (mRNA cap-binding protein),Danio rerio (Zebrafish) (Brachydanio rerio),62.2,196.0,3.3e-73,276.2,sp|Q9DFS6|IF4EA_DANRE Eukaryotic translation initiation factor 4E-1A OS=Danio rerio OX=7955 GN=eif4ea PE=1 SV=1,GO:0000340; GO:0003743; GO:0005634; GO:0005737; GO:0006406; GO:0006413; GO:0006417; GO:0016281; GO:0016607,mRNA export from nucleus [GO:0006406]; regulation of translation [GO:0006417]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; eukaryotic translation initiation factor 4F complex [GO:0016281]; nuclear speck [GO:0016607]; nucleus [GO:0005634],RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0005634; GO:0006913; GO:0043226,RNA binding; nucleus; nucleocytoplasmic transport; organelle
OG_08379,FUN_036956-T1,Peve_00040028,Pocillopora_meandrina_HIv1___RNAseq.g10866.t1,three_way,55.576,FUN_036956-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),26.9,357.0,2.3e-32,142.1,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_08380,FUN_036957-T1,Peve_00040027,Pocillopora_meandrina_HIv1___RNAseq.g10871.t1,three_way,78.528,FUN_036957-T1,Q68F72,S15A4_XENLA,,Solute carrier family 15 member 4,Xenopus laevis (African clawed frog),36.0,483.0,8.700000000000001e-78,292.7,sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_08381,FUN_036966-T1,Peve_00040025,Pocillopora_meandrina_HIv1___RNAseq.g10876.t1,three_way,65.13166666666666,FUN_036966-T1,Q68F72,S15A4_XENLA,,Solute carrier family 15 member 4,Xenopus laevis (African clawed frog),36.3,477.0,1.2e-76,288.9,sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_08382,FUN_036967-T1,Peve_00040021,Pocillopora_meandrina_HIv1___RNAseq.g10880.t1,three_way,57.36033333333334,FUN_036967-T1,Q8NBR6,MINY2_HUMAN,,Ubiquitin carboxyl-terminal hydrolase MINDY-2 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-2) (Protein FAM63B),Homo sapiens (Human),57.9,328.0,8.6e-100,365.9,sp|Q8NBR6|MINY2_HUMAN Ubiquitin carboxyl-terminal hydrolase MINDY-2 OS=Homo sapiens OX=9606 GN=MINDY2 PE=1 SV=2,GO:0004843; GO:0005654; GO:0006508; GO:0016807; GO:0036435; GO:0070530; GO:0071795; GO:0071796; GO:1990380,proteolysis [GO:0006508],nucleoplasm [GO:0005654],cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type deubiquitinase activity [GO:0004843]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked deubiquitinase activity [GO:1990380]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530],GO:0003824; GO:0005654; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; catalytic activity, acting on a protein"
OG_08383,FUN_036982-T1,Peve_00003608,Pocillopora_meandrina_HIv1___RNAseq.g26802.t1,three_way,67.02433333333333,FUN_036982-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),36.2,694.0,7.799999999999999e-105,383.3,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_08384,FUN_036983-T1,Peve_00003610,Pocillopora_meandrina_HIv1___RNAseq.g26799.t1,three_way,71.97066666666667,FUN_036983-T1,P18293,ANPRA_MOUSE,,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),Mus musculus (Mouse),38.7,1036.0,8.099999999999999e-189,662.5,sp|P18293|ANPRA_MOUSE Atrial natriuretic peptide receptor 1 OS=Mus musculus OX=10090 GN=Npr1 PE=1 SV=2,GO:0004383; GO:0004672; GO:0005524; GO:0005525; GO:0007168; GO:0008217; GO:0010753; GO:0016020; GO:0016941; GO:0017046; GO:0019934; GO:0042417; GO:0043235; GO:0048662; GO:0097746; GO:1990620,blood vessel diameter maintenance [GO:0097746]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217],ANPR-A receptor complex [GO:1990620]; membrane [GO:0016020]; receptor complex [GO:0043235],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; protein kinase activity [GO:0004672],GO:0003013; GO:0003824; GO:0009975; GO:0016740; GO:0016829; GO:0060089; GO:0140096,"circulatory system process; catalytic activity; cyclase activity; transferase activity; lyase activity; molecular transducer activity; catalytic activity, acting on a protein"
OG_08385,FUN_036984-T1,Peve_00002155,Pocillopora_meandrina_HIv1___RNAseq.g26705.t1,three_way,55.851333333333336,FUN_036984-T1,O95948,ONEC2_HUMAN,,One cut domain family member 2 (Hepatocyte nuclear factor 6-beta) (HNF-6-beta) (One cut homeobox 2) (Transcription factor ONECUT-2) (OC-2),Homo sapiens (Human),56.5,154.0,9.3e-42,172.6,sp|O95948|ONEC2_HUMAN One cut domain family member 2 OS=Homo sapiens OX=9606 GN=ONECUT2 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001889; GO:0001952; GO:0002064; GO:0005634; GO:0005654; GO:0006357; GO:0007179; GO:0009887; GO:0015629; GO:0030512; GO:0031018; GO:0045165; GO:0045944; GO:0048935; GO:0060271; GO:1905319; GO:1905322; GO:1990837,animal organ morphogenesis [GO:0009887]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; mesenchymal stem cell migration [GO:1905319]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of mesenchymal stem cell migration [GO:1905322]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952]; regulation of transcription by RNA polymerase II [GO:0006357]; transforming growth factor beta receptor signaling pathway [GO:0007179],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005856; GO:0006355; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; nucleoplasm; cytoskeleton; regulation of DNA-templated transcription; organelle; cilium organization; anatomical structure development; cell motility; transcription regulator activity
OG_08386,FUN_036993-T1,Peve_00002136,Pocillopora_meandrina_HIv1___RNAseq.g26710.t1,three_way,55.684333333333335,FUN_036993-T1,Q6L8S8,,,,,31.9,990.0,7.700000000000001e-126,453.4,"sp|Q6L8S8|B4GN3_MOUSE Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Mus musculus OX=10090 GN=B4galnt3 PE=2 SV=1",,,,,,
OG_08387,FUN_036995-T1,Peve_00002140,Pocillopora_meandrina_HIv1___RNAseq.9756_t,three_way,45.89866666666667,FUN_036995-T1,Q9DEQ4,,,,,26.8,317.0,3.5e-20,100.5,sp|Q9DEQ4|SFRP1_CHICK Secreted frizzled-related protein 1 OS=Gallus gallus OX=9031 GN=SFRP1 PE=2 SV=1,,,,,,
OG_08388,FUN_036996-T1,Peve_00002148,Pocillopora_meandrina_HIv1___RNAseq.g26772.t1,three_way,73.63133333333333,FUN_036996-T1,O43826,G6PT1_HUMAN,,Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19),Homo sapiens (Human),40.1,421.0,3.3000000000000003e-80,300.4,sp|O43826|G6PT1_HUMAN Glucose-6-phosphate exchanger SLC37A4 OS=Homo sapiens OX=9606 GN=SLC37A4 PE=1 SV=1,GO:0005783; GO:0005789; GO:0006006; GO:0006094; GO:0015152; GO:0015760; GO:0016020; GO:0035435; GO:0042593; GO:0061513,gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glucose-6-phosphate transport [GO:0015760]; phosphate ion transmembrane transport [GO:0035435],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],glucose 6-phosphate:phosphate antiporter activity [GO:0061513]; glucose-6-phosphate transmembrane transporter activity [GO:0015152],GO:0005215; GO:0005783; GO:0005975; GO:0043226; GO:0055085,transporter activity; endoplasmic reticulum; carbohydrate metabolic process; organelle; transmembrane transport
OG_08389,FUN_036997-T1,Peve_00002149,Pocillopora_meandrina_HIv1___RNAseq.g26735.t1,three_way,73.018,FUN_036997-T1,A0A1L8GLK3,,,,,39.7,534.0,6.4e-101,369.8,sp|A0A1L8GLK3|RFW3L_XENLA E3 ubiquitin-protein ligase rfwd3.L OS=Xenopus laevis OX=8355 GN=rfwd3.L PE=1 SV=1,,,,,,
OG_08390,FUN_036999-T1,Peve_00002150,Pocillopora_meandrina_HIv1___TS.g14072.t1,three_way,67.99333333333334,FUN_036999-T1,Q17QR6,,,,,30.8,390.0,1.4e-45,185.7,sp|Q17QR6|MOT13_BOVIN Monocarboxylate transporter 13 OS=Bos taurus OX=9913 GN=SLC16A13 PE=2 SV=1,,,,,,
OG_08391,FUN_037001-T1,Peve_00002157,Pocillopora_meandrina_HIv1___RNAseq.g26679.t1,three_way,50.65266666666667,,,,,,,,,,,,,,,,,
OG_08392,FUN_037004-T1,Peve_00002158,Pocillopora_meandrina_HIv1___RNAseq.g26681.t1,three_way,58.53766666666667,FUN_037004-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),35.2,267.0,1.5999999999999998e-41,172.9,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08393,FUN_037005-T1,Peve_00032342,Pocillopora_meandrina_HIv1___RNAseq.g26694.t1,three_way,58.15716666666667,FUN_037005-T1,Q9NZM4,BICRA_HUMAN,,BRD4-interacting chromatin-remodeling complex-associated protein (Glioma tumor suppressor candidate region gene 1 protein),Homo sapiens (Human),50.0,118.0,1.2e-22,110.5,sp|Q9NZM4|BICRA_HUMAN BRD4-interacting chromatin-remodeling complex-associated protein OS=Homo sapiens OX=9606 GN=BICRA PE=1 SV=2,GO:0000785; GO:0005634; GO:0006338; GO:0006357; GO:0008284; GO:0016514; GO:0045596; GO:0045893; GO:0140288; GO:0140537; GO:1902459,chromatin remodeling [GO:0006338]; negative regulation of cell differentiation [GO:0045596]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; GBAF complex [GO:0140288]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],transcription regulator activator activity [GO:0140537],GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0098772,nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_08394,FUN_037006-T1,Peve_00032341,Pocillopora_meandrina_HIv1___RNAseq.g26695.t1,three_way,75.10066666666667,FUN_037006-T1,Q8GX78,ANTR2_ARATH,,"Ascorbate transporter, chloroplastic (Phosphate transporter PHT4;4) (AtPHT4;4) (Probable anion transporter 2)",Arabidopsis thaliana (Mouse-ear cress),32.4,435.0,1.8000000000000001e-65,251.5,"sp|Q8GX78|ANTR2_ARATH Ascorbate transporter, chloroplastic OS=Arabidopsis thaliana OX=3702 GN=PHT4;4 PE=1 SV=1",GO:0005315; GO:0009507; GO:0009536; GO:0009706; GO:0009941; GO:0010028; GO:0015229; GO:0015882,L-ascorbic acid transmembrane transport [GO:0015882]; xanthophyll cycle [GO:0010028],chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; chloroplast inner membrane [GO:0009706]; plastid [GO:0009536],L-ascorbic acid transmembrane transporter activity [GO:0015229]; phosphate transmembrane transporter activity [GO:0005315],GO:0005215; GO:0006629; GO:0009536; GO:0043226; GO:0055085,transporter activity; lipid metabolic process; plastid; organelle; transmembrane transport
OG_08395,FUN_037007-T1,Peve_00032339,Pocillopora_meandrina_HIv1___RNAseq.g26697.t1,three_way,81.91016666666667,,,,,,,,,,,,,,,,,
OG_08396,FUN_037010-T1,Peve_00032338,Pocillopora_meandrina_HIv1___RNAseq.g26698.t1,three_way,85.58966666666667,FUN_037010-T1,Q8N2G6,,,,,56.0,234.0,5.3e-63,242.7,sp|Q8N2G6|ZCH24_HUMAN Zinc finger CCHC domain-containing protein 24 OS=Homo sapiens OX=9606 GN=ZCCHC24 PE=1 SV=1,,,,,,
OG_08397,FUN_037044-T1,Peve_00032333,Pocillopora_meandrina_HIv1___RNAseq.9744_t,three_way,73.64533333333333,FUN_037044-T1,X6R8R1,ST15B_HUMAN,,Synaptotagmin-15B,Homo sapiens (Human),37.5,301.0,1.5999999999999998e-49,198.0,sp|X6R8R1|ST15B_HUMAN Synaptotagmin-15B OS=Homo sapiens OX=9606 GN=SYT15B PE=3 SV=1,GO:0000149; GO:0005544; GO:0005886; GO:0016192; GO:0017158; GO:0061891; GO:0070382,regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886],calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; SNARE binding [GO:0000149],GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_08398,FUN_037046-T1,Peve_00032332,Pocillopora_meandrina_HIv1___RNAseq.g26796.t1,three_way,71.37566666666666,FUN_037046-T1,Q5T7P8,SYT6_HUMAN,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Homo sapiens (Human),41.5,311.0,2.7e-55,217.6,sp|Q5T7P8|SYT6_HUMAN Synaptotagmin-6 OS=Homo sapiens OX=9606 GN=SYT6 PE=1 SV=3,GO:0000149; GO:0005829; GO:0005886; GO:0007268; GO:0009898; GO:0016020; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0046872; GO:0060478; GO:0061891; GO:0070382; GO:0097038,acrosomal vesicle exocytosis [GO:0060478]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion sensor activity [GO:0061891]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005829; GO:0005886; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0098772; GO:0140299,cytosol; plasma membrane; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_08399,FUN_037047-T1,Peve_00032331,Pocillopora_meandrina_HIv1___RNAseq.g26795.t1,three_way,63.76116666666667,FUN_037047-T1,Q9UUH2,,,,,29.0,269.0,5.8e-15,83.2,sp|Q9UUH2|BMT2_SCHPO 25S rRNA adenine-N(1) methyltransferase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC630.10 PE=3 SV=1,,,,,,
OG_08400,FUN_037048-T1,Peve_00032330,Pocillopora_meandrina_HIv1___RNAseq.g26794.t1,three_way,85.69433333333333,FUN_037048-T1,Q56JU9,,,,,76.4,127.0,1e-40,167.5,sp|Q56JU9|RS24_BOVIN Small ribosomal subunit protein eS24 OS=Bos taurus OX=9913 GN=RPS24 PE=2 SV=2,,,,,,
OG_08401,FUN_037052-T1,Peve_00032336,Pocillopora_meandrina_HIv1___RNAseq.g26789.t1,three_way,75.614,FUN_037052-T1,Q8TBG4,AT2L1_HUMAN,,Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1),Homo sapiens (Human),60.5,435.0,2.2000000000000007e-149,530.4,sp|Q8TBG4|AT2L1_HUMAN Ethanolamine-phosphate phospho-lyase OS=Homo sapiens OX=9606 GN=ETNPPL PE=1 SV=1,GO:0005759; GO:0006649; GO:0008483; GO:0016020; GO:0030170; GO:0032094; GO:0050459; GO:0055088; GO:0071385; GO:1905372,cellular response to glucocorticoid stimulus [GO:0071385]; ceramide phosphoethanolamine catabolic process [GO:1905372]; lipid homeostasis [GO:0055088]; phospholipid transfer to membrane [GO:0006649]; response to food [GO:0032094],membrane [GO:0016020]; mitochondrial matrix [GO:0005759],ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],GO:0003824; GO:0006629; GO:0016740; GO:0016829,catalytic activity; lipid metabolic process; transferase activity; lyase activity
OG_08402,FUN_037053-T1,Peve_00032337,Pocillopora_meandrina_HIv1___RNAseq.g26788.t1,three_way,70.36133333333333,FUN_037053-T1,O88622,PARG_MOUSE,,Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143),Mus musculus (Mouse),54.2,524.0,3.1000000000000004e-157,557.0,sp|O88622|PARG_MOUSE Poly(ADP-ribose) glycohydrolase OS=Mus musculus OX=10090 GN=Parg PE=1 SV=2,GO:0004649; GO:0005634; GO:0005829; GO:0005975; GO:0006282; GO:0006974; GO:0016045; GO:1990966,ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; detection of bacterium [GO:0016045]; DNA damage response [GO:0006974]; regulation of DNA repair [GO:0006282],cytosol [GO:0005829]; nucleus [GO:0005634],poly(ADP-ribose) glycohydrolase activity [GO:0004649],GO:0003824; GO:0005634; GO:0005829; GO:0005975; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; cytosol; carbohydrate metabolic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08403,FUN_037054-T1,Peve_00042415,Pocillopora_meandrina_HIv1___RNAseq.g26787.t1,three_way,89.36016666666667,FUN_037054-T1,Q3UIK4,MET14_MOUSE,,N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 (Methyltransferase-like protein 14),Mus musculus (Mouse),60.6,436.0,4e-148,526.2,sp|Q3UIK4|MET14_MOUSE N(6)-adenosine-methyltransferase non-catalytic subunit METTL14 OS=Mus musculus OX=10090 GN=Mettl14 PE=1 SV=1,GO:0000398; GO:0001510; GO:0001734; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0007283; GO:0016556; GO:0019827; GO:0021861; GO:0031667; GO:0036396; GO:0042063; GO:0045664; GO:0045727; GO:0048255; GO:0061157; GO:1901533,"forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of hematopoietic progenitor cell differentiation [GO:1901533]; positive regulation of translation [GO:0045727]; regulation of neuron differentiation [GO:0045664]; response to nutrient levels [GO:0031667]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396],mRNA binding [GO:0003729]; mRNA m(6)A methyltransferase activity [GO:0001734],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; transferase activity; reproductive process; cell differentiation; organelle; catalytic activity, acting on RNA"
OG_08404,FUN_037055-T2,Peve_00018388,Pocillopora_meandrina_HIv1___RNAseq.g26786.t1,three_way,66.5235,,,,,,,,,,,,,,,,,
OG_08405,FUN_037056-T1,Peve_00018389,Pocillopora_meandrina_HIv1___RNAseq.g26785.t1,three_way,92.43566666666666,FUN_037056-T1,P23358,,,,,79.1,163.0,2.6e-70,266.2,sp|P23358|RL12_RAT Large ribosomal subunit protein uL11 OS=Rattus norvegicus OX=10116 GN=Rpl12 PE=2 SV=1,,,,,,
OG_08406,FUN_037057-T1,Peve_00018391,Pocillopora_meandrina_HIv1___RNAseq.g26784.t1,three_way,86.48433333333334,FUN_037057-T1,P43332,SNRPA_DROME,,U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A) (Sex determination protein snf),Drosophila melanogaster (Fruit fly),70.9,234.0,2.4e-69,263.5,sp|P43332|SNRPA_DROME U1 small nuclear ribonucleoprotein A OS=Drosophila melanogaster OX=7227 GN=snf PE=1 SV=1,GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005681; GO:0005685; GO:0005686; GO:0007539; GO:0008266; GO:0008380; GO:0019099; GO:0030532; GO:0030619; GO:0030620; GO:0032991; GO:0035614; GO:0042802; GO:0048477; GO:0071011; GO:0071013; GO:0097158; GO:1990904,"female germ-line sex determination [GO:0019099]; mRNA splicing, via spliceosome [GO:0000398]; oogenesis [GO:0048477]; primary sex determination, soma [GO:0007539]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686],identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620],GO:0003723; GO:0005634; GO:0016071; GO:0022414; GO:0043226; GO:0048856,RNA binding; nucleus; mRNA metabolic process; reproductive process; organelle; anatomical structure development
OG_08407,FUN_037058-T1,Peve_00018392,Pocillopora_meandrina_HIv1___RNAseq.g26774.t2,three_way,52.75666666666667,,,,,,,,,,,,,,,,,
OG_08408,FUN_037059-T1,Peve_00018393,Pocillopora_meandrina_HIv1___RNAseq.g26776.t1,three_way,70.49933333333334,,,,,,,,,,,,,,,,,
OG_08409,FUN_037060-T1,Peve_00018394,Pocillopora_meandrina_HIv1___RNAseq.g26777.t1,three_way,73.381,FUN_037060-T1,Q5ZK10,NSF1C_CHICK,,NSFL1 cofactor p47 (p97 cofactor p47),Gallus gallus (Chicken),51.3,388.0,2.1e-70,267.7,sp|Q5ZK10|NSF1C_CHICK NSFL1 cofactor p47 OS=Gallus gallus OX=9031 GN=NSFL1C PE=2 SV=1,GO:0000045; GO:0000132; GO:0005634; GO:0005795; GO:0005813; GO:0005829; GO:0007030; GO:0008289; GO:0031468; GO:0043130; GO:0043161; GO:0046604; GO:0061025; GO:1904780; GO:1990730,autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear membrane reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; VCP-NSFL1C complex [GO:1990730],lipid binding [GO:0008289]; ubiquitin binding [GO:0043130],GO:0005634; GO:0005815; GO:0005829; GO:0007010; GO:0008289; GO:0030163; GO:0043226; GO:0061024,nucleus; microtubule organizing center; cytosol; cytoskeleton organization; lipid binding; protein catabolic process; organelle; membrane organization
OG_08410,FUN_037061-T1,Peve_00018395,Pocillopora_meandrina_HIv1___RNAseq.g26778.t1,three_way,63.92483333333333,FUN_037061-T1,Q5U2U2,CRKL_RAT,,Crk-like protein,Rattus norvegicus (Rat),37.5,293.0,5.8e-46,186.0,sp|Q5U2U2|CRKL_RAT Crk-like protein OS=Rattus norvegicus OX=10116 GN=Crkl PE=1 SV=1,GO:0001558; GO:0001568; GO:0001655; GO:0001764; GO:0001783; GO:0001784; GO:0002685; GO:0003151; GO:0005654; GO:0005737; GO:0005829; GO:0006629; GO:0007167; GO:0007283; GO:0007338; GO:0007389; GO:0007507; GO:0008284; GO:0008543; GO:0008584; GO:0009887; GO:0009952; GO:0010468; GO:0010629; GO:0016358; GO:0016477; GO:0021766; GO:0021987; GO:0030010; GO:0030971; GO:0031594; GO:0032991; GO:0033628; GO:0035022; GO:0035591; GO:0035685; GO:0038026; GO:0042802; GO:0043410; GO:0045202; GO:0048384; GO:0048538; GO:0050773; GO:0050852; GO:0060017; GO:0060326; GO:0060392; GO:0061629; GO:0070374; GO:0071466; GO:0071560; GO:0071774; GO:0086100; GO:0095500; GO:0098698; GO:0098749; GO:0098761; GO:0098890; GO:0160093; GO:1900026; GO:1903977; GO:1904393; GO:1904395; GO:1904888; GO:2000404,acetylcholine receptor signaling pathway [GO:0095500]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; B cell apoptotic process [GO:0001783]; blood vessel development [GO:0001568]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cellular response to interleukin-7 [GO:0098761]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; chordate pharynx development [GO:0160093]; cranial skeletal system development [GO:1904888]; dendrite development [GO:0016358]; endothelin receptor signaling pathway [GO:0086100]; enzyme-linked receptor protein signaling pathway [GO:0007167]; establishment of cell polarity [GO:0030010]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; male gonad development [GO:0008584]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; neuron migration [GO:0001764]; outflow tract morphogenesis [GO:0003151]; parathyroid gland development [GO:0060017]; pattern specification process [GO:0007389]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glial cell migration [GO:1903977]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; reelin-mediated signaling pathway [GO:0038026]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell growth [GO:0001558]; regulation of dendrite development [GO:0050773]; regulation of gene expression [GO:0010468]; regulation of leukocyte migration [GO:0002685]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; regulation of T cell migration [GO:2000404]; response to fibroblast growth factor [GO:0071774]; retinoic acid receptor signaling pathway [GO:0048384]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; urogenital system development [GO:0001655],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of postsynaptic membrane [GO:0098890]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; synapse [GO:0045202],identical protein binding [GO:0042802]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling adaptor activity [GO:0035591],GO:0002376; GO:0005654; GO:0005829; GO:0006629; GO:0007163; GO:0012501; GO:0022414; GO:0048856; GO:0048870; GO:0060090,immune system process; nucleoplasm; cytosol; lipid metabolic process; establishment or maintenance of cell polarity; programmed cell death; reproductive process; anatomical structure development; cell motility; molecular adaptor activity
OG_08411,FUN_037062-T1,Peve_00018396,Pocillopora_meandrina_HIv1___RNAseq.g26779.t1,three_way,65.08266666666667,FUN_037062-T1,O95628,CNOT4_HUMAN,,CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4),Homo sapiens (Human),48.8,441.0,2.6e-103,377.9,sp|O95628|CNOT4_HUMAN CCR4-NOT transcription complex subunit 4 OS=Homo sapiens OX=9606 GN=CNOT4 PE=1 SV=3,GO:0000289; GO:0003723; GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0030014; GO:0045652; GO:0051865,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634],RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08412,FUN_037063-T1,Peve_00018397,Pocillopora_meandrina_HIv1___RNAseq.g26780.t1,three_way,79.46383333333334,FUN_037063-T1,Q5RJA1,RFX6_DANRE,,DNA-binding protein RFX6 (Regulatory factor X 6),Danio rerio (Zebrafish) (Brachydanio rerio),57.0,293.0,4.9e-93,343.6,sp|Q5RJA1|RFX6_DANRE DNA-binding protein RFX6 OS=Danio rerio OX=7955 GN=rfx6 PE=2 SV=2,GO:0000976; GO:0000978; GO:0000981; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104,endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_08413,FUN_037064-T1,Peve_00004737,Pocillopora_meandrina_HIv1___RNAseq.g26781.t1,three_way,82.664,FUN_037064-T1,Q9UBQ7,GRHPR_HUMAN,,Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81),Homo sapiens (Human),58.4,327.0,2.8e-101,370.2,sp|Q9UBQ7|GRHPR_HUMAN Glyoxylate reductase/hydroxypyruvate reductase OS=Homo sapiens OX=9606 GN=GRHPR PE=1 SV=1,GO:0005737; GO:0005739; GO:0005782; GO:0005829; GO:0008465; GO:0016618; GO:0019752; GO:0030267; GO:0031406; GO:0042803; GO:0043648; GO:0046487; GO:0051287; GO:0070062; GO:0070402; GO:0120509; GO:1902494,carboxylic acid metabolic process [GO:0019752]; dicarboxylic acid metabolic process [GO:0043648]; glyoxylate metabolic process [GO:0046487],catalytic complex [GO:1902494]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782],carboxylic acid binding [GO:0031406]; glyoxylate reductase (NADPH) activity [GO:0030267]; hydroxypyruvate reductase (NADH) activity [GO:0008465]; hydroxypyruvate reductase (NADPH) activity [GO:0120509]; hydroxypyruvate reductase [NAD(P)H] activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005739; GO:0005829; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; oxidoreductase activity; organelle
OG_08414,FUN_037070-T1,Peve_00004738,Pocillopora_meandrina_HIv1___RNAseq.g26782.t2,three_way,48.457166666666666,FUN_037070-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),28.6,706.0,1.4999999999999998e-62,242.7,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_08415,FUN_037071-T1,Peve_00004736,Pocillopora_meandrina_HIv1___RNAseq.g26783.t1,three_way,86.73233333333333,FUN_037071-T1,Q99973,TEP1_HUMAN,,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),Homo sapiens (Human),26.9,577.0,1.6999999999999998e-43,179.9,sp|Q99973|TEP1_HUMAN Telomerase protein component 1 OS=Homo sapiens OX=9606 GN=TEP1 PE=1 SV=2,GO:0000722; GO:0000781; GO:0002039; GO:0003720; GO:0003723; GO:0005524; GO:0005697; GO:0005737; GO:0016363; GO:0019899; GO:0070034; GO:1990904,telomere maintenance via recombination [GO:0000722],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0006310; GO:0016740; GO:0032200; GO:0140097,"RNA binding; catalytic activity; DNA recombination; transferase activity; telomere organization; catalytic activity, acting on DNA"
OG_08416,FUN_037073-T2,Peve_00004734,Pocillopora_meandrina_HIv1___RNAseq.g26677.t1,three_way,46.369166666666665,,,,,,,,,,,,,,,,,
OG_08417,FUN_037075-T1,Peve_00004732,Pocillopora_meandrina_HIv1___RNAseq.g26676.t1,three_way,77.25566666666667,FUN_037075-T1,Q6ZT07,,,,,45.3,1328.0,2.4e-304,1046.6,sp|Q6ZT07|TBCD9_HUMAN TBC1 domain family member 9 OS=Homo sapiens OX=9606 GN=TBC1D9 PE=1 SV=2,,,,,,
OG_08418,FUN_037076-T1,Peve_00004731,Pocillopora_meandrina_HIv1___TS.g13654.t2,three_way,65.30366666666667,FUN_037076-T1,Q6DEW6,,,,,38.3,321.0,3.2e-51,203.8,sp|Q6DEW6|REXO4_XENTR RNA exonuclease 4 OS=Xenopus tropicalis OX=8364 GN=rexo4 PE=2 SV=1,,,,,,
OG_08419,FUN_037077-T1,Peve_00004730,Pocillopora_meandrina_HIv1___RNAseq.g11154.t1,three_way,74.945,FUN_037077-T1,Q8WV41,SNX33_HUMAN,,Sorting nexin-33 (SH3 and PX domain-containing protein 3),Homo sapiens (Human),39.2,576.0,3.0000000000000003e-107,390.6,sp|Q8WV41|SNX33_HUMAN Sorting nexin-33 OS=Homo sapiens OX=9606 GN=SNX33 PE=1 SV=1,GO:0000281; GO:0005829; GO:0005886; GO:0006886; GO:0006897; GO:0007032; GO:0016020; GO:0016197; GO:0017038; GO:0030659; GO:0031410; GO:0035091; GO:0036089; GO:0042802; GO:0044351; GO:0045806; GO:0051044; GO:0097320; GO:2000009; GO:2000010,cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038],cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0000910; GO:0005829; GO:0005886; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,cytokinesis; cytosol; plasma membrane; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_08420,FUN_037078-T1,Peve_00004729,Pocillopora_meandrina_HIv1___RNAseq.23010_t,three_way,85.36133333333333,FUN_037078-T1,A7SVT1,FICD_NEMVE,,Protein adenylyltransferase Fic (EC 2.7.7.108) (De-AMPylase Fic) (EC 3.1.4.-),Nematostella vectensis (Starlet sea anemone),66.5,412.0,1.5e-154,547.4,sp|A7SVT1|FICD_NEMVE Protein adenylyltransferase Fic OS=Nematostella vectensis OX=45351 GN=v1g194069 PE=3 SV=1,GO:0005524; GO:0016020; GO:0016787; GO:0070733,,membrane [GO:0016020],AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787],GO:0003824; GO:0016740; GO:0016787,catalytic activity; transferase activity; hydrolase activity
OG_08421,FUN_037079-T1,Peve_00004727,Pocillopora_meandrina_HIv1___TS.g13651.t2,three_way,79.86733333333333,FUN_037079-T1,Q5F362,CC50A_CHICK,,Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A),Gallus gallus (Chicken),52.8,339.0,4.2e-97,356.3,sp|Q5F362|CC50A_CHICK Cell cycle control protein 50A OS=Gallus gallus OX=9031 GN=TMEM30A PE=2 SV=1,GO:0001750; GO:0001917; GO:0005783; GO:0005794; GO:0005886; GO:0016324; GO:0030658; GO:0045332; GO:1990531,phospholipid translocation [GO:0045332],apical plasma membrane [GO:0016324]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; phospholipid-translocating ATPase complex [GO:1990531]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; transport vesicle membrane [GO:0030658],,GO:0005783; GO:0005794; GO:0005886; GO:0043226; GO:0061024,endoplasmic reticulum; Golgi apparatus; plasma membrane; organelle; membrane organization
OG_08422,FUN_037080-T1,Peve_00004726,Pocillopora_meandrina_HIv1___RNAseq.g11151.t1,three_way,82.979,FUN_037080-T1,Q5I0J5,,,,,53.9,232.0,3.1e-69,263.5,sp|Q5I0J5|MITD1_RAT MIT domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Mitd1 PE=2 SV=1,,,,,,
OG_08423,FUN_037082-T1,Peve_00004722,Pocillopora_meandrina_HIv1___RNAseq.g11121.t1,three_way,46.04966666666667,FUN_037082-T1,Q7T2Z5,UNC5C_CHICK,,Netrin receptor UNC5C (Protein unc-5 homolog 3) (cUNC-5H3) (Protein unc-5 homolog C),Gallus gallus (Chicken),24.0,1007.0,2.7e-64,248.8,sp|Q7T2Z5|UNC5C_CHICK Netrin receptor UNC5C OS=Gallus gallus OX=9031 GN=UNC5C PE=2 SV=1,GO:0005042; GO:0005886; GO:0007411; GO:0009986; GO:0030027; GO:0030175; GO:0030425; GO:0030426; GO:0045202; GO:1990791,axon guidance [GO:0007411]; dorsal root ganglion development [GO:1990791],cell surface [GO:0009986]; dendrite [GO:0030425]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; synapse [GO:0045202],netrin receptor activity [GO:0005042],GO:0005886; GO:0048856; GO:0060089,plasma membrane; anatomical structure development; molecular transducer activity
OG_08424,FUN_037083-T1,Peve_00004720,Pocillopora_meandrina_HIv1___TS.g13397.t1,three_way,58.36266666666667,,,,,,,,,,,,,,,,,
OG_08425,FUN_037084-T1,Peve_00004717,Pocillopora_meandrina_HIv1___RNAseq.g11110.t1,three_way,84.65833333333333,FUN_037084-T1,Q3SZE2,,,,,53.2,111.0,1.1e-22,107.5,sp|Q3SZE2|PFD1_BOVIN Prefoldin subunit 1 OS=Bos taurus OX=9913 GN=PFDN1 PE=2 SV=1,,,,,,
OG_08426,FUN_037087-T1,Peve_00004772,Pocillopora_meandrina_HIv1___RNAseq.g11102.t1,three_way,80.21233333333333,FUN_037087-T1,Q8IVV2,,,,,26.6,2021.0,6.8e-184,647.5,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_08427,FUN_037089-T1,Peve_00004758,Pocillopora_meandrina_HIv1___RNAseq.g11095.t1,three_way,84.80416666666667,FUN_037089-T1,Q9NQ94,,,,,49.9,583.0,6.8e-140,499.2,sp|Q9NQ94|A1CF_HUMAN APOBEC1 complementation factor OS=Homo sapiens OX=9606 GN=A1CF PE=1 SV=1,,,,,,
OG_08428,FUN_037090-T1,Peve_00004757,Pocillopora_meandrina_HIv1___RNAseq.g11094.t1,three_way,85.29466666666666,FUN_037090-T1,Q5THR3,EFCB6_HUMAN,,EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP),Homo sapiens (Human),19.6,678.0,3.4e-23,112.1,sp|Q5THR3|EFCB6_HUMAN EF-hand calcium-binding domain-containing protein 6 OS=Homo sapiens OX=9606 GN=EFCAB6 PE=1 SV=1,GO:0005509; GO:0005654; GO:0030317; GO:0036126; GO:0160111,flagellated sperm motility [GO:0030317],axonemal A tubule inner sheath [GO:0160111]; nucleoplasm [GO:0005654]; sperm flagellum [GO:0036126],calcium ion binding [GO:0005509],GO:0005654; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleoplasm; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_08429,FUN_037092-T1,Peve_00004755,Pocillopora_meandrina_HIv1___RNAseq.g11092.t1,three_way,57.061,,,,,,,,,,,,,,,,,
OG_08430,FUN_037093-T1,Peve_00004753,Pocillopora_meandrina_HIv1___RNAseq.g11091.t1,three_way,85.9675,FUN_037093-T1,Q53GS9,UBP39_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 39 (EC 3.4.19.12) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein),Homo sapiens (Human),67.1,477.0,6.8e-191,668.3,sp|Q53GS9|UBP39_HUMAN Ubiquitin carboxyl-terminal hydrolase 39 OS=Homo sapiens OX=9606 GN=USP39 PE=1 SV=2,GO:0000245; GO:0000398; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008270; GO:0008380; GO:0016579; GO:0016787; GO:0046540; GO:0051301,"cell division [GO:0051301]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540],hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; organelle; protein-containing complex assembly
OG_08431,FUN_037095-T1,Peve_00019443,Pocillopora_meandrina_HIv1___TS.g13583.t1,three_way,81.38766666666668,FUN_037095-T1,Q8TC84,,,,,59.9,277.0,3e-34,147.5,sp|Q8TC84|FANK1_HUMAN Fibronectin type 3 and ankyrin repeat domains protein 1 OS=Homo sapiens OX=9606 GN=FANK1 PE=1 SV=3,,,,,,
OG_08432,FUN_037097-T1,Peve_00031943,Pocillopora_meandrina_HIv1___RNAseq.g11082.t1,three_way,73.8455,FUN_037097-T1,Q6GN08,CND3L_XENLA,,Condensin-2 complex subunit D3-L,Xenopus laevis (African clawed frog),37.1,1165.0,4.2e-193,676.8,sp|Q6GN08|CND3L_XENLA Condensin-2 complex subunit D3-L OS=Xenopus laevis OX=8355 GN=ncapd3.L PE=1 SV=1,GO:0000779; GO:0000796; GO:0005634; GO:0007076; GO:0010032; GO:0042393; GO:0051301,cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076],"condensed chromosome, centromeric region [GO:0000779]; condensin complex [GO:0000796]; nucleus [GO:0005634]",histone binding [GO:0042393],GO:0005634; GO:0022414; GO:0042393; GO:0043226,nucleus; reproductive process; histone binding; organelle
OG_08433,FUN_037167-T1,Peve_00003254,Pocillopora_meandrina_HIv1___RNAseq.g11080.t1,three_way,59.40383333333333,,,,,,,,,,,,,,,,,
OG_08434,FUN_037169-T1,Peve_00003253,Pocillopora_meandrina_HIv1___RNAseq.g19772.t1,three_way,45.2665,FUN_037169-T1,P29275,AA2BR_HUMAN,,Adenosine receptor A2b,Homo sapiens (Human),24.0,312.0,3.5e-10,67.4,sp|P29275|AA2BR_HUMAN Adenosine receptor A2b OS=Homo sapiens OX=9606 GN=ADORA2B PE=1 SV=1,GO:0001609; GO:0002882; GO:0004930; GO:0005886; GO:0007186; GO:0007189; GO:0007190; GO:0010575; GO:0010753; GO:0019934; GO:0032722; GO:0032755; GO:0042311; GO:0043303; GO:0043306; GO:0060087; GO:0098685; GO:0098793; GO:0098978; GO:0099171,activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; mast cell degranulation [GO:0043303]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to non-antigenic stimulus [GO:0002882]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vascular endothelial growth factor production [GO:0010575]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; relaxation of vascular associated smooth muscle [GO:0060087]; vasodilation [GO:0042311],glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685],G protein-coupled adenosine receptor activity [GO:0001609]; G protein-coupled receptor activity [GO:0004930],GO:0002376; GO:0003012; GO:0003013; GO:0005886; GO:0016192; GO:0060089,immune system process; muscle system process; circulatory system process; plasma membrane; vesicle-mediated transport; molecular transducer activity
OG_08435,FUN_037170-T1,Peve_00003252,Pocillopora_meandrina_HIv1___TS.g13578.t1b,three_way,65.45,FUN_037170-T1,P36514,,,,,30.8,494.0,4.5e-60,233.8,sp|P36514|UD2C1_RABIT UDP-glucuronosyltransferase 2C1 (Fragment) OS=Oryctolagus cuniculus OX=9986 GN=UGT2C1 PE=2 SV=1,,,,,,
OG_08436,FUN_037171-T1,Peve_00003251,Pocillopora_meandrina_HIv1___TS.g13578.t1c,three_way,49.90583333333333,FUN_037171-T1,O94481,,,,,26.0,435.0,8.6e-12,73.6,sp|O94481|TFC5_SCHPO Transcription factor TFIIIB component B'' OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=bdp1 PE=3 SV=2,,,,,,
OG_08437,FUN_037196-T1,Peve_00004715,Pocillopora_meandrina_HIv1___RNAseq.g11075.t2,three_way,81.52866666666667,FUN_037196-T1,Q15111,PLCL1_HUMAN,,Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein) (PRIP),Homo sapiens (Human),49.5,1043.0,1.4e-302,1040.4,sp|Q15111|PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens OX=9606 GN=PLCL1 PE=1 SV=3,GO:0004435; GO:0004629; GO:0005737; GO:0007214; GO:0032228; GO:0035556; GO:0046488; GO:0048015; GO:0051209; GO:0120163,"gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209]",cytoplasm [GO:0005737],"phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]",GO:0003824; GO:0006629; GO:0016787; GO:0023052; GO:0055085,catalytic activity; lipid metabolic process; hydrolase activity; signaling; transmembrane transport
OG_08438,FUN_037197-T1,Peve_00004751,Pocillopora_meandrina_HIv1___RNAseq.g11073.t1,three_way,80.64233333333334,FUN_037197-T1,O88818,,,,,54.1,628.0,4.1e-185,649.4,sp|O88818|PLST_CRIGR Plastin-3 OS=Cricetulus griseus OX=10029 GN=PLS3 PE=2 SV=3,,,,,,
OG_08439,FUN_037198-T1,Peve_00004769,Pocillopora_meandrina_HIv1___RNAseq.g11072.t1,three_way,63.464,,,,,,,,,,,,,,,,,
OG_08440,FUN_037199-T1,Peve_00004724,Pocillopora_meandrina_HIv1___RNAseq.g11071.t1,three_way,64.9865,FUN_037199-T1,F1M3L7,EPS8_RAT,,Epidermal growth factor receptor kinase substrate 8,Rattus norvegicus (Rat),31.0,826.0,2.5e-71,272.3,sp|F1M3L7|EPS8_RAT Epidermal growth factor receptor kinase substrate 8 OS=Rattus norvegicus OX=10116 GN=Eps8 PE=1 SV=2,GO:0003779; GO:0005886; GO:0005903; GO:0005938; GO:0007266; GO:0008344; GO:0008360; GO:0010458; GO:0014069; GO:0016601; GO:0017146; GO:0030036; GO:0030426; GO:0030832; GO:0031267; GO:0032420; GO:0032421; GO:0032426; GO:0032587; GO:0035023; GO:0036336; GO:0045202; GO:0048149; GO:0051016; GO:0051017; GO:0051764; GO:0070358; GO:0098978; GO:0099072; GO:1900029; GO:1990830,actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],brush border [GO:0005903]; cell cortex [GO:0005938]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202],actin binding [GO:0003779]; small GTPase binding [GO:0031267],GO:0002376; GO:0005886; GO:0007010; GO:0008092; GO:0043226; GO:0048870,immune system process; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle; cell motility
OG_08441,FUN_037201-T1,Peve_00004749,Pocillopora_meandrina_HIv1___RNAseq.g11069.t1b,three_way,41.9715,,,,,,,,,,,,,,,,,
OG_08442,FUN_037204-T1,Peve_00019442,Pocillopora_meandrina_HIv1___RNAseq.g11069.t1a,three_way,78.51766666666667,FUN_037204-T1,O35623,,,,,49.0,96.0,3.9e-17,89.0,sp|O35623|BET1_MOUSE BET1 homolog OS=Mus musculus OX=10090 GN=Bet1 PE=1 SV=1,,,,,,
OG_08443,FUN_037205-T1,Peve_00019447,Pocillopora_meandrina_HIv1___RNAseq.g11068.t1,three_way,81.48166666666667,FUN_037205-T1,O75600,KBL_HUMAN,,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase)",Homo sapiens (Human),66.1,401.0,3.4e-154,546.2,"sp|O75600|KBL_HUMAN 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial OS=Homo sapiens OX=9606 GN=GCAT PE=1 SV=1",GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006520; GO:0006567; GO:0008890; GO:0009058; GO:0016607; GO:0030170,amino acid metabolic process [GO:0006520]; biosynthetic process [GO:0009058]; threonine catabolic process [GO:0006567],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006520; GO:0016740; GO:0043226,catalytic activity; nucleus; nucleoplasm; mitochondrion; amino acid metabolic process; transferase activity; organelle
OG_08444,FUN_037206-T1,Peve_00019446,Pocillopora_meandrina_HIv1___RNAseq.g11067.t1,three_way,66.86016666666666,FUN_037206-T1,P41236,IPP2_HUMAN,,Protein phosphatase inhibitor 2 (IPP-2),Homo sapiens (Human),35.5,141.0,3.4e-10,66.6,sp|P41236|IPP2_HUMAN Protein phosphatase inhibitor 2 OS=Homo sapiens OX=9606 GN=PPP1R2 PE=1 SV=2,GO:0004864; GO:0004865; GO:0005977; GO:0006091; GO:0009966; GO:0035556; GO:0140678,generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; regulation of signal transduction [GO:0009966],,molecular function inhibitor activity [GO:0140678]; protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],GO:0005975; GO:0006091; GO:0098772,carbohydrate metabolic process; generation of precursor metabolites and energy; molecular function regulator activity
OG_08445,FUN_037209-T1,Peve_00019441,Pocillopora_meandrina_HIv1___RNAseq.g11065.t1,three_way,51.843,FUN_037209-T1,Q54VB4,HBX9_DICDI,,Homeobox protein 9 (DdHbx-9),Dictyostelium discoideum (Social amoeba),52.7,55.0,3.7e-07,57.4,sp|Q54VB4|HBX9_DICDI Homeobox protein 9 OS=Dictyostelium discoideum OX=44689 GN=hbx9 PE=3 SV=1,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0010628; GO:0048468; GO:0106070,cell development [GO:0048468]; positive regulation of gene expression [GO:0010628]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_08446,FUN_037210-T1,Peve_00039307,Pocillopora_meandrina_HIv1___RNAseq.g11064.t1,three_way,50.45466666666667,,,,,,,,,,,,,,,,,
OG_08447,FUN_037211-T1,Peve_00039306,Pocillopora_meandrina_HIv1___RNAseq.g11063.t1,three_way,76.10916666666667,FUN_037211-T1,Q32NQ7,,,,,42.5,466.0,4.7e-104,379.8,sp|Q32NQ7|DAAF3_XENLA Dynein axonemal assembly factor 3 OS=Xenopus laevis OX=8355 GN=dnaaf3 PE=2 SV=1,,,,,,
OG_08448,FUN_037212-T1,Peve_00039296,Pocillopora_meandrina_HIv1___RNAseq.g11061.t1,three_way,42.151333333333326,,,,,,,,,,,,,,,,,
OG_08449,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),43.2,586.0,1.7999999999999998e-127,459.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08449,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),49.5,105.0,7.2e-15,85.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08450,FUN_037214-T1,Peve_00012947,Pocillopora_meandrina_HIv1___RNAseq.g11059.t1,three_way,90.98433333333334,,,,,,,,,,,,,,,,,
OG_08451,FUN_037216-T1,Peve_00006684,Pocillopora_meandrina_HIv1___RNAseq.g11058.t1,three_way,62.538,FUN_037216-T1,P55302,AMRP_MOUSE,,Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Heparin-binding protein 44) (HBP-44) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP),Mus musculus (Mouse),33.9,316.0,3e-27,124.0,sp|P55302|AMRP_MOUSE Alpha-2-macroglobulin receptor-associated protein OS=Mus musculus OX=10090 GN=Lrpap1 PE=1 SV=1,GO:0002091; GO:0005768; GO:0005793; GO:0005794; GO:0005796; GO:0005801; GO:0005886; GO:0008201; GO:0009986; GO:0010916; GO:0031904; GO:0035473; GO:0048018; GO:0048019; GO:0048237; GO:0048259; GO:0050750; GO:0070326; GO:0150093; GO:1900222,amyloid-beta clearance by transcytosis [GO:0150093]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; regulation of receptor-mediated endocytosis [GO:0048259],cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237],heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; receptor ligand activity [GO:0048018]; very-low-density lipoprotein particle receptor binding [GO:0070326],GO:0005768; GO:0005794; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0048018; GO:0098772,endosome; Golgi apparatus; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_08452,FUN_037217-T2,Peve_00006683,Pocillopora_meandrina_HIv1___RNAseq.g11057.t1,three_way,61.09466666666667,FUN_037217-T2,Q8BFR2,,,,,25.6,789.0,5.4e-64,247.3,sp|Q8BFR2|FSTL5_MOUSE Follistatin-related protein 5 OS=Mus musculus OX=10090 GN=Fstl5 PE=2 SV=1,,,,,,
OG_08453,FUN_037220-T1,Peve_00044300,Pocillopora_meandrina_HIv1___RNAseq.g11045.t1,three_way,58.061,FUN_037220-T1,Q8K5B3,,,,,46.1,76.0,5.5e-10,65.1,sp|Q8K5B3|MCFD2_RAT Multiple coagulation factor deficiency protein 2 homolog OS=Rattus norvegicus OX=10116 GN=Mcfd2 PE=1 SV=1,,,,,,
OG_08454,FUN_037221-T1,Peve_00044303,Pocillopora_meandrina_HIv1___RNAseq.g11044.t1,three_way,87.619,FUN_037221-T1,Q9Z120,TRMB_MOUSE,,tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (mRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (miRNA (guanine-N(7)-)-methyltransferase) (EC 2.1.1.-) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase),Mus musculus (Mouse),65.6,250.0,5.6e-93,342.0,sp|Q9Z120|TRMB_MOUSE tRNA (guanine-N(7)-)-methyltransferase OS=Mus musculus OX=10090 GN=Mettl1 PE=1 SV=1,GO:0000049; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006400; GO:0008176; GO:0033554; GO:0036416; GO:0106004; GO:0106143; GO:0160090,cellular response to stress [GO:0033554]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (m7G46) methyltransferase complex [GO:0106143],internal mRNA (guanine-N7-)-methyltransferase activity [GO:0160090]; tRNA (guanine(46)-N7)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_08455,FUN_037222-T1,Peve_00044308,Pocillopora_meandrina_HIv1___RNAseq.g11043.t1,three_way,83.7925,FUN_037222-T1,Q3B8G4,,,,,49.3,284.0,8.2e-66,252.3,sp|Q3B8G4|YIPF3_XENLA Protein YIPF3 OS=Xenopus laevis OX=8355 GN=yipf3 PE=2 SV=1,,,,,,
OG_08456,FUN_037224-T1,Peve_00044309,Pocillopora_meandrina_HIv1___RNAseq.g11042.t1,three_way,59.601333333333336,,,,,,,,,,,,,,,,,
OG_08457,FUN_037226-T2,Peve_00044301,Pocillopora_meandrina_HIv1___RNAseq.g11037.t1,three_way,73.50366666666666,FUN_037226-T2,Q6TCG8,PAQR3_MOUSE,,Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG),Mus musculus (Mouse),45.4,280.0,3.4e-71,270.0,sp|Q6TCG8|PAQR3_MOUSE Progestin and adipoQ receptor family member 3 OS=Mus musculus OX=10090 GN=Paqr3 PE=1 SV=1,GO:0000139; GO:0005794; GO:0010977; GO:0032436; GO:0034067; GO:0035359; GO:0043495; GO:0045542; GO:1990756; GO:2000640,negative regulation of neuron projection development [GO:0010977]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of SREBP signaling pathway [GO:2000640]; protein localization to Golgi apparatus [GO:0034067],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],protein-membrane adaptor activity [GO:0043495]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005794; GO:0043226; GO:0060090,Golgi apparatus; organelle; molecular adaptor activity
OG_08458,FUN_037227-T1,Peve_00044302,Pocillopora_meandrina_HIv1___RNAseq.g11036.t1,three_way,72.9805,FUN_037227-T1,Q68F99,,,,,26.3,278.0,2.8000000000000004e-22,108.6,sp|Q68F99|STAC3_XENTR SH3 and cysteine-rich domain-containing protein 3 OS=Xenopus tropicalis OX=8364 GN=stac3 PE=2 SV=1,,,,,,
OG_08459,FUN_037228-T1,Peve_00044304,Pocillopora_meandrina_HIv1___TS.g13535.t1,three_way,54.508833333333335,,,,,,,,,,,,,,,,,
OG_08460,FUN_037229-T1,Peve_00006216,Pocillopora_meandrina_HIv1___RNAseq.g11032.t1,three_way,76.78283333333334,FUN_037229-T1,B6D5P3,DAAF1_PERLE,,Dynein axonemal assembly factor 1 (Leucine-rich repeat-containing protein 50),Peromyscus leucopus (White-footed mouse),53.7,326.0,1.7e-26,122.5,sp|B6D5P3|DAAF1_PERLE Dynein axonemal assembly factor 1 OS=Peromyscus leucopus OX=10041 GN=Dnaaf1 PE=2 SV=1,GO:0005930; GO:0035082; GO:0060271; GO:0070840,axoneme assembly [GO:0035082]; cilium assembly [GO:0060271],axoneme [GO:0005930],dynein complex binding [GO:0070840],GO:0007010; GO:0044782,cytoskeleton organization; cilium organization
OG_08461,FUN_037230-T1,Peve_00006215,Pocillopora_meandrina_HIv1___RNAseq.g11016.t1a,three_way,72.01233333333333,FUN_037230-T1,P35295,,,,,39.6,212.0,7.6e-33,142.1,sp|P35295|RAB20_MOUSE Ras-related protein Rab-20 OS=Mus musculus OX=10090 GN=Rab20 PE=2 SV=2,,,,,,
OG_08462,FUN_037231-T1,Peve_00006214,Pocillopora_meandrina_HIv1___RNAseq.g11018.t1,three_way,95.307,FUN_037231-T1,P61092,SIA1A_MOUSE,,E3 ubiquitin-protein ligase SIAH1A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1A) (Seven in absentia homolog 1a) (Siah-1a) (Siah1a) (mSiah-1a),Mus musculus (Mouse),84.6,266.0,2.4e-135,483.0,sp|P61092|SIA1A_MOUSE E3 ubiquitin-protein ligase SIAH1A OS=Mus musculus OX=10090 GN=Siah1a PE=1 SV=1,GO:0004842; GO:0005634; GO:0005829; GO:0006511; GO:0007141; GO:0007283; GO:0008270; GO:0009791; GO:0016567; GO:0019005; GO:0030154; GO:0040014; GO:0042803; GO:0043161; GO:0051402; GO:0060070; GO:0061630; GO:0097718,canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],disordered domain specific binding [GO:0097718]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140013; GO:0140096,"catalytic activity; nucleus; cytosol; programmed cell death; transferase activity; reproductive process; cell differentiation; protein catabolic process; organelle; meiotic nuclear division; catalytic activity, acting on a protein"
OG_08463,FUN_037232-T2,Peve_00006212,Pocillopora_meandrina_HIv1___RNAseq.g11014.t1,three_way,94.32066666666668,FUN_037232-T2,P79101,,,,,70.0,683.0,1.9e-287,989.6,sp|P79101|CPSF3_BOVIN Cleavage and polyadenylation specificity factor subunit 3 OS=Bos taurus OX=9913 GN=CPSF3 PE=1 SV=1,,,,,,
OG_08464,FUN_037233-T1,Peve_00034021,Pocillopora_meandrina_HIv1___RNAseq.g14907.t1,three_way,41.4985,FUN_037233-T1,Q7JK24,,,,,27.4,292.0,3.9e-25,117.5,"sp|Q7JK24|B3GT1_GORGO Beta-1,3-galactosyltransferase 1 OS=Gorilla gorilla gorilla OX=9595 GN=B3GALT1 PE=3 SV=1",,,,,,
OG_08465,FUN_037235-T1,Peve_00006207,Pocillopora_meandrina_HIv1___RNAseq.g11013.t1,three_way,53.57233333333333,,,,,,,,,,,,,,,,,
OG_08466,FUN_037278-T1,Peve_00001629,Pocillopora_meandrina_HIv1___RNAseq.g26884.t1,three_way,88.282,FUN_037278-T1,Q14117,DPYS_HUMAN,,Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase),Homo sapiens (Human),66.6,515.0,2.2000000000000004e-201,703.4,sp|Q14117|DPYS_HUMAN Dihydropyrimidinase OS=Homo sapiens OX=9606 GN=DPYS PE=1 SV=1,GO:0004157; GO:0005829; GO:0006208; GO:0006210; GO:0006212; GO:0006248; GO:0006249; GO:0008270; GO:0042802; GO:0046050; GO:0046079; GO:0051219; GO:0070062,CMP catabolic process [GO:0006248]; dCMP catabolic process [GO:0006249]; dUMP catabolic process [GO:0046079]; pyrimidine nucleobase catabolic process [GO:0006208]; thymine catabolic process [GO:0006210]; UMP catabolic process [GO:0046050]; uracil catabolic process [GO:0006212],cytosol [GO:0005829]; extracellular exosome [GO:0070062],dihydropyrimidinase activity [GO:0004157]; identical protein binding [GO:0042802]; phosphoprotein binding [GO:0051219]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08467,FUN_037279-T1,Peve_00001637,Pocillopora_meandrina_HIv1___RNAseq.g26883.t1,three_way,45.025666666666666,,,,,,,,,,,,,,,,,
OG_08468,FUN_037280-T1,Peve_00001636,Pocillopora_meandrina_HIv1___RNAseq.g26882.t1,three_way,43.292,,,,,,,,,,,,,,,,,
OG_08469,FUN_037281-T1,Peve_00001634,Pocillopora_meandrina_HIv1___RNAseq.g26881.t1,three_way,79.723,,,,,,,,,,,,,,,,,
OG_08470,FUN_037286-T1,Peve_00013168,Pocillopora_meandrina_HIv1___RNAseq.g10669.t1,three_way,85.501,FUN_037286-T1,A7RU46,,,,,69.8,1121.0,0.0,1594.7,sp|A7RU46|NAPA_NEMVE Nck-associated protein 1 homolog OS=Nematostella vectensis OX=45351 GN=napA PE=3 SV=1,,,,,,
OG_08471,FUN_037287-T1,Peve_00013164,Pocillopora_meandrina_HIv1___RNAseq.g10670.t1,three_way,45.357,,,,,,,,,,,,,,,,,
OG_08472,FUN_037288-T1,Peve_00013165,Pocillopora_meandrina_HIv1___RNAseq.g10671.t1,three_way,91.804,FUN_037288-T1,Q86YI8,PHF13_HUMAN,,PHD finger protein 13 (Survival time-associated PHD finger protein in ovarian cancer 1) (SPOC1),Homo sapiens (Human),72.4,76.0,9.5e-29,128.3,sp|Q86YI8|PHF13_HUMAN PHD finger protein 13 OS=Homo sapiens OX=9606 GN=PHF13 PE=1 SV=2,GO:0000278; GO:0003682; GO:0005634; GO:0005654; GO:0006974; GO:0007059; GO:0007076; GO:0008270; GO:0035064; GO:0051301; GO:0062072; GO:0140463,cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; histone H3K9me2/3 reader activity [GO:0062072]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270],GO:0000278; GO:0005634; GO:0005654; GO:0007059; GO:0043226; GO:0060090,mitotic cell cycle; nucleus; nucleoplasm; chromosome segregation; organelle; molecular adaptor activity
OG_08473,FUN_037290-T1,Peve_00032665,Pocillopora_meandrina_HIv1___RNAseq.g10674.t1,three_way,91.80166666666666,FUN_037290-T1,A7SWD3,,,,,71.6,215.0,1.4e-83,310.8,sp|A7SWD3|GID8_NEMVE Glucose-induced degradation protein 8 homolog OS=Nematostella vectensis OX=45351 GN=v1g247787 PE=3 SV=1,,,,,,
OG_08474,FUN_037291-T1,Peve_00032666,Pocillopora_meandrina_HIv1___RNAseq.22530_t,three_way,88.56233333333334,FUN_037291-T1,Q5EAD6,RL15_BOVIN,,Large ribosomal subunit protein eL15 (60S ribosomal protein L15),Bos taurus (Bovine),76.0,204.0,2.1e-90,333.2,sp|Q5EAD6|RL15_BOVIN Large ribosomal subunit protein eL15 OS=Bos taurus OX=9913 GN=RPL15 PE=2 SV=3,GO:0002181; GO:0003723; GO:0003735; GO:0022625,cytoplasmic translation [GO:0002181],cytosolic large ribosomal subunit [GO:0022625],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0002181; GO:0003723; GO:0005198,cytoplasmic translation; RNA binding; structural molecule activity
OG_08475,FUN_037298-T1,Peve_00004415,Pocillopora_meandrina_HIv1___RNAseq.g10685.t1,three_way,84.8545,FUN_037298-T1,Q8IVV2,,,,,40.2,2254.0,0.0,1702.6,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_08476,FUN_037299-T1,Peve_00045277,Pocillopora_meandrina_HIv1___RNAseq.g10686.t1,three_way,70.14133333333334,FUN_037299-T1,Q4KLQ5,,,,,39.0,505.0,1.8e-83,311.6,sp|Q4KLQ5|WDR76_XENLA WD repeat-containing protein 76 OS=Xenopus laevis OX=8355 GN=wdr76 PE=2 SV=1,,,,,,
OG_08477,FUN_037302-T1,Peve_00045270,Pocillopora_meandrina_HIv1___RNAseq.g10687.t1,three_way,93.6245,FUN_037302-T1,Q9NW08,RPC2_HUMAN,,DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B),Homo sapiens (Human),76.5,1136.0,0.0,1823.9,sp|Q9NW08|RPC2_HUMAN DNA-directed RNA polymerase III subunit RPC2 OS=Homo sapiens OX=9606 GN=POLR3B PE=1 SV=2,GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0032549; GO:0032728; GO:0042796; GO:0045087; GO:0045089; GO:0051607; GO:0071667,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; snRNA transcription by RNA polymerase III [GO:0042796],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666],DNA binding [GO:0003677]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; ribonucleoside binding [GO:0032549]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0006351; GO:0016073; GO:0016740; GO:0043226; GO:0098542; GO:0140098,"immune system process; DNA binding; catalytic activity; nucleoplasm; mitochondrion; cytosol; DNA-templated transcription; snRNA metabolic process; transferase activity; organelle; defense response to other organism; catalytic activity, acting on RNA"
OG_08478,FUN_037305-T1,Peve_00045269,Pocillopora_meandrina_HIv1___RNAseq.g10723.t1,three_way,44.54433333333333,,,,,,,,,,,,,,,,,
OG_08479,FUN_037306-T1,Peve_00004061,Pocillopora_meandrina_HIv1___RNAseq.g1298.t1,three_way,93.64216666666668,FUN_037306-T1,A5PJN8,,,,,82.2,214.0,7.1e-99,361.7,sp|A5PJN8|SF3A2_BOVIN Splicing factor 3A subunit 2 OS=Bos taurus OX=9913 GN=SF3A2 PE=2 SV=1,,,,,,
OG_08480,FUN_037309-T1,Peve_00011738,Pocillopora_meandrina_HIv1___TS.g13226.t1,three_way,73.53399999999999,FUN_037309-T1,Q96C86,DCPS_HUMAN,,m7GpppX diphosphatase (EC 3.6.1.59) (DCS-1) (Decapping scavenger enzyme) (Hint-related 7meGMP-directed hydrolase) (Histidine triad nucleotide-binding protein 5) (Histidine triad protein member 5) (HINT-5) (Scavenger mRNA-decapping enzyme DcpS),Homo sapiens (Human),55.3,291.0,1.4e-88,327.8,sp|Q96C86|DCPS_HUMAN m7GpppX diphosphatase OS=Homo sapiens OX=9606 GN=DCPS PE=1 SV=2,GO:0000288; GO:0000290; GO:0000340; GO:0000932; GO:0004532; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0042802; GO:0045292; GO:0110156; GO:0140932,"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA methylguanosine-cap decapping [GO:0110156]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932],5'-(N(7)-methyl 5'-triphosphoguanosine)-[mRNA] diphosphatase activity [GO:0140932]; identical protein binding [GO:0042802]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA exonuclease activity [GO:0004532],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_08481,FUN_037310-T1,Peve_00011736,Pocillopora_meandrina_HIv1___RNAseq.g10709.t1,three_way,72.46583333333334,FUN_037310-T1,Q08CX1,,,,,28.3,853.0,6.6e-61,237.3,sp|Q08CX1|RASEF_XENTR Ras and EF-hand domain-containing protein OS=Xenopus tropicalis OX=8364 GN=rasef PE=2 SV=1,,,,,,
OG_08482,FUN_037313-T1,Peve_00006178,Pocillopora_meandrina_HIv1___RNAseq.g10707.t1,three_way,74.689,FUN_037313-T1,Q32PP9,,,,,66.0,94.0,6.7e-27,122.5,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_08483,FUN_037317-T1,Peve_00009173,Pocillopora_meandrina_HIv1___RNAseq.g24177.t1,three_way,64.93,FUN_037317-T1,O73888,,,,,38.0,216.0,6.1e-27,122.5,sp|O73888|HPGDS_CHICK Hematopoietic prostaglandin D synthase OS=Gallus gallus OX=9031 GN=HPGDS PE=1 SV=3,,,,,,
OG_08484,FUN_037320-T1,Peve_00006220,Pocillopora_meandrina_HIv1___RNAseq.g10703.t1,three_way,66.359,FUN_037320-T1,A2VE04,FRRS1_BOVIN,,Ferric-chelate reductase 1 (EC 1.-.-.-),Bos taurus (Bovine),29.7,202.0,6.1e-07,57.4,sp|A2VE04|FRRS1_BOVIN Ferric-chelate reductase 1 OS=Bos taurus OX=9913 GN=FRRS1 PE=2 SV=1,GO:0006879; GO:0016020; GO:0016722; GO:0046872,intracellular iron ion homeostasis [GO:0006879],membrane [GO:0016020],"metal ion binding [GO:0046872]; oxidoreductase activity, acting on metal ions [GO:0016722]",GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_08485,FUN_037321-T1,Peve_00006223,Pocillopora_meandrina_HIv1___RNAseq.g10702.t1,three_way,81.63366666666667,FUN_037321-T1,A4IFE4,,,,,53.6,440.0,2.4e-126,454.1,sp|A4IFE4|RGF1B_BOVIN Ras-GEF domain-containing family member 1B OS=Bos taurus OX=9913 GN=RASGEF1B PE=2 SV=1,,,,,,
OG_08486,FUN_037322-T1,Peve_00006225,Pocillopora_meandrina_HIv1___RNAseq.g10701.t1,three_way,68.66866666666667,FUN_037322-T1,Q28309,,,,,24.8,307.0,1.2e-08,62.4,sp|Q28309|AA3R_CANLF Adenosine receptor A3 OS=Canis lupus familiaris OX=9615 GN=ADORA3 PE=2 SV=1,,,,,,
OG_08487,FUN_037323-T1,Peve_00006230,Pocillopora_meandrina_HIv1___RNAseq.g10700.t1,three_way,56.69433333333333,FUN_037323-T1,B3LYS5,,,,,43.9,123.0,2e-18,94.7,sp|B3LYS5|FOXO_DROAN Forkhead box protein O OS=Drosophila ananassae OX=7217 GN=foxo PE=3 SV=2,,,,,,
OG_08488,FUN_037324-T1,Peve_00006231,Pocillopora_meandrina_HIv1___RNAseq.g10699.t1,three_way,65.4175,FUN_037324-T1,Q8CF97,VCIP1_RAT,,Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein),Rattus norvegicus (Rat),47.3,994.0,4.7e-244,846.3,sp|Q8CF97|VCIP1_RAT Deubiquitinating protein VCPIP1 OS=Rattus norvegicus OX=10116 GN=Vcpip1 PE=1 SV=2,GO:0004843; GO:0005634; GO:0005783; GO:0005795; GO:0006508; GO:0006974; GO:0007030; GO:0016320; GO:0016567; GO:0016579; GO:0035871; GO:0045202; GO:0071108; GO:0090168; GO:0106300; GO:1905634,DNA damage response [GO:0006974]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; regulation of protein localization to chromatin [GO:1905634],endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; synapse [GO:0045202],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0005783; GO:0006281; GO:0016787; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; DNA repair; hydrolase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_08489,FUN_037325-T1,Peve_00006232,Pocillopora_meandrina_HIv1___RNAseq.g10696.t2,three_way,81.88216666666666,FUN_037325-T1,Q0VDN7,,,,,32.6,657.0,4.6e-78,293.9,sp|Q0VDN7|RUND1_MOUSE RUN domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rundc1 PE=1 SV=1,,,,,,
OG_08490,FUN_037327-T1,Peve_00006233,Pocillopora_meandrina_HIv1___RNAseq.g10694.t1,three_way,65.693,FUN_037327-T1,Q90YK3,,,,,49.0,437.0,2.1e-133,477.2,sp|Q90YK3|GGLO_SCYTO L-gulonolactone oxidase OS=Scyliorhinus torazame OX=75743 GN=GULO PE=2 SV=1,,,,,,
OG_08491,FUN_037330-T1,Peve_00006234,Pocillopora_meandrina_HIv1___RNAseq.g10692.t1,three_way,60.120000000000005,FUN_037330-T1,Q8IVV2,,,,,39.6,273.0,5.8e-47,192.2,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_08492,FUN_037334-T1,Peve_00006154,Pocillopora_meandrina_HIv1___RNAseq.g10739.t1,three_way,47.57333333333333,FUN_037334-T1,O22558,STY8_ARATH,,Serine/threonine-protein kinase STY8 (EC 2.7.11.1) (Serine/threonine/tyrosine-protein kinase 8),Arabidopsis thaliana (Mouse-ear cress),25.3,277.0,4.9e-16,88.2,sp|O22558|STY8_ARATH Serine/threonine-protein kinase STY8 OS=Arabidopsis thaliana OX=3702 GN=STY8 PE=1 SV=2,GO:0004674; GO:0004712; GO:0005524; GO:0005829; GO:0009658; GO:0106310,chloroplast organization [GO:0009658],cytosol [GO:0005829],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712],GO:0003824; GO:0005829; GO:0016740; GO:0140096,"catalytic activity; cytosol; transferase activity; catalytic activity, acting on a protein"
OG_08493,FUN_037341-T1,Peve_00006166,Pocillopora_meandrina_HIv1___RNAseq.g10757.t1,three_way,60.51666666666667,FUN_037341-T1,Q1MT80,GBP4_DANRE,,Guanylate-binding protein 4 (EC 3.6.5.-) (GTP-binding protein 4) (GBP-4) (Guanine nucleotide-binding protein 4),Danio rerio (Zebrafish) (Brachydanio rerio),31.1,370.0,4.899999999999998e-35,151.0,sp|Q1MT80|GBP4_DANRE Guanylate-binding protein 4 OS=Danio rerio OX=7955 GN=gbp4 PE=1 SV=1,GO:0001780; GO:0003924; GO:0005525; GO:0006954; GO:0042742; GO:0042981; GO:0045087; GO:0061702; GO:0070944,defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; neutrophil homeostasis [GO:0001780]; neutrophil-mediated killing of bacterium [GO:0070944]; regulation of apoptotic process [GO:0042981],canonical inflammasome complex [GO:0061702],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0002376; GO:0003824; GO:0003924; GO:0006954; GO:0016787; GO:0098542,immune system process; catalytic activity; GTPase activity; inflammatory response; hydrolase activity; defense response to other organism
OG_08494,FUN_037369-T1,Peve_00006168,Pocillopora_meandrina_HIv1___RNAseq.g10992.t1,three_way,75.4555,FUN_037369-T1,Q9VC57,ATLAS_DROME,,Atlastin (EC 3.6.5.-),Drosophila melanogaster (Fruit fly),22.9,398.0,4.7e-06,54.7,sp|Q9VC57|ATLAS_DROME Atlastin OS=Drosophila melanogaster OX=7227 GN=atl PE=1 SV=1,GO:0000139; GO:0003924; GO:0005525; GO:0005737; GO:0005783; GO:0005789; GO:0005794; GO:0007019; GO:0007029; GO:0007030; GO:0007517; GO:0007528; GO:0008582; GO:0012505; GO:0016020; GO:0016320; GO:0030742; GO:0031114; GO:0032561; GO:0042802; GO:0048691; GO:0051124; GO:0051260; GO:0061025; GO:0061709; GO:0140506; GO:0140523; GO:1990809,endoplasmic reticulum membrane fusion [GO:0016320]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; microtubule depolymerization [GO:0007019]; muscle organ development [GO:0007517]; neuromuscular junction development [GO:0007528]; positive regulation of axon extension involved in regeneration [GO:0048691]; protein homooligomerization [GO:0051260]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; reticulophagy [GO:0061709]; synaptic assembly at neuromuscular junction [GO:0051124],cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],endoplasmic reticulum-autophagosome adaptor activity [GO:0140506]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; GTPase-dependent fusogenic activity [GO:0140523]; guanyl ribonucleotide binding [GO:0032561]; identical protein binding [GO:0042802],GO:0003824; GO:0003924; GO:0005783; GO:0005794; GO:0006914; GO:0007010; GO:0016787; GO:0034330; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003,catalytic activity; GTPase activity; endoplasmic reticulum; Golgi apparatus; autophagy; cytoskeleton organization; hydrolase activity; cell junction organization; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly
OG_08495,FUN_037370-T1,Peve_00006176,Pocillopora_meandrina_HIv1___RNAseq.g10994.t1,three_way,65.214,FUN_037370-T1,Q18775,DOPR4_CAEEL,,Dopamine receptor 4,Caenorhabditis elegans,31.3,134.0,9.4e-12,72.8,sp|Q18775|DOPR4_CAEEL Dopamine receptor 4 OS=Caenorhabditis elegans OX=6239 GN=dop-4 PE=2 SV=2,GO:0004952; GO:0004993; GO:0005886; GO:0007186; GO:0007187; GO:0007191; GO:0007198; GO:0007268; GO:0030425; GO:0030594; GO:0045211,"adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]",dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],dopamine neurotransmitter receptor activity [GO:0004952]; G protein-coupled serotonin receptor activity [GO:0004993]; neurotransmitter receptor activity [GO:0030594],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_08496,FUN_037376-T1,Peve_00006191,Pocillopora_meandrina_HIv1___RNAseq.g10997.t1,three_way,65.648,FUN_037376-T1,Q25190,,,,,36.6,82.0,4.8e-07,57.0,sp|Q25190|5HTR_HELVI 5-hydroxytryptamine receptor OS=Heliothis virescens OX=7102 PE=2 SV=1,,,,,,
OG_08497,FUN_037377-T1,Peve_00006192,Pocillopora_meandrina_HIv1___RNAseq.g10998.t1,three_way,90.17766666666668,FUN_037377-T1,O96019,ACL6A_HUMAN,,Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K),Homo sapiens (Human),68.9,434.0,1.2e-172,607.4,sp|O96019|ACL6A_HUMAN Actin-like protein 6A OS=Homo sapiens OX=9606 GN=ACTL6A PE=1 SV=1,GO:0000723; GO:0000776; GO:0000785; GO:0000786; GO:0001825; GO:0003407; GO:0003682; GO:0003713; GO:0005634; GO:0005654; GO:0005886; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0006355; GO:0006357; GO:0007165; GO:0007399; GO:0008284; GO:0016363; GO:0016514; GO:0016586; GO:0021510; GO:0030071; GO:0031011; GO:0032991; GO:0033044; GO:0035060; GO:0035267; GO:0042981; GO:0045582; GO:0045596; GO:0045597; GO:0045663; GO:0045739; GO:0045893; GO:0045995; GO:0051726; GO:0060382; GO:0070316; GO:0071564; GO:0140288; GO:1902459; GO:1904507; GO:1905168; GO:2000045; GO:2000779; GO:2000781; GO:2000819,blastocyst formation [GO:0001825]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of cell differentiation [GO:0045596]; nervous system development [GO:0007399]; neural retina development [GO:0003407]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of embryonic development [GO:0045995]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; spinal cord development [GO:0021510]; telomere maintenance [GO:0000723],brahma complex [GO:0035060]; chromatin [GO:0000785]; GBAF complex [GO:0140288]; Ino80 complex [GO:0031011]; kinetochore [GO:0000776]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RSC-type complex [GO:0016586]; SWI/SNF complex [GO:0016514],chromatin binding [GO:0003682]; transcription coactivator activity [GO:0003713],GO:0005634; GO:0005654; GO:0005886; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0032200; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; plasma membrane; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_08498,FUN_037381-T1,Peve_00006193,Pocillopora_meandrina_HIv1___RNAseq.g11000.t1,three_way,64.39816666666667,,,,,,,,,,,,,,,,,
OG_08499,FUN_037383-T2,Peve_00006197,Pocillopora_meandrina_HIv1___TS.g13502.t1,three_way,59.019,FUN_037383-T2,Q99MU3,,,,,44.6,505.0,7.2e-106,387.1,sp|Q99MU3|DSRAD_MOUSE Double-stranded RNA-specific adenosine deaminase OS=Mus musculus OX=10090 GN=Adar PE=1 SV=2,,,,,,
OG_08500,FUN_037384-T1,Peve_00006200,Pocillopora_meandrina_HIv1___RNAseq.g11005.t1,three_way,63.612,FUN_037384-T1,Q7YS61,,,,,44.8,433.0,1.8e-91,337.8,sp|Q7YS61|TRDMT_BOVIN tRNA (cytosine(38)-C(5))-methyltransferase OS=Bos taurus OX=9913 GN=TRDMT1 PE=2 SV=1,,,,,,
OG_08501,FUN_037385-T1,Peve_00014721,Pocillopora_meandrina_HIv1___RNAseq.g26899.t1,three_way,86.40616666666666,FUN_037385-T1,Q8K4Z5,,,,,62.7,762.0,3.3e-170,600.1,sp|Q8K4Z5|SF3A1_MOUSE Splicing factor 3A subunit 1 OS=Mus musculus OX=10090 GN=Sf3a1 PE=1 SV=1,,,,,,
OG_08502,FUN_037391-T2,Peve_00014719,Pocillopora_meandrina_HIv1___RNAseq.g26892.t1,three_way,61.102,,,,,,,,,,,,,,,,,
OG_08503,FUN_037394-T1,Peve_00038947,Pocillopora_meandrina_HIv1___RNAseq.g26891.t1,three_way,46.80433333333333,,,,,,,,,,,,,,,,,
OG_08504,FUN_037400-T1,Peve_00038953,Pocillopora_meandrina_HIv1___RNAseq.g10926.t1,three_way,37.313,,,,,,,,,,,,,,,,,
OG_08505,FUN_037404-T1,Peve_00028554,Pocillopora_meandrina_HIv1___RNAseq.g10936.t1,three_way,65.14683333333333,FUN_037404-T1,Q8R2Q6,TECT3_MOUSE,,Tectonic-3,Mus musculus (Mouse),30.9,556.0,8.399999999999998e-55,216.5,sp|Q8R2Q6|TECT3_MOUSE Tectonic-3 OS=Mus musculus OX=10090 GN=Tctn3 PE=1 SV=1,GO:0005634; GO:0006915; GO:0007224; GO:0016020; GO:0043065; GO:0060271,apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; positive regulation of apoptotic process [GO:0043065]; smoothened signaling pathway [GO:0007224],membrane [GO:0016020]; nucleus [GO:0005634],,GO:0005634; GO:0012501; GO:0043226; GO:0044782,nucleus; programmed cell death; organelle; cilium organization
OG_08506,FUN_037409-T1,Peve_00028255,Pocillopora_meandrina_HIv1___RNAseq.g10935.t1,three_way,69.74066666666667,FUN_037409-T1,Q9C8L4,ETHE1_ARATH,,"Persulfide dioxygenase ETHE1 homolog, mitochondrial (EC 1.13.11.18) (Glyoxalase II) (Glx II) (Sulfur dioxygenase ETHE1)",Arabidopsis thaliana (Mouse-ear cress),59.1,242.0,8.899999999999999e-75,281.6,"sp|Q9C8L4|ETHE1_ARATH Persulfide dioxygenase ETHE1 homolog, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=GLY3 PE=1 SV=3",GO:0005634; GO:0005739; GO:0006749; GO:0009793; GO:0009960; GO:0016788; GO:0046872; GO:0048316; GO:0050313,embryo development ending in seed dormancy [GO:0009793]; endosperm development [GO:0009960]; glutathione metabolic process [GO:0006749]; seed development [GO:0048316],mitochondrion [GO:0005739]; nucleus [GO:0005634],"hydrolase activity, acting on ester bonds [GO:0016788]; metal ion binding [GO:0046872]; sulfur dioxygenase activity [GO:0050313]",GO:0003824; GO:0005634; GO:0005739; GO:0006575; GO:0006790; GO:0016491; GO:0016787; GO:0022414; GO:0043226; GO:0048856,catalytic activity; nucleus; mitochondrion; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity; hydrolase activity; reproductive process; organelle; anatomical structure development
OG_08507,FUN_037415-T1,Peve_00028254,Pocillopora_meandrina_HIv1___RNAseq.g10939.t1,three_way,73.82433333333333,FUN_037415-T1,A5PJF6,,,,,47.9,303.0,2.3e-73,277.3,sp|A5PJF6|HSDL1_BOVIN Inactive hydroxysteroid dehydrogenase-like protein 1 OS=Bos taurus OX=9913 GN=HSDL1 PE=2 SV=1,,,,,,
OG_08508,FUN_037416-T2,Peve_00028857,Pocillopora_meandrina_HIv1___RNAseq.g10945.t1,three_way,60.57983333333333,FUN_037416-T2,Q569T7,,,,,33.2,400.0,7.700000000000001e-48,193.0,sp|Q569T7|MFS4B_XENLA Sodium-dependent glucose transporter 1 OS=Xenopus laevis OX=8355 GN=mfsd4b PE=2 SV=1,,,,,,
OG_08509,FUN_037422-T1,Peve_00000594,Pocillopora_meandrina_HIv1___RNAseq.g10949.t1,three_way,81.52333333333333,FUN_037422-T1,Q6QA33,,,,,49.3,306.0,1.5e-71,271.2,sp|Q6QA33|DH12B_DANRE Very-long-chain 3-oxoacyl-CoA reductase-B OS=Danio rerio OX=7955 GN=hsd17b12b PE=2 SV=2,,,,,,
OG_08510,FUN_037424-T1,Peve_00000597,Pocillopora_meandrina_HIv1___RNAseq.g10952.t1a,three_way,54.638333333333335,,,,,,,,,,,,,,,,,
OG_08511,FUN_037425-T2,Peve_00014237,Pocillopora_meandrina_HIv1___RNAseq.g10955.t1,three_way,83.41216666666666,FUN_037425-T2,P31266,,,,,75.5,440.0,3.4e-193,676.0,sp|P31266|SUH_MOUSE Recombining binding protein suppressor of hairless OS=Mus musculus OX=10090 GN=Rbpj PE=1 SV=1,,,,,,
OG_08512,FUN_037430-T2,Peve_00014228,Pocillopora_meandrina_HIv1___RNAseq.g10960.t1,three_way,48.326,,,,,,,,,,,,,,,,,
OG_08513,FUN_037439-T1,Peve_00014239,Pocillopora_meandrina_HIv1___RNAseq.g10962.t1,three_way,78.76766666666666,FUN_037439-T1,P97393,RHG05_MOUSE,,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),Mus musculus (Mouse),30.1,1790.0,6.2e-194,680.2,sp|P97393|RHG05_MOUSE Rho GTPase-activating protein 5 OS=Mus musculus OX=10090 GN=Arhgap5 PE=1 SV=3,GO:0002053; GO:0005096; GO:0005783; GO:0005829; GO:0005886; GO:0007165; GO:0008361; GO:0010631; GO:0010634; GO:0016477; GO:0030879; GO:0042169,cell migration [GO:0016477]; epithelial cell migration [GO:0010631]; mammary gland development [GO:0030879]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of mesenchymal cell proliferation [GO:0002053]; regulation of cell size [GO:0008361]; signal transduction [GO:0007165],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; SH2 domain binding [GO:0042169],GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0048856; GO:0048870; GO:0098772,endoplasmic reticulum; cytosol; plasma membrane; organelle; anatomical structure development; cell motility; molecular function regulator activity
OG_08514,FUN_037440-T1,Peve_00014235,Pocillopora_meandrina_HIv1___RNAseq.22823_t,three_way,64.086,FUN_037440-T1,Q9M9E8,,,,,30.9,269.0,4.400000000000001e-28,127.1,sp|Q9M9E8|JMJ21_ARATH Lysine-specific demethylase JMJ21 OS=Arabidopsis thaliana OX=3702 GN=JMJ21 PE=2 SV=3,,,,,,
OG_08515,FUN_037441-T2,Peve_00034993,Pocillopora_meandrina_HIv1___RNAseq.g10964.t1,three_way,68.80016666666667,FUN_037441-T2,Q08BH7,UBE2T_DANRE,,Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T),Danio rerio (Zebrafish) (Brachydanio rerio),65.6,151.0,2.1e-59,230.3,sp|Q08BH7|UBE2T_DANRE Ubiquitin-conjugating enzyme E2 T OS=Danio rerio OX=7955 GN=ube2t PE=2 SV=1,GO:0000209; GO:0003682; GO:0004842; GO:0005524; GO:0005634; GO:0006281; GO:0006513; GO:0006974; GO:0051865; GO:0061631,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209],nucleus [GO:0005634],ATP binding [GO:0005524]; chromatin binding [GO:0003682]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0006281; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA repair; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08516,FUN_037445-T1,Peve_00027035,Pocillopora_meandrina_HIv1___RNAseq.g10976.t1,three_way,56.40266666666667,FUN_037445-T1,Q56UN5,M3K19_HUMAN,,"Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)",Homo sapiens (Human),61.7,274.0,1.7999999999999997e-95,353.2,sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens OX=9606 GN=MAP3K19 PE=2 SV=1,GO:0000165; GO:0004709; GO:0005524; GO:0106310,MAPK cascade [GO:0000165],,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_08517,FUN_037447-T1,Peve_00027251,Pocillopora_meandrina_HIv1___RNAseq.g10986.t1,three_way,85.654,FUN_037447-T1,Q3T0V4,,,,,75.0,156.0,5.2e-61,235.3,sp|Q3T0V4|RS11_BOVIN Small ribosomal subunit protein uS17 OS=Bos taurus OX=9913 GN=RPS11 PE=2 SV=3,,,,,,
OG_08518,FUN_037448-T1,Peve_00027252,Pocillopora_meandrina_HIv1___RNAseq.g10987.t1,three_way,73.10766666666667,FUN_037448-T1,Q8AVL0,,,,,50.8,543.0,6.4e-150,532.3,sp|Q8AVL0|C19L1_XENLA CWF19-like protein 1 OS=Xenopus laevis OX=8355 GN=cwf19l1 PE=2 SV=1,,,,,,
OG_08519,FUN_037451-T1,Peve_00044121,Pocillopora_meandrina_HIv1___RNAseq.g1365.t1,three_way,62.06366666666667,,,,,,,,,,,,,,,,,
OG_08520,FUN_037452-T1,Peve_00044119,Pocillopora_meandrina_HIv1___RNAseq.g1368.t1,three_way,59.91483333333333,FUN_037452-T1,Q9IA95,,,,,32.7,266.0,2.4e-45,184.1,sp|Q9IA95|SFRP3_CHICK Secreted frizzled-related protein 3 OS=Gallus gallus OX=9031 GN=FRZB PE=2 SV=1,,,,,,
OG_08521,FUN_037454-T1,Peve_00044133,Pocillopora_meandrina_HIv1___RNAseq.g1366.t1,three_way,42.83116666666667,,,,,,,,,,,,,,,,,
OG_08522,FUN_037455-T2,Peve_00044122,Pocillopora_meandrina_HIv1___RNAseq.g1369.t1,three_way,78.81866666666667,FUN_037455-T2,B2GUP8,MITOS_XENTR,,"Mitochondrial potassium channel ATP-binding subunit (ATP-binding cassette sub-family B member 8, mitochondrial) (ABCB8) (Mitochondrial sulfonylurea-receptor) (MITOSUR)",Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),59.1,613.0,1.9999999999999999e-193,677.2,sp|B2GUP8|MITOS_XENTR Mitochondrial potassium channel ATP-binding subunit OS=Xenopus tropicalis OX=8364 GN=abcb8 PE=2 SV=1,GO:0005524; GO:0005739; GO:0005743; GO:0016887; GO:0062157; GO:0071805; GO:0140359,potassium ion transmembrane transport [GO:0071805],mitochondrial ATP-gated potassium channel complex [GO:0062157]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005215; GO:0005739; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; mitochondrion; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_08523,FUN_037456-T1,Peve_00044116,Pocillopora_meandrina_HIv1___RNAseq.g1370.t1,three_way,87.71366666666667,FUN_037456-T1,Q8BQ89,,,,,65.0,283.0,3.9e-101,369.4,sp|Q8BQ89|LIX1L_MOUSE LIX1-like protein OS=Mus musculus OX=10090 GN=Lix1l PE=2 SV=2,,,,,,
OG_08524,FUN_037457-T1,Peve_00036022,Pocillopora_meandrina_HIv1___RNAseq.g1371.t1,three_way,46.4685,,,,,,,,,,,,,,,,,
OG_08525,FUN_037458-T2,Peve_00036027,Pocillopora_meandrina_HIv1___RNAseq.g1372.t1,three_way,51.31883333333333,,,,,,,,,,,,,,,,,
OG_08526,FUN_037463-T1,Peve_00036016,Pocillopora_meandrina_HIv1___TS.g22784.t2,three_way,69.82633333333334,FUN_037463-T1,Q9Z0U4,GABR1_RAT,,Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1),Rattus norvegicus (Rat),39.1,578.0,2.5e-110,401.0,sp|Q9Z0U4|GABR1_RAT Gamma-aminobutyric acid type B receptor subunit 1 OS=Rattus norvegicus OX=10116 GN=Gabbr1 PE=1 SV=2,GO:0001649; GO:0004965; GO:0005615; GO:0005737; GO:0005789; GO:0005886; GO:0007193; GO:0007214; GO:0008021; GO:0008285; GO:0014048; GO:0014049; GO:0014053; GO:0016020; GO:0030673; GO:0031966; GO:0032811; GO:0033602; GO:0035094; GO:0038037; GO:0038039; GO:0042734; GO:0043025; GO:0043197; GO:0043198; GO:0043204; GO:0045211; GO:0045471; GO:0046982; GO:0050805; GO:0051932; GO:0060124; GO:0097060; GO:0098685; GO:0098793; GO:0098978; GO:0098982; GO:0099579; GO:0150047; GO:0150099; GO:1902710; GO:1902712; GO:1990430,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of synaptic transmission [GO:0050805]; neuron-glial cell signaling [GO:0150099]; osteoblast differentiation [GO:0001649]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of growth hormone secretion [GO:0060124]; regulation of glutamate secretion [GO:0014048]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; synaptic transmission, GABAergic [GO:0051932]",axolemma [GO:0030673]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor dimeric complex [GO:0038037]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021],extracellular matrix protein binding [GO:1990430]; G protein-coupled GABA receptor activity [GO:0004965]; G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO:0099579]; G protein-coupled neurotransmitter receptor activity involved in regulation of presynaptic membrane potential [GO:0150047]; protein heterodimerization activity [GO:0046982],GO:0005615; GO:0005886; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0060089,extracellular space; plasma membrane; signaling; cell differentiation; cytoplasmic vesicle; organelle; molecular transducer activity
OG_08527,FUN_037464-T1,Peve_00036017,Pocillopora_meandrina_HIv1___RNAseq.g1379.t1,three_way,57.99766666666667,FUN_037464-T1,B1WAR9,GWL_XENTR,,Serine/threonine-protein kinase greatwall (GW) (GWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),34.7,920.0,2.8e-115,417.9,sp|B1WAR9|GWL_XENTR Serine/threonine-protein kinase greatwall OS=Xenopus tropicalis OX=8364 GN=mastl PE=2 SV=1,GO:0000086; GO:0000278; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0032154; GO:0051301; GO:0051721; GO:0106310,cell division [GO:0051301]; DNA damage response [GO:0006974]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278],centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein phosphatase 2A binding [GO:0051721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000278; GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"mitotic cell cycle; catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08528,FUN_037469-T1,Peve_00036019,Pocillopora_meandrina_HIv1___RNAseq.g1383.t1,three_way,59.05133333333333,FUN_037469-T1,Q7Z407,CSMD3_HUMAN,,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),Homo sapiens (Human),27.5,262.0,1.4e-15,85.5,sp|Q7Z407|CSMD3_HUMAN CUB and sushi domain-containing protein 3 OS=Homo sapiens OX=9606 GN=CSMD3 PE=1 SV=3,GO:0005886; GO:0050773,regulation of dendrite development [GO:0050773],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_08529,FUN_037474-T1,Peve_00036026,Pocillopora_meandrina_HIv1___RNAseq.g1385.t1,three_way,56.428666666666665,,,,,,,,,,,,,,,,,
OG_08530,FUN_037477-T1,Peve_00020433,Pocillopora_meandrina_HIv1___RNAseq.g1391.t1,three_way,71.99733333333333,FUN_037477-T1,Q3TDN2,FAF2_MOUSE,,FAS-associated factor 2 (UBX domain-containing protein 8),Mus musculus (Mouse),45.3,267.0,3.1e-59,230.3,sp|Q3TDN2|FAF2_MOUSE FAS-associated factor 2 OS=Mus musculus OX=10090 GN=Faf2 PE=1 SV=2,GO:0005783; GO:0005811; GO:0006986; GO:0030674; GO:0030970; GO:0031625; GO:0034098; GO:0034389; GO:0035473; GO:0035617; GO:0036503; GO:0043130; GO:0043161; GO:0055102,"ERAD pathway [GO:0036503]; lipid droplet organization [GO:0034389]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]",endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],lipase binding [GO:0035473]; lipase inhibitor activity [GO:0055102]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],GO:0005783; GO:0005811; GO:0006886; GO:0030163; GO:0043226; GO:0060090; GO:0098772,endoplasmic reticulum; lipid droplet; intracellular protein transport; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_08531,FUN_037480-T1,Peve_00020428,Pocillopora_meandrina_HIv1___RNAseq.g1395.t1,three_way,61.86533333333333,,,,,,,,,,,,,,,,,
OG_08532,FUN_037482-T1,Peve_00020426,Pocillopora_meandrina_HIv1___RNAseq.g1396.t1,three_way,70.77866666666667,,,,,,,,,,,,,,,,,
OG_08533,FUN_037483-T1,Peve_00020422,Pocillopora_meandrina_HIv1___RNAseq.g1397.t1,three_way,72.69066666666667,,,,,,,,,,,,,,,,,
OG_08534,FUN_037484-T1,Peve_00020421,Pocillopora_meandrina_HIv1___RNAseq.g1398.t1,three_way,57.21716666666666,FUN_037484-T1,A0A8C2M425,,,,,33.9,431.0,4.5e-49,196.8,"sp|A0A8C2M425|PIGV_CRIGR GPI alpha-1,6-mannosyltransferase 2 OS=Cricetulus griseus OX=10029 GN=PIGV PE=1 SV=1",,,,,,
OG_08535,FUN_037485-T2,Peve_00020418,Pocillopora_meandrina_HIv1___RNAseq.g1299.t1,three_way,72.62033333333333,FUN_037485-T2,Q8CHC4,SYNJ1_MOUSE,,"Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)",Mus musculus (Mouse),54.1,1036.0,0.0,1097.0,sp|Q8CHC4|SYNJ1_MOUSE Synaptojanin-1 OS=Mus musculus OX=10090 GN=Synj1 PE=1 SV=3,GO:0003723; GO:0004439; GO:0006836; GO:0007612; GO:0012506; GO:0016082; GO:0016191; GO:0030117; GO:0030118; GO:0030132; GO:0034595; GO:0043195; GO:0046488; GO:0046856; GO:0048015; GO:0048471; GO:0048488; GO:0048489; GO:0097060; GO:0098685; GO:0098978; GO:0099149; GO:1903423,learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of synaptic vesicle recycling [GO:1903423]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191],clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; glutamatergic synapse [GO:0098978]; membrane coat [GO:0030117]; perinuclear region of cytoplasm [GO:0048471]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506],"phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; RNA binding [GO:0003723]",GO:0003723; GO:0003824; GO:0006629; GO:0016192; GO:0016787; GO:0050877; GO:0065003,RNA binding; catalytic activity; lipid metabolic process; vesicle-mediated transport; hydrolase activity; nervous system process; protein-containing complex assembly
OG_08536,FUN_037486-T1,Peve_00020414,Pocillopora_meandrina_HIv1___RNAseq.g1300.t1,three_way,64.04466666666667,FUN_037486-T1,Q6TLI7,AA2AR_HORSE,,Adenosine receptor A2a,Equus caballus (Horse),24.3,296.0,4.7e-07,57.0,sp|Q6TLI7|AA2AR_HORSE Adenosine receptor A2a OS=Equus caballus OX=9796 GN=ADORA2A PE=2 SV=1,GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005886; GO:0007189; GO:0007626; GO:0008289; GO:0014074; GO:0019899; GO:0032230; GO:0042755; GO:0042802; GO:0046636; GO:0050728; GO:0060080; GO:0097190; GO:0098794; GO:2001235,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic signaling pathway [GO:0097190]; eating behavior [GO:0042755]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; response to amphetamine [GO:0001975]; response to purine-containing compound [GO:0014074]; synaptic transmission, dopaminergic [GO:0001963]",plasma membrane [GO:0005886]; postsynapse [GO:0098794],calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],GO:0005886; GO:0008289; GO:0023052; GO:0060089,plasma membrane; lipid binding; signaling; molecular transducer activity
OG_08537,FUN_037487-T1,Peve_00020437,Pocillopora_meandrina_HIv1___RNAseq.g1303.t1,three_way,53.88616666666667,,,,,,,,,,,,,,,,,
OG_08538,FUN_037488-T1,Peve_00020417,Pocillopora_meandrina_HIv1___TS.g22716.t1,three_way,79.14133333333334,FUN_037488-T1,Q08BI9,MCU_DANRE,,"Calcium uniporter protein, mitochondrial",Danio rerio (Zebrafish) (Brachydanio rerio),55.8,283.0,5.2e-86,319.3,"sp|Q08BI9|MCU_DANRE Calcium uniporter protein, mitochondrial OS=Danio rerio OX=7955 GN=mcu PE=1 SV=1",GO:0005262; GO:0005743; GO:0006851; GO:0007015; GO:0008016; GO:0015292; GO:0019722; GO:0032024; GO:0034704; GO:0036444; GO:0042593; GO:0042802; GO:0043009; GO:0046872; GO:0051259; GO:0051560; GO:0051561; GO:0051649; GO:0060027; GO:1990246,actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; establishment of localization in cell [GO:0051649]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016],calcium channel complex [GO:0034704]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246],calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; uniporter activity [GO:0015292],GO:0005215; GO:0048856; GO:0055085; GO:0065003,transporter activity; anatomical structure development; transmembrane transport; protein-containing complex assembly
OG_08539,FUN_037489-T1,Peve_00020410,Pocillopora_meandrina_HIv1___RNAseq.g1305.t1,three_way,76.29033333333334,FUN_037489-T1,A2VEI2,MICU1_DROME,,"Calcium uptake protein 1 homolog, mitochondrial (Mitochondrial calcium uptake 1)",Drosophila melanogaster (Fruit fly),53.7,376.0,1.5e-108,394.8,"sp|A2VEI2|MICU1_DROME Calcium uptake protein 1 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=MICU1 PE=2 SV=1",GO:0005509; GO:0005758; GO:0007615; GO:0036444; GO:0051560; GO:0051561; GO:0072375; GO:1990246,anesthesia-resistant memory [GO:0007615]; calcium import into the mitochondrion [GO:0036444]; medium-term memory [GO:0072375]; mitochondrial calcium ion homeostasis [GO:0051560]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246],calcium ion binding [GO:0005509],GO:0050877; GO:0055085,nervous system process; transmembrane transport
OG_08540,FUN_037491-T1,Peve_00028570,Pocillopora_meandrina_HIv1___RNAseq.g1307.t1,three_way,88.51766666666667,FUN_037491-T1,P31153,METK2_HUMAN,,S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II),Homo sapiens (Human),79.0,381.0,3.6e-177,622.5,sp|P31153|METK2_HUMAN S-adenosylmethionine synthase isoform type-2 OS=Homo sapiens OX=9606 GN=MAT2A PE=1 SV=1,GO:0004478; GO:0005524; GO:0005829; GO:0006556; GO:0006730; GO:0034214; GO:0036094; GO:0042802; GO:0046872; GO:0048269; GO:0051291; GO:0061431; GO:1904263; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to methionine [GO:0061431]; one-carbon metabolic process [GO:0006730]; positive regulation of TORC1 signaling [GO:1904263]; protein heterooligomerization [GO:0051291]; protein hexamerization [GO:0034214]; S-adenosylmethionine biosynthetic process [GO:0006556],cytosol [GO:0005829]; methionine adenosyltransferase complex [GO:0048269],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; small molecule binding [GO:0036094],GO:0003824; GO:0005829; GO:0006790; GO:0016740; GO:0065003,catalytic activity; cytosol; sulfur compound metabolic process; transferase activity; protein-containing complex assembly
OG_08541,FUN_037492-T1,Peve_00028569,Pocillopora_meandrina_HIv1___RNAseq.g1308.t1,three_way,98.157,FUN_037492-T1,Q7L9L4,MOB1B_HUMAN,,MOB kinase activator 1B (Mob1 homolog 1A) (Mob1A) (Mob1B) (Mps one binder kinase activator-like 1A),Homo sapiens (Human),87.5,216.0,3.6e-112,405.6,sp|Q7L9L4|MOB1B_HUMAN MOB kinase activator 1B OS=Homo sapiens OX=9606 GN=MOB1B PE=1 SV=3,GO:0005634; GO:0005737; GO:0005829; GO:0019209; GO:0019900; GO:0030295; GO:0031952; GO:0035329; GO:0043539; GO:0046872; GO:0070062,hippo signaling [GO:0035329]; regulation of protein autophosphorylation [GO:0031952],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],kinase activator activity [GO:0019209]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein serine/threonine kinase activator activity [GO:0043539],GO:0005634; GO:0005829; GO:0043226; GO:0098772,nucleus; cytosol; organelle; molecular function regulator activity
OG_08542,FUN_037495-T1,Peve_00028567,Pocillopora_meandrina_HIv1___TS.g22722.t1,three_way,69.01516666666667,FUN_037495-T1,Q60431,CASP3_MESAU,,Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12],Mesocricetus auratus (Golden hamster),44.7,255.0,1.6e-54,214.9,sp|Q60431|CASP3_MESAU Caspase-3 OS=Mesocricetus auratus OX=10036 GN=CASP3 PE=2 SV=1,GO:0004175; GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0030182; GO:0030216; GO:0030218; GO:0031264; GO:0031647; GO:0043525; GO:1902004,apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of neuron apoptotic process [GO:0043525]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytoplasm [GO:0005737]; death-inducing signaling complex [GO:0031264],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175],GO:0003824; GO:0012501; GO:0016787; GO:0030154; GO:0140096,"catalytic activity; programmed cell death; hydrolase activity; cell differentiation; catalytic activity, acting on a protein"
OG_08543,FUN_037496-T1,Peve_00028565,Pocillopora_meandrina_HIv1___RNAseq.g1312.t1,three_way,79.1105,FUN_037496-T1,P36895,BMR1A_MOUSE,,Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (BMP-2/BMP-4 receptor) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292),Mus musculus (Mouse),53.0,487.0,2.7e-145,516.9,sp|P36895|BMR1A_MOUSE Bone morphogenetic protein receptor type-1A OS=Mus musculus OX=10090 GN=Bmpr1a PE=1 SV=1,GO:0001525; GO:0001649; GO:0001701; GO:0001707; GO:0001756; GO:0001880; GO:0002053; GO:0002062; GO:0003007; GO:0003148; GO:0003151; GO:0003161; GO:0003171; GO:0003183; GO:0003186; GO:0003203; GO:0003215; GO:0003222; GO:0003223; GO:0003272; GO:0004674; GO:0005025; GO:0005524; GO:0005901; GO:0006955; GO:0007179; GO:0007389; GO:0007398; GO:0007399; GO:0007492; GO:0007507; GO:0009897; GO:0009950; GO:0009952; GO:0009953; GO:0009986; GO:0010629; GO:0014032; GO:0014912; GO:0021953; GO:0021983; GO:0021998; GO:0030324; GO:0030425; GO:0030501; GO:0030509; GO:0032915; GO:0035019; GO:0035137; GO:0035912; GO:0036122; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0045669; GO:0045944; GO:0046332; GO:0046872; GO:0048339; GO:0048352; GO:0048368; GO:0048378; GO:0048382; GO:0048568; GO:0048589; GO:0048598; GO:0048863; GO:0050673; GO:0050679; GO:0050768; GO:0051148; GO:0051216; GO:0060021; GO:0060043; GO:0060045; GO:0060391; GO:0060412; GO:0060896; GO:0060914; GO:0060928; GO:0061626; GO:0098821; GO:1902895; GO:1904414; GO:1904707; GO:1905285; GO:2000772,angiogenesis [GO:0001525]; anterior/posterior pattern specification [GO:0009952]; atrioventricular node cell development [GO:0060928]; atrioventricular valve development [GO:0003171]; BMP signaling pathway [GO:0030509]; cardiac conduction system development [GO:0003161]; cardiac right ventricle morphogenesis [GO:0003215]; cartilage development [GO:0051216]; central nervous system neuron differentiation [GO:0021953]; chondrocyte differentiation [GO:0002062]; developmental growth [GO:0048589]; dorsal aorta morphogenesis [GO:0035912]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digit morphogenesis [GO:0042733]; embryonic morphogenesis [GO:0048598]; embryonic organ development [GO:0048568]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; endoderm development [GO:0007492]; epithelial cell proliferation [GO:0050673]; fibrous ring of heart morphogenesis [GO:1905285]; heart development [GO:0007507]; heart formation [GO:0060914]; heart morphogenesis [GO:0003007]; hindlimb morphogenesis [GO:0035137]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; lateral mesoderm development [GO:0048368]; lung development [GO:0030324]; mesendoderm development [GO:0048382]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; Mullerian duct regression [GO:0001880]; negative regulation of gene expression [GO:0010629]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of neurogenesis [GO:0050768]; negative regulation of smooth muscle cell migration [GO:0014912]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural plate mediolateral regionalization [GO:0021998]; neural plate pattern specification [GO:0060896]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; outflow tract septum morphogenesis [GO:0003148]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm structural organization [GO:0048352]; pattern specification process [GO:0007389]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac ventricle development [GO:1904414]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cellular senescence [GO:2000772]; regulation of lateral mesodermal cell fate specification [GO:0048378]; roof of mouth development [GO:0060021]; somatic stem cell population maintenance [GO:0035019]; somitogenesis [GO:0001756]; stem cell differentiation [GO:0048863]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tricuspid valve morphogenesis [GO:0003186]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],caveola [GO:0005901]; cell surface [GO:0009986]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; neuronal cell body [GO:0043025],"ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta receptor activity, type I [GO:0005025]",GO:0002376; GO:0003824; GO:0006355; GO:0016740; GO:0022414; GO:0030154; GO:0048856; GO:0060089; GO:0140096,"immune system process; catalytic activity; regulation of DNA-templated transcription; transferase activity; reproductive process; cell differentiation; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_08544,FUN_037498-T1,Peve_00028564,Pocillopora_meandrina_HIv1___RNAseq.g1313.t1,three_way,55.20616666666667,FUN_037498-T1,C3ZQF9,,,,,26.2,320.0,1.4e-16,89.0,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_08545,FUN_037499-T1,Peve_00028563,Pocillopora_meandrina_HIv1___RNAseq.g1314.t1,three_way,52.762,FUN_037499-T1,Q6V0I7,FAT4_HUMAN,,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Homo sapiens (Human),26.9,750.0,3.7e-53,211.8,sp|Q6V0I7|FAT4_HUMAN Protocadherin Fat 4 OS=Homo sapiens OX=9606 GN=FAT4 PE=1 SV=2,GO:0005509; GO:0005886; GO:0007156; GO:0007157; GO:0021987; GO:0022008; GO:0035329; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008],extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0043226; GO:0048856,plasma membrane; cell adhesion; cell differentiation; organelle; anatomical structure development
OG_08546,FUN_037508-T1,Peve_00028562,Pocillopora_meandrina_HIv1___RNAseq.g1315.t1,three_way,65.59033333333333,,,,,,,,,,,,,,,,,
OG_08547,FUN_037509-T1,Peve_00028560,Pocillopora_meandrina_HIv1___RNAseq.g1316.t1,three_way,73.96033333333334,,,,,,,,,,,,,,,,,
OG_08548,FUN_037511-T1,Peve_00028555,Pocillopora_meandrina_HIv1___RNAseq.g1319.t1,three_way,77.14016666666667,,,,,,,,,,,,,,,,,
OG_08549,FUN_037517-T1,Peve_00025027,Pocillopora_meandrina_HIv1___RNAseq.g1320.t1,three_way,85.71833333333333,FUN_037517-T1,A4IGP0,,,,,63.3,196.0,1.6e-66,253.8,sp|A4IGP0|HIKES_XENTR Protein Hikeshi OS=Xenopus tropicalis OX=8364 GN=hikeshi PE=2 SV=1,,,,,,
OG_08550,FUN_037519-T1,Peve_00025030,Pocillopora_meandrina_HIv1___RNAseq.g1323.t1,three_way,77.389,FUN_037519-T1,A7RF00,,,,,62.2,349.0,2.1e-117,423.7,sp|A7RF00|MTNA_NEMVE Methylthioribose-1-phosphate isomerase OS=Nematostella vectensis OX=45351 GN=v1g237765 PE=3 SV=1,,,,,,
OG_08551,FUN_037526-T1,Peve_00044841,Pocillopora_meandrina_HIv1___RNAseq.g10605.t1,three_way,68.244,,,,,,,,,,,,,,,,,
OG_08552,FUN_037527-T1,Peve_00018746,Pocillopora_meandrina_HIv1___RNAseq.g10588.t1,three_way,45.45016666666667,,,,,,,,,,,,,,,,,
OG_08553,FUN_037529-T1,Peve_00018745,Pocillopora_meandrina_HIv1___RNAseq.g10587.t1,three_way,78.19266666666667,FUN_037529-T1,P97479,,,,,53.2,485.0,6.6e-146,518.8,sp|P97479|MYO7A_MOUSE Unconventional myosin-VIIa OS=Mus musculus OX=10090 GN=Myo7a PE=1 SV=2,,,,,,
OG_08554,FUN_037536-T1,Peve_00018744,Pocillopora_meandrina_HIv1___RNAseq.g10586.t1,three_way,61.52,FUN_037536-T1,P58308,OX2R_MOUSE,,Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2),Mus musculus (Mouse),28.0,382.0,7.1e-21,103.2,sp|P58308|OX2R_MOUSE Orexin receptor type 2 OS=Mus musculus OX=10090 GN=Hcrtr2 PE=2 SV=2,GO:0005654; GO:0005886; GO:0007200; GO:0007218; GO:0007631; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0040011; GO:0051480,"circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; locomotion [GO:0040011]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]",nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046],GO:0005654; GO:0005886; GO:0060089,nucleoplasm; plasma membrane; molecular transducer activity
OG_08555,FUN_037537-T2,Peve_00032233,Pocillopora_meandrina_HIv1___RNAseq.g1638.t1,three_way,66.20966666666666,,,,,,,,,,,,,,,,,
OG_08556,FUN_037544-T1,Peve_00032232,Pocillopora_meandrina_HIv1___RNAseq.g10583.t1,three_way,85.05866666666667,FUN_037544-T1,Q8R4C2,,,,,36.0,406.0,1.4e-57,226.1,sp|Q8R4C2|RUFY2_MOUSE RUN and FYVE domain-containing protein 2 OS=Mus musculus OX=10090 GN=Rufy2 PE=1 SV=2,,,,,,
OG_08557,FUN_037545-T1,Peve_00032229,Pocillopora_meandrina_HIv1___RNAseq.g1633.t2,three_way,65.51433333333333,FUN_037545-T1,P60483,,,,,47.9,382.0,1.2e-98,361.7,"sp|P60483|PTEN_CANLF Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN OS=Canis lupus familiaris OX=9615 GN=PTEN PE=2 SV=1",,,,,,
OG_08558,FUN_037546-T1,Peve_00032228,Pocillopora_meandrina_HIv1___RNAseq.g1632.t1,three_way,64.18333333333334,,,,,,,,,,,,,,,,,
OG_08559,FUN_037547-T1,Peve_00032227,Pocillopora_meandrina_HIv1___RNAseq.g1631.t1,three_way,77.2375,,,,,,,,,,,,,,,,,
OG_08560,FUN_037548-T1,Peve_00032226,Pocillopora_meandrina_HIv1___RNAseq.g1628.t1,three_way,68.57633333333334,FUN_037548-T1,Q8VC74,,,,,40.3,278.0,1.2e-48,195.3,"sp|Q8VC74|COX18_MOUSE Cytochrome c oxidase assembly protein COX18, mitochondrial OS=Mus musculus OX=10090 GN=Cox18 PE=1 SV=5",,,,,,
OG_08561,FUN_037553-T1,Peve_00032237,Pocillopora_meandrina_HIv1___RNAseq.g1625.t1,three_way,70.45266666666666,FUN_037553-T1,Q04861,,,,,40.6,894.0,1.9e-154,548.1,sp|Q04861|NFKB1_CHICK Nuclear factor NF-kappa-B p105 subunit OS=Gallus gallus OX=9031 GN=NFKB1 PE=2 SV=2,,,,,,
OG_08562,FUN_037555-T2,Peve_00044142,Pocillopora_meandrina_HIv1___RNAseq.g1623.t3,three_way,81.39433333333334,FUN_037555-T2,Q8TEU7,,,,,43.2,1168.0,7.5e-253,875.5,sp|Q8TEU7|RPGF6_HUMAN Rap guanine nucleotide exchange factor 6 OS=Homo sapiens OX=9606 GN=RAPGEF6 PE=1 SV=2,,,,,,
OG_08563,FUN_037556-T1,Peve_00017815,Pocillopora_meandrina_HIv1___RNAseq.g1622.t1,three_way,60.89583333333333,FUN_037556-T1,O95069,,,,,32.3,260.0,7.4e-29,130.2,sp|O95069|KCNK2_HUMAN Potassium channel subfamily K member 2 OS=Homo sapiens OX=9606 GN=KCNK2 PE=1 SV=2,,,,,,
OG_08564,FUN_037564-T1,Peve_00017811,Pocillopora_meandrina_HIv1___RNAseq.g1620.t1,three_way,60.96666666666667,FUN_037564-T1,Q8CFX1,G6PE_MOUSE,,GDH/6PGL endoplasmic bifunctional protein [Includes: Hexose-6-phosphate dehydrogenase (Glucose 1-dehydrogenase) (EC 1.1.1.47) (Glucose-6-phosphate dehydrogenase) (EC 1.1.1.363); 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)],Mus musculus (Mouse),42.7,784.0,1.5e-169,598.2,sp|Q8CFX1|G6PE_MOUSE GDH/6PGL endoplasmic bifunctional protein OS=Mus musculus OX=10090 GN=H6pd PE=1 SV=2,GO:0004345; GO:0005783; GO:0005788; GO:0006006; GO:0006098; GO:0009051; GO:0016529; GO:0017057; GO:0030246; GO:0031667; GO:0047934; GO:0047935; GO:0050661; GO:0097305; GO:2000064,"glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt, oxidative branch [GO:0009051]; regulation of cortisol biosynthetic process [GO:2000064]; response to alcohol [GO:0097305]; response to nutrient levels [GO:0031667]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; sarcoplasmic reticulum [GO:0016529],6-phosphogluconolactonase activity [GO:0017057]; carbohydrate binding [GO:0030246]; glucose 1-dehydrogenase (NAD+) activity [GO:0047934]; glucose 1-dehydrogenase (NADP+) activity [GO:0047935]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661],GO:0003824; GO:0005783; GO:0005975; GO:0006091; GO:0016491; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08565,FUN_037566-T1,Peve_00035307,Pocillopora_meandrina_HIv1___RNAseq.g1582.t1,three_way,73.695,FUN_037566-T1,P49614,,,,,51.9,505.0,4.3e-146,519.6,sp|P49614|HEXB_FELCA Beta-hexosaminidase subunit beta OS=Felis catus OX=9685 GN=HEXB PE=2 SV=2,,,,,,
OG_08566,FUN_037567-T1,Peve_00035306,Pocillopora_meandrina_HIv1___RNAseq.g1583.t1,three_way,65.91883333333334,FUN_037567-T1,Q6DDX3,,,,,42.9,77.0,8.7e-12,72.8,sp|Q6DDX3|F19XB_XENLA Protein FAM199X-B OS=Xenopus laevis OX=8355 GN=fam199x-b PE=2 SV=1,,,,,,
OG_08567,FUN_037568-T1,Peve_00035302,Pocillopora_meandrina_HIv1___RNAseq.g1585.t1,three_way,85.8415,FUN_037568-T1,A7SFP1,,,,,81.5,578.0,2.3e-41,171.8,sp|A7SFP1|SHOC2_NEMVE Leucine-rich repeat protein soc-2 homolog OS=Nematostella vectensis OX=45351 GN=v1g189306 PE=3 SV=1,,,,,,
OG_08568,FUN_037569-T1,Peve_00035301,Pocillopora_meandrina_HIv1___RNAseq.g1586.t1,three_way,72.47983333333333,FUN_037569-T1,Q9D168,,,,,31.7,259.0,2.5000000000000002e-22,107.8,sp|Q9D168|INT12_MOUSE Integrator complex subunit 12 OS=Mus musculus OX=10090 GN=Ints12 PE=1 SV=1,,,,,,
OG_08569,FUN_037571-T1,Peve_00035300,Pocillopora_meandrina_HIv1___RNAseq.g1588.t1,three_way,37.914,,,,,,,,,,,,,,,,,
OG_08570,FUN_037572-T1,Peve_00035299,Pocillopora_meandrina_HIv1___RNAseq.g1589.t1,three_way,74.71266666666666,,,,,,,,,,,,,,,,,
OG_08571,FUN_037573-T1,Peve_00035298,Pocillopora_meandrina_HIv1___RNAseq.g1590.t1,three_way,98.75133333333332,FUN_037573-T1,O42586,,,,,85.2,405.0,2.1000000000000001e-196,686.4,sp|O42586|PR6AB_XENLA 26S proteasome regulatory subunit 6A-B OS=Xenopus laevis OX=8355 GN=psmc3-b PE=2 SV=1,,,,,,
OG_08572,FUN_037574-T1,Peve_00035297,Pocillopora_meandrina_HIv1___RNAseq.g1591.t2,three_way,50.35733333333334,,,,,,,,,,,,,,,,,
OG_08573,FUN_037584-T1,Peve_00035296,Pocillopora_meandrina_HIv1___TS.g22988.t1,three_way,76.06266666666667,FUN_037584-T1,Q9D0K0,TBCD7_MOUSE,,TBC1 domain family member 7,Mus musculus (Mouse),42.4,295.0,1.1e-58,228.4,sp|Q9D0K0|TBCD7_MOUSE TBC1 domain family member 7 OS=Mus musculus OX=10090 GN=Tbc1d7 PE=1 SV=1,GO:0005096; GO:0005765; GO:0005829; GO:0009267; GO:0031267; GO:0031398; GO:0031410; GO:0032007; GO:0033596; GO:0036064; GO:0070848; GO:0090630; GO:1902018; GO:1904262,activation of GTPase activity [GO:0090630]; cellular response to starvation [GO:0009267]; negative regulation of cilium assembly [GO:1902018]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of protein ubiquitination [GO:0031398]; response to growth factor [GO:0070848],ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; TSC1-TSC2 complex [GO:0033596],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005815; GO:0005829; GO:0031410; GO:0043226; GO:0098772,microtubule organizing center; cytosol; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08574,FUN_037585-T1,Peve_00035295,Pocillopora_meandrina_HIv1___RNAseq.g1593.t1,three_way,55.684666666666665,FUN_037585-T1,Q6AY61,,,,,27.9,272.0,1.1e-15,85.5,sp|Q6AY61|PRS23_RAT Serine protease 23 OS=Rattus norvegicus OX=10116 GN=Prss23 PE=2 SV=1,,,,,,
OG_08575,FUN_037586-T1,Peve_00035294,Pocillopora_meandrina_HIv1___RNAseq.g1594.t1,three_way,57.32,FUN_037586-T1,Q2TBA3,MALT1_MOUSE,,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog (EC 3.4.22.-) (Paracaspase),Mus musculus (Mouse),30.2,394.0,3.9e-35,151.4,sp|Q2TBA3|MALT1_MOUSE Mucosa-associated lymphoid tissue lymphoma translocation protein 1 homolog OS=Mus musculus OX=10090 GN=Malt1 PE=1 SV=2,GO:0001650; GO:0001923; GO:0002020; GO:0002096; GO:0002726; GO:0004175; GO:0004197; GO:0004842; GO:0005829; GO:0006508; GO:0009620; GO:0019209; GO:0031663; GO:0032449; GO:0032731; GO:0032743; GO:0042098; GO:0042113; GO:0042802; GO:0042981; GO:0043123; GO:0045087; GO:0048471; GO:0050852; GO:0050856; GO:0050870; GO:0051168; GO:0051603; GO:0061133; GO:0071222; GO:2000321,B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; cellular response to lipopolysaccharide [GO:0071222]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; nuclear export [GO:0051168]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],CBM complex [GO:0032449]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; perinuclear region of cytoplasm [GO:0048471]; polkadots [GO:0002096],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activator activity [GO:0061133]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; kinase activator activity [GO:0019209]; protease binding [GO:0002020]; ubiquitin-protein transferase activity [GO:0004842],GO:0002376; GO:0003824; GO:0005829; GO:0006913; GO:0016740; GO:0016787; GO:0030154; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; cytosol; nucleocytoplasmic transport; transferase activity; hydrolase activity; cell differentiation; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08576,FUN_037588-T1,Peve_00035293,Pocillopora_meandrina_HIv1___RNAseq.g1595.t1,three_way,69.3425,FUN_037588-T1,P38935,SMBP2_HUMAN,,DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2),Homo sapiens (Human),52.6,831.0,1.4e-215,751.1,sp|P38935|SMBP2_HUMAN DNA-binding protein SMUBP-2 OS=Homo sapiens OX=9606 GN=IGHMBP2 PE=1 SV=3,GO:0000049; GO:0003677; GO:0003678; GO:0003697; GO:0003723; GO:0003727; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008094; GO:0008186; GO:0008270; GO:0016020; GO:0016604; GO:0016887; GO:0030424; GO:0030426; GO:0032574; GO:0036121; GO:0042802; GO:0043022; GO:0043139; GO:0140296; GO:1990904,,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],"5'-3' DNA helicase activity [GO:0043139]; 5'-3' RNA helicase activity [GO:0032574]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent activity, acting on RNA [GO:0008186]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA helicase activity [GO:0036121]; general transcription initiation factor binding [GO:0140296]; identical protein binding [GO:0042802]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08577,FUN_037589-T1,Peve_00035292,Pocillopora_meandrina_HIv1___RNAseq.g1596.t1,three_way,82.638,FUN_037589-T1,P70032,,,,,57.4,608.0,4.1e-204,712.6,sp|P70032|PLK1_XENLA Serine/threonine-protein kinase PLK1 OS=Xenopus laevis OX=8355 GN=plk1 PE=1 SV=1,,,,,,
OG_08578,FUN_037681-T1,Peve_00042426,Pocillopora_meandrina_HIv1___RNAseq.g1611.t1,three_way,55.60116666666666,,,,,,,,,,,,,,,,,
OG_08579,FUN_037682-T1,Peve_00042425,Pocillopora_meandrina_HIv1___RNAseq.g1612.t1,three_way,55.28383333333333,,,,,,,,,,,,,,,,,
OG_08580,FUN_037683-T1,Peve_00042424,Pocillopora_meandrina_HIv1___RNAseq.g1613.t1,three_way,49.037333333333336,,,,,,,,,,,,,,,,,
OG_08581,FUN_037684-T1,Peve_00042423,Pocillopora_meandrina_HIv1___RNAseq.g1614.t1,three_way,85.39283333333333,FUN_037684-T1,Q6PFM0,JMJD6_DANRE,,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR) (zfpsr),Danio rerio (Zebrafish) (Brachydanio rerio),67.4,340.0,2.6e-143,510.0,sp|Q6PFM0|JMJD6_DANRE Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 OS=Danio rerio OX=7955 GN=jmjd6 PE=2 SV=2,GO:0002040; GO:0003727; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006397; GO:0006909; GO:0008380; GO:0018395; GO:0030154; GO:0032452; GO:0033746; GO:0033749; GO:0046872; GO:0048024; GO:0051260; GO:0070815; GO:0106140,"cell differentiation [GO:0030154]; mRNA processing [GO:0006397]; peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine [GO:0018395]; phagocytosis [GO:0006909]; protein homooligomerization [GO:0051260]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sprouting angiogenesis [GO:0002040]",cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone demethylase activity [GO:0032452]; histone H3R2 demethylase activity [GO:0033746]; histone H4R3 demethylase activity [GO:0033749]; metal ion binding [GO:0046872]; P-TEFb complex binding [GO:0106140]; peptidyl-lysine 5-dioxygenase activity [GO:0070815]; single-stranded RNA binding [GO:0003727],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016071; GO:0016192; GO:0016491; GO:0030154; GO:0043226; GO:0065003; GO:0140096,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mRNA metabolic process; vesicle-mediated transport; oxidoreductase activity; cell differentiation; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_08582,FUN_037686-T1,Peve_00042420,Pocillopora_meandrina_HIv1___TS.g23014.t1,three_way,56.54033333333333,FUN_037686-T1,G5EFS2,MSI1H_CAEEL,,RNA-binding protein Musashi homolog 1 (Musashi-1),Caenorhabditis elegans,43.9,214.0,2.1000000000000005e-44,181.4,sp|G5EFS2|MSI1H_CAEEL RNA-binding protein Musashi homolog 1 OS=Caenorhabditis elegans OX=6239 GN=msi-1 PE=1 SV=1,GO:0003729; GO:0005737; GO:0006417; GO:0043204; GO:0050877,nervous system process [GO:0050877]; regulation of translation [GO:0006417],cytoplasm [GO:0005737]; perikaryon [GO:0043204],mRNA binding [GO:0003729],GO:0003723; GO:0050877,RNA binding; nervous system process
OG_08583,FUN_037687-T1,Peve_00042417,Pocillopora_meandrina_HIv1___RNAseq.g1616.t1,three_way,68.82533333333333,FUN_037687-T1,A0A0G2KQY6,S39AE_DANRE,,Metal cation symporter ZIP14 (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14),Danio rerio (Zebrafish) (Brachydanio rerio),38.7,473.0,2.6e-78,294.3,sp|A0A0G2KQY6|S39AE_DANRE Metal cation symporter ZIP14 OS=Danio rerio OX=7955 GN=slc39a14 PE=2 SV=1,GO:0005381; GO:0005384; GO:0005385; GO:0005765; GO:0005886; GO:0006829; GO:0006882; GO:0015086; GO:0015296; GO:0016323; GO:0016324; GO:0030003; GO:0031901; GO:0031902; GO:0032869; GO:0033212; GO:0034755; GO:0045745; GO:0055071; GO:0071333; GO:0071421; GO:0071577; GO:0071578; GO:0098662; GO:0098739; GO:0140410,cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; import across plasma membrane [GO:0098739]; inorganic cation transmembrane transport [GO:0098662]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; iron import into cell [GO:0033212]; iron ion transmembrane transport [GO:0034755]; manganese ion homeostasis [GO:0055071]; manganese ion transmembrane transport [GO:0071421]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],cadmium ion transmembrane transporter activity [GO:0015086]; iron ion transmembrane transporter activity [GO:0005381]; manganese ion transmembrane transporter activity [GO:0005384]; monoatomic anion:monoatomic cation symporter activity [GO:0015296]; monoatomic cation:bicarbonate symporter activity [GO:0140410]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_08584,FUN_037688-T1,Peve_00001248,Pocillopora_meandrina_HIv1___RNAseq.g1581.t1,three_way,87.84166666666667,FUN_037688-T1,Q9VQG2,APH1_DROME,,Gamma-secretase subunit Aph-1 (Presenilin-stabilization factor),Drosophila melanogaster (Fruit fly),49.6,228.0,9.999999999999999e-55,214.9,sp|Q9VQG2|APH1_DROME Gamma-secretase subunit Aph-1 OS=Drosophila melanogaster OX=7227 GN=aph-1 PE=1 SV=1,GO:0005770; GO:0005783; GO:0005886; GO:0006509; GO:0007219; GO:0007220; GO:0016485; GO:0030674; GO:0034205; GO:0035333; GO:0050821; GO:0055037; GO:0070765,"amyloid-beta formation [GO:0034205]; membrane protein ectodomain proteolysis [GO:0006509]; Notch receptor processing [GO:0007220]; Notch receptor processing, ligand-dependent [GO:0035333]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; protein stabilization [GO:0050821]",endoplasmic reticulum [GO:0005783]; gamma-secretase complex [GO:0070765]; late endosome [GO:0005770]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],protein-macromolecule adaptor activity [GO:0030674],GO:0005768; GO:0005783; GO:0005886; GO:0031410; GO:0043226; GO:0051604; GO:0060090,endosome; endoplasmic reticulum; plasma membrane; cytoplasmic vesicle; organelle; protein maturation; molecular adaptor activity
OG_08585,FUN_037689-T1,Peve_00001249,Pocillopora_meandrina_HIv1___RNAseq.g1580.t1,three_way,63.23266666666667,FUN_037689-T1,Q5XI67,FBX30_RAT,,F-box only protein 30,Rattus norvegicus (Rat),28.3,703.0,2.9000000000000007e-71,271.2,sp|Q5XI67|FBX30_RAT F-box only protein 30 OS=Rattus norvegicus OX=10116 GN=Fbxo30 PE=1 SV=1,GO:0006325; GO:0007059; GO:0008270; GO:0010467; GO:0016567; GO:0030261; GO:0061630,chromatin organization [GO:0006325]; chromosome condensation [GO:0030261]; chromosome segregation [GO:0007059]; gene expression [GO:0010467]; protein ubiquitination [GO:0016567],,ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0006325; GO:0007059; GO:0016740; GO:0140096,"catalytic activity; chromatin organization; chromosome segregation; transferase activity; catalytic activity, acting on a protein"
OG_08586,FUN_037690-T1,Peve_00001242,Pocillopora_meandrina_HIv1___RNAseq.g1579.t1,three_way,69.16366666666667,FUN_037690-T1,Q8TEM1,PO210_HUMAN,,Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa),Homo sapiens (Human),34.5,1584.0,2.7e-254,880.9,sp|Q8TEM1|PO210_HUMAN Nuclear pore membrane glycoprotein 210 OS=Homo sapiens OX=9606 GN=NUP210 PE=1 SV=3,GO:0005635; GO:0005643; GO:0005789; GO:0006913; GO:0015031; GO:0016020; GO:0031965; GO:0051028,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643],,GO:0005635; GO:0006913,nuclear envelope; nucleocytoplasmic transport
OG_08587,FUN_037696-T1,Peve_00044128,Pocillopora_meandrina_HIv1___RNAseq.g1356.t1,three_way,59.11833333333333,FUN_037696-T1,P79113,,,,,28.7,310.0,4.3e-15,84.0,sp|P79113|NPY2R_BOVIN Neuropeptide Y receptor type 2 OS=Bos taurus OX=9913 GN=NPY2R PE=2 SV=1,,,,,,
OG_08588,FUN_037697-T1,Peve_00044127,Pocillopora_meandrina_HIv1___RNAseq.g1357.t1,three_way,66.68333333333334,FUN_037697-T1,Q6NZQ2,DDX31_MOUSE,,ATP-dependent DNA helicase DDX31 (EC 5.6.2.-) (DEAD box protein 31) (Probable ATP-dependent RNA helicase DDX31) (EC 3.6.4.13),Mus musculus (Mouse),46.4,686.0,1.2e-148,528.5,sp|Q6NZQ2|DDX31_MOUSE ATP-dependent DNA helicase DDX31 OS=Mus musculus OX=10090 GN=Ddx31 PE=2 SV=2,GO:0003723; GO:0003724; GO:0005524; GO:0005730; GO:0005794; GO:0016887; GO:0042254,ribosome biogenesis [GO:0042254],Golgi apparatus [GO:0005794]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005730; GO:0005794; GO:0016787; GO:0016853; GO:0042254; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleolus; Golgi apparatus; hydrolase activity; isomerase activity; ribosome biogenesis; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08589,FUN_037698-T1,Peve_00044125,Pocillopora_meandrina_HIv1___TS.g22767.t1b,three_way,68.75333333333333,FUN_037698-T1,F1QC45,XRP2_DANRE,,Protein XRP2,Danio rerio (Zebrafish) (Brachydanio rerio),56.6,325.0,8.6e-84,312.0,sp|F1QC45|XRP2_DANRE Protein XRP2 OS=Danio rerio OX=7955 GN=rp2 PE=1 SV=1,GO:0001947; GO:0005096; GO:0005525; GO:0005929; GO:0006892; GO:0010842; GO:0015031; GO:0035845; GO:0042461; GO:0045494; GO:0048793; GO:0060041; GO:0061371; GO:1990075,determination of heart left/right asymmetry [GO:0061371]; heart looping [GO:0001947]; photoreceptor cell development [GO:0042461]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; post-Golgi vesicle-mediated transport [GO:0006892]; pronephros development [GO:0048793]; protein transport [GO:0015031]; retina development in camera-type eye [GO:0060041]; retina layer formation [GO:0010842],cilium [GO:0005929]; periciliary membrane compartment [GO:1990075],GTP binding [GO:0005525]; GTPase activator activity [GO:0005096],GO:0005929; GO:0016192; GO:0043226; GO:0048856; GO:0098772,cilium; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_08590,FUN_037699-T1,Peve_00044124,Pocillopora_meandrina_HIv1___TS.g22767.t1a,three_way,74.662,FUN_037699-T1,A4IH88,,,,,32.0,616.0,2.3e-66,255.0,sp|A4IH88|K2013_XENTR Uncharacterized protein KIAA2013 homolog OS=Xenopus tropicalis OX=8364 PE=2 SV=1,,,,,,
OG_08591,FUN_037700-T1,Peve_00044123,Pocillopora_meandrina_HIv1___RNAseq.g1360.t1,three_way,70.3135,FUN_037700-T1,Q6DCC6,,,,,41.9,434.0,6.4e-86,319.7,sp|Q6DCC6|GTPB6_XENLA Putative GTP-binding protein 6 OS=Xenopus laevis OX=8355 GN=gtpbp6 PE=2 SV=1,,,,,,
OG_08592,FUN_037701-T1,Peve_00027706,Pocillopora_meandrina_HIv1___RNAseq.g1400.t1,three_way,82.70333333333333,FUN_037701-T1,Q9U5N1,,,,,62.8,382.0,5.5e-140,498.8,sp|Q9U5N1|VATC_MANSE V-type proton ATPase subunit C OS=Manduca sexta OX=7130 PE=2 SV=1,,,,,,
OG_08593,FUN_037702-T1,Peve_00027442,Pocillopora_meandrina_HIv1___RNAseq.g1401.t1,three_way,72.17066666666668,FUN_037702-T1,Q96BX8,,,,,62.1,211.0,2.5e-79,296.6,sp|Q96BX8|MOB3A_HUMAN MOB kinase activator 3A OS=Homo sapiens OX=9606 GN=MOB3A PE=1 SV=1,,,,,,
OG_08594,FUN_037709-T1,Peve_00027437,Pocillopora_meandrina_HIv1___RNAseq.g1402.t1,three_way,58.09033333333333,FUN_037709-T1,E7F1U2,DNMBP_DANRE,,Dynamin-binding protein (Scaffold protein Tuba),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,728.0,7.8e-103,377.5,sp|E7F1U2|DNMBP_DANRE Dynamin-binding protein OS=Danio rerio OX=7955 GN=dnmbp PE=2 SV=1,GO:0001822; GO:0005085; GO:0005737; GO:0005794; GO:0005795; GO:0005856; GO:0005911; GO:0035556; GO:0045202; GO:0060271; GO:0098793,cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; presynapse [GO:0098793]; synapse [GO:0045202],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005794; GO:0005856; GO:0043226; GO:0044782; GO:0048856; GO:0098772,Golgi apparatus; cytoskeleton; organelle; cilium organization; anatomical structure development; molecular function regulator activity
OG_08595,FUN_037710-T1,Peve_00027436,Pocillopora_meandrina_HIv1___RNAseq.g1403.t1,three_way,86.10866666666666,,,,,,,,,,,,,,,,,
OG_08596,FUN_037738-T1,Peve_00014190,Pocillopora_meandrina_HIv1___RNAseq.g26602.t1,three_way,53.47566666666667,FUN_037738-T1,Q76KP1,B4GN4_HUMAN,,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)",Homo sapiens (Human),37.1,286.0,2.8e-51,204.9,sp|Q76KP1|B4GN4_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=B4GALNT4 PE=1 SV=1,GO:0008376; GO:0032580; GO:0033842,,Golgi cisterna membrane [GO:0032580],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_08597,FUN_037739-T1,Peve_00037364,Pocillopora_meandrina_HIv1___RNAseq.g1330.t1,three_way,79.21866666666666,FUN_037739-T1,Q8T293,,,,,40.8,353.0,1.5e-70,268.1,sp|Q8T293|DIAC2_DICDI Probable di-N-acetylchitobiase 2 OS=Dictyostelium discoideum OX=44689 GN=ctbs2 PE=3 SV=1,,,,,,
OG_08598,FUN_037740-T1,Peve_00037367,Pocillopora_meandrina_HIv1___RNAseq.g1331.t2,three_way,82.32733333333333,,,,,,,,,,,,,,,,,
OG_08599,FUN_037741-T1,Peve_00037358,Pocillopora_meandrina_HIv1___RNAseq.g1334.t1,three_way,67.00733333333334,,,,,,,,,,,,,,,,,
OG_08600,FUN_037743-T1,Peve_00037357,Pocillopora_meandrina_HIv1___RNAseq.g1333.t1,three_way,65.298,FUN_037743-T1,Q9EP82,,,,,31.0,355.0,1.4e-37,158.7,sp|Q9EP82|WDR4_MOUSE tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 OS=Mus musculus OX=10090 GN=Wdr4 PE=1 SV=2,,,,,,
OG_08601,FUN_037744-T1,Peve_00037368,Pocillopora_meandrina_HIv1___RNAseq.g1332.t1,three_way,88.86283333333334,FUN_037744-T1,Q5ZI08,SPT5H_CHICK,,Transcription elongation factor SPT5 (DRB sensitivity-inducing factor large subunit) (DSIF large subunit),Gallus gallus (Chicken),57.9,1017.0,1.5e-258,894.0,sp|Q5ZI08|SPT5H_CHICK Transcription elongation factor SPT5 OS=Gallus gallus OX=9031 GN=SUPT5H PE=2 SV=1,GO:0003729; GO:0006357; GO:0006368; GO:0032044; GO:0032784; GO:0140673,regulation of DNA-templated transcription elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation by RNA polymerase II [GO:0006368]; transcription elongation-coupled chromatin remodeling [GO:0140673],DSIF complex [GO:0032044],mRNA binding [GO:0003729],GO:0003723; GO:0006325; GO:0006355,RNA binding; chromatin organization; regulation of DNA-templated transcription
OG_08602,FUN_037745-T1,Peve_00037361,Pocillopora_meandrina_HIv1___RNAseq.g1335.t1,three_way,75.479,FUN_037745-T1,Q91X20,ASH2L_MOUSE,,Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein),Mus musculus (Mouse),60.0,345.0,3e-116,420.2,sp|Q91X20|ASH2L_MOUSE Set1/Ash2 histone methyltransferase complex subunit ASH2 OS=Mus musculus OX=10090 GN=Ash2l PE=1 SV=1,GO:0000791; GO:0003677; GO:0005634; GO:0005654; GO:0006974; GO:0008270; GO:0035097; GO:0045815; GO:0045944; GO:0048188; GO:0071339,DNA damage response [GO:0006974]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription initiation-coupled chromatin remodeling [GO:0045815],euchromatin [GO:0000791]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; organelle
OG_08603,FUN_037746-T1,Peve_00037365,Pocillopora_meandrina_HIv1___RNAseq.g1336.t1,three_way,86.29599999999999,FUN_037746-T1,P12003,,,,,38.8,1139.0,2.9999999999999998e-182,640.6,sp|P12003|VINC_CHICK Vinculin OS=Gallus gallus OX=9031 GN=VCL PE=1 SV=4,,,,,,
OG_08604,FUN_037750-T1,Peve_00038308,Pocillopora_meandrina_HIv1___TS.g22747.t1,three_way,55.69183333333333,FUN_037750-T1,Q5HYC2,,,,,33.3,420.0,9.399999999999999e-55,217.6,sp|Q5HYC2|BRD10_HUMAN Uncharacterized bromodomain-containing protein 10 OS=Homo sapiens OX=9606 GN=BRD10 PE=1 SV=2,,,,,,
OG_08605,FUN_037751-T1,Peve_00038307,Pocillopora_meandrina_HIv1___RNAseq.g1339.t1,three_way,62.05533333333333,FUN_037751-T1,Q13445,,,,,33.2,217.0,3.7e-27,123.2,sp|Q13445|TMED1_HUMAN Transmembrane emp24 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TMED1 PE=1 SV=1,,,,,,
OG_08606,FUN_037752-T1,Peve_00038306,Pocillopora_meandrina_HIv1___RNAseq.g1340.t1,three_way,82.766,FUN_037752-T1,A2BGM5,FOXN4_DANRE,,Forkhead box protein N4,Danio rerio (Zebrafish) (Brachydanio rerio),68.4,117.0,7.3e-42,172.9,sp|A2BGM5|FOXN4_DANRE Forkhead box protein N4 OS=Danio rerio OX=7955 GN=foxn4 PE=1 SV=1,GO:0000981; GO:0000987; GO:0001947; GO:0003170; GO:0003682; GO:0003700; GO:0005634; GO:0006355; GO:0008016; GO:0010842; GO:0035881; GO:0036302; GO:0043565; GO:0045893; GO:0045944; GO:0060579,amacrine cell differentiation [GO:0035881]; atrioventricular canal development [GO:0036302]; heart looping [GO:0001947]; heart valve development [GO:0003170]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of heart contraction [GO:0008016]; retina layer formation [GO:0010842]; ventral spinal cord interneuron fate commitment [GO:0060579],nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_08607,FUN_037753-T1,Peve_00038304,Pocillopora_meandrina_HIv1___RNAseq.g1341.t1,three_way,59.559333333333335,FUN_037753-T1,A7SKJ3,DPH2_NEMVE,,2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2),Nematostella vectensis (Starlet sea anemone),44.1,313.0,3.2000000000000008e-65,250.4,sp|A7SKJ3|DPH2_NEMVE 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 OS=Nematostella vectensis OX=45351 GN=dph2 PE=3 SV=1,GO:0017183; GO:0046872; GO:0051539; GO:0090560; GO:0120513,protein histidyl modification to diphthamide [GO:0017183],2-(3-amino-3-carboxypropyl)histidine synthase complex [GO:0120513],"2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]",GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_08608,FUN_037755-T1,Peve_00038299,Pocillopora_meandrina_HIv1___RNAseq.g1343.t1,three_way,92.71533333333332,FUN_037755-T1,Q4KLA0,,,,,64.0,267.0,6.3e-101,368.6,sp|Q4KLA0|CCNC_XENLA Cyclin-C OS=Xenopus laevis OX=8355 GN=ccnc PE=2 SV=1,,,,,,
OG_08609,FUN_037756-T1,Peve_00014342,Pocillopora_meandrina_HIv1___RNAseq.27166_t,three_way,81.311,FUN_037756-T1,Q9D3W1,RSP14_MOUSE,,Radial spoke head 14 homolog (Rhabdoid tumor deletion region protein 1),Mus musculus (Mouse),49.6,224.0,8.4e-52,205.3,sp|Q9D3W1|RSP14_MOUSE Radial spoke head 14 homolog OS=Mus musculus OX=10090 GN=Rsph14 PE=1 SV=1,GO:0001534; GO:0003351; GO:0005576; GO:0007618; GO:0030317; GO:0036126; GO:0097729,epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618],9+2 motile cilium [GO:0097729]; extracellular region [GO:0005576]; radial spoke [GO:0001534]; sperm flagellum [GO:0036126],,GO:0005576; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,extracellular region; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_08610,FUN_037757-T1,Peve_00014341,Pocillopora_meandrina_HIv1___RNAseq.g1500.t1,three_way,54.698166666666665,FUN_037757-T1,Q3KQ71,,,,,36.7,294.0,1.2e-30,135.2,sp|Q3KQ71|SCNM1_XENLA Sodium channel modifier 1 OS=Xenopus laevis OX=8355 GN=scnm1 PE=2 SV=1,,,,,,
OG_08611,FUN_037758-T1,Peve_00014340,Pocillopora_meandrina_HIv1___RNAseq.g1498.t1,three_way,47.662333333333336,,,,,,,,,,,,,,,,,
OG_08612,FUN_037759-T1,Peve_00014339,Pocillopora_meandrina_HIv1___RNAseq.g1497.t1,three_way,74.42666666666666,,,,,,,,,,,,,,,,,
OG_08613,FUN_037760-T1,Peve_00014335,Pocillopora_meandrina_HIv1___RNAseq.g1495.t2c,three_way,43.376333333333335,,,,,,,,,,,,,,,,,
OG_08614,FUN_037761-T1,Peve_00014333,Pocillopora_meandrina_HIv1___RNAseq.g1495.t2a,three_way,37.405,,,,,,,,,,,,,,,,,
OG_08615,FUN_037763-T1,Peve_00014331,Pocillopora_meandrina_HIv1___RNAseq.g1494.t1,three_way,49.86833333333333,FUN_037763-T1,Q5ZJX4,,,,,57.6,92.0,4.4e-26,120.2,sp|Q5ZJX4|RBM38_CHICK RNA-binding protein 38 OS=Gallus gallus OX=9031 GN=RBM38 PE=2 SV=1,,,,,,
OG_08616,FUN_037765-T1,Peve_00014329,Pocillopora_meandrina_HIv1___RNAseq.g1491.t1,three_way,56.507,,,,,,,,,,,,,,,,,
OG_08617,FUN_037768-T1,Peve_00014328,Pocillopora_meandrina_HIv1___RNAseq.g1480.t1,three_way,79.92966666666668,FUN_037768-T1,O35552,F263_RAT,,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain-type isozyme) (RB2K) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",Rattus norvegicus (Rat),53.4,440.0,1.1000000000000001e-130,468.4,"sp|O35552|F263_RAT 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 OS=Rattus norvegicus OX=10116 GN=Pfkfb3 PE=2 SV=1",GO:0003873; GO:0004331; GO:0005524; GO:0005654; GO:0005829; GO:0006000; GO:0006003; GO:0006096; GO:0006110; GO:0006915; GO:0010001; GO:0061744,"apoptotic process [GO:0006915]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; glial cell differentiation [GO:0010001]; glycolytic process [GO:0006096]; motor behavior [GO:0061744]; regulation of glycolytic process [GO:0006110]",cytosol [GO:0005829]; nucleoplasm [GO:0005654],"6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]",GO:0003824; GO:0005654; GO:0005829; GO:0005975; GO:0006091; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0055086; GO:1901135,catalytic activity; nucleoplasm; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; programmed cell death; transferase activity; hydrolase activity; cell differentiation; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08618,FUN_037769-T1,Peve_00014327,Pocillopora_meandrina_HIv1___RNAseq.g1481.t1,three_way,74.75533333333334,FUN_037769-T1,O95147,,,,,47.9,167.0,1.2999999999999998e-43,177.6,sp|O95147|DUS14_HUMAN Dual specificity protein phosphatase 14 OS=Homo sapiens OX=9606 GN=DUSP14 PE=1 SV=1,,,,,,
OG_08619,FUN_037772-T1,Peve_00014348,Pocillopora_meandrina_HIv1___RNAseq.g1505.t1,three_way,75.424,FUN_037772-T1,Q32P28,P3H1_HUMAN,,Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1),Homo sapiens (Human),33.7,692.0,1e-99,365.9,sp|Q32P28|P3H1_HUMAN Prolyl 3-hydroxylase 1 OS=Homo sapiens OX=9606 GN=P3H1 PE=1 SV=2,GO:0005506; GO:0005634; GO:0005737; GO:0005783; GO:0005788; GO:0006457; GO:0008285; GO:0010976; GO:0016020; GO:0018126; GO:0019797; GO:0030199; GO:0030278; GO:0030308; GO:0031418; GO:0032963; GO:0032991; GO:0050708; GO:0050821; GO:0060348; GO:0061077; GO:0070062; GO:1901874,bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of post-translational protein modification [GO:1901874]; positive regulation of neuron projection development [GO:0010976]; protein folding [GO:0006457]; protein hydroxylation [GO:0018126]; protein stabilization [GO:0050821]; regulation of ossification [GO:0030278]; regulation of protein secretion [GO:0050708],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 3-dioxygenase activity [GO:0019797],GO:0003824; GO:0005634; GO:0005783; GO:0006457; GO:0016491; GO:0030198; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; endoplasmic reticulum; protein folding; oxidoreductase activity; extracellular matrix organization; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08620,FUN_037775-T1,Peve_00040704,Pocillopora_meandrina_HIv1___RNAseq.g1512.t1,three_way,79.25166666666667,FUN_037775-T1,P48630,,,,,49.3,377.0,7.5e-100,365.5,"sp|P48630|FD6E1_SOYBN Omega-6 fatty acid desaturase, endoplasmic reticulum isozyme 1 OS=Glycine max OX=3847 GN=FAD2-1 PE=2 SV=1",,,,,,
OG_08621,FUN_037776-T1,Peve_00040706,Pocillopora_meandrina_HIv1___RNAseq.g1509.t1,three_way,81.93966666666667,,,,,,,,,,,,,,,,,
OG_08622,FUN_037777-T1,Peve_00040703,Pocillopora_meandrina_HIv1___RNAseq.g1513.t1,three_way,63.26116666666667,FUN_037777-T1,B3EWZ5,,,,,36.2,696.0,3e-109,399.1,sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_08623,FUN_037778-T1,Peve_00040702,Pocillopora_meandrina_HIv1___RNAseq.g1514.t1,three_way,68.98816666666667,,,,,,,,,,,,,,,,,
OG_08624,FUN_037784-T1,Peve_00026141,Pocillopora_meandrina_HIv1___RNAseq.g1520.t1,three_way,78.41366666666667,FUN_037784-T1,Q9VCA2,,,,,27.9,524.0,4.1e-58,227.3,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_08625,FUN_037791-T1,Peve_00026138,Pocillopora_meandrina_HIv1___RNAseq.g10947.t1,three_way,61.035,FUN_037791-T1,Q9Z0E8,,,,,29.9,532.0,1.3e-54,215.7,sp|Q9Z0E8|S22A5_MOUSE Organic cation/carnitine transporter 2 OS=Mus musculus OX=10090 GN=Slc22a5 PE=1 SV=1,,,,,,
OG_08626,FUN_037794-T1,Peve_00026137,Pocillopora_meandrina_HIv1___RNAseq.g1554.t1,three_way,80.52866666666667,FUN_037794-T1,P08836,,,,,56.7,275.0,4.8e-89,329.3,sp|P08836|FPPS_CHICK Farnesyl pyrophosphate synthase OS=Gallus gallus OX=9031 GN=FDPS PE=1 SV=2,,,,,,
OG_08627,FUN_037795-T1,Peve_00026136,Pocillopora_meandrina_HIv1___RNAseq.g1555.t3,three_way,71.708,FUN_037795-T1,P51960,,,,,33.6,758.0,4.3e-85,317.4,sp|P51960|MYBA_MOUSE Myb-related protein A OS=Mus musculus OX=10090 GN=Mybl1 PE=1 SV=2,,,,,,
OG_08628,FUN_037796-T1,Peve_00026135,Pocillopora_meandrina_HIv1___RNAseq.g1556.t1,three_way,91.083,FUN_037796-T1,Q9CWF6,BBS2_MOUSE,,BBSome complex member BBS2 (Bardet-Biedl syndrome 2 protein homolog),Mus musculus (Mouse),66.9,718.0,8.9e-285,980.7,sp|Q9CWF6|BBS2_MOUSE BBSome complex member BBS2 OS=Mus musculus OX=10090 GN=Bbs2 PE=1 SV=1,GO:0005737; GO:0005902; GO:0007288; GO:0007601; GO:0008104; GO:0010467; GO:0010629; GO:0014824; GO:0016020; GO:0021756; GO:0021766; GO:0021987; GO:0030534; GO:0031514; GO:0032420; GO:0033210; GO:0033365; GO:0034451; GO:0034464; GO:0036064; GO:0038108; GO:0040015; GO:0040018; GO:0042311; GO:0043001; GO:0043005; GO:0044321; GO:0045444; GO:0045494; GO:0048854; GO:0051216; GO:0060170; GO:0060271; GO:0060296; GO:0061629; GO:1905515,adult behavior [GO:0030534]; artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; response to leptin [GO:0044321]; sperm axoneme assembly [GO:0007288]; striatum development [GO:0021756]; vasodilation [GO:0042311]; visual perception [GO:0007601],BBSome [GO:0034464]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; neuron projection [GO:0043005]; stereocilium [GO:0032420],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629],GO:0003012; GO:0003013; GO:0005815; GO:0005929; GO:0007010; GO:0016192; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0072659,muscle system process; circulatory system process; microtubule organizing center; cilium; cytoskeleton organization; vesicle-mediated transport; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein localization to plasma membrane
OG_08629,FUN_037798-T1,Peve_00026125,Pocillopora_meandrina_HIv1___RNAseq.g1558.t1,three_way,81.751,,,,,,,,,,,,,,,,,
OG_08630,FUN_037799-T1,Peve_00026124,Pocillopora_meandrina_HIv1___RNAseq.27229_t,three_way,73.94533333333334,,,,,,,,,,,,,,,,,
OG_08631,FUN_037800-T1,Peve_00026123,Pocillopora_meandrina_HIv1___RNAseq.g1560.t1,three_way,68.60266666666666,FUN_037800-T1,Q5RJA1,RFX6_DANRE,,DNA-binding protein RFX6 (Regulatory factor X 6),Danio rerio (Zebrafish) (Brachydanio rerio),47.5,482.0,3.5e-115,417.5,sp|Q5RJA1|RFX6_DANRE DNA-binding protein RFX6 OS=Danio rerio OX=7955 GN=rfx6 PE=2 SV=2,GO:0000976; GO:0000978; GO:0000981; GO:0003309; GO:0003310; GO:0003311; GO:0005634; GO:0006357; GO:0031018; GO:0035774; GO:0042593; GO:0045893; GO:0045944; GO:0050796; GO:0090104,endocrine pancreas development [GO:0031018]; glucose homeostasis [GO:0042593]; pancreatic A cell differentiation [GO:0003310]; pancreatic D cell differentiation [GO:0003311]; pancreatic epsilon cell differentiation [GO:0090104]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; type B pancreatic cell differentiation [GO:0003309],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_08632,FUN_037801-T1,Peve_00026143,Pocillopora_meandrina_HIv1___RNAseq.g1561.t1,three_way,77.64,FUN_037801-T1,Q8INF0,GCY8E_DROME,,Soluble guanylate cyclase 88E (EC 4.6.1.2),Drosophila melanogaster (Fruit fly),41.3,620.0,2.4e-140,500.7,sp|Q8INF0|GCY8E_DROME Soluble guanylate cyclase 88E OS=Drosophila melanogaster OX=7227 GN=Gyc88E PE=1 SV=4,GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482,cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302],"guanylate cyclase complex, soluble [GO:0008074]",carbon monoxide binding [GO:0070025]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0009975; GO:0016787; GO:0016829; GO:0098772; GO:0140299,catalytic activity; GTPase activity; cyclase activity; hydrolase activity; lyase activity; molecular function regulator activity; molecular sensor activity
OG_08633,FUN_037802-T1,Peve_00026129,Pocillopora_meandrina_HIv1___RNAseq.g1562.t1,three_way,59.398,,,,,,,,,,,,,,,,,
OG_08634,FUN_037805-T1,Peve_00003981,Pocillopora_meandrina_HIv1___RNAseq.g1563.t1,three_way,73.59433333333334,FUN_037805-T1,A0JM24,,,,,32.9,347.0,7.399999999999998e-41,169.5,sp|A0JM24|NXRD1_XENTR NADP-dependent oxidoreductase domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=noxred1 PE=2 SV=1,,,,,,
OG_08635,FUN_037806-T1,Peve_00003980,Pocillopora_meandrina_HIv1___RNAseq.g1566.t1,three_way,45.65533333333333,,,,,,,,,,,,,,,,,
OG_08636,FUN_037808-T1,Peve_00003982,Pocillopora_meandrina_HIv1___RNAseq.g1570.t1,three_way,66.05983333333333,FUN_037808-T1,P51954,NEK1_MOUSE,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1),Mus musculus (Mouse),41.6,308.0,5.2e-66,253.4,sp|P51954|NEK1_MOUSE Serine/threonine-protein kinase Nek1 OS=Mus musculus OX=10090 GN=Nek1 PE=1 SV=2,GO:0001822; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0006974; GO:0007283; GO:0010212; GO:0030030; GO:0035264; GO:0046872; GO:0051301; GO:0071889; GO:0106310; GO:2000001,cell division [GO:0051301]; cell projection organization [GO:0030030]; DNA damage response [GO:0006974]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08637,FUN_037809-T1,Peve_00018926,Pocillopora_meandrina_HIv1___RNAseq.g1571.t1,three_way,92.06116666666668,FUN_037809-T1,Q99496,RING2_HUMAN,,E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (Huntingtin-interacting protein 2-interacting protein 3) (HIP2-interacting protein 3) (Protein DinG) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING finger protein BAP-1) (RING-type E3 ubiquitin transferase RING2),Homo sapiens (Human),59.6,339.0,1.6e-98,360.9,sp|Q99496|RING2_HUMAN E3 ubiquitin-protein ligase RING2 OS=Homo sapiens OX=9606 GN=RNF2 PE=1 SV=1,GO:0000122; GO:0000151; GO:0000278; GO:0000791; GO:0001702; GO:0001739; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0006338; GO:0007281; GO:0008270; GO:0009948; GO:0010467; GO:0016567; GO:0016604; GO:0031519; GO:0035102; GO:0040029; GO:0043433; GO:0061630; GO:0071339; GO:0071535; GO:0140862,anterior/posterior axis specification [GO:0009948]; chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; gastrulation with mouth forming second [GO:0001702]; gene expression [GO:0010467]; germ cell development [GO:0007281]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; euchromatin [GO:0000791]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; sex chromatin [GO:0001739]; ubiquitin ligase complex [GO:0000151],chromatin binding [GO:0003682]; histone H2AK119 ubiquitin ligase activity [GO:0140862]; RING-like zinc finger domain binding [GO:0071535]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0000278; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"mitotic cell cycle; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_08638,FUN_037810-T1,Peve_00028101,Pocillopora_meandrina_HIv1___RNAseq.g1572.t1,three_way,58.22133333333333,,,,,,,,,,,,,,,,,
OG_08639,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_08640,FUN_037825-T1,Peve_00002906,Pocillopora_meandrina_HIv1___RNAseq.g1448.t1,three_way,60.30683333333334,FUN_037825-T1,Q9QZ49,,,,,29.2,226.0,2e-11,71.2,sp|Q9QZ49|UBXN8_MOUSE UBX domain-containing protein 8 OS=Mus musculus OX=10090 GN=Ubxn8 PE=1 SV=1,,,,,,
OG_08641,FUN_037826-T1,Peve_00002905,Pocillopora_meandrina_HIv1___RNAseq.g1449.t1,three_way,85.02733333333333,FUN_037826-T1,Q9JHI5,IVD_MOUSE,,"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) (Butyryl-CoA dehydrogenase) (EC 1.3.8.1)",Mus musculus (Mouse),73.5,388.0,3.4e-169,597.0,"sp|Q9JHI5|IVD_MOUSE Isovaleryl-CoA dehydrogenase, mitochondrial OS=Mus musculus OX=10090 GN=Ivd PE=1 SV=1",GO:0005654; GO:0005739; GO:0005759; GO:0006552; GO:0008470; GO:0009083; GO:0031966; GO:0042802; GO:0050660,branched-chain amino acid catabolic process [GO:0009083]; L-leucine catabolic process [GO:0006552],mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],3-methylbutanoyl-CoA dehydrogenase activity [GO:0008470]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802],GO:0003824; GO:0005654; GO:0005739; GO:0006520; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; mitochondrion; amino acid metabolic process; oxidoreductase activity; organelle
OG_08642,FUN_037830-T1,Peve_00002898,Pocillopora_meandrina_HIv1___RNAseq.g1454.t1,three_way,64.4625,FUN_037830-T1,Q5U4T7,,,,,42.1,932.0,1.4e-163,578.6,sp|Q5U4T7|BIC1B_XENLA Protein bicaudal C homolog 1-B OS=Xenopus laevis OX=8355 GN=bicc1-b PE=2 SV=1,,,,,,
OG_08643,FUN_037834-T1,Peve_00029596,Pocillopora_meandrina_HIv1___RNAseq.g1455.t1,three_way,63.28266666666666,FUN_037834-T1,P05423,RPC4_HUMAN,,DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog),Homo sapiens (Human),40.7,413.0,3.7e-38,160.6,sp|P05423|RPC4_HUMAN DNA-directed RNA polymerase III subunit RPC4 OS=Homo sapiens OX=9606 GN=POLR3D PE=1 SV=2,GO:0003677; GO:0003682; GO:0005654; GO:0005666; GO:0005829; GO:0032728; GO:0042797; GO:0045087; GO:0045089; GO:0051607,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; tRNA transcription by RNA polymerase III [GO:0042797],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666],chromatin binding [GO:0003682]; DNA binding [GO:0003677],GO:0002376; GO:0003677; GO:0005654; GO:0005829; GO:0006351; GO:0006399; GO:0098542,immune system process; DNA binding; nucleoplasm; cytosol; DNA-templated transcription; tRNA metabolic process; defense response to other organism
OG_08644,FUN_037835-T1,Peve_00000571,Pocillopora_meandrina_HIv1___RNAseq.g1459.t1,three_way,87.0945,FUN_037835-T1,A0JNC1,CDS2_BOVIN,,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),Bos taurus (Bovine),57.1,410.0,3.5e-138,493.0,sp|A0JNC1|CDS2_BOVIN Phosphatidate cytidylyltransferase 2 OS=Bos taurus OX=9913 GN=CDS2 PE=2 SV=1,GO:0004605; GO:0005783; GO:0005789; GO:0016020; GO:0016024; GO:0140042,CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],phosphatidate cytidylyltransferase activity [GO:0004605],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_08645,FUN_037836-T1,Peve_00000570,Pocillopora_meandrina_HIv1___RNAseq.g1460.t1,three_way,80.37733333333334,FUN_037836-T1,P12004,PCNA_HUMAN,,Proliferating cell nuclear antigen (PCNA) (Cyclin),Homo sapiens (Human),65.3,259.0,5e-100,365.5,sp|P12004|PCNA_HUMAN Proliferating cell nuclear antigen OS=Homo sapiens OX=9606 GN=PCNA PE=1 SV=1,GO:0000122; GO:0000307; GO:0000701; GO:0000781; GO:0000785; GO:0001673; GO:0003682; GO:0003684; GO:0005634; GO:0005652; GO:0005654; GO:0005657; GO:0005813; GO:0006272; GO:0006287; GO:0006298; GO:0006325; GO:0007507; GO:0016604; GO:0019899; GO:0019985; GO:0030331; GO:0030337; GO:0030855; GO:0030894; GO:0030971; GO:0031297; GO:0032077; GO:0032139; GO:0032355; GO:0032405; GO:0034644; GO:0035035; GO:0042802; GO:0043596; GO:0043626; GO:0044849; GO:0044877; GO:0045739; GO:0045740; GO:0046686; GO:0070062; GO:0070182; GO:0070301; GO:0070557; GO:0071466; GO:0071548; GO:0097421; GO:1900264; GO:1902065; GO:1902990,"base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; chromatin organization [GO:0006325]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; translesion synthesis [GO:0019985]","centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]",chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; nuclear estrogen receptor binding [GO:0030331]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0022414; GO:0030154; GO:0032200; GO:0043226; GO:0048856; GO:0098772; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; reproductive process; cell differentiation; telomere organization; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA"
OG_08646,FUN_037837-T1,Peve_00000568,Pocillopora_meandrina_HIv1___RNAseq.g1461.t1,three_way,77.83033333333334,FUN_037837-T1,F6QV99,,,,,62.9,345.0,2.2e-119,430.3,sp|F6QV99|ATAD1_BOVIN Outer mitochondrial transmembrane helix translocase OS=Bos taurus OX=9913 GN=ATAD1 PE=2 SV=2,,,,,,
OG_08647,FUN_037838-T1,Peve_00000575,Pocillopora_meandrina_HIv1___TS.g22869.t1,three_way,95.46833333333332,FUN_037838-T1,P62265,,,,,88.2,152.0,1.3e-68,260.4,sp|P62265|RS14_CRIGR Small ribosomal subunit protein uS11 OS=Cricetulus griseus OX=10029 GN=RPS14 PE=2 SV=3,,,,,,
OG_08648,FUN_037843-T1,Peve_00025123,Pocillopora_meandrina_HIv1___RNAseq.g1437.t1,three_way,91.50183333333334,FUN_037843-T1,P56701,,,,,72.5,861.0,0.0,1194.9,sp|P56701|PSMD2_BOVIN 26S proteasome non-ATPase regulatory subunit 2 OS=Bos taurus OX=9913 GN=PSMD2 PE=1 SV=2,,,,,,
OG_08649,FUN_037845-T1,Peve_00032827,Pocillopora_meandrina_HIv1___RNAseq.g1431.t1,three_way,93.189,FUN_037845-T1,Q8C0E2,VP26B_MOUSE,,Vacuolar protein sorting-associated protein 26B (Vesicle protein sorting 26B),Mus musculus (Mouse),79.1,301.0,1.4e-141,503.8,sp|Q8C0E2|VP26B_MOUSE Vacuolar protein sorting-associated protein 26B OS=Mus musculus OX=10090 GN=Vps26b PE=1 SV=1,GO:0005769; GO:0005770; GO:0005829; GO:0006886; GO:0030904; GO:0042147; GO:0045335; GO:0071346; GO:0098696; GO:0098837; GO:0098842; GO:0098978,"cellular response to type II interferon [GO:0071346]; intracellular protein transport [GO:0006886]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; postsynaptic early endosome [GO:0098842]; postsynaptic recycling endosome [GO:0098837]; retromer complex [GO:0030904],,GO:0005768; GO:0005829; GO:0006886; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_08650,FUN_037846-T1,Peve_00023798,Pocillopora_meandrina_HIv1___RNAseq.g1441.t1,three_way,80.704,,,,,,,,,,,,,,,,,
OG_08651,FUN_037847-T1,Peve_00023799,Pocillopora_meandrina_HIv1___RNAseq.g1440.t1,three_way,86.37266666666667,FUN_037847-T1,P59015,VPS18_DANRE,,Vacuolar protein sorting-associated protein 18 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),45.1,987.0,1.5e-247,857.4,sp|P59015|VPS18_DANRE Vacuolar protein sorting-associated protein 18 homolog OS=Danio rerio OX=7955 GN=vps18 PE=2 SV=2,GO:0005765; GO:0005768; GO:0006886; GO:0006904; GO:0007032; GO:0007040; GO:0007634; GO:0008270; GO:0008333; GO:0015721; GO:0030674; GO:0030897; GO:0031902; GO:0043485; GO:0045176; GO:0048069; GO:0048284; GO:0048757; GO:0060036,apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; organelle fusion [GO:0048284]; pigment granule maturation [GO:0048757]; vesicle docking involved in exocytosis [GO:0006904],endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765],protein-macromolecule adaptor activity [GO:0030674]; zinc ion binding [GO:0008270],GO:0005768; GO:0006886; GO:0007040; GO:0016192; GO:0031410; GO:0043226; GO:0060090,endosome; intracellular protein transport; lysosome organization; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_08652,FUN_037848-T1,Peve_00002751,Pocillopora_meandrina_HIv1___RNAseq.g1439.t1,three_way,86.26866666666666,FUN_037848-T1,Q0VC03,,,,,47.5,394.0,1.8e-102,374.4,sp|Q0VC03|MFSD5_BOVIN Molybdate-anion transporter OS=Bos taurus OX=9913 GN=MFSD5 PE=2 SV=1,,,,,,
OG_08653,FUN_037849-T1,Peve_00002752,Pocillopora_meandrina_HIv1___RNAseq.g1438.t1,three_way,68.4055,,,,,,,,,,,,,,,,,
OG_08654,FUN_037852-T1,Peve_00024537,Pocillopora_meandrina_HIv1___RNAseq.g1422.t1,three_way,60.72333333333333,,,,,,,,,,,,,,,,,
OG_08655,FUN_037853-T1,Peve_00024528,Pocillopora_meandrina_HIv1___RNAseq.g1420.t1,three_way,82.55333333333334,FUN_037853-T1,P38487,,,,,66.5,409.0,1.9e-160,567.0,sp|P38487|CREA_BACB0 Creatinase OS=Bacillus sp. (strain B-0618) OX=69000 PE=1 SV=3,,,,,,
OG_08656,FUN_037862-T1,Peve_00022156,Pocillopora_meandrina_HIv1___RNAseq.g1427.t2,three_way,73.77433333333333,FUN_037862-T1,P30839,AL3A2_RAT,,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 4) (Fatty aldehyde dehydrogenase) (Microsomal aldehyde dehydrogenase) (msALDH),Rattus norvegicus (Rat),52.2,454.0,5.5e-140,499.2,sp|P30839|AL3A2_RAT Aldehyde dehydrogenase family 3 member A2 OS=Rattus norvegicus OX=10116 GN=Aldh3a2 PE=1 SV=1,GO:0000302; GO:0004028; GO:0004029; GO:0005737; GO:0005783; GO:0005789; GO:0006081; GO:0006631; GO:0007417; GO:0007422; GO:0008544; GO:0016020; GO:0033306; GO:0042803; GO:0043231; GO:0046292; GO:0046458; GO:0046577; GO:0050061; GO:0052814,aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; formaldehyde metabolic process [GO:0046292]; hexadecanal metabolic process [GO:0046458]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; response to reactive oxygen species [GO:0000302],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; long-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0050061]; long-chain-alcohol oxidase activity [GO:0046577]; medium-chain fatty aldehyde dehydrogenase (NAD+) activity [GO:0052814]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226; GO:0048856,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle; anatomical structure development
OG_08657,FUN_037867-T2,Peve_00024529,Pocillopora_meandrina_HIv1___RNAseq.g1412.t1,three_way,72.27066666666667,FUN_037867-T2,Q9C0H5,,,,,58.9,384.0,1.7e-133,478.4,sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2,,,,,,
OG_08657,FUN_037867-T2,Peve_00024529,Pocillopora_meandrina_HIv1___RNAseq.g1412.t1,three_way,72.27066666666667,FUN_037867-T2,Q9C0H5,,,,,68.3,82.0,2.2e-08,62.8,sp|Q9C0H5|RHG39_HUMAN Rho GTPase-activating protein 39 OS=Homo sapiens OX=9606 GN=ARHGAP39 PE=1 SV=2,,,,,,
OG_08658,FUN_037870-T1,Peve_00024531,Pocillopora_meandrina_HIv1___RNAseq.g1409.t1,three_way,93.36216666666668,FUN_037870-T1,P08642,,,,,80.5,174.0,5.3e-75,282.0,sp|P08642|RASH_CHICK GTPase HRas OS=Gallus gallus OX=9031 GN=HRAS PE=1 SV=1,,,,,,
OG_08659,FUN_037871-T1,Peve_00019039,Pocillopora_meandrina_HIv1___RNAseq.g10667.t1,three_way,64.23066666666666,FUN_037871-T1,Q9P2E2,KIF17_HUMAN,,Kinesin-like protein KIF17 (KIF3-related motor protein),Homo sapiens (Human),51.4,481.0,5.700000000000001e-124,446.4,sp|Q9P2E2|KIF17_HUMAN Kinesin-like protein KIF17 OS=Homo sapiens OX=9606 GN=KIF17 PE=1 SV=3,GO:0001750; GO:0001917; GO:0005524; GO:0005737; GO:0005815; GO:0005829; GO:0005871; GO:0005874; GO:0005929; GO:0005930; GO:0008017; GO:0008574; GO:0015031; GO:0016192; GO:0016887; GO:0030030; GO:0032391; GO:0032839; GO:0036064; GO:0043005; GO:0098794; GO:0098971; GO:1990075,anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; plus-end-directed microtubule motor activity [GO:0008574],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cilium; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_08660,FUN_037875-T1,Peve_00005853,Pocillopora_meandrina_HIv1___RNAseq.g10665.t1,three_way,84.873,FUN_037875-T1,O86938,,,,,32.4,376.0,3.4e-48,194.1,sp|O86938|PPD_STRVT Phosphonopyruvate decarboxylase OS=Streptomyces viridochromogenes (strain DSM 40736 / JCM 4977 / BCRC 1201 / Tue 494) OX=591159 GN=ppd PE=1 SV=1,,,,,,
OG_08661,FUN_037877-T1,Peve_00027466,Pocillopora_meandrina_HIv1___TS.g13174.t1,three_way,47.705333333333336,FUN_037877-T1,P86733,,,,,41.8,110.0,7.4e-27,125.6,sp|P86733|KCP_HALAI BPTI/Kunitz domain-containing protein (Fragment) OS=Haliotis asinina OX=109174 PE=1 SV=1,,,,,,
OG_08662,FUN_037878-T1,Peve_00027465,Pocillopora_meandrina_HIv1___RNAseq.g10658.t1,three_way,88.8,FUN_037878-T1,A7S7F2,BYST_NEMVE,,Bystin,Nematostella vectensis (Starlet sea anemone),83.2,101.0,5.7e-42,171.4,sp|A7S7F2|BYST_NEMVE Bystin OS=Nematostella vectensis OX=45351 GN=bysl PE=3 SV=1,GO:0005730; GO:0005737; GO:0006364; GO:0030515; GO:0030688,rRNA processing [GO:0006364],"cytoplasm [GO:0005737]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]",snoRNA binding [GO:0030515],GO:0003723; GO:0005730; GO:0043226,RNA binding; nucleolus; organelle
OG_08663,FUN_037896-T1,Peve_00028733,Pocillopora_meandrina_HIv1___TS.g8473.t1,three_way,53.025666666666666,FUN_037896-T1,Q7TN88,,,,,25.8,1720.0,6.2e-137,491.9,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08664,FUN_037898-T1,Peve_00028732,Pocillopora_meandrina_HIv1___RNAseq.g28683.t1,three_way,62.17966666666667,FUN_037898-T1,Q8CBH5,,,,,22.7,569.0,1.1e-22,109.8,sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1,,,,,,
OG_08665,FUN_037899-T1,Peve_00028724,Pocillopora_meandrina_HIv1___RNAseq.g28680.t1,three_way,74.81033333333333,FUN_037899-T1,F5H4B4,,,,,26.1,502.0,3.7e-37,157.9,sp|F5H4B4|F227A_HUMAN Protein FAM227A OS=Homo sapiens OX=9606 GN=FAM227A PE=1 SV=1,,,,,,
OG_08666,FUN_037900-T1,Peve_00028723,Pocillopora_meandrina_HIv1___RNAseq.g28679.t1,three_way,73.453,FUN_037900-T1,Q8NEP7,,,,,30.5,295.0,1.8e-27,125.2,sp|Q8NEP7|KLDC9_HUMAN Kelch domain-containing protein 9 OS=Homo sapiens OX=9606 GN=KLHDC9 PE=1 SV=2,,,,,,
OG_08667,FUN_037903-T1,Peve_00028717,Pocillopora_meandrina_HIv1___RNAseq.g28653.t1,three_way,61.3495,FUN_037903-T1,Q5XK85,,,,,25.0,1134.0,1.4e-34,150.2,sp|Q5XK85|KATIP_XENLA Protein KATNIP homolog OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_08668,FUN_037904-T1,Peve_00028715,Pocillopora_meandrina_HIv1___RNAseq.g28654.t1,three_way,50.38033333333333,,,,,,,,,,,,,,,,,
OG_08669,FUN_037905-T1,Peve_00028714,Pocillopora_meandrina_HIv1___RNAseq.g28655.t1,three_way,58.46,,,,,,,,,,,,,,,,,
OG_08670,FUN_037906-T1,Peve_00004640,Pocillopora_meandrina_HIv1___TS.g3117.t1,three_way,86.05966666666667,FUN_037906-T1,Q8BGX0,TRI23_MOUSE,,E3 ubiquitin-protein ligase TRIM23 (EC 2.3.2.27) (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23),Mus musculus (Mouse),62.5,544.0,6.7e-203,708.4,sp|Q8BGX0|TRI23_MOUSE E3 ubiquitin-protein ligase TRIM23 OS=Mus musculus OX=10090 GN=Trim23 PE=2 SV=1,GO:0000139; GO:0003924; GO:0004842; GO:0005525; GO:0005634; GO:0005737; GO:0005765; GO:0008270; GO:0010508; GO:0016567; GO:0019003; GO:0042802; GO:0061630,positive regulation of autophagy [GO:0010508]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nucleus [GO:0005634],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0003924; GO:0005634; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; GTPase activity; nucleus; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08671,FUN_037907-T1,Peve_00004641,Pocillopora_meandrina_HIv1___RNAseq.g17360.t1,three_way,85.071,FUN_037907-T1,Q0VFT9,,,,,56.3,423.0,5.6e-120,432.6,sp|Q0VFT9|TPC13_XENTR Trafficking protein particle complex subunit 13 OS=Xenopus tropicalis OX=8364 GN=trappc13 PE=2 SV=1,,,,,,
OG_08672,FUN_037908-T1,Peve_00000402,Pocillopora_meandrina_HIv1___RNAseq.g25226.t1,three_way,81.01,FUN_037908-T1,Q575S9,CYGB2_ORYLA,,Cytoglobin-2 (Nitric oxygen dioxygenase CYGB) (EC 1.14.12.-) (Nitrite reductase CYGB) (EC 1.7.-.-) (Pseudoperoxidase CYGB) (EC 1.11.1.-) (Superoxide dismutase CYGB) (EC 1.15.1.1),Oryzias latipes (Japanese rice fish) (Japanese killifish),32.1,137.0,3.5e-14,79.7,sp|Q575S9|CYGB2_ORYLA Cytoglobin-2 OS=Oryzias latipes OX=8090 GN=cygb2 PE=2 SV=2,GO:0004784; GO:0005506; GO:0005634; GO:0005737; GO:0015671; GO:0016491; GO:0019430; GO:0019825; GO:0020037; GO:0046210; GO:0098809; GO:0141118,nitric oxide catabolic process [GO:0046210]; oxygen transport [GO:0015671]; removal of superoxide radicals [GO:0019430],cytoplasm [GO:0005737]; nucleus [GO:0005634],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; nitric oxide dioxygenase activity, heme protein as donor [GO:0141118]; nitrite reductase activity [GO:0098809]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; superoxide dismutase activity [GO:0004784]",GO:0003824; GO:0005634; GO:0016209; GO:0016491; GO:0043226; GO:0098754,catalytic activity; nucleus; antioxidant activity; oxidoreductase activity; organelle; detoxification
OG_08673,FUN_037909-T1,Peve_00020691,Pocillopora_meandrina_HIv1___RNAseq.g1145.t1,three_way,93.333,FUN_037909-T1,P48149,,,,,84.6,130.0,6.6e-61,234.6,sp|P48149|RS15A_DROME Small ribosomal subunit protein uS8A OS=Drosophila melanogaster OX=7227 GN=RpS15Aa PE=1 SV=2,,,,,,
OG_08674,FUN_037910-T1,Peve_00004651,Pocillopora_meandrina_HIv1___TS.g5680.t1,three_way,79.7845,FUN_037910-T1,Q8IV35,,,,,30.2,865.0,1.6e-100,369.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_08675,FUN_037911-T1,Peve_00043969,Pocillopora_meandrina_HIv1___RNAseq.g1041.t1,three_way,62.98866666666667,FUN_037911-T1,Q9H7B4,SMYD3_HUMAN,,Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1),Homo sapiens (Human),32.7,452.0,2.9999999999999997e-71,270.8,sp|Q9H7B4|SMYD3_HUMAN Histone-lysine N-methyltransferase SMYD3 OS=Homo sapiens OX=9606 GN=SMYD3 PE=1 SV=4,GO:0000978; GO:0000993; GO:0001162; GO:0005634; GO:0005654; GO:0005829; GO:0006334; GO:0008270; GO:0014904; GO:0032259; GO:0045184; GO:0045944; GO:0071549; GO:0140939; GO:0140954; GO:0140999,cellular response to dexamethasone stimulus [GO:0071549]; establishment of protein localization [GO:0045184]; methylation [GO:0032259]; myotube cell development [GO:0014904]; nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone H4 methyltransferase activity [GO:0140939]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0065003; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; chromatin organization; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_08676,FUN_037915-T1,Peve_00006148,Pocillopora_meandrina_HIv1___RNAseq.g1174.t1,three_way,75.068,FUN_037915-T1,O43149,,,,,34.5,3025.0,0.0,1415.6,sp|O43149|ZZEF1_HUMAN Zinc finger ZZ-type and EF-hand domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ZZEF1 PE=1 SV=6,,,,,,
OG_08677,FUN_037916-T1,Peve_00006147,Pocillopora_meandrina_HIv1___RNAseq.g1173.t1,three_way,71.1675,FUN_037916-T1,Q2KIH4,,,,,50.7,292.0,1.5e-72,274.6,sp|Q2KIH4|RRS1_BOVIN Ribosome biogenesis regulatory protein homolog OS=Bos taurus OX=9913 GN=RRS1 PE=2 SV=1,,,,,,
OG_08678,FUN_037917-T1,Peve_00013499,Pocillopora_meandrina_HIv1___RNAseq.g26497.t1,three_way,94.88433333333332,FUN_037917-T1,Q8IVV7,GID4_HUMAN,,Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog),Homo sapiens (Human),79.3,188.0,5.6e-91,335.1,sp|Q8IVV7|GID4_HUMAN Glucose-induced degradation protein 4 homolog OS=Homo sapiens OX=9606 GN=GID4 PE=1 SV=1,GO:0000151; GO:0005829; GO:0043161; GO:0061630,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],cytosol [GO:0005829]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005829; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; cytosol; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_08679,FUN_037918-T1,Peve_00013502,Pocillopora_meandrina_HIv1___RNAseq.g26498.t1,three_way,75.19133333333333,,,,,,,,,,,,,,,,,
OG_08680,FUN_037920-T1,Peve_00010402,Pocillopora_meandrina_HIv1___RNAseq.g26500.t1,three_way,76.47983333333333,FUN_037920-T1,Q8BIF2,RFOX3_MOUSE,,RNA binding protein fox-1 homolog 3 (Fox-1 homolog C) (Hexaribonucleotide-binding protein 3) (Fox-3) (Neuronal nuclei antigen) (NeuN antigen),Mus musculus (Mouse),58.4,149.0,1.5e-33,144.8,sp|Q8BIF2|RFOX3_MOUSE RNA binding protein fox-1 homolog 3 OS=Mus musculus OX=10090 GN=Rbfox3 PE=1 SV=2,GO:0000381; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005737; GO:0006397; GO:0007399; GO:0008380; GO:0043025; GO:0043204,"mRNA processing [GO:0006397]; nervous system development [GO:0007399]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204],DNA binding [GO:0003677]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0048856,DNA binding; RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; anatomical structure development
OG_08681,FUN_037921-T1,Peve_00035204,Pocillopora_meandrina_HIv1___TS.g19251.t1,three_way,64.265,,,,,,,,,,,,,,,,,
OG_08682,FUN_037922-T1,Peve_00010400,Pocillopora_meandrina_HIv1___RNAseq.g26502.t1,three_way,77.08500000000001,FUN_037922-T1,O48767,,,,,24.0,154.0,2.4e-10,67.4,sp|O48767|AUG2_ARATH AUGMIN subunit 2 OS=Arabidopsis thaliana OX=3702 GN=AUG2 PE=1 SV=2,,,,,,
OG_08683,FUN_037923-T2,Peve_00004174,Pocillopora_meandrina_HIv1___RNAseq.g26228.t1,three_way,76.59416666666667,FUN_037923-T2,P51178,PLCD1_HUMAN,,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III) (PLC-III) (Phospholipase C-delta-1) (PLC-delta-1)",Homo sapiens (Human),30.7,792.0,1.8000000000000002e-86,322.4,"sp|P51178|PLCD1_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 OS=Homo sapiens OX=9606 GN=PLCD1 PE=1 SV=2",GO:0001786; GO:0004435; GO:0005509; GO:0005546; GO:0005737; GO:0005886; GO:0006644; GO:0016042; GO:0032794; GO:0046488; GO:0070062; GO:0070300; GO:0141212,lipid catabolic process [GO:0016042]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C/protein kinase C signal transduction [GO:0141212]; phospholipid metabolic process [GO:0006644],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],"calcium ion binding [GO:0005509]; GTPase activating protein binding [GO:0032794]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phosphatidylserine binding [GO:0001786]",GO:0003824; GO:0005886; GO:0006629; GO:0008289; GO:0016787; GO:0043226,catalytic activity; plasma membrane; lipid metabolic process; lipid binding; hydrolase activity; organelle
OG_08684,FUN_037925-T1,Peve_00005839,Pocillopora_meandrina_HIv1___RNAseq.g26225.t1,three_way,43.84433333333333,,,,,,,,,,,,,,,,,
OG_08685,FUN_037926-T1,Peve_00005837,Pocillopora_meandrina_HIv1___RNAseq.g26224.t1,three_way,74.24433333333334,FUN_037926-T1,A0A0G2K1Q8,ABCA3_RAT,,Phospholipid-transporting ATPase ABCA3 (EC 7.6.2.1) (ATP-binding cassette sub-family A member 3) (Xenobiotic-transporting ATPase ABCA3) (EC 7.6.2.2) [Cleaved into: 150 Kda mature form],Rattus norvegicus (Rat),46.9,1760.0,0.0,1404.0,sp|A0A0G2K1Q8|ABCA3_RAT Phospholipid-transporting ATPase ABCA3 OS=Rattus norvegicus OX=10116 GN=Abca3 PE=1 SV=1,GO:0005319; GO:0005524; GO:0005765; GO:0005770; GO:0005886; GO:0006855; GO:0006869; GO:0008559; GO:0010875; GO:0015914; GO:0016887; GO:0030324; GO:0030659; GO:0032368; GO:0032464; GO:0032585; GO:0042599; GO:0042626; GO:0042908; GO:0043129; GO:0043231; GO:0046470; GO:0046471; GO:0046618; GO:0046890; GO:0051384; GO:0055091; GO:0070925; GO:0097208; GO:0097232; GO:0097233; GO:0120019; GO:0140345; GO:0150172; GO:1902995; GO:2001140,lipid transport [GO:0006869]; lung development [GO:0030324]; organelle assembly [GO:0070925]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid homeostasis [GO:0055091]; phospholipid transport [GO:0015914]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of phospholipid transport [GO:2001140]; positive regulation of protein homooligomerization [GO:0032464]; regulation of lipid biosynthetic process [GO:0046890]; regulation of lipid transport [GO:0032368]; regulation of phosphatidylcholine metabolic process [GO:0150172]; response to glucocorticoid [GO:0051384]; surfactant homeostasis [GO:0043129]; xenobiotic export from cell [GO:0046618]; xenobiotic transmembrane transport [GO:0006855]; xenobiotic transport [GO:0042908],alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; cytoplasmic vesicle membrane [GO:0030659]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body [GO:0042599]; lamellar body membrane [GO:0097232]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; lipid transporter activity [GO:0005319]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine transfer activity [GO:0120019],GO:0003824; GO:0005215; GO:0005768; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; endosome; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_08686,FUN_037927-T1,Peve_00005836,Pocillopora_meandrina_HIv1___RNAseq.g26223.t1,three_way,75.379,FUN_037927-T1,Q96QE5,TEFM_HUMAN,,"Transcription elongation factor, mitochondrial",Homo sapiens (Human),26.8,235.0,5.2e-14,80.5,"sp|Q96QE5|TEFM_HUMAN Transcription elongation factor, mitochondrial OS=Homo sapiens OX=9606 GN=TEFM PE=1 SV=1",GO:0002082; GO:0003711; GO:0003723; GO:0005739; GO:0005759; GO:0006390; GO:0006392; GO:0030337; GO:0042645; GO:1903109; GO:1990904,mitochondrial transcription [GO:0006390]; positive regulation of mitochondrial transcription [GO:1903109]; regulation of oxidative phosphorylation [GO:0002082]; transcription elongation by mitochondrial RNA polymerase [GO:0006392],mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ribonucleoprotein complex [GO:1990904],DNA polymerase processivity factor activity [GO:0030337]; RNA binding [GO:0003723]; transcription elongation factor activity [GO:0003711],GO:0003723; GO:0005739; GO:0006351; GO:0006355; GO:0043226; GO:0098772; GO:0140110,RNA binding; mitochondrion; DNA-templated transcription; regulation of DNA-templated transcription; organelle; molecular function regulator activity; transcription regulator activity
OG_08687,FUN_037929-T1,Peve_00005835,Pocillopora_meandrina_HIv1___RNAseq.g26222.t1,three_way,56.6,,,,,,,,,,,,,,,,,
OG_08688,FUN_037931-T1,Peve_00015637,Pocillopora_meandrina_HIv1___RNAseq.g26217.t1,three_way,82.56883333333333,FUN_037931-T1,A7M7B9,NTH_CHICK,,Endonuclease III-like protein 1 (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase),Gallus gallus (Chicken),64.4,225.0,3.2e-85,316.6,sp|A7M7B9|NTH_CHICK Endonuclease III-like protein 1 OS=Gallus gallus OX=9031 GN=NTHL1 PE=2 SV=1,GO:0000703; GO:0003677; GO:0003906; GO:0005634; GO:0005739; GO:0006285; GO:0006289; GO:0046872; GO:0051539; GO:0140078,"base-excision repair, AP site formation [GO:0006285]; nucleotide-excision repair [GO:0006289]",mitochondrion [GO:0005739]; nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; metal ion binding [GO:0046872]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]",GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_08689,FUN_037932-T1,Peve_00015636,Pocillopora_meandrina_HIv1___RNAseq.g26216.t1,three_way,64.56266666666667,FUN_037932-T1,F4KFT7,TENAC_ARATH,,"Bifunctional TH2 protein, mitochondrial (THIAMINE REQUIRING 2) [Includes: Thiamine phosphate phosphatase (EC 3.1.3.100); Aminopyrimidine aminohydrolase (EC 3.5.99.2)]",Arabidopsis thaliana (Mouse-ear cress),27.5,298.0,3.8999999999999995e-28,127.1,"sp|F4KFT7|TENAC_ARATH Bifunctional TH2 protein, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=TH2 PE=1 SV=1",GO:0005739; GO:0005829; GO:0009228; GO:0042131; GO:0050334,thiamine biosynthetic process [GO:0009228],cytosol [GO:0005829]; mitochondrion [GO:0005739],thiaminase activity [GO:0050334]; thiamine phosphate phosphatase activity [GO:0042131],GO:0003824; GO:0005739; GO:0005829; GO:0006766; GO:0006790; GO:0016787; GO:0043226,catalytic activity; mitochondrion; cytosol; vitamin metabolic process; sulfur compound metabolic process; hydrolase activity; organelle
OG_08690,FUN_037933-T1,Peve_00025647,Pocillopora_meandrina_HIv1___RNAseq.g26215.t1,three_way,47.622,FUN_037933-T1,Q4V832,,,,,29.1,413.0,9.999999999999999e-27,123.2,sp|Q4V832|AP4AT_XENLA AP-4 complex accessory subunit tepsin OS=Xenopus laevis OX=8355 GN=tepsin PE=2 SV=2,,,,,,
OG_08691,FUN_037935-T1,Peve_00015640,Pocillopora_meandrina_HIv1___RNAseq.g26204.t1,three_way,78.68583333333333,,,,,,,,,,,,,,,,,
OG_08692,FUN_037936-T1,Peve_00015639,Pocillopora_meandrina_HIv1___RNAseq.g26203.t1,three_way,85.81533333333333,FUN_037936-T1,Q3MHZ2,,,,,40.0,210.0,1.7e-35,151.0,sp|Q3MHZ2|SPSB3_BOVIN SPRY domain-containing SOCS box protein 3 OS=Bos taurus OX=9913 GN=SPSB3 PE=2 SV=1,,,,,,
OG_08693,FUN_037937-T1,Peve_00015638,Pocillopora_meandrina_HIv1___RNAseq.g26202.t1,three_way,78.55583333333333,FUN_037937-T1,Q5M9B1,,,,,51.3,226.0,6.9e-63,242.3,sp|Q5M9B1|SPSB3_XENLA SPRY domain-containing SOCS box protein 3 OS=Xenopus laevis OX=8355 GN=spsb3 PE=2 SV=1,,,,,,
OG_08694,FUN_037938-T1,Peve_00027269,Pocillopora_meandrina_HIv1___RNAseq.g26201.t1,three_way,89.87166666666667,FUN_037938-T1,Q76MZ1,,,,,68.1,282.0,7.8e-115,414.8,sp|Q76MZ1|CYH1_CHLAE Cytohesin-1 OS=Chlorocebus aethiops OX=9534 GN=CYTH1 PE=2 SV=1,,,,,,
OG_08695,FUN_037941-T1,Peve_00027810,Pocillopora_meandrina_HIv1___RNAseq.g26198.t1,three_way,90.45533333333331,FUN_037941-T1,Q9D8W5,PSD12_MOUSE,,26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55),Mus musculus (Mouse),63.6,445.0,7.2e-163,575.1,sp|Q9D8W5|PSD12_MOUSE 26S proteasome non-ATPase regulatory subunit 12 OS=Mus musculus OX=10090 GN=Psmd12 PE=1 SV=4,GO:0005838; GO:0022624,,proteasome accessory complex [GO:0022624]; proteasome regulatory particle [GO:0005838],,,
OG_08696,FUN_037942-T1,Peve_00027811,Pocillopora_meandrina_HIv1___RNAseq.g26523.t1,three_way,52.276333333333326,,,,,,,,,,,,,,,,,
OG_08697,FUN_037943-T2,Peve_00027812,Pocillopora_meandrina_HIv1___RNAseq.g26522.t1,three_way,43.655,,,,,,,,,,,,,,,,,
OG_08698,FUN_037944-T1,Peve_00040741,Pocillopora_meandrina_HIv1___RNAseq.g26521.t1,three_way,95.45466666666668,FUN_037944-T1,Q32KN5,,,,,79.8,94.0,7.6e-42,171.0,sp|Q32KN5|DNAL4_BOVIN Dynein axonemal light chain 4 OS=Bos taurus OX=9913 GN=DNAL4 PE=3 SV=1,,,,,,
OG_08699,FUN_037945-T1,Peve_00031504,Pocillopora_meandrina_HIv1___TS.g19268.t1,three_way,71.524,FUN_037945-T1,Q8C9A2,ENDOV_MOUSE,,Endonuclease V (EC 3.1.26.-),Mus musculus (Mouse),58.4,243.0,5e-79,295.8,sp|Q8C9A2|ENDOV_MOUSE Endonuclease V OS=Mus musculus OX=10090 GN=Endov PE=1 SV=2,GO:0000287; GO:0003677; GO:0003727; GO:0005730; GO:0005737; GO:0006281; GO:0010494; GO:0016888; GO:0016891,DNA repair [GO:0006281],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; magnesium ion binding [GO:0000287]; RNA endonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; single-stranded RNA binding [GO:0003727]",GO:0003677; GO:0003723; GO:0003824; GO:0005730; GO:0006281; GO:0016787; GO:0043226; GO:0140097; GO:0140098,"DNA binding; RNA binding; catalytic activity; nucleolus; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_08700,FUN_037949-T1,Peve_00040737,Pocillopora_meandrina_HIv1___RNAseq.g26517.t1,three_way,58.639,,,,,,,,,,,,,,,,,
OG_08701,FUN_037950-T1,Peve_00040736,Pocillopora_meandrina_HIv1___RNAseq.g26516.t1,three_way,47.437000000000005,,,,,,,,,,,,,,,,,
OG_08702,FUN_037951-T1,Peve_00040735,Pocillopora_meandrina_HIv1___RNAseq.g26515.t1,three_way,57.99533333333333,FUN_037951-T1,Q7TSH4,,,,,28.3,226.0,1.3e-11,73.6,sp|Q7TSH4|CP110_MOUSE Centriolar coiled-coil protein of 110 kDa OS=Mus musculus OX=10090 GN=Ccp110 PE=1 SV=1,,,,,,
OG_08703,FUN_037952-T1,Peve_00040734,Pocillopora_meandrina_HIv1___RNAseq.g26514.t2,three_way,73.35300000000001,FUN_037952-T1,Q6PIF6,MYO7B_HUMAN,,Unconventional myosin-VIIb,Homo sapiens (Human),26.7,797.0,3.1000000000000003e-66,255.4,sp|Q6PIF6|MYO7B_HUMAN Unconventional myosin-VIIb OS=Homo sapiens OX=9606 GN=MYO7B PE=1 SV=2,GO:0000146; GO:0005524; GO:0005737; GO:0005902; GO:0005903; GO:0007015; GO:0007605; GO:0015629; GO:0016020; GO:0016459; GO:0030048; GO:0030154; GO:0051015; GO:0090651; GO:1904970,actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; brush border assembly [GO:1904970]; cell differentiation [GO:0030154]; sensory perception of sound [GO:0007605],actin cytoskeleton [GO:0015629]; apical cytoplasm [GO:0090651]; brush border [GO:0005903]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microvillus [GO:0005902]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146],GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0016853; GO:0030154; GO:0043226; GO:0050877; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; isomerase activity; cell differentiation; organelle; nervous system process; ATP-dependent activity
OG_08704,FUN_037953-T1,Peve_00040733,Pocillopora_meandrina_HIv1___RNAseq.g26512.t1,three_way,50.168,FUN_037953-T1,Q91905,,,,,68.3,60.0,4.7e-18,92.8,sp|Q91905|FXI1B_XENLA Forkhead box protein I1-B OS=Xenopus laevis OX=8355 GN=foxi1-b PE=2 SV=1,,,,,,
OG_08705,FUN_037955-T1,Peve_00040732,Pocillopora_meandrina_HIv1___TS.g19261.t1,three_way,55.23566666666667,FUN_037955-T1,Q9PVY9,,,,,40.6,217.0,5.7000000000000006e-36,153.3,sp|Q9PVY9|FXC2A_XENLA Forkhead box protein C2-A OS=Xenopus laevis OX=8355 GN=foxc2-a PE=2 SV=1,,,,,,
OG_08706,FUN_037956-T1,Peve_00040731,Pocillopora_meandrina_HIv1___RNAseq.g26511.t1,three_way,46.48166666666667,,,,,,,,,,,,,,,,,
OG_08707,FUN_037957-T1,Peve_00040730,Pocillopora_meandrina_HIv1___TS.g19259.t1,three_way,88.39133333333334,FUN_037957-T1,Q96HU1,SGSM3_HUMAN,,Small G protein signaling modulator 3 (Merlin-associated protein) (RUN and TBC1 domain-containing protein 3) (Rab-GTPase-activating protein-like protein) (RabGAPLP),Homo sapiens (Human),61.7,798.0,1.2e-288,993.8,sp|Q96HU1|SGSM3_HUMAN Small G protein signaling modulator 3 OS=Homo sapiens OX=9606 GN=SGSM3 PE=1 SV=1,GO:0005096; GO:0005829; GO:0005921; GO:0031267; GO:0032483; GO:0032486; GO:0043547; GO:0045732; GO:0048227; GO:0051726,plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein catabolic process [GO:0045732]; Rap protein signal transduction [GO:0032486]; regulation of cell cycle [GO:0051726]; regulation of Rab protein signal transduction [GO:0032483],cytosol [GO:0005829]; gap junction [GO:0005921],GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0005829; GO:0016192; GO:0098772,cytosol; vesicle-mediated transport; molecular function regulator activity
OG_08708,FUN_037960-T1,Peve_00009704,Pocillopora_meandrina_HIv1___RNAseq.17936_t,three_way,68.97666666666666,FUN_037960-T1,Q0V9C9,,,,,31.6,339.0,3e-45,184.1,"sp|Q0V9C9|ECSIT_XENTR Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial OS=Xenopus tropicalis OX=8364 GN=ecsit PE=2 SV=1",,,,,,
OG_08709,FUN_037961-T1,Peve_00009703,Pocillopora_meandrina_HIv1___RNAseq.g26230.t1,three_way,75.68066666666667,FUN_037961-T1,A7RKS5,RSSA_NEMVE,,Small ribosomal subunit protein uS2 (40S ribosomal protein SA),Nematostella vectensis (Starlet sea anemone),75.9,257.0,1e-107,391.3,sp|A7RKS5|RSSA_NEMVE Small ribosomal subunit protein uS2 OS=Nematostella vectensis OX=45351 GN=v1g198553 PE=3 SV=1,GO:0000028; GO:0002181; GO:0003735; GO:0022627,cytoplasmic translation [GO:0002181]; ribosomal small subunit assembly [GO:0000028],cytosolic small ribosomal subunit [GO:0022627],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0065003,cytoplasmic translation; structural molecule activity; protein-containing complex assembly
OG_08710,FUN_037962-T1,Peve_00016282,Pocillopora_meandrina_HIv1___RNAseq.g29749.t1,three_way,70.62566666666666,FUN_037962-T1,Q8BZK4,,,,,35.1,385.0,7.4e-49,196.1,sp|Q8BZK4|S35F4_MOUSE Solute carrier family 35 member F4 OS=Mus musculus OX=10090 GN=Slc35f4 PE=2 SV=1,,,,,,
OG_08711,FUN_037963-T1,Peve_00009702,Pocillopora_meandrina_HIv1___RNAseq.17939_t,three_way,61.76616666666666,FUN_037963-T1,Q80YR4,,,,,47.4,310.0,3e-77,291.2,sp|Q80YR4|ZN598_MOUSE E3 ubiquitin-protein ligase ZNF598 OS=Mus musculus OX=10090 GN=Znf598 PE=1 SV=1,,,,,,
OG_08712,FUN_037964-T1,Peve_00009700,Pocillopora_meandrina_HIv1___RNAseq.g26233.t1,three_way,73.965,FUN_037964-T1,P11914,MPPA_YEAST,,Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha) (Matrix processing peptidase) (MPP) (Mitochondrial assembly protein 2) (Mitochondrial import function protein 2),Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast),29.8,416.0,9.1e-36,152.9,sp|P11914|MPPA_YEAST Mitochondrial-processing peptidase subunit alpha OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=MAS2 PE=1 SV=1,GO:0004222; GO:0005739; GO:0005759; GO:0006508; GO:0006627; GO:0017087; GO:0046872; GO:0061133,protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508],mitochondrial matrix [GO:0005759]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrion [GO:0005739],endopeptidase activator activity [GO:0061133]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08713,FUN_037965-T1,Peve_00009707,Pocillopora_meandrina_HIv1___RNAseq.g26234.t1,three_way,48.86333333333334,,,,,,,,,,,,,,,,,
OG_08714,FUN_037966-T1,Peve_00009699,Pocillopora_meandrina_HIv1___RNAseq.g26235.t1,three_way,47.697,,,,,,,,,,,,,,,,,
OG_08715,FUN_037967-T1,Peve_00012656,Pocillopora_meandrina_HIv1___RNAseq.g26236.t1,three_way,59.54,FUN_037967-T1,Q09630,,,,,24.1,906.0,2.2e-38,162.5,sp|Q09630|GRM1_CAEEL Probable metabotropic glutamate receptor mgl-1 OS=Caenorhabditis elegans OX=6239 GN=mgl-1 PE=3 SV=1,,,,,,
OG_08716,FUN_037968-T1,Peve_00012657,Pocillopora_meandrina_HIv1___RNAseq.g26237.t1,three_way,76.11933333333333,FUN_037968-T1,Q16658,FSCN1_HUMAN,,Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55),Homo sapiens (Human),40.2,488.0,2.5e-97,357.5,sp|Q16658|FSCN1_HUMAN Fascin OS=Homo sapiens OX=9606 GN=FSCN1 PE=1 SV=3,GO:0001725; GO:0001726; GO:0002102; GO:0003723; GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0005902; GO:0005911; GO:0005938; GO:0007043; GO:0007163; GO:0010592; GO:0015629; GO:0016477; GO:0030027; GO:0030035; GO:0030036; GO:0030046; GO:0030175; GO:0030426; GO:0030674; GO:0031253; GO:0032534; GO:0032956; GO:0035089; GO:0044393; GO:0045296; GO:0048870; GO:0051015; GO:0051017; GO:0051491; GO:0070062; GO:0071803; GO:0090091,actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell-cell junction assembly [GO:0007043]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725],actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0005856; GO:0007010; GO:0007163; GO:0008092; GO:0034330; GO:0043226; GO:0048870; GO:0060090,RNA binding; cytosol; cytoskeleton; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; cell junction organization; organelle; cell motility; molecular adaptor activity
OG_08717,FUN_037969-T1,Peve_00012654,Pocillopora_meandrina_HIv1___TS.g18990.t1,three_way,55.461,FUN_037969-T1,Q7TN88,,,,,26.7,1919.0,1.5e-169,600.1,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08718,FUN_037970-T1,Peve_00032390,Pocillopora_meandrina_HIv1___RNAseq.g9858.t1a,three_way,78.12766666666666,FUN_037970-T1,D4D448,,,,,26.9,458.0,2.2e-24,115.2,sp|D4D448|EASE_TRIVH FAD-linked oxidoreductase easE OS=Trichophyton verrucosum (strain HKI 0517) OX=663202 GN=easE PE=3 SV=1,,,,,,
OG_08719,FUN_037971-T1,Peve_00012655,Pocillopora_meandrina_HIv1___RNAseq.g26242.t1,three_way,62.08233333333333,FUN_037971-T1,Q9C0C9,UBE2O_HUMAN,,(E3-independent) E2 ubiquitin-conjugating enzyme (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O),Homo sapiens (Human),43.4,376.0,1.2e-78,296.6,sp|Q9C0C9|UBE2O_HUMAN (E3-independent) E2 ubiquitin-conjugating enzyme OS=Homo sapiens OX=9606 GN=UBE2O PE=1 SV=3,GO:0003723; GO:0004842; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006513; GO:0016604; GO:0030513; GO:0042147; GO:0061630; GO:0061631; GO:0070534,"positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016192; GO:0016740; GO:0043226; GO:0140096,"RNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; vesicle-mediated transport; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08720,FUN_037973-T1,Peve_00013891,Pocillopora_meandrina_HIv1___RNAseq.g26182.t1,three_way,74.1255,FUN_037973-T1,Q9UPN4,CP131_HUMAN,,Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) (Pre-acrosome localization protein 1),Homo sapiens (Human),42.9,688.0,9.3e-66,253.8,sp|Q9UPN4|CP131_HUMAN Centrosomal protein of 131 kDa OS=Homo sapiens OX=9606 GN=CEP131 PE=1 SV=3,GO:0001669; GO:0002177; GO:0005813; GO:0005814; GO:0005829; GO:0005929; GO:0007288; GO:0008284; GO:0010824; GO:0015630; GO:0034451; GO:0035735; GO:0035869; GO:0036064; GO:0042803; GO:0043231; GO:0044877; GO:0045171; GO:0060271; GO:0071539; GO:0090316; GO:0120212; GO:1905198; GO:1905515; GO:1990953,cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; intramanchette transport [GO:1990953]; manchette assembly [GO:1905198]; non-motile cilium assembly [GO:1905515]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; regulation of centrosome duplication [GO:0010824]; sperm axoneme assembly [GO:0007288],acrosomal vesicle [GO:0001669]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; intracellular membrane-bounded organelle [GO:0043231]; manchette [GO:0002177]; microtubule cytoskeleton [GO:0015630]; sperm head-tail coupling apparatus [GO:0120212],protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0006886; GO:0007010; GO:0007018; GO:0022414; GO:0031410; GO:0043226; GO:0044782,microtubule organizing center; cytosol; cytoskeleton; cilium; intracellular protein transport; cytoskeleton organization; microtubule-based movement; reproductive process; cytoplasmic vesicle; organelle; cilium organization
OG_08721,FUN_037974-T1,Peve_00013894,Pocillopora_meandrina_HIv1___RNAseq.g26183.t1,three_way,56.88933333333333,FUN_037974-T1,Q3UHR0,,,,,27.2,746.0,2.1e-45,187.6,sp|Q3UHR0|BAHC1_MOUSE BAH and coiled-coil domain-containing protein 1 OS=Mus musculus OX=10090 GN=Bahcc1 PE=1 SV=2,,,,,,
OG_08722,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),36.1,280.0,6.1e-42,174.9,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08722,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),43.2,148.0,5.4e-22,108.6,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08723,FUN_037976-T1,Peve_00028106,Pocillopora_meandrina_HIv1___TS.g18935.t1,three_way,73.48466666666667,FUN_037976-T1,Q9D9S1,,,,,44.3,192.0,1.9000000000000003e-28,127.5,sp|Q9D9S1|EVG1_MOUSE UPF0193 protein EVG1 homolog OS=Mus musculus OX=10090 PE=2 SV=1,,,,,,
OG_08724,FUN_037977-T1,Peve_00019559,Pocillopora_meandrina_HIv1___RNAseq.g26186.t1,three_way,79.00166666666667,FUN_037977-T1,A0JP70,,,,,42.9,1940.0,0.0,1565.1,sp|A0JP70|WDR90_XENTR WD repeat-containing protein 90 OS=Xenopus tropicalis OX=8364 GN=wdr90 PE=2 SV=1,,,,,,
OG_08725,FUN_037978-T1,Peve_00019558,Pocillopora_meandrina_HIv1___RNAseq.g26187.t1,three_way,70.464,FUN_037978-T1,Q9UTA8,,,,,32.4,262.0,8.2e-29,129.0,sp|Q9UTA8|YL8A_SCHPO Uncharacterized methyltransferase-like C25B8.10 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC25B8.10 PE=3 SV=1,,,,,,
OG_08726,FUN_037979-T1,Peve_00018336,Pocillopora_meandrina_HIv1___RNAseq.g26195.t1,three_way,82.28633333333333,FUN_037979-T1,P51570,GALK1_HUMAN,,Galactokinase (EC 2.7.1.6) (Galactose kinase),Homo sapiens (Human),60.5,385.0,5.799999999999999e-129,462.2,sp|P51570|GALK1_HUMAN Galactokinase OS=Homo sapiens OX=9606 GN=GALK1 PE=1 SV=1,GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0005829; GO:0006012; GO:0016020; GO:0019402; GO:0033499; GO:0061623; GO:0070062,"galactitol metabolic process [GO:0019402]; galactose catabolic process via UDP-galactose, Leloir pathway [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020],ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08727,FUN_037982-T1,Peve_00018338,Pocillopora_meandrina_HIv1___RNAseq.g26193.t1,three_way,71.84733333333332,,,,,,,,,,,,,,,,,
OG_08728,FUN_037983-T1,Peve_00026785,Pocillopora_meandrina_HIv1___RNAseq.g26190.t1,three_way,60.70233333333333,FUN_037983-T1,Q8BTK5,SMYD4_MOUSE,,Protein-lysine N-methyltransferase SMYD4 (EC 2.1.1.-) (SET and MYND domain-containing protein 4),Mus musculus (Mouse),28.3,600.0,9.799999999999999e-55,216.5,sp|Q8BTK5|SMYD4_MOUSE Protein-lysine N-methyltransferase SMYD4 OS=Mus musculus OX=10090 GN=Smyd4 PE=2 SV=2,GO:0005634; GO:0005737; GO:0007507; GO:0008168; GO:0008270; GO:0032259,heart development [GO:0007507]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleus; transferase activity; organelle; anatomical structure development
OG_08729,FUN_037985-T1,Peve_00026786,Pocillopora_meandrina_HIv1___RNAseq.g26188.t1,three_way,96.05633333333331,FUN_037985-T1,Q9QZB9,,,,,85.0,107.0,2.6e-48,193.0,sp|Q9QZB9|DCTN5_MOUSE Dynactin subunit 5 OS=Mus musculus OX=10090 GN=Dctn5 PE=1 SV=1,,,,,,
OG_08730,FUN_037986-T1,Peve_00025061,Pocillopora_meandrina_HIv1___RNAseq.g26274.t1,three_way,63.13133333333333,FUN_037986-T1,Q8BX80,,,,,37.7,703.0,9.5e-121,436.0,sp|Q8BX80|ENASE_MOUSE Cytosolic endo-beta-N-acetylglucosaminidase OS=Mus musculus OX=10090 GN=Engase PE=1 SV=1,,,,,,
OG_08731,FUN_037988-T1,Peve_00025059,Pocillopora_meandrina_HIv1___RNAseq.g26272.t1,three_way,38.300666666666665,,,,,,,,,,,,,,,,,
OG_08732,FUN_037989-T1,Peve_00034263,Pocillopora_meandrina_HIv1___RNAseq.g26271.t1,three_way,62.78233333333333,FUN_037989-T1,Q6ZUK4,,,,,46.2,91.0,4.4e-13,77.4,sp|Q6ZUK4|TMM26_HUMAN Transmembrane protein 26 OS=Homo sapiens OX=9606 GN=TMEM26 PE=1 SV=1,,,,,,
OG_08733,FUN_037990-T1,Peve_00023488,Pocillopora_meandrina_HIv1___RNAseq.g26269.t1,three_way,90.14733333333334,FUN_037990-T1,A5PKG7,,,,,68.2,198.0,5.2e-73,275.4,sp|A5PKG7|KCTD5_BOVIN BTB/POZ domain-containing protein KCTD5 OS=Bos taurus OX=9913 GN=KCTD5 PE=2 SV=1,,,,,,
OG_08734,FUN_037991-T1,Peve_00023489,Pocillopora_meandrina_HIv1___RNAseq.g26268.t1,three_way,49.46833333333333,FUN_037991-T1,Q9D666,SUN1_MOUSE,,SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1),Mus musculus (Mouse),45.6,206.0,2.7e-47,191.0,sp|Q9D666|SUN1_MOUSE SUN domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sun1 PE=1 SV=2,GO:0000781; GO:0002080; GO:0002081; GO:0005521; GO:0005634; GO:0005635; GO:0005637; GO:0005737; GO:0006998; GO:0007129; GO:0007283; GO:0016020; GO:0021817; GO:0034993; GO:0042802; GO:0051642; GO:0070197; GO:0090292; GO:0140444,centrosome localization [GO:0051642]; homologous chromosome pairing at meiosis [GO:0007129]; meiotic attachment of telomere to nuclear envelope [GO:0070197]; nuclear envelope organization [GO:0006998]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration [GO:0021817]; spermatogenesis [GO:0007283],"acrosomal membrane [GO:0002080]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]",cytoskeleton-nuclear membrane anchor activity [GO:0140444]; identical protein binding [GO:0042802]; lamin binding [GO:0005521],GO:0005634; GO:0005635; GO:0007018; GO:0022414; GO:0043226; GO:0060090; GO:0061024,nucleus; nuclear envelope; microtubule-based movement; reproductive process; organelle; molecular adaptor activity; membrane organization
OG_08735,FUN_037992-T1,Peve_00023490,Pocillopora_meandrina_HIv1___RNAseq.g26267.t1,three_way,59.86366666666667,,,,,,,,,,,,,,,,,
OG_08736,FUN_037993-T2,Peve_00023491,Pocillopora_meandrina_HIv1___RNAseq.g26266.t1,three_way,66.48783333333333,FUN_037993-T2,Q8K448,ABCA5_MOUSE,,Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5),Mus musculus (Mouse),33.3,1722.0,6.4e-233,809.7,sp|Q8K448|ABCA5_MOUSE Cholesterol transporter ABCA5 OS=Mus musculus OX=10090 GN=Abca5 PE=1 SV=2,GO:0000139; GO:0005524; GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008203; GO:0010745; GO:0010874; GO:0016887; GO:0031902; GO:0033344; GO:0034375; GO:0042632; GO:0043691; GO:0140359; GO:1903064,cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle remodeling [GO:0034375]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; positive regulation of reverse cholesterol transport [GO:1903064]; regulation of cholesterol efflux [GO:0010874]; reverse cholesterol transport [GO:0043691],Golgi membrane [GO:0000139]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0140657,catalytic activity; transporter activity; lysosome; endosome; vacuole; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; ATP-dependent activity
OG_08737,FUN_037996-T1,Peve_00021252,Pocillopora_meandrina_HIv1___RNAseq.g26261.t1,three_way,74.359,FUN_037996-T1,B4F7A1,,,,,45.2,84.0,7.5e-15,81.3,sp|B4F7A1|LYRM7_RAT Complex III assembly factor LYRM7 OS=Rattus norvegicus OX=10116 GN=Lyrm7 PE=3 SV=1,,,,,,
OG_08738,FUN_037997-T1,Peve_00021251,Pocillopora_meandrina_HIv1___RNAseq.g26260.t1,three_way,62.4075,FUN_037997-T1,Q4WU07,,,,,42.5,299.0,1.2e-52,208.8,sp|Q4WU07|CWC2_ASPFU Pre-mRNA-splicing factor cwc2 OS=Aspergillus fumigatus (strain ATCC MYA-4609 / CBS 101355 / FGSC A1100 / Af293) OX=330879 GN=cwc2 PE=3 SV=1,,,,,,
OG_08739,FUN_037998-T1,Peve_00021258,Pocillopora_meandrina_HIv1___RNAseq.g26259.t1,three_way,71.65033333333334,FUN_037998-T1,Q5HZT0,DXO_XENLA,,Decapping and exoribonuclease protein (DXO) (EC 3.6.1.-) (5'-3' exoribonuclease DXO) (EC 3.1.13.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase DXO) (DeNADding enzyme DXO) (EC 3.6.1.-),Xenopus laevis (African clawed frog),39.8,369.0,5.7e-79,296.2,sp|Q5HZT0|DXO_XENLA Decapping and exoribonuclease protein OS=Xenopus laevis OX=8355 GN=dxo PE=2 SV=1,GO:0000166; GO:0000287; GO:0000956; GO:0003729; GO:0005634; GO:0005829; GO:0006402; GO:0008409; GO:0034353; GO:0050779; GO:0071028; GO:0090304; GO:0110152; GO:0110155,mRNA catabolic process [GO:0006402]; NAD-cap decapping [GO:0110155]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nucleic acid metabolic process [GO:0090304]; RNA destabilization [GO:0050779],cytosol [GO:0005829]; nucleus [GO:0005634],5'-3' exonuclease activity [GO:0008409]; magnesium ion binding [GO:0000287]; mRNA 5'-diphosphatase activity [GO:0034353]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; RNA NAD+-cap (NAD+-forming) hydrolase activity [GO:0110152],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_08740,FUN_037999-T1,Peve_00021257,Pocillopora_meandrina_HIv1___TS.g19007.t1,three_way,55.495666666666665,FUN_037999-T1,Q09655,,,,,34.5,284.0,1.2e-28,129.0,sp|Q09655|GPAN1_CAEEL G patch domain and ankyrin repeat-containing protein 1 homolog OS=Caenorhabditis elegans OX=6239 GN=ZK1320.7 PE=4 SV=3,,,,,,
OG_08741,FUN_038000-T1,Peve_00021256,Pocillopora_meandrina_HIv1___RNAseq.g26257.t1,three_way,91.26966666666668,FUN_038000-T1,Q6GR34,,,,,50.0,164.0,1.5e-41,170.6,sp|Q6GR34|CP52A_XENLA Uncharacterized protein C16orf52 homolog A OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_08742,FUN_038002-T1,Peve_00021254,Pocillopora_meandrina_HIv1___RNAseq.g26255.t1,three_way,77.611,FUN_038002-T1,Q9DCH2,,,,,50.4,121.0,5.0999999999999995e-24,112.1,sp|Q9DCH2|POP7_MOUSE Ribonuclease P protein subunit p20 OS=Mus musculus OX=10090 GN=Pop7 PE=2 SV=1,,,,,,
OG_08743,FUN_038003-T1,Peve_00021250,Pocillopora_meandrina_HIv1___RNAseq.g26254.t1,three_way,76.49766666666667,FUN_038003-T1,Q6DJF8,,,,,51.0,210.0,5.999999999999999e-62,238.8,sp|Q6DJF8|MET23_XENLA Histone-arginine methyltransferase METTL23 OS=Xenopus laevis OX=8355 GN=mettl23 PE=2 SV=1,,,,,,
OG_08744,FUN_038004-T1,Peve_00004462,Pocillopora_meandrina_HIv1___RNAseq.g26252.t1,three_way,74.46366666666667,FUN_038004-T1,Q5XX13,FBW10_HUMAN,,F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10) (Ubiquitin ligase-specificity factor),Homo sapiens (Human),35.0,762.0,7.6e-99,363.6,sp|Q5XX13|FBW10_HUMAN F-box/WD repeat-containing protein 10 OS=Homo sapiens OX=9606 GN=FBXW10 PE=1 SV=2,GO:0005829,,cytosol [GO:0005829],,GO:0005829,cytosol
OG_08745,FUN_038006-T1,Peve_00013512,Pocillopora_meandrina_HIv1___RNAseq.g26245.t1,three_way,55.17616666666667,,,,,,,,,,,,,,,,,
OG_08746,FUN_038007-T1,Peve_00013511,Pocillopora_meandrina_HIv1___RNAseq.g26246.t1,three_way,53.48683333333334,,,,,,,,,,,,,,,,,
OG_08747,FUN_038011-T1,Peve_00013509,Pocillopora_meandrina_HIv1___RNAseq.g26524.t1,three_way,63.710166666666666,FUN_038011-T1,Q8CGS5,,,,,36.2,804.0,2.0000000000000002e-131,471.5,sp|Q8CGS5|RNZ2_RAT Zinc phosphodiesterase ELAC protein 2 OS=Rattus norvegicus OX=10116 GN=Elac2 PE=1 SV=1,,,,,,
OG_08748,FUN_038013-T1,Peve_00013505,Pocillopora_meandrina_HIv1___RNAseq.g26527.t1,three_way,72.60583333333334,,,,,,,,,,,,,,,,,
OG_08749,FUN_038016-T1,Peve_00013503,Pocillopora_meandrina_HIv1___RNAseq.g26529.t1,three_way,82.377,FUN_038016-T1,Q91XV4,,,,,61.6,242.0,8.500000000000001e-78,291.6,sp|Q91XV4|DCXR_MESAU L-xylulose reductase OS=Mesocricetus auratus OX=10036 GN=DCXR PE=1 SV=1,,,,,,
OG_08750,FUN_038017-T1,Peve_00009818,Pocillopora_meandrina_HIv1___RNAseq.g26530.t2,three_way,84.67783333333334,FUN_038017-T1,A6NCI4,VWA3A_HUMAN,,von Willebrand factor A domain-containing protein 3A,Homo sapiens (Human),37.6,1172.0,1.8e-227,791.2,sp|A6NCI4|VWA3A_HUMAN von Willebrand factor A domain-containing protein 3A OS=Homo sapiens OX=9606 GN=VWA3A PE=1 SV=3,GO:0005576,,extracellular region [GO:0005576],,GO:0005576,extracellular region
OG_08751,FUN_038018-T1,Peve_00022791,Pocillopora_meandrina_HIv1___RNAseq.g26531.t1,three_way,70.62033333333333,FUN_038018-T1,A7UA95,RADIL_DANRE,,Ras-associating and dilute domain-containing protein,Danio rerio (Zebrafish) (Brachydanio rerio),28.0,1225.0,3e-109,398.7,sp|A7UA95|RADIL_DANRE Ras-associating and dilute domain-containing protein OS=Danio rerio OX=7955 GN=radil PE=2 SV=1,GO:0001755; GO:0005874; GO:0007165; GO:0034446; GO:0051020,neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],microtubule [GO:0005874],GTPase binding [GO:0051020],GO:0007155; GO:0048870,cell adhesion; cell motility
OG_08752,FUN_038020-T1,Peve_00010579,Pocillopora_meandrina_HIv1___TS.g18660.t1,three_way,50.464,FUN_038020-T1,P19477,,,,,41.5,135.0,1.1e-23,112.1,sp|P19477|FIBA_APOPA Fibrinogen-like protein A OS=Apostichopus parvimensis OX=1902835 PE=2 SV=1,,,,,,
OG_08753,FUN_038022-T1,Peve_00032780,Pocillopora_meandrina_HIv1___RNAseq.g26533.t1,three_way,53.67933333333333,FUN_038022-T1,P25931,,,,,27.0,211.0,6.9e-12,72.8,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_08754,FUN_038023-T1,Peve_00018114,Pocillopora_meandrina_HIv1___RNAseq.g26535.t1,three_way,57.67633333333333,FUN_038023-T1,Q8BKN6,,,,,55.4,260.0,1.5e-77,291.6,sp|Q8BKN6|HS3SA_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 OS=Mus musculus OX=10090 GN=Hs3st3a1 PE=2 SV=1,,,,,,
OG_08755,FUN_038024-T1,Peve_00018113,Pocillopora_meandrina_HIv1___TS.g19285.t1,three_way,85.45183333333334,FUN_038024-T1,P55884,EIF3B_HUMAN,,Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116),Homo sapiens (Human),62.8,646.0,3e-256,885.9,sp|P55884|EIF3B_HUMAN Eukaryotic translation initiation factor 3 subunit B OS=Homo sapiens OX=9606 GN=EIF3B PE=1 SV=3,GO:0001732; GO:0003723; GO:0003743; GO:0005829; GO:0005852; GO:0006413; GO:0006446; GO:0010494; GO:0016282; GO:0031369; GO:0033290; GO:0045202; GO:0060090; GO:0070062; GO:0071541; GO:0075522; GO:0075525,formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],"cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]",molecular adaptor activity [GO:0060090]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369],GO:0003723; GO:0005829; GO:0043226; GO:0060090; GO:0065003,RNA binding; cytosol; organelle; molecular adaptor activity; protein-containing complex assembly
OG_08756,FUN_038027-T1,Peve_00002132,Pocillopora_meandrina_HIv1___RNAseq.g26538.t1,three_way,88.28966666666666,FUN_038027-T1,Q9VVS4,,,,,39.3,107.0,7.4e-16,84.7,sp|Q9VVS4|MED11_DROME Mediator of RNA polymerase II transcription subunit 11 OS=Drosophila melanogaster OX=7227 GN=MED11 PE=1 SV=1,,,,,,
OG_08757,FUN_038028-T1,Peve_00002131,Pocillopora_meandrina_HIv1___TS.g19287.t1a,three_way,79.5965,FUN_038028-T1,Q80U30,CL16A_MOUSE,,Protein CLEC16A,Mus musculus (Mouse),42.5,1092.0,9.9e-206,718.8,sp|Q80U30|CL16A_MOUSE Protein CLEC16A OS=Mus musculus OX=10090 GN=Clec16a PE=1 SV=2,GO:0006914; GO:0031648; GO:0032434; GO:0032435; GO:0036020; GO:0043161; GO:1901098; GO:1901525,autophagy [GO:0006914]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],endolysosome membrane [GO:0036020],,GO:0006914; GO:0030163,autophagy; protein catabolic process
OG_08758,FUN_038031-T1,Peve_00021541,Pocillopora_meandrina_HIv1___RNAseq.g26541.t1,three_way,69.925,FUN_038031-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),28.9,256.0,8.2e-25,116.3,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_08759,FUN_038032-T1,Peve_00021540,Pocillopora_meandrina_HIv1___RNAseq.g26542.t1,three_way,53.04466666666666,FUN_038032-T1,Q96B70,,,,,45.8,96.0,1.3e-15,86.7,sp|Q96B70|LENG9_HUMAN Leukocyte receptor cluster member 9 OS=Homo sapiens OX=9606 GN=LENG9 PE=1 SV=2,,,,,,
OG_08760,FUN_038033-T1,Peve_00016936,Pocillopora_meandrina_HIv1___RNAseq.g26544.t1,three_way,89.779,FUN_038033-T1,P63283,,,,,84.6,156.0,1e-79,297.4,sp|P63283|UBC9_CHICK SUMO-conjugating enzyme UBC9 OS=Gallus gallus OX=9031 GN=UBE2I PE=1 SV=1,,,,,,
OG_08761,FUN_038034-T1,Peve_00016941,Pocillopora_meandrina_HIv1___RNAseq.g26545.t1,three_way,84.4425,FUN_038034-T1,O55173,PDPK1_RAT,,3-phosphoinositide-dependent protein kinase 1 (EC 2.7.11.1) (Protein kinase B kinase) (PkB kinase),Rattus norvegicus (Rat),63.1,474.0,4.8e-168,592.4,sp|O55173|PDPK1_RAT 3-phosphoinositide-dependent protein kinase 1 OS=Rattus norvegicus OX=10116 GN=Pdpk1 PE=1 SV=2,GO:0003323; GO:0004674; GO:0004676; GO:0005158; GO:0005524; GO:0005634; GO:0005737; GO:0005886; GO:0005925; GO:0006972; GO:0007173; GO:0008286; GO:0010594; GO:0010667; GO:0014069; GO:0016004; GO:0016477; GO:0019722; GO:0019901; GO:0030512; GO:0031410; GO:0032869; GO:0034122; GO:0035556; GO:0042995; GO:0043122; GO:0043204; GO:0043274; GO:0043304; GO:0043491; GO:0043524; GO:0043536; GO:0045766; GO:0048009; GO:0048041; GO:0051281; GO:0051897; GO:0071364; GO:0097191; GO:0106310; GO:1903078; GO:1903672; GO:1905564; GO:1990416; GO:2000352,calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of endothelial cell migration [GO:0010594]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005886; GO:0016740; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0098772; GO:0140096,"catalytic activity; nucleus; plasma membrane; transferase activity; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_08762,FUN_038036-T1,Peve_00016937,Pocillopora_meandrina_HIv1___RNAseq.g26546.t1,three_way,47.29133333333333,,,,,,,,,,,,,,,,,
OG_08763,FUN_038037-T1,Peve_00016939,Pocillopora_meandrina_HIv1___RNAseq.g26547.t1,three_way,82.486,FUN_038037-T1,Q3B8H3,,,,,62.8,164.0,6.6e-56,218.4,"sp|Q3B8H3|TM11B_XENLA Transmembrane protein 11-B, mitochondrial OS=Xenopus laevis OX=8355 GN=tmem11-b PE=2 SV=1",,,,,,
OG_08764,FUN_038038-T1,Peve_00016940,Pocillopora_meandrina_HIv1___RNAseq.g26548.t1,three_way,72.556,FUN_038038-T1,O88746,TOM1_MOUSE,,Target of Myb1 membrane trafficking protein (Target of Myb protein 1),Mus musculus (Mouse),41.5,561.0,1.3e-102,375.2,sp|O88746|TOM1_MOUSE Target of Myb1 membrane trafficking protein OS=Mus musculus OX=10090 GN=Tom1 PE=1 SV=1,GO:0005737; GO:0005768; GO:0005769; GO:0005794; GO:0005829; GO:0010008; GO:0010314; GO:0015031; GO:0016020; GO:0016197; GO:0031593; GO:0031901; GO:0032050; GO:0043130; GO:0061753; GO:0061909; GO:0070853; GO:1901098; GO:1904978,autophagosome-lysosome fusion [GO:0061909]; endosomal transport [GO:0016197]; positive regulation of autophagosome maturation [GO:1901098]; protein transport [GO:0015031]; regulation of endosome organization [GO:1904978]; substrate localization to autophagosome [GO:0061753],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],clathrin heavy chain binding [GO:0032050]; myosin VI binding [GO:0070853]; phosphatidylinositol-5-phosphate binding [GO:0010314]; polyubiquitin modification-dependent protein binding [GO:0031593]; ubiquitin binding [GO:0043130],GO:0005768; GO:0005794; GO:0005829; GO:0008092; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; Golgi apparatus; cytosol; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_08765,FUN_038040-T1,Peve_00024877,Pocillopora_meandrina_HIv1___RNAseq.g26549.t1,three_way,88.22833333333332,FUN_038040-T1,Q5DU02,UBP22_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22),Mus musculus (Mouse),61.3,530.0,6.3e-179,628.6,sp|Q5DU02|UBP22_MOUSE Ubiquitin carboxyl-terminal hydrolase 22 OS=Mus musculus OX=10090 GN=Usp22 PE=1 SV=2,GO:0000086; GO:0000124; GO:0003713; GO:0004843; GO:0005737; GO:0006282; GO:0006357; GO:0006511; GO:0008270; GO:0010485; GO:0016579; GO:0019899; GO:0032481; GO:0033276; GO:0043484; GO:0045893; GO:0045931; GO:0140936; GO:0140950,G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of type I interferon production [GO:0032481]; protein deubiquitination [GO:0016579]; regulation of DNA repair [GO:0006282]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; SAGA complex [GO:0000124]; transcription factor TFTC complex [GO:0033276],cysteine-type deubiquitinase activity [GO:0004843]; enzyme binding [GO:0019899]; histone H2A deubiquitinase activity [GO:0140950]; histone H2B deubiquitinase activity [GO:0140936]; histone H4 acetyltransferase activity [GO:0010485]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003824; GO:0006355; GO:0016740; GO:0016787; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; regulation of DNA-templated transcription; transferase activity; hydrolase activity; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_08766,FUN_038041-T1,Peve_00024876,Pocillopora_meandrina_HIv1___RNAseq.g26550.t1,three_way,79.8755,FUN_038041-T1,Q0VA03,,,,,44.2,674.0,1.0999999999999999e-148,528.5,sp|Q0VA03|SUZ12_XENTR Polycomb protein suz12 OS=Xenopus tropicalis OX=8364 GN=suz12 PE=2 SV=1,,,,,,
OG_08767,FUN_038042-T1,Peve_00019950,Pocillopora_meandrina_HIv1___RNAseq.g26551.t1,three_way,83.6265,FUN_038042-T1,Q8N0W5,,,,,47.4,171.0,4.7e-37,156.4,sp|Q8N0W5|IQCK_HUMAN IQ domain-containing protein K OS=Homo sapiens OX=9606 GN=IQCK PE=1 SV=1,,,,,,
OG_08768,FUN_038045-T1,Peve_00016980,Pocillopora_meandrina_HIv1___RNAseq.g843.t1,three_way,44.053,FUN_038045-T1,Q20176,NAS39_CAEEL,,Zinc metalloproteinase nas-39 (EC 3.4.24.-) (Nematode astacin 39),Caenorhabditis elegans,33.8,130.0,1.2e-13,79.7,sp|Q20176|NAS39_CAEEL Zinc metalloproteinase nas-39 OS=Caenorhabditis elegans OX=6239 GN=nas-39 PE=2 SV=4,GO:0004222; GO:0005509; GO:0005615; GO:0008237; GO:0008270; GO:0009953; GO:0016485,dorsal/ventral pattern formation [GO:0009953]; protein processing [GO:0016485],extracellular space [GO:0005615],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_08769,FUN_038049-T1,Peve_00020389,Pocillopora_meandrina_HIv1___RNAseq.g848.t1,three_way,72.76566666666666,FUN_038049-T1,P49842,WHR1_HUMAN,,Winged helix repair factor 1 (Inactive serine/threonine-protein kinase 19) (Protein G11) (Protein RP1) (Tandem winged helix protein formerly known as STK19),Homo sapiens (Human),41.1,219.0,2.1e-45,184.1,sp|P49842|WHR1_HUMAN Winged helix repair factor 1 OS=Homo sapiens OX=9606 GN=WHR1 PE=1 SV=3,GO:0003690; GO:0003725; GO:0005524; GO:0005634; GO:0005737; GO:0016301; GO:0016607; GO:0042803; GO:0046579; GO:1903518,positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of single strand break repair [GO:1903518],cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; kinase activity [GO:0016301]; protein homodimerization activity [GO:0042803],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0016740; GO:0043226,DNA binding; RNA binding; catalytic activity; nucleus; transferase activity; organelle
OG_08770,FUN_038053-T1,Peve_00018147,Pocillopora_meandrina_HIv1___TS.g5311.t1,three_way,63.9905,,,,,,,,,,,,,,,,,
OG_08771,FUN_038055-T1,Peve_00018151,Pocillopora_meandrina_HIv1___TS.g5314.t1,three_way,87.48233333333333,FUN_038055-T1,Q3UJZ3,,,,,44.1,170.0,8.999999999999999e-32,138.3,sp|Q3UJZ3|ARMC7_MOUSE Armadillo repeat-containing protein 7 OS=Mus musculus OX=10090 GN=Armc7 PE=1 SV=2,,,,,,
OG_08772,FUN_038056-T1,Peve_00018152,Pocillopora_meandrina_HIv1___TS.g5315.t2,three_way,86.20166666666667,FUN_038056-T1,Q9D2C6,,,,,63.4,202.0,3.3e-75,282.7,sp|Q9D2C6|RPC8_MOUSE DNA-directed RNA polymerase III subunit RPC8 OS=Mus musculus OX=10090 GN=Polr3h PE=1 SV=2,,,,,,
OG_08773,FUN_038057-T1,Peve_00030106,Pocillopora_meandrina_HIv1___RNAseq.g785.t1,three_way,62.62983333333333,FUN_038057-T1,Q8S8T8,,,,,30.1,153.0,4.1e-09,62.8,sp|Q8S8T8|PCR10_ARATH Protein PLANT CADMIUM RESISTANCE 10 OS=Arabidopsis thaliana OX=3702 GN=PCR10 PE=2 SV=1,,,,,,
OG_08774,FUN_038058-T1,Peve_00000945,Pocillopora_meandrina_HIv1___RNAseq.g798.t1,three_way,76.90766666666667,,,,,,,,,,,,,,,,,
OG_08775,FUN_038060-T1,Peve_00000948,Pocillopora_meandrina_HIv1___RNAseq.g795.t1,three_way,78.47183333333334,FUN_038060-T1,Q70CQ4,UBP31_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31),Homo sapiens (Human),42.1,537.0,7.000000000000002e-110,399.4,sp|Q70CQ4|UBP31_HUMAN Ubiquitin carboxyl-terminal hydrolase 31 OS=Homo sapiens OX=9606 GN=USP31 PE=1 SV=2,GO:0004843; GO:0005634; GO:0006508; GO:0016579,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08776,FUN_038062-T1,Peve_00000949,Pocillopora_meandrina_HIv1___TS.g5325.t1b,three_way,70.5955,,,,,,,,,,,,,,,,,
OG_08777,FUN_038063-T1,Peve_00032860,Pocillopora_meandrina_HIv1___TS.g5325.t1a,three_way,74.28,FUN_038063-T1,Q80YF0,,,,,28.1,734.0,6.5999999999999986e-49,197.2,sp|Q80YF0|MD1L1_CRIGR Mitotic spindle assembly checkpoint protein MAD1 OS=Cricetulus griseus OX=10029 GN=MAD1L1 PE=2 SV=1,,,,,,
OG_08778,FUN_038064-T1,Peve_00031820,Pocillopora_meandrina_HIv1___RNAseq.g792.t1,three_way,45.79133333333333,,,,,,,,,,,,,,,,,
OG_08779,FUN_038065-T1,Peve_00010941,Pocillopora_meandrina_HIv1___RNAseq.g789.t1,three_way,67.371,FUN_038065-T1,O66515,,,,,27.3,388.0,2.3e-27,125.9,sp|O66515|AMT_AQUAE Ammonium transporter OS=Aquifex aeolicus (strain VF5) OX=224324 GN=amt PE=1 SV=1,,,,,,
OG_08780,FUN_038066-T1,Peve_00010943,Pocillopora_meandrina_HIv1___RNAseq.g788.t1,three_way,58.48233333333334,FUN_038066-T1,O43184,,,,,37.5,637.0,5.4e-120,433.3,sp|O43184|ADA12_HUMAN Disintegrin and metalloproteinase domain-containing protein 12 OS=Homo sapiens OX=9606 GN=ADAM12 PE=1 SV=3,,,,,,
OG_08781,FUN_038067-T1,Peve_00010945,Pocillopora_meandrina_HIv1___RNAseq.g787.t1,three_way,64.63766666666666,,,,,,,,,,,,,,,,,
OG_08782,FUN_038068-T1,Peve_00030105,Pocillopora_meandrina_HIv1___RNAseq.g786.t1,three_way,71.34216666666667,FUN_038068-T1,Q5HZH2,TSR3_MOUSE,,18S rRNA aminocarboxypropyltransferase (EC 2.5.1.157) (20S S rRNA accumulation protein 3 homolog),Mus musculus (Mouse),58.3,175.0,4.9e-51,202.2,sp|Q5HZH2|TSR3_MOUSE 18S rRNA aminocarboxypropyltransferase OS=Mus musculus OX=10090 GN=Tsr3 PE=1 SV=1,GO:0000455; GO:0005737; GO:0106388; GO:1904047,enzyme-directed rRNA pseudouridine synthesis [GO:0000455],cytoplasm [GO:0005737],18S rRNA aminocarboxypropyltransferase activity [GO:0106388]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003824; GO:0016740; GO:0140098,"catalytic activity; transferase activity; catalytic activity, acting on RNA"
OG_08783,FUN_038072-T1,Peve_00000952,Pocillopora_meandrina_HIv1___TS.g5330.t1,three_way,63.88366666666666,FUN_038072-T1,A2A870,,,,,41.9,74.0,6.3e-06,55.5,sp|A2A870|FBF1_MOUSE Fas-binding factor 1 OS=Mus musculus OX=10090 GN=Fbf1 PE=1 SV=1,,,,,,
OG_08784,FUN_038073-T1,Peve_00000951,Pocillopora_meandrina_HIv1___RNAseq.g800.t1,three_way,73.37466666666667,,,,,,,,,,,,,,,,,
OG_08785,FUN_038074-T1,Peve_00000950,Pocillopora_meandrina_HIv1___RNAseq.g801.t1,three_way,77.11666666666666,FUN_038074-T1,A7MBC2,,,,,36.1,660.0,2.4e-110,401.4,sp|A7MBC2|PDXD1_BOVIN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PDXDC1 PE=2 SV=1,,,,,,
OG_08786,FUN_038078-T1,Peve_00004947,Pocillopora_meandrina_HIv1___RNAseq.g803.t1,three_way,45.19883333333333,FUN_038078-T1,O88783,FA5_MOUSE,,Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain],Mus musculus (Mouse),36.0,172.0,4.1e-24,114.8,sp|O88783|FA5_MOUSE Coagulation factor V OS=Mus musculus OX=10090 GN=F5 PE=1 SV=1,GO:0005507; GO:0005615; GO:0007596; GO:0008015; GO:0031091; GO:0032571,blood circulation [GO:0008015]; blood coagulation [GO:0007596]; response to vitamin K [GO:0032571],extracellular space [GO:0005615]; platelet alpha granule [GO:0031091],copper ion binding [GO:0005507],GO:0003013; GO:0005615; GO:0031410; GO:0043226,circulatory system process; extracellular space; cytoplasmic vesicle; organelle
OG_08787,FUN_038079-T1,Peve_00004953,Pocillopora_meandrina_HIv1___TS.g5335.t1,three_way,71.60533333333333,FUN_038079-T1,Q5RCV1,,,,,54.4,493.0,5.9e-136,485.7,sp|Q5RCV1|TM104_PONAB Transmembrane protein 104 OS=Pongo abelii OX=9601 GN=TMEM104 PE=2 SV=1,,,,,,
OG_08788,FUN_038080-T1,Peve_00030065,Pocillopora_meandrina_HIv1___RNAseq.g805.t1,three_way,70.712,FUN_038080-T1,A7SLC8,,,,,63.6,176.0,5.8e-59,228.8,sp|A7SLC8|NAT9_NEMVE N-acetyltransferase 9-like protein OS=Nematostella vectensis OX=45351 GN=nat9 PE=3 SV=1,,,,,,
OG_08789,FUN_038081-T1,Peve_00004950,Pocillopora_meandrina_HIv1___RNAseq.g806.t1,three_way,60.84433333333333,FUN_038081-T1,O75689,ADAP1_HUMAN,,Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25),Homo sapiens (Human),42.3,364.0,2.9000000000000004e-80,300.4,sp|O75689|ADAP1_HUMAN Arf-GAP with dual PH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ADAP1 PE=1 SV=2,GO:0005096; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007166; GO:0008270; GO:0043087; GO:0043231; GO:0043533; GO:1902936,cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"GTPase activator activity [GO:0005096]; inositol 1,3,4,5 tetrakisphosphate binding [GO:0043533]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; zinc ion binding [GO:0008270]",GO:0005634; GO:0005829; GO:0005886; GO:0008289; GO:0043226; GO:0098772,nucleus; cytosol; plasma membrane; lipid binding; organelle; molecular function regulator activity
OG_08790,FUN_038086-T1,Peve_00004946,Pocillopora_meandrina_HIv1___RNAseq.g808.t1,three_way,57.21116666666666,,,,,,,,,,,,,,,,,
OG_08791,FUN_038087-T1,Peve_00036442,Pocillopora_meandrina_HIv1___TS.g5341.t2,three_way,72.54633333333332,,,,,,,,,,,,,,,,,
OG_08792,FUN_038088-T1,Peve_00007106,Pocillopora_meandrina_HIv1___RNAseq.g815.t1,three_way,76.33416666666666,FUN_038088-T1,P54922,ADPRH_HUMAN,,ADP-ribosylhydrolase ARH1 (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme) ([Protein ADP-ribosylarginine] hydrolase) (ADP-ribosylarginine hydrolase) (hARH1),Homo sapiens (Human),57.1,350.0,2.3e-116,420.2,sp|P54922|ADPRH_HUMAN ADP-ribosylhydrolase ARH1 OS=Homo sapiens OX=9606 GN=ADPRH PE=1 SV=1,GO:0000287; GO:0003875; GO:0005615; GO:0030955; GO:0036211; GO:0051725,protein de-ADP-ribosylation [GO:0051725]; protein modification process [GO:0036211],extracellular space [GO:0005615],ADP-ribosylarginine hydrolase activity [GO:0003875]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_08793,FUN_038089-T1,Peve_00007107,Pocillopora_meandrina_HIv1___RNAseq.g816.t1,three_way,59.5495,FUN_038089-T1,P22981,LET60_CAEEL,,Ras protein let-60 (EC 3.6.5.2) (Abnormal cell lineage protein 34) (Lethal protein 60),Caenorhabditis elegans,31.4,169.0,7.5e-17,89.0,sp|P22981|LET60_CAEEL Ras protein let-60 OS=Caenorhabditis elegans OX=6239 GN=let-60 PE=1 SV=1,GO:0002119; GO:0003924; GO:0005525; GO:0005886; GO:0005938; GO:0007173; GO:0007265; GO:0007517; GO:0007614; GO:0008306; GO:0019003; GO:0022414; GO:0031344; GO:0040026; GO:0040028; GO:0042659; GO:0043274; GO:0048477; GO:0072327; GO:0120283; GO:1902685,associative learning [GO:0008306]; epidermal growth factor receptor signaling pathway [GO:0007173]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; oogenesis [GO:0048477]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of vulval development [GO:0040026]; Ras protein signal transduction [GO:0007265]; regulation of cell fate specification [GO:0042659]; regulation of cell projection organization [GO:0031344]; regulation of vulval development [GO:0040028]; reproductive process [GO:0022414]; short-term memory [GO:0007614]; vulval cell fate specification [GO:0072327],cell cortex [GO:0005938]; plasma membrane [GO:0005886],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phospholipase binding [GO:0043274]; protein serine/threonine kinase binding [GO:0120283],GO:0003824; GO:0003924; GO:0005886; GO:0016787; GO:0022414; GO:0048856; GO:0050877,catalytic activity; GTPase activity; plasma membrane; hydrolase activity; reproductive process; anatomical structure development; nervous system process
OG_08794,FUN_038090-T1,Peve_00007108,Pocillopora_meandrina_HIv1___RNAseq.g817.t1,three_way,61.42433333333333,FUN_038090-T1,Q9SCN0,STL2_ARATH,,Probable glycosyltransferase STELLO2 (EC 2.4.-.-),Arabidopsis thaliana (Mouse-ear cress),22.5,275.0,1.1e-11,72.4,sp|Q9SCN0|STL2_ARATH Probable glycosyltransferase STELLO2 OS=Arabidopsis thaliana OX=3702 GN=STL2 PE=1 SV=1,GO:0000139; GO:0005794; GO:0016757; GO:0042802; GO:0052324; GO:2001009,plant-type cell wall cellulose biosynthetic process [GO:0052324]; regulation of plant-type cell wall cellulose biosynthetic process [GO:2001009],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],glycosyltransferase activity [GO:0016757]; identical protein binding [GO:0042802],GO:0003824; GO:0005794; GO:0005975; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; carbohydrate metabolic process; transferase activity; organelle
OG_08795,FUN_038091-T1,Peve_00007109,Pocillopora_meandrina_HIv1___RNAseq.g818.t1,three_way,94.97433333333332,FUN_038091-T1,A6QLG5,RS9_BOVIN,,Small ribosomal subunit protein uS4 (40S ribosomal protein S9),Bos taurus (Bovine),90.0,170.0,6.9e-83,308.1,sp|A6QLG5|RS9_BOVIN Small ribosomal subunit protein uS4 OS=Bos taurus OX=9913 GN=RPS9 PE=2 SV=1,GO:0003735; GO:0005730; GO:0006412; GO:0019843; GO:0022627; GO:0032040; GO:0042274; GO:1990904,ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; small-subunit processome [GO:0032040],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_08796,FUN_038092-T1,Peve_00007110,Pocillopora_meandrina_HIv1___RNAseq.g820.t1,three_way,74.33033333333333,FUN_038092-T1,Q9FPH3,,,,,49.0,361.0,4.1e-91,336.7,sp|Q9FPH3|THA2_ARATH Probable low-specificity L-threonine aldolase 2 OS=Arabidopsis thaliana OX=3702 GN=THA2 PE=1 SV=1,,,,,,
OG_08797,FUN_038099-T1,Peve_00007113,Pocillopora_meandrina_HIv1___RNAseq.g830.t1,three_way,45.14216666666667,,,,,,,,,,,,,,,,,
OG_08798,FUN_038100-T1,Peve_00025352,Pocillopora_meandrina_HIv1___TS.g5371.t2,three_way,85.98966666666666,FUN_038100-T1,P05696,KPCA_RAT,,Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13),Rattus norvegicus (Rat),67.3,652.0,6.6e-269,927.9,sp|P05696|KPCA_RAT Protein kinase C alpha type OS=Rattus norvegicus OX=10116 GN=Prkca PE=1 SV=3,GO:0000302; GO:0001525; GO:0001938; GO:0002026; GO:0002062; GO:0002159; GO:0004672; GO:0004674; GO:0004697; GO:0004698; GO:0005102; GO:0005178; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006874; GO:0006937; GO:0007155; GO:0007611; GO:0008270; GO:0008283; GO:0008285; GO:0008289; GO:0009612; GO:0009636; GO:0010595; GO:0010613; GO:0014704; GO:0016020; GO:0017148; GO:0018107; GO:0019899; GO:0021955; GO:0030335; GO:0030424; GO:0030425; GO:0030593; GO:0031666; GO:0031966; GO:0032355; GO:0032991; GO:0034351; GO:0035403; GO:0035556; GO:0035866; GO:0036064; GO:0043025; GO:0043409; GO:0043434; GO:0043536; GO:0044305; GO:0045177; GO:0045184; GO:0045471; GO:0045651; GO:0045766; GO:0045780; GO:0045785; GO:0045921; GO:0045931; GO:0046325; GO:0046627; GO:0046716; GO:0048471; GO:0048661; GO:0048863; GO:0050729; GO:0050930; GO:0051412; GO:0051965; GO:0070374; GO:0070528; GO:0070555; GO:0071322; GO:0090330; GO:0097193; GO:0099171; GO:0099523; GO:0106310; GO:0110063; GO:0120199; GO:1904627; GO:1990917; GO:2000300; GO:2000707,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cellular response to carbohydrate stimulus [GO:0071322]; central nervous system neuron axonogenesis [GO:0021955]; chondrocyte differentiation [GO:0002062]; desmosome assembly [GO:0002159]; establishment of protein localization [GO:0045184]; induction of positive chemotaxis [GO:0050930]; intracellular calcium ion homeostasis [GO:0006874]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; learning or memory [GO:0007611]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of D-glucose import [GO:0046325]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of translation [GO:0017148]; neutrophil chemotaxis [GO:0030593]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of angiotensin-activated signaling pathway [GO:0110063]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone resorption [GO:0045780]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dense core granule biogenesis [GO:2000707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of inflammatory response [GO:0050729]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of synapse assembly [GO:0051965]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein kinase C signaling [GO:0070528]; regulation of muscle contraction [GO:0006937]; regulation of platelet aggregation [GO:0090330]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of the force of heart contraction [GO:0002026]; response to corticosterone [GO:0051412]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; response to phorbol 13-acetate 12-myristate [GO:1904627]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; stem cell differentiation [GO:0048863],alphav-beta3 integrin-PKCalpha complex [GO:0035866]; apical part of cell [GO:0045177]; axon [GO:0030424]; calyx of Held [GO:0044305]; ciliary basal body [GO:0036064]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; intercalated disc [GO:0014704]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; ooplasm [GO:1990917]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991],"ATP binding [GO:0005524]; calcium,diacylglycerol-dependent serine/threonine kinase activity [GO:0004698]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; enzyme binding [GO:0019899]; histone H3T6 kinase activity [GO:0035403]; integrin binding [GO:0005178]; lipid binding [GO:0008289]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003824; GO:0005634; GO:0005739; GO:0005783; GO:0005815; GO:0005829; GO:0005886; GO:0007155; GO:0008289; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0048870; GO:0050877; GO:0140096,"immune system process; catalytic activity; nucleus; mitochondrion; endoplasmic reticulum; microtubule organizing center; cytosol; plasma membrane; cell adhesion; lipid binding; transferase activity; cell differentiation; cell junction organization; organelle; cell motility; nervous system process; catalytic activity, acting on a protein"
OG_08799,FUN_038101-T2,Peve_00009167,Pocillopora_meandrina_HIv1___RNAseq.g25708.t1,three_way,60.379666666666665,,,,,,,,,,,,,,,,,
OG_08800,FUN_038103-T1,Peve_00025353,Pocillopora_meandrina_HIv1___RNAseq.g837.t1,three_way,71.89616666666667,FUN_038103-T1,Q4R7U0,,,,,32.1,701.0,1.2e-85,319.3,sp|Q4R7U0|TMC7_MACFA Transmembrane channel-like protein 7 OS=Macaca fascicularis OX=9541 GN=TMC7 PE=2 SV=1,,,,,,
OG_08801,FUN_038117-T2,Peve_00025358,Pocillopora_meandrina_HIv1___TS.g5367.t1,three_way,69.53733333333334,FUN_038117-T2,P49815,TSC2_HUMAN,,Tuberin (Tuberous sclerosis 2 protein),Homo sapiens (Human),35.0,1988.0,3.9999999999999998e-292,1006.5,sp|P49815|TSC2_HUMAN Tuberin OS=Homo sapiens OX=9606 GN=TSC2 PE=1 SV=2,GO:0001843; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005794; GO:0005829; GO:0006606; GO:0006897; GO:0007507; GO:0008104; GO:0008285; GO:0009267; GO:0014069; GO:0016020; GO:0016192; GO:0016239; GO:0019902; GO:0030100; GO:0030178; GO:0031267; GO:0032007; GO:0033596; GO:0042803; GO:0043276; GO:0046626; GO:0046627; GO:0048471; GO:0050918; GO:0051056; GO:0051726; GO:0051879; GO:0051898; GO:1901525; GO:1904262,anoikis [GO:0043276]; cellular response to starvation [GO:0009267]; endocytosis [GO:0006897]; heart development [GO:0007507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of mitophagy [GO:1901525]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of Wnt signaling pathway [GO:0030178]; neural tube closure [GO:0001843]; positive chemotaxis [GO:0050918]; positive regulation of macroautophagy [GO:0016239]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of small GTPase mediated signal transduction [GO:0051056]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; TSC1-TSC2 complex [GO:0033596],GTPase activator activity [GO:0005096]; Hsp90 protein binding [GO:0051879]; phosphatase binding [GO:0019902]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],GO:0005634; GO:0005764; GO:0005773; GO:0005794; GO:0005829; GO:0006886; GO:0006913; GO:0012501; GO:0016192; GO:0043226; GO:0048856; GO:0098772,nucleus; lysosome; vacuole; Golgi apparatus; cytosol; intracellular protein transport; nucleocytoplasmic transport; programmed cell death; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_08802,FUN_038118-T1,Peve_00025357,Pocillopora_meandrina_HIv1___RNAseq.g836.t1,three_way,55.861,,,,,,,,,,,,,,,,,
OG_08803,FUN_038122-T1,Peve_00003003,Pocillopora_meandrina_HIv1___RNAseq.g28329.t1,three_way,90.11766666666666,FUN_038122-T1,Q9H1Z4,,,,,48.8,363.0,1.7e-85,317.8,sp|Q9H1Z4|WDR13_HUMAN WD repeat-containing protein 13 OS=Homo sapiens OX=9606 GN=WDR13 PE=1 SV=3,,,,,,
OG_08804,FUN_038125-T1,Peve_00003033,Pocillopora_meandrina_HIv1___RNAseq.g772.t1,three_way,60.788,,,,,,,,,,,,,,,,,
OG_08805,FUN_038126-T1,Peve_00003032,Pocillopora_meandrina_HIv1___RNAseq.g771.t1,three_way,81.03983333333333,FUN_038126-T1,Q2TBT5,RNH2A_BOVIN,,Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A),Bos taurus (Bovine),52.0,298.0,4e-85,316.2,sp|Q2TBT5|RNH2A_BOVIN Ribonuclease H2 subunit A OS=Bos taurus OX=9913 GN=RNASEH2A PE=1 SV=1,GO:0003723; GO:0004523; GO:0005654; GO:0005829; GO:0006298; GO:0006401; GO:0032299; GO:0043137; GO:0046872,"DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]; RNA catabolic process [GO:0006401]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonuclease H2 complex [GO:0032299],metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523],GO:0003723; GO:0003824; GO:0005654; GO:0005829; GO:0006281; GO:0016787; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; cytosol; DNA repair; hydrolase activity; catalytic activity, acting on RNA"
OG_08806,FUN_038127-T1,Peve_00003031,Pocillopora_meandrina_HIv1___RNAseq.g770.t1,three_way,67.37616666666666,FUN_038127-T1,Q9FKY3,,,,,25.2,373.0,1.3999999999999999e-24,115.9,sp|Q9FKY3|AVT3A_ARATH Amino acid transporter AVT3A OS=Arabidopsis thaliana OX=3702 GN=AVT3A PE=1 SV=1,,,,,,
OG_08807,FUN_038128-T1,Peve_00003025,Pocillopora_meandrina_HIv1___RNAseq.g769.t1,three_way,53.877,FUN_038128-T1,Q5M9H0,ANKS3_RAT,,Ankyrin repeat and SAM domain-containing protein 3,Rattus norvegicus (Rat),35.6,132.0,4.1e-11,71.2,sp|Q5M9H0|ANKS3_RAT Ankyrin repeat and SAM domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Anks3 PE=1 SV=1,GO:0005737; GO:0005929,,cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005929; GO:0043226,cilium; organelle
OG_08808,FUN_038129-T1,Peve_00003024,Pocillopora_meandrina_HIv1___TS.g5300.t1,three_way,68.43533333333333,FUN_038129-T1,Q9SVG0,,,,,25.9,491.0,9.6e-31,136.3,sp|Q9SVG0|AVT3C_ARATH Amino acid transporter AVT3C OS=Arabidopsis thaliana OX=3702 GN=AVT3C PE=1 SV=1,,,,,,
OG_08809,FUN_038132-T1,Peve_00043373,Pocillopora_meandrina_HIv1___RNAseq.g766.t1,three_way,72.71566666666666,FUN_038132-T1,Q9JL56,GDE1_MOUSE,,Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16),Mus musculus (Mouse),37.6,295.0,5.9e-47,189.5,sp|Q9JL56|GDE1_MOUSE Glycerophosphodiester phosphodiesterase 1 OS=Mus musculus OX=10090 GN=Gde1 PE=1 SV=1,GO:0004622; GO:0005886; GO:0006580; GO:0006644; GO:0007186; GO:0008081; GO:0008889; GO:0016020; GO:0030659; GO:0046872; GO:0047395; GO:0070291,ethanolamine metabolic process [GO:0006580]; G protein-coupled receptor signaling pathway [GO:0007186]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644],cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; plasma membrane [GO:0005886],glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol glycerophosphodiesterase activity [GO:0047395]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081],GO:0003824; GO:0005886; GO:0006629; GO:0016787,catalytic activity; plasma membrane; lipid metabolic process; hydrolase activity
OG_08810,FUN_038133-T1,Peve_00043371,Pocillopora_meandrina_HIv1___TS.g5294.t1,three_way,78.59133333333334,FUN_038133-T1,Q9JL56,GDE1_MOUSE,,Glycerophosphodiester phosphodiesterase 1 (Glycerophosphoinositol glycerophosphodiesterase GDE1) (EC 3.1.4.44) (Lysophospholipase D GDE1) (EC 3.1.4.-) (Membrane-interacting protein of RGS16),Mus musculus (Mouse),41.8,306.0,4.9e-60,233.0,sp|Q9JL56|GDE1_MOUSE Glycerophosphodiester phosphodiesterase 1 OS=Mus musculus OX=10090 GN=Gde1 PE=1 SV=1,GO:0004622; GO:0005886; GO:0006580; GO:0006644; GO:0007186; GO:0008081; GO:0008889; GO:0016020; GO:0030659; GO:0046872; GO:0047395; GO:0070291,ethanolamine metabolic process [GO:0006580]; G protein-coupled receptor signaling pathway [GO:0007186]; N-acylethanolamine metabolic process [GO:0070291]; phospholipid metabolic process [GO:0006644],cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; plasma membrane [GO:0005886],glycerophosphodiester phosphodiesterase activity [GO:0008889]; glycerophosphoinositol glycerophosphodiesterase activity [GO:0047395]; lysophospholipase activity [GO:0004622]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081],GO:0003824; GO:0005886; GO:0006629; GO:0016787,catalytic activity; plasma membrane; lipid metabolic process; hydrolase activity
OG_08811,FUN_038134-T1,Peve_00043379,Pocillopora_meandrina_HIv1___RNAseq.g764.t1,three_way,80.85533333333333,FUN_038134-T1,Q8L7C8,RWA1_ARATH,,Protein REDUCED WALL ACETYLATION 1 (EC 2.3.1.-),Arabidopsis thaliana (Mouse-ear cress),42.3,433.0,1.8000000000000002e-81,305.1,sp|Q8L7C8|RWA1_ARATH Protein REDUCED WALL ACETYLATION 1 OS=Arabidopsis thaliana OX=3702 GN=RWA1 PE=2 SV=1,GO:0000139; GO:0005794; GO:0009834; GO:0016491; GO:0016740; GO:0045491; GO:0045492; GO:1990937,plant-type secondary cell wall biogenesis [GO:0009834]; xylan acetylation [GO:1990937]; xylan biosynthetic process [GO:0045492]; xylan metabolic process [GO:0045491],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740],GO:0003824; GO:0005794; GO:0005975; GO:0016491; GO:0016740; GO:0043226; GO:0071554,catalytic activity; Golgi apparatus; carbohydrate metabolic process; oxidoreductase activity; transferase activity; organelle; cell wall organization or biogenesis
OG_08812,FUN_038138-T1,Peve_00043375,Pocillopora_meandrina_HIv1___RNAseq.g762.t1,three_way,72.461,FUN_038138-T1,Q1T7B9,,,,,31.4,159.0,1.1e-19,98.2,sp|Q1T7B9|CENPM_CHICK Centromere protein M OS=Gallus gallus OX=9031 GN=CENPM PE=1 SV=1,,,,,,
OG_08813,FUN_038139-T1,Peve_00043370,Pocillopora_meandrina_HIv1___RNAseq.g761.t1,three_way,73.74383333333333,FUN_038139-T1,Q12767,,,,,33.1,1424.0,3.2e-177,624.4,sp|Q12767|TMM94_HUMAN Transmembrane protein 94 OS=Homo sapiens OX=9606 GN=TMEM94 PE=1 SV=1,,,,,,
OG_08814,FUN_038141-T1,Peve_00015891,Pocillopora_meandrina_HIv1___RNAseq.g756.t1,three_way,91.86566666666668,FUN_038141-T1,A7RUD5,NUBP1_NEMVE,,Cytosolic Fe-S cluster assembly factor NUBP1 homolog,Nematostella vectensis (Starlet sea anemone),82.2,314.0,2.4e-155,549.7,sp|A7RUD5|NUBP1_NEMVE Cytosolic Fe-S cluster assembly factor NUBP1 homolog OS=Nematostella vectensis OX=45351 GN=v1g236650 PE=3 SV=1,GO:0005524; GO:0005829; GO:0016226; GO:0046872; GO:0051536; GO:0051539; GO:0140663,iron-sulfur cluster assembly [GO:0016226],cytosol [GO:0005829],"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]",GO:0005829; GO:0140104; GO:0140657,cytosol; molecular carrier activity; ATP-dependent activity
OG_08815,FUN_038142-T1,Peve_00015889,Pocillopora_meandrina_HIv1___RNAseq.g755.t1,three_way,74.73966666666666,FUN_038142-T1,Q8IWF2,FXRD2_HUMAN,,FAD-dependent oxidoreductase domain-containing protein 2 (Endoplasmic reticulum flavoprotein associated with degradation),Homo sapiens (Human),53.4,597.0,5.4e-181,636.0,sp|Q8IWF2|FXRD2_HUMAN FAD-dependent oxidoreductase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=FOXRED2 PE=1 SV=1,GO:0004497; GO:0005788; GO:0036503; GO:0050660,ERAD pathway [GO:0036503],endoplasmic reticulum lumen [GO:0005788],flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497],GO:0003824; GO:0016491; GO:0030163,catalytic activity; oxidoreductase activity; protein catabolic process
OG_08816,FUN_038143-T1,Peve_00026425,Pocillopora_meandrina_HIv1___RNAseq.g754.t1,three_way,89.606,FUN_038143-T1,Q96AX2,RAB37_HUMAN,,Ras-related protein Rab-37 (EC 3.6.5.2),Homo sapiens (Human),68.2,201.0,5.6e-78,292.0,sp|Q96AX2|RAB37_HUMAN Ras-related protein Rab-37 OS=Homo sapiens OX=9606 GN=RAB37 PE=1 SV=3,GO:0003924; GO:0003925; GO:0005525; GO:0005768; GO:0005793; GO:0005794; GO:0005886; GO:0010508; GO:0015031; GO:0017157; GO:0032391; GO:0035577; GO:0035579; GO:0042478,positive regulation of autophagy [GO:0010508]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of eye photoreceptor cell development [GO:0042478],azurophil granule membrane [GO:0035577]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005794; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098772,catalytic activity; GTPase activity; endosome; Golgi apparatus; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08817,FUN_038145-T1,Peve_00026423,Pocillopora_meandrina_HIv1___RNAseq.g753.t1,three_way,57.66566666666667,FUN_038145-T1,Q4V9P9,,,,,22.8,762.0,2.6999999999999997e-31,138.7,sp|Q4V9P9|NOL11_DANRE Nucleolar protein 11-like OS=Danio rerio OX=7955 GN=nol11 PE=2 SV=1,,,,,,
OG_08818,FUN_038146-T1,Peve_00026422,Pocillopora_meandrina_HIv1___RNAseq.g752.t1,three_way,48.41766666666667,,,,,,,,,,,,,,,,,
OG_08819,FUN_038147-T2,Peve_00044177,Pocillopora_meandrina_HIv1___RNAseq.g1065.t1,three_way,70.619,,,,,,,,,,,,,,,,,
OG_08820,FUN_038148-T1,Peve_00044178,Pocillopora_meandrina_HIv1___RNAseq.g1064.t1,three_way,76.99816666666666,FUN_038148-T1,O70157,,,,,53.0,1054.0,0.0,1084.3,sp|O70157|TOP3A_MOUSE DNA topoisomerase 3-alpha OS=Mus musculus OX=10090 GN=Top3a PE=2 SV=1,,,,,,
OG_08821,FUN_038152-T1,Peve_00044174,Pocillopora_meandrina_HIv1___RNAseq.g1156.t1,three_way,82.86966666666666,FUN_038152-T1,Q1W376,,,,,68.3,240.0,2.4e-91,336.7,sp|Q1W376|PMM_SOYBN Phosphomannomutase OS=Glycine max OX=3847 GN=PMM PE=1 SV=1,,,,,,
OG_08822,FUN_038153-T1,Peve_00038320,Pocillopora_meandrina_HIv1___RNAseq.g1149.t1,three_way,68.13433333333333,FUN_038153-T1,Q7Z020,,,,,26.1,898.0,5e-40,168.3,sp|Q7Z020|TRPA1_DROME Transient receptor potential cation channel subfamily A member 1 OS=Drosophila melanogaster OX=7227 GN=TrpA1 PE=1 SV=4,,,,,,
OG_08823,FUN_038158-T1,Peve_00038318,Pocillopora_meandrina_HIv1___RNAseq.g1152.t1,three_way,49.616,,,,,,,,,,,,,,,,,
OG_08824,FUN_038161-T1,Peve_00033052,Pocillopora_meandrina_HIv1___RNAseq.g1154.t1,three_way,72.33833333333334,FUN_038161-T1,Q8BHY8,SNX14_MOUSE,,Sorting nexin-14,Mus musculus (Mouse),35.9,892.0,3e-144,514.2,sp|Q8BHY8|SNX14_MOUSE Sorting nexin-14 OS=Mus musculus OX=10090 GN=Snx14 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0030425; GO:0031902; GO:0045202; GO:0080025; GO:0097352; GO:0098794; GO:0099170,autophagosome maturation [GO:0097352]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein transport [GO:0015031],cytosol [GO:0005829]; dendrite [GO:0030425]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; postsynapse [GO:0098794]; synapse [GO:0045202],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]",GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0008289; GO:0031410; GO:0043226,lysosome; endosome; vacuole; cytosol; lipid binding; cytoplasmic vesicle; organelle
OG_08825,FUN_038162-T1,Peve_00038319,Pocillopora_meandrina_HIv1___RNAseq.g1076.t1,three_way,58.09933333333333,,,,,,,,,,,,,,,,,
OG_08826,FUN_038163-T1,Peve_00025803,Pocillopora_meandrina_HIv1___RNAseq.g1066.t1,three_way,90.66833333333334,FUN_038163-T1,Q6Q0C0,TRAF7_HUMAN,,E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.-) (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7),Homo sapiens (Human),53.5,486.0,1.1000000000000003e-111,405.6,sp|Q6Q0C0|TRAF7_HUMAN E3 ubiquitin-protein ligase TRAF7 OS=Homo sapiens OX=9606 GN=TRAF7 PE=1 SV=1,GO:0000151; GO:0004842; GO:0005634; GO:0005886; GO:0006915; GO:0008270; GO:0016567; GO:0031410; GO:0035519; GO:0043231; GO:0043410; GO:0043525; GO:0061630; GO:0070372; GO:2000060; GO:2001235,apoptotic process [GO:0006915]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein K29-linked ubiquitination [GO:0035519]; protein ubiquitination [GO:0016567]; regulation of ERK1 and ERK2 cascade [GO:0070372],cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005886; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleus; plasma membrane; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_08827,FUN_038164-T1,Peve_00025796,Pocillopora_meandrina_HIv1___RNAseq.g1067.t1,three_way,72.954,FUN_038164-T1,Q9CR92,,,,,46.4,248.0,3.4e-43,177.6,sp|Q9CR92|CF184_MOUSE Cilia- and flagella-associated protein 184 OS=Mus musculus OX=10090 GN=Cfap184 PE=2 SV=1,,,,,,
OG_08828,FUN_038165-T1,Peve_00025795,Pocillopora_meandrina_HIv1___RNAseq.g1068.t1,three_way,82.789,FUN_038165-T1,P04047,,,,,61.3,173.0,8.000000000000002e-57,221.5,"sp|P04047|KITH_CHICK Thymidine kinase, cytosolic OS=Gallus gallus OX=9031 GN=TK1 PE=1 SV=1",,,,,,
OG_08829,FUN_038166-T1,Peve_00025794,Pocillopora_meandrina_HIv1___RNAseq.g1069.t1,three_way,75.97183333333332,FUN_038166-T1,P85037,FOXK1_HUMAN,,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),Homo sapiens (Human),48.9,499.0,9.7e-110,399.1,sp|P85037|FOXK1_HUMAN Forkhead box protein K1 OS=Homo sapiens OX=9606 GN=FOXK1 PE=1 SV=1,GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001227; GO:0001678; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007517; GO:0010507; GO:0010906; GO:0030154; GO:0042594; GO:0045892; GO:0045893; GO:0061621; GO:0071889; GO:1990837,canonical glycolysis [GO:0061621]; cell differentiation [GO:0030154]; intracellular glucose homeostasis [GO:0001678]; muscle organ development [GO:0007517]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of glucose metabolic process [GO:0010906]; regulation of transcription by RNA polymerase II [GO:0006357]; response to starvation [GO:0042594],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"14-3-3 protein binding [GO:0071889]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0005634; GO:0005654; GO:0005975; GO:0006091; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0140110; GO:1901135,DNA binding; nucleus; nucleoplasm; carbohydrate metabolic process; generation of precursor metabolites and energy; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; transcription regulator activity; carbohydrate derivative metabolic process
OG_08830,FUN_038167-T1,Peve_00025790,Pocillopora_meandrina_HIv1___RNAseq.g1070.t1,three_way,91.073,FUN_038167-T1,P23098,,,,,73.8,4465.0,0.0,6623.9,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_08831,FUN_038168-T1,Peve_00025789,Pocillopora_meandrina_HIv1___RNAseq.g1071.t1,three_way,77.63566666666667,,,,,,,,,,,,,,,,,
OG_08832,FUN_038170-T1,Peve_00025787,Pocillopora_meandrina_HIv1___RNAseq.g1073.t1,three_way,75.25566666666666,FUN_038170-T1,Q71RS6,NCKX5_HUMAN,,Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5),Homo sapiens (Human),38.0,440.0,2.3e-83,312.0,sp|Q71RS6|NCKX5_HUMAN Sodium/potassium/calcium exchanger 5 OS=Homo sapiens OX=9606 GN=SLC24A5 PE=1 SV=1,GO:0005262; GO:0005802; GO:0006811; GO:0006874; GO:0008273; GO:0015293; GO:0032588; GO:0034220; GO:0042438; GO:0042470; GO:0048022; GO:0070509; GO:0070588,calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; melanin biosynthetic process [GO:0042438]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of melanin biosynthetic process [GO:0048022],melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]",GO:0005215; GO:0031410; GO:0043226; GO:0055085,transporter activity; cytoplasmic vesicle; organelle; transmembrane transport
OG_08833,FUN_038171-T1,Peve_00025782,Pocillopora_meandrina_HIv1___RNAseq.g1075.t1,three_way,73.20766666666667,FUN_038171-T1,Q3U829,AP5Z1_MOUSE,,AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit) (Zeta5),Mus musculus (Mouse),37.1,528.0,6.7e-83,310.5,sp|Q3U829|AP5Z1_MOUSE AP-5 complex subunit zeta-1 OS=Mus musculus OX=10090 GN=Ap5z1 PE=2 SV=1,GO:0000045; GO:0000724; GO:0005634; GO:0005737; GO:0005764; GO:0005770; GO:0006886; GO:0006914; GO:0007030; GO:0007040; GO:0010467; GO:0016192; GO:0016197; GO:0016607; GO:0034499; GO:0044599; GO:0061564; GO:1905146,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon development [GO:0061564]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; gene expression [GO:0010467]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; late endosome to Golgi transport [GO:0034499]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; vesicle-mediated transport [GO:0016192],AP-5 adaptor complex [GO:0044599]; cytoplasm [GO:0005737]; late endosome [GO:0005770]; lysosome [GO:0005764]; nuclear speck [GO:0016607]; nucleus [GO:0005634],,GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0006281; GO:0006310; GO:0006886; GO:0006914; GO:0007040; GO:0016192; GO:0030163; GO:0031410; GO:0043226,nucleus; lysosome; endosome; vacuole; DNA repair; DNA recombination; intracellular protein transport; autophagy; lysosome organization; vesicle-mediated transport; protein catabolic process; cytoplasmic vesicle; organelle
OG_08834,FUN_038174-T1,Peve_00010077,Pocillopora_meandrina_HIv1___RNAseq.g1157.t1,three_way,76.404,FUN_038174-T1,C3YWU0,FUCO_BRAFL,,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),Branchiostoma floridae (Florida lancelet) (Amphioxus),67.4,448.0,4.8e-191,668.7,sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2,GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139,fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],extracellular region [GO:0005576]; lysosome [GO:0005764],alpha-L-fucosidase activity [GO:0004560],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0005975; GO:0016787; GO:0043226; GO:1901135,catalytic activity; extracellular region; lysosome; vacuole; carbohydrate metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_08835,FUN_038179-T1,Peve_00009439,Pocillopora_meandrina_HIv1___RNAseq.g965.t1,three_way,67.80166666666668,FUN_038179-T1,Q9Y4F3,,,,,28.7,1454.0,1.1e-132,476.9,sp|Q9Y4F3|MARF1_HUMAN Meiosis regulator and mRNA stability factor 1 OS=Homo sapiens OX=9606 GN=MARF1 PE=1 SV=6,,,,,,
OG_08836,FUN_038180-T1,Peve_00009434,Pocillopora_meandrina_HIv1___RNAseq.g964.t1,three_way,80.498,FUN_038180-T1,E3SCZ8,BIRC5_CAVPO,,Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor survivin),Cavia porcellus (Guinea pig),50.4,125.0,7.1e-31,134.8,sp|E3SCZ8|BIRC5_CAVPO Baculoviral IAP repeat-containing protein 5 OS=Cavia porcellus OX=10141 GN=BIRC5 PE=1 SV=1,GO:0000226; GO:0000775; GO:0000776; GO:0004869; GO:0005634; GO:0005737; GO:0005874; GO:0006915; GO:0007059; GO:0007127; GO:0007346; GO:0007605; GO:0030496; GO:0043066; GO:0043524; GO:0046872; GO:0051233; GO:0051301; GO:0061178; GO:0061469,apoptotic process [GO:0006915]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiosis I [GO:0007127]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of mitotic cell cycle [GO:0007346]; regulation of type B pancreatic cell proliferation [GO:0061469]; sensory perception of sound [GO:0007605],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]",cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872],GO:0005634; GO:0007010; GO:0007059; GO:0012501; GO:0022414; GO:0043226; GO:0050877; GO:0098772; GO:0140013,nucleus; cytoskeleton organization; chromosome segregation; programmed cell death; reproductive process; organelle; nervous system process; molecular function regulator activity; meiotic nuclear division
OG_08837,FUN_038181-T1,Peve_00009435,Pocillopora_meandrina_HIv1___TS.g5496.t3,three_way,80.30433333333333,FUN_038181-T1,Q8TAT6,NPL4_HUMAN,,Nuclear protein localization protein 4 homolog (Protein NPL4),Homo sapiens (Human),53.6,616.0,7.4e-203,708.4,sp|Q8TAT6|NPL4_HUMAN Nuclear protein localization protein 4 homolog OS=Homo sapiens OX=9606 GN=NPLOC4 PE=1 SV=3,GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006511; GO:0007030; GO:0008270; GO:0030970; GO:0031625; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0042175; GO:0043130; GO:0043161; GO:0044877; GO:0051117; GO:0070530,"ERAD pathway [GO:0036503]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0006886; GO:0030163; GO:0043226,nucleus; nucleoplasm; endoplasmic reticulum; cytosol; intracellular protein transport; protein catabolic process; organelle
OG_08838,FUN_038182-T2,Peve_00009437,Pocillopora_meandrina_HIv1___TS.g5485.t1,three_way,80.94600000000001,FUN_038182-T2,O14981,,,,,52.2,1928.0,0.0,1865.1,sp|O14981|BTAF1_HUMAN TATA-binding protein-associated factor 172 OS=Homo sapiens OX=9606 GN=BTAF1 PE=1 SV=2,,,,,,
OG_08839,FUN_038183-T1,Peve_00006343,Pocillopora_meandrina_HIv1___RNAseq.g949.t1,three_way,67.59766666666667,FUN_038183-T1,Q4R8G6,,,,,34.9,344.0,1.3e-49,198.4,sp|Q4R8G6|MEIOB_MACFA Meiosis-specific with OB domain-containing protein OS=Macaca fascicularis OX=9541 GN=MEIOB PE=2 SV=1,,,,,,
OG_08840,FUN_038184-T1,Peve_00006348,Pocillopora_meandrina_HIv1___RNAseq.g948.t1,three_way,86.82066666666667,FUN_038184-T1,A0A0R4IVA4,CC14A_DANRE,,Dual specificity protein phosphatase CDC14AB (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog AB),Danio rerio (Zebrafish) (Brachydanio rerio),44.8,344.0,1.1e-73,278.5,sp|A0A0R4IVA4|CC14A_DANRE Dual specificity protein phosphatase CDC14AB OS=Danio rerio OX=7955 GN=cdc14ab PE=3 SV=1,GO:0000226; GO:0000922; GO:0004722; GO:0004725; GO:0005730; GO:0005737; GO:0005813; GO:0007096; GO:0032467; GO:0051301; GO:0060091; GO:0060271; GO:0072686,cell division [GO:0051301]; cilium assembly [GO:0060271]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096],centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; spindle pole [GO:0000922],protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005730; GO:0005815; GO:0005929; GO:0007010; GO:0016787; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleolus; microtubule organizing center; cilium; cytoskeleton organization; hydrolase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_08841,FUN_038186-T1,Peve_00006346,Pocillopora_meandrina_HIv1___RNAseq.g946.t1,three_way,45.531666666666666,,,,,,,,,,,,,,,,,
OG_08842,FUN_038187-T1,Peve_00006347,Pocillopora_meandrina_HIv1___RNAseq.g945.t1,three_way,61.87833333333334,FUN_038187-T1,Q80ZA4,PKHL1_MOUSE,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1) (Protein D86),Mus musculus (Mouse),34.3,4297.0,0.0,2329.7,sp|Q80ZA4|PKHL1_MOUSE Fibrocystin-L OS=Mus musculus OX=10090 GN=Pkhd1l1 PE=1 SV=1,GO:0007605; GO:0032426; GO:0060171; GO:0120234,sensory perception of sound [GO:0007605],stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],,GO:0030312; GO:0050877,external encapsulating structure; nervous system process
OG_08843,FUN_038188-T1,Peve_00003232,Pocillopora_meandrina_HIv1___RNAseq.g28758.t2,three_way,72.086,FUN_038188-T1,Q94AM1,,,,,47.9,666.0,7.099999999999998e-175,615.5,"sp|Q94AM1|OOPDA_ARATH Organellar oligopeptidase A, chloroplastic/mitochondrial OS=Arabidopsis thaliana OX=3702 GN=OOP PE=1 SV=1",,,,,,
OG_08844,FUN_038195-T1,Peve_00008324,Pocillopora_meandrina_HIv1___RNAseq.g939.t1,three_way,54.577666666666666,,,,,,,,,,,,,,,,,
OG_08845,FUN_038203-T1,Peve_00003233,Pocillopora_meandrina_HIv1___RNAseq.g3265.t1,three_way,66.08316666666667,FUN_038203-T1,O76021,RL1D1_HUMAN,,Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1),Homo sapiens (Human),36.4,250.0,3.4000000000000003e-32,140.2,sp|O76021|RL1D1_HUMAN Ribosomal L1 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=RSL1D1 PE=1 SV=3,GO:0001649; GO:0003723; GO:0003730; GO:0005694; GO:0005730; GO:0005829; GO:0005929; GO:0016020; GO:0032880; GO:0042981; GO:0043231; GO:0045296; GO:0048027; GO:2000772,osteoblast differentiation [GO:0001649]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880],chromosome [GO:0005694]; cilium [GO:0005929]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730],cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723],GO:0003723; GO:0005694; GO:0005730; GO:0005829; GO:0005929; GO:0030154; GO:0043226,RNA binding; chromosome; nucleolus; cytosol; cilium; cell differentiation; organelle
OG_08846,FUN_038204-T1,Peve_00006771,Pocillopora_meandrina_HIv1___RNAseq.g930.t1,three_way,91.27933333333333,FUN_038204-T1,P26368,U2AF2_HUMAN,,Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit),Homo sapiens (Human),67.7,387.0,2.5e-142,506.9,sp|P26368|U2AF2_HUMAN Splicing factor U2AF 65 kDa subunit OS=Homo sapiens OX=9606 GN=U2AF2 PE=1 SV=4,GO:0000243; GO:0000245; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0006397; GO:0008187; GO:0016607; GO:0019899; GO:0030628; GO:0031397; GO:0033120; GO:0048025; GO:0070742; GO:0071004; GO:0089701; GO:0140678,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of RNA splicing [GO:0033120]; spliceosomal complex assembly [GO:0000245]",commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF complex [GO:0089701],C2H2 zinc finger domain binding [GO:0070742]; enzyme binding [GO:0019899]; molecular function inhibitor activity [GO:0140678]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003; GO:0098772,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly; molecular function regulator activity
OG_08847,FUN_038205-T2,Peve_00038838,Pocillopora_meandrina_HIv1___TS.g5464.t1,three_way,60.227,FUN_038205-T2,D3ZQF9,LX12E_RAT,,"Polyunsaturated fatty acid (12S)/(13S)-lipoxygenase, epidermal-type (EC 1.13.11.-) (Arachidonate (12S)-lipoxygenase, epidermal-type) (12-LOX-e) (e(12S)-LOX) (EC 1.13.11.31) (Linoleate (13S)-lipoxygenase)",Rattus norvegicus (Rat),24.7,425.0,4.2e-26,120.9,"sp|D3ZQF9|LX12E_RAT Polyunsaturated fatty acid (12S)/(13S)-lipoxygenase, epidermal-type OS=Rattus norvegicus OX=10116 GN=Alox12e PE=3 SV=1",GO:0004052; GO:0005506; GO:0005829; GO:0005886; GO:0016165; GO:0019369; GO:0019372; GO:0034440; GO:0050473,arachidonate metabolic process [GO:0019369]; lipid oxidation [GO:0034440]; lipoxygenase pathway [GO:0019372],cytosol [GO:0005829]; plasma membrane [GO:0005886],arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165],GO:0003824; GO:0005829; GO:0005886; GO:0006629; GO:0016491,catalytic activity; cytosol; plasma membrane; lipid metabolic process; oxidoreductase activity
OG_08848,FUN_038208-T1,Peve_00038843,Pocillopora_meandrina_HIv1___RNAseq.g894.t1,three_way,54.641,,,,,,,,,,,,,,,,,
OG_08849,FUN_038210-T1,Peve_00038842,Pocillopora_meandrina_HIv1___TS.g5429.t1,three_way,51.66433333333333,FUN_038210-T1,Q7TN88,,,,,27.8,967.0,4.1e-93,344.7,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08850,FUN_038213-T1,Peve_00038850,Pocillopora_meandrina_HIv1___RNAseq.g897.t1,three_way,68.68866666666666,FUN_038213-T1,Q7Z402,,,,,32.1,639.0,1e-79,299.7,sp|Q7Z402|TMC7_HUMAN Transmembrane channel-like protein 7 OS=Homo sapiens OX=9606 GN=TMC7 PE=1 SV=1,,,,,,
OG_08851,FUN_038214-T1,Peve_00038839,Pocillopora_meandrina_HIv1___RNAseq.g898.t1,three_way,50.641666666666666,,,,,,,,,,,,,,,,,
OG_08852,FUN_038217-T1,Peve_00038841,Pocillopora_meandrina_HIv1___RNAseq.g901.t2,three_way,66.15016666666666,FUN_038217-T1,Q9UKN7,,,,,32.5,2688.0,0.0,1096.6,sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2,,,,,,
OG_08853,FUN_038218-T1,Peve_00038844,Pocillopora_meandrina_HIv1___RNAseq.g902.t1,three_way,77.83533333333334,FUN_038218-T1,Q08BA6,ALKB5_DANRE,,RNA demethylase ALKBH5 (EC 1.14.11.53) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5),Danio rerio (Zebrafish) (Brachydanio rerio),59.5,222.0,1.7999999999999996e-68,260.8,sp|Q08BA6|ALKB5_DANRE RNA demethylase ALKBH5 OS=Danio rerio OX=7955 GN=alkbh5 PE=1 SV=1,GO:0001666; GO:0005634; GO:0006397; GO:0006417; GO:0007283; GO:0010793; GO:0016607; GO:0016706; GO:0035515; GO:0042382; GO:0046872; GO:0050684; GO:0061157; GO:0140693; GO:0140694; GO:1990931,membraneless organelle assembly [GO:0140694]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of translation [GO:0006417]; response to hypoxia [GO:0001666]; spermatogenesis [GO:0007283],nuclear speck [GO:0016607]; nucleus [GO:0005634]; paraspeckles [GO:0042382],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; mRNA N6-methyladenosine dioxygenase activity [GO:1990931]; oxidative RNA demethylase activity [GO:0035515],GO:0003824; GO:0005634; GO:0016071; GO:0016491; GO:0022414; GO:0043226; GO:0060090; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; oxidoreductase activity; reproductive process; organelle; molecular adaptor activity; catalytic activity, acting on RNA"
OG_08854,FUN_038234-T1,Peve_00015705,Pocillopora_meandrina_HIv1___RNAseq.g911.t1,three_way,83.20466666666667,FUN_038234-T1,Q96S06,LMF1_HUMAN,,Lipase maturation factor 1 (Transmembrane protein 112),Homo sapiens (Human),58.9,207.0,3.3e-73,276.6,sp|Q96S06|LMF1_HUMAN Lipase maturation factor 1 OS=Homo sapiens OX=9606 GN=LMF1 PE=1 SV=1,GO:0005789; GO:0006486; GO:0006641; GO:0006888; GO:0009306; GO:0034382; GO:0051604; GO:0090181; GO:0090207,chylomicron remnant clearance [GO:0034382]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein glycosylation [GO:0006486]; protein maturation [GO:0051604]; protein secretion [GO:0009306]; regulation of cholesterol metabolic process [GO:0090181]; regulation of triglyceride metabolic process [GO:0090207]; triglyceride metabolic process [GO:0006641],endoplasmic reticulum membrane [GO:0005789],,GO:0006486; GO:0006629; GO:0016192; GO:0051604,protein glycosylation; lipid metabolic process; vesicle-mediated transport; protein maturation
OG_08855,FUN_038236-T1,Peve_00015712,Pocillopora_meandrina_HIv1___RNAseq.g910.t1,three_way,73.396,FUN_038236-T1,Q8C2A2,,,,,23.9,507.0,6.5e-20,99.8,sp|Q8C2A2|SEN54_MOUSE tRNA-splicing endonuclease subunit Sen54 OS=Mus musculus OX=10090 GN=Tsen54 PE=2 SV=2,,,,,,
OG_08856,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_08857,FUN_038243-T1,Peve_00029667,Pocillopora_meandrina_HIv1___TS.g5440.t1,three_way,80.75166666666667,FUN_038243-T1,P12389,ACHA2_RAT,,Neuronal acetylcholine receptor subunit alpha-2,Rattus norvegicus (Rat),36.7,436.0,2.8999999999999996e-68,260.8,sp|P12389|ACHA2_RAT Neuronal acetylcholine receptor subunit alpha-2 OS=Rattus norvegicus OX=10116 GN=Chrna2 PE=1 SV=2,GO:0005654; GO:0005886; GO:0005892; GO:0007165; GO:0007271; GO:0007274; GO:0015464; GO:0022848; GO:0032991; GO:0034220; GO:0034703; GO:0035094; GO:0043005; GO:0045171; GO:0045202; GO:0045211; GO:0050997; GO:0051899; GO:0071316; GO:0071944; GO:0095500; GO:0098828; GO:0098878; GO:0120111; GO:1901363; GO:1905144,"acetylcholine receptor signaling pathway [GO:0095500]; cellular response to nicotine [GO:0071316]; membrane depolarization [GO:0051899]; modulation of inhibitory postsynaptic potential [GO:0098828]; monoatomic ion transmembrane transport [GO:0034220]; neuromuscular synaptic transmission [GO:0007274]; response to acetylcholine [GO:1905144]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cell periphery [GO:0071944]; intercellular bridge [GO:0045171]; neuron projection [GO:0043005]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synapse [GO:0045202],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; nucleoplasm; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_08858,FUN_038244-T2,Peve_00029668,Pocillopora_meandrina_HIv1___TS.g5461.t1,three_way,77.83200000000001,FUN_038244-T2,Q15822,ACHA2_HUMAN,,Neuronal acetylcholine receptor subunit alpha-2 (Nicotinic acetylcholine receptor subunit alpha-2),Homo sapiens (Human),34.7,505.0,3.8e-83,310.5,sp|Q15822|ACHA2_HUMAN Neuronal acetylcholine receptor subunit alpha-2 OS=Homo sapiens OX=9606 GN=CHRNA2 PE=1 SV=2,GO:0005654; GO:0005886; GO:0005892; GO:0006811; GO:0007165; GO:0007271; GO:0007274; GO:0015464; GO:0016020; GO:0022848; GO:0034220; GO:0034703; GO:0035094; GO:0043005; GO:0045171; GO:0045202; GO:0045211; GO:0050997; GO:0051899; GO:0071316; GO:0095500; GO:0098828; GO:0098878; GO:0120111; GO:1901363,"acetylcholine receptor signaling pathway [GO:0095500]; cellular response to nicotine [GO:0071316]; membrane depolarization [GO:0051899]; modulation of inhibitory postsynaptic potential [GO:0098828]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; neuromuscular synaptic transmission [GO:0007274]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; intercellular bridge [GO:0045171]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; nucleoplasm; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_08859,FUN_038245-T1,Peve_00007985,Pocillopora_meandrina_HIv1___TS.g5460.t2,three_way,84.75483333333334,FUN_038245-T1,P24733,,,,,61.2,841.0,5e-306,1052.7,"sp|P24733|MYS_ARGIR Myosin heavy chain, striated muscle OS=Argopecten irradians OX=31199 PE=1 SV=1",,,,,,
OG_08860,FUN_038246-T1,Peve_00007987,Pocillopora_meandrina_HIv1___RNAseq.g924.t1,three_way,77.44533333333334,FUN_038246-T1,Q9UBH6,S53A1_HUMAN,,Solute carrier family 53 member 1 (Phosphate exporter SLC53A1) (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor) (Xenotropic and polytropic retrovirus receptor 1),Homo sapiens (Human),44.3,395.0,5.400000000000001e-89,329.7,sp|Q9UBH6|S53A1_HUMAN Solute carrier family 53 member 1 OS=Homo sapiens OX=9606 GN=XPR1 PE=1 SV=1,GO:0000822; GO:0001618; GO:0005315; GO:0005886; GO:0006817; GO:0009615; GO:0015562; GO:0016036; GO:0030643; GO:0035435,cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817]; response to virus [GO:0009615],plasma membrane [GO:0005886],efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate transmembrane transporter activity [GO:0005315]; virus receptor activity [GO:0001618],GO:0001618; GO:0005215; GO:0005886; GO:0055085,virus receptor activity; transporter activity; plasma membrane; transmembrane transport
OG_08861,FUN_038247-T1,Peve_00007988,Pocillopora_meandrina_HIv1___RNAseq.g923.t1,three_way,78.74566666666666,FUN_038247-T1,P15170,ERF3A_HUMAN,,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (EC 3.6.5.-) (G1 to S phase transition protein 1 homolog),Homo sapiens (Human),71.9,427.0,3.8e-190,666.0,sp|P15170|ERF3A_HUMAN Eukaryotic peptide chain release factor GTP-binding subunit ERF3A OS=Homo sapiens OX=9606 GN=GSPT1 PE=1 SV=1,GO:0000082; GO:0000184; GO:0003723; GO:0003747; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0006412; GO:0006415; GO:0006449; GO:0006479; GO:0018444; GO:0022626,"G1/S transition of mitotic cell cycle [GO:0000082]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; regulation of translational termination [GO:0006449]; translation [GO:0006412]; translational termination [GO:0006415]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; translation release factor complex [GO:0018444],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; translation release factor activity [GO:0003747],GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0005840; GO:0016071; GO:0016787; GO:0043226,RNA binding; catalytic activity; GTPase activity; cytosol; ribosome; mRNA metabolic process; hydrolase activity; organelle
OG_08862,FUN_038252-T1,Peve_00007989,Pocillopora_meandrina_HIv1___RNAseq.g922.t1,three_way,87.688,FUN_038252-T1,Q5ZHN3,,,,,65.4,442.0,1.1e-157,557.8,sp|Q5ZHN3|WIPI2_CHICK WD repeat domain phosphoinositide-interacting protein 2 OS=Gallus gallus OX=9031 GN=WIPI2 PE=2 SV=1,,,,,,
OG_08863,FUN_038255-T1,Peve_00007991,Pocillopora_meandrina_HIv1___RNAseq.g920.t1,three_way,62.71116666666666,FUN_038255-T1,Q91ZW6,TMLH_RAT,,"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)",Rattus norvegicus (Rat),39.7,358.0,4.9e-73,276.6,"sp|Q91ZW6|TMLH_RAT Trimethyllysine dioxygenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Tmlhe PE=1 SV=2",GO:0005506; GO:0005739; GO:0005759; GO:0016702; GO:0045329; GO:0050353,carnitine biosynthetic process [GO:0045329],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]",GO:0003824; GO:0005739; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_08864,FUN_038256-T1,Peve_00007992,Pocillopora_meandrina_HIv1___RNAseq.g919.t1,three_way,77.747,FUN_038256-T1,Q14CZ0,HAPR1_HUMAN,,HUWE1-associated protein modifying stress responses 1 (Telomere attrition and p53 response 1 protein),Homo sapiens (Human),33.2,259.0,1.6e-18,94.7,sp|Q14CZ0|HAPR1_HUMAN HUWE1-associated protein modifying stress responses 1 OS=Homo sapiens OX=9606 GN=HAPSTR1 PE=1 SV=1,GO:0005634; GO:0005737; GO:0031625; GO:0080135; GO:1901797,negative regulation of signal transduction by p53 class mediator [GO:1901797]; regulation of cellular response to stress [GO:0080135],cytoplasm [GO:0005737]; nucleus [GO:0005634],ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0043226,nucleus; organelle
OG_08865,FUN_038257-T1,Peve_00007993,Pocillopora_meandrina_HIv1___RNAseq.g918.t1,three_way,71.358,FUN_038257-T1,Q7YR75,,,,,46.6,161.0,9.3e-27,121.7,sp|Q7YR75|RM12_BOVIN Large ribosomal subunit protein bL12m OS=Bos taurus OX=9913 GN=MRPL12 PE=1 SV=1,,,,,,
OG_08866,FUN_038258-T1,Peve_00007994,Pocillopora_meandrina_HIv1___RNAseq.g917.t1,three_way,77.65366666666667,FUN_038258-T1,P51798,CLCN7_HUMAN,,H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7),Homo sapiens (Human),54.4,803.0,4.6e-237,822.4,sp|P51798|CLCN7_HUMAN H(+)/Cl(-) exchange transporter 7 OS=Homo sapiens OX=9606 GN=CLCN7 PE=1 SV=2,GO:0005254; GO:0005524; GO:0005765; GO:0009268; GO:0015108; GO:0016020; GO:0030321; GO:0034707; GO:0043231; GO:0062158,response to pH [GO:0009268]; transepithelial chloride transport [GO:0030321],chloride channel complex [GO:0034707]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride transmembrane transporter activity [GO:0015108]; chloride:proton antiporter activity [GO:0062158],GO:0005215; GO:0043226,transporter activity; organelle
OG_08867,FUN_038259-T1,Peve_00007995,Pocillopora_meandrina_HIv1___RNAseq.g916.t1,three_way,69.33433333333333,,,,,,,,,,,,,,,,,
OG_08868,FUN_038260-T1,Peve_00007996,Pocillopora_meandrina_HIv1___RNAseq.g915.t1,three_way,66.451,FUN_038260-T1,P30552,,,,,30.7,192.0,8.4e-15,82.8,sp|P30552|GASR_CANLF Gastrin/cholecystokinin type B receptor OS=Canis lupus familiaris OX=9615 GN=CCKBR PE=2 SV=1,,,,,,
OG_08869,FUN_038265-T1,Peve_00007997,Pocillopora_meandrina_HIv1___RNAseq.g914.t1,three_way,86.61366666666667,FUN_038265-T1,A6HD62,CHIP_RAT,,E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1),Rattus norvegicus (Rat),58.4,238.0,7.000000000000001e-75,282.0,sp|A6HD62|CHIP_RAT E3 ubiquitin-protein ligase CHIP OS=Rattus norvegicus OX=10116 GN=Stub1 PE=1 SV=1,GO:0000151; GO:0000165; GO:0000209; GO:0001664; GO:0002931; GO:0004842; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0006281; GO:0006511; GO:0006513; GO:0006515; GO:0010614; GO:0016567; GO:0019899; GO:0019900; GO:0030018; GO:0030512; GO:0030544; GO:0030911; GO:0030968; GO:0031072; GO:0031398; GO:0031625; GO:0031647; GO:0031943; GO:0032436; GO:0034392; GO:0034393; GO:0034450; GO:0034605; GO:0035359; GO:0036503; GO:0042405; GO:0042803; GO:0043066; GO:0043161; GO:0045862; GO:0046332; GO:0050821; GO:0051087; GO:0051787; GO:0051865; GO:0051879; GO:0061630; GO:0061684; GO:0070412; GO:0070534; GO:0071218; GO:0071456; GO:0090035; GO:0101031; GO:1901526; GO:1904294; GO:1904694,cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; MAPK cascade [GO:0000165]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035359]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular associated smooth muscle contraction [GO:1904694]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of mitophagy [GO:1901526]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018],enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],GO:0003013; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005829; GO:0006281; GO:0006914; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"circulatory system process; catalytic activity; nucleus; nucleoplasm; mitochondrion; endoplasmic reticulum; cytosol; DNA repair; autophagy; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_08870,FUN_038266-T1,Peve_00007998,Pocillopora_meandrina_HIv1___RNAseq.g913.t1,three_way,78.818,FUN_038266-T1,Q15546,,,,,42.0,224.0,7.7e-44,178.7,sp|Q15546|PAQRB_HUMAN Monocyte to macrophage differentiation factor OS=Homo sapiens OX=9606 GN=MMD PE=1 SV=2,,,,,,
OG_08871,FUN_038268-T1,Peve_00008000,Pocillopora_meandrina_HIv1___TS.g5412.t1,three_way,67.79916666666666,FUN_038268-T1,Q8N5R6,,,,,28.3,782.0,1.1e-70,270.0,sp|Q8N5R6|CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens OX=9606 GN=CCDC33 PE=1 SV=3,,,,,,
OG_08872,FUN_038269-T1,Peve_00007979,Pocillopora_meandrina_HIv1___RNAseq.g28326.t1,three_way,89.67233333333333,FUN_038269-T1,P45985,MP2K4_HUMAN,,Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK),Homo sapiens (Human),66.9,354.0,3.1e-132,473.0,sp|P45985|MP2K4_HUMAN Dual specificity mitogen-activated protein kinase kinase 4 OS=Homo sapiens OX=9606 GN=MAP2K4 PE=1 SV=1,GO:0000165; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005829; GO:0007165; GO:0007254; GO:0008545; GO:0009611; GO:0034390; GO:0036481; GO:0038095; GO:0060090; GO:0071260; GO:0090398; GO:0106310; GO:2000672,cellular response to mechanical stimulus [GO:0071260]; cellular senescence [GO:0090398]; Fc-epsilon receptor signaling pathway [GO:0038095]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; smooth muscle cell apoptotic process [GO:0034390],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; molecular adaptor activity [GO:0060090]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005829; GO:0012501; GO:0016740; GO:0043226; GO:0060090; GO:0140096,"catalytic activity; nucleus; cytosol; programmed cell death; transferase activity; organelle; molecular adaptor activity; catalytic activity, acting on a protein"
OG_08873,FUN_038270-T1,Peve_00007980,Pocillopora_meandrina_HIv1___TS.g21499.t1,three_way,66.01583333333333,FUN_038270-T1,Q8NCG7,DGLB_HUMAN,,Diacylglycerol lipase-beta (DAGL-beta) (DGL-beta) (EC 3.1.1.116) (KCCR13L) (PUFA-specific triacylglycerol lipase) (EC 3.1.1.3) (Sn1-specific diacylglycerol lipase beta),Homo sapiens (Human),36.5,698.0,2.7e-105,384.4,sp|Q8NCG7|DGLB_HUMAN Diacylglycerol lipase-beta OS=Homo sapiens OX=9606 GN=DAGLB PE=1 SV=2,GO:0001516; GO:0004806; GO:0005654; GO:0005765; GO:0005886; GO:0006640; GO:0007405; GO:0010898; GO:0016298; GO:0019369; GO:0022008; GO:0046340; GO:0046872; GO:0047372; GO:0050727; GO:1901696,arachidonate metabolic process [GO:0019369]; cannabinoid biosynthetic process [GO:1901696]; diacylglycerol catabolic process [GO:0046340]; monoacylglycerol biosynthetic process [GO:0006640]; neuroblast proliferation [GO:0007405]; neurogenesis [GO:0022008]; positive regulation of triglyceride catabolic process [GO:0010898]; prostaglandin biosynthetic process [GO:0001516]; regulation of inflammatory response [GO:0050727],lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],lipase activity [GO:0016298]; metal ion binding [GO:0046872]; monoacylglycerol lipase activity [GO:0047372]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005654; GO:0005886; GO:0006629; GO:0016787; GO:0030154,catalytic activity; nucleoplasm; plasma membrane; lipid metabolic process; hydrolase activity; cell differentiation
OG_08874,FUN_038271-T1,Peve_00010406,Pocillopora_meandrina_HIv1___RNAseq.g28323.t1,three_way,64.48483333333333,FUN_038271-T1,Q7TN88,,,,,29.4,1654.0,3.4e-170,602.1,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08875,FUN_038274-T1,Peve_00010404,Pocillopora_meandrina_HIv1___RNAseq.g28322.t1,three_way,79.786,FUN_038274-T1,Q5U4D9,,,,,44.8,299.0,7.8e-76,285.4,sp|Q5U4D9|THOC6_MOUSE THO complex subunit 6 homolog OS=Mus musculus OX=10090 GN=Thoc6 PE=1 SV=1,,,,,,
OG_08876,FUN_038275-T1,Peve_00041698,Pocillopora_meandrina_HIv1___RNAseq.g28318.t1,three_way,51.19616666666667,,,,,,,,,,,,,,,,,
OG_08877,FUN_038276-T1,Peve_00041699,Pocillopora_meandrina_HIv1___RNAseq.g28317.t1,three_way,92.74166666666666,FUN_038276-T1,Q8IV36,HID1_HUMAN,,Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog),Homo sapiens (Human),67.8,793.0,1.2e-311,1070.1,sp|Q8IV36|HID1_HUMAN Protein HID1 OS=Homo sapiens OX=9606 GN=HID1 PE=1 SV=1,GO:0000138; GO:0005737; GO:0005794; GO:0005797; GO:0005829; GO:0005881; GO:0009749; GO:0016020; GO:0030070; GO:0042144; GO:0061792; GO:0070062; GO:0098548,"insulin processing [GO:0030070]; response to glucose [GO:0009749]; secretory granule maturation [GO:0061792]; vacuole fusion, non-autophagic [GO:0042144]",cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic side of Golgi membrane [GO:0098548]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020],,GO:0005794; GO:0005829; GO:0043226; GO:0051604,Golgi apparatus; cytosol; organelle; protein maturation
OG_08878,FUN_038277-T1,Peve_00041700,Pocillopora_meandrina_HIv1___TS.g8098.t1,three_way,74.06316666666667,FUN_038277-T1,Q0V8S9,,,,,34.8,135.0,1.4e-13,84.7,sp|Q0V8S9|CNTP5_CHICK Contactin-associated protein-like 5 OS=Gallus gallus OX=9031 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_08879,FUN_038279-T1,Peve_00041709,Pocillopora_meandrina_HIv1___RNAseq.g28314.t1,three_way,89.11583333333333,FUN_038279-T1,Q4G0X9,CCD40_HUMAN,,Coiled-coil domain-containing protein 40,Homo sapiens (Human),30.7,969.0,3.8e-100,367.9,sp|Q4G0X9|CCD40_HUMAN Coiled-coil domain-containing protein 40 OS=Homo sapiens OX=9606 GN=CCDC40 PE=1 SV=2,GO:0001947; GO:0003341; GO:0003351; GO:0003356; GO:0005576; GO:0005737; GO:0005929; GO:0005930; GO:0030317; GO:0030324; GO:0031514; GO:0035082; GO:0035469; GO:0036159; GO:0044458; GO:0060287; GO:0061512; GO:0070286; GO:0071907; GO:0071910,axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356],axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514],,GO:0005576; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0048870; GO:0065003,extracellular region; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; cilium organization; anatomical structure development; cell motility; protein-containing complex assembly
OG_08880,FUN_038280-T1,Peve_00041710,Pocillopora_meandrina_HIv1___RNAseq.g28313.t1,three_way,72.69066666666667,FUN_038280-T1,Q3TEL6,RN157_MOUSE,,E3 ubiquitin ligase Rnf157 (EC 2.3.2.27) (RING finger protein 157) (RING-type E3 ubiquitin transferase Rnf157),Mus musculus (Mouse),47.4,380.0,9.999999999999999e-92,339.0,sp|Q3TEL6|RN157_MOUSE E3 ubiquitin ligase Rnf157 OS=Mus musculus OX=10090 GN=Rnf157 PE=1 SV=2,GO:0005737; GO:0008270; GO:0016567; GO:0043066; GO:0044297; GO:0061630; GO:1903861,negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite extension [GO:1903861]; protein ubiquitination [GO:0016567],cell body [GO:0044297]; cytoplasm [GO:0005737],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_08881,FUN_038282-T1,Peve_00041717,Pocillopora_meandrina_HIv1___RNAseq.g28312.t1,three_way,62.675,,,,,,,,,,,,,,,,,
OG_08882,FUN_038284-T1,Peve_00041720,Pocillopora_meandrina_HIv1___RNAseq.g28310.t1,three_way,75.99766666666667,FUN_038284-T1,Q60631,GRB2_MOUSE,,Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2),Mus musculus (Mouse),62.0,213.0,1.7000000000000002e-74,280.4,sp|Q60631|GRB2_MOUSE Growth factor receptor-bound protein 2 OS=Mus musculus OX=10090 GN=Grb2 PE=1 SV=1,GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019903; GO:0019904; GO:0030036; GO:0030674; GO:0030838; GO:0031623; GO:0035987; GO:0038133; GO:0042110; GO:0042267; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0045953; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0060090; GO:0060670; GO:0070436; GO:0071479; GO:2000379,actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction in response to DNA damage [GO:0042770]; T cell activation [GO:0042110],cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506],ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; molecular adaptor activity [GO:0060090]; neurotrophin TRKA receptor binding [GO:0005168]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0002376; GO:0005634; GO:0005768; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0007010; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0098772,immune system process; nucleus; endosome; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; cytoskeleton organization; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_08883,FUN_038285-T1,Peve_00041722,Pocillopora_meandrina_HIv1___RNAseq.g28309.t1a,three_way,84.59233333333333,FUN_038285-T1,A7SE05,UBE2S_NEMVE,,Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (Ubiquitin carrier protein S) (Ubiquitin-protein ligase S),Nematostella vectensis (Starlet sea anemone),74.8,206.0,2.1e-82,306.6,sp|A7SE05|UBE2S_NEMVE Ubiquitin-conjugating enzyme E2 S OS=Nematostella vectensis OX=45351 GN=v1g237158 PE=3 SV=1,GO:0000209; GO:0005524; GO:0005634; GO:0005680; GO:0006511; GO:0010458; GO:0010994; GO:0031145; GO:0051301; GO:0061631; GO:0070979; GO:1904668,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],anaphase-promoting complex [GO:0005680]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],GO:0003824; GO:0005634; GO:0016740; GO:0030163; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; nucleus; transferase activity; protein catabolic process; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_08884,FUN_038286-T1,Peve_00041723,Pocillopora_meandrina_HIv1___RNAseq.g28308.t1,three_way,69.07466666666667,FUN_038286-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),52.2,69.0,7.9e-14,81.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_08885,FUN_038290-T1,Peve_00041725,Pocillopora_meandrina_HIv1___RNAseq.g28307.t1,three_way,85.748,FUN_038290-T1,A7SE07,,,,,77.1,253.0,1.4e-121,437.2,sp|A7SE07|NUBP2_NEMVE Cytosolic Fe-S cluster assembly factor NUBP2 homolog OS=Nematostella vectensis OX=45351 GN=v1g229988 PE=3 SV=1,,,,,,
OG_08886,FUN_038292-T1,Peve_00041726,Pocillopora_meandrina_HIv1___RNAseq.g28306.t1,three_way,85.80533333333334,FUN_038292-T1,P94598,,,,,64.2,438.0,3.3e-168,592.8,sp|P94598|DHE3_BACTN Glutamate dehydrogenase OS=Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50) OX=226186 GN=gdhA PE=3 SV=2,,,,,,
OG_08887,FUN_038293-T1,Peve_00041729,Pocillopora_meandrina_HIv1___RNAseq.g28295.t1,three_way,42.59433333333333,,,,,,,,,,,,,,,,,
OG_08888,FUN_038294-T1,Peve_00041731,Pocillopora_meandrina_HIv1___RNAseq.g28300.t1,three_way,63.32116666666666,FUN_038294-T1,Q7YR76,,,,,24.8,440.0,1.6e-15,86.7,sp|Q7YR76|MYCD_PIG Myocardin OS=Sus scrofa OX=9823 GN=MYOCD PE=2 SV=1,,,,,,
OG_08889,FUN_038295-T1,Peve_00041732,Pocillopora_meandrina_HIv1___RNAseq.g28299.t1,three_way,78.112,FUN_038295-T1,Q5E9V1,DCNL3_BOVIN,,DCN1-like protein 3 (DCNL3) (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3),Bos taurus (Bovine),59.8,204.0,2.3e-64,247.3,sp|Q5E9V1|DCNL3_BOVIN DCN1-like protein 3 OS=Bos taurus OX=9913 GN=DCUN1D3 PE=2 SV=1,GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0010225; GO:0010332; GO:0010564; GO:0030308; GO:0031624; GO:0032182; GO:0043065; GO:0045116; GO:0048471; GO:0097602; GO:2000134; GO:2000434; GO:2000435; GO:2000436,negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of protein neddylation [GO:2000435]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein neddylation [GO:2000436]; protein neddylation [GO:0045116]; regulation of cell cycle process [GO:0010564]; regulation of protein neddylation [GO:2000434]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151],cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182],GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0043226,nucleus; nucleoplasm; cytosol; plasma membrane; organelle
OG_08890,FUN_038296-T1,Peve_00041733,Pocillopora_meandrina_HIv1___RNAseq.g28298.t1,three_way,74.72033333333333,FUN_038296-T1,Q15750,,,,,44.6,424.0,8.1e-89,329.3,sp|Q15750|TAB1_HUMAN TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 OS=Homo sapiens OX=9606 GN=TAB1 PE=1 SV=1,,,,,,
OG_08891,FUN_038298-T1,Peve_00041737,Pocillopora_meandrina_HIv1___RNAseq.g28296.t1,three_way,96.35433333333332,FUN_038298-T1,Q6P8E9,,,,,85.9,128.0,2.2e-56,219.5,sp|Q6P8E9|NH2L1_XENTR NHP2-like protein 1 OS=Xenopus tropicalis OX=8364 GN=snu13 PE=2 SV=1,,,,,,
OG_08892,FUN_038299-T1,Peve_00041738,Pocillopora_meandrina_HIv1___RNAseq.g28301.t1,three_way,89.779,FUN_038299-T1,Q9UPM9,,,,,72.0,182.0,2.4e-79,296.6,sp|Q9UPM9|B9D1_HUMAN B9 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=B9D1 PE=1 SV=1,,,,,,
OG_08893,FUN_038300-T1,Peve_00041739,Pocillopora_meandrina_HIv1___RNAseq.g28302.t1,three_way,86.363,FUN_038300-T1,E9PY46,IF140_MOUSE,,Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2),Mus musculus (Mouse),53.5,1487.0,0.0,1540.0,sp|E9PY46|IF140_MOUSE Intraflagellar transport protein 140 homolog OS=Mus musculus OX=10090 GN=Ift140 PE=1 SV=1,GO:0005654; GO:0005739; GO:0005813; GO:0005814; GO:0005929; GO:0005930; GO:0007368; GO:0007507; GO:0008589; GO:0021532; GO:0030991; GO:0031076; GO:0032391; GO:0035108; GO:0035721; GO:0035845; GO:0036064; GO:0042073; GO:0042733; GO:0048701; GO:0060271; GO:0061512; GO:0097730; GO:0120199; GO:1902017; GO:1905515; GO:1990403,cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589],axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cone photoreceptor outer segment [GO:0120199]; intraciliary transport particle A [GO:0030991]; mitochondrion [GO:0005739]; non-motile cilium [GO:0097730]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391],,GO:0005654; GO:0005739; GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,nucleoplasm; mitochondrion; microtubule organizing center; cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_08894,FUN_038301-T1,Peve_00000032,Pocillopora_meandrina_HIv1___TS.g8084.t1,three_way,46.3595,FUN_038301-T1,Q1RLU1,BRAT1_DANRE,,Integrator complex assembly factor BRAT1 (BRCA1-associated ATM activator 1) (BRCA1-associated protein required for ATM activation protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),24.8,404.0,4.7e-23,111.7,sp|Q1RLU1|BRAT1_DANRE Integrator complex assembly factor BRAT1 OS=Danio rerio OX=7955 GN=brat1 PE=2 SV=1,GO:0001934; GO:0005634; GO:0005737; GO:0006974; GO:0008283; GO:0008428; GO:0010212; GO:0034504; GO:0160234,cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; integrator complex assembly [GO:0160234]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to nucleus [GO:0034504]; response to ionizing radiation [GO:0010212],cytoplasm [GO:0005737]; nucleus [GO:0005634],ribonuclease inhibitor activity [GO:0008428],GO:0005634; GO:0043226; GO:0065003; GO:0098772,nucleus; organelle; protein-containing complex assembly; molecular function regulator activity
OG_08895,FUN_038302-T1,Peve_00000035,Pocillopora_meandrina_HIv1___RNAseq.g28304.t1,three_way,90.22033333333331,FUN_038302-T1,F8WK50,,,,,59.3,1273.0,2.6e-295,1016.5,sp|F8WK50|FLII_DANRE Protein flightless-1 homolog OS=Danio rerio OX=7955 GN=flii PE=1 SV=1,,,,,,
OG_08896,FUN_038303-T1,Peve_00000042,Pocillopora_meandrina_HIv1___RNAseq.g28305.t1,three_way,74.95766666666667,FUN_038303-T1,Q60631,GRB2_MOUSE,,Growth factor receptor-bound protein 2 (Adapter protein GRB2) (SH2/SH3 adapter GRB2),Mus musculus (Mouse),52.4,212.0,9e-63,241.5,sp|Q60631|GRB2_MOUSE Growth factor receptor-bound protein 2 OS=Mus musculus OX=10090 GN=Grb2 PE=1 SV=1,GO:0001784; GO:0005068; GO:0005091; GO:0005154; GO:0005168; GO:0005634; GO:0005737; GO:0005768; GO:0005794; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005938; GO:0007173; GO:0007265; GO:0008180; GO:0008286; GO:0008543; GO:0012506; GO:0014044; GO:0016020; GO:0017124; GO:0019903; GO:0019904; GO:0030036; GO:0030674; GO:0030838; GO:0031623; GO:0035987; GO:0038133; GO:0042110; GO:0042267; GO:0042552; GO:0042770; GO:0042802; GO:0043408; GO:0043560; GO:0045953; GO:0046875; GO:0048009; GO:0048646; GO:0050853; GO:0060090; GO:0060670; GO:0070436; GO:0071479; GO:2000379,actin cytoskeleton organization [GO:0030036]; anatomical structure formation involved in morphogenesis [GO:0048646]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2-ERBB3 signaling pathway [GO:0038133]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction in response to DNA damage [GO:0042770]; T cell activation [GO:0042110],cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506],ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; molecular adaptor activity [GO:0060090]; neurotrophin TRKA receptor binding [GO:0005168]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; protein-macromolecule adaptor activity [GO:0030674]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0002376; GO:0005634; GO:0005768; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0007010; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0098772,immune system process; nucleus; endosome; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; cytoskeleton organization; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_08897,FUN_038310-T1,Peve_00031058,Pocillopora_meandrina_HIv1___TS.g5675.t2,three_way,77.90333333333334,FUN_038310-T1,Q6NVC5,MIRO1_DANRE,,Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A),Danio rerio (Zebrafish) (Brachydanio rerio),53.8,617.0,3.1000000000000003e-185,649.8,sp|Q6NVC5|MIRO1_DANRE Mitochondrial Rho GTPase 1-A OS=Danio rerio OX=7955 GN=rhot1a PE=2 SV=1,GO:0003924; GO:0005509; GO:0005525; GO:0005739; GO:0005741; GO:0007005; GO:0019725; GO:0047497; GO:0097345,cellular homeostasis [GO:0019725]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrion organization [GO:0007005]; mitochondrion transport along microtubule [GO:0047497],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0007005; GO:0007018; GO:0016787; GO:0043226; GO:0061024,catalytic activity; GTPase activity; mitochondrion; mitochondrion organization; microtubule-based movement; hydrolase activity; organelle; membrane organization
OG_08898,FUN_038311-T1,Peve_00020693,Pocillopora_meandrina_HIv1___RNAseq.g1142.t1,three_way,76.04366666666667,FUN_038311-T1,Q8R5K6,,,,,43.3,217.0,3.8e-39,163.3,sp|Q8R5K6|TOB1_RAT Protein Tob1 OS=Rattus norvegicus OX=10116 GN=Tob1 PE=1 SV=1,,,,,,
OG_08899,FUN_038313-T1,Peve_00012900,Pocillopora_meandrina_HIv1___RNAseq.g1140.t1,three_way,82.80183333333333,FUN_038313-T1,P51892,,,,,59.5,797.0,1.5e-269,930.6,sp|P51892|DNLI1_XENLA DNA ligase 1 OS=Xenopus laevis OX=8355 GN=lig1 PE=2 SV=1,,,,,,
OG_08900,FUN_038314-T2,Peve_00012903,Pocillopora_meandrina_HIv1___RNAseq.g1121.t1,three_way,49.371833333333335,,,,,,,,,,,,,,,,,
OG_08901,FUN_038315-T1,Peve_00035853,Pocillopora_meandrina_HIv1___RNAseq.g1120.t1,three_way,66.31266666666666,FUN_038315-T1,Q8NDV7,,,,,34.4,224.0,3.4e-17,93.2,sp|Q8NDV7|TNR6A_HUMAN Trinucleotide repeat-containing gene 6A protein OS=Homo sapiens OX=9606 GN=TNRC6A PE=1 SV=2,,,,,,
OG_08902,FUN_038330-T1,Peve_00023108,Pocillopora_meandrina_HIv1___RNAseq.g1119.t2,three_way,80.42033333333333,FUN_038330-T1,Q9EQY0,ERN1_MOUSE,,Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],Mus musculus (Mouse),44.5,954.0,2.3e-213,743.8,sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus OX=10090 GN=Ern1 PE=1 SV=1,GO:0000287; GO:0001935; GO:0004519; GO:0004521; GO:0004674; GO:0005161; GO:0005524; GO:0005637; GO:0005739; GO:0005789; GO:0006468; GO:0017148; GO:0019899; GO:0030544; GO:0030968; GO:0033120; GO:0035924; GO:0036498; GO:0042803; GO:0043507; GO:0043531; GO:0046777; GO:0051879; GO:0070054; GO:0070059; GO:0070301; GO:0071333; GO:0106310; GO:1900103; GO:1901142; GO:1904294; GO:1904707; GO:1990597; GO:1990604; GO:1990630,"cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA splicing, via endonucleolytic cleavage and ligation [GO:0070054]; negative regulation of translation [GO:0017148]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]",AIP1-IRE1 complex [GO:1990597]; endoplasmic reticulum membrane [GO:0005789]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637],ADP binding [GO:0043531]; ATP binding [GO:0005524]; endonuclease activity [GO:0004519]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA endonuclease activity [GO:0004521],GO:0003824; GO:0005739; GO:0016071; GO:0016740; GO:0043226; GO:0140096; GO:0140098,"catalytic activity; mitochondrion; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_08903,FUN_038332-T1,Peve_00023107,Pocillopora_meandrina_HIv1___RNAseq.g1118.t1,three_way,64.6005,FUN_038332-T1,Q6ZPJ0,,,,,28.1,720.0,3.7e-42,175.3,sp|Q6ZPJ0|TEX2_MOUSE Testis-expressed protein 2 OS=Mus musculus OX=10090 GN=Tex2 PE=1 SV=2,,,,,,
OG_08904,FUN_038333-T1,Peve_00023105,Pocillopora_meandrina_HIv1___RNAseq.g1117.t1,three_way,47.60166666666667,FUN_038333-T1,Q1JPJ9,,,,,41.1,202.0,1.7999999999999998e-35,151.8,sp|Q1JPJ9|EF2KT_BOVIN Protein-lysine N-methyltransferase EEF2KMT OS=Bos taurus OX=9913 GN=EEF2KMT PE=2 SV=2,,,,,,
OG_08905,FUN_038335-T1,Peve_00000103,Pocillopora_meandrina_HIv1___RNAseq.g1115.t1,three_way,73.825,FUN_038335-T1,Q8L8B8,,,,,46.1,180.0,3e-41,169.9,sp|Q8L8B8|LOG3_ARATH Cytokinin riboside 5'-monophosphate phosphoribohydrolase LOG3 OS=Arabidopsis thaliana OX=3702 GN=LOG3 PE=1 SV=1,,,,,,
OG_08906,FUN_038337-T1,Peve_00000101,Pocillopora_meandrina_HIv1___RNAseq.g1113.t1,three_way,71.11383333333333,FUN_038337-T1,Q553D3,,,,,30.7,212.0,2.5e-20,102.4,sp|Q553D3|GXCJJ_DICDI Rac guanine nucleotide exchange factor JJ OS=Dictyostelium discoideum OX=44689 GN=gxcJJ PE=1 SV=1,,,,,,
OG_08907,FUN_038338-T1,Peve_00000098,Pocillopora_meandrina_HIv1___RNAseq.g1110.t1,three_way,67.40100000000001,,,,,,,,,,,,,,,,,
OG_08908,FUN_038339-T1,Peve_00000097,Pocillopora_meandrina_HIv1___RNAseq.g1109.t1,three_way,75.68266666666666,FUN_038339-T1,P52565,GDIR1_HUMAN,,Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha),Homo sapiens (Human),55.7,194.0,1.4999999999999999e-53,211.1,sp|P52565|GDIR1_HUMAN Rho GDP-dissociation inhibitor 1 OS=Homo sapiens OX=9606 GN=ARHGDIA PE=1 SV=3,GO:0001772; GO:0005094; GO:0005096; GO:0005634; GO:0005829; GO:0005856; GO:0007266; GO:0016020; GO:0032880; GO:0035023; GO:0043066; GO:0070062; GO:0071526; GO:0098685; GO:0098693,negative regulation of apoptotic process [GO:0043066]; regulation of protein localization [GO:0032880]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synaptic vesicle cycle [GO:0098693]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; Schaffer collateral - CA1 synapse [GO:0098685],GTPase activator activity [GO:0005096]; Rho GDP-dissociation inhibitor activity [GO:0005094],GO:0005634; GO:0005829; GO:0005856; GO:0043226; GO:0098772,nucleus; cytosol; cytoskeleton; organelle; molecular function regulator activity
OG_08909,FUN_038340-T1,Peve_00000096,Pocillopora_meandrina_HIv1___RNAseq.g1108.t1,three_way,79.30233333333334,FUN_038340-T1,Q17770,,,,,56.6,431.0,9.2e-145,515.0,sp|Q17770|PDI2_CAEEL Protein disulfide-isomerase 2 OS=Caenorhabditis elegans OX=6239 GN=pdi-2 PE=1 SV=1,,,,,,
OG_08910,FUN_038344-T1,Peve_00030150,Pocillopora_meandrina_HIv1___TS.g5636.t1,three_way,69.94033333333333,,,,,,,,,,,,,,,,,
OG_08911,FUN_038345-T1,Peve_00000092,Pocillopora_meandrina_HIv1___RNAseq.g1104.t1,three_way,95.93,FUN_038345-T1,A4IHR1,IT70A_XENTR,,Intraflagellar transport protein 70A (Tetratricopeptide repeat protein 30A) (TPR repeat protein 30A),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),78.8,646.0,2.0000000000000002e-307,1055.8,sp|A4IHR1|IT70A_XENTR Intraflagellar transport protein 70A OS=Xenopus tropicalis OX=8364 GN=ift70a PE=2 SV=1,GO:0001501; GO:0001822; GO:0005879; GO:0005929; GO:0018095; GO:0042073; GO:0060271,cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; protein polyglutamylation [GO:0018095]; skeletal system development [GO:0001501],axonemal microtubule [GO:0005879]; cilium [GO:0005929],,GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_08912,FUN_038346-T1,Peve_00000091,Pocillopora_meandrina_HIv1___RNAseq.g1103.t2,three_way,68.69033333333334,FUN_038346-T1,Q9JJW6,ALRF2_MOUSE,,Aly/REF export factor 2 (Alyref) (RNA and export factor-binding protein 2),Mus musculus (Mouse),62.2,164.0,9.5e-45,181.8,sp|Q9JJW6|ALRF2_MOUSE Aly/REF export factor 2 OS=Mus musculus OX=10090 GN=Alyref2 PE=1 SV=1,GO:0003697; GO:0003723; GO:0005681; GO:0005737; GO:0006397; GO:0008380; GO:0051028,mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380],cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681],RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003723; GO:0016071,DNA binding; RNA binding; mRNA metabolic process
OG_08913,FUN_038347-T1,Peve_00000085,Pocillopora_meandrina_HIv1___TS.g5633.t1,three_way,80.90433333333333,FUN_038347-T1,Q6P1R4,DUS1L_HUMAN,,tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (EC 1.3.1.88) (tRNA-dihydrouridine synthase 1-like),Homo sapiens (Human),54.5,429.0,1.7e-135,484.2,sp|Q6P1R4|DUS1L_HUMAN tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like OS=Homo sapiens OX=9606 GN=DUS1L PE=1 SV=1,GO:0002943; GO:0005634; GO:0005737; GO:0017150; GO:0050660; GO:0102262; GO:0102263,tRNA dihydrouridine synthesis [GO:0002943],cytoplasm [GO:0005737]; nucleus [GO:0005634],flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150]; tRNA-dihydrouridine16 synthase activity [GO:0102262]; tRNA-dihydrouridine17 synthase activity [GO:0102263],GO:0003824; GO:0005634; GO:0006399; GO:0016491; GO:0043226; GO:0140098,"catalytic activity; nucleus; tRNA metabolic process; oxidoreductase activity; organelle; catalytic activity, acting on RNA"
OG_08914,FUN_038348-T1,Peve_00000084,Pocillopora_meandrina_HIv1___RNAseq.g1098.t1b,three_way,54.40266666666667,FUN_038348-T1,Q7TN88,,,,,23.8,1878.0,2.4e-117,426.8,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_08915,FUN_038370-T1,Peve_00000083,Pocillopora_meandrina_HIv1___RNAseq.g1095.t1,three_way,58.55733333333333,,,,,,,,,,,,,,,,,
OG_08916,FUN_038372-T1,Peve_00000082,Pocillopora_meandrina_HIv1___TS.g5627.t2,three_way,66.95883333333333,FUN_038372-T1,Q8VCY6,,,,,37.0,332.0,1.1e-48,195.3,sp|Q8VCY6|UTP6_MOUSE U3 small nucleolar RNA-associated protein 6 homolog OS=Mus musculus OX=10090 GN=Utp6 PE=2 SV=1,,,,,,
OG_08917,FUN_038373-T1,Peve_00000079,Pocillopora_meandrina_HIv1___RNAseq.g1092.t1,three_way,85.541,FUN_038373-T1,Q9UBX3,DIC_HUMAN,,Mitochondrial dicarboxylate carrier (DIC) (Solute carrier family 25 member 10),Homo sapiens (Human),58.7,286.0,3.7e-91,336.3,sp|Q9UBX3|DIC_HUMAN Mitochondrial dicarboxylate carrier OS=Homo sapiens OX=9606 GN=SLC25A10 PE=1 SV=2,GO:0005310; GO:0005634; GO:0005654; GO:0005739; GO:0005743; GO:0006094; GO:0006811; GO:0006835; GO:0006869; GO:0015116; GO:0015117; GO:0015131; GO:0015140; GO:0015141; GO:0015297; GO:0015709; GO:0015729; GO:0035435; GO:0046166; GO:0070221; GO:0071422; GO:0071423; GO:1902358,"dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; lipid transport [GO:0006869]; malate transmembrane transport [GO:0071423]; monoatomic ion transport [GO:0006811]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transmembrane transport [GO:1902358]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117],GO:0005215; GO:0005634; GO:0005654; GO:0005739; GO:0005975; GO:0006790; GO:0043226; GO:0055085; GO:1901135,transporter activity; nucleus; nucleoplasm; mitochondrion; carbohydrate metabolic process; sulfur compound metabolic process; organelle; transmembrane transport; carbohydrate derivative metabolic process
OG_08918,FUN_038374-T1,Peve_00000080,Pocillopora_meandrina_HIv1___RNAseq.g1093.t1,three_way,64.227,FUN_038374-T1,Q9YHV3,,,,,38.1,176.0,5.8999999999999994e-31,136.0,sp|Q9YHV3|NOGG3_DANRE Noggin-3 OS=Danio rerio OX=7955 GN=nog3 PE=1 SV=1,,,,,,
OG_08919,FUN_038375-T2,Peve_00000078,Pocillopora_meandrina_HIv1___RNAseq.g1091.t1,three_way,51.34516666666666,,,,,,,,,,,,,,,,,
OG_08920,FUN_038376-T1,Peve_00000077,Pocillopora_meandrina_HIv1___RNAseq.g1090.t1,three_way,74.45483333333334,FUN_038376-T1,F1LQX4,RHG44_RAT,,Rho GTPase-activating protein 44 (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2),Rattus norvegicus (Rat),43.8,486.0,3.8e-108,393.7,sp|F1LQX4|RHG44_RAT Rho GTPase-activating protein 44 OS=Rattus norvegicus OX=10116 GN=Arhgap44 PE=1 SV=2,GO:0005096; GO:0005543; GO:0005886; GO:0006887; GO:0007165; GO:0014069; GO:0030425; GO:0031256; GO:0031267; GO:0032956; GO:0035021; GO:0043087; GO:0043197; GO:0048786; GO:0050804; GO:0051490; GO:0055037; GO:0061001; GO:0098793; GO:0098794; GO:0098978; GO:0099010; GO:0099152,"exocytosis [GO:0006887]; modification of postsynaptic structure [GO:0099010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of Rac protein signal transduction [GO:0035021]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of GTPase activity [GO:0043087]; regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0099152]; signal transduction [GO:0007165]",dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; recycling endosome [GO:0055037],GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0098772,endosome; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; molecular function regulator activity
OG_08921,FUN_038377-T1,Peve_00000076,Pocillopora_meandrina_HIv1___RNAseq.g1089.t1,three_way,90.58716666666666,FUN_038377-T1,Q7ZXB7,,,,,66.4,125.0,2.1e-40,166.4,sp|Q7ZXB7|LTR2B_XENLA Ragulator complex protein LAMTOR2-B OS=Xenopus laevis OX=8355 GN=lamtor2-b PE=2 SV=1,,,,,,
OG_08922,FUN_038378-T1,Peve_00000075,Pocillopora_meandrina_HIv1___TS.g5619.t2,three_way,74.34866666666667,FUN_038378-T1,Q08170,SRSF4_HUMAN,,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",Homo sapiens (Human),55.8,190.0,7.6e-51,202.2,sp|Q08170|SRSF4_HUMAN Serine/arginine-rich splicing factor 4 OS=Homo sapiens OX=9606 GN=SRSF4 PE=1 SV=2,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0006397; GO:0008380; GO:0016607; GO:0032868; GO:0048025; GO:1990825,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; response to insulin [GO:0032868]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_08923,FUN_038380-T1,Peve_00000073,Pocillopora_meandrina_HIv1___RNAseq.g1059.t1,three_way,73.2775,FUN_038380-T1,Q8VCC8,RPGF3_MOUSE,,Rap guanine nucleotide exchange factor 3 (Exchange factor directly activated by cAMP 1) (Exchange protein directly activated by cAMP 1) (EPAC 1) (cAMP-regulated guanine nucleotide exchange factor I) (cAMP-GEFI),Mus musculus (Mouse),32.5,123.0,8.6e-08,60.8,sp|Q8VCC8|RPGF3_MOUSE Rap guanine nucleotide exchange factor 3 OS=Mus musculus OX=10090 GN=Rapgef3 PE=1 SV=2,GO:0001525; GO:0005085; GO:0005886; GO:0005902; GO:0008306; GO:0019904; GO:0030027; GO:0030175; GO:0030552; GO:0030864; GO:0032486; GO:0032956; GO:0034242; GO:0043547; GO:0045766; GO:0046827; GO:0051496; GO:0051896; GO:0060143; GO:0061028; GO:0071320,angiogenesis [GO:0001525]; associative learning [GO:0008306]; cellular response to cAMP [GO:0071320]; establishment of endothelial barrier [GO:0061028]; negative regulation of syncytium formation by plasma membrane fusion [GO:0034242]; positive regulation of angiogenesis [GO:0045766]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of syncytium formation by plasma membrane fusion [GO:0060143]; Rap protein signal transduction [GO:0032486]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896],cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; plasma membrane [GO:0005886],cAMP binding [GO:0030552]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein domain specific binding [GO:0019904],GO:0005856; GO:0005886; GO:0043226; GO:0048856; GO:0050877; GO:0098772,cytoskeleton; plasma membrane; organelle; anatomical structure development; nervous system process; molecular function regulator activity
OG_08924,FUN_038381-T1,Peve_00000068,Pocillopora_meandrina_HIv1___RNAseq.g28294.t2,three_way,78.44800000000001,FUN_038381-T1,Q9UNK0,STX8_HUMAN,,Syntaxin-8,Homo sapiens (Human),41.1,224.0,7.199999999999998e-35,149.1,sp|Q9UNK0|STX8_HUMAN Syntaxin-8 OS=Homo sapiens OX=9606 GN=STX8 PE=1 SV=2,GO:0000149; GO:0005484; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005802; GO:0005886; GO:0006886; GO:0006906; GO:0012505; GO:0019869; GO:0019905; GO:0031201; GO:0031625; GO:0031982; GO:0045022; GO:0045335; GO:0048278; GO:0048471; GO:0055037; GO:0071346; GO:1903076,cellular response to type II interferon [GO:0071346]; early endosome to late endosome transport [GO:0045022]; intracellular protein transport [GO:0006886]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],early endosome [GO:0005769]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; vesicle [GO:0031982],chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; ubiquitin protein ligase binding [GO:0031625],GO:0005768; GO:0005783; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090; GO:0061024; GO:0098772,endosome; endoplasmic reticulum; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization; molecular function regulator activity
OG_08925,FUN_038382-T1,Peve_00000067,Pocillopora_meandrina_HIv1___RNAseq.g28293.t1,three_way,74.66466666666666,FUN_038382-T1,O09118,NET1_MOUSE,,Netrin-1,Mus musculus (Mouse),49.0,571.0,1.2000000000000003e-167,591.3,sp|O09118|NET1_MOUSE Netrin-1 OS=Mus musculus OX=10090 GN=Ntn1 PE=1 SV=3,GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0007409; GO:0007411; GO:0008283; GO:0014009; GO:0015629; GO:0030334; GO:0030517; GO:0030879; GO:0032488; GO:0033564; GO:0042472; GO:0045202; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0062023; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147,"anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]",actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; synapse [GO:0045202],,GO:0005576; GO:0005654; GO:0005829; GO:0005856; GO:0007155; GO:0012501; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870,extracellular region; nucleoplasm; cytosol; cytoskeleton; cell adhesion; programmed cell death; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility
OG_08926,FUN_038383-T2,Peve_00000066,Pocillopora_meandrina_HIv1___RNAseq.g28291.t1,three_way,63.75116666666667,FUN_038383-T2,P16065,,,,,37.5,1140.0,3e-191,670.6,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08927,FUN_038385-T1,Peve_00000064,Pocillopora_meandrina_HIv1___RNAseq.g28289.t1,three_way,68.722,FUN_038385-T1,Q7JQ32,GC76C_DROME,,Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1),Drosophila melanogaster (Fruit fly),39.3,1091.0,6.199999999999998e-206,719.9,sp|Q7JQ32|GC76C_DROME Receptor-type guanylate cyclase Gyc76C OS=Drosophila melanogaster OX=7227 GN=Gyc76C PE=1 SV=1,GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0030198; GO:0030215; GO:0030510; GO:0035556; GO:0038023; GO:0046872; GO:0050830,"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]",plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023],GO:0003824; GO:0005886; GO:0009975; GO:0016829; GO:0030198; GO:0048856; GO:0055086; GO:0060089; GO:1901135,catalytic activity; plasma membrane; cyclase activity; lyase activity; extracellular matrix organization; anatomical structure development; nucleobase-containing small molecule metabolic process; molecular transducer activity; carbohydrate derivative metabolic process
OG_08928,FUN_038386-T1,Peve_00000061,Pocillopora_meandrina_HIv1___RNAseq.g28288.t1,three_way,58.09316666666667,FUN_038386-T1,P16065,,,,,37.9,1080.0,5.1e-181,636.7,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08929,FUN_038387-T1,Peve_00000060,Pocillopora_meandrina_HIv1___RNAseq.g28287.t1,three_way,63.87316666666666,FUN_038387-T1,P55202,,,,,36.6,940.0,3e-137,491.1,sp|P55202|ANPRB_ANGJA Atrial natriuretic peptide receptor 2 OS=Anguilla japonica OX=7937 GN=npr2 PE=2 SV=1,,,,,,
OG_08930,FUN_038392-T1,Peve_00000048,Pocillopora_meandrina_HIv1___RNAseq.g28264.t1,three_way,76.04899999999999,FUN_038392-T1,P16065,,,,,36.6,998.0,4.4e-160,567.0,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08931,FUN_038393-T1,Peve_00000047,Pocillopora_meandrina_HIv1___RNAseq.g28265.t1,three_way,73.06066666666668,FUN_038393-T1,P22570,ADRO_HUMAN,,"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase) (EC 1.18.1.-)",Homo sapiens (Human),57.3,464.0,8.3e-144,511.9,"sp|P22570|ADRO_HUMAN NADPH:adrenodoxin oxidoreductase, mitochondrial OS=Homo sapiens OX=9606 GN=FDXR PE=1 SV=3",GO:0004324; GO:0005739; GO:0005743; GO:0005759; GO:0006091; GO:0006694; GO:0006744; GO:0008203,cholesterol metabolic process [GO:0008203]; generation of precursor metabolites and energy [GO:0006091]; steroid biosynthetic process [GO:0006694]; ubiquinone biosynthetic process [GO:0006744],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ferredoxin-NADP+ reductase activity [GO:0004324],GO:0003824; GO:0005739; GO:0006091; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; oxidoreductase activity; organelle
OG_08932,FUN_038394-T1,Peve_00000046,Pocillopora_meandrina_HIv1___RNAseq.g28266.t1,three_way,82.16016666666667,FUN_038394-T1,Q9HCN4,,,,,64.7,317.0,5.6000000000000014e-111,402.5,sp|Q9HCN4|GPN1_HUMAN GPN-loop GTPase 1 OS=Homo sapiens OX=9606 GN=GPN1 PE=1 SV=1,,,,,,
OG_08933,FUN_038395-T1,Peve_00000045,Pocillopora_meandrina_HIv1___RNAseq.g28267.t1,three_way,81.313,FUN_038395-T1,Q96DY2,,,,,34.0,429.0,5e-53,210.3,sp|Q96DY2|DRC10_HUMAN Dynein regulatory complex protein 10 OS=Homo sapiens OX=9606 GN=IQCD PE=1 SV=2,,,,,,
OG_08934,FUN_038396-T1,Peve_00000044,Pocillopora_meandrina_HIv1___RNAseq.g28268.t1,three_way,67.62233333333333,FUN_038396-T1,P52189,KCNJ4_MOUSE,,"Inward rectifier potassium channel 4 (Inward rectifier K(+) channel Kir2.3) (IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4)",Mus musculus (Mouse),44.0,357.0,2.8999999999999997e-75,283.9,sp|P52189|KCNJ4_MOUSE Inward rectifier potassium channel 4 OS=Mus musculus OX=10090 GN=Kcnj4 PE=1 SV=1,GO:0005242; GO:0030659; GO:0034702; GO:0045211; GO:0098978,,cytoplasmic vesicle membrane [GO:0030659]; glutamatergic synapse [GO:0098978]; monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211],inward rectifier potassium channel activity [GO:0005242],GO:0005215,transporter activity
OG_08935,FUN_038398-T1,Peve_00000041,Pocillopora_meandrina_HIv1___RNAseq.g28273.t1,three_way,71.20833333333333,FUN_038398-T1,Q4TZY1,KCJ12_BOVIN,,"ATP-sensitive inward rectifier potassium channel 12 (Potassium channel, inwardly rectifying subfamily J member 12)",Bos taurus (Bovine),44.9,381.0,2.6e-85,317.4,sp|Q4TZY1|KCJ12_BOVIN ATP-sensitive inward rectifier potassium channel 12 OS=Bos taurus OX=9913 GN=KCNJ12 PE=2 SV=1,GO:0005242; GO:0005886; GO:0006813; GO:0016020; GO:0034702; GO:0034765; GO:0046872; GO:0051289; GO:1990573,potassium ion import across plasma membrane [GO:1990573]; potassium ion transport [GO:0006813]; protein homotetramerization [GO:0051289]; regulation of monoatomic ion transmembrane transport [GO:0034765],membrane [GO:0016020]; monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],inward rectifier potassium channel activity [GO:0005242]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_08936,FUN_038400-T1,Peve_00000036,Pocillopora_meandrina_HIv1___RNAseq.g28274.t1,three_way,75.47866666666667,FUN_038400-T1,Q6P5D8,SMHD1_MOUSE,,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-),Mus musculus (Mouse),23.5,2075.0,6.200000000000001e-86,321.6,sp|Q6P5D8|SMHD1_MOUSE Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Mus musculus OX=10090 GN=Smchd1 PE=1 SV=2,GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0016604; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060818; GO:2000042; GO:2001034,chromosome organization [GO:0051276]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],"Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006325; GO:0016787; GO:0043226; GO:0048856,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; chromatin organization; hydrolase activity; organelle; anatomical structure development
OG_08937,FUN_038401-T1,Peve_00000033,Pocillopora_meandrina_HIv1___RNAseq.g28276.t1,three_way,76.06083333333333,FUN_038401-T1,Q9BG91,,,,,65.5,148.0,5e-50,200.3,sp|Q9BG91|SOX9_CALJA Transcription factor SOX-9 OS=Callithrix jacchus OX=9483 GN=SOX9 PE=2 SV=1,,,,,,
OG_08938,FUN_038403-T1,Peve_00000025,Pocillopora_meandrina_HIv1___RNAseq.g28277.t1,three_way,85.76366666666667,FUN_038403-T1,A3KPA3,NAA60_DANRE,,N-alpha-acetyltransferase 60 (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF),Danio rerio (Zebrafish) (Brachydanio rerio),59.1,186.0,6.999999999999999e-62,238.4,sp|A3KPA3|NAA60_DANRE N-alpha-acetyltransferase 60 OS=Danio rerio OX=7955 GN=naa60 PE=2 SV=1,GO:0000139; GO:0004402; GO:0004596; GO:0006334; GO:0006474; GO:0007059; GO:0008283; GO:0010485; GO:0017196; GO:0042803; GO:0120518,cell population proliferation [GO:0008283]; chromosome segregation [GO:0007059]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; nucleosome assembly [GO:0006334],Golgi membrane [GO:0000139],histone acetyltransferase activity [GO:0004402]; histone H4 acetyltransferase activity [GO:0010485]; protein homodimerization activity [GO:0042803]; protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596],GO:0003824; GO:0006325; GO:0007059; GO:0016740; GO:0051604; GO:0065003; GO:0140096,"catalytic activity; chromatin organization; chromosome segregation; transferase activity; protein maturation; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_08939,FUN_038404-T1,Peve_00000024,Pocillopora_meandrina_HIv1___RNAseq.g28278.t1,three_way,76.78699999999999,FUN_038404-T1,P9WM78,,,,,42.5,365.0,1e-80,302.0,sp|P9WM78|Y0574_MYCTO Probable polyglutamine synthesis accessory protein MT0602 OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=MT0602 PE=2 SV=1,,,,,,
OG_08940,FUN_038405-T1,Peve_00000017,Pocillopora_meandrina_HIv1___RNAseq.g28279.t1,three_way,71.28666666666668,FUN_038405-T1,Q6PHN1,,,,,25.6,1091.0,7.900000000000002e-59,230.7,sp|Q6PHN1|CCD57_MOUSE Coiled-coil domain-containing protein 57 OS=Mus musculus OX=10090 GN=Ccdc57 PE=1 SV=1,,,,,,
OG_08941,FUN_038410-T1,Peve_00000012,Pocillopora_meandrina_HIv1___RNAseq.g28285.t1,three_way,90.88266666666668,FUN_038410-T1,Q66IZ7,,,,,48.4,287.0,1.4e-49,198.4,sp|Q66IZ7|NDL1B_XENLA Nuclear distribution protein nudE-like 1-B OS=Xenopus laevis OX=8355 GN=ndel1-b PE=2 SV=1,,,,,,
OG_08942,FUN_038415-T1,Peve_00000011,Pocillopora_meandrina_HIv1___RNAseq.g1190.t1,three_way,60.18366666666667,FUN_038415-T1,Q9NZS9,,,,,33.4,416.0,1.4e-60,235.3,sp|Q9NZS9|BFAR_HUMAN Bifunctional apoptosis regulator OS=Homo sapiens OX=9606 GN=BFAR PE=1 SV=1,,,,,,
OG_08943,FUN_038416-T1,Peve_00000009,Pocillopora_meandrina_HIv1___RNAseq.g1188.t1,three_way,76.13,FUN_038416-T1,Q8L7C9,,,,,33.3,216.0,4.1e-29,129.8,sp|Q8L7C9|GSTUK_ARATH Glutathione S-transferase U20 OS=Arabidopsis thaliana OX=3702 GN=GSTU20 PE=1 SV=1,,,,,,
OG_08944,FUN_038417-T1,Peve_00000007,Pocillopora_meandrina_HIv1___RNAseq.g25849.t1,three_way,58.776,FUN_038417-T1,Q28955,NTAN1_PIG,,Protein N-terminal asparagine amidohydrolase (EC 3.5.1.121) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein NTN-amidase),Sus scrofa (Pig),38.5,304.0,1.3e-54,214.9,sp|Q28955|NTAN1_PIG Protein N-terminal asparagine amidohydrolase OS=Sus scrofa OX=9823 GN=NTAN1 PE=1 SV=4,GO:0005634; GO:0005737; GO:0006511; GO:0007613; GO:0008344; GO:0008418,adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634],protein-N-terminal asparagine amidohydrolase activity [GO:0008418],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0050877; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; nervous system process; catalytic activity, acting on a protein"
OG_08945,FUN_038418-T1,Peve_00000006,Pocillopora_meandrina_HIv1___RNAseq.g1186.t1,three_way,79.584,FUN_038418-T1,P17844,DDX5_HUMAN,,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),Homo sapiens (Human),68.1,470.0,2.2e-192,673.7,sp|P17844|DDX5_HUMAN Probable ATP-dependent RNA helicase DDX5 OS=Homo sapiens OX=9606 GN=DDX5 PE=1 SV=1,GO:0000122; GO:0000380; GO:0000381; GO:0000398; GO:0000956; GO:0001837; GO:0003723; GO:0003724; GO:0003729; GO:0003730; GO:0005516; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006357; GO:0009299; GO:0016020; GO:0016607; GO:0016887; GO:0019899; GO:0030509; GO:0030520; GO:0030521; GO:0031053; GO:0035500; GO:0036002; GO:0043021; GO:0043517; GO:0045069; GO:0045445; GO:0045667; GO:0046332; GO:0048306; GO:0048511; GO:0050681; GO:0060765; GO:0061614; GO:0070062; GO:0070412; GO:0070878; GO:0071013; GO:0072332; GO:1990841; GO:1990904; GO:2001014,"alternative mRNA splicing, via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; epithelial to mesenchymal transition [GO:0001837]; estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; miRNA transcription [GO:0061614]; mRNA splicing, via spliceosome [GO:0000398]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; primary miRNA processing [GO:0031053]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069]; rhythmic process [GO:0048511]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_08946,FUN_038419-T1,Peve_00000005,Pocillopora_meandrina_HIv1___RNAseq.g1185.t2,three_way,81.85316666666667,FUN_038419-T1,Q5E9X2,MP2K6_BOVIN,,Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6),Bos taurus (Bovine),59.4,342.0,1e-108,394.8,sp|Q5E9X2|MP2K6_BOVIN Dual specificity mitogen-activated protein kinase kinase 6 OS=Bos taurus OX=9913 GN=MAP2K6 PE=2 SV=1,GO:0000165; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0006915; GO:0106310,apoptotic process [GO:0006915]; MAPK cascade [GO:0000165],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005856; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytoskeleton; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08947,FUN_038420-T1,Peve_00000003,Pocillopora_meandrina_HIv1___RNAseq.g1183.t1,three_way,75.96466666666667,FUN_038420-T1,P49005,DPOD2_HUMAN,,DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50),Homo sapiens (Human),55.6,457.0,3.6e-136,486.5,sp|P49005|DPOD2_HUMAN DNA polymerase delta subunit 2 OS=Homo sapiens OX=9606 GN=POLD2 PE=1 SV=1,GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006261; GO:0006271; GO:0016035; GO:0042276; GO:0043625; GO:0071897,DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]; DNA strand elongation involved in DNA replication [GO:0006271]; DNA-templated DNA replication [GO:0006261]; error-prone translesion synthesis [GO:0042276],delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; zeta DNA polymerase complex [GO:0016035],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0043226,DNA binding; nucleus; nucleoplasm; DNA replication; DNA repair; organelle
OG_08948,FUN_038421-T1,Peve_00000002,Pocillopora_meandrina_HIv1___RNAseq.g1182.t1,three_way,53.663,FUN_038421-T1,Q29RP1,UBP1_BOVIN,,"Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) [Cleaved into: Ubiquitin carboxyl-terminal hydrolase 1, N-terminal fragment]",Bos taurus (Bovine),32.2,423.0,4.6e-41,171.0,sp|Q29RP1|UBP1_BOVIN Ubiquitin carboxyl-terminal hydrolase 1 OS=Bos taurus OX=9913 GN=USP1 PE=2 SV=1,GO:0004197; GO:0004843; GO:0005634; GO:0005829; GO:0006281; GO:0006282; GO:0006508; GO:0009411; GO:0016579; GO:0031647; GO:0035520,DNA repair [GO:0006281]; monoubiquitinated protein deubiquitination [GO:0035520]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of DNA repair [GO:0006282]; regulation of protein stability [GO:0031647]; response to UV [GO:0009411],cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; DNA repair; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_08949,FUN_038422-T1,Peve_00000123,Pocillopora_meandrina_HIv1___RNAseq.g1181.t1,three_way,79.913,FUN_038422-T1,Q5ZI23,GLO2_CHICK,,"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II)",Gallus gallus (Chicken),62.0,295.0,4.0000000000000003e-104,379.4,"sp|Q5ZI23|GLO2_CHICK Hydroxyacylglutathione hydrolase, mitochondrial OS=Gallus gallus OX=9031 GN=HAGH PE=2 SV=1",GO:0004416; GO:0005739; GO:0005759; GO:0006749; GO:0019243; GO:0019853; GO:0046872,glutathione metabolic process [GO:0006749]; L-ascorbic acid biosynthetic process [GO:0019853]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0005975; GO:0006575; GO:0006766; GO:0006790; GO:0016787; GO:0043226; GO:0098754,catalytic activity; mitochondrion; carbohydrate metabolic process; modified amino acid metabolic process; vitamin metabolic process; sulfur compound metabolic process; hydrolase activity; organelle; detoxification
OG_08950,FUN_038423-T2,Peve_00000121,Pocillopora_meandrina_HIv1___RNAseq.g1180.t1,three_way,68.95383333333334,FUN_038423-T2,B2RS91,RRN3_MOUSE,,RNA polymerase I-specific transcription initiation factor RRN3,Mus musculus (Mouse),41.0,575.0,1.8e-113,411.4,sp|B2RS91|RRN3_MOUSE RNA polymerase I-specific transcription initiation factor RRN3 OS=Mus musculus OX=10090 GN=Rrn3 PE=1 SV=1,GO:0001164; GO:0001181; GO:0001701; GO:0005730; GO:0006352; GO:0006361; GO:0007000; GO:0007028; GO:0010976; GO:0042254; GO:0045893; GO:0048144; GO:0048872; GO:0070063; GO:0072332; GO:1902254; GO:2000142,cytoplasm organization [GO:0007028]; DNA-templated transcription initiation [GO:0006352]; fibroblast proliferation [GO:0048144]; homeostasis of number of cells [GO:0048872]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; nucleolus organization [GO:0007000]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection development [GO:0010976]; regulation of DNA-templated transcription initiation [GO:2000142]; ribosome biogenesis [GO:0042254]; transcription initiation at RNA polymerase I promoter [GO:0006361],nucleolus [GO:0005730],RNA polymerase binding [GO:0070063]; RNA polymerase I core promoter sequence-specific DNA binding [GO:0001164]; RNA polymerase I general transcription initiation factor activity [GO:0001181],GO:0003677; GO:0005730; GO:0006355; GO:0042254; GO:0043226; GO:0048856; GO:0140223,DNA binding; nucleolus; regulation of DNA-templated transcription; ribosome biogenesis; organelle; anatomical structure development; general transcription initiation factor activity
OG_08951,FUN_038424-T1,Peve_00000118,Pocillopora_meandrina_HIv1___RNAseq.g1179.t1,three_way,52.31733333333333,FUN_038424-T1,Q9DCV4,,,,,48.9,237.0,4.7e-57,223.0,sp|Q9DCV4|RMD1_MOUSE Regulator of microtubule dynamics protein 1 OS=Mus musculus OX=10090 GN=Rmdn1 PE=1 SV=2,,,,,,
OG_08952,FUN_038426-T1,Peve_00000114,Pocillopora_meandrina_HIv1___RNAseq.g1178.t1,three_way,77.04633333333334,FUN_038426-T1,F1R8Z9,FXJ1B_DANRE,,Forkhead box protein J1-B,Danio rerio (Zebrafish) (Brachydanio rerio),45.4,282.0,2.2e-51,204.5,sp|F1R8Z9|FXJ1B_DANRE Forkhead box protein J1-B OS=Danio rerio OX=7955 GN=foxj1b PE=2 SV=1,GO:0000978; GO:0000981; GO:0001947; GO:0003146; GO:0005634; GO:0006357; GO:0007368; GO:0044458; GO:0060088; GO:0060271,auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; heart jogging [GO:0003146]; heart looping [GO:0001947]; motile cilium assembly [GO:0044458]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0044782; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cilium organization; transcription regulator activity
OG_08953,FUN_038427-T1,Peve_00000113,Pocillopora_meandrina_HIv1___RNAseq.g1177.t1,three_way,70.89833333333333,FUN_038427-T1,Q86XK2,FBX11_HUMAN,,F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1),Homo sapiens (Human),41.5,82.0,9.1e-08,59.3,sp|Q86XK2|FBX11_HUMAN F-box only protein 11 OS=Homo sapiens OX=9606 GN=FBXO11 PE=1 SV=3,GO:0000151; GO:0004842; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006511; GO:0007605; GO:0008270; GO:0010719; GO:0016274; GO:0016567; GO:0036211; GO:0042981; GO:0043161; GO:1990756,negative regulation of epithelial to mesenchymal transition [GO:0010719]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; sensory perception of sound [GO:0007605]; ubiquitin-dependent protein catabolic process [GO:0006511],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],protein-arginine N-methyltransferase activity [GO:0016274]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0050877; GO:0060090; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; transferase activity; protein catabolic process; organelle; nervous system process; molecular adaptor activity; catalytic activity, acting on a protein"
OG_08954,FUN_038428-T1,Peve_00000110,Pocillopora_meandrina_HIv1___RNAseq.g1063.t1,three_way,62.013666666666666,FUN_038428-T1,Q26657,,,,,50.0,74.0,5.7e-14,79.3,sp|Q26657|ALX_STRPU Aristaless homeobox protein (Fragment) OS=Strongylocentrotus purpuratus OX=7668 GN=ALX PE=2 SV=2,,,,,,
OG_08955,FUN_038430-T1,Peve_00000108,Pocillopora_meandrina_HIv1___RNAseq.g1061.t1,three_way,76.83583333333334,FUN_038430-T1,Q6P4S8,INT1_MOUSE,,Integrator complex subunit 1 (Int1),Mus musculus (Mouse),39.8,2366.0,0.0,1481.8,sp|Q6P4S8|INT1_MOUSE Integrator complex subunit 1 OS=Mus musculus OX=10090 GN=Ints1 PE=1 SV=2,GO:0001832; GO:0001833; GO:0005634; GO:0007566; GO:0031965; GO:0032039; GO:0034474; GO:0043066; GO:0160232; GO:0160240,blastocyst growth [GO:0001832]; embryo implantation [GO:0007566]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; RNA polymerase II transcription initiation surveillance [GO:0160240]; U2 snRNA 3'-end processing [GO:0034474],INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634],,GO:0005634; GO:0016073; GO:0022414; GO:0043226,nucleus; snRNA metabolic process; reproductive process; organelle
OG_08956,FUN_038431-T1,Peve_00000107,Pocillopora_meandrina_HIv1___RNAseq.g1060.t1,three_way,80.83533333333334,FUN_038431-T1,Q8IX18,,,,,54.5,730.0,2.7000000000000003e-223,776.5,sp|Q8IX18|DHX40_HUMAN Probable ATP-dependent RNA helicase DHX40 OS=Homo sapiens OX=9606 GN=DHX40 PE=1 SV=2,,,,,,
OG_08957,FUN_038432-T1,Peve_00029453,Pocillopora_meandrina_HIv1___RNAseq.g880.t1,three_way,75.93416666666667,FUN_038432-T1,Q3T0M9,,,,,45.9,181.0,2.5e-41,170.2,sp|Q3T0M9|ARL4A_BOVIN ADP-ribosylation factor-like protein 4A OS=Bos taurus OX=9913 GN=ARL4A PE=2 SV=1,,,,,,
OG_08958,FUN_038436-T1,Peve_00029448,Pocillopora_meandrina_HIv1___TS.g5415.t2,three_way,79.24033333333334,FUN_038436-T1,Q2TBW2,COQ7_BOVIN,,"NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial (EC 1.14.13.253) (3-demethoxyubiquinone 3-hydroxylase (NADH)) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)",Bos taurus (Bovine),67.6,173.0,7.099999999999999e-62,238.4,"sp|Q2TBW2|COQ7_BOVIN NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial OS=Bos taurus OX=9913 GN=COQ7 PE=2 SV=1",GO:0005634; GO:0005743; GO:0006744; GO:0008340; GO:0008682; GO:0010468; GO:0031314; GO:0046872; GO:0110142; GO:0160224; GO:2000377,determination of adult lifespan [GO:0008340]; regulation of gene expression [GO:0010468]; regulation of reactive oxygen species metabolic process [GO:2000377]; ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; ubiquinone biosynthesis complex [GO:0110142],3-demethoxyubiquinol 3-hydroxylase activity [GO:0008682]; 3-demethoxyubiquinone 3-hydroxylase (NADH) activity [GO:0160224]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0016491; GO:0043226,catalytic activity; nucleus; oxidoreductase activity; organelle
OG_08959,FUN_038437-T2,Peve_00029447,Pocillopora_meandrina_HIv1___RNAseq.25797_t,three_way,40.388666666666666,,,,,,,,,,,,,,,,,
OG_08960,FUN_038438-T1,Peve_00029444,Pocillopora_meandrina_HIv1___RNAseq.g885.t1,three_way,75.46883333333334,FUN_038438-T1,O43670,ZN207_HUMAN,,BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (hBuGZ) (Zinc finger protein 207),Homo sapiens (Human),86.7,90.0,2.7e-43,177.9,sp|O43670|ZN207_HUMAN BUB3-interacting and GLEBS motif-containing protein ZNF207 OS=Homo sapiens OX=9606 GN=ZNF207 PE=1 SV=1,GO:0000070; GO:0000776; GO:0001578; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005819; GO:0005874; GO:0007094; GO:0008017; GO:0008201; GO:0008270; GO:0008608; GO:0046785; GO:0050821; GO:0051301; GO:0051983; GO:0090307; GO:1990047,attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983],cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047],DNA binding [GO:0003677]; heparin binding [GO:0008201]; microtubule binding [GO:0008017]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0007010; GO:0007059; GO:0008092; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; nucleolus; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_08961,FUN_038439-T1,Peve_00029443,Pocillopora_meandrina_HIv1___RNAseq.g886.t1,three_way,77.404,FUN_038439-T1,Q8VIJ8,,,,,47.7,572.0,3.7e-137,490.0,sp|Q8VIJ8|NPRL3_MOUSE GATOR1 complex protein NPRL3 OS=Mus musculus OX=10090 GN=Nprl3 PE=1 SV=1,,,,,,
OG_08962,FUN_038456-T1,Peve_00020975,Pocillopora_meandrina_HIv1___RNAseq.g28256.t1,three_way,69.28483333333334,FUN_038456-T1,Q5RA17,,,,,43.3,261.0,7.999999999999999e-50,198.7,sp|Q5RA17|RRP7A_PONAB Ribosomal RNA-processing protein 7 homolog A OS=Pongo abelii OX=9601 GN=RRP7A PE=2 SV=1,,,,,,
OG_08963,FUN_038457-T1,Peve_00032632,Pocillopora_meandrina_HIv1___RNAseq.g28255.t1,three_way,73.14583333333333,FUN_038457-T1,Q8R0H9,GGA1_MOUSE,,"ADP-ribosylation factor-binding protein GGA1 (Gamma-adaptin-related protein 1) (Golgi-localized, gamma ear-containing, ARF-binding protein 1)",Mus musculus (Mouse),40.6,712.0,5.1e-115,416.8,sp|Q8R0H9|GGA1_MOUSE ADP-ribosylation factor-binding protein GGA1 OS=Mus musculus OX=10090 GN=Gga1 PE=1 SV=1,GO:0005654; GO:0005769; GO:0005802; GO:0005829; GO:0006886; GO:0006893; GO:0008104; GO:0030163; GO:0031267; GO:0031901; GO:0032991; GO:0034394; GO:0035091; GO:0042147; GO:0043001; GO:0043130; GO:0045732; GO:1903441,"Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; protein localization [GO:0008104]; protein localization to cell surface [GO:0034394]; protein localization to ciliary membrane [GO:1903441]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; trans-Golgi network [GO:0005802],phosphatidylinositol binding [GO:0035091]; small GTPase binding [GO:0031267]; ubiquitin binding [GO:0043130],GO:0005654; GO:0005768; GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0030163; GO:0031410; GO:0043226; GO:0072659,nucleoplasm; endosome; cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; protein catabolic process; cytoplasmic vesicle; organelle; protein localization to plasma membrane
OG_08964,FUN_038464-T1,Peve_00010728,Pocillopora_meandrina_HIv1___RNAseq.g28234.t1,three_way,87.458,FUN_038464-T1,P14604,ECHM_RAT,,"Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH)",Rattus norvegicus (Rat),65.4,295.0,1.3e-101,370.9,"sp|P14604|ECHM_RAT Enoyl-CoA hydratase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Echs1 PE=1 SV=1",GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092,fatty acid beta-oxidation [GO:0006635],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],3-hydroxypropionyl-CoA dehydratase activity [GO:0043956]; crotonyl-CoA hydratase activity [GO:0120092]; delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300],GO:0003824; GO:0005739; GO:0006629; GO:0016829; GO:0016853; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; lyase activity; isomerase activity; organelle
OG_08965,FUN_038465-T1,Peve_00029024,Pocillopora_meandrina_HIv1___RNAseq.g28233.t1,three_way,83.47149999999999,FUN_038465-T1,Q6NUH3,,,,,57.2,306.0,2.3e-93,343.6,sp|Q6NUH3|NOSIP_XENLA Nitric oxide synthase-interacting protein OS=Xenopus laevis OX=8355 GN=nosip PE=2 SV=1,,,,,,
OG_08966,FUN_038466-T1,Peve_00026092,Pocillopora_meandrina_HIv1___RNAseq.g28232.t1,three_way,60.737,FUN_038466-T1,O75762,TRPA1_HUMAN,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor),Homo sapiens (Human),26.4,1123.0,1.2e-52,210.3,sp|O75762|TRPA1_HUMAN Transient receptor potential cation channel subfamily A member 1 OS=Homo sapiens OX=9606 GN=TRPA1 PE=1 SV=3,GO:0005245; GO:0005262; GO:0005886; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transport [GO:0006811]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_08967,FUN_038472-T1,Peve_00039876,Pocillopora_meandrina_HIv1___RNAseq.g28229.t1,three_way,51.10716666666666,,,,,,,,,,,,,,,,,
OG_08968,FUN_038473-T1,Peve_00039889,Pocillopora_meandrina_HIv1___RNAseq.g28228.t1,three_way,77.87266666666666,FUN_038473-T1,Q9QYU4,CRYM_RAT,,Ketimine reductase mu-crystallin (EC 1.5.1.25) (1-piperideine-2-carboxylate/1-pyrroline-2-carboxylate reductase) (P2C/Pyr2C reductase) (EC 1.5.1.1) (CDK108) (NADP-regulated thyroid-hormone-binding protein),Rattus norvegicus (Rat),50.2,299.0,5.9999999999999995e-71,269.2,sp|Q9QYU4|CRYM_RAT Ketimine reductase mu-crystallin OS=Rattus norvegicus OX=10116 GN=Crym PE=1 SV=1,GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005739; GO:0006839; GO:0007605; GO:0009725; GO:0033280; GO:0042403; GO:0042562; GO:0042803; GO:0047127; GO:0050661; GO:0070324; GO:0070327,mitochondrial transport [GO:0006839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to hormone [GO:0009725]; response to vitamin D [GO:0033280]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],hormone binding [GO:0042562]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005739; GO:0006355; GO:0006575; GO:0016491; GO:0043226; GO:0050877; GO:0060090; GO:0140110,catalytic activity; nucleus; mitochondrion; regulation of DNA-templated transcription; modified amino acid metabolic process; oxidoreductase activity; organelle; nervous system process; molecular adaptor activity; transcription regulator activity
OG_08969,FUN_038474-T1,Peve_00039890,Pocillopora_meandrina_HIv1___RNAseq.g28227.t1,three_way,84.79233333333333,FUN_038474-T1,Q9R0Q6,,,,,53.0,372.0,2.5e-108,393.7,sp|Q9R0Q6|ARC1A_MOUSE Actin-related protein 2/3 complex subunit 1A OS=Mus musculus OX=10090 GN=Arpc1a PE=1 SV=1,,,,,,
OG_08970,FUN_038475-T1,Peve_00013533,Pocillopora_meandrina_HIv1___RNAseq.g28226.t1,three_way,95.814,FUN_038475-T1,Q8BS45,IFT56_MOUSE,,Intraflagellar transport protein 56 (Protein hop-sterile) (Tetratricopeptide repeat protein 26) (TPR repeat protein 26),Mus musculus (Mouse),80.8,557.0,3.3999999999999995e-271,935.3,sp|Q8BS45|IFT56_MOUSE Intraflagellar transport protein 56 OS=Mus musculus OX=10090 GN=Ift56 PE=1 SV=1,GO:0005813; GO:0005929; GO:0007224; GO:0007286; GO:0008594; GO:0015031; GO:0030992; GO:0035082; GO:0035720; GO:0036064; GO:0042073; GO:0043005; GO:0046530; GO:0060271; GO:0061512; GO:0120170; GO:1905198,axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; protein transport [GO:0015031]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; neuron projection [GO:0043005],intraciliary transport particle B binding [GO:0120170],GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development
OG_08971,FUN_038476-T1,Peve_00013532,Pocillopora_meandrina_HIv1___RNAseq.g28225.t1,three_way,74.16799999999999,FUN_038476-T1,Q9SY00,,,,,44.4,117.0,7.4e-26,119.4,sp|Q9SY00|WDR5B_ARATH COMPASS-like H3K4 histone methylase component WDR5B OS=Arabidopsis thaliana OX=3702 GN=WDR5B PE=1 SV=1,,,,,,
OG_08972,FUN_038477-T1,Peve_00013530,Pocillopora_meandrina_HIv1___RNAseq.g28224.t1,three_way,96.67533333333331,FUN_038477-T1,Q9EP80,PICK1_RAT,,PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein),Rattus norvegicus (Rat),65.2,365.0,4.5e-139,495.7,sp|Q9EP80|PICK1_RAT PRKCA-binding protein OS=Rattus norvegicus OX=10116 GN=Pick1 PE=1 SV=1,GO:0001664; GO:0002092; GO:0005080; GO:0005102; GO:0005484; GO:0005543; GO:0005737; GO:0005739; GO:0005794; GO:0005856; GO:0005886; GO:0006468; GO:0006605; GO:0006886; GO:0008021; GO:0008092; GO:0010629; GO:0014069; GO:0015844; GO:0015872; GO:0019904; GO:0021782; GO:0030425; GO:0030971; GO:0032588; GO:0032991; GO:0034315; GO:0034316; GO:0035255; GO:0035256; GO:0036294; GO:0042149; GO:0042734; GO:0042802; GO:0043005; GO:0043113; GO:0043197; GO:0045202; GO:0046872; GO:0046875; GO:0048471; GO:0050796; GO:0051015; GO:0051020; GO:0060292; GO:0071933; GO:0097061; GO:0097062; GO:0098843; GO:0098978; GO:0099149; GO:0099572; GO:0140090,cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; dopamine transport [GO:0015872]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of gene expression [GO:0010629]; positive regulation of receptor internalization [GO:0002092]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone [GO:0098843]; postsynaptic specialization [GO:0099572]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588],actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; G protein-coupled glutamate receptor binding [GO:0035256]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; SNAP receptor activity [GO:0005484],GO:0005739; GO:0005794; GO:0005856; GO:0005886; GO:0006886; GO:0008092; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140299,mitochondrion; Golgi apparatus; cytoskeleton; plasma membrane; intracellular protein transport; cytoskeletal protein binding; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; molecular sensor activity
OG_08973,FUN_038478-T1,Peve_00013529,Pocillopora_meandrina_HIv1___RNAseq.g28223.t1,three_way,87.73433333333332,FUN_038478-T1,Q5XI54,DRC3_RAT,,Dynein regulatory complex subunit 3 (Leucine-rich repeat-containing protein 48),Rattus norvegicus (Rat),56.3,520.0,1.2e-100,368.6,sp|Q5XI54|DRC3_RAT Dynein regulatory complex subunit 3 OS=Rattus norvegicus OX=10116 GN=Drc3 PE=2 SV=1,GO:0005929; GO:0005930; GO:0036126,,axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126],,GO:0005929; GO:0043226,cilium; organelle
OG_08974,FUN_038480-T1,Peve_00013528,Pocillopora_meandrina_HIv1___RNAseq.g28221.t1,three_way,32.98216666666667,,,,,,,,,,,,,,,,,
OG_08975,FUN_038482-T1,Peve_00013523,Pocillopora_meandrina_HIv1___RNAseq.g6991.t1,three_way,43.61266666666667,,,,,,,,,,,,,,,,,
OG_08976,FUN_038487-T1,Peve_00013520,Pocillopora_meandrina_HIv1___TS.g8002.t1b,three_way,68.375,FUN_038487-T1,Q91YY4,,,,,49.8,231.0,8.4e-61,235.3,sp|Q91YY4|ATPF2_MOUSE ATP synthase mitochondrial F1 complex assembly factor 2 OS=Mus musculus OX=10090 GN=Atpaf2 PE=1 SV=1,,,,,,
OG_08977,FUN_038488-T1,Peve_00013519,Pocillopora_meandrina_HIv1___TS.g8002.t1a,three_way,57.826,FUN_038488-T1,Q8JHF2,,,,,52.1,263.0,1.5e-77,291.6,"sp|Q8JHF2|LFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe OS=Danio rerio OX=7955 GN=lfng PE=2 SV=2",,,,,,
OG_08978,FUN_038489-T1,Peve_00013518,Pocillopora_meandrina_HIv1___RNAseq.g28213.t1,three_way,49.112,,,,,,,,,,,,,,,,,
OG_08979,FUN_038496-T1,Peve_00013514,Pocillopora_meandrina_HIv1___RNAseq.g28199.t1,three_way,76.533,FUN_038496-T1,Q9Y6N1,COX11_HUMAN,,"Cytochrome c oxidase assembly protein COX11, mitochondrial",Homo sapiens (Human),67.8,180.0,1.7e-66,254.2,"sp|Q9Y6N1|COX11_HUMAN Cytochrome c oxidase assembly protein COX11, mitochondrial OS=Homo sapiens OX=9606 GN=COX11 PE=1 SV=3",GO:0005507; GO:0005739; GO:0005743; GO:0006754; GO:0009055; GO:0030003; GO:0032991,ATP biosynthetic process [GO:0006754]; intracellular monoatomic cation homeostasis [GO:0030003],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991],copper ion binding [GO:0005507]; electron transfer activity [GO:0009055],GO:0005739; GO:0043226; GO:0055086; GO:1901135,mitochondrion; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_08980,FUN_038498-T1,Peve_00013507,Pocillopora_meandrina_HIv1___RNAseq.g28197.t1,three_way,73.013,FUN_038498-T1,Q96FN9,,,,,54.3,162.0,1.5e-46,187.2,sp|Q96FN9|DTD2_HUMAN D-aminoacyl-tRNA deacylase 2 OS=Homo sapiens OX=9606 GN=DTD2 PE=1 SV=1,,,,,,
OG_08981,FUN_038499-T1,Peve_00013488,Pocillopora_meandrina_HIv1___RNAseq.g28195.t1,three_way,71.18633333333334,FUN_038499-T1,Q6DGP7,,,,,47.9,117.0,2.0000000000000002e-24,113.2,sp|Q6DGP7|LYRM1_DANRE LYR motif containing protein 1 OS=Danio rerio OX=7955 GN=lyrm1 PE=3 SV=1,,,,,,
OG_08982,FUN_038500-T1,Peve_00013485,Pocillopora_meandrina_HIv1___RNAseq.g28194.t1,three_way,84.38300000000001,FUN_038500-T1,Q8K4R4,,,,,65.7,251.0,8.2e-100,364.8,sp|Q8K4R4|PITC1_MOUSE Cytoplasmic phosphatidylinositol transfer protein 1 OS=Mus musculus OX=10090 GN=Pitpnc1 PE=1 SV=1,,,,,,
OG_08983,FUN_038502-T1,Peve_00013538,Pocillopora_meandrina_HIv1___RNAseq.g28192.t1,three_way,75.99333333333333,FUN_038502-T1,Q7RTV0,PHF5A_HUMAN,,PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b),Homo sapiens (Human),97.1,104.0,8.6e-59,229.9,sp|Q7RTV0|PHF5A_HUMAN PHD finger-like domain-containing protein 5A OS=Homo sapiens OX=9606 GN=PHF5A PE=1 SV=1,GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011; GO:1903241,"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of DNA-templated transcription [GO:0045893]; stem cell differentiation [GO:0048863]; U2-type prespliceosome assembly [GO:1903241]",nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0030154; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_08984,FUN_038503-T1,Peve_00041694,Pocillopora_meandrina_HIv1___RNAseq.g28159.t1,three_way,62.70366666666667,,,,,,,,,,,,,,,,,
OG_08985,FUN_038504-T1,Peve_00041693,Pocillopora_meandrina_HIv1___TS.g7946.t1,three_way,87.35516666666666,FUN_038504-T1,Q9Y5X2,SNX8_HUMAN,,Sorting nexin-8,Homo sapiens (Human),46.6,399.0,4.6e-97,356.7,sp|Q9Y5X2|SNX8_HUMAN Sorting nexin-8 OS=Homo sapiens OX=9606 GN=SNX8 PE=1 SV=1,GO:0005829; GO:0006886; GO:0031901; GO:0034498; GO:0035091; GO:0042802; GO:0043231,early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886],cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091],GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0043226,cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; organelle
OG_08986,FUN_038505-T1,Peve_00041692,Pocillopora_meandrina_HIv1___RNAseq.g28161.t1,three_way,75.56566666666666,FUN_038505-T1,Q9WV68,DECR2_MOUSE,,"Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] (EC 1.3.1.124) (2,4-dienoyl-CoA reductase 2)",Mus musculus (Mouse),55.0,291.0,7.899999999999999e-83,308.5,"sp|Q9WV68|DECR2_MOUSE Peroxisomal 2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing] OS=Mus musculus OX=10090 GN=Decr2 PE=1 SV=1",GO:0005777; GO:0006636; GO:0008670; GO:0009062; GO:0019166; GO:0044877; GO:0051020,fatty acid catabolic process [GO:0009062]; unsaturated fatty acid biosynthetic process [GO:0006636],peroxisome [GO:0005777],"2,4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; GTPase binding [GO:0051020]; protein-containing complex binding [GO:0044877]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]",GO:0003824; GO:0005777; GO:0006629; GO:0016491; GO:0043226,catalytic activity; peroxisome; lipid metabolic process; oxidoreductase activity; organelle
OG_08987,FUN_038507-T2,Peve_00041684,Pocillopora_meandrina_HIv1___RNAseq.g28173.t1,three_way,75.75433333333334,FUN_038507-T2,Q4R7R1,,,,,61.6,357.0,4.3e-122,439.5,sp|Q4R7R1|D42E1_MACFA Short-chain dehydrogenase/reductase family 42E member 1 OS=Macaca fascicularis OX=9541 GN=SDR42E1 PE=2 SV=1,,,,,,
OG_08988,FUN_038508-T1,Peve_00041683,Pocillopora_meandrina_HIv1___RNAseq.g28175.t1,three_way,84.98566666666667,FUN_038508-T1,P10644,KAP0_HUMAN,,cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1),Homo sapiens (Human),70.1,374.0,1.1e-140,501.1,sp|P10644|KAP0_HUMAN cAMP-dependent protein kinase type I-alpha regulatory subunit OS=Homo sapiens OX=9606 GN=PRKAR1A PE=1 SV=1,GO:0001707; GO:0004862; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005952; GO:0006357; GO:0007189; GO:0008603; GO:0010629; GO:0016020; GO:0019904; GO:0030552; GO:0031588; GO:0031594; GO:0031625; GO:0032024; GO:0032991; GO:0034236; GO:0035556; GO:0044853; GO:0045214; GO:0046007; GO:0060038; GO:0071377; GO:0097546; GO:0098978; GO:0120212; GO:0141162,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cardiac muscle cell proliferation [GO:0060038]; cellular response to glucagon stimulus [GO:0071377]; intracellular signal transduction [GO:0035556]; mesoderm formation [GO:0001707]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of gene expression [GO:0010629]; positive regulation of insulin secretion [GO:0032024]; regulation of transcription by RNA polymerase II [GO:0006357]; sarcomere organization [GO:0045214],cAMP-dependent protein kinase complex [GO:0005952]; centrosome [GO:0005813]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuromuscular junction [GO:0031594]; nucleotide-activated protein kinase complex [GO:0031588]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sperm head-tail coupling apparatus [GO:0120212],cAMP binding [GO:0030552]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; protein domain specific binding [GO:0019904]; protein kinase A catalytic subunit binding [GO:0034236]; ubiquitin protein ligase binding [GO:0031625],GO:0005768; GO:0005815; GO:0005829; GO:0006355; GO:0007010; GO:0031410; GO:0043226; GO:0098772,endosome; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08989,FUN_038510-T1,Peve_00041680,Pocillopora_meandrina_HIv1___RNAseq.g28178.t1,three_way,57.87533333333334,,,,,,,,,,,,,,,,,
OG_08990,FUN_038512-T1,Peve_00041679,Pocillopora_meandrina_HIv1___RNAseq.20620_t,three_way,87.99716666666667,FUN_038512-T1,Q6P1M3,L2GL2_HUMAN,,LLGL scribble cell polarity complex component 2 (HGL) (Lethal(2) giant larvae protein homolog 2),Homo sapiens (Human),41.5,959.0,1.6e-203,711.4,sp|Q6P1M3|L2GL2_HUMAN LLGL scribble cell polarity complex component 2 OS=Homo sapiens OX=9606 GN=LLGL2 PE=1 SV=2,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005912; GO:0006887; GO:0006893; GO:0008593; GO:0009791; GO:0015820; GO:0016332; GO:0030165; GO:0030864; GO:0030866; GO:0032878; GO:0035264; GO:0043231; GO:0045159; GO:0045197; GO:0051294; GO:0051301; GO:0060670; GO:0060716,branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell division [GO:0051301]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; L-leucine transport [GO:0015820]; labyrinthine layer blood vessel development [GO:0060716]; multicellular organism growth [GO:0035264]; post-embryonic development [GO:0009791]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],adherens junction [GO:0005912]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; PDZ domain binding [GO:0030165],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0043226; GO:0048856; GO:0098772,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; organelle; anatomical structure development; molecular function regulator activity
OG_08991,FUN_038513-T1,Peve_00041678,Pocillopora_meandrina_HIv1___RNAseq.g28180.t1,three_way,68.10366666666667,FUN_038513-T1,Q9HAS0,,,,,32.8,354.0,1.9e-43,178.3,sp|Q9HAS0|NJMU_HUMAN Protein Njmu-R1 OS=Homo sapiens OX=9606 GN=C17orf75 PE=1 SV=2,,,,,,
OG_08992,FUN_038514-T2,Peve_00041677,Pocillopora_meandrina_HIv1___RNAseq.g28181.t1,three_way,81.65366666666667,FUN_038514-T2,Q9NWX6,,,,,63.8,268.0,2.5e-96,353.2,sp|Q9NWX6|THG1_HUMAN Probable tRNA(His) guanylyltransferase OS=Homo sapiens OX=9606 GN=THG1L PE=1 SV=2,,,,,,
OG_08993,FUN_038523-T1,Peve_00041676,Pocillopora_meandrina_HIv1___RNAseq.g28185.t1,three_way,88.359,FUN_038523-T1,P0C0A3,CHMP6_MOUSE,,Charged multivesicular body protein 6 (Chromatin-modifying protein 6),Mus musculus (Mouse),62.5,168.0,7.5e-51,201.8,sp|P0C0A3|CHMP6_MOUSE Charged multivesicular body protein 6 OS=Mus musculus OX=10090 GN=Chmp6 PE=1 SV=2,GO:0000421; GO:0000776; GO:0000815; GO:0001778; GO:0005643; GO:0005765; GO:0005828; GO:0005886; GO:0006914; GO:0006997; GO:0007080; GO:0015031; GO:0030496; GO:0031468; GO:0032585; GO:0036258; GO:0039702; GO:0042176; GO:0043162; GO:0044877; GO:0046761; GO:0051469; GO:0061763; GO:0061952; GO:0071985; GO:0090148; GO:0097352; GO:1901673; GO:1902774; GO:1904930,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; late endosome to lysosome transport [GO:1902774]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; ESCRT III complex [GO:0000815]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; midbody [GO:0030496]; multivesicular body membrane [GO:0032585]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886],protein-containing complex binding [GO:0044877],GO:0005886; GO:0006914; GO:0016192; GO:0043226; GO:0061024,plasma membrane; autophagy; vesicle-mediated transport; organelle; membrane organization
OG_08994,FUN_038524-T1,Peve_00041750,Pocillopora_meandrina_HIv1___RNAseq.g28186.t1,three_way,79.337,FUN_038524-T1,Q8BKX6,SMG1_MOUSE,,Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1),Mus musculus (Mouse),37.7,3713.0,0.0,2274.6,sp|Q8BKX6|SMG1_MOUSE Serine/threonine-protein kinase SMG1 OS=Mus musculus OX=10090 GN=Smg1 PE=1 SV=3,GO:0000184; GO:0004674; GO:0005524; GO:0005654; GO:0006281; GO:0032204; GO:0033391; GO:0042162; GO:0046854; GO:0046872; GO:0106310,"DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of telomere maintenance [GO:0032204]",chromatoid body [GO:0033391]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005654; GO:0006281; GO:0006629; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleoplasm; DNA repair; lipid metabolic process; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_08995,FUN_038525-T1,Peve_00041748,Pocillopora_meandrina_HIv1___RNAseq.g28187.t1,three_way,68.14699999999999,,,,,,,,,,,,,,,,,
OG_08996,FUN_038531-T1,Peve_00041675,Pocillopora_meandrina_HIv1___RNAseq.g28189.t1,three_way,88.41799999999999,FUN_038531-T1,P34897,GLYM_HUMAN,,"Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)",Homo sapiens (Human),65.1,458.0,4.5e-176,619.0,"sp|P34897|GLYM_HUMAN Serine hydroxymethyltransferase, mitochondrial OS=Homo sapiens OX=9606 GN=SHMT2 PE=1 SV=3",GO:0002082; GO:0003682; GO:0004372; GO:0005634; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006544; GO:0006563; GO:0006564; GO:0006730; GO:0008284; GO:0008732; GO:0015630; GO:0015943; GO:0016597; GO:0019264; GO:0030170; GO:0034340; GO:0035999; GO:0042645; GO:0042802; GO:0046653; GO:0051262; GO:0051289; GO:0070062; GO:0070129; GO:0070536; GO:0070552; GO:1903715,formate biosynthetic process [GO:0015943]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell population proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634],amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005634; GO:0005739; GO:0005856; GO:0006520; GO:0006575; GO:0016740; GO:0016829; GO:0043226; GO:0065003,catalytic activity; nucleus; mitochondrion; cytoskeleton; amino acid metabolic process; modified amino acid metabolic process; transferase activity; lyase activity; organelle; protein-containing complex assembly
OG_08997,FUN_038533-T1,Peve_00013531,Pocillopora_meandrina_HIv1___RNAseq.g28191.t1,three_way,83.86566666666667,FUN_038533-T1,O00116,ADAS_HUMAN,,"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)",Homo sapiens (Human),58.7,623.0,3.6e-226,785.8,"sp|O00116|ADAS_HUMAN Alkyldihydroxyacetonephosphate synthase, peroxisomal OS=Homo sapiens OX=9606 GN=AGPS PE=1 SV=1",GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0008609; GO:0008610; GO:0008611; GO:0016020; GO:0071949,ether lipid biosynthetic process [GO:0008611]; lipid biosynthetic process [GO:0008610],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; transferase activity; organelle
OG_08998,FUN_038535-T1,Peve_00009817,Pocillopora_meandrina_HIv1___TS.g7943.t1,three_way,65.10233333333333,FUN_038535-T1,Q9JIA7,SPHK2_MOUSE,,Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91),Mus musculus (Mouse),34.2,547.0,3.6e-73,277.3,sp|Q9JIA7|SPHK2_MOUSE Sphingosine kinase 2 OS=Mus musculus OX=10090 GN=Sphk2 PE=1 SV=2,GO:0000786; GO:0001568; GO:0002720; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005743; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006669; GO:0006670; GO:0007420; GO:0007565; GO:0008283; GO:0008284; GO:0008481; GO:0016020; GO:0017050; GO:0030308; GO:0032736; GO:0032755; GO:0032760; GO:0033008; GO:0035556; GO:0038036; GO:0042393; GO:0043065; GO:0043122; GO:0043306; GO:0045815; GO:0046512; GO:1903426; GO:1904628; GO:1904959; GO:2000304; GO:2001169,blood vessel development [GO:0001568]; brain development [GO:0007420]; cell population proliferation [GO:0008283]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; female pregnancy [GO:0007565]; intracellular signal transduction [GO:0035556]; negative regulation of cell growth [GO:0030308]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation involved in immune response [GO:0033008]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of ATP biosynthetic process [GO:2001169]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; sphinganine-1-phosphate biosynthetic process [GO:0006669]; sphingosine biosynthetic process [GO:0046512]; sphingosine metabolic process [GO:0006670]; transcription initiation-coupled chromatin remodeling [GO:0045815],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; D-erythro-sphingosine kinase activity [GO:0017050]; histone binding [GO:0042393]; sphingosine kinase activity [GO:0008481]; sphingosine-1-phosphate receptor activity [GO:0038036],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005829; GO:0005886; GO:0006325; GO:0006629; GO:0016740; GO:0022414; GO:0042393; GO:0043226; GO:0048856; GO:0060089,catalytic activity; nucleus; nucleoplasm; mitochondrion; endoplasmic reticulum; cytosol; plasma membrane; chromatin organization; lipid metabolic process; transferase activity; reproductive process; histone binding; organelle; anatomical structure development; molecular transducer activity
OG_08999,FUN_038540-T1,Peve_00009816,Pocillopora_meandrina_HIv1___RNAseq.g28156.t1,three_way,75.49133333333333,FUN_038540-T1,Q9CQY1,ATG12_MOUSE,,Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like),Mus musculus (Mouse),46.2,130.0,8.7e-29,127.9,sp|Q9CQY1|ATG12_MOUSE Ubiquitin-like protein ATG12 OS=Mus musculus OX=10090 GN=Atg12 PE=1 SV=1,GO:0000045; GO:0005654; GO:0005776; GO:0005829; GO:0006914; GO:0016020; GO:0016236; GO:0032480; GO:0032991; GO:0034045; GO:0034274; GO:0045824; GO:0050687; GO:1901096; GO:1904973; GO:1990234,autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; macroautophagy [GO:0016236]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of type I interferon production [GO:0032480]; positive regulation of viral translation [GO:1904973]; regulation of autophagosome maturation [GO:1901096],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; transferase complex [GO:1990234],,GO:0005654; GO:0005773; GO:0005829; GO:0006914; GO:0043226,nucleoplasm; vacuole; cytosol; autophagy; organelle
OG_09000,FUN_038541-T1,Peve_00009815,Pocillopora_meandrina_HIv1___RNAseq.g28155.t1,three_way,87.0155,FUN_038541-T1,B5X2S3,,,,,48.5,582.0,3.1e-163,576.6,sp|B5X2S3|ARP8_SALSA Actin-related protein 8 OS=Salmo salar OX=8030 GN=actr8 PE=2 SV=1,,,,,,
OG_09001,FUN_038545-T1,Peve_00037480,Pocillopora_meandrina_HIv1___RNAseq.g1038.t1,three_way,81.75566666666667,FUN_038545-T1,Q28J44,,,,,62.9,342.0,1e-89,331.6,sp|Q28J44|S39AB_XENTR Zinc transporter ZIP11 OS=Xenopus tropicalis OX=8364 GN=slc39a11 PE=2 SV=1,,,,,,
OG_09002,FUN_038547-T1,Peve_00037482,Pocillopora_meandrina_HIv1___RNAseq.g1037.t1,three_way,73.7495,FUN_038547-T1,Q5U4T9,MBOA7_XENLA,,Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 (EC 2.3.1.-) (Leukocyte receptor cluster member 4) (Lysophospholipid acyltransferase 7) (LPLAT 7) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7),Xenopus laevis (African clawed frog),37.2,473.0,4.3e-86,320.1,sp|Q5U4T9|MBOA7_XENLA Membrane-bound acylglycerophosphatidylinositol O-acyltransferase mboat7 OS=Xenopus laevis OX=8355 GN=mboat7 PE=2 SV=1,GO:0005789; GO:0006661; GO:0008374; GO:0016020; GO:0030258; GO:0036149; GO:0036151; GO:0044233; GO:0071617; GO:0090207,lipid modification [GO:0030258]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylinositol acyl-chain remodeling [GO:0036149]; phosphatidylinositol biosynthetic process [GO:0006661]; regulation of triglyceride metabolic process [GO:0090207],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233],lysophospholipid acyltransferase activity [GO:0071617]; O-acyltransferase activity [GO:0008374],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_09003,FUN_038548-T1,Peve_00037483,Pocillopora_meandrina_HIv1___RNAseq.g1036.t1,three_way,61.59066666666666,FUN_038548-T1,Q9Z0Y8,CAC1I_RAT,,Voltage-dependent T-type calcium channel subunit alpha-1I (CaVT.3) (Voltage-gated calcium channel subunit alpha Cav3.3),Rattus norvegicus (Rat),37.5,1870.0,1.6e-259,898.3,sp|Q9Z0Y8|CAC1I_RAT Voltage-dependent T-type calcium channel subunit alpha-1I OS=Rattus norvegicus OX=10116 GN=Cacna1i PE=1 SV=3,GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0006816; GO:0008332; GO:0019228; GO:0030431; GO:0042391; GO:0043005; GO:0045956; GO:0060402; GO:0070509; GO:0086010,calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of membrane potential [GO:0042391]; sleep [GO:0030431],neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518],low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_09004,FUN_038550-T1,Peve_00035828,Pocillopora_meandrina_HIv1___RNAseq.g1030.t1,three_way,62.074666666666666,FUN_038550-T1,F1MV99,,,,,30.8,302.0,2.9e-23,110.9,sp|F1MV99|SSR5_BOVIN Somatostatin receptor type 5 OS=Bos taurus OX=9913 GN=SSTR5 PE=3 SV=2,,,,,,
OG_09005,FUN_038554-T1,Peve_00020197,Pocillopora_meandrina_HIv1___RNAseq.g1028.t1,three_way,68.93333333333334,FUN_038554-T1,P83858,QRFPR_RAT,,Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),Rattus norvegicus (Rat),26.1,310.0,4.9e-19,96.7,sp|P83858|QRFPR_RAT Pyroglutamylated RF-amide peptide receptor OS=Rattus norvegicus OX=10116 GN=Qrfpr PE=2 SV=1,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0032870; GO:0097730,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186],non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0005929; GO:0043226; GO:0060089,plasma membrane; cilium; organelle; molecular transducer activity
OG_09006,FUN_038555-T2,Peve_00020193,Pocillopora_meandrina_HIv1___RNAseq.g1027.t1,three_way,61.790333333333336,FUN_038555-T2,Q708S4,ASI4A_DANRE,,Acid-sensing ion channel 4-A (ASIC4-A) (Acid-sensing ion channel 4.1) (Amiloride-sensitive cation channel 4-A) (ZASIC4.1),Danio rerio (Zebrafish) (Brachydanio rerio),29.3,464.0,2.1e-40,168.3,sp|Q708S4|ASI4A_DANRE Acid-sensing ion channel 4-A OS=Danio rerio OX=7955 GN=asic4a PE=1 SV=1,GO:0005248; GO:0005261; GO:0005886; GO:0015280; GO:0035725; GO:0045177,sodium ion transmembrane transport [GO:0035725],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_09007,FUN_038557-T1,Peve_00020191,Pocillopora_meandrina_HIv1___RNAseq.g1024.t1,three_way,38.4565,,,,,,,,,,,,,,,,,
OG_09008,FUN_038565-T1,Peve_00020185,Pocillopora_meandrina_HIv1___RNAseq.g1021.t1,three_way,72.52799999999999,FUN_038565-T1,Q8C5H1,ANO4_MOUSE,,Anoctamin-4 (Transmembrane protein 16D),Mus musculus (Mouse),36.6,846.0,1.5e-148,528.5,sp|Q8C5H1|ANO4_MOUSE Anoctamin-4 OS=Mus musculus OX=10090 GN=Ano4 PE=1 SV=2,GO:0005886; GO:0017128; GO:0046983; GO:0051649; GO:0061589; GO:0061590; GO:0061591; GO:1902476,calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; establishment of localization in cell [GO:0051649],plasma membrane [GO:0005886],phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0055085; GO:0061024,transporter activity; plasma membrane; transmembrane transport; membrane organization
OG_09009,FUN_038568-T1,Peve_00020181,Pocillopora_meandrina_HIv1___RNAseq.g1018.t1,three_way,78.31666666666666,FUN_038568-T1,A2AHL1,ANO3_MOUSE,,Anoctamin-3 (Transmembrane protein 16C),Mus musculus (Mouse),39.6,847.0,1.3e-160,568.5,sp|A2AHL1|ANO3_MOUSE Anoctamin-3 OS=Mus musculus OX=10090 GN=Ano3 PE=1 SV=1,GO:0005886; GO:0016048; GO:0017128; GO:0046983; GO:0050982; GO:0051649; GO:0061590; GO:0061591,calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048]; establishment of localization in cell [GO:0051649],plasma membrane [GO:0005886],phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0061024,transporter activity; plasma membrane; membrane organization
OG_09010,FUN_038569-T1,Peve_00020176,Pocillopora_meandrina_HIv1___RNAseq.g1017.t1,three_way,78.48866666666667,FUN_038569-T1,Q8C5H1,ANO4_MOUSE,,Anoctamin-4 (Transmembrane protein 16D),Mus musculus (Mouse),40.2,815.0,2.7e-152,540.8,sp|Q8C5H1|ANO4_MOUSE Anoctamin-4 OS=Mus musculus OX=10090 GN=Ano4 PE=1 SV=2,GO:0005886; GO:0017128; GO:0046983; GO:0051649; GO:0061589; GO:0061590; GO:0061591; GO:1902476,calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; calcium activated phosphatidylserine scrambling [GO:0061589]; chloride transmembrane transport [GO:1902476]; establishment of localization in cell [GO:0051649],plasma membrane [GO:0005886],phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0055085; GO:0061024,transporter activity; plasma membrane; transmembrane transport; membrane organization
OG_09011,FUN_038571-T2,Peve_00020178,Pocillopora_meandrina_HIv1___RNAseq.g1016.t1,three_way,72.84416666666667,FUN_038571-T2,Q75V66,ANO5_HUMAN,,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),Homo sapiens (Human),42.9,821.0,8.6e-166,585.9,sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; plasma membrane; organelle; transmembrane transport; membrane organization
OG_09012,FUN_038572-T1,Peve_00020175,Pocillopora_meandrina_HIv1___TS.g5545.t1,three_way,48.534666666666666,FUN_038572-T1,Q8C2E4,,,,,25.4,627.0,2.2e-35,152.1,"sp|Q8C2E4|PTCD1_MOUSE Pentatricopeptide repeat-containing protein 1, mitochondrial OS=Mus musculus OX=10090 GN=Ptcd1 PE=2 SV=2",,,,,,
OG_09013,FUN_038574-T1,Peve_00020171,Pocillopora_meandrina_HIv1___RNAseq.g1013.t1,three_way,55.36533333333333,FUN_038574-T1,Q10660,DXO_CAEEL,,Decapping nuclease dom-3 (EC 3.6.1.-) (Dom-3 homolog Z) (NAD-capped RNA hydrolase dom-3) (DeNADding enzyme dom-3) (EC 3.6.1.-),Caenorhabditis elegans,26.4,254.0,2.9e-12,75.1,sp|Q10660|DXO_CAEEL Decapping nuclease dom-3 OS=Caenorhabditis elegans OX=6239 GN=dom-3 PE=2 SV=1,GO:0000166; GO:0000956; GO:0003723; GO:0004518; GO:0005634; GO:0005829; GO:0034353; GO:0046872; GO:0110152; GO:0110155,NAD-cap decapping [GO:0110155]; nuclear-transcribed mRNA catabolic process [GO:0000956],cytosol [GO:0005829]; nucleus [GO:0005634],metal ion binding [GO:0046872]; mRNA 5'-diphosphatase activity [GO:0034353]; nuclease activity [GO:0004518]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA NAD+-cap (NAD+-forming) hydrolase activity [GO:0110152],GO:0003723; GO:0003824; GO:0005634; GO:0005829; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; cytosol; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_09014,FUN_038576-T1,Peve_00012106,Pocillopora_meandrina_HIv1___RNAseq.g1012.t1,three_way,84.76333333333334,FUN_038576-T1,Q17QF0,AGT2_BOVIN,,"Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (EC 2.6.1.18) (D-3-aminoisobutyrate-pyruvate aminotransferase) (D-AIBAT) (D-beta-aminoisobutyrate-pyruvate aminotransferase)",Bos taurus (Bovine),57.4,462.0,1.3e-163,577.8,"sp|Q17QF0|AGT2_BOVIN Alanine--glyoxylate aminotransferase 2, mitochondrial OS=Bos taurus OX=9913 GN=AGXT2 PE=2 SV=1",GO:0005739; GO:0008453; GO:0009436; GO:0016223; GO:0019481; GO:0030170; GO:0047305; GO:2001299,"glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process, by transamination [GO:0019481]; N(omega),N(omega)-dimethyl-L-arginine catabolic process [GO:2001299]",mitochondrion [GO:0005739],(R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; beta-alanine:pyruvate transaminase activity [GO:0016223]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0006520; GO:0006575; GO:0016740; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; transferase activity; organelle
OG_09015,FUN_038577-T1,Peve_00012107,Pocillopora_meandrina_HIv1___RNAseq.g1011.t1,three_way,67.471,FUN_038577-T1,Q0QWG9,GRD2I_MOUSE,,"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)",Mus musculus (Mouse),28.8,420.0,9.800000000000001e-34,147.1,sp|Q0QWG9|GRD2I_MOUSE Delphilin OS=Mus musculus OX=10090 GN=Grid2ip PE=1 SV=1,GO:0007216; GO:0030036; GO:0043197; GO:0045202; GO:0045211; GO:0060292; GO:0098688; GO:0098978; GO:0099072; GO:0099092; GO:0099566; GO:0150048,actin cytoskeleton organization [GO:0030036]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; long-term synaptic depression [GO:0060292]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072],"cerebellar granule cell to Purkinje cell synapse [GO:0150048]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]",,GO:0007010; GO:0043226,cytoskeleton organization; organelle
OG_09016,FUN_038578-T1,Peve_00012102,Pocillopora_meandrina_HIv1___TS.g5540.t1,three_way,63.539,FUN_038578-T1,Q9Z207,DIAP3_MOUSE,,Protein diaphanous homolog 3 (Diaphanous-related formin-3) (DRF3) (p134mDIA2) (mDIA2),Mus musculus (Mouse),27.2,290.0,2e-21,105.1,sp|Q9Z207|DIAP3_MOUSE Protein diaphanous homolog 3 OS=Mus musculus OX=10090 GN=Diaph3 PE=1 SV=1,GO:0000226; GO:0000813; GO:0000922; GO:0001701; GO:0003779; GO:0005634; GO:0005737; GO:0005815; GO:0007010; GO:0007015; GO:0007026; GO:0007059; GO:0007229; GO:0007605; GO:0008017; GO:0008092; GO:0010467; GO:0016197; GO:0030010; GO:0030030; GO:0030036; GO:0030041; GO:0030182; GO:0030218; GO:0030225; GO:0031267; GO:0031941; GO:0032154; GO:0032432; GO:0034367; GO:0042803; GO:0043131; GO:0045010; GO:0046785; GO:0051017; GO:0051764; GO:0060113; GO:0060322; GO:0061909; GO:0071800; GO:0097470; GO:1990427,actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; autophagosome-lysosome fusion [GO:0061909]; cell projection organization [GO:0030030]; chromosome segregation [GO:0007059]; cytoskeleton organization [GO:0007010]; endosomal transport [GO:0016197]; erythrocyte differentiation [GO:0030218]; erythrocyte enucleation [GO:0043131]; establishment of cell polarity [GO:0030010]; gene expression [GO:0010467]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; inner ear receptor cell differentiation [GO:0060113]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron differentiation [GO:0030182]; podosome assembly [GO:0071800]; protein-containing complex remodeling [GO:0034367]; sensory perception of sound [GO:0007605],actin filament bundle [GO:0032432]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; ESCRT I complex [GO:0000813]; filamentous actin [GO:0031941]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ribbon synapse [GO:0097470]; spindle pole [GO:0000922]; stereocilia tip-link density [GO:1990427],actin binding [GO:0003779]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; small GTPase binding [GO:0031267],GO:0005634; GO:0005815; GO:0007010; GO:0007059; GO:0007163; GO:0008092; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0061024; GO:0065003,nucleus; microtubule organizing center; cytoskeleton organization; chromosome segregation; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; nervous system process; membrane organization; protein-containing complex assembly
OG_09017,FUN_038580-T1,Peve_00012104,Pocillopora_meandrina_HIv1___RNAseq.g1008.t1,three_way,76.07866666666666,FUN_038580-T1,Q8BYA0,,,,,54.4,1010.0,0.0,1093.2,sp|Q8BYA0|TBCD_MOUSE Tubulin-specific chaperone D OS=Mus musculus OX=10090 GN=Tbcd PE=1 SV=1,,,,,,
OG_09018,FUN_038583-T1,Peve_00010568,Pocillopora_meandrina_HIv1___TS.g5537.t1,three_way,51.0455,,,,,,,,,,,,,,,,,
OG_09019,FUN_038607-T1,Peve_00005402,Pocillopora_meandrina_HIv1___TS.g5522.t2,three_way,74.475,FUN_038607-T1,Q8BJ51,,,,,48.3,379.0,6.799999999999998e-91,335.9,sp|Q8BJ51|MFS11_MOUSE UNC93-like protein MFSD11 OS=Mus musculus OX=10090 GN=Mfsd11 PE=1 SV=1,,,,,,
OG_09020,FUN_038608-T1,Peve_00005403,Pocillopora_meandrina_HIv1___RNAseq.g989.t1,three_way,57.90166666666666,,,,,,,,,,,,,,,,,
OG_09021,FUN_038610-T1,Peve_00002803,Pocillopora_meandrina_HIv1___RNAseq.g988.t1,three_way,58.11266666666667,FUN_038610-T1,Q60437,BAIP2_CRIGR,,BAR/IMD domain-containing adapter protein 2 (Brain-specific angiogenesis inhibitor 1-associated protein 2) (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53),Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus),31.7,221.0,2.2e-23,111.7,sp|Q60437|BAIP2_CRIGR BAR/IMD domain-containing adapter protein 2 OS=Cricetulus griseus OX=10029 GN=BAIAP2 PE=1 SV=1,GO:0001726; GO:0005654; GO:0005829; GO:0005856; GO:0007009; GO:0008093; GO:0008360; GO:0016020; GO:0030175; GO:0030838; GO:0032956; GO:0051017; GO:0051764; GO:0070064,actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; plasma membrane organization [GO:0007009]; positive regulation of actin filament polymerization [GO:0030838]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell shape [GO:0008360],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ruffle [GO:0001726],cytoskeletal anchor activity [GO:0008093]; proline-rich region binding [GO:0070064],GO:0005654; GO:0005829; GO:0005856; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; cytosol; cytoskeleton; organelle; molecular adaptor activity; membrane organization
OG_09022,FUN_038611-T1,Peve_00044574,Pocillopora_meandrina_HIv1___RNAseq.g9728.t2,three_way,43.10066666666667,,,,,,,,,,,,,,,,,
OG_09023,FUN_038613-T1,Peve_00002805,Pocillopora_meandrina_HIv1___RNAseq.g973.t1b,three_way,59.701,FUN_038613-T1,Q6ICB0,DESI1_HUMAN,,Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2) (Palmitoyl protein thioesterase DESI1) (EC 3.1.2.22) (Polyubiquitinated substrate transporter) (POST) (S-depalmitoylase DESI1),Homo sapiens (Human),63.3,150.0,1e-55,219.2,sp|Q6ICB0|DESI1_HUMAN Desumoylating isopeptidase 1 OS=Homo sapiens OX=9606 GN=DESI1 PE=1 SV=1,GO:0005634; GO:0005829; GO:0006508; GO:0006611; GO:0008474; GO:0016926; GO:0016929; GO:0032434; GO:0032991; GO:0042802; GO:0052816; GO:0061676,protein desumoylation [GO:0016926]; protein export from nucleus [GO:0006611]; proteolysis [GO:0006508]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],deSUMOylase activity [GO:0016929]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; palmitoyl-(protein) hydrolase activity [GO:0008474],GO:0003824; GO:0005634; GO:0005829; GO:0006886; GO:0006913; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; intracellular protein transport; nucleocytoplasmic transport; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09024,FUN_038614-T1,Peve_00002807,Pocillopora_meandrina_HIv1___RNAseq.g972.t1,three_way,69.6525,FUN_038614-T1,Q9Z0Y8,CAC1I_RAT,,Voltage-dependent T-type calcium channel subunit alpha-1I (CaVT.3) (Voltage-gated calcium channel subunit alpha Cav3.3),Rattus norvegicus (Rat),43.5,1698.0,3.3e-299,1030.0,sp|Q9Z0Y8|CAC1I_RAT Voltage-dependent T-type calcium channel subunit alpha-1I OS=Rattus norvegicus OX=10116 GN=Cacna1i PE=1 SV=3,GO:0001518; GO:0005245; GO:0005248; GO:0005891; GO:0006816; GO:0008332; GO:0019228; GO:0030431; GO:0042391; GO:0043005; GO:0045956; GO:0060402; GO:0070509; GO:0086010,calcium ion import [GO:0070509]; calcium ion transport [GO:0006816]; calcium ion transport into cytosol [GO:0060402]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of membrane potential [GO:0042391]; sleep [GO:0030431],neuron projection [GO:0043005]; voltage-gated calcium channel complex [GO:0005891]; voltage-gated sodium channel complex [GO:0001518],low voltage-gated calcium channel activity [GO:0008332]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_09025,FUN_038617-T1,Peve_00042051,Pocillopora_meandrina_HIv1___RNAseq.g971.t1,three_way,90.041,FUN_038617-T1,Q6NRT5,,,,,64.5,476.0,3.4e-176,619.4,sp|Q6NRT5|CSN1_XENLA COP9 signalosome complex subunit 1 OS=Xenopus laevis OX=8355 GN=csn1 PE=2 SV=1,,,,,,
OG_09026,FUN_038619-T1,Peve_00042042,Pocillopora_meandrina_HIv1___RNAseq.g1162.t1,three_way,51.708333333333336,,,,,,,,,,,,,,,,,
OG_09027,FUN_038620-T1,Peve_00033707,Pocillopora_meandrina_HIv1___TS.g5695.t1,three_way,47.649,,,,,,,,,,,,,,,,,
OG_09028,FUN_038621-T1,Peve_00042047,Pocillopora_meandrina_HIv1___RNAseq.g1161.t1,three_way,51.117666666666665,FUN_038621-T1,Q5NVA9,,,,,38.2,327.0,3.0999999999999995e-43,178.3,sp|Q5NVA9|EME1_PONAB Structure-specific endonuclease subunit EME1 OS=Pongo abelii OX=9601 GN=EME1 PE=3 SV=1,,,,,,
OG_09029,FUN_038622-T1,Peve_00042048,Pocillopora_meandrina_HIv1___RNAseq.g1159.t1,three_way,78.449,FUN_038622-T1,P22448,,,,,31.8,349.0,7.2e-41,169.5,sp|P22448|RARB_CHICK Retinoic acid receptor beta OS=Gallus gallus OX=9031 GN=RARB PE=2 SV=2,,,,,,
OG_09030,FUN_038628-T2,Peve_00042041,Pocillopora_meandrina_HIv1___RNAseq.g1170.t1,three_way,91.91266666666668,FUN_038628-T2,Q08DM7,SEPT3_BOVIN,,Neuronal-specific septin-3,Bos taurus (Bovine),62.9,294.0,5.4e-109,396.0,sp|Q08DM7|SEPT3_BOVIN Neuronal-specific septin-3 OS=Bos taurus OX=9913 GN=SEPTIN3 PE=2 SV=3,GO:0003924; GO:0005525; GO:0005940; GO:0008104; GO:0015630; GO:0031105; GO:0032153; GO:0060090; GO:0061640; GO:0098793,cytoskeleton-dependent cytokinesis [GO:0061640]; protein localization [GO:0008104],cell division site [GO:0032153]; microtubule cytoskeleton [GO:0015630]; presynapse [GO:0098793]; septin complex [GO:0031105]; septin ring [GO:0005940],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; molecular adaptor activity [GO:0060090],GO:0000910; GO:0003824; GO:0003924; GO:0005856; GO:0016787; GO:0043226; GO:0060090,cytokinesis; catalytic activity; GTPase activity; cytoskeleton; hydrolase activity; organelle; molecular adaptor activity
OG_09031,FUN_038630-T1,Peve_00006142,Pocillopora_meandrina_HIv1___RNAseq.g1172.t1,three_way,62.70033333333333,,,,,,,,,,,,,,,,,
OG_09032,FUN_038632-T1,Peve_00013498,Pocillopora_meandrina_HIv1___RNAseq.g26496.t1,three_way,88.648,FUN_038632-T1,Q58DC5,GTPB1_BOVIN,,GTP-binding protein 1,Bos taurus (Bovine),72.5,534.0,3.9e-228,792.3,sp|Q58DC5|GTPB1_BOVIN GTP-binding protein 1 OS=Bos taurus OX=9913 GN=GTPBP1 PE=2 SV=2,GO:0000049; GO:0000177; GO:0002181; GO:0003746; GO:0003924; GO:0005525; GO:0005829; GO:0006414; GO:0046039; GO:0061014; GO:1904678,cytoplasmic translation [GO:0002181]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414],cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829],alpha-aminoacyl-tRNA binding [GO:1904678]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049],GO:0002181; GO:0003723; GO:0003824; GO:0003924; GO:0005829; GO:0016787; GO:0055086; GO:1901135,cytoplasmic translation; RNA binding; catalytic activity; GTPase activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09033,FUN_038633-T1,Peve_00013497,Pocillopora_meandrina_HIv1___RNAseq.g26495.t1,three_way,75.706,FUN_038633-T1,Q5EAE5,JOS1_BOVIN,,Josephin-1 (EC 3.4.19.12) (Josephin domain-containing protein 1),Bos taurus (Bovine),47.4,175.0,6.499999999999999e-43,175.3,sp|Q5EAE5|JOS1_BOVIN Josephin-1 OS=Bos taurus OX=9913 GN=JOSD1 PE=2 SV=1,GO:0004843; GO:0005737; GO:0005886; GO:0006508; GO:0006897; GO:0016579; GO:0044091; GO:0048870; GO:0061024,cell motility [GO:0048870]; endocytosis [GO:0006897]; membrane biogenesis [GO:0044091]; membrane organization [GO:0061024]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005886; GO:0016192; GO:0016787; GO:0048870; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; vesicle-mediated transport; hydrolase activity; cell motility; membrane organization; catalytic activity, acting on a protein"
OG_09034,FUN_038634-T1,Peve_00013495,Pocillopora_meandrina_HIv1___RNAseq.g26493.t1,three_way,76.94633333333333,FUN_038634-T1,Q99PT9,KIF19_MOUSE,,Kinesin-like protein KIF19,Mus musculus (Mouse),46.3,864.0,9.200000000000002e-180,632.5,sp|Q99PT9|KIF19_MOUSE Kinesin-like protein KIF19 OS=Mus musculus OX=10090 GN=Kif19 PE=1 SV=2,GO:0005524; GO:0005874; GO:0005929; GO:0005930; GO:0007018; GO:0008017; GO:0008574; GO:0060404; GO:0070462,axonemal microtubule depolymerization [GO:0060404]; microtubule-based movement [GO:0007018]; plus-end specific microtubule depolymerization [GO:0070462],axoneme [GO:0005930]; cilium [GO:0005929]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; plus-end-directed microtubule motor activity [GO:0008574],GO:0003774; GO:0003824; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_09035,FUN_038636-T1,Peve_00013494,Pocillopora_meandrina_HIv1___RNAseq.g26492.t1,three_way,69.60633333333334,,,,,,,,,,,,,,,,,
OG_09036,FUN_038637-T1,Peve_00013493,Pocillopora_meandrina_HIv1___RNAseq.g26491.t1,three_way,71.66766666666666,FUN_038637-T1,P70426,,,,,43.2,183.0,1.3999999999999998e-29,131.7,sp|P70426|RIT1_MOUSE GTP-binding protein Rit1 OS=Mus musculus OX=10090 GN=Rit1 PE=1 SV=1,,,,,,
OG_09037,FUN_038638-T1,Peve_00013491,Pocillopora_meandrina_HIv1___RNAseq.g26490.t2,three_way,56.39266666666666,FUN_038638-T1,Q8WXD9,,,,,42.0,143.0,2e-27,126.7,sp|Q8WXD9|CSKI1_HUMAN Caskin-1 OS=Homo sapiens OX=9606 GN=CASKIN1 PE=1 SV=1,,,,,,
OG_09038,FUN_038682-T1,Peve_00013483,Pocillopora_meandrina_HIv1___TS.g19232.t2,three_way,92.927,FUN_038682-T1,Q803V5,,,,,76.8,220.0,3.699999999999999e-105,382.9,sp|Q803V5|LST8_DANRE Target of rapamycin complex subunit lst8 OS=Danio rerio OX=7955 GN=mlst8 PE=2 SV=1,,,,,,
OG_09039,FUN_038685-T1,Peve_00013482,Pocillopora_meandrina_HIv1___TS.g19231.t1,three_way,85.41833333333334,FUN_038685-T1,Q96QU8,,,,,53.9,1170.0,0.0,1206.0,sp|Q96QU8|XPO6_HUMAN Exportin-6 OS=Homo sapiens OX=9606 GN=XPO6 PE=1 SV=1,,,,,,
OG_09040,FUN_038688-T1,Peve_00013481,Pocillopora_meandrina_HIv1___TS.g19229.t1b,three_way,89.20133333333334,FUN_038688-T1,Q99KI0,,,,,76.7,769.0,0.0,1237.2,"sp|Q99KI0|ACON_MOUSE Aconitate hydratase, mitochondrial OS=Mus musculus OX=10090 GN=Aco2 PE=1 SV=1",,,,,,
OG_09041,FUN_038691-T1,Peve_00013477,Pocillopora_meandrina_HIv1___RNAseq.g26476.t1,three_way,88.76283333333333,FUN_038691-T1,A7SDW5,,,,,76.3,539.0,2.5e-247,855.9,sp|A7SDW5|EIF3L_NEMVE Eukaryotic translation initiation factor 3 subunit L OS=Nematostella vectensis OX=45351 GN=v1g169424 PE=3 SV=1,,,,,,
OG_09042,FUN_038695-T1,Peve_00013474,Pocillopora_meandrina_HIv1___RNAseq.g26473.t1,three_way,63.010333333333335,,,,,,,,,,,,,,,,,
OG_09043,FUN_038697-T1,Peve_00013468,Pocillopora_meandrina_HIv1___RNAseq.g26461.t2,three_way,78.3395,FUN_038697-T1,Q9Y383,LC7L2_HUMAN,,Putative RNA-binding protein Luc7-like 2,Homo sapiens (Human),60.3,239.0,6.6e-79,295.8,sp|Q9Y383|LC7L2_HUMAN Putative RNA-binding protein Luc7-like 2 OS=Homo sapiens OX=9606 GN=LUC7L2 PE=1 SV=2,GO:0003723; GO:0003729; GO:0005685; GO:0006376; GO:0016607; GO:0019899; GO:0071004,mRNA splice site recognition [GO:0006376],nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004],enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723],GO:0003723; GO:0043226; GO:0065003,RNA binding; organelle; protein-containing complex assembly
OG_09044,FUN_038706-T1,Peve_00013466,Pocillopora_meandrina_HIv1___TS.g19207.t1,three_way,72.16366666666667,FUN_038706-T1,Q8CGQ8,NCKX4_MOUSE,,Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4),Mus musculus (Mouse),39.6,545.0,1.9e-100,367.9,sp|Q8CGQ8|NCKX4_MOUSE Sodium/potassium/calcium exchanger 4 OS=Mus musculus OX=10090 GN=Slc24a4 PE=1 SV=2,GO:0005432; GO:0005516; GO:0005737; GO:0005886; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0071486; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834,amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608],apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982],"calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]",GO:0005215; GO:0005886; GO:0043226; GO:0050877; GO:0055085,transporter activity; plasma membrane; organelle; nervous system process; transmembrane transport
OG_09045,FUN_038707-T1,Peve_00013464,Pocillopora_meandrina_HIv1___RNAseq.g23383.t1,three_way,72.31633333333333,FUN_038707-T1,Q8BGA7,,,,,31.7,436.0,7.5e-40,166.4,sp|Q8BGA7|INT15_MOUSE Integrator complex subunit 15 OS=Mus musculus OX=10090 GN=Ints15 PE=2 SV=1,,,,,,
OG_09046,FUN_038717-T1,Peve_00002624,Pocillopora_meandrina_HIv1___RNAseq.g26442.t1a,three_way,83.539,FUN_038717-T1,P04464,,,,,32.2,143.0,3.7e-13,76.3,sp|P04464|CALM_WHEAT Calmodulin OS=Triticum aestivum OX=4565 PE=1 SV=3,,,,,,
OG_09047,FUN_038718-T1,Peve_00002623,Pocillopora_meandrina_HIv1___RNAseq.g26441.t1,three_way,74.53816666666667,,,,,,,,,,,,,,,,,
OG_09048,FUN_038727-T1,Peve_00017651,Pocillopora_meandrina_HIv1___RNAseq.g26440.t1,three_way,92.25766666666668,FUN_038727-T1,P21265,,,,,75.8,454.0,5e-204,711.8,sp|P21265|PUR8_CHICK Adenylosuccinate lyase OS=Gallus gallus OX=9031 GN=ADSL PE=2 SV=2,,,,,,
OG_09049,FUN_038728-T1,Peve_00016751,Pocillopora_meandrina_HIv1___RNAseq.g26438.t1,three_way,50.05666666666667,,,,,,,,,,,,,,,,,
OG_09050,FUN_038730-T1,Peve_00016753,Pocillopora_meandrina_HIv1___RNAseq.g26437.t1,three_way,53.7555,,,,,,,,,,,,,,,,,
OG_09051,FUN_038731-T1,Peve_00013930,Pocillopora_meandrina_HIv1___RNAseq.g26436.t1,three_way,77.78783333333334,FUN_038731-T1,O42115,,,,,50.0,84.0,1.3e-11,70.9,sp|O42115|ARX_DANRE Aristaless-related homeobox protein OS=Danio rerio OX=7955 GN=arx PE=2 SV=1,,,,,,
OG_09052,FUN_038733-T1,Peve_00013932,Pocillopora_meandrina_HIv1___RNAseq.g26435.t1,three_way,77.6025,FUN_038733-T1,O75175,CNOT3_HUMAN,,CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2),Homo sapiens (Human),43.1,826.0,1.5e-134,481.9,sp|O75175|CNOT3_HUMAN CCR4-NOT transcription complex subunit 3 OS=Homo sapiens OX=9606 GN=CNOT3 PE=1 SV=1,GO:0000289; GO:0000932; GO:0001829; GO:0005634; GO:0005829; GO:0006355; GO:0006417; GO:0030014; GO:0030015; GO:0031047; GO:0120162; GO:2000036,nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell population maintenance [GO:2000036]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; trophectodermal cell differentiation [GO:0001829],CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932],,GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0030154; GO:0031047; GO:0043226,nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle
OG_09053,FUN_038734-T1,Peve_00013933,Pocillopora_meandrina_HIv1___RNAseq.g26434.t1,three_way,82.597,FUN_038734-T1,Q8TB22,,,,,50.1,743.0,9.099999999999999e-217,755.0,sp|Q8TB22|SPT20_HUMAN Spermatogenesis-associated protein 20 OS=Homo sapiens OX=9606 GN=SPATA20 PE=1 SV=3,,,,,,
OG_09054,FUN_038735-T2,Peve_00009270,Pocillopora_meandrina_HIv1___RNAseq.g26433.t2,three_way,69.43966666666667,,,,,,,,,,,,,,,,,
OG_09055,FUN_038736-T1,Peve_00009275,Pocillopora_meandrina_HIv1___RNAseq.g26432.t1,three_way,43.091,,,,,,,,,,,,,,,,,
OG_09056,FUN_038737-T1,Peve_00009276,Pocillopora_meandrina_HIv1___RNAseq.g26431.t1,three_way,65.04966666666667,FUN_038737-T1,Q5TM57,,,,,43.9,123.0,4.7e-23,109.0,sp|Q5TM57|RPP21_MACMU Ribonuclease P protein subunit p21 OS=Macaca mulatta OX=9544 GN=RPP21 PE=3 SV=1,,,,,,
OG_09057,FUN_038738-T1,Peve_00009277,Pocillopora_meandrina_HIv1___TS.g19181.t1,three_way,76.819,FUN_038738-T1,Q8CFY5,COX10_MOUSE,,"Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.141) (Heme O synthase)",Mus musculus (Mouse),48.7,386.0,6.6e-91,335.9,"sp|Q8CFY5|COX10_MOUSE Protoheme IX farnesyltransferase, mitochondrial OS=Mus musculus OX=10090 GN=Cox10 PE=2 SV=1",GO:0000266; GO:0002521; GO:0004311; GO:0005730; GO:0005739; GO:0005759; GO:0005829; GO:0006629; GO:0006784; GO:0007005; GO:0008495; GO:0008535; GO:0009060; GO:0017004; GO:0031966; GO:0035264; GO:0048034; GO:0055070; GO:0070069,aerobic respiration [GO:0009060]; copper ion homeostasis [GO:0055070]; cytochrome complex assembly [GO:0017004]; heme A biosynthetic process [GO:0006784]; heme O biosynthetic process [GO:0048034]; leukocyte differentiation [GO:0002521]; lipid metabolic process [GO:0006629]; mitochondrial fission [GO:0000266]; mitochondrion organization [GO:0007005]; multicellular organism growth [GO:0035264]; respiratory chain complex IV assembly [GO:0008535],cytochrome complex [GO:0070069]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],geranylgeranyl diphosphate synthase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495],GO:0003824; GO:0005730; GO:0005739; GO:0005829; GO:0006091; GO:0006629; GO:0007005; GO:0016740; GO:0030154; GO:0043226; GO:0065003,catalytic activity; nucleolus; mitochondrion; cytosol; generation of precursor metabolites and energy; lipid metabolic process; mitochondrion organization; transferase activity; cell differentiation; organelle; protein-containing complex assembly
OG_09058,FUN_038740-T1,Peve_00009049,Pocillopora_meandrina_HIv1___RNAseq.g26428.t1,three_way,80.50066666666666,FUN_038740-T1,O54922,,,,,41.2,677.0,9.7e-140,498.8,sp|O54922|EXOC7_RAT Exocyst complex component 7 OS=Rattus norvegicus OX=10116 GN=Exoc7 PE=1 SV=1,,,,,,
OG_09059,FUN_038742-T1,Peve_00009051,Pocillopora_meandrina_HIv1___RNAseq.g26426.t1,three_way,86.85000000000001,FUN_038742-T1,Q8TB05,,,,,74.4,86.0,2.5e-28,125.9,sp|Q8TB05|UBAD1_HUMAN UBA-like domain-containing protein 1 OS=Homo sapiens OX=9606 GN=UBALD1 PE=1 SV=1,,,,,,
OG_09060,FUN_038746-T1,Peve_00044517,Pocillopora_meandrina_HIv1___TS.g19172.t1,three_way,66.80933333333334,FUN_038746-T1,Q5BKS4,ERI2_MOUSE,,ERI1 exoribonuclease 2 (EC 3.1.-.-) (Exonuclease domain-containing protein 1),Mus musculus (Mouse),56.5,253.0,5.900000000000001e-80,298.9,sp|Q5BKS4|ERI2_MOUSE ERI1 exoribonuclease 2 OS=Mus musculus OX=10090 GN=Eri2 PE=2 SV=1,GO:0000175; GO:0003676; GO:0008270,,,3'-5'-RNA exonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0003824; GO:0016787; GO:0140098,"catalytic activity; hydrolase activity; catalytic activity, acting on RNA"
OG_09061,FUN_038756-T1,Peve_00022724,Pocillopora_meandrina_HIv1___RNAseq.g26409.t1,three_way,77.744,FUN_038756-T1,Q8NBN7,RDH13_HUMAN,,Retinol dehydrogenase 13 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 7C member 3),Homo sapiens (Human),46.0,302.0,6.2e-63,242.7,sp|Q8NBN7|RDH13_HUMAN Retinol dehydrogenase 13 OS=Homo sapiens OX=9606 GN=RDH13 PE=1 SV=2,GO:0005739; GO:0005743; GO:0009644; GO:0010842; GO:0042462; GO:0042574; GO:0052650,eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226; GO:0048856,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle; anatomical structure development
OG_09062,FUN_038769-T1,Peve_00022730,Pocillopora_meandrina_HIv1___RNAseq.g26408.t1,three_way,76.67533333333333,,,,,,,,,,,,,,,,,
OG_09063,FUN_038770-T1,Peve_00022729,Pocillopora_meandrina_HIv1___RNAseq.g26407.t1,three_way,62.81733333333333,FUN_038770-T1,B0S6U7,ERAL1_DANRE,,"GTPase Era, mitochondrial (ERA-like protein 1)",Danio rerio (Zebrafish) (Brachydanio rerio),35.7,308.0,4.2e-42,173.7,"sp|B0S6U7|ERAL1_DANRE GTPase Era, mitochondrial OS=Danio rerio OX=7955 GN=eral1 PE=2 SV=1",GO:0000028; GO:0005525; GO:0005743; GO:0005759; GO:0019843; GO:0043024,ribosomal small subunit assembly [GO:0000028],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759],GTP binding [GO:0005525]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_09064,FUN_038771-T1,Peve_00022728,Pocillopora_meandrina_HIv1___RNAseq.g26406.t1,three_way,64.24583333333334,,,,,,,,,,,,,,,,,
OG_09065,FUN_038783-T1,Peve_00022727,Pocillopora_meandrina_HIv1___TS.g19156.t1,three_way,75.868,FUN_038783-T1,P49288,,,,,28.5,305.0,1.6e-16,88.6,sp|P49288|MTR1C_CHICK Melatonin receptor type 1C OS=Gallus gallus OX=9031 PE=2 SV=1,,,,,,
OG_09066,FUN_038784-T1,Peve_00007211,Pocillopora_meandrina_HIv1___RNAseq.g26404.t1,three_way,97.22233333333334,FUN_038784-T1,Q962X9,,,,,91.7,144.0,1.5e-77,290.0,sp|Q962X9|BUD31_BRABE Protein BUD31 homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1,,,,,,
OG_09067,FUN_038786-T1,Peve_00007210,Pocillopora_meandrina_HIv1___RNAseq.g26402.t1,three_way,79.763,FUN_038786-T1,Q7ZX59,,,,,28.9,463.0,5.4e-46,186.8,sp|Q7ZX59|CRLF3_XENLA Cytokine receptor-like factor 3 OS=Xenopus laevis OX=8355 GN=crlf3 PE=2 SV=1,,,,,,
OG_09068,FUN_038789-T1,Peve_00007206,Pocillopora_meandrina_HIv1___RNAseq.g26399.t1,three_way,63.13333333333333,FUN_038789-T1,Q9CS74,ECD_MOUSE,,Protein ecdysoneless homolog,Mus musculus (Mouse),41.7,643.0,1.3999999999999998e-127,458.4,sp|Q9CS74|ECD_MOUSE Protein ecdysoneless homolog OS=Mus musculus OX=10090 GN=Ecd PE=1 SV=2,GO:0005654; GO:0005829; GO:0006397; GO:0008380; GO:0035035; GO:0045944; GO:0048144; GO:2000045,fibroblast proliferation [GO:0048144]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380],cytosol [GO:0005829]; nucleoplasm [GO:0005654],histone acetyltransferase binding [GO:0035035],GO:0005654; GO:0005829; GO:0006355; GO:0016071,nucleoplasm; cytosol; regulation of DNA-templated transcription; mRNA metabolic process
OG_09069,FUN_038793-T1,Peve_00007204,Pocillopora_meandrina_HIv1___RNAseq.g26398.t1,three_way,68.06166666666667,,,,,,,,,,,,,,,,,
OG_09070,FUN_038795-T1,Peve_00007232,Pocillopora_meandrina_HIv1___RNAseq.g26384.t1,three_way,72.97933333333333,FUN_038795-T1,P09848,LPH_HUMAN,,Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)],Homo sapiens (Human),49.1,489.0,1.3e-139,498.0,sp|P09848|LPH_HUMAN Lactase/phlorizin hydrolase OS=Homo sapiens OX=9606 GN=LCT PE=1 SV=3,GO:0000016; GO:0004336; GO:0004348; GO:0005886; GO:0005990; GO:0008422; GO:0042803; GO:0046477; GO:0080079; GO:0098591; GO:0140749; GO:1901733; GO:2000892,cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733],external side of apical plasma membrane [GO:0098591]; plasma membrane [GO:0005886],beta-glucosidase activity [GO:0008422]; cellobiose glucosidase activity [GO:0080079]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005886; GO:0005975; GO:0006629; GO:0016787; GO:1901135,catalytic activity; plasma membrane; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_09071,FUN_038799-T1,Peve_00007230,Pocillopora_meandrina_HIv1___RNAseq.g26382.t1,three_way,59.84366666666666,,,,,,,,,,,,,,,,,
OG_09072,FUN_038800-T1,Peve_00007227,Pocillopora_meandrina_HIv1___RNAseq.g26372.t1,three_way,62.00983333333333,,,,,,,,,,,,,,,,,
OG_09073,FUN_038801-T1,Peve_00007226,Pocillopora_meandrina_HIv1___RNAseq.g28547.t1,three_way,79.16683333333334,FUN_038801-T1,E5RQL4,,,,,37.8,185.0,1e-17,92.4,sp|E5RQL4|FONG_HUMAN Formiminotransferase N-terminal subdomain-containing protein OS=Homo sapiens OX=9606 GN=FTCDNL1 PE=2 SV=1,,,,,,
OG_09074,FUN_038803-T1,Peve_00007224,Pocillopora_meandrina_HIv1___RNAseq.g28545.t1,three_way,82.41499999999999,FUN_038803-T1,Q8BL48,UNK_MOUSE,,RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5),Mus musculus (Mouse),46.5,778.0,5.5e-160,567.0,sp|Q8BL48|UNK_MOUSE RING finger protein unkempt homolog OS=Mus musculus OX=10090 GN=Unk PE=1 SV=1,GO:0001701; GO:0001764; GO:0005737; GO:0008270; GO:0043022; GO:0048667; GO:1990715; GO:2000766,cell morphogenesis involved in neuron differentiation [GO:0048667]; in utero embryonic development [GO:0001701]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764],cytoplasm [GO:0005737],mRNA CDS binding [GO:1990715]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270],GO:0003723; GO:0048856; GO:0048870,RNA binding; anatomical structure development; cell motility
OG_09075,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_09076,FUN_038805-T1,Peve_00007221,Pocillopora_meandrina_HIv1___RNAseq.g28540.t1,three_way,72.57433333333333,FUN_038805-T1,Q6GMF8,RHDF1_DANRE,,Inactive rhomboid protein 1 (iRhom1) (Rhomboid family member 1),Danio rerio (Zebrafish) (Brachydanio rerio),43.3,716.0,4.9999999999999995e-142,506.5,sp|Q6GMF8|RHDF1_DANRE Inactive rhomboid protein 1 OS=Danio rerio OX=7955 GN=rhbdf1 PE=2 SV=1,GO:0000139; GO:0005789; GO:0008283; GO:0015031; GO:0016477; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0061136,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],growth factor binding [GO:0019838],GO:0048870,cell motility
OG_09077,FUN_038806-T1,Peve_00007222,Pocillopora_meandrina_HIv1___RNAseq.g28541.t1,three_way,73.68900000000001,FUN_038806-T1,P28606,,,,,50.2,255.0,1.6e-68,261.2,sp|P28606|Y1628_PICP2 Uncharacterized protein SYNPCC7002_A1628 OS=Picosynechococcus sp. (strain ATCC 27264 / PCC 7002 / PR-6) OX=32049 GN=SYNPCC7002_A1628 PE=3 SV=2,,,,,,
OG_09078,FUN_038807-T1,Peve_00007223,Pocillopora_meandrina_HIv1___RNAseq.g28543.t1,three_way,87.99033333333333,FUN_038807-T1,Q9LQC8,,,,,68.6,153.0,1.1e-56,221.1,sp|Q9LQC8|ARF2A_ARATH ADP-ribosylation factor 2-A OS=Arabidopsis thaliana OX=3702 GN=ARF2-A PE=2 SV=2,,,,,,
OG_09079,FUN_038808-T1,Peve_00007219,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1a,three_way,79.655,FUN_038808-T1,A4QNE0,,,,,50.2,297.0,3.1e-83,310.1,sp|A4QNE0|GET4_XENTR Golgi to ER traffic protein 4 homolog OS=Xenopus tropicalis OX=8364 GN=get4 PE=2 SV=1,,,,,,
OG_09080,FUN_038809-T1,Peve_00007217,Pocillopora_meandrina_HIv1___RNAseq.g28538.t1,three_way,66.77766666666668,FUN_038809-T1,Q9CYU6,,,,,38.5,260.0,2.3e-41,171.8,sp|Q9CYU6|DPH7_MOUSE Diphthine methyltransferase OS=Mus musculus OX=10090 GN=Dph7 PE=2 SV=1,,,,,,
OG_09081,FUN_038811-T1,Peve_00007216,Pocillopora_meandrina_HIv1___RNAseq.g28537.t1,three_way,90.37766666666668,FUN_038811-T1,Q92503,S14L1_HUMAN,,SEC14-like protein 1,Homo sapiens (Human),56.3,712.0,6.1e-230,798.5,sp|Q92503|S14L1_HUMAN SEC14-like protein 1 OS=Homo sapiens OX=9606 GN=SEC14L1 PE=1 SV=2,GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0015871; GO:0039532; GO:0039536; GO:0039552; GO:0045087; GO:0140311,choline transport [GO:0015871]; innate immune response [GO:0045087]; negative regulation of cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; negative regulation of RIG-I signaling pathway [GO:0039536],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654],protein sequestering activity [GO:0140311]; RIG-I binding [GO:0039552],GO:0002376; GO:0005654; GO:0005794; GO:0005829; GO:0043226; GO:0098542; GO:0140313,immune system process; nucleoplasm; Golgi apparatus; cytosol; organelle; defense response to other organism; molecular sequestering activity
OG_09082,FUN_038816-T1,Peve_00007229,Pocillopora_meandrina_HIv1___RNAseq.g28534.t1,three_way,57.37033333333333,,,,,,,,,,,,,,,,,
OG_09083,FUN_038819-T1,Peve_00007201,Pocillopora_meandrina_HIv1___TS.g8309.t1,three_way,65.90066666666667,,,,,,,,,,,,,,,,,
OG_09084,FUN_038831-T1,Peve_00028780,Pocillopora_meandrina_HIv1___RNAseq.g28634.t1,three_way,67.26416666666667,FUN_038831-T1,F8VPZ5,ERCC6_MOUSE,,DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB),Mus musculus (Mouse),51.2,1068.0,1.6000000000000004e-277,957.6,sp|F8VPZ5|ERCC6_MOUSE DNA excision repair protein ERCC-6 OS=Mus musculus OX=10090 GN=Ercc6 PE=1 SV=1,GO:0000012; GO:0000077; GO:0000303; GO:0003677; GO:0003682; GO:0004386; GO:0005524; GO:0005634; GO:0005730; GO:0006281; GO:0006283; GO:0006284; GO:0006290; GO:0006338; GO:0006362; GO:0006974; GO:0006979; GO:0007254; GO:0008023; GO:0008094; GO:0008630; GO:0009411; GO:0009636; GO:0010165; GO:0010224; GO:0010332; GO:0016887; GO:0022008; GO:0030182; GO:0030296; GO:0031175; GO:0032786; GO:0034243; GO:0035264; GO:0042262; GO:0045494; GO:0045943; GO:0045944; GO:0045945; GO:0060261; GO:0090734; GO:0097680; GO:0110016; GO:0140463; GO:0140658; GO:0140664; GO:1905168; GO:2001033,"base-excision repair [GO:0006284]; chromatin remodeling [GO:0006338]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; multicellular organism growth [GO:0035264]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; pyrimidine dimer repair [GO:0006290]; regulation of transcription elongation by RNA polymerase II [GO:0034243]; response to gamma radiation [GO:0010332]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]; response to toxic substance [GO:0009636]; response to UV [GO:0009411]; response to UV-B [GO:0010224]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; transcription elongation by RNA polymerase I [GO:0006362]; transcription-coupled nucleotide-excision repair [GO:0006283]",B-WICH complex [GO:0110016]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; transcription elongation factor complex [GO:0008023],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent chromatin remodeler activity [GO:0140658]; ATP-dependent DNA damage sensor activity [GO:0140664]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein tyrosine kinase activator activity [GO:0030296]",GO:0003677; GO:0003824; GO:0005634; GO:0005730; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0060090; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleolus; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; cell differentiation; organelle; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_09085,FUN_038832-T1,Peve_00028782,Pocillopora_meandrina_HIv1___RNAseq.g28635.t1,three_way,79.33633333333334,FUN_038832-T1,Q6DBY0,NUP85_DANRE,,Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1),Danio rerio (Zebrafish) (Brachydanio rerio),45.4,670.0,9.9e-161,568.5,sp|Q6DBY0|NUP85_DANRE Nuclear pore complex protein Nup85 OS=Danio rerio OX=7955 GN=nup85 PE=2 SV=1,GO:0006406; GO:0006606; GO:0017056; GO:0031080; GO:0031965; GO:0045893; GO:0072006,mRNA export from nucleus [GO:0006406]; nephron development [GO:0072006]; positive regulation of DNA-templated transcription [GO:0045893]; protein import into nucleus [GO:0006606],nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080],structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0006355; GO:0006886; GO:0006913; GO:0048856,structural molecule activity; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; anatomical structure development
OG_09086,FUN_038833-T1,Peve_00028686,Pocillopora_meandrina_HIv1___RNAseq.21094_t,three_way,62.954166666666666,FUN_038833-T1,O15169,AXIN1_HUMAN,,Axin-1 (Axis inhibition protein 1) (hAxin),Homo sapiens (Human),27.2,904.0,3.3e-52,208.4,sp|O15169|AXIN1_HUMAN Axin-1 OS=Homo sapiens OX=9606 GN=AXIN1 PE=1 SV=2,GO:0000209; GO:0001701; GO:0002039; GO:0005634; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0005938; GO:0006913; GO:0006915; GO:0007605; GO:0008013; GO:0009950; GO:0010629; GO:0015630; GO:0016328; GO:0019899; GO:0019901; GO:0030511; GO:0030877; GO:0031122; GO:0031398; GO:0031410; GO:0031625; GO:0032436; GO:0034244; GO:0035591; GO:0036342; GO:0042802; GO:0042803; GO:0043161; GO:0043539; GO:0044725; GO:0045599; GO:0045732; GO:0046330; GO:0046332; GO:0048320; GO:0048468; GO:0048471; GO:0051248; GO:0060070; GO:0060090; GO:0060322; GO:0065003; GO:0070016; GO:0070411; GO:0070412; GO:0071944; GO:0090090; GO:0120283; GO:1904885; GO:1990756; GO:1990909; GO:2000060,apoptotic process [GO:0006915]; axial mesoderm formation [GO:0048320]; beta-catenin destruction complex assembly [GO:1904885]; canonical Wnt signaling pathway [GO:0060070]; cell development [GO:0048468]; cytoplasmic microtubule organization [GO:0031122]; dorsal/ventral axis specification [GO:0009950]; epigenetic programming in the zygotic pronuclei [GO:0044725]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; nucleocytoplasmic transport [GO:0006913]; positive regulation of JNK cascade [GO:0046330]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; post-anal tail morphogenesis [GO:0036342]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein-containing complex assembly [GO:0065003]; sensory perception of sound [GO:0007605],beta-catenin destruction complex [GO:0030877]; cell cortex [GO:0005938]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lateral plasma membrane [GO:0016328]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],armadillo repeat domain binding [GO:0070016]; beta-catenin binding [GO:0008013]; enzyme binding [GO:0019899]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; R-SMAD binding [GO:0070412]; signaling adaptor activity [GO:0035591]; SMAD binding [GO:0046332]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0005730; GO:0005829; GO:0005856; GO:0005886; GO:0006325; GO:0006355; GO:0006913; GO:0007010; GO:0012501; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0065003; GO:0098772,nucleus; nucleolus; cytosol; cytoskeleton; plasma membrane; chromatin organization; regulation of DNA-templated transcription; nucleocytoplasmic transport; cytoskeleton organization; programmed cell death; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity
OG_09087,FUN_038834-T1,Peve_00028687,Pocillopora_meandrina_HIv1___RNAseq.g28645.t1,three_way,66.54333333333334,FUN_038834-T1,Q8VBT9,ASPC1_MOUSE,,Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein homolog),Mus musculus (Mouse),31.0,574.0,7.1e-64,246.5,sp|Q8VBT9|ASPC1_MOUSE Tether containing UBX domain for GLUT4 OS=Mus musculus OX=10090 GN=Aspscr1 PE=1 SV=1,GO:0005654; GO:0005829; GO:0006886; GO:0009898; GO:0012505; GO:0012506; GO:0030659; GO:0033116; GO:0042593; GO:0046324; GO:0048471,glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; regulation of D-glucose import [GO:0046324],cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506],,GO:0005654; GO:0005829; GO:0006886,nucleoplasm; cytosol; intracellular protein transport
OG_09088,FUN_038886-T1,Peve_00028696,Pocillopora_meandrina_HIv1___RNAseq.g28678.t1,three_way,74.4045,FUN_038886-T1,Q9CZT4,,,,,39.5,714.0,3.8e-131,470.3,sp|Q9CZT4|RPC5_MOUSE DNA-directed RNA polymerase III subunit RPC5 OS=Mus musculus OX=10090 GN=Polr3e PE=1 SV=2,,,,,,
OG_09089,FUN_038887-T1,Peve_00028697,Pocillopora_meandrina_HIv1___RNAseq.g28665.t1,three_way,61.27033333333333,FUN_038887-T1,D2HD32,,,,,48.9,131.0,9.9e-26,118.2,sp|D2HD32|ICT1_AILME Large ribosomal subunit protein mL62 OS=Ailuropoda melanoleuca OX=9646 GN=MRPL58 PE=3 SV=1,,,,,,
OG_09090,FUN_038888-T1,Peve_00028698,Pocillopora_meandrina_HIv1___RNAseq.g28664.t1,three_way,53.45483333333333,FUN_038888-T1,Q9BXA6,,,,,25.8,256.0,3.6e-17,91.3,sp|Q9BXA6|TSSK6_HUMAN Testis-specific serine/threonine-protein kinase 6 OS=Homo sapiens OX=9606 GN=TSSK6 PE=1 SV=1,,,,,,
OG_09091,FUN_038889-T1,Peve_00028699,Pocillopora_meandrina_HIv1___RNAseq.g28663.t1,three_way,51.704,,,,,,,,,,,,,,,,,
OG_09092,FUN_038890-T1,Peve_00028701,Pocillopora_meandrina_HIv1___RNAseq.g28661.t1,three_way,58.92133333333333,,,,,,,,,,,,,,,,,
OG_09093,FUN_038891-T1,Peve_00028706,Pocillopora_meandrina_HIv1___RNAseq.g28660.t1,three_way,59.693333333333335,FUN_038891-T1,Q8CBY3,,,,,44.1,488.0,6.6999999999999995e-90,333.6,sp|Q8CBY3|LENG8_MOUSE Leukocyte receptor cluster member 8 homolog OS=Mus musculus OX=10090 GN=Leng8 PE=1 SV=1,,,,,,
OG_09094,FUN_038892-T2,Peve_00028707,Pocillopora_meandrina_HIv1___TS.g8447.t1,three_way,77.16033333333333,FUN_038892-T2,P56391,,,,,56.8,74.0,1.3e-22,106.7,sp|P56391|CX6B1_MOUSE Cytochrome c oxidase subunit 6B1 OS=Mus musculus OX=10090 GN=Cox6b1 PE=1 SV=2,,,,,,
OG_09095,FUN_038893-T1,Peve_00028708,Pocillopora_meandrina_HIv1___RNAseq.g28659.t1,three_way,61.70583333333334,,,,,,,,,,,,,,,,,
OG_09096,FUN_038901-T1,Peve_00028737,Pocillopora_meandrina_HIv1___TS.g8477.t1a,three_way,68.12616666666666,FUN_038901-T1,Q6NU40,,,,,42.3,1032.0,7.199999999999999e-189,662.5,sp|Q6NU40|CTF18_XENLA Chromosome transmission fidelity protein 18 homolog OS=Xenopus laevis OX=8355 GN=chtf18 PE=2 SV=1,,,,,,
OG_09097,FUN_038902-T1,Peve_00034716,Pocillopora_meandrina_HIv1___TS.g21791.t1c,three_way,82.05616666666667,,,,,,,,,,,,,,,,,
OG_09098,FUN_038913-T1,Peve_00006149,Pocillopora_meandrina_HIv1___RNAseq.g1175.t1,three_way,65.38966666666666,FUN_038913-T1,Q504A5,,,,,36.9,198.0,3.2e-30,133.7,sp|Q504A5|TPMT_DANRE Probable thiopurine S-methyltransferase OS=Danio rerio OX=7955 GN=tpmt PE=2 SV=1,,,,,,
OG_09099,FUN_038915-T1,Peve_00004520,Pocillopora_meandrina_HIv1___RNAseq.g1077.t1,three_way,83.61666666666666,FUN_038915-T1,Q8BWQ6,VP35L_MOUSE,,VPS35 endosomal protein-sorting factor-like,Mus musculus (Mouse),55.1,976.0,2.5e-308,1059.7,sp|Q8BWQ6|VP35L_MOUSE VPS35 endosomal protein-sorting factor-like OS=Mus musculus OX=10090 GN=Vps35l PE=1 SV=2,GO:0005768; GO:0006893; GO:0015031; GO:0016020; GO:0032456,endocytic recycling [GO:0032456]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],endosome [GO:0005768]; membrane [GO:0016020],,GO:0005768; GO:0016192; GO:0031410; GO:0043226,endosome; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09100,FUN_038917-T1,Peve_00004515,Pocillopora_meandrina_HIv1___RNAseq.g1080.t1,three_way,61.212,,,,,,,,,,,,,,,,,
OG_09101,FUN_038918-T1,Peve_00004516,Pocillopora_meandrina_HIv1___RNAseq.g1083.t1,three_way,89.98166666666667,FUN_038918-T1,Q5ZL26,,,,,61.2,366.0,3.8e-122,439.5,sp|Q5ZL26|KPRB_CHICK Phosphoribosyl pyrophosphate synthase-associated protein 2 OS=Gallus gallus OX=9031 GN=PRPSAP2 PE=2 SV=1,,,,,,
OG_09102,FUN_038919-T1,Peve_00023621,Pocillopora_meandrina_HIv1___RNAseq.g1058.t1,three_way,88.84166666666667,FUN_038919-T1,Q9R1C6,DGKE_MOUSE,,Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon),Mus musculus (Mouse),48.7,487.0,5.9e-148,525.8,sp|Q9R1C6|DGKE_MOUSE Diacylglycerol kinase epsilon OS=Mus musculus OX=10090 GN=Dgke PE=1 SV=1,GO:0004143; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006654; GO:0006661; GO:0007200; GO:0008270; GO:0016020; GO:0046339; GO:0046834; GO:0050804; GO:0098978,diacylglycerol metabolic process [GO:0046339]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylinositol biosynthetic process [GO:0006661]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0006629; GO:0016740,catalytic activity; nucleoplasm; cytosol; lipid metabolic process; transferase activity
OG_09103,FUN_038920-T1,Peve_00023617,Pocillopora_meandrina_HIv1___RNAseq.g1055.t1,three_way,85.27,FUN_038920-T1,Q6DE58,,,,,62.4,186.0,3.8e-65,249.2,sp|Q6DE58|ATGA1_XENLA Autophagy-related protein 101 OS=Xenopus laevis OX=8355 GN=atg101 PE=2 SV=1,,,,,,
OG_09104,FUN_038927-T1,Peve_00043970,Pocillopora_meandrina_HIv1___RNAseq.g1051.t1,three_way,67.732,FUN_038927-T1,P56213,,,,,52.0,100.0,1.3999999999999999e-24,114.0,sp|P56213|ALR_MOUSE FAD-linked sulfhydryl oxidase ALR OS=Mus musculus OX=10090 GN=Gfer PE=1 SV=2,,,,,,
OG_09105,FUN_038932-T1,Peve_00043961,Pocillopora_meandrina_HIv1___RNAseq.g1044.t1,three_way,59.352,,,,,,,,,,,,,,,,,
OG_09106,FUN_038933-T1,Peve_00043963,Pocillopora_meandrina_HIv1___TS.g5573.t1,three_way,82.23966666666666,FUN_038933-T1,S4R2P9,NAC3_MOUSE,,Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3),Mus musculus (Mouse),37.2,888.0,1.1e-137,492.3,sp|S4R2P9|NAC3_MOUSE Sodium/calcium exchanger 3 OS=Mus musculus OX=10090 GN=Slc8a3 PE=1 SV=1,GO:0002244; GO:0005432; GO:0005516; GO:0005654; GO:0005741; GO:0005789; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0006851; GO:0006874; GO:0007154; GO:0007611; GO:0007612; GO:0007613; GO:0014069; GO:0014819; GO:0015368; GO:0016528; GO:0021537; GO:0030001; GO:0031594; GO:0035725; GO:0042383; GO:0042552; GO:0043197; GO:0043204; GO:0043679; GO:0045202; GO:0045211; GO:0046872; GO:0048471; GO:0048709; GO:0050808; GO:0051560; GO:0060291; GO:0060402; GO:0070161; GO:0070588; GO:0071320; GO:0071456; GO:0098703; GO:0098815; GO:1902532; GO:1905060; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport into cytosol [GO:0060402]; cell communication [GO:0007154]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular calcium ion homeostasis [GO:0006874]; learning [GO:0007612]; learning or memory [GO:0007611]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; metal ion transport [GO:0030001]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; modulation of excitatory postsynaptic potential [GO:0098815]; myelination [GO:0042552]; negative regulation of intracellular signal transduction [GO:1902532]; oligodendrocyte differentiation [GO:0048709]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; telencephalon development [GO:0021537],anchoring junction [GO:0070161]; axon terminus [GO:0043679]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; synapse [GO:0045202],calcium:monoatomic cation antiporter activity [GO:0015368]; calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration [GO:1905060]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872],GO:0005215; GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0055085,transporter activity; nucleoplasm; microtubule organizing center; cytosol; plasma membrane; cell differentiation; cell junction organization; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_09107,FUN_038934-T1,Peve_00043964,Pocillopora_meandrina_HIv1___RNAseq.g1039.t1,three_way,93.333,FUN_038934-T1,Q5ZLL1,KC1E_CHICK,,Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1),Gallus gallus (Chicken),76.2,420.0,1.2e-178,627.5,sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus OX=9031 GN=CSNK1E PE=2 SV=2,GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0006468; GO:0006897; GO:0007165; GO:0032436; GO:0048511; GO:0090263; GO:0106310,endocytosis [GO:0006897]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; rhythmic process [GO:0048511]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016192; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vesicle-mediated transport; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09108,FUN_038944-T1,Peve_00002531,Pocillopora_meandrina_HIv1___RNAseq.g14594.t2,three_way,79.45400000000001,,,,,,,,,,,,,,,,,
OG_09109,FUN_039035-T1,Peve_00028757,Pocillopora_meandrina_HIv1___RNAseq.g28691.t1,three_way,48.852,,,,,,,,,,,,,,,,,
OG_09110,FUN_039036-T1,Peve_00028756,Pocillopora_meandrina_HIv1___RNAseq.g28692.t1,three_way,82.128,FUN_039036-T1,Q8N8E3,,,,,40.0,442.0,1.5e-65,251.9,sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2,,,,,,
OG_09111,FUN_039042-T1,Peve_00033257,Pocillopora_meandrina_HIv1___RNAseq.g28715.t1,three_way,63.381,,,,,,,,,,,,,,,,,
OG_09112,FUN_039043-T2,Peve_00033251,Pocillopora_meandrina_HIv1___TS.g8508.t1,three_way,66.37,FUN_039043-T2,P08510,,,,,31.7,104.0,1.1e-06,55.5,sp|P08510|KCNAS_DROME Potassium voltage-gated channel protein Shaker OS=Drosophila melanogaster OX=7227 GN=Sh PE=1 SV=3,,,,,,
OG_09113,FUN_039082-T1,Peve_00044314,Pocillopora_meandrina_HIv1___RNAseq.g28712.t1,three_way,73.46883333333334,FUN_039082-T1,F1SS88,,,,,50.5,586.0,6.4e-165,582.4,sp|F1SS88|CFA52_PIG Cilia- and flagella-associated protein 52 OS=Sus scrofa OX=9823 GN=CFAP52 PE=1 SV=3,,,,,,
OG_09114,FUN_039085-T1,Peve_00028747,Pocillopora_meandrina_HIv1___RNAseq.g28710.t1,three_way,81.78133333333334,FUN_039085-T1,Q8TBZ9,,,,,30.7,218.0,9.2e-27,122.1,sp|Q8TBZ9|TEX47_HUMAN Testis-expressed protein 47 OS=Homo sapiens OX=9606 GN=TEX47 PE=1 SV=1,,,,,,
OG_09115,FUN_039086-T1,Peve_00028750,Pocillopora_meandrina_HIv1___RNAseq.g28709.t1,three_way,86.96933333333334,FUN_039086-T1,Q96AJ1,,,,,65.0,286.0,1.6e-97,357.8,sp|Q96AJ1|CLUA1_HUMAN Clusterin-associated protein 1 OS=Homo sapiens OX=9606 GN=CLUAP1 PE=1 SV=4,,,,,,
OG_09116,FUN_039091-T1,Peve_00028752,Pocillopora_meandrina_HIv1___RNAseq.g28707.t1,three_way,75.19333333333334,FUN_039091-T1,A0A571BF63,ANKF1_MOUSE,,Ankyrin-repeat and fibronectin type III domain-containing 1,Mus musculus (Mouse),35.6,824.0,9.6e-135,483.0,sp|A0A571BF63|ANKF1_MOUSE Ankyrin-repeat and fibronectin type III domain-containing 1 OS=Mus musculus OX=10090 GN=Ankfn1 PE=1 SV=1,GO:0001662; GO:0045475; GO:0050957,behavioral fear response [GO:0001662]; equilibrioception [GO:0050957]; locomotor rhythm [GO:0045475],,,GO:0050877,nervous system process
OG_09117,FUN_039101-T1,Peve_00028755,Pocillopora_meandrina_HIv1___RNAseq.g28705.t1,three_way,90.875,FUN_039101-T1,P27600,GNA12_MOUSE,,Guanine nucleotide-binding protein subunit alpha-12 (G alpha-12) (G-protein subunit alpha-12),Mus musculus (Mouse),67.3,349.0,4.800000000000001e-130,465.7,sp|P27600|GNA12_MOUSE Guanine nucleotide-binding protein subunit alpha-12 OS=Mus musculus OX=10090 GN=Gna12 PE=1 SV=3,GO:0001701; GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005834; GO:0007186; GO:0007266; GO:0008217; GO:0008360; GO:0009410; GO:0010762; GO:0016328; GO:0030154; GO:0031526; GO:0031683; GO:0031752; GO:0032006; GO:0032434; GO:0035556; GO:0042733; GO:0043005; GO:0043025; GO:0046872; GO:0051721; GO:0072542; GO:0160221; GO:1904706; GO:1904753,cell differentiation [GO:0030154]; embryonic digit morphogenesis [GO:0042733]; G protein-coupled receptor signaling pathway [GO:0007186]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; regulation of blood pressure [GO:0008217]; regulation of cell shape [GO:0008360]; regulation of fibroblast migration [GO:0010762]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of TOR signaling [GO:0032006]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221],brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; heterotrimeric G-protein complex [GO:0005834]; lateral plasma membrane [GO:0016328]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],D5 dopamine receptor binding [GO:0031752]; G protein activity [GO:0003925]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase activator activity [GO:0072542],GO:0003824; GO:0003924; GO:0016787; GO:0030154; GO:0048856; GO:0098772,catalytic activity; GTPase activity; hydrolase activity; cell differentiation; anatomical structure development; molecular function regulator activity
OG_09118,FUN_039264-T1,Peve_00019986,Pocillopora_meandrina_HIv1___RNAseq.g13571.t1,three_way,41.18666666666667,,,,,,,,,,,,,,,,,
OG_09119,FUN_039265-T1,Peve_00019987,Pocillopora_meandrina_HIv1___RNAseq.g13572.t1,three_way,65.6775,FUN_039265-T1,Q1JV40,HVCN1_CIOIN,,Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1) (Voltage sensor domain-only protein),Ciona intestinalis (Transparent sea squirt) (Ascidia intestinalis),33.6,128.0,7.3e-09,62.4,sp|Q1JV40|HVCN1_CIOIN Voltage-gated hydrogen channel 1 OS=Ciona intestinalis OX=7719 GN=HVCN1 PE=2 SV=1,GO:0005886; GO:0030171; GO:0034702; GO:0071294; GO:0071467; GO:1902600,cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600],monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],voltage-gated proton channel activity [GO:0030171],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_09120,FUN_039266-T1,Peve_00002772,Pocillopora_meandrina_HIv1___RNAseq.g13577.t1,three_way,76.14266666666667,FUN_039266-T1,P12394,,,,,43.7,462.0,3.9e-109,396.7,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_09121,FUN_039269-T1,Peve_00002766,Pocillopora_meandrina_HIv1___RNAseq.14855_t,three_way,50.418,FUN_039269-T1,P15384,,,,,32.5,428.0,9.999999999999999e-51,202.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_09122,FUN_039274-T1,Peve_00034826,Pocillopora_meandrina_HIv1___RNAseq.g13579.t1,three_way,72.836,,,,,,,,,,,,,,,,,
OG_09123,FUN_039296-T1,Peve_00034840,Pocillopora_meandrina_HIv1___RNAseq.g13603.t1,three_way,76.90333333333334,,,,,,,,,,,,,,,,,
OG_09124,FUN_039301-T1,Peve_00022667,Pocillopora_meandrina_HIv1___RNAseq.g13600.t1,three_way,56.62916666666666,,,,,,,,,,,,,,,,,
OG_09125,FUN_039302-T1,Peve_00022669,Pocillopora_meandrina_HIv1___RNAseq.g13599.t1,three_way,74.29766666666667,,,,,,,,,,,,,,,,,
OG_09126,FUN_039319-T2,Peve_00037934,Pocillopora_meandrina_HIv1___TS.g2591.t1,three_way,56.69116666666667,FUN_039319-T2,Q9JJP2,P73_MOUSE,,Tumor protein p73 (p53-like transcription factor) (p53-related protein),Mus musculus (Mouse),35.0,369.0,2.7e-50,201.4,sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0001836; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005886; GO:0006954; GO:0006974; GO:0007346; GO:0009410; GO:0009791; GO:0010468; GO:0019901; GO:0021766; GO:0030054; GO:0030900; GO:0033326; GO:0036064; GO:0042771; GO:0042802; GO:0043410; GO:0043523; GO:0043524; GO:0045665; GO:0045793; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0048666; GO:0048714; GO:0051262; GO:0060044; GO:0061629; GO:0097371; GO:1901248; GO:1902167; GO:2001235,cerebrospinal fluid secretion [GO:0033326]; digestive tract morphogenesis [GO:0048546]; DNA damage response [GO:0006974]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein tetramerization [GO:0051262]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron apoptotic process [GO:0043523]; release of cytochrome c from mitochondria [GO:0001836]; response to xenobiotic stimulus [GO:0009410],cell junction [GO:0030054]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005886; GO:0006355; GO:0006954; GO:0007005; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; plasma membrane; regulation of DNA-templated transcription; inflammatory response; mitochondrion organization; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_09127,FUN_039433-T1,Peve_00012689,Pocillopora_meandrina_HIv1___RNAseq.g15609.t1,three_way,76.06366666666666,FUN_039433-T1,Q9D411,TSSK4_MOUSE,,Testis-specific serine/threonine-protein kinase 4 (TSK-4) (TSSK-4) (Testis-specific kinase 4) (EC 2.7.11.1),Mus musculus (Mouse),45.5,191.0,2.9999999999999996e-42,173.3,sp|Q9D411|TSSK4_MOUSE Testis-specific serine/threonine-protein kinase 4 OS=Mus musculus OX=10090 GN=Tssk4 PE=1 SV=1,GO:0000287; GO:0001669; GO:0004672; GO:0004674; GO:0005524; GO:0006468; GO:0007286; GO:0009566; GO:0018105; GO:0030317; GO:0031514; GO:0032793; GO:0036126; GO:0042802; GO:0042803; GO:0044877; GO:0106310; GO:1990443,fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine autophosphorylation [GO:1990443]; positive regulation of CREB transcription factor activity [GO:0032793]; protein phosphorylation [GO:0006468]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005929; GO:0006355; GO:0007018; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; cilium; regulation of DNA-templated transcription; microtubule-based movement; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_09128,FUN_039434-T1,Peve_00012688,Pocillopora_meandrina_HIv1___RNAseq.g15607.t1,three_way,52.38966666666666,FUN_039434-T1,Q27312,NADA_APLKU,,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase (EC 3.2.2.-) (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase) (ADPRC) (ADRC) (NAD glycohydrolase) (NAD(+) nucleosidase) (NADase),Aplysia kurodai (Kuroda's sea hare),36.9,260.0,1.9e-40,167.9,sp|Q27312|NADA_APLKU ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia kurodai OX=6501 PE=1 SV=1,GO:0005886; GO:0007338; GO:0016740; GO:0016849; GO:0030890; GO:0031410; GO:0061809,positive regulation of B cell proliferation [GO:0030890]; single fertilization [GO:0007338],cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; phosphorus-oxygen lyase activity [GO:0016849]; transferase activity [GO:0016740]",GO:0003824; GO:0005886; GO:0016740; GO:0016787; GO:0016829; GO:0022414; GO:0031410; GO:0043226,catalytic activity; plasma membrane; transferase activity; hydrolase activity; lyase activity; reproductive process; cytoplasmic vesicle; organelle
OG_09129,FUN_039435-T1,Peve_00012694,Pocillopora_meandrina_HIv1___RNAseq.g15606.t1,three_way,76.65166666666667,FUN_039435-T1,O57321,,,,,48.3,466.0,6.6e-113,409.5,sp|O57321|EAA1_AMBTI Excitatory amino acid transporter 1 OS=Ambystoma tigrinum OX=8305 GN=SLC1A3 PE=1 SV=1,,,,,,
OG_09130,FUN_039512-T1,Peve_00003617,Pocillopora_meandrina_HIv1___RNAseq.g27137.t1,three_way,55.90733333333333,,,,,,,,,,,,,,,,,
OG_09131,FUN_039595-T2,Peve_00019660,Pocillopora_meandrina_HIv1___RNAseq.g2829.t1,three_way,56.74166666666667,,,,,,,,,,,,,,,,,
OG_09132,FUN_039607-T1,Peve_00035010,Pocillopora_meandrina_HIv1___RNAseq.g5325.t1,three_way,91.42866666666669,,,,,,,,,,,,,,,,,
OG_09133,FUN_039688-T1,Peve_00037355,Pocillopora_meandrina_HIv1___RNAseq.g2945.t1,three_way,47.48633333333333,,,,,,,,,,,,,,,,,
OG_09134,FUN_039701-T1,Peve_00008100,Pocillopora_meandrina_HIv1___RNAseq.g14123.t1,three_way,57.217333333333336,,,,,,,,,,,,,,,,,
OG_09135,FUN_039740-T1,Peve_00033350,Pocillopora_meandrina_HIv1___RNAseq.g15605.t1,three_way,62.17133333333333,,,,,,,,,,,,,,,,,
OG_09136,FUN_039774-T1,Peve_00030564,Pocillopora_meandrina_HIv1___RNAseq.g7453.t1,three_way,59.15083333333333,FUN_039774-T1,Q810V0,,,,,40.6,702.0,1.4999999999999998e-68,262.3,sp|Q810V0|MPP10_MOUSE U3 small nucleolar ribonucleoprotein protein MPP10 OS=Mus musculus OX=10090 GN=Mphosph10 PE=1 SV=2,,,,,,
OG_09137,FUN_039776-T1,Peve_00017576,Pocillopora_meandrina_HIv1___RNAseq.g7455.t1,three_way,87.746,FUN_039776-T1,O14775,GNB5_HUMAN,,Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5),Homo sapiens (Human),61.0,344.0,9.3e-94,345.1,sp|O14775|GNB5_HUMAN Guanine nucleotide-binding protein subunit beta-5 OS=Homo sapiens OX=9606 GN=GNB5 PE=1 SV=2,GO:0003924; GO:0005096; GO:0005634; GO:0005737; GO:0005829; GO:0005834; GO:0007165; GO:0007212; GO:0030159; GO:0030425; GO:0031682; GO:0036367; GO:0042734; GO:0043547; GO:0045211; GO:0051087; GO:0051286; GO:0098688; GO:1901386; GO:1902773; GO:1990603,dark adaptation [GO:1990603]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; light adaption [GO:0036367]; negative regulation of voltage-gated calcium channel activity [GO:1901386]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165],cell tip [GO:0051286]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; GTPase activator complex [GO:1902773]; heterotrimeric G-protein complex [GO:0005834]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],G-protein gamma-subunit binding [GO:0031682]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; protein-folding chaperone binding [GO:0051087]; signaling receptor complex adaptor activity [GO:0030159],GO:0003824; GO:0003924; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0060090; GO:0098772,catalytic activity; GTPase activity; nucleus; cytosol; hydrolase activity; organelle; molecular adaptor activity; molecular function regulator activity
OG_09138,FUN_039777-T1,Peve_00017586,Pocillopora_meandrina_HIv1___TS.g1210.t1,three_way,63.503,,,,,,,,,,,,,,,,,
OG_09139,FUN_039778-T1,Peve_00017603,Pocillopora_meandrina_HIv1___RNAseq.g7459.t1,three_way,79.53533333333333,FUN_039778-T1,Q5E9E4,,,,,44.0,182.0,4e-43,176.0,sp|Q5E9E4|SSRB_BOVIN Translocon-associated protein subunit beta OS=Bos taurus OX=9913 GN=SSR2 PE=2 SV=1,,,,,,
OG_09140,FUN_039779-T1,Peve_00017588,Pocillopora_meandrina_HIv1___RNAseq.g7461.t1,three_way,84.48583333333333,FUN_039779-T1,O95263,,,,,46.7,904.0,5.4e-218,759.2,"sp|O95263|PDE8B_HUMAN High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B OS=Homo sapiens OX=9606 GN=PDE8B PE=1 SV=2",,,,,,
OG_09141,FUN_039788-T1,Peve_00017599,Pocillopora_meandrina_HIv1___RNAseq.g7462.t1,three_way,52.11383333333333,FUN_039788-T1,O42357,,,,,56.1,66.0,2.2e-11,71.6,sp|O42357|RX2_DANRE Retinal homeobox protein Rx2 OS=Danio rerio OX=7955 GN=rx2 PE=2 SV=1,,,,,,
OG_09142,FUN_039789-T1,Peve_00017600,Pocillopora_meandrina_HIv1___RNAseq.g7463.t1,three_way,74.41883333333334,FUN_039789-T1,O54714,,,,,50.4,468.0,2.5e-120,434.1,sp|O54714|PIAS3_MOUSE E3 SUMO-protein ligase PIAS3 OS=Mus musculus OX=10090 GN=Pias3 PE=1 SV=3,,,,,,
OG_09143,FUN_039791-T2,Peve_00017605,Pocillopora_meandrina_HIv1___TS.g1219.t1,three_way,73.25066666666666,FUN_039791-T2,Q8RYE9,,,,,39.4,216.0,1.7999999999999998e-35,151.0,sp|Q8RYE9|GPPL3_ARATH Haloacid dehalogenase-like hydrolase domain-containing protein At2g33255 OS=Arabidopsis thaliana OX=3702 GN=At2g33255 PE=1 SV=1,,,,,,
OG_09144,FUN_039792-T1,Peve_00033492,Pocillopora_meandrina_HIv1___RNAseq.g7466.t1,three_way,68.956,,,,,,,,,,,,,,,,,
OG_09145,FUN_039793-T1,Peve_00017607,Pocillopora_meandrina_HIv1___RNAseq.g7472.t1,three_way,87.68633333333334,FUN_039793-T1,Q6AZN6,PK3C3_XENLA,,Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphoinositide-3-kinase class 3),Xenopus laevis (African clawed frog),66.7,884.0,0.0,1166.0,sp|Q6AZN6|PK3C3_XENLA Phosphatidylinositol 3-kinase catalytic subunit type 3 OS=Xenopus laevis OX=8355 GN=pik3c3 PE=2 SV=1,GO:0000045; GO:0000407; GO:0000425; GO:0005524; GO:0005737; GO:0005768; GO:0005777; GO:0006897; GO:0016020; GO:0016303; GO:0030496; GO:0032465; GO:0034271; GO:0034272; GO:0036092; GO:0048015; GO:0051301,autophagosome assembly [GO:0000045]; cell division [GO:0051301]; endocytosis [GO:0006897]; pexophagy [GO:0000425]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465],"cytoplasm [GO:0005737]; endosome [GO:0005768]; membrane [GO:0016020]; midbody [GO:0030496]; peroxisome [GO:0005777]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]",1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524],GO:0003824; GO:0005768; GO:0005777; GO:0006629; GO:0006914; GO:0016192; GO:0016740; GO:0031410; GO:0043226,catalytic activity; endosome; peroxisome; lipid metabolic process; autophagy; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle
OG_09146,FUN_039798-T1,Peve_00017577,Pocillopora_meandrina_HIv1___RNAseq.g7474.t1,three_way,69.27600000000001,,,,,,,,,,,,,,,,,
OG_09147,FUN_039800-T1,Peve_00032689,Pocillopora_meandrina_HIv1___RNAseq.g7475.t1,three_way,61.298,FUN_039800-T1,Q9BQ24,ZFY21_HUMAN,,Zinc finger FYVE domain-containing protein 21 (ZF21),Homo sapiens (Human),39.2,102.0,2e-11,73.9,sp|Q9BQ24|ZFY21_HUMAN Zinc finger FYVE domain-containing protein 21 OS=Homo sapiens OX=9606 GN=ZFYVE21 PE=1 SV=1,GO:0005768; GO:0005925; GO:0008270,,endosome [GO:0005768]; focal adhesion [GO:0005925],zinc ion binding [GO:0008270],GO:0005768; GO:0031410; GO:0043226,endosome; cytoplasmic vesicle; organelle
OG_09148,FUN_039802-T1,Peve_00017579,Pocillopora_meandrina_HIv1___RNAseq.g7476.t1,three_way,50.124,,,,,,,,,,,,,,,,,
OG_09149,FUN_039803-T1,Peve_00017581,Pocillopora_meandrina_HIv1___RNAseq.g7477.t2,three_way,74.33033333333334,FUN_039803-T1,Q6BZW3,,,,,30.8,399.0,7.6e-32,139.8,sp|Q6BZW3|BTN1_YARLI Protein BTN1 OS=Yarrowia lipolytica (strain CLIB 122 / E 150) OX=284591 GN=BTN1 PE=3 SV=1,,,,,,
OG_09150,FUN_039805-T1,Peve_00020316,Pocillopora_meandrina_HIv1___RNAseq.g7483.t1,three_way,80.803,,,,,,,,,,,,,,,,,
OG_09151,FUN_039806-T1,Peve_00020315,Pocillopora_meandrina_HIv1___RNAseq.g7484.t1,three_way,36.24133333333334,,,,,,,,,,,,,,,,,
OG_09152,FUN_039807-T1,Peve_00033774,Pocillopora_meandrina_HIv1___RNAseq.g7485.t1,three_way,53.678666666666665,,,,,,,,,,,,,,,,,
OG_09153,FUN_039808-T1,Peve_00020313,Pocillopora_meandrina_HIv1___RNAseq.g7486.t1,three_way,89.93166666666667,FUN_039808-T1,P42026,NDUS7_BOVIN,,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 7.1.1.2) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)",Bos taurus (Bovine),82.2,169.0,2.1e-81,303.1,"sp|P42026|NDUS7_BOVIN NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial OS=Bos taurus OX=9913 GN=NDUFS7 PE=1 SV=1",GO:0005743; GO:0006120; GO:0008137; GO:0009060; GO:0015990; GO:0032981; GO:0045271; GO:0046872; GO:0048038; GO:0051539,"aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]",mitochondrial inner membrane [GO:0005743]; respiratory chain complex I [GO:0045271],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]",GO:0005215; GO:0006091; GO:0055085; GO:0065003,transporter activity; generation of precursor metabolites and energy; transmembrane transport; protein-containing complex assembly
OG_09154,FUN_039813-T1,Peve_00039066,Pocillopora_meandrina_HIv1___RNAseq.5181_t,three_way,66.70066666666666,FUN_039813-T1,Q3SYY2,TPST2_BOVIN,,Protein-tyrosine sulfotransferase 2 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 2) (TPST-2),Bos taurus (Bovine),49.5,285.0,9.6e-78,292.0,sp|Q3SYY2|TPST2_BOVIN Protein-tyrosine sulfotransferase 2 OS=Bos taurus OX=9913 GN=TPST2 PE=2 SV=1,GO:0000139; GO:0005794; GO:0006478; GO:0008476,peptidyl-tyrosine sulfation [GO:0006478],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],protein-tyrosine sulfotransferase activity [GO:0008476],GO:0003824; GO:0005794; GO:0006790; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; sulfur compound metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09155,FUN_039814-T1,Peve_00039067,Pocillopora_meandrina_HIv1___RNAseq.g7502.t1,three_way,68.30133333333333,,,,,,,,,,,,,,,,,
OG_09156,FUN_039815-T1,Peve_00039069,Pocillopora_meandrina_HIv1___RNAseq.g7503.t1,three_way,89.79966666666667,FUN_039815-T1,Q92759,TF2H4_HUMAN,,General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit),Homo sapiens (Human),63.9,457.0,3.2e-166,586.3,sp|Q92759|TF2H4_HUMAN General transcription factor IIH subunit 4 OS=Homo sapiens OX=9606 GN=GTF2H4 PE=1 SV=1,GO:0000438; GO:0000439; GO:0001671; GO:0003690; GO:0005634; GO:0005654; GO:0005669; GO:0005675; GO:0006281; GO:0006289; GO:0006366; GO:0016251; GO:0016607,DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; transcription by RNA polymerase II [GO:0006366],core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675],ATPase activator activity [GO:0001671]; double-stranded DNA binding [GO:0003690]; RNA polymerase II general transcription initiation factor activity [GO:0016251],GO:0003677; GO:0005634; GO:0005654; GO:0006281; GO:0006351; GO:0043226; GO:0098772; GO:0140223,DNA binding; nucleus; nucleoplasm; DNA repair; DNA-templated transcription; organelle; molecular function regulator activity; general transcription initiation factor activity
OG_09157,FUN_039816-T3,Peve_00039070,Pocillopora_meandrina_HIv1___TS.g1258.t1,three_way,80.97083333333333,FUN_039816-T3,Q9BZC7,ABCA2_HUMAN,,ATP-binding cassette sub-family A member 2 (EC 7.6.2.-) (ATP-binding cassette transporter 2) (ATP-binding cassette 2),Homo sapiens (Human),45.9,2470.0,0.0,1970.7,sp|Q9BZC7|ABCA2_HUMAN ATP-binding cassette sub-family A member 2 OS=Homo sapiens OX=9606 GN=ABCA2 PE=1 SV=4,GO:0000166; GO:0001573; GO:0005319; GO:0005524; GO:0005764; GO:0005765; GO:0005768; GO:0005815; GO:0005886; GO:0006629; GO:0006684; GO:0006687; GO:0006869; GO:0007626; GO:0009410; GO:0010008; GO:0016020; GO:0016887; GO:0019218; GO:0031410; GO:0032289; GO:0032383; GO:0032384; GO:0032805; GO:0042626; GO:0042632; GO:0042986; GO:0043190; GO:0043231; GO:0045939; GO:0046512; GO:0048545; GO:0055085; GO:0060049; GO:0061135; GO:0070723; GO:0071072; GO:0090155; GO:0090156; GO:0090370; GO:0099038; GO:0099040; GO:0140359; GO:0150104; GO:1901873; GO:1902004; GO:1902993; GO:1904375; GO:1905601; GO:2000008,central nervous system myelin formation [GO:0032289]; ceramide translocation [GO:0099040]; cholesterol homeostasis [GO:0042632]; ganglioside metabolic process [GO:0001573]; glycosphingolipid metabolic process [GO:0006687]; intracellular sphingolipid homeostasis [GO:0090156]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; locomotory behavior [GO:0007626]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of intracellular cholesterol transport [GO:0032384]; negative regulation of phospholipid biosynthetic process [GO:0071072]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative regulation of steroid metabolic process [GO:0045939]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; regulation of intracellular cholesterol transport [GO:0032383]; regulation of post-translational protein modification [GO:1901873]; regulation of protein glycosylation [GO:0060049]; regulation of protein localization to cell periphery [GO:1904375]; regulation of protein localization to cell surface [GO:2000008]; regulation of steroid metabolic process [GO:0019218]; response to cholesterol [GO:0070723]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]; sphingomyelin metabolic process [GO:0006684]; sphingosine biosynthetic process [GO:0046512]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104],ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; ceramide floppase activity [GO:0099038]; endopeptidase regulator activity [GO:0061135]; lipid transporter activity [GO:0005319]; nucleotide binding [GO:0000166],GO:0003013; GO:0003824; GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005815; GO:0005886; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0055085; GO:0061024; GO:0098772; GO:0140657; GO:1901135,circulatory system process; catalytic activity; transporter activity; lysosome; endosome; vacuole; microtubule organizing center; plasma membrane; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; transmembrane transport; membrane organization; molecular function regulator activity; ATP-dependent activity; carbohydrate derivative metabolic process
OG_09158,FUN_039817-T1,Peve_00039024,Pocillopora_meandrina_HIv1___RNAseq.g7505.t1,three_way,89.61566666666667,FUN_039817-T1,Q9Z1Q9,,,,,66.3,991.0,0.0,1398.6,sp|Q9Z1Q9|SYVC_MOUSE Valine--tRNA ligase OS=Mus musculus OX=10090 GN=Vars1 PE=1 SV=1,,,,,,
OG_09159,FUN_039818-T1,Peve_00039027,Pocillopora_meandrina_HIv1___RNAseq.g7506.t1,three_way,77.87733333333334,FUN_039818-T1,Q6DH69,,,,,52.3,493.0,4.3e-132,473.0,sp|Q6DH69|FAH2A_DANRE Fatty-acid amide hydrolase 2-A OS=Danio rerio OX=7955 GN=faah2a PE=2 SV=1,,,,,,
OG_09160,FUN_039819-T1,Peve_00005180,Pocillopora_meandrina_HIv1___RNAseq.g7317.t2,three_way,75.87833333333333,FUN_039819-T1,Q6AXY7,,,,,72.6,215.0,1.7e-90,334.3,sp|Q6AXY7|PR38B_RAT Pre-mRNA-splicing factor 38B OS=Rattus norvegicus OX=10116 GN=Prpf38b PE=1 SV=1,,,,,,
OG_09161,FUN_039820-T1,Peve_00009577,Pocillopora_meandrina_HIv1___RNAseq.g7314.t2,three_way,67.855,FUN_039820-T1,Q3U0J8,,,,,31.8,406.0,2.6e-50,202.6,sp|Q3U0J8|TBD2B_MOUSE TBC1 domain family member 2B OS=Mus musculus OX=10090 GN=Tbc1d2b PE=1 SV=2,,,,,,
OG_09162,FUN_039821-T1,Peve_00005159,Pocillopora_meandrina_HIv1___RNAseq.g7313.t1,three_way,78.86933333333333,FUN_039821-T1,Q9I8I2,,,,,32.9,170.0,1.7e-24,114.4,sp|Q9I8I2|BOK_CHICK Bcl-2-related ovarian killer protein OS=Gallus gallus OX=9031 GN=BOK PE=1 SV=1,,,,,,
OG_09163,FUN_039824-T1,Peve_00005158,Pocillopora_meandrina_HIv1___RNAseq.g7312.t1,three_way,81.45366666666666,FUN_039824-T1,P42700,,,,,51.9,536.0,4.3e-154,546.2,sp|P42700|RO60_XENLA RNA-binding protein RO60 OS=Xenopus laevis OX=8355 GN=ro60 PE=1 SV=1,,,,,,
OG_09164,FUN_039826-T2,Peve_00014198,Pocillopora_meandrina_HIv1___RNAseq.g25896.t1,three_way,49.993833333333335,,,,,,,,,,,,,,,,,
OG_09165,FUN_039827-T1,Peve_00005157,Pocillopora_meandrina_HIv1___RNAseq.g7311.t1,three_way,64.71333333333334,FUN_039827-T1,P00520,,,,,67.9,483.0,8.4e-202,705.7,sp|P00520|ABL1_MOUSE Tyrosine-protein kinase ABL1 OS=Mus musculus OX=10090 GN=Abl1 PE=1 SV=3,,,,,,
OG_09166,FUN_039828-T1,Peve_00005156,Pocillopora_meandrina_HIv1___RNAseq.g7310.t1,three_way,59.853,,,,,,,,,,,,,,,,,
OG_09167,FUN_039830-T1,Peve_00005155,Pocillopora_meandrina_HIv1___RNAseq.g7309.t1b,three_way,70.53166666666667,FUN_039830-T1,O08841,,,,,36.4,525.0,4e-92,340.5,sp|O08841|QSOX1_CAVPO Sulfhydryl oxidase 1 OS=Cavia porcellus OX=10141 GN=QSOX1 PE=1 SV=2,,,,,,
OG_09168,FUN_039832-T1,Peve_00005161,Pocillopora_meandrina_HIv1___RNAseq.g7305.t1,three_way,75.39766666666667,,,,,,,,,,,,,,,,,
OG_09169,FUN_039835-T1,Peve_00005154,Pocillopora_meandrina_HIv1___RNAseq.4974_t,three_way,57.41133333333333,,,,,,,,,,,,,,,,,
OG_09170,FUN_039836-T1,Peve_00006312,Pocillopora_meandrina_HIv1___RNAseq.g7301.t1,three_way,84.05966666666666,FUN_039836-T1,Q5R971,HEM2_PONAB,,Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),66.0,326.0,4.3e-125,449.1,sp|Q5R971|HEM2_PONAB Delta-aminolevulinic acid dehydratase OS=Pongo abelii OX=9601 GN=ALAD PE=2 SV=2,GO:0004655; GO:0005829; GO:0006782; GO:0006783; GO:0008270,heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],cytosol [GO:0005829],porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016829,catalytic activity; cytosol; lyase activity
OG_09171,FUN_039837-T2,Peve_00006311,Pocillopora_meandrina_HIv1___RNAseq.g7300.t1,three_way,76.486,FUN_039837-T2,Q5R7V3,,,,,48.8,80.0,4.4e-16,86.7,sp|Q5R7V3|ACBD5_PONAB Acyl-CoA-binding domain-containing protein 5 OS=Pongo abelii OX=9601 GN=ACBD5 PE=2 SV=1,,,,,,
OG_09172,FUN_039848-T1,Peve_00006309,Pocillopora_meandrina_HIv1___TS.g1047.t1,three_way,71.90033333333334,FUN_039848-T1,Q9JHB4,,,,,40.2,306.0,1.3e-50,201.8,sp|Q9JHB4|WDR31_MOUSE WD repeat-containing protein 31 OS=Mus musculus OX=10090 GN=Wdr31 PE=2 SV=1,,,,,,
OG_09173,FUN_039849-T1,Peve_00006320,Pocillopora_meandrina_HIv1___RNAseq.g7298.t1,three_way,70.33566666666667,FUN_039849-T1,A8WQK3,,,,,33.2,506.0,8.5e-67,256.5,sp|A8WQK3|ACH1_CAEBR Acetylcholine receptor subunit alpha-type acr-16 OS=Caenorhabditis briggsae OX=6238 GN=acr-16 PE=3 SV=2,,,,,,
OG_09174,FUN_039850-T1,Peve_00002765,Pocillopora_meandrina_HIv1___RNAseq.g7297.t1b,three_way,65.15933333333334,FUN_039850-T1,Q9R0M0,CELR2_MOUSE,,Cadherin EGF LAG seven-pass G-type receptor 2 (Flamingo homolog),Mus musculus (Mouse),24.0,484.0,2.4e-22,110.5,sp|Q9R0M0|CELR2_MOUSE Cadherin EGF LAG seven-pass G-type receptor 2 OS=Mus musculus OX=10090 GN=Celsr2 PE=1 SV=3,GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0016055; GO:0021591; GO:0021999; GO:0032880; GO:0033326; GO:0060271; GO:0097475,cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; neural plate anterior/posterior regionalization [GO:0021999]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization [GO:0032880]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0006355; GO:0007018; GO:0007155; GO:0044782; GO:0048856; GO:0048870; GO:0060089,plasma membrane; regulation of DNA-templated transcription; microtubule-based movement; cell adhesion; cilium organization; anatomical structure development; cell motility; molecular transducer activity
OG_09175,FUN_039851-T1,Peve_00002763,Pocillopora_meandrina_HIv1___RNAseq.g7297.t1a,three_way,73.80716666666667,FUN_039851-T1,Q5RAN1,,,,,44.1,933.0,7.1e-188,659.4,sp|Q5RAN1|RBGP1_PONAB Rab GTPase-activating protein 1 OS=Pongo abelii OX=9601 GN=RABGAP1 PE=2 SV=1,,,,,,
OG_09176,FUN_039852-T1,Peve_00002762,Pocillopora_meandrina_HIv1___RNAseq.g7296.t1,three_way,73.5855,FUN_039852-T1,Q9Y399,RT02_HUMAN,,"Small ribosomal subunit protein uS2m (28S ribosomal protein S2, mitochondrial) (MRP-S2) (S2mt)",Homo sapiens (Human),53.2,220.0,2.2e-58,227.3,sp|Q9Y399|RT02_HUMAN Small ribosomal subunit protein uS2m OS=Homo sapiens OX=9606 GN=MRPS2 PE=1 SV=1,GO:0003735; GO:0005739; GO:0005743; GO:0005759; GO:0005763; GO:0032543; GO:0061668,mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739],structural constituent of ribosome [GO:0003735],GO:0005198; GO:0005739; GO:0043226,structural molecule activity; mitochondrion; organelle
OG_09177,FUN_039853-T1,Peve_00020651,Pocillopora_meandrina_HIv1___RNAseq.g7295.t2,three_way,71.36883333333333,FUN_039853-T1,Q8QFV0,,,,,43.4,1143.0,3.5e-251,869.8,sp|Q8QFV0|KCNT1_CHICK Potassium channel subfamily T member 1 OS=Gallus gallus OX=9031 GN=KCNT1 PE=1 SV=1,,,,,,
OG_09178,FUN_039858-T1,Peve_00020641,Pocillopora_meandrina_HIv1___RNAseq.g7287.t1a,three_way,34.05316666666667,,,,,,,,,,,,,,,,,
OG_09179,FUN_039859-T1,Peve_00014928,Pocillopora_meandrina_HIv1___TS.g1031.t1,three_way,39.94166666666667,,,,,,,,,,,,,,,,,
OG_09180,FUN_039860-T1,Peve_00014924,Pocillopora_meandrina_HIv1___TS.g1030.t3,three_way,76.61816666666667,,,,,,,,,,,,,,,,,
OG_09181,FUN_039861-T1,Peve_00020818,Pocillopora_meandrina_HIv1___RNAseq.g7282.t1,three_way,67.37366666666667,FUN_039861-T1,Q9H816,DCR1B_HUMAN,,5' exonuclease Apollo (EC 3.1.-.-) (Beta-lactamase DCLRE1B) (EC 3.5.2.6) (DNA cross-link repair 1B protein) (SNM1 homolog B) (SNMIB) (hSNM1B),Homo sapiens (Human),42.8,318.0,1.4e-65,252.7,sp|Q9H816|DCR1B_HUMAN 5' exonuclease Apollo OS=Homo sapiens OX=9606 GN=DCLRE1B PE=1 SV=1,GO:0000723; GO:0000781; GO:0003684; GO:0005654; GO:0005737; GO:0005813; GO:0006303; GO:0008409; GO:0008800; GO:0010833; GO:0016233; GO:0016604; GO:0031627; GO:0031848; GO:0031860; GO:0035312; GO:0036297; GO:0042803; GO:0044877,double-strand break repair via nonhomologous end joining [GO:0006303]; interstrand cross-link repair [GO:0036297]; protection from non-homologous end joining at telomere [GO:0031848]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627],"centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]",5'-3' DNA exonuclease activity [GO:0035312]; 5'-3' exonuclease activity [GO:0008409]; beta-lactamase activity [GO:0008800]; damaged DNA binding [GO:0003684]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0003677; GO:0003824; GO:0005654; GO:0005815; GO:0006281; GO:0016787; GO:0032200; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleoplasm; microtubule organizing center; DNA repair; hydrolase activity; telomere organization; organelle; catalytic activity, acting on DNA"
OG_09182,FUN_039862-T1,Peve_00020823,Pocillopora_meandrina_HIv1___RNAseq.g7281.t1,three_way,61.18333333333333,FUN_039862-T1,Q8IYT2,CMTR2_HUMAN,,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (HMTr2) (MTr2) (FtsJ methyltransferase domain-containing protein 1) (Protein adrift homolog),Homo sapiens (Human),32.7,822.0,5.5e-100,367.1,sp|Q8IYT2|CMTR2_HUMAN Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 OS=Homo sapiens OX=9606 GN=CMTR2 PE=1 SV=2,GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0032259,7-methylguanosine mRNA capping [GO:0006370]; methylation [GO:0032259],cytoplasm [GO:0005737]; nucleus [GO:0005634],mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483],GO:0003824; GO:0005634; GO:0016071; GO:0016740; GO:0043226; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_09183,FUN_039863-T1,Peve_00020822,Pocillopora_meandrina_HIv1___RNAseq.g7280.t1,three_way,68.19433333333333,FUN_039863-T1,B5XF11,KDM8_SALSA,,Lysine-specific demethylase 8 (EC 1.14.11.27) (JmjC domain-containing protein 5) (Jumonji domain-containing protein 5),Salmo salar (Atlantic salmon),47.1,401.0,1.6e-104,381.3,sp|B5XF11|KDM8_SALSA Lysine-specific demethylase 8 OS=Salmo salar OX=8030 GN=kdm8 PE=2 SV=1,GO:0000086; GO:0003682; GO:0005634; GO:0032922; GO:0045893; GO:0046872; GO:0051864; GO:0140680,circadian regulation of gene expression [GO:0032922]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of DNA-templated transcription [GO:0045893],nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0006355; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_09184,FUN_039864-T1,Peve_00020821,Pocillopora_meandrina_HIv1___RNAseq.g7279.t1,three_way,63.61533333333333,,,,,,,,,,,,,,,,,
OG_09185,FUN_039866-T1,Peve_00034792,Pocillopora_meandrina_HIv1___RNAseq.g7277.t1,three_way,59.47166666666666,,,,,,,,,,,,,,,,,
OG_09186,FUN_039867-T1,Peve_00041831,Pocillopora_meandrina_HIv1___RNAseq.g7276.t1,three_way,76.83066666666667,FUN_039867-T1,F2Z4R5,T163B_DANRE,,Transmembrane protein 163b,Danio rerio (Zebrafish) (Brachydanio rerio),35.5,211.0,4.9e-26,119.8,sp|F2Z4R5|T163B_DANRE Transmembrane protein 163b OS=Danio rerio OX=7955 GN=tmem163b PE=2 SV=1,GO:0005765; GO:0005886; GO:0008270; GO:0008324; GO:0014003; GO:0030672; GO:0031901; GO:0031902; GO:0042552,myelination [GO:0042552]; oligodendrocyte development [GO:0014003],early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],monoatomic cation transmembrane transporter activity [GO:0008324]; zinc ion binding [GO:0008270],GO:0005215; GO:0005886; GO:0048856,transporter activity; plasma membrane; anatomical structure development
OG_09187,FUN_039868-T3,Peve_00011731,Pocillopora_meandrina_HIv1___RNAseq.g7379.t1,three_way,76.36233333333334,FUN_039868-T3,Q9CW79,GOGA1_MOUSE,,Golgin subfamily A member 1 (Golgin-97),Mus musculus (Mouse),38.5,78.0,2.3e-07,59.3,sp|Q9CW79|GOGA1_MOUSE Golgin subfamily A member 1 OS=Mus musculus OX=10090 GN=Golga1 PE=1 SV=2,GO:0001669; GO:0005794; GO:0005802; GO:0016020; GO:0048471,,acrosomal vesicle [GO:0001669]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802],,GO:0005794; GO:0031410; GO:0043226,Golgi apparatus; cytoplasmic vesicle; organelle
OG_09188,FUN_039870-T1,Peve_00006913,Pocillopora_meandrina_HIv1___RNAseq.g7377.t1,three_way,54.30833333333333,,,,,,,,,,,,,,,,,
OG_09189,FUN_039871-T1,Peve_00011726,Pocillopora_meandrina_HIv1___RNAseq.g7376.t1,three_way,52.6305,FUN_039871-T1,Q54PX0,Y4251_DICDI,,Probable serine/threonine-protein kinase DDB_G0284251 (EC 2.7.11.1),Dictyostelium discoideum (Social amoeba),27.9,201.0,3e-07,58.2,sp|Q54PX0|Y4251_DICDI Probable serine/threonine-protein kinase DDB_G0284251 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0284251 PE=3 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0046872; GO:0106310,,cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09190,FUN_039872-T1,Peve_00011727,Pocillopora_meandrina_HIv1___RNAseq.g7375.t1,three_way,52.92466666666667,FUN_039872-T1,Q9ULM3,YETS2_HUMAN,,YEATS domain-containing protein 2,Homo sapiens (Human),67.7,155.0,9.9e-59,229.9,sp|Q9ULM3|YETS2_HUMAN YEATS domain-containing protein 2 OS=Homo sapiens OX=9606 GN=YEATS2 PE=1 SV=2,GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0006338; GO:0006355; GO:0006357; GO:0017025; GO:0035267; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140030; GO:0140566; GO:0140672,chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357],ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone binding [GO:0042393]; histone reader activity [GO:0140566]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_09191,FUN_039873-T1,Peve_00011728,Pocillopora_meandrina_HIv1___RNAseq.g7374.t1,three_way,85.6805,FUN_039873-T1,A2AJ77,PRD12_MOUSE,,PR domain zinc finger protein 12 (PR domain-containing protein 12),Mus musculus (Mouse),45.0,289.0,1.8e-61,238.0,sp|A2AJ77|PRD12_MOUSE PR domain zinc finger protein 12 OS=Mus musculus OX=10090 GN=Prdm12 PE=2 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0005654; GO:0008168; GO:0008270; GO:0019233; GO:0022008; GO:0031175; GO:0032259; GO:0050965; GO:0140713; GO:1990226,detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008]; neuron projection development [GO:0031175]; sensory perception of pain [GO:0019233],nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone chaperone activity [GO:0140713]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0050877; GO:0140104,DNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; nervous system process; molecular carrier activity
OG_09192,FUN_039874-T1,Peve_00004940,Pocillopora_meandrina_HIv1___RNAseq.g7373.t1,three_way,90.32533333333332,FUN_039874-T1,Q2KID0,EXOS2_BOVIN,,Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4),Bos taurus (Bovine),65.1,298.0,1.2e-102,374.4,sp|Q2KID0|EXOS2_BOVIN Exosome complex component RRP4 OS=Bos taurus OX=9913 GN=EXOSC2 PE=2 SV=1,GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0000956; GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0030307; GO:0034475; GO:0071034; GO:0071035; GO:0071038; GO:0071051,"CUT catabolic process [GO:0071034]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U4 snRNA 3'-end processing [GO:0034475]",cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0005730; GO:0005829; GO:0006399; GO:0016071; GO:0016073; GO:0043226,RNA binding; nucleoplasm; nucleolus; cytosol; tRNA metabolic process; mRNA metabolic process; snRNA metabolic process; organelle
OG_09193,FUN_039875-T1,Peve_00004944,Pocillopora_meandrina_HIv1___RNAseq.g7357.t1,three_way,83.253,FUN_039875-T1,Q3T1G7,,,,,39.1,780.0,1.2e-146,521.9,sp|Q3T1G7|COG7_RAT Conserved oligomeric Golgi complex subunit 7 OS=Rattus norvegicus OX=10116 GN=Cog7 PE=2 SV=1,,,,,,
OG_09194,FUN_039876-T1,Peve_00004937,Pocillopora_meandrina_HIv1___RNAseq.g7360.t1,three_way,87.82566666666666,FUN_039876-T1,Q26626,,,,,65.3,792.0,5.3e-252,872.1,sp|Q26626|KIFA3_STRPU Kinesin-associated protein 3 OS=Strongylocentrotus purpuratus OX=7668 GN=KAP115 PE=1 SV=1,,,,,,
OG_09195,FUN_039878-T1,Peve_00004939,Pocillopora_meandrina_HIv1___RNAseq.g7349.t1,three_way,88.2645,FUN_039878-T1,Q9Z325,DPM2_RAT,,Dolichol phosphate-mannose biosynthesis regulatory protein (Dolichol-phosphate mannose synthase subunit 2) (DPM synthase subunit 2),Rattus norvegicus (Rat),52.4,82.0,1.3e-17,90.1,sp|Q9Z325|DPM2_RAT Dolichol phosphate-mannose biosynthesis regulatory protein OS=Rattus norvegicus OX=10116 GN=Dpm2 PE=1 SV=3,GO:0000506; GO:0004582; GO:0005783; GO:0005789; GO:0006486; GO:0006506; GO:0008047; GO:0019348; GO:0030234; GO:0031647; GO:0033185; GO:0048471; GO:0180047,dolichol metabolic process [GO:0019348]; dolichol phosphate mannose biosynthetic process [GO:0180047]; GPI anchor biosynthetic process [GO:0006506]; protein glycosylation [GO:0006486]; regulation of protein stability [GO:0031647],dolichol-phosphate-mannose synthase complex [GO:0033185]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; perinuclear region of cytoplasm [GO:0048471],dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; enzyme activator activity [GO:0008047]; enzyme regulator activity [GO:0030234],GO:0003824; GO:0005783; GO:0006486; GO:0006629; GO:0016740; GO:0043226; GO:0098772; GO:1901135,catalytic activity; endoplasmic reticulum; protein glycosylation; lipid metabolic process; transferase activity; organelle; molecular function regulator activity; carbohydrate derivative metabolic process
OG_09196,FUN_039879-T1,Peve_00004941,Pocillopora_meandrina_HIv1___RNAseq.g7350.t1,three_way,71.38633333333334,FUN_039879-T1,Q9VX10,,,,,61.9,105.0,5e-33,141.7,sp|Q9VX10|SRX_DROME Sulfiredoxin OS=Drosophila melanogaster OX=7227 GN=Srx PE=1 SV=1,,,,,,
OG_09197,FUN_039880-T1,Peve_00004942,Pocillopora_meandrina_HIv1___RNAseq.g7353.t1,three_way,56.60916666666667,FUN_039880-T1,Q9NX45,,,,,52.0,75.0,2.7e-12,75.5,sp|Q9NX45|SOLH2_HUMAN Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2 OS=Homo sapiens OX=9606 GN=SOHLH2 PE=1 SV=2,,,,,,
OG_09198,FUN_039883-T1,Peve_00011734,Pocillopora_meandrina_HIv1___RNAseq.g7356.t1,three_way,74.50316666666667,FUN_039883-T1,Q6GQB9,EDEM3_XENLA,,"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)",Xenopus laevis (African clawed frog),59.0,761.0,5.3e-264,912.1,sp|Q6GQB9|EDEM3_XENLA ER degradation-enhancing alpha-mannosidase-like protein 3 OS=Xenopus laevis OX=8355 GN=edem3 PE=2 SV=2,GO:0004571; GO:0005509; GO:0005783; GO:0005788; GO:0005975; GO:0006058; GO:0006486; GO:0016020; GO:0030968; GO:0044322; GO:0097466; GO:1904380,carbohydrate metabolic process [GO:0005975]; endoplasmic reticulum mannose trimming [GO:1904380]; endoplasmic reticulum unfolded protein response [GO:0030968]; mannoprotein catabolic process [GO:0006058]; protein glycosylation [GO:0006486]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005975; GO:0006486; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; protein glycosylation; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_09199,FUN_039884-T1,Peve_00021849,Pocillopora_meandrina_HIv1___RNAseq.g7372.t1,three_way,83.127,FUN_039884-T1,Q96NC0,ZMAT2_HUMAN,,Zinc finger matrin-type protein 2,Homo sapiens (Human),65.7,134.0,3.7e-42,172.9,sp|Q96NC0|ZMAT2_HUMAN Zinc finger matrin-type protein 2 OS=Homo sapiens OX=9606 GN=ZMAT2 PE=1 SV=1,GO:0000398; GO:0003677; GO:0005634; GO:0005654; GO:0008270; GO:0046540; GO:0071005,"mRNA splicing, via spliceosome [GO:0000398]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0016071; GO:0043226,DNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle
OG_09200,FUN_039885-T1,Peve_00021850,Pocillopora_meandrina_HIv1___TS.g1125.t1,three_way,87.84066666666666,FUN_039885-T1,D3Z902,FBXW7_RAT,,F-box/WD repeat-containing protein 7,Rattus norvegicus (Rat),61.1,216.0,4.6e-73,277.3,sp|D3Z902|FBXW7_RAT F-box/WD repeat-containing protein 7 OS=Rattus norvegicus OX=10116 GN=Fbxw7 PE=1 SV=2,GO:0001570; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0006974; GO:0007062; GO:0007219; GO:0010629; GO:0010992; GO:0016567; GO:0019005; GO:0030324; GO:0030332; GO:0030674; GO:0031146; GO:0031398; GO:0031625; GO:0031648; GO:0042752; GO:0042802; GO:0043130; GO:0043161; GO:0048471; GO:0048511; GO:0050816; GO:0050821; GO:0070374; GO:0070534; GO:0090049; GO:0097027; GO:1901524; GO:1901800; GO:1903378; GO:1903955; GO:1990452; GO:1990756; GO:2000060; GO:2001205,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; lung development [GO:0030324]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast development [GO:2001205]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein destabilization [GO:0031648]; protein K63-linked ubiquitination [GO:0070534]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of circadian rhythm [GO:0042752]; regulation of mitophagy [GO:1901524]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; sister chromatid cohesion [GO:0007062]; ubiquitin recycling [GO:0010992]; vasculogenesis [GO:0001570],chromosome [GO:0005694]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; SCF ubiquitin ligase complex [GO:0019005],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; phosphothreonine residue binding [GO:0050816]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-protein transferase activator activity [GO:0097027],GO:0005634; GO:0005694; GO:0005730; GO:0005739; GO:0005783; GO:0005794; GO:0006281; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleus; chromosome; nucleolus; mitochondrion; endoplasmic reticulum; Golgi apparatus; DNA repair; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_09201,FUN_039886-T1,Peve_00021852,Pocillopora_meandrina_HIv1___RNAseq.g7370.t1,three_way,57.459,FUN_039886-T1,Q9H8P0,SR5A3_HUMAN,,Polyprenal reductase (EC 1.3.1.94) (3-oxo-5-alpha-steroid 4-dehydrogenase 3) (EC 1.3.1.22) (Steroid 5-alpha-reductase 2-like) (Steroid 5-alpha-reductase 3) (S5AR 3) (SR type 3),Homo sapiens (Human),33.1,275.0,6e-33,142.9,sp|Q9H8P0|SR5A3_HUMAN Polyprenal reductase OS=Homo sapiens OX=9606 GN=SRD5A3 PE=1 SV=1,GO:0003865; GO:0005783; GO:0005789; GO:0006488; GO:0006489; GO:0006702; GO:0016095; GO:0016628; GO:0019348; GO:0019408; GO:0047751; GO:0102389; GO:0160198,androgen biosynthetic process [GO:0006702]; dolichol biosynthetic process [GO:0019408]; dolichol metabolic process [GO:0019348]; dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; dolichyl diphosphate biosynthetic process [GO:0006489]; polyprenol catabolic process [GO:0016095],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],"3-oxo-5-alpha-steroid 4-dehydrogenase (NADP+) activity [GO:0047751]; 3-oxo-5-alpha-steroid 4-dehydrogenase activity [GO:0003865]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; polyprenal reductase activity [GO:0160198]; polyprenol reductase activity [GO:0102389]",GO:0003824; GO:0005783; GO:0006629; GO:0016491; GO:0043226; GO:1901135,catalytic activity; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; organelle; carbohydrate derivative metabolic process
OG_09202,FUN_039887-T1,Peve_00021853,Pocillopora_meandrina_HIv1___RNAseq.g7369.t1,three_way,90.38766666666666,FUN_039887-T1,Q7SXP0,,,,,61.7,214.0,2.3000000000000002e-71,270.0,sp|Q7SXP0|S22BB_DANRE Vesicle-trafficking protein SEC22b-B OS=Danio rerio OX=7955 GN=sec22bb PE=2 SV=1,,,,,,
OG_09203,FUN_039889-T1,Peve_00021857,Pocillopora_meandrina_HIv1___RNAseq.g7366.t1,three_way,37.58166666666666,,,,,,,,,,,,,,,,,
OG_09204,FUN_039892-T1,Peve_00021860,Pocillopora_meandrina_HIv1___RNAseq.g7364.t1,three_way,45.9685,FUN_039892-T1,Q9JK41,COPT1_RAT,,High affinity copper uptake protein 1 (Copper transporter 1) (rCTR1) (Liver regeneration-related protein LRRGT00200) (Solute carrier family 31 member 1) [Cleaved into: Truncated CTR1 form],Rattus norvegicus (Rat),31.9,144.0,2e-09,64.3,sp|Q9JK41|COPT1_RAT High affinity copper uptake protein 1 OS=Rattus norvegicus OX=10116 GN=Slc31a1 PE=2 SV=1,GO:0001525; GO:0005375; GO:0005507; GO:0005770; GO:0005886; GO:0006825; GO:0006878; GO:0014704; GO:0015080; GO:0015677; GO:0015679; GO:0016323; GO:0016324; GO:0031901; GO:0031902; GO:0036324; GO:0042802; GO:0042908; GO:0042910; GO:0043025; GO:0051259; GO:0051649; GO:0055037; GO:0055038; GO:0055085; GO:0072719; GO:0098705; GO:1902601,angiogenesis [GO:0001525]; cellular response to cisplatin [GO:0072719]; copper ion import [GO:0015677]; copper ion import across plasma membrane [GO:0098705]; copper ion transport [GO:0006825]; establishment of localization in cell [GO:0051649]; intracellular copper ion homeostasis [GO:0006878]; plasma membrane copper ion transport [GO:0015679]; protein complex oligomerization [GO:0051259]; silver ion transmembrane transport [GO:1902601]; transmembrane transport [GO:0055085]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; xenobiotic transport [GO:0042908],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; early endosome membrane [GO:0031901]; intercalated disc [GO:0014704]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; identical protein binding [GO:0042802]; silver ion transmembrane transporter activity [GO:0015080]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085; GO:0065003,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport; protein-containing complex assembly
OG_09205,FUN_039893-T1,Peve_00021861,Pocillopora_meandrina_HIv1___RNAseq.g7363.t1,three_way,81.48033333333333,FUN_039893-T1,Q7ZVB2,,,,,62.8,487.0,9.4e-183,641.3,sp|Q7ZVB2|A9A1A_DANRE 4-trimethylaminobutyraldehyde dehydrogenase A OS=Danio rerio OX=7955 GN=aldh9a1a PE=2 SV=1,,,,,,
OG_09206,FUN_039894-T1,Peve_00010149,Pocillopora_meandrina_HIv1___RNAseq.g7347.t1,three_way,56.650333333333336,FUN_039894-T1,Q9I829,,,,,33.9,419.0,1.1e-60,235.7,sp|Q9I829|KCNA1_ONCMY Shaker-related potassium channel tsha2 OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1,,,,,,
OG_09207,FUN_039895-T1,Peve_00010157,Pocillopora_meandrina_HIv1___RNAseq.g7346.t1,three_way,66.7045,,,,,,,,,,,,,,,,,
OG_09208,FUN_039896-T2,Peve_00010139,Pocillopora_meandrina_HIv1___RNAseq.g7345.t1,three_way,50.531666666666666,,,,,,,,,,,,,,,,,
OG_09209,FUN_039921-T1,Peve_00010140,Pocillopora_meandrina_HIv1___RNAseq.g7341.t1,three_way,65.0695,FUN_039921-T1,Q9V6X7,OFUT1_DROME,,GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Neurotic protein) (Peptide-O-fucosyltransferase 1) (O-FucT-1),Drosophila melanogaster (Fruit fly),45.8,369.0,9.6e-90,332.0,sp|Q9V6X7|OFUT1_DROME GDP-fucose protein O-fucosyltransferase 1 OS=Drosophila melanogaster OX=7227 GN=O-fut1 PE=1 SV=1,GO:0005112; GO:0005788; GO:0006004; GO:0007219; GO:0036066; GO:0045165; GO:0045747; GO:0045807; GO:0046922,cell fate commitment [GO:0045165]; fucose metabolic process [GO:0006004]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked fucosylation [GO:0036066],endoplasmic reticulum lumen [GO:0005788],Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922],GO:0003824; GO:0005975; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_09210,FUN_039923-T1,Peve_00010141,Pocillopora_meandrina_HIv1___RNAseq.g7340.t1,three_way,61.899,,,,,,,,,,,,,,,,,
OG_09211,FUN_039924-T1,Peve_00010142,Pocillopora_meandrina_HIv1___RNAseq.g7338.t1,three_way,76.45366666666666,FUN_039924-T1,P58389,PTPA_MOUSE,,"Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')",Mus musculus (Mouse),64.7,295.0,3.3e-115,416.4,sp|P58389|PTPA_MOUSE Serine/threonine-protein phosphatase 2A activator OS=Mus musculus OX=10090 GN=Ptpa PE=1 SV=1,GO:0000159; GO:0003755; GO:0004721; GO:0005102; GO:0005524; GO:0005654; GO:0005737; GO:0008160; GO:0019888; GO:0034704; GO:0042803; GO:0043065; GO:0046872; GO:0051721; GO:1904949,positive regulation of apoptotic process [GO:0043065],ATPase complex [GO:1904949]; calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein phosphatase type 2A complex [GO:0000159],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein phosphatase activity [GO:0004721]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005654; GO:0016787; GO:0016853; GO:0098772; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; isomerase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09212,FUN_039928-T1,Peve_00002279,Pocillopora_meandrina_HIv1___TS.g307.t1,three_way,71.687,,,,,,,,,,,,,,,,,
OG_09213,FUN_039930-T2,Peve_00010154,Pocillopora_meandrina_HIv1___TS.g1088.t1,three_way,69.904,FUN_039930-T2,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),33.0,5128.0,0.0,2459.9,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09214,FUN_039931-T1,Peve_00036243,Pocillopora_meandrina_HIv1___RNAseq.g7332.t1,three_way,58.890166666666666,FUN_039931-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),40.3,578.0,1.6e-96,355.9,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_09215,FUN_039932-T1,Peve_00036232,Pocillopora_meandrina_HIv1___RNAseq.g7329.t1,three_way,50.97533333333333,,,,,,,,,,,,,,,,,
OG_09216,FUN_039935-T1,Peve_00036234,Pocillopora_meandrina_HIv1___RNAseq.g7328.t1,three_way,60.9255,FUN_039935-T1,Q3TLH4,,,,,29.5,451.0,5.8e-24,116.3,sp|Q3TLH4|PRC2C_MOUSE Protein PRRC2C OS=Mus musculus OX=10090 GN=Prrc2c PE=1 SV=3,,,,,,
OG_09217,FUN_039937-T1,Peve_00007733,Pocillopora_meandrina_HIv1___RNAseq.g15743.t1,three_way,79.05833333333334,FUN_039937-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),32.4,451.0,1.1e-66,255.8,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_09218,FUN_039938-T1,Peve_00004407,Pocillopora_meandrina_HIv1___TS.g1076.t1,three_way,66.03833333333333,FUN_039938-T1,Q28DX0,QTRT2_XENTR,,Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),42.0,257.0,1.2e-51,204.9,sp|Q28DX0|QTRT2_XENTR Queuine tRNA-ribosyltransferase accessory subunit 2 OS=Xenopus tropicalis OX=8364 GN=qtrt2 PE=2 SV=1,GO:0000049; GO:0005737; GO:0005739; GO:0005741; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0101030,tRNA-guanine transglycosylation [GO:0101030],cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; tRNA-guanosine(34) queuine transglycosylase activity [GO:0008479],GO:0003723; GO:0003824; GO:0005739; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; mitochondrion; transferase activity; organelle; catalytic activity, acting on RNA"
OG_09219,FUN_039939-T1,Peve_00010697,Pocillopora_meandrina_HIv1___RNAseq.g7326.t1,three_way,81.12766666666667,FUN_039939-T1,A5PK45,,,,,51.9,540.0,2.3e-161,570.5,sp|A5PK45|GT251_BOVIN Procollagen galactosyltransferase 1 OS=Bos taurus OX=9913 GN=COLGALT1 PE=2 SV=1,,,,,,
OG_09220,FUN_039940-T1,Peve_00010696,Pocillopora_meandrina_HIv1___TS.g1074.t1,three_way,39.912,,,,,,,,,,,,,,,,,
OG_09221,FUN_039942-T1,Peve_00010695,Pocillopora_meandrina_HIv1___RNAseq.g7324.t1,three_way,69.87466666666667,FUN_039942-T1,Q04108,,,,,36.8,117.0,2.3e-14,80.5,sp|Q04108|PR04_SOLLC Pathogenesis-related leaf protein 4 OS=Solanum lycopersicum OX=4081 PE=2 SV=1,,,,,,
OG_09222,FUN_039943-T1,Peve_00010694,Pocillopora_meandrina_HIv1___RNAseq.g7323.t1,three_way,74.54066666666667,,,,,,,,,,,,,,,,,
OG_09223,FUN_039944-T1,Peve_00010693,Pocillopora_meandrina_HIv1___RNAseq.g7322.t1,three_way,63.66116666666667,,,,,,,,,,,,,,,,,
OG_09224,FUN_039946-T1,Peve_00010690,Pocillopora_meandrina_HIv1___RNAseq.g7320.t1,three_way,85.51166666666667,FUN_039946-T1,Q9DAJ4,WDR83_MOUSE,,WD repeat domain-containing protein 83 (Mitogen-activated protein kinase organizer 1) (MAPK organizer 1),Mus musculus (Mouse),49.0,302.0,8.000000000000001e-49,195.7,sp|Q9DAJ4|WDR83_MOUSE WD repeat domain-containing protein 83 OS=Mus musculus OX=10090 GN=Wdr83 PE=1 SV=1,GO:0000398; GO:0001666; GO:0001843; GO:0005634; GO:0005737; GO:0005764; GO:0009611; GO:0032496; GO:0043122; GO:0060674; GO:0071013; GO:0090594,"inflammatory response to wounding [GO:0090594]; mRNA splicing, via spliceosome [GO:0000398]; neural tube closure [GO:0001843]; placenta blood vessel development [GO:0060674]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to wounding [GO:0009611]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; lysosome [GO:0005764]; nucleus [GO:0005634],,GO:0005634; GO:0005764; GO:0005773; GO:0006954; GO:0016071; GO:0043226; GO:0048856,nucleus; lysosome; vacuole; inflammatory response; mRNA metabolic process; organelle; anatomical structure development
OG_09225,FUN_039947-T1,Peve_00039029,Pocillopora_meandrina_HIv1___RNAseq.g7508.t1,three_way,78.4495,FUN_039947-T1,Q5T280,SPOUT_HUMAN,,28S rRNA (uridine-N(3))-methyltransferase (EC 2.1.1.-) (Centromere protein 32) (CENP-32) (Kinetochore-associated protein) (Methyltransferase C9orf114) (Ribosomal RNA methyltransferase SPOUT1) (SPOUT domain-containing methyltransferase 1),Homo sapiens (Human),60.8,237.0,1.3e-79,297.7,sp|Q5T280|SPOUT_HUMAN 28S rRNA (uridine-N(3))-methyltransferase OS=Homo sapiens OX=9606 GN=SPOUT1 PE=1 SV=3,GO:0000776; GO:0003723; GO:0005737; GO:0010608; GO:0031616; GO:0035196; GO:0035198; GO:0051301; GO:0051661; GO:0070042; GO:0070475; GO:0072686; GO:1904047,cell division [GO:0051301]; maintenance of centrosome location [GO:0051661]; miRNA processing [GO:0035196]; post-transcriptional regulation of gene expression [GO:0010608]; rRNA base methylation [GO:0070475],cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; spindle pole centrosome [GO:0031616],miRNA binding [GO:0035198]; RNA binding [GO:0003723]; rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]; S-adenosyl-L-methionine binding [GO:1904047],GO:0003723; GO:0003824; GO:0005815; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on RNA"
OG_09226,FUN_039948-T1,Peve_00039030,Pocillopora_meandrina_HIv1___RNAseq.g7509.t1,three_way,83.78416666666666,FUN_039948-T1,A7SKE9,EIF3G_NEMVE,,Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4),Nematostella vectensis (Starlet sea anemone),63.5,296.0,6.8e-98,358.6,sp|A7SKE9|EIF3G_NEMVE Eukaryotic translation initiation factor 3 subunit G OS=Nematostella vectensis OX=45351 GN=v1g171563 PE=3 SV=1,GO:0001732; GO:0003723; GO:0003743; GO:0005852; GO:0016282; GO:0033290,formation of cytoplasmic translation initiation complex [GO:0001732],eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852],RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_09227,FUN_039950-T1,Peve_00039033,Pocillopora_meandrina_HIv1___RNAseq.g7515.t1,three_way,56.91766666666667,FUN_039950-T1,P17124,,,,,28.3,311.0,4.3e-13,77.0,sp|P17124|HRH2_CANLF Histamine H2 receptor OS=Canis lupus familiaris OX=9615 GN=HRH2 PE=1 SV=1,,,,,,
OG_09228,FUN_039965-T1,Peve_00039032,Pocillopora_meandrina_HIv1___RNAseq.g7516.t1,three_way,86.89633333333333,FUN_039965-T1,P28700,RXRA_MOUSE,,Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha),Mus musculus (Mouse),37.9,340.0,1.9999999999999998e-53,211.1,sp|P28700|RXRA_MOUSE Retinoic acid receptor RXR-alpha OS=Mus musculus OX=10090 GN=Rxra PE=1 SV=1,GO:0000122; GO:0000977; GO:0000978; GO:0001162; GO:0001223; GO:0001701; GO:0001890; GO:0001893; GO:0002157; GO:0003007; GO:0003677; GO:0003700; GO:0003707; GO:0004879; GO:0005634; GO:0005654; GO:0005667; GO:0005739; GO:0006355; GO:0006357; GO:0007507; GO:0007566; GO:0008270; GO:0009755; GO:0010467; GO:0010629; GO:0030501; GO:0031490; GO:0042789; GO:0042802; GO:0043010; GO:0043565; GO:0045893; GO:0045944; GO:0045994; GO:0048384; GO:0055007; GO:0055010; GO:0055012; GO:0060038; GO:0060485; GO:0060528; GO:0060687; GO:0060978; GO:0061032; GO:0070564; GO:0090575,angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; camera-type eye development [GO:0043010]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell proliferation [GO:0060038]; embryo implantation [GO:0007566]; gene expression [GO:0010467]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; hormone-mediated signaling pathway [GO:0009755]; in utero embryonic development [GO:0001701]; maternal placenta development [GO:0001893]; mesenchyme development [GO:0060485]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; placenta development [GO:0001890]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of thyroid hormone receptor signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational initiation by iron [GO:0045994]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retinoic acid receptor signaling pathway [GO:0048384]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral serous pericardium development [GO:0061032],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667],chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006351; GO:0006355; GO:0016071; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_09229,FUN_039966-T1,Peve_00039035,Pocillopora_meandrina_HIv1___RNAseq.g7517.t1a,three_way,70.402,,,,,,,,,,,,,,,,,
OG_09230,FUN_039968-T1,Peve_00039036,Pocillopora_meandrina_HIv1___RNAseq.g7517.t1c,three_way,57.724,,,,,,,,,,,,,,,,,
OG_09231,FUN_039972-T1,Peve_00000412,Pocillopora_meandrina_HIv1___RNAseq.g7539.t1,three_way,84.46716666666667,FUN_039972-T1,A7RWC9,ITPA_NEMVE,,Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.66) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase) (XTP/dITP diphosphatase),Nematostella vectensis (Starlet sea anemone),76.0,196.0,1.6e-88,327.0,sp|A7RWC9|ITPA_NEMVE Inosine triphosphate pyrophosphatase OS=Nematostella vectensis OX=45351 GN=v1g163483 PE=3 SV=1,GO:0000166; GO:0005737; GO:0009117; GO:0009143; GO:0009204; GO:0035870; GO:0036220; GO:0036222; GO:0046872; GO:0047429,deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117],cytoplasm [GO:0005737],dITP diphosphatase activity [GO:0035870]; ITP diphosphatase activity [GO:0036220]; metal ion binding [GO:0046872]; nucleoside triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; XTP diphosphatase activity [GO:0036222],GO:0003824; GO:0016787; GO:0055086,catalytic activity; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_09232,FUN_039973-T1,Peve_00000409,Pocillopora_meandrina_HIv1___RNAseq.g7541.t1,three_way,75.81366666666666,FUN_039973-T1,A0A1L8GVF0,RA50S_XENLA,,DNA repair protein RAD50.S (EC 3.6.-.-),Xenopus laevis (African clawed frog),38.8,1313.0,5.3e-182,640.2,sp|A0A1L8GVF0|RA50S_XENLA DNA repair protein RAD50.S OS=Xenopus laevis OX=8355 GN=rad50.S PE=1 SV=1,GO:0000722; GO:0000729; GO:0000781; GO:0000794; GO:0003691; GO:0005524; GO:0006302; GO:0007004; GO:0016887; GO:0030870; GO:0035861; GO:0043047; GO:0043539; GO:0046872; GO:0051310; GO:0051880; GO:0062176; GO:0070192; GO:0110025,chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA double-strand break processing [GO:0000729]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; metaphase chromosome alignment [GO:0051310]; R-loop processing [GO:0062176]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004],"chromosome, telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; Mre11 complex [GO:0030870]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded telomeric DNA binding [GO:0003691]; G-quadruplex DNA binding [GO:0051880]; metal ion binding [GO:0046872]; protein serine/threonine kinase activator activity [GO:0043539]; single-stranded telomeric DNA binding [GO:0043047],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006310; GO:0006325; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0098772,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; DNA recombination; chromatin organization; hydrolase activity; reproductive process; telomere organization; organelle; molecular function regulator activity
OG_09233,FUN_039977-T1,Peve_00029897,Pocillopora_meandrina_HIv1___RNAseq.g7542.t1,three_way,56.55166666666666,FUN_039977-T1,Q9ULJ7,,,,,25.1,427.0,1.1e-26,124.8,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_09234,FUN_039978-T1,Peve_00014318,Pocillopora_meandrina_HIv1___RNAseq.g7546.t1,three_way,93.03066666666666,FUN_039978-T1,Q8C754,VPS52_MOUSE,,Vacuolar protein sorting-associated protein 52 homolog,Mus musculus (Mouse),64.2,338.0,1.5e-128,460.7,sp|Q8C754|VPS52_MOUSE Vacuolar protein sorting-associated protein 52 homolog OS=Mus musculus OX=10090 GN=Vps52 PE=1 SV=1,GO:0000938; GO:0005829; GO:0006605; GO:0007041; GO:0010008; GO:0010668; GO:0015031; GO:0016020; GO:0019905; GO:0032456; GO:0048471; GO:0048611; GO:0055037; GO:0090119; GO:0098793; GO:0098794; GO:1990745,ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein targeting [GO:0006605]; protein transport [GO:0015031]; vesicle-mediated cholesterol transport [GO:0090119],cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; recycling endosome [GO:0055037],syntaxin binding [GO:0019905],GO:0005768; GO:0005829; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0048856,endosome; cytosol; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development
OG_09235,FUN_039980-T1,Peve_00014321,Pocillopora_meandrina_HIv1___RNAseq.g7547.t1,three_way,79.15883333333333,FUN_039980-T1,Q55G75,,,,,35.5,265.0,6.200000000000001e-44,179.5,sp|Q55G75|Y7786_DICDI PH domain-containing protein DDB_G0267786 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0267786 PE=4 SV=1,,,,,,
OG_09236,FUN_039982-T1,Peve_00014323,Pocillopora_meandrina_HIv1___RNAseq.g7548.t1,three_way,78.11166666666666,FUN_039982-T1,Q9R0C8,VAV3_MOUSE,,Guanine nucleotide exchange factor VAV3 (VAV-3),Mus musculus (Mouse),36.8,766.0,1.9e-123,444.9,sp|Q9R0C8|VAV3_MOUSE Guanine nucleotide exchange factor VAV3 OS=Mus musculus OX=10090 GN=Vav3 PE=1 SV=2,GO:0001525; GO:0001772; GO:0005085; GO:0005154; GO:0005737; GO:0005886; GO:0006906; GO:0006974; GO:0007229; GO:0007264; GO:0008270; GO:0008361; GO:0009410; GO:0016477; GO:0030031; GO:0030032; GO:0030593; GO:0030890; GO:0045785; GO:0050853; GO:0051897,angiogenesis [GO:0001525]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; DNA damage response [GO:0006974]; integrin-mediated signaling pathway [GO:0007229]; lamellipodium assembly [GO:0030032]; neutrophil chemotaxis [GO:0030593]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell adhesion [GO:0045785]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of cell size [GO:0008361]; response to xenobiotic stimulus [GO:0009410]; small GTPase-mediated signal transduction [GO:0007264]; vesicle fusion [GO:0006906],cytoplasm [GO:0005737]; immunological synapse [GO:0001772]; plasma membrane [GO:0005886],epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270],GO:0002376; GO:0005886; GO:0048870; GO:0061024; GO:0098772,immune system process; plasma membrane; cell motility; membrane organization; molecular function regulator activity
OG_09237,FUN_039990-T1,Peve_00004422,Pocillopora_meandrina_HIv1___RNAseq.g7562.t1,three_way,81.36533333333333,FUN_039990-T1,Q96CN4,EVI5L_HUMAN,,EVI5-like protein (Ecotropic viral integration site 5-like protein),Homo sapiens (Human),45.3,516.0,1.2e-114,415.2,sp|Q96CN4|EVI5L_HUMAN EVI5-like protein OS=Homo sapiens OX=9606 GN=EVI5L PE=1 SV=1,GO:0005096; GO:0031267; GO:0043547; GO:1902018,negative regulation of cilium assembly [GO:1902018]; positive regulation of GTPase activity [GO:0043547],,GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267],GO:0098772,molecular function regulator activity
OG_09238,FUN_040004-T1,Peve_00004960,Pocillopora_meandrina_HIv1___RNAseq.g8430.t1,three_way,87.48266666666667,FUN_040004-T1,Q3T197,,,,,59.5,220.0,3.1e-63,243.0,sp|Q3T197|STEEP_BOVIN STING ER exit protein OS=Bos taurus OX=9913 GN=STEEP1 PE=2 SV=1,,,,,,
OG_09239,FUN_040009-T1,Peve_00031111,Pocillopora_meandrina_HIv1___RNAseq.g8428.t1,three_way,70.12066666666666,FUN_040009-T1,Q20471,KIN20_CAEEL,,Casein kinase I isoform delta (EC 2.7.11.1) (Protein kinase 20),Caenorhabditis elegans,53.4,234.0,6.799999999999998e-69,262.3,sp|Q20471|KIN20_CAEEL Casein kinase I isoform delta OS=Caenorhabditis elegans OX=6239 GN=kin-20 PE=1 SV=3,GO:0000775; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005912; GO:0006897; GO:0007165; GO:0032436; GO:0040012; GO:0048511; GO:0048670; GO:0090263; GO:0106310,endocytosis [GO:0006897]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of collateral sprouting [GO:0048670]; regulation of locomotion [GO:0040012]; rhythmic process [GO:0048511]; signal transduction [GO:0007165],"adherens junction [GO:0005912]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]",ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016192; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; vesicle-mediated transport; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09240,FUN_040028-T1,Peve_00004957,Pocillopora_meandrina_HIv1___RNAseq.g8435.t1,three_way,50.78683333333333,FUN_040028-T1,Q8C1B2,PARPT_MOUSE,,Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (TCDD-inducible poly [ADP-ribose] polymerase),Mus musculus (Mouse),32.0,453.0,8.3e-47,190.3,sp|Q8C1B2|PARPT_MOUSE Protein mono-ADP-ribosyltransferase TIPARP OS=Mus musculus OX=10090 GN=Tiparp PE=2 SV=1,GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0008209; GO:0008210; GO:0008270; GO:0008585; GO:0009791; GO:0010629; GO:0016779; GO:0030097; GO:0045732; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0140803; GO:0140806; GO:0140807; GO:1904612,"androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]",nucleus [GO:0005634],cis-regulatory region sequence-specific DNA binding [GO:0000987]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006629; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; lipid metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09241,FUN_040029-T1,Peve_00025977,Pocillopora_meandrina_HIv1___RNAseq.g8448.t1,three_way,44.02483333333333,FUN_040029-T1,Q8BZ20,,,,,27.0,711.0,1.1e-55,220.7,sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3,,,,,,
OG_09242,FUN_040031-T1,Peve_00025983,Pocillopora_meandrina_HIv1___RNAseq.g8450.t1,three_way,77.15466666666667,FUN_040031-T1,Q5T1B0,AXDN1_HUMAN,,Axonemal dynein light chain domain-containing protein 1,Homo sapiens (Human),29.0,1055.0,1.3e-109,399.4,sp|Q5T1B0|AXDN1_HUMAN Axonemal dynein light chain domain-containing protein 1 OS=Homo sapiens OX=9606 GN=AXDND1 PE=1 SV=1,GO:0005737; GO:0005829; GO:0005929; GO:0007283; GO:0036064; GO:1905198,manchette assembly [GO:1905198]; spermatogenesis [GO:0007283],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829],,GO:0005815; GO:0005829; GO:0005929; GO:0022414; GO:0043226,microtubule organizing center; cytosol; cilium; reproductive process; organelle
OG_09243,FUN_040032-T1,Peve_00025984,Pocillopora_meandrina_HIv1___RNAseq.g8451.t1,three_way,93.09433333333332,FUN_040032-T1,O18405,,,,,65.8,266.0,9.3e-99,361.7,sp|O18405|SURF4_DROME Surfeit locus protein 4 homolog OS=Drosophila melanogaster OX=7227 GN=Surf4 PE=2 SV=1,,,,,,
OG_09244,FUN_040034-T1,Peve_00025985,Pocillopora_meandrina_HIv1___RNAseq.g8452.t1,three_way,70.306,,,,,,,,,,,,,,,,,
OG_09245,FUN_040035-T1,Peve_00025986,Pocillopora_meandrina_HIv1___RNAseq.g8453.t1,three_way,51.272,FUN_040035-T1,Q8BUH7,RNF26_MOUSE,,E3 ubiquitin-protein ligase RNF26 (EC 2.3.2.27) (RING finger protein 26),Mus musculus (Mouse),35.3,85.0,1.1e-08,62.8,sp|Q8BUH7|RNF26_MOUSE E3 ubiquitin-protein ligase RNF26 OS=Mus musculus OX=10090 GN=Rnf26 PE=2 SV=1,GO:0005789; GO:0007032; GO:0008270; GO:0016567; GO:0032479; GO:0050687; GO:0061630; GO:0070979; GO:1905719,endosome organization [GO:0007032]; negative regulation of defense response to virus [GO:0050687]; protein K11-linked ubiquitination [GO:0070979]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein ubiquitination [GO:0016567]; regulation of type I interferon production [GO:0032479],endoplasmic reticulum membrane [GO:0005789],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09246,FUN_040036-T1,Peve_00040432,Pocillopora_meandrina_HIv1___RNAseq.g8455.t1,three_way,69.15733333333333,,,,,,,,,,,,,,,,,
OG_09247,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09248,FUN_040038-T1,Peve_00040429,Pocillopora_meandrina_HIv1___RNAseq.g8457.t1,three_way,69.05233333333334,FUN_040038-T1,F6VAN0,ATF6A_MOUSE,,Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha],Mus musculus (Mouse),29.6,663.0,4.5e-36,154.5,sp|F6VAN0|ATF6A_MOUSE Cyclic AMP-dependent transcription factor ATF-6 alpha OS=Mus musculus OX=10090 GN=Atf6 PE=1 SV=2,GO:0000139; GO:0000977; GO:0000978; GO:0001228; GO:0001654; GO:0005634; GO:0005783; GO:0005789; GO:0006986; GO:0007601; GO:0010508; GO:0019899; GO:0034976; GO:0042802; GO:0043065; GO:0045944; GO:0046982; GO:0090575; GO:1903893,eye development [GO:0001654]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATF6-mediated unfolded protein response [GO:1903893]; positive regulation of autophagy [GO:0010508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; visual perception [GO:0007601],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0005783; GO:0006355; GO:0043226; GO:0048856; GO:0050877; GO:0140110,DNA binding; nucleus; endoplasmic reticulum; regulation of DNA-templated transcription; organelle; anatomical structure development; nervous system process; transcription regulator activity
OG_09249,FUN_040039-T1,Peve_00040428,Pocillopora_meandrina_HIv1___RNAseq.g8458.t1,three_way,71.936,FUN_040039-T1,Q4R7W3,,,,,46.6,567.0,3.6999999999999997e-121,436.8,sp|Q4R7W3|RGPS2_MACFA Ras-specific guanine nucleotide-releasing factor RalGPS2 OS=Macaca fascicularis OX=9541 GN=RALGPS2 PE=2 SV=1,,,,,,
OG_09250,FUN_040040-T1,Peve_00040427,Pocillopora_meandrina_HIv1___RNAseq.g8459.t1,three_way,75.77216666666668,FUN_040040-T1,Q9BRS2,RIOK1_HUMAN,,Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.1.-) (RIO kinase 1),Homo sapiens (Human),55.6,459.0,1.2e-133,478.4,sp|Q9BRS2|RIOK1_HUMAN Serine/threonine-protein kinase RIO1 OS=Homo sapiens OX=9606 GN=RIOK1 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005654; GO:0005829; GO:0016787; GO:0030490; GO:0030688; GO:0034708; GO:0042274; GO:0046872; GO:0106310; GO:2000234,maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274],"cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome, small subunit precursor [GO:0030688]",ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_09251,FUN_040041-T1,Peve_00040425,Pocillopora_meandrina_HIv1___TS.g20197.t1,three_way,47.19116666666667,,,,,,,,,,,,,,,,,
OG_09252,FUN_040042-T1,Peve_00032519,Pocillopora_meandrina_HIv1___RNAseq.g8461.t1,three_way,62.42433333333334,FUN_040042-T1,Q7ZWG9,SGMR1_DANRE,,Sigma non-opioid intracellular receptor 1 (Sigma 1-type opioid receptor) (Sigma1-receptor) (Sigma1R),Danio rerio (Zebrafish) (Brachydanio rerio),51.8,197.0,2e-60,233.8,sp|Q7ZWG9|SGMR1_DANRE Sigma non-opioid intracellular receptor 1 OS=Danio rerio OX=7955 GN=sigmar1 PE=2 SV=1,GO:0005637; GO:0005640; GO:0005783; GO:0005789; GO:0006869; GO:0009611; GO:0016020; GO:0031410; GO:0036269; GO:0043457; GO:0046548; GO:1905897,lipid transport [GO:0006869]; regulation of cellular respiration [GO:0043457]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to wounding [GO:0009611]; retinal rod cell development [GO:0046548]; swimming behavior [GO:0036269],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear outer membrane [GO:0005640],,GO:0005783; GO:0031410; GO:0043226; GO:0048856,endoplasmic reticulum; cytoplasmic vesicle; organelle; anatomical structure development
OG_09253,FUN_040050-T2,Peve_00011374,Pocillopora_meandrina_HIv1___RNAseq.g7070.t1,three_way,47.5455,FUN_040050-T2,P79100,TRPC4_BOVIN,,Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel 1) (CCE1),Bos taurus (Bovine),29.4,480.0,4e-41,171.4,sp|P79100|TRPC4_BOVIN Short transient receptor potential channel 4 OS=Bos taurus OX=9913 GN=TRPC4 PE=2 SV=2,GO:0005886; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679,calcium ion transmembrane transport [GO:0070588]; regulation of cytosolic calcium ion concentration [GO:0051480],cation channel complex [GO:0034703]; plasma membrane [GO:0005886],"inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_09254,FUN_040053-T1,Peve_00016113,Pocillopora_meandrina_HIv1___RNAseq.g8469.t1,three_way,77.773,,,,,,,,,,,,,,,,,
OG_09255,FUN_040054-T1,Peve_00016114,Pocillopora_meandrina_HIv1___RNAseq.g8468.t1,three_way,76.35666666666667,FUN_040054-T1,O09172,GSH0_MOUSE,,Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit),Mus musculus (Mouse),40.4,275.0,1.6000000000000002e-48,194.5,sp|O09172|GSH0_MOUSE Glutamate--cysteine ligase regulatory subunit OS=Mus musculus OX=10090 GN=Gclm PE=1 SV=1,GO:0004357; GO:0006534; GO:0006536; GO:0006749; GO:0006750; GO:0006979; GO:0007584; GO:0008637; GO:0009410; GO:0014823; GO:0017109; GO:0035226; GO:0035729; GO:0035733; GO:0043524; GO:0044344; GO:0044752; GO:0044877; GO:0051409; GO:0051900; GO:0071333; GO:0071372; GO:0097069; GO:0097746; GO:1990830; GO:2001237,apoptotic mitochondrial changes [GO:0008637]; blood vessel diameter maintenance [GO:0097746]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],glutamate-cysteine ligase complex [GO:0017109],glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein-containing complex binding [GO:0044877],GO:0003013; GO:0003824; GO:0006520; GO:0006575; GO:0006790; GO:0007005; GO:0016874,circulatory system process; catalytic activity; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; mitochondrion organization; ligase activity
OG_09256,FUN_040058-T1,Peve_00018499,Pocillopora_meandrina_HIv1___RNAseq.g7727.t1b,three_way,76.5945,FUN_040058-T1,Q8CFI0,NED4L_MOUSE,,E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (EC 2.3.2.36) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2),Mus musculus (Mouse),47.7,973.0,1.6e-243,844.0,sp|Q8CFI0|NED4L_MOUSE E3 ubiquitin-protein ligase NEDD4-like OS=Mus musculus OX=10090 GN=Nedd4l PE=1 SV=2,GO:0002028; GO:0003085; GO:0005771; GO:0005794; GO:0006511; GO:0006814; GO:0009651; GO:0010765; GO:0010766; GO:0016567; GO:0019871; GO:0030154; GO:0031647; GO:0051649; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252; GO:1902305; GO:2000810,cell differentiation [GO:0030154]; establishment of localization in cell [GO:0051649]; negative regulation of sodium ion transport [GO:0010766]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of sodium ion transport [GO:0010765]; protein ubiquitination [GO:0016567]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein stability [GO:0031647]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; regulation protein catabolic process at postsynapse [GO:0140252]; response to salt stress [GO:0009651]; sodium ion transport [GO:0006814]; ubiquitin-dependent protein catabolic process [GO:0006511],glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; multivesicular body [GO:0005771]; postsynapse [GO:0098794],sodium channel inhibitor activity [GO:0019871]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005768; GO:0005794; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endosome; Golgi apparatus; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09257,FUN_040059-T1,Peve_00014920,Pocillopora_meandrina_HIv1___RNAseq.g7726.t1,three_way,86.54366666666667,FUN_040059-T1,Q99LC5,,,,,71.0,328.0,1.4e-123,444.1,"sp|Q99LC5|ETFA_MOUSE Electron transfer flavoprotein subunit alpha, mitochondrial OS=Mus musculus OX=10090 GN=Etfa PE=1 SV=2",,,,,,
OG_09258,FUN_040060-T1,Peve_00014922,Pocillopora_meandrina_HIv1___TS.g1475.t1,three_way,71.22749999999999,FUN_040060-T1,Q9N4H4,,,,,28.1,512.0,3.5e-49,199.9,sp|Q9N4H4|PARP1_CAEEL Poly [ADP-ribose] polymerase 1 OS=Caenorhabditis elegans OX=6239 GN=parp-1 PE=1 SV=1,,,,,,
OG_09259,FUN_040062-T1,Peve_00033907,Pocillopora_meandrina_HIv1___RNAseq.g7705.t1,three_way,81.21966666666667,FUN_040062-T1,Q2TBW7,SNX2_BOVIN,,Sorting nexin-2,Bos taurus (Bovine),45.7,523.0,5.7e-97,356.3,sp|Q2TBW7|SNX2_BOVIN Sorting nexin-2 OS=Bos taurus OX=9913 GN=SNX2 PE=2 SV=1,GO:0005768; GO:0005829; GO:0006886; GO:0010008; GO:0030027; GO:0030904; GO:0031901; GO:0034498; GO:0035091; GO:0042147; GO:0072673,"early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; retromer complex [GO:0030904],phosphatidylinositol binding [GO:0035091],GO:0005768; GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09260,FUN_040063-T1,Peve_00033906,Pocillopora_meandrina_HIv1___RNAseq.g7704.t1,three_way,56.58866666666667,,,,,,,,,,,,,,,,,
OG_09261,FUN_040065-T1,Peve_00033905,Pocillopora_meandrina_HIv1___RNAseq.g7703.t1,three_way,57.22366666666667,,,,,,,,,,,,,,,,,
OG_09262,FUN_040067-T1,Peve_00033898,Pocillopora_meandrina_HIv1___RNAseq.g7701.t2,three_way,60.609,FUN_040067-T1,A8VU90,ANKL1_MOUSE,,Ankyrin repeat and LEM domain-containing protein 1 (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3),Mus musculus (Mouse),45.4,251.0,4.0999999999999996e-53,210.7,sp|A8VU90|ANKL1_MOUSE Ankyrin repeat and LEM domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankle1 PE=2 SV=1,GO:0004519; GO:0005654; GO:0005829; GO:0006611; GO:0045950; GO:1905453; GO:1905456,negative regulation of mitotic recombination [GO:0045950]; protein export from nucleus [GO:0006611]; regulation of lymphoid progenitor cell differentiation [GO:1905456]; regulation of myeloid progenitor cell differentiation [GO:1905453],cytosol [GO:0005829]; nucleoplasm [GO:0005654],endonuclease activity [GO:0004519],GO:0003824; GO:0005654; GO:0005829; GO:0006886; GO:0006913,catalytic activity; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport
OG_09263,FUN_040068-T1,Peve_00033896,Pocillopora_meandrina_HIv1___RNAseq.g7698.t1,three_way,65.987,FUN_040068-T1,Q68FU5,,,,,58.5,106.0,3.3e-29,129.8,sp|Q68FU5|CI085_RAT Uncharacterized protein C9orf85 homolog OS=Rattus norvegicus OX=10116 PE=1 SV=1,,,,,,
OG_09264,FUN_040069-T2,Peve_00033916,Pocillopora_meandrina_HIv1___TS.g1452.t1,three_way,49.821666666666665,,,,,,,,,,,,,,,,,
OG_09265,FUN_040070-T1,Peve_00033911,Pocillopora_meandrina_HIv1___RNAseq.g7694.t2,three_way,69.4475,FUN_040070-T1,A6H8J1,,,,,38.2,262.0,7.299999999999999e-46,186.0,sp|A6H8J1|PRRCA_XENLA Protein PRRC1-A OS=Xenopus laevis OX=8355 GN=prrc1-a PE=2 SV=1,,,,,,
OG_09266,FUN_040071-T1,Peve_00021006,Pocillopora_meandrina_HIv1___RNAseq.g7693.t1,three_way,74.35883333333334,FUN_040071-T1,P17439,GBA1_MOUSE,,Lysosomal acid glucosylceramidase (Lysosomal acid GCase) (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (Cholesterol glucosyltransferase) (SGTase) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase) (EC 3.2.1.-) (D-glucosyl-N-acylsphingosine glucohydrolase) (Lysosomal cholesterol glycosyltransferase) (Lysosomal galactosylceramidase) (EC 3.2.1.46) (Lysosomal glycosylceramidase),Mus musculus (Mouse),48.2,500.0,5.9999999999999985e-140,499.2,sp|P17439|GBA1_MOUSE Lysosomal acid glucosylceramidase OS=Mus musculus OX=10090 GN=Gba1 PE=1 SV=1,GO:0000423; GO:0004336; GO:0004348; GO:0005102; GO:0005124; GO:0005615; GO:0005764; GO:0005765; GO:0005783; GO:0005794; GO:0005802; GO:0006678; GO:0006680; GO:0006914; GO:0007005; GO:0007040; GO:0007417; GO:0008203; GO:0008340; GO:0008422; GO:0009267; GO:0009268; GO:0014004; GO:0016787; GO:0019882; GO:0019915; GO:0021694; GO:0021859; GO:0022904; GO:0023021; GO:0030259; GO:0031333; GO:0032006; GO:0032436; GO:0032715; GO:0033077; GO:0033574; GO:0042391; GO:0043161; GO:0043202; GO:0043409; GO:0043524; GO:0043627; GO:0046512; GO:0046513; GO:0046527; GO:0048469; GO:0048854; GO:0048872; GO:0050295; GO:0050728; GO:0050877; GO:0050905; GO:0051246; GO:0051248; GO:0051402; GO:0061436; GO:0061518; GO:0061744; GO:0071356; GO:0071425; GO:0071548; GO:0072676; GO:0097066; GO:1901805; GO:1903052; GO:1904457; GO:1905037; GO:1905091; GO:1905146,antigen processing and presentation [GO:0019882]; autophagosome organization [GO:1905037]; autophagy [GO:0006914]; beta-glucoside catabolic process [GO:1901805]; brain morphogenesis [GO:0048854]; cell maturation [GO:0048469]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; central nervous system development [GO:0007417]; ceramide biosynthetic process [GO:0046513]; cerebellar Purkinje cell layer formation [GO:0021694]; cholesterol metabolic process [GO:0008203]; determination of adult lifespan [GO:0008340]; establishment of skin barrier [GO:0061436]; glucosylceramide catabolic process [GO:0006680]; glucosylceramide metabolic process [GO:0006678]; hematopoietic stem cell proliferation [GO:0071425]; homeostasis of number of cells [GO:0048872]; lipid glycosylation [GO:0030259]; lipid storage [GO:0019915]; lymphocyte migration [GO:0072676]; lysosomal protein catabolic process [GO:1905146]; lysosome organization [GO:0007040]; microglia differentiation [GO:0014004]; microglial cell proliferation [GO:0061518]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; motor behavior [GO:0061744]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein-containing complex assembly [GO:0031333]; nervous system process [GO:0050877]; neuromuscular process [GO:0050905]; neuron apoptotic process [GO:0051402]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; positive regulation of type 2 mitophagy [GO:1905091]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; pyramidal neuron differentiation [GO:0021859]; regulation of membrane potential [GO:0042391]; regulation of protein metabolic process [GO:0051246]; regulation of TOR signaling [GO:0032006]; respiratory electron transport chain [GO:0022904]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; sphingosine biosynthetic process [GO:0046512]; T cell differentiation in thymus [GO:0033077]; termination of signal transduction [GO:0023021],endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; trans-Golgi network [GO:0005802],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; steryl-beta-glucosidase activity [GO:0050295],GO:0002376; GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0005794; GO:0006091; GO:0006629; GO:0006914; GO:0007005; GO:0007040; GO:0012501; GO:0016740; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:1901135,immune system process; catalytic activity; extracellular space; lysosome; vacuole; endoplasmic reticulum; Golgi apparatus; generation of precursor metabolites and energy; lipid metabolic process; autophagy; mitochondrion organization; lysosome organization; programmed cell death; transferase activity; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; cell motility; nervous system process; carbohydrate derivative metabolic process
OG_09267,FUN_040072-T1,Peve_00021005,Pocillopora_meandrina_HIv1___RNAseq.g7692.t2,three_way,86.87233333333333,FUN_040072-T1,Q6PB70,,,,,38.3,838.0,5e-155,549.7,sp|Q6PB70|ANO8_MOUSE Anoctamin-8 OS=Mus musculus OX=10090 GN=Ano8 PE=1 SV=3,,,,,,
OG_09268,FUN_040074-T2,Peve_00021004,Pocillopora_meandrina_HIv1___RNAseq.g7691.t1,three_way,66.16066666666667,FUN_040074-T2,Q6DHG8,SKA1_DANRE,,SKA complex subunit 1 (Spindle and kinetochore-associated protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),28.6,196.0,1.6e-16,87.8,sp|Q6DHG8|SKA1_DANRE SKA complex subunit 1 OS=Danio rerio OX=7955 GN=ska1 PE=2 SV=1,GO:0000070; GO:0000278; GO:0000940; GO:0005737; GO:0005876; GO:0007059; GO:0007080; GO:0008017; GO:0031110; GO:0051301; GO:0051315; GO:0072686; GO:0072687,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; regulation of microtubule polymerization or depolymerization [GO:0031110],cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; mitotic spindle [GO:0072686]; outer kinetochore [GO:0000940]; spindle microtubule [GO:0005876],microtubule binding [GO:0008017],GO:0000278; GO:0007059; GO:0008092; GO:0043226,mitotic cell cycle; chromosome segregation; cytoskeletal protein binding; organelle
OG_09269,FUN_040075-T1,Peve_00021003,Pocillopora_meandrina_HIv1___RNAseq.g7690.t1,three_way,38.61383333333333,,,,,,,,,,,,,,,,,
OG_09270,FUN_040076-T1,Peve_00011678,Pocillopora_meandrina_HIv1___RNAseq.g7621.t1,three_way,86.5475,FUN_040076-T1,A0JMA9,,,,,57.6,564.0,2.2e-169,597.0,sp|A0JMA9|KATL2_XENTR Katanin p60 ATPase-containing subunit A-like 2 OS=Xenopus tropicalis OX=8364 GN=katnal2 PE=2 SV=1,,,,,,
OG_09271,FUN_040077-T1,Peve_00011685,Pocillopora_meandrina_HIv1___RNAseq.g7622.t1,three_way,85.2825,FUN_040077-T1,Q5RCK5,,,,,47.2,324.0,4.2e-40,166.8,sp|Q5RCK5|ASB7_PONAB Ankyrin repeat and SOCS box protein 7 OS=Pongo abelii OX=9601 GN=ASB7 PE=2 SV=1,,,,,,
OG_09272,FUN_040078-T1,Peve_00011677,Pocillopora_meandrina_HIv1___TS.g1373.t1,three_way,72.69366666666666,FUN_040078-T1,Q9GZQ6,NPFF1_HUMAN,,Neuropeptide FF receptor 1 (G-protein coupled receptor 147) (RFamide-related peptide receptor OT7T022),Homo sapiens (Human),30.8,331.0,3.7e-34,147.1,sp|Q9GZQ6|NPFF1_HUMAN Neuropeptide FF receptor 1 OS=Homo sapiens OX=9606 GN=NPFFR1 PE=1 SV=1,GO:0004930; GO:0005886; GO:0005929; GO:0007186; GO:0007218; GO:0008188; GO:0032870,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218],cilium [GO:0005929]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188],GO:0005886; GO:0005929; GO:0043226; GO:0060089,plasma membrane; cilium; organelle; molecular transducer activity
OG_09273,FUN_040082-T1,Peve_00041152,Pocillopora_meandrina_HIv1___RNAseq.g7687.t1,three_way,78.7585,FUN_040082-T1,Q8NFF2,NCKX4_HUMAN,,Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4),Homo sapiens (Human),38.9,609.0,2.7e-103,377.5,sp|Q8NFF2|NCKX4_HUMAN Sodium/potassium/calcium exchanger 4 OS=Homo sapiens OX=9606 GN=SLC24A4 PE=1 SV=2,GO:0005262; GO:0005516; GO:0005737; GO:0005886; GO:0006811; GO:0006874; GO:0007602; GO:0007608; GO:0008273; GO:0008277; GO:0009644; GO:0010628; GO:0015293; GO:0016020; GO:0016324; GO:0021630; GO:0031982; GO:0035725; GO:0036368; GO:0042756; GO:0048306; GO:0050849; GO:0050911; GO:0055074; GO:0070166; GO:0070588; GO:0071486; GO:0071805; GO:0086009; GO:0097186; GO:0098703; GO:0120199; GO:1903998; GO:1990034; GO:1990680; GO:1990834,amelogenesis [GO:0097186]; calcium ion export across plasma membrane [GO:1990034]; calcium ion homeostasis [GO:0055074]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to high light intensity [GO:0071486]; cone photoresponse recovery [GO:0036368]; detection of chemical stimulus involved in sensory perception of smell [GO:0050911]; drinking behavior [GO:0042756]; enamel mineralization [GO:0070166]; intracellular calcium ion homeostasis [GO:0006874]; membrane repolarization [GO:0086009]; monoatomic ion transport [GO:0006811]; negative regulation of calcium-mediated signaling [GO:0050849]; olfactory nerve maturation [GO:0021630]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; regulation of eating behavior [GO:1903998]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to high light intensity [GO:0009644]; response to melanocyte-stimulating hormone [GO:1990680]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; cone photoreceptor outer segment [GO:0120199]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vesicle [GO:0031982],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; symporter activity [GO:0015293]",GO:0005215; GO:0005886; GO:0043226; GO:0048856; GO:0050877; GO:0055085,transporter activity; plasma membrane; organelle; anatomical structure development; nervous system process; transmembrane transport
OG_09274,FUN_040084-T1,Peve_00041154,Pocillopora_meandrina_HIv1___RNAseq.g7620.t1,three_way,62.22566666666666,,,,,,,,,,,,,,,,,
OG_09275,FUN_040085-T1,Peve_00041155,Pocillopora_meandrina_HIv1___RNAseq.g7619.t1,three_way,75.82766666666666,FUN_040085-T1,Q96M60,,,,,31.1,437.0,5.7e-50,200.3,sp|Q96M60|F227B_HUMAN Protein FAM227B OS=Homo sapiens OX=9606 GN=FAM227B PE=1 SV=2,,,,,,
OG_09276,FUN_040086-T1,Peve_00043013,Pocillopora_meandrina_HIv1___RNAseq.g7618.t1,three_way,61.819833333333335,FUN_040086-T1,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),26.7,420.0,1.1e-39,166.4,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_09277,FUN_040087-T1,Peve_00043018,Pocillopora_meandrina_HIv1___RNAseq.g7617.t1,three_way,86.96233333333333,FUN_040087-T1,Q2TBV5,,,,,56.7,187.0,3.4e-61,236.1,sp|Q2TBV5|TF2H2_BOVIN General transcription factor IIH subunit 2 OS=Bos taurus OX=9913 GN=GTF2H2 PE=2 SV=1,,,,,,
OG_09278,FUN_040091-T3,Peve_00041161,Pocillopora_meandrina_HIv1___RNAseq.g7616.t1b,three_way,72.00633333333333,FUN_040091-T3,Q7ZYC4,,,,,55.2,696.0,1.8e-216,753.8,sp|Q7ZYC4|ACBG2_XENLA Long-chain-fatty-acid--CoA ligase ACSBG2 OS=Xenopus laevis OX=8355 GN=acsbg2 PE=2 SV=1,,,,,,
OG_09279,FUN_040093-T1,Peve_00043015,Pocillopora_meandrina_HIv1___RNAseq.g7607.t2,three_way,55.234,,,,,,,,,,,,,,,,,
OG_09280,FUN_040095-T1,Peve_00037198,Pocillopora_meandrina_HIv1___RNAseq.g7609.t1,three_way,67.75166666666667,,,,,,,,,,,,,,,,,
OG_09281,FUN_040096-T1,Peve_00037197,Pocillopora_meandrina_HIv1___TS.g1363.t2,three_way,88.01,FUN_040096-T1,Q9CQC8,SPG21_MOUSE,,Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein homolog),Mus musculus (Mouse),66.7,294.0,6.099999999999999e-116,418.7,sp|Q9CQC8|SPG21_MOUSE Maspardin OS=Mus musculus OX=10090 GN=Spg21 PE=1 SV=1,GO:0005829; GO:0007173; GO:0007626; GO:0010467; GO:0030140; GO:0042551; GO:0042609; GO:0048668; GO:0050905; GO:0060173; GO:0070849,collateral sprouting [GO:0048668]; epidermal growth factor receptor signaling pathway [GO:0007173]; gene expression [GO:0010467]; limb development [GO:0060173]; locomotory behavior [GO:0007626]; neuromuscular process [GO:0050905]; neuron maturation [GO:0042551]; response to epidermal growth factor [GO:0070849],cytosol [GO:0005829]; trans-Golgi network transport vesicle [GO:0030140],CD4 receptor binding [GO:0042609],GO:0005829; GO:0031410; GO:0043226; GO:0048856; GO:0050877,cytosol; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process
OG_09282,FUN_040097-T1,Peve_00037195,Pocillopora_meandrina_HIv1___RNAseq.g7573.t1,three_way,68.70466666666667,,,,,,,,,,,,,,,,,
OG_09283,FUN_040102-T1,Peve_00037277,Pocillopora_meandrina_HIv1___RNAseq.g8727.t1,three_way,80.4645,FUN_040102-T1,O02810,PI4KB_BOVIN,,Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67),Bos taurus (Bovine),46.0,496.0,2e-98,361.3,sp|O02810|PI4KB_BOVIN Phosphatidylinositol 4-kinase beta OS=Bos taurus OX=9913 GN=PI4KB PE=1 SV=2,GO:0000139; GO:0004430; GO:0005524; GO:0005737; GO:0005741; GO:0016020; GO:0030867; GO:0046854; GO:0048015; GO:0048839; GO:0071889,inner ear development [GO:0048839]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015],cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; rough endoplasmic reticulum membrane [GO:0030867],1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524],GO:0003824; GO:0006629; GO:0016740; GO:0048856,catalytic activity; lipid metabolic process; transferase activity; anatomical structure development
OG_09284,FUN_040103-T1,Peve_00037278,Pocillopora_meandrina_HIv1___TS.15901_t,three_way,92.47733333333332,FUN_040103-T1,Q5M786,,,,,79.0,324.0,5.5e-22,106.7,sp|Q5M786|WDR5_XENTR WD repeat-containing protein 5 OS=Xenopus tropicalis OX=8364 GN=wdr5 PE=2 SV=1,,,,,,
OG_09285,FUN_040106-T1,Peve_00037279,Pocillopora_meandrina_HIv1___RNAseq.g8725.t1,three_way,92.27733333333332,FUN_040106-T1,Q9R1A8,COP1_MOUSE,,E3 ubiquitin-protein ligase COP1 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (mCOP1) (RING finger and WD repeat domain protein 2) (RING-type E3 ubiquitin transferase RFWD2),Mus musculus (Mouse),62.3,648.0,1.5e-230,800.4,sp|Q9R1A8|COP1_MOUSE E3 ubiquitin-protein ligase COP1 OS=Mus musculus OX=10090 GN=Cop1 PE=1 SV=2,GO:0000139; GO:0008270; GO:0010212; GO:0016567; GO:0016607; GO:0031464; GO:0032436; GO:0043161; GO:0061630,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; response to ionizing radiation [GO:0010212],Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Golgi membrane [GO:0000139]; nuclear speck [GO:0016607],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09286,FUN_040107-T1,Peve_00037281,Pocillopora_meandrina_HIv1___RNAseq.g8724.t1,three_way,86.47783333333334,FUN_040107-T1,Q0VCX2,BIP_BOVIN,,Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein),Bos taurus (Bovine),83.2,637.0,9.8e-294,1010.4,sp|Q0VCX2|BIP_BOVIN Endoplasmic reticulum chaperone BiP OS=Bos taurus OX=9913 GN=HSPA5 PE=2 SV=1,GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005788; GO:0005789; GO:0005793; GO:0005829; GO:0005886; GO:0006983; GO:0008180; GO:0009986; GO:0016020; GO:0016887; GO:0019904; GO:0021589; GO:0021680; GO:0030291; GO:0030335; GO:0030496; GO:0030512; GO:0030968; GO:0031072; GO:0031204; GO:0031333; GO:0031398; GO:0031625; GO:0034663; GO:0035437; GO:0036503; GO:0042026; GO:0042149; GO:0042470; GO:0043022; GO:0043066; GO:0043231; GO:0044183; GO:0051085; GO:0051787; GO:0071353; GO:0140662; GO:1903895; GO:1903898,"cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-4 [GO:0071353]; cerebellar Purkinje cell layer development [GO:0021680]; cerebellum structural organization [GO:0021589]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; ER overload response [GO:0006983]; ERAD pathway [GO:0036503]; maintenance of protein localization in endoplasmic reticulum [GO:0035437]; negative regulation of apoptotic process [GO:0043066]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of cell migration [GO:0030335]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein targeting to membrane, translocation [GO:0031204]; protein refolding [GO:0042026]",cell surface [GO:0009986]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein domain specific binding [GO:0019904]; protein folding chaperone [GO:0044183]; protein serine/threonine kinase inhibitor activity [GO:0030291]; ribosome binding [GO:0043022]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0005886; GO:0006457; GO:0006886; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0044183; GO:0048856; GO:0055085; GO:0098772; GO:0140657,catalytic activity; nucleus; mitochondrion; cytosol; plasma membrane; protein folding; intracellular protein transport; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; protein folding chaperone; anatomical structure development; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_09287,FUN_040113-T1,Peve_00019474,Pocillopora_meandrina_HIv1___RNAseq.15744_t,three_way,66.83666666666666,FUN_040113-T1,O75063,XYLK_HUMAN,,Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase),Homo sapiens (Human),56.3,350.0,6.4e-116,419.1,sp|O75063|XYLK_HUMAN Glycosaminoglycan xylosylkinase OS=Homo sapiens OX=9606 GN=FAM20B PE=1 SV=1,GO:0000139; GO:0005524; GO:0005654; GO:0005794; GO:0016301; GO:0016773; GO:0030166; GO:0046872,proteoglycan biosynthetic process [GO:0030166],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654],"ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]",GO:0003824; GO:0005654; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; nucleoplasm; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_09288,FUN_040114-T1,Peve_00019475,Pocillopora_meandrina_HIv1___RNAseq.g8713.t1,three_way,64.46833333333333,FUN_040114-T1,Q6PFL0,,,,,32.9,298.0,2.6e-34,147.5,sp|Q6PFL0|MED27_DANRE Mediator of RNA polymerase II transcription subunit 27 OS=Danio rerio OX=7955 GN=med27 PE=2 SV=1,,,,,,
OG_09289,FUN_040116-T1,Peve_00043154,Pocillopora_meandrina_HIv1___RNAseq.g8711.t1,three_way,56.97933333333333,FUN_040116-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),35.8,545.0,3.2e-85,317.4,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09290,FUN_040133-T1,Peve_00038121,Pocillopora_meandrina_HIv1___RNAseq.g6681.t1,three_way,79.771,FUN_040133-T1,Q08257,QOR_HUMAN,,Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin),Homo sapiens (Human),59.5,321.0,4.100000000000001e-104,379.4,sp|Q08257|QOR_HUMAN Quinone oxidoreductase OS=Homo sapiens OX=9606 GN=CRYZ PE=1 SV=1,GO:0003730; GO:0003960; GO:0005739; GO:0005829; GO:0007601; GO:0008270; GO:0042178; GO:0042802; GO:0051289; GO:0070062; GO:0070402,protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005739; GO:0005829; GO:0016491; GO:0043226; GO:0050877; GO:0065003,RNA binding; catalytic activity; mitochondrion; cytosol; oxidoreductase activity; organelle; nervous system process; protein-containing complex assembly
OG_09291,FUN_040134-T1,Peve_00038119,Pocillopora_meandrina_HIv1___RNAseq.g6685.t1,three_way,73.86166666666666,FUN_040134-T1,Q6H2Y3,BRS3_MACMU,,Bombesin receptor subtype-3 (BRS-3),Macaca mulatta (Rhesus macaque),26.1,356.0,1.7999999999999997e-24,115.2,sp|Q6H2Y3|BRS3_MACMU Bombesin receptor subtype-3 OS=Macaca mulatta OX=9544 GN=BRS3 PE=2 SV=1,GO:0004946; GO:0005886; GO:0007186; GO:0008188,G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],bombesin receptor activity [GO:0004946]; neuropeptide receptor activity [GO:0008188],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_09292,FUN_040137-T1,Peve_00038117,Pocillopora_meandrina_HIv1___RNAseq.g6687.t1,three_way,85.08683333333333,FUN_040137-T1,Q9DC33,HM20A_MOUSE,,High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein HMGX1) (Inhibitor of BRAF35) (iBRAF),Mus musculus (Mouse),39.6,386.0,2.9e-64,247.7,sp|Q9DC33|HM20A_MOUSE High mobility group protein 20A OS=Mus musculus OX=10090 GN=Hmg20a PE=1 SV=1,GO:0000122; GO:0003677; GO:0005634; GO:0006325; GO:0033234; GO:0042802; GO:0045665,chromatin organization [GO:0006325]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122],nucleus [GO:0005634],DNA binding [GO:0003677]; identical protein binding [GO:0042802],GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0043226,DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; organelle
OG_09293,FUN_040138-T1,Peve_00038115,Pocillopora_meandrina_HIv1___RNAseq.g8515.t1,three_way,76.93733333333334,FUN_040138-T1,Q5NVI9,DNJA1_PONAB,,DnaJ homolog subfamily A member 1,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),56.7,404.0,5.1e-128,459.1,sp|Q5NVI9|DNJA1_PONAB DnaJ homolog subfamily A member 1 OS=Pongo abelii OX=9601 GN=DNAJA1 PE=2 SV=1,GO:0001671; GO:0005524; GO:0005634; GO:0005739; GO:0005783; GO:0006457; GO:0008270; GO:0009408; GO:0016020; GO:0030544; GO:0043065; GO:0043066; GO:0043508; GO:0048471; GO:0051082; GO:0051087; GO:0051223; GO:0070585,negative regulation of apoptotic process [GO:0043066]; negative regulation of JUN kinase activity [GO:0043508]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; Hsp70 protein binding [GO:0030544]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],GO:0005634; GO:0005739; GO:0005783; GO:0006457; GO:0043226; GO:0098772,nucleus; mitochondrion; endoplasmic reticulum; protein folding; organelle; molecular function regulator activity
OG_09294,FUN_040140-T1,Peve_00038114,Pocillopora_meandrina_HIv1___RNAseq.g8514.t1,three_way,65.46633333333334,FUN_040140-T1,Q66LN0,PGES2_BOVIN,,Prostaglandin E synthase 2 (EC 5.3.99.3) (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) [Cleaved into: Prostaglandin E synthase 2 truncated form],Bos taurus (Bovine),47.7,176.0,2.8e-42,173.7,sp|Q66LN0|PGES2_BOVIN Prostaglandin E synthase 2 OS=Bos taurus OX=9913 GN=PTGES2 PE=1 SV=3,GO:0001516; GO:0005739; GO:0005783; GO:0016020; GO:0016829; GO:0020037; GO:0036134; GO:0043295; GO:0050220,prostaglandin biosynthetic process [GO:0001516],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; mitochondrion [GO:0005739],12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; glutathione binding [GO:0043295]; heme binding [GO:0020037]; lyase activity [GO:0016829]; prostaglandin-E synthase activity [GO:0050220],GO:0003824; GO:0005739; GO:0005783; GO:0006629; GO:0016491; GO:0016829; GO:0016853; GO:0043226,catalytic activity; mitochondrion; endoplasmic reticulum; lipid metabolic process; oxidoreductase activity; lyase activity; isomerase activity; organelle
OG_09295,FUN_040146-T1,Peve_00038108,Pocillopora_meandrina_HIv1___RNAseq.g8511.t1,three_way,40.80866666666667,,,,,,,,,,,,,,,,,
OG_09296,FUN_040149-T1,Peve_00036065,Pocillopora_meandrina_HIv1___RNAseq.g8499.t1,three_way,87.29899999999999,FUN_040149-T1,O67802,,,,,30.3,211.0,3.5e-17,90.1,sp|O67802|DLHH_AQUAE Putative carboxymethylenebutenolidase OS=Aquifex aeolicus (strain VF5) OX=224324 GN=aq_1997 PE=3 SV=1,,,,,,
OG_09297,FUN_040150-T1,Peve_00038146,Pocillopora_meandrina_HIv1___TS.g20237.t1,three_way,63.22716666666667,FUN_040150-T1,Q7Z591,AKNA_HUMAN,,Microtubule organization protein AKNA (AT-hook-containing transcription factor),Homo sapiens (Human),27.6,254.0,1.3e-09,67.4,sp|Q7Z591|AKNA_HUMAN Microtubule organization protein AKNA OS=Homo sapiens OX=9606 GN=AKNA PE=1 SV=2,GO:0001650; GO:0001837; GO:0003677; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0005874; GO:0016020; GO:0021849; GO:0043231; GO:0045944; GO:0050727; GO:0060232; GO:0060234,delamination [GO:0060232]; epithelial to mesenchymal transition [GO:0001837]; neuroblast delamination [GO:0060234]; neuroblast division in subventricular zone [GO:0021849]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of inflammatory response [GO:0050727],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleoplasm [GO:0005654],DNA binding [GO:0003677],GO:0003677; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0030154; GO:0043226,DNA binding; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle
OG_09298,FUN_040151-T1,Peve_00038145,Pocillopora_meandrina_HIv1___RNAseq.g8497.t1,three_way,64.9255,FUN_040151-T1,Q4PJX1,,,,,32.3,452.0,6.5e-52,206.5,sp|Q4PJX1|ODR4_MOUSE Protein odr-4 homolog OS=Mus musculus OX=10090 GN=Odr4 PE=1 SV=2,,,,,,
OG_09299,FUN_040152-T1,Peve_00038144,Pocillopora_meandrina_HIv1___RNAseq.g8496.t1,three_way,65.6315,FUN_040152-T1,P17702,,,,,49.2,122.0,2.3e-24,113.2,sp|P17702|RL28_RAT Large ribosomal subunit protein eL28 OS=Rattus norvegicus OX=10116 GN=Rpl28 PE=1 SV=4,,,,,,
OG_09300,FUN_040153-T1,Peve_00038143,Pocillopora_meandrina_HIv1___RNAseq.g8494.t1,three_way,62.255,FUN_040153-T1,B3RNE8,,,,,46.8,248.0,4.1999999999999996e-47,190.7,sp|B3RNE8|ATAT_TRIAD Alpha-tubulin N-acetyltransferase OS=Trichoplax adhaerens OX=10228 GN=TRIADDRAFT_53139 PE=3 SV=1,,,,,,
OG_09301,FUN_040154-T1,Peve_00038141,Pocillopora_meandrina_HIv1___RNAseq.g8495.t1,three_way,69.84266666666667,FUN_040154-T1,Q3UHC7,DAB2P_MOUSE,,Disabled homolog 2-interacting protein (DAB2-interacting protein) (ASK-interacting protein 1) (DOC-2/DAB-2 interactive protein),Mus musculus (Mouse),30.2,1068.0,1.5e-116,422.5,sp|Q3UHC7|DAB2P_MOUSE Disabled homolog 2-interacting protein OS=Mus musculus OX=10090 GN=Dab2ip PE=1 SV=1,GO:0000122; GO:0001525; GO:0005096; GO:0005123; GO:0005737; GO:0005886; GO:0006954; GO:0006986; GO:0008285; GO:0008625; GO:0010596; GO:0010633; GO:0010719; GO:0010976; GO:0016525; GO:0017124; GO:0019901; GO:0021814; GO:0021819; GO:0030139; GO:0030163; GO:0030424; GO:0030425; GO:0030948; GO:0031334; GO:0031434; GO:0031435; GO:0032266; GO:0032809; GO:0033209; GO:0034144; GO:0034260; GO:0035148; GO:0035591; GO:0035924; GO:0036312; GO:0036324; GO:0042177; GO:0042803; GO:0043025; GO:0043065; GO:0043087; GO:0043122; GO:0043123; GO:0043124; GO:0043184; GO:0043254; GO:0043409; GO:0043410; GO:0043539; GO:0043548; GO:0044300; GO:0044301; GO:0044877; GO:0045087; GO:0045732; GO:0045892; GO:0045944; GO:0046330; GO:0048147; GO:0048812; GO:0050679; GO:0050680; GO:0051721; GO:0051726; GO:0051898; GO:0070059; GO:0070273; GO:0070317; GO:0070373; GO:0071222; GO:0071347; GO:0071356; GO:0071889; GO:0090090; GO:0090129; GO:1900006; GO:1900744; GO:1900747; GO:1901800; GO:1990032; GO:1990597; GO:2001224; GO:2001235,angiogenesis [GO:0001525]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cell cycle [GO:0051726]; regulation of GTPase activity [GO:0043087]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein-containing complex assembly [GO:0043254]; response to unfolded protein [GO:0006986]; tube formation [GO:0035148]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886],14-3-3 protein binding [GO:0071889]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184],GO:0002376; GO:0005886; GO:0006355; GO:0006954; GO:0008289; GO:0030163; GO:0031410; GO:0043226; GO:0048870; GO:0060090; GO:0098542; GO:0098772,immune system process; plasma membrane; regulation of DNA-templated transcription; inflammatory response; lipid binding; protein catabolic process; cytoplasmic vesicle; organelle; cell motility; molecular adaptor activity; defense response to other organism; molecular function regulator activity
OG_09302,FUN_040166-T1,Peve_00038137,Pocillopora_meandrina_HIv1___RNAseq.g8483.t1,three_way,54.029,,,,,,,,,,,,,,,,,
OG_09303,FUN_040171-T1,Peve_00038130,Pocillopora_meandrina_HIv1___RNAseq.g7735.t1,three_way,58.53033333333333,FUN_040171-T1,A2RUS2,DEND3_HUMAN,,DENN domain-containing protein 3,Homo sapiens (Human),25.9,1218.0,7.5e-110,401.0,sp|A2RUS2|DEND3_HUMAN DENN domain-containing protein 3 OS=Homo sapiens OX=9606 GN=DENND3 PE=1 SV=2,GO:0005085; GO:0005829; GO:0008333; GO:0030163; GO:0031410; GO:0032483,endosome to lysosome transport [GO:0008333]; protein catabolic process [GO:0030163]; regulation of Rab protein signal transduction [GO:0032483],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0016192; GO:0030163; GO:0031410; GO:0043226; GO:0098772,cytosol; vesicle-mediated transport; protein catabolic process; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09304,FUN_040172-T1,Peve_00038126,Pocillopora_meandrina_HIv1___RNAseq.g7734.t1,three_way,59.11516666666667,FUN_040172-T1,Q6NZ18,,,,,43.9,374.0,1.4e-61,239.2,sp|Q6NZ18|KHDC4_DANRE KH homology domain-containing protein 4 OS=Danio rerio OX=7955 GN=khdc4 PE=2 SV=1,,,,,,
OG_09305,FUN_040173-T1,Peve_00038124,Pocillopora_meandrina_HIv1___RNAseq.g7732.t2,three_way,76.989,FUN_040173-T1,Q9HAD4,,,,,29.1,433.0,1.6e-50,201.8,sp|Q9HAD4|WDR41_HUMAN WD repeat-containing protein 41 OS=Homo sapiens OX=9606 GN=WDR41 PE=1 SV=3,,,,,,
OG_09306,FUN_040203-T1,Peve_00038111,Pocillopora_meandrina_HIv1___TS.g1483.t1,three_way,55.532,,,,,,,,,,,,,,,,,
OG_09307,FUN_040204-T1,Peve_00038097,Pocillopora_meandrina_HIv1___RNAseq.g7737.t1,three_way,73.24666666666667,FUN_040204-T1,Q9CXZ1,NDUS4_MOUSE,,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)",Mus musculus (Mouse),60.4,144.0,4.699999999999999e-43,175.6,"sp|Q9CXZ1|NDUS4_MOUSE NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial OS=Mus musculus OX=10090 GN=Ndufs4 PE=1 SV=3",GO:0003016; GO:0005739; GO:0005743; GO:0006099; GO:0006954; GO:0007420; GO:0007601; GO:0007605; GO:0007628; GO:0008137; GO:0009060; GO:0014876; GO:0022904; GO:0030534; GO:0032981; GO:0036343; GO:0042417; GO:0042776; GO:0045087; GO:0045271; GO:0048666; GO:0050890; GO:0051402; GO:0051881; GO:0071453; GO:0072593,adult behavior [GO:0030534]; adult walking behavior [GO:0007628]; aerobic respiration [GO:0009060]; brain development [GO:0007420]; cellular response to oxygen levels [GO:0071453]; cognition [GO:0050890]; dopamine metabolic process [GO:0042417]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; psychomotor behavior [GO:0036343]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881]; respiratory electron transport chain [GO:0022904]; respiratory system process [GO:0003016]; response to injury involved in regulation of muscle adaptation [GO:0014876]; sensory perception of sound [GO:0007605]; tricarboxylic acid cycle [GO:0006099]; visual perception [GO:0007601],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex I [GO:0045271],NADH dehydrogenase (ubiquinone) activity [GO:0008137],GO:0002376; GO:0003016; GO:0005215; GO:0005739; GO:0006091; GO:0006954; GO:0012501; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:0065003; GO:0098542; GO:1901135,immune system process; respiratory system process; transporter activity; mitochondrion; generation of precursor metabolites and energy; inflammatory response; programmed cell death; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; protein-containing complex assembly; defense response to other organism; carbohydrate derivative metabolic process
OG_09308,FUN_040205-T1,Peve_00038142,Pocillopora_meandrina_HIv1___RNAseq.g7738.t1,three_way,81.12466666666667,FUN_040205-T1,Q8AXU9,,,,,51.1,356.0,5.9e-88,325.9,sp|Q8AXU9|SH3G3_CHICK Endophilin-A3 OS=Gallus gallus OX=9031 GN=SH3GL3 PE=1 SV=1,,,,,,
OG_09309,FUN_040206-T1,Peve_00038134,Pocillopora_meandrina_HIv1___RNAseq.g7739.t1,three_way,73.89966666666666,FUN_040206-T1,Q5EA19,,,,,50.3,181.0,5.1e-47,189.1,sp|Q5EA19|ARL15_BOVIN ADP-ribosylation factor-like protein 15 OS=Bos taurus OX=9913 GN=ARL15 PE=2 SV=1,,,,,,
OG_09310,FUN_040209-T1,Peve_00038127,Pocillopora_meandrina_HIv1___RNAseq.g7741.t1b,three_way,71.60266666666666,FUN_040209-T1,Q70E20,,,,,53.0,251.0,2.2e-72,275.8,"sp|Q70E20|SNED1_MOUSE Sushi, nidogen and EGF-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Sned1 PE=2 SV=2",,,,,,
OG_09311,FUN_040215-T1,Peve_00023450,Pocillopora_meandrina_HIv1___RNAseq.g7755.t1,three_way,55.80383333333333,FUN_040215-T1,Q6DRL5,MBB1A_DANRE,,Myb-binding protein 1A-like protein,Danio rerio (Zebrafish) (Brachydanio rerio),36.2,519.0,9.5e-36,153.3,sp|Q6DRL5|MBB1A_DANRE Myb-binding protein 1A-like protein OS=Danio rerio OX=7955 GN=mybbp1a PE=1 SV=1,GO:0003714; GO:0005730; GO:0043565; GO:0048511,rhythmic process [GO:0048511],nucleolus [GO:0005730],sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714],GO:0003677; GO:0005730; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleolus; organelle; molecular adaptor activity; transcription regulator activity
OG_09312,FUN_040217-T1,Peve_00023451,Pocillopora_meandrina_HIv1___RNAseq.g7756.t1,three_way,77.917,FUN_040217-T1,H2FLJ1,,,,,69.5,302.0,1.4e-88,328.2,sp|H2FLJ1|STML1_CAEEL Stomatin-like protein stl-1 OS=Caenorhabditis elegans OX=6239 GN=stl-1 PE=2 SV=1,,,,,,
OG_09313,FUN_040220-T1,Peve_00023452,Pocillopora_meandrina_HIv1___RNAseq.g7757.t1,three_way,57.968833333333336,FUN_040220-T1,Q64264,5HT1A_MOUSE,,5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (Serotonin receptor 1A),Mus musculus (Mouse),23.7,396.0,4.7e-13,77.4,sp|Q64264|5HT1A_MOUSE 5-hydroxytryptamine receptor 1A OS=Mus musculus OX=10090 GN=Htr1a PE=2 SV=2,GO:0001586; GO:0001662; GO:0004993; GO:0005886; GO:0007198; GO:0007210; GO:0007214; GO:0014062; GO:0019229; GO:0030425; GO:0035640; GO:0042053; GO:0042428; GO:0046883; GO:0050795; GO:0090722; GO:0099589,adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; behavioral fear response [GO:0001662]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of behavior [GO:0050795]; regulation of dopamine metabolic process [GO:0042053]; regulation of hormone secretion [GO:0046883]; regulation of serotonin secretion [GO:0014062]; regulation of vasoconstriction [GO:0019229]; serotonin metabolic process [GO:0042428]; serotonin receptor signaling pathway [GO:0007210],dendrite [GO:0030425]; plasma membrane [GO:0005886],G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; receptor-receptor interaction [GO:0090722]; serotonin receptor activity [GO:0099589],GO:0003013; GO:0005886; GO:0023052; GO:0060089,circulatory system process; plasma membrane; signaling; molecular transducer activity
OG_09314,FUN_040221-T1,Peve_00023453,Pocillopora_meandrina_HIv1___RNAseq.g7758.t1,three_way,81.74016666666667,,,,,,,,,,,,,,,,,
OG_09315,FUN_040222-T1,Peve_00023454,Pocillopora_meandrina_HIv1___RNAseq.g7759.t1,three_way,64.82433333333333,FUN_040222-T1,Q7TN31,AGGF1_MOUSE,,Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (mVG5Q),Mus musculus (Mouse),45.0,300.0,1.7e-60,235.3,sp|Q7TN31|AGGF1_MOUSE Angiogenic factor with G patch and FHA domains 1 OS=Mus musculus OX=10090 GN=Aggf1 PE=2 SV=1,GO:0001525; GO:0001938; GO:0003676; GO:0005576; GO:0005737; GO:0007155; GO:0030154; GO:0042802; GO:0045766; GO:0048471,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471],identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676],GO:0005576; GO:0007155; GO:0030154,extracellular region; cell adhesion; cell differentiation
OG_09316,FUN_040223-T1,Peve_00010288,Pocillopora_meandrina_HIv1___RNAseq.g7763.t1,three_way,89.218,FUN_040223-T1,P85007,,,,,68.3,82.0,2.6e-23,109.0,sp|P85007|IR3IP_RAT Immediate early response 3-interacting protein 1 OS=Rattus norvegicus OX=10116 GN=Ier3ip1 PE=3 SV=1,,,,,,
OG_09317,FUN_040226-T1,Peve_00010289,Pocillopora_meandrina_HIv1___RNAseq.g7764.t1,three_way,44.96533333333333,,,,,,,,,,,,,,,,,
OG_09318,FUN_040230-T1,Peve_00013005,Pocillopora_meandrina_HIv1___RNAseq.g7765.t1,three_way,66.33933333333333,FUN_040230-T1,Q9CYC6,DCP2_MOUSE,,m7GpppN-mRNA hydrolase (EC 3.6.1.62) (mRNA-decapping enzyme 2),Mus musculus (Mouse),49.6,137.0,2.2e-37,157.9,sp|Q9CYC6|DCP2_MOUSE m7GpppN-mRNA hydrolase OS=Mus musculus OX=10090 GN=Dcp2 PE=1 SV=2,GO:0000184; GO:0000290; GO:0000932; GO:0004534; GO:0005654; GO:0006402; GO:0016442; GO:0030054; GO:0030145; GO:0032211; GO:0043488; GO:0070034; GO:0071044; GO:0140933; GO:1904872,"deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; histone mRNA catabolic process [GO:0071044]; mRNA catabolic process [GO:0006402]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]",cell junction [GO:0030054]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RISC complex [GO:0016442],5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity [GO:0140933]; 5'-3' RNA exonuclease activity [GO:0004534]; manganese ion binding [GO:0030145]; telomerase RNA binding [GO:0070034],GO:0003723; GO:0003824; GO:0005654; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_09319,FUN_040232-T1,Peve_00013006,Pocillopora_meandrina_HIv1___RNAseq.g7766.t1,three_way,61.32533333333333,FUN_040232-T1,Q9JJI6,,,,,35.0,1137.0,2.2000000000000007e-149,531.6,"sp|Q9JJI6|PIGO_MOUSE GPI ethanolamine phosphate transferase 3, catalytic subunit OS=Mus musculus OX=10090 GN=Pigo PE=1 SV=2",,,,,,
OG_09320,FUN_040234-T1,Peve_00042156,Pocillopora_meandrina_HIv1___RNAseq.g7774.t1,three_way,43.47166666666666,,,,,,,,,,,,,,,,,
OG_09321,FUN_040235-T1,Peve_00021816,Pocillopora_meandrina_HIv1___RNAseq.g7786.t1,three_way,79.80866666666667,FUN_040235-T1,A7S4N4,,,,,48.4,432.0,6.5e-100,365.9,sp|A7S4N4|SERIC_NEMVE Probable serine incorporator OS=Nematostella vectensis OX=45351 GN=serinc PE=3 SV=1,,,,,,
OG_09322,FUN_040238-T1,Peve_00021820,Pocillopora_meandrina_HIv1___RNAseq.g7784.t1,three_way,85.20433333333332,FUN_040238-T1,Q5ZIG3,,,,,44.6,332.0,5.1e-77,289.7,sp|Q5ZIG3|S2546_CHICK Mitochondrial outer membrane protein SLC25A46 OS=Gallus gallus OX=9031 GN=SLC25A46 PE=2 SV=1,,,,,,
OG_09323,FUN_040239-T1,Peve_00018574,Pocillopora_meandrina_HIv1___RNAseq.g7783.t2,three_way,78.91716666666666,FUN_040239-T1,Q8NEV4,MYO3A_HUMAN,,Myosin-IIIa (EC 2.7.11.1),Homo sapiens (Human),43.7,812.0,1.4e-169,598.6,sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2,GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310,cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003774; GO:0003824; GO:0008092; GO:0016740; GO:0016787; GO:0016853; GO:0050877; GO:0140096; GO:0140657,"cytoskeletal motor activity; catalytic activity; cytoskeletal protein binding; transferase activity; hydrolase activity; isomerase activity; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_09324,FUN_040241-T1,Peve_00018573,Pocillopora_meandrina_HIv1___RNAseq.g7782.t1,three_way,95.93533333333332,FUN_040241-T1,Q7ZVZ7,,,,,75.6,287.0,3.9e-138,492.3,sp|Q7ZVZ7|AB17C_DANRE Alpha/beta hydrolase domain-containing protein 17C OS=Danio rerio OX=7955 GN=abhd17c PE=2 SV=1,,,,,,
OG_09325,FUN_040242-T2,Peve_00018572,Pocillopora_meandrina_HIv1___RNAseq.g7781.t1,three_way,83.071,FUN_040242-T2,Q5ZK21,,,,,46.6,506.0,5.4e-119,429.5,sp|Q5ZK21|INT14_CHICK Integrator complex subunit 14 OS=Gallus gallus OX=9031 GN=INTS14 PE=2 SV=1,,,,,,
OG_09326,FUN_040243-T1,Peve_00018570,Pocillopora_meandrina_HIv1___RNAseq.g7780.t1,three_way,87.146,FUN_040243-T1,P49419,AL7A1_HUMAN,,Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase),Homo sapiens (Human),70.7,508.0,2.5e-223,776.2,sp|P49419|AL7A1_HUMAN Alpha-aminoadipic semialdehyde dehydrogenase OS=Homo sapiens OX=9606 GN=ALDH7A1 PE=1 SV=5,GO:0004029; GO:0004043; GO:0005634; GO:0005739; GO:0005759; GO:0005829; GO:0006081; GO:0007605; GO:0008802; GO:0019285; GO:0042426; GO:0042802; GO:0070062,aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; sensory perception of sound [GO:0007605],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase (NAD+) activity [GO:0008802]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006575; GO:0016491; GO:0043226; GO:0050877,catalytic activity; nucleus; mitochondrion; cytosol; modified amino acid metabolic process; oxidoreductase activity; organelle; nervous system process
OG_09327,FUN_040244-T1,Peve_00018569,Pocillopora_meandrina_HIv1___RNAseq.g7779.t1,three_way,90.07933333333334,FUN_040244-T1,P00637,,,,,64.3,328.0,5.4e-123,442.2,"sp|P00637|F16P1_RABIT Fructose-1,6-bisphosphatase 1 OS=Oryctolagus cuniculus OX=9986 GN=FBP1 PE=1 SV=4",,,,,,
OG_09328,FUN_040260-T1,Peve_00029136,Pocillopora_meandrina_HIv1___RNAseq.g7787.t1,three_way,84.27333333333333,FUN_040260-T1,Q5VZE5,NAA35_HUMAN,,"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein homolog) (Protein MAK10 homolog)",Homo sapiens (Human),51.8,706.0,1.6e-188,661.0,"sp|Q5VZE5|NAA35_HUMAN N-alpha-acetyltransferase 35, NatC auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA35 PE=1 SV=1",GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0031417; GO:0043066; GO:0048659,negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659],cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],,GO:0005654; GO:0005829; GO:0005886,nucleoplasm; cytosol; plasma membrane
OG_09329,FUN_040263-T1,Peve_00029137,Pocillopora_meandrina_HIv1___RNAseq.g7788.t1,three_way,72.762,,,,,,,,,,,,,,,,,
OG_09330,FUN_040266-T1,Peve_00007660,Pocillopora_meandrina_HIv1___RNAseq.g6541.t1,three_way,71.622,FUN_040266-T1,O54784,DAPK3_MOUSE,,Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (ZIP-kinase),Mus musculus (Mouse),56.0,273.0,9.1e-84,311.6,sp|O54784|DAPK3_MOUSE Death-associated protein kinase 3 OS=Mus musculus OX=10090 GN=Dapk3 PE=1 SV=1,GO:0000775; GO:0004674; GO:0005524; GO:0005634; GO:0005813; GO:0005819; GO:0005829; GO:0005929; GO:0006325; GO:0006468; GO:0007346; GO:0008360; GO:0016301; GO:0016605; GO:0017148; GO:0030335; GO:0030496; GO:0031267; GO:0035556; GO:0042803; GO:0043065; GO:0043519; GO:0043522; GO:0046777; GO:0051893; GO:0071346; GO:0090263; GO:0097190; GO:0106310,apoptotic signaling pathway [GO:0097190]; cellular response to type II interferon [GO:0071346]; chromatin organization [GO:0006325]; intracellular signal transduction [GO:0035556]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; regulation of focal adhesion assembly [GO:0051893]; regulation of mitotic cell cycle [GO:0007346]; regulation of myosin II filament organization [GO:0043519],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cilium [GO:0005929]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; PML body [GO:0016605]; spindle [GO:0005819]",ATP binding [GO:0005524]; kinase activity [GO:0016301]; leucine zipper domain binding [GO:0043522]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; small GTPase binding [GO:0031267],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0006325; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; cilium; chromatin organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09331,FUN_040267-T1,Peve_00014979,Pocillopora_meandrina_HIv1___RNAseq.g7811.t1,three_way,61.712,FUN_040267-T1,Q5M824,SHC1_RAT,,SHC-transforming protein 1 (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1),Rattus norvegicus (Rat),35.5,541.0,3.7e-73,277.3,sp|Q5M824|SHC1_RAT SHC-transforming protein 1 OS=Rattus norvegicus OX=10116 GN=Shc1 PE=1 SV=1,GO:0001525; GO:0001666; GO:0001784; GO:0005068; GO:0005154; GO:0005158; GO:0005159; GO:0005168; GO:0005829; GO:0005886; GO:0005925; GO:0006940; GO:0007173; GO:0007507; GO:0008284; GO:0008286; GO:0010008; GO:0030036; GO:0030182; GO:0030971; GO:0031100; GO:0031175; GO:0032868; GO:0032869; GO:0035094; GO:0035556; GO:0042127; GO:0042742; GO:0043066; GO:0043410; GO:0044877; GO:0045892; GO:0045893; GO:0045907; GO:0046875; GO:0048009; GO:0048408; GO:0048661; GO:0051219; GO:0051384; GO:0051721; GO:0070301; GO:0070374; GO:0070435; GO:0071363; GO:0097237; GO:0098609; GO:1904628; GO:1990839,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cell-cell adhesion [GO:0098609]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to insulin stimulus [GO:0032869]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to toxic substance [GO:0097237]; defense response to bacterium [GO:0042742]; epidermal growth factor receptor signaling pathway [GO:0007173]; heart development [GO:0007507]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vasoconstriction [GO:0045907]; regulation of cell population proliferation [GO:0042127]; regulation of smooth muscle contraction [GO:0006940]; response to endothelin [GO:1990839]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nicotine [GO:0035094],cytosol [GO:0005829]; endosome membrane [GO:0010008]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435],ephrin receptor binding [GO:0046875]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],GO:0003013; GO:0005829; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0030154; GO:0048856; GO:0060090,circulatory system process; cytosol; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; cell differentiation; anatomical structure development; molecular adaptor activity
OG_09332,FUN_040271-T1,Peve_00014976,Pocillopora_meandrina_HIv1___RNAseq.g7810.t1,three_way,81.51333333333334,FUN_040271-T1,P36776,LONM_HUMAN,,"Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)",Homo sapiens (Human),65.2,838.0,0.0,1104.0,"sp|P36776|LONM_HUMAN Lon protease homolog, mitochondrial OS=Homo sapiens OX=9606 GN=LONP1 PE=1 SV=2",GO:0000002; GO:0001666; GO:0003697; GO:0003727; GO:0004176; GO:0004252; GO:0005524; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006515; GO:0007005; GO:0009725; GO:0010044; GO:0016020; GO:0016887; GO:0030163; GO:0032042; GO:0034599; GO:0035694; GO:0042645; GO:0042731; GO:0042802; GO:0043531; GO:0043560; GO:0043565; GO:0046627; GO:0051131; GO:0051603; GO:0051880; GO:0070182; GO:0070407,cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]; negative regulation of insulin receptor signaling pathway [GO:0046627]; oxidation-dependent protein catabolic process [GO:0070407]; protein catabolic process [GO:0030163]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; PH domain binding [GO:0042731]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727],GO:0003677; GO:0003723; GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0007005; GO:0016787; GO:0030163; GO:0043226; GO:0065003; GO:0140096; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleoplasm; mitochondrion; cytosol; mitochondrion organization; hydrolase activity; protein catabolic process; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; ATP-dependent activity"
OG_09333,FUN_040272-T1,Peve_00014975,Pocillopora_meandrina_HIv1___RNAseq.g7809.t1,three_way,79.45949999999999,FUN_040272-T1,Q13247,SRSF6_HUMAN,,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",Homo sapiens (Human),42.9,184.0,5e-38,159.8,sp|Q13247|SRSF6_HUMAN Serine/arginine-rich splicing factor 6 OS=Homo sapiens OX=9606 GN=SRSF6 PE=1 SV=2,GO:0000380; GO:0000381; GO:0000398; GO:0003723; GO:0005654; GO:0006376; GO:0010837; GO:0016607; GO:0032868; GO:0036002; GO:0045617; GO:0048025; GO:0060501; GO:0061041; GO:2000675,"alternative mRNA splicing, via spliceosome [GO:0000380]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of type B pancreatic cell apoptotic process [GO:2000675]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of keratinocyte proliferation [GO:0010837]; regulation of wound healing [GO:0061041]; response to insulin [GO:0032868]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_09334,FUN_040273-T1,Peve_00014971,Pocillopora_meandrina_HIv1___RNAseq.g9069.t1,three_way,63.76,FUN_040273-T1,Q3ZBH3,,,,,27.7,242.0,9e-19,95.5,sp|Q3ZBH3|CD151_BOVIN CD151 antigen OS=Bos taurus OX=9913 GN=CD151 PE=2 SV=1,,,,,,
OG_09335,FUN_040284-T1,Peve_00038643,Pocillopora_meandrina_HIv1___RNAseq.g9071.t1,three_way,80.21133333333333,FUN_040284-T1,Q8IUZ0,,,,,50.3,620.0,8.7e-68,260.0,sp|Q8IUZ0|LRC49_HUMAN Leucine-rich repeat-containing protein 49 OS=Homo sapiens OX=9606 GN=LRRC49 PE=1 SV=2,,,,,,
OG_09336,FUN_040299-T1,Peve_00038649,Pocillopora_meandrina_HIv1___TS.g20792.t1,three_way,42.627833333333335,FUN_040299-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),24.5,4769.0,0.0,1096.6,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_09337,FUN_040300-T1,Peve_00038648,Pocillopora_meandrina_HIv1___RNAseq.g9074.t1,three_way,74.62133333333334,,,,,,,,,,,,,,,,,
OG_09338,FUN_040301-T1,Peve_00038647,Pocillopora_meandrina_HIv1___RNAseq.g9075.t1,three_way,65.522,FUN_040301-T1,Q80T21,ATL4_MOUSE,,ADAMTS-like protein 4 (ADAMTSL-4) (Thrombospondin repeat-containing protein 1),Mus musculus (Mouse),33.5,731.0,7.7e-109,396.4,sp|Q80T21|ATL4_MOUSE ADAMTS-like protein 4 OS=Mus musculus OX=10090 GN=Adamtsl4 PE=2 SV=1,GO:0002020; GO:0002064; GO:0005576; GO:0005614; GO:0006915; GO:0030198; GO:0031012; GO:0043065; GO:0070285,apoptotic process [GO:0006915]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; pigment cell development [GO:0070285]; positive regulation of apoptotic process [GO:0043065],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614],protease binding [GO:0002020],GO:0005576; GO:0012501; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; programmed cell death; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09339,FUN_040302-T1,Peve_00038640,Pocillopora_meandrina_HIv1___TS.g20795.t2,three_way,55.475,,,,,,,,,,,,,,,,,
OG_09340,FUN_040305-T1,Peve_00020534,Pocillopora_meandrina_HIv1___RNAseq.g9077.t1,three_way,49.45333333333333,FUN_040305-T1,P52954,LBX1_HUMAN,,Transcription factor LBX1 (Ladybird homeobox protein homolog 1),Homo sapiens (Human),46.8,62.0,3.4e-08,60.1,sp|P52954|LBX1_HUMAN Transcription factor LBX1 OS=Homo sapiens OX=9606 GN=LBX1 PE=1 SV=2,GO:0000785; GO:0000981; GO:0001947; GO:0005634; GO:0005667; GO:0006357; GO:0007517; GO:0008283; GO:0008285; GO:0009653; GO:0021522; GO:0048664; GO:0120007; GO:1905962; GO:1990837,anatomical structure morphogenesis [GO:0009653]; cell population proliferation [GO:0008283]; glutamatergic neuron differentiation [GO:1905962]; heart looping [GO:0001947]; muscle organ development [GO:0007517]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of glutamatergic neuron differentiation [GO:0120007]; neuron fate determination [GO:0048664]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron differentiation [GO:0021522],chromatin [GO:0000785]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09341,FUN_040306-T1,Peve_00020535,Pocillopora_meandrina_HIv1___RNAseq.g9079.t1,three_way,53.34833333333333,FUN_040306-T1,Q8BH48,UBAP1_MOUSE,,Ubiquitin-associated protein 1 (UBAP-1),Mus musculus (Mouse),28.2,202.0,2.4e-08,62.0,sp|Q8BH48|UBAP1_MOUSE Ubiquitin-associated protein 1 OS=Mus musculus OX=10090 GN=Ubap1 PE=1 SV=1,GO:0000813; GO:0005829; GO:0005886; GO:0015031; GO:0043130; GO:0043162,protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; plasma membrane [GO:0005886],ubiquitin binding [GO:0043130],GO:0005829; GO:0005886,cytosol; plasma membrane
OG_09342,FUN_040307-T1,Peve_00020536,Pocillopora_meandrina_HIv1___RNAseq.g9080.t1,three_way,67.85483333333333,FUN_040307-T1,Q9NVE4,,,,,22.6,783.0,2.2e-23,112.8,sp|Q9NVE4|CCD87_HUMAN Coiled-coil domain-containing protein 87 OS=Homo sapiens OX=9606 GN=CCDC87 PE=1 SV=2,,,,,,
OG_09343,FUN_040322-T1,Peve_00027395,Pocillopora_meandrina_HIv1___RNAseq.g13815.t1,three_way,45.257,FUN_040322-T1,A0JPE1,,,,,24.4,373.0,5.2e-25,117.1,sp|A0JPE1|DIK1B_XENTR Divergent protein kinase domain 1B OS=Xenopus tropicalis OX=8364 GN=dipk1b PE=2 SV=1,,,,,,
OG_09344,FUN_040326-T1,Peve_00025747,Pocillopora_meandrina_HIv1___TS.g20801.t1a,three_way,54.72883333333333,FUN_040326-T1,P08478,,,,,40.1,696.0,3.6000000000000002e-146,520.8,sp|P08478|AMDA_XENLA Peptidyl-glycine alpha-amidating monooxygenase A OS=Xenopus laevis OX=8355 GN=pam-a PE=1 SV=3,,,,,,
OG_09345,FUN_040328-T1,Peve_00025748,Pocillopora_meandrina_HIv1___RNAseq.g9085.t1,three_way,73.42633333333333,,,,,,,,,,,,,,,,,
OG_09346,FUN_040329-T1,Peve_00014960,Pocillopora_meandrina_HIv1___TS.g20804.t1,three_way,59.10066666666667,FUN_040329-T1,Q96JI7,SPTCS_HUMAN,,Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein),Homo sapiens (Human),27.8,1418.0,1.1e-133,480.3,sp|Q96JI7|SPTCS_HUMAN Spatacsin OS=Homo sapiens OX=9606 GN=SPG11 PE=1 SV=3,GO:0005730; GO:0005737; GO:0005765; GO:0005783; GO:0005829; GO:0005886; GO:0006606; GO:0007040; GO:0007268; GO:0007409; GO:0007528; GO:0007613; GO:0008088; GO:0019901; GO:0021957; GO:0030163; GO:0030424; GO:0030425; GO:0031410; GO:0033344; GO:0045202; GO:0047496; GO:0048489; GO:0048675; GO:0048741; GO:0051668; GO:0061744; GO:0090389; GO:0090659; GO:0097049; GO:1905037; GO:2001256,autophagosome organization [GO:1905037]; axo-dendritic transport [GO:0008088]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; chemical synaptic transmission [GO:0007268]; cholesterol efflux [GO:0033344]; corticospinal tract morphogenesis [GO:0021957]; localization within membrane [GO:0051668]; lysosome organization [GO:0007040]; memory [GO:0007613]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; neuromuscular junction development [GO:0007528]; phagosome-lysosome fusion involved in apoptotic cell clearance [GO:0090389]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; regulation of store-operated calcium entry [GO:2001256]; skeletal muscle fiber development [GO:0048741]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; walking behavior [GO:0090659],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; lysosomal membrane [GO:0005765]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; synapse [GO:0045202],protein kinase binding [GO:0019901],GO:0005730; GO:0005783; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0007018; GO:0007040; GO:0012501; GO:0023052; GO:0030163; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0061024,nucleolus; endoplasmic reticulum; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; microtubule-based movement; lysosome organization; programmed cell death; signaling; protein catabolic process; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process; membrane organization
OG_09347,FUN_040402-T1,Peve_00014984,Pocillopora_meandrina_HIv1___RNAseq.g6531.t1,three_way,64.912,FUN_040402-T1,P19137,LAMA1_MOUSE,,Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha),Mus musculus (Mouse),22.5,3355.0,9.5e-78,295.0,sp|P19137|LAMA1_MOUSE Laminin subunit alpha-1 OS=Mus musculus OX=10090 GN=Lama1 PE=1 SV=2,GO:0002011; GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005608; GO:0005615; GO:0005911; GO:0006468; GO:0007155; GO:0007166; GO:0009888; GO:0016020; GO:0030334; GO:0031012; GO:0031175; GO:0043208; GO:0043256; GO:0045198; GO:0045785; GO:0045995; GO:0051149; GO:0060041; GO:0060441; GO:0060445; GO:0061304; GO:0062023; GO:0098637; GO:0110011; GO:2001046,branching involved in salivary gland morphogenesis [GO:0060445]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein phosphorylation [GO:0006468]; regulation of basement membrane organization [GO:0110011]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retina development in camera-type eye [GO:0060041]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888],basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin complex [GO:0043256]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]; protein complex involved in cell-matrix adhesion [GO:0098637],extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; signaling receptor binding [GO:0005102],GO:0005198; GO:0005576; GO:0005615; GO:0007155; GO:0007163; GO:0008289; GO:0030154; GO:0030312; GO:0031012; GO:0048856,structural molecule activity; extracellular region; extracellular space; cell adhesion; establishment or maintenance of cell polarity; lipid binding; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09348,FUN_040403-T1,Peve_00014974,Pocillopora_meandrina_HIv1___RNAseq.g9090.t1,three_way,76.05033333333334,FUN_040403-T1,A7SGF0,,,,,62.4,133.0,2.3999999999999998e-39,163.3,sp|A7SGF0|BORC8_NEMVE BLOC-1-related complex subunit 8 homolog OS=Nematostella vectensis OX=45351 GN=v1g233178 PE=3 SV=1,,,,,,
OG_09349,FUN_040406-T1,Peve_00012177,Pocillopora_meandrina_HIv1___RNAseq.g10345.t1,three_way,54.08983333333333,FUN_040406-T1,Q8IUK5,,,,,36.4,382.0,1.3e-52,208.8,sp|Q8IUK5|PLDX1_HUMAN Plexin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PLXDC1 PE=1 SV=2,,,,,,
OG_09350,FUN_040421-T1,Peve_00014973,Pocillopora_meandrina_HIv1___RNAseq.g9088.t2,three_way,72.28966666666666,FUN_040421-T1,Q8K2V6,,,,,45.0,398.0,6.799999999999999e-96,352.4,sp|Q8K2V6|IPO11_MOUSE Importin-11 OS=Mus musculus OX=10090 GN=Ipo11 PE=1 SV=1,,,,,,
OG_09351,FUN_040422-T1,Peve_00014972,Pocillopora_meandrina_HIv1___RNAseq.g9087.t1,three_way,49.143,,,,,,,,,,,,,,,,,
OG_09352,FUN_040423-T1,Peve_00004008,Pocillopora_meandrina_HIv1___RNAseq.g6507.t1,three_way,77.71566666666666,FUN_040423-T1,Q96LP2,,,,,27.0,337.0,2.6e-27,124.4,sp|Q96LP2|FA81B_HUMAN Protein FAM81B OS=Homo sapiens OX=9606 GN=FAM81B PE=1 SV=4,,,,,,
OG_09353,FUN_040424-T1,Peve_00004009,Pocillopora_meandrina_HIv1___RNAseq.g6508.t1,three_way,80.8135,FUN_040424-T1,Q13367,,,,,64.1,1065.0,1.8e-297,1023.5,sp|Q13367|AP3B2_HUMAN AP-3 complex subunit beta-2 OS=Homo sapiens OX=9606 GN=AP3B2 PE=1 SV=2,,,,,,
OG_09354,FUN_040425-T1,Peve_00004010,Pocillopora_meandrina_HIv1___RNAseq.g6509.t1,three_way,76.108,,,,,,,,,,,,,,,,,
OG_09355,FUN_040426-T1,Peve_00004011,Pocillopora_meandrina_HIv1___RNAseq.g6510.t1,three_way,61.7445,FUN_040426-T1,A6QQM4,,,,,30.2,341.0,5.8e-25,117.1,sp|A6QQM4|ZN474_BOVIN Zinc finger protein 474 OS=Bos taurus OX=9913 GN=ZNF474 PE=2 SV=1,,,,,,
OG_09356,FUN_040442-T1,Peve_00004014,Pocillopora_meandrina_HIv1___RNAseq.g6514.t1,three_way,66.56633333333333,FUN_040442-T1,Q14318,,,,,43.3,319.0,1.5999999999999999e-62,241.9,sp|Q14318|FKBP8_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP8 OS=Homo sapiens OX=9606 GN=FKBP8 PE=1 SV=2,,,,,,
OG_09357,FUN_040443-T1,Peve_00004016,Pocillopora_meandrina_HIv1___RNAseq.g6517.t1,three_way,78.62,FUN_040443-T1,Q8BUY9,,,,,58.1,344.0,1.7e-114,414.1,sp|Q8BUY9|PGTB1_MOUSE Geranylgeranyl transferase type-1 subunit beta OS=Mus musculus OX=10090 GN=Pggt1b PE=1 SV=1,,,,,,
OG_09358,FUN_040444-T1,Peve_00004018,Pocillopora_meandrina_HIv1___RNAseq.g6519.t1,three_way,96.19533333333334,FUN_040444-T1,P80021,,,,,82.6,552.0,6.3e-254,877.9,"sp|P80021|ATPA_PIG ATP synthase F(1) complex subunit alpha, mitochondrial OS=Sus scrofa OX=9823 GN=ATP5F1A PE=1 SV=2",,,,,,
OG_09359,FUN_040445-T1,Peve_00004020,Pocillopora_meandrina_HIv1___RNAseq.g6520.t1,three_way,58.768,,,,,,,,,,,,,,,,,
OG_09360,FUN_040464-T1,Peve_00031480,Pocillopora_meandrina_HIv1___RNAseq.g24771.t1,three_way,53.88366666666667,,,,,,,,,,,,,,,,,
OG_09361,FUN_040473-T1,Peve_00004019,Pocillopora_meandrina_HIv1___TS.g256.t1,three_way,67.65716666666667,FUN_040473-T1,Q68ED7,CRTC1_MOUSE,,CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1 homolog) (Transducer of regulated cAMP response element-binding protein 1) (TORC-1) (Transducer of CREB protein 1),Mus musculus (Mouse),36.4,132.0,1.2e-08,62.4,sp|Q68ED7|CRTC1_MOUSE CREB-regulated transcription coactivator 1 OS=Mus musculus OX=10090 GN=Crtc1 PE=1 SV=1,GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0007613; GO:0008140; GO:0016604; GO:0032793; GO:0043153; GO:0045944; GO:0048511; GO:0051289; GO:0097009; GO:1902631,energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886],cAMP response element binding protein binding [GO:0008140],GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0043226; GO:0050877; GO:0065003,nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; organelle; nervous system process; protein-containing complex assembly
OG_09362,FUN_040477-T1,Peve_00015410,Pocillopora_meandrina_HIv1___RNAseq.g6522.t1,three_way,73.125,FUN_040477-T1,Q3UHD6,SNX27_MOUSE,,Sorting nexin-27,Mus musculus (Mouse),49.7,503.0,5.2e-142,506.1,sp|Q3UHD6|SNX27_MOUSE Sorting nexin-27 OS=Mus musculus OX=10090 GN=Snx27 PE=1 SV=2,GO:0001772; GO:0005768; GO:0005769; GO:0005829; GO:0006886; GO:0007165; GO:0008333; GO:0016197; GO:0030904; GO:0031901; GO:0032266; GO:0032456; GO:0071203; GO:0090128; GO:0098685; GO:0098794; GO:0098837; GO:0098842; GO:0098978; GO:0099072,endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165],cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; postsynapse [GO:0098794]; postsynaptic early endosome [GO:0098842]; postsynaptic recycling endosome [GO:0098837]; retromer complex [GO:0030904]; Schaffer collateral - CA1 synapse [GO:0098685]; WASH complex [GO:0071203],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0005768; GO:0005829; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09363,FUN_040478-T1,Peve_00015419,Pocillopora_meandrina_HIv1___RNAseq.g6523.t1,three_way,71.109,FUN_040478-T1,Q6VAB6,KSR2_HUMAN,,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),Homo sapiens (Human),36.8,277.0,4.1e-47,191.0,sp|Q6VAB6|KSR2_HUMAN Kinase suppressor of Ras 2 OS=Homo sapiens OX=9606 GN=KSR2 PE=1 SV=2,GO:0004672; GO:0004674; GO:0005078; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007265; GO:0008270; GO:0019722; GO:0031434; GO:0043410; GO:0106310; GO:0120162,calcium-mediated signaling [GO:0019722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; Ras protein signal transduction [GO:0007265],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0060090; GO:0140096,"catalytic activity; cytosol; plasma membrane; transferase activity; molecular adaptor activity; catalytic activity, acting on a protein"
OG_09364,FUN_040479-T1,Peve_00015393,Pocillopora_meandrina_HIv1___RNAseq.g6524.t1,three_way,54.452,,,,,,,,,,,,,,,,,
OG_09365,FUN_040489-T1,Peve_00015394,Pocillopora_meandrina_HIv1___TS.g260.t2,three_way,90.586,FUN_040489-T1,Q8C5T8,,,,,41.3,363.0,5.6e-57,223.0,sp|Q8C5T8|CF263_MOUSE Cilia- and flagella-associated protein 263 OS=Mus musculus OX=10090 GN=Cfap263 PE=2 SV=1,,,,,,
OG_09366,FUN_040490-T1,Peve_00015395,Pocillopora_meandrina_HIv1___RNAseq.g6526.t1,three_way,97.22233333333334,FUN_040490-T1,Q3ZC10,SMD1_BOVIN,,Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (snRNP core protein D1),Bos taurus (Bovine),92.7,82.0,4e-36,152.1,sp|Q3ZC10|SMD1_BOVIN Small nuclear ribonucleoprotein Sm D1 OS=Bos taurus OX=9913 GN=SNRPD1 PE=3 SV=1,GO:0000243; GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005682; GO:0005684; GO:0005685; GO:0005686; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071011; GO:0071013; GO:0097526,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]",catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; SMN-Sm protein complex [GO:0034719]; spliceosomal tri-snRNP complex [GO:0097526]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_09367,FUN_040491-T1,Peve_00015396,Pocillopora_meandrina_HIv1___RNAseq.g6527.t1,three_way,80.93116666666667,FUN_040491-T1,P29120,NEC1_HUMAN,,Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Prohormone convertase 1) (Proprotein convertase 1) (PC1),Homo sapiens (Human),56.1,601.0,2.5e-198,693.7,sp|P29120|NEC1_HUMAN Neuroendocrine convertase 1 OS=Homo sapiens OX=9606 GN=PCSK1 PE=1 SV=2,GO:0004252; GO:0005615; GO:0006508; GO:0007267; GO:0016020; GO:0016486; GO:0030070; GO:0030133; GO:0034774; GO:0042802; GO:0043005; GO:0043043,cell-cell signaling [GO:0007267]; insulin processing [GO:0030070]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; proteolysis [GO:0006508],extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133],identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005615; GO:0016787; GO:0023052; GO:0031410; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; signaling; cytoplasmic vesicle; organelle; protein maturation; catalytic activity, acting on a protein"
OG_09368,FUN_040492-T1,Peve_00015397,Pocillopora_meandrina_HIv1___RNAseq.g6528.t1b,three_way,84.31433333333334,FUN_040492-T1,Q5ZLF4,ZNT5_CHICK,,Proton-coupled zinc antiporter SLC30A5 (Solute carrier family 30 member 5) (Zinc transporter 5) (ZnT-5),Gallus gallus (Chicken),53.0,760.0,1.5e-181,637.9,sp|Q5ZLF4|ZNT5_CHICK Proton-coupled zinc antiporter SLC30A5 OS=Gallus gallus OX=9031 GN=SLC30A5 PE=2 SV=1,GO:0000139; GO:0005385; GO:0005789; GO:0005794; GO:0006506; GO:0006882; GO:0012507; GO:0030667; GO:0031410; GO:0032588; GO:0046872; GO:0062111; GO:0140826; GO:1904257; GO:1990674,GPI anchor biosynthetic process [GO:0006506]; intracellular zinc ion homeostasis [GO:0006882]; zinc ion import into Golgi lumen [GO:1904257]; zinc ion import into organelle [GO:0062111],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi cis cisterna membrane [GO:1990674]; Golgi membrane [GO:0000139]; secretory granule membrane [GO:0030667]; trans-Golgi network membrane [GO:0032588],metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826],GO:0005215; GO:0005794; GO:0006629; GO:0031410; GO:0043226; GO:0055085; GO:1901135,transporter activity; Golgi apparatus; lipid metabolic process; cytoplasmic vesicle; organelle; transmembrane transport; carbohydrate derivative metabolic process
OG_09369,FUN_040493-T1,Peve_00015398,Pocillopora_meandrina_HIv1___RNAseq.g6529.t1,three_way,81.2965,FUN_040493-T1,Q69ZF3,GBA2_MOUSE,,Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Bile acid beta-glucosidase GBA2) (Bile acid glucosyl transferase GBA2) (Cholesterol glucosyltransferase GBA2) (EC 2.4.1.-) (Cholesteryl-beta-glucosidase GBA2) (EC 3.2.1.-) (Glucosylceramidase 2) (Non-lysosomal cholesterol glycosyltransferase) (Non-lysosomal galactosylceramidase) (EC 3.2.1.46) (Non-lysosomal glycosylceramidase),Mus musculus (Mouse),52.7,827.0,2.4e-249,863.2,sp|Q69ZF3|GBA2_MOUSE Non-lysosomal glucosylceramidase OS=Mus musculus OX=10090 GN=Gba2 PE=1 SV=2,GO:0000139; GO:0004336; GO:0004348; GO:0005789; GO:0005829; GO:0005975; GO:0006680; GO:0008203; GO:0008422; GO:0016139; GO:0021954; GO:0030259; GO:0030833; GO:0031113; GO:0046527; GO:0050295; GO:0097035,carbohydrate metabolic process [GO:0005975]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; glucosylceramide catabolic process [GO:0006680]; glycoside catabolic process [GO:0016139]; lipid glycosylation [GO:0030259]; regulation of actin filament polymerization [GO:0030833]; regulation of membrane lipid distribution [GO:0097035]; regulation of microtubule polymerization [GO:0031113],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; glucosyltransferase activity [GO:0046527]; steryl-beta-glucosidase activity [GO:0050295],GO:0003824; GO:0005829; GO:0005975; GO:0006629; GO:0016740; GO:0016787; GO:0048856; GO:0061024; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; lipid metabolic process; transferase activity; hydrolase activity; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_09370,FUN_040494-T1,Peve_00015399,Pocillopora_meandrina_HIv1___RNAseq.g6530.t1c,three_way,67.13566666666667,FUN_040494-T1,Q9D2E1,TSSK3_MOUSE,,Testis-specific serine/threonine-protein kinase 3 (TSK-3) (TSSK-3) (Testis-specific kinase 3) (EC 2.7.11.1) (Serine/threonine-protein kinase 22C),Mus musculus (Mouse),48.7,224.0,4.2e-56,219.9,sp|Q9D2E1|TSSK3_MOUSE Testis-specific serine/threonine-protein kinase 3 OS=Mus musculus OX=10090 GN=Tssk3 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0006468; GO:0007283; GO:0007286; GO:0030145; GO:0035556; GO:0036126; GO:0048240; GO:0106310,intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; sperm capacitation [GO:0048240]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283],sperm flagellum [GO:0036126],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005929; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cilium; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09371,FUN_040525-T2,Peve_00024707,Pocillopora_meandrina_HIv1___RNAseq.g1445.t1,three_way,77.679,,,,,,,,,,,,,,,,,
OG_09372,FUN_040547-T1,Peve_00015401,Pocillopora_meandrina_HIv1___RNAseq.g6506.t1,three_way,82.78766666666667,FUN_040547-T1,P46940,IQGA1_HUMAN,,Ras GTPase-activating-like protein IQGAP1 (p195),Homo sapiens (Human),54.6,1653.0,0.0,1496.9,sp|P46940|IQGA1_HUMAN Ras GTPase-activating-like protein IQGAP1 OS=Homo sapiens OX=9606 GN=IQGAP1 PE=1 SV=1,GO:0001726; GO:0001817; GO:0005078; GO:0005095; GO:0005096; GO:0005509; GO:0005516; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005874; GO:0005884; GO:0005886; GO:0005925; GO:0005938; GO:0007165; GO:0007173; GO:0007346; GO:0008543; GO:0009898; GO:0010761; GO:0016323; GO:0016324; GO:0016328; GO:0016477; GO:0019901; GO:0019903; GO:0019904; GO:0030424; GO:0030426; GO:0030496; GO:0030667; GO:0030864; GO:0031267; GO:0035305; GO:0036057; GO:0036120; GO:0036464; GO:0043005; GO:0043410; GO:0043539; GO:0044548; GO:0045296; GO:0048008; GO:0051015; GO:0060090; GO:0070062; GO:0070836; GO:0071277; GO:0071364; GO:0072015; GO:1903479; GO:1990138; GO:1990904,caveola assembly [GO:0070836]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast migration [GO:0010761]; mitotic actomyosin contractile ring assembly actin filament organization [GO:1903479]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; positive regulation of MAPK cascade [GO:0043410]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; signal transduction [GO:0007165],actin filament [GO:0005884]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057],"actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; MAP-kinase scaffold activity [GO:0005078]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]",GO:0005634; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0008289; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0061024; GO:0098772,nucleus; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; lipid binding; organelle; anatomical structure development; cell motility; molecular adaptor activity; membrane organization; molecular function regulator activity
OG_09373,FUN_040548-T1,Peve_00015402,Pocillopora_meandrina_HIv1___RNAseq.g6505.t1,three_way,73.82566666666666,FUN_040548-T1,Q9H267,,,,,45.4,579.0,5.8e-143,509.2,sp|Q9H267|VP33B_HUMAN Vacuolar protein sorting-associated protein 33B OS=Homo sapiens OX=9606 GN=VPS33B PE=1 SV=2,,,,,,
OG_09374,FUN_040549-T1,Peve_00015403,Pocillopora_meandrina_HIv1___RNAseq.g6504.t1,three_way,72.52266666666667,FUN_040549-T1,Q2TBV6,CC124_BOVIN,,Coiled-coil domain-containing protein 124,Bos taurus (Bovine),70.7,75.0,3.7e-24,113.2,sp|Q2TBV6|CC124_BOVIN Coiled-coil domain-containing protein 124 OS=Bos taurus OX=9913 GN=CCDC124 PE=2 SV=1,GO:0003713; GO:0005634; GO:0005737; GO:0005813; GO:0006366; GO:0030496; GO:0051301,cell division [GO:0051301]; transcription by RNA polymerase II [GO:0006366],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; nucleus [GO:0005634],transcription coactivator activity [GO:0003713],GO:0005634; GO:0005815; GO:0006351; GO:0043226; GO:0060090; GO:0140110,nucleus; microtubule organizing center; DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_09375,FUN_040550-T1,Peve_00015404,Pocillopora_meandrina_HIv1___RNAseq.g6474.t1,three_way,68.12883333333333,FUN_040550-T1,A7RSH7,,,,,47.5,139.0,4.399999999999999e-24,113.2,sp|A7RSH7|EIF3J_NEMVE Eukaryotic translation initiation factor 3 subunit J OS=Nematostella vectensis OX=45351 GN=v1g240395 PE=3 SV=1,,,,,,
OG_09376,FUN_040563-T1,Peve_00037644,Pocillopora_meandrina_HIv1___TS.g14456.t1,three_way,58.42783333333333,,,,,,,,,,,,,,,,,
OG_09377,FUN_040610-T1,Peve_00015406,Pocillopora_meandrina_HIv1___TS.g215.t1,three_way,55.4595,,,,,,,,,,,,,,,,,
OG_09378,FUN_040611-T1,Peve_00015408,Pocillopora_meandrina_HIv1___RNAseq.g6473.t1,three_way,53.87766666666667,FUN_040611-T1,B4F785,EGFLA_RAT,,"Pikachurin (EGF-like, fibronectin type-III and laminin G-like domain-containing protein)",Rattus norvegicus (Rat),24.3,370.0,3.7e-15,85.5,sp|B4F785|EGFLA_RAT Pikachurin OS=Rattus norvegicus OX=10116 GN=Egflam PE=2 SV=1,GO:0005509; GO:0005539; GO:0005604; GO:0005614; GO:0009986; GO:0010811; GO:0030198; GO:0031012; GO:0042995; GO:0043083; GO:0048786; GO:0098684,extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811],basement membrane [GO:0005604]; cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular matrix [GO:0031012]; interstitial matrix [GO:0005614]; photoreceptor ribbon synapse [GO:0098684]; presynaptic active zone [GO:0048786]; synaptic cleft [GO:0043083],calcium ion binding [GO:0005509]; glycosaminoglycan binding [GO:0005539],GO:0005576; GO:0030198; GO:0030312; GO:0031012,extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_09379,FUN_040615-T1,Peve_00015411,Pocillopora_meandrina_HIv1___RNAseq.g6470.t1,three_way,87.62333333333333,FUN_040615-T1,E9PV86,,,,,44.3,711.0,1.7e-153,544.7,sp|E9PV86|MCTP1_MOUSE Multiple C2 and transmembrane domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mctp1 PE=1 SV=1,,,,,,
OG_09380,FUN_040663-T1,Peve_00015413,Pocillopora_meandrina_HIv1___RNAseq.g6468.t1,three_way,48.03816666666667,,,,,,,,,,,,,,,,,
OG_09381,FUN_040666-T1,Peve_00015414,Pocillopora_meandrina_HIv1___RNAseq.g6466.t1,three_way,64.68233333333333,,,,,,,,,,,,,,,,,
OG_09382,FUN_040668-T1,Peve_00015417,Pocillopora_meandrina_HIv1___RNAseq.g6463.t1,three_way,49.15766666666666,,,,,,,,,,,,,,,,,
OG_09383,FUN_040672-T1,Peve_00015418,Pocillopora_meandrina_HIv1___RNAseq.g6459.t1,three_way,56.578833333333336,,,,,,,,,,,,,,,,,
OG_09384,FUN_040673-T1,Peve_00015420,Pocillopora_meandrina_HIv1___RNAseq.g6458.t1,three_way,49.12566666666667,,,,,,,,,,,,,,,,,
OG_09385,FUN_040674-T1,Peve_00015421,Pocillopora_meandrina_HIv1___RNAseq.g6457.t1,three_way,43.42233333333333,,,,,,,,,,,,,,,,,
OG_09386,FUN_040676-T1,Peve_00009590,Pocillopora_meandrina_HIv1___RNAseq.g6455.t1,three_way,80.988,FUN_040676-T1,Q9Y3Y4,,,,,62.9,70.0,4.0000000000000004e-23,109.4,sp|Q9Y3Y4|PYGO1_HUMAN Pygopus homolog 1 OS=Homo sapiens OX=9606 GN=PYGO1 PE=1 SV=2,,,,,,
OG_09387,FUN_040680-T1,Peve_00009589,Pocillopora_meandrina_HIv1___RNAseq.g6447.t1,three_way,74.92949999999999,FUN_040680-T1,Q13972,RGRF1_HUMAN,,Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25),Homo sapiens (Human),40.1,1471.0,1.8e-260,901.0,sp|Q13972|RGRF1_HUMAN Ras-specific guanine nucleotide-releasing factor 1 OS=Homo sapiens OX=9606 GN=RASGRF1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0030426; GO:0031175; GO:0034976; GO:0035022; GO:0035254; GO:0043005; GO:0043409; GO:0043410; GO:0044342; GO:0046578; GO:0046579; GO:0048167; GO:0048168,long-term memory [GO:0007616]; negative regulation of MAPK cascade [GO:0043409]; neuron projection development [GO:0031175]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of Ras protein signal transduction [GO:0046578]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0050877; GO:0098772,cytosol; plasma membrane; nervous system process; molecular function regulator activity
OG_09388,FUN_040683-T1,Peve_00009586,Pocillopora_meandrina_HIv1___RNAseq.g6449.t1,three_way,70.731,FUN_040683-T1,P47708,RP3A_MOUSE,,Rabphilin-3A (Exophilin-1),Mus musculus (Mouse),25.4,287.0,6.7e-18,93.2,sp|P47708|RP3A_MOUSE Rabphilin-3A OS=Mus musculus OX=10090 GN=Rph3a PE=1 SV=2,GO:0005509; GO:0005544; GO:0005546; GO:0006886; GO:0008270; GO:0008430; GO:0016082; GO:0019898; GO:0030141; GO:0030672; GO:0031267; GO:0032991; GO:0042301; GO:0043005; GO:0043197; GO:0044877; GO:0045202; GO:0045211; GO:0061669; GO:0070679,intracellular protein transport [GO:0006886]; spontaneous neurotransmitter secretion [GO:0061669]; synaptic vesicle priming [GO:0016082],dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],"calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0006886; GO:0008289; GO:0031410; GO:0043226; GO:0065003,intracellular protein transport; lipid binding; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_09389,FUN_040685-T1,Peve_00007653,Pocillopora_meandrina_HIv1___RNAseq.g6451.t2,three_way,64.74666666666667,FUN_040685-T1,Q7ZXZ2,,,,,41.9,492.0,1.2e-116,421.8,sp|Q7ZXZ2|UTP15_XENLA U3 small nucleolar RNA-associated protein 15 homolog OS=Xenopus laevis OX=8355 GN=utp15 PE=2 SV=1,,,,,,
OG_09390,FUN_040686-T1,Peve_00007674,Pocillopora_meandrina_HIv1___RNAseq.g6452.t1,three_way,90.56466666666668,FUN_040686-T1,G1U0Q2,,,,,80.8,146.0,1.8e-62,240.0,sp|G1U0Q2|RS15_RABIT Small ribosomal subunit protein uS19 OS=Oryctolagus cuniculus OX=9986 GN=RPS15 PE=1 SV=1,,,,,,
OG_09391,FUN_040687-T1,Peve_00042976,Pocillopora_meandrina_HIv1___RNAseq.g6440.t2,three_way,44.80716666666667,FUN_040687-T1,Q8AVX1,,,,,26.1,299.0,2.6e-09,64.7,sp|Q8AVX1|GKP1B_XENLA G kinase-anchoring protein 1-B OS=Xenopus laevis OX=8355 GN=gkap1-b PE=2 SV=1,,,,,,
OG_09392,FUN_040688-T1,Peve_00033378,Pocillopora_meandrina_HIv1___RNAseq.g6441.t1,three_way,70.6605,FUN_040688-T1,Q9DBN9,DDX59_MOUSE,,Probable ATP-dependent RNA helicase DDX59 (EC 3.6.4.13) (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5),Mus musculus (Mouse),45.4,654.0,5.9e-150,532.7,sp|Q9DBN9|DDX59_MOUSE Probable ATP-dependent RNA helicase DDX59 OS=Mus musculus OX=10090 GN=Ddx59 PE=1 SV=1,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0008270; GO:0016887,,cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_09393,FUN_040690-T1,Peve_00025667,Pocillopora_meandrina_HIv1___RNAseq.g27964.t1b,three_way,74.64766666666667,FUN_040690-T1,A4IFB6,,,,,44.1,737.0,4.4e-154,546.6,sp|A4IFB6|CNO10_BOVIN CCR4-NOT transcription complex subunit 10 OS=Bos taurus OX=9913 GN=CNOT10 PE=2 SV=1,,,,,,
OG_09394,FUN_040692-T1,Peve_00042946,Pocillopora_meandrina_HIv1___RNAseq.g6443.t2,three_way,69.873,FUN_040692-T1,Q9QZM0,,,,,54.4,630.0,4.9e-60,233.8,sp|Q9QZM0|UBQL2_MOUSE Ubiquilin-2 OS=Mus musculus OX=10090 GN=Ubqln2 PE=1 SV=2,,,,,,
OG_09395,FUN_040693-T1,Peve_00042935,Pocillopora_meandrina_HIv1___RNAseq.g6444.t1,three_way,73.92966666666666,FUN_040693-T1,Q9Y6G5,COMDA_HUMAN,,COMM domain-containing protein 10,Homo sapiens (Human),57.4,197.0,6.3e-55,215.3,sp|Q9Y6G5|COMDA_HUMAN COMM domain-containing protein 10 OS=Homo sapiens OX=9606 GN=COMMD10 PE=1 SV=1,GO:0005654; GO:0005737,,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654],,GO:0005654,nucleoplasm
OG_09396,FUN_040694-T1,Peve_00029582,Pocillopora_meandrina_HIv1___TS.g20808.t2,three_way,54.065333333333335,FUN_040694-T1,Q24322,SEM1A_DROME,,Semaphorin-1A (Semaphorin-I) (Sema I),Drosophila melanogaster (Fruit fly),31.1,550.0,8.8e-52,206.8,sp|Q24322|SEM1A_DROME Semaphorin-1A OS=Drosophila melanogaster OX=7227 GN=Sema1a PE=1 SV=3,GO:0005886; GO:0007411; GO:0007416; GO:0008039; GO:0008045; GO:0008201; GO:0016020; GO:0016199; GO:0030215; GO:0030335; GO:0045499; GO:0045792; GO:0048813; GO:0050919; GO:0071526; GO:0072499,axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; dendrite morphogenesis [GO:0048813]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of cell size [GO:0045792]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]; synapse assembly [GO:0007416]; synaptic target recognition [GO:0008039],membrane [GO:0016020]; plasma membrane [GO:0005886],chemorepellent activity [GO:0045499]; heparin binding [GO:0008201]; semaphorin receptor binding [GO:0030215],GO:0005886; GO:0034330; GO:0048018; GO:0098772,plasma membrane; cell junction organization; receptor ligand activity; molecular function regulator activity
OG_09397,FUN_040695-T1,Peve_00029579,Pocillopora_meandrina_HIv1___RNAseq.g9092.t1,three_way,83.89,FUN_040695-T1,Q5RF04,,,,,63.8,160.0,1.5999999999999996e-53,210.3,sp|Q5RF04|RLP24_PONAB Probable ribosome biogenesis protein RLP24 OS=Pongo abelii OX=9601 GN=RSL24D1 PE=2 SV=1,,,,,,
OG_09398,FUN_040712-T1,Peve_00002271,Pocillopora_meandrina_HIv1___RNAseq.g6565.t2,three_way,80.74266666666666,FUN_040712-T1,Q6NVR1,,,,,43.1,102.0,3.8e-12,72.4,sp|Q6NVR1|ENSA_XENTR Alpha-endosulfine OS=Xenopus tropicalis OX=8364 GN=ensa PE=2 SV=1,,,,,,
OG_09399,FUN_040713-T1,Peve_00002272,Pocillopora_meandrina_HIv1___TS.g280.t1,three_way,81.17566666666667,FUN_040713-T1,Q9Z2E1,,,,,43.9,255.0,6.899999999999999e-49,195.7,sp|Q9Z2E1|MBD2_MOUSE Methyl-CpG-binding domain protein 2 OS=Mus musculus OX=10090 GN=Mbd2 PE=1 SV=2,,,,,,
OG_09400,FUN_040714-T1,Peve_00002273,Pocillopora_meandrina_HIv1___RNAseq.g6550.t1,three_way,90.7025,FUN_040714-T1,A1L3F4,,,,,49.5,552.0,8.6e-96,352.4,sp|A1L3F4|MEX3B_XENLA RNA-binding protein MEX3B OS=Xenopus laevis OX=8355 GN=mex3b PE=2 SV=1,,,,,,
OG_09401,FUN_040716-T1,Peve_00002274,Pocillopora_meandrina_HIv1___RNAseq.g6551.t1,three_way,71.84733333333334,FUN_040716-T1,Q9Z160,,,,,34.9,590.0,2.3e-95,351.3,sp|Q9Z160|COG1_MOUSE Conserved oligomeric Golgi complex subunit 1 OS=Mus musculus OX=10090 GN=Cog1 PE=1 SV=3,,,,,,
OG_09402,FUN_040717-T1,Peve_00002276,Pocillopora_meandrina_HIv1___RNAseq.g6552.t1,three_way,45.09733333333333,,,,,,,,,,,,,,,,,
OG_09403,FUN_040783-T1,Peve_00042929,Pocillopora_meandrina_HIv1___RNAseq.4208_tb,three_way,87.373,FUN_040783-T1,Q04467,IDHP_BOVIN,,"Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)",Bos taurus (Bovine),67.1,423.0,6.3e-167,588.6,"sp|Q04467|IDHP_BOVIN Isocitrate dehydrogenase [NADP], mitochondrial OS=Bos taurus OX=9913 GN=IDH2 PE=1 SV=2",GO:0000287; GO:0004450; GO:0005739; GO:0005743; GO:0005777; GO:0005829; GO:0006097; GO:0006099; GO:0006102; GO:0006103; GO:0006739; GO:0051287,2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; NADP metabolic process [GO:0006739]; tricarboxylic acid cycle [GO:0006099],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777],isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0005975; GO:0016491; GO:0043226; GO:0055086,catalytic activity; mitochondrion; peroxisome; cytosol; carbohydrate metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_09404,FUN_040784-T1,Peve_00042932,Pocillopora_meandrina_HIv1___RNAseq.g17859.t1,three_way,80.83433333333333,FUN_040784-T1,Q9LMI7,,,,,34.0,664.0,2.5e-87,324.7,"sp|Q9LMI7|ACO32_ARATH Putative acyl-coenzyme A oxidase 3.2, peroxisomal OS=Arabidopsis thaliana OX=3702 GN=ACX3.2 PE=3 SV=1",,,,,,
OG_09405,FUN_040854-T1,Peve_00007658,Pocillopora_meandrina_HIv1___RNAseq.g6539.t1,three_way,73.32966666666667,FUN_040854-T1,P82911,,,,,45.1,142.0,2.5e-26,120.2,sp|P82911|RT11_BOVIN Small ribosomal subunit protein uS11m OS=Bos taurus OX=9913 GN=MRPS11 PE=1 SV=2,,,,,,
OG_09406,FUN_040856-T2,Peve_00032788,Pocillopora_meandrina_HIv1___RNAseq.g6544.t1,three_way,56.886,,,,,,,,,,,,,,,,,
OG_09407,FUN_040857-T1,Peve_00002299,Pocillopora_meandrina_HIv1___RNAseq.4208_ta,three_way,65.18433333333333,FUN_040857-T1,Q6NRK9,,,,,43.9,223.0,2.5999999999999997e-47,190.3,sp|Q6NRK9|CCNQ_XENLA Cyclin-Q OS=Xenopus laevis OX=8355 GN=ccnq PE=2 SV=2,,,,,,
OG_09408,FUN_040860-T1,Peve_00002267,Pocillopora_meandrina_HIv1___RNAseq.g6567.t1,three_way,58.133,FUN_040860-T1,C0HBB2,,,,,26.4,363.0,4e-21,104.0,sp|C0HBB2|GLMP_SALSA Glycosylated lysosomal membrane protein OS=Salmo salar OX=8030 GN=glmp PE=2 SV=1,,,,,,
OG_09409,FUN_040861-T1,Peve_00002298,Pocillopora_meandrina_HIv1___RNAseq.g6554.t1,three_way,84.35516666666666,FUN_040861-T1,Q5RE70,,,,,41.1,995.0,2.5e-211,737.3,sp|Q5RE70|INT3_PONAB Integrator complex subunit 3 OS=Pongo abelii OX=9601 GN=INTS3 PE=2 SV=1,,,,,,
OG_09410,FUN_040878-T1,Peve_00002288,Pocillopora_meandrina_HIv1___RNAseq.g6534.t1,three_way,77.77733333333333,FUN_040878-T1,A0A250YGJ5,SIR6_CASCN,,NAD-dependent protein deacylase sirtuin-6 (EC 2.3.1.-) (NAD-dependent protein deacetylase sirtuin-6) (EC 2.3.1.286) (Protein mono-ADP-ribosyltransferase sirtuin-6) (EC 2.4.2.-),Castor canadensis (American beaver),63.8,246.0,2.9e-92,339.7,sp|A0A250YGJ5|SIR6_CASCN NAD-dependent protein deacylase sirtuin-6 OS=Castor canadensis OX=51338 GN=SIRT6 PE=1 SV=1,GO:0000122; GO:0000781; GO:0000785; GO:0003684; GO:0003714; GO:0003723; GO:0005634; GO:0005783; GO:0006302; GO:0008340; GO:0010526; GO:0010569; GO:0016779; GO:0016787; GO:0019216; GO:0031490; GO:0031491; GO:0031508; GO:0031648; GO:0032024; GO:0032922; GO:0034244; GO:0034979; GO:0042181; GO:0042308; GO:0042752; GO:0042803; GO:0045600; GO:0045721; GO:0045820; GO:0046827; GO:0046872; GO:0046969; GO:0050994; GO:0051697; GO:0055007; GO:0070403; GO:0097372; GO:0106274; GO:0120162; GO:0120187; GO:0140612; GO:0140765; GO:0140773; GO:0140774; GO:1904841; GO:2000738; GO:2000781,cardiac muscle cell differentiation [GO:0055007]; circadian regulation of gene expression [GO:0032922]; determination of adult lifespan [GO:0008340]; double-strand break repair [GO:0006302]; ketone biosynthetic process [GO:0042181]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of glycolytic process [GO:0045820]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; pericentric heterochromatin formation [GO:0031508]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of stem cell differentiation [GO:2000738]; protein delipidation [GO:0051697]; protein destabilization [GO:0031648]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of lipid catabolic process [GO:0050994]; regulation of lipid metabolic process [GO:0019216]; transposable element silencing [GO:0010526],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]","chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; histone H3K18 deacetylase activity, NAD-dependent [GO:0097372]; histone H3K56 deacetylase activity, NAD-dependent [GO:0140765]; histone H3K9 deacetylase activity, NAD-dependent [GO:0046969]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD+-protein-arginine ADP-ribosyltransferase activity [GO:0106274]; NAD-dependent protein demyristoylase activity [GO:0140773]; NAD-dependent protein depalmitoylase activity [GO:0140774]; NAD-dependent protein lysine deacetylase activity [GO:0034979]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; TORC2 complex binding [GO:1904841]; transcription corepressor activity [GO:0003714]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005783; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0016787; GO:0030154; GO:0043226; GO:0060090; GO:0098772; GO:0140096; GO:0140110; GO:0140299,"DNA binding; RNA binding; catalytic activity; nucleus; endoplasmic reticulum; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; hydrolase activity; cell differentiation; organelle; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein; transcription regulator activity; molecular sensor activity"
OG_09411,FUN_040901-T1,Peve_00002290,Pocillopora_meandrina_HIv1___TS.g269.t1,three_way,62.087,FUN_040901-T1,O95059,,,,,41.4,116.0,1e-18,94.4,sp|O95059|RPP14_HUMAN Ribonuclease P protein subunit p14 OS=Homo sapiens OX=9606 GN=RPP14 PE=1 SV=3,,,,,,
OG_09412,FUN_040923-T1,Peve_00012313,Pocillopora_meandrina_HIv1___RNAseq.g27560.t1,three_way,85.5445,FUN_040923-T1,Q4G0P3,HYDIN_HUMAN,,Hydrocephalus-inducing protein homolog,Homo sapiens (Human),43.3,3001.0,0.0,2169.8,sp|Q4G0P3|HYDIN_HUMAN Hydrocephalus-inducing protein homolog OS=Homo sapiens OX=9606 GN=HYDIN PE=1 SV=3,GO:0002064; GO:0003341; GO:0005929; GO:0005930; GO:0021591; GO:0036126; GO:0060438; GO:1904158; GO:1990716; GO:1990718,axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],axonemal central apparatus [GO:1990716]; axonemal central pair projection [GO:1990718]; axoneme [GO:0005930]; cilium [GO:0005929]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0043226; GO:0048856,cilium; microtubule-based movement; organelle; anatomical structure development
OG_09413,FUN_040950-T1,Peve_00008820,Pocillopora_meandrina_HIv1___RNAseq.g27113.t1,three_way,67.32266666666666,FUN_040950-T1,Q969X6,UTP4_HUMAN,,U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component),Homo sapiens (Human),32.1,701.0,1.7e-102,375.2,sp|Q969X6|UTP4_HUMAN U3 small nucleolar RNA-associated protein 4 homolog OS=Homo sapiens OX=9606 GN=UTP4 PE=1 SV=1,GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0030490; GO:0030686; GO:0032040; GO:0034455; GO:0042274,"maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; regulation of DNA-templated transcription [GO:0006355]; ribosomal small subunit biogenesis [GO:0042274]",90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0005694; GO:0005730; GO:0006355; GO:0043226,RNA binding; nucleoplasm; chromosome; nucleolus; regulation of DNA-templated transcription; organelle
OG_09414,FUN_040955-T1,Peve_00008822,Pocillopora_meandrina_HIv1___RNAseq.g27057.t1,three_way,69.997,FUN_040955-T1,A7S710,DRE2_NEMVE,,Anamorsin homolog (Fe-S cluster assembly protein DRE2 homolog),Nematostella vectensis (Starlet sea anemone),57.5,292.0,7.5e-84,312.0,sp|A7S710|DRE2_NEMVE Anamorsin homolog OS=Nematostella vectensis OX=45351 GN=v1g167244 PE=3 SV=1,GO:0005737; GO:0005758; GO:0009055; GO:0016226; GO:0046872; GO:0051537; GO:0051539,iron-sulfur cluster assembly [GO:0016226],cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758],"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]",,
OG_09415,FUN_040956-T1,Peve_00008821,Pocillopora_meandrina_HIv1___RNAseq.g6177.t1,three_way,66.24066666666667,FUN_040956-T1,A7YVH9,PYRD1_BOVIN,,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (EC 1.8.1.-),Bos taurus (Bovine),54.3,508.0,6.5e-151,535.8,sp|A7YVH9|PYRD1_BOVIN Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 OS=Bos taurus OX=9913 GN=PYROXD1 PE=2 SV=1,GO:0005634; GO:0005737; GO:0016491; GO:0030017; GO:0034599,cellular response to oxidative stress [GO:0034599],cytoplasm [GO:0005737]; nucleus [GO:0005634]; sarcomere [GO:0030017],oxidoreductase activity [GO:0016491],GO:0003824; GO:0005634; GO:0016491; GO:0043226,catalytic activity; nucleus; oxidoreductase activity; organelle
OG_09416,FUN_040957-T1,Peve_00031410,Pocillopora_meandrina_HIv1___RNAseq.g27053.t1,three_way,76.98966666666666,FUN_040957-T1,Q9CQ02,,,,,59.0,188.0,2.6000000000000004e-57,223.8,sp|Q9CQ02|COMD4_MOUSE COMM domain-containing protein 4 OS=Mus musculus OX=10090 GN=Commd4 PE=1 SV=1,,,,,,
OG_09417,FUN_040958-T1,Peve_00031409,Pocillopora_meandrina_HIv1___RNAseq.g27054.t1,three_way,67.29966666666667,,,,,,,,,,,,,,,,,
OG_09418,FUN_040964-T1,Peve_00031412,Pocillopora_meandrina_HIv1___RNAseq.g12095.t1,three_way,67.30933333333333,FUN_040964-T1,Q640F2,,,,,32.0,540.0,1.3e-73,278.9,sp|Q640F2|SHCBB_XENLA SHC SH2 domain-binding protein 1 homolog B OS=Xenopus laevis OX=8355 GN=shcbp1-b PE=2 SV=1,,,,,,
OG_09419,FUN_040971-T1,Peve_00036103,Pocillopora_meandrina_HIv1___RNAseq.g12084.t1,three_way,60.7185,FUN_040971-T1,A2VDZ9,VAPB_BOVIN,,Vesicle-associated membrane protein-associated protein B (VAMP-B) (VAMP-associated protein B) (VAP-B),Bos taurus (Bovine),57.4,162.0,2.7e-48,193.7,sp|A2VDZ9|VAPB_BOVIN Vesicle-associated membrane protein-associated protein B OS=Bos taurus OX=9913 GN=VAPB PE=2 SV=1,GO:0005789; GO:0005886; GO:0006874; GO:0036498; GO:0043495; GO:0061817; GO:0090158,endoplasmic reticulum membrane organization [GO:0090158]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; intracellular calcium ion homeostasis [GO:0006874]; IRE1-mediated unfolded protein response [GO:0036498],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],protein-membrane adaptor activity [GO:0043495],GO:0005886; GO:0060090; GO:0061024,plasma membrane; molecular adaptor activity; membrane organization
OG_09420,FUN_040987-T1,Peve_00031413,Pocillopora_meandrina_HIv1___RNAseq.g12093.t1,three_way,53.817,FUN_040987-T1,Q8TCF1,ZFAN1_HUMAN,,AN1-type zinc finger protein 1 (Zinc finger AN1-type-containing protein 1),Homo sapiens (Human),40.6,266.0,4.9e-48,193.0,sp|Q8TCF1|ZFAN1_HUMAN AN1-type zinc finger protein 1 OS=Homo sapiens OX=9606 GN=ZFAND1 PE=1 SV=1,GO:0005737; GO:0008270; GO:0010494; GO:0035617; GO:0070628; GO:0090316; GO:1903843,cellular response to arsenite ion [GO:1903843]; positive regulation of intracellular protein transport [GO:0090316]; stress granule disassembly [GO:0035617],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494],proteasome binding [GO:0070628]; zinc ion binding [GO:0008270],GO:0043226,organelle
OG_09421,FUN_040988-T1,Peve_00036072,Pocillopora_meandrina_HIv1___TS.g3430.t1,three_way,62.085,FUN_040988-T1,A7SGU6,,,,,53.0,217.0,3.5e-58,226.5,sp|A7SGU6|PSMG2_NEMVE Proteasome assembly chaperone 2 OS=Nematostella vectensis OX=45351 GN=psmg2 PE=3 SV=1,,,,,,
OG_09422,FUN_041209-T1,Peve_00023415,Pocillopora_meandrina_HIv1___RNAseq.g16121.t1,three_way,62.034,FUN_041209-T1,Q96QS3,ARX_HUMAN,,Homeobox protein ARX (Aristaless-related homeobox),Homo sapiens (Human),40.6,234.0,3.3e-23,110.5,sp|Q96QS3|ARX_HUMAN Homeobox protein ARX OS=Homo sapiens OX=9606 GN=ARX PE=1 SV=1,GO:0000122; GO:0000785; GO:0000977; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0003682; GO:0005634; GO:0006357; GO:0007411; GO:0010628; GO:0021759; GO:0021800; GO:0021831; GO:0021846; GO:0021853; GO:0035265; GO:0044241; GO:0045944; GO:0046622; GO:0048663; GO:0050678; GO:0072148; GO:1990837,axon guidance [GO:0007411]; cell proliferation in forebrain [GO:0021846]; cerebral cortex GABAergic interneuron migration [GO:0021853]; cerebral cortex tangential migration [GO:0021800]; embryonic olfactory bulb interneuron precursor migration [GO:0021831]; epithelial cell fate commitment [GO:0072148]; globus pallidus development [GO:0021759]; lipid digestion [GO:0044241]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate commitment [GO:0048663]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of organ growth [GO:0046622]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of epithelial cell proliferation [GO:0050678]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_09423,FUN_041212-T1,Peve_00021331,Pocillopora_meandrina_HIv1___RNAseq.g16096.t1,three_way,86.64866666666667,FUN_041212-T1,P10114,RAP2A_HUMAN,,Ras-related protein Rap-2a (EC 3.6.5.2) (RbBP-30),Homo sapiens (Human),76.6,154.0,7.7e-65,248.1,sp|P10114|RAP2A_HUMAN Ras-related protein Rap-2a OS=Homo sapiens OX=9606 GN=RAP2A PE=1 SV=1,GO:0000287; GO:0001934; GO:0003924; GO:0003925; GO:0005525; GO:0005829; GO:0005886; GO:0008104; GO:0019003; GO:0030033; GO:0030036; GO:0030336; GO:0030496; GO:0031954; GO:0032486; GO:0045184; GO:0046328; GO:0048814; GO:0051963; GO:0055037; GO:0055038; GO:0071466; GO:0072659; GO:0097060; GO:0098685; GO:0099072,actin cytoskeleton organization [GO:0030036]; cellular response to xenobiotic stimulus [GO:0071466]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of cell migration [GO:0030336]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein phosphorylation [GO:0001934]; protein localization [GO:0008104]; protein localization to plasma membrane [GO:0072659]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of synapse assembly [GO:0051963],cytosol [GO:0005829]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287],GO:0003824; GO:0003924; GO:0005768; GO:0005829; GO:0005886; GO:0007010; GO:0016787; GO:0031410; GO:0043226; GO:0072659; GO:0098772,catalytic activity; GTPase activity; endosome; cytosol; plasma membrane; cytoskeleton organization; hydrolase activity; cytoplasmic vesicle; organelle; protein localization to plasma membrane; molecular function regulator activity
OG_09424,FUN_041213-T1,Peve_00021335,Pocillopora_meandrina_HIv1___RNAseq.g16095.t1,three_way,68.873,FUN_041213-T1,Q5R6R1,EYS_PONAB,,Protein eyes shut homolog (Epidermal growth factor-like protein 10) (EGF-like protein 10) (Epidermal growth factor-like protein 11) (EGF-like protein 11) (Protein spacemaker homolog),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),26.7,243.0,2.9e-16,89.0,sp|Q5R6R1|EYS_PONAB Protein eyes shut homolog OS=Pongo abelii OX=9601 GN=EYS PE=2 SV=3,GO:0001750; GO:0005509; GO:0005576; GO:0005737; GO:0005813; GO:0005886; GO:0007157; GO:0032991; GO:0033165; GO:0043403; GO:0045197; GO:0050908,detection of light stimulus involved in visual perception [GO:0050908]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; skeletal muscle tissue regeneration [GO:0043403],centrosome [GO:0005813]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],calcium ion binding [GO:0005509],GO:0005576; GO:0005815; GO:0005886; GO:0007155; GO:0007163; GO:0030312; GO:0031012; GO:0048856,extracellular region; microtubule organizing center; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09425,FUN_041214-T1,Peve_00021334,Pocillopora_meandrina_HIv1___TS.g11107.t1,three_way,66.5295,FUN_041214-T1,Q8VEL0,MSPD1_MOUSE,,Motile sperm domain-containing protein 1,Mus musculus (Mouse),48.3,207.0,1.7e-45,184.1,sp|Q8VEL0|MSPD1_MOUSE Motile sperm domain-containing protein 1 OS=Mus musculus OX=10090 GN=Mospd1 PE=1 SV=1,GO:0000122; GO:0000139; GO:0005634; GO:0005737; GO:0005789; GO:0030154; GO:0045944; GO:0048471,cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],,GO:0005634; GO:0006355; GO:0030154; GO:0043226,nucleus; regulation of DNA-templated transcription; cell differentiation; organelle
OG_09426,FUN_041310-T1,Peve_00023188,Pocillopora_meandrina_HIv1___TS.g11106.t1,three_way,76.71966666666667,FUN_041310-T1,P50532,,,,,62.6,1213.0,5.000000000000001e-227,789.6,sp|P50532|SMC4_XENLA Structural maintenance of chromosomes protein 4 OS=Xenopus laevis OX=8355 GN=smc4 PE=1 SV=1,,,,,,
OG_09427,FUN_041311-T1,Peve_00036795,Pocillopora_meandrina_HIv1___RNAseq.g16009.t1,three_way,64.30933333333334,FUN_041311-T1,A7MFZ8,,,,,30.6,288.0,3.9e-34,147.1,sp|A7MFZ8|GHRA_CROS8 Glyoxylate/hydroxypyruvate reductase A OS=Cronobacter sakazakii (strain ATCC BAA-894) OX=290339 GN=ghrA PE=3 SV=1,,,,,,
OG_09428,FUN_041312-T1,Peve_00032356,Pocillopora_meandrina_HIv1___RNAseq.6732_t,three_way,92.53633333333332,FUN_041312-T1,Q5XGA9,NAA50_XENTR,,N-alpha-acetyltransferase 50 (EC 2.3.1.258) (N-acetyltransferase NAT13) (N-epsilon-acetyltransferase 50) (EC 2.3.1.-) (NatE catalytic subunit),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),81.0,153.0,6.1e-70,265.0,sp|Q5XGA9|NAA50_XENTR N-alpha-acetyltransferase 50 OS=Xenopus tropicalis OX=8364 GN=naa50 PE=2 SV=1,GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0006474; GO:0010485; GO:0034087; GO:0061733; GO:0071962; GO:0120518,"establishment of mitotic sister chromatid cohesion [GO:0034087]; mitotic sister chromatid cohesion, centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],histone H4 acetyltransferase activity [GO:0010485]; protein N-terminal-methionine acetyltransferase activity [GO:0120518]; protein-lysine-acetyltransferase activity [GO:0061733]; protein-N-terminal amino-acid acetyltransferase activity [GO:0004596],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_09429,FUN_041313-T1,Peve_00002269,Pocillopora_meandrina_HIv1___RNAseq.g6990.t1,three_way,68.18166666666667,FUN_041313-T1,P90543,,,,,68.5,108.0,4.9999999999999995e-31,135.6,sp|P90543|H3_EUPCR Histone H3 OS=Euplotes crassus OX=5936 PE=3 SV=3,,,,,,
OG_09430,FUN_041368-T1,Peve_00037822,Pocillopora_meandrina_HIv1___RNAseq.g16110.t1,three_way,54.66166666666667,FUN_041368-T1,Q92622,RUBIC_HUMAN,,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron),Homo sapiens (Human),31.9,973.0,2.4e-104,381.7,sp|Q92622|RUBIC_HUMAN Run domain Beclin-1-interacting and cysteine-rich domain-containing protein OS=Homo sapiens OX=9606 GN=RUBCN PE=1 SV=4,GO:0002376; GO:0005654; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0006909; GO:0006914; GO:0010507; GO:0043231; GO:0045806; GO:0051898; GO:0071985; GO:0141039; GO:1901097; GO:1901981,autophagy [GO:0006914]; immune system process [GO:0002376]; multivesicular body sorting pathway [GO:0071985]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of autophagy [GO:0010507]; negative regulation of endocytosis [GO:0045806]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; phagocytosis [GO:0006909],cytosol [GO:0005829]; early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleoplasm [GO:0005654],phosphatidylinositol 3-kinase inhibitor activity [GO:0141039]; phosphatidylinositol phosphate binding [GO:1901981],GO:0002376; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0006914; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0098772,immune system process; nucleoplasm; lysosome; endosome; vacuole; cytosol; autophagy; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09431,FUN_041369-T1,Peve_00037815,Pocillopora_meandrina_HIv1___RNAseq.g16109.t2,three_way,79.78216666666667,,,,,,,,,,,,,,,,,
OG_09432,FUN_041389-T1,Peve_00044211,Pocillopora_meandrina_HIv1___RNAseq.g15715.t1,three_way,84.4495,FUN_041389-T1,Q32PP9,,,,,49.8,245.0,5.5e-50,199.5,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_09433,FUN_041390-T1,Peve_00044208,Pocillopora_meandrina_HIv1___RNAseq.g15716.t1,three_way,66.44733333333333,FUN_041390-T1,Q8NEZ2,VP37A_HUMAN,,Vacuolar protein sorting-associated protein 37A (hVps37A) (ESCRT-I complex subunit VPS37A) (Hepatocellular carcinoma-related protein 1),Homo sapiens (Human),32.2,395.0,5.7e-44,179.9,sp|Q8NEZ2|VP37A_HUMAN Vacuolar protein sorting-associated protein 37A OS=Homo sapiens OX=9606 GN=VPS37A PE=1 SV=1,GO:0000813; GO:0005654; GO:0005813; GO:0005829; GO:0006612; GO:0006623; GO:0010008; GO:0016236; GO:0031902; GO:0036258; GO:0039702; GO:0043162; GO:0043231; GO:0043328; GO:0090148,macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702],centrosome [GO:0005813]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654],,GO:0005654; GO:0005815; GO:0005829; GO:0006886; GO:0006914; GO:0016192; GO:0043226; GO:0061024,nucleoplasm; microtubule organizing center; cytosol; intracellular protein transport; autophagy; vesicle-mediated transport; organelle; membrane organization
OG_09434,FUN_041404-T1,Peve_00020588,Pocillopora_meandrina_HIv1___RNAseq.g15720.t1,three_way,81.456,,,,,,,,,,,,,,,,,
OG_09435,FUN_041407-T1,Peve_00020004,Pocillopora_meandrina_HIv1___RNAseq.g15728.t1,three_way,74.4565,FUN_041407-T1,Q5HZP1,,,,,41.7,307.0,7.099999999999999e-53,209.1,sp|Q5HZP1|RNH2B_XENLA Ribonuclease H2 subunit B OS=Xenopus laevis OX=8355 GN=rnaseh2b PE=2 SV=1,,,,,,
OG_09436,FUN_041408-T1,Peve_00017539,Pocillopora_meandrina_HIv1___RNAseq.g15729.t1,three_way,62.90833333333333,,,,,,,,,,,,,,,,,
OG_09437,FUN_041409-T1,Peve_00017538,Pocillopora_meandrina_HIv1___RNAseq.g15730.t1,three_way,78.86233333333334,FUN_041409-T1,O94826,,,,,36.7,578.0,1.9e-104,381.3,sp|O94826|TOM70_HUMAN Mitochondrial import receptor subunit TOM70 OS=Homo sapiens OX=9606 GN=TOMM70 PE=1 SV=1,,,,,,
OG_09438,FUN_041410-T1,Peve_00017540,Pocillopora_meandrina_HIv1___RNAseq.g15731.t1,three_way,64.53566666666667,FUN_041410-T1,Q95241,A4_SAISC,,Amyloid-beta precursor protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Gamma-CTF(50)); C31],Saimiri sciureus (Common squirrel monkey),24.4,737.0,3.4e-45,184.5,sp|Q95241|A4_SAISC Amyloid-beta precursor protein OS=Saimiri sciureus OX=9521 GN=APP PE=2 SV=1,GO:0003677; GO:0004867; GO:0005102; GO:0005576; GO:0005634; GO:0005737; GO:0005769; GO:0005783; GO:0005794; GO:0005798; GO:0005886; GO:0005905; GO:0006417; GO:0006878; GO:0006897; GO:0006915; GO:0007155; GO:0007219; GO:0007409; GO:0007417; GO:0007617; GO:0007626; GO:0008088; GO:0008201; GO:0008344; GO:0008542; GO:0009986; GO:0016020; GO:0016199; GO:0016322; GO:0016358; GO:0030198; GO:0030424; GO:0030426; GO:0030546; GO:0031175; GO:0035235; GO:0040014; GO:0043204; GO:0045121; GO:0045931; GO:0046914; GO:0048669; GO:0050803; GO:0055037,adult locomotory behavior [GO:0008344]; apoptotic process [GO:0006915]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; collateral sprouting in absence of injury [GO:0048669]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; intracellular copper ion homeostasis [GO:0006878]; ionotropic glutamate receptor signaling pathway [GO:0035235]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; neuron projection development [GO:0031175]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of multicellular organism growth [GO:0040014]; regulation of synapse structure or activity [GO:0050803]; regulation of translation [GO:0006417]; visual learning [GO:0008542],axon [GO:0030424]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],DNA binding [GO:0003677]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914],GO:0003677; GO:0005576; GO:0005634; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0007018; GO:0007155; GO:0012501; GO:0016192; GO:0022414; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0098772,DNA binding; extracellular region; nucleus; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; microtubule-based movement; cell adhesion; programmed cell death; vesicle-mediated transport; reproductive process; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular function regulator activity
OG_09439,FUN_041411-T1,Peve_00030724,Pocillopora_meandrina_HIv1___RNAseq.g15738.t1,three_way,81.83433333333333,FUN_041411-T1,Q9FKD0,,,,,25.6,355.0,7.9e-14,79.7,sp|Q9FKD0|MT797_ARATH Probable S-adenosylmethionine-dependent methyltransferase At5g37970 OS=Arabidopsis thaliana OX=3702 GN=At5g37970 PE=3 SV=1,,,,,,
OG_09440,FUN_041426-T1,Peve_00008987,Pocillopora_meandrina_HIv1___RNAseq.g15735.t2,three_way,80.48633333333333,FUN_041426-T1,P97360,ETV6_MOUSE,,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),Mus musculus (Mouse),44.6,65.0,1.7e-11,70.9,sp|P97360|ETV6_MOUSE Transcription factor ETV6 OS=Mus musculus OX=10090 GN=Etv6 PE=1 SV=1,GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005730; GO:0005829; GO:0006355; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0045944; GO:0071425; GO:0097152,cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; vitellogenesis [GO:0007296],cytosol [GO:0005829]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005730; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleolus; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; transcription regulator activity
OG_09441,FUN_041428-T1,Peve_00008985,Pocillopora_meandrina_HIv1___RNAseq.g15734.t1,three_way,66.91566666666667,FUN_041428-T1,Q9D786,,,,,21.5,665.0,1.9e-13,79.3,sp|Q9D786|HAUS5_MOUSE HAUS augmin-like complex subunit 5 OS=Mus musculus OX=10090 GN=Haus5 PE=1 SV=1,,,,,,
OG_09442,FUN_041431-T1,Peve_00008988,Pocillopora_meandrina_HIv1___RNAseq.g15733.t1,three_way,55.95633333333333,FUN_041431-T1,Q1LZD0,,,,,27.8,309.0,1.9e-09,65.1,sp|Q1LZD0|AA2BR_BOVIN Adenosine receptor A2b OS=Bos taurus OX=9913 GN=ADORA2B PE=2 SV=1,,,,,,
OG_09443,FUN_041432-T2,Peve_00027845,Pocillopora_meandrina_HIv1___RNAseq.g15740.t1,three_way,86.71633333333334,FUN_041432-T2,Q90837,,,,,41.4,459.0,1.8000000000000002e-81,304.7,sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1,,,,,,
OG_09444,FUN_041433-T1,Peve_00007738,Pocillopora_meandrina_HIv1___RNAseq.g15741.t1,three_way,69.05766666666666,,,,,,,,,,,,,,,,,
OG_09445,FUN_041437-T1,Peve_00007743,Pocillopora_meandrina_HIv1___RNAseq.g15744.t2,three_way,80.71600000000001,FUN_041437-T1,Q96MT8,,,,,30.8,240.0,5.7e-19,97.1,sp|Q96MT8|CEP63_HUMAN Centrosomal protein of 63 kDa OS=Homo sapiens OX=9606 GN=CEP63 PE=1 SV=1,,,,,,
OG_09446,FUN_041438-T1,Peve_00007741,Pocillopora_meandrina_HIv1___RNAseq.g15745.t2,three_way,77.23666666666666,,,,,,,,,,,,,,,,,
OG_09447,FUN_041439-T1,Peve_00007740,Pocillopora_meandrina_HIv1___RNAseq.g15746.t1,three_way,66.59533333333333,,,,,,,,,,,,,,,,,
OG_09448,FUN_041440-T1,Peve_00007732,Pocillopora_meandrina_HIv1___RNAseq.g15747.t1,three_way,78.19133333333333,FUN_041440-T1,Q24JY4,,,,,53.2,158.0,1.2e-37,157.5,sp|Q24JY4|ZNHI1_BOVIN Zinc finger HIT domain-containing protein 1 OS=Bos taurus OX=9913 GN=ZNHIT1 PE=2 SV=1,,,,,,
OG_09449,FUN_041441-T1,Peve_00007412,Pocillopora_meandrina_HIv1___RNAseq.g15693.t1,three_way,71.821,FUN_041441-T1,Q29R99,LIPT2_DANRE,,"Octanoyl-[acyl-carrier-protein]:protein N-octanoyltransferase LIPT2, mitochondrial (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Lipoyltransferase 2) (EC 2.3.1.181) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase)",Danio rerio (Zebrafish) (Brachydanio rerio),53.8,210.0,1.3e-64,247.7,"sp|Q29R99|LIPT2_DANRE Octanoyl-[acyl-carrier-protein]:protein N-octanoyltransferase LIPT2, mitochondrial OS=Danio rerio OX=7955 GN=lipt2 PE=2 SV=1",GO:0005739; GO:0009249; GO:0016874; GO:0033819; GO:2000376,positive regulation of oxygen metabolic process [GO:2000376]; protein lipoylation [GO:0009249],mitochondrion [GO:0005739],ligase activity [GO:0016874]; lipoyl(octanoyl) transferase activity [GO:0033819],GO:0003824; GO:0005739; GO:0016740; GO:0016874; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; mitochondrion; transferase activity; ligase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_09450,FUN_041442-T1,Peve_00007411,Pocillopora_meandrina_HIv1___RNAseq.g15694.t1,three_way,75.69166666666666,FUN_041442-T1,Q08623,HDHD1_HUMAN,,Pseudouridine-5'-phosphatase (EC 3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase),Homo sapiens (Human),53.4,221.0,1.4e-61,237.7,sp|Q08623|HDHD1_HUMAN Pseudouridine-5'-phosphatase OS=Homo sapiens OX=9606 GN=PUDP PE=1 SV=3,GO:0005829; GO:0009117; GO:0016791; GO:0046872; GO:1990738,nucleotide metabolic process [GO:0009117],cytosol [GO:0005829],metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; pseudouridine 5'-phosphatase activity [GO:1990738],GO:0003824; GO:0005829; GO:0016787; GO:0055086,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_09451,FUN_041443-T1,Peve_00007410,Pocillopora_meandrina_HIv1___RNAseq.g15695.t1,three_way,79.225,,,,,,,,,,,,,,,,,
OG_09452,FUN_041460-T1,Peve_00007409,Pocillopora_meandrina_HIv1___RNAseq.g15692.t1,three_way,85.84066666666666,FUN_041460-T1,Q68FP9,,,,,56.8,628.0,1e-207,724.5,sp|Q68FP9|COG6_RAT Conserved oligomeric Golgi complex subunit 6 OS=Rattus norvegicus OX=10116 GN=Cog6 PE=2 SV=1,,,,,,
OG_09453,FUN_041461-T1,Peve_00007408,Pocillopora_meandrina_HIv1___RNAseq.g15690.t1,three_way,83.71133333333334,FUN_041461-T1,P61602,,,,,48.9,184.0,7.9e-45,181.8,sp|P61602|NCALD_BOVIN Neurocalcin-delta OS=Bos taurus OX=9913 GN=NCALD PE=1 SV=2,,,,,,
OG_09454,FUN_041462-T1,Peve_00007415,Pocillopora_meandrina_HIv1___RNAseq.g15691.t1,three_way,68.71033333333334,FUN_041462-T1,A8JF70,ODA1_CHLRE,,Outer dynein arm protein 1 (Docking complex component 2),Chlamydomonas reinhardtii (Chlamydomonas smithii),25.0,504.0,9.999999999999999e-29,129.8,sp|A8JF70|ODA1_CHLRE Outer dynein arm protein 1 OS=Chlamydomonas reinhardtii OX=3055 GN=ODA1 PE=1 SV=1,GO:0036157; GO:0036158; GO:0060294,cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158],outer dynein arm [GO:0036157],,GO:0007018; GO:0065003,microtubule-based movement; protein-containing complex assembly
OG_09455,FUN_041463-T1,Peve_00013687,Pocillopora_meandrina_HIv1___RNAseq.g15689.t1,three_way,54.7395,FUN_041463-T1,Q95209,SORL_RABIT,,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),Oryctolagus cuniculus (Rabbit),36.6,2110.0,7.4e-199,697.2,sp|Q95209|SORL_RABIT Sortilin-related receptor OS=Oryctolagus cuniculus OX=9986 GN=SORL1 PE=1 SV=1,GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845,adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],,GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226,extracellular space; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09456,FUN_041464-T1,Peve_00013686,Pocillopora_meandrina_HIv1___RNAseq.g15688.t1,three_way,73.06016666666666,FUN_041464-T1,Q06AU2,RAP2A_PIG,,Ras-related protein Rap-2a (EC 3.6.5.2),Sus scrofa (Pig),43.6,165.0,3.3e-29,130.6,sp|Q06AU2|RAP2A_PIG Ras-related protein Rap-2a OS=Sus scrofa OX=9823 GN=RAP2A PE=2 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005829; GO:0005886; GO:0005923; GO:0008104; GO:0019003; GO:0019904; GO:0030036; GO:0030336; GO:0030496; GO:0031954; GO:0032486; GO:0044291; GO:0045121; GO:0046328; GO:0048814; GO:0055038; GO:0070062; GO:0070527,actin cytoskeleton organization [GO:0030036]; negative regulation of cell migration [GO:0030336]; platelet aggregation [GO:0070527]; positive regulation of protein autophosphorylation [GO:0031954]; protein localization [GO:0008104]; Rap protein signal transduction [GO:0032486]; regulation of dendrite morphogenesis [GO:0048814]; regulation of JNK cascade [GO:0046328],bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane raft [GO:0045121]; midbody [GO:0030496]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904],GO:0003824; GO:0003924; GO:0005829; GO:0005886; GO:0007010; GO:0007155; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; cytosol; plasma membrane; cytoskeleton organization; cell adhesion; hydrolase activity; organelle; molecular function regulator activity
OG_09457,FUN_041465-T1,Peve_00041301,Pocillopora_meandrina_HIv1___RNAseq.g15686.t1,three_way,66.148,FUN_041465-T1,P51175,,,,,45.3,461.0,4e-111,403.3,sp|P51175|PPOX_MOUSE Protoporphyrinogen oxidase OS=Mus musculus OX=10090 GN=Ppox PE=1 SV=1,,,,,,
OG_09458,FUN_041466-T1,Peve_00028293,Pocillopora_meandrina_HIv1___RNAseq.g15685.t1,three_way,68.417,FUN_041466-T1,Q6NYE7,,,,,35.5,231.0,5.700000000000001e-30,132.9,sp|Q6NYE7|TM192_DANRE Transmembrane protein 192 OS=Danio rerio OX=7955 GN=tmem192 PE=2 SV=1,,,,,,
OG_09459,FUN_041468-T1,Peve_00028292,Pocillopora_meandrina_HIv1___RNAseq.g15684.t1,three_way,56.53566666666667,,,,,,,,,,,,,,,,,
OG_09460,FUN_041478-T1,Peve_00009786,Pocillopora_meandrina_HIv1___RNAseq.g15675.t1,three_way,83.17233333333333,FUN_041478-T1,P10768,ESTD_HUMAN,,S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) (Methylumbelliferyl-acetate deacetylase) (EC 3.1.1.56),Homo sapiens (Human),68.5,276.0,4.3e-116,420.6,sp|P10768|ESTD_HUMAN S-formylglutathione hydrolase OS=Homo sapiens OX=9606 GN=ESD PE=1 SV=2,GO:0005788; GO:0005829; GO:0016788; GO:0018738; GO:0031410; GO:0042802; GO:0046294; GO:0047374; GO:0052689; GO:0070062,formaldehyde catabolic process [GO:0046294],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062],"carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; S-formylglutathione hydrolase activity [GO:0018738]",GO:0003824; GO:0005829; GO:0016787; GO:0031410; GO:0043226; GO:0098754,catalytic activity; cytosol; hydrolase activity; cytoplasmic vesicle; organelle; detoxification
OG_09461,FUN_041480-T1,Peve_00028683,Pocillopora_meandrina_HIv1___TS.g10702.t1,three_way,66.502,FUN_041480-T1,P33277,,,,,29.5,499.0,4.1e-42,174.1,sp|P33277|GAP1_SCHPO GTPase-activating protein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=gap1 PE=4 SV=1,,,,,,
OG_09462,FUN_041481-T1,Peve_00015167,Pocillopora_meandrina_HIv1___RNAseq.g15673.t1,three_way,81.04583333333333,FUN_041481-T1,Q6NVN0,SOX2_XENTR,,Transcription factor Sox-2 (SRY (sex determining region Y)-box 2),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),45.8,271.0,2.8e-42,174.1,sp|Q6NVN0|SOX2_XENTR Transcription factor Sox-2 OS=Xenopus tropicalis OX=8364 GN=sox2 PE=2 SV=1,GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0007399; GO:0008283; GO:0021522; GO:0021538; GO:0021982; GO:0031101; GO:0043565; GO:0045893; GO:0045944; GO:0048592; GO:0060119; GO:0071599; GO:1905040; GO:1905812,cell population proliferation [GO:0008283]; epithalamus development [GO:0021538]; eye morphogenesis [GO:0048592]; fin regeneration [GO:0031101]; inner ear receptor cell development [GO:0060119]; nervous system development [GO:0007399]; otic placode development [GO:1905040]; otic vesicle development [GO:0071599]; pineal gland development [GO:0021982]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of motor neuron axon guidance [GO:1905812]; spinal cord motor neuron differentiation [GO:0021522],cytoplasm [GO:0005737]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09463,FUN_041486-T1,Peve_00004078,Pocillopora_meandrina_HIv1___RNAseq.g15672.t2,three_way,56.60683333333333,FUN_041486-T1,D3ZZL9,,,,,35.3,388.0,1.7e-30,137.9,sp|D3ZZL9|GCC2_RAT GRIP and coiled-coil domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Gcc2 PE=1 SV=1,,,,,,
OG_09464,FUN_041487-T1,Peve_00004076,Pocillopora_meandrina_HIv1___RNAseq.g15671.t1,three_way,60.05166666666667,FUN_041487-T1,Q9R1A9,,,,,39.0,218.0,3.5e-30,133.7,sp|Q9R1A9|TREX2_MOUSE Three prime repair exonuclease 2 OS=Mus musculus OX=10090 GN=Trex2 PE=1 SV=1,,,,,,
OG_09465,FUN_041488-T1,Peve_00004075,Pocillopora_meandrina_HIv1___RNAseq.g15670.t1,three_way,61.912,FUN_041488-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),36.2,549.0,2.1e-95,351.3,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09466,FUN_041490-T1,Peve_00004073,Pocillopora_meandrina_HIv1___RNAseq.g15669.t1,three_way,79.144,FUN_041490-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),33.6,420.0,1.3e-68,262.3,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_09467,FUN_041492-T1,Peve_00004081,Pocillopora_meandrina_HIv1___RNAseq.g15668.t1,three_way,52.13483333333333,FUN_041492-T1,Q8TF71,MOT10_HUMAN,,Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1),Homo sapiens (Human),32.3,310.0,8.000000000000002e-44,180.3,sp|Q8TF71|MOT10_HUMAN Monocarboxylate transporter 10 OS=Homo sapiens OX=9606 GN=SLC16A10 PE=1 SV=1,GO:0005302; GO:0005886; GO:0006590; GO:0006865; GO:0015171; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0030054; GO:0043231; GO:0070327; GO:0070460,amino acid transport [GO:0006865]; aromatic amino acid transport [GO:0015801]; thyroid hormone generation [GO:0006590]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460],basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886; GO:0006575; GO:0043226,transporter activity; plasma membrane; modified amino acid metabolic process; organelle
OG_09468,FUN_041493-T1,Peve_00004072,Pocillopora_meandrina_HIv1___TS.g10693.t1,three_way,72.808,FUN_041493-T1,Q9I829,,,,,34.0,391.0,6.899999999999999e-49,196.4,sp|Q9I829|KCNA1_ONCMY Shaker-related potassium channel tsha2 OS=Oncorhynchus mykiss OX=8022 PE=2 SV=1,,,,,,
OG_09469,FUN_041494-T2,Peve_00017071,Pocillopora_meandrina_HIv1___RNAseq.g15664.t2,three_way,87.778,FUN_041494-T2,Q14409,,,,,63.3,542.0,7e-203,708.4,sp|Q14409|GLPK3_HUMAN Glycerol kinase 3 OS=Homo sapiens OX=9606 GN=GK3 PE=1 SV=2,,,,,,
OG_09470,FUN_041495-T1,Peve_00017070,Pocillopora_meandrina_HIv1___RNAseq.g15663.t1,three_way,63.118,FUN_041495-T1,Q9H1I8,ASCC2_HUMAN,,Activating signal cointegrator 1 complex subunit 2 (ASC-1 complex subunit p100) (Trip4 complex subunit p100),Homo sapiens (Human),41.7,769.0,1.1e-126,455.7,sp|Q9H1I8|ASCC2_HUMAN Activating signal cointegrator 1 complex subunit 2 OS=Homo sapiens OX=9606 GN=ASCC2 PE=1 SV=3,GO:0005634; GO:0005654; GO:0006307; GO:0006355; GO:0016607; GO:0022626; GO:0032790; GO:0043130; GO:0070530; GO:0072344; GO:0180022; GO:1990116; GO:1990391,DNA alkylation repair [GO:0006307]; regulation of DNA-templated transcription [GO:0006355]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytosolic ribosome [GO:0022626]; DNA repair complex [GO:1990391]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RQC-trigger complex [GO:0180022],K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; ubiquitin binding [GO:0043130],GO:0005634; GO:0005654; GO:0005840; GO:0006281; GO:0006355; GO:0030163; GO:0043226,nucleus; nucleoplasm; ribosome; DNA repair; regulation of DNA-templated transcription; protein catabolic process; organelle
OG_09471,FUN_041497-T1,Peve_00017073,Pocillopora_meandrina_HIv1___RNAseq.g15661.t1,three_way,80.51666666666667,FUN_041497-T1,P62046,,,,,32.5,711.0,2.7e-36,155.2,sp|P62046|LRCH1_MOUSE Leucine-rich repeat and calponin homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrch1 PE=1 SV=2,,,,,,
OG_09472,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_09473,FUN_041499-T1,Peve_00007701,Pocillopora_meandrina_HIv1___RNAseq.g15656.t1,three_way,76.57366666666667,FUN_041499-T1,Q8WY91,THAP4_HUMAN,,Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (Ferric Homo sapiens nitrobindin) (Hs-Nb(III)) (THAP domain-containing protein 4),Homo sapiens (Human),39.2,166.0,1.3000000000000001e-33,144.4,sp|Q8WY91|THAP4_HUMAN Peroxynitrite isomerase THAP4 OS=Homo sapiens OX=9606 GN=THAP4 PE=1 SV=2,GO:0003677; GO:0005654; GO:0005829; GO:0006570; GO:0008270; GO:0020037; GO:0042126; GO:0042802; GO:0062213; GO:0070026,nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570],cytosol [GO:0005829]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006520; GO:0016853,DNA binding; catalytic activity; nucleoplasm; cytosol; amino acid metabolic process; isomerase activity
OG_09474,FUN_041501-T1,Peve_00028685,Pocillopora_meandrina_HIv1___RNAseq.g15660.t1,three_way,84.75066666666666,FUN_041501-T1,P70191,TRAF5_MOUSE,,TNF receptor-associated factor 5,Mus musculus (Mouse),38.3,193.0,2.8e-32,141.0,sp|P70191|TRAF5_MOUSE TNF receptor-associated factor 5 OS=Mus musculus OX=10090 GN=Traf5 PE=1 SV=1,GO:0005164; GO:0005813; GO:0005829; GO:0006915; GO:0007165; GO:0008270; GO:0008284; GO:0009898; GO:0023019; GO:0023035; GO:0031625; GO:0031996; GO:0033209; GO:0035631; GO:0042802; GO:0042981; GO:0043123; GO:0048255; GO:0051092; GO:0061630; GO:0097400,apoptotic process [GO:0006915]; CD40 signaling pathway [GO:0023035]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA stabilization [GO:0048255]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; centrosome [GO:0005813]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829],identical protein binding [GO:0042802]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0005829; GO:0006355; GO:0012501; GO:0016740; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; regulation of DNA-templated transcription; programmed cell death; transferase activity; catalytic activity, acting on a protein"
OG_09475,FUN_041502-T1,Peve_00021434,Pocillopora_meandrina_HIv1___RNAseq.g15963.t1,three_way,73.652,FUN_041502-T1,Q62623,CDC20_RAT,,Cell division cycle protein 20 homolog (p55CDC),Rattus norvegicus (Rat),51.9,507.0,4.5e-129,463.0,sp|Q62623|CDC20_RAT Cell division cycle protein 20 homolog OS=Rattus norvegicus OX=10116 GN=Cdc20 PE=1 SV=2,GO:0000776; GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005829; GO:0007064; GO:0008284; GO:0010997; GO:0016567; GO:0031145; GO:0031915; GO:0032991; GO:0033597; GO:0040020; GO:0042826; GO:0044784; GO:0045842; GO:0048471; GO:0050773; GO:0051301; GO:0090129; GO:0090307; GO:1904146; GO:1904668; GO:1905786; GO:1990756; GO:1990757; GO:1990949,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; metaphase/anaphase transition of cell cycle [GO:0044784]; metaphase/anaphase transition of meiosis I [GO:1990949]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of meiotic cell cycle process involved in oocyte maturation [GO:1904146]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic nuclear division [GO:0040020],anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922],anaphase-promoting complex binding [GO:0010997]; histone deacetylase binding [GO:0042826]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0022414; GO:0030163; GO:0043226; GO:0060090; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; reproductive process; protein catabolic process; organelle; molecular adaptor activity; molecular function regulator activity
OG_09476,FUN_041503-T1,Peve_00021433,Pocillopora_meandrina_HIv1___RNAseq.g15964.t1,three_way,62.67066666666667,,,,,,,,,,,,,,,,,
OG_09477,FUN_041504-T1,Peve_00021429,Pocillopora_meandrina_HIv1___RNAseq.g15966.t1,three_way,72.34566666666666,FUN_041504-T1,Q9WU81,,,,,54.1,495.0,5.3e-144,512.7,sp|Q9WU81|G6PT3_MOUSE Glucose-6-phosphate exchanger SLC37A2 OS=Mus musculus OX=10090 GN=Slc37a2 PE=1 SV=1,,,,,,
OG_09478,FUN_041505-T1,Peve_00021428,Pocillopora_meandrina_HIv1___RNAseq.g15967.t1,three_way,66.66633333333334,FUN_041505-T1,A7RR34,,,,,77.5,89.0,7.8e-36,151.8,sp|A7RR34|FLTOP_NEMVE Protein Flattop homolog OS=Nematostella vectensis OX=45351 GN=v1g200856 PE=3 SV=1,,,,,,
OG_09479,FUN_041506-T1,Peve_00039613,Pocillopora_meandrina_HIv1___RNAseq.g15968.t1,three_way,75.15433333333333,FUN_041506-T1,B5DDX6,,,,,48.4,341.0,5.2e-84,313.2,sp|B5DDX6|SMG9_XENTR Nonsense-mediated mRNA decay factor SMG9 OS=Xenopus tropicalis OX=8364 GN=smg9 PE=2 SV=1,,,,,,
OG_09480,FUN_041507-T1,Peve_00033124,Pocillopora_meandrina_HIv1___RNAseq.g15969.t1,three_way,75.157,FUN_041507-T1,Q8JHF0,,,,,64.3,84.0,8.1e-29,127.5,sp|Q8JHF0|PEN2_DANRE Gamma-secretase subunit PEN-2 OS=Danio rerio OX=7955 GN=psenen PE=3 SV=1,,,,,,
OG_09481,FUN_041509-T1,Peve_00025395,Pocillopora_meandrina_HIv1___RNAseq.g16082.t1,three_way,78.44016666666667,FUN_041509-T1,P13773,,,,,23.2,228.0,1.4e-12,75.5,sp|P13773|CAR1_DICDI Cyclic AMP receptor 1 OS=Dictyostelium discoideum OX=44689 GN=carA-1 PE=1 SV=1,,,,,,
OG_09482,FUN_041510-T1,Peve_00025394,Pocillopora_meandrina_HIv1___RNAseq.g16083.t1,three_way,76.65133333333333,FUN_041510-T1,Q9EQN9,,,,,45.4,449.0,1.5e-99,364.8,sp|Q9EQN9|S19A2_MOUSE Thiamine transporter 1 OS=Mus musculus OX=10090 GN=Slc19a2 PE=1 SV=1,,,,,,
OG_09483,FUN_041512-T1,Peve_00039616,Pocillopora_meandrina_HIv1___RNAseq.g16011.t1,three_way,88.092,FUN_041512-T1,Q5F415,,,,,48.7,678.0,6.4e-184,645.6,sp|Q5F415|TBC23_CHICK TBC1 domain family member 23 OS=Gallus gallus OX=9031 GN=TBC1D23 PE=2 SV=1,,,,,,
OG_09484,FUN_041516-T1,Peve_00021419,Pocillopora_meandrina_HIv1___RNAseq.g16018.t1,three_way,81.921,FUN_041516-T1,Q5RF33,,,,,65.7,213.0,1.2e-80,300.8,sp|Q5RF33|VP26C_PONAB Vacuolar protein sorting-associated protein 26C OS=Pongo abelii OX=9601 GN=VPS26C PE=2 SV=1,,,,,,
OG_09485,FUN_041518-T1,Peve_00024144,Pocillopora_meandrina_HIv1___RNAseq.6295_t,three_way,45.930166666666665,,,,,,,,,,,,,,,,,
OG_09486,FUN_041519-T1,Peve_00024151,Pocillopora_meandrina_HIv1___RNAseq.g15592.t1,three_way,58.06766666666667,FUN_041519-T1,P27393,,,,,62.9,224.0,9e-84,314.3,sp|P27393|CO4A2_ASCSU Collagen alpha-2(IV) chain OS=Ascaris suum OX=6253 PE=2 SV=1,,,,,,
OG_09487,FUN_041521-T2,Peve_00024136,Pocillopora_meandrina_HIv1___RNAseq.g15591.t1,three_way,53.47683333333333,FUN_041521-T2,Q7SIB2,CO4A1_BOVIN,,Collagen alpha-1(IV) chain [Cleaved into: Arresten],Bos taurus (Bovine),66.8,226.0,2.6e-91,339.3,sp|Q7SIB2|CO4A1_BOVIN Collagen alpha-1(IV) chain OS=Bos taurus OX=9913 GN=COL4A1 PE=1 SV=2,GO:0005581; GO:0005604; GO:0005615; GO:0030020; GO:0062023,,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],extracellular matrix structural constituent conferring tensile strength [GO:0030020],GO:0005198; GO:0005615; GO:0030312; GO:0031012,structural molecule activity; extracellular space; external encapsulating structure; extracellular matrix
OG_09488,FUN_041522-T1,Peve_00024135,Pocillopora_meandrina_HIv1___TS.g10406.t1,three_way,83.81533333333333,FUN_041522-T1,Q5JVF3,PCID2_HUMAN,,PCI domain-containing protein 2 (CSN12-like protein),Homo sapiens (Human),66.0,394.0,1e-149,531.2,sp|Q5JVF3|PCID2_HUMAN PCI domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PCID2 PE=1 SV=2,GO:0000973; GO:0003690; GO:0003723; GO:0005634; GO:0005737; GO:0006368; GO:0015031; GO:0016973; GO:0044615; GO:0045579; GO:0045814; GO:0048536; GO:0070390; GO:1905457,"negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein transport [GO:0015031]; spleen development [GO:0048536]; transcription elongation by RNA polymerase II [GO:0006368]",cytoplasm [GO:0005737]; nuclear pore nuclear basket [GO:0044615]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390],double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0006325; GO:0006913; GO:0043226; GO:0048856,DNA binding; RNA binding; nucleus; chromatin organization; nucleocytoplasmic transport; organelle; anatomical structure development
OG_09489,FUN_041524-T1,Peve_00000980,Pocillopora_meandrina_HIv1___RNAseq.g15379.t1,three_way,54.44833333333333,FUN_041524-T1,O43933,,,,,28.6,255.0,4.9e-20,100.5,sp|O43933|PEX1_HUMAN Peroxisomal ATPase PEX1 OS=Homo sapiens OX=9606 GN=PEX1 PE=1 SV=1,,,,,,
OG_09490,FUN_041526-T1,Peve_00017090,Pocillopora_meandrina_HIv1___RNAseq.g2461.t1,three_way,40.93683333333333,FUN_041526-T1,P78345,RPP38_HUMAN,,Ribonuclease P protein subunit p38 (RNaseP protein p38),Homo sapiens (Human),29.5,251.0,2.5e-13,77.8,sp|P78345|RPP38_HUMAN Ribonuclease P protein subunit p38 OS=Homo sapiens OX=9606 GN=RPP38 PE=1 SV=2,GO:0000172; GO:0001650; GO:0001682; GO:0004526; GO:0005654; GO:0005655; GO:0005730; GO:0006364; GO:0030681; GO:0033204,rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682],fibrillar center [GO:0001650]; multimeric ribonuclease P complex [GO:0030681]; nucleolar ribonuclease P complex [GO:0005655]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonuclease MRP complex [GO:0000172],ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204],GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0006399; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; nucleolus; tRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_09491,FUN_041530-T1,Peve_00017083,Pocillopora_meandrina_HIv1___RNAseq.g15378.t1,three_way,85.99833333333333,FUN_041530-T1,Q5W111,SPRY7_HUMAN,,SPRY domain-containing protein 7 (Chronic lymphocytic leukemia deletion region gene 6 protein) (CLL deletion region gene 6 protein),Homo sapiens (Human),55.5,191.0,2.3e-57,223.4,sp|Q5W111|SPRY7_HUMAN SPRY domain-containing protein 7 OS=Homo sapiens OX=9606 GN=SPRYD7 PE=1 SV=2,,,,,,
OG_09492,FUN_041531-T2,Peve_00017082,Pocillopora_meandrina_HIv1___RNAseq.g15377.t1,three_way,75.96633333333332,FUN_041531-T2,Q5ZKC1,EIF2A_CHICK,,Eukaryotic translation initiation factor 2A (eIF-2A),Gallus gallus (Chicken),56.2,461.0,3.3e-154,546.6,sp|Q5ZKC1|EIF2A_CHICK Eukaryotic translation initiation factor 2A OS=Gallus gallus OX=9031 GN=EIF2A PE=2 SV=1,GO:0000049; GO:0003729; GO:0003743; GO:0005737; GO:0005850; GO:0006417; GO:0022627; GO:0042255; GO:0043022,regulation of translation [GO:0006417]; ribosome assembly [GO:0042255],cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850],mRNA binding [GO:0003729]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049],GO:0003723,RNA binding
OG_09493,FUN_041532-T1,Peve_00017081,Pocillopora_meandrina_HIv1___RNAseq.g15376.t1,three_way,72.252,FUN_041532-T1,Q60525,TCAB1_MESAU,,Telomerase Cajal body protein 1 (Guanine nucleotide-binding protein beta 5) (WD repeat-containing protein 79) (WD40 repeat-containing protein antisense to TP53 gene homolog),Mesocricetus auratus (Golden hamster),49.7,346.0,6.4e-92,339.7,sp|Q60525|TCAB1_MESAU Telomerase Cajal body protein 1 OS=Mesocricetus auratus OX=10036 GN=Wrap53 PE=2 SV=1,GO:0000781; GO:0003723; GO:0005697; GO:0005829; GO:0006281; GO:0007004; GO:0015030; GO:0030576; GO:0031625; GO:0032203; GO:0032212; GO:0034337; GO:0035861; GO:0042393; GO:0042802; GO:0044877; GO:0045739; GO:0051087; GO:0070034; GO:0090666; GO:0090671; GO:0140597; GO:0140691; GO:1904851; GO:1904867; GO:1905168; GO:2000781; GO:2001034,Cajal body organization [GO:0030576]; DNA repair [GO:0006281]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein localization to Cajal body [GO:1904867]; RNA folding [GO:0034337]; scaRNA localization to Cajal body [GO:0090666]; telomerase RNA localization to Cajal body [GO:0090671]; telomere formation via telomerase [GO:0032203]; telomere maintenance via telomerase [GO:0007004],"Cajal body [GO:0015030]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; site of double-strand break [GO:0035861]; telomerase holoenzyme complex [GO:0005697]",histone binding [GO:0042393]; identical protein binding [GO:0042802]; protein carrier chaperone [GO:0140597]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; RNA folding chaperone [GO:0140691]; telomerase RNA binding [GO:0070034]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005829; GO:0006281; GO:0032200; GO:0042393; GO:0043226; GO:0140104,RNA binding; cytosol; DNA repair; telomere organization; histone binding; organelle; molecular carrier activity
OG_09494,FUN_041533-T1,Peve_00017080,Pocillopora_meandrina_HIv1___RNAseq.g15375.t1,three_way,44.41416666666667,,,,,,,,,,,,,,,,,
OG_09495,FUN_041535-T1,Peve_00039113,Pocillopora_meandrina_HIv1___RNAseq.g15374.t1,three_way,78.69216666666667,FUN_041535-T1,Q5R7X2,,,,,44.6,655.0,4.1e-134,480.7,sp|Q5R7X2|SR140_PONAB U2 snRNP-associated SURP motif-containing protein OS=Pongo abelii OX=9601 GN=U2SURP PE=2 SV=1,,,,,,
OG_09496,FUN_041538-T1,Peve_00039114,Pocillopora_meandrina_HIv1___RNAseq.g15372.t1,three_way,79.35366666666667,FUN_041538-T1,B2VG45,,,,,39.6,273.0,2.5e-51,204.5,sp|B2VG45|TATD_ERWT9 3'-5' ssDNA/RNA exonuclease TatD OS=Erwinia tasmaniensis (strain DSM 17950 / CFBP 7177 / CIP 109463 / NCPPB 4357 / Et1/99) OX=465817 GN=tatD PE=3 SV=1,,,,,,
OG_09497,FUN_041539-T1,Peve_00039111,Pocillopora_meandrina_HIv1___RNAseq.g15371.t1,three_way,64.235,FUN_041539-T1,P18887,XRCC1_HUMAN,,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),Homo sapiens (Human),36.6,696.0,1.2e-97,359.0,sp|P18887|XRCC1_HUMAN DNA repair protein XRCC1 OS=Homo sapiens OX=9606 GN=XRCC1 PE=1 SV=3,GO:0000012; GO:0000781; GO:0000785; GO:0005634; GO:0005654; GO:0005730; GO:0006284; GO:0006302; GO:0006303; GO:0010836; GO:0019899; GO:0021766; GO:0032356; GO:0033194; GO:0061819; GO:0070522; GO:0072572; GO:0090734; GO:0160002; GO:1905051; GO:1905765; GO:1990599,base-excision repair [GO:0006284]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; regulation of base-excision repair [GO:1905051]; response to hydroperoxide [GO:0033194]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]",3' overhang single-stranded DNA endodeoxyribonuclease activity [GO:1990599]; ADP-D-ribose modification-dependent protein binding [GO:0160002]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; poly-ADP-D-ribose binding [GO:0072572],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016787; GO:0032200; GO:0043226; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; hydrolase activity; telomere organization; organelle; anatomical structure development; catalytic activity, acting on DNA"
OG_09498,FUN_041540-T1,Peve_00007703,Pocillopora_meandrina_HIv1___RNAseq.g15651.t1,three_way,66.28366666666666,FUN_041540-T1,P51521,OVO_DROME,,Transcriptional regulator ovo (Transcriptional repressor shavenbaby) (Transcriptional repressor svb) [Cleaved into: Transcriptional activator shavenbaby (Transcriptional activator svb)],Drosophila melanogaster (Fruit fly),66.4,128.0,4.1e-08,60.8,sp|P51521|OVO_DROME Transcriptional regulator ovo OS=Drosophila melanogaster OX=7227 GN=ovo PE=1 SV=2,GO:0000122; GO:0000978; GO:0000981; GO:0001223; GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0007010; GO:0008270; GO:0008343; GO:0008360; GO:0009913; GO:0016348; GO:0018992; GO:0032196; GO:0035017; GO:0035316; GO:0043565; GO:0045892; GO:0045893; GO:0045944; GO:0048067; GO:0048477; GO:1990837,adult feeding behavior [GO:0008343]; cuticle pattern formation [GO:0035017]; cuticle pigmentation [GO:0048067]; cytoskeleton organization [GO:0007010]; epidermal cell differentiation [GO:0009913]; germ-line sex determination [GO:0018992]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-sensory hair organization [GO:0035316]; oogenesis [GO:0048477]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; regulation of transcription by RNA polymerase II [GO:0006357]; transposition [GO:0032196],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007010; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09499,FUN_041543-T1,Peve_00021435,Pocillopora_meandrina_HIv1___RNAseq.g15962.t2,three_way,59.63633333333333,,,,,,,,,,,,,,,,,
OG_09500,FUN_041544-T1,Peve_00021436,Pocillopora_meandrina_HIv1___RNAseq.g15993.t1,three_way,85.34433333333334,FUN_041544-T1,Q9Z2W1,STK25_MOUSE,,Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1),Mus musculus (Mouse),63.5,417.0,2.7e-143,510.0,sp|Q9Z2W1|STK25_MOUSE Serine/threonine-protein kinase 25 OS=Mus musculus OX=10090 GN=Stk25 PE=1 SV=2,GO:0004674; GO:0005524; GO:0005794; GO:0007163; GO:0007409; GO:0032874; GO:0036481; GO:0042803; GO:0046872; GO:0050772; GO:0051645; GO:0051683; GO:0090168; GO:0090443; GO:0106310,axonogenesis [GO:0007409]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874],FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005794; GO:0007163; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; Golgi apparatus; establishment or maintenance of cell polarity; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09501,FUN_041545-T1,Peve_00000890,Pocillopora_meandrina_HIv1___RNAseq.g15994.t2,three_way,60.269666666666666,FUN_041545-T1,Q80TI0,ASTRB_MOUSE,,Protein Aster-B (GRAM domain-containing protein 1B),Mus musculus (Mouse),34.0,679.0,3.2e-86,321.2,sp|Q80TI0|ASTRB_MOUSE Protein Aster-B OS=Mus musculus OX=10090 GN=Gramd1b PE=1 SV=2,GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268,cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786],GO:0005215; GO:0005886; GO:0008289,transporter activity; plasma membrane; lipid binding
OG_09502,FUN_041546-T1,Peve_00023189,Pocillopora_meandrina_HIv1___RNAseq.g15991.t1,three_way,94.7,FUN_041546-T1,Q5TTG1,,,,,84.8,613.0,1.2e-309,1063.1,sp|Q5TTG1|VATA_ANOGA V-type proton ATPase catalytic subunit A OS=Anopheles gambiae OX=7165 GN=Vha68-2 PE=3 SV=1,,,,,,
OG_09503,FUN_041547-T1,Peve_00023190,Pocillopora_meandrina_HIv1___RNAseq.g15992.t1,three_way,62.568,FUN_041547-T1,Q6DE06,,,,,52.5,202.0,6.7e-57,222.2,sp|Q6DE06|TM2D3_XENLA TM2 domain-containing protein 3 OS=Xenopus laevis OX=8355 GN=tm2d3 PE=2 SV=1,,,,,,
OG_09504,FUN_041548-T1,Peve_00025399,Pocillopora_meandrina_HIv1___RNAseq.g15995.t1,three_way,92.62566666666667,FUN_041548-T1,Q32PI5,2AAA_BOVIN,,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (PP2Aa) (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha),Bos taurus (Bovine),84.9,199.0,4.7e-90,333.6,sp|Q32PI5|2AAA_BOVIN Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform OS=Bos taurus OX=9913 GN=PPP2R1A PE=1 SV=1,GO:0000159; GO:0000775; GO:0000785; GO:0005634; GO:0005737; GO:0005829; GO:0016328; GO:0019888; GO:0030425; GO:0035331; GO:0043029; GO:0051225; GO:0051754; GO:0051898; GO:0090443,"meiotic sister chromatid cohesion, centromeric [GO:0051754]; negative regulation of hippo signaling [GO:0035331]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; spindle assembly [GO:0051225]; T cell homeostasis [GO:0043029]","chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; lateral plasma membrane [GO:0016328]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]",protein phosphatase regulator activity [GO:0019888],GO:0002376; GO:0005634; GO:0005829; GO:0007010; GO:0043226; GO:0098772,immune system process; nucleus; cytosol; cytoskeleton organization; organelle; molecular function regulator activity
OG_09505,FUN_041549-T1,Peve_00033123,Pocillopora_meandrina_HIv1___TS.g10992.t2,three_way,86.3905,FUN_041549-T1,A1A4K8,U2AF1_BOVIN,,Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 snRNP auxiliary factor small subunit),Bos taurus (Bovine),86.2,188.0,1.4e-96,354.0,sp|A1A4K8|U2AF1_BOVIN Splicing factor U2AF 35 kDa subunit OS=Bos taurus OX=9913 GN=U2AF1 PE=2 SV=1,GO:0000398; GO:0005681; GO:0008270; GO:0016607; GO:0030628; GO:0089701,"mRNA splicing, via spliceosome [GO:0000398]",nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701],pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270],GO:0003723; GO:0016071; GO:0043226,RNA binding; mRNA metabolic process; organelle
OG_09506,FUN_041551-T1,Peve_00025197,Pocillopora_meandrina_HIv1___RNAseq.g16000.t2,three_way,86.78033333333333,FUN_041551-T1,Q62829,PAK3_RAT,,Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (p21-activated kinase 3) (PAK-3) (p65-PAK),Rattus norvegicus (Rat),65.6,547.0,2.1e-185,650.2,sp|Q62829|PAK3_RAT Serine/threonine-protein kinase PAK 3 OS=Rattus norvegicus OX=10116 GN=Pak3 PE=1 SV=1,GO:0004672; GO:0004674; GO:0004708; GO:0005524; GO:0005737; GO:0005768; GO:0007409; GO:0009267; GO:0010763; GO:0010975; GO:0014069; GO:0016358; GO:0016477; GO:0017124; GO:0030833; GO:0031267; GO:0032956; GO:0035556; GO:0043408; GO:0043525; GO:0046872; GO:0050770; GO:0051020; GO:0060996; GO:0060997; GO:0061003; GO:0098978; GO:0099175; GO:0106310; GO:2000573,axonogenesis [GO:0007409]; cell migration [GO:0016477]; cellular response to starvation [GO:0009267]; dendrite development [GO:0016358]; dendritic spine development [GO:0060996]; dendritic spine morphogenesis [GO:0060997]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; regulation of neuron projection development [GO:0010975]; regulation of postsynapse organization [GO:0099175],cytoplasm [GO:0005737]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; GTPase binding [GO:0051020]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267],GO:0003824; GO:0005768; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; endosome; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_09507,FUN_041552-T1,Peve_00025202,Pocillopora_meandrina_HIv1___RNAseq.g15999.t1,three_way,89.03266666666666,FUN_041552-T1,Q8NBZ7,,,,,78.6,243.0,1.1e-113,411.0,sp|Q8NBZ7|UXS1_HUMAN UDP-glucuronic acid decarboxylase 1 OS=Homo sapiens OX=9606 GN=UXS1 PE=1 SV=1,,,,,,
OG_09508,FUN_041556-T1,Peve_00033126,Pocillopora_meandrina_HIv1___RNAseq.g16080.t1,three_way,62.22316666666666,FUN_041556-T1,Q6P549,SHIP2_MOUSE,,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)",Mus musculus (Mouse),30.0,330.0,1.1e-19,99.0,"sp|Q6P549|SHIP2_MOUSE Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 OS=Mus musculus OX=10090 GN=Inppl1 PE=1 SV=1",GO:0000132; GO:0000922; GO:0001958; GO:0002376; GO:0003779; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006006; GO:0006629; GO:0006661; GO:0006897; GO:0006915; GO:0007015; GO:0007155; GO:0008285; GO:0009791; GO:0009925; GO:0010467; GO:0010629; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0032880; GO:0034485; GO:0042169; GO:0043491; GO:0046856; GO:0070371; GO:0097178; GO:0110053,actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; lipid metabolic process [GO:0006629]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; regulation of actin filament organization [GO:0110053]; regulation of protein localization [GO:0032880]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178],basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],"actin binding [GO:0003779]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]",GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006629; GO:0007010; GO:0007155; GO:0008092; GO:0012501; GO:0016192; GO:0016787; GO:0043226,immune system process; catalytic activity; nucleus; Golgi apparatus; cytosol; plasma membrane; carbohydrate metabolic process; lipid metabolic process; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; programmed cell death; vesicle-mediated transport; hydrolase activity; organelle
OG_09509,FUN_041557-T1,Peve_00033125,Pocillopora_meandrina_HIv1___RNAseq.g16079.t1,three_way,82.36866666666667,FUN_041557-T1,F1LP64,TRIPC_RAT,,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),Rattus norvegicus (Rat),52.2,1669.0,0.0,1587.8,sp|F1LP64|TRIPC_RAT E3 ubiquitin-protein ligase TRIP12 OS=Rattus norvegicus OX=10116 GN=Trip12 PE=1 SV=1,GO:0000209; GO:0005654; GO:0006281; GO:0006511; GO:0006974; GO:0008270; GO:0016607; GO:0033696; GO:0043161; GO:0045995; GO:0046966; GO:0061630; GO:0140861,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA repair-dependent chromatin remodeling [GO:0140861]; heterochromatin boundary formation [GO:0033696]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],nuclear thyroid hormone receptor binding [GO:0046966]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006281; GO:0006325; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; DNA repair; chromatin organization; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09510,FUN_041562-T1,Peve_00033130,Pocillopora_meandrina_HIv1___RNAseq.g16036.t1,three_way,88.02866666666667,FUN_041562-T1,Q93008,USP9X_HUMAN,,"Ubiquitin carboxyl-terminal hydrolase 9X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)",Homo sapiens (Human),61.0,2508.0,0.0,2993.4,sp|Q93008|USP9X_HUMAN Ubiquitin carboxyl-terminal hydrolase 9X OS=Homo sapiens OX=9606 GN=USP9X PE=1 SV=4,GO:0000122; GO:0001764; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006307; GO:0007059; GO:0007179; GO:0007292; GO:0008104; GO:0008234; GO:0016020; GO:0016477; GO:0016562; GO:0016567; GO:0016579; GO:0030426; GO:0030509; GO:0031647; GO:0032092; GO:0032435; GO:0035520; GO:0042752; GO:0048511; GO:0048675; GO:0050821; GO:0051301; GO:0060271; GO:0061578; GO:0061824; GO:0070410; GO:0070536; GO:0071947; GO:0101005; GO:0140313; GO:0180017; GO:1904515; GO:1990000; GO:1990380,"amyloid fibril formation [GO:1990000]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell division [GO:0051301]; cell migration [GO:0016477]; chromosome segregation [GO:0007059]; cilium assembly [GO:0060271]; cytosolic ciliogenesis [GO:0061824]; DNA alkylation repair [GO:0006307]; female gamete generation [GO:0007292]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of protein binding [GO:0032092]; positive regulation of TORC2 signaling [GO:1904515]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein K63-linked deubiquitination [GO:0070536]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of circadian rhythm [GO:0042752]; regulation of protein stability [GO:0031647]; rhythmic process [GO:0048511]; transforming growth factor beta receptor signaling pathway [GO:0007179]",centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634],co-SMAD binding [GO:0070410]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; deubiquitinase activity [GO:0101005]; K11-linked deubiquitinase activity [GO:0180017]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; molecular sequestering activity [GO:0140313],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0006281; GO:0006355; GO:0007059; GO:0016787; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140096; GO:0140313,"catalytic activity; nucleus; microtubule organizing center; cytosol; cilium; DNA repair; regulation of DNA-templated transcription; chromosome segregation; hydrolase activity; reproductive process; organelle; cilium organization; cell motility; catalytic activity, acting on a protein; molecular sequestering activity"
OG_09511,FUN_041565-T1,Peve_00033117,Pocillopora_meandrina_HIv1___RNAseq.g15976.t1,three_way,84.76766666666667,FUN_041565-T1,O70589,,,,,55.9,942.0,1.7e-296,1020.0,sp|O70589|CSKP_MOUSE Peripheral plasma membrane protein CASK OS=Mus musculus OX=10090 GN=Cask PE=1 SV=2,,,,,,
OG_09512,FUN_041566-T1,Peve_00033115,Pocillopora_meandrina_HIv1___TS.g10998.t1,three_way,76.251,FUN_041566-T1,P57080,UBP25_MOUSE,,Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25) (mUSP25),Mus musculus (Mouse),40.6,1023.0,9.3e-192,672.2,sp|P57080|UBP25_MOUSE Ubiquitin carboxyl-terminal hydrolase 25 OS=Mus musculus OX=10090 GN=Usp25 PE=1 SV=2,GO:0000502; GO:0004843; GO:0005634; GO:0005737; GO:0006511; GO:0006955; GO:0006979; GO:0016071; GO:0016579; GO:0031098; GO:0097400; GO:0101005,immune response [GO:0006955]; interleukin-17-mediated signaling pathway [GO:0097400]; mRNA metabolic process [GO:0016071]; protein deubiquitination [GO:0016579]; response to oxidative stress [GO:0006979]; stress-activated protein kinase signaling cascade [GO:0031098]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502],cysteine-type deubiquitinase activity [GO:0004843]; deubiquitinase activity [GO:0101005],GO:0002376; GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09513,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,27.8,752.0,2.7e-39,166.4,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_09513,FUN_041567-T1,Peve_00033111,Pocillopora_meandrina_HIv1___RNAseq.g15979.t1,three_way,54.623333333333335,FUN_041567-T1,Q924A2,,,,,36.9,187.0,1.8e-19,100.5,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_09514,FUN_041569-T1,Peve_00033110,Pocillopora_meandrina_HIv1___RNAseq.g15980.t1,three_way,70.16366666666667,FUN_041569-T1,Q5U239,,,,,48.1,399.0,5.6e-110,399.4,sp|Q5U239|TM145_XENLA Transmembrane protein 145 OS=Xenopus laevis OX=8355 GN=tmem145 PE=2 SV=1,,,,,,
OG_09515,FUN_041574-T1,Peve_00028456,Pocillopora_meandrina_HIv1___TS.g10953.t2,three_way,76.517,FUN_041574-T1,Q86BN8,,,,,47.2,195.0,5.9e-47,188.7,sp|Q86BN8|PTPM1_DROME Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 OS=Drosophila melanogaster OX=7227 GN=PTPMT1 PE=2 SV=1,,,,,,
OG_09516,FUN_041575-T1,Peve_00028457,Pocillopora_meandrina_HIv1___RNAseq.g15935.t1,three_way,72.03699999999999,FUN_041575-T1,Q32KS0,,,,,30.6,222.0,7.3e-16,86.7,sp|Q32KS0|TBCE_BOVIN Tubulin-specific chaperone E OS=Bos taurus OX=9913 GN=TBCE PE=2 SV=1,,,,,,
OG_09517,FUN_041576-T1,Peve_00028458,Pocillopora_meandrina_HIv1___RNAseq.g15933.t1,three_way,67.36333333333333,FUN_041576-T1,Q7ZZ00,,,,,35.4,237.0,6.799999999999998e-35,149.1,sp|Q7ZZ00|ZN511_DANRE Zinc finger protein 511 OS=Danio rerio OX=7955 GN=znf511 PE=2 SV=1,,,,,,
OG_09518,FUN_041578-T1,Peve_00028459,Pocillopora_meandrina_HIv1___TS.g10950.t2,three_way,69.42166666666667,FUN_041578-T1,Q6GPD0,,,,,44.5,659.0,2.9e-150,534.3,sp|Q6GPD0|RHG32_XENLA Rho GTPase-activating protein 32 OS=Xenopus laevis OX=8355 GN=arhgap32 PE=2 SV=1,,,,,,
OG_09519,FUN_041579-T1,Peve_00028461,Pocillopora_meandrina_HIv1___RNAseq.g15926.t1,three_way,73.14333333333333,FUN_041579-T1,P07221,,,,,34.3,344.0,6.5e-56,219.5,sp|P07221|CASQ1_RABIT Calsequestrin-1 OS=Oryctolagus cuniculus OX=9986 GN=CASQ1 PE=1 SV=1,,,,,,
OG_09520,FUN_041580-T1,Peve_00028462,Pocillopora_meandrina_HIv1___RNAseq.g15925.t1,three_way,85.135,FUN_041580-T1,Q2KIN5,,,,,57.0,279.0,6.7e-82,305.4,sp|Q2KIN5|HEM3_BOVIN Porphobilinogen deaminase OS=Bos taurus OX=9913 GN=HMBS PE=2 SV=1,,,,,,
OG_09521,FUN_041581-T1,Peve_00028463,Pocillopora_meandrina_HIv1___RNAseq.g15924.t1,three_way,61.268,FUN_041581-T1,Q8SPH6,,,,,41.1,95.0,2.4e-10,66.2,"sp|Q8SPH6|ATP5J_MACFA ATP synthase peripheral stalk subunit F6, mitochondrial OS=Macaca fascicularis OX=9541 GN=ATP5PF PE=3 SV=1",,,,,,
OG_09522,FUN_041582-T1,Peve_00028464,Pocillopora_meandrina_HIv1___RNAseq.g15923.t1,three_way,86.17166666666667,FUN_041582-T1,Q6DGL7,TM147_DANRE,,BOS complex subunit TMEM147 (Transmembrane protein 147),Danio rerio (Zebrafish) (Brachydanio rerio),59.7,221.0,5.9e-73,275.4,sp|Q6DGL7|TM147_DANRE BOS complex subunit TMEM147 OS=Danio rerio OX=7955 GN=tmem147 PE=2 SV=1,GO:0005789; GO:0005886; GO:0031965; GO:0036228; GO:0043022; GO:0160063,multi-pass transmembrane protein insertion into ER membrane [GO:0160063]; protein localization to nuclear inner membrane [GO:0036228],endoplasmic reticulum membrane [GO:0005789]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886],ribosome binding [GO:0043022],GO:0005886,plasma membrane
OG_09523,FUN_041584-T1,Peve_00028467,Pocillopora_meandrina_HIv1___RNAseq.g15263.t1,three_way,60.64533333333333,FUN_041584-T1,O02824,,,,,25.6,317.0,7.5e-28,126.3,sp|O02824|ADA1A_RABIT Alpha-1A adrenergic receptor OS=Oryctolagus cuniculus OX=9986 GN=ADRA1A PE=2 SV=1,,,,,,
OG_09524,FUN_041586-T1,Peve_00028474,Pocillopora_meandrina_HIv1___RNAseq.g15266.t1,three_way,66.81083333333333,FUN_041586-T1,Q4VSN4,DUSTY_CANLF,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Canis lupus familiaris (Dog) (Canis familiaris),27.4,893.0,3.3000000000000003e-80,301.6,sp|Q4VSN4|DUSTY_CANLF Dual serine/threonine and tyrosine protein kinase OS=Canis lupus familiaris OX=9615 GN=DSTYK PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0033674; GO:0043066; GO:0044344; GO:0045743; GO:0070161; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of kinase activity [GO:0033674],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09525,FUN_041593-T1,Peve_00036096,Pocillopora_meandrina_HIv1___RNAseq.g15279.t1,three_way,53.03233333333333,,,,,,,,,,,,,,,,,
OG_09526,FUN_041594-T1,Peve_00036095,Pocillopora_meandrina_HIv1___RNAseq.g15282.t1,three_way,68.71033333333334,FUN_041594-T1,P81134,RENR_BOVIN,,Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (V-ATPase M8.9 subunit) [Cleaved into: Renin receptor extracellular fragment; Renin receptor cytoplasmic fragment],Bos taurus (Bovine),47.4,57.0,1.4e-07,59.3,sp|P81134|RENR_BOVIN Renin receptor OS=Bos taurus OX=9913 GN=ATP6AP2 PE=1 SV=2,GO:0000220; GO:0000421; GO:0005765; GO:0005789; GO:0007042; GO:0009897; GO:0010008; GO:0030177; GO:0030424; GO:0030665; GO:0030672; GO:0032591; GO:0038023; GO:0045211; GO:0045851; GO:0090263; GO:1902600,lysosomal lumen acidification [GO:0007042]; pH reduction [GO:0045851]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; proton transmembrane transport [GO:1902600],"autophagosome membrane [GO:0000421]; axon [GO:0030424]; clathrin-coated vesicle membrane [GO:0030665]; dendritic spine membrane [GO:0032591]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; lysosomal membrane [GO:0005765]; postsynaptic membrane [GO:0045211]; synaptic vesicle membrane [GO:0030672]; vacuolar proton-transporting V-type ATPase, V0 domain [GO:0000220]",signaling receptor activity [GO:0038023],GO:0055085; GO:0060089,transmembrane transport; molecular transducer activity
OG_09527,FUN_041595-T1,Peve_00036094,Pocillopora_meandrina_HIv1___RNAseq.g15283.t1,three_way,62.94383333333334,FUN_041595-T1,A2AQH4,,,,,38.7,331.0,1.8e-09,67.0,sp|A2AQH4|BCORL_MOUSE BCL-6 corepressor-like protein 1 OS=Mus musculus OX=10090 GN=Bcorl1 PE=2 SV=1,,,,,,
OG_09528,FUN_041599-T1,Peve_00025739,Pocillopora_meandrina_HIv1___RNAseq.g15300.t1,three_way,61.832,,,,,,,,,,,,,,,,,
OG_09529,FUN_041606-T1,Peve_00025723,Pocillopora_meandrina_HIv1___TS.g10333.t1,three_way,67.37066666666666,FUN_041606-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),33.2,304.0,1.2e-38,162.2,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_09530,FUN_041607-T1,Peve_00026860,Pocillopora_meandrina_HIv1___RNAseq.g15307.t1,three_way,78.76933333333334,FUN_041607-T1,P49748,ACADV_HUMAN,,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)",Homo sapiens (Human),64.5,595.0,5.3e-212,738.8,"sp|P49748|ACADV_HUMAN Very long-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens OX=9606 GN=ACADVL PE=1 SV=1",GO:0000062; GO:0001659; GO:0003995; GO:0004466; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0009409; GO:0015980; GO:0017099; GO:0030855; GO:0031966; GO:0033539; GO:0042645; GO:0042802; GO:0045717; GO:0046322; GO:0050660; GO:0090181,energy derivation by oxidation of organic compounds [GO:0015980]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; long-chain fatty acyl-CoA dehydrogenase activity [GO:0004466]; very-long-chain fatty acyl-CoA dehydrogenase activity [GO:0017099],GO:0003824; GO:0005654; GO:0005730; GO:0005739; GO:0006091; GO:0006629; GO:0008289; GO:0016491; GO:0030154; GO:0043226,catalytic activity; nucleoplasm; nucleolus; mitochondrion; generation of precursor metabolites and energy; lipid metabolic process; lipid binding; oxidoreductase activity; cell differentiation; organelle
OG_09531,FUN_041609-T1,Peve_00036118,Pocillopora_meandrina_HIv1___RNAseq.g15296.t1,three_way,62.51383333333334,,,,,,,,,,,,,,,,,
OG_09532,FUN_041610-T1,Peve_00036122,Pocillopora_meandrina_HIv1___RNAseq.g15295.t1,three_way,47.48716666666667,,,,,,,,,,,,,,,,,
OG_09533,FUN_041619-T1,Peve_00036077,Pocillopora_meandrina_HIv1___RNAseq.g15288.t1,three_way,59.80466666666667,FUN_041619-T1,P22182,,,,,38.7,318.0,7.2e-49,196.4,sp|P22182|FGFR1_XENLA Fibroblast growth factor receptor 1 OS=Xenopus laevis OX=8355 GN=fgfr1 PE=1 SV=1,,,,,,
OG_09534,FUN_041620-T1,Peve_00036082,Pocillopora_meandrina_HIv1___RNAseq.g15287.t1,three_way,58.816,FUN_041620-T1,P48442,CASR_RAT,,Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR),Rattus norvegicus (Rat),30.8,840.0,4.6e-80,300.8,sp|P48442|CASR_RAT Extracellular calcium-sensing receptor OS=Rattus norvegicus OX=10116 GN=Casr PE=1 SV=1,GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; vasodilation [GO:0042311],apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0005886; GO:0048856; GO:0055085; GO:0060089,circulatory system process; plasma membrane; anatomical structure development; transmembrane transport; molecular transducer activity
OG_09535,FUN_041622-T1,Peve_00036084,Pocillopora_meandrina_HIv1___TS.g10312.t1b,three_way,81.132,FUN_041622-T1,P41247,PLPL4_HUMAN,,Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2),Homo sapiens (Human),48.4,248.0,4.8e-61,236.1,sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3,GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088,lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739],"acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806]",GO:0003824; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_09536,FUN_041630-T1,Peve_00023649,Pocillopora_meandrina_HIv1___RNAseq.g14228.t1,three_way,83.92399999999999,FUN_041630-T1,Q6P825,,,,,56.2,283.0,1.4e-94,347.8,sp|Q6P825|TOM40_XENTR Mitochondrial import receptor subunit TOM40 homolog OS=Xenopus tropicalis OX=8364 GN=tomm40 PE=2 SV=1,,,,,,
OG_09537,FUN_041631-T1,Peve_00023648,Pocillopora_meandrina_HIv1___RNAseq.g14227.t1,three_way,71.397,FUN_041631-T1,Q62384,,,,,54.9,435.0,2.6000000000000003e-133,476.9,sp|Q62384|ZPR1_MOUSE Zinc finger protein ZPR1 OS=Mus musculus OX=10090 GN=Zpr1 PE=1 SV=1,,,,,,
OG_09538,FUN_041632-T1,Peve_00023647,Pocillopora_meandrina_HIv1___RNAseq.g14226.t1,three_way,47.36566666666667,,,,,,,,,,,,,,,,,
OG_09539,FUN_041633-T1,Peve_00023646,Pocillopora_meandrina_HIv1___RNAseq.g14223.t1,three_way,72.00033333333333,FUN_041633-T1,Q47898,ASPG_ELIMR,,N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain],Elizabethkingia miricola (Chryseobacterium miricola),40.3,119.0,4.7e-17,89.0,sp|Q47898|ASPG_ELIMR N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase OS=Elizabethkingia miricola OX=172045 PE=1 SV=1,GO:0003948; GO:0005737; GO:0006508; GO:0008233; GO:0042597,proteolysis [GO:0006508],cytoplasm [GO:0005737]; periplasmic space [GO:0042597],N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_09540,FUN_041634-T1,Peve_00023645,Pocillopora_meandrina_HIv1___RNAseq.g14222.t1,three_way,82.26466666666667,FUN_041634-T1,Q9H0K1,SIK2_HUMAN,,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),Homo sapiens (Human),46.9,631.0,4.8999999999999996e-135,483.4,sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens OX=9606 GN=SIK2 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0046626; GO:0046777; GO:0106310,intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09541,FUN_041635-T1,Peve_00023644,Pocillopora_meandrina_HIv1___RNAseq.g14220.t1,three_way,80.10966666666667,FUN_041635-T1,Q6DJI4,,,,,50.6,83.0,6.9e-13,74.7,sp|Q6DJI4|RM41A_XENLA Large ribosomal subunit protein mL41A OS=Xenopus laevis OX=8355 GN=mrpl41-a PE=2 SV=1,,,,,,
OG_09542,FUN_041636-T1,Peve_00023643,Pocillopora_meandrina_HIv1___RNAseq.g14219.t1,three_way,57.825,,,,,,,,,,,,,,,,,
OG_09543,FUN_041638-T1,Peve_00040173,Pocillopora_meandrina_HIv1___RNAseq.g14218.t1,three_way,75.633,FUN_041638-T1,Q6P4S6,SIK3_MOUSE,,Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK),Mus musculus (Mouse),44.5,643.0,6.7e-122,440.3,sp|Q6P4S6|SIK3_MOUSE Serine/threonine-protein kinase SIK3 OS=Mus musculus OX=10090 GN=Sik3 PE=1 SV=4,GO:0000287; GO:0001958; GO:0004674; GO:0005524; GO:0005737; GO:0006468; GO:0032880; GO:0035108; GO:0035264; GO:0048705; GO:0060351; GO:0106310; GO:1904263; GO:1904515,cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; limb morphogenesis [GO:0035108]; multicellular organism growth [GO:0035264]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of TORC2 signaling [GO:1904515]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705],cytoplasm [GO:0005737],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_09544,FUN_041639-T1,Peve_00007388,Pocillopora_meandrina_HIv1___RNAseq.g14209.t1,three_way,52.72933333333334,,,,,,,,,,,,,,,,,
OG_09545,FUN_041642-T1,Peve_00007386,Pocillopora_meandrina_HIv1___RNAseq.g14207.t1,three_way,91.14133333333334,FUN_041642-T1,Q13620,,,,,73.3,580.0,1.9e-245,849.7,sp|Q13620|CUL4B_HUMAN Cullin-4B OS=Homo sapiens OX=9606 GN=CUL4B PE=1 SV=4,,,,,,
OG_09546,FUN_041644-T1,Peve_00037268,Pocillopora_meandrina_HIv1___RNAseq.g14206.t1,three_way,62.803333333333335,FUN_041644-T1,Q10751,ACE_CHICK,,Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II),Gallus gallus (Chicken),41.6,587.0,1.4e-125,451.8,sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2,GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573,angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030154; GO:0048856; GO:0050886; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; cell differentiation; anatomical structure development; endocrine process; protein maturation; catalytic activity, acting on a protein"
OG_09547,FUN_041645-T1,Peve_00000469,Pocillopora_meandrina_HIv1___RNAseq.g14205.t1,three_way,76.259,FUN_041645-T1,Q10751,ACE_CHICK,,Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II),Gallus gallus (Chicken),52.3,583.0,2.7e-176,620.2,sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2,GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573,angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030154; GO:0048856; GO:0050886; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; cell differentiation; anatomical structure development; endocrine process; protein maturation; catalytic activity, acting on a protein"
OG_09548,FUN_041647-T1,Peve_00000475,Pocillopora_meandrina_HIv1___RNAseq.g14158.t1b,three_way,82.60300000000001,FUN_041647-T1,A7RR04,EFGM_NEMVE,,"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)",Nematostella vectensis (Starlet sea anemone),76.9,606.0,1.9e-275,949.5,"sp|A7RR04|EFGM_NEMVE Elongation factor G, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g236547 PE=3 SV=1",GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125,mitochondrial translational elongation [GO:0070125],mitochondrion [GO:0005739],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005739; GO:0016787; GO:0043226,catalytic activity; GTPase activity; mitochondrion; hydrolase activity; organelle
OG_09549,FUN_041648-T1,Peve_00000476,Pocillopora_meandrina_HIv1___TS.g11937.t1,three_way,62.53166666666666,FUN_041648-T1,B1KHT1,,,,,36.7,120.0,1.2e-13,78.6,sp|B1KHT1|TPMT_SHEWM Thiopurine S-methyltransferase OS=Shewanella woodyi (strain ATCC 51908 / MS32) OX=392500 GN=tpm PE=3 SV=1,,,,,,
OG_09550,FUN_041650-T1,Peve_00000473,Pocillopora_meandrina_HIv1___RNAseq.g14154.t1,three_way,53.79916666666667,FUN_041650-T1,Q9P2K2,TXD16_HUMAN,,Thioredoxin domain-containing protein 16,Homo sapiens (Human),26.4,250.0,2.4e-15,86.3,sp|Q9P2K2|TXD16_HUMAN Thioredoxin domain-containing protein 16 OS=Homo sapiens OX=9606 GN=TXNDC16 PE=1 SV=4,GO:0005788; GO:0070062,,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062],,GO:0043226,organelle
OG_09551,FUN_041651-T1,Peve_00000466,Pocillopora_meandrina_HIv1___RNAseq.g14153.t1,three_way,42.71266666666666,,,,,,,,,,,,,,,,,
OG_09552,FUN_041652-T1,Peve_00012481,Pocillopora_meandrina_HIv1___RNAseq.g13865.t1,three_way,59.31333333333333,FUN_041652-T1,O15266,SHOX_HUMAN,,Short stature homeobox protein (Pseudoautosomal homeobox-containing osteogenic protein) (Short stature homeobox-containing protein),Homo sapiens (Human),49.1,106.0,4.9e-20,99.8,sp|O15266|SHOX_HUMAN Short stature homeobox protein OS=Homo sapiens OX=9606 GN=SHOX PE=1 SV=1,GO:0000785; GO:0000981; GO:0001228; GO:0001501; GO:0005634; GO:0005654; GO:0006357; GO:0043231; GO:0043565; GO:0045944; GO:1990837,positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal system development [GO:0001501],chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_09553,FUN_041653-T1,Peve_00012482,Pocillopora_meandrina_HIv1___RNAseq.g13863.t1,three_way,65.15316666666666,,,,,,,,,,,,,,,,,
OG_09554,FUN_041657-T1,Peve_00033087,Pocillopora_meandrina_HIv1___RNAseq.g13861.t2,three_way,47.284333333333336,,,,,,,,,,,,,,,,,
OG_09555,FUN_041658-T1,Peve_00033089,Pocillopora_meandrina_HIv1___RNAseq.g13859.t2,three_way,82.45566666666667,FUN_041658-T1,Q5XGI1,KMCP1_XENTR,,Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),57.3,293.0,1.8e-93,344.0,sp|Q5XGI1|KMCP1_XENTR Kidney mitochondrial carrier protein 1 OS=Xenopus tropicalis OX=8364 GN=slc25a30 PE=2 SV=1,GO:0005452; GO:0005743; GO:0015698,inorganic anion transport [GO:0015698],mitochondrial inner membrane [GO:0005743],solute:inorganic anion antiporter activity [GO:0005452],GO:0005215,transporter activity
OG_09556,FUN_041659-T1,Peve_00033090,Pocillopora_meandrina_HIv1___RNAseq.g13858.t1,three_way,62.041,FUN_041659-T1,P39963,,,,,55.5,274.0,1e-79,298.9,sp|P39963|CCNB3_CHICK G2/mitotic-specific cyclin-B3 OS=Gallus gallus OX=9031 GN=CCNB3 PE=2 SV=1,,,,,,
OG_09557,FUN_041660-T1,Peve_00033088,Pocillopora_meandrina_HIv1___RNAseq.g13860.t1,three_way,66.66033333333334,,,,,,,,,,,,,,,,,
OG_09558,FUN_041662-T1,Peve_00033099,Pocillopora_meandrina_HIv1___RNAseq.g14009.t1,three_way,75.99116666666667,FUN_041662-T1,Q9P2U8,VGLU2_HUMAN,,Vesicular glutamate transporter 2 (VGluT2) (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6),Homo sapiens (Human),46.6,453.0,7.9999999999999995e-115,415.6,sp|Q9P2U8|VGLU2_HUMAN Vesicular glutamate transporter 2 OS=Homo sapiens OX=9606 GN=SLC17A6 PE=1 SV=1,GO:0005254; GO:0005313; GO:0005326; GO:0005436; GO:0005886; GO:0006811; GO:0006817; GO:0015386; GO:0030672; GO:0034707; GO:0035249; GO:0043005; GO:0044341; GO:0050803; GO:0051938; GO:0055062; GO:0060076; GO:0098700; GO:0140788; GO:1990384,"hyaloid vascular plexus regression [GO:1990384]; L-glutamate import [GO:0051938]; monoatomic ion transport [GO:0006811]; neurotransmitter loading into synaptic vesicle [GO:0098700]; phosphate ion homeostasis [GO:0055062]; phosphate ion transport [GO:0006817]; regulation of synapse structure or activity [GO:0050803]; sodium-dependent phosphate transport [GO:0044341]; synaptic transmission, glutamatergic [GO:0035249]",chloride channel complex [GO:0034707]; excitatory synapse [GO:0060076]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],chloride channel activity [GO:0005254]; L-glutamate transmembrane transporter activity [GO:0005313]; L-glutamate uniporter activity [GO:0140788]; neurotransmitter transmembrane transporter activity [GO:0005326]; potassium:proton antiporter activity [GO:0015386]; sodium:phosphate symporter activity [GO:0005436],GO:0005215; GO:0005886; GO:0023052,transporter activity; plasma membrane; signaling
OG_09559,FUN_041668-T1,Peve_00041077,Pocillopora_meandrina_HIv1___TS.g11779.t1,three_way,59.742,FUN_041668-T1,O88871,GABR2_RAT,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51),Rattus norvegicus (Rat),39.2,745.0,8.899999999999999e-153,542.7,sp|O88871|GABR2_RAT Gamma-aminobutyric acid type B receptor subunit 2 OS=Rattus norvegicus OX=10116 GN=Gabbr2 PE=1 SV=2,GO:0004965; GO:0005737; GO:0005886; GO:0007193; GO:0007214; GO:0030425; GO:0038039; GO:0042734; GO:0043005; GO:0043204; GO:0045211; GO:0046982; GO:0051932; GO:0098978; GO:0098982; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; gamma-aminobutyric acid signaling pathway [GO:0007214]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; dendrite [GO:0030425]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_09560,FUN_041669-T1,Peve_00031770,Pocillopora_meandrina_HIv1___RNAseq.g13997.t1,three_way,78.03516666666667,FUN_041669-T1,Q32NT4,,,,,52.5,118.0,7.100000000000001e-28,126.3,sp|Q32NT4|LRC58_XENLA Leucine-rich repeat-containing protein 58 OS=Xenopus laevis OX=8355 GN=lrrc58 PE=2 SV=1,,,,,,
OG_09561,FUN_041671-T1,Peve_00029014,Pocillopora_meandrina_HIv1___RNAseq.g14002.t1,three_way,76.55633333333333,FUN_041671-T1,A2VE52,ORN_BOVIN,,"Oligoribonuclease, mitochondrial (EC 3.1.15.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)",Bos taurus (Bovine),66.5,176.0,8.299999999999999e-68,258.1,"sp|A2VE52|ORN_BOVIN Oligoribonuclease, mitochondrial OS=Bos taurus OX=9913 GN=REXO2 PE=2 SV=1",GO:0000175; GO:0000287; GO:0003676; GO:0005634; GO:0005730; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005925; GO:0008296; GO:0008408,,cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634],3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; 3'-5'-RNA exonuclease activity [GO:0000175]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676],GO:0003824; GO:0005634; GO:0005730; GO:0005739; GO:0016787; GO:0043226; GO:0140097; GO:0140098,"catalytic activity; nucleus; nucleolus; mitochondrion; hydrolase activity; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA"
OG_09562,FUN_041672-T1,Peve_00007760,Pocillopora_meandrina_HIv1___RNAseq.g14001.t1,three_way,59.1795,,,,,,,,,,,,,,,,,
OG_09563,FUN_041673-T1,Peve_00031771,Pocillopora_meandrina_HIv1___RNAseq.g14000.t1,three_way,72.09633333333333,,,,,,,,,,,,,,,,,
OG_09564,FUN_041674-T1,Peve_00007763,Pocillopora_meandrina_HIv1___RNAseq.g14003.t1,three_way,80.41466666666666,FUN_041674-T1,Q9H0N5,PHS2_HUMAN,,Pterin-4-alpha-carbinolamine dehydratase 2 (PHS 2) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase 2) (DcoH-like protein DCoHm) (Dimerization cofactor of hepatocyte nuclear factor 1 from muscle) (HNF-1-alpha dimerization cofactor),Homo sapiens (Human),64.3,126.0,1.1e-36,154.1,sp|Q9H0N5|PHS2_HUMAN Pterin-4-alpha-carbinolamine dehydratase 2 OS=Homo sapiens OX=9606 GN=PCBD2 PE=1 SV=4,GO:0005739; GO:0006729; GO:0008124; GO:0045893,positive regulation of DNA-templated transcription [GO:0045893]; tetrahydrobiopterin biosynthetic process [GO:0006729],mitochondrion [GO:0005739],4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124],GO:0003824; GO:0005739; GO:0006355; GO:0016829; GO:0043226,catalytic activity; mitochondrion; regulation of DNA-templated transcription; lyase activity; organelle
OG_09565,FUN_041675-T1,Peve_00009958,Pocillopora_meandrina_HIv1___RNAseq.g14004.t1,three_way,61.77533333333333,FUN_041675-T1,Q5R7U2,PEX19_PONAB,,Peroxisomal biogenesis factor 19 (Peroxin-19) (Peroxisomal farnesylated protein),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),39.1,276.0,2.5e-42,174.1,sp|Q5R7U2|PEX19_PONAB Peroxisomal biogenesis factor 19 OS=Pongo abelii OX=9601 GN=PEX19 PE=2 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005778; GO:0005829; GO:0006625; GO:0007031; GO:0016020; GO:0016557; GO:0016559; GO:0032991; GO:0036105; GO:0045046; GO:0050821; GO:0051117; GO:0061077; GO:0140597,chaperone-mediated protein folding [GO:0061077]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; protein-containing complex [GO:0032991],ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; protein carrier chaperone [GO:0140597],GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0007031; GO:0043226; GO:0140104,nucleus; nucleoplasm; cytosol; intracellular protein transport; peroxisome organization; organelle; molecular carrier activity
OG_09566,FUN_041688-T1,Peve_00041074,Pocillopora_meandrina_HIv1___RNAseq.25430_t,three_way,47.72233333333333,,,,,,,,,,,,,,,,,
OG_09567,FUN_041691-T1,Peve_00041081,Pocillopora_meandrina_HIv1___TS.g11766.t1a,three_way,79.19200000000001,FUN_041691-T1,Q9Y0H3,,,,,62.6,139.0,2e-47,189.9,sp|Q9Y0H3|RS19_MYXGL Small ribosomal subunit protein eS19 OS=Myxine glutinosa OX=7769 GN=rps19 PE=2 SV=1,,,,,,
OG_09568,FUN_041699-T1,Peve_00004376,Pocillopora_meandrina_HIv1___TS.g11737.t1,three_way,75.67750000000001,FUN_041699-T1,P17635,,,,,34.0,503.0,4.8e-70,266.9,sp|P17635|FMO2_RABIT Dimethylaniline monooxygenase [N-oxide-forming] 2 OS=Oryctolagus cuniculus OX=9986 GN=FMO2 PE=1 SV=3,,,,,,
OG_09569,FUN_041700-T1,Peve_00004374,Pocillopora_meandrina_HIv1___RNAseq.g13955.t1,three_way,80.44200000000001,FUN_041700-T1,P49585,PCY1A_HUMAN,,Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A),Homo sapiens (Human),42.7,375.0,6.1e-72,272.7,sp|P49585|PCY1A_HUMAN Choline-phosphate cytidylyltransferase A OS=Homo sapiens OX=9606 GN=PCYT1A PE=1 SV=2,GO:0004105; GO:0005516; GO:0005634; GO:0005635; GO:0005783; GO:0005789; GO:0005829; GO:0006656; GO:0006657; GO:0031210; GO:0042100; GO:0042587; GO:0042802; GO:0042803; GO:0045190; GO:0140678,B cell proliferation [GO:0042100]; CDP-choline pathway [GO:0006657]; isotype switching [GO:0045190]; phosphatidylcholine biosynthetic process [GO:0006656],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; glycogen granule [GO:0042587]; nuclear envelope [GO:0005635]; nucleus [GO:0005634],calmodulin binding [GO:0005516]; choline-phosphate cytidylyltransferase activity [GO:0004105]; identical protein binding [GO:0042802]; molecular function inhibitor activity [GO:0140678]; phosphatidylcholine binding [GO:0031210]; protein homodimerization activity [GO:0042803],GO:0002376; GO:0003824; GO:0005634; GO:0005635; GO:0005783; GO:0005829; GO:0006310; GO:0006629; GO:0008289; GO:0016740; GO:0043226; GO:0098772,immune system process; catalytic activity; nucleus; nuclear envelope; endoplasmic reticulum; cytosol; DNA recombination; lipid metabolic process; lipid binding; transferase activity; organelle; molecular function regulator activity
OG_09570,FUN_041701-T1,Peve_00004373,Pocillopora_meandrina_HIv1___RNAseq.g13956.t1,three_way,61.80266666666666,FUN_041701-T1,A6H694,,,,,51.6,312.0,4.7e-19,97.8,sp|A6H694|LRC63_MOUSE Leucine-rich repeat-containing protein 63 OS=Mus musculus OX=10090 GN=Lrrc63 PE=2 SV=2,,,,,,
OG_09571,FUN_041702-T1,Peve_00004372,Pocillopora_meandrina_HIv1___RNAseq.g13968.t1,three_way,73.64,,,,,,,,,,,,,,,,,
OG_09572,FUN_041703-T1,Peve_00004371,Pocillopora_meandrina_HIv1___RNAseq.g13969.t1,three_way,83.44083333333333,FUN_041703-T1,Q9R062,,,,,48.6,329.0,7.9e-90,332.0,sp|Q9R062|GLYG_MOUSE Glycogenin-1 OS=Mus musculus OX=10090 GN=Gyg1 PE=1 SV=3,,,,,,
OG_09573,FUN_041705-T1,Peve_00001480,Pocillopora_meandrina_HIv1___RNAseq.g13973.t1,three_way,45.37833333333334,FUN_041705-T1,Q95VY2,,,,,43.7,174.0,1.7000000000000002e-32,140.6,sp|Q95VY2|TCTP_BRABE Translationally-controlled tumor protein homolog OS=Branchiostoma belcheri OX=7741 PE=2 SV=1,,,,,,
OG_09574,FUN_041706-T2,Peve_00001479,Pocillopora_meandrina_HIv1___RNAseq.g13974.t1,three_way,47.231,FUN_041706-T2,Q8BQ48,CE295_MOUSE,,Centrosomal protein of 295 kDa,Mus musculus (Mouse),29.4,452.0,1.2e-32,144.1,sp|Q8BQ48|CE295_MOUSE Centrosomal protein of 295 kDa OS=Mus musculus OX=10090 GN=Cep295 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0008017; GO:0010825; GO:0030030; GO:1901985; GO:1903724; GO:1904951; GO:1990498,cell projection organization [GO:0030030]; centriole replication [GO:0007099]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; mitotic spindle microtubule [GO:1990498],microtubule binding [GO:0008017],GO:0005815; GO:0008092; GO:0043226,microtubule organizing center; cytoskeletal protein binding; organelle
OG_09575,FUN_041710-T1,Peve_00021477,Pocillopora_meandrina_HIv1___RNAseq.g13976.t1,three_way,87.94433333333333,FUN_041710-T1,Q91ZA3,PCCA_MOUSE,,"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)",Mus musculus (Mouse),62.9,642.0,5.4e-229,795.4,"sp|Q91ZA3|PCCA_MOUSE Propionyl-CoA carboxylase alpha chain, mitochondrial OS=Mus musculus OX=10090 GN=Pcca PE=1 SV=2",GO:0004658; GO:0005524; GO:0005739; GO:0005759; GO:0016042; GO:0019899; GO:0046872; GO:1902494,lipid catabolic process [GO:0016042],catalytic complex [GO:1902494]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],GO:0003824; GO:0005739; GO:0006629; GO:0016874; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; ligase activity; organelle
OG_09576,FUN_041711-T1,Peve_00034441,Pocillopora_meandrina_HIv1___RNAseq.g13977.t1,three_way,99.00466666666668,FUN_041711-T1,Q9VC49,,,,,95.5,67.0,5.1e-33,141.0,"sp|Q9VC49|RPAB5_DROME DNA-directed RNA polymerases I, II, and III subunit RPABC5 OS=Drosophila melanogaster OX=7227 GN=Polr2L PE=1 SV=1",,,,,,
OG_09577,FUN_041712-T1,Peve_00021480,Pocillopora_meandrina_HIv1___RNAseq.g13978.t1,three_way,69.24766666666667,,,,,,,,,,,,,,,,,
OG_09578,FUN_041713-T1,Peve_00001623,Pocillopora_meandrina_HIv1___RNAseq.g13949.t1,three_way,68.122,FUN_041713-T1,Q8VIG3,RSPH1_MOUSE,,Radial spoke head 1 homolog (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),Mus musculus (Mouse),65.5,194.0,1.2e-14,81.6,sp|Q8VIG3|RSPH1_MOUSE Radial spoke head 1 homolog OS=Mus musculus OX=10090 GN=Rsph1 PE=1 SV=2,GO:0000794; GO:0001520; GO:0001534; GO:0001535; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007286; GO:0007618; GO:0030317; GO:0031514; GO:0035082; GO:0036126; GO:0051321; GO:0072687; GO:0097729; GO:0120336; GO:0120338,axoneme assembly [GO:0035082]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; flagellated sperm motility [GO:0030317]; mating [GO:0007618]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; radial spoke [GO:0001534]; radial spoke head [GO:0001535]; radial spoke head 1 [GO:0120336]; radial spoke head 3 [GO:0120338]; sperm flagellum [GO:0036126],,GO:0000228; GO:0005576; GO:0005694; GO:0005929; GO:0007010; GO:0007018; GO:0022414; GO:0043226; GO:0048856; GO:0048870,nuclear chromosome; extracellular region; chromosome; cilium; cytoskeleton organization; microtubule-based movement; reproductive process; organelle; anatomical structure development; cell motility
OG_09579,FUN_041717-T1,Peve_00024455,Pocillopora_meandrina_HIv1___RNAseq.g13945.t1,three_way,63.239333333333335,FUN_041717-T1,O43543,XRCC2_HUMAN,,DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2),Homo sapiens (Human),35.3,252.0,5.1e-35,149.4,sp|O43543|XRCC2_HUMAN DNA repair protein XRCC2 OS=Homo sapiens OX=9606 GN=XRCC2 PE=1 SV=1,GO:0000278; GO:0000724; GO:0001701; GO:0001756; GO:0003677; GO:0005524; GO:0005654; GO:0005657; GO:0005737; GO:0005813; GO:0006281; GO:0007098; GO:0010165; GO:0010332; GO:0022008; GO:0033063; GO:0035264; GO:0042148; GO:0043231; GO:0043524; GO:0050769; GO:0051321; GO:0140664; GO:2000269,centrosome cycle [GO:0007098]; DNA repair [GO:0006281]; DNA strand invasion [GO:0042148]; double-strand break repair via homologous recombination [GO:0000724]; in utero embryonic development [GO:0001701]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; multicellular organism growth [GO:0035264]; negative regulation of neuron apoptotic process [GO:0043524]; neurogenesis [GO:0022008]; positive regulation of neurogenesis [GO:0050769]; regulation of fibroblast apoptotic process [GO:2000269]; response to gamma radiation [GO:0010332]; response to X-ray [GO:0010165]; somitogenesis [GO:0001756],centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657],ATP binding [GO:0005524]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677],GO:0000278; GO:0003677; GO:0003824; GO:0005654; GO:0005815; GO:0006281; GO:0006310; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"mitotic cell cycle; DNA binding; catalytic activity; nucleoplasm; microtubule organizing center; DNA repair; DNA recombination; reproductive process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_09580,FUN_041718-T1,Peve_00024454,Pocillopora_meandrina_HIv1___RNAseq.g13944.t1,three_way,59.919,FUN_041718-T1,Q92542,NICA_HUMAN,,Nicastrin,Homo sapiens (Human),35.0,718.0,6.4e-110,399.8,sp|Q92542|NICA_HUMAN Nicastrin OS=Homo sapiens OX=9606 GN=NCSTN PE=1 SV=2,GO:0000139; GO:0002262; GO:0005765; GO:0005769; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0005925; GO:0006508; GO:0006509; GO:0007212; GO:0007215; GO:0007219; GO:0007220; GO:0007611; GO:0008021; GO:0010008; GO:0016020; GO:0016485; GO:0021549; GO:0022010; GO:0030534; GO:0030674; GO:0031293; GO:0034205; GO:0035577; GO:0042098; GO:0042383; GO:0042470; GO:0042500; GO:0042734; GO:0042982; GO:0042983; GO:0042986; GO:0042987; GO:0050673; GO:0051117; GO:0051402; GO:0061133; GO:0070062; GO:0070765; GO:0070851; GO:0071277; GO:1900271; GO:1990926,adult behavior [GO:0030534]; amyloid precursor protein biosynthetic process [GO:0042983]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; amyloid-beta formation [GO:0034205]; cellular response to calcium ion [GO:0071277]; central nervous system myelination [GO:0022010]; cerebellum development [GO:0021549]; epithelial cell proliferation [GO:0050673]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glutamate receptor signaling pathway [GO:0007215]; learning or memory [GO:0007611]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; myeloid cell homeostasis [GO:0002262]; neuron apoptotic process [GO:0051402]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid precursor protein biosynthetic process [GO:0042986]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of long-term synaptic potentiation [GO:1900271]; short-term synaptic potentiation [GO:1990926]; T cell proliferation [GO:0042098],azurophil granule membrane [GO:0035577]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021],"aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; ATPase binding [GO:0051117]; endopeptidase activator activity [GO:0061133]; growth factor receptor binding [GO:0070851]; protein-macromolecule adaptor activity [GO:0030674]",GO:0002376; GO:0003824; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0012501; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0051604; GO:0060090; GO:0098772; GO:0140096,"immune system process; catalytic activity; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; programmed cell death; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; protein maturation; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09581,FUN_041719-T1,Peve_00020367,Pocillopora_meandrina_HIv1___RNAseq.g13943.t1,three_way,79.1255,,,,,,,,,,,,,,,,,
OG_09582,FUN_041720-T1,Peve_00020366,Pocillopora_meandrina_HIv1___RNAseq.g13942.t1,three_way,60.73533333333334,FUN_041720-T1,O45830,,,,,44.8,105.0,3.3e-19,97.1,sp|O45830|NDX1_CAEEL Putative nudix hydrolase 1 OS=Caenorhabditis elegans OX=6239 GN=ndx-1 PE=3 SV=1,,,,,,
OG_09583,FUN_041721-T1,Peve_00020371,Pocillopora_meandrina_HIv1___RNAseq.g13941.t1,three_way,81.38799999999999,FUN_041721-T1,Q61205,PA1B3_MOUSE,,Platelet-activating factor acetylhydrolase IB subunit alpha1 (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma),Mus musculus (Mouse),54.5,165.0,4.8e-51,202.2,sp|Q61205|PA1B3_MOUSE Platelet-activating factor acetylhydrolase IB subunit alpha1 OS=Mus musculus OX=10090 GN=Pafah1b3 PE=1 SV=1,GO:0003847; GO:0005737; GO:0007283; GO:0008247; GO:0016042; GO:0042803; GO:0044877; GO:0046982; GO:0047179,lipid catabolic process [GO:0016042]; spermatogenesis [GO:0007283],1-alkyl-2-acetylglycerophosphocholine esterase complex [GO:0008247]; cytoplasm [GO:0005737],1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0006629; GO:0016740; GO:0016787; GO:0022414,catalytic activity; lipid metabolic process; transferase activity; hydrolase activity; reproductive process
OG_09584,FUN_041722-T1,Peve_00014616,Pocillopora_meandrina_HIv1___RNAseq.g15476.t1,three_way,61.13666666666667,,,,,,,,,,,,,,,,,
OG_09585,FUN_041725-T1,Peve_00014618,Pocillopora_meandrina_HIv1___RNAseq.g15480.t2b,three_way,60.04133333333333,,,,,,,,,,,,,,,,,
OG_09586,FUN_041726-T1,Peve_00014620,Pocillopora_meandrina_HIv1___RNAseq.g15481.t1,three_way,91.062,FUN_041726-T1,Q9ES56,TPPC4_MOUSE,,Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog),Mus musculus (Mouse),64.6,212.0,7.3e-81,301.6,sp|Q9ES56|TPPC4_MOUSE Trafficking protein particle complex subunit 4 OS=Mus musculus OX=10090 GN=Trappc4 PE=1 SV=1,GO:0000139; GO:0005737; GO:0005783; GO:0005795; GO:0005886; GO:0006888; GO:0006901; GO:0006914; GO:0008021; GO:0016192; GO:0016358; GO:0030008; GO:0030425; GO:0045202; GO:0048208; GO:0048786; GO:0098839; GO:0099022; GO:1990071; GO:1990072,autophagy [GO:0006914]; COPII vesicle coating [GO:0048208]; dendrite development [GO:0016358]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072],,GO:0005783; GO:0005886; GO:0006914; GO:0016192; GO:0031410; GO:0043226; GO:0048856; GO:0065003,endoplasmic reticulum; plasma membrane; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly
OG_09587,FUN_041727-T2,Peve_00014621,Pocillopora_meandrina_HIv1___RNAseq.g15482.t1,three_way,56.12166666666667,FUN_041727-T2,A0A1L8EYB2,,,,,30.0,1104.0,5.6000000000000014e-111,404.4,sp|A0A1L8EYB2|DAAF8_XENLA Dynein axonemal assembly factor 8 OS=Xenopus laevis OX=8355 GN=dnaaf8 PE=1 SV=1,,,,,,
OG_09588,FUN_041730-T1,Peve_00006454,Pocillopora_meandrina_HIv1___TS.g10510.t1,three_way,71.7615,FUN_041730-T1,Q6DFR2,CBLB_XENTR,,E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),62.5,491.0,5.1e-171,603.2,sp|Q6DFR2|CBLB_XENTR E3 ubiquitin-protein ligase CBL-B OS=Xenopus tropicalis OX=8364 GN=cblb PE=2 SV=1,GO:0001784; GO:0004842; GO:0005509; GO:0005737; GO:0007166; GO:0008270; GO:0016567; GO:2000583,cell surface receptor signaling pathway [GO:0007166]; protein ubiquitination [GO:0016567]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583],cytoplasm [GO:0005737],calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_09589,FUN_041731-T1,Peve_00023310,Pocillopora_meandrina_HIv1___TS.g10511.t2,three_way,73.30466666666666,FUN_041731-T1,Q5ZLS8,,,,,29.0,758.0,8e-95,349.7,sp|Q5ZLS8|INT10_CHICK Integrator complex subunit 10 OS=Gallus gallus OX=9031 GN=INTS10 PE=2 SV=1,,,,,,
OG_09590,FUN_041732-T2,Peve_00023309,Pocillopora_meandrina_HIv1___RNAseq.g15486.t1,three_way,62.4405,FUN_041732-T2,Q9UMN6,KMT2B_HUMAN,,Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.364) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7),Homo sapiens (Human),27.4,1814.0,3.7e-155,551.6,sp|Q9UMN6|KMT2B_HUMAN Histone-lysine N-methyltransferase 2B OS=Homo sapiens OX=9606 GN=KMT2B PE=1 SV=1,GO:0005634; GO:0005654; GO:0008270; GO:0032259; GO:0035097; GO:0042800; GO:0044665; GO:0045322; GO:0045893; GO:0140945; GO:0140999,methylation [GO:0032259]; positive regulation of DNA-templated transcription [GO:0045893],histone methyltransferase complex [GO:0035097]; MLL1/2 complex [GO:0044665]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09591,FUN_041734-T1,Peve_00024444,Pocillopora_meandrina_HIv1___RNAseq.6485_t,three_way,58.46866666666666,FUN_041734-T1,Q7Z7M0,MEGF8_HUMAN,,Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4),Homo sapiens (Human),33.1,2861.0,0.0,1367.4,sp|Q7Z7M0|MEGF8_HUMAN Multiple epidermal growth factor-like domains protein 8 OS=Homo sapiens OX=9606 GN=MEGF8 PE=1 SV=2,GO:0000151; GO:0003143; GO:0005509; GO:0005634; GO:0007224; GO:0010468; GO:0016020; GO:0016567; GO:0030326; GO:0030509; GO:0035108; GO:0035904; GO:0042074; GO:0042733; GO:0045879; GO:0048704; GO:0048842; GO:0055113; GO:0060971; GO:0060972; GO:0060976; GO:0061371; GO:0061626; GO:0065003; GO:0070062; GO:0071907; GO:0097094; GO:0097155; GO:1990403,aorta development [GO:0035904]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of axon extension involved in axon guidance [GO:0048842]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of gene expression [GO:0010468]; smoothened signaling pathway [GO:0007224],extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],calcium ion binding [GO:0005509],GO:0005634; GO:0043226; GO:0048856; GO:0048870; GO:0065003,nucleus; organelle; anatomical structure development; cell motility; protein-containing complex assembly
OG_09592,FUN_041737-T1,Peve_00002192,Pocillopora_meandrina_HIv1___RNAseq.g15780.t1,three_way,71.5,FUN_041737-T1,Q61070,EI24_MOUSE,,Etoposide-induced protein 2.4 (p53-induced gene 8 protein),Mus musculus (Mouse),40.5,309.0,4.4e-56,219.9,sp|Q61070|EI24_MOUSE Etoposide-induced protein 2.4 OS=Mus musculus OX=10090 GN=Ei24 PE=1 SV=3,GO:0005789; GO:0005794; GO:0005829; GO:0006914; GO:0008630; GO:0009410; GO:0030308; GO:0031965; GO:0042308; GO:0050885; GO:0061676; GO:0071494; GO:2001244,autophagy [GO:0006914]; cellular response to UV-C [GO:0071494]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cell growth [GO:0030308]; negative regulation of protein import into nucleus [GO:0042308]; neuromuscular process controlling balance [GO:0050885]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965],importin-alpha family protein binding [GO:0061676],GO:0005794; GO:0005829; GO:0006914; GO:0043226; GO:0050877,Golgi apparatus; cytosol; autophagy; organelle; nervous system process
OG_09593,FUN_041738-T1,Peve_00002190,Pocillopora_meandrina_HIv1___RNAseq.g15782.t1,three_way,65.286,FUN_041738-T1,Q766D5,,,,,40.6,320.0,1.8e-71,271.9,sp|Q766D5|B4GN4_MOUSE N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=B4galnt4 PE=2 SV=1,,,,,,
OG_09594,FUN_041740-T1,Peve_00002189,Pocillopora_meandrina_HIv1___RNAseq.g15783.t1,three_way,60.20783333333333,,,,,,,,,,,,,,,,,
OG_09595,FUN_041741-T2,Peve_00002194,Pocillopora_meandrina_HIv1___TS.g10807.t1,three_way,87.13516666666666,FUN_041741-T2,Q9WVF7,DPOE1_MOUSE,,DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A),Mus musculus (Mouse),61.3,2303.0,0.0,2863.2,sp|Q9WVF7|DPOE1_MOUSE DNA polymerase epsilon catalytic subunit A OS=Mus musculus OX=10090 GN=Pole PE=1 SV=3,GO:0000082; GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005654; GO:0005886; GO:0006261; GO:0006287; GO:0006297; GO:0008270; GO:0008622; GO:0016787; GO:0048568; GO:0051539,"base-excision repair, gap-filling [GO:0006287]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; nucleotide-excision repair, DNA gap filling [GO:0006297]",epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005654; GO:0005886; GO:0006260; GO:0016740; GO:0016787; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleoplasm; plasma membrane; DNA replication; transferase activity; hydrolase activity; anatomical structure development; catalytic activity, acting on DNA"
OG_09596,FUN_041743-T1,Peve_00002188,Pocillopora_meandrina_HIv1___RNAseq.g15788.t1,three_way,64.87933333333334,,,,,,,,,,,,,,,,,
OG_09597,FUN_041744-T1,Peve_00000340,Pocillopora_meandrina_HIv1___RNAseq.g15789.t1,three_way,72.12516666666667,,,,,,,,,,,,,,,,,
OG_09598,FUN_041745-T1,Peve_00000338,Pocillopora_meandrina_HIv1___RNAseq.g15790.t1,three_way,56.4945,,,,,,,,,,,,,,,,,
OG_09599,FUN_041749-T1,Peve_00042718,Pocillopora_meandrina_HIv1___RNAseq.g15090.t1,three_way,53.022333333333336,,,,,,,,,,,,,,,,,
OG_09600,FUN_041750-T1,Peve_00042716,Pocillopora_meandrina_HIv1___RNAseq.g15091.t1,three_way,84.30533333333332,FUN_041750-T1,Q5ZJH9,DKC1_CHICK,,H/ACA ribonucleoprotein complex subunit DKC1 (EC 5.4.99.-) (Dyskerin),Gallus gallus (Chicken),71.6,437.0,1.2e-177,624.4,sp|Q5ZJH9|DKC1_CHICK H/ACA ribonucleoprotein complex subunit DKC1 OS=Gallus gallus OX=9031 GN=DKC1 PE=2 SV=1,GO:0000455; GO:0000495; GO:0003723; GO:0005654; GO:0005697; GO:0007004; GO:0009982; GO:0015030; GO:0031118; GO:0031120; GO:0031429; GO:1990481,box H/ACA sno(s)RNA 3'-end processing [GO:0000495]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004],box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; nucleoplasm [GO:0005654]; telomerase holoenzyme complex [GO:0005697],pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005654; GO:0016071; GO:0016073; GO:0016853; GO:0032200; GO:0043226,RNA binding; catalytic activity; nucleoplasm; mRNA metabolic process; snRNA metabolic process; isomerase activity; telomere organization; organelle
OG_09601,FUN_041753-T1,Peve_00042722,Pocillopora_meandrina_HIv1___RNAseq.g15094.t1,three_way,66.52616666666667,,,,,,,,,,,,,,,,,
OG_09602,FUN_041754-T2,Peve_00042720,Pocillopora_meandrina_HIv1___RNAseq.g15095.t1,three_way,70.03033333333333,FUN_041754-T2,Q9D8Z1,,,,,43.4,355.0,9e-76,285.4,sp|Q9D8Z1|ASCC1_MOUSE Activating signal cointegrator 1 complex subunit 1 OS=Mus musculus OX=10090 GN=Ascc1 PE=1 SV=1,,,,,,
OG_09603,FUN_041757-T1,Peve_00042719,Pocillopora_meandrina_HIv1___RNAseq.g15100.t1,three_way,78.65766666666667,,,,,,,,,,,,,,,,,
OG_09604,FUN_041758-T1,Peve_00041570,Pocillopora_meandrina_HIv1___RNAseq.g15101.t1,three_way,70.423,FUN_041758-T1,Q90416,RXRGA_DANRE,,Retinoic acid receptor RXR-gamma-A (Nuclear receptor subfamily 2 group B member 3-A) (Retinoic acid receptor RXR-alpha) (Retinoid X receptor alpha) (Retinoid X receptor gamma-A),Danio rerio (Zebrafish) (Brachydanio rerio),33.6,357.0,6.5e-52,206.5,sp|Q90416|RXRGA_DANRE Retinoic acid receptor RXR-gamma-A OS=Danio rerio OX=7955 GN=rxrga PE=2 SV=2,GO:0003700; GO:0003707; GO:0004879; GO:0007399; GO:0008270; GO:0030154; GO:0044323; GO:0045893; GO:0045944; GO:0048384; GO:0090575,cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384],RNA polymerase II transcription regulator complex [GO:0090575],DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; zinc ion binding [GO:0008270],GO:0003677; GO:0006355; GO:0030154; GO:0048856; GO:0060089; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_09605,FUN_041759-T1,Peve_00041567,Pocillopora_meandrina_HIv1___RNAseq.g15102.t1,three_way,88.23033333333333,FUN_041759-T1,Q7XMK8,,,,,72.9,402.0,1.1e-173,610.9,sp|Q7XMK8|RH6_ORYSJ DEAD-box ATP-dependent RNA helicase 6 OS=Oryza sativa subsp. japonica OX=39947 GN=Os04g0533000 PE=2 SV=1,,,,,,
OG_09606,FUN_041760-T1,Peve_00041568,Pocillopora_meandrina_HIv1___RNAseq.g15241.t1,three_way,74.42366666666666,FUN_041760-T1,A6H7H7,FBX3_BOVIN,,F-box only protein 3,Bos taurus (Bovine),45.3,391.0,5.5e-96,352.8,sp|A6H7H7|FBX3_BOVIN F-box only protein 3 OS=Bos taurus OX=9913 GN=FBXO3 PE=2 SV=1,GO:0005634; GO:0005737; GO:0016567; GO:0019005; GO:0031146; GO:0032496; GO:1990756,protein ubiquitination [GO:0016567]; response to lipopolysaccharide [GO:0032496]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005634; GO:0030163; GO:0043226; GO:0060090,nucleus; protein catabolic process; organelle; molecular adaptor activity
OG_09607,FUN_041761-T1,Peve_00041569,Pocillopora_meandrina_HIv1___RNAseq.g15242.t1,three_way,76.12466666666667,,,,,,,,,,,,,,,,,
OG_09608,FUN_041762-T1,Peve_00041571,Pocillopora_meandrina_HIv1___RNAseq.g15243.t1,three_way,78.552,FUN_041762-T1,Q9NXL6,,,,,58.9,280.0,1.1e-89,331.3,sp|Q9NXL6|SIDT1_HUMAN SID1 transmembrane family member 1 OS=Homo sapiens OX=9606 GN=SIDT1 PE=1 SV=2,,,,,,
OG_09609,FUN_041767-T1,Peve_00041572,Pocillopora_meandrina_HIv1___RNAseq.g15244.t1,three_way,57.924,FUN_041767-T1,Q6WRH9,,,,,29.6,406.0,5.6000000000000005e-28,128.6,sp|Q6WRH9|IGS10_RAT Immunoglobulin superfamily member 10 OS=Rattus norvegicus OX=10116 GN=Igsf10 PE=1 SV=1,,,,,,
OG_09610,FUN_041768-T1,Peve_00041573,Pocillopora_meandrina_HIv1___RNAseq.g15245.t1,three_way,58.71716666666667,FUN_041768-T1,Q641Q2,WAC2A_HUMAN,,WASH complex subunit 2A,Homo sapiens (Human),43.1,202.0,2.6000000000000002e-37,159.8,sp|Q641Q2|WAC2A_HUMAN WASH complex subunit 2A OS=Homo sapiens OX=9606 GN=WASHC2A PE=1 SV=3,GO:0005730; GO:0005769; GO:0005829; GO:0005886; GO:0015031; GO:0016197; GO:0031901; GO:0034315; GO:0036010; GO:0042147; GO:0043231; GO:0071203; GO:1901981; GO:1905394,"endosomal transport [GO:0016197]; protein localization to endosome [GO:0036010]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203],phosphatidylinositol phosphate binding [GO:1901981]; retromer complex binding [GO:1905394],GO:0005730; GO:0005768; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226,nucleolus; endosome; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_09611,FUN_041769-T1,Peve_00041575,Pocillopora_meandrina_HIv1___RNAseq.g15246.t1,three_way,89.10266666666666,,,,,,,,,,,,,,,,,
OG_09612,FUN_041770-T1,Peve_00041576,Pocillopora_meandrina_HIv1___RNAseq.g15248.t1,three_way,82.624,,,,,,,,,,,,,,,,,
OG_09613,FUN_041771-T1,Peve_00021185,Pocillopora_meandrina_HIv1___RNAseq.g15894.t1,three_way,85.66066666666667,FUN_041771-T1,P17870,ARRB1_BOVIN,,Beta-arrestin-1 (Arrestin beta-1) (Arrestin-2),Bos taurus (Bovine),64.8,341.0,1.1000000000000001e-118,427.9,sp|P17870|ARRB1_BOVIN Beta-arrestin-1 OS=Bos taurus OX=9913 GN=ARRB1 PE=1 SV=1,GO:0000822; GO:0001664; GO:0001934; GO:0002029; GO:0002031; GO:0002092; GO:0005547; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006511; GO:0007165; GO:0015031; GO:0030132; GO:0030276; GO:0031143; GO:0031410; GO:0031623; GO:0032050; GO:0033130; GO:0035612; GO:0036094; GO:0045746; GO:0060090; GO:0070374; GO:0072583,clathrin-dependent endocytosis [GO:0072583]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; receptor internalization [GO:0031623]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],"acetylcholine receptor binding [GO:0033130]; AP-2 adaptor complex binding [GO:0035612]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; G protein-coupled receptor binding [GO:0001664]; inositol hexakisphosphate binding [GO:0000822]; molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small molecule binding [GO:0036094]",GO:0005634; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0060090,nucleus; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_09614,FUN_041772-T1,Peve_00014829,Pocillopora_meandrina_HIv1___RNAseq.g15893.t1,three_way,61.36133333333333,FUN_041772-T1,Q80T32,AGRD1_MOUSE,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Mus musculus (Mouse),23.3,270.0,6.5e-12,73.9,sp|Q80T32|AGRD1_MOUSE Adhesion G-protein coupled receptor D1 OS=Mus musculus OX=10090 GN=Adgrd1 PE=2 SV=2,GO:0004930; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016607; GO:0022008,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; neurogenesis [GO:0022008]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005829; GO:0005886; GO:0030154; GO:0043226; GO:0060089,cytosol; plasma membrane; cell differentiation; organelle; molecular transducer activity
OG_09615,FUN_041775-T1,Peve_00014827,Pocillopora_meandrina_HIv1___RNAseq.g15891.t1,three_way,93.94866666666668,FUN_041775-T1,Q8I1F4,,,,,87.3,236.0,1.4e-117,424.1,sp|Q8I1F4|FBRL_DROER rRNA 2'-O-methyltransferase fibrillarin OS=Drosophila erecta OX=7220 GN=Fib PE=3 SV=1,,,,,,
OG_09616,FUN_041776-T1,Peve_00010497,Pocillopora_meandrina_HIv1___RNAseq.g15888.t1,three_way,68.81383333333333,FUN_041776-T1,Q6DRG1,,,,,67.6,142.0,1.9999999999999998e-50,201.1,sp|Q6DRG1|RBM42_DANRE RNA-binding protein 42 OS=Danio rerio OX=7955 GN=rbm42 PE=2 SV=2,,,,,,
OG_09617,FUN_041777-T1,Peve_00042840,Pocillopora_meandrina_HIv1___RNAseq.g15886.t1,three_way,86.59949999999999,FUN_041777-T1,Q13627,DYR1A_HUMAN,,Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.11.23) (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB),Homo sapiens (Human),78.0,410.0,2.1e-190,667.2,sp|Q13627|DYR1A_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Homo sapiens OX=9606 GN=DYRK1A PE=1 SV=2,GO:0000381; GO:0003713; GO:0003779; GO:0004672; GO:0004674; GO:0004712; GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0007399; GO:0007623; GO:0008092; GO:0008353; GO:0015631; GO:0016607; GO:0018108; GO:0030424; GO:0030425; GO:0031115; GO:0031452; GO:0033120; GO:0042802; GO:0043518; GO:0045893; GO:0046777; GO:0048025; GO:0048156; GO:0050321; GO:0106310; GO:0140857; GO:1902003; GO:1902996; GO:1990904; GO:1990935,"circadian rhythm [GO:0007623]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of heterochromatin formation [GO:0031452]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; nervous system development [GO:0007399]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of RNA splicing [GO:0033120]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of amyloid-beta formation [GO:1902003]; regulation of neurofibrillary tangle assembly [GO:1902996]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],actin binding [GO:0003779]; ATP binding [GO:0005524]; cytoskeletal protein binding [GO:0008092]; histone H3T45 kinase activity [GO:0140857]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; splicing factor binding [GO:1990935]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_09618,FUN_041778-T1,Peve_00023858,Pocillopora_meandrina_HIv1___RNAseq.g15879.t1,three_way,69.843,FUN_041778-T1,Q8R123,FAD1_MOUSE,,FAD synthase (EC 2.7.7.2) (FAD pyrophosphorylase) (FMN adenylyltransferase) (Flavin adenine dinucleotide synthase) [Includes: Molybdenum cofactor biosynthesis protein-like region; FAD synthase region],Mus musculus (Mouse),45.5,517.0,1.2e-121,438.3,sp|Q8R123|FAD1_MOUSE FAD synthase OS=Mus musculus OX=10090 GN=Flad1 PE=1 SV=1,GO:0003919; GO:0005524; GO:0005759; GO:0005829; GO:0005886; GO:0006747; GO:0006771; GO:0042802; GO:0072388,FAD biosynthetic process [GO:0006747]; flavin adenine dinucleotide biosynthetic process [GO:0072388]; riboflavin metabolic process [GO:0006771],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; identical protein binding [GO:0042802],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0055086,catalytic activity; cytosol; plasma membrane; transferase activity; nucleobase-containing small molecule metabolic process
OG_09619,FUN_041779-T1,Peve_00042838,Pocillopora_meandrina_HIv1___RNAseq.g15878.t1,three_way,82.13516666666666,FUN_041779-T1,P23098,,,,,25.2,3572.0,0.0,1097.8,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_09620,FUN_041782-T1,Peve_00010485,Pocillopora_meandrina_HIv1___RNAseq.g15874.t1,three_way,77.181,,,,,,,,,,,,,,,,,
OG_09621,FUN_041784-T1,Peve_00025206,Pocillopora_meandrina_HIv1___RNAseq.g15487.t1,three_way,95.13633333333333,FUN_041784-T1,P16912,KAPC3_DROME,,cAMP-dependent protein kinase catalytic subunit 3 (EC 2.7.11.1) (Protein kinase DC2),Drosophila melanogaster (Fruit fly),66.2,314.0,8.1e-132,471.5,sp|P16912|KAPC3_DROME cAMP-dependent protein kinase catalytic subunit 3 OS=Drosophila melanogaster OX=7227 GN=Pka-C3 PE=2 SV=2,GO:0004691; GO:0005524; GO:0005829; GO:0005952; GO:0007155; GO:0007165; GO:0007476; GO:0106310,cell adhesion [GO:0007155]; imaginal disc-derived wing morphogenesis [GO:0007476]; signal transduction [GO:0007165],cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829],ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005829; GO:0007155; GO:0016740; GO:0140096,"catalytic activity; cytosol; cell adhesion; transferase activity; catalytic activity, acting on a protein"
OG_09622,FUN_041786-T1,Peve_00038537,Pocillopora_meandrina_HIv1___RNAseq.g15774.t1,three_way,61.81633333333333,FUN_041786-T1,Q01887,,,,,38.8,624.0,3.9e-114,413.7,sp|Q01887|RYK_MOUSE Tyrosine-protein kinase RYK OS=Mus musculus OX=10090 GN=Ryk PE=1 SV=2,,,,,,
OG_09623,FUN_041787-T1,Peve_00038538,Pocillopora_meandrina_HIv1___RNAseq.g15773.t1,three_way,47.7465,FUN_041787-T1,Q9UT40,,,,,34.3,105.0,4.5e-10,67.0,"sp|Q9UT40|YIQ3_SCHPO Uncharacterized protein C824.03c, mitochondrial OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC824.03c PE=4 SV=1",,,,,,
OG_09624,FUN_041788-T1,Peve_00038539,Pocillopora_meandrina_HIv1___RNAseq.g15771.t1,three_way,71.78066666666666,FUN_041788-T1,Q8BX90,FND3A_MOUSE,,Fibronectin type-III domain-containing protein 3A,Mus musculus (Mouse),35.3,996.0,1.6e-163,578.6,sp|Q8BX90|FND3A_MOUSE Fibronectin type-III domain-containing protein 3A OS=Mus musculus OX=10090 GN=Fndc3a PE=1 SV=3,GO:0000139; GO:0001669; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0031410; GO:0060009; GO:0098609,cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; vesicle membrane [GO:0012506],,GO:0005829; GO:0007155; GO:0022414; GO:0031410; GO:0043226; GO:0048856,cytosol; cell adhesion; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development
OG_09625,FUN_041789-T1,Peve_00038532,Pocillopora_meandrina_HIv1___RNAseq.g15770.t1,three_way,64.701,FUN_041789-T1,O15072,ATS3_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme),Homo sapiens (Human),30.6,992.0,5.3e-119,430.6,sp|O15072|ATS3_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 3 OS=Homo sapiens OX=9606 GN=ADAMTS3 PE=1 SV=4,GO:0001701; GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0008201; GO:0008270; GO:0010573; GO:0016485; GO:0030198; GO:0030199; GO:0030574; GO:0031012; GO:0032964; GO:0070062; GO:0097435; GO:1900748,collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; proteolysis [GO:0006508]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573],extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615],endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_09626,FUN_041790-T1,Peve_00038533,Pocillopora_meandrina_HIv1___RNAseq.g15769.t1,three_way,61.01483333333333,FUN_041790-T1,Q8TE57,ATS16_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Homo sapiens (Human),30.0,1013.0,6.7e-112,407.1,sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein"
OG_09627,FUN_041794-T1,Peve_00009375,Pocillopora_meandrina_HIv1___RNAseq.g15767.t1,three_way,43.15016666666666,FUN_041794-T1,Q4VC17,ATS18_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-),Mus musculus (Mouse),27.2,1006.0,3.1e-77,292.0,sp|Q4VC17|ATS18_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 18 OS=Mus musculus OX=10090 GN=Adamts18 PE=2 SV=2,GO:0001654; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0090331,extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331]; proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0030198; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; extracellular matrix organization; anatomical structure development; catalytic activity, acting on a protein"
OG_09628,FUN_041799-T1,Peve_00025729,Pocillopora_meandrina_HIv1___RNAseq.g15850.t2,three_way,48.657,FUN_041799-T1,Q4VSN1,DUSTY_DANRE,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Danio rerio (Zebrafish) (Brachydanio rerio),33.2,265.0,3.3e-27,125.6,sp|Q4VSN1|DUSTY_DANRE Dual serine/threonine and tyrosine protein kinase OS=Danio rerio OX=7955 GN=dstyk PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0043066; GO:0044344; GO:0045743; GO:0048568; GO:0048570; GO:0060036; GO:0070161; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; embryonic organ development [GO:0048568]; negative regulation of apoptotic process [GO:0043066]; notochord cell vacuolation [GO:0060036]; notochord morphogenesis [GO:0048570]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_09629,FUN_041812-T1,Peve_00025193,Pocillopora_meandrina_HIv1___RNAseq.g15795.t1,three_way,74.94233333333334,,,,,,,,,,,,,,,,,
OG_09630,FUN_041815-T1,Peve_00025189,Pocillopora_meandrina_HIv1___RNAseq.g15799.t1,three_way,65.50633333333333,FUN_041815-T1,Q92551,IP6K1_HUMAN,,Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1),Homo sapiens (Human),42.7,433.0,1.4e-86,321.6,sp|Q92551|IP6K1_HUMAN Inositol hexakisphosphate kinase 1 OS=Homo sapiens OX=9606 GN=IP6K1 PE=1 SV=3,GO:0000827; GO:0000828; GO:0000829; GO:0000832; GO:0001650; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0032958; GO:0043647; GO:0046854; GO:0052836; GO:0052839; GO:0120163,inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphate biosynthetic process [GO:0046854],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ATP binding [GO:0005524]; diphosphoinositol pentakisphosphate kinase activity [GO:0000829]; diphosphoinositol tetrakisphosphate kinase activity [GO:0052839]; inositol 5-diphosphate pentakisphosphate 5-kinase activity [GO:0052836]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1,3,4,5,6-pentakisphosphate kinase activity [GO:0000827]",GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0016740; GO:0043226,catalytic activity; nucleus; nucleoplasm; cytosol; lipid metabolic process; transferase activity; organelle
OG_09631,FUN_041817-T1,Peve_00025201,Pocillopora_meandrina_HIv1___RNAseq.g15801.t1,three_way,78.85666666666667,FUN_041817-T1,Q6PHN7,,,,,45.5,268.0,4.8e-56,219.5,sp|Q6PHN7|TM164_MOUSE Transmembrane protein 164 OS=Mus musculus OX=10090 GN=Tmem164 PE=1 SV=1,,,,,,
OG_09632,FUN_041818-T2,Peve_00025199,Pocillopora_meandrina_HIv1___RNAseq.g15802.t1,three_way,72.51433333333334,FUN_041818-T2,Q1L8W0,ZBT18_DANRE,,Zinc finger and BTB domain-containing protein 18 (Zinc finger protein 238),Danio rerio (Zebrafish) (Brachydanio rerio),38.6,70.0,6.9e-06,54.3,sp|Q1L8W0|ZBT18_DANRE Zinc finger and BTB domain-containing protein 18 OS=Danio rerio OX=7955 GN=zbtb18 PE=2 SV=1,GO:0000981; GO:0003677; GO:0005634; GO:0006357; GO:0008270,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_09633,FUN_041820-T1,Peve_00025198,Pocillopora_meandrina_HIv1___RNAseq.g15803.t1,three_way,68.35566666666666,FUN_041820-T1,P47793,WNT4A_DANRE,,Protein Wnt-4a,Danio rerio (Zebrafish) (Brachydanio rerio),43.4,334.0,3.1000000000000003e-76,287.0,sp|P47793|WNT4A_DANRE Protein Wnt-4a OS=Danio rerio OX=7955 GN=wnt4a PE=2 SV=1,GO:0005109; GO:0005125; GO:0005615; GO:0007507; GO:0021986; GO:0030182; GO:0042074; GO:0045165; GO:0045893; GO:0048703; GO:0048841; GO:0060070; GO:0070654,canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell migration involved in gastrulation [GO:0042074]; embryonic viscerocranium morphogenesis [GO:0048703]; habenula development [GO:0021986]; heart development [GO:0007507]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of axon extension involved in axon guidance [GO:0048841]; sensory epithelium regeneration [GO:0070654],extracellular space [GO:0005615],cytokine activity [GO:0005125]; frizzled binding [GO:0005109],GO:0005615; GO:0006355; GO:0030154; GO:0048018; GO:0048856; GO:0048870; GO:0098772,extracellular space; regulation of DNA-templated transcription; cell differentiation; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_09634,FUN_041821-T1,Peve_00025187,Pocillopora_meandrina_HIv1___RNAseq.g15804.t1,three_way,89.15533333333333,FUN_041821-T1,P42325,NCAH_DROME,,Neurocalcin homolog (DrosNCa),Drosophila melanogaster (Fruit fly),50.3,187.0,4e-46,186.0,sp|P42325|NCAH_DROME Neurocalcin homolog OS=Drosophila melanogaster OX=7227 GN=Nca PE=1 SV=2,GO:0005509; GO:0009966; GO:0045938; GO:1902848,"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; regulation of signal transduction [GO:0009966]",,calcium ion binding [GO:0005509],,
OG_09635,FUN_041824-T1,Peve_00039128,Pocillopora_meandrina_HIv1___RNAseq.g15806.t1,three_way,95.95933333333332,FUN_041824-T1,P0C6F1,DYH2_MOUSE,,Dynein axonemal heavy chain 2 (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2),Mus musculus (Mouse),72.9,2852.0,0.0,4229.9,sp|P0C6F1|DYH2_MOUSE Dynein axonemal heavy chain 2 OS=Mus musculus OX=10090 GN=Dnah2 PE=1 SV=1,GO:0003341; GO:0005524; GO:0005858; GO:0005874; GO:0005929; GO:0005930; GO:0008569; GO:0016887; GO:0031514; GO:0036126; GO:0036156; GO:0036159; GO:0045505; GO:0051959; GO:0060285,cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159],axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; cilium [GO:0005929]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0048870; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; cell motility; protein-containing complex assembly; ATP-dependent activity
OG_09636,FUN_041827-T1,Peve_00039124,Pocillopora_meandrina_HIv1___RNAseq.g15809.t1,three_way,78.95666666666666,FUN_041827-T1,Q9UL03,,,,,53.7,536.0,5.9e-156,552.4,sp|Q9UL03|INT6_HUMAN Integrator complex subunit 6 OS=Homo sapiens OX=9606 GN=INTS6 PE=1 SV=1,,,,,,
OG_09637,FUN_041829-T1,Peve_00039123,Pocillopora_meandrina_HIv1___RNAseq.g15810.t1,three_way,56.943333333333335,,,,,,,,,,,,,,,,,
OG_09638,FUN_041833-T1,Peve_00039120,Pocillopora_meandrina_HIv1___RNAseq.g15818.t1,three_way,53.50833333333333,,,,,,,,,,,,,,,,,
OG_09639,FUN_041834-T1,Peve_00029683,Pocillopora_meandrina_HIv1___RNAseq.g15086.t1,three_way,80.92266666666667,FUN_041834-T1,B0R0T1,VWA8_DANRE,,von Willebrand factor A domain-containing protein 8,Danio rerio (Zebrafish) (Brachydanio rerio),55.4,1896.0,0.0,2025.0,sp|B0R0T1|VWA8_DANRE von Willebrand factor A domain-containing protein 8 OS=Danio rerio OX=7955 GN=vwa8 PE=3 SV=1,GO:0005524; GO:0005737; GO:0005739; GO:0016887; GO:0030903,notochord development [GO:0030903],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0048856,catalytic activity; mitochondrion; hydrolase activity; organelle; anatomical structure development
OG_09640,FUN_041835-T1,Peve_00009638,Pocillopora_meandrina_HIv1___RNAseq.g15085.t1,three_way,89.23433333333334,FUN_041835-T1,Q2HJ40,BACE1_BOVIN,,Beta-secretase 1 (EC 3.4.23.46) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2),Bos taurus (Bovine),47.6,429.0,8.5e-117,422.2,sp|Q2HJ40|BACE1_BOVIN Beta-secretase 1 OS=Bos taurus OX=9913 GN=BACE1 PE=2 SV=1,GO:0004175; GO:0004190; GO:0005764; GO:0005768; GO:0005769; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005886; GO:0006508; GO:0006509; GO:0009986; GO:0030424; GO:0030425; GO:0030659; GO:0045121; GO:0050435; GO:0055037,amyloid-beta metabolic process [GO:0050435]; membrane protein ectodomain proteolysis [GO:0006509]; proteolysis [GO:0006508],axon [GO:0030424]; cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_09641,FUN_041836-T1,Peve_00009646,Pocillopora_meandrina_HIv1___RNAseq.g15084.t1,three_way,72.85733333333333,FUN_041836-T1,Q8CHP8,PGP_MOUSE,,Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP),Mus musculus (Mouse),45.7,302.0,3.3e-71,270.0,sp|Q8CHP8|PGP_MOUSE Glycerol-3-phosphate phosphatase OS=Mus musculus OX=10090 GN=Pgp PE=1 SV=1,GO:0000121; GO:0000287; GO:0004725; GO:0006114; GO:0006650; GO:0008967; GO:0043136; GO:0043262; GO:0045721,glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721],,ADP phosphatase activity [GO:0043262]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005975; GO:0006629; GO:0016787; GO:0140096,"catalytic activity; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; catalytic activity, acting on a protein"
OG_09642,FUN_041837-T1,Peve_00009647,Pocillopora_meandrina_HIv1___RNAseq.g15083.t1,three_way,77.079,FUN_041837-T1,Q676U5,A16L1_HUMAN,,Autophagy-related protein 16-1 (APG16-like 1),Homo sapiens (Human),34.9,601.0,7.8e-79,296.2,sp|Q676U5|A16L1_HUMAN Autophagy-related protein 16-1 OS=Homo sapiens OX=9606 GN=ATG16L1 PE=1 SV=2,GO:0000045; GO:0000421; GO:0005776; GO:0005829; GO:0005930; GO:0006501; GO:0010508; GO:0015031; GO:0016236; GO:0016237; GO:0019787; GO:0021766; GO:0022038; GO:0030424; GO:0034045; GO:0034274; GO:0034497; GO:0036020; GO:0039689; GO:0042802; GO:0043495; GO:0051020; GO:0051607; GO:0097225; GO:0098792; GO:0098930; GO:0098978; GO:0120095; GO:0140059; GO:1903860,autophagosome assembly [GO:0000045]; axonal transport [GO:0098930]; C-terminal protein lipidation [GO:0006501]; corpus callosum development [GO:0022038]; defense response to virus [GO:0051607]; dendrite arborization [GO:0140059]; hippocampus development [GO:0021766]; macroautophagy [GO:0016236]; microautophagy [GO:0016237]; negative regulation of dendrite extension [GO:1903860]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; axoneme [GO:0005930]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; glutamatergic synapse [GO:0098978]; phagophore assembly site membrane [GO:0034045]; sperm midpiece [GO:0097225]; vacuole-isolation membrane contact site [GO:0120095],GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; protein-membrane adaptor activity [GO:0043495]; ubiquitin-like protein transferase activity [GO:0019787],GO:0003824; GO:0005773; GO:0005829; GO:0006914; GO:0007018; GO:0016740; GO:0043226; GO:0048856; GO:0060090; GO:0140096,"catalytic activity; vacuole; cytosol; autophagy; microtubule-based movement; transferase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein"
OG_09643,FUN_041838-T1,Peve_00009649,Pocillopora_meandrina_HIv1___RNAseq.g15082.t1,three_way,72.66499999999999,FUN_041838-T1,Q6GLB0,,,,,49.1,108.0,2.6e-14,79.7,sp|Q6GLB0|PP1RB_XENTR E3 ubiquitin-protein ligase PPP1R11 OS=Xenopus tropicalis OX=8364 GN=ppp1r11 PE=3 SV=1,,,,,,
OG_09644,FUN_041839-T1,Peve_00009639,Pocillopora_meandrina_HIv1___RNAseq.g15081.t1,three_way,63.03933333333333,FUN_041839-T1,Q9UKB3,,,,,38.9,144.0,6e-25,115.5,sp|Q9UKB3|DJC12_HUMAN DnaJ homolog subfamily C member 12 OS=Homo sapiens OX=9606 GN=DNAJC12 PE=1 SV=1,,,,,,
OG_09645,FUN_041840-T1,Peve_00009640,Pocillopora_meandrina_HIv1___RNAseq.g15080.t1,three_way,69.50733333333334,,,,,,,,,,,,,,,,,
OG_09646,FUN_041841-T1,Peve_00009641,Pocillopora_meandrina_HIv1___RNAseq.g15079.t1,three_way,63.284666666666666,,,,,,,,,,,,,,,,,
OG_09647,FUN_041843-T1,Peve_00010472,Pocillopora_meandrina_HIv1___RNAseq.g15076.t1,three_way,72.31716666666667,FUN_041843-T1,Q99PD7,NCKX3_MOUSE,,Sodium/potassium/calcium exchanger 3 (Na(+)/K(+)/Ca(2+)-exchange protein 3) (Solute carrier family 24 member 3),Mus musculus (Mouse),32.6,613.0,6.9e-56,220.3,sp|Q99PD7|NCKX3_MOUSE Sodium/potassium/calcium exchanger 3 OS=Mus musculus OX=10090 GN=Slc24a3 PE=1 SV=3,GO:0005886; GO:0006874; GO:0008273; GO:0010628; GO:0010629; GO:0015293; GO:0030282; GO:0071944,bone mineralization [GO:0030282]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628],cell periphery [GO:0071944]; plasma membrane [GO:0005886],"calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]",GO:0005215; GO:0005886; GO:0048856,transporter activity; plasma membrane; anatomical structure development
OG_09648,FUN_041845-T1,Peve_00010476,Pocillopora_meandrina_HIv1___RNAseq.g15075.t1,three_way,61.001000000000005,FUN_041845-T1,P41596,,,,,29.2,284.0,7.6e-22,106.3,sp|P41596|DOPR1_DROME Dopamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=Dop1R1 PE=2 SV=2,,,,,,
OG_09649,FUN_041846-T1,Peve_00010477,Pocillopora_meandrina_HIv1___RNAseq.g15074.t1,three_way,93.05533333333334,FUN_041846-T1,A7SM54,,,,,88.5,165.0,4.5e-78,292.0,sp|A7SM54|UFC1_NEMVE Ubiquitin-fold modifier-conjugating enzyme 1 OS=Nematostella vectensis OX=45351 GN=v1g214407 PE=3 SV=1,,,,,,
OG_09650,FUN_041848-T1,Peve_00010478,Pocillopora_meandrina_HIv1___RNAseq.g15073.t1,three_way,64.9195,FUN_041848-T1,P78543,BTG2_HUMAN,,Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3),Homo sapiens (Human),41.4,116.0,4e-19,96.3,sp|P78543|BTG2_HUMAN Protein BTG2 OS=Homo sapiens OX=9606 GN=BTG2 PE=1 SV=1,GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007405; GO:0007406; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0051602; GO:0060213; GO:0070062; GO:1904628,anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuroblast proliferation [GO:0007405]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0005829; GO:0006281; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140110,nucleus; cytosol; DNA repair; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; transcription regulator activity
OG_09651,FUN_041850-T1,Peve_00010479,Pocillopora_meandrina_HIv1___RNAseq.g15071.t1,three_way,44.224500000000006,FUN_041850-T1,P11279,LAMP1_HUMAN,,Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a),Homo sapiens (Human),28.6,231.0,2.1e-08,62.0,sp|P11279|LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens OX=9606 GN=LAMP1 PE=1 SV=3,GO:0000421; GO:0001618; GO:0005737; GO:0005764; GO:0005765; GO:0005770; GO:0005771; GO:0005829; GO:0005886; GO:0007042; GO:0008021; GO:0008200; GO:0009897; GO:0010008; GO:0016020; GO:0019899; GO:0019904; GO:0031902; GO:0035577; GO:0042383; GO:0042470; GO:0043323; GO:0044754; GO:0045954; GO:0048471; GO:0050821; GO:0061474; GO:0070062; GO:0072594; GO:0090160; GO:0101003; GO:0101004; GO:0140507; GO:1902513,establishment of protein localization to organelle [GO:0072594]; Golgi to lysosome transport [GO:0090160]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; lysosomal lumen acidification [GO:0007042]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; protein stabilization [GO:0050821]; regulation of organelle transport along microtubule [GO:1902513],autolysosome [GO:0044754]; autophagosome membrane [GO:0000421]; azurophil granule membrane [GO:0035577]; cytolytic granule membrane [GO:0101004]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagolysosome membrane [GO:0061474]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; synaptic vesicle [GO:0008021],enzyme binding [GO:0019899]; ion channel inhibitor activity [GO:0008200]; protein domain specific binding [GO:0019904]; virus receptor activity [GO:0001618],GO:0001618; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,virus receptor activity; lysosome; endosome; vacuole; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09652,FUN_041852-T1,Peve_00030440,Pocillopora_meandrina_HIv1___TS.g10103.t1,three_way,49.88133333333333,FUN_041852-T1,P05300,,,,,25.1,211.0,3.6e-07,57.0,sp|P05300|LAMP1_CHICK Lysosome-associated membrane glycoprotein 1 OS=Gallus gallus OX=9031 GN=LAMP1 PE=2 SV=1,,,,,,
OG_09653,FUN_041854-T1,Peve_00025833,Pocillopora_meandrina_HIv1___RNAseq.g15067.t2,three_way,60.3945,FUN_041854-T1,Q8N137,CNTRB_HUMAN,,Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8),Homo sapiens (Human),35.5,242.0,1.8e-21,106.7,sp|Q8N137|CNTRB_HUMAN Centrobin OS=Homo sapiens OX=9606 GN=CNTROB PE=1 SV=1,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0036064; GO:0051299; GO:1902017; GO:1902410,centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829],protein domain specific binding [GO:0019904],GO:0005815; GO:0005829; GO:0043226,microtubule organizing center; cytosol; organelle
OG_09654,FUN_041857-T1,Peve_00025834,Pocillopora_meandrina_HIv1___RNAseq.g15066.t2,three_way,58.90233333333333,FUN_041857-T1,Q5EA49,,,,,30.3,185.0,2.1e-14,80.9,sp|Q5EA49|MIS12_BOVIN Protein MIS12 homolog OS=Bos taurus OX=9913 GN=MIS12 PE=2 SV=1,,,,,,
OG_09655,FUN_041860-T1,Peve_00030446,Pocillopora_meandrina_HIv1___RNAseq.g15125.t1,three_way,65.9885,FUN_041860-T1,Q9D099,ACER3_MOUSE,,Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (EC 3.5.1.23) (Alkaline phytoceramidase) (aPHC),Mus musculus (Mouse),45.8,249.0,1e-56,221.9,sp|Q9D099|ACER3_MOUSE Alkaline ceramidase 3 OS=Mus musculus OX=10090 GN=Acer3 PE=1 SV=1,GO:0000139; GO:0005509; GO:0005789; GO:0006954; GO:0008270; GO:0008284; GO:0017040; GO:0042552; GO:0043067; GO:0046512; GO:0046514; GO:0071602,ceramide catabolic process [GO:0046514]; inflammatory response [GO:0006954]; myelination [GO:0042552]; phytosphingosine biosynthetic process [GO:0071602]; positive regulation of cell population proliferation [GO:0008284]; regulation of programmed cell death [GO:0043067]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; N-acylsphingosine amidohydrolase activity [GO:0017040]; zinc ion binding [GO:0008270],GO:0003824; GO:0006629; GO:0006954; GO:0016787,catalytic activity; lipid metabolic process; inflammatory response; hydrolase activity
OG_09656,FUN_041861-T1,Peve_00030447,Pocillopora_meandrina_HIv1___RNAseq.g15124.t1,three_way,98.80966666666669,FUN_041861-T1,P62333,PRS10_HUMAN,,26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42),Homo sapiens (Human),86.2,385.0,1e-189,664.1,sp|P62333|PRS10_HUMAN 26S proteasome regulatory subunit 10B OS=Homo sapiens OX=9606 GN=PSMC6 PE=1 SV=1,GO:0000502; GO:0005524; GO:0005634; GO:0005654; GO:0005829; GO:0008540; GO:0016020; GO:0016234; GO:0016887; GO:0022624; GO:0030674; GO:0031597; GO:0036402; GO:0036503; GO:0042802; GO:0043161; GO:0045899; GO:0070062; GO:0090261; GO:1901800,ERAD pathway [GO:0036503]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],"cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; extracellular exosome [GO:0070062]; inclusion body [GO:0016234]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle, base subcomplex [GO:0008540]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome-activating activity [GO:0036402]; protein-macromolecule adaptor activity [GO:0030674],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0016787; GO:0016853; GO:0030163; GO:0043226; GO:0060090; GO:0140657,catalytic activity; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; protein catabolic process; organelle; molecular adaptor activity; ATP-dependent activity
OG_09657,FUN_041862-T1,Peve_00030448,Pocillopora_meandrina_HIv1___RNAseq.g15123.t1,three_way,78.17916666666666,FUN_041862-T1,A0A8C0TYJ0,DLG1_CANLF,,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97),Canis lupus familiaris (Dog) (Canis familiaris),54.7,959.0,1.8e-266,920.2,sp|A0A8C0TYJ0|DLG1_CANLF Disks large homolog 1 OS=Canis lupus familiaris OX=9615 GN=DLG1 PE=3 SV=1,GO:0000122; GO:0001658; GO:0001771; GO:0001772; GO:0001935; GO:0002088; GO:0005604; GO:0005634; GO:0005789; GO:0005794; GO:0005874; GO:0005923; GO:0007268; GO:0008284; GO:0008360; GO:0009898; GO:0010669; GO:0014069; GO:0015459; GO:0016323; GO:0016324; GO:0016328; GO:0019900; GO:0019902; GO:0030041; GO:0030432; GO:0030838; GO:0030866; GO:0030953; GO:0031253; GO:0031579; GO:0031594; GO:0031641; GO:0033268; GO:0035748; GO:0042098; GO:0042130; GO:0042383; GO:0042982; GO:0043219; GO:0043268; GO:0043491; GO:0043622; GO:0044325; GO:0045121; GO:0048471; GO:0048608; GO:0048704; GO:0048745; GO:0050680; GO:0051660; GO:0051898; GO:0060022; GO:0060090; GO:0070373; GO:0070830; GO:0072659; GO:0097016; GO:0097025; GO:0097060; GO:0098609; GO:0098911; GO:0098915; GO:0098919; GO:0098978; GO:0099645; GO:1902473; GO:1903078; GO:1903286; GO:1903753; GO:1903764; GO:2000134,actin filament polymerization [GO:0030041]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; epithelial structure maintenance [GO:0010669]; establishment of centrosome localization [GO:0051660]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; membrane raft organization [GO:0031579]; membrane repolarization during ventricular cardiac muscle cell action potential [GO:0098915]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of cell shape [GO:0008360]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of protein localization to synapse [GO:1902473]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell proliferation [GO:0042098],apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell projection membrane [GO:0031253]; cytoplasmic side of plasma membrane [GO:0009898]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; synaptic membrane [GO:0097060],kinase binding [GO:0019900]; L27 domain binding [GO:0097016]; molecular adaptor activity [GO:0060090]; phosphatase binding [GO:0019902]; potassium channel regulator activity [GO:0015459]; structural constituent of postsynaptic density [GO:0098919]; transmembrane transporter binding [GO:0044325],GO:0002376; GO:0003012; GO:0005198; GO:0005634; GO:0005794; GO:0005886; GO:0006355; GO:0007010; GO:0007155; GO:0022414; GO:0023052; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0060090; GO:0061024; GO:0065003; GO:0072659; GO:0098772,immune system process; muscle system process; structural molecule activity; nucleus; Golgi apparatus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cell adhesion; reproductive process; signaling; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; molecular adaptor activity; membrane organization; protein-containing complex assembly; protein localization to plasma membrane; molecular function regulator activity
OG_09658,FUN_041863-T1,Peve_00030452,Pocillopora_meandrina_HIv1___RNAseq.g15122.t1,three_way,75.155,FUN_041863-T1,Q561X3,,,,,44.8,279.0,1.9e-25,117.9,sp|Q561X3|MED4_DANRE Mediator of RNA polymerase II transcription subunit 4 OS=Danio rerio OX=7955 GN=med4 PE=2 SV=1,,,,,,
OG_09659,FUN_041869-T1,Peve_00023976,Pocillopora_meandrina_HIv1___RNAseq.g15113.t1,three_way,75.20066666666666,FUN_041869-T1,Q10751,ACE_CHICK,,Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II),Gallus gallus (Chicken),46.9,582.0,1.4e-155,551.6,sp|Q10751|ACE_CHICK Angiotensin-converting enzyme OS=Gallus gallus OX=9031 GN=ACE PE=2 SV=2,GO:0001822; GO:0002003; GO:0003081; GO:0003084; GO:0004180; GO:0004222; GO:0005737; GO:0005886; GO:0008217; GO:0008237; GO:0008241; GO:0008270; GO:0008283; GO:0010814; GO:0010815; GO:0016020; GO:0031404; GO:0042445; GO:0042447; GO:0048167; GO:0060319; GO:0070573,angiotensin maturation [GO:0002003]; bradykinin catabolic process [GO:0010815]; cell population proliferation [GO:0008283]; hormone catabolic process [GO:0042447]; hormone metabolic process [GO:0042445]; kidney development [GO:0001822]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of blood pressure [GO:0008217]; regulation of synaptic plasticity [GO:0048167]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; substance P catabolic process [GO:0010814],cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270],GO:0003824; GO:0005886; GO:0016787; GO:0030154; GO:0048856; GO:0050886; GO:0051604; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; cell differentiation; anatomical structure development; endocrine process; protein maturation; catalytic activity, acting on a protein"
OG_09660,FUN_041870-T1,Peve_00023975,Pocillopora_meandrina_HIv1___TS.g10144.t1,three_way,73.77166666666666,FUN_041870-T1,Q3B752,KTHY_DANRE,,Thymidylate kinase (EC 2.7.4.9) (dTMP kinase),Danio rerio (Zebrafish) (Brachydanio rerio),51.0,206.0,1.7999999999999997e-55,217.6,sp|Q3B752|KTHY_DANRE Thymidylate kinase OS=Danio rerio OX=7955 GN=dtymk PE=2 SV=1,GO:0004550; GO:0004798; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0006227; GO:0006233; GO:0006235; GO:0006281; GO:0021954,central nervous system neuron development [GO:0021954]; DNA repair [GO:0006281]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; dTMP kinase activity [GO:0004798]; nucleoside diphosphate kinase activity [GO:0004550],GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0016740; GO:0043226; GO:0048856; GO:0055086; GO:1901135,catalytic activity; nucleus; mitochondrion; DNA repair; transferase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09661,FUN_041871-T1,Peve_00023974,Pocillopora_meandrina_HIv1___RNAseq.g15111.t1,three_way,70.967,FUN_041871-T1,Q9IB89,,,,,56.4,101.0,2.1e-30,135.2,sp|Q9IB89|ZIC5_XENLA Zinc finger protein ZIC 5 OS=Xenopus laevis OX=8355 GN=zic5 PE=2 SV=1,,,,,,
OG_09662,FUN_041873-T1,Peve_00040565,Pocillopora_meandrina_HIv1___TS.g10137.t1b,three_way,58.01883333333333,FUN_041873-T1,Q5R9Y1,,,,,42.6,282.0,1.7000000000000002e-58,228.0,sp|Q5R9Y1|FSTL1_PONAB Follistatin-related protein 1 OS=Pongo abelii OX=9601 GN=FSTL1 PE=2 SV=2,,,,,,
OG_09663,FUN_041874-T1,Peve_00040563,Pocillopora_meandrina_HIv1___RNAseq.g15106.t3,three_way,72.21516666666666,FUN_041874-T1,P49959,MRE11_HUMAN,,Double-strand break repair protein MRE11 (EC 3.1.-.-) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A),Homo sapiens (Human),55.2,538.0,4.6e-166,586.3,sp|P49959|MRE11_HUMAN Double-strand break repair protein MRE11 OS=Homo sapiens OX=9606 GN=MRE11 PE=1 SV=3,GO:0000014; GO:0000019; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0003690; GO:0004518; GO:0004520; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006302; GO:0006303; GO:0006310; GO:0006974; GO:0007004; GO:0007062; GO:0007095; GO:0007129; GO:0007131; GO:0008283; GO:0008296; GO:0008408; GO:0016605; GO:0030145; GO:0030870; GO:0031573; GO:0031860; GO:0032206; GO:0035825; GO:0035861; GO:0042138; GO:0042802; GO:0043066; GO:0044818; GO:0045296; GO:0062176; GO:0070533; GO:0097552; GO:0098687; GO:0110025; GO:2000781; GO:2001033,cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; homologous chromosome pairing at meiosis [GO:0007129]; homologous recombination [GO:0035825]; meiotic DNA double-strand break formation [GO:0042138]; mitochondrial double-strand break repair via homologous recombination [GO:0097552]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of telomere maintenance [GO:0032206]; R-loop processing [GO:0062176]; reciprocal meiotic recombination [GO:0007131]; regulation of mitotic recombination [GO:0000019]; sister chromatid cohesion [GO:0007062]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; telomeric 3' overhang formation [GO:0031860],"BRCA1-C complex [GO:0070533]; chromosomal region [GO:0098687]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]",3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; cadherin binding [GO:0045296]; DNA endonuclease activity [GO:0004520]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; nuclease activity [GO:0004518]; single-stranded DNA endodeoxyribonuclease activity [GO:0000014],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0016787; GO:0022414; GO:0032200; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; hydrolase activity; reproductive process; telomere organization; organelle; catalytic activity, acting on DNA"
OG_09664,FUN_041875-T1,Peve_00040575,Pocillopora_meandrina_HIv1___RNAseq.g15107.t1,three_way,97.13533333333334,FUN_041875-T1,P49841,GSK3B_HUMAN,,Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1),Homo sapiens (Human),88.7,212.0,1.4000000000000003e-111,403.7,sp|P49841|GSK3B_HUMAN Glycogen synthase kinase-3 beta OS=Homo sapiens OX=9606 GN=GSK3B PE=1 SV=2,GO:0001837; GO:0001954; GO:0002020; GO:0002039; GO:0003170; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0005977; GO:0006468; GO:0006983; GO:0007005; GO:0007212; GO:0007623; GO:0008013; GO:0008286; GO:0010508; GO:0010628; GO:0010629; GO:0010719; GO:0010975; GO:0016055; GO:0016301; GO:0018105; GO:0019082; GO:0019901; GO:0021766; GO:0030010; GO:0030011; GO:0030154; GO:0030336; GO:0030424; GO:0030425; GO:0030516; GO:0030877; GO:0031175; GO:0031333; GO:0031334; GO:0031398; GO:0031625; GO:0032007; GO:0032092; GO:0032436; GO:0032886; GO:0034236; GO:0034452; GO:0034976; GO:0035556; GO:0036016; GO:0042752; GO:0043066; GO:0043161; GO:0043525; GO:0045597; GO:0045668; GO:0045719; GO:0045724; GO:0045732; GO:0046777; GO:0046825; GO:0046827; GO:0048156; GO:0048814; GO:0050321; GO:0050770; GO:0051059; GO:0060070; GO:0060079; GO:0061629; GO:0070507; GO:0070885; GO:0071109; GO:0071300; GO:0090090; GO:0097110; GO:0097191; GO:0097192; GO:0098793; GO:0098794; GO:0098978; GO:0099171; GO:0106027; GO:0106310; GO:0150101; GO:1900034; GO:1900181; GO:1900271; GO:1901030; GO:1902042; GO:1903566; GO:1903940; GO:1904339; GO:1904646; GO:1904781; GO:1990909; GO:2000077; GO:2000466; GO:2000740,canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glycogen metabolic process [GO:0005977]; heart valve development [GO:0003170]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of TOR signaling [GO:0032007]; negative regulation of TORC2 signaling [GO:1903940]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of autophagy [GO:0010508]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of protein-containing complex assembly [GO:0031334]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; response to endoplasmic reticulum stress [GO:0034976]; superior temporal gyrus development [GO:0071109]; viral protein processing [GO:0019082]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Wnt signalosome [GO:1990909],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; scaffold protein binding [GO:0097110]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0005975; GO:0006091; GO:0007005; GO:0007163; GO:0008092; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0061024; GO:0140096,"catalytic activity; nucleus; nucleoplasm; mitochondrion; microtubule organizing center; cytosol; plasma membrane; carbohydrate metabolic process; generation of precursor metabolites and energy; mitochondrion organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; transferase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; membrane organization; catalytic activity, acting on a protein"
OG_09665,FUN_041877-T1,Peve_00000883,Pocillopora_meandrina_HIv1___TS.g10136.t1,three_way,95.18533333333332,FUN_041877-T1,B5DF89,CUL3_RAT,,Cullin-3,Rattus norvegicus (Rat),75.7,760.0,0.0,1124.4,sp|B5DF89|CUL3_RAT Cullin-3 OS=Rattus norvegicus OX=10116 GN=Cul3 PE=1 SV=2,GO:0000122; GO:0000209; GO:0000278; GO:0000902; GO:0000922; GO:0001701; GO:0001822; GO:0001831; GO:0005112; GO:0005634; GO:0005737; GO:0005794; GO:0005813; GO:0005827; GO:0005886; GO:0006357; GO:0006511; GO:0006513; GO:0006888; GO:0006954; GO:0007080; GO:0007229; GO:0007369; GO:0010467; GO:0016055; GO:0016477; GO:0016567; GO:0017145; GO:0030030; GO:0030163; GO:0030332; GO:0031145; GO:0031208; GO:0031398; GO:0031463; GO:0031625; GO:0031648; GO:0032467; GO:0032480; GO:0034599; GO:0035024; GO:0036126; GO:0040016; GO:0042802; GO:0043149; GO:0043161; GO:0044346; GO:0045842; GO:0048208; GO:0051865; GO:0061630; GO:0070936; GO:0071230; GO:0071630; GO:0072576; GO:0072686; GO:0098794; GO:0098978; GO:0140252; GO:0160072; GO:1900076; GO:1901992; GO:1904263,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell projection organization [GO:0030030]; cellular response to amino acid stimulus [GO:0071230]; cellular response to oxidative stress [GO:0034599]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; fibroblast apoptotic process [GO:0044346]; gastrulation [GO:0007369]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; kidney development [GO:0001822]; liver morphogenesis [GO:0072576]; mitotic cell cycle [GO:0000278]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type I interferon production [GO:0032480]; nuclear protein quality control by the ubiquitin-proteasome system [GO:0071630]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of TORC1 signaling [GO:1904263]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation protein catabolic process at postsynapse [GO:0140252]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149]; trophectodermal cellular morphogenesis [GO:0001831]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; polar microtubule [GO:0005827]; postsynapse [GO:0098794]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922],cyclin binding [GO:0030332]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; POZ domain binding [GO:0031208]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625],GO:0000278; GO:0003824; GO:0005634; GO:0005794; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0006954; GO:0007010; GO:0012501; GO:0016192; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0065003; GO:0140096,"mitotic cell cycle; catalytic activity; nucleus; Golgi apparatus; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; inflammatory response; cytoskeleton organization; programmed cell death; vesicle-mediated transport; transferase activity; protein catabolic process; organelle; anatomical structure development; cell motility; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_09666,FUN_041883-T1,Peve_00026884,Pocillopora_meandrina_HIv1___RNAseq.g15394.t1,three_way,70.99433333333333,FUN_041883-T1,Q90X46,GP161_DANRE,,G-protein coupled receptor 161,Danio rerio (Zebrafish) (Brachydanio rerio),28.0,314.0,1e-25,119.4,sp|Q90X46|GP161_DANRE G-protein coupled receptor 161 OS=Danio rerio OX=7955 GN=gpr161 PE=2 SV=2,GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0007368; GO:0051924; GO:0055037; GO:0060170; GO:1901621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; determination of left/right symmetry [GO:0007368]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; regulation of calcium ion transport [GO:0051924],ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037],G protein-coupled receptor activity [GO:0004930],GO:0005768; GO:0005929; GO:0031410; GO:0043226; GO:0060089,endosome; cilium; cytoplasmic vesicle; organelle; molecular transducer activity
OG_09667,FUN_041884-T1,Peve_00012643,Pocillopora_meandrina_HIv1___RNAseq.g15395.t1,three_way,72.869,FUN_041884-T1,F4IF36,FGT1_ARATH,,Protein FORGETTER 1 (Protein EMBRYO DEFECTIVE 1135),Arabidopsis thaliana (Mouse-ear cress),38.7,1090.0,1.2e-201,705.7,sp|F4IF36|FGT1_ARATH Protein FORGETTER 1 OS=Arabidopsis thaliana OX=3702 GN=FGT1 PE=1 SV=1,GO:0005634; GO:0006338; GO:0006355; GO:0008270; GO:0009408; GO:0010286; GO:0031490; GO:0040029; GO:0042393; GO:1900036; GO:1990841,chromatin remodeling [GO:0006338]; epigenetic regulation of gene expression [GO:0040029]; heat acclimation [GO:0010286]; positive regulation of cellular response to heat [GO:1900036]; regulation of DNA-templated transcription [GO:0006355]; response to heat [GO:0009408],nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; histone binding [GO:0042393]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006325; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleus; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle
OG_09668,FUN_041885-T1,Peve_00033410,Pocillopora_meandrina_HIv1___RNAseq.g15398.t1,three_way,89.648,FUN_041885-T1,Q6PFS7,,,,,65.3,144.0,1.9e-48,193.4,sp|Q6PFS7|ATG3_DANRE Ubiquitin-like-conjugating enzyme ATG3 OS=Danio rerio OX=7955 GN=atg3 PE=2 SV=1,,,,,,
OG_09669,FUN_041887-T1,Peve_00033408,Pocillopora_meandrina_HIv1___RNAseq.g15415.t1,three_way,34.96633333333333,,,,,,,,,,,,,,,,,
OG_09670,FUN_041888-T1,Peve_00033407,Pocillopora_meandrina_HIv1___RNAseq.g15416.t1,three_way,83.91333333333334,FUN_041888-T1,Q3SZ65,,,,,83.1,397.0,6.9e-189,661.4,sp|Q3SZ65|IF4A2_BOVIN Eukaryotic initiation factor 4A-II OS=Bos taurus OX=9913 GN=EIF4A2 PE=2 SV=1,,,,,,
OG_09671,FUN_041889-T1,Peve_00033396,Pocillopora_meandrina_HIv1___RNAseq.g15418.t1,three_way,84.536,FUN_041889-T1,A7MBP4,IFT46_DANRE,,Intraflagellar transport protein 46 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),61.5,364.0,1.1999999999999999e-92,341.7,sp|A7MBP4|IFT46_DANRE Intraflagellar transport protein 46 homolog OS=Danio rerio OX=7955 GN=ift46 PE=2 SV=2,GO:0005737; GO:0005815; GO:0030992; GO:0031514; GO:0036064; GO:0042073; GO:0048264; GO:0048793; GO:0060041; GO:0060271,cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; microtubule organizing center [GO:0005815]; motile cilium [GO:0031514],,GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_09672,FUN_041890-T1,Peve_00033394,Pocillopora_meandrina_HIv1___RNAseq.g15420.t1,three_way,92.026,FUN_041890-T1,P38117,ETFB_HUMAN,,Electron transfer flavoprotein subunit beta (Beta-ETF),Homo sapiens (Human),68.8,253.0,1.4e-94,347.4,sp|P38117|ETFB_HUMAN Electron transfer flavoprotein subunit beta OS=Homo sapiens OX=9606 GN=ETFB PE=1 SV=3,GO:0005739; GO:0005759; GO:0009055; GO:0009063; GO:0022904; GO:0033539; GO:0045251,amino acid catabolic process [GO:0009063]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904],electron transfer flavoprotein complex [GO:0045251]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],electron transfer activity [GO:0009055],GO:0005739; GO:0006091; GO:0006520; GO:0006629; GO:0043226,mitochondrion; generation of precursor metabolites and energy; amino acid metabolic process; lipid metabolic process; organelle
OG_09673,FUN_041895-T1,Peve_00026172,Pocillopora_meandrina_HIv1___RNAseq.g15351.t1,three_way,68.37666666666668,FUN_041895-T1,Q505H7,,,,,49.0,392.0,1.3e-80,302.4,sp|Q505H7|IWS1_XENTR Protein IWS1 homolog OS=Xenopus tropicalis OX=8364 GN=iws1 PE=2 SV=1,,,,,,
OG_09674,FUN_041896-T1,Peve_00026173,Pocillopora_meandrina_HIv1___RNAseq.6056_t,three_way,57.614666666666665,FUN_041896-T1,Q90WM5,,,,,36.3,292.0,2.0000000000000002e-29,131.7,sp|Q90WM5|DMRT3_TAKRU Doublesex- and mab-3-related transcription factor 3 OS=Takifugu rubripes OX=31033 GN=dmrt3 PE=2 SV=2,,,,,,
OG_09675,FUN_041897-T1,Peve_00028578,Pocillopora_meandrina_HIv1___RNAseq.g15353.t1,three_way,97.285,FUN_041897-T1,Q3SX43,RRAGA_BOVIN,,Ras-related GTP-binding protein A (Rag A) (RagA) (EC 3.6.5.-),Bos taurus (Bovine),90.2,215.0,1.5e-109,397.1,sp|Q3SX43|RRAGA_BOVIN Ras-related GTP-binding protein A OS=Bos taurus OX=9913 GN=RRAGA PE=2 SV=1,GO:0003924; GO:0005525; GO:0005634; GO:0005764; GO:0005765; GO:0006915; GO:0008104; GO:0009267; GO:0010507; GO:0034198; GO:0043200; GO:0043495; GO:0071230; GO:0072657; GO:1903432; GO:1904263; GO:1990131,apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; negative regulation of autophagy [GO:0010507]; positive regulation of TORC1 signaling [GO:1904263]; protein localization [GO:0008104]; protein localization to membrane [GO:0072657]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200],Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-membrane adaptor activity [GO:0043495],GO:0003824; GO:0003924; GO:0005634; GO:0005764; GO:0005773; GO:0012501; GO:0016787; GO:0043226; GO:0060090,catalytic activity; GTPase activity; nucleus; lysosome; vacuole; programmed cell death; hydrolase activity; organelle; molecular adaptor activity
OG_09676,FUN_041900-T1,Peve_00015834,Pocillopora_meandrina_HIv1___RNAseq.g15356.t1,three_way,56.85066666666667,FUN_041900-T1,Q0P5B7,AAAD_BOVIN,,Arylacetamide deacetylase (EC 3.1.1.3),Bos taurus (Bovine),39.9,308.0,1.2999999999999999e-46,188.7,sp|Q0P5B7|AAAD_BOVIN Arylacetamide deacetylase OS=Bos taurus OX=9913 GN=AADAC PE=2 SV=1,GO:0004806; GO:0005789; GO:0006629; GO:0010898; GO:0017171,lipid metabolic process [GO:0006629]; positive regulation of triglyceride catabolic process [GO:0010898],endoplasmic reticulum membrane [GO:0005789],serine hydrolase activity [GO:0017171]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_09677,FUN_041901-T1,Peve_00017951,Pocillopora_meandrina_HIv1___RNAseq.g15357.t1,three_way,67.588,FUN_041901-T1,Q0P5B7,AAAD_BOVIN,,Arylacetamide deacetylase (EC 3.1.1.3),Bos taurus (Bovine),35.9,337.0,8.299999999999998e-41,169.5,sp|Q0P5B7|AAAD_BOVIN Arylacetamide deacetylase OS=Bos taurus OX=9913 GN=AADAC PE=2 SV=1,GO:0004806; GO:0005789; GO:0006629; GO:0010898; GO:0017171,lipid metabolic process [GO:0006629]; positive regulation of triglyceride catabolic process [GO:0010898],endoplasmic reticulum membrane [GO:0005789],serine hydrolase activity [GO:0017171]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_09678,FUN_041902-T1,Peve_00030476,Pocillopora_meandrina_HIv1___RNAseq.g15359.t1,three_way,84.79933333333334,FUN_041902-T1,A0A8M3B525,BRCC3_DANRE,,Lys-63-specific deubiquitinase (EC 3.4.19.-),Danio rerio (Zebrafish) (Brachydanio rerio),57.4,258.0,4.6e-75,282.7,sp|A0A8M3B525|BRCC3_DANRE Lys-63-specific deubiquitinase OS=Danio rerio OX=7955 GN=brcc3 PE=1 SV=1,GO:0000922; GO:0001525; GO:0004843; GO:0005737; GO:0006302; GO:0006508; GO:0008237; GO:0031593; GO:0046872; GO:0051301; GO:0070531; GO:0070536; GO:0070552,angiogenesis [GO:0001525]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508],BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; spindle pole [GO:0000922],cysteine-type deubiquitinase activity [GO:0004843]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593],GO:0003824; GO:0006281; GO:0016787; GO:0140096,"catalytic activity; DNA repair; hydrolase activity; catalytic activity, acting on a protein"
OG_09679,FUN_041903-T1,Peve_00030474,Pocillopora_meandrina_HIv1___RNAseq.g15367.t1,three_way,66.04633333333334,FUN_041903-T1,Q80W94,MOGT2_MOUSE,,2-acylglycerol O-acyltransferase 2 (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 1-like) (Monoacylglycerol O-acyltransferase 2),Mus musculus (Mouse),40.6,315.0,1.3000000000000002e-60,235.0,sp|Q80W94|MOGT2_MOUSE 2-acylglycerol O-acyltransferase 2 OS=Mus musculus OX=10090 GN=Mogat2 PE=1 SV=1,GO:0003846; GO:0004144; GO:0005783; GO:0005789; GO:0006071; GO:0006629; GO:0006640; GO:0006651; GO:0016407; GO:0019432; GO:0046462; GO:0050892; GO:1990578,diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; intestinal absorption [GO:0050892]; lipid metabolic process [GO:0006629]; monoacylglycerol biosynthetic process [GO:0006640]; monoacylglycerol metabolic process [GO:0046462]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; perinuclear endoplasmic reticulum membrane [GO:1990578],2-acylglycerol O-acyltransferase activity [GO:0003846]; acetyltransferase activity [GO:0016407]; diacylglycerol O-acyltransferase activity [GO:0004144],GO:0003824; GO:0005783; GO:0005975; GO:0006629; GO:0016740; GO:0022600; GO:0043226,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; lipid metabolic process; transferase activity; digestive system process; organelle
OG_09680,FUN_041905-T1,Peve_00007895,Pocillopora_meandrina_HIv1___RNAseq.g15368.t2,three_way,66.51333333333334,,,,,,,,,,,,,,,,,
OG_09681,FUN_041906-T1,Peve_00007893,Pocillopora_meandrina_HIv1___RNAseq.g15370.t2,three_way,66.65266666666666,FUN_041906-T1,Q8TEB9,RHBL4_HUMAN,,Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4),Homo sapiens (Human),41.0,300.0,2.9e-57,224.2,sp|Q8TEB9|RHBL4_HUMAN Rhomboid-related protein 4 OS=Homo sapiens OX=9606 GN=RHBDD1 PE=1 SV=1,GO:0004175; GO:0004252; GO:0005783; GO:0005789; GO:0006915; GO:0010954; GO:0031293; GO:0031966; GO:0033619; GO:0034620; GO:0034644; GO:0036503; GO:0043066; GO:0043687; GO:0044322; GO:0045732; GO:0048515; GO:0051047; GO:1904211,"apoptotic process [GO:0006915]; cellular response to unfolded protein [GO:0034620]; cellular response to UV [GO:0034644]; ERAD pathway [GO:0036503]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; membrane protein proteolysis involved in retrograde protein transport, ER to cytosol [GO:1904211]; negative regulation of apoptotic process [GO:0043066]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein processing [GO:0010954]; positive regulation of secretion [GO:0051047]; post-translational protein modification [GO:0043687]; spermatid differentiation [GO:0048515]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; mitochondrial membrane [GO:0031966],endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005783; GO:0012501; GO:0016787; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; programmed cell death; hydrolase activity; reproductive process; cell differentiation; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09682,FUN_041907-T1,Peve_00007890,Pocillopora_meandrina_HIv1___TS.g10677.t1,three_way,73.91533333333334,FUN_041907-T1,Q64560,TPP2_RAT,,Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II),Rattus norvegicus (Rat),51.1,1253.0,0.0,1293.9,sp|Q64560|TPP2_RAT Tripeptidyl-peptidase 2 OS=Rattus norvegicus OX=10116 GN=Tpp2 PE=2 SV=3,GO:0004177; GO:0004252; GO:0005634; GO:0005829; GO:0006508; GO:0008240; GO:0030163; GO:0042277; GO:0042802; GO:0080144,intracellular amino acid homeostasis [GO:0080144]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],cytosol [GO:0005829]; nucleus [GO:0005634],aminopeptidase activity [GO:0004177]; identical protein binding [GO:0042802]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_09683,FUN_041908-T1,Peve_00007888,Pocillopora_meandrina_HIv1___RNAseq.g15648.t1,three_way,83.73049999999999,FUN_041908-T1,Q17QZ4,,,,,57.2,383.0,2e-95,351.3,sp|Q17QZ4|TFDP1_BOVIN Transcription factor Dp-1 OS=Bos taurus OX=9913 GN=TFDP1 PE=2 SV=1,,,,,,
OG_09684,FUN_041910-T1,Peve_00007887,Pocillopora_meandrina_HIv1___RNAseq.g15647.t1,three_way,64.52366666666667,FUN_041910-T1,Q9DB94,,,,,33.1,357.0,7.6e-45,182.6,sp|Q9DB94|WDR53_MOUSE WD repeat-containing protein 53 OS=Mus musculus OX=10090 GN=Wdr53 PE=1 SV=1,,,,,,
OG_09685,FUN_041912-T1,Peve_00007884,Pocillopora_meandrina_HIv1___RNAseq.g15645.t1,three_way,77.636,FUN_041912-T1,Q86V85,,,,,37.3,415.0,1.4e-64,248.4,sp|Q86V85|GP180_HUMAN Integral membrane protein GPR180 OS=Homo sapiens OX=9606 GN=GPR180 PE=1 SV=1,,,,,,
OG_09686,FUN_041913-T1,Peve_00007882,Pocillopora_meandrina_HIv1___RNAseq.g15642.t1,three_way,70.99933333333333,FUN_041913-T1,P16388,KCNA1_MOUSE,,Potassium voltage-gated channel subfamily A member 1 (MBK1) (MKI) (Voltage-gated potassium channel subunit Kv1.1),Mus musculus (Mouse),36.4,382.0,8.799999999999999e-62,239.2,sp|P16388|KCNA1_MOUSE Potassium voltage-gated channel subfamily A member 1 OS=Mus musculus OX=10090 GN=Kcna1 PE=1 SV=1,GO:0001964; GO:0005251; GO:0005783; GO:0005829; GO:0005886; GO:0006937; GO:0007405; GO:0007420; GO:0008076; GO:0009986; GO:0010644; GO:0010960; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030424; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0070161; GO:0071286; GO:0071805; GO:0086011; GO:0097718,brain development [GO:0007420]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; membrane repolarization during action potential [GO:0086011]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],anchoring junction [GO:0070161]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; juxtaparanode region of axon [GO:0044224]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; protein-containing complex assembly
OG_09687,FUN_041914-T1,Peve_00007879,Pocillopora_meandrina_HIv1___TS.g10669.t1,three_way,68.09316666666666,FUN_041914-T1,Q9JJZ8,CNGA3_MOUSE,,Cyclic nucleotide-gated channel alpha-3 (CNG channel alpha-3) (CNG-3) (CNG3) (Cone photoreceptor cGMP-gated channel subunit alpha-3) (Gustatory cyclic nucleotide-gated cation channel) (CNGgust),Mus musculus (Mouse),40.8,530.0,1.1e-104,382.9,sp|Q9JJZ8|CNGA3_MOUSE Cyclic nucleotide-gated channel alpha-3 OS=Mus musculus OX=10090 GN=Cnga3 PE=1 SV=2,GO:0001750; GO:0005221; GO:0005262; GO:0005272; GO:0005886; GO:0007601; GO:0030553; GO:0046549; GO:0060041; GO:0120199,retina development in camera-type eye [GO:0060041]; retinal cone cell development [GO:0046549]; visual perception [GO:0007601],cone photoreceptor outer segment [GO:0120199]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; cGMP binding [GO:0030553]; intracellularly cyclic nucleotide-activated monoatomic cation channel activity [GO:0005221]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0048856; GO:0050877,transporter activity; plasma membrane; anatomical structure development; nervous system process
OG_09688,FUN_041916-T1,Peve_00007878,Pocillopora_meandrina_HIv1___RNAseq.g15640.t1,three_way,85.84533333333333,FUN_041916-T1,Q03041,CNGA2_BOVIN,,Cyclic nucleotide-gated channel alpha-2 (CNG channel alpha-2) (CNG-2) (CNG2) (Cyclic nucleotide-gated channel alpha 3) (CNCalpha3) (CNGa3) (Olfactory cyclic nucleotide-gated channel subunit 1) (OCNC1),Bos taurus (Bovine),46.7,587.0,1.6999999999999998e-151,537.7,sp|Q03041|CNGA2_BOVIN Cyclic nucleotide-gated channel alpha-2 OS=Bos taurus OX=9913 GN=CNGA2 PE=1 SV=1,GO:0005216; GO:0005222; GO:0005223; GO:0005262; GO:0005516; GO:0005886; GO:0006813; GO:0006814; GO:0006816; GO:0007608; GO:0017071; GO:0030552; GO:0030553; GO:0044877; GO:0098655; GO:0098804,calcium ion transport [GO:0006816]; monoatomic cation transmembrane transport [GO:0098655]; potassium ion transport [GO:0006813]; sensory perception of smell [GO:0007608]; sodium ion transport [GO:0006814],intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; non-motile cilium membrane [GO:0098804]; plasma membrane [GO:0005886],calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; monoatomic ion channel activity [GO:0005216]; protein-containing complex binding [GO:0044877],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_09689,FUN_041917-T1,Peve_00007877,Pocillopora_meandrina_HIv1___RNAseq.g15639.t1,three_way,79.75916666666667,FUN_041917-T1,Q33E94,RFX4_HUMAN,,Transcription factor RFX4 (Regulatory factor X 4) (Testis development protein NYD-SP10),Homo sapiens (Human),50.0,494.0,4.500000000000001e-130,466.8,sp|Q33E94|RFX4_HUMAN Transcription factor RFX4 OS=Homo sapiens OX=9606 GN=RFX4 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0021537; GO:0045879; GO:0045944; GO:0060271; GO:0070613; GO:1990837,cilium assembly [GO:0060271]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of protein processing [GO:0070613]; regulation of transcription by RNA polymerase II [GO:0006357]; telencephalon development [GO:0021537],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0044782; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; cilium organization; anatomical structure development; transcription regulator activity
OG_09690,FUN_041919-T1,Peve_00007876,Pocillopora_meandrina_HIv1___RNAseq.g15621.t1,three_way,38.177,,,,,,,,,,,,,,,,,
OG_09691,FUN_041920-T1,Peve_00007875,Pocillopora_meandrina_HIv1___RNAseq.g15622.t1,three_way,92.08833333333334,FUN_041920-T1,A6QQ21,,,,,59.4,266.0,1.6999999999999996e-75,284.3,sp|A6QQ21|CSN6_BOVIN COP9 signalosome complex subunit 6 OS=Bos taurus OX=9913 GN=COPS6 PE=2 SV=1,,,,,,
OG_09692,FUN_041921-T1,Peve_00007872,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1a,three_way,76.00366666666666,FUN_041921-T1,Q68F70,,,,,40.3,1001.0,6.6e-185,649.4,sp|Q68F70|INT4_XENLA Integrator complex subunit 4 OS=Xenopus laevis OX=8355 GN=ints4 PE=2 SV=1,,,,,,
OG_09693,FUN_041922-T1,Peve_00007867,Pocillopora_meandrina_HIv1___RNAseq.g15626.t1,three_way,82.96933333333334,FUN_041922-T1,Q5I0R4,,,,,53.6,222.0,4.2e-63,242.7,sp|Q5I0R4|CF300_XENTR Cilia- and flagella-associated protein 300 OS=Xenopus tropicalis OX=8364 GN=cfap300 PE=2 SV=1,,,,,,
OG_09694,FUN_041923-T1,Peve_00007865,Pocillopora_meandrina_HIv1___RNAseq.g15625.t1,three_way,75.917,FUN_041923-T1,D6C652,YAP1A_XENLA,,Transcriptional coactivator YAP1-A (Yes-associated protein 1-A) (xYAP) (Protein yorkie homolog-A) (Yes-associated protein YAP65 homolog A),Xenopus laevis (African clawed frog),28.5,456.0,6.000000000000001e-28,126.7,sp|D6C652|YAP1A_XENLA Transcriptional coactivator YAP1-A OS=Xenopus laevis OX=8355 GN=yap1-a PE=1 SV=1,GO:0003713; GO:0003714; GO:0005634; GO:0005737; GO:0005886; GO:0005911; GO:0005923; GO:0035329; GO:0045944,hippo signaling [GO:0035329]; positive regulation of transcription by RNA polymerase II [GO:0045944],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886],transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005886; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; plasma membrane; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_09695,FUN_041924-T1,Peve_00007863,Pocillopora_meandrina_HIv1___TS.g10650.t1,three_way,81.45066666666666,FUN_041924-T1,Q9H8V3,,,,,44.9,864.0,3.6e-184,646.7,sp|Q9H8V3|ECT2_HUMAN Protein ECT2 OS=Homo sapiens OX=9606 GN=ECT2 PE=1 SV=4,,,,,,
OG_09696,FUN_041927-T1,Peve_00025329,Pocillopora_meandrina_HIv1___RNAseq.g15250.t1,three_way,59.38166666666667,FUN_041927-T1,Q3UPY5,,,,,44.6,630.0,8.2e-144,512.3,sp|Q3UPY5|GLBL2_MOUSE Beta-galactosidase-1-like protein 2 OS=Mus musculus OX=10090 GN=Glb1l2 PE=1 SV=1,,,,,,
OG_09697,FUN_041928-T1,Peve_00022682,Pocillopora_meandrina_HIv1___RNAseq.g15696.t1,three_way,66.166,FUN_041928-T1,Q8BG19,TMTC4_MOUSE,,Protein O-mannosyl-transferase TMTC4 (EC 2.4.1.109) (Transmembrane O-mannosyltransferase targeting cadherins 4) (Transmembrane and tetratricopeptide repeat-containing 4),Mus musculus (Mouse),52.0,481.0,5.7e-131,469.9,sp|Q8BG19|TMTC4_MOUSE Protein O-mannosyl-transferase TMTC4 OS=Mus musculus OX=10090 GN=Tmtc4 PE=2 SV=1,GO:0004169; GO:0005783; GO:0007605; GO:0016020; GO:0030968; GO:0032470; GO:0035269; GO:0051117; GO:1905584,endoplasmic reticulum unfolded protein response [GO:0030968]; outer hair cell apoptotic process [GO:1905584]; positive regulation of endoplasmic reticulum calcium ion concentration [GO:0032470]; protein O-linked mannosylation [GO:0035269]; sensory perception of sound [GO:0007605],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],ATPase binding [GO:0051117]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169],GO:0003824; GO:0005783; GO:0009101; GO:0012501; GO:0016740; GO:0043226; GO:0050877; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; programmed cell death; transferase activity; organelle; nervous system process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_09698,FUN_041929-T1,Peve_00022681,Pocillopora_meandrina_HIv1___RNAseq.g15697.t1,three_way,59.108,FUN_041929-T1,Q6AYB8,GO45_RAT,,Golgin-45 (Basic leucine zipper nuclear factor 1),Rattus norvegicus (Rat),29.6,422.0,1.5e-25,119.0,sp|Q6AYB8|GO45_RAT Golgin-45 OS=Rattus norvegicus OX=10116 GN=Blzf1 PE=1 SV=1,GO:0000139; GO:0005634; GO:0005794; GO:0007030; GO:0019899; GO:0031625; GO:0043001,Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],enzyme binding [GO:0019899]; ubiquitin protein ligase binding [GO:0031625],GO:0005634; GO:0005794; GO:0016192; GO:0043226; GO:0072659,nucleus; Golgi apparatus; vesicle-mediated transport; organelle; protein localization to plasma membrane
OG_09699,FUN_041930-T1,Peve_00023596,Pocillopora_meandrina_HIv1___RNAseq.g15698.t1,three_way,81.762,,,,,,,,,,,,,,,,,
OG_09700,FUN_041931-T1,Peve_00026029,Pocillopora_meandrina_HIv1___TS.g24009.t1,three_way,33.93566666666666,,,,,,,,,,,,,,,,,
OG_09701,FUN_041932-T1,Peve_00023598,Pocillopora_meandrina_HIv1___RNAseq.g15699.t1,three_way,75.34166666666667,FUN_041932-T1,P53356,,,,,49.0,796.0,1e-215,751.5,sp|P53356|HTK16_HYDVU Tyrosine-protein kinase HTK16 OS=Hydra vulgaris OX=6087 GN=HTK16 PE=2 SV=1,,,,,,
OG_09702,FUN_041933-T1,Peve_00023581,Pocillopora_meandrina_HIv1___RNAseq.g15700.t1,three_way,61.377,FUN_041933-T1,P52594,AGFG1_HUMAN,,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),Homo sapiens (Human),57.9,183.0,3.4e-54,214.9,sp|P52594|AGFG1_HUMAN Arf-GAP domain and FG repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=AGFG1 PE=1 SV=2,GO:0001675; GO:0003677; GO:0003723; GO:0005096; GO:0005643; GO:0005737; GO:0005829; GO:0006406; GO:0007289; GO:0008270; GO:0031410; GO:0042995; GO:0043025; GO:0043231; GO:0045109,acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; mRNA export from nucleus [GO:0006406]; spermatid nucleus differentiation [GO:0007289],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nuclear pore [GO:0005643],DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005829; GO:0006913; GO:0007010; GO:0022414; GO:0031410; GO:0043226; GO:0098772,DNA binding; RNA binding; cytosol; nucleocytoplasmic transport; cytoskeleton organization; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09703,FUN_041935-T1,Peve_00023583,Pocillopora_meandrina_HIv1___RNAseq.g15701.t2,three_way,79.72516666666667,FUN_041935-T1,Q9ES28,,,,,36.5,902.0,1.6e-131,471.9,sp|Q9ES28|ARHG7_MOUSE Rho guanine nucleotide exchange factor 7 OS=Mus musculus OX=10090 GN=Arhgef7 PE=1 SV=2,,,,,,
OG_09704,FUN_041938-T1,Peve_00023588,Pocillopora_meandrina_HIv1___TS.g10732.t1,three_way,61.260666666666665,FUN_041938-T1,P05619,,,,,35.9,376.0,1.1e-65,252.3,sp|P05619|ILEU_HORSE Leukocyte elastase inhibitor OS=Equus caballus OX=9796 GN=SERPINB1 PE=1 SV=3,,,,,,
OG_09705,FUN_041939-T1,Peve_00023589,Pocillopora_meandrina_HIv1___RNAseq.g15705.t1,three_way,68.18516666666667,FUN_041939-T1,Q15696,U2AFM_HUMAN,,"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)",Homo sapiens (Human),56.4,172.0,6.7e-51,202.6,sp|Q15696|U2AFM_HUMAN U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 OS=Homo sapiens OX=9606 GN=ZRSR2 PE=1 SV=2,GO:0000245; GO:0000398; GO:0005654; GO:0005681; GO:0005689; GO:0008270; GO:0008380; GO:0030628; GO:0042802; GO:0089701,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2AF complex [GO:0089701],identical protein binding [GO:0042802]; pre-mRNA 3'-splice site binding [GO:0030628]; zinc ion binding [GO:0008270],GO:0003723; GO:0005654; GO:0016071; GO:0065003,RNA binding; nucleoplasm; mRNA metabolic process; protein-containing complex assembly
OG_09706,FUN_041940-T1,Peve_00023590,Pocillopora_meandrina_HIv1___RNAseq.g15638.t2,three_way,64.672,FUN_041940-T1,Q9UPV0,CE164_HUMAN,,Centrosomal protein of 164 kDa (Cep164),Homo sapiens (Human),68.5,89.0,1.8e-32,143.7,sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3,GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539,cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],,GO:0005615; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0043226; GO:0044782,extracellular space; nucleoplasm; microtubule organizing center; cytosol; DNA repair; organelle; cilium organization
OG_09706,FUN_041940-T1,Peve_00023590,Pocillopora_meandrina_HIv1___RNAseq.g15638.t2,three_way,64.672,FUN_041940-T1,Q9UPV0,CE164_HUMAN,,Centrosomal protein of 164 kDa (Cep164),Homo sapiens (Human),29.7,138.0,2.2e-06,57.0,sp|Q9UPV0|CE164_HUMAN Centrosomal protein of 164 kDa OS=Homo sapiens OX=9606 GN=CEP164 PE=1 SV=3,GO:0005615; GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0006281; GO:0043231; GO:0051301; GO:0060271; GO:0097539,cell division [GO:0051301]; cilium assembly [GO:0060271]; DNA repair [GO:0006281],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654],,GO:0005615; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0043226; GO:0044782,extracellular space; nucleoplasm; microtubule organizing center; cytosol; DNA repair; organelle; cilium organization
OG_09707,FUN_041944-T1,Peve_00023595,Pocillopora_meandrina_HIv1___RNAseq.g15636.t1,three_way,61.59033333333333,FUN_041944-T1,P25169,,,,,28.7,293.0,1.3e-21,105.1,sp|P25169|AT1B1_ARTSF Sodium/potassium-transporting ATPase subunit beta OS=Artemia franciscana OX=6661 PE=2 SV=1,,,,,,
OG_09708,FUN_041945-T2,Peve_00023597,Pocillopora_meandrina_HIv1___RNAseq.g15635.t1,three_way,78.51766666666667,FUN_041945-T2,Q16760,DGKD_HUMAN,,Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) (130 kDa diacylglycerol kinase) (Diglyceride kinase delta) (DGK-delta),Homo sapiens (Human),46.2,1230.0,1.2e-279,964.5,sp|Q16760|DGKD_HUMAN Diacylglycerol kinase delta OS=Homo sapiens OX=9606 GN=DGKD PE=1 SV=4,GO:0004143; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005905; GO:0006654; GO:0006897; GO:0007165; GO:0007200; GO:0008270; GO:0015031; GO:0019900; GO:0019992; GO:0030168; GO:0031410; GO:0035556; GO:0042802; GO:0042803; GO:0045742; GO:0046339; GO:0046340; GO:0046834; GO:0046982; GO:0160195; GO:2000370,diacylglycerol catabolic process [GO:0046340]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; negative regulation of phospholipase C/protein kinase C signal transduction [GO:0160195]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; platelet activation [GO:0030168]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; protein transport [GO:0015031]; signal transduction [GO:0007165],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP-dependent diacylglycerol kinase activity [GO:0004143]; diacylglycerol binding [GO:0019992]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006629; GO:0008289; GO:0016192; GO:0016740; GO:0031410; GO:0043226,catalytic activity; nucleus; cytosol; plasma membrane; lipid metabolic process; lipid binding; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle
OG_09709,FUN_041947-T1,Peve_00007871,Pocillopora_meandrina_HIv1___TS.g10659.t1,three_way,67.32600000000001,,,,,,,,,,,,,,,,,
OG_09710,FUN_041950-T1,Peve_00025328,Pocillopora_meandrina_HIv1___RNAseq.g15251.t1,three_way,82.19333333333333,FUN_041950-T1,Q6PBU5,,,,,49.8,325.0,8.4e-92,338.6,sp|Q6PBU5|GRT1A_DANRE Growth hormone-regulated TBC protein 1-A OS=Danio rerio OX=7955 GN=grtp1a PE=2 SV=1,,,,,,
OG_09711,FUN_041951-T1,Peve_00022248,Pocillopora_meandrina_HIv1___RNAseq.g15252.t1,three_way,67.0045,FUN_041951-T1,Q498F0,,,,,52.2,592.0,2.6e-153,544.3,sp|Q498F0|WDR44_XENLA WD repeat-containing protein 44 OS=Xenopus laevis OX=8355 GN=wdr44 PE=2 SV=1,,,,,,
OG_09712,FUN_041952-T1,Peve_00022247,Pocillopora_meandrina_HIv1___RNAseq.g15253.t2,three_way,73.839,FUN_041952-T1,Q8N695,SC5A8_HUMAN,,Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8),Homo sapiens (Human),44.6,552.0,1.9e-121,438.0,sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2,GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0140161; GO:0160081; GO:2001142,acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886],iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552],GO:0005215; GO:0005886; GO:0012501; GO:0043226; GO:0055085,transporter activity; plasma membrane; programmed cell death; organelle; transmembrane transport
OG_09713,FUN_041958-T2,Peve_00027292,Pocillopora_meandrina_HIv1___RNAseq.g15161.t1,three_way,50.98183333333333,FUN_041958-T2,O93274,,,,,38.8,116.0,7.3e-23,110.2,sp|O93274|FZD8_XENLA Frizzled-8 OS=Xenopus laevis OX=8355 GN=fzd8 PE=1 SV=1,,,,,,
OG_09714,FUN_041959-T1,Peve_00043500,Pocillopora_meandrina_HIv1___RNAseq.g15157.t1,three_way,69.572,FUN_041959-T1,P91891,,,,,66.1,336.0,8.800000000000001e-118,424.9,sp|P91891|MO25_DROME Protein Mo25 OS=Drosophila melanogaster OX=7227 GN=Mo25 PE=2 SV=2,,,,,,
OG_09715,FUN_041961-T1,Peve_00043496,Pocillopora_meandrina_HIv1___RNAseq.g15155.t1,three_way,54.928,,,,,,,,,,,,,,,,,
OG_09716,FUN_041962-T1,Peve_00043495,Pocillopora_meandrina_HIv1___RNAseq.g15154.t1,three_way,93.26933333333334,FUN_041962-T1,P20340,RAB6A_HUMAN,,Ras-related protein Rab-6A (Rab-6) (EC 3.6.5.2),Homo sapiens (Human),85.4,205.0,1.1e-94,347.4,sp|P20340|RAB6A_HUMAN Ras-related protein Rab-6A OS=Homo sapiens OX=9606 GN=RAB6A PE=1 SV=3,GO:0000139; GO:0002080; GO:0003924; GO:0005525; GO:0005654; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0006890; GO:0006891; GO:0012505; GO:0016020; GO:0018125; GO:0019882; GO:0019904; GO:0030667; GO:0031175; GO:0031410; GO:0031489; GO:0032588; GO:0034067; GO:0034498; GO:0036064; GO:0042147; GO:0070062; GO:0070381; GO:0072385; GO:1903292,"antigen processing and presentation [GO:0019882]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; minus-end-directed organelle transport along microtubule [GO:0072385]; neuron projection development [GO:0031175]; peptidyl-cysteine methylation [GO:0018125]; protein localization to Golgi apparatus [GO:0034067]; protein localization to Golgi membrane [GO:1903292]; retrograde transport, endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",acrosomal membrane [GO:0002080]; ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0031410; GO:0043226,immune system process; catalytic activity; GTPase activity; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_09717,FUN_041963-T1,Peve_00043506,Pocillopora_meandrina_HIv1___RNAseq.g15912.t1,three_way,78.311,FUN_041963-T1,O35547,ACSL4_RAT,,Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain acyl-CoA synthetase 4) (LACS 4),Rattus norvegicus (Rat),53.7,706.0,2.6e-220,766.5,sp|O35547|ACSL4_RAT Long-chain-fatty-acid--CoA ligase 4 OS=Rattus norvegicus OX=10116 GN=Acsl4 PE=1 SV=2,GO:0001676; GO:0004467; GO:0005524; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005778; GO:0005783; GO:0005789; GO:0005811; GO:0005886; GO:0006629; GO:0006631; GO:0007584; GO:0015908; GO:0019432; GO:0030182; GO:0031957; GO:0031966; GO:0032024; GO:0035336; GO:0035338; GO:0043025; GO:0044233; GO:0047676; GO:0060136; GO:0060996; GO:0070672,dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; lipid metabolic process [GO:0006629]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; long-chain fatty-acyl-CoA metabolic process [GO:0035336]; neuron differentiation [GO:0030182]; positive regulation of insulin secretion [GO:0032024]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886],arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957],GO:0003824; GO:0005739; GO:0005777; GO:0005783; GO:0005811; GO:0005886; GO:0006629; GO:0006790; GO:0016874; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:0140657,catalytic activity; mitochondrion; peroxisome; endoplasmic reticulum; lipid droplet; plasma membrane; lipid metabolic process; sulfur compound metabolic process; ligase activity; reproductive process; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; ATP-dependent activity
OG_09718,FUN_041964-T1,Peve_00043505,Pocillopora_meandrina_HIv1___RNAseq.g15913.t3,three_way,63.089666666666666,FUN_041964-T1,O31463,,,,,40.8,304.0,3.8000000000000003e-59,229.9,sp|O31463|HMT_BACSU Homocysteine S-methyltransferase YbgG OS=Bacillus subtilis (strain 168) OX=224308 GN=ybgG PE=4 SV=1,,,,,,
OG_09719,FUN_041965-T1,Peve_00043497,Pocillopora_meandrina_HIv1___RNAseq.g15914.t1,three_way,83.61466666666666,FUN_041965-T1,Q9Y5B8,,,,,57.9,373.0,2.1000000000000003e-123,443.7,sp|Q9Y5B8|NDK7_HUMAN Nucleoside diphosphate kinase homolog 7 OS=Homo sapiens OX=9606 GN=NME7 PE=1 SV=1,,,,,,
OG_09720,FUN_041966-T1,Peve_00043494,Pocillopora_meandrina_HIv1___RNAseq.g15916.t1,three_way,81.62733333333334,FUN_041966-T1,P19984,,,,,44.6,130.0,2.5e-20,99.8,sp|P19984|PROF2_ACACA Profilin-2 OS=Acanthamoeba castellanii OX=5755 PE=1 SV=3,,,,,,
OG_09721,FUN_041967-T1,Peve_00033991,Pocillopora_meandrina_HIv1___RNAseq.g15917.t1,three_way,83.85133333333333,FUN_041967-T1,Q03123,,,,,46.5,260.0,5.2e-54,212.6,sp|Q03123|T2FB_XENLA General transcription factor IIF subunit 2 OS=Xenopus laevis OX=8355 GN=gtf2f2 PE=2 SV=1,,,,,,
OG_09722,FUN_041968-T1,Peve_00033990,Pocillopora_meandrina_HIv1___RNAseq.g15918.t1,three_way,58.185833333333335,,,,,,,,,,,,,,,,,
OG_09723,FUN_041969-T1,Peve_00028276,Pocillopora_meandrina_HIv1___RNAseq.g15919.t1,three_way,82.10000000000001,FUN_041969-T1,Q66JG5,,,,,47.9,443.0,1.4e-95,351.7,sp|Q66JG5|TADA3_XENTR Transcriptional adapter 3 OS=Xenopus tropicalis OX=8364 GN=tada3 PE=2 SV=1,,,,,,
OG_09724,FUN_041970-T1,Peve_00028273,Pocillopora_meandrina_HIv1___RNAseq.g15920.t1,three_way,90.77,FUN_041970-T1,P39825,,,,,38.0,129.0,2e-17,90.1,sp|P39825|PROF_SCHPO Profilin OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=cdc3 PE=1 SV=1,,,,,,
OG_09725,FUN_041971-T1,Peve_00028271,Pocillopora_meandrina_HIv1___RNAseq.g15921.t1,three_way,89.0265,FUN_041971-T1,Q99J62,,,,,66.6,359.0,8.6e-127,454.9,sp|Q99J62|RFC4_MOUSE Replication factor C subunit 4 OS=Mus musculus OX=10090 GN=Rfc4 PE=1 SV=1,,,,,,
OG_09726,FUN_041972-T1,Peve_00001550,Pocillopora_meandrina_HIv1___RNAseq.g15259.t1,three_way,64.15933333333334,FUN_041972-T1,Q3U9N9,MOT10_MOUSE,,Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1),Mus musculus (Mouse),29.3,434.0,1.0000000000000001e-49,199.5,sp|Q3U9N9|MOT10_MOUSE Monocarboxylate transporter 10 OS=Mus musculus OX=10090 GN=Slc16a10 PE=1 SV=1,GO:0005302; GO:0006590; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0030054; GO:0043231; GO:0070327; GO:0070460,aromatic amino acid transport [GO:0015801]; thyroid hormone generation [GO:0006590]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460],basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349],GO:0005215; GO:0006575; GO:0043226,transporter activity; modified amino acid metabolic process; organelle
OG_09727,FUN_041980-T1,Peve_00001545,Pocillopora_meandrina_HIv1___RNAseq.g15256.t1,three_way,86.63666666666666,FUN_041980-T1,Q14644,RASA3_HUMAN,,Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein),Homo sapiens (Human),47.9,821.0,2.6e-211,736.9,sp|Q14644|RASA3_HUMAN Ras GTPase-activating protein 3 OS=Homo sapiens OX=9606 GN=RASA3 PE=1 SV=3,GO:0005096; GO:0005246; GO:0005829; GO:0007165; GO:0008270; GO:0009898; GO:0030168; GO:0035556; GO:0046580,intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; platelet activation [GO:0030168]; signal transduction [GO:0007165],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829],calcium channel regulator activity [GO:0005246]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_09728,FUN_041981-T1,Peve_00001546,Pocillopora_meandrina_HIv1___RNAseq.g15162.t1,three_way,54.784666666666666,FUN_041981-T1,P06400,RB_HUMAN,,Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110),Homo sapiens (Human),27.8,857.0,8.2e-74,280.0,sp|P06400|RB_HUMAN Retinoblastoma-associated protein OS=Homo sapiens OX=9606 GN=RB1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000785; GO:0000977; GO:0001894; GO:0002062; GO:0003180; GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0005819; GO:0005829; GO:0006338; GO:0006355; GO:0006366; GO:0006469; GO:0007224; GO:0007265; GO:0007283; GO:0007346; GO:0010629; GO:0014009; GO:0016514; GO:0016605; GO:0019900; GO:0030154; GO:0030308; GO:0031134; GO:0031175; GO:0031507; GO:0031625; GO:0032869; GO:0034088; GO:0034349; GO:0035189; GO:0035914; GO:0042551; GO:0042802; GO:0043353; GO:0043433; GO:0043550; GO:0045445; GO:0045651; GO:0045786; GO:0045842; GO:0045879; GO:0045892; GO:0045944; GO:0048565; GO:0048667; GO:0050673; GO:0050680; GO:0050728; GO:0051146; GO:0051219; GO:0051276; GO:0051301; GO:0051402; GO:0051726; GO:0060090; GO:0060253; GO:0061629; GO:0061676; GO:0061793; GO:0071459; GO:0071466; GO:0090230; GO:0097284; GO:0097718; GO:0120163; GO:0140297; GO:1903055; GO:1903944; GO:1904028; GO:1904761; GO:2000134; GO:2000679; GO:2001234,"aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell morphogenesis involved in neuron differentiation [GO:0048667]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; chondrocyte differentiation [GO:0002062]; chromatin remodeling [GO:0006338]; chromosome organization [GO:0051276]; digestive tract development [GO:0048565]; enucleate erythrocyte differentiation [GO:0043353]; epithelial cell proliferation [GO:0050673]; G1/S transition of mitotic cell cycle [GO:0000082]; glial cell apoptotic process [GO:0034349]; glial cell proliferation [GO:0014009]; hepatocyte apoptotic process [GO:0097284]; heterochromatin formation [GO:0031507]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; myoblast differentiation [GO:0045445]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of hepatocyte apoptotic process [GO:1903944]; negative regulation of inflammatory response [GO:0050728]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; neuron maturation [GO:0042551]; neuron projection development [GO:0031175]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein localization to chromosome, centromeric region [GO:0071459]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of centromere complex assembly [GO:0090230]; regulation of DNA-templated transcription [GO:0006355]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; sister chromatid biorientation [GO:0031134]; skeletal muscle cell differentiation [GO:0035914]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283]; striated muscle cell differentiation [GO:0051146]; tissue homeostasis [GO:0001894]; transcription by RNA polymerase II [GO:0006366]",chromatin [GO:0000785]; chromatin lock complex [GO:0061793]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; Rb-E2F complex [GO:0035189]; spindle [GO:0005819]; SWI/SNF complex [GO:0016514],disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; phosphoprotein binding [GO:0051219]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006351; GO:0006355; GO:0012501; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; chromatin organization; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; reproductive process; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_09729,FUN_041984-T1,Peve_00031636,Pocillopora_meandrina_HIv1___RNAseq.g15165.t1,three_way,54.239,,,,,,,,,,,,,,,,,
OG_09730,FUN_041986-T1,Peve_00010444,Pocillopora_meandrina_HIv1___RNAseq.g15235.t1,three_way,60.22733333333333,,,,,,,,,,,,,,,,,
OG_09731,FUN_041989-T1,Peve_00010446,Pocillopora_meandrina_HIv1___RNAseq.g15231.t1,three_way,48.022,,,,,,,,,,,,,,,,,
OG_09732,FUN_041991-T1,Peve_00020704,Pocillopora_meandrina_HIv1___RNAseq.g15229.t1,three_way,48.99766666666667,,,,,,,,,,,,,,,,,
OG_09733,FUN_041992-T1,Peve_00020703,Pocillopora_meandrina_HIv1___RNAseq.g15228.t1,three_way,52.0685,,,,,,,,,,,,,,,,,
OG_09734,FUN_041993-T1,Peve_00014041,Pocillopora_meandrina_HIv1___RNAseq.g15227.t1,three_way,47.711666666666666,,,,,,,,,,,,,,,,,
OG_09735,FUN_041994-T1,Peve_00014040,Pocillopora_meandrina_HIv1___RNAseq.g15226.t1,three_way,52.767833333333336,,,,,,,,,,,,,,,,,
OG_09736,FUN_041995-T1,Peve_00023725,Pocillopora_meandrina_HIv1___RNAseq.g15224.t1,three_way,92.50633333333332,FUN_041995-T1,Q7ZXB1,MCM7B_XENLA,,DNA replication licensing factor mcm7-B (EC 3.6.4.12) (CDC47 homolog B) (CDC47-2p) (Minichromosome maintenance protein 7-B) (xMCM7-B),Xenopus laevis (African clawed frog),74.5,718.0,1.4e-309,1063.1,sp|Q7ZXB1|MCM7B_XENLA DNA replication licensing factor mcm7-B OS=Xenopus laevis OX=8355 GN=mcm7-b PE=1 SV=1,GO:0000727; GO:0000785; GO:0003697; GO:0005524; GO:0005634; GO:0006260; GO:0006270; GO:0006271; GO:0008270; GO:0016887; GO:0017116; GO:0030174; GO:0042555; GO:0071162,DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via break-induced replication [GO:0000727]; regulation of DNA-templated DNA replication initiation [GO:0030174],chromatin [GO:0000785]; CMG complex [GO:0071162]; MCM complex [GO:0042555]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; single-stranded DNA binding [GO:0003697]; single-stranded DNA helicase activity [GO:0017116]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_09737,FUN_041999-T3,Peve_00034150,Pocillopora_meandrina_HIv1___RNAseq.g15222.t1,three_way,51.45166666666667,FUN_041999-T3,Q9ERU9,RBP2_MOUSE,,E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (Ran-binding protein 2) (RanBP2),Mus musculus (Mouse),23.6,3401.0,5.800000000000001e-178,628.2,sp|Q9ERU9|RBP2_MOUSE E3 SUMO-protein ligase RanBP2 OS=Mus musculus OX=10090 GN=Ranbp2 PE=1 SV=2,GO:0001975; GO:0003723; GO:0003755; GO:0005635; GO:0005642; GO:0005643; GO:0005654; GO:0005829; GO:0006111; GO:0006457; GO:0006607; GO:0006913; GO:0008270; GO:0016925; GO:0019209; GO:0019789; GO:0031267; GO:0031965; GO:0042405; GO:0044614; GO:0044615; GO:0044877; GO:0051028; GO:0051168; GO:0051642; GO:0061665; GO:0106068; GO:1990723,centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975],annulate lamellae [GO:0005642]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068],kinase activator activity [GO:0019209]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005635; GO:0005654; GO:0005829; GO:0006457; GO:0006886; GO:0006913; GO:0016740; GO:0016853; GO:0098772; GO:0140096,"RNA binding; catalytic activity; nuclear envelope; nucleoplasm; cytosol; protein folding; intracellular protein transport; nucleocytoplasmic transport; transferase activity; isomerase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09738,FUN_042000-T1,Peve_00016463,Pocillopora_meandrina_HIv1___RNAseq.g15221.t1,three_way,69.44083333333333,,,,,,,,,,,,,,,,,
OG_09739,FUN_042001-T1,Peve_00016464,Pocillopora_meandrina_HIv1___RNAseq.g15220.t1,three_way,91.06033333333332,FUN_042001-T1,Q9P013,CWC15_HUMAN,,Spliceosome-associated protein CWC15 homolog,Homo sapiens (Human),73.8,229.0,3.2e-52,206.5,sp|Q9P013|CWC15_HUMAN Spliceosome-associated protein CWC15 homolog OS=Homo sapiens OX=9606 GN=CWC15 PE=1 SV=2,GO:0000398; GO:0000974; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005739; GO:0016607; GO:0045292; GO:0071007; GO:0071013,"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mitochondrion; mRNA metabolic process; organelle
OG_09740,FUN_042002-T1,Peve_00016466,Pocillopora_meandrina_HIv1___RNAseq.g15218.t1,three_way,89.01233333333333,FUN_042002-T1,Q96GG9,DCNL1_HUMAN,,DCN1-like protein 1 (DCNL1) (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene),Homo sapiens (Human),68.3,259.0,8.2e-106,385.2,sp|Q96GG9|DCNL1_HUMAN DCN1-like protein 1 OS=Homo sapiens OX=9606 GN=DCUN1D1 PE=1 SV=1,GO:0000151; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0031396; GO:0031624; GO:0032182; GO:0045116; GO:0097602; GO:2000434; GO:2000436,positive regulation of protein neddylation [GO:2000436]; protein neddylation [GO:0045116]; regulation of protein neddylation [GO:2000434]; regulation of protein ubiquitination [GO:0031396],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182],GO:0005634; GO:0005654; GO:0005829; GO:0043226,nucleus; nucleoplasm; cytosol; organelle
OG_09741,FUN_042004-T1,Peve_00026002,Pocillopora_meandrina_HIv1___TS.g7940.t2,three_way,74.858,FUN_042004-T1,P15848,ARSB_HUMAN,,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),Homo sapiens (Human),45.7,497.0,4.5e-123,443.0,sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1,GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813,autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0006914; GO:0007040; GO:0016787; GO:0043226; GO:0048870,catalytic activity; extracellular region; lysosome; vacuole; autophagy; lysosome organization; hydrolase activity; organelle; cell motility
OG_09742,FUN_042007-T1,Peve_00021044,Pocillopora_meandrina_HIv1___TS.g10228.t1,three_way,79.82566666666666,,,,,,,,,,,,,,,,,
OG_09743,FUN_042009-T1,Peve_00031038,Pocillopora_meandrina_HIv1___RNAseq.g15212.t1,three_way,48.658166666666666,,,,,,,,,,,,,,,,,
OG_09744,FUN_042010-T1,Peve_00035507,Pocillopora_meandrina_HIv1___RNAseq.g15214.t1,three_way,59.618,,,,,,,,,,,,,,,,,
OG_09745,FUN_042012-T1,Peve_00016467,Pocillopora_meandrina_HIv1___RNAseq.g15217.t1,three_way,92.84933333333332,FUN_042012-T1,Q9UBF6,,,,,87.5,88.0,4.7e-47,188.3,sp|Q9UBF6|RBX2_HUMAN RING-box protein 2 OS=Homo sapiens OX=9606 GN=RNF7 PE=1 SV=1,,,,,,
OG_09746,FUN_042013-T1,Peve_00026003,Pocillopora_meandrina_HIv1___RNAseq.g28153.t1,three_way,77.80266666666667,FUN_042013-T1,P50430,,,,,49.3,495.0,9.7e-137,488.4,sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2,,,,,,
OG_09747,FUN_042015-T1,Peve_00044147,Pocillopora_meandrina_HIv1___RNAseq.g15196.t1,three_way,62.627,FUN_042015-T1,Q8IZQ1,WDFY3_HUMAN,,WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy),Homo sapiens (Human),43.3,67.0,2.3e-09,65.5,sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2,GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204,aggrephagy [GO:0035973],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605],1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270],GO:0005635; GO:0005654; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006914; GO:0008289; GO:0043226,nuclear envelope; nucleoplasm; nucleolus; vacuole; cytosol; plasma membrane; autophagy; lipid binding; organelle
OG_09748,FUN_042017-T1,Peve_00044151,Pocillopora_meandrina_HIv1___RNAseq.g15194.t1,three_way,79.5055,FUN_042017-T1,B5FXE5,FSP1_TAEGU,,Ferroptosis suppressor protein 1 (FSP1) (EC 1.6.5.-) (Apoptosis-inducing factor homologous mitochondrion-associated inducer of death) (AMID) (p53-responsive gene 3 protein),Taeniopygia guttata (Zebra finch) (Poephila guttata),39.4,373.0,2.1e-70,267.7,sp|B5FXE5|FSP1_TAEGU Ferroptosis suppressor protein 1 OS=Taeniopygia guttata OX=59729 GN=AIFM2 PE=2 SV=1,GO:0004174; GO:0005634; GO:0005811; GO:0005886; GO:0008637; GO:0016655; GO:0031966; GO:0042373; GO:0043065; GO:0050660,apoptotic mitochondrial changes [GO:0008637]; positive regulation of apoptotic process [GO:0043065]; vitamin K metabolic process [GO:0042373],lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]",GO:0003824; GO:0005634; GO:0005811; GO:0005886; GO:0007005; GO:0016491; GO:0043226,catalytic activity; nucleus; lipid droplet; plasma membrane; mitochondrion organization; oxidoreductase activity; organelle
OG_09749,FUN_042018-T1,Peve_00044152,Pocillopora_meandrina_HIv1___RNAseq.g15193.t1,three_way,65.04350000000001,FUN_042018-T1,Q7Z589,EMSY_HUMAN,,BRCA2-interacting transcriptional repressor EMSY,Homo sapiens (Human),63.2,106.0,5.8999999999999994e-31,138.3,sp|Q7Z589|EMSY_HUMAN BRCA2-interacting transcriptional repressor EMSY OS=Homo sapiens OX=9606 GN=EMSY PE=1 SV=2,GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0042802,chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of DNA-templated transcription [GO:0006355],nucleoplasm [GO:0005654],identical protein binding [GO:0042802],GO:0005654; GO:0006281; GO:0006325; GO:0006355,nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription
OG_09750,FUN_042019-T1,Peve_00044153,Pocillopora_meandrina_HIv1___RNAseq.g15192.t1,three_way,80.45633333333333,FUN_042019-T1,Q9DAN9,,,,,37.8,148.0,6.900000000000001e-23,109.0,sp|Q9DAN9|CF97D_MOUSE Sperm axonemal maintenance protein CFAP97D1 OS=Mus musculus OX=10090 GN=Cfap97d1 PE=2 SV=1,,,,,,
OG_09751,FUN_042020-T1,Peve_00044154,Pocillopora_meandrina_HIv1___RNAseq.g15191.t1,three_way,64.08616666666667,FUN_042020-T1,Q0II91,,,,,32.0,585.0,8.1e-57,223.0,sp|Q0II91|DJC21_BOVIN DnaJ homolog subfamily C member 21 OS=Bos taurus OX=9913 GN=DNAJC21 PE=2 SV=2,,,,,,
OG_09752,FUN_042022-T1,Peve_00044156,Pocillopora_meandrina_HIv1___RNAseq.g15166.t1,three_way,51.5335,,,,,,,,,,,,,,,,,
OG_09753,FUN_042023-T1,Peve_00044157,Pocillopora_meandrina_HIv1___RNAseq.g15167.t1,three_way,91.09866666666666,FUN_042023-T1,Q0V9R4,,,,,42.4,877.0,1.1e-163,578.9,sp|Q0V9R4|CCD39_XENTR Coiled-coil domain-containing protein 39 OS=Xenopus tropicalis OX=8364 GN=ccdc39 PE=2 SV=1,,,,,,
OG_09754,FUN_042025-T1,Peve_00030370,Pocillopora_meandrina_HIv1___RNAseq.g15170.t1,three_way,94.194,FUN_042025-T1,G3MZY8,RPB1_BOVIN,,DNA-directed RNA polymerase II subunit RPB1 (EC 2.7.7.6) (3'-5' exoribonuclease) (EC 3.1.13.-) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),Bos taurus (Bovine),77.4,1533.0,0.0,2438.7,sp|G3MZY8|RPB1_BOVIN DNA-directed RNA polymerase II subunit RPB1 OS=Bos taurus OX=9913 GN=POLR2A PE=1 SV=2,GO:0000287; GO:0000791; GO:0001046; GO:0003899; GO:0003968; GO:0005665; GO:0005739; GO:0006366; GO:0008270; GO:0016787; GO:0071667,transcription by RNA polymerase II [GO:0006366],"euchromatin [GO:0000791]; mitochondrion [GO:0005739]; RNA polymerase II, core complex [GO:0005665]",core promoter sequence-specific DNA binding [GO:0001046]; DNA-directed RNA polymerase activity [GO:0003899]; DNA/RNA hybrid binding [GO:0071667]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; RNA-directed RNA polymerase activity [GO:0003968]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005739; GO:0006351; GO:0016740; GO:0016787; GO:0043226; GO:0140098,"DNA binding; catalytic activity; mitochondrion; DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_09755,FUN_042027-T1,Peve_00025064,Pocillopora_meandrina_HIv1___RNAseq.g15172.t1,three_way,61.967,,,,,,,,,,,,,,,,,
OG_09756,FUN_042028-T1,Peve_00025065,Pocillopora_meandrina_HIv1___RNAseq.g15173.t1,three_way,82.21866666666666,FUN_042028-T1,Q9VUX2,MIB_DROME,,E3 ubiquitin-protein ligase mind-bomb (EC 2.3.2.27) (Mind bomb homolog) (D-mib) (RING-type E3 ubiquitin transferase mind-bomb),Drosophila melanogaster (Fruit fly),41.3,75.0,1.5e-08,62.4,sp|Q9VUX2|MIB_DROME E3 ubiquitin-protein ligase mind-bomb OS=Drosophila melanogaster OX=7227 GN=mib1 PE=1 SV=3,GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006897; GO:0007219; GO:0007423; GO:0008104; GO:0008270; GO:0008593; GO:0016567; GO:0045179; GO:0045747; GO:0045807; GO:0046331; GO:0061630,endocytosis [GO:0006897]; lateral inhibition [GO:0046331]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; positive regulation of Notch signaling pathway [GO:0045747]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of Notch signaling pathway [GO:0008593]; sensory organ development [GO:0007423],apical cortex [GO:0045179]; cytoplasm [GO:0005737]; cytosol [GO:0005829],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016192; GO:0016740; GO:0023052; GO:0048856; GO:0140096,"catalytic activity; cytosol; vesicle-mediated transport; transferase activity; signaling; anatomical structure development; catalytic activity, acting on a protein"
OG_09757,FUN_042029-T1,Peve_00025063,Pocillopora_meandrina_HIv1___RNAseq.g15174.t1,three_way,47.64533333333333,FUN_042029-T1,Q9QYM2,,,,,31.9,354.0,1.1e-38,163.7,sp|Q9QYM2|PARG_RAT Poly(ADP-ribose) glycohydrolase OS=Rattus norvegicus OX=10116 GN=Parg PE=1 SV=1,,,,,,
OG_09758,FUN_042032-T1,Peve_00009551,Pocillopora_meandrina_HIv1___RNAseq.g15177.t1,three_way,62.97916666666666,FUN_042032-T1,P25931,,,,,30.1,306.0,9.5e-28,125.9,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_09759,FUN_042033-T1,Peve_00009547,Pocillopora_meandrina_HIv1___RNAseq.g15179.t1,three_way,83.29033333333334,,,,,,,,,,,,,,,,,
OG_09760,FUN_042034-T1,Peve_00035625,Pocillopora_meandrina_HIv1___RNAseq.g15181.t1,three_way,72.15583333333333,FUN_042034-T1,Q8C0W1,,,,,27.5,840.0,4.6e-70,268.1,sp|Q8C0W1|ANMY1_MOUSE Ankyrin repeat and MYND domain-containing protein 1 OS=Mus musculus OX=10090 GN=Ankmy1 PE=1 SV=1,,,,,,
OG_09761,FUN_042035-T1,Peve_00025402,Pocillopora_meandrina_HIv1___RNAseq.g15189.t2,three_way,83.28566666666667,FUN_042035-T1,Q96P53,WDFY2_HUMAN,,WD repeat and FYVE domain-containing protein 2 (Propeller-FYVE protein) (Prof) (WD40- and FYVE domain-containing protein 2) (Zinc finger FYVE domain-containing protein 22),Homo sapiens (Human),56.6,387.0,6.2e-121,435.6,sp|Q96P53|WDFY2_HUMAN WD repeat and FYVE domain-containing protein 2 OS=Homo sapiens OX=9606 GN=WDFY2 PE=1 SV=2,GO:0001934; GO:0005769; GO:0008270; GO:0031982; GO:0043231; GO:0045600,positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934],early endosome [GO:0005769]; intracellular membrane-bounded organelle [GO:0043231]; vesicle [GO:0031982],zinc ion binding [GO:0008270],GO:0005768; GO:0031410; GO:0043226,endosome; cytoplasmic vesicle; organelle
OG_09762,FUN_042036-T1,Peve_00025426,Pocillopora_meandrina_HIv1___RNAseq.g15187.t1,three_way,89.87166666666667,FUN_042036-T1,O00410,IPO5_HUMAN,,Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5),Homo sapiens (Human),54.7,1080.0,0.0,1178.7,sp|O00410|IPO5_HUMAN Importin-5 OS=Homo sapiens OX=9606 GN=IPO5 PE=1 SV=4,GO:0002753; GO:0003723; GO:0005095; GO:0005634; GO:0005643; GO:0005654; GO:0005730; GO:0005737; GO:0005794; GO:0005829; GO:0006606; GO:0006607; GO:0006610; GO:0008139; GO:0016020; GO:0031267; GO:0031965; GO:0042307; GO:0045786; GO:0061608; GO:0071230,cellular response to amino acid stimulus [GO:0071230]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; negative regulation of cell cycle [GO:0045786]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],GTPase inhibitor activity [GO:0005095]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267],GO:0002376; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005794; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0098772; GO:0140104,immune system process; RNA binding; nucleus; nucleoplasm; nucleolus; Golgi apparatus; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular function regulator activity; molecular carrier activity
OG_09763,FUN_042040-T1,Peve_00025408,Pocillopora_meandrina_HIv1___RNAseq.g15182.t1,three_way,54.059333333333335,FUN_042040-T1,Q63155,DCC_RAT,,Netrin receptor DCC (Tumor suppressor protein DCC),Rattus norvegicus (Rat),29.4,687.0,1.7e-55,219.2,sp|Q63155|DCC_RAT Netrin receptor DCC OS=Rattus norvegicus OX=10116 GN=Dcc PE=1 SV=2,GO:0001764; GO:0001975; GO:0003713; GO:0005042; GO:0005886; GO:0006915; GO:0007411; GO:0009986; GO:0010976; GO:0021554; GO:0021965; GO:0021987; GO:0022038; GO:0030424; GO:0032584; GO:0033563; GO:0033564; GO:0042802; GO:0061564; GO:0070374; GO:0098609; GO:0098685; GO:0098839; GO:0099170,anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon development [GO:0061564]; axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; dorsal/ventral axon guidance [GO:0033563]; neuron migration [GO:0001764]; optic nerve development [GO:0021554]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron projection development [GO:0010976]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; response to amphetamine [GO:0001975]; spinal cord ventral commissure morphogenesis [GO:0021965],axon [GO:0030424]; cell surface [GO:0009986]; growth cone membrane [GO:0032584]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685],identical protein binding [GO:0042802]; netrin receptor activity [GO:0005042]; transcription coactivator activity [GO:0003713],GO:0005886; GO:0007155; GO:0012501; GO:0048856; GO:0048870; GO:0060089; GO:0060090; GO:0140110,plasma membrane; cell adhesion; programmed cell death; anatomical structure development; cell motility; molecular transducer activity; molecular adaptor activity; transcription regulator activity
OG_09764,FUN_042043-T1,Peve_00025406,Pocillopora_meandrina_HIv1___RNAseq.g15137.t1,three_way,85.81366666666666,FUN_042043-T1,Q70VZ7,MOGT1_BOVIN,,2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Monoacylglycerol O-acyltransferase 1),Bos taurus (Bovine),56.3,332.0,2.7e-106,386.7,sp|Q70VZ7|MOGT1_BOVIN 2-acylglycerol O-acyltransferase 1 OS=Bos taurus OX=9913 GN=MOGAT1 PE=2 SV=1,GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006651; GO:0019432,diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum membrane [GO:0005789],2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144],GO:0003824; GO:0005975; GO:0006629; GO:0016740,catalytic activity; carbohydrate metabolic process; lipid metabolic process; transferase activity
OG_09765,FUN_042045-T1,Peve_00025407,Pocillopora_meandrina_HIv1___RNAseq.g15139.t1,three_way,83.75016666666666,FUN_042045-T1,Q8VC85,,,,,64.3,129.0,3.1e-40,166.0,sp|Q8VC85|LSM1_MOUSE U6 snRNA-associated Sm-like protein LSm1 OS=Mus musculus OX=10090 GN=Lsm1 PE=1 SV=1,,,,,,
OG_09766,FUN_042047-T1,Peve_00025413,Pocillopora_meandrina_HIv1___RNAseq.g15141.t1,three_way,69.27166666666666,FUN_042047-T1,Q8AYS7,,,,,32.5,673.0,4.1e-93,344.0,sp|Q8AYS7|CENPI_CHICK Centromere protein I OS=Gallus gallus OX=9031 GN=CENPI PE=1 SV=1,,,,,,
OG_09767,FUN_042048-T1,Peve_00025414,Pocillopora_meandrina_HIv1___RNAseq.g15142.t1,three_way,77.533,FUN_042048-T1,Q8BH01,,,,,43.5,666.0,3.1e-136,487.3,sp|Q8BH01|TMCO3_MOUSE Transmembrane and coiled-coil domain-containing protein 3 OS=Mus musculus OX=10090 GN=Tmco3 PE=2 SV=1,,,,,,
OG_09768,FUN_042049-T1,Peve_00025415,Pocillopora_meandrina_HIv1___RNAseq.g15143.t1,three_way,63.039,,,,,,,,,,,,,,,,,
OG_09769,FUN_042050-T1,Peve_00025417,Pocillopora_meandrina_HIv1___TS.g10177.t1,three_way,70.72583333333334,FUN_042050-T1,P34949,MPI_HUMAN,,Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI),Homo sapiens (Human),48.8,418.0,1.8e-107,391.0,sp|P34949|MPI_HUMAN Mannose-6-phosphate isomerase OS=Homo sapiens OX=9606 GN=MPI PE=1 SV=2,GO:0004476; GO:0005829; GO:0008270; GO:0009298; GO:0061611; GO:0061729; GO:0070062,GDP-D-mannose biosynthetic process from fructose-6-phosphate [GO:0061729]; GDP-mannose biosynthetic process [GO:0009298]; mannose to fructose-6-phosphate catabolic process [GO:0061611],cytosol [GO:0005829]; extracellular exosome [GO:0070062],mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005975; GO:0016853; GO:0043226; GO:0055086; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; isomerase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09770,FUN_042051-T1,Peve_00025418,Pocillopora_meandrina_HIv1___RNAseq.g15145.t1,three_way,44.09616666666667,FUN_042051-T1,Q8BHR2,,,,,29.9,294.0,1.7e-33,146.4,sp|Q8BHR2|ENOX1_MOUSE Ecto-NOX disulfide-thiol exchanger 1 OS=Mus musculus OX=10090 GN=Enox1 PE=2 SV=1,,,,,,
OG_09771,FUN_042052-T1,Peve_00016579,Pocillopora_meandrina_HIv1___RNAseq.g15147.t1,three_way,47.97166666666666,FUN_042052-T1,Q7Z6V5,ADAT2_HUMAN,,tRNA-specific adenosine deaminase 2 (EC 3.5.4.33) (Deaminase domain-containing protein 1) (tRNA-specific adenosine-34 deaminase subunit ADAT2),Homo sapiens (Human),67.8,118.0,1.7e-41,171.0,sp|Q7Z6V5|ADAT2_HUMAN tRNA-specific adenosine deaminase 2 OS=Homo sapiens OX=9606 GN=ADAT2 PE=1 SV=1,GO:0002100; GO:0005654; GO:0008270; GO:0052717,tRNA wobble adenosine to inosine editing [GO:0002100],nucleoplasm [GO:0005654],tRNA-specific adenosine-34 deaminase activity [GO:0052717]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0006399; GO:0016787; GO:0140098,"catalytic activity; nucleoplasm; tRNA metabolic process; hydrolase activity; catalytic activity, acting on RNA"
OG_09772,FUN_042053-T1,Peve_00016580,Pocillopora_meandrina_HIv1___RNAseq.g15148.t2,three_way,81.407,FUN_042053-T1,P51464,,,,,65.1,464.0,3.0999999999999997e-177,622.9,sp|P51464|ARLY_AQUCT Argininosuccinate lyase OS=Aquarana catesbeiana OX=8400 GN=ASL PE=3 SV=1,,,,,,
OG_09773,FUN_042059-T1,Peve_00019720,Pocillopora_meandrina_HIv1___RNAseq.g22264.t1,three_way,82.29466666666667,FUN_042059-T1,Q84JS1,,,,,32.8,458.0,6.8e-63,243.0,sp|Q84JS1|PAE6_ARATH Pectin acetylesterase 6 OS=Arabidopsis thaliana OX=3702 GN=PAE6 PE=2 SV=1,,,,,,
OG_09774,FUN_042060-T1,Peve_00019715,Pocillopora_meandrina_HIv1___RNAseq.g22263.t1,three_way,39.5205,,,,,,,,,,,,,,,,,
OG_09775,FUN_042071-T1,Peve_00038496,Pocillopora_meandrina_HIv1___RNAseq.g6232.t1,three_way,63.51566666666667,FUN_042071-T1,Q96MM6,,,,,35.6,643.0,1.3e-106,388.7,sp|Q96MM6|HS12B_HUMAN Heat shock 70 kDa protein 12B OS=Homo sapiens OX=9606 GN=HSPA12B PE=1 SV=2,,,,,,
OG_09776,FUN_042099-T1,Peve_00001856,Pocillopora_meandrina_HIv1___RNAseq.g21788.t1,three_way,68.22566666666667,FUN_042099-T1,Q09143,CTR1_MOUSE,,High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor) (Ecotropic retrovirus receptor) (ERR) (EcoR) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter),Mus musculus (Mouse),36.9,601.0,2.6e-97,357.8,sp|Q09143|CTR1_MOUSE High affinity cationic amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a1 PE=1 SV=1,GO:0000064; GO:0001618; GO:0005290; GO:0015189; GO:0015819; GO:0016020; GO:0016323; GO:0016324; GO:0032991; GO:0042102; GO:0061459; GO:1903352; GO:1903810; GO:1903826,L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; positive regulation of T cell proliferation [GO:0042102],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; protein-containing complex [GO:0032991],L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; virus receptor activity [GO:0001618],GO:0001618; GO:0005215; GO:0055085,virus receptor activity; transporter activity; transmembrane transport
OG_09777,FUN_042107-T1,Peve_00009513,Pocillopora_meandrina_HIv1___RNAseq.g21779.t1,three_way,95.49616666666668,FUN_042107-T1,Q6GQ52,,,,,67.9,84.0,1.4e-28,126.7,sp|Q6GQ52|TI10B_XENLA Mitochondrial import inner membrane translocase subunit Tim10-B OS=Xenopus laevis OX=8355 GN=timm10-b PE=3 SV=1,,,,,,
OG_09778,FUN_042118-T1,Peve_00043537,Pocillopora_meandrina_HIv1___TS.g14841.t1,three_way,58.468,,,,,,,,,,,,,,,,,
OG_09779,FUN_042125-T1,Peve_00009509,Pocillopora_meandrina_HIv1___RNAseq.g19349.t1,three_way,54.792,,,,,,,,,,,,,,,,,
OG_09780,FUN_042358-T1,Peve_00028693,Pocillopora_meandrina_HIv1___RNAseq.g10283.t1,three_way,44.92333333333333,,,,,,,,,,,,,,,,,
OG_09781,FUN_042470-T1,Peve_00040509,Pocillopora_meandrina_HIv1___RNAseq.g6561.t1a,three_way,68.43166666666666,,,,,,,,,,,,,,,,,
OG_09782,FUN_042478-T1,Peve_00001805,Pocillopora_meandrina_HIv1___RNAseq.g25171.t1,three_way,45.98733333333333,,,,,,,,,,,,,,,,,
OG_09783,FUN_042583-T1,Peve_00034294,Pocillopora_meandrina_HIv1___RNAseq.g16882.t1,three_way,83.662,FUN_042583-T1,P09132,SRP19_HUMAN,,Signal recognition particle 19 kDa protein (SRP19),Homo sapiens (Human),47.1,140.0,3.1e-27,122.9,sp|P09132|SRP19_HUMAN Signal recognition particle 19 kDa protein OS=Homo sapiens OX=9606 GN=SRP19 PE=1 SV=3,GO:0003723; GO:0005730; GO:0005786; GO:0005829; GO:0006613; GO:0006617; GO:0008312; GO:0016604; GO:0048500,"cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]","cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]",7S RNA binding [GO:0008312]; RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0005829; GO:0043226; GO:0065003,RNA binding; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_09784,FUN_042585-T1,Peve_00012677,Pocillopora_meandrina_HIv1___TS.g17705.t2,three_way,90.76733333333334,FUN_042585-T1,A7MBF6,,,,,54.0,400.0,6.5e-115,415.6,sp|A7MBF6|ARMD1_BOVIN Armadillo-like helical domain containing protein 1 OS=Bos taurus OX=9913 GN=ARMH1 PE=2 SV=1,,,,,,
OG_09785,FUN_042586-T1,Peve_00012676,Pocillopora_meandrina_HIv1___RNAseq.g16876.t1,three_way,62.93516666666667,FUN_042586-T1,P17972,KCNAW_DROME,,Potassium voltage-gated channel protein Shaw (Shaw2),Drosophila melanogaster (Fruit fly),40.1,431.0,2.8e-81,304.7,sp|P17972|KCNAW_DROME Potassium voltage-gated channel protein Shaw OS=Drosophila melanogaster OX=7227 GN=Shaw PE=2 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0022843; GO:0030431; GO:0032590; GO:0032809; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; sleep [GO:0030431],axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_09786,FUN_042588-T1,Peve_00012675,Pocillopora_meandrina_HIv1___RNAseq.g16872.t1,three_way,74.26766666666667,FUN_042588-T1,P17972,KCNAW_DROME,,Potassium voltage-gated channel protein Shaw (Shaw2),Drosophila melanogaster (Fruit fly),40.7,437.0,4.5e-92,340.5,sp|P17972|KCNAW_DROME Potassium voltage-gated channel protein Shaw OS=Drosophila melanogaster OX=7227 GN=Shaw PE=2 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0005886; GO:0006813; GO:0008076; GO:0022843; GO:0030431; GO:0032590; GO:0032809; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; sleep [GO:0030431],axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_09787,FUN_042589-T1,Peve_00012671,Pocillopora_meandrina_HIv1___RNAseq.g16875.t1,three_way,61.26133333333333,FUN_042589-T1,P25122,KCNC1_RAT,,Voltage-gated potassium channel KCNC1 (NGK2) (Potassium voltage-gated channel subfamily C member 1) (RAW2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4),Rattus norvegicus (Rat),43.0,461.0,4.9e-93,344.0,sp|P25122|KCNC1_RAT Voltage-gated potassium channel KCNC1 OS=Rattus norvegicus OX=10116 GN=Kcnc1 PE=1 SV=1,GO:0001508; GO:0005249; GO:0005251; GO:0008076; GO:0009636; GO:0009642; GO:0009986; GO:0010996; GO:0014075; GO:0019894; GO:0021549; GO:0021554; GO:0021759; GO:0022038; GO:0030425; GO:0030673; GO:0032589; GO:0032590; GO:0032809; GO:0034765; GO:0034767; GO:0035864; GO:0042734; GO:0043025; GO:0043679; GO:0044305; GO:0044325; GO:0045211; GO:0046872; GO:0051260; GO:0051262; GO:0071466; GO:0071774; GO:0071805; GO:0099508; GO:1901379; GO:1901381; GO:1990089,action potential [GO:0001508]; cellular response to xenobiotic stimulus [GO:0071466]; cerebellum development [GO:0021549]; corpus callosum development [GO:0022038]; globus pallidus development [GO:0021759]; optic nerve development [GO:0021554]; positive regulation of monoatomic ion transmembrane transport [GO:0034767]; positive regulation of potassium ion transmembrane transport [GO:1901381]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; protein tetramerization [GO:0051262]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of potassium ion transmembrane transport [GO:1901379]; response to amine [GO:0014075]; response to auditory stimulus [GO:0010996]; response to fibroblast growth factor [GO:0071774]; response to light intensity [GO:0009642]; response to nerve growth factor [GO:1990089]; response to potassium ion [GO:0035864]; response to toxic substance [GO:0009636],axolemma [GO:0030673]; axon terminus [GO:0043679]; calyx of Held [GO:0044305]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendrite membrane [GO:0032590]; neuron projection membrane [GO:0032589]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; kinesin binding [GO:0019894]; metal ion binding [GO:0046872]; transmembrane transporter binding [GO:0044325]; voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099508]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0008092; GO:0048856; GO:0055085; GO:0065003,transporter activity; cytoskeletal protein binding; anatomical structure development; transmembrane transport; protein-containing complex assembly
OG_09788,FUN_042590-T1,Peve_00012672,Pocillopora_meandrina_HIv1___RNAseq.g16871.t1,three_way,78.65733333333333,FUN_042590-T1,P15388,,,,,37.5,469.0,8.3e-81,302.8,sp|P15388|KCNC1_MOUSE Voltage-gated potassium channel KCNC1 OS=Mus musculus OX=10090 GN=Kcnc1 PE=1 SV=1,,,,,,
OG_09789,FUN_042591-T1,Peve_00012673,Pocillopora_meandrina_HIv1___RNAseq.g16869.t1,three_way,79.75733333333334,FUN_042591-T1,Q87PP5,,,,,36.3,535.0,8.499999999999999e-92,339.7,sp|Q87PP5|BCCT1_VIBPA Glycine betaine/proline/choline/ectoine transporter VP1456 OS=Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) OX=223926 GN=VP1456 PE=1 SV=1,,,,,,
OG_09790,FUN_042592-T1,Peve_00038355,Pocillopora_meandrina_HIv1___RNAseq.g16868.t1,three_way,96.93166666666666,FUN_042592-T1,Q80UW8,,,,,81.8,209.0,9.8e-99,360.9,"sp|Q80UW8|RPAB1_MOUSE DNA-directed RNA polymerases I, II, and III subunit RPABC1 OS=Mus musculus OX=10090 GN=Polr2e PE=1 SV=1",,,,,,
OG_09791,FUN_042593-T1,Peve_00008128,Pocillopora_meandrina_HIv1___RNAseq.g16867.t1,three_way,79.72,FUN_042593-T1,Q80TC6,,,,,50.6,1158.0,2.7e-309,1062.8,sp|Q80TC6|ZSWM5_MOUSE Zinc finger SWIM domain-containing protein 5 OS=Mus musculus OX=10090 GN=Zswim5 PE=2 SV=2,,,,,,
OG_09792,FUN_042594-T1,Peve_00008122,Pocillopora_meandrina_HIv1___RNAseq.g16865.t1,three_way,78.67766666666667,FUN_042594-T1,Q9D531,NXNL2_MOUSE,,Nucleoredoxin-like protein 2 (Rod-derived cone viability factor 2) (RdCVF2),Mus musculus (Mouse),47.3,146.0,7.7e-34,145.2,sp|Q9D531|NXNL2_MOUSE Nucleoredoxin-like protein 2 OS=Mus musculus OX=10090 GN=Nxnl2 PE=1 SV=1,GO:0007601; GO:0007608; GO:0045494,photoreceptor cell maintenance [GO:0045494]; sensory perception of smell [GO:0007608]; visual perception [GO:0007601],,,GO:0050877,nervous system process
OG_09793,FUN_042595-T1,Peve_00008123,Pocillopora_meandrina_HIv1___RNAseq.g16864.t1,three_way,83.503,FUN_042595-T1,Q8T3X9,,,,,67.9,131.0,2.1e-43,176.4,"sp|Q8T3X9|ISCA1_DROME Iron-sulfur cluster assembly 1 homolog, mitochondrial OS=Drosophila melanogaster OX=7227 GN=MagR PE=1 SV=1",,,,,,
OG_09794,FUN_042597-T1,Peve_00008125,Pocillopora_meandrina_HIv1___RNAseq.g16860.t1,three_way,82.09866666666666,FUN_042597-T1,Q8BGV9,ATG4D_MOUSE,,"Cysteine protease ATG4D (EC 3.4.22.-) (AUT-like 4 cysteine endopeptidase) (Autophagy-related cysteine endopeptidase 4) (Autophagin-4) (Autophagy-related protein 4 homolog D) [Cleaved into: Cysteine protease ATG4D, mitochondrial]",Mus musculus (Mouse),44.8,402.0,5.1e-100,366.3,sp|Q8BGV9|ATG4D_MOUSE Cysteine protease ATG4D OS=Mus musculus OX=10090 GN=Atg4d PE=1 SV=1,GO:0000423; GO:0005654; GO:0005759; GO:0006508; GO:0006914; GO:0006915; GO:0008234; GO:0015031; GO:0019786; GO:0034497; GO:0051697,apoptotic process [GO:0006915]; autophagy [GO:0006914]; mitophagy [GO:0000423]; protein delipidation [GO:0051697]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; proteolysis [GO:0006508],mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654],cysteine-type peptidase activity [GO:0008234]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786],GO:0003824; GO:0005654; GO:0006914; GO:0012501; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; autophagy; programmed cell death; hydrolase activity; catalytic activity, acting on a protein"
OG_09795,FUN_042602-T1,Peve_00034908,Pocillopora_meandrina_HIv1___RNAseq.g16851.t1,three_way,67.051,FUN_042602-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),26.5,701.0,3.3e-62,241.9,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_09796,FUN_042604-T1,Peve_00034911,Pocillopora_meandrina_HIv1___RNAseq.g16849.t1b,three_way,68.75966666666666,FUN_042604-T1,Q96HU8,DIRA2_HUMAN,,GTP-binding protein Di-Ras2 (EC 3.6.5.-) (Distinct subgroup of the Ras family member 2),Homo sapiens (Human),41.2,194.0,4.6e-25,117.1,sp|Q96HU8|DIRA2_HUMAN GTP-binding protein Di-Ras2 OS=Homo sapiens OX=9606 GN=DIRAS2 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005886; GO:0007165; GO:0019003,signal transduction [GO:0007165],plasma membrane [GO:0005886],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005886; GO:0016787,catalytic activity; GTPase activity; plasma membrane; hydrolase activity
OG_09797,FUN_042605-T1,Peve_00034914,Pocillopora_meandrina_HIv1___RNAseq.g16849.t1a,three_way,81.68166666666667,FUN_042605-T1,Q9QUM7,,,,,46.1,798.0,1.1e-204,714.9,sp|Q9QUM7|MSH5_MOUSE MutS protein homolog 5 OS=Mus musculus OX=10090 GN=Msh5 PE=1 SV=1,,,,,,
OG_09798,FUN_042606-T1,Peve_00034915,Pocillopora_meandrina_HIv1___RNAseq.g16848.t1,three_way,70.83866666666667,FUN_042606-T1,O77627,,,,,34.6,318.0,4.900000000000002e-22,107.5,sp|O77627|JUN_BOVIN Transcription factor Jun OS=Bos taurus OX=9913 GN=JUN PE=2 SV=2,,,,,,
OG_09799,FUN_042609-T1,Peve_00034917,Pocillopora_meandrina_HIv1___RNAseq.g16823.t1b,three_way,64.12866666666666,,,,,,,,,,,,,,,,,
OG_09800,FUN_042610-T1,Peve_00034918,Pocillopora_meandrina_HIv1___RNAseq.g16820.t1,three_way,81.64233333333333,FUN_042610-T1,O02811,,,,,47.5,2112.0,0.0,1828.1,sp|O02811|PI4KA_BOVIN Phosphatidylinositol 4-kinase alpha OS=Bos taurus OX=9913 GN=PI4KA PE=2 SV=2,,,,,,
OG_09801,FUN_042611-T1,Peve_00031582,Pocillopora_meandrina_HIv1___RNAseq.24516_t,three_way,71.33033333333334,FUN_042611-T1,Q18248,DMD4_CAEEL,,Doublesex- and mab-3-related transcription factor dmd-4,Caenorhabditis elegans,34.5,174.0,2.7e-16,87.8,sp|Q18248|DMD4_CAEEL Doublesex- and mab-3-related transcription factor dmd-4 OS=Caenorhabditis elegans OX=6239 GN=dmd-4 PE=1 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007548; GO:0043130; GO:0046872; GO:0098883,regulation of transcription by RNA polymerase II [GO:0006357]; sex differentiation [GO:0007548]; synapse pruning [GO:0098883],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin binding [GO:0043130]",GO:0003677; GO:0005634; GO:0006355; GO:0022414; GO:0034330; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; reproductive process; cell junction organization; organelle; transcription regulator activity
OG_09802,FUN_042613-T1,Peve_00034927,Pocillopora_meandrina_HIv1___RNAseq.g17029.t1,three_way,47.558,,,,,,,,,,,,,,,,,
OG_09803,FUN_042614-T1,Peve_00034928,Pocillopora_meandrina_HIv1___RNAseq.g17030.t1,three_way,75.631,FUN_042614-T1,A0A1D5PXA5,TRPV4_CHICK,,Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Vanilloid receptor-related osmotically activated channel) (VR-OAC),Gallus gallus (Chicken),20.4,313.0,1.5e-08,63.2,sp|A0A1D5PXA5|TRPV4_CHICK Transient receptor potential cation channel subfamily V member 4 OS=Gallus gallus OX=9031 GN=TRPV4 PE=1 SV=1,GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005886; GO:0005912; GO:0005929; GO:0006874; GO:0007015; GO:0007231; GO:0008289; GO:0016324; GO:0017124; GO:0035091; GO:0046872; GO:0098703,actin filament organization [GO:0007015]; calcium ion import across plasma membrane [GO:0098703]; intracellular calcium ion homeostasis [GO:0006874]; osmosensory signaling pathway [GO:0007231],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cilium [GO:0005929]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; monoatomic cation channel activity [GO:0005261]; phosphatidylinositol binding [GO:0035091]; SH3 domain binding [GO:0017124],GO:0005215; GO:0005886; GO:0005929; GO:0008289; GO:0043226; GO:0055085,transporter activity; plasma membrane; cilium; lipid binding; organelle; transmembrane transport
OG_09804,FUN_042622-T1,Peve_00029438,Pocillopora_meandrina_HIv1___RNAseq.g11513.t1,three_way,76.01333333333334,FUN_042622-T1,A7YWD2,,,,,36.5,941.0,1.5e-175,618.2,sp|A7YWD2|IPO13_BOVIN Importin-13 OS=Bos taurus OX=9913 GN=IPO13 PE=2 SV=1,,,,,,
OG_09805,FUN_042623-T1,Peve_00016196,Pocillopora_meandrina_HIv1___RNAseq.g11512.t1,three_way,79.597,FUN_042623-T1,Q5F3Z7,,,,,46.0,448.0,2.6e-95,350.5,sp|Q5F3Z7|CTSL2_CHICK CTD small phosphatase-like protein 2 OS=Gallus gallus OX=9031 GN=CTDSPL2 PE=2 SV=2,,,,,,
OG_09806,FUN_042624-T1,Peve_00016197,Pocillopora_meandrina_HIv1___RNAseq.g11511.t1,three_way,48.837833333333336,FUN_042624-T1,E9Q414,APOB_MOUSE,,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],Mus musculus (Mouse),24.7,1102.0,3e-65,254.6,sp|E9Q414|APOB_MOUSE Apolipoprotein B-100 OS=Mus musculus OX=10090 GN=Apob PE=1 SV=1,GO:0001701; GO:0005543; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0006642; GO:0007283; GO:0007399; GO:0008201; GO:0008203; GO:0009566; GO:0009615; GO:0009791; GO:0010628; GO:0010744; GO:0010886; GO:0016042; GO:0019433; GO:0030301; GO:0030317; GO:0033344; GO:0034359; GO:0034361; GO:0034362; GO:0034363; GO:0034374; GO:0034383; GO:0035473; GO:0042157; GO:0042158; GO:0042159; GO:0042632; GO:0042953; GO:0043025; GO:0045540; GO:0048018; GO:0048844; GO:0050750; GO:0051649; GO:0070971; GO:0071402; GO:0120020,artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein metabolic process [GO:0042157]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; extracellular region [GO:0005576]; intermediate-density lipoprotein particle [GO:0034363]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; very-low-density lipoprotein particle [GO:0034361],cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; receptor ligand activity [GO:0048018],GO:0005215; GO:0005576; GO:0005783; GO:0005811; GO:0005829; GO:0006629; GO:0007018; GO:0008289; GO:0022414; GO:0030163; GO:0043226; GO:0048018; GO:0048856; GO:0048870; GO:0098772,transporter activity; extracellular region; endoplasmic reticulum; lipid droplet; cytosol; lipid metabolic process; microtubule-based movement; lipid binding; reproductive process; protein catabolic process; organelle; receptor ligand activity; anatomical structure development; cell motility; molecular function regulator activity
OG_09807,FUN_042628-T1,Peve_00016195,Pocillopora_meandrina_HIv1___RNAseq.g11508.t1,three_way,45.25,FUN_042628-T1,O95390,GDF11_HUMAN,,Growth/differentiation factor 11 (GDF-11) (Bone morphogenetic protein 11) (BMP-11),Homo sapiens (Human),29.0,372.0,2.3000000000000002e-33,144.8,sp|O95390|GDF11_HUMAN Growth/differentiation factor 11 OS=Homo sapiens OX=9606 GN=GDF11 PE=1 SV=1,GO:0001501; GO:0001656; GO:0001657; GO:0005125; GO:0005615; GO:0007399; GO:0007498; GO:0008083; GO:0008283; GO:0008285; GO:0021512; GO:0032924; GO:0032991; GO:0035881; GO:0048593; GO:0060021; GO:0060391; GO:0072560; GO:1902870,activin receptor signaling pathway [GO:0032924]; amacrine cell differentiation [GO:0035881]; camera-type eye morphogenesis [GO:0048593]; cell population proliferation [GO:0008283]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of SMAD protein signal transduction [GO:0060391]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; spinal cord anterior/posterior patterning [GO:0021512]; type B pancreatic cell maturation [GO:0072560]; ureteric bud development [GO:0001657],extracellular space [GO:0005615]; protein-containing complex [GO:0032991],cytokine activity [GO:0005125]; growth factor activity [GO:0008083],GO:0005615; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_09808,FUN_042630-T1,Peve_00033746,Pocillopora_meandrina_HIv1___RNAseq.g11507.t1,three_way,66.90383333333334,FUN_042630-T1,Q8TEK3,DOT1L_HUMAN,,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.360) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",Homo sapiens (Human),42.8,636.0,2.1e-129,465.7,"sp|Q8TEK3|DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 specific OS=Homo sapiens OX=9606 GN=DOT1L PE=1 SV=3",GO:0000077; GO:0000781; GO:0003676; GO:0003677; GO:0003713; GO:0005634; GO:0005654; GO:0005737; GO:0006281; GO:0010467; GO:0031151; GO:0031509; GO:0032200; GO:0032259; GO:0032991; GO:0042054; GO:0043231; GO:0045944; GO:0046425; GO:0061629; GO:0140938; GO:0140956; GO:2000677,DNA damage checkpoint signaling [GO:0000077]; DNA repair [GO:0006281]; gene expression [GO:0010467]; methylation [GO:0032259]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]; regulation of transcription regulatory region DNA binding [GO:2000677]; subtelomeric heterochromatin formation [GO:0031509]; telomere organization [GO:0032200],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",DNA binding [GO:0003677]; histone H3 methyltransferase activity [GO:0140938]; histone H3K79 methyltransferase activity [GO:0031151]; histone H3K79 trimethyltransferase activity [GO:0140956]; histone methyltransferase activity [GO:0042054]; nucleic acid binding [GO:0003676]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0032200; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; telomere organization; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_09809,FUN_042631-T1,Peve_00030043,Pocillopora_meandrina_HIv1___RNAseq.g11506.t1,three_way,73.376,FUN_042631-T1,Q5VTB9,RN220_HUMAN,,E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220),Homo sapiens (Human),33.0,657.0,4e-63,244.2,sp|Q5VTB9|RN220_HUMAN E3 ubiquitin-protein ligase RNF220 OS=Homo sapiens OX=9606 GN=RNF220 PE=1 SV=1,GO:0003358; GO:0004842; GO:0005634; GO:0005652; GO:0005654; GO:0005737; GO:0006513; GO:0008013; GO:0008270; GO:0016567; GO:0021904; GO:0032991; GO:0051091; GO:0051865; GO:0061630; GO:0090263; GO:0098794; GO:0098978; GO:0099149; GO:2000677,dorsal/ventral neural tube patterning [GO:0021904]; noradrenergic neuron development [GO:0003358]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein autoubiquitination [GO:0051865]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of transcription regulatory region DNA binding [GO:2000677],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nuclear lamina [GO:0005652]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],beta-catenin binding [GO:0008013]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09810,FUN_042632-T1,Peve_00030047,Pocillopora_meandrina_HIv1___RNAseq.19517_t,three_way,44.0685,FUN_042632-T1,Q14315,FLNC_HUMAN,,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),Homo sapiens (Human),26.4,208.0,3.7e-09,65.5,sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015,sarcomere organization [GO:0045214],costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018],actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_09811,FUN_042633-T1,Peve_00030033,Pocillopora_meandrina_HIv1___RNAseq.19516_t,three_way,82.042,FUN_042633-T1,P08651,NFIC_HUMAN,,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),Homo sapiens (Human),48.2,390.0,3.2e-79,297.7,sp|P08651|NFIC_HUMAN Nuclear factor 1 C-type OS=Homo sapiens OX=9606 GN=NFIC PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001650; GO:0003700; GO:0005634; GO:0005654; GO:0006260; GO:0006357; GO:0006366; GO:0042475; GO:0045944; GO:1990837,DNA replication [GO:0006260]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0006260; GO:0006351; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA replication; DNA-templated transcription; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_09812,FUN_042636-T1,Peve_00030037,Pocillopora_meandrina_HIv1___RNAseq.g11500.t1,three_way,76.48533333333333,FUN_042636-T1,Q9HBI6,CP4FB_HUMAN,,Cytochrome P450 4F11 (CYPIVF11) (EC 1.14.14.1) (3-hydroxy fatty acids omega-hydroxylase CYP4F11) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) (Phylloquinone omega-hydroxylase CYP4F11) (EC 1.14.14.78),Homo sapiens (Human),42.0,471.0,8.3e-107,389.0,sp|Q9HBI6|CP4FB_HUMAN Cytochrome P450 4F11 OS=Homo sapiens OX=9606 GN=CYP4F11 PE=1 SV=3,GO:0004497; GO:0005504; GO:0005506; GO:0005789; GO:0006631; GO:0007596; GO:0016709; GO:0019369; GO:0020037; GO:0031408; GO:0042361; GO:0042376; GO:0042377; GO:0052869; GO:0097267; GO:0102033; GO:1903604,arachidonate metabolic process [GO:0019369]; blood coagulation [GO:0007596]; cytochrome metabolic process [GO:1903604]; fatty acid metabolic process [GO:0006631]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; phylloquinone catabolic process [GO:0042376]; vitamin K catabolic process [GO:0042377],endoplasmic reticulum membrane [GO:0005789],"arachidonate omega-hydroxylase activity [GO:0052869]; fatty acid binding [GO:0005504]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity
OG_09813,FUN_042641-T1,Peve_00030040,Pocillopora_meandrina_HIv1___TS.g8660.t1,three_way,76.05799999999999,FUN_042641-T1,Q561T9,,,,,53.5,127.0,4.1e-31,135.6,sp|Q561T9|OBRG_DANRE Leptin receptor gene-related protein OS=Danio rerio OX=7955 GN=leprot PE=2 SV=1,,,,,,
OG_09814,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),49.4,1473.0,0.0,1337.0,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09814,FUN_042642-T1,Peve_00030041,Pocillopora_meandrina_HIv1___RNAseq.g11525.t1,three_way,76.9845,FUN_042642-T1,Q6KC79,NIPBL_HUMAN,,Nipped-B-like protein (Delangin) (SCC2 homolog),Homo sapiens (Human),30.0,247.0,2.5e-08,63.9,sp|Q6KC79|NIPBL_HUMAN Nipped-B-like protein OS=Homo sapiens OX=9606 GN=NIPBL PE=1 SV=2,GO:0000070; GO:0000122; GO:0000785; GO:0001656; GO:0003007; GO:0003151; GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006338; GO:0006974; GO:0007064; GO:0007420; GO:0007605; GO:0008104; GO:0032039; GO:0032116; GO:0034087; GO:0034088; GO:0035019; GO:0035115; GO:0035136; GO:0035261; GO:0036033; GO:0040018; GO:0042471; GO:0042634; GO:0042826; GO:0043231; GO:0045444; GO:0045778; GO:0045944; GO:0045995; GO:0048557; GO:0048565; GO:0048589; GO:0048592; GO:0048638; GO:0048703; GO:0050890; GO:0060325; GO:0061010; GO:0061038; GO:0061775; GO:0070062; GO:0070087; GO:0071169; GO:0071481; GO:0090694; GO:0140588; GO:1990414; GO:1990841; GO:2001224,brain development [GO:0007420]; cellular response to X-ray [GO:0071481]; chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; cognition [GO:0050890]; developmental growth [GO:0048589]; digestive tract development [GO:0048565]; DNA damage response [GO:0006974]; ear morphogenesis [GO:0042471]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gallbladder development [GO:0061010]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; metanephros development [GO:0001656]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid segregation [GO:0000070]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract morphogenesis [GO:0003151]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization [GO:0008104]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; somatic stem cell population maintenance [GO:0035019]; uterus morphogenesis [GO:0061038],chromatin [GO:0000785]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; integrator complex [GO:0032039]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116],chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; cohesin loader activity [GO:0061775]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; promoter-specific chromatin binding [GO:1990841]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0007059; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140097; GO:0140110,"catalytic activity; nucleus; nucleoplasm; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; chromosome segregation; reproductive process; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; catalytic activity, acting on DNA; transcription regulator activity"
OG_09815,FUN_042643-T1,Peve_00030042,Pocillopora_meandrina_HIv1___TS.g7635.t1,three_way,52.61466666666667,,,,,,,,,,,,,,,,,
OG_09816,FUN_042644-T1,Peve_00030045,Pocillopora_meandrina_HIv1___RNAseq.g11519.t1,three_way,70.136,FUN_042644-T1,Q68EI0,WDR18_DANRE,,WD repeat-containing protein 18,Danio rerio (Zebrafish) (Brachydanio rerio),44.1,204.0,6.7e-47,188.7,sp|Q68EI0|WDR18_DANRE WD repeat-containing protein 18 OS=Danio rerio OX=7955 GN=wdr18 PE=2 SV=1,GO:0005656; GO:0005730; GO:0006261; GO:0006364; GO:0007368; GO:0070121; GO:0120293; GO:0120330,determination of left/right symmetry [GO:0007368]; DNA-templated DNA replication [GO:0006261]; Kupffer's vesicle development [GO:0070121]; rRNA processing [GO:0006364],dynein axonemal particle [GO:0120293]; nuclear pre-replicative complex [GO:0005656]; nucleolus [GO:0005730]; rixosome complex [GO:0120330],,GO:0005730; GO:0006260; GO:0043226; GO:0048856,nucleolus; DNA replication; organelle; anatomical structure development
OG_09817,FUN_042650-T1,Peve_00027725,Pocillopora_meandrina_HIv1___RNAseq.g11515.t1,three_way,49.031,,,,,,,,,,,,,,,,,
OG_09818,FUN_042651-T1,Peve_00027722,Pocillopora_meandrina_HIv1___RNAseq.g11514.t1,three_way,40.99366666666667,,,,,,,,,,,,,,,,,
OG_09819,FUN_042652-T1,Peve_00027724,Pocillopora_meandrina_HIv1___RNAseq.g16711.t1a,three_way,73.1215,FUN_042652-T1,Q80UK7,SAS6_MOUSE,,Spindle assembly abnormal protein 6 homolog (Spindle assembly defective protein 6) (SAS-6),Mus musculus (Mouse),45.9,294.0,1.5e-60,235.7,sp|Q80UK7|SAS6_MOUSE Spindle assembly abnormal protein 6 homolog OS=Mus musculus OX=10090 GN=Sass6 PE=2 SV=2,GO:0005737; GO:0005813; GO:0005814; GO:0007099; GO:0046601; GO:0060236; GO:0098536; GO:0120099; GO:1900087; GO:1905832,centriole replication [GO:0007099]; positive regulation of centriole replication [GO:0046601]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of spindle assembly [GO:1905832]; regulation of mitotic spindle organization [GO:0060236],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; deuterosome [GO:0098536]; procentriole replication complex [GO:0120099],,GO:0005815; GO:0043226,microtubule organizing center; organelle
OG_09820,FUN_042653-T1,Peve_00038268,Pocillopora_meandrina_HIv1___RNAseq.g16812.t1,three_way,75.381,FUN_042653-T1,Q8R4F0,MCLN3_MOUSE,,Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3),Mus musculus (Mouse),39.9,491.0,5.2000000000000004e-89,330.1,sp|Q8R4F0|MCLN3_MOUSE Mucolipin-3 OS=Mus musculus OX=10090 GN=Mcoln3 PE=1 SV=1,GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171,inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626],autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171],lipid binding [GO:0008289]; monoatomic anion channel activity [GO:0005253]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289; GO:0030154,transporter activity; plasma membrane; lipid binding; cell differentiation
OG_09821,FUN_042654-T1,Peve_00031585,Pocillopora_meandrina_HIv1___RNAseq.g4912.t1,three_way,68.26350000000001,FUN_042654-T1,Q9JJP2,P73_MOUSE,,Tumor protein p73 (p53-like transcription factor) (p53-related protein),Mus musculus (Mouse),45.5,266.0,9.2e-51,202.6,sp|Q9JJP2|P73_MOUSE Tumor protein p73 OS=Mus musculus OX=10090 GN=Tp73 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001822; GO:0001836; GO:0002039; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005794; GO:0005813; GO:0005886; GO:0006954; GO:0006974; GO:0007346; GO:0009410; GO:0009791; GO:0010468; GO:0019901; GO:0021766; GO:0030054; GO:0030900; GO:0033326; GO:0036064; GO:0042771; GO:0042802; GO:0043410; GO:0043523; GO:0043524; GO:0045665; GO:0045793; GO:0045893; GO:0045944; GO:0046872; GO:0048546; GO:0048666; GO:0048714; GO:0051262; GO:0060044; GO:0061629; GO:0097371; GO:1901248; GO:1902167; GO:2001235,cerebrospinal fluid secretion [GO:0033326]; digestive tract morphogenesis [GO:0048546]; DNA damage response [GO:0006974]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; kidney development [GO:0001822]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of lung ciliated cell differentiation [GO:1901248]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein tetramerization [GO:0051262]; regulation of gene expression [GO:0010468]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuron apoptotic process [GO:0043523]; release of cytochrome c from mitochondria [GO:0001836]; response to xenobiotic stimulus [GO:0009410],cell junction [GO:0030054]; centrosome [GO:0005813]; chromatin [GO:0000785]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005886; GO:0006355; GO:0006954; GO:0007005; GO:0043226; GO:0048856; GO:0065003; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; plasma membrane; regulation of DNA-templated transcription; inflammatory response; mitochondrion organization; organelle; anatomical structure development; protein-containing complex assembly; transcription regulator activity
OG_09822,FUN_042655-T1,Peve_00031586,Pocillopora_meandrina_HIv1___RNAseq.g4911.t2,three_way,59.10533333333333,FUN_042655-T1,Q8R4F0,MCLN3_MOUSE,,Mucolipin-3 (Transient receptor potential channel mucolipin 3) (TRPML3),Mus musculus (Mouse),39.7,546.0,7.899999999999999e-99,362.8,sp|Q8R4F0|MCLN3_MOUSE Mucolipin-3 OS=Mus musculus OX=10090 GN=Mcoln3 PE=1 SV=1,GO:0000421; GO:0005253; GO:0005267; GO:0005272; GO:0005737; GO:0005886; GO:0007626; GO:0008289; GO:0031901; GO:0031902; GO:0042491; GO:0060171,inner ear auditory receptor cell differentiation [GO:0042491]; locomotory behavior [GO:0007626],autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; stereocilium membrane [GO:0060171],lipid binding [GO:0008289]; monoatomic anion channel activity [GO:0005253]; potassium channel activity [GO:0005267]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289; GO:0030154,transporter activity; plasma membrane; lipid binding; cell differentiation
OG_09823,FUN_042656-T1,Peve_00031588,Pocillopora_meandrina_HIv1___RNAseq.g4910.t1a,three_way,75.37983333333334,FUN_042656-T1,Q5VYK3,ECM29_HUMAN,,Proteasome adapter and scaffold protein ECM29 (Ecm29 proteasome adapter and scaffold) (Proteasome-associated protein ECM29 homolog),Homo sapiens (Human),44.3,1886.0,0.0,1510.7,sp|Q5VYK3|ECM29_HUMAN Proteasome adapter and scaffold protein ECM29 OS=Homo sapiens OX=9606 GN=ECPAS PE=1 SV=2,GO:0000502; GO:0005634; GO:0005654; GO:0005737; GO:0005769; GO:0005770; GO:0005771; GO:0005783; GO:0005793; GO:0005813; GO:0016020; GO:0030134; GO:0030139; GO:0031410; GO:0036503; GO:0043248; GO:0060090; GO:0070628,ERAD pathway [GO:0036503]; proteasome assembly [GO:0043248],centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; membrane [GO:0016020]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502],molecular adaptor activity [GO:0060090]; proteasome binding [GO:0070628],GO:0005634; GO:0005654; GO:0005768; GO:0005783; GO:0005815; GO:0030163; GO:0031410; GO:0043226; GO:0060090; GO:0065003,nucleus; nucleoplasm; endosome; endoplasmic reticulum; microtubule organizing center; protein catabolic process; cytoplasmic vesicle; organelle; molecular adaptor activity; protein-containing complex assembly
OG_09824,FUN_042657-T1,Peve_00031589,Pocillopora_meandrina_HIv1___RNAseq.g4909.t1,three_way,75.765,FUN_042657-T1,Q66KA5,,,,,51.1,237.0,1.9999999999999998e-53,210.7,sp|Q66KA5|YIPF5_XENTR Protein YIPF5 OS=Xenopus tropicalis OX=8364 GN=yipf5 PE=2 SV=1,,,,,,
OG_09825,FUN_042658-T1,Peve_00031590,Pocillopora_meandrina_HIv1___RNAseq.g4908.t1,three_way,46.239,,,,,,,,,,,,,,,,,
OG_09826,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_09827,FUN_042663-T1,Peve_00031592,Pocillopora_meandrina_HIv1___RNAseq.g4878.t1,three_way,53.35733333333333,,,,,,,,,,,,,,,,,
OG_09828,FUN_042664-T1,Peve_00031593,Pocillopora_meandrina_HIv1___RNAseq.g16712.t1,three_way,76.901,FUN_042664-T1,Q96K37,,,,,52.1,217.0,4.2e-50,199.5,sp|Q96K37|S35E1_HUMAN Solute carrier family 35 member E1 OS=Homo sapiens OX=9606 GN=SLC35E1 PE=1 SV=2,,,,,,
OG_09829,FUN_042665-T1,Peve_00022240,Pocillopora_meandrina_HIv1___RNAseq.g15585.t1,three_way,56.434000000000005,,,,,,,,,,,,,,,,,
OG_09830,FUN_042807-T1,Peve_00003076,Pocillopora_meandrina_HIv1___RNAseq.g7424.t1,three_way,78.86633333333333,FUN_042807-T1,P41240,CSK_HUMAN,,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL),Homo sapiens (Human),56.1,442.0,8.4e-143,508.4,sp|P41240|CSK_HUMAN Tyrosine-protein kinase CSK OS=Homo sapiens OX=9606 GN=CSK PE=1 SV=1,GO:0002250; GO:0004713; GO:0004715; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0005911; GO:0006468; GO:0008285; GO:0010989; GO:0019903; GO:0031295; GO:0032715; GO:0034236; GO:0034332; GO:0035556; GO:0042802; GO:0042997; GO:0045779; GO:0046872; GO:0048709; GO:0050765; GO:0050852; GO:0050860; GO:0050868; GO:0060368; GO:0070062; GO:0070064; GO:0070373; GO:0071375; GO:1990782,adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell receptor signaling pathway [GO:0050860]; oligodendrocyte differentiation [GO:0048709]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; protein tyrosine kinase binding [GO:1990782],GO:0002376; GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0140096,"immune system process; catalytic activity; cytosol; plasma membrane; transferase activity; cell differentiation; cell junction organization; organelle; catalytic activity, acting on a protein"
OG_09831,FUN_042808-T1,Peve_00003077,Pocillopora_meandrina_HIv1___RNAseq.g7425.t1,three_way,92.786,FUN_042808-T1,Q5F448,GPHR_CHICK,,Golgi pH regulator (Protein GPR89),Gallus gallus (Chicken),68.6,455.0,9.7e-176,617.8,sp|Q5F448|GPHR_CHICK Golgi pH regulator OS=Gallus gallus OX=9031 GN=GPR89 PE=2 SV=1,GO:0000139; GO:0008308; GO:0015031; GO:0030217; GO:0030660; GO:0032580; GO:0034702; GO:0043588; GO:0051452,intracellular pH reduction [GO:0051452]; protein transport [GO:0015031]; skin development [GO:0043588]; T cell differentiation [GO:0030217],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; monoatomic ion channel complex [GO:0034702],voltage-gated monoatomic anion channel activity [GO:0008308],GO:0002376; GO:0005215; GO:0030154; GO:0048856,immune system process; transporter activity; cell differentiation; anatomical structure development
OG_09832,FUN_042809-T1,Peve_00003078,Pocillopora_meandrina_HIv1___RNAseq.g7426.t1,three_way,69.40266666666666,FUN_042809-T1,P15206,,,,,51.8,342.0,4.4e-84,313.2,sp|P15206|CCNB_MARGL G2/mitotic-specific cyclin-B OS=Marthasterias glacialis OX=7609 PE=2 SV=1,,,,,,
OG_09833,FUN_042810-T1,Peve_00028055,Pocillopora_meandrina_HIv1___RNAseq.g7427.t1,three_way,89.57733333333333,FUN_042810-T1,Q9R1P4,PSA1_MOUSE,,Proteasome subunit alpha type-1 (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain) (Proteasome subunit alpha-6) (alpha-6),Mus musculus (Mouse),76.5,243.0,6.3e-109,395.2,sp|Q9R1P4|PSA1_MOUSE Proteasome subunit alpha type-1 OS=Mus musculus OX=10090 GN=Psma1 PE=1 SV=1,GO:0000502; GO:0001530; GO:0002376; GO:0002862; GO:0005654; GO:0005813; GO:0005829; GO:0005839; GO:0006511; GO:0019773,immune system process [GO:0002376]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; ubiquitin-dependent protein catabolic process [GO:0006511],"centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]",lipopolysaccharide binding [GO:0001530],GO:0002376; GO:0005654; GO:0005815; GO:0005829; GO:0008289,immune system process; nucleoplasm; microtubule organizing center; cytosol; lipid binding
OG_09834,FUN_042811-T1,Peve_00028976,Pocillopora_meandrina_HIv1___RNAseq.g7428.t1,three_way,73.61033333333333,FUN_042811-T1,Q4R8R3,,,,,51.1,444.0,2.9e-53,211.1,sp|Q4R8R3|CC112_MACFA Coiled-coil domain-containing protein 112 OS=Macaca fascicularis OX=9541 GN=CCDC112 PE=2 SV=1,,,,,,
OG_09835,FUN_042814-T1,Peve_00021878,Pocillopora_meandrina_HIv1___RNAseq.g7429.t1,three_way,82.54266666666666,FUN_042814-T1,E9Q634,MYO1E_MOUSE,,Unconventional myosin-Ie (Unconventional myosin 1E),Mus musculus (Mouse),66.0,1113.0,0.0,1439.5,sp|E9Q634|MYO1E_MOUSE Unconventional myosin-Ie OS=Mus musculus OX=10090 GN=Myo1e PE=1 SV=1,GO:0001570; GO:0001701; GO:0001822; GO:0003094; GO:0003774; GO:0005516; GO:0005524; GO:0005737; GO:0005856; GO:0005903; GO:0005912; GO:0006897; GO:0016459; GO:0016887; GO:0030097; GO:0032836; GO:0035091; GO:0035166; GO:0045334; GO:0048008; GO:0051015; GO:0072015,endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; podocyte development [GO:0072015]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],adherens junction [GO:0005912]; brush border [GO:0005903]; clathrin-coated endocytic vesicle [GO:0045334]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; myosin complex [GO:0016459],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; cytoskeletal motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091],GO:0003014; GO:0003774; GO:0003824; GO:0005856; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856,renal system process; cytoskeletal motor activity; catalytic activity; cytoskeleton; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development
OG_09836,FUN_042815-T1,Peve_00033308,Pocillopora_meandrina_HIv1___RNAseq.g7431.t1,three_way,72.99733333333333,FUN_042815-T1,Q4V9P6,ADAL_DANRE,,N6-Methyl-AMP deaminase (EC 3.5.4.-) (Adenosine deaminase-like protein),Danio rerio (Zebrafish) (Brachydanio rerio),52.1,317.0,6.4e-88,326.6,sp|Q4V9P6|ADAL_DANRE N6-Methyl-AMP deaminase OS=Danio rerio OX=7955 GN=mapda PE=2 SV=1,GO:0004000; GO:0006154; GO:0009117; GO:0043010; GO:0046103; GO:0046872; GO:0062154,adenosine catabolic process [GO:0006154]; camera-type eye development [GO:0043010]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117],,adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; N6-methyl-AMP deaminase activity [GO:0062154],GO:0003824; GO:0016787; GO:0048856; GO:0055086; GO:1901135,catalytic activity; hydrolase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_09837,FUN_042817-T1,Peve_00019562,Pocillopora_meandrina_HIv1___RNAseq.g7434.t3,three_way,67.52316666666667,FUN_042817-T1,Q8N1W1,ARG28_HUMAN,,Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor) (p190-RhoGEF) (p190RhoGEF) (Rho guanine nucleotide exchange factor),Homo sapiens (Human),26.8,1282.0,1.1e-79,300.4,sp|Q8N1W1|ARG28_HUMAN Rho guanine nucleotide exchange factor 28 OS=Homo sapiens OX=9606 GN=ARHGEF28 PE=1 SV=3,GO:0000902; GO:0003723; GO:0005085; GO:0005829; GO:0005886; GO:0008270; GO:0021955; GO:0035023; GO:0048013; GO:0051056; GO:0060052,cell morphogenesis [GO:0000902]; central nervous system neuron axonogenesis [GO:0021955]; ephrin receptor signaling pathway [GO:0048013]; neurofilament cytoskeleton organization [GO:0060052]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],cytosol [GO:0005829]; plasma membrane [GO:0005886],guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005829; GO:0005886; GO:0007010; GO:0098772,RNA binding; cytosol; plasma membrane; cytoskeleton organization; molecular function regulator activity
OG_09838,FUN_042819-T1,Peve_00019566,Pocillopora_meandrina_HIv1___RNAseq.g7436.t1,three_way,66.37966666666667,FUN_042819-T1,Q3KP44,ANR55_HUMAN,,Ankyrin repeat domain-containing protein 55,Homo sapiens (Human),34.0,156.0,7.8e-09,63.5,sp|Q3KP44|ANR55_HUMAN Ankyrin repeat domain-containing protein 55 OS=Homo sapiens OX=9606 GN=ANKRD55 PE=1 SV=3,,,,,,
OG_09839,FUN_042820-T1,Peve_00019572,Pocillopora_meandrina_HIv1___RNAseq.g7438.t1,three_way,89.72666666666667,FUN_042820-T1,P40424,PBX1_HUMAN,,Pre-B-cell leukemia transcription factor 1 (Homeobox protein PBX1) (Homeobox protein PRL),Homo sapiens (Human),69.0,407.0,9.8e-132,471.9,sp|P40424|PBX1_HUMAN Pre-B-cell leukemia transcription factor 1 OS=Homo sapiens OX=9606 GN=PBX1 PE=1 SV=1,GO:0000086; GO:0000785; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001222; GO:0001228; GO:0001654; GO:0001655; GO:0001658; GO:0001779; GO:0003677; GO:0003700; GO:0005634; GO:0005654; GO:0005737; GO:0006694; GO:0007420; GO:0007548; GO:0009887; GO:0009952; GO:0009954; GO:0010971; GO:0030278; GO:0030325; GO:0030326; GO:0035162; GO:0043433; GO:0045665; GO:0045944; GO:0048536; GO:0048538; GO:0048568; GO:0048666; GO:0048706; GO:0072089; GO:0090575; GO:0140297; GO:1990837; GO:2000648,adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic hemopoiesis [GO:0035162]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; G2/M transition of mitotic cell cycle [GO:0000086]; natural killer cell differentiation [GO:0001779]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron differentiation [GO:0045665]; neuron development [GO:0048666]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of ossification [GO:0030278]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; steroid biosynthetic process [GO:0006694]; thymus development [GO:0048538]; urogenital system development [GO:0001655],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]",GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0006629; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; lipid metabolic process; reproductive process; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_09840,FUN_042821-T1,Peve_00019575,Pocillopora_meandrina_HIv1___RNAseq.g7439.t2,three_way,61.8725,FUN_042821-T1,A2RV61,,,,,30.5,1466.0,5.5e-152,540.4,sp|A2RV61|GAPD1_XENLA GTPase-activating protein and VPS9 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=gapvd1 PE=2 SV=1,,,,,,
OG_09841,FUN_042822-T2,Peve_00019576,Pocillopora_meandrina_HIv1___TS.g1194.t1,three_way,82.61283333333333,FUN_042822-T2,Q28WQ1,KIF1A_DROPS,,Kinesin-like protein unc-104,Drosophila pseudoobscura pseudoobscura (Fruit fly),47.8,1673.0,0.0,1395.2,sp|Q28WQ1|KIF1A_DROPS Kinesin-like protein unc-104 OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=unc-104 PE=3 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005875; GO:0008017; GO:0047496; GO:0048489,synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0007018; GO:0008092; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule-based movement; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_09842,FUN_042823-T1,Peve_00019578,Pocillopora_meandrina_HIv1___RNAseq.g7442.t1,three_way,68.97233333333334,FUN_042823-T1,Q9HAV7,GRPE1_HUMAN,,"GrpE protein homolog 1, mitochondrial (HMGE) (Mt-GrpE#1)",Homo sapiens (Human),57.7,194.0,1.3e-48,194.5,"sp|Q9HAV7|GRPE1_HUMAN GrpE protein homolog 1, mitochondrial OS=Homo sapiens OX=9606 GN=GRPEL1 PE=1 SV=2",GO:0000774; GO:0001405; GO:0005654; GO:0005739; GO:0005743; GO:0005744; GO:0005759; GO:0006457; GO:0006886; GO:0030150; GO:0042802; GO:0042803; GO:0051082; GO:0051087,intracellular protein transport [GO:0006886]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150],"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; PAM complex, Tim23 associated import motor [GO:0001405]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]",adenyl-nucleotide exchange factor activity [GO:0000774]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005654; GO:0005739; GO:0006457; GO:0006886; GO:0043226; GO:0055085; GO:0098772,nucleoplasm; mitochondrion; protein folding; intracellular protein transport; organelle; transmembrane transport; molecular function regulator activity
OG_09843,FUN_042828-T1,Peve_00041828,Pocillopora_meandrina_HIv1___RNAseq.g7273.t1,three_way,72.41866666666667,FUN_042828-T1,Q5IS35,,,,,48.6,315.0,4e-78,293.1,sp|Q5IS35|TPC_MACFA Mitochondrial thiamine pyrophosphate carrier OS=Macaca fascicularis OX=9541 GN=SLC25A19 PE=2 SV=1,,,,,,
OG_09844,FUN_042829-T1,Peve_00041827,Pocillopora_meandrina_HIv1___RNAseq.g7272.t1,three_way,75.69333333333333,,,,,,,,,,,,,,,,,
OG_09845,FUN_042830-T1,Peve_00041826,Pocillopora_meandrina_HIv1___RNAseq.g7271.t1,three_way,92.688,FUN_042830-T1,P62915,TF2B_MOUSE,,Transcription initiation factor IIB (EC 2.3.1.48) (General transcription factor TFIIB) (RNA polymerase II alpha initiation factor),Mus musculus (Mouse),79.1,316.0,4.3e-135,482.3,sp|P62915|TF2B_MOUSE Transcription initiation factor IIB OS=Mus musculus OX=10090 GN=Gtf2b PE=1 SV=1,GO:0000776; GO:0000793; GO:0000979; GO:0000993; GO:0001174; GO:0003677; GO:0004402; GO:0005634; GO:0005669; GO:0005694; GO:0006366; GO:0006367; GO:0006473; GO:0008270; GO:0010467; GO:0016251; GO:0016407; GO:0016604; GO:0017025; GO:0019083; GO:0032153; GO:0032993; GO:0042585; GO:0046966; GO:0051123; GO:0051177; GO:0051225; GO:0051276; GO:1990114; GO:1990841,chromosome organization [GO:0051276]; gene expression [GO:0010467]; meiotic sister chromatid cohesion [GO:0051177]; protein acetylation [GO:0006473]; RNA polymerase II core complex assembly [GO:1990114]; RNA polymerase II preinitiation complex assembly [GO:0051123]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcriptional start site selection at RNA polymerase II promoter [GO:0001174]; viral transcription [GO:0019083],cell division site [GO:0032153]; chromosome [GO:0005694]; condensed chromosome [GO:0000793]; germinal vesicle [GO:0042585]; kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription factor TFIID complex [GO:0005669],acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; nuclear thyroid hormone receptor binding [GO:0046966]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; TBP-class protein binding [GO:0017025]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006351; GO:0007010; GO:0016740; GO:0043226; GO:0065003; GO:0140096; GO:0140223,"DNA binding; catalytic activity; nucleus; chromosome; DNA-templated transcription; cytoskeleton organization; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein; general transcription initiation factor activity"
OG_09846,FUN_042835-T1,Peve_00022002,Pocillopora_meandrina_HIv1___RNAseq.g7265.t1,three_way,62.422,,,,,,,,,,,,,,,,,
OG_09847,FUN_042837-T1,Peve_00007263,Pocillopora_meandrina_HIv1___RNAseq.g7264.t1,three_way,78.92983333333333,FUN_042837-T1,Q32S26,BRD2_BOVIN,,Bromodomain-containing protein 2,Bos taurus (Bovine),50.9,737.0,1.5e-137,492.3,sp|Q32S26|BRD2_BOVIN Bromodomain-containing protein 2 OS=Bos taurus OX=9913 GN=BRD2 PE=3 SV=1,GO:0000785; GO:0005634; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0070577; GO:0071168; GO:0140012; GO:0140588; GO:2000330,chromatin looping [GO:0140588]; chromatin remodeling [GO:0006338]; nucleosome assembly [GO:0006334]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; protein localization to chromatin [GO:0071168]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],histone H4K5ac reader activity [GO:0140012]; lysine-acetylated histone binding [GO:0070577],GO:0005634; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0065003,nucleus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly
OG_09848,FUN_042839-T1,Peve_00007265,Pocillopora_meandrina_HIv1___RNAseq.g7262.t1,three_way,92.87733333333334,FUN_042839-T1,Q3ZBE7,,,,,82.5,114.0,5.2e-49,194.9,sp|Q3ZBE7|YPEL5_BOVIN Protein yippee-like 5 OS=Bos taurus OX=9913 GN=YPEL5 PE=2 SV=1,,,,,,
OG_09849,FUN_042840-T1,Peve_00007266,Pocillopora_meandrina_HIv1___RNAseq.g7261.t1,three_way,47.549,,,,,,,,,,,,,,,,,
OG_09850,FUN_042841-T1,Peve_00007267,Pocillopora_meandrina_HIv1___RNAseq.g7258.t1,three_way,84.73333333333333,FUN_042841-T1,Q2TBQ5,RL7A_BOVIN,,Large ribosomal subunit protein eL8 (60S ribosomal protein L7a),Bos taurus (Bovine),63.1,263.0,3.5e-85,316.2,sp|Q2TBQ5|RL7A_BOVIN Large ribosomal subunit protein eL8 OS=Bos taurus OX=9913 GN=RPL7A PE=2 SV=3,GO:0000470; GO:0003723; GO:0003735; GO:0005730; GO:0016020; GO:0022625; GO:0045202,maturation of LSU-rRNA [GO:0000470],cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; nucleolus [GO:0005730]; synapse [GO:0045202],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005730; GO:0043226,RNA binding; structural molecule activity; nucleolus; organelle
OG_09851,FUN_042842-T1,Peve_00007268,Pocillopora_meandrina_HIv1___RNAseq.g7257.t1,three_way,86.659,FUN_042842-T1,Q800L3,,,,,65.2,135.0,3.700000000000001e-44,179.5,sp|Q800L3|MED22_CHICK Mediator of RNA polymerase II transcription subunit 22 OS=Gallus gallus OX=9031 GN=MED22 PE=3 SV=1,,,,,,
OG_09852,FUN_042843-T1,Peve_00023281,Pocillopora_meandrina_HIv1___RNAseq.g7256.t1,three_way,66.93900000000001,FUN_042843-T1,Q6ZZY0,,,,,56.5,483.0,1.4e-176,620.9,sp|Q6ZZY0|CRY1_SYLBO Cryptochrome-1 OS=Sylvia borin OX=73324 GN=CRY1 PE=2 SV=1,,,,,,
OG_09853,FUN_042844-T1,Peve_00023280,Pocillopora_meandrina_HIv1___RNAseq.g7255.t1,three_way,77.436,,,,,,,,,,,,,,,,,
OG_09854,FUN_042847-T1,Peve_00023278,Pocillopora_meandrina_HIv1___RNAseq.g7253.t2,three_way,70.20666666666666,FUN_042847-T1,Q924L9,,,,,46.9,557.0,1.5e-131,471.5,"sp|Q924L9|FOLC_CRIGR Folylpolyglutamate synthase, mitochondrial OS=Cricetulus griseus OX=10029 GN=FPGS PE=2 SV=1",,,,,,
OG_09855,FUN_042848-T1,Peve_00023277,Pocillopora_meandrina_HIv1___RNAseq.g7251.t2,three_way,92.89133333333334,FUN_042848-T1,Q9Z1N5,,,,,85.5,429.0,4.2000000000000003e-213,741.9,sp|Q9Z1N5|DX39B_MOUSE Spliceosome RNA helicase Ddx39b OS=Mus musculus OX=10090 GN=Ddx39b PE=1 SV=1,,,,,,
OG_09856,FUN_042850-T1,Peve_00023276,Pocillopora_meandrina_HIv1___RNAseq.g7250.t1,three_way,70.27033333333333,FUN_042850-T1,O94431,,,,,26.4,405.0,1.9e-36,155.2,sp|O94431|EGT2_SCHPO Hercynylcysteine sulfoxide lyase OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=egt2 PE=3 SV=1,,,,,,
OG_09857,FUN_042851-T2,Peve_00023271,Pocillopora_meandrina_HIv1___RNAseq.g7248.t1,three_way,55.37016666666667,FUN_042851-T2,P62285,,,,,47.2,733.0,1.3e-174,616.7,sp|P62285|ASPM_BOVIN Abnormal spindle-like microcephaly-associated protein homolog (Fragment) OS=Bos taurus OX=9913 GN=ASPM PE=2 SV=1,,,,,,
OG_09857,FUN_042851-T2,Peve_00023271,Pocillopora_meandrina_HIv1___RNAseq.g7248.t1,three_way,55.37016666666667,FUN_042851-T2,P62285,,,,,26.6,466.0,1.1e-35,155.2,sp|P62285|ASPM_BOVIN Abnormal spindle-like microcephaly-associated protein homolog (Fragment) OS=Bos taurus OX=9913 GN=ASPM PE=2 SV=1,,,,,,
OG_09858,FUN_042852-T1,Peve_00023270,Pocillopora_meandrina_HIv1___RNAseq.g7247.t1,three_way,60.656666666666666,FUN_042852-T1,Q15527,,,,,37.4,163.0,5.4e-20,99.8,sp|Q15527|SURF2_HUMAN Surfeit locus protein 2 OS=Homo sapiens OX=9606 GN=SURF2 PE=1 SV=4,,,,,,
OG_09859,FUN_042853-T1,Peve_00023269,Pocillopora_meandrina_HIv1___RNAseq.g7246.t1,three_way,67.13683333333333,FUN_042853-T1,Q9JII1,INP5E_MOUSE,,"Phosphatidylinositol polyphosphate 5-phosphatase type IV (72 kDa inositol polyphosphate 5-phosphatase) (Inositol polyphosphate-5-phosphatase E) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (EC 3.1.3.36) (Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.86)",Mus musculus (Mouse),47.6,391.0,6.8999999999999995e-99,363.2,sp|Q9JII1|INP5E_MOUSE Phosphatidylinositol polyphosphate 5-phosphatase type IV OS=Mus musculus OX=10090 GN=Inpp5e PE=1 SV=1,GO:0000139; GO:0001726; GO:0004439; GO:0004445; GO:0005634; GO:0005886; GO:0005929; GO:0005930; GO:0016314; GO:0017148; GO:0032580; GO:0034485; GO:0043813; GO:0046488; GO:0046856; GO:0051898; GO:0060271; GO:1902140; GO:1903565,cilium assembly [GO:0060271]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein localization to cilium [GO:1903565]; negative regulation of translation [GO:0017148]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; response to inositol [GO:1902140],axoneme [GO:0005930]; cilium [GO:0005929]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726],"inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]",GO:0003824; GO:0005634; GO:0005886; GO:0005929; GO:0006629; GO:0016787; GO:0043226; GO:0044782,catalytic activity; nucleus; plasma membrane; cilium; lipid metabolic process; hydrolase activity; organelle; cilium organization
OG_09860,FUN_042855-T1,Peve_00023267,Pocillopora_meandrina_HIv1___RNAseq.g7245.t1,three_way,50.41616666666667,,,,,,,,,,,,,,,,,
OG_09861,FUN_042856-T1,Peve_00023265,Pocillopora_meandrina_HIv1___TS.g991.t1,three_way,72.62433333333333,FUN_042856-T1,Q8TB37,NUBPL_HUMAN,,Iron-sulfur cluster transfer protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1),Homo sapiens (Human),65.9,270.0,1.1e-101,371.3,sp|Q8TB37|NUBPL_HUMAN Iron-sulfur cluster transfer protein NUBPL OS=Homo sapiens OX=9606 GN=NUBPL PE=1 SV=3,GO:0005524; GO:0005739; GO:0005759; GO:0005886; GO:0007005; GO:0016226; GO:0032981; GO:0046872; GO:0051539; GO:0140663,iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion organization [GO:0007005],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; metal ion binding [GO:0046872]",GO:0005739; GO:0005886; GO:0007005; GO:0043226; GO:0065003; GO:0140104; GO:0140657,mitochondrion; plasma membrane; mitochondrion organization; organelle; protein-containing complex assembly; molecular carrier activity; ATP-dependent activity
OG_09862,FUN_042871-T1,Peve_00023282,Pocillopora_meandrina_HIv1___RNAseq.g7234.t1,three_way,64.53166666666667,FUN_042871-T1,Q8CAE2,HENMT_MOUSE,,Small RNA 2'-O-methyltransferase (EC 2.1.1.386) (HEN1 methyltransferase homolog 1) (mHEN1),Mus musculus (Mouse),36.6,366.0,2.9e-54,214.5,sp|Q8CAE2|HENMT_MOUSE Small RNA 2'-O-methyltransferase OS=Mus musculus OX=10090 GN=Henmt1 PE=1 SV=1,GO:0001510; GO:0003723; GO:0005829; GO:0008171; GO:0008173; GO:0034587; GO:0043186; GO:0046872; GO:0090486,piRNA processing [GO:0034587]; RNA methylation [GO:0001510],cytosol [GO:0005829]; P granule [GO:0043186],metal ion binding [GO:0046872]; O-methyltransferase activity [GO:0008171]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; small RNA 2'-O-methyltransferase activity [GO:0090486],GO:0003723; GO:0003824; GO:0005829; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; cytosol; transferase activity; organelle; catalytic activity, acting on RNA"
OG_09863,FUN_042872-T1,Peve_00023268,Pocillopora_meandrina_HIv1___RNAseq.g7235.t1,three_way,71.824,,,,,,,,,,,,,,,,,
OG_09864,FUN_042873-T1,Peve_00028527,Pocillopora_meandrina_HIv1___TS.g983.t1,three_way,62.68216666666667,FUN_042873-T1,Q8BZM1,GLMN_MOUSE,,Glomulin (FK506-binding protein-associated protein) (FAP) (FKBP-associated protein),Mus musculus (Mouse),27.1,619.0,2.1e-59,231.9,sp|Q8BZM1|GLMN_MOUSE Glomulin OS=Mus musculus OX=10090 GN=Glmn PE=1 SV=1,GO:0001570; GO:0001819; GO:0001843; GO:0005102; GO:0005171; GO:0007166; GO:0008285; GO:0031461; GO:0031462; GO:0031463; GO:0031464; GO:0031625; GO:0032434; GO:0032743; GO:0040029; GO:0042130; GO:0042327; GO:0042692; GO:0055105; GO:0072359,cell surface receptor signaling pathway [GO:0007166]; circulatory system development [GO:0072359]; epigenetic regulation of gene expression [GO:0040029]; muscle cell differentiation [GO:0042692]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine production [GO:0001819]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of phosphorylation [GO:0042327]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570],Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461],hepatocyte growth factor receptor binding [GO:0005171]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105],GO:0006325; GO:0030154; GO:0048856; GO:0098772,chromatin organization; cell differentiation; anatomical structure development; molecular function regulator activity
OG_09865,FUN_042874-T1,Peve_00040164,Pocillopora_meandrina_HIv1___RNAseq.g7232.t1,three_way,80.68933333333334,FUN_042874-T1,Q3MHZ7,GPI8_BOVIN,,GPI-anchor transamidase (EC 2.6.1.-) (GPI-anchor transamidase component PIGK) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K),Bos taurus (Bovine),58.2,366.0,9.999999999999999e-123,441.4,sp|Q3MHZ7|GPI8_BOVIN GPI-anchor transamidase OS=Bos taurus OX=9913 GN=PIGK PE=2 SV=1,GO:0003923; GO:0006506; GO:0006508; GO:0016255; GO:0042765,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; proteolysis [GO:0006508],GPI-anchor transamidase complex [GO:0042765],GPI-anchor transamidase activity [GO:0003923],GO:0003824; GO:0006629; GO:0016740; GO:0016787; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; lipid metabolic process; transferase activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_09866,FUN_042875-T1,Peve_00040165,Pocillopora_meandrina_HIv1___RNAseq.g7231.t1,three_way,78.882,FUN_042875-T1,Q9Y6K8,,,,,36.4,563.0,2e-101,372.1,sp|Q9Y6K8|KAD5_HUMAN Adenylate kinase isoenzyme 5 OS=Homo sapiens OX=9606 GN=AK5 PE=1 SV=2,,,,,,
OG_09867,FUN_042876-T1,Peve_00040153,Pocillopora_meandrina_HIv1___TS.g977.t1,three_way,68.58266666666667,,,,,,,,,,,,,,,,,
OG_09868,FUN_042877-T1,Peve_00040154,Pocillopora_meandrina_HIv1___RNAseq.g7229.t1,three_way,78.41433333333333,FUN_042877-T1,A4IFD0,,,,,38.2,76.0,8.1e-08,57.8,sp|A4IFD0|KAD5_BOVIN Adenylate kinase isoenzyme 5 OS=Bos taurus OX=9913 GN=Ak5 PE=2 SV=1,,,,,,
OG_09869,FUN_042878-T1,Peve_00015664,Pocillopora_meandrina_HIv1___RNAseq.g7228.t1,three_way,78.19666666666667,FUN_042878-T1,Q9UHB4,,,,,54.6,599.0,1.2e-192,674.5,sp|Q9UHB4|NDOR1_HUMAN NADPH-dependent diflavin oxidoreductase 1 OS=Homo sapiens OX=9606 GN=NDOR1 PE=1 SV=1,,,,,,
OG_09870,FUN_042905-T1,Peve_00019284,Pocillopora_meandrina_HIv1___RNAseq.g7203.t1,three_way,47.36533333333333,,,,,,,,,,,,,,,,,
OG_09871,FUN_042907-T1,Peve_00019285,Pocillopora_meandrina_HIv1___RNAseq.g7202.t1,three_way,76.76766666666667,FUN_042907-T1,Q76KB1,HS2ST_CHICK,,Heparan sulfate 2-O-sulfotransferase 1 (EC 2.8.2.-) (2-O-sulfotransferase) (2-OST) (2OST) (HS 2-O-sulfotransferase) (cHS2ST) (Heparan sulfate 2-sulfotransferase),Gallus gallus (Chicken),56.1,303.0,2.1e-104,380.6,sp|Q76KB1|HS2ST_CHICK Heparan sulfate 2-O-sulfotransferase 1 OS=Gallus gallus OX=9031 GN=HS2ST1 PE=1 SV=1,GO:0000139; GO:0004394; GO:0010467; GO:0015012; GO:0030202; GO:0042802; GO:0060676,gene expression [GO:0010467]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan metabolic process [GO:0030202]; ureteric bud formation [GO:0060676],Golgi membrane [GO:0000139],heparan sulfate 2-sulfotransferase activity [GO:0004394]; identical protein binding [GO:0042802],GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_09872,FUN_042910-T1,Peve_00019286,Pocillopora_meandrina_HIv1___RNAseq.g7200.t1,three_way,80.18383333333334,FUN_042910-T1,E7F021,,,,,36.5,249.0,4.6e-24,114.8,sp|E7F021|ZD12B_DANRE Palmitoyltransferase ZDHHC12-B OS=Danio rerio OX=7955 GN=zdhhc12b PE=3 SV=1,,,,,,
OG_09873,FUN_042911-T1,Peve_00019287,Pocillopora_meandrina_HIv1___RNAseq.g7198.t1,three_way,79.53966666666666,FUN_042911-T1,P52826,,,,,44.9,630.0,6.6e-154,545.8,sp|P52826|CACP_COLLI Carnitine O-acetyltransferase OS=Columba livia OX=8932 GN=CRAT PE=1 SV=1,,,,,,
OG_09874,FUN_042912-T1,Peve_00019289,Pocillopora_meandrina_HIv1___RNAseq.g7196.t1,three_way,79.65833333333333,FUN_042912-T1,B0KWE9,,,,,51.6,225.0,4.9e-63,242.7,sp|B0KWE9|DOPP1_CALJA Dolichyldiphosphatase 1 OS=Callithrix jacchus OX=9483 GN=DOLPP1 PE=3 SV=1,,,,,,
OG_09875,FUN_042913-T1,Peve_00019291,Pocillopora_meandrina_HIv1___RNAseq.g7195.t1,three_way,51.347,,,,,,,,,,,,,,,,,
OG_09876,FUN_042914-T1,Peve_00019292,Pocillopora_meandrina_HIv1___RNAseq.g7194.t1,three_way,51.987,,,,,,,,,,,,,,,,,
OG_09877,FUN_042915-T1,Peve_00019293,Pocillopora_meandrina_HIv1___RNAseq.g7193.t1,three_way,36.81733333333334,,,,,,,,,,,,,,,,,
OG_09878,FUN_042920-T1,Peve_00007251,Pocillopora_meandrina_HIv1___RNAseq.g7180.t1,three_way,66.58233333333334,,,,,,,,,,,,,,,,,
OG_09879,FUN_042933-T1,Peve_00007250,Pocillopora_meandrina_HIv1___RNAseq.g7179.t1,three_way,37.31933333333333,,,,,,,,,,,,,,,,,
OG_09880,FUN_042945-T1,Peve_00026954,Pocillopora_meandrina_HIv1___RNAseq.g7152.t1,three_way,63.92066666666667,FUN_042945-T1,P35409,,,,,26.3,316.0,1.3e-11,72.8,sp|P35409|GLHR_ANTEL Probable glycoprotein hormone G-protein coupled receptor OS=Anthopleura elegantissima OX=6110 PE=2 SV=1,,,,,,
OG_09881,FUN_042949-T1,Peve_00019972,Pocillopora_meandrina_HIv1___TS.g886.t1,three_way,68.23983333333334,FUN_042949-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),34.1,560.0,6.8e-78,293.1,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_09882,FUN_042955-T1,Peve_00025634,Pocillopora_meandrina_HIv1___RNAseq.g7125.t1,three_way,73.877,FUN_042955-T1,Q8BMI0,FBX38_MOUSE,,F-box only protein 38 (Modulator of KLF7 activity) (MoKA),Mus musculus (Mouse),42.1,439.0,9.499999999999999e-99,362.8,sp|Q8BMI0|FBX38_MOUSE F-box only protein 38 OS=Mus musculus OX=10090 GN=Fbxo38 PE=1 SV=1,GO:0002250; GO:0002842; GO:0005634; GO:0005737; GO:0005829; GO:0010976; GO:0031146; GO:0050870; GO:0070936; GO:1990756,adaptive immune response [GO:0002250]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; protein K48-linked ubiquitination [GO:0070936]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0005634; GO:0005829; GO:0030163; GO:0043226; GO:0060090,immune system process; nucleus; cytosol; protein catabolic process; organelle; molecular adaptor activity
OG_09883,FUN_042956-T1,Peve_00025632,Pocillopora_meandrina_HIv1___RNAseq.g7124.t1,three_way,69.03333333333333,FUN_042956-T1,Q9JIM4,DUS12_RAT,,Dual specificity protein phosphatase 12 (EC 3.1.3.16) (EC 3.1.3.48) (Glucokinase-associated dual specificity phosphatase) (GKAP),Rattus norvegicus (Rat),44.9,303.0,2e-60,234.2,sp|Q9JIM4|DUS12_RAT Dual specificity protein phosphatase 12 OS=Rattus norvegicus OX=10116 GN=Dusp12 PE=1 SV=1,GO:0004721; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0008138; GO:0008270; GO:0016791; GO:0019900,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],kinase binding [GO:0019900]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_09884,FUN_042957-T1,Peve_00039056,Pocillopora_meandrina_HIv1___RNAseq.g7123.t1,three_way,46.98266666666667,FUN_042957-T1,Q5TM64,,,,,30.0,120.0,2.3e-13,78.2,sp|Q5TM64|CF136_MACMU Uncharacterized protein C6orf136 homolog OS=Macaca mulatta OX=9544 PE=4 SV=1,,,,,,
OG_09885,FUN_042958-T1,Peve_00039055,Pocillopora_meandrina_HIv1___RNAseq.g7122.t1,three_way,87.16766666666666,FUN_042958-T1,Q9HD20,,,,,56.8,1187.0,0.0,1261.5,sp|Q9HD20|AT131_HUMAN Endoplasmic reticulum transmembrane helix translocase OS=Homo sapiens OX=9606 GN=ATP13A1 PE=1 SV=2,,,,,,
OG_09886,FUN_042959-T1,Peve_00039053,Pocillopora_meandrina_HIv1___RNAseq.g7120.t1,three_way,63.528,FUN_042959-T1,B8PYG1,NSMF_DANRE,,NMDA receptor synaptonuclear signaling and neuronal migration factor (Nasal embryonic luteinizing hormone-releasing hormone factor) (Nasal embryonic LHRH factor),Danio rerio (Zebrafish) (Brachydanio rerio),33.0,221.0,3.7e-32,141.0,sp|B8PYG1|NSMF_DANRE NMDA receptor synaptonuclear signaling and neuronal migration factor OS=Danio rerio OX=7955 GN=nsmf PE=2 SV=1,GO:0005634; GO:0005737; GO:0005856; GO:0005886; GO:0005938; GO:0014069; GO:0016363; GO:0030425; GO:0031965; GO:0045773; GO:0048168; GO:2001224,positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; regulation of neuronal synaptic plasticity [GO:0048168],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],,GO:0005634; GO:0005856; GO:0005886; GO:0043226,nucleus; cytoskeleton; plasma membrane; organelle
OG_09887,FUN_042961-T1,Peve_00039052,Pocillopora_meandrina_HIv1___RNAseq.g7119.t1,three_way,84.45566666666667,FUN_042961-T1,Q66II5,,,,,57.4,343.0,1.5999999999999999e-114,414.1,sp|Q66II5|T3HPD_XENTR Trans-L-3-hydroxyproline dehydratase OS=Xenopus tropicalis OX=8364 GN=l3hypdh PE=2 SV=1,,,,,,
OG_09888,FUN_042963-T1,Peve_00039045,Pocillopora_meandrina_HIv1___RNAseq.4783_t,three_way,65.88283333333334,FUN_042963-T1,Q4VGL6,RC3H1_MOUSE,,Roquin-1 (Roquin) (EC 2.3.2.27) (Protein Sanroque) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1),Mus musculus (Mouse),60.2,523.0,1.3e-165,585.5,sp|Q4VGL6|RC3H1_MOUSE Roquin-1 OS=Mus musculus OX=10090 GN=Rc3h1 PE=1 SV=1,GO:0000184; GO:0000209; GO:0000288; GO:0000932; GO:0000956; GO:0001782; GO:0002634; GO:0002635; GO:0003725; GO:0003729; GO:0003730; GO:0004842; GO:0005737; GO:0008270; GO:0010468; GO:0010494; GO:0010608; GO:0030889; GO:0033962; GO:0035198; GO:0035613; GO:0042098; GO:0043029; GO:0043488; GO:0045623; GO:0046007; GO:0048535; GO:0048536; GO:0050852; GO:0050856; GO:0061014; GO:0061158; GO:0061470; GO:0071347; GO:1900151; GO:1901224; GO:1905762; GO:2000320; GO:2000628,"3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; P-body assembly [GO:0033962]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; post-transcriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900151]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932],CCR4-NOT complex binding [GO:1905762]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0016071; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"immune system process; RNA binding; catalytic activity; mRNA metabolic process; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09889,FUN_042965-T1,Peve_00039044,Pocillopora_meandrina_HIv1___RNAseq.g7111.t1,three_way,59.85383333333333,FUN_042965-T1,Q80ZJ6,,,,,34.8,771.0,3.4e-101,370.9,sp|Q80ZJ6|ZER1_MOUSE Protein zer-1 homolog OS=Mus musculus OX=10090 GN=Zer1 PE=1 SV=1,,,,,,
OG_09890,FUN_042969-T1,Peve_00039038,Pocillopora_meandrina_HIv1___RNAseq.g7107.t1,three_way,70.73766666666667,FUN_042969-T1,Q9UJX4,,,,,33.8,754.0,2.1e-106,388.3,sp|Q9UJX4|APC5_HUMAN Anaphase-promoting complex subunit 5 OS=Homo sapiens OX=9606 GN=ANAPC5 PE=1 SV=2,,,,,,
OG_09891,FUN_042970-T1,Peve_00039048,Pocillopora_meandrina_HIv1___RNAseq.g7106.t1,three_way,87.69833333333334,FUN_042970-T1,Q9WUP7,UCHL5_MOUSE,,Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5),Mus musculus (Mouse),61.1,350.0,4.6e-117,422.5,sp|Q9WUP7|UCHL5_MOUSE Ubiquitin carboxyl-terminal hydrolase isozyme L5 OS=Mus musculus OX=10090 GN=Uchl5 PE=1 SV=2,GO:0000502; GO:0000723; GO:0004843; GO:0004866; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006275; GO:0006281; GO:0006282; GO:0006310; GO:0006338; GO:0006511; GO:0016579; GO:0021670; GO:0030901; GO:0031011; GO:0032435; GO:0033044; GO:0045739; GO:0045880; GO:0045893; GO:0045995; GO:0048853; GO:0051726; GO:0060382; GO:0070628; GO:1904507,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; protein deubiquitination [GO:0016579]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; Ino80 complex [GO:0031011]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502],cysteine-type deubiquitinase activity [GO:0004843]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0016787; GO:0032200; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; telomere organization; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09892,FUN_042971-T1,Peve_00039041,Pocillopora_meandrina_HIv1___RNAseq.g7105.t1,three_way,58.312333333333335,FUN_042971-T1,Q9NRR4,,,,,54.2,879.0,1.8999999999999998e-283,977.6,sp|Q9NRR4|RNC_HUMAN Ribonuclease 3 OS=Homo sapiens OX=9606 GN=DROSHA PE=1 SV=2,,,,,,
OG_09893,FUN_042972-T1,Peve_00039022,Pocillopora_meandrina_HIv1___RNAseq.g7104.t1,three_way,74.01466666666667,FUN_042972-T1,A5PMR2,UBP33_DANRE,,Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33),Danio rerio (Zebrafish) (Brachydanio rerio),44.1,884.0,6.5e-205,715.7,sp|A5PMR2|UBP33_DANRE Ubiquitin carboxyl-terminal hydrolase 33 OS=Danio rerio OX=7955 GN=usp33 PE=2 SV=1,GO:0004197; GO:0004843; GO:0005813; GO:0006508; GO:0006897; GO:0007399; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108,axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],centrosome [GO:0005813]; perinuclear region of cytoplasm [GO:0048471],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0016192; GO:0016787; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; microtubule organizing center; vesicle-mediated transport; hydrolase activity; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_09894,FUN_042988-T1,Peve_00036062,Pocillopora_meandrina_HIv1___RNAseq.g7093.t1,three_way,53.70933333333333,,,,,,,,,,,,,,,,,
OG_09895,FUN_042989-T1,Peve_00031072,Pocillopora_meandrina_HIv1___RNAseq.g7089.t1,three_way,80.24966666666667,FUN_042989-T1,Q8BS35,,,,,54.4,397.0,1.2e-125,451.4,sp|Q8BS35|ALKMO_MOUSE Alkylglycerol monooxygenase OS=Mus musculus OX=10090 GN=Agmo PE=1 SV=1,,,,,,
OG_09896,FUN_042991-T1,Peve_00031067,Pocillopora_meandrina_HIv1___RNAseq.g7016.t1,three_way,70.472,FUN_042991-T1,Q28BT4,,,,,38.4,307.0,9.8e-50,198.7,sp|Q28BT4|CALU_XENTR Calumenin OS=Xenopus tropicalis OX=8364 GN=calu PE=2 SV=1,,,,,,
OG_09897,FUN_042992-T1,Peve_00031062,Pocillopora_meandrina_HIv1___TS.g753.t1,three_way,81.38566666666667,FUN_042992-T1,Q7SXV9,,,,,42.9,289.0,1.3e-49,198.4,sp|Q7SXV9|CALUB_DANRE Calumenin-B OS=Danio rerio OX=7955 GN=calub PE=2 SV=1,,,,,,
OG_09898,FUN_042993-T1,Peve_00031061,Pocillopora_meandrina_HIv1___RNAseq.g7018.t1,three_way,67.28066666666666,,,,,,,,,,,,,,,,,
OG_09899,FUN_042994-T1,Peve_00031060,Pocillopora_meandrina_HIv1___RNAseq.g7019.t1,three_way,70.261,,,,,,,,,,,,,,,,,
OG_09900,FUN_042996-T1,Peve_00012463,Pocillopora_meandrina_HIv1___RNAseq.g7020.t1,three_way,61.57683333333333,,,,,,,,,,,,,,,,,
OG_09901,FUN_042997-T1,Peve_00015175,Pocillopora_meandrina_HIv1___RNAseq.g7021.t1,three_way,84.85766666666666,FUN_042997-T1,Q148F0,,,,,69.1,97.0,3e-37,155.6,sp|Q148F0|URM1_BOVIN Ubiquitin-related modifier 1 OS=Bos taurus OX=9913 GN=URM1 PE=3 SV=1,,,,,,
OG_09902,FUN_042998-T1,Peve_00015176,Pocillopora_meandrina_HIv1___RNAseq.g7022.t1,three_way,83.66866666666667,FUN_042998-T1,Q6ZWV7,RL35_MOUSE,,Large ribosomal subunit protein uL29 (60S ribosomal protein L35),Mus musculus (Mouse),78.7,122.0,6.5e-42,171.4,sp|Q6ZWV7|RL35_MOUSE Large ribosomal subunit protein uL29 OS=Mus musculus OX=10090 GN=Rpl35 PE=1 SV=1,GO:0000463; GO:0002181; GO:0003735; GO:0005737; GO:0005829; GO:0005840; GO:0022625; GO:0045202; GO:0098793; GO:0098794; GO:0140236; GO:0140242,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; translation at postsynapse [GO:0140242]; translation at presynapse [GO:0140236]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ribosome [GO:0005840]; synapse [GO:0045202],structural constituent of ribosome [GO:0003735],GO:0002181; GO:0005198; GO:0005829; GO:0005840; GO:0043226,cytoplasmic translation; structural molecule activity; cytosol; ribosome; organelle
OG_09903,FUN_042999-T1,Peve_00017784,Pocillopora_meandrina_HIv1___RNAseq.g7023.t1,three_way,56.351,,,,,,,,,,,,,,,,,
OG_09904,FUN_043000-T1,Peve_00017783,Pocillopora_meandrina_HIv1___RNAseq.g7024.t1,three_way,81.55316666666667,FUN_043000-T1,Q5BJQ7,,,,,42.2,320.0,9.4e-64,245.4,sp|Q5BJQ7|TADA1_RAT Transcriptional adapter 1 OS=Rattus norvegicus OX=10116 GN=Tada1 PE=2 SV=2,,,,,,
OG_09905,FUN_043002-T1,Peve_00017780,Pocillopora_meandrina_HIv1___RNAseq.g7026.t1,three_way,77.39216666666667,FUN_043002-T1,P46209,,,,,33.0,179.0,6.8e-14,79.3,sp|P46209|USF_AQUPY Protein usf OS=Aquifex pyrophilus OX=2714 GN=usf PE=4 SV=1,,,,,,
OG_09906,FUN_043003-T1,Peve_00017777,Pocillopora_meandrina_HIv1___RNAseq.g7027.t1,three_way,86.71766666666667,FUN_043003-T1,Q66L49,SCMC1_DANRE,,Mitochondrial adenyl nucleotide antiporter SLC25A24 (Small calcium-binding mitochondrial carrier protein 1) (SCaMC-1) (Solute carrier family 25 member 24),Danio rerio (Zebrafish) (Brachydanio rerio),54.6,467.0,1e-146,521.5,sp|Q66L49|SCMC1_DANRE Mitochondrial adenyl nucleotide antiporter SLC25A24 OS=Danio rerio OX=7955 GN=slc25a24 PE=2 SV=1,GO:0000295; GO:0005347; GO:0005509; GO:0005739; GO:0005743; GO:0015866; GO:0015867; GO:0016020; GO:0051503; GO:0071277; GO:0140987; GO:0140988; GO:1990544,adenine nucleotide transport [GO:0051503]; ADP transport [GO:0015866]; ATP transport [GO:0015867]; cellular response to calcium ion [GO:0071277]; mitochondrial ATP transmembrane transport [GO:1990544],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],adenine nucleotide transmembrane transporter activity [GO:0000295]; ADP:phosphate antiporter activity [GO:0140988]; ATP transmembrane transporter activity [GO:0005347]; ATP:phosphate antiporter activity [GO:0140987]; calcium ion binding [GO:0005509],GO:0005215; GO:0005739; GO:0043226; GO:0055085,transporter activity; mitochondrion; organelle; transmembrane transport
OG_09907,FUN_043004-T1,Peve_00017776,Pocillopora_meandrina_HIv1___RNAseq.g7028.t1,three_way,85.60833333333333,FUN_043004-T1,Q64380,SARDH_RAT,,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3)",Rattus norvegicus (Rat),66.3,750.0,0.0,1121.7,"sp|Q64380|SARDH_RAT Sarcosine dehydrogenase, mitochondrial OS=Rattus norvegicus OX=10116 GN=Sardh PE=1 SV=2",GO:0005542; GO:0005737; GO:0005739; GO:0005759; GO:0006545; GO:0008480; GO:0016491; GO:0035999; GO:0042426; GO:0050660; GO:1901053,choline catabolic process [GO:0042426]; glycine biosynthetic process [GO:0006545]; sarcosine catabolic process [GO:1901053]; tetrahydrofolate interconversion [GO:0035999],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],flavin adenine dinucleotide binding [GO:0050660]; folic acid binding [GO:0005542]; oxidoreductase activity [GO:0016491]; sarcosine dehydrogenase activity [GO:0008480],GO:0003824; GO:0005739; GO:0006520; GO:0006575; GO:0016491; GO:0043226,catalytic activity; mitochondrion; amino acid metabolic process; modified amino acid metabolic process; oxidoreductase activity; organelle
OG_09908,FUN_043005-T1,Peve_00017775,Pocillopora_meandrina_HIv1___RNAseq.g7029.t1,three_way,70.90416666666667,FUN_043005-T1,Q90416,RXRGA_DANRE,,Retinoic acid receptor RXR-gamma-A (Nuclear receptor subfamily 2 group B member 3-A) (Retinoic acid receptor RXR-alpha) (Retinoid X receptor alpha) (Retinoid X receptor gamma-A),Danio rerio (Zebrafish) (Brachydanio rerio),36.4,365.0,1.2e-61,239.2,sp|Q90416|RXRGA_DANRE Retinoic acid receptor RXR-gamma-A OS=Danio rerio OX=7955 GN=rxrga PE=2 SV=2,GO:0003700; GO:0003707; GO:0004879; GO:0007399; GO:0008270; GO:0030154; GO:0044323; GO:0045893; GO:0045944; GO:0048384; GO:0090575,cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; retinoic acid receptor signaling pathway [GO:0048384],RNA polymerase II transcription regulator complex [GO:0090575],DNA-binding transcription factor activity [GO:0003700]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; zinc ion binding [GO:0008270],GO:0003677; GO:0006355; GO:0030154; GO:0048856; GO:0060089; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_09909,FUN_043007-T1,Peve_00017772,Pocillopora_meandrina_HIv1___RNAseq.4691_t,three_way,55.84033333333333,FUN_043007-T1,A3BF39,HMA2_ORYSJ,,Cadmium/zinc-transporting ATPase HMA2 (EC 7.2.2.12) (EC 7.2.2.21) (Protein HEAVY METAL ATPASE 2) (OsHMA2),Oryza sativa subsp. japonica (Rice),39.4,746.0,3.1e-123,444.9,sp|A3BF39|HMA2_ORYSJ Cadmium/zinc-transporting ATPase HMA2 OS=Oryza sativa subsp. japonica OX=39947 GN=HMA2 PE=1 SV=1,GO:0005524; GO:0005886; GO:0008551; GO:0016020; GO:0016463; GO:0016887; GO:0022857; GO:0046872; GO:0055085,transmembrane transport [GO:0055085],membrane [GO:0016020]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; metal ion binding [GO:0046872]; P-type cadmium transporter activity [GO:0008551]; P-type zinc transporter activity [GO:0016463]; transmembrane transporter activity [GO:0022857],GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0055085; GO:0140657,catalytic activity; transporter activity; plasma membrane; hydrolase activity; transmembrane transport; ATP-dependent activity
OG_09910,FUN_043008-T1,Peve_00017770,Pocillopora_meandrina_HIv1___RNAseq.g7032.t1,three_way,89.62533333333333,FUN_043008-T1,Q9JKK1,STX6_MOUSE,,Syntaxin-6,Mus musculus (Mouse),50.4,232.0,1.3e-55,218.0,sp|Q9JKK1|STX6_MOUSE Syntaxin-6 OS=Mus musculus OX=10090 GN=Stx6 PE=1 SV=1,GO:0000139; GO:0005484; GO:0005654; GO:0005769; GO:0005794; GO:0005802; GO:0005829; GO:0006886; GO:0006906; GO:0007032; GO:0016020; GO:0019905; GO:0031201; GO:0032456; GO:0032588; GO:0032880; GO:0042147; GO:0045335; GO:0048193; GO:0048471; GO:0055037; GO:0055038,"endocytic recycling [GO:0032456]; endosome organization [GO:0007032]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; regulation of protein localization [GO:0032880]; retrograde transport, endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906]",cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905],GO:0005654; GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090; GO:0061024,nucleoplasm; endosome; Golgi apparatus; cytosol; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity; membrane organization
OG_09911,FUN_043009-T1,Peve_00017769,Pocillopora_meandrina_HIv1___RNAseq.g7033.t1,three_way,66.84566666666667,,,,,,,,,,,,,,,,,
OG_09912,FUN_043010-T1,Peve_00017768,Pocillopora_meandrina_HIv1___RNAseq.g7034.t1,three_way,65.28,FUN_043010-T1,Q8CGF6,WDR47_MOUSE,,WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin),Mus musculus (Mouse),31.1,1178.0,1.9e-103,379.0,sp|Q8CGF6|WDR47_MOUSE WD repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Wdr47 PE=1 SV=2,GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168,adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150],axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],protein-containing complex binding [GO:0044877],GO:0006914; GO:0007010; GO:0048856; GO:0048870,autophagy; cytoskeleton organization; anatomical structure development; cell motility
OG_09913,FUN_043011-T1,Peve_00017767,Pocillopora_meandrina_HIv1___RNAseq.g7035.t1,three_way,43.78216666666667,,,,,,,,,,,,,,,,,
OG_09914,FUN_043014-T1,Peve_00017765,Pocillopora_meandrina_HIv1___RNAseq.g7037.t1,three_way,69.486,FUN_043014-T1,Q4R3Y4,S27A4_MACFA,,Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4) (EC 6.2.1.-),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),48.2,627.0,1.8e-170,600.9,sp|Q4R3Y4|S27A4_MACFA Long-chain fatty acid transport protein 4 OS=Macaca fascicularis OX=9541 GN=SLC27A4 PE=2 SV=2,GO:0000166; GO:0001579; GO:0005324; GO:0005789; GO:0005886; GO:0031957; GO:0044539; GO:0047676; GO:0090434,long-chain fatty acid import into cell [GO:0044539]; medium-chain fatty acid transport [GO:0001579],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; nucleotide binding [GO:0000166]; oleoyl-CoA ligase activity [GO:0090434]; very long-chain fatty acid-CoA ligase activity [GO:0031957],GO:0003824; GO:0005215; GO:0005886; GO:0016874; GO:0140657,catalytic activity; transporter activity; plasma membrane; ligase activity; ATP-dependent activity
OG_09915,FUN_043019-T1,Peve_00017760,Pocillopora_meandrina_HIv1___RNAseq.g7041.t1,three_way,78.64333333333333,FUN_043019-T1,P11645,,,,,47.6,286.0,3.4000000000000003e-81,303.1,sp|P11645|URIC_RABIT Uricase OS=Oryctolagus cuniculus OX=9986 GN=UOX PE=2 SV=1,,,,,,
OG_09916,FUN_043025-T1,Peve_00041863,Pocillopora_meandrina_HIv1___TS.g23978.t1,three_way,79.40066666666667,,,,,,,,,,,,,,,,,
OG_09917,FUN_043027-T1,Peve_00026962,Pocillopora_meandrina_HIv1___TS.g790.t1,three_way,57.98016666666667,FUN_043027-T1,Q8AYG3,TTK_DANRE,,Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap),Danio rerio (Zebrafish) (Brachydanio rerio),30.7,960.0,1.6999999999999998e-92,342.4,sp|Q8AYG3|TTK_DANRE Dual specificity protein kinase Ttk OS=Danio rerio OX=7955 GN=ttk PE=1 SV=2,GO:0000776; GO:0001100; GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0007059; GO:0007060; GO:0007094; GO:0016321; GO:0031101; GO:0033316; GO:0034501; GO:0042246; GO:0046872; GO:0051301; GO:0060249; GO:0106310,anatomical structure homeostasis [GO:0060249]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; female meiosis chromosome segregation [GO:0016321]; fin regeneration [GO:0031101]; male meiosis chromosome segregation [GO:0007060]; meiotic spindle assembly checkpoint signaling [GO:0033316]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of exit from mitosis [GO:0001100]; protein localization to kinetochore [GO:0034501]; tissue regeneration [GO:0042246],kinetochore [GO:0000776]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0007059; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; chromosome segregation; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09918,FUN_043029-T2,Peve_00026963,Pocillopora_meandrina_HIv1___RNAseq.g7057.t1,three_way,56.766666666666666,FUN_043029-T2,Q9W6G7,,,,,27.6,428.0,3.2e-37,157.5,"sp|Q9W6G7|DPOG2_XENLA DNA polymerase subunit gamma-2, mitochondrial OS=Xenopus laevis OX=8355 GN=polg2 PE=1 SV=1",,,,,,
OG_09919,FUN_043030-T1,Peve_00026964,Pocillopora_meandrina_HIv1___RNAseq.g7058.t1,three_way,69.98333333333333,FUN_043030-T1,Q0P5A6,,,,,35.4,491.0,1.2e-81,305.4,sp|Q0P5A6|PSMD5_BOVIN 26S proteasome non-ATPase regulatory subunit 5 OS=Bos taurus OX=9913 GN=PSMD5 PE=2 SV=1,,,,,,
OG_09920,FUN_043031-T1,Peve_00026965,Pocillopora_meandrina_HIv1___TS.g793.t1,three_way,52.451,FUN_043031-T1,Q9FN03,,,,,28.7,334.0,5.500000000000001e-28,129.0,sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1,,,,,,
OG_09921,FUN_043033-T1,Peve_00026967,Pocillopora_meandrina_HIv1___TS.g794.t2,three_way,75.653,FUN_043033-T1,Q9P1Z9,,,,,29.7,851.0,7.199999999999999e-95,350.9,sp|Q9P1Z9|CC180_HUMAN Coiled-coil domain-containing protein 180 OS=Homo sapiens OX=9606 GN=CCDC180 PE=1 SV=3,,,,,,
OG_09922,FUN_043034-T1,Peve_00026968,Pocillopora_meandrina_HIv1___RNAseq.g7061.t1,three_way,59.995666666666665,,,,,,,,,,,,,,,,,
OG_09923,FUN_043035-T1,Peve_00026975,Pocillopora_meandrina_HIv1___RNAseq.g7043.t1,three_way,57.261,FUN_043035-T1,Q9UBN4,,,,,29.3,744.0,3.7999999999999996e-68,261.2,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_09924,FUN_043037-T1,Peve_00026463,Pocillopora_meandrina_HIv1___TS.g811.t1,three_way,81.205,FUN_043037-T1,Q3ZBX1,,,,,53.2,280.0,6.7e-72,272.3,sp|Q3ZBX1|PIGC_BOVIN Phosphatidylinositol N-acetylglucosaminyltransferase subunit C OS=Bos taurus OX=9913 GN=PIGC PE=2 SV=1,,,,,,
OG_09925,FUN_043038-T1,Peve_00026462,Pocillopora_meandrina_HIv1___RNAseq.g7077.t1,three_way,42.869166666666665,,,,,,,,,,,,,,,,,
OG_09926,FUN_043040-T1,Peve_00026460,Pocillopora_meandrina_HIv1___RNAseq.g7078.t1,three_way,76.39316666666667,FUN_043040-T1,Q5T8I3,,,,,43.2,359.0,2.5e-57,224.2,sp|Q5T8I3|EEIG2_HUMAN EEIG family member 2 OS=Homo sapiens OX=9606 GN=EEIG2 PE=1 SV=2,,,,,,
OG_09927,FUN_043082-T1,Peve_00026459,Pocillopora_meandrina_HIv1___TS.g814.t1,three_way,74.149,FUN_043082-T1,P0DX22,,,,,37.1,280.0,7.699999999999999e-49,195.7,"sp|P0DX22|FCNLN_PSEA6 L-fucono-1,5-lactonase OS=Pseudoalteromonas atlantica (strain T6c / ATCC BAA-1087) OX=3042615 GN=Patl_0798 PE=1 SV=1",,,,,,
OG_09928,FUN_043084-T1,Peve_00026456,Pocillopora_meandrina_HIv1___RNAseq.g7081.t1,three_way,62.529833333333336,FUN_043084-T1,Q9UBN4,,,,,30.1,742.0,4.2e-83,310.8,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_09929,FUN_043085-T1,Peve_00026453,Pocillopora_meandrina_HIv1___RNAseq.g7084.t1,three_way,60.2325,FUN_043085-T1,Q9UL62,TRPC5_HUMAN,,Short transient receptor potential channel 5 (TrpC5) (Transient receptor protein 5) (TRP-5) (hTRP-5) (hTRP5),Homo sapiens (Human),30.3,785.0,1.7000000000000002e-74,282.3,sp|Q9UL62|TRPC5_HUMAN Short transient receptor potential channel 5 OS=Homo sapiens OX=9606 GN=TRPC5 PE=1 SV=1,GO:0003779; GO:0005262; GO:0005886; GO:0006816; GO:0007204; GO:0007399; GO:0008284; GO:0015279; GO:0030182; GO:0030276; GO:0030425; GO:0030426; GO:0034703; GO:0034704; GO:0042805; GO:0043025; GO:0045666; GO:0045773; GO:0050774; GO:0051117; GO:0051402; GO:0051480; GO:0070588; GO:0070679; GO:0070782; GO:0098793; GO:1902630,calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; negative regulation of dendrite morphogenesis [GO:0050774]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; phosphatidylserine exposure on apoptotic cell surface [GO:0070782]; positive regulation of axon extension [GO:0045773]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of neuron differentiation [GO:0045666]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of membrane hyperpolarization [GO:1902630],calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; dendrite [GO:0030425]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793],"actin binding [GO:0003779]; actinin binding [GO:0042805]; ATPase binding [GO:0051117]; calcium channel activity [GO:0005262]; clathrin binding [GO:0030276]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0005215; GO:0005886; GO:0008092; GO:0012501; GO:0030154; GO:0048856; GO:0055085; GO:0061024,transporter activity; plasma membrane; cytoskeletal protein binding; programmed cell death; cell differentiation; anatomical structure development; transmembrane transport; membrane organization
OG_09930,FUN_043086-T1,Peve_00001644,Pocillopora_meandrina_HIv1___TS.g825.t1,three_way,66.956,FUN_043086-T1,Q501I9,,,,,35.5,445.0,2.3000000000000002e-74,281.2,sp|Q501I9|DIRC2_XENTR Solute carrier family 49 member 4 homolog OS=Xenopus tropicalis OX=8364 GN=slc49a4 PE=2 SV=1,,,,,,
OG_09931,FUN_043087-T1,Peve_00001643,Pocillopora_meandrina_HIv1___RNAseq.g7088.t2,three_way,65.04733333333333,FUN_043087-T1,Q8N9H8,,,,,31.9,793.0,2e-93,345.5,sp|Q8N9H8|MUT7_HUMAN Exonuclease mut-7 homolog OS=Homo sapiens OX=9606 GN=EXD3 PE=1 SV=3,,,,,,
OG_09932,FUN_043089-T1,Peve_00001654,Pocillopora_meandrina_HIv1___RNAseq.g7087.t1,three_way,89.93299999999999,FUN_043089-T1,Q9NX01,TXN4B_HUMAN,,Thioredoxin-like protein 4B (Dim1-like protein),Homo sapiens (Human),75.2,149.0,5.8e-61,235.0,sp|Q9NX01|TXN4B_HUMAN Thioredoxin-like protein 4B OS=Homo sapiens OX=9606 GN=TXNL4B PE=1 SV=1,GO:0000398; GO:0005654; GO:0005681; GO:0005682; GO:0005829; GO:0046540,"mRNA splicing, via spliceosome [GO:0000398]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],,GO:0005654; GO:0005829; GO:0016071,nucleoplasm; cytosol; mRNA metabolic process
OG_09933,FUN_043091-T1,Peve_00001653,Pocillopora_meandrina_HIv1___RNAseq.g6995.t1,three_way,75.982,FUN_043091-T1,O95870,ABHGA_HUMAN,,Phosphatidylserine lipase ABHD16A (EC 3.1.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5) (hBAT5) (Monoacylglycerol lipase ABHD16A) (EC 3.1.1.23) (Protein G5),Homo sapiens (Human),43.3,563.0,5.9e-132,472.6,sp|O95870|ABHGA_HUMAN Phosphatidylserine lipase ABHD16A OS=Homo sapiens OX=9606 GN=ABHD16A PE=1 SV=3,GO:0004620; GO:0006660; GO:0016020; GO:0047372; GO:0052651; GO:1905344,monoacylglycerol catabolic process [GO:0052651]; phosphatidylserine catabolic process [GO:0006660]; prostaglandin catabolic process [GO:1905344],membrane [GO:0016020],monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620],GO:0003824; GO:0006575; GO:0006629; GO:0016787,catalytic activity; modified amino acid metabolic process; lipid metabolic process; hydrolase activity
OG_09934,FUN_043092-T2,Peve_00038925,Pocillopora_meandrina_HIv1___RNAseq.g6998.t1,three_way,64.206,FUN_043092-T2,P55268,LAMB2_HUMAN,,Laminin subunit beta-2 (Laminin B1s chain) (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta) (S-LAM beta),Homo sapiens (Human),29.3,844.0,9.599999999999999e-61,238.0,sp|P55268|LAMB2_HUMAN Laminin subunit beta-2 OS=Homo sapiens OX=9606 GN=LAMB2 PE=1 SV=2,GO:0005178; GO:0005198; GO:0005201; GO:0005576; GO:0005604; GO:0005608; GO:0005788; GO:0007155; GO:0007411; GO:0007528; GO:0007601; GO:0014002; GO:0014044; GO:0031594; GO:0043083; GO:0043260; GO:0045785; GO:0048677; GO:0051149; GO:0060041; GO:0062023; GO:0070062; GO:0072249; GO:0072274; GO:0098637; GO:0110011; GO:0150043; GO:2001046,astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; metanephric glomerular basement membrane development [GO:0072274]; metanephric podocyte development [GO:0072249]; neuromuscular junction development [GO:0007528]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of basement membrane organization [GO:0110011]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; visual perception [GO:0007601],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083],extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural constituent of synapse-associated extracellular matrix [GO:0150043]; structural molecule activity [GO:0005198],GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0034330; GO:0043226; GO:0048856; GO:0050877,structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cell junction organization; organelle; anatomical structure development; nervous system process
OG_09935,FUN_043094-T1,Peve_00038927,Pocillopora_meandrina_HIv1___RNAseq.g7010.t1,three_way,77.438,FUN_043094-T1,Q7XP59,,,,,24.4,475.0,3.8e-18,95.9,sp|Q7XP59|GLR31_ORYSJ Glutamate receptor 3.1 OS=Oryza sativa subsp. japonica OX=39947 GN=GLR3.1 PE=1 SV=1,,,,,,
OG_09936,FUN_043096-T1,Peve_00033763,Pocillopora_meandrina_HIv1___RNAseq.g7008.t1,three_way,52.39533333333333,,,,,,,,,,,,,,,,,
OG_09937,FUN_043097-T2,Peve_00033762,Pocillopora_meandrina_HIv1___RNAseq.g7007.t1,three_way,79.86333333333333,FUN_043097-T2,Q6DD44,XPR1_XENLA,,Xenotropic and polytropic retrovirus receptor 1 homolog,Xenopus laevis (African clawed frog),51.0,700.0,4.5e-193,676.0,sp|Q6DD44|XPR1_XENLA Xenotropic and polytropic retrovirus receptor 1 homolog OS=Xenopus laevis OX=8355 GN=xpr1 PE=2 SV=1,GO:0000822; GO:0005315; GO:0005794; GO:0005886; GO:0006817; GO:0015562; GO:0016036; GO:0030643; GO:0035435,cellular response to phosphate starvation [GO:0016036]; intracellular phosphate ion homeostasis [GO:0030643]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817],Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],efflux transmembrane transporter activity [GO:0015562]; inositol hexakisphosphate binding [GO:0000822]; phosphate transmembrane transporter activity [GO:0005315],GO:0005215; GO:0005794; GO:0005886; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; plasma membrane; organelle; transmembrane transport
OG_09938,FUN_043098-T1,Peve_00033761,Pocillopora_meandrina_HIv1___RNAseq.g7006.t1,three_way,61.962,FUN_043098-T1,Q08BM0,,,,,41.0,266.0,4.4e-45,184.1,sp|Q08BM0|TM10B_DANRE tRNA methyltransferase 10 homolog B OS=Danio rerio OX=7955 GN=trmt10b PE=2 SV=1,,,,,,
OG_09939,FUN_043099-T1,Peve_00026300,Pocillopora_meandrina_HIv1___RNAseq.g7004.t1,three_way,80.35766666666666,FUN_043099-T1,Q92540,SMG7_HUMAN,,Nonsense-mediated mRNA decay factor SMG7 (SMG-7 homolog) (hSMG-7),Homo sapiens (Human),43.2,475.0,1.8e-94,348.6,sp|Q92540|SMG7_HUMAN Nonsense-mediated mRNA decay factor SMG7 OS=Homo sapiens OX=9606 GN=SMG7 PE=1 SV=2,GO:0000184; GO:0005634; GO:0005697; GO:0005737; GO:0005829; GO:0006406; GO:0035303; GO:0042162; GO:0051721; GO:0070034,"mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697],protein phosphatase 2A binding [GO:0051721]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0006913; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; cytosol; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_09940,FUN_043101-T1,Peve_00026301,Pocillopora_meandrina_HIv1___TS.g740.t1,three_way,67.05266666666667,FUN_043101-T1,Q8R4K8,PAPP1_MOUSE,,Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A),Mus musculus (Mouse),39.8,1552.0,3.3e-308,1059.7,sp|Q8R4K8|PAPP1_MOUSE Pappalysin-1 OS=Mus musculus OX=10090 GN=Pappa PE=2 SV=2,GO:0004175; GO:0005615; GO:0006508; GO:0008237; GO:0046872,proteolysis [GO:0006508],extracellular space [GO:0005615],endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005615; GO:0016787; GO:0140096,"catalytic activity; extracellular space; hydrolase activity; catalytic activity, acting on a protein"
OG_09941,FUN_043104-T1,Peve_00026302,Pocillopora_meandrina_HIv1___RNAseq.g7898.t1,three_way,87.68966666666667,FUN_043104-T1,P53611,PGTB2_HUMAN,,Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta),Homo sapiens (Human),72.1,330.0,9.2e-51,202.2,sp|P53611|PGTB2_HUMAN Geranylgeranyl transferase type-2 subunit beta OS=Homo sapiens OX=9606 GN=RABGGTB PE=1 SV=2,GO:0004663; GO:0005829; GO:0005886; GO:0005968; GO:0006888; GO:0007601; GO:0008270; GO:0018344; GO:0031267; GO:0036211,endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein geranylgeranylation [GO:0018344]; protein modification process [GO:0036211]; visual perception [GO:0007601],cytosol [GO:0005829]; plasma membrane [GO:0005886]; Rab-protein geranylgeranyltransferase complex [GO:0005968],Rab geranylgeranyltransferase activity [GO:0004663]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016192; GO:0016740; GO:0050877; GO:0140096,"catalytic activity; cytosol; plasma membrane; vesicle-mediated transport; transferase activity; nervous system process; catalytic activity, acting on a protein"
OG_09942,FUN_043106-T1,Peve_00014958,Pocillopora_meandrina_HIv1___RNAseq.g7005.t1,three_way,83.65,FUN_043106-T1,Q17GZ9,,,,,39.5,731.0,1.6e-124,448.4,sp|Q17GZ9|ARP5_AEDAE Actin-related protein 5 OS=Aedes aegypti OX=7159 GN=Arp5 PE=3 SV=1,,,,,,
OG_09943,FUN_043110-T1,Peve_00019983,Pocillopora_meandrina_HIv1___TS.g2567.t1,three_way,57.29733333333333,FUN_043110-T1,O73853,,,,,34.5,496.0,2.1e-86,321.2,"sp|O73853|CP17A_ICTPU Steroid 17-alpha-hydroxylase/17,20 lyase OS=Ictalurus punctatus OX=7998 GN=cyp17a1 PE=2 SV=1",,,,,,
OG_09944,FUN_043111-T1,Peve_00014954,Pocillopora_meandrina_HIv1___RNAseq.g7894.t1,three_way,96.616,FUN_043111-T1,Q8JGS9,,,,,89.1,101.0,5.5e-47,188.0,sp|Q8JGS9|RS18_DANRE Small ribosomal subunit protein uS13 OS=Danio rerio OX=7955 GN=rps18 PE=1 SV=1,,,,,,
OG_09945,FUN_043112-T1,Peve_00027467,Pocillopora_meandrina_HIv1___RNAseq.g7893.t1,three_way,72.89099999999999,FUN_043112-T1,Q9P4X3,,,,,50.9,450.0,2e-135,484.2,sp|Q9P4X3|UTP7_SCHPO Probable U3 small nucleolar RNA-associated protein 7 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=utp7 PE=3 SV=1,,,,,,
OG_09946,FUN_043113-T1,Peve_00031007,Pocillopora_meandrina_HIv1___RNAseq.g7892.t1,three_way,82.40066666666667,FUN_043113-T1,Q99961,SH3G1_HUMAN,,Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1),Homo sapiens (Human),41.6,368.0,3.1e-65,250.4,sp|Q99961|SH3G1_HUMAN Endophilin-A2 OS=Homo sapiens OX=9606 GN=SH3GL1 PE=1 SV=1,GO:0002102; GO:0005737; GO:0005829; GO:0006897; GO:0007165; GO:0007417; GO:0008289; GO:0031901; GO:0042802; GO:0042995; GO:0045296; GO:0070161; GO:0098793; GO:0098978,central nervous system development [GO:0007417]; endocytosis [GO:0006897]; signal transduction [GO:0007165],anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793],cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],GO:0005829; GO:0008289; GO:0016192; GO:0043226; GO:0048856,cytosol; lipid binding; vesicle-mediated transport; organelle; anatomical structure development
OG_09947,FUN_043114-T1,Peve_00026299,Pocillopora_meandrina_HIv1___RNAseq.g7891.t2,three_way,80.283,,,,,,,,,,,,,,,,,
OG_09948,FUN_043115-T2,Peve_00026298,Pocillopora_meandrina_HIv1___RNAseq.g7890.t1,three_way,78.194,FUN_043115-T2,Q9NQH7,XPP3_HUMAN,,Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3),Homo sapiens (Human),46.0,461.0,1.6e-124,448.0,sp|Q9NQH7|XPP3_HUMAN Xaa-Pro aminopeptidase 3 OS=Homo sapiens OX=9606 GN=XPNPEP3 PE=1 SV=1,GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006,glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003014; GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"renal system process; catalytic activity; mitochondrion; cytosol; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_09949,FUN_043116-T1,Peve_00026297,Pocillopora_meandrina_HIv1___RNAseq.g7889.t1,three_way,69.772,FUN_043116-T1,O77633,,,,,35.3,744.0,1.4e-117,425.2,sp|O77633|ADA10_PIG Disintegrin and metalloproteinase domain-containing protein 10 OS=Sus scrofa OX=9823 GN=ADAM10 PE=2 SV=2,,,,,,
OG_09950,FUN_043117-T1,Peve_00026296,Pocillopora_meandrina_HIv1___RNAseq.g7888.t1,three_way,60.290333333333336,,,,,,,,,,,,,,,,,
OG_09951,FUN_043118-T1,Peve_00026295,Pocillopora_meandrina_HIv1___RNAseq.g7887.t1,three_way,78.261,FUN_043118-T1,P08081,CLCA_RAT,,Clathrin light chain A (Lca),Rattus norvegicus (Rat),34.8,221.0,5.9e-23,109.0,sp|P08081|CLCA_RAT Clathrin light chain A OS=Rattus norvegicus OX=10116 GN=Clta PE=1 SV=1,GO:0005198; GO:0005764; GO:0005768; GO:0005819; GO:0005886; GO:0005905; GO:0006886; GO:0006897; GO:0030118; GO:0030125; GO:0030130; GO:0030132; GO:0030136; GO:0030669; GO:0030672; GO:0031410; GO:0032050; GO:0042277; GO:0044877; GO:0048268; GO:0048488; GO:0051020; GO:0051301; GO:0071439; GO:0072583; GO:0098835; GO:0098843; GO:0098978,cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; synaptic vesicle endocytosis [GO:0048488],clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672],clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198],GO:0005198; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0065003,structural molecule activity; lysosome; endosome; vacuole; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_09952,FUN_043119-T1,Peve_00025023,Pocillopora_meandrina_HIv1___RNAseq.g7886.t1,three_way,82.92333333333333,FUN_043119-T1,Q3ZBN8,,,,,62.8,113.0,6e-34,144.8,sp|Q3ZBN8|TIM14_BOVIN Mitochondrial import inner membrane translocase subunit TIM14 OS=Bos taurus OX=9913 GN=DNAJC19 PE=3 SV=3,,,,,,
OG_09953,FUN_043123-T1,Peve_00026287,Pocillopora_meandrina_HIv1___RNAseq.g7879.t1,three_way,62.23166666666667,FUN_043123-T1,P11616,,,,,22.5,293.0,5.5e-08,60.1,sp|P11616|AA1R_CANLF Adenosine receptor A1 OS=Canis lupus familiaris OX=9615 GN=ADORA1 PE=2 SV=1,,,,,,
OG_09954,FUN_043124-T1,Peve_00026286,Pocillopora_meandrina_HIv1___RNAseq.g7878.t1,three_way,43.88933333333333,,,,,,,,,,,,,,,,,
OG_09955,FUN_043125-T1,Peve_00033022,Pocillopora_meandrina_HIv1___RNAseq.g7877.t1,three_way,80.55266666666667,FUN_043125-T1,A4FUB8,,,,,43.9,310.0,9.4e-62,238.8,sp|A4FUB8|TM115_BOVIN Transmembrane protein 115 OS=Bos taurus OX=9913 GN=TMEM115 PE=2 SV=1,,,,,,
OG_09956,FUN_043126-T1,Peve_00013593,Pocillopora_meandrina_HIv1___TS.g1627.t1,three_way,55.45466666666667,FUN_043126-T1,Q1LZE9,,,,,32.7,275.0,1.4e-27,125.2,sp|Q1LZE9|PRS23_BOVIN Serine protease 23 OS=Bos taurus OX=9913 GN=PRSS23 PE=2 SV=1,,,,,,
OG_09957,FUN_043127-T1,Peve_00013592,Pocillopora_meandrina_HIv1___RNAseq.g7874.t2,three_way,84.74233333333333,FUN_043127-T1,P61763,,,,,60.6,589.0,3.7e-196,686.0,sp|P61763|STXB1_BOVIN Syntaxin-binding protein 1 OS=Bos taurus OX=9913 GN=STXBP1 PE=1 SV=1,,,,,,
OG_09958,FUN_043129-T1,Peve_00021467,Pocillopora_meandrina_HIv1___RNAseq.g6873.t1,three_way,80.0845,FUN_043129-T1,Q9V6Y3,,,,,52.3,107.0,2.8e-25,116.3,sp|Q9V6Y3|RT16_DROME Small ribosomal subunit protein bS16m OS=Drosophila melanogaster OX=7227 GN=mRpS16 PE=2 SV=1,,,,,,
OG_09959,FUN_043130-T1,Peve_00013596,Pocillopora_meandrina_HIv1___TS.g613.t1,three_way,62.32033333333334,FUN_043130-T1,Q9JI70,MKKS_MOUSE,,Molecular chaperone MKKS (McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin) (Protein Bbs6 homolog),Mus musculus (Mouse),30.4,586.0,6.2e-74,280.0,sp|Q9JI70|MKKS_MOUSE Molecular chaperone MKKS OS=Mus musculus OX=10090 GN=Mkks PE=2 SV=2,GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006457; GO:0007286; GO:0007608; GO:0010467; GO:0010629; GO:0014824; GO:0021756; GO:0021766; GO:0021987; GO:0030837; GO:0031514; GO:0033210; GO:0035176; GO:0036064; GO:0038108; GO:0040018; GO:0042311; GO:0044321; GO:0045444; GO:0045494; GO:0045776; GO:0048854; GO:0050910; GO:0051082; GO:0051131; GO:0051216; GO:0051492; GO:0060271; GO:0060296; GO:0060324; GO:0061629; GO:1902140; GO:1902636; GO:1905515,artery smooth muscle contraction [GO:0014824]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cerebral cortex development [GO:0021987]; chaperone-mediated protein complex assembly [GO:0051131]; cilium assembly [GO:0060271]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; hippocampus development [GO:0021766]; leptin-mediated signaling pathway [GO:0033210]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of blood pressure [GO:0045776]; negative regulation of gene expression [GO:0010629]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; positive regulation of multicellular organism growth [GO:0040018]; protein folding [GO:0006457]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of stress fiber assembly [GO:0051492]; response to inositol [GO:1902140]; response to leptin [GO:0044321]; sensory perception of smell [GO:0007608]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; vasodilation [GO:0042311],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; motile cilium [GO:0031514]; nucleus [GO:0005634],ATP binding [GO:0005524]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; unfolded protein binding [GO:0051082],GO:0003012; GO:0003013; GO:0005634; GO:0005815; GO:0005829; GO:0005929; GO:0006457; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0050877; GO:0065003,muscle system process; circulatory system process; nucleus; microtubule organizing center; cytosol; cilium; protein folding; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development; nervous system process; protein-containing complex assembly
OG_09960,FUN_043131-T1,Peve_00021463,Pocillopora_meandrina_HIv1___RNAseq.g6875.t1,three_way,87.29066666666667,FUN_043131-T1,Q9D0W5,PPIL1_MOUSE,,Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1),Mus musculus (Mouse),74.8,151.0,4.2e-65,248.8,sp|Q9D0W5|PPIL1_MOUSE Peptidyl-prolyl cis-trans isomerase-like 1 OS=Mus musculus OX=10090 GN=Ppil1 PE=1 SV=1,GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0006457; GO:0071007; GO:0097718; GO:1990403,"embryonic brain development [GO:1990403]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]",nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007],disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0005634; GO:0006457; GO:0016071; GO:0016853; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; protein folding; mRNA metabolic process; isomerase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09961,FUN_043135-T1,Peve_00034953,Pocillopora_meandrina_HIv1___RNAseq.g6877.t1,three_way,79.015,FUN_043135-T1,Q8N3C7,CLIP4_HUMAN,,CAP-Gly domain-containing linker protein 4 (Restin-like protein 2),Homo sapiens (Human),36.4,715.0,3.6e-115,417.2,sp|Q8N3C7|CLIP4_HUMAN CAP-Gly domain-containing linker protein 4 OS=Homo sapiens OX=9606 GN=CLIP4 PE=1 SV=1,GO:0005634; GO:0005938; GO:0031122; GO:0035371; GO:0043231; GO:0051010,cytoplasmic microtubule organization [GO:0031122],cell cortex [GO:0005938]; intracellular membrane-bounded organelle [GO:0043231]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634],microtubule plus-end binding [GO:0051010],GO:0005634; GO:0007010; GO:0008092; GO:0043226,nucleus; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_09962,FUN_043143-T1,Peve_00034956,Pocillopora_meandrina_HIv1___RNAseq.g6885.t1,three_way,65.38133333333333,FUN_043143-T1,O89110,CASP8_MOUSE,,Caspase-8 (CASP-8) (EC 3.4.22.61) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10],Mus musculus (Mouse),26.6,533.0,8.6e-51,203.0,sp|O89110|CASP8_MOUSE Caspase-8 OS=Mus musculus OX=10090 GN=Casp8 PE=1 SV=1,GO:0001525; GO:0001817; GO:0001841; GO:0004175; GO:0004197; GO:0005634; GO:0005737; GO:0005739; GO:0005886; GO:0006915; GO:0007507; GO:0008233; GO:0008625; GO:0008656; GO:0016485; GO:0030225; GO:0030690; GO:0043065; GO:0045088; GO:0048738; GO:0051603; GO:0060546; GO:0070243; GO:0070266; GO:0070269; GO:0097190; GO:0097191; GO:0097194; GO:0097264; GO:0097284; GO:0097342; GO:1900119; GO:2001233; GO:2001238,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cardiac muscle tissue development [GO:0048738]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; heart development [GO:0007507]; hepatocyte apoptotic process [GO:0097284]; macrophage differentiation [GO:0030225]; necroptotic process [GO:0070266]; negative regulation of necroptotic process [GO:0060546]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein processing [GO:0016485]; proteolysis involved in protein catabolic process [GO:0051603]; pyroptotic inflammatory response [GO:0070269]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of cytokine production [GO:0001817]; regulation of innate immune response [GO:0045088]; regulation of thymocyte apoptotic process [GO:0070243]; self proteolysis [GO:0097264],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; Noc1p-Noc2p complex [GO:0030690]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ripoptosome [GO:0097342],cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233],GO:0003824; GO:0005634; GO:0005739; GO:0005886; GO:0006954; GO:0012501; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; nucleus; mitochondrion; plasma membrane; inflammatory response; programmed cell death; hydrolase activity; cell differentiation; organelle; anatomical structure development; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_09963,FUN_043144-T1,Peve_00034957,Pocillopora_meandrina_HIv1___RNAseq.g6886.t1,three_way,84.25150000000001,FUN_043144-T1,Q26481,,,,,73.1,279.0,2e-116,420.2,sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3,,,,,,
OG_09964,FUN_043145-T1,Peve_00044698,Pocillopora_meandrina_HIv1___RNAseq.g6860.t1,three_way,79.27533333333334,,,,,,,,,,,,,,,,,
OG_09965,FUN_043146-T1,Peve_00044697,Pocillopora_meandrina_HIv1___RNAseq.g6859.t1,three_way,68.785,FUN_043146-T1,Q9DBQ7,PACE1_MOUSE,,Protein-associating with the carboxyl-terminal domain of ezrin (Ezrin-binding protein PACE-1) (SCY1-like protein 3),Mus musculus (Mouse),38.7,493.0,3.3e-85,317.8,sp|Q9DBQ7|PACE1_MOUSE Protein-associating with the carboxyl-terminal domain of ezrin OS=Mus musculus OX=10090 GN=Scyl3 PE=1 SV=3,GO:0000139; GO:0004672; GO:0005524; GO:0005783; GO:0005794; GO:0005829; GO:0006954; GO:0008104; GO:0021522; GO:0030027; GO:0042802; GO:0048666,inflammatory response [GO:0006954]; neuron development [GO:0048666]; protein localization [GO:0008104]; spinal cord motor neuron differentiation [GO:0021522],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672],GO:0003824; GO:0005783; GO:0005794; GO:0005829; GO:0006954; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endoplasmic reticulum; Golgi apparatus; cytosol; inflammatory response; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_09966,FUN_043147-T1,Peve_00044693,Pocillopora_meandrina_HIv1___RNAseq.g6856.t1,three_way,68.74549999999999,,,,,,,,,,,,,,,,,
OG_09967,FUN_043148-T1,Peve_00044685,Pocillopora_meandrina_HIv1___RNAseq.g6855.t1,three_way,81.35900000000001,FUN_043148-T1,A4QNE9,,,,,54.8,115.0,1.3e-07,57.4,sp|A4QNE9|VATG3_XENTR V-type proton ATPase subunit G 3 OS=Xenopus tropicalis OX=8364 GN=atp6v1g3 PE=3 SV=1,,,,,,
OG_09968,FUN_043149-T1,Peve_00011390,Pocillopora_meandrina_HIv1___RNAseq.g6853.t1,three_way,78.382,FUN_043149-T1,Q8TE57,ATS16_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Homo sapiens (Human),35.3,1002.0,3.1000000000000004e-157,558.1,sp|Q8TE57|ATS16_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Homo sapiens OX=9606 GN=ADAMTS16 PE=1 SV=3,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0031012; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein"
OG_09969,FUN_043151-T1,Peve_00011388,Pocillopora_meandrina_HIv1___RNAseq.g6826.t2,three_way,67.76333333333334,FUN_043151-T1,Q00685,,,,,27.6,1792.0,7.4e-160,567.0,sp|Q00685|CO3_LETCA Complement C3 (Fragment) OS=Lethenteron camtschaticum OX=980415 GN=C3 PE=2 SV=1,,,,,,
OG_09970,FUN_043152-T1,Peve_00011385,Pocillopora_meandrina_HIv1___TS.g568.t1,three_way,62.409,FUN_043152-T1,C3ZQF9,,,,,28.2,287.0,3.8e-20,100.5,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_09971,FUN_043153-T1,Peve_00011383,Pocillopora_meandrina_HIv1___RNAseq.g6828.t1,three_way,51.65116666666667,FUN_043153-T1,Q3SZ21,RPP30_BOVIN,,Ribonuclease P protein subunit p30 (RNaseP protein p30) (RNase P subunit 2),Bos taurus (Bovine),37.7,292.0,8.9e-42,172.2,sp|Q3SZ21|RPP30_BOVIN Ribonuclease P protein subunit p30 OS=Bos taurus OX=9913 GN=RPP30 PE=2 SV=1,GO:0000172; GO:0001682; GO:0003723; GO:0004526; GO:0005655; GO:0006364; GO:0008033; GO:0033204,rRNA processing [GO:0006364]; tRNA 5'-leader removal [GO:0001682]; tRNA processing [GO:0008033],nucleolar ribonuclease P complex [GO:0005655]; ribonuclease MRP complex [GO:0000172],ribonuclease P activity [GO:0004526]; ribonuclease P RNA binding [GO:0033204]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0006399; GO:0016787; GO:0140098,"RNA binding; catalytic activity; tRNA metabolic process; hydrolase activity; catalytic activity, acting on RNA"
OG_09972,FUN_043155-T1,Peve_00011378,Pocillopora_meandrina_HIv1___RNAseq.g6836.t1,three_way,39.551,,,,,,,,,,,,,,,,,
OG_09973,FUN_043157-T1,Peve_00011373,Pocillopora_meandrina_HIv1___TS.g580.t1,three_way,67.015,FUN_043157-T1,Q5XIJ1,HMCES_RAT,,Abasic site processing protein HMCES (EC 4.-.-.-) (Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein) (ES cell-specific 5hmC-binding protein) (Peptidase HMCES) (EC 3.4.-.-) (SRAP domain-containing protein 1),Rattus norvegicus (Rat),46.5,329.0,7.700000000000001e-74,278.9,sp|Q5XIJ1|HMCES_RAT Abasic site processing protein HMCES OS=Rattus norvegicus OX=10116 GN=Hmces PE=2 SV=1,GO:0003697; GO:0005657; GO:0006508; GO:0006974; GO:0008233; GO:0016446; GO:0036297; GO:0045830; GO:0097681; GO:0106300; GO:0140431; GO:0160129,DNA damage response [GO:0006974]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; interstrand cross-link repair [GO:0036297]; positive regulation of isotype switching [GO:0045830]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; somatic hypermutation of immunoglobulin genes [GO:0016446],replication fork [GO:0005657],DNA-(abasic site) binding [GO:0140431]; peptidase activity [GO:0008233]; protein-DNA covalent cross-linking activity [GO:0160129]; single-stranded DNA binding [GO:0003697],GO:0002376; GO:0003677; GO:0003824; GO:0006281; GO:0016787; GO:0016829; GO:0140096,"immune system process; DNA binding; catalytic activity; DNA repair; hydrolase activity; lyase activity; catalytic activity, acting on a protein"
OG_09974,FUN_043158-T1,Peve_00011401,Pocillopora_meandrina_HIv1___RNAseq.g6840.t1,three_way,89.59033333333333,FUN_043158-T1,A0A087WRI3,CFA77_MOUSE,,Cilia- and flagella-associated protein 77,Mus musculus (Mouse),37.8,238.0,7.1e-40,165.6,sp|A0A087WRI3|CFA77_MOUSE Cilia- and flagella-associated protein 77 OS=Mus musculus OX=10090 GN=Cfap77 PE=1 SV=1,GO:0030317; GO:0036126; GO:0160112,flagellated sperm motility [GO:0030317],axonemal B tubule inner sheath [GO:0160112]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_09975,FUN_043159-T1,Peve_00011398,Pocillopora_meandrina_HIv1___RNAseq.g6841.t1,three_way,86.38266666666667,FUN_043159-T1,Q6P618,,,,,48.2,477.0,5.1e-135,482.6,sp|Q6P618|KAD8_XENTR Adenylate kinase 8 OS=Xenopus tropicalis OX=8364 GN=ak8 PE=2 SV=1,,,,,,
OG_09976,FUN_043161-T1,Peve_00011372,Pocillopora_meandrina_HIv1___TS.g583.t1,three_way,72.84033333333333,,,,,,,,,,,,,,,,,
OG_09977,FUN_043162-T1,Peve_00036512,Pocillopora_meandrina_HIv1___RNAseq.g6843.t1,three_way,53.319,,,,,,,,,,,,,,,,,
OG_09978,FUN_043163-T1,Peve_00032683,Pocillopora_meandrina_HIv1___RNAseq.g7575.t1,three_way,40.59066666666667,,,,,,,,,,,,,,,,,
OG_09979,FUN_043165-T1,Peve_00036509,Pocillopora_meandrina_HIv1___RNAseq.g6824.t1,three_way,76.43816666666667,FUN_043165-T1,Q9NPC3,CIP1_HUMAN,,E3 ubiquitin-protein ligase CCNB1IP1 (EC 2.3.2.27) (Cyclin-B1-interacting protein 1) (Human enhancer of invasion 10) (RING-type E3 ubiquitin transferase CCNB1IP1),Homo sapiens (Human),49.5,105.0,2.4e-25,117.5,sp|Q9NPC3|CIP1_HUMAN E3 ubiquitin-protein ligase CCNB1IP1 OS=Homo sapiens OX=9606 GN=CCNB1IP1 PE=1 SV=1,GO:0000795; GO:0001825; GO:0007131; GO:0007286; GO:0008270; GO:0016567; GO:0042802; GO:0051026; GO:0061630,blastocyst formation [GO:0001825]; chiasma assembly [GO:0051026]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatid development [GO:0007286],synaptonemal complex [GO:0000795],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0006310; GO:0016740; GO:0022414; GO:0048856; GO:0140096,"catalytic activity; DNA recombination; transferase activity; reproductive process; anatomical structure development; catalytic activity, acting on a protein"
OG_09980,FUN_043169-T1,Peve_00025850,Pocillopora_meandrina_HIv1___RNAseq.g6792.t1,three_way,52.61283333333333,,,,,,,,,,,,,,,,,
OG_09981,FUN_043171-T1,Peve_00025849,Pocillopora_meandrina_HIv1___RNAseq.g6793.t1,three_way,67.71433333333333,,,,,,,,,,,,,,,,,
OG_09982,FUN_043174-T1,Peve_00025847,Pocillopora_meandrina_HIv1___RNAseq.g6799.t1,three_way,67.927,,,,,,,,,,,,,,,,,
OG_09983,FUN_043175-T1,Peve_00025846,Pocillopora_meandrina_HIv1___RNAseq.g6800.t1,three_way,71.23483333333334,FUN_043175-T1,Q28036,SL9A1_BOVIN,,Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1),Bos taurus (Bovine),47.8,557.0,4.9e-141,503.4,sp|Q28036|SL9A1_BOVIN Sodium/hydrogen exchanger 1 OS=Bos taurus OX=9913 GN=SLC9A1 PE=2 SV=2,GO:0005516; GO:0005543; GO:0005654; GO:0005737; GO:0005886; GO:0006883; GO:0006885; GO:0010447; GO:0010613; GO:0010882; GO:0015385; GO:0015386; GO:0016323; GO:0016324; GO:0030346; GO:0035994; GO:0036376; GO:0042802; GO:0045121; GO:0045944; GO:0048306; GO:0048863; GO:0051259; GO:0051453; GO:0055007; GO:0070886; GO:0071468; GO:0071805; GO:0071872; GO:0086092; GO:0090533; GO:0098719; GO:0098735,cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to epinephrine stimulus [GO:0071872]; intracellular sodium ion homeostasis [GO:0006883]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; stem cell differentiation [GO:0048863],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005654; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0055085; GO:0065003,transporter activity; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; transmembrane transport; protein-containing complex assembly
OG_09984,FUN_043176-T1,Peve_00025845,Pocillopora_meandrina_HIv1___RNAseq.g6801.t1,three_way,80.18466666666667,FUN_043176-T1,Q6YP21,KAT3_HUMAN,,Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III),Homo sapiens (Human),55.5,411.0,1.1999999999999999e-132,474.6,sp|Q6YP21|KAT3_HUMAN Kynurenine--oxoglutarate transaminase 3 OS=Homo sapiens OX=9606 GN=KYAT3 PE=1 SV=1,GO:0003723; GO:0005737; GO:0005739; GO:0006103; GO:0006520; GO:0009058; GO:0016212; GO:0030170; GO:0042803; GO:0047315; GO:0047804; GO:0070189; GO:0097053,2-oxoglutarate metabolic process [GO:0006103]; amino acid metabolic process [GO:0006520]; biosynthetic process [GO:0009058]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0006520; GO:0016740; GO:0016829; GO:0043226,RNA binding; catalytic activity; mitochondrion; amino acid metabolic process; transferase activity; lyase activity; organelle
OG_09985,FUN_043178-T1,Peve_00025844,Pocillopora_meandrina_HIv1___RNAseq.g6802.t1,three_way,72.97566666666667,FUN_043178-T1,Q8NHH1,TTL11_HUMAN,,Tubulin polyglutamylase TTLL11 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 11),Homo sapiens (Human),40.7,536.0,8.499999999999999e-114,412.5,sp|Q8NHH1|TTL11_HUMAN Tubulin polyglutamylase TTLL11 OS=Homo sapiens OX=9606 GN=TTLL11 PE=1 SV=3,GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0015631; GO:0036064; GO:0036211; GO:0046872; GO:0051013; GO:0070740; GO:0106437; GO:0106438,microtubule cytoskeleton organization [GO:0000226]; microtubule severing [GO:0051013]; protein modification process [GO:0036211],ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule [GO:0005874],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity, elongating [GO:0106438]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0016874; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; ligase activity; catalytic activity, acting on a protein"
OG_09986,FUN_043179-T1,Peve_00025843,Pocillopora_meandrina_HIv1___TS.g546.t1,three_way,66.02266666666667,FUN_043179-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),33.3,1426.0,9.8e-216,753.1,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_09987,FUN_043181-T1,Peve_00043024,Pocillopora_meandrina_HIv1___RNAseq.g18637.t1,three_way,60.36716666666666,FUN_043181-T1,Q8MIQ9,,,,,52.9,493.0,4.6e-133,476.9,sp|Q8MIQ9|P_PIG P protein OS=Sus scrofa OX=9823 GN=Oca2 PE=2 SV=3,,,,,,
OG_09988,FUN_043182-T1,Peve_00043027,Pocillopora_meandrina_HIv1___RNAseq.g6806.t1,three_way,59.36083333333333,FUN_043182-T1,Q9Z136,,,,,38.8,361.0,3.4e-62,241.9,sp|Q9Z136|TSC1_RAT Hamartin OS=Rattus norvegicus OX=10116 GN=Tsc1 PE=1 SV=1,,,,,,
OG_09989,FUN_043190-T1,Peve_00039859,Pocillopora_meandrina_HIv1___RNAseq.g6807.t1,three_way,79.56916666666666,FUN_043190-T1,Q1LUI2,,,,,59.7,181.0,2.7e-55,216.5,sp|Q1LUI2|HDDC2_DANRE 5'-deoxynucleotidase HDDC2 OS=Danio rerio OX=7955 GN=hddc2 PE=2 SV=1,,,,,,
OG_09990,FUN_043192-T1,Peve_00039864,Pocillopora_meandrina_HIv1___RNAseq.g6808.t1,three_way,67.83833333333334,FUN_043192-T1,Q12904,AIMP1_HUMAN,,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)],Homo sapiens (Human),49.2,315.0,8.1e-58,225.7,sp|Q12904|AIMP1_HUMAN Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 OS=Homo sapiens OX=9606 GN=AIMP1 PE=1 SV=2,GO:0000049; GO:0001525; GO:0001937; GO:0005125; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006412; GO:0006915; GO:0006954; GO:0007267; GO:0009986; GO:0016020; GO:0017101; GO:0042803; GO:0050900; GO:0051020; GO:0051607; GO:0070094,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634],cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049],GO:0002376; GO:0003723; GO:0005615; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006954; GO:0012501; GO:0023052; GO:0043226; GO:0048018; GO:0048870; GO:0098772,immune system process; RNA binding; extracellular space; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; inflammatory response; programmed cell death; signaling; organelle; receptor ligand activity; cell motility; molecular function regulator activity
OG_09991,FUN_043193-T2,Peve_00039868,Pocillopora_meandrina_HIv1___RNAseq.g6809.t1,three_way,40.069833333333335,,,,,,,,,,,,,,,,,
OG_09992,FUN_043195-T1,Peve_00039869,Pocillopora_meandrina_HIv1___RNAseq.g6810.t1,three_way,93.42966666666666,FUN_043195-T1,Q9Y2T2,,,,,70.7,417.0,4.2e-178,625.5,sp|Q9Y2T2|AP3M1_HUMAN AP-3 complex subunit mu-1 OS=Homo sapiens OX=9606 GN=AP3M1 PE=1 SV=1,,,,,,
OG_09993,FUN_043204-T1,Peve_00039861,Pocillopora_meandrina_HIv1___RNAseq.g6812.t1,three_way,71.00066666666667,,,,,,,,,,,,,,,,,
OG_09994,FUN_043207-T1,Peve_00039862,Pocillopora_meandrina_HIv1___RNAseq.g6814.t1,three_way,65.258,FUN_043207-T1,Q6DCP1,,,,,40.3,273.0,5.8e-50,199.1,sp|Q6DCP1|FXRD1_XENLA FAD-dependent oxidoreductase domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=foxred1 PE=2 SV=1,,,,,,
OG_09995,FUN_043216-T1,Peve_00037098,Pocillopora_meandrina_HIv1___RNAseq.g6783.t1,three_way,45.59333333333333,FUN_043216-T1,O88854,,,,,22.8,329.0,1.1e-10,69.3,sp|O88854|GALR2_MOUSE Galanin receptor type 2 OS=Mus musculus OX=10090 GN=Galr2 PE=2 SV=2,,,,,,
OG_09996,FUN_043221-T1,Peve_00037105,Pocillopora_meandrina_HIv1___RNAseq.g6778.t1,three_way,51.28266666666666,FUN_043221-T1,Q91770,,,,,71.2,59.0,1.8e-16,87.8,sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1,,,,,,
OG_09997,FUN_043222-T1,Peve_00007691,Pocillopora_meandrina_HIv1___RNAseq.g6774.t1a,three_way,69.872,FUN_043222-T1,Q22885,,,,,27.1,362.0,1.3e-21,105.5,sp|Q22885|BROX_CAEEL BRO1 domain-containing protein BROX homolog OS=Caenorhabditis elegans OX=6239 GN=B0507.2 PE=3 SV=2,,,,,,
OG_09998,FUN_043224-T1,Peve_00007692,Pocillopora_meandrina_HIv1___RNAseq.g6773.t1,three_way,90.942,FUN_043224-T1,Q5ZKU5,RAB14_CHICK,,Ras-related protein Rab-14 (EC 3.6.5.2),Gallus gallus (Chicken),80.5,215.0,6.4e-93,341.7,sp|Q5ZKU5|RAB14_CHICK Ras-related protein Rab-14 OS=Gallus gallus OX=9031 GN=RAB14 PE=2 SV=3,GO:0000139; GO:0001845; GO:0003924; GO:0003925; GO:0005525; GO:0005769; GO:0005802; GO:0005829; GO:0006886; GO:0006895; GO:0008543; GO:0012505; GO:0031901; GO:0032456; GO:0042742; GO:0045335; GO:0045995; GO:0055037,defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; intracellular protein transport [GO:0006886]; phagolysosome assembly [GO:0001845]; regulation of embryonic development [GO:0045995],cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005768; GO:0005829; GO:0006886; GO:0007040; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0098772,catalytic activity; GTPase activity; endosome; cytosol; intracellular protein transport; lysosome organization; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_09999,FUN_043231-T1,Peve_00019451,Pocillopora_meandrina_HIv1___TS.g505.t1,three_way,79.51733333333333,FUN_043231-T1,Q8TDX7,NEK7_HUMAN,,Serine/threonine-protein kinase Nek7 (EC 2.7.11.34) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7),Homo sapiens (Human),83.6,280.0,5.0999999999999996e-138,491.9,sp|Q8TDX7|NEK7_HUMAN Serine/threonine-protein kinase Nek7 OS=Homo sapiens OX=9606 GN=NEK7 PE=1 SV=1,GO:0000922; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005815; GO:0005874; GO:0006468; GO:0007346; GO:0032206; GO:0035865; GO:0046872; GO:0051225; GO:0106310; GO:0140677; GO:1900227,cellular response to potassium ion [GO:0035865]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of telomere maintenance [GO:0032206]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0007010; GO:0016740; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytoskeleton organization; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10000,FUN_043232-T1,Peve_00019448,Pocillopora_meandrina_HIv1___TS.g503.t2,three_way,77.37666666666667,FUN_043232-T1,P48053,,,,,33.4,984.0,4e-153,543.9,sp|P48053|YPD1_CAEEL Uncharacterized protein C05D11.1 OS=Caenorhabditis elegans OX=6239 GN=C05D11.1 PE=4 SV=2,,,,,,
OG_10001,FUN_043234-T1,Peve_00001448,Pocillopora_meandrina_HIv1___RNAseq.g6754.t1,three_way,72.01266666666666,FUN_043234-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),39.5,309.0,3.7e-52,207.2,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_10002,FUN_043236-T1,Peve_00001435,Pocillopora_meandrina_HIv1___RNAseq.g6748.t1,three_way,69.04316666666666,FUN_043236-T1,Q30D77,COOA1_MOUSE,,Collagen alpha-1(XXIV) chain,Mus musculus (Mouse),41.1,107.0,1.5e-17,94.0,sp|Q30D77|COOA1_MOUSE Collagen alpha-1(XXIV) chain OS=Mus musculus OX=10090 GN=Col24a1 PE=2 SV=2,GO:0002244; GO:0005201; GO:0005576; GO:0005581; GO:0062023,hematopoietic progenitor cell differentiation [GO:0002244],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0030154,structural molecule activity; extracellular region; cell differentiation
OG_10003,FUN_043237-T1,Peve_00001437,Pocillopora_meandrina_HIv1___TS.g490.t1,three_way,69.25716666666668,FUN_043237-T1,O00411,RPOM_HUMAN,,"DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6)",Homo sapiens (Human),40.9,938.0,1.7e-193,678.3,"sp|O00411|RPOM_HUMAN DNA-directed RNA polymerase, mitochondrial OS=Homo sapiens OX=9606 GN=POLRMT PE=1 SV=2",GO:0000175; GO:0001018; GO:0003723; GO:0003899; GO:0005739; GO:0005759; GO:0006264; GO:0006390; GO:0006391; GO:0032991; GO:0034245; GO:0042645; GO:0043565,mitochondrial DNA replication [GO:0006264]; mitochondrial transcription [GO:0006390]; transcription initiation at mitochondrial promoter [GO:0006391],mitochondrial DNA-directed RNA polymerase complex [GO:0034245]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991],3'-5'-RNA exonuclease activity [GO:0000175]; DNA-directed RNA polymerase activity [GO:0003899]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0003723; GO:0003824; GO:0005739; GO:0006260; GO:0006351; GO:0016740; GO:0016787; GO:0043226; GO:0140098,"DNA binding; RNA binding; catalytic activity; mitochondrion; DNA replication; DNA-templated transcription; transferase activity; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_10004,FUN_043238-T1,Peve_00001438,Pocillopora_meandrina_HIv1___TS.g489.t1,three_way,63.77933333333333,FUN_043238-T1,P35441,TSP1_MOUSE,,Thrombospondin-1 (Glycoprotein G),Mus musculus (Mouse),41.3,206.0,2.4e-43,177.6,sp|P35441|TSP1_MOUSE Thrombospondin-1 OS=Mus musculus OX=10090 GN=Thbs1 PE=1 SV=1,GO:0001525; GO:0001937; GO:0001953; GO:0001968; GO:0003151; GO:0003197; GO:0003417; GO:0005509; GO:0005576; GO:0005615; GO:0005783; GO:0006915; GO:0006954; GO:0006986; GO:0008201; GO:0009986; GO:0010751; GO:0010759; GO:0010811; GO:0016525; GO:0016529; GO:0030511; GO:0031012; GO:0034976; GO:0048266; GO:0048514; GO:0050840; GO:0062023; GO:0070487; GO:0071732; GO:2001027,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; blood vessel morphogenesis [GO:0048514]; cellular response to nitric oxide [GO:0071732]; endocardial cushion development [GO:0003197]; growth plate cartilage development [GO:0003417]; inflammatory response [GO:0006954]; monocyte aggregation [GO:0070487]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; outflow tract morphogenesis [GO:0003151]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529],calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201],GO:0005576; GO:0005615; GO:0005783; GO:0006954; GO:0007155; GO:0012501; GO:0030312; GO:0031012; GO:0043226; GO:0048856,extracellular region; extracellular space; endoplasmic reticulum; inflammatory response; cell adhesion; programmed cell death; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_10005,FUN_043240-T1,Peve_00001439,Pocillopora_meandrina_HIv1___RNAseq.g6713.t1,three_way,70.26633333333334,FUN_043240-T1,P28304,,,,,38.9,319.0,9.5e-54,212.2,sp|P28304|QOR1_ECOLI Quinone oxidoreductase 1 OS=Escherichia coli (strain K12) OX=83333 GN=qorA PE=1 SV=1,,,,,,
OG_10006,FUN_043241-T1,Peve_00001440,Pocillopora_meandrina_HIv1___RNAseq.g6712.t1,three_way,87.51866666666666,FUN_043241-T1,Q66I24,,,,,69.6,405.0,2.3999999999999998e-173,609.8,sp|Q66I24|ASSY_DANRE Argininosuccinate synthase OS=Danio rerio OX=7955 GN=ass1 PE=2 SV=1,,,,,,
OG_10007,FUN_043242-T1,Peve_00001436,Pocillopora_meandrina_HIv1___RNAseq.g6708.t1,three_way,59.496500000000005,FUN_043242-T1,Q6YHK3,CD109_HUMAN,,CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109),Homo sapiens (Human),25.8,1416.0,2.8e-104,382.1,sp|Q6YHK3|CD109_HUMAN CD109 antigen OS=Homo sapiens OX=9606 GN=CD109 PE=1 SV=2,GO:0001942; GO:0004867; GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0009986; GO:0010839; GO:0030512; GO:0031092; GO:0043616; GO:0045616; GO:0061045; GO:0072089; GO:0072675; GO:0098552; GO:2000647,hair follicle development [GO:0001942]; keratinocyte proliferation [GO:0043616]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; regulation of keratinocyte differentiation [GO:0045616]; stem cell proliferation [GO:0072089],cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; side of membrane [GO:0098552],serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005576; GO:0005615; GO:0005829; GO:0005886; GO:0048856; GO:0098772,extracellular region; extracellular space; cytosol; plasma membrane; anatomical structure development; molecular function regulator activity
OG_10008,FUN_043243-T1,Peve_00001453,Pocillopora_meandrina_HIv1___RNAseq.g8840.t1,three_way,57.674,FUN_043243-T1,B3EWZ3,,,,,34.4,180.0,7.2e-26,119.4,sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10009,FUN_043244-T1,Peve_00001455,Pocillopora_meandrina_HIv1___RNAseq.g8844.t1,three_way,80.65866666666668,FUN_043244-T1,Q5ZJF4,PRDX6_CHICK,,Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx),Gallus gallus (Chicken),69.4,219.0,2.4e-87,323.2,sp|Q5ZJF4|PRDX6_CHICK Peroxiredoxin-6 OS=Gallus gallus OX=9031 GN=PRDX6 PE=2 SV=3,GO:0004601; GO:0004623; GO:0005615; GO:0005764; GO:0005829; GO:0016042; GO:0045454; GO:0047184; GO:0051920,cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042],cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005829; GO:0006629; GO:0016209; GO:0016491; GO:0016740; GO:0016787; GO:0043226,catalytic activity; extracellular space; lysosome; vacuole; cytosol; lipid metabolic process; antioxidant activity; oxidoreductase activity; transferase activity; hydrolase activity; organelle
OG_10010,FUN_043245-T1,Peve_00001456,Pocillopora_meandrina_HIv1___TS.g20570.t1,three_way,67.59233333333333,FUN_043245-T1,Q60695,,,,,39.4,754.0,3.9e-110,400.6,sp|Q60695|RGL1_MOUSE Ral guanine nucleotide dissociation stimulator-like 1 OS=Mus musculus OX=10090 GN=Rgl1 PE=1 SV=2,,,,,,
OG_10011,FUN_043248-T1,Peve_00001457,Pocillopora_meandrina_HIv1___RNAseq.g8849.t1,three_way,80.36166666666666,FUN_043248-T1,Q5TJE6,,,,,43.5,115.0,1.2e-19,97.4,sp|Q5TJE6|PFD6_CANLF Prefoldin subunit 6 OS=Canis lupus familiaris OX=9615 GN=PFDN6 PE=3 SV=1,,,,,,
OG_10012,FUN_043249-T1,Peve_00001459,Pocillopora_meandrina_HIv1___RNAseq.g8850.t1,three_way,76.58266666666667,FUN_043249-T1,A4IHH4,,,,,47.4,266.0,8.5e-66,251.9,sp|A4IHH4|SURF1_XENTR Surfeit locus protein 1 OS=Xenopus tropicalis OX=8364 GN=surf1 PE=2 SV=1,,,,,,
OG_10013,FUN_043250-T1,Peve_00028667,Pocillopora_meandrina_HIv1___RNAseq.g8852.t1,three_way,78.99966666666667,FUN_043250-T1,Q9PUB8,S39A7_DANRE,,"Zinc transporter Slc39a7 (Histidine-rich membrane protein Ke4) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7)",Danio rerio (Zebrafish) (Brachydanio rerio),64.0,342.0,3.1e-85,317.4,sp|Q9PUB8|S39A7_DANRE Zinc transporter Slc39a7 OS=Danio rerio OX=7955 GN=slc39a7 PE=2 SV=2,GO:0005385; GO:0005789; GO:0005794; GO:0006829; GO:0006882; GO:0030183; GO:0071577; GO:0098773; GO:0110075,B cell differentiation [GO:0030183]; intracellular zinc ion homeostasis [GO:0006882]; regulation of ferroptosis [GO:0110075]; skin epidermis development [GO:0098773]; zinc ion transmembrane transport [GO:0071577]; zinc ion transport [GO:0006829],endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794],zinc ion transmembrane transporter activity [GO:0005385],GO:0002376; GO:0005215; GO:0005794; GO:0030154; GO:0043226; GO:0048856; GO:0055085,immune system process; transporter activity; Golgi apparatus; cell differentiation; organelle; anatomical structure development; transmembrane transport
OG_10014,FUN_043251-T1,Peve_00028668,Pocillopora_meandrina_HIv1___RNAseq.g8853.t1,three_way,68.52266666666667,FUN_043251-T1,Q5NU14,,,,,48.7,394.0,4e-85,316.6,sp|Q5NU14|MKRN1_TAKRU Probable E3 ubiquitin-protein ligase makorin-1 OS=Takifugu rubripes OX=31033 GN=mkrn1 PE=2 SV=1,,,,,,
OG_10015,FUN_043252-T1,Peve_00029557,Pocillopora_meandrina_HIv1___RNAseq.g8856.t1,three_way,77.27233333333334,FUN_043252-T1,F1QF89,POMT1_DANRE,,Protein O-mannosyl-transferase 1 (EC 2.4.1.109),Danio rerio (Zebrafish) (Brachydanio rerio),47.0,719.0,3.8e-180,633.3,sp|F1QF89|POMT1_DANRE Protein O-mannosyl-transferase 1 OS=Danio rerio OX=7955 GN=pomt1 PE=1 SV=1,GO:0004169; GO:0005783; GO:0005789; GO:0035269; GO:0042478; GO:0048742,protein O-linked mannosylation [GO:0035269]; regulation of eye photoreceptor cell development [GO:0042478]; regulation of skeletal muscle fiber development [GO:0048742],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169],GO:0003824; GO:0005783; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; endoplasmic reticulum; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_10016,FUN_043253-T1,Peve_00029558,Pocillopora_meandrina_HIv1___TS.g20579.t1,three_way,86.185,FUN_043253-T1,Q9Z321,,,,,69.0,854.0,0.0,1221.5,sp|Q9Z321|TOP3B_MOUSE DNA topoisomerase 3-beta-1 OS=Mus musculus OX=10090 GN=Top3b PE=1 SV=1,,,,,,
OG_10017,FUN_043254-T1,Peve_00030637,Pocillopora_meandrina_HIv1___RNAseq.g8858.t1,three_way,79.7325,,,,,,,,,,,,,,,,,
OG_10018,FUN_043258-T1,Peve_00024820,Pocillopora_meandrina_HIv1___RNAseq.g8859.t1,three_way,85.99666666666667,FUN_043258-T1,P81274,GPSM2_HUMAN,,G-protein-signaling modulator 2 (Mosaic protein LGN),Homo sapiens (Human),83.2,197.0,6.3e-55,216.9,sp|P81274|GPSM2_HUMAN G-protein-signaling modulator 2 OS=Homo sapiens OX=9606 GN=GPSM2 PE=1 SV=3,GO:0000132; GO:0000166; GO:0001965; GO:0005092; GO:0005737; GO:0005813; GO:0005829; GO:0005938; GO:0007052; GO:0007186; GO:0009642; GO:0014069; GO:0016328; GO:0019904; GO:0032991; GO:0042802; GO:0051301; GO:0051661; GO:0060236; GO:0070840; GO:0097431; GO:0097575; GO:0099645; GO:0099738; GO:1904778; GO:1905832,cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; regulation of mitotic spindle organization [GO:0060236]; response to light intensity [GO:0009642],cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991],dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein domain specific binding [GO:0019904],GO:0005815; GO:0005829; GO:0007010; GO:0043226; GO:0098772,microtubule organizing center; cytosol; cytoskeleton organization; organelle; molecular function regulator activity
OG_10019,FUN_043260-T1,Peve_00032621,Pocillopora_meandrina_HIv1___TS.g20584.t1,three_way,80.86,FUN_043260-T1,Q32LH4,,,,,54.2,275.0,3.6000000000000004e-86,319.7,sp|Q32LH4|NIT1_BOVIN Deaminated glutathione amidase OS=Bos taurus OX=9913 GN=NIT1 PE=2 SV=1,,,,,,
OG_10020,FUN_043261-T1,Peve_00032607,Pocillopora_meandrina_HIv1___RNAseq.g8893.t1,three_way,65.95816666666667,FUN_043261-T1,Q7Z7G8,VP13B_HUMAN,,Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B),Homo sapiens (Human),28.7,4270.0,0.0,1449.5,sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2,GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168,acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0008289; GO:0016192; GO:0022414; GO:0048856; GO:0050877,lipid binding; vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process
OG_10021,FUN_043262-T1,Peve_00032608,Pocillopora_meandrina_HIv1___RNAseq.g8892.t1,three_way,72.44983333333333,FUN_043262-T1,Q9Z0H0,,,,,35.1,559.0,3.6e-82,307.4,sp|Q9Z0H0|CDC7_MOUSE Cell division cycle 7-related protein kinase OS=Mus musculus OX=10090 GN=Cdc7 PE=1 SV=2,,,,,,
OG_10022,FUN_043264-T1,Peve_00032613,Pocillopora_meandrina_HIv1___RNAseq.g8889.t1,three_way,60.43216666666667,FUN_043264-T1,P79795,NRP1_CHICK,,Neuropilin-1 (A5 protein),Gallus gallus (Chicken),28.2,255.0,3.2e-12,75.9,sp|P79795|NRP1_CHICK Neuropilin-1 OS=Gallus gallus OX=9031 GN=NRP1 PE=2 SV=1,GO:0001570; GO:0001755; GO:0002040; GO:0005021; GO:0005886; GO:0005925; GO:0007155; GO:0007411; GO:0008201; GO:0009611; GO:0010595; GO:0017154; GO:0022035; GO:0030424; GO:0030947; GO:0031966; GO:0032584; GO:0038085; GO:0043679; GO:0044295; GO:0046872; GO:0048010; GO:0048729; GO:0051491; GO:0070852; GO:0098743,axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell aggregation [GO:0098743]; neural crest cell migration [GO:0001755]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to wounding [GO:0009611]; rhombomere cell migration [GO:0022035]; sprouting angiogenesis [GO:0002040]; tissue morphogenesis [GO:0048729]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570],axon [GO:0030424]; axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell body fiber [GO:0070852]; focal adhesion [GO:0005925]; growth cone membrane [GO:0032584]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886],heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0030154; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; cell differentiation; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10023,FUN_043266-T1,Peve_00032614,Pocillopora_meandrina_HIv1___RNAseq.g8887.t1b,three_way,38.228,,,,,,,,,,,,,,,,,
OG_10024,FUN_043277-T1,Peve_00007457,Pocillopora_meandrina_HIv1___RNAseq.g8877.t1,three_way,52.60616666666667,FUN_043277-T1,B3EWY9,,,,,42.2,102.0,9.4e-15,84.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10025,FUN_043278-T1,Peve_00007456,Pocillopora_meandrina_HIv1___TS.g20597.t1,three_way,67.2045,FUN_043278-T1,P29241,,,,,34.5,249.0,7.499999999999999e-43,176.4,sp|P29241|NADA_APLCA ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase OS=Aplysia californica OX=6500 PE=1 SV=1,,,,,,
OG_10026,FUN_043279-T1,Peve_00007455,Pocillopora_meandrina_HIv1___RNAseq.g8875.t1,three_way,77.92,FUN_043279-T1,Q08832,GBRB3_DROME,,Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor),Drosophila melanogaster (Fruit fly),34.6,457.0,7.399999999999999e-75,282.7,sp|Q08832|GBRB3_DROME Gamma-aminobutyric acid receptor subunit beta-like OS=Drosophila melanogaster OX=7227 GN=Lcch3 PE=1 SV=2,GO:0004890; GO:0005886; GO:0022851; GO:0034707; GO:0045211; GO:1902476; GO:1902711,chloride transmembrane transport [GO:1902476],chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_10027,FUN_043281-T1,Peve_00007453,Pocillopora_meandrina_HIv1___TS.g20595.t1c,three_way,70.7575,FUN_043281-T1,Q8IYH5,ZZZ3_HUMAN,,ZZ-type zinc finger-containing protein 3,Homo sapiens (Human),45.6,450.0,2.1e-88,328.2,sp|Q8IYH5|ZZZ3_HUMAN ZZ-type zinc finger-containing protein 3 OS=Homo sapiens OX=9606 GN=ZZZ3 PE=1 SV=1,GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0006357; GO:0008270; GO:0042393; GO:0045995; GO:0051302; GO:0051726; GO:0072686; GO:0140672,chromatin organization [GO:0006325]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357],ATAC complex [GO:0140672]; mitotic spindle [GO:0072686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; histone binding [GO:0042393]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0042393; GO:0043226,DNA binding; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle
OG_10028,FUN_043283-T1,Peve_00007451,Pocillopora_meandrina_HIv1___RNAseq.g8872.t1,three_way,45.01633333333333,,,,,,,,,,,,,,,,,
OG_10029,FUN_043284-T1,Peve_00007450,Pocillopora_meandrina_HIv1___TS.g20593.t1,three_way,50.120333333333335,,,,,,,,,,,,,,,,,
OG_10030,FUN_043285-T1,Peve_00007449,Pocillopora_meandrina_HIv1___RNAseq.g8870.t1,three_way,64.02566666666667,FUN_043285-T1,Q99943,PLCA_HUMAN,,1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15),Homo sapiens (Human),37.9,243.0,3.9e-42,173.3,sp|Q99943|PLCA_HUMAN 1-acyl-sn-glycerol-3-phosphate acyltransferase alpha OS=Homo sapiens OX=9606 GN=AGPAT1 PE=1 SV=2,GO:0001819; GO:0001961; GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016024,CDP-diacylglycerol biosynthetic process [GO:0016024]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid metabolic process [GO:0006644]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine-mediated signaling pathway [GO:0001961],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_10031,FUN_043286-T1,Peve_00007448,Pocillopora_meandrina_HIv1___RNAseq.g8869.t1,three_way,90.06933333333333,FUN_043286-T1,Q5ZKN1,CDK9_CHICK,,Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9),Gallus gallus (Chicken),71.5,375.0,2.3e-151,536.6,sp|Q5ZKN1|CDK9_CHICK Cyclin-dependent kinase 9 OS=Gallus gallus OX=9031 GN=CDK9 PE=2 SV=1,GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0006366; GO:0008353; GO:0032968; GO:0045944; GO:0070691; GO:0106310; GO:0120187,positive regulation of protein localization to chromatin [GO:0120187]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634]; P-TEFb complex [GO:0070691],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0006351; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_10032,FUN_043287-T1,Peve_00007447,Pocillopora_meandrina_HIv1___RNAseq.g8868.t1,three_way,66.945,FUN_043287-T1,Q641F8,,,,,51.9,187.0,1.9e-48,194.1,sp|Q641F8|TYW3_XENLA tRNA wybutosine-synthesizing protein 3 homolog OS=Xenopus laevis OX=8355 GN=tyw3 PE=2 SV=1,,,,,,
OG_10033,FUN_043290-T1,Peve_00016457,Pocillopora_meandrina_HIv1___RNAseq.g8864.t1,three_way,76.351,FUN_043290-T1,Q6GN42,CTL4_XENLA,,Choline transporter-like protein 4 (Solute carrier family 44 member 4),Xenopus laevis (African clawed frog),41.9,704.0,1e-147,525.4,sp|Q6GN42|CTL4_XENLA Choline transporter-like protein 4 OS=Xenopus laevis OX=8355 GN=slc44a4 PE=2 SV=1,GO:0005886; GO:0008292; GO:0015220; GO:0015297; GO:0015871; GO:0016324; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0061526; GO:0090422,acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422],GO:0005215; GO:0005886; GO:0048856; GO:0055085,transporter activity; plasma membrane; anatomical structure development; transmembrane transport
OG_10034,FUN_043298-T1,Peve_00016456,Pocillopora_meandrina_HIv1___RNAseq.g8863.t1,three_way,87.58033333333333,FUN_043298-T1,Q52I78,,,,,56.2,475.0,2.3e-159,563.5,sp|Q52I78|NAMPT_PIG Nicotinamide phosphoribosyltransferase OS=Sus scrofa OX=9823 GN=NAMPT PE=2 SV=2,,,,,,
OG_10035,FUN_043299-T1,Peve_00026362,Pocillopora_meandrina_HIv1___RNAseq.g8894.t1,three_way,72.17666666666666,FUN_043299-T1,Q6P9Q6,FKB15_MOUSE,,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),Mus musculus (Mouse),36.7,619.0,1.2e-80,303.5,sp|Q6P9Q6|FKB15_MOUSE FK506-binding protein 15 OS=Mus musculus OX=10090 GN=Fkbp15 PE=1 SV=2,GO:0003779; GO:0005768; GO:0005769; GO:0006897; GO:0015629; GO:0016020; GO:0030424; GO:0030426,endocytosis [GO:0006897],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; early endosome [GO:0005769]; endosome [GO:0005768]; growth cone [GO:0030426]; membrane [GO:0016020],actin binding [GO:0003779],GO:0005768; GO:0005856; GO:0008092; GO:0016192; GO:0031410; GO:0043226,endosome; cytoskeleton; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_10036,FUN_043300-T1,Peve_00007445,Pocillopora_meandrina_HIv1___RNAseq.g8897.t1,three_way,92.66466666666666,FUN_043300-T1,Q8IRC7,AWH_DROME,,LIM/homeobox protein Awh (Protein arrowhead),Drosophila melanogaster (Fruit fly),55.3,217.0,7.2e-66,251.9,sp|Q8IRC7|AWH_DROME LIM/homeobox protein Awh OS=Drosophila melanogaster OX=7227 GN=Awh PE=1 SV=1,GO:0000977; GO:0000981; GO:0003700; GO:0005634; GO:0006355; GO:0006357; GO:0007444; GO:0010468; GO:0030182; GO:0046872; GO:0048749,compound eye development [GO:0048749]; imaginal disc development [GO:0007444]; neuron differentiation [GO:0030182]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_10037,FUN_043301-T1,Peve_00007494,Pocillopora_meandrina_HIv1___RNAseq.g8920.t1,three_way,66.76633333333334,FUN_043301-T1,Q54H55,,,,,28.4,437.0,4.1e-46,187.2,sp|Q54H55|Y8969_DICDI FAD-linked oxidoreductase DDB_G0289697 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0289697 PE=2 SV=1,,,,,,
OG_10038,FUN_043303-T1,Peve_00007504,Pocillopora_meandrina_HIv1___RNAseq.g8922.t1,three_way,84.536,FUN_043303-T1,A0JNI8,,,,,54.2,271.0,1.3e-80,301.2,sp|A0JNI8|LHX9_BOVIN LIM/homeobox protein Lhx9 OS=Bos taurus OX=9913 GN=LHX9 PE=2 SV=2,,,,,,
OG_10039,FUN_043309-T1,Peve_00007495,Pocillopora_meandrina_HIv1___RNAseq.g8924.t1,three_way,66.18766666666667,FUN_043309-T1,P33450,FAT_DROME,,Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito],Drosophila melanogaster (Fruit fly),27.1,816.0,1.3e-70,270.0,sp|P33450|FAT_DROME Cadherin-related tumor suppressor OS=Drosophila melanogaster OX=7227 GN=ft PE=1 SV=3,GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0090175; GO:0090176; GO:0090251; GO:0098609,"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]",apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509],GO:0005739; GO:0005886; GO:0007010; GO:0007155; GO:0007163; GO:0043226; GO:0048856,mitochondrion; plasma membrane; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; organelle; anatomical structure development
OG_10040,FUN_043311-T1,Peve_00007498,Pocillopora_meandrina_HIv1___RNAseq.g8926.t1,three_way,86.447,FUN_043311-T1,A9JS51,,,,,37.0,297.0,1.5e-52,208.0,sp|A9JS51|CMI2B_XENLA Ciliary microtubule inner protein 2B OS=Xenopus laevis OX=8355 GN=cimip2b PE=2 SV=1,,,,,,
OG_10041,FUN_043312-T1,Peve_00007499,Pocillopora_meandrina_HIv1___RNAseq.g8928.t1,three_way,77.94933333333333,FUN_043312-T1,P36916,,,,,53.7,488.0,4.9e-143,509.6,sp|P36916|GNL1_MOUSE Guanine nucleotide-binding protein-like 1 OS=Mus musculus OX=10090 GN=Gnl1 PE=1 SV=4,,,,,,
OG_10042,FUN_043313-T1,Peve_00007500,Pocillopora_meandrina_HIv1___RNAseq.g8929.t1,three_way,90.50566666666668,FUN_043313-T1,Q812D3,,,,,80.6,160.0,5.9e-75,281.6,sp|Q812D3|PPIL3_RAT Peptidyl-prolyl cis-trans isomerase-like 3 OS=Rattus norvegicus OX=10116 GN=Ppil3 PE=2 SV=1,,,,,,
OG_10043,FUN_043315-T1,Peve_00007501,Pocillopora_meandrina_HIv1___RNAseq.g8930.t1,three_way,80.94866666666667,FUN_043315-T1,A0JMW2,,,,,51.3,314.0,1.2e-86,321.6,sp|A0JMW2|DAAF5_XENLA Dynein axonemal assembly factor 5 OS=Xenopus laevis OX=8355 GN=dnaaf5 PE=2 SV=1,,,,,,
OG_10044,FUN_043316-T1,Peve_00007502,Pocillopora_meandrina_HIv1___RNAseq.g8931.t1,three_way,71.72133333333333,FUN_043316-T1,Q28DE7,,,,,45.1,344.0,2.1e-83,310.8,sp|Q28DE7|KLD10_XENTR Kelch domain-containing protein 10 OS=Xenopus tropicalis OX=8364 GN=klhdc10 PE=2 SV=2,,,,,,
OG_10045,FUN_043317-T1,Peve_00007503,Pocillopora_meandrina_HIv1___RNAseq.g8932.t2b,three_way,56.23733333333333,FUN_043317-T1,O60462,NRP2_HUMAN,,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),Homo sapiens (Human),27.6,315.0,8.3e-18,93.2,sp|O60462|NRP2_HUMAN Neuropilin-2 OS=Homo sapiens OX=9606 GN=NRP2 PE=1 SV=3,GO:0001525; GO:0001938; GO:0002116; GO:0003148; GO:0005021; GO:0005576; GO:0005886; GO:0007155; GO:0007411; GO:0008201; GO:0010595; GO:0016020; GO:0017154; GO:0019838; GO:0019955; GO:0021612; GO:0021637; GO:0021649; GO:0021675; GO:0021785; GO:0021828; GO:0030424; GO:0036486; GO:0038023; GO:0042802; GO:0045211; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0071526; GO:0097374; GO:0097490; GO:0097491; GO:0098978; GO:0099175; GO:1901166; GO:1903375; GO:1904835; GO:1990830,angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116],cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0003824; GO:0005576; GO:0005886; GO:0007155; GO:0016740; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; extracellular region; plasma membrane; cell adhesion; transferase activity; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10046,FUN_043318-T1,Peve_00007505,Pocillopora_meandrina_HIv1___RNAseq.g8933.t1b,three_way,57.265166666666666,,,,,,,,,,,,,,,,,
OG_10047,FUN_043320-T1,Peve_00018052,Pocillopora_meandrina_HIv1___TS.g20669.t1,three_way,62.268,FUN_043320-T1,Q5TYP4,,,,,30.4,859.0,4.3e-98,360.9,sp|Q5TYP4|FIRRM_DANRE FIGNL1-interacting regulator of recombination and mitosis OS=Danio rerio OX=7955 GN=firrm PE=2 SV=1,,,,,,
OG_10048,FUN_043322-T1,Peve_00007511,Pocillopora_meandrina_HIv1___RNAseq.g8949.t1,three_way,57.72333333333333,FUN_043322-T1,Q03146,DDR1_MOUSE,,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (Protein-tyrosine kinase MPK-6) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),Mus musculus (Mouse),49.6,373.0,3.5e-93,344.7,sp|Q03146|DDR1_MOUSE Epithelial discoidin domain-containing receptor 1 OS=Mus musculus OX=10090 GN=Ddr1 PE=2 SV=2,GO:0001558; GO:0001952; GO:0005518; GO:0005524; GO:0005886; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0014909; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046872; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:1990138,"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell population proliferation [GO:0008283]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]",plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0022414; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; reproductive process; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_10049,FUN_043323-T1,Peve_00007512,Pocillopora_meandrina_HIv1___RNAseq.g8950.t1,three_way,56.72266666666666,,,,,,,,,,,,,,,,,
OG_10050,FUN_043324-T1,Peve_00036591,Pocillopora_meandrina_HIv1___RNAseq.g8951.t1,three_way,74.779,FUN_043324-T1,Q59228,,,,,31.3,361.0,3.9e-44,181.0,sp|Q59228|AAT_GEOSE Aspartate aminotransferase OS=Geobacillus stearothermophilus OX=1422 GN=aspC PE=3 SV=1,,,,,,
OG_10051,FUN_043325-T1,Peve_00043035,Pocillopora_meandrina_HIv1___RNAseq.g8952.t1,three_way,72.11733333333333,FUN_043325-T1,Q2HWF0,FBP1L_RAT,,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),Rattus norvegicus (Rat),31.6,604.0,1.9000000000000002e-74,281.6,sp|Q2HWF0|FBP1L_RAT Formin-binding protein 1-like OS=Rattus norvegicus OX=10116 GN=Fnbp1l PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006900; GO:0006914; GO:0007165; GO:0007399; GO:0008289; GO:0010324; GO:0016050; GO:0030050; GO:0030154; GO:0031410; GO:0051020; GO:0051491; GO:0060271; GO:0072583; GO:0097320,autophagy [GO:0006914]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; nervous system development [GO:0007399]; plasma membrane tubulation [GO:0097320]; positive regulation of filopodium assembly [GO:0051491]; signal transduction [GO:0007165]; vesicle budding from membrane [GO:0006900]; vesicle organization [GO:0016050]; vesicle transport along actin filament [GO:0030050],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886],GTPase binding [GO:0051020]; lipid binding [GO:0008289],GO:0005829; GO:0005856; GO:0005886; GO:0006914; GO:0008289; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0044782; GO:0048856; GO:0061024,cytosol; cytoskeleton; plasma membrane; autophagy; lipid binding; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development; membrane organization
OG_10052,FUN_043326-T1,Peve_00043041,Pocillopora_meandrina_HIv1___RNAseq.g8953.t1,three_way,56.76033333333333,FUN_043326-T1,D3ZAZ5,BCAR3_RAT,,"Breast cancer anti-estrogen resistance protein 3 homolog (BCAR3 adapter protein, NSP family member) (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) (p130Cas-binding protein AND-34)",Rattus norvegicus (Rat),23.4,785.0,4.2e-25,118.2,sp|D3ZAZ5|BCAR3_RAT Breast cancer anti-estrogen resistance protein 3 homolog OS=Rattus norvegicus OX=10116 GN=Bcar3 PE=1 SV=1,GO:0001784; GO:0002089; GO:0005085; GO:0005737; GO:0005925; GO:0007173; GO:0007264; GO:0008284; GO:0008286; GO:0016020; GO:0019900; GO:0043410; GO:0043547; GO:0086100,endothelin receptor signaling pathway [GO:0086100]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; lens morphogenesis in camera-type eye [GO:0002089]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of GTPase activity [GO:0043547]; positive regulation of MAPK cascade [GO:0043410]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; membrane [GO:0016020],guanyl-nucleotide exchange factor activity [GO:0005085]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784],GO:0098772,molecular function regulator activity
OG_10053,FUN_043327-T1,Peve_00043037,Pocillopora_meandrina_HIv1___RNAseq.g8955.t1,three_way,55.082,FUN_043327-T1,D6WMX4,PINK1_TRICA,,"Serine/threonine-protein kinase Pink1, mitochondrial (EC 2.7.11.1) (PTEN-induced putative kinase 1)",Tribolium castaneum (Red flour beetle),36.7,450.0,9.499999999999999e-69,262.7,"sp|D6WMX4|PINK1_TRICA Serine/threonine-protein kinase Pink1, mitochondrial OS=Tribolium castaneum OX=7070 GN=Pink1 PE=1 SV=1",GO:0000422; GO:0004674; GO:0005524; GO:0005739; GO:0005741; GO:0005743; GO:0005829; GO:0031398; GO:0031625; GO:0042981; GO:0046777; GO:0046872; GO:0090141; GO:1904544,autophagy of mitochondrion [GO:0000422]; positive regulation of free ubiquitin chain polymerization [GO:1904544]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein ubiquitination [GO:0031398]; protein autophosphorylation [GO:0046777]; regulation of apoptotic process [GO:0042981],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625],GO:0003824; GO:0005739; GO:0005829; GO:0006914; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; cytosol; autophagy; transferase activity; organelle; catalytic activity, acting on a protein"
OG_10054,FUN_043347-T1,Peve_00043038,Pocillopora_meandrina_HIv1___RNAseq.g8956.t1,three_way,86.98733333333334,FUN_043347-T1,Q5NVD0,,,,,55.9,288.0,4.3e-79,297.0,sp|Q5NVD0|PRP4_PONAB U4/U6 small nuclear ribonucleoprotein Prp4 OS=Pongo abelii OX=9601 GN=PRPF4 PE=2 SV=1,,,,,,
OG_10055,FUN_043349-T1,Peve_00043040,Pocillopora_meandrina_HIv1___TS.g20680.t2,three_way,60.5675,FUN_043349-T1,P20909,,,,,33.1,236.0,3.2e-34,149.4,sp|P20909|COBA1_RAT Collagen alpha-1(XI) chain OS=Rattus norvegicus OX=10116 GN=Col11a1 PE=1 SV=2,,,,,,
OG_10056,FUN_043350-T1,Peve_00022831,Pocillopora_meandrina_HIv1___RNAseq.g8959.t1,three_way,62.689,,,,,,,,,,,,,,,,,
OG_10057,FUN_043351-T1,Peve_00022832,Pocillopora_meandrina_HIv1___TS.g20682.t1,three_way,75.10366666666667,FUN_043351-T1,Q9UJX6,,,,,44.4,762.0,8.299999999999998e-175,615.5,sp|Q9UJX6|ANC2_HUMAN Anaphase-promoting complex subunit 2 OS=Homo sapiens OX=9606 GN=ANAPC2 PE=1 SV=1,,,,,,
OG_10058,FUN_043354-T1,Peve_00016648,Pocillopora_meandrina_HIv1___RNAseq.g8962.t1,three_way,73.71866666666666,FUN_043354-T1,Q5U1W5,,,,,65.5,165.0,7.3e-58,225.7,sp|Q5U1W5|U1SBP_RAT U11/U12 small nuclear ribonucleoprotein 35 kDa protein OS=Rattus norvegicus OX=10116 GN=Snrnp35 PE=2 SV=1,,,,,,
OG_10059,FUN_043355-T1,Peve_00016650,Pocillopora_meandrina_HIv1___TS.g20685.t1a,three_way,62.21816666666667,FUN_043355-T1,A1L1H3,,,,,26.3,758.0,1.4e-48,196.4,sp|A1L1H3|TDRD5_XENLA Tudor domain-containing protein 5 OS=Xenopus laevis OX=8355 GN=tdrd5 PE=2 SV=1,,,,,,
OG_10060,FUN_043356-T1,Peve_00016651,Pocillopora_meandrina_HIv1___TS.g20685.t1b,three_way,83.92116666666666,FUN_043356-T1,Q9VE46,,,,,62.7,509.0,1.6e-169,597.4,sp|Q9VE46|SC5A7_DROME High-affinity choline transporter 1 OS=Drosophila melanogaster OX=7227 GN=ChT PE=2 SV=2,,,,,,
OG_10061,FUN_043361-T1,Peve_00016655,Pocillopora_meandrina_HIv1___RNAseq.g8968.t1,three_way,78.50683333333333,FUN_043361-T1,Q5YCC7,,,,,32.4,641.0,1.9e-69,265.0,sp|Q5YCC7|TMC3_CHICK Transmembrane channel-like protein 3 OS=Gallus gallus OX=9031 GN=Tmc3 PE=2 SV=1,,,,,,
OG_10062,FUN_043362-T1,Peve_00016657,Pocillopora_meandrina_HIv1___RNAseq.g8969.t1,three_way,65.42666666666666,FUN_043362-T1,Q8STF6,DYC1_CAEEL,,Dystrophin-like protein 1 (Dyb-1-binding and CAPON-related protein),Caenorhabditis elegans,41.2,228.0,8.5e-40,166.4,sp|Q8STF6|DYC1_CAEEL Dystrophin-like protein 1 OS=Caenorhabditis elegans OX=6239 GN=dyc-1 PE=1 SV=1,GO:0007626; GO:0008307; GO:0016010; GO:0030235; GO:0030424; GO:0040017; GO:0045214; GO:0046662; GO:0046716; GO:0050998; GO:0055120,locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of locomotion [GO:0040017]; regulation of egg-laying behavior [GO:0046662]; sarcomere organization [GO:0045214],axon [GO:0030424]; dystrophin-associated glycoprotein complex [GO:0016010]; striated muscle dense body [GO:0055120],nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase regulator activity [GO:0030235]; structural constituent of muscle [GO:0008307],GO:0005198; GO:0007010; GO:0098772,structural molecule activity; cytoskeleton organization; molecular function regulator activity
OG_10063,FUN_043363-T1,Peve_00016658,Pocillopora_meandrina_HIv1___RNAseq.g8970.t1,three_way,82.36583333333333,FUN_043363-T1,Q8C4Y3,NELFB_MOUSE,,Negative elongation factor B (NELF-B) (Cofactor of BRCA1),Mus musculus (Mouse),45.5,587.0,1.2e-135,485.0,sp|Q8C4Y3|NELFB_MOUSE Negative elongation factor B OS=Mus musculus OX=10090 GN=Nelfb PE=1 SV=2,GO:0003723; GO:0005741; GO:0005829; GO:0008283; GO:0032021; GO:0034244; GO:0048863; GO:2000737,cell population proliferation [GO:0008283]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; stem cell differentiation [GO:0048863],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; NELF complex [GO:0032021],RNA binding [GO:0003723],GO:0003723; GO:0005829; GO:0006355; GO:0030154,RNA binding; cytosol; regulation of DNA-templated transcription; cell differentiation
OG_10064,FUN_043368-T1,Peve_00016662,Pocillopora_meandrina_HIv1___RNAseq.g8973.t1,three_way,54.678666666666665,FUN_043368-T1,Q16880,CGT_HUMAN,,2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase),Homo sapiens (Human),30.1,521.0,2.6e-52,208.0,sp|Q16880|CGT_HUMAN 2-hydroxyacylsphingosine 1-beta-galactosyltransferase OS=Homo sapiens OX=9606 GN=UGT8 PE=1 SV=2,GO:0002175; GO:0003851; GO:0005783; GO:0005789; GO:0006682; GO:0006688; GO:0007010; GO:0007417; GO:0007422; GO:0008489; GO:0030913; GO:0035902; GO:0048812,central nervous system development [GO:0007417]; cytoskeleton organization [GO:0007010]; galactosylceramide biosynthetic process [GO:0006682]; glycosphingolipid biosynthetic process [GO:0006688]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to paranode region of axon [GO:0002175]; response to immobilization stress [GO:0035902],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],"N-acylsphingosine galactosyltransferase activity [GO:0003851]; UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity [GO:0008489]",GO:0003824; GO:0005783; GO:0006629; GO:0007010; GO:0016740; GO:0034330; GO:0043226; GO:0048856; GO:1901135,catalytic activity; endoplasmic reticulum; lipid metabolic process; cytoskeleton organization; transferase activity; cell junction organization; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_10065,FUN_043369-T1,Peve_00011704,Pocillopora_meandrina_HIv1___RNAseq.g8974.t1,three_way,82.904,FUN_043369-T1,Q6NZR5,,,,,51.1,1307.0,0.0,1185.2,sp|Q6NZR5|SKI2_MOUSE Superkiller complex protein 2 OS=Mus musculus OX=10090 GN=Skic2 PE=2 SV=1,,,,,,
OG_10066,FUN_043370-T1,Peve_00004904,Pocillopora_meandrina_HIv1___RNAseq.g8975.t1,three_way,68.366,,,,,,,,,,,,,,,,,
OG_10067,FUN_043371-T1,Peve_00004903,Pocillopora_meandrina_HIv1___RNAseq.g8976.t1,three_way,72.36966666666666,FUN_043371-T1,Q8VHQ9,ACO11_MOUSE,,Acyl-coenzyme A thioesterase 11 (Acyl-CoA thioesterase 11) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 11) (Adipose-associated thioesterase) (Brown fat-inducible thioesterase) (BFIT) (Palmitoyl-coenzyme A thioesterase) (EC 3.1.2.2),Mus musculus (Mouse),44.0,550.0,4.4e-114,413.3,sp|Q8VHQ9|ACO11_MOUSE Acyl-coenzyme A thioesterase 11 OS=Mus musculus OX=10090 GN=Acot11 PE=1 SV=1,GO:0005737; GO:0005759; GO:0005829; GO:0006631; GO:0008289; GO:0009266; GO:0009409; GO:0035556; GO:0047617; GO:0052689; GO:0052816; GO:0120163,fatty acid metabolic process [GO:0006631]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; response to cold [GO:0009409]; response to temperature stimulus [GO:0009266],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759],carboxylic ester hydrolase activity [GO:0052689]; fatty acyl-CoA hydrolase activity [GO:0047617]; lipid binding [GO:0008289]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816],GO:0003824; GO:0005829; GO:0006629; GO:0008289; GO:0016787,catalytic activity; cytosol; lipid metabolic process; lipid binding; hydrolase activity
OG_10068,FUN_043373-T1,Peve_00004901,Pocillopora_meandrina_HIv1___RNAseq.g8977.t1,three_way,57.378,FUN_043373-T1,Q76EC5,,,,,29.8,275.0,1.6000000000000002e-33,144.8,sp|Q76EC5|CHST9_MOUSE Carbohydrate sulfotransferase 9 OS=Mus musculus OX=10090 GN=Chst9 PE=2 SV=1,,,,,,
OG_10069,FUN_043374-T1,Peve_00004909,Pocillopora_meandrina_HIv1___RNAseq.g8978.t1,three_way,63.316,,,,,,,,,,,,,,,,,
OG_10070,FUN_043375-T1,Peve_00004908,Pocillopora_meandrina_HIv1___RNAseq.g8979.t1,three_way,59.082,FUN_043375-T1,Q7T320,,,,,39.1,192.0,1.5e-23,112.1,sp|Q7T320|GORAB_DANRE RAB6-interacting golgin OS=Danio rerio OX=7955 GN=gorab PE=2 SV=1,,,,,,
OG_10071,FUN_043376-T1,Peve_00004907,Pocillopora_meandrina_HIv1___RNAseq.g8980.t1,three_way,66.022,,,,,,,,,,,,,,,,,
OG_10072,FUN_043377-T1,Peve_00004902,Pocillopora_meandrina_HIv1___RNAseq.g8983.t1,three_way,73.03099999999999,FUN_043377-T1,Q5ZIL9,,,,,45.7,588.0,2.2e-138,494.2,sp|Q5ZIL9|KBP_CHICK KIF-binding protein OS=Gallus gallus OX=9031 GN=Kifbp PE=2 SV=1,,,,,,
OG_10073,FUN_043379-T1,Peve_00027430,Pocillopora_meandrina_HIv1___RNAseq.g8985.t1,three_way,83.51266666666666,FUN_043379-T1,Q5F3K4,WDR48_CHICK,,WD repeat-containing protein 48 (USP1-associated factor 1),Gallus gallus (Chicken),62.4,697.0,1.0999999999999999e-189,664.8,sp|Q5F3K4|WDR48_CHICK WD repeat-containing protein 48 OS=Gallus gallus OX=9031 GN=WDR48 PE=2 SV=1,GO:0000724; GO:0003677; GO:0003690; GO:0003697; GO:0005634; GO:0005764; GO:0005770; GO:0006974; GO:0007283; GO:0007338; GO:0035264; GO:0035800; GO:0043130; GO:0043588; GO:0046427; GO:0048568; GO:0048705; GO:0048872; GO:0050679; GO:0072520; GO:1902525; GO:1905168,DNA damage response [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; embryonic organ development [GO:0048568]; homeostasis of number of cells [GO:0048872]; multicellular organism growth [GO:0035264]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of protein monoubiquitination [GO:1902525]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; spermatogenesis [GO:0007283],late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634],deubiquitinase activator activity [GO:0035800]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130],GO:0003677; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0006281; GO:0006310; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0098772,DNA binding; nucleus; lysosome; endosome; vacuole; DNA repair; DNA recombination; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_10074,FUN_043382-T1,Peve_00038075,Pocillopora_meandrina_HIv1___TS.g20712.t1,three_way,72.01299999999999,,,,,,,,,,,,,,,,,
OG_10075,FUN_043383-T1,Peve_00024257,Pocillopora_meandrina_HIv1___RNAseq.g8994.t1,three_way,42.839666666666666,FUN_043383-T1,Q5DTW2,SMBT2_MOUSE,,Scm-like with four MBT domains protein 2,Mus musculus (Mouse),48.4,62.0,7.3e-08,60.1,sp|Q5DTW2|SMBT2_MOUSE Scm-like with four MBT domains protein 2 OS=Mus musculus OX=10090 GN=Sfmbt2 PE=1 SV=2,GO:0003714; GO:0005634; GO:0010629; GO:0042393,negative regulation of gene expression [GO:0010629],nucleus [GO:0005634],histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_10076,FUN_043384-T3,Peve_00024255,Pocillopora_meandrina_HIv1___TS.g20714.t2,three_way,80.06733333333334,FUN_043384-T3,Q5VVW2,,,,,49.2,772.0,8.9e-212,738.4,sp|Q5VVW2|GARL3_HUMAN GTPase-activating Rap/Ran-GAP domain-like protein 3 OS=Homo sapiens OX=9606 GN=GARNL3 PE=1 SV=2,,,,,,
OG_10077,FUN_043385-T1,Peve_00024254,Pocillopora_meandrina_HIv1___RNAseq.g8996.t1,three_way,60.781666666666666,FUN_043385-T1,Q90923,,,,,32.9,474.0,3e-58,229.6,sp|Q90923|NET3_CHICK Netrin-3 (Fragment) OS=Gallus gallus OX=9031 GN=NTN3 PE=2 SV=1,,,,,,
OG_10078,FUN_043387-T1,Peve_00024251,Pocillopora_meandrina_HIv1___RNAseq.g8999.t1,three_way,69.81466666666667,FUN_043387-T1,P02468,LAMC1_MOUSE,,Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma),Mus musculus (Mouse),41.9,1369.0,3.9e-227,790.4,sp|P02468|LAMC1_MOUSE Laminin subunit gamma-1 OS=Mus musculus OX=10090 GN=Lamc1 PE=1 SV=2,GO:0005201; GO:0005576; GO:0005604; GO:0006325; GO:0007155; GO:0010467; GO:0016477; GO:0022617; GO:0031069; GO:0031175; GO:0031581; GO:0031594; GO:0035315; GO:0043083; GO:0043208; GO:0043259; GO:0045785; GO:0048729; GO:0051149; GO:0062023; GO:0065003; GO:0071335; GO:0098637; GO:0110011; GO:2001046,cell adhesion [GO:0007155]; cell migration [GO:0016477]; chromatin organization [GO:0006325]; extracellular matrix disassembly [GO:0022617]; gene expression [GO:0010467]; hair cell differentiation [GO:0035315]; hair follicle cell proliferation [GO:0071335]; hair follicle morphogenesis [GO:0031069]; hemidesmosome assembly [GO:0031581]; neuron projection development [GO:0031175]; positive regulation of cell adhesion [GO:0045785]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of muscle cell differentiation [GO:0051149]; protein-containing complex assembly [GO:0065003]; regulation of basement membrane organization [GO:0110011]; tissue morphogenesis [GO:0048729],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin-10 complex [GO:0043259]; neuromuscular junction [GO:0031594]; protein complex involved in cell-matrix adhesion [GO:0098637]; synaptic cleft [GO:0043083],extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208],GO:0005198; GO:0005576; GO:0006325; GO:0007155; GO:0008289; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0034330; GO:0048870; GO:0065003,structural molecule activity; extracellular region; chromatin organization; cell adhesion; lipid binding; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; cell junction organization; cell motility; protein-containing complex assembly
OG_10079,FUN_043389-T1,Peve_00024250,Pocillopora_meandrina_HIv1___RNAseq.g9000.t1,three_way,64.57716666666667,FUN_043389-T1,Q64322,,,,,41.2,131.0,5.3e-15,83.6,sp|Q64322|NPDC1_MOUSE Neural proliferation differentiation and control protein 1 OS=Mus musculus OX=10090 GN=Npdc1 PE=2 SV=2,,,,,,
OG_10080,FUN_043390-T1,Peve_00024249,Pocillopora_meandrina_HIv1___RNAseq.g9001.t1,three_way,67.44416666666666,FUN_043390-T1,A7SBN6,,,,,51.0,480.0,1.3e-114,414.8,sp|A7SBN6|ZGPAT_NEMVE Zinc finger CCCH-type with G patch domain-containing protein OS=Nematostella vectensis OX=45351 GN=v1g244155 PE=3 SV=1,,,,,,
OG_10081,FUN_043392-T1,Peve_00024262,Pocillopora_meandrina_HIv1___RNAseq.g9003.t1,three_way,69.4955,FUN_043392-T1,Q32P51,RA1L2_HUMAN,,Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2),Homo sapiens (Human),40.3,186.0,4.3e-31,137.1,sp|Q32P51|RA1L2_HUMAN Heterogeneous nuclear ribonucleoprotein A1-like 2 OS=Homo sapiens OX=9606 GN=HNRNPA1L2 PE=1 SV=2,GO:0000398; GO:0003723; GO:0005737; GO:0051028; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737],RNA binding [GO:0003723],GO:0003723; GO:0016071,RNA binding; mRNA metabolic process
OG_10082,FUN_043399-T1,Peve_00024256,Pocillopora_meandrina_HIv1___RNAseq.g9063.t2,three_way,80.929,FUN_043399-T1,Q9NVG8,,,,,60.4,356.0,4.2e-118,426.0,sp|Q9NVG8|TBC13_HUMAN TBC1 domain family member 13 OS=Homo sapiens OX=9606 GN=TBC1D13 PE=1 SV=3,,,,,,
OG_10083,FUN_043400-T1,Peve_00024252,Pocillopora_meandrina_HIv1___RNAseq.g9065.t1,three_way,77.465,FUN_043400-T1,Q5R513,MPPA_PONAB,,Mitochondrial-processing peptidase subunit alpha (Alpha-MPP) (Inactive zinc metalloprotease alpha),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),47.8,435.0,3.7e-116,419.9,sp|Q5R513|MPPA_PONAB Mitochondrial-processing peptidase subunit alpha OS=Pongo abelii OX=9601 GN=PMPCA PE=2 SV=2,GO:0004222; GO:0005743; GO:0005759; GO:0006627; GO:0046872,protein processing involved in protein targeting to mitochondrion [GO:0006627],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_10084,FUN_043401-T1,Peve_00024054,Pocillopora_meandrina_HIv1___RNAseq.g9066.t1,three_way,43.906,,,,,,,,,,,,,,,,,
OG_10085,FUN_043403-T1,Peve_00007567,Pocillopora_meandrina_HIv1___RNAseq.g9068.t1,three_way,45.621,,,,,,,,,,,,,,,,,
OG_10086,FUN_043412-T1,Peve_00045006,Pocillopora_meandrina_HIv1___RNAseq.g7824.t1,three_way,79.78466666666667,FUN_043412-T1,P54319,,,,,54.9,814.0,2.6e-171,604.0,sp|P54319|PLAP_RAT Phospholipase A-2-activating protein OS=Rattus norvegicus OX=10116 GN=Plaa PE=1 SV=3,,,,,,
OG_10087,FUN_043414-T1,Peve_00045005,Pocillopora_meandrina_HIv1___RNAseq.g7825.t1,three_way,56.5365,FUN_043414-T1,Q69Z28,ATS16_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Mus musculus (Mouse),30.5,1138.0,9.8e-129,463.0,sp|Q69Z28|ATS16_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Mus musculus OX=10090 GN=Adamts16 PE=2 SV=2,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; catalytic activity, acting on a protein"
OG_10088,FUN_043417-T1,Peve_00026858,Pocillopora_meandrina_HIv1___RNAseq.g7829.t1,three_way,78.89,FUN_043417-T1,Q28DG7,,,,,43.1,390.0,3.9e-66,253.4,sp|Q28DG7|UBAC1_XENTR Ubiquitin-associated domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=ubac1 PE=2 SV=1,,,,,,
OG_10089,FUN_043418-T1,Peve_00026856,Pocillopora_meandrina_HIv1___RNAseq.g7830.t1,three_way,78.10233333333333,,,,,,,,,,,,,,,,,
OG_10090,FUN_043420-T1,Peve_00005576,Pocillopora_meandrina_HIv1___TS.g1600.t1,three_way,92.59866666666667,FUN_043420-T1,Q13813,,,,,59.0,2468.0,0.0,2752.6,"sp|Q13813|SPTN1_HUMAN Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTAN1 PE=1 SV=3",,,,,,
OG_10091,FUN_043421-T2,Peve_00005574,Pocillopora_meandrina_HIv1___RNAseq.g7847.t2,three_way,87.131,FUN_043421-T2,Q28141,DHX9_BOVIN,,ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (Nuclear DNA helicase II) (NDH II),Bos taurus (Bovine),58.5,1043.0,0.0,1176.8,sp|Q28141|DHX9_BOVIN ATP-dependent RNA helicase A OS=Bos taurus OX=9913 GN=DHX9 PE=1 SV=1,GO:0000380; GO:0000978; GO:0003677; GO:0003688; GO:0003690; GO:0003697; GO:0003713; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0005737; GO:0005813; GO:0006260; GO:0006325; GO:0006353; GO:0006954; GO:0015629; GO:0016442; GO:0016604; GO:0016887; GO:0017111; GO:0031490; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0033679; GO:0034458; GO:0035195; GO:0035613; GO:0036464; GO:0043138; GO:0045087; GO:0045142; GO:0045739; GO:0045740; GO:0045944; GO:0046833; GO:0046872; GO:0047429; GO:0048146; GO:0048511; GO:0050684; GO:0051028; GO:0051092; GO:0060760; GO:0061676; GO:0070063; GO:0070578; GO:0070922; GO:0070937; GO:0071360; GO:0097165; GO:0140640; GO:1905172; GO:1990518; GO:1990825; GO:1990841; GO:1990904; GO:2000765; GO:2000767,"alternative mRNA splicing, via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; chromatin organization [GO:0006325]; DNA replication [GO:0006260]; DNA-templated transcription termination [GO:0006353]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; miRNA-mediated post-transcriptional gene silencing [GO:0035195]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; rhythmic process [GO:0048511]; RISC complex assembly [GO:0070922]",actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578],"3'-5' DNA helicase activity [GO:0043138]; 3'-5' DNA/RNA helicase activity [GO:0033679]; 3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside triphosphate diphosphatase activity [GO:0047429]; promoter-specific chromatin binding [GO:1990841]; ribonucleoside triphosphate phosphatase activity [GO:0017111]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase binding [GO:0070063]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]",GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005815; GO:0005856; GO:0006260; GO:0006325; GO:0006355; GO:0006954; GO:0016071; GO:0016787; GO:0016853; GO:0031047; GO:0043226; GO:0060090; GO:0065003; GO:0098542; GO:0140097; GO:0140098; GO:0140110; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; microtubule organizing center; cytoskeleton; DNA replication; chromatin organization; regulation of DNA-templated transcription; inflammatory response; mRNA metabolic process; hydrolase activity; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on DNA; catalytic activity, acting on RNA; transcription regulator activity; ATP-dependent activity"
OG_10092,FUN_043422-T1,Peve_00022204,Pocillopora_meandrina_HIv1___RNAseq.g7846.t1,three_way,90.86,FUN_043422-T1,Q5ZLM0,,,,,61.8,523.0,7e-167,588.6,sp|Q5ZLM0|CDC73_CHICK Parafibromin OS=Gallus gallus OX=9031 GN=CDC73 PE=2 SV=1,,,,,,
OG_10093,FUN_043424-T1,Peve_00022202,Pocillopora_meandrina_HIv1___RNAseq.g7845.t1,three_way,57.81816666666666,,,,,,,,,,,,,,,,,
OG_10094,FUN_043425-T1,Peve_00041795,Pocillopora_meandrina_HIv1___RNAseq.g7842.t1,three_way,85.91533333333334,FUN_043425-T1,A7MBH5,ODAD3_BOVIN,,Outer dynein arm-docking complex subunit 3 (Coiled-coil domain-containing protein 151),Bos taurus (Bovine),36.1,559.0,2.3e-62,241.5,sp|A7MBH5|ODAD3_BOVIN Outer dynein arm-docking complex subunit 3 OS=Bos taurus OX=9913 GN=ODAD3 PE=1 SV=1,GO:0003341; GO:0005814; GO:0005929; GO:0005930; GO:0035253; GO:0036064; GO:0036158; GO:0097542; GO:0120228; GO:1902017,cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; regulation of cilium assembly [GO:1902017],axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary tip [GO:0097542]; cilium [GO:0005929]; outer dynein arm docking complex [GO:0120228],,GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0065003,microtubule organizing center; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_10095,FUN_043427-T1,Peve_00041803,Pocillopora_meandrina_HIv1___RNAseq.g7840.t1,three_way,67.638,,,,,,,,,,,,,,,,,
OG_10096,FUN_043428-T1,Peve_00028848,Pocillopora_meandrina_HIv1___RNAseq.g7838.t1,three_way,67.12,FUN_043428-T1,O42409,,,,,84.0,50.0,4.5e-20,100.5,sp|O42409|GFI1B_CHICK Zinc finger protein Gfi-1b OS=Gallus gallus OX=9031 GN=GFI1B PE=2 SV=1,,,,,,
OG_10097,FUN_043429-T1,Peve_00028846,Pocillopora_meandrina_HIv1___RNAseq.g7837.t1,three_way,59.028,,,,,,,,,,,,,,,,,
OG_10098,FUN_043432-T1,Peve_00028843,Pocillopora_meandrina_HIv1___RNAseq.g7835.t1,three_way,77.25450000000001,FUN_043432-T1,Q6NT16,S18B1_HUMAN,,MFS-type transporter SLC18B1 (Solute carrier family 18 member B1) (Vesicular polyamine transporter) (VPAT),Homo sapiens (Human),38.8,387.0,1.0000000000000001e-66,255.8,sp|Q6NT16|S18B1_HUMAN MFS-type transporter SLC18B1 OS=Homo sapiens OX=9606 GN=SLC18B1 PE=1 SV=1,GO:0000296; GO:0015311; GO:0015312; GO:0015848; GO:0022857; GO:0030667; GO:0030672; GO:0051610,serotonin uptake [GO:0051610]; spermidine transport [GO:0015848]; spermine transport [GO:0000296],secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672],monoamine:proton antiporter activity [GO:0015311]; polyamine:proton antiporter activity [GO:0015312]; transmembrane transporter activity [GO:0022857],GO:0005215,transporter activity
OG_10099,FUN_043435-T1,Peve_00028842,Pocillopora_meandrina_HIv1___RNAseq.g7834.t1,three_way,66.19233333333334,FUN_043435-T1,Q9WU63,,,,,37.7,151.0,4.9e-23,110.5,sp|Q9WU63|HEBP2_MOUSE Heme-binding protein 2 OS=Mus musculus OX=10090 GN=Hebp2 PE=1 SV=1,,,,,,
OG_10100,FUN_043438-T1,Peve_00028841,Pocillopora_meandrina_HIv1___RNAseq.g7850.t1,three_way,48.59733333333333,FUN_043438-T1,F6RRD7,,,,,49.2,181.0,8.9e-38,159.8,sp|F6RRD7|RPAP2_BOVIN Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 OS=Bos taurus OX=9913 GN=RPAP2 PE=2 SV=1,,,,,,
OG_10101,FUN_043439-T1,Peve_00028851,Pocillopora_meandrina_HIv1___RNAseq.g7000.t1,three_way,91.469,FUN_043439-T1,P62167,,,,,65.2,158.0,4.7e-58,225.7,sp|P62167|NCS1_CHICK Neuronal calcium sensor 1 OS=Gallus gallus OX=9031 GN=NCS1 PE=1 SV=2,,,,,,
OG_10102,FUN_043440-T1,Peve_00028850,Pocillopora_meandrina_HIv1___RNAseq.g7001.t1,three_way,87.993,FUN_043440-T1,P62167,,,,,77.4,190.0,1.4e-83,310.5,sp|P62167|NCS1_CHICK Neuronal calcium sensor 1 OS=Gallus gallus OX=9031 GN=NCS1 PE=1 SV=2,,,,,,
OG_10103,FUN_043441-T1,Peve_00028849,Pocillopora_meandrina_HIv1___TS.g739.t1,three_way,68.189,FUN_043441-T1,Q2KIB7,,,,,36.6,101.0,6.6e-06,51.6,sp|Q2KIB7|BORC7_BOVIN BLOC-1-related complex subunit 7 OS=Bos taurus OX=9913 GN=BORCS7 PE=3 SV=2,,,,,,
OG_10104,FUN_043446-T1,Peve_00028845,Pocillopora_meandrina_HIv1___TS.g1655.t1,three_way,49.04,FUN_043446-T1,O60241,AGRB2_HUMAN,,Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2),Homo sapiens (Human),30.9,175.0,8.7e-11,70.5,sp|O60241|AGRB2_HUMAN Adhesion G protein-coupled receptor B2 OS=Homo sapiens OX=9606 GN=ADGRB2 PE=1 SV=2,GO:0004930; GO:0005576; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0007422; GO:0016020; GO:0016525; GO:0033173; GO:0051965; GO:0098978,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; calcineurin-NFAT signaling cascade [GO:0033173]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of angiogenesis [GO:0016525]; peripheral nervous system development [GO:0007422]; positive regulation of synapse assembly [GO:0051965],extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005576; GO:0005886; GO:0048856; GO:0060089,extracellular region; plasma membrane; anatomical structure development; molecular transducer activity
OG_10105,FUN_043447-T1,Peve_00015294,Pocillopora_meandrina_HIv1___RNAseq.g7900.t1,three_way,62.12,FUN_043447-T1,Q9Z148,EHMT2_MOUSE,,Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.367) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a),Mus musculus (Mouse),35.3,538.0,2.6e-88,328.6,sp|Q9Z148|EHMT2_MOUSE Histone-lysine N-methyltransferase EHMT2 OS=Mus musculus OX=10090 GN=Ehmt2 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000977; GO:0001222; GO:0002039; GO:0005634; GO:0005654; GO:0006275; GO:0006346; GO:0006357; GO:0007130; GO:0007286; GO:0008270; GO:0009267; GO:0009566; GO:0016279; GO:0016607; GO:0018027; GO:0035265; GO:0036166; GO:0044027; GO:0046974; GO:0046976; GO:0048148; GO:0048599; GO:0048665; GO:0070742; GO:0071314; GO:0140759; GO:0140947; GO:1902902; GO:1990841,behavioral response to cocaine [GO:0048148]; cellular response to cocaine [GO:0071314]; cellular response to starvation [GO:0009267]; DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; fertilization [GO:0009566]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron fate specification [GO:0048665]; oocyte development [GO:0048599]; organ growth [GO:0035265]; peptidyl-lysine dimethylation [GO:0018027]; phenotypic switching [GO:0036166]; regulation of DNA replication [GO:0006275]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid development [GO:0007286]; synaptonemal complex assembly [GO:0007130],chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],C2H2 zinc finger domain binding [GO:0070742]; histone H3K27 methyltransferase activity [GO:0046976]; histone H3K56 methyltransferase activity [GO:0140759]; histone H3K9 methyltransferase activity [GO:0046974]; histone H3K9me2 methyltransferase activity [GO:0140947]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protein-lysine N-methyltransferase activity [GO:0016279]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10106,FUN_043448-T1,Peve_00015295,Pocillopora_meandrina_HIv1___RNAseq.g7901.t1,three_way,74.55666666666667,FUN_043448-T1,Q3UNX5,ACSM3_MOUSE,,"Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Propionate--CoA ligase) (EC 6.2.1.17) (Protein SA homolog)",Mus musculus (Mouse),55.6,347.0,4.4e-119,429.5,"sp|Q3UNX5|ACSM3_MOUSE Acyl-coenzyme A synthetase ACSM3, mitochondrial OS=Mus musculus OX=10090 GN=Acsm3 PE=1 SV=2",GO:0005524; GO:0005739; GO:0005759; GO:0006633; GO:0015645; GO:0018729; GO:0031956; GO:0043759; GO:0046872; GO:0050218,fatty acid biosynthetic process [GO:0006633],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],2-methylbutanoate-CoA ligase activity [GO:0043759]; ATP binding [GO:0005524]; fatty acid ligase activity [GO:0015645]; medium-chain fatty acid-CoA ligase activity [GO:0031956]; metal ion binding [GO:0046872]; propionate CoA-transferase activity [GO:0018729]; propionate-CoA ligase activity [GO:0050218],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0016874; GO:0043226; GO:0140657,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; ligase activity; organelle; ATP-dependent activity
OG_10107,FUN_043455-T1,Peve_00031074,Pocillopora_meandrina_HIv1___RNAseq.g7903.t1,three_way,72.78833333333333,,,,,,,,,,,,,,,,,
OG_10108,FUN_043456-T1,Peve_00031070,Pocillopora_meandrina_HIv1___RNAseq.g7904.t1,three_way,80.63666666666667,FUN_043456-T1,Q9JM13,RABX5_MOUSE,,Rab5 GDP/GTP exchange factor (Rabex-5),Mus musculus (Mouse),40.0,468.0,2.6e-94,347.4,sp|Q9JM13|RABX5_MOUSE Rab5 GDP/GTP exchange factor OS=Mus musculus OX=10090 GN=Rabgef1 PE=1 SV=1,GO:0002686; GO:0003677; GO:0005085; GO:0005730; GO:0005769; GO:0005829; GO:0006612; GO:0006898; GO:0007265; GO:0008270; GO:0015031; GO:0030425; GO:0031267; GO:0031982; GO:0032715; GO:0032764; GO:0033004; GO:0038109; GO:0043303; GO:0043305; GO:0046580; GO:0048261; GO:0050728; GO:0051649; GO:0055037; GO:0060368; GO:0061630; GO:0097531; GO:0098830; GO:0098935; GO:1900235,dendritic transport [GO:0098935]; establishment of localization in cell [GO:0051649]; Kit signaling pathway [GO:0038109]; mast cell degranulation [GO:0043303]; mast cell migration [GO:0097531]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of Kit signaling pathway [GO:1900235]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mast cell activation [GO:0033004]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of receptor-mediated endocytosis [GO:0048261]; protein targeting to membrane [GO:0006612]; protein transport [GO:0015031]; Ras protein signal transduction [GO:0007265]; receptor-mediated endocytosis [GO:0006898]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; nucleolus [GO:0005730]; presynaptic endosome [GO:0098830]; recycling endosome [GO:0055037]; vesicle [GO:0031982],DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005730; GO:0005768; GO:0005829; GO:0007018; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0048870; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; nucleolus; endosome; cytosol; microtubule-based movement; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10109,FUN_043479-T1,Peve_00021731,Pocillopora_meandrina_HIv1___RNAseq.g7915.t1,three_way,47.53266666666666,,,,,,,,,,,,,,,,,
OG_10110,FUN_043480-T1,Peve_00021725,Pocillopora_meandrina_HIv1___RNAseq.g7918.t1,three_way,87.28833333333333,FUN_043480-T1,Q8UVR3,,,,,49.4,237.0,7.3e-58,226.1,sp|Q8UVR3|LMX1B_XENLA LIM homeobox transcription factor 1-beta.1 OS=Xenopus laevis OX=8355 GN=lmx1b.1 PE=2 SV=1,,,,,,
OG_10111,FUN_043481-T1,Peve_00021726,Pocillopora_meandrina_HIv1___RNAseq.g7917.t1,three_way,78.01516666666667,FUN_043481-T1,Q6GLQ4,,,,,30.6,710.0,2.3999999999999998e-39,165.6,sp|Q6GLQ4|PP1RA_XENLA Serine/threonine-protein phosphatase 1 regulatory subunit 10 OS=Xenopus laevis OX=8355 GN=ppp1r10 PE=2 SV=1,,,,,,
OG_10112,FUN_043482-T1,Peve_00021727,Pocillopora_meandrina_HIv1___RNAseq.g7916.t1,three_way,54.00966666666667,,,,,,,,,,,,,,,,,
OG_10113,FUN_043483-T1,Peve_00021710,Pocillopora_meandrina_HIv1___RNAseq.g7933.t1,three_way,81.26899999999999,FUN_043483-T1,Q96E35,,,,,48.1,241.0,4.4e-58,226.1,sp|Q96E35|ZMY19_HUMAN Zinc finger MYND domain-containing protein 19 OS=Homo sapiens OX=9606 GN=ZMYND19 PE=1 SV=1,,,,,,
OG_10114,FUN_043484-T1,Peve_00021709,Pocillopora_meandrina_HIv1___RNAseq.g7934.t1,three_way,54.963,FUN_043484-T1,Q8R2H1,,,,,25.2,357.0,1.1e-17,92.4,sp|Q8R2H1|IKBL1_RAT NF-kappa-B inhibitor-like protein 1 OS=Rattus norvegicus OX=10116 GN=Nfkbil1 PE=2 SV=2,,,,,,
OG_10115,FUN_043488-T1,Peve_00021724,Pocillopora_meandrina_HIv1___RNAseq.g7937.t1,three_way,57.274,,,,,,,,,,,,,,,,,
OG_10116,FUN_043491-T1,Peve_00008684,Pocillopora_meandrina_HIv1___RNAseq.g7963.t1,three_way,83.608,FUN_043491-T1,A8WGF7,,,,,26.4,406.0,2.9e-13,78.6,sp|A8WGF7|SPNS1_XENTR Protein spinster homolog 1 OS=Xenopus tropicalis OX=8364 GN=spns1 PE=2 SV=2,,,,,,
OG_10117,FUN_043492-T1,Peve_00008687,Pocillopora_meandrina_HIv1___RNAseq.g7961.t1,three_way,79.793,FUN_043492-T1,O95295,,,,,57.5,113.0,2.1e-27,123.2,sp|O95295|SNAPN_HUMAN SNARE-associated protein Snapin OS=Homo sapiens OX=9606 GN=SNAPIN PE=1 SV=1,,,,,,
OG_10118,FUN_043494-T1,Peve_00024917,Pocillopora_meandrina_HIv1___RNAseq.g7959.t1,three_way,56.26416666666667,,,,,,,,,,,,,,,,,
OG_10119,FUN_043495-T1,Peve_00024915,Pocillopora_meandrina_HIv1___TS.g1707.t3,three_way,64.6395,FUN_043495-T1,Q7Z7A1,CNTRL_HUMAN,,Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110),Homo sapiens (Human),33.3,916.0,5.599999999999998e-29,132.9,sp|Q7Z7A1|CNTRL_HUMAN Centriolin OS=Homo sapiens OX=9606 GN=CNTRL PE=1 SV=2,GO:0001822; GO:0003281; GO:0005794; GO:0005813; GO:0005815; GO:0005829; GO:0005886; GO:0016020; GO:0034451; GO:0035904; GO:0036064; GO:0048471; GO:0051301; GO:0060976; GO:0090543; GO:0090619; GO:0097431; GO:0120103,aorta development [GO:0035904]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; ventricular septum development [GO:0003281],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],,GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0048856,Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; organelle; anatomical structure development
OG_10120,FUN_043496-T1,Peve_00024914,Pocillopora_meandrina_HIv1___RNAseq.g7956.t1,three_way,81.046,FUN_043496-T1,Q9D2R8,,,,,45.1,102.0,1.4e-13,77.0,sp|Q9D2R8|RT33_MOUSE Small ribosomal subunit protein mS33 OS=Mus musculus OX=10090 GN=Mrps33 PE=1 SV=1,,,,,,
OG_10121,FUN_043499-T1,Peve_00024907,Pocillopora_meandrina_HIv1___RNAseq.g7964.t1,three_way,56.86333333333334,FUN_043499-T1,P82279,CRUM1_HUMAN,,Protein crumbs homolog 1,Homo sapiens (Human),23.8,741.0,3.6e-48,196.4,sp|P82279|CRUM1_HUMAN Protein crumbs homolog 1 OS=Homo sapiens OX=9606 GN=CRB1 PE=1 SV=2,GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0008104; GO:0010001; GO:0010467; GO:0010842; GO:0016324; GO:0032991; GO:0035003; GO:0035845; GO:0042462; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0071482; GO:0097386,blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; protein localization [GO:0008104]; retina layer formation [GO:0010842],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003],calcium ion binding [GO:0005509],GO:0005576; GO:0005886; GO:0007155; GO:0007163; GO:0023052; GO:0030154; GO:0048856; GO:0061024,extracellular region; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; signaling; cell differentiation; anatomical structure development; membrane organization
OG_10122,FUN_043500-T1,Peve_00024905,Pocillopora_meandrina_HIv1___RNAseq.g7966.t1,three_way,90.83083333333332,FUN_043500-T1,Q9DCD2,,,,,62.9,852.0,2e-304,1046.2,sp|Q9DCD2|SYF1_MOUSE Pre-mRNA-splicing factor SYF1 OS=Mus musculus OX=10090 GN=Xab2 PE=1 SV=1,,,,,,
OG_10123,FUN_043501-T1,Peve_00024904,Pocillopora_meandrina_HIv1___RNAseq.g7967.t1,three_way,79.778,FUN_043501-T1,Q13526,PIN1_HUMAN,,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1),Homo sapiens (Human),61.1,157.0,1.1e-48,194.1,sp|Q13526|PIN1_HUMAN Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 OS=Homo sapiens OX=9606 GN=PIN1 PE=1 SV=1,GO:0000413; GO:0001666; GO:0001934; GO:0003755; GO:0003774; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006626; GO:0007088; GO:0007266; GO:0008013; GO:0010468; GO:0016607; GO:0016859; GO:0030182; GO:0030496; GO:0030512; GO:0031434; GO:0031647; GO:0032091; GO:0032465; GO:0032794; GO:0036064; GO:0042177; GO:0045944; GO:0048156; GO:0050808; GO:0050815; GO:0050816; GO:0050821; GO:0051219; GO:0060392; GO:0070373; GO:0071456; GO:0090263; GO:0098978; GO:0099524; GO:1900180; GO:1902430; GO:1990757; GO:2000146,cellular response to hypoxia [GO:0071456]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein binding [GO:0032091]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuron differentiation [GO:0030182]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein peptidyl-prolyl isomerization [GO:0000413]; protein stabilization [GO:0050821]; protein targeting to mitochondrion [GO:0006626]; regulation of cytokinesis [GO:0032465]; regulation of gene expression [GO:0010468]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; response to hypoxia [GO:0001666]; Rho protein signal transduction [GO:0007266]; synapse organization [GO:0050808],ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524],beta-catenin binding [GO:0008013]; cis-trans isomerase activity [GO:0016859]; cytoskeletal motor activity [GO:0003774]; GTPase activating protein binding [GO:0032794]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; phosphothreonine residue binding [GO:0050816]; tau protein binding [GO:0048156]; ubiquitin ligase activator activity [GO:1990757],GO:0003774; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0008092; GO:0016853; GO:0030154; GO:0034330; GO:0043226; GO:0098772; GO:0140096,"cytoskeletal motor activity; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeletal protein binding; isomerase activity; cell differentiation; cell junction organization; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10124,FUN_043502-T1,Peve_00024903,Pocillopora_meandrina_HIv1___RNAseq.g7968.t1,three_way,87.12333333333333,FUN_043502-T1,Q642A5,,,,,71.7,99.0,8.2e-34,144.8,sp|Q642A5|DPOE3_RAT DNA polymerase epsilon subunit 3 OS=Rattus norvegicus OX=10116 GN=Pole3 PE=1 SV=1,,,,,,
OG_10125,FUN_043503-T1,Peve_00024902,Pocillopora_meandrina_HIv1___RNAseq.g7969.t1,three_way,98.50533333333334,FUN_043503-T1,P67868,,,,,94.1,205.0,2.2e-117,422.9,sp|P67868|CSK2B_BOVIN Casein kinase II subunit beta OS=Bos taurus OX=9913 GN=CSNK2B PE=1 SV=1,,,,,,
OG_10126,FUN_043504-T1,Peve_00024900,Pocillopora_meandrina_HIv1___RNAseq.g7970.t1,three_way,98.85533333333332,FUN_043504-T1,Q9Y333,LSM2_HUMAN,,U6 snRNA-associated Sm-like protein LSm2 (Protein G7b) (Small nuclear ribonuclear protein D homolog) (snRNP core Sm-like protein Sm-x5),Homo sapiens (Human),86.2,94.0,1.4e-39,163.7,sp|Q9Y333|LSM2_HUMAN U6 snRNA-associated Sm-like protein LSm2 OS=Homo sapiens OX=9606 GN=LSM2 PE=1 SV=1,GO:0000244; GO:0000398; GO:0000932; GO:0003723; GO:0005634; GO:0005654; GO:0005688; GO:0005737; GO:0005829; GO:0006402; GO:0017070; GO:0031267; GO:0046540; GO:0071005; GO:0071011; GO:0071013; GO:0120115; GO:1990726,"mRNA catabolic process [GO:0006402]; mRNA splicing, via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688],RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; U6 snRNA binding [GO:0017070],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_10127,FUN_043505-T1,Peve_00024899,Pocillopora_meandrina_HIv1___RNAseq.g7971.t1,three_way,91.31233333333331,FUN_043505-T1,O09061,PSB1_MOUSE,,Proteasome subunit beta type-1 (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain) (Proteasome subunit beta-6) (beta-6),Mus musculus (Mouse),68.1,226.0,1.3e-88,327.4,sp|O09061|PSB1_MOUSE Proteasome subunit beta type-1 OS=Mus musculus OX=10090 GN=Psmb1 PE=1 SV=1,GO:0005654; GO:0005829; GO:0005839; GO:0019774; GO:0051603,proteolysis involved in protein catabolic process [GO:0051603],"cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]",,GO:0005654; GO:0005829,nucleoplasm; cytosol
OG_10128,FUN_043506-T1,Peve_00024898,Pocillopora_meandrina_HIv1___RNAseq.g7991.t2,three_way,71.03933333333333,FUN_043506-T1,Q9IAK8,TBX5A_DANRE,,T-box transcription factor TBX5-A (zftbx5a) (T-box protein 5) (zTbx5),Danio rerio (Zebrafish) (Brachydanio rerio),39.9,233.0,2.7e-41,171.0,sp|Q9IAK8|TBX5A_DANRE T-box transcription factor TBX5-A OS=Danio rerio OX=7955 GN=tbx5a PE=2 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0001947; GO:0003007; GO:0003143; GO:0003146; GO:0003190; GO:0003206; GO:0003218; GO:0003294; GO:0003342; GO:0003344; GO:0003700; GO:0005634; GO:0005737; GO:0006351; GO:0006355; GO:0006357; GO:0007389; GO:0007507; GO:0009887; GO:0015629; GO:0021554; GO:0032991; GO:0032993; GO:0033339; GO:0035050; GO:0035118; GO:0035138; GO:0036302; GO:0043565; GO:0045893; GO:0045944; GO:0055007; GO:0060042; GO:0060174; GO:0061026; GO:0061629,animal organ morphogenesis [GO:0009887]; atrial ventricular junction remodeling [GO:0003294]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; cardiac chamber morphogenesis [GO:0003206]; cardiac left ventricle formation [GO:0003218]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle tissue regeneration [GO:0061026]; cell fate specification [GO:0001708]; DNA-templated transcription [GO:0006351]; embryonic heart tube development [GO:0035050]; embryonic heart tube morphogenesis [GO:0003143]; embryonic pectoral fin morphogenesis [GO:0035118]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; limb bud formation [GO:0060174]; optic nerve development [GO:0021554]; pattern specification process [GO:0007389]; pectoral fin development [GO:0033339]; pectoral fin morphogenesis [GO:0035138]; pericardium morphogenesis [GO:0003344]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proepicardium development [GO:0003342]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; retina morphogenesis in camera-type eye [GO:0060042],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0005856; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_10129,FUN_043508-T1,Peve_00033841,Pocillopora_meandrina_HIv1___RNAseq.g7974.t1,three_way,83.73433333333334,FUN_043508-T1,Q3TXU5,,,,,67.4,350.0,3.5e-144,512.7,sp|Q3TXU5|DHYS_MOUSE Deoxyhypusine synthase OS=Mus musculus OX=10090 GN=Dhps PE=1 SV=2,,,,,,
OG_10130,FUN_043510-T1,Peve_00018552,Pocillopora_meandrina_HIv1___RNAseq.g7994.t1,three_way,87.425,FUN_043510-T1,Q0VFN8,,,,,58.4,245.0,9.4e-64,246.1,sp|Q0VFN8|CF157_XENTR Cilia- and flagella-associated protein 157 OS=Xenopus tropicalis OX=8364 GN=cfap157 PE=2 SV=1,,,,,,
OG_10131,FUN_043513-T1,Peve_00011968,Pocillopora_meandrina_HIv1___RNAseq.g7999.t1,three_way,51.190666666666665,,,,,,,,,,,,,,,,,
OG_10132,FUN_043515-T1,Peve_00040847,Pocillopora_meandrina_HIv1___RNAseq.g15975.t1,three_way,75.199,,,,,,,,,,,,,,,,,
OG_10133,FUN_043517-T1,Peve_00017256,Pocillopora_meandrina_HIv1___RNAseq.g8028.t1,three_way,92.006,FUN_043517-T1,O61491,,,,,66.1,419.0,1.6e-84,314.7,sp|O61491|FLOT1_DROME Flotillin-1 OS=Drosophila melanogaster OX=7227 GN=Flo1 PE=2 SV=1,,,,,,
OG_10134,FUN_043519-T1,Peve_00016245,Pocillopora_meandrina_HIv1___RNAseq.g8030.t1,three_way,81.026,FUN_043519-T1,A7RWD2,,,,,79.0,324.0,1.8e-49,198.0,sp|A7RWD2|CIAO1_NEMVE Probable cytosolic iron-sulfur protein assembly protein CIAO1 homolog OS=Nematostella vectensis OX=45351 GN=v1g226592 PE=3 SV=1,,,,,,
OG_10135,FUN_043520-T1,Peve_00016242,Pocillopora_meandrina_HIv1___RNAseq.g8031.t1,three_way,87.03166666666667,FUN_043520-T1,Q6QLW4,,,,,84.7,85.0,1.0000000000000001e-39,163.7,sp|Q6QLW4|CYC_PECGU Cytochrome c OS=Pectinaria gouldii OX=260746 PE=3 SV=1,,,,,,
OG_10136,FUN_043521-T1,Peve_00016243,Pocillopora_meandrina_HIv1___RNAseq.g8032.t1,three_way,84.66666666666667,FUN_043521-T1,Q641B9,,,,,62.0,150.0,4.6e-42,172.2,sp|Q641B9|APC5C_XENLA Actin-related protein 2/3 complex subunit 5-C OS=Xenopus laevis OX=8355 GN=arpc5-c PE=2 SV=1,,,,,,
OG_10137,FUN_043522-T1,Peve_00015611,Pocillopora_meandrina_HIv1___RNAseq.g8037.t1,three_way,57.667,FUN_043522-T1,P63157,BARH1_MOUSE,,BarH-like 1 homeobox protein (Bar-class homeodomain protein MBH2) (BarH-related homeobox protein 1),Mus musculus (Mouse),43.9,132.0,9.9e-17,88.6,sp|P63157|BARH1_MOUSE BarH-like 1 homeobox protein OS=Mus musculus OX=10090 GN=Barhl1 PE=2 SV=1,GO:0001228; GO:0001764; GO:0005634; GO:0007605; GO:0030901; GO:0043524; GO:0045944; GO:0051402; GO:1905584; GO:1905586; GO:1990837,midbrain development [GO:0030901]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of outer hair cell apoptotic process [GO:1905586]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; outer hair cell apoptotic process [GO:1905584]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory perception of sound [GO:0007605],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0012501; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; programmed cell death; organelle; anatomical structure development; cell motility; nervous system process; transcription regulator activity
OG_10138,FUN_043525-T1,Peve_00027815,Pocillopora_meandrina_HIv1___RNAseq.g8035.t1,three_way,75.3475,FUN_043525-T1,P53547,,,,,61.0,59.0,2e-11,70.9,sp|P53547|HM01_CAEEL Homeobox protein ceh-1 (Fragment) OS=Caenorhabditis elegans OX=6239 GN=ceh-1 PE=3 SV=1,,,,,,
OG_10139,FUN_043526-T1,Peve_00011962,Pocillopora_meandrina_HIv1___RNAseq.g8034.t1,three_way,58.651,FUN_043526-T1,Q9NY43,,,,,44.1,118.0,1.7e-15,84.3,sp|Q9NY43|BARH2_HUMAN BarH-like 2 homeobox protein OS=Homo sapiens OX=9606 GN=BARHL2 PE=1 SV=2,,,,,,
OG_10140,FUN_043529-T1,Peve_00011972,Pocillopora_meandrina_HIv1___RNAseq.g8039.t1,three_way,62.42733333333334,FUN_043529-T1,P22933,GBRD_MOUSE,,Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) (GABAAR subunit delta),Mus musculus (Mouse),32.4,417.0,2.1e-53,211.5,sp|P22933|GBRD_MOUSE Gamma-aminobutyric acid receptor subunit delta OS=Mus musculus OX=10090 GN=Gabrd PE=2 SV=1,GO:0004890; GO:0005254; GO:0005886; GO:0007214; GO:0030424; GO:0030425; GO:0034707; GO:0043025; GO:0045211; GO:0051932; GO:0098978; GO:0098982; GO:1902711; GO:1904315,"gamma-aminobutyric acid signaling pathway [GO:0007214]; synaptic transmission, GABAergic [GO:0051932]",axon [GO:0030424]; chloride channel complex [GO:0034707]; dendrite [GO:0030425]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],chloride channel activity [GO:0005254]; GABA-A receptor activity [GO:0004890]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0060089,transporter activity; plasma membrane; signaling; molecular transducer activity
OG_10141,FUN_043530-T1,Peve_00011963,Pocillopora_meandrina_HIv1___RNAseq.g8041.t1,three_way,88.138,FUN_043530-T1,O35130,NEP1_MOUSE,,Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1),Mus musculus (Mouse),65.8,225.0,6.3e-83,308.5,sp|O35130|NEP1_MOUSE Ribosomal RNA small subunit methyltransferase NEP1 OS=Mus musculus OX=10090 GN=Emg1 PE=1 SV=1,GO:0001824; GO:0005654; GO:0005694; GO:0005730; GO:0017126; GO:0019843; GO:0032040; GO:0042274; GO:0042802; GO:0070037; GO:0070475,blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; ribosomal small subunit biogenesis [GO:0042274]; rRNA base methylation [GO:0070475],chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040],identical protein binding [GO:0042802]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843],GO:0003723; GO:0003824; GO:0005654; GO:0005694; GO:0005730; GO:0016740; GO:0043226; GO:0048856; GO:0140098,"RNA binding; catalytic activity; nucleoplasm; chromosome; nucleolus; transferase activity; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_10142,FUN_043531-T1,Peve_00011964,Pocillopora_meandrina_HIv1___RNAseq.g8001.t1,three_way,71.50766666666667,FUN_043531-T1,Q5R792,ATG5_PONAB,,Autophagy protein 5 (APG5-like),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),62.4,194.0,1.2e-74,280.8,sp|Q5R792|ATG5_PONAB Autophagy protein 5 OS=Pongo abelii OX=9601 GN=ATG5 PE=2 SV=1,GO:0000045; GO:0000422; GO:0001974; GO:0002718; GO:0005776; GO:0005930; GO:0006325; GO:0006914; GO:0006995; GO:0009410; GO:0009620; GO:0010659; GO:0010667; GO:0016567; GO:0019776; GO:0019883; GO:0030424; GO:0031397; GO:0032480; GO:0034045; GO:0034274; GO:0034727; GO:0035973; GO:0039689; GO:0042311; GO:0044233; GO:0045060; GO:0045087; GO:0045824; GO:0048840; GO:0050687; GO:0050765; GO:0051279; GO:0051607; GO:0055015; GO:0060047; GO:0061908; GO:0070254; GO:0070257; GO:0071500; GO:0098685; GO:0098794; GO:0098930; GO:0098978; GO:0099072; GO:0099170; GO:1901096; GO:1902017; GO:1904093; GO:1904973; GO:2000377,aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; axonal transport [GO:0098930]; blood vessel remodeling [GO:0001974]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to nitrogen starvation [GO:0006995]; cellular response to nitrosative stress [GO:0071500]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; heart contraction [GO:0060047]; innate immune response [GO:0045087]; mucus secretion [GO:0070254]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of defense response to virus [GO:0050687]; negative regulation of innate immune response [GO:0045824]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of type I interferon production [GO:0032480]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of mucus secretion [GO:0070257]; positive regulation of viral translation [GO:1904973]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein ubiquitination [GO:0016567]; regulation of autophagosome maturation [GO:1901096]; regulation of cilium assembly [GO:1902017]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to fungus [GO:0009620]; response to xenobiotic stimulus [GO:0009410]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015],Atg12-Atg5-Atg16 complex [GO:0034274]; autophagosome [GO:0005776]; axon [GO:0030424]; axoneme [GO:0005930]; glutamatergic synapse [GO:0098978]; mitochondria-associated endoplasmic reticulum membrane contact site [GO:0044233]; phagophore [GO:0061908]; phagophore assembly site membrane [GO:0034045]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685],Atg8-family ligase activity [GO:0019776],GO:0002376; GO:0003013; GO:0003824; GO:0005773; GO:0006325; GO:0006914; GO:0007018; GO:0012501; GO:0016740; GO:0043226; GO:0048856; GO:0098542; GO:0140096,"immune system process; circulatory system process; catalytic activity; vacuole; chromatin organization; autophagy; microtubule-based movement; programmed cell death; transferase activity; organelle; anatomical structure development; defense response to other organism; catalytic activity, acting on a protein"
OG_10143,FUN_043532-T1,Peve_00011701,Pocillopora_meandrina_HIv1___RNAseq.g7872.t2,three_way,69.67033333333333,FUN_043532-T1,Q96AE4,FUBP1_HUMAN,,Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V),Homo sapiens (Human),39.9,471.0,6.300000000000001e-73,277.3,sp|Q96AE4|FUBP1_HUMAN Far upstream element-binding protein 1 OS=Homo sapiens OX=9606 GN=FUBP1 PE=1 SV=3,GO:0003697; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0006357; GO:0010628,positive regulation of gene expression [GO:0010628]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle
OG_10144,FUN_043534-T1,Peve_00011700,Pocillopora_meandrina_HIv1___RNAseq.g7871.t1,three_way,76.01166666666667,FUN_043534-T1,Q7T381,BOKB_DANRE,,Bcl-2-related ovarian killer protein homolog B (zBok2),Danio rerio (Zebrafish) (Brachydanio rerio),38.0,71.0,1.1e-09,64.3,sp|Q7T381|BOKB_DANRE Bcl-2-related ovarian killer protein homolog B OS=Danio rerio OX=7955 GN=bokb PE=2 SV=1,GO:0005741; GO:0006915; GO:0015267; GO:0042981,apoptotic process [GO:0006915]; regulation of apoptotic process [GO:0042981],mitochondrial outer membrane [GO:0005741],channel activity [GO:0015267],GO:0005215; GO:0012501,transporter activity; programmed cell death
OG_10145,FUN_043535-T1,Peve_00016667,Pocillopora_meandrina_HIv1___RNAseq.g8056.t1,three_way,80.87466666666667,FUN_043535-T1,O14733,,,,,44.9,256.0,1.8e-48,194.5,sp|O14733|MP2K7_HUMAN Dual specificity mitogen-activated protein kinase kinase 7 OS=Homo sapiens OX=9606 GN=MAP2K7 PE=1 SV=2,,,,,,
OG_10146,FUN_043536-T1,Peve_00016668,Pocillopora_meandrina_HIv1___RNAseq.g8057.t1,three_way,72.70433333333334,FUN_043536-T1,Q03393,PTPS_HUMAN,,6-pyruvoyl tetrahydrobiopterin synthase (PTP synthase) (PTPS) (EC 4.2.3.12),Homo sapiens (Human),51.5,132.0,5.2e-34,145.6,sp|Q03393|PTPS_HUMAN 6-pyruvoyl tetrahydrobiopterin synthase OS=Homo sapiens OX=9606 GN=PTS PE=1 SV=1,GO:0003874; GO:0005737; GO:0005739; GO:0005829; GO:0006520; GO:0006729; GO:0007417; GO:0042802; GO:0046872,amino acid metabolic process [GO:0006520]; central nervous system development [GO:0007417]; tetrahydrobiopterin biosynthetic process [GO:0006729],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],6-pyruvoyltetrahydropterin synthase activity [GO:0003874]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872],GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016829; GO:0043226; GO:0048856,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; lyase activity; organelle; anatomical structure development
OG_10147,FUN_043537-T1,Peve_00016669,Pocillopora_meandrina_HIv1___RNAseq.g24410.t1,three_way,56.086666666666666,,,,,,,,,,,,,,,,,
OG_10148,FUN_043539-T1,Peve_00012551,Pocillopora_meandrina_HIv1___TS.g1775.t1,three_way,61.17516666666667,FUN_043539-T1,Q9DBQ9,,,,,27.4,592.0,6.5e-46,187.6,sp|Q9DBQ9|SWT1_MOUSE Transcriptional protein SWT1 OS=Mus musculus OX=10090 GN=Swt1 PE=2 SV=3,,,,,,
OG_10149,FUN_043541-T1,Peve_00011556,Pocillopora_meandrina_HIv1___TS.g1771.t2,three_way,54.464666666666666,FUN_043541-T1,P07307,ASGR2_HUMAN,,Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2),Homo sapiens (Human),30.1,153.0,7.5e-13,76.6,sp|P07307|ASGR2_HUMAN Asialoglycoprotein receptor 2 OS=Homo sapiens OX=9606 GN=ASGR2 PE=1 SV=2,GO:0004873; GO:0005537; GO:0005886; GO:0006897; GO:0006955; GO:0007166; GO:0009897; GO:0038187; GO:0042806; GO:0044322; GO:0048471,cell surface receptor signaling pathway [GO:0007166]; endocytosis [GO:0006897]; immune response [GO:0006955],endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],asialoglycoprotein receptor activity [GO:0004873]; D-mannose binding [GO:0005537]; fucose binding [GO:0042806]; pattern recognition receptor activity [GO:0038187],GO:0002376; GO:0005886; GO:0016192; GO:0038024; GO:0060089,immune system process; plasma membrane; vesicle-mediated transport; cargo receptor activity; molecular transducer activity
OG_10150,FUN_043543-T1,Peve_00011561,Pocillopora_meandrina_HIv1___RNAseq.g8017.t1,three_way,66.94916666666667,FUN_043543-T1,Q8R2T8,TF3C5_MOUSE,,General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon),Mus musculus (Mouse),41.8,433.0,5.199999999999999e-90,333.2,sp|Q8R2T8|TF3C5_MOUSE General transcription factor 3C polypeptide 5 OS=Mus musculus OX=10090 GN=Gtf3c5 PE=2 SV=2,GO:0000127; GO:0000995; GO:0003677; GO:0005654; GO:0006384; GO:0035914,skeletal muscle cell differentiation [GO:0035914]; transcription initiation at RNA polymerase III promoter [GO:0006384],nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127],DNA binding [GO:0003677]; RNA polymerase III general transcription initiation factor activity [GO:0000995],GO:0003677; GO:0005654; GO:0030154; GO:0140223,DNA binding; nucleoplasm; cell differentiation; general transcription initiation factor activity
OG_10151,FUN_043544-T1,Peve_00011562,Pocillopora_meandrina_HIv1___RNAseq.g8016.t1,three_way,85.31166666666667,FUN_043544-T1,Q7SYK1,TGT_DANRE,,Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.64) (Guanine insertion enzyme) (tRNA-guanine transglycosylase),Danio rerio (Zebrafish) (Brachydanio rerio),69.4,356.0,2e-150,533.5,sp|Q7SYK1|TGT_DANRE Queuine tRNA-ribosyltransferase catalytic subunit 1 OS=Danio rerio OX=7955 GN=qtrt1 PE=2 SV=1,GO:0005741; GO:0008479; GO:0042803; GO:0046872; GO:0046982; GO:0101030,tRNA-guanine transglycosylation [GO:0101030],mitochondrial outer membrane [GO:0005741],metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; tRNA-guanosine(34) queuine transglycosylase activity [GO:0008479],GO:0003824; GO:0016740; GO:0140098,"catalytic activity; transferase activity; catalytic activity, acting on RNA"
OG_10152,FUN_043545-T1,Peve_00011554,Pocillopora_meandrina_HIv1___RNAseq.g8015.t1,three_way,81.398,FUN_043545-T1,Q3TQI7,,,,,46.6,262.0,7.4e-50,199.1,sp|Q3TQI7|TLS1_MOUSE Splicing factor C9orf78 homolog OS=Mus musculus OX=10090 PE=1 SV=2,,,,,,
OG_10153,FUN_043546-T1,Peve_00011555,Pocillopora_meandrina_HIv1___RNAseq.g8014.t1,three_way,78.13083333333334,,,,,,,,,,,,,,,,,
OG_10154,FUN_043549-T1,Peve_00011559,Pocillopora_meandrina_HIv1___RNAseq.g8013.t1,three_way,40.39266666666667,,,,,,,,,,,,,,,,,
OG_10155,FUN_043550-T1,Peve_00009532,Pocillopora_meandrina_HIv1___RNAseq.g8005.t3,three_way,70.52333333333333,FUN_043550-T1,Q5XJS0,,,,,31.4,544.0,1.1000000000000004e-59,232.6,sp|Q5XJS0|MIGA1_DANRE Mitoguardin 1 OS=Danio rerio OX=7955 GN=miga1 PE=2 SV=1,,,,,,
OG_10156,FUN_043551-T2,Peve_00009530,Pocillopora_meandrina_HIv1___RNAseq.g8004.t1,three_way,67.68966666666667,,,,,,,,,,,,,,,,,
OG_10157,FUN_043552-T1,Peve_00009534,Pocillopora_meandrina_HIv1___RNAseq.g8003.t1,three_way,72.05633333333333,,,,,,,,,,,,,,,,,
OG_10158,FUN_043553-T1,Peve_00009529,Pocillopora_meandrina_HIv1___RNAseq.g8042.t1,three_way,85.187,FUN_043553-T1,Q8NE28,,,,,26.2,443.0,8.100000000000001e-38,160.2,sp|Q8NE28|STKL1_HUMAN Serine/threonine kinase-like domain-containing protein STKLD1 OS=Homo sapiens OX=9606 GN=STKLD1 PE=1 SV=5,,,,,,
OG_10159,FUN_043556-T1,Peve_00022070,Pocillopora_meandrina_HIv1___RNAseq.g8045.t1,three_way,53.502,,,,,,,,,,,,,,,,,
OG_10160,FUN_043558-T1,Peve_00022071,Pocillopora_meandrina_HIv1___RNAseq.g8044.t1,three_way,60.96266666666666,,,,,,,,,,,,,,,,,
OG_10161,FUN_043559-T1,Peve_00022066,Pocillopora_meandrina_HIv1___RNAseq.g8043.t1,three_way,42.258833333333335,,,,,,,,,,,,,,,,,
OG_10162,FUN_043561-T1,Peve_00008975,Pocillopora_meandrina_HIv1___RNAseq.g8048.t1,three_way,90.788,FUN_043561-T1,Q27433,MEC2_CAEEL,,Mechanosensory protein 2,Caenorhabditis elegans,76.9,255.0,1.3e-103,377.5,sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1,GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792,detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612],neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289,transporter activity; plasma membrane; lipid binding
OG_10163,FUN_043562-T1,Peve_00008974,Pocillopora_meandrina_HIv1___RNAseq.5765_t,three_way,65.81866666666667,FUN_043562-T1,Q6DHJ3,NVD_DANRE,,Cholesterol 7-desaturase nvd (EC 1.14.19.21) (Protein neverland) (Nvd protein) (nvd-Dr),Danio rerio (Zebrafish) (Brachydanio rerio),50.6,401.0,2.1e-125,450.7,sp|Q6DHJ3|NVD_DANRE Cholesterol 7-desaturase nvd OS=Danio rerio OX=7955 GN=nvd PE=1 SV=1,GO:0005737; GO:0008203; GO:0016020; GO:0016491; GO:0046872; GO:0051537; GO:0170056,cholesterol metabolic process [GO:0008203],cytoplasm [GO:0005737]; membrane [GO:0016020],"2 iron, 2 sulfur cluster binding [GO:0051537]; cholesterol 7-desaturase (NAD(P)H) activity [GO:0170056]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_10164,FUN_043563-T1,Peve_00008973,Pocillopora_meandrina_HIv1___RNAseq.g8051.t1,three_way,64.55266666666667,FUN_043563-T1,P53812,PIPNB_RAT,,Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta),Rattus norvegicus (Rat),55.7,264.0,4.7e-75,283.1,sp|P53812|PIPNB_RAT Phosphatidylinositol transfer protein beta isoform OS=Rattus norvegicus OX=10116 GN=Pitpnb PE=1 SV=2,GO:0000139; GO:0001701; GO:0005737; GO:0005789; GO:0005794; GO:0006890; GO:0008525; GO:0008526; GO:0015914; GO:0031210; GO:0035091; GO:0120019; GO:0140338,"in utero embryonic development [GO:0001701]; phospholipid transport [GO:0015914]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transfer activity [GO:0120019]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transfer activity [GO:0008526]; sphingomyelin transfer activity [GO:0140338],GO:0005215; GO:0005794; GO:0008289; GO:0016192; GO:0043226; GO:0048856,transporter activity; Golgi apparatus; lipid binding; vesicle-mediated transport; organelle; anatomical structure development
OG_10165,FUN_043564-T1,Peve_00008977,Pocillopora_meandrina_HIv1___RNAseq.g8052.t1,three_way,74.235,FUN_043564-T1,Q5M8Y1,,,,,53.6,196.0,5.6e-54,212.2,sp|Q5M8Y1|SPCS2_XENTR Signal peptidase complex subunit 2 OS=Xenopus tropicalis OX=8364 GN=spcs2 PE=2 SV=1,,,,,,
OG_10166,FUN_043565-T1,Peve_00008972,Pocillopora_meandrina_HIv1___RNAseq.g8053.t1a,three_way,82.33433333333333,FUN_043565-T1,Q6MG08,ABCF1_RAT,,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50),Rattus norvegicus (Rat),63.4,565.0,7.8e-198,691.8,sp|Q6MG08|ABCF1_RAT ATP-binding cassette sub-family F member 1 OS=Rattus norvegicus OX=10116 GN=Abcf1 PE=1 SV=1,GO:0005524; GO:0005635; GO:0005654; GO:0005737; GO:0005840; GO:0006412; GO:0006413; GO:0008494; GO:0016887; GO:0043022; GO:0045727,positive regulation of translation [GO:0045727]; translation [GO:0006412]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; ribosome [GO:0005840],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494],GO:0003824; GO:0005635; GO:0005654; GO:0005840; GO:0016787; GO:0043226; GO:0045182,catalytic activity; nuclear envelope; nucleoplasm; ribosome; hydrolase activity; organelle; translation regulator activity
OG_10167,FUN_043567-T1,Peve_00030048,Pocillopora_meandrina_HIv1___RNAseq.g8054.t1,three_way,49.1965,,,,,,,,,,,,,,,,,
OG_10168,FUN_043569-T1,Peve_00034600,Pocillopora_meandrina_HIv1___RNAseq.g8023.t1,three_way,58.73266666666667,FUN_043569-T1,A8WGS4,,,,,41.0,212.0,8.400000000000001e-33,142.1,sp|A8WGS4|TLCD2_DANRE TLC domain-containing protein 2 OS=Danio rerio OX=7955 GN=tlcd2 PE=2 SV=1,,,,,,
OG_10169,FUN_043572-T1,Peve_00017257,Pocillopora_meandrina_HIv1___RNAseq.g8027.t1,three_way,71.741,FUN_043572-T1,Q91YU8,,,,,53.6,302.0,3.1e-84,313.9,sp|Q91YU8|SSF1_MOUSE Suppressor of SWI4 1 homolog OS=Mus musculus OX=10090 GN=Ppan PE=1 SV=2,,,,,,
OG_10170,FUN_043573-T1,Peve_00011698,Pocillopora_meandrina_HIv1___TS.g1621.t2,three_way,82.74133333333333,FUN_043573-T1,Q5ZIR1,,,,,52.2,364.0,7.2e-94,345.5,sp|Q5ZIR1|SHLB1_CHICK Endophilin-B1 OS=Gallus gallus OX=9031 GN=SH3GLB1 PE=2 SV=1,,,,,,
OG_10171,FUN_043574-T1,Peve_00011699,Pocillopora_meandrina_HIv1___RNAseq.g7870.t2,three_way,82.55833333333334,FUN_043574-T1,Q5ZKK5,,,,,31.7,703.0,1.4e-15,86.7,sp|Q5ZKK5|ODFP2_CHICK Outer dense fiber protein 2 OS=Gallus gallus OX=9031 GN=ODF2 PE=2 SV=1,,,,,,
OG_10172,FUN_043581-T1,Peve_00045208,Pocillopora_meandrina_HIv1___RNAseq.g6993.t1,three_way,68.211,FUN_043581-T1,Q803A6,,,,,45.8,631.0,4.4e-147,523.1,sp|Q803A6|MCMBP_DANRE Mini-chromosome maintenance complex-binding protein OS=Danio rerio OX=7955 GN=mcmbp PE=2 SV=2,,,,,,
OG_10173,FUN_043582-T1,Peve_00045207,Pocillopora_meandrina_HIv1___RNAseq.g6992.t1,three_way,95.25533333333334,FUN_043582-T1,Q6DGW9,TMCO1_DANRE,,Calcium load-activated calcium channel (CLAC channel) (GEL complex subunit TMCO1) (Transmembrane and coiled-coil domain-containing protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),67.6,179.0,2e-55,216.9,sp|Q6DGW9|TMCO1_DANRE Calcium load-activated calcium channel OS=Danio rerio OX=7955 GN=tmco1 PE=2 SV=1,GO:0000139; GO:0005262; GO:0005737; GO:0005783; GO:0005789; GO:0006983; GO:0032469; GO:0043022; GO:0070588; GO:0160063; GO:0160064,calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983]; multi-pass transmembrane protein insertion into ER membrane [GO:0160063],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; multi-pass translocon complex [GO:0160064],calcium channel activity [GO:0005262]; ribosome binding [GO:0043022],GO:0005215; GO:0005783; GO:0043226; GO:0055085,transporter activity; endoplasmic reticulum; organelle; transmembrane transport
OG_10174,FUN_043583-T1,Peve_00045199,Pocillopora_meandrina_HIv1___RNAseq.g6989.t1,three_way,62.69716666666667,FUN_043583-T1,Q68F67,,,,,45.0,467.0,4.1e-113,410.6,sp|Q68F67|DEN1A_XENLA DENN domain-containing protein 1A OS=Xenopus laevis OX=8355 GN=dennd1a PE=2 SV=1,,,,,,
OG_10175,FUN_043584-T1,Peve_00045195,Pocillopora_meandrina_HIv1___RNAseq.g6988.t1,three_way,66.09083333333334,FUN_043584-T1,P21180,CO2_MOUSE,,Complement C2 (C3/C5 convertase) [Cleaved into: Complement C2a; Serine protease complement C2b (EC 3.4.21.43)],Mus musculus (Mouse),25.1,491.0,5.4e-29,131.0,sp|P21180|CO2_MOUSE Complement C2 OS=Mus musculus OX=10090 GN=C2 PE=1 SV=2,GO:0004252; GO:0005615; GO:0006508; GO:0006958; GO:0007584; GO:0032496; GO:0045087; GO:0046872; GO:0097066; GO:2000427,"complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]; proteolysis [GO:0006508]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to thyroid hormone [GO:0097066]",extracellular space [GO:0005615],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003824; GO:0005615; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_10176,FUN_043585-T1,Peve_00045227,Pocillopora_meandrina_HIv1___RNAseq.g6986.t1,three_way,56.91216666666666,FUN_043585-T1,Q9BYX4,IFIH1_HUMAN,,Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116),Homo sapiens (Human),27.6,1184.0,1e-88,330.1,sp|Q9BYX4|IFIH1_HUMAN Interferon-induced helicase C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=IFIH1 PE=1 SV=3,GO:0002753; GO:0003677; GO:0003723; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0008270; GO:0009597; GO:0009615; GO:0016887; GO:0016925; GO:0032727; GO:0032728; GO:0032755; GO:0032760; GO:0034344; GO:0038187; GO:0039530; GO:0042802; GO:0043021; GO:0045071; GO:0045087; GO:0051259; GO:0051607; GO:0060337; GO:0060760; GO:0071360; GO:0098586; GO:0140374,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to virus [GO:0098586]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of viral genome replication [GO:0045071]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0016787; GO:0016853; GO:0043226; GO:0060089; GO:0065003; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; hydrolase activity; isomerase activity; organelle; molecular transducer activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10177,FUN_043586-T1,Peve_00045222,Pocillopora_meandrina_HIv1___RNAseq.g6984.t1,three_way,54.448,,,,,,,,,,,,,,,,,
OG_10178,FUN_043587-T1,Peve_00045219,Pocillopora_meandrina_HIv1___RNAseq.g6976.t1,three_way,63.38583333333333,FUN_043587-T1,Q0IH40,,,,,49.5,103.0,3e-23,109.8,sp|Q0IH40|DNLZ_XENLA DNL-type zinc finger protein OS=Xenopus laevis OX=8355 GN=dnlz PE=2 SV=1,,,,,,
OG_10179,FUN_043588-T1,Peve_00026153,Pocillopora_meandrina_HIv1___TS.g713.t1,three_way,63.68,FUN_043588-T1,Q86Y79,,,,,40.7,172.0,1.1e-31,137.9,sp|Q86Y79|PTH_HUMAN Peptidyl-tRNA hydrolase OS=Homo sapiens OX=9606 GN=PTRH1 PE=1 SV=1,,,,,,
OG_10180,FUN_043593-T1,Peve_00010457,Pocillopora_meandrina_HIv1___RNAseq.g6971.t1,three_way,55.73066666666666,FUN_043593-T1,Q96PZ7,,,,,29.0,497.0,3.2e-52,208.4,sp|Q96PZ7|CSMD1_HUMAN CUB and sushi domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CSMD1 PE=1 SV=3,,,,,,
OG_10181,FUN_043595-T1,Peve_00002201,Pocillopora_meandrina_HIv1___TS.g695.t1,three_way,48.877833333333335,FUN_043595-T1,Q22328,,,,,26.1,601.0,1.6e-52,209.9,sp|Q22328|LEV9_CAEEL Protein lev-9 OS=Caenorhabditis elegans OX=6239 GN=lev-9 PE=1 SV=3,,,,,,
OG_10182,FUN_043597-T1,Peve_00007614,Pocillopora_meandrina_HIv1___RNAseq.g6953.t1,three_way,44.255,FUN_043597-T1,Q80T79,CSMD3_MOUSE,,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),Mus musculus (Mouse),31.6,730.0,4.6e-97,357.5,sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3,GO:0005886; GO:0050773,regulation of dendrite development [GO:0050773],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_10183,FUN_043598-T1,Peve_00007613,Pocillopora_meandrina_HIv1___RNAseq.g6952.t1,three_way,57.1735,FUN_043598-T1,P28175,,,,,28.1,467.0,5.1e-39,164.1,sp|P28175|CFC_TACTR Clotting factor C OS=Tachypleus tridentatus OX=6853 PE=1 SV=1,,,,,,
OG_10184,FUN_043599-T1,Peve_00007612,Pocillopora_meandrina_HIv1___RNAseq.g6951.t1,three_way,61.132,FUN_043599-T1,Q68CP4,HGNAT_HUMAN,,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),Homo sapiens (Human),42.6,591.0,3.1e-113,410.6,sp|Q68CP4|HGNAT_HUMAN Heparan-alpha-glucosaminide N-acetyltransferase OS=Homo sapiens OX=9606 GN=HGSNAT PE=1 SV=2,GO:0005765; GO:0005886; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0035579; GO:0043202; GO:0051259; GO:0070821,heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019],GO:0003824; GO:0005886; GO:0016740; GO:0030163; GO:0065003; GO:1901135,catalytic activity; plasma membrane; transferase activity; protein catabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_10185,FUN_043600-T1,Peve_00007617,Pocillopora_meandrina_HIv1___RNAseq.g6950.t1,three_way,63.14633333333333,FUN_043600-T1,Q3UDW8,HGNAT_MOUSE,,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),Mus musculus (Mouse),37.9,504.0,4.2e-82,307.0,sp|Q3UDW8|HGNAT_MOUSE Heparan-alpha-glucosaminide N-acetyltransferase OS=Mus musculus OX=10090 GN=Hgsnat PE=1 SV=2,GO:0005765; GO:0007041; GO:0015019; GO:0016746; GO:0030200; GO:0043202; GO:0051259,heparan sulfate proteoglycan catabolic process [GO:0030200]; lysosomal transport [GO:0007041]; protein complex oligomerization [GO:0051259],lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765],acyltransferase activity [GO:0016746]; heparan-alpha-glucosaminide N-acetyltransferase activity [GO:0015019],GO:0003824; GO:0016740; GO:0030163; GO:0065003; GO:1901135,catalytic activity; transferase activity; protein catabolic process; protein-containing complex assembly; carbohydrate derivative metabolic process
OG_10186,FUN_043601-T1,Peve_00040384,Pocillopora_meandrina_HIv1___RNAseq.g6949.t1,three_way,45.54,FUN_043601-T1,Q4LDE5,SVEP1_HUMAN,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)",Homo sapiens (Human),28.0,1276.0,2.1e-133,478.8,"sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3",GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193,epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0034330; GO:0043226; GO:0048856; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell junction organization; organelle; anatomical structure development; cell adhesion mediator activity
OG_10187,FUN_043604-T1,Peve_00040380,Pocillopora_meandrina_HIv1___RNAseq.4608_t,three_way,88.10233333333333,FUN_043604-T1,P55008,AIF1_HUMAN,,Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1),Homo sapiens (Human),55.9,143.0,3.8e-36,152.5,sp|P55008|AIF1_HUMAN Allograft inflammatory factor 1 OS=Homo sapiens OX=9606 GN=AIF1 PE=1 SV=1,GO:0001726; GO:0001774; GO:0001891; GO:0005509; GO:0005634; GO:0005737; GO:0005829; GO:0005884; GO:0006911; GO:0006954; GO:0008284; GO:0010468; GO:0016601; GO:0030027; GO:0030041; GO:0030046; GO:0030335; GO:0032587; GO:0032722; GO:0032755; GO:0034599; GO:0042102; GO:0048471; GO:0048661; GO:0048662; GO:0050921; GO:0051015; GO:0051017; GO:0051764; GO:0071346; GO:0071672; GO:0071673; GO:0071677; GO:0090026; GO:0090271; GO:0097178; GO:0097386; GO:1900087; GO:2000406,"actin crosslink formation [GO:0051764]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; cellular response to type II interferon [GO:0071346]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; parallel actin filament bundle assembly [GO:0030046]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; regulation of gene expression [GO:0010468]; ruffle assembly [GO:0097178]",actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle [GO:0001726]; ruffle membrane [GO:0032587],actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0002376; GO:0005634; GO:0005829; GO:0006954; GO:0008092; GO:0043226; GO:0061024; GO:0065003,immune system process; nucleus; cytosol; inflammatory response; cytoskeletal protein binding; organelle; membrane organization; protein-containing complex assembly
OG_10188,FUN_043605-T1,Peve_00040379,Pocillopora_meandrina_HIv1___RNAseq.g6947.t1,three_way,86.577,FUN_043605-T1,Q32L97,,,,,35.8,123.0,8.5e-12,71.6,sp|Q32L97|VAMP4_BOVIN Vesicle-associated membrane protein 4 OS=Bos taurus OX=9913 GN=VAMP4 PE=2 SV=1,,,,,,
OG_10189,FUN_043608-T1,Peve_00040378,Pocillopora_meandrina_HIv1___RNAseq.g6946.t1,three_way,60.33733333333333,FUN_043608-T1,Q5TZ07,PLPP6_DANRE,,Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 (EC 3.1.3.-) (EC 3.6.1.-) (EC 3.6.1.68) (Phosphatidic acid phosphatase type 2 domain-containing protein 2) (Phospholipid phosphatase 6),Danio rerio (Zebrafish) (Brachydanio rerio),44.4,180.0,2.8e-34,147.1,sp|Q5TZ07|PLPP6_DANRE Polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6 OS=Danio rerio OX=7955 GN=plpp6 PE=2 SV=1,GO:0005637; GO:0005789; GO:0016020; GO:0018342; GO:0031965; GO:0033383; GO:0042392; GO:0045339; GO:0046839; GO:1902247,farnesyl diphosphate catabolic process [GO:0045339]; geranyl diphosphate metabolic process [GO:0033383]; geranylgeranyl diphosphate catabolic process [GO:1902247]; phospholipid dephosphorylation [GO:0046839]; protein prenylation [GO:0018342],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965],sphingosine-1-phosphate phosphatase activity [GO:0042392],GO:0003824; GO:0006629; GO:0016787,catalytic activity; lipid metabolic process; hydrolase activity
OG_10190,FUN_043609-T1,Peve_00040374,Pocillopora_meandrina_HIv1___TS.g684.t1,three_way,52.197833333333335,FUN_043609-T1,P0C6B8,,,,,28.0,1915.0,1.8e-253,879.0,"sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1",,,,,,
OG_10191,FUN_043611-T1,Peve_00040373,Pocillopora_meandrina_HIv1___RNAseq.g6942.t1,three_way,43.37433333333333,FUN_043611-T1,P0C6B8,,,,,43.6,117.0,2.7e-25,117.9,"sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1",,,,,,
OG_10192,FUN_043612-T1,Peve_00040372,Pocillopora_meandrina_HIv1___RNAseq.4603_t,three_way,52.043,FUN_043612-T1,P48970,,,,,38.5,104.0,1.5e-19,98.6,sp|P48970|UNIV_STRPU Univin OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=2,,,,,,
OG_10193,FUN_043617-T1,Peve_00008238,Pocillopora_meandrina_HIv1___RNAseq.g6934.t1,three_way,43.36033333333333,,,,,,,,,,,,,,,,,
OG_10194,FUN_043618-T2,Peve_00008246,Pocillopora_meandrina_HIv1___RNAseq.g6933.t1,three_way,53.74066666666667,FUN_043618-T2,P34821,BMP8A_MOUSE,,Bone morphogenetic protein 8A (BMP-8A) (Osteogenic protein 2) (OP-2),Mus musculus (Mouse),32.2,345.0,3.1e-34,147.5,sp|P34821|BMP8A_MOUSE Bone morphogenetic protein 8A OS=Mus musculus OX=10090 GN=Bmp8a PE=2 SV=1,GO:0001649; GO:0005125; GO:0005615; GO:0007179; GO:0007281; GO:0007283; GO:0008083; GO:0051216,cartilage development [GO:0051216]; germ cell development [GO:0007281]; osteoblast differentiation [GO:0001649]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179],extracellular space [GO:0005615],cytokine activity [GO:0005125]; growth factor activity [GO:0008083],GO:0005615; GO:0022414; GO:0030154; GO:0048018; GO:0048856; GO:0098772,extracellular space; reproductive process; cell differentiation; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_10195,FUN_043619-T1,Peve_00008225,Pocillopora_meandrina_HIv1___RNAseq.g6932.t1,three_way,88.456,FUN_043619-T1,Q6DJ06,,,,,63.2,125.0,1e-48,194.5,sp|Q6DJ06|LMO42_XENTR LIM domain transcription factor LMO4.2 OS=Xenopus tropicalis OX=8364 GN=lmo4.2 PE=2 SV=1,,,,,,
OG_10196,FUN_043620-T1,Peve_00008227,Pocillopora_meandrina_HIv1___RNAseq.g6930.t1,three_way,51.489333333333335,,,,,,,,,,,,,,,,,
OG_10197,FUN_043621-T1,Peve_00008231,Pocillopora_meandrina_HIv1___RNAseq.g6929.t1,three_way,80.29433333333333,,,,,,,,,,,,,,,,,
OG_10198,FUN_043622-T1,Peve_00008234,Pocillopora_meandrina_HIv1___RNAseq.g6927.t1,three_way,76.94266666666667,FUN_043622-T1,Q9VUX3,NOTUM_DROME,,Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (Protein Notum) (Protein wingful) (dNOTUM),Drosophila melanogaster (Fruit fly),28.2,347.0,8.8e-26,119.8,sp|Q9VUX3|NOTUM_DROME Palmitoleoyl-protein carboxylesterase NOTUM OS=Drosophila melanogaster OX=7227 GN=Notum PE=1 SV=3,GO:0005615; GO:0007419; GO:0009986; GO:0016055; GO:0035220; GO:0035222; GO:0045880; GO:0048076; GO:0048190; GO:0048546; GO:0090090; GO:1990697; GO:1990699,digestive tract morphogenesis [GO:0048546]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of smoothened signaling pathway [GO:0045880]; protein depalmitoleylation [GO:1990697]; regulation of compound eye pigmentation [GO:0048076]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; extracellular space [GO:0005615],palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005615; GO:0016787; GO:0030163; GO:0048856,catalytic activity; extracellular space; hydrolase activity; protein catabolic process; anatomical structure development
OG_10199,FUN_043626-T1,Peve_00008236,Pocillopora_meandrina_HIv1___TS.g640.t1a,three_way,85.859,FUN_043626-T1,Q96J01,THOC3_HUMAN,,THO complex subunit 3 (Tho3) (TEX1 homolog) (hTREX45),Homo sapiens (Human),73.2,321.0,1e-147,524.2,sp|Q96J01|THOC3_HUMAN THO complex subunit 3 OS=Homo sapiens OX=9606 GN=THOC3 PE=1 SV=1,GO:0000346; GO:0000445; GO:0003723; GO:0005654; GO:0006397; GO:0006406; GO:0008380; GO:0016607,mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346],RNA binding [GO:0003723],GO:0003723; GO:0005654; GO:0006913; GO:0016071; GO:0043226,RNA binding; nucleoplasm; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_10200,FUN_043628-T1,Peve_00008239,Pocillopora_meandrina_HIv1___TS.g640.t1b,three_way,64.35733333333333,FUN_043628-T1,Q504Y2,PKDCC_HUMAN,,"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)",Homo sapiens (Human),40.7,243.0,2.7e-47,190.3,sp|Q504Y2|PKDCC_HUMAN Extracellular tyrosine-protein kinase PKDCC OS=Homo sapiens OX=9606 GN=PKDCC PE=1 SV=2,GO:0001501; GO:0004672; GO:0004715; GO:0005524; GO:0005576; GO:0005794; GO:0015031; GO:0018108; GO:0030154; GO:0030282; GO:0030501; GO:0032332; GO:0035108; GO:0035264; GO:0042997; GO:0048286; GO:0048566; GO:0060021,bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672],GO:0003824; GO:0005576; GO:0005794; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular region; Golgi apparatus; transferase activity; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10201,FUN_043629-T1,Peve_00008240,Pocillopora_meandrina_HIv1___RNAseq.g6901.t1,three_way,72.333,FUN_043629-T1,B2GUY0,MA1B1_RAT,,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Mannosidase alpha class 1B member 1)",Rattus norvegicus (Rat),48.4,674.0,2.1e-163,577.4,"sp|B2GUY0|MA1B1_RAT Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase OS=Rattus norvegicus OX=10116 GN=Man1b1 PE=2 SV=2",GO:0004571; GO:0005509; GO:0005783; GO:0005789; GO:0005975; GO:0006058; GO:0006486; GO:0016020; GO:0031410; GO:0036503; GO:0044322,carbohydrate metabolic process [GO:0005975]; ERAD pathway [GO:0036503]; mannoprotein catabolic process [GO:0006058]; protein glycosylation [GO:0006486],cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; membrane [GO:0016020],"calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity [GO:0004571]",GO:0003824; GO:0005783; GO:0005975; GO:0006486; GO:0016787; GO:0030163; GO:0031410; GO:0043226,catalytic activity; endoplasmic reticulum; carbohydrate metabolic process; protein glycosylation; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle
OG_10202,FUN_043630-T1,Peve_00008241,Pocillopora_meandrina_HIv1___RNAseq.g6906.t1,three_way,61.4405,FUN_043630-T1,D3ZWZ9,,,,,57.8,339.0,5.1e-111,403.3,sp|D3ZWZ9|GP107_RAT Protein GPR107 OS=Rattus norvegicus OX=10116 GN=Gpr107 PE=1 SV=1,,,,,,
OG_10203,FUN_043635-T1,Peve_00008248,Pocillopora_meandrina_HIv1___RNAseq.g6908.t1,three_way,75.81833333333333,,,,,,,,,,,,,,,,,
OG_10204,FUN_043636-T1,Peve_00008249,Pocillopora_meandrina_HIv1___RNAseq.g6909.t1,three_way,53.50783333333334,FUN_043636-T1,Q8NDA2,,,,,26.3,753.0,7.900000000000002e-59,231.5,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_10205,FUN_043638-T1,Peve_00003079,Pocillopora_meandrina_HIv1___RNAseq.g7413.t1,three_way,47.27816666666666,FUN_043638-T1,B3EWY7,,,,,95.8,359.0,2.8e-170,599.4,sp|B3EWY7|ASOMP_ACRMI Acidic skeletal organic matrix protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10206,FUN_043641-T1,Peve_00003065,Pocillopora_meandrina_HIv1___RNAseq.g7412.t1,three_way,54.37166666666667,,,,,,,,,,,,,,,,,
OG_10207,FUN_043642-T1,Peve_00041942,Pocillopora_meandrina_HIv1___RNAseq.g7410.t1,three_way,83.61566666666667,,,,,,,,,,,,,,,,,
OG_10208,FUN_043643-T1,Peve_00004207,Pocillopora_meandrina_HIv1___RNAseq.g7409.t1,three_way,56.01,,,,,,,,,,,,,,,,,
OG_10209,FUN_043644-T1,Peve_00034903,Pocillopora_meandrina_HIv1___RNAseq.g7405.t1,three_way,71.678,,,,,,,,,,,,,,,,,
OG_10210,FUN_043647-T1,Peve_00026900,Pocillopora_meandrina_HIv1___RNAseq.g7403.t1b,three_way,74.66133333333333,,,,,,,,,,,,,,,,,
OG_10211,FUN_043649-T1,Peve_00026898,Pocillopora_meandrina_HIv1___RNAseq.g7402.t1,three_way,54.823,FUN_043649-T1,O01635,,,,,29.5,369.0,1.5e-35,152.5,sp|O01635|ASIC1_CAEEL Degenerin-like protein asic-1 OS=Caenorhabditis elegans OX=6239 GN=asic-1 PE=3 SV=2,,,,,,
OG_10212,FUN_043650-T1,Peve_00028909,Pocillopora_meandrina_HIv1___RNAseq.g7400.t1,three_way,62.379333333333335,FUN_043650-T1,P51167,,,,,26.5,551.0,1.6e-37,159.1,sp|P51167|SCNNA_XENLA Epithelial sodium channel subunit alpha OS=Xenopus laevis OX=8355 GN=scnn1a PE=1 SV=1,,,,,,
OG_10213,FUN_043651-T1,Peve_00029225,Pocillopora_meandrina_HIv1___RNAseq.g7398.t1,three_way,70.681,FUN_043651-T1,Q5E9M5,,,,,45.8,306.0,7e-65,249.2,sp|Q5E9M5|SNPC3_BOVIN snRNA-activating protein complex subunit 3 OS=Bos taurus OX=9913 GN=SNAPC3 PE=2 SV=1,,,,,,
OG_10214,FUN_043658-T1,Peve_00044842,Pocillopora_meandrina_HIv1___RNAseq.g10606.t1,three_way,50.08533333333333,,,,,,,,,,,,,,,,,
OG_10215,FUN_043661-T1,Peve_00001423,Pocillopora_meandrina_HIv1___RNAseq.g7396.t1,three_way,70.6425,FUN_043661-T1,Q5M836,,,,,30.6,255.0,3.9e-21,103.6,sp|Q5M836|LYSM3_RAT LysM and putative peptidoglycan-binding domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Lysmd3 PE=2 SV=1,,,,,,
OG_10216,FUN_043662-T1,Peve_00001429,Pocillopora_meandrina_HIv1___RNAseq.g7395.t2,three_way,79.739,FUN_043662-T1,P98198,AT8B2_HUMAN,,Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2),Homo sapiens (Human),52.5,1179.0,0.0,1144.4,sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2,GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531,Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
OG_10217,FUN_043671-T1,Peve_00041773,Pocillopora_meandrina_HIv1___RNAseq.g24352.t1,three_way,61.07233333333333,FUN_043671-T1,A1L3G4,,,,,36.6,287.0,1.6e-36,154.8,sp|A1L3G4|TM241_XENLA UDP-N-acetylglucosamine transporter TMEM241 homolog OS=Xenopus laevis OX=8355 GN=tmem241 PE=2 SV=1,,,,,,
OG_10218,FUN_043696-T1,Peve_00035265,Pocillopora_meandrina_HIv1___RNAseq.g8910.t2,three_way,40.40266666666667,,,,,,,,,,,,,,,,,
OG_10219,FUN_043778-T1,Peve_00000667,Pocillopora_meandrina_HIv1___RNAseq.g24686.t1,three_way,81.80733333333333,FUN_043778-T1,Q9ES46,PARVB_MOUSE,,Beta-parvin,Mus musculus (Mouse),52.6,371.0,1e-90,335.1,sp|Q9ES46|PARVB_MOUSE Beta-parvin OS=Mus musculus OX=10090 GN=Parvb PE=1 SV=1,GO:0003779; GO:0005886; GO:0005925; GO:0007155; GO:0015629; GO:0030018; GO:0030027; GO:0030031; GO:0030032; GO:0030036; GO:0071963,actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032],actin cytoskeleton [GO:0015629]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018],actin binding [GO:0003779],GO:0005856; GO:0005886; GO:0007010; GO:0007155; GO:0007163; GO:0008092; GO:0043226,cytoskeleton; plasma membrane; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; cytoskeletal protein binding; organelle
OG_10220,FUN_043795-T1,Peve_00030767,Pocillopora_meandrina_HIv1___RNAseq.g14508.t1,three_way,61.468,,,,,,,,,,,,,,,,,
OG_10221,FUN_043835-T1,Peve_00041794,Pocillopora_meandrina_HIv1___TS.g12323.t1,three_way,54.1065,,,,,,,,,,,,,,,,,
OG_10222,FUN_044275-T2,Peve_00026564,Pocillopora_meandrina_HIv1___TS.g27908.t1,three_way,73.819,FUN_044275-T2,Q9PT84,,,,,52.5,472.0,4.3e-137,490.0,sp|Q9PT84|KCNH6_CHICK Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Gallus gallus OX=9031 GN=KCNH6 PE=2 SV=2,,,,,,
OG_10223,FUN_044276-T1,Peve_00026563,Pocillopora_meandrina_HIv1___RNAseq.g18517.t1,three_way,81.17766666666667,FUN_044276-T1,A4FV08,GNPI1_BOVIN,,Glucosamine-6-phosphate deaminase 1 (GlcN6P deaminase 1) (EC 3.5.99.6) (Glucosamine-6-phosphate isomerase 1) (Protein oscillin),Bos taurus (Bovine),72.6,285.0,1.4e-119,430.6,sp|A4FV08|GNPI1_BOVIN Glucosamine-6-phosphate deaminase 1 OS=Bos taurus OX=9913 GN=GNPDA1 PE=1 SV=1,GO:0004342; GO:0005737; GO:0005975; GO:0006043; GO:0006046; GO:0006048; GO:0016853; GO:0019262; GO:0042802,carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],cytoplasm [GO:0005737],glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853],GO:0003824; GO:0005975; GO:0016787; GO:0016853; GO:0055086; GO:1901135,catalytic activity; carbohydrate metabolic process; hydrolase activity; isomerase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_10224,FUN_044375-T1,Peve_00019414,Pocillopora_meandrina_HIv1___RNAseq.g28923.t1,three_way,51.111,,,,,,,,,,,,,,,,,
OG_10225,FUN_044376-T1,Peve_00012020,Pocillopora_meandrina_HIv1___RNAseq.g28947.t1,three_way,72.203,FUN_044376-T1,P14618,KPYM_HUMAN,,Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2) (p58),Homo sapiens (Human),60.0,518.0,1.8999999999999998e-173,610.5,sp|P14618|KPYM_HUMAN Pyruvate kinase PKM OS=Homo sapiens OX=9606 GN=PKM PE=1 SV=4,GO:0000287; GO:0003713; GO:0003723; GO:0003729; GO:0004713; GO:0004743; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005791; GO:0005829; GO:0005929; GO:0006096; GO:0012501; GO:0023026; GO:0030955; GO:0031982; GO:0032869; GO:0034774; GO:0035402; GO:0042803; GO:0043231; GO:0045296; GO:0045944; GO:0061621; GO:0062023; GO:0070062; GO:1903561; GO:1903672; GO:1904813; GO:2000767,canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death [GO:0012501],cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982],ATP binding [GO:0005524]; cadherin binding [GO:0045296]; histone H3T11 kinase activity [GO:0035402]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0003824; GO:0005576; GO:0005634; GO:0005739; GO:0005783; GO:0005829; GO:0005929; GO:0005975; GO:0006091; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0055086; GO:0060090; GO:0140096; GO:0140110; GO:1901135,"RNA binding; catalytic activity; extracellular region; nucleus; mitochondrion; endoplasmic reticulum; cytosol; cilium; carbohydrate metabolic process; generation of precursor metabolites and energy; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; nucleobase-containing small molecule metabolic process; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity; carbohydrate derivative metabolic process"
OG_10226,FUN_044378-T1,Peve_00032442,Pocillopora_meandrina_HIv1___RNAseq.g14683.t1,three_way,76.715,,,,,,,,,,,,,,,,,
OG_10227,FUN_044381-T1,Peve_00033525,Pocillopora_meandrina_HIv1___RNAseq.g29121.t1,three_way,79.15566666666666,FUN_044381-T1,Q9D845,,,,,35.2,378.0,4e-36,154.1,sp|Q9D845|TEX9_MOUSE Testis-expressed protein 9 OS=Mus musculus OX=10090 GN=Tex9 PE=2 SV=1,,,,,,
OG_10228,FUN_044389-T2,Peve_00010046,Pocillopora_meandrina_HIv1___RNAseq.g29496.t1,three_way,75.71933333333334,FUN_044389-T2,Q14191,WRN_HUMAN,,"Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (DNA helicase, RecQ-like type 3) (RecQ protein-like 2) (Werner syndrome protein) [Includes: 3'-5' exonuclease (EC 3.1.-.-); ATP-dependent helicase (EC 5.6.2.4) (DNA 3'-5' helicase WRN)]",Homo sapiens (Human),42.5,894.0,1.6e-202,708.0,sp|Q14191|WRN_HUMAN Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN OS=Homo sapiens OX=9606 GN=WRN PE=1 SV=2,GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006284; GO:0006298; GO:0006302; GO:0006974; GO:0006979; GO:0008340; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032392; GO:0032405; GO:0040009; GO:0042803; GO:0043138; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090398; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773,base-excision repair [GO:0006284]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA geometric change [GO:0032392]; DNA metabolic process [GO:0006259]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820],"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]",3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005815; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; microtubule organizing center; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_10229,FUN_044396-T1,Peve_00003174,Pocillopora_meandrina_HIv1___TS.g6576.t1,three_way,85.75066666666666,FUN_044396-T1,Q0VCJ7,RERG_BOVIN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Bos taurus (Bovine),37.4,190.0,6.5e-29,129.0,sp|Q0VCJ7|RERG_BOVIN Ras-related and estrogen-regulated growth inhibitor OS=Bos taurus OX=9913 GN=RERG PE=2 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005654; GO:0005829; GO:0005886; GO:0008285; GO:0009725; GO:0019003; GO:0030308,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0098772,catalytic activity; GTPase activity; nucleoplasm; cytosol; plasma membrane; hydrolase activity; molecular function regulator activity
OG_10230,FUN_044397-T1,Peve_00003175,Pocillopora_meandrina_HIv1___RNAseq.g29384.t1,three_way,80.52233333333334,FUN_044397-T1,Q8R2H4,,,,,32.1,333.0,4.6e-45,184.1,sp|Q8R2H4|KLH12_RAT Kelch-like protein 12 OS=Rattus norvegicus OX=10116 GN=Klhl12 PE=2 SV=2,,,,,,
OG_10231,FUN_044401-T1,Peve_00036975,Pocillopora_meandrina_HIv1___RNAseq.g2300.t1,three_way,60.745,FUN_044401-T1,P46616,,,,,27.9,283.0,7.3e-16,85.9,sp|P46616|AA2AR_CAVPO Adenosine receptor A2a OS=Cavia porcellus OX=10141 GN=ADORA2A PE=2 SV=1,,,,,,
OG_10232,FUN_044408-T1,Peve_00027710,Pocillopora_meandrina_HIv1___RNAseq.g4473.t1,three_way,76.58466666666666,FUN_044408-T1,Q4KML2,CRYD_DANRE,,Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH),Danio rerio (Zebrafish) (Brachydanio rerio),55.7,530.0,9.4e-170,598.2,sp|Q4KML2|CRYD_DANRE Cryptochrome DASH OS=Danio rerio OX=7955 GN=cry-dash PE=2 SV=2,GO:0000719; GO:0003684; GO:0003904; GO:0050660; GO:0071949,photoreactive repair [GO:0000719],,damaged DNA binding [GO:0003684]; deoxyribodipyrimidine photo-lyase activity [GO:0003904]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660],GO:0003677; GO:0003824; GO:0006281; GO:0016829; GO:0140097,"DNA binding; catalytic activity; DNA repair; lyase activity; catalytic activity, acting on DNA"
OG_10233,FUN_044409-T1,Peve_00009928,Pocillopora_meandrina_HIv1___TS.g4670.t3,three_way,49.284,,,,,,,,,,,,,,,,,
OG_10234,FUN_044448-T1,Peve_00034014,Pocillopora_meandrina_HIv1___RNAseq.30209_t,three_way,65.55833333333334,FUN_044448-T1,Q758C3,,,,,26.9,416.0,6.9e-33,143.3,sp|Q758C3|BTN1_EREGS Protein BTN1 OS=Eremothecium gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) OX=284811 GN=BTN1 PE=3 SV=1,,,,,,
OG_10235,FUN_044449-T1,Peve_00034028,Pocillopora_meandrina_HIv1___RNAseq.g14840.t1,three_way,63.86466666666667,FUN_044449-T1,Q6PHU5,SORT_MOUSE,,Sortilin (Neurotensin receptor 3) (NTR3) (mNTR3),Mus musculus (Mouse),36.4,750.0,2.6e-126,454.5,sp|Q6PHU5|SORT_MOUSE Sortilin OS=Mus musculus OX=10090 GN=Sort1 PE=1 SV=1,GO:0001503; GO:0005764; GO:0005765; GO:0005769; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006622; GO:0006895; GO:0006897; GO:0007218; GO:0008333; GO:0008625; GO:0009986; GO:0010008; GO:0010465; GO:0010468; GO:0014902; GO:0016050; GO:0019899; GO:0030140; GO:0030379; GO:0030659; GO:0031965; GO:0032509; GO:0032580; GO:0032868; GO:0045599; GO:0046323; GO:0048011; GO:0048227; GO:0048406; GO:0048471; GO:0090160; GO:0099558; GO:0150053; GO:1905394,D-glucose import [GO:0046323]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; Golgi to endosome transport [GO:0006895]; Golgi to lysosome transport [GO:0090160]; maintenance of synapse structure [GO:0099558]; myotube differentiation [GO:0014902]; negative regulation of fat cell differentiation [GO:0045599]; neuropeptide signaling pathway [GO:0007218]; neurotrophin TRK receptor signaling pathway [GO:0048011]; ossification [GO:0001503]; plasma membrane to endosome transport [GO:0048227]; protein targeting to lysosome [GO:0006622]; regulation of gene expression [GO:0010468]; response to insulin [GO:0032868]; vesicle organization [GO:0016050],cell surface [GO:0009986]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network transport vesicle [GO:0030140],"enzyme binding [GO:0019899]; nerve growth factor binding [GO:0048406]; nerve growth factor receptor activity [GO:0010465]; neurotensin receptor activity, non-G protein-coupled [GO:0030379]; retromer complex binding [GO:1905394]",GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0016192; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0055085; GO:0060089,lysosome; endosome; vacuole; Golgi apparatus; cytosol; plasma membrane; intracellular protein transport; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; transmembrane transport; molecular transducer activity
OG_10236,FUN_044461-T2,Peve_00009948,Pocillopora_meandrina_HIv1___TS.g27749.t2,three_way,59.470666666666666,FUN_044461-T2,Q8R5I0,,,,,34.2,240.0,3.1e-24,114.4,sp|Q8R5I0|KCNKF_RAT Potassium channel subfamily K member 15 OS=Rattus norvegicus OX=10116 GN=Kcnk15 PE=2 SV=1,,,,,,
OG_10237,FUN_044475-T1,Peve_00026902,Pocillopora_meandrina_HIv1___RNAseq.g17187.t1,three_way,56.778333333333336,,,,,,,,,,,,,,,,,
OG_10238,FUN_044487-T1,Peve_00001359,Pocillopora_meandrina_HIv1___RNAseq.g17370.t1,three_way,94.9875,FUN_044487-T1,Q6GL04,TERA_XENTR,,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (p97) (Valosin-containing protein) (VCP),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),85.7,799.0,0.0,1355.9,sp|Q6GL04|TERA_XENTR Transitional endoplasmic reticulum ATPase OS=Xenopus tropicalis OX=8364 GN=vcp PE=2 SV=1,GO:0000785; GO:0005524; GO:0005634; GO:0005737; GO:0005783; GO:0005829; GO:0006281; GO:0006302; GO:0006914; GO:0006974; GO:0007626; GO:0008289; GO:0010494; GO:0010498; GO:0010506; GO:0016236; GO:0016567; GO:0016887; GO:0019985; GO:0030239; GO:0032434; GO:0032510; GO:0034605; GO:0035617; GO:0035861; GO:0036297; GO:0036503; GO:0042802; GO:0043009; GO:0043161; GO:0044877; GO:0055013; GO:0060047; GO:0061857; GO:0097352; GO:1903843; GO:1905634,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cardiac muscle cell development [GO:0055013]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; chordate embryonic development [GO:0043009]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; heart contraction [GO:0060047]; interstrand cross-link repair [GO:0036297]; locomotory behavior [GO:0007626]; macroautophagy [GO:0016236]; myofibril assembly [GO:0030239]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of protein localization to chromatin [GO:1905634]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877],GO:0003013; GO:0003824; GO:0005634; GO:0005783; GO:0005829; GO:0006281; GO:0006914; GO:0007010; GO:0008289; GO:0016192; GO:0016787; GO:0030163; GO:0043226; GO:0048856,circulatory system process; catalytic activity; nucleus; endoplasmic reticulum; cytosol; DNA repair; autophagy; cytoskeleton organization; lipid binding; vesicle-mediated transport; hydrolase activity; protein catabolic process; organelle; anatomical structure development
OG_10239,FUN_044495-T1,Peve_00041382,Pocillopora_meandrina_HIv1___RNAseq.g11754.t1,three_way,79.58216666666667,FUN_044495-T1,Q15386,UBE3C_HUMAN,,Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (Homologous to E6AP carboxyl terminus homologous protein 2) (HectH2) (RTA-associated ubiquitin ligase) (RAUL),Homo sapiens (Human),45.7,1112.0,2.5e-251,870.2,sp|Q15386|UBE3C_HUMAN Ubiquitin-protein ligase E3C OS=Homo sapiens OX=9606 GN=UBE3C PE=1 SV=3,GO:0000209; GO:0000502; GO:0006511; GO:0035519; GO:0061630; GO:0070936,protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],proteasome complex [GO:0000502],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_10240,FUN_044499-T2,Peve_00001930,Pocillopora_meandrina_HIv1___RNAseq.g11528.t1,three_way,64.94266666666667,FUN_044499-T2,A2AM05,CNTLN_MOUSE,,Centlein (Centrosomal protein),Mus musculus (Mouse),22.4,420.0,4.2e-11,72.4,sp|A2AM05|CNTLN_MOUSE Centlein OS=Mus musculus OX=10090 GN=Cntln PE=1 SV=1,GO:0005654; GO:0005813; GO:0005814; GO:0005829; GO:0007283; GO:0007338; GO:0008104; GO:0010457; GO:0019901; GO:0019904; GO:0030674; GO:0032880; GO:0033365; GO:0065003; GO:0120212,centriole-centriole cohesion [GO:0010457]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365]; protein-containing complex assembly [GO:0065003]; regulation of protein localization [GO:0032880]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; sperm head-tail coupling apparatus [GO:0120212],protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674],GO:0005654; GO:0005815; GO:0005829; GO:0022414; GO:0043226; GO:0060090; GO:0065003,nucleoplasm; microtubule organizing center; cytosol; reproductive process; organelle; molecular adaptor activity; protein-containing complex assembly
OG_10241,FUN_044500-T1,Peve_00006786,Pocillopora_meandrina_HIv1___RNAseq.g11527.t1,three_way,70.53,FUN_044500-T1,Q0EEE2,PTHD3_MOUSE,,Patched domain-containing protein 3 (RND-type protein RNDEu-3),Mus musculus (Mouse),24.3,873.0,1.6e-60,236.1,sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0097225,,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225],,GO:0005783; GO:0005886; GO:0043226,endoplasmic reticulum; plasma membrane; organelle
OG_10242,FUN_044507-T1,Peve_00044058,Pocillopora_meandrina_HIv1___TS.g7422.t1b,three_way,83.77,FUN_044507-T1,Q5R7B8,KLH20_PONAB,,Kelch-like protein 20,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),42.1,335.0,2.8e-77,291.2,sp|Q5R7B8|KLH20_PONAB Kelch-like protein 20 OS=Pongo abelii OX=9601 GN=KLHL20 PE=2 SV=3,GO:0003779; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390,Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802],actin binding [GO:0003779]; type II interferon binding [GO:0019964],GO:0005829; GO:0008092; GO:0016192; GO:0030163; GO:0043226,cytosol; cytoskeletal protein binding; vesicle-mediated transport; protein catabolic process; organelle
OG_10243,FUN_044513-T1,Peve_00023829,Pocillopora_meandrina_HIv1___RNAseq.g8575.t1,three_way,63.514833333333335,FUN_044513-T1,Q6DFA8,GLD2B_XENLA,,Poly(A) RNA polymerase GLD2-B (xGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4-B),Xenopus laevis (African clawed frog),41.2,337.0,1.1e-58,229.2,sp|Q6DFA8|GLD2B_XENLA Poly(A) RNA polymerase GLD2-B OS=Xenopus laevis OX=8355 GN=tent2-b PE=1 SV=1,GO:0005524; GO:0005737; GO:0006397; GO:0031123; GO:0046872; GO:0048477; GO:1990817; GO:2000626,mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; oogenesis [GO:0048477]; RNA 3'-end processing [GO:0031123],cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003824; GO:0016071; GO:0016740; GO:0022414; GO:0048856,catalytic activity; mRNA metabolic process; transferase activity; reproductive process; anatomical structure development
OG_10244,FUN_044515-T1,Peve_00044502,Pocillopora_meandrina_HIv1___RNAseq.g8348.t1,three_way,92.61833333333334,FUN_044515-T1,Q9EPU0,RENT1_MOUSE,,Regulator of nonsense transcripts 1 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (mUpf1),Mus musculus (Mouse),75.1,1026.0,0.0,1577.8,sp|Q9EPU0|RENT1_MOUSE Regulator of nonsense transcripts 1 OS=Mus musculus OX=10090 GN=Upf1 PE=1 SV=2,GO:0000184; GO:0000781; GO:0000785; GO:0000932; GO:0003682; GO:0003723; GO:0003724; GO:0005524; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006449; GO:0008270; GO:0016887; GO:0032201; GO:0032204; GO:0035145; GO:0036121; GO:0042162; GO:0044530; GO:0044770; GO:0044877; GO:0048471; GO:0061158; GO:0071044; GO:0071222; GO:0071347; GO:1905746,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of mRNA cis splicing, via spliceosome [GO:1905746]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; supraspliceosomal complex [GO:0044530]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; double-stranded DNA helicase activity [GO:0036121]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0003824; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0016071; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleoplasm; cytosol; DNA replication; DNA repair; mRNA metabolic process; hydrolase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10245,FUN_044521-T1,Peve_00030187,Pocillopora_meandrina_HIv1___RNAseq.g8279.t1,three_way,59.047666666666665,FUN_044521-T1,Q9Y573,,,,,29.2,322.0,1.7000000000000003e-28,129.0,sp|Q9Y573|IPP_HUMAN Actin-binding protein IPP OS=Homo sapiens OX=9606 GN=IPP PE=1 SV=1,,,,,,
OG_10246,FUN_044524-T1,Peve_00007481,Pocillopora_meandrina_HIv1___TS.g20020.t1,three_way,64.71833333333333,FUN_044524-T1,O35709,,,,,25.1,526.0,1.2e-32,142.9,sp|O35709|ENC1_MOUSE Ectoderm-neural cortex protein 1 OS=Mus musculus OX=10090 GN=Enc1 PE=2 SV=2,,,,,,
OG_10247,FUN_044527-T1,Peve_00036935,Pocillopora_meandrina_HIv1___RNAseq.g7582.t2,three_way,67.97666666666666,FUN_044527-T1,P52654,,,,,40.8,373.0,7.4e-26,119.4,sp|P52654|TF2AA_DROME Transcription initiation factor IIA subunit 1 OS=Drosophila melanogaster OX=7227 GN=TfIIA-L PE=1 SV=2,,,,,,
OG_10248,FUN_044534-T2,Peve_00002291,Pocillopora_meandrina_HIv1___TS.g268.t1,three_way,68.19333333333333,,,,,,,,,,,,,,,,,
OG_10249,FUN_044539-T1,Peve_00009896,Pocillopora_meandrina_HIv1___RNAseq.g6578.t1,three_way,75.57783333333333,FUN_044539-T1,Q9D2K4,,,,,42.1,1088.0,2e-244,847.4,sp|Q9D2K4|IQCH_MOUSE IQ domain-containing protein H OS=Mus musculus OX=10090 GN=Iqch PE=2 SV=3,,,,,,
OG_10250,FUN_044560-T1,Peve_00019630,Pocillopora_meandrina_HIv1___RNAseq.g8545.t1,three_way,64.44933333333333,,,,,,,,,,,,,,,,,
OG_10251,FUN_044584-T1,Peve_00044193,Pocillopora_meandrina_HIv1___RNAseq.g26720.t1,three_way,66.58966666666666,,,,,,,,,,,,,,,,,
OG_10252,FUN_044594-T1,Peve_00042021,Pocillopora_meandrina_HIv1___RNAseq.g20152.t1,three_way,81.90666666666667,FUN_044594-T1,O94889,KLH18_HUMAN,,Kelch-like protein 18,Homo sapiens (Human),45.6,320.0,2.5e-75,284.6,sp|O94889|KLH18_HUMAN Kelch-like protein 18 OS=Homo sapiens OX=9606 GN=KLHL18 PE=1 SV=3,GO:0005737; GO:0016567; GO:0031463; GO:0043161; GO:0051301; GO:1901992; GO:1990756,cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_10253,FUN_044618-T2,Peve_00040456,Pocillopora_meandrina_HIv1___RNAseq.g18424.t1,three_way,66.92816666666667,FUN_044618-T2,Q9NRL2,BAZ1A_HUMAN,,Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1),Homo sapiens (Human),33.2,1927.0,9.1e-135,483.8,sp|Q9NRL2|BAZ1A_HUMAN Bromodomain adjacent to zinc finger domain protein 1A OS=Homo sapiens OX=9606 GN=BAZ1A PE=1 SV=2,GO:0000228; GO:0003677; GO:0005634; GO:0005721; GO:0006261; GO:0006275; GO:0006334; GO:0006338; GO:0006355; GO:0006357; GO:0008270; GO:0008623; GO:0016590; GO:0031445; GO:0045740,chromatin remodeling [GO:0006338]; DNA-templated DNA replication [GO:0006261]; nucleosome assembly [GO:0006334]; positive regulation of DNA replication [GO:0045740]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated transcription [GO:0006355]; regulation of heterochromatin formation [GO:0031445]; regulation of transcription by RNA polymerase II [GO:0006357],ACF complex [GO:0016590]; CHRAC [GO:0008623]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721],DNA binding [GO:0003677]; zinc ion binding [GO:0008270],GO:0000228; GO:0003677; GO:0005634; GO:0005694; GO:0006260; GO:0006325; GO:0006355; GO:0043226; GO:0065003,nuclear chromosome; DNA binding; nucleus; chromosome; DNA replication; chromatin organization; regulation of DNA-templated transcription; organelle; protein-containing complex assembly
OG_10254,FUN_044619-T1,Peve_00030086,Pocillopora_meandrina_HIv1___RNAseq.g30295.t1,three_way,57.208666666666666,,,,,,,,,,,,,,,,,
OG_10255,FUN_044621-T2,Peve_00005983,Pocillopora_meandrina_HIv1___RNAseq.g30162.t1,three_way,89.36316666666667,FUN_044621-T2,O60306,AQR_HUMAN,,RNA helicase aquarius (EC 3.6.4.13) (Intron-binding protein of 160 kDa) (IBP160),Homo sapiens (Human),68.6,1368.0,0.0,1934.8,sp|O60306|AQR_HUMAN RNA helicase aquarius OS=Homo sapiens OX=9606 GN=AQR PE=1 SV=4,GO:0000398; GO:0003723; GO:0003727; GO:0003729; GO:0005524; GO:0005634; GO:0005654; GO:0016020; GO:0016887; GO:0034458; GO:0071007; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10256,FUN_044628-T1,Peve_00009141,Pocillopora_meandrina_HIv1___RNAseq.g17960.t1,three_way,83.56766666666667,FUN_044628-T1,A4IFG2,,,,,57.8,569.0,8.1e-191,668.3,sp|A4IFG2|BTBD9_BOVIN BTB/POZ domain-containing protein 9 OS=Bos taurus OX=9913 GN=BTBD9 PE=2 SV=2,,,,,,
OG_10257,FUN_044630-T1,Peve_00018508,Pocillopora_meandrina_HIv1___RNAseq.g18022.t1,three_way,87.94683333333333,FUN_044630-T1,Q6P2Y1,,,,,62.4,367.0,4.1e-124,446.4,sp|Q6P2Y1|PAF1_XENTR RNA polymerase II-associated factor 1 homolog OS=Xenopus tropicalis OX=8364 GN=paf1 PE=2 SV=1,,,,,,
OG_10258,FUN_044639-T1,Peve_00040316,Pocillopora_meandrina_HIv1___RNAseq.g6262.t1,three_way,56.815000000000005,,,,,,,,,,,,,,,,,
OG_10259,FUN_044684-T1,Peve_00024035,Pocillopora_meandrina_HIv1___RNAseq.g8907.t1a,three_way,57.141333333333336,,,,,,,,,,,,,,,,,
OG_10260,FUN_044693-T1,Peve_00012080,Pocillopora_meandrina_HIv1___RNAseq.g16102.t1,three_way,72.97866666666667,,,,,,,,,,,,,,,,,
OG_10261,FUN_044696-T1,Peve_00031262,Pocillopora_meandrina_HIv1___RNAseq.g25996.t1,three_way,56.51833333333333,,,,,,,,,,,,,,,,,
OG_10262,FUN_044704-T2,Peve_00032831,Pocillopora_meandrina_HIv1___TS.g17454.t1,three_way,75.62033333333333,FUN_044704-T2,Q53G59,KLH12_HUMAN,,Kelch-like protein 12 (CUL3-interacting protein 1) (DKIR homolog) (hDKIR),Homo sapiens (Human),61.7,329.0,7.4e-117,422.5,sp|Q53G59|KLH12_HUMAN Kelch-like protein 12 OS=Homo sapiens OX=9606 GN=KLHL12 PE=1 SV=2,GO:0005737; GO:0005829; GO:0006513; GO:0006888; GO:0014029; GO:0014032; GO:0016055; GO:0030127; GO:0030134; GO:0031463; GO:0034451; GO:0042802; GO:0043161; GO:0043231; GO:0048208; GO:1990756,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; Wnt signaling pathway [GO:0016055],centriolar satellite [GO:0034451]; COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231],identical protein binding [GO:0042802]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005829; GO:0016192; GO:0030154; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:0060090; GO:0065003,cytosol; vesicle-mediated transport; cell differentiation; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_10263,FUN_044722-T2,Peve_00035833,Pocillopora_meandrina_HIv1___RNAseq.g21035.t1,three_way,75.08583333333333,FUN_044722-T2,Q7T0T9,PA24A_XENLA,,Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)],Xenopus laevis (African clawed frog),39.4,747.0,7.7e-146,519.2,sp|Q7T0T9|PA24A_XENLA Cytosolic phospholipase A2 OS=Xenopus laevis OX=8355 GN=pla2g4a PE=2 SV=1,GO:0004622; GO:0005509; GO:0005544; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0031410; GO:0046475; GO:0047498,glycerophospholipid catabolic process [GO:0046475],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; calcium-dependent phospholipid binding [GO:0005544]; lysophospholipase activity [GO:0004622],GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0006629; GO:0008289; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; lipid metabolic process; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle
OG_10264,FUN_044745-T1,Peve_00026509,Pocillopora_meandrina_HIv1___RNAseq.g337.t1,three_way,89.2155,,,,,,,,,,,,,,,,,
OG_10265,FUN_044760-T1,Peve_00005547,Pocillopora_meandrina_HIv1___RNAseq.g23802.t1,three_way,60.6935,,,,,,,,,,,,,,,,,
OG_10266,FUN_044770-T1,Peve_00037668,Pocillopora_meandrina_HIv1___TS.g16929.t1,three_way,51.8545,FUN_044770-T1,Q8IVG5,SAM9L_HUMAN,,Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like),Homo sapiens (Human),24.4,1536.0,2.1e-93,346.7,sp|Q8IVG5|SAM9L_HUMAN Sterile alpha motif domain-containing protein 9-like OS=Homo sapiens OX=9606 GN=SAMD9L PE=1 SV=2,GO:0005737; GO:0005739; GO:0005769,,cytoplasm [GO:0005737]; early endosome [GO:0005769]; mitochondrion [GO:0005739],,GO:0005739; GO:0005768; GO:0031410; GO:0043226,mitochondrion; endosome; cytoplasmic vesicle; organelle
OG_10267,FUN_044779-T1,Peve_00020564,Pocillopora_meandrina_HIv1___RNAseq.g23527.t1,three_way,100.0,FUN_044779-T1,P0CH28,,,,,97.4,380.0,5.799999999999999e-206,718.0,sp|P0CH28|UBC_BOVIN Polyubiquitin-C OS=Bos taurus OX=9913 GN=UBC PE=1 SV=1,,,,,,
OG_10268,FUN_044791-T1,Peve_00037649,Pocillopora_meandrina_HIv1___RNAseq.g13649.t1,three_way,76.09466666666667,FUN_044791-T1,P43138,APEX1_RAT,,"DNA repair nuclease/redox regulator APEX1 (EC 3.1.11.2) (EC 3.1.21.-) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (Redox factor-1) (REF-1) [Cleaved into: DNA repair nuclease/redox regulator APEX1, mitochondrial]",Rattus norvegicus (Rat),61.8,267.0,1.6e-92,340.9,sp|P43138|APEX1_RAT DNA repair nuclease/redox regulator APEX1 OS=Rattus norvegicus OX=10116 GN=Apex1 PE=1 SV=2,GO:0000723; GO:0003677; GO:0003684; GO:0003691; GO:0003713; GO:0003723; GO:0003906; GO:0004519; GO:0004521; GO:0005634; GO:0005667; GO:0005730; GO:0005737; GO:0005739; GO:0005783; GO:0006281; GO:0006284; GO:0006308; GO:0006310; GO:0008081; GO:0008296; GO:0008309; GO:0008311; GO:0008408; GO:0009410; GO:0014912; GO:0016491; GO:0016607; GO:0016890; GO:0031490; GO:0042981; GO:0043488; GO:0044029; GO:0044877; GO:0045454; GO:0045944; GO:0046872; GO:0048471; GO:0051059; GO:0052720; GO:0070301; GO:0071320; GO:0090580; GO:0097698; GO:0140431; GO:1900087; GO:1904401,base-excision repair [GO:0006284]; cell redox homeostasis [GO:0045454]; cellular response to cAMP [GO:0071320]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to Thyroid stimulating hormone [GO:1904401]; DNA catabolic process [GO:0006308]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of smooth muscle cell migration [GO:0014912]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; telomere maintenance via base-excision repair [GO:0097698],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; transcription regulator complex [GO:0005667],"3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; chromatin DNA binding [GO:0031490]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-(abasic site) binding [GO:0140431]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; double-stranded telomeric DNA binding [GO:0003691]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; oxidoreductase activity [GO:0016491]; phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands [GO:0090580]; phosphoric diester hydrolase activity [GO:0008081]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; RNA endonuclease activity [GO:0004521]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; transcription coactivator activity [GO:0003713]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0005739; GO:0005783; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0016491; GO:0016787; GO:0032200; GO:0043226; GO:0060090; GO:0140097; GO:0140098; GO:0140110,"DNA binding; RNA binding; catalytic activity; nucleus; nucleolus; mitochondrion; endoplasmic reticulum; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; oxidoreductase activity; hydrolase activity; telomere organization; organelle; molecular adaptor activity; catalytic activity, acting on DNA; catalytic activity, acting on RNA; transcription regulator activity"
OG_10269,FUN_044804-T1,Peve_00009358,Pocillopora_meandrina_HIv1___RNAseq.g12965.t1,three_way,91.47233333333334,FUN_044804-T1,Q5ZIH0,INT11_CHICK,,Integrator complex subunit 11 (Int11) (EC 3.1.27.-) (Cleavage and polyadenylation-specific factor 3-like protein) (CPSF3-like protein),Gallus gallus (Chicken),72.4,572.0,7.400000000000001e-253,874.4,sp|Q5ZIH0|INT11_CHICK Integrator complex subunit 11 OS=Gallus gallus OX=9031 GN=INTS11 PE=2 SV=1,GO:0004521; GO:0005634; GO:0005737; GO:0016180; GO:0032039; GO:0034472; GO:0160232; GO:0160240,RNA polymerase II transcription initiation surveillance [GO:0160240]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],cytoplasm [GO:0005737]; INTAC complex [GO:0160232]; integrator complex [GO:0032039]; nucleus [GO:0005634],RNA endonuclease activity [GO:0004521],GO:0003824; GO:0005634; GO:0016073; GO:0043226; GO:0140098,"catalytic activity; nucleus; snRNA metabolic process; organelle; catalytic activity, acting on RNA"
OG_10270,FUN_044844-T1,Peve_00001993,Pocillopora_meandrina_HIv1___RNAseq.g12394.t1,three_way,49.958,FUN_044844-T1,Q95SX7,,,,,24.9,173.0,6.9e-06,53.1,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_10271,FUN_044848-T1,Peve_00009613,Pocillopora_meandrina_HIv1___RNAseq.g22835.t1,three_way,66.31033333333333,FUN_044848-T1,Q01588,,,,,45.9,643.0,3.6e-160,566.6,sp|Q01588|RFA1_XENLA Replication protein A 70 kDa DNA-binding subunit OS=Xenopus laevis OX=8355 GN=rpa1 PE=1 SV=1,,,,,,
OG_10272,FUN_044851-T1,Peve_00001901,Pocillopora_meandrina_HIv1___RNAseq.g22751.t1,three_way,71.9595,,,,,,,,,,,,,,,,,
OG_10273,FUN_044853-T1,Peve_00039149,Pocillopora_meandrina_HIv1___RNAseq.g22449.t1,three_way,85.593,FUN_044853-T1,Q92890,UFD1_HUMAN,,Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1),Homo sapiens (Human),64.2,293.0,3.3e-95,349.7,sp|Q92890|UFD1_HUMAN Ubiquitin recognition factor in ER-associated degradation protein 1 OS=Homo sapiens OX=9606 GN=UFD1 PE=1 SV=3,GO:0001501; GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006511; GO:0030970; GO:0031593; GO:0032480; GO:0034098; GO:0036435; GO:0036501; GO:0036503; GO:0039536; GO:0043161; GO:0071218,"cellular response to misfolded protein [GO:0071218]; ERAD pathway [GO:0036503]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],cysteine-type deubiquitinase activity [GO:0004843]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0016787; GO:0030163; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; intracellular protein transport; hydrolase activity; protein catabolic process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10274,FUN_044855-T1,Peve_00017210,Pocillopora_meandrina_HIv1___RNAseq.g11141.t1,three_way,65.04066666666667,,,,,,,,,,,,,,,,,
OG_10275,FUN_044861-T1,Peve_00023050,Pocillopora_meandrina_HIv1___RNAseq.g26001.t1,three_way,55.79233333333333,,,,,,,,,,,,,,,,,
OG_10276,FUN_044866-T1,Peve_00000207,Pocillopora_meandrina_HIv1___RNAseq.g334.t1,three_way,47.43566666666667,FUN_044866-T1,Q8WZ60,KLHL6_HUMAN,,Kelch-like protein 6,Homo sapiens (Human),28.0,289.0,1.0999999999999998e-24,116.3,sp|Q8WZ60|KLHL6_HUMAN Kelch-like protein 6 OS=Homo sapiens OX=9606 GN=KLHL6 PE=1 SV=3,GO:0002467; GO:0005737; GO:0009617; GO:0031463; GO:0043161; GO:0050853; GO:1990756,B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to bacterium [GO:0009617],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0002376; GO:0030163; GO:0060090,immune system process; protein catabolic process; molecular adaptor activity
OG_10277,FUN_044902-T1,Peve_00013819,Pocillopora_meandrina_HIv1___RNAseq.g9839.t1,three_way,74.02383333333334,FUN_044902-T1,Q3SZK1,,,,,47.0,349.0,1.3e-91,338.2,sp|Q3SZK1|AAMP_BOVIN Angio-associated migratory cell protein OS=Bos taurus OX=9913 GN=AAMP PE=2 SV=1,,,,,,
OG_10278,FUN_044925-T1,Peve_00025277,Pocillopora_meandrina_HIv1___RNAseq.g9896.t1,three_way,85.537,FUN_044925-T1,Q6AX60,,,,,52.1,839.0,8.499999999999998e-243,841.6,sp|Q6AX60|PTHB1_XENLA Protein PTHB1 OS=Xenopus laevis OX=8355 GN=bbs9 PE=2 SV=1,,,,,,
OG_10279,FUN_044949-T1,Peve_00040534,Pocillopora_meandrina_HIv1___RNAseq.g9519.t1,three_way,84.15683333333334,FUN_044949-T1,Q6IQC7,,,,,41.0,256.0,5.5e-54,212.6,sp|Q6IQC7|TMX2B_DANRE Thioredoxin-related transmembrane protein 2-B OS=Danio rerio OX=7955 GN=tmx2b PE=2 SV=1,,,,,,
OG_10280,FUN_044950-T1,Peve_00016639,Pocillopora_meandrina_HIv1___TS.g23122.t1,three_way,68.547,FUN_044950-T1,Q9EQD2,NPFF2_RAT,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor),Rattus norvegicus (Rat),23.8,294.0,4e-09,63.9,sp|Q9EQD2|NPFF2_RAT Neuropeptide FF receptor 2 OS=Rattus norvegicus OX=10116 GN=Npffr2 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_10281,FUN_044959-T1,Peve_00019452,Pocillopora_meandrina_HIv1___RNAseq.g26820.t1a,three_way,87.71466666666666,,,,,,,,,,,,,,,,,
OG_10282,FUN_044975-T1,Peve_00004402,Pocillopora_meandrina_HIv1___RNAseq.g24706.t1,three_way,58.88066666666666,,,,,,,,,,,,,,,,,
OG_10283,FUN_044988-T1,Peve_00020573,Pocillopora_meandrina_HIv1___RNAseq.g22577.t1,three_way,42.0115,,,,,,,,,,,,,,,,,
OG_10284,FUN_045021-T1,Peve_00035559,Pocillopora_meandrina_HIv1___RNAseq.g12484.t1,three_way,96.05,,,,,,,,,,,,,,,,,
OG_10285,FUN_045045-T1,Peve_00036115,Pocillopora_meandrina_HIv1___RNAseq.g2824.t1a,three_way,89.07933333333334,,,,,,,,,,,,,,,,,
OG_10286,FUN_045068-T1,Peve_00043993,Pocillopora_meandrina_HIv1___RNAseq.g4720.t1,three_way,68.57933333333332,FUN_045068-T1,O94889,KLH18_HUMAN,,Kelch-like protein 18,Homo sapiens (Human),41.2,320.0,3.3000000000000004e-60,234.2,sp|O94889|KLH18_HUMAN Kelch-like protein 18 OS=Homo sapiens OX=9606 GN=KLHL18 PE=1 SV=3,GO:0005737; GO:0016567; GO:0031463; GO:0043161; GO:0051301; GO:1901992; GO:1990756,cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_10287,FUN_045078-T1,Peve_00037591,Pocillopora_meandrina_HIv1___RNAseq.g4342.t1,three_way,74.74499999999999,FUN_045078-T1,Q149C2,,,,,46.9,627.0,9.7e-61,236.1,sp|Q149C2|MIPT3_MOUSE TRAF3-interacting protein 1 OS=Mus musculus OX=10090 GN=Traf3ip1 PE=1 SV=2,,,,,,
OG_10288,FUN_045085-T1,Peve_00038865,Pocillopora_meandrina_HIv1___RNAseq.g3024.t1,three_way,62.34233333333333,FUN_045085-T1,Q5RBB1,SENP1_PONAB,,Sentrin-specific protease 1 (EC 3.4.22.-) (Sentrin/SUMO-specific protease SENP1),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),32.3,561.0,9.4e-66,253.1,sp|Q5RBB1|SENP1_PONAB Sentrin-specific protease 1 OS=Pongo abelii OX=9601 GN=SENP1 PE=2 SV=1,GO:0005634; GO:0005737; GO:0006508; GO:0016926; GO:0016929; GO:0070139,protein desumoylation [GO:0016926]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; nucleus [GO:0005634],deSUMOylase activity [GO:0016929]; SUMO-specific endopeptidase activity [GO:0070139],GO:0003824; GO:0005634; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_10289,FUN_045091-T1,Peve_00008512,Pocillopora_meandrina_HIv1___TS.g10042.t2b,three_way,37.21533333333333,,,,,,,,,,,,,,,,,
OG_10290,FUN_045095-T1,Peve_00018799,Pocillopora_meandrina_HIv1___RNAseq.g639.t1,three_way,83.39433333333334,FUN_045095-T1,Q9D051,ODPB_MOUSE,,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)",Mus musculus (Mouse),73.2,340.0,1.7e-146,520.4,"sp|Q9D051|ODPB_MOUSE Pyruvate dehydrogenase E1 component subunit beta, mitochondrial OS=Mus musculus OX=10090 GN=Pdhb PE=1 SV=1",GO:0004739; GO:0005654; GO:0005739; GO:0005759; GO:0006006; GO:0006086; GO:0006099; GO:0034604; GO:0045254; GO:0046872; GO:1902493; GO:1902494,glucose metabolic process [GO:0006006]; pyruvate decarboxylation to acetyl-CoA [GO:0006086]; tricarboxylic acid cycle [GO:0006099],acetyltransferase complex [GO:1902493]; catalytic complex [GO:1902494]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; pyruvate dehydrogenase complex [GO:0045254],metal ion binding [GO:0046872]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase (NAD+) activity [GO:0034604],GO:0003824; GO:0005654; GO:0005739; GO:0005975; GO:0006790; GO:0016491; GO:0043226; GO:0055086,catalytic activity; nucleoplasm; mitochondrion; carbohydrate metabolic process; sulfur compound metabolic process; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process
OG_10291,FUN_045131-T1,Peve_00020350,Pocillopora_meandrina_HIv1___RNAseq.g19262.t1,three_way,67.20883333333333,FUN_045131-T1,Q13639,,,,,27.5,149.0,1.1e-08,61.6,sp|Q13639|5HT4R_HUMAN 5-hydroxytryptamine receptor 4 OS=Homo sapiens OX=9606 GN=HTR4 PE=1 SV=2,,,,,,
OG_10292,FUN_045137-T1,Peve_00019881,Pocillopora_meandrina_HIv1___RNAseq.g19844.t1,three_way,60.03666666666666,,,,,,,,,,,,,,,,,
OG_10293,FUN_045150-T1,Peve_00027328,Pocillopora_meandrina_HIv1___RNAseq.g19152.t1,three_way,62.7535,FUN_045150-T1,Q8CDF7,EXD1_MOUSE,,piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1) (mExd1),Mus musculus (Mouse),40.2,264.0,5.400000000000001e-44,180.6,sp|Q8CDF7|EXD1_MOUSE piRNA biogenesis protein EXD1 OS=Mus musculus OX=10090 GN=Exd1 PE=1 SV=1,GO:0003723; GO:0031047; GO:0034587; GO:0042803; GO:0043186; GO:0051321; GO:1990923,meiotic cell cycle [GO:0051321]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated gene silencing [GO:0031047],P granule [GO:0043186]; PET complex [GO:1990923],protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723],GO:0003723; GO:0022414; GO:0031047; GO:0043226,RNA binding; reproductive process; regulatory ncRNA-mediated gene silencing; organelle
OG_10294,FUN_045163-T1,Peve_00035917,Pocillopora_meandrina_HIv1___RNAseq.g19246.t1,three_way,91.29666666666668,,,,,,,,,,,,,,,,,
OG_10295,FUN_045178-T1,Peve_00005457,Pocillopora_meandrina_HIv1___RNAseq.g13246.t1,three_way,51.747,,,,,,,,,,,,,,,,,
OG_10296,FUN_045186-T1,Peve_00006550,Pocillopora_meandrina_HIv1___RNAseq.g23143.t1,three_way,90.09616666666666,FUN_045186-T1,Q6TDP4,KLH17_HUMAN,,Kelch-like protein 17 (Actinfilin),Homo sapiens (Human),59.9,322.0,1.1e-107,392.1,sp|Q6TDP4|KLH17_HUMAN Kelch-like protein 17 OS=Homo sapiens OX=9606 GN=KLHL17 PE=1 SV=1,GO:0003779; GO:0005615; GO:0005737; GO:0014069; GO:0015629; GO:0016567; GO:0030036; GO:0031463; GO:0043161; GO:0060090; GO:1990756,actin cytoskeleton organization [GO:0030036]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],actin cytoskeleton [GO:0015629]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; postsynaptic density [GO:0014069],actin binding [GO:0003779]; molecular adaptor activity [GO:0060090]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005615; GO:0005856; GO:0007010; GO:0008092; GO:0030163; GO:0043226; GO:0060090,extracellular space; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; protein catabolic process; organelle; molecular adaptor activity
OG_10297,FUN_045187-T1,Peve_00002533,Pocillopora_meandrina_HIv1___RNAseq.g23085.t1,three_way,78.89966666666666,FUN_045187-T1,Q0VA16,,,,,56.0,602.0,2.5e-185,650.2,sp|Q0VA16|WDR70_XENTR WD repeat-containing protein 70 OS=Xenopus tropicalis OX=8364 GN=wdr70 PE=2 SV=1,,,,,,
OG_10298,FUN_045203-T1,Peve_00006895,Pocillopora_meandrina_HIv1___RNAseq.g3200.t1,three_way,94.99766666666666,FUN_045203-T1,Q9VFP2,,,,,74.5,361.0,7.3e-158,558.1,sp|Q9VFP2|RDX_DROME Protein roadkill OS=Drosophila melanogaster OX=7227 GN=rdx PE=1 SV=2,,,,,,
OG_10299,FUN_045323-T1,Peve_00031953,Pocillopora_meandrina_HIv1___RNAseq.g25672.t1,three_way,81.76783333333334,FUN_045323-T1,Q7ZX31,,,,,51.5,433.0,1.4e-80,301.6,sp|Q7ZX31|ING3_XENLA Inhibitor of growth protein 3 OS=Xenopus laevis OX=8355 GN=ing3 PE=2 SV=1,,,,,,
OG_10300,FUN_045329-T1,Peve_00024386,Pocillopora_meandrina_HIv1___RNAseq.g15029.t1,three_way,80.72066666666667,FUN_045329-T1,Q3UXZ9,KDM5A_MOUSE,,Lysine-specific demethylase 5A (EC 1.14.11.67) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2) ([histone H3]-trimethyl-L-lysine(4) demethylase 5A),Mus musculus (Mouse),54.5,319.0,3.7e-84,313.5,sp|Q3UXZ9|KDM5A_MOUSE Lysine-specific demethylase 5A OS=Mus musculus OX=10090 GN=Kdm5a PE=1 SV=2,GO:0000122; GO:0000976; GO:0003682; GO:0003713; GO:0004857; GO:0005634; GO:0005654; GO:0005730; GO:0007283; GO:0008270; GO:0008584; GO:0031490; GO:0032453; GO:0032922; GO:0032993; GO:0034647; GO:0036211; GO:0042393; GO:0140718,circadian regulation of gene expression [GO:0032922]; facultative heterochromatin formation [GO:0140718]; male gonad development [GO:0008584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein modification process [GO:0036211]; spermatogenesis [GO:0007283],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993],chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H3K4 demethylase activity [GO:0032453]; histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO:0034647]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0016491; GO:0022414; GO:0042393; GO:0043226; GO:0048856; GO:0060090; GO:0098772; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; oxidoreductase activity; reproductive process; histone binding; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_10301,FUN_045331-T1,Peve_00028496,Pocillopora_meandrina_HIv1___RNAseq.g23215.t1,three_way,95.19766666666666,,,,,,,,,,,,,,,,,
OG_10302,FUN_045359-T1,Peve_00043527,Pocillopora_meandrina_HIv1___RNAseq.g17351.t1,three_way,90.969,FUN_045359-T1,Q9YHC3,,,,,66.4,444.0,5.5e-179,628.6,sp|Q9YHC3|TBB1_GADMO Tubulin beta-1 chain OS=Gadus morhua OX=8049 PE=2 SV=1,,,,,,
OG_10303,FUN_045378-T1,Peve_00003097,Pocillopora_meandrina_HIv1___RNAseq.g19244.t1,three_way,66.60766666666666,,,,,,,,,,,,,,,,,
OG_10304,FUN_045412-T1,Peve_00035276,Pocillopora_meandrina_HIv1___RNAseq.g25679.t1,three_way,61.03066666666667,FUN_045412-T1,Q9CXI3,,,,,43.5,462.0,2.9000000000000004e-111,404.1,sp|Q9CXI3|MOXD1_MOUSE DBH-like monooxygenase protein 1 OS=Mus musculus OX=10090 GN=Moxd1 PE=1 SV=1,,,,,,
OG_10305,FUN_045415-T1,Peve_00033982,Pocillopora_meandrina_HIv1___RNAseq.g5358.t1,three_way,57.47133333333333,FUN_045415-T1,Q9DCB8,,,,,45.2,73.0,3e-09,62.8,"sp|Q9DCB8|ISCA2_MOUSE Iron-sulfur cluster assembly 2 homolog, mitochondrial OS=Mus musculus OX=10090 GN=Isca2 PE=1 SV=2",,,,,,
OG_10306,FUN_045416-T1,Peve_00010619,Pocillopora_meandrina_HIv1___TS.g17165.t1a,three_way,58.57866666666666,,,,,,,,,,,,,,,,,
OG_10307,FUN_045417-T1,Peve_00015560,Pocillopora_meandrina_HIv1___RNAseq.g9499.t1,three_way,79.34766666666667,FUN_045417-T1,Q8NBS9,,,,,40.5,321.0,2.3000000000000002e-71,270.8,sp|Q8NBS9|TXND5_HUMAN Thioredoxin domain-containing protein 5 OS=Homo sapiens OX=9606 GN=TXNDC5 PE=1 SV=2,,,,,,
OG_10308,FUN_045428-T1,Peve_00041500,Pocillopora_meandrina_HIv1___RNAseq.g1807.t1,three_way,65.13850000000001,,,,,,,,,,,,,,,,,
OG_10309,FUN_045467-T1,Peve_00034135,Pocillopora_meandrina_HIv1___RNAseq.g26021.t1,three_way,81.107,FUN_045467-T1,Q4U0Y4,NPL1A_XENLA,,Nucleosome assembly protein 1-like 1-A (xNAP1L-A) (Nucleosome assembly protein 1) (NAP-1) (NAP1) (xNAP-1) (xNAP1),Xenopus laevis (African clawed frog),55.9,340.0,7.4e-103,375.6,sp|Q4U0Y4|NPL1A_XENLA Nucleosome assembly protein 1-like 1-A OS=Xenopus laevis OX=8355 GN=nap1l1-a PE=1 SV=1,GO:0000785; GO:0003682; GO:0005634; GO:0005737; GO:0006334; GO:0007283; GO:0030332; GO:0042393; GO:0042802; GO:0045944; GO:0060215,nucleosome assembly [GO:0006334]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive hemopoiesis [GO:0060215]; spermatogenesis [GO:0007283],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],chromatin binding [GO:0003682]; cyclin binding [GO:0030332]; histone binding [GO:0042393]; identical protein binding [GO:0042802],GO:0005634; GO:0006325; GO:0006355; GO:0022414; GO:0042393; GO:0043226; GO:0048856; GO:0065003,nucleus; chromatin organization; regulation of DNA-templated transcription; reproductive process; histone binding; organelle; anatomical structure development; protein-containing complex assembly
OG_10310,FUN_045468-T1,Peve_00034139,Pocillopora_meandrina_HIv1___RNAseq.g26023.t1,three_way,66.84366666666666,,,,,,,,,,,,,,,,,
OG_10311,FUN_045475-T1,Peve_00027538,Pocillopora_meandrina_HIv1___RNAseq.g26171.t1,three_way,73.489,FUN_045475-T1,P46063,RECQ1_HUMAN,,"ATP-dependent DNA helicase Q1 (EC 5.6.2.4) (DNA 3'-5' helicase Q1) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)",Homo sapiens (Human),56.0,523.0,1e-173,611.7,sp|P46063|RECQ1_HUMAN ATP-dependent DNA helicase Q1 OS=Homo sapiens OX=9606 GN=RECQL PE=1 SV=3,GO:0000724; GO:0003678; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0009378; GO:0016020; GO:0016887; GO:0031297; GO:0036121; GO:0043138; GO:0046872; GO:1990814,DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; replication fork processing [GO:0031297],chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA helicase activity [GO:0003678]; DNA/DNA annealing activity [GO:1990814]; double-stranded DNA helicase activity [GO:0036121]; four-way junction helicase activity [GO:0009378]; metal ion binding [GO:0046872],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_10312,FUN_045480-T1,Peve_00019145,Pocillopora_meandrina_HIv1___RNAseq.g28459.t1,three_way,46.046,,,,,,,,,,,,,,,,,
OG_10313,FUN_045489-T1,Peve_00042270,Pocillopora_meandrina_HIv1___RNAseq.g9140.t1,three_way,51.053,,,,,,,,,,,,,,,,,
OG_10314,FUN_045497-T1,Peve_00018025,Pocillopora_meandrina_HIv1___RNAseq.g27824.t1,three_way,95.44266666666668,FUN_045497-T1,Q3ZBG0,,,,,82.3,231.0,3.1e-107,389.4,sp|Q3ZBG0|PSA7_BOVIN Proteasome subunit alpha type-7 OS=Bos taurus OX=9913 GN=PSMA7 PE=1 SV=1,,,,,,
OG_10315,FUN_045498-T1,Peve_00028345,Pocillopora_meandrina_HIv1___RNAseq.g12175.t1,three_way,47.88966666666666,FUN_045498-T1,Q8N8U2,,,,,56.1,57.0,2.7e-10,67.0,sp|Q8N8U2|CDYL2_HUMAN Chromodomain Y-like protein 2 OS=Homo sapiens OX=9606 GN=CDYL2 PE=1 SV=2,,,,,,
OG_10316,FUN_045508-T1,Peve_00035355,Pocillopora_meandrina_HIv1___TS.g23718.t1a,three_way,45.33866666666667,,,,,,,,,,,,,,,,,
OG_10317,FUN_045517-T1,Peve_00012139,Pocillopora_meandrina_HIv1___RNAseq.g26977.t1,three_way,82.21133333333333,FUN_045517-T1,Q96KP1,,,,,46.5,426.0,4.3e-99,363.2,sp|Q96KP1|EXOC2_HUMAN Exocyst complex component 2 OS=Homo sapiens OX=9606 GN=EXOC2 PE=1 SV=1,,,,,,
OG_10318,FUN_045533-T2,Peve_00015191,Pocillopora_meandrina_HIv1___RNAseq.g11916.t1,three_way,72.19216666666667,FUN_045533-T2,O94761,RECQ4_HUMAN,,"ATP-dependent DNA helicase Q4 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ4) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)",Homo sapiens (Human),42.6,1036.0,3.4e-206,720.7,sp|O94761|RECQ4_HUMAN ATP-dependent DNA helicase Q4 OS=Homo sapiens OX=9606 GN=RECQL4 PE=1 SV=2,GO:0000405; GO:0000723; GO:0000724; GO:0000781; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0006260; GO:0006281; GO:0009378; GO:0016020; GO:0016887; GO:0032357; GO:0046872; GO:0061820; GO:0061821; GO:1990814,DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820],"chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA/DNA annealing activity [GO:1990814]; four-way junction helicase activity [GO:0009378]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; oxidized purine DNA binding [GO:0032357]; telomeric D-loop binding [GO:0061821],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_10319,FUN_045539-T1,Peve_00006628,Pocillopora_meandrina_HIv1___RNAseq.g12333.t1,three_way,77.75733333333334,FUN_045539-T1,Q08BL9,KL24A_DANRE,,Kelch-like protein 24a (Kelch-like family member 24a),Danio rerio (Zebrafish) (Brachydanio rerio),33.1,305.0,1.8e-39,165.6,sp|Q08BL9|KL24A_DANRE Kelch-like protein 24a OS=Danio rerio OX=7955 GN=klhl24a PE=2 SV=1,GO:0005737; GO:0005912; GO:0007507; GO:0030057; GO:0030424; GO:0031463; GO:0043161; GO:0043204; GO:1990756,heart development [GO:0007507]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0048856; GO:0060090,protein catabolic process; anatomical structure development; molecular adaptor activity
OG_10320,FUN_045542-T2,Peve_00018980,Pocillopora_meandrina_HIv1___RNAseq.g27404.t1,three_way,61.17033333333333,FUN_045542-T2,Q8BG58,P4HTM_MOUSE,,Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4),Mus musculus (Mouse),29.4,470.0,1.3000000000000002e-44,182.6,sp|Q8BG58|P4HTM_MOUSE Transmembrane prolyl 4-hydroxylase OS=Mus musculus OX=10090 GN=P4htm PE=1 SV=1,GO:0005506; GO:0005509; GO:0005789; GO:0008270; GO:0016706; GO:0031418; GO:0045646; GO:0160082,regulation of erythrocyte differentiation [GO:0045646],endoplasmic reticulum membrane [GO:0005789],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; calcium ion binding [GO:0005509]; hypoxia-inducible factor-proline dioxygenase activity [GO:0160082]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; zinc ion binding [GO:0008270],GO:0003824; GO:0016491; GO:0140096,"catalytic activity; oxidoreductase activity; catalytic activity, acting on a protein"
OG_10321,FUN_045550-T1,Peve_00025932,Pocillopora_meandrina_HIv1___RNAseq.g27382.t1,three_way,84.01666666666667,,,,,,,,,,,,,,,,,
OG_10322,FUN_045557-T1,Peve_00036910,Pocillopora_meandrina_HIv1___RNAseq.17971_t,three_way,74.02000000000001,,,,,,,,,,,,,,,,,
OG_10323,FUN_045577-T1,Peve_00004718,Pocillopora_meandrina_HIv1___RNAseq.g11109.t1,three_way,92.38233333333334,FUN_045577-T1,Q8JZP3,,,,,65.6,317.0,3.8e-116,420.2,sp|Q8JZP3|KLHL2_MOUSE Kelch-like protein 2 OS=Mus musculus OX=10090 GN=Klhl2 PE=2 SV=1,,,,,,
OG_10324,FUN_045580-T1,Peve_00045340,Pocillopora_meandrina_HIv1___TS.g15566.t1,three_way,47.37433333333333,FUN_045580-T1,P04323,,,,,27.1,720.0,6.299999999999998e-69,264.6,sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1,,,,,,
OG_10325,FUN_045594-T1,Peve_00022490,Pocillopora_meandrina_HIv1___RNAseq.g10219.t1,three_way,44.515166666666666,,,,,,,,,,,,,,,,,
OG_10326,FUN_045607-T1,Peve_00003002,Pocillopora_meandrina_HIv1___RNAseq.g28328.t1,three_way,59.46833333333333,FUN_045607-T1,Q8R1C6,,,,,44.9,254.0,3.3999999999999995e-53,209.9,sp|Q8R1C6|MET22_MOUSE Methyltransferase-like protein 22 OS=Mus musculus OX=10090 GN=Mettl22 PE=2 SV=1,,,,,,
OG_10327,FUN_045608-T1,Peve_00041697,Pocillopora_meandrina_HIv1___RNAseq.g28319.t1,three_way,52.1635,FUN_045608-T1,Q14781,CBX2_HUMAN,,Chromobox protein homolog 2,Homo sapiens (Human),75.5,49.0,3.8e-17,90.9,sp|Q14781|CBX2_HUMAN Chromobox protein homolog 2 OS=Homo sapiens OX=9606 GN=CBX2 PE=1 SV=2,GO:0000122; GO:0000791; GO:0000792; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0030154; GO:0031519; GO:0035064; GO:0035102; GO:0045137; GO:0062072,cell differentiation [GO:0030154]; development of primary sexual characteristics [GO:0045137]; negative regulation of transcription by RNA polymerase II [GO:0000122],euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone H3K9me2/3 reader activity [GO:0062072]; methylated histone binding [GO:0035064],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0022414; GO:0030154; GO:0043226; GO:0060090,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; reproductive process; cell differentiation; organelle; molecular adaptor activity
OG_10328,FUN_045609-T1,Peve_00000099,Pocillopora_meandrina_HIv1___RNAseq.g1111.t1,three_way,88.27383333333333,FUN_045609-T1,Q9Y519,,,,,62.8,360.0,8.3e-121,435.3,sp|Q9Y519|T184B_HUMAN Transmembrane protein 184B OS=Homo sapiens OX=9606 GN=TMEM184B PE=1 SV=2,,,,,,
OG_10329,FUN_045611-T1,Peve_00000004,Pocillopora_meandrina_HIv1___RNAseq.g1184.t1,three_way,87.42933333333333,FUN_045611-T1,Q08DK3,KLH20_BOVIN,,Kelch-like protein 20,Bos taurus (Bovine),45.9,314.0,4.4e-77,290.4,sp|Q08DK3|KLH20_BOVIN Kelch-like protein 20 OS=Bos taurus OX=9913 GN=KLHL20 PE=2 SV=3,GO:0003779; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390; GO:1990756,Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802],actin binding [GO:0003779]; type II interferon binding [GO:0019964]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005829; GO:0008092; GO:0016192; GO:0030163; GO:0043226; GO:0060090,cytosol; cytoskeletal protein binding; vesicle-mediated transport; protein catabolic process; organelle; molecular adaptor activity
OG_10330,FUN_045628-T1,Peve_00004517,Pocillopora_meandrina_HIv1___RNAseq.g1084.t1,three_way,59.288,FUN_045628-T1,Q55DL2,MET18_DICDI,,Histidine protein methyltransferase 1 homolog (EC 2.1.1.85) (Protein METTL18 homolog),Dictyostelium discoideum (Social amoeba),42.5,212.0,2.5e-42,174.1,sp|Q55DL2|MET18_DICDI Histidine protein methyltransferase 1 homolog OS=Dictyostelium discoideum OX=44689 GN=DDB_G0270580 PE=3 SV=1,GO:0005634; GO:0005730; GO:0005829; GO:0006417; GO:0018026; GO:0018064,peptidyl-lysine monomethylation [GO:0018026]; regulation of translation [GO:0006417],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634],protein-L-histidine N-tele-methyltransferase activity [GO:0018064],GO:0003824; GO:0005634; GO:0005730; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleolus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_10331,FUN_045646-T1,Peve_00013416,Pocillopora_meandrina_HIv1___TS.g15513.t1,three_way,69.82733333333333,,,,,,,,,,,,,,,,,
OG_10332,FUN_045674-T1,Peve_00021856,Pocillopora_meandrina_HIv1___RNAseq.g7367.t1,three_way,74.59866666666666,FUN_045674-T1,P12107,COBA1_HUMAN,,Collagen alpha-1(XI) chain,Homo sapiens (Human),41.3,252.0,7.5e-45,184.9,sp|P12107|COBA1_HUMAN Collagen alpha-1(XI) chain OS=Homo sapiens OX=9606 GN=COL11A1 PE=1 SV=4,GO:0001502; GO:0002063; GO:0005201; GO:0005576; GO:0005592; GO:0005615; GO:0005788; GO:0006029; GO:0007601; GO:0007605; GO:0008201; GO:0030020; GO:0030198; GO:0030199; GO:0030674; GO:0035987; GO:0035989; GO:0042472; GO:0046872; GO:0048704; GO:0050840; GO:0050910; GO:0055010; GO:0062023,cartilage condensation [GO:0001502]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; embryonic skeletal system morphogenesis [GO:0048704]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; inner ear morphogenesis [GO:0042472]; proteoglycan metabolic process [GO:0006029]; sensory perception of sound [GO:0007605]; tendon development [GO:0035989]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visual perception [GO:0007601],collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615],extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674],GO:0005198; GO:0005576; GO:0005615; GO:0030154; GO:0030198; GO:0048856; GO:0050877; GO:0060090; GO:1901135,structural molecule activity; extracellular region; extracellular space; cell differentiation; extracellular matrix organization; anatomical structure development; nervous system process; molecular adaptor activity; carbohydrate derivative metabolic process
OG_10333,FUN_045675-T1,Peve_00010148,Pocillopora_meandrina_HIv1___RNAseq.g7361.t1,three_way,48.47666666666667,FUN_045675-T1,O15432,COPT2_HUMAN,,Protein SLC31A2 (Copper transporter 2) (hCTR2) (Solute carrier family 31 member 2),Homo sapiens (Human),30.9,136.0,3.3e-08,59.7,sp|O15432|COPT2_HUMAN Protein SLC31A2 OS=Homo sapiens OX=9606 GN=SLC31A2 PE=1 SV=1,GO:0005375; GO:0005765; GO:0005886; GO:0006825; GO:0006878; GO:0015677; GO:0031902; GO:0055037; GO:1902311,copper ion import [GO:0015677]; copper ion transport [GO:0006825]; intracellular copper ion homeostasis [GO:0006878]; regulation of copper ion transmembrane transport [GO:1902311],late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],copper ion transmembrane transporter activity [GO:0005375],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle
OG_10334,FUN_045682-T2,Peve_00025981,Pocillopora_meandrina_HIv1___RNAseq.g8449.t1,three_way,49.386,FUN_045682-T2,Q7Z2W4,ZCCHV_HUMAN,,Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Inactive Poly [ADP-ribose] polymerase 13) (PARP13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP),Homo sapiens (Human),24.5,216.0,3.6e-06,55.1,sp|Q7Z2W4|ZCCHV_HUMAN Zinc finger CCCH-type antiviral protein 1 OS=Homo sapiens OX=9606 GN=ZC3HAV1 PE=1 SV=3,GO:0003723; GO:0005634; GO:0005737; GO:0005764; GO:0005770; GO:0005829; GO:0008270; GO:0009615; GO:0032481; GO:0032727; GO:0032728; GO:0043123; GO:0045071; GO:0045087; GO:0045296; GO:0051607; GO:0061014; GO:1900246,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; response to virus [GO:0009615],cytoplasm [GO:0005737]; cytosol [GO:0005829]; late endosome [GO:0005770]; lysosome [GO:0005764]; nucleus [GO:0005634],cadherin binding [GO:0045296]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0005634; GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0031410; GO:0043226; GO:0098542,immune system process; RNA binding; nucleus; lysosome; endosome; vacuole; cytosol; cytoplasmic vesicle; organelle; defense response to other organism
OG_10335,FUN_045698-T1,Peve_00012233,Pocillopora_meandrina_HIv1___TS.g23755.t1,three_way,52.998666666666665,,,,,,,,,,,,,,,,,
OG_10336,FUN_045700-T1,Peve_00004015,Pocillopora_meandrina_HIv1___RNAseq.g6515.t1,three_way,78.45066666666666,FUN_045700-T1,Q8QGW7,,,,,38.7,93.0,1.8e-10,67.0,sp|Q8QGW7|LITAF_CHICK Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog OS=Gallus gallus OX=9031 GN=LITAF PE=2 SV=1,,,,,,
OG_10337,FUN_045718-T1,Peve_00015412,Pocillopora_meandrina_HIv1___RNAseq.g6469.t1,three_way,92.39633333333332,FUN_045718-T1,P50143,,,,,74.7,541.0,9.400000000000001e-234,810.8,sp|P50143|TCPG_XENLA T-complex protein 1 subunit gamma OS=Xenopus laevis OX=8355 GN=cct3 PE=2 SV=2,,,,,,
OG_10338,FUN_045727-T1,Peve_00002292,Pocillopora_meandrina_HIv1___RNAseq.g6553.t1,three_way,62.71033333333334,FUN_045727-T1,O88700,BLM_MOUSE,,RecQ-like DNA helicase BLM (EC 5.6.2.4) (Bloom syndrome protein homolog) (mBLM) (DNA 3'-5' helicase BLM) (RecQ helicase homolog),Mus musculus (Mouse),48.3,603.0,1.1e-157,559.3,sp|O88700|BLM_MOUSE RecQ-like DNA helicase BLM OS=Mus musculus OX=10090 GN=Blm PE=1 SV=1,GO:0000228; GO:0000400; GO:0000723; GO:0000724; GO:0000729; GO:0000781; GO:0001673; GO:0003677; GO:0003678; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0006260; GO:0006281; GO:0006312; GO:0006974; GO:0008270; GO:0009378; GO:0016887; GO:0031297; GO:0031422; GO:0032392; GO:0033080; GO:0033092; GO:0042803; GO:0043138; GO:0045120; GO:0045950; GO:0046632; GO:0046633; GO:0046641; GO:0051259; GO:0051260; GO:0051276; GO:0061749; GO:0070244; GO:0071139; GO:0071466; GO:0071479; GO:0072711; GO:0072757; GO:1904157; GO:1905168; GO:1990414,alpha-beta T cell differentiation [GO:0046632]; alpha-beta T cell proliferation [GO:0046633]; cellular response to camptothecin [GO:0072757]; cellular response to hydroxyurea [GO:0072711]; cellular response to ionizing radiation [GO:0071479]; cellular response to xenobiotic stimulus [GO:0071466]; chromosome organization [GO:0051276]; DN4 thymocyte differentiation [GO:1904157]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA geometric change [GO:0032392]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; immature T cell proliferation in thymus [GO:0033080]; mitotic recombination [GO:0006312]; negative regulation of mitotic recombination [GO:0045950]; negative regulation of thymocyte apoptotic process [GO:0070244]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; protein complex oligomerization [GO:0051259]; protein homooligomerization [GO:0051260]; replication fork processing [GO:0031297]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; resolution of DNA recombination intermediates [GO:0071139]; telomere maintenance [GO:0000723],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pronucleus [GO:0045120]; RecQ family helicase-topoisomerase III complex [GO:0031422]; replication fork [GO:0005657]",3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; protein homodimerization activity [GO:0042803]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270],GO:0000228; GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0030154; GO:0032200; GO:0043226; GO:0065003; GO:0140097; GO:0140657,"nuclear chromosome; immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; cell differentiation; telomere organization; organelle; protein-containing complex assembly; catalytic activity, acting on DNA; ATP-dependent activity"
OG_10339,FUN_045745-T1,Peve_00023681,Pocillopora_meandrina_HIv1___RNAseq.g25191.t1,three_way,71.5295,,,,,,,,,,,,,,,,,
OG_10340,FUN_045792-T1,Peve_00011892,Pocillopora_meandrina_HIv1___RNAseq.g28851.t1,three_way,44.45366666666666,,,,,,,,,,,,,,,,,
OG_10341,FUN_045795-T1,Peve_00035545,Pocillopora_meandrina_HIv1___RNAseq.g21095.t1,three_way,60.833,,,,,,,,,,,,,,,,,
OG_10342,FUN_045814-T1,Peve_00039046,Pocillopora_meandrina_HIv1___RNAseq.g7113.t1,three_way,62.10533333333333,FUN_045814-T1,P08912,ACM5_HUMAN,,Muscarinic acetylcholine receptor M5,Homo sapiens (Human),28.3,205.0,2.1e-06,55.1,sp|P08912|ACM5_HUMAN Muscarinic acetylcholine receptor M5 OS=Homo sapiens OX=9606 GN=CHRM5 PE=1 SV=2,GO:0001696; GO:0004435; GO:0005886; GO:0007187; GO:0007197; GO:0007213; GO:0007268; GO:0015872; GO:0016907; GO:0019226; GO:0030425; GO:0045202; GO:0045211; GO:0060304,"adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway [GO:0007197]; chemical synaptic transmission [GO:0007268]; dopamine transport [GO:0015872]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; regulation of phosphatidylinositol dephosphorylation [GO:0060304]; transmission of nerve impulse [GO:0019226]",dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],"G protein-coupled acetylcholine receptor activity [GO:0016907]; phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]",GO:0003824; GO:0005886; GO:0016787; GO:0022600; GO:0023052; GO:0050877; GO:0060089,catalytic activity; plasma membrane; hydrolase activity; digestive system process; signaling; nervous system process; molecular transducer activity
OG_10343,FUN_045818-T1,Peve_00039040,Pocillopora_meandrina_HIv1___TS.g848.t1,three_way,69.99266666666666,FUN_045818-T1,Q9Y6Y0,NS1BP_HUMAN,,Influenza virus NS1A-binding protein (NS1-BP) (NS1-binding protein) (Aryl hydrocarbon receptor-associated protein 3) (Kelch-like protein 39),Homo sapiens (Human),26.4,406.0,8.3e-35,150.2,sp|Q9Y6Y0|NS1BP_HUMAN Influenza virus NS1A-binding protein OS=Homo sapiens OX=9606 GN=IVNS1ABP PE=1 SV=3,GO:0005654; GO:0005667; GO:0005681; GO:0005737; GO:0005829; GO:0005856; GO:0006383; GO:0006397; GO:0008380; GO:0009615; GO:0031397; GO:0031463; GO:0043161; GO:0097193; GO:1990756; GO:2001243,intrinsic apoptotic signaling pathway [GO:0097193]; mRNA processing [GO:0006397]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to virus [GO:0009615]; RNA splicing [GO:0008380]; transcription by RNA polymerase III [GO:0006383],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; transcription regulator complex [GO:0005667],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005829; GO:0005856; GO:0006351; GO:0016071; GO:0030163; GO:0043226; GO:0060090,nucleoplasm; cytosol; cytoskeleton; DNA-templated transcription; mRNA metabolic process; protein catabolic process; organelle; molecular adaptor activity
OG_10344,FUN_045819-T1,Peve_00017773,Pocillopora_meandrina_HIv1___RNAseq.g7030.t1,three_way,77.214,,,,,,,,,,,,,,,,,
OG_10345,FUN_045821-T1,Peve_00026304,Pocillopora_meandrina_HIv1___RNAseq.g7895.t1,three_way,91.27066666666668,FUN_045821-T1,Q08DK3,KLH20_BOVIN,,Kelch-like protein 20,Bos taurus (Bovine),75.9,323.0,4.6e-146,519.6,sp|Q08DK3|KLH20_BOVIN Kelch-like protein 20 OS=Bos taurus OX=9913 GN=KLHL20 PE=2 SV=3,GO:0003779; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390; GO:1990756,Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802],actin binding [GO:0003779]; type II interferon binding [GO:0019964]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005829; GO:0008092; GO:0016192; GO:0030163; GO:0043226; GO:0060090,cytosol; cytoskeletal protein binding; vesicle-mediated transport; protein catabolic process; organelle; molecular adaptor activity
OG_10346,FUN_045842-T1,Peve_00029224,Pocillopora_meandrina_HIv1___RNAseq.g7399.t1,three_way,89.373,FUN_045842-T1,Q9BX70,BTBD2_HUMAN,,BTB/POZ domain-containing protein 2,Homo sapiens (Human),72.0,432.0,3.5e-183,642.5,sp|Q9BX70|BTBD2_HUMAN BTB/POZ domain-containing protein 2 OS=Homo sapiens OX=9606 GN=BTBD2 PE=1 SV=1,GO:0000932; GO:0005829; GO:0022008,neurogenesis [GO:0022008],cytosol [GO:0005829]; P-body [GO:0000932],,GO:0005829; GO:0030154; GO:0043226,cytosol; cell differentiation; organelle
OG_10347,FUN_000108-T1,Peve_00024901,,apul_peve,68.468,FUN_000108-T1,P35061,,,,,100.0,99.0,5.6999999999999995e-47,188.7,sp|P35061|H2A_ACRFO Histone H2A OS=Acropora formosa OX=126732 PE=3 SV=2,,,,,,
OG_10348,FUN_000199-T1,Peve_00032080,,apul_peve,64.516,,,,,,,,,,,,,,,,,
OG_10349,FUN_000204-T2,Peve_00019864,,apul_peve,64.062,FUN_000204-T2,A6H7D1,,,,,31.8,280.0,1.5000000000000002e-22,109.0,sp|A6H7D1|TT23L_BOVIN Tetratricopeptide repeat protein 23-like OS=Bos taurus OX=9913 GN=TTC23L PE=2 SV=2,,,,,,
OG_10350,FUN_000209-T1,Peve_00026217,,apul_peve,74.8715,FUN_000209-T1,B8V7S0,,,,,49.2,252.0,1.2e-58,228.4,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10351,FUN_000224-T2,Peve_00012030,,apul_peve,40.7385,FUN_000224-T2,Q6NZK5,,,,,41.7,84.0,5.9e-09,64.7,sp|Q6NZK5|K1328_MOUSE Protein hinderin OS=Mus musculus OX=10090 GN=Kiaa1328 PE=1 SV=2,,,,,,
OG_10352,FUN_000250-T1,Peve_00018026,,apul_peve,47.581,,,,,,,,,,,,,,,,,
OG_10353,FUN_000271-T1,Peve_00027797,,apul_peve,61.857,,,,,,,,,,,,,,,,,
OG_10354,FUN_000273-T1,Peve_00044035,,apul_peve,55.737,,,,,,,,,,,,,,,,,
OG_10355,FUN_000274-T4,Peve_00044033,,apul_peve,70.082,FUN_000274-T4,P55115,,,,,43.1,197.0,4e-37,157.1,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_10356,FUN_000277-T1,Peve_00044050,,apul_peve,57.143,FUN_000277-T1,P22031,,,,,41.8,91.0,1.6e-13,77.8,sp|P22031|LEG_HELCR D-galactoside-specific lectin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=1,,,,,,
OG_10357,FUN_000282-T1,Peve_00041456,,apul_peve,40.382000000000005,,,,,,,,,,,,,,,,,
OG_10358,FUN_000284-T1,Peve_00033556,,apul_peve,33.071,,,,,,,,,,,,,,,,,
OG_10359,FUN_000286-T1,Peve_00022646,,apul_peve,68.227,FUN_000286-T1,Q0P4P2,,,,,48.8,240.0,1.3e-59,231.5,sp|Q0P4P2|FBCD1_XENTR Fibrinogen C domain-containing protein 1 OS=Xenopus tropicalis OX=8364 GN=fibcd1 PE=2 SV=1,,,,,,
OG_10360,FUN_000292-T1,Peve_00009811,,apul_peve,90.385,,,,,,,,,,,,,,,,,
OG_10361,FUN_000304-T1,Peve_00033568,,apul_peve,50.863,FUN_000304-T1,P25291,,,,,40.1,137.0,4.8e-19,97.4,sp|P25291|GP2_CANLF Pancreatic secretory granule membrane major glycoprotein GP2 OS=Canis lupus familiaris OX=9615 GN=GP2 PE=1 SV=1,,,,,,
OG_10362,FUN_000317-T1,Peve_00033572,,apul_peve,41.333,,,,,,,,,,,,,,,,,
OG_10363,FUN_000321-T1,Peve_00033576,,apul_peve,70.5655,,,,,,,,,,,,,,,,,
OG_10364,FUN_000327-T1,Peve_00033551,,apul_peve,64.4745,FUN_000327-T1,G5EBQ8,CHS2_CAEEL,,Chitin synthase chs-2 (EC 2.4.1.16) (Chitin-UDP acetyl-glucosaminyl transferase chs-2),Caenorhabditis elegans,33.5,731.0,2.5e-103,379.0,sp|G5EBQ8|CHS2_CAEEL Chitin synthase chs-2 OS=Caenorhabditis elegans OX=6239 GN=chs-2 PE=1 SV=1,GO:0004100; GO:0005886; GO:0006031; GO:0061063,chitin biosynthetic process [GO:0006031]; positive regulation of nematode larval development [GO:0061063],plasma membrane [GO:0005886],chitin synthase activity [GO:0004100],GO:0003824; GO:0005886; GO:0016740; GO:1901135,catalytic activity; plasma membrane; transferase activity; carbohydrate derivative metabolic process
OG_10365,FUN_000328-T1,Peve_00033550,,apul_peve,42.2685,FUN_000328-T1,O74999,,,,,24.6,281.0,3.2e-11,72.4,sp|O74999|RAD7_SCHPO DNA repair protein rhp7 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=rhp7 PE=3 SV=1,,,,,,
OG_10366,FUN_000331-T1,Peve_00033546,,apul_peve,73.333,,,,,,,,,,,,,,,,,
OG_10367,FUN_000341-T1,Peve_00034268,,apul_peve,44.316,FUN_000341-T1,Q6XHB2,ROCO4_DICDI,,Probable serine/threonine-protein kinase roco4 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 4),Dictyostelium discoideum (Social amoeba),27.1,413.0,3e-21,106.7,sp|Q6XHB2|ROCO4_DICDI Probable serine/threonine-protein kinase roco4 OS=Dictyostelium discoideum OX=44689 GN=roco4 PE=1 SV=1,GO:0000302; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006120; GO:0007165; GO:0031150; GO:0042331; GO:0106310,"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; phototaxis [GO:0042331]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]; sorocarp stalk development [GO:0031150]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005739; GO:0005829; GO:0006091; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; generation of precursor metabolites and energy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_10368,FUN_000347-T1,Peve_00033539,,apul_peve,44.825,,,,,,,,,,,,,,,,,
OG_10369,FUN_000360-T1,Peve_00028516,,apul_peve,31.734,,,,,,,,,,,,,,,,,
OG_10370,FUN_000394-T1,Peve_00033590,,apul_peve,76.687,,,,,,,,,,,,,,,,,
OG_10371,FUN_000415-T1,Peve_00026199,,apul_peve,89.447,FUN_000415-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),27.4,274.0,2.7e-17,90.9,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_10372,FUN_000439-T1,Peve_00003438,,apul_peve,60.315,FUN_000439-T1,Q8N6Q8,,,,,32.0,674.0,2.5e-76,288.1,sp|Q8N6Q8|MET25_HUMAN Probable methyltransferase-like protein 25 OS=Homo sapiens OX=9606 GN=METTL25 PE=1 SV=2,,,,,,
OG_10373,FUN_000441-T1,Peve_00034725,,apul_peve,48.697,FUN_000441-T1,P79100,TRPC4_BOVIN,,Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel 1) (CCE1),Bos taurus (Bovine),22.7,488.0,1.2e-22,109.8,sp|P79100|TRPC4_BOVIN Short transient receptor potential channel 4 OS=Bos taurus OX=9913 GN=TRPC4 PE=2 SV=2,GO:0005886; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679,calcium ion transmembrane transport [GO:0070588]; regulation of cytosolic calcium ion concentration [GO:0051480],cation channel complex [GO:0034703]; plasma membrane [GO:0005886],"inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_10374,FUN_000450-T1,Peve_00020155,,apul_peve,39.7,FUN_000450-T1,F1PZV2,,,,,32.0,225.0,7.299999999999999e-24,114.0,sp|F1PZV2|MFS12_CANLF Major facilitator superfamily domain-containing protein 12 OS=Canis lupus familiaris OX=9615 GN=MFSD12 PE=1 SV=3,,,,,,
OG_10375,FUN_000514-T1,Peve_00044935,,apul_peve,49.1845,,,,,,,,,,,,,,,,,
OG_10376,FUN_000518-T1,Peve_00030735,,apul_peve,86.172,FUN_000518-T1,Q9PWF7,,,,,66.7,496.0,3.9999999999999995e-199,695.7,sp|Q9PWF7|CATA_GLARU Catalase OS=Glandirana rugosa OX=8410 GN=cat PE=2 SV=3,,,,,,
OG_10377,FUN_000520-T1,Peve_00039798,,apul_peve,73.846,FUN_000520-T1,P08684,CP3A4_HUMAN,,"Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)",Homo sapiens (Human),38.1,499.0,2.5e-92,340.9,sp|P08684|CP3A4_HUMAN Cytochrome P450 3A4 OS=Homo sapiens OX=9606 GN=CYP3A4 PE=1 SV=4,GO:0002933; GO:0004497; GO:0005496; GO:0005506; GO:0005737; GO:0005789; GO:0006629; GO:0006706; GO:0006805; GO:0008202; GO:0008203; GO:0008209; GO:0008210; GO:0008395; GO:0008401; GO:0009822; GO:0016098; GO:0016491; GO:0019825; GO:0019899; GO:0020037; GO:0030343; GO:0034875; GO:0042178; GO:0042359; GO:0042369; GO:0042572; GO:0042573; GO:0042759; GO:0043231; GO:0046222; GO:0050591; GO:0050649; GO:0062181; GO:0062187; GO:0062188; GO:0062189; GO:0070576; GO:0070989; GO:0101020; GO:0101021; GO:0102320,aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; androgen metabolic process [GO:0008209]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"1,8-cineole 2-exo-monooxygenase activity [GO:0102320]; 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; quinine 3-monooxygenase activity [GO:0050591]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]",GO:0003824; GO:0006629; GO:0006766; GO:0008289; GO:0016491; GO:0043226,catalytic activity; lipid metabolic process; vitamin metabolic process; lipid binding; oxidoreductase activity; organelle
OG_10378,FUN_000521-T1,Peve_00030477,,apul_peve,73.022,FUN_000521-T1,A0A0B5RUB0,,,,,39.1,532.0,1.5e-96,355.5,sp|A0A0B5RUB0|TMAT_MYRPR Trimethylamine transporter OS=Myroides profundi OX=480520 GN=tmaT PE=1 SV=1,,,,,,
OG_10379,FUN_000522-T1,Peve_00043211,,apul_peve,58.7115,FUN_000522-T1,Q9BX84,,,,,32.0,225.0,2.2e-20,101.7,sp|Q9BX84|TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens OX=9606 GN=TRPM6 PE=1 SV=2,,,,,,
OG_10380,FUN_000523-T1,Peve_00043210,,apul_peve,73.58,,,,,,,,,,,,,,,,,
OG_10381,FUN_000524-T1,Peve_00034804,,apul_peve,55.821,,,,,,,,,,,,,,,,,
OG_10382,FUN_000548-T1,Peve_00039826,,apul_peve,51.765,,,,,,,,,,,,,,,,,
OG_10383,FUN_000552-T1,Peve_00039817,,apul_peve,73.43,FUN_000552-T1,Q8NC69,KCTD6_HUMAN,,BTB/POZ domain-containing protein KCTD6 (KCASH3 protein) (Potassium channel tetramerization domain-containing protein 6),Homo sapiens (Human),65.6,96.0,5.400000000000001e-28,125.9,sp|Q8NC69|KCTD6_HUMAN BTB/POZ domain-containing protein KCTD6 OS=Homo sapiens OX=9606 GN=KCTD6 PE=1 SV=2,GO:0005829; GO:0006511; GO:0016567; GO:0030506; GO:0031430; GO:0042802; GO:0045879; GO:0051260; GO:0097602,negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; M band [GO:0031430],ankyrin binding [GO:0030506]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802],GO:0005829; GO:0008092; GO:0065003,cytosol; cytoskeletal protein binding; protein-containing complex assembly
OG_10384,FUN_000567-T1,Peve_00041891,,apul_peve,44.3395,,,,,,,,,,,,,,,,,
OG_10385,FUN_000579-T1,Peve_00034763,,apul_peve,54.995,FUN_000579-T1,P08872,,,,,38.1,168.0,8e-22,105.1,sp|P08872|PA2A_AIPLA Acidic phospholipase A2 OS=Aipysurus laevis OX=8678 PE=2 SV=1,,,,,,
OG_10386,FUN_000584-T1,Peve_00034704,,apul_peve,58.983,FUN_000584-T1,Q9UHM6,,,,,25.5,259.0,2.5e-10,67.8,sp|Q9UHM6|OPN4_HUMAN Melanopsin OS=Homo sapiens OX=9606 GN=OPN4 PE=1 SV=1,,,,,,
OG_10387,FUN_000587-T1,Peve_00025318,,apul_peve,30.387,,,,,,,,,,,,,,,,,
OG_10388,FUN_000599-T1,Peve_00041264,,apul_peve,68.182,FUN_000599-T1,P25962,ADRB3_MOUSE,,Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor),Mus musculus (Mouse),25.4,327.0,1.1e-13,79.0,sp|P25962|ADRB3_MOUSE Beta-3 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb3 PE=2 SV=2,GO:0002024; GO:0002025; GO:0004939; GO:0005886; GO:0007189; GO:0009409; GO:0015052; GO:0016020; GO:0031649; GO:0031699; GO:0040015; GO:0042755; GO:0042803; GO:0043235; GO:0043410; GO:0050873; GO:0051379; GO:0051380; GO:0071880; GO:0120162,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; eating behavior [GO:0042755]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; response to cold [GO:0009409],membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],beta-3 adrenergic receptor binding [GO:0031699]; beta-adrenergic receptor activity [GO:0004939]; beta3-adrenergic receptor activity [GO:0015052]; epinephrine binding [GO:0051379]; norepinephrine binding [GO:0051380]; protein homodimerization activity [GO:0042803],GO:0003013; GO:0005886; GO:0030154; GO:0060089,circulatory system process; plasma membrane; cell differentiation; molecular transducer activity
OG_10389,FUN_000611-T1,Peve_00007071,,apul_peve,66.334,FUN_000611-T1,P83102,DYRK3_DROME,,Putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog (EC 2.7.12.1),Drosophila melanogaster (Fruit fly),32.0,344.0,6.7e-37,157.1,sp|P83102|DYRK3_DROME Putative dual specificity tyrosine-phosphorylation-regulated kinase 3 homolog OS=Drosophila melanogaster OX=7227 GN=Dyrk3 PE=1 SV=3,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0106310,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005856; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytoskeleton; transferase activity; organelle; catalytic activity, acting on a protein"
OG_10390,FUN_000613-T1,Peve_00023944,,apul_peve,39.7535,,,,,,,,,,,,,,,,,
OG_10391,FUN_000619-T1,Peve_00043933,,apul_peve,38.922,,,,,,,,,,,,,,,,,
OG_10392,FUN_000627-T1,Peve_00025540,,apul_peve,73.881,,,,,,,,,,,,,,,,,
OG_10393,FUN_000630-T1,Peve_00025539,,apul_peve,75.379,,,,,,,,,,,,,,,,,
OG_10394,FUN_000864-T1,Peve_00015203,,apul_peve,46.667,,,,,,,,,,,,,,,,,
OG_10395,FUN_000888-T1,Peve_00029324,,apul_peve,64.706,FUN_000888-T1,Q99715,COCA1_HUMAN,,Collagen alpha-1(XII) chain,Homo sapiens (Human),28.2,255.0,4.1e-16,89.7,sp|Q99715|COCA1_HUMAN Collagen alpha-1(XII) chain OS=Homo sapiens OX=9606 GN=COL12A1 PE=1 SV=2,GO:0005576; GO:0005595; GO:0005615; GO:0005788; GO:0007155; GO:0030020; GO:0030199; GO:0035987; GO:0062023; GO:0070062; GO:1903561,cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987],collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561],extracellular matrix structural constituent conferring tensile strength [GO:0030020],GO:0005198; GO:0005576; GO:0005615; GO:0007155; GO:0030154; GO:0030198; GO:0043226,structural molecule activity; extracellular region; extracellular space; cell adhesion; cell differentiation; extracellular matrix organization; organelle
OG_10396,FUN_000889-T1,Peve_00017794,,apul_peve,61.974,,,,,,,,,,,,,,,,,
OG_10397,FUN_000897-T1,Peve_00009743,,apul_peve,54.7365,,,,,,,,,,,,,,,,,
OG_10398,FUN_000938-T1,Peve_00001196,,apul_peve,70.633,,,,,,,,,,,,,,,,,
OG_10399,FUN_000942-T1,Peve_00010047,,apul_peve,71.111,,,,,,,,,,,,,,,,,
OG_10400,FUN_000964-T1,Peve_00028377,,apul_peve,52.268,FUN_000964-T1,Q7RTX9,,,,,32.6,172.0,1.3e-21,105.9,sp|Q7RTX9|MOT14_HUMAN Monocarboxylate transporter 14 OS=Homo sapiens OX=9606 GN=SLC16A14 PE=1 SV=1,,,,,,
OG_10401,FUN_000967-T1,Peve_00028379,,apul_peve,57.931,,,,,,,,,,,,,,,,,
OG_10402,FUN_000968-T1,Peve_00031228,,apul_peve,75.721,FUN_000968-T1,Q5GQ66,PIOX_PEA,,Alpha-dioxygenase PIOX (EC 1.13.11.92) (Pathogen-induced oxygenase),Pisum sativum (Garden pea) (Lathyrus oleraceus),39.5,420.0,2.3e-78,294.3,sp|Q5GQ66|PIOX_PEA Alpha-dioxygenase PIOX OS=Pisum sativum OX=3888 GN=alphaDOX1 PE=1 SV=1,GO:0004601; GO:0006633; GO:0006952; GO:0006979; GO:0016702; GO:0020037; GO:0031408; GO:0046872,defense response [GO:0006952]; fatty acid biosynthetic process [GO:0006633]; oxylipin biosynthetic process [GO:0031408]; response to oxidative stress [GO:0006979],,"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]",GO:0003824; GO:0006629; GO:0016209; GO:0016491,catalytic activity; lipid metabolic process; antioxidant activity; oxidoreductase activity
OG_10403,FUN_000976-T1,Peve_00004381,,apul_peve,43.137,,,,,,,,,,,,,,,,,
OG_10404,FUN_000979-T1,Peve_00007803,,apul_peve,31.343,,,,,,,,,,,,,,,,,
OG_10405,FUN_000997-T1,Peve_00004450,,apul_peve,55.556,,,,,,,,,,,,,,,,,
OG_10406,FUN_000998-T1,Peve_00012484,,apul_peve,31.737,,,,,,,,,,,,,,,,,
OG_10407,FUN_001000-T1,Peve_00033477,,apul_peve,81.295,,,,,,,,,,,,,,,,,
OG_10408,FUN_001002-T2,Peve_00015277,,apul_peve,46.831,,,,,,,,,,,,,,,,,
OG_10409,FUN_001026-T1,Peve_00041058,,apul_peve,40.543,,,,,,,,,,,,,,,,,
OG_10410,FUN_001036-T1,Peve_00041070,,apul_peve,33.056,,,,,,,,,,,,,,,,,
OG_10411,FUN_001042-T1,Peve_00036955,,apul_peve,75.153,,,,,,,,,,,,,,,,,
OG_10412,FUN_001070-T1,Peve_00019959,,apul_peve,51.397,,,,,,,,,,,,,,,,,
OG_10413,FUN_001102-T2,Peve_00041030,,apul_peve,77.7865,FUN_001102-T2,Q9FN03,,,,,32.0,366.0,4.1e-54,215.3,sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1,,,,,,
OG_10414,FUN_001123-T1,Peve_00013191,,apul_peve,48.413,,,,,,,,,,,,,,,,,
OG_10415,FUN_001124-T1,Peve_00023615,,apul_peve,40.0,,,,,,,,,,,,,,,,,
OG_10416,FUN_001128-T1,Peve_00023614,,apul_peve,38.211,,,,,,,,,,,,,,,,,
OG_10417,FUN_001133-T1,Peve_00029381,,apul_peve,54.741,FUN_001133-T1,P55115,,,,,36.6,202.0,3.9999999999999994e-28,126.3,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_10418,FUN_001164-T1,Peve_00002996,,apul_peve,93.407,,,,,,,,,,,,,,,,,
OG_10419,FUN_001179-T1,Peve_00034698,,apul_peve,69.176,FUN_001179-T1,P26779,SAP_BOVIN,,Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)],Bos taurus (Bovine),33.7,178.0,1.6e-16,88.2,sp|P26779|SAP_BOVIN Prosaposin OS=Bos taurus OX=9913 GN=PSAP PE=1 SV=3,GO:0005576; GO:0005615; GO:0005764; GO:0005770; GO:0006665; GO:0007041; GO:0007193; GO:0016020; GO:0019216; GO:0060736; GO:0060742,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; lysosomal transport [GO:0007041]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665],extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020],,GO:0005576; GO:0005615; GO:0005764; GO:0005768; GO:0005773; GO:0006629; GO:0022414; GO:0030154; GO:0031410; GO:0043226,extracellular region; extracellular space; lysosome; endosome; vacuole; lipid metabolic process; reproductive process; cell differentiation; cytoplasmic vesicle; organelle
OG_10420,FUN_001216-T1,Peve_00035369,,apul_peve,34.045500000000004,FUN_001216-T1,Q96T21,SEBP2_HUMAN,,Selenocysteine insertion sequence-binding protein 2 (SECIS-binding protein 2),Homo sapiens (Human),27.8,212.0,1.9e-07,59.3,sp|Q96T21|SEBP2_HUMAN Selenocysteine insertion sequence-binding protein 2 OS=Homo sapiens OX=9606 GN=SECISBP2 PE=1 SV=2,GO:0001514; GO:0003677; GO:0003723; GO:0003730; GO:0005654; GO:0005739; GO:0006401; GO:0021756; GO:0021884; GO:0035368; GO:0043021; GO:0048255; GO:1990904; GO:2000623,"forebrain neuron development [GO:0021884]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; RNA catabolic process [GO:0006401]; selenocysteine incorporation [GO:0001514]; striatum development [GO:0021756]",mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904],DNA binding [GO:0003677]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368],GO:0003677; GO:0003723; GO:0005654; GO:0005739; GO:0043226; GO:0048856,DNA binding; RNA binding; nucleoplasm; mitochondrion; organelle; anatomical structure development
OG_10421,FUN_001220-T1,Peve_00035364,,apul_peve,47.143,,,,,,,,,,,,,,,,,
OG_10422,FUN_001221-T1,Peve_00014738,,apul_peve,42.534,,,,,,,,,,,,,,,,,
OG_10423,FUN_001232-T1,Peve_00022951,,apul_peve,46.564,FUN_001232-T1,P52551,,,,,31.1,151.0,1.4e-14,84.3,sp|P52551|MYBB_XENLA Myb-related protein B OS=Xenopus laevis OX=8355 GN=mybl2 PE=2 SV=2,,,,,,
OG_10424,FUN_001239-T1,Peve_00022816,,apul_peve,49.818,FUN_001239-T1,O77408,,,,,33.9,121.0,2.2e-12,74.7,sp|O77408|OAR1_LYMST Octopamine receptor 1 OS=Lymnaea stagnalis OX=6523 PE=1 SV=1,,,,,,
OG_10425,FUN_001257-T1,Peve_00008795,,apul_peve,68.563,FUN_001257-T1,Q804X9,,,,,31.8,314.0,2.3e-36,154.5,sp|Q804X9|OPN4A_GADMO Melanopsin-A OS=Gadus morhua OX=8049 GN=opn4a PE=2 SV=1,,,,,,
OG_10426,FUN_001269-T3,Peve_00008772,,apul_peve,41.176,FUN_001269-T3,P00994,,,,,54.5,55.0,1.5e-13,79.3,sp|P00994|ISIK_HELPO Isoinhibitor K OS=Helix pomatia OX=6536 PE=1 SV=1,,,,,,
OG_10427,FUN_001274-T1,Peve_00037877,,apul_peve,36.4635,,,,,,,,,,,,,,,,,
OG_10428,FUN_001275-T1,Peve_00030829,,apul_peve,37.775000000000006,,,,,,,,,,,,,,,,,
OG_10429,FUN_001288-T1,Peve_00013896,,apul_peve,49.14,FUN_001288-T1,Q9ZQ47,GRDP1_ARATH,,Glycine-rich domain-containing protein 1 (AtGRDP1),Arabidopsis thaliana (Mouse-ear cress),38.0,284.0,3.5e-52,208.4,sp|Q9ZQ47|GRDP1_ARATH Glycine-rich domain-containing protein 1 OS=Arabidopsis thaliana OX=3702 GN=GRDP1 PE=2 SV=1,GO:0005886; GO:0009738; GO:0009787; GO:0071470,abscisic acid-activated signaling pathway [GO:0009738]; cellular response to osmotic stress [GO:0071470]; regulation of abscisic acid-activated signaling pathway [GO:0009787],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_10430,FUN_001301-T2,Peve_00036996,,apul_peve,50.03,,,,,,,,,,,,,,,,,
OG_10431,FUN_001308-T1,Peve_00036986,,apul_peve,46.444,,,,,,,,,,,,,,,,,
OG_10432,FUN_001311-T1,Peve_00036983,,apul_peve,65.179,,,,,,,,,,,,,,,,,
OG_10433,FUN_001357-T1,Peve_00030053,,apul_peve,49.456500000000005,,,,,,,,,,,,,,,,,
OG_10434,FUN_001361-T1,Peve_00043946,,apul_peve,55.556,,,,,,,,,,,,,,,,,
OG_10435,FUN_001362-T1,Peve_00043945,,apul_peve,54.61,,,,,,,,,,,,,,,,,
OG_10436,FUN_001366-T1,Peve_00036759,,apul_peve,84.539,FUN_001366-T1,A0A455ZMR3,,,,,31.9,279.0,1.3e-30,135.2,sp|A0A455ZMR3|PPZD_METMF 2-oxoglutarate-Fe(II) type oxidoreductase ppzD OS=Metarhizium majus (strain ARSEF 297) OX=1276143 GN=ppzD PE=1 SV=1,,,,,,
OG_10437,FUN_001371-T1,Peve_00025096,,apul_peve,68.0,FUN_001371-T1,P30975,,,,,26.8,291.0,1.3e-21,105.5,sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2,,,,,,
OG_10438,FUN_001380-T1,Peve_00012534,,apul_peve,54.6285,,,,,,,,,,,,,,,,,
OG_10439,FUN_001383-T1,Peve_00019342,,apul_peve,52.528,FUN_001383-T1,C3ZQF9,,,,,31.0,336.0,3.7e-24,114.4,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_10440,FUN_001387-T1,Peve_00019353,,apul_peve,63.975,FUN_001387-T1,Q8BZL4,,,,,28.3,346.0,1.5e-21,105.1,sp|Q8BZL4|GPR22_MOUSE G-protein coupled receptor 22 OS=Mus musculus OX=10090 GN=Gpr22 PE=2 SV=1,,,,,,
OG_10441,FUN_001398-T1,Peve_00019364,,apul_peve,73.064,FUN_001398-T1,F1R332,,,,,20.7,295.0,1.6e-09,65.1,sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2,,,,,,
OG_10442,FUN_001400-T1,Peve_00008771,,apul_peve,68.601,FUN_001400-T1,P47751,,,,,23.3,352.0,6e-09,63.5,sp|P47751|BRS4_BOMOR [Phe13]-bombesin receptor OS=Bombina orientalis OX=8346 GN=BB4 PE=2 SV=2,,,,,,
OG_10443,FUN_001410-T1,Peve_00008756,,apul_peve,43.22,,,,,,,,,,,,,,,,,
OG_10444,FUN_001419-T1,Peve_00020523,,apul_peve,46.096,FUN_001419-T1,Q9UBN4,,,,,25.7,327.0,8.8e-17,91.3,sp|Q9UBN4|TRPC4_HUMAN Short transient receptor potential channel 4 OS=Homo sapiens OX=9606 GN=TRPC4 PE=1 SV=1,,,,,,
OG_10445,FUN_001421-T1,Peve_00008800,,apul_peve,42.675,FUN_001421-T1,A2AKX3,SETX_MOUSE,,Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein homolog) (SEN1 homolog),Mus musculus (Mouse),30.7,866.0,9.7e-84,314.7,sp|A2AKX3|SETX_MOUSE Probable helicase senataxin OS=Mus musculus OX=10090 GN=Setx PE=1 SV=1,GO:0000228; GO:0000781; GO:0001147; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:2000144; GO:2000806,"cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; mRNA splice site recognition [GO:0006376]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; transcription termination site sequence-specific DNA binding [GO:0001147],GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006310; GO:0006355; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0140657,nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; DNA recombination; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; ATP-dependent activity
OG_10445,FUN_001421-T1,Peve_00008800,,apul_peve,42.675,FUN_001421-T1,A2AKX3,SETX_MOUSE,,Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein homolog) (SEN1 homolog),Mus musculus (Mouse),30.4,312.0,2.6e-36,157.1,sp|A2AKX3|SETX_MOUSE Probable helicase senataxin OS=Mus musculus OX=10090 GN=Setx PE=1 SV=1,GO:0000228; GO:0000781; GO:0001147; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0006302; GO:0006310; GO:0006353; GO:0006369; GO:0006376; GO:0006974; GO:0007283; GO:0007399; GO:0007623; GO:0010976; GO:0016604; GO:0016787; GO:0030154; GO:0030424; GO:0030426; GO:0033120; GO:0034599; GO:0042802; GO:0045171; GO:0045944; GO:0060566; GO:0070301; GO:2000144; GO:2000806,"cell differentiation [GO:0030154]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to oxidative stress [GO:0034599]; circadian rhythm [GO:0007623]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA-templated transcription termination [GO:0006353]; double-strand break repair [GO:0006302]; mRNA splice site recognition [GO:0006376]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription initiation [GO:2000144]; positive regulation of neuron projection development [GO:0010976]; positive regulation of RNA splicing [GO:0033120]; positive regulation of termination of DNA-templated transcription [GO:0060566]; positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled [GO:2000806]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; intercellular bridge [GO:0045171]; nuclear body [GO:0016604]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; transcription termination site sequence-specific DNA binding [GO:0001147],GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006281; GO:0006310; GO:0006355; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0140657,nuclear chromosome; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; DNA repair; DNA recombination; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; ATP-dependent activity
OG_10446,FUN_001429-T1,Peve_00027105,,apul_peve,59.911,FUN_001429-T1,P58912,,,,,39.0,428.0,6.1e-80,300.4,sp|P58912|TX60B_PHYSE DELTA-alicitoxin-Pse2b OS=Phyllodiscus semoni OX=163701 PE=1 SV=2,,,,,,
OG_10447,FUN_001485-T1,Peve_00002873,,apul_peve,50.327,FUN_001485-T1,Q8BZ39,NMUR2_MOUSE,,Neuromedin-U receptor 2 (NMU-R2),Mus musculus (Mouse),25.3,288.0,2.8e-07,57.8,sp|Q8BZ39|NMUR2_MOUSE Neuromedin-U receptor 2 OS=Mus musculus OX=10090 GN=Nmur2 PE=2 SV=1,GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482,arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; response to pain [GO:0048265],membrane [GO:0016020]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188],GO:0005215; GO:0005886; GO:0060089,transporter activity; plasma membrane; molecular transducer activity
OG_10448,FUN_001488-T1,Peve_00002881,,apul_peve,62.626,,,,,,,,,,,,,,,,,
OG_10449,FUN_001494-T1,Peve_00002851,,apul_peve,56.14,,,,,,,,,,,,,,,,,
OG_10450,FUN_001498-T1,Peve_00008198,,apul_peve,62.094,,,,,,,,,,,,,,,,,
OG_10451,FUN_001518-T1,Peve_00023388,,apul_peve,65.269,FUN_001518-T1,P56571,,,,,68.3,224.0,4.2e-88,325.9,"sp|P56571|ES1_RAT ES1 protein homolog, mitochondrial OS=Rattus norvegicus OX=10116 PE=1 SV=2",,,,,,
OG_10452,FUN_001521-T1,Peve_00029800,,apul_peve,51.692,FUN_001521-T1,C3ZQF9,,,,,29.8,325.0,2.4e-25,117.9,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_10453,FUN_001524-T1,Peve_00032010,,apul_peve,54.103,,,,,,,,,,,,,,,,,
OG_10454,FUN_001533-T1,Peve_00000624,,apul_peve,48.848,FUN_001533-T1,Q5T7M9,,,,,26.7,352.0,2.3000000000000002e-33,144.8,sp|Q5T7M9|DIK1A_HUMAN Divergent protein kinase domain 1A OS=Homo sapiens OX=9606 GN=DIPK1A PE=1 SV=1,,,,,,
OG_10455,FUN_001549-T1,Peve_00003915,,apul_peve,81.308,FUN_001549-T1,Q6BLK0,,,,,82.9,105.0,3.9e-44,179.9,sp|Q6BLK0|RL44_DEBHA Large ribosomal subunit protein eL42 OS=Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) OX=284592 GN=RPL44 PE=3 SV=3,,,,,,
OG_10456,FUN_001552-T1,Peve_00003907,,apul_peve,54.236,FUN_001552-T1,P12259,FA5_HUMAN,,"Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]",Homo sapiens (Human),37.3,161.0,2.3e-19,99.8,sp|P12259|FA5_HUMAN Coagulation factor V OS=Homo sapiens OX=9606 GN=F5 PE=1 SV=4,GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0007596; GO:0008015; GO:0016020; GO:0030134; GO:0031091; GO:0031093; GO:0032571; GO:0033116; GO:1903561,blood circulation [GO:0008015]; blood coagulation [GO:0007596]; response to vitamin K [GO:0032571],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093],copper ion binding [GO:0005507],GO:0003013; GO:0005576; GO:0005615; GO:0005886; GO:0031410; GO:0043226,circulatory system process; extracellular region; extracellular space; plasma membrane; cytoplasmic vesicle; organelle
OG_10457,FUN_001578-T2,Peve_00005418,,apul_peve,54.393,,,,,,,,,,,,,,,,,
OG_10458,FUN_001585-T2,Peve_00034529,,apul_peve,65.497,,,,,,,,,,,,,,,,,
OG_10459,FUN_001589-T1,Peve_00023230,,apul_peve,95.0,FUN_001589-T1,Q8WXF0,,,,,72.4,58.0,2.9e-19,95.1,sp|Q8WXF0|SRS12_HUMAN Serine/arginine-rich splicing factor 12 OS=Homo sapiens OX=9606 GN=SRSF12 PE=1 SV=1,,,,,,
OG_10460,FUN_001605-T2,Peve_00004142,,apul_peve,53.846,,,,,,,,,,,,,,,,,
OG_10461,FUN_001605-T4,Peve_00043868,,apul_peve,49.3035,FUN_001605-T4,H9JD76,,,,,27.5,160.0,7.8e-06,54.3,sp|H9JD76|TDRKH_BOMMO Tudor and KH domain-containing protein homolog OS=Bombyx mori OX=7091 GN=PAPI PE=1 SV=2,,,,,,
OG_10462,FUN_001611-T1,Peve_00010546,,apul_peve,37.229,,,,,,,,,,,,,,,,,
OG_10463,FUN_001617-T1,Peve_00045299,,apul_peve,70.8635,,,,,,,,,,,,,,,,,
OG_10464,FUN_001635-T1,Peve_00030250,,apul_peve,35.246,,,,,,,,,,,,,,,,,
OG_10465,FUN_001651-T1,Peve_00038367,,apul_peve,69.845,FUN_001651-T1,Q5FVR2,TYPH_RAT,,Thymidine phosphorylase (TP) (EC 2.4.2.4) (TdRPase),Rattus norvegicus (Rat),51.0,410.0,6.5e-103,375.9,sp|Q5FVR2|TYPH_RAT Thymidine phosphorylase OS=Rattus norvegicus OX=10116 GN=Tymp PE=1 SV=1,GO:0000002; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0009032; GO:0031641; GO:0042803; GO:0046074; GO:0051969; GO:1905333,dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],cytosol [GO:0005829],"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; thymidine phosphorylase activity [GO:0009032]",GO:0003824; GO:0005829; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_10466,FUN_001674-T1,Peve_00041624,,apul_peve,63.462,FUN_001674-T1,C3ZQF9,,,,,34.1,302.0,1.1e-33,145.6,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_10467,FUN_001683-T1,Peve_00033963,,apul_peve,60.265,FUN_001683-T1,Q02974,KHK_RAT,,Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase),Rattus norvegicus (Rat),47.3,298.0,6.8e-80,298.9,sp|Q02974|KHK_RAT Ketohexokinase OS=Rattus norvegicus OX=10116 GN=Khk PE=1 SV=1,GO:0004454; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006000; GO:0006001; GO:0009744; GO:0009749; GO:0009750; GO:0010043; GO:0016052; GO:0032868; GO:0042802; GO:0042803; GO:0061624; GO:0070061; GO:0070873,carbohydrate catabolic process [GO:0016052]; fructose catabolic process [GO:0006001]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; regulation of glycogen metabolic process [GO:0070873]; response to fructose [GO:0009750]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; response to zinc ion [GO:0010043],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; fructose binding [GO:0070061]; identical protein binding [GO:0042802]; ketohexokinase activity [GO:0004454]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005634; GO:0005829; GO:0005975; GO:0016740; GO:0043226; GO:1901135,catalytic activity; nucleus; cytosol; carbohydrate metabolic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_10468,FUN_001741-T1,Peve_00025010,,apul_peve,31.8115,,,,,,,,,,,,,,,,,
OG_10469,FUN_001762-T1,Peve_00019398,,apul_peve,56.304,FUN_001762-T1,C5G6D7,CABC2_BACT4,,Chondroitin sulfate ABC exolyase (EC 4.2.2.21) (Chondroitin ABC exoeliminase) (Chondroitin ABC lyase II) (Chondroitin sulfate ABC lyase II) (ChS ABC lyase II) (Chondroitinase ABC II) (cABC II) (Exochondroitinase ABC),Bacteroides thetaiotaomicron,27.6,783.0,3.4e-50,202.2,sp|C5G6D7|CABC2_BACT4 Chondroitin sulfate ABC exolyase OS=Bacteroides thetaiotaomicron OX=818 GN=chonabc PE=1 SV=2,GO:0000287; GO:0005509; GO:0005576; GO:0005975; GO:0006027; GO:0030209; GO:0030246; GO:0034000; GO:0034001; GO:0042597,carbohydrate metabolic process [GO:0005975]; dermatan sulfate proteoglycan catabolic process [GO:0030209]; glycosaminoglycan catabolic process [GO:0006027],extracellular region [GO:0005576]; periplasmic space [GO:0042597],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; chondroitin-sulfate-ABC endolyase activity [GO:0034000]; chondroitin-sulfate-ABC exolyase activity [GO:0034001]; magnesium ion binding [GO:0000287],GO:0003824; GO:0005576; GO:0005975; GO:0016829; GO:0030163; GO:1901135,catalytic activity; extracellular region; carbohydrate metabolic process; lyase activity; protein catabolic process; carbohydrate derivative metabolic process
OG_10470,FUN_001767-T1,Peve_00035583,,apul_peve,46.853,,,,,,,,,,,,,,,,,
OG_10471,FUN_001776-T1,Peve_00035571,,apul_peve,48.352,,,,,,,,,,,,,,,,,
OG_10472,FUN_001808-T1,Peve_00012542,,apul_peve,43.233,FUN_001808-T1,B8V7P3,,,,,98.3,120.0,2.0000000000000007e-65,250.8,sp|B8V7P3|CAH_ACRMI Putative carbonic anhydrase (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10473,FUN_001838-T1,Peve_00035576,,apul_peve,33.058,,,,,,,,,,,,,,,,,
OG_10474,FUN_001871-T1,Peve_00031380,,apul_peve,38.793,,,,,,,,,,,,,,,,,
OG_10475,FUN_001884-T2,Peve_00030488,,apul_peve,74.53399999999999,FUN_001884-T2,B8V7S0,,,,,48.4,248.0,3.1999999999999998e-55,216.9,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10476,FUN_001902-T1,Peve_00031041,,apul_peve,85.764,FUN_001902-T1,Q16549,PCSK7_HUMAN,,Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7),Homo sapiens (Human),57.1,459.0,3.8e-149,530.0,sp|Q16549|PCSK7_HUMAN Proprotein convertase subtilisin/kexin type 7 OS=Homo sapiens OX=9606 GN=PCSK7 PE=1 SV=2,GO:0000139; GO:0004252; GO:0005802; GO:0008233; GO:0016485; GO:0016486,peptide hormone processing [GO:0016486]; protein processing [GO:0016485],Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_10477,FUN_001903-T1,Peve_00013097,,apul_peve,72.222,FUN_001903-T1,Q66IM5,,,,,52.0,102.0,4.5000000000000003e-23,108.6,sp|Q66IM5|NATD1_XENTR Protein NATD1 OS=Xenopus tropicalis OX=8364 GN=natd1 PE=3 SV=1,,,,,,
OG_10478,FUN_001906-T1,Peve_00024471,,apul_peve,65.4085,FUN_001906-T1,Q9H0J4,QRIC2_HUMAN,,Glutamine-rich protein 2,Homo sapiens (Human),23.5,549.0,1.4e-15,86.7,sp|Q9H0J4|QRIC2_HUMAN Glutamine-rich protein 2 OS=Homo sapiens OX=9606 GN=QRICH2 PE=1 SV=1,GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059,cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; sperm flagellum [GO:0036126],,GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_10479,FUN_001929-T1,Peve_00026032,,apul_peve,43.099,,,,,,,,,,,,,,,,,
OG_10480,FUN_001932-T1,Peve_00027794,,apul_peve,59.425,FUN_001932-T1,B8V7S0,,,,,49.6,250.0,4.6e-61,236.9,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10481,FUN_001939-T1,Peve_00006401,,apul_peve,40.385,,,,,,,,,,,,,,,,,
OG_10482,FUN_001945-T1,Peve_00002854,,apul_peve,43.155,,,,,,,,,,,,,,,,,
OG_10483,FUN_001976-T1,Peve_00002551,,apul_peve,38.2075,,,,,,,,,,,,,,,,,
OG_10484,FUN_001981-T1,Peve_00010744,,apul_peve,40.7655,,,,,,,,,,,,,,,,,
OG_10485,FUN_001985-T1,Peve_00023747,,apul_peve,65.0,,,,,,,,,,,,,,,,,
OG_10486,FUN_002032-T1,Peve_00035013,,apul_peve,91.447,,,,,,,,,,,,,,,,,
OG_10487,FUN_002041-T1,Peve_00024885,,apul_peve,61.18,,,,,,,,,,,,,,,,,
OG_10488,FUN_002043-T1,Peve_00034084,,apul_peve,43.269,,,,,,,,,,,,,,,,,
OG_10489,FUN_002055-T1,Peve_00021950,,apul_peve,55.66,,,,,,,,,,,,,,,,,
OG_10490,FUN_002075-T1,Peve_00002237,,apul_peve,31.429,,,,,,,,,,,,,,,,,
OG_10491,FUN_002076-T1,Peve_00030261,,apul_peve,51.977,FUN_002076-T1,Q8C206,,,,,35.9,284.0,3.6e-40,167.2,sp|Q8C206|GP157_MOUSE G-protein coupled receptor 157 OS=Mus musculus OX=10090 GN=Gpr157 PE=1 SV=1,,,,,,
OG_10492,FUN_002082-T1,Peve_00006418,,apul_peve,71.429,FUN_002082-T1,Q9C004,SPY4_HUMAN,,Protein sprouty homolog 4 (Spry-4),Homo sapiens (Human),49.3,75.0,3.6e-15,83.6,sp|Q9C004|SPY4_HUMAN Protein sprouty homolog 4 OS=Homo sapiens OX=9606 GN=SPRY4 PE=1 SV=2,GO:0004860; GO:0005737; GO:0005829; GO:0005925; GO:0032587; GO:0040037; GO:0046580; GO:0048513; GO:0070373; GO:1900025; GO:1990830,animal organ development [GO:0048513]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025],cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; ruffle membrane [GO:0032587],protein kinase inhibitor activity [GO:0004860],GO:0005829; GO:0048856; GO:0098772,cytosol; anatomical structure development; molecular function regulator activity
OG_10493,FUN_002098-T2,Peve_00004293,,apul_peve,61.938,FUN_002098-T2,Q8JG38,,,,,33.0,209.0,3.5e-25,117.1,sp|Q8JG38|FGFR2_DANRE Fibroblast growth factor receptor 2 OS=Danio rerio OX=7955 GN=fgfr2 PE=1 SV=1,,,,,,
OG_10494,FUN_002111-T1,Peve_00022236,,apul_peve,89.163,,,,,,,,,,,,,,,,,
OG_10495,FUN_002130-T1,Peve_00035305,,apul_peve,90.306,,,,,,,,,,,,,,,,,
OG_10496,FUN_002133-T1,Peve_00021187,,apul_peve,41.818,,,,,,,,,,,,,,,,,
OG_10497,FUN_002139-T1,Peve_00026349,,apul_peve,45.217,,,,,,,,,,,,,,,,,
OG_10498,FUN_002140-T1,Peve_00022693,,apul_peve,31.579,,,,,,,,,,,,,,,,,
OG_10499,FUN_002177-T1,Peve_00035327,,apul_peve,60.87,,,,,,,,,,,,,,,,,
OG_10500,FUN_002348-T1,Peve_00016156,,apul_peve,38.971,,,,,,,,,,,,,,,,,
OG_10501,FUN_002349-T1,Peve_00005305,,apul_peve,92.375,,,,,,,,,,,,,,,,,
OG_10502,FUN_002354-T1,Peve_00033245,,apul_peve,53.824,FUN_002354-T1,A4RKC3,DCL1_PYRO7,,Dicer-like protein 1 [Includes: Endoribonuclease DCL1 (EC 3.1.26.-); ATP-dependent helicase DCL1 (EC 3.6.4.-)],Pyricularia oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) (Rice blast fungus) (Magnaporthe oryzae),34.7,245.0,1.7e-23,113.2,sp|A4RKC3|DCL1_PYRO7 Dicer-like protein 1 OS=Pyricularia oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) OX=242507 GN=DCL1 PE=3 SV=2,GO:0003677; GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0030422; GO:0046872; GO:0050688; GO:0051607,defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688]; siRNA processing [GO:0030422],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10503,FUN_002356-T1,Peve_00023009,,apul_peve,77.34649999999999,FUN_002356-T1,Q9BXW9,,,,,42.2,1418.0,2.7e-296,1020.0,sp|Q9BXW9|FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens OX=9606 GN=FANCD2 PE=1 SV=2,,,,,,
OG_10504,FUN_002363-T2,Peve_00014903,,apul_peve,45.875,FUN_002363-T2,Q6FN53,STE20_CANGA,,Serine/threonine-protein kinase STE20 (EC 2.7.11.1),Candida glabrata (strain ATCC 2001 / BCRC 20586 / JCM 3761 / NBRC 0622 / NRRL Y-65 / CBS 138) (Yeast) (Nakaseomyces glabratus),32.2,199.0,6.3e-17,90.1,sp|Q6FN53|STE20_CANGA Serine/threonine-protein kinase STE20 OS=Candida glabrata (strain ATCC 2001 / BCRC 20586 / JCM 3761 / NBRC 0622 / NRRL Y-65 / CBS 138) OX=284593 GN=STE20 PE=3 SV=1,GO:0001402; GO:0005524; GO:0005634; GO:0005737; GO:0008349; GO:0019236; GO:0031505; GO:0071470; GO:0106310,cellular response to osmotic stress [GO:0071470]; fungal-type cell wall organization [GO:0031505]; response to pheromone [GO:0019236]; signal transduction involved in filamentous growth [GO:0001402],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0071554; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; cell wall organization or biogenesis; catalytic activity, acting on a protein"
OG_10505,FUN_002375-T1,Peve_00019288,,apul_peve,54.949,,,,,,,,,,,,,,,,,
OG_10506,FUN_002384-T1,Peve_00034023,,apul_peve,57.0945,,,,,,,,,,,,,,,,,
OG_10507,FUN_002472-T1,Peve_00034052,,apul_peve,73.333,,,,,,,,,,,,,,,,,
OG_10508,FUN_002509-T1,Peve_00032444,,apul_peve,75.2,,,,,,,,,,,,,,,,,
OG_10509,FUN_002531-T1,Peve_00005707,,apul_peve,49.1865,FUN_002531-T1,B8HCF8,,,,,26.0,358.0,4.3e-11,72.8,sp|B8HCF8|MSHA_PSECP D-inositol 3-phosphate glycosyltransferase OS=Pseudarthrobacter chlorophenolicus (strain ATCC 700700 / DSM 12829 / CIP 107037 / JCM 12360 / KCTC 9906 / NCIMB 13794 / A6) OX=452863 GN=mshA PE=3 SV=1,,,,,,
OG_10510,FUN_002570-T1,Peve_00007441,,apul_peve,40.323,,,,,,,,,,,,,,,,,
OG_10511,FUN_002574-T1,Peve_00001819,,apul_peve,75.6335,FUN_002574-T1,Q8R151,ZNFX1_MOUSE,,NFX1-type zinc finger-containing protein 1,Mus musculus (Mouse),39.6,1998.0,2.8e-294,1013.8,sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3,GO:0002218; GO:0003723; GO:0004386; GO:0005634; GO:0005741; GO:0008270; GO:0010494; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0016853; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; nucleus; isomerase activity; organelle; defense response to other organism; ATP-dependent activity
OG_10512,FUN_002576-T1,Peve_00025549,,apul_peve,72.09100000000001,FUN_002576-T1,O46385,,,,,38.4,910.0,4.7e-176,620.9,sp|O46385|SVIL_BOVIN Supervillin OS=Bos taurus OX=9913 GN=SVIL PE=1 SV=2,,,,,,
OG_10513,FUN_002584-T1,Peve_00002781,,apul_peve,82.799,,,,,,,,,,,,,,,,,
OG_10514,FUN_002618-T1,Peve_00008558,,apul_peve,64.103,,,,,,,,,,,,,,,,,
OG_10515,FUN_002645-T1,Peve_00035416,,apul_peve,52.333,FUN_002645-T1,B3EWZ3,,,,,41.7,115.0,1.2e-21,106.3,sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10516,FUN_002646-T1,Peve_00040090,,apul_peve,56.995,FUN_002646-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),44.6,332.0,4.1e-78,294.7,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_10517,FUN_002657-T1,Peve_00040099,,apul_peve,52.459,,,,,,,,,,,,,,,,,
OG_10518,FUN_002659-T1,Peve_00022948,,apul_peve,57.391,,,,,,,,,,,,,,,,,
OG_10519,FUN_002662-T1,Peve_00019802,,apul_peve,41.199,,,,,,,,,,,,,,,,,
OG_10520,FUN_002663-T1,Peve_00015035,,apul_peve,44.9905,,,,,,,,,,,,,,,,,
OG_10521,FUN_002665-T1,Peve_00025033,,apul_peve,60.554,FUN_002665-T1,P47747,,,,,24.2,289.0,1.8e-12,75.1,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_10522,FUN_002671-T1,Peve_00005215,,apul_peve,43.4805,FUN_002671-T1,B3EWZ3,,,,,35.7,1523.0,1.2e-218,761.9,sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10523,FUN_002672-T2,Peve_00007257,,apul_peve,38.3955,FUN_002672-T2,B3EWZ3,,,,,94.6,1675.0,0.0,3131.3,sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10524,FUN_002682-T1,Peve_00007262,,apul_peve,53.571,FUN_002682-T1,P11362,FGFR1_HUMAN,,Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331),Homo sapiens (Human),48.1,293.0,3e-72,274.6,sp|P11362|FGFR1_HUMAN Fibroblast growth factor receptor 1 OS=Homo sapiens OX=9606 GN=FGFR1 PE=1 SV=3,GO:0000122; GO:0000165; GO:0001501; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001764; GO:0001837; GO:0002053; GO:0002062; GO:0004713; GO:0005007; GO:0005524; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006468; GO:0007605; GO:0008201; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010518; GO:0010966; GO:0010976; GO:0016020; GO:0016477; GO:0017134; GO:0018108; GO:0021847; GO:0030031; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0035607; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043009; GO:0043235; GO:0043406; GO:0043410; GO:0043536; GO:0044344; GO:0045595; GO:0045597; GO:0045666; GO:0046777; GO:0048015; GO:0048339; GO:0048378; GO:0048469; GO:0048705; GO:0048863; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0070640; GO:0071344; GO:0071529; GO:0072089; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell projection assembly [GO:0030031]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cementum mineralization [GO:0071529]; chondrocyte differentiation [GO:0002062]; chordate embryonic development [GO:0043009]; diphosphate metabolic process [GO:0071344]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung-associated mesenchyme development [GO:0060484]; MAPK cascade [GO:0000165]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell differentiation [GO:0045595]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of postsynaptic density assembly [GO:0099151]; response to sodium phosphate [GO:1904383]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169],GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_10525,FUN_002685-T1,Peve_00007258,,apul_peve,52.157,FUN_002685-T1,G5ECS8,,,,,40.9,110.0,1.8e-19,98.2,sp|G5ECS8|ADT1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs adt-1 OS=Caenorhabditis elegans OX=6239 GN=adt-1 PE=2 SV=1,,,,,,
OG_10526,FUN_002686-T1,Peve_00019926,,apul_peve,80.357,,,,,,,,,,,,,,,,,
OG_10527,FUN_002689-T1,Peve_00007259,,apul_peve,41.2685,FUN_002689-T1,P25102,HRH2_RAT,,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),Rattus norvegicus (Rat),26.8,339.0,1.1e-09,65.9,sp|P25102|HRH2_RAT Histamine H2 receptor OS=Rattus norvegicus OX=10116 GN=Hrh2 PE=3 SV=1,GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:0071420; GO:1900139; GO:1901363,"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542]",dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202],heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594],GO:0003013; GO:0005886; GO:0022600; GO:0023052; GO:0048856; GO:0050877; GO:0060089,circulatory system process; plasma membrane; digestive system process; signaling; anatomical structure development; nervous system process; molecular transducer activity
OG_10528,FUN_002696-T2,Peve_00034500,,apul_peve,69.412,FUN_002696-T2,Q9UP83,COG5_HUMAN,,Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (13S Golgi transport complex 90 kDa subunit) (GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1),Homo sapiens (Human),56.2,560.0,9.3e-163,575.1,sp|Q9UP83|COG5_HUMAN Conserved oligomeric Golgi complex subunit 5 OS=Homo sapiens OX=9606 GN=COG5 PE=1 SV=4,GO:0000139; GO:0000301; GO:0005654; GO:0005794; GO:0005829; GO:0006891; GO:0007030; GO:0015031; GO:0016020; GO:0017119; GO:0032588; GO:0048219; GO:0070085,"glycosylation [GO:0070085]; Golgi organization [GO:0007030]; inter-Golgi cisterna vesicle-mediated transport [GO:0048219]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde transport, vesicle recycling within Golgi [GO:0000301]",cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588],,GO:0005654; GO:0005794; GO:0005829; GO:0016192; GO:0043226,nucleoplasm; Golgi apparatus; cytosol; vesicle-mediated transport; organelle
OG_10529,FUN_002711-T1,Peve_00005217,,apul_peve,61.811,,,,,,,,,,,,,,,,,
OG_10530,FUN_002712-T1,Peve_00005189,,apul_peve,44.466,,,,,,,,,,,,,,,,,
OG_10531,FUN_002727-T1,Peve_00019120,,apul_peve,49.533,,,,,,,,,,,,,,,,,
OG_10532,FUN_002793-T1,Peve_00001793,,apul_peve,94.483,,,,,,,,,,,,,,,,,
OG_10533,FUN_002812-T1,Peve_00025580,,apul_peve,70.175,FUN_002812-T1,Q9UBN7,HDAC6_HUMAN,,Protein deacetylase HDAC6 (EC 3.5.1.-) (E3 ubiquitin-protein ligase HDAC6) (EC 2.3.2.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-),Homo sapiens (Human),45.8,96.0,3.7e-23,109.0,sp|Q9UBN7|HDAC6_HUMAN Protein deacetylase HDAC6 OS=Homo sapiens OX=9606 GN=HDAC6 PE=1 SV=2,GO:0000118; GO:0000209; GO:0000978; GO:0001222; GO:0001975; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0010821; GO:0016234; GO:0016235; GO:0016241; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0033148; GO:0033558; GO:0034605; GO:0035902; GO:0035967; GO:0036064; GO:0036479; GO:0040029; GO:0042030; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045814; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051412; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061523; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0071218; GO:0071374; GO:0071548; GO:0090042; GO:0140374; GO:0141221; GO:1900246; GO:1900409; GO:1903146; GO:1904056; GO:1904115; GO:1905091; GO:1905336,"actin filament organization [GO:0007015]; aggresome assembly [GO:0070842]; antiviral innate immune response [GO:0140374]; axonal transport of mitochondrion [GO:0019896]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; epigenetic regulation of gene expression [GO:0040029]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of aggrephagy [GO:1905336]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cellular response to oxidative stress [GO:1900409]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of type 2 mitophagy [GO:1905091]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to dexamethasone [GO:0071548]; response to immobilization stress [GO:0035902]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]",aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471],"actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0006325; GO:0006355; GO:0006886; GO:0006914; GO:0007018; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; endosome; microtubule organizing center; cytosol; chromatin organization; regulation of DNA-templated transcription; intracellular protein transport; autophagy; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10534,FUN_002856-T1,Peve_00031181,,apul_peve,81.462,FUN_002856-T1,Q49UX2,,,,,50.2,570.0,1e-150,535.0,sp|Q49UX2|ILVD2_STAS1 Dihydroxy-acid dehydratase 2 OS=Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41) OX=342451 GN=ilvD2 PE=3 SV=1,,,,,,
OG_10535,FUN_002908-T1,Peve_00017165,,apul_peve,74.286,,,,,,,,,,,,,,,,,
OG_10536,FUN_003160-T1,Peve_00033051,,apul_peve,57.246,,,,,,,,,,,,,,,,,
OG_10537,FUN_003171-T1,Peve_00044812,,apul_peve,41.912,,,,,,,,,,,,,,,,,
OG_10538,FUN_003173-T1,Peve_00009894,,apul_peve,51.128,,,,,,,,,,,,,,,,,
OG_10539,FUN_003219-T1,Peve_00030720,,apul_peve,57.752,FUN_003219-T1,Q54DF2,MRKA_DICDI,,Probable serine/threonine-protein kinase MARK-A (EC 2.7.11.1),Dictyostelium discoideum (Social amoeba),31.6,155.0,4.5e-10,67.4,sp|Q54DF2|MRKA_DICDI Probable serine/threonine-protein kinase MARK-A OS=Dictyostelium discoideum OX=44689 GN=mrkA PE=3 SV=1,GO:0004674; GO:0005524; GO:0005737; GO:0035556; GO:0106310,intracellular signal transduction [GO:0035556],cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_10540,FUN_003382-T1,Peve_00018890,,apul_peve,50.909,,,,,,,,,,,,,,,,,
OG_10541,FUN_003400-T1,Peve_00022261,,apul_peve,38.71,,,,,,,,,,,,,,,,,
OG_10542,FUN_003402-T1,Peve_00042970,,apul_peve,41.538,,,,,,,,,,,,,,,,,
OG_10543,FUN_003419-T1,Peve_00029938,,apul_peve,31.818,,,,,,,,,,,,,,,,,
OG_10544,FUN_003435-T1,Peve_00010922,,apul_peve,40.532,,,,,,,,,,,,,,,,,
OG_10545,FUN_003456-T1,Peve_00036665,,apul_peve,53.986,,,,,,,,,,,,,,,,,
OG_10546,FUN_003523-T1,Peve_00005126,,apul_peve,91.791,,,,,,,,,,,,,,,,,
OG_10547,FUN_003530-T1,Peve_00029202,,apul_peve,54.545,,,,,,,,,,,,,,,,,
OG_10548,FUN_003537-T1,Peve_00027640,,apul_peve,80.667,,,,,,,,,,,,,,,,,
OG_10549,FUN_003545-T1,Peve_00011134,,apul_peve,89.08,,,,,,,,,,,,,,,,,
OG_10550,FUN_003591-T3,Peve_00016328,,apul_peve,45.324,,,,,,,,,,,,,,,,,
OG_10551,FUN_003636-T1,Peve_00042009,,apul_peve,54.497,,,,,,,,,,,,,,,,,
OG_10552,FUN_003646-T1,Peve_00006106,,apul_peve,81.395,,,,,,,,,,,,,,,,,
OG_10553,FUN_003654-T1,Peve_00004112,,apul_peve,57.7925,,,,,,,,,,,,,,,,,
OG_10554,FUN_003669-T1,Peve_00024422,,apul_peve,87.755,,,,,,,,,,,,,,,,,
OG_10555,FUN_003676-T1,Peve_00034326,,apul_peve,48.536,,,,,,,,,,,,,,,,,
OG_10556,FUN_003709-T1,Peve_00001361,,apul_peve,73.25550000000001,FUN_003709-T1,Q6AXK4,BABA1_DANRE,,BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex),Danio rerio (Zebrafish) (Brachydanio rerio),38.0,245.0,1.3e-38,161.8,sp|Q6AXK4|BABA1_DANRE BRISC and BRCA1-A complex member 1 OS=Danio rerio OX=7955 GN=babam1 PE=1 SV=2,GO:0005634; GO:0005737; GO:0006302; GO:0007095; GO:0010212; GO:0016604; GO:0045739; GO:0051301; GO:0070531; GO:0070552; GO:0140861,cell division [GO:0051301]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; positive regulation of DNA repair [GO:0045739]; response to ionizing radiation [GO:0010212],BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634],,GO:0005634; GO:0006281; GO:0006325; GO:0043226,nucleus; DNA repair; chromatin organization; organelle
OG_10557,FUN_003716-T1,Peve_00017918,,apul_peve,73.894,FUN_003716-T1,Q91398,,,,,51.2,209.0,3.2e-58,226.9,sp|Q91398|CSK2B_DANRE Casein kinase II subunit beta OS=Danio rerio OX=7955 GN=csnk2b PE=2 SV=1,,,,,,
OG_10558,FUN_003720-T1,Peve_00045210,,apul_peve,62.431,FUN_003720-T1,Q15485,FCN2_HUMAN,,Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35),Homo sapiens (Human),59.0,217.0,3.3e-70,266.9,sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2,GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370],antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005576; GO:0005615; GO:0043226; GO:0098542,immune system process; extracellular region; extracellular space; organelle; defense response to other organism
OG_10559,FUN_003727-T1,Peve_00018930,,apul_peve,58.9015,,,,,,,,,,,,,,,,,
OG_10560,FUN_003737-T1,Peve_00012745,,apul_peve,47.17,,,,,,,,,,,,,,,,,
OG_10561,FUN_003746-T1,Peve_00009236,,apul_peve,51.653000000000006,,,,,,,,,,,,,,,,,
OG_10562,FUN_003748-T1,Peve_00013689,,apul_peve,73.077,,,,,,,,,,,,,,,,,
OG_10563,FUN_003759-T1,Peve_00002692,,apul_peve,54.082,,,,,,,,,,,,,,,,,
OG_10564,FUN_003764-T1,Peve_00032704,,apul_peve,48.387,,,,,,,,,,,,,,,,,
OG_10565,FUN_003767-T1,Peve_00005464,,apul_peve,43.411,,,,,,,,,,,,,,,,,
OG_10566,FUN_003772-T1,Peve_00023853,,apul_peve,31.655,,,,,,,,,,,,,,,,,
OG_10567,FUN_003779-T1,Peve_00041952,,apul_peve,56.818,,,,,,,,,,,,,,,,,
OG_10568,FUN_003784-T1,Peve_00023318,,apul_peve,40.645,,,,,,,,,,,,,,,,,
OG_10569,FUN_003786-T1,Peve_00021191,,apul_peve,60.119,,,,,,,,,,,,,,,,,
OG_10570,FUN_003791-T2,Peve_00007939,,apul_peve,36.508,,,,,,,,,,,,,,,,,
OG_10571,FUN_003792-T1,Peve_00008593,,apul_peve,61.047,,,,,,,,,,,,,,,,,
OG_10572,FUN_003844-T1,Peve_00042648,,apul_peve,81.618,FUN_003844-T1,Q52KD7,ZNT7A_XENLA,,Zinc transporter 7-A (Solute carrier family 30 member 7-A),Xenopus laevis (African clawed frog),67.1,386.0,1.2e-102,374.8,sp|Q52KD7|ZNT7A_XENLA Zinc transporter 7-A OS=Xenopus laevis OX=8355 GN=slc30a7-a PE=2 SV=1,GO:0000139; GO:0005385; GO:0005739; GO:0005794; GO:0006882; GO:0031410; GO:0033017; GO:1904257; GO:1990674,intracellular zinc ion homeostasis [GO:0006882]; zinc ion import into Golgi lumen [GO:1904257],cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; Golgi cis cisterna membrane [GO:1990674]; Golgi membrane [GO:0000139]; mitochondrion [GO:0005739]; sarcoplasmic reticulum membrane [GO:0033017],zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005739; GO:0005794; GO:0031410; GO:0043226; GO:0055085,transporter activity; mitochondrion; Golgi apparatus; cytoplasmic vesicle; organelle; transmembrane transport
OG_10573,FUN_003855-T1,Peve_00015770,,apul_peve,49.58,,,,,,,,,,,,,,,,,
OG_10574,FUN_003860-T1,Peve_00042367,,apul_peve,82.036,,,,,,,,,,,,,,,,,
OG_10575,FUN_003863-T1,Peve_00011470,,apul_peve,82.057,FUN_003863-T1,A0A0C2SRU0,,,,,43.9,330.0,3.6e-69,263.8,sp|A0A0C2SRU0|IBOD_AMAMK Decarboxylase iboD OS=Amanita muscaria (strain Koide BX008) OX=946122 GN=iboD PE=2 SV=1,,,,,,
OG_10576,FUN_003882-T1,Peve_00028983,,apul_peve,55.351,FUN_003882-T1,Q90610,,,,,33.0,303.0,2.7e-30,136.0,sp|Q90610|NEO1_CHICK Neogenin (Fragment) OS=Gallus gallus OX=9031 PE=2 SV=1,,,,,,
OG_10577,FUN_003885-T1,Peve_00008628,,apul_peve,41.2675,FUN_003885-T1,Q7XIT1,,,,,28.0,429.0,2.3000000000000003e-28,129.8,sp|Q7XIT1|IRE1_ORYSJ Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Oryza sativa subsp. japonica OX=39947 GN=IRE1 PE=1 SV=1,,,,,,
OG_10578,FUN_003886-T1,Peve_00015149,,apul_peve,70.7495,FUN_003886-T1,Q02508,,,,,45.1,466.0,1.3e-32,142.5,sp|Q02508|HGV2_HALRO Protein HGV2 OS=Halocynthia roretzi OX=7729 GN=HGV2 PE=2 SV=1,,,,,,
OG_10579,FUN_003891-T1,Peve_00026526,,apul_peve,60.749,FUN_003891-T1,B8VIU6,,,,,55.9,195.0,3.6e-57,223.4,sp|B8VIU6|USOM5_ACRMI Uncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10580,FUN_003930-T1,Peve_00003882,,apul_peve,53.285,FUN_003930-T1,Q90610,,,,,25.7,300.0,3.8e-17,92.0,sp|Q90610|NEO1_CHICK Neogenin (Fragment) OS=Gallus gallus OX=9031 PE=2 SV=1,,,,,,
OG_10581,FUN_003936-T1,Peve_00014890,,apul_peve,66.8475,,,,,,,,,,,,,,,,,
OG_10582,FUN_003957-T1,Peve_00044905,,apul_peve,53.543,,,,,,,,,,,,,,,,,
OG_10583,FUN_003977-T3,Peve_00009033,,apul_peve,71.56,FUN_003977-T3,Q96LX7,CCD17_HUMAN,,Coiled-coil domain-containing protein 17,Homo sapiens (Human),31.1,383.0,7.5e-28,128.3,sp|Q96LX7|CCD17_HUMAN Coiled-coil domain-containing protein 17 OS=Homo sapiens OX=9606 GN=CCDC17 PE=1 SV=2,,,,,,
OG_10584,FUN_003983-T3,Peve_00020940,,apul_peve,52.307,FUN_003983-T3,O57382,,,,,32.0,244.0,2.5e-29,133.3,sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1,,,,,,
OG_10585,FUN_003984-T1,Peve_00038445,,apul_peve,53.994,,,,,,,,,,,,,,,,,
OG_10586,FUN_003989-T1,Peve_00038454,,apul_peve,51.8495,FUN_003989-T1,Q80XJ3,,,,,25.3,624.0,1.4e-32,142.9,sp|Q80XJ3|TTC28_MOUSE Tetratricopeptide repeat protein 28 OS=Mus musculus OX=10090 GN=Ttc28 PE=1 SV=3,,,,,,
OG_10587,FUN_004016-T1,Peve_00030678,,apul_peve,81.275,FUN_004016-T1,Q9DCK3,,,,,35.3,241.0,1.2e-34,148.3,sp|Q9DCK3|TSN4_MOUSE Tetraspanin-4 OS=Mus musculus OX=10090 GN=Tspan4 PE=1 SV=1,,,,,,
OG_10588,FUN_004019-T1,Peve_00043453,,apul_peve,56.79,,,,,,,,,,,,,,,,,
OG_10589,FUN_004034-T1,Peve_00033223,,apul_peve,44.33,,,,,,,,,,,,,,,,,
OG_10590,FUN_004040-T1,Peve_00008963,,apul_peve,44.61,FUN_004040-T1,Q5TAX3,TUT4_HUMAN,,Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11),Homo sapiens (Human),53.8,420.0,1.0999999999999999e-121,439.9,sp|Q5TAX3|TUT4_HUMAN Terminal uridylyltransferase 4 OS=Homo sapiens OX=9606 GN=TUT4 PE=1 SV=3,GO:0001556; GO:0003723; GO:0005615; GO:0005730; GO:0005737; GO:0005829; GO:0008270; GO:0010586; GO:0010587; GO:0019827; GO:0031054; GO:0031123; GO:0035198; GO:0036464; GO:0050265; GO:0070062; GO:0141008; GO:1990074,miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827]; transposable element silencing by mRNA destabilization [GO:0141008],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730],miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005615; GO:0005730; GO:0005829; GO:0016071; GO:0016740; GO:0022414; GO:0043226; GO:0140098,"RNA binding; catalytic activity; extracellular space; nucleolus; cytosol; mRNA metabolic process; transferase activity; reproductive process; organelle; catalytic activity, acting on RNA"
OG_10591,FUN_004048-T1,Peve_00004924,,apul_peve,37.85,,,,,,,,,,,,,,,,,
OG_10592,FUN_004067-T1,Peve_00006657,,apul_peve,42.157,FUN_004067-T1,Q3UH53,SDK1_MOUSE,,Protein sidekick-1,Mus musculus (Mouse),21.4,387.0,1.4e-11,72.4,sp|Q3UH53|SDK1_MOUSE Protein sidekick-1 OS=Mus musculus OX=10090 GN=Sdk1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202; GO:0048148; GO:0060998,behavioral response to cocaine [GO:0048148]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; regulation of dendritic spine development [GO:0060998]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_10593,FUN_004069-T1,Peve_00006658,,apul_peve,46.405,,,,,,,,,,,,,,,,,
OG_10594,FUN_004071-T1,Peve_00007128,,apul_peve,36.9955,FUN_004071-T1,P16621,,,,,24.7,405.0,1.6e-17,93.2,sp|P16621|LAR_DROME Tyrosine-protein phosphatase Lar OS=Drosophila melanogaster OX=7227 GN=Lar PE=1 SV=2,,,,,,
OG_10595,FUN_004076-T1,Peve_00012615,,apul_peve,47.967,,,,,,,,,,,,,,,,,
OG_10596,FUN_004082-T1,Peve_00018107,,apul_peve,56.3265,FUN_004082-T1,P11985,DYLT2_MOUSE,,Dynein light chain Tctex-type protein 2 (LC2) (T-complex testis-specific protein 2) (T-complex testis-specific protein 3) (T-complex-associated testis-expressed protein 3) (Tcte-3) (T-complex-associated testis-expressed protein 4) (TCTEX-4) (TCTEX-2) (Tctex1 domain-containing protein 3),Mus musculus (Mouse),32.0,100.0,4.5e-07,56.2,sp|P11985|DYLT2_MOUSE Dynein light chain Tctex-type protein 2 OS=Mus musculus OX=10090 GN=Dynlt2 PE=1 SV=2,GO:0005829; GO:0005868; GO:0005874; GO:0007018; GO:0016020; GO:0036126,microtubule-based movement [GO:0007018],cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; sperm flagellum [GO:0036126],,GO:0005829; GO:0005929; GO:0007018; GO:0043226,cytosol; cilium; microtubule-based movement; organelle
OG_10597,FUN_004083-T1,Peve_00019549,,apul_peve,78.788,FUN_004083-T1,Q9ET22,DPP2_MOUSE,,Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase),Mus musculus (Mouse),52.3,444.0,5.5000000000000005e-126,452.6,sp|Q9ET22|DPP2_MOUSE Dipeptidyl peptidase 2 OS=Mus musculus OX=10090 GN=Dpp7 PE=1 SV=2,GO:0004177; GO:0005576; GO:0005764; GO:0005794; GO:0006508; GO:0008239; GO:0031410; GO:0070008; GO:1905146,lysosomal protein catabolic process [GO:1905146]; proteolysis [GO:0006508],cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764],aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; serine-type exopeptidase activity [GO:0070008],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0005794; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; extracellular region; lysosome; vacuole; Golgi apparatus; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_10598,FUN_004104-T1,Peve_00017988,,apul_peve,55.882,,,,,,,,,,,,,,,,,
OG_10599,FUN_004111-T1,Peve_00015642,,apul_peve,50.151,FUN_004111-T1,Q9Z2D5,,,,,25.6,309.0,1.5e-11,72.0,sp|Q9Z2D5|NPY2R_CAVPO Neuropeptide Y receptor type 2 OS=Cavia porcellus OX=10141 GN=NPY2R PE=3 SV=1,,,,,,
OG_10600,FUN_004112-T1,Peve_00015646,,apul_peve,46.61,FUN_004112-T1,P30989,NTR1_HUMAN,,Neurotensin receptor type 1 (NT-R-1) (NTR1) (High-affinity levocabastine-insensitive neurotensin receptor) (NTRH),Homo sapiens (Human),26.0,362.0,1.4e-09,65.5,sp|P30989|NTR1_HUMAN Neurotensin receptor type 1 OS=Homo sapiens OX=9606 GN=NTSR1 PE=1 SV=2,GO:0001659; GO:0003085; GO:0003254; GO:0004930; GO:0005783; GO:0005794; GO:0005886; GO:0007186; GO:0007218; GO:0007268; GO:0007612; GO:0008344; GO:0009898; GO:0009986; GO:0010628; GO:0014049; GO:0014054; GO:0016492; GO:0032280; GO:0033993; GO:0042802; GO:0043065; GO:0043066; GO:0043195; GO:0043197; GO:0043198; GO:0043204; GO:0043576; GO:0044877; GO:0045121; GO:0050965; GO:0051280; GO:0051281; GO:0060732; GO:0070779; GO:0071545; GO:0090238; GO:0097151; GO:0098712,adult locomotory behavior [GO:0008344]; chemical synaptic transmission [GO:0007268]; D-aspartate import across plasma membrane [GO:0070779]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate catabolic process [GO:0071545]; L-glutamate import across plasma membrane [GO:0098712]; learning [GO:0007612]; negative regulation of apoptotic process [GO:0043066]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of apoptotic process [GO:0043065]; positive regulation of arachidonate secretion [GO:0090238]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of membrane depolarization [GO:0003254]; regulation of respiratory gaseous exchange [GO:0043576]; response to lipid [GO:0033993]; temperature homeostasis [GO:0001659],cell surface [GO:0009986]; cytoplasmic side of plasma membrane [GO:0009898]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; terminal bouton [GO:0043195],G protein-coupled neurotensin receptor activity [GO:0016492]; G protein-coupled receptor activity [GO:0004930]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877],GO:0005783; GO:0005794; GO:0005886; GO:0023052; GO:0043226; GO:0050877; GO:0055085; GO:0060089,endoplasmic reticulum; Golgi apparatus; plasma membrane; signaling; organelle; nervous system process; transmembrane transport; molecular transducer activity
OG_10601,FUN_004116-T1,Peve_00038520,,apul_peve,39.667,FUN_004116-T1,Q9H772,GREM2_HUMAN,,"Gremlin-2 (Cysteine knot superfamily 1, BMP antagonist 2) (DAN domain family member 3) (Protein related to DAN and cerberus)",Homo sapiens (Human),43.2,95.0,4e-18,93.6,sp|Q9H772|GREM2_HUMAN Gremlin-2 OS=Homo sapiens OX=9606 GN=GREM2 PE=1 SV=1,GO:0005125; GO:0005576; GO:0005615; GO:0008201; GO:0010172; GO:0019221; GO:0036122; GO:0038098; GO:0042802; GO:0048018; GO:0048263; GO:0060300,cytokine-mediated signaling pathway [GO:0019221]; determination of dorsal identity [GO:0048263]; embryonic body morphogenesis [GO:0010172]; regulation of cytokine activity [GO:0060300]; sequestering of BMP from receptor via BMP binding [GO:0038098],extracellular region [GO:0005576]; extracellular space [GO:0005615],BMP binding [GO:0036122]; cytokine activity [GO:0005125]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; receptor ligand activity [GO:0048018],GO:0005576; GO:0005615; GO:0048018; GO:0098772,extracellular region; extracellular space; receptor ligand activity; molecular function regulator activity
OG_10602,FUN_004122-T1,Peve_00009571,,apul_peve,94.664,FUN_004122-T1,Q9D180,CFA57_MOUSE,,Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65),Mus musculus (Mouse),69.7,865.0,2.6e-169,597.4,sp|Q9D180|CFA57_MOUSE Cilia- and flagella-associated protein 57 OS=Mus musculus OX=10090 GN=Cfap57 PE=1 SV=3,GO:0005737; GO:0005856; GO:0007338; GO:0036126; GO:0044782; GO:0070286; GO:0120316,axonemal dynein complex assembly [GO:0070286]; cilium organization [GO:0044782]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126],,GO:0005856; GO:0005929; GO:0022414; GO:0043226; GO:0044782; GO:0065003,cytoskeleton; cilium; reproductive process; organelle; cilium organization; protein-containing complex assembly
OG_10603,FUN_004143-T1,Peve_00037443,,apul_peve,61.29,FUN_004143-T1,Q0V8T0,,,,,33.3,231.0,1.8e-27,125.9,sp|Q0V8T0|CNTP5_CANLF Contactin-associated protein-like 5 OS=Canis lupus familiaris OX=9615 GN=CNTNAP5 PE=2 SV=1,,,,,,
OG_10604,FUN_004153-T1,Peve_00012143,,apul_peve,50.376,,,,,,,,,,,,,,,,,
OG_10605,FUN_004154-T1,Peve_00031604,,apul_peve,32.53,,,,,,,,,,,,,,,,,
OG_10606,FUN_004155-T1,Peve_00031603,,apul_peve,81.667,,,,,,,,,,,,,,,,,
OG_10607,FUN_004157-T1,Peve_00012142,,apul_peve,88.1945,FUN_004157-T1,Q12834,CDC20_HUMAN,,Cell division cycle protein 20 homolog (p55CDC),Homo sapiens (Human),56.2,507.0,1.5e-148,527.7,sp|Q12834|CDC20_HUMAN Cell division cycle protein 20 homolog OS=Homo sapiens OX=9606 GN=CDC20 PE=1 SV=2,GO:0000776; GO:0000922; GO:0005654; GO:0005680; GO:0005813; GO:0005819; GO:0005829; GO:0007064; GO:0007094; GO:0007346; GO:0007399; GO:0008284; GO:0010997; GO:0016567; GO:0030154; GO:0031145; GO:0031915; GO:0033597; GO:0040020; GO:0042826; GO:0044784; GO:0045842; GO:0048471; GO:0050773; GO:0051301; GO:0051445; GO:0090129; GO:0090307; GO:1904668; GO:1905786; GO:1990756; GO:1990757; GO:1990949,anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell differentiation [GO:0030154]; cell division [GO:0051301]; metaphase/anaphase transition of cell cycle [GO:0044784]; metaphase/anaphase transition of meiosis I [GO:1990949]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint signaling [GO:0007094]; nervous system development [GO:0007399]; positive regulation of anaphase-promoting complex-dependent catabolic process [GO:1905786]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein ubiquitination [GO:0016567]; regulation of dendrite development [GO:0050773]; regulation of meiotic cell cycle [GO:0051445]; regulation of meiotic nuclear division [GO:0040020]; regulation of mitotic cell cycle [GO:0007346],anaphase-promoting complex [GO:0005680]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; spindle pole [GO:0000922],anaphase-promoting complex binding [GO:0010997]; histone deacetylase binding [GO:0042826]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0022414; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; reproductive process; cell differentiation; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_10608,FUN_004176-T2,Peve_00028371,,apul_peve,69.192,FUN_004176-T2,O00442,RTCA_HUMAN,,RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1) (RTC domain-containing protein 1),Homo sapiens (Human),35.1,367.0,8.4e-56,219.5,sp|O00442|RTCA_HUMAN RNA 3'-terminal phosphate cyclase OS=Homo sapiens OX=9606 GN=RTCA PE=1 SV=1,GO:0003723; GO:0003963; GO:0005524; GO:0005634; GO:0005654; GO:0006396; GO:1905592,negative regulation of optical nerve axon regeneration [GO:1905592]; RNA processing [GO:0006396],nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA-3'-phosphate cyclase activity [GO:0003963],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0009975; GO:0016874; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; cyclase activity; ligase activity; organelle; catalytic activity, acting on RNA"
OG_10609,FUN_004179-T1,Peve_00028373,,apul_peve,43.192,FUN_004179-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),26.8,224.0,3e-07,57.8,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_10610,FUN_004180-T1,Peve_00033282,,apul_peve,50.292,,,,,,,,,,,,,,,,,
OG_10611,FUN_004183-T1,Peve_00021843,,apul_peve,63.1325,FUN_004183-T1,O75762,TRPA1_HUMAN,,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120) (p120) (Wasabi receptor),Homo sapiens (Human),28.0,1033.0,4.8e-64,248.1,sp|O75762|TRPA1_HUMAN Transient receptor potential cation channel subfamily A member 1 OS=Homo sapiens OX=9606 GN=TRPA1 PE=1 SV=3,GO:0005245; GO:0005262; GO:0005886; GO:0006811; GO:0006874; GO:0007166; GO:0009409; GO:0009410; GO:0014832; GO:0015267; GO:0015278; GO:0016324; GO:0019233; GO:0030424; GO:0032421; GO:0034605; GO:0035774; GO:0042802; GO:0048265; GO:0050955; GO:0050966; GO:0050968; GO:0051289; GO:0070301; GO:0070417; GO:0070588; GO:0071240; GO:0071244; GO:0071313; GO:0097237; GO:0097553; GO:0097604; GO:0098908; GO:1903522; GO:1903793; GO:1990760,calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to caffeine [GO:0071313]; cellular response to carbon dioxide [GO:0071244]; cellular response to cold [GO:0070417]; cellular response to food [GO:0071240]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to toxic substance [GO:0097237]; detection of chemical stimulus involved in sensory perception of pain [GO:0050968]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transport [GO:0006811]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of monoatomic anion transport [GO:1903793]; protein homotetramerization [GO:0051289]; regulation of blood circulation [GO:1903522]; regulation of neuronal action potential [GO:0098908]; response to cold [GO:0009409]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; thermoception [GO:0050955]; urinary bladder smooth muscle contraction [GO:0014832],apical plasma membrane [GO:0016324]; axon [GO:0030424]; plasma membrane [GO:0005886]; stereocilium bundle [GO:0032421],calcium channel activity [GO:0005262]; channel activity [GO:0015267]; identical protein binding [GO:0042802]; intracellularly gated calcium channel activity [GO:0015278]; osmolarity-sensing monoatomic cation channel activity [GO:1990760]; temperature-gated cation channel activity [GO:0097604]; voltage-gated calcium channel activity [GO:0005245],GO:0003012; GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; transporter activity; plasma membrane; nervous system process; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_10612,FUN_004193-T1,Peve_00030932,,apul_peve,47.9675,,,,,,,,,,,,,,,,,
OG_10613,FUN_004194-T1,Peve_00030934,,apul_peve,36.450500000000005,,,,,,,,,,,,,,,,,
OG_10614,FUN_004228-T1,Peve_00004608,,apul_peve,70.748,FUN_004228-T1,Q8IUS5,,,,,44.8,339.0,3.7e-79,296.6,sp|Q8IUS5|EPHX4_HUMAN Epoxide hydrolase 4 OS=Homo sapiens OX=9606 GN=EPHX4 PE=1 SV=2,,,,,,
OG_10615,FUN_004234-T1,Peve_00037953,,apul_peve,46.642,,,,,,,,,,,,,,,,,
OG_10616,FUN_004240-T1,Peve_00017638,,apul_peve,37.8715,,,,,,,,,,,,,,,,,
OG_10617,FUN_004243-T1,Peve_00019437,,apul_peve,63.547,,,,,,,,,,,,,,,,,
OG_10618,FUN_004244-T1,Peve_00019435,,apul_peve,60.965,,,,,,,,,,,,,,,,,
OG_10619,FUN_004278-T1,Peve_00008950,,apul_peve,67.752,FUN_004278-T1,P11614,,,,,23.3,347.0,1.7e-10,68.6,sp|P11614|5HT1D_CANLF 5-hydroxytryptamine receptor 1D OS=Canis lupus familiaris OX=9615 GN=HTR1D PE=2 SV=1,,,,,,
OG_10620,FUN_004279-T1,Peve_00008952,,apul_peve,66.094,FUN_004279-T1,Q566N0,ENPP4_DANRE,,Bis(5'-adenosyl)-triphosphatase enpp4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4),Danio rerio (Zebrafish) (Brachydanio rerio),32.7,434.0,1.6000000000000004e-59,231.9,sp|Q566N0|ENPP4_DANRE Bis(5'-adenosyl)-triphosphatase enpp4 OS=Danio rerio OX=7955 GN=enpp4 PE=2 SV=1,GO:0005886; GO:0007596; GO:0046872; GO:0047710,blood coagulation [GO:0007596],plasma membrane [GO:0005886],bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; metal ion binding [GO:0046872],GO:0003824; GO:0005886; GO:0016787,catalytic activity; plasma membrane; hydrolase activity
OG_10621,FUN_004281-T1,Peve_00008954,,apul_peve,71.134,FUN_004281-T1,Q6P5L8,,,,,51.9,412.0,4.200000000000001e-111,402.9,sp|Q6P5L8|HSDL2_DANRE Hydroxysteroid dehydrogenase-like protein 2 OS=Danio rerio OX=7955 GN=hsdl2 PE=2 SV=1,,,,,,
OG_10622,FUN_004283-T1,Peve_00030014,,apul_peve,80.667,,,,,,,,,,,,,,,,,
OG_10623,FUN_004289-T1,Peve_00035089,,apul_peve,46.2015,,,,,,,,,,,,,,,,,
OG_10624,FUN_004315-T1,Peve_00005663,,apul_peve,66.923,,,,,,,,,,,,,,,,,
OG_10625,FUN_004318-T1,Peve_00016510,,apul_peve,47.115,,,,,,,,,,,,,,,,,
OG_10626,FUN_004340-T1,Peve_00016485,,apul_peve,53.782,,,,,,,,,,,,,,,,,
OG_10627,FUN_004353-T1,Peve_00016539,,apul_peve,55.09,,,,,,,,,,,,,,,,,
OG_10628,FUN_004382-T1,Peve_00021145,,apul_peve,69.767,,,,,,,,,,,,,,,,,
OG_10629,FUN_004393-T1,Peve_00034323,,apul_peve,52.017,FUN_004393-T1,Q9I931,,,,,36.1,169.0,6.4e-20,100.9,sp|Q9I931|FUCL1_ANGJA Fucolectin-1 OS=Anguilla japonica OX=7937 PE=2 SV=1,,,,,,
OG_10630,FUN_004400-T1,Peve_00005567,,apul_peve,72.222,FUN_004400-T1,Q64487,PTPRD_MOUSE,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Mus musculus (Mouse),30.7,1096.0,5.9e-137,491.1,sp|Q64487|PTPRD_MOUSE Receptor-type tyrosine-protein phosphatase delta OS=Mus musculus OX=10090 GN=Ptprd PE=1 SV=3,GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102],GO:0003824; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0061024; GO:0140096,"catalytic activity; cell adhesion; hydrolase activity; signaling; cell differentiation; membrane organization; catalytic activity, acting on a protein"
OG_10631,FUN_004410-T1,Peve_00000128,,apul_peve,49.135,FUN_004410-T1,Q923X6,,,,,25.8,353.0,1.2e-08,62.4,sp|Q923X6|TAA7E_RAT Trace amine-associated receptor 7e OS=Rattus norvegicus OX=10116 GN=Taar7e PE=3 SV=1,,,,,,
OG_10632,FUN_004413-T1,Peve_00008402,,apul_peve,92.754,FUN_004413-T1,P04464,,,,,49.3,144.0,2.1e-34,146.7,sp|P04464|CALM_WHEAT Calmodulin OS=Triticum aestivum OX=4565 PE=1 SV=3,,,,,,
OG_10633,FUN_004418-T1,Peve_00033987,,apul_peve,82.6085,FUN_004418-T1,P09661,RU2A_HUMAN,,U2 small nuclear ribonucleoprotein A' (U2 snRNP A'),Homo sapiens (Human),59.9,257.0,4.500000000000001e-74,279.3,sp|P09661|RU2A_HUMAN U2 small nuclear ribonucleoprotein A' OS=Homo sapiens OX=9606 GN=SNRPA1 PE=1 SV=2,GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0007283; GO:0008380; GO:0016604; GO:0016607; GO:0030532; GO:0030620; GO:0071005; GO:0071007; GO:0071013; GO:1903241,"mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283]; U2-type prespliceosome assembly [GO:1903241]",catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0022414; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; reproductive process; organelle; protein-containing complex assembly
OG_10634,FUN_004419-T1,Peve_00026931,,apul_peve,51.579,,,,,,,,,,,,,,,,,
OG_10635,FUN_004423-T1,Peve_00024112,,apul_peve,86.63650000000001,FUN_004423-T1,Q9NPF5,DMAP1_HUMAN,,DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1),Homo sapiens (Human),49.2,457.0,7.5e-99,362.5,sp|Q9NPF5|DMAP1_HUMAN DNA methyltransferase 1-associated protein 1 OS=Homo sapiens OX=9606 GN=DMAP1 PE=1 SV=1,GO:0000122; GO:0000786; GO:0000812; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006338; GO:0006355; GO:0035267; GO:0042307; GO:0042981; GO:0045471; GO:0045892; GO:0045893; GO:0051726; GO:0061629; GO:1905168; GO:2000779,chromatin remodeling [GO:0006338]; DNA repair [GO:0006281]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; response to ethanol [GO:0045471],cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; replication fork [GO:0005657]; Swr1 complex [GO:0000812],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_10636,FUN_004430-T1,Peve_00033221,,apul_peve,61.5195,,,,,,,,,,,,,,,,,
OG_10637,FUN_004433-T1,Peve_00033217,,apul_peve,62.441,FUN_004433-T1,Q28DB0,,,,,40.4,572.0,5.9000000000000006e-123,443.0,sp|Q28DB0|TT39B_XENTR Tetratricopeptide repeat protein 39B OS=Xenopus tropicalis OX=8364 GN=ttc39b PE=2 SV=1,,,,,,
OG_10638,FUN_004445-T2,Peve_00033231,,apul_peve,54.525,,,,,,,,,,,,,,,,,
OG_10639,FUN_004449-T1,Peve_00024323,,apul_peve,81.159,FUN_004449-T1,Q9Y547,IFT25_HUMAN,,Intraflagellar transport protein 25 homolog (Heat shock protein beta-11) (Hspb11) (Heat shock protein family B member 11) (Placental protein 25) (PP25),Homo sapiens (Human),54.8,135.0,1.6000000000000002e-33,143.7,sp|Q9Y547|IFT25_HUMAN Intraflagellar transport protein 25 homolog OS=Homo sapiens OX=9606 GN=IFT25 PE=1 SV=1,GO:0001501; GO:0001822; GO:0005813; GO:0005929; GO:0007224; GO:0007283; GO:0007507; GO:0015031; GO:0030154; GO:0030324; GO:0030992; GO:0035720; GO:0046872; GO:0060271; GO:0070986; GO:0097542,cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; heart development [GO:0007507]; intraciliary anterograde transport [GO:0035720]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; protein transport [GO:0015031]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992],metal ion binding [GO:0046872],GO:0005815; GO:0005929; GO:0007018; GO:0022414; GO:0030154; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cilium; microtubule-based movement; reproductive process; cell differentiation; organelle; cilium organization; anatomical structure development
OG_10640,FUN_004458-T1,Peve_00028022,,apul_peve,59.788,,,,,,,,,,,,,,,,,
OG_10641,FUN_004483-T1,Peve_00008404,,apul_peve,77.866,FUN_004483-T1,P28472,GBRB3_HUMAN,,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) (GABAAR subunit beta-3),Homo sapiens (Human),28.1,281.0,1.3e-25,118.2,sp|P28472|GBRB3_HUMAN Gamma-aminobutyric acid receptor subunit beta-3 OS=Homo sapiens OX=9606 GN=GABRB3 PE=1 SV=1,GO:0004890; GO:0005886; GO:0007165; GO:0007214; GO:0007612; GO:0007613; GO:0009410; GO:0009986; GO:0019098; GO:0021549; GO:0022851; GO:0030659; GO:0034707; GO:0035176; GO:0035640; GO:0042747; GO:0042802; GO:0043197; GO:0045211; GO:0051932; GO:0060021; GO:0060022; GO:0060080; GO:0060119; GO:0060384; GO:0061744; GO:0071294; GO:0071420; GO:0072347; GO:0090102; GO:0098982; GO:0099634; GO:1902476; GO:1902711; GO:1904315; GO:1904862,"cellular response to histamine [GO:0071420]; cellular response to zinc ion [GO:0071294]; cerebellum development [GO:0021549]; chloride transmembrane transport [GO:1902476]; circadian sleep/wake cycle, REM sleep [GO:0042747]; cochlea development [GO:0090102]; exploration behavior [GO:0035640]; gamma-aminobutyric acid signaling pathway [GO:0007214]; hard palate development [GO:0060022]; inhibitory postsynaptic potential [GO:0060080]; inhibitory synapse assembly [GO:1904862]; inner ear receptor cell development [GO:0060119]; innervation [GO:0060384]; learning [GO:0007612]; memory [GO:0007613]; motor behavior [GO:0061744]; reproductive behavior [GO:0019098]; response to anesthetic [GO:0072347]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synaptic transmission, GABAergic [GO:0051932]",cell surface [GO:0009986]; chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; dendritic spine [GO:0043197]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0022414; GO:0023052; GO:0034330; GO:0048856; GO:0050877; GO:0055085; GO:0060089,transporter activity; plasma membrane; reproductive process; signaling; cell junction organization; anatomical structure development; nervous system process; transmembrane transport; molecular transducer activity
OG_10642,FUN_004487-T1,Peve_00003218,,apul_peve,80.857,,,,,,,,,,,,,,,,,
OG_10643,FUN_004489-T1,Peve_00008399,,apul_peve,74.434,FUN_004489-T1,Q9NXG6,,,,,48.5,66.0,2.2e-14,81.3,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_10644,FUN_004500-T1,Peve_00044070,,apul_peve,76.9565,FUN_004500-T1,A6QR31,,,,,63.1,111.0,3.4e-21,102.4,sp|A6QR31|FA32A_BOVIN Protein FAM32A OS=Bos taurus OX=9913 GN=FAM32A PE=3 SV=1,,,,,,
OG_10645,FUN_004501-T1,Peve_00026072,,apul_peve,64.672,FUN_004501-T1,Q9H583,HEAT1_HUMAN,,"HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed]",Homo sapiens (Human),34.9,736.0,6.5e-113,410.2,sp|Q9H583|HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=HEATR1 PE=1 SV=3,GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0016020; GO:0016072; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0042274; GO:0045943; GO:0061351; GO:1902570; GO:2000234,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; neural precursor cell proliferation [GO:0061351]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein localization to nucleolus [GO:1902570]; ribosomal small subunit biogenesis [GO:0042274]; rRNA metabolic process [GO:0016072]",90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455],RNA binding [GO:0003723]; snoRNA binding [GO:0030515],GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006355; GO:0043226,RNA binding; nucleoplasm; nucleolus; mitochondrion; regulation of DNA-templated transcription; organelle
OG_10646,FUN_004502-T1,Peve_00024330,,apul_peve,69.741,FUN_004502-T1,Q9H583,HEAT1_HUMAN,,"HEAT repeat-containing protein 1 (Protein BAP28) (U3 small nucleolar RNA-associated protein 10 homolog) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed]",Homo sapiens (Human),44.2,615.0,6e-136,486.1,sp|Q9H583|HEAT1_HUMAN HEAT repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=HEATR1 PE=1 SV=3,GO:0000462; GO:0001650; GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0016020; GO:0016072; GO:0030515; GO:0030686; GO:0032040; GO:0034455; GO:0042274; GO:0045943; GO:0061351; GO:1902570; GO:2000234,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; neural precursor cell proliferation [GO:0061351]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; protein localization to nucleolus [GO:1902570]; ribosomal small subunit biogenesis [GO:0042274]; rRNA metabolic process [GO:0016072]",90S preribosome [GO:0030686]; fibrillar center [GO:0001650]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455],RNA binding [GO:0003723]; snoRNA binding [GO:0030515],GO:0003723; GO:0005654; GO:0005730; GO:0005739; GO:0006355; GO:0043226,RNA binding; nucleoplasm; nucleolus; mitochondrion; regulation of DNA-templated transcription; organelle
OG_10647,FUN_004512-T1,Peve_00012955,,apul_peve,66.974,FUN_004512-T1,Q9H8E8,,,,,40.2,727.0,4e-135,483.4,sp|Q9H8E8|CSR2B_HUMAN Cysteine-rich protein 2-binding protein OS=Homo sapiens OX=9606 GN=KAT14 PE=1 SV=3,,,,,,
OG_10648,FUN_004524-T1,Peve_00044055,,apul_peve,51.9255,FUN_004524-T1,Q9NS56,TOPRS_HUMAN,,E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3),Homo sapiens (Human),42.7,192.0,3.9e-29,131.3,sp|Q9NS56|TOPRS_HUMAN E3 ubiquitin-protein ligase Topors OS=Homo sapiens OX=9606 GN=TOPORS PE=1 SV=1,GO:0000151; GO:0000209; GO:0000922; GO:0000930; GO:0003677; GO:0003823; GO:0004842; GO:0005634; GO:0005654; GO:0005814; GO:0006351; GO:0006511; GO:0006513; GO:0006974; GO:0008270; GO:0008630; GO:0010842; GO:0016605; GO:0016607; GO:0016925; GO:0019789; GO:0030496; GO:0032391; GO:0034504; GO:0035845; GO:0036064; GO:0042127; GO:0042771; GO:0043066; GO:0043161; GO:0044547; GO:0045893; GO:0051457; GO:0061630; GO:0070936,DNA damage response [GO:0006974]; DNA-templated transcription [GO:0006351]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of apoptotic process [GO:0043066]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of DNA-templated transcription [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein localization to nucleus [GO:0034504]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; regulation of cell population proliferation [GO:0042127]; retina layer formation [GO:0010842]; ubiquitin-dependent protein catabolic process [GO:0006511],centriole [GO:0005814]; ciliary basal body [GO:0036064]; gamma-tubulin complex [GO:0000930]; midbody [GO:0030496]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; PML body [GO:0016605]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151],antigen binding [GO:0003823]; DNA binding [GO:0003677]; DNA topoisomerase binding [GO:0044547]; SUMO transferase activity [GO:0019789]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0006351; GO:0006355; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; DNA-templated transcription; regulation of DNA-templated transcription; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_10649,FUN_004548-T1,Peve_00042942,,apul_peve,34.109,,,,,,,,,,,,,,,,,
OG_10650,FUN_004603-T2,Peve_00027281,,apul_peve,51.892,FUN_004603-T2,M9NDE3,,,,,19.3,1279.0,1.1e-13,81.6,sp|M9NDE3|BARK_DROME Protein bark beetle OS=Drosophila melanogaster OX=7227 GN=bark PE=1 SV=1,,,,,,
OG_10651,FUN_004605-T1,Peve_00027283,,apul_peve,59.8745,,,,,,,,,,,,,,,,,
OG_10652,FUN_004609-T2,Peve_00015876,,apul_peve,64.6345,FUN_004609-T2,Q4LDE5,SVEP1_HUMAN,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)",Homo sapiens (Human),32.0,122.0,2.2e-11,72.8,"sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3",GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193,epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0034330; GO:0043226; GO:0048856; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell junction organization; organelle; anatomical structure development; cell adhesion mediator activity
OG_10653,FUN_004614-T1,Peve_00002783,,apul_peve,56.432,,,,,,,,,,,,,,,,,
OG_10654,FUN_004619-T1,Peve_00038761,,apul_peve,46.667,,,,,,,,,,,,,,,,,
OG_10655,FUN_004621-T1,Peve_00036226,,apul_peve,55.804,,,,,,,,,,,,,,,,,
OG_10656,FUN_004623-T1,Peve_00039251,,apul_peve,56.401,FUN_004623-T1,Q8K4Z4,,,,,24.2,326.0,3.1e-10,67.4,sp|Q8K4Z4|ADRB2_CAVPO Beta-2 adrenergic receptor OS=Cavia porcellus OX=10141 GN=Adrb2 PE=3 SV=1,,,,,,
OG_10657,FUN_004628-T1,Peve_00013937,,apul_peve,55.27,FUN_004628-T1,P0C5E4,PTPRQ_MOUSE,,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.36) (EC 3.1.3.67) (EC 3.1.3.86) (EC 3.1.3.95) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q),Mus musculus (Mouse),23.4,1124.0,1.2e-42,177.6,sp|P0C5E4|PTPRQ_MOUSE Phosphatidylinositol phosphatase PTPRQ OS=Mus musculus OX=10090 GN=Ptprq PE=1 SV=1,GO:0002244; GO:0004439; GO:0004725; GO:0009925; GO:0016314; GO:0016324; GO:0032421; GO:0034485; GO:0042472; GO:0043813; GO:0045598; GO:0050885; GO:0050910; GO:0052629; GO:0060116; GO:0120044,detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; stereocilium base [GO:0120044]; stereocilium bundle [GO:0032421],"phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; protein tyrosine phosphatase activity [GO:0004725]",GO:0003824; GO:0016787; GO:0030154; GO:0050877; GO:0140096,"catalytic activity; hydrolase activity; cell differentiation; nervous system process; catalytic activity, acting on a protein"
OG_10658,FUN_004629-T1,Peve_00027256,,apul_peve,47.033,FUN_004629-T1,P12263,,,,,30.8,172.0,1.8e-16,89.7,sp|P12263|FA8_PIG Coagulation factor VIII OS=Sus scrofa OX=9823 GN=F8 PE=1 SV=2,,,,,,
OG_10659,FUN_004634-T1,Peve_00039277,,apul_peve,59.36,FUN_004634-T1,O95395,,,,,35.2,341.0,1.2e-58,228.8,"sp|O95395|GCNT3_HUMAN Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 OS=Homo sapiens OX=9606 GN=GCNT3 PE=1 SV=1",,,,,,
OG_10660,FUN_004636-T1,Peve_00027506,,apul_peve,56.686,,,,,,,,,,,,,,,,,
OG_10661,FUN_004637-T1,Peve_00039271,,apul_peve,42.604,,,,,,,,,,,,,,,,,
OG_10662,FUN_004646-T1,Peve_00006483,,apul_peve,40.047,FUN_004646-T1,P48442,CASR_RAT,,Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor) (PCaR1) (RaKCaR),Rattus norvegicus (Rat),29.9,904.0,2.7e-92,341.7,sp|P48442|CASR_RAT Extracellular calcium-sensing receptor OS=Rattus norvegicus OX=10116 GN=Casr PE=1 SV=1,GO:0001503; GO:0002931; GO:0004930; GO:0005178; GO:0005509; GO:0005513; GO:0005886; GO:0006874; GO:0007186; GO:0007193; GO:0007200; GO:0007254; GO:0008284; GO:0009986; GO:0010038; GO:0010628; GO:0016323; GO:0016324; GO:0016597; GO:0019901; GO:0030424; GO:0032024; GO:0032782; GO:0035729; GO:0042311; GO:0042734; GO:0042803; GO:0043025; GO:0043679; GO:0044325; GO:0045907; GO:0048754; GO:0050927; GO:0051592; GO:0051924; GO:0060613; GO:0070374; GO:0070509; GO:0071305; GO:0071333; GO:0071404; GO:0071456; GO:0071774; GO:0090280; GO:0098978; GO:0099505; GO:1901653; GO:1902476,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; bile acid secretion [GO:0032782]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium ion import [GO:0070509]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to hypoxia [GO:0071456]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to peptide [GO:1901653]; cellular response to vitamin D [GO:0071305]; chloride transmembrane transport [GO:1902476]; detection of calcium ion [GO:0005513]; fat pad development [GO:0060613]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular calcium ion homeostasis [GO:0006874]; JNK cascade [GO:0007254]; ossification [GO:0001503]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of vasoconstriction [GO:0045907]; regulation of calcium ion transport [GO:0051924]; regulation of presynaptic membrane potential [GO:0099505]; response to calcium ion [GO:0051592]; response to fibroblast growth factor [GO:0071774]; response to ischemia [GO:0002931]; response to metal ion [GO:0010038]; vasodilation [GO:0042311],apical plasma membrane [GO:0016324]; axon [GO:0030424]; axon terminus [GO:0043679]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734],amino acid binding [GO:0016597]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; integrin binding [GO:0005178]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transmembrane transporter binding [GO:0044325],GO:0003013; GO:0005886; GO:0048856; GO:0055085; GO:0060089,circulatory system process; plasma membrane; anatomical structure development; transmembrane transport; molecular transducer activity
OG_10663,FUN_004655-T1,Peve_00014671,,apul_peve,59.144,,,,,,,,,,,,,,,,,
OG_10664,FUN_004666-T1,Peve_00011961,,apul_peve,48.8585,,,,,,,,,,,,,,,,,
OG_10665,FUN_004688-T1,Peve_00000669,,apul_peve,42.045,,,,,,,,,,,,,,,,,
OG_10666,FUN_004703-T1,Peve_00044683,,apul_peve,37.374,,,,,,,,,,,,,,,,,
OG_10667,FUN_004704-T1,Peve_00005094,,apul_peve,31.959,,,,,,,,,,,,,,,,,
OG_10668,FUN_004709-T1,Peve_00005087,,apul_peve,83.757,FUN_004709-T1,Q8IY17,,,,,47.7,1311.0,0.0,1118.2,sp|Q8IY17|PLPL6_HUMAN Patatin-like phospholipase domain-containing protein 6 OS=Homo sapiens OX=9606 GN=PNPLA6 PE=1 SV=3,,,,,,
OG_10669,FUN_004713-T1,Peve_00005081,,apul_peve,64.0,FUN_004713-T1,P42289,,,,,32.7,330.0,7.8e-32,139.4,sp|P42289|DRD1_XENLA D(1A) dopamine receptor OS=Xenopus laevis OX=8355 GN=drd1 PE=2 SV=1,,,,,,
OG_10670,FUN_004728-T1,Peve_00003872,,apul_peve,44.61,,,,,,,,,,,,,,,,,
OG_10671,FUN_004731-T1,Peve_00015877,,apul_peve,47.043,,,,,,,,,,,,,,,,,
OG_10672,FUN_004739-T1,Peve_00037687,,apul_peve,70.508,FUN_004739-T1,Q3TTL0,,,,,38.3,274.0,2.4e-47,190.7,sp|Q3TTL0|CC038_MOUSE Uncharacterized protein C3orf38 homolog OS=Mus musculus OX=10090 PE=2 SV=1,,,,,,
OG_10673,FUN_004757-T1,Peve_00003221,,apul_peve,75.72,FUN_004757-T1,Q6ZNF0,,,,,34.3,435.0,3.7e-63,243.8,sp|Q6ZNF0|ACP7_HUMAN Acid phosphatase type 7 OS=Homo sapiens OX=9606 GN=ACP7 PE=1 SV=2,,,,,,
OG_10674,FUN_004758-T1,Peve_00019320,,apul_peve,66.248,FUN_004758-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),24.1,336.0,4.4e-10,67.0,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_10675,FUN_004759-T1,Peve_00007777,,apul_peve,57.3725,FUN_004759-T1,Q8IZJ3,CPMD8_HUMAN,,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8,Homo sapiens (Human),28.4,735.0,1.3000000000000002e-57,226.1,sp|Q8IZJ3|CPMD8_HUMAN C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8 OS=Homo sapiens OX=9606 GN=CPAMD8 PE=1 SV=2,GO:0001654; GO:0004867; GO:0005615; GO:0005886,eye development [GO:0001654],extracellular space [GO:0005615]; plasma membrane [GO:0005886],serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005615; GO:0005886; GO:0048856; GO:0098772,extracellular space; plasma membrane; anatomical structure development; molecular function regulator activity
OG_10676,FUN_004788-T1,Peve_00042927,,apul_peve,55.862,FUN_004788-T1,P79166,,,,,27.8,277.0,1.5e-11,72.0,sp|P79166|MSHR_HORSE Melanocyte-stimulating hormone receptor OS=Equus caballus OX=9796 GN=MC1R PE=3 SV=2,,,,,,
OG_10677,FUN_004798-T1,Peve_00010274,,apul_peve,73.9355,FUN_004798-T1,Q95M17,CHIA_BOVIN,,Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04),Bos taurus (Bovine),49.1,393.0,1.7e-103,377.9,sp|Q95M17|CHIA_BOVIN Acidic mammalian chitinase OS=Bos taurus OX=9913 GN=CHIA PE=1 SV=1,GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0008843; GO:0032722,apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005975; GO:0012501; GO:0016787; GO:1901135,immune system process; catalytic activity; extracellular region; extracellular space; carbohydrate metabolic process; programmed cell death; hydrolase activity; carbohydrate derivative metabolic process
OG_10678,FUN_004802-T1,Peve_00010276,,apul_peve,39.91,,,,,,,,,,,,,,,,,
OG_10679,FUN_004814-T1,Peve_00023836,,apul_peve,62.988,,,,,,,,,,,,,,,,,
OG_10680,FUN_004848-T1,Peve_00043718,,apul_peve,70.543,FUN_004848-T1,Q8BYH3,,,,,38.2,482.0,6.9e-87,322.8,sp|Q8BYH3|TRM13_MOUSE tRNA:m(4)X modification enzyme TRM13 homolog OS=Mus musculus OX=10090 GN=Trmt13 PE=2 SV=1,,,,,,
OG_10681,FUN_004871-T2,Peve_00043735,,apul_peve,55.662,FUN_004871-T2,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),47.4,340.0,8e-101,370.2,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_10682,FUN_004879-T2,Peve_00044554,,apul_peve,41.337,FUN_004879-T2,P00973,OAS1_HUMAN,,2'-5'-oligoadenylate synthase 1 ((2-5')oligo(A) synthase 1) (2-5A synthase 1) (EC 2.7.7.84) (E18/E16) (p46/p42 OAS),Homo sapiens (Human),29.1,326.0,8.000000000000001e-34,146.0,sp|P00973|OAS1_HUMAN 2'-5'-oligoadenylate synthase 1 OS=Homo sapiens OX=9606 GN=OAS1 PE=1 SV=4,GO:0001730; GO:0003725; GO:0005524; GO:0005576; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0006006; GO:0009615; GO:0016020; GO:0032728; GO:0032760; GO:0034138; GO:0034142; GO:0035457; GO:0035458; GO:0042593; GO:0042742; GO:0043129; GO:0045071; GO:0046872; GO:0051259; GO:0051607; GO:0060337; GO:0060339; GO:0060700; GO:0070106; GO:0071360; GO:0071639; GO:0071659; GO:0098586; GO:0140374; GO:1901857; GO:2000342,antiviral innate immune response [GO:0140374]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; interleukin-27-mediated signaling pathway [GO:0070106]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of IP-10 production [GO:0071659]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cellular respiration [GO:1901857]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of tumor necrosis factor production [GO:0032760]; protein complex oligomerization [GO:0051259]; regulation of ribonuclease activity [GO:0060700]; response to virus [GO:0009615]; surfactant homeostasis [GO:0043129]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; type I interferon-mediated signaling pathway [GO:0060337],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840],2'-5'-oligoadenylate synthetase activity [GO:0001730]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872],GO:0002376; GO:0003723; GO:0003824; GO:0005576; GO:0005634; GO:0005654; GO:0005739; GO:0005783; GO:0005829; GO:0005840; GO:0005975; GO:0016740; GO:0043226; GO:0065003; GO:0098542,immune system process; RNA binding; catalytic activity; extracellular region; nucleus; nucleoplasm; mitochondrion; endoplasmic reticulum; cytosol; ribosome; carbohydrate metabolic process; transferase activity; organelle; protein-containing complex assembly; defense response to other organism
OG_10683,FUN_004883-T1,Peve_00007982,,apul_peve,71.264,,,,,,,,,,,,,,,,,
OG_10684,FUN_004893-T1,Peve_00043721,,apul_peve,66.304,FUN_004893-T1,Q6DIP8,,,,,46.4,375.0,3.8e-85,316.6,sp|Q6DIP8|ARB2A_XENTR Cotranscriptional regulator ARB2A homolog OS=Xenopus tropicalis OX=8364 GN=arb2a PE=2 SV=2,,,,,,
OG_10685,FUN_004927-T1,Peve_00034770,,apul_peve,74.902,FUN_004927-T1,O42358,RX3_DANRE,,Retinal homeobox protein Rx3,Danio rerio (Zebrafish) (Brachydanio rerio),48.7,191.0,1.8e-33,144.4,sp|O42358|RX3_DANRE Retinal homeobox protein Rx3 OS=Danio rerio OX=7955 GN=rx3 PE=2 SV=1,GO:0000978; GO:0000981; GO:0001654; GO:0001708; GO:0001755; GO:0005634; GO:0006357; GO:0021854; GO:0021984; GO:0030900; GO:0045944; GO:0048593; GO:0048596; GO:0060041; GO:0060898,adenohypophysis development [GO:0021984]; camera-type eye morphogenesis [GO:0048593]; cell fate specification [GO:0001708]; embryonic camera-type eye morphogenesis [GO:0048596]; eye development [GO:0001654]; eye field cell fate commitment involved in camera-type eye formation [GO:0060898]; forebrain development [GO:0030900]; hypothalamus development [GO:0021854]; neural crest cell migration [GO:0001755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_10686,FUN_004966-T1,Peve_00018074,,apul_peve,48.438,,,,,,,,,,,,,,,,,
OG_10687,FUN_004967-T1,Peve_00043268,,apul_peve,60.0,FUN_004967-T1,P79748,,,,,27.7,159.0,1e-08,62.8,sp|P79748|5HT1D_TAKRU 5-hydroxytryptamine receptor 1D OS=Takifugu rubripes OX=31033 GN=htr1d PE=3 SV=1,,,,,,
OG_10688,FUN_004972-T1,Peve_00043768,,apul_peve,76.0,,,,,,,,,,,,,,,,,
OG_10689,FUN_004973-T1,Peve_00027459,,apul_peve,66.667,FUN_004973-T1,Q9FT73,,,,,27.9,473.0,6.2e-36,153.7,sp|Q9FT73|RECQ2_ARATH ATP-dependent DNA helicase Q-like 2 OS=Arabidopsis thaliana OX=3702 GN=RECQL2 PE=1 SV=1,,,,,,
OG_10690,FUN_004978-T1,Peve_00035393,,apul_peve,43.644,,,,,,,,,,,,,,,,,
OG_10691,FUN_004980-T2,Peve_00017620,,apul_peve,46.7555,FUN_004980-T2,P04157,,,,,34.2,307.0,2.9e-34,149.4,sp|P04157|PTPRC_RAT Receptor-type tyrosine-protein phosphatase C OS=Rattus norvegicus OX=10116 GN=Ptprc PE=1 SV=2,,,,,,
OG_10692,FUN_004987-T1,Peve_00006180,,apul_peve,45.907,,,,,,,,,,,,,,,,,
OG_10693,FUN_004991-T1,Peve_00015852,,apul_peve,65.482,,,,,,,,,,,,,,,,,
OG_10694,FUN_005025-T1,Peve_00028652,,apul_peve,61.314,FUN_005025-T1,B4LZT9,HH_DROVI,,Protein hedgehog (EC 3.1.-.-) [Cleaved into: Protein hedgehog N-product],Drosophila virilis (Fruit fly),31.4,207.0,3.3e-21,104.4,sp|B4LZT9|HH_DROVI Protein hedgehog OS=Drosophila virilis OX=7244 GN=hh PE=3 SV=1,GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005634; GO:0005737; GO:0005886; GO:0007224; GO:0007267; GO:0007367; GO:0008233; GO:0009653; GO:0010468; GO:0016015; GO:0016539; GO:0016540; GO:0048731; GO:0097264; GO:0140853,anatomical structure morphogenesis [GO:0009653]; cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; intein-mediated protein splicing [GO:0016539]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; segment polarity determination [GO:0007367]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224]; system development [GO:0048731],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; peptidase activity [GO:0008233],GO:0003824; GO:0005615; GO:0005634; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0043226; GO:0048018; GO:0048856; GO:0051604; GO:0098772; GO:0140096,"catalytic activity; extracellular space; nucleus; plasma membrane; transferase activity; hydrolase activity; signaling; organelle; receptor ligand activity; anatomical structure development; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10695,FUN_005030-T1,Peve_00028656,,apul_peve,64.478,FUN_005030-T1,Q6P839,,,,,58.5,123.0,6.300000000000001e-36,152.9,sp|Q6P839|FOXA4_XENTR Forkhead box protein A4 OS=Xenopus tropicalis OX=8364 GN=foxa4 PE=2 SV=1,,,,,,
OG_10696,FUN_005044-T1,Peve_00031048,,apul_peve,75.148,,,,,,,,,,,,,,,,,
OG_10697,FUN_005070-T1,Peve_00022508,,apul_peve,79.926,,,,,,,,,,,,,,,,,
OG_10698,FUN_005075-T2,Peve_00021447,,apul_peve,95.477,FUN_005075-T2,Q95P04,,,,,98.4,186.0,4.5e-109,395.2,sp|Q95P04|NFCP_GONTE GFP-like non-fluorescent chromoprotein OS=Goniopora tenuidens OX=75301 PE=1 SV=1,,,,,,
OG_10699,FUN_005090-T1,Peve_00018082,,apul_peve,95.0,FUN_005090-T1,Q95P04,,,,,96.8,221.0,1.6e-128,459.9,sp|Q95P04|NFCP_GONTE GFP-like non-fluorescent chromoprotein OS=Goniopora tenuidens OX=75301 PE=1 SV=1,,,,,,
OG_10700,FUN_005103-T1,Peve_00007474,,apul_peve,63.433,,,,,,,,,,,,,,,,,
OG_10701,FUN_005121-T1,Peve_00026680,,apul_peve,57.5135,FUN_005121-T1,Q26486,FKBP4_SPOFR,,46 kDa FK506-binding nuclear protein (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase) (PPIase) (Rotamase),Spodoptera frugiperda (Fall armyworm),48.7,458.0,9.400000000000001e-30,132.9,sp|Q26486|FKBP4_SPOFR 46 kDa FK506-binding nuclear protein OS=Spodoptera frugiperda OX=7108 GN=FKBP46 PE=2 SV=1,GO:0000785; GO:0003677; GO:0003755; GO:0005730,,chromatin [GO:0000785]; nucleolus [GO:0005730],DNA binding [GO:0003677]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003677; GO:0003824; GO:0005730; GO:0016853; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleolus; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_10702,FUN_005134-T1,Peve_00026673,,apul_peve,37.2665,,,,,,,,,,,,,,,,,
OG_10703,FUN_005139-T1,Peve_00009386,,apul_peve,44.776,,,,,,,,,,,,,,,,,
OG_10704,FUN_005163-T1,Peve_00015382,,apul_peve,49.087,FUN_005163-T1,Q9BU70,,,,,38.1,431.0,3.1e-60,234.2,sp|Q9BU70|TRMO_HUMAN tRNA (adenine(37)-N6)-methyltransferase OS=Homo sapiens OX=9606 GN=TRMO PE=1 SV=2,,,,,,
OG_10705,FUN_005187-T1,Peve_00017155,,apul_peve,69.737,,,,,,,,,,,,,,,,,
OG_10706,FUN_005188-T1,Peve_00017154,,apul_peve,57.955,FUN_005188-T1,Q58CR4,,,,,40.4,317.0,4.5e-55,216.5,sp|Q58CR4|DOLK_BOVIN Dolichol kinase OS=Bos taurus OX=9913 GN=DOLK PE=2 SV=1,,,,,,
OG_10707,FUN_005190-T1,Peve_00033575,,apul_peve,53.602,,,,,,,,,,,,,,,,,
OG_10708,FUN_005191-T2,Peve_00017152,,apul_peve,37.349,,,,,,,,,,,,,,,,,
OG_10709,FUN_005200-T1,Peve_00017147,,apul_peve,69.705,FUN_005200-T1,Q6P3P5,,,,,31.6,225.0,3.7999999999999995e-24,114.0,"sp|Q6P3P5|B3GN5_XENTR Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase OS=Xenopus tropicalis OX=8364 GN=b3gnt5 PE=2 SV=1",,,,,,
OG_10710,FUN_005201-T1,Peve_00017149,,apul_peve,56.65,FUN_005201-T1,Q5XGM3,,,,,57.4,394.0,6.4e-131,468.8,sp|Q5XGM3|BHMT1_XENLA Betaine--homocysteine S-methyltransferase 1 OS=Xenopus laevis OX=8355 GN=bhmt PE=2 SV=1,,,,,,
OG_10711,FUN_005212-T1,Peve_00035496,,apul_peve,65.72550000000001,FUN_005212-T1,Q21974,UNC8_CAEEL,,Degenerin unc-8 (Putative ligand-gated sodium channel unc-8) (Uncoordinated protein 8),Caenorhabditis elegans,32.4,336.0,8.000000000000001e-39,162.9,sp|Q21974|UNC8_CAEEL Degenerin unc-8 OS=Caenorhabditis elegans OX=6239 GN=unc-8 PE=2 SV=1,GO:0005261; GO:0005886; GO:0006812; GO:0015280; GO:0016322; GO:0035725; GO:0040011; GO:0043025,locomotion [GO:0040011]; monoatomic cation transport [GO:0006812]; neuron remodeling [GO:0016322]; sodium ion transmembrane transport [GO:0035725],neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_10712,FUN_005219-T1,Peve_00035488,,apul_peve,61.847,FUN_005219-T1,Q5BCH7,,,,,31.7,186.0,1.2e-13,78.6,"sp|Q5BCH7|FMP52_EMENI Protein fmp52, mitochondrial OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=fmp52 PE=3 SV=1",,,,,,
OG_10713,FUN_005255-T1,Peve_00018468,,apul_peve,45.55,,,,,,,,,,,,,,,,,
OG_10714,FUN_005269-T1,Peve_00003343,,apul_peve,62.676,,,,,,,,,,,,,,,,,
OG_10715,FUN_005273-T2,Peve_00003338,,apul_peve,60.364,,,,,,,,,,,,,,,,,
OG_10716,FUN_005301-T1,Peve_00006824,,apul_peve,39.08,,,,,,,,,,,,,,,,,
OG_10717,FUN_005312-T1,Peve_00034275,,apul_peve,40.359,,,,,,,,,,,,,,,,,
OG_10718,FUN_005340-T1,Peve_00035215,,apul_peve,62.745,FUN_005340-T1,P20397,,,,,42.1,76.0,6.7e-06,52.0,sp|P20397|NUCL_XENLA Nucleolin OS=Xenopus laevis OX=8355 GN=ncl PE=2 SV=3,,,,,,
OG_10719,FUN_005360-T1,Peve_00016033,,apul_peve,55.63,,,,,,,,,,,,,,,,,
OG_10720,FUN_005376-T1,Peve_00021806,,apul_peve,52.381,,,,,,,,,,,,,,,,,
OG_10721,FUN_005384-T1,Peve_00027156,,apul_peve,63.889,FUN_005384-T1,Q5TYW4,NBAS_DANRE,,NBAS subunit of NRZ tethering complex (Neuroblastoma-amplified gene protein homolog) (Neuroblastoma-amplified sequence),Danio rerio (Zebrafish) (Brachydanio rerio),34.7,975.0,1.1e-142,509.2,sp|Q5TYW4|NBAS_DANRE NBAS subunit of NRZ tethering complex OS=Danio rerio OX=7955 GN=nbas PE=2 SV=1,GO:0000149; GO:0000184; GO:0000956; GO:0006890; GO:0015031; GO:0043009; GO:0048703; GO:0070939; GO:2000623,"chordate embryonic development [GO:0043009]; embryonic viscerocranium morphogenesis [GO:0048703]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",Dsl1/NZR complex [GO:0070939],SNARE binding [GO:0000149],GO:0016071; GO:0016192; GO:0048856,mRNA metabolic process; vesicle-mediated transport; anatomical structure development
OG_10722,FUN_005385-T1,Peve_00044214,,apul_peve,68.3955,FUN_005385-T1,A2RRP1,NBAS_HUMAN,,NBAS subunit of NRZ tethering complex (Neuroblastoma-amplified gene protein) (Neuroblastoma-amplified sequence),Homo sapiens (Human),43.5,1246.0,3.1e-272,939.9,sp|A2RRP1|NBAS_HUMAN NBAS subunit of NRZ tethering complex OS=Homo sapiens OX=9606 GN=NBAS PE=1 SV=2,GO:0000149; GO:0000956; GO:0005783; GO:0005789; GO:0005829; GO:0006890; GO:0015031; GO:0016020; GO:0070939; GO:2000623,"negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],SNARE binding [GO:0000149],GO:0005783; GO:0005829; GO:0016071; GO:0016192; GO:0043226,endoplasmic reticulum; cytosol; mRNA metabolic process; vesicle-mediated transport; organelle
OG_10723,FUN_005420-T1,Peve_00032387,,apul_peve,71.127,,,,,,,,,,,,,,,,,
OG_10724,FUN_005423-T1,Peve_00032388,,apul_peve,61.832,,,,,,,,,,,,,,,,,
OG_10725,FUN_005454-T2,Peve_00002284,,apul_peve,75.916,FUN_005454-T2,P24367,,,,,76.6,175.0,1.4e-78,293.9,sp|P24367|PPIB_CHICK Peptidyl-prolyl cis-trans isomerase B OS=Gallus gallus OX=9031 GN=PPIB PE=2 SV=1,,,,,,
OG_10726,FUN_005464-T1,Peve_00033809,,apul_peve,51.568,FUN_005464-T1,Q6PD74,AAGAB_HUMAN,,Alpha- and gamma-adaptin-binding protein p34,Homo sapiens (Human),30.9,291.0,8.4e-26,119.0,sp|Q6PD74|AAGAB_HUMAN Alpha- and gamma-adaptin-binding protein p34 OS=Homo sapiens OX=9606 GN=AAGAB PE=1 SV=1,GO:0005737; GO:0005829; GO:0015031; GO:0016607,protein transport [GO:0015031],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607],,GO:0005829; GO:0043226,cytosol; organelle
OG_10727,FUN_005477-T1,Peve_00024775,,apul_peve,40.217,,,,,,,,,,,,,,,,,
OG_10728,FUN_005497-T1,Peve_00042203,,apul_peve,50.286,,,,,,,,,,,,,,,,,
OG_10729,FUN_005679-T1,Peve_00009779,,apul_peve,33.534,,,,,,,,,,,,,,,,,
OG_10730,FUN_005688-T1,Peve_00039683,,apul_peve,70.109,FUN_005688-T1,Q23915,,,,,28.8,212.0,7.6e-11,69.7,sp|Q23915|KINX_DICDI Probable serine/threonine-protein kinase kinX OS=Dictyostelium discoideum OX=44689 GN=kinX PE=3 SV=2,,,,,,
OG_10731,FUN_005707-T1,Peve_00039687,,apul_peve,38.393,,,,,,,,,,,,,,,,,
OG_10732,FUN_005818-T1,Peve_00040484,,apul_peve,37.359,,,,,,,,,,,,,,,,,
OG_10733,FUN_005820-T1,Peve_00034065,,apul_peve,68.031,,,,,,,,,,,,,,,,,
OG_10734,FUN_005840-T1,Peve_00001400,,apul_peve,54.167,,,,,,,,,,,,,,,,,
OG_10735,FUN_005863-T1,Peve_00007479,,apul_peve,58.442,,,,,,,,,,,,,,,,,
OG_10736,FUN_005902-T1,Peve_00038133,,apul_peve,60.317,,,,,,,,,,,,,,,,,
OG_10737,FUN_005911-T1,Peve_00008483,,apul_peve,58.095,FUN_005911-T1,Q4AC94,C2CD3_HUMAN,,C2 domain-containing protein 3,Homo sapiens (Human),30.9,456.0,1.2e-32,142.5,sp|Q4AC94|C2CD3_HUMAN C2 domain-containing protein 3 OS=Homo sapiens OX=9606 GN=C2CD3 PE=1 SV=4,GO:0001701; GO:0001947; GO:0005813; GO:0005814; GO:0005815; GO:0005829; GO:0007420; GO:0008589; GO:0016485; GO:0021915; GO:0021997; GO:0030162; GO:0034451; GO:0036064; GO:0042733; GO:0060271; GO:0061511; GO:0071539; GO:1905515,brain development [GO:0007420]; centriole elongation [GO:0061511]; cilium assembly [GO:0060271]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815],,GO:0005815; GO:0005829; GO:0043226; GO:0044782; GO:0048856; GO:0051604,microtubule organizing center; cytosol; organelle; cilium organization; anatomical structure development; protein maturation
OG_10738,FUN_005915-T4,Peve_00008477,,apul_peve,82.399,FUN_005915-T4,A7Y2X0,,,,,38.2,573.0,4.5e-108,393.7,sp|A7Y2X0|SC6A5_XENLA Sodium- and chloride-dependent glycine transporter 2 OS=Xenopus laevis OX=8355 GN=slc6a5 PE=2 SV=1,,,,,,
OG_10739,FUN_005919-T1,Peve_00029739,,apul_peve,65.0,,,,,,,,,,,,,,,,,
OG_10740,FUN_005921-T1,Peve_00020258,,apul_peve,60.659,,,,,,,,,,,,,,,,,
OG_10741,FUN_005925-T1,Peve_00014632,,apul_peve,43.8465,,,,,,,,,,,,,,,,,
OG_10742,FUN_005936-T1,Peve_00042836,,apul_peve,56.193,FUN_005936-T1,Q60629,EPHA5_MOUSE,,Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (CEK-7) (EPH homology kinase 1) (EHK-1),Mus musculus (Mouse),29.4,170.0,2.3e-08,61.6,sp|Q60629|EPHA5_MOUSE Ephrin type-A receptor 5 OS=Mus musculus OX=10090 GN=Epha5 PE=1 SV=2,GO:0005003; GO:0005004; GO:0005524; GO:0005886; GO:0005912; GO:0007162; GO:0007411; GO:0021766; GO:0030424; GO:0030425; GO:0032793; GO:0032956; GO:0043087; GO:0048013; GO:0061178; GO:0071372; GO:0071944; GO:1904322,axon guidance [GO:0007411]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to forskolin [GO:1904322]; ephrin receptor signaling pathway [GO:0048013]; hippocampus development [GO:0021766]; negative regulation of cell adhesion [GO:0007162]; positive regulation of CREB transcription factor activity [GO:0032793]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178],adherens junction [GO:0005912]; axon [GO:0030424]; cell periphery [GO:0071944]; dendrite [GO:0030425]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004],GO:0003824; GO:0005886; GO:0006355; GO:0016740; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; regulation of DNA-templated transcription; transferase activity; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_10743,FUN_005939-T1,Peve_00000430,,apul_peve,35.378,,,,,,,,,,,,,,,,,
OG_10744,FUN_005942-T2,Peve_00029968,,apul_peve,84.722,,,,,,,,,,,,,,,,,
OG_10745,FUN_005943-T1,Peve_00029987,,apul_peve,89.081,,,,,,,,,,,,,,,,,
OG_10746,FUN_005959-T1,Peve_00005621,,apul_peve,66.393,,,,,,,,,,,,,,,,,
OG_10747,FUN_005960-T1,Peve_00005913,,apul_peve,67.5895,,,,,,,,,,,,,,,,,
OG_10748,FUN_005962-T2,Peve_00008711,,apul_peve,40.265,FUN_005962-T2,Q5R412,,,,,36.0,125.0,1e-09,65.5,sp|Q5R412|NEGR1_PONAB Neuronal growth regulator 1 OS=Pongo abelii OX=9601 GN=NEGR1 PE=2 SV=1,,,,,,
OG_10749,FUN_005985-T1,Peve_00015065,,apul_peve,53.171,FUN_005985-T1,P55115,,,,,41.2,257.0,2.7000000000000004e-44,181.0,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_10750,FUN_005993-T1,Peve_00008881,,apul_peve,70.745,FUN_005993-T1,Q91175,,,,,27.8,371.0,3.4e-28,127.5,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_10751,FUN_005997-T1,Peve_00036049,,apul_peve,74.038,FUN_005997-T1,P23780,BGAL_MOUSE,,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),Mus musculus (Mouse),49.4,648.0,1.4e-175,617.8,sp|P23780|BGAL_MOUSE Beta-galactosidase OS=Mus musculus OX=10090 GN=Glb1 PE=1 SV=1,GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0006516; GO:0006689; GO:0016020; GO:0016787; GO:0016936; GO:0019388; GO:0042340; GO:0042803; GO:0051413; GO:1904016,galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; keratan sulfate proteoglycan catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020],beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0005975; GO:0006629; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; Golgi apparatus; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_10752,FUN_006005-T1,Peve_00004690,,apul_peve,57.436,FUN_006005-T1,Q6P2T7,,,,,49.0,198.0,8.9e-52,204.9,sp|Q6P2T7|CD033_DANRE UPF0462 protein C4orf33 homolog OS=Danio rerio OX=7955 GN=zgc:77739 PE=2 SV=1,,,,,,
OG_10753,FUN_006104-T1,Peve_00017138,,apul_peve,84.561,FUN_006104-T1,Q9UBN7,HDAC6_HUMAN,,Protein deacetylase HDAC6 (EC 3.5.1.-) (E3 ubiquitin-protein ligase HDAC6) (EC 2.3.2.-) (Tubulin-lysine deacetylase HDAC6) (EC 3.5.1.-),Homo sapiens (Human),55.6,286.0,4.5e-89,329.3,sp|Q9UBN7|HDAC6_HUMAN Protein deacetylase HDAC6 OS=Homo sapiens OX=9606 GN=HDAC6 PE=1 SV=2,GO:0000118; GO:0000209; GO:0000978; GO:0001222; GO:0001975; GO:0003779; GO:0004407; GO:0005634; GO:0005654; GO:0005737; GO:0005771; GO:0005813; GO:0005829; GO:0005874; GO:0005875; GO:0005901; GO:0006476; GO:0006515; GO:0006886; GO:0007015; GO:0007026; GO:0007173; GO:0008013; GO:0008017; GO:0008270; GO:0010506; GO:0010634; GO:0010727; GO:0010821; GO:0016234; GO:0016235; GO:0016241; GO:0019896; GO:0019899; GO:0030424; GO:0030425; GO:0031252; GO:0031333; GO:0031593; GO:0031625; GO:0031647; GO:0031648; GO:0032418; GO:0032461; GO:0032984; GO:0033148; GO:0033558; GO:0034605; GO:0035902; GO:0035967; GO:0036064; GO:0036479; GO:0040029; GO:0042030; GO:0042826; GO:0042903; GO:0043014; GO:0043130; GO:0043131; GO:0043162; GO:0043204; GO:0043242; GO:0045598; GO:0045814; GO:0045861; GO:0045892; GO:0048156; GO:0048471; GO:0048487; GO:0048668; GO:0048843; GO:0050775; GO:0051412; GO:0051787; GO:0051788; GO:0051879; GO:0051968; GO:0060271; GO:0060632; GO:0060765; GO:0060997; GO:0061523; GO:0061734; GO:0070201; GO:0070301; GO:0070840; GO:0070842; GO:0070845; GO:0071218; GO:0071374; GO:0071548; GO:0090042; GO:0140374; GO:0141221; GO:1900246; GO:1900409; GO:1903146; GO:1904056; GO:1904115; GO:1905091; GO:1905336,"actin filament organization [GO:0007015]; aggresome assembly [GO:0070842]; antiviral innate immune response [GO:0140374]; axonal transport of mitochondrion [GO:0019896]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; cilium disassembly [GO:0061523]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; epidermal growth factor receptor signaling pathway [GO:0007173]; epigenetic regulation of gene expression [GO:0040029]; erythrocyte enucleation [GO:0043131]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; negative regulation of aggrephagy [GO:1905336]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of cellular response to oxidative stress [GO:1900409]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of type 2 mitophagy [GO:1905091]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of mitochondrion organization [GO:0010821]; regulation of protein stability [GO:0031647]; response to amphetamine [GO:0001975]; response to corticosterone [GO:0051412]; response to dexamethasone [GO:0071548]; response to immobilization stress [GO:0035902]; response to misfolded protein [GO:0051788]; tubulin deacetylation [GO:0090042]; type 2 mitophagy [GO:0061734]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]",aggresome [GO:0016235]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; caveola [GO:0005901]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471],"actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATPase inhibitor activity [GO:0042030]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase activity, hydrolytic mechanism [GO:0141221]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; peroxidase inhibitor activity [GO:0036479]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein lysine deacetylase activity [GO:0033558]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; transcription corepressor binding [GO:0001222]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]",GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0006325; GO:0006355; GO:0006886; GO:0006914; GO:0007018; GO:0008092; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; endosome; microtubule organizing center; cytosol; chromatin organization; regulation of DNA-templated transcription; intracellular protein transport; autophagy; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_10754,FUN_006114-T1,Peve_00011649,,apul_peve,71.166,FUN_006114-T1,Q28558,MTR1L_SHEEP,,Melatonin-related receptor (G protein-coupled receptor 50) (H9),Ovis aries (Sheep),27.0,282.0,7.5e-20,99.8,sp|Q28558|MTR1L_SHEEP Melatonin-related receptor OS=Ovis aries OX=9940 GN=GPR50 PE=2 SV=2,GO:0005886; GO:0008502,,plasma membrane [GO:0005886],melatonin receptor activity [GO:0008502],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_10755,FUN_006119-T2,Peve_00011429,,apul_peve,32.4765,,,,,,,,,,,,,,,,,
OG_10756,FUN_006123-T1,Peve_00002484,,apul_peve,32.7855,,,,,,,,,,,,,,,,,
OG_10757,FUN_006130-T1,Peve_00011425,,apul_peve,59.394,,,,,,,,,,,,,,,,,
OG_10758,FUN_006135-T1,Peve_00008285,,apul_peve,46.5735,FUN_006135-T1,B8V7S0,,,,,80.9,425.0,1e-198,696.0,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10759,FUN_006140-T1,Peve_00044540,,apul_peve,39.1895,FUN_006140-T1,B3EX02,,,,,72.9,388.0,6.2e-166,586.3,sp|B3EX02|MFP1_ACRMI MAM and fibronectin type III domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10760,FUN_006161-T2,Peve_00029981,,apul_peve,47.458,,,,,,,,,,,,,,,,,
OG_10761,FUN_006171-T1,Peve_00020215,,apul_peve,77.72,FUN_006171-T1,Q96CQ1,,,,,44.9,305.0,2e-60,234.2,sp|Q96CQ1|S2536_HUMAN Solute carrier family 25 member 36 OS=Homo sapiens OX=9606 GN=SLC25A36 PE=1 SV=1,,,,,,
OG_10762,FUN_006180-T1,Peve_00003921,,apul_peve,45.946,,,,,,,,,,,,,,,,,
OG_10763,FUN_006191-T1,Peve_00034001,,apul_peve,66.094,,,,,,,,,,,,,,,,,
OG_10764,FUN_006199-T1,Peve_00043607,,apul_peve,52.414,,,,,,,,,,,,,,,,,
OG_10765,FUN_006228-T1,Peve_00025162,,apul_peve,81.266,FUN_006228-T1,Q91YL7,,,,,43.7,732.0,3.9999999999999996e-172,606.7,sp|Q91YL7|PG2IP_MOUSE PGAP2-interacting protein OS=Mus musculus OX=10090 GN=Cwh43 PE=1 SV=1,,,,,,
OG_10766,FUN_006256-T1,Peve_00012683,,apul_peve,68.082,,,,,,,,,,,,,,,,,
OG_10767,FUN_006263-T1,Peve_00042732,,apul_peve,54.286,FUN_006263-T1,P31696,,,,,35.8,165.0,2.6e-25,117.9,sp|P31696|AGRIN_CHICK Agrin OS=Gallus gallus OX=9031 GN=AGRN PE=1 SV=3,,,,,,
OG_10768,FUN_006277-T1,Peve_00032495,,apul_peve,62.109,FUN_006277-T1,P14207,FOLR2_HUMAN,,"Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP)",Homo sapiens (Human),38.2,228.0,8.7e-45,182.2,sp|P14207|FOLR2_HUMAN Folate receptor beta OS=Homo sapiens OX=9606 GN=FOLR2 PE=1 SV=4,GO:0005542; GO:0005576; GO:0005886; GO:0006954; GO:0007155; GO:0007342; GO:0008284; GO:0009897; GO:0009986; GO:0015884; GO:0035036; GO:0038023; GO:0061714,cell adhesion [GO:0007155]; folic acid transport [GO:0015884]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; inflammatory response [GO:0006954]; positive regulation of cell population proliferation [GO:0008284]; sperm-egg recognition [GO:0035036],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],folic acid binding [GO:0005542]; folic acid receptor activity [GO:0061714]; signaling receptor activity [GO:0038023],GO:0005576; GO:0005886; GO:0006954; GO:0007155; GO:0022414; GO:0038024; GO:0060089; GO:0061024,extracellular region; plasma membrane; inflammatory response; cell adhesion; reproductive process; cargo receptor activity; molecular transducer activity; membrane organization
OG_10769,FUN_006291-T1,Peve_00008706,,apul_peve,63.725,,,,,,,,,,,,,,,,,
OG_10770,FUN_006325-T1,Peve_00012588,,apul_peve,38.009,,,,,,,,,,,,,,,,,
OG_10771,FUN_006334-T1,Peve_00037431,,apul_peve,67.284,FUN_006334-T1,Q1JPS6,OPN4L_DANRE,,Melanopsin-like (Melanopsin) (Opsin-4-like),Danio rerio (Zebrafish) (Brachydanio rerio),29.5,319.0,4.6e-17,90.5,sp|Q1JPS6|OPN4L_DANRE Melanopsin-like OS=Danio rerio OX=7955 GN=opn4l PE=2 SV=1,GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0009881; GO:0030265; GO:0071482; GO:1904059,cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; phospholipase C-activating opsin-mediated signaling pathway [GO:0030265]; phototransduction [GO:0007602]; regulation of locomotor rhythm [GO:1904059]; visual perception [GO:0007601],plasma membrane [GO:0005886],G protein-coupled photoreceptor activity [GO:0008020]; photoreceptor activity [GO:0009881],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_10772,FUN_006376-T1,Peve_00021374,,apul_peve,48.695,,,,,,,,,,,,,,,,,
OG_10773,FUN_006409-T1,Peve_00027297,,apul_peve,36.0745,,,,,,,,,,,,,,,,,
OG_10774,FUN_006413-T1,Peve_00018196,,apul_peve,71.875,FUN_006413-T1,Q9ESQ4,NMUR2_RAT,,Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor TGR-1) (G-protein-coupled receptor FM-4),Rattus norvegicus (Rat),25.9,352.0,1.5e-12,75.5,sp|Q9ESQ4|NMUR2_RAT Neuromedin-U receptor 2 OS=Rattus norvegicus OX=10116 GN=Nmur2 PE=1 SV=2,GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0051930,arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265],membrane [GO:0016020]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188],GO:0005215; GO:0005886; GO:0060089,transporter activity; plasma membrane; molecular transducer activity
OG_10775,FUN_006416-T1,Peve_00043555,,apul_peve,75.41,FUN_006416-T1,Q8N695,SC5A8_HUMAN,,Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8),Homo sapiens (Human),41.9,532.0,1.2e-106,388.7,sp|Q8N695|SC5A8_HUMAN Sodium-coupled monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC5A8 PE=1 SV=2,GO:0000811; GO:0005343; GO:0005886; GO:0006811; GO:0006814; GO:0006821; GO:0006846; GO:0006848; GO:0006915; GO:0008028; GO:0015129; GO:0015552; GO:0015705; GO:0015706; GO:0015727; GO:0015730; GO:0016324; GO:0070062; GO:0140161; GO:0160081; GO:2001142,acetate transport [GO:0006846]; apoptotic process [GO:0006915]; chloride transport [GO:0006821]; iodide transport [GO:0015705]; lactate transport [GO:0015727]; monoatomic ion transport [GO:0006811]; nicotinate transport [GO:2001142]; nitrate transmembrane transport [GO:0015706]; propanoate transmembrane transport [GO:0015730]; pyruvate transport [GO:0006848]; sodium ion transport [GO:0006814],apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; GINS complex [GO:0000811]; plasma membrane [GO:0005886],iodide channel activity [GO:0160081]; lactate transmembrane transporter activity [GO:0015129]; monocarboxylate:sodium symporter activity [GO:0140161]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; organic acid:sodium symporter activity [GO:0005343]; propionate transmembrane transporter activity [GO:0015552],GO:0005215; GO:0005886; GO:0012501; GO:0043226; GO:0055085,transporter activity; plasma membrane; programmed cell death; organelle; transmembrane transport
OG_10776,FUN_006433-T1,Peve_00024933,,apul_peve,96.269,FUN_006433-T1,P35061,,,,,98.1,104.0,7.9e-50,198.0,sp|P35061|H2A_ACRFO Histone H2A OS=Acropora formosa OX=126732 PE=3 SV=2,,,,,,
OG_10777,FUN_006454-T1,Peve_00008468,,apul_peve,46.914,,,,,,,,,,,,,,,,,
OG_10778,FUN_006460-T1,Peve_00040547,,apul_peve,55.805,,,,,,,,,,,,,,,,,
OG_10779,FUN_006532-T1,Peve_00012372,,apul_peve,85.465,,,,,,,,,,,,,,,,,
OG_10780,FUN_006569-T1,Peve_00038416,,apul_peve,71.277,,,,,,,,,,,,,,,,,
OG_10781,FUN_006575-T1,Peve_00011462,,apul_peve,65.714,FUN_006575-T1,Q63447,,,,,30.3,241.0,7e-19,95.9,sp|Q63447|NPY4R_RAT Neuropeptide Y receptor type 4 OS=Rattus norvegicus OX=10116 GN=Npy4r PE=2 SV=1,,,,,,
OG_10782,FUN_006577-T1,Peve_00011456,,apul_peve,56.954,FUN_006577-T1,P30098,,,,,27.9,283.0,3.4e-13,77.4,sp|P30098|NK3R_CAVPO Neuromedin-K receptor OS=Cavia porcellus OX=10141 GN=TACR3 PE=2 SV=1,,,,,,
OG_10783,FUN_006582-T1,Peve_00031279,,apul_peve,45.578,FUN_006582-T1,P98160,PGBM_HUMAN,,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide],Homo sapiens (Human),21.7,423.0,1e-09,67.4,sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4,GO:0001525; GO:0001540; GO:0001666; GO:0001938; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005796; GO:0005886; GO:0005925; GO:0006629; GO:0006898; GO:0006954; GO:0007162; GO:0007224; GO:0007420; GO:0007566; GO:0008285; GO:0009410; GO:0016525; GO:0030021; GO:0030154; GO:0031100; GO:0043005; GO:0043202; GO:0050750; GO:0062023; GO:0070052; GO:0070062; GO:0072359; GO:0098797,angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell differentiation [GO:0030154]; circulatory system development [GO:0072359]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of endothelial cell proliferation [GO:0001938]; receptor-mediated endocytosis [GO:0006898]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; smoothened signaling pathway [GO:0007224],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797],amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; low-density lipoprotein particle receptor binding [GO:0050750],GO:0005198; GO:0005576; GO:0005615; GO:0005886; GO:0006629; GO:0006954; GO:0016192; GO:0022414; GO:0030154; GO:0030312; GO:0031012; GO:0043226; GO:0048856,structural molecule activity; extracellular region; extracellular space; plasma membrane; lipid metabolic process; inflammatory response; vesicle-mediated transport; reproductive process; cell differentiation; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_10784,FUN_006589-T1,Peve_00015616,,apul_peve,30.043,,,,,,,,,,,,,,,,,
OG_10785,FUN_006604-T1,Peve_00034376,,apul_peve,43.75,,,,,,,,,,,,,,,,,
OG_10786,FUN_006605-T1,Peve_00011990,,apul_peve,51.678,,,,,,,,,,,,,,,,,
OG_10787,FUN_006610-T1,Peve_00011988,,apul_peve,38.298,,,,,,,,,,,,,,,,,
OG_10788,FUN_006635-T1,Peve_00025751,,apul_peve,62.6665,FUN_006635-T1,O95487,SC24B_HUMAN,,Protein transport protein Sec24B (SEC24-related protein B),Homo sapiens (Human),58.6,766.0,6.999999999999999e-266,918.7,sp|O95487|SC24B_HUMAN Protein transport protein Sec24B OS=Homo sapiens OX=9606 GN=SEC24B PE=1 SV=2,GO:0000149; GO:0001843; GO:0003151; GO:0005789; GO:0005829; GO:0006886; GO:0006888; GO:0008270; GO:0012507; GO:0021747; GO:0030127; GO:0035909; GO:0060088; GO:0060463; GO:0060982; GO:0061156; GO:0070971; GO:0090110; GO:0090178; GO:1901301,aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cochlear nucleus development [GO:0021747]; COPII-coated vesicle cargo loading [GO:0090110]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178],COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507],SNARE binding [GO:0000149]; zinc ion binding [GO:0008270],GO:0005829; GO:0006886; GO:0016192; GO:0048856,cytosol; intracellular protein transport; vesicle-mediated transport; anatomical structure development
OG_10789,FUN_006645-T2,Peve_00029048,,apul_peve,40.36,,,,,,,,,,,,,,,,,
OG_10790,FUN_006657-T1,Peve_00029044,,apul_peve,79.282,FUN_006657-T1,A7RRZ8,NNRD_NEMVE,,ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase),Nematostella vectensis (Starlet sea anemone),54.4,364.0,8.200000000000001e-104,378.6,sp|A7RRZ8|NNRD_NEMVE ATP-dependent (S)-NAD(P)H-hydrate dehydratase OS=Nematostella vectensis OX=45351 GN=v1g162096 PE=3 SV=1,GO:0005524; GO:0046496; GO:0047453; GO:0110051,metabolite repair [GO:0110051]; nicotinamide nucleotide metabolic process [GO:0046496],,ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453],GO:0003824; GO:0016829; GO:0055086,catalytic activity; lyase activity; nucleobase-containing small molecule metabolic process
OG_10791,FUN_006670-T1,Peve_00029053,,apul_peve,45.714,,,,,,,,,,,,,,,,,
OG_10792,FUN_006677-T1,Peve_00015825,,apul_peve,37.766,,,,,,,,,,,,,,,,,
OG_10793,FUN_006679-T1,Peve_00015829,,apul_peve,62.191,FUN_006679-T1,Q3UY23,,,,,27.9,656.0,9e-47,189.9,sp|Q3UY23|FDXA1_MOUSE Ferredoxin-fold anticodon-binding domain-containing protein 1 homolog OS=Mus musculus OX=10090 GN=Fdxacb1 PE=2 SV=2,,,,,,
OG_10794,FUN_006688-T2,Peve_00015824,,apul_peve,43.669,,,,,,,,,,,,,,,,,
OG_10795,FUN_006691-T1,Peve_00029049,,apul_peve,47.253,,,,,,,,,,,,,,,,,
OG_10796,FUN_006701-T1,Peve_00029056,,apul_peve,40.4125,,,,,,,,,,,,,,,,,
OG_10797,FUN_006718-T1,Peve_00022744,,apul_peve,57.137,FUN_006718-T1,O94913,PCF11_HUMAN,,Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11),Homo sapiens (Human),50.3,191.0,1.9e-40,169.9,sp|O94913|PCF11_HUMAN Pre-mRNA cleavage complex 2 protein Pcf11 OS=Homo sapiens OX=9606 GN=PCF11 PE=1 SV=3,GO:0000993; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0180010,"co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; termination of RNA polymerase II transcription [GO:0006369]",cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993],GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mitochondrion; mRNA metabolic process; organelle
OG_10797,FUN_006718-T1,Peve_00022744,,apul_peve,57.137,FUN_006718-T1,O94913,PCF11_HUMAN,,Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11),Homo sapiens (Human),29.0,338.0,2.4e-27,126.3,sp|O94913|PCF11_HUMAN Pre-mRNA cleavage complex 2 protein Pcf11 OS=Homo sapiens OX=9606 GN=PCF11 PE=1 SV=3,GO:0000993; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005849; GO:0006369; GO:0180010,"co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; termination of RNA polymerase II transcription [GO:0006369]",cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993],GO:0003723; GO:0005634; GO:0005654; GO:0005739; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; mitochondrion; mRNA metabolic process; organelle
OG_10798,FUN_006719-T1,Peve_00039548,,apul_peve,64.003,FUN_006719-T1,Q4V786,,,,,44.5,146.0,1.4e-28,127.9,sp|Q4V786|NFIP1_XENTR NEDD4 family-interacting protein 1 OS=Xenopus tropicalis OX=8364 GN=ndfip1 PE=2 SV=1,,,,,,
OG_10799,FUN_006762-T1,Peve_00029278,,apul_peve,69.17,,,,,,,,,,,,,,,,,
OG_10800,FUN_006791-T1,Peve_00013587,,apul_peve,35.433,,,,,,,,,,,,,,,,,
OG_10801,FUN_006797-T1,Peve_00019181,,apul_peve,69.57900000000001,FUN_006797-T1,Q9WTN3,SRBP1_MOUSE,,Sterol regulatory element-binding protein 1 (SREBP-1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1 (Transcription factor SREBF1)],Mus musculus (Mouse),39.9,920.0,1.6e-156,555.4,sp|Q9WTN3|SRBP1_MOUSE Sterol regulatory element-binding protein 1 OS=Mus musculus OX=10090 GN=Srebf1 PE=1 SV=4,GO:0000122; GO:0000139; GO:0000976; GO:0000978; GO:0000981; GO:0001221; GO:0001228; GO:0003062; GO:0003677; GO:0003682; GO:0003700; GO:0004879; GO:0005634; GO:0005654; GO:0005737; GO:0005789; GO:0006355; GO:0006357; GO:0006366; GO:0006695; GO:0007584; GO:0007623; GO:0008286; GO:0008610; GO:0009267; GO:0009410; GO:0009749; GO:0009750; GO:0010867; GO:0010883; GO:0012507; GO:0016020; GO:0019217; GO:0019901; GO:0030073; GO:0030324; GO:0031647; GO:0032094; GO:0032526; GO:0032570; GO:0032810; GO:0032933; GO:0032991; GO:0033762; GO:0042789; GO:0043565; GO:0044877; GO:0045089; GO:0045444; GO:0045471; GO:0045542; GO:0045723; GO:0045893; GO:0045944; GO:0046676; GO:0046889; GO:0046983; GO:0050796; GO:0051591; GO:0071398; GO:0090209; GO:1901524; GO:1902895; GO:1903214,cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol biosynthetic process [GO:0006695]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; insulin secretion [GO:0030073]; lipid biosynthetic process [GO:0008610]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of triglyceride metabolic process [GO:0090209]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of innate immune response [GO:0045089]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of DNA-templated transcription [GO:0006355]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; regulation of mitophagy [GO:1901524]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to fructose [GO:0009750]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to nutrient [GO:0007584]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; SREBP signaling pathway [GO:0032933]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sterol response element binding [GO:0032810]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]",GO:0003677; GO:0005634; GO:0005654; GO:0006351; GO:0006355; GO:0006629; GO:0016071; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; nucleoplasm; DNA-templated transcription; regulation of DNA-templated transcription; lipid metabolic process; mRNA metabolic process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_10802,FUN_006801-T1,Peve_00019093,,apul_peve,75.93,FUN_006801-T1,Q04656,ATP7A_HUMAN,,Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein),Homo sapiens (Human),45.1,1420.0,2e-309,1063.5,sp|Q04656|ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens OX=9606 GN=ATP7A PE=1 SV=4,GO:0001568; GO:0001836; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006568; GO:0006570; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007626; GO:0009101; GO:0010273; GO:0010468; GO:0014069; GO:0015677; GO:0016020; GO:0016323; GO:0016532; GO:0016887; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030198; GO:0030199; GO:0030424; GO:0030425; GO:0030670; GO:0031069; GO:0031901; GO:0032588; GO:0032767; GO:0033162; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042421; GO:0042428; GO:0043005; GO:0043025; GO:0043473; GO:0043524; GO:0043588; GO:0043682; GO:0045914; GO:0046034; GO:0048023; GO:0048251; GO:0048286; GO:0048471; GO:0048812; GO:0048813; GO:0051216; GO:0051402; GO:0051649; GO:0060003; GO:0070050; GO:0140581; GO:1903136,ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; epinephrine metabolic process [GO:0042414]; establishment of localization in cell [GO:0051649]; extracellular matrix organization [GO:0030198]; glycoprotein biosynthetic process [GO:0009101]; hair follicle morphogenesis [GO:0031069]; intracellular copper ion homeostasis [GO:0006878]; L-tryptophan metabolic process [GO:0006568]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catecholamine metabolic process [GO:0045914]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; pigmentation [GO:0043473]; positive regulation of melanin biosynthetic process [GO:0048023]; pyramidal neuron development [GO:0021860]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tyrosine metabolic process [GO:0006570],axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; superoxide dismutase copper chaperone activity [GO:0016532],GO:0002376; GO:0003824; GO:0005215; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006520; GO:0007005; GO:0009101; GO:0012501; GO:0016787; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0055086; GO:0098754; GO:0140104; GO:0140657; GO:1901135,immune system process; catalytic activity; transporter activity; endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; amino acid metabolic process; mitochondrion organization; glycoprotein biosynthetic process; programmed cell death; hydrolase activity; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; nucleobase-containing small molecule metabolic process; detoxification; molecular carrier activity; ATP-dependent activity; carbohydrate derivative metabolic process
OG_10803,FUN_006804-T1,Peve_00023737,,apul_peve,69.247,FUN_006804-T1,A5PN43,TM175_DANRE,,Endosomal/lysosomal proton channel TMEM175 (Potassium channel TMEM175) (Transmembrane protein 175),Danio rerio (Zebrafish) (Brachydanio rerio),30.3,442.0,3e-49,198.7,sp|A5PN43|TM175_DANRE Endosomal/lysosomal proton channel TMEM175 OS=Danio rerio OX=7955 GN=tmem175 PE=3 SV=1,GO:0005267; GO:0005764; GO:0005765; GO:0005768; GO:0010008; GO:0015252; GO:0022841; GO:0035751; GO:0035752; GO:0050544; GO:0070050; GO:0071805; GO:0090385; GO:1902600,lysosomal lumen pH elevation [GO:0035752]; neuron cellular homeostasis [GO:0070050]; phagosome-lysosome fusion [GO:0090385]; potassium ion transmembrane transport [GO:0071805]; proton transmembrane transport [GO:1902600]; regulation of lysosomal lumen pH [GO:0035751],endosome [GO:0005768]; endosome membrane [GO:0010008]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],arachidonate binding [GO:0050544]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; proton channel activity [GO:0015252],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0008289; GO:0031410; GO:0043226; GO:0055085; GO:0061024,transporter activity; lysosome; endosome; vacuole; lipid binding; cytoplasmic vesicle; organelle; transmembrane transport; membrane organization
OG_10804,FUN_006825-T1,Peve_00023769,,apul_peve,53.882,FUN_006825-T1,Q566X8,DMX1B_DANRE,,Diencephalon/mesencephalon homeobox protein 1-B,Danio rerio (Zebrafish) (Brachydanio rerio),56.7,104.0,1.5999999999999999e-24,114.4,sp|Q566X8|DMX1B_DANRE Diencephalon/mesencephalon homeobox protein 1-B OS=Danio rerio OX=7955 GN=dmbx1b PE=2 SV=1,GO:0000977; GO:0000981; GO:0005634; GO:0006357; GO:0007346; GO:0030901; GO:0050767; GO:0051726; GO:0060041; GO:0061074,midbrain development [GO:0030901]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; retina development in camera-type eye [GO:0060041],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_10805,FUN_006833-T1,Peve_00044902,,apul_peve,36.8,,,,,,,,,,,,,,,,,
OG_10806,FUN_006842-T1,Peve_00023778,,apul_peve,40.5,FUN_006842-T1,B6ZIW0,KUN_HAELO,,Thrombin inhibitor hemalin (Thrombin inhibitor haemalin),Haemaphysalis longicornis (Bush tick),51.6,62.0,4.5e-14,79.3,sp|B6ZIW0|KUN_HAELO Thrombin inhibitor hemalin OS=Haemaphysalis longicornis OX=44386 PE=2 SV=1,GO:0004867; GO:0005615; GO:0044562; GO:0090729,envenomation resulting in negative regulation of voltage-gated potassium channel activity in another organism [GO:0044562],extracellular space [GO:0005615],serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729],GO:0005615; GO:0090729; GO:0098772,extracellular space; toxin activity; molecular function regulator activity
OG_10807,FUN_006850-T1,Peve_00012333,,apul_peve,37.736,FUN_006850-T1,A1EA99,,,,,29.8,141.0,4.1e-07,59.3,sp|A1EA99|ALL2L_IXORI Mite group 2 allergen-like Ixo r 2 OS=Ixodes ricinus OX=34613 PE=2 SV=1,,,,,,
OG_10808,FUN_006863-T2,Peve_00029678,,apul_peve,68.712,,,,,,,,,,,,,,,,,
OG_10809,FUN_006866-T1,Peve_00039243,,apul_peve,56.687,FUN_006866-T1,Q55E58,PATS1_DICDI,,Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1),Dictyostelium discoideum (Social amoeba),26.3,270.0,1.3e-15,87.4,sp|Q55E58|PATS1_DICDI Probable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1,GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310,cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856],actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0140096,"cytokinesis; catalytic activity; cytosol; lipid metabolic process; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_10810,FUN_006883-T1,Peve_00039242,,apul_peve,61.751,FUN_006883-T1,P13908,,,,,32.8,433.0,4.4e-56,220.3,sp|P13908|ACHN2_CARAU Neuronal acetylcholine receptor subunit non-alpha-2 OS=Carassius auratus OX=7957 PE=2 SV=1,,,,,,
OG_10811,FUN_006888-T2,Peve_00009908,,apul_peve,55.286,FUN_006888-T2,Q7TN88,,,,,28.0,1340.0,2e-136,489.2,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_10812,FUN_006894-T1,Peve_00024779,,apul_peve,55.814,FUN_006894-T1,Q29RU2,,,,,32.5,200.0,1.2e-17,94.4,sp|Q29RU2|OIT3_BOVIN Oncoprotein-induced transcript 3 protein OS=Bos taurus OX=9913 GN=OIT3 PE=2 SV=1,,,,,,
OG_10813,FUN_006899-T1,Peve_00044407,,apul_peve,43.75,,,,,,,,,,,,,,,,,
OG_10814,FUN_006912-T1,Peve_00000656,,apul_peve,66.5,,,,,,,,,,,,,,,,,
OG_10815,FUN_006915-T1,Peve_00009371,,apul_peve,55.295,FUN_006915-T1,Q29RU2,,,,,47.6,82.0,4.4e-16,89.0,sp|Q29RU2|OIT3_BOVIN Oncoprotein-induced transcript 3 protein OS=Bos taurus OX=9913 GN=OIT3 PE=2 SV=1,,,,,,
OG_10816,FUN_006919-T1,Peve_00044399,,apul_peve,63.901,FUN_006919-T1,Q61687,,,,,50.7,913.0,1.1e-193,679.5,sp|Q61687|ATRX_MOUSE Transcriptional regulator ATRX OS=Mus musculus OX=10090 GN=Atrx PE=1 SV=3,,,,,,
OG_10816,FUN_006919-T1,Peve_00044399,,apul_peve,63.901,FUN_006919-T1,Q61687,,,,,27.8,399.0,2.1e-27,127.1,sp|Q61687|ATRX_MOUSE Transcriptional regulator ATRX OS=Mus musculus OX=10090 GN=Atrx PE=1 SV=3,,,,,,
OG_10817,FUN_006924-T1,Peve_00044406,,apul_peve,56.579,FUN_006924-T1,Q54Y55,SHKC_DICDI,,Dual specificity protein kinase shkC (EC 2.7.11.1) (SH2 domain-containing protein 3) (SH2 domain-containing protein C),Dictyostelium discoideum (Social amoeba),29.2,250.0,3.2000000000000003e-22,107.8,sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum OX=44689 GN=shkC PE=3 SV=1,GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0106310,signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_10818,FUN_006930-T1,Peve_00044432,,apul_peve,68.374,FUN_006930-T1,Q4LDE5,SVEP1_HUMAN,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)",Homo sapiens (Human),33.1,2117.0,9.4e-81,304.7,"sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3",GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193,epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0034330; GO:0043226; GO:0048856; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell junction organization; organelle; anatomical structure development; cell adhesion mediator activity
OG_10819,FUN_006934-T1,Peve_00001496,,apul_peve,64.439,,,,,,,,,,,,,,,,,
OG_10820,FUN_006964-T1,Peve_00022098,,apul_peve,30.909,,,,,,,,,,,,,,,,,
OG_10821,FUN_006972-T1,Peve_00042005,,apul_peve,30.0,FUN_006972-T1,Q2I6J1,SHP2A_DANRE,,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A)",Danio rerio (Zebrafish) (Brachydanio rerio),48.4,62.0,4.9e-06,53.9,"sp|Q2I6J1|SHP2A_DANRE Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A OS=Danio rerio OX=7955 GN=inppl1a PE=2 SV=2",GO:0002376; GO:0003779; GO:0004445; GO:0005634; GO:0005829; GO:0005856; GO:0007155; GO:0016020; GO:0016607; GO:0030027; GO:0030175; GO:0030509; GO:0034485; GO:0040037; GO:0043569; GO:0046856; GO:0050776; GO:0090024,BMP signaling pathway [GO:0030509]; cell adhesion [GO:0007155]; immune system process [GO:0002376]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of neutrophil chemotaxis [GO:0090024]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of immune response [GO:0050776],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634],"actin binding [GO:0003779]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]",GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005856; GO:0006629; GO:0007155; GO:0008092; GO:0016787; GO:0043226,immune system process; catalytic activity; nucleus; cytosol; cytoskeleton; lipid metabolic process; cell adhesion; cytoskeletal protein binding; hydrolase activity; organelle
OG_10822,FUN_006979-T1,Peve_00026703,,apul_peve,87.072,FUN_006979-T1,P50851,LRBA_HUMAN,,Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein),Homo sapiens (Human),40.2,2923.0,0.0,2040.0,sp|P50851|LRBA_HUMAN Lipopolysaccharide-responsive and beige-like anchor protein OS=Homo sapiens OX=9606 GN=LRBA PE=1 SV=4,GO:0000423; GO:0005765; GO:0005789; GO:0005794; GO:0005829; GO:0005886; GO:0008104; GO:0016020; GO:0019901; GO:0034497,mitophagy [GO:0000423]; protein localization [GO:0008104]; protein localization to phagophore assembly site [GO:0034497],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886],protein kinase binding [GO:0019901],GO:0005794; GO:0005829; GO:0005886; GO:0006914; GO:0043226,Golgi apparatus; cytosol; plasma membrane; autophagy; organelle
OG_10823,FUN_006994-T1,Peve_00010185,,apul_peve,46.032,,,,,,,,,,,,,,,,,
OG_10824,FUN_006996-T1,Peve_00035636,,apul_peve,68.4135,FUN_006996-T1,Q5ZLF0,F10A1_CHICK,,Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog),Gallus gallus (Chicken),67.1,374.0,1.1e-64,248.8,sp|Q5ZLF0|F10A1_CHICK Hsc70-interacting protein OS=Gallus gallus OX=9031 GN=ST13 PE=2 SV=1,GO:0005737; GO:0030544; GO:0046983; GO:0051085,chaperone cofactor-dependent protein refolding [GO:0051085],cytoplasm [GO:0005737],Hsp70 protein binding [GO:0030544]; protein dimerization activity [GO:0046983],,
OG_10825,FUN_006999-T1,Peve_00029462,,apul_peve,39.707,,,,,,,,,,,,,,,,,
OG_10826,FUN_007025-T2,Peve_00037179,,apul_peve,67.066,FUN_007025-T2,Q55E58,PATS1_DICDI,,Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1),Dictyostelium discoideum (Social amoeba),22.1,393.0,1.1e-17,94.4,sp|Q55E58|PATS1_DICDI Probable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1,GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310,cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856],actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0140096,"cytokinesis; catalytic activity; cytosol; lipid metabolic process; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_10827,FUN_007059-T1,Peve_00022321,,apul_peve,38.6185,,,,,,,,,,,,,,,,,
OG_10828,FUN_007067-T2,Peve_00008211,,apul_peve,78.102,FUN_007067-T2,O77457,,,,,54.2,253.0,7.3e-64,245.7,"sp|O77457|T23O_ANOGA Tryptophan 2,3-dioxygenase OS=Anopheles gambiae OX=7165 GN=AGAP002721 PE=2 SV=1",,,,,,
OG_10829,FUN_007071-T1,Peve_00019899,,apul_peve,51.196,FUN_007071-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),27.2,390.0,1.2e-37,159.1,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_10830,FUN_007074-T2,Peve_00019896,,apul_peve,79.856,,,,,,,,,,,,,,,,,
OG_10831,FUN_007089-T1,Peve_00024415,,apul_peve,48.095,,,,,,,,,,,,,,,,,
OG_10832,FUN_007090-T1,Peve_00033781,,apul_peve,51.6305,FUN_007090-T1,O70244,,,,,21.7,290.0,6.4e-08,60.5,sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2,,,,,,
OG_10833,FUN_007093-T1,Peve_00019880,,apul_peve,59.3005,,,,,,,,,,,,,,,,,
OG_10834,FUN_007112-T1,Peve_00042987,,apul_peve,36.396,FUN_007112-T1,P23468,PTPRD_HUMAN,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Homo sapiens (Human),26.4,508.0,3.2000000000000003e-23,111.3,sp|P23468|PTPRD_HUMAN Receptor-type tyrosine-protein phosphatase delta OS=Homo sapiens OX=9606 GN=PTPRD PE=1 SV=2,GO:0004725; GO:0005001; GO:0005102; GO:0005886; GO:0006796; GO:0007157; GO:0007165; GO:0007185; GO:0030182; GO:0042734; GO:0046426; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0070062; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099054; GO:0099151; GO:0099545; GO:0099560,cell surface receptor protein tyrosine phosphatase signaling pathway [GO:0007185]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],GO:0003824; GO:0005886; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0043226; GO:0060089; GO:0061024; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; hydrolase activity; signaling; cell differentiation; organelle; molecular transducer activity; membrane organization; catalytic activity, acting on a protein"
OG_10835,FUN_007129-T1,Peve_00019730,,apul_peve,63.9135,FUN_007129-T1,Q60997,DMBT1_MOUSE,,Scavenger receptor cysteine-rich domain-containing protein DMBT1 (Apactin) (CRP-ductin) (Deleted in malignant brain tumors 1 protein) (Glycoprotein 300) (gp300) (Hensin) (Mucin-like glycoprotein) (Muclin) (Vomeroglandin) (p80),Mus musculus (Mouse),31.0,252.0,8e-21,102.8,sp|Q60997|DMBT1_MOUSE Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Mus musculus OX=10090 GN=Dmbt1 PE=1 SV=2,GO:0001824; GO:0001833; GO:0002065; GO:0005576; GO:0009617; GO:0015031; GO:0030658; GO:0030858; GO:0031012; GO:0035375; GO:0042589; GO:0050829; GO:0050830; GO:0062023,blastocyst development [GO:0001824]; columnar/cuboidal epithelial cell differentiation [GO:0002065]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589],zymogen binding [GO:0035375],GO:0005576; GO:0030154; GO:0030312; GO:0031012; GO:0048856,extracellular region; cell differentiation; external encapsulating structure; extracellular matrix; anatomical structure development
OG_10836,FUN_007158-T1,Peve_00028236,,apul_peve,75.94,,,,,,,,,,,,,,,,,
OG_10837,FUN_007159-T1,Peve_00028235,,apul_peve,73.745,,,,,,,,,,,,,,,,,
OG_10838,FUN_007178-T1,Peve_00029011,,apul_peve,52.346,FUN_007178-T1,B8VIU6,,,,,57.4,155.0,2.1e-46,188.0,sp|B8VIU6|USOM5_ACRMI Uncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10839,FUN_007179-T1,Peve_00009909,,apul_peve,56.176,,,,,,,,,,,,,,,,,
OG_10840,FUN_007184-T2,Peve_00040119,,apul_peve,85.409,FUN_007184-T2,Q58A42,DD3_DICDI,,Protein DD3-3,Dictyostelium discoideum (Social amoeba),32.7,661.0,1.1e-71,273.5,sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_10841,FUN_007572-T1,Peve_00029036,,apul_peve,90.226,,,,,,,,,,,,,,,,,
OG_10842,FUN_007575-T1,Peve_00039418,,apul_peve,48.246,,,,,,,,,,,,,,,,,
OG_10843,FUN_007577-T1,Peve_00042360,,apul_peve,57.463,,,,,,,,,,,,,,,,,
OG_10844,FUN_007587-T1,Peve_00027232,,apul_peve,44.052,,,,,,,,,,,,,,,,,
OG_10845,FUN_007594-T1,Peve_00032675,,apul_peve,76.823,,,,,,,,,,,,,,,,,
OG_10846,FUN_007610-T1,Peve_00039714,,apul_peve,54.108,,,,,,,,,,,,,,,,,
OG_10847,FUN_007635-T1,Peve_00022857,,apul_peve,64.13,,,,,,,,,,,,,,,,,
OG_10848,FUN_007655-T1,Peve_00009079,,apul_peve,43.265,FUN_007655-T1,Q58L91,FA5V_OXYSU,,Venom prothrombin activator oscutarin-C non-catalytic subunit (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Oscutarin-C non-catalytic subunit heavy chain; Oscutarin-C non-catalytic subunit light chain],Oxyuranus scutellatus (Coastal taipan),34.9,307.0,7.8e-43,177.2,sp|Q58L91|FA5V_OXYSU Venom prothrombin activator oscutarin-C non-catalytic subunit OS=Oxyuranus scutellatus OX=8668 PE=1 SV=1,GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729,venom-mediated blood coagulation [GO:0044469],extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729],GO:0005576; GO:0005886; GO:0060089; GO:0090729; GO:0098772,extracellular region; plasma membrane; molecular transducer activity; toxin activity; molecular function regulator activity
OG_10849,FUN_007671-T1,Peve_00040082,,apul_peve,56.738,,,,,,,,,,,,,,,,,
OG_10850,FUN_007676-T1,Peve_00033174,,apul_peve,45.455,,,,,,,,,,,,,,,,,
OG_10851,FUN_007698-T1,Peve_00028500,,apul_peve,59.921,FUN_007698-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),24.9,345.0,5.5e-14,80.5,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_10852,FUN_007711-T1,Peve_00018588,,apul_peve,38.177,FUN_007711-T1,Q5R7B8,KLH20_PONAB,,Kelch-like protein 20,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),33.0,112.0,4.2e-10,67.0,sp|Q5R7B8|KLH20_PONAB Kelch-like protein 20 OS=Pongo abelii OX=9601 GN=KLHL20 PE=2 SV=3,GO:0003779; GO:0005737; GO:0005802; GO:0005829; GO:0006895; GO:0015031; GO:0016567; GO:0016605; GO:0019964; GO:0030424; GO:0030425; GO:0031463; GO:0043066; GO:0043161; GO:0048471; GO:1990390,Golgi to endosome transport [GO:0006895]; negative regulation of apoptotic process [GO:0043066]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K33-linked ubiquitination [GO:1990390]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; trans-Golgi network [GO:0005802],actin binding [GO:0003779]; type II interferon binding [GO:0019964],GO:0005829; GO:0008092; GO:0016192; GO:0030163; GO:0043226,cytosol; cytoskeletal protein binding; vesicle-mediated transport; protein catabolic process; organelle
OG_10853,FUN_007712-T1,Peve_00003328,,apul_peve,63.559,,,,,,,,,,,,,,,,,
OG_10854,FUN_007714-T1,Peve_00023366,,apul_peve,49.58,,,,,,,,,,,,,,,,,
OG_10855,FUN_007749-T1,Peve_00041400,,apul_peve,59.429,FUN_007749-T1,Q9Y394,DHRS7_HUMAN,,Dehydrogenase/reductase SDR family member 7 (EC 1.1.1.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1) (Protein SDR34C1),Homo sapiens (Human),46.7,276.0,2.6e-58,229.2,sp|Q9Y394|DHRS7_HUMAN Dehydrogenase/reductase SDR family member 7 OS=Homo sapiens OX=9606 GN=DHRS7 PE=1 SV=1,GO:0004090; GO:0005789; GO:0016020; GO:0016616; GO:0052650,,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],"all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_10856,FUN_007751-T1,Peve_00033183,,apul_peve,40.0535,,,,,,,,,,,,,,,,,
OG_10857,FUN_007761-T2,Peve_00032252,,apul_peve,64.341,FUN_007761-T2,O88994,,,,,33.2,229.0,9.999999999999999e-29,128.6,sp|O88994|MARC2_RAT Mitochondrial amidoxime reducing component 2 OS=Rattus norvegicus OX=10116 GN=Mtarc2 PE=2 SV=1,,,,,,
OG_10858,FUN_007763-T1,Peve_00017224,,apul_peve,48.8065,,,,,,,,,,,,,,,,,
OG_10859,FUN_007770-T1,Peve_00000578,,apul_peve,86.876,,,,,,,,,,,,,,,,,
OG_10860,FUN_007772-T1,Peve_00032265,,apul_peve,62.264,FUN_007772-T1,Q9CW42,MARC1_MOUSE,,Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.7.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1) (MOSC domain-containing protein 1) (Moco sulfurase C-terminal domain-containing protein 1),Mus musculus (Mouse),34.0,291.0,1.4e-43,178.3,sp|Q9CW42|MARC1_MOUSE Mitochondrial amidoxime-reducing component 1 OS=Mus musculus OX=10090 GN=Mtarc1 PE=1 SV=2,GO:0005739; GO:0005741; GO:0005743; GO:0006809; GO:0008940; GO:0030151; GO:0030170; GO:0042126; GO:0043546; GO:0050421; GO:0070458; GO:1903958,cellular detoxification of nitrogen compound [GO:0070458]; nitrate metabolic process [GO:0042126]; nitric oxide biosynthetic process [GO:0006809],mitochondrial inner membrane [GO:0005743]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nitric-oxide synthase complex [GO:1903958],molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; nitrite reductase (NO-forming) activity [GO:0050421]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005739; GO:0016491; GO:0043226; GO:0098754,catalytic activity; mitochondrion; oxidoreductase activity; organelle; detoxification
OG_10861,FUN_007777-T1,Peve_00030235,,apul_peve,43.755,FUN_007777-T1,C6FG12,,,,,24.6,529.0,2.8000000000000004e-22,109.4,sp|C6FG12|NLRC5_ICTPU Protein NLRC5 OS=Ictalurus punctatus OX=7998 GN=nlrc5 PE=2 SV=1,,,,,,
OG_10862,FUN_007792-T1,Peve_00026502,,apul_peve,38.679,FUN_007792-T1,Q8K1P8,MOT8_RAT,,Monocarboxylate transporter 8 (MCT 8) (Solute carrier family 16 member 2),Rattus norvegicus (Rat),23.9,431.0,4.2e-30,134.0,sp|Q8K1P8|MOT8_RAT Monocarboxylate transporter 8 OS=Rattus norvegicus OX=10116 GN=SLC16A2 PE=1 SV=2,GO:0005886; GO:0006520; GO:0006590; GO:0009914; GO:0015171; GO:0015349; GO:0016324; GO:0042403; GO:0042802; GO:0070327; GO:0070460; GO:0089718; GO:0150104; GO:2000178,amino acid import across plasma membrane [GO:0089718]; amino acid metabolic process [GO:0006520]; hormone transport [GO:0009914]; negative regulation of neural precursor cell proliferation [GO:2000178]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; identical protein binding [GO:0042802]; thyroid hormone transmembrane transporter activity [GO:0015349],GO:0003013; GO:0005215; GO:0005886; GO:0006520; GO:0006575; GO:0055085,circulatory system process; transporter activity; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; transmembrane transport
OG_10863,FUN_007813-T1,Peve_00038751,,apul_peve,71.058,FUN_007813-T1,Q9WVK8,CP46A_MOUSE,,Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1),Mus musculus (Mouse),38.3,494.0,1.6e-86,321.6,sp|Q9WVK8|CP46A_MOUSE Cholesterol 24-hydroxylase OS=Mus musculus OX=10090 GN=Cyp46a1 PE=1 SV=1,GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044,cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805],dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793],cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_10864,FUN_007841-T1,Peve_00040439,,apul_peve,71.782,FUN_007841-T1,Q9UI43,MRM2_HUMAN,,"rRNA methyltransferase 2, mitochondrial (EC 2.1.1.-) (16S rRNA (uridine(1369)-2'-O)-methyltransferase) (16S rRNA [Um1369] 2'-O-methyltransferase) (Protein ftsJ homolog 2)",Homo sapiens (Human),42.6,216.0,4.9e-46,186.0,"sp|Q9UI43|MRM2_HUMAN rRNA methyltransferase 2, mitochondrial OS=Homo sapiens OX=9606 GN=MRM2 PE=1 SV=1",GO:0000451; GO:0001510; GO:0005730; GO:0005739; GO:0005759; GO:0006364; GO:0008650; GO:0031167; GO:1902775,mitochondrial large ribosomal subunit assembly [GO:1902775]; RNA methylation [GO:0001510]; rRNA 2'-O-methylation [GO:0000451]; rRNA methylation [GO:0031167]; rRNA processing [GO:0006364],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730],rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650],GO:0003824; GO:0005730; GO:0005739; GO:0016740; GO:0043226; GO:0065003; GO:0140098,"catalytic activity; nucleolus; mitochondrion; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on RNA"
OG_10865,FUN_007843-T1,Peve_00040458,,apul_peve,57.447,,,,,,,,,,,,,,,,,
OG_10866,FUN_007845-T1,Peve_00007305,,apul_peve,70.219,FUN_007845-T1,Q9H6P5,TASP1_HUMAN,,Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta],Homo sapiens (Human),45.2,389.0,4.3e-84,313.2,sp|Q9H6P5|TASP1_HUMAN Threonine aspartase 1 OS=Homo sapiens OX=9606 GN=TASP1 PE=1 SV=1,GO:0004298; GO:0005737; GO:0005829; GO:0006508; GO:0042802; GO:0045893; GO:0051604,positive regulation of DNA-templated transcription [GO:0045893]; protein maturation [GO:0051604]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829],identical protein binding [GO:0042802]; threonine-type endopeptidase activity [GO:0004298],GO:0003824; GO:0005829; GO:0006355; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; cytosol; regulation of DNA-templated transcription; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_10867,FUN_007853-T1,Peve_00040564,,apul_peve,54.5885,FUN_007853-T1,Q8N8X9,MB213_HUMAN,,Protein mab-21-like 3,Homo sapiens (Human),27.8,176.0,2.9e-09,65.9,sp|Q8N8X9|MB213_HUMAN Protein mab-21-like 3 OS=Homo sapiens OX=9606 GN=MAB21L3 PE=1 SV=2,,,,,,
OG_10868,FUN_007870-T1,Peve_00044454,,apul_peve,62.032,FUN_007870-T1,Q498R1,MTRR_RAT,,Methionine synthase reductase (MSR) (EC 1.16.1.8) (Aquacobalamin reductase) (AqCbl reductase),Rattus norvegicus (Rat),40.9,727.0,1.6e-138,495.0,sp|Q498R1|MTRR_RAT Methionine synthase reductase OS=Rattus norvegicus OX=10116 GN=Mtrr PE=2 SV=2,GO:0003958; GO:0005829; GO:0009086; GO:0009235; GO:0010181; GO:0016723; GO:0030586; GO:0033353; GO:0043418; GO:0046655; GO:0050660; GO:0050667; GO:0070402; GO:0071949,cobalamin metabolic process [GO:0009235]; folic acid metabolic process [GO:0046655]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; methionine biosynthetic process [GO:0009086]; S-adenosylmethionine cycle [GO:0033353],cytosol [GO:0005829],"[methionine synthase] reductase (NADPH) activity [GO:0030586]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor [GO:0016723]",GO:0003824; GO:0005829; GO:0006520; GO:0006575; GO:0006790; GO:0016491,catalytic activity; cytosol; amino acid metabolic process; modified amino acid metabolic process; sulfur compound metabolic process; oxidoreductase activity
OG_10869,FUN_007874-T1,Peve_00009883,,apul_peve,33.0155,,,,,,,,,,,,,,,,,
OG_10870,FUN_007884-T1,Peve_00009878,,apul_peve,34.0075,,,,,,,,,,,,,,,,,
OG_10871,FUN_007887-T1,Peve_00009876,,apul_peve,41.9175,,,,,,,,,,,,,,,,,
OG_10872,FUN_007889-T1,Peve_00020360,,apul_peve,48.066,,,,,,,,,,,,,,,,,
OG_10873,FUN_007893-T1,Peve_00020364,,apul_peve,70.769,FUN_007893-T1,Q0IH72,,,,,50.9,293.0,7.9e-86,318.9,"sp|Q0IH72|EXOG_XENLA Nuclease EXOG, mitochondrial OS=Xenopus laevis OX=8355 GN=exog PE=2 SV=1",,,,,,
OG_10874,FUN_007894-T1,Peve_00009869,,apul_peve,37.0675,,,,,,,,,,,,,,,,,
OG_10875,FUN_007898-T1,Peve_00025750,,apul_peve,48.333,,,,,,,,,,,,,,,,,
OG_10876,FUN_007908-T1,Peve_00040663,,apul_peve,81.19999999999999,FUN_007908-T1,Q7TNY6,GCP60_RAT,,Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (DMT1-associated protein) (DAP) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1),Rattus norvegicus (Rat),38.6,132.0,2.6e-20,100.5,sp|Q7TNY6|GCP60_RAT Golgi resident protein GCP60 OS=Rattus norvegicus OX=10116 GN=Acbd3 PE=1 SV=3,GO:0000062; GO:0000139; GO:0005739; GO:0006694; GO:0034237,steroid biosynthetic process [GO:0006694],Golgi membrane [GO:0000139]; mitochondrion [GO:0005739],fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237],GO:0005739; GO:0006629; GO:0008289; GO:0043226,mitochondrion; lipid metabolic process; lipid binding; organelle
OG_10877,FUN_007911-T1,Peve_00040667,,apul_peve,69.73949999999999,,,,,,,,,,,,,,,,,
OG_10878,FUN_007926-T1,Peve_00040686,,apul_peve,77.747,FUN_007926-T1,Q7SY06,HACD3_DANRE,,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase) (HACD) (Protein-tyrosine phosphatase-like A domain-containing protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),37.3,367.0,4.499999999999999e-62,240.0,sp|Q7SY06|HACD3_DANRE Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase OS=Danio rerio OX=7955 GN=hacd3 PE=2 SV=2,GO:0005783; GO:0005789; GO:0018812; GO:0030148; GO:0030497; GO:0042761; GO:0102158,fatty acid elongation [GO:0030497]; sphingolipid biosynthetic process [GO:0030148]; very long-chain fatty acid biosynthetic process [GO:0042761],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity [GO:0102158],GO:0003824; GO:0005783; GO:0006629; GO:0016829; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; lyase activity; organelle
OG_10879,FUN_007932-T1,Peve_00040693,,apul_peve,68.985,,,,,,,,,,,,,,,,,
OG_10880,FUN_007942-T1,Peve_00040698,,apul_peve,56.849,,,,,,,,,,,,,,,,,
OG_10881,FUN_007945-T1,Peve_00021147,,apul_peve,61.452,FUN_007945-T1,P36862,,,,,39.1,184.0,2.5e-26,121.7,sp|P36862|YPTV3_VOLCA GTP-binding protein yptV3 OS=Volvox carteri OX=3067 GN=YPTV3 PE=3 SV=1,,,,,,
OG_10882,FUN_007949-T2,Peve_00027154,,apul_peve,82.051,FUN_007949-T2,Q3SZC0,,,,,69.6,79.0,8.300000000000001e-28,124.0,sp|Q3SZC0|ERH_BOVIN Enhancer of rudimentary homolog OS=Bos taurus OX=9913 GN=ERH PE=3 SV=1,,,,,,
OG_10883,FUN_007950-T1,Peve_00039192,,apul_peve,59.459,FUN_007950-T1,Q16667,CDKN3_HUMAN,,Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Cyclin-dependent kinase interactor 1) (Cyclin-dependent kinase-interacting protein 2) (Kinase-associated phosphatase),Homo sapiens (Human),41.8,213.0,7.2e-40,166.4,sp|Q16667|CDKN3_HUMAN Cyclin-dependent kinase inhibitor 3 OS=Homo sapiens OX=9606 GN=CDKN3 PE=1 SV=1,GO:0000079; GO:0000082; GO:0004722; GO:0004725; GO:0005634; GO:0005737; GO:0005829; GO:0008138; GO:0008285; GO:0048471; GO:0051726,G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138],GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_10884,FUN_007962-T1,Peve_00030169,,apul_peve,52.362,,,,,,,,,,,,,,,,,
OG_10885,FUN_007969-T1,Peve_00030084,,apul_peve,61.417,,,,,,,,,,,,,,,,,
OG_10886,FUN_007978-T1,Peve_00040183,,apul_peve,59.943,FUN_007978-T1,Q9QUP4,,,,,27.4,339.0,8.000000000000001e-24,112.8,sp|Q9QUP4|CHST5_MOUSE Carbohydrate sulfotransferase 5 OS=Mus musculus OX=10090 GN=Chst5 PE=2 SV=1,,,,,,
OG_10887,FUN_007982-T1,Peve_00030869,,apul_peve,62.032,,,,,,,,,,,,,,,,,
OG_10888,FUN_007988-T1,Peve_00041078,,apul_peve,44.8945,FUN_007988-T1,P61916,NPC2_HUMAN,,NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1) (He1) (Niemann-Pick disease type C2 protein),Homo sapiens (Human),52.8,144.0,2.3e-36,153.3,sp|P61916|NPC2_HUMAN NPC intracellular cholesterol transporter 2 OS=Homo sapiens OX=9606 GN=NPC2 PE=1 SV=1,GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0009615; GO:0010467; GO:0010878; GO:0015485; GO:0015914; GO:0019747; GO:0019899; GO:0030301; GO:0032366; GO:0032367; GO:0033344; GO:0035578; GO:0042632; GO:0043202; GO:0046836; GO:0070062; GO:0120020,cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; gene expression [GO:0010467]; glycolipid transport [GO:0046836]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; phospholipid transport [GO:0015914]; regulation of isoprenoid metabolic process [GO:0019747]; response to virus [GO:0009615],azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899],GO:0005215; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0006629; GO:0008289; GO:0043226,transporter activity; extracellular region; extracellular space; lysosome; vacuole; endoplasmic reticulum; lipid metabolic process; lipid binding; organelle
OG_10889,FUN_007988-T2,Peve_00040187,,apul_peve,48.351,FUN_007988-T2,P61916,NPC2_HUMAN,,NPC intracellular cholesterol transporter 2 (Epididymal secretory protein E1) (Human epididymis-specific protein 1) (He1) (Niemann-Pick disease type C2 protein),Homo sapiens (Human),48.8,121.0,5.8e-26,118.6,sp|P61916|NPC2_HUMAN NPC intracellular cholesterol transporter 2 OS=Homo sapiens OX=9606 GN=NPC2 PE=1 SV=1,GO:0005576; GO:0005615; GO:0005764; GO:0005783; GO:0008203; GO:0009615; GO:0010467; GO:0010878; GO:0015485; GO:0015914; GO:0019747; GO:0019899; GO:0030301; GO:0032366; GO:0032367; GO:0033344; GO:0035578; GO:0042632; GO:0043202; GO:0046836; GO:0070062; GO:0120020,cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol storage [GO:0010878]; cholesterol transport [GO:0030301]; gene expression [GO:0010467]; glycolipid transport [GO:0046836]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; phospholipid transport [GO:0015914]; regulation of isoprenoid metabolic process [GO:0019747]; response to virus [GO:0009615],azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899],GO:0005215; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0005783; GO:0006629; GO:0008289; GO:0043226,transporter activity; extracellular region; extracellular space; lysosome; vacuole; endoplasmic reticulum; lipid metabolic process; lipid binding; organelle
OG_10890,FUN_007992-T1,Peve_00040194,,apul_peve,56.688500000000005,FUN_007992-T1,Q9BUD6,,,,,39.6,187.0,4.2e-28,127.5,sp|Q9BUD6|SPON2_HUMAN Spondin-2 OS=Homo sapiens OX=9606 GN=SPON2 PE=1 SV=4,,,,,,
OG_10891,FUN_007999-T2,Peve_00022013,,apul_peve,69.12049999999999,FUN_007999-T2,Q8NDG6,TDRD9_HUMAN,,ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9),Homo sapiens (Human),43.3,1223.0,2.2e-273,943.7,sp|Q8NDG6|TDRD9_HUMAN ATP-dependent RNA helicase TDRD9 OS=Homo sapiens OX=9606 GN=TDRD9 PE=1 SV=3,GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007283; GO:0009566; GO:0016887; GO:0030154; GO:0034587; GO:0071547; GO:0141006; GO:0141196,cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0031047; GO:0043226; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; chromatin organization; hydrolase activity; isomerase activity; reproductive process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_10892,FUN_008002-T1,Peve_00006655,,apul_peve,46.519,,,,,,,,,,,,,,,,,
OG_10893,FUN_008007-T1,Peve_00020930,,apul_peve,55.8685,,,,,,,,,,,,,,,,,
OG_10894,FUN_008024-T1,Peve_00011344,,apul_peve,36.872,,,,,,,,,,,,,,,,,
OG_10895,FUN_008026-T1,Peve_00011350,,apul_peve,72.819,FUN_008026-T1,A0MGZ5,,,,,56.7,284.0,2.8e-97,356.7,sp|A0MGZ5|H6S1B_DANRE Heparan-sulfate 6-O-sulfotransferase 1-B OS=Danio rerio OX=7955 GN=hs6st1b PE=2 SV=3,,,,,,
OG_10896,FUN_008027-T2,Peve_00011349,,apul_peve,72.697,FUN_008027-T2,Q3TJZ6,,,,,44.7,309.0,1.1e-68,261.9,sp|Q3TJZ6|FA98A_MOUSE Protein FAM98A OS=Mus musculus OX=10090 GN=Fam98a PE=1 SV=1,,,,,,
OG_10897,FUN_008030-T1,Peve_00031391,,apul_peve,60.104,,,,,,,,,,,,,,,,,
OG_10898,FUN_008033-T1,Peve_00020770,,apul_peve,53.906,FUN_008033-T1,A7MTX1,,,,,27.9,183.0,4.3e-11,70.5,sp|A7MTX1|UBIE_VIBC1 Ubiquinone/menaquinone biosynthesis C-methyltransferase UbiE OS=Vibrio campbellii (strain ATCC BAA-1116) OX=2902295 GN=ubiE PE=3 SV=1,,,,,,
OG_10899,FUN_008037-T1,Peve_00045158,,apul_peve,73.968,FUN_008037-T1,Q2KI83,,,,,46.0,315.0,3.5e-47,190.3,sp|Q2KI83|DJC17_BOVIN DnaJ homolog subfamily C member 17 OS=Bos taurus OX=9913 GN=DNAJC17 PE=2 SV=1,,,,,,
OG_10900,FUN_008052-T1,Peve_00005980,,apul_peve,83.299,FUN_008052-T1,Q5R7H0,DHTK1_PONAB,,"2-oxoadipate dehydrogenase complex component E1 (E1a) (OADC-E1) (OADH-E1) (EC 1.2.4.-) (2-oxoadipate dehydrogenase, mitochondrial) (Alpha-ketoadipate dehydrogenase) (Alpha-KADH-E1) (Dehydrogenase E1 and transketolase domain-containing protein 1) (Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),57.6,904.0,4.2e-311,1068.5,sp|Q5R7H0|DHTK1_PONAB 2-oxoadipate dehydrogenase complex component E1 OS=Pongo abelii OX=9601 GN=DHTKD1 PE=2 SV=1,GO:0004591; GO:0005739; GO:0005759; GO:0006091; GO:0006096; GO:0030976; GO:0160166,generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],2-oxoadipate dehydrogenase activity [GO:0160166]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976],GO:0003824; GO:0005739; GO:0005975; GO:0006091; GO:0016491; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; carbohydrate metabolic process; generation of precursor metabolites and energy; oxidoreductase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_10901,FUN_008055-T1,Peve_00014702,,apul_peve,56.364,FUN_008055-T1,Q9VVE5,,,,,37.1,70.0,1.1e-08,60.8,sp|Q9VVE5|MSIR6_DROME RNA-binding protein Musashi homolog Rbp6 OS=Drosophila melanogaster OX=7227 GN=Rbp6 PE=2 SV=3,,,,,,
OG_10902,FUN_008056-T2,Peve_00005977,,apul_peve,69.29050000000001,FUN_008056-T2,O14678,ABCD4_HUMAN,,Lysosomal cobalamin transporter ABCD4 (EC 7.6.2.8) (ATP-binding cassette sub-family D member 4) (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69),Homo sapiens (Human),51.9,509.0,3.6e-137,490.0,sp|O14678|ABCD4_HUMAN Lysosomal cobalamin transporter ABCD4 OS=Homo sapiens OX=9606 GN=ABCD4 PE=1 SV=1,GO:0005324; GO:0005524; GO:0005765; GO:0005777; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015420; GO:0015889; GO:0015910; GO:0016020; GO:0016887; GO:0042626; GO:0042760; GO:0042802; GO:0043190; GO:0055085; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760],ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; long-chain fatty acid transmembrane transporter activity [GO:0005324],GO:0003824; GO:0005215; GO:0005777; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; peroxisome; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_10903,FUN_008064-T1,Peve_00041230,,apul_peve,56.958,FUN_008064-T1,Q5DUB3,NK1R_CANLF,,Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1),Canis lupus familiaris (Dog) (Canis familiaris),26.7,292.0,5.8e-13,76.6,sp|Q5DUB3|NK1R_CANLF Substance-P receptor OS=Canis lupus familiaris OX=9615 GN=TACR1 PE=2 SV=1,GO:0005886; GO:0007204; GO:0016496; GO:0048265; GO:0061827; GO:0070472; GO:0097225; GO:1902093,positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of flagellated sperm motility [GO:1902093]; regulation of uterine smooth muscle contraction [GO:0070472]; response to pain [GO:0048265],plasma membrane [GO:0005886]; sperm head [GO:0061827]; sperm midpiece [GO:0097225],substance P receptor activity [GO:0016496],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_10904,FUN_008076-T1,Peve_00013208,,apul_peve,80.685,FUN_008076-T1,P56261,,,,,56.8,88.0,2.2e-12,74.7,sp|P56261|CEBPE_RAT CCAAT/enhancer-binding protein epsilon OS=Rattus norvegicus OX=10116 GN=Cebpe PE=1 SV=2,,,,,,
OG_10905,FUN_008077-T1,Peve_00032592,,apul_peve,81.132,FUN_008077-T1,Q28DN4,,,,,52.8,108.0,1.9e-10,66.6,sp|Q28DN4|WASH1_XENTR WASH complex subunit 1 OS=Xenopus tropicalis OX=8364 GN=washc1 PE=2 SV=1,,,,,,
OG_10906,FUN_008081-T1,Peve_00036767,,apul_peve,55.799,FUN_008081-T1,O88451,,,,,41.6,303.0,6.300000000000002e-60,232.6,sp|O88451|RDH7_MOUSE Retinol dehydrogenase 7 OS=Mus musculus OX=10090 GN=Rdh7 PE=1 SV=1,,,,,,
OG_10907,FUN_008089-T2,Peve_00033654,,apul_peve,48.7315,FUN_008089-T2,P12259,FA5_HUMAN,,"Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]",Homo sapiens (Human),33.6,318.0,1.4999999999999999e-40,169.1,sp|P12259|FA5_HUMAN Coagulation factor V OS=Homo sapiens OX=9606 GN=F5 PE=1 SV=4,GO:0005507; GO:0005576; GO:0005615; GO:0005788; GO:0005886; GO:0007596; GO:0008015; GO:0016020; GO:0030134; GO:0031091; GO:0031093; GO:0032571; GO:0033116; GO:1903561,blood circulation [GO:0008015]; blood coagulation [GO:0007596]; response to vitamin K [GO:0032571],COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093],copper ion binding [GO:0005507],GO:0003013; GO:0005576; GO:0005615; GO:0005886; GO:0031410; GO:0043226,circulatory system process; extracellular region; extracellular space; plasma membrane; cytoplasmic vesicle; organelle
OG_10908,FUN_008102-T1,Peve_00038882,,apul_peve,55.369,FUN_008102-T1,P49259,,,,,36.7,128.0,2.7e-12,74.3,sp|P49259|PLA2R_BOVIN Secretory phospholipase A2 receptor OS=Bos taurus OX=9913 GN=PLA2R1 PE=1 SV=1,,,,,,
OG_10909,FUN_008115-T2,Peve_00022342,,apul_peve,64.927,FUN_008115-T2,A6NMZ7,CO6A6_HUMAN,,Collagen alpha-6(VI) chain,Homo sapiens (Human),31.6,196.0,3.4e-12,74.7,sp|A6NMZ7|CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens OX=9606 GN=COL6A6 PE=1 SV=2,GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],,GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_10910,FUN_008123-T1,Peve_00022349,,apul_peve,49.1565,,,,,,,,,,,,,,,,,
OG_10911,FUN_008159-T1,Peve_00021712,,apul_peve,45.502,,,,,,,,,,,,,,,,,
OG_10912,FUN_008169-T1,Peve_00042114,,apul_peve,66.942,,,,,,,,,,,,,,,,,
OG_10913,FUN_008191-T1,Peve_00034185,,apul_peve,54.391,,,,,,,,,,,,,,,,,
OG_10914,FUN_008203-T1,Peve_00022160,,apul_peve,86.39750000000001,FUN_008203-T1,A0A1D5P556,,,,,57.3,1080.0,2.6e-243,843.6,sp|A0A1D5P556|DAAM2_CHICK Disheveled-associated activator of morphogenesis 2 OS=Gallus gallus OX=9031 GN=DAAM2 PE=1 SV=2,,,,,,
OG_10915,FUN_008216-T1,Peve_00005270,,apul_peve,69.65,FUN_008216-T1,Q4KLT0,RN217_XENLA,,E3 ubiquitin-protein ligase RNF217 (EC 2.3.2.31) (RING finger protein 217),Xenopus laevis (African clawed frog),35.2,267.0,9.7e-47,188.7,sp|Q4KLT0|RN217_XENLA E3 ubiquitin-protein ligase RNF217 OS=Xenopus laevis OX=8355 GN=rnf217 PE=2 SV=1,GO:0000151; GO:0005737; GO:0006511; GO:0008270; GO:0016020; GO:0016567; GO:0031624; GO:0061630,protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; membrane [GO:0016020]; ubiquitin ligase complex [GO:0000151],ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_10916,FUN_008221-T1,Peve_00012568,,apul_peve,68.896,,,,,,,,,,,,,,,,,
OG_10917,FUN_008223-T1,Peve_00012068,,apul_peve,75.28,FUN_008223-T1,Q9QYY8,,,,,52.9,476.0,1.1000000000000001e-118,428.3,sp|Q9QYY8|SPAST_MOUSE Spastin OS=Mus musculus OX=10090 GN=Spast PE=1 SV=3,,,,,,
OG_10918,FUN_008236-T3,Peve_00003867,,apul_peve,67.35,FUN_008236-T3,Q5EAR5,,,,,57.0,142.0,2.2e-37,156.8,sp|Q5EAR5|TRPT1_DANRE tRNA 2'-phosphotransferase 1 OS=Danio rerio OX=7955 GN=trpt1 PE=2 SV=2,,,,,,
OG_10919,FUN_008240-T1,Peve_00031780,,apul_peve,71.269,FUN_008240-T1,Q8UUY8,,,,,27.5,305.0,1.6e-12,75.5,sp|Q8UUY8|ADRB2_ONCMY Beta-2 adrenergic receptor OS=Oncorhynchus mykiss OX=8022 GN=adrb2 PE=2 SV=1,,,,,,
OG_10920,FUN_008251-T1,Peve_00024421,,apul_peve,57.514,FUN_008251-T1,Q9LIN3,RZ1A_ARATH,,Glycine-rich RNA-binding protein RZ1A (AtRZ-1a),Arabidopsis thaliana (Mouse-ear cress),36.0,86.0,5e-06,53.5,sp|Q9LIN3|RZ1A_ARATH Glycine-rich RNA-binding protein RZ1A OS=Arabidopsis thaliana OX=3702 GN=RZ1A PE=1 SV=1,GO:0000166; GO:0003677; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0009409,response to cold [GO:0009409],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA binding [GO:0003677]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005829; GO:0043226,DNA binding; RNA binding; nucleus; cytosol; organelle
OG_10921,FUN_008255-T1,Peve_00009134,,apul_peve,78.576,FUN_008255-T1,Q9IAL1,,,,,44.8,105.0,3e-11,69.3,sp|Q9IAL1|VSX2_CHICK Visual system homeobox 2 OS=Gallus gallus OX=9031 GN=VSX2 PE=2 SV=1,,,,,,
OG_10922,FUN_008257-T1,Peve_00042071,,apul_peve,84.783,FUN_008257-T1,P46825,,,,,68.9,502.0,4.6e-72,273.9,sp|P46825|KLC_DORPE Kinesin light chain OS=Doryteuthis pealeii OX=1051067 PE=2 SV=1,,,,,,
OG_10923,FUN_008261-T1,Peve_00042077,,apul_peve,57.585,FUN_008261-T1,O88451,,,,,42.1,302.0,8.100000000000002e-60,232.3,sp|O88451|RDH7_MOUSE Retinol dehydrogenase 7 OS=Mus musculus OX=10090 GN=Rdh7 PE=1 SV=1,,,,,,
OG_10924,FUN_008287-T1,Peve_00018509,,apul_peve,51.582,,,,,,,,,,,,,,,,,
OG_10925,FUN_008291-T1,Peve_00005971,,apul_peve,47.671,,,,,,,,,,,,,,,,,
OG_10926,FUN_008299-T1,Peve_00012976,,apul_peve,60.151,FUN_008299-T1,Q9H7Z3,NRDE2_HUMAN,,Nuclear exosome regulator NRDE2 (Protein NRDE2 homolog),Homo sapiens (Human),31.9,407.0,2.7e-49,197.6,sp|Q9H7Z3|NRDE2_HUMAN Nuclear exosome regulator NRDE2 OS=Homo sapiens OX=9606 GN=NRDE2 PE=1 SV=3,GO:0000278; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006974; GO:0008380; GO:0016607; GO:0031048; GO:0046833; GO:0048255; GO:0051301; GO:1902369,cell division [GO:0051301]; DNA damage response [GO:0006974]; mitotic cell cycle [GO:0000278]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0000278; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0016071; GO:0031047; GO:0043226,mitotic cell cycle; nucleus; nucleoplasm; nucleolus; chromatin organization; mRNA metabolic process; regulatory ncRNA-mediated gene silencing; organelle
OG_10927,FUN_008301-T1,Peve_00012975,,apul_peve,48.695,FUN_008301-T1,Q9H7Z3,NRDE2_HUMAN,,Nuclear exosome regulator NRDE2 (Protein NRDE2 homolog),Homo sapiens (Human),35.4,339.0,5.3e-47,190.3,sp|Q9H7Z3|NRDE2_HUMAN Nuclear exosome regulator NRDE2 OS=Homo sapiens OX=9606 GN=NRDE2 PE=1 SV=3,GO:0000278; GO:0005634; GO:0005654; GO:0005730; GO:0006397; GO:0006974; GO:0008380; GO:0016607; GO:0031048; GO:0046833; GO:0048255; GO:0051301; GO:1902369,cell division [GO:0051301]; DNA damage response [GO:0006974]; mitotic cell cycle [GO:0000278]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of RNA catabolic process [GO:1902369]; positive regulation of RNA export from nucleus [GO:0046833]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]; RNA splicing [GO:0008380],nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,GO:0000278; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0016071; GO:0031047; GO:0043226,mitotic cell cycle; nucleus; nucleoplasm; nucleolus; chromatin organization; mRNA metabolic process; regulatory ncRNA-mediated gene silencing; organelle
OG_10928,FUN_008313-T3,Peve_00025217,,apul_peve,75.842,FUN_008313-T3,Q8BXJ9,,,,,41.2,493.0,7.6e-111,402.5,sp|Q8BXJ9|TMM62_MOUSE Transmembrane protein 62 OS=Mus musculus OX=10090 GN=Tmem62 PE=2 SV=1,,,,,,
OG_10929,FUN_008317-T1,Peve_00005689,,apul_peve,40.577,,,,,,,,,,,,,,,,,
OG_10930,FUN_008330-T1,Peve_00000557,,apul_peve,41.875,FUN_008330-T1,B8V7S0,,,,,53.9,165.0,1.4999999999999999e-40,171.0,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10931,FUN_008375-T1,Peve_00042636,,apul_peve,51.138,,,,,,,,,,,,,,,,,
OG_10932,FUN_008387-T1,Peve_00028174,,apul_peve,74.501,FUN_008387-T1,F1NZI4,,,,,37.4,684.0,2.0000000000000003e-124,448.0,sp|F1NZI4|PGGHG_CHICK Protein-glucosylgalactosylhydroxylysine glucosidase OS=Gallus gallus OX=9031 GN=PGGHG PE=1 SV=3,,,,,,
OG_10933,FUN_008391-T1,Peve_00034701,,apul_peve,48.148,FUN_008391-T1,Q66KB7,,,,,33.8,133.0,5.8e-20,99.4,sp|Q66KB7|UEVLD_XENTR Ubiquitin-conjugating enzyme E2 variant 3 OS=Xenopus tropicalis OX=8364 GN=uevld PE=2 SV=1,,,,,,
OG_10934,FUN_008417-T1,Peve_00009797,,apul_peve,88.863,FUN_008417-T1,Q8TBZ3,WDR20_HUMAN,,WD repeat-containing protein 20 (Protein DMR),Homo sapiens (Human),54.1,560.0,2.6e-148,526.9,sp|Q8TBZ3|WDR20_HUMAN WD repeat-containing protein 20 OS=Homo sapiens OX=9606 GN=WDR20 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005737; GO:0035800,,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],deubiquitinase activator activity [GO:0035800],GO:0005634; GO:0005654; GO:0043226; GO:0098772,nucleus; nucleoplasm; organelle; molecular function regulator activity
OG_10935,FUN_008422-T2,Peve_00033726,,apul_peve,79.52250000000001,FUN_008422-T2,Q6RT24,CENPE_MOUSE,,Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10),Mus musculus (Mouse),51.6,436.0,7.599999999999999e-107,391.0,sp|Q6RT24|CENPE_MOUSE Centromere-associated protein E OS=Mus musculus OX=10090 GN=Cenpe PE=1 SV=1,GO:0000775; GO:0000776; GO:0000940; GO:0003777; GO:0005524; GO:0005737; GO:0005819; GO:0007018; GO:0007057; GO:0007080; GO:0007088; GO:0007094; GO:0008017; GO:0008608; GO:0019901; GO:0031647; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051301; GO:0051310; GO:0051315; GO:0051984; GO:0051987; GO:0099607,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; establishment of protein localization [GO:0045184]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; outer kinetochore [GO:0000940]; spindle [GO:0005819]",ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901],GO:0003774; GO:0003824; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0022414; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; reproductive process; organelle; ATP-dependent activity
OG_10936,FUN_008461-T1,Peve_00011003,,apul_peve,68.5595,FUN_008461-T1,Q2EG98,PK1L3_MOUSE,,Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3),Mus musculus (Mouse),25.0,1197.0,9.4e-90,334.3,sp|Q2EG98|PK1L3_MOUSE Polycystin-1-like protein 3 OS=Mus musculus OX=10090 GN=Pkd1l3 PE=1 SV=3,GO:0001581; GO:0005227; GO:0005509; GO:0005886; GO:0006812; GO:0030246; GO:0034703; GO:0043235; GO:0044325; GO:0070588; GO:0071468; GO:0160128,calcium ion transmembrane transport [GO:0070588]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; monoatomic cation transport [GO:0006812],cation channel complex [GO:0034703]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; carbohydrate binding [GO:0030246]; pH-gated monoatomic ion channel activity [GO:0160128]; transmembrane transporter binding [GO:0044325],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_10937,FUN_008465-T1,Peve_00011012,,apul_peve,48.994,FUN_008465-T1,Q7TN88,,,,,33.8,376.0,2.4e-59,233.4,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_10938,FUN_008474-T1,Peve_00028802,,apul_peve,65.169,FUN_008474-T1,Q2EG98,PK1L3_MOUSE,,Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3),Mus musculus (Mouse),24.0,1164.0,9.999999999999999e-87,323.9,sp|Q2EG98|PK1L3_MOUSE Polycystin-1-like protein 3 OS=Mus musculus OX=10090 GN=Pkd1l3 PE=1 SV=3,GO:0001581; GO:0005227; GO:0005509; GO:0005886; GO:0006812; GO:0030246; GO:0034703; GO:0043235; GO:0044325; GO:0070588; GO:0071468; GO:0160128,calcium ion transmembrane transport [GO:0070588]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; monoatomic cation transport [GO:0006812],cation channel complex [GO:0034703]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; carbohydrate binding [GO:0030246]; pH-gated monoatomic ion channel activity [GO:0160128]; transmembrane transporter binding [GO:0044325],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_10939,FUN_008476-T1,Peve_00028800,,apul_peve,54.815,,,,,,,,,,,,,,,,,
OG_10940,FUN_008478-T1,Peve_00038343,,apul_peve,55.7075,FUN_008478-T1,Q9JJS0,SCUB2_MOUSE,,"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1) (Scube/You)",Mus musculus (Mouse),52.4,42.0,3.4e-06,55.1,"sp|Q9JJS0|SCUB2_MOUSE Signal peptide, CUB and EGF-like domain-containing protein 2 OS=Mus musculus OX=10090 GN=Scube2 PE=1 SV=1",GO:0003413; GO:0005509; GO:0005615; GO:0008289; GO:0009986; GO:0019897; GO:0042802; GO:0045669; GO:0045778; GO:0045880; GO:0097108; GO:1902732,chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smoothened signaling pathway [GO:0045880],cell surface [GO:0009986]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897],calcium ion binding [GO:0005509]; hedgehog family protein binding [GO:0097108]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],GO:0005615; GO:0008289; GO:0030154,extracellular space; lipid binding; cell differentiation
OG_10941,FUN_008480-T1,Peve_00028796,,apul_peve,78.532,FUN_008480-T1,P15388,,,,,38.9,478.0,8.9e-83,309.3,sp|P15388|KCNC1_MOUSE Voltage-gated potassium channel KCNC1 OS=Mus musculus OX=10090 GN=Kcnc1 PE=1 SV=1,,,,,,
OG_10942,FUN_008485-T1,Peve_00028793,,apul_peve,69.684,FUN_008485-T1,Q9UJA9,ENPP5_HUMAN,,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-),Homo sapiens (Human),35.9,415.0,2.7e-75,284.3,sp|Q9UJA9|ENPP5_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Homo sapiens OX=9606 GN=ENPP5 PE=1 SV=1,GO:0000210; GO:0005576; GO:0005886; GO:0007154; GO:0008270,cell communication [GO:0007154],extracellular region [GO:0005576]; plasma membrane [GO:0005886],NAD+ diphosphatase activity [GO:0000210]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005886; GO:0016787,catalytic activity; extracellular region; plasma membrane; hydrolase activity
OG_10943,FUN_008526-T1,Peve_00035658,,apul_peve,65.031,FUN_008526-T1,P49454,CENPF_HUMAN,,Centromere protein F (CENP-F) (AH antigen) (Kinetochore protein CENPF) (Mitosin),Homo sapiens (Human),60.4,48.0,8.9e-08,58.5,sp|P49454|CENPF_HUMAN Centromere protein F OS=Homo sapiens OX=9606 GN=CENPF PE=1 SV=3,GO:0000278; GO:0000775; GO:0000776; GO:0000785; GO:0000922; GO:0000940; GO:0001822; GO:0003682; GO:0005634; GO:0005635; GO:0005654; GO:0005737; GO:0005813; GO:0005819; GO:0005829; GO:0005930; GO:0007059; GO:0007094; GO:0007517; GO:0008017; GO:0009410; GO:0010389; GO:0015031; GO:0016202; GO:0016363; GO:0021591; GO:0030154; GO:0030496; GO:0036064; GO:0042803; GO:0045120; GO:0045892; GO:0048471; GO:0051301; GO:0051310; GO:0051382; GO:0070840; GO:0071897; GO:0097539; GO:0140297,cell differentiation [GO:0030154]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase chromosome alignment [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint signaling [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of DNA-templated transcription [GO:0045892]; protein transport [GO:0015031]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to xenobiotic stimulus [GO:0009410]; ventricular system development [GO:0021591],"axoneme [GO:0005930]; centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]",chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0000278; GO:0005634; GO:0005635; GO:0005654; GO:0005815; GO:0005829; GO:0006355; GO:0007059; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0065003,mitotic cell cycle; nucleus; nuclear envelope; nucleoplasm; microtubule organizing center; cytosol; regulation of DNA-templated transcription; chromosome segregation; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly
OG_10944,FUN_008539-T2,Peve_00014612,,apul_peve,83.489,FUN_008539-T2,Q32KW0,,,,,60.9,156.0,4.6e-39,163.3,sp|Q32KW0|NFYB_BOVIN Nuclear transcription factor Y subunit beta OS=Bos taurus OX=9913 GN=NFYB PE=2 SV=1,,,,,,
OG_10945,FUN_008546-T1,Peve_00013779,,apul_peve,38.75,,,,,,,,,,,,,,,,,
OG_10946,FUN_008554-T1,Peve_00039129,,apul_peve,70.218,,,,,,,,,,,,,,,,,
OG_10947,FUN_008557-T1,Peve_00033373,,apul_peve,59.69,,,,,,,,,,,,,,,,,
OG_10948,FUN_008574-T1,Peve_00044726,,apul_peve,57.447,FUN_008574-T1,P02678,,,,,41.4,58.0,4.3e-06,53.9,sp|P02678|FIBB_PETMA Fibrinogen beta chain (Fragments) OS=Petromyzon marinus OX=7757 PE=1 SV=2,,,,,,
OG_10949,FUN_008589-T1,Peve_00026588,,apul_peve,35.736000000000004,,,,,,,,,,,,,,,,,
OG_10950,FUN_008591-T1,Peve_00036216,,apul_peve,53.78,FUN_008591-T1,Q6PDJ1,,,,,30.3,1080.0,4.4e-131,471.1,sp|Q6PDJ1|CAHD1_MOUSE VWFA and cache domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cachd1 PE=1 SV=1,,,,,,
OG_10951,FUN_008593-T1,Peve_00036205,,apul_peve,50.4935,FUN_008593-T1,Q5VU97,CAHD1_HUMAN,,VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1),Homo sapiens (Human),29.8,1157.0,5.8e-128,460.7,sp|Q5VU97|CAHD1_HUMAN VWFA and cache domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CACHD1 PE=1 SV=2,GO:0005245; GO:0005891,,voltage-gated calcium channel complex [GO:0005891],voltage-gated calcium channel activity [GO:0005245],GO:0005215,transporter activity
OG_10952,FUN_008630-T1,Peve_00012385,,apul_peve,32.751,,,,,,,,,,,,,,,,,
OG_10953,FUN_008637-T1,Peve_00036533,,apul_peve,44.9055,,,,,,,,,,,,,,,,,
OG_10954,FUN_008639-T1,Peve_00036531,,apul_peve,46.6025,,,,,,,,,,,,,,,,,
OG_10955,FUN_008655-T1,Peve_00040323,,apul_peve,52.874,,,,,,,,,,,,,,,,,
OG_10956,FUN_008692-T1,Peve_00040324,,apul_peve,48.238,FUN_008692-T1,P30974,,,,,25.3,392.0,3.4000000000000003e-22,107.5,sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2,,,,,,
OG_10957,FUN_008693-T2,Peve_00040326,,apul_peve,57.411,FUN_008693-T2,O97512,,,,,27.5,298.0,1.8e-20,101.7,sp|O97512|NK3R_RABIT Neuromedin-K receptor OS=Oryctolagus cuniculus OX=9986 GN=TACR3 PE=2 SV=2,,,,,,
OG_10958,FUN_008698-T1,Peve_00001074,,apul_peve,63.952,FUN_008698-T1,Q6PDJ1,,,,,31.5,1092.0,8.1e-147,523.1,sp|Q6PDJ1|CAHD1_MOUSE VWFA and cache domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cachd1 PE=1 SV=1,,,,,,
OG_10959,FUN_008715-T1,Peve_00017041,,apul_peve,39.437,,,,,,,,,,,,,,,,,
OG_10960,FUN_008722-T1,Peve_00019171,,apul_peve,40.283,,,,,,,,,,,,,,,,,
OG_10961,FUN_008728-T1,Peve_00034532,,apul_peve,52.921,,,,,,,,,,,,,,,,,
OG_10962,FUN_008738-T1,Peve_00013707,,apul_peve,30.205,FUN_008738-T1,O42357,,,,,26.5,147.0,3.8e-06,53.9,sp|O42357|RX2_DANRE Retinal homeobox protein Rx2 OS=Danio rerio OX=7955 GN=rx2 PE=2 SV=1,,,,,,
OG_10963,FUN_008741-T1,Peve_00033274,,apul_peve,49.103,,,,,,,,,,,,,,,,,
OG_10964,FUN_008744-T1,Peve_00015783,,apul_peve,38.506,,,,,,,,,,,,,,,,,
OG_10965,FUN_008750-T1,Peve_00022486,,apul_peve,82.132,,,,,,,,,,,,,,,,,
OG_10966,FUN_008764-T1,Peve_00042303,,apul_peve,39.921,,,,,,,,,,,,,,,,,
OG_10967,FUN_008775-T1,Peve_00036713,,apul_peve,60.007,FUN_008775-T1,E7F7V7,,,,,28.1,292.0,5.1e-19,97.1,sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1,,,,,,
OG_10968,FUN_008777-T1,Peve_00043618,,apul_peve,58.763,FUN_008777-T1,P10181,ROUGH_DROME,,Homeobox protein rough,Drosophila melanogaster (Fruit fly),40.3,62.0,4.7e-06,53.5,sp|P10181|ROUGH_DROME Homeobox protein rough OS=Drosophila melanogaster OX=7227 GN=ro PE=2 SV=4,GO:0000977; GO:0000978; GO:0000981; GO:0005634; GO:0006357; GO:0007463; GO:0007601; GO:0042067; GO:0045944; GO:0048054,establishment of ommatidial planar polarity [GO:0042067]; positive regulation of transcription by RNA polymerase II [GO:0045944]; R2/R5 cell differentiation [GO:0048054]; R2/R5 cell fate commitment [GO:0007463]; regulation of transcription by RNA polymerase II [GO:0006357]; visual perception [GO:0007601],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0007163; GO:0030154; GO:0043226; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; establishment or maintenance of cell polarity; cell differentiation; organelle; nervous system process; transcription regulator activity
OG_10969,FUN_008779-T1,Peve_00034024,,apul_peve,58.847,,,,,,,,,,,,,,,,,
OG_10970,FUN_008819-T1,Peve_00043544,,apul_peve,54.167,,,,,,,,,,,,,,,,,
OG_10971,FUN_008823-T1,Peve_00031984,,apul_peve,50.7325,,,,,,,,,,,,,,,,,
OG_10972,FUN_008840-T1,Peve_00025917,,apul_peve,72.715,,,,,,,,,,,,,,,,,
OG_10973,FUN_008854-T1,Peve_00039796,,apul_peve,78.295,,,,,,,,,,,,,,,,,
OG_10974,FUN_008891-T1,Peve_00002345,,apul_peve,64.103,FUN_008891-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),31.2,327.0,1.6e-27,125.2,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_10975,FUN_008892-T1,Peve_00015980,,apul_peve,64.286,,,,,,,,,,,,,,,,,
OG_10976,FUN_008899-T1,Peve_00007332,,apul_peve,58.879,,,,,,,,,,,,,,,,,
OG_10977,FUN_008920-T1,Peve_00020780,,apul_peve,60.574,,,,,,,,,,,,,,,,,
OG_10978,FUN_008925-T1,Peve_00036400,,apul_peve,62.5,FUN_008925-T1,P10620,MGST1_HUMAN,,Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I),Homo sapiens (Human),43.8,121.0,1.4e-12,73.9,sp|P10620|MGST1_HUMAN Microsomal glutathione S-transferase 1 OS=Homo sapiens OX=9606 GN=MGST1 PE=1 SV=1,GO:0004364; GO:0004602; GO:0005739; GO:0005741; GO:0005778; GO:0005783; GO:0005789; GO:0005886; GO:0016020; GO:0034635; GO:0035577; GO:0071449,cellular response to lipid hydroperoxide [GO:0071449]; glutathione transport [GO:0034635],azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886],glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364],GO:0003824; GO:0005739; GO:0005783; GO:0005886; GO:0016209; GO:0016491; GO:0016740; GO:0043226,catalytic activity; mitochondrion; endoplasmic reticulum; plasma membrane; antioxidant activity; oxidoreductase activity; transferase activity; organelle
OG_10979,FUN_008937-T1,Peve_00036389,,apul_peve,78.305,FUN_008937-T1,A4YI89,,,,,36.0,214.0,3.8e-32,140.2,sp|A4YI89|HPCD_METS5 3-hydroxypropionyl-coenzyme A dehydratase OS=Metallosphaera sedula (strain ATCC 51363 / DSM 5348 / JCM 9185 / NBRC 15509 / TH2) OX=399549 GN=Msed_2001 PE=1 SV=1,,,,,,
OG_10980,FUN_008939-T1,Peve_00007193,,apul_peve,68.97800000000001,FUN_008939-T1,Q09081,KCNA2_RABIT,,Potassium voltage-gated channel subfamily A member 2 (KC22) (Voltage-gated potassium channel subunit Kv1.2),Oryctolagus cuniculus (Rabbit),39.8,231.0,2.7e-38,160.6,sp|Q09081|KCNA2_RABIT Potassium voltage-gated channel subfamily A member 2 OS=Oryctolagus cuniculus OX=9986 GN=KCNA2 PE=1 SV=2,GO:0005249; GO:0005251; GO:0005789; GO:0005886; GO:0008076; GO:0014059; GO:0019228; GO:0019233; GO:0021633; GO:0030027; GO:0030424; GO:0030425; GO:0031258; GO:0032809; GO:0033010; GO:0042734; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045188; GO:0051260; GO:0071805,"neuronal action potential [GO:0019228]; optic nerve structural organization [GO:0021633]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of dopamine secretion [GO:0014059]; sensory perception of pain [GO:0019233]",axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; juxtaparanode region of axon [GO:0044224]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; neuronal cell body membrane [GO:0032809]; paranodal junction [GO:0033010]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0050877; GO:0055085; GO:0065003,transporter activity; plasma membrane; nervous system process; transmembrane transport; protein-containing complex assembly
OG_10981,FUN_008957-T1,Peve_00021625,,apul_peve,53.191,FUN_008957-T1,P0CT24,,,,,53.7,54.0,6.6e-11,68.6,sp|P0CT24|GLU2B_MYCMD Glucosidase 2 subunit beta OS=Mycosarcoma maydis OX=5270 GN=UMAG_12045 PE=3 SV=1,,,,,,
OG_10982,FUN_008963-T1,Peve_00007335,,apul_peve,73.52,FUN_008963-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),28.6,304.0,3.2e-16,87.4,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_10983,FUN_008971-T1,Peve_00007341,,apul_peve,75.694,FUN_008971-T1,A1L2F6,,,,,33.3,171.0,1e-18,95.1,sp|A1L2F6|TM205_DANRE Transmembrane protein 205 OS=Danio rerio OX=7955 GN=tmem205 PE=2 SV=1,,,,,,
OG_10984,FUN_008976-T1,Peve_00007754,,apul_peve,71.972,FUN_008976-T1,Q3MIE0,,,,,67.3,254.0,1.2999999999999996e-90,334.3,"sp|Q3MIE0|ECHD3_RAT Enoyl-CoA hydratase domain-containing protein 3, mitochondrial OS=Rattus norvegicus OX=10116 GN=Echdc3 PE=2 SV=1",,,,,,
OG_10985,FUN_008987-T2,Peve_00001697,,apul_peve,92.606,FUN_008987-T2,E1BKH1,EFHC1_BOVIN,,EF-hand domain-containing protein 1 (Myoclonin-1),Bos taurus (Bovine),59.7,551.0,1.2e-199,697.6,sp|E1BKH1|EFHC1_BOVIN EF-hand domain-containing protein 1 OS=Bos taurus OX=9913 GN=EFHC1 PE=1 SV=1,GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005879; GO:0005930; GO:0007052; GO:0021795; GO:0030317; GO:0036126; GO:0043014; GO:0051302; GO:0060285; GO:0072686; GO:0160111,cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; flagellated sperm motility [GO:0030317]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922],alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509],GO:0000910; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0048870,cytokinesis; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; cell motility
OG_10986,FUN_008992-T2,Peve_00023811,,apul_peve,62.658,FUN_008992-T2,Q91611,DHHB_XENLA,,Desert hedgehog protein B (EC 3.1.-.-) (Desert hedgehog protein 2) (DHH-2) (Hedgehog protein 4) (X-HH4) [Cleaved into: Desert hedgehog protein B N-product],Xenopus laevis (African clawed frog),36.1,194.0,1.3e-27,125.6,sp|Q91611|DHHB_XENLA Desert hedgehog protein B OS=Xenopus laevis OX=8355 GN=dhh-b PE=2 SV=1,GO:0000139; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005789; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0010468; GO:0016540; GO:0045880; GO:0097264; GO:0140853,cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224],endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233],GO:0003824; GO:0005615; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; transferase activity; hydrolase activity; signaling; protein maturation; catalytic activity, acting on a protein"
OG_10987,FUN_008995-T1,Peve_00013184,,apul_peve,86.31,FUN_008995-T1,A8XJ93,RL112_CAEBR,,Large ribosomal subunit protein uL5B (60S ribosomal protein L11-2),Caenorhabditis briggsae,82.6,167.0,1.1e-76,287.3,sp|A8XJ93|RL112_CAEBR Large ribosomal subunit protein uL5B OS=Caenorhabditis briggsae OX=6238 GN=rpl-11.2 PE=3 SV=1,GO:0003723; GO:0003735; GO:0005634; GO:0006412; GO:0019843; GO:0022625,translation [GO:0006412],cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],GO:0003723; GO:0005198; GO:0005634; GO:0043226,RNA binding; structural molecule activity; nucleus; organelle
OG_10988,FUN_008998-T1,Peve_00021073,,apul_peve,37.3665,FUN_008998-T1,B3EWY6,,,,,27.2,239.0,2.3000000000000003e-22,107.8,sp|B3EWY6|SAAR1_ACRMI Skeletal aspartic acid-rich protein 1 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_10989,FUN_009001-T1,Peve_00023429,,apul_peve,70.783,FUN_009001-T1,Q2YDN1,,,,,29.1,309.0,2.1e-26,121.3,sp|Q2YDN1|GP161_BOVIN G protein-coupled receptor 161 OS=Bos taurus OX=9913 GN=GPR161 PE=2 SV=1,,,,,,
OG_10990,FUN_009005-T1,Peve_00023427,,apul_peve,47.2325,FUN_009005-T1,Q5ZID2,,,,,30.8,413.0,1e-43,179.1,sp|Q5ZID2|PDD2L_CHICK Programmed cell death protein 2-like OS=Gallus gallus OX=9031 GN=PDCD2L PE=2 SV=1,,,,,,
OG_10991,FUN_009011-T1,Peve_00031166,,apul_peve,36.517,,,,,,,,,,,,,,,,,
OG_10992,FUN_009020-T1,Peve_00044340,,apul_peve,65.217,FUN_009020-T1,Q90678,,,,,39.5,377.0,6.7e-65,249.6,sp|Q90678|PAFA_CHICK Platelet-activating factor acetylhydrolase OS=Gallus gallus OX=9031 GN=PLA2G7 PE=2 SV=1,,,,,,
OG_10993,FUN_009030-T1,Peve_00034081,,apul_peve,53.268,,,,,,,,,,,,,,,,,
OG_10994,FUN_009123-T1,Peve_00022658,,apul_peve,60.331,,,,,,,,,,,,,,,,,
OG_10995,FUN_009127-T1,Peve_00000230,,apul_peve,49.138,,,,,,,,,,,,,,,,,
OG_10996,FUN_009158-T1,Peve_00038962,,apul_peve,78.125,,,,,,,,,,,,,,,,,
OG_10997,FUN_009255-T1,Peve_00026351,,apul_peve,37.267,,,,,,,,,,,,,,,,,
OG_10998,FUN_009256-T1,Peve_00023011,,apul_peve,57.303,,,,,,,,,,,,,,,,,
OG_10999,FUN_009257-T1,Peve_00027037,,apul_peve,36.17,,,,,,,,,,,,,,,,,
OG_11000,FUN_009266-T2,Peve_00032034,,apul_peve,68.8295,FUN_009266-T2,O35413,SRBS2_RAT,,Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Neural ArgBP2) (nArgBP2) (Sorbin),Rattus norvegicus (Rat),34.8,339.0,4.1e-40,168.3,sp|O35413|SRBS2_RAT Sorbin and SH3 domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Sorbs2 PE=1 SV=2,GO:0005886; GO:0005925; GO:0007219; GO:0016324; GO:0019904; GO:0030027; GO:0030425; GO:0043025; GO:0045202; GO:0048471; GO:0061049; GO:0095500; GO:1904393,acetylcholine receptor signaling pathway [GO:0095500]; cell growth involved in cardiac muscle cell development [GO:0061049]; Notch signaling pathway [GO:0007219]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393],apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; synapse [GO:0045202],protein domain specific binding [GO:0019904],GO:0005886,plasma membrane
OG_11001,FUN_009287-T1,Peve_00042345,,apul_peve,84.184,,,,,,,,,,,,,,,,,
OG_11002,FUN_009288-T1,Peve_00016951,,apul_peve,48.5565,,,,,,,,,,,,,,,,,
OG_11003,FUN_009300-T1,Peve_00014038,,apul_peve,45.977,,,,,,,,,,,,,,,,,
OG_11004,FUN_009302-T1,Peve_00005832,,apul_peve,51.289,,,,,,,,,,,,,,,,,
OG_11005,FUN_009310-T1,Peve_00021838,,apul_peve,49.479,,,,,,,,,,,,,,,,,
OG_11006,FUN_009319-T1,Peve_00007349,,apul_peve,53.846,,,,,,,,,,,,,,,,,
OG_11007,FUN_009321-T1,Peve_00007344,,apul_peve,57.388,FUN_009321-T1,P48733,,,,,39.3,145.0,4.7e-23,110.2,sp|P48733|UROM_BOVIN Uromodulin OS=Bos taurus OX=9913 GN=UMOD PE=2 SV=1,,,,,,
OG_11008,FUN_009341-T1,Peve_00020241,,apul_peve,55.718,FUN_009341-T1,Q862Z3,,,,,29.0,279.0,5.1e-18,93.6,sp|Q862Z3|UROM_CANLF Uromodulin OS=Canis lupus familiaris OX=9615 GN=UMOD PE=2 SV=1,,,,,,
OG_11009,FUN_009346-T1,Peve_00026200,,apul_peve,35.577,FUN_009346-T1,Q90268,PAX2A_DANRE,,Paired box protein Pax-2a (No isthmus protein) (Pax[Zf-b]),Danio rerio (Zebrafish) (Brachydanio rerio),76.0,104.0,4.5e-40,167.5,sp|Q90268|PAX2A_DANRE Paired box protein Pax-2a OS=Danio rerio OX=7955 GN=pax2a PE=2 SV=2,GO:0000978; GO:0000981; GO:0001708; GO:0001822; GO:0003677; GO:0003700; GO:0005634; GO:0006357; GO:0007399; GO:0007422; GO:0007423; GO:0009880; GO:0009952; GO:0021549; GO:0021588; GO:0021703; GO:0030878; GO:0030901; GO:0030902; GO:0030917; GO:0034672; GO:0035775; GO:0043049; GO:0043565; GO:0048596; GO:0048793; GO:0060113; GO:0060118; GO:0060271; GO:0061386; GO:0072114,anterior/posterior pattern specification [GO:0009952]; anterior/posterior pattern specification involved in pronephros development [GO:0034672]; cell fate specification [GO:0001708]; cerebellum development [GO:0021549]; cerebellum formation [GO:0021588]; cilium assembly [GO:0060271]; closure of optic fissure [GO:0061386]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic pattern specification [GO:0009880]; hindbrain development [GO:0030902]; inner ear receptor cell differentiation [GO:0060113]; kidney development [GO:0001822]; locus ceruleus development [GO:0021703]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; nervous system development [GO:0007399]; otic placode formation [GO:0043049]; peripheral nervous system development [GO:0007422]; pronephric glomerulus morphogenesis [GO:0035775]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423]; thyroid gland development [GO:0030878]; vestibular receptor cell development [GO:0060118],nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0044782; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; cilium organization; anatomical structure development; transcription regulator activity
OG_11010,FUN_009352-T1,Peve_00038077,,apul_peve,67.763,,,,,,,,,,,,,,,,,
OG_11011,FUN_009358-T1,Peve_00003730,,apul_peve,49.511,FUN_009358-T1,Q9DBN1,STR6L_MOUSE,,Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2),Mus musculus (Mouse),28.3,643.0,1.2e-43,179.5,sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1,GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939,establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939],plasma membrane [GO:0005886],retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_11012,FUN_009363-T1,Peve_00030308,,apul_peve,70.99799999999999,FUN_009363-T1,P35601,RFC1_MOUSE,,Replication factor C subunit 1 (A1-P145) (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (Differentiation-specific element-binding protein) (ISRE-binding protein) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit),Mus musculus (Mouse),46.1,959.0,1.7e-202,708.0,sp|P35601|RFC1_MOUSE Replication factor C subunit 1 OS=Mus musculus OX=10090 GN=Rfc1 PE=1 SV=2,GO:0003677; GO:0003689; GO:0005524; GO:0005634; GO:0005663; GO:0006261; GO:0006281; GO:0016887; GO:0031391; GO:0061860,DNA repair [GO:0006281]; DNA-templated DNA replication [GO:0006261],DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860],GO:0003677; GO:0003824; GO:0005634; GO:0006260; GO:0006281; GO:0016787; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA replication; DNA repair; hydrolase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_11013,FUN_009364-T1,Peve_00033729,,apul_peve,35.769,FUN_009364-T1,Q9Y6Z7,COL10_HUMAN,,Collectin-10 (Collectin liver protein 1) (CL-L1) (Collectin-34) (CL-34),Homo sapiens (Human),30.3,119.0,5.7e-07,56.6,sp|Q9Y6Z7|COL10_HUMAN Collectin-10 OS=Homo sapiens OX=9606 GN=COLEC10 PE=1 SV=2,GO:0001867; GO:0002752; GO:0005537; GO:0005576; GO:0005581; GO:0005615; GO:0005737; GO:0005794; GO:0006508; GO:0009897; GO:0042056; GO:1903028; GO:1904888; GO:1905370,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; cranial skeletal system development [GO:1904888]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]",collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; serine-type endopeptidase complex [GO:1905370],chemoattractant activity [GO:0042056]; D-mannose binding [GO:0005537],GO:0002376; GO:0005576; GO:0005615; GO:0005794; GO:0043226; GO:0048018; GO:0048856; GO:0098542; GO:0098772,immune system process; extracellular region; extracellular space; Golgi apparatus; organelle; receptor ligand activity; anatomical structure development; defense response to other organism; molecular function regulator activity
OG_11014,FUN_009370-T1,Peve_00033727,,apul_peve,35.766,FUN_009370-T1,Q8HY11,,,,,36.0,136.0,1.1e-15,85.5,sp|Q8HY11|CLC4M_SYMSY C-type lectin domain family 4 member M OS=Symphalangus syndactylus OX=9590 GN=CLEC4M PE=3 SV=1,,,,,,
OG_11015,FUN_009372-T1,Peve_00033733,,apul_peve,36.641,FUN_009372-T1,Q8HY06,,,,,33.8,139.0,5.8e-15,83.2,sp|Q8HY06|CLC4M_GORGO C-type lectin domain family 4 member M OS=Gorilla gorilla gorilla OX=9595 GN=CLEC4M PE=3 SV=1,,,,,,
OG_11016,FUN_009373-T1,Peve_00019202,,apul_peve,40.526,,,,,,,,,,,,,,,,,
OG_11017,FUN_009387-T1,Peve_00015471,,apul_peve,47.7625,FUN_009387-T1,B8VIU6,,,,,62.3,151.0,4.2e-51,203.8,sp|B8VIU6|USOM5_ACRMI Uncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11018,FUN_009395-T1,Peve_00028627,,apul_peve,42.751,,,,,,,,,,,,,,,,,
OG_11019,FUN_009407-T1,Peve_00000231,,apul_peve,50.6895,,,,,,,,,,,,,,,,,
OG_11020,FUN_009436-T1,Peve_00025245,,apul_peve,45.404,FUN_009436-T1,A8E627,,,,,30.3,221.0,1.6e-19,98.6,sp|A8E627|ENDUD_XENLA Uridylate-specific endoribonuclease D OS=Xenopus laevis OX=8355 GN=endou-d PE=2 SV=1,,,,,,
OG_11021,FUN_009449-T1,Peve_00006080,,apul_peve,70.346,FUN_009449-T1,Q9DBW0,CP4V2_MOUSE,,Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),Mus musculus (Mouse),47.4,502.0,1.7e-128,461.1,sp|Q9DBW0|CP4V2_MOUSE Cytochrome P450 4V2 OS=Mus musculus OX=10090 GN=Cyp4v2 PE=1 SV=1,GO:0005506; GO:0005789; GO:0010430; GO:0020037; GO:0102033,fatty acid omega-oxidation [GO:0010430],endoplasmic reticulum membrane [GO:0005789],heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_11022,FUN_009458-T1,Peve_00015360,,apul_peve,33.917,,,,,,,,,,,,,,,,,
OG_11023,FUN_009460-T1,Peve_00008163,,apul_peve,58.874,,,,,,,,,,,,,,,,,
OG_11024,FUN_009473-T1,Peve_00031014,,apul_peve,52.747,FUN_009473-T1,Q8HY02,,,,,35.4,127.0,6.8e-14,79.7,sp|Q8HY02|CD209_SYMSY CD209 antigen OS=Symphalangus syndactylus OX=9590 GN=CD209 PE=3 SV=1,,,,,,
OG_11025,FUN_009480-T1,Peve_00034434,,apul_peve,48.516000000000005,,,,,,,,,,,,,,,,,
OG_11026,FUN_009503-T1,Peve_00017363,,apul_peve,36.782,,,,,,,,,,,,,,,,,
OG_11027,FUN_009511-T4,Peve_00016362,,apul_peve,68.268,FUN_009511-T4,Q6WRI0,IGS10_HUMAN,,Immunoglobulin superfamily member 10 (IgSF10) (Calvaria mechanical force protein 608) (CMF608),Homo sapiens (Human),25.7,280.0,3.5e-16,88.6,sp|Q6WRI0|IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens OX=9606 GN=IGSF10 PE=1 SV=1,GO:0001503; GO:0005576; GO:0030154; GO:2001222,cell differentiation [GO:0030154]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222],extracellular region [GO:0005576],,GO:0005576; GO:0030154,extracellular region; cell differentiation
OG_11028,FUN_009520-T1,Peve_00014187,,apul_peve,61.751,,,,,,,,,,,,,,,,,
OG_11029,FUN_009571-T1,Peve_00039057,,apul_peve,81.7795,,,,,,,,,,,,,,,,,
OG_11030,FUN_009609-T1,Peve_00002976,,apul_peve,55.128,,,,,,,,,,,,,,,,,
OG_11031,FUN_009644-T1,Peve_00022311,,apul_peve,46.774,FUN_009644-T1,P48800,,,,,42.0,112.0,1e-19,97.8,sp|P48800|FGF2_CHICK Fibroblast growth factor 2 OS=Gallus gallus OX=9031 GN=FGF2 PE=2 SV=1,,,,,,
OG_11032,FUN_009647-T1,Peve_00022309,,apul_peve,35.1495,,,,,,,,,,,,,,,,,
OG_11033,FUN_009663-T1,Peve_00030561,,apul_peve,60.349,,,,,,,,,,,,,,,,,
OG_11034,FUN_009668-T1,Peve_00009668,,apul_peve,58.195,,,,,,,,,,,,,,,,,
OG_11035,FUN_009670-T2,Peve_00009669,,apul_peve,80.263,FUN_009670-T2,Q56K04,,,,,78.9,76.0,1.1e-34,146.7,sp|Q56K04|CRIP1_BOVIN Cysteine-rich protein 1 OS=Bos taurus OX=9913 GN=CRIP1 PE=3 SV=3,,,,,,
OG_11036,FUN_009676-T1,Peve_00024096,,apul_peve,47.942,,,,,,,,,,,,,,,,,
OG_11037,FUN_009679-T1,Peve_00005648,,apul_peve,60.685,,,,,,,,,,,,,,,,,
OG_11038,FUN_009692-T1,Peve_00012206,,apul_peve,56.144,FUN_009692-T1,Q9JLC8,,,,,31.1,4710.0,0.0,2036.5,sp|Q9JLC8|SACS_MOUSE Sacsin OS=Mus musculus OX=10090 GN=Sacs PE=1 SV=2,,,,,,
OG_11039,FUN_009708-T1,Peve_00027334,,apul_peve,32.231,,,,,,,,,,,,,,,,,
OG_11040,FUN_009715-T1,Peve_00020587,,apul_peve,58.715500000000006,,,,,,,,,,,,,,,,,
OG_11041,FUN_009726-T1,Peve_00033389,,apul_peve,47.842,,,,,,,,,,,,,,,,,
OG_11042,FUN_009734-T1,Peve_00010203,,apul_peve,34.105999999999995,,,,,,,,,,,,,,,,,
OG_11043,FUN_009748-T1,Peve_00008735,,apul_peve,42.6735,,,,,,,,,,,,,,,,,
OG_11044,FUN_009800-T1,Peve_00003421,,apul_peve,62.382,FUN_009800-T1,Q80XJ3,,,,,29.7,327.0,8.700000000000002e-30,135.2,sp|Q80XJ3|TTC28_MOUSE Tetratricopeptide repeat protein 28 OS=Mus musculus OX=10090 GN=Ttc28 PE=1 SV=3,,,,,,
OG_11045,FUN_009834-T1,Peve_00000531,,apul_peve,71.901,,,,,,,,,,,,,,,,,
OG_11046,FUN_009862-T1,Peve_00036452,,apul_peve,62.921,,,,,,,,,,,,,,,,,
OG_11047,FUN_009950-T1,Peve_00012428,,apul_peve,47.009,,,,,,,,,,,,,,,,,
OG_11048,FUN_009952-T1,Peve_00042713,,apul_peve,44.156,,,,,,,,,,,,,,,,,
OG_11049,FUN_009955-T1,Peve_00034074,,apul_peve,54.167,,,,,,,,,,,,,,,,,
OG_11050,FUN_009959-T1,Peve_00036448,,apul_peve,100.0,FUN_009959-T1,P08991,,,,,96.8,125.0,1.3e-58,226.9,sp|P08991|H2AV_STRPU Histone H2A.V (Fragment) OS=Strongylocentrotus purpuratus OX=7668 GN=H2A.F/Z PE=1 SV=1,,,,,,
OG_11051,FUN_010018-T1,Peve_00036454,,apul_peve,66.99,,,,,,,,,,,,,,,,,
OG_11052,FUN_010022-T1,Peve_00013287,,apul_peve,49.573,,,,,,,,,,,,,,,,,
OG_11053,FUN_010033-T1,Peve_00000546,,apul_peve,52.016,,,,,,,,,,,,,,,,,
OG_11054,FUN_010039-T1,Peve_00002735,,apul_peve,94.737,,,,,,,,,,,,,,,,,
OG_11055,FUN_010064-T1,Peve_00037691,,apul_peve,73.134,,,,,,,,,,,,,,,,,
OG_11056,FUN_010072-T1,Peve_00045321,,apul_peve,91.429,,,,,,,,,,,,,,,,,
OG_11057,FUN_010084-T1,Peve_00003772,,apul_peve,61.450500000000005,,,,,,,,,,,,,,,,,
OG_11058,FUN_010123-T1,Peve_00027931,,apul_peve,57.042,,,,,,,,,,,,,,,,,
OG_11059,FUN_010138-T1,Peve_00036708,,apul_peve,53.631,FUN_010138-T1,Q08C99,,,,,29.0,272.0,6e-13,76.6,sp|Q08C99|VRTN_DANRE Vertnin OS=Danio rerio OX=7955 GN=vrtn PE=2 SV=1,,,,,,
OG_11060,FUN_010142-T1,Peve_00026994,,apul_peve,83.594,,,,,,,,,,,,,,,,,
OG_11061,FUN_010152-T1,Peve_00014010,,apul_peve,57.143,,,,,,,,,,,,,,,,,
OG_11062,FUN_010167-T1,Peve_00039421,,apul_peve,38.675,,,,,,,,,,,,,,,,,
OG_11063,FUN_010182-T1,Peve_00029792,,apul_peve,37.138000000000005,,,,,,,,,,,,,,,,,
OG_11064,FUN_010184-T1,Peve_00013283,,apul_peve,60.465,,,,,,,,,,,,,,,,,
OG_11065,FUN_010186-T1,Peve_00032753,,apul_peve,68.5185,,,,,,,,,,,,,,,,,
OG_11066,FUN_010219-T1,Peve_00015442,,apul_peve,49.699,,,,,,,,,,,,,,,,,
OG_11067,FUN_010223-T1,Peve_00002747,,apul_peve,57.955,,,,,,,,,,,,,,,,,
OG_11068,FUN_010234-T1,Peve_00006440,,apul_peve,92.49,,,,,,,,,,,,,,,,,
OG_11069,FUN_010236-T1,Peve_00040599,,apul_peve,36.994,,,,,,,,,,,,,,,,,
OG_11070,FUN_010239-T1,Peve_00011691,,apul_peve,48.338,,,,,,,,,,,,,,,,,
OG_11071,FUN_010483-T1,Peve_00018738,,apul_peve,47.692,FUN_010483-T1,Q8BGE7,TRIM6_MOUSE,,Tripartite motif-containing protein 6 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM6),Mus musculus (Mouse),35.8,81.0,2.6e-08,61.2,sp|Q8BGE7|TRIM6_MOUSE Tripartite motif-containing protein 6 OS=Mus musculus OX=10090 GN=Trim6 PE=1 SV=1,GO:0000209; GO:0002230; GO:0002720; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0010628; GO:0010629; GO:0010994; GO:0019901; GO:0030674; GO:0032496; GO:0035458; GO:0042802; GO:0045071; GO:0045892; GO:0060340; GO:0061630; GO:0070936; GO:0098586; GO:0140297; GO:0140374; GO:1990782; GO:2000737,antiviral innate immune response [GO:0140374]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; free ubiquitin chain polymerization [GO:0010994]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; response to lipopolysaccharide [GO:0032496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0065003; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on a protein"
OG_11072,FUN_010503-T1,Peve_00045203,,apul_peve,46.539,,,,,,,,,,,,,,,,,
OG_11073,FUN_010504-T1,Peve_00001330,,apul_peve,48.034,,,,,,,,,,,,,,,,,
OG_11074,FUN_010559-T1,Peve_00032727,,apul_peve,45.852,,,,,,,,,,,,,,,,,
OG_11075,FUN_010572-T1,Peve_00032731,,apul_peve,52.239,,,,,,,,,,,,,,,,,
OG_11076,FUN_010580-T1,Peve_00032741,,apul_peve,30.622,,,,,,,,,,,,,,,,,
OG_11077,FUN_010581-T1,Peve_00015351,,apul_peve,52.539,,,,,,,,,,,,,,,,,
OG_11078,FUN_010582-T1,Peve_00032743,,apul_peve,34.109,,,,,,,,,,,,,,,,,
OG_11079,FUN_010589-T1,Peve_00032701,,apul_peve,51.429,,,,,,,,,,,,,,,,,
OG_11080,FUN_010607-T1,Peve_00003668,,apul_peve,62.353,FUN_010607-T1,Q9RX93,,,,,33.9,127.0,7e-12,72.8,sp|Q9RX93|TAM_DEIRA Trans-aconitate 2-methyltransferase OS=Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / CCUG 27074 / LMG 4051 / NBRC 15346 / NCIMB 9279 / VKM B-1422 / R1) OX=243230 GN=tam PE=3 SV=1,,,,,,
OG_11081,FUN_010618-T1,Peve_00013411,,apul_peve,64.865,FUN_010618-T1,Q1T7B8,,,,,38.5,109.0,2.1e-14,80.9,sp|Q1T7B8|CENPO_CHICK Centromere protein O OS=Gallus gallus OX=9031 GN=CENPO PE=1 SV=2,,,,,,
OG_11082,FUN_010631-T1,Peve_00004480,,apul_peve,92.908,FUN_010631-T1,P52758,RIDA_HUMAN,,2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (14.5 kDa translational inhibitor protein) (hp14.5) (p14.5) (Heat-responsive protein 12) (Reactive intermediate imine deaminase A homolog) (Translation inhibitor L-PSP ribonuclease) (UK114 antigen homolog),Homo sapiens (Human),62.0,137.0,2.6e-42,172.9,sp|P52758|RIDA_HUMAN 2-iminobutanoate/2-iminopropanoate deaminase OS=Homo sapiens OX=9606 GN=RIDA PE=1 SV=1,GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0006402; GO:0006629; GO:0016892; GO:0017148; GO:0019239; GO:0019518; GO:0061157; GO:0070062; GO:0120242; GO:0120243,L-threonine catabolic process to glycine [GO:0019518]; lipid metabolic process [GO:0006629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of translation [GO:0017148],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777],"2-iminobutanoate deaminase activity [GO:0120242]; 2-iminopropanoate deaminase activity [GO:0120243]; deaminase activity [GO:0019239]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA endonuclease activity, producing 3'-phosphomonoesters [GO:0016892]",GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005777; GO:0005829; GO:0006520; GO:0006629; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mitochondrion; peroxisome; cytosol; amino acid metabolic process; lipid metabolic process; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_11083,FUN_010645-T1,Peve_00009328,,apul_peve,64.184,,,,,,,,,,,,,,,,,
OG_11084,FUN_010649-T1,Peve_00033908,,apul_peve,35.904,,,,,,,,,,,,,,,,,
OG_11085,FUN_010658-T1,Peve_00031471,,apul_peve,55.076,FUN_010658-T1,P97793,ALK_MOUSE,,ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246),Mus musculus (Mouse),42.9,105.0,4.2e-10,67.4,sp|P97793|ALK_MOUSE ALK tyrosine kinase receptor OS=Mus musculus OX=10090 GN=Alk PE=1 SV=2,GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006950; GO:0007169; GO:0007420; GO:0008201; GO:0021766; GO:0030298; GO:0030424; GO:0030534; GO:0032991; GO:0036269; GO:0038083; GO:0042127; GO:0042802; GO:0044297; GO:0050995; GO:0060159; GO:0090648; GO:0097009; GO:1900006,adult behavior [GO:0030534]; brain development [GO:0007420]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; negative regulation of lipid catabolic process [GO:0050995]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of dendrite development [GO:1900006]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; response to environmental enrichment [GO:0090648]; response to stress [GO:0006950]; swimming behavior [GO:0036269],axon [GO:0030424]; cell body [GO:0044297]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005886; GO:0016740; GO:0048856; GO:0060089; GO:0098772; GO:0140096,"catalytic activity; plasma membrane; transferase activity; anatomical structure development; molecular transducer activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_11086,FUN_010669-T3,Peve_00031449,,apul_peve,75.837,,,,,,,,,,,,,,,,,
OG_11087,FUN_010676-T1,Peve_00044780,,apul_peve,89.474,FUN_010676-T1,P42325,NCAH_DROME,,Neurocalcin homolog (DrosNCa),Drosophila melanogaster (Fruit fly),90.5,189.0,2.9e-97,355.9,sp|P42325|NCAH_DROME Neurocalcin homolog OS=Drosophila melanogaster OX=7227 GN=Nca PE=1 SV=2,GO:0005509; GO:0009966; GO:0045938; GO:1902848,"negative regulation of neuronal signal transduction [GO:1902848]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; regulation of signal transduction [GO:0009966]",,calcium ion binding [GO:0005509],,
OG_11088,FUN_010689-T1,Peve_00012868,,apul_peve,68.269,,,,,,,,,,,,,,,,,
OG_11089,FUN_010723-T1,Peve_00028322,,apul_peve,70.702,,,,,,,,,,,,,,,,,
OG_11090,FUN_010725-T1,Peve_00038970,,apul_peve,67.0655,FUN_010725-T1,Q61074,PPM1G_MOUSE,,Protein phosphatase 1G (EC 3.1.3.16) (Fibroblast growth factor-inducible protein 13) (FIN13) (Protein phosphatase 1C) (Protein phosphatase 2C isoform gamma) (PP2C-gamma) (Protein phosphatase magnesium-dependent 1 gamma),Mus musculus (Mouse),48.1,514.0,1.1e-80,302.4,sp|Q61074|PPM1G_MOUSE Protein phosphatase 1G OS=Mus musculus OX=10090 GN=Ppm1g PE=1 SV=3,GO:0004721; GO:0004722; GO:0005634; GO:0005654; GO:0016020; GO:0046872; GO:0051726,regulation of cell cycle [GO:0051726],membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005634; GO:0005654; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_11091,FUN_010742-T2,Peve_00038407,,apul_peve,30.6255,,,,,,,,,,,,,,,,,
OG_11092,FUN_010750-T1,Peve_00010094,,apul_peve,62.261,FUN_010750-T1,Q5RF77,CHFR_PONAB,,E3 ubiquitin-protein ligase CHFR (EC 2.3.2.27) (Checkpoint with forkhead and RING finger domains protein) (RING-type E3 ubiquitin transferase CHFR),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),37.1,574.0,7.3e-93,342.8,sp|Q5RF77|CHFR_PONAB E3 ubiquitin-protein ligase CHFR OS=Pongo abelii OX=9601 GN=CHFR PE=2 SV=1,GO:0000166; GO:0004842; GO:0005634; GO:0006511; GO:0008270; GO:0016567; GO:0016605; GO:0044818; GO:0051301,cell division [GO:0051301]; mitotic G2/M transition checkpoint [GO:0044818]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],nucleus [GO:0005634]; PML body [GO:0016605],nucleotide binding [GO:0000166]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_11093,FUN_010780-T2,Peve_00004486,,apul_peve,66.221,FUN_010780-T2,Q9DCK3,,,,,27.8,230.0,3.1e-13,77.4,sp|Q9DCK3|TSN4_MOUSE Tetraspanin-4 OS=Mus musculus OX=10090 GN=Tspan4 PE=1 SV=1,,,,,,
OG_11094,FUN_010787-T1,Peve_00007160,,apul_peve,50.1155,FUN_010787-T1,G5EG78,PXDN2_CAEEL,,Peroxidasin homolog pxn-2 (EC 1.11.2.-),Caenorhabditis elegans,33.2,614.0,3.5e-75,284.6,sp|G5EG78|PXDN2_CAEEL Peroxidasin homolog pxn-2 OS=Caenorhabditis elegans OX=6239 GN=pxn-2 PE=1 SV=1,GO:0004601; GO:0005604; GO:0005615; GO:0006979; GO:0007411; GO:0010172; GO:0016203; GO:0020037; GO:0046872; GO:0048681; GO:0071711; GO:0110011; GO:0140825,axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; embryonic body morphogenesis [GO:0010172]; muscle attachment [GO:0016203]; negative regulation of axon regeneration [GO:0048681]; regulation of basement membrane organization [GO:0110011]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; extracellular space [GO:0005615],heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601],GO:0003824; GO:0005615; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012,catalytic activity; extracellular space; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_11095,FUN_010794-T1,Peve_00031932,,apul_peve,49.5655,FUN_010794-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),37.4,604.0,2.6e-94,347.8,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_11096,FUN_010795-T1,Peve_00007586,,apul_peve,55.766,FUN_010795-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),37.6,620.0,3.8e-93,344.0,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_11097,FUN_010797-T1,Peve_00017296,,apul_peve,76.495,FUN_010797-T1,Q8NDA2,,,,,32.8,247.0,1.2e-25,119.8,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_11098,FUN_010813-T1,Peve_00006519,,apul_peve,59.428,FUN_010813-T1,Q5F349,,,,,39.2,288.0,1.6e-51,204.9,sp|Q5F349|SG196_CHICK Protein O-mannose kinase OS=Gallus gallus OX=9031 GN=POMK PE=2 SV=1,,,,,,
OG_11099,FUN_010816-T1,Peve_00001135,,apul_peve,69.192,,,,,,,,,,,,,,,,,
OG_11100,FUN_010817-T1,Peve_00017552,,apul_peve,39.521,,,,,,,,,,,,,,,,,
OG_11101,FUN_010843-T1,Peve_00030156,,apul_peve,55.955,,,,,,,,,,,,,,,,,
OG_11102,FUN_010847-T1,Peve_00000424,,apul_peve,94.477,,,,,,,,,,,,,,,,,
OG_11103,FUN_010880-T1,Peve_00035842,,apul_peve,67.0,FUN_010880-T1,P06171,,,,,33.5,182.0,4.7e-13,76.3,sp|P06171|MYC1_XENLA Transcriptional regulator Myc-A OS=Xenopus laevis OX=8355 GN=myc-a PE=2 SV=1,,,,,,
OG_11104,FUN_010895-T1,Peve_00027258,,apul_peve,98.894,FUN_010895-T1,Q2HJ86,TBA1D_BOVIN,,Tubulin alpha-1D chain (EC 3.6.5.-) [Cleaved into: Detyrosinated tubulin alpha-1D chain],Bos taurus (Bovine),97.9,436.0,5.3e-259,894.4,sp|Q2HJ86|TBA1D_BOVIN Tubulin alpha-1D chain OS=Bos taurus OX=9913 GN=TUBA1D PE=1 SV=1,GO:0000226; GO:0000278; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0016787; GO:0046872,microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278],cytoplasm [GO:0005737]; microtubule [GO:0005874],GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0003824; GO:0005198; GO:0007010; GO:0016787,mitotic cell cycle; catalytic activity; structural molecule activity; cytoskeleton organization; hydrolase activity
OG_11105,FUN_010917-T1,Peve_00044946,,apul_peve,36.856,,,,,,,,,,,,,,,,,
OG_11106,FUN_010936-T1,Peve_00025017,,apul_peve,78.583,FUN_010936-T1,A0A2P1BRQ0,,,,,32.6,503.0,2.8e-73,279.3,sp|A0A2P1BRQ0|CTXA_SCOPL Cytolytic toxin-alpha OS=Scorpaena plumieri OX=274700 PE=1 SV=1,,,,,,
OG_11107,FUN_010963-T1,Peve_00007922,,apul_peve,79.456,FUN_010963-T1,Q9QZX7,SRR_MOUSE,,Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17),Mus musculus (Mouse),53.4,322.0,3.2e-88,326.6,sp|Q9QZX7|SRR_MOUSE Serine racemase OS=Mus musculus OX=10090 GN=Srr PE=1 SV=1,GO:0000287; GO:0003941; GO:0005509; GO:0005524; GO:0005737; GO:0006563; GO:0008721; GO:0009410; GO:0016594; GO:0018114; GO:0030165; GO:0030170; GO:0030378; GO:0032496; GO:0042802; GO:0042803; GO:0042866; GO:0043025; GO:0045177; GO:0070179,D-serine biosynthetic process [GO:0070179]; L-serine metabolic process [GO:0006563]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410],apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114],GO:0003824; GO:0006520; GO:0016829; GO:0016853,catalytic activity; amino acid metabolic process; lyase activity; isomerase activity
OG_11108,FUN_010967-T1,Peve_00036902,,apul_peve,43.9775,,,,,,,,,,,,,,,,,
OG_11109,FUN_010972-T1,Peve_00029719,,apul_peve,66.667,FUN_010972-T1,O57422,,,,,28.6,294.0,3.1e-25,117.5,sp|O57422|OPN4B_XENLA Melanopsin-B OS=Xenopus laevis OX=8355 GN=opn4b PE=2 SV=1,,,,,,
OG_11110,FUN_010992-T1,Peve_00013398,,apul_peve,41.7605,,,,,,,,,,,,,,,,,
OG_11111,FUN_011060-T1,Peve_00009501,,apul_peve,38.793,,,,,,,,,,,,,,,,,
OG_11112,FUN_011062-T1,Peve_00009499,,apul_peve,68.519,,,,,,,,,,,,,,,,,
OG_11113,FUN_011123-T1,Peve_00022318,,apul_peve,81.564,,,,,,,,,,,,,,,,,
OG_11114,FUN_011133-T1,Peve_00009171,,apul_peve,54.904,,,,,,,,,,,,,,,,,
OG_11115,FUN_011143-T1,Peve_00045159,,apul_peve,42.991,,,,,,,,,,,,,,,,,
OG_11116,FUN_011152-T1,Peve_00032816,,apul_peve,43.85,,,,,,,,,,,,,,,,,
OG_11117,FUN_011171-T1,Peve_00002480,,apul_peve,77.12450000000001,,,,,,,,,,,,,,,,,
OG_11118,FUN_011184-T1,Peve_00030753,,apul_peve,88.471,FUN_011184-T1,Q15818,NPTX1_HUMAN,,Neuronal pentraxin-1 (NP1) (Neuronal pentraxin I) (NP-I),Homo sapiens (Human),31.3,166.0,6.4e-16,89.4,sp|Q15818|NPTX1_HUMAN Neuronal pentraxin-1 OS=Homo sapiens OX=9606 GN=NPTX1 PE=1 SV=2,GO:0005783; GO:0006839; GO:0007268; GO:0007417; GO:0030133; GO:0035865; GO:0043083; GO:0043653; GO:0046872; GO:0060385; GO:0071333; GO:0097107; GO:0098978; GO:0099645,axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; postsynaptic density assembly [GO:0097107],endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133],metal ion binding [GO:0046872],GO:0005576; GO:0005783; GO:0007005; GO:0023052; GO:0031410; GO:0043226; GO:0048856,extracellular region; endoplasmic reticulum; mitochondrion organization; signaling; cytoplasmic vesicle; organelle; anatomical structure development
OG_11119,FUN_011225-T1,Peve_00035525,,apul_peve,56.897,,,,,,,,,,,,,,,,,
OG_11120,FUN_011257-T1,Peve_00024713,,apul_peve,48.78,,,,,,,,,,,,,,,,,
OG_11121,FUN_011268-T1,Peve_00019210,,apul_peve,43.1395,,,,,,,,,,,,,,,,,
OG_11122,FUN_011278-T1,Peve_00030532,,apul_peve,56.818,FUN_011278-T1,P08253,MMP2_HUMAN,,72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX],Homo sapiens (Human),54.0,50.0,5.8e-10,65.9,sp|P08253|MMP2_HUMAN 72 kDa type IV collagenase OS=Homo sapiens OX=9606 GN=MMP2 PE=1 SV=2,GO:0001525; GO:0001541; GO:0001542; GO:0001553; GO:0001666; GO:0001955; GO:0001957; GO:0001968; GO:0004175; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005886; GO:0006508; GO:0007162; GO:0007507; GO:0007567; GO:0008237; GO:0008270; GO:0009410; GO:0009612; GO:0014012; GO:0014823; GO:0016477; GO:0022617; GO:0030017; GO:0030163; GO:0030198; GO:0030335; GO:0030574; GO:0032526; GO:0034614; GO:0035094; GO:0035987; GO:0042542; GO:0043627; GO:0045906; GO:0048013; GO:0048246; GO:0048771; GO:0051602; GO:0055093; GO:0060325; GO:0060346; GO:0060740; GO:0061450; GO:0062023; GO:0071230; GO:0071347; GO:0071392; GO:0071492; GO:0071498; GO:1903378; GO:1904645; GO:1904707,angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; macrophage chemotaxis [GO:0048246]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell migration [GO:0030335]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771]; trophoblast cell migration [GO:0061450],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017],endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005739; GO:0005886; GO:0016787; GO:0022414; GO:0030154; GO:0030163; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"immune system process; circulatory system process; catalytic activity; extracellular region; extracellular space; nucleus; mitochondrion; plasma membrane; hydrolase activity; reproductive process; cell differentiation; protein catabolic process; extracellular matrix organization; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_11123,FUN_011281-T1,Peve_00019681,,apul_peve,68.276,FUN_011281-T1,D8VNS7,,,,,48.6,218.0,1.8e-58,227.6,sp|D8VNS7|FCNV1_CERRY Ryncolin-1 OS=Cerberus rynchops OX=46267 PE=1 SV=1,,,,,,
OG_11124,FUN_011286-T1,Peve_00028126,,apul_peve,72.509,,,,,,,,,,,,,,,,,
OG_11125,FUN_011287-T1,Peve_00006855,,apul_peve,80.635,FUN_011287-T1,Q8N0X4,CLYBL_HUMAN,,"Citramalyl-CoA lyase, mitochondrial (EC 4.1.3.25) ((3S)-malyl-CoA thioesterase) (EC 3.1.2.30) (Beta-methylmalate synthase) (EC 2.3.3.-) (Citrate lyase subunit beta-like protein) (Citrate lyase beta-like) (Malate synthase) (EC 2.3.3.9)",Homo sapiens (Human),49.1,293.0,8e-79,295.4,"sp|Q8N0X4|CLYBL_HUMAN Citramalyl-CoA lyase, mitochondrial OS=Homo sapiens OX=9606 GN=CLYBL PE=1 SV=2",GO:0000287; GO:0004474; GO:0005739; GO:0016787; GO:0047777; GO:0070207; GO:0106064; GO:0106121,positive regulation of cobalamin metabolic process [GO:0106121]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064],mitochondrion [GO:0005739],(S)-citramalyl-CoA lyase activity [GO:0047777]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474],GO:0003824; GO:0005739; GO:0016740; GO:0016787; GO:0016829; GO:0043226; GO:0065003,catalytic activity; mitochondrion; transferase activity; hydrolase activity; lyase activity; organelle; protein-containing complex assembly
OG_11126,FUN_011330-T1,Peve_00000599,,apul_peve,68.166,,,,,,,,,,,,,,,,,
OG_11127,FUN_011333-T1,Peve_00044531,,apul_peve,68.627,,,,,,,,,,,,,,,,,
OG_11128,FUN_011345-T1,Peve_00019914,,apul_peve,72.0815,,,,,,,,,,,,,,,,,
OG_11129,FUN_011360-T1,Peve_00000428,,apul_peve,32.743,,,,,,,,,,,,,,,,,
OG_11130,FUN_011362-T1,Peve_00005121,,apul_peve,44.179,,,,,,,,,,,,,,,,,
OG_11131,FUN_011412-T1,Peve_00023167,,apul_peve,67.47,,,,,,,,,,,,,,,,,
OG_11132,FUN_011486-T1,Peve_00000322,,apul_peve,58.914,,,,,,,,,,,,,,,,,
OG_11133,FUN_011513-T1,Peve_00005642,,apul_peve,57.944,,,,,,,,,,,,,,,,,
OG_11134,FUN_011558-T1,Peve_00037272,,apul_peve,78.049,,,,,,,,,,,,,,,,,
OG_11135,FUN_011584-T1,Peve_00008360,,apul_peve,39.301,,,,,,,,,,,,,,,,,
OG_11136,FUN_011688-T1,Peve_00027014,,apul_peve,60.571,,,,,,,,,,,,,,,,,
OG_11137,FUN_011690-T1,Peve_00027017,,apul_peve,88.19300000000001,FUN_011690-T1,P29146,,,,,53.6,793.0,2.8e-232,806.6,sp|P29146|NECA_HYDVU PC3-like endoprotease variant A OS=Hydra vulgaris OX=6087 PE=2 SV=1,,,,,,
OG_11138,FUN_011712-T1,Peve_00025141,,apul_peve,69.274,,,,,,,,,,,,,,,,,
OG_11139,FUN_011719-T1,Peve_00039712,,apul_peve,57.492,FUN_011719-T1,Q9EP86,,,,,29.0,300.0,1.5e-23,112.1,sp|Q9EP86|NPFF1_RAT Neuropeptide FF receptor 1 OS=Rattus norvegicus OX=10116 GN=Npffr1 PE=1 SV=1,,,,,,
OG_11140,FUN_011721-T1,Peve_00014016,,apul_peve,42.807500000000005,,,,,,,,,,,,,,,,,
OG_11141,FUN_011726-T1,Peve_00001122,,apul_peve,62.452,FUN_011726-T1,Q5ZIE4,CHSTA_CHICK,,Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST),Gallus gallus (Chicken),32.3,269.0,8.000000000000001e-29,129.0,sp|Q5ZIE4|CHSTA_CHICK Carbohydrate sulfotransferase 10 OS=Gallus gallus OX=9031 GN=CHST10 PE=2 SV=1,GO:0000139; GO:0008146; GO:0016051; GO:0030166,carbohydrate biosynthetic process [GO:0016051]; proteoglycan biosynthetic process [GO:0030166],Golgi membrane [GO:0000139],sulfotransferase activity [GO:0008146],GO:0003824; GO:0005975; GO:0009101; GO:0016740; GO:1901135,catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_11142,FUN_011759-T1,Peve_00044712,,apul_peve,41.837,FUN_011759-T1,Q9U7D5,,,,,30.7,179.0,6.4e-09,63.2,sp|Q9U7D5|ACM3_CAEEL Muscarinic acetylcholine receptor gar-3 OS=Caenorhabditis elegans OX=6239 GN=gar-3 PE=1 SV=2,,,,,,
OG_11143,FUN_011767-T1,Peve_00020120,,apul_peve,32.747,,,,,,,,,,,,,,,,,
OG_11144,FUN_011768-T2,Peve_00035312,,apul_peve,83.704,FUN_011768-T2,Q08832,GBRB3_DROME,,Gamma-aminobutyric acid receptor subunit beta-like (GABA(A) receptor),Drosophila melanogaster (Fruit fly),32.6,258.0,2.2e-25,117.5,sp|Q08832|GBRB3_DROME Gamma-aminobutyric acid receptor subunit beta-like OS=Drosophila melanogaster OX=7227 GN=Lcch3 PE=1 SV=2,GO:0004890; GO:0005886; GO:0022851; GO:0034707; GO:0045211; GO:1902476; GO:1902711,chloride transmembrane transport [GO:1902476],chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_11145,FUN_011779-T1,Peve_00006121,,apul_peve,52.614,FUN_011779-T1,Q9NU22,MDN1_HUMAN,,Midasin (Dynein-related AAA-ATPase MDN1) (MIDAS-containing protein),Homo sapiens (Human),41.3,5807.0,0.0,3266.9,sp|Q9NU22|MDN1_HUMAN Midasin OS=Homo sapiens OX=9606 GN=MDN1 PE=1 SV=2,GO:0000027; GO:0000055; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016020; GO:0016887; GO:0030687; GO:0045111,ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit export from nucleus [GO:0000055],"cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome, large subunit precursor [GO:0030687]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005856; GO:0006913; GO:0016787; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; cytoskeleton; nucleocytoplasmic transport; hydrolase activity; organelle; protein-containing complex assembly
OG_11146,FUN_011793-T1,Peve_00000254,,apul_peve,53.767,FUN_011793-T1,C3ZQF9,,,,,30.2,305.0,2.9e-23,110.9,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_11147,FUN_011800-T1,Peve_00034595,,apul_peve,55.556,FUN_011800-T1,Q9GZQ4,NMUR2_HUMAN,,Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1),Homo sapiens (Human),30.9,317.0,2.9e-19,97.8,sp|Q9GZQ4|NMUR2_HUMAN Neuromedin-U receptor 2 OS=Homo sapiens OX=9606 GN=NMUR2 PE=1 SV=2,GO:0001607; GO:0002023; GO:0004930; GO:0005229; GO:0005525; GO:0005886; GO:0006940; GO:0007200; GO:0007218; GO:0007267; GO:0007417; GO:0007625; GO:0007631; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0050850,arachidonate secretion [GO:0050482]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; feeding behavior [GO:0007631]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium-mediated signaling [GO:0050850]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of smooth muscle contraction [GO:0006940]; response to pain [GO:0048265],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188],GO:0005215; GO:0005886; GO:0023052; GO:0048856; GO:0060089,transporter activity; plasma membrane; signaling; anatomical structure development; molecular transducer activity
OG_11148,FUN_011854-T1,Peve_00034402,,apul_peve,74.552,FUN_011854-T1,Q9IA05,,,,,49.3,511.0,4.1e-144,513.1,sp|Q9IA05|FZD4_CHICK Frizzled-4 OS=Gallus gallus OX=9031 GN=FZD4 PE=1 SV=1,,,,,,
OG_11149,FUN_011858-T1,Peve_00034378,,apul_peve,62.453,,,,,,,,,,,,,,,,,
OG_11150,FUN_011887-T1,Peve_00014805,,apul_peve,70.9625,FUN_011887-T1,O34363,,,,,28.3,540.0,2.1e-38,162.2,sp|O34363|YOBN_BACSU Putative L-amino-acid oxidase YobN OS=Bacillus subtilis (strain 168) OX=224308 GN=yobN PE=3 SV=3,,,,,,
OG_11151,FUN_011891-T1,Peve_00014844,,apul_peve,46.914,,,,,,,,,,,,,,,,,
OG_11152,FUN_011896-T1,Peve_00034906,,apul_peve,81.048,,,,,,,,,,,,,,,,,
OG_11153,FUN_011902-T2,Peve_00042801,,apul_peve,72.40950000000001,FUN_011902-T2,Q5JWR5,DOP1A_HUMAN,,Protein DOP1A,Homo sapiens (Human),32.0,2504.0,4e-304,1046.6,sp|Q5JWR5|DOP1A_HUMAN Protein DOP1A OS=Homo sapiens OX=9606 GN=DOP1A PE=1 SV=1,GO:0000139; GO:0005768; GO:0005798; GO:0005802; GO:0005829; GO:0006895; GO:0015031,Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; trans-Golgi network [GO:0005802],,GO:0005768; GO:0005829; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_11154,FUN_011904-T1,Peve_00042399,,apul_peve,56.347,FUN_011904-T1,Q8K2J9,,,,,32.6,433.0,1.1e-51,205.7,sp|Q8K2J9|BTBD6_MOUSE BTB/POZ domain-containing protein 6 OS=Mus musculus OX=10090 GN=Btbd6 PE=2 SV=3,,,,,,
OG_11155,FUN_011905-T2,Peve_00026369,,apul_peve,48.510000000000005,FUN_011905-T2,Q9D4G9,RMI1_MOUSE,,RecQ-mediated genome instability protein 1,Mus musculus (Mouse),42.9,210.0,8.8e-38,160.2,sp|Q9D4G9|RMI1_MOUSE RecQ-mediated genome instability protein 1 OS=Mus musculus OX=10090 GN=Rmi1 PE=2 SV=1,GO:0000166; GO:0000724; GO:0002021; GO:0002023; GO:0005634; GO:0006260; GO:0009749; GO:0016604; GO:0031422; GO:0035264; GO:0042593; GO:0071139,DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; resolution of DNA recombination intermediates [GO:0071139]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749],nuclear body [GO:0016604]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422],nucleotide binding [GO:0000166],GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0043226,nucleus; DNA replication; DNA repair; DNA recombination; organelle
OG_11156,FUN_011916-T1,Peve_00037785,,apul_peve,78.52,,,,,,,,,,,,,,,,,
OG_11157,FUN_011938-T1,Peve_00025119,,apul_peve,59.288,,,,,,,,,,,,,,,,,
OG_11158,FUN_011948-T1,Peve_00016918,,apul_peve,90.994,FUN_011948-T1,Q6P3A8,ODBB_MOUSE,,"2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDE1B) (BCKDH E1-beta)",Mus musculus (Mouse),77.3,322.0,3.7e-153,542.3,"sp|Q6P3A8|ODBB_MOUSE 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial OS=Mus musculus OX=10090 GN=Bckdhb PE=1 SV=2",GO:0003863; GO:0005654; GO:0005730; GO:0005739; GO:0005743; GO:0005759; GO:0006629; GO:0009063; GO:0009083; GO:0046872; GO:0047101; GO:0160157,amino acid catabolic process [GO:0009063]; branched-chain amino acid catabolic process [GO:0009083]; lipid metabolic process [GO:0006629],branched-chain alpha-ketoacid dehydrogenase complex [GO:0160157]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; branched-chain alpha-keto acid dehydrogenase activity [GO:0047101]; metal ion binding [GO:0046872],GO:0003824; GO:0005654; GO:0005730; GO:0005739; GO:0006520; GO:0006629; GO:0016491; GO:0043226,catalytic activity; nucleoplasm; nucleolus; mitochondrion; amino acid metabolic process; lipid metabolic process; oxidoreductase activity; organelle
OG_11159,FUN_011958-T1,Peve_00020308,,apul_peve,33.498,,,,,,,,,,,,,,,,,
OG_11160,FUN_011962-T1,Peve_00011889,,apul_peve,84.462,FUN_011962-T1,Q6TGS6,,,,,70.5,346.0,4.4e-139,495.7,"sp|Q6TGS6|SYYC_DANRE Tyrosine--tRNA ligase, cytoplasmic OS=Danio rerio OX=7955 GN=yars1 PE=2 SV=2",,,,,,
OG_11161,FUN_011981-T1,Peve_00000988,,apul_peve,50.8975,FUN_011981-T1,G3V8T1,,,,,37.1,116.0,5.2e-09,65.1,sp|G3V8T1|MPP8_RAT M-phase phosphoprotein 8 OS=Rattus norvegicus OX=10116 GN=Mphosph8 PE=2 SV=1,,,,,,
OG_11162,FUN_012006-T1,Peve_00035604,,apul_peve,52.187,,,,,,,,,,,,,,,,,
OG_11163,FUN_012017-T1,Peve_00030439,,apul_peve,62.672,FUN_012017-T1,Q91X60,ACHA2_MOUSE,,Neuronal acetylcholine receptor subunit alpha-2,Mus musculus (Mouse),46.2,106.0,2.1e-17,91.7,sp|Q91X60|ACHA2_MOUSE Neuronal acetylcholine receptor subunit alpha-2 OS=Mus musculus OX=10090 GN=Chrna2 PE=2 SV=1,GO:0005654; GO:0005892; GO:0015464; GO:0022848; GO:0034703; GO:0045171; GO:0045211; GO:0048167; GO:0050997; GO:0071316; GO:0071944; GO:0098828; GO:0098878; GO:0120111; GO:1901363; GO:1905144,cellular response to nicotine [GO:0071316]; modulation of inhibitory postsynaptic potential [GO:0098828]; regulation of synaptic plasticity [GO:0048167]; response to acetylcholine [GO:1905144],acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; cell periphery [GO:0071944]; intercellular bridge [GO:0045171]; neuron projection cytoplasm [GO:0120111]; neurotransmitter receptor complex [GO:0098878]; nucleoplasm [GO:0005654]; postsynaptic membrane [GO:0045211],acetylcholine receptor activity [GO:0015464]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; quaternary ammonium group binding [GO:0050997],GO:0005215; GO:0005654; GO:0060089,transporter activity; nucleoplasm; molecular transducer activity
OG_11164,FUN_012018-T1,Peve_00030375,,apul_peve,69.508,FUN_012018-T1,P22770,,,,,36.3,521.0,2.3e-83,311.2,sp|P22770|ACHA7_CHICK Neuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1,,,,,,
OG_11165,FUN_012024-T1,Peve_00023336,,apul_peve,67.354,FUN_012024-T1,Q9N126,,,,,43.4,281.0,6.8e-50,199.1,sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1,,,,,,
OG_11166,FUN_012030-T1,Peve_00044956,,apul_peve,55.657,FUN_012030-T1,Q8C206,,,,,33.7,323.0,5.9e-40,166.4,sp|Q8C206|GP157_MOUSE G-protein coupled receptor 157 OS=Mus musculus OX=10090 GN=Gpr157 PE=1 SV=1,,,,,,
OG_11167,FUN_012051-T1,Peve_00004086,,apul_peve,37.5,,,,,,,,,,,,,,,,,
OG_11168,FUN_012071-T1,Peve_00025865,,apul_peve,79.468,FUN_012071-T1,Q8BH58,,,,,51.7,265.0,5.1e-76,285.8,sp|Q8BH58|TIPRL_MOUSE TIP41-like protein OS=Mus musculus OX=10090 GN=Tiprl PE=1 SV=1,,,,,,
OG_11169,FUN_012110-T1,Peve_00045235,,apul_peve,76.8065,FUN_012110-T1,Q7TMK9,HNRPQ_MOUSE,,"Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68)",Mus musculus (Mouse),56.2,395.0,5.4e-124,446.4,sp|Q7TMK9|HNRPQ_MOUSE Heterogeneous nuclear ribonucleoprotein Q OS=Mus musculus OX=10090 GN=Syncrip PE=1 SV=2,GO:0005634; GO:0005654; GO:0005681; GO:0005737; GO:0005783; GO:0005829; GO:0006397; GO:0008143; GO:0008380; GO:0016556; GO:0045293; GO:0070934; GO:0070937; GO:0071204; GO:0106002; GO:0141166; GO:1900152; GO:1990904; GO:2000623; GO:2000767,"chromosomal 5-methylcytosine DNA demethylation pathway [GO:0141166]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; positive regulation of cytoplasmic translation [GO:2000767]; RNA splicing [GO:0008380]",CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; histone pre-mRNA 3'end processing complex [GO:0071204]; mCRD-mediated mRNA stability complex [GO:0106002]; mRNA editing complex [GO:0045293]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681],poly(A) binding [GO:0008143],GO:0003723; GO:0005634; GO:0005654; GO:0005783; GO:0005829; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; endoplasmic reticulum; cytosol; mRNA metabolic process; organelle
OG_11170,FUN_012111-T1,Peve_00045234,,apul_peve,75.564,,,,,,,,,,,,,,,,,
OG_11171,FUN_012114-T1,Peve_00011023,,apul_peve,52.5655,FUN_012114-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),37.2,234.0,1.5e-42,176.0,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_11172,FUN_012117-T1,Peve_00007419,,apul_peve,66.79400000000001,FUN_012117-T1,D8VNS7,,,,,54.5,213.0,1.5e-60,235.7,sp|D8VNS7|FCNV1_CERRY Ryncolin-1 OS=Cerberus rynchops OX=46267 PE=1 SV=1,,,,,,
OG_11173,FUN_012121-T1,Peve_00041341,,apul_peve,83.217,,,,,,,,,,,,,,,,,
OG_11174,FUN_012131-T1,Peve_00035466,,apul_peve,62.338,FUN_012131-T1,P14780,MMP9_HUMAN,,Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9],Homo sapiens (Human),54.5,44.0,1.3e-06,55.5,sp|P14780|MMP9_HUMAN Matrix metalloproteinase-9 OS=Homo sapiens OX=9606 GN=MMP9 PE=1 SV=3,GO:0001501; GO:0001934; GO:0004175; GO:0004222; GO:0004252; GO:0005518; GO:0005576; GO:0005615; GO:0006508; GO:0006915; GO:0007566; GO:0008233; GO:0008237; GO:0008270; GO:0016477; GO:0022617; GO:0030198; GO:0030225; GO:0030574; GO:0035987; GO:0042802; GO:0043065; GO:0043066; GO:0043388; GO:0045742; GO:0048013; GO:0051549; GO:0062023; GO:0070062; GO:0071222; GO:0071492; GO:0090200; GO:0150077; GO:1900122; GO:1904645; GO:1904707; GO:1904724; GO:1904813; GO:2000697; GO:2001243; GO:2001258,apoptotic process [GO:0006915]; cell migration [GO:0016477]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; macrophage differentiation [GO:0030225]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cation channel activity [GO:2001258]; negative regulation of epithelial cell differentiation involved in kidney development [GO:2000697]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor binding [GO:1900122]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteolysis [GO:0006508]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645]; skeletal system development [GO:0001501],collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724],collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0012501; GO:0016787; GO:0022414; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; extracellular space; programmed cell death; hydrolase activity; reproductive process; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_11175,FUN_012149-T1,Peve_00035448,,apul_peve,56.316,,,,,,,,,,,,,,,,,
OG_11176,FUN_012157-T1,Peve_00033920,,apul_peve,32.6975,,,,,,,,,,,,,,,,,
OG_11177,FUN_012163-T1,Peve_00024134,,apul_peve,55.2935,FUN_012163-T1,A7T1N0,TMP2L_NEMVE,,Transient receptor potential cation channel subfamily M member-like 2 (nvTRPM2),Nematostella vectensis (Starlet sea anemone),35.5,1627.0,1.4e-258,894.8,sp|A7T1N0|TMP2L_NEMVE Transient receptor potential cation channel subfamily M member-like 2 OS=Nematostella vectensis OX=45351 GN=TRPM2 PE=1 SV=1,GO:0005886; GO:0015280; GO:0035725; GO:0046872; GO:0047631; GO:0070588; GO:0099604,calcium ion transmembrane transport [GO:0070588]; sodium ion transmembrane transport [GO:0035725],plasma membrane [GO:0005886],ADP-ribose diphosphatase activity [GO:0047631]; ligand-gated calcium channel activity [GO:0099604]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872],GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0055085,catalytic activity; transporter activity; plasma membrane; hydrolase activity; transmembrane transport
OG_11178,FUN_012173-T2,Peve_00008638,,apul_peve,49.174,FUN_012173-T2,Q62935,VWF_RAT,,von Willebrand factor (vWF),Rattus norvegicus (Rat),21.5,381.0,4e-18,94.4,sp|Q62935|VWF_RAT von Willebrand factor (Fragment) OS=Rattus norvegicus OX=10116 GN=Vwf PE=2 SV=2,GO:0001889; GO:0001890; GO:0002020; GO:0002543; GO:0005178; GO:0005518; GO:0005576; GO:0005615; GO:0005783; GO:0006954; GO:0007155; GO:0007596; GO:0007599; GO:0009897; GO:0010165; GO:0019865; GO:0030168; GO:0030198; GO:0031589; GO:0033093; GO:0033591; GO:0035902; GO:0042802; GO:0051087; GO:0062023; GO:0070417; GO:0071222; GO:0097421; GO:1902533,activation of blood coagulation via clotting cascade [GO:0002543]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; cellular response to cold [GO:0070417]; cellular response to lipopolysaccharide [GO:0071222]; extracellular matrix organization [GO:0030198]; hemostasis [GO:0007599]; inflammatory response [GO:0006954]; liver development [GO:0001889]; liver regeneration [GO:0097421]; placenta development [GO:0001890]; platelet activation [GO:0030168]; positive regulation of intracellular signal transduction [GO:1902533]; response to immobilization stress [GO:0035902]; response to L-ascorbic acid [GO:0033591]; response to X-ray [GO:0010165],collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Weibel-Palade body [GO:0033093],collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein-folding chaperone binding [GO:0051087],GO:0005576; GO:0005615; GO:0005783; GO:0006954; GO:0007155; GO:0030198; GO:0031410; GO:0043226; GO:0048856,extracellular region; extracellular space; endoplasmic reticulum; inflammatory response; cell adhesion; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development
OG_11179,FUN_012181-T2,Peve_00033048,,apul_peve,62.414,,,,,,,,,,,,,,,,,
OG_11180,FUN_012182-T1,Peve_00020511,,apul_peve,89.845,FUN_012182-T1,Q62388,ATM_MOUSE,,Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated homolog) (A-T mutated homolog),Mus musculus (Mouse),56.8,565.0,6.3e-177,622.1,sp|Q62388|ATM_MOUSE Serine-protein kinase ATM OS=Mus musculus OX=10090 GN=Atm PE=1 SV=2,GO:0000077; GO:0000425; GO:0000724; GO:0000729; GO:0000781; GO:0001541; GO:0001756; GO:0002331; GO:0002376; GO:0003677; GO:0004672; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005782; GO:0005813; GO:0005819; GO:0006281; GO:0006302; GO:0006974; GO:0007094; GO:0007095; GO:0007140; GO:0007143; GO:0007292; GO:0007420; GO:0007507; GO:0008340; GO:0008585; GO:0008630; GO:0009791; GO:0010212; GO:0010506; GO:0010628; GO:0016303; GO:0030335; GO:0030889; GO:0032212; GO:0033151; GO:0034614; GO:0035264; GO:0035861; GO:0035979; GO:0042159; GO:0042770; GO:0042802; GO:0043517; GO:0043525; GO:0044877; GO:0045141; GO:0045785; GO:0045944; GO:0046777; GO:0048538; GO:0048599; GO:0051402; GO:0070192; GO:0071044; GO:0071300; GO:0071480; GO:0071481; GO:0071500; GO:0090399; GO:0097694; GO:0097695; GO:0098850; GO:0106310; GO:1904262; GO:1904354; GO:1904884; GO:1990391; GO:2000781,"brain development [GO:0007420]; cellular response to gamma radiation [GO:0071480]; cellular response to nitrosative stress [GO:0071500]; cellular response to reactive oxygen species [GO:0034614]; cellular response to retinoic acid [GO:0071300]; cellular response to X-ray [GO:0071481]; chromosome organization involved in meiotic cell cycle [GO:0070192]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein-containing complex localization to telomere [GO:0097695]; establishment of RNA localization to telomere [GO:0097694]; female gamete generation [GO:0007292]; female gonad development [GO:0008585]; female meiotic nuclear division [GO:0007143]; heart development [GO:0007507]; histone mRNA catabolic process [GO:0071044]; immune system process [GO:0002376]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; lipoprotein catabolic process [GO:0042159]; male meiotic nuclear division [GO:0007140]; meiotic telomere clustering [GO:0045141]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic spindle assembly checkpoint signaling [GO:0007094]; multicellular organism growth [GO:0035264]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of telomere capping [GO:1904354]; negative regulation of TORC1 signaling [GO:1904262]; neuron apoptotic process [GO:0051402]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; pexophagy [GO:0000425]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043517]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of telomerase catalytic core complex assembly [GO:1904884]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; pre-B cell allelic exclusion [GO:0002331]; protein autophosphorylation [GO:0046777]; regulation of autophagy [GO:0010506]; replicative senescence [GO:0090399]; response to ionizing radiation [GO:0010212]; signal transduction in response to DNA damage [GO:0042770]; somitogenesis [GO:0001756]; thymus development [GO:0048538]; V(D)J recombination [GO:0033151]","centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; extrinsic component of synaptic vesicle membrane [GO:0098850]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; site of double-strand break [GO:0035861]; spindle [GO:0005819]",1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005815; GO:0006281; GO:0006310; GO:0006355; GO:0006914; GO:0012501; GO:0016071; GO:0016740; GO:0022414; GO:0030163; GO:0043226; GO:0048856; GO:0140013; GO:0140096,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; microtubule organizing center; DNA repair; DNA recombination; regulation of DNA-templated transcription; autophagy; programmed cell death; mRNA metabolic process; transferase activity; reproductive process; protein catabolic process; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on a protein"
OG_11181,FUN_012184-T1,Peve_00016117,,apul_peve,77.532,FUN_012184-T1,P74308,,,,,45.2,312.0,2.0000000000000003e-74,280.8,sp|P74308|AKR_SYNY3 Aldo/keto reductase slr0942 OS=Synechocystis sp. (strain ATCC 27184 / PCC 6803 / Kazusa) OX=1111708 GN=slr0942 PE=1 SV=1,,,,,,
OG_11182,FUN_012188-T1,Peve_00027772,,apul_peve,38.663,,,,,,,,,,,,,,,,,
OG_11183,FUN_012190-T1,Peve_00013742,,apul_peve,70.45,FUN_012190-T1,Q99N01,,,,,36.6,601.0,2.1e-104,381.3,sp|Q99N01|SO4A1_RAT Solute carrier organic anion transporter family member 4A1 OS=Rattus norvegicus OX=10116 GN=Slco4a1 PE=2 SV=1,,,,,,
OG_11184,FUN_012195-T1,Peve_00013744,,apul_peve,47.089,,,,,,,,,,,,,,,,,
OG_11185,FUN_012200-T1,Peve_00003474,,apul_peve,49.844,,,,,,,,,,,,,,,,,
OG_11186,FUN_012215-T1,Peve_00005374,,apul_peve,57.216,FUN_012215-T1,A8WFT6,,,,,28.2,376.0,8.7e-35,149.4,sp|A8WFT6|HYKK_DANRE Hydroxylysine kinase OS=Danio rerio OX=7955 GN=hykk PE=2 SV=1,,,,,,
OG_11187,FUN_012220-T1,Peve_00005379,,apul_peve,36.066,,,,,,,,,,,,,,,,,
OG_11188,FUN_012221-T1,Peve_00005370,,apul_peve,80.982,FUN_012221-T1,Q008S8,,,,,40.8,233.0,6.0999999999999996e-46,186.4,sp|Q008S8|ECT2L_HUMAN Epithelial cell-transforming sequence 2 oncogene-like OS=Homo sapiens OX=9606 GN=ECT2L PE=1 SV=2,,,,,,
OG_11189,FUN_012226-T1,Peve_00036352,,apul_peve,70.42,FUN_012226-T1,P08289,PPBT_RAT,,"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) (Phosphoamidase) (Phosphocreatine phosphatase) (EC 3.9.1.1)",Rattus norvegicus (Rat),48.2,481.0,3.9e-118,426.8,"sp|P08289|PPBT_RAT Alkaline phosphatase, tissue-nonspecific isozyme OS=Rattus norvegicus OX=10116 GN=Alpl PE=1 SV=2",GO:0001958; GO:0003006; GO:0004035; GO:0004427; GO:0005509; GO:0005615; GO:0005758; GO:0005886; GO:0016462; GO:0016887; GO:0019725; GO:0030282; GO:0031012; GO:0031214; GO:0031966; GO:0032496; GO:0032868; GO:0033280; GO:0033883; GO:0034516; GO:0036005; GO:0042822; GO:0043262; GO:0046677; GO:0050187; GO:0051384; GO:0052732; GO:0055062; GO:0055074; GO:0065010; GO:0071529; GO:0098552; GO:0120162; GO:0140651; GO:0140928; GO:1904383,biomineral tissue development [GO:0031214]; bone mineralization [GO:0030282]; calcium ion homeostasis [GO:0055074]; cellular homeostasis [GO:0019725]; cementum mineralization [GO:0071529]; developmental process involved in reproduction [GO:0003006]; endochondral ossification [GO:0001958]; futile creatine cycle [GO:0140651]; inhibition of non-skeletal tissue mineralization [GO:0140928]; phosphate ion homeostasis [GO:0055062]; positive regulation of cold-induced thermogenesis [GO:0120162]; pyridoxal phosphate metabolic process [GO:0042822]; response to antibiotic [GO:0046677]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to macrophage colony-stimulating factor [GO:0036005]; response to sodium phosphate [GO:1904383]; response to vitamin B6 [GO:0034516]; response to vitamin D [GO:0033280],extracellular matrix [GO:0031012]; extracellular membrane-bounded organelle [GO:0065010]; extracellular space [GO:0005615]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],ADP phosphatase activity [GO:0043262]; alkaline phosphatase activity [GO:0004035]; ATP hydrolysis activity [GO:0016887]; calcium ion binding [GO:0005509]; inorganic diphosphate phosphatase activity [GO:0004427]; phosphoamidase activity [GO:0050187]; phosphoethanolamine phosphatase activity [GO:0052732]; pyridoxal phosphatase activity [GO:0033883]; pyrophosphatase activity [GO:0016462],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0022414; GO:0030312; GO:0031012; GO:0043226; GO:0048856,catalytic activity; extracellular space; plasma membrane; hydrolase activity; reproductive process; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_11190,FUN_012228-T1,Peve_00020577,,apul_peve,56.364,,,,,,,,,,,,,,,,,
OG_11191,FUN_012230-T1,Peve_00020572,,apul_peve,63.372,FUN_012230-T1,Q9VCZ3,OCTB1_DROME,,Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R),Drosophila melanogaster (Fruit fly),32.1,318.0,3.1e-25,117.5,sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1,GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410],membrane [GO:0016020]; plasma membrane [GO:0005886],adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_11192,FUN_012234-T2,Peve_00035728,,apul_peve,83.082,FUN_012234-T2,Q2TA00,,,,,28.1,285.0,1.4e-26,122.1,sp|Q2TA00|CCD83_BOVIN Coiled-coil domain-containing protein 83 OS=Bos taurus OX=9913 GN=CCDC83 PE=2 SV=1,,,,,,
OG_11193,FUN_012242-T1,Peve_00018302,,apul_peve,54.032,,,,,,,,,,,,,,,,,
OG_11194,FUN_012244-T1,Peve_00018299,,apul_peve,38.644,,,,,,,,,,,,,,,,,
OG_11195,FUN_012255-T1,Peve_00036359,,apul_peve,71.429,FUN_012255-T1,Q9H3M0,KCNF1_HUMAN,,Voltage-gated potassium channel regulatory subunit KCNF1 (Potassium voltage-gated channel subfamily F member 1) (Voltage-gated potassium channel subunit Kv5.1) (kH1),Homo sapiens (Human),38.7,75.0,9.1e-08,60.1,sp|Q9H3M0|KCNF1_HUMAN Voltage-gated potassium channel regulatory subunit KCNF1 OS=Homo sapiens OX=9606 GN=KCNF1 PE=1 SV=1,GO:0001508; GO:0005249; GO:0005886; GO:0006813; GO:0008076; GO:0015459; GO:0016020; GO:0043266; GO:0051260; GO:0071805; GO:0097546; GO:1905515,action potential [GO:0001508]; non-motile cilium assembly [GO:1905515]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of potassium ion transport [GO:0043266],ciliary base [GO:0097546]; membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076],potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0044782; GO:0055085; GO:0065003; GO:0098772,transporter activity; plasma membrane; cilium organization; transmembrane transport; protein-containing complex assembly; molecular function regulator activity
OG_11196,FUN_012263-T1,Peve_00036388,,apul_peve,38.663,FUN_012263-T1,Q559T8,,,,,29.8,104.0,4.1e-06,56.2,sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0272282 PE=3 SV=1,,,,,,
OG_11197,FUN_012264-T1,Peve_00036386,,apul_peve,45.241,,,,,,,,,,,,,,,,,
OG_11198,FUN_012269-T1,Peve_00020520,,apul_peve,65.139,FUN_012269-T1,Q9VCZ3,OCTB1_DROME,,Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R),Drosophila melanogaster (Fruit fly),21.1,313.0,6.5e-08,60.1,sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1,GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410],membrane [GO:0016020]; plasma membrane [GO:0005886],adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_11199,FUN_012277-T1,Peve_00010525,,apul_peve,60.553,,,,,,,,,,,,,,,,,
OG_11200,FUN_012282-T1,Peve_00023638,,apul_peve,58.269,FUN_012282-T1,O94885,,,,,39.4,142.0,1.5e-23,113.6,sp|O94885|SASH1_HUMAN SAM and SH3 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SASH1 PE=1 SV=3,,,,,,
OG_11201,FUN_012287-T1,Peve_00010524,,apul_peve,68.8015,FUN_012287-T1,Q8VHE0,SEC63_MOUSE,,Translocation protein SEC63 homolog (DnaJ homolog subfamily C member 23),Mus musculus (Mouse),48.4,774.0,6.9e-137,489.6,sp|Q8VHE0|SEC63_MOUSE Translocation protein SEC63 homolog OS=Mus musculus OX=10090 GN=Sec63 PE=1 SV=4,GO:0001889; GO:0005789; GO:0006614; GO:0006620; GO:0016020; GO:0031204; GO:0071941,"liver development [GO:0001889]; nitrogen cycle metabolic process [GO:0071941]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; post-translational protein targeting to membrane, translocation [GO:0031204]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]",endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],,GO:0006886; GO:0048856; GO:0055085; GO:0071941,intracellular protein transport; anatomical structure development; transmembrane transport; nitrogen cycle metabolic process
OG_11202,FUN_012290-T1,Peve_00036370,,apul_peve,60.0395,FUN_012290-T1,P48146,NPBW2_HUMAN,,Neuropeptides B/W receptor type 2 (G-protein coupled receptor 8),Homo sapiens (Human),24.1,315.0,2.4e-09,64.7,sp|P48146|NPBW2_HUMAN Neuropeptides B/W receptor type 2 OS=Homo sapiens OX=9606 GN=NPBWR2 PE=1 SV=2,GO:0004930; GO:0004985; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0016020; GO:0042923; GO:0043005,G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218],membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],G protein-coupled opioid receptor activity [GO:0004985]; G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; neuropeptide receptor activity [GO:0008188],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_11203,FUN_012305-T1,Peve_00038605,,apul_peve,43.5105,,,,,,,,,,,,,,,,,
OG_11204,FUN_012308-T2,Peve_00038601,,apul_peve,67.434,,,,,,,,,,,,,,,,,
OG_11205,FUN_012310-T1,Peve_00038596,,apul_peve,70.509,FUN_012310-T1,Q8BHP7,OLM2A_MOUSE,,Olfactomedin-like protein 2A (Photomedin-1),Mus musculus (Mouse),37.9,264.0,6.9e-46,186.0,sp|Q8BHP7|OLM2A_MOUSE Olfactomedin-like protein 2A OS=Mus musculus OX=10090 GN=Olfml2a PE=1 SV=1,GO:0005576; GO:0030198; GO:0031012; GO:0042802; GO:0050840,extracellular matrix organization [GO:0030198],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],extracellular matrix binding [GO:0050840]; identical protein binding [GO:0042802],GO:0005576; GO:0030198; GO:0030312; GO:0031012,extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_11206,FUN_012323-T1,Peve_00038590,,apul_peve,54.348,FUN_012323-T1,P55022,,,,,29.7,276.0,5.8e-16,87.0,sp|P55022|TYRO_STRGB Tyrosinase OS=Streptomyces galbus OX=33898 GN=melC2 PE=3 SV=2,,,,,,
OG_11207,FUN_012334-T1,Peve_00015494,,apul_peve,75.325,FUN_012334-T1,Q61493,,,,,28.8,2887.0,3.9e-226,787.7,sp|Q61493|REV3L_MOUSE DNA polymerase zeta catalytic subunit OS=Mus musculus OX=10090 GN=Rev3l PE=1 SV=3,,,,,,
OG_11208,FUN_012337-T1,Peve_00021552,,apul_peve,75.95349999999999,FUN_012337-T1,O75417,DPOLQ_HUMAN,,DNA polymerase theta (DNA polymerase eta) [Includes: Helicase POLQ (EC 3.6.4.12); DNA polymerase POLQ (EC 2.7.7.7) (RNA-directed DNA polymerase POLQ) (EC 2.7.7.49)],Homo sapiens (Human),32.4,1923.0,1.3e-224,781.9,sp|O75417|DPOLQ_HUMAN DNA polymerase theta OS=Homo sapiens OX=9606 GN=POLQ PE=1 SV=2,GO:0000287; GO:0003678; GO:0003682; GO:0003684; GO:0003887; GO:0003964; GO:0005524; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0006284; GO:0006302; GO:0006974; GO:0016446; GO:0016887; GO:0017116; GO:0031297; GO:0035861; GO:0042276; GO:0042645; GO:0042802; GO:0051260; GO:0051575; GO:0090734; GO:0097681; GO:2000042,base-excision repair [GO:0006284]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; error-prone translesion synthesis [GO:0042276]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; replication fork processing [GO:0031297]; somatic hypermutation of immunoglobulin genes [GO:0016446],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861],5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; RNA-directed DNA polymerase activity [GO:0003964]; single-stranded DNA helicase activity [GO:0017116],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0006281; GO:0016740; GO:0016787; GO:0016829; GO:0016853; GO:0043226; GO:0065003; GO:0140097; GO:0140657,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; Golgi apparatus; cytosol; DNA repair; transferase activity; hydrolase activity; lyase activity; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on DNA; ATP-dependent activity"
OG_11209,FUN_012354-T1,Peve_00044138,,apul_peve,63.366,,,,,,,,,,,,,,,,,
OG_11210,FUN_012367-T1,Peve_00024419,,apul_peve,43.939,,,,,,,,,,,,,,,,,
OG_11211,FUN_012368-T1,Peve_00015815,,apul_peve,62.934,FUN_012368-T1,A8MXE2,B3GT9_HUMAN,,"Beta-1,3-galactosyltransferase 9 (EC 2.4.1.-) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 10)",Homo sapiens (Human),32.3,226.0,2.2e-22,107.8,"sp|A8MXE2|B3GT9_HUMAN Beta-1,3-galactosyltransferase 9 OS=Homo sapiens OX=9606 GN=B3GALT9 PE=1 SV=2",GO:0000139; GO:0006493; GO:0016757; GO:0016758,protein O-linked glycosylation [GO:0006493],Golgi membrane [GO:0000139],glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758],GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_11212,FUN_012392-T1,Peve_00008848,,apul_peve,58.084,,,,,,,,,,,,,,,,,
OG_11213,FUN_012393-T1,Peve_00008849,,apul_peve,54.98,,,,,,,,,,,,,,,,,
OG_11214,FUN_012394-T1,Peve_00008845,,apul_peve,68.919,,,,,,,,,,,,,,,,,
OG_11215,FUN_012397-T1,Peve_00008846,,apul_peve,63.4115,FUN_012397-T1,Q80X19,COEA1_MOUSE,,Collagen alpha-1(XIV) chain,Mus musculus (Mouse),31.5,162.0,5.3e-13,77.8,sp|Q80X19|COEA1_MOUSE Collagen alpha-1(XIV) chain OS=Mus musculus OX=10090 GN=Col14a1 PE=1 SV=2,GO:0003229; GO:0005581; GO:0005614; GO:0005615; GO:0007155; GO:0030199; GO:0048873; GO:0061050; GO:0062023,cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; homeostasis of number of cells within a tissue [GO:0048873]; regulation of cell growth involved in cardiac muscle cell development [GO:0061050]; ventricular cardiac muscle tissue development [GO:0003229],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614],,GO:0005615; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular space; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_11216,FUN_012410-T2,Peve_00023480,,apul_peve,69.471,FUN_012410-T2,P46939,UTRN_HUMAN,,Utrophin (Dystrophin-related protein 1) (DRP-1),Homo sapiens (Human),28.3,784.0,3.8e-76,287.7,sp|P46939|UTRN_HUMAN Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,GO:0001954; GO:0003779; GO:0005178; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0006936; GO:0007517; GO:0008270; GO:0016010; GO:0016020; GO:0017166; GO:0019901; GO:0030175; GO:0031527; GO:0031594; GO:0032991; GO:0036064; GO:0042383; GO:0045211; GO:0070062; GO:0099536; GO:1902305,muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transport [GO:1902305]; synaptic signaling [GO:0099536],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383],actin binding [GO:0003779]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270],GO:0003012; GO:0005654; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0008092; GO:0023052; GO:0043226; GO:0048856,muscle system process; nucleoplasm; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeletal protein binding; signaling; organelle; anatomical structure development
OG_11217,FUN_012411-T1,Peve_00037992,,apul_peve,40.779,FUN_012411-T1,P11277,SPTB1_HUMAN,,"Spectrin beta chain, erythrocytic (Beta-I spectrin)",Homo sapiens (Human),28.6,269.0,4.5e-29,131.7,"sp|P11277|SPTB1_HUMAN Spectrin beta chain, erythrocytic OS=Homo sapiens OX=9606 GN=SPTB PE=1 SV=5",GO:0003779; GO:0005200; GO:0005829; GO:0005886; GO:0008091; GO:0009898; GO:0009986; GO:0014731; GO:0015629; GO:0030036; GO:0030054; GO:0030506; GO:0030864; GO:0032991; GO:0042995; GO:0051015; GO:0051693; GO:0098794; GO:0098885; GO:0098978,actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; modification of postsynaptic actin cytoskeleton [GO:0098885],actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cell projection [GO:0042995]; cell surface [GO:0009986]; cortical actin cytoskeleton [GO:0030864]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731],actin binding [GO:0003779]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; structural constituent of cytoskeleton [GO:0005200],GO:0005198; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0034330; GO:0043226,structural molecule activity; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; cell junction organization; organelle
OG_11218,FUN_012423-T1,Peve_00020929,,apul_peve,62.923,,,,,,,,,,,,,,,,,
OG_11219,FUN_012429-T2,Peve_00026914,,apul_peve,47.048,,,,,,,,,,,,,,,,,
OG_11220,FUN_012432-T1,Peve_00010669,,apul_peve,76.05600000000001,,,,,,,,,,,,,,,,,
OG_11221,FUN_012436-T1,Peve_00026920,,apul_peve,64.984,FUN_012436-T1,Q0EEE2,PTHD3_MOUSE,,Patched domain-containing protein 3 (RND-type protein RNDEu-3),Mus musculus (Mouse),27.8,844.0,6.3e-68,260.8,sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0097225,,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225],,GO:0005783; GO:0005886; GO:0043226,endoplasmic reticulum; plasma membrane; organelle
OG_11222,FUN_012450-T1,Peve_00023865,,apul_peve,71.875,,,,,,,,,,,,,,,,,
OG_11223,FUN_012451-T1,Peve_00015634,,apul_peve,83.333,,,,,,,,,,,,,,,,,
OG_11224,FUN_012453-T1,Peve_00000519,,apul_peve,40.9195,,,,,,,,,,,,,,,,,
OG_11225,FUN_012455-T1,Peve_00023435,,apul_peve,95.052,,,,,,,,,,,,,,,,,
OG_11226,FUN_012474-T1,Peve_00018314,,apul_peve,43.878,,,,,,,,,,,,,,,,,
OG_11227,FUN_012483-T1,Peve_00010910,,apul_peve,76.398,FUN_012483-T1,Q641A1,,,,,38.1,307.0,1.1e-48,195.3,sp|Q641A1|GLD2A_XENLA Poly(A) RNA polymerase GLD2-A OS=Xenopus laevis OX=8355 GN=tent2-a PE=1 SV=1,,,,,,
OG_11228,FUN_012493-T1,Peve_00007951,,apul_peve,69.477,FUN_012493-T1,O77408,,,,,38.6,140.0,9e-17,89.4,sp|O77408|OAR1_LYMST Octopamine receptor 1 OS=Lymnaea stagnalis OX=6523 PE=1 SV=1,,,,,,
OG_11229,FUN_012509-T1,Peve_00002165,,apul_peve,74.233,,,,,,,,,,,,,,,,,
OG_11230,FUN_012515-T1,Peve_00022369,,apul_peve,69.231,,,,,,,,,,,,,,,,,
OG_11231,FUN_012537-T1,Peve_00034219,,apul_peve,56.604,,,,,,,,,,,,,,,,,
OG_11232,FUN_012550-T1,Peve_00030418,,apul_peve,70.796,FUN_012550-T1,Q8VCE1,,,,,40.4,339.0,5.5e-67,256.1,sp|Q8VCE1|DJC28_MOUSE DnaJ homolog subfamily C member 28 OS=Mus musculus OX=10090 GN=Dnajc28 PE=1 SV=2,,,,,,
OG_11233,FUN_012553-T1,Peve_00030420,,apul_peve,74.38,FUN_012553-T1,P79945,,,,,44.8,337.0,6.299999999999998e-69,262.7,sp|P79945|PSP24_XENLA High-affinity lysophosphatidic acid receptor OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_11234,FUN_012572-T1,Peve_00009080,,apul_peve,65.3125,FUN_012572-T1,Q7TN88,,,,,22.9,1204.0,8.5e-83,310.8,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_11235,FUN_012585-T1,Peve_00038786,,apul_peve,40.999,,,,,,,,,,,,,,,,,
OG_11236,FUN_012593-T1,Peve_00028910,,apul_peve,43.218,,,,,,,,,,,,,,,,,
OG_11237,FUN_012596-T1,Peve_00029459,,apul_peve,98.1305,FUN_012596-T1,Q15427,SF3B4_HUMAN,,Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (Spliceosome-associated protein 49) (SAP 49),Homo sapiens (Human),91.5,212.0,1.5e-112,407.9,sp|Q15427|SF3B4_HUMAN Splicing factor 3B subunit 4 OS=Homo sapiens OX=9606 GN=SF3B4 PE=1 SV=1,GO:0000375; GO:0000398; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0006397; GO:0008380; GO:0071005; GO:0071011; GO:1903241; GO:1990935,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; U2-type prespliceosome assembly [GO:1903241]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],RNA binding [GO:0003723]; splicing factor binding [GO:1990935],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_11238,FUN_012597-T1,Peve_00042798,,apul_peve,65.631,FUN_012597-T1,P35409,,,,,27.1,306.0,1.8e-10,69.3,sp|P35409|GLHR_ANTEL Probable glycoprotein hormone G-protein coupled receptor OS=Anthopleura elegantissima OX=6110 PE=2 SV=1,,,,,,
OG_11239,FUN_012610-T1,Peve_00019996,,apul_peve,89.2615,FUN_012610-T1,Q0P5D0,PPIH_BOVIN,,Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H),Bos taurus (Bovine),79.1,177.0,1.1e-81,304.3,sp|Q0P5D0|PPIH_BOVIN Peptidyl-prolyl cis-trans isomerase H OS=Bos taurus OX=9913 GN=PPIH PE=2 SV=1,GO:0003755; GO:0005681; GO:0005737; GO:0006397; GO:0006457; GO:0008380; GO:0016018; GO:0016607; GO:0043231,mRNA processing [GO:0006397]; protein folding [GO:0006457]; RNA splicing [GO:0008380],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681],cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],GO:0003824; GO:0006457; GO:0016071; GO:0016853; GO:0043226; GO:0140096,"catalytic activity; protein folding; mRNA metabolic process; isomerase activity; organelle; catalytic activity, acting on a protein"
OG_11240,FUN_012617-T1,Peve_00034199,,apul_peve,41.228,FUN_012617-T1,Q9EQD2,NPFF2_RAT,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor),Rattus norvegicus (Rat),28.3,325.0,4.2e-15,84.0,sp|Q9EQD2|NPFF2_RAT Neuropeptide FF receptor 2 OS=Rattus norvegicus OX=10116 GN=Npffr2 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_11241,FUN_012623-T1,Peve_00017737,,apul_peve,56.944,,,,,,,,,,,,,,,,,
OG_11242,FUN_012634-T1,Peve_00036811,,apul_peve,34.02,,,,,,,,,,,,,,,,,
OG_11243,FUN_012637-T2,Peve_00036808,,apul_peve,77.612,FUN_012637-T2,Q91V01,MBOA5_MOUSE,,Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (mLPCAT3) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5),Mus musculus (Mouse),41.5,439.0,5.8e-91,336.3,sp|Q91V01|MBOA5_MOUSE Lysophospholipid acyltransferase 5 OS=Mus musculus OX=10090 GN=Lpcat3 PE=1 SV=1,GO:0005789; GO:0008654; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047184; GO:0050728; GO:0090158; GO:0097006; GO:0106262; GO:0106263; GO:1903573; GO:1905885,chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of plasma lipoprotein particle levels [GO:0097006]; very-low-density lipoprotein particle assembly [GO:0034379],endoplasmic reticulum membrane [GO:0005789],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263],GO:0003824; GO:0006575; GO:0006629; GO:0016740; GO:0061024; GO:0065003,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity; membrane organization; protein-containing complex assembly
OG_11244,FUN_012643-T2,Peve_00020923,,apul_peve,52.997,,,,,,,,,,,,,,,,,
OG_11245,FUN_012656-T1,Peve_00022125,,apul_peve,54.4825,,,,,,,,,,,,,,,,,
OG_11246,FUN_012658-T1,Peve_00020499,,apul_peve,80.303,FUN_012658-T1,Q96S94,CCNL2_HUMAN,,Cyclin-L2 (Paneth cell-enhanced expression protein),Homo sapiens (Human),62.8,121.0,5.7e-37,155.2,sp|Q96S94|CCNL2_HUMAN Cyclin-L2 OS=Homo sapiens OX=9606 GN=CCNL2 PE=1 SV=1,GO:0000307; GO:0005634; GO:0005654; GO:0006357; GO:0016538; GO:0016607; GO:0042981; GO:0043231; GO:0043484; GO:0046605; GO:0051726,regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of centrosome cycle [GO:0046605]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357],cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538],GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0098772,nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular function regulator activity
OG_11247,FUN_012661-T1,Peve_00020501,,apul_peve,63.684,FUN_012661-T1,A3KQ55,MEPCE_DANRE,,7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog) (zBCDIN3),Danio rerio (Zebrafish) (Brachydanio rerio),33.4,557.0,1.9e-72,275.0,sp|A3KQ55|MEPCE_DANRE 7SK snRNA methylphosphate capping enzyme OS=Danio rerio OX=7955 GN=mepce PE=3 SV=2,GO:0001510; GO:0005634; GO:0008171; GO:0008173; GO:0008757; GO:0016073; GO:0017069; GO:0040031; GO:1904871; GO:1905382; GO:1990276; GO:1990904,positive regulation of protein localization to Cajal body [GO:1904871]; positive regulation of snRNA transcription by RNA polymerase II [GO:1905382]; RNA methylation [GO:0001510]; snRNA metabolic process [GO:0016073]; snRNA modification [GO:0040031],nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],O-methyltransferase activity [GO:0008171]; RNA 5'-gamma-phosphate methyltransferase activity [GO:1990276]; RNA methyltransferase activity [GO:0008173]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; snRNA binding [GO:0017069],GO:0003723; GO:0003824; GO:0005634; GO:0006355; GO:0016073; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; snRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_11248,FUN_012669-T1,Peve_00007057,,apul_peve,66.48,,,,,,,,,,,,,,,,,
OG_11249,FUN_012679-T1,Peve_00044336,,apul_peve,64.606,FUN_012679-T1,O22943,STL1_ARATH,,Probable glycosyltransferase STELLO1 (EC 2.4.-.-),Arabidopsis thaliana (Mouse-ear cress),39.5,405.0,2.9e-82,307.4,sp|O22943|STL1_ARATH Probable glycosyltransferase STELLO1 OS=Arabidopsis thaliana OX=3702 GN=STL1 PE=1 SV=1,GO:0000139; GO:0005768; GO:0005794; GO:0005802; GO:0016757; GO:0042802; GO:0052324; GO:2001009,plant-type cell wall cellulose biosynthetic process [GO:0052324]; regulation of plant-type cell wall cellulose biosynthetic process [GO:2001009],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],glycosyltransferase activity [GO:0016757]; identical protein binding [GO:0042802],GO:0003824; GO:0005768; GO:0005794; GO:0005975; GO:0016740; GO:0031410; GO:0043226,catalytic activity; endosome; Golgi apparatus; carbohydrate metabolic process; transferase activity; cytoplasmic vesicle; organelle
OG_11250,FUN_012690-T1,Peve_00016819,,apul_peve,77.265,FUN_012690-T1,P52569,CTR2_HUMAN,,Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2),Homo sapiens (Human),47.3,601.0,3.8e-143,510.0,sp|P52569|CTR2_HUMAN Cationic amino acid transporter 2 OS=Homo sapiens OX=9606 GN=SLC7A2 PE=1 SV=2,GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352; GO:1903826,amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104],cell junction [GO:0030054]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],GO:0003013; GO:0005215; GO:0005886; GO:0055085,circulatory system process; transporter activity; plasma membrane; transmembrane transport
OG_11251,FUN_012695-T1,Peve_00016825,,apul_peve,66.933,,,,,,,,,,,,,,,,,
OG_11252,FUN_012703-T1,Peve_00016839,,apul_peve,57.2705,,,,,,,,,,,,,,,,,
OG_11253,FUN_012705-T1,Peve_00004314,,apul_peve,60.897,,,,,,,,,,,,,,,,,
OG_11254,FUN_012709-T1,Peve_00004158,,apul_peve,65.29849999999999,FUN_012709-T1,Q9JHE4,G3ST1_MOUSE,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Mus musculus (Mouse),36.2,345.0,2.4e-49,198.0,sp|Q9JHE4|G3ST1_MOUSE Galactosylceramide sulfotransferase OS=Mus musculus OX=10090 GN=Gal3st1 PE=1 SV=2,GO:0000139; GO:0001733; GO:0006681; GO:0006682; GO:0007283; GO:0009247; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycolipid biosynthetic process [GO:0009247]; myelination [GO:0042552]; spermatogenesis [GO:0007283],Golgi membrane [GO:0000139]; membrane [GO:0016020],galactosylceramide sulfotransferase activity [GO:0001733],GO:0003824; GO:0006629; GO:0016740; GO:0022414; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_11255,FUN_012729-T1,Peve_00001016,,apul_peve,53.623,,,,,,,,,,,,,,,,,
OG_11256,FUN_012737-T1,Peve_00036155,,apul_peve,37.261,,,,,,,,,,,,,,,,,
OG_11257,FUN_012738-T1,Peve_00035345,,apul_peve,40.0765,,,,,,,,,,,,,,,,,
OG_11258,FUN_012751-T1,Peve_00044220,,apul_peve,37.022000000000006,,,,,,,,,,,,,,,,,
OG_11259,FUN_012752-T2,Peve_00044224,,apul_peve,45.877,,,,,,,,,,,,,,,,,
OG_11260,FUN_012763-T2,Peve_00006125,,apul_peve,65.939,,,,,,,,,,,,,,,,,
OG_11261,FUN_012767-T1,Peve_00033805,,apul_peve,73.547,FUN_012767-T1,G3V7L1,UTRN_RAT,,Utrophin (Dystrophin-related protein 1) (DRP-1),Rattus norvegicus (Rat),20.1,2265.0,1.4e-31,142.1,sp|G3V7L1|UTRN_RAT Utrophin OS=Rattus norvegicus OX=10116 GN=Utrn PE=1 SV=3,GO:0001954; GO:0003779; GO:0005178; GO:0005737; GO:0005886; GO:0007528; GO:0008270; GO:0014894; GO:0016010; GO:0017166; GO:0019901; GO:0030175; GO:0030426; GO:0030864; GO:0031527; GO:0031594; GO:0032991; GO:0042383; GO:0045202; GO:0045211; GO:0051015; GO:0070938; GO:0099536,neuromuscular junction development [GO:0007528]; positive regulation of cell-matrix adhesion [GO:0001954]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; synaptic signaling [GO:0099536],contractile ring [GO:0070938]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; dystrophin-associated glycoprotein complex [GO:0016010]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; growth cone [GO:0030426]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; synapse [GO:0045202],actin binding [GO:0003779]; actin filament binding [GO:0051015]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270],GO:0005856; GO:0005886; GO:0008092; GO:0023052; GO:0034330; GO:0043226,cytoskeleton; plasma membrane; cytoskeletal protein binding; signaling; cell junction organization; organelle
OG_11262,FUN_012780-T1,Peve_00007526,,apul_peve,81.098,,,,,,,,,,,,,,,,,
OG_11263,FUN_012794-T2,Peve_00010082,,apul_peve,87.376,FUN_012794-T2,O15439,MRP4_HUMAN,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4),Homo sapiens (Human),39.8,1288.0,3.5999999999999996e-268,926.4,sp|O15439|MRP4_HUMAN ATP-binding cassette sub-family C member 4 OS=Homo sapiens OX=9606 GN=ABCC4 PE=1 SV=3,GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0043231; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003013; GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016192; GO:0016491; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,circulatory system process; catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; vesicle-mediated transport; oxidoreductase activity; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_11264,FUN_012796-T1,Peve_00034573,,apul_peve,63.551,FUN_012796-T1,Q05793,PGBM_MOUSE,,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) [Cleaved into: Endorepellin; LG3 peptide],Mus musculus (Mouse),33.8,846.0,9.399999999999999e-140,499.2,sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1,GO:0001525; GO:0001958; GO:0002020; GO:0002062; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007420; GO:0008104; GO:0030198; GO:0031012; GO:0048704; GO:0048738; GO:0060351; GO:0062023,angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796],calcium ion binding [GO:0005509]; protease binding [GO:0002020],GO:0005576; GO:0016192; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; vesicle-mediated transport; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_11265,FUN_012798-T1,Peve_00019854,,apul_peve,45.736,FUN_012798-T1,Q05793,PGBM_MOUSE,,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) [Cleaved into: Endorepellin; LG3 peptide],Mus musculus (Mouse),29.2,120.0,2.1e-07,59.7,sp|Q05793|PGBM_MOUSE Basement membrane-specific heparan sulfate proteoglycan core protein OS=Mus musculus OX=10090 GN=Hspg2 PE=1 SV=1,GO:0001525; GO:0001958; GO:0002020; GO:0002062; GO:0005509; GO:0005576; GO:0005604; GO:0005796; GO:0006898; GO:0007420; GO:0008104; GO:0030198; GO:0031012; GO:0048704; GO:0048738; GO:0060351; GO:0062023,angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiac muscle tissue development [GO:0048738]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; chondrocyte differentiation [GO:0002062]; embryonic skeletal system morphogenesis [GO:0048704]; endochondral ossification [GO:0001958]; extracellular matrix organization [GO:0030198]; protein localization [GO:0008104]; receptor-mediated endocytosis [GO:0006898],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796],calcium ion binding [GO:0005509]; protease binding [GO:0002020],GO:0005576; GO:0016192; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; vesicle-mediated transport; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_11266,FUN_012805-T1,Peve_00026604,,apul_peve,56.9815,,,,,,,,,,,,,,,,,
OG_11267,FUN_012829-T1,Peve_00001823,,apul_peve,75.294,,,,,,,,,,,,,,,,,
OG_11268,FUN_012830-T1,Peve_00026214,,apul_peve,59.2605,,,,,,,,,,,,,,,,,
OG_11269,FUN_012842-T1,Peve_00029223,,apul_peve,39.623,,,,,,,,,,,,,,,,,
OG_11270,FUN_012843-T1,Peve_00028299,,apul_peve,88.235,,,,,,,,,,,,,,,,,
OG_11271,FUN_012877-T1,Peve_00036269,,apul_peve,40.449,,,,,,,,,,,,,,,,,
OG_11272,FUN_012885-T1,Peve_00040877,,apul_peve,53.3945,,,,,,,,,,,,,,,,,
OG_11273,FUN_012890-T1,Peve_00003931,,apul_peve,82.105,,,,,,,,,,,,,,,,,
OG_11274,FUN_012902-T1,Peve_00010563,,apul_peve,59.067,,,,,,,,,,,,,,,,,
OG_11275,FUN_012911-T1,Peve_00010559,,apul_peve,56.8,,,,,,,,,,,,,,,,,
OG_11276,FUN_012929-T1,Peve_00031188,,apul_peve,67.876,,,,,,,,,,,,,,,,,
OG_11277,FUN_012930-T1,Peve_00044002,,apul_peve,77.091,,,,,,,,,,,,,,,,,
OG_11278,FUN_012975-T1,Peve_00032583,,apul_peve,60.69,FUN_012975-T1,Q9V3R8,UBIA1_DROME,,UbiA prenyltransferase domain-containing protein 1 homolog (EC 2.5.1.-) (Protein heixuedian),Drosophila melanogaster (Fruit fly),32.9,292.0,2.7e-30,134.0,sp|Q9V3R8|UBIA1_DROME UbiA prenyltransferase domain-containing protein 1 homolog OS=Drosophila melanogaster OX=7227 GN=heix PE=2 SV=1,GO:0000139; GO:0004659; GO:0005739; GO:0005783; GO:0005789; GO:0007005; GO:0009234; GO:0016020; GO:0031966; GO:0035167; GO:0035204; GO:0035207; GO:0042371; GO:0045611,larval lymph gland hemopoiesis [GO:0035167]; menaquinone biosynthetic process [GO:0009234]; mitochondrion organization [GO:0007005]; negative regulation of hemocyte differentiation [GO:0045611]; negative regulation of hemocyte proliferation [GO:0035207]; negative regulation of lamellocyte differentiation [GO:0035204]; vitamin K biosynthetic process [GO:0042371],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],prenyltransferase activity [GO:0004659],GO:0003824; GO:0005739; GO:0005783; GO:0006766; GO:0007005; GO:0016740; GO:0043226; GO:0048856,catalytic activity; mitochondrion; endoplasmic reticulum; vitamin metabolic process; mitochondrion organization; transferase activity; organelle; anatomical structure development
OG_11279,FUN_012999-T1,Peve_00000257,,apul_peve,66.8425,,,,,,,,,,,,,,,,,
OG_11280,FUN_013015-T1,Peve_00014305,,apul_peve,47.059,,,,,,,,,,,,,,,,,
OG_11281,FUN_013017-T1,Peve_00032443,,apul_peve,55.172,,,,,,,,,,,,,,,,,
OG_11282,FUN_013032-T1,Peve_00020924,,apul_peve,59.3585,,,,,,,,,,,,,,,,,
OG_11283,FUN_013040-T1,Peve_00025635,,apul_peve,73.913,,,,,,,,,,,,,,,,,
OG_11284,FUN_013053-T1,Peve_00045351,,apul_peve,51.276,,,,,,,,,,,,,,,,,
OG_11285,FUN_013078-T1,Peve_00027400,,apul_peve,74.8585,FUN_013078-T1,P46087,NOP2_HUMAN,,28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120),Homo sapiens (Human),62.1,448.0,9.7e-150,531.9,sp|P46087|NOP2_HUMAN 28S rRNA (cytosine(4447)-C(5))-methyltransferase OS=Homo sapiens OX=9606 GN=NOP2 PE=1 SV=2,GO:0000027; GO:0000470; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0008284; GO:0009383; GO:0042273; GO:0070475; GO:1901796,maturation of LSU-rRNA [GO:0000470]; positive regulation of cell population proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA base methylation [GO:0070475]; rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016740; GO:0043226; GO:0065003; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on RNA"
OG_11286,FUN_013084-T1,Peve_00027385,,apul_peve,57.2425,FUN_013084-T1,Q2YDM7,,,,,49.1,656.0,2.6e-158,560.5,sp|Q2YDM7|LSG1_BOVIN Large subunit GTPase 1 homolog OS=Bos taurus OX=9913 GN=LSG1 PE=2 SV=1,,,,,,
OG_11287,FUN_013108-T1,Peve_00035570,,apul_peve,35.333,,,,,,,,,,,,,,,,,
OG_11288,FUN_013127-T1,Peve_00005798,,apul_peve,89.011,,,,,,,,,,,,,,,,,
OG_11289,FUN_013129-T1,Peve_00011389,,apul_peve,56.158,,,,,,,,,,,,,,,,,
OG_11290,FUN_013131-T1,Peve_00011707,,apul_peve,51.19,,,,,,,,,,,,,,,,,
OG_11291,FUN_013132-T1,Peve_00000442,,apul_peve,52.8845,FUN_013132-T1,O62806,,,,,36.2,290.0,7.9e-34,146.0,sp|O62806|MMP13_RABIT Collagenase 3 OS=Oryctolagus cuniculus OX=9986 GN=MMP13 PE=2 SV=1,,,,,,
OG_11292,FUN_013133-T1,Peve_00013809,,apul_peve,56.98,FUN_013133-T1,Q99542,MMP19_HUMAN,,Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18),Homo sapiens (Human),46.1,241.0,1.6e-47,191.4,sp|Q99542|MMP19_HUMAN Matrix metalloproteinase-19 OS=Homo sapiens OX=9606 GN=MMP19 PE=1 SV=1,GO:0001525; GO:0001541; GO:0001542; GO:0001554; GO:0004222; GO:0004252; GO:0005576; GO:0005615; GO:0006508; GO:0008270; GO:0009725; GO:0022617; GO:0030154; GO:0030198; GO:0030574; GO:0031012; GO:0051591,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; luteolysis [GO:0001554]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; proteolysis [GO:0006508]; response to cAMP [GO:0051591]; response to hormone [GO:0009725],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615],metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0022414; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; reproductive process; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; catalytic activity, acting on a protein"
OG_11293,FUN_013147-T1,Peve_00027396,,apul_peve,54.378,FUN_013147-T1,Q5WM45,,,,,49.5,109.0,1.5e-25,118.2,sp|Q5WM45|FOXD5_XENTR Forkhead box protein D5 OS=Xenopus tropicalis OX=8364 GN=foxd5 PE=2 SV=1,,,,,,
OG_11294,FUN_013283-T1,Peve_00018767,,apul_peve,66.015,,,,,,,,,,,,,,,,,
OG_11295,FUN_013287-T1,Peve_00014913,,apul_peve,88.175,FUN_013287-T1,Q0V8L6,PLD2_BOVIN,,Phospholipase D2 (PLD 2) (EC 3.1.4.4) (Choline phosphatase 2) (Phosphatidylcholine-hydrolyzing phospholipase D2),Bos taurus (Bovine),37.4,660.0,1.7e-115,418.3,sp|Q0V8L6|PLD2_BOVIN Phospholipase D2 OS=Bos taurus OX=9913 GN=PLD2 PE=2 SV=1,GO:0004630; GO:0005886; GO:0006654; GO:0009395; GO:0031410; GO:0035091; GO:0035556; GO:0060627,intracellular signal transduction [GO:0035556]; phosphatidic acid biosynthetic process [GO:0006654]; phospholipid catabolic process [GO:0009395]; regulation of vesicle-mediated transport [GO:0060627],cytoplasmic vesicle [GO:0031410]; plasma membrane [GO:0005886],phosphatidylinositol binding [GO:0035091]; phospholipase D activity [GO:0004630],GO:0003824; GO:0005886; GO:0006629; GO:0008289; GO:0016787; GO:0031410; GO:0043226,catalytic activity; plasma membrane; lipid metabolic process; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle
OG_11296,FUN_013328-T1,Peve_00022433,,apul_peve,65.306,FUN_013328-T1,Q8IS64,,,,,37.4,690.0,1.2e-141,505.4,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_11297,FUN_013344-T1,Peve_00042390,,apul_peve,54.6645,FUN_013344-T1,O13146,,,,,35.0,943.0,7.4e-146,519.6,sp|O13146|EPHA3_DANRE Ephrin type-A receptor 3 OS=Danio rerio OX=7955 GN=epha3 PE=1 SV=1,,,,,,
OG_11298,FUN_013346-T1,Peve_00008585,,apul_peve,46.464,FUN_013346-T1,Q06807,TIE2_BOVIN,,Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TIE-2) (CD antigen CD202b),Bos taurus (Bovine),32.9,605.0,5.300000000000001e-74,280.8,sp|Q06807|TIE2_BOVIN Angiopoietin-1 receptor OS=Bos taurus OX=9913 GN=TEK PE=2 SV=1,GO:0001525; GO:0001935; GO:0002040; GO:0004714; GO:0005524; GO:0005576; GO:0005737; GO:0005856; GO:0005886; GO:0005925; GO:0007169; GO:0007507; GO:0010595; GO:0016525; GO:0030154; GO:0032878; GO:0034446; GO:0043235; GO:0043410; GO:0045766; GO:0048014; GO:0051894; GO:0051897; GO:0060347; GO:0070374; GO:1902533; GO:2000352,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; endothelial cell proliferation [GO:0001935]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of establishment or maintenance of cell polarity [GO:0032878]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005576; GO:0005856; GO:0005886; GO:0007155; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; extracellular region; cytoskeleton; plasma membrane; cell adhesion; transferase activity; cell differentiation; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_11299,FUN_013353-T1,Peve_00041991,,apul_peve,52.256,,,,,,,,,,,,,,,,,
OG_11300,FUN_013356-T1,Peve_00042001,,apul_peve,51.064,,,,,,,,,,,,,,,,,
OG_11301,FUN_013362-T1,Peve_00001195,,apul_peve,68.932,FUN_013362-T1,A4FV54,RAB8A_BOVIN,,Ras-related protein Rab-8A (EC 3.6.5.2),Bos taurus (Bovine),59.8,169.0,5.4e-57,222.2,sp|A4FV54|RAB8A_BOVIN Ras-related protein Rab-8A OS=Bos taurus OX=9913 GN=RAB8A PE=1 SV=1,GO:0003924; GO:0005525; GO:0005764; GO:0005768; GO:0005794; GO:0005813; GO:0005814; GO:0005886; GO:0005929; GO:0006887; GO:0006914; GO:0007030; GO:0007409; GO:0008021; GO:0010008; GO:0010506; GO:0019003; GO:0030140; GO:0030496; GO:0030670; GO:0031267; GO:0032456; GO:0032869; GO:0036064; GO:0045335; GO:0055038; GO:0060271; GO:0061512; GO:0072659; GO:0098969,autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; protein localization to cilium [GO:0061512]; protein localization to plasma membrane [GO:0072659]; regulation of autophagy [GO:0010506],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; midbody [GO:0030496]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network transport vesicle [GO:0030140],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase binding [GO:0031267],GO:0003824; GO:0003924; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0005815; GO:0005886; GO:0005929; GO:0006914; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0072659,catalytic activity; GTPase activity; lysosome; endosome; vacuole; Golgi apparatus; microtubule organizing center; plasma membrane; cilium; autophagy; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; protein localization to plasma membrane
OG_11302,FUN_013380-T1,Peve_00020450,,apul_peve,74.561,FUN_013380-T1,Q8WVL7,,,,,52.1,188.0,1.6e-14,81.3,sp|Q8WVL7|ANR49_HUMAN Ankyrin repeat domain-containing protein 49 OS=Homo sapiens OX=9606 GN=ANKRD49 PE=1 SV=1,,,,,,
OG_11303,FUN_013382-T1,Peve_00015987,,apul_peve,47.225,,,,,,,,,,,,,,,,,
OG_11304,FUN_013414-T1,Peve_00028074,,apul_peve,35.573,,,,,,,,,,,,,,,,,
OG_11305,FUN_013426-T1,Peve_00044833,,apul_peve,50.898,FUN_013426-T1,Q28107,FA5_BOVIN,,Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain],Bos taurus (Bovine),39.0,172.0,2.1e-26,120.6,sp|Q28107|FA5_BOVIN Coagulation factor V OS=Bos taurus OX=9913 GN=F5 PE=1 SV=1,GO:0005507; GO:0005576; GO:0007596; GO:0008015; GO:0031091,blood circulation [GO:0008015]; blood coagulation [GO:0007596],extracellular region [GO:0005576]; platelet alpha granule [GO:0031091],copper ion binding [GO:0005507],GO:0003013; GO:0005576; GO:0031410; GO:0043226,circulatory system process; extracellular region; cytoplasmic vesicle; organelle
OG_11306,FUN_013468-T1,Peve_00038338,,apul_peve,40.968,FUN_013468-T1,O88783,FA5_MOUSE,,Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain],Mus musculus (Mouse),37.7,175.0,3.0000000000000004e-22,107.5,sp|O88783|FA5_MOUSE Coagulation factor V OS=Mus musculus OX=10090 GN=F5 PE=1 SV=1,GO:0005507; GO:0005615; GO:0007596; GO:0008015; GO:0031091; GO:0032571,blood circulation [GO:0008015]; blood coagulation [GO:0007596]; response to vitamin K [GO:0032571],extracellular space [GO:0005615]; platelet alpha granule [GO:0031091],copper ion binding [GO:0005507],GO:0003013; GO:0005615; GO:0031410; GO:0043226,circulatory system process; extracellular space; cytoplasmic vesicle; organelle
OG_11307,FUN_013484-T1,Peve_00043953,,apul_peve,54.696,FUN_013484-T1,Q9R9N2,,,,,31.5,124.0,2.6e-07,60.1,sp|Q9R9N2|LPSB_RHIME Lipopolysaccharide core biosynthesis mannosyltransferase LpsB OS=Rhizobium meliloti (strain 1021) OX=266834 GN=lpsB PE=3 SV=1,,,,,,
OG_11308,FUN_013536-T1,Peve_00000840,,apul_peve,71.698,,,,,,,,,,,,,,,,,
OG_11309,FUN_013560-T1,Peve_00018162,,apul_peve,79.375,FUN_013560-T1,Q6DIQ3,,,,,73.5,34.0,1.3e-06,55.5,sp|Q6DIQ3|PP1R7_XENTR Protein phosphatase 1 regulatory subunit 7 OS=Xenopus tropicalis OX=8364 GN=ppp1r7 PE=2 SV=1,,,,,,
OG_11310,FUN_013561-T1,Peve_00038579,,apul_peve,80.617,FUN_013561-T1,Q7TNE3,,,,,50.9,226.0,3.7e-51,203.0,sp|Q7TNE3|SPAG7_MOUSE Sperm-associated antigen 7 OS=Mus musculus OX=10090 GN=Spag7 PE=1 SV=1,,,,,,
OG_11311,FUN_013563-T1,Peve_00018192,,apul_peve,46.9495,FUN_013563-T1,P35443,TSP4_HUMAN,,Thrombospondin-4,Homo sapiens (Human),37.0,92.0,3.9e-06,54.7,sp|P35443|TSP4_HUMAN Thrombospondin-4 OS=Homo sapiens OX=9606 GN=THBS4 PE=1 SV=2,GO:0001938; GO:0005178; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006986; GO:0008083; GO:0008201; GO:0016525; GO:0016529; GO:0034103; GO:0034976; GO:0048266; GO:0048771; GO:0050731; GO:0051451; GO:0051781; GO:0062023; GO:0070062; GO:0071603; GO:0090023,behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178],GO:0005576; GO:0005615; GO:0005783; GO:0007155; GO:0030312; GO:0031012; GO:0043226; GO:0048018; GO:0048870; GO:0098772,extracellular region; extracellular space; endoplasmic reticulum; cell adhesion; external encapsulating structure; extracellular matrix; organelle; receptor ligand activity; cell motility; molecular function regulator activity
OG_11312,FUN_013564-T1,Peve_00018155,,apul_peve,42.446,,,,,,,,,,,,,,,,,
OG_11313,FUN_013572-T2,Peve_00022295,,apul_peve,72.417,FUN_013572-T2,Q9TRC7,AOC1_PIG,,Diamine oxidase [copper-containing] (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein) (Amine oxidase copper domain-containing protein 1) (Histaminase),Sus scrofa (Pig),39.2,734.0,2.4e-156,554.3,sp|Q9TRC7|AOC1_PIG Diamine oxidase [copper-containing] OS=Sus scrofa OX=9823 GN=AOC1 PE=1 SV=3,GO:0005507; GO:0005509; GO:0005615; GO:0005886; GO:0005923; GO:0008131; GO:0008201; GO:0009445; GO:0042803; GO:0048038; GO:0050232; GO:0052597; GO:0052598; GO:0070062,putrescine metabolic process [GO:0009445],bicellular tight junction [GO:0005923]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; diamine oxidase activity [GO:0052597]; heparin binding [GO:0008201]; histamine oxidase activity [GO:0052598]; primary methylamine oxidase activity [GO:0008131]; protein homodimerization activity [GO:0042803]; putrescine oxidase activity [GO:0050232]; quinone binding [GO:0048038],GO:0003824; GO:0005615; GO:0005886; GO:0016491; GO:0043226,catalytic activity; extracellular space; plasma membrane; oxidoreductase activity; organelle
OG_11314,FUN_013598-T1,Peve_00018168,,apul_peve,50.605,,,,,,,,,,,,,,,,,
OG_11315,FUN_013600-T1,Peve_00025749,,apul_peve,75.0,,,,,,,,,,,,,,,,,
OG_11316,FUN_013609-T1,Peve_00002651,,apul_peve,39.535,,,,,,,,,,,,,,,,,
OG_11317,FUN_013624-T1,Peve_00013599,,apul_peve,63.83,,,,,,,,,,,,,,,,,
OG_11318,FUN_013630-T1,Peve_00018591,,apul_peve,56.187,,,,,,,,,,,,,,,,,
OG_11319,FUN_013632-T1,Peve_00039073,,apul_peve,40.84,FUN_013632-T1,P0DY19,,,,,31.4,118.0,6.7e-10,65.1,sp|P0DY19|INS_OULSP Insulin-like peptide IlO1_i1 OS=Oulactis sp. OX=2093647 PE=2 SV=1,,,,,,
OG_11320,FUN_013633-T1,Peve_00039090,,apul_peve,48.889,,,,,,,,,,,,,,,,,
OG_11321,FUN_013685-T1,Peve_00001266,,apul_peve,72.131,FUN_013685-T1,Q09811,HUS2_SCHPO,,ATP-dependent DNA helicase hus2/rqh1 (EC 5.6.2.4) (DNA 3'-5' helicase Rqh1),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),31.8,110.0,1.9e-09,63.5,sp|Q09811|HUS2_SCHPO ATP-dependent DNA helicase hus2/rqh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=rqh1 PE=1 SV=1,GO:0000228; GO:0000724; GO:0000725; GO:0000729; GO:0003677; GO:0005524; GO:0005634; GO:0005694; GO:0005730; GO:0005737; GO:0006260; GO:0006301; GO:0006974; GO:0009378; GO:0016887; GO:0031297; GO:0031422; GO:0031573; GO:0035861; GO:0043007; GO:0043138; GO:0043596; GO:0070914; GO:0071140; GO:1990426,DNA damage response [GO:0006974]; DNA double-strand break processing [GO:0000729]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; maintenance of rDNA [GO:0043007]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; mitotic recombination-dependent replication fork processing [GO:1990426]; postreplication repair [GO:0006301]; recombinational repair [GO:0000725]; replication fork processing [GO:0031297]; resolution of mitotic recombination intermediates [GO:0071140]; UV-damage excision repair [GO:0070914],chromosome [GO:0005694]; cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422]; site of double-strand break [GO:0035861],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378],GO:0000228; GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0005730; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"nuclear chromosome; DNA binding; catalytic activity; nucleus; chromosome; nucleolus; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_11322,FUN_013793-T1,Peve_00029120,,apul_peve,56.069,,,,,,,,,,,,,,,,,
OG_11323,FUN_013806-T1,Peve_00005884,,apul_peve,58.242,,,,,,,,,,,,,,,,,
OG_11324,FUN_013826-T1,Peve_00006249,,apul_peve,59.036,,,,,,,,,,,,,,,,,
OG_11325,FUN_013833-T1,Peve_00043592,,apul_peve,48.045,,,,,,,,,,,,,,,,,
OG_11326,FUN_013845-T1,Peve_00031242,,apul_peve,62.5,,,,,,,,,,,,,,,,,
OG_11327,FUN_013853-T1,Peve_00037504,,apul_peve,58.128,,,,,,,,,,,,,,,,,
OG_11328,FUN_013908-T1,Peve_00003452,,apul_peve,47.511,,,,,,,,,,,,,,,,,
OG_11329,FUN_013960-T1,Peve_00008058,,apul_peve,43.137,,,,,,,,,,,,,,,,,
OG_11330,FUN_013972-T1,Peve_00019652,,apul_peve,95.967,,,,,,,,,,,,,,,,,
OG_11331,FUN_013992-T1,Peve_00041728,,apul_peve,79.139,,,,,,,,,,,,,,,,,
OG_11332,FUN_014051-T1,Peve_00001899,,apul_peve,51.546,,,,,,,,,,,,,,,,,
OG_11333,FUN_014101-T1,Peve_00027308,,apul_peve,69.733,FUN_014101-T1,P25025,CXCR2_HUMAN,,C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (IL-8 receptor type 2) (CD antigen CD182),Homo sapiens (Human),27.1,262.0,7e-09,63.2,sp|P25025|CXCR2_HUMAN C-X-C chemokine receptor type 2 OS=Homo sapiens OX=9606 GN=CXCR2 PE=1 SV=2,GO:0002407; GO:0004918; GO:0004930; GO:0005654; GO:0005886; GO:0006935; GO:0006954; GO:0006955; GO:0006968; GO:0007165; GO:0007166; GO:0007200; GO:0007204; GO:0008284; GO:0009897; GO:0009986; GO:0015630; GO:0016020; GO:0016493; GO:0016494; GO:0019722; GO:0019957; GO:0019959; GO:0030593; GO:0030667; GO:0031623; GO:0038112; GO:0042119; GO:0042629; GO:0043066; GO:0072686,calcium-mediated signaling [GO:0019722]; cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-8-mediated signaling pathway [GO:0038112]; negative regulation of apoptotic process [GO:0043066]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; receptor internalization [GO:0031623]; signal transduction [GO:0007165],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; mast cell granule [GO:0042629]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667],C-C chemokine binding [GO:0019957]; C-C chemokine receptor activity [GO:0016493]; C-X-C chemokine receptor activity [GO:0016494]; G protein-coupled receptor activity [GO:0004930]; interleukin-8 binding [GO:0019959]; interleukin-8 receptor activity [GO:0004918],GO:0002376; GO:0005654; GO:0005764; GO:0005773; GO:0005856; GO:0005886; GO:0006954; GO:0016192; GO:0043226; GO:0048870; GO:0060089,immune system process; nucleoplasm; lysosome; vacuole; cytoskeleton; plasma membrane; inflammatory response; vesicle-mediated transport; organelle; cell motility; molecular transducer activity
OG_11334,FUN_014117-T1,Peve_00024142,,apul_peve,80.80199999999999,FUN_014117-T1,O57321,,,,,49.5,489.0,8.4e-118,425.6,sp|O57321|EAA1_AMBTI Excitatory amino acid transporter 1 OS=Ambystoma tigrinum OX=8305 GN=SLC1A3 PE=1 SV=1,,,,,,
OG_11335,FUN_014122-T1,Peve_00024140,,apul_peve,52.06,,,,,,,,,,,,,,,,,
OG_11336,FUN_014130-T1,Peve_00025855,,apul_peve,44.086,,,,,,,,,,,,,,,,,
OG_11337,FUN_014154-T1,Peve_00023554,,apul_peve,62.3905,,,,,,,,,,,,,,,,,
OG_11338,FUN_014161-T1,Peve_00035288,,apul_peve,44.482,,,,,,,,,,,,,,,,,
OG_11339,FUN_014188-T1,Peve_00019655,,apul_peve,60.976,,,,,,,,,,,,,,,,,
OG_11340,FUN_014233-T1,Peve_00036130,,apul_peve,64.062,,,,,,,,,,,,,,,,,
OG_11341,FUN_014285-T1,Peve_00030988,,apul_peve,33.663,,,,,,,,,,,,,,,,,
OG_11342,FUN_014367-T1,Peve_00039358,,apul_peve,55.689,,,,,,,,,,,,,,,,,
OG_11343,FUN_014376-T1,Peve_00039681,,apul_peve,68.644,,,,,,,,,,,,,,,,,
OG_11344,FUN_014437-T1,Peve_00020054,,apul_peve,47.893,FUN_014437-T1,Q8WUA4,TF3C2_HUMAN,,General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta),Homo sapiens (Human),31.7,587.0,4.6e-79,298.5,sp|Q8WUA4|TF3C2_HUMAN General transcription factor 3C polypeptide 2 OS=Homo sapiens OX=9606 GN=GTF3C2 PE=1 SV=2,GO:0000127; GO:0000995; GO:0005654; GO:0006383; GO:0042791; GO:0042797,5S class rRNA transcription by RNA polymerase III [GO:0042791]; transcription by RNA polymerase III [GO:0006383]; tRNA transcription by RNA polymerase III [GO:0042797],nucleoplasm [GO:0005654]; transcription factor TFIIIC complex [GO:0000127],RNA polymerase III general transcription initiation factor activity [GO:0000995],GO:0005654; GO:0006351; GO:0006399; GO:0140223,nucleoplasm; DNA-templated transcription; tRNA metabolic process; general transcription initiation factor activity
OG_11345,FUN_014469-T1,Peve_00011743,,apul_peve,73.429,,,,,,,,,,,,,,,,,
OG_11346,FUN_014470-T1,Peve_00021241,,apul_peve,62.8765,,,,,,,,,,,,,,,,,
OG_11347,FUN_014488-T1,Peve_00013876,,apul_peve,68.471,FUN_014488-T1,Q15056,IF4H_HUMAN,,Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein),Homo sapiens (Human),39.3,239.0,1.8e-32,141.4,sp|Q15056|IF4H_HUMAN Eukaryotic translation initiation factor 4H OS=Homo sapiens OX=9606 GN=EIF4H PE=1 SV=5,GO:0001731; GO:0003723; GO:0003743; GO:0005829; GO:0006446; GO:0008135; GO:0016020; GO:0016281; GO:0019953; GO:0033592; GO:0034057; GO:0043024; GO:0045296; GO:0048471; GO:0048589; GO:0097010,developmental growth [GO:0048589]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; sexual reproduction [GO:0019953],cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471],"cadherin binding [GO:0045296]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]",GO:0003723; GO:0003824; GO:0005829; GO:0016853; GO:0022414; GO:0065003; GO:0140098,"RNA binding; catalytic activity; cytosol; isomerase activity; reproductive process; protein-containing complex assembly; catalytic activity, acting on RNA"
OG_11348,FUN_014495-T1,Peve_00037308,,apul_peve,60.227,,,,,,,,,,,,,,,,,
OG_11349,FUN_014504-T1,Peve_00026170,,apul_peve,68.4845,FUN_014504-T1,Q9NDJ2,,,,,41.5,2267.0,0.0,1242.6,sp|Q9NDJ2|DOM_DROME Helicase domino OS=Drosophila melanogaster OX=7227 GN=dom PE=1 SV=2,,,,,,
OG_11350,FUN_014526-T1,Peve_00009402,,apul_peve,49.554,,,,,,,,,,,,,,,,,
OG_11351,FUN_014537-T1,Peve_00040827,,apul_peve,64.231,FUN_014537-T1,Q68F72,S15A4_XENLA,,Solute carrier family 15 member 4,Xenopus laevis (African clawed frog),35.5,468.0,1.3000000000000001e-71,273.1,sp|Q68F72|S15A4_XENLA Solute carrier family 15 member 4 OS=Xenopus laevis OX=8355 GN=slc15a4 PE=2 SV=1,GO:0005290; GO:0005765; GO:0015031; GO:0015333; GO:0015647; GO:0015835; GO:0016020; GO:0031901; GO:0033023; GO:0034157; GO:0034161; GO:0034165; GO:0036020; GO:0045087; GO:0045089; GO:0048302; GO:0070424; GO:0070430; GO:0070434; GO:0071916; GO:0140206,"dipeptide import across plasma membrane [GO:0140206]; innate immune response [GO:0045087]; mast cell homeostasis [GO:0033023]; peptidoglycan transport [GO:0015835]; positive regulation of innate immune response [GO:0045089]; positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070430]; positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070434]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]; positive regulation of toll-like receptor 8 signaling pathway [GO:0034161]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; protein transport [GO:0015031]; regulation of isotype switching to IgG isotypes [GO:0048302]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]",early endosome membrane [GO:0031901]; endolysosome membrane [GO:0036020]; lysosomal membrane [GO:0005765]; membrane [GO:0016020],dipeptide transmembrane transporter activity [GO:0071916]; L-histidine transmembrane transporter activity [GO:0005290]; peptide:proton symporter activity [GO:0015333]; peptidoglycan transmembrane transporter activity [GO:0015647],GO:0002376; GO:0005215; GO:0055085; GO:0098542,immune system process; transporter activity; transmembrane transport; defense response to other organism
OG_11352,FUN_014538-T1,Peve_00036864,,apul_peve,58.904,,,,,,,,,,,,,,,,,
OG_11353,FUN_014540-T1,Peve_00037115,,apul_peve,53.66,,,,,,,,,,,,,,,,,
OG_11354,FUN_014541-T1,Peve_00036000,,apul_peve,87.546,FUN_014541-T1,Q8N815,,,,,34.8,247.0,9.4e-33,142.1,sp|Q8N815|CNTD1_HUMAN Cyclin N-terminal domain-containing protein 1 OS=Homo sapiens OX=9606 GN=CNTD1 PE=2 SV=2,,,,,,
OG_11355,FUN_014559-T1,Peve_00009114,,apul_peve,90.756,FUN_014559-T1,O13085,,,,,52.3,88.0,5.600000000000001e-22,105.1,"sp|O13085|COX6A_ONCMY Cytochrome c oxidase subunit 6A, mitochondrial OS=Oncorhynchus mykiss OX=8022 PE=3 SV=1",,,,,,
OG_11356,FUN_014563-T1,Peve_00009698,,apul_peve,90.141,FUN_014563-T1,Q9K9H0,,,,,68.1,414.0,1.6000000000000002e-164,580.5,sp|Q9K9H0|ACEA_HALH5 Isocitrate lyase OS=Halalkalibacterium halodurans (strain ATCC BAA-125 / DSM 18197 / FERM 7344 / JCM 9153 / C-125) OX=272558 GN=aceA PE=3 SV=1,,,,,,
OG_11357,FUN_014565-T1,Peve_00023546,,apul_peve,87.554,FUN_014565-T1,Q9ZH77,MASY_STRCL,,Malate synthase (EC 2.3.3.9),Streptomyces clavuligerus,55.2,232.0,5.5e-66,252.3,sp|Q9ZH77|MASY_STRCL Malate synthase OS=Streptomyces clavuligerus OX=1901 GN=aceB PE=3 SV=1,GO:0004474; GO:0005737; GO:0006097; GO:0006099,glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737],malate synthase activity [GO:0004474],GO:0003824; GO:0005975; GO:0016740,catalytic activity; carbohydrate metabolic process; transferase activity
OG_11358,FUN_014568-T1,Peve_00012931,,apul_peve,32.237,,,,,,,,,,,,,,,,,
OG_11359,FUN_014581-T1,Peve_00001492,,apul_peve,73.183,FUN_014581-T1,P32018,,,,,33.5,182.0,7.4e-18,93.2,sp|P32018|COEA1_CHICK Collagen alpha-1(XIV) chain OS=Gallus gallus OX=9031 GN=COL14A1 PE=1 SV=2,,,,,,
OG_11360,FUN_014582-T1,Peve_00001484,,apul_peve,58.1735,FUN_014582-T1,B3EWZ3,,,,,44.3,115.0,1.7e-26,122.5,sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11361,FUN_014590-T1,Peve_00011852,,apul_peve,52.5465,FUN_014590-T1,Q9QUP4,,,,,27.0,344.0,1.8000000000000001e-22,108.6,sp|Q9QUP4|CHST5_MOUSE Carbohydrate sulfotransferase 5 OS=Mus musculus OX=10090 GN=Chst5 PE=2 SV=1,,,,,,
OG_11362,FUN_014592-T2,Peve_00031717,,apul_peve,60.217,FUN_014592-T2,Q9EQM6,DGCR8_MOUSE,,Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8 homolog) (Gy1),Mus musculus (Mouse),33.1,550.0,3.3e-70,267.7,sp|Q9EQM6|DGCR8_MOUSE Microprocessor complex subunit DGCR8 OS=Mus musculus OX=10090 GN=Dgcr8 PE=1 SV=2,GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006974; GO:0014069; GO:0016604; GO:0020037; GO:0031053; GO:0042803; GO:0046872; GO:0070877; GO:0070878; GO:0072091; GO:0098978; GO:0140517; GO:2000633,DNA damage response [GO:0006974]; positive regulation of pre-miRNA processing [GO:2000633]; primary miRNA processing [GO:0031053]; regulation of stem cell proliferation [GO:0072091],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-RNA adaptor activity [GO:0140517],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0043226; GO:0060090,RNA binding; nucleus; nucleoplasm; nucleolus; cytosol; organelle; molecular adaptor activity
OG_11363,FUN_014609-T2,Peve_00002416,,apul_peve,63.2715,,,,,,,,,,,,,,,,,
OG_11364,FUN_014665-T1,Peve_00040976,,apul_peve,30.9075,,,,,,,,,,,,,,,,,
OG_11365,FUN_014688-T1,Peve_00028117,,apul_peve,63.24,FUN_014688-T1,B3EWZ5,,,,,41.2,153.0,3.4e-23,110.9,sp|B3EWZ5|MLRP1_ACRMI MAM and LDL-receptor class A domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11366,FUN_014695-T1,Peve_00006825,,apul_peve,57.711,,,,,,,,,,,,,,,,,
OG_11367,FUN_014708-T1,Peve_00004187,,apul_peve,72.136,FUN_014708-T1,Q9GV41,,,,,47.3,264.0,7.9e-71,268.9,"sp|Q9GV41|PGFS_TRYBB 9,11-endoperoxide prostaglandin H2 reductase OS=Trypanosoma brucei brucei OX=5702 PE=1 SV=1",,,,,,
OG_11368,FUN_014746-T1,Peve_00007243,,apul_peve,62.963,FUN_014746-T1,O70528,,,,,30.8,315.0,1.0000000000000001e-29,132.5,sp|O70528|5HT4R_CAVPO 5-hydroxytryptamine receptor 4 OS=Cavia porcellus OX=10141 GN=HTR4 PE=2 SV=1,,,,,,
OG_11369,FUN_014759-T1,Peve_00003584,,apul_peve,92.486,FUN_014759-T1,Q9HC77,,,,,73.1,93.0,6.2e-31,136.7,sp|Q9HC77|CPAP_HUMAN Centrosomal P4.1-associated protein OS=Homo sapiens OX=9606 GN=CPAP PE=1 SV=2,,,,,,
OG_11370,FUN_014760-T1,Peve_00043743,,apul_peve,32.685,,,,,,,,,,,,,,,,,
OG_11371,FUN_014768-T1,Peve_00034848,,apul_peve,75.54,FUN_014768-T1,Q9CHD0,,,,,25.5,235.0,1.3e-13,78.6,sp|Q9CHD0|RNC_LACLA Ribonuclease 3 OS=Lactococcus lactis subsp. lactis (strain IL1403) OX=272623 GN=rnc PE=3 SV=1,,,,,,
OG_11372,FUN_014772-T1,Peve_00014606,,apul_peve,39.301,,,,,,,,,,,,,,,,,
OG_11373,FUN_014773-T1,Peve_00014605,,apul_peve,37.722,,,,,,,,,,,,,,,,,
OG_11374,FUN_014779-T1,Peve_00033321,,apul_peve,38.321,,,,,,,,,,,,,,,,,
OG_11375,FUN_014781-T1,Peve_00014592,,apul_peve,44.958,FUN_014781-T1,B3EWZ8,,,,,42.8,145.0,7.1e-24,112.5,sp|B3EWZ8|ECT_ACRMI Ectin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11376,FUN_014782-T1,Peve_00014594,,apul_peve,49.181,FUN_014782-T1,Q9CYL5,,,,,40.8,142.0,1.4e-19,99.0,sp|Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr2 PE=1 SV=3,,,,,,
OG_11377,FUN_014784-T2,Peve_00001850,,apul_peve,50.49,FUN_014784-T2,B3EWZ8,,,,,43.8,153.0,3.8e-23,109.8,sp|B3EWZ8|ECT_ACRMI Ectin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11378,FUN_014815-T1,Peve_00038836,,apul_peve,76.547,FUN_014815-T1,Q08CA1,,,,,34.9,338.0,6.3e-48,193.0,sp|Q08CA1|GDPP1_DANRE GDP-D-glucose phosphorylase 1 OS=Danio rerio OX=7955 GN=gdpgp1 PE=2 SV=1,,,,,,
OG_11379,FUN_014817-T1,Peve_00038834,,apul_peve,55.069,FUN_014817-T1,B3EWZ6,,,,,32.7,957.0,6.8e-112,406.8,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11380,FUN_014830-T1,Peve_00038822,,apul_peve,72.21600000000001,FUN_014830-T1,A2AX52,CO6A4_MOUSE,,Collagen alpha-4(VI) chain,Mus musculus (Mouse),24.5,661.0,3.2e-26,123.2,sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2,GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991],collagen binding [GO:0005518],GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_11381,FUN_014831-T1,Peve_00038824,,apul_peve,72.901,FUN_014831-T1,P13944,,,,,39.0,164.0,5.9e-22,109.8,sp|P13944|COCA1_CHICK Collagen alpha-1(XII) chain OS=Gallus gallus OX=9031 GN=COL12A1 PE=1 SV=3,,,,,,
OG_11382,FUN_014841-T1,Peve_00038819,,apul_peve,31.0175,,,,,,,,,,,,,,,,,
OG_11383,FUN_014843-T1,Peve_00028529,,apul_peve,56.701,FUN_014843-T1,P49410,,,,,68.6,398.0,4.2e-162,573.5,"sp|P49410|EFTU_BOVIN Elongation factor Tu, mitochondrial OS=Bos taurus OX=9913 GN=TUFM PE=1 SV=1",,,,,,
OG_11384,FUN_014867-T1,Peve_00012978,,apul_peve,33.422,FUN_014867-T1,Q24432,OMB_DROME,,Optomotor-blind protein (Lethal(1)optomotor-blind) (L(1)omb) (Protein bifid),Drosophila melanogaster (Fruit fly),38.3,209.0,1.6e-35,153.3,sp|Q24432|OMB_DROME Optomotor-blind protein OS=Drosophila melanogaster OX=7227 GN=bi PE=1 SV=3,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001708; GO:0001745; GO:0003677; GO:0005634; GO:0006357; GO:0007472; GO:0007476; GO:0035265; GO:0045893; GO:0048066; GO:0048100,cell fate specification [GO:0001708]; compound eye morphogenesis [GO:0001745]; developmental pigmentation [GO:0048066]; imaginal disc-derived wing morphogenesis [GO:0007476]; negative regulation of transcription by RNA polymerase II [GO:0000122]; organ growth [GO:0035265]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; wing disc anterior/posterior pattern formation [GO:0048100]; wing disc morphogenesis [GO:0007472],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_11385,FUN_014878-T1,Peve_00013642,,apul_peve,60.116,,,,,,,,,,,,,,,,,
OG_11386,FUN_014913-T1,Peve_00003531,,apul_peve,65.766,FUN_014913-T1,O17185,SUP9_CAEEL,,Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38),Caenorhabditis elegans,30.8,247.0,6.5e-23,109.8,sp|O17185|SUP9_CAEEL Two pore potassium channel protein sup-9 OS=Caenorhabditis elegans OX=6239 GN=sup-9 PE=1 SV=2,GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0036195; GO:0055120; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937],muscle cell projection membrane [GO:0036195]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120],outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_11387,FUN_014914-T1,Peve_00003530,,apul_peve,40.535,FUN_014914-T1,Q9QZR0,,,,,43.2,264.0,2.2999999999999997e-53,211.8,sp|Q9QZR0|RNF25_MOUSE E3 ubiquitin-protein ligase RNF25 OS=Mus musculus OX=10090 GN=Rnf25 PE=1 SV=2,,,,,,
OG_11388,FUN_014919-T1,Peve_00003533,,apul_peve,55.2655,FUN_014919-T1,P27139,CAH2_RAT,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Rattus norvegicus (Rat),38.6,264.0,1.2999999999999998e-43,178.3,sp|P27139|CAH2_RAT Carbonic anhydrase 2 OS=Rattus norvegicus OX=10116 GN=Ca2 PE=1 SV=2,GO:0001822; GO:0002009; GO:0004064; GO:0004089; GO:0005615; GO:0005737; GO:0005829; GO:0005886; GO:0005902; GO:0008270; GO:0009268; GO:0010043; GO:0015670; GO:0016323; GO:0018820; GO:0030316; GO:0030424; GO:0030641; GO:0032230; GO:0032849; GO:0038166; GO:0042475; GO:0043209; GO:0043627; GO:0044070; GO:0044849; GO:0045124; GO:0045177; GO:0045672; GO:0045780; GO:0046903; GO:0048545; GO:0051453; GO:0070050; GO:0071498; GO:1904404; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; estrous cycle [GO:0044849]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of bone resorption [GO:0045124]; regulation of cellular pH [GO:0030641]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; response to estrogen [GO:0043627]; response to formaldehyde [GO:1904404]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903]",apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0022414; GO:0030154; GO:0048856,catalytic activity; extracellular space; cytosol; plasma membrane; hydrolase activity; lyase activity; reproductive process; cell differentiation; anatomical structure development
OG_11389,FUN_014927-T1,Peve_00006242,,apul_peve,76.342,FUN_014927-T1,Q04336,,,,,47.2,947.0,9.6e-256,884.8,sp|Q04336|YM54_YEAST Uncharacterized protein YMR196W OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YMR196W PE=1 SV=1,,,,,,
OG_11390,FUN_014933-T1,Peve_00037143,,apul_peve,64.393,FUN_014933-T1,Q9UMQ3,BARX2_HUMAN,,Homeobox protein BarH-like 2,Homo sapiens (Human),50.6,89.0,5e-15,83.2,sp|Q9UMQ3|BARX2_HUMAN Homeobox protein BarH-like 2 OS=Homo sapiens OX=9606 GN=BARX2 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001502; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0006366; GO:0014902; GO:0015629; GO:0035914; GO:0045944; GO:1990837,cartilage condensation [GO:0001502]; myotube differentiation [GO:0014902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005856; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_11391,FUN_014957-T1,Peve_00006255,,apul_peve,75.117,,,,,,,,,,,,,,,,,
OG_11392,FUN_014963-T1,Peve_00040332,,apul_peve,69.231,,,,,,,,,,,,,,,,,
OG_11393,FUN_014994-T1,Peve_00033190,,apul_peve,49.0685,,,,,,,,,,,,,,,,,
OG_11394,FUN_015004-T1,Peve_00034679,,apul_peve,36.799,,,,,,,,,,,,,,,,,
OG_11395,FUN_015013-T1,Peve_00034689,,apul_peve,92.14,FUN_015013-T1,Q1AYM8,DAO_RUBXD,,D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3),Rubrobacter xylanophilus (strain DSM 9941 / JCM 11954 / NBRC 16129 / PRD-1),32.6,221.0,6.2e-22,105.9,sp|Q1AYM8|DAO_RUBXD D-amino-acid oxidase OS=Rubrobacter xylanophilus (strain DSM 9941 / JCM 11954 / NBRC 16129 / PRD-1) OX=266117 GN=dao PE=1 SV=1,GO:0003884; GO:0005576; GO:0005737; GO:0009274; GO:0019478; GO:0071949,D-amino acid catabolic process [GO:0019478],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; peptidoglycan-based cell wall [GO:0009274],D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949],GO:0003824; GO:0005576; GO:0005618; GO:0006520; GO:0016491; GO:0030312,catalytic activity; extracellular region; cell wall; amino acid metabolic process; oxidoreductase activity; external encapsulating structure
OG_11396,FUN_015029-T1,Peve_00004802,,apul_peve,43.823,FUN_015029-T1,A0A8J1M587,FANCJ_XENLA,,Fanconi anemia group J protein homolog (EC 5.6.2.3) (BRCA1-interacting protein C-terminal helicase homolog 1.L) (BRCA1-interacting protein homolog 1.L) (DNA 5'-3' helicase FANCJ),Xenopus laevis (African clawed frog),57.1,198.0,2.1e-64,248.8,sp|A0A8J1M587|FANCJ_XENLA Fanconi anemia group J protein homolog OS=Xenopus laevis OX=8355 GN=brip1.L PE=3 SV=2,GO:0003677; GO:0005524; GO:0005634; GO:0006289; GO:0016818; GO:0043139; GO:0046872; GO:0051539; GO:0106300; GO:1990918,double-strand break repair involved in meiotic recombination [GO:1990918]; nucleotide-excision repair [GO:0006289]; protein-DNA covalent cross-linking repair [GO:0106300],nucleus [GO:0005634],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; metal ion binding [GO:0046872]",GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; isomerase activity; reproductive process; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_11397,FUN_015030-T1,Peve_00004785,,apul_peve,39.542,,,,,,,,,,,,,,,,,
OG_11398,FUN_015045-T2,Peve_00035542,,apul_peve,66.325,FUN_015045-T2,O95294,RASL1_HUMAN,,RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein),Homo sapiens (Human),40.4,844.0,2.2000000000000004e-165,584.3,sp|O95294|RASL1_HUMAN RasGAP-activating-like protein 1 OS=Homo sapiens OX=9606 GN=RASAL1 PE=1 SV=3,GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0008270; GO:0030154; GO:0035556; GO:0046580; GO:0071277; GO:1903861,cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; signal transduction [GO:0007165],cytosol [GO:0005829],GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270],GO:0005829; GO:0008289; GO:0030154; GO:0098772,cytosol; lipid binding; cell differentiation; molecular function regulator activity
OG_11399,FUN_015060-T1,Peve_00015742,,apul_peve,71.631,,,,,,,,,,,,,,,,,
OG_11400,FUN_015105-T1,Peve_00036872,,apul_peve,68.876,FUN_015105-T1,Q5XXP2,OPN4_PHOSU,,Melanopsin (Opsin-4),Phodopus sungorus (Striped hairy-footed hamster) (Djungarian hamster),30.6,317.0,3.3e-31,137.5,sp|Q5XXP2|OPN4_PHOSU Melanopsin OS=Phodopus sungorus OX=10044 GN=OPN4 PE=2 SV=1,GO:0005502; GO:0005886; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016020; GO:0030424; GO:0030425; GO:0042752; GO:0043204; GO:0048511; GO:1990384,hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020],GO:0005886; GO:0008289; GO:0050877; GO:0060089,plasma membrane; lipid binding; nervous system process; molecular transducer activity
OG_11401,FUN_015112-T1,Peve_00001076,,apul_peve,73.037,FUN_015112-T1,Q8VD75,HIP1_MOUSE,,Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I),Mus musculus (Mouse),46.3,408.0,3.4e-82,307.8,sp|Q8VD75|HIP1_MOUSE Huntingtin-interacting protein 1 OS=Mus musculus OX=10090 GN=Hip1 PE=1 SV=2,GO:0005634; GO:0005737; GO:0005794; GO:0006897; GO:0006915; GO:0030136; GO:0030154; GO:0030276; GO:0030665; GO:0032051; GO:0032266; GO:0035091; GO:0035612; GO:0042803; GO:0042981; GO:0043325; GO:0045742; GO:0046982; GO:0048260; GO:0048268; GO:0050821; GO:0051015; GO:0080025; GO:0097190; GO:0098685; GO:0098793; GO:0098978; GO:0099149; GO:0099171; GO:2000588,apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of receptor-mediated endocytosis [GO:0048260]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149],clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685],"actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]",GO:0005634; GO:0005794; GO:0008092; GO:0008289; GO:0012501; GO:0016192; GO:0030154; GO:0031410; GO:0043226; GO:0065003,nucleus; Golgi apparatus; cytoskeletal protein binding; lipid binding; programmed cell death; vesicle-mediated transport; cell differentiation; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_11402,FUN_015134-T1,Peve_00025082,,apul_peve,55.367,,,,,,,,,,,,,,,,,
OG_11403,FUN_015137-T1,Peve_00001079,,apul_peve,56.901,,,,,,,,,,,,,,,,,
OG_11404,FUN_015163-T1,Peve_00001859,,apul_peve,56.41,,,,,,,,,,,,,,,,,
OG_11405,FUN_015165-T1,Peve_00001861,,apul_peve,57.6485,FUN_015165-T1,Q4KLT3,,,,,40.3,750.0,8.899999999999999e-129,462.6,sp|Q4KLT3|TRM44_XENLA Probable tRNA (uracil-O(2)-)-methyltransferase OS=Xenopus laevis OX=8355 GN=trmt44 PE=2 SV=1,,,,,,
OG_11406,FUN_015188-T1,Peve_00013017,,apul_peve,35.271,,,,,,,,,,,,,,,,,
OG_11407,FUN_015224-T1,Peve_00005306,,apul_peve,78.297,,,,,,,,,,,,,,,,,
OG_11408,FUN_015233-T1,Peve_00030806,,apul_peve,52.915,FUN_015233-T1,G5EDR5,FUTA_CAEEL,,"Alpha-(1,3)-fucosyltransferase fut-1 (EC 2.4.1.214) (Fucosyltransferase fut-1)",Caenorhabditis elegans,31.3,259.0,5e-28,127.1,"sp|G5EDR5|FUTA_CAEEL Alpha-(1,3)-fucosyltransferase fut-1 OS=Caenorhabditis elegans OX=6239 GN=fut-1 PE=1 SV=1",GO:0000139; GO:0006486; GO:0008417; GO:0016051; GO:0017060; GO:0018392; GO:0032580; GO:0036065; GO:0046872; GO:0046920,carbohydrate biosynthetic process [GO:0016051]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486],Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139],3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity [GO:0017060]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; glycoprotein 3-alpha-L-fucosyltransferase activity [GO:0018392]; metal ion binding [GO:0046872],GO:0003824; GO:0005975; GO:0006486; GO:0016740; GO:0140096,"catalytic activity; carbohydrate metabolic process; protein glycosylation; transferase activity; catalytic activity, acting on a protein"
OG_11409,FUN_015243-T1,Peve_00003460,,apul_peve,38.6,FUN_015243-T1,B3EX00,,,,,86.9,449.0,1.1e-197,691.4,sp|B3EX00|USOM1_ACRMI Uncharacterized skeletal organic matrix protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11410,FUN_015251-T1,Peve_00003459,,apul_peve,47.0365,,,,,,,,,,,,,,,,,
OG_11411,FUN_015261-T1,Peve_00013250,,apul_peve,55.859,FUN_015261-T1,Q3USF0,,,,,32.7,217.0,7.400000000000001e-22,106.3,"sp|Q3USF0|B3GN6_MOUSE Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase OS=Mus musculus OX=10090 GN=B3gnt6 PE=2 SV=2",,,,,,
OG_11412,FUN_015265-T1,Peve_00044774,,apul_peve,64.0,FUN_015265-T1,B5YFT1,DDL_THEYD,,D-alanine--D-alanine ligase (EC 6.3.2.4) (D-Ala-D-Ala ligase) (D-alanylalanine synthetase),Thermodesulfovibrio yellowstonii (strain ATCC 51303 / DSM 11347 / YP87),26.9,286.0,9.7e-17,89.4,sp|B5YFT1|DDL_THEYD D-alanine--D-alanine ligase OS=Thermodesulfovibrio yellowstonii (strain ATCC 51303 / DSM 11347 / YP87) OX=289376 GN=ddl PE=3 SV=1,GO:0005524; GO:0005737; GO:0008360; GO:0008716; GO:0009252; GO:0046872; GO:0071555,cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],cytoplasm [GO:0005737],ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872],GO:0003824; GO:0016874; GO:0071554; GO:1901135,catalytic activity; ligase activity; cell wall organization or biogenesis; carbohydrate derivative metabolic process
OG_11413,FUN_015273-T1,Peve_00044761,,apul_peve,50.0,,,,,,,,,,,,,,,,,
OG_11414,FUN_015274-T1,Peve_00014301,,apul_peve,37.356,,,,,,,,,,,,,,,,,
OG_11415,FUN_015276-T1,Peve_00004794,,apul_peve,65.489,FUN_015276-T1,Q9Z0J4,,,,,46.7,1126.0,6.2e-301,1035.0,sp|Q9Z0J4|NOS1_MOUSE Nitric oxide synthase 1 OS=Mus musculus OX=10090 GN=Nos1 PE=1 SV=1,,,,,,
OG_11416,FUN_015282-T1,Peve_00031526,,apul_peve,60.162,FUN_015282-T1,O15439,MRP4_HUMAN,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4),Homo sapiens (Human),35.7,1343.0,3.2000000000000003e-211,737.3,sp|O15439|MRP4_HUMAN ATP-binding cassette sub-family C member 4 OS=Homo sapiens OX=9606 GN=ABCC4 PE=1 SV=3,GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0043231; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003013; GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016192; GO:0016491; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,circulatory system process; catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; vesicle-mediated transport; oxidoreductase activity; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_11417,FUN_015295-T1,Peve_00004804,,apul_peve,57.2505,,,,,,,,,,,,,,,,,
OG_11418,FUN_015302-T1,Peve_00004799,,apul_peve,56.522,,,,,,,,,,,,,,,,,
OG_11419,FUN_015312-T1,Peve_00030497,,apul_peve,59.198,FUN_015312-T1,O93429,,,,,40.8,343.0,4.1e-58,226.9,sp|O93429|TRFE_PAROL Serotransferrin OS=Paralichthys olivaceus OX=8255 GN=tf PE=2 SV=1,,,,,,
OG_11420,FUN_015320-T1,Peve_00017181,,apul_peve,55.801,FUN_015320-T1,B7W114,,,,,90.4,450.0,1.8e-220,767.7,sp|B7W114|CTXL_ACRMI Cephalotoxin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11421,FUN_015326-T1,Peve_00023984,,apul_peve,50.1275,,,,,,,,,,,,,,,,,
OG_11422,FUN_015328-T1,Peve_00005924,,apul_peve,49.677,FUN_015328-T1,A5A4L1,GHSR_MUSPF,,Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor),Mustela putorius furo (European domestic ferret) (Mustela furo),26.0,319.0,1e-06,55.8,sp|A5A4L1|GHSR_MUSPF Growth hormone secretagogue receptor type 1 OS=Mustela putorius furo OX=9669 GN=GHSR PE=2 SV=1,GO:0001616; GO:0005886; GO:0008154; GO:0008343; GO:0009755; GO:0009986; GO:0016520; GO:0030252; GO:0032094; GO:0032100; GO:0032691; GO:0032715; GO:0032720; GO:0032869; GO:0040018; GO:0043005; GO:0043568; GO:0045121; GO:0046697; GO:0048009; GO:0050728; GO:0051963,actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cellular response to insulin stimulus [GO:0032869]; decidualization [GO:0046697]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of appetite [GO:0032100]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; regulation of synapse assembly [GO:0051963]; response to food [GO:0032094],cell surface [GO:0009986]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_11423,FUN_015348-T1,Peve_00017517,,apul_peve,74.283,FUN_015348-T1,A0A1S4F2V5,,,,,40.4,307.0,4.200000000000001e-57,224.2,sp|A0A1S4F2V5|CATL_AEDAE Cathepsin L-like peptidase OS=Aedes aegypti OX=7159 PE=1 SV=1,,,,,,
OG_11424,FUN_015370-T1,Peve_00019381,,apul_peve,52.529,,,,,,,,,,,,,,,,,
OG_11425,FUN_015380-T1,Peve_00000224,,apul_peve,64.42349999999999,FUN_015380-T1,P97793,ALK_MOUSE,,ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246),Mus musculus (Mouse),29.5,139.0,2.3e-06,55.1,sp|P97793|ALK_MOUSE ALK tyrosine kinase receptor OS=Mus musculus OX=10090 GN=Alk PE=1 SV=2,GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006950; GO:0007169; GO:0007420; GO:0008201; GO:0021766; GO:0030298; GO:0030424; GO:0030534; GO:0032991; GO:0036269; GO:0038083; GO:0042127; GO:0042802; GO:0044297; GO:0050995; GO:0060159; GO:0090648; GO:0097009; GO:1900006,adult behavior [GO:0030534]; brain development [GO:0007420]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; energy homeostasis [GO:0097009]; hippocampus development [GO:0021766]; negative regulation of lipid catabolic process [GO:0050995]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of dendrite development [GO:1900006]; regulation of cell population proliferation [GO:0042127]; regulation of dopamine receptor signaling pathway [GO:0060159]; response to environmental enrichment [GO:0090648]; response to stress [GO:0006950]; swimming behavior [GO:0036269],axon [GO:0030424]; cell body [GO:0044297]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein tyrosine kinase activity [GO:0004713]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005886; GO:0016740; GO:0048856; GO:0060089; GO:0098772; GO:0140096,"catalytic activity; plasma membrane; transferase activity; anatomical structure development; molecular transducer activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_11426,FUN_015385-T1,Peve_00018752,,apul_peve,69.521,,,,,,,,,,,,,,,,,
OG_11427,FUN_015404-T1,Peve_00000199,,apul_peve,61.435,FUN_015404-T1,P42262,GRIA2_HUMAN,,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2)",Homo sapiens (Human),30.0,822.0,2.3e-88,328.6,sp|P42262|GRIA2_HUMAN Glutamate receptor 2 OS=Homo sapiens OX=9606 GN=GRIA2 PE=1 SV=3,GO:0001540; GO:0004970; GO:0004971; GO:0005886; GO:0007165; GO:0007268; GO:0009897; GO:0014069; GO:0030425; GO:0030666; GO:0032279; GO:0032281; GO:0035235; GO:0035249; GO:0043025; GO:0043197; GO:0050804; GO:0060076; GO:0098794; GO:0098839; GO:0098843; GO:0099094; GO:1904315,"chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; modulation of chemical synaptic transmission [GO:0050804]; signal transduction [GO:0007165]; synaptic transmission, glutamatergic [GO:0035249]",AMPA glutamate receptor complex [GO:0032281]; asymmetric synapse [GO:0032279]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic endocytic zone [GO:0098843],AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate-gated receptor activity [GO:0004970]; ligand-gated monoatomic cation channel activity [GO:0099094]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0043226; GO:0060089,transporter activity; plasma membrane; signaling; organelle; molecular transducer activity
OG_11428,FUN_015416-T1,Peve_00011433,,apul_peve,92.157,,,,,,,,,,,,,,,,,
OG_11429,FUN_015425-T1,Peve_00011812,,apul_peve,51.881,FUN_015425-T1,Q20191,,,,,40.4,230.0,1.1e-39,166.4,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_11430,FUN_015433-T1,Peve_00033648,,apul_peve,64.045,,,,,,,,,,,,,,,,,
OG_11431,FUN_015439-T1,Peve_00033642,,apul_peve,55.14,FUN_015439-T1,P58307,,,,,29.4,201.0,1.1e-16,89.4,sp|P58307|OX1R_MOUSE Orexin/Hypocretin receptor type 1 OS=Mus musculus OX=10090 GN=Hcrtr1 PE=2 SV=3,,,,,,
OG_11432,FUN_015452-T1,Peve_00006828,,apul_peve,81.1,FUN_015452-T1,Q8BHL3,,,,,53.0,328.0,8.4e-103,375.2,sp|Q8BHL3|TB10B_MOUSE TBC1 domain family member 10B OS=Mus musculus OX=10090 GN=Tbc1d10b PE=1 SV=2,,,,,,
OG_11433,FUN_015453-T2,Peve_00006856,,apul_peve,58.24,FUN_015453-T2,Q29A33,,,,,32.4,238.0,2.5e-18,95.5,sp|Q29A33|ATX2_DROPS Ataxin-2 homolog OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=Atx2 PE=3 SV=2,,,,,,
OG_11434,FUN_015461-T1,Peve_00022243,,apul_peve,66.181,,,,,,,,,,,,,,,,,
OG_11435,FUN_015468-T1,Peve_00001857,,apul_peve,56.593,FUN_015468-T1,Q6ZQF0,TOPB1_MOUSE,,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),Mus musculus (Mouse),28.4,250.0,2.0000000000000002e-23,112.8,sp|Q6ZQF0|TOPB1_MOUSE DNA topoisomerase 2-binding protein 1 OS=Mus musculus OX=10090 GN=Topbp1 PE=1 SV=2,GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006281; GO:0006974; GO:0007131; GO:0010212; GO:0015629; GO:0016605; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166,broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; protein localization to site of double-strand break [GO:1990166]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212],actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922],chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0000228; GO:0003677; GO:0005634; GO:0005694; GO:0005815; GO:0005856; GO:0005886; GO:0006281; GO:0006310; GO:0022414; GO:0043226; GO:0060090; GO:0098772,nuclear chromosome; DNA binding; nucleus; chromosome; microtubule organizing center; cytoskeleton; plasma membrane; DNA repair; DNA recombination; reproductive process; organelle; molecular adaptor activity; molecular function regulator activity
OG_11436,FUN_015471-T1,Peve_00009522,,apul_peve,76.724,,,,,,,,,,,,,,,,,
OG_11437,FUN_015472-T1,Peve_00009514,,apul_peve,50.802,,,,,,,,,,,,,,,,,
OG_11438,FUN_015518-T1,Peve_00019905,,apul_peve,50.0895,,,,,,,,,,,,,,,,,
OG_11439,FUN_015557-T1,Peve_00017990,,apul_peve,54.491,,,,,,,,,,,,,,,,,
OG_11440,FUN_015575-T1,Peve_00031583,,apul_peve,54.797,,,,,,,,,,,,,,,,,
OG_11441,FUN_015579-T1,Peve_00000908,,apul_peve,93.443,,,,,,,,,,,,,,,,,
OG_11442,FUN_015588-T1,Peve_00021978,,apul_peve,56.041,,,,,,,,,,,,,,,,,
OG_11443,FUN_015630-T1,Peve_00037270,,apul_peve,65.0,,,,,,,,,,,,,,,,,
OG_11444,FUN_015645-T1,Peve_00033856,,apul_peve,36.527,,,,,,,,,,,,,,,,,
OG_11445,FUN_015656-T1,Peve_00002977,,apul_peve,70.218,,,,,,,,,,,,,,,,,
OG_11446,FUN_015685-T1,Peve_00038202,,apul_peve,47.7005,,,,,,,,,,,,,,,,,
OG_11447,FUN_015697-T1,Peve_00000593,,apul_peve,55.709,,,,,,,,,,,,,,,,,
OG_11448,FUN_015699-T1,Peve_00004572,,apul_peve,43.089,,,,,,,,,,,,,,,,,
OG_11449,FUN_015721-T1,Peve_00022452,,apul_peve,32.483000000000004,,,,,,,,,,,,,,,,,
OG_11450,FUN_015723-T1,Peve_00022455,,apul_peve,51.852,,,,,,,,,,,,,,,,,
OG_11451,FUN_015735-T1,Peve_00002746,,apul_peve,33.75,,,,,,,,,,,,,,,,,
OG_11452,FUN_015736-T1,Peve_00028875,,apul_peve,76.471,,,,,,,,,,,,,,,,,
OG_11453,FUN_015757-T1,Peve_00009785,,apul_peve,97.328,,,,,,,,,,,,,,,,,
OG_11454,FUN_015765-T1,Peve_00009504,,apul_peve,72.493,FUN_015765-T1,Q5F371,,,,,74.8,468.0,1.6e-200,701.0,sp|Q5F371|SBNO1_CHICK Protein strawberry notch homolog 1 OS=Gallus gallus OX=9031 GN=SBNO1 PE=2 SV=1,,,,,,
OG_11455,FUN_015804-T1,Peve_00043459,,apul_peve,80.91900000000001,,,,,,,,,,,,,,,,,
OG_11456,FUN_015806-T1,Peve_00043090,,apul_peve,37.709500000000006,,,,,,,,,,,,,,,,,
OG_11457,FUN_015809-T1,Peve_00022407,,apul_peve,33.108,,,,,,,,,,,,,,,,,
OG_11458,FUN_015872-T1,Peve_00042218,,apul_peve,63.462,,,,,,,,,,,,,,,,,
OG_11459,FUN_015895-T1,Peve_00007177,,apul_peve,35.8685,,,,,,,,,,,,,,,,,
OG_11460,FUN_015898-T1,Peve_00040356,,apul_peve,43.605,,,,,,,,,,,,,,,,,
OG_11461,FUN_015940-T1,Peve_00033612,,apul_peve,67.435,,,,,,,,,,,,,,,,,
OG_11462,FUN_015950-T1,Peve_00033766,,apul_peve,60.938,,,,,,,,,,,,,,,,,
OG_11463,FUN_015952-T1,Peve_00022534,,apul_peve,54.023,,,,,,,,,,,,,,,,,
OG_11464,FUN_015970-T1,Peve_00038900,,apul_peve,67.961,,,,,,,,,,,,,,,,,
OG_11465,FUN_015975-T1,Peve_00020765,,apul_peve,64.097,,,,,,,,,,,,,,,,,
OG_11466,FUN_015979-T1,Peve_00024019,,apul_peve,44.128,,,,,,,,,,,,,,,,,
OG_11467,FUN_015987-T1,Peve_00024003,,apul_peve,39.815,,,,,,,,,,,,,,,,,
OG_11468,FUN_015997-T2,Peve_00023992,,apul_peve,70.547,FUN_015997-T2,Q9R244,TRPC2_MOUSE,,Short transient receptor potential channel 2 (TrpC2) (Transient receptor protein 2) (TRP-2) (mTrp2),Mus musculus (Mouse),27.5,501.0,3.3e-22,109.8,sp|Q9R244|TRPC2_MOUSE Short transient receptor potential channel 2 OS=Mus musculus OX=10090 GN=Trpc2 PE=2 SV=2,GO:0000012; GO:0000139; GO:0002118; GO:0002121; GO:0002124; GO:0003684; GO:0005516; GO:0005634; GO:0005635; GO:0005789; GO:0005886; GO:0006816; GO:0007204; GO:0007340; GO:0008050; GO:0010468; GO:0012505; GO:0015279; GO:0019236; GO:0019992; GO:0032590; GO:0048047; GO:0070679; GO:1902436,"acrosome reaction [GO:0007340]; aggressive behavior [GO:0002118]; calcium ion transport [GO:0006816]; female courtship behavior [GO:0008050]; inter-male aggressive behavior [GO:0002121]; mating behavior, sex discrimination [GO:0048047]; negative regulation of male mating behavior [GO:1902436]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of gene expression [GO:0010468]; response to pheromone [GO:0019236]; single strand break repair [GO:0000012]; territorial aggressive behavior [GO:0002124]",dendrite membrane [GO:0032590]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calmodulin binding [GO:0005516]; damaged DNA binding [GO:0003684]; diacylglycerol binding [GO:0019992]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0003677; GO:0005215; GO:0005634; GO:0005635; GO:0005886; GO:0006281; GO:0008289; GO:0022414; GO:0043226,DNA binding; transporter activity; nucleus; nuclear envelope; plasma membrane; DNA repair; lipid binding; reproductive process; organelle
OG_11469,FUN_016013-T1,Peve_00044914,,apul_peve,55.4525,FUN_016013-T1,Q8UVD9,FUBP2_CHICK,,Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (Zipcode-binding protein 2),Gallus gallus (Chicken),28.8,118.0,9.6e-08,60.1,sp|Q8UVD9|FUBP2_CHICK Far upstream element-binding protein 2 OS=Gallus gallus OX=9031 GN=KHSRP PE=1 SV=1,GO:0003729; GO:0003730; GO:0005634; GO:0005737; GO:0006357; GO:0008298; GO:0010586; GO:0035925; GO:0043488; GO:0045019; GO:0051028; GO:0061014; GO:0061158; GO:0071345,3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to cytokine stimulus [GO:0071345]; intracellular mRNA localization [GO:0008298]; miRNA metabolic process [GO:0010586]; mRNA transport [GO:0051028]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; nucleus [GO:0005634],mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729],GO:0003723; GO:0005634; GO:0006355; GO:0043226,RNA binding; nucleus; regulation of DNA-templated transcription; organelle
OG_11470,FUN_016016-T1,Peve_00027523,,apul_peve,64.612,FUN_016016-T1,Q8IUH2,,,,,40.2,169.0,4.1e-37,156.8,sp|Q8IUH2|CREG2_HUMAN Protein CREG2 OS=Homo sapiens OX=9606 GN=CREG2 PE=1 SV=1,,,,,,
OG_11471,FUN_016023-T1,Peve_00024755,,apul_peve,67.88300000000001,,,,,,,,,,,,,,,,,
OG_11472,FUN_016030-T1,Peve_00029636,,apul_peve,65.772,,,,,,,,,,,,,,,,,
OG_11473,FUN_016040-T1,Peve_00011806,,apul_peve,68.75,FUN_016040-T1,P48375,,,,,65.3,98.0,3.8e-30,132.1,sp|P48375|FKB12_DROME Peptidyl-prolyl cis-trans isomerase Fkbp12 OS=Drosophila melanogaster OX=7227 GN=Fkbp12 PE=3 SV=2,,,,,,
OG_11474,FUN_016061-T1,Peve_00012779,,apul_peve,61.708,FUN_016061-T1,P07314,GGT1_RAT,,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],Rattus norvegicus (Rat),40.9,584.0,3.1e-110,400.6,sp|P07314|GGT1_RAT Glutathione hydrolase 1 proenzyme OS=Rattus norvegicus OX=10116 GN=Ggt1 PE=1 SV=4,GO:0000048; GO:0002682; GO:0002951; GO:0005615; GO:0005886; GO:0006508; GO:0006520; GO:0006536; GO:0006631; GO:0006691; GO:0006750; GO:0006751; GO:0007283; GO:0016755; GO:0019344; GO:0031179; GO:0031638; GO:0031982; GO:0032355; GO:0032496; GO:0034599; GO:0034612; GO:0036374; GO:0050727; GO:0061017; GO:0070365; GO:0097305; GO:0097421; GO:0103068; GO:1901750,amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; hepatoblast differentiation [GO:0061017]; hepatocyte differentiation [GO:0070365]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; liver regeneration [GO:0097421]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to alcohol [GO:0097305]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular space [GO:0005615]; plasma membrane [GO:0005886]; vesicle [GO:0031982],aminoacyltransferase activity [GO:0016755]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],GO:0003824; GO:0005615; GO:0005886; GO:0006520; GO:0006575; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0051604; GO:0140096; GO:0140098,"catalytic activity; extracellular space; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein; catalytic activity, acting on RNA"
OG_11475,FUN_016069-T2,Peve_00021914,,apul_peve,73.684,FUN_016069-T2,P62261,,,,,61.0,246.0,2.2e-74,280.4,sp|P62261|1433E_BOVIN 14-3-3 protein epsilon OS=Bos taurus OX=9913 GN=YWHAE PE=2 SV=1,,,,,,
OG_11476,FUN_016079-T1,Peve_00021925,,apul_peve,74.522,FUN_016079-T1,Q91175,,,,,26.9,316.0,1.6e-13,78.6,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_11477,FUN_016092-T1,Peve_00018224,,apul_peve,71.924,FUN_016092-T1,F1MV99,,,,,26.6,293.0,5.8e-16,86.7,sp|F1MV99|SSR5_BOVIN Somatostatin receptor type 5 OS=Bos taurus OX=9913 GN=SSTR5 PE=3 SV=2,,,,,,
OG_11478,FUN_016094-T1,Peve_00010754,,apul_peve,55.797,,,,,,,,,,,,,,,,,
OG_11479,FUN_016120-T1,Peve_00013350,,apul_peve,65.789,FUN_016120-T1,Q9XWZ2,,,,,24.6,228.0,8.7e-11,68.2,sp|Q9XWZ2|ACD11_CAEEL Acyl-CoA dehydrogenase family member 11 OS=Caenorhabditis elegans OX=6239 GN=acdh-11 PE=1 SV=1,,,,,,
OG_11480,FUN_016135-T3,Peve_00003393,,apul_peve,51.342,,,,,,,,,,,,,,,,,
OG_11481,FUN_016153-T1,Peve_00022568,,apul_peve,42.217,,,,,,,,,,,,,,,,,
OG_11482,FUN_016165-T1,Peve_00022616,,apul_peve,68.31,FUN_016165-T1,Q9NPJ3,ACO13_HUMAN,,"Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Hotdog-fold thioesterase superfamily member 2) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Thioesterase superfamily member 2) (THEM2) [Cleaved into: Acyl-coenzyme A thioesterase 13, N-terminally processed]",Homo sapiens (Human),51.3,119.0,5.9e-29,128.6,sp|Q9NPJ3|ACO13_HUMAN Acyl-coenzyme A thioesterase 13 OS=Homo sapiens OX=9606 GN=ACOT13 PE=1 SV=1,GO:0005634; GO:0005739; GO:0005759; GO:0005819; GO:0005829; GO:0006629; GO:0046872; GO:0047617; GO:0051289; GO:0120163,lipid metabolic process [GO:0006629]; negative regulation of cold-induced thermogenesis [GO:0120163]; protein homotetramerization [GO:0051289],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819],fatty acyl-CoA hydrolase activity [GO:0047617]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006629; GO:0016787; GO:0043226; GO:0065003,catalytic activity; nucleus; mitochondrion; cytosol; lipid metabolic process; hydrolase activity; organelle; protein-containing complex assembly
OG_11483,FUN_016179-T1,Peve_00023845,,apul_peve,62.8,,,,,,,,,,,,,,,,,
OG_11484,FUN_016202-T1,Peve_00030471,,apul_peve,65.288,FUN_016202-T1,P51587,BRCA2_HUMAN,,Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein),Homo sapiens (Human),32.6,1293.0,1.9999999999999997e-152,543.5,sp|P51587|BRCA2_HUMAN Breast cancer type 2 susceptibility protein OS=Homo sapiens OX=9606 GN=BRCA2 PE=1 SV=4,GO:0000152; GO:0000722; GO:0000724; GO:0000781; GO:0000800; GO:0001556; GO:0001833; GO:0002020; GO:0003697; GO:0005634; GO:0005654; GO:0005813; GO:0005829; GO:0006289; GO:0006302; GO:0006355; GO:0007141; GO:0007283; GO:0007420; GO:0008585; GO:0010165; GO:0010225; GO:0010332; GO:0010484; GO:0010485; GO:0030141; GO:0030330; GO:0032465; GO:0032991; GO:0033593; GO:0033600; GO:0042771; GO:0042802; GO:0043015; GO:0045893; GO:0045931; GO:0051298; GO:0070200; GO:0071425; GO:0071479; GO:0090398; GO:1990391; GO:1990426; GO:2000001,"brain development [GO:0007420]; cellular response to ionizing radiation [GO:0071479]; cellular senescence [GO:0090398]; centrosome duplication [GO:0051298]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; establishment of protein localization to telomere [GO:0070200]; female gonad development [GO:0008585]; hematopoietic stem cell proliferation [GO:0071425]; inner cell mass cell proliferation [GO:0001833]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; male meiosis I [GO:0007141]; mitotic recombination-dependent replication fork processing [GO:1990426]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; nucleotide-excision repair [GO:0006289]; oocyte maturation [GO:0001556]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of mitotic cell cycle [GO:0045931]; regulation of cytokinesis [GO:0032465]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA-templated transcription [GO:0006355]; response to gamma radiation [GO:0010332]; response to UV-C [GO:0010225]; response to X-ray [GO:0010165]; spermatogenesis [GO:0007283]; telomere maintenance via recombination [GO:0000722]","BRCA2-MAGE-D1 complex [GO:0033593]; centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA repair complex [GO:1990391]; lateral element [GO:0000800]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]",gamma-tubulin binding [GO:0043015]; histone H3 acetyltransferase activity [GO:0010484]; histone H4 acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0006281; GO:0006310; GO:0006355; GO:0008092; GO:0016740; GO:0022414; GO:0031410; GO:0032200; GO:0043226; GO:0048856; GO:0140013; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; DNA repair; DNA recombination; regulation of DNA-templated transcription; cytoskeletal protein binding; transferase activity; reproductive process; cytoplasmic vesicle; telomere organization; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on a protein"
OG_11485,FUN_016220-T1,Peve_00016279,,apul_peve,76.143,,,,,,,,,,,,,,,,,
OG_11486,FUN_016222-T1,Peve_00002229,,apul_peve,44.262,,,,,,,,,,,,,,,,,
OG_11487,FUN_016235-T1,Peve_00040364,,apul_peve,78.261,,,,,,,,,,,,,,,,,
OG_11488,FUN_016267-T1,Peve_00011215,,apul_peve,92.015,,,,,,,,,,,,,,,,,
OG_11489,FUN_016287-T1,Peve_00010630,,apul_peve,59.483,,,,,,,,,,,,,,,,,
OG_11490,FUN_016292-T2,Peve_00001306,,apul_peve,65.491,,,,,,,,,,,,,,,,,
OG_11491,FUN_016298-T1,Peve_00023859,,apul_peve,74.39,FUN_016298-T1,Q7ZTY7,USE1_DANRE,,Vesicle transport protein USE1 (USE1-like protein),Danio rerio (Zebrafish) (Brachydanio rerio),35.8,240.0,4.900000000000001e-33,142.9,sp|Q7ZTY7|USE1_DANRE Vesicle transport protein USE1 OS=Danio rerio OX=7955 GN=use1 PE=2 SV=1,GO:0005484; GO:0005783; GO:0005789; GO:0006890; GO:0015031; GO:0031201,"protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; SNARE complex [GO:0031201],SNAP receptor activity [GO:0005484],GO:0005783; GO:0016192; GO:0043226; GO:0060090,endoplasmic reticulum; vesicle-mediated transport; organelle; molecular adaptor activity
OG_11492,FUN_016301-T1,Peve_00025291,,apul_peve,31.0395,,,,,,,,,,,,,,,,,
OG_11493,FUN_016307-T1,Peve_00015279,,apul_peve,43.452,FUN_016307-T1,Q13445,,,,,30.5,177.0,2.4e-13,77.0,sp|Q13445|TMED1_HUMAN Transmembrane emp24 domain-containing protein 1 OS=Homo sapiens OX=9606 GN=TMED1 PE=1 SV=1,,,,,,
OG_11494,FUN_016315-T1,Peve_00034249,,apul_peve,62.0,,,,,,,,,,,,,,,,,
OG_11495,FUN_016321-T1,Peve_00000580,,apul_peve,52.8895,,,,,,,,,,,,,,,,,
OG_11496,FUN_016328-T1,Peve_00032371,,apul_peve,32.8065,,,,,,,,,,,,,,,,,
OG_11497,FUN_016367-T1,Peve_00004343,,apul_peve,66.34649999999999,FUN_016367-T1,O43614,OX2R_HUMAN,,Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2),Homo sapiens (Human),30.7,336.0,8.7e-35,149.4,sp|O43614|OX2R_HUMAN Orexin receptor type 2 OS=Homo sapiens OX=9606 GN=HCRTR2 PE=1 SV=2,GO:0005654; GO:0005886; GO:0007200; GO:0007218; GO:0007268; GO:0007631; GO:0008188; GO:0010840; GO:0016499; GO:0017046; GO:0022410; GO:0032870; GO:0040011; GO:0045202; GO:0051480,"cellular response to hormone stimulus [GO:0032870]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; locomotion [GO:0040011]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle, wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480]",nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202],neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046],GO:0005654; GO:0005886; GO:0023052; GO:0060089,nucleoplasm; plasma membrane; signaling; molecular transducer activity
OG_11498,FUN_016369-T1,Peve_00019685,,apul_peve,71.3195,FUN_016369-T1,Q9DBR1,XRN2_MOUSE,,5'-3' exoribonuclease 2 (EC 3.1.13.-) (Protein Dhm1),Mus musculus (Mouse),55.6,989.0,3.8e-289,995.7,sp|Q9DBR1|XRN2_MOUSE 5'-3' exoribonuclease 2 OS=Mus musculus OX=10090 GN=Xrn2 PE=1 SV=1,GO:0001147; GO:0004534; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0006369; GO:0006397; GO:0007017; GO:0007283; GO:0008270; GO:0008409; GO:0016070; GO:0016235; GO:0021766; GO:0030182; GO:0042802; GO:0060041,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; hippocampus development [GO:0021766]; microtubule-based process [GO:0007017]; mRNA processing [GO:0006397]; neuron differentiation [GO:0030182]; retina development in camera-type eye [GO:0060041]; RNA metabolic process [GO:0016070]; spermatogenesis [GO:0007283]; termination of RNA polymerase II transcription [GO:0006369],aggresome [GO:0016235]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],5'-3' exonuclease activity [GO:0008409]; 5'-3' RNA exonuclease activity [GO:0004534]; identical protein binding [GO:0042802]; transcription termination site sequence-specific DNA binding [GO:0001147]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016071; GO:0016787; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140098,"DNA binding; catalytic activity; nucleoplasm; nucleolus; DNA repair; DNA recombination; mRNA metabolic process; hydrolase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_11499,FUN_016384-T1,Peve_00022909,,apul_peve,56.927,,,,,,,,,,,,,,,,,
OG_11500,FUN_016395-T2,Peve_00006416,,apul_peve,62.0805,,,,,,,,,,,,,,,,,
OG_11501,FUN_016403-T1,Peve_00020792,,apul_peve,71.408,FUN_016403-T1,P32796,,,,,23.1,373.0,3.5e-10,68.6,"sp|P32796|CACP_YEAST Carnitine O-acetyltransferase, mitochondrial OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=CAT2 PE=1 SV=2",,,,,,
OG_11502,FUN_016404-T1,Peve_00020791,,apul_peve,81.818,,,,,,,,,,,,,,,,,
OG_11503,FUN_016405-T1,Peve_00020786,,apul_peve,80.579,,,,,,,,,,,,,,,,,
OG_11504,FUN_016406-T1,Peve_00020798,,apul_peve,77.91,FUN_016406-T1,Q2UPB1,,,,,27.4,387.0,1.3000000000000001e-37,159.1,sp|Q2UPB1|ACLC_ASPOR Cytochrome P450 monooxygenase aclC OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) OX=510516 GN=aclC PE=3 SV=1,,,,,,
OG_11505,FUN_016413-T1,Peve_00019846,,apul_peve,44.4645,,,,,,,,,,,,,,,,,
OG_11506,FUN_016414-T1,Peve_00018207,,apul_peve,77.398,FUN_016414-T1,Q5PPZ9,,,,,32.5,615.0,3.5e-80,300.8,sp|Q5PPZ9|GDS1B_XENLA Rap1 GTPase-GDP dissociation stimulator 1-B OS=Xenopus laevis OX=8355 GN=rap1gds1-b PE=2 SV=1,,,,,,
OG_11507,FUN_016424-T1,Peve_00004361,,apul_peve,53.061,,,,,,,,,,,,,,,,,
OG_11508,FUN_016426-T1,Peve_00004358,,apul_peve,72.263,FUN_016426-T1,O73755,,,,,47.5,99.0,3.4e-21,102.8,sp|O73755|GREM1_CHICK Gremlin-1 OS=Gallus gallus OX=9031 GN=GREM1 PE=2 SV=1,,,,,,
OG_11509,FUN_016443-T2,Peve_00013820,,apul_peve,74.51,FUN_016443-T2,Q99MS8,,,,,34.2,263.0,1.8999999999999998e-24,114.4,sp|Q99MS8|TPGS1_MOUSE Tubulin polyglutamylase complex subunit 1 OS=Mus musculus OX=10090 GN=Tpgs1 PE=1 SV=1,,,,,,
OG_11510,FUN_016448-T1,Peve_00016433,,apul_peve,66.856,FUN_016448-T1,O43347,,,,,25.9,166.0,1e-10,69.3,sp|O43347|MSI1H_HUMAN RNA-binding protein Musashi homolog 1 OS=Homo sapiens OX=9606 GN=MSI1 PE=1 SV=1,,,,,,
OG_11511,FUN_016458-T1,Peve_00040147,,apul_peve,77.052,FUN_016458-T1,Q9I9M5,,,,,58.0,517.0,9.899999999999999e-175,614.8,sp|Q9I9M5|FZD1_XENLA Frizzled-1 OS=Xenopus laevis OX=8355 GN=fzd1 PE=1 SV=1,,,,,,
OG_11512,FUN_016461-T1,Peve_00040140,,apul_peve,77.71199999999999,FUN_016461-T1,P58421,,,,,62.6,497.0,3.1e-181,636.3,sp|P58421|FZD5_XENLA Frizzled-5 OS=Xenopus laevis OX=8355 GN=fzd5 PE=2 SV=1,,,,,,
OG_11513,FUN_016462-T1,Peve_00006183,,apul_peve,88.065,FUN_016462-T1,Q9EPQ0,NCKX3_RAT,,Sodium/potassium/calcium exchanger 3 (Na(+)/K(+)/Ca(2+)-exchange protein 3) (Solute carrier family 24 member 3),Rattus norvegicus (Rat),38.2,557.0,3.6e-92,340.5,sp|Q9EPQ0|NCKX3_RAT Sodium/potassium/calcium exchanger 3 (Fragment) OS=Rattus norvegicus OX=10116 GN=Slc24a3 PE=1 SV=1,GO:0005262; GO:0005886; GO:0006812; GO:0006874; GO:0008273; GO:0010628; GO:0010629; GO:0015293; GO:0030282; GO:0035725; GO:0070588; GO:0071805; GO:0071944,bone mineralization [GO:0030282]; calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic cation transport [GO:0006812]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; potassium ion transmembrane transport [GO:0071805]; sodium ion transmembrane transport [GO:0035725],cell periphery [GO:0071944]; plasma membrane [GO:0005886],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]",GO:0005215; GO:0005886; GO:0048856; GO:0055085,transporter activity; plasma membrane; anatomical structure development; transmembrane transport
OG_11514,FUN_016463-T1,Peve_00006185,,apul_peve,96.241,FUN_016463-T1,Q9EPR4,S23A2_MOUSE,,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2),Mus musculus (Mouse),47.7,585.0,2.2e-151,537.3,sp|Q9EPR4|S23A2_MOUSE Solute carrier family 23 member 2 OS=Mus musculus OX=10090 GN=Slc23a2 PE=1 SV=2,GO:0005737; GO:0006979; GO:0007155; GO:0008015; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0071361; GO:1903861,blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229],GO:0003013; GO:0005215; GO:0005975; GO:0007155; GO:0055085,circulatory system process; transporter activity; carbohydrate metabolic process; cell adhesion; transmembrane transport
OG_11515,FUN_016466-T1,Peve_00040141,,apul_peve,71.844,FUN_016466-T1,Q9I7T7,,,,,65.0,183.0,6e-64,246.9,sp|Q9I7T7|LAR4_DROME La-related protein Larp4B OS=Drosophila melanogaster OX=7227 GN=Larp4B PE=1 SV=2,,,,,,
OG_11516,FUN_016474-T1,Peve_00015315,,apul_peve,94.179,FUN_016474-T1,Q63170,,,,,69.1,3998.0,0.0,5637.4,sp|Q63170|DYH7_RAT Dynein axonemal heavy chain 7 OS=Rattus norvegicus OX=10116 GN=Dnah7 PE=2 SV=2,,,,,,
OG_11517,FUN_016485-T1,Peve_00024207,,apul_peve,45.255,,,,,,,,,,,,,,,,,
OG_11518,FUN_016486-T1,Peve_00001320,,apul_peve,71.749,FUN_016486-T1,Q4GZT4,ABCG2_BOVIN,,Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Urate exporter) (CD antigen CD338),Bos taurus (Bovine),49.2,626.0,1.1e-164,581.6,sp|Q4GZT4|ABCG2_BOVIN Broad substrate specificity ATP-binding cassette transporter ABCG2 OS=Bos taurus OX=9913 GN=ABCG2 PE=3 SV=2,GO:0005524; GO:0005886; GO:0006869; GO:0008559; GO:0015143; GO:0015225; GO:0015562; GO:0015878; GO:0016324; GO:0016887; GO:0031526; GO:0031966; GO:0032217; GO:0032218; GO:0042626; GO:0045121; GO:0055085; GO:0097744,biotin transport [GO:0015878]; lipid transport [GO:0006869]; renal urate salt excretion [GO:0097744]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; biotin transmembrane transporter activity [GO:0015225]; efflux transmembrane transporter activity [GO:0015562]; riboflavin transmembrane transporter activity [GO:0032217]; urate transmembrane transporter activity [GO:0015143],GO:0003014; GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0055085; GO:0140657,renal system process; catalytic activity; transporter activity; plasma membrane; hydrolase activity; transmembrane transport; ATP-dependent activity
OG_11519,FUN_016498-T1,Peve_00010551,,apul_peve,52.595,FUN_016498-T1,Q9ULL1,,,,,50.7,150.0,1.8e-37,159.5,sp|Q9ULL1|PKHG1_HUMAN Pleckstrin homology domain-containing family G member 1 OS=Homo sapiens OX=9606 GN=PLEKHG1 PE=1 SV=2,,,,,,
OG_11520,FUN_016499-T2,Peve_00038311,,apul_peve,86.731,FUN_016499-T2,P00565,,,,,74.9,367.0,9.8e-166,584.3,sp|P00565|KCRM_CHICK Creatine kinase M-type OS=Gallus gallus OX=9031 GN=CKM PE=1 SV=1,,,,,,
OG_11521,FUN_016500-T1,Peve_00016814,,apul_peve,78.47,FUN_016500-T1,Q5XGM3,,,,,61.6,357.0,2.2999999999999998e-127,456.8,sp|Q5XGM3|BHMT1_XENLA Betaine--homocysteine S-methyltransferase 1 OS=Xenopus laevis OX=8355 GN=bhmt PE=2 SV=1,,,,,,
OG_11522,FUN_016505-T1,Peve_00006954,,apul_peve,50.36,,,,,,,,,,,,,,,,,
OG_11523,FUN_016510-T1,Peve_00030910,,apul_peve,40.761,,,,,,,,,,,,,,,,,
OG_11524,FUN_016576-T1,Peve_00042763,,apul_peve,65.109,FUN_016576-T1,P34968,5HT2C_MOUSE,,5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C),Mus musculus (Mouse),26.2,328.0,1.2e-18,95.5,sp|P34968|5HT2C_MOUSE 5-hydroxytryptamine receptor 2C OS=Mus musculus OX=10090 GN=Htr2c PE=1 SV=2,GO:0001587; GO:0001662; GO:0004993; GO:0005886; GO:0006874; GO:0007200; GO:0007208; GO:0007626; GO:0007631; GO:0009897; GO:0010513; GO:0019934; GO:0031644; GO:0032098; GO:0042802; GO:0043397; GO:0045600; GO:0050850; GO:0051209; GO:0051378; GO:0070374; GO:0071886; GO:0098666; GO:0099589,behavioral fear response [GO:0001662]; cGMP-mediated signaling [GO:0019934]; feeding behavior [GO:0007631]; intracellular calcium ion homeostasis [GO:0006874]; locomotory behavior [GO:0007626]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; regulation of appetite [GO:0032098]; regulation of corticotropin-releasing hormone secretion [GO:0043397]; regulation of nervous system process [GO:0031644]; release of sequestered calcium ion into cytosol [GO:0051209],external side of plasma membrane [GO:0009897]; G protein-coupled serotonin receptor complex [GO:0098666]; plasma membrane [GO:0005886],"1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding [GO:0071886]; G protein-coupled serotonin receptor activity [GO:0004993]; Gq/11-coupled serotonin receptor activity [GO:0001587]; identical protein binding [GO:0042802]; serotonin binding [GO:0051378]; serotonin receptor activity [GO:0099589]",GO:0005886; GO:0055085; GO:0060089,plasma membrane; transmembrane transport; molecular transducer activity
OG_11525,FUN_016584-T1,Peve_00026528,,apul_peve,49.3685,FUN_016584-T1,Q17RS7,GEN_HUMAN,,Flap endonuclease GEN homolog 1 (EC 3.1.-.-),Homo sapiens (Human),35.1,464.0,2.1e-74,281.2,sp|Q17RS7|GEN_HUMAN Flap endonuclease GEN homolog 1 OS=Homo sapiens OX=9606 GN=GEN1 PE=1 SV=2,GO:0000287; GO:0000400; GO:0000724; GO:0005654; GO:0005813; GO:0008821; GO:0010824; GO:0017108; GO:0031297; GO:0042803; GO:0071139; GO:0071140; GO:0090267,double-strand break repair via homologous recombination [GO:0000724]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of centrosome duplication [GO:0010824]; replication fork processing [GO:0031297]; resolution of DNA recombination intermediates [GO:0071139]; resolution of mitotic recombination intermediates [GO:0071140],centrosome [GO:0005813]; nucleoplasm [GO:0005654],5'-flap endonuclease activity [GO:0017108]; crossover junction DNA endonuclease activity [GO:0008821]; four-way junction DNA binding [GO:0000400]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],GO:0003677; GO:0003824; GO:0005654; GO:0005815; GO:0006281; GO:0006310; GO:0016787; GO:0140097,"DNA binding; catalytic activity; nucleoplasm; microtubule organizing center; DNA repair; DNA recombination; hydrolase activity; catalytic activity, acting on DNA"
OG_11526,FUN_016585-T1,Peve_00016677,,apul_peve,63.731,FUN_016585-T1,P55786,PSA_HUMAN,,Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S),Homo sapiens (Human),60.3,865.0,0.0,1083.2,sp|P55786|PSA_HUMAN Puromycin-sensitive aminopeptidase OS=Homo sapiens OX=9606 GN=NPEPPS PE=1 SV=2,GO:0000209; GO:0004177; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0008270; GO:0016020; GO:0016285; GO:0042277; GO:0043171; GO:0070006; GO:0070062; GO:0071456; GO:1903955,cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],alanyl aminopeptidase activity [GO:0016285]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; extracellular space; nucleus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_11527,FUN_016600-T1,Peve_00003403,,apul_peve,50.98,FUN_016600-T1,P21956,MFGM_MOUSE,,Lactadherin (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) (Sperm surface protein SP47) (MP47),Mus musculus (Mouse),31.7,161.0,2.2e-17,92.8,sp|P21956|MFGM_MOUSE Lactadherin OS=Mus musculus OX=10090 GN=Mfge8 PE=1 SV=3,GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005615; GO:0006910; GO:0006911; GO:0007155; GO:0007338; GO:0008429; GO:0009897; GO:0043277; GO:0050766; GO:0062023,"angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]",acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615],integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786],GO:0005615; GO:0007155; GO:0008289; GO:0016192; GO:0022414; GO:0061024,extracellular space; cell adhesion; lipid binding; vesicle-mediated transport; reproductive process; membrane organization
OG_11528,FUN_016619-T1,Peve_00016177,,apul_peve,63.158,FUN_016619-T1,Q96EH3,,,,,51.3,115.0,2.7e-25,117.1,sp|Q96EH3|MASU1_HUMAN Mitochondrial assembly of ribosomal large subunit protein 1 OS=Homo sapiens OX=9606 GN=MALSU1 PE=1 SV=1,,,,,,
OG_11529,FUN_016624-T1,Peve_00026350,,apul_peve,59.452,FUN_016624-T1,O02824,,,,,23.3,318.0,8.4e-21,102.8,sp|O02824|ADA1A_RABIT Alpha-1A adrenergic receptor OS=Oryctolagus cuniculus OX=9986 GN=ADRA1A PE=2 SV=1,,,,,,
OG_11530,FUN_016637-T1,Peve_00026356,,apul_peve,41.107,,,,,,,,,,,,,,,,,
OG_11531,FUN_016644-T1,Peve_00042748,,apul_peve,54.172,FUN_016644-T1,Q6PB44,PTN23_MOUSE,,Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48),Mus musculus (Mouse),36.9,808.0,3.2e-122,442.6,sp|Q6PB44|PTN23_MOUSE Tyrosine-protein phosphatase non-receptor type 23 OS=Mus musculus OX=10090 GN=Ptpn23 PE=1 SV=2,GO:0004725; GO:0005634; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0010633; GO:0015031; GO:0016604; GO:0019901; GO:0032456; GO:0034451; GO:0036064; GO:0043162; GO:0045022; GO:0060271; GO:0061357; GO:1903387; GO:1903393; GO:2000643,cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleus [GO:0005634],protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; endosome; microtubule organizing center; cytosol; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; cilium organization; catalytic activity, acting on a protein"
OG_11532,FUN_016667-T1,Peve_00032321,,apul_peve,54.867,,,,,,,,,,,,,,,,,
OG_11533,FUN_016684-T1,Peve_00032404,,apul_peve,65.336,,,,,,,,,,,,,,,,,
OG_11534,FUN_016699-T1,Peve_00004836,,apul_peve,38.679,,,,,,,,,,,,,,,,,
OG_11535,FUN_016721-T1,Peve_00014672,,apul_peve,48.497,,,,,,,,,,,,,,,,,
OG_11536,FUN_016734-T1,Peve_00020655,,apul_peve,42.623,,,,,,,,,,,,,,,,,
OG_11537,FUN_016743-T1,Peve_00018615,,apul_peve,63.4585,FUN_016743-T1,Q8R314,,,,,45.5,446.0,7.3e-102,374.0,sp|Q8R314|S35F5_MOUSE Solute carrier family 35 member F5 OS=Mus musculus OX=10090 GN=Slc35f5 PE=2 SV=1,,,,,,
OG_11538,FUN_016793-T1,Peve_00018611,,apul_peve,60.8265,FUN_016793-T1,Q24W96,,,,,28.1,153.0,5.2e-11,69.7,sp|Q24W96|MENG_DESHY Demethylmenaquinone methyltransferase OS=Desulfitobacterium hafniense (strain Y51) OX=138119 GN=menG PE=3 SV=1,,,,,,
OG_11539,FUN_016795-T1,Peve_00017531,,apul_peve,91.0975,FUN_016795-T1,Q08C72,CWC22_DANRE,,Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog),Danio rerio (Zebrafish) (Brachydanio rerio),85.5,62.0,2.5e-25,116.3,sp|Q08C72|CWC22_DANRE Pre-mRNA-splicing factor CWC22 homolog OS=Danio rerio OX=7955 GN=cwc22 PE=2 SV=1,GO:0000398; GO:0003723; GO:0005634; GO:0005681; GO:0016607; GO:0071005; GO:0071006; GO:0071007; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_11540,FUN_016796-T1,Peve_00018603,,apul_peve,77.328,,,,,,,,,,,,,,,,,
OG_11541,FUN_016803-T2,Peve_00025623,,apul_peve,55.527,FUN_016803-T2,Q58L91,FA5V_OXYSU,,Venom prothrombin activator oscutarin-C non-catalytic subunit (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Oscutarin-C non-catalytic subunit heavy chain; Oscutarin-C non-catalytic subunit light chain],Oxyuranus scutellatus (Coastal taipan),37.7,159.0,2.4e-19,99.4,sp|Q58L91|FA5V_OXYSU Venom prothrombin activator oscutarin-C non-catalytic subunit OS=Oxyuranus scutellatus OX=8668 PE=1 SV=1,GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729,venom-mediated blood coagulation [GO:0044469],extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729],GO:0005576; GO:0005886; GO:0060089; GO:0090729; GO:0098772,extracellular region; plasma membrane; molecular transducer activity; toxin activity; molecular function regulator activity
OG_11542,FUN_016815-T1,Peve_00018607,,apul_peve,46.459,FUN_016815-T1,D8VNS8,,,,,39.5,228.0,4.9e-41,171.8,sp|D8VNS8|FCNV2_CERRY Ryncolin-2 OS=Cerberus rynchops OX=46267 PE=1 SV=1,,,,,,
OG_11543,FUN_016836-T1,Peve_00018609,,apul_peve,51.42,FUN_016836-T1,P60755,MDGA2_MOUSE,,MAM domain-containing glycosylphosphatidylinositol anchor protein 2 (MAM domain-containing protein 1),Mus musculus (Mouse),40.7,140.0,4.9e-17,90.1,sp|P60755|MDGA2_MOUSE MAM domain-containing glycosylphosphatidylinositol anchor protein 2 OS=Mus musculus OX=10090 GN=Mdga2 PE=1 SV=1,GO:0001764; GO:0005886; GO:0007389; GO:0010467; GO:0043524; GO:0050905; GO:0061744; GO:0098552; GO:0098978; GO:0098982; GO:0099179; GO:1905606,gene expression [GO:0010467]; motor behavior [GO:0061744]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; pattern specification process [GO:0007389]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic membrane adhesion [GO:0099179],GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],,GO:0005886; GO:0048870; GO:0050877,plasma membrane; cell motility; nervous system process
OG_11544,FUN_016867-T1,Peve_00028265,,apul_peve,42.039,,,,,,,,,,,,,,,,,
OG_11545,FUN_016869-T1,Peve_00020509,,apul_peve,56.958,,,,,,,,,,,,,,,,,
OG_11546,FUN_016875-T1,Peve_00037276,,apul_peve,67.094,FUN_016875-T1,Q9CD89,,,,,34.0,156.0,4e-11,70.5,sp|Q9CD89|RNMT_MYCLE Rhamnosyl O-methyltransferase OS=Mycobacterium leprae (strain TN) OX=272631 GN=ML0127 PE=3 SV=1,,,,,,
OG_11547,FUN_016891-T1,Peve_00022783,,apul_peve,69.504,,,,,,,,,,,,,,,,,
OG_11548,FUN_016904-T1,Peve_00043779,,apul_peve,59.836,,,,,,,,,,,,,,,,,
OG_11549,FUN_016916-T1,Peve_00040348,,apul_peve,86.705,,,,,,,,,,,,,,,,,
OG_11550,FUN_016962-T1,Peve_00018872,,apul_peve,56.637,,,,,,,,,,,,,,,,,
OG_11551,FUN_016972-T1,Peve_00025292,,apul_peve,67.49,FUN_016972-T1,P14184,,,,,32.7,98.0,3.2e-09,63.9,sp|P14184|LICD_HAEIN Lipopolysaccharide cholinephosphotransferase LicD OS=Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) OX=71421 GN=licD PE=3 SV=2,,,,,,
OG_11552,FUN_016987-T1,Peve_00026099,,apul_peve,61.532,,,,,,,,,,,,,,,,,
OG_11553,FUN_016989-T1,Peve_00025275,,apul_peve,40.526,,,,,,,,,,,,,,,,,
OG_11554,FUN_017005-T1,Peve_00018612,,apul_peve,62.264,FUN_017005-T1,P9WEH7,,,,,37.3,118.0,4.4e-09,63.2,sp|P9WEH7|LTBC_ASPLT Probable methyltransferase ltbC OS=Aspergillus luteorubrus OX=2715282 GN=ltbC PE=3 SV=1,,,,,,
OG_11555,FUN_017025-T1,Peve_00026243,,apul_peve,75.253,,,,,,,,,,,,,,,,,
OG_11556,FUN_017187-T1,Peve_00005447,,apul_peve,66.372,,,,,,,,,,,,,,,,,
OG_11557,FUN_017193-T1,Peve_00012375,,apul_peve,58.0315,,,,,,,,,,,,,,,,,
OG_11558,FUN_017196-T1,Peve_00000255,,apul_peve,74.737,,,,,,,,,,,,,,,,,
OG_11559,FUN_017197-T1,Peve_00000252,,apul_peve,58.692,,,,,,,,,,,,,,,,,
OG_11560,FUN_017198-T1,Peve_00000845,,apul_peve,57.576,,,,,,,,,,,,,,,,,
OG_11561,FUN_017201-T1,Peve_00037519,,apul_peve,55.556,,,,,,,,,,,,,,,,,
OG_11562,FUN_017203-T1,Peve_00033134,,apul_peve,60.991,,,,,,,,,,,,,,,,,
OG_11563,FUN_017213-T1,Peve_00034994,,apul_peve,41.6,,,,,,,,,,,,,,,,,
OG_11564,FUN_017229-T1,Peve_00041516,,apul_peve,50.15,,,,,,,,,,,,,,,,,
OG_11565,FUN_017232-T1,Peve_00004032,,apul_peve,81.818,,,,,,,,,,,,,,,,,
OG_11566,FUN_017240-T1,Peve_00007122,,apul_peve,46.61,,,,,,,,,,,,,,,,,
OG_11567,FUN_017257-T1,Peve_00014830,,apul_peve,43.421,,,,,,,,,,,,,,,,,
OG_11568,FUN_017263-T1,Peve_00031535,,apul_peve,55.276,,,,,,,,,,,,,,,,,
OG_11569,FUN_017264-T1,Peve_00024549,,apul_peve,52.795,,,,,,,,,,,,,,,,,
OG_11570,FUN_017273-T1,Peve_00034739,,apul_peve,70.1945,,,,,,,,,,,,,,,,,
OG_11571,FUN_017613-T1,Peve_00029791,,apul_peve,31.122,,,,,,,,,,,,,,,,,
OG_11572,FUN_017628-T1,Peve_00001197,,apul_peve,64.246,,,,,,,,,,,,,,,,,
OG_11573,FUN_017633-T1,Peve_00042215,,apul_peve,38.31,,,,,,,,,,,,,,,,,
OG_11574,FUN_017634-T1,Peve_00007148,,apul_peve,49.624,,,,,,,,,,,,,,,,,
OG_11575,FUN_017642-T1,Peve_00043660,,apul_peve,38.406,,,,,,,,,,,,,,,,,
OG_11576,FUN_017683-T1,Peve_00022983,,apul_peve,73.115,,,,,,,,,,,,,,,,,
OG_11577,FUN_017687-T1,Peve_00010198,,apul_peve,41.379,,,,,,,,,,,,,,,,,
OG_11578,FUN_017702-T1,Peve_00041817,,apul_peve,60.784,,,,,,,,,,,,,,,,,
OG_11579,FUN_017713-T1,Peve_00014388,,apul_peve,54.667,,,,,,,,,,,,,,,,,
OG_11580,FUN_017755-T1,Peve_00003213,,apul_peve,70.414,,,,,,,,,,,,,,,,,
OG_11581,FUN_017769-T1,Peve_00006868,,apul_peve,51.097,FUN_017769-T1,Q99759,M3K3_HUMAN,,Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3),Homo sapiens (Human),35.3,258.0,3.3e-38,161.4,sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens OX=9606 GN=MAP3K3 PE=1 SV=2,GO:0000165; GO:0001568; GO:0004672; GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005829; GO:0035556; GO:0043123; GO:0046777; GO:0046872; GO:0106310; GO:1900745,blood vessel development [GO:0001568]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005829; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; cytosol; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_11582,FUN_017772-T1,Peve_00018704,,apul_peve,78.667,FUN_017772-T1,Q8QGW7,,,,,55.9,68.0,2.4e-19,96.7,sp|Q8QGW7|LITAF_CHICK Lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog OS=Gallus gallus OX=9031 GN=LITAF PE=2 SV=1,,,,,,
OG_11583,FUN_017775-T1,Peve_00017199,,apul_peve,82.73,FUN_017775-T1,Q5PR00,,,,,32.8,348.0,1.2999999999999998e-43,178.7,sp|Q5PR00|DJC22_RAT DnaJ homolog subfamily C member 22 OS=Rattus norvegicus OX=10116 GN=Dnajc22 PE=2 SV=1,,,,,,
OG_11584,FUN_017776-T1,Peve_00006866,,apul_peve,74.86,FUN_017776-T1,A4FUD4,PEX12_BOVIN,,Peroxisome assembly protein 12 (Peroxin-12),Bos taurus (Bovine),40.6,367.0,1.7e-66,254.6,sp|A4FUD4|PEX12_BOVIN Peroxisome assembly protein 12 OS=Bos taurus OX=9913 GN=PEX12 PE=2 SV=1,GO:0000209; GO:0004842; GO:0005778; GO:0006513; GO:0007031; GO:0008270; GO:0016558; GO:0016562; GO:0034614; GO:1990429; GO:1990757,"cellular response to reactive oxygen species [GO:0034614]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]",peroxisomal importomer complex [GO:1990429]; peroxisomal membrane [GO:0005778],ubiquitin ligase activator activity [GO:1990757]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0006886; GO:0007031; GO:0016740; GO:0043226; GO:0055085; GO:0098772; GO:0140096,"catalytic activity; intracellular protein transport; peroxisome organization; transferase activity; organelle; transmembrane transport; molecular function regulator activity; catalytic activity, acting on a protein"
OG_11585,FUN_017778-T1,Peve_00006876,,apul_peve,88.095,FUN_017778-T1,Q5BKY9,,,,,68.8,80.0,3.7e-24,112.8,sp|Q5BKY9|F133B_HUMAN Protein FAM133B OS=Homo sapiens OX=9606 GN=FAM133B PE=1 SV=1,,,,,,
OG_11586,FUN_017779-T1,Peve_00006872,,apul_peve,47.154,,,,,,,,,,,,,,,,,
OG_11587,FUN_017785-T1,Peve_00040533,,apul_peve,80.0,FUN_017785-T1,P27467,WNT3A_MOUSE,,Protein Wnt-3a,Mus musculus (Mouse),47.6,353.0,3.2e-94,346.7,sp|P27467|WNT3A_MOUSE Protein Wnt-3a OS=Mus musculus OX=10090 GN=Wnt3a PE=1 SV=1,GO:0001649; GO:0001701; GO:0001756; GO:0001819; GO:0001947; GO:0002092; GO:0003713; GO:0005102; GO:0005109; GO:0005576; GO:0005615; GO:0005788; GO:0006366; GO:0007165; GO:0007267; GO:0007368; GO:0007409; GO:0007411; GO:0007498; GO:0008104; GO:0008284; GO:0009887; GO:0009952; GO:0009986; GO:0010387; GO:0010977; GO:0016055; GO:0019904; GO:0021527; GO:0021766; GO:0021846; GO:0021874; GO:0021904; GO:0022008; GO:0030097; GO:0030168; GO:0030198; GO:0030509; GO:0030879; GO:0030890; GO:0030901; GO:0032212; GO:0033278; GO:0035567; GO:0035914; GO:0036342; GO:0039706; GO:0042100; GO:0042472; GO:0042802; GO:0045202; GO:0045444; GO:0045445; GO:0045595; GO:0045599; GO:0045893; GO:0045944; GO:0048018; GO:0048103; GO:0048337; GO:0048343; GO:0048643; GO:0048697; GO:0048843; GO:0050768; GO:0050770; GO:0050804; GO:0060070; GO:0060923; GO:0061184; GO:0062009; GO:0070507; GO:0070527; GO:0071542; GO:0090245; GO:0090263; GO:0090676; GO:0098978; GO:1903078; GO:1904339; GO:1905539; GO:1905606; GO:1990851; GO:1990909; GO:2000049; GO:2000179; GO:2000347; GO:2000727; GO:2001141,animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; B cell proliferation [GO:0042100]; BMP signaling pathway [GO:0030509]; calcium ion transmembrane transport via low voltage-gated calcium channel [GO:0090676]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle cell fate commitment [GO:0060923]; cell proliferation in forebrain [GO:0021846]; cell proliferation in midbrain [GO:0033278]; cell-cell signaling [GO:0007267]; COP9 signalosome assembly [GO:0010387]; determination of left/right symmetry [GO:0007368]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; extracellular matrix organization [GO:0030198]; fat cell differentiation [GO:0045444]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mesoderm development [GO:0007498]; midbrain development [GO:0030901]; modulation of chemical synaptic transmission [GO:0050804]; myoblast differentiation [GO:0045445]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron projection development [GO:0010977]; neurogenesis [GO:0022008]; non-canonical Wnt signaling pathway [GO:0035567]; osteoblast differentiation [GO:0001649]; paraxial mesodermal cell fate commitment [GO:0048343]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of cytokine production [GO:0001819]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of mesodermal cell fate specification [GO:0048337]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of receptor internalization [GO:0002092]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; protein localization [GO:0008104]; regulation of axonogenesis [GO:0050770]; regulation of cell differentiation [GO:0045595]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of postsynapse to nucleus signaling pathway [GO:1905539]; regulation of presynapse assembly [GO:1905606]; regulation of RNA biosynthetic process [GO:2001141]; secondary palate development [GO:0062009]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; somitogenesis [GO:0001756]; spinal cord association neuron differentiation [GO:0021527]; transcription by RNA polymerase II [GO:0006366]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874],cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851],co-receptor binding [GO:0039706]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713],GO:0002376; GO:0005576; GO:0005615; GO:0006351; GO:0006355; GO:0007155; GO:0023052; GO:0030154; GO:0030198; GO:0048018; GO:0048856; GO:0055085; GO:0060090; GO:0065003; GO:0098772; GO:0140110,immune system process; extracellular region; extracellular space; DNA-templated transcription; regulation of DNA-templated transcription; cell adhesion; signaling; cell differentiation; extracellular matrix organization; receptor ligand activity; anatomical structure development; transmembrane transport; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity; transcription regulator activity
OG_11588,FUN_017789-T1,Peve_00015143,,apul_peve,40.517,,,,,,,,,,,,,,,,,
OG_11589,FUN_017793-T1,Peve_00040538,,apul_peve,62.953,FUN_017793-T1,E7F7V7,,,,,26.0,342.0,3.5e-11,70.9,sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1,,,,,,
OG_11590,FUN_017794-T1,Peve_00034852,,apul_peve,64.11,,,,,,,,,,,,,,,,,
OG_11591,FUN_017797-T1,Peve_00015559,,apul_peve,58.656,,,,,,,,,,,,,,,,,
OG_11592,FUN_017802-T1,Peve_00040754,,apul_peve,47.974,FUN_017802-T1,P20905,,,,,29.8,181.0,1.8e-15,85.9,sp|P20905|5HT1R_DROME 5-hydroxytryptamine receptor 1 OS=Drosophila melanogaster OX=7227 GN=5-HT7 PE=2 SV=1,,,,,,
OG_11593,FUN_017805-T1,Peve_00040749,,apul_peve,59.866,FUN_017805-T1,O13018,,,,,34.4,285.0,7.7e-40,166.0,sp|O13018|OPSO_SALSA Vertebrate ancient opsin OS=Salmo salar OX=8030 PE=1 SV=1,,,,,,
OG_11594,FUN_017817-T1,Peve_00033198,,apul_peve,37.879,,,,,,,,,,,,,,,,,
OG_11595,FUN_017838-T1,Peve_00011464,,apul_peve,68.666,FUN_017838-T1,Q9UPV9,,,,,26.8,537.0,4.3e-21,105.1,sp|Q9UPV9|TRAK1_HUMAN Trafficking kinesin-binding protein 1 OS=Homo sapiens OX=9606 GN=TRAK1 PE=1 SV=1,,,,,,
OG_11596,FUN_017842-T1,Peve_00016637,,apul_peve,59.761,FUN_017842-T1,Q5EA66,ANGL7_BOVIN,,Angiopoietin-related protein 7 (Angiopoietin-like protein 7),Bos taurus (Bovine),40.7,268.0,1.1999999999999999e-46,189.1,sp|Q5EA66|ANGL7_BOVIN Angiopoietin-related protein 7 OS=Bos taurus OX=9913 GN=ANGPTL7 PE=2 SV=1,GO:0005576; GO:0005615; GO:0007596; GO:0042802; GO:0062023; GO:1901346; GO:1903053,blood coagulation [GO:0007596]; negative regulation of vasculature development involved in avascular cornea development in camera-type eye [GO:1901346]; regulation of extracellular matrix organization [GO:1903053],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615],identical protein binding [GO:0042802],GO:0005576; GO:0005615,extracellular region; extracellular space
OG_11597,FUN_017863-T1,Peve_00032145,,apul_peve,60.159,,,,,,,,,,,,,,,,,
OG_11598,FUN_017875-T1,Peve_00013941,,apul_peve,47.601,FUN_017875-T1,P41983,,,,,23.0,278.0,4e-07,57.0,sp|P41983|MC5R_SHEEP Melanocortin receptor 5 OS=Ovis aries OX=9940 GN=MC5R PE=3 SV=1,,,,,,
OG_11599,FUN_017876-T1,Peve_00000374,,apul_peve,57.988,,,,,,,,,,,,,,,,,
OG_11600,FUN_017877-T1,Peve_00038917,,apul_peve,46.732,,,,,,,,,,,,,,,,,
OG_11601,FUN_017879-T1,Peve_00001601,,apul_peve,47.037,FUN_017879-T1,Q16950,,,,,35.7,126.0,3.3e-07,57.4,sp|Q16950|5HTB1_APLCA 5-hydroxytryptamine receptor 1 OS=Aplysia californica OX=6500 GN=5HTB1 PE=2 SV=1,,,,,,
OG_11602,FUN_017880-T1,Peve_00001923,,apul_peve,64.733,FUN_017880-T1,Q9VH19,LMLN_DROME,,Leishmanolysin-like peptidase (EC 3.4.24.-) (Invadolysin),Drosophila melanogaster (Fruit fly),41.7,631.0,2.2e-136,487.6,sp|Q9VH19|LMLN_DROME Leishmanolysin-like peptidase OS=Drosophila melanogaster OX=7227 GN=Invadolysin PE=2 SV=2,GO:0004222; GO:0005737; GO:0006338; GO:0006508; GO:0007052; GO:0007076; GO:0007100; GO:0007155; GO:0007420; GO:0007444; GO:0008233; GO:0008354; GO:0008406; GO:0016020; GO:0019915; GO:0022900; GO:0045842; GO:0046872; GO:0051298; GO:0051301; GO:0051881,brain development [GO:0007420]; cell adhesion [GO:0007155]; cell division [GO:0051301]; centrosome duplication [GO:0051298]; chromatin remodeling [GO:0006338]; electron transport chain [GO:0022900]; germ cell migration [GO:0008354]; gonad development [GO:0008406]; imaginal disc development [GO:0007444]; lipid storage [GO:0019915]; mitotic centrosome separation [GO:0007100]; mitotic chromosome condensation [GO:0007076]; mitotic spindle organization [GO:0007052]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteolysis [GO:0006508]; regulation of mitochondrial membrane potential [GO:0051881],cytoplasm [GO:0005737]; membrane [GO:0016020],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233],GO:0003824; GO:0006091; GO:0006325; GO:0007010; GO:0007155; GO:0016787; GO:0022414; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; generation of precursor metabolites and energy; chromatin organization; cytoskeleton organization; cell adhesion; hydrolase activity; reproductive process; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_11603,FUN_017883-T1,Peve_00001919,,apul_peve,84.422,FUN_017883-T1,Q7TT50,,,,,56.8,952.0,1.6e-202,708.0,sp|Q7TT50|MRCKB_MOUSE Serine/threonine-protein kinase MRCK beta OS=Mus musculus OX=10090 GN=Cdc42bpb PE=1 SV=2,,,,,,
OG_11604,FUN_017894-T2,Peve_00000240,,apul_peve,57.336,FUN_017894-T2,Q09328,MGT5A_HUMAN,,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]",Homo sapiens (Human),42.0,636.0,3e-138,493.8,"sp|Q09328|MGT5A_HUMAN Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Homo sapiens OX=9606 GN=MGAT5 PE=1 SV=1",GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1904894,positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]",GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_11605,FUN_017909-T1,Peve_00023226,,apul_peve,70.474,,,,,,,,,,,,,,,,,
OG_11606,FUN_017931-T2,Peve_00001594,,apul_peve,55.5065,FUN_017931-T2,Q9NZM3,,,,,26.4,390.0,6.3e-21,105.5,sp|Q9NZM3|ITSN2_HUMAN Intersectin-2 OS=Homo sapiens OX=9606 GN=ITSN2 PE=1 SV=3,,,,,,
OG_11607,FUN_017942-T1,Peve_00001584,,apul_peve,52.126000000000005,FUN_017942-T1,P0CB49,,,,,55.0,338.0,2.5e-91,339.3,sp|P0CB49|YLPM1_RAT YLP motif-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Ylpm1 PE=1 SV=1,,,,,,
OG_11608,FUN_017989-T1,Peve_00023902,,apul_peve,58.617,FUN_017989-T1,Q9P2E3,ZNFX1_HUMAN,,NFX1-type zinc finger-containing protein 1,Homo sapiens (Human),38.8,1881.0,4.2e-262,906.7,sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2,GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0006325; GO:0016853; GO:0031047; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; chromatin organization; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; defense response to other organism; ATP-dependent activity
OG_11609,FUN_017994-T1,Peve_00044835,,apul_peve,49.091,FUN_017994-T1,Q9XWB9,,,,,34.1,164.0,9.2e-18,92.4,sp|Q9XWB9|BAT36_CAEEL BTB and MATH domain-containing protein 36 OS=Caenorhabditis elegans OX=6239 GN=bath-36 PE=4 SV=1,,,,,,
OG_11610,FUN_017996-T1,Peve_00023911,,apul_peve,52.709,FUN_017996-T1,Q20681,,,,,32.3,130.0,5.3e-11,69.7,sp|Q20681|BAT38_CAEEL BTB and MATH domain-containing protein 38 OS=Caenorhabditis elegans OX=6239 GN=bath-38 PE=4 SV=1,,,,,,
OG_11611,FUN_018001-T1,Peve_00044837,,apul_peve,81.132,FUN_018001-T1,Q13257,,,,,56.2,208.0,1e-58,228.0,sp|Q13257|MD2L1_HUMAN Mitotic spindle assembly checkpoint protein MAD2A OS=Homo sapiens OX=9606 GN=MAD2L1 PE=1 SV=1,,,,,,
OG_11612,FUN_018003-T1,Peve_00044830,,apul_peve,62.425,FUN_018003-T1,Q9H501,,,,,49.2,565.0,6.2e-84,313.5,sp|Q9H501|ESF1_HUMAN ESF1 homolog OS=Homo sapiens OX=9606 GN=ESF1 PE=1 SV=1,,,,,,
OG_11613,FUN_018020-T1,Peve_00005732,,apul_peve,86.245,FUN_018020-T1,O88327,,,,,41.0,497.0,3.1999999999999996e-90,334.0,sp|O88327|CTNL1_MOUSE Alpha-catulin OS=Mus musculus OX=10090 GN=Ctnnal1 PE=1 SV=1,,,,,,
OG_11614,FUN_018028-T1,Peve_00017617,,apul_peve,56.875,FUN_018028-T1,Q8TC26,,,,,32.3,217.0,1.5e-19,98.2,sp|Q8TC26|TM163_HUMAN Transmembrane protein 163 OS=Homo sapiens OX=9606 GN=TMEM163 PE=1 SV=1,,,,,,
OG_11615,FUN_018032-T1,Peve_00023694,,apul_peve,33.665,,,,,,,,,,,,,,,,,
OG_11616,FUN_018041-T1,Peve_00024070,,apul_peve,59.747,,,,,,,,,,,,,,,,,
OG_11617,FUN_018055-T1,Peve_00007551,,apul_peve,38.0425,,,,,,,,,,,,,,,,,
OG_11618,FUN_018058-T1,Peve_00030522,,apul_peve,70.225,,,,,,,,,,,,,,,,,
OG_11619,FUN_018123-T1,Peve_00001669,,apul_peve,63.2,FUN_018123-T1,Q8WMP9,,,,,42.5,388.0,7.9e-92,339.0,sp|Q8WMP9|PAG15_BOVIN Lysosomal phospholipase A and acyltransferase OS=Bos taurus OX=9913 GN=PLA2G15 PE=1 SV=1,,,,,,
OG_11620,FUN_018131-T1,Peve_00001002,,apul_peve,56.571,,,,,,,,,,,,,,,,,
OG_11621,FUN_018132-T1,Peve_00028961,,apul_peve,41.709,,,,,,,,,,,,,,,,,
OG_11622,FUN_018133-T1,Peve_00023223,,apul_peve,41.322,,,,,,,,,,,,,,,,,
OG_11623,FUN_018134-T1,Peve_00003765,,apul_peve,77.13,,,,,,,,,,,,,,,,,
OG_11624,FUN_018135-T1,Peve_00003756,,apul_peve,76.419,,,,,,,,,,,,,,,,,
OG_11625,FUN_018137-T2,Peve_00001659,,apul_peve,71.91,FUN_018137-T2,Q8MSF5,,,,,48.4,91.0,8.8e-15,80.9,sp|Q8MSF5|RNK_DROME Ribonuclease kappa OS=Drosophila melanogaster OX=7227 GN=RNASEK PE=3 SV=1,,,,,,
OG_11626,FUN_018166-T1,Peve_00023532,,apul_peve,97.516,,,,,,,,,,,,,,,,,
OG_11627,FUN_018224-T1,Peve_00028392,,apul_peve,55.44,,,,,,,,,,,,,,,,,
OG_11628,FUN_018259-T1,Peve_00011973,,apul_peve,74.648,,,,,,,,,,,,,,,,,
OG_11629,FUN_018262-T1,Peve_00003250,,apul_peve,96.833,,,,,,,,,,,,,,,,,
OG_11630,FUN_018263-T1,Peve_00024887,,apul_peve,53.097,,,,,,,,,,,,,,,,,
OG_11631,FUN_018298-T1,Peve_00021597,,apul_peve,51.363,FUN_018298-T1,Q8BQC3,,,,,31.5,149.0,1e-09,66.6,sp|Q8BQC3|IGDC3_MOUSE Immunoglobulin superfamily DCC subclass member 3 OS=Mus musculus OX=10090 GN=Igdcc3 PE=2 SV=1,,,,,,
OG_11632,FUN_018319-T1,Peve_00041495,,apul_peve,62.557,FUN_018319-T1,Q8BQC3,,,,,32.4,213.0,2.5e-15,85.5,sp|Q8BQC3|IGDC3_MOUSE Immunoglobulin superfamily DCC subclass member 3 OS=Mus musculus OX=10090 GN=Igdcc3 PE=2 SV=1,,,,,,
OG_11633,FUN_018331-T1,Peve_00025911,,apul_peve,49.351,,,,,,,,,,,,,,,,,
OG_11634,FUN_018334-T1,Peve_00019127,,apul_peve,64.784,FUN_018334-T1,Q8BQC3,,,,,37.0,92.0,1.2e-06,56.2,sp|Q8BQC3|IGDC3_MOUSE Immunoglobulin superfamily DCC subclass member 3 OS=Mus musculus OX=10090 GN=Igdcc3 PE=2 SV=1,,,,,,
OG_11635,FUN_018394-T1,Peve_00031704,,apul_peve,62.288,,,,,,,,,,,,,,,,,
OG_11636,FUN_018400-T1,Peve_00003132,,apul_peve,64.176,FUN_018400-T1,Q96DZ1,ERLEC_HUMAN,,Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin) (XTP3-transactivated gene B protein),Homo sapiens (Human),39.0,459.0,2.5e-91,337.4,sp|Q96DZ1|ERLEC_HUMAN Endoplasmic reticulum lectin 1 OS=Homo sapiens OX=9606 GN=ERLEC1 PE=1 SV=1,GO:0005788; GO:0030968; GO:0030970; GO:0036503; GO:0044322; GO:0051082; GO:1904153,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; retrograde protein transport, ER to cytosol [GO:0030970]",endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322],unfolded protein binding [GO:0051082],GO:0006886; GO:0030163,intracellular protein transport; protein catabolic process
OG_11637,FUN_018413-T1,Peve_00031695,,apul_peve,43.651,,,,,,,,,,,,,,,,,
OG_11638,FUN_018415-T1,Peve_00031693,,apul_peve,74.219,,,,,,,,,,,,,,,,,
OG_11639,FUN_018421-T1,Peve_00035861,,apul_peve,36.741,FUN_018421-T1,P86982,,,,,40.0,150.0,5e-19,96.7,sp|P86982|IMSP1_RUDPH Insoluble matrix shell protein 1 (Fragment) OS=Ruditapes philippinarum OX=129788 PE=1 SV=1,,,,,,
OG_11640,FUN_018480-T1,Peve_00015701,,apul_peve,62.847,,,,,,,,,,,,,,,,,
OG_11641,FUN_018524-T1,Peve_00034175,,apul_peve,36.8865,,,,,,,,,,,,,,,,,
OG_11642,FUN_018528-T1,Peve_00039206,,apul_peve,57.622,FUN_018528-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),42.2,351.0,1.4e-88,330.5,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_11643,FUN_018534-T1,Peve_00039200,,apul_peve,51.309,FUN_018534-T1,Q2M3R5,S35G1_HUMAN,,Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20),Homo sapiens (Human),37.4,297.0,2.1000000000000005e-44,181.4,sp|Q2M3R5|S35G1_HUMAN Solute carrier family 35 member G1 OS=Homo sapiens OX=9606 GN=SLC35G1 PE=1 SV=1,GO:0005789; GO:0005886; GO:0051480; GO:1990034,calcium ion export across plasma membrane [GO:1990034]; regulation of cytosolic calcium ion concentration [GO:0051480],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],,GO:0005886; GO:0055085,plasma membrane; transmembrane transport
OG_11644,FUN_018547-T1,Peve_00003124,,apul_peve,62.324,FUN_018547-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),42.8,362.0,5.1e-89,330.1,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_11645,FUN_018552-T1,Peve_00032309,,apul_peve,57.341,FUN_018552-T1,M9MRD1,,,,,18.0,3119.0,4.3e-11,75.1,sp|M9MRD1|MS300_DROME Muscle-specific protein 300 kDa OS=Drosophila melanogaster OX=7227 GN=Msp300 PE=1 SV=1,,,,,,
OG_11646,FUN_018600-T1,Peve_00035650,,apul_peve,45.988,FUN_018600-T1,Q0CSA1,,,,,27.9,427.0,1.6000000000000002e-23,112.1,sp|Q0CSA1|TAZG_ASPTN FAD-linked oxidoreductase tazG OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) OX=341663 GN=tazG PE=2 SV=1,,,,,,
OG_11647,FUN_018603-T1,Peve_00041793,,apul_peve,72.372,,,,,,,,,,,,,,,,,
OG_11648,FUN_018660-T1,Peve_00015911,,apul_peve,41.257000000000005,,,,,,,,,,,,,,,,,
OG_11649,FUN_018718-T1,Peve_00006139,,apul_peve,38.6725,,,,,,,,,,,,,,,,,
OG_11650,FUN_018759-T1,Peve_00010356,,apul_peve,35.7565,,,,,,,,,,,,,,,,,
OG_11651,FUN_018784-T1,Peve_00012998,,apul_peve,38.9845,FUN_018784-T1,Q86W26,NAL10_HUMAN,,"NACHT, LRR and PYD domains-containing protein 10 (Nucleotide-binding oligomerization domain protein 8)",Homo sapiens (Human),25.8,368.0,2.4e-12,77.4,"sp|Q86W26|NAL10_HUMAN NACHT, LRR and PYD domains-containing protein 10 OS=Homo sapiens OX=9606 GN=NLRP10 PE=1 SV=1",GO:0002218; GO:0002250; GO:0002827; GO:0003924; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0009898; GO:0016887; GO:0031965; GO:0032730; GO:0032755; GO:0032757; GO:0045087; GO:0050727; GO:0050729; GO:0050832; GO:1900426; GO:2000318,activation of innate immune response [GO:0002218]; adaptive immune response [GO:0002250]; defense response to fungus [GO:0050832]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of T-helper 17 type immune response [GO:2000318]; regulation of inflammatory response [GO:0050727],cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; GTPase activity [GO:0003924],GO:0002376; GO:0003824; GO:0003924; GO:0005654; GO:0005829; GO:0006954; GO:0016787; GO:0098542,immune system process; catalytic activity; GTPase activity; nucleoplasm; cytosol; inflammatory response; hydrolase activity; defense response to other organism
OG_11652,FUN_018786-T1,Peve_00036140,,apul_peve,43.447,,,,,,,,,,,,,,,,,
OG_11653,FUN_018798-T1,Peve_00023612,,apul_peve,46.062,FUN_018798-T1,Q6XHB2,ROCO4_DICDI,,Probable serine/threonine-protein kinase roco4 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 4),Dictyostelium discoideum (Social amoeba),25.0,424.0,1.8e-13,80.1,sp|Q6XHB2|ROCO4_DICDI Probable serine/threonine-protein kinase roco4 OS=Dictyostelium discoideum OX=44689 GN=roco4 PE=1 SV=1,GO:0000302; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006120; GO:0007165; GO:0031150; GO:0042331; GO:0106310,"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; phototaxis [GO:0042331]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]; sorocarp stalk development [GO:0031150]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005739; GO:0005829; GO:0006091; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; generation of precursor metabolites and energy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_11654,FUN_018817-T1,Peve_00027714,,apul_peve,40.625,,,,,,,,,,,,,,,,,
OG_11655,FUN_018826-T1,Peve_00001312,,apul_peve,45.7075,FUN_018826-T1,Q6E2N3,TRI33_DANRE,,E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (Protein moonshine) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33),Danio rerio (Zebrafish) (Brachydanio rerio),27.1,218.0,1.7e-21,106.3,sp|Q6E2N3|TRI33_DANRE E3 ubiquitin-protein ligase TRIM33 OS=Danio rerio OX=7955 GN=trim33 PE=2 SV=1,GO:0000785; GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740; GO:0030218; GO:0030593; GO:0033333; GO:0034243; GO:0035162; GO:0035166; GO:0048066; GO:0048246; GO:0060215; GO:1905517; GO:1990266,developmental pigmentation [GO:0048066]; embryonic hemopoiesis [GO:0035162]; erythrocyte differentiation [GO:0030218]; fin development [GO:0033333]; macrophage chemotaxis [GO:0048246]; macrophage migration [GO:1905517]; neutrophil chemotaxis [GO:0030593]; neutrophil migration [GO:1990266]; post-embryonic hemopoiesis [GO:0035166]; primitive hemopoiesis [GO:0060215]; protein ubiquitination [GO:0016567]; regulation of transcription elongation by RNA polymerase II [GO:0034243],chromatin [GO:0000785]; nucleus [GO:0005634],DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0048870,immune system process; DNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; anatomical structure development; cell motility
OG_11656,FUN_018829-T1,Peve_00012537,,apul_peve,77.7935,,,,,,,,,,,,,,,,,
OG_11657,FUN_018837-T1,Peve_00038666,,apul_peve,63.81,,,,,,,,,,,,,,,,,
OG_11658,FUN_018844-T1,Peve_00010303,,apul_peve,53.125,FUN_018844-T1,Q9D1M0,SEC13_MOUSE,,Protein SEC13 homolog (GATOR2 complex protein SEC13) (SEC13-like protein 1) (SEC13-related protein),Mus musculus (Mouse),56.7,60.0,4.4e-10,67.0,sp|Q9D1M0|SEC13_MOUSE Protein SEC13 homolog OS=Mus musculus OX=10090 GN=Sec13 PE=1 SV=3,GO:0000776; GO:0005198; GO:0005635; GO:0005643; GO:0005654; GO:0005765; GO:0005783; GO:0005789; GO:0006888; GO:0006913; GO:0030127; GO:0031080; GO:0031669; GO:0032527; GO:0042802; GO:0051028; GO:0061700; GO:0072659; GO:0090110; GO:1904263,cellular response to nutrient levels [GO:0031669]; COPII-coated vesicle cargo loading [GO:0090110]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659],COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654],identical protein binding [GO:0042802]; structural molecule activity [GO:0005198],GO:0005198; GO:0005635; GO:0005654; GO:0005783; GO:0006886; GO:0006913; GO:0016192; GO:0043226; GO:0072659,structural molecule activity; nuclear envelope; nucleoplasm; endoplasmic reticulum; intracellular protein transport; nucleocytoplasmic transport; vesicle-mediated transport; organelle; protein localization to plasma membrane
OG_11659,FUN_018846-T1,Peve_00039337,,apul_peve,96.774,,,,,,,,,,,,,,,,,
OG_11660,FUN_018855-T1,Peve_00034553,,apul_peve,36.408,,,,,,,,,,,,,,,,,
OG_11661,FUN_018868-T1,Peve_00041905,,apul_peve,35.74,,,,,,,,,,,,,,,,,
OG_11662,FUN_018920-T1,Peve_00027036,,apul_peve,41.014,,,,,,,,,,,,,,,,,
OG_11663,FUN_018921-T1,Peve_00027564,,apul_peve,94.937,,,,,,,,,,,,,,,,,
OG_11664,FUN_018924-T1,Peve_00001892,,apul_peve,69.063,,,,,,,,,,,,,,,,,
OG_11665,FUN_018925-T2,Peve_00001110,,apul_peve,45.875,,,,,,,,,,,,,,,,,
OG_11666,FUN_018935-T1,Peve_00000251,,apul_peve,79.167,,,,,,,,,,,,,,,,,
OG_11667,FUN_018951-T1,Peve_00007068,,apul_peve,83.168,,,,,,,,,,,,,,,,,
OG_11668,FUN_018967-T1,Peve_00042879,,apul_peve,32.075,,,,,,,,,,,,,,,,,
OG_11669,FUN_018987-T1,Peve_00018708,,apul_peve,74.522,,,,,,,,,,,,,,,,,
OG_11670,FUN_018992-T1,Peve_00042584,,apul_peve,70.526,,,,,,,,,,,,,,,,,
OG_11671,FUN_018995-T1,Peve_00001396,,apul_peve,63.158,,,,,,,,,,,,,,,,,
OG_11672,FUN_019009-T1,Peve_00030814,,apul_peve,64.912,,,,,,,,,,,,,,,,,
OG_11673,FUN_019010-T1,Peve_00030813,,apul_peve,47.262,,,,,,,,,,,,,,,,,
OG_11674,FUN_019020-T1,Peve_00026057,,apul_peve,66.355,,,,,,,,,,,,,,,,,
OG_11675,FUN_019021-T1,Peve_00002983,,apul_peve,66.299,FUN_019021-T1,Q8N539,FBCD1_HUMAN,,Fibrinogen C domain-containing protein 1,Homo sapiens (Human),52.4,212.0,4.9999999999999996e-57,224.6,sp|Q8N539|FBCD1_HUMAN Fibrinogen C domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FIBCD1 PE=1 SV=2,GO:0005615; GO:0008061; GO:0016020; GO:0046872; GO:0062023,,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; membrane [GO:0016020],chitin binding [GO:0008061]; metal ion binding [GO:0046872],GO:0005615,extracellular space
OG_11676,FUN_019035-T1,Peve_00023067,,apul_peve,53.659,,,,,,,,,,,,,,,,,
OG_11677,FUN_019043-T1,Peve_00020748,,apul_peve,41.522,,,,,,,,,,,,,,,,,
OG_11678,FUN_019075-T1,Peve_00026790,,apul_peve,37.838,,,,,,,,,,,,,,,,,
OG_11679,FUN_019089-T1,Peve_00022849,,apul_peve,39.773,,,,,,,,,,,,,,,,,
OG_11680,FUN_019095-T1,Peve_00003428,,apul_peve,87.5,,,,,,,,,,,,,,,,,
OG_11681,FUN_019100-T1,Peve_00004211,,apul_peve,73.626,,,,,,,,,,,,,,,,,
OG_11682,FUN_019259-T1,Peve_00010052,,apul_peve,72.934,FUN_019259-T1,Q3KQG9,,,,,40.8,358.0,1.6e-73,278.1,sp|Q3KQG9|PPAT_XENLA Testicular acid phosphatase homolog OS=Xenopus laevis OX=8355 GN=acp4 PE=2 SV=1,,,,,,
OG_11683,FUN_019282-T1,Peve_00035687,,apul_peve,74.876,,,,,,,,,,,,,,,,,
OG_11684,FUN_019300-T1,Peve_00022429,,apul_peve,67.0,,,,,,,,,,,,,,,,,
OG_11685,FUN_019343-T1,Peve_00032925,,apul_peve,65.485,FUN_019343-T1,Q63016,LAT1_RAT,,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (Integral membrane protein E16) (Protein TA1) (L-type amino acid transporter 1) (LAT-1) (Solute carrier family 7 member 5),Rattus norvegicus (Rat),39.3,484.0,2.8000000000000002e-89,330.9,sp|Q63016|LAT1_RAT Large neutral amino acids transporter small subunit 1 OS=Rattus norvegicus OX=10116 GN=Slc7a5 PE=1 SV=2,GO:0003333; GO:0005765; GO:0005829; GO:0005886; GO:0009925; GO:0010507; GO:0010629; GO:0014850; GO:0015171; GO:0015173; GO:0015175; GO:0015179; GO:0015190; GO:0015196; GO:0015297; GO:0015349; GO:0015804; GO:0015807; GO:0015818; GO:0015820; GO:0015821; GO:0015823; GO:0015824; GO:0015827; GO:0015828; GO:0015829; GO:0016020; GO:0016323; GO:0016324; GO:0031528; GO:0032328; GO:0032729; GO:0032740; GO:0032753; GO:0042149; GO:0042605; GO:0042908; GO:0055093; GO:0060252; GO:0070327; GO:0071222; GO:0071230; GO:0089718; GO:0097421; GO:0098591; GO:1902024; GO:1903577; GO:1903801; GO:1904556; GO:1905460; GO:1905534; GO:1990184,alanine transport [GO:0032328]; amino acid import across plasma membrane [GO:0089718]; amino acid transmembrane transport [GO:0003333]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to L-arginine [GO:1903577]; cellular response to lipopolysaccharide [GO:0071222]; isoleucine transport [GO:0015818]; L-amino acid transport [GO:0015807]; L-histidine transport [GO:1902024]; L-leucine import across plasma membrane [GO:1903801]; L-leucine transport [GO:0015820]; L-tryptophan transmembrane transport [GO:1904556]; liver regeneration [GO:0097421]; methionine transport [GO:0015821]; negative regulation of autophagy [GO:0010507]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; neutral amino acid transport [GO:0015804]; phenylalanine transport [GO:0015823]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of L-leucine import across plasma membrane [GO:1905534]; positive regulation of type II interferon production [GO:0032729]; proline transport [GO:0015824]; response to hyperoxia [GO:0055093]; response to muscle activity [GO:0014850]; thyroid hormone transport [GO:0070327]; tryptophan transport [GO:0015827]; tyrosine transport [GO:0015828]; valine transport [GO:0015829]; xenobiotic transport [GO:0042908],amino acid transport complex [GO:1990184]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; external side of apical plasma membrane [GO:0098591]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; antiporter activity [GO:0015297]; aromatic amino acid transmembrane transporter activity [GO:0015173]; L-amino acid transmembrane transporter activity [GO:0015179]; L-leucine transmembrane transporter activity [GO:0015190]; L-tryptophan transmembrane transporter activity [GO:0015196]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; thyroid hormone transmembrane transporter activity [GO:0015349],GO:0005215; GO:0005829; GO:0005886; GO:0048856; GO:0055085,transporter activity; cytosol; plasma membrane; anatomical structure development; transmembrane transport
OG_11686,FUN_019349-T1,Peve_00013972,,apul_peve,55.008,FUN_019349-T1,Q10656,EGL15_CAEEL,,Myoblast growth factor receptor egl-15 (EC 2.7.10.1) (Egg-laying defective protein 15),Caenorhabditis elegans,26.6,707.0,1.1e-52,209.9,sp|Q10656|EGL15_CAEEL Myoblast growth factor receptor egl-15 OS=Caenorhabditis elegans OX=6239 GN=egl-15 PE=1 SV=1,GO:0002119; GO:0004672; GO:0004714; GO:0005524; GO:0005886; GO:0007517; GO:0008284; GO:0008543; GO:0016477; GO:0018991; GO:0031344; GO:0031647; GO:0043235; GO:0043410; GO:0046716; GO:0046872; GO:0048546,cell migration [GO:0016477]; digestive tract morphogenesis [GO:0048546]; egg-laying behavior [GO:0018991]; fibroblast growth factor receptor signaling pathway [GO:0008543]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; nematode larval development [GO:0002119]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of cell projection organization [GO:0031344]; regulation of protein stability [GO:0031647],plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005886; GO:0016740; GO:0022414; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; transferase activity; reproductive process; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_11687,FUN_019352-T1,Peve_00006367,,apul_peve,35.557500000000005,,,,,,,,,,,,,,,,,
OG_11688,FUN_019392-T1,Peve_00041804,,apul_peve,54.955,,,,,,,,,,,,,,,,,
OG_11689,FUN_019422-T1,Peve_00022941,,apul_peve,63.571,,,,,,,,,,,,,,,,,
OG_11690,FUN_019430-T1,Peve_00038545,,apul_peve,58.087,FUN_019430-T1,P9WMV8,,,,,24.6,590.0,3.6e-21,105.1,sp|P9WMV8|CHOD_MYCTO Cholesterol oxidase OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=choD PE=3 SV=1,,,,,,
OG_11691,FUN_019432-T1,Peve_00032899,,apul_peve,54.213,FUN_019432-T1,P98069,,,,,30.5,239.0,1.2e-23,112.5,sp|P98069|BMPH_STRPU Bone morphogenetic protein 1 homolog OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_11692,FUN_019436-T1,Peve_00010309,,apul_peve,50.316,,,,,,,,,,,,,,,,,
OG_11693,FUN_019453-T1,Peve_00012416,,apul_peve,57.088,,,,,,,,,,,,,,,,,
OG_11694,FUN_019472-T1,Peve_00018263,,apul_peve,38.793000000000006,,,,,,,,,,,,,,,,,
OG_11695,FUN_019473-T1,Peve_00007401,,apul_peve,63.427,,,,,,,,,,,,,,,,,
OG_11696,FUN_019477-T1,Peve_00022275,,apul_peve,32.051,,,,,,,,,,,,,,,,,
OG_11697,FUN_019495-T1,Peve_00045272,,apul_peve,30.769,,,,,,,,,,,,,,,,,
OG_11698,FUN_019518-T1,Peve_00021908,,apul_peve,61.724,FUN_019518-T1,Q5QD25,TAAR2_RAT,,Trace amine-associated receptor 2 (TaR-2) (Trace amine receptor 2) (G-protein coupled receptor 58),Rattus norvegicus (Rat),26.5,294.0,1.5e-07,58.5,sp|Q5QD25|TAAR2_RAT Trace amine-associated receptor 2 OS=Rattus norvegicus OX=10116 GN=Taar2 PE=2 SV=1,GO:0001594; GO:0005886; GO:0007186,G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],trace-amine receptor activity [GO:0001594],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_11699,FUN_019519-T1,Peve_00044259,,apul_peve,94.585,,,,,,,,,,,,,,,,,
OG_11700,FUN_019528-T1,Peve_00032806,,apul_peve,48.101,,,,,,,,,,,,,,,,,
OG_11701,FUN_019559-T3,Peve_00006777,,apul_peve,69.016,FUN_019559-T3,P09917,LOX5_HUMAN,,Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34),Homo sapiens (Human),26.9,484.0,1.9e-41,172.2,sp|P09917|LOX5_HUMAN Polyunsaturated fatty acid 5-lipoxygenase OS=Homo sapiens OX=9606 GN=ALOX5 PE=1 SV=2,GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016491; GO:0016525; GO:0016701; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301,arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426],cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774],"arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701]",GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005635; GO:0005654; GO:0005829; GO:0006629; GO:0016491; GO:0016787; GO:0048870,immune system process; catalytic activity; extracellular region; extracellular space; nuclear envelope; nucleoplasm; cytosol; lipid metabolic process; oxidoreductase activity; hydrolase activity; cell motility
OG_11702,FUN_019562-T1,Peve_00032908,,apul_peve,69.942,,,,,,,,,,,,,,,,,
OG_11703,FUN_019563-T1,Peve_00018787,,apul_peve,55.6,,,,,,,,,,,,,,,,,
OG_11704,FUN_019572-T1,Peve_00021592,,apul_peve,66.667,,,,,,,,,,,,,,,,,
OG_11705,FUN_019608-T1,Peve_00029501,,apul_peve,38.5195,,,,,,,,,,,,,,,,,
OG_11706,FUN_019622-T1,Peve_00042029,,apul_peve,73.134,,,,,,,,,,,,,,,,,
OG_11707,FUN_019688-T1,Peve_00016963,,apul_peve,39.855,,,,,,,,,,,,,,,,,
OG_11708,FUN_019770-T1,Peve_00035042,,apul_peve,49.128,,,,,,,,,,,,,,,,,
OG_11709,FUN_020597-T1,Peve_00011489,,apul_peve,51.926,,,,,,,,,,,,,,,,,
OG_11710,FUN_020735-T1,Peve_00032907,,apul_peve,95.556,FUN_020735-T1,Q9DAM2,EFCB9_MOUSE,,EF-hand calcium-binding domain-containing protein 9,Mus musculus (Mouse),47.7,149.0,1.4e-36,154.1,sp|Q9DAM2|EFCB9_MOUSE EF-hand calcium-binding domain-containing protein 9 OS=Mus musculus OX=10090 GN=Efcab9 PE=1 SV=2,GO:0005509; GO:0005516; GO:0005737; GO:0007283; GO:0030317; GO:0036128; GO:0048240; GO:0061891; GO:0097228,flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283],CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228],calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calmodulin binding [GO:0005516],GO:0007018; GO:0022414; GO:0048870; GO:0098772; GO:0140299,microtubule-based movement; reproductive process; cell motility; molecular function regulator activity; molecular sensor activity
OG_11711,FUN_020737-T1,Peve_00036135,,apul_peve,68.0,,,,,,,,,,,,,,,,,
OG_11712,FUN_020755-T1,Peve_00024996,,apul_peve,87.915,,,,,,,,,,,,,,,,,
OG_11713,FUN_020781-T1,Peve_00024079,,apul_peve,59.935,FUN_020781-T1,Q8LBW2,,,,,36.4,88.0,4.5e-07,57.8,sp|Q8LBW2|OTU9_ARATH OVARIAN TUMOR DOMAIN-containing deubiquitinating enzyme 9 OS=Arabidopsis thaliana OX=3702 GN=OTU9 PE=1 SV=1,,,,,,
OG_11714,FUN_020791-T1,Peve_00018101,,apul_peve,76.228,,,,,,,,,,,,,,,,,
OG_11715,FUN_020859-T1,Peve_00042260,,apul_peve,91.558,FUN_020859-T1,Q3SYK4,,,,,28.5,207.0,1.7e-14,82.0,sp|Q3SYK4|VRTN_MOUSE Vertnin OS=Mus musculus OX=10090 GN=Vrtn PE=2 SV=1,,,,,,
OG_11716,FUN_020896-T1,Peve_00042588,,apul_peve,62.731,FUN_020896-T1,Q8CIR4,TRPM6_MOUSE,,"Transient receptor potential cation channel subfamily M member 6 (EC 2.7.11.1) (Channel kinase 2) (Melastatin-related TRP cation channel 6) [Cleaved into: TRPM6 kinase, cleaved form]",Mus musculus (Mouse),24.2,269.0,1.8e-11,72.4,sp|Q8CIR4|TRPM6_MOUSE Transient receptor potential cation channel subfamily M member 6 OS=Mus musculus OX=10090 GN=Trpm6 PE=1 SV=1,GO:0004672; GO:0004674; GO:0005261; GO:0005262; GO:0005524; GO:0005634; GO:0009636; GO:0015095; GO:0016324; GO:0030001; GO:0031526; GO:0046872; GO:0051262; GO:0106310,metal ion transport [GO:0030001]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; nucleus [GO:0005634],ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; magnesium ion transmembrane transporter activity [GO:0015095]; metal ion binding [GO:0046872]; monoatomic cation channel activity [GO:0005261]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005215; GO:0005634; GO:0016740; GO:0043226; GO:0065003; GO:0140096,"catalytic activity; transporter activity; nucleus; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_11717,FUN_020901-T1,Peve_00034735,,apul_peve,65.8655,,,,,,,,,,,,,,,,,
OG_11718,FUN_020903-T1,Peve_00033628,,apul_peve,49.087,,,,,,,,,,,,,,,,,
OG_11719,FUN_020912-T1,Peve_00017980,,apul_peve,40.0745,,,,,,,,,,,,,,,,,
OG_11720,FUN_020918-T1,Peve_00024031,,apul_peve,32.432,,,,,,,,,,,,,,,,,
OG_11721,FUN_020921-T1,Peve_00019454,,apul_peve,56.643,,,,,,,,,,,,,,,,,
OG_11722,FUN_020923-T1,Peve_00019457,,apul_peve,53.191,,,,,,,,,,,,,,,,,
OG_11723,FUN_020975-T1,Peve_00044568,,apul_peve,40.541,,,,,,,,,,,,,,,,,
OG_11724,FUN_020976-T1,Peve_00017101,,apul_peve,50.0,,,,,,,,,,,,,,,,,
OG_11725,FUN_021033-T1,Peve_00035060,,apul_peve,87.9485,,,,,,,,,,,,,,,,,
OG_11726,FUN_021048-T1,Peve_00017987,,apul_peve,58.219,,,,,,,,,,,,,,,,,
OG_11727,FUN_021112-T1,Peve_00039167,,apul_peve,81.527,FUN_021112-T1,O64894,,,,,33.0,625.0,3.3e-84,314.3,"sp|O64894|ACOX2_CUCMA Acyl-coenzyme A oxidase, peroxisomal OS=Cucurbita maxima OX=3661 GN=Acx PE=1 SV=1",,,,,,
OG_11728,FUN_021122-T1,Peve_00011339,,apul_peve,53.548,,,,,,,,,,,,,,,,,
OG_11729,FUN_021145-T1,Peve_00006184,,apul_peve,47.253,,,,,,,,,,,,,,,,,
OG_11730,FUN_021181-T1,Peve_00030983,,apul_peve,44.56,,,,,,,,,,,,,,,,,
OG_11731,FUN_021190-T1,Peve_00021632,,apul_peve,73.684,,,,,,,,,,,,,,,,,
OG_11732,FUN_021194-T2,Peve_00032628,,apul_peve,64.47399999999999,FUN_021194-T2,Q5REX6,CK5P3_PONAB,,CDK5 regulatory subunit-associated protein 3,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),50.4,228.0,8.5e-56,218.8,sp|Q5REX6|CK5P3_PONAB CDK5 regulatory subunit-associated protein 3 OS=Pongo abelii OX=9601 GN=CDK5RAP3 PE=2 SV=1,GO:0001889; GO:0001933; GO:0005634; GO:0005737; GO:0005789; GO:0005813; GO:0007095; GO:0008283; GO:0010921; GO:0030262; GO:0030968; GO:0031398; GO:0032088; GO:0032790; GO:0034976; GO:0042177; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0060318; GO:0071569; GO:0071901; GO:0140501; GO:1900182; GO:1901798; GO:1990756,apoptotic nuclear changes [GO:0030262]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of reticulophagy [GO:0140501]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein ufmylation [GO:0071569]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]; ribosome disassembly [GO:0032790],centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-like protein ligase binding [GO:0044389],GO:0005634; GO:0005815; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090,nucleus; microtubule organizing center; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity
OG_11733,FUN_021450-T1,Peve_00016697,,apul_peve,74.324,,,,,,,,,,,,,,,,,
OG_11734,FUN_021453-T1,Peve_00037432,,apul_peve,48.238,FUN_021453-T1,Q60519,SEM5B_MOUSE,,Semaphorin-5B (Semaphorin-G) (Sema G),Mus musculus (Mouse),57.4,54.0,2.3e-09,66.2,sp|Q60519|SEM5B_MOUSE Semaphorin-5B OS=Mus musculus OX=10090 GN=Sema5b PE=2 SV=2,GO:0016020; GO:0030215; GO:0048675; GO:0050908; GO:0097485; GO:1990138,axon extension [GO:0048675]; detection of light stimulus involved in visual perception [GO:0050908]; neuron projection extension [GO:1990138]; neuron projection guidance [GO:0097485],membrane [GO:0016020],semaphorin receptor binding [GO:0030215],,
OG_11735,FUN_021469-T1,Peve_00013047,,apul_peve,50.0,,,,,,,,,,,,,,,,,
OG_11736,FUN_021470-T1,Peve_00002283,,apul_peve,56.291,,,,,,,,,,,,,,,,,
OG_11737,FUN_021798-T1,Peve_00045313,,apul_peve,81.2885,,,,,,,,,,,,,,,,,
OG_11738,FUN_021799-T1,Peve_00035908,,apul_peve,79.024,,,,,,,,,,,,,,,,,
OG_11739,FUN_021812-T1,Peve_00005854,,apul_peve,37.681,,,,,,,,,,,,,,,,,
OG_11740,FUN_021815-T1,Peve_00034261,,apul_peve,77.907,,,,,,,,,,,,,,,,,
OG_11741,FUN_021828-T1,Peve_00045202,,apul_peve,33.762,,,,,,,,,,,,,,,,,
OG_11742,FUN_021830-T1,Peve_00045284,,apul_peve,72.804,,,,,,,,,,,,,,,,,
OG_11743,FUN_021834-T1,Peve_00009165,,apul_peve,46.875,,,,,,,,,,,,,,,,,
OG_11744,FUN_021940-T2,Peve_00023929,,apul_peve,75.985,FUN_021940-T2,Q8VBW1,SC6A8_MOUSE,,Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8),Mus musculus (Mouse),52.5,560.0,7.1e-179,628.6,sp|Q8VBW1|SC6A8_MOUSE Sodium- and chloride-dependent creatine transporter 1 OS=Mus musculus OX=10090 GN=Slc6a8 PE=1 SV=2,GO:0005309; GO:0006836; GO:0015881; GO:0016324,creatine transmembrane transport [GO:0015881]; neurotransmitter transport [GO:0006836],apical plasma membrane [GO:0016324],creatine:sodium symporter activity [GO:0005309],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_11745,FUN_021944-T1,Peve_00022504,,apul_peve,63.303,,,,,,,,,,,,,,,,,
OG_11746,FUN_021959-T1,Peve_00010126,,apul_peve,83.459,,,,,,,,,,,,,,,,,
OG_11747,FUN_021966-T1,Peve_00026890,,apul_peve,53.659,,,,,,,,,,,,,,,,,
OG_11748,FUN_021973-T1,Peve_00029001,,apul_peve,63.265,,,,,,,,,,,,,,,,,
OG_11749,FUN_021974-T1,Peve_00028999,,apul_peve,76.392,,,,,,,,,,,,,,,,,
OG_11750,FUN_021978-T1,Peve_00008367,,apul_peve,70.199,,,,,,,,,,,,,,,,,
OG_11751,FUN_021984-T1,Peve_00036435,,apul_peve,31.2665,,,,,,,,,,,,,,,,,
OG_11752,FUN_021995-T1,Peve_00037230,,apul_peve,35.371,,,,,,,,,,,,,,,,,
OG_11753,FUN_021997-T1,Peve_00026694,,apul_peve,91.667,,,,,,,,,,,,,,,,,
OG_11754,FUN_021999-T1,Peve_00026612,,apul_peve,52.19,,,,,,,,,,,,,,,,,
OG_11755,FUN_022000-T1,Peve_00039769,,apul_peve,60.559,FUN_022000-T1,P10090,WHITE_DROME,,Protein white (EC 7.6.2.-) (EC 7.6.2.6) (ATP-binding cassette transporter sub-family G member white) (Broad substrate specificity ATP-binding cassette transporter white),Drosophila melanogaster (Fruit fly),43.3,635.0,5.7e-140,499.6,sp|P10090|WHITE_DROME Protein white OS=Drosophila melanogaster OX=7227 GN=w PE=1 SV=2,GO:0005275; GO:0005524; GO:0005886; GO:0006856; GO:0007613; GO:0008049; GO:0008558; GO:0015196; GO:0015208; GO:0015827; GO:0015842; GO:0015854; GO:0016887; GO:0022857; GO:0030659; GO:0031409; GO:0031410; GO:0032217; GO:0032218; GO:0042332; GO:0042401; GO:0042441; GO:0042626; GO:0042906; GO:0042907; GO:0048072; GO:0048770; GO:0051615; GO:0055085; GO:0070731; GO:0090741; GO:0098793; GO:1905948,aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; guanine transport [GO:0015854]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; riboflavin transport [GO:0032218]; transmembrane transport [GO:0055085]; tryptophan transport [GO:0015827]; xanthine transport [GO:0042906],cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; pigment granule [GO:0048770]; pigment granule membrane [GO:0090741]; plasma membrane [GO:0005886]; presynapse [GO:0098793],"ABC-type 3',5'-cyclic GMP transmembrane transporter activity [GO:1905948]; ABC-type guanine transporter activity [GO:0008558]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; guanine transmembrane transporter activity [GO:0015208]; L-tryptophan transmembrane transporter activity [GO:0015196]; pigment binding [GO:0031409]; riboflavin transmembrane transporter activity [GO:0032217]; transmembrane transporter activity [GO:0022857]; xanthine transmembrane transporter activity [GO:0042907]",GO:0003824; GO:0005215; GO:0005886; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0050877; GO:0055085; GO:0140657,catalytic activity; transporter activity; plasma membrane; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; nervous system process; transmembrane transport; ATP-dependent activity
OG_11756,FUN_022004-T1,Peve_00039765,,apul_peve,52.874,,,,,,,,,,,,,,,,,
OG_11757,FUN_022008-T1,Peve_00000445,,apul_peve,75.0,,,,,,,,,,,,,,,,,
OG_11758,FUN_022021-T1,Peve_00003817,,apul_peve,48.421,,,,,,,,,,,,,,,,,
OG_11759,FUN_022037-T1,Peve_00019002,,apul_peve,78.077,FUN_022037-T1,P95896,,,,,48.9,507.0,3e-128,460.3,sp|P95896|AMID_SACS2 Amidase OS=Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) OX=273057 GN=SSO2122 PE=1 SV=1,,,,,,
OG_11760,FUN_022039-T1,Peve_00016626,,apul_peve,68.872,FUN_022039-T1,B4MR74,,,,,44.3,115.0,3e-17,90.5,sp|B4MR74|EAF_DROWI Ell-associated factor Eaf OS=Drosophila willistoni OX=7260 GN=Eaf PE=3 SV=1,,,,,,
OG_11761,FUN_022050-T1,Peve_00014017,,apul_peve,61.108,FUN_022050-T1,Q5ZI74,DHX30_CHICK,,ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30),Gallus gallus (Chicken),41.8,832.0,2.9999999999999998e-170,600.9,sp|Q5ZI74|DHX30_CHICK ATP-dependent RNA helicase DHX30 OS=Gallus gallus OX=9031 GN=DHX30 PE=2 SV=1,GO:0002151; GO:0003678; GO:0003682; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0007417; GO:0016887; GO:0042254; GO:0042645,central nervous system development [GO:0007417]; ribosome biogenesis [GO:0042254],cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; DNA helicase activity [GO:0003678]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0016787; GO:0016853; GO:0042254; GO:0043226; GO:0048856; GO:0140097; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; mitochondrion; hydrolase activity; isomerase activity; ribosome biogenesis; organelle; anatomical structure development; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_11762,FUN_022088-T1,Peve_00038685,,apul_peve,53.521,FUN_022088-T1,G8HTB6,,,,,29.1,337.0,4.3e-34,147.9,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11763,FUN_022109-T4,Peve_00020400,,apul_peve,65.027,FUN_022109-T4,Q9BQS8,FYCO1_HUMAN,,FYVE and coiled-coil domain-containing protein 1 (Zinc finger FYVE domain-containing protein 7),Homo sapiens (Human),39.8,201.0,3.5e-39,165.2,sp|Q9BQS8|FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FYCO1 PE=1 SV=3,GO:0005764; GO:0005770; GO:0005776; GO:0005794; GO:0008270; GO:0016020; GO:0043231; GO:0072383; GO:1901098,plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098],autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020],zinc ion binding [GO:0008270],GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0007018; GO:0031410; GO:0043226,lysosome; endosome; vacuole; Golgi apparatus; microtubule-based movement; cytoplasmic vesicle; organelle
OG_11764,FUN_022111-T1,Peve_00010587,,apul_peve,76.268,FUN_022111-T1,Q14679,TTLL4_HUMAN,,Tubulin monoglutamylase TTLL4 (EC 6.3.2.-) (Protein monoglutamylase TTLL4) (Tubulin--tyrosine ligase-like protein 4),Homo sapiens (Human),52.8,634.0,7.100000000000001e-180,632.5,sp|Q14679|TTLL4_HUMAN Tubulin monoglutamylase TTLL4 OS=Homo sapiens OX=9606 GN=TTLL4 PE=1 SV=2,GO:0000226; GO:0005524; GO:0005829; GO:0005874; GO:0015631; GO:0018095; GO:0018200; GO:0036064; GO:0046872; GO:0070739; GO:0070740; GO:0097731; GO:0106437; GO:0120222,microtubule cytoskeleton organization [GO:0000226]; peptidyl-glutamic acid modification [GO:0018200]; protein polyglutamylation [GO:0018095]; regulation of blastocyst development [GO:0120222],9+0 non-motile cilium [GO:0097731]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule [GO:0005874],"ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein-glutamic acid ligase activity [GO:0070739]; protein-glutamic acid ligase activity, initiating [GO:0106437]; tubulin binding [GO:0015631]; tubulin-glutamic acid ligase activity [GO:0070740]",GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0007010; GO:0008092; GO:0016874; GO:0043226; GO:0140096,"catalytic activity; microtubule organizing center; cytosol; cilium; cytoskeleton organization; cytoskeletal protein binding; ligase activity; organelle; catalytic activity, acting on a protein"
OG_11765,FUN_022176-T1,Peve_00006378,,apul_peve,46.833,,,,,,,,,,,,,,,,,
OG_11766,FUN_022177-T1,Peve_00029375,,apul_peve,53.425,,,,,,,,,,,,,,,,,
OG_11767,FUN_022181-T1,Peve_00036609,,apul_peve,65.82050000000001,FUN_022181-T1,Q98SI1,,,,,58.1,74.0,8.6e-17,89.0,sp|Q98SI1|HXA1A_DANRE Homeobox protein Hox-A1a OS=Danio rerio OX=7955 GN=hoxa1a PE=2 SV=1,,,,,,
OG_11768,FUN_022184-T1,Peve_00036594,,apul_peve,58.065,FUN_022184-T1,Q8R527,RHOQ_MOUSE,,Rho-related GTP-binding protein RhoQ (Ras-like protein TC10),Mus musculus (Mouse),35.7,185.0,9.6e-24,111.7,sp|Q8R527|RHOQ_MOUSE Rho-related GTP-binding protein RhoQ OS=Mus musculus OX=10090 GN=Rhoq PE=1 SV=2,GO:0003924; GO:0005522; GO:0005525; GO:0005737; GO:0005884; GO:0005886; GO:0007264; GO:0008286; GO:0008360; GO:0030036; GO:0030866; GO:0032427; GO:0032869; GO:0045121; GO:0045944; GO:0046039; GO:0046325; GO:0046326; GO:0051491; GO:1903077,actin cytoskeleton organization [GO:0030036]; cellular response to insulin stimulus [GO:0032869]; cortical actin cytoskeleton organization [GO:0030866]; GTP metabolic process [GO:0046039]; insulin receptor signaling pathway [GO:0008286]; negative regulation of D-glucose import [GO:0046325]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of D-glucose import [GO:0046326]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; small GTPase-mediated signal transduction [GO:0007264],actin filament [GO:0005884]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; profilin binding [GO:0005522],GO:0003824; GO:0003924; GO:0005886; GO:0006355; GO:0007010; GO:0016787; GO:0055086; GO:1901135,catalytic activity; GTPase activity; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_11769,FUN_022190-T1,Peve_00018624,,apul_peve,58.364,,,,,,,,,,,,,,,,,
OG_11770,FUN_022201-T1,Peve_00041447,,apul_peve,67.568,FUN_022201-T1,M0R6D8,,,,,81.7,60.0,4.7e-20,99.4,sp|M0R6D8|MNX1_RAT Motor neuron and pancreas homeobox 1 OS=Rattus norvegicus OX=10116 GN=Mnx1 PE=3 SV=2,,,,,,
OG_11771,FUN_022211-T1,Peve_00021097,,apul_peve,83.564,FUN_022211-T1,F8WLE0,,,,,36.8,881.0,4.8e-143,510.4,sp|F8WLE0|KIF28_RAT Kinesin-like protein KIF28 OS=Rattus norvegicus OX=10116 GN=Kif28 PE=2 SV=1,,,,,,
OG_11772,FUN_022219-T2,Peve_00027149,,apul_peve,48.555,FUN_022219-T2,Q8K2C7,OS9_MOUSE,,Protein OS-9,Mus musculus (Mouse),42.9,133.0,9.4e-25,117.1,sp|Q8K2C7|OS9_MOUSE Protein OS-9 OS=Mus musculus OX=10090 GN=Os9 PE=1 SV=2,GO:0000836; GO:0002020; GO:0005788; GO:0006511; GO:0006605; GO:0006621; GO:0016567; GO:0030246; GO:0030968; GO:0034976; GO:0036503; GO:0140032; GO:1904153,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein retention in ER lumen [GO:0006621]; protein targeting [GO:0006605]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent protein catabolic process [GO:0006511]",endoplasmic reticulum lumen [GO:0005788]; Hrd1p ubiquitin ligase complex [GO:0000836],carbohydrate binding [GO:0030246]; glycosylation-dependent protein binding [GO:0140032]; protease binding [GO:0002020],GO:0030163,protein catabolic process
OG_11773,FUN_022222-T1,Peve_00030818,,apul_peve,60.453,FUN_022222-T1,P46197,,,,,59.6,223.0,3.2e-70,267.7,sp|P46197|ANPRB_BOVIN Atrial natriuretic peptide receptor 2 OS=Bos taurus OX=9913 GN=NPR2 PE=2 SV=1,,,,,,
OG_11774,FUN_022237-T2,Peve_00037415,,apul_peve,59.9375,FUN_022237-T2,Q9ULF5,S39AA_HUMAN,,Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10),Homo sapiens (Human),35.3,510.0,2.6e-62,241.9,sp|Q9ULF5|S39AA_HUMAN Zinc transporter ZIP10 OS=Homo sapiens OX=9606 GN=SLC39A10 PE=1 SV=2,GO:0001837; GO:0002903; GO:0005385; GO:0005886; GO:0006882; GO:0008160; GO:0016324; GO:0030003; GO:0030890; GO:0050861; GO:0071577; GO:0071578; GO:0140410,epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],monoatomic cation:bicarbonate symporter activity [GO:0140410]; protein tyrosine phosphatase activator activity [GO:0008160]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005886; GO:0030154; GO:0055085; GO:0098772,transporter activity; plasma membrane; cell differentiation; transmembrane transport; molecular function regulator activity
OG_11775,FUN_022238-T1,Peve_00029744,,apul_peve,87.603,FUN_022238-T1,Q96H20,,,,,58.7,242.0,2e-79,297.0,sp|Q96H20|SNF8_HUMAN Vacuolar-sorting protein SNF8 OS=Homo sapiens OX=9606 GN=SNF8 PE=1 SV=1,,,,,,
OG_11776,FUN_022246-T1,Peve_00022829,,apul_peve,57.552,,,,,,,,,,,,,,,,,
OG_11777,FUN_022270-T1,Peve_00032546,,apul_peve,85.4865,FUN_022270-T1,Q5E9C0,,,,,74.2,271.0,1.7e-10,68.2,sp|Q5E9C0|RSU1_BOVIN Ras suppressor protein 1 OS=Bos taurus OX=9913 GN=RSU1 PE=2 SV=1,,,,,,
OG_11778,FUN_022274-T1,Peve_00017841,,apul_peve,63.514,,,,,,,,,,,,,,,,,
OG_11779,FUN_022275-T1,Peve_00017842,,apul_peve,72.789,FUN_022275-T1,P74897,,,,,34.5,142.0,5.9e-13,75.5,sp|P74897|YQA3_THEAQ Universal stress protein in QAH/OAS sulfhydrylase 3'region OS=Thermus aquaticus OX=271 PE=3 SV=1,,,,,,
OG_11780,FUN_022277-T1,Peve_00035513,,apul_peve,57.925,,,,,,,,,,,,,,,,,
OG_11781,FUN_022290-T2,Peve_00003679,,apul_peve,65.35050000000001,,,,,,,,,,,,,,,,,
OG_11782,FUN_022302-T1,Peve_00003680,,apul_peve,72.218,,,,,,,,,,,,,,,,,
OG_11783,FUN_022310-T1,Peve_00021686,,apul_peve,80.303,FUN_022310-T1,Q9W719,,,,,65.3,196.0,2.3e-73,276.6,sp|Q9W719|HPRT_CHICK Hypoxanthine-guanine phosphoribosyltransferase OS=Gallus gallus OX=9031 GN=HPRT1 PE=2 SV=1,,,,,,
OG_11784,FUN_022313-T1,Peve_00021689,,apul_peve,34.696,FUN_022313-T1,Q8NFT6,DBF4B_HUMAN,,Protein DBF4 homolog B (Activator of S phase kinase-like protein 1) (ASK-like protein 1) (Chiffon homolog B) (Dbf4-related factor 1),Homo sapiens (Human),31.3,323.0,1.8e-27,127.1,sp|Q8NFT6|DBF4B_HUMAN Protein DBF4 homolog B OS=Homo sapiens OX=9606 GN=DBF4B PE=1 SV=1,GO:0003676; GO:0005634; GO:0005654; GO:0005737; GO:0008270; GO:0008284; GO:0010571; GO:0010971; GO:0019901; GO:0030295; GO:0031431; GO:0043231; GO:0043539; GO:1901987,positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; regulation of cell cycle phase transition [GO:1901987],cytoplasm [GO:0005737]; Dbf4-dependent protein kinase complex [GO:0031431]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],nucleic acid binding [GO:0003676]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0043226; GO:0098772,nucleus; nucleoplasm; organelle; molecular function regulator activity
OG_11785,FUN_022326-T1,Peve_00021646,,apul_peve,54.2225,,,,,,,,,,,,,,,,,
OG_11786,FUN_022330-T2,Peve_00021650,,apul_peve,52.837,FUN_022330-T2,B8JK39,ITA9_MOUSE,,Integrin alpha-9,Mus musculus (Mouse),29.2,997.0,3.1e-97,358.2,sp|B8JK39|ITA9_MOUSE Integrin alpha-9 OS=Mus musculus OX=10090 GN=Itga9 PE=1 SV=1,GO:0005518; GO:0007155; GO:0007229; GO:0009925; GO:0030593; GO:0034679; GO:0043236; GO:0045906; GO:0046872; GO:0098640,cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593],basal plasma membrane [GO:0009925]; integrin alpha9-beta1 complex [GO:0034679],collagen binding [GO:0005518]; integrin binding involved in cell-matrix adhesion [GO:0098640]; laminin binding [GO:0043236]; metal ion binding [GO:0046872],GO:0002376; GO:0003013; GO:0007155; GO:0048870; GO:0098631,immune system process; circulatory system process; cell adhesion; cell motility; cell adhesion mediator activity
OG_11787,FUN_022350-T1,Peve_00028290,,apul_peve,37.617,FUN_022350-T1,Q8WPA2,,,,,29.6,270.0,7.3e-11,70.1,sp|Q8WPA2|AR_BOMMO Allatostatin-A receptor OS=Bombyx mori OX=7091 GN=AR PE=2 SV=1,,,,,,
OG_11788,FUN_022384-T1,Peve_00013220,,apul_peve,44.976,FUN_022384-T1,P31314,TLX1_HUMAN,,T-cell leukemia homeobox protein 1 (Homeobox protein Hox-11) (Proto-oncogene TCL-3) (T-cell leukemia/lymphoma protein 3),Homo sapiens (Human),60.0,65.0,4.2e-15,83.2,sp|P31314|TLX1_HUMAN T-cell leukemia homeobox protein 1 OS=Homo sapiens OX=9606 GN=TLX1 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0006357; GO:0048513,animal organ development [GO:0048513]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_11789,FUN_022399-T1,Peve_00037638,,apul_peve,54.19,,,,,,,,,,,,,,,,,
OG_11790,FUN_022400-T1,Peve_00037593,,apul_peve,64.387,FUN_022400-T1,P96738,,,,,28.9,280.0,3e-24,114.4,sp|P96738|CAPA_BACSU PGA biosynthesis protein CapA OS=Bacillus subtilis (strain 168) OX=224308 GN=capA PE=3 SV=1,,,,,,
OG_11791,FUN_022404-T1,Peve_00034360,,apul_peve,76.471,,,,,,,,,,,,,,,,,
OG_11792,FUN_022407-T1,Peve_00037584,,apul_peve,33.962,,,,,,,,,,,,,,,,,
OG_11793,FUN_022410-T1,Peve_00037639,,apul_peve,71.681,FUN_022410-T1,Q9XT26,,,,,67.9,262.0,3e-101,370.9,sp|Q9XT26|CCNT1_HORSE Cyclin-T1 OS=Equus caballus OX=9796 GN=CCNT1 PE=1 SV=1,,,,,,
OG_11794,FUN_022418-T1,Peve_00037626,,apul_peve,63.363,,,,,,,,,,,,,,,,,
OG_11795,FUN_022423-T1,Peve_00037616,,apul_peve,70.034,FUN_022423-T1,P30531,SC6A1_HUMAN,,Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1),Homo sapiens (Human),43.5,510.0,1.7e-135,484.6,sp|P30531|SC6A1_HUMAN Sodium- and chloride-dependent GABA transporter 1 OS=Homo sapiens OX=9606 GN=SLC6A1 PE=1 SV=2,GO:0005332; GO:0005886; GO:0006865; GO:0007268; GO:0007613; GO:0008306; GO:0009986; GO:0015185; GO:0015378; GO:0016020; GO:0030424; GO:0035725; GO:0043025; GO:0046872; GO:0050808; GO:0051936; GO:0051939; GO:0098658; GO:0098719; GO:0098793; GO:0098982; GO:0150104; GO:1902476,amino acid transport [GO:0006865]; associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid import [GO:0051939]; gamma-aminobutyric acid reuptake [GO:0051936]; inorganic anion import across plasma membrane [GO:0098658]; memory [GO:0007613]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; synapse organization [GO:0050808]; transport across blood-brain barrier [GO:0150104],axon [GO:0030424]; cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; presynapse [GO:0098793],gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; metal ion binding [GO:0046872]; sodium:chloride symporter activity [GO:0015378],GO:0003013; GO:0005215; GO:0005886; GO:0023052; GO:0034330; GO:0050877; GO:0055085,circulatory system process; transporter activity; plasma membrane; signaling; cell junction organization; nervous system process; transmembrane transport
OG_11796,FUN_022426-T1,Peve_00037612,,apul_peve,85.915,FUN_022426-T1,Q62425,,,,,54.5,77.0,1.2e-17,90.1,sp|Q62425|NDUA4_MOUSE Cytochrome c oxidase subunit NDUFA4 OS=Mus musculus OX=10090 GN=Ndufa4 PE=1 SV=2,,,,,,
OG_11797,FUN_022431-T1,Peve_00037597,,apul_peve,63.551,,,,,,,,,,,,,,,,,
OG_11798,FUN_022442-T1,Peve_00017894,,apul_peve,45.745,,,,,,,,,,,,,,,,,
OG_11799,FUN_022443-T1,Peve_00017893,,apul_peve,100.0,FUN_022443-T1,P02552,,,,,98.0,451.0,1.5e-266,919.5,sp|P02552|TBA1A_CHICK Tubulin alpha-1A chain OS=Gallus gallus OX=9031 GN=TUBA1A PE=1 SV=2,,,,,,
OG_11800,FUN_022451-T1,Peve_00009230,,apul_peve,69.73,,,,,,,,,,,,,,,,,
OG_11801,FUN_022458-T1,Peve_00014438,,apul_peve,46.821,,,,,,,,,,,,,,,,,
OG_11802,FUN_022459-T1,Peve_00014437,,apul_peve,57.333,,,,,,,,,,,,,,,,,
OG_11803,FUN_022464-T1,Peve_00031893,,apul_peve,57.062,,,,,,,,,,,,,,,,,
OG_11804,FUN_022468-T1,Peve_00021890,,apul_peve,79.05250000000001,,,,,,,,,,,,,,,,,
OG_11805,FUN_022488-T1,Peve_00028062,,apul_peve,44.898,FUN_022488-T1,P83858,QRFPR_RAT,,Pyroglutamylated RF-amide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),Rattus norvegicus (Rat),27.5,316.0,2.5000000000000002e-22,107.8,sp|P83858|QRFPR_RAT Pyroglutamylated RF-amide peptide receptor OS=Rattus norvegicus OX=10116 GN=Qrfpr PE=2 SV=1,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0032870; GO:0097730,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186],non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0005929; GO:0043226; GO:0060089,plasma membrane; cilium; organelle; molecular transducer activity
OG_11806,FUN_022490-T1,Peve_00043032,,apul_peve,57.225,FUN_022490-T1,Q01758,,,,,31.1,135.0,1.1e-07,61.2,sp|Q01758|ISP2_OSMMO Type-2 ice-structuring protein OS=Osmerus mordax OX=8014 PE=1 SV=1,,,,,,
OG_11807,FUN_022504-T1,Peve_00040390,,apul_peve,63.354,,,,,,,,,,,,,,,,,
OG_11808,FUN_022526-T1,Peve_00020801,,apul_peve,40.8465,FUN_022526-T1,Q6J6I8,BRCA1_GORGO,,Breast cancer type 1 susceptibility protein homolog (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BRCA1),Gorilla gorilla gorilla (Western lowland gorilla),44.4,99.0,1.4e-14,84.7,sp|Q6J6I8|BRCA1_GORGO Breast cancer type 1 susceptibility protein homolog OS=Gorilla gorilla gorilla OX=9595 GN=BRCA1 PE=3 SV=1,GO:0000724; GO:0003677; GO:0003713; GO:0004842; GO:0005634; GO:0005694; GO:0005737; GO:0006357; GO:0006633; GO:0007095; GO:0007549; GO:0008270; GO:0031436; GO:0043009; GO:0045717; GO:0045893; GO:0045944; GO:0051865; GO:0070063; GO:0070531; GO:0085020,chordate embryonic development [GO:0043009]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357]; sex-chromosome dosage compensation [GO:0007549],BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634],DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005694; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0006629; GO:0016740; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"DNA binding; catalytic activity; nucleus; chromosome; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_11809,FUN_022529-T1,Peve_00002050,,apul_peve,77.969,FUN_022529-T1,Q149M9,,,,,29.1,914.0,7.399999999999998e-90,334.3,sp|Q149M9|NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=NWD1 PE=1 SV=3,,,,,,
OG_11810,FUN_022531-T1,Peve_00002047,,apul_peve,69.748,,,,,,,,,,,,,,,,,
OG_11811,FUN_022533-T1,Peve_00021936,,apul_peve,65.3,FUN_022533-T1,Q91175,,,,,27.2,334.0,1.6e-18,95.1,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_11812,FUN_022534-T1,Peve_00044332,,apul_peve,41.4745,FUN_022534-T1,B7WFQ1,,,,,97.0,505.0,8.3e-301,1033.5,sp|B7WFQ1|USOM2_ACRMI Uncharacterized skeletal organic matrix protein 2 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11813,FUN_022536-T1,Peve_00021937,,apul_peve,39.749,FUN_022536-T1,D9IQ16,,,,,97.4,77.0,1.6e-37,158.3,sp|D9IQ16|GXN_ACRMI Galaxin OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11814,FUN_022537-T1,Peve_00043560,,apul_peve,61.762,,,,,,,,,,,,,,,,,
OG_11815,FUN_022542-T1,Peve_00020943,,apul_peve,53.0015,FUN_022542-T1,Q7T3E6,,,,,36.6,191.0,9.9e-26,119.4,sp|Q7T3E6|BMI1B_DANRE Polycomb complex protein BMI-1-B OS=Danio rerio OX=7955 GN=bmi1b PE=2 SV=1,,,,,,
OG_11816,FUN_022543-T1,Peve_00020944,,apul_peve,39.194,,,,,,,,,,,,,,,,,
OG_11817,FUN_022561-T1,Peve_00009466,,apul_peve,88.372,FUN_022561-T1,P25291,,,,,49.1,116.0,9.999999999999999e-27,124.0,sp|P25291|GP2_CANLF Pancreatic secretory granule membrane major glycoprotein GP2 OS=Canis lupus familiaris OX=9615 GN=GP2 PE=1 SV=1,,,,,,
OG_11818,FUN_022570-T1,Peve_00000938,,apul_peve,80.513,FUN_022570-T1,Q3SZ76,,,,,42.7,192.0,1.1e-38,161.4,sp|Q3SZ76|COMD3_BOVIN COMM domain-containing protein 3 OS=Bos taurus OX=9913 GN=COMMD3 PE=2 SV=1,,,,,,
OG_11819,FUN_022573-T1,Peve_00005461,,apul_peve,86.614,,,,,,,,,,,,,,,,,
OG_11820,FUN_022581-T1,Peve_00020594,,apul_peve,41.2145,,,,,,,,,,,,,,,,,
OG_11821,FUN_022600-T2,Peve_00012220,,apul_peve,52.1075,FUN_022600-T2,Q9ULF5,S39AA_HUMAN,,Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10),Homo sapiens (Human),36.3,521.0,4.4e-60,234.2,sp|Q9ULF5|S39AA_HUMAN Zinc transporter ZIP10 OS=Homo sapiens OX=9606 GN=SLC39A10 PE=1 SV=2,GO:0001837; GO:0002903; GO:0005385; GO:0005886; GO:0006882; GO:0008160; GO:0016324; GO:0030003; GO:0030890; GO:0050861; GO:0071577; GO:0071578; GO:0140410,epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],monoatomic cation:bicarbonate symporter activity [GO:0140410]; protein tyrosine phosphatase activator activity [GO:0008160]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005886; GO:0030154; GO:0055085; GO:0098772,transporter activity; plasma membrane; cell differentiation; transmembrane transport; molecular function regulator activity
OG_11822,FUN_022606-T1,Peve_00012251,,apul_peve,57.951,FUN_022606-T1,Q9DFS4,,,,,31.2,413.0,3.7e-47,190.7,sp|Q9DFS4|STAR3_DANRE StAR-related lipid transfer protein 3 OS=Danio rerio OX=7955 GN=stard3 PE=2 SV=2,,,,,,
OG_11823,FUN_022621-T1,Peve_00012272,,apul_peve,46.0,FUN_022621-T1,Q6Y1S1,MYD88_RAT,,Myeloid differentiation primary response protein MyD88,Rattus norvegicus (Rat),24.6,285.0,6.3e-20,100.1,sp|Q6Y1S1|MYD88_RAT Myeloid differentiation primary response protein MyD88 OS=Rattus norvegicus OX=10116 GN=Myd88 PE=2 SV=2,GO:0002238; GO:0002269; GO:0002283; GO:0002755; GO:0005102; GO:0005121; GO:0005149; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006325; GO:0006909; GO:0006915; GO:0006954; GO:0007166; GO:0007254; GO:0008063; GO:0009615; GO:0009682; GO:0009986; GO:0010467; GO:0010468; GO:0010628; GO:0014004; GO:0014075; GO:0016064; GO:0019221; GO:0019897; GO:0022008; GO:0031234; GO:0031663; GO:0032481; GO:0032494; GO:0032496; GO:0032675; GO:0032680; GO:0032722; GO:0032731; GO:0032740; GO:0032747; GO:0032755; GO:0032757; GO:0032760; GO:0032991; GO:0034142; GO:0034146; GO:0034158; GO:0035325; GO:0035591; GO:0038124; GO:0038172; GO:0042127; GO:0042742; GO:0042802; GO:0043123; GO:0043200; GO:0043588; GO:0045087; GO:0045471; GO:0045944; GO:0046330; GO:0048661; GO:0050671; GO:0050727; GO:0050830; GO:0051607; GO:0060090; GO:0060337; GO:0060907; GO:0070498; GO:0070555; GO:0070935; GO:0070944; GO:0070976; GO:0071260; GO:0090557; GO:0140052; GO:0140674; GO:1900017; GO:1900227; GO:1902622; GO:2000338; GO:2000341,3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; chromatin organization [GO:0006325]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; establishment of endothelial intestinal barrier [GO:0090557]; gene expression [GO:0010467]; immunoglobulin mediated immune response [GO:0016064]; induced systemic resistance [GO:0009682]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; leukocyte activation involved in inflammatory response [GO:0002269]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; microglia differentiation [GO:0014004]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neurogenesis [GO:0022008]; neutrophil activation involved in immune response [GO:0002283]; neutrophil-mediated killing of bacterium [GO:0070944]; phagocytosis [GO:0006909]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; regulation of cell population proliferation [GO:0042127]; regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000338]; regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000341]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-6 production [GO:0032675]; regulation of neutrophil migration [GO:1902622]; regulation of tumor necrosis factor production [GO:0032680]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to ethanol [GO:0045471]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to molecule of fungal origin [GO:0002238]; response to peptidoglycan [GO:0032494]; response to virus [GO:0009615]; skin development [GO:0043588]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 5 signaling pathway [GO:0034146]; toll-like receptor 8 signaling pathway [GO:0034158]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; type I interferon-mediated signaling pathway [GO:0060337],cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of plasma membrane [GO:0019897]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP-dependent histone chaperone activity [GO:0140674]; identical protein binding [GO:0042802]; interleukin-1 receptor binding [GO:0005149]; molecular adaptor activity [GO:0060090]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; TIR domain binding [GO:0070976]; Toll binding [GO:0005121]; Toll-like receptor binding [GO:0035325],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006325; GO:0006355; GO:0006954; GO:0012501; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0140096; GO:0140097; GO:0140104; GO:0140657,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; chromatin organization; regulation of DNA-templated transcription; inflammatory response; programmed cell death; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein; catalytic activity, acting on DNA; molecular carrier activity; ATP-dependent activity"
OG_11824,FUN_022629-T1,Peve_00012282,,apul_peve,61.1675,FUN_022629-T1,Q8BRH4,KMT2C_MOUSE,,Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.364) (Myeloid/lymphoid or mixed-lineage leukemia protein 3 homolog),Mus musculus (Mouse),25.4,5464.0,1.2e-141,508.1,sp|Q8BRH4|KMT2C_MOUSE Histone-lysine N-methyltransferase 2C OS=Mus musculus OX=10090 GN=Kmt2c PE=1 SV=2,GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0007338; GO:0008270; GO:0010468; GO:0016746; GO:0032259; GO:0035097; GO:0035264; GO:0042054; GO:0042800; GO:0044666; GO:0048146; GO:0061029; GO:0140945; GO:0140999,eyelid development in camera-type eye [GO:0061029]; methylation [GO:0032259]; multicellular organism growth [GO:0035264]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; single fertilization [GO:0007338],histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],acyltransferase activity [GO:0016746]; DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H3K4 trimethyltransferase activity [GO:0140999]; histone methyltransferase activity [GO:0042054]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_11825,FUN_022633-T1,Peve_00012224,,apul_peve,63.573,FUN_022633-T1,A2AWR3,,,,,34.5,814.0,8.5e-117,422.9,sp|A2AWR3|LYCHS_MOUSE Lysosomal cholesterol signaling protein OS=Mus musculus OX=10090 GN=Gpr155 PE=2 SV=1,,,,,,
OG_11826,FUN_022638-T1,Peve_00020789,,apul_peve,74.265,,,,,,,,,,,,,,,,,
OG_11827,FUN_022654-T1,Peve_00026382,,apul_peve,63.167,FUN_022654-T1,Q63886,UD11_MOUSE,,UDP-glucuronosyltransferase 1A1 (UGT1A1) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-1) (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (UGTBR1),Mus musculus (Mouse),34.1,487.0,9.9e-75,282.3,sp|Q63886|UD11_MOUSE UDP-glucuronosyltransferase 1A1 OS=Mus musculus OX=10090 GN=Ugt1a1 PE=1 SV=2,GO:0001972; GO:0004857; GO:0005496; GO:0005789; GO:0005886; GO:0006805; GO:0008210; GO:0015020; GO:0019899; GO:0034663; GO:0042803; GO:0051552,estrogen metabolic process [GO:0008210]; flavone metabolic process [GO:0051552]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496],GO:0003824; GO:0005886; GO:0006629; GO:0008289; GO:0016740; GO:0098772,catalytic activity; plasma membrane; lipid metabolic process; lipid binding; transferase activity; molecular function regulator activity
OG_11828,FUN_022657-T1,Peve_00024896,,apul_peve,38.4795,,,,,,,,,,,,,,,,,
OG_11829,FUN_022658-T1,Peve_00038862,,apul_peve,77.429,FUN_022658-T1,Q91175,,,,,23.0,326.0,1.3e-14,82.0,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_11830,FUN_022661-T1,Peve_00024895,,apul_peve,77.762,FUN_022661-T1,P34611,NCL1_CAEEL,,B-box type zinc finger protein ncl-1,Caenorhabditis elegans,23.9,401.0,9.7e-18,93.6,sp|P34611|NCL1_CAEEL B-box type zinc finger protein ncl-1 OS=Caenorhabditis elegans OX=6239 GN=ncl-1 PE=2 SV=1,GO:0005737; GO:0008270; GO:0016479; GO:0016480; GO:0017126; GO:0017148; GO:0030371; GO:0042254; GO:0072697; GO:0090071; GO:2000114,negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of transcription by RNA polymerase I [GO:0016479]; negative regulation of transcription by RNA polymerase III [GO:0016480]; negative regulation of translation [GO:0017148]; nucleologenesis [GO:0017126]; protein localization to cell cortex [GO:0072697]; regulation of establishment of cell polarity [GO:2000114]; ribosome biogenesis [GO:0042254],cytoplasm [GO:0005737],translation repressor activity [GO:0030371]; zinc ion binding [GO:0008270],GO:0006355; GO:0042254; GO:0045182,regulation of DNA-templated transcription; ribosome biogenesis; translation regulator activity
OG_11831,FUN_022669-T2,Peve_00003748,,apul_peve,41.6315,FUN_022669-T2,B8UU59,PK1L_ACRMI,,Polycystin-1-related protein (Polycystic kidney disease 1-related protein),Acropora millepora (Staghorn coral) (Heteropora millepora),96.0,2348.0,0.0,4417.1,sp|B8UU59|PK1L_ACRMI Polycystin-1-related protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005261; GO:0005886; GO:0005929; GO:0006816,calcium ion transport [GO:0006816],cilium [GO:0005929]; plasma membrane [GO:0005886],monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_11832,FUN_022674-T1,Peve_00010101,,apul_peve,64.308,FUN_022674-T1,Q5YKK9,OPN4_FELCA,,Melanopsin (Opsin-4),Felis catus (Cat) (Felis silvestris catus),27.4,292.0,3.6e-10,67.4,sp|Q5YKK9|OPN4_FELCA Melanopsin OS=Felis catus OX=9685 GN=OPN4 PE=2 SV=1,GO:0005502; GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016020; GO:0030424; GO:0030425; GO:0042752; GO:0043204; GO:0048511; GO:0071482; GO:1990384,cellular response to light stimulus [GO:0071482]; G protein-coupled receptor signaling pathway [GO:0007186]; hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020],GO:0005886; GO:0008289; GO:0050877; GO:0060089,plasma membrane; lipid binding; nervous system process; molecular transducer activity
OG_11833,FUN_022676-T1,Peve_00021757,,apul_peve,60.775,FUN_022676-T1,Q91717,,,,,44.3,228.0,4.7e-51,205.3,sp|Q91717|CO2A1_XENLA Collagen alpha-1(II) chain OS=Xenopus laevis OX=8355 GN=col2a1 PE=2 SV=2,,,,,,
OG_11834,FUN_022690-T1,Peve_00022678,,apul_peve,66.292,,,,,,,,,,,,,,,,,
OG_11835,FUN_022691-T1,Peve_00045108,,apul_peve,75.61449999999999,FUN_022691-T1,Q4VBS4,MAP12_DANRE,,"Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D)",Danio rerio (Zebrafish) (Brachydanio rerio),55.5,272.0,8e-85,315.5,"sp|Q4VBS4|MAP12_DANRE Methionine aminopeptidase 1D, mitochondrial OS=Danio rerio OX=7955 GN=metap1d PE=2 SV=1",GO:0004239; GO:0005739; GO:0006508; GO:0046872; GO:0070006,proteolysis [GO:0006508],mitochondrion [GO:0005739],initiator methionyl aminopeptidase activity [GO:0004239]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_11836,FUN_022698-T1,Peve_00045104,,apul_peve,66.071,FUN_022698-T1,Q5ICW4,,,,,30.7,150.0,4.7e-10,66.2,sp|Q5ICW4|GRB14_BOVIN Growth factor receptor-bound protein 14 OS=Bos taurus OX=9913 GN=GRB14 PE=1 SV=1,,,,,,
OG_11837,FUN_022699-T1,Peve_00018676,,apul_peve,37.931,FUN_022699-T1,Q5ICW4,,,,,36.3,248.0,8.000000000000001e-39,163.3,sp|Q5ICW4|GRB14_BOVIN Growth factor receptor-bound protein 14 OS=Bos taurus OX=9913 GN=GRB14 PE=1 SV=1,,,,,,
OG_11838,FUN_022705-T1,Peve_00018679,,apul_peve,66.85,FUN_022705-T1,Q922Y2,,,,,35.7,84.0,2.3e-08,62.4,sp|Q922Y2|TRI59_MOUSE Tripartite motif-containing protein 59 OS=Mus musculus OX=10090 GN=Trim59 PE=1 SV=2,,,,,,
OG_11839,FUN_022724-T1,Peve_00009023,,apul_peve,57.816,FUN_022724-T1,Q6V0K7,,,,,43.6,133.0,1.9e-26,122.1,sp|Q6V0K7|OIT3_RAT Oncoprotein-induced transcript 3 protein OS=Rattus norvegicus OX=10116 GN=Oit3 PE=2 SV=1,,,,,,
OG_11840,FUN_022731-T1,Peve_00032936,,apul_peve,52.53,FUN_022731-T1,Q6V0K7,,,,,43.6,133.0,1.2e-26,122.5,sp|Q6V0K7|OIT3_RAT Oncoprotein-induced transcript 3 protein OS=Rattus norvegicus OX=10116 GN=Oit3 PE=2 SV=1,,,,,,
OG_11841,FUN_022770-T1,Peve_00043385,,apul_peve,70.901,FUN_022770-T1,Q91WN1,,,,,46.5,260.0,2.1000000000000002e-58,227.3,sp|Q91WN1|DNJC9_MOUSE DnaJ homolog subfamily C member 9 OS=Mus musculus OX=10090 GN=Dnajc9 PE=1 SV=2,,,,,,
OG_11842,FUN_022779-T1,Peve_00021169,,apul_peve,68.846,FUN_022779-T1,Q9YGN6,,,,,52.1,240.0,1.7e-71,270.8,sp|Q9YGN6|SMUG1_XENLA Single-strand selective monofunctional uracil DNA glycosylase OS=Xenopus laevis OX=8355 GN=smug1 PE=1 SV=1,,,,,,
OG_11843,FUN_022806-T1,Peve_00032584,,apul_peve,67.921,FUN_022806-T1,A8WGA0,C27C1_DANRE,,"Cytochrome P450 27C1 (EC 1.14.19.53) (All-trans retinol 3,4-desaturase)",Danio rerio (Zebrafish) (Brachydanio rerio),33.1,496.0,5.4e-77,290.0,sp|A8WGA0|C27C1_DANRE Cytochrome P450 27C1 OS=Danio rerio OX=7955 GN=cyp27c1 PE=1 SV=2,GO:0001972; GO:0004497; GO:0005506; GO:0005739; GO:0006629; GO:0016020; GO:0020037; GO:0061896; GO:0061897; GO:0061898; GO:1904768,lipid metabolic process [GO:0006629],membrane [GO:0016020]; mitochondrion [GO:0005739],"all-trans retinal 3,4-desaturase activity [GO:0061897]; all-trans retinoic acid 3,4-desaturase activity [GO:0061898]; all-trans retinol 3,4-desaturase activity [GO:0061896]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid binding [GO:0001972]",GO:0003824; GO:0005739; GO:0006629; GO:0008289; GO:0016491; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; lipid binding; oxidoreductase activity; organelle
OG_11844,FUN_022811-T1,Peve_00031619,,apul_peve,50.0,,,,,,,,,,,,,,,,,
OG_11845,FUN_022816-T1,Peve_00017631,,apul_peve,37.9,,,,,,,,,,,,,,,,,
OG_11846,FUN_022828-T1,Peve_00028895,,apul_peve,60.086,,,,,,,,,,,,,,,,,
OG_11847,FUN_022836-T1,Peve_00032605,,apul_peve,57.459,,,,,,,,,,,,,,,,,
OG_11848,FUN_022848-T1,Peve_00037022,,apul_peve,51.418,,,,,,,,,,,,,,,,,
OG_11849,FUN_022853-T2,Peve_00028877,,apul_peve,62.45,,,,,,,,,,,,,,,,,
OG_11850,FUN_022860-T1,Peve_00025612,,apul_peve,38.0315,FUN_022860-T1,Q3SWS9,JKIP1_RAT,,Janus kinase and microtubule-interacting protein 1 (Multiple alpha helices and RNA-linker protein 1) (Marlin-1),Rattus norvegicus (Rat),31.9,595.0,3.1999999999999998e-24,117.9,sp|Q3SWS9|JKIP1_RAT Janus kinase and microtubule-interacting protein 1 OS=Rattus norvegicus OX=10116 GN=Jakmip1 PE=1 SV=1,GO:0003723; GO:0005737; GO:0005874; GO:0008017; GO:0015031; GO:0015630; GO:0016020; GO:0019894; GO:0019900; GO:0050811; GO:0050890; GO:1990904,cognition [GO:0050890]; protein transport [GO:0015031],cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; ribonucleoprotein complex [GO:1990904],GABA receptor binding [GO:0050811]; kinase binding [GO:0019900]; kinesin binding [GO:0019894]; microtubule binding [GO:0008017]; RNA binding [GO:0003723],GO:0003723; GO:0005856; GO:0008092; GO:0043226; GO:0050877,RNA binding; cytoskeleton; cytoskeletal protein binding; organelle; nervous system process
OG_11851,FUN_022867-T3,Peve_00025613,,apul_peve,48.387,FUN_022867-T3,Q795M8,,,,,31.7,101.0,2.9e-06,55.1,sp|Q795M8|YUGO_BACSU Putative potassium channel protein YugO OS=Bacillus subtilis (strain 168) OX=224308 GN=yugO PE=4 SV=2,,,,,,
OG_11852,FUN_022874-T1,Peve_00012295,,apul_peve,69.82,FUN_022874-T1,Q16651,PRSS8_HUMAN,,Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain],Homo sapiens (Human),39.2,265.0,2.7e-48,194.5,sp|Q16651|PRSS8_HUMAN Prostasin OS=Homo sapiens OX=9606 GN=PRSS8 PE=1 SV=1,GO:0004252; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0010765; GO:0070062,positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005576; GO:0005615; GO:0005886; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; plasma membrane; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_11853,FUN_022881-T1,Peve_00001743,,apul_peve,39.474,,,,,,,,,,,,,,,,,
OG_11854,FUN_022910-T1,Peve_00024854,,apul_peve,48.9735,FUN_022910-T1,Q8J2V8,,,,,36.1,454.0,1.2e-65,252.3,sp|Q8J2V8|P2OX_TRIMT Pyranose 2-oxidase OS=Tricholoma matsutake OX=40145 GN=p2ox PE=1 SV=1,,,,,,
OG_11855,FUN_022923-T1,Peve_00008663,,apul_peve,76.959,FUN_022923-T1,Q58A42,DD3_DICDI,,Protein DD3-3,Dictyostelium discoideum (Social amoeba),32.1,664.0,5.999999999999999e-62,240.4,sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_11856,FUN_022925-T2,Peve_00034416,,apul_peve,70.476,FUN_022925-T2,Q58A42,DD3_DICDI,,Protein DD3-3,Dictyostelium discoideum (Social amoeba),31.3,659.0,4.6e-67,257.3,sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_11857,FUN_022932-T1,Peve_00037577,,apul_peve,69.231,FUN_022932-T1,Q32LB9,,,,,36.1,263.0,3.6e-37,157.1,sp|Q32LB9|NOA1_BOVIN Nitric oxide-associated protein 1 OS=Bos taurus OX=9913 GN=NOA1 PE=2 SV=1,,,,,,
OG_11858,FUN_022962-T1,Peve_00011603,,apul_peve,70.06,,,,,,,,,,,,,,,,,
OG_11859,FUN_022974-T1,Peve_00011909,,apul_peve,49.234,FUN_022974-T1,Q8BP74,,,,,30.8,344.0,4.7e-29,130.6,sp|Q8BP74|PSTK_MOUSE L-seryl-tRNA(Sec) kinase OS=Mus musculus OX=10090 GN=Pstk PE=1 SV=2,,,,,,
OG_11860,FUN_022985-T1,Peve_00032866,,apul_peve,36.864,,,,,,,,,,,,,,,,,
OG_11861,FUN_022995-T1,Peve_00043403,,apul_peve,53.061,,,,,,,,,,,,,,,,,
OG_11862,FUN_023009-T1,Peve_00009993,,apul_peve,56.664,,,,,,,,,,,,,,,,,
OG_11863,FUN_023020-T2,Peve_00010021,,apul_peve,55.185,,,,,,,,,,,,,,,,,
OG_11864,FUN_023024-T1,Peve_00010023,,apul_peve,77.358,FUN_023024-T1,P50430,,,,,42.5,503.0,1.2e-111,405.2,sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2,,,,,,
OG_11865,FUN_023075-T1,Peve_00014066,,apul_peve,76.012,FUN_023075-T1,Q9NZM1,MYOF_HUMAN,,Myoferlin (Fer-1-like protein 3),Homo sapiens (Human),44.3,2102.0,0.0,1687.2,sp|Q9NZM1|MYOF_HUMAN Myoferlin OS=Homo sapiens OX=9606 GN=MYOF PE=1 SV=1,GO:0001778; GO:0005509; GO:0005543; GO:0005635; GO:0005886; GO:0005901; GO:0005929; GO:0006936; GO:0008015; GO:0030672; GO:0031410; GO:0031965; GO:0034451; GO:0036064; GO:0043231; GO:0046928; GO:0070062,blood circulation [GO:0008015]; muscle contraction [GO:0006936]; plasma membrane repair [GO:0001778]; regulation of neurotransmitter secretion [GO:0046928],caveola [GO:0005901]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543],GO:0003012; GO:0003013; GO:0005635; GO:0005815; GO:0005886; GO:0005929; GO:0008289; GO:0031410; GO:0043226; GO:0061024,muscle system process; circulatory system process; nuclear envelope; microtubule organizing center; plasma membrane; cilium; lipid binding; cytoplasmic vesicle; organelle; membrane organization
OG_11866,FUN_023089-T1,Peve_00037475,,apul_peve,66.234,FUN_023089-T1,P30974,,,,,23.8,298.0,1.6e-10,68.6,sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2,,,,,,
OG_11867,FUN_023095-T1,Peve_00006988,,apul_peve,71.915,FUN_023095-T1,Q9CYL5,,,,,47.9,146.0,1.9999999999999998e-32,141.7,sp|Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr2 PE=1 SV=3,,,,,,
OG_11868,FUN_023101-T1,Peve_00008488,,apul_peve,52.747,,,,,,,,,,,,,,,,,
OG_11869,FUN_023104-T1,Peve_00038936,,apul_peve,45.038,,,,,,,,,,,,,,,,,
OG_11870,FUN_023107-T1,Peve_00038937,,apul_peve,70.459,FUN_023107-T1,B3EWZ9,HEPHL_ACRMI,,Hephaestin-like protein (EC 1.-.-.-),Acropora millepora (Staghorn coral) (Heteropora millepora),52.5,1107.0,0.0,1186.8,sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491,copper ion transport [GO:0006825]; iron ion transport [GO:0006826],plasma membrane [GO:0005886],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005886; GO:0016491,catalytic activity; plasma membrane; oxidoreductase activity
OG_11871,FUN_023114-T1,Peve_00045018,,apul_peve,60.125,FUN_023114-T1,P35406,,,,,28.3,300.0,1.5e-16,88.6,sp|P35406|DRD1_CARAU D(1) dopamine receptor OS=Carassius auratus OX=7957 PE=2 SV=1,,,,,,
OG_11872,FUN_023116-T1,Peve_00045009,,apul_peve,36.095,,,,,,,,,,,,,,,,,
OG_11873,FUN_023131-T1,Peve_00011776,,apul_peve,71.774,,,,,,,,,,,,,,,,,
OG_11874,FUN_023141-T1,Peve_00025756,,apul_peve,44.277,FUN_023141-T1,C3ZQF9,,,,,27.8,306.0,1.4e-17,92.0,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_11875,FUN_023143-T1,Peve_00014160,,apul_peve,55.8,FUN_023143-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),29.4,289.0,5.2e-21,105.1,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_11876,FUN_023158-T1,Peve_00017449,,apul_peve,67.396,FUN_023158-T1,P53634,CATC_HUMAN,,Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)],Homo sapiens (Human),54.6,452.0,1.2e-146,521.2,sp|P53634|CATC_HUMAN Dipeptidyl peptidase 1 OS=Homo sapiens OX=9606 GN=CTSC PE=1 SV=2,GO:0001913; GO:0004197; GO:0004252; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005788; GO:0005813; GO:0006508; GO:0006955; GO:0008234; GO:0008239; GO:0016020; GO:0016505; GO:0019902; GO:0030134; GO:0031404; GO:0031642; GO:0033116; GO:0035578; GO:0042802; GO:0043231; GO:0051087; GO:0051603; GO:0062023; GO:0070062; GO:1903052; GO:1903980; GO:2001235,immune response [GO:0006955]; negative regulation of myelination [GO:0031642]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of proteolysis involved in protein catabolic process [GO:1903052]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; T cell mediated cytotoxicity [GO:0001913],azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; collagen-containing extracellular matrix [GO:0062023]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654],chloride ion binding [GO:0031404]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; peptidase activator activity involved in apoptotic process [GO:0016505]; phosphatase binding [GO:0019902]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005654; GO:0005764; GO:0005773; GO:0005815; GO:0016787; GO:0031410; GO:0043226; GO:0098772; GO:0140096,"immune system process; catalytic activity; extracellular region; extracellular space; nucleoplasm; lysosome; vacuole; microtubule organizing center; hydrolase activity; cytoplasmic vesicle; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_11877,FUN_023171-T1,Peve_00010030,,apul_peve,55.8825,,,,,,,,,,,,,,,,,
OG_11878,FUN_023179-T1,Peve_00009978,,apul_peve,88.194,FUN_023179-T1,Q95WA0,,,,,75.4,142.0,6.2e-52,204.9,sp|Q95WA0|RL26_LITLI Large ribosomal subunit protein uL24 OS=Littorina littorea OX=31216 GN=RPL26 PE=2 SV=1,,,,,,
OG_11879,FUN_023193-T1,Peve_00009997,,apul_peve,73.0915,FUN_023193-T1,O95279,KCNK5_HUMAN,,Potassium channel subfamily K member 5 (Acid-sensitive potassium channel protein TASK-2) (TWIK-related acid-sensitive K(+) channel 2),Homo sapiens (Human),36.8,209.0,3.4e-25,117.1,sp|O95279|KCNK5_HUMAN Potassium channel subfamily K member 5 OS=Homo sapiens OX=9606 GN=KCNK5 PE=1 SV=1,GO:0005267; GO:0005886; GO:0006813; GO:0015271; GO:0022841; GO:0034702; GO:0046872; GO:0046982; GO:0060075; GO:0071805; GO:0097623; GO:1990573,potassium ion export across plasma membrane [GO:0097623]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075],monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],metal ion binding [GO:0046872]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_11880,FUN_023195-T1,Peve_00009998,,apul_peve,89.355,FUN_023195-T1,O17185,SUP9_CAEEL,,Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38),Caenorhabditis elegans,37.6,234.0,7.3e-34,146.0,sp|O17185|SUP9_CAEEL Two pore potassium channel protein sup-9 OS=Caenorhabditis elegans OX=6239 GN=sup-9 PE=1 SV=2,GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0036195; GO:0055120; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937],muscle cell projection membrane [GO:0036195]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120],outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_11881,FUN_023196-T1,Peve_00009999,,apul_peve,59.239,FUN_023196-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),37.5,152.0,2.0000000000000002e-24,114.0,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_11882,FUN_023198-T3,Peve_00010000,,apul_peve,85.015,FUN_023198-T3,D6REC4,,,,,35.3,635.0,8.7e-69,263.1,sp|D6REC4|CFA99_HUMAN Cilia- and flagella-associated protein 99 OS=Homo sapiens OX=9606 GN=CFAP99 PE=1 SV=3,,,,,,
OG_11883,FUN_023199-T1,Peve_00003586,,apul_peve,63.044,FUN_023199-T1,Q8IY21,DDX60_HUMAN,,Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60),Homo sapiens (Human),35.4,1839.0,5.0000000000000005e-272,939.9,sp|Q8IY21|DDX60_HUMAN Probable ATP-dependent RNA helicase DDX60 OS=Homo sapiens OX=9606 GN=DDX60 PE=1 SV=3,GO:0003690; GO:0003724; GO:0003725; GO:0003727; GO:0005524; GO:0005737; GO:0005829; GO:0009615; GO:0016887; GO:0045087; GO:0045111; GO:0051607; GO:1900245; GO:1900246,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA helicase activity [GO:0003724]; single-stranded RNA binding [GO:0003727],GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005829; GO:0005856; GO:0016787; GO:0016853; GO:0043226; GO:0098542; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; cytosol; cytoskeleton; hydrolase activity; isomerase activity; organelle; defense response to other organism; catalytic activity, acting on RNA; ATP-dependent activity"
OG_11884,FUN_023207-T1,Peve_00010003,,apul_peve,46.602,FUN_023207-T1,Q91770,,,,,54.4,103.0,1e-20,101.7,sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1,,,,,,
OG_11885,FUN_023210-T1,Peve_00010005,,apul_peve,74.924,FUN_023210-T1,Q9WYP5,,,,,39.9,328.0,2.6e-61,237.3,sp|Q9WYP5|IOLG_THEMA Myo-inositol 2-dehydrogenase OS=Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) OX=243274 GN=iolG PE=1 SV=1,,,,,,
OG_11886,FUN_023229-T2,Peve_00029861,,apul_peve,64.603,FUN_023229-T2,P50430,,,,,41.1,511.0,1.7e-103,378.6,sp|P50430|ARSB_RAT Arylsulfatase B OS=Rattus norvegicus OX=10116 GN=Arsb PE=2 SV=2,,,,,,
OG_11887,FUN_023241-T2,Peve_00019209,,apul_peve,65.53200000000001,FUN_023241-T2,Q9CXR1,,,,,46.0,313.0,4.9e-68,259.6,sp|Q9CXR1|DHRS7_MOUSE Dehydrogenase/reductase SDR family member 7 OS=Mus musculus OX=10090 GN=Dhrs7 PE=1 SV=2,,,,,,
OG_11888,FUN_023245-T1,Peve_00033771,,apul_peve,64.242,FUN_023245-T1,Q9Y394,DHRS7_HUMAN,,Dehydrogenase/reductase SDR family member 7 (EC 1.1.1.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1) (Protein SDR34C1),Homo sapiens (Human),45.5,323.0,2.2e-68,260.8,sp|Q9Y394|DHRS7_HUMAN Dehydrogenase/reductase SDR family member 7 OS=Homo sapiens OX=9606 GN=DHRS7 PE=1 SV=1,GO:0004090; GO:0005789; GO:0016020; GO:0016616; GO:0052650,,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],"all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_11889,FUN_023273-T1,Peve_00031865,,apul_peve,51.852,,,,,,,,,,,,,,,,,
OG_11890,FUN_023277-T1,Peve_00015367,,apul_peve,59.626,FUN_023277-T1,A0A2B4SJA1,,,,,54.8,363.0,1.5e-102,374.4,sp|A0A2B4SJA1|STNG2_STYPI Stimulator of interferon genes protein 2 OS=Stylophora pistillata OX=50429 GN=STING2 PE=3 SV=1,,,,,,
OG_11891,FUN_023297-T1,Peve_00041304,,apul_peve,39.269,,,,,,,,,,,,,,,,,
OG_11892,FUN_023318-T1,Peve_00017884,,apul_peve,67.568,FUN_023318-T1,P56475,GBRR1_MOUSE,,Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABAAR subunit rho-1) (GABA(C) receptor),Mus musculus (Mouse),34.0,423.0,4.9e-56,220.3,sp|P56475|GBRR1_MOUSE Gamma-aminobutyric acid receptor subunit rho-1 OS=Mus musculus OX=10090 GN=Gabrr1 PE=1 SV=2,GO:0004890; GO:0005886; GO:0019904; GO:0022851; GO:0034707; GO:0042734; GO:0042802; GO:0044877; GO:0045211; GO:0050804; GO:0097708; GO:0098978; GO:0098982; GO:0099507,modulation of chemical synaptic transmission [GO:0050804],chloride channel complex [GO:0034707]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877],GO:0005215; GO:0005886; GO:0043226; GO:0060089,transporter activity; plasma membrane; organelle; molecular transducer activity
OG_11893,FUN_023320-T2,Peve_00017886,,apul_peve,51.608,FUN_023320-T2,P46869,,,,,36.9,415.0,1.1e-58,231.1,sp|P46869|FLA10_CHLRE Kinesin-like protein FLA10 OS=Chlamydomonas reinhardtii OX=3055 GN=FLA10 PE=1 SV=1,,,,,,
OG_11894,FUN_023329-T1,Peve_00036364,,apul_peve,49.579,,,,,,,,,,,,,,,,,
OG_11895,FUN_023340-T1,Peve_00023291,,apul_peve,62.796,FUN_023340-T1,O94993,SOX30_HUMAN,,Transcription factor SOX-30,Homo sapiens (Human),64.0,86.0,3.4e-26,120.9,sp|O94993|SOX30_HUMAN Transcription factor SOX-30 OS=Homo sapiens OX=9606 GN=SOX30 PE=1 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006357; GO:0007286; GO:0008013; GO:0010369; GO:0030178; GO:0031960; GO:0043231; GO:0045944; GO:0120211; GO:1990837,negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proacrosomal vesicle fusion [GO:0120211]; regulation of transcription by RNA polymerase II [GO:0006357]; response to corticosteroid [GO:0031960]; spermatid development [GO:0007286],chromatin [GO:0000785]; chromocenter [GO:0010369]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0022414; GO:0043226; GO:0048856; GO:0061024; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; reproductive process; organelle; anatomical structure development; membrane organization; transcription regulator activity
OG_11896,FUN_023362-T1,Peve_00005340,,apul_peve,31.7955,,,,,,,,,,,,,,,,,
OG_11897,FUN_023377-T4,Peve_00005366,,apul_peve,57.772,,,,,,,,,,,,,,,,,
OG_11898,FUN_023396-T1,Peve_00033708,,apul_peve,59.5795,FUN_023396-T1,Q9VU84,DBNL_DROME,,Drebrin-like protein (Actin binding protein 1),Drosophila melanogaster (Fruit fly),75.0,60.0,2.8000000000000004e-22,107.5,sp|Q9VU84|DBNL_DROME Drebrin-like protein OS=Drosophila melanogaster OX=7227 GN=Abp1 PE=1 SV=1,GO:0001786; GO:0003779; GO:0005546; GO:0005547; GO:0005856; GO:0005938; GO:0014069; GO:0022416; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0030427; GO:0030833; GO:0031594; GO:0045211; GO:0045773; GO:0045887; GO:0048812; GO:0051015; GO:0061176; GO:0061177; GO:0072553; GO:0098974,chaeta development [GO:0022416]; neuron projection morphogenesis [GO:0048812]; positive regulation of axon extension [GO:0045773]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; terminal button organization [GO:0072553],axon [GO:0030424]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; site of polarized growth [GO:0030427]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]",GO:0005856; GO:0007010; GO:0008092; GO:0008289; GO:0043226; GO:0048856,cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; lipid binding; organelle; anatomical structure development
OG_11899,FUN_023403-T2,Peve_00038670,,apul_peve,46.9365,FUN_023403-T2,P14272,KLKB1_RAT,,Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain],Rattus norvegicus (Rat),42.7,253.0,3e-52,208.0,sp|P14272|KLKB1_RAT Plasma kallikrein OS=Rattus norvegicus OX=10116 GN=Klkb1 PE=1 SV=1,GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0051919; GO:0097421,blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; liver regeneration [GO:0097421]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919],extracellular space [GO:0005615],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005615; GO:0006954; GO:0016787; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular space; inflammatory response; hydrolase activity; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_11900,FUN_023404-T1,Peve_00038653,,apul_peve,82.692,FUN_023404-T1,P98074,,,,,36.4,264.0,3.3e-43,176.8,sp|P98074|ENTK_PIG Enteropeptidase OS=Sus scrofa OX=9823 GN=TMPRSS15 PE=1 SV=1,,,,,,
OG_11901,FUN_023411-T1,Peve_00017401,,apul_peve,35.9465,FUN_023411-T1,Q5TCZ1,SPD2A_HUMAN,,SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains),Homo sapiens (Human),25.5,149.0,2.5e-06,55.5,sp|Q5TCZ1|SPD2A_HUMAN SH3 and PX domain-containing protein 2A OS=Homo sapiens OX=9606 GN=SH3PXD2A PE=1 SV=1,GO:0001701; GO:0002020; GO:0002102; GO:0005546; GO:0005737; GO:0005829; GO:0006801; GO:0010314; GO:0016176; GO:0032266; GO:0042554; GO:0042995; GO:0043325; GO:0070161; GO:0070273; GO:0072675,in utero embryonic development [GO:0001701]; osteoclast fusion [GO:0072675]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801],anchoring junction [GO:0070161]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; podosome [GO:0002102],"phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protease binding [GO:0002020]; superoxide-generating NADPH oxidase activator activity [GO:0016176]",GO:0005829; GO:0008289; GO:0043226; GO:0048856; GO:0098772,cytosol; lipid binding; organelle; anatomical structure development; molecular function regulator activity
OG_11902,FUN_023414-T1,Peve_00017404,,apul_peve,33.062,,,,,,,,,,,,,,,,,
OG_11903,FUN_023424-T1,Peve_00031379,,apul_peve,33.735,,,,,,,,,,,,,,,,,
OG_11904,FUN_023432-T2,Peve_00019223,,apul_peve,56.66,FUN_023432-T2,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),36.4,165.0,1.4e-20,102.4,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_11905,FUN_023438-T1,Peve_00019232,,apul_peve,59.8545,FUN_023438-T1,P91753,,,,,41.4,111.0,4e-14,80.9,sp|P91753|MP62_LYTPI Mitotic apparatus protein p62 OS=Lytechinus pictus OX=7653 PE=2 SV=1,,,,,,
OG_11905,FUN_023438-T1,Peve_00019232,,apul_peve,59.8545,FUN_023438-T1,P91753,,,,,41.7,48.0,4.4e-05,50.8,sp|P91753|MP62_LYTPI Mitotic apparatus protein p62 OS=Lytechinus pictus OX=7653 PE=2 SV=1,,,,,,
OG_11906,FUN_023444-T1,Peve_00019241,,apul_peve,58.685,,,,,,,,,,,,,,,,,
OG_11907,FUN_023478-T1,Peve_00017468,,apul_peve,59.564,FUN_023478-T1,B8VIU6,,,,,46.3,164.0,8.400000000000001e-33,142.9,sp|B8VIU6|USOM5_ACRMI Uncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11908,FUN_023495-T1,Peve_00017461,,apul_peve,46.8335,FUN_023495-T1,E9Q6J5,,,,,41.7,115.0,7.7e-19,97.4,sp|E9Q6J5|BD1L1_MOUSE Biorientation of chromosomes in cell division protein 1-like 1 OS=Mus musculus OX=10090 GN=Bod1l PE=1 SV=1,,,,,,
OG_11909,FUN_023521-T1,Peve_00009064,,apul_peve,72.238,FUN_023521-T1,Q91175,,,,,31.6,323.0,2e-38,161.4,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_11910,FUN_023524-T1,Peve_00009061,,apul_peve,54.691,FUN_023524-T1,Q5PQR6,,,,,43.1,102.0,2.3e-10,69.7,sp|Q5PQR6|SMA2L_RAT Sperm microtubule associated protein 2-like OS=Rattus norvegicus OX=10116 GN=Spmap2l PE=2 SV=1,,,,,,
OG_11911,FUN_023536-T1,Peve_00042361,,apul_peve,42.254,,,,,,,,,,,,,,,,,
OG_11912,FUN_023548-T1,Peve_00010881,,apul_peve,69.7295,,,,,,,,,,,,,,,,,
OG_11913,FUN_023549-T1,Peve_00041542,,apul_peve,52.028000000000006,FUN_023549-T1,Q96RS0,TGS1_HUMAN,,Trimethylguanosine synthase (EC 2.1.1.-) (CLL-associated antigen KW-2) (Cap-specific guanine-N(2) methyltransferase) (Hepatocellular carcinoma-associated antigen 137) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT),Homo sapiens (Human),41.1,462.0,3.9999999999999997e-84,314.7,sp|Q96RS0|TGS1_HUMAN Trimethylguanosine synthase OS=Homo sapiens OX=9606 GN=TGS1 PE=1 SV=3,GO:0000387; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0008173; GO:0015030; GO:0022613; GO:0030532; GO:0036261; GO:0071164,7-methylguanosine cap hypermethylation [GO:0036261]; ribonucleoprotein complex biogenesis [GO:0022613]; spliceosomal snRNP assembly [GO:0000387],Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532],RNA cap trimethylguanosine synthase activity [GO:0071164]; RNA methyltransferase activity [GO:0008173],GO:0003824; GO:0005615; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0016740; GO:0043226; GO:0065003; GO:0140098,"catalytic activity; extracellular space; nucleus; nucleoplasm; nucleolus; cytosol; transferase activity; organelle; protein-containing complex assembly; catalytic activity, acting on RNA"
OG_11914,FUN_023560-T1,Peve_00037260,,apul_peve,32.941,,,,,,,,,,,,,,,,,
OG_11915,FUN_023566-T1,Peve_00037264,,apul_peve,78.027,FUN_023566-T1,Q14728,MFS10_HUMAN,,Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein),Homo sapiens (Human),46.4,431.0,2.1e-101,370.9,sp|Q14728|MFS10_HUMAN Major facilitator superfamily domain-containing protein 10 OS=Homo sapiens OX=9606 GN=MFSD10 PE=1 SV=1,GO:0005637; GO:0006915; GO:0008493; GO:0008514; GO:0016020; GO:0030659; GO:0031526; GO:0043252,apoptotic process [GO:0006915]; sodium-independent organic anion transport [GO:0043252],brush border membrane [GO:0031526]; cytoplasmic vesicle membrane [GO:0030659]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637],organic anion transmembrane transporter activity [GO:0008514]; tetracycline transmembrane transporter activity [GO:0008493],GO:0005215; GO:0012501,transporter activity; programmed cell death
OG_11916,FUN_023576-T1,Peve_00009072,,apul_peve,55.953,,,,,,,,,,,,,,,,,
OG_11917,FUN_023583-T1,Peve_00035144,,apul_peve,40.016000000000005,FUN_023583-T1,Q58EK5,TDRD1_DANRE,,Tudor domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),26.2,854.0,5.5e-65,251.9,sp|Q58EK5|TDRD1_DANRE Tudor domain-containing protein 1 OS=Danio rerio OX=7955 GN=tdrd1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0034584; GO:0034587; GO:0043186; GO:0051321; GO:0071546; GO:0141196,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546],piRNA binding [GO:0034584]; zinc ion binding [GO:0008270],GO:0003723; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,RNA binding; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_11918,FUN_023593-T2,Peve_00032462,,apul_peve,60.526,FUN_023593-T2,Q6PIW4,FIGL1_HUMAN,,Fidgetin-like protein 1 (EC 3.6.4.-),Homo sapiens (Human),30.5,469.0,1.2e-40,169.1,sp|Q6PIW4|FIGL1_HUMAN Fidgetin-like protein 1 OS=Homo sapiens OX=9606 GN=FIGNL1 PE=1 SV=2,GO:0000228; GO:0000287; GO:0001649; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0007140; GO:0008568; GO:0010569; GO:0016787; GO:0016887; GO:0033687; GO:0043066; GO:0046034; GO:0048471; GO:0051726; GO:0070062; GO:0071479; GO:2001243,ATP metabolic process [GO:0046034]; cellular response to ionizing radiation [GO:0071479]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; regulation of cell cycle [GO:0051726]; regulation of double-strand break repair via homologous recombination [GO:0010569],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; microtubule severing ATPase activity [GO:0008568],GO:0000228; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0055086; GO:0140013; GO:0140096; GO:0140657; GO:1901135,"nuclear chromosome; catalytic activity; nucleus; nucleoplasm; chromosome; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; nucleobase-containing small molecule metabolic process; meiotic nuclear division; catalytic activity, acting on a protein; ATP-dependent activity; carbohydrate derivative metabolic process"
OG_11919,FUN_023618-T1,Peve_00034085,,apul_peve,57.554,FUN_023618-T1,P47032,PRY1_YEAST,,Protein PRY1 (Pathogenesis-related protein 1),Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast),37.9,140.0,1.8e-14,81.6,sp|P47032|PRY1_YEAST Protein PRY1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PRY1 PE=1 SV=1,GO:0000287; GO:0000324; GO:0005504; GO:0005576; GO:0005615; GO:0005635; GO:0005783; GO:0015485; GO:0015908; GO:0015918; GO:0019953; GO:0032934,fatty acid transport [GO:0015908]; sexual reproduction [GO:0019953]; sterol transport [GO:0015918],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fungal-type vacuole [GO:0000324]; nuclear envelope [GO:0005635],cholesterol binding [GO:0015485]; fatty acid binding [GO:0005504]; magnesium ion binding [GO:0000287]; sterol binding [GO:0032934],GO:0005576; GO:0005615; GO:0005635; GO:0005773; GO:0005783; GO:0008289; GO:0022414; GO:0043226,extracellular region; extracellular space; nuclear envelope; vacuole; endoplasmic reticulum; lipid binding; reproductive process; organelle
OG_11920,FUN_023624-T1,Peve_00010905,,apul_peve,53.0195,,,,,,,,,,,,,,,,,
OG_11921,FUN_023628-T1,Peve_00037263,,apul_peve,88.8,FUN_023628-T1,Q6DFJ9,,,,,46.2,132.0,7.8e-25,114.8,sp|Q6DFJ9|CCNJ_XENLA Cyclin-J OS=Xenopus laevis OX=8355 GN=ccnj PE=2 SV=1,,,,,,
OG_11922,FUN_023637-T1,Peve_00029806,,apul_peve,50.2615,,,,,,,,,,,,,,,,,
OG_11923,FUN_023669-T2,Peve_00031936,,apul_peve,83.3065,FUN_023669-T2,Q62824,EXOC4_RAT,,Exocyst complex component 4 (Exocyst complex component Sec8) (rSec8),Rattus norvegicus (Rat),37.4,730.0,1.4999999999999999e-120,435.3,sp|Q62824|EXOC4_RAT Exocyst complex component 4 OS=Rattus norvegicus OX=10116 GN=Exoc4 PE=1 SV=1,GO:0000145; GO:0005768; GO:0005813; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006903; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0030010; GO:0030165; GO:0030425; GO:0030426; GO:0031252; GO:0032584; GO:0032991; GO:0035255; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0044091; GO:0044877; GO:0045202; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0071806; GO:0090522; GO:0090543; GO:0098685; GO:0098696; GO:0099092,chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; protein transmembrane transport [GO:0071806]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522],"cell leading edge [GO:0031252]; centrosome [GO:0005813]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; endosome [GO:0005768]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]",ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877],GO:0005768; GO:0005815; GO:0007163; GO:0016192; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0055085,endosome; microtubule organizing center; establishment or maintenance of cell polarity; vesicle-mediated transport; signaling; cell differentiation; cytoplasmic vesicle; organelle; transmembrane transport
OG_11924,FUN_023670-T1,Peve_00012776,,apul_peve,74.719,FUN_023670-T1,P11309,PIM1_HUMAN,,Serine/threonine-protein kinase pim-1 (EC 2.7.11.1),Homo sapiens (Human),39.4,208.0,1.4e-36,154.8,sp|P11309|PIM1_HUMAN Serine/threonine-protein kinase pim-1 OS=Homo sapiens OX=9606 GN=PIM1 PE=1 SV=4,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007346; GO:0008134; GO:0022898; GO:0030145; GO:0043024; GO:0043066; GO:0043433; GO:0043539; GO:0045737; GO:0045824; GO:0045893; GO:0046777; GO:0050821; GO:0060045; GO:0070561; GO:0071346; GO:0071902; GO:0090336; GO:0106310; GO:1902033; GO:1904263; GO:1905062; GO:1990748,apoptotic process [GO:0006915]; cellular detoxification [GO:1990748]; cellular response to type II interferon [GO:0071346]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of innate immune response [GO:0045824]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of TORC1 signaling [GO:1904263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of mitotic cell cycle [GO:0007346]; regulation of transmembrane transporter activity [GO:0022898]; vitamin D receptor signaling pathway [GO:0070561],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024]; transcription factor binding [GO:0008134],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098754; GO:0098772; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; plasma membrane; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; detoxification; molecular function regulator activity; catalytic activity, acting on a protein"
OG_11925,FUN_023695-T1,Peve_00017428,,apul_peve,39.4115,,,,,,,,,,,,,,,,,
OG_11926,FUN_023779-T2,Peve_00035449,,apul_peve,59.091,,,,,,,,,,,,,,,,,
OG_11927,FUN_023796-T1,Peve_00039444,,apul_peve,40.145,FUN_023796-T1,Q3ZK22,VEZA_MOUSE,,Vezatin,Mus musculus (Mouse),23.5,622.0,6.5e-11,70.9,sp|Q3ZK22|VEZA_MOUSE Vezatin OS=Mus musculus OX=10090 GN=Vezt PE=1 SV=2,GO:0001669; GO:0002142; GO:0005634; GO:0005886; GO:0005912; GO:0017022; GO:0043009; GO:0060074; GO:0060171; GO:0098609; GO:0098794; GO:0098978,cell-cell adhesion [GO:0098609]; chordate embryonic development [GO:0043009]; synapse maturation [GO:0060074],acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; stereocilia ankle link complex [GO:0002142]; stereocilium membrane [GO:0060171],myosin binding [GO:0017022],GO:0005634; GO:0005886; GO:0007155; GO:0008092; GO:0031410; GO:0034330; GO:0043226; GO:0048856,nucleus; plasma membrane; cell adhesion; cytoskeletal protein binding; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development
OG_11928,FUN_023819-T1,Peve_00045275,,apul_peve,32.456,,,,,,,,,,,,,,,,,
OG_11929,FUN_023932-T2,Peve_00026573,,apul_peve,37.3715,FUN_023932-T2,Q6P1D7,SLX4_MOUSE,,Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12),Mus musculus (Mouse),32.1,243.0,2.5e-18,97.1,sp|Q6P1D7|SLX4_MOUSE Structure-specific endonuclease subunit SLX4 OS=Mus musculus OX=10090 GN=Slx4 PE=1 SV=1,GO:0000724; GO:0000781; GO:0000785; GO:0003677; GO:0005654; GO:0006260; GO:0006289; GO:0008047; GO:0008270; GO:0010792; GO:0032206; GO:0033557; GO:0048476; GO:0061820; GO:0070522; GO:0072429; GO:0090656; GO:1904357; GO:1904431,DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; positive regulation of telomere maintenance [GO:0032206]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; Holliday junction resolvase complex [GO:0048476]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]",DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0006260; GO:0006281; GO:0006310; GO:0032200; GO:0098772,DNA binding; nucleoplasm; DNA replication; DNA repair; DNA recombination; telomere organization; molecular function regulator activity
OG_11929,FUN_023932-T2,Peve_00026573,,apul_peve,37.3715,FUN_023932-T2,Q6P1D7,SLX4_MOUSE,,Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12),Mus musculus (Mouse),46.8,77.0,1.9e-10,70.9,sp|Q6P1D7|SLX4_MOUSE Structure-specific endonuclease subunit SLX4 OS=Mus musculus OX=10090 GN=Slx4 PE=1 SV=1,GO:0000724; GO:0000781; GO:0000785; GO:0003677; GO:0005654; GO:0006260; GO:0006289; GO:0008047; GO:0008270; GO:0010792; GO:0032206; GO:0033557; GO:0048476; GO:0061820; GO:0070522; GO:0072429; GO:0090656; GO:1904357; GO:1904431,DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; positive regulation of telomere maintenance [GO:0032206]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820],"chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; ERCC4-ERCC1 complex [GO:0070522]; Holliday junction resolvase complex [GO:0048476]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]",DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; zinc ion binding [GO:0008270],GO:0003677; GO:0005654; GO:0006260; GO:0006281; GO:0006310; GO:0032200; GO:0098772,DNA binding; nucleoplasm; DNA replication; DNA repair; DNA recombination; telomere organization; molecular function regulator activity
OG_11930,FUN_023946-T1,Peve_00010792,,apul_peve,89.56,FUN_023946-T1,P70704,AT8A1_MOUSE,,Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1),Mus musculus (Mouse),59.1,1138.0,0.0,1317.8,sp|P70704|AT8A1_MOUSE Phospholipid-transporting ATPase IA OS=Mus musculus OX=10090 GN=Atp8a1 PE=1 SV=2,GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007612; GO:0016887; GO:0030335; GO:0030672; GO:0031090; GO:0031410; GO:0042584; GO:0045202; GO:0048488; GO:0061092; GO:0090556; GO:0098978; GO:0140331; GO:0140346; GO:1990531,aminophospholipid translocation [GO:0140331]; learning [GO:0007612]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; synaptic vesicle endocytosis [GO:0048488],chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556],GO:0003824; GO:0005215; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0050877; GO:0061024; GO:0140657,catalytic activity; transporter activity; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; nervous system process; membrane organization; ATP-dependent activity
OG_11931,FUN_023968-T1,Peve_00043980,,apul_peve,56.024,FUN_023968-T1,B8NHE3,FLVH_ASPFN,,Methyltransferase flvH (EC 2.1.1.-) (Flavunoidine biosynthesis cluster protein H),Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167),26.2,126.0,2.4e-07,57.0,sp|B8NHE3|FLVH_ASPFN Methyltransferase flvH OS=Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) OX=332952 GN=flvH PE=1 SV=1,GO:0008168; GO:0016114; GO:0032259; GO:0046872,methylation [GO:0032259]; terpenoid biosynthetic process [GO:0016114],,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_11932,FUN_023980-T1,Peve_00020885,,apul_peve,51.032,FUN_023980-T1,Q9GZQ4,NMUR2_HUMAN,,Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1),Homo sapiens (Human),25.7,296.0,1.9e-14,81.6,sp|Q9GZQ4|NMUR2_HUMAN Neuromedin-U receptor 2 OS=Homo sapiens OX=9606 GN=NMUR2 PE=1 SV=2,GO:0001607; GO:0002023; GO:0004930; GO:0005229; GO:0005525; GO:0005886; GO:0006940; GO:0007200; GO:0007218; GO:0007267; GO:0007417; GO:0007625; GO:0007631; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482; GO:0050850,arachidonate secretion [GO:0050482]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; feeding behavior [GO:0007631]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium-mediated signaling [GO:0050850]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of smooth muscle contraction [GO:0006940]; response to pain [GO:0048265],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188],GO:0005215; GO:0005886; GO:0023052; GO:0048856; GO:0060089,transporter activity; plasma membrane; signaling; anatomical structure development; molecular transducer activity
OG_11933,FUN_023984-T1,Peve_00020890,,apul_peve,78.49600000000001,FUN_023984-T1,Q08CX2,,,,,48.9,135.0,3.6e-35,151.4,sp|Q08CX2|SH24A_XENTR SH2 domain-containing protein 4A OS=Xenopus tropicalis OX=8364 GN=sh2d4a PE=2 SV=1,,,,,,
OG_11933,FUN_023984-T1,Peve_00020890,,apul_peve,78.49600000000001,FUN_023984-T1,Q08CX2,,,,,55.6,90.0,4e-18,94.7,sp|Q08CX2|SH24A_XENTR SH2 domain-containing protein 4A OS=Xenopus tropicalis OX=8364 GN=sh2d4a PE=2 SV=1,,,,,,
OG_11934,FUN_024006-T1,Peve_00031281,,apul_peve,67.0255,FUN_024006-T1,Q9UBS3,DNJB9_HUMAN,,DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4) (ER-resident protein ERdj4) (ERdj4) (Microvascular endothelial differentiation gene 1 protein) (Mdg-1),Homo sapiens (Human),44.5,227.0,2.1e-25,117.5,sp|Q9UBS3|DNJB9_HUMAN DnaJ homolog subfamily B member 9 OS=Homo sapiens OX=9606 GN=DNAJB9 PE=1 SV=1,GO:0002639; GO:0005730; GO:0005737; GO:0005783; GO:0005788; GO:0005789; GO:0006986; GO:0030183; GO:0030544; GO:0034976; GO:0036503; GO:0051087; GO:0051787; GO:0070062; GO:1903895,B cell differentiation [GO:0030183]; ERAD pathway [GO:0036503]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; positive regulation of immunoglobulin production [GO:0002639]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730],Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; protein-folding chaperone binding [GO:0051087],GO:0002376; GO:0005730; GO:0005783; GO:0030154; GO:0030163; GO:0043226,immune system process; nucleolus; endoplasmic reticulum; cell differentiation; protein catabolic process; organelle
OG_11935,FUN_024020-T1,Peve_00002556,,apul_peve,47.471,,,,,,,,,,,,,,,,,
OG_11936,FUN_024021-T1,Peve_00002554,,apul_peve,62.007,FUN_024021-T1,Q63415,PCSK6_RAT,,Proprotein convertase subtilisin/kexin type 6 (EC 3.4.21.-) (Paired basic amino acid cleaving enzyme 4) (Subtilisin-like proprotein convertase 4) (SPC4) (Subtilisin/kexin-like protease PACE4),Rattus norvegicus (Rat),39.2,572.0,1.3e-112,408.7,sp|Q63415|PCSK6_RAT Proprotein convertase subtilisin/kexin type 6 OS=Rattus norvegicus OX=10116 GN=Pcsk6 PE=1 SV=1,GO:0004175; GO:0004252; GO:0005615; GO:0007354; GO:0007368; GO:0008201; GO:0009100; GO:0009986; GO:0016020; GO:0016485; GO:0016486; GO:0032902; GO:0032940; GO:0048406; GO:0062023,"determination of left/right symmetry [GO:0007368]; glycoprotein metabolic process [GO:0009100]; nerve growth factor production [GO:0032902]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; secretion by cell [GO:0032940]; zygotic determination of anterior/posterior axis, embryo [GO:0007354]",cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; membrane [GO:0016020],endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; nerve growth factor binding [GO:0048406]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005615; GO:0016787; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; extracellular space; hydrolase activity; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_11937,FUN_024035-T1,Peve_00020331,,apul_peve,94.937,FUN_024035-T1,Q5RGV1,,,,,79.6,481.0,1.4e-220,766.9,sp|Q5RGV1|IMDH3_DANRE Inosine-5'-monophosphate dehydrogenase 1b OS=Danio rerio OX=7955 GN=impdh1b PE=2 SV=1,,,,,,
OG_11938,FUN_024036-T1,Peve_00032402,,apul_peve,55.48,FUN_024036-T1,P69478,CHSTB_RAT,,Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1),Rattus norvegicus (Rat),35.5,251.0,2.2e-36,154.5,sp|P69478|CHSTB_RAT Carbohydrate sulfotransferase 11 OS=Rattus norvegicus OX=10116 GN=Chst11 PE=1 SV=1,GO:0000139; GO:0001537; GO:0001701; GO:0002063; GO:0006915; GO:0007179; GO:0007585; GO:0008146; GO:0009791; GO:0016051; GO:0030166; GO:0030326; GO:0030512; GO:0033037; GO:0036342; GO:0042127; GO:0042733; GO:0043066; GO:0047756; GO:0048589; GO:0048703; GO:0048704; GO:0050659; GO:0051216,apoptotic process [GO:0006915]; carbohydrate biosynthetic process [GO:0016051]; cartilage development [GO:0051216]; chondrocyte development [GO:0002063]; developmental growth [GO:0048589]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; embryonic viscerocranium morphogenesis [GO:0048703]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; polysaccharide localization [GO:0033037]; post-anal tail morphogenesis [GO:0036342]; post-embryonic development [GO:0009791]; proteoglycan biosynthetic process [GO:0030166]; regulation of cell population proliferation [GO:0042127]; respiratory gaseous exchange by respiratory system [GO:0007585]; transforming growth factor beta receptor signaling pathway [GO:0007179],Golgi membrane [GO:0000139],chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity [GO:0050659]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005975; GO:0009101; GO:0012501; GO:0016740; GO:0048856; GO:1901135,catalytic activity; carbohydrate metabolic process; glycoprotein biosynthetic process; programmed cell death; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_11939,FUN_024038-T1,Peve_00020337,,apul_peve,64.08,FUN_024038-T1,Q9LIG0,,,,,26.5,321.0,2.1e-25,118.2,sp|Q9LIG0|Y3136_ARATH Clavaminate synthase-like protein At3g21360 OS=Arabidopsis thaliana OX=3702 GN=At3g21360 PE=1 SV=1,,,,,,
OG_11940,FUN_024048-T1,Peve_00020346,,apul_peve,72.436,FUN_024048-T1,Q0P5B3,,,,,54.5,123.0,1.9e-38,160.2,sp|Q0P5B3|RBTN1_BOVIN Rhombotin-1 OS=Bos taurus OX=9913 GN=LMO1 PE=2 SV=1,,,,,,
OG_11941,FUN_024050-T1,Peve_00020345,,apul_peve,42.5,,,,,,,,,,,,,,,,,
OG_11942,FUN_024057-T1,Peve_00000166,,apul_peve,63.6435,,,,,,,,,,,,,,,,,
OG_11943,FUN_024069-T1,Peve_00000148,,apul_peve,66.7405,FUN_024069-T1,E9Q236,MRP4_MOUSE,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4),Mus musculus (Mouse),46.1,1323.0,0.0,1099.3,sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1,GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015431; GO:0015432; GO:0015562; GO:0015665; GO:0015721; GO:0015732; GO:0015747; GO:0015850; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0060271; GO:0070730; GO:0071716; GO:0140115; GO:1901571,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; fatty acid derivative transport [GO:1901571]; leukotriene transport [GO:0071716]; organic hydroxy compound transport [GO:0015850]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; alcohol transmembrane transporter activity [GO:0015665]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_11944,FUN_024078-T1,Peve_00000133,,apul_peve,63.45,FUN_024078-T1,P58307,,,,,26.6,331.0,5.3e-20,100.1,sp|P58307|OX1R_MOUSE Orexin/Hypocretin receptor type 1 OS=Mus musculus OX=10090 GN=Hcrtr1 PE=2 SV=3,,,,,,
OG_11945,FUN_024079-T1,Peve_00000126,,apul_peve,48.058,FUN_024079-T1,C3ZQF9,,,,,27.1,336.0,1.7e-21,105.1,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_11946,FUN_024105-T1,Peve_00000189,,apul_peve,43.6545,FUN_024105-T1,Q9EQD2,NPFF2_RAT,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor),Rattus norvegicus (Rat),22.1,308.0,1.7e-12,75.1,sp|Q9EQD2|NPFF2_RAT Neuropeptide FF receptor 2 OS=Rattus norvegicus OX=10116 GN=Npffr2 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_11947,FUN_024116-T1,Peve_00000179,,apul_peve,46.479,,,,,,,,,,,,,,,,,
OG_11948,FUN_024117-T1,Peve_00000178,,apul_peve,66.176,,,,,,,,,,,,,,,,,
OG_11949,FUN_024138-T1,Peve_00006752,,apul_peve,73.542,FUN_024138-T1,Q5U317,,,,,35.6,317.0,1.2e-19,99.8,sp|Q5U317|FIP1_RAT Pre-mRNA 3'-end-processing factor FIP1 OS=Rattus norvegicus OX=10116 GN=Fip1l1 PE=1 SV=1,,,,,,
OG_11950,FUN_024139-T1,Peve_00006750,,apul_peve,62.526,FUN_024139-T1,O35114,SCRB2_MOUSE,,Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2),Mus musculus (Mouse),32.7,486.0,1.2e-78,295.4,sp|O35114|SCRB2_MOUSE Lysosome membrane protein 2 OS=Mus musculus OX=10090 GN=Scarb2 PE=1 SV=3,GO:0001786; GO:0005044; GO:0005765; GO:0005886; GO:0006622; GO:0006898; GO:0007605; GO:0015485; GO:0015917; GO:0019899; GO:0030666; GO:0031210; GO:0038024; GO:0042803; GO:0043202; GO:0043470; GO:0051087; GO:0099638; GO:1905123,aminophospholipid transport [GO:0015917]; endosome to plasma membrane protein transport [GO:0099638]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of carbohydrate catabolic process [GO:0043470]; regulation of glucosylceramidase activity [GO:1905123]; sensory perception of sound [GO:0007605],endocytic vesicle membrane [GO:0030666]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886],cargo receptor activity [GO:0038024]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; phosphatidylcholine binding [GO:0031210]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; scavenger receptor activity [GO:0005044],GO:0005886; GO:0006886; GO:0008289; GO:0016192; GO:0038024; GO:0050877; GO:0072659,plasma membrane; intracellular protein transport; lipid binding; vesicle-mediated transport; cargo receptor activity; nervous system process; protein localization to plasma membrane
OG_11951,FUN_024141-T1,Peve_00036829,,apul_peve,74.157,FUN_024141-T1,Q9TUP7,,,,,25.2,318.0,1.2e-20,102.4,sp|Q9TUP7|OX2R_CANLF Orexin receptor type 2 OS=Canis lupus familiaris OX=9615 GN=HCRTR2 PE=1 SV=1,,,,,,
OG_11952,FUN_024143-T1,Peve_00036830,,apul_peve,46.041,FUN_024143-T1,Q8K458,,,,,31.7,259.0,7.8e-12,73.2,sp|Q8K458|PKR2_MOUSE Prokineticin receptor 2 OS=Mus musculus OX=10090 GN=Prokr2 PE=2 SV=1,,,,,,
OG_11953,FUN_024145-T1,Peve_00036835,,apul_peve,42.81,,,,,,,,,,,,,,,,,
OG_11954,FUN_024149-T1,Peve_00036838,,apul_peve,70.068,,,,,,,,,,,,,,,,,
OG_11955,FUN_024153-T1,Peve_00003154,,apul_peve,71.792,,,,,,,,,,,,,,,,,
OG_11956,FUN_024154-T1,Peve_00034620,,apul_peve,46.882000000000005,FUN_024154-T1,Q76FK4,NOL8_HUMAN,,Nucleolar protein 8 (Nucleolar protein Nop132),Homo sapiens (Human),46.5,200.0,1.3999999999999998e-41,173.3,sp|Q76FK4|NOL8_HUMAN Nucleolar protein 8 OS=Homo sapiens OX=9606 GN=NOL8 PE=1 SV=1,GO:0003723; GO:0005694; GO:0005730; GO:0006364; GO:1902570,protein localization to nucleolus [GO:1902570]; rRNA processing [GO:0006364],chromosome [GO:0005694]; nucleolus [GO:0005730],RNA binding [GO:0003723],GO:0003723; GO:0005694; GO:0005730; GO:0043226,RNA binding; chromosome; nucleolus; organelle
OG_11957,FUN_024159-T1,Peve_00012378,,apul_peve,44.572,FUN_024159-T1,O60494,CUBN_HUMAN,,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Homo sapiens (Human),23.8,940.0,1.5e-54,216.5,sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5,GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_11958,FUN_024163-T1,Peve_00012377,,apul_peve,71.15100000000001,FUN_024163-T1,Q8AV28,,,,,33.4,965.0,2.9000000000000007e-71,273.1,sp|Q8AV28|PCM1_CHICK Pericentriolar material 1 protein OS=Gallus gallus OX=9031 GN=PCM1 PE=2 SV=1,,,,,,
OG_11959,FUN_024168-T1,Peve_00018701,,apul_peve,40.235,,,,,,,,,,,,,,,,,
OG_11960,FUN_024175-T1,Peve_00031892,,apul_peve,64.3085,FUN_024175-T1,Q5ZMS6,,,,,55.4,168.0,1.2e-42,176.8,sp|Q5ZMS6|TDRD3_CHICK Tudor domain-containing protein 3 OS=Gallus gallus OX=9031 GN=TDRD3 PE=2 SV=1,,,,,,
OG_11961,FUN_024186-T1,Peve_00018697,,apul_peve,66.818,FUN_024186-T1,Q2TBE0,C19L2_HUMAN,,CWF19-like protein 2,Homo sapiens (Human),40.5,896.0,8.8e-133,476.1,sp|Q2TBE0|C19L2_HUMAN CWF19-like protein 2 OS=Homo sapiens OX=9606 GN=CWF19L2 PE=1 SV=4,GO:0000398; GO:0005654; GO:0071014,"mRNA splicing, via spliceosome [GO:0000398]",nucleoplasm [GO:0005654]; post-mRNA release spliceosomal complex [GO:0071014],,GO:0005654; GO:0016071,nucleoplasm; mRNA metabolic process
OG_11962,FUN_024205-T1,Peve_00011549,,apul_peve,40.989,,,,,,,,,,,,,,,,,
OG_11963,FUN_024212-T1,Peve_00023897,,apul_peve,80.413,,,,,,,,,,,,,,,,,
OG_11964,FUN_024269-T1,Peve_00028682,,apul_peve,52.4855,FUN_024269-T1,F1RWC3,CUBN_PIG,,Cubilin (Intrinsic factor-cobalamin receptor),Sus scrofa (Pig),24.3,904.0,7.7e-55,217.2,sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3,GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419,cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031],apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765],calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005615; GO:0005768; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; extracellular space; endosome; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_11965,FUN_024296-T1,Peve_00044688,,apul_peve,76.818,,,,,,,,,,,,,,,,,
OG_11966,FUN_024329-T1,Peve_00016297,,apul_peve,73.71350000000001,FUN_024329-T1,Q21565,,,,,49.5,418.0,2.8e-109,397.1,sp|Q21565|AMT3_CAEEL Putative ammonium transporter 3 OS=Caenorhabditis elegans OX=6239 GN=amt-3 PE=3 SV=2,,,,,,
OG_11967,FUN_024338-T3,Peve_00013126,,apul_peve,72.867,FUN_024338-T3,Q9NPG3,UBN1_HUMAN,,Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein),Homo sapiens (Human),40.4,594.0,1.8e-63,246.1,sp|Q9NPG3|UBN1_HUMAN Ubinuclein-1 OS=Homo sapiens OX=9606 GN=UBN1 PE=1 SV=2,GO:0003677; GO:0005634; GO:0005654; GO:0005923; GO:0006325; GO:0006334; GO:0016604; GO:0016605; GO:0034451,chromatin organization [GO:0006325]; nucleosome assembly [GO:0006334],bicellular tight junction [GO:0005923]; centriolar satellite [GO:0034451]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0043226; GO:0065003,DNA binding; nucleus; nucleoplasm; chromatin organization; organelle; protein-containing complex assembly
OG_11968,FUN_024340-T1,Peve_00016803,,apul_peve,58.053,FUN_024340-T1,A0A0R4IWG9,,,,,46.4,239.0,4.5e-56,221.5,sp|A0A0R4IWG9|GCNA_DANRE Germ cell nuclear acidic protein OS=Danio rerio OX=7955 GN=gcna PE=3 SV=1,,,,,,
OG_11969,FUN_024345-T1,Peve_00010793,,apul_peve,62.185,FUN_024345-T1,P69527,,,,,37.9,617.0,5.1e-112,407.9,sp|P69527|AMPO_RAT Aminopeptidase O OS=Rattus norvegicus OX=10116 GN=Aopep PE=2 SV=2,,,,,,
OG_11970,FUN_024362-T1,Peve_00015481,,apul_peve,51.231,,,,,,,,,,,,,,,,,
OG_11971,FUN_024396-T2,Peve_00021810,,apul_peve,79.021,FUN_024396-T2,P57101,,,,,52.9,119.0,5.699999999999999e-24,112.1,sp|P57101|HAND2_XENLA Heart- and neural crest derivatives-expressed protein 2 OS=Xenopus laevis OX=8355 GN=hand2 PE=2 SV=1,,,,,,
OG_11972,FUN_024397-T1,Peve_00021811,,apul_peve,77.934,FUN_024397-T1,O95671,ASML_HUMAN,,Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein [Includes: dTTP/UTP pyrophosphatase (dTTPase/UTPase) (EC 3.6.1.9) (Nucleoside triphosphate pyrophosphatase) (Nucleotide pyrophosphatase) (Nucleotide PPase); N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-)],Homo sapiens (Human),49.8,211.0,1.1999999999999999e-54,214.5,sp|O95671|ASML_HUMAN Probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein OS=Homo sapiens OX=9606 GN=ASMTL PE=1 SV=3,GO:0005829; GO:0008171; GO:0009117; GO:0032259; GO:0036218; GO:0036221; GO:0046983; GO:0047429,methylation [GO:0032259]; nucleotide metabolic process [GO:0009117],cytosol [GO:0005829],dTTP diphosphatase activity [GO:0036218]; nucleoside triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171]; protein dimerization activity [GO:0046983]; UTP diphosphatase activity [GO:0036221],GO:0003824; GO:0005829; GO:0016740; GO:0016787; GO:0055086,catalytic activity; cytosol; transferase activity; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_11973,FUN_024404-T1,Peve_00029252,,apul_peve,51.392,FUN_024404-T1,O77408,,,,,30.3,165.0,4.6e-12,73.9,sp|O77408|OAR1_LYMST Octopamine receptor 1 OS=Lymnaea stagnalis OX=6523 PE=1 SV=1,,,,,,
OG_11974,FUN_024415-T1,Peve_00009799,,apul_peve,91.525,FUN_024415-T1,A0A3G9HPE6,,,,,33.9,384.0,3.9e-41,170.6,sp|A0A3G9HPE6|ALT3_ALTAL Dehydrogenase ALT3 OS=Alternaria alternata OX=5599 GN=ALT3 PE=3 SV=1,,,,,,
OG_11975,FUN_024416-T1,Peve_00027661,,apul_peve,60.0685,FUN_024416-T1,Q09YK6,,,,,38.1,388.0,2e-27,125.6,"sp|Q09YK6|ASZ1_ATEGE Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 OS=Ateles geoffroyi OX=9509 GN=ASZ1 PE=3 SV=1",,,,,,
OG_11976,FUN_024436-T1,Peve_00004167,,apul_peve,54.3625,,,,,,,,,,,,,,,,,
OG_11977,FUN_024440-T1,Peve_00004164,,apul_peve,64.085,,,,,,,,,,,,,,,,,
OG_11978,FUN_024442-T1,Peve_00025485,,apul_peve,58.226,,,,,,,,,,,,,,,,,
OG_11979,FUN_024443-T1,Peve_00025481,,apul_peve,44.0765,FUN_024443-T1,O18738,DAG1_BOVIN,,Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)],Bos taurus (Bovine),32.3,232.0,7.900000000000001e-28,128.3,sp|O18738|DAG1_BOVIN Dystroglycan 1 OS=Bos taurus OX=9913 GN=DAG1 PE=1 SV=1,GO:0002009; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005654; GO:0005737; GO:0005856; GO:0005886; GO:0007411; GO:0016011; GO:0016020; GO:0016203; GO:0021675; GO:0042383; GO:0043236; GO:0045211,axon guidance [GO:0007411]; morphogenesis of an epithelium [GO:0002009]; muscle attachment [GO:0016203]; nerve development [GO:0021675],basement membrane [GO:0005604]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383],calcium ion binding [GO:0005509]; laminin binding [GO:0043236],GO:0005576; GO:0005615; GO:0005654; GO:0005856; GO:0005886; GO:0030312; GO:0031012; GO:0043226; GO:0048856,extracellular region; extracellular space; nucleoplasm; cytoskeleton; plasma membrane; external encapsulating structure; extracellular matrix; organelle; anatomical structure development
OG_11980,FUN_024471-T1,Peve_00041387,,apul_peve,53.614,,,,,,,,,,,,,,,,,
OG_11981,FUN_024486-T1,Peve_00042023,,apul_peve,32.468,,,,,,,,,,,,,,,,,
OG_11982,FUN_024504-T1,Peve_00035376,,apul_peve,75.853,,,,,,,,,,,,,,,,,
OG_11983,FUN_024514-T1,Peve_00001222,,apul_peve,46.984,FUN_024514-T1,B3EWZ6,,,,,35.8,162.0,1.2e-18,97.1,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_11984,FUN_024546-T1,Peve_00034565,,apul_peve,55.2965,FUN_024546-T1,O57382,,,,,28.3,431.0,1.3e-36,155.6,sp|O57382|TLL2_XENLA Tolloid-like protein 2 OS=Xenopus laevis OX=8355 GN=tll2 PE=2 SV=1,,,,,,
OG_11985,FUN_024552-T1,Peve_00017337,,apul_peve,63.778000000000006,FUN_024552-T1,P25931,,,,,26.7,270.0,2e-06,55.1,sp|P25931|RYAR_DROME RYamide receptor OS=Drosophila melanogaster OX=7227 GN=RYa-R PE=2 SV=2,,,,,,
OG_11986,FUN_024562-T2,Peve_00009967,,apul_peve,79.8765,FUN_024562-T2,Q5R724,,,,,44.4,399.0,1.1e-82,309.7,sp|Q5R724|SP20H_PONAB Transcription factor SPT20 homolog OS=Pongo abelii OX=9601 GN=SUPT20H PE=2 SV=1,,,,,,
OG_11987,FUN_024568-T2,Peve_00043624,,apul_peve,53.611,FUN_024568-T2,P46597,ASMT_HUMAN,,Acetylserotonin O-methyltransferase (EC 2.1.1.4) (Hydroxyindole O-methyltransferase) (HIOMT),Homo sapiens (Human),38.4,341.0,7.6e-60,232.6,sp|P46597|ASMT_HUMAN Acetylserotonin O-methyltransferase OS=Homo sapiens OX=9606 GN=ASMT PE=1 SV=1,GO:0005829; GO:0006412; GO:0006629; GO:0008171; GO:0008172; GO:0017096; GO:0030187; GO:0032259; GO:0042802; GO:0042803; GO:0046219,indolalkylamine biosynthetic process [GO:0046219]; lipid metabolic process [GO:0006629]; melatonin biosynthetic process [GO:0030187]; methylation [GO:0032259]; translation [GO:0006412],cytosol [GO:0005829],acetylserotonin O-methyltransferase activity [GO:0017096]; identical protein binding [GO:0042802]; O-methyltransferase activity [GO:0008171]; protein homodimerization activity [GO:0042803]; S-methyltransferase activity [GO:0008172],GO:0003824; GO:0005829; GO:0006629; GO:0016740,catalytic activity; cytosol; lipid metabolic process; transferase activity
OG_11988,FUN_024575-T1,Peve_00026366,,apul_peve,68.0655,,,,,,,,,,,,,,,,,
OG_11989,FUN_024591-T1,Peve_00007646,,apul_peve,58.411,,,,,,,,,,,,,,,,,
OG_11990,FUN_024603-T1,Peve_00002379,,apul_peve,47.557,FUN_024603-T1,O60494,CUBN_HUMAN,,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Homo sapiens (Human),27.9,247.0,1.1e-13,79.0,sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5,GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_11991,FUN_024622-T1,Peve_00027339,,apul_peve,92.308,FUN_024622-T1,Q7ZVE0,,,,,69.0,100.0,4.3e-37,156.0,sp|Q7ZVE0|GAR1_DANRE H/ACA ribonucleoprotein complex subunit 1 OS=Danio rerio OX=7955 GN=gar1 PE=2 SV=1,,,,,,
OG_11992,FUN_024659-T1,Peve_00012849,,apul_peve,54.338,,,,,,,,,,,,,,,,,
OG_11993,FUN_024673-T1,Peve_00027341,,apul_peve,86.49,FUN_024673-T1,Q9Y3M8,,,,,34.7,1062.0,1.7e-147,525.0,sp|Q9Y3M8|STA13_HUMAN StAR-related lipid transfer protein 13 OS=Homo sapiens OX=9606 GN=STARD13 PE=1 SV=2,,,,,,
OG_11994,FUN_024701-T1,Peve_00045231,,apul_peve,60.593,,,,,,,,,,,,,,,,,
OG_11995,FUN_024708-T1,Peve_00012724,,apul_peve,50.523,FUN_024708-T1,Q6NZG4,DDIAS_MOUSE,,DNA damage-induced apoptosis suppressor protein (Nitric oxide-inducible gene protein),Mus musculus (Mouse),31.1,132.0,5.5e-13,76.6,sp|Q6NZG4|DDIAS_MOUSE DNA damage-induced apoptosis suppressor protein OS=Mus musculus OX=10090 GN=Ddias PE=2 SV=1,GO:0005634; GO:0005737; GO:0006974; GO:0007286; GO:0030097; GO:0034644; GO:0044346; GO:0051726; GO:0071345; GO:0071447; GO:0071480; GO:1902230; GO:2000270,cellular response to cytokine stimulus [GO:0071345]; cellular response to gamma radiation [GO:0071480]; cellular response to hydroperoxide [GO:0071447]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; fibroblast apoptotic process [GO:0044346]; hemopoiesis [GO:0030097]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; regulation of cell cycle [GO:0051726]; spermatid development [GO:0007286],cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0012501; GO:0022414; GO:0043226; GO:0048856,nucleus; programmed cell death; reproductive process; organelle; anatomical structure development
OG_11996,FUN_024713-T1,Peve_00012729,,apul_peve,53.37,,,,,,,,,,,,,,,,,
OG_11997,FUN_024718-T1,Peve_00012703,,apul_peve,62.476,FUN_024718-T1,Q6AXC6,DDX11_MOUSE,,ATP-dependent DNA helicase DDX11 (EC 5.6.2.3) (DEAD/H-box protein 11) (DNA 5'-3' helicase DDX11),Mus musculus (Mouse),48.9,701.0,4.9e-166,586.3,sp|Q6AXC6|DDX11_MOUSE ATP-dependent DNA helicase DDX11 OS=Mus musculus OX=10090 GN=Ddx11 PE=1 SV=2,GO:0000785; GO:0000922; GO:0003677; GO:0003682; GO:0003688; GO:0003690; GO:0003697; GO:0003727; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0007062; GO:0008186; GO:0016887; GO:0030496; GO:0031297; GO:0032091; GO:0035563; GO:0043139; GO:0045142; GO:0045876; GO:0046872; GO:0051539; GO:0051880; GO:0070062; GO:0072711; GO:0072719; GO:0140640; GO:1901838; GO:1904976; GO:1990700; GO:2000781,cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to hydroxyurea [GO:0072711]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of protein binding [GO:0032091]; nucleolar chromatin organization [GO:1990700]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; replication fork processing [GO:0031297]; sister chromatid cohesion [GO:0007062],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; catalytic activity, acting on a nucleic acid [GO:0140640]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; triplex DNA binding [GO:0045142]",GO:0003677; GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0005815; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleoplasm; nucleolus; microtubule organizing center; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_11998,FUN_024721-T1,Peve_00012711,,apul_peve,66.894,,,,,,,,,,,,,,,,,
OG_11999,FUN_024759-T1,Peve_00029132,,apul_peve,38.889,,,,,,,,,,,,,,,,,
OG_12000,FUN_024764-T1,Peve_00026073,,apul_peve,80.901,FUN_024764-T1,O60879,DIAP2_HUMAN,,Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2),Homo sapiens (Human),44.9,1086.0,5.5e-183,643.3,sp|O60879|DIAP2_HUMAN Protein diaphanous homolog 2 OS=Homo sapiens OX=9606 GN=DIAPH2 PE=1 SV=1,GO:0003779; GO:0005102; GO:0005730; GO:0005769; GO:0005783; GO:0005829; GO:0005884; GO:0007292; GO:0030041; GO:0031267; GO:0043231; GO:0048477,actin filament polymerization [GO:0030041]; female gamete generation [GO:0007292]; oogenesis [GO:0048477],actin filament [GO:0005884]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730],actin binding [GO:0003779]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267],GO:0005730; GO:0005768; GO:0005783; GO:0005829; GO:0008092; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0065003,nucleolus; endosome; endoplasmic reticulum; cytosol; cytoskeletal protein binding; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; protein-containing complex assembly
OG_12001,FUN_024830-T1,Peve_00029672,,apul_peve,78.261,,,,,,,,,,,,,,,,,
OG_12002,FUN_024838-T1,Peve_00041947,,apul_peve,73.585,,,,,,,,,,,,,,,,,
OG_12003,FUN_024878-T1,Peve_00006276,,apul_peve,56.054,FUN_024878-T1,Q9U6Y5,,,,,85.2,230.0,9.4e-119,427.6,sp|Q9U6Y5|GFPL1_ZOASP GFP-like fluorescent chromoprotein FP506 OS=Zoanthus sp. OX=105402 PE=1 SV=1,,,,,,
OG_12004,FUN_024883-T1,Peve_00020961,,apul_peve,50.469,,,,,,,,,,,,,,,,,
OG_12005,FUN_024885-T1,Peve_00008005,,apul_peve,90.618,FUN_024885-T1,M9NDE3,,,,,20.2,1708.0,8.9e-48,195.7,sp|M9NDE3|BARK_DROME Protein bark beetle OS=Drosophila melanogaster OX=7227 GN=bark PE=1 SV=1,,,,,,
OG_12006,FUN_024886-T1,Peve_00044614,,apul_peve,69.697,FUN_024886-T1,Q96PZ2,F111A_HUMAN,,Serine protease FAM111A (EC 3.4.21.-),Homo sapiens (Human),26.0,443.0,1.3e-13,79.7,sp|Q96PZ2|F111A_HUMAN Serine protease FAM111A OS=Homo sapiens OX=9606 GN=FAM111A PE=1 SV=2,GO:0000785; GO:0001650; GO:0003697; GO:0005634; GO:0005654; GO:0005737; GO:0006260; GO:0006508; GO:0006974; GO:0008233; GO:0016540; GO:0031297; GO:0045071; GO:0106300,DNA damage response [GO:0006974]; DNA replication [GO:0006260]; negative regulation of viral genome replication [GO:0045071]; protein autoprocessing [GO:0016540]; protein-DNA covalent cross-linking repair [GO:0106300]; proteolysis [GO:0006508]; replication fork processing [GO:0031297],chromatin [GO:0000785]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],peptidase activity [GO:0008233]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006260; GO:0006281; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA replication; DNA repair; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_12007,FUN_024894-T1,Peve_00008004,,apul_peve,94.602,FUN_024894-T1,Q9NYQ6,CELR1_HUMAN,,Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2),Homo sapiens (Human),31.4,229.0,2.3e-21,106.7,sp|Q9NYQ6|CELR1_HUMAN Cadherin EGF LAG seven-pass G-type receptor 1 OS=Homo sapiens OX=9606 GN=CELSR1 PE=1 SV=1,GO:0001736; GO:0001764; GO:0001843; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007266; GO:0007417; GO:0016020; GO:0032956; GO:0042249; GO:0045176; GO:0048105; GO:0060071; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0098609,"apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lateral sprouting involved in lung morphogenesis [GO:0060490]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005886; GO:0007155; GO:0048856; GO:0048870; GO:0060089,nucleoplasm; plasma membrane; cell adhesion; anatomical structure development; cell motility; molecular transducer activity
OG_12008,FUN_024910-T1,Peve_00036824,,apul_peve,39.189,,,,,,,,,,,,,,,,,
OG_12009,FUN_024938-T1,Peve_00003009,,apul_peve,58.8165,FUN_024938-T1,Q9JHS6,,,,,24.7,393.0,3.9e-25,117.5,sp|Q9JHS6|ASIC4_RAT Acid-sensing ion channel 4 OS=Rattus norvegicus OX=10116 GN=Asic4 PE=1 SV=1,,,,,,
OG_12010,FUN_025032-T1,Peve_00038378,,apul_peve,82.4105,FUN_025032-T1,O18875,,,,,55.9,562.0,2.900000000000001e-196,686.4,sp|O18875|SC6A8_BOVIN Sodium- and chloride-dependent creatine transporter 1 OS=Bos taurus OX=9913 GN=SLC6A8 PE=2 SV=1,,,,,,
OG_12011,FUN_025048-T1,Peve_00030550,,apul_peve,77.011,,,,,,,,,,,,,,,,,
OG_12012,FUN_025104-T1,Peve_00037628,,apul_peve,36.842,,,,,,,,,,,,,,,,,
OG_12013,FUN_025138-T1,Peve_00002686,,apul_peve,39.13,,,,,,,,,,,,,,,,,
OG_12014,FUN_025161-T1,Peve_00006110,,apul_peve,63.37,,,,,,,,,,,,,,,,,
OG_12015,FUN_025231-T2,Peve_00034829,,apul_peve,71.295,FUN_025231-T2,P21127,CD11B_HUMAN,,Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1),Homo sapiens (Human),82.4,261.0,1.4e-123,445.7,sp|P21127|CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens OX=9606 GN=CDK11B PE=1 SV=4,GO:0000278; GO:0000307; GO:0001558; GO:0003723; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006468; GO:0006915; GO:0042981; GO:0043484; GO:0046605; GO:0050684; GO:0051726; GO:0106310,apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centrosome cycle [GO:0046605]; regulation of DNA-templated transcription [GO:0006355]; regulation of mRNA processing [GO:0050684]; regulation of RNA splicing [GO:0043484],cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723],GO:0000278; GO:0003723; GO:0003824; GO:0005634; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"mitotic cell cycle; RNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_12016,FUN_025232-T1,Peve_00002770,,apul_peve,86.262,FUN_025232-T1,P17244,,,,,76.6,333.0,3.8e-145,515.8,sp|P17244|G3P_CRIGR Glyceraldehyde-3-phosphate dehydrogenase OS=Cricetulus griseus OX=10029 GN=GAPDH PE=2 SV=2,,,,,,
OG_12017,FUN_025235-T1,Peve_00034839,,apul_peve,79.167,FUN_025235-T1,Q0IIF0,,,,,50.7,355.0,2.3e-95,350.5,sp|Q0IIF0|ILKAP_BOVIN Integrin-linked kinase-associated serine/threonine phosphatase 2C OS=Bos taurus OX=9913 GN=ILKAP PE=2 SV=1,,,,,,
OG_12018,FUN_025253-T1,Peve_00023064,,apul_peve,48.155,,,,,,,,,,,,,,,,,
OG_12019,FUN_025262-T1,Peve_00009060,,apul_peve,54.737,FUN_025262-T1,Q9BZ76,,,,,31.2,205.0,4.1e-22,108.2,sp|Q9BZ76|CNTP3_HUMAN Contactin-associated protein-like 3 OS=Homo sapiens OX=9606 GN=CNTNAP3 PE=1 SV=3,,,,,,
OG_12020,FUN_025264-T1,Peve_00014009,,apul_peve,54.394000000000005,,,,,,,,,,,,,,,,,
OG_12021,FUN_025267-T1,Peve_00030517,,apul_peve,63.078,,,,,,,,,,,,,,,,,
OG_12022,FUN_025268-T2,Peve_00035195,,apul_peve,63.497,,,,,,,,,,,,,,,,,
OG_12023,FUN_025270-T2,Peve_00029242,,apul_peve,50.641,FUN_025270-T2,Q86SQ4,AGRG6_HUMAN,,"Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: Adhesion G-protein coupled receptor G6, N-terminal fragment (ADGRG6 N-terminal fragment) (ADGRG6-NTF); Adhesion G-protein coupled receptor G6, C-terminal fragment (ADGRG6 C-terminal fragment) (ADGRG6-CTF)]",Homo sapiens (Human),31.5,168.0,9.4e-13,77.0,sp|Q86SQ4|AGRG6_HUMAN Adhesion G-protein coupled receptor G6 OS=Homo sapiens OX=9606 GN=ADGRG6 PE=1 SV=3,GO:0001890; GO:0004175; GO:0004930; GO:0005518; GO:0005737; GO:0005789; GO:0005886; GO:0007166; GO:0007186; GO:0007188; GO:0007189; GO:0007193; GO:0007399; GO:0009986; GO:0014037; GO:0016020; GO:0022011; GO:0030500; GO:0042552; GO:0043236; GO:0050840; GO:0051216; GO:0060347; GO:0060856; GO:1903670,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; establishment of blood-brain barrier [GO:0060856]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; nervous system development [GO:0007399]; placenta development [GO:0001890]; regulation of bone mineralization [GO:0030500]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236],GO:0003824; GO:0005886; GO:0016787; GO:0030154; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; cell differentiation; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_12024,FUN_025292-T1,Peve_00040961,,apul_peve,34.783,,,,,,,,,,,,,,,,,
OG_12025,FUN_025293-T1,Peve_00040960,,apul_peve,60.0,,,,,,,,,,,,,,,,,
OG_12026,FUN_025301-T1,Peve_00040948,,apul_peve,40.226,,,,,,,,,,,,,,,,,
OG_12027,FUN_025305-T1,Peve_00040946,,apul_peve,88.69,FUN_025305-T1,Q05048,,,,,51.2,422.0,6.2e-100,365.9,sp|Q05048|CSTF1_HUMAN Cleavage stimulation factor subunit 1 OS=Homo sapiens OX=9606 GN=CSTF1 PE=1 SV=1,,,,,,
OG_12028,FUN_025316-T1,Peve_00027084,,apul_peve,57.2085,,,,,,,,,,,,,,,,,
OG_12029,FUN_025326-T1,Peve_00027066,,apul_peve,46.875,,,,,,,,,,,,,,,,,
OG_12030,FUN_025344-T1,Peve_00014398,,apul_peve,65.092,FUN_025344-T1,P31696,,,,,25.3,1525.0,4.7e-96,355.9,sp|P31696|AGRIN_CHICK Agrin OS=Gallus gallus OX=9031 GN=AGRN PE=1 SV=3,,,,,,
OG_12031,FUN_025345-T1,Peve_00029676,,apul_peve,53.283,FUN_025345-T1,B3EWZ3,,,,,31.3,563.0,1e-52,213.4,sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12032,FUN_025346-T1,Peve_00034882,,apul_peve,62.022,FUN_025346-T1,B3EWZ3,,,,,31.1,560.0,9.4e-65,253.1,sp|B3EWZ3|CADN_ACRMI Coadhesin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12033,FUN_025351-T2,Peve_00004323,,apul_peve,64.67699999999999,FUN_025351-T2,Q6RFZ7,PKHG5_RAT,,Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Neuronal RhoA GEF protein) (Transcript highly enriched in cortex and hippocampus),Rattus norvegicus (Rat),35.4,758.0,1.3e-101,373.2,sp|Q6RFZ7|PKHG5_RAT Pleckstrin homology domain-containing family G member 5 OS=Rattus norvegicus OX=10116 GN=Plekhg5 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0048471; GO:0098793; GO:0140251,endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation protein catabolic process at presynapse [GO:0140251]; Rho protein signal transduction [GO:0007266],axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005886; GO:0031410; GO:0043226; GO:0048870; GO:0098772,plasma membrane; cytoplasmic vesicle; organelle; cell motility; molecular function regulator activity
OG_12034,FUN_025367-T1,Peve_00040519,,apul_peve,90.411,FUN_025367-T1,P51913,,,,,77.9,430.0,1.2e-194,680.6,sp|P51913|ENOA_CHICK Alpha-enolase OS=Gallus gallus OX=9031 GN=ENO1 PE=2 SV=2,,,,,,
OG_12035,FUN_025370-T1,Peve_00040521,,apul_peve,35.668,,,,,,,,,,,,,,,,,
OG_12036,FUN_025377-T1,Peve_00017571,,apul_peve,57.798,FUN_025377-T1,A1L0Y2,,,,,44.0,125.0,6e-25,116.3,sp|A1L0Y2|NEUL4_XENTR Neuralized-like protein 4 OS=Xenopus tropicalis OX=8364 GN=neurl4 PE=2 SV=1,,,,,,
OG_12037,FUN_025384-T1,Peve_00034075,,apul_peve,65.761,,,,,,,,,,,,,,,,,
OG_12038,FUN_025397-T1,Peve_00010776,,apul_peve,54.709,FUN_025397-T1,Q2LE78,,,,,35.9,443.0,1.7e-63,245.0,sp|Q2LE78|BTBD6_XENLA BTB/POZ domain-containing protein 6 OS=Xenopus laevis OX=8355 GN=btbd6 PE=1 SV=1,,,,,,
OG_12039,FUN_025404-T1,Peve_00024120,,apul_peve,51.7595,FUN_025404-T1,Q5TJE8,,,,,30.5,266.0,1.5e-23,112.1,"sp|Q5TJE8|B3GT4_CANLF Beta-1,3-galactosyltransferase 4 OS=Canis lupus familiaris OX=9615 GN=B3GALT4 PE=3 SV=1",,,,,,
OG_12040,FUN_025429-T1,Peve_00030584,,apul_peve,49.367,,,,,,,,,,,,,,,,,
OG_12041,FUN_025433-T1,Peve_00011643,,apul_peve,92.964,,,,,,,,,,,,,,,,,
OG_12042,FUN_025437-T1,Peve_00029484,,apul_peve,46.981,,,,,,,,,,,,,,,,,
OG_12043,FUN_025440-T1,Peve_00029479,,apul_peve,57.068,,,,,,,,,,,,,,,,,
OG_12044,FUN_025461-T1,Peve_00025918,,apul_peve,49.148,,,,,,,,,,,,,,,,,
OG_12045,FUN_025462-T1,Peve_00037206,,apul_peve,37.946,,,,,,,,,,,,,,,,,
OG_12046,FUN_025476-T1,Peve_00043845,,apul_peve,44.2975,,,,,,,,,,,,,,,,,
OG_12047,FUN_025502-T1,Peve_00012876,,apul_peve,58.368,FUN_025502-T1,P21927,,,,,38.3,470.0,1.7e-77,291.6,sp|P21927|CHLE_RABIT Cholinesterase OS=Oryctolagus cuniculus OX=9986 GN=BCHE PE=2 SV=1,,,,,,
OG_12048,FUN_025509-T1,Peve_00002254,,apul_peve,50.505,,,,,,,,,,,,,,,,,
OG_12049,FUN_025514-T1,Peve_00002248,,apul_peve,72.165,FUN_025514-T1,P24392,PEX2_RAT,,Peroxisome biogenesis factor 2 (EC 2.3.2.27) (EC 2.3.2.36) (Peroxin-2) (Peroxisomal membrane protein 3) (Peroxisome assembly factor 1) (PAF-1),Rattus norvegicus (Rat),38.4,198.0,1.6999999999999996e-31,137.5,sp|P24392|PEX2_RAT Peroxisome biogenesis factor 2 OS=Rattus norvegicus OX=10116 GN=Pex2 PE=2 SV=1,GO:0000038; GO:0000425; GO:0001764; GO:0005777; GO:0005778; GO:0006513; GO:0006635; GO:0006699; GO:0007031; GO:0007399; GO:0008270; GO:0016558; GO:0016562; GO:0016593; GO:0031648; GO:0034614; GO:0042632; GO:0045540; GO:0048147; GO:0050680; GO:0061630; GO:1990928,"bile acid biosynthetic process [GO:0006699]; cellular response to reactive oxygen species [GO:0034614]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation [GO:0006635]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fibroblast proliferation [GO:0048147]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; protein destabilization [GO:0031648]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein monoubiquitination [GO:0006513]; regulation of cholesterol biosynthetic process [GO:0045540]; response to amino acid starvation [GO:1990928]; very long-chain fatty acid metabolic process [GO:0000038]",Cdc73/Paf1 complex [GO:0016593]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005777; GO:0006629; GO:0006886; GO:0006914; GO:0007031; GO:0016740; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0140096,"catalytic activity; peroxisome; lipid metabolic process; intracellular protein transport; autophagy; peroxisome organization; transferase activity; organelle; anatomical structure development; cell motility; transmembrane transport; catalytic activity, acting on a protein"
OG_12050,FUN_025534-T1,Peve_00039839,,apul_peve,55.124,,,,,,,,,,,,,,,,,
OG_12051,FUN_025535-T1,Peve_00032946,,apul_peve,64.246,FUN_025535-T1,Q4W1X2,GLFA_ASPFM,,UDP-galactopyranose mutase (UGM) (EC 5.4.99.9),Aspergillus fumigatus (Neosartorya fumigata),38.5,517.0,2.7e-101,370.9,sp|Q4W1X2|GLFA_ASPFM UDP-galactopyranose mutase OS=Aspergillus fumigatus OX=746128 GN=glfA PE=1 SV=1,GO:0000166; GO:0008767; GO:0071555,cell wall organization [GO:0071555],,nucleotide binding [GO:0000166]; UDP-galactopyranose mutase activity [GO:0008767],GO:0003824; GO:0016853; GO:0071554,catalytic activity; isomerase activity; cell wall organization or biogenesis
OG_12052,FUN_025537-T1,Peve_00009474,,apul_peve,47.387,,,,,,,,,,,,,,,,,
OG_12053,FUN_025546-T1,Peve_00041136,,apul_peve,63.47,,,,,,,,,,,,,,,,,
OG_12054,FUN_025575-T1,Peve_00001258,,apul_peve,60.198,FUN_025575-T1,Q92113,,,,,33.8,468.0,2.1000000000000002e-73,278.1,"sp|Q92113|CP17A_SQUAC Steroid 17-alpha-hydroxylase/17,20 lyase OS=Squalus acanthias OX=7797 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_12055,FUN_025588-T1,Peve_00019372,,apul_peve,32.439,,,,,,,,,,,,,,,,,
OG_12056,FUN_025590-T1,Peve_00019375,,apul_peve,41.351,,,,,,,,,,,,,,,,,
OG_12057,FUN_025597-T1,Peve_00041091,,apul_peve,74.688,,,,,,,,,,,,,,,,,
OG_12058,FUN_025603-T1,Peve_00006547,,apul_peve,68.519,FUN_025603-T1,P70115,,,,,22.1,303.0,1.4e-06,55.5,sp|P70115|ACTHR_MESAU Adrenocorticotropic hormone receptor OS=Mesocricetus auratus OX=10036 GN=MC2R PE=2 SV=1,,,,,,
OG_12059,FUN_025605-T1,Peve_00033151,,apul_peve,70.053,FUN_025605-T1,P29274,AA2AR_HUMAN,,Adenosine receptor A2a,Homo sapiens (Human),28.6,311.0,6.5e-17,89.7,sp|P29274|AA2AR_HUMAN Adenosine receptor A2a OS=Homo sapiens OX=9606 GN=ADORA2A PE=1 SV=2,GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005882; GO:0005886; GO:0006355; GO:0006909; GO:0006915; GO:0006954; GO:0006968; GO:0007188; GO:0007189; GO:0007200; GO:0007267; GO:0007271; GO:0007417; GO:0007596; GO:0007600; GO:0007626; GO:0008015; GO:0008285; GO:0008289; GO:0009410; GO:0014049; GO:0014057; GO:0014061; GO:0014074; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0042311; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0070374; GO:0097190; GO:0098978; GO:0099171; GO:1900273; GO:2001235,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; blood circulation [GO:0008015]; blood coagulation [GO:0007596]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; central nervous system development [GO:0007417]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; inflammatory response [GO:0006954]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of calcium ion transport [GO:0051924]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to purine-containing compound [GO:0014074]; response to xenobiotic stimulus [GO:0009410]; sensory perception [GO:0007600]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]",asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734],alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802],GO:0003013; GO:0003014; GO:0005886; GO:0006355; GO:0006954; GO:0008092; GO:0008289; GO:0012501; GO:0016192; GO:0023052; GO:0048856; GO:0050877; GO:0060089,circulatory system process; renal system process; plasma membrane; regulation of DNA-templated transcription; inflammatory response; cytoskeletal protein binding; lipid binding; programmed cell death; vesicle-mediated transport; signaling; anatomical structure development; nervous system process; molecular transducer activity
OG_12060,FUN_025608-T1,Peve_00009536,,apul_peve,55.793,FUN_025608-T1,Q16832,DDR2_HUMAN,,"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)",Homo sapiens (Human),35.1,168.0,1.1e-16,89.0,sp|Q16832|DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens OX=9606 GN=DDR2 PE=1 SV=2,GO:0001503; GO:0003416; GO:0004714; GO:0005518; GO:0005524; GO:0005886; GO:0005925; GO:0007155; GO:0007165; GO:0007169; GO:0010715; GO:0010763; GO:0010976; GO:0015629; GO:0016324; GO:0018108; GO:0030199; GO:0030500; GO:0031214; GO:0032967; GO:0034103; GO:0035988; GO:0035994; GO:0038062; GO:0038063; GO:0043066; GO:0043235; GO:0045669; GO:0045860; GO:0046777; GO:0048146; GO:0051091; GO:0051897; GO:0070374; GO:0071456; GO:0071560; GO:0090091; GO:0090303; GO:1900087; GO:1901299; GO:1904385; GO:1904707; GO:1904754; GO:1904899; GO:2000491,biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; endochondral bone growth [GO:0003416]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; ossification [GO:0001503]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of neuron projection development [GO:0010976]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of wound healing [GO:0090303]; protein autophosphorylation [GO:0046777]; regulation of bone mineralization [GO:0030500]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of tissue remodeling [GO:0034103]; response to muscle stretch [GO:0035994]; signal transduction [GO:0007165],actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005856; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030198; GO:0043226; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; extracellular matrix organization; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_12061,FUN_025627-T1,Peve_00022368,,apul_peve,37.778,FUN_025627-T1,D2YW40,,,,,26.3,133.0,2.9e-07,57.4,sp|D2YW40|SLED_CALRH Snaclec rhodocetin subunit delta OS=Calloselasma rhodostoma OX=8717 PE=1 SV=2,,,,,,
OG_12062,FUN_025635-T1,Peve_00005252,,apul_peve,40.8955,,,,,,,,,,,,,,,,,
OG_12063,FUN_025640-T1,Peve_00041899,,apul_peve,74.286,FUN_025640-T1,Q64559,BACH_RAT,,Cytosolic acyl coenzyme A thioester hydrolase (EC 3.1.2.2) (ACH1) (ACT) (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase) (BACH) (CTE-IIa) (CTE-IIb) (CTE-II) (LACH1) (Long chain acyl-CoA thioester hydrolase) (MTE-II),Rattus norvegicus (Rat),53.1,339.0,1.2e-88,328.2,sp|Q64559|BACH_RAT Cytosolic acyl coenzyme A thioester hydrolase OS=Rattus norvegicus OX=10116 GN=Acot7 PE=1 SV=4,GO:0000062; GO:0005737; GO:0005759; GO:0005829; GO:0006637; GO:0009062; GO:0015937; GO:0036042; GO:0036114; GO:0036116; GO:0042803; GO:0043005; GO:0043025; GO:0047617; GO:0051792; GO:0052689; GO:0052816; GO:1900535,acyl-CoA metabolic process [GO:0006637]; coenzyme A biosynthetic process [GO:0015937]; fatty acid catabolic process [GO:0009062]; long-chain fatty-acyl-CoA catabolic process [GO:0036116]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; palmitic acid biosynthetic process [GO:1900535],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],carboxylic ester hydrolase activity [GO:0052689]; fatty acyl-CoA hydrolase activity [GO:0047617]; fatty-acyl-CoA binding [GO:0000062]; long-chain fatty acyl-CoA binding [GO:0036042]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005829; GO:0006629; GO:0006790; GO:0008289; GO:0016787; GO:0055086,catalytic activity; cytosol; lipid metabolic process; sulfur compound metabolic process; lipid binding; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_12064,FUN_025645-T1,Peve_00039655,,apul_peve,38.2615,,,,,,,,,,,,,,,,,
OG_12065,FUN_025655-T1,Peve_00002535,,apul_peve,59.932,,,,,,,,,,,,,,,,,
OG_12066,FUN_025674-T1,Peve_00035724,,apul_peve,47.185,,,,,,,,,,,,,,,,,
OG_12067,FUN_025687-T1,Peve_00025337,,apul_peve,60.384,FUN_025687-T1,Q08CS6,MOXD2_DANRE,,DBH-like monooxygenase protein 2 homolog (EC 1.14.17.-),Danio rerio (Zebrafish) (Brachydanio rerio),33.8,554.0,4.3e-78,293.9,sp|Q08CS6|MOXD2_DANRE DBH-like monooxygenase protein 2 homolog OS=Danio rerio OX=7955 GN=moxd2 PE=2 SV=2,GO:0004500; GO:0005507; GO:0005615; GO:0006589; GO:0030667; GO:0042420; GO:0042421,dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],extracellular space [GO:0005615]; secretory granule membrane [GO:0030667],copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500],GO:0003824; GO:0005615; GO:0016491,catalytic activity; extracellular space; oxidoreductase activity
OG_12068,FUN_025694-T1,Peve_00004697,,apul_peve,56.944,,,,,,,,,,,,,,,,,
OG_12069,FUN_025709-T1,Peve_00038390,,apul_peve,42.2495,,,,,,,,,,,,,,,,,
OG_12070,FUN_025732-T1,Peve_00015496,,apul_peve,33.312,FUN_025732-T1,Q2VPA6,HELQ_MOUSE,,Helicase POLQ-like (EC 5.6.2.4) (Mus308-like helicase) (POLQ-like helicase),Mus musculus (Mouse),50.6,780.0,1.2e-215,751.5,sp|Q2VPA6|HELQ_MOUSE Helicase POLQ-like OS=Mus musculus OX=10090 GN=Helq PE=1 SV=2,GO:0003677; GO:0005524; GO:0005634; GO:0006259; GO:0010792; GO:0016887; GO:0017116; GO:0017117; GO:0045003; GO:0090734; GO:0097681; GO:1905168; GO:1990518,DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA metabolic process [GO:0006259]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; positive regulation of double-strand break repair via homologous recombination [GO:1905168],nucleus [GO:0005634]; single-stranded DNA-dependent ATP-dependent DNA helicase complex [GO:0017117]; site of DNA damage [GO:0090734],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; single-stranded 3'-5' DNA helicase activity [GO:1990518]; single-stranded DNA helicase activity [GO:0017116],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_12071,FUN_025747-T1,Peve_00031104,,apul_peve,64.011,FUN_025747-T1,Q86VZ6,JAZF1_HUMAN,,Juxtaposed with another zinc finger protein 1 (TAK1-interacting protein 27) (Zinc finger protein 802),Homo sapiens (Human),35.1,188.0,7.3e-17,89.7,sp|Q86VZ6|JAZF1_HUMAN Juxtaposed with another zinc finger protein 1 OS=Homo sapiens OX=9606 GN=JAZF1 PE=1 SV=2,GO:0000122; GO:0001650; GO:0003714; GO:0005634; GO:0005654; GO:0005829; GO:0006629; GO:0008270; GO:0017053,lipid metabolic process [GO:0006629]; negative regulation of transcription by RNA polymerase II [GO:0000122],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0006629; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; lipid metabolic process; organelle; molecular adaptor activity; transcription regulator activity
OG_12072,FUN_025749-T1,Peve_00007727,,apul_peve,85.47300000000001,FUN_025749-T1,Q66J74,,,,,44.0,298.0,5.299999999999999e-53,209.5,sp|Q66J74|TFP11_XENLA Tuftelin-interacting protein 11 OS=Xenopus laevis OX=8355 GN=tfip11 PE=2 SV=1,,,,,,
OG_12073,FUN_025752-T1,Peve_00007730,,apul_peve,83.642,FUN_025752-T1,Q569Z5,DDX46_MOUSE,,Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46),Mus musculus (Mouse),61.4,817.0,2.1000000000000002e-277,956.8,sp|Q569Z5|DDX46_MOUSE Probable ATP-dependent RNA helicase DDX46 OS=Mus musculus OX=10090 GN=Ddx46 PE=1 SV=2,GO:0000398; GO:0001650; GO:0003723; GO:0003724; GO:0005524; GO:0005684; GO:0015030; GO:0016607; GO:0016887; GO:1903241,"mRNA splicing, via spliceosome [GO:0000398]; U2-type prespliceosome assembly [GO:1903241]",Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; U2-type spliceosomal complex [GO:0005684],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0065003; GO:0140098; GO:0140657,"RNA binding; catalytic activity; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; protein-containing complex assembly; catalytic activity, acting on RNA; ATP-dependent activity"
OG_12074,FUN_025753-T1,Peve_00014396,,apul_peve,71.611,FUN_025753-T1,Q8IV01,,,,,38.5,130.0,2e-18,95.5,sp|Q8IV01|SYT12_HUMAN Synaptotagmin-12 OS=Homo sapiens OX=9606 GN=SYT12 PE=1 SV=1,,,,,,
OG_12075,FUN_025754-T1,Peve_00014394,,apul_peve,74.414,,,,,,,,,,,,,,,,,
OG_12076,FUN_025759-T2,Peve_00041454,,apul_peve,74.604,FUN_025759-T2,Q7PQ25,,,,,23.6,609.0,4.7e-13,78.2,sp|Q7PQ25|CCDCX_ANOGA Coiled-coil domain-containing protein AGAP005037 OS=Anopheles gambiae OX=7165 GN=AGAP005037 PE=4 SV=4,,,,,,
OG_12077,FUN_025763-T1,Peve_00041466,,apul_peve,77.228,FUN_025763-T1,Q9QZM5,ABI1_RAT,,Abl interactor 1 (Abelson interactor 1) (Abi-1) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (e3B1),Rattus norvegicus (Rat),48.8,207.0,4.4e-43,176.8,sp|Q9QZM5|ABI1_RAT Abl interactor 1 OS=Rattus norvegicus OX=10116 GN=Abi1 PE=1 SV=3,GO:0001756; GO:0001764; GO:0005634; GO:0005856; GO:0014069; GO:0017124; GO:0030027; GO:0030296; GO:0030426; GO:0031209; GO:0031252; GO:0032433; GO:0035591; GO:0035855; GO:0043005; GO:0048813; GO:0048858; GO:0072673; GO:0098858; GO:0098978; GO:0099527,cell projection morphogenesis [GO:0048858]; dendrite morphogenesis [GO:0048813]; lamellipodium morphogenesis [GO:0072673]; megakaryocyte development [GO:0035855]; neuron migration [GO:0001764]; postsynapse to nucleus signaling pathway [GO:0099527]; somitogenesis [GO:0001756],actin-based cell projection [GO:0098858]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SCAR complex [GO:0031209],protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591],GO:0005634; GO:0005856; GO:0043226; GO:0048856; GO:0048870; GO:0060090; GO:0098772,nucleus; cytoskeleton; organelle; anatomical structure development; cell motility; molecular adaptor activity; molecular function regulator activity
OG_12078,FUN_025766-T1,Peve_00021327,,apul_peve,58.838,FUN_025766-T1,Q5M8E6,,,,,51.7,333.0,2.1e-90,334.0,sp|Q5M8E6|METL2_XENTR tRNA N(3)-cytidine methyltransferase METTL2 OS=Xenopus tropicalis OX=8364 GN=mettl2 PE=2 SV=1,,,,,,
OG_12079,FUN_025769-T1,Peve_00021325,,apul_peve,57.207,FUN_025769-T1,O17185,SUP9_CAEEL,,Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38),Caenorhabditis elegans,28.5,207.0,6.5e-16,85.9,sp|O17185|SUP9_CAEEL Two pore potassium channel protein sup-9 OS=Caenorhabditis elegans OX=6239 GN=sup-9 PE=1 SV=2,GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0036195; GO:0055120; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937],muscle cell projection membrane [GO:0036195]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120],outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_12080,FUN_025770-T1,Peve_00031609,,apul_peve,59.813,,,,,,,,,,,,,,,,,
OG_12081,FUN_025776-T2,Peve_00012557,,apul_peve,38.49,FUN_025776-T2,Q5SUD9,BBS12_MOUSE,,Chaperonin-containing T-complex member BBS12 (Bardet-Biedl syndrome 12 protein homolog),Mus musculus (Mouse),25.4,496.0,1.9e-22,109.8,sp|Q5SUD9|BBS12_MOUSE Chaperonin-containing T-complex member BBS12 OS=Mus musculus OX=10090 GN=Bbs12 PE=3 SV=2,GO:0005524; GO:0005929; GO:0042073; GO:0042755; GO:0045444; GO:0045494; GO:0045599; GO:0048863; GO:0051131; GO:2000737,chaperone-mediated protein complex assembly [GO:0051131]; eating behavior [GO:0042755]; fat cell differentiation [GO:0045444]; intraciliary transport [GO:0042073]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of stem cell differentiation [GO:2000737]; photoreceptor cell maintenance [GO:0045494]; stem cell differentiation [GO:0048863],cilium [GO:0005929],ATP binding [GO:0005524],GO:0005929; GO:0007018; GO:0030154; GO:0043226; GO:0065003,cilium; microtubule-based movement; cell differentiation; organelle; protein-containing complex assembly
OG_12082,FUN_025781-T1,Peve_00009653,,apul_peve,80.0,FUN_025781-T1,Q9W6X3,,,,,63.9,83.0,8.000000000000001e-23,107.5,"sp|Q9W6X3|CH10_ORYLA 10 kDa heat shock protein, mitochondrial OS=Oryzias latipes OX=8090 GN=hspe1 PE=3 SV=1",,,,,,
OG_12083,FUN_025783-T1,Peve_00037926,,apul_peve,68.421,,,,,,,,,,,,,,,,,
OG_12084,FUN_025789-T1,Peve_00020405,,apul_peve,93.359,FUN_025789-T1,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),31.8,531.0,3.5e-69,264.6,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_12085,FUN_025794-T1,Peve_00021326,,apul_peve,82.353,FUN_025794-T1,P61356,,,,,72.1,136.0,1.7e-51,203.4,sp|P61356|RL27_BOVIN Large ribosomal subunit protein eL27 OS=Bos taurus OX=9913 GN=RPL27 PE=2 SV=2,,,,,,
OG_12086,FUN_025795-T1,Peve_00017922,,apul_peve,40.86,,,,,,,,,,,,,,,,,
OG_12087,FUN_025797-T1,Peve_00017925,,apul_peve,48.684,,,,,,,,,,,,,,,,,
OG_12088,FUN_025799-T2,Peve_00017923,,apul_peve,57.092,FUN_025799-T2,O17185,SUP9_CAEEL,,Two pore potassium channel protein sup-9 (Suppressor of unc-93 protein 9) (n2P38),Caenorhabditis elegans,28.1,256.0,4.5e-25,116.7,sp|O17185|SUP9_CAEEL Two pore potassium channel protein sup-9 OS=Caenorhabditis elegans OX=6239 GN=sup-9 PE=1 SV=2,GO:0005267; GO:0005886; GO:0006813; GO:0006937; GO:0015271; GO:0022841; GO:0036195; GO:0055120; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of muscle contraction [GO:0006937],muscle cell projection membrane [GO:0036195]; plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120],outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_12089,FUN_025805-T1,Peve_00017930,,apul_peve,76.875,FUN_025805-T1,O16005,,,,,28.3,272.0,7.399999999999998e-25,116.3,sp|O16005|OPSD_SEPOF Rhodopsin OS=Sepia officinalis OX=6610 GN=RHO PE=2 SV=1,,,,,,
OG_12090,FUN_025808-T1,Peve_00009844,,apul_peve,79.225,FUN_025808-T1,O32210,,,,,47.8,272.0,6.8e-66,252.3,sp|O32210|GR_BACSU Glyoxal reductase OS=Bacillus subtilis (strain 168) OX=224308 GN=yvgN PE=1 SV=1,,,,,,
OG_12091,FUN_025819-T1,Peve_00002520,,apul_peve,76.939,FUN_025819-T1,Q60HE9,,,,,50.5,975.0,5.6e-269,928.7,sp|Q60HE9|MA2B1_MACFA Lysosomal alpha-mannosidase OS=Macaca fascicularis OX=9541 GN=MAN2B1 PE=2 SV=1,,,,,,
OG_12092,FUN_025822-T1,Peve_00036283,,apul_peve,60.6835,FUN_025822-T1,Q9P2P5,HECW2_HUMAN,,"E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2)",Homo sapiens (Human),51.1,840.0,1.1e-221,772.7,sp|Q9P2P5|HECW2_HUMAN E3 ubiquitin-protein ligase HECW2 OS=Homo sapiens OX=9606 GN=HECW2 PE=1 SV=2,GO:0005737; GO:0006511; GO:0016567; GO:0030071; GO:0048814; GO:0061630; GO:0072686,protein ubiquitination [GO:0016567]; regulation of dendrite morphogenesis [GO:0048814]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; mitotic spindle [GO:0072686],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; transferase activity; organelle; catalytic activity, acting on a protein"
OG_12093,FUN_025834-T1,Peve_00028301,,apul_peve,61.868,,,,,,,,,,,,,,,,,
OG_12094,FUN_025837-T1,Peve_00028308,,apul_peve,46.477,FUN_025837-T1,Q6GX86,HROB_RAT,,Homologous recombination OB-fold protein,Rattus norvegicus (Rat),33.3,309.0,3.5e-29,131.3,sp|Q6GX86|HROB_RAT Homologous recombination OB-fold protein OS=Rattus norvegicus OX=10116 GN=Hrob PE=2 SV=1,GO:0000725; GO:0000731; GO:0003697; GO:0005634; GO:0006974; GO:0007292; GO:0036297; GO:0048232; GO:0090734,DNA damage response [GO:0006974]; DNA synthesis involved in DNA repair [GO:0000731]; female gamete generation [GO:0007292]; interstrand cross-link repair [GO:0036297]; male gamete generation [GO:0048232]; recombinational repair [GO:0000725],nucleus [GO:0005634]; site of DNA damage [GO:0090734],single-stranded DNA binding [GO:0003697],GO:0003677; GO:0005634; GO:0006281; GO:0006310; GO:0022414; GO:0043226,DNA binding; nucleus; DNA repair; DNA recombination; reproductive process; organelle
OG_12095,FUN_025899-T1,Peve_00010486,,apul_peve,47.2715,FUN_025899-T1,P80405,,,,,59.2,103.0,3.7e-28,127.9,sp|P80405|MTHFS_RABIT 5-formyltetrahydrofolate cyclo-ligase OS=Oryctolagus cuniculus OX=9986 GN=MTHFS PE=1 SV=1,,,,,,
OG_12096,FUN_025900-T1,Peve_00034884,,apul_peve,42.459,,,,,,,,,,,,,,,,,
OG_12097,FUN_025901-T1,Peve_00028920,,apul_peve,55.844,,,,,,,,,,,,,,,,,
OG_12098,FUN_025902-T1,Peve_00034885,,apul_peve,53.943,,,,,,,,,,,,,,,,,
OG_12099,FUN_025911-T1,Peve_00021823,,apul_peve,85.65899999999999,FUN_025911-T1,Q9Y4A5,TRRAP_HUMAN,,Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog),Homo sapiens (Human),55.0,3128.0,0.0,3315.0,sp|Q9Y4A5|TRRAP_HUMAN Transformation/transcription domain-associated protein OS=Homo sapiens OX=9606 GN=TRRAP PE=1 SV=3,GO:0000124; GO:0000786; GO:0000812; GO:0003712; GO:0005634; GO:0005654; GO:0005794; GO:0006282; GO:0006355; GO:0006357; GO:0033276; GO:0035267; GO:0042981; GO:0043484; GO:0045893; GO:0051726; GO:0140861; GO:1905168; GO:2000779,DNA repair-dependent chromatin remodeling [GO:0140861]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair [GO:2000779]; regulation of RNA splicing [GO:0043484]; regulation of transcription by RNA polymerase II [GO:0006357],Golgi apparatus [GO:0005794]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; SAGA complex [GO:0000124]; Swr1 complex [GO:0000812]; transcription factor TFTC complex [GO:0033276],transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0005794; GO:0006325; GO:0006355; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; Golgi apparatus; chromatin organization; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_12100,FUN_025922-T1,Peve_00018906,,apul_peve,63.636,,,,,,,,,,,,,,,,,
OG_12101,FUN_025928-T1,Peve_00027747,,apul_peve,51.6735,,,,,,,,,,,,,,,,,
OG_12102,FUN_025942-T1,Peve_00003740,,apul_peve,62.924,FUN_025942-T1,Q2EG98,PK1L3_MOUSE,,Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3),Mus musculus (Mouse),21.5,1417.0,6.4e-64,248.1,sp|Q2EG98|PK1L3_MOUSE Polycystin-1-like protein 3 OS=Mus musculus OX=10090 GN=Pkd1l3 PE=1 SV=3,GO:0001581; GO:0005227; GO:0005509; GO:0005886; GO:0006812; GO:0030246; GO:0034703; GO:0043235; GO:0044325; GO:0070588; GO:0071468; GO:0160128,calcium ion transmembrane transport [GO:0070588]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; monoatomic cation transport [GO:0006812],cation channel complex [GO:0034703]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; carbohydrate binding [GO:0030246]; pH-gated monoatomic ion channel activity [GO:0160128]; transmembrane transporter binding [GO:0044325],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_12103,FUN_025951-T2,Peve_00003734,,apul_peve,56.853,FUN_025951-T2,E2RFJ3,,,,,35.9,496.0,2.3e-65,251.5,sp|E2RFJ3|S40A1_CANLF Ferroportin OS=Canis lupus familiaris OX=9615 GN=SLC40A1 PE=3 SV=3,,,,,,
OG_12104,FUN_025973-T1,Peve_00034297,,apul_peve,72.4,FUN_025973-T1,Q5I020,ZNT8_XENLA,,Proton-coupled zinc antiporter SLC30A8 (Solute carrier family 30 member 8) (Zinc transporter 8) (ZnT-8),Xenopus laevis (African clawed frog),36.4,253.0,7.499999999999999e-43,175.6,sp|Q5I020|ZNT8_XENLA Proton-coupled zinc antiporter SLC30A8 OS=Xenopus laevis OX=8355 GN=slc30a8 PE=2 SV=1,GO:0005385; GO:0005886; GO:0009749; GO:0010043; GO:0030073; GO:0030658; GO:0030667; GO:0046872; GO:0062111; GO:0071577; GO:0140826,insulin secretion [GO:0030073]; response to glucose [GO:0009749]; response to zinc ion [GO:0010043]; zinc ion import into organelle [GO:0062111]; zinc ion transmembrane transport [GO:0071577],plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658],metal ion binding [GO:0046872]; zinc ion transmembrane transporter activity [GO:0005385]; zinc:proton antiporter activity [GO:0140826],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_12105,FUN_025979-T1,Peve_00042787,,apul_peve,49.708,,,,,,,,,,,,,,,,,
OG_12106,FUN_025987-T1,Peve_00044985,,apul_peve,62.824,FUN_025987-T1,P49183,DNAS1_MOUSE,,Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I),Mus musculus (Mouse),45.8,262.0,2.3e-62,241.1,sp|P49183|DNAS1_MOUSE Deoxyribonuclease-1 OS=Mus musculus OX=10090 GN=Dnase1 PE=1 SV=2,GO:0002283; GO:0002673; GO:0003779; GO:0004530; GO:0005576; GO:0005635; GO:0006308; GO:0006915; GO:0042588; GO:0070948,apoptotic process [GO:0006915]; DNA catabolic process [GO:0006308]; neutrophil activation involved in immune response [GO:0002283]; regulation of acute inflammatory response [GO:0002673]; regulation of neutrophil mediated cytotoxicity [GO:0070948],extracellular region [GO:0005576]; nuclear envelope [GO:0005635]; zymogen granule [GO:0042588],actin binding [GO:0003779]; deoxyribonuclease I activity [GO:0004530],GO:0002376; GO:0003824; GO:0005576; GO:0005635; GO:0008092; GO:0012501; GO:0016787; GO:0031410; GO:0043226; GO:0140097,"immune system process; catalytic activity; extracellular region; nuclear envelope; cytoskeletal protein binding; programmed cell death; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on DNA"
OG_12107,FUN_026009-T1,Peve_00045068,,apul_peve,59.2905,FUN_026009-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),48.8,346.0,1.2e-109,399.8,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_12108,FUN_026011-T1,Peve_00024501,,apul_peve,63.423,FUN_026011-T1,Q6P4Z2,CO2A1_XENTR,,Collagen alpha-1(II) chain (Alpha-1 type II collagen),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),37.5,267.0,1.3e-45,187.2,sp|Q6P4Z2|CO2A1_XENTR Collagen alpha-1(II) chain OS=Xenopus tropicalis OX=8364 GN=col2a1 PE=2 SV=1,GO:0005201; GO:0005576; GO:0005581; GO:0046872,,collagen trimer [GO:0005581]; extracellular region [GO:0005576],extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872],GO:0005198; GO:0005576,structural molecule activity; extracellular region
OG_12109,FUN_026016-T2,Peve_00020199,,apul_peve,62.215,FUN_026016-T2,Q8NFW1,,,,,27.4,164.0,4.3e-13,79.7,sp|Q8NFW1|COMA1_HUMAN Collagen alpha-1(XXII) chain OS=Homo sapiens OX=9606 GN=COL22A1 PE=1 SV=2,,,,,,
OG_12110,FUN_026026-T1,Peve_00026726,,apul_peve,67.273,FUN_026026-T1,P50222,MEOX2_HUMAN,,Homeobox protein MOX-2 (Growth arrest-specific homeobox) (Mesenchyme homeobox 2),Homo sapiens (Human),83.9,62.0,1.7e-21,104.4,sp|P50222|MEOX2_HUMAN Homeobox protein MOX-2 OS=Homo sapiens OX=9606 GN=MEOX2 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0001757; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0007519; GO:0016607; GO:0043565; GO:0045944; GO:0060021; GO:0060173; GO:0061053; GO:0090051; GO:1990837,angiogenesis [GO:0001525]; limb development [GO:0060173]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519]; somite development [GO:0061053]; somite specification [GO:0001757],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_12111,FUN_026028-T1,Peve_00003807,,apul_peve,58.333,FUN_026028-T1,F1Q4R9,MEOX1_DANRE,,Homeobox protein MOX-1 (Mesenchyme homeobox 1) (Protein choker),Danio rerio (Zebrafish) (Brachydanio rerio),73.0,74.0,1.3e-21,104.8,sp|F1Q4R9|MEOX1_DANRE Homeobox protein MOX-1 OS=Danio rerio OX=7955 GN=meox1 PE=2 SV=1,GO:0000978; GO:0000981; GO:0001501; GO:0003682; GO:0003700; GO:0005634; GO:0005737; GO:0006357; GO:0030097; GO:0043565; GO:0045944; GO:0048066; GO:0055001; GO:0060218; GO:0061053; GO:0061056,developmental pigmentation [GO:0048066]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; muscle cell development [GO:0055001]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sclerotome development [GO:0061056]; skeletal system development [GO:0001501]; somite development [GO:0061053],cytoplasm [GO:0005737]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_12112,FUN_026059-T1,Peve_00022195,,apul_peve,54.101,,,,,,,,,,,,,,,,,
OG_12113,FUN_026080-T1,Peve_00016851,,apul_peve,82.917,FUN_026080-T1,P47727,CBR1_RAT,,"Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.196, EC 1.1.1.197) (20-beta-hydroxysteroid dehydrogenase) (Alcohol dehydrogenase [NAD(P)+] CBR1) (EC 1.1.1.71) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (PG-9-KR) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189)",Rattus norvegicus (Rat),62.5,275.0,6.6e-95,348.6,sp|P47727|CBR1_RAT Carbonyl reductase [NADPH] 1 OS=Rattus norvegicus OX=10116 GN=Cbr1 PE=1 SV=2,GO:0001542; GO:0004090; GO:0005737; GO:0005902; GO:0006706; GO:0006805; GO:0008211; GO:0016616; GO:0016655; GO:0030855; GO:0032355; GO:0032496; GO:0032570; GO:0033574; GO:0034698; GO:0042373; GO:0042376; GO:0047020; GO:0047021; GO:0050221; GO:0160163; GO:1905344; GO:2000379,epithelial cell differentiation [GO:0030855]; glucocorticoid metabolic process [GO:0008211]; ovulation from ovarian follicle [GO:0001542]; phylloquinone catabolic process [GO:0042376]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; prostaglandin catabolic process [GO:1905344]; response to estradiol [GO:0032355]; response to gonadotropin [GO:0034698]; response to lipopolysaccharide [GO:0032496]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; steroid catabolic process [GO:0006706]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; microvillus [GO:0005902],"15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]; prostaglandin E2 9-reductase activity [GO:0050221]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163]",GO:0003824; GO:0006629; GO:0006766; GO:0016491; GO:0022414; GO:0030154,catalytic activity; lipid metabolic process; vitamin metabolic process; oxidoreductase activity; reproductive process; cell differentiation
OG_12114,FUN_026086-T1,Peve_00037977,,apul_peve,55.128,,,,,,,,,,,,,,,,,
OG_12115,FUN_026099-T1,Peve_00022029,,apul_peve,65.424,,,,,,,,,,,,,,,,,
OG_12116,FUN_026119-T1,Peve_00014000,,apul_peve,60.906,,,,,,,,,,,,,,,,,
OG_12117,FUN_026141-T1,Peve_00014869,,apul_peve,41.699,FUN_026141-T1,Q5IS54,CASP3_PANTR,,Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12],Pan troglodytes (Chimpanzee),33.2,289.0,1.9e-32,142.5,sp|Q5IS54|CASP3_PANTR Caspase-3 OS=Pan troglodytes OX=9598 GN=CASP3 PE=2 SV=1,GO:0001782; GO:0001818; GO:0004175; GO:0004190; GO:0004197; GO:0004861; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007507; GO:0007605; GO:0008047; GO:0008627; GO:0009411; GO:0009611; GO:0014069; GO:0016485; GO:0030163; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0031647; GO:0034349; GO:0043029; GO:0043525; GO:0044346; GO:0045165; GO:0045786; GO:0046007; GO:0048011; GO:0051402; GO:0061713; GO:0070269; GO:0072734; GO:0097194; GO:0098693; GO:0098978; GO:0140639; GO:1902004; GO:1904019,anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to staurosporine [GO:0072734]; DNA damage response [GO:0006974]; epithelial cell apoptotic process [GO:1904019]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; fibroblast apoptotic process [GO:0044346]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production [GO:0001818]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of pyroptotic inflammatory response [GO:0140639]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; pyroptotic inflammatory response [GO:0070269]; regulation of protein stability [GO:0031647]; regulation of synaptic vesicle cycle [GO:0098693]; response to UV [GO:0009411]; response to wounding [GO:0009611]; sensory perception of sound [GO:0007605]; T cell homeostasis [GO:0043029],cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; enzyme activator activity [GO:0008047],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006954; GO:0012501; GO:0016787; GO:0030154; GO:0030163; GO:0043226; GO:0048856; GO:0050877; GO:0051604; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; inflammatory response; programmed cell death; hydrolase activity; cell differentiation; protein catabolic process; organelle; anatomical structure development; nervous system process; protein maturation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_12118,FUN_026149-T2,Peve_00014877,,apul_peve,73.1175,FUN_026149-T2,Q15032,,,,,39.9,398.0,7.3e-48,194.1,sp|Q15032|R3HD1_HUMAN R3H domain-containing protein 1 OS=Homo sapiens OX=9606 GN=R3HDM1 PE=1 SV=3,,,,,,
OG_12119,FUN_026159-T1,Peve_00030356,,apul_peve,65.306,FUN_026159-T1,Q8N0W4,NLGNX_HUMAN,,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",Homo sapiens (Human),33.3,589.0,7e-86,319.7,"sp|Q8N0W4|NLGNX_HUMAN Neuroligin-4, X-linked OS=Homo sapiens OX=9606 GN=NLGN4X PE=1 SV=1",GO:0003360; GO:0005886; GO:0007158; GO:0007612; GO:0009986; GO:0016020; GO:0021549; GO:0030182; GO:0030425; GO:0030534; GO:0031404; GO:0035176; GO:0035265; GO:0042043; GO:0042803; GO:0045202; GO:0045216; GO:0050804; GO:0050808; GO:0050839; GO:0051963; GO:0060076; GO:0071625; GO:0090394; GO:0097105; GO:0097110; GO:0098839; GO:0098978; GO:0098982; GO:0098983; GO:0098985; GO:0099054; GO:0099634,adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; regulation of synapse assembly [GO:0051963]; social behavior [GO:0035176]; synapse organization [GO:0050808]; vocalization behavior [GO:0071625],"asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic specialization membrane [GO:0099634]; symmetric, GABA-ergic, inhibitory synapse [GO:0098983]; synapse [GO:0045202]",cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110],GO:0005886; GO:0007155; GO:0030154; GO:0034330; GO:0048856; GO:0050877; GO:0061024,plasma membrane; cell adhesion; cell differentiation; cell junction organization; anatomical structure development; nervous system process; membrane organization
OG_12120,FUN_026164-T1,Peve_00006891,,apul_peve,62.9675,,,,,,,,,,,,,,,,,
OG_12121,FUN_026183-T1,Peve_00016123,,apul_peve,71.508,FUN_026183-T1,Q6GP89,,,,,38.1,176.0,6.6e-27,122.1,sp|Q6GP89|LSM12_XENLA Protein LSM12 OS=Xenopus laevis OX=8355 GN=lsm12 PE=2 SV=1,,,,,,
OG_12122,FUN_026184-T1,Peve_00000284,,apul_peve,49.898,,,,,,,,,,,,,,,,,
OG_12123,FUN_026201-T1,Peve_00044666,,apul_peve,61.065,FUN_026201-T1,Q8C6K9,,,,,23.4,1345.0,2.8e-67,259.6,sp|Q8C6K9|CO6A6_MOUSE Collagen alpha-6(VI) chain OS=Mus musculus OX=10090 GN=Col6a6 PE=1 SV=2,,,,,,
OG_12124,FUN_026212-T1,Peve_00036503,,apul_peve,63.959,FUN_026212-T1,A6NMZ7,CO6A6_HUMAN,,Collagen alpha-6(VI) chain,Homo sapiens (Human),20.5,1078.0,2.1e-38,164.9,sp|A6NMZ7|CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens OX=9606 GN=COL6A6 PE=1 SV=2,GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],,GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_12125,FUN_026225-T1,Peve_00038506,,apul_peve,42.211,FUN_026225-T1,D5UJ42,,,,,30.8,182.0,4.8e-09,65.9,sp|D5UJ42|MSHA_CELFN D-inositol 3-phosphate glycosyltransferase OS=Cellulomonas flavigena (strain ATCC 482 / DSM 20109 / BCRC 11376 / JCM 18109 / NBRC 3775 / NCIMB 8073 / NRS 134) OX=446466 GN=mshA PE=3 SV=1,,,,,,
OG_12126,FUN_026228-T1,Peve_00013014,,apul_peve,78.947,,,,,,,,,,,,,,,,,
OG_12127,FUN_026238-T1,Peve_00012894,,apul_peve,60.5235,,,,,,,,,,,,,,,,,
OG_12128,FUN_026269-T1,Peve_00035775,,apul_peve,56.863,,,,,,,,,,,,,,,,,
OG_12129,FUN_026313-T1,Peve_00036862,,apul_peve,65.673,FUN_026313-T1,Q91X17,UROM_MOUSE,,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",Mus musculus (Mouse),48.5,97.0,5.7e-23,111.3,sp|Q91X17|UROM_MOUSE Uromodulin OS=Mus musculus OX=10090 GN=Umod PE=1 SV=1,GO:0000922; GO:0001822; GO:0002251; GO:0003091; GO:0003094; GO:0005509; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006874; GO:0006883; GO:0006914; GO:0006915; GO:0006954; GO:0006986; GO:0007029; GO:0007157; GO:0007159; GO:0008217; GO:0008380; GO:0009410; GO:0009414; GO:0010467; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0019864; GO:0030643; GO:0030644; GO:0032496; GO:0033209; GO:0033554; GO:0033555; GO:0034620; GO:0034976; GO:0035809; GO:0036503; GO:0044861; GO:0046720; GO:0048871; GO:0048878; GO:0050801; GO:0050829; GO:0050891; GO:0051223; GO:0055062; GO:0055064; GO:0055074; GO:0055075; GO:0055078; GO:0060073; GO:0060170; GO:0061077; GO:0070294; GO:0071918; GO:0072044; GO:0072051; GO:0072070; GO:0072218; GO:0072221; GO:0072233; GO:0072665; GO:0097190; GO:0097709; GO:0097744; GO:0098552; GO:0140367; GO:1990266,antibacterial innate immune response [GO:0140367]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; calcium ion homeostasis [GO:0055074]; cellular response to stress [GO:0033554]; cellular response to unfolded protein [GO:0034620]; chaperone-mediated protein folding [GO:0061077]; chemical homeostasis [GO:0048878]; chloride ion homeostasis [GO:0055064]; citric acid secretion [GO:0046720]; collecting duct development [GO:0072044]; connective tissue replacement [GO:0097709]; defense response to Gram-negative bacterium [GO:0050829]; endoplasmic reticulum organization [GO:0007029]; ERAD pathway [GO:0036503]; gene expression [GO:0010467]; glomerular filtration [GO:0003094]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; inflammatory response [GO:0006954]; intracellular calcium ion homeostasis [GO:0006874]; intracellular chloride ion homeostasis [GO:0030644]; intracellular phosphate ion homeostasis [GO:0030643]; intracellular sodium ion homeostasis [GO:0006883]; juxtaglomerular apparatus development [GO:0072051]; kidney development [GO:0001822]; leukocyte cell-cell adhesion [GO:0007159]; lipid metabolic process [GO:0006629]; loop of Henle development [GO:0072070]; metanephric ascending thin limb development [GO:0072218]; metanephric distal convoluted tubule development [GO:0072221]; metanephric thick ascending limb development [GO:0072233]; micturition [GO:0060073]; monoatomic ion homeostasis [GO:0050801]; multicellular organismal response to stress [GO:0033555]; multicellular organismal-level homeostasis [GO:0048871]; multicellular organismal-level water homeostasis [GO:0050891]; neutrophil migration [GO:1990266]; organ or tissue specific immune response [GO:0002251]; phosphate ion homeostasis [GO:0055062]; potassium ion homeostasis [GO:0055075]; protein localization to vacuole [GO:0072665]; protein transport into plasma membrane raft [GO:0044861]; regulation of blood pressure [GO:0008217]; regulation of protein transport [GO:0051223]; regulation of urine volume [GO:0035809]; renal sodium ion absorption [GO:0070294]; renal urate salt excretion [GO:0097744]; renal water homeostasis [GO:0003091]; response to endoplasmic reticulum stress [GO:0034976]; response to lipopolysaccharide [GO:0032496]; response to unfolded protein [GO:0006986]; response to water deprivation [GO:0009414]; response to xenobiotic stimulus [GO:0009410]; RNA splicing [GO:0008380]; sodium ion homeostasis [GO:0055078]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; urate transport [GO:0015747]; urea transmembrane transport [GO:0071918],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509]; IgG binding [GO:0019864],GO:0002376; GO:0003014; GO:0005615; GO:0005783; GO:0005886; GO:0005929; GO:0006629; GO:0006886; GO:0006914; GO:0006954; GO:0007155; GO:0012501; GO:0030163; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0061024; GO:0098542,immune system process; renal system process; extracellular space; endoplasmic reticulum; plasma membrane; cilium; lipid metabolic process; intracellular protein transport; autophagy; inflammatory response; cell adhesion; programmed cell death; protein catabolic process; organelle; anatomical structure development; cell motility; transmembrane transport; membrane organization; defense response to other organism
OG_12130,FUN_026348-T1,Peve_00028924,,apul_peve,51.872,,,,,,,,,,,,,,,,,
OG_12131,FUN_026363-T1,Peve_00004989,,apul_peve,67.806,FUN_026363-T1,O54697,NALDL_RAT,,Aminopeptidase NAALADL1 (EC 3.4.11.-) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L),Rattus norvegicus (Rat),35.0,729.0,2.5000000000000002e-104,381.3,sp|O54697|NALDL_RAT Aminopeptidase NAALADL1 OS=Rattus norvegicus OX=10116 GN=Naaladl1 PE=1 SV=1,GO:0004177; GO:0004180; GO:0005509; GO:0006508; GO:0008237; GO:0008270; GO:0016020; GO:0016324; GO:0042803; GO:0043171,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],apical plasma membrane [GO:0016324]; membrane [GO:0016020],aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_12132,FUN_026367-T1,Peve_00035565,,apul_peve,63.846,FUN_026367-T1,P54277,PMS1_HUMAN,,PMS1 protein homolog 1 (DNA mismatch repair protein PMS1),Homo sapiens (Human),32.3,1061.0,1.6e-112,409.1,sp|P54277|PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens OX=9606 GN=PMS1 PE=1 SV=1,GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0009410; GO:0016887; GO:0019899; GO:0030983; GO:0032389; GO:0140664,mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410],MutLalpha complex [GO:0032389]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_12133,FUN_026367-T2,Peve_00004984,,apul_peve,68.719,FUN_026367-T2,P54277,PMS1_HUMAN,,PMS1 protein homolog 1 (DNA mismatch repair protein PMS1),Homo sapiens (Human),39.7,484.0,1.3e-84,315.8,sp|P54277|PMS1_HUMAN PMS1 protein homolog 1 OS=Homo sapiens OX=9606 GN=PMS1 PE=1 SV=1,GO:0003677; GO:0005524; GO:0005634; GO:0006298; GO:0009410; GO:0016887; GO:0019899; GO:0030983; GO:0032389; GO:0140664,mismatch repair [GO:0006298]; response to xenobiotic stimulus [GO:0009410],MutLalpha complex [GO:0032389]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; mismatched DNA binding [GO:0030983],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0043226; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_12134,FUN_026380-T1,Peve_00010510,,apul_peve,79.233,FUN_026380-T1,Q8VDG5,,,,,44.9,303.0,3.4e-63,243.4,sp|Q8VDG5|PPCS_MOUSE Phosphopantothenate--cysteine ligase OS=Mus musculus OX=10090 GN=Ppcs PE=1 SV=1,,,,,,
OG_12135,FUN_026401-T1,Peve_00009398,,apul_peve,82.645,,,,,,,,,,,,,,,,,
OG_12136,FUN_026402-T1,Peve_00034539,,apul_peve,65.563,FUN_026402-T1,O46503,,,,,41.1,282.0,4.7e-49,196.4,sp|O46503|ST1C2_RABIT Sulfotransferase 1C2 OS=Oryctolagus cuniculus OX=9986 GN=SULT1C2 PE=1 SV=1,,,,,,
OG_12137,FUN_026418-T1,Peve_00029797,,apul_peve,45.192,FUN_026418-T1,Q6R5N8,TLR13_MOUSE,,Toll-like receptor 13,Mus musculus (Mouse),32.5,114.0,2.1e-10,68.6,sp|Q6R5N8|TLR13_MOUSE Toll-like receptor 13 OS=Mus musculus OX=10090 GN=Tlr13 PE=1 SV=1,GO:0002755; GO:0005737; GO:0005768; GO:0006954; GO:0009615; GO:0010008; GO:0019843; GO:0034178; GO:0042802; GO:0043408; GO:0045087; GO:0061809,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178],cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008],"identical protein binding [GO:0042802]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; rRNA binding [GO:0019843]",GO:0002376; GO:0003723; GO:0003824; GO:0005768; GO:0006954; GO:0016787; GO:0031410; GO:0043226; GO:0098542,immune system process; RNA binding; catalytic activity; endosome; inflammatory response; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism
OG_12138,FUN_026419-T2,Peve_00012176,,apul_peve,38.559,,,,,,,,,,,,,,,,,
OG_12139,FUN_026423-T1,Peve_00022965,,apul_peve,71.223,FUN_026423-T1,Q9V477,TOLL8_DROME,,Toll-like receptor Tollo (Toll-like receptor 8),Drosophila melanogaster (Fruit fly),29.8,151.0,1e-07,58.9,sp|Q9V477|TOLL8_DROME Toll-like receptor Tollo OS=Drosophila melanogaster OX=7227 GN=Tollo PE=1 SV=1,GO:0003401; GO:0005886; GO:0007165; GO:0016324; GO:0045087; GO:0048018; GO:0048935; GO:0060026; GO:0060049; GO:0061809,axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; receptor ligand activity [GO:0048018]",GO:0002376; GO:0003824; GO:0005886; GO:0016787; GO:0048018; GO:0048856; GO:0098542; GO:0098772,immune system process; catalytic activity; plasma membrane; hydrolase activity; receptor ligand activity; anatomical structure development; defense response to other organism; molecular function regulator activity
OG_12140,FUN_026432-T1,Peve_00020583,,apul_peve,48.276,,,,,,,,,,,,,,,,,
OG_12141,FUN_026446-T1,Peve_00030844,,apul_peve,33.548,,,,,,,,,,,,,,,,,
OG_12142,FUN_026462-T1,Peve_00001255,,apul_peve,50.398,,,,,,,,,,,,,,,,,
OG_12143,FUN_026469-T1,Peve_00027361,,apul_peve,48.736,FUN_026469-T1,Q6R5N8,TLR13_MOUSE,,Toll-like receptor 13,Mus musculus (Mouse),30.1,133.0,7.4e-10,67.0,sp|Q6R5N8|TLR13_MOUSE Toll-like receptor 13 OS=Mus musculus OX=10090 GN=Tlr13 PE=1 SV=1,GO:0002755; GO:0005737; GO:0005768; GO:0006954; GO:0009615; GO:0010008; GO:0019843; GO:0034178; GO:0042802; GO:0043408; GO:0045087; GO:0061809,inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; regulation of MAPK cascade [GO:0043408]; response to virus [GO:0009615]; toll-like receptor 13 signaling pathway [GO:0034178],cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008],"identical protein binding [GO:0042802]; NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; rRNA binding [GO:0019843]",GO:0002376; GO:0003723; GO:0003824; GO:0005768; GO:0006954; GO:0016787; GO:0031410; GO:0043226; GO:0098542,immune system process; RNA binding; catalytic activity; endosome; inflammatory response; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism
OG_12144,FUN_026493-T1,Peve_00000771,,apul_peve,49.192,,,,,,,,,,,,,,,,,
OG_12145,FUN_026512-T2,Peve_00040210,,apul_peve,34.343,,,,,,,,,,,,,,,,,
OG_12146,FUN_026513-T1,Peve_00007000,,apul_peve,75.194,FUN_026513-T1,A2AR02,,,,,62.3,371.0,1.8999999999999998e-68,261.9,sp|A2AR02|PPIG_MOUSE Peptidyl-prolyl cis-trans isomerase G OS=Mus musculus OX=10090 GN=Ppig PE=1 SV=1,,,,,,
OG_12147,FUN_026517-T1,Peve_00036238,,apul_peve,56.187,FUN_026517-T1,U3NEE3,HNMTL_CHICK,,Carnosine N-methyltransferase 2 (EC 2.1.1.22) (Histamine N-methyltransferase-like) (HNMT-like),Gallus gallus (Chicken),30.2,281.0,8.2e-19,95.9,sp|U3NEE3|HNMTL_CHICK Carnosine N-methyltransferase 2 OS=Gallus gallus OX=9031 PE=1 SV=1,GO:0008170; GO:0030735; GO:0032259; GO:0035498,carnosine metabolic process [GO:0035498]; methylation [GO:0032259],,carnosine N-methyltransferase activity [GO:0030735]; N-methyltransferase activity [GO:0008170],GO:0003824; GO:0006520; GO:0016740,catalytic activity; amino acid metabolic process; transferase activity
OG_12148,FUN_026538-T2,Peve_00021543,,apul_peve,75.3735,FUN_026538-T2,P30419,NMT1_HUMAN,,Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (HsNMT1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1) (Protein-lysine myristoyltransferase NMT1) (EC 2.3.1.-),Homo sapiens (Human),70.7,423.0,7.2e-175,615.1,sp|P30419|NMT1_HUMAN Glycylpeptide N-tetradecanoyltransferase 1 OS=Homo sapiens OX=9606 GN=NMT1 PE=1 SV=2,GO:0001701; GO:0004379; GO:0005737; GO:0005829; GO:0005886; GO:0018008; GO:0018030; GO:0019107; GO:0022400; GO:0042180; GO:0072657; GO:1903749,in utero embryonic development [GO:0001701]; ketone metabolic process [GO:0042180]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; positive regulation of establishment of protein localization to mitochondrion [GO:1903749]; protein localization to membrane [GO:0072657]; regulation of opsin-mediated signaling pathway [GO:0022400],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]; peptidyl-lysine N6-myristoyltransferase activity [GO:0018030],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; cytosol; plasma membrane; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_12149,FUN_026555-T1,Peve_00043078,,apul_peve,60.494,FUN_026555-T1,B3EWZ8,,,,,55.4,56.0,7.9e-15,82.0,sp|B3EWZ8|ECT_ACRMI Ectin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12150,FUN_026558-T1,Peve_00030954,,apul_peve,48.485,,,,,,,,,,,,,,,,,
OG_12151,FUN_026565-T4,Peve_00043279,,apul_peve,46.869,FUN_026565-T4,P22897,MRC1_HUMAN,,Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206),Homo sapiens (Human),28.7,1060.0,4.7e-126,455.3,sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1,GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353,cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898],cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618],GO:0001618; GO:0005886; GO:0016192; GO:0038024; GO:0060089,virus receptor activity; plasma membrane; vesicle-mediated transport; cargo receptor activity; molecular transducer activity
OG_12152,FUN_026583-T2,Peve_00006461,,apul_peve,73.46,FUN_026583-T2,Q2TAW0,,,,,34.2,1126.0,1.9e-151,538.5,sp|Q2TAW0|CNDG2_XENLA Condensin-2 complex subunit G2 OS=Xenopus laevis OX=8355 GN=ncapg2 PE=1 SV=1,,,,,,
OG_12153,FUN_026587-T1,Peve_00024968,,apul_peve,85.088,,,,,,,,,,,,,,,,,
OG_12154,FUN_026593-T1,Peve_00023866,,apul_peve,64.323,,,,,,,,,,,,,,,,,
OG_12155,FUN_026594-T1,Peve_00030523,,apul_peve,88.889,,,,,,,,,,,,,,,,,
OG_12156,FUN_026595-T3,Peve_00035406,,apul_peve,34.876,,,,,,,,,,,,,,,,,
OG_12157,FUN_026598-T1,Peve_00043914,,apul_peve,34.667,,,,,,,,,,,,,,,,,
OG_12158,FUN_026599-T1,Peve_00030645,,apul_peve,52.495,,,,,,,,,,,,,,,,,
OG_12159,FUN_026618-T1,Peve_00043916,,apul_peve,69.258,FUN_026618-T1,Q76HN1,HYAL1_RAT,,Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1),Rattus norvegicus (Rat),40.9,303.0,7.4e-63,242.3,sp|Q76HN1|HYAL1_RAT Hyaluronidase-1 OS=Rattus norvegicus OX=10116 GN=Hyal1 PE=2 SV=1,GO:0000302; GO:0004415; GO:0005615; GO:0005764; GO:0005975; GO:0006954; GO:0009615; GO:0030207; GO:0030212; GO:0030214; GO:0030307; GO:0030308; GO:0031410; GO:0036117; GO:0036120; GO:0044344; GO:0045766; GO:0045785; GO:0046677; GO:0051216; GO:0052757; GO:0060272; GO:0071347; GO:0071356; GO:0071467; GO:0071493; GO:1900106,carbohydrate metabolic process [GO:0005975]; cartilage development [GO:0051216]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to pH [GO:0071467]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to UV-B [GO:0071493]; chondroitin sulfate proteoglycan catabolic process [GO:0030207]; embryonic skeletal joint morphogenesis [GO:0060272]; hyaluronan catabolic process [GO:0030214]; hyaluronan metabolic process [GO:0030212]; inflammatory response [GO:0006954]; negative regulation of cell growth [GO:0030308]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of hyaluranon cable assembly [GO:1900106]; response to antibiotic [GO:0046677]; response to reactive oxygen species [GO:0000302]; response to virus [GO:0009615],cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; hyaluranon cable [GO:0036117]; lysosome [GO:0005764],chondroitin hydrolase activity [GO:0052757]; hyalurononglucosaminidase activity [GO:0004415],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005975; GO:0006954; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0048856; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; carbohydrate metabolic process; inflammatory response; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; anatomical structure development; carbohydrate derivative metabolic process
OG_12160,FUN_026620-T1,Peve_00028781,,apul_peve,69.841,,,,,,,,,,,,,,,,,
OG_12161,FUN_026673-T1,Peve_00009441,,apul_peve,45.262,,,,,,,,,,,,,,,,,
OG_12162,FUN_026676-T1,Peve_00025343,,apul_peve,51.23,FUN_026676-T1,Q9NZJ4,,,,,30.9,3304.0,0.0,1361.3,sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2,,,,,,
OG_12163,FUN_026676-T2,Peve_00009442,,apul_peve,52.511,FUN_026676-T2,Q9NZJ4,,,,,32.0,4137.0,0.0,1872.4,sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2,,,,,,
OG_12164,FUN_026677-T1,Peve_00005903,,apul_peve,38.462,,,,,,,,,,,,,,,,,
OG_12165,FUN_026681-T2,Peve_00015019,,apul_peve,53.895,FUN_026681-T2,Q9NZJ4,,,,,31.9,4586.0,0.0,2022.3,sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2,,,,,,
OG_12166,FUN_026683-T1,Peve_00030203,,apul_peve,51.5145,FUN_026683-T1,Q9NZJ4,,,,,31.6,4639.0,0.0,1998.0,sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2,,,,,,
OG_12167,FUN_026688-T1,Peve_00036583,,apul_peve,34.157,,,,,,,,,,,,,,,,,
OG_12168,FUN_026691-T1,Peve_00015293,,apul_peve,42.149,,,,,,,,,,,,,,,,,
OG_12169,FUN_026707-T1,Peve_00040683,,apul_peve,66.393,,,,,,,,,,,,,,,,,
OG_12170,FUN_026710-T2,Peve_00018522,,apul_peve,64.2615,,,,,,,,,,,,,,,,,
OG_12171,FUN_026711-T1,Peve_00018521,,apul_peve,64.474,,,,,,,,,,,,,,,,,
OG_12172,FUN_026719-T1,Peve_00018532,,apul_peve,50.7725,,,,,,,,,,,,,,,,,
OG_12173,FUN_026730-T1,Peve_00021675,,apul_peve,62.791,,,,,,,,,,,,,,,,,
OG_12174,FUN_026731-T1,Peve_00021673,,apul_peve,30.27,,,,,,,,,,,,,,,,,
OG_12175,FUN_026735-T1,Peve_00021669,,apul_peve,62.933,FUN_026735-T1,B0UYT5,,,,,24.8,375.0,6.4e-21,104.0,sp|B0UYT5|MFD6B_DANRE Major facilitator superfamily domain-containing protein 6-B OS=Danio rerio OX=7955 GN=mfsd6b PE=3 SV=1,,,,,,
OG_12176,FUN_026736-T1,Peve_00021668,,apul_peve,49.618,,,,,,,,,,,,,,,,,
OG_12177,FUN_026746-T1,Peve_00021931,,apul_peve,65.046,,,,,,,,,,,,,,,,,
OG_12178,FUN_026747-T1,Peve_00032036,,apul_peve,44.231,,,,,,,,,,,,,,,,,
OG_12179,FUN_026751-T1,Peve_00005856,,apul_peve,52.419,,,,,,,,,,,,,,,,,
OG_12180,FUN_026753-T1,Peve_00039286,,apul_peve,77.483,,,,,,,,,,,,,,,,,
OG_12181,FUN_026757-T1,Peve_00032760,,apul_peve,87.603,,,,,,,,,,,,,,,,,
OG_12182,FUN_026772-T1,Peve_00039904,,apul_peve,61.124,,,,,,,,,,,,,,,,,
OG_12183,FUN_026779-T1,Peve_00006618,,apul_peve,59.441,,,,,,,,,,,,,,,,,
OG_12184,FUN_026782-T1,Peve_00007278,,apul_peve,66.238,,,,,,,,,,,,,,,,,
OG_12185,FUN_026797-T1,Peve_00027854,,apul_peve,40.65,,,,,,,,,,,,,,,,,
OG_12186,FUN_026813-T1,Peve_00013325,,apul_peve,70.707,,,,,,,,,,,,,,,,,
OG_12187,FUN_026814-T1,Peve_00008470,,apul_peve,89.744,,,,,,,,,,,,,,,,,
OG_12188,FUN_026817-T1,Peve_00021299,,apul_peve,46.465,,,,,,,,,,,,,,,,,
OG_12189,FUN_026830-T1,Peve_00020644,,apul_peve,34.7825,,,,,,,,,,,,,,,,,
OG_12190,FUN_026832-T1,Peve_00018465,,apul_peve,78.896,,,,,,,,,,,,,,,,,
OG_12191,FUN_026836-T1,Peve_00022982,,apul_peve,49.667,,,,,,,,,,,,,,,,,
OG_12192,FUN_026846-T1,Peve_00015178,,apul_peve,81.039,,,,,,,,,,,,,,,,,
OG_12193,FUN_026851-T1,Peve_00030909,,apul_peve,41.6285,,,,,,,,,,,,,,,,,
OG_12194,FUN_026862-T1,Peve_00040640,,apul_peve,88.265,,,,,,,,,,,,,,,,,
OG_12195,FUN_026871-T1,Peve_00008428,,apul_peve,59.701,,,,,,,,,,,,,,,,,
OG_12196,FUN_026890-T1,Peve_00027260,,apul_peve,60.0,,,,,,,,,,,,,,,,,
OG_12197,FUN_026895-T1,Peve_00021664,,apul_peve,63.344,FUN_026895-T1,Q8BKN6,,,,,51.0,263.0,6.7e-72,272.3,sp|Q8BKN6|HS3SA_MOUSE Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 OS=Mus musculus OX=10090 GN=Hs3st3a1 PE=2 SV=1,,,,,,
OG_12198,FUN_026898-T1,Peve_00021660,,apul_peve,77.344,,,,,,,,,,,,,,,,,
OG_12199,FUN_026927-T1,Peve_00026127,,apul_peve,48.009,FUN_026927-T1,Q91X34,BAAT_MOUSE,,Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2),Mus musculus (Mouse),39.8,427.0,3.700000000000001e-71,270.4,sp|Q91X34|BAAT_MOUSE Bile acid-CoA:amino acid N-acyltransferase OS=Mus musculus OX=10090 GN=Baat PE=1 SV=1,GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817,acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530],cytosol [GO:0005829]; peroxisome [GO:0005777],carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; glycine N-choloyltransferase activity [GO:0047963]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; N-acyltransferase activity [GO:0016410]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817],GO:0003824; GO:0005777; GO:0005829; GO:0006520; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0043226; GO:0048856; GO:0055086,catalytic activity; peroxisome; cytosol; amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_12200,FUN_026929-T1,Peve_00036109,,apul_peve,66.851,,,,,,,,,,,,,,,,,
OG_12201,FUN_026970-T1,Peve_00008704,,apul_peve,70.755,,,,,,,,,,,,,,,,,
OG_12202,FUN_026971-T1,Peve_00002736,,apul_peve,63.194,,,,,,,,,,,,,,,,,
OG_12203,FUN_026973-T1,Peve_00013688,,apul_peve,55.466,,,,,,,,,,,,,,,,,
OG_12204,FUN_026978-T1,Peve_00013248,,apul_peve,62.338,FUN_026978-T1,F4J0A8,,,,,29.9,224.0,1.1e-15,85.5,sp|F4J0A8|P4H6_ARATH Probable prolyl 4-hydroxylase 6 OS=Arabidopsis thaliana OX=3702 GN=P4H6 PE=2 SV=1,,,,,,
OG_12205,FUN_026984-T1,Peve_00012929,,apul_peve,65.063,FUN_026984-T1,Q8WVS4,DC2I1_HUMAN,,Cytoplasmic dynein 2 intermediate chain 1 (Dynein 2 intermediate chain 1) (WD repeat-containing protein 60),Homo sapiens (Human),36.5,666.0,5.099999999999999e-109,397.5,sp|Q8WVS4|DC2I1_HUMAN Cytoplasmic dynein 2 intermediate chain 1 OS=Homo sapiens OX=9606 GN=DYNC2I1 PE=1 SV=3,GO:0000242; GO:0005615; GO:0005813; GO:0005829; GO:0005868; GO:0005929; GO:0035721; GO:0036064; GO:0045503; GO:0045504; GO:0048704; GO:0060271; GO:0097542; GO:0097546,cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; intraciliary retrograde transport [GO:0035721],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; extracellular space [GO:0005615]; pericentriolar material [GO:0000242],dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503],GO:0005615; GO:0005815; GO:0005829; GO:0005929; GO:0007018; GO:0043226; GO:0044782,extracellular space; microtubule organizing center; cytosol; cilium; microtubule-based movement; organelle; cilium organization
OG_12206,FUN_026992-T1,Peve_00041417,,apul_peve,72.3155,,,,,,,,,,,,,,,,,
OG_12207,FUN_026993-T1,Peve_00029124,,apul_peve,80.0,,,,,,,,,,,,,,,,,
OG_12208,FUN_026994-T1,Peve_00024175,,apul_peve,73.0,,,,,,,,,,,,,,,,,
OG_12209,FUN_027001-T1,Peve_00041945,,apul_peve,53.922,,,,,,,,,,,,,,,,,
OG_12210,FUN_027012-T1,Peve_00030962,,apul_peve,53.571,,,,,,,,,,,,,,,,,
OG_12211,FUN_027029-T1,Peve_00017298,,apul_peve,33.108,,,,,,,,,,,,,,,,,
OG_12212,FUN_027055-T1,Peve_00013015,,apul_peve,98.301,,,,,,,,,,,,,,,,,
OG_12213,FUN_027079-T1,Peve_00023591,,apul_peve,88.796,,,,,,,,,,,,,,,,,
OG_12214,FUN_027132-T1,Peve_00044923,,apul_peve,42.951,,,,,,,,,,,,,,,,,
OG_12215,FUN_027149-T1,Peve_00000859,,apul_peve,64.398,FUN_027149-T1,Q9TXJ8,,,,,24.5,249.0,3.8e-11,70.5,sp|Q9TXJ8|RECQ1_CAEEL Putative ATP-dependent DNA helicase Q1 OS=Caenorhabditis elegans OX=6239 GN=K02F3.12 PE=3 SV=3,,,,,,
OG_12216,FUN_027184-T1,Peve_00043135,,apul_peve,96.8,,,,,,,,,,,,,,,,,
OG_12217,FUN_027191-T1,Peve_00016964,,apul_peve,81.05199999999999,,,,,,,,,,,,,,,,,
OG_12218,FUN_027238-T1,Peve_00011533,,apul_peve,36.26049999999999,,,,,,,,,,,,,,,,,
OG_12219,FUN_027253-T1,Peve_00027860,,apul_peve,86.582,,,,,,,,,,,,,,,,,
OG_12220,FUN_027254-T1,Peve_00008113,,apul_peve,71.307,FUN_027254-T1,Q8WVM7,,,,,41.9,1041.0,5.700000000000001e-227,789.6,sp|Q8WVM7|STAG1_HUMAN Cohesin subunit SA-1 OS=Homo sapiens OX=9606 GN=STAG1 PE=1 SV=3,,,,,,
OG_12221,FUN_027273-T1,Peve_00035916,,apul_peve,56.371,,,,,,,,,,,,,,,,,
OG_12222,FUN_027281-T2,Peve_00029710,,apul_peve,71.139,FUN_027281-T2,Q8IW92,,,,,37.9,396.0,1.4999999999999998e-68,261.5,sp|Q8IW92|GLBL2_HUMAN Beta-galactosidase-1-like protein 2 OS=Homo sapiens OX=9606 GN=GLB1L2 PE=1 SV=1,,,,,,
OG_12223,FUN_027283-T1,Peve_00014840,,apul_peve,46.729,,,,,,,,,,,,,,,,,
OG_12224,FUN_027285-T1,Peve_00029778,,apul_peve,32.931,FUN_027285-T1,P31836,,,,,25.3,450.0,1.3e-22,110.2,sp|P31836|NCAM1_BOVIN Neural cell adhesion molecule 1 OS=Bos taurus OX=9913 GN=NCAM1 PE=1 SV=1,,,,,,
OG_12225,FUN_027296-T1,Peve_00037342,,apul_peve,53.313,,,,,,,,,,,,,,,,,
OG_12226,FUN_027312-T1,Peve_00001094,,apul_peve,62.147000000000006,,,,,,,,,,,,,,,,,
OG_12227,FUN_027364-T1,Peve_00003977,,apul_peve,44.0,,,,,,,,,,,,,,,,,
OG_12228,FUN_027423-T1,Peve_00027172,,apul_peve,53.0,,,,,,,,,,,,,,,,,
OG_12229,FUN_027443-T1,Peve_00018982,,apul_peve,77.679,,,,,,,,,,,,,,,,,
OG_12230,FUN_027463-T1,Peve_00005669,,apul_peve,60.63,,,,,,,,,,,,,,,,,
OG_12231,FUN_027468-T1,Peve_00014317,,apul_peve,52.041,,,,,,,,,,,,,,,,,
OG_12232,FUN_027478-T1,Peve_00021871,,apul_peve,63.095,,,,,,,,,,,,,,,,,
OG_12233,FUN_027514-T1,Peve_00016754,,apul_peve,39.679,,,,,,,,,,,,,,,,,
OG_12234,FUN_027516-T1,Peve_00000833,,apul_peve,34.5005,,,,,,,,,,,,,,,,,
OG_12235,FUN_027590-T1,Peve_00007119,,apul_peve,50.3835,,,,,,,,,,,,,,,,,
OG_12236,FUN_027618-T1,Peve_00024009,,apul_peve,66.30449999999999,,,,,,,,,,,,,,,,,
OG_12237,FUN_027620-T1,Peve_00029836,,apul_peve,37.097,,,,,,,,,,,,,,,,,
OG_12238,FUN_027651-T1,Peve_00036818,,apul_peve,60.0,,,,,,,,,,,,,,,,,
OG_12239,FUN_027709-T1,Peve_00025881,,apul_peve,33.333,,,,,,,,,,,,,,,,,
OG_12240,FUN_027712-T1,Peve_00012128,,apul_peve,48.333,,,,,,,,,,,,,,,,,
OG_12241,FUN_027713-T1,Peve_00028404,,apul_peve,60.563,,,,,,,,,,,,,,,,,
OG_12242,FUN_027751-T1,Peve_00041522,,apul_peve,65.589,FUN_027751-T1,O88572,LRP6_MOUSE,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Mus musculus (Mouse),51.3,958.0,6.5e-81,305.1,sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1,GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043065; GO:0045121; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0110135; GO:1990963; GO:2000051; GO:2000648,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005768; GO:0005783; GO:0005886; GO:0006355; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0048870; GO:0060089,transporter activity; endosome; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_12243,FUN_027791-T1,Peve_00022415,,apul_peve,64.368,,,,,,,,,,,,,,,,,
OG_12244,FUN_027800-T1,Peve_00034152,,apul_peve,71.1985,,,,,,,,,,,,,,,,,
OG_12245,FUN_027816-T1,Peve_00022548,,apul_peve,52.125,,,,,,,,,,,,,,,,,
OG_12246,FUN_027821-T1,Peve_00042263,,apul_peve,92.308,,,,,,,,,,,,,,,,,
OG_12247,FUN_027851-T1,Peve_00011582,,apul_peve,45.288,FUN_027851-T1,Q9CR50,ZN363_MOUSE,,RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363),Mus musculus (Mouse),31.6,177.0,2.2e-20,103.2,sp|Q9CR50|ZN363_MOUSE RING finger and CHY zinc finger domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rchy1 PE=1 SV=1,GO:0000151; GO:0002039; GO:0005634; GO:0005829; GO:0006511; GO:0008270; GO:0016567; GO:0016607; GO:0031398; GO:0032436; GO:0042803; GO:0051865; GO:0061630; GO:0072344,positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; transferase activity; organelle; catalytic activity, acting on a protein"
OG_12248,FUN_027861-T1,Peve_00013346,,apul_peve,44.375,,,,,,,,,,,,,,,,,
OG_12249,FUN_027872-T1,Peve_00002779,,apul_peve,43.5945,,,,,,,,,,,,,,,,,
OG_12250,FUN_027886-T1,Peve_00023893,,apul_peve,72.906,,,,,,,,,,,,,,,,,
OG_12251,FUN_027924-T1,Peve_00020110,,apul_peve,50.938500000000005,FUN_027924-T1,Q90X46,GP161_DANRE,,G-protein coupled receptor 161,Danio rerio (Zebrafish) (Brachydanio rerio),35.3,184.0,7.099999999999999e-26,120.2,sp|Q90X46|GP161_DANRE G-protein coupled receptor 161 OS=Danio rerio OX=7955 GN=gpr161 PE=2 SV=2,GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0007368; GO:0051924; GO:0055037; GO:0060170; GO:1901621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; determination of left/right symmetry [GO:0007368]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; regulation of calcium ion transport [GO:0051924],ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037],G protein-coupled receptor activity [GO:0004930],GO:0005768; GO:0005929; GO:0031410; GO:0043226; GO:0060089,endosome; cilium; cytoplasmic vesicle; organelle; molecular transducer activity
OG_12252,FUN_027927-T1,Peve_00020112,,apul_peve,57.2695,,,,,,,,,,,,,,,,,
OG_12253,FUN_027936-T1,Peve_00023145,,apul_peve,56.436,,,,,,,,,,,,,,,,,
OG_12254,FUN_027937-T1,Peve_00032460,,apul_peve,58.537,FUN_027937-T1,P28715,ERCC5_HUMAN,,DNA excision repair protein ERCC-5 (EC 3.1.-.-) (DNA repair protein complementing XP-G cells) (XPG) (Xeroderma pigmentosum group G-complementing protein),Homo sapiens (Human),32.6,963.0,2.8e-110,401.4,sp|P28715|ERCC5_HUMAN DNA excision repair protein ERCC-5 OS=Homo sapiens OX=9606 GN=ERCC5 PE=1 SV=3,GO:0000109; GO:0000405; GO:0000724; GO:0000993; GO:0003684; GO:0003690; GO:0003697; GO:0004519; GO:0004520; GO:0005634; GO:0005654; GO:0005694; GO:0006283; GO:0006285; GO:0006289; GO:0008047; GO:0009411; GO:0010225; GO:0032991; GO:0042803; GO:0043066; GO:0044877; GO:0046872,"base-excision repair, AP site formation [GO:0006285]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; response to UV [GO:0009411]; response to UV-C [GO:0010225]; transcription-coupled nucleotide-excision repair [GO:0006283]",chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; DNA endonuclease activity [GO:0004520]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; enzyme activator activity [GO:0008047]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; RNA polymerase II complex binding [GO:0000993]; single-stranded DNA binding [GO:0003697],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006281; GO:0006310; GO:0043226; GO:0098772; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; DNA repair; DNA recombination; organelle; molecular function regulator activity; catalytic activity, acting on DNA"
OG_12255,FUN_027951-T1,Peve_00039334,,apul_peve,78.744,,,,,,,,,,,,,,,,,
OG_12256,FUN_027957-T1,Peve_00042117,,apul_peve,64.291,FUN_027957-T1,Q80XJ3,,,,,29.7,327.0,1.2e-28,131.3,sp|Q80XJ3|TTC28_MOUSE Tetratricopeptide repeat protein 28 OS=Mus musculus OX=10090 GN=Ttc28 PE=1 SV=3,,,,,,
OG_12257,FUN_027965-T1,Peve_00031348,,apul_peve,58.559,FUN_027965-T1,Q24255,BARH1_DROME,,Homeobox protein B-H1 (Homeobox protein BarH1),Drosophila melanogaster (Fruit fly),45.5,66.0,5.7e-07,56.2,sp|Q24255|BARH1_DROME Homeobox protein B-H1 OS=Drosophila melanogaster OX=7227 GN=B-H1 PE=2 SV=2,GO:0000122; GO:0000977; GO:0000981; GO:0001751; GO:0005634; GO:0006357; GO:0007455; GO:0007479; GO:0007601; GO:0008052; GO:0008057; GO:0008407; GO:0045892,chaeta morphogenesis [GO:0008407]; compound eye photoreceptor cell differentiation [GO:0001751]; eye pigment granule organization [GO:0008057]; eye-antennal disc morphogenesis [GO:0007455]; leg disc proximal/distal pattern formation [GO:0007479]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ boundary specification [GO:0008052]; visual perception [GO:0007601],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0050877; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; nervous system process; transcription regulator activity
OG_12258,FUN_027967-T1,Peve_00031352,,apul_peve,56.109,,,,,,,,,,,,,,,,,
OG_12259,FUN_027973-T1,Peve_00031358,,apul_peve,67.512,FUN_027973-T1,Q9QYS2,GRM3_MOUSE,,Metabotropic glutamate receptor 3 (mGluR3),Mus musculus (Mouse),40.9,828.0,2.8e-171,604.0,sp|Q9QYS2|GRM3_MOUSE Metabotropic glutamate receptor 3 OS=Mus musculus OX=10090 GN=Grm3 PE=1 SV=1,GO:0001641; GO:0005246; GO:0005886; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0035249; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0048786; GO:0051930; GO:0097110; GO:0097449; GO:0098978; GO:0099170,"cellular response to stress [GO:0033554]; gene expression [GO:0010467]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of sensory perception of pain [GO:0051930]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249]",astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734],calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110],GO:0005886; GO:0023052; GO:0043226; GO:0050877; GO:0060089; GO:0098772,plasma membrane; signaling; organelle; nervous system process; molecular transducer activity; molecular function regulator activity
OG_12260,FUN_027978-T1,Peve_00031367,,apul_peve,60.307500000000005,,,,,,,,,,,,,,,,,
OG_12261,FUN_027991-T1,Peve_00023126,,apul_peve,43.023,,,,,,,,,,,,,,,,,
OG_12262,FUN_027995-T1,Peve_00023122,,apul_peve,50.0,,,,,,,,,,,,,,,,,
OG_12263,FUN_027999-T1,Peve_00023149,,apul_peve,54.286,,,,,,,,,,,,,,,,,
OG_12264,FUN_028001-T1,Peve_00023114,,apul_peve,53.81,FUN_028001-T1,Q24K12,,,,,42.0,766.0,8.4e-142,506.1,sp|Q24K12|GPTC1_BOVIN G patch domain-containing protein 1 OS=Bos taurus OX=9913 GN=GPATCH1 PE=2 SV=1,,,,,,
OG_12265,FUN_028006-T1,Peve_00032129,,apul_peve,76.471,FUN_028006-T1,Q9NVE7,PANK4_HUMAN,,4'-phosphopantetheine phosphatase (EC 3.1.3.-) (Inactive pantothenic acid kinase 4) (hPanK4),Homo sapiens (Human),42.3,142.0,9.2e-21,101.7,sp|Q9NVE7|PANK4_HUMAN 4'-phosphopantetheine phosphatase OS=Homo sapiens OX=9606 GN=PANK4 PE=1 SV=1,GO:0005524; GO:0005634; GO:0005829; GO:0015937; GO:0015939; GO:0016791; GO:0046872,coenzyme A biosynthetic process [GO:0015937]; pantothenate metabolic process [GO:0015939],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791],GO:0003824; GO:0005634; GO:0005829; GO:0006575; GO:0006790; GO:0016787; GO:0043226; GO:0055086,catalytic activity; nucleus; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_12266,FUN_028031-T1,Peve_00020093,,apul_peve,33.7875,,,,,,,,,,,,,,,,,
OG_12267,FUN_028043-T2,Peve_00020099,,apul_peve,48.328,FUN_028043-T2,Q5ZK28,DPOD3_CHICK,,DNA polymerase delta subunit 3 (DNA polymerase delta subunit p66),Gallus gallus (Chicken),33.1,489.0,6.8e-34,146.7,sp|Q5ZK28|DPOD3_CHICK DNA polymerase delta subunit 3 OS=Gallus gallus OX=9031 GN=POLD3 PE=1 SV=2,GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0043625; GO:0071897,DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA replication [GO:0006260],cytoplasm [GO:0005737]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654],,GO:0005654; GO:0006260; GO:0006281,nucleoplasm; DNA replication; DNA repair
OG_12268,FUN_028061-T1,Peve_00012554,,apul_peve,47.074,,,,,,,,,,,,,,,,,
OG_12269,FUN_028064-T1,Peve_00020683,,apul_peve,47.927,,,,,,,,,,,,,,,,,
OG_12270,FUN_028075-T1,Peve_00020100,,apul_peve,38.1765,FUN_028075-T1,P13474,,,,,44.1,102.0,8.3e-20,99.8,sp|P13474|ETS1A_CHICK Transforming protein p54/c-ets-1 OS=Gallus gallus OX=9031 GN=ETS1 PE=2 SV=1,,,,,,
OG_12271,FUN_028078-T1,Peve_00020101,,apul_peve,69.261,FUN_028078-T1,P13474,,,,,61.2,103.0,5.200000000000001e-33,142.9,sp|P13474|ETS1A_CHICK Transforming protein p54/c-ets-1 OS=Gallus gallus OX=9031 GN=ETS1 PE=2 SV=1,,,,,,
OG_12272,FUN_028085-T2,Peve_00031648,,apul_peve,35.6175,,,,,,,,,,,,,,,,,
OG_12273,FUN_028096-T1,Peve_00004886,,apul_peve,52.982,FUN_028096-T1,Q9UHK0,NUFP1_HUMAN,,FMR1-interacting protein NUFIP1 (Nuclear FMR1-interacting protein 1) (Nuclear FMRP-interacting protein 1),Homo sapiens (Human),28.9,363.0,3.8e-26,120.9,sp|Q9UHK0|NUFP1_HUMAN FMR1-interacting protein NUFIP1 OS=Homo sapiens OX=9606 GN=NUFIP1 PE=1 SV=2,GO:0000492; GO:0001650; GO:0003723; GO:0005634; GO:0005654; GO:0005726; GO:0005730; GO:0006396; GO:0008023; GO:0008270; GO:0016363; GO:0030674; GO:0032991; GO:0042802; GO:0045944; GO:0048786; GO:0051117; GO:0070761,box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA processing [GO:0006396],fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; transcription elongation factor complex [GO:0008023],ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006355; GO:0043226; GO:0060090; GO:0065003,RNA binding; nucleus; nucleoplasm; nucleolus; regulation of DNA-templated transcription; organelle; molecular adaptor activity; protein-containing complex assembly
OG_12274,FUN_028097-T1,Peve_00026161,,apul_peve,70.175,FUN_028097-T1,Q96L58,,,,,47.6,273.0,3.8e-76,286.6,"sp|Q96L58|B3GT6_HUMAN Beta-1,3-galactosyltransferase 6 OS=Homo sapiens OX=9606 GN=B3GALT6 PE=1 SV=2",,,,,,
OG_12275,FUN_028107-T1,Peve_00004889,,apul_peve,62.923,FUN_028107-T1,Q5SVL6,RPGP2_MOUSE,,Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4),Mus musculus (Mouse),41.3,327.0,8.7e-57,223.4,sp|Q5SVL6|RPGP2_MOUSE Rap1 GTPase-activating protein 2 OS=Mus musculus OX=10090 GN=Rap1gap2 PE=1 SV=1,GO:0005096; GO:0005737; GO:0010977; GO:0043005; GO:0051056,negative regulation of neuron projection development [GO:0010977]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; neuron projection [GO:0043005],GTPase activator activity [GO:0005096],GO:0098772,molecular function regulator activity
OG_12276,FUN_028113-T1,Peve_00019694,,apul_peve,53.714,,,,,,,,,,,,,,,,,
OG_12277,FUN_028118-T1,Peve_00030852,,apul_peve,78.39,FUN_028118-T1,Q8CN40,,,,,26.3,179.0,9.5e-11,68.9,sp|Q8CN40|Y2036_STAES Uncharacterized oxidoreductase SE_2036 OS=Staphylococcus epidermidis (strain ATCC 12228 / FDA PCI 1200) OX=176280 GN=SE_2036 PE=3 SV=1,,,,,,
OG_12278,FUN_028131-T1,Peve_00000989,,apul_peve,41.907,,,,,,,,,,,,,,,,,
OG_12279,FUN_028144-T1,Peve_00037723,,apul_peve,36.452,,,,,,,,,,,,,,,,,
OG_12280,FUN_028153-T1,Peve_00010468,,apul_peve,30.939,,,,,,,,,,,,,,,,,
OG_12281,FUN_028154-T1,Peve_00031153,,apul_peve,34.463,,,,,,,,,,,,,,,,,
OG_12282,FUN_028159-T1,Peve_00018134,,apul_peve,81.29400000000001,,,,,,,,,,,,,,,,,
OG_12283,FUN_028168-T1,Peve_00039304,,apul_peve,54.545,,,,,,,,,,,,,,,,,
OG_12284,FUN_028175-T1,Peve_00001283,,apul_peve,69.851,,,,,,,,,,,,,,,,,
OG_12285,FUN_028184-T1,Peve_00001288,,apul_peve,35.7675,FUN_028184-T1,Q8N8U9,BMPER_HUMAN,,BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2),Homo sapiens (Human),23.3,301.0,1.7e-08,62.4,sp|Q8N8U9|BMPER_HUMAN BMP-binding endothelial regulator protein OS=Homo sapiens OX=9606 GN=BMPER PE=1 SV=3,GO:0001568; GO:0001657; GO:0002043; GO:0005615; GO:0010594; GO:0030509; GO:0030514; GO:0031012; GO:0032880; GO:0042118; GO:0045765; GO:0048839; GO:0060391; GO:0060395; GO:0070374; GO:1903672,blood vessel development [GO:0001568]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of angiogenesis [GO:0045765]; regulation of endothelial cell migration [GO:0010594]; regulation of protein localization [GO:0032880]; SMAD protein signal transduction [GO:0060395]; ureteric bud development [GO:0001657],extracellular matrix [GO:0031012]; extracellular space [GO:0005615],,GO:0005615; GO:0030312; GO:0031012; GO:0048856,extracellular space; external encapsulating structure; extracellular matrix; anatomical structure development
OG_12286,FUN_028190-T1,Peve_00003601,,apul_peve,52.482,FUN_028190-T1,B8VIW9,,,,,46.0,437.0,8.6e-103,376.3,sp|B8VIW9|FP_ACRMI Fibronectin type III domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12287,FUN_028202-T1,Peve_00013347,,apul_peve,41.558,,,,,,,,,,,,,,,,,
OG_12288,FUN_028239-T1,Peve_00019540,,apul_peve,81.673,FUN_028239-T1,Q9DBT5,AMPD2_MOUSE,,AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L),Mus musculus (Mouse),61.2,743.0,1.3e-252,874.0,sp|Q9DBT5|AMPD2_MOUSE AMP deaminase 2 OS=Mus musculus OX=10090 GN=Ampd2 PE=1 SV=2,GO:0003876; GO:0005829; GO:0006188; GO:0009117; GO:0032263; GO:0032264; GO:0042632; GO:0046033; GO:0046034; GO:0046039; GO:0046872; GO:0052652; GO:0072015; GO:0097009,AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; GMP salvage [GO:0032263]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]; podocyte development [GO:0072015],cytosol [GO:0005829],AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872],GO:0003824; GO:0005829; GO:0016787; GO:0048856; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_12289,FUN_028263-T1,Peve_00015247,,apul_peve,81.84,FUN_028263-T1,P24140,,,,,62.8,401.0,1.5e-138,494.2,sp|P24140|GPT_CRIGR UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase OS=Cricetulus griseus OX=10029 GN=DPAGT1 PE=1 SV=1,,,,,,
OG_12290,FUN_028271-T1,Peve_00013157,,apul_peve,55.152,,,,,,,,,,,,,,,,,
OG_12291,FUN_028284-T1,Peve_00029772,,apul_peve,42.512,FUN_028284-T1,P07949,RET_HUMAN,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Homo sapiens (Human),47.8,293.0,3.8999999999999996e-75,284.6,sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens OX=9606 GN=RET PE=1 SV=3,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0010008; GO:0010628; GO:0010976; GO:0030155; GO:0030335; GO:0030424; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:0160144; GO:2001241,axon guidance [GO:0007411]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; posterior midgut development [GO:0007497]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; signal transduction [GO:0007165]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"immune system process; catalytic activity; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_12292,FUN_028314-T1,Peve_00025175,,apul_peve,66.102,FUN_028314-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),26.5,774.0,2.1e-52,209.9,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_12293,FUN_028320-T1,Peve_00002320,,apul_peve,39.749,FUN_028320-T1,Q8NDA2,,,,,21.5,874.0,4.1e-24,115.5,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_12294,FUN_028348-T2,Peve_00011253,,apul_peve,56.818,,,,,,,,,,,,,,,,,
OG_12295,FUN_028355-T1,Peve_00026761,,apul_peve,45.612,FUN_028355-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),44.9,303.0,1.6e-75,285.8,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_12296,FUN_028436-T1,Peve_00008338,,apul_peve,55.814,,,,,,,,,,,,,,,,,
OG_12297,FUN_028445-T1,Peve_00026235,,apul_peve,37.143,FUN_028445-T1,Q8NDA2,,,,,23.9,566.0,1.3e-36,156.4,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_12298,FUN_028450-T2,Peve_00002374,,apul_peve,37.34,FUN_028450-T2,P13595,NCAM1_MOUSE,,Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56),Mus musculus (Mouse),30.5,131.0,4.2e-08,61.2,sp|P13595|NCAM1_MOUSE Neural cell adhesion molecule 1 OS=Mus musculus OX=10090 GN=Ncam1 PE=1 SV=3,GO:0001837; GO:0001928; GO:0005886; GO:0005911; GO:0007166; GO:0008201; GO:0009897; GO:0019722; GO:0030424; GO:0030426; GO:0031175; GO:0034109; GO:0043025; GO:0043209; GO:0050850; GO:0071679; GO:2001260,calcium-mediated signaling [GO:0019722]; cell surface receptor signaling pathway [GO:0007166]; commissural neuron axon guidance [GO:0071679]; epithelial to mesenchymal transition [GO:0001837]; homotypic cell-cell adhesion [GO:0034109]; neuron projection development [GO:0031175]; positive regulation of calcium-mediated signaling [GO:0050850]; regulation of exocyst assembly [GO:0001928]; regulation of semaphorin-plexin signaling pathway [GO:2001260],axon [GO:0030424]; cell-cell junction [GO:0005911]; external side of plasma membrane [GO:0009897]; growth cone [GO:0030426]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],heparin binding [GO:0008201],GO:0005886; GO:0007155; GO:0030154,plasma membrane; cell adhesion; cell differentiation
OG_12299,FUN_028451-T2,Peve_00026209,,apul_peve,53.528,FUN_028451-T2,P35546,RET_MOUSE,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Mus musculus (Mouse),45.4,326.0,7.100000000000001e-76,287.0,sp|P35546|RET_MOUSE Proto-oncogene tyrosine-protein kinase receptor Ret OS=Mus musculus OX=10090 GN=Ret PE=1 SV=2,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0009653; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144; GO:1904894,anatomical structure morphogenesis [GO:0009653]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; regulation of axonogenesis [GO:0050770]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_12300,FUN_028453-T1,Peve_00001096,,apul_peve,42.231,,,,,,,,,,,,,,,,,
OG_12301,FUN_028465-T1,Peve_00003106,,apul_peve,65.4505,FUN_028465-T1,Q2UY09,COSA1_HUMAN,,Collagen alpha-1(XXVIII) chain,Homo sapiens (Human),30.4,204.0,9e-14,79.3,sp|Q2UY09|COSA1_HUMAN Collagen alpha-1(XXVIII) chain OS=Homo sapiens OX=9606 GN=COL28A1 PE=1 SV=2,GO:0004867; GO:0005576; GO:0005592; GO:0005604; GO:0005615; GO:0005788; GO:0007155; GO:0008201; GO:0030020; GO:0062023,cell adhesion [GO:0007155],basement membrane [GO:0005604]; collagen type XI trimer [GO:0005592]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615],extracellular matrix structural constituent conferring tensile strength [GO:0030020]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005198; GO:0005576; GO:0005615; GO:0007155; GO:0030312; GO:0031012; GO:0098772,structural molecule activity; extracellular region; extracellular space; cell adhesion; external encapsulating structure; extracellular matrix; molecular function regulator activity
OG_12302,FUN_028466-T1,Peve_00003104,,apul_peve,42.857,,,,,,,,,,,,,,,,,
OG_12303,FUN_028467-T1,Peve_00034089,,apul_peve,35.945,FUN_028467-T1,O89029,,,,,29.3,215.0,2.6e-11,72.8,sp|O89029|MATN4_MOUSE Matrilin-4 OS=Mus musculus OX=10090 GN=Matn4 PE=1 SV=1,,,,,,
OG_12304,FUN_028488-T1,Peve_00015132,,apul_peve,54.5245,FUN_028488-T1,O95251,KAT7_HUMAN,,"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)",Homo sapiens (Human),32.2,311.0,1.3e-29,132.5,sp|O95251|KAT7_HUMAN Histone acetyltransferase KAT7 OS=Homo sapiens OX=9606 GN=KAT7 PE=1 SV=1,GO:0000123; GO:0000775; GO:0000785; GO:0001558; GO:0001779; GO:0003682; GO:0003688; GO:0003712; GO:0004402; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006275; GO:0006281; GO:0006355; GO:0006357; GO:0008270; GO:0010484; GO:0010485; GO:0018393; GO:0030174; GO:0030217; GO:0031098; GO:0032786; GO:0036408; GO:0036409; GO:0043994; GO:0043995; GO:0043996; GO:0043997; GO:0044016; GO:0045648; GO:0045740; GO:0045815; GO:0045944; GO:0051726; GO:0072708; GO:0072710; GO:0072716; GO:0072720; GO:0072739; GO:0090734; GO:0140889; GO:1900182; GO:1902035; GO:2000278; GO:2000819,"DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-dependent chromatin disassembly [GO:0140889]; internal peptidyl-lysine acetylation [GO:0018393]; natural killer cell differentiation [GO:0001779]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of DNA biosynthetic process [GO:2000278]; regulation of DNA replication [GO:0006275]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of DNA-templated transcription [GO:0006355]; regulation of nucleotide-excision repair [GO:2000819]; regulation of transcription by RNA polymerase II [GO:0006357]; response to actinomycin D [GO:0072716]; response to anisomycin [GO:0072739]; response to dithiothreitol [GO:0072720]; response to hydroxyurea [GO:0072710]; response to sorbitol [GO:0072708]; stress-activated protein kinase signaling cascade [GO:0031098]; T cell differentiation [GO:0030217]; transcription initiation-coupled chromatin remodeling [GO:0045815]","chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; histone H3-K14 acetyltransferase complex [GO:0036409]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; site of DNA damage [GO:0090734]",chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; histone H3K23 acetyltransferase activity [GO:0043994]; histone H3K4 acetyltransferase activity [GO:0044016]; histone H4 acetyltransferase activity [GO:0010485]; histone H4K12 acetyltransferase activity [GO:0043997]; histone H4K5 acetyltransferase activity [GO:0043995]; histone H4K8 acetyltransferase activity [GO:0043996]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270],GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006260; GO:0006281; GO:0006325; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0060090; GO:0140096; GO:0140110,"immune system process; DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; cytosol; DNA replication; DNA repair; chromatin organization; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_12305,FUN_028504-T1,Peve_00022931,,apul_peve,63.9995,FUN_028504-T1,Q14692,BMS1_HUMAN,,Ribosome biogenesis protein BMS1 homolog (EC 3.6.5.-) (Ribosome assembly protein BMS1 homolog),Homo sapiens (Human),50.8,1271.0,0.0,1081.2,sp|Q14692|BMS1_HUMAN Ribosome biogenesis protein BMS1 homolog OS=Homo sapiens OX=9606 GN=BMS1 PE=1 SV=1,GO:0000462; GO:0000479; GO:0003723; GO:0003924; GO:0005524; GO:0005525; GO:0005654; GO:0005694; GO:0005730; GO:0032040; GO:0034511; GO:0042274,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000479]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]",chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040],ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511],GO:0003723; GO:0003824; GO:0003924; GO:0005654; GO:0005694; GO:0005730; GO:0016787; GO:0043226,RNA binding; catalytic activity; GTPase activity; nucleoplasm; chromosome; nucleolus; hydrolase activity; organelle
OG_12306,FUN_028507-T1,Peve_00035762,,apul_peve,73.852,FUN_028507-T1,P50429,,,,,47.1,497.0,3.800000000000001e-130,466.5,sp|P50429|ARSB_MOUSE Arylsulfatase B OS=Mus musculus OX=10090 GN=Arsb PE=1 SV=3,,,,,,
OG_12307,FUN_028517-T1,Peve_00002972,,apul_peve,80.256,,,,,,,,,,,,,,,,,
OG_12308,FUN_028518-T1,Peve_00002973,,apul_peve,74.37,,,,,,,,,,,,,,,,,
OG_12309,FUN_028540-T1,Peve_00022116,,apul_peve,33.333,,,,,,,,,,,,,,,,,
OG_12310,FUN_028586-T1,Peve_00002810,,apul_peve,85.348,,,,,,,,,,,,,,,,,
OG_12311,FUN_028610-T1,Peve_00010837,,apul_peve,84.545,,,,,,,,,,,,,,,,,
OG_12312,FUN_028642-T1,Peve_00027117,,apul_peve,74.232,,,,,,,,,,,,,,,,,
OG_12313,FUN_028643-T1,Peve_00033498,,apul_peve,71.93,,,,,,,,,,,,,,,,,
OG_12314,FUN_028680-T1,Peve_00034714,,apul_peve,81.875,,,,,,,,,,,,,,,,,
OG_12315,FUN_028690-T1,Peve_00016594,,apul_peve,62.6985,FUN_028690-T1,Q7S1Z3,,,,,39.3,84.0,1.7e-06,54.7,sp|Q7S1Z3|RM17_NEUCR Large ribosomal subunit protein mL46 OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) OX=367110 GN=mrpl17 PE=1 SV=1,,,,,,
OG_12316,FUN_028758-T1,Peve_00010350,,apul_peve,60.981,,,,,,,,,,,,,,,,,
OG_12317,FUN_028763-T1,Peve_00016591,,apul_peve,75.728,FUN_028763-T1,Q3UFF7,,,,,31.3,201.0,1.2e-24,114.8,sp|Q3UFF7|LYPL1_MOUSE Lysophospholipase-like protein 1 OS=Mus musculus OX=10090 GN=Lyplal1 PE=1 SV=3,,,,,,
OG_12318,FUN_028798-T1,Peve_00008464,,apul_peve,58.4555,,,,,,,,,,,,,,,,,
OG_12319,FUN_028838-T1,Peve_00024572,,apul_peve,91.703,FUN_028838-T1,P70618,,,,,76.4,229.0,1.3e-104,380.6,sp|P70618|MK14_RAT Mitogen-activated protein kinase 14 OS=Rattus norvegicus OX=10116 GN=Mapk14 PE=1 SV=3,,,,,,
OG_12320,FUN_028840-T1,Peve_00024570,,apul_peve,52.548,FUN_028840-T1,Q9Z1L4,XLRS1_MOUSE,,Retinoschisin (X-linked juvenile retinoschisis protein homolog),Mus musculus (Mouse),33.3,123.0,3.2e-11,71.6,sp|Q9Z1L4|XLRS1_MOUSE Retinoschisin OS=Mus musculus OX=10090 GN=Rs1 PE=1 SV=1,GO:0001786; GO:0001917; GO:0005546; GO:0005547; GO:0005576; GO:0005615; GO:0007155; GO:0007601; GO:0009897; GO:0009986; GO:0010314; GO:0010842; GO:0032266; GO:0032991; GO:0043325; GO:0044877; GO:0051260; GO:0070273; GO:0080025; GO:0098984,cell adhesion [GO:0007155]; protein homooligomerization [GO:0051260]; retina layer formation [GO:0010842]; visual perception [GO:0007601],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; protein-containing complex [GO:0032991],"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]",GO:0005576; GO:0005615; GO:0007155; GO:0008289; GO:0050877; GO:0065003,extracellular region; extracellular space; cell adhesion; lipid binding; nervous system process; protein-containing complex assembly
OG_12321,FUN_028841-T1,Peve_00008229,,apul_peve,40.726,,,,,,,,,,,,,,,,,
OG_12322,FUN_028895-T1,Peve_00031681,,apul_peve,43.213,,,,,,,,,,,,,,,,,
OG_12323,FUN_028917-T2,Peve_00028027,,apul_peve,88.134,FUN_028917-T2,Q494V2,CP100_HUMAN,,Cilia- and flagella-associated protein 100 (Coiled-coil domain-containing protein 37),Homo sapiens (Human),35.4,455.0,1.9e-60,235.0,sp|Q494V2|CP100_HUMAN Cilia- and flagella-associated protein 100 OS=Homo sapiens OX=9606 GN=CFAP100 PE=1 SV=1,GO:0003341; GO:0031514; GO:0036064; GO:0036159; GO:0070840; GO:0097545,cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159],axonemal doublet microtubule [GO:0097545]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514],dynein complex binding [GO:0070840],GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0065003,microtubule organizing center; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_12324,FUN_028928-T1,Peve_00024159,,apul_peve,32.352999999999994,FUN_028928-T1,O77408,,,,,22.9,144.0,9.8e-07,56.6,sp|O77408|OAR1_LYMST Octopamine receptor 1 OS=Lymnaea stagnalis OX=6523 PE=1 SV=1,,,,,,
OG_12325,FUN_028934-T1,Peve_00026874,,apul_peve,54.612,FUN_028934-T1,O18276,GBRB_CAEEL,,Gamma-aminobutyric acid receptor subunit beta (GABA(A) receptor subunit beta),Caenorhabditis elegans,30.0,506.0,4.5e-56,220.3,sp|O18276|GBRB_CAEEL Gamma-aminobutyric acid receptor subunit beta OS=Caenorhabditis elegans OX=6239 GN=gab-1 PE=2 SV=3,GO:0004890; GO:0005230; GO:0005254; GO:0006811; GO:0007268; GO:0034707; GO:0045202; GO:0045211; GO:1902476; GO:1902711,chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; monoatomic ion transport [GO:0006811],chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],chloride channel activity [GO:0005254]; extracellular ligand-gated monoatomic ion channel activity [GO:0005230]; GABA-A receptor activity [GO:0004890],GO:0005215; GO:0023052; GO:0055085; GO:0060089,transporter activity; signaling; transmembrane transport; molecular transducer activity
OG_12326,FUN_028944-T1,Peve_00026869,,apul_peve,35.294,,,,,,,,,,,,,,,,,
OG_12327,FUN_028955-T2,Peve_00029301,,apul_peve,47.1135,FUN_028955-T2,P0C218,,,,,64.7,405.0,6.5e-145,516.5,sp|P0C218|DDX20_DANRE Probable ATP-dependent RNA helicase DDX20 OS=Danio rerio OX=7955 GN=ddx20 PE=3 SV=1,,,,,,
OG_12328,FUN_028996-T1,Peve_00034534,,apul_peve,59.366,,,,,,,,,,,,,,,,,
OG_12329,FUN_029005-T1,Peve_00000039,,apul_peve,45.652,FUN_029005-T1,A0A2Z5Z9X0,ACT1_CRIJA,,Deep-sea actinoporin Cjtox I (DELTA-actitoxin-Cja1a) (DELTA-AITX-Cja1a),Cribrinopsis japonica (Deep-sea anemone),47.5,202.0,1.1e-42,174.9,sp|A0A2Z5Z9X0|ACT1_CRIJA Deep-sea actinoporin Cjtox I OS=Cribrinopsis japonica OX=1799150 PE=2 SV=1,GO:0005576; GO:0006812; GO:0015267; GO:0042151; GO:0044218; GO:0046930; GO:0046931; GO:0051715; GO:0090729,cytolysis in another organism [GO:0051715]; monoatomic cation transport [GO:0006812]; pore complex assembly [GO:0046931],extracellular region [GO:0005576]; nematocyst [GO:0042151]; other organism cell membrane [GO:0044218]; pore complex [GO:0046930],channel activity [GO:0015267]; toxin activity [GO:0090729],GO:0005215; GO:0005576; GO:0043226; GO:0065003; GO:0090729,transporter activity; extracellular region; organelle; protein-containing complex assembly; toxin activity
OG_12330,FUN_029006-T1,Peve_00025769,,apul_peve,68.421,FUN_029006-T1,P19223,,,,,32.4,352.0,1.5999999999999996e-53,211.5,sp|P19223|CBPB1_RAT Carboxypeptidase B OS=Rattus norvegicus OX=10116 GN=Cpb1 PE=1 SV=1,,,,,,
OG_12331,FUN_029013-T1,Peve_00014381,,apul_peve,57.8775,FUN_029013-T1,B8VIW9,,,,,56.5,754.0,4.7e-244,845.5,sp|B8VIW9|FP_ACRMI Fibronectin type III domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12332,FUN_029017-T1,Peve_00003116,,apul_peve,61.8095,FUN_029017-T1,Q6IC98,GRAM4_HUMAN,,GRAM domain-containing protein 4 (Death-inducing protein),Homo sapiens (Human),32.4,482.0,1e-59,232.6,sp|Q6IC98|GRAM4_HUMAN GRAM domain-containing protein 4 OS=Homo sapiens OX=9606 GN=GRAMD4 PE=1 SV=1,GO:0005739; GO:0005789; GO:0006915; GO:0031966; GO:0034164; GO:0043065,apoptotic process [GO:0006915]; negative regulation of toll-like receptor 9 signaling pathway [GO:0034164]; positive regulation of apoptotic process [GO:0043065],endoplasmic reticulum membrane [GO:0005789]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],,GO:0005739; GO:0012501; GO:0043226,mitochondrion; programmed cell death; organelle
OG_12333,FUN_029023-T3,Peve_00026881,,apul_peve,57.336,FUN_029023-T3,Q07973,CP24A_HUMAN,,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (24-OHase) (Vitamin D(3) 24-hydroxylase) (EC 1.14.15.16) (Cytochrome P450 24A1) (Cytochrome P450-CC24)",Homo sapiens (Human),31.5,438.0,8.100000000000001e-65,249.6,"sp|Q07973|CP24A_HUMAN 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial OS=Homo sapiens OX=9606 GN=CYP24A1 PE=1 SV=2",GO:0001649; GO:0005506; GO:0005739; GO:0005743; GO:0006766; GO:0008403; GO:0020037; GO:0030342; GO:0030343; GO:0033280; GO:0042359; GO:0042369; GO:0062180; GO:0062181; GO:0070561,osteoblast differentiation [GO:0001649]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin D receptor signaling pathway [GO:0070561]; vitamin metabolic process [GO:0006766],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],"1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity [GO:0030342]; 25-hydroxycholecalciferol-23-hydroxylase activity [GO:0062180]; 25-hydroxycholecalciferol-24-hydroxylase activity [GO:0008403]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; vitamin D3 25-hydroxylase activity [GO:0030343]",GO:0003824; GO:0005739; GO:0006629; GO:0006766; GO:0016491; GO:0030154; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; vitamin metabolic process; oxidoreductase activity; cell differentiation; organelle
OG_12334,FUN_029050-T1,Peve_00017369,,apul_peve,32.898,,,,,,,,,,,,,,,,,
OG_12335,FUN_029054-T1,Peve_00020303,,apul_peve,32.979,,,,,,,,,,,,,,,,,
OG_12336,FUN_029055-T1,Peve_00040051,,apul_peve,38.4735,,,,,,,,,,,,,,,,,
OG_12337,FUN_029063-T1,Peve_00043252,,apul_peve,38.5085,,,,,,,,,,,,,,,,,
OG_12338,FUN_029067-T1,Peve_00043256,,apul_peve,71.86099999999999,FUN_029067-T1,A4IFD2,,,,,43.7,334.0,7.600000000000002e-66,253.4,sp|A4IFD2|FOXP1_BOVIN Forkhead box protein P1 OS=Bos taurus OX=9913 GN=FOXP1 PE=2 SV=1,,,,,,
OG_12339,FUN_029068-T1,Peve_00043248,,apul_peve,64.548,,,,,,,,,,,,,,,,,
OG_12340,FUN_029069-T1,Peve_00040068,,apul_peve,34.641,FUN_029069-T1,B8RJM0,,,,,92.2,180.0,4.3e-91,335.5,sp|B8RJM0|USOM3_ACRMI Uncharacterized skeletal organic matrix protein 3 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12341,FUN_029082-T2,Peve_00042921,,apul_peve,31.217,,,,,,,,,,,,,,,,,
OG_12342,FUN_029084-T2,Peve_00042922,,apul_peve,32.907,,,,,,,,,,,,,,,,,
OG_12343,FUN_029101-T1,Peve_00038067,,apul_peve,50.754,FUN_029101-T1,Q15723,ELF2_HUMAN,,ETS-related transcription factor Elf-2 (E74-like factor 2) (New ETS-related factor),Homo sapiens (Human),52.3,88.0,2e-19,97.8,sp|Q15723|ELF2_HUMAN ETS-related transcription factor Elf-2 OS=Homo sapiens OX=9606 GN=ELF2 PE=1 SV=2,GO:0000785; GO:0000981; GO:0003700; GO:0005634; GO:0005654; GO:0005829; GO:0006357; GO:0016604; GO:0030154; GO:0043565; GO:0045892; GO:0045893; GO:1990837,cell differentiation [GO:0030154]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_12344,FUN_029103-T1,Peve_00038070,,apul_peve,46.557,FUN_029103-T1,P41970,ELK3_HUMAN,,ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2),Homo sapiens (Human),53.8,93.0,2.6e-20,100.9,sp|P41970|ELK3_HUMAN ETS domain-containing protein Elk-3 OS=Homo sapiens OX=9606 GN=ELK3 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0001228; GO:0001525; GO:0003700; GO:0005634; GO:0005654; GO:0005739; GO:0006357; GO:0007165; GO:0030154; GO:0032422; GO:0042060; GO:0045944; GO:1990837,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; wound healing [GO:0042060],chromatin [GO:0000785]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; purine-rich negative regulatory element binding [GO:0032422]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005739; GO:0006355; GO:0030154; GO:0042060; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; mitochondrion; regulation of DNA-templated transcription; cell differentiation; wound healing; organelle; transcription regulator activity
OG_12345,FUN_029109-T1,Peve_00012496,,apul_peve,75.676,FUN_029109-T1,Q7T2E8,RHOAC_DANRE,,Rho-related GTP-binding protein RhoA-C,Danio rerio (Zebrafish) (Brachydanio rerio),86.5,193.0,1.6999999999999998e-92,340.1,sp|Q7T2E8|RHOAC_DANRE Rho-related GTP-binding protein RhoA-C OS=Danio rerio OX=7955 GN=rhoac PE=1 SV=1,GO:0003924; GO:0005525; GO:0005829; GO:0005886; GO:0007266; GO:0016477; GO:0019901; GO:0032154; GO:0032956; GO:0043149; GO:0043197; GO:0044319; GO:1902766,"cell migration [GO:0016477]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; skeletal muscle satellite cell migration [GO:1902766]; stress fiber assembly [GO:0043149]; wound healing, spreading of cells [GO:0044319]",cleavage furrow [GO:0032154]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005829; GO:0005886; GO:0007010; GO:0016787; GO:0048870,catalytic activity; GTPase activity; cytosol; plasma membrane; cytoskeleton organization; hydrolase activity; cell motility
OG_12346,FUN_029124-T1,Peve_00024867,,apul_peve,65.507,,,,,,,,,,,,,,,,,
OG_12347,FUN_029131-T1,Peve_00042118,,apul_peve,45.5265,,,,,,,,,,,,,,,,,
OG_12348,FUN_029146-T1,Peve_00000510,,apul_peve,51.381,,,,,,,,,,,,,,,,,
OG_12349,FUN_029147-T1,Peve_00000514,,apul_peve,93.151,FUN_029147-T1,Q8BTM8,FLNA_MOUSE,,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),Mus musculus (Mouse),34.4,2556.0,0.0,1275.4,sp|Q8BTM8|FLNA_MOUSE Filamin-A OS=Mus musculus OX=10090 GN=Flna PE=1 SV=5,GO:0001525; GO:0001837; GO:0001974; GO:0002102; GO:0003007; GO:0003779; GO:0005080; GO:0005634; GO:0005737; GO:0005802; GO:0005886; GO:0005903; GO:0005911; GO:0005938; GO:0007195; GO:0007597; GO:0010572; GO:0010977; GO:0015459; GO:0015629; GO:0030018; GO:0030030; GO:0030036; GO:0030334; GO:0030426; GO:0031267; GO:0031523; GO:0032231; GO:0032432; GO:0034394; GO:0034988; GO:0035855; GO:0042177; GO:0042307; GO:0043113; GO:0043123; GO:0043204; GO:0043433; GO:0044295; GO:0044319; GO:0045022; GO:0045184; GO:0045216; GO:0048680; GO:0050808; GO:0050821; GO:0051015; GO:0051209; GO:0051764; GO:0071526; GO:0072659; GO:0090307; GO:0140297; GO:0140311; GO:1901381; GO:1905000; GO:1905031; GO:1990779,"actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell projection organization [GO:0030030]; cell-cell junction organization [GO:0045216]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; wound healing, spreading of cells [GO:0044319]",actin cytoskeleton [GO:0015629]; actin filament bundle [GO:0032432]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; glycoprotein Ib-IX-V complex [GO:1990779]; growth cone [GO:0030426]; Myb complex [GO:0031523]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; podosome [GO:0002102]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018],actin binding [GO:0003779]; actin filament binding [GO:0051015]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; potassium channel regulator activity [GO:0015459]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; small GTPase binding [GO:0031267],GO:0005634; GO:0005856; GO:0005886; GO:0006355; GO:0007010; GO:0008092; GO:0016192; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0051604; GO:0055085; GO:0072659; GO:0098772; GO:0140313,nucleus; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; vesicle-mediated transport; cell differentiation; cell junction organization; organelle; anatomical structure development; cell motility; protein maturation; transmembrane transport; protein localization to plasma membrane; molecular function regulator activity; molecular sequestering activity
OG_12350,FUN_029150-T1,Peve_00009087,,apul_peve,78.537,FUN_029150-T1,Q9D4D4,,,,,61.5,623.0,1.7000000000000002e-218,760.4,sp|Q9D4D4|TKTL2_MOUSE Transketolase-like protein 2 OS=Mus musculus OX=10090 GN=Tktl2 PE=1 SV=1,,,,,,
OG_12351,FUN_029151-T1,Peve_00009088,,apul_peve,75.262,FUN_029151-T1,Q60HC7,,,,,61.5,623.0,7.4e-219,761.5,sp|Q60HC7|TKT_MACFA Transketolase OS=Macaca fascicularis OX=9541 GN=TKT PE=2 SV=1,,,,,,
OG_12352,FUN_029177-T2,Peve_00031202,,apul_peve,76.038,FUN_029177-T2,Q9DC53,,,,,63.7,518.0,6.9e-194,678.3,sp|Q9DC53|CPNE8_MOUSE Copine-8 OS=Mus musculus OX=10090 GN=Cpne8 PE=2 SV=3,,,,,,
OG_12353,FUN_029184-T1,Peve_00031204,,apul_peve,65.075,FUN_029184-T1,Q9LQV2,,,,,38.7,754.0,1.7e-121,440.3,sp|Q9LQV2|RDR1_ARATH RNA-dependent RNA polymerase 1 OS=Arabidopsis thaliana OX=3702 GN=RDR1 PE=2 SV=1,,,,,,
OG_12354,FUN_029190-T1,Peve_00017676,,apul_peve,67.857,,,,,,,,,,,,,,,,,
OG_12355,FUN_029200-T1,Peve_00035858,,apul_peve,58.475,FUN_029200-T1,Q9LQV2,,,,,32.1,1104.0,2.3e-131,473.0,sp|Q9LQV2|RDR1_ARATH RNA-dependent RNA polymerase 1 OS=Arabidopsis thaliana OX=3702 GN=RDR1 PE=2 SV=1,,,,,,
OG_12356,FUN_029201-T1,Peve_00012544,,apul_peve,69.7325,FUN_029201-T1,Q96N23,,,,,27.5,2621.0,3.0999999999999997e-229,798.1,sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3,,,,,,
OG_12357,FUN_029203-T1,Peve_00024709,,apul_peve,60.417,,,,,,,,,,,,,,,,,
OG_12358,FUN_029207-T1,Peve_00022650,,apul_peve,48.527,FUN_029207-T1,B8VIW9,,,,,44.8,201.0,7.4e-39,163.7,sp|B8VIW9|FP_ACRMI Fibronectin type III domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12359,FUN_029237-T1,Peve_00024308,,apul_peve,83.75,FUN_029237-T1,O60870,KIN17_HUMAN,,"DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein homolog)",Homo sapiens (Human),76.1,67.0,7.5e-23,107.8,sp|O60870|KIN17_HUMAN DNA/RNA-binding protein KIN17 OS=Homo sapiens OX=9606 GN=KIN PE=1 SV=2,GO:0003677; GO:0003690; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0006397; GO:0006974; GO:0008270; GO:0016363; GO:0032991,DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; mRNA processing [GO:0006397],cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006260; GO:0006281; GO:0006310; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; cytosol; DNA replication; DNA repair; DNA recombination; mRNA metabolic process; organelle
OG_12360,FUN_029238-T1,Peve_00045047,,apul_peve,37.532,,,,,,,,,,,,,,,,,
OG_12361,FUN_029245-T1,Peve_00013748,,apul_peve,31.208,,,,,,,,,,,,,,,,,
OG_12362,FUN_029256-T1,Peve_00024368,,apul_peve,68.5,,,,,,,,,,,,,,,,,
OG_12363,FUN_029284-T1,Peve_00036553,,apul_peve,71.868,FUN_029284-T1,P25162,ACH4_DROME,,Acetylcholine receptor subunit beta-like 2 (Nicotinic acetylcholine receptor beta 2),Drosophila melanogaster (Fruit fly),33.8,305.0,9.4e-43,176.0,sp|P25162|ACH4_DROME Acetylcholine receptor subunit beta-like 2 OS=Drosophila melanogaster OX=7227 GN=nAChRbeta2 PE=2 SV=3,GO:0004888; GO:0005886; GO:0005892; GO:0007268; GO:0007271; GO:0017085; GO:0022848; GO:0034220; GO:0042391; GO:0043005; GO:0045202; GO:0045211,"chemical synaptic transmission [GO:0007268]; monoatomic ion transmembrane transport [GO:0034220]; regulation of membrane potential [GO:0042391]; response to insecticide [GO:0017085]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_12364,FUN_029292-T1,Peve_00036560,,apul_peve,47.368,,,,,,,,,,,,,,,,,
OG_12365,FUN_029293-T2,Peve_00031914,,apul_peve,56.047,FUN_029293-T2,Q9BDJ4,,,,,36.8,323.0,4.5000000000000005e-48,193.4,sp|Q9BDJ4|LIPH_RABIT Lipase member H OS=Oryctolagus cuniculus OX=9986 GN=LIPH PE=2 SV=1,,,,,,
OG_12366,FUN_029318-T1,Peve_00038251,,apul_peve,61.4925,FUN_029318-T1,Q5ZK84,AK1A1_CHICK,,Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-),Gallus gallus (Chicken),62.9,318.0,2.5e-118,426.8,sp|Q5ZK84|AK1A1_CHICK Aldo-keto reductase family 1 member A1 OS=Gallus gallus OX=9031 GN=AKR1A1 PE=2 SV=1,GO:0004032; GO:0005829; GO:0006629; GO:0016324; GO:0046185; GO:0110095; GO:0160163,aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; lipid metabolic process [GO:0006629],apical plasma membrane [GO:0016324]; cytosol [GO:0005829],aldose reductase (NADPH) activity [GO:0004032]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163],GO:0003824; GO:0005829; GO:0006629; GO:0016491; GO:0098754,catalytic activity; cytosol; lipid metabolic process; oxidoreductase activity; detoxification
OG_12367,FUN_029321-T1,Peve_00031598,,apul_peve,49.0,FUN_029321-T1,P28693,,,,,34.3,230.0,5.3e-24,115.9,sp|P28693|EPHB2_CHICK Ephrin type-B receptor 2 OS=Gallus gallus OX=9031 GN=EPHB2 PE=1 SV=3,,,,,,
OG_12368,FUN_029324-T1,Peve_00031599,,apul_peve,66.787,FUN_029324-T1,Q6F2E4,FOXD1_XENTR,,Forkhead box protein D1 (FoxD1) (Brain factor 2) (BF-2),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),67.3,150.0,9.999999999999999e-51,201.8,sp|Q6F2E4|FOXD1_XENTR Forkhead box protein D1 OS=Xenopus tropicalis OX=8364 GN=foxd1 PE=2 SV=1,GO:0000122; GO:0001755; GO:0003700; GO:0005634; GO:0007398; GO:0007399; GO:0007498; GO:0030336; GO:0030900; GO:0043565; GO:0045892,ectoderm development [GO:0007398]; forebrain development [GO:0030900]; mesoderm development [GO:0007498]; negative regulation of cell migration [GO:0030336]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755],nucleus [GO:0005634],DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_12369,FUN_029327-T2,Peve_00010684,,apul_peve,44.354,,,,,,,,,,,,,,,,,
OG_12370,FUN_029342-T1,Peve_00023372,,apul_peve,70.357,FUN_029342-T1,P25325,THTM_HUMAN,,3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2),Homo sapiens (Human),34.9,281.0,5.5e-44,179.5,sp|P25325|THTM_HUMAN 3-mercaptopyruvate sulfurtransferase OS=Homo sapiens OX=9606 GN=MPST PE=1 SV=3,GO:0000098; GO:0001822; GO:0001889; GO:0004792; GO:0005739; GO:0005759; GO:0009440; GO:0009636; GO:0016784; GO:0019346; GO:0021510; GO:0042802; GO:0043005; GO:0045202; GO:0070062; GO:0070814,cyanate catabolic process [GO:0009440]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; response to toxic substance [GO:0009636]; spinal cord development [GO:0021510]; sulfur amino acid catabolic process [GO:0000098]; transsulfuration [GO:0019346],extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202],3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate-cyanide sulfurtransferase activity [GO:0004792],GO:0003824; GO:0005739; GO:0006520; GO:0006790; GO:0016740; GO:0043226; GO:0048856,catalytic activity; mitochondrion; amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle; anatomical structure development
OG_12371,FUN_029365-T1,Peve_00008925,,apul_peve,49.414,,,,,,,,,,,,,,,,,
OG_12372,FUN_029409-T1,Peve_00043418,,apul_peve,60.659,,,,,,,,,,,,,,,,,
OG_12373,FUN_029415-T1,Peve_00040743,,apul_peve,48.37,,,,,,,,,,,,,,,,,
OG_12374,FUN_029417-T1,Peve_00000245,,apul_peve,33.3715,,,,,,,,,,,,,,,,,
OG_12375,FUN_029425-T1,Peve_00039473,,apul_peve,68.3065,FUN_029425-T1,Q8N9T8,,,,,43.7,446.0,4.7e-50,200.3,sp|Q8N9T8|KRI1_HUMAN Protein KRI1 homolog OS=Homo sapiens OX=9606 GN=KRI1 PE=1 SV=3,,,,,,
OG_12376,FUN_029427-T1,Peve_00039464,,apul_peve,70.552,,,,,,,,,,,,,,,,,
OG_12377,FUN_029432-T1,Peve_00031337,,apul_peve,35.35,,,,,,,,,,,,,,,,,
OG_12378,FUN_029436-T1,Peve_00039459,,apul_peve,59.569,FUN_029436-T1,Q9QUP4,,,,,24.9,334.0,7.8e-13,76.6,sp|Q9QUP4|CHST5_MOUSE Carbohydrate sulfotransferase 5 OS=Mus musculus OX=10090 GN=Chst5 PE=2 SV=1,,,,,,
OG_12379,FUN_029444-T1,Peve_00039458,,apul_peve,62.56,,,,,,,,,,,,,,,,,
OG_12380,FUN_029465-T1,Peve_00024858,,apul_peve,40.087,,,,,,,,,,,,,,,,,
OG_12381,FUN_029489-T1,Peve_00017241,,apul_peve,51.575,,,,,,,,,,,,,,,,,
OG_12382,FUN_029502-T1,Peve_00017248,,apul_peve,72.61,FUN_029502-T1,O43854,EDIL3_HUMAN,,EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1),Homo sapiens (Human),36.8,329.0,9e-46,188.3,sp|O43854|EDIL3_HUMAN EGF-like repeat and discoidin I-like domain-containing protein 3 OS=Homo sapiens OX=9606 GN=EDIL3 PE=1 SV=1,GO:0005178; GO:0005509; GO:0005576; GO:0007155; GO:0010811; GO:0062023; GO:0070062; GO:1903561,cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811],collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561],calcium ion binding [GO:0005509]; integrin binding [GO:0005178],GO:0005576; GO:0007155; GO:0043226,extracellular region; cell adhesion; organelle
OG_12383,FUN_029515-T1,Peve_00031815,,apul_peve,51.724,,,,,,,,,,,,,,,,,
OG_12384,FUN_029523-T1,Peve_00038358,,apul_peve,61.761,FUN_029523-T1,Q6UXI7,VITRN_HUMAN,,Vitrin,Homo sapiens (Human),37.3,185.0,6.2e-27,124.4,sp|Q6UXI7|VITRN_HUMAN Vitrin OS=Homo sapiens OX=9606 GN=VIT PE=1 SV=1,GO:0005539; GO:0005576; GO:0005614; GO:0010811; GO:0021510; GO:0030198,extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]; spinal cord development [GO:0021510],extracellular region [GO:0005576]; interstitial matrix [GO:0005614],glycosaminoglycan binding [GO:0005539],GO:0005576; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_12385,FUN_029532-T1,Peve_00006383,,apul_peve,60.59,,,,,,,,,,,,,,,,,
OG_12386,FUN_029539-T1,Peve_00023334,,apul_peve,69.31,FUN_029539-T1,Q9N126,,,,,42.6,284.0,9.199999999999999e-55,215.3,sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1,,,,,,
OG_12387,FUN_029542-T1,Peve_00023340,,apul_peve,62.996,FUN_029542-T1,Q91ZV2,,,,,32.6,135.0,1.1e-10,70.5,"sp|Q91ZV2|DCBD2_RAT Discoidin, CUB and LCCL domain-containing protein 2 OS=Rattus norvegicus OX=10116 GN=Dcbld2 PE=2 SV=1",,,,,,
OG_12388,FUN_029545-T1,Peve_00023338,,apul_peve,70.169,FUN_029545-T1,Q9N126,,,,,44.5,274.0,2.0000000000000003e-49,197.6,sp|Q9N126|RDH8_BOVIN Retinol dehydrogenase 8 OS=Bos taurus OX=9913 GN=RDH8 PE=1 SV=1,,,,,,
OG_12389,FUN_029546-T1,Peve_00023345,,apul_peve,70.732,FUN_029546-T1,Q8BQS5,PAQR2_MOUSE,,Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member 2) (Progestin and adipoQ receptor family member II),Mus musculus (Mouse),51.6,283.0,2.7e-82,307.0,sp|Q8BQS5|PAQR2_MOUSE Adiponectin receptor protein 2 OS=Mus musculus OX=10090 GN=Adipor2 PE=1 SV=2,GO:0005886; GO:0007507; GO:0007565; GO:0007584; GO:0009410; GO:0009750; GO:0009755; GO:0010629; GO:0014075; GO:0019395; GO:0030308; GO:0032496; GO:0033211; GO:0038023; GO:0042593; GO:0042802; GO:0045471; GO:0046326; GO:0046872; GO:0055100; GO:0061042; GO:0061871; GO:0071398; GO:0097003; GO:0120162,adiponectin-activated signaling pathway [GO:0033211]; cellular response to fatty acid [GO:0071398]; fatty acid oxidation [GO:0019395]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of cell growth [GO:0030308]; negative regulation of gene expression [GO:0010629]; negative regulation of hepatic stellate cell migration [GO:0061871]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of D-glucose import [GO:0046326]; response to amine [GO:0014075]; response to ethanol [GO:0045471]; response to fructose [GO:0009750]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; vascular wound healing [GO:0061042],plasma membrane [GO:0005886],adipokinetic hormone receptor activity [GO:0097003]; adiponectin binding [GO:0055100]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023],GO:0005886; GO:0006629; GO:0022414; GO:0048856; GO:0060089,plasma membrane; lipid metabolic process; reproductive process; anatomical structure development; molecular transducer activity
OG_12390,FUN_029547-T1,Peve_00023347,,apul_peve,52.9685,,,,,,,,,,,,,,,,,
OG_12391,FUN_029573-T1,Peve_00037900,,apul_peve,57.88,,,,,,,,,,,,,,,,,
OG_12392,FUN_029578-T1,Peve_00028950,,apul_peve,56.012,FUN_029578-T1,Q9C040,TRIM2_HUMAN,,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2),Homo sapiens (Human),21.8,550.0,5.800000000000001e-30,135.2,sp|Q9C040|TRIM2_HUMAN Tripartite motif-containing protein 2 OS=Homo sapiens OX=9606 GN=TRIM2 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005737; GO:0008270; GO:0043161; GO:0043523; GO:0061630; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],cytoplasm [GO:0005737],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_12393,FUN_029598-T1,Peve_00023403,,apul_peve,60.822,FUN_029598-T1,Q6PFY8,TRI45_MOUSE,,E3 ubiquitin-protein ligase TRIM45 (EC 2.3.2.27) (RING finger protein 99) (Tripartite motif-containing protein 45),Mus musculus (Mouse),22.9,485.0,1.2e-24,116.7,sp|Q6PFY8|TRI45_MOUSE E3 ubiquitin-protein ligase TRIM45 OS=Mus musculus OX=10090 GN=Trim45 PE=1 SV=2,GO:0005654; GO:0005829; GO:0008270; GO:0043161; GO:0045171; GO:0050728; GO:0060348; GO:0061630; GO:0070936,bone development [GO:0060348]; negative regulation of inflammatory response [GO:0050728]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0016740; GO:0030163; GO:0048856; GO:0140096,"catalytic activity; nucleoplasm; cytosol; transferase activity; protein catabolic process; anatomical structure development; catalytic activity, acting on a protein"
OG_12394,FUN_029615-T1,Peve_00037899,,apul_peve,56.132,FUN_029615-T1,P30975,,,,,23.5,336.0,2.3e-17,91.7,sp|P30975|TLR2_DROME Tachykinin-like peptides receptor 99D OS=Drosophila melanogaster OX=7227 GN=TkR99D PE=2 SV=2,,,,,,
OG_12395,FUN_029623-T1,Peve_00013161,,apul_peve,53.374,,,,,,,,,,,,,,,,,
OG_12396,FUN_029624-T1,Peve_00026140,,apul_peve,41.27,,,,,,,,,,,,,,,,,
OG_12397,FUN_029679-T1,Peve_00003135,,apul_peve,34.091,,,,,,,,,,,,,,,,,
OG_12398,FUN_029703-T1,Peve_00025510,,apul_peve,74.586,,,,,,,,,,,,,,,,,
OG_12399,FUN_029711-T2,Peve_00018725,,apul_peve,38.7235,FUN_029711-T2,Q9UGU5,HMGX4_HUMAN,,HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG),Homo sapiens (Human),39.9,178.0,1e-25,120.6,sp|Q9UGU5|HMGX4_HUMAN HMG domain-containing protein 4 OS=Homo sapiens OX=9606 GN=HMGXB4 PE=1 SV=2,GO:0003677; GO:0008333; GO:0016055; GO:0016589; GO:0030178; GO:0042802,endosome to lysosome transport [GO:0008333]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NURF complex [GO:0016589],DNA binding [GO:0003677]; identical protein binding [GO:0042802],GO:0003677; GO:0016192,DNA binding; vesicle-mediated transport
OG_12400,FUN_029715-T1,Peve_00044613,,apul_peve,51.852,,,,,,,,,,,,,,,,,
OG_12401,FUN_029719-T1,Peve_00033361,,apul_peve,43.14,FUN_029719-T1,Q9NUV9,GIMA4_HUMAN,,GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein) (IAN-1) (hIAN1) (Immunity-associated protein 4),Homo sapiens (Human),32.6,221.0,7.7e-20,100.9,sp|Q9NUV9|GIMA4_HUMAN GTPase IMAP family member 4 OS=Homo sapiens OX=9606 GN=GIMAP4 PE=1 SV=1,GO:0005525; GO:0005829; GO:0043231,,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231],GTP binding [GO:0005525],GO:0005829; GO:0043226,cytosol; organelle
OG_12402,FUN_029725-T1,Peve_00018244,,apul_peve,41.745,FUN_029725-T1,Q9I931,,,,,34.9,169.0,4.1e-20,102.4,sp|Q9I931|FUCL1_ANGJA Fucolectin-1 OS=Anguilla japonica OX=7937 PE=2 SV=1,,,,,,
OG_12403,FUN_029727-T1,Peve_00024657,,apul_peve,89.691,,,,,,,,,,,,,,,,,
OG_12404,FUN_029744-T1,Peve_00031273,,apul_peve,70.504,,,,,,,,,,,,,,,,,
OG_12405,FUN_029770-T1,Peve_00019512,,apul_peve,64.053,,,,,,,,,,,,,,,,,
OG_12406,FUN_029776-T1,Peve_00003937,,apul_peve,75.168,,,,,,,,,,,,,,,,,
OG_12407,FUN_029793-T1,Peve_00038664,,apul_peve,47.059,,,,,,,,,,,,,,,,,
OG_12408,FUN_029794-T1,Peve_00011714,,apul_peve,39.0495,,,,,,,,,,,,,,,,,
OG_12409,FUN_029802-T1,Peve_00011474,,apul_peve,79.316,,,,,,,,,,,,,,,,,
OG_12410,FUN_029823-T1,Peve_00017019,,apul_peve,47.772,,,,,,,,,,,,,,,,,
OG_12411,FUN_029840-T1,Peve_00035727,,apul_peve,34.657,,,,,,,,,,,,,,,,,
OG_12412,FUN_029854-T1,Peve_00042883,,apul_peve,61.905,,,,,,,,,,,,,,,,,
OG_12413,FUN_029890-T2,Peve_00008447,,apul_peve,67.327,FUN_029890-T2,O75943,RAD17_HUMAN,,Cell cycle checkpoint protein RAD17 (hRad17) (RF-C/activator 1 homolog),Homo sapiens (Human),39.6,626.0,5.4e-114,413.3,sp|O75943|RAD17_HUMAN Cell cycle checkpoint protein RAD17 OS=Homo sapiens OX=9606 GN=RAD17 PE=1 SV=2,GO:0000076; GO:0000077; GO:0003682; GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006974; GO:0008156; GO:0031389; GO:0031573; GO:0033314; GO:0035861; GO:0042325; GO:0140463; GO:1990166,DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA replication [GO:0008156]; protein localization to site of double-strand break [GO:1990166]; regulation of phosphorylation [GO:0042325],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]; site of double-strand break [GO:0035861],ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA clamp loader activity [GO:0003689],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0043226; GO:0060090; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; organelle; molecular adaptor activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_12414,FUN_029903-T1,Peve_00030296,,apul_peve,69.444,,,,,,,,,,,,,,,,,
OG_12415,FUN_029955-T1,Peve_00029994,,apul_peve,44.068,,,,,,,,,,,,,,,,,
OG_12416,FUN_029972-T1,Peve_00031187,,apul_peve,65.0,FUN_029972-T1,Q5F4A1,,,,,26.0,281.0,2.4e-10,68.9,sp|Q5F4A1|G2E3_CHICK G2/M phase-specific E3 ubiquitin-protein ligase OS=Gallus gallus OX=9031 GN=G2E3 PE=2 SV=1,,,,,,
OG_12417,FUN_029978-T1,Peve_00039413,,apul_peve,57.282,,,,,,,,,,,,,,,,,
OG_12418,FUN_030008-T1,Peve_00008679,,apul_peve,53.2785,,,,,,,,,,,,,,,,,
OG_12419,FUN_030010-T1,Peve_00007126,,apul_peve,78.882,,,,,,,,,,,,,,,,,
OG_12420,FUN_030030-T1,Peve_00022895,,apul_peve,72.727,,,,,,,,,,,,,,,,,
OG_12421,FUN_030037-T1,Peve_00000333,,apul_peve,57.895,,,,,,,,,,,,,,,,,
OG_12422,FUN_030043-T1,Peve_00016226,,apul_peve,61.165,,,,,,,,,,,,,,,,,
OG_12423,FUN_030061-T1,Peve_00014494,,apul_peve,33.65,,,,,,,,,,,,,,,,,
OG_12424,FUN_030063-T1,Peve_00021149,,apul_peve,63.974,FUN_030063-T1,Q08879,FBLN1_MOUSE,,Fibulin-1 (FIBL-1) (Basement-membrane protein 90) (BM-90),Mus musculus (Mouse),53.3,45.0,4.1e-07,61.2,sp|Q08879|FBLN1_MOUSE Fibulin-1 OS=Mus musculus OX=10090 GN=Fbln1 PE=1 SV=2,GO:0001968; GO:0005178; GO:0005201; GO:0005509; GO:0005604; GO:0005615; GO:0007566; GO:0016504; GO:0030198; GO:0042802; GO:0062023; GO:0070051; GO:0070373; GO:0071953; GO:0072378; GO:1900025; GO:2000146; GO:2000647,"blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]",basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504],GO:0005198; GO:0005615; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0051604; GO:0098772,structural molecule activity; extracellular space; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; protein maturation; molecular function regulator activity
OG_12425,FUN_030064-T1,Peve_00038675,,apul_peve,53.0155,,,,,,,,,,,,,,,,,
OG_12426,FUN_030070-T1,Peve_00043521,,apul_peve,70.909,FUN_030070-T1,Q8BX79,GPR21_MOUSE,,Probable G-protein coupled receptor 21,Mus musculus (Mouse),22.5,293.0,2.3e-07,58.2,sp|Q8BX79|GPR21_MOUSE Probable G-protein coupled receptor 21 OS=Mus musculus OX=10090 GN=Gpr21 PE=2 SV=1,GO:0004930; GO:0005886; GO:0008286; GO:0040018; GO:0042593; GO:0046627,glucose homeostasis [GO:0042593]; insulin receptor signaling pathway [GO:0008286]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of multicellular organism growth [GO:0040018],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_12427,FUN_030075-T1,Peve_00031098,,apul_peve,53.153,,,,,,,,,,,,,,,,,
OG_12428,FUN_030076-T1,Peve_00011132,,apul_peve,75.714,,,,,,,,,,,,,,,,,
OG_12429,FUN_030094-T1,Peve_00008047,,apul_peve,83.268,,,,,,,,,,,,,,,,,
OG_12430,FUN_030095-T1,Peve_00018715,,apul_peve,96.269,,,,,,,,,,,,,,,,,
OG_12431,FUN_030108-T1,Peve_00022989,,apul_peve,66.038,,,,,,,,,,,,,,,,,
OG_12432,FUN_030109-T1,Peve_00041661,,apul_peve,70.67099999999999,,,,,,,,,,,,,,,,,
OG_12433,FUN_030117-T1,Peve_00000910,,apul_peve,46.569,,,,,,,,,,,,,,,,,
OG_12434,FUN_030119-T1,Peve_00008345,,apul_peve,43.519,,,,,,,,,,,,,,,,,
OG_12435,FUN_030151-T1,Peve_00017398,,apul_peve,30.496,,,,,,,,,,,,,,,,,
OG_12436,FUN_030160-T1,Peve_00031852,,apul_peve,48.095,,,,,,,,,,,,,,,,,
OG_12437,FUN_030180-T1,Peve_00002691,,apul_peve,48.696,,,,,,,,,,,,,,,,,
OG_12438,FUN_030472-T1,Peve_00031445,,apul_peve,74.0315,FUN_030472-T1,P35067,,,,,99.2,125.0,9.9e-59,228.4,sp|P35067|H2B_ACRFO Histone H2B OS=Acropora formosa OX=126732 PE=3 SV=1,,,,,,
OG_12439,FUN_030564-T1,Peve_00014416,,apul_peve,53.644,,,,,,,,,,,,,,,,,
OG_12440,FUN_030568-T1,Peve_00027234,,apul_peve,53.661,,,,,,,,,,,,,,,,,
OG_12441,FUN_030620-T1,Peve_00034399,,apul_peve,94.615,,,,,,,,,,,,,,,,,
OG_12442,FUN_030626-T1,Peve_00042737,,apul_peve,67.261,,,,,,,,,,,,,,,,,
OG_12443,FUN_030631-T1,Peve_00022480,,apul_peve,87.712,,,,,,,,,,,,,,,,,
OG_12444,FUN_030652-T1,Peve_00040146,,apul_peve,32.7525,,,,,,,,,,,,,,,,,
OG_12445,FUN_030665-T1,Peve_00043676,,apul_peve,90.741,,,,,,,,,,,,,,,,,
OG_12446,FUN_030667-T2,Peve_00009118,,apul_peve,71.747,FUN_030667-T2,Q9H079,KTBL1_HUMAN,,KATNB1-like protein 1 (Katanin p80 subunit B-like 1),Homo sapiens (Human),41.8,134.0,9.8e-22,105.5,sp|Q9H079|KTBL1_HUMAN KATNB1-like protein 1 OS=Homo sapiens OX=9606 GN=KATNBL1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0008017; GO:0008352; GO:0015630; GO:0030496; GO:0031122; GO:0032154; GO:0051495; GO:0072686; GO:0097431,cytoplasmic microtubule organization [GO:0031122]; positive regulation of cytoskeleton organization [GO:0051495],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],microtubule binding [GO:0008017],GO:0005634; GO:0005654; GO:0005730; GO:0005856; GO:0007010; GO:0008092; GO:0043226,nucleus; nucleoplasm; nucleolus; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_12447,FUN_030674-T1,Peve_00028164,,apul_peve,59.0045,FUN_030674-T1,Q9UGM3,,,,,30.1,782.0,4.5e-84,314.3,sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,,,,,,
OG_12448,FUN_030677-T1,Peve_00028162,,apul_peve,46.067,,,,,,,,,,,,,,,,,
OG_12449,FUN_030680-T1,Peve_00028158,,apul_peve,71.795,FUN_030680-T1,Q8BFQ2,,,,,57.3,124.0,2.7000000000000004e-32,140.6,sp|Q8BFQ2|T229B_MOUSE Transmembrane protein 229B OS=Mus musculus OX=10090 GN=TMEM229B PE=2 SV=1,,,,,,
OG_12450,FUN_030681-T2,Peve_00028147,,apul_peve,58.883,FUN_030681-T2,Q6YHU6,THADA_HUMAN,,tRNA (32-2'-O)-methyltransferase regulator THADA (Gene inducing thyroid adenomas protein) (Thyroid adenoma-associated protein),Homo sapiens (Human),29.7,1958.0,1.1e-212,742.7,sp|Q6YHU6|THADA_HUMAN tRNA (32-2'-O)-methyltransferase regulator THADA OS=Homo sapiens OX=9606 GN=THADA PE=1 SV=1,GO:0002128; GO:0030234; GO:0030488; GO:0032471; GO:0055088; GO:0098554; GO:1990845,adaptive thermogenesis [GO:1990845]; lipid homeostasis [GO:0055088]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]; tRNA nucleoside ribose methylation [GO:0002128],cytoplasmic side of endoplasmic reticulum membrane [GO:0098554],enzyme regulator activity [GO:0030234],GO:0006399; GO:0098772,tRNA metabolic process; molecular function regulator activity
OG_12451,FUN_030684-T1,Peve_00016167,,apul_peve,55.882,,,,,,,,,,,,,,,,,
OG_12452,FUN_030692-T1,Peve_00035046,,apul_peve,35.526,,,,,,,,,,,,,,,,,
OG_12453,FUN_030701-T1,Peve_00036699,,apul_peve,56.287,,,,,,,,,,,,,,,,,
OG_12454,FUN_030707-T1,Peve_00024749,,apul_peve,41.226,,,,,,,,,,,,,,,,,
OG_12455,FUN_030711-T1,Peve_00043201,,apul_peve,68.302,,,,,,,,,,,,,,,,,
OG_12456,FUN_030733-T1,Peve_00021570,,apul_peve,61.465,,,,,,,,,,,,,,,,,
OG_12457,FUN_030737-T1,Peve_00011488,,apul_peve,37.949,,,,,,,,,,,,,,,,,
OG_12458,FUN_030853-T1,Peve_00021831,,apul_peve,56.522,FUN_030853-T1,Q9W6K2,,,,,34.0,235.0,2.5e-27,124.0,sp|Q9W6K2|EXO1_XENLA Exonuclease 1 OS=Xenopus laevis OX=8355 GN=exo1 PE=2 SV=1,,,,,,
OG_12459,FUN_030855-T1,Peve_00038313,,apul_peve,51.233,,,,,,,,,,,,,,,,,
OG_12460,FUN_030859-T1,Peve_00030750,,apul_peve,51.515,,,,,,,,,,,,,,,,,
OG_12461,FUN_030871-T1,Peve_00002846,,apul_peve,93.966,,,,,,,,,,,,,,,,,
OG_12462,FUN_030877-T1,Peve_00043620,,apul_peve,71.759,,,,,,,,,,,,,,,,,
OG_12463,FUN_030879-T1,Peve_00043619,,apul_peve,56.992,,,,,,,,,,,,,,,,,
OG_12464,FUN_030990-T1,Peve_00026647,,apul_peve,71.545,,,,,,,,,,,,,,,,,
OG_12465,FUN_030992-T1,Peve_00003967,,apul_peve,51.333,,,,,,,,,,,,,,,,,
OG_12466,FUN_031002-T1,Peve_00005604,,apul_peve,70.588,,,,,,,,,,,,,,,,,
OG_12467,FUN_031005-T1,Peve_00022115,,apul_peve,31.818,,,,,,,,,,,,,,,,,
OG_12468,FUN_031024-T1,Peve_00023100,,apul_peve,43.548,,,,,,,,,,,,,,,,,
OG_12469,FUN_031043-T1,Peve_00029824,,apul_peve,55.897,,,,,,,,,,,,,,,,,
OG_12470,FUN_031048-T1,Peve_00012152,,apul_peve,91.935,,,,,,,,,,,,,,,,,
OG_12471,FUN_031059-T1,Peve_00040333,,apul_peve,58.065,,,,,,,,,,,,,,,,,
OG_12472,FUN_031061-T1,Peve_00029620,,apul_peve,58.272,,,,,,,,,,,,,,,,,
OG_12473,FUN_031069-T1,Peve_00013426,,apul_peve,42.342,FUN_031069-T1,P25102,HRH2_RAT,,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),Rattus norvegicus (Rat),26.6,335.0,2.1e-16,88.2,sp|P25102|HRH2_RAT Histamine H2 receptor OS=Rattus norvegicus OX=10116 GN=Hrh2 PE=3 SV=1,GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007187; GO:0007268; GO:0007613; GO:0008542; GO:0030425; GO:0030594; GO:0045202; GO:0045907; GO:0048167; GO:0048565; GO:0048732; GO:0071420; GO:1900139; GO:1901363,"cellular response to histamine [GO:0071420]; chemical synaptic transmission [GO:0007268]; digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; negative regulation of arachidonate secretion [GO:1900139]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542]",dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202],heterocyclic compound binding [GO:1901363]; histamine receptor activity [GO:0004969]; neurotransmitter receptor activity [GO:0030594],GO:0003013; GO:0005886; GO:0022600; GO:0023052; GO:0048856; GO:0050877; GO:0060089,circulatory system process; plasma membrane; digestive system process; signaling; anatomical structure development; nervous system process; molecular transducer activity
OG_12474,FUN_031072-T1,Peve_00024594,,apul_peve,46.218,,,,,,,,,,,,,,,,,
OG_12475,FUN_031092-T1,Peve_00031055,,apul_peve,48.798,FUN_031092-T1,B8VIU6,,,,,52.0,150.0,2.5e-42,174.5,sp|B8VIU6|USOM5_ACRMI Uncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12476,FUN_031093-T1,Peve_00032405,,apul_peve,69.767,FUN_031093-T1,B8VIU6,,,,,57.7,149.0,5.4e-46,186.4,sp|B8VIU6|USOM5_ACRMI Uncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12477,FUN_031182-T1,Peve_00016089,,apul_peve,56.768,FUN_031182-T1,Q504A5,,,,,34.8,207.0,1.6e-27,125.6,sp|Q504A5|TPMT_DANRE Probable thiopurine S-methyltransferase OS=Danio rerio OX=7955 GN=tpmt PE=2 SV=1,,,,,,
OG_12478,FUN_031198-T1,Peve_00035349,,apul_peve,60.137,,,,,,,,,,,,,,,,,
OG_12479,FUN_031208-T1,Peve_00041865,,apul_peve,71.22300000000001,FUN_031208-T1,Q8T135,KIF5_DICDI,,Kinesin-related protein 5 (Kinesin family member 5) (Kinesin-1),Dictyostelium discoideum (Social amoeba),30.9,456.0,5.5e-46,187.6,sp|Q8T135|KIF5_DICDI Kinesin-related protein 5 OS=Dictyostelium discoideum OX=44689 GN=kif5 PE=1 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017; GO:0030864; GO:0031252; GO:0051015; GO:0051017,actin filament bundle assembly [GO:0051017]; microtubule-based movement [GO:0007018],cell leading edge [GO:0031252]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; microtubule [GO:0005874],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005856; GO:0007018; GO:0008092; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton; microtubule-based movement; cytoskeletal protein binding; isomerase activity; organelle; ATP-dependent activity
OG_12480,FUN_031209-T1,Peve_00009841,,apul_peve,65.217,,,,,,,,,,,,,,,,,
OG_12481,FUN_031210-T1,Peve_00041870,,apul_peve,53.1605,FUN_031210-T1,Q868Z9,,,,,37.4,661.0,1.2e-125,453.0,sp|Q868Z9|PPN_DROME Papilin OS=Drosophila melanogaster OX=7227 GN=Ppn PE=1 SV=2,,,,,,
OG_12482,FUN_031232-T1,Peve_00021549,,apul_peve,55.9095,FUN_031232-T1,B1WAZ6,PA24A_XENTR,,Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),39.8,718.0,4.1e-150,533.5,sp|B1WAZ6|PA24A_XENTR Cytosolic phospholipase A2 OS=Xenopus tropicalis OX=8364 GN=pla2g4a PE=2 SV=1,GO:0004622; GO:0004623; GO:0005509; GO:0009395; GO:0031410,phospholipid catabolic process [GO:0009395],cytoplasmic vesicle [GO:0031410],calcium ion binding [GO:0005509]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623],GO:0003824; GO:0006629; GO:0016787; GO:0031410; GO:0043226,catalytic activity; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_12483,FUN_031235-T1,Peve_00043061,,apul_peve,64.304,,,,,,,,,,,,,,,,,
OG_12484,FUN_031248-T1,Peve_00033687,,apul_peve,43.75,,,,,,,,,,,,,,,,,
OG_12485,FUN_031255-T1,Peve_00023797,,apul_peve,36.735,,,,,,,,,,,,,,,,,
OG_12486,FUN_031260-T1,Peve_00043068,,apul_peve,41.1375,,,,,,,,,,,,,,,,,
OG_12487,FUN_031266-T1,Peve_00014384,,apul_peve,46.667,,,,,,,,,,,,,,,,,
OG_12488,FUN_031270-T1,Peve_00036738,,apul_peve,34.86750000000001,,,,,,,,,,,,,,,,,
OG_12489,FUN_031278-T1,Peve_00036746,,apul_peve,59.354,,,,,,,,,,,,,,,,,
OG_12490,FUN_031282-T1,Peve_00044134,,apul_peve,61.719,FUN_031282-T1,Q5U3T0,,,,,32.1,399.0,4.1e-50,200.7,"sp|Q5U3T0|MGT4C_DANRE Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C OS=Danio rerio OX=7955 GN=mgat4c PE=2 SV=1",,,,,,
OG_12491,FUN_031288-T1,Peve_00026531,,apul_peve,81.503,FUN_031288-T1,Q07130,,,,,63.0,511.0,3.5000000000000005e-180,632.9,sp|Q07130|UGPA_BOVIN UTP--glucose-1-phosphate uridylyltransferase OS=Bos taurus OX=9913 GN=UGP2 PE=1 SV=2,,,,,,
OG_12492,FUN_031290-T1,Peve_00026524,,apul_peve,53.4785,FUN_031290-T1,Q8IYD8,FANCM_HUMAN,,Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog),Homo sapiens (Human),45.7,932.0,6.5e-203,710.7,sp|Q8IYD8|FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens OX=9606 GN=FANCM PE=1 SV=2,GO:0000400; GO:0000712; GO:0000785; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0005829; GO:0009378; GO:0016887; GO:0031297; GO:0036297; GO:0043138; GO:0043240; GO:0045003; GO:0071821; GO:1902527,double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0022414; GO:0140097; GO:0140098; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; isomerase activity; reproductive process; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_12492,FUN_031290-T1,Peve_00026524,,apul_peve,53.4785,FUN_031290-T1,Q8IYD8,FANCM_HUMAN,,Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog),Homo sapiens (Human),39.3,229.0,4.6e-39,166.4,sp|Q8IYD8|FANCM_HUMAN Fanconi anemia group M protein OS=Homo sapiens OX=9606 GN=FANCM PE=1 SV=2,GO:0000400; GO:0000712; GO:0000785; GO:0003682; GO:0003724; GO:0004518; GO:0005524; GO:0005654; GO:0005829; GO:0009378; GO:0016887; GO:0031297; GO:0036297; GO:0043138; GO:0043240; GO:0045003; GO:0071821; GO:1902527,double-strand break repair via synthesis-dependent strand annealing [GO:0045003]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],chromatin [GO:0000785]; cytosol [GO:0005829]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; nuclease activity [GO:0004518]; RNA helicase activity [GO:0003724],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0022414; GO:0140097; GO:0140098; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; cytosol; DNA repair; DNA recombination; hydrolase activity; isomerase activity; reproductive process; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_12493,FUN_031295-T1,Peve_00026520,,apul_peve,62.832,FUN_031295-T1,Q8CEE7,,,,,47.8,322.0,5.9e-67,256.1,sp|Q8CEE7|RDH13_MOUSE Retinol dehydrogenase 13 OS=Mus musculus OX=10090 GN=Rdh13 PE=1 SV=1,,,,,,
OG_12494,FUN_031296-T1,Peve_00026519,,apul_peve,65.476,FUN_031296-T1,Q8CEE7,,,,,47.5,320.0,1.4e-63,245.0,sp|Q8CEE7|RDH13_MOUSE Retinol dehydrogenase 13 OS=Mus musculus OX=10090 GN=Rdh13 PE=1 SV=1,,,,,,
OG_12495,FUN_031329-T1,Peve_00038209,,apul_peve,62.745,,,,,,,,,,,,,,,,,
OG_12496,FUN_031419-T1,Peve_00036819,,apul_peve,52.1575,FUN_031419-T1,Q7TPV2,DZIP3_MOUSE,,E3 ubiquitin-protein ligase DZIP3 (EC 2.3.2.27) (DAZ-interacting protein 3 homolog) (RING-type E3 ubiquitin transferase DZIP3),Mus musculus (Mouse),26.0,192.0,6.3e-08,62.0,sp|Q7TPV2|DZIP3_MOUSE E3 ubiquitin-protein ligase DZIP3 OS=Mus musculus OX=10090 GN=Dzip3 PE=1 SV=2,GO:0000209; GO:0003723; GO:0005737; GO:0008270; GO:0019902; GO:0061630,protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737],phosphatase binding [GO:0019902]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0140096,"RNA binding; catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_12497,FUN_031440-T1,Peve_00002399,,apul_peve,44.8015,,,,,,,,,,,,,,,,,
OG_12498,FUN_031455-T1,Peve_00037976,,apul_peve,70.37,,,,,,,,,,,,,,,,,
OG_12499,FUN_031464-T1,Peve_00026561,,apul_peve,38.021,,,,,,,,,,,,,,,,,
OG_12500,FUN_031488-T1,Peve_00026543,,apul_peve,30.682,,,,,,,,,,,,,,,,,
OG_12501,FUN_031490-T1,Peve_00026540,,apul_peve,86.538,FUN_031490-T1,P04464,,,,,46.2,143.0,2.3e-26,120.2,sp|P04464|CALM_WHEAT Calmodulin OS=Triticum aestivum OX=4565 PE=1 SV=3,,,,,,
OG_12502,FUN_031496-T1,Peve_00026534,,apul_peve,56.693,,,,,,,,,,,,,,,,,
OG_12503,FUN_031504-T1,Peve_00004807,,apul_peve,79.817,FUN_031504-T1,Q60613,AA2AR_MOUSE,,Adenosine receptor A2a,Mus musculus (Mouse),26.1,341.0,4.6e-10,67.0,sp|Q60613|AA2AR_MOUSE Adenosine receptor A2a OS=Mus musculus OX=10090 GN=Adora2a PE=1 SV=3,GO:0001609; GO:0001963; GO:0001973; GO:0001975; GO:0005516; GO:0005882; GO:0005886; GO:0006355; GO:0007186; GO:0007189; GO:0007200; GO:0007271; GO:0007626; GO:0008285; GO:0008289; GO:0009410; GO:0014049; GO:0014057; GO:0014061; GO:0016020; GO:0019899; GO:0030425; GO:0030673; GO:0031000; GO:0031802; GO:0032230; GO:0032279; GO:0035249; GO:0035810; GO:0042311; GO:0042734; GO:0042755; GO:0042802; GO:0043025; GO:0043116; GO:0043524; GO:0044877; GO:0045211; GO:0045938; GO:0046636; GO:0048143; GO:0048786; GO:0048812; GO:0050714; GO:0050728; GO:0051393; GO:0051881; GO:0051899; GO:0051924; GO:0051968; GO:0060079; GO:0060080; GO:0060134; GO:0070374; GO:0097190; GO:0098978; GO:0099171; GO:0140928; GO:1900273; GO:2001235,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic signaling pathway [GO:0097190]; astrocyte activation [GO:0048143]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; G protein-coupled receptor signaling pathway [GO:0007186]; inhibition of non-skeletal tissue mineralization [GO:0140928]; inhibitory postsynaptic potential [GO:0060080]; locomotory behavior [GO:0007626]; membrane depolarization [GO:0051899]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular permeability [GO:0043116]; neuron projection morphogenesis [GO:0048812]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of acetylcholine secretion, neurotransmission [GO:0014057]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of circadian sleep/wake cycle, sleep [GO:0045938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein secretion [GO:0050714]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of urine volume [GO:0035810]; prepulse inhibition [GO:0060134]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of calcium ion transport [GO:0051924]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of norepinephrine secretion [GO:0014061]; response to amphetamine [GO:0001975]; response to caffeine [GO:0031000]; response to xenobiotic stimulus [GO:0009410]; synaptic transmission, cholinergic [GO:0007271]; synaptic transmission, dopaminergic [GO:0001963]; synaptic transmission, glutamatergic [GO:0035249]; vasodilation [GO:0042311]",asymmetric synapse [GO:0032279]; axolemma [GO:0030673]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; intermediate filament [GO:0005882]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734],alpha-actinin binding [GO:0051393]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; G protein-coupled adenosine receptor activity [GO:0001609]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; type 5 metabotropic glutamate receptor binding [GO:0031802],GO:0003013; GO:0003014; GO:0005886; GO:0006355; GO:0008092; GO:0008289; GO:0023052; GO:0060089,circulatory system process; renal system process; plasma membrane; regulation of DNA-templated transcription; cytoskeletal protein binding; lipid binding; signaling; molecular transducer activity
OG_12504,FUN_031510-T2,Peve_00045256,,apul_peve,68.1455,FUN_031510-T2,Q8CCP0,NEMF_MOUSE,,Ribosome quality control complex subunit NEMF (Nuclear export mediator factor),Mus musculus (Mouse),63.9,679.0,1.0000000000000001e-226,788.5,sp|Q8CCP0|NEMF_MOUSE Ribosome quality control complex subunit NEMF OS=Mus musculus OX=10090 GN=Nemf PE=1 SV=2,GO:0005634; GO:0005829; GO:0022626; GO:0043023; GO:0051168; GO:0065003; GO:0140708; GO:1904678; GO:1990112; GO:1990116,CAT tailing [GO:0140708]; nuclear export [GO:0051168]; protein-containing complex assembly [GO:0065003]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; RQC complex [GO:1990112],alpha-aminoacyl-tRNA binding [GO:1904678]; ribosomal large subunit binding [GO:0043023],GO:0003723; GO:0005634; GO:0005829; GO:0005840; GO:0006913; GO:0030163; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; ribosome; nucleocytoplasmic transport; protein catabolic process; organelle; protein-containing complex assembly
OG_12505,FUN_031529-T1,Peve_00022763,,apul_peve,57.469,FUN_031529-T1,Q9TTY2,FER_CANLF,,Tyrosine-protein kinase Fer (EC 2.7.10.2) (Proto-oncogene c-Fer) (p94-Fer),Canis lupus familiaris (Dog) (Canis familiaris),29.2,277.0,4.8e-23,110.9,sp|Q9TTY2|FER_CANLF Tyrosine-protein kinase Fer OS=Canis lupus familiaris OX=9615 GN=FER PE=2 SV=1,GO:0004713; GO:0004715; GO:0005524; GO:0005634; GO:0005856; GO:0005886; GO:0005938; GO:0006935; GO:0007155; GO:0008289; GO:0038095; GO:0042995; GO:0070161,cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; Fc-epsilon receptor signaling pathway [GO:0038095],anchoring junction [GO:0070161]; cell cortex [GO:0005938]; cell projection [GO:0042995]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005856; GO:0005886; GO:0007155; GO:0008289; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytoskeleton; plasma membrane; cell adhesion; lipid binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_12506,FUN_031531-T1,Peve_00022766,,apul_peve,59.429,,,,,,,,,,,,,,,,,
OG_12507,FUN_031533-T1,Peve_00034985,,apul_peve,37.162,,,,,,,,,,,,,,,,,
OG_12508,FUN_031538-T1,Peve_00030771,,apul_peve,38.835,,,,,,,,,,,,,,,,,
OG_12509,FUN_031551-T1,Peve_00022774,,apul_peve,54.902,FUN_031551-T1,Q8HYJ7,,,,,35.7,277.0,4.6e-39,164.1,sp|Q8HYJ7|FUT5_GORGO 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 OS=Gorilla gorilla gorilla OX=9595 GN=FUT5 PE=3 SV=1,,,,,,
OG_12510,FUN_031563-T1,Peve_00025443,,apul_peve,85.294,FUN_031563-T1,Q8K2Q5,,,,,49.2,63.0,3e-12,72.8,sp|Q8K2Q5|CHCH7_MOUSE Coiled-coil-helix-coiled-coil-helix domain-containing protein 7 OS=Mus musculus OX=10090 GN=Chchd7 PE=1 SV=1,,,,,,
OG_12511,FUN_031571-T1,Peve_00026511,,apul_peve,60.0255,,,,,,,,,,,,,,,,,
OG_12512,FUN_031588-T1,Peve_00021512,,apul_peve,52.866,FUN_031588-T1,P16537,,,,,44.0,75.0,1.8e-13,77.8,sp|P16537|SPC3_STRPU Protein SPEC3 OS=Strongylocentrotus purpuratus OX=7668 GN=SPEC3 PE=3 SV=1,,,,,,
OG_12513,FUN_031594-T1,Peve_00012521,,apul_peve,32.198,,,,,,,,,,,,,,,,,
OG_12514,FUN_031601-T1,Peve_00012510,,apul_peve,57.093,FUN_031601-T1,P70490,,,,,36.4,154.0,6.900000000000001e-23,109.4,sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1,,,,,,
OG_12515,FUN_031611-T1,Peve_00006818,,apul_peve,50.0,,,,,,,,,,,,,,,,,
OG_12516,FUN_031629-T1,Peve_00012500,,apul_peve,38.031,,,,,,,,,,,,,,,,,
OG_12517,FUN_031634-T1,Peve_00044263,,apul_peve,37.818,,,,,,,,,,,,,,,,,
OG_12518,FUN_031661-T1,Peve_00015112,,apul_peve,62.922,FUN_031661-T1,Q9NZJ4,,,,,31.6,4657.0,0.0,1991.9,sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2,,,,,,
OG_12519,FUN_031674-T1,Peve_00012837,,apul_peve,60.089,FUN_031674-T1,O95907,MOT3_HUMAN,,Monocarboxylate transporter 3 (MCT 3) (Solute carrier family 16 member 8),Homo sapiens (Human),34.6,408.0,2e-40,168.3,sp|O95907|MOT3_HUMAN Monocarboxylate transporter 3 OS=Homo sapiens OX=9606 GN=SLC16A8 PE=1 SV=1,GO:0005886; GO:0008028; GO:0015129; GO:0015293; GO:0015727; GO:0016020; GO:0016323; GO:0016324,lactate transport [GO:0015727],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; plasma membrane [GO:0005886],lactate transmembrane transporter activity [GO:0015129]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; symporter activity [GO:0015293],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_12520,FUN_031677-T1,Peve_00026338,,apul_peve,63.265,FUN_031677-T1,Q8K1C7,,,,,23.6,471.0,3.6e-29,131.0,sp|Q8K1C7|MOT14_MOUSE Monocarboxylate transporter 14 OS=Mus musculus OX=10090 GN=Slc16a14 PE=2 SV=1,,,,,,
OG_12521,FUN_031680-T1,Peve_00012831,,apul_peve,80.22,,,,,,,,,,,,,,,,,
OG_12522,FUN_031682-T1,Peve_00026504,,apul_peve,49.015,FUN_031682-T1,D4A734,MOT12_RAT,,Monocarboxylate transporter 12 (MCT 12) (Solute carrier family 16 member 12),Rattus norvegicus (Rat),24.9,433.0,3.4000000000000004e-27,124.4,sp|D4A734|MOT12_RAT Monocarboxylate transporter 12 OS=Rattus norvegicus OX=10116 GN=Slc16a12 PE=1 SV=1,GO:0005308; GO:0005886; GO:0015292; GO:0015881; GO:0016323; GO:0022857; GO:0046449,creatine transmembrane transport [GO:0015881]; creatinine metabolic process [GO:0046449],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],creatine transmembrane transporter activity [GO:0005308]; transmembrane transporter activity [GO:0022857]; uniporter activity [GO:0015292],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_12523,FUN_031690-T1,Peve_00039840,,apul_peve,57.491,FUN_031690-T1,Q54PK9,PDPKB_DICDI,,3-phosphoinositide-dependent protein kinase B (EC 2.7.11.1) (Pdk-class protein kinase b),Dictyostelium discoideum (Social amoeba),29.6,277.0,1.9e-16,90.5,sp|Q54PK9|PDPKB_DICDI 3-phosphoinositide-dependent protein kinase B OS=Dictyostelium discoideum OX=44689 GN=pdkB PE=3 SV=1,GO:0004672; GO:0004674; GO:0004676; GO:0005524; GO:0005829; GO:0030295; GO:0030587; GO:0035556; GO:0043327; GO:0051897; GO:0106310,chemotaxis to cAMP [GO:0043327]; intracellular signal transduction [GO:0035556]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; sorocarp development [GO:0030587],cytosol [GO:0005829],3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005829; GO:0016740; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; cytosol; transferase activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_12524,FUN_031701-T1,Peve_00008194,,apul_peve,40.042,,,,,,,,,,,,,,,,,
OG_12525,FUN_031716-T1,Peve_00039097,,apul_peve,56.4915,FUN_031716-T1,P58283,RN216_MOUSE,,E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (UbcM4-interacting protein 83) (Ubiquitin-conjugating enzyme 7-interacting protein 1),Mus musculus (Mouse),36.6,506.0,2.6e-84,314.7,sp|P58283|RN216_MOUSE E3 ubiquitin-protein ligase RNF216 OS=Mus musculus OX=10090 GN=Rnf216 PE=1 SV=3,GO:0005654; GO:0005829; GO:0006915; GO:0008270; GO:0016740; GO:0030136; GO:0032648; GO:0043161; GO:0050691; GO:0070936; GO:0098685; GO:0098793; GO:0098843; GO:0098978; GO:0099149; GO:0099546,"apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process, modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]",clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; postsynaptic endocytic zone [GO:0098843]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685],transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005829; GO:0012501; GO:0016740; GO:0030163; GO:0031410; GO:0043226,catalytic activity; nucleoplasm; cytosol; programmed cell death; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle
OG_12526,FUN_031727-T2,Peve_00040634,,apul_peve,82.645,,,,,,,,,,,,,,,,,
OG_12527,FUN_031729-T1,Peve_00039245,,apul_peve,64.069,,,,,,,,,,,,,,,,,
OG_12528,FUN_031730-T1,Peve_00029896,,apul_peve,66.197,FUN_031730-T1,Q55BP0,H33C_DICDI,,"Histone H3.3 type c (Histone 3, variant 3 type c)",Dictyostelium discoideum (Social amoeba),54.3,92.0,7.5e-20,98.6,sp|Q55BP0|H33C_DICDI Histone H3.3 type c OS=Dictyostelium discoideum OX=44689 GN=H3c PE=1 SV=1,GO:0000786; GO:0003677; GO:0005634; GO:0019954; GO:0030527; GO:0034644; GO:0040029; GO:0046982,asexual reproduction [GO:0019954]; cellular response to UV [GO:0034644]; epigenetic regulation of gene expression [GO:0040029],nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527],GO:0003677; GO:0005198; GO:0005634; GO:0006325; GO:0022414; GO:0043226,DNA binding; structural molecule activity; nucleus; chromatin organization; reproductive process; organelle
OG_12529,FUN_031745-T1,Peve_00004679,,apul_peve,37.079,FUN_031745-T1,P25962,ADRB3_MOUSE,,Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor),Mus musculus (Mouse),23.5,315.0,1.3e-08,62.0,sp|P25962|ADRB3_MOUSE Beta-3 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb3 PE=2 SV=2,GO:0002024; GO:0002025; GO:0004939; GO:0005886; GO:0007189; GO:0009409; GO:0015052; GO:0016020; GO:0031649; GO:0031699; GO:0040015; GO:0042755; GO:0042803; GO:0043235; GO:0043410; GO:0050873; GO:0051379; GO:0051380; GO:0071880; GO:0120162,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; eating behavior [GO:0042755]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; response to cold [GO:0009409],membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],beta-3 adrenergic receptor binding [GO:0031699]; beta-adrenergic receptor activity [GO:0004939]; beta3-adrenergic receptor activity [GO:0015052]; epinephrine binding [GO:0051379]; norepinephrine binding [GO:0051380]; protein homodimerization activity [GO:0042803],GO:0003013; GO:0005886; GO:0030154; GO:0060089,circulatory system process; plasma membrane; cell differentiation; molecular transducer activity
OG_12530,FUN_031759-T1,Peve_00000541,,apul_peve,43.307,,,,,,,,,,,,,,,,,
OG_12531,FUN_031792-T1,Peve_00020206,,apul_peve,58.333,,,,,,,,,,,,,,,,,
OG_12532,FUN_031841-T2,Peve_00030280,,apul_peve,82.051,FUN_031841-T2,Q9VT65,CANB_DROME,,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],Drosophila melanogaster (Fruit fly),43.0,703.0,3.4e-159,563.5,sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2,GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; membrane [GO:0016020],calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198],GO:0003824; GO:0016787; GO:0048870; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_12533,FUN_031846-T1,Peve_00039792,,apul_peve,53.947,,,,,,,,,,,,,,,,,
OG_12534,FUN_031889-T1,Peve_00033493,,apul_peve,61.85,,,,,,,,,,,,,,,,,
OG_12535,FUN_031895-T1,Peve_00031824,,apul_peve,63.612,FUN_031895-T1,Q8N8S7,ENAH_HUMAN,,Protein enabled homolog,Homo sapiens (Human),56.1,132.0,3.3000000000000003e-34,147.5,sp|Q8N8S7|ENAH_HUMAN Protein enabled homolog OS=Homo sapiens OX=9606 GN=ENAH PE=1 SV=2,GO:0003779; GO:0005522; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0007411; GO:0008154; GO:0017124; GO:0030027; GO:0030175; GO:0050699; GO:0070358; GO:0098794; GO:0098982; GO:0099188,actin polymerization or depolymerization [GO:0008154]; actin polymerization-dependent cell motility [GO:0070358]; axon guidance [GO:0007411]; postsynaptic cytoskeleton organization [GO:0099188],cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; WW domain binding [GO:0050699],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226; GO:0048870,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle; cell motility
OG_12536,FUN_031899-T1,Peve_00037706,,apul_peve,46.088,,,,,,,,,,,,,,,,,
OG_12537,FUN_031912-T1,Peve_00038998,,apul_peve,63.636,,,,,,,,,,,,,,,,,
OG_12538,FUN_031916-T1,Peve_00013257,,apul_peve,67.129,FUN_031916-T1,Q9YGX2,,,,,39.3,534.0,3.1e-98,360.5,sp|Q9YGX2|RPE65_CHICK Retinoid isomerohydrolase OS=Gallus gallus OX=9031 GN=RPE65 PE=1 SV=1,,,,,,
OG_12539,FUN_031926-T1,Peve_00004241,,apul_peve,42.027,,,,,,,,,,,,,,,,,
OG_12540,FUN_031933-T1,Peve_00035175,,apul_peve,71.62450000000001,,,,,,,,,,,,,,,,,
OG_12541,FUN_031947-T1,Peve_00031821,,apul_peve,66.097,,,,,,,,,,,,,,,,,
OG_12542,FUN_031961-T1,Peve_00043674,,apul_peve,59.048,FUN_031961-T1,P51049,,,,,25.3,296.0,6.1e-21,103.2,sp|P51049|MR1BB_DANRE Melatonin receptor type 1B-B OS=Danio rerio OX=7955 GN=mtnr1bb PE=2 SV=2,,,,,,
OG_12543,FUN_031968-T1,Peve_00043667,,apul_peve,48.218,,,,,,,,,,,,,,,,,
OG_12544,FUN_031973-T1,Peve_00043668,,apul_peve,43.774,FUN_031973-T1,P22182,,,,,36.2,392.0,1.8e-60,236.5,sp|P22182|FGFR1_XENLA Fibroblast growth factor receptor 1 OS=Xenopus laevis OX=8355 GN=fgfr1 PE=1 SV=1,,,,,,
OG_12545,FUN_031978-T1,Peve_00028817,,apul_peve,44.382000000000005,FUN_031978-T1,P79100,TRPC4_BOVIN,,Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel 1) (CCE1),Bos taurus (Bovine),23.0,495.0,4.7e-14,81.6,sp|P79100|TRPC4_BOVIN Short transient receptor potential channel 4 OS=Bos taurus OX=9913 GN=TRPC4 PE=2 SV=2,GO:0005886; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679,calcium ion transmembrane transport [GO:0070588]; regulation of cytosolic calcium ion concentration [GO:0051480],cation channel complex [GO:0034703]; plasma membrane [GO:0005886],"inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_12546,FUN_031984-T1,Peve_00019716,,apul_peve,43.673,,,,,,,,,,,,,,,,,
OG_12547,FUN_031993-T1,Peve_00008888,,apul_peve,48.079,,,,,,,,,,,,,,,,,
OG_12548,FUN_032005-T1,Peve_00028810,,apul_peve,53.073,FUN_032005-T1,Q49LS7,,,,,23.3,309.0,1.1e-07,59.3,sp|Q49LS7|XKR8_TETNG XK-related protein 8 OS=Tetraodon nigroviridis OX=99883 GN=xkr8 PE=2 SV=1,,,,,,
OG_12549,FUN_032020-T1,Peve_00041124,,apul_peve,35.547,,,,,,,,,,,,,,,,,
OG_12550,FUN_032026-T1,Peve_00019086,,apul_peve,63.129,FUN_032026-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),35.3,550.0,2.3e-86,321.2,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_12551,FUN_032028-T1,Peve_00043001,,apul_peve,60.254,FUN_032028-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),34.0,544.0,3.5e-87,323.9,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_12552,FUN_032031-T1,Peve_00013565,,apul_peve,55.0,,,,,,,,,,,,,,,,,
OG_12553,FUN_032046-T1,Peve_00013567,,apul_peve,60.432,FUN_032046-T1,Q03701,CEBPZ_HUMAN,,CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor),Homo sapiens (Human),39.5,749.0,5.1e-134,479.9,sp|Q03701|CEBPZ_HUMAN CCAAT/enhancer-binding protein zeta OS=Homo sapiens OX=9606 GN=CEBPZ PE=1 SV=3,GO:0003713; GO:0003723; GO:0005634; GO:0005654; GO:0016602; GO:0043231; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],CCAAT-binding factor complex [GO:0016602]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0043226; GO:0060090; GO:0140110,RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_12554,FUN_032049-T1,Peve_00012448,,apul_peve,69.027,FUN_032049-T1,Q3UYG8,MACD2_MOUSE,,ADP-ribose glycohydrolase MACROD2 (MACRO domain-containing protein 2) (O-acetyl-ADP-ribose deacetylase MACROD2) (EC 3.5.1.-) ([Protein ADP-ribosylaspartate] hydrolase MACROD2) (EC 3.2.2.-) ([Protein ADP-ribosylglutamate] hydrolase MACROD2) (EC 3.2.2.-),Mus musculus (Mouse),44.9,294.0,1.8e-59,231.1,sp|Q3UYG8|MACD2_MOUSE ADP-ribose glycohydrolase MACROD2 OS=Mus musculus OX=10090 GN=Macrod2 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005730; GO:0006974; GO:0007420; GO:0009617; GO:0016798; GO:0042278; GO:0051725; GO:0061463; GO:0140291; GO:0140293,brain development [GO:0007420]; DNA damage response [GO:0006974]; peptidyl-glutamate ADP-deribosylation [GO:0140291]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ADP-ribosylglutamate hydrolase activity [GO:0140293]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; O-acetyl-ADP-ribose deacetylase activity [GO:0061463]",GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0016787; GO:0043226; GO:0048856; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; nucleus; nucleoplasm; nucleolus; hydrolase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_12555,FUN_032060-T1,Peve_00000264,,apul_peve,64.027,,,,,,,,,,,,,,,,,
OG_12556,FUN_032075-T1,Peve_00028534,,apul_peve,69.644,FUN_032075-T1,A7SAZ1,,,,,56.6,143.0,4.8e-42,172.2,sp|A7SAZ1|U669_NEMVE UPF0669 protein v1g209471 OS=Nematostella vectensis OX=45351 GN=v1g209471 PE=3 SV=1,,,,,,
OG_12557,FUN_032076-T1,Peve_00011634,,apul_peve,39.895,FUN_032076-T1,Q9D9K3,,,,,37.1,116.0,1.9e-09,65.1,sp|Q9D9K3|AVEN_MOUSE Cell death regulator Aven OS=Mus musculus OX=10090 GN=Aven PE=1 SV=2,,,,,,
OG_12558,FUN_032077-T1,Peve_00011632,,apul_peve,61.745,,,,,,,,,,,,,,,,,
OG_12559,FUN_032078-T1,Peve_00033284,,apul_peve,43.131,FUN_032078-T1,Q6P0N0,M18BP_HUMAN,,Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog) (HsKNL-2) (P243),Homo sapiens (Human),24.8,218.0,1.8e-08,63.5,sp|Q6P0N0|M18BP_HUMAN Mis18-binding protein 1 OS=Homo sapiens OX=9606 GN=MIS18BP1 PE=1 SV=1,GO:0000775; GO:0003677; GO:0005654; GO:0051301,cell division [GO:0051301],"chromosome, centromeric region [GO:0000775]; nucleoplasm [GO:0005654]",DNA binding [GO:0003677],GO:0003677; GO:0005654,DNA binding; nucleoplasm
OG_12560,FUN_032080-T1,Peve_00016086,,apul_peve,48.402,,,,,,,,,,,,,,,,,
OG_12561,FUN_032086-T1,Peve_00026035,,apul_peve,70.50200000000001,FUN_032086-T1,P56199,ITA1_HUMAN,,Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a),Homo sapiens (Human),26.2,195.0,1.5e-06,55.1,sp|P56199|ITA1_HUMAN Integrin alpha-1 OS=Homo sapiens OX=9606 GN=ITGA1 PE=1 SV=2,GO:0001669; GO:0005178; GO:0005518; GO:0005886; GO:0005925; GO:0007160; GO:0007229; GO:0008285; GO:0008305; GO:0009897; GO:0009986; GO:0016020; GO:0019211; GO:0019903; GO:0030593; GO:0033627; GO:0034665; GO:0042059; GO:0042311; GO:0043204; GO:0043410; GO:0043525; GO:0045123; GO:0045178; GO:0046872; GO:0048812; GO:0070062; GO:0098609; GO:0098639,cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular extravasation [GO:0045123]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; neuron projection morphogenesis [GO:0048812]; neutrophil chemotaxis [GO:0030593]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron apoptotic process [GO:0043525]; vasodilation [GO:0042311],acrosomal vesicle [GO:0001669]; basal part of cell [GO:0045178]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integrin alpha1-beta1 complex [GO:0034665]; integrin complex [GO:0008305]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],collagen binding [GO:0005518]; collagen binding involved in cell-matrix adhesion [GO:0098639]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]; phosphatase activator activity [GO:0019211]; protein phosphatase binding [GO:0019903],GO:0002376; GO:0003013; GO:0005886; GO:0007155; GO:0031410; GO:0043226; GO:0048870; GO:0098631; GO:0098772,immune system process; circulatory system process; plasma membrane; cell adhesion; cytoplasmic vesicle; organelle; cell motility; cell adhesion mediator activity; molecular function regulator activity
OG_12562,FUN_032094-T1,Peve_00024860,,apul_peve,66.24600000000001,FUN_032094-T1,A2RRH5,,,,,31.7,851.0,2.8e-107,391.3,sp|A2RRH5|WDR27_HUMAN WD repeat-containing protein 27 OS=Homo sapiens OX=9606 GN=WDR27 PE=1 SV=3,,,,,,
OG_12563,FUN_032105-T1,Peve_00007297,,apul_peve,48.299,FUN_032105-T1,Q6DJN2,TRF6B_XENLA,,TNF receptor-associated factor 6-B (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6-B),Xenopus laevis (African clawed frog),29.2,487.0,1.9999999999999998e-53,211.5,sp|Q6DJN2|TRF6B_XENLA TNF receptor-associated factor 6-B OS=Xenopus laevis OX=8355 GN=traf6-b PE=2 SV=1,GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0007250; GO:0008270; GO:0009898; GO:0031663; GO:0035591; GO:0042981; GO:0043122; GO:0045087; GO:0061630; GO:0070534; GO:0098978,activation of NF-kappaB-inducing kinase activity [GO:0007250]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634],signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0016740; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; transferase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_12564,FUN_032120-T1,Peve_00040726,,apul_peve,67.524,FUN_032120-T1,V5YMB3,DAPB3_PSEMX,,Dipeptidyl aminopeptidase BIII (DAP BIII) (EC 3.4.14.-),Pseudoxanthomonas mexicana,32.7,208.0,8.3e-21,103.6,sp|V5YMB3|DAPB3_PSEMX Dipeptidyl aminopeptidase BIII OS=Pseudoxanthomonas mexicana OX=128785 GN=dapb3 PE=1 SV=1,GO:0004175; GO:0004177; GO:0004252; GO:0008239; GO:0051603,proteolysis involved in protein catabolic process [GO:0051603],,aminopeptidase activity [GO:0004177]; dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_12565,FUN_032133-T2,Peve_00029142,,apul_peve,79.751,FUN_032133-T2,Q9ULQ1,,,,,28.2,596.0,3.4999999999999998e-46,188.0,sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3,,,,,,
OG_12566,FUN_032134-T1,Peve_00006393,,apul_peve,44.304,,,,,,,,,,,,,,,,,
OG_12567,FUN_032141-T1,Peve_00007910,,apul_peve,58.748,,,,,,,,,,,,,,,,,
OG_12568,FUN_032150-T2,Peve_00008075,,apul_peve,56.549,FUN_032150-T2,Q9R0S2,MMP24_MOUSE,,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Matrix metalloproteinase-21) (MMP-21) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],Mus musculus (Mouse),36.9,458.0,3.9e-44,181.0,sp|Q9R0S2|MMP24_MOUSE Matrix metalloproteinase-24 OS=Mus musculus OX=10090 GN=Mmp24 PE=1 SV=2,GO:0004222; GO:0005576; GO:0005886; GO:0006508; GO:0008270; GO:0010001; GO:0031012; GO:0032588; GO:0044331; GO:0045296; GO:0050965; GO:0097150; GO:0098742,cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; glial cell differentiation [GO:0010001]; neuronal stem cell population maintenance [GO:0097150]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],cadherin binding [GO:0045296]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005886; GO:0007155; GO:0016787; GO:0030154; GO:0030312; GO:0031012; GO:0140096,"catalytic activity; extracellular region; plasma membrane; cell adhesion; hydrolase activity; cell differentiation; external encapsulating structure; extracellular matrix; catalytic activity, acting on a protein"
OG_12569,FUN_032199-T1,Peve_00017489,,apul_peve,42.74,FUN_032199-T1,Q8BKG4,FZD10_MOUSE,,Frizzled-10 (Fz-10) (CD antigen CD350),Mus musculus (Mouse),43.2,132.0,5.5e-27,124.4,sp|Q8BKG4|FZD10_MOUSE Frizzled-10 OS=Mus musculus OX=10090 GN=Fzd10 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005737; GO:0005886; GO:0009986; GO:0016055; GO:0017147; GO:0032956; GO:0035567; GO:0042813; GO:0046330; GO:0060070,canonical Wnt signaling pathway [GO:0060070]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005654; GO:0005886; GO:0060089,nucleoplasm; plasma membrane; molecular transducer activity
OG_12570,FUN_032202-T1,Peve_00017493,,apul_peve,68.654,FUN_032202-T1,Q9Z1N0,,,,,44.5,663.0,4.9e-160,566.2,sp|Q9Z1N0|ACOX1_CAVPO Peroxisomal acyl-coenzyme A oxidase 1 OS=Cavia porcellus OX=10141 GN=ACOX1 PE=2 SV=1,,,,,,
OG_12571,FUN_032205-T1,Peve_00013800,,apul_peve,69.159,FUN_032205-T1,Q7ZXH2,NSE2_XENLA,,E3 SUMO-protein ligase NSE2 (EC 2.3.2.-) (E3 SUMO-protein transferase NSE2) (MMS21 homolog) (Non-structural maintenance of chromosomes element 2 homolog) (Non-SMC element 2 homolog),Xenopus laevis (African clawed frog),30.4,230.0,2.1e-22,107.5,sp|Q7ZXH2|NSE2_XENLA E3 SUMO-protein ligase NSE2 OS=Xenopus laevis OX=8355 GN=nsmce2 PE=2 SV=1,GO:0000722; GO:0000724; GO:0000781; GO:0005634; GO:0008270; GO:0016605; GO:0016925; GO:0019789; GO:0030915; GO:0034184; GO:0045842; GO:0051301; GO:0061665; GO:0090398,cell division [GO:0051301]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; protein sumoylation [GO:0016925]; telomere maintenance via recombination [GO:0000722],"chromosome, telomeric region [GO:0000781]; nucleus [GO:0005634]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]",SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016740; GO:0032200; GO:0043226; GO:0140096,"catalytic activity; nucleus; DNA repair; DNA recombination; transferase activity; telomere organization; organelle; catalytic activity, acting on a protein"
OG_12572,FUN_032206-T1,Peve_00013801,,apul_peve,73.569,,,,,,,,,,,,,,,,,
OG_12573,FUN_032210-T1,Peve_00018884,,apul_peve,74.797,,,,,,,,,,,,,,,,,
OG_12574,FUN_032211-T1,Peve_00029912,,apul_peve,38.07,,,,,,,,,,,,,,,,,
OG_12575,FUN_032214-T1,Peve_00013797,,apul_peve,83.973,FUN_032214-T1,Q91W86,VPS11_MOUSE,,Vacuolar protein sorting-associated protein 11 homolog,Mus musculus (Mouse),54.0,962.0,1.4e-287,990.3,sp|Q91W86|VPS11_MOUSE Vacuolar protein sorting-associated protein 11 homolog OS=Mus musculus OX=10090 GN=Vps11 PE=1 SV=3,GO:0000166; GO:0005765; GO:0005769; GO:0005776; GO:0005884; GO:0006886; GO:0006914; GO:0008270; GO:0016192; GO:0030136; GO:0030139; GO:0031902; GO:0033263; GO:0048786,autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],actin filament [GO:0005884]; autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; CORVET complex [GO:0033263]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; presynaptic active zone [GO:0048786],nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270],GO:0005768; GO:0005773; GO:0006886; GO:0006914; GO:0016192; GO:0031410; GO:0043226,endosome; vacuole; intracellular protein transport; autophagy; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_12576,FUN_032237-T1,Peve_00027546,,apul_peve,66.465,FUN_032237-T1,P51029,,,,,36.5,340.0,8e-55,215.7,sp|P51029|WNT8B_DANRE Protein Wnt-8b OS=Danio rerio OX=7955 GN=wnt8b PE=2 SV=1,,,,,,
OG_12577,FUN_032239-T1,Peve_00028072,,apul_peve,63.372,FUN_032239-T1,P51029,,,,,42.6,319.0,6.7e-65,249.2,sp|P51029|WNT8B_DANRE Protein Wnt-8b OS=Danio rerio OX=7955 GN=wnt8b PE=2 SV=1,,,,,,
OG_12578,FUN_032244-T1,Peve_00014124,,apul_peve,59.02,FUN_032244-T1,Q6DFX2,ANTR2_MOUSE,,Anthrax toxin receptor 2,Mus musculus (Mouse),30.2,490.0,1.4e-53,212.2,sp|Q6DFX2|ANTR2_MOUSE Anthrax toxin receptor 2 OS=Mus musculus OX=10090 GN=Antxr2 PE=1 SV=1,GO:0007338; GO:0009897; GO:0009986; GO:0016020; GO:0030199; GO:0038023; GO:0046872; GO:0060065,collagen fibril organization [GO:0030199]; single fertilization [GO:0007338]; uterus development [GO:0060065],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; membrane [GO:0016020],metal ion binding [GO:0046872]; signaling receptor activity [GO:0038023],GO:0022414; GO:0030198; GO:0048856; GO:0060089,reproductive process; extracellular matrix organization; anatomical structure development; molecular transducer activity
OG_12579,FUN_032251-T1,Peve_00042109,,apul_peve,46.98,,,,,,,,,,,,,,,,,
OG_12580,FUN_032260-T1,Peve_00011394,,apul_peve,33.468,FUN_032260-T1,Q99NB2,,,,,26.1,276.0,2.4e-17,91.3,"sp|Q99NB2|B3GN5_RAT Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase OS=Rattus norvegicus OX=10116 GN=B3gnt5 PE=2 SV=2",,,,,,
OG_12581,FUN_032292-T1,Peve_00037777,,apul_peve,32.075,,,,,,,,,,,,,,,,,
OG_12582,FUN_032294-T1,Peve_00015558,,apul_peve,78.267,FUN_032294-T1,Q91XL9,,,,,43.9,1046.0,4.6e-205,716.5,sp|Q91XL9|OSBL1_MOUSE Oxysterol-binding protein-related protein 1 OS=Mus musculus OX=10090 GN=Osbpl1a PE=1 SV=2,,,,,,
OG_12583,FUN_032296-T1,Peve_00015552,,apul_peve,51.9965,FUN_032296-T1,Q9BXJ7,,,,,29.3,321.0,6.799999999999998e-35,150.2,sp|Q9BXJ7|AMNLS_HUMAN Protein amnionless OS=Homo sapiens OX=9606 GN=AMN PE=1 SV=2,,,,,,
OG_12584,FUN_032297-T1,Peve_00015545,,apul_peve,49.4465,,,,,,,,,,,,,,,,,
OG_12585,FUN_032300-T1,Peve_00005300,,apul_peve,49.634,FUN_032300-T1,O95429,BAG4_HUMAN,,BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains),Homo sapiens (Human),28.2,312.0,5.9e-09,64.3,sp|O95429|BAG4_HUMAN BAG family molecular chaperone regulator 4 OS=Homo sapiens OX=9606 GN=BAG4 PE=1 SV=1,GO:0000774; GO:0003723; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0010763; GO:0016020; GO:0030838; GO:0031625; GO:0043066; GO:0044877; GO:0045785; GO:0050821; GO:0051087; GO:0051496; GO:0051897; GO:0071356; GO:0071364; GO:0072659; GO:0090367; GO:0097178; GO:1903215,cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mRNA modification [GO:0090367]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; ruffle assembly [GO:0097178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886],adenyl-nucleotide exchange factor activity [GO:0000774]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625],GO:0003723; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0043226; GO:0072659; GO:0098772,RNA binding; nucleus; cytosol; plasma membrane; protein folding; organelle; protein localization to plasma membrane; molecular function regulator activity
OG_12586,FUN_032306-T1,Peve_00027300,,apul_peve,46.341,,,,,,,,,,,,,,,,,
OG_12587,FUN_032320-T1,Peve_00010338,,apul_peve,69.804,FUN_032320-T1,Q24488,ROR1_DROME,,Tyrosine-protein kinase transmembrane receptor Ror (dRor) (EC 2.7.10.1),Drosophila melanogaster (Fruit fly),56.2,162.0,5.5e-52,206.8,sp|Q24488|ROR1_DROME Tyrosine-protein kinase transmembrane receptor Ror OS=Drosophila melanogaster OX=7227 GN=Ror PE=1 SV=1,GO:0004713; GO:0004714; GO:0005524; GO:0005886; GO:0006468; GO:0007169; GO:0007417; GO:0016020; GO:0017147; GO:0030424; GO:0043235,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; central nervous system development [GO:0007417]; protein phosphorylation [GO:0006468],axon [GO:0030424]; membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005886; GO:0016740; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; transferase activity; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_12588,FUN_032338-T1,Peve_00042080,,apul_peve,47.682,FUN_032338-T1,P47972,,,,,34.1,170.0,5.2e-22,106.7,sp|P47972|NPTX2_HUMAN Neuronal pentraxin-2 OS=Homo sapiens OX=9606 GN=NPTX2 PE=1 SV=2,,,,,,
OG_12589,FUN_032340-T1,Peve_00042078,,apul_peve,45.652,,,,,,,,,,,,,,,,,
OG_12590,FUN_032375-T1,Peve_00041774,,apul_peve,59.091,,,,,,,,,,,,,,,,,
OG_12591,FUN_032402-T1,Peve_00027517,,apul_peve,42.202,FUN_032402-T1,P82279,CRUM1_HUMAN,,Protein crumbs homolog 1,Homo sapiens (Human),55.6,45.0,2.1e-08,61.6,sp|P82279|CRUM1_HUMAN Protein crumbs homolog 1 OS=Homo sapiens OX=9606 GN=CRB1 PE=1 SV=2,GO:0001750; GO:0001917; GO:0001974; GO:0005509; GO:0005576; GO:0005886; GO:0005902; GO:0005912; GO:0007009; GO:0007157; GO:0007163; GO:0007267; GO:0008104; GO:0010001; GO:0010467; GO:0010842; GO:0016324; GO:0032991; GO:0035003; GO:0035845; GO:0042462; GO:0043296; GO:0045197; GO:0045494; GO:0050908; GO:0060060; GO:0061159; GO:0071482; GO:0097386,blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cellular response to light stimulus [GO:0071482]; detection of light stimulus involved in visual perception [GO:0050908]; establishment of bipolar cell polarity involved in cell morphogenesis [GO:0061159]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; eye photoreceptor cell development [GO:0042462]; gene expression [GO:0010467]; glial cell differentiation [GO:0010001]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; plasma membrane organization [GO:0007009]; post-embryonic retina morphogenesis in camera-type eye [GO:0060060]; protein localization [GO:0008104]; retina layer formation [GO:0010842],adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003],calcium ion binding [GO:0005509],GO:0005576; GO:0005886; GO:0007155; GO:0007163; GO:0023052; GO:0030154; GO:0048856; GO:0061024,extracellular region; plasma membrane; cell adhesion; establishment or maintenance of cell polarity; signaling; cell differentiation; anatomical structure development; membrane organization
OG_12592,FUN_032406-T1,Peve_00029330,,apul_peve,42.754,FUN_032406-T1,P34579,,,,,25.9,441.0,7.3e-33,143.3,sp|P34579|UNC47_CAEEL Vesicular GABA transporter OS=Caenorhabditis elegans OX=6239 GN=unc-47 PE=1 SV=2,,,,,,
OG_12593,FUN_032417-T1,Peve_00009163,,apul_peve,39.394,,,,,,,,,,,,,,,,,
OG_12594,FUN_032437-T2,Peve_00043628,,apul_peve,47.765,,,,,,,,,,,,,,,,,
OG_12595,FUN_032443-T1,Peve_00041761,,apul_peve,41.087,,,,,,,,,,,,,,,,,
OG_12596,FUN_032462-T1,Peve_00009182,,apul_peve,50.450500000000005,FUN_032462-T1,Q6QNK2,AGRD1_HUMAN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Homo sapiens (Human),29.6,605.0,7.2e-57,223.8,sp|Q6QNK2|AGRD1_HUMAN Adhesion G-protein coupled receptor D1 OS=Homo sapiens OX=9606 GN=ADGRD1 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005829; GO:0005886; GO:0007166; GO:0007186; GO:0007189; GO:0014819; GO:0016020; GO:0016607,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of skeletal muscle contraction [GO:0014819],cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005829; GO:0005886; GO:0043226; GO:0060089,nucleoplasm; cytosol; plasma membrane; organelle; molecular transducer activity
OG_12597,FUN_032487-T2,Peve_00045335,,apul_peve,67.6,,,,,,,,,,,,,,,,,
OG_12598,FUN_032505-T1,Peve_00000686,,apul_peve,36.0,,,,,,,,,,,,,,,,,
OG_12599,FUN_032506-T1,Peve_00000685,,apul_peve,42.077,,,,,,,,,,,,,,,,,
OG_12600,FUN_032511-T1,Peve_00000673,,apul_peve,40.642,,,,,,,,,,,,,,,,,
OG_12601,FUN_032530-T1,Peve_00000687,,apul_peve,36.2385,,,,,,,,,,,,,,,,,
OG_12602,FUN_032563-T1,Peve_00010107,,apul_peve,69.097,FUN_032563-T1,Q6P4F1,OFUT3_HUMAN,,"GDP-fucose protein O-fucosyltransferase 3 (EC 2.4.1.221) (Alpha-(1,3)-fucosyltransferase 10) (EC 2.4.1.-) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10)",Homo sapiens (Human),26.9,349.0,5.8e-23,110.5,sp|Q6P4F1|OFUT3_HUMAN GDP-fucose protein O-fucosyltransferase 3 OS=Homo sapiens OX=9606 GN=FUT10 PE=1 SV=2,GO:0000139; GO:0005654; GO:0005764; GO:0005783; GO:0005789; GO:0005794; GO:0006457; GO:0006486; GO:0006605; GO:0007399; GO:0008417; GO:0009312; GO:0009566; GO:0021799; GO:0030097; GO:0036065; GO:0036071; GO:0036445; GO:0042060; GO:0042355; GO:0046920; GO:0046922; GO:0050714; GO:0097150; GO:0097402,cerebral cortex radially oriented cell migration [GO:0021799]; fertilization [GO:0009566]; fucosylation [GO:0036065]; hemopoiesis [GO:0030097]; L-fucose catabolic process [GO:0042355]; N-glycan fucosylation [GO:0036071]; nervous system development [GO:0007399]; neuroblast migration [GO:0097402]; neuronal stem cell division [GO:0036445]; neuronal stem cell population maintenance [GO:0097150]; oligosaccharide biosynthetic process [GO:0009312]; positive regulation of protein secretion [GO:0050714]; protein folding [GO:0006457]; protein glycosylation [GO:0006486]; protein targeting [GO:0006605]; wound healing [GO:0042060],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; nucleoplasm [GO:0005654],alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922],GO:0003824; GO:0005654; GO:0005764; GO:0005773; GO:0005783; GO:0005794; GO:0005975; GO:0006457; GO:0006486; GO:0016740; GO:0022414; GO:0042060; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; nucleoplasm; lysosome; vacuole; endoplasmic reticulum; Golgi apparatus; carbohydrate metabolic process; protein folding; protein glycosylation; transferase activity; reproductive process; wound healing; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_12603,FUN_032572-T1,Peve_00020085,,apul_peve,58.025,,,,,,,,,,,,,,,,,
OG_12604,FUN_032576-T1,Peve_00039172,,apul_peve,53.684,,,,,,,,,,,,,,,,,
OG_12605,FUN_032585-T1,Peve_00016019,,apul_peve,64.119,,,,,,,,,,,,,,,,,
OG_12606,FUN_032587-T1,Peve_00016023,,apul_peve,70.87100000000001,,,,,,,,,,,,,,,,,
OG_12607,FUN_032623-T1,Peve_00024065,,apul_peve,55.776,FUN_032623-T1,P49887,,,,,39.1,276.0,9.5e-50,198.7,sp|P49887|ST1E1_CAVPO Sulfotransferase 1E1 OS=Cavia porcellus OX=10141 GN=SULT1E1 PE=1 SV=1,,,,,,
OG_12608,FUN_032626-T1,Peve_00022088,,apul_peve,57.878,FUN_032626-T1,Q3T0Y3,ST1B1_BOVIN,,Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase family cytosolic 1B member 1),Bos taurus (Bovine),37.5,275.0,6.8e-48,192.6,sp|Q3T0Y3|ST1B1_BOVIN Sulfotransferase 1B1 OS=Bos taurus OX=9913 GN=SULT1B1 PE=1 SV=1,GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0009812; GO:0030855; GO:0042403; GO:0050427; GO:0051923,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytosol [GO:0005829],aryl sulfotransferase activity [GO:0004062],GO:0003824; GO:0005829; GO:0006575; GO:0006790; GO:0016740; GO:0030154; GO:0055086; GO:1901135,catalytic activity; cytosol; modified amino acid metabolic process; sulfur compound metabolic process; transferase activity; cell differentiation; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_12609,FUN_032640-T1,Peve_00015952,,apul_peve,58.209,FUN_032640-T1,Q4LBB9,OCTB2_DROME,,Octopamine receptor beta-2R (DmOct-beta-12) (DmOct-beta-2R),Drosophila melanogaster (Fruit fly),21.4,322.0,1.5e-08,62.0,sp|Q4LBB9|OCTB2_DROME Octopamine receptor beta-2R OS=Drosophila melanogaster OX=7227 GN=Octbeta2R PE=2 SV=2,GO:0003700; GO:0004989; GO:0005886; GO:0007186; GO:0007189; GO:0008227; GO:0009566; GO:0016020; GO:0030728; GO:0043410; GO:0045887; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; fertilization [GO:0009566]; G protein-coupled receptor signaling pathway [GO:0007186]; ovulation [GO:0030728]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887],membrane [GO:0016020]; plasma membrane [GO:0005886],DNA-binding transcription factor activity [GO:0003700]; G protein-coupled amine receptor activity [GO:0008227]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0022414; GO:0060089; GO:0140110,plasma membrane; reproductive process; molecular transducer activity; transcription regulator activity
OG_12610,FUN_032645-T1,Peve_00008495,,apul_peve,34.717,,,,,,,,,,,,,,,,,
OG_12611,FUN_032651-T1,Peve_00041052,,apul_peve,59.259,,,,,,,,,,,,,,,,,
OG_12612,FUN_032653-T1,Peve_00041053,,apul_peve,57.034,,,,,,,,,,,,,,,,,
OG_12613,FUN_032659-T1,Peve_00014717,,apul_peve,39.891,,,,,,,,,,,,,,,,,
OG_12614,FUN_032662-T1,Peve_00037540,,apul_peve,60.145,,,,,,,,,,,,,,,,,
OG_12615,FUN_032670-T1,Peve_00025166,,apul_peve,61.053,FUN_032670-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),39.0,154.0,3.4e-19,98.2,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_12616,FUN_032684-T1,Peve_00015967,,apul_peve,66.809,,,,,,,,,,,,,,,,,
OG_12617,FUN_032688-T1,Peve_00006295,,apul_peve,76.411,FUN_032688-T1,Q8N4S7,PAQR4_HUMAN,,Progestin and adipoQ receptor family member 4 (Progestin and adipoQ receptor family member IV),Homo sapiens (Human),43.2,264.0,1.1999999999999999e-46,188.3,sp|Q8N4S7|PAQR4_HUMAN Progestin and adipoQ receptor family member 4 OS=Homo sapiens OX=9606 GN=PAQR4 PE=1 SV=3,GO:0000139; GO:0050821; GO:0060090; GO:2000303,protein stabilization [GO:0050821]; regulation of ceramide biosynthetic process [GO:2000303],Golgi membrane [GO:0000139],molecular adaptor activity [GO:0060090],GO:0060090,molecular adaptor activity
OG_12618,FUN_032695-T1,Peve_00012981,,apul_peve,41.152,FUN_032695-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),31.6,193.0,3.8e-15,84.7,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_12619,FUN_032698-T1,Peve_00006279,,apul_peve,62.6585,,,,,,,,,,,,,,,,,
OG_12620,FUN_032702-T1,Peve_00014079,,apul_peve,62.195,FUN_032702-T1,Q9CYF5,,,,,39.4,421.0,2.3e-75,284.3,sp|Q9CYF5|RCC1L_MOUSE RCC1-like G exchanging factor-like protein OS=Mus musculus OX=10090 GN=Rcc1l PE=1 SV=1,,,,,,
OG_12621,FUN_032759-T1,Peve_00023821,,apul_peve,54.167,FUN_032759-T1,P58467,SETD4_MOUSE,,SET domain-containing protein 4 (EC 2.1.1.-) (EC 2.1.1.364),Mus musculus (Mouse),33.8,432.0,1.8e-46,188.3,sp|P58467|SETD4_MOUSE SET domain-containing protein 4 OS=Mus musculus OX=10090 GN=Setd4 PE=1 SV=2,GO:0005634; GO:0005829; GO:0006338; GO:0006954; GO:0032259; GO:0032755; GO:0032760; GO:0042799; GO:0042800; GO:0050729; GO:0071863; GO:0140941; GO:0140944; GO:0140945,chromatin remodeling [GO:0006338]; inflammatory response [GO:0006954]; methylation [GO:0032259]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation in bone marrow [GO:0071863],cytosol [GO:0005829]; nucleus [GO:0005634],histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006954; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; chromatin organization; inflammatory response; transferase activity; organelle; catalytic activity, acting on a protein"
OG_12622,FUN_032765-T1,Peve_00008109,,apul_peve,39.71,FUN_032765-T1,Q20911,,,,,35.0,100.0,4.8e-06,53.9,sp|Q20911|CUBN_CAEEL Cubilin homolog OS=Caenorhabditis elegans OX=6239 GN=cubn-1 PE=1 SV=4,,,,,,
OG_12623,FUN_032769-T1,Peve_00039325,,apul_peve,31.22,,,,,,,,,,,,,,,,,
OG_12624,FUN_032780-T1,Peve_00010366,,apul_peve,71.25,FUN_032780-T1,Q9TUP7,,,,,24.9,370.0,5.3e-20,100.1,sp|Q9TUP7|OX2R_CANLF Orexin receptor type 2 OS=Canis lupus familiaris OX=9615 GN=HCRTR2 PE=1 SV=1,,,,,,
OG_12625,FUN_032795-T1,Peve_00010368,,apul_peve,73.381,FUN_032795-T1,P53454,,,,,25.7,307.0,1.9e-19,98.2,sp|P53454|DRD5L_TAKRU D(5)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=dl PE=3 SV=1,,,,,,
OG_12626,FUN_032800-T1,Peve_00010365,,apul_peve,63.097,FUN_032800-T1,Q61184,,,,,27.5,291.0,7.2e-23,109.8,sp|Q61184|MTR1A_MOUSE Melatonin receptor type 1A OS=Mus musculus OX=10090 GN=Mtnr1a PE=2 SV=1,,,,,,
OG_12627,FUN_032822-T1,Peve_00042294,,apul_peve,47.826,,,,,,,,,,,,,,,,,
OG_12628,FUN_032829-T1,Peve_00014281,,apul_peve,77.869,,,,,,,,,,,,,,,,,
OG_12629,FUN_032835-T1,Peve_00014561,,apul_peve,57.269,FUN_032835-T1,Q38912,RAC3_ARATH,,Rac-like GTP-binding protein ARAC3 (AtRAC1) (GTPase protein ROP6),Arabidopsis thaliana (Mouse-ear cress),36.8,190.0,1.2e-19,98.6,sp|Q38912|RAC3_ARATH Rac-like GTP-binding protein ARAC3 OS=Arabidopsis thaliana OX=3702 GN=ARAC3 PE=1 SV=1,GO:0003924; GO:0005525; GO:0005634; GO:0005730; GO:0005737; GO:0005819; GO:0005886; GO:0007264; GO:0009734; GO:0009958; GO:0010928; GO:0019003; GO:0030427; GO:0043622; GO:0048446; GO:0048766; GO:0048767; GO:0051211,anisotropic cell growth [GO:0051211]; auxin-activated signaling pathway [GO:0009734]; cortical microtubule organization [GO:0043622]; petal morphogenesis [GO:0048446]; positive gravitropism [GO:0009958]; regulation of auxin mediated signaling pathway [GO:0010928]; root hair elongation [GO:0048767]; root hair initiation [GO:0048766]; small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of polarized growth [GO:0030427]; spindle [GO:0005819],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005634; GO:0005730; GO:0005886; GO:0007010; GO:0016787; GO:0022414; GO:0043226,catalytic activity; GTPase activity; nucleus; nucleolus; plasma membrane; cytoskeleton organization; hydrolase activity; reproductive process; organelle
OG_12630,FUN_032856-T1,Peve_00035111,,apul_peve,47.917,FUN_032856-T1,Q28596,,,,,25.2,314.0,1e-12,75.9,sp|Q28596|TRHR_SHEEP Thyrotropin-releasing hormone receptor OS=Ovis aries OX=9940 GN=TRHR PE=2 SV=1,,,,,,
OG_12631,FUN_032861-T1,Peve_00030199,,apul_peve,48.667,FUN_032861-T1,Q969F8,KISSR_HUMAN,,KiSS-1 receptor (KiSS-1R) (G-protein coupled receptor 54) (G-protein coupled receptor OT7T175) (hOT7T175) (Hypogonadotropin-1) (Kisspeptins receptor) (Metastin receptor),Homo sapiens (Human),22.2,297.0,3.1e-08,60.8,sp|Q969F8|KISSR_HUMAN KiSS-1 receptor OS=Homo sapiens OX=9606 GN=KISS1R PE=1 SV=2,GO:0005886; GO:0005929; GO:0007186; GO:0007218; GO:0008188; GO:0008528; GO:0009986; GO:0016020; GO:0043231,G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218],cell surface [GO:0009986]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; neuropeptide receptor activity [GO:0008188],GO:0005886; GO:0005929; GO:0043226; GO:0060089,plasma membrane; cilium; organelle; molecular transducer activity
OG_12632,FUN_032864-T1,Peve_00009424,,apul_peve,34.22,,,,,,,,,,,,,,,,,
OG_12633,FUN_032866-T1,Peve_00014571,,apul_peve,52.263,FUN_032866-T1,Q6BD04,GPR54_ORENI,,G-protein coupled receptor 54,Oreochromis niloticus (Nile tilapia) (Tilapia nilotica),24.8,258.0,7.9e-13,75.9,sp|Q6BD04|GPR54_ORENI G-protein coupled receptor 54 OS=Oreochromis niloticus OX=8128 GN=gpr54 PE=2 SV=1,GO:0004930; GO:0005886,,plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_12634,FUN_032876-T2,Peve_00014577,,apul_peve,63.7,FUN_032876-T2,P48058,GRIA4_HUMAN,,"Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4)",Homo sapiens (Human),36.4,541.0,1.3e-88,329.3,sp|P48058|GRIA4_HUMAN Glutamate receptor 4 OS=Homo sapiens OX=9606 GN=GRIA4 PE=1 SV=2,GO:0001540; GO:0004970; GO:0004971; GO:0005886; GO:0007215; GO:0030425; GO:0030666; GO:0032281; GO:0034392; GO:0035249; GO:0043025; GO:0043197; GO:0050804; GO:0098839; GO:0099507; GO:1903561; GO:1904315,"glutamate receptor signaling pathway [GO:0007215]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; synaptic transmission, glutamatergic [GO:0035249]",AMPA glutamate receptor complex [GO:0032281]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; extracellular vesicle [GO:1903561]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839],AMPA glutamate receptor activity [GO:0004971]; amyloid-beta binding [GO:0001540]; glutamate-gated receptor activity [GO:0004970]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0043226; GO:0060089,transporter activity; plasma membrane; signaling; organelle; molecular transducer activity
OG_12635,FUN_032877-T1,Peve_00017495,,apul_peve,49.7635,,,,,,,,,,,,,,,,,
OG_12636,FUN_032968-T1,Peve_00015776,,apul_peve,48.78,FUN_032968-T1,Q0V9E9,KMT5A_XENTR,,N-lysine methyltransferase KMT5A (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine-specific methylase 5A) (SET domain-containing protein 8),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),37.5,168.0,1.3e-19,98.2,sp|Q0V9E9|KMT5A_XENTR N-lysine methyltransferase KMT5A OS=Xenopus tropicalis OX=8364 GN=kmt5a PE=2 SV=1,GO:0005634; GO:0005694; GO:0032259; GO:0042054; GO:0051301; GO:0140944,cell division [GO:0051301]; methylation [GO:0032259],chromosome [GO:0005694]; nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054],GO:0003824; GO:0005634; GO:0005694; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; transferase activity; organelle; catalytic activity, acting on a protein"
OG_12637,FUN_032982-T1,Peve_00014552,,apul_peve,87.195,FUN_032982-T1,P54985,,,,,76.8,164.0,4.700000000000002e-72,271.9,sp|P54985|PPIA_BLAGE Peptidyl-prolyl cis-trans isomerase OS=Blattella germanica OX=6973 GN=CYPA PE=2 SV=1,,,,,,
OG_12638,FUN_032985-T1,Peve_00014550,,apul_peve,59.898,FUN_032985-T1,P78536,ADA17_HUMAN,,Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b),Homo sapiens (Human),39.6,689.0,1.3e-132,475.3,sp|P78536|ADA17_HUMAN Disintegrin and metalloproteinase domain-containing protein 17 OS=Homo sapiens OX=9606 GN=ADAM17 PE=1 SV=1,GO:0000139; GO:0001666; GO:0002446; GO:0002467; GO:0002532; GO:0002690; GO:0004175; GO:0004222; GO:0005112; GO:0005138; GO:0005178; GO:0005737; GO:0005788; GO:0005829; GO:0005886; GO:0006508; GO:0006509; GO:0007155; GO:0007173; GO:0007219; GO:0007220; GO:0008233; GO:0008237; GO:0008284; GO:0009410; GO:0009986; GO:0010820; GO:0010977; GO:0015629; GO:0016020; GO:0016324; GO:0016485; GO:0017124; GO:0019955; GO:0023061; GO:0030165; GO:0030183; GO:0030307; GO:0030335; GO:0030512; GO:0032496; GO:0032722; GO:0032760; GO:0033025; GO:0033077; GO:0033627; GO:0035313; GO:0042987; GO:0043120; GO:0043491; GO:0043536; GO:0045121; GO:0045741; GO:0045742; GO:0046872; GO:0048536; GO:0048679; GO:0048870; GO:0050830; GO:0070573; GO:0071403; GO:0071679; GO:0120163; GO:0140447; GO:1900087; GO:1902945; GO:1903265; GO:1905564; GO:2001222,"amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; commissural neuron axon guidance [GO:0071679]; cytokine precursor processing [GO:0140447]; defense response to Gram-positive bacterium [GO:0050830]; epidermal growth factor receptor signaling pathway [GO:0007173]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil mediated immunity [GO:0002446]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; production of molecular mediator involved in inflammatory response [GO:0002532]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of axon regeneration [GO:0048679]; regulation of mast cell apoptotic process [GO:0033025]; regulation of neuron migration [GO:2001222]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; signal release [GO:0023061]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; wound healing, spreading of epidermal cells [GO:0035313]",actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],cytokine binding [GO:0019955]; endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; interleukin-6 receptor binding [GO:0005138]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; peptidase activity [GO:0008233]; SH3 domain binding [GO:0017124]; tumor necrosis factor binding [GO:0043120],GO:0002376; GO:0003824; GO:0005829; GO:0005856; GO:0005886; GO:0007155; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0051604; GO:0140096,"immune system process; catalytic activity; cytosol; cytoskeleton; plasma membrane; cell adhesion; hydrolase activity; cell differentiation; organelle; anatomical structure development; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_12639,FUN_032990-T1,Peve_00003489,,apul_peve,65.68,,,,,,,,,,,,,,,,,
OG_12640,FUN_032991-T1,Peve_00014543,,apul_peve,50.852,FUN_032991-T1,G3M4F8,,,,,23.8,315.0,1.2e-08,62.4,sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1,,,,,,
OG_12641,FUN_032994-T1,Peve_00015575,,apul_peve,58.0345,FUN_032994-T1,Q5RHP9,ERIC3_HUMAN,,Glutamate-rich protein 3,Homo sapiens (Human),30.8,490.0,1.5e-48,196.8,sp|Q5RHP9|ERIC3_HUMAN Glutamate-rich protein 3 OS=Homo sapiens OX=9606 GN=ERICH3 PE=1 SV=1,GO:0005737; GO:0060271; GO:0097730,cilium assembly [GO:0060271],cytoplasm [GO:0005737]; non-motile cilium [GO:0097730],,GO:0005929; GO:0043226; GO:0044782,cilium; organelle; cilium organization
OG_12642,FUN_032998-T1,Peve_00045057,,apul_peve,49.66,FUN_032998-T1,P0C6B8,,,,,37.2,207.0,1.9e-32,141.4,"sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1",,,,,,
OG_12643,FUN_033005-T1,Peve_00015574,,apul_peve,36.4545,,,,,,,,,,,,,,,,,
OG_12644,FUN_033024-T1,Peve_00017505,,apul_peve,60.041,FUN_033024-T1,Q5M954,SEN2_RAT,,tRNA-splicing endonuclease subunit Sen2 (EC 4.6.1.16) (tRNA-intron endonuclease Sen2),Rattus norvegicus (Rat),29.7,498.0,2.1e-51,204.9,sp|Q5M954|SEN2_RAT tRNA-splicing endonuclease subunit Sen2 OS=Rattus norvegicus OX=10116 GN=Tsen2 PE=1 SV=1,GO:0000213; GO:0000214; GO:0000379; GO:0003676; GO:0005730; GO:0005737; GO:0006388; GO:0006397; GO:0008033; GO:0016829,"mRNA processing [GO:0006397]; tRNA processing [GO:0008033]; tRNA splicing, via endonucleolytic cleavage and ligation [GO:0006388]; tRNA-type intron splice site recognition and cleavage [GO:0000379]",cytoplasm [GO:0005737]; nucleolus [GO:0005730]; tRNA-intron endonuclease complex [GO:0000214],lyase activity [GO:0016829]; nucleic acid binding [GO:0003676]; tRNA-intron endonuclease activity [GO:0000213],GO:0003824; GO:0005730; GO:0006399; GO:0016071; GO:0016829; GO:0043226; GO:0140098,"catalytic activity; nucleolus; tRNA metabolic process; mRNA metabolic process; lyase activity; organelle; catalytic activity, acting on RNA"
OG_12645,FUN_033043-T1,Peve_00007969,,apul_peve,56.112,FUN_033043-T1,P46023,,,,,45.3,338.0,3.7e-76,289.7,sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_12646,FUN_033057-T1,Peve_00041591,,apul_peve,63.919,,,,,,,,,,,,,,,,,
OG_12647,FUN_033061-T1,Peve_00017715,,apul_peve,53.6705,FUN_033061-T1,F7J220,,,,,50.9,161.0,2.2e-43,178.3,sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1,,,,,,
OG_12648,FUN_033076-T1,Peve_00027701,,apul_peve,99.091,,,,,,,,,,,,,,,,,
OG_12649,FUN_033079-T1,Peve_00042618,,apul_peve,96.356,,,,,,,,,,,,,,,,,
OG_12650,FUN_033085-T1,Peve_00026831,,apul_peve,88.06,,,,,,,,,,,,,,,,,
OG_12651,FUN_033091-T1,Peve_00009774,,apul_peve,74.648,,,,,,,,,,,,,,,,,
OG_12652,FUN_033094-T1,Peve_00023680,,apul_peve,87.931,,,,,,,,,,,,,,,,,
OG_12653,FUN_033107-T1,Peve_00035695,,apul_peve,49.6,,,,,,,,,,,,,,,,,
OG_12654,FUN_033120-T1,Peve_00043511,,apul_peve,66.131,FUN_033120-T1,Q3M6C3,,,,,39.5,377.0,7.699999999999999e-68,260.4,sp|Q3M6C3|DDGS_TRIV2 Demethyl-4-deoxygadusol synthase OS=Trichormus variabilis (strain ATCC 29413 / PCC 7937) OX=240292 GN=Ava_3858 PE=1 SV=1,,,,,,
OG_12655,FUN_033146-T1,Peve_00003497,,apul_peve,74.269,,,,,,,,,,,,,,,,,
OG_12656,FUN_033221-T1,Peve_00020998,,apul_peve,74.061,FUN_033221-T1,Q2HJF4,,,,,54.9,293.0,2.3e-80,300.4,sp|Q2HJF4|PBLD_BOVIN Phenazine biosynthesis-like domain-containing protein OS=Bos taurus OX=9913 GN=PBLD PE=2 SV=1,,,,,,
OG_12657,FUN_033222-T1,Peve_00028973,,apul_peve,58.5685,FUN_033222-T1,Q5U2X2,,,,,28.9,990.0,1.2e-85,319.7,sp|Q5U2X2|SPAG1_RAT Sperm-associated antigen 1 OS=Rattus norvegicus OX=10116 GN=Spag1 PE=1 SV=1,,,,,,
OG_12658,FUN_033297-T1,Peve_00000704,,apul_peve,59.748,,,,,,,,,,,,,,,,,
OG_12659,FUN_033298-T1,Peve_00025356,,apul_peve,54.605,FUN_033298-T1,Q5S006,LRRK2_MOUSE,,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (EC 3.6.5.-),Mus musculus (Mouse),22.1,384.0,1.8e-11,73.2,sp|Q5S006|LRRK2_MOUSE Leucine-rich repeat serine/threonine-protein kinase 2 OS=Mus musculus OX=10090 GN=Lrrk2 PE=1 SV=2,GO:0000139; GO:0000287; GO:0003779; GO:0003924; GO:0004672; GO:0004674; GO:0004706; GO:0005096; GO:0005524; GO:0005525; GO:0005654; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005764; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005798; GO:0005802; GO:0005829; GO:0005886; GO:0005902; GO:0006468; GO:0006606; GO:0006897; GO:0006914; GO:0007005; GO:0007029; GO:0007030; GO:0007254; GO:0007266; GO:0007283; GO:0007528; GO:0008021; GO:0008104; GO:0008340; GO:0009267; GO:0010468; GO:0010508; GO:0010955; GO:0010977; GO:0014041; GO:0015631; GO:0016301; GO:0017075; GO:0019722; GO:0021756; GO:0022028; GO:0030159; GO:0030182; GO:0030276; GO:0030424; GO:0030425; GO:0030426; GO:0030672; GO:0031267; GO:0031410; GO:0031647; GO:0031965; GO:0032436; GO:0032473; GO:0032760; GO:0032839; GO:0034211; GO:0034614; GO:0035556; GO:0035564; GO:0035641; GO:0035751; GO:0036064; GO:0036465; GO:0036479; GO:0040012; GO:0042802; GO:0042803; GO:0043068; GO:0043195; GO:0043204; GO:0044325; GO:0044753; GO:0044754; GO:0044877; GO:0045121; GO:0045202; GO:0045335; GO:0045746; GO:0046039; GO:0048312; GO:0048812; GO:0051018; GO:0051900; GO:0051966; GO:0060079; GO:0060159; GO:0060161; GO:0060628; GO:0060828; GO:0061001; GO:0070971; GO:0070973; GO:0071287; GO:0090263; GO:0090394; GO:0097487; GO:0098794; GO:0098978; GO:0099400; GO:0099523; GO:0106310; GO:0140058; GO:0141161; GO:1900242; GO:1900244; GO:1902236; GO:1902499; GO:1902692; GO:1902803; GO:1902902; GO:1903215; GO:1903351; GO:1903980; GO:1904713; GO:1904887; GO:1905279; GO:1905289; GO:1990904; GO:1990909; GO:2000172; GO:2000300; GO:2000377,"autophagy [GO:0006914]; calcium-mediated signaling [GO:0019722]; cellular response to dopamine [GO:1903351]; cellular response to manganese ion [GO:0071287]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; determination of adult lifespan [GO:0008340]; endocytosis [GO:0006897]; endoplasmic reticulum organization [GO:0007029]; excitatory postsynaptic potential [GO:0060079]; Golgi organization [GO:0007030]; GTP metabolic process [GO:0046039]; intracellular distribution of mitochondria [GO:0048312]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; locomotory exploration behavior [GO:0035641]; mitochondrion organization [GO:0007005]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein processing [GO:0010955]; negative regulation of protein targeting to mitochondrion [GO:1903215]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neuron projection arborization [GO:0140058]; neuron projection morphogenesis [GO:0048812]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of programmed cell death [GO:0043068]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein autoubiquitination [GO:1902499]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein phosphorylation [GO:0006468]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP/PKA signal transduction [GO:0141161]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of gene expression [GO:0010468]; regulation of kidney size [GO:0035564]; regulation of locomotion [GO:0040012]; regulation of lysosomal lumen pH [GO:0035751]; regulation of mitochondrial depolarization [GO:0051900]; regulation of neuroblast proliferation [GO:1902692]; regulation of neuron maturation [GO:0014041]; regulation of protein stability [GO:0031647]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of retrograde transport, endosome to Golgi [GO:1905279]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle transport [GO:1902803]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; synaptic vesicle recycling [GO:0036465]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; Wnt signalosome assembly [GO:1904887]","amphisome [GO:0044753]; autolysosome [GO:0044754]; axon [GO:0030424]; caveola neck [GO:0099400]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; growth cone [GO:0030426]; lysosome [GO:0005764]; membrane raft [GO:0045121]; microvillus [GO:0005902]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; multivesicular body, internal vesicle [GO:0097487]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; Wnt signalosome [GO:1990909]",actin binding [GO:0003779]; ATP binding [GO:0005524]; beta-catenin destruction complex binding [GO:1904713]; clathrin binding [GO:0030276]; GTP binding [GO:0005525]; GTP-dependent protein kinase activity [GO:0034211]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; peroxidase inhibitor activity [GO:0036479]; protein homodimerization activity [GO:0042803]; protein kinase A binding [GO:0051018]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; signaling receptor complex adaptor activity [GO:0030159]; small GTPase binding [GO:0031267]; syntaxin-1 binding [GO:0017075]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631],GO:0003824; GO:0003924; GO:0005654; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0006886; GO:0006913; GO:0006914; GO:0007005; GO:0008092; GO:0016192; GO:0016740; GO:0016787; GO:0022414; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0055086; GO:0060090; GO:0065003; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; GTPase activity; nucleoplasm; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; intracellular protein transport; nucleocytoplasmic transport; autophagy; mitochondrion organization; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; hydrolase activity; reproductive process; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; cell motility; nucleobase-containing small molecule metabolic process; molecular adaptor activity; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_12660,FUN_033308-T2,Peve_00026897,,apul_peve,55.856,,,,,,,,,,,,,,,,,
OG_12661,FUN_033309-T1,Peve_00026895,,apul_peve,74.433,FUN_033309-T1,Q8NB78,,,,,48.5,787.0,1e-220,768.1,sp|Q8NB78|KDM1B_HUMAN Lysine-specific histone demethylase 2 OS=Homo sapiens OX=9606 GN=KDM1B PE=1 SV=3,,,,,,
OG_12662,FUN_033313-T1,Peve_00041565,,apul_peve,47.619,,,,,,,,,,,,,,,,,
OG_12663,FUN_033318-T1,Peve_00038207,,apul_peve,55.294,,,,,,,,,,,,,,,,,
OG_12664,FUN_033489-T1,Peve_00010671,,apul_peve,86.7655,,,,,,,,,,,,,,,,,
OG_12665,FUN_033491-T1,Peve_00013374,,apul_peve,65.333,FUN_033491-T1,G3MZR2,FUT7_BOVIN,,"Alpha-(1,3)-fucosyltransferase 7 (bfut7) (EC 2.4.1.-) (Fucosyltransferase 7) (Fucosyltransferase VII) (Fuc-TVII) (FucT-VII) (Galactoside 3-L-fucosyltransferase) (Selectin ligand synthase)",Bos taurus (Bovine),35.2,267.0,3.8e-37,157.1,"sp|G3MZR2|FUT7_BOVIN Alpha-(1,3)-fucosyltransferase 7 OS=Bos taurus OX=9913 GN=FUT7 PE=1 SV=2",GO:0001807; GO:0002523; GO:0006486; GO:0006954; GO:0016020; GO:0017083; GO:0022407; GO:0022409; GO:0036065; GO:0045785; GO:0046626; GO:0046920; GO:0097022; GO:1902624; GO:1903238; GO:1904996,fucosylation [GO:0036065]; inflammatory response [GO:0006954]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte migration into lymph node [GO:0097022]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of neutrophil migration [GO:1902624]; protein glycosylation [GO:0006486]; regulation of cell-cell adhesion [GO:0022407]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of type IV hypersensitivity [GO:0001807],membrane [GO:0016020],4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity [GO:0017083]; alpha-(1->3)-fucosyltransferase activity [GO:0046920],GO:0002376; GO:0003824; GO:0006486; GO:0006954; GO:0016740; GO:0048870,immune system process; catalytic activity; protein glycosylation; inflammatory response; transferase activity; cell motility
OG_12666,FUN_033495-T1,Peve_00014562,,apul_peve,40.0645,,,,,,,,,,,,,,,,,
OG_12667,FUN_033507-T1,Peve_00009169,,apul_peve,60.849,FUN_033507-T1,P27012,,,,,32.4,222.0,4.3e-25,116.3,sp|P27012|SCRY4_ENTDO S-crystallin 4 OS=Enteroctopus dofleini OX=267067 PE=2 SV=1,,,,,,
OG_12668,FUN_033514-T1,Peve_00016598,,apul_peve,68.15199999999999,,,,,,,,,,,,,,,,,
OG_12669,FUN_033549-T1,Peve_00007838,,apul_peve,78.542,FUN_033549-T1,Q4R9C4,,,,,24.9,321.0,8.7e-14,80.5,sp|Q4R9C4|G2E3_MACFA G2/M phase-specific E3 ubiquitin-protein ligase OS=Macaca fascicularis OX=9541 GN=G2E3 PE=2 SV=2,,,,,,
OG_12670,FUN_033551-T1,Peve_00032756,,apul_peve,70.517,,,,,,,,,,,,,,,,,
OG_12671,FUN_033566-T1,Peve_00012923,,apul_peve,58.007,,,,,,,,,,,,,,,,,
OG_12672,FUN_033621-T1,Peve_00019490,,apul_peve,61.204,,,,,,,,,,,,,,,,,
OG_12673,FUN_033622-T1,Peve_00009307,,apul_peve,72.683,,,,,,,,,,,,,,,,,
OG_12674,FUN_033623-T1,Peve_00019020,,apul_peve,80.941,,,,,,,,,,,,,,,,,
OG_12675,FUN_033673-T1,Peve_00006806,,apul_peve,66.013,FUN_033673-T1,O80800,,,,,51.5,97.0,2.3e-17,90.1,"sp|O80800|ACPM2_ARATH Acyl carrier protein 2, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=MTACP2 PE=1 SV=1",,,,,,
OG_12676,FUN_033686-T1,Peve_00031299,,apul_peve,55.897,FUN_033686-T1,Q5GFL6,VWA2_HUMAN,,von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen) (AMACO) (Colon cancer secreted protein 2) (CCSP-2),Homo sapiens (Human),30.8,143.0,1.4e-10,68.2,sp|Q5GFL6|VWA2_HUMAN von Willebrand factor A domain-containing protein 2 OS=Homo sapiens OX=9606 GN=VWA2 PE=1 SV=1,GO:0005509; GO:0005604; GO:0005615; GO:0007161; GO:0042802; GO:0046626; GO:0070062,calcium-independent cell-matrix adhesion [GO:0007161]; regulation of insulin receptor signaling pathway [GO:0046626],basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; identical protein binding [GO:0042802],GO:0005615; GO:0007155; GO:0030312; GO:0031012; GO:0043226,extracellular space; cell adhesion; external encapsulating structure; extracellular matrix; organelle
OG_12677,FUN_033705-T1,Peve_00028389,,apul_peve,49.038,,,,,,,,,,,,,,,,,
OG_12678,FUN_033722-T1,Peve_00027595,,apul_peve,68.788,FUN_033722-T1,Q4G0X4,KCD21_HUMAN,,BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21),Homo sapiens (Human),44.8,116.0,9.7e-19,95.9,sp|Q4G0X4|KCD21_HUMAN BTB/POZ domain-containing protein KCTD21 OS=Homo sapiens OX=9606 GN=KCTD21 PE=1 SV=1,GO:0006511; GO:0016567; GO:0042802; GO:0042826; GO:0045879; GO:0051260; GO:0097602,negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],,cullin family protein binding [GO:0097602]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802],GO:0065003,protein-containing complex assembly
OG_12679,FUN_033723-T1,Peve_00027611,,apul_peve,67.262,FUN_033723-T1,Q4G0X4,KCD21_HUMAN,,BTB/POZ domain-containing protein KCTD21 (KCASH2 protein) (Potassium channel tetramerization domain-containing protein 21),Homo sapiens (Human),51.9,108.0,8.8e-20,99.4,sp|Q4G0X4|KCD21_HUMAN BTB/POZ domain-containing protein KCTD21 OS=Homo sapiens OX=9606 GN=KCTD21 PE=1 SV=1,GO:0006511; GO:0016567; GO:0042802; GO:0042826; GO:0045879; GO:0051260; GO:0097602,negative regulation of smoothened signaling pathway [GO:0045879]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],,cullin family protein binding [GO:0097602]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802],GO:0065003,protein-containing complex assembly
OG_12680,FUN_033765-T1,Peve_00033798,,apul_peve,68.798,FUN_033765-T1,O15439,MRP4_HUMAN,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4),Homo sapiens (Human),35.1,1315.0,9.800000000000001e-213,742.3,sp|O15439|MRP4_HUMAN ATP-binding cassette sub-family C member 4 OS=Homo sapiens OX=9606 GN=ABCC4 PE=1 SV=3,GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0043231; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003013; GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016192; GO:0016491; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,circulatory system process; catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; vesicle-mediated transport; oxidoreductase activity; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_12681,FUN_033772-T1,Peve_00027656,,apul_peve,67.969,FUN_033772-T1,O60669,MOT2_HUMAN,,Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7),Homo sapiens (Human),27.1,432.0,4.7000000000000005e-38,160.6,sp|O60669|MOT2_HUMAN Monocarboxylate transporter 2 OS=Homo sapiens OX=9606 GN=SLC16A7 PE=1 SV=2,GO:0005477; GO:0005654; GO:0005829; GO:0005886; GO:0015129; GO:0015293; GO:0016323; GO:0035873; GO:0035879; GO:0042802; GO:0050833; GO:0098685; GO:0098686; GO:0098688; GO:0098839; GO:0098978; GO:0150104; GO:1901475,lactate transmembrane transport [GO:0035873]; plasma membrane lactate transport [GO:0035879]; pyruvate transmembrane transport [GO:1901475]; transport across blood-brain barrier [GO:0150104],basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleoplasm [GO:0005654]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; Schaffer collateral - CA1 synapse [GO:0098685],identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; pyruvate secondary active transmembrane transporter activity [GO:0005477]; pyruvate transmembrane transporter activity [GO:0050833]; symporter activity [GO:0015293],GO:0003013; GO:0005215; GO:0005654; GO:0005829; GO:0005886; GO:0055085,circulatory system process; transporter activity; nucleoplasm; cytosol; plasma membrane; transmembrane transport
OG_12682,FUN_033779-T1,Peve_00018803,,apul_peve,84.592,FUN_033779-T1,P54145,,,,,49.0,420.0,2.1e-100,367.5,sp|P54145|AMT1_CAEEL Putative ammonium transporter 1 OS=Caenorhabditis elegans OX=6239 GN=amt-1 PE=3 SV=1,,,,,,
OG_12683,FUN_033789-T1,Peve_00014253,,apul_peve,55.686,FUN_033789-T1,Q4PZA2,ECE1_MOUSE,,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),Mus musculus (Mouse),36.0,728.0,1.9e-123,444.9,sp|Q4PZA2|ECE1_MOUSE Endothelin-converting enzyme 1 OS=Mus musculus OX=10090 GN=Ece1 PE=1 SV=1,GO:0001921; GO:0004222; GO:0005768; GO:0005794; GO:0007411; GO:0008270; GO:0009897; GO:0009986; GO:0010467; GO:0010814; GO:0010815; GO:0010816; GO:0016486; GO:0031175; GO:0033093; GO:0034959; GO:0035050; GO:0042733; GO:0042803; GO:0043583; GO:0048471; GO:0060037; GO:0060385; GO:0097492; GO:1902287,axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; bradykinin catabolic process [GO:0010815]; calcitonin catabolic process [GO:0010816]; ear development [GO:0043583]; embryonic digit morphogenesis [GO:0042733]; embryonic heart tube development [GO:0035050]; endothelin maturation [GO:0034959]; gene expression [GO:0010467]; neuron projection development [GO:0031175]; peptide hormone processing [GO:0016486]; pharyngeal system development [GO:0060037]; positive regulation of receptor recycling [GO:0001921]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; substance P catabolic process [GO:0010814]; sympathetic neuron axon guidance [GO:0097492],cell surface [GO:0009986]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; Weibel-Palade body [GO:0033093],metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005794; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; endosome; Golgi apparatus; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_12684,FUN_033807-T1,Peve_00033384,,apul_peve,84.675,FUN_033807-T1,A0JN95,,,,,45.3,353.0,1.7999999999999998e-69,264.6,sp|A0JN95|MET15_BOVIN 12S rRNA N(4)-cytidine methyltransferase METTL15 OS=Bos taurus OX=9913 GN=METTL15 PE=2 SV=1,,,,,,
OG_12685,FUN_033826-T1,Peve_00028772,,apul_peve,52.778,FUN_033826-T1,Q6L8S8,,,,,32.4,327.0,2.5e-52,208.4,"sp|Q6L8S8|B4GN3_MOUSE Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Mus musculus OX=10090 GN=B4galnt3 PE=2 SV=1",,,,,,
OG_12686,FUN_033850-T1,Peve_00039881,,apul_peve,70.047,FUN_033850-T1,O60462,NRP2_HUMAN,,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),Homo sapiens (Human),28.6,322.0,2.8e-31,137.9,sp|O60462|NRP2_HUMAN Neuropilin-2 OS=Homo sapiens OX=9606 GN=NRP2 PE=1 SV=3,GO:0001525; GO:0001938; GO:0002116; GO:0003148; GO:0005021; GO:0005576; GO:0005886; GO:0007155; GO:0007411; GO:0008201; GO:0010595; GO:0016020; GO:0017154; GO:0019838; GO:0019955; GO:0021612; GO:0021637; GO:0021649; GO:0021675; GO:0021785; GO:0021828; GO:0030424; GO:0036486; GO:0038023; GO:0042802; GO:0045211; GO:0046872; GO:0048846; GO:0050919; GO:0061549; GO:0061551; GO:0071526; GO:0097374; GO:0097490; GO:0097491; GO:0098978; GO:0099175; GO:1901166; GO:1903375; GO:1904835; GO:1990830,angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; semaphorin receptor complex [GO:0002116],cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0003824; GO:0005576; GO:0005886; GO:0007155; GO:0016740; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; extracellular region; plasma membrane; cell adhesion; transferase activity; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_12687,FUN_033858-T1,Peve_00043299,,apul_peve,45.5585,FUN_033858-T1,Q6NZF1,ZC11A_MOUSE,,Zinc finger CCCH domain-containing protein 11A,Mus musculus (Mouse),44.2,154.0,2.7e-26,122.5,sp|Q6NZF1|ZC11A_MOUSE Zinc finger CCCH domain-containing protein 11A OS=Mus musculus OX=10090 GN=Zc3h11a PE=1 SV=1,GO:0008270; GO:0016607; GO:0016973,poly(A)+ mRNA export from nucleus [GO:0016973],nuclear speck [GO:0016607],zinc ion binding [GO:0008270],GO:0006913; GO:0043226,nucleocytoplasmic transport; organelle
OG_12688,FUN_033888-T1,Peve_00043322,,apul_peve,49.035,,,,,,,,,,,,,,,,,
OG_12689,FUN_033895-T1,Peve_00020591,,apul_peve,62.025,,,,,,,,,,,,,,,,,
OG_12690,FUN_033912-T2,Peve_00032119,,apul_peve,58.605,FUN_033912-T2,Q4R899,,,,,50.0,108.0,6.4e-26,120.6,sp|Q4R899|LMTD1_MACFA Lamin tail domain-containing protein 1 OS=Macaca fascicularis OX=9541 GN=LMNTD1 PE=2 SV=1,,,,,,
OG_12691,FUN_033916-T1,Peve_00037248,,apul_peve,36.047,,,,,,,,,,,,,,,,,
OG_12692,FUN_033930-T1,Peve_00025008,,apul_peve,53.889,,,,,,,,,,,,,,,,,
OG_12693,FUN_033940-T1,Peve_00020993,,apul_peve,64.286,FUN_033940-T1,Q25158,,,,,28.1,302.0,1.4e-21,105.5,sp|Q25158|OPSC2_HEMSA Compound eye opsin BCRH2 OS=Hemigrapsus sanguineus OX=40176 PE=2 SV=1,,,,,,
OG_12694,FUN_033956-T1,Peve_00032108,,apul_peve,45.6015,,,,,,,,,,,,,,,,,
OG_12695,FUN_033961-T1,Peve_00028768,,apul_peve,35.714,,,,,,,,,,,,,,,,,
OG_12696,FUN_033972-T1,Peve_00015227,,apul_peve,34.239,,,,,,,,,,,,,,,,,
OG_12697,FUN_033984-T1,Peve_00045147,,apul_peve,53.6625,,,,,,,,,,,,,,,,,
OG_12698,FUN_033987-T1,Peve_00004910,,apul_peve,75.947,FUN_033987-T1,D4A770,,,,,40.6,547.0,4.7e-108,393.3,sp|D4A770|FERY3_RAT FERRY endosomal RAB5 effector complex subunit 3 OS=Rattus norvegicus OX=10116 GN=Ferry3 PE=1 SV=1,,,,,,
OG_12699,FUN_033993-T1,Peve_00004926,,apul_peve,60.784,FUN_033993-T1,Q93127,,,,,20.9,339.0,4e-06,53.9,sp|Q93127|GPR18_AMPAM Probable G-protein coupled receptor No18 OS=Amphibalanus amphitrite OX=1232801 PE=3 SV=1,,,,,,
OG_12700,FUN_034001-T1,Peve_00011028,,apul_peve,68.894,,,,,,,,,,,,,,,,,
OG_12701,FUN_034002-T1,Peve_00011026,,apul_peve,56.65,,,,,,,,,,,,,,,,,
OG_12702,FUN_034020-T1,Peve_00034961,,apul_peve,66.819,FUN_034020-T1,Q8C726,,,,,27.7,177.0,2.1e-09,66.2,sp|Q8C726|BTBD9_MOUSE BTB/POZ domain-containing protein 9 OS=Mus musculus OX=10090 GN=Btbd9 PE=1 SV=1,,,,,,
OG_12703,FUN_034023-T1,Peve_00034134,,apul_peve,55.204,FUN_034023-T1,Q9DCK3,,,,,35.8,229.0,1.4e-32,141.4,sp|Q9DCK3|TSN4_MOUSE Tetraspanin-4 OS=Mus musculus OX=10090 GN=Tspan4 PE=1 SV=1,,,,,,
OG_12704,FUN_034044-T1,Peve_00026110,,apul_peve,77.366,,,,,,,,,,,,,,,,,
OG_12705,FUN_034046-T1,Peve_00038326,,apul_peve,38.116,FUN_034046-T1,Q6DCQ6,,,,,26.9,234.0,2.2e-11,71.6,sp|Q6DCQ6|VWA2_XENLA von Willebrand factor A domain-containing protein 2 OS=Xenopus laevis OX=8355 GN=vwa2 PE=2 SV=1,,,,,,
OG_12706,FUN_034068-T1,Peve_00021715,,apul_peve,31.25,,,,,,,,,,,,,,,,,
OG_12707,FUN_034074-T1,Peve_00031928,,apul_peve,66.055,FUN_034074-T1,P00708,,,,,49.5,107.0,7.6e-22,104.8,sp|P00708|LYSC_COLLI Lysozyme C OS=Columba livia OX=8932 GN=LYZ PE=1 SV=1,,,,,,
OG_12708,FUN_034075-T1,Peve_00023261,,apul_peve,49.413,,,,,,,,,,,,,,,,,
OG_12709,FUN_034076-T1,Peve_00023260,,apul_peve,41.737,,,,,,,,,,,,,,,,,
OG_12710,FUN_034079-T1,Peve_00023258,,apul_peve,43.702,,,,,,,,,,,,,,,,,
OG_12711,FUN_034087-T1,Peve_00037075,,apul_peve,82.543,FUN_034087-T1,Q2S1V4,,,,,52.1,491.0,1.6e-142,507.7,sp|Q2S1V4|TNAA_SALRD Tryptophanase OS=Salinibacter ruber (strain DSM 13855 / M31) OX=309807 GN=tnaA PE=3 SV=1,,,,,,
OG_12712,FUN_034100-T1,Peve_00042344,,apul_peve,85.0,FUN_034100-T1,P50429,,,,,43.1,504.0,2.7999999999999998e-112,408.3,sp|P50429|ARSB_MOUSE Arylsulfatase B OS=Mus musculus OX=10090 GN=Arsb PE=1 SV=3,,,,,,
OG_12713,FUN_034115-T1,Peve_00034858,,apul_peve,61.0265,FUN_034115-T1,Q96AD5,PLPL2_HUMAN,,Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Calcium-independent phospholipase A2-zeta) (iPLA2-zeta) (EC 3.1.1.4) (Desnutrin) (Pigment epithelium-derived factor receptor) (PEDF-R) (TTS2.2) (Transport-secretion protein 2) (TTS2),Homo sapiens (Human),47.4,247.0,1.5e-57,225.3,sp|Q96AD5|PLPL2_HUMAN Patatin-like phospholipase domain-containing protein 2 OS=Homo sapiens OX=9606 GN=PNPLA2 PE=1 SV=1,GO:0004465; GO:0004623; GO:0004806; GO:0005654; GO:0005737; GO:0005788; GO:0005789; GO:0005811; GO:0005829; GO:0005886; GO:0006651; GO:0007603; GO:0010891; GO:0010898; GO:0016020; GO:0016411; GO:0019433; GO:0019915; GO:0035356; GO:0036155; GO:0050253; GO:0051264; GO:0051265; GO:0055088; GO:0160077; GO:1905691,"acylglycerol acyl-chain remodeling [GO:0036155]; diacylglycerol biosynthetic process [GO:0006651]; intracellular triglyceride homeostasis [GO:0035356]; lipid droplet disassembly [GO:1905691]; lipid droplet fusion [GO:0160077]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of triglyceride storage [GO:0010891]; phototransduction, visible light [GO:0007603]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],acylglycerol O-acyltransferase activity [GO:0016411]; diolein transacylation activity [GO:0051265]; lipoprotein lipase activity [GO:0004465]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005654; GO:0005811; GO:0005829; GO:0005886; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; nucleoplasm; lipid droplet; cytosol; plasma membrane; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_12714,FUN_034140-T1,Peve_00018764,,apul_peve,40.198,,,,,,,,,,,,,,,,,
OG_12715,FUN_034148-T1,Peve_00039355,,apul_peve,44.366,,,,,,,,,,,,,,,,,
OG_12716,FUN_034151-T1,Peve_00018773,,apul_peve,66.127,FUN_034151-T1,Q0P5X1,,,,,25.9,710.0,9.099999999999998e-24,114.8,sp|Q0P5X1|LRIQ1_MOUSE Leucine-rich repeat- and IQ domain-containing protein 1 OS=Mus musculus OX=10090 GN=Lrriq1 PE=2 SV=2,,,,,,
OG_12717,FUN_034164-T1,Peve_00028319,,apul_peve,69.578,FUN_034164-T1,Q9Z2L6,,,,,31.4,462.0,1.8e-52,208.4,sp|Q9Z2L6|MINP1_MOUSE Multiple inositol polyphosphate phosphatase 1 OS=Mus musculus OX=10090 GN=Minpp1 PE=1 SV=3,,,,,,
OG_12718,FUN_034176-T1,Peve_00019099,,apul_peve,45.192,,,,,,,,,,,,,,,,,
OG_12719,FUN_034180-T1,Peve_00019100,,apul_peve,67.257,FUN_034180-T1,P55115,,,,,40.5,215.0,8.7e-34,146.0,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_12720,FUN_034190-T1,Peve_00019095,,apul_peve,50.316,,,,,,,,,,,,,,,,,
OG_12721,FUN_034202-T1,Peve_00015722,,apul_peve,44.274,,,,,,,,,,,,,,,,,
OG_12722,FUN_034203-T2,Peve_00027542,,apul_peve,71.5995,,,,,,,,,,,,,,,,,
OG_12723,FUN_034206-T1,Peve_00014563,,apul_peve,40.541,,,,,,,,,,,,,,,,,
OG_12724,FUN_034221-T1,Peve_00027526,,apul_peve,52.041,,,,,,,,,,,,,,,,,
OG_12725,FUN_034228-T1,Peve_00034342,,apul_peve,40.115,,,,,,,,,,,,,,,,,
OG_12726,FUN_034239-T1,Peve_00003147,,apul_peve,50.9805,,,,,,,,,,,,,,,,,
OG_12727,FUN_034250-T1,Peve_00009526,,apul_peve,40.942,,,,,,,,,,,,,,,,,
OG_12728,FUN_034253-T2,Peve_00031517,,apul_peve,48.8715,FUN_034253-T2,Q04589,FGFR1_RAT,,Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331),Rattus norvegicus (Rat),26.7,472.0,1.3e-26,122.9,sp|Q04589|FGFR1_RAT Fibroblast growth factor receptor 1 OS=Rattus norvegicus OX=10116 GN=Fgfr1 PE=1 SV=1,GO:0000122; GO:0001525; GO:0001657; GO:0001701; GO:0001759; GO:0001837; GO:0002053; GO:0002062; GO:0002931; GO:0004713; GO:0005007; GO:0005102; GO:0005524; GO:0005634; GO:0005829; GO:0005886; GO:0007420; GO:0007435; GO:0007565; GO:0007605; GO:0008201; GO:0008283; GO:0008284; GO:0008543; GO:0010463; GO:0010467; GO:0010468; GO:0010629; GO:0010763; GO:0010966; GO:0010976; GO:0017134; GO:0019827; GO:0021769; GO:0021827; GO:0021847; GO:0021954; GO:0022028; GO:0030031; GO:0030324; GO:0030326; GO:0030901; GO:0031175; GO:0031410; GO:0031667; GO:0035607; GO:0042127; GO:0042169; GO:0042472; GO:0042473; GO:0042474; GO:0042802; GO:0042803; GO:0043235; GO:0043410; GO:0043536; GO:0043583; GO:0044344; GO:0044877; GO:0045597; GO:0045666; GO:0045668; GO:0045787; GO:0045944; GO:0046777; GO:0048339; GO:0048378; GO:0048469; GO:0048471; GO:0048514; GO:0048699; GO:0048762; GO:0048863; GO:0050678; GO:0050839; GO:0051174; GO:0051897; GO:0055074; GO:0060038; GO:0060045; GO:0060117; GO:0060445; GO:0060484; GO:0060665; GO:0070640; GO:0071222; GO:0071344; GO:0071420; GO:0071529; GO:0072089; GO:0072091; GO:0090080; GO:0090272; GO:0090722; GO:0098794; GO:0098978; GO:0099151; GO:1903465; GO:1904383; GO:1905564; GO:1990090; GO:2000491; GO:2000648; GO:2000830; GO:2001028; GO:2001239,angiogenesis [GO:0001525]; auditory receptor cell development [GO:0060117]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium ion homeostasis [GO:0055074]; cardiac muscle cell proliferation [GO:0060038]; cell maturation [GO:0048469]; cell population proliferation [GO:0008283]; cell projection assembly [GO:0030031]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to histamine [GO:0071420]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nerve growth factor stimulus [GO:1990090]; cementum mineralization [GO:0071529]; central nervous system neuron development [GO:0021954]; chondrocyte differentiation [GO:0002062]; diphosphate metabolic process [GO:0071344]; ear development [GO:0043583]; embryonic limb morphogenesis [GO:0030326]; epithelial to mesenchymal transition [GO:0001837]; female pregnancy [GO:0007565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; gene expression [GO:0010467]; generation of neurons [GO:0048699]; in utero embryonic development [GO:0001701]; inner ear morphogenesis [GO:0042472]; lung development [GO:0030324]; lung-associated mesenchyme development [GO:0060484]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation [GO:0010463]; midbrain development [GO:0030901]; middle ear morphogenesis [GO:0042474]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron projection development [GO:0031175]; orbitofrontal cortex development [GO:0021769]; organ induction [GO:0001759]; outer ear morphogenesis [GO:0042473]; paraxial mesoderm development [GO:0048339]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic cell cycle DNA replication [GO:1903465]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postnatal olfactory bulb interneuron migration [GO:0021827]; protein autophosphorylation [GO:0046777]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001239]; regulation of gene expression [GO:0010468]; regulation of lateral mesodermal cell fate specification [GO:0048378]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; regulation of postsynaptic density assembly [GO:0099151]; regulation of stem cell proliferation [GO:0072091]; response to ischemia [GO:0002931]; response to nutrient levels [GO:0031667]; response to sodium phosphate [GO:1904383]; salivary gland morphogenesis [GO:0007435]; sensory perception of sound [GO:0007605]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]; ureteric bud development [GO:0001657]; ventricular zone neuroblast division [GO:0021847]; vitamin D3 metabolic process [GO:0070640],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; receptor complex [GO:0043235],ATP binding [GO:0005524]; cell adhesion molecule binding [GO:0050839]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor activity [GO:0005007]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; receptor-receptor interaction [GO:0090722]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006355; GO:0006629; GO:0016740; GO:0022414; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060089; GO:0140096,"catalytic activity; nucleus; cytosol; plasma membrane; regulation of DNA-templated transcription; lipid metabolic process; transferase activity; reproductive process; signaling; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; nervous system process; molecular transducer activity; catalytic activity, acting on a protein"
OG_12729,FUN_034256-T1,Peve_00011314,,apul_peve,30.07,,,,,,,,,,,,,,,,,
OG_12730,FUN_034266-T1,Peve_00044769,,apul_peve,49.149,,,,,,,,,,,,,,,,,
OG_12731,FUN_034274-T1,Peve_00026011,,apul_peve,45.0835,FUN_034274-T1,Q9P1Y6,,,,,46.8,77.0,6e-10,68.2,sp|Q9P1Y6|PHRF1_HUMAN PHD and RING finger domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PHRF1 PE=1 SV=3,,,,,,
OG_12732,FUN_034280-T1,Peve_00012563,,apul_peve,75.904,FUN_034280-T1,Q7SYE0,,,,,56.1,212.0,4.1e-62,240.0,sp|Q7SYE0|ATG13_DANRE Autophagy-related protein 13 OS=Danio rerio OX=7955 GN=atg13 PE=2 SV=1,,,,,,
OG_12733,FUN_034288-T1,Peve_00013960,,apul_peve,36.799,FUN_034288-T1,Q6VMQ6,MCAF1_HUMAN,,Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621),Homo sapiens (Human),54.5,99.0,1.3e-19,99.8,sp|Q6VMQ6|MCAF1_HUMAN Activating transcription factor 7-interacting protein 1 OS=Homo sapiens OX=9606 GN=ATF7IP PE=1 SV=3,GO:0000122; GO:0003712; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006346; GO:0006355; GO:0016604; GO:0016887; GO:0045892; GO:0045893,DNA methylation-dependent constitutive heterochromatin formation [GO:0006346]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355],cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],ATP hydrolysis activity [GO:0016887]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0016787; GO:0043226; GO:0060090; GO:0140110,catalytic activity; nucleus; nucleoplasm; cytosol; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; organelle; molecular adaptor activity; transcription regulator activity
OG_12734,FUN_034304-T1,Peve_00027559,,apul_peve,79.449,FUN_034304-T1,Q6ICG6,K0930_HUMAN,,Uncharacterized protein KIAA0930,Homo sapiens (Human),42.2,379.0,2.1e-70,267.7,sp|Q6ICG6|K0930_HUMAN Uncharacterized protein KIAA0930 OS=Homo sapiens OX=9606 GN=KIAA0930 PE=1 SV=1,,,,,,
OG_12735,FUN_034306-T1,Peve_00011304,,apul_peve,77.83,,,,,,,,,,,,,,,,,
OG_12736,FUN_034315-T1,Peve_00016717,,apul_peve,64.49,FUN_034315-T1,Q8NI77,KI18A_HUMAN,,Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A),Homo sapiens (Human),44.0,659.0,7.4e-141,503.1,sp|Q8NI77|KI18A_HUMAN Kinesin-like protein KIF18A OS=Homo sapiens OX=9606 GN=KIF18A PE=1 SV=2,GO:0000070; GO:0000776; GO:0001726; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005828; GO:0005829; GO:0005871; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023,cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520],caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule cytoskeleton [GO:0015630]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726],actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463],GO:0003774; GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0007018; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0140013; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; microtubule-based movement; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; organelle; anatomical structure development; meiotic nuclear division; ATP-dependent activity
OG_12737,FUN_034329-T1,Peve_00019142,,apul_peve,38.298,,,,,,,,,,,,,,,,,
OG_12738,FUN_034330-T1,Peve_00019137,,apul_peve,34.8965,,,,,,,,,,,,,,,,,
OG_12739,FUN_034345-T1,Peve_00017476,,apul_peve,56.593,FUN_034345-T1,Q15485,FCN2_HUMAN,,Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35),Homo sapiens (Human),53.9,217.0,6e-64,246.1,sp|Q15485|FCN2_HUMAN Ficolin-2 OS=Homo sapiens OX=9606 GN=FCN2 PE=1 SV=2,GO:0001867; GO:0002752; GO:0003823; GO:0005102; GO:0005576; GO:0005581; GO:0005615; GO:0006508; GO:0008228; GO:0009897; GO:0043394; GO:0043654; GO:0046872; GO:0048306; GO:0050829; GO:0050830; GO:0062023; GO:0070062; GO:0072562; GO:0097367; GO:1903028; GO:1905370; GO:2001065,"cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]",blood microparticle [GO:0072562]; collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370],antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005576; GO:0005615; GO:0043226; GO:0098542,immune system process; extracellular region; extracellular space; organelle; defense response to other organism
OG_12740,FUN_034347-T1,Peve_00030809,,apul_peve,47.2355,,,,,,,,,,,,,,,,,
OG_12741,FUN_034357-T1,Peve_00038244,,apul_peve,77.976,FUN_034357-T1,O46669,,,,,33.8,136.0,1.5e-15,84.3,sp|O46669|SCNAA_CANLF Sodium channel protein type 10 subunit alpha OS=Canis lupus familiaris OX=9615 GN=SCN10A PE=2 SV=1,,,,,,
OG_12742,FUN_034358-T1,Peve_00026452,,apul_peve,92.053,FUN_034358-T1,A3RL54,SL9C1_STRPU,,Sperm-specific sodium:proton exchanger (Solute carrier family 9 member C1) (Voltage-gated Na(+)/H(+) exchanger),Strongylocentrotus purpuratus (Purple sea urchin),58.3,533.0,3.1e-165,583.2,sp|A3RL54|SL9C1_STRPU Sperm-specific sodium:proton exchanger OS=Strongylocentrotus purpuratus OX=7668 GN=SLC9C1 PE=1 SV=1,GO:0005886; GO:0007338; GO:0015385; GO:0015386; GO:0030552; GO:0030553; GO:0036126; GO:0042803; GO:0051453; GO:0061827; GO:0071805; GO:0098719,potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; single fertilization [GO:0007338]; sodium ion import across plasma membrane [GO:0098719],plasma membrane [GO:0005886]; sperm flagellum [GO:0036126]; sperm head [GO:0061827],cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; potassium:proton antiporter activity [GO:0015386]; protein homodimerization activity [GO:0042803]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005886; GO:0005929; GO:0022414; GO:0043226; GO:0055085,transporter activity; plasma membrane; cilium; reproductive process; organelle; transmembrane transport
OG_12743,FUN_034360-T1,Peve_00036162,,apul_peve,80.0,FUN_034360-T1,Q3SZW1,TSSK1_BOVIN,,Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1),Bos taurus (Bovine),49.5,307.0,1.1e-69,265.0,sp|Q3SZW1|TSSK1_BOVIN Testis-specific serine/threonine-protein kinase 1 OS=Bos taurus OX=9913 GN=TSSK1B PE=2 SV=1,GO:0000226; GO:0000287; GO:0001669; GO:0004674; GO:0005524; GO:0005737; GO:0007286; GO:0031514; GO:0035556; GO:0050321; GO:0106310,intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; motile cilium [GO:0031514],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005929; GO:0007010; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cilium; cytoskeleton organization; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_12744,FUN_034364-T1,Peve_00040130,,apul_peve,84.685,,,,,,,,,,,,,,,,,
OG_12745,FUN_034411-T1,Peve_00013277,,apul_peve,87.766,,,,,,,,,,,,,,,,,
OG_12746,FUN_034417-T1,Peve_00012442,,apul_peve,78.0815,,,,,,,,,,,,,,,,,
OG_12747,FUN_034439-T1,Peve_00044233,,apul_peve,73.077,,,,,,,,,,,,,,,,,
OG_12748,FUN_034484-T1,Peve_00035631,,apul_peve,91.339,,,,,,,,,,,,,,,,,
OG_12749,FUN_034594-T1,Peve_00038718,,apul_peve,56.796,FUN_034594-T1,Q21540,,,,,25.6,164.0,2.2e-08,60.8,sp|Q21540|CUT6_CAEEL Cuticlin-6 OS=Caenorhabditis elegans OX=6239 GN=cut-6 PE=1 SV=2,,,,,,
OG_12750,FUN_034609-T1,Peve_00041660,,apul_peve,65.937,,,,,,,,,,,,,,,,,
OG_12751,FUN_034621-T1,Peve_00008350,,apul_peve,66.667,,,,,,,,,,,,,,,,,
OG_12752,FUN_034624-T1,Peve_00026908,,apul_peve,72.832,,,,,,,,,,,,,,,,,
OG_12753,FUN_034640-T1,Peve_00017171,,apul_peve,32.143,,,,,,,,,,,,,,,,,
OG_12754,FUN_034647-T1,Peve_00010712,,apul_peve,51.351,,,,,,,,,,,,,,,,,
OG_12755,FUN_034650-T1,Peve_00029126,,apul_peve,38.806,,,,,,,,,,,,,,,,,
OG_12756,FUN_034652-T1,Peve_00016415,,apul_peve,83.425,,,,,,,,,,,,,,,,,
OG_12757,FUN_034654-T1,Peve_00008854,,apul_peve,93.333,,,,,,,,,,,,,,,,,
OG_12758,FUN_034660-T1,Peve_00036584,,apul_peve,62.054,FUN_034660-T1,Q8N6F8,MET27_HUMAN,,Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein),Homo sapiens (Human),35.3,173.0,1.8e-16,87.8,sp|Q8N6F8|MET27_HUMAN Methyltransferase-like protein 27 OS=Homo sapiens OX=9606 GN=METTL27 PE=1 SV=2,,,,,,
OG_12759,FUN_034661-T1,Peve_00008362,,apul_peve,53.623,,,,,,,,,,,,,,,,,
OG_12760,FUN_034677-T1,Peve_00008363,,apul_peve,42.202,,,,,,,,,,,,,,,,,
OG_12761,FUN_034678-T1,Peve_00039484,,apul_peve,37.079,,,,,,,,,,,,,,,,,
OG_12762,FUN_034688-T1,Peve_00036124,,apul_peve,89.49100000000001,,,,,,,,,,,,,,,,,
OG_12763,FUN_034694-T1,Peve_00011840,,apul_peve,44.395,,,,,,,,,,,,,,,,,
OG_12764,FUN_034719-T2,Peve_00015779,,apul_peve,64.583,,,,,,,,,,,,,,,,,
OG_12765,FUN_034811-T1,Peve_00003623,,apul_peve,79.452,FUN_034811-T1,O75191,XYLB_HUMAN,,Xylulose kinase (Xylulokinase) (EC 2.7.1.17),Homo sapiens (Human),60.8,439.0,3.4000000000000004e-157,556.2,sp|O75191|XYLB_HUMAN Xylulose kinase OS=Homo sapiens OX=9606 GN=XYLB PE=1 SV=3,GO:0004856; GO:0005524; GO:0005829; GO:0005975; GO:0005997; GO:0005998; GO:0006091; GO:0019640; GO:0042732,carbohydrate metabolic process [GO:0005975]; D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; D-xylose metabolic process [GO:0042732]; generation of precursor metabolites and energy [GO:0006091]; xylulose catabolic process [GO:0005998]; xylulose metabolic process [GO:0005997],cytosol [GO:0005829],ATP binding [GO:0005524]; D-xylulokinase activity [GO:0004856],GO:0003824; GO:0005829; GO:0005975; GO:0006091; GO:0016740; GO:1901135,catalytic activity; cytosol; carbohydrate metabolic process; generation of precursor metabolites and energy; transferase activity; carbohydrate derivative metabolic process
OG_12766,FUN_034814-T1,Peve_00003619,,apul_peve,79.381,FUN_034814-T1,Q6TMK8,,,,,52.8,142.0,2.5e-32,140.2,sp|Q6TMK8|PLD3B_CRIGR PRELI domain containing protein 3B OS=Cricetulus griseus OX=10029 GN=PRELID3B PE=2 SV=1,,,,,,
OG_12767,FUN_034817-T1,Peve_00013635,,apul_peve,58.333,FUN_034817-T1,Q5XKA2,,,,,44.9,107.0,5.8e-16,85.9,sp|Q5XKA2|TIM21_XENLA Mitochondrial import inner membrane translocase subunit Tim21 OS=Xenopus laevis OX=8355 GN=timm21 PE=2 SV=1,,,,,,
OG_12768,FUN_034823-T1,Peve_00010845,,apul_peve,36.443,,,,,,,,,,,,,,,,,
OG_12769,FUN_034831-T1,Peve_00022085,,apul_peve,54.724,FUN_034831-T1,Q5R5W9,,,,,34.7,484.0,2.3e-69,264.6,sp|Q5R5W9|CE022_PONAB UPF0489 protein C5orf22 homolog OS=Pongo abelii OX=9601 PE=2 SV=1,,,,,,
OG_12770,FUN_034839-T1,Peve_00014500,,apul_peve,65.741,FUN_034839-T1,O14718,,,,,26.6,290.0,2.3e-26,121.3,sp|O14718|OPSX_HUMAN Visual pigment-like receptor peropsin OS=Homo sapiens OX=9606 GN=RRH PE=1 SV=1,,,,,,
OG_12771,FUN_034841-T1,Peve_00007327,,apul_peve,76.042,,,,,,,,,,,,,,,,,
OG_12772,FUN_034846-T1,Peve_00037375,,apul_peve,71.6805,FUN_034846-T1,A6QLU6,AGRD1_BOVIN,,"Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) [Cleaved into: Adhesion G-protein coupled receptor D1, N-terminal fragment (ADGRD1 N-terminal fragment); Adhesion G-protein coupled receptor D1, C-terminal fragment (ADGRD1 C-terminal fragment)]",Bos taurus (Bovine),42.8,320.0,4.5e-69,265.0,sp|A6QLU6|AGRD1_BOVIN Adhesion G-protein coupled receptor D1 OS=Bos taurus OX=9913 GN=ADGRD1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007189,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_12773,FUN_034852-T1,Peve_00008088,,apul_peve,51.982,FUN_034852-T1,P51028,,,,,40.5,296.0,6.5e-58,226.9,sp|P51028|WNT8A_DANRE Protein Wnt-8a OS=Danio rerio OX=7955 GN=wnt8a PE=2 SV=2,,,,,,
OG_12774,FUN_034862-T1,Peve_00032634,,apul_peve,62.599,,,,,,,,,,,,,,,,,
OG_12775,FUN_034863-T1,Peve_00005783,,apul_peve,71.127,FUN_034863-T1,P07203,GPX1_HUMAN,,Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) (Phospholipid-hydroperoxide glutathione peroxidase GPX1) (EC 1.11.1.12),Homo sapiens (Human),57.9,140.0,3e-43,176.0,sp|P07203|GPX1_HUMAN Glutathione peroxidase 1 OS=Homo sapiens OX=9606 GN=GPX1 PE=1 SV=4,GO:0001659; GO:0001885; GO:0002862; GO:0004602; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006641; GO:0006749; GO:0007605; GO:0008631; GO:0009410; GO:0009609; GO:0009650; GO:0009725; GO:0010269; GO:0010332; GO:0017124; GO:0019369; GO:0019372; GO:0032355; GO:0032496; GO:0033194; GO:0033197; GO:0033599; GO:0034599; GO:0035094; GO:0040029; GO:0042311; GO:0042542; GO:0042744; GO:0043403; GO:0043534; GO:0045444; GO:0045445; GO:0045454; GO:0047066; GO:0048144; GO:0048741; GO:0051402; GO:0051450; GO:0051593; GO:0051702; GO:0051897; GO:0060047; GO:0060055; GO:0061136; GO:0071333; GO:0090201; GO:1902042; GO:1902176; GO:1902905; GO:1990782,angiogenesis involved in wound healing [GO:0060055]; arachidonate metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; epigenetic regulation of gene expression [GO:0040029]; fat cell differentiation [GO:0045444]; fibroblast proliferation [GO:0048144]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; protein tyrosine kinase binding [GO:1990782]; SH3 domain binding [GO:0017124],GO:0003013; GO:0003824; GO:0005739; GO:0005829; GO:0006325; GO:0006575; GO:0006629; GO:0006790; GO:0012501; GO:0016209; GO:0016491; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0050877,circulatory system process; catalytic activity; mitochondrion; cytosol; chromatin organization; modified amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; programmed cell death; antioxidant activity; oxidoreductase activity; cell differentiation; organelle; anatomical structure development; cell motility; nervous system process
OG_12776,FUN_034864-T2,Peve_00005781,,apul_peve,93.301,FUN_034864-T2,A5YKK6,CNOT1_HUMAN,,CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1),Homo sapiens (Human),62.4,2093.0,0.0,2305.4,sp|A5YKK6|CNOT1_HUMAN CCR4-NOT transcription complex subunit 1 OS=Homo sapiens OX=9606 GN=CNOT1 PE=1 SV=2,GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0001829; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:1900153; GO:2000036,"miRNA-mediated post-transcriptional gene silencing [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; trophectodermal cell differentiation [GO:0001829]",CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778],armadillo repeat domain binding [GO:0070016]; molecular adaptor activity [GO:0060090]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723],GO:0003723; GO:0005615; GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0030154; GO:0031047; GO:0043226; GO:0060090,RNA binding; extracellular space; nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity
OG_12777,FUN_034868-T1,Peve_00042508,,apul_peve,59.551,,,,,,,,,,,,,,,,,
OG_12778,FUN_034895-T1,Peve_00037332,,apul_peve,63.825500000000005,FUN_034895-T1,Q54WH2,FORA_DICDI,,Formin-A,Dictyostelium discoideum (Social amoeba),28.3,374.0,1.2e-32,144.1,sp|Q54WH2|FORA_DICDI Formin-A OS=Dictyostelium discoideum OX=44689 GN=forA PE=1 SV=1,GO:0000281; GO:0005522; GO:0005938; GO:0015629; GO:0016477; GO:0030041; GO:0030587; GO:0030866; GO:0031254; GO:0031267; GO:0032154; GO:0035091; GO:0045010; GO:0051015; GO:0070060; GO:1904171,'de novo' actin filament nucleation [GO:0070060]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; mitotic cytokinesis [GO:0000281]; negative regulation of bleb assembly [GO:1904171]; sorocarp development [GO:0030587],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell trailing edge [GO:0031254]; cleavage furrow [GO:0032154],actin filament binding [GO:0051015]; phosphatidylinositol binding [GO:0035091]; profilin binding [GO:0005522]; small GTPase binding [GO:0031267],GO:0000910; GO:0005856; GO:0007010; GO:0008092; GO:0008289; GO:0043226; GO:0048856; GO:0048870; GO:0065003,cytokinesis; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; lipid binding; organelle; anatomical structure development; cell motility; protein-containing complex assembly
OG_12779,FUN_034898-T2,Peve_00037049,,apul_peve,38.202,,,,,,,,,,,,,,,,,
OG_12780,FUN_034901-T1,Peve_00037349,,apul_peve,38.095,,,,,,,,,,,,,,,,,
OG_12781,FUN_034904-T1,Peve_00011768,,apul_peve,38.5915,,,,,,,,,,,,,,,,,
OG_12782,FUN_034910-T1,Peve_00037350,,apul_peve,37.17,,,,,,,,,,,,,,,,,
OG_12783,FUN_034911-T1,Peve_00011766,,apul_peve,45.105500000000006,,,,,,,,,,,,,,,,,
OG_12784,FUN_034916-T1,Peve_00039134,,apul_peve,62.0,,,,,,,,,,,,,,,,,
OG_12785,FUN_034923-T1,Peve_00014648,,apul_peve,58.469,FUN_034923-T1,B8WI85,,,,,96.4,422.0,5.899999999999999e-244,844.3,sp|B8WI85|USOM7_ACRMI Uncharacterized skeletal organic matrix protein 7 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12786,FUN_034939-T1,Peve_00028343,,apul_peve,90.98,,,,,,,,,,,,,,,,,
OG_12787,FUN_034952-T1,Peve_00036671,,apul_peve,57.328,,,,,,,,,,,,,,,,,
OG_12788,FUN_034988-T1,Peve_00024613,,apul_peve,46.29,FUN_034988-T1,O14786,,,,,40.9,164.0,5.8e-22,107.8,sp|O14786|NRP1_HUMAN Neuropilin-1 OS=Homo sapiens OX=9606 GN=NRP1 PE=1 SV=3,,,,,,
OG_12789,FUN_034989-T1,Peve_00027893,,apul_peve,43.963,FUN_034989-T1,P79385,,,,,31.7,164.0,4.3e-17,90.9,sp|P79385|MFGM_PIG Lactadherin OS=Sus scrofa OX=9823 GN=MFGE8 PE=1 SV=2,,,,,,
OG_12790,FUN_034995-T1,Peve_00024603,,apul_peve,47.636,,,,,,,,,,,,,,,,,
OG_12791,FUN_035017-T3,Peve_00024644,,apul_peve,38.462,,,,,,,,,,,,,,,,,
OG_12792,FUN_035025-T1,Peve_00024647,,apul_peve,61.017,FUN_035025-T1,P47032,PRY1_YEAST,,Protein PRY1 (Pathogenesis-related protein 1),Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast),37.8,143.0,3.2e-14,81.3,sp|P47032|PRY1_YEAST Protein PRY1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PRY1 PE=1 SV=1,GO:0000287; GO:0000324; GO:0005504; GO:0005576; GO:0005615; GO:0005635; GO:0005783; GO:0015485; GO:0015908; GO:0015918; GO:0019953; GO:0032934,fatty acid transport [GO:0015908]; sexual reproduction [GO:0019953]; sterol transport [GO:0015918],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fungal-type vacuole [GO:0000324]; nuclear envelope [GO:0005635],cholesterol binding [GO:0015485]; fatty acid binding [GO:0005504]; magnesium ion binding [GO:0000287]; sterol binding [GO:0032934],GO:0005576; GO:0005615; GO:0005635; GO:0005773; GO:0005783; GO:0008289; GO:0022414; GO:0043226,extracellular region; extracellular space; nuclear envelope; vacuole; endoplasmic reticulum; lipid binding; reproductive process; organelle
OG_12793,FUN_035026-T1,Peve_00024630,,apul_peve,40.1095,,,,,,,,,,,,,,,,,
OG_12794,FUN_035029-T1,Peve_00024628,,apul_peve,72.84,FUN_035029-T1,Q9ZNS4,PRB1_ARATH,,Pathogenesis-related protein 1 (AtPRB1),Arabidopsis thaliana (Mouse-ear cress),36.8,136.0,3.7e-15,83.6,sp|Q9ZNS4|PRB1_ARATH Pathogenesis-related protein 1 OS=Arabidopsis thaliana OX=3702 GN=PRB1 PE=2 SV=1,GO:0005576; GO:0009611; GO:0009617; GO:0009723; GO:0009751; GO:0009753; GO:0080027; GO:0098542,defense response to other organism [GO:0098542]; response to bacterium [GO:0009617]; response to ethylene [GO:0009723]; response to herbivore [GO:0080027]; response to jasmonic acid [GO:0009753]; response to salicylic acid [GO:0009751]; response to wounding [GO:0009611],extracellular region [GO:0005576],,GO:0005576; GO:0098542,extracellular region; defense response to other organism
OG_12795,FUN_035047-T1,Peve_00044757,,apul_peve,50.7435,,,,,,,,,,,,,,,,,
OG_12796,FUN_035050-T3,Peve_00011122,,apul_peve,64.419,,,,,,,,,,,,,,,,,
OG_12797,FUN_035062-T1,Peve_00028784,,apul_peve,45.3575,,,,,,,,,,,,,,,,,
OG_12798,FUN_035066-T1,Peve_00002214,,apul_peve,56.522,FUN_035066-T1,Q8LET2,NUD11_ARATH,,Nudix hydrolase 11 (AtNUDT11) (EC 3.6.1.-) (Coenzyme A diphosphatase NUDT11),Arabidopsis thaliana (Mouse-ear cress),37.4,214.0,3.9e-29,130.2,sp|Q8LET2|NUD11_ARATH Nudix hydrolase 11 OS=Arabidopsis thaliana OX=3702 GN=NUDT11 PE=1 SV=2,GO:0000210; GO:0005778; GO:0005829; GO:0006753; GO:0008893; GO:0010945; GO:0015937; GO:0046872; GO:2001294,coenzyme A biosynthetic process [GO:0015937]; malonyl-CoA catabolic process [GO:2001294]; nucleoside phosphate metabolic process [GO:0006753],cytosol [GO:0005829]; peroxisomal membrane [GO:0005778],"coenzyme A diphosphatase activity [GO:0010945]; guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210]",GO:0003824; GO:0005829; GO:0006790; GO:0016787; GO:0043226; GO:0055086,catalytic activity; cytosol; sulfur compound metabolic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_12799,FUN_035072-T1,Peve_00016417,,apul_peve,64.356,FUN_035072-T1,Q3V050,S47A2_MOUSE,,Multidrug and toxin extrusion protein 2 (MATE-2) (mMATE-2) (H(+)/organic cation antiporter kidney-specific) (Solute carrier family 47 member 2),Mus musculus (Mouse),40.6,362.0,2.1e-71,271.2,sp|Q3V050|S47A2_MOUSE Multidrug and toxin extrusion protein 2 OS=Mus musculus OX=10090 GN=Slc47a2 PE=1 SV=1,GO:0005886; GO:0015101; GO:0015695; GO:0042910; GO:0140968; GO:1990961,organic cation transport [GO:0015695]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961],plasma membrane [GO:0005886],organic cation transmembrane transporter activity [GO:0015101]; polyspecific organic cation:proton antiporter activity [GO:0140968]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_12800,FUN_035083-T1,Peve_00003513,,apul_peve,51.448,FUN_035083-T1,Q5BIM1,,,,,24.1,473.0,1.8e-29,133.7,sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1,,,,,,
OG_12801,FUN_035084-T1,Peve_00003521,,apul_peve,53.826,FUN_035084-T1,Q5BIM1,,,,,24.0,480.0,1.4000000000000001e-33,146.4,sp|Q5BIM1|TRI45_BOVIN E3 ubiquitin-protein ligase TRIM45 OS=Bos taurus OX=9913 GN=TRIM45 PE=2 SV=1,,,,,,
OG_12802,FUN_035092-T1,Peve_00012603,,apul_peve,63.32899999999999,FUN_035092-T1,Q96CG8,CTHR1_HUMAN,,Collagen triple helix repeat-containing protein 1,Homo sapiens (Human),46.0,139.0,2.5e-29,130.6,sp|Q96CG8|CTHR1_HUMAN Collagen triple helix repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=CTHRC1 PE=1 SV=1,GO:0001649; GO:0004666; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0005737; GO:0016528; GO:0017147; GO:0019371; GO:0033687; GO:0033690; GO:0043005; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177,"cochlea morphogenesis [GO:0090103]; cyclooxygenase pathway [GO:0019371]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; sarcoplasm [GO:0016528],frizzled binding [GO:0005109]; prostaglandin-endoperoxide synthase activity [GO:0004666]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005576; GO:0005615; GO:0006629; GO:0016491; GO:0030154,catalytic activity; extracellular region; extracellular space; lipid metabolic process; oxidoreductase activity; cell differentiation
OG_12803,FUN_035095-T1,Peve_00019851,,apul_peve,67.164,FUN_035095-T1,Q1RMU2,CYLD_BOVIN,,Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD),Bos taurus (Bovine),31.4,1088.0,5.4999999999999995e-127,457.2,sp|Q1RMU2|CYLD_BOVIN Ubiquitin carboxyl-terminal hydrolase CYLD OS=Bos taurus OX=9913 GN=CYLD PE=2 SV=1,GO:0004843; GO:0005813; GO:0005819; GO:0005829; GO:0005874; GO:0005886; GO:0006508; GO:0007346; GO:0008270; GO:0010803; GO:0016055; GO:0016579; GO:0032088; GO:0036064; GO:0043124; GO:0045087; GO:0046329; GO:0048471; GO:0050727; GO:0050728; GO:0061578; GO:0070266; GO:0070536; GO:0090090; GO:0097542; GO:1901223; GO:1902017; GO:1903753; GO:1990108; GO:2000493; GO:2001238; GO:2001242,innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18-mediated signaling pathway [GO:2000493]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of mitotic cell cycle [GO:0007346]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytosol [GO:0005829]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819],cysteine-type deubiquitinase activity [GO:0004843]; K63-linked deubiquitinase activity [GO:0061578]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005886; GO:0006355; GO:0012501; GO:0016787; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; plasma membrane; regulation of DNA-templated transcription; programmed cell death; hydrolase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_12804,FUN_035110-T1,Peve_00039357,,apul_peve,83.582,,,,,,,,,,,,,,,,,
OG_12805,FUN_035132-T1,Peve_00005899,,apul_peve,50.117,FUN_035132-T1,Q2EG98,PK1L3_MOUSE,,Polycystin-1-like protein 3 (Polycystin-1L3) (PC1-like 3 protein) (Polycystic kidney disease protein 1-like 3),Mus musculus (Mouse),24.1,1513.0,2.4e-82,310.5,sp|Q2EG98|PK1L3_MOUSE Polycystin-1-like protein 3 OS=Mus musculus OX=10090 GN=Pkd1l3 PE=1 SV=3,GO:0001581; GO:0005227; GO:0005509; GO:0005886; GO:0006812; GO:0030246; GO:0034703; GO:0043235; GO:0044325; GO:0070588; GO:0071468; GO:0160128,calcium ion transmembrane transport [GO:0070588]; cellular response to acidic pH [GO:0071468]; detection of chemical stimulus involved in sensory perception of sour taste [GO:0001581]; monoatomic cation transport [GO:0006812],cation channel complex [GO:0034703]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; calcium-activated cation channel activity [GO:0005227]; carbohydrate binding [GO:0030246]; pH-gated monoatomic ion channel activity [GO:0160128]; transmembrane transporter binding [GO:0044325],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_12806,FUN_035134-T1,Peve_00043432,,apul_peve,34.545,,,,,,,,,,,,,,,,,
OG_12807,FUN_035143-T1,Peve_00008291,,apul_peve,37.609,FUN_035143-T1,Q86WI3,NLRC5_HUMAN,,Protein NLRC5 (Caterpiller protein 16.1) (CLR16.1) (Nucleotide-binding oligomerization domain protein 27) (Nucleotide-binding oligomerization domain protein 4),Homo sapiens (Human),24.2,505.0,6e-23,112.5,sp|Q86WI3|NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens OX=9606 GN=NLRC5 PE=1 SV=3,GO:0000978; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0009617; GO:0032088; GO:0043549; GO:0045087; GO:0045345; GO:0045944; GO:0051607; GO:0060335; GO:0060339; GO:0060340,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type II interferon-mediated signaling pathway [GO:0060335]; regulation of kinase activity [GO:0043549]; response to bacterium [GO:0009617],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0002376; GO:0003677; GO:0005634; GO:0005815; GO:0005829; GO:0006355; GO:0043226; GO:0098542,immune system process; DNA binding; nucleus; microtubule organizing center; cytosol; regulation of DNA-templated transcription; organelle; defense response to other organism
OG_12808,FUN_035152-T1,Peve_00030324,,apul_peve,77.163,FUN_035152-T1,P00491,PNPH_HUMAN,,Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase),Homo sapiens (Human),52.3,279.0,5.9e-81,302.4,sp|P00491|PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens OX=9606 GN=PNP PE=1 SV=2,GO:0000255; GO:0001882; GO:0002060; GO:0004731; GO:0005576; GO:0005737; GO:0005829; GO:0006139; GO:0006148; GO:0006149; GO:0006157; GO:0006166; GO:0006204; GO:0006738; GO:0006955; GO:0009165; GO:0009410; GO:0032743; GO:0034418; GO:0034774; GO:0042102; GO:0042301; GO:0042802; GO:0043101; GO:0046059; GO:0046638; GO:0047975; GO:0070062; GO:1904813,allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774],guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731],GO:0002376; GO:0003824; GO:0005576; GO:0005829; GO:0016740; GO:0043226; GO:0055086; GO:1901135,immune system process; catalytic activity; extracellular region; cytosol; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_12809,FUN_035153-T2,Peve_00006877,,apul_peve,68.18950000000001,,,,,,,,,,,,,,,,,
OG_12810,FUN_035156-T1,Peve_00009559,,apul_peve,44.048,,,,,,,,,,,,,,,,,
OG_12811,FUN_035160-T1,Peve_00006322,,apul_peve,40.0,,,,,,,,,,,,,,,,,
OG_12812,FUN_035165-T1,Peve_00010652,,apul_peve,49.444,,,,,,,,,,,,,,,,,
OG_12813,FUN_035175-T1,Peve_00036188,,apul_peve,50.669,,,,,,,,,,,,,,,,,
OG_12814,FUN_035176-T1,Peve_00036191,,apul_peve,53.484,,,,,,,,,,,,,,,,,
OG_12815,FUN_035178-T1,Peve_00017566,,apul_peve,40.984,,,,,,,,,,,,,,,,,
OG_12816,FUN_035197-T1,Peve_00038562,,apul_peve,43.243,,,,,,,,,,,,,,,,,
OG_12817,FUN_035218-T1,Peve_00035883,,apul_peve,51.852,,,,,,,,,,,,,,,,,
OG_12818,FUN_035238-T1,Peve_00007095,,apul_peve,82.812,FUN_035238-T1,Q0MQI8,,,,,69.5,243.0,2.1e-95,350.1,"sp|Q0MQI8|NDUV2_GORGO NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial OS=Gorilla gorilla gorilla OX=9595 GN=NDUFV2 PE=2 SV=1",,,,,,
OG_12819,FUN_035242-T1,Peve_00029135,,apul_peve,70.98,FUN_035242-T1,Q96AN5,,,,,31.4,408.0,1.2e-36,156.0,sp|Q96AN5|TM143_HUMAN Transmembrane protein 143 OS=Homo sapiens OX=9606 GN=TMEM143 PE=1 SV=1,,,,,,
OG_12820,FUN_035250-T1,Peve_00013714,,apul_peve,38.849,FUN_035250-T1,A4WDE9,,,,,40.8,206.0,5.500000000000001e-30,133.3,sp|A4WDE9|UNG_ENT38 Uracil-DNA glycosylase OS=Enterobacter sp. (strain 638) OX=399742 GN=ung PE=3 SV=1,,,,,,
OG_12821,FUN_035252-T3,Peve_00032652,,apul_peve,59.631,,,,,,,,,,,,,,,,,
OG_12822,FUN_035259-T3,Peve_00005410,,apul_peve,72.993,FUN_035259-T3,O16025,AOSL_PLEHO,,Allene oxide synthase-lipoxygenase protein [Includes: Allene oxide synthase (AOS) (EC 4.2.1.-) (Hydroperoxidehydrase); Arachidonate 8-lipoxygenase (EC 1.13.11.40)],Plexaura homomalla (Black sea rod),44.4,693.0,5e-176,619.4,sp|O16025|AOSL_PLEHO Allene oxide synthase-lipoxygenase protein OS=Plexaura homomalla OX=47982 PE=1 SV=1,GO:0005506; GO:0005737; GO:0006633; GO:0009978; GO:0016020; GO:0019369; GO:0020037; GO:0031408; GO:0034440; GO:0047677,arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; lipid oxidation [GO:0034440]; oxylipin biosynthetic process [GO:0031408],cytoplasm [GO:0005737]; membrane [GO:0016020],allene oxide synthase activity [GO:0009978]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; heme binding [GO:0020037]; iron ion binding [GO:0005506],GO:0003824; GO:0006629; GO:0016491; GO:0016829,catalytic activity; lipid metabolic process; oxidoreductase activity; lyase activity
OG_12823,FUN_035263-T1,Peve_00032646,,apul_peve,77.241,FUN_035263-T1,P80971,,,,,41.4,99.0,6.1e-15,82.0,"sp|P80971|COX42_THUOB Cytochrome c oxidase subunit 4 isoform 2, mitochondrial OS=Thunnus obesus OX=8241 PE=1 SV=2",,,,,,
OG_12824,FUN_035287-T1,Peve_00026794,,apul_peve,83.448,,,,,,,,,,,,,,,,,
OG_12825,FUN_035295-T1,Peve_00006999,,apul_peve,42.051,,,,,,,,,,,,,,,,,
OG_12826,FUN_035311-T1,Peve_00013826,,apul_peve,47.26,,,,,,,,,,,,,,,,,
OG_12827,FUN_035345-T1,Peve_00032935,,apul_peve,86.022,FUN_035345-T1,Q96NH3,BROMI_HUMAN,,Protein broad-minded (TBC1 domain family member 32),Homo sapiens (Human),30.5,226.0,4.4e-18,93.2,sp|Q96NH3|BROMI_HUMAN Protein broad-minded OS=Homo sapiens OX=9606 GN=TBC1D32 PE=1 SV=4,GO:0001822; GO:0002088; GO:0003406; GO:0005737; GO:0005929; GO:0007368; GO:0007507; GO:0042733; GO:0060021; GO:0060831; GO:0061512; GO:1905515,determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005929; GO:0043226; GO:0044782; GO:0048856,cilium; organelle; cilium organization; anatomical structure development
OG_12828,FUN_035350-T1,Peve_00016240,,apul_peve,40.589,,,,,,,,,,,,,,,,,
OG_12829,FUN_035352-T1,Peve_00020294,,apul_peve,55.906,FUN_035352-T1,Q56R14,TRI33_XENLA,,E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33),Xenopus laevis (African clawed frog),27.1,166.0,7.4e-09,63.5,sp|Q56R14|TRI33_XENLA E3 ubiquitin-protein ligase TRIM33 OS=Xenopus laevis OX=8355 GN=trim33 PE=1 SV=1,GO:0000785; GO:0003677; GO:0005634; GO:0008270; GO:0016567; GO:0016740,protein ubiquitination [GO:0016567],chromatin [GO:0000785]; nucleus [GO:0005634],DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0016740; GO:0043226,DNA binding; catalytic activity; nucleus; transferase activity; organelle
OG_12830,FUN_035353-T2,Peve_00020293,,apul_peve,39.744,FUN_035353-T2,Q4J9D2,,,,,47.3,182.0,3e-34,149.1,sp|Q4J9D2|Y1252_SULAC Uncharacterized protein Saci_1252 OS=Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) OX=330779 GN=Saci_1252 PE=4 SV=1,,,,,,
OG_12831,FUN_035355-T1,Peve_00016232,,apul_peve,47.836,FUN_035355-T1,Q8TDB6,DTX3L_HUMAN,,E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2),Homo sapiens (Human),56.7,180.0,1.1e-56,223.8,sp|Q8TDB6|DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1,GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008270; GO:0008333; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646,defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H4K91 ubiquitin ligase activity [GO:0141000]; histone ubiquitin ligase activity [GO:0140852]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0016192; GO:0016740; GO:0042393; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; lysosome; vacuole; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; vesicle-mediated transport; transferase activity; histone binding; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_12832,FUN_035357-T1,Peve_00020295,,apul_peve,45.252,FUN_035357-T1,Q8TDB6,DTX3L_HUMAN,,E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2),Homo sapiens (Human),58.7,179.0,1.8e-58,228.8,sp|Q8TDB6|DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1,GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008270; GO:0008333; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646,defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H4K91 ubiquitin ligase activity [GO:0141000]; histone ubiquitin ligase activity [GO:0140852]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0016192; GO:0016740; GO:0042393; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; lysosome; vacuole; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; vesicle-mediated transport; transferase activity; histone binding; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_12833,FUN_035359-T1,Peve_00008443,,apul_peve,52.885,FUN_035359-T1,Q2EMV9,PAR14_MOUSE,,Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14),Mus musculus (Mouse),27.5,1927.0,2.4e-170,602.1,sp|Q2EMV9|PAR14_MOUSE Protein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3,GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0045087; GO:0060336; GO:0140807; GO:1902216; GO:1990404,innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_12834,FUN_035375-T1,Peve_00016211,,apul_peve,51.456,,,,,,,,,,,,,,,,,
OG_12835,FUN_035377-T1,Peve_00016210,,apul_peve,57.955,,,,,,,,,,,,,,,,,
OG_12836,FUN_035379-T1,Peve_00016214,,apul_peve,48.485,,,,,,,,,,,,,,,,,
OG_12837,FUN_035383-T1,Peve_00016213,,apul_peve,78.16,FUN_035383-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),45.1,350.0,4.3e-95,351.7,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_12838,FUN_035388-T1,Peve_00005175,,apul_peve,78.55,,,,,,,,,,,,,,,,,
OG_12839,FUN_035390-T1,Peve_00005176,,apul_peve,64.8905,,,,,,,,,,,,,,,,,
OG_12840,FUN_035396-T1,Peve_00006515,,apul_peve,49.0,,,,,,,,,,,,,,,,,
OG_12841,FUN_035398-T1,Peve_00011118,,apul_peve,68.64150000000001,FUN_035398-T1,Q5YLG1,GUNA_BACPU,,"Endoglucanase A (EC 3.2.1.4) (Endo-1,4-beta-glucanase A)",Bacillus pumilus (Bacillus mesentericus),51.1,450.0,1.2999999999999999e-120,434.9,sp|Q5YLG1|GUNA_BACPU Endoglucanase A OS=Bacillus pumilus OX=1408 GN=eglA PE=1 SV=1,GO:0005576; GO:0008810; GO:0030245; GO:0030248,cellulose catabolic process [GO:0030245],extracellular region [GO:0005576],cellulase activity [GO:0008810]; cellulose binding [GO:0030248],GO:0003824; GO:0005576; GO:0005975; GO:0016787,catalytic activity; extracellular region; carbohydrate metabolic process; hydrolase activity
OG_12842,FUN_035407-T1,Peve_00018733,,apul_peve,34.1095,,,,,,,,,,,,,,,,,
OG_12843,FUN_035410-T1,Peve_00035785,,apul_peve,31.838,,,,,,,,,,,,,,,,,
OG_12844,FUN_035431-T1,Peve_00031976,,apul_peve,61.281,FUN_035431-T1,P78357,CNTP1_HUMAN,,Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190),Homo sapiens (Human),36.8,228.0,4.3e-33,143.7,sp|P78357|CNTP1_HUMAN Contactin-associated protein 1 OS=Homo sapiens OX=9606 GN=CNTNAP1 PE=1 SV=1,GO:0002175; GO:0007005; GO:0007010; GO:0007155; GO:0007165; GO:0007409; GO:0016020; GO:0017124; GO:0019227; GO:0022010; GO:0022011; GO:0030913; GO:0033010; GO:0033270; GO:0038023; GO:0048812; GO:0050884; GO:0050885; GO:0071205; GO:0090128; GO:0097106; GO:0098529; GO:0098978; GO:1990227,"axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cytoskeleton organization [GO:0007010]; mitochondrion organization [GO:0007005]; myelination in peripheral nervous system [GO:0022011]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process controlling balance [GO:0050885]; neuromuscular process controlling posture [GO:0050884]; neuron projection morphogenesis [GO:0048812]; neuronal action potential propagation [GO:0019227]; paranodal junction assembly [GO:0030913]; paranodal junction maintenance [GO:1990227]; postsynaptic density organization [GO:0097106]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; regulation of synapse maturation [GO:0090128]; signal transduction [GO:0007165]",glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270],SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023],GO:0007005; GO:0007010; GO:0007155; GO:0034330; GO:0050877; GO:0060089,mitochondrion organization; cytoskeleton organization; cell adhesion; cell junction organization; nervous system process; molecular transducer activity
OG_12845,FUN_035446-T1,Peve_00004788,,apul_peve,31.579,,,,,,,,,,,,,,,,,
OG_12846,FUN_035447-T1,Peve_00004796,,apul_peve,30.0,,,,,,,,,,,,,,,,,
OG_12847,FUN_035463-T1,Peve_00015561,,apul_peve,35.7645,,,,,,,,,,,,,,,,,
OG_12848,FUN_035479-T1,Peve_00033968,,apul_peve,56.348,FUN_035479-T1,Q0P678,ZCH18_MOUSE,,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),Mus musculus (Mouse),37.5,176.0,2e-16,89.7,sp|Q0P678|ZCH18_MOUSE Zinc finger CCCH domain-containing protein 18 OS=Mus musculus OX=10090 GN=Zc3h18 PE=1 SV=1,GO:0005634; GO:0008270,,nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0043226,nucleus; organelle
OG_12849,FUN_035480-T1,Peve_00033967,,apul_peve,72.045,FUN_035480-T1,Q6ZQ11,,,,,39.8,716.0,9.8e-154,545.4,sp|Q6ZQ11|CHSS1_MOUSE Chondroitin sulfate synthase 1 OS=Mus musculus OX=10090 GN=Chsy1 PE=2 SV=2,,,,,,
OG_12850,FUN_035514-T1,Peve_00039976,,apul_peve,68.12950000000001,FUN_035514-T1,Q9P209,CEP72_HUMAN,,Centrosomal protein of 72 kDa (Cep72),Homo sapiens (Human),26.1,664.0,2e-38,162.2,sp|Q9P209|CEP72_HUMAN Centrosomal protein of 72 kDa OS=Homo sapiens OX=9606 GN=CEP72 PE=1 SV=2,GO:0005813; GO:0005829; GO:0007051; GO:0007099; GO:0033566; GO:0034451; GO:0036064; GO:0042802; GO:1904779,centriole replication [GO:0007099]; gamma-tubulin complex localization [GO:0033566]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829],identical protein binding [GO:0042802],GO:0005815; GO:0005829; GO:0007010,microtubule organizing center; cytosol; cytoskeleton organization
OG_12851,FUN_035523-T1,Peve_00028184,,apul_peve,87.019,,,,,,,,,,,,,,,,,
OG_12852,FUN_035526-T1,Peve_00019038,,apul_peve,43.902,,,,,,,,,,,,,,,,,
OG_12853,FUN_035528-T1,Peve_00021384,,apul_peve,69.231,FUN_035528-T1,P35668,,,,,43.7,449.0,1.9e-97,357.8,sp|P35668|GSHB_XENLA Glutathione synthetase OS=Xenopus laevis OX=8355 GN=gss PE=2 SV=1,,,,,,
OG_12854,FUN_035541-T1,Peve_00036927,,apul_peve,61.769,FUN_035541-T1,Q09225,NRF6_CAEEL,,Nose resistant to fluoxetine protein 6 (Protein nrf-6),Caenorhabditis elegans,29.9,713.0,1.5e-66,255.8,sp|Q09225|NRF6_CAEEL Nose resistant to fluoxetine protein 6 OS=Caenorhabditis elegans OX=6239 GN=nrf-6 PE=1 SV=3,GO:0006869; GO:0008289; GO:0016020; GO:0016747,lipid transport [GO:0006869],membrane [GO:0016020],"acyltransferase activity, transferring groups other than amino-acyl groups [GO:0016747]; lipid binding [GO:0008289]",GO:0003824; GO:0008289; GO:0016740,catalytic activity; lipid binding; transferase activity
OG_12855,FUN_035550-T1,Peve_00014008,,apul_peve,61.644,,,,,,,,,,,,,,,,,
OG_12856,FUN_035572-T1,Peve_00027485,,apul_peve,49.529,,,,,,,,,,,,,,,,,
OG_12857,FUN_035594-T1,Peve_00036930,,apul_peve,68.354,,,,,,,,,,,,,,,,,
OG_12858,FUN_035595-T1,Peve_00001433,,apul_peve,65.789,,,,,,,,,,,,,,,,,
OG_12859,FUN_035597-T1,Peve_00027487,,apul_peve,44.225,,,,,,,,,,,,,,,,,
OG_12860,FUN_035603-T2,Peve_00035441,,apul_peve,81.25,FUN_035603-T2,Q92556,ELMO1_HUMAN,,Engulfment and cell motility protein 1 (Protein ced-12 homolog),Homo sapiens (Human),43.0,586.0,4.3e-136,486.5,sp|Q92556|ELMO1_HUMAN Engulfment and cell motility protein 1 OS=Homo sapiens OX=9606 GN=ELMO1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0005886; GO:0006911; GO:0006915; GO:0007015; GO:0016020; GO:0016601; GO:0017124; GO:0030036; GO:0032045; GO:0048870; GO:0098794; GO:0098978; GO:0150052,"actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell motility [GO:0048870]; phagocytosis, engulfment [GO:0006911]; Rac protein signal transduction [GO:0016601]; regulation of postsynapse assembly [GO:0150052]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],SH3 domain binding [GO:0017124],GO:0005829; GO:0005886; GO:0007010; GO:0012501; GO:0048870; GO:0061024,cytosol; plasma membrane; cytoskeleton organization; programmed cell death; cell motility; membrane organization
OG_12861,FUN_035606-T1,Peve_00027475,,apul_peve,43.773,FUN_035606-T1,Q01177,PLMN_RAT,,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]",Rattus norvegicus (Rat),39.2,120.0,2e-15,86.3,sp|Q01177|PLMN_RAT Plasminogen OS=Rattus norvegicus OX=10116 GN=Plg PE=2 SV=2,GO:0002020; GO:0004175; GO:0004252; GO:0005102; GO:0005615; GO:0006508; GO:0007596; GO:0009897; GO:0009986; GO:0010812; GO:0016485; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0034185; GO:0042246; GO:0042730; GO:0043536; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051603; GO:0051918; GO:0051919; GO:0060707; GO:0060716; GO:0071674; GO:0098685; GO:0098978; GO:0099183; GO:1990405,"blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; protein processing [GO:0016485]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]",cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Schaffer collateral - CA1 synapse [GO:0098685],apolipoprotein binding [GO:0034185]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; protease binding [GO:0002020]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102],GO:0002376; GO:0003824; GO:0005615; GO:0016787; GO:0022414; GO:0023052; GO:0030154; GO:0030198; GO:0048856; GO:0048870; GO:0051604; GO:0140096,"immune system process; catalytic activity; extracellular space; hydrolase activity; reproductive process; signaling; cell differentiation; extracellular matrix organization; anatomical structure development; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_12862,FUN_035621-T1,Peve_00029648,,apul_peve,73.115,,,,,,,,,,,,,,,,,
OG_12863,FUN_035625-T2,Peve_00029662,,apul_peve,83.085,FUN_035625-T2,Q66L58,,,,,54.0,365.0,1.3e-94,348.2,sp|Q66L58|VAC14_DANRE Protein VAC14 homolog OS=Danio rerio OX=7955 GN=vac14 PE=2 SV=1,,,,,,
OG_12864,FUN_035628-T1,Peve_00029645,,apul_peve,70.588,,,,,,,,,,,,,,,,,
OG_12865,FUN_035632-T1,Peve_00044828,,apul_peve,70.701,,,,,,,,,,,,,,,,,
OG_12866,FUN_035633-T1,Peve_00044827,,apul_peve,46.523,,,,,,,,,,,,,,,,,
OG_12867,FUN_035641-T1,Peve_00020460,,apul_peve,53.448,,,,,,,,,,,,,,,,,
OG_12868,FUN_035651-T1,Peve_00016719,,apul_peve,54.491,,,,,,,,,,,,,,,,,
OG_12869,FUN_035657-T2,Peve_00038550,,apul_peve,52.108,FUN_035657-T2,Q9UPN9,,,,,28.1,331.0,9.999999999999999e-32,139.8,sp|Q9UPN9|TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens OX=9606 GN=TRIM33 PE=1 SV=3,,,,,,
OG_12870,FUN_035658-T1,Peve_00023928,,apul_peve,63.302,FUN_035658-T1,P31646,S6A13_RAT,,Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13),Rattus norvegicus (Rat),52.1,595.0,7.6e-181,635.2,sp|P31646|S6A13_RAT Sodium- and chloride-dependent GABA transporter 2 OS=Rattus norvegicus OX=10116 GN=Slc6a13 PE=1 SV=1,GO:0005283; GO:0005308; GO:0005332; GO:0005368; GO:0005369; GO:0005886; GO:0006836; GO:0006865; GO:0008028; GO:0015171; GO:0015185; GO:0015718; GO:0015734; GO:0015881; GO:0016323; GO:0016597; GO:0035725; GO:0042995; GO:0051939; GO:0071705; GO:0089718,amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; creatine transmembrane transport [GO:0015881]; gamma-aminobutyric acid import [GO:0051939]; monocarboxylic acid transport [GO:0015718]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; sodium ion transmembrane transport [GO:0035725]; taurine transmembrane transport [GO:0015734],basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; plasma membrane [GO:0005886],amino acid binding [GO:0016597]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; creatine transmembrane transporter activity [GO:0005308]; gamma-aminobutyric acid transmembrane transporter activity [GO:0015185]; gamma-aminobutyric acid:sodium:chloride symporter activity [GO:0005332]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; taurine transmembrane transporter activity [GO:0005368]; taurine:sodium symporter activity [GO:0005369],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_12871,FUN_035659-T1,Peve_00038558,,apul_peve,53.492,FUN_035659-T1,Q9UPN9,,,,,29.3,338.0,8.7e-34,146.7,sp|Q9UPN9|TRI33_HUMAN E3 ubiquitin-protein ligase TRIM33 OS=Homo sapiens OX=9606 GN=TRIM33 PE=1 SV=3,,,,,,
OG_12872,FUN_035690-T1,Peve_00041300,,apul_peve,61.977,,,,,,,,,,,,,,,,,
OG_12873,FUN_035691-T1,Peve_00039169,,apul_peve,35.537,,,,,,,,,,,,,,,,,
OG_12874,FUN_035695-T1,Peve_00037578,,apul_peve,73.121,,,,,,,,,,,,,,,,,
OG_12875,FUN_035704-T1,Peve_00044080,,apul_peve,51.136,FUN_035704-T1,B5DF45,TRAF6_RAT,,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6),Rattus norvegicus (Rat),39.7,58.0,9e-07,55.1,sp|B5DF45|TRAF6_RAT TNF receptor-associated factor 6 OS=Rattus norvegicus OX=10116 GN=Traf6 PE=2 SV=1,GO:0000045; GO:0000122; GO:0000209; GO:0001503; GO:0001701; GO:0001843; GO:0002637; GO:0002726; GO:0002753; GO:0002931; GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005829; GO:0005886; GO:0005938; GO:0006955; GO:0006974; GO:0007165; GO:0007249; GO:0007254; GO:0007416; GO:0008270; GO:0009887; GO:0009898; GO:0016567; GO:0019221; GO:0019886; GO:0023035; GO:0030316; GO:0030674; GO:0031624; GO:0031663; GO:0031666; GO:0032481; GO:0032735; GO:0032743; GO:0032755; GO:0032991; GO:0034142; GO:0034450; GO:0035591; GO:0035631; GO:0038061; GO:0038172; GO:0038173; GO:0042088; GO:0042102; GO:0042475; GO:0042802; GO:0042826; GO:0042981; GO:0043011; GO:0043122; GO:0043123; GO:0043422; GO:0045087; GO:0045453; GO:0045672; GO:0045892; GO:0045944; GO:0046849; GO:0048468; GO:0048471; GO:0048661; GO:0050852; GO:0051092; GO:0051865; GO:0061630; GO:0070301; GO:0070498; GO:0070534; GO:0070555; GO:0071222; GO:0071345; GO:0097400; GO:0098696; GO:0098794; GO:0098978; GO:0140252; GO:0140374; GO:0141198; GO:1904385; GO:1904996,animal organ morphogenesis [GO:0009887]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone remodeling [GO:0046849]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cell development [GO:0048468]; cellular response to angiotensin [GO:1904385]; cellular response to cytokine stimulus [GO:0071345]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; DNA damage response [GO:0006974]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein branched polyubiquitination [GO:0141198]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation protein catabolic process at postsynapse [GO:0140252]; response to interleukin-1 [GO:0070555]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; synapse assembly [GO:0007416]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 4 signaling pathway [GO:0034142],CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; protein-macromolecule adaptor activity [GO:0030674]; signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0005829; GO:0005886; GO:0006355; GO:0016740; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; cytosol; plasma membrane; regulation of DNA-templated transcription; transferase activity; cell differentiation; cell junction organization; organelle; anatomical structure development; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_12876,FUN_035705-T1,Peve_00044095,,apul_peve,50.625,FUN_035705-T1,Q6DJN2,TRF6B_XENLA,,TNF receptor-associated factor 6-B (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (RING-type E3 ubiquitin transferase TRAF6-B),Xenopus laevis (African clawed frog),38.2,228.0,1.3e-34,149.4,sp|Q6DJN2|TRF6B_XENLA TNF receptor-associated factor 6-B OS=Xenopus laevis OX=8355 GN=traf6-b PE=2 SV=1,GO:0004842; GO:0005164; GO:0005634; GO:0005737; GO:0005811; GO:0005938; GO:0007250; GO:0008270; GO:0009898; GO:0031663; GO:0035591; GO:0042981; GO:0043122; GO:0045087; GO:0061630; GO:0070534; GO:0098978,activation of NF-kappaB-inducing kinase activity [GO:0007250]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634],signaling adaptor activity [GO:0035591]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005811; GO:0016740; GO:0043226; GO:0060090; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; lipid droplet; transferase activity; organelle; molecular adaptor activity; defense response to other organism; catalytic activity, acting on a protein"
OG_12877,FUN_035725-T1,Peve_00044106,,apul_peve,32.414,,,,,,,,,,,,,,,,,
OG_12878,FUN_035728-T2,Peve_00044110,,apul_peve,76.879,FUN_035728-T2,Q26636,CATL_SARPE,,Cathepsin L (EC 3.4.22.15) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain],Sarcophaga peregrina (Flesh fly) (Boettcherisca peregrina),55.8,339.0,6.200000000000001e-106,385.6,sp|Q26636|CATL_SARPE Cathepsin L OS=Sarcophaga peregrina OX=7386 PE=1 SV=1,GO:0004197; GO:0005764; GO:0006508; GO:0030154,cell differentiation [GO:0030154]; proteolysis [GO:0006508],lysosome [GO:0005764],cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; lysosome; vacuole; hydrolase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_12879,FUN_035732-T1,Peve_00024983,,apul_peve,37.788,FUN_035732-T1,Q875S9,,,,,25.9,216.0,5.8e-07,58.2,sp|Q875S9|AKR1_LACK1 Palmitoyltransferase AKR1 OS=Lachancea kluyveri (strain ATCC 58438 / CBS 3082 / BCRC 21498 / NBRC 1685 / JCM 7257 / NCYC 543 / NRRL Y-12651) OX=226302 GN=AKR1 PE=3 SV=1,,,,,,
OG_12880,FUN_035733-T1,Peve_00044114,,apul_peve,83.283,FUN_035733-T1,Q95029,CATL1_DROME,,Cathepsin L1 (EC 3.4.22.15) (Cysteine proteinase 1) [Cleaved into: Cathepsin L heavy chain; Cathepsin L light chain],Drosophila melanogaster (Fruit fly),58.1,315.0,2.5e-101,370.2,sp|Q95029|CATL1_DROME Cathepsin L1 OS=Drosophila melanogaster OX=7227 GN=CtsL1 PE=2 SV=2,GO:0004197; GO:0005615; GO:0005764; GO:0005770; GO:0006508; GO:0007586; GO:0008233; GO:0008234; GO:0044754; GO:0045169; GO:0051603,digestion [GO:0007586]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],autolysosome [GO:0044754]; extracellular space [GO:0005615]; fusome [GO:0045169]; late endosome [GO:0005770]; lysosome [GO:0005764],cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233],GO:0003824; GO:0005615; GO:0005764; GO:0005768; GO:0005773; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; extracellular space; lysosome; endosome; vacuole; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_12881,FUN_035741-T1,Peve_00043830,,apul_peve,40.496,,,,,,,,,,,,,,,,,
OG_12882,FUN_035747-T1,Peve_00016723,,apul_peve,52.3935,FUN_035747-T1,Q8R151,ZNFX1_MOUSE,,NFX1-type zinc finger-containing protein 1,Mus musculus (Mouse),35.3,1303.0,1.2e-187,659.8,sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3,GO:0002218; GO:0003723; GO:0004386; GO:0005634; GO:0005741; GO:0008270; GO:0010494; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0016853; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; nucleus; isomerase activity; organelle; defense response to other organism; ATP-dependent activity
OG_12883,FUN_035763-T1,Peve_00033440,,apul_peve,84.366,FUN_035763-T1,Q8K0C9,,,,,73.1,349.0,9.1e-153,541.2,"sp|Q8K0C9|GMDS_MOUSE GDP-mannose 4,6 dehydratase OS=Mus musculus OX=10090 GN=Gmds PE=1 SV=1",,,,,,
OG_12884,FUN_035764-T1,Peve_00033442,,apul_peve,51.673,,,,,,,,,,,,,,,,,
OG_12885,FUN_035772-T1,Peve_00027762,,apul_peve,64.024,,,,,,,,,,,,,,,,,
OG_12886,FUN_035774-T1,Peve_00022874,,apul_peve,74.933,FUN_035774-T1,Q09694,LYS1_SCHPO,,"Saccharopine dehydrogenase [NAD(+), L-lysine-forming] (SDH) (EC 1.5.1.7) (Lysine--2-oxoglutarate reductase)",Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),48.9,366.0,4.1e-98,359.8,"sp|Q09694|LYS1_SCHPO Saccharopine dehydrogenase [NAD(+), L-lysine-forming] OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=lys3 PE=1 SV=2",GO:0004753; GO:0004754; GO:0005737; GO:0019878,lysine biosynthetic process via aminoadipic acid [GO:0019878],cytoplasm [GO:0005737],"saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO:0004754]; saccharopine dehydrogenase activity [GO:0004753]",GO:0003824; GO:0006520; GO:0016491,catalytic activity; amino acid metabolic process; oxidoreductase activity
OG_12887,FUN_035790-T1,Peve_00018852,,apul_peve,40.659,,,,,,,,,,,,,,,,,
OG_12888,FUN_035808-T1,Peve_00021613,,apul_peve,64.73949999999999,FUN_035808-T1,B8V7Q1,,,,,97.1,4467.0,0.0,8356.5,sp|B8V7Q1|PCDL_ACRMI Protocadherin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_12889,FUN_035809-T1,Peve_00037791,,apul_peve,58.1295,FUN_035809-T1,Q14517,,,,,27.3,2415.0,3.8e-196,688.0,sp|Q14517|FAT1_HUMAN Protocadherin Fat 1 OS=Homo sapiens OX=9606 GN=FAT1 PE=1 SV=2,,,,,,
OG_12890,FUN_035827-T1,Peve_00002589,,apul_peve,59.4035,FUN_035827-T1,B6H3T4,NOP9_PENRW,,Nucleolar protein 9 (Pumilio domain-containing protein nop9),Penicillium rubens (strain ATCC 28089 / DSM 1075 / NRRL 1951 / Wisconsin 54-1255) (Penicillium chrysogenum),23.7,633.0,4.3e-35,151.4,sp|B6H3T4|NOP9_PENRW Nucleolar protein 9 OS=Penicillium rubens (strain ATCC 28089 / DSM 1075 / NRRL 1951 / Wisconsin 54-1255) OX=500485 GN=nop9 PE=3 SV=1,GO:0000056; GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005730; GO:0030686; GO:0030688,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit export from nucleus [GO:0000056]","90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]",RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0006913; GO:0043226,RNA binding; nucleolus; nucleocytoplasmic transport; organelle
OG_12891,FUN_035832-T1,Peve_00033603,,apul_peve,69.128,FUN_035832-T1,O74212,,,,,44.6,437.0,2.3e-108,394.0,sp|O74212|D5FAD_MORAP Acyl-lipid (8-3)-desaturase OS=Mortierella alpina OX=64518 GN=DES1 PE=1 SV=1,,,,,,
OG_12892,FUN_035835-T1,Peve_00040160,,apul_peve,43.75,,,,,,,,,,,,,,,,,
OG_12893,FUN_035836-T1,Peve_00032501,,apul_peve,58.64,,,,,,,,,,,,,,,,,
OG_12894,FUN_035893-T1,Peve_00029393,,apul_peve,63.873,FUN_035893-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),28.7,303.0,3.9999999999999996e-26,120.6,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_12895,FUN_035896-T2,Peve_00029405,,apul_peve,43.328,,,,,,,,,,,,,,,,,
OG_12896,FUN_035904-T1,Peve_00042158,,apul_peve,54.0495,,,,,,,,,,,,,,,,,
OG_12897,FUN_035946-T1,Peve_00036634,,apul_peve,38.79,FUN_035946-T1,O14544,SOCS6_HUMAN,,Suppressor of cytokine signaling 6 (SOCS-6) (Cytokine-inducible SH2 protein 4) (CIS-4) (Suppressor of cytokine signaling 4) (SOCS-4),Homo sapiens (Human),44.4,162.0,1.1e-27,125.9,sp|O14544|SOCS6_HUMAN Suppressor of cytokine signaling 6 OS=Homo sapiens OX=9606 GN=SOCS6 PE=1 SV=2,GO:0001772; GO:0005737; GO:0005829; GO:0006952; GO:0007259; GO:0009968; GO:0010498; GO:0016567; GO:0035556; GO:0035591; GO:0040008; GO:0050868,cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; defense response [GO:0006952]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; negative regulation of T cell activation [GO:0050868]; proteasomal protein catabolic process [GO:0010498]; protein ubiquitination [GO:0016567]; regulation of growth [GO:0040008],cytoplasm [GO:0005737]; cytosol [GO:0005829]; immunological synapse [GO:0001772],signaling adaptor activity [GO:0035591],GO:0005829; GO:0030163; GO:0060090,cytosol; protein catabolic process; molecular adaptor activity
OG_12898,FUN_035948-T1,Peve_00036637,,apul_peve,61.551,,,,,,,,,,,,,,,,,
OG_12899,FUN_035964-T1,Peve_00006625,,apul_peve,69.455,FUN_035964-T1,Q6L9W6,B4GN3_HUMAN,,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",Homo sapiens (Human),43.7,309.0,7.1e-71,268.9,"sp|Q6L9W6|B4GN3_HUMAN Beta-1,4-N-acetylgalactosaminyltransferase 3 OS=Homo sapiens OX=9606 GN=B4GALNT3 PE=1 SV=2",GO:0005794; GO:0008376; GO:0032580; GO:0033842; GO:0043231,,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; intracellular membrane-bounded organelle [GO:0043231],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0005794; GO:0016740; GO:0043226,catalytic activity; Golgi apparatus; transferase activity; organelle
OG_12900,FUN_035971-T1,Peve_00045078,,apul_peve,63.251,FUN_035971-T1,Q864U8,,,,,32.0,219.0,3.6000000000000003e-28,127.1,"sp|Q864U8|B3GN5_PIG Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase OS=Sus scrofa OX=9823 GN=B3GNT5 PE=2 SV=1",,,,,,
OG_12901,FUN_035979-T1,Peve_00045079,,apul_peve,48.189,,,,,,,,,,,,,,,,,
OG_12902,FUN_035982-T1,Peve_00031763,,apul_peve,45.471,FUN_035982-T1,Q501L1,,,,,49.4,399.0,1.9e-101,372.5,sp|Q501L1|P20D2_XENTR Peptidase M20 domain-containing protein 2 OS=Xenopus tropicalis OX=8364 GN=pm20d2 PE=2 SV=1,,,,,,
OG_12903,FUN_035990-T1,Peve_00041855,,apul_peve,40.29,FUN_035990-T1,O13076,,,,,24.2,318.0,2.4e-14,81.3,sp|O13076|AA2BR_CHICK Adenosine receptor A2b OS=Gallus gallus OX=9031 GN=ADORA2B PE=2 SV=1,,,,,,
OG_12904,FUN_035997-T1,Peve_00038186,,apul_peve,41.742,FUN_035997-T1,Q49LX5,,,,,21.8,335.0,4e-09,63.9,sp|Q49LX5|SSR1_CANLF Somatostatin receptor type 1 OS=Canis lupus familiaris OX=9615 GN=SSTR1 PE=3 SV=1,,,,,,
OG_12905,FUN_036007-T1,Peve_00042877,,apul_peve,68.329,FUN_036007-T1,Q9QZ85,IIGP1_MOUSE,,Interferon-inducible GTPase 1 (EC 3.6.5.-),Mus musculus (Mouse),34.1,349.0,1.4999999999999998e-43,178.7,sp|Q9QZ85|IIGP1_MOUSE Interferon-inducible GTPase 1 OS=Mus musculus OX=10090 GN=Iigp1 PE=1 SV=2,GO:0003924; GO:0005525; GO:0005737; GO:0005789; GO:0009617; GO:0010506; GO:0019003; GO:0019221; GO:0020005; GO:0031965; GO:0032580; GO:0035458; GO:0042802; GO:0042832; GO:0045087; GO:0050829,cellular response to interferon-beta [GO:0035458]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; regulation of autophagy [GO:0010506]; response to bacterium [GO:0009617],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; nuclear membrane [GO:0031965]; symbiont-containing vacuole membrane [GO:0020005],GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802],GO:0002376; GO:0003824; GO:0003924; GO:0016787; GO:0098542,immune system process; catalytic activity; GTPase activity; hydrolase activity; defense response to other organism
OG_12906,FUN_036016-T1,Peve_00009355,,apul_peve,60.165,FUN_036016-T1,A8MXE2,B3GT9_HUMAN,,"Beta-1,3-galactosyltransferase 9 (EC 2.4.1.-) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 10)",Homo sapiens (Human),34.3,210.0,1.2e-27,125.6,"sp|A8MXE2|B3GT9_HUMAN Beta-1,3-galactosyltransferase 9 OS=Homo sapiens OX=9606 GN=B3GALT9 PE=1 SV=2",GO:0000139; GO:0006493; GO:0016757; GO:0016758,protein O-linked glycosylation [GO:0006493],Golgi membrane [GO:0000139],glycosyltransferase activity [GO:0016757]; hexosyltransferase activity [GO:0016758],GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_12907,FUN_036033-T1,Peve_00011101,,apul_peve,59.649,,,,,,,,,,,,,,,,,
OG_12908,FUN_036034-T1,Peve_00011098,,apul_peve,59.0655,FUN_036034-T1,Q587J7,TDR12_HUMAN,,Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12),Homo sapiens (Human),27.4,742.0,9.7e-78,293.9,sp|Q587J7|TDR12_HUMAN Putative ATP-dependent RNA helicase TDRD12 OS=Homo sapiens OX=9606 GN=TDRD12 PE=1 SV=2,GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007283; GO:0009566; GO:0016887; GO:0034587; GO:0042078; GO:0141196; GO:1990923,fertilization [GO:0009566]; germ-line stem cell division [GO:0042078]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],PET complex [GO:1990923],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724],GO:0003824; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0140013; GO:0140098; GO:0140657,"catalytic activity; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_12909,FUN_036048-T1,Peve_00029866,,apul_peve,53.586,,,,,,,,,,,,,,,,,
OG_12910,FUN_036053-T1,Peve_00029873,,apul_peve,56.965,,,,,,,,,,,,,,,,,
OG_12911,FUN_036092-T1,Peve_00032186,,apul_peve,32.7715,,,,,,,,,,,,,,,,,
OG_12912,FUN_036102-T1,Peve_00032198,,apul_peve,74.659,FUN_036102-T1,Q0P8I7,GMHD_CAMJE,,GDP-D-glycero-alpha-D-manno-heptose dehydrogenase (EC 1.1.98.-),Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168),42.8,297.0,5.9e-67,256.1,sp|Q0P8I7|GMHD_CAMJE GDP-D-glycero-alpha-D-manno-heptose dehydrogenase OS=Campylobacter jejuni subsp. jejuni serotype O:2 (strain ATCC 700819 / NCTC 11168) OX=192222 GN=Cj1427c PE=1 SV=1,GO:0003978; GO:0016491; GO:0019003; GO:0042802; GO:0045227; GO:0051289; GO:0070404,capsule polysaccharide biosynthetic process [GO:0045227]; protein homotetramerization [GO:0051289],,GDP binding [GO:0019003]; identical protein binding [GO:0042802]; NADH binding [GO:0070404]; oxidoreductase activity [GO:0016491]; UDP-glucose 4-epimerase activity [GO:0003978],GO:0003824; GO:0005975; GO:0016491; GO:0016853; GO:0065003,catalytic activity; carbohydrate metabolic process; oxidoreductase activity; isomerase activity; protein-containing complex assembly
OG_12913,FUN_036104-T1,Peve_00003692,,apul_peve,77.305,FUN_036104-T1,Q62687,S6A18_RAT,,Sodium-dependent neutral amino acid transporter B(0)AT3 (Renal osmotic stress-induced Na-Cl organic solute cotransporter) (ROSIT) (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3),Rattus norvegicus (Rat),39.8,548.0,1e-106,389.0,sp|Q62687|S6A18_RAT Sodium-dependent neutral amino acid transporter B(0)AT3 OS=Rattus norvegicus OX=10116 GN=Slc6a18 PE=2 SV=1,GO:0003333; GO:0005886; GO:0006836; GO:0006865; GO:0006972; GO:0015175; GO:0015804; GO:0016324; GO:0031526; GO:0035725; GO:0140931; GO:1990297,amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; hyperosmotic response [GO:0006972]; neurotransmitter transport [GO:0006836]; neutral amino acid transport [GO:0015804]; renal amino acid absorption [GO:1990297]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; plasma membrane [GO:0005886],neutral L-amino acid transmembrane transporter activity [GO:0015175]; neutral L-amino acid:sodium:chloride symporter activity [GO:0140931],GO:0003014; GO:0005215; GO:0005886; GO:0055085,renal system process; transporter activity; plasma membrane; transmembrane transport
OG_12914,FUN_036105-T1,Peve_00003694,,apul_peve,74.257,,,,,,,,,,,,,,,,,
OG_12915,FUN_036107-T1,Peve_00003697,,apul_peve,49.468,,,,,,,,,,,,,,,,,
OG_12916,FUN_036131-T1,Peve_00027677,,apul_peve,81.25,FUN_036131-T1,P84227,H32_BOVIN,,Histone H3.2,Bos taurus (Bovine),100.0,102.0,2.8e-46,187.2,sp|P84227|H32_BOVIN Histone H3.2 OS=Bos taurus OX=9913 PE=1 SV=2,GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982,,nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527],GO:0003677; GO:0005198; GO:0005634; GO:0043226,DNA binding; structural molecule activity; nucleus; organelle
OG_12917,FUN_036134-T1,Peve_00007761,,apul_peve,78.444,FUN_036134-T1,P84227,H32_BOVIN,,Histone H3.2,Bos taurus (Bovine),100.0,102.0,2.2e-46,187.6,sp|P84227|H32_BOVIN Histone H3.2 OS=Bos taurus OX=9913 PE=1 SV=2,GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982,,nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527],GO:0003677; GO:0005198; GO:0005634; GO:0043226,DNA binding; structural molecule activity; nucleus; organelle
OG_12918,FUN_036148-T1,Peve_00000293,,apul_peve,99.105,FUN_036148-T1,Q3MHM5,TBB4B_BOVIN,,Tubulin beta-4B chain (Tubulin beta-2C chain),Bos taurus (Bovine),99.3,430.0,4.6e-255,881.3,sp|Q3MHM5|TBB4B_BOVIN Tubulin beta-4B chain OS=Bos taurus OX=9913 GN=TUBB4B PE=1 SV=1,GO:0000226; GO:0000278; GO:0003725; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0005879; GO:0030317; GO:0036126; GO:0045171; GO:0046872; GO:0072686,flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278],axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; intercellular bridge [GO:0045171]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; sperm flagellum [GO:0036126],double-stranded RNA binding [GO:0003725]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; structural constituent of cytoskeleton [GO:0005200],GO:0000278; GO:0003723; GO:0003824; GO:0003924; GO:0005198; GO:0005929; GO:0007010; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0048870,mitotic cell cycle; RNA binding; catalytic activity; GTPase activity; structural molecule activity; cilium; cytoskeleton organization; microtubule-based movement; hydrolase activity; reproductive process; organelle; cell motility
OG_12919,FUN_036157-T1,Peve_00043536,,apul_peve,47.793000000000006,,,,,,,,,,,,,,,,,
OG_12920,FUN_036194-T1,Peve_00037547,,apul_peve,45.833,FUN_036194-T1,Q8R3F5,,,,,57.1,56.0,7.2e-10,65.1,"sp|Q8R3F5|FABD_MOUSE Malonyl-CoA-acyl carrier protein transacylase, mitochondrial OS=Mus musculus OX=10090 GN=Mcat PE=1 SV=3",,,,,,
OG_12921,FUN_036201-T1,Peve_00011148,,apul_peve,50.866,,,,,,,,,,,,,,,,,
OG_12922,FUN_036203-T1,Peve_00038739,,apul_peve,33.242000000000004,,,,,,,,,,,,,,,,,
OG_12923,FUN_036213-T1,Peve_00025931,,apul_peve,81.837,,,,,,,,,,,,,,,,,
OG_12924,FUN_036214-T1,Peve_00025938,,apul_peve,38.983,,,,,,,,,,,,,,,,,
OG_12925,FUN_036217-T1,Peve_00001647,,apul_peve,53.811,,,,,,,,,,,,,,,,,
OG_12926,FUN_036228-T1,Peve_00032840,,apul_peve,74.0975,FUN_036228-T1,Q63ZR5,,,,,36.9,569.0,1.6e-97,358.6,sp|Q63ZR5|RHN2B_XENLA Rhophilin-2-B OS=Xenopus laevis OX=8355 GN=rhpn2-b PE=2 SV=1,,,,,,
OG_12927,FUN_036236-T1,Peve_00010254,,apul_peve,59.479,FUN_036236-T1,Q94887,,,,,33.0,215.0,5.9e-28,127.5,sp|Q94887|NRX4_DROME Neurexin-4 OS=Drosophila melanogaster OX=7227 GN=Nrx-IV PE=1 SV=2,,,,,,
OG_12928,FUN_036244-T2,Peve_00037537,,apul_peve,82.13550000000001,FUN_036244-T2,Q924N4,S12A6_MOUSE,,Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3),Mus musculus (Mouse),54.6,1032.0,2.9e-289,996.1,sp|Q924N4|S12A6_MOUSE Solute carrier family 12 member 6 OS=Mus musculus OX=10090 GN=Slc12a6 PE=1 SV=2,GO:0005886; GO:0006884; GO:0015379; GO:0016323; GO:0019901; GO:0030424; GO:0046872; GO:0055064; GO:0055075; GO:0071333; GO:0071477; GO:0071805; GO:1990573,cell volume homeostasis [GO:0006884]; cellular hypotonic salinity response [GO:0071477]; cellular response to glucose stimulus [GO:0071333]; chloride ion homeostasis [GO:0055064]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; potassium ion transmembrane transport [GO:0071805],axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],metal ion binding [GO:0046872]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_12929,FUN_036272-T1,Peve_00025594,,apul_peve,41.684,,,,,,,,,,,,,,,,,
OG_12930,FUN_036277-T1,Peve_00010028,,apul_peve,93.476,,,,,,,,,,,,,,,,,
OG_12931,FUN_036324-T1,Peve_00000997,,apul_peve,48.454,,,,,,,,,,,,,,,,,
OG_12932,FUN_036328-T1,Peve_00041529,,apul_peve,50.495,,,,,,,,,,,,,,,,,
OG_12933,FUN_036438-T1,Peve_00020203,,apul_peve,80.357,,,,,,,,,,,,,,,,,
OG_12934,FUN_036452-T1,Peve_00029169,,apul_peve,34.921,,,,,,,,,,,,,,,,,
OG_12935,FUN_036463-T1,Peve_00009983,,apul_peve,68.2575,,,,,,,,,,,,,,,,,
OG_12936,FUN_036475-T1,Peve_00002092,,apul_peve,77.273,,,,,,,,,,,,,,,,,
OG_12937,FUN_036519-T2,Peve_00029400,,apul_peve,77.079,FUN_036519-T2,Q7ZVE6,PLGT2_DANRE,,Protein O-glucosyltransferase 2 (EC 2.4.1.-) (KDEL motif-containing protein 1) (Protein O-xylosyltransferase POGLUT2) (EC 2.4.2.-),Danio rerio (Zebrafish) (Brachydanio rerio),60.2,470.0,6.7e-170,598.6,sp|Q7ZVE6|PLGT2_DANRE Protein O-glucosyltransferase 2 OS=Danio rerio OX=7955 GN=poglut2 PE=2 SV=1,GO:0005788; GO:0007399; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0046527; GO:0140561; GO:0140562,nervous system development [GO:0007399]; protein O-linked glycosylation via serine [GO:0018242],endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788],EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252],GO:0003824; GO:0016740; GO:0048856,catalytic activity; transferase activity; anatomical structure development
OG_12938,FUN_036523-T1,Peve_00031407,,apul_peve,90.991,FUN_036523-T1,A7SGU3,,,,,76.1,142.0,3.3e-55,216.1,sp|A7SGU3|DCTN6_NEMVE Dynactin subunit 6 OS=Nematostella vectensis OX=45351 GN=dctn6 PE=3 SV=1,,,,,,
OG_12939,FUN_036548-T1,Peve_00035032,,apul_peve,85.621,,,,,,,,,,,,,,,,,
OG_12940,FUN_036564-T2,Peve_00018084,,apul_peve,55.556,FUN_036564-T2,Q91W78,,,,,35.9,237.0,9.999999999999999e-33,142.1,sp|Q91W78|USB1_MOUSE U6 snRNA phosphodiesterase 1 OS=Mus musculus OX=10090 GN=Usb1 PE=2 SV=1,,,,,,
OG_12941,FUN_036705-T1,Peve_00037158,,apul_peve,56.318,FUN_036705-T1,Q9FT69,,,,,30.7,137.0,2.3e-09,65.1,sp|Q9FT69|RQSIM_ARATH ATP-dependent DNA helicase Q-like SIM OS=Arabidopsis thaliana OX=3702 GN=RECQSIM PE=2 SV=1,,,,,,
OG_12942,FUN_036754-T1,Peve_00027842,,apul_peve,58.865,FUN_036754-T1,Q2KIB9,,,,,32.6,132.0,1.3e-10,67.8,sp|Q2KIB9|RPP29_BOVIN Ribonuclease P protein subunit p29 OS=Bos taurus OX=9913 GN=POP4 PE=2 SV=1,,,,,,
OG_12943,FUN_036758-T1,Peve_00001062,,apul_peve,67.778,FUN_036758-T1,Q3T0Z5,,,,,38.1,260.0,1.6e-21,104.8,sp|Q3T0Z5|LENG1_BOVIN Leukocyte receptor cluster member 1 homolog OS=Bos taurus OX=9913 GN=LENG1 PE=2 SV=1,,,,,,
OG_12944,FUN_036773-T1,Peve_00010464,,apul_peve,59.5545,FUN_036773-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),45.1,293.0,5.3e-72,273.9,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_12945,FUN_036774-T1,Peve_00037201,,apul_peve,67.647,,,,,,,,,,,,,,,,,
OG_12946,FUN_036803-T1,Peve_00018142,,apul_peve,30.973,,,,,,,,,,,,,,,,,
OG_12947,FUN_036808-T3,Peve_00006529,,apul_peve,54.232,FUN_036808-T3,Q99MW1,,,,,25.3,738.0,1.1e-41,173.3,sp|Q99MW1|STK31_MOUSE Serine/threonine-protein kinase 31 OS=Mus musculus OX=10090 GN=Stk31 PE=1 SV=2,,,,,,
OG_12948,FUN_036849-T1,Peve_00008807,,apul_peve,46.154,,,,,,,,,,,,,,,,,
OG_12949,FUN_036861-T1,Peve_00021188,,apul_peve,47.297,,,,,,,,,,,,,,,,,
OG_12950,FUN_036866-T1,Peve_00004119,,apul_peve,51.851,,,,,,,,,,,,,,,,,
OG_12951,FUN_036871-T1,Peve_00004115,,apul_peve,45.395,,,,,,,,,,,,,,,,,
OG_12952,FUN_036876-T1,Peve_00039749,,apul_peve,46.216,FUN_036876-T1,A8TX70,CO6A5_HUMAN,,Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4),Homo sapiens (Human),25.8,629.0,6.6e-36,155.2,sp|A8TX70|CO6A5_HUMAN Collagen alpha-5(VI) chain OS=Homo sapiens OX=9606 GN=COL6A5 PE=1 SV=1,GO:0005576; GO:0005589; GO:0007155; GO:0030020; GO:0030198; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],extracellular matrix structural constituent conferring tensile strength [GO:0030020],GO:0005198; GO:0005576; GO:0007155; GO:0030198,structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization
OG_12953,FUN_036877-T1,Peve_00039751,,apul_peve,65.5415,FUN_036877-T1,F1RRV3,THYG_PIG,,Thyroglobulin,Sus scrofa (Pig),24.6,1263.0,1e-61,243.0,sp|F1RRV3|THYG_PIG Thyroglobulin OS=Sus scrofa OX=9823 GN=TG PE=1 SV=5,GO:0005179; GO:0005615; GO:0006590; GO:0042446; GO:0042802,hormone biosynthetic process [GO:0042446]; thyroid hormone generation [GO:0006590],extracellular space [GO:0005615],hormone activity [GO:0005179]; identical protein binding [GO:0042802],GO:0005615; GO:0006575; GO:0048018; GO:0098772,extracellular space; modified amino acid metabolic process; receptor ligand activity; molecular function regulator activity
OG_12954,FUN_036880-T1,Peve_00031255,,apul_peve,68.401,,,,,,,,,,,,,,,,,
OG_12955,FUN_036890-T1,Peve_00002365,,apul_peve,64.416,,,,,,,,,,,,,,,,,
OG_12956,FUN_036893-T1,Peve_00018378,,apul_peve,62.921,FUN_036893-T1,Q90Z12,HES4A_XENLA,,Transcription factor HES-4-A (Hairy and enhancer of split 4-A) (Protein hairy-2) (Xhairy2) (Protein hairy-2a) (Xhairy2a),Xenopus laevis (African clawed frog),39.3,234.0,5.700000000000001e-30,132.9,sp|Q90Z12|HES4A_XENLA Transcription factor HES-4-A OS=Xenopus laevis OX=8355 GN=hes4-a PE=1 SV=2,GO:0000122; GO:0000978; GO:0002088; GO:0005634; GO:0014029; GO:0021501; GO:0030509; GO:0033504; GO:0043066; GO:0043425; GO:0043565; GO:0045892; GO:0046983; GO:0050767,BMP signaling pathway [GO:0030509]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501]; regulation of neurogenesis [GO:0050767],nucleus [GO:0005634],bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development
OG_12957,FUN_036905-T1,Peve_00018426,,apul_peve,61.864,FUN_036905-T1,O15439,MRP4_HUMAN,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4),Homo sapiens (Human),36.9,1323.0,2.6e-237,823.9,sp|O15439|MRP4_HUMAN ATP-binding cassette sub-family C member 4 OS=Homo sapiens OX=9606 GN=ABCC4 PE=1 SV=3,GO:0001409; GO:0002576; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006805; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015216; GO:0015431; GO:0015432; GO:0015562; GO:0015721; GO:0015732; GO:0015747; GO:0016020; GO:0016323; GO:0016324; GO:0016404; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0043225; GO:0043231; GO:0055085; GO:0060271; GO:0070730; GO:0071716; GO:0098591; GO:0140115; GO:0140359; GO:0150104,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; leukotriene transport [GO:0071716]; platelet degranulation [GO:0002576]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; urate transport [GO:0015747]; xenobiotic metabolic process [GO:0006805]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type transporter activity [GO:0140359]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; purine nucleotide transmembrane transporter activity [GO:0015216]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003013; GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016192; GO:0016491; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,circulatory system process; catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; vesicle-mediated transport; oxidoreductase activity; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_12958,FUN_036914-T1,Peve_00018399,,apul_peve,60.656,,,,,,,,,,,,,,,,,
OG_12959,FUN_036926-T1,Peve_00040015,,apul_peve,67.407,,,,,,,,,,,,,,,,,
OG_12960,FUN_036958-T1,Peve_00040023,,apul_peve,58.657,FUN_036958-T1,Q84WG0,,,,,33.3,496.0,7.1e-64,246.5,sp|Q84WG0|PTR26_ARATH Protein NRT1/ PTR FAMILY 8.4 OS=Arabidopsis thaliana OX=3702 GN=NPF8.4 PE=2 SV=2,,,,,,
OG_12961,FUN_036972-T1,Peve_00040019,,apul_peve,75.405,FUN_036972-T1,Q9R0G6,COMP_MOUSE,,Cartilage oligomeric matrix protein (COMP),Mus musculus (Mouse),47.7,671.0,1.6e-50,204.5,sp|Q9R0G6|COMP_MOUSE Cartilage oligomeric matrix protein OS=Mus musculus OX=10090 GN=Comp PE=1 SV=2,GO:0001501; GO:0001503; GO:0002020; GO:0002063; GO:0003416; GO:0003417; GO:0005178; GO:0005509; GO:0005518; GO:0005576; GO:0005615; GO:0006915; GO:0006986; GO:0007596; GO:0008201; GO:0009306; GO:0010468; GO:0014829; GO:0016485; GO:0030199; GO:0030282; GO:0030500; GO:0030509; GO:0031012; GO:0032991; GO:0035264; GO:0035988; GO:0035989; GO:0036122; GO:0043066; GO:0043394; GO:0043395; GO:0043588; GO:0048844; GO:0050881; GO:0050905; GO:0051216; GO:0051260; GO:0055001; GO:0060173; GO:0060349; GO:0070527; GO:0090398; GO:0097084; GO:0098868; GO:1900047; GO:1902732; GO:1990079,apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blood coagulation [GO:0007596]; BMP signaling pathway [GO:0030509]; bone growth [GO:0098868]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cartilage development [GO:0051216]; cartilage homeostasis [GO:1990079]; cellular senescence [GO:0090398]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; endochondral bone growth [GO:0003416]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism growth [GO:0035264]; muscle cell development [GO:0055001]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; neuromuscular process [GO:0050905]; ossification [GO:0001503]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991],BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020]; proteoglycan binding [GO:0043394],GO:0003012; GO:0003013; GO:0005576; GO:0005615; GO:0007155; GO:0012501; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0050877; GO:0051604; GO:0065003,muscle system process; circulatory system process; extracellular region; extracellular space; cell adhesion; programmed cell death; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; nervous system process; protein maturation; protein-containing complex assembly
OG_12962,FUN_036977-T1,Peve_00022522,,apul_peve,34.688,,,,,,,,,,,,,,,,,
OG_12963,FUN_036981-T1,Peve_00002833,,apul_peve,53.623,FUN_036981-T1,P48040,,,,,27.9,290.0,9.8e-20,99.0,sp|P48040|MTR1A_SHEEP Melatonin receptor type 1A OS=Ovis aries OX=9940 GN=MTNR1A PE=2 SV=1,,,,,,
OG_12964,FUN_036998-T1,Peve_00040035,,apul_peve,59.459,FUN_036998-T1,Q15818,NPTX1_HUMAN,,Neuronal pentraxin-1 (NP1) (Neuronal pentraxin I) (NP-I),Homo sapiens (Human),41.1,209.0,5.600000000000001e-33,142.9,sp|Q15818|NPTX1_HUMAN Neuronal pentraxin-1 OS=Homo sapiens OX=9606 GN=NPTX1 PE=1 SV=2,GO:0005783; GO:0006839; GO:0007268; GO:0007417; GO:0030133; GO:0035865; GO:0043083; GO:0043653; GO:0046872; GO:0060385; GO:0071333; GO:0097107; GO:0098978; GO:0099645,axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; postsynaptic density assembly [GO:0097107],endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133],metal ion binding [GO:0046872],GO:0005576; GO:0005783; GO:0007005; GO:0023052; GO:0031410; GO:0043226; GO:0048856,extracellular region; endoplasmic reticulum; mitochondrion organization; signaling; cytoplasmic vesicle; organelle; anatomical structure development
OG_12965,FUN_037030-T1,Peve_00023165,,apul_peve,30.645,,,,,,,,,,,,,,,,,
OG_12966,FUN_037041-T1,Peve_00044732,,apul_peve,79.13,,,,,,,,,,,,,,,,,
OG_12967,FUN_037074-T1,Peve_00004733,,apul_peve,33.647,,,,,,,,,,,,,,,,,
OG_12968,FUN_037081-T1,Peve_00032326,,apul_peve,62.291,FUN_037081-T1,Q6DBY9,CHST1_DANRE,,Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST),Danio rerio (Zebrafish) (Brachydanio rerio),26.8,380.0,5.7e-21,103.6,sp|Q6DBY9|CHST1_DANRE Carbohydrate sulfotransferase 1 OS=Danio rerio OX=7955 GN=chst1 PE=2 SV=2,GO:0000139; GO:0001517; GO:0005975; GO:0006044; GO:0042339; GO:0045130,carbohydrate metabolic process [GO:0005975]; keratan sulfate proteoglycan metabolic process [GO:0042339]; N-acetylglucosamine metabolic process [GO:0006044],Golgi membrane [GO:0000139],keratan sulfotransferase activity [GO:0045130]; N-acetylglucosamine 6-O-sulfotransferase activity [GO:0001517],GO:0003824; GO:0005975; GO:0016740; GO:1901135,catalytic activity; carbohydrate metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_12969,FUN_037086-T1,Peve_00004773,,apul_peve,44.612,,,,,,,,,,,,,,,,,
OG_12970,FUN_037088-T1,Peve_00004759,,apul_peve,55.233,FUN_037088-T1,Q8SQA4,,,,,31.8,311.0,7.4e-31,137.5,sp|Q8SQA4|AGRE5_BOVIN Adhesion G protein-coupled receptor E5 OS=Bos taurus OX=9913 GN=ADGRE5 PE=2 SV=1,,,,,,
OG_12971,FUN_037091-T1,Peve_00004756,,apul_peve,81.046,FUN_037091-T1,A2CEI6,PIWL2_DANRE,,Piwi-like protein 2 (EC 3.1.26.-),Danio rerio (Zebrafish) (Brachydanio rerio),49.3,762.0,1.4999999999999996e-229,797.7,sp|A2CEI6|PIWL2_DANRE Piwi-like protein 2 OS=Danio rerio OX=7955 GN=piwil2 PE=1 SV=2,GO:0004521; GO:0005634; GO:0005737; GO:0006417; GO:0007276; GO:0007283; GO:0010628; GO:0030718; GO:0031047; GO:0034584; GO:0034587; GO:0043186; GO:0046872; GO:0048477; GO:0048511; GO:0051321; GO:0060392; GO:0071546; GO:0140965; GO:0141005; GO:0141196; GO:1990923,gamete generation [GO:0007276]; germ-line stem cell population maintenance [GO:0030718]; meiotic cell cycle [GO:0051321]; negative regulation of SMAD protein signal transduction [GO:0060392]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; positive regulation of gene expression [GO:0010628]; regulation of translation [GO:0006417]; regulatory ncRNA-mediated gene silencing [GO:0031047]; rhythmic process [GO:0048511]; secondary piRNA processing [GO:0140965]; spermatogenesis [GO:0007283]; transposable element silencing by heterochromatin formation [GO:0141005]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytoplasm [GO:0005737]; nucleus [GO:0005634]; P granule [GO:0043186]; PET complex [GO:1990923]; pi-body [GO:0071546],metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; RNA endonuclease activity [GO:0004521],GO:0003723; GO:0003824; GO:0005634; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140098,"RNA binding; catalytic activity; nucleus; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_12972,FUN_037103-T1,Peve_00003257,,apul_peve,56.855,FUN_037103-T1,P42695,CNDD3_HUMAN,,Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3),Homo sapiens (Human),22.1,195.0,4.2e-09,63.2,sp|P42695|CNDD3_HUMAN Condensin-2 complex subunit D3 OS=Homo sapiens OX=9606 GN=NCAPD3 PE=1 SV=2,GO:0000779; GO:0000794; GO:0000796; GO:0005654; GO:0005721; GO:0007076; GO:0010032; GO:0016020; GO:0042393; GO:0051301; GO:0051984; GO:0140117; GO:1905820; GO:1905821,cell division [GO:0051301]; meiotic chromosome condensation [GO:0010032]; mitotic chromosome condensation [GO:0007076]; positive regulation of chromosome condensation [GO:1905821]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820],"condensed chromosome, centromeric region [GO:0000779]; condensed nuclear chromosome [GO:0000794]; condensin complex [GO:0000796]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]",histone binding [GO:0042393]; histone H4K20me1 reader activity [GO:0140117],GO:0000228; GO:0005654; GO:0005694; GO:0022414; GO:0042393; GO:0043226; GO:0060090,nuclear chromosome; nucleoplasm; chromosome; reproductive process; histone binding; organelle; molecular adaptor activity
OG_12973,FUN_037115-T1,Peve_00043568,,apul_peve,41.2035,,,,,,,,,,,,,,,,,
OG_12974,FUN_037149-T1,Peve_00040266,,apul_peve,70.69,,,,,,,,,,,,,,,,,
OG_12975,FUN_037172-T1,Peve_00027865,,apul_peve,56.211,FUN_037172-T1,Q766D5,,,,,40.2,311.0,2.6e-62,241.5,sp|Q766D5|B4GN4_MOUSE N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Mus musculus OX=10090 GN=B4galnt4 PE=2 SV=1,,,,,,
OG_12976,FUN_037176-T2,Peve_00018047,,apul_peve,49.465,,,,,,,,,,,,,,,,,
OG_12977,FUN_037187-T1,Peve_00028521,,apul_peve,44.224,,,,,,,,,,,,,,,,,
OG_12978,FUN_037202-T1,Peve_00017726,,apul_peve,90.278,,,,,,,,,,,,,,,,,
OG_12979,FUN_037208-T1,Peve_00019445,,apul_peve,53.478,FUN_037208-T1,P37198,NUP62_HUMAN,,Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62),Homo sapiens (Human),64.0,197.0,4.1e-63,244.2,sp|P37198|NUP62_HUMAN Nuclear pore glycoprotein p62 OS=Homo sapiens OX=9606 GN=NUP62 PE=1 SV=3,GO:0000922; GO:0003682; GO:0005543; GO:0005635; GO:0005643; GO:0005654; GO:0005737; GO:0005813; GO:0006405; GO:0006606; GO:0006913; GO:0007080; GO:0007098; GO:0007100; GO:0007166; GO:0008285; GO:0009966; GO:0017056; GO:0030159; GO:0030544; GO:0031965; GO:0042059; GO:0042169; GO:0043066; GO:0043069; GO:0043123; GO:0043130; GO:0044613; GO:0045742; GO:0045840; GO:0045893; GO:0046578; GO:0046580; GO:0046601; GO:0051028; GO:0051425; GO:0051879; GO:0060236; GO:0072686; GO:0090398; GO:0090543; GO:0098534; GO:1903438; GO:1904781; GO:1990904,cell surface receptor signaling pathway [GO:0007166]; cellular senescence [GO:0090398]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; mitotic centrosome separation [GO:0007100]; mitotic metaphase chromosome alignment [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; nucleocytoplasmic transport [GO:0006913]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of centriole replication [GO:0046601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of Ras protein signal transduction [GO:0046578]; regulation of signal transduction [GO:0009966]; RNA export from nucleus [GO:0006405],centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922],chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; structural constituent of nuclear pore [GO:0017056]; ubiquitin binding [GO:0043130],GO:0005198; GO:0005635; GO:0005654; GO:0005815; GO:0006355; GO:0006886; GO:0006913; GO:0008289; GO:0043226; GO:0060090,structural molecule activity; nuclear envelope; nucleoplasm; microtubule organizing center; regulation of DNA-templated transcription; intracellular protein transport; nucleocytoplasmic transport; lipid binding; organelle; molecular adaptor activity
OG_12980,FUN_037238-T1,Peve_00020385,,apul_peve,53.398,FUN_037238-T1,A0A1X7TVA9,,,,,30.3,310.0,1.3e-19,98.6,sp|A0A1X7TVA9|DDAN_AMPQE Death domain-containing ATP nucleosidase OS=Amphimedon queenslandica OX=400682 GN=109585858 PE=1 SV=1,,,,,,
OG_12981,FUN_037240-T2,Peve_00014720,,apul_peve,56.667,FUN_037240-T2,Q3UCV8,OTUL_MOUSE,,Ubiquitin thioesterase otulin (EC 3.4.19.12) (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby),Mus musculus (Mouse),38.9,270.0,3.6e-47,191.4,sp|Q3UCV8|OTUL_MOUSE Ubiquitin thioesterase otulin OS=Mus musculus OX=10090 GN=Otulin PE=1 SV=1,GO:0002040; GO:0004843; GO:0005737; GO:0006508; GO:0008234; GO:0010803; GO:0016055; GO:0032088; GO:0045087; GO:0050728; GO:0060828; GO:0070431; GO:1990108,innate immune response [GO:0045087]; negative regulation of inflammatory response [GO:0050728]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; protein linear deubiquitination [GO:1990108]; proteolysis [GO:0006508]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type peptidase activity [GO:0008234],GO:0002376; GO:0003824; GO:0006355; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; regulation of DNA-templated transcription; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_12982,FUN_037243-T1,Peve_00015120,,apul_peve,38.28,FUN_037243-T1,Q91ZY1,,,,,35.4,96.0,4.6e-06,54.3,sp|Q91ZY1|HRH4_RAT Histamine H4 receptor OS=Rattus norvegicus OX=10116 GN=Hrh4 PE=2 SV=1,,,,,,
OG_12983,FUN_037265-T1,Peve_00015124,,apul_peve,42.692,,,,,,,,,,,,,,,,,
OG_12984,FUN_037274-T1,Peve_00021411,,apul_peve,46.992,,,,,,,,,,,,,,,,,
OG_12985,FUN_037275-T1,Peve_00035813,,apul_peve,60.331,FUN_037275-T1,P43166,CAH7_HUMAN,,Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII),Homo sapiens (Human),35.1,185.0,1.1e-16,89.0,sp|P43166|CAH7_HUMAN Carbonic anhydrase 7 OS=Homo sapiens OX=9606 GN=CA7 PE=1 SV=1,GO:0004089; GO:0005737; GO:0005829; GO:0008270; GO:0032230; GO:0032849; GO:0051453; GO:0070050; GO:2001225,"neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]",cytoplasm [GO:0005737]; cytosol [GO:0005829],carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0016829,catalytic activity; cytosol; lyase activity
OG_12986,FUN_037276-T1,Peve_00001630,,apul_peve,63.7135,,,,,,,,,,,,,,,,,
OG_12987,FUN_037282-T1,Peve_00032190,,apul_peve,40.625,,,,,,,,,,,,,,,,,
OG_12988,FUN_037285-T1,Peve_00013167,,apul_peve,42.424,,,,,,,,,,,,,,,,,
OG_12989,FUN_037292-T1,Peve_00032667,,apul_peve,65.03,FUN_037292-T1,P43141,,,,,27.7,300.0,2.1e-10,68.2,sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1,,,,,,
OG_12990,FUN_037296-T1,Peve_00004413,,apul_peve,57.142,FUN_037296-T1,Q9ES87,PRSS8_RAT,,Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain],Rattus norvegicus (Rat),39.0,259.0,7.6e-48,192.6,sp|Q9ES87|PRSS8_RAT Prostasin OS=Rattus norvegicus OX=10116 GN=Prss8 PE=2 SV=3,GO:0001942; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0009410; GO:0009897; GO:0010765; GO:0017080; GO:0043434; GO:0045121; GO:0051385; GO:0070633; GO:1902307,hair follicle development [GO:0001942]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; proteolysis [GO:0006508]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; transepithelial transport [GO:0070633],external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_12991,FUN_037307-T1,Peve_00015039,,apul_peve,97.143,FUN_037307-T1,P40946,ARF6_DROME,,ADP-ribosylation factor 6 (ARF6) (ADP ribosylation factor at 51F) (ADP-ribosylation factor 3),Drosophila melanogaster (Fruit fly),90.8,174.0,1.7e-91,336.7,sp|P40946|ARF6_DROME ADP-ribosylation factor 6 OS=Drosophila melanogaster OX=7227 GN=Arf6 PE=1 SV=3,GO:0001745; GO:0003924; GO:0005525; GO:0005737; GO:0005769; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007112; GO:0007269; GO:0007283; GO:0007476; GO:0007520; GO:0008047; GO:0010628; GO:0016192; GO:0030036; GO:0032154; GO:0048149; GO:0048488; GO:0055037; GO:0097305; GO:0098793,actin cytoskeleton organization [GO:0030036]; behavioral response to ethanol [GO:0048149]; compound eye morphogenesis [GO:0001745]; imaginal disc-derived wing morphogenesis [GO:0007476]; intracellular protein transport [GO:0006886]; male meiosis cytokinesis [GO:0007112]; myoblast fusion [GO:0007520]; neurotransmitter secretion [GO:0007269]; positive regulation of gene expression [GO:0010628]; response to alcohol [GO:0097305]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037],enzyme activator activity [GO:0008047]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0000910; GO:0003824; GO:0003924; GO:0005768; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0007010; GO:0016192; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0098772,cytokinesis; catalytic activity; GTPase activity; endosome; Golgi apparatus; cytosol; plasma membrane; intracellular protein transport; cytoskeleton organization; vesicle-mediated transport; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_12992,FUN_037315-T1,Peve_00006163,,apul_peve,35.493,,,,,,,,,,,,,,,,,
OG_12993,FUN_037318-T1,Peve_00006219,,apul_peve,54.362,FUN_037318-T1,P30938,,,,,25.7,288.0,1e-09,65.9,sp|P30938|SSR5_RAT Somatostatin receptor type 5 OS=Rattus norvegicus OX=10116 GN=Sstr5 PE=1 SV=2,,,,,,
OG_12994,FUN_037356-T1,Peve_00037518,,apul_peve,51.415,,,,,,,,,,,,,,,,,
OG_12995,FUN_037365-T1,Peve_00034393,,apul_peve,88.522,,,,,,,,,,,,,,,,,
OG_12996,FUN_037366-T1,Peve_00034392,,apul_peve,87.158,,,,,,,,,,,,,,,,,
OG_12997,FUN_037371-T1,Peve_00039752,,apul_peve,47.735,FUN_037371-T1,P47747,,,,,24.3,321.0,1.7e-12,75.1,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_12998,FUN_037379-T1,Peve_00006194,,apul_peve,36.697,,,,,,,,,,,,,,,,,
OG_12999,FUN_037397-T1,Peve_00038952,,apul_peve,79.505,FUN_037397-T1,P47862,AQP3_RAT,,Aquaporin-3 (AQP-3) (31.4 kDa water channel protein) (Aquaglyceroporin-3),Rattus norvegicus (Rat),50.4,262.0,5.3e-71,269.2,sp|P47862|AQP3_RAT Aquaporin-3 OS=Rattus norvegicus OX=10116 GN=Aqp3 PE=2 SV=1,GO:0002684; GO:0002931; GO:0005737; GO:0005886; GO:0005911; GO:0006833; GO:0015166; GO:0015250; GO:0015254; GO:0015791; GO:0015793; GO:0015840; GO:0016323; GO:0032526; GO:0042476; GO:0042802; GO:0051649; GO:0070295; GO:0071456,cellular response to hypoxia [GO:0071456]; establishment of localization in cell [GO:0051649]; glycerol transmembrane transport [GO:0015793]; odontogenesis [GO:0042476]; polyol transmembrane transport [GO:0015791]; positive regulation of immune system process [GO:0002684]; renal water absorption [GO:0070295]; response to ischemia [GO:0002931]; response to retinoic acid [GO:0032526]; urea transport [GO:0015840]; water transport [GO:0006833],basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],glycerol channel activity [GO:0015254]; identical protein binding [GO:0042802]; polyol transmembrane transporter activity [GO:0015166]; water channel activity [GO:0015250],GO:0003014; GO:0005215; GO:0005886; GO:0055085,renal system process; transporter activity; plasma membrane; transmembrane transport
OG_13000,FUN_037401-T1,Peve_00038957,,apul_peve,66.342,,,,,,,,,,,,,,,,,
OG_13001,FUN_037402-T2,Peve_00028552,,apul_peve,46.85,,,,,,,,,,,,,,,,,
OG_13002,FUN_037403-T1,Peve_00028553,,apul_peve,47.323,,,,,,,,,,,,,,,,,
OG_13003,FUN_037406-T1,Peve_00014872,,apul_peve,49.828,FUN_037406-T1,Q9EST2,,,,,26.0,288.0,1e-16,89.0,sp|Q9EST2|HNMT_CAVPO Histamine N-methyltransferase OS=Cavia porcellus OX=10141 GN=HNMT PE=2 SV=1,,,,,,
OG_13004,FUN_037417-T1,Peve_00031385,,apul_peve,82.92099999999999,FUN_037417-T1,O15066,KIF3B_HUMAN,,"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]",Homo sapiens (Human),68.2,510.0,1.5e-133,478.0,sp|O15066|KIF3B_HUMAN Kinesin-like protein KIF3B OS=Homo sapiens OX=9606 GN=KIF3B PE=1 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005813; GO:0005829; GO:0005871; GO:0005873; GO:0005874; GO:0005929; GO:0007018; GO:0007052; GO:0007100; GO:0007368; GO:0008017; GO:0008089; GO:0008574; GO:0015630; GO:0016020; GO:0016192; GO:0016887; GO:0016939; GO:0030425; GO:0030496; GO:0031267; GO:0032467; GO:0032839; GO:0036372; GO:0042073; GO:0043197; GO:0060271; GO:0070062; GO:0072383; GO:0090307; GO:0097542; GO:0098971; GO:0098978; GO:0120170; GO:1904115,anterograde axonal transport [GO:0008089]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; opsin transport [GO:0036372]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; vesicle-mediated transport [GO:0016192],axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574]; small GTPase binding [GO:0031267],GO:0003774; GO:0003824; GO:0005815; GO:0005829; GO:0005856; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0016192; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytosol; cytoskeleton; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; isomerase activity; organelle; cilium organization; ATP-dependent activity
OG_13005,FUN_037421-T1,Peve_00013025,,apul_peve,40.143,,,,,,,,,,,,,,,,,
OG_13006,FUN_037438-T1,Peve_00014249,,apul_peve,30.3385,,,,,,,,,,,,,,,,,
OG_13007,FUN_037442-T1,Peve_00033018,,apul_peve,67.683,FUN_037442-T1,Q9BSW2,EFC4B_HUMAN,,EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated calcium channel regulator 2A) (CRAC channel regulator 2A) (Calcium release-activated channel regulator 2A) (Ras-related protein Rab-46) (EC 3.6.5.2),Homo sapiens (Human),43.7,229.0,3.3e-47,191.8,sp|Q9BSW2|EFC4B_HUMAN EF-hand calcium-binding domain-containing protein 4B OS=Homo sapiens OX=9606 GN=CRACR2A PE=1 SV=2,GO:0000139; GO:0001772; GO:0002115; GO:0002250; GO:0003924; GO:0005509; GO:0005525; GO:0005576; GO:0005737; GO:0005815; GO:0005886; GO:0008104; GO:0016020; GO:0016192; GO:0016197; GO:0031982; GO:0032237; GO:0032588; GO:0033093; GO:0034776; GO:0035580; GO:0045063; GO:0046330; GO:0051928,activation of store-operated calcium channel activity [GO:0032237]; adaptive immune response [GO:0002250]; endosomal transport [GO:0016197]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of JNK cascade [GO:0046330]; protein localization [GO:0008104]; response to histamine [GO:0034776]; store-operated calcium entry [GO:0002115]; T-helper 1 cell differentiation [GO:0045063]; vesicle-mediated transport [GO:0016192],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; immunological synapse [GO:0001772]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; trans-Golgi network membrane [GO:0032588]; vesicle [GO:0031982]; Weibel-Palade body [GO:0033093],calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0002376; GO:0003824; GO:0003924; GO:0005576; GO:0005815; GO:0005886; GO:0016192; GO:0016787; GO:0030154; GO:0031410; GO:0043226,immune system process; catalytic activity; GTPase activity; extracellular region; microtubule organizing center; plasma membrane; vesicle-mediated transport; hydrolase activity; cell differentiation; cytoplasmic vesicle; organelle
OG_13008,FUN_037443-T2,Peve_00027241,,apul_peve,82.69,FUN_037443-T2,Q7Z4S6,KI21A_HUMAN,,Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62),Homo sapiens (Human),38.0,1411.0,1.5e-163,578.9,sp|Q7Z4S6|KI21A_HUMAN Kinesin-like protein KIF21A OS=Homo sapiens OX=9606 GN=KIF21A PE=1 SV=2,GO:0003777; GO:0005524; GO:0005737; GO:0005829; GO:0005871; GO:0005874; GO:0005938; GO:0007018; GO:0008017; GO:0008089; GO:0008574; GO:0016887; GO:0030425; GO:0031113; GO:0031114; GO:0043622; GO:0044295; GO:0071532; GO:0098793; GO:1902667; GO:1904115,anterograde axonal transport [GO:0008089]; cortical microtubule organization [GO:0043622]; microtubule-based movement [GO:0007018]; regulation of axon guidance [GO:1902667]; regulation of microtubule depolymerization [GO:0031114]; regulation of microtubule polymerization [GO:0031113],axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; presynapse [GO:0098793],ankyrin repeat binding [GO:0071532]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574],GO:0003774; GO:0003824; GO:0005829; GO:0007010; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; cytosol; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; ATP-dependent activity
OG_13009,FUN_037450-T1,Peve_00007928,,apul_peve,52.792,FUN_037450-T1,Q9VXD9,MTH1_DROME,,Probable G-protein coupled receptor Mth-like 1 (Protein methuselah-like 1),Drosophila melanogaster (Fruit fly),27.1,203.0,8.8e-08,58.9,sp|Q9VXD9|MTH1_DROME Probable G-protein coupled receptor Mth-like 1 OS=Drosophila melanogaster OX=7227 GN=mthl1 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007166; GO:0007186; GO:0007369; GO:0007472; GO:0007476; GO:0007509; GO:0008340; GO:0016020; GO:0042594; GO:0043519; GO:0048383; GO:0070252,actin-mediated cell contraction [GO:0070252]; cell surface receptor signaling pathway [GO:0007166]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation [GO:0007369]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesectoderm development [GO:0048383]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of myosin II filament organization [GO:0043519]; response to starvation [GO:0042594]; wing disc morphogenesis [GO:0007472],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0048856; GO:0048870; GO:0060089,plasma membrane; anatomical structure development; cell motility; molecular transducer activity
OG_13010,FUN_037453-T1,Peve_00044117,,apul_peve,41.558,FUN_037453-T1,B3DIG4,FZD5_DANRE,,Frizzled-5 (Fz-5),Danio rerio (Zebrafish) (Brachydanio rerio),42.2,90.0,5.7e-15,83.2,sp|B3DIG4|FZD5_DANRE Frizzled-5 OS=Danio rerio OX=7955 GN=fzd5 PE=2 SV=1,GO:0000139; GO:0001654; GO:0001889; GO:0004930; GO:0005886; GO:0008289; GO:0016055; GO:0017147; GO:0030154; GO:0030424; GO:0030425; GO:0035567; GO:0042813; GO:0043010; GO:0043204; GO:0045202; GO:0048794; GO:0060070; GO:0090090,camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; eye development [GO:0001654]; liver development [GO:0001889]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; non-canonical Wnt signaling pathway [GO:0035567]; swim bladder development [GO:0048794]; Wnt signaling pathway [GO:0016055],axon [GO:0030424]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; synapse [GO:0045202],G protein-coupled receptor activity [GO:0004930]; lipid binding [GO:0008289]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005886; GO:0008289; GO:0030154; GO:0048856; GO:0060089,plasma membrane; lipid binding; cell differentiation; anatomical structure development; molecular transducer activity
OG_13011,FUN_037461-T1,Peve_00036028,,apul_peve,72.5915,,,,,,,,,,,,,,,,,
OG_13012,FUN_037472-T1,Peve_00036024,,apul_peve,33.03,FUN_037472-T1,B3EWZ7,,,,,83.8,148.0,5.1e-66,253.1,sp|B3EWZ7|TRP_ACRMI Threonine-rich protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_13013,FUN_037479-T1,Peve_00020429,,apul_peve,55.112,FUN_037479-T1,P53461,,,,,67.1,371.0,1e-145,520.4,"sp|P53461|ACTC_HALRO Actin, nonmuscle OS=Halocynthia roretzi OX=7729 GN=CA1 PE=3 SV=1",,,,,,
OG_13014,FUN_037490-T1,Peve_00034260,,apul_peve,90.303,FUN_037490-T1,Q6NZZ9,RBM22_DANRE,,Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22),Danio rerio (Zebrafish) (Brachydanio rerio),67.7,362.0,3.3e-147,523.1,sp|Q6NZZ9|RBM22_DANRE Pre-mRNA-splicing factor RBM22 OS=Danio rerio OX=7955 GN=rbm22 PE=2 SV=1,GO:0000974; GO:0005634; GO:0005737; GO:0008270; GO:0017070; GO:0033120; GO:0036002; GO:0043009; GO:0045292; GO:0071006; GO:0071007,"chordate embryonic development [GO:0043009]; mRNA cis splicing, via spliceosome [GO:0045292]; positive regulation of RNA splicing [GO:0033120]",cytoplasm [GO:0005737]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007],pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]; zinc ion binding [GO:0008270],GO:0003723; GO:0005634; GO:0016071; GO:0043226; GO:0048856,RNA binding; nucleus; mRNA metabolic process; organelle; anatomical structure development
OG_13015,FUN_037500-T1,Peve_00032998,,apul_peve,37.363,,,,,,,,,,,,,,,,,
OG_13016,FUN_037510-T2,Peve_00028559,,apul_peve,83.207,FUN_037510-T2,C9D7C2,,,,,45.3,1538.0,0.0,1085.5,sp|C9D7C2|CAC1A_APIME Voltage-dependent calcium channel type A subunit alpha-1 OS=Apis mellifera OX=7460 GN=CAC PE=2 SV=1,,,,,,
OG_13017,FUN_037518-T1,Peve_00025028,,apul_peve,45.734,FUN_037518-T1,A0A1D5NSM8,SVEP1_DANRE,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (Polydom)",Danio rerio (Zebrafish) (Brachydanio rerio),27.2,213.0,7.7e-13,76.3,"sp|A0A1D5NSM8|SVEP1_DANRE Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Danio rerio OX=7955 GN=svep1 PE=1 SV=1",GO:0001945; GO:0005509; GO:0005576; GO:0005634; GO:0005737; GO:0008544; GO:0009913; GO:0016020; GO:0016477; GO:0036303; GO:0090136,cell migration [GO:0016477]; epidermal cell differentiation [GO:0009913]; epidermis development [GO:0008544]; epithelial cell-cell adhesion [GO:0090136]; lymph vessel development [GO:0001945]; lymph vessel morphogenesis [GO:0036303],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509],GO:0005576; GO:0005634; GO:0007155; GO:0030154; GO:0043226; GO:0048856; GO:0048870,extracellular region; nucleus; cell adhesion; cell differentiation; organelle; anatomical structure development; cell motility
OG_13018,FUN_037522-T1,Peve_00040389,,apul_peve,42.8,FUN_037522-T1,Q96A99,,,,,31.0,142.0,3.2e-11,70.5,sp|Q96A99|PTX4_HUMAN Pentraxin-4 OS=Homo sapiens OX=9606 GN=PTX4 PE=2 SV=2,,,,,,
OG_13019,FUN_037525-T1,Peve_00036449,,apul_peve,53.516,,,,,,,,,,,,,,,,,
OG_13020,FUN_037542-T1,Peve_00031179,,apul_peve,37.271,,,,,,,,,,,,,,,,,
OG_13021,FUN_037554-T1,Peve_00044136,,apul_peve,64.417,FUN_037554-T1,Q9H427,KCNKF_HUMAN,,Potassium channel subfamily K member 15 (Acid-sensitive potassium channel protein TASK-5) (TWIK-related acid-sensitive K(+) channel 5) (Two pore potassium channel KT3.3) (Two pore K(+) channel KT3.3),Homo sapiens (Human),38.7,142.0,2.3e-18,93.6,sp|Q9H427|KCNKF_HUMAN Potassium channel subfamily K member 15 OS=Homo sapiens OX=9606 GN=KCNK15 PE=1 SV=3,GO:0005886; GO:0022841; GO:0034702; GO:0071805,potassium ion transmembrane transport [GO:0071805],monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],potassium ion leak channel activity [GO:0022841],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_13022,FUN_037559-T4,Peve_00030227,,apul_peve,51.288,FUN_037559-T4,Q61382,TRAF4_MOUSE,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1),Mus musculus (Mouse),27.6,475.0,2e-58,228.0,sp|Q61382|TRAF4_MOUSE TNF receptor-associated factor 4 OS=Mus musculus OX=10090 GN=Traf4 PE=1 SV=2,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007165; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; defense response to other organism
OG_13023,FUN_037578-T1,Peve_00021278,,apul_peve,83.333,,,,,,,,,,,,,,,,,
OG_13024,FUN_037592-T2,Peve_00035309,,apul_peve,68.696,FUN_037592-T2,A4L691,PINX1_RAT,,PIN2/TERF1-interacting telomerase inhibitor 1 (Pin2-interacting protein X1),Rattus norvegicus (Rat),43.1,204.0,1.1e-37,159.1,sp|A4L691|PINX1_RAT PIN2/TERF1-interacting telomerase inhibitor 1 OS=Rattus norvegicus OX=10116 GN=Pinx1 PE=1 SV=1,GO:0000228; GO:0000776; GO:0000781; GO:0005730; GO:0005819; GO:0007004; GO:0007080; GO:0010521; GO:0010972; GO:0031397; GO:0031647; GO:0032211; GO:0044877; GO:0070034; GO:0070198; GO:1902570; GO:1904751,"mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of protein localization to nucleolus [GO:1904751]; protein localization to chromosome, telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; telomere maintenance via telomerase [GO:0007004]","chromosome, telomeric region [GO:0000781]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; spindle [GO:0005819]",protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034],GO:0000228; GO:0003723; GO:0005694; GO:0005730; GO:0032200; GO:0043226; GO:0098772,nuclear chromosome; RNA binding; chromosome; nucleolus; telomere organization; organelle; molecular function regulator activity
OG_13025,FUN_037593-T1,Peve_00035290,,apul_peve,70.201,FUN_037593-T1,Q9BXB4,,,,,43.0,498.0,2e-87,324.7,sp|Q9BXB4|OSB11_HUMAN Oxysterol-binding protein-related protein 11 OS=Homo sapiens OX=9606 GN=OSBPL11 PE=1 SV=2,,,,,,
OG_13026,FUN_037679-T1,Peve_00033288,,apul_peve,76.154,FUN_037679-T1,O95185,,,,,47.2,106.0,7.7e-22,109.0,sp|O95185|UNC5C_HUMAN Netrin receptor UNC5C OS=Homo sapiens OX=9606 GN=UNC5C PE=1 SV=2,,,,,,
OG_13027,FUN_037692-T1,Peve_00001245,,apul_peve,69.207,FUN_037692-T1,Q9UHM6,,,,,30.1,289.0,3.2e-29,131.0,sp|Q9UHM6|OPN4_HUMAN Melanopsin OS=Homo sapiens OX=9606 GN=OPN4 PE=1 SV=1,,,,,,
OG_13028,FUN_037693-T1,Peve_00044130,,apul_peve,51.675,FUN_037693-T1,Q4LDE5,SVEP1_HUMAN,,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)",Homo sapiens (Human),45.0,180.0,6.700000000000001e-36,152.9,"sp|Q4LDE5|SVEP1_HUMAN Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=SVEP1 PE=1 SV=3",GO:0003017; GO:0003682; GO:0005178; GO:0005509; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0008544; GO:0010467; GO:0010572; GO:0016020; GO:0036303; GO:0045906; GO:0048014; GO:0098640; GO:0120193,epidermis development [GO:0008544]; gene expression [GO:0010467]; lymph circulation [GO:0003017]; lymph vessel morphogenesis [GO:0036303]; negative regulation of vasoconstriction [GO:0045906]; positive regulation of platelet activation [GO:0010572]; Tie signaling pathway [GO:0048014]; tight junction organization [GO:0120193],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; integrin binding [GO:0005178]; integrin binding involved in cell-matrix adhesion [GO:0098640],GO:0003013; GO:0005576; GO:0005615; GO:0005634; GO:0034330; GO:0043226; GO:0048856; GO:0098631,circulatory system process; extracellular region; extracellular space; nucleus; cell junction organization; organelle; anatomical structure development; cell adhesion mediator activity
OG_13029,FUN_037706-T1,Peve_00027438,,apul_peve,61.111,FUN_037706-T1,P97259,,,,,42.2,545.0,2.1e-125,451.1,"sp|P97259|MGT5A_CRIGR Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Cricetulus griseus OX=10029 GN=MGAT5 PE=1 SV=1",,,,,,
OG_13030,FUN_037716-T1,Peve_00009807,,apul_peve,38.532,,,,,,,,,,,,,,,,,
OG_13031,FUN_037730-T1,Peve_00044275,,apul_peve,58.735,,,,,,,,,,,,,,,,,
OG_13032,FUN_037735-T1,Peve_00004122,,apul_peve,56.636,,,,,,,,,,,,,,,,,
OG_13033,FUN_037736-T1,Peve_00037928,,apul_peve,57.31,,,,,,,,,,,,,,,,,
OG_13034,FUN_037749-T1,Peve_00038309,,apul_peve,44.6555,FUN_037749-T1,A2BIL7,BAZ1B_DANRE,,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor homolog),Danio rerio (Zebrafish) (Brachydanio rerio),41.4,128.0,7.9e-18,93.6,sp|A2BIL7|BAZ1B_DANRE Tyrosine-protein kinase BAZ1B OS=Danio rerio OX=7955 GN=baz1b PE=1 SV=2,GO:0004715; GO:0005524; GO:0005634; GO:0006338; GO:0006974; GO:0008270; GO:0035173; GO:0042393; GO:0043687; GO:0090535; GO:0140801,chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; post-translational protein modification [GO:0043687],nucleus [GO:0005634]; WICH complex [GO:0090535],ATP binding [GO:0005524]; histone binding [GO:0042393]; histone H2AXY142 kinase activity [GO:0140801]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006325; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromatin organization; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_13035,FUN_037782-T1,Peve_00040705,,apul_peve,63.107,FUN_037782-T1,O76082,S22A5_HUMAN,,Organic cation/carnitine transporter 2 (High-affinity sodium-dependent carnitine cotransporter) (Solute carrier family 22 member 5),Homo sapiens (Human),35.2,409.0,3.0999999999999997e-53,211.1,sp|O76082|S22A5_HUMAN Organic cation/carnitine transporter 2 OS=Homo sapiens OX=9606 GN=SLC22A5 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005783; GO:0005829; GO:0005886; GO:0006814; GO:0009609; GO:0009925; GO:0015199; GO:0015226; GO:0015293; GO:0015651; GO:0015697; GO:0015879; GO:0016324; GO:0030165; GO:0031526; GO:0034341; GO:0034612; GO:0042910; GO:0060731; GO:0070062; GO:0070715; GO:0150104; GO:1900749; GO:1901235; GO:1902270; GO:1902603; GO:1990961,(R)-carnitine transmembrane transport [GO:1902270]; (R)-carnitine transport [GO:1900749]; carnitine transmembrane transport [GO:1902603]; carnitine transport [GO:0015879]; positive regulation of intestinal epithelial structure maintenance [GO:0060731]; quaternary ammonium group transport [GO:0015697]; response to symbiotic bacterium [GO:0009609]; response to tumor necrosis factor [GO:0034612]; response to type II interferon [GO:0034341]; sodium ion transport [GO:0006814]; sodium-dependent organic cation transport [GO:0070715]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886],(R)-carnitine transmembrane transporter activity [GO:1901235]; amino-acid betaine transmembrane transporter activity [GO:0015199]; ATP binding [GO:0005524]; carnitine transmembrane transporter activity [GO:0015226]; PDZ domain binding [GO:0030165]; quaternary ammonium group transmembrane transporter activity [GO:0015651]; symporter activity [GO:0015293]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003013; GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0055085,circulatory system process; transporter activity; endoplasmic reticulum; cytosol; plasma membrane; organelle; transmembrane transport
OG_13036,FUN_037787-T1,Peve_00014324,,apul_peve,44.51,,,,,,,,,,,,,,,,,
OG_13037,FUN_037807-T1,Peve_00003978,,apul_peve,72.965,FUN_037807-T1,Q8INF0,GCY8E_DROME,,Soluble guanylate cyclase 88E (EC 4.6.1.2),Drosophila melanogaster (Fruit fly),37.0,679.0,3.6e-126,453.8,sp|Q8INF0|GCY8E_DROME Soluble guanylate cyclase 88E OS=Drosophila melanogaster OX=7227 GN=Gyc88E PE=1 SV=4,GO:0000302; GO:0001666; GO:0003924; GO:0004383; GO:0005525; GO:0008074; GO:0019825; GO:0019826; GO:0019899; GO:0019934; GO:0020037; GO:0038060; GO:0042803; GO:0046872; GO:0046982; GO:0070025; GO:0070026; GO:0070482,cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to hypoxia [GO:0001666]; response to oxygen levels [GO:0070482]; response to reactive oxygen species [GO:0000302],"guanylate cyclase complex, soluble [GO:0008074]",carbon monoxide binding [GO:0070025]; enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0009975; GO:0016787; GO:0016829; GO:0098772; GO:0140299,catalytic activity; GTPase activity; cyclase activity; hydrolase activity; lyase activity; molecular function regulator activity; molecular sensor activity
OG_13038,FUN_037822-T1,Peve_00003108,,apul_peve,72.962,FUN_037822-T1,Q91YN5,UAP1_MOUSE,,UDP-N-acetylhexosamine pyrophosphorylase (Protein-pyrophosphorylation enzyme) (EC 2.7.4.-) (UDP-N-acetylgalactosamine pyrophosphorylase) (EC 2.7.7.83) (UDP-N-acetylglucosamine pyrophosphorylase) (EC 2.7.7.23),Mus musculus (Mouse),51.5,507.0,4.7e-139,496.1,sp|Q91YN5|UAP1_MOUSE UDP-N-acetylhexosamine pyrophosphorylase OS=Mus musculus OX=10090 GN=Uap1 PE=1 SV=1,GO:0003977; GO:0005829; GO:0006048; GO:0045087; GO:0052630; GO:0141090,innate immune response [GO:0045087]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],cytosol [GO:0005829],protein serine pyrophosphorylase activity [GO:0141090]; UDP-N-acetylgalactosamine diphosphorylase activity [GO:0052630]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977],GO:0002376; GO:0003824; GO:0005829; GO:0016740; GO:0055086; GO:0098542; GO:1901135,immune system process; catalytic activity; cytosol; transferase activity; nucleobase-containing small molecule metabolic process; defense response to other organism; carbohydrate derivative metabolic process
OG_13039,FUN_037823-T1,Peve_00003111,,apul_peve,47.039,,,,,,,,,,,,,,,,,
OG_13040,FUN_037839-T1,Peve_00000572,,apul_peve,65.7885,FUN_037839-T1,Q3UHH1,ZSWM8_MOUSE,,Zinc finger SWIM domain-containing protein 8,Mus musculus (Mouse),35.1,2133.0,1.2e-277,958.4,sp|Q3UHH1|ZSWM8_MOUSE Zinc finger SWIM domain-containing protein 8 OS=Mus musculus OX=10090 GN=Zswim8 PE=1 SV=1,GO:0005829; GO:0008270; GO:0016567; GO:0031461; GO:0031463; GO:0043161; GO:1990756; GO:2000627,positive regulation of miRNA catabolic process [GO:2000627]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul3-RING ubiquitin ligase complex [GO:0031463]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829],ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; zinc ion binding [GO:0008270],GO:0005829; GO:0030163; GO:0060090,cytosol; protein catabolic process; molecular adaptor activity
OG_13041,FUN_037840-T1,Peve_00007954,,apul_peve,56.955,FUN_037840-T1,F1LR10,LIMA1_RAT,,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),Rattus norvegicus (Rat),47.1,121.0,2.7e-27,125.9,sp|F1LR10|LIMA1_RAT LIM domain and actin-binding protein 1 OS=Rattus norvegicus OX=10116 GN=Lima1 PE=1 SV=2,GO:0001725; GO:0001726; GO:0003785; GO:0005737; GO:0005884; GO:0005886; GO:0005903; GO:0005925; GO:0008203; GO:0015629; GO:0016477; GO:0030299; GO:0030835; GO:0031526; GO:0031529; GO:0032154; GO:0042632; GO:0046872; GO:0051015; GO:0051017; GO:1902018,actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cilium assembly [GO:1902018]; ruffle organization [GO:0031529],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; metal ion binding [GO:0046872],GO:0005856; GO:0005886; GO:0006629; GO:0008092; GO:0022600; GO:0043226; GO:0048870,cytoskeleton; plasma membrane; lipid metabolic process; cytoskeletal protein binding; digestive system process; organelle; cell motility
OG_13042,FUN_037850-T2,Peve_00018231,,apul_peve,63.021,FUN_037850-T2,O45782,,,,,27.8,309.0,6.7e-18,93.2,sp|O45782|ARD17_CAEEL Arrestin domain-containing protein 17 OS=Caenorhabditis elegans OX=6239 GN=arrd-17 PE=1 SV=2,,,,,,
OG_13043,FUN_037855-T1,Peve_00024516,,apul_peve,68.409,FUN_037855-T1,Q8NCM2,KCNH5_HUMAN,,Voltage-gated delayed rectifier potassium channel KCNH5 (Ether-a-go-go potassium channel 2) (hEAG2) (Potassium voltage-gated channel subfamily H member 5) (Voltage-gated potassium channel subunit Kv10.2),Homo sapiens (Human),24.8,319.0,1.1e-11,72.8,sp|Q8NCM2|KCNH5_HUMAN Voltage-gated delayed rectifier potassium channel KCNH5 OS=Homo sapiens OX=9606 GN=KCNH5 PE=1 SV=3,GO:0005249; GO:0005251; GO:0005516; GO:0005886; GO:0006813; GO:0008076; GO:0009986; GO:0010389; GO:0042391; GO:0044325; GO:0044877; GO:0071805,potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of membrane potential [GO:0042391],cell surface [GO:0009986]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076],calmodulin binding [GO:0005516]; delayed rectifier potassium channel activity [GO:0005251]; protein-containing complex binding [GO:0044877]; transmembrane transporter binding [GO:0044325]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_13044,FUN_037858-T1,Peve_00019306,,apul_peve,75.0,FUN_037858-T1,Q24278,CNGA_DROME,,Cyclic nucleotide-gated cation channel subunit A (Cyclic nucleotide-gated ion channel subunit A) (CNG channel),Drosophila melanogaster (Fruit fly),26.8,377.0,3.9e-32,140.6,sp|Q24278|CNGA_DROME Cyclic nucleotide-gated cation channel subunit A OS=Drosophila melanogaster OX=7227 GN=CngA PE=2 SV=2,GO:0001666; GO:0005221; GO:0005222; GO:0005223; GO:0005886; GO:0017071; GO:0030553; GO:0044877; GO:0098655,monoatomic cation transmembrane transport [GO:0098655]; response to hypoxia [GO:0001666],intracellular cyclic nucleotide activated cation channel complex [GO:0017071]; plasma membrane [GO:0005886],cGMP binding [GO:0030553]; intracellularly cAMP-activated cation channel activity [GO:0005222]; intracellularly cGMP-activated cation channel activity [GO:0005223]; intracellularly cyclic nucleotide-activated monoatomic cation channel activity [GO:0005221]; protein-containing complex binding [GO:0044877],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_13045,FUN_037859-T1,Peve_00022155,,apul_peve,58.0,FUN_037859-T1,Q9UHR5,,,,,56.1,114.0,4.2e-28,126.7,sp|Q9UHR5|S30BP_HUMAN SAP30-binding protein OS=Homo sapiens OX=9606 GN=SAP30BP PE=1 SV=1,,,,,,
OG_13046,FUN_037865-T1,Peve_00018230,,apul_peve,72.346,FUN_037865-T1,O45782,,,,,25.0,428.0,2.8000000000000002e-33,144.4,sp|O45782|ARD17_CAEEL Arrestin domain-containing protein 17 OS=Caenorhabditis elegans OX=6239 GN=arrd-17 PE=1 SV=2,,,,,,
OG_13047,FUN_037866-T1,Peve_00024536,,apul_peve,71.134,FUN_037866-T1,Q6TXF1,,,,,27.6,275.0,3.5e-30,133.7,sp|Q6TXF1|ARRD3_RAT Arrestin domain-containing protein 3 OS=Rattus norvegicus OX=10116 GN=Arrdc3 PE=2 SV=1,,,,,,
OG_13048,FUN_037924-T1,Peve_00005840,,apul_peve,80.589,FUN_037924-T1,Q9Y2W2,WBP11_HUMAN,,WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1),Homo sapiens (Human),40.0,140.0,7.2e-19,97.1,sp|Q9Y2W2|WBP11_HUMAN WW domain-binding protein 11 OS=Homo sapiens OX=9606 GN=WBP11 PE=1 SV=1,GO:0003697; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006364; GO:0006397; GO:0008380; GO:0043231; GO:0050699,mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; WW domain binding [GO:0050699],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleus; nucleoplasm; cytosol; mRNA metabolic process; organelle
OG_13049,FUN_037928-T1,Peve_00012005,,apul_peve,71.574,FUN_037928-T1,Q96CG8,CTHR1_HUMAN,,Collagen triple helix repeat-containing protein 1,Homo sapiens (Human),43.2,139.0,1.1000000000000001e-30,134.8,sp|Q96CG8|CTHR1_HUMAN Collagen triple helix repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=CTHRC1 PE=1 SV=1,GO:0001649; GO:0004666; GO:0005109; GO:0005576; GO:0005581; GO:0005615; GO:0005737; GO:0016528; GO:0017147; GO:0019371; GO:0033687; GO:0033690; GO:0043005; GO:0043932; GO:0045669; GO:0060071; GO:0060122; GO:0062023; GO:0090090; GO:0090103; GO:0090177,"cochlea morphogenesis [GO:0090103]; cyclooxygenase pathway [GO:0019371]; establishment of planar polarity involved in neural tube closure [GO:0090177]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; ossification involved in bone remodeling [GO:0043932]; osteoblast differentiation [GO:0001649]; osteoblast proliferation [GO:0033687]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; sarcoplasm [GO:0016528],frizzled binding [GO:0005109]; prostaglandin-endoperoxide synthase activity [GO:0004666]; Wnt-protein binding [GO:0017147],GO:0003824; GO:0005576; GO:0005615; GO:0006629; GO:0016491; GO:0030154,catalytic activity; extracellular region; extracellular space; lipid metabolic process; oxidoreductase activity; cell differentiation
OG_13050,FUN_037940-T1,Peve_00027809,,apul_peve,99.202,FUN_037940-T1,P12716,,,,,97.6,376.0,1.6e-216,753.1,"sp|P12716|ACTC_PISOC Actin, cytoplasmic OS=Pisaster ochraceus OX=7612 PE=3 SV=1",,,,,,
OG_13051,FUN_037948-T1,Peve_00040738,,apul_peve,97.26,FUN_037948-T1,Q9VHI4,,,,,71.8,71.0,1.8e-27,122.9,sp|Q9VHI4|SF3B5_DROME Splicing factor 3B subunit 5 OS=Drosophila melanogaster OX=7227 GN=Sf3b5 PE=1 SV=1,,,,,,
OG_13052,FUN_037959-T2,Peve_00015022,,apul_peve,66.506,FUN_037959-T2,Q08E50,GBRA5_BOVIN,,Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) (GABAAR subunit alpha-5),Bos taurus (Bovine),28.3,453.0,7.9e-51,203.0,sp|Q08E50|GBRA5_BOVIN Gamma-aminobutyric acid receptor subunit alpha-5 OS=Bos taurus OX=9913 GN=GABRA5 PE=2 SV=1,GO:0004890; GO:0007214; GO:0022851; GO:0032590; GO:0034707; GO:0045211; GO:0051932; GO:0098794; GO:1902476; GO:1902711; GO:1904862,"chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851],GO:0005215; GO:0023052; GO:0034330; GO:0055085; GO:0060089,transporter activity; signaling; cell junction organization; transmembrane transport; molecular transducer activity
OG_13053,FUN_037987-T1,Peve_00017110,,apul_peve,83.809,,,,,,,,,,,,,,,,,
OG_13054,FUN_038001-T1,Peve_00004456,,apul_peve,90.278,FUN_038001-T1,Q95V84,,,,,95.7,70.0,2.8e-29,129.0,sp|Q95V84|RL38_BRABE Large ribosomal subunit protein eL38 OS=Branchiostoma belcheri OX=7741 GN=RPL38 PE=3 SV=1,,,,,,
OG_13055,FUN_038010-T1,Peve_00022135,,apul_peve,69.986,FUN_038010-T1,Q80Y81,,,,,28.5,737.0,1.3e-74,282.7,sp|Q80Y81|RNZ2_MOUSE Zinc phosphodiesterase ELAC protein 2 OS=Mus musculus OX=10090 GN=Elac2 PE=1 SV=1,,,,,,
OG_13056,FUN_038012-T1,Peve_00022136,,apul_peve,50.315,FUN_038012-T1,Q8R4S6,,,,,27.0,477.0,3.2e-32,142.1,sp|Q8R4S6|AHR_MUSMC Aryl hydrocarbon receptor OS=Mus musculus castaneus OX=10091 GN=Ahr PE=2 SV=1,,,,,,
OG_13057,FUN_038019-T3,Peve_00022787,,apul_peve,47.2435,,,,,,,,,,,,,,,,,
OG_13058,FUN_038043-T1,Peve_00019951,,apul_peve,87.18799999999999,FUN_038043-T1,Q8K4Q0,,,,,60.9,1344.0,0.0,1619.4,sp|Q8K4Q0|RPTOR_MOUSE Regulatory-associated protein of mTOR OS=Mus musculus OX=10090 GN=Rptor PE=1 SV=1,,,,,,
OG_13059,FUN_038046-T1,Peve_00028869,,apul_peve,58.378,FUN_038046-T1,C6KFA3,AGRG6_DANRE,,"Adhesion G-protein coupled receptor G6 (G-protein coupled receptor 126) [Cleaved into: Adhesion G-protein coupled receptor G6, N-terminal fragment (ADGRG6 N-terminal fragment) (ADGRG6-NTF); Adhesion G-protein coupled receptor G6, C-terminal fragment (ADGRG6 C-terminal fragment) (ADGRG6-CTF)]",Danio rerio (Zebrafish) (Brachydanio rerio),34.3,140.0,4.5e-11,71.2,sp|C6KFA3|AGRG6_DANRE Adhesion G-protein coupled receptor G6 OS=Danio rerio OX=7955 GN=adgrg6 PE=1 SV=1,GO:0001503; GO:0004930; GO:0005518; GO:0005886; GO:0007005; GO:0007166; GO:0007188; GO:0007189; GO:0007193; GO:0007507; GO:0014037; GO:0022011; GO:0030500; GO:0032290; GO:0042552; GO:0043236; GO:0043583; GO:0048932; GO:0050840; GO:0051216; GO:0060347; GO:0060879; GO:1903670,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of bone mineralization [GO:0030500]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879],plasma membrane [GO:0005886],collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236],GO:0005886; GO:0007005; GO:0030154; GO:0048856; GO:0060089,plasma membrane; mitochondrion organization; cell differentiation; anatomical structure development; molecular transducer activity
OG_13060,FUN_038050-T1,Peve_00020387,,apul_peve,47.817,FUN_038050-T1,C3YWU0,FUCO_BRAFL,,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),Branchiostoma floridae (Florida lancelet) (Amphioxus),56.2,436.0,4.8e-156,553.5,sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2,GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139,fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],extracellular region [GO:0005576]; lysosome [GO:0005764],alpha-L-fucosidase activity [GO:0004560],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0005975; GO:0016787; GO:0043226; GO:1901135,catalytic activity; extracellular region; lysosome; vacuole; carbohydrate metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_13061,FUN_038093-T1,Peve_00007111,,apul_peve,46.61,,,,,,,,,,,,,,,,,
OG_13062,FUN_038094-T1,Peve_00018667,,apul_peve,36.0485,,,,,,,,,,,,,,,,,
OG_13063,FUN_038095-T1,Peve_00018668,,apul_peve,61.747,,,,,,,,,,,,,,,,,
OG_13064,FUN_038105-T1,Peve_00002243,,apul_peve,42.6655,FUN_038105-T1,Q9BYK8,,,,,29.0,2899.0,2.9e-270,934.9,sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7,,,,,,
OG_13065,FUN_038123-T1,Peve_00003036,,apul_peve,47.388000000000005,,,,,,,,,,,,,,,,,
OG_13066,FUN_038124-T1,Peve_00003034,,apul_peve,98.67,FUN_038124-T1,Q964E3,,,,,96.8,376.0,1e-215,750.4,"sp|Q964E3|ACTC_BIOAL Actin, cytoplasmic OS=Biomphalaria alexandrina OX=50959 PE=3 SV=1",,,,,,
OG_13067,FUN_038136-T1,Peve_00043378,,apul_peve,68.421,,,,,,,,,,,,,,,,,
OG_13068,FUN_038140-T1,Peve_00015894,,apul_peve,84.817,FUN_038140-T1,O14562,,,,,61.4,228.0,2.6e-76,287.7,sp|O14562|UBFD1_HUMAN Ubiquitin domain-containing protein UBFD1 OS=Homo sapiens OX=9606 GN=UBFD1 PE=1 SV=2,,,,,,
OG_13069,FUN_038149-T1,Peve_00044179,,apul_peve,60.5,,,,,,,,,,,,,,,,,
OG_13070,FUN_038151-T1,Peve_00009020,,apul_peve,50.893,,,,,,,,,,,,,,,,,
OG_13071,FUN_038154-T1,Peve_00038317,,apul_peve,46.296,,,,,,,,,,,,,,,,,
OG_13072,FUN_038159-T1,Peve_00019036,,apul_peve,63.158,,,,,,,,,,,,,,,,,
OG_13073,FUN_038160-T1,Peve_00019035,,apul_peve,39.444,FUN_038160-T1,Q2T9U5,,,,,32.3,251.0,2.1e-29,131.3,sp|Q2T9U5|REXO5_BOVIN RNA exonuclease 5 OS=Bos taurus OX=9913 GN=REXO5 PE=2 SV=1,,,,,,
OG_13074,FUN_038202-T1,Peve_00008322,,apul_peve,50.462,,,,,,,,,,,,,,,,,
OG_13075,FUN_038206-T1,Peve_00006774,,apul_peve,52.838,,,,,,,,,,,,,,,,,
OG_13076,FUN_038215-T2,Peve_00038840,,apul_peve,52.665,,,,,,,,,,,,,,,,,
OG_13077,FUN_038235-T1,Peve_00015711,,apul_peve,74.51,FUN_038235-T1,Q0P5C0,,,,,45.0,160.0,1.6e-32,140.6,sp|Q0P5C0|LMF1_BOVIN Lipase maturation factor 1 OS=Bos taurus OX=9913 GN=LMF1 PE=2 SV=1,,,,,,
OG_13078,FUN_038254-T3,Peve_00007990,,apul_peve,69.913,FUN_038254-T3,Q80T11,USH1G_MOUSE,,pre-mRNA splicing regulator USH1G (Jackson shaker protein) (Scaffold protein containing ankyrin repeats and SAM domain) (Usher syndrome type-1G protein homolog),Mus musculus (Mouse),38.2,477.0,3e-18,94.7,sp|Q80T11|USH1G_MOUSE pre-mRNA splicing regulator USH1G OS=Mus musculus OX=10090 GN=Ush1g PE=1 SV=1,GO:0001917; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007605; GO:0015030; GO:0015629; GO:0016020; GO:0016607; GO:0030507; GO:0032391; GO:0036064; GO:0042472; GO:0042802; GO:0045494; GO:0050953; GO:0050957; GO:0060113; GO:0060122; GO:0097546; GO:2000369,equilibrioception [GO:0050957]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; photoreceptor cell maintenance [GO:0045494]; regulation of clathrin-dependent endocytosis [GO:2000369]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin cytoskeleton [GO:0015629]; Cajal body [GO:0015030]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; spectrin binding [GO:0030507],GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0030154; GO:0043226; GO:0050877,microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell differentiation; organelle; nervous system process
OG_13079,FUN_038273-T1,Peve_00010405,,apul_peve,90.625,FUN_038273-T1,A7SMR0,,,,,77.5,89.0,4.1e-36,151.8,sp|A7SMR0|MEIG1_NEMVE Meiosis expressed gene 1 protein homolog OS=Nematostella vectensis OX=45351 GN=v1g237368 PE=3 SV=1,,,,,,
OG_13080,FUN_038281-T1,Peve_00041715,,apul_peve,43.91,,,,,,,,,,,,,,,,,
OG_13081,FUN_038283-T1,Peve_00041718,,apul_peve,71.515,,,,,,,,,,,,,,,,,
OG_13082,FUN_038306-T1,Peve_00000058,,apul_peve,57.527,,,,,,,,,,,,,,,,,
OG_13083,FUN_038323-T1,Peve_00010027,,apul_peve,71.273,,,,,,,,,,,,,,,,,
OG_13084,FUN_038336-T1,Peve_00033488,,apul_peve,74.312,FUN_038336-T1,Q04841,,,,,51.2,215.0,1.5e-54,214.5,sp|Q04841|3MG_MOUSE DNA-3-methyladenine glycosylase OS=Mus musculus OX=10090 GN=Mpg PE=2 SV=3,,,,,,
OG_13085,FUN_038433-T1,Peve_00029449,,apul_peve,72.843,FUN_038433-T1,Q92820,GGH_HUMAN,,Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase),Homo sapiens (Human),45.3,316.0,7.5e-74,278.9,sp|Q92820|GGH_HUMAN Gamma-glutamyl hydrolase OS=Homo sapiens OX=9606 GN=GGH PE=1 SV=2,GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724,tetrahydrofolylpolyglutamate metabolic process [GO:0046900],azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773],exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242],GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0006575; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; nucleus; vacuole; modified amino acid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_13086,FUN_038441-T1,Peve_00029442,,apul_peve,51.307,,,,,,,,,,,,,,,,,
OG_13087,FUN_038448-T1,Peve_00020977,,apul_peve,60.3,,,,,,,,,,,,,,,,,
OG_13088,FUN_038458-T1,Peve_00010729,,apul_peve,51.261,,,,,,,,,,,,,,,,,
OG_13089,FUN_038484-T1,Peve_00013521,,apul_peve,39.597,,,,,,,,,,,,,,,,,
OG_13090,FUN_038490-T1,Peve_00030024,,apul_peve,65.877,,,,,,,,,,,,,,,,,
OG_13091,FUN_038506-T1,Peve_00041687,,apul_peve,41.215,FUN_038506-T1,A1R8N8,,,,,23.5,281.0,5.7e-08,60.8,sp|A1R8N8|MSHA_PAEAT D-inositol 3-phosphate glycosyltransferase OS=Paenarthrobacter aurescens (strain TC1) OX=290340 GN=mshA PE=3 SV=1,,,,,,
OG_13092,FUN_038515-T1,Peve_00042011,,apul_peve,75.0,,,,,,,,,,,,,,,,,
OG_13093,FUN_038516-T1,Peve_00000438,,apul_peve,35.982,,,,,,,,,,,,,,,,,
OG_13094,FUN_038526-T2,Peve_00041741,,apul_peve,49.7715,,,,,,,,,,,,,,,,,
OG_13095,FUN_038527-T1,Peve_00043749,,apul_peve,63.993,,,,,,,,,,,,,,,,,
OG_13096,FUN_038532-T1,Peve_00013492,,apul_peve,63.6125,FUN_038532-T1,Q9PW70,,,,,34.0,194.0,1.9e-16,87.4,sp|Q9PW70|CISH_CHICK Cytokine-inducible SH2-containing protein OS=Gallus gallus OX=9031 GN=CISH PE=2 SV=1,,,,,,
OG_13097,FUN_038542-T1,Peve_00009820,,apul_peve,77.5,FUN_038542-T1,P83861,,,,,25.8,306.0,1.2999999999999998e-24,115.5,sp|P83861|QRFPR_MOUSE Pyroglutamylated RF-amide peptide receptor OS=Mus musculus OX=10090 GN=Qrfpr PE=2 SV=1,,,,,,
OG_13098,FUN_038562-T1,Peve_00020189,,apul_peve,71.066,FUN_038562-T1,A6L330,,,,,53.8,279.0,7.5e-84,312.4,sp|A6L330|END4_PHOV8 Probable endonuclease 4 OS=Phocaeicola vulgatus (strain ATCC 8482 / DSM 1447 / JCM 5826 / CCUG 4940 / NBRC 14291 / NCTC 11154) OX=435590 GN=nfo PE=3 SV=1,,,,,,
OG_13099,FUN_038573-T2,Peve_00020172,,apul_peve,40.9685,,,,,,,,,,,,,,,,,
OG_13100,FUN_038581-T1,Peve_00009481,,apul_peve,65.449,,,,,,,,,,,,,,,,,
OG_13101,FUN_038595-T1,Peve_00005393,,apul_peve,65.147,FUN_038595-T1,P30974,,,,,25.6,317.0,1.4e-21,105.1,sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2,,,,,,
OG_13102,FUN_038604-T1,Peve_00005392,,apul_peve,74.214,FUN_038604-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),28.7,321.0,7.8e-21,102.8,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_13103,FUN_038606-T1,Peve_00005400,,apul_peve,59.048,,,,,,,,,,,,,,,,,
OG_13104,FUN_038618-T1,Peve_00042049,,apul_peve,73.548,FUN_038618-T1,C3YWU0,FUCO_BRAFL,,Alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase),Branchiostoma floridae (Florida lancelet) (Amphioxus),55.3,450.0,9.6e-155,548.1,sp|C3YWU0|FUCO_BRAFL Alpha-L-fucosidase OS=Branchiostoma floridae OX=7739 GN=BRAFLDRAFT_56888 PE=3 SV=2,GO:0004560; GO:0005576; GO:0005764; GO:0006004; GO:0016139,fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],extracellular region [GO:0005576]; lysosome [GO:0005764],alpha-L-fucosidase activity [GO:0004560],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0005975; GO:0016787; GO:0043226; GO:1901135,catalytic activity; extracellular region; lysosome; vacuole; carbohydrate metabolic process; hydrolase activity; organelle; carbohydrate derivative metabolic process
OG_13105,FUN_038679-T1,Peve_00043123,,apul_peve,58.696,,,,,,,,,,,,,,,,,
OG_13106,FUN_038683-T1,Peve_00013484,,apul_peve,53.719,FUN_038683-T1,Q8BIR2,,,,,31.3,619.0,1.2e-59,232.6,sp|Q8BIR2|ASTE1_MOUSE Single-strand DNA endonuclease ASTE1 OS=Mus musculus OX=10090 GN=Aste1 PE=2 SV=1,,,,,,
OG_13107,FUN_038690-T1,Peve_00013480,,apul_peve,60.484,FUN_038690-T1,Q4V7Q8,,,,,41.9,105.0,5.5e-17,89.0,sp|Q4V7Q8|TM220_XENLA Transmembrane protein 220 OS=Xenopus laevis OX=8355 GN=tmem220 PE=2 SV=1,,,,,,
OG_13108,FUN_038693-T1,Peve_00013475,,apul_peve,31.176,,,,,,,,,,,,,,,,,
OG_13109,FUN_038696-T1,Peve_00013470,,apul_peve,60.624,,,,,,,,,,,,,,,,,
OG_13110,FUN_038719-T1,Peve_00016748,,apul_peve,75.048,,,,,,,,,,,,,,,,,
OG_13111,FUN_038723-T1,Peve_00008752,,apul_peve,89.634,,,,,,,,,,,,,,,,,
OG_13112,FUN_038739-T1,Peve_00009050,,apul_peve,87.391,FUN_038739-T1,A7RJI7,,,,,73.5,460.0,4.8e-207,721.8,sp|A7RJI7|CCZ1_NEMVE Vacuolar fusion protein CCZ1 homolog OS=Nematostella vectensis OX=45351 GN=v1g238755 PE=3 SV=1,,,,,,
OG_13113,FUN_038743-T1,Peve_00044512,,apul_peve,61.176,,,,,,,,,,,,,,,,,
OG_13114,FUN_038744-T1,Peve_00045356,,apul_peve,62.4665,,,,,,,,,,,,,,,,,
OG_13115,FUN_038753-T1,Peve_00040767,,apul_peve,88.316,FUN_038753-T1,P42620,,,,,59.4,288.0,1.9e-91,337.4,sp|P42620|YQJG_ECOLI Glutathionyl-hydroquinone reductase YqjG OS=Escherichia coli (strain K12) OX=83333 GN=yqjG PE=1 SV=1,,,,,,
OG_13116,FUN_038782-T1,Peve_00015067,,apul_peve,56.26,FUN_038782-T1,E9Q236,MRP4_MOUSE,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4),Mus musculus (Mouse),38.1,1286.0,2.5e-245,850.5,sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1,GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015431; GO:0015432; GO:0015562; GO:0015665; GO:0015721; GO:0015732; GO:0015747; GO:0015850; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0060271; GO:0070730; GO:0071716; GO:0140115; GO:1901571,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; fatty acid derivative transport [GO:1901571]; leukotriene transport [GO:0071716]; organic hydroxy compound transport [GO:0015850]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; alcohol transmembrane transporter activity [GO:0015665]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_13117,FUN_038787-T1,Peve_00007209,,apul_peve,48.4695,,,,,,,,,,,,,,,,,
OG_13118,FUN_038788-T1,Peve_00007208,,apul_peve,60.847,,,,,,,,,,,,,,,,,
OG_13119,FUN_038790-T1,Peve_00029876,,apul_peve,96.748,FUN_038790-T1,P35067,,,,,87.2,125.0,2.7e-48,192.6,sp|P35067|H2B_ACRFO Histone H2B OS=Acropora formosa OX=126732 PE=3 SV=1,,,,,,
OG_13120,FUN_038794-T1,Peve_00007202,,apul_peve,53.328,,,,,,,,,,,,,,,,,
OG_13121,FUN_038798-T1,Peve_00007231,,apul_peve,78.15,FUN_038798-T1,W5PLZ6,LPH_SHEEP,,Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)],Ovis aries (Sheep),47.7,495.0,5.399999999999999e-141,502.7,sp|W5PLZ6|LPH_SHEEP Lactase/phlorizin hydrolase OS=Ovis aries OX=9940 GN=LCT PE=1 SV=1,GO:0000016; GO:0004336; GO:0004348; GO:0005990; GO:0008422; GO:0016324; GO:0046477; GO:0140749; GO:1901733; GO:2000892,cellobiose catabolic process [GO:2000892]; glycosylceramide catabolic process [GO:0046477]; lactose catabolic process [GO:0005990]; quercetin catabolic process [GO:1901733],apical plasma membrane [GO:0016324],beta-glucosidase activity [GO:0008422]; galactosylceramidase activity [GO:0004336]; glucosylceramidase activity [GO:0004348]; lactase activity [GO:0000016]; phlorizin hydrolase activity [GO:0140749],GO:0003824; GO:0005975; GO:0006629; GO:0016787; GO:1901135,catalytic activity; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_13122,FUN_038830-T1,Peve_00024593,,apul_peve,63.303,,,,,,,,,,,,,,,,,
OG_13123,FUN_038854-T1,Peve_00019022,,apul_peve,37.597,,,,,,,,,,,,,,,,,
OG_13124,FUN_038861-T1,Peve_00013306,,apul_peve,94.776,,,,,,,,,,,,,,,,,
OG_13125,FUN_038868-T1,Peve_00020622,,apul_peve,36.471,,,,,,,,,,,,,,,,,
OG_13126,FUN_038883-T3,Peve_00027787,,apul_peve,50.467,,,,,,,,,,,,,,,,,
OG_13127,FUN_038912-T1,Peve_00004511,,apul_peve,55.043,,,,,,,,,,,,,,,,,
OG_13128,FUN_038930-T1,Peve_00043958,,apul_peve,75.0485,FUN_038930-T1,C3ZQF9,,,,,29.0,279.0,8.899999999999999e-25,115.9,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_13129,FUN_038935-T1,Peve_00043965,,apul_peve,46.3645,,,,,,,,,,,,,,,,,
OG_13130,FUN_038936-T1,Peve_00028761,,apul_peve,88.489,FUN_038936-T1,Q7ZUY3,H2AX_DANRE,,Histone H2AX (H2a/x) (Histone H2A.X),Danio rerio (Zebrafish) (Brachydanio rerio),78.2,142.0,6e-52,204.9,sp|Q7ZUY3|H2AX_DANRE Histone H2AX OS=Danio rerio OX=7955 GN=h2ax PE=2 SV=3,GO:0000786; GO:0003677; GO:0005634; GO:0005694; GO:0005813; GO:0006281; GO:0006310; GO:0006974; GO:0030527; GO:0031507; GO:0046982; GO:0051321,DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; heterochromatin formation [GO:0031507]; meiotic cell cycle [GO:0051321],centrosome [GO:0005813]; chromosome [GO:0005694]; nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527],GO:0003677; GO:0005198; GO:0005634; GO:0005694; GO:0005815; GO:0006281; GO:0006310; GO:0006325; GO:0022414; GO:0043226,DNA binding; structural molecule activity; nucleus; chromosome; microtubule organizing center; DNA repair; DNA recombination; chromatin organization; reproductive process; organelle
OG_13131,FUN_038969-T1,Peve_00003383,,apul_peve,77.011,,,,,,,,,,,,,,,,,
OG_13132,FUN_038979-T1,Peve_00022479,,apul_peve,65.55449999999999,,,,,,,,,,,,,,,,,
OG_13133,FUN_038991-T1,Peve_00023774,,apul_peve,32.5195,,,,,,,,,,,,,,,,,
OG_13134,FUN_038994-T1,Peve_00034833,,apul_peve,54.521,,,,,,,,,,,,,,,,,
OG_13135,FUN_038996-T1,Peve_00027562,,apul_peve,54.825,,,,,,,,,,,,,,,,,
OG_13136,FUN_039001-T1,Peve_00009000,,apul_peve,48.026,,,,,,,,,,,,,,,,,
OG_13137,FUN_039002-T1,Peve_00007118,,apul_peve,98.592,,,,,,,,,,,,,,,,,
OG_13138,FUN_039005-T1,Peve_00039575,,apul_peve,34.545,,,,,,,,,,,,,,,,,
OG_13139,FUN_039016-T1,Peve_00014360,,apul_peve,43.2955,,,,,,,,,,,,,,,,,
OG_13140,FUN_039022-T1,Peve_00035029,,apul_peve,82.0,,,,,,,,,,,,,,,,,
OG_13141,FUN_039029-T1,Peve_00028759,,apul_peve,55.5875,FUN_039029-T1,Q5XI03,,,,,35.4,316.0,6.8e-39,164.5,sp|Q5XI03|CEP95_RAT Centrosomal protein of 95 kDa OS=Rattus norvegicus OX=10116 GN=Cep95 PE=2 SV=1,,,,,,
OG_13141,FUN_039029-T1,Peve_00028759,,apul_peve,55.5875,FUN_039029-T1,Q5XI03,,,,,48.2,112.0,2e-22,109.8,sp|Q5XI03|CEP95_RAT Centrosomal protein of 95 kDa OS=Rattus norvegicus OX=10116 GN=Cep95 PE=2 SV=1,,,,,,
OG_13142,FUN_039098-T1,Peve_00011930,,apul_peve,38.095,,,,,,,,,,,,,,,,,
OG_13143,FUN_039110-T1,Peve_00029963,,apul_peve,86.916,,,,,,,,,,,,,,,,,
OG_13144,FUN_039175-T1,Peve_00018339,,apul_peve,91.854,,,,,,,,,,,,,,,,,
OG_13145,FUN_039206-T1,Peve_00026178,,apul_peve,96.296,,,,,,,,,,,,,,,,,
OG_13146,FUN_039214-T1,Peve_00018346,,apul_peve,96.947,,,,,,,,,,,,,,,,,
OG_13147,FUN_039267-T1,Peve_00002773,,apul_peve,63.275,,,,,,,,,,,,,,,,,
OG_13148,FUN_039273-T1,Peve_00039059,,apul_peve,33.3325,,,,,,,,,,,,,,,,,
OG_13149,FUN_039285-T1,Peve_00040657,,apul_peve,51.594,,,,,,,,,,,,,,,,,
OG_13150,FUN_039287-T1,Peve_00002768,,apul_peve,74.66149999999999,FUN_039287-T1,P21127,CD11B_HUMAN,,Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1),Homo sapiens (Human),73.5,388.0,6.9999999999999996e-161,569.7,sp|P21127|CD11B_HUMAN Cyclin-dependent kinase 11B OS=Homo sapiens OX=9606 GN=CDK11B PE=1 SV=4,GO:0000278; GO:0000307; GO:0001558; GO:0003723; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0006355; GO:0006468; GO:0006915; GO:0042981; GO:0043484; GO:0046605; GO:0050684; GO:0051726; GO:0106310,apoptotic process [GO:0006915]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of centrosome cycle [GO:0046605]; regulation of DNA-templated transcription [GO:0006355]; regulation of mRNA processing [GO:0050684]; regulation of RNA splicing [GO:0043484],cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723],GO:0000278; GO:0003723; GO:0003824; GO:0005634; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"mitotic cell cycle; RNA binding; catalytic activity; nucleus; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_13151,FUN_039307-T1,Peve_00042369,,apul_peve,47.967,,,,,,,,,,,,,,,,,
OG_13152,FUN_039315-T1,Peve_00029204,,apul_peve,44.211,,,,,,,,,,,,,,,,,
OG_13153,FUN_039330-T1,Peve_00027003,,apul_peve,47.8425,,,,,,,,,,,,,,,,,
OG_13154,FUN_039344-T1,Peve_00040100,,apul_peve,60.36,FUN_039344-T1,Q86Y13,DZIP3_HUMAN,,E3 ubiquitin-protein ligase DZIP3 (EC 2.3.2.27) (DAZ-interacting protein 3) (RING-type E3 ubiquitin transferase DZIP3) (RNA-binding ubiquitin ligase of 138 kDa) (hRUL138),Homo sapiens (Human),27.0,152.0,9.8e-10,65.5,sp|Q86Y13|DZIP3_HUMAN E3 ubiquitin-protein ligase DZIP3 OS=Homo sapiens OX=9606 GN=DZIP3 PE=1 SV=2,GO:0000209; GO:0003723; GO:0004842; GO:0005737; GO:0008270; GO:0019902; GO:0031593; GO:0061630,protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737],phosphatase binding [GO:0019902]; polyubiquitin modification-dependent protein binding [GO:0031593]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0140096,"RNA binding; catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_13155,FUN_039347-T1,Peve_00006328,,apul_peve,54.757,,,,,,,,,,,,,,,,,
OG_13156,FUN_039348-T1,Peve_00036691,,apul_peve,59.774,FUN_039348-T1,Q8H0T4,,,,,24.6,382.0,1.9e-13,79.0,sp|Q8H0T4|UPL2_ARATH E3 ubiquitin-protein ligase UPL2 OS=Arabidopsis thaliana OX=3702 GN=UPL2 PE=1 SV=3,,,,,,
OG_13157,FUN_039395-T1,Peve_00036789,,apul_peve,32.743,,,,,,,,,,,,,,,,,
OG_13158,FUN_039455-T1,Peve_00022020,,apul_peve,65.409,,,,,,,,,,,,,,,,,
OG_13159,FUN_039466-T1,Peve_00005633,,apul_peve,31.818,,,,,,,,,,,,,,,,,
OG_13160,FUN_039485-T1,Peve_00005478,,apul_peve,31.731,,,,,,,,,,,,,,,,,
OG_13161,FUN_039492-T1,Peve_00036145,,apul_peve,70.0,,,,,,,,,,,,,,,,,
OG_13162,FUN_039497-T1,Peve_00042266,,apul_peve,45.847,,,,,,,,,,,,,,,,,
OG_13163,FUN_039502-T1,Peve_00035359,,apul_peve,56.614,,,,,,,,,,,,,,,,,
OG_13164,FUN_039504-T1,Peve_00006646,,apul_peve,83.333,,,,,,,,,,,,,,,,,
OG_13165,FUN_039539-T1,Peve_00021162,,apul_peve,40.458,,,,,,,,,,,,,,,,,
OG_13166,FUN_039545-T1,Peve_00018253,,apul_peve,64.286,,,,,,,,,,,,,,,,,
OG_13167,FUN_039576-T1,Peve_00016568,,apul_peve,30.909,,,,,,,,,,,,,,,,,
OG_13168,FUN_039610-T1,Peve_00022106,,apul_peve,30.061,,,,,,,,,,,,,,,,,
OG_13169,FUN_039611-T1,Peve_00018267,,apul_peve,43.956,,,,,,,,,,,,,,,,,
OG_13170,FUN_039639-T1,Peve_00003611,,apul_peve,40.984,,,,,,,,,,,,,,,,,
OG_13171,FUN_039654-T1,Peve_00034506,,apul_peve,75.414,,,,,,,,,,,,,,,,,
OG_13172,FUN_039655-T1,Peve_00034507,,apul_peve,62.23,FUN_039655-T1,Q5GLZ8,HERC4_HUMAN,,Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4),Homo sapiens (Human),22.4,379.0,1.7e-08,62.8,sp|Q5GLZ8|HERC4_HUMAN Probable E3 ubiquitin-protein ligase HERC4 OS=Homo sapiens OX=9606 GN=HERC4 PE=1 SV=1,GO:0001650; GO:0005737; GO:0005829; GO:0006511; GO:0007283; GO:0016567; GO:0030154; GO:0045879; GO:0061630,cell differentiation [GO:0030154]; negative regulation of smoothened signaling pathway [GO:0045879]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650],ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0005829; GO:0016740; GO:0022414; GO:0030154; GO:0140096,"catalytic activity; cytosol; transferase activity; reproductive process; cell differentiation; catalytic activity, acting on a protein"
OG_13173,FUN_039669-T1,Peve_00038214,,apul_peve,66.197,FUN_039669-T1,Q9BX84,,,,,27.0,196.0,6.4e-10,67.0,sp|Q9BX84|TRPM6_HUMAN Transient receptor potential cation channel subfamily M member 6 OS=Homo sapiens OX=9606 GN=TRPM6 PE=1 SV=2,,,,,,
OG_13174,FUN_039685-T1,Peve_00040357,,apul_peve,67.213,,,,,,,,,,,,,,,,,
OG_13175,FUN_039692-T1,Peve_00035287,,apul_peve,96.0,,,,,,,,,,,,,,,,,
OG_13176,FUN_039702-T1,Peve_00022239,,apul_peve,45.4795,,,,,,,,,,,,,,,,,
OG_13177,FUN_039709-T1,Peve_00005873,,apul_peve,90.0,,,,,,,,,,,,,,,,,
OG_13178,FUN_039721-T1,Peve_00027205,,apul_peve,95.082,,,,,,,,,,,,,,,,,
OG_13179,FUN_039740-T2,Peve_00012693,,apul_peve,77.551,,,,,,,,,,,,,,,,,
OG_13180,FUN_039750-T1,Peve_00011333,,apul_peve,88.0,,,,,,,,,,,,,,,,,
OG_13181,FUN_039773-T2,Peve_00001426,,apul_peve,59.4635,FUN_039773-T2,Q99767,APBA2_HUMAN,,Amyloid-beta A4 precursor protein-binding family A member 2 (Adapter protein X11beta) (Neuron-specific X11L protein) (Neuronal Munc18-1-interacting protein 2) (Mint-2),Homo sapiens (Human),53.7,397.0,1.4000000000000004e-118,429.5,sp|Q99767|APBA2_HUMAN Amyloid-beta A4 precursor protein-binding family A member 2 OS=Homo sapiens OX=9606 GN=APBA2 PE=1 SV=3,GO:0001540; GO:0001701; GO:0005737; GO:0005886; GO:0007268; GO:0007399; GO:0007626; GO:0010468; GO:0015031; GO:0035264; GO:0042802; GO:0043197; GO:0098685; GO:0098793; GO:0099171,chemical synaptic transmission [GO:0007268]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein transport [GO:0015031]; regulation of gene expression [GO:0010468],cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685],amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802],GO:0005886; GO:0023052; GO:0048856,plasma membrane; signaling; anatomical structure development
OG_13182,FUN_039775-T1,Peve_00030562,,apul_peve,88.194,FUN_039775-T1,E1BNS6,SPAG8_BOVIN,,Sperm-associated antigen 8,Bos taurus (Bovine),40.7,177.0,7e-27,122.1,sp|E1BNS6|SPAG8_BOVIN Sperm-associated antigen 8 OS=Bos taurus OX=9913 GN=SPAG8 PE=1 SV=3,GO:0001669; GO:0005634; GO:0005737; GO:0005815; GO:0005819; GO:0005879; GO:0007283; GO:0007338; GO:0008017; GO:0030154; GO:0030317; GO:0036126; GO:0045944; GO:0160111,cell differentiation [GO:0030154]; flagellated sperm motility [GO:0030317]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005634; GO:0005815; GO:0005929; GO:0006355; GO:0007018; GO:0008092; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048870,nucleus; microtubule organizing center; cilium; regulation of DNA-templated transcription; microtubule-based movement; cytoskeletal protein binding; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; cell motility
OG_13183,FUN_039787-T1,Peve_00017597,,apul_peve,50.0,FUN_039787-T1,Q7L1S5,CHST9_HUMAN,,Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2),Homo sapiens (Human),33.3,276.0,6.9e-37,156.0,sp|Q7L1S5|CHST9_HUMAN Carbohydrate sulfotransferase 9 OS=Homo sapiens OX=9606 GN=CHST9 PE=1 SV=2,GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0030203; GO:0042446; GO:0047756,carbohydrate biosynthetic process [GO:0016051]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790],extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; membrane [GO:0016020],chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005576; GO:0005975; GO:0006790; GO:0009101; GO:0016740; GO:1901135,catalytic activity; extracellular region; carbohydrate metabolic process; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_13184,FUN_039790-T2,Peve_00017602,,apul_peve,79.078,FUN_039790-T2,Q6DE75,S2538_XENLA,,Mitochondrial glycine transporter (Solute carrier family 25 member 38),Xenopus laevis (African clawed frog),53.6,276.0,1e-77,291.6,sp|Q6DE75|S2538_XENLA Mitochondrial glycine transporter OS=Xenopus laevis OX=8355 GN=slc25a38 PE=2 SV=1,GO:0005739; GO:0005743; GO:0015187; GO:0030218; GO:1904983,erythrocyte differentiation [GO:0030218]; glycine import into mitochondrion [GO:1904983],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],glycine transmembrane transporter activity [GO:0015187],GO:0005215; GO:0005739; GO:0030154; GO:0043226; GO:0055085,transporter activity; mitochondrion; cell differentiation; organelle; transmembrane transport
OG_13185,FUN_039796-T1,Peve_00038698,,apul_peve,51.834,FUN_039796-T1,Q6XHA5,,,,,26.0,169.0,3.7e-06,55.5,sp|Q6XHA5|ROC11_DICDI Probable serine/threonine-protein kinase roco11 OS=Dictyostelium discoideum OX=44689 GN=roco11 PE=3 SV=1,,,,,,
OG_13186,FUN_039809-T1,Peve_00020309,,apul_peve,65.646,FUN_039809-T1,P11616,,,,,26.3,319.0,5.1e-06,53.5,sp|P11616|AA1R_CANLF Adenosine receptor A1 OS=Canis lupus familiaris OX=9615 GN=ADORA1 PE=2 SV=1,,,,,,
OG_13187,FUN_039812-T1,Peve_00012989,,apul_peve,45.679,,,,,,,,,,,,,,,,,
OG_13188,FUN_039865-T1,Peve_00020820,,apul_peve,75.15899999999999,FUN_039865-T1,Q19UN5,CK5P2_PANTR,,CDK5 regulatory subunit-associated protein 2,Pan troglodytes (Chimpanzee),35.9,410.0,1.9e-10,70.9,sp|Q19UN5|CK5P2_PANTR CDK5 regulatory subunit-associated protein 2 OS=Pan troglodytes OX=9598 GN=CDK5RAP2 PE=2 SV=1,GO:0000132; GO:0000226; GO:0000242; GO:0000922; GO:0000976; GO:0001578; GO:0005516; GO:0005737; GO:0005794; GO:0005813; GO:0005874; GO:0007059; GO:0007098; GO:0007099; GO:0007420; GO:0008017; GO:0022008; GO:0031023; GO:0035371; GO:0043015; GO:0045893; GO:0046600; GO:0048471; GO:0090266; GO:0097431,brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; neurogenesis [GO:0022008]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266],centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922],calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; transcription cis-regulatory region binding [GO:0000976],GO:0003677; GO:0005794; GO:0005815; GO:0006355; GO:0007010; GO:0007059; GO:0008092; GO:0030154; GO:0043226; GO:0048856,DNA binding; Golgi apparatus; microtubule organizing center; regulation of DNA-templated transcription; cytoskeleton organization; chromosome segregation; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development
OG_13189,FUN_039877-T1,Peve_00004938,,apul_peve,35.1515,,,,,,,,,,,,,,,,,
OG_13190,FUN_039881-T1,Peve_00004945,,apul_peve,83.531,FUN_039881-T1,O00555,CAC1A_HUMAN,,"Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I) (BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)",Homo sapiens (Human),55.6,669.0,1e-160,568.9,sp|O00555|CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens OX=9606 GN=CACNA1A PE=1 SV=3,GO:0001540; GO:0005245; GO:0005634; GO:0005737; GO:0005886; GO:0005891; GO:0007204; GO:0008331; GO:0016020; GO:0019905; GO:0042995; GO:0043025; GO:0046872; GO:0050804; GO:0070588; GO:0098703; GO:1904645; GO:1904646,calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to amyloid-beta [GO:1904646]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to amyloid-beta [GO:1904645],cell projection [GO:0042995]; cytoplasm [GO:0005737]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891],amyloid-beta binding [GO:0001540]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; syntaxin binding [GO:0019905]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005634; GO:0005886; GO:0043226; GO:0055085,transporter activity; nucleus; plasma membrane; organelle; transmembrane transport
OG_13190,FUN_039881-T1,Peve_00004945,,apul_peve,83.531,FUN_039881-T1,O00555,CAC1A_HUMAN,,"Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I) (BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)",Homo sapiens (Human),48.1,54.0,4e-08,62.0,sp|O00555|CAC1A_HUMAN Voltage-dependent P/Q-type calcium channel subunit alpha-1A OS=Homo sapiens OX=9606 GN=CACNA1A PE=1 SV=3,GO:0001540; GO:0005245; GO:0005634; GO:0005737; GO:0005886; GO:0005891; GO:0007204; GO:0008331; GO:0016020; GO:0019905; GO:0042995; GO:0043025; GO:0046872; GO:0050804; GO:0070588; GO:0098703; GO:1904645; GO:1904646,calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cellular response to amyloid-beta [GO:1904646]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to amyloid-beta [GO:1904645],cell projection [GO:0042995]; cytoplasm [GO:0005737]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; voltage-gated calcium channel complex [GO:0005891],amyloid-beta binding [GO:0001540]; high voltage-gated calcium channel activity [GO:0008331]; metal ion binding [GO:0046872]; syntaxin binding [GO:0019905]; voltage-gated calcium channel activity [GO:0005245],GO:0005215; GO:0005634; GO:0005886; GO:0043226; GO:0055085,transporter activity; nucleus; plasma membrane; organelle; transmembrane transport
OG_13191,FUN_039882-T1,Peve_00011732,,apul_peve,78.85499999999999,FUN_039882-T1,C9D7C2,,,,,50.1,756.0,2.0000000000000003e-187,657.5,sp|C9D7C2|CAC1A_APIME Voltage-dependent calcium channel type A subunit alpha-1 OS=Apis mellifera OX=7460 GN=CAC PE=2 SV=1,,,,,,
OG_13192,FUN_039897-T1,Peve_00037058,,apul_peve,51.724,FUN_039897-T1,Q9QZU7,,,,,37.2,379.0,1e-73,278.9,sp|Q9QZU7|BODG_RAT Gamma-butyrobetaine dioxygenase OS=Rattus norvegicus OX=10116 GN=Bbox1 PE=1 SV=1,,,,,,
OG_13193,FUN_039912-T1,Peve_00041536,,apul_peve,81.313,,,,,,,,,,,,,,,,,
OG_13194,FUN_039953-T1,Peve_00009539,,apul_peve,58.036,,,,,,,,,,,,,,,,,
OG_13195,FUN_039955-T1,Peve_00033672,,apul_peve,49.02,,,,,,,,,,,,,,,,,
OG_13196,FUN_039961-T1,Peve_00030112,,apul_peve,57.937,,,,,,,,,,,,,,,,,
OG_13197,FUN_039969-T1,Peve_00000415,,apul_peve,58.568,FUN_039969-T1,Q9UGM3,,,,,27.3,1812.0,3.9e-144,516.2,sp|Q9UGM3|DMBT1_HUMAN Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Homo sapiens OX=9606 GN=DMBT1 PE=1 SV=2,,,,,,
OG_13198,FUN_039971-T1,Peve_00000414,,apul_peve,52.101,,,,,,,,,,,,,,,,,
OG_13199,FUN_039992-T1,Peve_00004419,,apul_peve,71.87049999999999,FUN_039992-T1,Q08431,MFGM_HUMAN,,Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin],Homo sapiens (Human),36.2,188.0,2.8e-17,91.3,sp|Q08431|MFGM_HUMAN Lactadherin OS=Homo sapiens OX=9606 GN=MFGE8 PE=1 SV=3,GO:0001525; GO:0001786; GO:0002080; GO:0005178; GO:0005576; GO:0005615; GO:0005788; GO:0007155; GO:0007338; GO:0009897; GO:0016020; GO:0043277; GO:0062023; GO:0070062; GO:1903561,angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; single fertilization [GO:0007338],acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; membrane [GO:0016020],integrin binding [GO:0005178]; phosphatidylserine binding [GO:0001786],GO:0005576; GO:0005615; GO:0007155; GO:0008289; GO:0016192; GO:0022414; GO:0043226,extracellular region; extracellular space; cell adhesion; lipid binding; vesicle-mediated transport; reproductive process; organelle
OG_13200,FUN_040000-T1,Peve_00037231,,apul_peve,37.805,,,,,,,,,,,,,,,,,
OG_13201,FUN_040002-T1,Peve_00004712,,apul_peve,49.61,FUN_040002-T1,O88783,FA5_MOUSE,,Coagulation factor V (Activated protein C cofactor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain],Mus musculus (Mouse),32.6,325.0,1.3e-41,174.1,sp|O88783|FA5_MOUSE Coagulation factor V OS=Mus musculus OX=10090 GN=F5 PE=1 SV=1,GO:0005507; GO:0005615; GO:0007596; GO:0008015; GO:0031091; GO:0032571,blood circulation [GO:0008015]; blood coagulation [GO:0007596]; response to vitamin K [GO:0032571],extracellular space [GO:0005615]; platelet alpha granule [GO:0031091],copper ion binding [GO:0005507],GO:0003013; GO:0005615; GO:0031410; GO:0043226,circulatory system process; extracellular space; cytoplasmic vesicle; organelle
OG_13202,FUN_040005-T1,Peve_00004963,,apul_peve,64.39099999999999,FUN_040005-T1,P35507,KC1B_BOVIN,,Casein kinase I isoform beta (CKI-beta) (EC 2.7.11.1),Bos taurus (Bovine),42.7,75.0,8.1e-07,54.7,sp|P35507|KC1B_BOVIN Casein kinase I isoform beta OS=Bos taurus OX=9913 GN=CSNK1B PE=2 SV=1,GO:0000139; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0016055; GO:0018105; GO:0090090; GO:0106310,negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; nucleus [GO:0005634],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_13203,FUN_040008-T1,Peve_00031110,,apul_peve,45.502,,,,,,,,,,,,,,,,,
OG_13204,FUN_040010-T1,Peve_00031112,,apul_peve,71.01,FUN_040010-T1,P11617,,,,,24.8,282.0,1.7e-09,65.1,sp|P11617|AA2AR_CANLF Adenosine receptor A2a OS=Canis lupus familiaris OX=9615 GN=ADORA2A PE=2 SV=1,,,,,,
OG_13205,FUN_040016-T1,Peve_00004959,,apul_peve,48.2285,FUN_040016-T1,Q7Z3E1,PARPT_HUMAN,,Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (Poly [ADP-ribose] polymerase 7) (PARP-7) (TCDD-inducible poly [ADP-ribose] polymerase),Homo sapiens (Human),37.0,235.0,1.3e-38,163.7,sp|Q7Z3E1|PARPT_HUMAN Protein mono-ADP-ribosyltransferase TIPARP OS=Homo sapiens OX=9606 GN=TIPARP PE=1 SV=1,GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0008209; GO:0008210; GO:0008270; GO:0008585; GO:0009791; GO:0010629; GO:0016779; GO:0030097; GO:0045732; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0140803; GO:0140806; GO:0140807; GO:1904612; GO:1990404,"androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]",nucleus [GO:0005634],cis-regulatory region sequence-specific DNA binding [GO:0000987]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006629; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; lipid metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_13206,FUN_040061-T1,Peve_00014918,,apul_peve,88.696,FUN_040061-T1,P62958,HINT1_BOVIN,,Adenosine 5'-monophosphoramidase HINT1 (EC 3.9.1.-) (17 kDa inhibitor of protein kinase C) (Desumoylating isopeptidase HINT1) (EC 3.4.22.-) (Histidine triad nucleotide-binding protein 1) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1),Bos taurus (Bovine),65.2,112.0,1.8e-41,169.9,sp|P62958|HINT1_BOVIN Adenosine 5'-monophosphoramidase HINT1 OS=Bos taurus OX=9913 GN=HINT1 PE=1 SV=2,GO:0000118; GO:0000166; GO:0005634; GO:0005737; GO:0006355; GO:0006508; GO:0009154; GO:0016787; GO:0016926; GO:0016929; GO:0043530; GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; protein desumoylation [GO:0016926]; proteolysis [GO:0006508]; purine ribonucleotide catabolic process [GO:0009154]; regulation of DNA-templated transcription [GO:0006355],cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634],adenosine 5'-monophosphoramidase activity [GO:0043530]; deSUMOylase activity [GO:0016929]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166],GO:0003824; GO:0005634; GO:0006355; GO:0016787; GO:0043226; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; nucleus; regulation of DNA-templated transcription; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_13207,FUN_040081-T1,Peve_00041164,,apul_peve,68.058,FUN_040081-T1,Q99999,G3ST1_HUMAN,,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),Homo sapiens (Human),34.8,356.0,3.8e-45,184.1,sp|Q99999|G3ST1_HUMAN Galactosylceramide sulfotransferase OS=Homo sapiens OX=9606 GN=GAL3ST1 PE=1 SV=1,GO:0000139; GO:0001733; GO:0005886; GO:0006487; GO:0006665; GO:0006681; GO:0006682; GO:0006688; GO:0007283; GO:0008146; GO:0016020; GO:0042552; GO:0046486,galactosylceramide biosynthetic process [GO:0006682]; galactosylceramide metabolic process [GO:0006681]; glycerolipid metabolic process [GO:0046486]; glycosphingolipid biosynthetic process [GO:0006688]; myelination [GO:0042552]; protein N-linked glycosylation [GO:0006487]; spermatogenesis [GO:0007283]; sphingolipid metabolic process [GO:0006665],Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886],galactosylceramide sulfotransferase activity [GO:0001733]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005886; GO:0006629; GO:0009101; GO:0016740; GO:0022414; GO:1901135,catalytic activity; plasma membrane; lipid metabolic process; glycoprotein biosynthetic process; transferase activity; reproductive process; carbohydrate derivative metabolic process
OG_13208,FUN_040098-T1,Peve_00027080,,apul_peve,43.979,,,,,,,,,,,,,,,,,
OG_13209,FUN_040111-T1,Peve_00019477,,apul_peve,50.502,,,,,,,,,,,,,,,,,
OG_13210,FUN_040115-T1,Peve_00042348,,apul_peve,46.951,,,,,,,,,,,,,,,,,
OG_13211,FUN_040120-T1,Peve_00040880,,apul_peve,63.0,,,,,,,,,,,,,,,,,
OG_13212,FUN_040128-T1,Peve_00012490,,apul_peve,34.3855,,,,,,,,,,,,,,,,,
OG_13213,FUN_040132-T2,Peve_00012495,,apul_peve,33.752,,,,,,,,,,,,,,,,,
OG_13214,FUN_040159-T1,Peve_00038140,,apul_peve,49.853,,,,,,,,,,,,,,,,,
OG_13215,FUN_040162-T1,Peve_00038139,,apul_peve,64.978,,,,,,,,,,,,,,,,,
OG_13216,FUN_040176-T1,Peve_00038131,,apul_peve,80.0,,,,,,,,,,,,,,,,,
OG_13217,FUN_040180-T1,Peve_00005467,,apul_peve,41.206,,,,,,,,,,,,,,,,,
OG_13218,FUN_040188-T1,Peve_00037036,,apul_peve,46.199,,,,,,,,,,,,,,,,,
OG_13219,FUN_040191-T1,Peve_00043286,,apul_peve,67.73,,,,,,,,,,,,,,,,,
OG_13220,FUN_040211-T1,Peve_00007418,,apul_peve,49.324,FUN_040211-T1,Q01727,MSHR_MOUSE,,Melanocyte-stimulating hormone receptor (MSH-R) (Melanocortin receptor 1) (MC1-R),Mus musculus (Mouse),24.7,279.0,3.4e-07,57.4,sp|Q01727|MSHR_MOUSE Melanocyte-stimulating hormone receptor OS=Mus musculus OX=10090 GN=Mc1r PE=2 SV=2,GO:0004977; GO:0004980; GO:0005886; GO:0007189; GO:0007200; GO:0019233; GO:0031625; GO:0032720; GO:0035556; GO:0042438; GO:0042562; GO:0045944; GO:0070914; GO:0141163; GO:2000253,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; negative regulation of tumor necrosis factor production [GO:0032720]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of feeding behavior [GO:2000253]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory perception of pain [GO:0019233]; UV-damage excision repair [GO:0070914],plasma membrane [GO:0005886],hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625],GO:0005886; GO:0006281; GO:0006355; GO:0050877; GO:0060089,plasma membrane; DNA repair; regulation of DNA-templated transcription; nervous system process; molecular transducer activity
OG_13221,FUN_040212-T1,Peve_00019688,,apul_peve,48.667,FUN_040212-T1,Q9GLJ8,,,,,26.2,263.0,2.8e-09,64.3,sp|Q9GLJ8|MC4R_BOVIN Melanocortin receptor 4 OS=Bos taurus OX=9913 GN=MC4R PE=2 SV=1,,,,,,
OG_13222,FUN_040227-T1,Peve_00010290,,apul_peve,62.047,FUN_040227-T1,Q9UKP5,ATS6_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-),Homo sapiens (Human),33.3,619.0,1.4e-84,315.8,sp|Q9UKP5|ATS6_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 6 OS=Homo sapiens OX=9606 GN=ADAMTS6 PE=1 SV=2,GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976,aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; catalytic activity, acting on a protein"
OG_13223,FUN_040229-T1,Peve_00017093,,apul_peve,36.873,,,,,,,,,,,,,,,,,
OG_13224,FUN_040237-T1,Peve_00021819,,apul_peve,92.5,FUN_040237-T1,Q29RM3,,,,,58.5,94.0,1.2e-26,120.9,sp|Q29RM3|REEP5_BOVIN Receptor expression-enhancing protein 5 OS=Bos taurus OX=9913 GN=REEP5 PE=2 SV=1,,,,,,
OG_13225,FUN_040246-T1,Peve_00001729,,apul_peve,50.251,FUN_040246-T1,P0C6B8,,,,,35.8,201.0,5.1e-28,126.3,"sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1",,,,,,
OG_13226,FUN_040269-T1,Peve_00016265,,apul_peve,44.212,FUN_040269-T1,Q9JHA8,,,,,25.5,506.0,7.399999999999998e-25,117.1,sp|Q9JHA8|VWA7_MOUSE von Willebrand factor A domain-containing protein 7 OS=Mus musculus OX=10090 GN=Vwa7 PE=2 SV=1,,,,,,
OG_13227,FUN_040270-T1,Peve_00008067,,apul_peve,53.094,FUN_040270-T1,Q95254,GHSR_PIG,,Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor),Sus scrofa (Pig),24.5,302.0,5.1e-11,70.1,sp|Q95254|GHSR_PIG Growth hormone secretagogue receptor type 1 OS=Sus scrofa OX=9823 GN=GHSR PE=2 SV=1,GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0008154; GO:0009725; GO:0009755; GO:0009986; GO:0016520; GO:0032691; GO:0032715; GO:0032720; GO:0040018; GO:0043005; GO:0045121; GO:0046697; GO:0050728,actin polymerization or depolymerization [GO:0008154]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of multicellular organism growth [GO:0040018]; response to hormone [GO:0009725],cell surface [GO:0009986]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_13228,FUN_040304-T1,Peve_00020532,,apul_peve,74.107,FUN_040304-T1,Q8JFN7,,,,,38.7,318.0,8.4e-66,252.7,sp|Q8JFN7|ACH91_ONCMY Neuronal acetylcholine receptor subunit alpha-9-I OS=Oncorhynchus mykiss OX=8022 GN=nachra9 PE=2 SV=1,,,,,,
OG_13229,FUN_040310-T1,Peve_00035005,,apul_peve,59.901,,,,,,,,,,,,,,,,,
OG_13230,FUN_040324-T1,Peve_00020533,,apul_peve,55.522,FUN_040324-T1,P97718,ADA1A_MOUSE,,Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor),Mus musculus (Mouse),26.0,312.0,1.5e-19,98.6,sp|P97718|ADA1A_MOUSE Alpha-1A adrenergic receptor OS=Mus musculus OX=10090 GN=Adra1a PE=1 SV=3,GO:0000165; GO:0001985; GO:0001994; GO:0001996; GO:0001997; GO:0004937; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0005901; GO:0007200; GO:0007512; GO:0008217; GO:0010507; GO:0010613; GO:0016020; GO:0019229; GO:0031965; GO:0035024; GO:0035265; GO:0043410; GO:0045987; GO:0046982; GO:0055117; GO:0061049; GO:0071875; GO:0097195; GO:0150099,adrenergic receptor signaling pathway [GO:0071875]; adult heart development [GO:0007512]; cell growth involved in cardiac muscle cell development [GO:0061049]; MAPK cascade [GO:0000165]; negative regulation of autophagy [GO:0010507]; negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001985]; negative regulation of Rho protein signal transduction [GO:0035024]; neuron-glial cell signaling [GO:0150099]; norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [GO:0001994]; organ growth [GO:0035265]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; pilomotor reflex [GO:0097195]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of heart rate by epinephrine-norepinephrine [GO:0001996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by epinephrine-norepinephrine [GO:0001997]; regulation of blood pressure [GO:0008217]; regulation of cardiac muscle contraction [GO:0055117]; regulation of vasoconstriction [GO:0019229],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],alpha1-adrenergic receptor activity [GO:0004937]; protein heterodimerization activity [GO:0046982],GO:0003013; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0023052; GO:0043226; GO:0048856; GO:0060089,circulatory system process; nucleus; nucleoplasm; cytosol; plasma membrane; signaling; organelle; anatomical structure development; molecular transducer activity
OG_13231,FUN_040336-T1,Peve_00004424,,apul_peve,68.896,FUN_040336-T1,P97292,HRH2_MOUSE,,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),Mus musculus (Mouse),26.2,309.0,7.2e-11,69.7,sp|P97292|HRH2_MOUSE Histamine H2 receptor OS=Mus musculus OX=10090 GN=Hrh2 PE=2 SV=2,GO:0001696; GO:0001697; GO:0001698; GO:0003382; GO:0004969; GO:0005886; GO:0007613; GO:0008542; GO:0045907; GO:0048167; GO:0048565; GO:0048732,digestive tract development [GO:0048565]; epithelial cell morphogenesis [GO:0003382]; gastric acid secretion [GO:0001696]; gastrin-induced gastric acid secretion [GO:0001698]; gland development [GO:0048732]; histamine-induced gastric acid secretion [GO:0001697]; memory [GO:0007613]; positive regulation of vasoconstriction [GO:0045907]; regulation of synaptic plasticity [GO:0048167]; visual learning [GO:0008542],plasma membrane [GO:0005886],histamine receptor activity [GO:0004969],GO:0003013; GO:0005886; GO:0022600; GO:0048856; GO:0050877; GO:0060089,circulatory system process; plasma membrane; digestive system process; anatomical structure development; nervous system process; molecular transducer activity
OG_13232,FUN_040364-T1,Peve_00027107,,apul_peve,52.493,,,,,,,,,,,,,,,,,
OG_13233,FUN_040365-T1,Peve_00027108,,apul_peve,80.923,,,,,,,,,,,,,,,,,
OG_13234,FUN_040382-T1,Peve_00018576,,apul_peve,70.213,,,,,,,,,,,,,,,,,
OG_13235,FUN_040383-T1,Peve_00012069,,apul_peve,35.593,,,,,,,,,,,,,,,,,
OG_13236,FUN_040405-T1,Peve_00011129,,apul_peve,54.545,FUN_040405-T1,Q9UTA8,,,,,35.9,170.0,1.3e-21,105.1,sp|Q9UTA8|YL8A_SCHPO Uncharacterized methyltransferase-like C25B8.10 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPAC25B8.10 PE=3 SV=1,,,,,,
OG_13237,FUN_040407-T2,Peve_00006444,,apul_peve,48.1845,FUN_040407-T2,Q8IUK5,,,,,38.4,307.0,4.9e-50,200.7,sp|Q8IUK5|PLDX1_HUMAN Plexin domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PLXDC1 PE=1 SV=2,,,,,,
OG_13238,FUN_040415-T1,Peve_00044066,,apul_peve,60.771,FUN_040415-T1,A0ZSK4,STXB_SYNVE,,Neoverrucotoxin subunit beta (NeoVTX subunit beta),Synanceia verrucosa (Reef stonefish),26.1,571.0,1.3e-52,210.3,sp|A0ZSK4|STXB_SYNVE Neoverrucotoxin subunit beta OS=Synanceia verrucosa OX=51996 PE=1 SV=1,GO:0005576; GO:0031640; GO:0090729,killing of cells of another organism [GO:0031640],extracellular region [GO:0005576],toxin activity [GO:0090729],GO:0005576; GO:0090729,extracellular region; toxin activity
OG_13239,FUN_040419-T1,Peve_00028307,,apul_peve,50.396,,,,,,,,,,,,,,,,,
OG_13240,FUN_040427-T1,Peve_00004013,,apul_peve,40.711,FUN_040427-T1,O60140,,,,,31.0,310.0,4e-38,161.8,sp|O60140|YNS9_SCHPO Uncharacterized protein C18H10.09 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC18H10.09 PE=4 SV=2,,,,,,
OG_13241,FUN_040433-T1,Peve_00037553,,apul_peve,36.893,,,,,,,,,,,,,,,,,
OG_13242,FUN_040435-T1,Peve_00029627,,apul_peve,60.052,,,,,,,,,,,,,,,,,
OG_13243,FUN_040455-T1,Peve_00043929,,apul_peve,46.5455,,,,,,,,,,,,,,,,,
OG_13244,FUN_040456-T1,Peve_00041324,,apul_peve,52.542,,,,,,,,,,,,,,,,,
OG_13245,FUN_040465-T1,Peve_00019423,,apul_peve,95.802,,,,,,,,,,,,,,,,,
OG_13246,FUN_040501-T1,Peve_00036185,,apul_peve,90.526,,,,,,,,,,,,,,,,,
OG_13247,FUN_040512-T1,Peve_00042186,,apul_peve,78.75,,,,,,,,,,,,,,,,,
OG_13248,FUN_040514-T1,Peve_00019053,,apul_peve,93.75,,,,,,,,,,,,,,,,,
OG_13249,FUN_040529-T1,Peve_00022083,,apul_peve,46.79,,,,,,,,,,,,,,,,,
OG_13250,FUN_040542-T1,Peve_00043052,,apul_peve,65.789,,,,,,,,,,,,,,,,,
OG_13251,FUN_040568-T1,Peve_00011481,,apul_peve,48.148,,,,,,,,,,,,,,,,,
OG_13252,FUN_040575-T1,Peve_00016879,,apul_peve,60.274,,,,,,,,,,,,,,,,,
OG_13253,FUN_040600-T1,Peve_00011881,,apul_peve,75.3955,,,,,,,,,,,,,,,,,
OG_13254,FUN_040607-T1,Peve_00034952,,apul_peve,87.444,,,,,,,,,,,,,,,,,
OG_13255,FUN_040623-T1,Peve_00034113,,apul_peve,84.222,FUN_040623-T1,Q8GY23,,,,,24.0,417.0,1.1e-08,63.5,sp|Q8GY23|UPL1_ARATH E3 ubiquitin-protein ligase UPL1 OS=Arabidopsis thaliana OX=3702 GN=UPL1 PE=1 SV=3,,,,,,
OG_13256,FUN_040630-T1,Peve_00019633,,apul_peve,67.188,,,,,,,,,,,,,,,,,
OG_13257,FUN_040641-T1,Peve_00028414,,apul_peve,45.312,,,,,,,,,,,,,,,,,
OG_13258,FUN_040644-T1,Peve_00009628,,apul_peve,50.126,,,,,,,,,,,,,,,,,
OG_13259,FUN_040647-T1,Peve_00018812,,apul_peve,50.0,,,,,,,,,,,,,,,,,
OG_13260,FUN_040675-T2,Peve_00015422,,apul_peve,60.102,FUN_040675-T2,E7FGT5,,,,,31.8,1854.0,1.7e-239,831.6,sp|E7FGT5|FOCAD_DANRE Focadhesin OS=Danio rerio OX=7955 GN=focad PE=3 SV=2,,,,,,
OG_13261,FUN_040691-T2,Peve_00042967,,apul_peve,63.333,,,,,,,,,,,,,,,,,
OG_13262,FUN_040696-T1,Peve_00029578,,apul_peve,60.756,FUN_040696-T1,Q9D668,,,,,32.8,293.0,4.4e-32,140.2,sp|Q9D668|ARRD2_MOUSE Arrestin domain-containing protein 2 OS=Mus musculus OX=10090 GN=Arrdc2 PE=2 SV=1,,,,,,
OG_13263,FUN_040702-T1,Peve_00032513,,apul_peve,47.869,FUN_040702-T1,Q01727,MSHR_MOUSE,,Melanocyte-stimulating hormone receptor (MSH-R) (Melanocortin receptor 1) (MC1-R),Mus musculus (Mouse),24.5,294.0,3.1e-06,54.3,sp|Q01727|MSHR_MOUSE Melanocyte-stimulating hormone receptor OS=Mus musculus OX=10090 GN=Mc1r PE=2 SV=2,GO:0004977; GO:0004980; GO:0005886; GO:0007189; GO:0007200; GO:0019233; GO:0031625; GO:0032720; GO:0035556; GO:0042438; GO:0042562; GO:0045944; GO:0070914; GO:0141163; GO:2000253,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; intracellular signal transduction [GO:0035556]; melanin biosynthetic process [GO:0042438]; negative regulation of tumor necrosis factor production [GO:0032720]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of feeding behavior [GO:2000253]; positive regulation of transcription by RNA polymerase II [GO:0045944]; sensory perception of pain [GO:0019233]; UV-damage excision repair [GO:0070914],plasma membrane [GO:0005886],hormone binding [GO:0042562]; melanocortin receptor activity [GO:0004977]; melanocyte-stimulating hormone receptor activity [GO:0004980]; ubiquitin protein ligase binding [GO:0031625],GO:0005886; GO:0006281; GO:0006355; GO:0050877; GO:0060089,plasma membrane; DNA repair; regulation of DNA-templated transcription; nervous system process; molecular transducer activity
OG_13264,FUN_040724-T1,Peve_00030500,,apul_peve,43.712,,,,,,,,,,,,,,,,,
OG_13265,FUN_040725-T1,Peve_00022853,,apul_peve,70.89,FUN_040725-T1,Q5M7L9,FOXD3_XENTR,,Forkhead box protein D3 (FoxD3),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),48.0,150.0,9.5e-36,152.1,sp|Q5M7L9|FOXD3_XENTR Forkhead box protein D3 OS=Xenopus tropicalis OX=8364 GN=foxd3 PE=2 SV=1,GO:0001755; GO:0003677; GO:0003700; GO:0005634; GO:0006366; GO:0007422; GO:0010629; GO:0014034; GO:0030318; GO:0043565; GO:0045892; GO:0048484; GO:0048485; GO:0048937; GO:0050768; GO:0050769; GO:0050935; GO:0060351; GO:0097066,cartilage development involved in endochondral bone morphogenesis [GO:0060351]; enteric nervous system development [GO:0048484]; iridophore differentiation [GO:0050935]; lateral line nerve glial cell development [GO:0048937]; melanocyte differentiation [GO:0030318]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of neurogenesis [GO:0050768]; neural crest cell fate commitment [GO:0014034]; neural crest cell migration [GO:0001755]; peripheral nervous system development [GO:0007422]; positive regulation of neurogenesis [GO:0050769]; response to thyroid hormone [GO:0097066]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366],nucleus [GO:0005634],DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_13266,FUN_040782-T1,Peve_00022842,,apul_peve,65.94550000000001,FUN_040782-T1,Q15751,HERC1_HUMAN,,Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619),Homo sapiens (Human),42.4,5002.0,0.0,3489.9,sp|Q15751|HERC1_HUMAN Probable E3 ubiquitin-protein ligase HERC1 OS=Homo sapiens OX=9606 GN=HERC1 PE=1 SV=2,GO:0004842; GO:0005085; GO:0005737; GO:0005794; GO:0005829; GO:0006914; GO:0010467; GO:0010507; GO:0016020; GO:0016567; GO:0021702; GO:0022038; GO:0030282; GO:0031175; GO:0046849; GO:0050885,autophagy [GO:0006914]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; cerebellar Purkinje cell differentiation [GO:0021702]; corpus callosum development [GO:0022038]; gene expression [GO:0010467]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020],guanyl-nucleotide exchange factor activity [GO:0005085]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005794; GO:0005829; GO:0006914; GO:0016740; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0098772; GO:0140096,"catalytic activity; Golgi apparatus; cytosol; autophagy; transferase activity; cell differentiation; organelle; anatomical structure development; nervous system process; molecular function regulator activity; catalytic activity, acting on a protein"
OG_13267,FUN_040795-T1,Peve_00026645,,apul_peve,68.293,,,,,,,,,,,,,,,,,
OG_13268,FUN_040796-T1,Peve_00026646,,apul_peve,64.068,,,,,,,,,,,,,,,,,
OG_13269,FUN_040828-T1,Peve_00022182,,apul_peve,49.322500000000005,,,,,,,,,,,,,,,,,
OG_13270,FUN_040829-T1,Peve_00042275,,apul_peve,84.892,,,,,,,,,,,,,,,,,
OG_13271,FUN_040832-T1,Peve_00042639,,apul_peve,47.2,,,,,,,,,,,,,,,,,
OG_13272,FUN_040869-T1,Peve_00019300,,apul_peve,43.161,,,,,,,,,,,,,,,,,
OG_13273,FUN_040888-T1,Peve_00029308,,apul_peve,83.68549999999999,,,,,,,,,,,,,,,,,
OG_13274,FUN_040909-T1,Peve_00042835,,apul_peve,48.372,,,,,,,,,,,,,,,,,
OG_13275,FUN_040911-T1,Peve_00042834,,apul_peve,54.076,,,,,,,,,,,,,,,,,
OG_13276,FUN_040918-T1,Peve_00039682,,apul_peve,45.087,,,,,,,,,,,,,,,,,
OG_13277,FUN_040926-T1,Peve_00026390,,apul_peve,55.625,,,,,,,,,,,,,,,,,
OG_13278,FUN_040953-T1,Peve_00016970,,apul_peve,50.2535,,,,,,,,,,,,,,,,,
OG_13279,FUN_041003-T1,Peve_00004217,,apul_peve,74.424,,,,,,,,,,,,,,,,,
OG_13280,FUN_041066-T1,Peve_00013697,,apul_peve,80.272,,,,,,,,,,,,,,,,,
OG_13281,FUN_041134-T1,Peve_00035050,,apul_peve,92.814,,,,,,,,,,,,,,,,,
OG_13282,FUN_041155-T1,Peve_00006357,,apul_peve,68.946,FUN_041155-T1,Q0EEE2,PTHD3_MOUSE,,Patched domain-containing protein 3 (RND-type protein RNDEu-3),Mus musculus (Mouse),28.0,750.0,8.5e-65,250.4,sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0097225,,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225],,GO:0005783; GO:0005886; GO:0043226,endoplasmic reticulum; plasma membrane; organelle
OG_13283,FUN_041158-T1,Peve_00015154,,apul_peve,59.154,FUN_041158-T1,Q7TXL8,,,,,25.9,2232.0,6.6e-163,578.2,sp|Q7TXL8|PPSC_MYCBO Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) OX=233413 GN=ppsC PE=1 SV=1,,,,,,
OG_13284,FUN_041163-T1,Peve_00044854,,apul_peve,89.823,,,,,,,,,,,,,,,,,
OG_13285,FUN_041165-T1,Peve_00019635,,apul_peve,34.164,,,,,,,,,,,,,,,,,
OG_13286,FUN_041276-T1,Peve_00003468,,apul_peve,49.145,,,,,,,,,,,,,,,,,
OG_13287,FUN_041295-T1,Peve_00008461,,apul_peve,40.123,,,,,,,,,,,,,,,,,
OG_13288,FUN_041354-T1,Peve_00012665,,apul_peve,40.705,,,,,,,,,,,,,,,,,
OG_13289,FUN_041361-T1,Peve_00000567,,apul_peve,31.667,,,,,,,,,,,,,,,,,
OG_13290,FUN_041370-T1,Peve_00044210,,apul_peve,53.282,FUN_041370-T1,Q8C9E8,CAHM6_MOUSE,,Calcium homeostasis modulator protein 6 (IFN regulatory factor 3-dependent NK-activating molecule) (INAM) (Protein FAM26F),Mus musculus (Mouse),26.6,305.0,4.2e-16,87.0,sp|Q8C9E8|CAHM6_MOUSE Calcium homeostasis modulator protein 6 OS=Mus musculus OX=10090 GN=Calhm6 PE=1 SV=1,GO:0001772; GO:0002727; GO:0006954; GO:0022832; GO:0034220; GO:0045087; GO:1904669,ATP export [GO:1904669]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; monoatomic ion transmembrane transport [GO:0034220]; regulation of natural killer cell cytokine production [GO:0002727],immunological synapse [GO:0001772],voltage-gated channel activity [GO:0022832],GO:0002376; GO:0005215; GO:0006954; GO:0055085; GO:0098542,immune system process; transporter activity; inflammatory response; transmembrane transport; defense response to other organism
OG_13291,FUN_041384-T1,Peve_00044209,,apul_peve,55.999,FUN_041384-T1,Q76MS7,,,,,27.5,291.0,3e-24,114.4,sp|Q76MS7|HRH2_GORGO Histamine H2 receptor OS=Gorilla gorilla gorilla OX=9595 GN=HRH2 PE=3 SV=1,,,,,,
OG_13292,FUN_041387-T2,Peve_00044205,,apul_peve,82.488,FUN_041387-T2,Q8BIK4,DOCK9_MOUSE,,Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1),Mus musculus (Mouse),42.8,2059.0,0.0,1516.1,sp|Q8BIK4|DOCK9_MOUSE Dedicator of cytokinesis protein 9 OS=Mus musculus OX=10090 GN=Dock9 PE=1 SV=2,GO:0005085; GO:0007264; GO:0012505; GO:0016020; GO:0031267; GO:0043547,positive regulation of GTPase activity [GO:0043547]; small GTPase-mediated signal transduction [GO:0007264],endomembrane system [GO:0012505]; membrane [GO:0016020],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0098772,molecular function regulator activity
OG_13293,FUN_041405-T1,Peve_00020007,,apul_peve,59.945,FUN_041405-T1,Q8JI28,,,,,43.8,112.0,8.8e-20,102.1,sp|Q8JI28|TLL1_XENLA Tolloid-like protein 1 OS=Xenopus laevis OX=8355 GN=tll1 PE=1 SV=1,,,,,,
OG_13294,FUN_041406-T1,Peve_00020006,,apul_peve,39.855,,,,,,,,,,,,,,,,,
OG_13295,FUN_041429-T1,Peve_00036320,,apul_peve,58.735,FUN_041429-T1,P43141,,,,,26.6,305.0,1.9e-14,81.6,sp|P43141|ADB4C_MELGA Beta-4C adrenergic receptor OS=Meleagris gallopavo OX=9103 GN=ADRB4C PE=2 SV=1,,,,,,
OG_13296,FUN_041430-T1,Peve_00004525,,apul_peve,53.42,FUN_041430-T1,Q9N0P9,,,,,39.1,253.0,1.8e-47,191.8,sp|Q9N0P9|PIM1_BOVIN Serine/threonine-protein kinase pim-1 OS=Bos taurus OX=9913 GN=PIM1 PE=2 SV=1,,,,,,
OG_13297,FUN_041456-T1,Peve_00004721,,apul_peve,61.765,,,,,,,,,,,,,,,,,
OG_13298,FUN_041469-T1,Peve_00017079,,apul_peve,30.7145,,,,,,,,,,,,,,,,,
OG_13299,FUN_041473-T1,Peve_00029555,,apul_peve,54.605,,,,,,,,,,,,,,,,,
OG_13300,FUN_041496-T1,Peve_00027719,,apul_peve,90.948,FUN_041496-T1,Q8ISN9,,,,,80.0,115.0,8.000000000000001e-34,144.4,sp|Q8ISN9|RS25_BRABE Small ribosomal subunit protein eS25 OS=Branchiostoma belcheri OX=7741 GN=RPS25 PE=2 SV=1,,,,,,
OG_13301,FUN_041513-T1,Peve_00039627,,apul_peve,63.392,FUN_041513-T1,Q9NZN5,ARHGC_HUMAN,,Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF),Homo sapiens (Human),28.2,673.0,7.799999999999999e-46,187.2,sp|Q9NZN5|ARHGC_HUMAN Rho guanine nucleotide exchange factor 12 OS=Homo sapiens OX=9606 GN=ARHGEF12 PE=1 SV=1,GO:0001664; GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007186; GO:0007266; GO:0016020; GO:0051056; GO:0070062; GO:0160221,G protein-coupled receptor signaling pathway [GO:0007186]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020],G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0043226; GO:0098772,cytosol; organelle; molecular function regulator activity
OG_13302,FUN_041537-T1,Peve_00039117,,apul_peve,32.222,,,,,,,,,,,,,,,,,
OG_13303,FUN_041560-T1,Peve_00033128,,apul_peve,38.7365,,,,,,,,,,,,,,,,,
OG_13304,FUN_041563-T1,Peve_00020329,,apul_peve,58.696,,,,,,,,,,,,,,,,,
OG_13305,FUN_041570-T1,Peve_00043707,,apul_peve,63.636,FUN_041570-T1,Q0P5A5,CKS1_BOVIN,,Cyclin-dependent kinases regulatory subunit 1 (CKS-1),Bos taurus (Bovine),75.3,73.0,3.6e-30,131.7,sp|Q0P5A5|CKS1_BOVIN Cyclin-dependent kinases regulatory subunit 1 OS=Bos taurus OX=9913 GN=CKS1B PE=3 SV=1,GO:0000307; GO:0006355; GO:0007346; GO:0019005; GO:0019901; GO:0042393; GO:0043130; GO:0044772; GO:0048144; GO:0051301; GO:0061575,cell division [GO:0051301]; fibroblast proliferation [GO:0048144]; mitotic cell cycle phase transition [GO:0044772]; regulation of DNA-templated transcription [GO:0006355]; regulation of mitotic cell cycle [GO:0007346],cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005],cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130],GO:0006355; GO:0042393; GO:0098772,regulation of DNA-templated transcription; histone binding; molecular function regulator activity
OG_13306,FUN_041585-T1,Peve_00028472,,apul_peve,74.286,FUN_041585-T1,P18320,,,,,76.4,140.0,6.200000000000002e-57,221.5,sp|P18320|PROF_HELCR Profilin OS=Heliocidaris crassispina OX=1043166 PE=1 SV=2,,,,,,
OG_13307,FUN_041589-T1,Peve_00036090,,apul_peve,49.498,FUN_041589-T1,Q5U4V2,,,,,26.0,250.0,9.5e-15,82.4,sp|Q5U4V2|HNMTA_XENLA Histamine N-methyltransferase A OS=Xenopus laevis OX=8355 GN=hnmt-a PE=2 SV=1,,,,,,
OG_13308,FUN_041591-T1,Peve_00036097,,apul_peve,56.84,FUN_041591-T1,Q1L6Q1,DUSTY_APIME,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Apis mellifera (Honeybee),21.9,947.0,2.1e-31,139.4,sp|Q1L6Q1|DUSTY_APIME Dual serine/threonine and tyrosine protein kinase OS=Apis mellifera OX=7460 GN=DSTYK PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0043066; GO:0044344; GO:0045743; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; negative regulation of apoptotic process [GO:0043066]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_13309,FUN_041601-T1,Peve_00025735,,apul_peve,54.7925,FUN_041601-T1,P24612,MEC4_CAEEL,,Degenerin mec-4 (Mechanosensory abnormality protein 4),Caenorhabditis elegans,34.6,315.0,1.8e-38,162.2,sp|P24612|MEC4_CAEEL Degenerin mec-4 OS=Caenorhabditis elegans OX=6239 GN=mec-4 PE=1 SV=3,GO:0005886; GO:0006813; GO:0007638; GO:0009612; GO:0015280; GO:0016020; GO:0030424; GO:0032589; GO:0035725; GO:0050976; GO:0061096; GO:1905789; GO:1905792,detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; negative regulation of turning behavior involved in mating [GO:0061096]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612]; sodium ion transmembrane transport [GO:0035725],axon [GO:0030424]; membrane [GO:0016020]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886],ligand-gated sodium channel activity [GO:0015280],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_13310,FUN_041611-T2,Peve_00036073,,apul_peve,88.766,FUN_041611-T2,Q3V096,,,,,55.3,432.0,1.1e-40,169.5,sp|Q3V096|ANR42_MOUSE Ankyrin repeat domain-containing protein 42 OS=Mus musculus OX=10090 GN=Ankrd42 PE=1 SV=1,,,,,,
OG_13311,FUN_041618-T1,Peve_00036074,,apul_peve,75.155,FUN_041618-T1,O08688,,,,,45.7,643.0,2.7e-163,577.0,sp|O08688|CAN5_MOUSE Calpain-5 OS=Mus musculus OX=10090 GN=Capn5 PE=1 SV=1,,,,,,
OG_13312,FUN_041640-T1,Peve_00007385,,apul_peve,42.541,,,,,,,,,,,,,,,,,
OG_13313,FUN_041676-T1,Peve_00007769,,apul_peve,88.166,FUN_041676-T1,P42577,,,,,71.9,167.0,3.8e-64,245.7,sp|P42577|FRIS_LYMST Soma ferritin OS=Lymnaea stagnalis OX=6523 PE=2 SV=2,,,,,,
OG_13314,FUN_041680-T1,Peve_00009954,,apul_peve,60.247,,,,,,,,,,,,,,,,,
OG_13315,FUN_041681-T1,Peve_00041076,,apul_peve,49.704,FUN_041681-T1,P07949,RET_HUMAN,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Homo sapiens (Human),42.9,308.0,1.1e-70,270.4,sp|P07949|RET_HUMAN Proto-oncogene tyrosine-protein kinase receptor Ret OS=Homo sapiens OX=9606 GN=RET PE=1 SV=3,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0007156; GO:0007158; GO:0007165; GO:0007169; GO:0007411; GO:0007497; GO:0010008; GO:0010628; GO:0010976; GO:0030155; GO:0030335; GO:0030424; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0038023; GO:0042551; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0061146; GO:0071300; GO:0072300; GO:0097021; GO:0098797; GO:0160144; GO:2001241,axon guidance [GO:0007411]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; lymphocyte migration into lymphoid organs [GO:0097021]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; posterior midgut development [GO:0007497]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; signal transduction [GO:0007165]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0002376; GO:0003824; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"immune system process; catalytic activity; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_13316,FUN_041690-T1,Peve_00041073,,apul_peve,62.057,FUN_041690-T1,Q91175,,,,,20.9,340.0,6.1e-10,66.6,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_13317,FUN_041692-T1,Peve_00041080,,apul_peve,65.2745,,,,,,,,,,,,,,,,,
OG_13318,FUN_041698-T1,Peve_00001624,,apul_peve,84.505,FUN_041698-T1,Q9DE46,DPOLA_XENLA,,DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180),Xenopus laevis (African clawed frog),61.0,1005.0,0.0,1199.1,sp|Q9DE46|DPOLA_XENLA DNA polymerase alpha catalytic subunit OS=Xenopus laevis OX=8355 GN=pola1 PE=1 SV=1,GO:0000166; GO:0000785; GO:0003677; GO:0003682; GO:0003688; GO:0003697; GO:0003887; GO:0005634; GO:0005635; GO:0005654; GO:0005658; GO:0005730; GO:0006260; GO:0006269; GO:0006270; GO:0006271; GO:0006272; GO:0006273; GO:0006303; GO:0008270; GO:0016363; GO:1902975,"DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272]; mitotic DNA replication initiation [GO:1902975]",alpha DNA polymerase:primase complex [GO:0005658]; chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; DNA-directed DNA polymerase activity [GO:0003887]; nucleotide binding [GO:0000166]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005635; GO:0005654; GO:0005730; GO:0006260; GO:0006281; GO:0016740; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nuclear envelope; nucleoplasm; nucleolus; DNA replication; DNA repair; transferase activity; organelle; catalytic activity, acting on DNA"
OG_13319,FUN_041708-T1,Peve_00001478,,apul_peve,71.703,FUN_041708-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),36.7,357.0,1.6999999999999998e-69,264.6,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_13320,FUN_041715-T1,Peve_00034180,,apul_peve,33.644000000000005,,,,,,,,,,,,,,,,,
OG_13321,FUN_041723-T1,Peve_00006445,,apul_peve,89.85,FUN_041723-T1,Q9VPH8,,,,,61.2,459.0,2.8e-155,550.1,sp|Q9VPH8|RBBP5_DROME Retinoblastoma-binding protein 5 homolog OS=Drosophila melanogaster OX=7227 GN=Rbbp5 PE=1 SV=2,,,,,,
OG_13322,FUN_041724-T1,Peve_00014619,,apul_peve,42.601,,,,,,,,,,,,,,,,,
OG_13323,FUN_041733-T1,Peve_00024445,,apul_peve,37.0385,,,,,,,,,,,,,,,,,
OG_13324,FUN_041736-T1,Peve_00036484,,apul_peve,49.581,FUN_041736-T1,Q8K0U4,,,,,36.9,632.0,4.1000000000000004e-110,400.2,sp|Q8K0U4|HS12A_MOUSE Heat shock 70 kDa protein 12A OS=Mus musculus OX=10090 GN=Hspa12a PE=1 SV=1,,,,,,
OG_13325,FUN_041742-T1,Peve_00033922,,apul_peve,73.427,FUN_041742-T1,Q0VAA2,,,,,41.2,97.0,9.5e-11,69.7,sp|Q0VAA2|LR74A_HUMAN Leucine-rich repeat-containing protein 74A OS=Homo sapiens OX=9606 GN=LRRC74A PE=1 SV=2,,,,,,
OG_13326,FUN_041751-T1,Peve_00013814,,apul_peve,77.13,FUN_041751-T1,P23416,GLRA2_HUMAN,,Glycine receptor subunit alpha-2,Homo sapiens (Human),38.5,423.0,1.6e-69,265.0,sp|P23416|GLRA2_HUMAN Glycine receptor subunit alpha-2 OS=Homo sapiens OX=9606 GN=GLRA2 PE=1 SV=1,GO:0004888; GO:0005886; GO:0007218; GO:0016594; GO:0016934; GO:0022852; GO:0034220; GO:0034707; GO:0042995; GO:0043231; GO:0046872; GO:0050804; GO:0071230; GO:0071294; GO:0071361; GO:0098690; GO:0098982; GO:0099634; GO:1902476; GO:1904315,cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chloride transmembrane transport [GO:1902476]; modulation of chemical synaptic transmission [GO:0050804]; monoatomic ion transmembrane transport [GO:0034220]; neuropeptide signaling pathway [GO:0007218],cell projection [GO:0042995]; chloride channel complex [GO:0034707]; GABA-ergic synapse [GO:0098982]; glycinergic synapse [GO:0098690]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0060089,transporter activity; plasma membrane; organelle; transmembrane transport; molecular transducer activity
OG_13327,FUN_041774-T1,Peve_00014828,,apul_peve,86.842,FUN_041774-T1,Q9CPQ8,,,,,39.8,103.0,1.6e-15,83.6,"sp|Q9CPQ8|ATP5L_MOUSE ATP synthase F(0) complex subunit g, mitochondrial OS=Mus musculus OX=10090 GN=Atp5mg PE=1 SV=1",,,,,,
OG_13328,FUN_041780-T1,Peve_00032045,,apul_peve,68.394,FUN_041780-T1,Q39610,DYHA_CHLRE,,"Dynein alpha chain, flagellar outer arm (DHC alpha)",Chlamydomonas reinhardtii (Chlamydomonas smithii),35.7,266.0,1e-12,78.2,"sp|Q39610|DYHA_CHLRE Dynein alpha chain, flagellar outer arm OS=Chlamydomonas reinhardtii OX=3055 GN=ODA11 PE=3 SV=2",GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008569; GO:0016887; GO:0030030; GO:0030286; GO:0031514; GO:0045505; GO:0051959,cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005929; GO:0007018; GO:0016787; GO:0016853; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cilium; microtubule-based movement; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_13329,FUN_041785-T1,Peve_00025204,,apul_peve,41.026,FUN_041785-T1,B5DF27,LOXL2_RAT,,Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2),Rattus norvegicus (Rat),40.0,135.0,1.9e-22,108.2,sp|B5DF27|LOXL2_RAT Lysyl oxidase homolog 2 OS=Rattus norvegicus OX=10116 GN=Loxl2 PE=2 SV=2,GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005783; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0036211; GO:0043542; GO:0045892; GO:0046688; GO:0062023; GO:0070492; GO:0070828; GO:1902455,collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; protein modification process [GO:0036211]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040],basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0005783; GO:0006325; GO:0006355; GO:0016491; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; extracellular space; nucleus; endoplasmic reticulum; chromatin organization; regulation of DNA-templated transcription; oxidoreductase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; cell motility; catalytic activity, acting on a protein"
OG_13330,FUN_041802-T1,Peve_00028124,,apul_peve,62.136,,,,,,,,,,,,,,,,,
OG_13331,FUN_041814-T1,Peve_00025191,,apul_peve,66.7305,FUN_041814-T1,Q91175,,,,,28.4,334.0,9.5e-26,119.0,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_13332,FUN_041822-T1,Peve_00033449,,apul_peve,88.791,,,,,,,,,,,,,,,,,
OG_13333,FUN_041826-T1,Peve_00039125,,apul_peve,68.841,FUN_041826-T1,Q9D0B5,,,,,43.3,127.0,3.9e-21,102.8,sp|Q9D0B5|TSTD3_MOUSE Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 OS=Mus musculus OX=10090 GN=Tstd3 PE=1 SV=1,,,,,,
OG_13334,FUN_041831-T1,Peve_00039121,,apul_peve,66.482,FUN_041831-T1,P69526,,,,,30.8,765.0,9.2e-106,386.3,sp|P69526|TMPS9_RAT Transmembrane protease serine 9 OS=Rattus norvegicus OX=10116 GN=Tmprss9 PE=3 SV=1,,,,,,
OG_13335,FUN_041832-T1,Peve_00043007,,apul_peve,90.965,FUN_041832-T1,A0A2B4RNI3,,,,,25.5,216.0,2.7e-06,55.1,sp|A0A2B4RNI3|CGLR2_STYPI Cyclic GMP-AMP synthase-like receptor 2 OS=Stylophora pistillata OX=50429 GN=cGLR2 PE=1 SV=1,,,,,,
OG_13336,FUN_041842-T1,Peve_00026145,,apul_peve,69.946,,,,,,,,,,,,,,,,,
OG_13337,FUN_041844-T1,Peve_00010474,,apul_peve,67.412,FUN_041844-T1,P47747,,,,,38.8,299.0,2.5e-40,167.5,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_13338,FUN_041853-T1,Peve_00025832,,apul_peve,90.071,FUN_041853-T1,Q5NCF2,TPPC1_MOUSE,,Trafficking protein particle complex subunit 1,Mus musculus (Mouse),62.4,141.0,7.2e-53,208.0,sp|Q5NCF2|TPPC1_MOUSE Trafficking protein particle complex subunit 1 OS=Mus musculus OX=10090 GN=Trappc1 PE=1 SV=1,GO:0005737; GO:0005783; GO:0006888; GO:0006901; GO:0030008; GO:0048208; GO:0099022; GO:1990071; GO:1990072,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; vesicle coating [GO:0006901]; vesicle tethering [GO:0099022],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072],,GO:0005783; GO:0016192; GO:0043226; GO:0065003,endoplasmic reticulum; vesicle-mediated transport; organelle; protein-containing complex assembly
OG_13339,FUN_041864-T1,Peve_00030115,,apul_peve,68.583,FUN_041864-T1,Q62880,,,,,52.1,192.0,7.7e-44,179.1,sp|Q62880|TAF9B_RAT Transcription initiation factor TFIID subunit 9B OS=Rattus norvegicus OX=10116 GN=Taf9b PE=2 SV=2,,,,,,
OG_13340,FUN_041865-T1,Peve_00030454,,apul_peve,76.474,,,,,,,,,,,,,,,,,
OG_13341,FUN_041866-T1,Peve_00030117,,apul_peve,71.287,FUN_041866-T1,Q90YT3,,,,,51.9,104.0,5.1e-26,118.6,sp|Q90YT3|RL35A_ICTPU Large ribosomal subunit protein eL33 OS=Ictalurus punctatus OX=7998 GN=rpl35a PE=3 SV=1,,,,,,
OG_13342,FUN_041872-T1,Peve_00031383,,apul_peve,72.0,FUN_041872-T1,Q6DG88,ATG4B_DANRE,,Cysteine protease ATG4B (EC 3.4.22.-) (Autophagy-related protein 4 homolog B),Danio rerio (Zebrafish) (Brachydanio rerio),45.5,134.0,1.1e-23,111.3,sp|Q6DG88|ATG4B_DANRE Cysteine protease ATG4B OS=Danio rerio OX=7955 GN=atg4b PE=2 SV=2,GO:0000045; GO:0000423; GO:0004197; GO:0005737; GO:0005739; GO:0005776; GO:0005783; GO:0005829; GO:0006914; GO:0015031; GO:0016237; GO:0016485; GO:0019786; GO:0031173; GO:0031410; GO:0034727; GO:0035973,aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; microautophagy [GO:0016237]; mitophagy [GO:0000423]; otolith mineralization completed early in development [GO:0031173]; piecemeal microautophagy of the nucleus [GO:0034727]; protein processing [GO:0016485]; protein transport [GO:0015031],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],cysteine-type endopeptidase activity [GO:0004197]; protein-phosphatidylethanolamide deconjugating activity [GO:0019786],GO:0003824; GO:0005739; GO:0005773; GO:0005783; GO:0005829; GO:0006914; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; mitochondrion; vacuole; endoplasmic reticulum; cytosol; autophagy; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_13343,FUN_041878-T1,Peve_00000878,,apul_peve,35.912,,,,,,,,,,,,,,,,,
OG_13344,FUN_041879-T1,Peve_00000877,,apul_peve,55.351,,,,,,,,,,,,,,,,,
OG_13345,FUN_041880-T1,Peve_00010076,,apul_peve,47.273,,,,,,,,,,,,,,,,,
OG_13346,FUN_041881-T1,Peve_00033404,,apul_peve,57.965,,,,,,,,,,,,,,,,,
OG_13347,FUN_041882-T1,Peve_00033387,,apul_peve,33.6655,,,,,,,,,,,,,,,,,
OG_13348,FUN_041886-T1,Peve_00033409,,apul_peve,62.024,,,,,,,,,,,,,,,,,
OG_13349,FUN_041894-T1,Peve_00026174,,apul_peve,74.064,FUN_041894-T1,Q09470,KCNA1_HUMAN,,Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1),Homo sapiens (Human),40.2,376.0,2.5e-68,260.8,sp|Q09470|KCNA1_HUMAN Potassium voltage-gated channel subfamily A member 1 OS=Homo sapiens OX=9606 GN=KCNA1 PE=1 SV=2,GO:0001508; GO:0001964; GO:0005249; GO:0005251; GO:0005783; GO:0005829; GO:0005886; GO:0006937; GO:0007405; GO:0008076; GO:0009986; GO:0010644; GO:0010960; GO:0016020; GO:0019228; GO:0021766; GO:0023041; GO:0030054; GO:0030425; GO:0031410; GO:0033270; GO:0042391; GO:0042734; GO:0043025; GO:0043194; GO:0043204; GO:0043679; GO:0044224; GO:0045202; GO:0050905; GO:0050966; GO:0050976; GO:0051260; GO:0070161; GO:0071286; GO:0071805; GO:0086011; GO:0097718,action potential [GO:0001508]; cell communication by electrical coupling [GO:0010644]; cellular response to magnesium ion [GO:0071286]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; hippocampus development [GO:0021766]; magnesium ion homeostasis [GO:0010960]; membrane repolarization during action potential [GO:0086011]; neuroblast proliferation [GO:0007405]; neuromuscular process [GO:0050905]; neuronal action potential [GO:0019228]; neuronal signal transduction [GO:0023041]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; startle response [GO:0001964],anchoring junction [GO:0070161]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; disordered domain specific binding [GO:0097718]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; transmembrane transport; protein-containing complex assembly
OG_13350,FUN_041898-T1,Peve_00015836,,apul_peve,61.054,FUN_041898-T1,B0S733,REN3A_DANRE,,Regulator of nonsense transcripts 3A (Up-frameshift suppressor 3 homolog A),Danio rerio (Zebrafish) (Brachydanio rerio),55.0,169.0,1.5000000000000002e-38,162.2,sp|B0S733|REN3A_DANRE Regulator of nonsense transcripts 3A OS=Danio rerio OX=7955 GN=upf3a PE=1 SV=2,GO:0000184; GO:0003723; GO:0005730; GO:0005737; GO:0032991; GO:0042162; GO:0045727; GO:0051028,"mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727]",cytoplasm [GO:0005737]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003723; GO:0005730; GO:0016071; GO:0043226,DNA binding; RNA binding; nucleolus; mRNA metabolic process; organelle
OG_13351,FUN_041904-T1,Peve_00034607,,apul_peve,53.448,FUN_041904-T1,Q5DU57,SPT13_MOUSE,,Spermatogenesis-associated protein 13 (APC-stimulated guanine nucleotide exchange factor 2) (Asef2),Mus musculus (Mouse),51.7,435.0,4e-120,434.9,sp|Q5DU57|SPT13_MOUSE Spermatogenesis-associated protein 13 OS=Mus musculus OX=10090 GN=Spata13 PE=1 SV=2,GO:0002102; GO:0005085; GO:0005737; GO:0016477; GO:0030027; GO:0030032; GO:0030175; GO:0030334; GO:0032587; GO:0035556; GO:0046847; GO:0070161,cell migration [GO:0016477]; filopodium assembly [GO:0046847]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; regulation of cell migration [GO:0030334],anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; lamellipodium [GO:0030027]; podosome [GO:0002102]; ruffle membrane [GO:0032587],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0043226; GO:0048870; GO:0098772,organelle; cell motility; molecular function regulator activity
OG_13352,FUN_041942-T1,Peve_00023592,,apul_peve,71.0395,FUN_041942-T1,E9Q5M6,CFA44_MOUSE,,Cilia- and flagella-associated protein 44,Mus musculus (Mouse),44.1,1785.0,0.0,1172.1,sp|E9Q5M6|CFA44_MOUSE Cilia- and flagella-associated protein 44 OS=Mus musculus OX=10090 GN=Cfap44 PE=2 SV=1,GO:0000226; GO:0000902; GO:0005930; GO:0006997; GO:0007283; GO:0007288; GO:0008233; GO:0030317; GO:0031514; GO:0044782,cell morphogenesis [GO:0000902]; cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; microtubule cytoskeleton organization [GO:0000226]; nucleus organization [GO:0006997]; sperm axoneme assembly [GO:0007288]; spermatogenesis [GO:0007283],axoneme [GO:0005930]; motile cilium [GO:0031514],peptidase activity [GO:0008233],GO:0003824; GO:0005929; GO:0007010; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0044782; GO:0048870; GO:0140096,"catalytic activity; cilium; cytoskeleton organization; microtubule-based movement; hydrolase activity; reproductive process; organelle; cilium organization; cell motility; catalytic activity, acting on a protein"
OG_13353,FUN_041953-T1,Peve_00022246,,apul_peve,71.515,FUN_041953-T1,P25962,ADRB3_MOUSE,,Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor),Mus musculus (Mouse),24.4,315.0,3.5e-08,60.8,sp|P25962|ADRB3_MOUSE Beta-3 adrenergic receptor OS=Mus musculus OX=10090 GN=Adrb3 PE=2 SV=2,GO:0002024; GO:0002025; GO:0004939; GO:0005886; GO:0007189; GO:0009409; GO:0015052; GO:0016020; GO:0031649; GO:0031699; GO:0040015; GO:0042755; GO:0042803; GO:0043235; GO:0043410; GO:0050873; GO:0051379; GO:0051380; GO:0071880; GO:0120162,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; eating behavior [GO:0042755]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; response to cold [GO:0009409],membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],beta-3 adrenergic receptor binding [GO:0031699]; beta-adrenergic receptor activity [GO:0004939]; beta3-adrenergic receptor activity [GO:0015052]; epinephrine binding [GO:0051379]; norepinephrine binding [GO:0051380]; protein homodimerization activity [GO:0042803],GO:0003013; GO:0005886; GO:0030154; GO:0060089,circulatory system process; plasma membrane; cell differentiation; molecular transducer activity
OG_13354,FUN_041979-T1,Peve_00001544,,apul_peve,58.219,FUN_041979-T1,Q9Z1L4,XLRS1_MOUSE,,Retinoschisin (X-linked juvenile retinoschisis protein homolog),Mus musculus (Mouse),33.8,154.0,1.4e-18,95.1,sp|Q9Z1L4|XLRS1_MOUSE Retinoschisin OS=Mus musculus OX=10090 GN=Rs1 PE=1 SV=1,GO:0001786; GO:0001917; GO:0005546; GO:0005547; GO:0005576; GO:0005615; GO:0007155; GO:0007601; GO:0009897; GO:0009986; GO:0010314; GO:0010842; GO:0032266; GO:0032991; GO:0043325; GO:0044877; GO:0051260; GO:0070273; GO:0080025; GO:0098984,cell adhesion [GO:0007155]; protein homooligomerization [GO:0051260]; retina layer formation [GO:0010842]; visual perception [GO:0007601],cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron to neuron synapse [GO:0098984]; photoreceptor inner segment [GO:0001917]; protein-containing complex [GO:0032991],"phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; phosphatidylserine binding [GO:0001786]; protein-containing complex binding [GO:0044877]",GO:0005576; GO:0005615; GO:0007155; GO:0008289; GO:0050877; GO:0065003,extracellular region; extracellular space; cell adhesion; lipid binding; nervous system process; protein-containing complex assembly
OG_13355,FUN_041982-T1,Peve_00001547,,apul_peve,43.269,FUN_041982-T1,Q9GLP1,,,,,36.4,151.0,5.2e-15,83.2,sp|Q9GLP1|FA5_PIG Coagulation factor V OS=Sus scrofa OX=9823 GN=F5 PE=2 SV=1,,,,,,
OG_13356,FUN_041988-T1,Peve_00010448,,apul_peve,42.2765,,,,,,,,,,,,,,,,,
OG_13357,FUN_041996-T1,Peve_00039127,,apul_peve,73.404,,,,,,,,,,,,,,,,,
OG_13358,FUN_042026-T2,Peve_00028953,,apul_peve,76.535,FUN_042026-T2,Q63406,MCF2L_RAT,,Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein) (OST oncogene),Rattus norvegicus (Rat),30.8,1090.0,2.3e-135,485.0,sp|Q63406|MCF2L_RAT Guanine nucleotide exchange factor DBS OS=Rattus norvegicus OX=10116 GN=Mcf2l PE=1 SV=3,GO:0005085; GO:0005545; GO:0005737; GO:0005886; GO:0007266; GO:0016020; GO:0030027; GO:0035091; GO:0035556; GO:0045944,intracellular signal transduction [GO:0035556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rho protein signal transduction [GO:0007266],cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886],1-phosphatidylinositol binding [GO:0005545]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091],GO:0005886; GO:0006355; GO:0008289; GO:0098772,plasma membrane; regulation of DNA-templated transcription; lipid binding; molecular function regulator activity
OG_13359,FUN_042030-T1,Peve_00037411,,apul_peve,66.46350000000001,FUN_042030-T1,C3ZQF9,,,,,29.9,341.0,1.4e-26,122.1,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_13360,FUN_042042-T1,Peve_00025405,,apul_peve,59.509,FUN_042042-T1,Q70VZ7,MOGT1_BOVIN,,2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Monoacylglycerol O-acyltransferase 1),Bos taurus (Bovine),39.1,312.0,8.7e-57,222.2,sp|Q70VZ7|MOGT1_BOVIN 2-acylglycerol O-acyltransferase 1 OS=Bos taurus OX=9913 GN=MOGAT1 PE=2 SV=1,GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006651; GO:0019432,diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum membrane [GO:0005789],2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144],GO:0003824; GO:0005975; GO:0006629; GO:0016740,catalytic activity; carbohydrate metabolic process; lipid metabolic process; transferase activity
OG_13361,FUN_042058-T1,Peve_00019719,,apul_peve,64.204,FUN_042058-T1,P40483,,,,,29.7,306.0,7.7e-26,120.6,sp|P40483|YIK8_YEAST Putative zinc metalloproteinase YIL108W OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YIL108W PE=1 SV=1,,,,,,
OG_13362,FUN_042070-T1,Peve_00038494,,apul_peve,47.175,,,,,,,,,,,,,,,,,
OG_13363,FUN_042078-T1,Peve_00016298,,apul_peve,37.624,,,,,,,,,,,,,,,,,
OG_13364,FUN_042087-T1,Peve_00025173,,apul_peve,59.524,,,,,,,,,,,,,,,,,
OG_13365,FUN_042100-T1,Peve_00001855,,apul_peve,57.323,FUN_042100-T1,P32945,,,,,35.6,239.0,1.9e-33,146.0,sp|P32945|PPQ1_YEAST Serine/threonine-protein phosphatase PPQ OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PPQ1 PE=1 SV=1,,,,,,
OG_13366,FUN_042102-T1,Peve_00017024,,apul_peve,48.734,,,,,,,,,,,,,,,,,
OG_13367,FUN_042120-T1,Peve_00011765,,apul_peve,48.014,,,,,,,,,,,,,,,,,
OG_13368,FUN_042134-T2,Peve_00002127,,apul_peve,57.637,FUN_042134-T2,E9Q236,MRP4_MOUSE,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4),Mus musculus (Mouse),35.6,1319.0,3.4000000000000004e-218,760.4,sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1,GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015431; GO:0015432; GO:0015562; GO:0015665; GO:0015721; GO:0015732; GO:0015747; GO:0015850; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0060271; GO:0070730; GO:0071716; GO:0140115; GO:1901571,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; fatty acid derivative transport [GO:1901571]; leukotriene transport [GO:0071716]; organic hydroxy compound transport [GO:0015850]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; alcohol transmembrane transporter activity [GO:0015665]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_13369,FUN_042174-T1,Peve_00036476,,apul_peve,68.535,,,,,,,,,,,,,,,,,
OG_13370,FUN_042202-T1,Peve_00037517,,apul_peve,88.169,,,,,,,,,,,,,,,,,
OG_13371,FUN_042213-T1,Peve_00001268,,apul_peve,70.469,,,,,,,,,,,,,,,,,
OG_13372,FUN_042230-T1,Peve_00030965,,apul_peve,63.636,,,,,,,,,,,,,,,,,
OG_13373,FUN_042231-T1,Peve_00045055,,apul_peve,74.223,,,,,,,,,,,,,,,,,
OG_13374,FUN_042247-T1,Peve_00016770,,apul_peve,76.19,,,,,,,,,,,,,,,,,
OG_13375,FUN_042251-T1,Peve_00035356,,apul_peve,32.639,,,,,,,,,,,,,,,,,
OG_13376,FUN_042266-T1,Peve_00034078,,apul_peve,37.255,,,,,,,,,,,,,,,,,
OG_13377,FUN_042308-T1,Peve_00039235,,apul_peve,49.383,,,,,,,,,,,,,,,,,
OG_13378,FUN_042327-T1,Peve_00040604,,apul_peve,90.8055,FUN_042327-T1,Q5XIP1,PELO_RAT,,Protein pelota homolog,Rattus norvegicus (Rat),66.0,385.0,6.9e-154,545.0,sp|Q5XIP1|PELO_RAT Protein pelota homolog OS=Rattus norvegicus OX=10116 GN=Pelo PE=1 SV=1,GO:0001833; GO:0005737; GO:0006417; GO:0007492; GO:0019827; GO:0022626; GO:0030513; GO:0032790; GO:0043022; GO:0046872; GO:0051276; GO:0051301; GO:0060231; GO:0060589; GO:0070481; GO:0070651; GO:0070966; GO:0071025; GO:0072344; GO:0170011; GO:1990533,"cell division [GO:0051301]; chromosome organization [GO:0051276]; endoderm development [GO:0007492]; inner cell mass cell proliferation [GO:0001833]; mesenchymal to epithelial transition [GO:0060231]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; stem cell population maintenance [GO:0019827]",cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; Dom34-Hbs1 complex [GO:1990533],metal ion binding [GO:0046872]; nucleoside-triphosphatase regulator activity [GO:0060589]; ribosome binding [GO:0043022]; stalled ribosome sensor activity [GO:0170011],GO:0005840; GO:0016071; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140299,ribosome; mRNA metabolic process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; molecular sensor activity
OG_13379,FUN_042328-T1,Peve_00021277,,apul_peve,43.871,,,,,,,,,,,,,,,,,
OG_13380,FUN_042339-T1,Peve_00014953,,apul_peve,41.611,,,,,,,,,,,,,,,,,
OG_13381,FUN_042351-T1,Peve_00011423,,apul_peve,64.0,,,,,,,,,,,,,,,,,
OG_13382,FUN_042375-T1,Peve_00006250,,apul_peve,36.659,,,,,,,,,,,,,,,,,
OG_13383,FUN_042381-T1,Peve_00024615,,apul_peve,39.759,,,,,,,,,,,,,,,,,
OG_13384,FUN_042384-T1,Peve_00006691,,apul_peve,31.579,,,,,,,,,,,,,,,,,
OG_13385,FUN_042403-T1,Peve_00004871,,apul_peve,42.105,,,,,,,,,,,,,,,,,
OG_13386,FUN_042404-T1,Peve_00023965,,apul_peve,37.5,,,,,,,,,,,,,,,,,
OG_13387,FUN_042426-T1,Peve_00033613,,apul_peve,75.828,,,,,,,,,,,,,,,,,
OG_13388,FUN_042436-T1,Peve_00026204,,apul_peve,51.515,,,,,,,,,,,,,,,,,
OG_13389,FUN_042452-T1,Peve_00027109,,apul_peve,65.385,,,,,,,,,,,,,,,,,
OG_13390,FUN_042486-T1,Peve_00026234,,apul_peve,59.542,,,,,,,,,,,,,,,,,
OG_13391,FUN_042581-T1,Peve_00016010,,apul_peve,78.614,FUN_042581-T1,G5EFC3,KCNAG_CAEEL,,Potassium voltage-gated channel protein egl-36 (Egg-laying defective protein 36),Caenorhabditis elegans,37.5,472.0,1.9e-84,314.7,sp|G5EFC3|KCNAG_CAEEL Potassium voltage-gated channel protein egl-36 OS=Caenorhabditis elegans OX=6239 GN=egl-36 PE=1 SV=1,GO:0001508; GO:0005244; GO:0005251; GO:0008076; GO:0032590; GO:0032809; GO:0034220; GO:0042734; GO:0043679; GO:0045211; GO:0051260; GO:0071805,action potential [GO:0001508]; monoatomic ion transmembrane transport [GO:0034220]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260],axon terminus [GO:0043679]; dendrite membrane [GO:0032590]; neuronal cell body membrane [GO:0032809]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; voltage-gated potassium channel complex [GO:0008076],delayed rectifier potassium channel activity [GO:0005251]; voltage-gated monoatomic ion channel activity [GO:0005244],GO:0005215; GO:0055085; GO:0065003,transporter activity; transmembrane transport; protein-containing complex assembly
OG_13392,FUN_042582-T1,Peve_00034295,,apul_peve,80.2,FUN_042582-T1,Q5JTW2,CEP78_HUMAN,,Centrosomal protein of 78 kDa (Cep78),Homo sapiens (Human),36.7,586.0,1.1e-91,339.0,sp|Q5JTW2|CEP78_HUMAN Centrosomal protein of 78 kDa OS=Homo sapiens OX=9606 GN=CEP78 PE=1 SV=1,GO:0005813; GO:0005814; GO:0005829; GO:0030317; GO:0031397; GO:0036064; GO:0044782; GO:0061512; GO:0071539,cilium organization [GO:0044782]; flagellated sperm motility [GO:0030317]; negative regulation of protein ubiquitination [GO:0031397]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829],,GO:0005815; GO:0005829; GO:0007018; GO:0022414; GO:0043226; GO:0044782; GO:0048870,microtubule organizing center; cytosol; microtubule-based movement; reproductive process; organelle; cilium organization; cell motility
OG_13393,FUN_042598-T1,Peve_00008129,,apul_peve,74.847,,,,,,,,,,,,,,,,,
OG_13394,FUN_042600-T1,Peve_00023343,,apul_peve,33.409,FUN_042600-T1,Q8WPD0,,,,,35.1,77.0,1.1e-07,59.7,sp|Q8WPD0|LECG_PATPE Alpha-N-acetylgalactosamine-specific lectin OS=Patiria pectinifera OX=7594 PE=1 SV=1,,,,,,
OG_13395,FUN_042612-T1,Peve_00034923,,apul_peve,80.69,FUN_042612-T1,Q6DID7,WLS_MOUSE,,Protein wntless homolog (Integral membrane protein GPR177) (Protein evenness interrupted homolog) (EVI),Mus musculus (Mouse),46.3,490.0,3e-122,440.3,sp|Q6DID7|WLS_MOUSE Protein wntless homolog OS=Mus musculus OX=10090 GN=Wls PE=1 SV=1,GO:0000139; GO:0001707; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0009948; GO:0016055; GO:0017147; GO:0030177; GO:0030901; GO:0030902; GO:0031017; GO:0031410; GO:0031852; GO:0031901; GO:0032590; GO:0032839; GO:0050775; GO:0061355; GO:0061357; GO:0071529; GO:0090263,anterior/posterior axis specification [GO:0009948]; cementum mineralization [GO:0071529]; exocrine pancreas development [GO:0031017]; hindbrain development [GO:0030902]; intracellular protein transport [GO:0006886]; mesoderm formation [GO:0001707]; midbrain development [GO:0030901]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],mu-type opioid receptor binding [GO:0031852]; Wnt-protein binding [GO:0017147],GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0031410; GO:0043226; GO:0048856,nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; intracellular protein transport; cytoplasmic vesicle; organelle; anatomical structure development
OG_13396,FUN_042618-T1,Peve_00027226,,apul_peve,61.499,FUN_042618-T1,Q64424,LIPR2_MYOCO,,Pancreatic lipase-related protein 2 (PL-RP2) (Cytotoxic T lymphocyte lipase) (Galactolipase) (EC 3.1.1.26) (Triacylglycerol lipase) (EC 3.1.1.3),Myocastor coypus (Coypu) (Mus coypus),38.4,391.0,2.4e-68,261.2,sp|Q64424|LIPR2_MYOCO Pancreatic lipase-related protein 2 OS=Myocastor coypus OX=10157 GN=PNLIPRP2 PE=1 SV=1,GO:0004465; GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0006644; GO:0009395; GO:0019376; GO:0019433; GO:0034638; GO:0042589; GO:0043005; GO:0047372; GO:0047714,galactolipid catabolic process [GO:0019376]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; triglyceride catabolic process [GO:0019433],extracellular space [GO:0005615]; neuron projection [GO:0043005]; zymogen granule membrane [GO:0042589],calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; lipoprotein lipase activity [GO:0004465]; monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005615; GO:0006629; GO:0016787; GO:1901135,catalytic activity; extracellular space; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_13397,FUN_042634-T2,Peve_00030036,,apul_peve,58.1575,,,,,,,,,,,,,,,,,
OG_13398,FUN_042637-T1,Peve_00030039,,apul_peve,46.047,,,,,,,,,,,,,,,,,
OG_13399,FUN_042649-T2,Peve_00027721,,apul_peve,41.788,,,,,,,,,,,,,,,,,
OG_13400,FUN_042667-T1,Peve_00002219,,apul_peve,72.026,,,,,,,,,,,,,,,,,
OG_13401,FUN_042825-T1,Peve_00041829,,apul_peve,59.015,FUN_042825-T1,Q15058,,,,,22.2,541.0,5.5e-09,64.3,sp|Q15058|KIF14_HUMAN Kinesin-like protein KIF14 OS=Homo sapiens OX=9606 GN=KIF14 PE=1 SV=1,,,,,,
OG_13402,FUN_042833-T1,Peve_00022001,,apul_peve,36.063,,,,,,,,,,,,,,,,,
OG_13403,FUN_042838-T1,Peve_00007264,,apul_peve,95.614,FUN_042838-T1,Q3ZBE7,,,,,79.8,114.0,3.6e-47,189.1,sp|Q3ZBE7|YPEL5_BOVIN Protein yippee-like 5 OS=Bos taurus OX=9913 GN=YPEL5 PE=2 SV=1,,,,,,
OG_13404,FUN_042845-T1,Peve_00023279,,apul_peve,42.294,,,,,,,,,,,,,,,,,
OG_13405,FUN_042903-T2,Peve_00040158,,apul_peve,65.52,FUN_042903-T2,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),32.5,3858.0,0.0,1773.8,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_13406,FUN_042917-T1,Peve_00040595,,apul_peve,64.613,FUN_042917-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),33.2,560.0,2.3999999999999997e-75,284.6,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_13407,FUN_042919-T1,Peve_00042320,,apul_peve,65.233,FUN_042919-T1,Q60803,TRAF3_MOUSE,,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (RING-type E3 ubiquitin transferase TRAF3),Mus musculus (Mouse),35.5,560.0,1.7e-89,331.6,sp|Q60803|TRAF3_MOUSE TNF receptor-associated factor 3 OS=Mus musculus OX=10090 GN=Traf3 PE=1 SV=2,GO:0001817; GO:0002224; GO:0005164; GO:0005739; GO:0006915; GO:0008063; GO:0008270; GO:0009898; GO:0010008; GO:0019901; GO:0019903; GO:0030162; GO:0031625; GO:0031996; GO:0032088; GO:0032481; GO:0032648; GO:0033209; GO:0034142; GO:0035631; GO:0042802; GO:0042981; GO:0045087; GO:0050688; GO:0061630,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; regulation of apoptotic process [GO:0042981]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005739; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; mitochondrion; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_13408,FUN_042937-T1,Peve_00040592,,apul_peve,66.176,FUN_042937-T1,B2LT65,TLR2_SHEEP,,Toll-like receptor 2 (CD antigen CD282),Ovis aries (Sheep),36.8,106.0,3.1e-15,83.6,sp|B2LT65|TLR2_SHEEP Toll-like receptor 2 OS=Ovis aries OX=9940 GN=TLR2 PE=2 SV=1,GO:0002224; GO:0004888; GO:0005794; GO:0005886; GO:0006954; GO:0030670; GO:0042497; GO:0043235; GO:0045087; GO:0045121; GO:0061809; GO:0071726; GO:0071727,cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; toll-like receptor signaling pathway [GO:0002224],Golgi apparatus [GO:0005794]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; transmembrane signaling receptor activity [GO:0004888]; triacyl lipopeptide binding [GO:0042497]",GO:0002376; GO:0003824; GO:0005794; GO:0005886; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060089; GO:0098542,immune system process; catalytic activity; Golgi apparatus; plasma membrane; inflammatory response; lipid binding; hydrolase activity; organelle; molecular transducer activity; defense response to other organism
OG_13409,FUN_042968-T1,Peve_00039039,,apul_peve,77.612,FUN_042968-T1,Q8R235,,,,,44.1,136.0,2.7e-25,116.3,sp|Q8R235|TM203_MOUSE Transmembrane protein 203 OS=Mus musculus OX=10090 GN=Tmem203 PE=1 SV=1,,,,,,
OG_13410,FUN_042986-T1,Peve_00002962,,apul_peve,40.541,,,,,,,,,,,,,,,,,
OG_13411,FUN_042987-T1,Peve_00036063,,apul_peve,67.976,FUN_042987-T1,Q60HG2,TOR1A_MACFA,,Torsin-1A (Dystonia 1 protein) (Torsin ATPase 1) (EC 3.6.4.-) (Torsin family 1 member A),Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),48.5,307.0,5.2e-86,319.3,sp|Q60HG2|TOR1A_MACFA Torsin-1A OS=Macaca fascicularis OX=9541 GN=TOR1A PE=2 SV=1,GO:0000338; GO:0005524; GO:0005635; GO:0005788; GO:0005789; GO:0005856; GO:0006998; GO:0007155; GO:0008021; GO:0016887; GO:0019894; GO:0030141; GO:0030426; GO:0030659; GO:0031175; GO:0031965; GO:0034504; GO:0036503; GO:0042802; GO:0044319; GO:0045104; GO:0048489; GO:0048499; GO:0051085; GO:0051584; GO:0061077; GO:0071763; GO:0140662; GO:1900244; GO:2000008,"cell adhesion [GO:0007155]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated protein folding [GO:0061077]; ERAD pathway [GO:0036503]; intermediate filament cytoskeleton organization [GO:0045104]; neuron projection development [GO:0031175]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; protein deneddylation [GO:0000338]; protein localization to nucleus [GO:0034504]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of protein localization to cell surface [GO:2000008]; synaptic vesicle membrane organization [GO:0048499]; synaptic vesicle transport [GO:0048489]; wound healing, spreading of cells [GO:0044319]",cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; growth cone [GO:0030426]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894],GO:0003824; GO:0005635; GO:0005856; GO:0007010; GO:0007155; GO:0008092; GO:0016787; GO:0030163; GO:0031410; GO:0043226; GO:0044183; GO:0048870; GO:0061024; GO:0140657,catalytic activity; nuclear envelope; cytoskeleton; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; hydrolase activity; protein catabolic process; cytoplasmic vesicle; organelle; protein folding chaperone; cell motility; membrane organization; ATP-dependent activity
OG_13412,FUN_042990-T1,Peve_00031068,,apul_peve,48.6485,,,,,,,,,,,,,,,,,
OG_13413,FUN_043015-T1,Peve_00017763,,apul_peve,68.883,FUN_043015-T1,C8YR32,,,,,42.1,121.0,1.1e-21,107.5,sp|C8YR32|LOXH1_MOUSE Lipoxygenase homology domain-containing protein 1 OS=Mus musculus OX=10090 GN=Loxhd1 PE=2 SV=1,,,,,,
OG_13414,FUN_043017-T1,Peve_00017762,,apul_peve,47.945,FUN_043017-T1,Q924A2,,,,,34.9,152.0,5.3e-13,77.4,sp|Q924A2|CIC_MOUSE Protein capicua homolog OS=Mus musculus OX=10090 GN=Cic PE=1 SV=2,,,,,,
OG_13415,FUN_043018-T1,Peve_00017761,,apul_peve,40.79600000000001,,,,,,,,,,,,,,,,,
OG_13416,FUN_043020-T1,Peve_00017771,,apul_peve,51.471,,,,,,,,,,,,,,,,,
OG_13417,FUN_043023-T1,Peve_00020209,,apul_peve,62.363,FUN_043023-T1,Q8BZ39,NMUR2_MOUSE,,Neuromedin-U receptor 2 (NMU-R2),Mus musculus (Mouse),26.2,317.0,7.1e-20,99.8,sp|Q8BZ39|NMUR2_MOUSE Neuromedin-U receptor 2 OS=Mus musculus OX=10090 GN=Nmur2 PE=2 SV=1,GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482,arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; response to pain [GO:0048265],membrane [GO:0016020]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188],GO:0005215; GO:0005886; GO:0060089,transporter activity; plasma membrane; molecular transducer activity
OG_13418,FUN_043049-T1,Peve_00016066,,apul_peve,70.588,,,,,,,,,,,,,,,,,
OG_13419,FUN_043090-T1,Peve_00006224,,apul_peve,58.472,,,,,,,,,,,,,,,,,
OG_13420,FUN_043107-T1,Peve_00026303,,apul_peve,82.944,FUN_043107-T1,Q8N9R8,SCAI_HUMAN,,Protein SCAI (Suppressor of cancer cell invasion protein),Homo sapiens (Human),53.0,472.0,1.3999999999999998e-135,484.6,sp|Q8N9R8|SCAI_HUMAN Protein SCAI OS=Homo sapiens OX=9606 GN=SCAI PE=1 SV=2,GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0030336; GO:0031965; GO:0035024,DNA-templated transcription [GO:0006351]; negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006351; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_13421,FUN_043121-T1,Peve_00025026,,apul_peve,58.412,FUN_043121-T1,Q9HCD6,TANC2_HUMAN,,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)",Homo sapiens (Human),24.0,584.0,1.2e-28,131.3,sp|Q9HCD6|TANC2_HUMAN Protein TANC2 OS=Homo sapiens OX=9606 GN=TANC2 PE=1 SV=3,GO:0030424; GO:0043197; GO:0060998; GO:0061001; GO:0099519,dense core granule cytoskeletal transport [GO:0099519]; regulation of dendritic spine development [GO:0060998]; regulation of dendritic spine morphogenesis [GO:0061001],axon [GO:0030424]; dendritic spine [GO:0043197],,,
OG_13422,FUN_043128-T1,Peve_00013591,,apul_peve,63.701,FUN_043128-T1,F1R6N4,,,,,48.4,248.0,7.9e-57,222.2,sp|F1R6N4|ECHD1_DANRE Ethylmalonyl-CoA decarboxylase OS=Danio rerio OX=7955 GN=echdc1 PE=3 SV=2,,,,,,
OG_13423,FUN_043132-T1,Peve_00013590,,apul_peve,87.879,FUN_043132-T1,Q9NU02,,,,,48.8,793.0,3.1e-97,357.8,sp|Q9NU02|ANKE1_HUMAN Ankyrin repeat and EF-hand domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKEF1 PE=1 SV=2,,,,,,
OG_13424,FUN_043136-T1,Peve_00034954,,apul_peve,66.501,FUN_043136-T1,Q15760,,,,,29.7,333.0,4.7e-25,117.1,sp|Q15760|GPR19_HUMAN Probable G-protein coupled receptor 19 OS=Homo sapiens OX=9606 GN=GPR19 PE=1 SV=2,,,,,,
OG_13425,FUN_043141-T1,Peve_00025842,,apul_peve,66.667,FUN_043141-T1,B8EIZ7,TMM_METSB,,Trimethylamine monooxygenase (TMA monooxygenase) (Tmm) (EC 1.14.13.148),Methylocella silvestris (strain DSM 15510 / CIP 108128 / LMG 27833 / NCIMB 13906 / BL2),53.0,445.0,5.5e-139,495.7,sp|B8EIZ7|TMM_METSB Trimethylamine monooxygenase OS=Methylocella silvestris (strain DSM 15510 / CIP 108128 / LMG 27833 / NCIMB 13906 / BL2) OX=395965 GN=tmm PE=1 SV=1,GO:0004499; GO:0034899; GO:0050660; GO:0050661,,,"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]",GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_13426,FUN_043154-T1,Peve_00011379,,apul_peve,50.0,,,,,,,,,,,,,,,,,
OG_13427,FUN_043164-T1,Peve_00036510,,apul_peve,81.416,FUN_043164-T1,Q66KY3,,,,,61.0,105.0,1.6e-34,146.7,sp|Q66KY3|CUTA_XENLA Protein CutA homolog OS=Xenopus laevis OX=8355 GN=cuta PE=2 SV=2,,,,,,
OG_13428,FUN_043166-T1,Peve_00036514,,apul_peve,38.351,FUN_043166-T1,P98157,,,,,25.4,1596.0,1.7e-77,293.9,sp|P98157|LRP1_CHICK Low-density lipoprotein receptor-related protein 1 OS=Gallus gallus OX=9031 GN=LRP1 PE=2 SV=1,,,,,,
OG_13429,FUN_043168-T1,Peve_00025851,,apul_peve,61.058,FUN_043168-T1,P47775,,,,,24.9,285.0,1.6e-06,56.2,sp|P47775|GPR12_HUMAN G-protein coupled receptor 12 OS=Homo sapiens OX=9606 GN=GPR12 PE=1 SV=1,,,,,,
OG_13430,FUN_043173-T1,Peve_00025848,,apul_peve,60.819,FUN_043173-T1,Q1LZD0,,,,,28.6,308.0,2e-19,98.2,sp|Q1LZD0|AA2BR_BOVIN Adenosine receptor A2b OS=Bos taurus OX=9913 GN=ADORA2B PE=2 SV=1,,,,,,
OG_13431,FUN_043180-T1,Peve_00022358,,apul_peve,46.605,,,,,,,,,,,,,,,,,
OG_13432,FUN_043194-T1,Peve_00043026,,apul_peve,31.122,,,,,,,,,,,,,,,,,
OG_13433,FUN_043199-T1,Peve_00039856,,apul_peve,76.868,FUN_043199-T1,P97402,GCNT2_MOUSE,,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT) (Large I antigen-forming beta-1,6-N-acetylglucosaminyltransferase)",Mus musculus (Mouse),38.5,322.0,4.3e-58,226.9,"sp|P97402|GCNT2_MOUSE N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase OS=Mus musculus OX=10090 GN=Gcnt2 PE=2 SV=2",GO:0000139; GO:0006486; GO:0007179; GO:0008109; GO:0008284; GO:0008375; GO:0010608; GO:0010718; GO:0051897; GO:0070374,positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; post-transcriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179],Golgi membrane [GO:0000139],"acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]",GO:0003824; GO:0006486; GO:0016740,catalytic activity; protein glycosylation; transferase activity
OG_13434,FUN_043200-T1,Peve_00039857,,apul_peve,55.09,,,,,,,,,,,,,,,,,
OG_13435,FUN_043211-T1,Peve_00037102,,apul_peve,50.784,FUN_043211-T1,A0A1U8QVN4,,,,,25.0,120.0,8.4e-06,53.9,sp|A0A1U8QVN4|BASR_EMENI Myb-like transcriptional regulator basR OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=basR PE=2 SV=1,,,,,,
OG_13436,FUN_043219-T1,Peve_00037103,,apul_peve,51.6115,FUN_043219-T1,Q969U6,FBXW5_HUMAN,,F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5),Homo sapiens (Human),31.5,565.0,1.1e-63,245.7,sp|Q969U6|FBXW5_HUMAN F-box/WD repeat-containing protein 5 OS=Homo sapiens OX=9606 GN=FBXW5 PE=1 SV=1,GO:0005737; GO:0005829; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005],protein kinase binding [GO:0019901],GO:0005829; GO:0030163,cytosol; protein catabolic process
OG_13437,FUN_043255-T1,Peve_00008978,,apul_peve,45.49,,,,,,,,,,,,,,,,,
OG_13438,FUN_043259-T1,Peve_00032616,,apul_peve,56.3775,FUN_043259-T1,E9Q309,,,,,27.8,2120.0,1.4999999999999999e-40,171.4,sp|E9Q309|CE350_MOUSE Centrosome-associated protein 350 OS=Mus musculus OX=10090 GN=Cep350 PE=1 SV=1,,,,,,
OG_13439,FUN_043259-T2,Peve_00030071,,apul_peve,59.1745,FUN_043259-T2,E9Q309,,,,,25.3,3253.0,5.4e-18,96.7,sp|E9Q309|CE350_MOUSE Centrosome-associated protein 350 OS=Mus musculus OX=10090 GN=Cep350 PE=1 SV=1,,,,,,
OG_13440,FUN_043263-T1,Peve_00032611,,apul_peve,53.302,,,,,,,,,,,,,,,,,
OG_13441,FUN_043269-T1,Peve_00032615,,apul_peve,55.135,,,,,,,,,,,,,,,,,
OG_13442,FUN_043272-T2,Peve_00032618,,apul_peve,57.562,,,,,,,,,,,,,,,,,
OG_13443,FUN_043274-T2,Peve_00026686,,apul_peve,55.7865,,,,,,,,,,,,,,,,,
OG_13444,FUN_043275-T1,Peve_00032620,,apul_peve,43.939,,,,,,,,,,,,,,,,,
OG_13445,FUN_043289-T1,Peve_00007513,,apul_peve,51.1835,FUN_043289-T1,E9QAT4,SC16A_MOUSE,,Protein transport protein Sec16A (SEC16 homolog A) (p250),Mus musculus (Mouse),24.3,905.0,1.2e-40,171.4,sp|E9QAT4|SC16A_MOUSE Protein transport protein Sec16A OS=Mus musculus OX=10090 GN=Sec16a PE=1 SV=1,GO:0000139; GO:0003400; GO:0005789; GO:0005829; GO:0006888; GO:0006893; GO:0007029; GO:0031090; GO:0032527; GO:0034976; GO:0048471; GO:0050821; GO:0070971; GO:0070973; GO:0072659,endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane transport [GO:0006893]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; regulation of COPII vesicle coating [GO:0003400]; response to endoplasmic reticulum stress [GO:0034976],cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471],,GO:0005829; GO:0006886; GO:0016192; GO:0072659,cytosol; intracellular protein transport; vesicle-mediated transport; protein localization to plasma membrane
OG_13446,FUN_043291-T1,Peve_00003682,,apul_peve,76.493,,,,,,,,,,,,,,,,,
OG_13447,FUN_043307-T1,Peve_00005882,,apul_peve,52.769,,,,,,,,,,,,,,,,,
OG_13448,FUN_043310-T1,Peve_00007497,,apul_peve,44.319500000000005,,,,,,,,,,,,,,,,,
OG_13449,FUN_043321-T1,Peve_00007510,,apul_peve,73.8545,FUN_043321-T1,Q92072,,,,,63.0,1289.0,0.0,1568.1,sp|Q92072|DNMT1_CHICK DNA (cytosine-5)-methyltransferase 1 OS=Gallus gallus OX=9031 GN=DNMT1 PE=1 SV=1,,,,,,
OG_13450,FUN_043346-T1,Peve_00040261,,apul_peve,33.6,,,,,,,,,,,,,,,,,
OG_13451,FUN_043348-T1,Peve_00043039,,apul_peve,71.152,FUN_043348-T1,C9D7C2,,,,,45.0,1610.0,0.0,1115.1,sp|C9D7C2|CAC1A_APIME Voltage-dependent calcium channel type A subunit alpha-1 OS=Apis mellifera OX=7460 GN=CAC PE=2 SV=1,,,,,,
OG_13452,FUN_043352-T1,Peve_00016647,,apul_peve,43.0955,,,,,,,,,,,,,,,,,
OG_13453,FUN_043365-T1,Peve_00030219,,apul_peve,85.235,FUN_043365-T1,A0A1D3PCM3,,,,,52.1,317.0,1.2e-91,338.2,sp|A0A1D3PCM3|SST_EMEND Serine O-succinyltransferase OS=Emericella nidulans OX=162425 GN=CysA PE=1 SV=1,,,,,,
OG_13454,FUN_043367-T1,Peve_00017610,,apul_peve,82.67,,,,,,,,,,,,,,,,,
OG_13455,FUN_043378-T2,Peve_00004897,,apul_peve,79.845,FUN_043378-T2,Q6GN42,CTL4_XENLA,,Choline transporter-like protein 4 (Solute carrier family 44 member 4),Xenopus laevis (African clawed frog),41.8,701.0,1.1e-146,521.9,sp|Q6GN42|CTL4_XENLA Choline transporter-like protein 4 OS=Xenopus laevis OX=8355 GN=slc44a4 PE=2 SV=1,GO:0005886; GO:0008292; GO:0015220; GO:0015297; GO:0015871; GO:0016324; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0061526; GO:0090422,acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422],GO:0005215; GO:0005886; GO:0048856; GO:0055085,transporter activity; plasma membrane; anatomical structure development; transmembrane transport
OG_13456,FUN_043380-T1,Peve_00024258,,apul_peve,63.405,FUN_043380-T1,P15848,ARSB_HUMAN,,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),Homo sapiens (Human),46.6,517.0,2.9e-136,486.9,sp|P15848|ARSB_HUMAN Arylsulfatase B OS=Homo sapiens OX=9606 GN=ARSB PE=1 SV=1,GO:0003943; GO:0004065; GO:0005576; GO:0005764; GO:0005788; GO:0006914; GO:0007040; GO:0007041; GO:0007584; GO:0009268; GO:0009986; GO:0010632; GO:0010976; GO:0035578; GO:0043202; GO:0043627; GO:0046872; GO:0051597; GO:0061580; GO:0070062; GO:1904813,autophagy [GO:0006914]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943],GO:0003824; GO:0005576; GO:0005764; GO:0005773; GO:0006914; GO:0007040; GO:0016787; GO:0043226; GO:0048870,catalytic activity; extracellular region; lysosome; vacuole; autophagy; lysosome organization; hydrolase activity; organelle; cell motility
OG_13457,FUN_043404-T1,Peve_00028358,,apul_peve,39.973,FUN_043404-T1,P47746,CNR1_MOUSE,,Cannabinoid receptor 1 (CB-R) (CB1) (Brain-type cannabinoid receptor),Mus musculus (Mouse),25.5,306.0,3.9e-06,53.9,sp|P47746|CNR1_MOUSE Cannabinoid receptor 1 OS=Mus musculus OX=10090 GN=Cnr1 PE=1 SV=1,GO:0004949; GO:0005739; GO:0005741; GO:0007188; GO:0007413; GO:0015629; GO:0030424; GO:0030426; GO:0042593; GO:0042734; GO:0042802; GO:0098921; GO:0098978; GO:0098982; GO:0099509,adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; axonal fasciculation [GO:0007413]; glucose homeostasis [GO:0042593]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; retrograde trans-synaptic signaling by endocannabinoid [GO:0098921],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; presynaptic membrane [GO:0042734],cannabinoid receptor activity [GO:0004949]; identical protein binding [GO:0042802],GO:0005739; GO:0005856; GO:0023052; GO:0043226; GO:0060089,mitochondrion; cytoskeleton; signaling; organelle; molecular transducer activity
OG_13458,FUN_043411-T1,Peve_00045007,,apul_peve,67.725,FUN_043411-T1,P53454,,,,,30.3,314.0,1.4e-27,125.9,sp|P53454|DRD5L_TAKRU D(5)-like dopamine receptor OS=Takifugu rubripes OX=31033 GN=dl PE=3 SV=1,,,,,,
OG_13459,FUN_043415-T1,Peve_00026733,,apul_peve,77.393,FUN_043415-T1,Q9UKP5,ATS6_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-),Homo sapiens (Human),36.7,815.0,5.1e-135,483.4,sp|Q9UKP5|ATS6_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 6 OS=Homo sapiens OX=9606 GN=ADAMTS6 PE=1 SV=2,GO:0001822; GO:0003279; GO:0004222; GO:0005576; GO:0006508; GO:0008237; GO:0030198; GO:0031012; GO:0035904; GO:0046872; GO:0060976,aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; extracellular matrix organization [GO:0030198]; kidney development [GO:0001822]; proteolysis [GO:0006508],extracellular matrix [GO:0031012]; extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0016787; GO:0030198; GO:0030312; GO:0031012; GO:0048856; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development; catalytic activity, acting on a protein"
OG_13460,FUN_043419-T2,Peve_00005570,,apul_peve,79.09700000000001,FUN_043419-T2,Q80ZI6,LRSM1_MOUSE,,E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase),Mus musculus (Mouse),38.8,730.0,3.9e-70,267.7,sp|Q80ZI6|LRSM1_MOUSE E3 ubiquitin-protein ligase LRSAM1 OS=Mus musculus OX=10090 GN=Lrsam1 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0008270; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786,autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006914; GO:0016192; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; cytosol; autophagy; vesicle-mediated transport; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_13461,FUN_043423-T1,Peve_00036787,,apul_peve,65.625,,,,,,,,,,,,,,,,,
OG_13462,FUN_043426-T2,Peve_00041798,,apul_peve,60.959,FUN_043426-T2,Q1ZZU3,SWI5_HUMAN,,DNA repair protein SWI5 homolog (HBV DNAPTP1-transactivated protein A) (Protein SAE3 homolog),Homo sapiens (Human),46.1,115.0,3.7e-15,82.8,sp|Q1ZZU3|SWI5_HUMAN DNA repair protein SWI5 homolog OS=Homo sapiens OX=9606 GN=SWI5 PE=1 SV=1,GO:0000724; GO:0005634; GO:0032798; GO:0071479,cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724],nucleus [GO:0005634]; Swi5-Sfr1 complex [GO:0032798],,GO:0005634; GO:0006281; GO:0006310; GO:0043226,nucleus; DNA repair; DNA recombination; organelle
OG_13463,FUN_043436-T1,Peve_00022333,,apul_peve,53.521,FUN_043436-T1,Q9WU63,,,,,38.2,173.0,2.2e-27,125.2,sp|Q9WU63|HEBP2_MOUSE Heme-binding protein 2 OS=Mus musculus OX=10090 GN=Hebp2 PE=1 SV=1,,,,,,
OG_13464,FUN_043443-T1,Peve_00031538,,apul_peve,36.817,,,,,,,,,,,,,,,,,
OG_13465,FUN_043460-T1,Peve_00021733,,apul_peve,60.714,,,,,,,,,,,,,,,,,
OG_13466,FUN_043461-T1,Peve_00021723,,apul_peve,42.984,,,,,,,,,,,,,,,,,
OG_13467,FUN_043485-T1,Peve_00021707,,apul_peve,43.537,FUN_043485-T1,Q4I963,,,,,32.9,149.0,6e-18,92.0,sp|Q4I963|COFI_GIBZE Cofilin OS=Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) OX=229533 GN=COF1 PE=3 SV=2,,,,,,
OG_13468,FUN_043486-T1,Peve_00021729,,apul_peve,70.0,,,,,,,,,,,,,,,,,
OG_13469,FUN_043489-T1,Peve_00008691,,apul_peve,78.906,FUN_043489-T1,P59083,,,,,53.7,121.0,5.7e-32,138.7,sp|P59083|PHP14_PIG 14 kDa phosphohistidine phosphatase OS=Sus scrofa OX=9823 GN=PHPT1 PE=1 SV=2,,,,,,
OG_13470,FUN_043497-T1,Peve_00024913,,apul_peve,61.559,FUN_043497-T1,Q5PQ50,NUD19_XENLA,,Acyl-coenzyme A diphosphatase NUDT19 (EC 3.6.1.-) (EC 3.6.1.77) (Nucleoside diphosphate-linked moiety X motif 19) (Nudix motif 19),Xenopus laevis (African clawed frog),41.9,322.0,2.4e-63,244.2,sp|Q5PQ50|NUD19_XENLA Acyl-coenzyme A diphosphatase NUDT19 OS=Xenopus laevis OX=8355 GN=nudt19 PE=2 SV=1,GO:0000287; GO:0005739; GO:0005777; GO:0010945; GO:0015938; GO:0036114; GO:0044580; GO:1901289; GO:1902858; GO:2001294,butyryl-CoA catabolic process [GO:0044580]; coenzyme A catabolic process [GO:0015938]; malonyl-CoA catabolic process [GO:2001294]; medium-chain fatty-acyl-CoA catabolic process [GO:0036114]; propionyl-CoA metabolic process [GO:1902858]; succinyl-CoA catabolic process [GO:1901289],mitochondrion [GO:0005739]; peroxisome [GO:0005777],coenzyme A diphosphatase activity [GO:0010945]; magnesium ion binding [GO:0000287],GO:0003824; GO:0005739; GO:0005777; GO:0006629; GO:0006790; GO:0016787; GO:0043226; GO:0055086,catalytic activity; mitochondrion; peroxisome; lipid metabolic process; sulfur compound metabolic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_13471,FUN_043498-T1,Peve_00024908,,apul_peve,69.281,FUN_043498-T1,P74897,,,,,34.0,144.0,2.4e-09,63.5,sp|P74897|YQA3_THEAQ Universal stress protein in QAH/OAS sulfhydrylase 3'region OS=Thermus aquaticus OX=271 PE=3 SV=1,,,,,,
OG_13472,FUN_043507-T2,Peve_00024918,,apul_peve,70.149,FUN_043507-T2,Q28CM7,,,,,61.2,170.0,9.499999999999999e-55,214.9,"sp|Q28CM7|COQ4_XENTR Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial OS=Xenopus tropicalis OX=8364 GN=coq4 PE=2 SV=1",,,,,,
OG_13473,FUN_043509-T1,Peve_00017612,,apul_peve,43.7825,FUN_043509-T1,Q8R2M2,,,,,34.8,132.0,1.2e-13,78.6,sp|Q8R2M2|TDIF2_MOUSE Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Mus musculus OX=10090 GN=Dnttip2 PE=1 SV=1,,,,,,
OG_13474,FUN_043518-T1,Peve_00017255,,apul_peve,94.286,FUN_043518-T1,Q5E988,,,,,91.5,199.0,8.3e-98,357.8,sp|Q5E988|RS5_BOVIN Small ribosomal subunit protein uS7 OS=Bos taurus OX=9913 GN=RPS5 PE=2 SV=3,,,,,,
OG_13475,FUN_043524-T1,Peve_00027814,,apul_peve,75.333,FUN_043524-T1,Q9BZE3,,,,,54.3,70.0,4.1e-14,79.3,sp|Q9BZE3|BARH1_HUMAN BarH-like 1 homeobox protein OS=Homo sapiens OX=9606 GN=BARHL1 PE=1 SV=1,,,,,,
OG_13476,FUN_043528-T1,Peve_00011971,,apul_peve,33.894000000000005,,,,,,,,,,,,,,,,,
OG_13477,FUN_043540-T2,Peve_00035660,,apul_peve,78.033,FUN_043540-T2,Q95LZ5,,,,,40.7,403.0,1.6e-91,338.2,sp|Q95LZ5|TTC16_MACFA Tetratricopeptide repeat protein 16 OS=Macaca fascicularis OX=9541 GN=TTC16 PE=2 SV=1,,,,,,
OG_13478,FUN_043557-T1,Peve_00022074,,apul_peve,73.171,,,,,,,,,,,,,,,,,
OG_13479,FUN_043568-T2,Peve_00016670,,apul_peve,60.0265,FUN_043568-T2,Q9HCU4,CELR2_HUMAN,,Cadherin EGF LAG seven-pass G-type receptor 2 (Cadherin family member 10) (Epidermal growth factor-like protein 2) (EGF-like protein 2) (Flamingo homolog 3) (Multiple epidermal growth factor-like domains protein 3) (Multiple EGF-like domains protein 3),Homo sapiens (Human),24.7,598.0,2.3e-29,133.3,sp|Q9HCU4|CELR2_HUMAN Cadherin EGF LAG seven-pass G-type receptor 2 OS=Homo sapiens OX=9606 GN=CELSR2 PE=1 SV=1,GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0007186; GO:0016020; GO:0016055; GO:0021591; GO:0021999; GO:0022407; GO:0032880; GO:0033326; GO:0048813; GO:0060071; GO:0060271; GO:0097475; GO:0098609,"cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; neural plate anterior/posterior regionalization [GO:0021999]; regulation of cell-cell adhesion [GO:0022407]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization [GO:0032880]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0006355; GO:0007018; GO:0007155; GO:0044782; GO:0048856; GO:0048870; GO:0060089,plasma membrane; regulation of DNA-templated transcription; microtubule-based movement; cell adhesion; cilium organization; anatomical structure development; cell motility; molecular transducer activity
OG_13480,FUN_043570-T1,Peve_00031733,,apul_peve,50.207,,,,,,,,,,,,,,,,,
OG_13481,FUN_043576-T1,Peve_00011686,,apul_peve,40.57,FUN_043576-T1,Q80T79,CSMD3_MOUSE,,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),Mus musculus (Mouse),30.1,532.0,6.100000000000001e-57,224.2,sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3,GO:0005886; GO:0050773,regulation of dendrite development [GO:0050773],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_13482,FUN_043580-T2,Peve_00018891,,apul_peve,85.3375,FUN_043580-T2,Q5T4S7,UBR4_HUMAN,,E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (p600) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600),Homo sapiens (Human),47.4,5166.0,0.0,4017.2,sp|Q5T4S7|UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens OX=9606 GN=UBR4 PE=1 SV=1,GO:0004842; GO:0005516; GO:0005654; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006979; GO:0007032; GO:0008270; GO:0010508; GO:0016020; GO:0035579; GO:0043161; GO:0044314; GO:0045717; GO:0050821; GO:0061630; GO:0070821; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0101003; GO:0140455; GO:0141191; GO:0141198,cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; endosome organization [GO:0007032]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of HRI-mediated signaling [GO:0141191]; positive regulation of autophagy [GO:0010508]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; endosome; microtubule organizing center; cytosol; plasma membrane; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_13483,FUN_043592-T1,Peve_00044644,,apul_peve,79.209,FUN_043592-T1,Q8NFG4,FLCN_HUMAN,,Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein),Homo sapiens (Human),42.9,592.0,3.8e-126,453.4,sp|Q8NFG4|FLCN_HUMAN Folliculin OS=Homo sapiens OX=9606 GN=FLCN PE=1 SV=1,GO:0000122; GO:0001701; GO:0004857; GO:0005096; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005813; GO:0005829; GO:0005886; GO:0005929; GO:0007043; GO:0007179; GO:0009267; GO:0010508; GO:0019899; GO:0030097; GO:0030511; GO:0031929; GO:0032006; GO:0032007; GO:0032008; GO:0032418; GO:0034198; GO:0035024; GO:0035556; GO:0043065; GO:0043231; GO:0043491; GO:0044877; GO:0045820; GO:0046578; GO:0050673; GO:0050680; GO:0051898; GO:0070371; GO:0070373; GO:0072111; GO:0072686; GO:0097009; GO:0097193; GO:0120163; GO:1901723; GO:1901874; GO:1903444; GO:1904263; GO:1905672; GO:1990877; GO:2000973; GO:2001244,cell proliferation involved in kidney development [GO:0072111]; cell-cell junction assembly [GO:0007043]; cellular response to amino acid starvation [GO:0034198]; cellular response to starvation [GO:0009267]; energy homeostasis [GO:0097009]; epithelial cell proliferation [GO:0050673]; ERK1 and ERK2 cascade [GO:0070371]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lysosome localization [GO:0032418]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell proliferation involved in kidney development [GO:1901723]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of glycolytic process [GO:0045820]; negative regulation of lysosome organization [GO:1905672]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of post-translational protein modification [GO:1901874]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of pro-B cell differentiation [GO:2000973]; regulation of Ras protein signal transduction [GO:0046578]; regulation of TOR signaling [GO:0032006]; TOR signaling [GO:0031929]; transforming growth factor beta receptor signaling pathway [GO:0007179],centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FNIP-folliculin RagC/D GAP [GO:1990877]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877],GO:0005634; GO:0005764; GO:0005773; GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0006355; GO:0034330; GO:0043226; GO:0048856; GO:0098772,nucleus; lysosome; vacuole; microtubule organizing center; cytosol; plasma membrane; cilium; regulation of DNA-templated transcription; cell junction organization; organelle; anatomical structure development; molecular function regulator activity
OG_13484,FUN_043594-T1,Peve_00044642,,apul_peve,58.658,FUN_043594-T1,P04186,CFAB_MOUSE,,Complement factor B (EC 3.4.21.47) (C3/C5 convertase) [Cleaved into: Complement factor B Ba; Complement factor B Bb],Mus musculus (Mouse),27.8,669.0,7.600000000000002e-57,223.4,sp|P04186|CFAB_MOUSE Complement factor B OS=Mus musculus OX=10090 GN=Cfb PE=1 SV=2,GO:0004252; GO:0005576; GO:0006508; GO:0006957; GO:0042100,"B cell proliferation [GO:0042100]; complement activation, alternative pathway [GO:0006957]; proteolysis [GO:0006508]",extracellular region [GO:0005576],serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003824; GO:0005576; GO:0016787; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular region; hydrolase activity; defense response to other organism; catalytic activity, acting on a protein"
OG_13485,FUN_043614-T1,Peve_00040371,,apul_peve,51.0515,FUN_043614-T1,P35658,NU214_HUMAN,,Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN),Homo sapiens (Human),26.5,1338.0,2.7e-79,299.7,sp|P35658|NU214_HUMAN Nuclear pore complex protein Nup214 OS=Homo sapiens OX=9606 GN=NUP214 PE=1 SV=2,GO:0005049; GO:0005635; GO:0005643; GO:0005654; GO:0005829; GO:0006405; GO:0006406; GO:0006606; GO:0006611; GO:0006913; GO:0008139; GO:0017056; GO:0046822; GO:0051726; GO:1990876,mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of nucleocytoplasmic transport [GO:0046822]; RNA export from nucleus [GO:0006405],cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654],nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0005635; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0140104,structural molecule activity; nuclear envelope; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; molecular carrier activity
OG_13486,FUN_043616-T1,Peve_00008224,,apul_peve,35.358,,,,,,,,,,,,,,,,,
OG_13487,FUN_043624-T2,Peve_00042817,,apul_peve,73.71549999999999,,,,,,,,,,,,,,,,,
OG_13488,FUN_043645-T1,Peve_00026901,,apul_peve,37.546,,,,,,,,,,,,,,,,,
OG_13489,FUN_043682-T1,Peve_00029002,,apul_peve,51.291,,,,,,,,,,,,,,,,,
OG_13490,FUN_043697-T1,Peve_00016640,,apul_peve,56.098,,,,,,,,,,,,,,,,,
OG_13491,FUN_043720-T1,Peve_00041985,,apul_peve,92.218,,,,,,,,,,,,,,,,,
OG_13492,FUN_043790-T1,Peve_00037515,,apul_peve,80.565,FUN_043790-T1,P95648,,,,,37.9,277.0,1.3e-40,168.3,sp|P95648|CBBX_CERSP Protein CbbX OS=Cereibacter sphaeroides OX=1063 GN=cbbX PE=1 SV=1,,,,,,
OG_13493,FUN_043808-T1,Peve_00021393,,apul_peve,41.949,FUN_043808-T1,P41892,,,,,30.9,194.0,7.2e-07,56.6,sp|P41892|CDC7_SCHPO Cell division control protein 7 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=cdc7 PE=1 SV=1,,,,,,
OG_13494,FUN_043813-T1,Peve_00038171,,apul_peve,82.143,,,,,,,,,,,,,,,,,
OG_13495,FUN_043827-T1,Peve_00008311,,apul_peve,44.56,,,,,,,,,,,,,,,,,
OG_13496,FUN_043834-T1,Peve_00035806,,apul_peve,63.291,,,,,,,,,,,,,,,,,
OG_13497,FUN_043909-T1,Peve_00037032,,apul_peve,82.4155,,,,,,,,,,,,,,,,,
OG_13498,FUN_043946-T1,Peve_00003954,,apul_peve,100.0,FUN_043946-T1,P84227,H32_BOVIN,,Histone H3.2,Bos taurus (Bovine),99.3,136.0,1.9000000000000001e-66,253.1,sp|P84227|H32_BOVIN Histone H3.2 OS=Bos taurus OX=9913 PE=1 SV=2,GO:0000786; GO:0003677; GO:0005634; GO:0030527; GO:0046982,,nucleosome [GO:0000786]; nucleus [GO:0005634],DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; structural constituent of chromatin [GO:0030527],GO:0003677; GO:0005198; GO:0005634; GO:0043226,DNA binding; structural molecule activity; nucleus; organelle
OG_13499,FUN_043980-T1,Peve_00044528,,apul_peve,100.0,FUN_043980-T1,P35059,,,,,100.0,103.0,9.9e-51,201.4,sp|P35059|H4_ACRFO Histone H4 OS=Acropora formosa OX=126732 PE=3 SV=2,,,,,,
OG_13500,FUN_043994-T1,Peve_00009136,,apul_peve,91.743,FUN_043994-T1,P35067,,,,,100.0,119.0,2.8e-56,219.9,sp|P35067|H2B_ACRFO Histone H2B OS=Acropora formosa OX=126732 PE=3 SV=1,,,,,,
OG_13501,FUN_044015-T1,Peve_00015654,,apul_peve,72.689,FUN_044015-T1,Q9NR20,DYRK4_HUMAN,,Dual specificity tyrosine-phosphorylation-regulated kinase 4 (EC 2.7.12.1),Homo sapiens (Human),62.2,217.0,2.8000000000000007e-74,280.4,sp|Q9NR20|DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens OX=9606 GN=DYRK4 PE=1 SV=2,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005856; GO:0043231; GO:0046872; GO:0106310,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005856; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytoskeleton; transferase activity; organelle; catalytic activity, acting on a protein"
OG_13502,FUN_044143-T1,Peve_00033390,,apul_peve,31.25,,,,,,,,,,,,,,,,,
OG_13503,FUN_044269-T1,Peve_00006442,,apul_peve,86.91499999999999,,,,,,,,,,,,,,,,,
OG_13504,FUN_044274-T1,Peve_00034910,,apul_peve,60.849,,,,,,,,,,,,,,,,,
OG_13505,FUN_044322-T1,Peve_00006092,,apul_peve,31.494,,,,,,,,,,,,,,,,,
OG_13506,FUN_044373-T1,Peve_00025896,,apul_peve,35.971,,,,,,,,,,,,,,,,,
OG_13507,FUN_044379-T1,Peve_00001771,,apul_peve,38.913,,,,,,,,,,,,,,,,,
OG_13508,FUN_044385-T1,Peve_00035362,,apul_peve,31.78,,,,,,,,,,,,,,,,,
OG_13509,FUN_044386-T1,Peve_00034803,,apul_peve,52.519,,,,,,,,,,,,,,,,,
OG_13510,FUN_044390-T1,Peve_00043121,,apul_peve,66.389,,,,,,,,,,,,,,,,,
OG_13511,FUN_044393-T1,Peve_00025483,,apul_peve,98.374,,,,,,,,,,,,,,,,,
OG_13512,FUN_044394-T1,Peve_00034315,,apul_peve,39.506,,,,,,,,,,,,,,,,,
OG_13513,FUN_044402-T1,Peve_00043105,,apul_peve,57.965,,,,,,,,,,,,,,,,,
OG_13514,FUN_044403-T1,Peve_00022319,,apul_peve,52.303,,,,,,,,,,,,,,,,,
OG_13515,FUN_044404-T1,Peve_00026464,,apul_peve,47.297,,,,,,,,,,,,,,,,,
OG_13516,FUN_044422-T1,Peve_00017399,,apul_peve,37.502,FUN_044422-T1,Q95SX7,,,,,28.1,445.0,7.7e-37,156.8,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13517,FUN_044426-T1,Peve_00024172,,apul_peve,62.422,FUN_044426-T1,Q9FT73,,,,,29.8,369.0,5.200000000000001e-32,140.6,sp|Q9FT73|RECQ2_ARATH ATP-dependent DNA helicase Q-like 2 OS=Arabidopsis thaliana OX=3702 GN=RECQL2 PE=1 SV=1,,,,,,
OG_13518,FUN_044427-T1,Peve_00016070,,apul_peve,36.9615,,,,,,,,,,,,,,,,,
OG_13519,FUN_044428-T1,Peve_00014919,,apul_peve,82.979,,,,,,,,,,,,,,,,,
OG_13520,FUN_044429-T1,Peve_00014411,,apul_peve,33.708,,,,,,,,,,,,,,,,,
OG_13521,FUN_044430-T1,Peve_00044356,,apul_peve,56.044,FUN_044430-T1,Q6XKE6,,,,,26.9,427.0,1.3e-31,140.6,sp|Q6XKE6|POLG_PVCV2 Genome polyprotein OS=Petunia vein clearing virus (isolate Hohn) OX=492095 PE=3 SV=1,,,,,,
OG_13522,FUN_044432-T1,Peve_00031565,,apul_peve,62.5,,,,,,,,,,,,,,,,,
OG_13523,FUN_044437-T1,Peve_00013118,,apul_peve,62.9075,,,,,,,,,,,,,,,,,
OG_13524,FUN_044450-T1,Peve_00040728,,apul_peve,99.613,,,,,,,,,,,,,,,,,
OG_13525,FUN_044453-T1,Peve_00042191,,apul_peve,33.333,,,,,,,,,,,,,,,,,
OG_13526,FUN_044454-T1,Peve_00019641,,apul_peve,64.819,,,,,,,,,,,,,,,,,
OG_13527,FUN_044458-T1,Peve_00023001,,apul_peve,48.611,,,,,,,,,,,,,,,,,
OG_13528,FUN_044462-T1,Peve_00005210,,apul_peve,60.777,,,,,,,,,,,,,,,,,
OG_13529,FUN_044472-T1,Peve_00017692,,apul_peve,62.5,,,,,,,,,,,,,,,,,
OG_13530,FUN_044474-T1,Peve_00012796,,apul_peve,61.202,,,,,,,,,,,,,,,,,
OG_13531,FUN_044476-T1,Peve_00045352,,apul_peve,48.389,,,,,,,,,,,,,,,,,
OG_13532,FUN_044478-T1,Peve_00038172,,apul_peve,84.896,,,,,,,,,,,,,,,,,
OG_13533,FUN_044483-T1,Peve_00027886,,apul_peve,40.833,,,,,,,,,,,,,,,,,
OG_13534,FUN_044488-T1,Peve_00041272,,apul_peve,34.848,FUN_044488-T1,Q95SX7,,,,,23.8,886.0,1.4999999999999999e-40,170.2,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13535,FUN_044498-T1,Peve_00008710,,apul_peve,56.332,,,,,,,,,,,,,,,,,
OG_13536,FUN_044503-T1,Peve_00029518,,apul_peve,59.459,FUN_044503-T1,P04323,,,,,27.4,544.0,2.0999999999999998e-55,218.8,sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1,,,,,,
OG_13537,FUN_044506-T1,Peve_00037094,,apul_peve,34.89,,,,,,,,,,,,,,,,,
OG_13538,FUN_044514-T1,Peve_00010840,,apul_peve,58.791,FUN_044514-T1,Q95SX7,,,,,26.3,338.0,2.9e-17,91.3,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13539,FUN_044522-T1,Peve_00018080,,apul_peve,96.729,FUN_044522-T1,Q95P04,,,,,98.1,214.0,3.3e-126,452.2,sp|Q95P04|NFCP_GONTE GFP-like non-fluorescent chromoprotein OS=Goniopora tenuidens OX=75301 PE=1 SV=1,,,,,,
OG_13540,FUN_044525-T1,Peve_00010225,,apul_peve,73.973,,,,,,,,,,,,,,,,,
OG_13541,FUN_044528-T1,Peve_00010687,,apul_peve,86.935,,,,,,,,,,,,,,,,,
OG_13542,FUN_044531-T1,Peve_00044877,,apul_peve,54.938,,,,,,,,,,,,,,,,,
OG_13543,FUN_044538-T1,Peve_00041306,,apul_peve,43.333,,,,,,,,,,,,,,,,,
OG_13544,FUN_044542-T1,Peve_00024108,,apul_peve,36.585,,,,,,,,,,,,,,,,,
OG_13545,FUN_044556-T1,Peve_00041617,,apul_peve,91.597,,,,,,,,,,,,,,,,,
OG_13546,FUN_044564-T1,Peve_00010179,,apul_peve,40.299,,,,,,,,,,,,,,,,,
OG_13547,FUN_044590-T1,Peve_00016200,,apul_peve,43.729,FUN_044590-T1,Q8BZ39,NMUR2_MOUSE,,Neuromedin-U receptor 2 (NMU-R2),Mus musculus (Mouse),27.7,296.0,2e-10,68.2,sp|Q8BZ39|NMUR2_MOUSE Neuromedin-U receptor 2 OS=Mus musculus OX=10090 GN=Nmur2 PE=2 SV=1,GO:0001607; GO:0002023; GO:0005229; GO:0005525; GO:0005886; GO:0007200; GO:0007218; GO:0007625; GO:0008188; GO:0016020; GO:0042924; GO:0048265; GO:0050482,arachidonate secretion [GO:0050482]; grooming behavior [GO:0007625]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; reduction of food intake in response to dietary excess [GO:0002023]; response to pain [GO:0048265],membrane [GO:0016020]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; intracellularly calcium-gated chloride channel activity [GO:0005229]; neuromedin U binding [GO:0042924]; neuromedin U receptor activity [GO:0001607]; neuropeptide receptor activity [GO:0008188],GO:0005215; GO:0005886; GO:0060089,transporter activity; plasma membrane; molecular transducer activity
OG_13548,FUN_044595-T1,Peve_00035240,,apul_peve,46.023,,,,,,,,,,,,,,,,,
OG_13549,FUN_044595-T2,Peve_00034715,,apul_peve,69.63,,,,,,,,,,,,,,,,,
OG_13550,FUN_044601-T1,Peve_00042272,,apul_peve,65.306,,,,,,,,,,,,,,,,,
OG_13551,FUN_044612-T1,Peve_00032245,,apul_peve,70.652,,,,,,,,,,,,,,,,,
OG_13552,FUN_044614-T1,Peve_00042198,,apul_peve,65.306,,,,,,,,,,,,,,,,,
OG_13553,FUN_044615-T1,Peve_00025999,,apul_peve,59.064,,,,,,,,,,,,,,,,,
OG_13554,FUN_044616-T1,Peve_00003441,,apul_peve,38.971,,,,,,,,,,,,,,,,,
OG_13555,FUN_044624-T1,Peve_00019971,,apul_peve,74.627,FUN_044624-T1,Q9NBX4,,,,,28.6,262.0,6.8e-24,112.8,sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1,,,,,,
OG_13556,FUN_044634-T1,Peve_00000727,,apul_peve,48.521,FUN_044634-T1,Q09575,,,,,28.0,1050.0,4.8e-101,371.3,sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1,,,,,,
OG_13557,FUN_044641-T1,Peve_00031087,,apul_peve,37.815,,,,,,,,,,,,,,,,,
OG_13558,FUN_044643-T1,Peve_00002738,,apul_peve,39.322,,,,,,,,,,,,,,,,,
OG_13559,FUN_044653-T1,Peve_00032762,,apul_peve,62.382,,,,,,,,,,,,,,,,,
OG_13560,FUN_044659-T1,Peve_00000856,,apul_peve,97.156,,,,,,,,,,,,,,,,,
OG_13561,FUN_044665-T1,Peve_00035236,,apul_peve,66.412,FUN_044665-T1,Q95SX7,,,,,28.8,379.0,5.7e-35,150.2,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13562,FUN_044667-T1,Peve_00035273,,apul_peve,57.746,FUN_044667-T1,Q03274,,,,,28.9,166.0,1e-08,62.8,sp|Q03274|PO22_POPJA Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Fragment) OS=Popillia japonica OX=7064 PE=4 SV=1,,,,,,
OG_13563,FUN_044668-T1,Peve_00015581,,apul_peve,61.157,,,,,,,,,,,,,,,,,
OG_13564,FUN_044671-T1,Peve_00002109,,apul_peve,43.684,FUN_044671-T1,P14381,,,,,27.1,1324.0,1.2e-114,416.4,sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1,,,,,,
OG_13565,FUN_044674-T1,Peve_00004728,,apul_peve,39.576,,,,,,,,,,,,,,,,,
OG_13566,FUN_044691-T1,Peve_00041953,,apul_peve,32.822,,,,,,,,,,,,,,,,,
OG_13567,FUN_044692-T1,Peve_00012081,,apul_peve,78.492,,,,,,,,,,,,,,,,,
OG_13568,FUN_044697-T1,Peve_00017984,,apul_peve,59.716,,,,,,,,,,,,,,,,,
OG_13569,FUN_044700-T1,Peve_00037321,,apul_peve,47.4095,,,,,,,,,,,,,,,,,
OG_13570,FUN_044717-T1,Peve_00014961,,apul_peve,46.789,FUN_044717-T1,P21328,,,,,24.7,247.0,4.2e-17,90.5,sp|P21328|RTJK_DROME RNA-directed DNA polymerase from mobile element jockey OS=Drosophila melanogaster OX=7227 GN=pol PE=1 SV=1,,,,,,
OG_13571,FUN_044734-T1,Peve_00038589,,apul_peve,79.053,FUN_044734-T1,Q9CU65,,,,,25.7,245.0,4.3e-11,70.9,sp|Q9CU65|ZMYM2_MOUSE Zinc finger MYM-type protein 2 OS=Mus musculus OX=10090 GN=Zmym2 PE=1 SV=3,,,,,,
OG_13572,FUN_044737-T1,Peve_00034083,,apul_peve,55.319,,,,,,,,,,,,,,,,,
OG_13573,FUN_044739-T1,Peve_00035034,,apul_peve,64.045,,,,,,,,,,,,,,,,,
OG_13574,FUN_044744-T1,Peve_00003019,,apul_peve,76.81,,,,,,,,,,,,,,,,,
OG_13575,FUN_044756-T1,Peve_00019129,,apul_peve,65.873,FUN_044756-T1,Q95SX7,,,,,31.8,267.0,4.2e-22,107.1,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13576,FUN_044769-T1,Peve_00007403,,apul_peve,75.652,,,,,,,,,,,,,,,,,
OG_13577,FUN_044781-T1,Peve_00034173,,apul_peve,38.166,FUN_044781-T1,Q95SX7,,,,,25.1,339.0,1.2e-15,85.9,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13578,FUN_044793-T1,Peve_00040215,,apul_peve,55.133,,,,,,,,,,,,,,,,,
OG_13579,FUN_044794-T1,Peve_00031760,,apul_peve,92.58,FUN_044794-T1,Q6AZB8,,,,,31.8,214.0,3.2e-21,104.0,sp|Q6AZB8|HARB1_DANRE Putative nuclease HARBI1 OS=Danio rerio OX=7955 GN=harbi1 PE=2 SV=1,,,,,,
OG_13580,FUN_044796-T2,Peve_00022507,,apul_peve,40.058,,,,,,,,,,,,,,,,,
OG_13581,FUN_044799-T1,Peve_00005015,,apul_peve,44.97,,,,,,,,,,,,,,,,,
OG_13582,FUN_044802-T1,Peve_00022537,,apul_peve,68.346,,,,,,,,,,,,,,,,,
OG_13583,FUN_044806-T1,Peve_00031257,,apul_peve,48.361,FUN_044806-T1,Q8I7P9,,,,,26.2,732.0,1.9e-51,206.5,sp|Q8I7P9|POL5_DROME Retrovirus-related Pol polyprotein from transposon opus OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1,,,,,,
OG_13584,FUN_044810-T1,Peve_00021990,,apul_peve,48.76,,,,,,,,,,,,,,,,,
OG_13585,FUN_044823-T1,Peve_00033710,,apul_peve,55.011,FUN_044823-T1,Q5UPX0,,,,,29.4,279.0,6e-19,97.1,sp|Q5UPX0|YR290_MIMIV Putative ATP-dependent RNA helicase R290 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R290 PE=3 SV=1,,,,,,
OG_13586,FUN_044824-T1,Peve_00031523,,apul_peve,32.677,,,,,,,,,,,,,,,,,
OG_13587,FUN_044827-T1,Peve_00021718,,apul_peve,79.435,,,,,,,,,,,,,,,,,
OG_13588,FUN_044829-T1,Peve_00030381,,apul_peve,30.319,FUN_044829-T1,P04323,,,,,29.5,907.0,5.2e-104,380.9,sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1,,,,,,
OG_13589,FUN_044832-T1,Peve_00015271,,apul_peve,71.429,,,,,,,,,,,,,,,,,
OG_13590,FUN_044834-T1,Peve_00000799,,apul_peve,45.882,,,,,,,,,,,,,,,,,
OG_13591,FUN_044837-T1,Peve_00016341,,apul_peve,57.485,,,,,,,,,,,,,,,,,
OG_13592,FUN_044847-T1,Peve_00037372,,apul_peve,68.205,,,,,,,,,,,,,,,,,
OG_13593,FUN_044850-T1,Peve_00029889,,apul_peve,32.941,,,,,,,,,,,,,,,,,
OG_13594,FUN_044863-T1,Peve_00027113,,apul_peve,87.225,,,,,,,,,,,,,,,,,
OG_13595,FUN_044869-T1,Peve_00008627,,apul_peve,94.34,,,,,,,,,,,,,,,,,
OG_13596,FUN_044874-T1,Peve_00017158,,apul_peve,63.158,,,,,,,,,,,,,,,,,
OG_13597,FUN_044878-T1,Peve_00027452,,apul_peve,77.037,,,,,,,,,,,,,,,,,
OG_13598,FUN_044897-T1,Peve_00041999,,apul_peve,52.323,,,,,,,,,,,,,,,,,
OG_13599,FUN_044899-T1,Peve_00041012,,apul_peve,79.625,,,,,,,,,,,,,,,,,
OG_13600,FUN_044901-T1,Peve_00023042,,apul_peve,58.209,FUN_044901-T1,Q9UFW8,CGBP1_HUMAN,,CGG triplet repeat-binding protein 1 (CGG-binding protein 1) (20 kDa CGG-binding protein) (p20-CGGBP DNA-binding protein),Homo sapiens (Human),34.1,91.0,1.1e-06,54.3,sp|Q9UFW8|CGBP1_HUMAN CGG triplet repeat-binding protein 1 OS=Homo sapiens OX=9606 GN=CGGBP1 PE=1 SV=2,GO:0000122; GO:0003690; GO:0005634; GO:0005654; GO:0005829; GO:0010468; GO:0040029; GO:0042802; GO:0140297,epigenetic regulation of gene expression [GO:0040029]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gene expression [GO:0010468],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006325; GO:0006355; GO:0043226,DNA binding; nucleus; nucleoplasm; cytosol; chromatin organization; regulation of DNA-templated transcription; organelle
OG_13601,FUN_044905-T1,Peve_00001321,,apul_peve,55.285,,,,,,,,,,,,,,,,,
OG_13602,FUN_044907-T1,Peve_00019902,,apul_peve,52.174,,,,,,,,,,,,,,,,,
OG_13603,FUN_044909-T1,Peve_00035253,,apul_peve,49.612,,,,,,,,,,,,,,,,,
OG_13604,FUN_044911-T1,Peve_00030888,,apul_peve,33.036,,,,,,,,,,,,,,,,,
OG_13605,FUN_044922-T2,Peve_00004839,,apul_peve,85.143,,,,,,,,,,,,,,,,,
OG_13606,FUN_044923-T1,Peve_00016778,,apul_peve,61.765,,,,,,,,,,,,,,,,,
OG_13607,FUN_044928-T1,Peve_00022513,,apul_peve,56.4845,FUN_044928-T1,Q6AZB8,,,,,34.6,324.0,1.7e-52,208.0,sp|Q6AZB8|HARB1_DANRE Putative nuclease HARBI1 OS=Danio rerio OX=7955 GN=harbi1 PE=2 SV=1,,,,,,
OG_13608,FUN_044929-T1,Peve_00008530,,apul_peve,36.638,,,,,,,,,,,,,,,,,
OG_13609,FUN_044932-T2,Peve_00018903,,apul_peve,50.353,,,,,,,,,,,,,,,,,
OG_13610,FUN_044935-T1,Peve_00034574,,apul_peve,36.364,,,,,,,,,,,,,,,,,
OG_13611,FUN_044960-T1,Peve_00001015,,apul_peve,42.941,FUN_044960-T1,Q9NBX4,,,,,27.9,301.0,2.6e-17,91.3,sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1,,,,,,
OG_13612,FUN_044962-T2,Peve_00021639,,apul_peve,62.698,,,,,,,,,,,,,,,,,
OG_13613,FUN_044965-T1,Peve_00039698,,apul_peve,93.056,,,,,,,,,,,,,,,,,
OG_13614,FUN_044973-T1,Peve_00039920,,apul_peve,98.176,,,,,,,,,,,,,,,,,
OG_13615,FUN_044974-T1,Peve_00031400,,apul_peve,64.815,,,,,,,,,,,,,,,,,
OG_13616,FUN_044979-T2,Peve_00022707,,apul_peve,53.892,,,,,,,,,,,,,,,,,
OG_13617,FUN_044982-T1,Peve_00039767,,apul_peve,67.089,,,,,,,,,,,,,,,,,
OG_13618,FUN_044985-T1,Peve_00035847,,apul_peve,54.305,FUN_044985-T1,P14381,,,,,33.5,695.0,1.4e-96,355.5,sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1,,,,,,
OG_13619,FUN_044997-T1,Peve_00032980,,apul_peve,51.429,,,,,,,,,,,,,,,,,
OG_13620,FUN_044998-T1,Peve_00040365,,apul_peve,56.5715,,,,,,,,,,,,,,,,,
OG_13621,FUN_045002-T1,Peve_00003234,,apul_peve,53.242,,,,,,,,,,,,,,,,,
OG_13622,FUN_045004-T1,Peve_00026327,,apul_peve,30.412,,,,,,,,,,,,,,,,,
OG_13623,FUN_045006-T1,Peve_00024168,,apul_peve,48.325,FUN_045006-T1,Q9FT73,,,,,24.6,475.0,8.6e-23,110.2,sp|Q9FT73|RECQ2_ARATH ATP-dependent DNA helicase Q-like 2 OS=Arabidopsis thaliana OX=3702 GN=RECQL2 PE=1 SV=1,,,,,,
OG_13624,FUN_045008-T1,Peve_00039684,,apul_peve,35.589,,,,,,,,,,,,,,,,,
OG_13625,FUN_045011-T1,Peve_00034644,,apul_peve,88.06,,,,,,,,,,,,,,,,,
OG_13626,FUN_045014-T1,Peve_00015671,,apul_peve,67.792,,,,,,,,,,,,,,,,,
OG_13627,FUN_045016-T1,Peve_00002011,,apul_peve,55.814,,,,,,,,,,,,,,,,,
OG_13628,FUN_045017-T1,Peve_00037512,,apul_peve,94.872,FUN_045017-T1,Q14191,WRN_HUMAN,,"Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN (DNA helicase, RecQ-like type 3) (RecQ protein-like 2) (Werner syndrome protein) [Includes: 3'-5' exonuclease (EC 3.1.-.-); ATP-dependent helicase (EC 5.6.2.4) (DNA 3'-5' helicase WRN)]",Homo sapiens (Human),30.4,171.0,8.3e-15,82.8,sp|Q14191|WRN_HUMAN Bifunctional 3'-5' exonuclease/ATP-dependent helicase WRN OS=Homo sapiens OX=9606 GN=WRN PE=1 SV=2,GO:0000287; GO:0000400; GO:0000403; GO:0000405; GO:0000723; GO:0000724; GO:0000731; GO:0000781; GO:0003677; GO:0003678; GO:0004527; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0005694; GO:0005730; GO:0005737; GO:0005813; GO:0006259; GO:0006260; GO:0006284; GO:0006298; GO:0006302; GO:0006974; GO:0006979; GO:0008340; GO:0008408; GO:0009267; GO:0009378; GO:0010225; GO:0016607; GO:0016887; GO:0030145; GO:0031297; GO:0032201; GO:0032392; GO:0032405; GO:0040009; GO:0042803; GO:0043138; GO:0044877; GO:0051345; GO:0051880; GO:0061749; GO:0061820; GO:0061821; GO:0061849; GO:0070337; GO:0071480; GO:0090398; GO:0090399; GO:0090656; GO:0098530; GO:1902570; GO:1905773,base-excision repair [GO:0006284]; cellular response to gamma radiation [GO:0071480]; cellular response to starvation [GO:0009267]; cellular senescence [GO:0090398]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA geometric change [GO:0032392]; DNA metabolic process [GO:0006259]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mismatch repair [GO:0006298]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of strand invasion [GO:0098530]; protein localization to nucleolus [GO:1902570]; regulation of growth rate [GO:0040009]; replication fork processing [GO:0031297]; replicative senescence [GO:0090399]; response to oxidative stress [GO:0006979]; response to UV-C [GO:0010225]; t-circle formation [GO:0090656]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomeric D-loop disassembly [GO:0061820],"centrosome [GO:0005813]; chromosome [GO:0005694]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]",3'-5' DNA helicase activity [GO:0043138]; 3'-5' exonuclease activity [GO:0008408]; 3'-flap-structured DNA binding [GO:0070337]; 8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; exonuclease activity [GO:0004527]; forked DNA-dependent helicase activity [GO:0061749]; four-way junction DNA binding [GO:0000400]; four-way junction helicase activity [GO:0009378]; G-quadruplex DNA binding [GO:0051880]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; MutLalpha complex binding [GO:0032405]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; telomeric D-loop binding [GO:0061821]; telomeric G-quadruplex DNA binding [GO:0061849]; Y-form DNA binding [GO:0000403],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005815; GO:0006260; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; microtubule organizing center; DNA replication; DNA repair; DNA recombination; hydrolase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_13629,FUN_045018-T1,Peve_00023238,,apul_peve,58.5895,,,,,,,,,,,,,,,,,
OG_13630,FUN_045020-T1,Peve_00036335,,apul_peve,37.097,,,,,,,,,,,,,,,,,
OG_13631,FUN_045022-T1,Peve_00008340,,apul_peve,59.138,,,,,,,,,,,,,,,,,
OG_13632,FUN_045026-T1,Peve_00029519,,apul_peve,52.538,,,,,,,,,,,,,,,,,
OG_13633,FUN_045027-T1,Peve_00020795,,apul_peve,67.184,,,,,,,,,,,,,,,,,
OG_13634,FUN_045028-T1,Peve_00038795,,apul_peve,63.03,FUN_045028-T1,Q09575,,,,,26.6,983.0,2.5000000000000002e-89,332.4,sp|Q09575|YRD6_CAEEL Uncharacterized protein K02A2.6 OS=Caenorhabditis elegans OX=6239 GN=K02A2.6 PE=4 SV=1,,,,,,
OG_13635,FUN_045032-T1,Peve_00014761,,apul_peve,43.1165,,,,,,,,,,,,,,,,,
OG_13636,FUN_045033-T1,Peve_00016676,,apul_peve,38.08,,,,,,,,,,,,,,,,,
OG_13637,FUN_045037-T2,Peve_00043997,,apul_peve,35.7855,,,,,,,,,,,,,,,,,
OG_13638,FUN_045040-T1,Peve_00022512,,apul_peve,50.909,,,,,,,,,,,,,,,,,
OG_13639,FUN_045044-T1,Peve_00041502,,apul_peve,90.476,,,,,,,,,,,,,,,,,
OG_13640,FUN_045048-T1,Peve_00041886,,apul_peve,72.059,,,,,,,,,,,,,,,,,
OG_13641,FUN_045049-T1,Peve_00038242,,apul_peve,82.4365,,,,,,,,,,,,,,,,,
OG_13642,FUN_045052-T1,Peve_00015383,,apul_peve,74.576,,,,,,,,,,,,,,,,,
OG_13643,FUN_045056-T1,Peve_00042498,,apul_peve,52.1295,,,,,,,,,,,,,,,,,
OG_13644,FUN_045065-T1,Peve_00032877,,apul_peve,35.745,,,,,,,,,,,,,,,,,
OG_13645,FUN_045075-T1,Peve_00042873,,apul_peve,65.2415,,,,,,,,,,,,,,,,,
OG_13646,FUN_045088-T2,Peve_00001687,,apul_peve,57.5915,FUN_045088-T2,Q8R3N1,,,,,40.4,757.0,5.9e-93,343.6,sp|Q8R3N1|NOP14_MOUSE Nucleolar protein 14 OS=Mus musculus OX=10090 GN=Nop14 PE=1 SV=2,,,,,,
OG_13647,FUN_045089-T1,Peve_00010012,,apul_peve,77.241,FUN_045089-T1,Q9DBI0,TMPS6_MOUSE,,Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2),Mus musculus (Mouse),37.8,262.0,3.3e-45,183.7,sp|Q9DBI0|TMPS6_MOUSE Transmembrane protease serine 6 OS=Mus musculus OX=10090 GN=Tmprss6 PE=1 SV=4,GO:0000122; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0006879; GO:0016020; GO:0030509; GO:0030514; GO:0033619; GO:0042730; GO:0045892; GO:0045944; GO:0060586; GO:0097264,BMP signaling pathway [GO:0030509]; fibrinolysis [GO:0042730]; intracellular iron ion homeostasis [GO:0006879]; membrane protein proteolysis [GO:0033619]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteolysis [GO:0006508]; self proteolysis [GO:0097264],extracellular space [GO:0005615]; membrane [GO:0016020]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005615; GO:0005886; GO:0006355; GO:0016787; GO:0140096,"catalytic activity; extracellular space; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; catalytic activity, acting on a protein"
OG_13648,FUN_045093-T1,Peve_00006978,,apul_peve,63.123,FUN_045093-T1,P30974,,,,,28.0,311.0,4.7e-12,73.6,sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2,,,,,,
OG_13649,FUN_045099-T2,Peve_00035618,,apul_peve,58.403,,,,,,,,,,,,,,,,,
OG_13650,FUN_045113-T1,Peve_00019056,,apul_peve,66.667,,,,,,,,,,,,,,,,,
OG_13651,FUN_045114-T1,Peve_00044924,,apul_peve,79.959,,,,,,,,,,,,,,,,,
OG_13652,FUN_045121-T1,Peve_00027858,,apul_peve,41.067,,,,,,,,,,,,,,,,,
OG_13653,FUN_045126-T1,Peve_00035432,,apul_peve,37.288,,,,,,,,,,,,,,,,,
OG_13654,FUN_045127-T1,Peve_00044230,,apul_peve,82.143,FUN_045127-T1,P0CT41,,,,,30.6,826.0,1.9e-89,332.8,sp|P0CT41|TF212_SCHPO Transposon Tf2-12 polyprotein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=Tf2-12 PE=3 SV=1,,,,,,
OG_13655,FUN_045129-T1,Peve_00041812,,apul_peve,43.629,FUN_045129-T1,P14381,,,,,36.3,361.0,9.9e-49,196.4,sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1,,,,,,
OG_13656,FUN_045133-T1,Peve_00010996,,apul_peve,45.86,,,,,,,,,,,,,,,,,
OG_13657,FUN_045138-T1,Peve_00044699,,apul_peve,72.868,,,,,,,,,,,,,,,,,
OG_13658,FUN_045142-T1,Peve_00005763,,apul_peve,65.598,,,,,,,,,,,,,,,,,
OG_13659,FUN_045154-T1,Peve_00039524,,apul_peve,61.3885,FUN_045154-T1,P20825,,,,,38.5,486.0,3.3999999999999996e-92,342.0,sp|P20825|POL2_DROME Retrovirus-related Pol polyprotein from transposon 297 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1,,,,,,
OG_13660,FUN_045175-T1,Peve_00045197,,apul_peve,37.755,,,,,,,,,,,,,,,,,
OG_13661,FUN_045189-T1,Peve_00038474,,apul_peve,48.333,,,,,,,,,,,,,,,,,
OG_13662,FUN_045191-T1,Peve_00036291,,apul_peve,48.649,,,,,,,,,,,,,,,,,
OG_13663,FUN_045194-T1,Peve_00015813,,apul_peve,63.4075,FUN_045194-T1,A2AUY4,,,,,37.5,1200.0,1.2e-136,489.6,sp|A2AUY4|BAZ2B_MOUSE Bromodomain adjacent to zinc finger domain protein 2B OS=Mus musculus OX=10090 GN=Baz2b PE=1 SV=1,,,,,,
OG_13664,FUN_045194-T2,Peve_00002917,,apul_peve,58.072500000000005,,,,,,,,,,,,,,,,,
OG_13665,FUN_045195-T1,Peve_00045201,,apul_peve,38.846500000000006,,,,,,,,,,,,,,,,,
OG_13666,FUN_045196-T1,Peve_00040770,,apul_peve,62.736,,,,,,,,,,,,,,,,,
OG_13667,FUN_045207-T1,Peve_00026813,,apul_peve,39.806,,,,,,,,,,,,,,,,,
OG_13668,FUN_045209-T1,Peve_00004004,,apul_peve,44.589,FUN_045209-T1,P04323,,,,,25.7,682.0,5.400000000000001e-65,251.1,sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1,,,,,,
OG_13669,FUN_045213-T1,Peve_00006998,,apul_peve,79.503,FUN_045213-T1,Q920Q4,,,,,39.8,171.0,6.5e-35,148.7,sp|Q920Q4|VPS16_MOUSE Vacuolar protein sorting-associated protein 16 homolog OS=Mus musculus OX=10090 GN=Vps16 PE=1 SV=3,,,,,,
OG_13670,FUN_045218-T1,Peve_00040344,,apul_peve,36.022,,,,,,,,,,,,,,,,,
OG_13671,FUN_045225-T1,Peve_00041373,,apul_peve,60.241,,,,,,,,,,,,,,,,,
OG_13672,FUN_045226-T1,Peve_00022278,,apul_peve,57.353,FUN_045226-T1,P04146,,,,,28.2,1440.0,1.7e-145,518.8,sp|P04146|COPIA_DROME Copia protein OS=Drosophila melanogaster OX=7227 GN=GIP PE=1 SV=3,,,,,,
OG_13673,FUN_045229-T1,Peve_00001820,,apul_peve,69.333,,,,,,,,,,,,,,,,,
OG_13674,FUN_045241-T1,Peve_00028523,,apul_peve,56.1685,,,,,,,,,,,,,,,,,
OG_13675,FUN_045246-T1,Peve_00032412,,apul_peve,83.028,,,,,,,,,,,,,,,,,
OG_13676,FUN_045249-T1,Peve_00033784,,apul_peve,64.444,,,,,,,,,,,,,,,,,
OG_13677,FUN_045250-T1,Peve_00043643,,apul_peve,64.634,,,,,,,,,,,,,,,,,
OG_13678,FUN_045259-T1,Peve_00025038,,apul_peve,46.25,FUN_045259-T1,Q9NBX4,,,,,26.2,282.0,3.1e-21,104.4,sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1,,,,,,
OG_13679,FUN_045264-T2,Peve_00001093,,apul_peve,68.33250000000001,,,,,,,,,,,,,,,,,
OG_13680,FUN_045266-T1,Peve_00001648,,apul_peve,68.404,,,,,,,,,,,,,,,,,
OG_13681,FUN_045267-T1,Peve_00001749,,apul_peve,37.589,,,,,,,,,,,,,,,,,
OG_13682,FUN_045268-T1,Peve_00016863,,apul_peve,48.175,,,,,,,,,,,,,,,,,
OG_13683,FUN_045271-T1,Peve_00043923,,apul_peve,87.356,,,,,,,,,,,,,,,,,
OG_13684,FUN_045272-T1,Peve_00018981,,apul_peve,92.182,,,,,,,,,,,,,,,,,
OG_13685,FUN_045277-T2,Peve_00034973,,apul_peve,73.526,FUN_045277-T2,O88572,LRP6_MOUSE,,Low-density lipoprotein receptor-related protein 6 (LRP-6),Mus musculus (Mouse),52.5,897.0,3.2e-77,291.6,sp|O88572|LRP6_MOUSE Low-density lipoprotein receptor-related protein 6 OS=Mus musculus OX=10090 GN=Lrp6 PE=1 SV=1,GO:0001702; GO:0001756; GO:0001843; GO:0001947; GO:0002053; GO:0003151; GO:0003344; GO:0003401; GO:0005041; GO:0005769; GO:0005783; GO:0005886; GO:0008078; GO:0009880; GO:0009950; GO:0009952; GO:0010463; GO:0010976; GO:0016020; GO:0017147; GO:0019534; GO:0021587; GO:0021794; GO:0021795; GO:0021861; GO:0021872; GO:0021874; GO:0021915; GO:0021943; GO:0021987; GO:0030326; GO:0030900; GO:0030901; GO:0030917; GO:0034185; GO:0035108; GO:0035115; GO:0035116; GO:0035261; GO:0036342; GO:0042074; GO:0042475; GO:0042733; GO:0042813; GO:0043065; GO:0045121; GO:0045444; GO:0045599; GO:0045778; GO:0045780; GO:0045944; GO:0046849; GO:0048596; GO:0048699; GO:0048705; GO:0050678; GO:0050680; GO:0051593; GO:0055008; GO:0060021; GO:0060026; GO:0060042; GO:0060059; GO:0060070; GO:0060284; GO:0060325; GO:0060412; GO:0060444; GO:0060535; GO:0060596; GO:0060603; GO:0060856; GO:0071542; GO:0072089; GO:0090009; GO:0090118; GO:0090244; GO:0090245; GO:0110135; GO:1990963; GO:2000051; GO:2000648,anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in gastrulation [GO:0042074]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; mesenchymal cell proliferation [GO:0010463]; mesodermal cell migration [GO:0008078]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; Norrin signaling pathway [GO:0110135]; odontogenesis of dentin-containing tooth [GO:0042475]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of epithelial cell proliferation [GO:0050678]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],apolipoprotein binding [GO:0034185]; low-density lipoprotein particle receptor activity [GO:0005041]; toxin transmembrane transporter activity [GO:0019534]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005215; GO:0005768; GO:0005783; GO:0005886; GO:0006355; GO:0016192; GO:0022414; GO:0030154; GO:0031410; GO:0038024; GO:0043226; GO:0048856; GO:0048870; GO:0060089,transporter activity; endosome; endoplasmic reticulum; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; reproductive process; cell differentiation; cytoplasmic vesicle; cargo receptor activity; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_13686,FUN_045281-T1,Peve_00041969,,apul_peve,58.371,,,,,,,,,,,,,,,,,
OG_13687,FUN_045289-T1,Peve_00003440,,apul_peve,36.268,FUN_045289-T1,P11369,,,,,30.9,544.0,2.8e-70,268.5,sp|P11369|LORF2_MOUSE LINE-1 retrotransposable element ORF2 protein OS=Mus musculus OX=10090 GN=Pol PE=1 SV=2,,,,,,
OG_13688,FUN_045293-T1,Peve_00032247,,apul_peve,57.188,,,,,,,,,,,,,,,,,
OG_13689,FUN_045296-T1,Peve_00013008,,apul_peve,54.286,FUN_045296-T1,Q5UPX0,,,,,32.0,147.0,4.2e-17,90.5,sp|Q5UPX0|YR290_MIMIV Putative ATP-dependent RNA helicase R290 OS=Acanthamoeba polyphaga mimivirus OX=212035 GN=MIMI_R290 PE=3 SV=1,,,,,,
OG_13690,FUN_045299-T1,Peve_00030209,,apul_peve,89.459,,,,,,,,,,,,,,,,,
OG_13691,FUN_045306-T1,Peve_00011480,,apul_peve,43.726,,,,,,,,,,,,,,,,,
OG_13692,FUN_045311-T1,Peve_00022706,,apul_peve,83.4225,,,,,,,,,,,,,,,,,
OG_13693,FUN_045320-T1,Peve_00037173,,apul_peve,53.878,,,,,,,,,,,,,,,,,
OG_13694,FUN_045321-T1,Peve_00008348,,apul_peve,74.722,,,,,,,,,,,,,,,,,
OG_13695,FUN_045325-T1,Peve_00028044,,apul_peve,49.466,,,,,,,,,,,,,,,,,
OG_13696,FUN_045336-T1,Peve_00035518,,apul_peve,62.456,,,,,,,,,,,,,,,,,
OG_13697,FUN_045340-T1,Peve_00030997,,apul_peve,36.765,,,,,,,,,,,,,,,,,
OG_13698,FUN_045344-T1,Peve_00011485,,apul_peve,41.86,,,,,,,,,,,,,,,,,
OG_13699,FUN_045347-T1,Peve_00025856,,apul_peve,44.892,,,,,,,,,,,,,,,,,
OG_13700,FUN_045357-T1,Peve_00035231,,apul_peve,42.403,,,,,,,,,,,,,,,,,
OG_13701,FUN_045362-T1,Peve_00024103,,apul_peve,47.577,,,,,,,,,,,,,,,,,
OG_13702,FUN_045369-T1,Peve_00010985,,apul_peve,56.8445,,,,,,,,,,,,,,,,,
OG_13703,FUN_045370-T1,Peve_00017170,,apul_peve,35.208,,,,,,,,,,,,,,,,,
OG_13704,FUN_045375-T1,Peve_00040354,,apul_peve,59.394,,,,,,,,,,,,,,,,,
OG_13705,FUN_045376-T1,Peve_00040352,,apul_peve,54.369,,,,,,,,,,,,,,,,,
OG_13706,FUN_045409-T1,Peve_00016913,,apul_peve,80.208,,,,,,,,,,,,,,,,,
OG_13707,FUN_045413-T1,Peve_00019511,,apul_peve,45.985,FUN_045413-T1,Q95SX7,,,,,28.1,445.0,6.6e-35,150.6,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13708,FUN_045419-T1,Peve_00029764,,apul_peve,78.947,,,,,,,,,,,,,,,,,
OG_13709,FUN_045424-T1,Peve_00043376,,apul_peve,67.516,,,,,,,,,,,,,,,,,
OG_13710,FUN_045430-T1,Peve_00005265,,apul_peve,36.0,FUN_045430-T1,Q95SX7,,,,,24.4,718.0,9.3e-35,150.6,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13711,FUN_045433-T1,Peve_00000063,,apul_peve,62.759,,,,,,,,,,,,,,,,,
OG_13712,FUN_045436-T1,Peve_00027090,,apul_peve,57.951,,,,,,,,,,,,,,,,,
OG_13713,FUN_045439-T1,Peve_00014642,,apul_peve,47.458,,,,,,,,,,,,,,,,,
OG_13714,FUN_045447-T1,Peve_00003848,,apul_peve,65.942,FUN_045447-T1,Q0R4F1,PIF1_XENLA,,ATP-dependent DNA helicase PIF1 (EC 5.6.2.3) (DNA 5'-3' helicase PIF1) (DNA repair and recombination helicase PIF1),Xenopus laevis (African clawed frog),28.2,454.0,3.1e-29,132.9,sp|Q0R4F1|PIF1_XENLA ATP-dependent DNA helicase PIF1 OS=Xenopus laevis OX=8355 GN=pif1 PE=2 SV=1,GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0016887; GO:0043139,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723],mitochondrion [GO:0005739]; nucleus [GO:0005634],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; DNA recombination; hydrolase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_13715,FUN_045450-T1,Peve_00005947,,apul_peve,94.595,,,,,,,,,,,,,,,,,
OG_13716,FUN_045453-T1,Peve_00029992,,apul_peve,48.297,,,,,,,,,,,,,,,,,
OG_13717,FUN_045456-T1,Peve_00032174,,apul_peve,72.441,FUN_045456-T1,P14381,,,,,30.1,978.0,4.4e-98,360.9,sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1,,,,,,
OG_13718,FUN_045461-T1,Peve_00016067,,apul_peve,95.077,,,,,,,,,,,,,,,,,
OG_13719,FUN_045481-T1,Peve_00026996,,apul_peve,54.444,,,,,,,,,,,,,,,,,
OG_13720,FUN_045483-T1,Peve_00033381,,apul_peve,40.541,,,,,,,,,,,,,,,,,
OG_13721,FUN_045491-T1,Peve_00024400,,apul_peve,58.261,,,,,,,,,,,,,,,,,
OG_13722,FUN_045494-T1,Peve_00017478,,apul_peve,48.679,,,,,,,,,,,,,,,,,
OG_13723,FUN_045496-T1,Peve_00022279,,apul_peve,38.013,FUN_045496-T1,P10978,,,,,33.4,877.0,1e-101,372.9,sp|P10978|POLX_TOBAC Retrovirus-related Pol polyprotein from transposon TNT 1-94 OS=Nicotiana tabacum OX=4097 PE=2 SV=1,,,,,,
OG_13724,FUN_045501-T1,Peve_00020962,,apul_peve,44.444,,,,,,,,,,,,,,,,,
OG_13725,FUN_045507-T1,Peve_00026231,,apul_peve,61.735,,,,,,,,,,,,,,,,,
OG_13726,FUN_045515-T1,Peve_00038292,,apul_peve,51.24,,,,,,,,,,,,,,,,,
OG_13727,FUN_045525-T1,Peve_00036171,,apul_peve,49.835,,,,,,,,,,,,,,,,,
OG_13728,FUN_045525-T2,Peve_00019639,,apul_peve,37.41,,,,,,,,,,,,,,,,,
OG_13729,FUN_045536-T1,Peve_00042478,,apul_peve,46.183,,,,,,,,,,,,,,,,,
OG_13730,FUN_045544-T1,Peve_00039234,,apul_peve,60.294,FUN_045544-T1,Q03278,,,,,21.3,319.0,8.9e-16,87.0,sp|Q03278|PO21_NASVI Retrovirus-related Pol polyprotein from type-1 retrotransposable element R2 (Fragment) OS=Nasonia vitripennis OX=7425 PE=4 SV=2,,,,,,
OG_13731,FUN_045554-T1,Peve_00019026,,apul_peve,37.363,,,,,,,,,,,,,,,,,
OG_13732,FUN_045600-T1,Peve_00013721,,apul_peve,47.965,,,,,,,,,,,,,,,,,
OG_13733,FUN_045602-T1,Peve_00005504,,apul_peve,37.3005,FUN_045602-T1,Q94K49,ALP1_ARATH,,Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 (EC 3.1.-.-),Arabidopsis thaliana (Mouse-ear cress),27.8,338.0,2.5e-32,141.4,sp|Q94K49|ALP1_ARATH Protein ANTAGONIST OF LIKE HETEROCHROMATIN PROTEIN 1 OS=Arabidopsis thaliana OX=3702 GN=ALP1 PE=1 SV=1,GO:0003682; GO:0004518; GO:0005634; GO:0035098; GO:0035102; GO:0040029; GO:0046872,epigenetic regulation of gene expression [GO:0040029],ESC/E(Z) complex [GO:0035098]; nucleus [GO:0005634]; PRC1 complex [GO:0035102],chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518],GO:0003824; GO:0005634; GO:0006325; GO:0043226,catalytic activity; nucleus; chromatin organization; organelle
OG_13734,FUN_045603-T1,Peve_00044118,,apul_peve,46.847,FUN_045603-T1,Q95SX7,,,,,27.6,312.0,2.3e-21,104.8,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13735,FUN_045604-T1,Peve_00042982,,apul_peve,44.304,,,,,,,,,,,,,,,,,
OG_13736,FUN_045605-T1,Peve_00008543,,apul_peve,50.3485,,,,,,,,,,,,,,,,,
OG_13737,FUN_045614-T1,Peve_00029035,,apul_peve,60.0,FUN_045614-T1,Q96KE9,,,,,34.3,437.0,2.3e-65,251.1,sp|Q96KE9|BTBD6_HUMAN BTB/POZ domain-containing protein 6 OS=Homo sapiens OX=9606 GN=BTBD6 PE=1 SV=4,,,,,,
OG_13738,FUN_045624-T1,Peve_00029282,,apul_peve,45.66,FUN_045624-T1,Q4QY64,ATAD5_MOUSE,,ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein),Mus musculus (Mouse),34.2,448.0,1.9e-45,187.2,sp|Q4QY64|ATAD5_MOUSE ATPase family AAA domain-containing protein 5 OS=Mus musculus OX=10090 GN=Atad5 PE=1 SV=1,GO:0005524; GO:0005634; GO:0006974; GO:0008283; GO:0008630; GO:0016887; GO:0030890; GO:0031391; GO:0033260; GO:0042770; GO:0042771; GO:0045190; GO:0045740; GO:0048304; GO:0061860; GO:1901990; GO:1902166; GO:1902230; GO:1902751,cell population proliferation [GO:0008283]; DNA damage response [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; isotype switching [GO:0045190]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; nuclear DNA replication [GO:0033260]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of DNA replication [GO:0045740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; regulation of mitotic cell cycle phase transition [GO:1901990]; signal transduction in response to DNA damage [GO:0042770],Elg1 RFC-like complex [GO:0031391]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA clamp unloader activity [GO:0061860],GO:0002376; GO:0003824; GO:0005634; GO:0006260; GO:0006310; GO:0016787; GO:0043226; GO:0140097; GO:0140657,"immune system process; catalytic activity; nucleus; DNA replication; DNA recombination; hydrolase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_13739,FUN_045625-T1,Peve_00026185,,apul_peve,45.082,,,,,,,,,,,,,,,,,
OG_13740,FUN_045627-T1,Peve_00004980,,apul_peve,68.421,,,,,,,,,,,,,,,,,
OG_13741,FUN_045631-T1,Peve_00016270,,apul_peve,98.319,,,,,,,,,,,,,,,,,
OG_13742,FUN_045640-T2,Peve_00042699,,apul_peve,43.3425,FUN_045640-T2,Q9CUX1,,,,,32.1,613.0,1.8e-82,308.9,sp|Q9CUX1|P52K_MOUSE 52 kDa repressor of the inhibitor of the protein kinase OS=Mus musculus OX=10090 GN=Thap12 PE=2 SV=2,,,,,,
OG_13743,FUN_045642-T1,Peve_00025889,,apul_peve,57.944,,,,,,,,,,,,,,,,,
OG_13744,FUN_045644-T1,Peve_00026177,,apul_peve,98.504,,,,,,,,,,,,,,,,,
OG_13745,FUN_045645-T1,Peve_00004037,,apul_peve,45.7465,,,,,,,,,,,,,,,,,
OG_13746,FUN_045648-T1,Peve_00032772,,apul_peve,85.083,,,,,,,,,,,,,,,,,
OG_13747,FUN_045663-T1,Peve_00016061,,apul_peve,53.465,,,,,,,,,,,,,,,,,
OG_13748,FUN_045666-T1,Peve_00033168,,apul_peve,60.0435,,,,,,,,,,,,,,,,,
OG_13749,FUN_045669-T1,Peve_00035014,,apul_peve,98.225,,,,,,,,,,,,,,,,,
OG_13750,FUN_045670-T1,Peve_00004482,,apul_peve,33.613,,,,,,,,,,,,,,,,,
OG_13751,FUN_045672-T1,Peve_00018287,,apul_peve,65.65549999999999,,,,,,,,,,,,,,,,,
OG_13752,FUN_045684-T1,Peve_00037214,,apul_peve,37.864,,,,,,,,,,,,,,,,,
OG_13753,FUN_045693-T1,Peve_00007713,,apul_peve,71.0085,,,,,,,,,,,,,,,,,
OG_13754,FUN_045710-T1,Peve_00011923,,apul_peve,31.926,FUN_045710-T1,P10394,,,,,35.0,472.0,1.0000000000000001e-71,273.9,sp|P10394|POL4_DROME Retrovirus-related Pol polyprotein from transposon 412 OS=Drosophila melanogaster OX=7227 GN=POL PE=4 SV=1,,,,,,
OG_13755,FUN_045715-T1,Peve_00008864,,apul_peve,85.156,,,,,,,,,,,,,,,,,
OG_13756,FUN_045716-T1,Peve_00030028,,apul_peve,64.706,,,,,,,,,,,,,,,,,
OG_13757,FUN_045719-T1,Peve_00030974,,apul_peve,60.741,,,,,,,,,,,,,,,,,
OG_13758,FUN_045720-T1,Peve_00016781,,apul_peve,45.349,,,,,,,,,,,,,,,,,
OG_13759,FUN_045728-T1,Peve_00001243,,apul_peve,41.304,,,,,,,,,,,,,,,,,
OG_13760,FUN_045736-T1,Peve_00017038,,apul_peve,41.975,,,,,,,,,,,,,,,,,
OG_13761,FUN_045738-T1,Peve_00036274,,apul_peve,60.227,FUN_045738-T1,Q95SX7,,,,,27.6,246.0,6e-15,82.8,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13762,FUN_045739-T1,Peve_00006568,,apul_peve,52.288,,,,,,,,,,,,,,,,,
OG_13763,FUN_045743-T1,Peve_00018714,,apul_peve,62.371,,,,,,,,,,,,,,,,,
OG_13764,FUN_045749-T1,Peve_00014316,,apul_peve,59.574,FUN_045749-T1,Q95SX7,,,,,29.6,419.0,2.9e-39,164.5,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_13765,FUN_045750-T1,Peve_00007604,,apul_peve,72.881,,,,,,,,,,,,,,,,,
OG_13766,FUN_045758-T1,Peve_00003056,,apul_peve,85.841,,,,,,,,,,,,,,,,,
OG_13767,FUN_045759-T1,Peve_00010983,,apul_peve,68.852,,,,,,,,,,,,,,,,,
OG_13768,FUN_045769-T1,Peve_00001617,,apul_peve,57.459,FUN_045769-T1,Q5U206,,,,,55.0,60.0,5.8e-10,65.9,sp|Q5U206|CALL3_RAT Calmodulin-like protein 3 OS=Rattus norvegicus OX=10116 GN=Calml3 PE=2 SV=1,,,,,,
OG_13769,FUN_045784-T1,Peve_00041544,,apul_peve,68.392,,,,,,,,,,,,,,,,,
OG_13770,FUN_045786-T1,Peve_00037975,,apul_peve,69.143,,,,,,,,,,,,,,,,,
OG_13771,FUN_045789-T1,Peve_00013135,,apul_peve,71.875,FUN_045789-T1,P16425,,,,,24.2,281.0,2.9e-06,55.5,sp|P16425|Y2R2_DROME Putative 115 kDa protein in type-1 retrotransposable element R1DM OS=Drosophila melanogaster OX=7227 GN=R1A1-element\ORF2 PE=4 SV=1,,,,,,
OG_13772,FUN_045791-T1,Peve_00032307,,apul_peve,51.0585,,,,,,,,,,,,,,,,,
OG_13773,FUN_045793-T1,Peve_00016861,,apul_peve,83.122,,,,,,,,,,,,,,,,,
OG_13774,FUN_045805-T1,Peve_00025403,,apul_peve,36.164,,,,,,,,,,,,,,,,,
OG_13775,FUN_045806-T1,Peve_00030993,,apul_peve,80.088,FUN_045806-T1,Q9EQU5,SET_MOUSE,,Protein SET (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I),Mus musculus (Mouse),56.2,219.0,2.1e-63,243.8,sp|Q9EQU5|SET_MOUSE Protein SET OS=Mus musculus OX=10090 GN=Set PE=1 SV=1,GO:0003677; GO:0005634; GO:0005654; GO:0005737; GO:0005783; GO:0005811; GO:0005829; GO:0006334; GO:0032991; GO:0043524; GO:0045892; GO:0048471,negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of neuron apoptotic process [GO:0043524]; nucleosome assembly [GO:0006334],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005654; GO:0005783; GO:0005811; GO:0005829; GO:0006325; GO:0006355; GO:0043226; GO:0065003,DNA binding; nucleus; nucleoplasm; endoplasmic reticulum; lipid droplet; cytosol; chromatin organization; regulation of DNA-templated transcription; organelle; protein-containing complex assembly
OG_13776,FUN_045807-T1,Peve_00023263,,apul_peve,51.994,,,,,,,,,,,,,,,,,
OG_13777,FUN_045816-T1,Peve_00015318,,apul_peve,38.265,,,,,,,,,,,,,,,,,
OG_13778,FUN_045830-T1,Peve_00014216,,apul_peve,84.348,,,,,,,,,,,,,,,,,
OG_13779,FUN_045832-T1,Peve_00039161,,apul_peve,44.681,,,,,,,,,,,,,,,,,
OG_13780,FUN_045838-T1,Peve_00018554,,apul_peve,43.799,,,,,,,,,,,,,,,,,
OG_13781,FUN_045849-T1,Peve_00008274,,apul_peve,90.659,FUN_045849-T1,Q6AZB8,,,,,43.8,178.0,3.1e-32,139.8,sp|Q6AZB8|HARB1_DANRE Putative nuclease HARBI1 OS=Danio rerio OX=7955 GN=harbi1 PE=2 SV=1,,,,,,
OG_13782,FUN_045852-T1,Peve_00009351,,apul_peve,53.012,,,,,,,,,,,,,,,,,
OG_13783,FUN_000186-T1,,Pocillopora_meandrina_HIv1___TS.g6106.t2,apul_ptua,58.776,FUN_000186-T1,A5HUI5,AMPE_GLOBR,,Aminopeptidase A (AP-A) (APA) (EC 3.4.11.7) (Glutamyl aminopeptidase) (EAP),Gloydius brevicauda (Korean slamosa snake) (Agkistrodon halys brevicaudus),36.2,434.0,1.1e-67,258.8,sp|A5HUI5|AMPE_GLOBR Aminopeptidase A OS=Gloydius brevicauda OX=3148161 PE=1 SV=2,GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0042277; GO:0043171; GO:0070006,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; catalytic activity, acting on a protein"
OG_13784,FUN_000201-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28905.t1,apul_ptua,60.552,FUN_000201-T1,Q9Y3Y2,,,,,37.1,143.0,3.6e-08,60.1,sp|Q9Y3Y2|CHTOP_HUMAN Chromatin target of PRMT1 protein OS=Homo sapiens OX=9606 GN=CHTOP PE=1 SV=2,,,,,,
OG_13785,FUN_000204-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28909.t1,apul_ptua,64.229,FUN_000204-T1,A6H7D1,,,,,31.8,280.0,1.6000000000000002e-22,109.0,sp|A6H7D1|TT23L_BOVIN Tetratricopeptide repeat protein 23-like OS=Bos taurus OX=9913 GN=TTC23L PE=2 SV=2,,,,,,
OG_13786,FUN_000211-T1,,Pocillopora_meandrina_HIv1___TS.g18103.t1,apul_ptua,61.722,FUN_000211-T1,Q58A42,DD3_DICDI,,Protein DD3-3,Dictyostelium discoideum (Social amoeba),31.1,530.0,1e-51,206.1,sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_13787,FUN_000224-T1,,Pocillopora_meandrina_HIv1___TS.g6154.t1b,apul_ptua,37.154,FUN_000224-T1,Q6NZK5,,,,,41.7,84.0,6.2e-09,64.7,sp|Q6NZK5|K1328_MOUSE Protein hinderin OS=Mus musculus OX=10090 GN=Kiaa1328 PE=1 SV=2,,,,,,
OG_13788,FUN_000228-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28942.t1,apul_ptua,92.825,FUN_000228-T1,P23640,RB27A_RAT,,Ras-related protein Rab-27A (Rab-27) (EC 3.6.5.2) (GTP-binding protein Ram) (Ram p25),Rattus norvegicus (Rat),67.9,224.0,2.8e-83,309.7,sp|P23640|RB27A_RAT Ras-related protein Rab-27A OS=Rattus norvegicus OX=10116 GN=Rab27a PE=1 SV=1,GO:0001750; GO:0003924; GO:0003925; GO:0005525; GO:0005764; GO:0005770; GO:0005794; GO:0006887; GO:0007596; GO:0009306; GO:0010628; GO:0016192; GO:0016324; GO:0019003; GO:0019882; GO:0019904; GO:0030141; GO:0030318; GO:0030425; GO:0031489; GO:0032400; GO:0032402; GO:0032585; GO:0033093; GO:0036257; GO:0042470; GO:0043316; GO:0043320; GO:0043473; GO:0045921; GO:0050766; GO:0051875; GO:0051904; GO:0070382; GO:0071985; GO:0097278; GO:1903307; GO:1903428; GO:1903435; GO:1990182,antigen processing and presentation [GO:0019882]; blood coagulation [GO:0007596]; complement-dependent cytotoxicity [GO:0097278]; cytotoxic T cell degranulation [GO:0043316]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; melanocyte differentiation [GO:0030318]; melanosome localization [GO:0032400]; melanosome transport [GO:0032402]; multivesicular body organization [GO:0036257]; multivesicular body sorting pathway [GO:0071985]; natural killer cell degranulation [GO:0043320]; pigment granule localization [GO:0051875]; pigment granule transport [GO:0051904]; pigmentation [GO:0043473]; positive regulation of constitutive secretory pathway [GO:1903435]; positive regulation of exocytosis [GO:0045921]; positive regulation of gene expression [GO:0010628]; positive regulation of phagocytosis [GO:0050766]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of regulated secretory pathway [GO:1903307]; protein secretion [GO:0009306]; vesicle-mediated transport [GO:0016192],apical plasma membrane [GO:0016324]; dendrite [GO:0030425]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; photoreceptor outer segment [GO:0001750]; secretory granule [GO:0030141]; Weibel-Palade body [GO:0033093],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; protein domain specific binding [GO:0019904],GO:0002376; GO:0003824; GO:0003924; GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0008092; GO:0016192; GO:0016787; GO:0030154; GO:0031410; GO:0043226; GO:0098772,immune system process; catalytic activity; GTPase activity; lysosome; endosome; vacuole; Golgi apparatus; cytoskeletal protein binding; vesicle-mediated transport; hydrolase activity; cell differentiation; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_13789,FUN_000244-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28958.t1b,apul_ptua,80.282,FUN_000244-T1,Q6P832,,,,,70.8,425.0,2.7e-180,632.9,"sp|Q6P832|GATM_XENTR Glycine amidinotransferase, mitochondrial OS=Xenopus tropicalis OX=8364 GN=gatm PE=2 SV=1",,,,,,
OG_13790,FUN_000252-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28935.t1,apul_ptua,43.443,,,,,,,,,,,,,,,,,
OG_13791,FUN_000267-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28981.t2,apul_ptua,58.17,,,,,,,,,,,,,,,,,
OG_13792,FUN_000274-T2,,Pocillopora_meandrina_HIv1___RNAseq.g28991.t1,apul_ptua,61.7645,FUN_000274-T2,P55115,,,,,43.1,197.0,4.1e-37,157.1,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_13793,FUN_000432-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15990.t1a,apul_ptua,45.652,FUN_000432-T1,Q15818,NPTX1_HUMAN,,Neuronal pentraxin-1 (NP1) (Neuronal pentraxin I) (NP-I),Homo sapiens (Human),39.1,197.0,3.1999999999999997e-31,136.7,sp|Q15818|NPTX1_HUMAN Neuronal pentraxin-1 OS=Homo sapiens OX=9606 GN=NPTX1 PE=1 SV=2,GO:0005783; GO:0006839; GO:0007268; GO:0007417; GO:0030133; GO:0035865; GO:0043083; GO:0043653; GO:0046872; GO:0060385; GO:0071333; GO:0097107; GO:0098978; GO:0099645,axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; postsynaptic density assembly [GO:0097107],endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133],metal ion binding [GO:0046872],GO:0005576; GO:0005783; GO:0007005; GO:0023052; GO:0031410; GO:0043226; GO:0048856,extracellular region; endoplasmic reticulum; mitochondrion organization; signaling; cytoplasmic vesicle; organelle; anatomical structure development
OG_13794,FUN_000460-T2,,Pocillopora_meandrina_HIv1___RNAseq.g3474.t1,apul_ptua,30.8335,,,,,,,,,,,,,,,,,
OG_13795,FUN_000467-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2421.t1,apul_ptua,54.373000000000005,,,,,,,,,,,,,,,,,
OG_13796,FUN_000477-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2348.t1,apul_ptua,60.69,FUN_000477-T1,Q61603,GLRA4_MOUSE,,Glycine receptor subunit alpha-4,Mus musculus (Mouse),36.2,417.0,5.6e-64,246.5,sp|Q61603|GLRA4_MOUSE Glycine receptor subunit alpha-4 OS=Mus musculus OX=10090 GN=Glra4 PE=1 SV=3,GO:0004888; GO:0005886; GO:0016594; GO:0016934; GO:0022824; GO:0030425; GO:0034707; GO:0043200; GO:0043204; GO:0098690; GO:0099634; GO:1902476,chloride transmembrane transport [GO:1902476]; response to amino acid [GO:0043200],chloride channel complex [GO:0034707]; dendrite [GO:0030425]; glycinergic synapse [GO:0098690]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_13797,FUN_000516-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4899.t1,apul_ptua,35.315,FUN_000516-T1,Q9UBY5,LPAR3_HUMAN,,Lysophosphatidic acid receptor 3 (LPA receptor 3) (LPA-3) (Lysophosphatidic acid receptor Edg-7),Homo sapiens (Human),22.5,284.0,5e-06,53.5,sp|Q9UBY5|LPAR3_HUMAN Lysophosphatidic acid receptor 3 OS=Homo sapiens OX=9606 GN=LPAR3 PE=1 SV=1,GO:0001965; GO:0004930; GO:0005543; GO:0005737; GO:0005886; GO:0005929; GO:0007187; GO:0007189; GO:0007204; GO:0007268; GO:0008289; GO:0010467; GO:0019222; GO:0030424; GO:0032060; GO:0043410; GO:0045202; GO:0048668; GO:0048672; GO:0051928; GO:0070915,"adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bleb assembly [GO:0032060]; chemical synaptic transmission [GO:0007268]; collateral sprouting [GO:0048668]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; gene expression [GO:0010467]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of MAPK cascade [GO:0043410]; regulation of metabolic process [GO:0019222]",axon [GO:0030424]; cilium [GO:0005929]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; synapse [GO:0045202],G protein-coupled receptor activity [GO:0004930]; G-protein alpha-subunit binding [GO:0001965]; lipid binding [GO:0008289]; lysophosphatidic acid receptor activity [GO:0070915]; phospholipid binding [GO:0005543],GO:0005886; GO:0005929; GO:0008289; GO:0023052; GO:0043226; GO:0060089,plasma membrane; cilium; lipid binding; signaling; organelle; molecular transducer activity
OG_13798,FUN_000526-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2387.t1,apul_ptua,69.215,FUN_000526-T1,O35119,TRPC4_RAT,,Short transient receptor potential channel 4 (Trp4) (TrpC4) (Capacitative calcium entry channel 1) (CCE1),Rattus norvegicus (Rat),21.2,260.0,3.1e-10,68.2,sp|O35119|TRPC4_RAT Short transient receptor potential channel 4 OS=Rattus norvegicus OX=10116 GN=Trpc4 PE=1 SV=2,GO:0005262; GO:0005886; GO:0005901; GO:0005911; GO:0006816; GO:0008013; GO:0009986; GO:0014051; GO:0015279; GO:0016323; GO:0030863; GO:0032991; GO:0034703; GO:0034704; GO:0045121; GO:0045296; GO:0048709; GO:0051480; GO:0051924; GO:0070509; GO:0070588; GO:0070679; GO:0099605; GO:0106129,calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; gamma-aminobutyric acid secretion [GO:0014051]; oligodendrocyte differentiation [GO:0048709]; positive regulation of store-operated calcium entry [GO:0106129]; regulation of action potential firing rate [GO:0099605]; regulation of calcium ion transport [GO:0051924]; regulation of cytosolic calcium ion concentration [GO:0051480],basolateral plasma membrane [GO:0016323]; calcium channel complex [GO:0034704]; cation channel complex [GO:0034703]; caveola [GO:0005901]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],"beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0005215; GO:0005856; GO:0005886; GO:0030154; GO:0043226; GO:0055085,transporter activity; cytoskeleton; plasma membrane; cell differentiation; organelle; transmembrane transport
OG_13799,FUN_000529-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2386.t1,apul_ptua,88.189,FUN_000529-T1,O62839,,,,,69.1,508.0,3.1e-215,749.2,sp|O62839|CATA_PIG Catalase OS=Sus scrofa OX=9823 GN=CAT PE=1 SV=4,,,,,,
OG_13800,FUN_000532-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2385.t1a,apul_ptua,33.057500000000005,,,,,,,,,,,,,,,,,
OG_13801,FUN_000540-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1650.t1,apul_ptua,50.938,,,,,,,,,,,,,,,,,
OG_13802,FUN_000547-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2367.t1,apul_ptua,66.355,FUN_000547-T1,Q54WT7,,,,,38.9,234.0,2.9e-43,177.2,sp|Q54WT7|CTNS_DICDI Cystinosin homolog OS=Dictyostelium discoideum OX=44689 GN=ctns PE=3 SV=1,,,,,,
OG_13803,FUN_000553-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2467.t1,apul_ptua,70.0,FUN_000553-T1,Q8BNL5,,,,,33.9,230.0,7.1e-23,109.0,sp|Q8BNL5|KCTD6_MOUSE BTB/POZ domain-containing protein KCTD6 OS=Mus musculus OX=10090 GN=Kctd6 PE=2 SV=1,,,,,,
OG_13804,FUN_000557-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2462.t1,apul_ptua,36.932,,,,,,,,,,,,,,,,,
OG_13805,FUN_000566-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2454.t1,apul_ptua,37.931,,,,,,,,,,,,,,,,,
OG_13806,FUN_000575-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2438.t1,apul_ptua,66.667,FUN_000575-T1,F1R332,,,,,31.9,235.0,1.1e-25,118.6,sp|F1R332|GAL2A_DANRE Galanin receptor 2a OS=Danio rerio OX=7955 GN=galr2a PE=2 SV=2,,,,,,
OG_13807,FUN_000583-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29299.t1,apul_ptua,55.09,FUN_000583-T1,Q9PUI1,,,,,45.7,116.0,8.899999999999999e-24,111.7,sp|Q9PUI1|PA2B2_AUSSU Basic phospholipase A2 S6-45 OS=Austrelaps superbus OX=29156 PE=2 SV=1,,,,,,
OG_13808,FUN_000589-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29292.t1,apul_ptua,47.5315,FUN_000589-T1,Q1JQA7,TIGAR_BOVIN,,"Fructose-2,6-bisphosphatase TIGAR (EC 3.1.3.46) (TP53-induced glycolysis and apoptosis regulator) (TP53-induced glycolysis regulatory phosphatase)",Bos taurus (Bovine),37.5,261.0,8.199999999999998e-35,149.1,"sp|Q1JQA7|TIGAR_BOVIN Fructose-2,6-bisphosphatase TIGAR OS=Bos taurus OX=9913 GN=TIGAR PE=2 SV=1",GO:0002931; GO:0004331; GO:0005634; GO:0005737; GO:0005739; GO:0005741; GO:0005829; GO:0006914; GO:0006915; GO:0006974; GO:0043069; GO:0043456; GO:0045739; GO:0045820; GO:0071456; GO:1902153; GO:1903301; GO:1905857,apoptotic process [GO:0006915]; autophagy [GO:0006914]; cellular response to hypoxia [GO:0071456]; DNA damage response [GO:0006974]; negative regulation of glycolytic process [GO:0045820]; negative regulation of programmed cell death [GO:0043069]; positive regulation of DNA repair [GO:0045739]; positive regulation of hexokinase activity [GO:1903301]; positive regulation of pentose-phosphate shunt [GO:1905857]; regulation of pentose-phosphate shunt [GO:0043456]; regulation of response to DNA damage checkpoint signaling [GO:1902153]; response to ischemia [GO:0002931],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634],"fructose-2,6-bisphosphate 2-phosphatase activity [GO:0004331]",GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006914; GO:0012501; GO:0016787; GO:0043226,catalytic activity; nucleus; mitochondrion; cytosol; autophagy; programmed cell death; hydrolase activity; organelle
OG_13809,FUN_000594-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29287.t1,apul_ptua,44.304,,,,,,,,,,,,,,,,,
OG_13810,FUN_000615-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1714.t1,apul_ptua,89.017,FUN_000615-T1,Q05B30,,,,,51.2,172.0,4.3e-47,189.1,sp|Q05B30|WDR91_XENTR WD repeat-containing protein 91 OS=Xenopus tropicalis OX=8364 GN=wdr91 PE=2 SV=1,,,,,,
OG_13811,FUN_000642-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1811.t1,apul_ptua,71.251,FUN_000642-T1,Q7Z3E2,,,,,32.1,685.0,6.3000000000000005e-30,134.4,sp|Q7Z3E2|CC186_HUMAN Coiled-coil domain-containing protein 186 OS=Homo sapiens OX=9606 GN=CCDC186 PE=1 SV=2,,,,,,
OG_13812,FUN_000865-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1855.t1,apul_ptua,40.284,,,,,,,,,,,,,,,,,
OG_13813,FUN_000884-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29434.t1,apul_ptua,41.333,,,,,,,,,,,,,,,,,
OG_13814,FUN_000903-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29452.t1,apul_ptua,45.869,,,,,,,,,,,,,,,,,
OG_13815,FUN_000911-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29491.t1,apul_ptua,74.933,FUN_000911-T1,Q5T7P8,SYT6_HUMAN,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Homo sapiens (Human),37.3,279.0,3.6e-43,177.2,sp|Q5T7P8|SYT6_HUMAN Synaptotagmin-6 OS=Homo sapiens OX=9606 GN=SYT6 PE=1 SV=3,GO:0000149; GO:0005829; GO:0005886; GO:0007268; GO:0009898; GO:0016020; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030672; GO:0042803; GO:0046872; GO:0060478; GO:0061891; GO:0070382; GO:0097038,acrosomal vesicle exocytosis [GO:0060478]; chemical synaptic transmission [GO:0007268]; regulation of calcium ion-dependent exocytosis [GO:0017158]; vesicle-mediated transport [GO:0016192],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; exocytic vesicle [GO:0070382]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium ion sensor activity [GO:0061891]; clathrin binding [GO:0030276]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905],GO:0005829; GO:0005886; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0098772; GO:0140299,cytosol; plasma membrane; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; molecular function regulator activity; molecular sensor activity
OG_13816,FUN_000923-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29472.t1,apul_ptua,58.824,,,,,,,,,,,,,,,,,
OG_13817,FUN_000925-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29469.t1,apul_ptua,38.357,,,,,,,,,,,,,,,,,
OG_13818,FUN_000956-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2481.t1,apul_ptua,40.741,FUN_000956-T1,D2X8K2,PA2_CONGI,,Phospholipase A2 A2-actitoxin-Cgg2a (A2-AITX-Cgg2a) (EC 3.1.1.4) (CgPLA2) (Phosphatidylcholine 2-acylhydrolase),Condylactis gigantea (Giant Caribbean anemone) (Condylactis passiflora),40.5,116.0,1.5e-21,105.9,sp|D2X8K2|PA2_CONGI Phospholipase A2 A2-actitoxin-Cgg2a OS=Condylactis gigantea OX=47073 PE=1 SV=1,GO:0005509; GO:0005543; GO:0005576; GO:0006644; GO:0016042; GO:0042151; GO:0044398; GO:0044470; GO:0044522; GO:0047498; GO:0050482; GO:0090729,arachidonate secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644]; venom-mediated edema in another organism [GO:0044398]; venom-mediated myocyte killing in another organism [GO:0044522]; venom-mediated suppression of blood coagulation [GO:0044470],extracellular region [GO:0005576]; nematocyst [GO:0042151],calcium ion binding [GO:0005509]; calcium-dependent phospholipase A2 activity [GO:0047498]; phospholipid binding [GO:0005543]; toxin activity [GO:0090729],GO:0003824; GO:0005576; GO:0006629; GO:0008289; GO:0016787; GO:0043226; GO:0090729,catalytic activity; extracellular region; lipid metabolic process; lipid binding; hydrolase activity; organelle; toxin activity
OG_13819,FUN_000965-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12015.t1,apul_ptua,31.034,FUN_000965-T1,Q8NDI1,EHBP1_HUMAN,,EH domain-binding protein 1,Homo sapiens (Human),34.0,106.0,7.2e-15,84.3,sp|Q8NDI1|EHBP1_HUMAN EH domain-binding protein 1 OS=Homo sapiens OX=9606 GN=EHBP1 PE=1 SV=3,GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0015031,endocytosis [GO:0006897]; protein transport [GO:0015031],cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],,GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; endosome; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_13820,FUN_000991-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29197.t1,apul_ptua,30.088,,,,,,,,,,,,,,,,,
OG_13821,FUN_001003-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29177.t1,apul_ptua,34.736000000000004,,,,,,,,,,,,,,,,,
OG_13822,FUN_001040-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29633.t1,apul_ptua,64.899,FUN_001040-T1,Q5VXJ0,LIPK_HUMAN,,Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2),Homo sapiens (Human),41.8,404.0,2.7e-92,340.5,sp|Q5VXJ0|LIPK_HUMAN Lipase member K OS=Homo sapiens OX=9606 GN=LIPK PE=1 SV=2,GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268,cornification [GO:0070268]; lipid catabolic process [GO:0016042],extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231],lipoprotein lipase activity [GO:0004465],GO:0003824; GO:0005576; GO:0006629; GO:0012501; GO:0016787; GO:0043226,catalytic activity; extracellular region; lipid metabolic process; programmed cell death; hydrolase activity; organelle
OG_13823,FUN_001058-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29646.t1,apul_ptua,60.0,,,,,,,,,,,,,,,,,
OG_13824,FUN_001065-T2,,Pocillopora_meandrina_HIv1___TS.g6827.t1,apul_ptua,49.1215,,,,,,,,,,,,,,,,,
OG_13825,FUN_001094-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29380.t1,apul_ptua,77.6005,,,,,,,,,,,,,,,,,
OG_13826,FUN_001097-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29379.t1b,apul_ptua,75.263,,,,,,,,,,,,,,,,,
OG_13827,FUN_001102-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25740.t1,apul_ptua,71.561,FUN_001102-T1,Q9FN03,,,,,32.0,366.0,5.1e-54,215.3,sp|Q9FN03|UVR8_ARATH Ultraviolet-B receptor UVR8 OS=Arabidopsis thaliana OX=3702 GN=UVR8 PE=1 SV=1,,,,,,
OG_13828,FUN_001105-T1,,Pocillopora_meandrina_HIv1___TS.g6564.t1,apul_ptua,68.433,FUN_001105-T1,P0DMV4,,,,,31.0,116.0,1.3e-07,59.3,sp|P0DMV4|ITLN_ONCMY Intelectin OS=Oncorhynchus mykiss OX=8022 GN=itln PE=1 SV=1,,,,,,
OG_13829,FUN_001112-T2,,Pocillopora_meandrina_HIv1___RNAseq.g29361.t1,apul_ptua,33.52,,,,,,,,,,,,,,,,,
OG_13830,FUN_001127-T1,,Pocillopora_meandrina_HIv1___TS.g14624.t1,apul_ptua,39.286,,,,,,,,,,,,,,,,,
OG_13831,FUN_001162-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29218.t1,apul_ptua,66.667,FUN_001162-T1,P28019,,,,,43.7,183.0,4e-43,176.0,sp|P28019|DYR_AEDAL Dihydrofolate reductase OS=Aedes albopictus OX=7160 GN=DHFR PE=3 SV=1,,,,,,
OG_13832,FUN_001164-T2,,Pocillopora_meandrina_HIv1___RNAseq.g29216.t1,apul_ptua,93.878,,,,,,,,,,,,,,,,,
OG_13833,FUN_001182-T1,,Pocillopora_meandrina_HIv1___TS.g6727.t1,apul_ptua,54.054,,,,,,,,,,,,,,,,,
OG_13834,FUN_001191-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29535.t1,apul_ptua,42.775,,,,,,,,,,,,,,,,,
OG_13835,FUN_001194-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29526.t1,apul_ptua,44.014,,,,,,,,,,,,,,,,,
OG_13836,FUN_001196-T1,,Pocillopora_meandrina_HIv1___TS.g6709.t1,apul_ptua,87.789,FUN_001196-T1,Q9CQR6,,,,,89.4,301.0,2e-169,596.3,sp|Q9CQR6|PPP6_MOUSE Serine/threonine-protein phosphatase 6 catalytic subunit OS=Mus musculus OX=10090 GN=Ppp6c PE=1 SV=1,,,,,,
OG_13837,FUN_001206-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29519.t1,apul_ptua,39.535,,,,,,,,,,,,,,,,,
OG_13838,FUN_001214-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29511.t1,apul_ptua,100.0,FUN_001214-T1,Q0P594,PP2AB_BOVIN,,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PP2A-beta) (EC 3.1.3.16),Bos taurus (Bovine),91.9,309.0,1.6e-177,623.2,sp|Q0P594|PP2AB_BOVIN Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform OS=Bos taurus OX=9913 GN=PPP2CB PE=1 SV=1,GO:0000278; GO:0000775; GO:0000922; GO:0004722; GO:0005634; GO:0005737; GO:0005829; GO:0046872; GO:0090443,mitotic cell cycle [GO:0000278],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FAR/SIN/STRIPAK complex [GO:0090443]; nucleus [GO:0005634]; spindle pole [GO:0000922]",metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722],GO:0000278; GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"mitotic cell cycle; catalytic activity; nucleus; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_13839,FUN_001230-T2,,Pocillopora_meandrina_HIv1___TS.g6454.t5,apul_ptua,74.6925,FUN_001230-T2,Q99081,HTF4_HUMAN,,Transcription factor 12 (TCF-12) (Class B basic helix-loop-helix protein 20) (bHLHb20) (DNA-binding protein HTF4) (E-box-binding protein) (Transcription factor HTF-4),Homo sapiens (Human),40.1,689.0,8.3e-62,240.0,sp|Q99081|HTF4_HUMAN Transcription factor 12 OS=Homo sapiens OX=9606 GN=TCF12 PE=1 SV=1,GO:0000785; GO:0000978; GO:0000981; GO:0000987; GO:0001228; GO:0003700; GO:0005634; GO:0005654; GO:0005667; GO:0005737; GO:0006357; GO:0006955; GO:0007399; GO:0007517; GO:0010467; GO:0010628; GO:0016607; GO:0030154; GO:0035497; GO:0043231; GO:0043425; GO:0045666; GO:0045944; GO:0046332; GO:0046982; GO:0070888; GO:0071837; GO:0090575; GO:0097210; GO:0140297; GO:1990837,cell differentiation [GO:0030154]; gene expression [GO:0010467]; immune response [GO:0006955]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; response to gonadotropin-releasing hormone [GO:0097210],chromatin [GO:0000785]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667],"bHLH transcription factor binding [GO:0043425]; cAMP response element binding [GO:0035497]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; E-box binding [GO:0070888]; HMG box domain binding [GO:0071837]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; SMAD binding [GO:0046332]",GO:0002376; GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,immune system process; DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_13840,FUN_001247-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2302.t1,apul_ptua,61.386,,,,,,,,,,,,,,,,,
OG_13841,FUN_001250-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2308.t1,apul_ptua,52.607,,,,,,,,,,,,,,,,,
OG_13842,FUN_001280-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7458.t1,apul_ptua,56.311,,,,,,,,,,,,,,,,,
OG_13843,FUN_001282-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16429.t1,apul_ptua,38.021,,,,,,,,,,,,,,,,,
OG_13844,FUN_001286-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2196.t1,apul_ptua,57.96,,,,,,,,,,,,,,,,,
OG_13845,FUN_001306-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2243.t1,apul_ptua,30.671,,,,,,,,,,,,,,,,,
OG_13846,FUN_001311-T2,,Pocillopora_meandrina_HIv1___RNAseq.g2260.t1,apul_ptua,57.778,,,,,,,,,,,,,,,,,
OG_13847,FUN_001322-T1,,Pocillopora_meandrina_HIv1___TS.g4771.t1a,apul_ptua,75.775,FUN_001322-T1,Q64640,ADK_RAT,,Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase),Rattus norvegicus (Rat),57.1,357.0,3.9e-116,419.5,sp|Q64640|ADK_RAT Adenosine kinase OS=Rattus norvegicus OX=10116 GN=Adk PE=1 SV=3,GO:0004001; GO:0004136; GO:0005524; GO:0005634; GO:0005829; GO:0006144; GO:0006166; GO:0006175; GO:0010613; GO:0032263; GO:0032922; GO:0042102; GO:0044209; GO:0044342; GO:0046085; GO:0046872; GO:0106383,adenosine metabolic process [GO:0046085]; AMP salvage [GO:0044209]; circadian regulation of gene expression [GO:0032922]; dAMP salvage [GO:0106383]; dATP biosynthetic process [GO:0006175]; GMP salvage [GO:0032263]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of T cell proliferation [GO:0042102]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleoside salvage [GO:0006166]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; nucleus [GO:0005634],adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; deoxyadenosine kinase activity [GO:0004136]; metal ion binding [GO:0046872],GO:0003824; GO:0005634; GO:0005829; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; cytosol; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_13848,FUN_001352-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1873.t1,apul_ptua,78.788,FUN_001352-T1,Q6P926,SPA24_MOUSE,,Spermatogenesis-associated protein 24 (TATA-binding protein-like factor-interacting protein) (TLF-interacting protein) (TRF2-interacting protein in testis) (Testis protein T6441 homolog),Mus musculus (Mouse),39.5,172.0,1.8e-25,117.5,sp|Q6P926|SPA24_MOUSE Spermatogenesis-associated protein 24 OS=Mus musculus OX=10090 GN=Spata24 PE=1 SV=1,GO:0001673; GO:0003677; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0007283; GO:0030154; GO:0042802,cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; identical protein binding [GO:0042802],GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0022414; GO:0030154; GO:0043226,DNA binding; nucleus; nucleoplasm; nucleolus; cytosol; reproductive process; cell differentiation; organelle
OG_13849,FUN_001391-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2124.t1,apul_ptua,55.785,,,,,,,,,,,,,,,,,
OG_13850,FUN_001396-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2116.t1,apul_ptua,85.39,FUN_001396-T1,O97562,,,,,56.8,294.0,4.7e-89,329.3,sp|O97562|UCP2_PIG Dicarboxylate carrier UCP2 OS=Sus scrofa OX=9823 GN=UCP2 PE=2 SV=1,,,,,,
OG_13851,FUN_001409-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2104.t1,apul_ptua,88.971,FUN_001409-T1,M0QWB7,,,,,60.4,91.0,3.4e-20,99.4,sp|M0QWB7|ASCL5_MOUSE Achaete-scute homolog 5 OS=Mus musculus OX=10090 GN=Ascl5 PE=1 SV=1,,,,,,
OG_13852,FUN_001470-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22902.t1,apul_ptua,80.556,,,,,,,,,,,,,,,,,
OG_13853,FUN_001474-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1973.t1,apul_ptua,56.6625,,,,,,,,,,,,,,,,,
OG_13854,FUN_001488-T2,,Pocillopora_meandrina_HIv1___TS.g4417.t1,apul_ptua,66.12,,,,,,,,,,,,,,,,,
OG_13855,FUN_001506-T1,,Pocillopora_meandrina_HIv1___TS.g4396.t1b,apul_ptua,63.134,,,,,,,,,,,,,,,,,
OG_13856,FUN_001523-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19753.t1,apul_ptua,57.622,,,,,,,,,,,,,,,,,
OG_13857,FUN_001555-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2002.t1,apul_ptua,71.296,FUN_001555-T1,P49892,,,,,27.5,335.0,1.7e-17,91.7,sp|P49892|AA1R_CHICK Adenosine receptor A1 OS=Gallus gallus OX=9031 GN=ADORA1 PE=2 SV=1,,,,,,
OG_13858,FUN_001574-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20435.t1a,apul_ptua,44.388,,,,,,,,,,,,,,,,,
OG_13859,FUN_001578-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2030.t1,apul_ptua,52.622,FUN_001578-T1,Q3UZY0,,,,,35.0,958.0,6.8e-26,121.7,sp|Q3UZY0|SFI1_MOUSE Protein SFI1 homolog OS=Mus musculus OX=10090 GN=Sfi1 PE=2 SV=1,,,,,,
OG_13860,FUN_001588-T1,,Pocillopora_meandrina_HIv1___TS.g4500.t1,apul_ptua,71.43299999999999,FUN_001588-T1,O75494,,,,,51.5,68.0,6.2e-12,72.4,sp|O75494|SRS10_HUMAN Serine/arginine-rich splicing factor 10 OS=Homo sapiens OX=9606 GN=SRSF10 PE=1 SV=1,,,,,,
OG_13861,FUN_001593-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1990.t1b,apul_ptua,68.194,FUN_001593-T1,F1NBT0,,,,,61.8,301.0,2.8e-113,411.8,sp|F1NBT0|STK10_CHICK Serine/threonine-protein kinase 10 OS=Gallus gallus OX=9031 GN=STK10 PE=3 SV=2,,,,,,
OG_13861,FUN_001593-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1990.t1b,apul_ptua,68.194,FUN_001593-T1,F1NBT0,,,,,37.0,127.0,4.5e-10,68.9,sp|F1NBT0|STK10_CHICK Serine/threonine-protein kinase 10 OS=Gallus gallus OX=9031 GN=STK10 PE=3 SV=2,,,,,,
OG_13862,FUN_001594-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1987.t1,apul_ptua,68.522,FUN_001594-T1,Q9LMG7,PPA2_ARATH,,Probable inactive purple acid phosphatase 2,Arabidopsis thaliana (Mouse-ear cress),33.5,573.0,1.5999999999999998e-85,318.5,sp|Q9LMG7|PPA2_ARATH Probable inactive purple acid phosphatase 2 OS=Arabidopsis thaliana OX=3702 GN=PAP2 PE=2 SV=1,GO:0003993; GO:0005576; GO:0005739; GO:0005740; GO:0005768; GO:0005794; GO:0005802; GO:0006109; GO:0006626; GO:0009507; GO:0009941; GO:0030943; GO:0045040; GO:0046872,protein insertion into mitochondrial outer membrane [GO:0045040]; protein targeting to mitochondrion [GO:0006626]; regulation of carbohydrate metabolic process [GO:0006109],chloroplast [GO:0009507]; chloroplast envelope [GO:0009941]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; mitochondrial envelope [GO:0005740]; mitochondrion [GO:0005739]; trans-Golgi network [GO:0005802],acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872]; mitochondrion targeting sequence binding [GO:0030943],GO:0003824; GO:0005576; GO:0005739; GO:0005768; GO:0005794; GO:0007005; GO:0009536; GO:0016787; GO:0031410; GO:0043226; GO:0061024,catalytic activity; extracellular region; mitochondrion; endosome; Golgi apparatus; mitochondrion organization; plastid; hydrolase activity; cytoplasmic vesicle; organelle; membrane organization
OG_13863,FUN_001598-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1983.t1,apul_ptua,82.07849999999999,FUN_001598-T1,P56394,COX17_MOUSE,,Cytochrome c oxidase copper chaperone,Mus musculus (Mouse),66.2,68.0,1.7e-18,93.2,sp|P56394|COX17_MOUSE Cytochrome c oxidase copper chaperone OS=Mus musculus OX=10090 GN=Cox17 PE=1 SV=2,GO:0005507; GO:0005739; GO:0005758; GO:0007507; GO:0008047; GO:0008284; GO:0016531; GO:0033617; GO:1903136,heart development [GO:0007507]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; positive regulation of cell population proliferation [GO:0008284],mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739],copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507]; cuprous ion binding [GO:1903136]; enzyme activator activity [GO:0008047],GO:0005739; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140104,mitochondrion; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; molecular carrier activity
OG_13864,FUN_001605-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1981.t1,apul_ptua,50.4815,,,,,,,,,,,,,,,,,
OG_13865,FUN_001634-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2158.t1,apul_ptua,33.7805,,,,,,,,,,,,,,,,,
OG_13866,FUN_001649-T1,,Pocillopora_meandrina_HIv1___TS.g6603.t1,apul_ptua,66.883,FUN_001649-T1,Q5FVR2,TYPH_RAT,,Thymidine phosphorylase (TP) (EC 2.4.2.4) (TdRPase),Rattus norvegicus (Rat),50.7,410.0,5.5e-102,372.9,sp|Q5FVR2|TYPH_RAT Thymidine phosphorylase OS=Rattus norvegicus OX=10116 GN=Tymp PE=1 SV=1,GO:0000002; GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0009032; GO:0031641; GO:0042803; GO:0046074; GO:0051969; GO:1905333,dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],cytosol [GO:0005829],"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; thymidine phosphorylase activity [GO:0009032]",GO:0003824; GO:0005829; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_13867,FUN_001652-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29415.t1,apul_ptua,42.1635,,,,,,,,,,,,,,,,,
OG_13868,FUN_001663-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29393.t1,apul_ptua,39.454,,,,,,,,,,,,,,,,,
OG_13869,FUN_001672-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2708.t1,apul_ptua,54.711,FUN_001672-T1,Q9Y5X5,NPFF2_HUMAN,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),Homo sapiens (Human),28.8,330.0,5.6000000000000005e-28,126.7,sp|Q9Y5X5|NPFF2_HUMAN Neuropeptide FF receptor 2 OS=Homo sapiens OX=9606 GN=NPFFR2 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0009582; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; detection of abiotic stimulus [GO:0009582]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_13870,FUN_001679-T1,,Pocillopora_meandrina_HIv1___TS.g5215.t1,apul_ptua,60.6405,FUN_001679-T1,P32745,SSR3_HUMAN,,Somatostatin receptor type 3 (SS-3-R) (SS3-R) (SS3R) (SST3) (SSR-28),Homo sapiens (Human),30.2,324.0,1.9e-16,88.6,sp|P32745|SSR3_HUMAN Somatostatin receptor type 3 OS=Homo sapiens OX=9606 GN=SSTR3 PE=1 SV=1,GO:0004930; GO:0004994; GO:0005102; GO:0005886; GO:0005929; GO:0007187; GO:0007218; GO:0007267; GO:0008285; GO:0008628; GO:0042923; GO:0043005; GO:0060170; GO:0097730,"cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; hormone-mediated apoptotic signaling pathway [GO:0008628]; negative regulation of cell population proliferation [GO:0008285]; neuropeptide signaling pathway [GO:0007218]",ciliary membrane [GO:0060170]; cilium [GO:0005929]; neuron projection [GO:0043005]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide binding [GO:0042923]; signaling receptor binding [GO:0005102]; somatostatin receptor activity [GO:0004994],GO:0005886; GO:0005929; GO:0023052; GO:0043226; GO:0060089,plasma membrane; cilium; signaling; organelle; molecular transducer activity
OG_13871,FUN_001734-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2643.t1,apul_ptua,58.262,FUN_001734-T1,P02752,,,,,39.2,171.0,1.2e-34,148.3,sp|P02752|RBP_CHICK Riboflavin-binding protein OS=Gallus gallus OX=9031 PE=1 SV=2,,,,,,
OG_13872,FUN_001740-T1,,Pocillopora_meandrina_HIv1___TS.g5159.t2,apul_ptua,38.462,FUN_001740-T1,B8VIU6,,,,,32.4,148.0,1.3e-12,75.5,sp|B8VIU6|USOM5_ACRMI Uncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_13873,FUN_001744-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2651.t1,apul_ptua,39.1895,,,,,,,,,,,,,,,,,
OG_13874,FUN_001786-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2640.t1b,apul_ptua,62.6245,FUN_001786-T1,P25054,APC_HUMAN,,Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5),Homo sapiens (Human),52.6,460.0,7.4e-119,430.6,sp|P25054|APC_HUMAN Adenomatous polyposis coli protein OS=Homo sapiens OX=9606 GN=APC PE=1 SV=2,GO:0000281; GO:0000776; GO:0001708; GO:0003170; GO:0003203; GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005813; GO:0005829; GO:0005874; GO:0005886; GO:0005912; GO:0005923; GO:0006974; GO:0007026; GO:0007094; GO:0007155; GO:0007389; GO:0007399; GO:0008013; GO:0008017; GO:0008285; GO:0008286; GO:0016055; GO:0016328; GO:0016342; GO:0016477; GO:0019887; GO:0019901; GO:0030027; GO:0030335; GO:0030877; GO:0031274; GO:0031625; GO:0032587; GO:0032886; GO:0043065; GO:0043161; GO:0045295; GO:0045732; GO:0045736; GO:0048471; GO:0051010; GO:0051988; GO:0060632; GO:0065003; GO:0070830; GO:0070840; GO:0090090; GO:0120162; GO:1902807; GO:1904781; GO:1990909; GO:2000134,bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell migration [GO:0016477]; DNA damage response [GO:0006974]; endocardial cushion morphogenesis [GO:0003203]; heart valve development [GO:0003170]; insulin receptor signaling pathway [GO:0008286]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly checkpoint signaling [GO:0007094]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; pattern specification process [GO:0007389]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of pseudopodium assembly [GO:0031274]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of microtubule-based movement [GO:0060632]; regulation of microtubule-based process [GO:0032886]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; beta-catenin destruction complex [GO:0030877]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; Wnt signalosome [GO:1990909],beta-catenin binding [GO:0008013]; dynein complex binding [GO:0070840]; gamma-catenin binding [GO:0045295]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin protein ligase binding [GO:0031625],GO:0000910; GO:0005634; GO:0005654; GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0007155; GO:0008092; GO:0030163; GO:0034330; GO:0043226; GO:0048856; GO:0048870; GO:0065003; GO:0098772,cytokinesis; nucleus; nucleoplasm; Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; cell adhesion; cytoskeletal protein binding; protein catabolic process; cell junction organization; organelle; anatomical structure development; cell motility; protein-containing complex assembly; molecular function regulator activity
OG_13875,FUN_001797-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2634.t1,apul_ptua,42.802,,,,,,,,,,,,,,,,,
OG_13876,FUN_001799-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23917.t1a,apul_ptua,59.35,FUN_001799-T1,P52430,PON1_MOUSE,,Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (Serum aryldialkylphosphatase 1),Mus musculus (Mouse),30.4,342.0,1.9e-41,171.4,sp|P52430|PON1_MOUSE Serum paraoxonase/arylesterase 1 OS=Mus musculus OX=10090 GN=Pon1 PE=1 SV=2,GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0008015; GO:0008035; GO:0008203; GO:0009636; GO:0010875; GO:0034366; GO:0042803; GO:0046395; GO:0046434; GO:0046470; GO:0102007; GO:1901335,blood circulation [GO:0008015]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lactone catabolic process [GO:1901335]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of cholesterol efflux [GO:0010875]; response to toxic substance [GO:0009636],spherical high-density lipoprotein particle [GO:0034366],acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; high-density lipoprotein particle binding [GO:0008035]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803],GO:0003013; GO:0003824; GO:0006629; GO:0008289; GO:0016787,circulatory system process; catalytic activity; lipid metabolic process; lipid binding; hydrolase activity
OG_13877,FUN_001809-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30110.t1,apul_ptua,47.296,FUN_001809-T1,B8V7P3,,,,,96.7,120.0,1.4e-64,248.1,sp|B8V7P3|CAH_ACRMI Putative carbonic anhydrase (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_13878,FUN_001819-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2846.t1,apul_ptua,35.606,,,,,,,,,,,,,,,,,
OG_13879,FUN_001823-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9138.t1,apul_ptua,63.736,,,,,,,,,,,,,,,,,
OG_13880,FUN_001826-T1,,Pocillopora_meandrina_HIv1___TS.g10367.t1,apul_ptua,47.043,FUN_001826-T1,O05485,,,,,25.8,360.0,1.6e-27,125.2,sp|O05485|EPRA1_AERHY Extracellular protease OS=Aeromonas hydrophila OX=644 GN=eprA1 PE=3 SV=1,,,,,,
OG_13881,FUN_001835-T1,,Pocillopora_meandrina_HIv1___TS.g10365.t1,apul_ptua,47.126,,,,,,,,,,,,,,,,,
OG_13882,FUN_001850-T1,,Pocillopora_meandrina_HIv1___TS.g5119.t2,apul_ptua,45.989,FUN_001850-T1,H9JIQ1,,,,,23.5,1004.0,7.5e-52,207.6,sp|H9JIQ1|MESH_BOMMO Protein mesh OS=Bombyx mori OX=7091 PE=1 SV=1,,,,,,
OG_13883,FUN_001851-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2605.t1,apul_ptua,52.5125,FUN_001851-T1,Q5VXM1,,,,,31.4,287.0,8.4e-26,119.8,sp|Q5VXM1|CDCP2_HUMAN CUB domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CDCP2 PE=2 SV=2,,,,,,
OG_13884,FUN_001890-T1,,Pocillopora_meandrina_HIv1___TS.g14196.t1,apul_ptua,48.396,,,,,,,,,,,,,,,,,
OG_13885,FUN_001902-T2,,Pocillopora_meandrina_HIv1___RNAseq.g2571.t1,apul_ptua,85.103,FUN_001902-T2,Q61139,,,,,54.5,640.0,4.3e-198,693.0,sp|Q61139|PCSK7_MOUSE Proprotein convertase subtilisin/kexin type 7 OS=Mus musculus OX=10090 GN=Pcsk7 PE=2 SV=2,,,,,,
OG_13886,FUN_001921-T2,,Pocillopora_meandrina_HIv1___RNAseq.g29240.t1,apul_ptua,56.8735,FUN_001921-T2,B8V7S0,,,,,47.4,251.0,2.7e-56,221.1,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_13887,FUN_001924-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24372.t1,apul_ptua,42.529,,,,,,,,,,,,,,,,,
OG_13888,FUN_001933-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3800.t1,apul_ptua,50.773,FUN_001933-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),26.9,428.0,1.7e-23,112.5,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_13889,FUN_001942-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2486.t1,apul_ptua,35.838,,,,,,,,,,,,,,,,,
OG_13890,FUN_001947-T2,,Pocillopora_meandrina_HIv1___RNAseq.g29221.t1,apul_ptua,54.065,FUN_001947-T2,P40818,UBP8_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8),Homo sapiens (Human),32.8,1322.0,3e-129,464.9,sp|P40818|UBP8_HUMAN Ubiquitin carboxyl-terminal hydrolase 8 OS=Homo sapiens OX=9606 GN=USP8 PE=1 SV=1,GO:0000281; GO:0002080; GO:0004197; GO:0004843; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006508; GO:0007032; GO:0007265; GO:0010008; GO:0014069; GO:0016579; GO:0017124; GO:0030496; GO:0031647; GO:0032880; GO:0045296; GO:0061578; GO:0070536; GO:0071108; GO:0071549; GO:0090263; GO:0098978; GO:0099576; GO:1905166; GO:1905908; GO:1990090; GO:1990380,"cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; negative regulation of lysosomal protein catabolic process [GO:1905166]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]",acrosomal membrane [GO:0002080]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],cadherin binding [GO:0045296]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; K48-linked deubiquitinase activity [GO:1990380]; K63-linked deubiquitinase activity [GO:0061578]; SH3 domain binding [GO:0017124],GO:0000910; GO:0003824; GO:0005634; GO:0005768; GO:0005829; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"cytokinesis; catalytic activity; nucleus; endosome; cytosol; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_13891,FUN_001971-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24960.t1,apul_ptua,30.7465,,,,,,,,,,,,,,,,,
OG_13892,FUN_001997-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30075.t1,apul_ptua,47.154,,,,,,,,,,,,,,,,,
OG_13893,FUN_002003-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14079.t1,apul_ptua,41.574,FUN_002003-T1,P54735,,,,,28.5,221.0,1.3e-11,72.4,sp|P54735|SPKD_SYNY3 Serine/threonine-protein kinase D OS=Synechocystis sp. (strain ATCC 27184 / PCC 6803 / Kazusa) OX=1111708 GN=spkD PE=1 SV=1,,,,,,
OG_13894,FUN_002012-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6740.t1,apul_ptua,50.336,,,,,,,,,,,,,,,,,
OG_13895,FUN_002013-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17712.t1,apul_ptua,51.961,,,,,,,,,,,,,,,,,
OG_13896,FUN_002057-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29649.t1,apul_ptua,40.361,,,,,,,,,,,,,,,,,
OG_13897,FUN_002090-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21912.t1,apul_ptua,59.2,,,,,,,,,,,,,,,,,
OG_13898,FUN_002103-T1,,Pocillopora_meandrina_HIv1___TS.g4247.t1,apul_ptua,59.747,FUN_002103-T1,P21803,,,,,44.3,472.0,6.5e-101,369.8,sp|P21803|FGFR2_MOUSE Fibroblast growth factor receptor 2 OS=Mus musculus OX=10090 GN=Fgfr2 PE=1 SV=4,,,,,,
OG_13899,FUN_002119-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9006.t1,apul_ptua,41.053,,,,,,,,,,,,,,,,,
OG_13900,FUN_002121-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17047.t1,apul_ptua,52.532,,,,,,,,,,,,,,,,,
OG_13901,FUN_002167-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25034.t1,apul_ptua,37.887,,,,,,,,,,,,,,,,,
OG_13902,FUN_002203-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9155.t1,apul_ptua,70.642,FUN_002203-T1,Q8BXN7,PPM1K_MOUSE,,Protein phosphatase Mn(2+)-dependent 1K (Branched-chain alpha-ketoacid dehydrogenase phosphatase) (BCKDH) (BDP) (EC 3.1.3.16) (Protein phosphatase 2C family member) (Protein phosphatase 2C isoform kappa) (PP2C-kappa) ([3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring)]-phosphatase) (EC 3.1.3.52),Mus musculus (Mouse),51.4,105.0,5.1e-21,102.8,sp|Q8BXN7|PPM1K_MOUSE Protein phosphatase Mn(2+)-dependent 1K OS=Mus musculus OX=10090 GN=Ppm1k PE=1 SV=1,GO:0004722; GO:0005739; GO:0005759; GO:0009083; GO:0030145; GO:0047385; GO:1902108,branched-chain amino acid catabolic process [GO:0009083]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],[3-methyl-2-oxobutanoate dehydrogenase (lipoamide)]-phosphatase activity [GO:0047385]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722],GO:0003824; GO:0005739; GO:0006520; GO:0007005; GO:0016787; GO:0043226; GO:0061024; GO:0140096,"catalytic activity; mitochondrion; amino acid metabolic process; mitochondrion organization; hydrolase activity; organelle; membrane organization; catalytic activity, acting on a protein"
OG_13903,FUN_002354-T2,,Pocillopora_meandrina_HIv1___RNAseq.g36.t1,apul_ptua,56.792,FUN_002354-T2,A4RKC3,DCL1_PYRO7,,Dicer-like protein 1 [Includes: Endoribonuclease DCL1 (EC 3.1.26.-); ATP-dependent helicase DCL1 (EC 3.6.4.-)],Pyricularia oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) (Rice blast fungus) (Magnaporthe oryzae),34.7,245.0,1.7e-23,113.2,sp|A4RKC3|DCL1_PYRO7 Dicer-like protein 1 OS=Pyricularia oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) OX=242507 GN=DCL1 PE=3 SV=2,GO:0003677; GO:0003723; GO:0004386; GO:0004525; GO:0005524; GO:0005634; GO:0005737; GO:0030422; GO:0046872; GO:0050688; GO:0051607,defense response to virus [GO:0051607]; regulation of defense response to virus [GO:0050688]; siRNA processing [GO:0030422],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_13904,FUN_002356-T2,,Pocillopora_meandrina_HIv1___RNAseq.g40.t1,apul_ptua,74.406,FUN_002356-T2,Q9BXW9,,,,,42.1,1400.0,3.8e-295,1016.1,sp|Q9BXW9|FACD2_HUMAN Fanconi anemia group D2 protein OS=Homo sapiens OX=9606 GN=FANCD2 PE=1 SV=2,,,,,,
OG_13905,FUN_002359-T1,,Pocillopora_meandrina_HIv1___RNAseq.g50.t1,apul_ptua,67.347,,,,,,,,,,,,,,,,,
OG_13906,FUN_002363-T1,,Pocillopora_meandrina_HIv1___RNAseq.g53.t1,apul_ptua,43.713,FUN_002363-T1,Q54R82,MKKA_DICDI,,Mitogen-activated protein kinase kinase kinase A (EC 2.7.11.25) (MAPK/ERK kinase 1) (MEK kinase 1) (MEKK 1) (MAPK/ERK kinase A) (MEK kinase A) (MEKK A) (MEKKalpha),Dictyostelium discoideum (Social amoeba),26.0,269.0,1.6e-17,92.0,sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum OX=44689 GN=mkkA PE=1 SV=2,GO:0004674; GO:0004709; GO:0005524; GO:0005737; GO:0005938; GO:0009653; GO:0016020; GO:0030435; GO:0030587; GO:0035556; GO:0046872; GO:0106310,anatomical structure morphogenesis [GO:0009653]; intracellular signal transduction [GO:0035556]; sorocarp development [GO:0030587]; sporulation resulting in formation of a cellular spore [GO:0030435],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_13907,FUN_002381-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14844.t1,apul_ptua,30.0,,,,,,,,,,,,,,,,,
OG_13908,FUN_002431-T1,,Pocillopora_meandrina_HIv1___TS.g3996.t1,apul_ptua,59.497,,,,,,,,,,,,,,,,,
OG_13909,FUN_002433-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14854.t1,apul_ptua,80.0,FUN_002433-T1,Q9JLZ3,AUHM_MOUSE,,"Methylglutaconyl-CoA hydratase, mitochondrial (3-MG-CoA hydratase) (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding enoyl-CoA hydratase) (muAUH) (Itaconyl-CoA hydratase) (EC 4.2.1.56)",Mus musculus (Mouse),56.4,289.0,1.2e-89,331.3,"sp|Q9JLZ3|AUHM_MOUSE Methylglutaconyl-CoA hydratase, mitochondrial OS=Mus musculus OX=10090 GN=Auh PE=1 SV=1",GO:0003723; GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0006552; GO:0050011,L-leucine catabolic process [GO:0006552],mitochondrion [GO:0005739],enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0006520; GO:0016829; GO:0043226,RNA binding; catalytic activity; mitochondrion; amino acid metabolic process; lyase activity; organelle
OG_13910,FUN_002435-T1,,Pocillopora_meandrina_HIv1___RNAseq.g778.t1,apul_ptua,98.138,FUN_002435-T1,P69004,,,,,97.9,376.0,7.0999999999999986e-217,754.2,sp|P69004|ACT2_MESFR Actin-15B OS=Mesocentrotus franciscanus OX=1328066 PE=2 SV=1,,,,,,
OG_13911,FUN_002457-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14893.t1,apul_ptua,69.512,FUN_002457-T1,Q3UHK1,,,,,51.1,538.0,9.7e-149,528.5,sp|Q3UHK1|MYCT_MOUSE Proton myo-inositol cotransporter OS=Mus musculus OX=10090 GN=Slc2a13 PE=1 SV=2,,,,,,
OG_13912,FUN_002465-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10985.t1,apul_ptua,48.2205,FUN_002465-T1,B2V017,,,,,36.4,228.0,3e-28,127.9,sp|B2V017|UNG_CLOBA Uracil-DNA glycosylase OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=ung PE=3 SV=1,,,,,,
OG_13913,FUN_002537-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9258.t1,apul_ptua,46.875,,,,,,,,,,,,,,,,,
OG_13914,FUN_002574-T2,,Pocillopora_meandrina_HIv1___RNAseq.g3715.t1,apul_ptua,68.548,FUN_002574-T2,Q8R151,ZNFX1_MOUSE,,NFX1-type zinc finger-containing protein 1,Mus musculus (Mouse),39.4,1977.0,8.9e-285,982.2,sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3,GO:0002218; GO:0003723; GO:0004386; GO:0005634; GO:0005741; GO:0008270; GO:0010494; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0016853; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; nucleus; isomerase activity; organelle; defense response to other organism; ATP-dependent activity
OG_13915,FUN_002602-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12482.t1,apul_ptua,35.429,,,,,,,,,,,,,,,,,
OG_13916,FUN_002648-T1,,Pocillopora_meandrina_HIv1___TS.g9155.t1,apul_ptua,63.677,FUN_002648-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),43.2,419.0,3.2e-84,315.1,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_13917,FUN_002664-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20665.t1,apul_ptua,55.449,FUN_002664-T1,P47747,,,,,25.2,309.0,6.2e-13,76.6,sp|P47747|HRH2_CAVPO Histamine H2 receptor OS=Cavia porcellus OX=10141 GN=HRH2 PE=3 SV=1,,,,,,
OG_13918,FUN_002668-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20690.t1,apul_ptua,57.335,FUN_002668-T1,Q01831,XPC_HUMAN,,DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125),Homo sapiens (Human),39.4,838.0,2.3e-114,415.2,sp|Q01831|XPC_HUMAN DNA repair protein complementing XP-C cells OS=Homo sapiens OX=9606 GN=XPC PE=1 SV=4,GO:0000109; GO:0000111; GO:0000404; GO:0000405; GO:0000720; GO:0000785; GO:0003684; GO:0003697; GO:0003713; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005829; GO:0005886; GO:0006281; GO:0006289; GO:0006298; GO:0009410; GO:0010224; GO:0010996; GO:0031573; GO:0043231; GO:0044877; GO:0045893; GO:0061629; GO:0070914; GO:0071942; GO:0090734; GO:0140612; GO:1901990,DNA repair [GO:0006281]; mismatch repair [GO:0006298]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; nucleotide-excision repair [GO:0006289]; positive regulation of DNA-templated transcription [GO:0045893]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to auditory stimulus [GO:0010996]; response to UV-B [GO:0010224]; response to xenobiotic stimulus [GO:0009410]; UV-damage excision repair [GO:0070914],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleotide-excision repair factor 2 complex [GO:0000111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of DNA damage [GO:0090734]; XPC complex [GO:0071942],bubble DNA binding [GO:0000405]; damaged DNA binding [GO:0003684]; DNA damage sensor activity [GO:0140612]; heteroduplex DNA loop binding [GO:0000404]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0005829; GO:0005886; GO:0006281; GO:0006355; GO:0043226; GO:0060090; GO:0098772; GO:0140110; GO:0140299,DNA binding; nucleus; nucleoplasm; nucleolus; mitochondrion; cytosol; plasma membrane; DNA repair; regulation of DNA-templated transcription; organelle; molecular adaptor activity; molecular function regulator activity; transcription regulator activity; molecular sensor activity
OG_13919,FUN_002688-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20730.t1,apul_ptua,52.381,,,,,,,,,,,,,,,,,
OG_13920,FUN_002737-T1,,Pocillopora_meandrina_HIv1___TS.g9339.t2,apul_ptua,74.941,FUN_002737-T1,Q5E9U9,NPRL2_BOVIN,,GATOR1 complex protein NPRL2 (Nitrogen permease regulator 2-like protein) (NPR2-like protein),Bos taurus (Bovine),52.1,403.0,3.5e-116,419.9,sp|Q5E9U9|NPRL2_BOVIN GATOR1 complex protein NPRL2 OS=Bos taurus OX=9913 GN=NPRL2 PE=2 SV=1,GO:0005096; GO:0005765; GO:0005774; GO:0010508; GO:0034198; GO:1904262; GO:1990130,cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508],GATOR1 complex [GO:1990130]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774],GTPase activator activity [GO:0005096],GO:0098772,molecular function regulator activity
OG_13921,FUN_002742-T1,,Pocillopora_meandrina_HIv1___TS.g7847.t1,apul_ptua,45.588,,,,,,,,,,,,,,,,,
OG_13922,FUN_002743-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20652.t1,apul_ptua,50.159,,,,,,,,,,,,,,,,,
OG_13923,FUN_002773-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14954.t1,apul_ptua,38.642,FUN_002773-T1,Q14112,NID2_HUMAN,,Nidogen-2 (NID-2) (Osteonidogen),Homo sapiens (Human),38.4,73.0,5.5e-08,60.5,sp|Q14112|NID2_HUMAN Nidogen-2 OS=Homo sapiens OX=9606 GN=NID2 PE=1 SV=3,GO:0005201; GO:0005509; GO:0005518; GO:0005576; GO:0005604; GO:0005615; GO:0005886; GO:0007155; GO:0007160; GO:0062023; GO:0070062; GO:0071711,basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160],basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0005576; GO:0005615; GO:0005886; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226,structural molecule activity; extracellular region; extracellular space; plasma membrane; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle
OG_13924,FUN_002846-T1,,Pocillopora_meandrina_HIv1___TS.g1416.t1,apul_ptua,68.182,,,,,,,,,,,,,,,,,
OG_13925,FUN_002909-T1,,Pocillopora_meandrina_HIv1___TS.g21518.t1,apul_ptua,73.929,,,,,,,,,,,,,,,,,
OG_13926,FUN_003214-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14081.t1,apul_ptua,34.898,,,,,,,,,,,,,,,,,
OG_13927,FUN_003387-T3,,Pocillopora_meandrina_HIv1___RNAseq.g20740.t1,apul_ptua,49.246,FUN_003387-T3,P48052,CBPA2_HUMAN,,Carboxypeptidase A2 (EC 3.4.17.15),Homo sapiens (Human),36.9,398.0,1e-73,278.9,sp|P48052|CBPA2_HUMAN Carboxypeptidase A2 OS=Homo sapiens OX=9606 GN=CPA2 PE=1 SV=3,GO:0004180; GO:0004181; GO:0005576; GO:0005615; GO:0005773; GO:0006508; GO:0007039; GO:0008270,protein catabolic process in the vacuole [GO:0007039]; proteolysis [GO:0006508],extracellular region [GO:0005576]; extracellular space [GO:0005615]; vacuole [GO:0005773],carboxypeptidase activity [GO:0004180]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; vacuole; hydrolase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_13928,FUN_003401-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19230.t1,apul_ptua,58.647,,,,,,,,,,,,,,,,,
OG_13929,FUN_003409-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9248.t1,apul_ptua,48.2895,,,,,,,,,,,,,,,,,
OG_13930,FUN_003423-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16337.t1,apul_ptua,89.116,,,,,,,,,,,,,,,,,
OG_13931,FUN_003444-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29564.t1,apul_ptua,48.6425,,,,,,,,,,,,,,,,,
OG_13932,FUN_003460-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15389.t1,apul_ptua,31.132,FUN_003460-T1,F1QU13,ALPK2_DANRE,,Alpha-protein kinase 2 (EC 2.7.11.1) (Heart alpha-protein kinase),Danio rerio (Zebrafish) (Brachydanio rerio),34.9,229.0,4.8e-19,97.1,sp|F1QU13|ALPK2_DANRE Alpha-protein kinase 2 OS=Danio rerio OX=7955 GN=alpk2 PE=2 SV=2,GO:0003007; GO:0004674; GO:0005524; GO:0016323; GO:0055013; GO:0060047; GO:0106310; GO:1905223,cardiac muscle cell development [GO:0055013]; epicardium morphogenesis [GO:1905223]; heart contraction [GO:0060047]; heart morphogenesis [GO:0003007],basolateral plasma membrane [GO:0016323],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003013; GO:0003824; GO:0016740; GO:0048856; GO:0140096,"circulatory system process; catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_13933,FUN_003482-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25875.t1,apul_ptua,35.965,,,,,,,,,,,,,,,,,
OG_13934,FUN_003513-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12921.t1,apul_ptua,58.3,,,,,,,,,,,,,,,,,
OG_13935,FUN_003548-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28798.t1a,apul_ptua,60.606,,,,,,,,,,,,,,,,,
OG_13936,FUN_003564-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3661.t1,apul_ptua,45.833,,,,,,,,,,,,,,,,,
OG_13937,FUN_003585-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17186.t1,apul_ptua,66.077,FUN_003585-T1,D3ZS74,OMA1_RAT,,"Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Overlapping with the m-AAA protease 1 homolog)",Rattus norvegicus (Rat),41.4,348.0,1.1e-66,255.4,"sp|D3ZS74|OMA1_RAT Metalloendopeptidase OMA1, mitochondrial OS=Rattus norvegicus OX=10116 GN=Oma1 PE=1 SV=1",GO:0002024; GO:0004222; GO:0005739; GO:0005743; GO:0005758; GO:0006006; GO:0006515; GO:0006629; GO:0007005; GO:0008289; GO:0010637; GO:0016540; GO:0031638; GO:0031966; GO:0033108; GO:0033554; GO:0034982; GO:0042407; GO:0043065; GO:0046872; GO:0097009; GO:0120162; GO:0140467; GO:0140468; GO:1903850,cellular response to stress [GO:0033554]; cristae formation [GO:0042407]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose metabolic process [GO:0006006]; HRI-mediated signaling [GO:0140468]; integrated stress response signaling [GO:0140467]; lipid metabolic process [GO:0006629]; mitochondrial protein processing [GO:0034982]; mitochondrial respiratory chain complex assembly [GO:0033108]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial fusion [GO:0010637]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein autoprocessing [GO:0016540]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cristae formation [GO:1903850]; zymogen activation [GO:0031638],mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739],lipid binding [GO:0008289]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005739; GO:0005975; GO:0006629; GO:0007005; GO:0008289; GO:0016787; GO:0043226; GO:0051604; GO:0061024; GO:0065003; GO:0140096,"catalytic activity; mitochondrion; carbohydrate metabolic process; lipid metabolic process; mitochondrion organization; lipid binding; hydrolase activity; organelle; protein maturation; membrane organization; protein-containing complex assembly; catalytic activity, acting on a protein"
OG_13938,FUN_003657-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25623.t1,apul_ptua,55.0385,,,,,,,,,,,,,,,,,
OG_13939,FUN_003679-T1,,Pocillopora_meandrina_HIv1___RNAseq.g619.t1,apul_ptua,59.722,,,,,,,,,,,,,,,,,
OG_13940,FUN_003712-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17372.t1,apul_ptua,64.706,,,,,,,,,,,,,,,,,
OG_13941,FUN_003780-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28133.t1,apul_ptua,46.4,,,,,,,,,,,,,,,,,
OG_13942,FUN_003822-T1,,Pocillopora_meandrina_HIv1___TS.g18385.t1,apul_ptua,53.608,,,,,,,,,,,,,,,,,
OG_13943,FUN_003846-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11166.t3,apul_ptua,49.3895,FUN_003846-T1,Q96MU7,YTDC1_HUMAN,,YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B),Homo sapiens (Human),60.8,171.0,3.2999999999999996e-53,211.5,sp|Q96MU7|YTDC1_HUMAN YTH domain-containing protein 1 OS=Homo sapiens OX=9606 GN=YTHDC1 PE=1 SV=3,GO:0000381; GO:0000398; GO:0001701; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005886; GO:0006376; GO:0006406; GO:0007283; GO:0009048; GO:0010608; GO:0016607; GO:0048024; GO:0048160; GO:0110104; GO:1990247,"dosage compensation by inactivation of X chromosome [GO:0009048]; in utero embryonic development [GO:0001701]; mRNA alternative polyadenylation [GO:0110104]; mRNA export from nucleus [GO:0006406]; mRNA splice site recognition [GO:0006376]; mRNA splicing, via spliceosome [GO:0000398]; post-transcriptional regulation of gene expression [GO:0010608]; primary follicle stage [GO:0048160]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of mRNA splicing, via spliceosome [GO:0048024]; spermatogenesis [GO:0007283]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA reader activity [GO:1990247]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0005886; GO:0006325; GO:0006913; GO:0016071; GO:0022414; GO:0043226; GO:0048856; GO:0060090; GO:0065003,RNA binding; nucleus; nucleoplasm; plasma membrane; chromatin organization; nucleocytoplasmic transport; mRNA metabolic process; reproductive process; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_13944,FUN_003888-T1,,Pocillopora_meandrina_HIv1___TS.g24629.t1,apul_ptua,36.709,,,,,,,,,,,,,,,,,
OG_13945,FUN_003896-T1,,Pocillopora_meandrina_HIv1___TS.g8775.t2,apul_ptua,54.7705,FUN_003896-T1,Q3MSQ8,DDX4_PELLE,,Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog),Pelophylax lessonae (Pool frog) (Rana lessonae),54.3,477.0,2.3e-139,498.0,sp|Q3MSQ8|DDX4_PELLE Probable ATP-dependent RNA helicase DDX4 OS=Pelophylax lessonae OX=45623 GN=ddx4 PE=2 SV=1,GO:0003676; GO:0003724; GO:0005524; GO:0007140; GO:0007141; GO:0007283; GO:0016887; GO:0034587; GO:0048477; GO:0071546; GO:0071547; GO:0141006; GO:0141196,male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; oogenesis [GO:0048477]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],pi-body [GO:0071546]; piP-body [GO:0071547],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; nucleic acid binding [GO:0003676]; RNA helicase activity [GO:0003724],GO:0003824; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140013; GO:0140098; GO:0140657,"catalytic activity; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_13946,FUN_003925-T1,,Pocillopora_meandrina_HIv1___TS.g7819.t1,apul_ptua,52.093,FUN_003925-T1,F1NWE3,,,,,30.2,1127.0,6.2e-122,440.7,sp|F1NWE3|PTPRS_CHICK Receptor-type tyrosine-protein phosphatase S OS=Gallus gallus OX=9031 GN=PTPRS PE=1 SV=3,,,,,,
OG_13947,FUN_003928-T1,,Pocillopora_meandrina_HIv1___TS.g7826.t1,apul_ptua,52.244,FUN_003928-T1,Q08345,DDR1_HUMAN,,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),Homo sapiens (Human),32.4,148.0,7.8e-10,67.8,sp|Q08345|DDR1_HUMAN Epithelial discoidin domain-containing receptor 1 OS=Homo sapiens OX=9606 GN=DDR1 PE=1 SV=1,GO:0001558; GO:0001952; GO:0004714; GO:0005518; GO:0005524; GO:0005615; GO:0005886; GO:0007155; GO:0007169; GO:0007566; GO:0007595; GO:0008283; GO:0008285; GO:0010715; GO:0010976; GO:0014909; GO:0038062; GO:0038063; GO:0038083; GO:0043235; GO:0043583; GO:0044319; GO:0046777; GO:0046872; GO:0051897; GO:0060444; GO:0060749; GO:0061302; GO:0061564; GO:0070062; GO:1990138,"axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell migration [GO:0014909]; smooth muscle cell-matrix adhesion [GO:0061302]; wound healing, spreading of cells [GO:0044319]",extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005615; GO:0005886; GO:0007155; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; extracellular space; plasma membrane; cell adhesion; transferase activity; reproductive process; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_13948,FUN_003977-T1,,Pocillopora_meandrina_HIv1___TS.g7874.t2,apul_ptua,61.2945,FUN_003977-T1,Q96LX7,CCD17_HUMAN,,Coiled-coil domain-containing protein 17,Homo sapiens (Human),31.1,383.0,6.200000000000001e-28,128.3,sp|Q96LX7|CCD17_HUMAN Coiled-coil domain-containing protein 17 OS=Homo sapiens OX=9606 GN=CCDC17 PE=1 SV=2,,,,,,
OG_13949,FUN_003997-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12628.t1,apul_ptua,72.204,FUN_003997-T1,Q17094,,,,,26.6,290.0,1.6e-19,98.6,sp|Q17094|OPSD_ALLSU Rhodopsin (Fragment) OS=Alloteuthis subulata OX=54069 GN=RHO PE=3 SV=1,,,,,,
OG_13950,FUN_004018-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4130.t1,apul_ptua,83.673,,,,,,,,,,,,,,,,,
OG_13951,FUN_004020-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17890.t1,apul_ptua,33.867999999999995,FUN_004020-T1,Q9W332,,,,,26.5,162.0,2.6e-11,73.2,sp|Q9W332|CUBN_DROME Cubilin homolog OS=Drosophila melanogaster OX=7227 GN=Cubn PE=2 SV=3,,,,,,
OG_13952,FUN_004057-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17244.t1b,apul_ptua,79.739,FUN_004057-T1,Q69DB9,,,,,69.9,153.0,1.1000000000000004e-59,230.7,sp|Q69DB9|AS1AA_XENLA Histone chaperone asf1a-A OS=Xenopus laevis OX=8355 GN=asf1aa PE=1 SV=1,,,,,,
OG_13953,FUN_004075-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5038.t1,apul_ptua,37.054,FUN_004075-T1,Q5F4A1,,,,,24.4,312.0,7.1e-17,90.1,sp|Q5F4A1|G2E3_CHICK G2/M phase-specific E3 ubiquitin-protein ligase OS=Gallus gallus OX=9031 GN=G2E3 PE=2 SV=1,,,,,,
OG_13954,FUN_004080-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12624.t1,apul_ptua,41.819500000000005,,,,,,,,,,,,,,,,,
OG_13955,FUN_004081-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12625.t1,apul_ptua,39.82599999999999,,,,,,,,,,,,,,,,,
OG_13956,FUN_004085-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12610.t1,apul_ptua,48.931,FUN_004085-T1,Q9HAR2,AGRL3_HUMAN,,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),Homo sapiens (Human),32.5,680.0,4.3e-82,308.1,sp|Q9HAR2|AGRL3_HUMAN Adhesion G protein-coupled receptor L3 OS=Homo sapiens OX=9606 GN=ADGRL3 PE=1 SV=2,GO:0001764; GO:0004930; GO:0005509; GO:0005886; GO:0005911; GO:0007166; GO:0007186; GO:0007189; GO:0007416; GO:0016020; GO:0030246; GO:0030424; GO:0098631; GO:0098742; GO:0098978; GO:0140693; GO:0160221; GO:1904861,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; excitatory synapse assembly [GO:1904861]; G protein-coupled receptor signaling pathway [GO:0007186]; neuron migration [GO:0001764]; Rho-activating G protein-coupled receptor signaling pathway [GO:0160221]; synapse assembly [GO:0007416],axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; cell adhesion mediator activity [GO:0098631]; G protein-coupled receptor activity [GO:0004930]; molecular condensate scaffold activity [GO:0140693],GO:0005886; GO:0007155; GO:0034330; GO:0048870; GO:0060089; GO:0060090; GO:0098631,plasma membrane; cell adhesion; cell junction organization; cell motility; molecular transducer activity; molecular adaptor activity; cell adhesion mediator activity
OG_13957,FUN_004122-T2,,Pocillopora_meandrina_HIv1___RNAseq.g11570.t2,apul_ptua,92.822,FUN_004122-T2,Q9D180,CFA57_MOUSE,,Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65),Mus musculus (Mouse),63.1,1238.0,5.1000000000000005e-272,939.1,sp|Q9D180|CFA57_MOUSE Cilia- and flagella-associated protein 57 OS=Mus musculus OX=10090 GN=Cfap57 PE=1 SV=3,GO:0005737; GO:0005856; GO:0007338; GO:0036126; GO:0044782; GO:0070286; GO:0120316,axonemal dynein complex assembly [GO:0070286]; cilium organization [GO:0044782]; single fertilization [GO:0007338]; sperm flagellum assembly [GO:0120316],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126],,GO:0005856; GO:0005929; GO:0022414; GO:0043226; GO:0044782; GO:0065003,cytoskeleton; cilium; reproductive process; organelle; cilium organization; protein-containing complex assembly
OG_13958,FUN_004161-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16769.t1,apul_ptua,76.712,FUN_004161-T1,Q9Z2X8,KEAP1_MOUSE,,Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2),Mus musculus (Mouse),40.2,179.0,4.7e-32,140.2,sp|Q9Z2X8|KEAP1_MOUSE Kelch-like ECH-associated protein 1 OS=Mus musculus OX=10090 GN=Keap1 PE=1 SV=1,GO:0000122; GO:0001701; GO:0005654; GO:0005737; GO:0005783; GO:0005829; GO:0005884; GO:0006355; GO:0006511; GO:0010506; GO:0016234; GO:0016567; GO:0030496; GO:0031463; GO:0032991; GO:0034451; GO:0034599; GO:0042802; GO:0043161; GO:0045604; GO:0061629; GO:0071353; GO:0097718; GO:0140416; GO:1902883; GO:1990756,cellular response to interleukin-4 [GO:0071353]; cellular response to oxidative stress [GO:0034599]; in utero embryonic development [GO:0001701]; negative regulation of response to oxidative stress [GO:1902883]; negative regulation of transcription by RNA polymerase II [GO:0000122]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of autophagy [GO:0010506]; regulation of DNA-templated transcription [GO:0006355]; regulation of epidermal cell differentiation [GO:0045604]; ubiquitin-dependent protein catabolic process [GO:0006511],actin filament [GO:0005884]; centriolar satellite [GO:0034451]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; inclusion body [GO:0016234]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator inhibitor activity [GO:0140416]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005654; GO:0005783; GO:0005829; GO:0006355; GO:0030163; GO:0043226; GO:0048856; GO:0060090; GO:0098772,nucleoplasm; endoplasmic reticulum; cytosol; regulation of DNA-templated transcription; protein catabolic process; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_13959,FUN_004173-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16729.t1,apul_ptua,52.431,,,,,,,,,,,,,,,,,
OG_13960,FUN_004175-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11173.t1,apul_ptua,59.664,,,,,,,,,,,,,,,,,
OG_13961,FUN_004241-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11531.t1,apul_ptua,64.983,,,,,,,,,,,,,,,,,
OG_13962,FUN_004256-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11415.t1,apul_ptua,45.679,,,,,,,,,,,,,,,,,
OG_13963,FUN_004262-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11365.t1,apul_ptua,38.7995,,,,,,,,,,,,,,,,,
OG_13964,FUN_004294-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11772.t1,apul_ptua,49.7255,,,,,,,,,,,,,,,,,
OG_13965,FUN_004319-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16990.t1,apul_ptua,48.6435,,,,,,,,,,,,,,,,,
OG_13966,FUN_004334-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12534.t1,apul_ptua,64.935,,,,,,,,,,,,,,,,,
OG_13967,FUN_004355-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12498.t1,apul_ptua,83.333,FUN_004355-T1,Q5RKS2,,,,,68.0,75.0,1.7e-19,96.3,sp|Q5RKS2|SMIM7_MOUSE Small integral membrane protein 7 OS=Mus musculus OX=10090 GN=Smim7 PE=3 SV=1,,,,,,
OG_13968,FUN_004429-T1,,Pocillopora_meandrina_HIv1___TS.g7495.t1,apul_ptua,63.725,FUN_004429-T1,Q41420,,,,,34.0,106.0,3.4e-11,69.3,sp|Q41420|CALM3_SOLTU Putative calmodulin-3 (Fragment) OS=Solanum tuberosum OX=4113 GN=PCM3 PE=5 SV=1,,,,,,
OG_13969,FUN_004450-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11279.t1,apul_ptua,39.689,,,,,,,,,,,,,,,,,
OG_13970,FUN_004488-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11625.t1,apul_ptua,61.702,FUN_004488-T1,Q9NXG6,,,,,36.8,239.0,2.6e-39,164.5,sp|Q9NXG6|P4HTM_HUMAN Transmembrane prolyl 4-hydroxylase OS=Homo sapiens OX=9606 GN=P4HTM PE=1 SV=2,,,,,,
OG_13971,FUN_004505-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12524.t1,apul_ptua,92.0,FUN_004505-T1,O88696,CLPP_MOUSE,,"ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Caseinolytic mitochondrial matrix peptidase proteolytic subunit) (Endopeptidase Clp)",Mus musculus (Mouse),76.0,125.0,4.3e-53,208.8,"sp|O88696|CLPP_MOUSE ATP-dependent Clp protease proteolytic subunit, mitochondrial OS=Mus musculus OX=10090 GN=Clpp PE=1 SV=1",GO:0004176; GO:0004252; GO:0005739; GO:0005759; GO:0006515; GO:0009368; GO:0033619; GO:0051603,membrane protein proteolysis [GO:0033619]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in protein catabolic process [GO:0051603],endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0140096; GO:0140657,"catalytic activity; mitochondrion; hydrolase activity; organelle; catalytic activity, acting on a protein; ATP-dependent activity"
OG_13972,FUN_004520-T1,,Pocillopora_meandrina_HIv1___TS.g7422.t1a,apul_ptua,57.6925,FUN_004520-T1,Q6AY85,,,,,56.4,110.0,7.000000000000001e-28,124.8,sp|Q6AY85|ALG14_RAT UDP-N-acetylglucosamine transferase subunit ALG14 OS=Rattus norvegicus OX=10116 GN=Alg14 PE=2 SV=1,,,,,,
OG_13973,FUN_004556-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8231.t1,apul_ptua,88.921,FUN_004556-T1,P50613,CDK7_HUMAN,,Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit),Homo sapiens (Human),70.4,345.0,1.3e-139,497.7,sp|P50613|CDK7_HUMAN Cyclin-dependent kinase 7 OS=Homo sapiens OX=9606 GN=CDK7 PE=1 SV=1,GO:0000307; GO:0000439; GO:0001650; GO:0001673; GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005654; GO:0005675; GO:0005737; GO:0005829; GO:0005886; GO:0006281; GO:0006366; GO:0006367; GO:0008094; GO:0008353; GO:0042795; GO:0045944; GO:0048471; GO:0050821; GO:0051301; GO:0051726; GO:0070516; GO:0070985; GO:0106310; GO:0140836; GO:2000045,cell division [GO:0051301]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; male germ cell nucleus [GO:0001673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985],"ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; RNA polymerase II CTD heptapeptide repeat S5 kinase activity [GO:0140836]",GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0006281; GO:0006351; GO:0006355; GO:0016073; GO:0016740; GO:0043226; GO:0140096; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; cytosol; plasma membrane; DNA repair; DNA-templated transcription; regulation of DNA-templated transcription; snRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein; catalytic activity, acting on DNA; ATP-dependent activity"
OG_13974,FUN_004571-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6646.t1b,apul_ptua,44.643,,,,,,,,,,,,,,,,,
OG_13975,FUN_004609-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8686.t1,apul_ptua,63.9765,,,,,,,,,,,,,,,,,
OG_13976,FUN_004648-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8092.t1,apul_ptua,90.222,FUN_004648-T1,Q06725,N2F1A_DANRE,,Nuclear receptor subfamily 2 group F member 1-A (COUP transcription factor 1-A) (COUP-TFalpha-A) (zCOUP-TFI) (Seven-up related 44) (Svp[44]) (zSvp[44]) (Steroid receptor homolog SVP 44),Danio rerio (Zebrafish) (Brachydanio rerio),41.1,207.0,2.5e-39,163.7,sp|Q06725|N2F1A_DANRE Nuclear receptor subfamily 2 group F member 1-A OS=Danio rerio OX=7955 GN=nr2f1a PE=2 SV=1,GO:0000122; GO:0000978; GO:0001935; GO:0001944; GO:0003209; GO:0004879; GO:0005634; GO:0007399; GO:0008270; GO:0030154; GO:0035284; GO:0048738; GO:0055011,atrial cardiac muscle cell differentiation [GO:0055011]; brain segmentation [GO:0035284]; cardiac atrium morphogenesis [GO:0003209]; cardiac muscle tissue development [GO:0048738]; cell differentiation [GO:0030154]; endothelial cell proliferation [GO:0001935]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; vasculature development [GO:0001944],nucleus [GO:0005634],nuclear receptor activity [GO:0004879]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular transducer activity; transcription regulator activity
OG_13977,FUN_004662-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8744.t1,apul_ptua,50.968,,,,,,,,,,,,,,,,,
OG_13978,FUN_004692-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8751.t1,apul_ptua,46.006,,,,,,,,,,,,,,,,,
OG_13979,FUN_004709-T2,,Pocillopora_meandrina_HIv1___RNAseq.g8793.t1,apul_ptua,81.502,FUN_004709-T2,Q8IY17,,,,,48.3,1245.0,0.0,1076.6,sp|Q8IY17|PLPL6_HUMAN Patatin-like phospholipase domain-containing protein 6 OS=Homo sapiens OX=9606 GN=PNPLA6 PE=1 SV=3,,,,,,
OG_13980,FUN_004730-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9230.t1,apul_ptua,33.333,,,,,,,,,,,,,,,,,
OG_13981,FUN_004756-T1,,Pocillopora_meandrina_HIv1___TS.g439.t2,apul_ptua,71.549,FUN_004756-T1,A5D6U8,ACP7_DANRE,,Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form),Danio rerio (Zebrafish) (Brachydanio rerio),37.7,419.0,5.8e-69,263.1,sp|A5D6U8|ACP7_DANRE Acid phosphatase type 7 OS=Danio rerio OX=7955 GN=acp7 PE=2 SV=1,GO:0003993; GO:0005576; GO:0046872,,extracellular region [GO:0005576],acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0016787,catalytic activity; extracellular region; hydrolase activity
OG_13982,FUN_004794-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8533.t1,apul_ptua,60.15,FUN_004794-T1,Q505I4,,,,,46.7,107.0,1.1e-16,88.2,sp|Q505I4|CO040_RAT UPF0235 protein C15orf40 homolog OS=Rattus norvegicus OX=10116 PE=2 SV=1,,,,,,
OG_13983,FUN_004827-T1,,Pocillopora_meandrina_HIv1___TS.g20314.t1b,apul_ptua,58.635,FUN_004827-T1,Q9BV99,,,,,50.2,239.0,3.5e-18,93.6,sp|Q9BV99|LRC61_HUMAN Leucine-rich repeat-containing protein 61 OS=Homo sapiens OX=9606 GN=LRRC61 PE=1 SV=1,,,,,,
OG_13984,FUN_004837-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8612.t1a,apul_ptua,64.348,FUN_004837-T1,Q9ER88,,,,,34.4,346.0,1.4e-54,214.9,sp|Q9ER88|RT29_MOUSE Small ribosomal subunit protein mS29 OS=Mus musculus OX=10090 GN=Dap3 PE=1 SV=1,,,,,,
OG_13985,FUN_004840-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8616.t1,apul_ptua,72.269,FUN_004840-T1,Q9I8C7,,,,,43.1,348.0,1.4e-79,298.5,sp|Q9I8C7|ACH10_CHICK Neuronal acetylcholine receptor subunit alpha-10 OS=Gallus gallus OX=9031 GN=CHRNA10 PE=3 SV=1,,,,,,
OG_13986,FUN_004842-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8618.t1,apul_ptua,73.378,FUN_004842-T1,Q8R4G9,ACHA3_MOUSE,,Neuronal acetylcholine receptor subunit alpha-3,Mus musculus (Mouse),33.5,462.0,1.2e-72,275.4,sp|Q8R4G9|ACHA3_MOUSE Neuronal acetylcholine receptor subunit alpha-3 OS=Mus musculus OX=10090 GN=Chrna3 PE=1 SV=1,GO:0004888; GO:0005783; GO:0005794; GO:0005892; GO:0006937; GO:0006940; GO:0007271; GO:0007626; GO:0014056; GO:0022848; GO:0035095; GO:0042391; GO:0045211; GO:0048814; GO:0060079; GO:0060084; GO:0098981; GO:0099634; GO:1904315,"behavioral response to nicotine [GO:0035095]; excitatory postsynaptic potential [GO:0060079]; locomotory behavior [GO:0007626]; regulation of acetylcholine secretion, neurotransmission [GO:0014056]; regulation of dendrite morphogenesis [GO:0048814]; regulation of membrane potential [GO:0042391]; regulation of muscle contraction [GO:0006937]; regulation of smooth muscle contraction [GO:0006940]; synaptic transmission involved in micturition [GO:0060084]; synaptic transmission, cholinergic [GO:0007271]",acetylcholine-gated channel complex [GO:0005892]; cholinergic synapse [GO:0098981]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; postsynaptic membrane [GO:0045211]; postsynaptic specialization membrane [GO:0099634],acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005783; GO:0005794; GO:0023052; GO:0043226; GO:0060089,transporter activity; endoplasmic reticulum; Golgi apparatus; signaling; organelle; molecular transducer activity
OG_13987,FUN_004901-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8676.t1,apul_ptua,66.667,FUN_004901-T1,P03967,RASD_DICDI,,Ras-like protein rasD (EC 3.6.5.2) (Transforming protein p23 homolog),Dictyostelium discoideum (Social amoeba),41.9,167.0,9.2e-34,145.2,sp|P03967|RASD_DICDI Ras-like protein rasD OS=Dictyostelium discoideum OX=44689 GN=rasD PE=1 SV=2,GO:0000281; GO:0003924; GO:0003925; GO:0004860; GO:0005525; GO:0005811; GO:0005829; GO:0005886; GO:0006935; GO:0009617; GO:0019003; GO:0019887; GO:0031005; GO:0042331; GO:0043052; GO:0043422; GO:0046956; GO:0051019; GO:0070371; GO:0070685; GO:0140582; GO:1905301,adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway [GO:0140582]; chemotaxis [GO:0006935]; ERK1 and ERK2 cascade [GO:0070371]; mitotic cytokinesis [GO:0000281]; phototaxis [GO:0042331]; positive phototaxis [GO:0046956]; regulation of macropinocytosis [GO:1905301]; response to bacterium [GO:0009617]; thermotaxis [GO:0043052],cytosol [GO:0005829]; lipid droplet [GO:0005811]; macropinocytic cup [GO:0070685]; plasma membrane [GO:0005886],filamin binding [GO:0031005]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase B binding [GO:0043422]; protein kinase inhibitor activity [GO:0004860]; protein kinase regulator activity [GO:0019887],GO:0000910; GO:0003824; GO:0003924; GO:0005811; GO:0005829; GO:0005886; GO:0008092; GO:0016787; GO:0043226; GO:0098772,cytokinesis; catalytic activity; GTPase activity; lipid droplet; cytosol; plasma membrane; cytoskeletal protein binding; hydrolase activity; organelle; molecular function regulator activity
OG_13988,FUN_004928-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8367.t1,apul_ptua,90.23,FUN_004928-T1,Q6SZ65,,,,,35.3,204.0,1e-19,98.2,sp|Q6SZ65|OTP_LYTVA Homeobox protein orthopedia OS=Lytechinus variegatus OX=7654 GN=Otp PE=2 SV=1,,,,,,
OG_13989,FUN_004931-T1,,Pocillopora_meandrina_HIv1___TS.g20110.t1,apul_ptua,66.925,,,,,,,,,,,,,,,,,
OG_13990,FUN_004937-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8381.t1,apul_ptua,68.935,,,,,,,,,,,,,,,,,
OG_13991,FUN_004955-T1,,Pocillopora_meandrina_HIv1___TS.g20135.t1,apul_ptua,46.433,FUN_004955-T1,Q5XXP2,OPN4_PHOSU,,Melanopsin (Opsin-4),Phodopus sungorus (Striped hairy-footed hamster) (Djungarian hamster),27.0,256.0,4.1e-06,54.3,sp|Q5XXP2|OPN4_PHOSU Melanopsin OS=Phodopus sungorus OX=10044 GN=OPN4 PE=2 SV=1,GO:0005502; GO:0005886; GO:0007601; GO:0007602; GO:0007634; GO:0008020; GO:0016020; GO:0030424; GO:0030425; GO:0042752; GO:0043204; GO:0048511; GO:1990384,hyaloid vascular plexus regression [GO:1990384]; optokinetic behavior [GO:0007634]; phototransduction [GO:0007602]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; visual perception [GO:0007601],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],11-cis retinal binding [GO:0005502]; G protein-coupled photoreceptor activity [GO:0008020],GO:0005886; GO:0008289; GO:0050877; GO:0060089,plasma membrane; lipid binding; nervous system process; molecular transducer activity
OG_13992,FUN_004962-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8904.t1b,apul_ptua,88.194,,,,,,,,,,,,,,,,,
OG_13993,FUN_004982-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8403.t1,apul_ptua,65.778,,,,,,,,,,,,,,,,,
OG_13994,FUN_005004-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25281.t2,apul_ptua,59.728,FUN_005004-T1,Q9P2E3,ZNFX1_HUMAN,,NFX1-type zinc finger-containing protein 1,Homo sapiens (Human),29.4,669.0,2.2e-69,265.0,sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2,GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0006325; GO:0016853; GO:0031047; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; chromatin organization; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; defense response to other organism; ATP-dependent activity
OG_13995,FUN_005026-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8325.t1,apul_ptua,54.6165,FUN_005026-T1,O43581,SYT7_HUMAN,,Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII),Homo sapiens (Human),27.7,285.0,1.6e-21,105.5,sp|O43581|SYT7_HUMAN Synaptotagmin-7 OS=Homo sapiens OX=9606 GN=SYT7 PE=1 SV=3,GO:0000149; GO:0001778; GO:0005509; GO:0005516; GO:0005544; GO:0005546; GO:0005764; GO:0005765; GO:0005777; GO:0005778; GO:0005829; GO:0005886; GO:0006906; GO:0006909; GO:0008021; GO:0016192; GO:0017158; GO:0019905; GO:0030276; GO:0030424; GO:0030670; GO:0030672; GO:0031045; GO:0032009; GO:0036465; GO:0042734; GO:0045202; GO:0045956; GO:0046850; GO:0048791; GO:0050764; GO:0050796; GO:0061891; GO:0070062; GO:0070092; GO:0090119; GO:0090385; GO:0098686; GO:0099502; GO:1900242; GO:1990926; GO:1990927,calcium ion regulated lysosome exocytosis [GO:1990927]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; calcium-dependent activation of synaptic vesicle fusion [GO:0099502]; phagocytosis [GO:0006909]; phagosome-lysosome fusion [GO:0090385]; plasma membrane repair [GO:0001778]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of bone remodeling [GO:0046850]; regulation of calcium ion-dependent exocytosis [GO:0017158]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of phagocytosis [GO:0050764]; regulation of synaptic vesicle endocytosis [GO:1900242]; short-term synaptic potentiation [GO:1990926]; synaptic vesicle recycling [GO:0036465]; vesicle fusion [GO:0006906]; vesicle-mediated cholesterol transport [GO:0090119]; vesicle-mediated transport [GO:0016192],axon [GO:0030424]; cytosol [GO:0005829]; dense core granule [GO:0031045]; early phagosome [GO:0032009]; extracellular exosome [GO:0070062]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672],"calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; calmodulin binding [GO:0005516]; clathrin binding [GO:0030276]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]",GO:0005764; GO:0005773; GO:0005777; GO:0005829; GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0098772; GO:0140299,lysosome; vacuole; peroxisome; cytosol; plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; molecular function regulator activity; molecular sensor activity
OG_13996,FUN_005027-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8324.t1,apul_ptua,70.261,,,,,,,,,,,,,,,,,
OG_13997,FUN_005039-T1,,Pocillopora_meandrina_HIv1___TS.g9824.t1,apul_ptua,65.714,,,,,,,,,,,,,,,,,
OG_13998,FUN_005043-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25109.t1b,apul_ptua,46.512,,,,,,,,,,,,,,,,,
OG_13999,FUN_005060-T1,,Pocillopora_meandrina_HIv1___TS.g20043.t1,apul_ptua,63.5385,FUN_005060-T1,Q3UKU1,,,,,29.9,633.0,1.4e-39,165.6,sp|Q3UKU1|ELL2_MOUSE RNA polymerase II elongation factor ELL2 OS=Mus musculus OX=10090 GN=Ell2 PE=1 SV=2,,,,,,
OG_14000,FUN_005068-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21087.t1b,apul_ptua,73.81,,,,,,,,,,,,,,,,,
OG_14001,FUN_005094-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16137.t1,apul_ptua,89.241,,,,,,,,,,,,,,,,,
OG_14002,FUN_005100-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8277.t1,apul_ptua,43.624,,,,,,,,,,,,,,,,,
OG_14003,FUN_005104-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8275.t1,apul_ptua,60.760000000000005,FUN_005104-T1,P55059,,,,,38.1,105.0,7.2e-17,90.5,sp|P55059|PDI_HUMIN Protein disulfide-isomerase OS=Humicola insolens OX=85995 PE=1 SV=1,,,,,,
OG_14004,FUN_005150-T1,,Pocillopora_meandrina_HIv1___TS.g19998.t1b,apul_ptua,42.082,,,,,,,,,,,,,,,,,
OG_14005,FUN_005174-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7577.t1a,apul_ptua,79.857,FUN_005174-T1,A7SUU7,SCC4_NEMVE,,MAU2 chromatid cohesion factor homolog (Cohesin loading complex subunit SCC4 homolog),Nematostella vectensis (Starlet sea anemone),56.5,565.0,3.3e-173,609.8,sp|A7SUU7|SCC4_NEMVE MAU2 chromatid cohesion factor homolog OS=Nematostella vectensis OX=45351 GN=v1g174619 PE=3 SV=1,GO:0000785; GO:0005634; GO:0005654; GO:0007059; GO:0032116; GO:0034088; GO:0051301,cell division [GO:0051301]; chromosome segregation [GO:0007059]; maintenance of mitotic sister chromatid cohesion [GO:0034088],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMC loading complex [GO:0032116],,GO:0005634; GO:0005654; GO:0007059; GO:0043226,nucleus; nucleoplasm; chromosome segregation; organelle
OG_14006,FUN_005199-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8136.t2,apul_ptua,56.657,FUN_005199-T1,Q1LWH4,FAN1_DANRE,,Fanconi-associated nuclease 1 (EC 3.1.21.-) (EC 3.1.4.1) (FANCD2/FANCI-associated nuclease 1) (Myotubularin-related protein 15),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,983.0,2.3000000000000003e-158,561.2,sp|Q1LWH4|FAN1_DANRE Fanconi-associated nuclease 1 OS=Danio rerio OX=7955 GN=fan1 PE=2 SV=2,GO:0000724; GO:0004528; GO:0005634; GO:0006281; GO:0006289; GO:0008270; GO:0008409; GO:0017108; GO:0036297; GO:0070336; GO:0140036,DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; nucleotide-excision repair [GO:0006289],nucleus [GO:0005634],5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; flap-structured DNA binding [GO:0070336]; phosphodiesterase I activity [GO:0004528]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0006310; GO:0016787; GO:0043226; GO:0060090; GO:0140097,"DNA binding; catalytic activity; nucleus; DNA repair; DNA recombination; hydrolase activity; organelle; molecular adaptor activity; catalytic activity, acting on DNA"
OG_14007,FUN_005204-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8132.t1,apul_ptua,61.142,FUN_005204-T1,Q21974,UNC8_CAEEL,,Degenerin unc-8 (Putative ligand-gated sodium channel unc-8) (Uncoordinated protein 8),Caenorhabditis elegans,29.9,338.0,3.3e-35,151.4,sp|Q21974|UNC8_CAEEL Degenerin unc-8 OS=Caenorhabditis elegans OX=6239 GN=unc-8 PE=2 SV=1,GO:0005261; GO:0005886; GO:0006812; GO:0015280; GO:0016322; GO:0035725; GO:0040011; GO:0043025,locomotion [GO:0040011]; monoatomic cation transport [GO:0006812]; neuron remodeling [GO:0016322]; sodium ion transmembrane transport [GO:0035725],neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_14008,FUN_005223-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8120.t1,apul_ptua,92.308,FUN_005223-T1,P22125,,,,,64.6,198.0,2.9000000000000007e-71,269.6,sp|P22125|RAB1_DIPOM Ras-related protein ORAB-1 OS=Diplobatis ommata OX=1870830 PE=2 SV=1,,,,,,
OG_14009,FUN_005227-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8117.t1,apul_ptua,37.0285,,,,,,,,,,,,,,,,,
OG_14010,FUN_005229-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8116.t1,apul_ptua,47.573,FUN_005229-T1,P11031,TCP4_MOUSE,,Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (Single-stranded DNA-binding protein p9) (p14),Mus musculus (Mouse),48.5,68.0,4.3e-14,79.0,sp|P11031|TCP4_MOUSE Activated RNA polymerase II transcriptional coactivator p15 OS=Mus musculus OX=10090 GN=Sub1 PE=1 SV=3,GO:0000978; GO:0001111; GO:0003678; GO:0003697; GO:0003713; GO:0005654; GO:0005667; GO:0005730; GO:0042802; GO:0051053; GO:0051260; GO:0060261; GO:0140297,negative regulation of DNA metabolic process [GO:0051053]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; protein homooligomerization [GO:0051260]; RNA polymerase II promoter clearance [GO:0001111],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],DNA helicase activity [GO:0003678]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713],GO:0003677; GO:0003824; GO:0005654; GO:0005730; GO:0006355; GO:0016853; GO:0043226; GO:0060090; GO:0065003; GO:0140097; GO:0140110; GO:0140657,"DNA binding; catalytic activity; nucleoplasm; nucleolus; regulation of DNA-templated transcription; isomerase activity; organelle; molecular adaptor activity; protein-containing complex assembly; catalytic activity, acting on DNA; transcription regulator activity; ATP-dependent activity"
OG_14011,FUN_005240-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8107.t1,apul_ptua,84.524,FUN_005240-T1,Q3ZCE8,RBM8A_BOVIN,,RNA-binding protein 8A (RNA-binding motif protein 8A),Bos taurus (Bovine),60.1,168.0,4.8e-48,192.2,sp|Q3ZCE8|RBM8A_BOVIN RNA-binding protein 8A OS=Bos taurus OX=9913 GN=RBM8A PE=2 SV=2,GO:0000184; GO:0000381; GO:0000398; GO:0003729; GO:0005634; GO:0005737; GO:0006417; GO:0008380; GO:0016607; GO:0035145; GO:0051028; GO:0071006,"mRNA splicing, via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380]",cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type catalytic step 1 spliceosome [GO:0071006],mRNA binding [GO:0003729],GO:0003723; GO:0005634; GO:0016071; GO:0043226,RNA binding; nucleus; mRNA metabolic process; organelle
OG_14012,FUN_005266-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8153.t1,apul_ptua,40.282,FUN_005266-T1,Q8BH97,RCN3_MOUSE,,Reticulocalbin-3,Mus musculus (Mouse),28.0,250.0,6.4e-16,86.3,sp|Q8BH97|RCN3_MOUSE Reticulocalbin-3 OS=Mus musculus OX=10090 GN=Rcn3 PE=1 SV=1,GO:0005509; GO:0005783; GO:0005788; GO:0009306; GO:0010952; GO:0015031; GO:0032964; GO:0036503; GO:0043129; GO:0051896; GO:0055091; GO:0060428,collagen biosynthetic process [GO:0032964]; ERAD pathway [GO:0036503]; lung epithelium development [GO:0060428]; phospholipid homeostasis [GO:0055091]; positive regulation of peptidase activity [GO:0010952]; protein secretion [GO:0009306]; protein transport [GO:0015031]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; surfactant homeostasis [GO:0043129],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788],calcium ion binding [GO:0005509],GO:0005783; GO:0030163; GO:0043226; GO:0048856,endoplasmic reticulum; protein catabolic process; organelle; anatomical structure development
OG_14013,FUN_005277-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10755.t1,apul_ptua,41.8785,,,,,,,,,,,,,,,,,
OG_14014,FUN_005296-T1,,Pocillopora_meandrina_HIv1___TS.g7698.t1,apul_ptua,53.296,,,,,,,,,,,,,,,,,
OG_14015,FUN_005299-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22539.t1,apul_ptua,37.1035,,,,,,,,,,,,,,,,,
OG_14016,FUN_005302-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8167.t1,apul_ptua,75.581,FUN_005302-T1,Q8BZB2,,,,,65.9,82.0,5.9000000000000005e-27,122.1,sp|Q8BZB2|COAC_MOUSE Phosphopantothenoylcysteine decarboxylase OS=Mus musculus OX=10090 GN=Ppcdc PE=1 SV=1,,,,,,
OG_14017,FUN_005323-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8185.t1,apul_ptua,51.528,FUN_005323-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),53.7,136.0,2.6e-38,161.4,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_14018,FUN_005327-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8187.t1,apul_ptua,57.948,FUN_005327-T1,Q9NQX0,,,,,31.6,342.0,8.6e-40,166.4,sp|Q9NQX0|PRDM6_HUMAN Putative histone-lysine N-methyltransferase PRDM6 OS=Homo sapiens OX=9606 GN=PRDM6 PE=1 SV=2,,,,,,
OG_14019,FUN_005329-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8188.t1,apul_ptua,52.072,FUN_005329-T1,Q3UZD5,PRDM6_MOUSE,,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.361) (PR domain zinc finger protein 6) (PR domain-containing protein 6) (PR domain-containing protein in smooth muscle),Mus musculus (Mouse),53.6,140.0,3.1e-40,167.9,sp|Q3UZD5|PRDM6_MOUSE Putative histone-lysine N-methyltransferase PRDM6 OS=Mus musculus OX=10090 GN=Prdm6 PE=1 SV=1,GO:0000122; GO:0005634; GO:0008270; GO:0022008; GO:0032259; GO:0042802; GO:0045892; GO:0051151; GO:0140944,methylation [GO:0032259]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurogenesis [GO:0022008],nucleus [GO:0005634],histone H4K20 monomethyltransferase activity [GO:0140944]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0030154; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; cell differentiation; organelle; catalytic activity, acting on a protein"
OG_14020,FUN_005341-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8201.t1a,apul_ptua,57.438,,,,,,,,,,,,,,,,,
OG_14021,FUN_005343-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8204.t1,apul_ptua,69.835,,,,,,,,,,,,,,,,,
OG_14022,FUN_005347-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8205.t1,apul_ptua,76.229,FUN_005347-T1,Q9FHN8,,,,,55.3,385.0,8.3e-108,394.0,sp|Q9FHN8|KN14E_ARATH Kinesin-like protein KIN-14E OS=Arabidopsis thaliana OX=3702 GN=KIN14E PE=1 SV=1,,,,,,
OG_14023,FUN_005350-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8207.t1,apul_ptua,37.269,FUN_005350-T1,Q58D84,,,,,44.3,70.0,5.4e-08,60.5,sp|Q58D84|FSTL1_BOVIN Follistatin-related protein 1 OS=Bos taurus OX=9913 GN=FSTL1 PE=2 SV=1,,,,,,
OG_14024,FUN_005351-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8208.t1,apul_ptua,83.636,FUN_005351-T1,Q05973,,,,,53.3,257.0,3.1e-74,280.0,sp|Q05973|SCN1_HETBL Sodium channel protein 1 brain OS=Heterololigo bleekeri OX=1423826 PE=2 SV=1,,,,,,
OG_14025,FUN_005353-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8211.t1,apul_ptua,74.468,FUN_005353-T1,A8JJB2,,,,,34.9,83.0,2.5e-09,62.8,sp|A8JJB2|MOC2A_CHLRE Molybdopterin synthase sulfur carrier subunit OS=Chlamydomonas reinhardtii OX=3055 GN=CHLREDRAFT_109356 PE=3 SV=1,,,,,,
OG_14026,FUN_005357-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8216.t1,apul_ptua,72.093,FUN_005357-T1,Q9D1I5,,,,,71.9,135.0,1.7e-54,213.8,"sp|Q9D1I5|MCEE_MOUSE Methylmalonyl-CoA epimerase, mitochondrial OS=Mus musculus OX=10090 GN=Mcee PE=1 SV=1",,,,,,
OG_14027,FUN_005383-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6617.t1,apul_ptua,78.571,FUN_005383-T1,Q9DCL2,,,,,66.7,120.0,1.2e-42,174.1,sp|Q9DCL2|CIA2A_MOUSE Cytosolic iron-sulfur assembly component 2A OS=Mus musculus OX=10090 GN=Ciao2a PE=1 SV=1,,,,,,
OG_14028,FUN_005392-T1,,Pocillopora_meandrina_HIv1___TS.g2867.t2a,apul_ptua,49.653,,,,,,,,,,,,,,,,,
OG_14029,FUN_005393-T1,,Pocillopora_meandrina_HIv1___TS.g2866.t1,apul_ptua,47.98650000000001,,,,,,,,,,,,,,,,,
OG_14030,FUN_005645-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9777.t1,apul_ptua,75.888,,,,,,,,,,,,,,,,,
OG_14031,FUN_005708-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19335.t1,apul_ptua,52.83,,,,,,,,,,,,,,,,,
OG_14032,FUN_005713-T1,,Pocillopora_meandrina_HIv1___TS.g14425.t1,apul_ptua,72.038,,,,,,,,,,,,,,,,,
OG_14033,FUN_005718-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19562.t1,apul_ptua,81.429,FUN_005718-T1,Q56W64,ASPG3_ARATH,,Probable isoaspartyl peptidase/L-asparaginase 3 (EC 3.4.19.5) (L-asparagine amidohydrolase 3) [Cleaved into: Isoaspartyl peptidase/L-asparaginase 3 subunit alpha; Isoaspartyl peptidase/L-asparaginase 3 subunit beta],Arabidopsis thaliana (Mouse-ear cress),44.8,67.0,1.8e-09,62.8,sp|Q56W64|ASPG3_ARATH Probable isoaspartyl peptidase/L-asparaginase 3 OS=Arabidopsis thaliana OX=3702 GN=At5g61540 PE=2 SV=1,GO:0006508; GO:0008798; GO:0016811,proteolysis [GO:0006508],,"beta-aspartyl-peptidase activity [GO:0008798]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]",GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_14034,FUN_005857-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19666.t1,apul_ptua,72.046,FUN_005857-T1,Q811U3,RB6I2_RAT,,ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (CAZ-associated structural protein 2) (CAST2) (Rab6-interacting protein 2),Rattus norvegicus (Rat),34.5,319.0,3.7e-31,138.7,sp|Q811U3|RB6I2_RAT ELKS/Rab6-interacting/CAST family member 1 OS=Rattus norvegicus OX=10116 GN=Erc1 PE=1 SV=1,GO:0000139; GO:0002102; GO:0005737; GO:0005813; GO:0006355; GO:0008021; GO:0008385; GO:0014069; GO:0015031; GO:0016020; GO:0016082; GO:0030165; GO:0031267; GO:0036064; GO:0042147; GO:0045202; GO:0048790; GO:0070161; GO:0098831; GO:0098882; GO:0098978; GO:0098982; GO:0099509; GO:0099523; GO:0150037,"maintenance of presynaptic active zone structure [GO:0048790]; protein transport [GO:0015031]; regulation of calcium-dependent activation of synaptic vesicle fusion [GO:0150037]; regulation of DNA-templated transcription [GO:0006355]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509]; retrograde transport, endosome to Golgi [GO:0042147]; synaptic vesicle priming [GO:0016082]",anchoring junction [GO:0070161]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; membrane [GO:0016020]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic cytosol [GO:0099523]; synapse [GO:0045202]; synaptic vesicle [GO:0008021],PDZ domain binding [GO:0030165]; small GTPase binding [GO:0031267]; structural constituent of presynaptic active zone [GO:0098882],GO:0005198; GO:0005815; GO:0005829; GO:0006355; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0065003,structural molecule activity; microtubule organizing center; cytosol; regulation of DNA-templated transcription; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; protein-containing complex assembly
OG_14035,FUN_005860-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8007.t1,apul_ptua,61.154,,,,,,,,,,,,,,,,,
OG_14036,FUN_005892-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19680.t1,apul_ptua,31.569,,,,,,,,,,,,,,,,,
OG_14037,FUN_005906-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19575.t1,apul_ptua,64.165,FUN_005906-T1,Q16720,,,,,32.1,1266.0,9.800000000000001e-170,599.4,sp|Q16720|AT2B3_HUMAN Plasma membrane calcium-transporting ATPase 3 OS=Homo sapiens OX=9606 GN=ATP2B3 PE=1 SV=3,,,,,,
OG_14038,FUN_005907-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19574.t1,apul_ptua,67.238,FUN_005907-T1,Q98SH2,,,,,41.7,1001.0,2.2e-218,760.8,sp|Q98SH2|AT2B1_CHICK Plasma membrane calcium-transporting ATPase 1 OS=Gallus gallus OX=9031 GN=ATP2B1 PE=2 SV=2,,,,,,
OG_14039,FUN_005915-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19567.t1,apul_ptua,80.121,FUN_005915-T1,A7Y2X0,,,,,38.2,573.0,4.3e-108,393.7,sp|A7Y2X0|SC6A5_XENLA Sodium- and chloride-dependent glycine transporter 2 OS=Xenopus laevis OX=8355 GN=slc6a5 PE=2 SV=1,,,,,,
OG_14040,FUN_005946-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10648.t1b,apul_ptua,69.2955,,,,,,,,,,,,,,,,,
OG_14041,FUN_005952-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13921.t1,apul_ptua,56.716,,,,,,,,,,,,,,,,,
OG_14042,FUN_005953-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3635.t1,apul_ptua,90.244,,,,,,,,,,,,,,,,,
OG_14043,FUN_005987-T1,,Pocillopora_meandrina_HIv1___TS.g12018.t1,apul_ptua,44.373000000000005,FUN_005987-T1,Q9TTQ9,,,,,31.2,282.0,3.1e-16,87.4,sp|Q9TTQ9|GPR83_CANLF G-protein coupled receptor 83 OS=Canis lupus familiaris OX=9615 GN=GPR83 PE=2 SV=1,,,,,,
OG_14044,FUN_005999-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19931.t1,apul_ptua,92.212,FUN_005999-T1,Q5MPA9,DCLK2_RAT,,Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2),Rattus norvegicus (Rat),43.5,717.0,2.2e-140,501.1,sp|Q5MPA9|DCLK2_RAT Serine/threonine-protein kinase DCLK2 OS=Rattus norvegicus OX=10116 GN=Dclk2 PE=1 SV=2,GO:0000226; GO:0004672; GO:0004674; GO:0005524; GO:0005737; GO:0005856; GO:0008017; GO:0021766; GO:0021860; GO:0034504; GO:0035556; GO:0106310; GO:1900181,hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of protein localization to nucleus [GO:1900181]; protein localization to nucleus [GO:0034504]; pyramidal neuron development [GO:0021860],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005856; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_14045,FUN_006014-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28600.t1,apul_ptua,71.223,,,,,,,,,,,,,,,,,
OG_14046,FUN_006016-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19917.t1,apul_ptua,53.333,,,,,,,,,,,,,,,,,
OG_14047,FUN_006018-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20250.t1,apul_ptua,67.05449999999999,FUN_006018-T1,P51957,NEK4_HUMAN,,Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-protein kinase NRK2),Homo sapiens (Human),66.7,294.0,6.8e-110,399.8,sp|P51957|NEK4_HUMAN Serine/threonine-protein kinase Nek4 OS=Homo sapiens OX=9606 GN=NEK4 PE=1 SV=2,GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006974; GO:0030145; GO:0035253; GO:0035869; GO:0036064; GO:0045893; GO:0051301; GO:0097014; GO:0106310; GO:2000772,cell division [GO:0051301]; DNA damage response [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of DNA-templated transcription [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772],ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000278; GO:0003824; GO:0005815; GO:0005829; GO:0006355; GO:0016740; GO:0140096,"mitotic cell cycle; catalytic activity; microtubule organizing center; cytosol; regulation of DNA-templated transcription; transferase activity; catalytic activity, acting on a protein"
OG_14048,FUN_006089-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27288.t1,apul_ptua,60.0,,,,,,,,,,,,,,,,,
OG_14049,FUN_006115-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20396.t1,apul_ptua,60.488,,,,,,,,,,,,,,,,,
OG_14050,FUN_006129-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20409.t1,apul_ptua,33.209999999999994,,,,,,,,,,,,,,,,,
OG_14051,FUN_006151-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30159.t1,apul_ptua,44.275,FUN_006151-T1,A1EA99,,,,,30.7,137.0,9.6e-09,61.6,sp|A1EA99|ALL2L_IXORI Mite group 2 allergen-like Ixo r 2 OS=Ixodes ricinus OX=34613 PE=2 SV=1,,,,,,
OG_14052,FUN_006240-T2,,Pocillopora_meandrina_HIv1___RNAseq.g21618.t1,apul_ptua,65.957,,,,,,,,,,,,,,,,,
OG_14053,FUN_006250-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20385.t1,apul_ptua,73.846,FUN_006250-T1,P0C5H0,,,,,56.6,143.0,3.3e-42,172.9,sp|P0C5H0|GLOD5_CANLF Glyoxalase domain-containing protein 5 OS=Canis lupus familiaris OX=9615 GN=GLOD5 PE=2 SV=1,,,,,,
OG_14054,FUN_006254-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20379.t1,apul_ptua,43.636,FUN_006254-T1,Q2PFN5,,,,,43.8,105.0,1.9e-16,88.2,sp|Q2PFN5|SPY2_MACFA Protein sprouty homolog 2 OS=Macaca fascicularis OX=9541 GN=SPRY2 PE=2 SV=1,,,,,,
OG_14055,FUN_006262-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20373.t1b,apul_ptua,49.3635,FUN_006262-T1,P0DKT1,,,,,51.1,45.0,9.3e-08,59.7,sp|P0DKT1|TU92_POLAB Turripeptide Pal9.2 OS=Polystira albida OX=394106 PE=2 SV=1,,,,,,
OG_14056,FUN_006269-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20371.t1,apul_ptua,52.56,FUN_006269-T1,P53370,NUDT6_HUMAN,,Nucleoside diphosphate-linked moiety X motif 6 (Nudix motif 6) (EC 3.6.1.-) (Antisense basic fibroblast growth factor) (Protein GFG),Homo sapiens (Human),41.3,271.0,2e-57,224.2,sp|P53370|NUDT6_HUMAN Nucleoside diphosphate-linked moiety X motif 6 OS=Homo sapiens OX=9606 GN=NUDT6 PE=1 SV=2,GO:0005634; GO:0005737; GO:0005739; GO:0008285; GO:0035529; GO:0045786; GO:0047631; GO:0051287,negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285],cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ADP-ribose diphosphatase activity [GO:0047631]; NAD binding [GO:0051287]; NADH pyrophosphatase activity [GO:0035529],GO:0003824; GO:0005634; GO:0005739; GO:0016787; GO:0043226,catalytic activity; nucleus; mitochondrion; hydrolase activity; organelle
OG_14057,FUN_006293-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18329.t1,apul_ptua,46.5395,,,,,,,,,,,,,,,,,
OG_14058,FUN_006333-T1,,Pocillopora_meandrina_HIv1___TS.g29725.t1b,apul_ptua,72.455,FUN_006333-T1,F1Q7H8,ZD20A_DANRE,,Palmitoyltransferase ZDHHC20-A (EC 2.3.1.225) (Acyltransferase ZDHHC20-A) (EC 2.3.1.-) (Zinc finger DHHC domain-containing protein 20-A),Danio rerio (Zebrafish) (Brachydanio rerio),49.2,331.0,7.9e-67,255.8,sp|F1Q7H8|ZD20A_DANRE Palmitoyltransferase ZDHHC20-A OS=Danio rerio OX=7955 GN=zdhhc20a PE=2 SV=1,GO:0000139; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006612; GO:0016188; GO:0018345; GO:0019705; GO:0019706; GO:0033116; GO:0046872; GO:0048471; GO:0140439,protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612]; synaptic vesicle maturation [GO:0016188],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],metal ion binding [GO:0046872]; protein-cysteine S-myristoyltransferase activity [GO:0019705]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; protein-cysteine S-stearoyltransferase activity [GO:0140439],GO:0003824; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; organelle; catalytic activity, acting on a protein"
OG_14059,FUN_006363-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8317.t1,apul_ptua,46.693,,,,,,,,,,,,,,,,,
OG_14060,FUN_006372-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20331.t1,apul_ptua,35.3535,,,,,,,,,,,,,,,,,
OG_14061,FUN_006412-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20263.t1,apul_ptua,63.7345,FUN_006412-T1,O97967,,,,,25.0,300.0,7.1e-14,79.7,sp|O97967|BRS3_SHEEP Bombesin receptor subtype-3 OS=Ovis aries OX=9940 GN=BRS3 PE=2 SV=1,,,,,,
OG_14062,FUN_006429-T1,,Pocillopora_meandrina_HIv1___TS.g29668.t1b,apul_ptua,69.912,FUN_006429-T1,B0JZP3,,,,,37.7,191.0,9.2e-26,118.6,sp|B0JZP3|THEM6_DANRE Protein THEM6 OS=Danio rerio OX=7955 GN=them6 PE=2 SV=1,,,,,,
OG_14063,FUN_006431-T1,,Pocillopora_meandrina_HIv1___TS.g29668.t1a,apul_ptua,80.198,FUN_006431-T1,Q5XK67,,,,,61.3,106.0,2.1e-32,139.8,sp|Q5XK67|RPAC2_XENLA DNA-directed RNA polymerases I and III subunit RPAC2 OS=Xenopus laevis OX=8355 GN=polr1d PE=3 SV=1,,,,,,
OG_14064,FUN_006437-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20294.t1,apul_ptua,58.4905,FUN_006437-T1,P29146,,,,,45.4,570.0,2.5000000000000004e-133,477.6,sp|P29146|NECA_HYDVU PC3-like endoprotease variant A OS=Hydra vulgaris OX=6087 PE=2 SV=1,,,,,,
OG_14065,FUN_006467-T1,,Pocillopora_meandrina_HIv1___TS.g15159.t1,apul_ptua,45.238,,,,,,,,,,,,,,,,,
OG_14066,FUN_006473-T1,,Pocillopora_meandrina_HIv1___TS.g17404.t1a,apul_ptua,59.847,,,,,,,,,,,,,,,,,
OG_14067,FUN_006554-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24750.t1,apul_ptua,43.775,,,,,,,,,,,,,,,,,
OG_14068,FUN_006574-T1,,Pocillopora_meandrina_HIv1___TS.g29609.t1,apul_ptua,54.114,FUN_006574-T1,Q8CIQ6,,,,,29.8,305.0,9.999999999999999e-27,123.2,sp|Q8CIQ6|MTR1B_MOUSE Melatonin receptor type 1B OS=Mus musculus OX=10090 GN=Mtnr1b PE=2 SV=1,,,,,,
OG_14069,FUN_006576-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20268.t1,apul_ptua,53.316,FUN_006576-T1,Q9EP86,,,,,25.8,298.0,1.1e-18,95.9,sp|Q9EP86|NPFF1_RAT Neuropeptide FF receptor 1 OS=Rattus norvegicus OX=10116 GN=Npffr1 PE=1 SV=1,,,,,,
OG_14070,FUN_006684-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19968.t1,apul_ptua,34.118,,,,,,,,,,,,,,,,,
OG_14071,FUN_006693-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19967.t1,apul_ptua,40.8575,,,,,,,,,,,,,,,,,
OG_14072,FUN_006696-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19972.t1,apul_ptua,39.4095,,,,,,,,,,,,,,,,,
OG_14073,FUN_006701-T2,,Pocillopora_meandrina_HIv1___RNAseq.g19976.t1,apul_ptua,37.17,,,,,,,,,,,,,,,,,
OG_14074,FUN_006720-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20005.t1,apul_ptua,62.36,,,,,,,,,,,,,,,,,
OG_14075,FUN_006734-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20523.t1,apul_ptua,71.6335,FUN_006734-T1,Q95M17,CHIA_BOVIN,,Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Chitin-binding protein b04) (CBPb04),Bos taurus (Bovine),51.9,374.0,2.2e-108,394.0,sp|Q95M17|CHIA_BOVIN Acidic mammalian chitinase OS=Bos taurus OX=9913 GN=CHIA PE=1 SV=1,GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0008843; GO:0032722,apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine production [GO:0032722]; production of molecular mediator involved in inflammatory response [GO:0002532],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615],chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005975; GO:0012501; GO:0016787; GO:1901135,immune system process; catalytic activity; extracellular region; extracellular space; carbohydrate metabolic process; programmed cell death; hydrolase activity; carbohydrate derivative metabolic process
OG_14076,FUN_006749-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20532.t1,apul_ptua,85.135,FUN_006749-T1,P70011,,,,,67.3,153.0,2.5e-59,229.6,sp|P70011|NDKA2_XENLA Nucleoside diphosphate kinase A2 OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_14077,FUN_006801-T2,,Pocillopora_meandrina_HIv1___RNAseq.g20492.t1,apul_ptua,73.7955,FUN_006801-T2,Q04656,ATP7A_HUMAN,,Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein),Homo sapiens (Human),45.1,1420.0,2e-309,1063.5,sp|Q04656|ATP7A_HUMAN Copper-transporting ATPase 1 OS=Homo sapiens OX=9606 GN=ATP7A PE=1 SV=4,GO:0001568; GO:0001836; GO:0001974; GO:0002082; GO:0005375; GO:0005507; GO:0005524; GO:0005770; GO:0005783; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006568; GO:0006570; GO:0006584; GO:0006825; GO:0006878; GO:0007005; GO:0007626; GO:0009101; GO:0010273; GO:0010468; GO:0014069; GO:0015677; GO:0016020; GO:0016323; GO:0016532; GO:0016887; GO:0019430; GO:0021702; GO:0021860; GO:0021954; GO:0030140; GO:0030198; GO:0030199; GO:0030424; GO:0030425; GO:0030670; GO:0031069; GO:0031901; GO:0032588; GO:0032767; GO:0033162; GO:0042093; GO:0042414; GO:0042415; GO:0042417; GO:0042421; GO:0042428; GO:0043005; GO:0043025; GO:0043473; GO:0043524; GO:0043588; GO:0043682; GO:0045914; GO:0046034; GO:0048023; GO:0048251; GO:0048286; GO:0048471; GO:0048812; GO:0048813; GO:0051216; GO:0051402; GO:0051649; GO:0060003; GO:0070050; GO:0140581; GO:1903136,ATP metabolic process [GO:0046034]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cartilage development [GO:0051216]; catecholamine metabolic process [GO:0006584]; central nervous system neuron development [GO:0021954]; cerebellar Purkinje cell differentiation [GO:0021702]; collagen fibril organization [GO:0030199]; copper ion export [GO:0060003]; copper ion import [GO:0015677]; copper ion transport [GO:0006825]; dendrite morphogenesis [GO:0048813]; detoxification of copper ion [GO:0010273]; dopamine metabolic process [GO:0042417]; elastic fiber assembly [GO:0048251]; epinephrine metabolic process [GO:0042414]; establishment of localization in cell [GO:0051649]; extracellular matrix organization [GO:0030198]; glycoprotein biosynthetic process [GO:0009101]; hair follicle morphogenesis [GO:0031069]; intracellular copper ion homeostasis [GO:0006878]; L-tryptophan metabolic process [GO:0006568]; locomotory behavior [GO:0007626]; lung alveolus development [GO:0048286]; mitochondrion organization [GO:0007005]; negative regulation of catecholamine metabolic process [GO:0045914]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; norepinephrine biosynthetic process [GO:0042421]; norepinephrine metabolic process [GO:0042415]; pigmentation [GO:0043473]; positive regulation of melanin biosynthetic process [GO:0048023]; pyramidal neuron development [GO:0021860]; regulation of gene expression [GO:0010468]; regulation of oxidative phosphorylation [GO:0002082]; release of cytochrome c from mitochondria [GO:0001836]; removal of superoxide radicals [GO:0019430]; serotonin metabolic process [GO:0042428]; skin development [GO:0043588]; T-helper cell differentiation [GO:0042093]; tyrosine metabolic process [GO:0006570],axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; copper ion binding [GO:0005507]; copper ion transmembrane transporter activity [GO:0005375]; copper-dependent protein binding [GO:0032767]; cuprous ion binding [GO:1903136]; P-type divalent copper transporter activity [GO:0043682]; P-type monovalent copper transporter activity [GO:0140581]; superoxide dismutase copper chaperone activity [GO:0016532],GO:0002376; GO:0003824; GO:0005215; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006520; GO:0007005; GO:0009101; GO:0012501; GO:0016787; GO:0030154; GO:0030198; GO:0031410; GO:0043226; GO:0048856; GO:0055085; GO:0055086; GO:0098754; GO:0140104; GO:0140657; GO:1901135,immune system process; catalytic activity; transporter activity; endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; amino acid metabolic process; mitochondrion organization; glycoprotein biosynthetic process; programmed cell death; hydrolase activity; cell differentiation; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development; transmembrane transport; nucleobase-containing small molecule metabolic process; detoxification; molecular carrier activity; ATP-dependent activity; carbohydrate derivative metabolic process
OG_14078,FUN_006823-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20480.t1,apul_ptua,71.399,FUN_006823-T1,P26630,,,,,41.0,388.0,1.1e-65,252.3,sp|P26630|PAX6_DANRE Paired box protein Pax-6 OS=Danio rerio OX=7955 GN=pax6a PE=2 SV=1,,,,,,
OG_14079,FUN_006841-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20470.t1,apul_ptua,48.4815,FUN_006841-T1,Q3UQ28,PXDN_MOUSE,,Peroxidasin homolog (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Mus musculus (Mouse),29.7,259.0,8.5e-24,113.6,sp|Q3UQ28|PXDN_MOUSE Peroxidasin homolog OS=Mus musculus OX=10090 GN=Pxdn PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005201; GO:0005604; GO:0005615; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0003824; GO:0005198; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003,catalytic activity; structural molecule activity; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly
OG_14080,FUN_006854-T1,,Pocillopora_meandrina_HIv1___RNAseq.3784_t,apul_ptua,49.1865,FUN_006854-T1,Q9NWZ8,,,,,51.2,82.0,4.2e-15,83.6,sp|Q9NWZ8|GEMI8_HUMAN Gem-associated protein 8 OS=Homo sapiens OX=9606 GN=GEMIN8 PE=1 SV=1,,,,,,
OG_14081,FUN_006871-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26240.t1,apul_ptua,51.075,FUN_006871-T1,P53985,MOT1_HUMAN,,Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1),Homo sapiens (Human),27.5,400.0,7.5e-28,126.3,sp|P53985|MOT1_HUMAN Monocarboxylate transporter 1 OS=Homo sapiens OX=9606 GN=SLC16A1 PE=1 SV=3,GO:0005813; GO:0005886; GO:0006629; GO:0007098; GO:0008028; GO:0009925; GO:0015129; GO:0015130; GO:0015141; GO:0015650; GO:0015718; GO:0015728; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0030054; GO:0032094; GO:0035879; GO:0042593; GO:0042802; GO:0042867; GO:0043231; GO:0045202; GO:0046943; GO:0050796; GO:0051780; GO:0070062; GO:0071422; GO:0150104; GO:1901475; GO:1905039,behavioral response to nutrient [GO:0051780]; carboxylic acid transmembrane transport [GO:1905039]; centrosome cycle [GO:0007098]; glucose homeostasis [GO:0042593]; lipid metabolic process [GO:0006629]; mevalonate transport [GO:0015728]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; pyruvate catabolic process [GO:0042867]; pyruvate transmembrane transport [GO:1901475]; regulation of insulin secretion [GO:0050796]; response to food [GO:0032094]; succinate transmembrane transport [GO:0071422]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; centrosome [GO:0005813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202],carboxylic acid transmembrane transporter activity [GO:0046943]; identical protein binding [GO:0042802]; lactate transmembrane transporter activity [GO:0015129]; lactate:proton symporter activity [GO:0015650]; mevalonate transmembrane transporter activity [GO:0015130]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; succinate transmembrane transporter activity [GO:0015141],GO:0003013; GO:0005215; GO:0005815; GO:0005886; GO:0006629; GO:0043226; GO:0055085,circulatory system process; transporter activity; microtubule organizing center; plasma membrane; lipid metabolic process; organelle; transmembrane transport
OG_14082,FUN_006874-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19800.t2,apul_ptua,59.111,FUN_006874-T1,Q8BMN3,ACHB3_MOUSE,,Neuronal acetylcholine receptor subunit beta-3,Mus musculus (Mouse),33.8,468.0,5.1e-60,233.4,sp|Q8BMN3|ACHB3_MOUSE Neuronal acetylcholine receptor subunit beta-3 OS=Mus musculus OX=10090 GN=Chrnb3 PE=2 SV=1,GO:0004888; GO:0005892; GO:0022848; GO:0034703; GO:0042166; GO:0045211; GO:0098691; GO:0098793; GO:0098878; GO:0099171; GO:1901363,presynaptic modulation of chemical synaptic transmission [GO:0099171],acetylcholine-gated channel complex [GO:0005892]; cation channel complex [GO:0034703]; dopaminergic synapse [GO:0098691]; neurotransmitter receptor complex [GO:0098878]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793],acetylcholine binding [GO:0042166]; acetylcholine-gated monoatomic cation-selective channel activity [GO:0022848]; heterocyclic compound binding [GO:1901363]; transmembrane signaling receptor activity [GO:0004888],GO:0005215; GO:0060089,transporter activity; molecular transducer activity
OG_14083,FUN_006887-T1,,Pocillopora_meandrina_HIv1___TS.g29220.t1,apul_ptua,46.8655,,,,,,,,,,,,,,,,,
OG_14084,FUN_006955-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29576.t1,apul_ptua,71.186,FUN_006955-T1,Q9U6Y6,,,,,65.8,225.0,3.9e-88,325.9,sp|Q9U6Y6|GFPL_ANEMA GFP-like fluorescent chromoprotein amFP486 OS=Anemonia manjano OX=105399 PE=1 SV=1,,,,,,
OG_14085,FUN_006974-T1,,Pocillopora_meandrina_HIv1___TS.g6767.t1,apul_ptua,42.466,,,,,,,,,,,,,,,,,
OG_14086,FUN_006977-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20161.t1,apul_ptua,59.596,,,,,,,,,,,,,,,,,
OG_14087,FUN_006992-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20068.t1,apul_ptua,63.946,,,,,,,,,,,,,,,,,
OG_14088,FUN_007006-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20037.t1,apul_ptua,47.5715,FUN_007006-T1,Q08DH3,TRM9B_BOVIN,,Probable tRNA methyltransferase 9B (Probable tRNA methyltransferase 9-like protein) (EC 2.1.1.-),Bos taurus (Bovine),49.7,179.0,1.1e-46,189.5,sp|Q08DH3|TRM9B_BOVIN Probable tRNA methyltransferase 9B OS=Bos taurus OX=9913 GN=TRMT9B PE=2 SV=1,GO:0000049; GO:0002098; GO:0005634; GO:0005737; GO:0008757; GO:0030488; GO:0106335,tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; nucleus [GO:0005634],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; tRNA (5-carboxymethyluridine(34)-5-O)-methyltransferase activity [GO:0106335]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005634; GO:0006399; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; tRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_14089,FUN_007022-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20543.t1,apul_ptua,78.486,FUN_007022-T1,Q5IZC5,CRY1_ERIRU,,Cryptochrome-1,Erithacus rubecula (European robin),50.7,491.0,4.900000000000001e-158,560.1,sp|Q5IZC5|CRY1_ERIRU Cryptochrome-1 OS=Erithacus rubecula OX=37610 GN=CRY1 PE=2 SV=2,GO:0003677; GO:0005634; GO:0005829; GO:0007623; GO:0009416; GO:0009881; GO:0032922; GO:0042622; GO:0043153; GO:0045721; GO:0045892; GO:0071949; GO:0097381,circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gluconeogenesis [GO:0045721]; response to light stimulus [GO:0009416],cytosol [GO:0005829]; nucleus [GO:0005634]; photoreceptor disc membrane [GO:0097381]; photoreceptor outer segment membrane [GO:0042622],DNA binding [GO:0003677]; FAD binding [GO:0071949]; photoreceptor activity [GO:0009881],GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0043226; GO:0060089,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; organelle; molecular transducer activity
OG_14090,FUN_007025-T3,,Pocillopora_meandrina_HIv1___RNAseq.g20018.t1,apul_ptua,59.058,FUN_007025-T3,Q55E58,PATS1_DICDI,,Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1),Dictyostelium discoideum (Social amoeba),22.1,393.0,9.9e-18,94.4,sp|Q55E58|PATS1_DICDI Probable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1,GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310,cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856],actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0140096,"cytokinesis; catalytic activity; cytosol; lipid metabolic process; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_14091,FUN_007042-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26821.t1,apul_ptua,40.0,,,,,,,,,,,,,,,,,
OG_14092,FUN_007061-T2,,Pocillopora_meandrina_HIv1___RNAseq.g20520.t1,apul_ptua,41.544,FUN_007061-T2,Q91VL8,TE2IP_MOUSE,,Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Repressor/activator protein 1 homolog) (RAP1 homolog),Mus musculus (Mouse),40.3,206.0,2.9e-27,124.8,sp|Q91VL8|TE2IP_MOUSE Telomeric repeat-binding factor 2-interacting protein 1 OS=Mus musculus OX=10090 GN=Terf2ip PE=1 SV=1,GO:0000781; GO:0001673; GO:0005634; GO:0005654; GO:0005737; GO:0006355; GO:0010569; GO:0010833; GO:0016233; GO:0016604; GO:0019902; GO:0032205; GO:0032206; GO:0035556; GO:0042162; GO:0043123; GO:0048239; GO:0051092; GO:0070187; GO:0070198; GO:0098505; GO:1901224,"intracellular signal transduction [GO:0035556]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of telomere maintenance [GO:0032206]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of DNA-templated transcription [GO:0006355]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere capping [GO:0016233]; telomere maintenance via telomere lengthening [GO:0010833]","chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; shelterin complex [GO:0070187]",G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0032200; GO:0043226,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; telomere organization; organelle
OG_14093,FUN_007066-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20105.t1,apul_ptua,54.015,FUN_007066-T1,Q09JY9,SHRM2_XENTR,,Protein Shroom2 (Protein Apxl),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),32.5,243.0,1.7000000000000002e-22,110.2,sp|Q09JY9|SHRM2_XENTR Protein Shroom2 OS=Xenopus tropicalis OX=8364 GN=shroom2 PE=2 SV=1,GO:0002089; GO:0003779; GO:0005737; GO:0005856; GO:0005874; GO:0005886; GO:0005923; GO:0007420; GO:0008057; GO:0016324; GO:0016477; GO:0032401; GO:0032438; GO:0043010; GO:0043482; GO:0043583; GO:0045176; GO:0048593; GO:0051015,apical protein localization [GO:0045176]; brain development [GO:0007420]; camera-type eye development [GO:0043010]; camera-type eye morphogenesis [GO:0048593]; cell migration [GO:0016477]; cellular pigment accumulation [GO:0043482]; ear development [GO:0043583]; establishment of melanosome localization [GO:0032401]; eye pigment granule organization [GO:0008057]; lens morphogenesis in camera-type eye [GO:0002089]; melanosome organization [GO:0032438],apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; plasma membrane [GO:0005886],actin binding [GO:0003779]; actin filament binding [GO:0051015],GO:0005856; GO:0005886; GO:0008092; GO:0043226; GO:0048856; GO:0048870,cytoskeleton; plasma membrane; cytoskeletal protein binding; organelle; anatomical structure development; cell motility
OG_14094,FUN_007068-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20093.t1,apul_ptua,59.2915,FUN_007068-T1,P43234,CATO_HUMAN,,Cathepsin O (EC 3.4.22.42),Homo sapiens (Human),43.5,292.0,4.5e-59,229.9,sp|P43234|CATO_HUMAN Cathepsin O OS=Homo sapiens OX=9606 GN=CTSO PE=1 SV=1,GO:0004197; GO:0005615; GO:0005764; GO:0006508; GO:0051603,proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603],extracellular space [GO:0005615]; lysosome [GO:0005764],cysteine-type endopeptidase activity [GO:0004197],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; extracellular space; lysosome; vacuole; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_14095,FUN_007074-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20080.t1,apul_ptua,83.824,,,,,,,,,,,,,,,,,
OG_14096,FUN_007107-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19112.t1,apul_ptua,36.318,,,,,,,,,,,,,,,,,
OG_14097,FUN_007175-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19767.t1,apul_ptua,52.123000000000005,,,,,,,,,,,,,,,,,
OG_14098,FUN_007177-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19769.t1,apul_ptua,52.113,,,,,,,,,,,,,,,,,
OG_14099,FUN_007570-T1,,Pocillopora_meandrina_HIv1___TS.g3910.t1,apul_ptua,65.909,,,,,,,,,,,,,,,,,
OG_14100,FUN_007651-T1,,Pocillopora_meandrina_HIv1___TS.g24548.t1,apul_ptua,50.302,FUN_007651-T1,Q9JLG4,,,,,26.5,524.0,7.6e-48,194.9,sp|Q9JLG4|PK2L2_MOUSE Polycystin-2-like protein 2 OS=Mus musculus OX=10090 GN=Pkd2l2 PE=2 SV=2,,,,,,
OG_14101,FUN_007652-T1,,Pocillopora_meandrina_HIv1___TS.g24532.t1,apul_ptua,64.646,FUN_007652-T1,Q6IVV8,PKD2_DANRE,,Polycystin-2 (Curly up) (Cup) (Polycystic kidney disease 2 protein homolog) (Transient receptor potential cation channel subfamily P member 2),Danio rerio (Zebrafish) (Brachydanio rerio),24.0,471.0,3.4e-34,147.9,sp|Q6IVV8|PKD2_DANRE Polycystin-2 OS=Danio rerio OX=7955 GN=pkd2 PE=1 SV=1,GO:0001822; GO:0001946; GO:0001947; GO:0003143; GO:0003146; GO:0003171; GO:0003173; GO:0005102; GO:0005245; GO:0005248; GO:0005261; GO:0005262; GO:0005267; GO:0005509; GO:0005783; GO:0005856; GO:0005886; GO:0005929; GO:0007166; GO:0007219; GO:0007368; GO:0007507; GO:0009953; GO:0010882; GO:0015271; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0030017; GO:0030659; GO:0032965; GO:0033017; GO:0034703; GO:0042383; GO:0048793; GO:0050982; GO:0051209; GO:0051262; GO:0051284; GO:0051290; GO:0051371; GO:0060271; GO:0060972; GO:0061371; GO:0065003; GO:0070121; GO:0070588; GO:0071277; GO:0071805; GO:0072019; GO:0072114; GO:0097704; GO:0098662,atrioventricular valve development [GO:0003171]; calcium ion transmembrane transport [GO:0070588]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; cellular response to oscillatory fluid shear stress [GO:0097704]; cilium assembly [GO:0060271]; detection of mechanical stimulus [GO:0050982]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inorganic cation transmembrane transport [GO:0098662]; kidney development [GO:0001822]; Kupffer's vesicle development [GO:0070121]; left/right pattern formation [GO:0060972]; lymphangiogenesis [GO:0001946]; Notch signaling pathway [GO:0007219]; positive regulation of sequestering of calcium ion [GO:0051284]; potassium ion transmembrane transport [GO:0071805]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; protein heterotetramerization [GO:0051290]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; proximal convoluted tubule development [GO:0072019]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of collagen biosynthetic process [GO:0032965]; release of sequestered calcium ion into cytosol [GO:0051209]; ventriculo bulbo valve development [GO:0003173],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation channel complex [GO:0034703]; cilium [GO:0005929]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcomere [GO:0030017]; sarcoplasmic reticulum membrane [GO:0033017],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; monoatomic cation channel activity [GO:0005261]; muscle alpha-actinin binding [GO:0051371]; outward rectifier potassium channel activity [GO:0015271]; potassium channel activity [GO:0005267]; signaling receptor binding [GO:0005102]; voltage-gated calcium channel activity [GO:0005245]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005783; GO:0005856; GO:0005886; GO:0005929; GO:0008092; GO:0043226; GO:0044782; GO:0048856; GO:0055085; GO:0065003,transporter activity; endoplasmic reticulum; cytoskeleton; plasma membrane; cilium; cytoskeletal protein binding; organelle; cilium organization; anatomical structure development; transmembrane transport; protein-containing complex assembly
OG_14102,FUN_007656-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16991.t1a,apul_ptua,38.652,,,,,,,,,,,,,,,,,
OG_14103,FUN_007663-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5894.t1b,apul_ptua,53.608,FUN_007663-T1,Q862Z3,,,,,54.2,48.0,1.1e-07,60.5,sp|Q862Z3|UROM_CANLF Uromodulin OS=Canis lupus familiaris OX=9615 GN=UMOD PE=2 SV=1,,,,,,
OG_14104,FUN_007707-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5862.t1,apul_ptua,80.623,FUN_007707-T1,P97363,SPTC2_MOUSE,,Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2),Mus musculus (Mouse),62.3,223.0,1.9e-77,291.6,sp|P97363|SPTC2_MOUSE Serine palmitoyltransferase 2 OS=Mus musculus OX=10090 GN=Sptlc2 PE=1 SV=2,GO:0004758; GO:0005739; GO:0005789; GO:0006686; GO:0017059; GO:0030148; GO:0030170; GO:0046511; GO:0046512; GO:0046513; GO:0060612; GO:0061724; GO:1904504,adipose tissue development [GO:0060612]; ceramide biosynthetic process [GO:0046513]; lipophagy [GO:0061724]; positive regulation of lipophagy [GO:1904504]; sphinganine biosynthetic process [GO:0046511]; sphingolipid biosynthetic process [GO:0030148]; sphingomyelin biosynthetic process [GO:0006686]; sphingosine biosynthetic process [GO:0046512],endoplasmic reticulum membrane [GO:0005789]; mitochondrion [GO:0005739]; serine palmitoyltransferase complex [GO:0017059],pyridoxal phosphate binding [GO:0030170]; serine C-palmitoyltransferase activity [GO:0004758],GO:0003824; GO:0005739; GO:0006629; GO:0006914; GO:0016740; GO:0043226; GO:0048856,catalytic activity; mitochondrion; lipid metabolic process; autophagy; transferase activity; organelle; anatomical structure development
OG_14105,FUN_007738-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16210.t1,apul_ptua,68.73949999999999,,,,,,,,,,,,,,,,,
OG_14106,FUN_007744-T1,,Pocillopora_meandrina_HIv1___TS.g8418.t1,apul_ptua,52.564,,,,,,,,,,,,,,,,,
OG_14107,FUN_007750-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5851.t1,apul_ptua,47.619,,,,,,,,,,,,,,,,,
OG_14108,FUN_007758-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5844.t2,apul_ptua,38.529,,,,,,,,,,,,,,,,,
OG_14109,FUN_007813-T3,,Pocillopora_meandrina_HIv1___RNAseq.3403_t,apul_ptua,65.415,FUN_007813-T3,Q9WVK8,CP46A_MOUSE,,Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1),Mus musculus (Mouse),38.3,494.0,1.6e-86,321.6,sp|Q9WVK8|CP46A_MOUSE Cholesterol 24-hydroxylase OS=Mus musculus OX=10090 GN=Cyp46a1 PE=1 SV=1,GO:0005506; GO:0005789; GO:0006707; GO:0006805; GO:0008395; GO:0020037; GO:0030425; GO:0033781; GO:0042448; GO:0050649; GO:0062184; GO:0098793; GO:0098794; GO:1900271; GO:1903044,cholesterol catabolic process [GO:0006707]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; xenobiotic metabolic process [GO:0006805],dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793],cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; testosterone 6-beta-hydroxylase activity [GO:0050649],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_14110,FUN_007826-T1,,Pocillopora_meandrina_HIv1___TS.g16090.t1,apul_ptua,66.667,,,,,,,,,,,,,,,,,
OG_14111,FUN_007840-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18429.t1,apul_ptua,77.32,FUN_007840-T1,Q96FW1,OTUB1_HUMAN,,Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (hOTU1) (Ubiquitin-specific-processing protease OTUB1),Homo sapiens (Human),58.0,181.0,8.5e-56,218.4,sp|Q96FW1|OTUB1_HUMAN Ubiquitin thioesterase OTUB1 OS=Homo sapiens OX=9606 GN=OTUB1 PE=1 SV=2,GO:0002250; GO:0004843; GO:0005654; GO:0005829; GO:0006281; GO:0006508; GO:0006974; GO:0016579; GO:0019784; GO:0031625; GO:0043130; GO:0055105; GO:0070062; GO:0071108; GO:1904263; GO:2000780,adaptive immune response [GO:0002250]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; positive regulation of TORC1 signaling [GO:1904263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; proteolysis [GO:0006508],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654],cysteine-type deubiquitinase activity [GO:0004843]; deNEDDylase activity [GO:0019784]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105],GO:0002376; GO:0003824; GO:0005654; GO:0005829; GO:0006281; GO:0016787; GO:0043226; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleoplasm; cytosol; DNA repair; hydrolase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_14112,FUN_007854-T1,,Pocillopora_meandrina_HIv1___TS.g21280.t1b,apul_ptua,42.495,,,,,,,,,,,,,,,,,
OG_14113,FUN_007861-T1,,Pocillopora_meandrina_HIv1___TS.g10531.t1,apul_ptua,58.525,,,,,,,,,,,,,,,,,
OG_14114,FUN_007868-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18304.t1,apul_ptua,73.74,FUN_007868-T1,O15315,RA51B_HUMAN,,DNA repair protein RAD51 homolog 2 (R51H2) (RAD51 homolog B) (Rad51B) (RAD51-like protein 1),Homo sapiens (Human),52.7,353.0,6.3e-96,352.4,sp|O15315|RA51B_HUMAN DNA repair protein RAD51 homolog 2 OS=Homo sapiens OX=9606 GN=RAD51B PE=1 SV=2,GO:0000724; GO:0001832; GO:0003677; GO:0003690; GO:0003697; GO:0005524; GO:0005634; GO:0005654; GO:0005657; GO:0006281; GO:0006310; GO:0007131; GO:0008094; GO:0008284; GO:0010971; GO:0016887; GO:0033063; GO:0061053; GO:0140664,blastocyst growth [GO:0001832]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; reciprocal meiotic recombination [GO:0007131]; somite development [GO:0061053],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad51B-Rad51C-Rad51D-XRCC2 complex [GO:0033063]; replication fork [GO:0005657],"ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; ATP-dependent DNA damage sensor activity [GO:0140664]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]",GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; hydrolase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_14115,FUN_007890-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18249.t1,apul_ptua,45.74,,,,,,,,,,,,,,,,,
OG_14116,FUN_007911-T2,,Pocillopora_meandrina_HIv1___TS.g22460.t1,apul_ptua,68.24,,,,,,,,,,,,,,,,,
OG_14117,FUN_007992-T2,,Pocillopora_meandrina_HIv1___RNAseq.g18165.t1,apul_ptua,51.203,FUN_007992-T2,Q9BUD6,,,,,40.6,187.0,1.5e-30,135.6,sp|Q9BUD6|SPON2_HUMAN Spondin-2 OS=Homo sapiens OX=9606 GN=SPON2 PE=1 SV=4,,,,,,
OG_14118,FUN_007999-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18156.t1,apul_ptua,67.61,FUN_007999-T1,Q8NDG6,TDRD9_HUMAN,,ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9),Homo sapiens (Human),43.0,1263.0,1.9e-278,960.7,sp|Q8NDG6|TDRD9_HUMAN ATP-dependent RNA helicase TDRD9 OS=Homo sapiens OX=9606 GN=TDRD9 PE=1 SV=3,GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0007140; GO:0007141; GO:0007283; GO:0009566; GO:0016887; GO:0030154; GO:0034587; GO:0071547; GO:0141006; GO:0141196,cell differentiation [GO:0030154]; fertilization [GO:0009566]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196]; transposable element silencing by piRNA-mediated heterochromatin formation [GO:0141006],cytoplasm [GO:0005737]; nucleus [GO:0005634]; piP-body [GO:0071547],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0031047; GO:0043226; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; chromatin organization; hydrolase activity; isomerase activity; reproductive process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_14119,FUN_008011-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27333.t1,apul_ptua,43.478,,,,,,,,,,,,,,,,,
OG_14120,FUN_008022-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30347.t1,apul_ptua,52.604,FUN_008022-T1,P47033,PRY3_YEAST,,Cell wall protein PRY3 (Pathogenesis-related protein 3),Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast),33.7,163.0,9.2e-14,78.6,sp|P47033|PRY3_YEAST Cell wall protein PRY3 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PRY3 PE=1 SV=1,GO:0000747; GO:0005615; GO:0009277; GO:0015908; GO:0015918; GO:0019953; GO:0071944; GO:0098552,conjugation with cellular fusion [GO:0000747]; fatty acid transport [GO:0015908]; sexual reproduction [GO:0019953]; sterol transport [GO:0015918],cell periphery [GO:0071944]; extracellular space [GO:0005615]; fungal-type cell wall [GO:0009277]; side of membrane [GO:0098552],,GO:0005615; GO:0005618; GO:0022414; GO:0030312,extracellular space; cell wall; reproductive process; external encapsulating structure
OG_14121,FUN_008027-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30352.t1,apul_ptua,67.5275,FUN_008027-T1,Q3TJZ6,,,,,44.7,309.0,1.2e-68,261.9,sp|Q3TJZ6|FA98A_MOUSE Protein FAM98A OS=Mus musculus OX=10090 GN=Fam98a PE=1 SV=1,,,,,,
OG_14122,FUN_008037-T2,,Pocillopora_meandrina_HIv1___RNAseq.g30366.t1,apul_ptua,65.605,FUN_008037-T2,Q2KI83,,,,,46.0,315.0,3.5e-47,190.3,sp|Q2KI83|DJC17_BOVIN DnaJ homolog subfamily C member 17 OS=Bos taurus OX=9913 GN=DNAJC17 PE=2 SV=1,,,,,,
OG_14123,FUN_008042-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30365.t1,apul_ptua,65.06,FUN_008042-T1,Q6PBT6,,,,,60.2,83.0,1.0999999999999998e-24,113.6,sp|Q6PBT6|GFRP_DANRE GTP cyclohydrolase 1 feedback regulatory protein OS=Danio rerio OX=7955 GN=gchfr PE=3 SV=1,,,,,,
OG_14124,FUN_008056-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30158.t2,apul_ptua,65.494,FUN_008056-T1,O14678,ABCD4_HUMAN,,Lysosomal cobalamin transporter ABCD4 (EC 7.6.2.8) (ATP-binding cassette sub-family D member 4) (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69),Homo sapiens (Human),50.5,610.0,3.4e-160,566.6,sp|O14678|ABCD4_HUMAN Lysosomal cobalamin transporter ABCD4 OS=Homo sapiens OX=9606 GN=ABCD4 PE=1 SV=1,GO:0005324; GO:0005524; GO:0005765; GO:0005777; GO:0005778; GO:0005789; GO:0006635; GO:0007031; GO:0009235; GO:0015420; GO:0015889; GO:0015910; GO:0016020; GO:0016887; GO:0042626; GO:0042760; GO:0042802; GO:0043190; GO:0055085; GO:1990830,cellular response to leukemia inhibitory factor [GO:1990830]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; peroxisome organization [GO:0007031]; transmembrane transport [GO:0055085]; very long-chain fatty acid catabolic process [GO:0042760],ATP-binding cassette (ABC) transporter complex [GO:0043190]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],ABC-type vitamin B12 transporter activity [GO:0015420]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; identical protein binding [GO:0042802]; long-chain fatty acid transmembrane transporter activity [GO:0005324],GO:0003824; GO:0005215; GO:0005777; GO:0006629; GO:0007031; GO:0016787; GO:0043226; GO:0055085; GO:0140657,catalytic activity; transporter activity; peroxisome; lipid metabolic process; peroxisome organization; hydrolase activity; organelle; transmembrane transport; ATP-dependent activity
OG_14125,FUN_008057-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11404.t1,apul_ptua,47.297,FUN_008057-T1,P49259,,,,,36.5,126.0,1.3e-11,72.0,sp|P49259|PLA2R_BOVIN Secretory phospholipase A2 receptor OS=Bos taurus OX=9913 GN=PLA2R1 PE=1 SV=1,,,,,,
OG_14126,FUN_008062-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17903.t1,apul_ptua,44.828,,,,,,,,,,,,,,,,,
OG_14127,FUN_008067-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29238.t1,apul_ptua,57.959,FUN_008067-T1,Q9QXE5,,,,,36.5,477.0,1.1e-76,288.9,sp|Q9QXE5|TSSP_MOUSE Thymus-specific serine protease OS=Mus musculus OX=10090 GN=Prss16 PE=2 SV=1,,,,,,
OG_14128,FUN_008073-T1,,Pocillopora_meandrina_HIv1___TS.g22375.t1b,apul_ptua,42.9725,FUN_008073-T1,Q8IW35,,,,,42.0,131.0,5.8e-14,81.6,sp|Q8IW35|CEP97_HUMAN Centrosomal protein of 97 kDa OS=Homo sapiens OX=9606 GN=CEP97 PE=1 SV=1,,,,,,
OG_14129,FUN_008105-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21984.t1,apul_ptua,57.647,,,,,,,,,,,,,,,,,
OG_14130,FUN_008115-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17888.t1,apul_ptua,60.02,FUN_008115-T1,A6NMZ7,CO6A6_HUMAN,,Collagen alpha-6(VI) chain,Homo sapiens (Human),31.6,196.0,4.6e-12,74.3,sp|A6NMZ7|CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens OX=9606 GN=COL6A6 PE=1 SV=2,GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],,GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_14131,FUN_008190-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30004.t1,apul_ptua,61.587,,,,,,,,,,,,,,,,,
OG_14132,FUN_008192-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30166.t1,apul_ptua,74.386,,,,,,,,,,,,,,,,,
OG_14133,FUN_008202-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30173.t1,apul_ptua,77.363,FUN_008202-T1,Q6ZMV9,,,,,39.3,247.0,1.1000000000000001e-30,135.6,sp|Q6ZMV9|KIF6_HUMAN Kinesin-like protein KIF6 OS=Homo sapiens OX=9606 GN=KIF6 PE=1 SV=3,,,,,,
OG_14134,FUN_008236-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17927.t1,apul_ptua,58.333,FUN_008236-T1,Q5EAR5,,,,,54.6,196.0,2.9e-56,219.9,sp|Q5EAR5|TRPT1_DANRE tRNA 2'-phosphotransferase 1 OS=Danio rerio OX=7955 GN=trpt1 PE=2 SV=2,,,,,,
OG_14135,FUN_008270-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17979.t1,apul_ptua,96.517,FUN_008270-T1,P62822,,,,,91.6,203.0,5.9e-101,368.2,sp|P62822|RAB1A_CANLF Ras-related protein Rab-1A OS=Canis lupus familiaris OX=9615 GN=RAB1A PE=1 SV=3,,,,,,
OG_14136,FUN_008302-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5800.t1,apul_ptua,68.12,FUN_008302-T1,Q9Z2F6,,,,,40.6,234.0,4.8e-35,150.2,sp|Q9Z2F6|BCL3_MOUSE B-cell lymphoma 3 protein homolog OS=Mus musculus OX=10090 GN=Bcl3 PE=1 SV=2,,,,,,
OG_14137,FUN_008303-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5799.t1,apul_ptua,51.556,FUN_008303-T1,A7MCS3,,,,,24.6,391.0,1.3e-22,109.4,sp|A7MCS3|CP089_DANRE UPF0764 protein C16orf89 homolog OS=Danio rerio OX=7955 PE=2 SV=2,,,,,,
OG_14138,FUN_008313-T2,,Pocillopora_meandrina_HIv1___TS.g24503.t1,apul_ptua,71.54,FUN_008313-T2,Q8BXJ9,,,,,39.5,630.0,5.100000000000001e-130,466.5,sp|Q8BXJ9|TMM62_MOUSE Transmembrane protein 62 OS=Mus musculus OX=10090 GN=Tmem62 PE=2 SV=1,,,,,,
OG_14139,FUN_008316-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28870.t1,apul_ptua,72.554,FUN_008316-T1,P36267,,,,,27.2,386.0,3.4e-16,87.8,sp|P36267|GGT_PSEUA Glutathione hydrolase proenzyme OS=Pseudomonas sp. (strain A14) OX=69010 GN=ggt PE=1 SV=1,,,,,,
OG_14140,FUN_008320-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18228.t1,apul_ptua,39.5305,FUN_008320-T1,B8V7S0,,,,,74.6,228.0,3.3e-99,364.0,sp|B8V7S0|CPP1_ACRMI CUB and peptidase domain-containing protein 1 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_14141,FUN_008334-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5439.t1a,apul_ptua,53.3935,,,,,,,,,,,,,,,,,
OG_14142,FUN_008371-T2,,Pocillopora_meandrina_HIv1___RNAseq.g5700.t1,apul_ptua,41.4365,,,,,,,,,,,,,,,,,
OG_14143,FUN_008376-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18440.t1,apul_ptua,48.469,,,,,,,,,,,,,,,,,
OG_14144,FUN_008410-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18039.t1,apul_ptua,53.674,FUN_008410-T1,Q95254,GHSR_PIG,,Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor),Sus scrofa (Pig),28.2,337.0,7.4e-11,69.7,sp|Q95254|GHSR_PIG Growth hormone secretagogue receptor type 1 OS=Sus scrofa OX=9823 GN=GHSR PE=2 SV=1,GO:0001616; GO:0004930; GO:0005886; GO:0007186; GO:0008154; GO:0009725; GO:0009755; GO:0009986; GO:0016520; GO:0032691; GO:0032715; GO:0032720; GO:0040018; GO:0043005; GO:0045121; GO:0046697; GO:0050728,actin polymerization or depolymerization [GO:0008154]; decidualization [GO:0046697]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of multicellular organism growth [GO:0040018]; response to hormone [GO:0009725],cell surface [GO:0009986]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; growth hormone secretagogue receptor activity [GO:0001616]; growth hormone-releasing hormone receptor activity [GO:0016520],GO:0005886; GO:0022414; GO:0048856; GO:0060089,plasma membrane; reproductive process; anatomical structure development; molecular transducer activity
OG_14145,FUN_008417-T2,,Pocillopora_meandrina_HIv1___RNAseq.g18044.t2,apul_ptua,86.085,FUN_008417-T2,Q8TBZ3,WDR20_HUMAN,,WD repeat-containing protein 20 (Protein DMR),Homo sapiens (Human),53.9,558.0,2.9e-147,523.5,sp|Q8TBZ3|WDR20_HUMAN WD repeat-containing protein 20 OS=Homo sapiens OX=9606 GN=WDR20 PE=1 SV=2,GO:0005634; GO:0005654; GO:0005737; GO:0035800,,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],deubiquitinase activator activity [GO:0035800],GO:0005634; GO:0005654; GO:0043226; GO:0098772,nucleus; nucleoplasm; organelle; molecular function regulator activity
OG_14146,FUN_008422-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14381.t1,apul_ptua,45.717,FUN_008422-T1,Q6RT24,CENPE_MOUSE,,Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin superfamily protein 10) (KIF10) (Motor domain of KIF10),Mus musculus (Mouse),51.6,436.0,8e-107,391.0,sp|Q6RT24|CENPE_MOUSE Centromere-associated protein E OS=Mus musculus OX=10090 GN=Cenpe PE=1 SV=1,GO:0000775; GO:0000776; GO:0000940; GO:0003777; GO:0005524; GO:0005737; GO:0005819; GO:0007018; GO:0007057; GO:0007080; GO:0007088; GO:0007094; GO:0008017; GO:0008608; GO:0019901; GO:0031647; GO:0043515; GO:0045184; GO:0045842; GO:0045860; GO:0050793; GO:0051301; GO:0051310; GO:0051315; GO:0051984; GO:0051987; GO:0099607,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; establishment of protein localization [GO:0045184]; lateral attachment of mitotic spindle microtubules to kinetochore [GO:0099607]; metaphase chromosome alignment [GO:0051310]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly checkpoint signaling [GO:0007094]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; positive regulation of protein kinase activity [GO:0045860]; regulation of developmental process [GO:0050793]; regulation of mitotic nuclear division [GO:0007088]; regulation of protein stability [GO:0031647]; spindle assembly involved in female meiosis I [GO:0007057],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; outer kinetochore [GO:0000940]; spindle [GO:0005819]",ATP binding [GO:0005524]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901],GO:0003774; GO:0003824; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0022414; GO:0043226; GO:0140657,cytoskeletal motor activity; catalytic activity; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; reproductive process; organelle; ATP-dependent activity
OG_14147,FUN_008539-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14662.t1,apul_ptua,76.97,FUN_008539-T1,P25210,,,,,58.9,190.0,4.2e-40,166.8,sp|P25210|NFYB_PETMA Nuclear transcription factor Y subunit beta OS=Petromyzon marinus OX=7757 GN=NFYB PE=2 SV=1,,,,,,
OG_14148,FUN_008570-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12788.t1,apul_ptua,52.137,,,,,,,,,,,,,,,,,
OG_14149,FUN_008588-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12771.t1,apul_ptua,75.037,FUN_008588-T1,Q5U3U3,CPT2_DANRE,,"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)",Danio rerio (Zebrafish) (Brachydanio rerio),53.9,668.0,3.5e-206,719.5,"sp|Q5U3U3|CPT2_DANRE Carnitine O-palmitoyltransferase 2, mitochondrial OS=Danio rerio OX=7955 GN=cpt2 PE=2 SV=2",GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458,fatty acid beta-oxidation [GO:0006635],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],carnitine O-octanoyltransferase activity [GO:0008458]; carnitine O-palmitoyltransferase activity [GO:0004095],GO:0003824; GO:0005739; GO:0006629; GO:0016740; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; transferase activity; organelle
OG_14150,FUN_008591-T2,,Pocillopora_meandrina_HIv1___RNAseq.g12764.t1,apul_ptua,54.3615,FUN_008591-T2,Q6PDJ1,,,,,30.1,1079.0,7e-129,463.8,sp|Q6PDJ1|CAHD1_MOUSE VWFA and cache domain-containing protein 1 OS=Mus musculus OX=10090 GN=Cachd1 PE=1 SV=1,,,,,,
OG_14151,FUN_008620-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6257.t1,apul_ptua,60.615,FUN_008620-T1,Q9W2U4,PP4R2_DROME,,Serine/threonine-protein phosphatase 4 regulatory subunit 2 (PPP4R2-related protein),Drosophila melanogaster (Fruit fly),44.0,168.0,8.2e-31,136.0,sp|Q9W2U4|PP4R2_DROME Serine/threonine-protein phosphatase 4 regulatory subunit 2 OS=Drosophila melanogaster OX=7227 GN=PPP4R2r PE=1 SV=2,GO:0000278; GO:0000775; GO:0005634; GO:0005737; GO:0019888; GO:0030289; GO:0045879; GO:0061060,mitotic cell cycle [GO:0000278]; negative regulation of peptidoglycan recognition protein signaling pathway [GO:0061060]; negative regulation of smoothened signaling pathway [GO:0045879],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase 4 complex [GO:0030289]",protein phosphatase regulator activity [GO:0019888],GO:0000278; GO:0005634; GO:0043226; GO:0098772,mitotic cell cycle; nucleus; organelle; molecular function regulator activity
OG_14152,FUN_008624-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30325.t1b,apul_ptua,37.916,,,,,,,,,,,,,,,,,
OG_14153,FUN_008667-T1,,Pocillopora_meandrina_HIv1___RNAseq.g66.t1,apul_ptua,84.845,FUN_008667-T1,Q921C5,,,,,39.0,300.0,1.3e-42,176.4,sp|Q921C5|BICD2_MOUSE Protein bicaudal D homolog 2 OS=Mus musculus OX=10090 GN=Bicd2 PE=1 SV=1,,,,,,
OG_14154,FUN_008680-T1,,Pocillopora_meandrina_HIv1___TS.g15626.t1b,apul_ptua,32.192,FUN_008680-T1,C6JUN9,,,,,27.5,142.0,1.1e-10,68.9,sp|C6JUN9|LEC1_MICCO C-type lectin OS=Micrurus corallinus OX=54390 PE=1 SV=1,,,,,,
OG_14155,FUN_008704-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25668.t1,apul_ptua,78.713,FUN_008704-T1,Q9R0X0,MED20_MOUSE,,Mediator of RNA polymerase II transcription subunit 20 (Mediator complex subunit 20) (TRF-proximal protein homolog),Mus musculus (Mouse),45.6,206.0,2.9e-47,189.9,sp|Q9R0X0|MED20_MOUSE Mediator of RNA polymerase II transcription subunit 20 OS=Mus musculus OX=10090 GN=Med20 PE=1 SV=1,GO:0003712; GO:0005634; GO:0005654; GO:0016592; GO:0032968; GO:0035914; GO:0051123; GO:0060261; GO:0070847,positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; RNA polymerase II preinitiation complex assembly [GO:0051123]; skeletal muscle cell differentiation [GO:0035914],core mediator complex [GO:0070847]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription coregulator activity [GO:0003712],GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0065003; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; protein-containing complex assembly; transcription regulator activity
OG_14156,FUN_008708-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25664.t1,apul_ptua,78.824,FUN_008708-T1,Q13936,,,,,53.3,60.0,8.9e-06,50.8,sp|Q13936|CAC1C_HUMAN Voltage-dependent L-type calcium channel subunit alpha-1C OS=Homo sapiens OX=9606 GN=CACNA1C PE=1 SV=4,,,,,,
OG_14157,FUN_008717-T1,,Pocillopora_meandrina_HIv1___RNAseq.g75.t1,apul_ptua,84.659,FUN_008717-T1,Q28G88,,,,,77.5,40.0,2e-11,71.6,sp|Q28G88|FEZF2_XENTR Fez family zinc finger protein 2 OS=Xenopus tropicalis OX=8364 GN=fezf2 PE=2 SV=1,,,,,,
OG_14158,FUN_008719-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3514.t1,apul_ptua,58.383,,,,,,,,,,,,,,,,,
OG_14159,FUN_008739-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12740.t1,apul_ptua,30.667,,,,,,,,,,,,,,,,,
OG_14160,FUN_008749-T1,,Pocillopora_meandrina_HIv1___TS.g58.t1,apul_ptua,52.439,,,,,,,,,,,,,,,,,
OG_14161,FUN_008757-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12708.t1,apul_ptua,45.455,,,,,,,,,,,,,,,,,
OG_14162,FUN_008774-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12701.t1,apul_ptua,45.598,FUN_008774-T1,E7F7V7,,,,,26.0,339.0,2.6e-20,101.7,sp|E7F7V7|GAL2B_DANRE Galanin receptor 2b OS=Danio rerio OX=7955 GN=galr2b PE=2 SV=1,,,,,,
OG_14163,FUN_008797-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10928.t1,apul_ptua,36.5025,,,,,,,,,,,,,,,,,
OG_14164,FUN_008861-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9866.t1,apul_ptua,76.526,,,,,,,,,,,,,,,,,
OG_14165,FUN_008875-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4011.t1,apul_ptua,59.449,,,,,,,,,,,,,,,,,
OG_14166,FUN_008942-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4062.t1,apul_ptua,97.222,FUN_008942-T1,Q9Y2Y1,RPC10_HUMAN,,DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III 12.5 kDa subunit) (RPC12.5) (RNA polymerase III subunit C11) (HsC11p) (RPC11) (hRPC11),Homo sapiens (Human),75.5,110.0,1.6e-45,183.3,sp|Q9Y2Y1|RPC10_HUMAN DNA-directed RNA polymerase III subunit RPC10 OS=Homo sapiens OX=9606 GN=POLR3K PE=1 SV=3,GO:0003676; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006383; GO:0008270; GO:0045087; GO:0051607,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666],DNA-directed RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005654; GO:0005829; GO:0006351; GO:0016740; GO:0098542; GO:0140098,"immune system process; catalytic activity; nucleoplasm; cytosol; DNA-templated transcription; transferase activity; defense response to other organism; catalytic activity, acting on RNA"
OG_14167,FUN_008966-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14277.t1,apul_ptua,46.548,,,,,,,,,,,,,,,,,
OG_14168,FUN_008987-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3900.t1,apul_ptua,90.829,FUN_008987-T1,E1BKH1,EFHC1_BOVIN,,EF-hand domain-containing protein 1 (Myoclonin-1),Bos taurus (Bovine),59.7,551.0,9.2e-200,698.0,sp|E1BKH1|EFHC1_BOVIN EF-hand domain-containing protein 1 OS=Bos taurus OX=9913 GN=EFHC1 PE=1 SV=1,GO:0000281; GO:0000922; GO:0005509; GO:0005813; GO:0005879; GO:0005930; GO:0007052; GO:0021795; GO:0030317; GO:0036126; GO:0043014; GO:0051302; GO:0060285; GO:0072686; GO:0160111,cerebral cortex cell migration [GO:0021795]; cilium-dependent cell motility [GO:0060285]; flagellated sperm motility [GO:0030317]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302],axonemal A tubule inner sheath [GO:0160111]; axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922],alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509],GO:0000910; GO:0005815; GO:0005929; GO:0007010; GO:0007018; GO:0008092; GO:0022414; GO:0043226; GO:0048870,cytokinesis; microtubule organizing center; cilium; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; reproductive process; organelle; cell motility
OG_14169,FUN_008992-T1,,Pocillopora_meandrina_HIv1___TS.g29938.t1,apul_ptua,54.571,FUN_008992-T1,Q91611,DHHB_XENLA,,Desert hedgehog protein B (EC 3.1.-.-) (Desert hedgehog protein 2) (DHH-2) (Hedgehog protein 4) (X-HH4) [Cleaved into: Desert hedgehog protein B N-product],Xenopus laevis (African clawed frog),36.1,194.0,1.4e-27,125.6,sp|Q91611|DHHB_XENLA Desert hedgehog protein B OS=Xenopus laevis OX=8355 GN=dhh-b PE=2 SV=1,GO:0000139; GO:0001708; GO:0005113; GO:0005509; GO:0005615; GO:0005789; GO:0005886; GO:0007224; GO:0007267; GO:0008233; GO:0010468; GO:0016540; GO:0045880; GO:0097264; GO:0140853,cell fate specification [GO:0001708]; cell-cell signaling [GO:0007267]; positive regulation of smoothened signaling pathway [GO:0045880]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; self proteolysis [GO:0097264]; smoothened signaling pathway [GO:0007224],endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cholesterol-protein transferase activity [GO:0140853]; patched binding [GO:0005113]; peptidase activity [GO:0008233],GO:0003824; GO:0005615; GO:0005886; GO:0016740; GO:0016787; GO:0023052; GO:0051604; GO:0140096,"catalytic activity; extracellular space; plasma membrane; transferase activity; hydrolase activity; signaling; protein maturation; catalytic activity, acting on a protein"
OG_14170,FUN_008997-T1,,Pocillopora_meandrina_HIv1___TS.g29955.t1,apul_ptua,61.667,,,,,,,,,,,,,,,,,
OG_14171,FUN_009020-T2,,Pocillopora_meandrina_HIv1___RNAseq.g3921.t2,apul_ptua,62.233,FUN_009020-T2,Q90678,,,,,39.5,377.0,1.2e-61,238.8,sp|Q90678|PAFA_CHICK Platelet-activating factor acetylhydrolase OS=Gallus gallus OX=9031 GN=PLA2G7 PE=2 SV=1,,,,,,
OG_14172,FUN_009040-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14375.t1,apul_ptua,71.50399999999999,,,,,,,,,,,,,,,,,
OG_14173,FUN_009121-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24183.t1,apul_ptua,63.052,,,,,,,,,,,,,,,,,
OG_14174,FUN_009239-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24208.t1,apul_ptua,67.521,,,,,,,,,,,,,,,,,
OG_14175,FUN_009337-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24637.t1,apul_ptua,44.643,FUN_009337-T1,Q8IX30,SCUB3_HUMAN,,"Signal peptide, CUB and EGF-like domain-containing protein 3",Homo sapiens (Human),51.1,47.0,1.4e-06,55.1,"sp|Q8IX30|SCUB3_HUMAN Signal peptide, CUB and EGF-like domain-containing protein 3 OS=Homo sapiens OX=9606 GN=SCUBE3 PE=1 SV=1",GO:0005509; GO:0005615; GO:0005886; GO:0007165; GO:0009986; GO:0030513; GO:0036122; GO:0042802; GO:0045669; GO:0070700,positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165],cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],BMP binding [GO:0036122]; BMP receptor binding [GO:0070700]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802],GO:0005615; GO:0005886,extracellular space; plasma membrane
OG_14176,FUN_009348-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14426.t1,apul_ptua,49.701,,,,,,,,,,,,,,,,,
OG_14177,FUN_009355-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14460.t1,apul_ptua,53.378,FUN_009355-T1,Q9DBN1,STR6L_MOUSE,,Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2),Mus musculus (Mouse),27.5,657.0,7.300000000000001e-44,180.3,sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1,GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939,establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939],plasma membrane [GO:0005886],retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_14178,FUN_009365-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27370.t1,apul_ptua,36.318,FUN_009365-T1,Q8HY02,,,,,35.8,120.0,1.4e-10,68.6,sp|Q8HY02|CD209_SYMSY CD209 antigen OS=Symphalangus syndactylus OX=9590 GN=CD209 PE=3 SV=1,,,,,,
OG_14179,FUN_009382-T1,,Pocillopora_meandrina_HIv1___TS.g6007.t1,apul_ptua,60.343,FUN_009382-T1,P56931,,,,,42.0,374.0,5.6e-56,219.9,sp|P56931|E2F2_MOUSE Transcription factor E2F2 OS=Mus musculus OX=10090 GN=E2f2 PE=1 SV=2,,,,,,
OG_14180,FUN_009432-T1,,Pocillopora_meandrina_HIv1___TS.g1292.t2,apul_ptua,41.985,FUN_009432-T1,Q95218,,,,,56.0,200.0,2.3e-61,237.3,sp|Q95218|DMBT1_RABIT Scavenger receptor cysteine-rich domain-containing protein DMBT1 OS=Oryctolagus cuniculus OX=9986 GN=Dmbt1 PE=1 SV=2,,,,,,
OG_14181,FUN_009453-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2826.t1,apul_ptua,61.905,,,,,,,,,,,,,,,,,
OG_14182,FUN_009457-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25120.t1,apul_ptua,82.215,FUN_009457-T1,P56966,,,,,65.3,291.0,1.3000000000000001e-110,401.0,sp|P56966|GGPPS_BOVIN Geranylgeranyl pyrophosphate synthase OS=Bos taurus OX=9913 GN=GGPS1 PE=1 SV=2,,,,,,
OG_14183,FUN_009511-T3,,Pocillopora_meandrina_HIv1___RNAseq.g24487.t1,apul_ptua,46.115,FUN_009511-T3,Q6WRI0,IGS10_HUMAN,,Immunoglobulin superfamily member 10 (IgSF10) (Calvaria mechanical force protein 608) (CMF608),Homo sapiens (Human),25.7,280.0,3.5e-16,88.6,sp|Q6WRI0|IGS10_HUMAN Immunoglobulin superfamily member 10 OS=Homo sapiens OX=9606 GN=IGSF10 PE=1 SV=1,GO:0001503; GO:0005576; GO:0030154; GO:2001222,cell differentiation [GO:0030154]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222],extracellular region [GO:0005576],,GO:0005576; GO:0030154,extracellular region; cell differentiation
OG_14184,FUN_009660-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24578.t1,apul_ptua,81.14699999999999,FUN_009660-T1,A5PJV0,MAFG_BOVIN,,Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G),Bos taurus (Bovine),58.8,68.0,1.6e-11,71.2,sp|A5PJV0|MAFG_BOVIN Transcription factor MafG OS=Bos taurus OX=9913 GN=MAFG PE=2 SV=1,GO:0000978; GO:0000981; GO:0001228; GO:0001701; GO:0005634; GO:0006357; GO:0010628; GO:0030534; GO:0042127; GO:0042802; GO:0045604; GO:0090575,adult behavior [GO:0030534]; in utero embryonic development [GO:0001701]; positive regulation of gene expression [GO:0010628]; regulation of cell population proliferation [GO:0042127]; regulation of epidermal cell differentiation [GO:0045604]; regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_14185,FUN_009670-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24574.t1,apul_ptua,69.231,FUN_009670-T1,Q56K04,,,,,77.8,63.0,1.9999999999999998e-26,119.0,sp|Q56K04|CRIP1_BOVIN Cysteine-rich protein 1 OS=Bos taurus OX=9913 GN=CRIP1 PE=3 SV=3,,,,,,
OG_14186,FUN_009701-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28608.t1a,apul_ptua,49.1935,,,,,,,,,,,,,,,,,
OG_14187,FUN_009716-T1,,Pocillopora_meandrina_HIv1___RNAseq.g122.t1,apul_ptua,66.071,,,,,,,,,,,,,,,,,
OG_14188,FUN_009850-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25165.t1,apul_ptua,36.792,,,,,,,,,,,,,,,,,
OG_14189,FUN_009861-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25127.t1,apul_ptua,52.564,FUN_009861-T1,Q8BZE1,,,,,38.9,234.0,9.6e-33,142.9,sp|Q8BZE1|DMBTL_MOUSE Putative DMBT1-like protein OS=Mus musculus OX=10090 GN=Cdcp3 PE=2 SV=2,,,,,,
OG_14190,FUN_009865-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14714.t1b,apul_ptua,48.413,,,,,,,,,,,,,,,,,
OG_14191,FUN_010021-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5034.t1,apul_ptua,78.333,,,,,,,,,,,,,,,,,
OG_14192,FUN_010063-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16587.t1,apul_ptua,79.464,,,,,,,,,,,,,,,,,
OG_14193,FUN_010078-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16158.t1,apul_ptua,60.606,,,,,,,,,,,,,,,,,
OG_14194,FUN_010081-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16069.t1a,apul_ptua,80.0,,,,,,,,,,,,,,,,,
OG_14195,FUN_010083-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25993.t1,apul_ptua,40.698,,,,,,,,,,,,,,,,,
OG_14196,FUN_010093-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2778.t1b,apul_ptua,48.333,,,,,,,,,,,,,,,,,
OG_14197,FUN_010106-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14340.t1,apul_ptua,39.5105,,,,,,,,,,,,,,,,,
OG_14198,FUN_010109-T1,,Pocillopora_meandrina_HIv1___TS.g17681.t1,apul_ptua,48.193,,,,,,,,,,,,,,,,,
OG_14199,FUN_010120-T1,,Pocillopora_meandrina_HIv1___TS.g21339.t1,apul_ptua,45.185,,,,,,,,,,,,,,,,,
OG_14200,FUN_010151-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7173.t1,apul_ptua,66.875,,,,,,,,,,,,,,,,,
OG_14201,FUN_010159-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22042.t1,apul_ptua,34.426,,,,,,,,,,,,,,,,,
OG_14202,FUN_010169-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11135.t1,apul_ptua,84.0,,,,,,,,,,,,,,,,,
OG_14203,FUN_010527-T1,,Pocillopora_meandrina_HIv1___TS.g17835.t1,apul_ptua,57.857,,,,,,,,,,,,,,,,,
OG_14204,FUN_010556-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21412.t2,apul_ptua,61.646,FUN_010556-T1,O60930,RNH1_HUMAN,,Ribonuclease H1 (RNase H1) (EC 3.1.26.4) (Ribonuclease H type II),Homo sapiens (Human),47.7,264.0,2.2999999999999998e-55,217.2,sp|O60930|RNH1_HUMAN Ribonuclease H1 OS=Homo sapiens OX=9606 GN=RNASEH1 PE=1 SV=2,GO:0000287; GO:0003676; GO:0003723; GO:0004523; GO:0004540; GO:0005739; GO:0005759; GO:0006401; GO:0043137,"DNA replication, removal of RNA primer [GO:0043137]; RNA catabolic process [GO:0006401]",mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; RNA nuclease activity [GO:0004540]; RNA-DNA hybrid ribonuclease activity [GO:0004523],GO:0003723; GO:0003824; GO:0005739; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; mitochondrion; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_14205,FUN_010560-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21415.t1,apul_ptua,64.9635,,,,,,,,,,,,,,,,,
OG_14206,FUN_010569-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21421.t1,apul_ptua,48.429,,,,,,,,,,,,,,,,,
OG_14207,FUN_010585-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21515.t1,apul_ptua,77.85,FUN_010585-T1,Q9GRC0,,,,,48.4,281.0,6.099999999999998e-69,262.7,sp|Q9GRC0|MOS_PATPE Serine/threonine-protein kinase mos OS=Patiria pectinifera OX=7594 GN=mos PE=1 SV=1,,,,,,
OG_14208,FUN_010587-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21513.t1,apul_ptua,40.3325,FUN_010587-T1,Q767L8,,,,,42.7,227.0,2e-40,169.9,sp|Q767L8|MDC1_PIG Mediator of DNA damage checkpoint protein 1 OS=Sus scrofa OX=9823 GN=MDC1 PE=3 SV=1,,,,,,
OG_14209,FUN_010593-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21508.t1,apul_ptua,69.838,,,,,,,,,,,,,,,,,
OG_14210,FUN_010616-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21486.t1c,apul_ptua,69.231,,,,,,,,,,,,,,,,,
OG_14211,FUN_010618-T2,,Pocillopora_meandrina_HIv1___RNAseq.g21486.t1a,apul_ptua,57.534,FUN_010618-T2,Q1T7B8,,,,,31.0,187.0,3.4e-17,90.5,sp|Q1T7B8|CENPO_CHICK Centromere protein O OS=Gallus gallus OX=9031 GN=CENPO PE=1 SV=2,,,,,,
OG_14212,FUN_010627-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21299.t1,apul_ptua,74.262,FUN_010627-T1,P70284,TGIF1_MOUSE,,Homeobox protein TGIF1 (5'-TG-3'-interacting factor 1),Mus musculus (Mouse),64.4,87.0,1e-27,125.2,sp|P70284|TGIF1_MOUSE Homeobox protein TGIF1 OS=Mus musculus OX=10090 GN=Tgif1 PE=1 SV=2,GO:0000122; GO:0000978; GO:0001227; GO:0001843; GO:0003682; GO:0005634; GO:0005654; GO:0007368; GO:0008283; GO:0008285; GO:0008432; GO:0009410; GO:0009953; GO:0010470; GO:0010629; GO:0030182; GO:0035881; GO:0038092; GO:0048144; GO:0048146; GO:0048387; GO:0060041; GO:0070410; GO:0071363; GO:1902871,amacrine cell differentiation [GO:0035881]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; fibroblast proliferation [GO:0048144]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neuron differentiation [GO:0030182]; nodal signaling pathway [GO:0038092]; positive regulation of amacrine cell differentiation [GO:1902871]; positive regulation of fibroblast proliferation [GO:0048146]; regulation of gastrulation [GO:0010470]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041],nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; JUN kinase binding [GO:0008432]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_14213,FUN_010628-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21300.t1,apul_ptua,69.364,FUN_010628-T1,O75414,NDK6_HUMAN,,Nucleoside diphosphate kinase 6 (NDK 6) (NDP kinase 6) (EC 2.7.4.6) (Inhibitor of p53-induced apoptosis-alpha) (IPIA-alpha) (nm23-H6),Homo sapiens (Human),44.8,172.0,7.4e-39,161.8,sp|O75414|NDK6_HUMAN Nucleoside diphosphate kinase 6 OS=Homo sapiens OX=9606 GN=NME6 PE=1 SV=3,GO:0004550; GO:0005524; GO:0005739; GO:0005743; GO:0005759; GO:0006183; GO:0006228; GO:0006241; GO:0006915; GO:0030308; GO:0045839; GO:0046872,apoptotic process [GO:0006915]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; negative regulation of cell growth [GO:0030308]; negative regulation of mitotic nuclear division [GO:0045839]; UTP biosynthetic process [GO:0006228],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550],GO:0003824; GO:0005739; GO:0012501; GO:0016740; GO:0043226; GO:0055086; GO:1901135,catalytic activity; mitochondrion; programmed cell death; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_14214,FUN_010631-T2,,Pocillopora_meandrina_HIv1___TS.g26053.t1,apul_ptua,81.203,FUN_010631-T2,P52758,RIDA_HUMAN,,2-iminobutanoate/2-iminopropanoate deaminase (EC 3.5.99.10) (14.5 kDa translational inhibitor protein) (hp14.5) (p14.5) (Heat-responsive protein 12) (Reactive intermediate imine deaminase A homolog) (Translation inhibitor L-PSP ribonuclease) (UK114 antigen homolog),Homo sapiens (Human),63.1,130.0,1.1e-40,167.5,sp|P52758|RIDA_HUMAN 2-iminobutanoate/2-iminopropanoate deaminase OS=Homo sapiens OX=9606 GN=RIDA PE=1 SV=1,GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005777; GO:0005829; GO:0006402; GO:0006629; GO:0016892; GO:0017148; GO:0019239; GO:0019518; GO:0061157; GO:0070062; GO:0120242; GO:0120243,L-threonine catabolic process to glycine [GO:0019518]; lipid metabolic process [GO:0006629]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; negative regulation of translation [GO:0017148],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisome [GO:0005777],"2-iminobutanoate deaminase activity [GO:0120242]; 2-iminopropanoate deaminase activity [GO:0120243]; deaminase activity [GO:0019239]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA endonuclease activity, producing 3'-phosphomonoesters [GO:0016892]",GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005777; GO:0005829; GO:0006520; GO:0006629; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; mitochondrion; peroxisome; cytosol; amino acid metabolic process; lipid metabolic process; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_14215,FUN_010641-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21363.t1,apul_ptua,43.636,,,,,,,,,,,,,,,,,
OG_14216,FUN_010653-T1,,Pocillopora_meandrina_HIv1___TS.g26074.t1,apul_ptua,36.641,,,,,,,,,,,,,,,,,
OG_14217,FUN_010657-T1,,Pocillopora_meandrina_HIv1___RNAseq.420_t,apul_ptua,54.878,,,,,,,,,,,,,,,,,
OG_14218,FUN_010669-T2,,Pocillopora_meandrina_HIv1___TS.g26105.t1,apul_ptua,68.075,,,,,,,,,,,,,,,,,
OG_14219,FUN_010688-T1,,Pocillopora_meandrina_HIv1___TS.g26089.t2,apul_ptua,82.09,FUN_010688-T1,Q91731,SX11A_XENLA,,Transcription factor Sox-11-A (xSox-11) (XLS13A),Xenopus laevis (African clawed frog),67.8,87.0,1.3e-27,125.2,sp|Q91731|SX11A_XENLA Transcription factor Sox-11-A OS=Xenopus laevis OX=8355 GN=sox11-a PE=1 SV=2,GO:0000122; GO:0000978; GO:0001228; GO:0005634; GO:0007399; GO:0007420; GO:0030182; GO:0043565; GO:0045944; GO:0048593,brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_14220,FUN_010722-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20950.t1,apul_ptua,40.5355,,,,,,,,,,,,,,,,,
OG_14221,FUN_010738-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20939.t1,apul_ptua,42.857,,,,,,,,,,,,,,,,,
OG_14222,FUN_010747-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18020.t1,apul_ptua,30.599,FUN_010747-T1,Q6DCQ5,,,,,27.0,244.0,4.4e-14,80.9,sp|Q6DCQ5|M212B_XENLA Protein mab-21-like 2-B OS=Xenopus laevis OX=8355 GN=mab21l2-b PE=2 SV=1,,,,,,
OG_14223,FUN_010758-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20921.t1,apul_ptua,80.208,FUN_010758-T1,Q9CYL5,,,,,33.1,157.0,3.1e-15,83.6,sp|Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr2 PE=1 SV=3,,,,,,
OG_14224,FUN_010759-T1,,Pocillopora_meandrina_HIv1___TS.g25680.t1a,apul_ptua,75.806,FUN_010759-T1,B3EWZ8,,,,,29.2,154.0,6.2e-12,72.4,sp|B3EWZ8|ECT_ACRMI Ectin (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_14225,FUN_010777-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21204.t1,apul_ptua,80.851,,,,,,,,,,,,,,,,,
OG_14226,FUN_010780-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21207.t2,apul_ptua,54.369,FUN_010780-T1,Q6AYR9,TSN1_RAT,,Tetraspanin-1 (Tspan-1),Rattus norvegicus (Rat),27.0,230.0,1.1e-07,58.9,sp|Q6AYR9|TSN1_RAT Tetraspanin-1 OS=Rattus norvegicus OX=10116 GN=Tspan1 PE=1 SV=1,GO:0005654; GO:0005737; GO:0005765; GO:0005886; GO:0016020; GO:0030054; GO:0031982; GO:0048471; GO:0050821,protein stabilization [GO:0050821],cell junction [GO:0030054]; cytoplasm [GO:0005737]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle [GO:0031982],,GO:0005654; GO:0005886; GO:0043226,nucleoplasm; plasma membrane; organelle
OG_14227,FUN_010821-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21905.t1,apul_ptua,56.376,,,,,,,,,,,,,,,,,
OG_14228,FUN_010822-T1,,Pocillopora_meandrina_HIv1___TS.g26663.t1,apul_ptua,57.36,,,,,,,,,,,,,,,,,
OG_14229,FUN_010828-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20911.t1,apul_ptua,63.815,FUN_010828-T1,C5PFX0,,,,,32.5,203.0,1.9e-16,89.0,sp|C5PFX0|LIS1_COCP7 Nuclear distribution protein PAC1 OS=Coccidioides posadasii (strain C735) OX=222929 GN=PAC1 PE=3 SV=2,,,,,,
OG_14230,FUN_010881-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21031.t1,apul_ptua,75.0,FUN_010881-T1,P52160,,,,,45.3,128.0,7.8e-16,85.1,sp|P52160|MYCA_DANRE Transcriptional regulator Myc-A OS=Danio rerio OX=7955 GN=myca PE=2 SV=3,,,,,,
OG_14231,FUN_010952-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21822.t3,apul_ptua,46.341,,,,,,,,,,,,,,,,,
OG_14232,FUN_010961-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21828.t1,apul_ptua,83.446,FUN_010961-T1,Q9Y2X7,GIT1_HUMAN,,ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1) (p95-APP1),Homo sapiens (Human),49.7,783.0,1.3999999999999998e-192,674.5,sp|Q9Y2X7|GIT1_HUMAN ARF GTPase-activating protein GIT1 OS=Homo sapiens OX=9606 GN=GIT1 PE=1 SV=2,GO:0001771; GO:0001957; GO:0005096; GO:0005739; GO:0005768; GO:0005813; GO:0005829; GO:0005925; GO:0007420; GO:0007626; GO:0008270; GO:0008277; GO:0014069; GO:0016020; GO:0019903; GO:0030027; GO:0030425; GO:0030426; GO:0031267; GO:0032012; GO:0032013; GO:0032465; GO:0032691; GO:0036465; GO:0042802; GO:0043005; GO:0043015; GO:0044305; GO:0044877; GO:0045202; GO:0045454; GO:0045820; GO:0048013; GO:0060076; GO:0060077; GO:0060996; GO:0061743; GO:0071222; GO:0071364; GO:0090063; GO:0097110; GO:0097431; GO:0098794; GO:0098879; GO:0098978; GO:0098982; GO:0099171; GO:0099645; GO:0106015; GO:1990782; GO:2000300; GO:2000646,brain development [GO:0007420]; cell redox homeostasis [GO:0045454]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to lipopolysaccharide [GO:0071222]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; immunological synapse formation [GO:0001771]; intramembranous ossification [GO:0001957]; locomotory behavior [GO:0007626]; motor learning [GO:0061743]; negative regulation of ARF protein signal transduction [GO:0032013]; negative regulation of glycolytic process [GO:0045820]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of interleukin-1 beta production [GO:0032691]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of receptor catabolic process [GO:2000646]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle recycling [GO:0036465],calyx of Held [GO:0044305]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; excitatory synapse [GO:0060076]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; inhibitory synapse [GO:0060077]; lamellipodium [GO:0030027]; membrane [GO:0016020]; mitochondrion [GO:0005739]; mitotic spindle pole [GO:0097431]; neuron projection [GO:0043005]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; synapse [GO:0045202],gamma-tubulin binding [GO:0043015]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; small GTPase binding [GO:0031267]; structural constituent of postsynaptic specialization [GO:0098879]; zinc ion binding [GO:0008270],GO:0005198; GO:0005739; GO:0005768; GO:0005815; GO:0005829; GO:0008092; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0098772,structural molecule activity; mitochondrion; endosome; microtubule organizing center; cytosol; cytoskeletal protein binding; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; molecular function regulator activity
OG_14233,FUN_010981-T1,,Pocillopora_meandrina_HIv1___TS.g26774.t1,apul_ptua,75.581,FUN_010981-T1,P49119,,,,,67.2,67.0,4.3e-17,90.5,sp|P49119|CDKA1_MESAU Cyclin-dependent kinase 2-associated protein 1 OS=Mesocricetus auratus OX=10036 GN=CDK2AP1 PE=2 SV=1,,,,,,
OG_14234,FUN_011050-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22323.t1,apul_ptua,51.958,FUN_011050-T1,Q9UDT6,CLIP2_HUMAN,,CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein),Homo sapiens (Human),38.4,380.0,1.4999999999999999e-53,213.4,sp|Q9UDT6|CLIP2_HUMAN CAP-Gly domain-containing linker protein 2 OS=Homo sapiens OX=9606 GN=CLIP2 PE=1 SV=1,GO:0005634; GO:0005875; GO:0005938; GO:0008017; GO:0031122; GO:0035371; GO:0051010,cytoplasmic microtubule organization [GO:0031122],cell cortex [GO:0005938]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; nucleus [GO:0005634],microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010],GO:0005634; GO:0007010; GO:0008092; GO:0043226,nucleus; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_14235,FUN_011067-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22324.t1,apul_ptua,66.887,FUN_011067-T1,Q9W074,HBS1_DROME,,Protein HBS1 (EC 3.6.5.-),Drosophila melanogaster (Fruit fly),34.8,161.0,5.8e-10,66.2,sp|Q9W074|HBS1_DROME Protein HBS1 OS=Drosophila melanogaster OX=7227 GN=HBS1 PE=1 SV=2,GO:0003924; GO:0005525; GO:0005737; GO:0006412; GO:0006417; GO:0007291; GO:0016441; GO:0045089; GO:0048137; GO:0050829,defense response to Gram-negative bacterium [GO:0050829]; positive regulation of innate immune response [GO:0045089]; post-transcriptional gene silencing [GO:0016441]; regulation of translation [GO:0006417]; sperm individualization [GO:0007291]; spermatocyte division [GO:0048137]; translation [GO:0006412],cytoplasm [GO:0005737],GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0016787; GO:0022414,catalytic activity; GTPase activity; hydrolase activity; reproductive process
OG_14236,FUN_011180-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26866.t1,apul_ptua,66.429,,,,,,,,,,,,,,,,,
OG_14237,FUN_011205-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16599.t1,apul_ptua,73.8485,,,,,,,,,,,,,,,,,
OG_14238,FUN_011232-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6710.t1,apul_ptua,45.296,,,,,,,,,,,,,,,,,
OG_14239,FUN_011237-T1,,Pocillopora_meandrina_HIv1___TS.g12563.t1,apul_ptua,32.903,,,,,,,,,,,,,,,,,
OG_14240,FUN_011423-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25142.t1,apul_ptua,44.643,,,,,,,,,,,,,,,,,
OG_14241,FUN_011460-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17645.t1,apul_ptua,66.667,,,,,,,,,,,,,,,,,
OG_14242,FUN_011485-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3364.t1,apul_ptua,76.364,,,,,,,,,,,,,,,,,
OG_14243,FUN_011511-T1,,Pocillopora_meandrina_HIv1___TS.g11254.t1,apul_ptua,49.677,,,,,,,,,,,,,,,,,
OG_14244,FUN_011512-T1,,Pocillopora_meandrina_HIv1___TS.g17165.t1b,apul_ptua,47.619,,,,,,,,,,,,,,,,,
OG_14245,FUN_011691-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23908.t1,apul_ptua,82.017,FUN_011691-T1,P29146,,,,,52.3,852.0,3.5e-238,826.2,sp|P29146|NECA_HYDVU PC3-like endoprotease variant A OS=Hydra vulgaris OX=6087 PE=2 SV=1,,,,,,
OG_14246,FUN_011711-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23815.t1,apul_ptua,53.592,FUN_011711-T1,Q99K82,,,,,31.9,539.0,2.9e-67,257.7,sp|Q99K82|SMOX_MOUSE Spermine oxidase OS=Mus musculus OX=10090 GN=Smox PE=1 SV=1,,,,,,
OG_14247,FUN_011720-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22003.t1,apul_ptua,51.546,,,,,,,,,,,,,,,,,
OG_14248,FUN_011736-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23839.t1,apul_ptua,68.7,FUN_011736-T1,P10696,PPBN_HUMAN,,"Alkaline phosphatase, germ cell type (EC 3.1.3.1) (ALP-1) (Alkaline phosphatase Nagao isozyme) (Alkaline phosphatase, placental-like) (Germ cell alkaline phosphatase) (GCAP) (Placental alkaline phosphatase-like) (PLAP-like)",Homo sapiens (Human),44.9,548.0,1.4e-115,418.3,"sp|P10696|PPBN_HUMAN Alkaline phosphatase, germ cell type OS=Homo sapiens OX=9606 GN=ALPG PE=1 SV=4",GO:0004035; GO:0005576; GO:0005886; GO:0046872; GO:0098552,,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0005886; GO:0016787,catalytic activity; extracellular region; plasma membrane; hydrolase activity
OG_14249,FUN_011738-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23804.t1,apul_ptua,52.1495,,,,,,,,,,,,,,,,,
OG_14250,FUN_011902-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23790.t2,apul_ptua,73.7425,FUN_011902-T1,Q5JWR5,DOP1A_HUMAN,,Protein DOP1A,Homo sapiens (Human),34.6,2688.0,0.0,1305.0,sp|Q5JWR5|DOP1A_HUMAN Protein DOP1A OS=Homo sapiens OX=9606 GN=DOP1A PE=1 SV=1,GO:0000139; GO:0005768; GO:0005798; GO:0005802; GO:0005829; GO:0006895; GO:0015031,Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; trans-Golgi network [GO:0005802],,GO:0005768; GO:0005829; GO:0016192; GO:0031410; GO:0043226,endosome; cytosol; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_14251,FUN_011905-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23366.t1,apul_ptua,47.712,FUN_011905-T1,Q9D4G9,RMI1_MOUSE,,RecQ-mediated genome instability protein 1,Mus musculus (Mouse),42.9,210.0,8.7e-38,160.2,sp|Q9D4G9|RMI1_MOUSE RecQ-mediated genome instability protein 1 OS=Mus musculus OX=10090 GN=Rmi1 PE=2 SV=1,GO:0000166; GO:0000724; GO:0002021; GO:0002023; GO:0005634; GO:0006260; GO:0009749; GO:0016604; GO:0031422; GO:0035264; GO:0042593; GO:0071139,DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; resolution of DNA recombination intermediates [GO:0071139]; response to dietary excess [GO:0002021]; response to glucose [GO:0009749],nuclear body [GO:0016604]; nucleus [GO:0005634]; RecQ family helicase-topoisomerase III complex [GO:0031422],nucleotide binding [GO:0000166],GO:0005634; GO:0006260; GO:0006281; GO:0006310; GO:0043226,nucleus; DNA replication; DNA repair; DNA recombination; organelle
OG_14252,FUN_011963-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23734.t1,apul_ptua,80.309,FUN_011963-T1,Q6TGS6,,,,,65.3,521.0,1e-190,667.9,"sp|Q6TGS6|SYYC_DANRE Tyrosine--tRNA ligase, cytoplasmic OS=Danio rerio OX=7955 GN=yars1 PE=2 SV=2",,,,,,
OG_14253,FUN_011964-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23733.t1,apul_ptua,57.2565,,,,,,,,,,,,,,,,,
OG_14254,FUN_011979-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23718.t1,apul_ptua,45.382,FUN_011979-T1,O62714,,,,,29.0,907.0,3.7e-82,308.1,sp|O62714|CASR_PIG Extracellular calcium-sensing receptor OS=Sus scrofa OX=9823 GN=CASR PE=2 SV=3,,,,,,
OG_14255,FUN_011989-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23711.t1,apul_ptua,92.814,FUN_011989-T1,Q6GQB5,,,,,51.6,182.0,9.4e-36,151.4,sp|Q6GQB5|AKIR2_XENLA Akirin-2 OS=Xenopus laevis OX=8355 GN=akirin2.S PE=1 SV=1,,,,,,
OG_14256,FUN_011996-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23702.t1,apul_ptua,52.941,FUN_011996-T1,Q3U9N9,MOT10_MOUSE,,Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1),Mus musculus (Mouse),29.0,431.0,2.2e-41,171.4,sp|Q3U9N9|MOT10_MOUSE Monocarboxylate transporter 10 OS=Mus musculus OX=10090 GN=Slc16a10 PE=1 SV=1,GO:0005302; GO:0006590; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0030054; GO:0043231; GO:0070327; GO:0070460,aromatic amino acid transport [GO:0015801]; thyroid hormone generation [GO:0006590]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460],basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; intracellular membrane-bounded organelle [GO:0043231],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349],GO:0005215; GO:0006575; GO:0043226,transporter activity; modified amino acid metabolic process; organelle
OG_14257,FUN_012010-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24031.t1,apul_ptua,42.6315,FUN_012010-T1,Q8C6K9,,,,,25.6,160.0,4.9e-06,53.1,sp|Q8C6K9|CO6A6_MOUSE Collagen alpha-6(VI) chain OS=Mus musculus OX=10090 GN=Col6a6 PE=1 SV=2,,,,,,
OG_14258,FUN_012031-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24055.t1,apul_ptua,48.048,FUN_012031-T1,Q5UAW9,GP157_HUMAN,,G-protein coupled receptor 157,Homo sapiens (Human),34.0,291.0,4.0000000000000004e-39,163.7,sp|Q5UAW9|GP157_HUMAN G-protein coupled receptor 157 OS=Homo sapiens OX=9606 GN=GPR157 PE=1 SV=2,GO:0004930; GO:0005886; GO:0007166; GO:0007189; GO:0007200; GO:0048512; GO:0060019; GO:0060170,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; circadian behavior [GO:0048512]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; radial glial cell differentiation [GO:0060019],ciliary membrane [GO:0060170]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0030154; GO:0060089,plasma membrane; cell differentiation; molecular transducer activity
OG_14259,FUN_012052-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23647.t1,apul_ptua,67.20949999999999,FUN_012052-T1,Q5FWR0,,,,,52.6,646.0,1.6e-187,657.9,sp|Q5FWR0|SMRCD_XENTR SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 OS=Xenopus tropicalis OX=8364 GN=smarcad1 PE=2 SV=1,,,,,,
OG_14260,FUN_012074-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23630.t1,apul_ptua,81.467,FUN_012074-T1,P21549,AGT1_HUMAN,,Alanine--glyoxylate aminotransferase (AGT) (EC 2.6.1.44) (Serine--pyruvate aminotransferase) (SPT) (EC 2.6.1.51),Homo sapiens (Human),51.9,258.0,6.3e-79,295.4,sp|P21549|AGT1_HUMAN Alanine--glyoxylate aminotransferase OS=Homo sapiens OX=9606 GN=AGXT PE=1 SV=1,GO:0004760; GO:0005777; GO:0005782; GO:0005829; GO:0006563; GO:0007219; GO:0008453; GO:0008483; GO:0009436; GO:0016597; GO:0019265; GO:0019448; GO:0030170; GO:0042802; GO:0042803; GO:0042853; GO:0043231; GO:0046487; GO:0046724,"glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; L-serine metabolic process [GO:0006563]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724]",cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; identical protein binding [GO:0042802]; L-serine-pyruvate transaminase activity [GO:0004760]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],GO:0003824; GO:0005777; GO:0005829; GO:0006520; GO:0006790; GO:0016740; GO:0043226,catalytic activity; peroxisome; cytosol; amino acid metabolic process; sulfur compound metabolic process; transferase activity; organelle
OG_14261,FUN_012104-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23935.t1,apul_ptua,64.103,FUN_012104-T1,Q9W0M3,KDM8_DROME,,Jumonji C domain-containing protein 5 (EC 1.14.11.73) (EC 3.4.-.-) (Lysine-specific demethylase 8),Drosophila melanogaster (Fruit fly),24.5,229.0,1.8e-14,82.0,sp|Q9W0M3|KDM8_DROME Jumonji C domain-containing protein 5 OS=Drosophila melanogaster OX=7227 GN=JMJD5 PE=2 SV=2,GO:0000086; GO:0003682; GO:0005634; GO:0005654; GO:0005737; GO:0045892; GO:0046872; GO:0048511; GO:0048512; GO:0051864; GO:0106157; GO:0140680,circadian behavior [GO:0048512]; G2/M transition of mitotic cell cycle [GO:0000086]; negative regulation of DNA-templated transcription [GO:0045892]; rhythmic process [GO:0048511],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3K36 demethylase activity [GO:0051864]; histone H3K36me/H3K36me2 demethylase activity [GO:0140680]; metal ion binding [GO:0046872]; peptidyl-arginine 3-dioxygenase activity [GO:0106157],GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016491; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; oxidoreductase activity; organelle; catalytic activity, acting on a protein"
OG_14262,FUN_012114-T2,,Pocillopora_meandrina_HIv1___RNAseq.g23923.t1,apul_ptua,63.078500000000005,FUN_012114-T2,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),37.2,234.0,1.6e-42,176.0,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_14263,FUN_012135-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23779.t1,apul_ptua,86.62,,,,,,,,,,,,,,,,,
OG_14264,FUN_012137-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23777.t1,apul_ptua,66.667,FUN_012137-T1,P37802,TAGL2_HUMAN,,Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog),Homo sapiens (Human),39.4,203.0,2.4e-25,117.1,sp|P37802|TAGL2_HUMAN Transgelin-2 OS=Homo sapiens OX=9606 GN=TAGLN2 PE=1 SV=3,GO:0005576; GO:0005829; GO:0007015; GO:0015629; GO:0030855; GO:0031982; GO:0045296; GO:0051015; GO:0070062,actin filament organization [GO:0007015]; epithelial cell differentiation [GO:0030855],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; vesicle [GO:0031982],actin filament binding [GO:0051015]; cadherin binding [GO:0045296],GO:0005576; GO:0005829; GO:0005856; GO:0008092; GO:0030154; GO:0043226,extracellular region; cytosol; cytoskeleton; cytoskeletal protein binding; cell differentiation; organelle
OG_14265,FUN_012172-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23455.t1,apul_ptua,59.786,FUN_012172-T1,Q96C24,SYTL4_HUMAN,,Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin),Homo sapiens (Human),42.4,328.0,1.2e-59,232.6,sp|Q96C24|SYTL4_HUMAN Synaptotagmin-like protein 4 OS=Homo sapiens OX=9606 GN=SYTL4 PE=1 SV=2,GO:0001778; GO:0005543; GO:0005768; GO:0005886; GO:0006886; GO:0006887; GO:0008270; GO:0030073; GO:0030658; GO:0031092; GO:0031267; GO:0032418; GO:0042043; GO:0045921; GO:0046676; GO:0050714; GO:0070382; GO:0071985; GO:1905684,exocytosis [GO:0006887]; insulin secretion [GO:0030073]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; multivesicular body sorting pathway [GO:0071985]; negative regulation of insulin secretion [GO:0046676]; plasma membrane repair [GO:0001778]; positive regulation of exocytosis [GO:0045921]; positive regulation of protein secretion [GO:0050714]; regulation of plasma membrane repair [GO:1905684],endosome [GO:0005768]; exocytic vesicle [GO:0070382]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; transport vesicle membrane [GO:0030658],neurexin family protein binding [GO:0042043]; phospholipid binding [GO:0005543]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270],GO:0005768; GO:0005886; GO:0006886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024,endosome; plasma membrane; intracellular protein transport; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization
OG_14266,FUN_012173-T3,,Pocillopora_meandrina_HIv1___RNAseq.g23406.t1,apul_ptua,48.423,FUN_012173-T3,Q62935,VWF_RAT,,von Willebrand factor (vWF),Rattus norvegicus (Rat),21.5,381.0,3.9e-18,94.4,sp|Q62935|VWF_RAT von Willebrand factor (Fragment) OS=Rattus norvegicus OX=10116 GN=Vwf PE=2 SV=2,GO:0001889; GO:0001890; GO:0002020; GO:0002543; GO:0005178; GO:0005518; GO:0005576; GO:0005615; GO:0005783; GO:0006954; GO:0007155; GO:0007596; GO:0007599; GO:0009897; GO:0010165; GO:0019865; GO:0030168; GO:0030198; GO:0031589; GO:0033093; GO:0033591; GO:0035902; GO:0042802; GO:0051087; GO:0062023; GO:0070417; GO:0071222; GO:0097421; GO:1902533,activation of blood coagulation via clotting cascade [GO:0002543]; blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; cellular response to cold [GO:0070417]; cellular response to lipopolysaccharide [GO:0071222]; extracellular matrix organization [GO:0030198]; hemostasis [GO:0007599]; inflammatory response [GO:0006954]; liver development [GO:0001889]; liver regeneration [GO:0097421]; placenta development [GO:0001890]; platelet activation [GO:0030168]; positive regulation of intracellular signal transduction [GO:1902533]; response to immobilization stress [GO:0035902]; response to L-ascorbic acid [GO:0033591]; response to X-ray [GO:0010165],collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Weibel-Palade body [GO:0033093],collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein-folding chaperone binding [GO:0051087],GO:0005576; GO:0005615; GO:0005783; GO:0006954; GO:0007155; GO:0030198; GO:0031410; GO:0043226; GO:0048856,extracellular region; extracellular space; endoplasmic reticulum; inflammatory response; cell adhesion; extracellular matrix organization; cytoplasmic vesicle; organelle; anatomical structure development
OG_14267,FUN_012174-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23409.t1,apul_ptua,51.073,FUN_012174-T1,Q19791,GON1_CAEEL,,A disintegrin and metalloproteinase with thrombospondin motifs gon-1 (ADAMTS gon-1) (EC 3.4.24.-) (Abnormal gonad development protein 1),Caenorhabditis elegans,50.9,57.0,4.2e-12,73.6,sp|Q19791|GON1_CAEEL A disintegrin and metalloproteinase with thrombospondin motifs gon-1 OS=Caenorhabditis elegans OX=6239 GN=gon-1 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005604; GO:0005783; GO:0005794; GO:0006508; GO:0006888; GO:0008237; GO:0008270; GO:0008406; GO:0015031; GO:0016477; GO:0030198; GO:0031012; GO:0048644; GO:1905607,cell migration [GO:0016477]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; extracellular matrix organization [GO:0030198]; gonad development [GO:0008406]; muscle organ morphogenesis [GO:0048644]; negative regulation of presynapse assembly [GO:1905607]; protein transport [GO:0015031]; proteolysis [GO:0006508],basement membrane [GO:0005604]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005783; GO:0005794; GO:0016192; GO:0016787; GO:0022414; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; extracellular region; endoplasmic reticulum; Golgi apparatus; vesicle-mediated transport; hydrolase activity; reproductive process; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_14268,FUN_012207-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23423.t1,apul_ptua,44.718,,,,,,,,,,,,,,,,,
OG_14269,FUN_012216-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23430.t1,apul_ptua,48.383,FUN_012216-T1,Q96B97,SH3K1_HUMAN,,SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1),Homo sapiens (Human),28.5,702.0,1.1999999999999999e-39,166.4,sp|Q96B97|SH3K1_HUMAN SH3 domain-containing kinase-binding protein 1 OS=Homo sapiens OX=9606 GN=SH3KBP1 PE=1 SV=2,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005911; GO:0005925; GO:0006897; GO:0006915; GO:0007010; GO:0007015; GO:0007267; GO:0008360; GO:0014069; GO:0016477; GO:0017124; GO:0030139; GO:0030659; GO:0031625; GO:0043005; GO:0050871; GO:0098978; GO:0098982,actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; positive regulation of B cell activation [GO:0050871]; regulation of cell shape [GO:0008360],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],SH3 domain binding [GO:0017124]; ubiquitin protein ligase binding [GO:0031625],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0012501; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0048870,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; programmed cell death; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; cell motility
OG_14270,FUN_012227-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23535.t1,apul_ptua,65.269,FUN_012227-T1,Q21540,,,,,32.8,131.0,2.9e-11,70.1,sp|Q21540|CUT6_CAEEL Cuticlin-6 OS=Caenorhabditis elegans OX=6239 GN=cut-6 PE=1 SV=2,,,,,,
OG_14271,FUN_012232-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23533.t1,apul_ptua,90.303,FUN_012232-T1,Q52KD8,,,,,67.9,112.0,8.099999999999998e-35,148.3,sp|Q52KD8|EAF6_XENLA Chromatin modification-related protein MEAF6 OS=Xenopus laevis OX=8355 GN=meaf6 PE=2 SV=1,,,,,,
OG_14272,FUN_012306-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23761.t1,apul_ptua,51.685,,,,,,,,,,,,,,,,,
OG_14273,FUN_012307-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23760.t1,apul_ptua,86.42,FUN_012307-T1,Q4QQS3,,,,,61.1,321.0,2.0000000000000002e-104,380.9,sp|Q4QQS3|OSCP1_RAT Protein OSCP1 OS=Rattus norvegicus OX=10116 GN=Oscp1 PE=2 SV=1,,,,,,
OG_14274,FUN_012331-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23755.t1,apul_ptua,63.269,FUN_012331-T1,Q96GD3,SCMH1_HUMAN,,Polycomb protein SCMH1 (Sex comb on midleg homolog 1),Homo sapiens (Human),36.7,442.0,1.4e-70,269.2,sp|Q96GD3|SCMH1_HUMAN Polycomb protein SCMH1 OS=Homo sapiens OX=9606 GN=SCMH1 PE=1 SV=1,GO:0003682; GO:0005634; GO:0005654; GO:0031507; GO:0042393; GO:0045892,heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0042393; GO:0043226,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; histone binding; organelle
OG_14275,FUN_012364-T1,,Pocillopora_meandrina_HIv1___TS.g16149.t1,apul_ptua,56.911,,,,,,,,,,,,,,,,,
OG_14276,FUN_012375-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23354.t1,apul_ptua,52.608,FUN_012375-T1,Q9NYQ8,FAT2_HUMAN,,Protocadherin Fat 2 (hFat2) (Cadherin family member 8) (Multiple epidermal growth factor-like domains protein 1) (Multiple EGF-like domains protein 1),Homo sapiens (Human),26.1,410.0,4.4e-12,76.3,sp|Q9NYQ8|FAT2_HUMAN Protocadherin Fat 2 OS=Homo sapiens OX=9606 GN=FAT2 PE=1 SV=2,GO:0005509; GO:0005794; GO:0005886; GO:0005912; GO:0007156; GO:0010631; GO:0031589; GO:0070062; GO:0098609,cell-cell adhesion [GO:0098609]; cell-substrate adhesion [GO:0031589]; epithelial cell migration [GO:0010631]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005794; GO:0005886; GO:0007155; GO:0043226; GO:0048870,Golgi apparatus; plasma membrane; cell adhesion; organelle; cell motility
OG_14277,FUN_012395-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23661.t1,apul_ptua,55.464,,,,,,,,,,,,,,,,,
OG_14278,FUN_012396-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23663.t1,apul_ptua,58.993,,,,,,,,,,,,,,,,,
OG_14279,FUN_012397-T2,,Pocillopora_meandrina_HIv1___TS.g16540.t1,apul_ptua,60.291,FUN_012397-T2,Q80X19,COEA1_MOUSE,,Collagen alpha-1(XIV) chain,Mus musculus (Mouse),31.5,162.0,4.8e-13,77.8,sp|Q80X19|COEA1_MOUSE Collagen alpha-1(XIV) chain OS=Mus musculus OX=10090 GN=Col14a1 PE=1 SV=2,GO:0003229; GO:0005581; GO:0005614; GO:0005615; GO:0007155; GO:0030199; GO:0048873; GO:0061050; GO:0062023,cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; homeostasis of number of cells within a tissue [GO:0048873]; regulation of cell growth involved in cardiac muscle cell development [GO:0061050]; ventricular cardiac muscle tissue development [GO:0003229],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614],,GO:0005615; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular space; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_14280,FUN_012410-T1,,Pocillopora_meandrina_HIv1___TS.g16550.t2,apul_ptua,67.917,FUN_012410-T1,P46939,UTRN_HUMAN,,Utrophin (Dystrophin-related protein 1) (DRP-1),Homo sapiens (Human),28.6,781.0,3.8e-76,287.7,sp|P46939|UTRN_HUMAN Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,GO:0001954; GO:0003779; GO:0005178; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0006936; GO:0007517; GO:0008270; GO:0016010; GO:0016020; GO:0017166; GO:0019901; GO:0030175; GO:0031527; GO:0031594; GO:0032991; GO:0036064; GO:0042383; GO:0045211; GO:0070062; GO:0099536; GO:1902305,muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; positive regulation of cell-matrix adhesion [GO:0001954]; regulation of sodium ion transmembrane transport [GO:1902305]; synaptic signaling [GO:0099536],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dystrophin-associated glycoprotein complex [GO:0016010]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383],actin binding [GO:0003779]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; vinculin binding [GO:0017166]; zinc ion binding [GO:0008270],GO:0003012; GO:0005654; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0008092; GO:0023052; GO:0043226; GO:0048856,muscle system process; nucleoplasm; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeletal protein binding; signaling; organelle; anatomical structure development
OG_14281,FUN_012429-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24007.t1b,apul_ptua,42.161,,,,,,,,,,,,,,,,,
OG_14282,FUN_012434-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28595.t1,apul_ptua,44.828,,,,,,,,,,,,,,,,,
OG_14283,FUN_012454-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4090.t1,apul_ptua,56.111,,,,,,,,,,,,,,,,,
OG_14284,FUN_012461-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23683.t1,apul_ptua,66.47800000000001,FUN_012461-T1,Q0EEE2,PTHD3_MOUSE,,Patched domain-containing protein 3 (RND-type protein RNDEu-3),Mus musculus (Mouse),28.7,763.0,1.0000000000000001e-65,253.4,sp|Q0EEE2|PTHD3_MOUSE Patched domain-containing protein 3 OS=Mus musculus OX=10090 GN=Ptchd3 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005886; GO:0097225,,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225],,GO:0005783; GO:0005886; GO:0043226,endoplasmic reticulum; plasma membrane; organelle
OG_14285,FUN_012484-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23997.t1,apul_ptua,73.333,FUN_012484-T1,Q6DFA8,GLD2B_XENLA,,Poly(A) RNA polymerase GLD2-B (xGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4-B),Xenopus laevis (African clawed frog),38.1,320.0,2.3e-46,187.6,sp|Q6DFA8|GLD2B_XENLA Poly(A) RNA polymerase GLD2-B OS=Xenopus laevis OX=8355 GN=tent2-b PE=1 SV=1,GO:0005524; GO:0005737; GO:0006397; GO:0031123; GO:0046872; GO:0048477; GO:1990817; GO:2000626,mRNA processing [GO:0006397]; negative regulation of miRNA catabolic process [GO:2000626]; oogenesis [GO:0048477]; RNA 3'-end processing [GO:0031123],cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A) RNA polymerase activity [GO:1990817],GO:0003824; GO:0016071; GO:0016740; GO:0022414; GO:0048856,catalytic activity; mRNA metabolic process; transferase activity; reproductive process; anatomical structure development
OG_14286,FUN_012508-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23969.t1,apul_ptua,62.103,,,,,,,,,,,,,,,,,
OG_14287,FUN_012516-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23970.t1,apul_ptua,67.619,FUN_012516-T1,Q9P3U4,,,,,43.1,58.0,1.4e-10,67.4,sp|Q9P3U4|HEL1_SCHPO E3 ubiquitin-protein ligase dbl4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=dbl4 PE=3 SV=1,,,,,,
OG_14288,FUN_012523-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23962.t1,apul_ptua,77.099,FUN_012523-T1,Q9VHK6,,,,,72.5,131.0,8.499999999999999e-49,194.5,sp|Q9VHK6|ISCU_DROME Iron-sulfur cluster assembly enzyme IscU OS=Drosophila melanogaster OX=7227 GN=IscU PE=1 SV=1,,,,,,
OG_14289,FUN_012540-T1,,Pocillopora_meandrina_HIv1___TS.g16498.t1,apul_ptua,45.349,,,,,,,,,,,,,,,,,
OG_14290,FUN_012543-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23622.t1,apul_ptua,53.5925,,,,,,,,,,,,,,,,,
OG_14291,FUN_012544-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23590.t1,apul_ptua,68.276,FUN_012544-T1,Q94C69,,,,,48.0,100.0,1.7e-17,90.5,sp|Q94C69|CSP3_ARATH Cold shock domain-containing protein 3 OS=Arabidopsis thaliana OX=3702 GN=CSP3 PE=1 SV=1,,,,,,
OG_14292,FUN_012552-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5622.t1,apul_ptua,37.5,,,,,,,,,,,,,,,,,
OG_14293,FUN_012583-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5823.t1,apul_ptua,54.07,,,,,,,,,,,,,,,,,
OG_14294,FUN_012597-T2,,Pocillopora_meandrina_HIv1___RNAseq.g13626.t1,apul_ptua,59.8035,FUN_012597-T2,P35409,,,,,27.1,306.0,1.8e-10,69.3,sp|P35409|GLHR_ANTEL Probable glycoprotein hormone G-protein coupled receptor OS=Anthopleura elegantissima OX=6110 PE=2 SV=1,,,,,,
OG_14295,FUN_012614-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13702.t1,apul_ptua,43.811,FUN_012614-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),36.2,177.0,1.4e-28,129.4,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_14296,FUN_012637-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22911.t2,apul_ptua,69.038,FUN_012637-T1,Q91V01,MBOA5_MOUSE,,Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (mLPCAT3) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5),Mus musculus (Mouse),40.0,472.0,2.9e-90,334.0,sp|Q91V01|MBOA5_MOUSE Lysophospholipid acyltransferase 5 OS=Mus musculus OX=10090 GN=Lpcat3 PE=1 SV=1,GO:0005789; GO:0008654; GO:0034378; GO:0034379; GO:0036150; GO:0036151; GO:0036152; GO:0036335; GO:0045540; GO:0045797; GO:0047184; GO:0050728; GO:0090158; GO:0097006; GO:0106262; GO:0106263; GO:1903573; GO:1905885,chylomicron assembly [GO:0034378]; endoplasmic reticulum membrane organization [GO:0090158]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid biosynthetic process [GO:0008654]; positive regulation of intestinal cholesterol absorption [GO:0045797]; positive regulation of triglyceride transport [GO:1905885]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of plasma lipoprotein particle levels [GO:0097006]; very-low-density lipoprotein particle assembly [GO:0034379],endoplasmic reticulum membrane [GO:0005789],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-acylglycerophosphoethanolamine O-acyltransferase activity [GO:0106262]; 1-acylglycerophosphoserine O-acyltransferase activity [GO:0106263],GO:0003824; GO:0006575; GO:0006629; GO:0016740; GO:0061024; GO:0065003,catalytic activity; modified amino acid metabolic process; lipid metabolic process; transferase activity; membrane organization; protein-containing complex assembly
OG_14297,FUN_012643-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22907.t1,apul_ptua,44.6955,,,,,,,,,,,,,,,,,
OG_14298,FUN_012654-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22897.t1,apul_ptua,66.938,FUN_012654-T1,O43246,,,,,41.6,591.0,5.600000000000001e-118,426.4,sp|O43246|CTR4_HUMAN Cationic amino acid transporter 4 OS=Homo sapiens OX=9606 GN=SLC7A4 PE=1 SV=3,,,,,,
OG_14299,FUN_012663-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22888.t1,apul_ptua,38.9695,FUN_012663-T1,Q6IR42,ZCPW1_MOUSE,,Zinc finger CW-type PWWP domain protein 1,Mus musculus (Mouse),34.4,270.0,3.6e-31,138.7,sp|Q6IR42|ZCPW1_MOUSE Zinc finger CW-type PWWP domain protein 1 OS=Mus musculus OX=10090 GN=Zcwpw1 PE=1 SV=2,GO:0001741; GO:0005634; GO:0007127; GO:0007129; GO:0007283; GO:0008270; GO:0030154; GO:0045911; GO:0140002; GO:0140003; GO:0140566; GO:1990918; GO:2000781,cell differentiation [GO:0030154]; double-strand break repair involved in meiotic recombination [GO:1990918]; homologous chromosome pairing at meiosis [GO:0007129]; meiosis I [GO:0007127]; positive regulation of DNA recombination [GO:0045911]; positive regulation of double-strand break repair [GO:2000781]; spermatogenesis [GO:0007283],nucleus [GO:0005634]; XY body [GO:0001741],histone H3K36me3 reader activity [GO:0140003]; histone H3K4me3 reader activity [GO:0140002]; histone reader activity [GO:0140566]; zinc ion binding [GO:0008270],GO:0005634; GO:0005694; GO:0006281; GO:0022414; GO:0030154; GO:0043226; GO:0060090; GO:0140013,nucleus; chromosome; DNA repair; reproductive process; cell differentiation; organelle; molecular adaptor activity; meiotic nuclear division
OG_14300,FUN_012682-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22876.t1,apul_ptua,71.392,FUN_012682-T1,O22943,STL1_ARATH,,Probable glycosyltransferase STELLO1 (EC 2.4.-.-),Arabidopsis thaliana (Mouse-ear cress),39.3,405.0,6.4e-82,306.2,sp|O22943|STL1_ARATH Probable glycosyltransferase STELLO1 OS=Arabidopsis thaliana OX=3702 GN=STL1 PE=1 SV=1,GO:0000139; GO:0005768; GO:0005794; GO:0005802; GO:0016757; GO:0042802; GO:0052324; GO:2001009,plant-type cell wall cellulose biosynthetic process [GO:0052324]; regulation of plant-type cell wall cellulose biosynthetic process [GO:2001009],endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802],glycosyltransferase activity [GO:0016757]; identical protein binding [GO:0042802],GO:0003824; GO:0005768; GO:0005794; GO:0005975; GO:0016740; GO:0031410; GO:0043226,catalytic activity; endosome; Golgi apparatus; carbohydrate metabolic process; transferase activity; cytoplasmic vesicle; organelle
OG_14301,FUN_012685-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22873.t1,apul_ptua,86.124,FUN_012685-T1,Q5EBG8,,,,,54.5,176.0,6.100000000000001e-48,192.2,sp|Q5EBG8|CA050_MOUSE Uncharacterized protein C1orf50 homolog OS=Mus musculus OX=10090 PE=1 SV=1,,,,,,
OG_14302,FUN_012690-T2,,Pocillopora_meandrina_HIv1___RNAseq.g22863.t1,apul_ptua,71.721,FUN_012690-T2,Q09143,CTR1_MOUSE,,High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor) (Ecotropic retrovirus receptor) (ERR) (EcoR) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter),Mus musculus (Mouse),47.0,594.0,1.9e-129,464.5,sp|Q09143|CTR1_MOUSE High affinity cationic amino acid transporter 1 OS=Mus musculus OX=10090 GN=Slc7a1 PE=1 SV=1,GO:0000064; GO:0001618; GO:0005290; GO:0015189; GO:0015819; GO:0016020; GO:0016323; GO:0016324; GO:0032991; GO:0042102; GO:0061459; GO:1903352; GO:1903810; GO:1903826,L-arginine transmembrane transport [GO:1903826]; L-histidine import across plasma membrane [GO:1903810]; L-ornithine transmembrane transport [GO:1903352]; lysine transport [GO:0015819]; positive regulation of T cell proliferation [GO:0042102],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; membrane [GO:0016020]; protein-containing complex [GO:0032991],L-arginine transmembrane transporter activity [GO:0061459]; L-histidine transmembrane transporter activity [GO:0005290]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064]; virus receptor activity [GO:0001618],GO:0001618; GO:0005215; GO:0055085,virus receptor activity; transporter activity; transmembrane transport
OG_14303,FUN_012694-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22858.t1,apul_ptua,79.679,FUN_012694-T1,Q8NB59,,,,,24.5,253.0,6e-18,92.8,sp|Q8NB59|SYT14_HUMAN Synaptotagmin-14 OS=Homo sapiens OX=9606 GN=SYT14 PE=1 SV=2,,,,,,
OG_14304,FUN_012721-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24689.t1,apul_ptua,58.667,,,,,,,,,,,,,,,,,
OG_14305,FUN_012726-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9012.t1,apul_ptua,73.451,,,,,,,,,,,,,,,,,
OG_14306,FUN_012748-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21854.t1,apul_ptua,71.005,,,,,,,,,,,,,,,,,
OG_14307,FUN_012752-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23175.t1,apul_ptua,40.5415,,,,,,,,,,,,,,,,,
OG_14308,FUN_012763-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23163.t1,apul_ptua,64.746,,,,,,,,,,,,,,,,,
OG_14309,FUN_012803-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27213.t1,apul_ptua,82.231,,,,,,,,,,,,,,,,,
OG_14310,FUN_012804-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1233.t1,apul_ptua,68.889,,,,,,,,,,,,,,,,,
OG_14311,FUN_012835-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9467.t1,apul_ptua,40.8,,,,,,,,,,,,,,,,,
OG_14312,FUN_012860-T1,,Pocillopora_meandrina_HIv1___TS.g11118.t1,apul_ptua,52.632,,,,,,,,,,,,,,,,,
OG_14313,FUN_012871-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12948.t1,apul_ptua,78.947,FUN_012871-T1,P00940,,,,,69.7,244.0,4.6e-95,349.0,sp|P00940|TPIS_CHICK Triosephosphate isomerase OS=Gallus gallus OX=9031 GN=TPI1 PE=1 SV=2,,,,,,
OG_14314,FUN_012971-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12972.t1,apul_ptua,64.052,,,,,,,,,,,,,,,,,
OG_14315,FUN_012972-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12973.t1,apul_ptua,43.855,,,,,,,,,,,,,,,,,
OG_14316,FUN_013036-T1,,Pocillopora_meandrina_HIv1___TS.g10847.t1,apul_ptua,47.887,,,,,,,,,,,,,,,,,
OG_14317,FUN_013044-T1,,Pocillopora_meandrina_HIv1___TS.g26842.t1,apul_ptua,34.8125,,,,,,,,,,,,,,,,,
OG_14318,FUN_013092-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23224.t1,apul_ptua,37.162,,,,,,,,,,,,,,,,,
OG_14319,FUN_013102-T1,,Pocillopora_meandrina_HIv1___TS.g14192.t1,apul_ptua,76.509,,,,,,,,,,,,,,,,,
OG_14320,FUN_013305-T1,,Pocillopora_meandrina_HIv1___TS.g2823.t1,apul_ptua,68.687,FUN_013305-T1,P32027,,,,,46.2,91.0,2.1e-18,93.6,sp|P32027|CROC_DROME Fork head domain-containing protein crocodile OS=Drosophila melanogaster OX=7227 GN=croc PE=2 SV=2,,,,,,
OG_14321,FUN_013325-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13100.t1,apul_ptua,82.258,FUN_013325-T1,B3CRZ0,,,,,49.1,114.0,2.1e-24,113.2,sp|B3CRZ0|RL20_ORITI Large ribosomal subunit protein bL20 OS=Orientia tsutsugamushi (strain Ikeda) OX=334380 GN=rplT PE=3 SV=1,,,,,,
OG_14322,FUN_013328-T2,,Pocillopora_meandrina_HIv1___TS.g1982.t1,apul_ptua,52.92,FUN_013328-T2,Q8IS64,,,,,34.8,635.0,5.2e-115,416.8,sp|Q8IS64|ECE_LOCMI Endothelin-converting enzyme homolog OS=Locusta migratoria OX=7004 PE=2 SV=1,,,,,,
OG_14323,FUN_013338-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23008.t1,apul_ptua,37.255,,,,,,,,,,,,,,,,,
OG_14324,FUN_013342-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23010.t1,apul_ptua,51.294,FUN_013342-T1,Q9VBW3,CAD96_DROME,,Tyrosine kinase receptor Cad96Ca (EC 2.7.10.1) (Cadherin-96Ca) (Tyrosine kinase receptor HD-14),Drosophila melanogaster (Fruit fly),41.3,303.0,4.8e-67,257.7,sp|Q9VBW3|CAD96_DROME Tyrosine kinase receptor Cad96Ca OS=Drosophila melanogaster OX=7227 GN=Cad96Ca PE=2 SV=2,GO:0004713; GO:0004714; GO:0005509; GO:0005524; GO:0005886; GO:0006468; GO:0007030; GO:0007156; GO:0007169; GO:0016339; GO:0042060; GO:0043235; GO:0045177; GO:0045792; GO:0051897; GO:0090303,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; Golgi organization [GO:0007030]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell size [GO:0045792]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein phosphorylation [GO:0006468]; wound healing [GO:0042060],apical part of cell [GO:0045177]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005886; GO:0007155; GO:0016740; GO:0042060; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; cell adhesion; transferase activity; wound healing; molecular transducer activity; catalytic activity, acting on a protein"
OG_14325,FUN_013352-T1,,Pocillopora_meandrina_HIv1___TS.g2168.t1b,apul_ptua,39.456,FUN_013352-T1,P0DRH9,,,,,46.8,77.0,4.6e-10,65.9,sp|P0DRH9|INS1_EXADI Insulin-like peptide 01 OS=Exaiptasia diaphana OX=2652724 PE=3 SV=1,,,,,,
OG_14326,FUN_013358-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13336.t1,apul_ptua,82.036,,,,,,,,,,,,,,,,,
OG_14327,FUN_013383-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22981.t1,apul_ptua,87.28,FUN_013383-T1,E9PU28,IMDH2_RAT,,Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205),Rattus norvegicus (Rat),74.7,514.0,1.3e-221,770.4,sp|E9PU28|IMDH2_RAT Inosine-5'-monophosphate dehydrogenase 2 OS=Rattus norvegicus OX=10116 GN=Impdh2 PE=1 SV=1,GO:0000166; GO:0003938; GO:0005634; GO:0005737; GO:0005829; GO:0006164; GO:0006177; GO:0006183; GO:0007623; GO:0042802; GO:0046651; GO:0046872; GO:0060041; GO:0071353; GO:0097294,'de novo' XMP biosynthetic process [GO:0097294]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183]; lymphocyte proliferation [GO:0046651]; purine nucleotide biosynthetic process [GO:0006164]; retina development in camera-type eye [GO:0060041],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],identical protein binding [GO:0042802]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0016491; GO:0043226; GO:0048856; GO:0055086; GO:1901135,immune system process; catalytic activity; nucleus; cytosol; oxidoreductase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_14328,FUN_013388-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22978.t1,apul_ptua,70.69,FUN_013388-T1,O75880,SCO1_HUMAN,,"Protein SCO1 homolog, mitochondrial",Homo sapiens (Human),54.9,215.0,2.5e-68,260.4,"sp|O75880|SCO1_HUMAN Protein SCO1 homolog, mitochondrial OS=Homo sapiens OX=9606 GN=SCO1 PE=1 SV=1",GO:0005507; GO:0005739; GO:0005743; GO:0006878; GO:0016531; GO:0030016; GO:0033617,intracellular copper ion homeostasis [GO:0006878]; mitochondrial cytochrome c oxidase assembly [GO:0033617],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myofibril [GO:0030016],copper chaperone activity [GO:0016531]; copper ion binding [GO:0005507],GO:0005739; GO:0043226; GO:0065003; GO:0140104,mitochondrion; organelle; protein-containing complex assembly; molecular carrier activity
OG_14329,FUN_013397-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22936.t1,apul_ptua,62.132,,,,,,,,,,,,,,,,,
OG_14330,FUN_013412-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6058.t1,apul_ptua,57.88,,,,,,,,,,,,,,,,,
OG_14331,FUN_013437-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25265.t1a,apul_ptua,52.201,FUN_013437-T1,Q9CPW0,CNTP2_MOUSE,,Contactin-associated protein-like 2 (Cell recognition molecule Caspr2),Mus musculus (Mouse),37.6,157.0,2.7e-19,96.7,sp|Q9CPW0|CNTP2_MOUSE Contactin-associated protein-like 2 OS=Mus musculus OX=10090 GN=Cntnap2 PE=1 SV=2,GO:0000902; GO:0001701; GO:0002021; GO:0005769; GO:0005794; GO:0006954; GO:0007005; GO:0007155; GO:0007268; GO:0007409; GO:0007612; GO:0007622; GO:0007625; GO:0007626; GO:0008038; GO:0008104; GO:0008283; GO:0008306; GO:0009408; GO:0009410; GO:0009612; GO:0009642; GO:0009725; GO:0009986; GO:0010467; GO:0014009; GO:0016020; GO:0019226; GO:0019228; GO:0019899; GO:0021549; GO:0021692; GO:0021761; GO:0022010; GO:0030165; GO:0030424; GO:0030425; GO:0030673; GO:0031175; GO:0031929; GO:0032229; GO:0033010; GO:0035176; GO:0035264; GO:0035556; GO:0042552; GO:0042745; GO:0043005; GO:0043025; GO:0043194; GO:0044224; GO:0044309; GO:0044853; GO:0045163; GO:0045202; GO:0045444; GO:0045475; GO:0048265; GO:0048266; GO:0048787; GO:0048812; GO:0050884; GO:0050905; GO:0051898; GO:0060076; GO:0060079; GO:0060996; GO:0061351; GO:0061744; GO:0070371; GO:0071205; GO:0071625; GO:0090659; GO:0097061; GO:0097062; GO:0097106; GO:0097396; GO:0098529; GO:0098793; GO:0098794; GO:0098976; GO:0098977; GO:0098978; GO:0099072; GO:0099558; GO:0099610; GO:0140059; GO:0150048; GO:1901558; GO:1904456; GO:1904457; GO:1904861; GO:1904862; GO:1905962; GO:1990403; GO:1990834,"action potential initiation [GO:0099610]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; central nervous system myelination [GO:0022010]; cerebellar Purkinje cell layer morphogenesis [GO:0021692]; cerebellum development [GO:0021549]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle [GO:0042745]; clustering of voltage-gated potassium channels [GO:0045163]; dendrite arborization [GO:0140059]; dendritic spine development [GO:0060996]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; embryonic brain development [GO:1990403]; ERK1 and ERK2 cascade [GO:0070371]; excitatory chemical synaptic transmission [GO:0098976]; excitatory postsynaptic potential [GO:0060079]; excitatory synapse assembly [GO:1904861]; fat cell differentiation [GO:0045444]; gene expression [GO:0010467]; glial cell proliferation [GO:0014009]; glutamatergic neuron differentiation [GO:1905962]; grooming behavior [GO:0007625]; in utero embryonic development [GO:0001701]; inflammatory response [GO:0006954]; inhibitory chemical synaptic transmission [GO:0098977]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; limbic system development [GO:0021761]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; maintenance of synapse structure [GO:0099558]; mitochondrion organization [GO:0007005]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; myelination [GO:0042552]; negative regulation of neuronal action potential [GO:1904456]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of synaptic transmission, GABAergic [GO:0032229]; neural precursor cell proliferation [GO:0061351]; neuromuscular junction development, skeletal muscle fiber [GO:0098529]; neuromuscular process [GO:0050905]; neuromuscular process controlling posture [GO:0050884]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; neuron recognition [GO:0008038]; neuronal action potential [GO:0019228]; positive regulation of neuronal action potential [GO:1904457]; postsynaptic density organization [GO:0097106]; protein localization [GO:0008104]; protein localization to juxtaparanode region of axon [GO:0071205]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to dietary excess [GO:0002021]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to interleukin-17 [GO:0097396]; response to light intensity [GO:0009642]; response to mechanical stimulus [GO:0009612]; response to metformin [GO:1901558]; response to odorant [GO:1990834]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; rhythmic behavior [GO:0007622]; social behavior [GO:0035176]; TOR signaling [GO:0031929]; transmission of nerve impulse [GO:0019226]; vocalization behavior [GO:0071625]; walking behavior [GO:0090659]",axolemma [GO:0030673]; axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; cerebellar granule cell to Purkinje cell synapse [GO:0150048]; dendrite [GO:0030425]; early endosome [GO:0005769]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; juxtaparanode region of axon [GO:0044224]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; neuronal cell body [GO:0043025]; paranodal junction [GO:0033010]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; synapse [GO:0045202],enzyme binding [GO:0019899]; PDZ domain binding [GO:0030165],GO:0005768; GO:0005794; GO:0006954; GO:0007005; GO:0007155; GO:0023052; GO:0030154; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0050877; GO:0061024,endosome; Golgi apparatus; inflammatory response; mitochondrion organization; cell adhesion; signaling; cell differentiation; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; nervous system process; membrane organization
OG_14332,FUN_013444-T1,,Pocillopora_meandrina_HIv1___TS.g16004.t1,apul_ptua,35.889,FUN_013444-T1,Q95114,MFGM_BOVIN,,Lactadherin (BP47) (Components 15/16) (MFGM) (MGP57/53) (Milk fat globule-EGF factor 8) (MFG-E8) (PAS-6/PAS-7 glycoprotein) (SED1) (Sperm surface protein SP47),Bos taurus (Bovine),37.5,120.0,2.9e-16,88.2,sp|Q95114|MFGM_BOVIN Lactadherin OS=Bos taurus OX=9913 GN=MFGE8 PE=1 SV=2,GO:0001525; GO:0002080; GO:0005576; GO:0007155; GO:0007338,angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; single fertilization [GO:0007338],acrosomal membrane [GO:0002080]; extracellular region [GO:0005576],,GO:0005576; GO:0007155; GO:0022414,extracellular region; cell adhesion; reproductive process
OG_14333,FUN_013486-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26928.t1a,apul_ptua,71.605,,,,,,,,,,,,,,,,,
OG_14334,FUN_013592-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13490.t1,apul_ptua,36.53,,,,,,,,,,,,,,,,,
OG_14335,FUN_013605-T2,,Pocillopora_meandrina_HIv1___RNAseq.g13518.t1,apul_ptua,79.192,FUN_013605-T2,Q6NYE2,RCC2_DANRE,,Protein RCC2 homolog,Danio rerio (Zebrafish) (Brachydanio rerio),51.8,419.0,2.1e-126,454.1,sp|Q6NYE2|RCC2_DANRE Protein RCC2 homolog OS=Danio rerio OX=7955 GN=rcc2 PE=2 SV=1,GO:0000775; GO:0001755; GO:0005730; GO:0005737; GO:0005819; GO:0005886; GO:0016020; GO:0030496; GO:0031267; GO:0051301; GO:0051987; GO:0072356,cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; neural crest cell migration [GO:0001755]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987],"chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; membrane [GO:0016020]; midbody [GO:0030496]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; spindle [GO:0005819]",small GTPase binding [GO:0031267],GO:0005730; GO:0005886; GO:0043226; GO:0048870,nucleolus; plasma membrane; organelle; cell motility
OG_14336,FUN_013612-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13532.t1,apul_ptua,72.102,FUN_013612-T1,Q5TDH0,DDI2_HUMAN,,Protein DDI1 homolog 2 (EC 3.4.23.-),Homo sapiens (Human),55.9,376.0,4.7e-109,396.4,sp|Q5TDH0|DDI2_HUMAN Protein DDI1 homolog 2 OS=Homo sapiens OX=9606 GN=DDI2 PE=1 SV=1,GO:0004190; GO:0005654; GO:0005694; GO:0005829; GO:0010498; GO:0016485; GO:0031647; GO:0042802; GO:0043130; GO:0072711; GO:0097752,cellular response to hydroxyurea [GO:0072711]; proteasomal protein catabolic process [GO:0010498]; protein processing [GO:0016485]; regulation of DNA stability [GO:0097752]; regulation of protein stability [GO:0031647],chromosome [GO:0005694]; cytosol [GO:0005829]; nucleoplasm [GO:0005654],aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130],GO:0003824; GO:0005654; GO:0005694; GO:0005829; GO:0016787; GO:0030163; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; nucleoplasm; chromosome; cytosol; hydrolase activity; protein catabolic process; organelle; protein maturation; catalytic activity, acting on a protein"
OG_14337,FUN_013624-T2,,Pocillopora_meandrina_HIv1___RNAseq.g13545.t2,apul_ptua,55.3065,,,,,,,,,,,,,,,,,
OG_14338,FUN_013645-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13578.t1,apul_ptua,59.487,,,,,,,,,,,,,,,,,
OG_14339,FUN_013689-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18875.t1,apul_ptua,80.914,,,,,,,,,,,,,,,,,
OG_14340,FUN_013694-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20841.t1,apul_ptua,63.462,,,,,,,,,,,,,,,,,
OG_14341,FUN_013726-T1,,Pocillopora_meandrina_HIv1___TS.g21178.t1,apul_ptua,45.588,,,,,,,,,,,,,,,,,
OG_14342,FUN_013789-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9024.t1,apul_ptua,31.847,,,,,,,,,,,,,,,,,
OG_14343,FUN_013821-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14702.t1,apul_ptua,92.969,,,,,,,,,,,,,,,,,
OG_14344,FUN_013842-T1,,Pocillopora_meandrina_HIv1___TS.g28263.t1,apul_ptua,77.778,,,,,,,,,,,,,,,,,
OG_14345,FUN_013849-T1,,Pocillopora_meandrina_HIv1___TS.g12784.t1a,apul_ptua,35.632,,,,,,,,,,,,,,,,,
OG_14346,FUN_013979-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26814.t1,apul_ptua,35.334500000000006,,,,,,,,,,,,,,,,,
OG_14347,FUN_013993-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27971.t1c,apul_ptua,85.3255,,,,,,,,,,,,,,,,,
OG_14348,FUN_014072-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10015.t1,apul_ptua,53.097,,,,,,,,,,,,,,,,,
OG_14349,FUN_014088-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25085.t1,apul_ptua,35.484,,,,,,,,,,,,,,,,,
OG_14350,FUN_014100-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14386.t1,apul_ptua,54.167,,,,,,,,,,,,,,,,,
OG_14351,FUN_014118-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15595.t1,apul_ptua,78.9325,FUN_014118-T1,O57321,,,,,50.3,471.0,1.6e-116,421.4,sp|O57321|EAA1_AMBTI Excitatory amino acid transporter 1 OS=Ambystoma tigrinum OX=8305 GN=SLC1A3 PE=1 SV=1,,,,,,
OG_14352,FUN_014165-T1,,Pocillopora_meandrina_HIv1___TS.g18796.t1,apul_ptua,72.664,FUN_014165-T1,P52569,CTR2_HUMAN,,Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2),Homo sapiens (Human),48.2,610.0,1.6e-143,511.1,sp|P52569|CTR2_HUMAN Cationic amino acid transporter 2 OS=Homo sapiens OX=9606 GN=SLC7A2 PE=1 SV=2,GO:0000064; GO:0005886; GO:0006865; GO:0015171; GO:0015174; GO:0015179; GO:0015189; GO:0015807; GO:0030054; GO:0061459; GO:0089718; GO:0097638; GO:0150104; GO:1902475; GO:1903352; GO:1903826,amino acid import across plasma membrane [GO:0089718]; amino acid transport [GO:0006865]; L-alpha-amino acid transmembrane transport [GO:1902475]; L-amino acid transport [GO:0015807]; L-arginine import across plasma membrane [GO:0097638]; L-arginine transmembrane transport [GO:1903826]; L-ornithine transmembrane transport [GO:1903352]; transport across blood-brain barrier [GO:0150104],cell junction [GO:0030054]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; basic amino acid transmembrane transporter activity [GO:0015174]; L-amino acid transmembrane transporter activity [GO:0015179]; L-arginine transmembrane transporter activity [GO:0061459]; L-lysine transmembrane transporter activity [GO:0015189]; L-ornithine transmembrane transporter activity [GO:0000064],GO:0003013; GO:0005215; GO:0005886; GO:0055085,circulatory system process; transporter activity; plasma membrane; transmembrane transport
OG_14353,FUN_014168-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22956.t1,apul_ptua,37.247,,,,,,,,,,,,,,,,,
OG_14354,FUN_014168-T2,,Pocillopora_meandrina_HIv1___RNAseq.g22957.t1,apul_ptua,41.722,,,,,,,,,,,,,,,,,
OG_14355,FUN_014178-T1,,Pocillopora_meandrina_HIv1___TS.g15602.t1,apul_ptua,54.032,FUN_014178-T1,Q8BGE7,TRIM6_MOUSE,,Tripartite motif-containing protein 6 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM6),Mus musculus (Mouse),35.8,81.0,2.8e-08,61.2,sp|Q8BGE7|TRIM6_MOUSE Tripartite motif-containing protein 6 OS=Mus musculus OX=10090 GN=Trim6 PE=1 SV=1,GO:0000209; GO:0002230; GO:0002720; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0010628; GO:0010629; GO:0010994; GO:0019901; GO:0030674; GO:0032496; GO:0035458; GO:0042802; GO:0045071; GO:0045892; GO:0060340; GO:0061630; GO:0070936; GO:0098586; GO:0140297; GO:0140374; GO:1990782; GO:2000737,antiviral innate immune response [GO:0140374]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; free ubiquitin chain polymerization [GO:0010994]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of viral genome replication [GO:0045071]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gene expression [GO:0010628]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; response to lipopolysaccharide [GO:0032496],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006355; GO:0016740; GO:0043226; GO:0060090; GO:0065003; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; regulation of DNA-templated transcription; transferase activity; organelle; molecular adaptor activity; protein-containing complex assembly; defense response to other organism; catalytic activity, acting on a protein"
OG_14356,FUN_014312-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20788.t1,apul_ptua,44.138,,,,,,,,,,,,,,,,,
OG_14357,FUN_014353-T1,,Pocillopora_meandrina_HIv1___TS.g7536.t1a,apul_ptua,40.0685,,,,,,,,,,,,,,,,,
OG_14358,FUN_014398-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9104.t1,apul_ptua,39.535,,,,,,,,,,,,,,,,,
OG_14359,FUN_014500-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22642.t1,apul_ptua,75.216,FUN_014500-T1,Q58DG1,,,,,61.6,346.0,1.9e-126,453.8,sp|Q58DG1|MYG1_BOVIN MYG1 exonuclease OS=Bos taurus OX=9913 GN=MYG1 PE=2 SV=1,,,,,,
OG_14360,FUN_014503-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12711.t1,apul_ptua,31.532,,,,,,,,,,,,,,,,,
OG_14361,FUN_014513-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22628.t1,apul_ptua,35.047,,,,,,,,,,,,,,,,,
OG_14362,FUN_014514-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22627.t1,apul_ptua,54.3815,,,,,,,,,,,,,,,,,
OG_14363,FUN_014515-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22626.t1,apul_ptua,48.589,FUN_014515-T1,C0H8I2,,,,,45.7,348.0,1.2e-80,302.4,sp|C0H8I2|SETD6_SALSA N-lysine methyltransferase setd6 OS=Salmo salar OX=8030 GN=setd6 PE=2 SV=1,,,,,,
OG_14364,FUN_014524-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22619.t1,apul_ptua,92.373,FUN_014524-T1,Q3ZBH8,,,,,85.5,117.0,1.8e-49,196.4,sp|Q3ZBH8|RS20_BOVIN Small ribosomal subunit protein uS10 OS=Bos taurus OX=9913 GN=RPS20 PE=1 SV=1,,,,,,
OG_14365,FUN_014580-T1,,Pocillopora_meandrina_HIv1___TS.g27478.t1,apul_ptua,58.396,FUN_014580-T1,A2AX52,CO6A4_MOUSE,,Collagen alpha-4(VI) chain,Mus musculus (Mouse),31.3,380.0,2.7e-42,174.5,sp|A2AX52|CO6A4_MOUSE Collagen alpha-4(VI) chain OS=Mus musculus OX=10090 GN=Col6a4 PE=1 SV=2,GO:0005518; GO:0005576; GO:0005589; GO:0007155; GO:0030198; GO:0031012; GO:0032991; GO:0062023,cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198],collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991],collagen binding [GO:0005518],GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012,extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_14366,FUN_014591-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22730.t1,apul_ptua,52.315,FUN_014591-T1,Q9EQ15,GNB1L_MOUSE,,Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF),Mus musculus (Mouse),35.4,322.0,1.7e-50,201.1,sp|Q9EQ15|GNB1L_MOUSE Guanine nucleotide-binding protein subunit beta-like protein 1 OS=Mus musculus OX=10090 GN=Gnb1l PE=2 SV=2,GO:0000077; GO:0005634; GO:0005737; GO:0006974; GO:0035176,DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; social behavior [GO:0035176],cytoplasm [GO:0005737]; nucleus [GO:0005634],,GO:0005634; GO:0043226,nucleus; organelle
OG_14367,FUN_014592-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22731.t1,apul_ptua,50.658,FUN_014592-T1,Q9EQM6,DGCR8_MOUSE,,Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8 homolog) (Gy1),Mus musculus (Mouse),33.1,550.0,3.3e-70,267.7,sp|Q9EQM6|DGCR8_MOUSE Microprocessor complex subunit DGCR8 OS=Mus musculus OX=10090 GN=Dgcr8 PE=1 SV=2,GO:0003725; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006974; GO:0014069; GO:0016604; GO:0020037; GO:0031053; GO:0042803; GO:0046872; GO:0070877; GO:0070878; GO:0072091; GO:0098978; GO:0140517; GO:2000633,DNA damage response [GO:0006974]; positive regulation of pre-miRNA processing [GO:2000633]; primary miRNA processing [GO:0031053]; regulation of stem cell proliferation [GO:0072091],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; microprocessor complex [GO:0070877]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069],double-stranded RNA binding [GO:0003725]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein homodimerization activity [GO:0042803]; protein-RNA adaptor activity [GO:0140517],GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0043226; GO:0060090,RNA binding; nucleus; nucleoplasm; nucleolus; cytosol; organelle; molecular adaptor activity
OG_14368,FUN_014597-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22738.t1,apul_ptua,73.358,FUN_014597-T1,P79100,TRPC4_BOVIN,,Short transient receptor potential channel 4 (TrpC4) (Capacitative calcium entry channel 1) (CCE1),Bos taurus (Bovine),27.5,211.0,8.2e-08,60.8,sp|P79100|TRPC4_BOVIN Short transient receptor potential channel 4 OS=Bos taurus OX=9913 GN=TRPC4 PE=2 SV=2,GO:0005886; GO:0015279; GO:0034703; GO:0051480; GO:0070588; GO:0070679,calcium ion transmembrane transport [GO:0070588]; regulation of cytosolic calcium ion concentration [GO:0051480],cation channel complex [GO:0034703]; plasma membrane [GO:0005886],"inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_14369,FUN_014609-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22763.t1,apul_ptua,55.875,FUN_014609-T1,Q0P5F3,LIN7C_BOVIN,,Protein lin-7 homolog C (Lin-7C),Bos taurus (Bovine),42.0,119.0,1.9e-18,95.5,sp|Q0P5F3|LIN7C_BOVIN Protein lin-7 homolog C OS=Bos taurus OX=9913 GN=LIN7C PE=2 SV=1,GO:0005911; GO:0005923; GO:0006887; GO:0007269; GO:0008582; GO:0015031; GO:0016323; GO:0030674; GO:0043005; GO:0045202; GO:0048489; GO:0097025; GO:0098793; GO:0098839,exocytosis [GO:0006887]; neurotransmitter secretion [GO:0007269]; protein transport [GO:0015031]; regulation of synaptic assembly at neuromuscular junction [GO:0008582]; synaptic vesicle transport [GO:0048489],basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202],protein-macromolecule adaptor activity [GO:0030674],GO:0016192; GO:0060090,vesicle-mediated transport; molecular adaptor activity
OG_14370,FUN_014620-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22776.t1,apul_ptua,50.164,,,,,,,,,,,,,,,,,
OG_14371,FUN_014652-T1,,Pocillopora_meandrina_HIv1___TS.g27446.t1,apul_ptua,69.951,,,,,,,,,,,,,,,,,
OG_14372,FUN_014666-T1,,Pocillopora_meandrina_HIv1___TS.g27436.t1b,apul_ptua,48.031,,,,,,,,,,,,,,,,,
OG_14373,FUN_014671-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22677.t1,apul_ptua,53.672,,,,,,,,,,,,,,,,,
OG_14374,FUN_014708-T2,,Pocillopora_meandrina_HIv1___RNAseq.g22532.t1,apul_ptua,72.013,FUN_014708-T2,Q9GV41,,,,,47.3,264.0,8.1e-71,268.9,"sp|Q9GV41|PGFS_TRYBB 9,11-endoperoxide prostaglandin H2 reductase OS=Trypanosoma brucei brucei OX=5702 PE=1 SV=1",,,,,,
OG_14375,FUN_014719-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22502.t1,apul_ptua,52.809,,,,,,,,,,,,,,,,,
OG_14376,FUN_014767-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22570.t1,apul_ptua,52.941,,,,,,,,,,,,,,,,,
OG_14377,FUN_014786-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22512.t1b,apul_ptua,66.8315,FUN_014786-T1,Q502P0,,,,,66.2,65.0,1.1e-17,91.7,sp|Q502P0|AR6P4_DANRE ADP-ribosylation factor-like protein 6-interacting protein 4 OS=Danio rerio OX=7955 GN=arl6ip4 PE=2 SV=1,,,,,,
OG_14378,FUN_014788-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22514.t1,apul_ptua,82.54,FUN_014788-T1,Q5ZJE4,,,,,50.8,132.0,4.3e-35,149.4,sp|Q5ZJE4|SPRNG_CHICK SREBP regulating gene protein OS=Gallus gallus OX=9031 GN=SPRING PE=2 SV=1,,,,,,
OG_14379,FUN_014811-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22404.t1,apul_ptua,42.51,,,,,,,,,,,,,,,,,
OG_14380,FUN_014813-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22401.t1,apul_ptua,57.11,FUN_014813-T1,O35453,HEPS_MOUSE,,Serine protease hepsin (EC 3.4.21.106) [Cleaved into: Serine protease hepsin non-catalytic chain; Serine protease hepsin catalytic chain],Mus musculus (Mouse),42.4,264.0,1.1e-50,202.6,sp|O35453|HEPS_MOUSE Serine protease hepsin OS=Mus musculus OX=10090 GN=Hpn PE=1 SV=3,GO:0004252; GO:0005576; GO:0005737; GO:0005789; GO:0005886; GO:0005911; GO:0006508; GO:0007605; GO:0008236; GO:0008360; GO:0009986; GO:0010628; GO:0010719; GO:0010756; GO:0016324; GO:0030307; GO:0034769; GO:0042632; GO:0043025; GO:0043066; GO:0043923; GO:0050680; GO:0050910; GO:0060429; GO:0070008; GO:0071805; GO:0090103; GO:0097066; GO:0097195; GO:2000347; GO:2000611,basement membrane disassembly [GO:0034769]; cholesterol homeostasis [GO:0042632]; cochlea morphogenesis [GO:0090103]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; epithelium development [GO:0060429]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; pilomotor reflex [GO:0097195]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of thyroid hormone generation [GO:2000611]; potassium ion transmembrane transport [GO:0071805]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0030198; GO:0048856; GO:0050877; GO:0055085; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; extracellular matrix organization; anatomical structure development; nervous system process; transmembrane transport; catalytic activity, acting on a protein"
OG_14381,FUN_014817-T2,,Pocillopora_meandrina_HIv1___RNAseq.g22397.t1,apul_ptua,57.91,FUN_014817-T2,B3EWZ6,,,,,32.7,957.0,6.9e-112,406.8,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_14382,FUN_014819-T1,,Pocillopora_meandrina_HIv1___TS.g27157.t1,apul_ptua,68.4465,FUN_014819-T1,Q60847,COCA1_MOUSE,,Collagen alpha-1(XII) chain,Mus musculus (Mouse),31.0,197.0,2.2e-18,97.8,sp|Q60847|COCA1_MOUSE Collagen alpha-1(XII) chain OS=Mus musculus OX=10090 GN=Col12a1 PE=2 SV=3,GO:0005581; GO:0005615; GO:0007155; GO:0035987; GO:0062023,cell adhesion [GO:0007155]; endodermal cell differentiation [GO:0035987],collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615],,GO:0005615; GO:0007155; GO:0030154,extracellular space; cell adhesion; cell differentiation
OG_14383,FUN_014845-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22388.t1,apul_ptua,73.718,,,,,,,,,,,,,,,,,
OG_14384,FUN_014851-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22381.t1,apul_ptua,66.458,FUN_014851-T1,Q9SJM7,URH1_ARATH,,Uridine nucleosidase 1 (EC 3.2.2.3) (Adenosine nucleosidase) (EC 3.2.2.7) (Inosine nucleosidase) (EC 3.2.2.2) (Nucleoside hydrolase 1) (Uridine ribohydrolase 1) (Xanthosine nucleosidase) (EC 3.2.2.-),Arabidopsis thaliana (Mouse-ear cress),35.1,322.0,1.5999999999999999e-31,138.3,sp|Q9SJM7|URH1_ARATH Uridine nucleosidase 1 OS=Arabidopsis thaliana OX=3702 GN=URH1 PE=1 SV=2,GO:0005829; GO:0006152; GO:0006218; GO:0042802; GO:0042803; GO:0045437; GO:0046982; GO:0047622; GO:0047724; GO:0072585,purine nucleoside catabolic process [GO:0006152]; uridine catabolic process [GO:0006218],cytosol [GO:0005829],adenosine nucleosidase activity [GO:0047622]; identical protein binding [GO:0042802]; inosine nucleosidase activity [GO:0047724]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; uridine nucleosidase activity [GO:0045437]; xanthosine nucleotidase activity [GO:0072585],GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_14385,FUN_014853-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22380.t1a,apul_ptua,46.067,,,,,,,,,,,,,,,,,
OG_14386,FUN_014863-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22346.t1b,apul_ptua,68.981,FUN_014863-T1,Q3SZR8,SRSF3_BOVIN,,"Serine/arginine-rich splicing factor 3 (Splicing factor, arginine/serine-rich 3)",Bos taurus (Bovine),67.9,81.0,1.3999999999999999e-24,114.0,sp|Q3SZR8|SRSF3_BOVIN Serine/arginine-rich splicing factor 3 OS=Bos taurus OX=9913 GN=SRSF3 PE=2 SV=1,GO:0003723; GO:0003729; GO:0005737; GO:0006406; GO:0016607; GO:0045292; GO:0048024; GO:0160134,"mRNA cis splicing, via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; regulation of mRNA splicing, via spliceosome [GO:0048024]",cytoplasm [GO:0005737]; nuclear speck [GO:0016607],mRNA binding [GO:0003729]; protein-RNA sequence-specific adaptor activity [GO:0160134]; RNA binding [GO:0003723],GO:0003723; GO:0006913; GO:0016071; GO:0043226; GO:0060090,RNA binding; nucleocytoplasmic transport; mRNA metabolic process; organelle; molecular adaptor activity
OG_14387,FUN_014884-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21058.t1,apul_ptua,59.5615,,,,,,,,,,,,,,,,,
OG_14388,FUN_014887-T1,,Pocillopora_meandrina_HIv1___RNAseq.162_t,apul_ptua,65.773,,,,,,,,,,,,,,,,,
OG_14389,FUN_014935-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21092.t1,apul_ptua,75.829,FUN_014935-T1,Q9UMQ3,BARX2_HUMAN,,Homeobox protein BarH-like 2,Homo sapiens (Human),34.8,184.0,3.6e-16,86.7,sp|Q9UMQ3|BARX2_HUMAN Homeobox protein BarH-like 2 OS=Homo sapiens OX=9606 GN=BARX2 PE=1 SV=3,GO:0000122; GO:0000785; GO:0000977; GO:0000981; GO:0001228; GO:0001502; GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005667; GO:0005794; GO:0005829; GO:0006357; GO:0006366; GO:0014902; GO:0015629; GO:0035914; GO:0045944; GO:1990837,cartilage condensation [GO:0001502]; myotube differentiation [GO:0014902]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0005654; GO:0005794; GO:0005829; GO:0005856; GO:0006351; GO:0006355; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleus; nucleoplasm; Golgi apparatus; cytosol; cytoskeleton; DNA-templated transcription; regulation of DNA-templated transcription; cell differentiation; organelle; transcription regulator activity
OG_14390,FUN_014961-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21124.t1,apul_ptua,71.831,,,,,,,,,,,,,,,,,
OG_14391,FUN_014967-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21130.t1a,apul_ptua,61.194500000000005,,,,,,,,,,,,,,,,,
OG_14392,FUN_014968-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21131.t2,apul_ptua,46.296,,,,,,,,,,,,,,,,,
OG_14393,FUN_014982-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21144.t1,apul_ptua,80.371,FUN_014982-T1,P82343,RENBP_MOUSE,,N-acylglucosamine 2-epimerase (AGE) (EC 5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein) (RnBP),Mus musculus (Mouse),50.9,375.0,9.9e-116,418.3,sp|P82343|RENBP_MOUSE N-acylglucosamine 2-epimerase OS=Mus musculus OX=10090 GN=Renbp PE=1 SV=4,GO:0005975; GO:0006044; GO:0019262; GO:0030414; GO:0042802; GO:0050121,carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylneuraminate catabolic process [GO:0019262],,identical protein binding [GO:0042802]; N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414],GO:0003824; GO:0005975; GO:0016853; GO:0098772; GO:1901135,catalytic activity; carbohydrate metabolic process; isomerase activity; molecular function regulator activity; carbohydrate derivative metabolic process
OG_14394,FUN_014996-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21163.t1,apul_ptua,59.0175,FUN_014996-T1,A9JRI0,,,,,34.1,1181.0,9.3e-152,539.7,sp|A9JRI0|HEAT6_DANRE HEAT repeat-containing protein 6 OS=Danio rerio OX=7955 GN=heatr6 PE=2 SV=1,,,,,,
OG_14395,FUN_014998-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16037.t1,apul_ptua,61.379,FUN_014998-T1,Q566C7,NUDT3_RAT,,Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP-1) (EC 3.6.1.52) (Diadenosine hexaphosphate hydrolase) (Ap6A hydrolase) (EC 3.6.1.61) (Endopolyphosphatase) (EC 3.6.1.10) (Nucleoside diphosphate-linked moiety X motif 3) (Nudix motif 3) (m7GpppN-mRNA hydrolase) (EC 3.6.1.62) (m7GpppX diphosphatase) (EC 3.6.1.59),Rattus norvegicus (Rat),55.2,134.0,5.2000000000000004e-37,155.6,sp|Q566C7|NUDT3_RAT Diphosphoinositol polyphosphate phosphohydrolase 1 OS=Rattus norvegicus OX=10116 GN=Nudt3 PE=1 SV=1,GO:0000287; GO:0000298; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0008486; GO:0030145; GO:0034431; GO:0034432; GO:0045202; GO:0052840; GO:0052842; GO:0052845; GO:0052848; GO:0071543; GO:0071544; GO:0098978; GO:0110154; GO:0140932; GO:0140933; GO:1901907; GO:1901909; GO:1901911,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process [GO:1901911]; diadenosine hexaphosphate catabolic process [GO:1901909]; diadenosine pentaphosphate catabolic process [GO:1901907]; diphosphoinositol polyphosphate catabolic process [GO:0071544]; diphosphoinositol polyphosphate metabolic process [GO:0071543]; RNA decapping [GO:0110154],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; synapse [GO:0045202],"5'-(N(7)-methyl 5'-triphosphoguanosine)-[mRNA] diphosphatase activity [GO:0140932]; 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity [GO:0140933]; bis(5'-adenosyl)-hexaphosphatase activity [GO:0034431]; bis(5'-adenosyl)-pentaphosphatase activity [GO:0034432]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol diphosphate pentakisphosphate diphosphatase activity [GO:0052842]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; nucleus; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_14396,FUN_015018-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27314.t1,apul_ptua,54.643,,,,,,,,,,,,,,,,,
OG_14397,FUN_015045-T3,,Pocillopora_meandrina_HIv1___TS.g26013.t1,apul_ptua,68.4165,FUN_015045-T3,O95294,RASL1_HUMAN,,RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein),Homo sapiens (Human),39.3,749.0,7.4e-133,476.1,sp|O95294|RASL1_HUMAN RasGAP-activating-like protein 1 OS=Homo sapiens OX=9606 GN=RASAL1 PE=1 SV=3,GO:0005096; GO:0005543; GO:0005829; GO:0007165; GO:0008270; GO:0030154; GO:0035556; GO:0046580; GO:0071277; GO:1903861,cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; intracellular signal transduction [GO:0035556]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of dendrite extension [GO:1903861]; signal transduction [GO:0007165],cytosol [GO:0005829],GTPase activator activity [GO:0005096]; phospholipid binding [GO:0005543]; zinc ion binding [GO:0008270],GO:0005829; GO:0008289; GO:0030154; GO:0098772,cytosol; lipid binding; cell differentiation; molecular function regulator activity
OG_14398,FUN_015070-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21193.t1,apul_ptua,83.838,FUN_015070-T1,Q969Q5,RAB24_HUMAN,,Ras-related protein Rab-24 (EC 3.6.5.2),Homo sapiens (Human),49.4,170.0,5.1e-41,169.1,sp|Q969Q5|RAB24_HUMAN Ras-related protein Rab-24 OS=Homo sapiens OX=9606 GN=RAB24 PE=1 SV=1,GO:0000421; GO:0001556; GO:0003924; GO:0003925; GO:0005525; GO:0005739; GO:0005768; GO:0005776; GO:0005819; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0008608; GO:0012505; GO:0030139; GO:0030667; GO:0048471; GO:0140013,attachment of spindle microtubules to kinetochore [GO:0008608]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; meiotic nuclear division [GO:0140013]; oocyte maturation [GO:0001556],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spindle [GO:0005819],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],GO:0003824; GO:0003924; GO:0005739; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0006886; GO:0006914; GO:0016787; GO:0022414; GO:0031410; GO:0043226; GO:0098772; GO:0140013,catalytic activity; GTPase activity; mitochondrion; endosome; vacuole; cytosol; plasma membrane; intracellular protein transport; autophagy; hydrolase activity; reproductive process; cytoplasmic vesicle; organelle; molecular function regulator activity; meiotic nuclear division
OG_14399,FUN_015087-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21188.t1,apul_ptua,76.22,FUN_015087-T1,Q4FAT7,,,,,54.6,614.0,1.8e-199,697.2,sp|Q4FAT7|BGLR_PIG Beta-glucuronidase OS=Sus scrofa OX=9823 GN=GUSB PE=3 SV=1,,,,,,
OG_14400,FUN_015097-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22144.t1,apul_ptua,78.845,,,,,,,,,,,,,,,,,
OG_14401,FUN_015153-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21759.t1,apul_ptua,42.994,,,,,,,,,,,,,,,,,
OG_14402,FUN_015235-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22176.t1,apul_ptua,90.39,FUN_015235-T1,Q9D0F6,,,,,76.9,325.0,1e-145,517.7,sp|Q9D0F6|RFC5_MOUSE Replication factor C subunit 5 OS=Mus musculus OX=10090 GN=Rfc5 PE=1 SV=1,,,,,,
OG_14403,FUN_015255-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22205.t2,apul_ptua,39.9995,,,,,,,,,,,,,,,,,
OG_14404,FUN_015270-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27133.t1,apul_ptua,65.0,FUN_015270-T1,B5YFT1,DDL_THEYD,,D-alanine--D-alanine ligase (EC 6.3.2.4) (D-Ala-D-Ala ligase) (D-alanylalanine synthetase),Thermodesulfovibrio yellowstonii (strain ATCC 51303 / DSM 11347 / YP87),28.0,225.0,5.9e-15,82.8,sp|B5YFT1|DDL_THEYD D-alanine--D-alanine ligase OS=Thermodesulfovibrio yellowstonii (strain ATCC 51303 / DSM 11347 / YP87) OX=289376 GN=ddl PE=3 SV=1,GO:0005524; GO:0005737; GO:0008360; GO:0008716; GO:0009252; GO:0046872; GO:0071555,cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],cytoplasm [GO:0005737],ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872],GO:0003824; GO:0016874; GO:0071554; GO:1901135,catalytic activity; ligase activity; cell wall organization or biogenesis; carbohydrate derivative metabolic process
OG_14405,FUN_015286-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13704.t1,apul_ptua,46.277,,,,,,,,,,,,,,,,,
OG_14406,FUN_015296-T1,,Pocillopora_meandrina_HIv1___TS.g26871.t1,apul_ptua,63.2,FUN_015296-T1,A1ZAY1,DLISH_DROME,,SH3 domain-containing protein Dlish (Dachs ligand with SH3 domains),Drosophila melanogaster (Fruit fly),29.2,308.0,1.3999999999999998e-29,132.1,sp|A1ZAY1|DLISH_DROME SH3 domain-containing protein Dlish OS=Drosophila melanogaster OX=7227 GN=Dlish PE=1 SV=1,GO:0001736; GO:0005737; GO:0005929; GO:0016327; GO:0032436; GO:0035331; GO:0045179; GO:0045296; GO:0090163; GO:0090251; GO:0120219,establishment of epithelial cell planar polarity [GO:0090163]; establishment of planar polarity [GO:0001736]; negative regulation of hippo signaling [GO:0035331]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein localization involved in establishment of planar polarity [GO:0090251],apical cortex [GO:0045179]; apicolateral plasma membrane [GO:0016327]; cilium [GO:0005929]; cytoplasm [GO:0005737]; subapical part of cell [GO:0120219],cadherin binding [GO:0045296],GO:0005929; GO:0007163; GO:0043226,cilium; establishment or maintenance of cell polarity; organelle
OG_14407,FUN_015337-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21724.t1,apul_ptua,70.632,FUN_015337-T1,Q54TR1,CFAD_DICDI,,Counting factor associated protein D,Dictyostelium discoideum (Social amoeba),37.3,533.0,3.5e-79,297.4,sp|Q54TR1|CFAD_DICDI Counting factor associated protein D OS=Dictyostelium discoideum OX=44689 GN=cfaD PE=1 SV=1,GO:0005576; GO:0005615; GO:0005764; GO:0006508; GO:0006955; GO:0031288; GO:0031410; GO:0072659; GO:0140986; GO:1903665; GO:2001235,G protein-coupled chemorepellent receptor signaling pathway [GO:0140986]; immune response [GO:0006955]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of apoptotic signaling pathway [GO:2001235]; protein localization to plasma membrane [GO:0072659]; proteolysis [GO:0006508]; sorocarp morphogenesis [GO:0031288],cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764],,GO:0002376; GO:0005576; GO:0005615; GO:0005764; GO:0005773; GO:0031410; GO:0043226; GO:0072659,immune system process; extracellular region; extracellular space; lysosome; vacuole; cytoplasmic vesicle; organelle; protein localization to plasma membrane
OG_14408,FUN_015348-T2,,Pocillopora_meandrina_HIv1___TS.g26462.t2,apul_ptua,70.098,FUN_015348-T2,A0A1S4F2V5,,,,,40.4,307.0,3.5000000000000005e-57,224.2,sp|A0A1S4F2V5|CATL_AEDAE Cathepsin L-like peptidase OS=Aedes aegypti OX=7159 PE=1 SV=1,,,,,,
OG_14409,FUN_015367-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21695.t1,apul_ptua,31.266,,,,,,,,,,,,,,,,,
OG_14410,FUN_015379-T1,,Pocillopora_meandrina_HIv1___TS.g26440.t1,apul_ptua,61.14,,,,,,,,,,,,,,,,,
OG_14411,FUN_015382-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29990.t1,apul_ptua,60.2605,,,,,,,,,,,,,,,,,
OG_14412,FUN_015398-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20100.t1,apul_ptua,57.28,,,,,,,,,,,,,,,,,
OG_14413,FUN_015408-T1,,Pocillopora_meandrina_HIv1___TS.g26427.t1,apul_ptua,69.084,FUN_015408-T1,P55087,AQP4_HUMAN,,Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4),Homo sapiens (Human),43.4,221.0,7.8e-45,182.2,sp|P55087|AQP4_HUMAN Aquaporin-4 OS=Homo sapiens OX=9606 GN=AQP4 PE=1 SV=2,GO:0003091; GO:0005576; GO:0005737; GO:0005886; GO:0006833; GO:0009897; GO:0009992; GO:0010008; GO:0015250; GO:0016323; GO:0042383; GO:0042802; GO:0050891; GO:0051289; GO:0071346; GO:0090660; GO:0097450,cellular response to type II interferon [GO:0071346]; cerebrospinal fluid circulation [GO:0090660]; intracellular water homeostasis [GO:0009992]; multicellular organismal-level water homeostasis [GO:0050891]; protein homotetramerization [GO:0051289]; renal water homeostasis [GO:0003091]; water transport [GO:0006833],astrocyte end-foot [GO:0097450]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],identical protein binding [GO:0042802]; water channel activity [GO:0015250],GO:0003014; GO:0005215; GO:0005576; GO:0005886; GO:0007018; GO:0050877; GO:0065003,renal system process; transporter activity; extracellular region; plasma membrane; microtubule-based movement; nervous system process; protein-containing complex assembly
OG_14414,FUN_015409-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21676.t1,apul_ptua,60.096,FUN_015409-T1,P55088,,,,,46.0,198.0,3.1000000000000003e-44,179.9,sp|P55088|AQP4_MOUSE Aquaporin-4 OS=Mus musculus OX=10090 GN=Aqp4 PE=1 SV=2,,,,,,
OG_14415,FUN_015435-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22218.t1,apul_ptua,66.933,FUN_015435-T1,Q9NWS8,,,,,41.1,338.0,3.3e-65,250.4,sp|Q9NWS8|RMND1_HUMAN Required for meiotic nuclear division protein 1 homolog OS=Homo sapiens OX=9606 GN=RMND1 PE=1 SV=2,,,,,,
OG_14416,FUN_015467-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21789.t1,apul_ptua,56.787,FUN_015467-T1,P32945,,,,,35.6,239.0,1.5e-33,146.4,sp|P32945|PPQ1_YEAST Serine/threonine-protein phosphatase PPQ OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PPQ1 PE=1 SV=1,,,,,,
OG_14417,FUN_015469-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4126.t1,apul_ptua,84.1245,,,,,,,,,,,,,,,,,
OG_14418,FUN_015481-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2930.t1,apul_ptua,48.438,,,,,,,,,,,,,,,,,
OG_14419,FUN_015608-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29915.t1,apul_ptua,91.057,,,,,,,,,,,,,,,,,
OG_14420,FUN_015633-T1,,Pocillopora_meandrina_HIv1___RNAseq.g248.t1,apul_ptua,82.8135,FUN_015633-T1,Q6B9X6,VWKA_DICDI,,Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase),Dictyostelium discoideum (Social amoeba),28.2,188.0,4.5e-11,70.9,sp|Q6B9X6|VWKA_DICDI Alpha-protein kinase vwkA OS=Dictyostelium discoideum OX=44689 GN=vwkA PE=1 SV=1,GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006971; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177; GO:0106310,contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288],contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005773; GO:0005829; GO:0007010; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"cytokinesis; catalytic activity; vacuole; cytosol; cytoskeleton organization; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_14421,FUN_015646-T1,,Pocillopora_meandrina_HIv1___TS.g17901.t1,apul_ptua,43.75,,,,,,,,,,,,,,,,,
OG_14422,FUN_015649-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27119.t1,apul_ptua,63.0135,,,,,,,,,,,,,,,,,
OG_14423,FUN_015690-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1787.t1,apul_ptua,31.538,,,,,,,,,,,,,,,,,
OG_14424,FUN_015724-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2085.t1,apul_ptua,66.883,,,,,,,,,,,,,,,,,
OG_14425,FUN_015748-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4982.t1,apul_ptua,63.704,,,,,,,,,,,,,,,,,
OG_14426,FUN_015751-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3504.t1,apul_ptua,72.82650000000001,,,,,,,,,,,,,,,,,
OG_14427,FUN_015767-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1212.t1,apul_ptua,87.302,,,,,,,,,,,,,,,,,
OG_14428,FUN_015803-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6583.t1,apul_ptua,46.429,,,,,,,,,,,,,,,,,
OG_14429,FUN_015867-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22365.t1,apul_ptua,85.195,FUN_015867-T1,Q5XIP1,PELO_RAT,,Protein pelota homolog,Rattus norvegicus (Rat),65.7,385.0,6.9e-154,545.0,sp|Q5XIP1|PELO_RAT Protein pelota homolog OS=Rattus norvegicus OX=10116 GN=Pelo PE=1 SV=1,GO:0001833; GO:0005737; GO:0006417; GO:0007492; GO:0019827; GO:0022626; GO:0030513; GO:0032790; GO:0043022; GO:0046872; GO:0051276; GO:0051301; GO:0060231; GO:0060589; GO:0070481; GO:0070651; GO:0070966; GO:0071025; GO:0072344; GO:0170011; GO:1990533,"cell division [GO:0051301]; chromosome organization [GO:0051276]; endoderm development [GO:0007492]; inner cell mass cell proliferation [GO:0001833]; mesenchymal to epithelial transition [GO:0060231]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of translation [GO:0006417]; rescue of stalled ribosome [GO:0072344]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; stem cell population maintenance [GO:0019827]",cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; Dom34-Hbs1 complex [GO:1990533],metal ion binding [GO:0046872]; nucleoside-triphosphatase regulator activity [GO:0060589]; ribosome binding [GO:0043022]; stalled ribosome sensor activity [GO:0170011],GO:0005840; GO:0016071; GO:0030154; GO:0043226; GO:0048856; GO:0098772; GO:0140299,ribosome; mRNA metabolic process; cell differentiation; organelle; anatomical structure development; molecular function regulator activity; molecular sensor activity
OG_14430,FUN_015912-T1,,Pocillopora_meandrina_HIv1___TS.g12899.t1,apul_ptua,50.794,,,,,,,,,,,,,,,,,
OG_14431,FUN_015919-T1,,Pocillopora_meandrina_HIv1___RNAseq.3964_t,apul_ptua,53.521,,,,,,,,,,,,,,,,,
OG_14432,FUN_015947-T1,,Pocillopora_meandrina_HIv1___TS.g26521.t1,apul_ptua,55.263,,,,,,,,,,,,,,,,,
OG_14433,FUN_015963-T1,,Pocillopora_meandrina_HIv1___RNAseq.g253.t1,apul_ptua,72.685,,,,,,,,,,,,,,,,,
OG_14434,FUN_015976-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24694.t1,apul_ptua,40.625,,,,,,,,,,,,,,,,,
OG_14435,FUN_015988-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21390.t1,apul_ptua,40.157,,,,,,,,,,,,,,,,,
OG_14436,FUN_015991-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21392.t1,apul_ptua,36.564,,,,,,,,,,,,,,,,,
OG_14437,FUN_015995-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21380.t1,apul_ptua,78.01,FUN_015995-T1,P02362,,,,,74.2,190.0,3.9e-70,265.8,sp|P02362|RS7_XENLA Small ribosomal subunit protein eS7 OS=Xenopus laevis OX=8355 GN=rps7 PE=1 SV=2,,,,,,
OG_14438,FUN_015997-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21379.t1,apul_ptua,66.741,FUN_015997-T1,Q9R244,TRPC2_MOUSE,,Short transient receptor potential channel 2 (TrpC2) (Transient receptor protein 2) (TRP-2) (mTrp2),Mus musculus (Mouse),27.5,501.0,3.4000000000000003e-22,109.8,sp|Q9R244|TRPC2_MOUSE Short transient receptor potential channel 2 OS=Mus musculus OX=10090 GN=Trpc2 PE=2 SV=2,GO:0000012; GO:0000139; GO:0002118; GO:0002121; GO:0002124; GO:0003684; GO:0005516; GO:0005634; GO:0005635; GO:0005789; GO:0005886; GO:0006816; GO:0007204; GO:0007340; GO:0008050; GO:0010468; GO:0012505; GO:0015279; GO:0019236; GO:0019992; GO:0032590; GO:0048047; GO:0070679; GO:1902436,"acrosome reaction [GO:0007340]; aggressive behavior [GO:0002118]; calcium ion transport [GO:0006816]; female courtship behavior [GO:0008050]; inter-male aggressive behavior [GO:0002121]; mating behavior, sex discrimination [GO:0048047]; negative regulation of male mating behavior [GO:1902436]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of gene expression [GO:0010468]; response to pheromone [GO:0019236]; single strand break repair [GO:0000012]; territorial aggressive behavior [GO:0002124]",dendrite membrane [GO:0032590]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"calmodulin binding [GO:0005516]; damaged DNA binding [GO:0003684]; diacylglycerol binding [GO:0019992]; inositol 1,4,5 trisphosphate binding [GO:0070679]; store-operated calcium channel activity [GO:0015279]",GO:0003677; GO:0005215; GO:0005634; GO:0005635; GO:0005886; GO:0006281; GO:0008289; GO:0022414; GO:0043226,DNA binding; transporter activity; nucleus; nuclear envelope; plasma membrane; DNA repair; lipid binding; reproductive process; organelle
OG_14439,FUN_016007-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25801.t1,apul_ptua,46.8705,FUN_016007-T1,Q8R151,ZNFX1_MOUSE,,NFX1-type zinc finger-containing protein 1,Mus musculus (Mouse),26.4,1135.0,1.6e-77,293.5,sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3,GO:0002218; GO:0003723; GO:0004386; GO:0005634; GO:0005741; GO:0008270; GO:0010494; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0016853; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; nucleus; isomerase activity; organelle; defense response to other organism; ATP-dependent activity
OG_14440,FUN_016029-T1,,Pocillopora_meandrina_HIv1___RNAseq.22521_t,apul_ptua,49.737,,,,,,,,,,,,,,,,,
OG_14441,FUN_016063-T1,,Pocillopora_meandrina_HIv1___TS.g26369.t1,apul_ptua,61.0675,FUN_016063-T1,P20735,,,,,41.3,545.0,2.4e-108,394.4,sp|P20735|GGT1_PIG Glutathione hydrolase 1 proenzyme OS=Sus scrofa OX=9823 GN=GGT1 PE=2 SV=1,,,,,,
OG_14442,FUN_016069-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21622.t1,apul_ptua,75.72,FUN_016069-T1,P92177,1433E_DROME,,14-3-3 protein epsilon (Suppressor of Ras1 3-9),Drosophila melanogaster (Fruit fly),62.4,234.0,5.7e-74,278.9,sp|P92177|1433E_DROME 14-3-3 protein epsilon OS=Drosophila melanogaster OX=7227 GN=14-3-3epsilon PE=1 SV=2,GO:0000077; GO:0001223; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0007088; GO:0007165; GO:0007294; GO:0007346; GO:0007411; GO:0007460; GO:0008103; GO:0008104; GO:0008340; GO:0008354; GO:0009411; GO:0035332; GO:0040008; GO:0045172; GO:0045927; GO:0046579; GO:0046982; GO:0048190; GO:0050815; GO:0051012; GO:0140313; GO:0150013,axon guidance [GO:0007411]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint signaling [GO:0000077]; germ cell migration [GO:0008354]; germarium-derived oocyte fate determination [GO:0007294]; microtubule sliding [GO:0051012]; negative regulation of neuron projection arborization [GO:0150013]; oocyte microtubule cytoskeleton polarization [GO:0008103]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; protein localization [GO:0008104]; R8 cell fate commitment [GO:0007460]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic nuclear division [GO:0007088]; response to UV [GO:0009411]; signal transduction [GO:0007165]; wing disc dorsal/ventral pattern formation [GO:0048190],centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],molecular sequestering activity [GO:0140313]; phosphoserine residue binding [GO:0050815]; protein heterodimerization activity [GO:0046982]; transcription coactivator binding [GO:0001223],GO:0005634; GO:0005654; GO:0005694; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0007018; GO:0022414; GO:0043226; GO:0048870; GO:0140313,nucleus; nucleoplasm; chromosome; mitochondrion; microtubule organizing center; cytosol; plasma membrane; microtubule-based movement; reproductive process; organelle; cell motility; molecular sequestering activity
OG_14443,FUN_016070-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21620.t1,apul_ptua,63.707,FUN_016070-T1,P62261,,,,,62.9,259.0,4.7e-79,295.8,sp|P62261|1433E_BOVIN 14-3-3 protein epsilon OS=Bos taurus OX=9913 GN=YWHAE PE=2 SV=1,,,,,,
OG_14444,FUN_016105-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21600.t1b,apul_ptua,70.745,FUN_016105-T1,P20735,,,,,47.0,538.0,1.3e-125,451.8,sp|P20735|GGT1_PIG Glutathione hydrolase 1 proenzyme OS=Sus scrofa OX=9823 GN=GGT1 PE=2 SV=1,,,,,,
OG_14445,FUN_016110-T2,,Pocillopora_meandrina_HIv1___RNAseq.g21554.t3,apul_ptua,73.1695,FUN_016110-T2,Q92614,MY18A_HUMAN,,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210),Homo sapiens (Human),41.6,1154.0,1.8e-235,818.5,sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3,GO:0000139; GO:0003677; GO:0003723; GO:0005524; GO:0005737; GO:0005793; GO:0005802; GO:0005815; GO:0006259; GO:0007030; GO:0008094; GO:0009986; GO:0016020; GO:0016460; GO:0016477; GO:0031032; GO:0032982; GO:0042641; GO:0043030; GO:0043066; GO:0043531; GO:0048194; GO:0050714; GO:0051015; GO:0090161; GO:0090164; GO:1903028,actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030],actomyosin [GO:0042641]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; myosin filament [GO:0032982]; myosin II complex [GO:0016460]; trans-Golgi network [GO:0005802],"actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent activity, acting on DNA [GO:0008094]; DNA binding [GO:0003677]; RNA binding [GO:0003723]",GO:0003677; GO:0003723; GO:0003824; GO:0005815; GO:0007010; GO:0008092; GO:0043226; GO:0048870; GO:0061024; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle; cell motility; membrane organization; catalytic activity, acting on DNA; ATP-dependent activity"
OG_14446,FUN_016119-T2,,Pocillopora_meandrina_HIv1___TS.g26292.t1b,apul_ptua,66.871,,,,,,,,,,,,,,,,,
OG_14447,FUN_016135-T2,,Pocillopora_meandrina_HIv1___TS.g7162.t1,apul_ptua,60.294,,,,,,,,,,,,,,,,,
OG_14448,FUN_016153-T2,,Pocillopora_meandrina_HIv1___RNAseq.g21230.t1,apul_ptua,37.928,,,,,,,,,,,,,,,,,
OG_14449,FUN_016161-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21015.t1,apul_ptua,81.078,FUN_016161-T1,Q99502,EYA1_HUMAN,,Protein phosphatase EYA1 (EC 3.1.3.16) (EC 3.1.3.48) (Eyes absent homolog 1),Homo sapiens (Human),77.4,270.0,4e-126,453.8,sp|Q99502|EYA1_HUMAN Protein phosphatase EYA1 OS=Homo sapiens OX=9606 GN=EYA1 PE=1 SV=2,GO:0001656; GO:0001658; GO:0003151; GO:0003723; GO:0004722; GO:0004725; GO:0005634; GO:0005654; GO:0005737; GO:0006302; GO:0007389; GO:0007501; GO:0007605; GO:0009653; GO:0010212; GO:0014706; GO:0016604; GO:0016925; GO:0030154; GO:0032993; GO:0035909; GO:0042473; GO:0042474; GO:0045664; GO:0045739; GO:0045944; GO:0046872; GO:0048665; GO:0048704; GO:0048752; GO:0050673; GO:0050679; GO:0060037; GO:0071600; GO:0072513; GO:0090103; GO:0097192; GO:0140793; GO:2001240,anatomical structure morphogenesis [GO:0009653]; aorta morphogenesis [GO:0035909]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cochlea morphogenesis [GO:0090103]; double-strand break repair [GO:0006302]; embryonic skeletal system morphogenesis [GO:0048704]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; mesodermal cell fate specification [GO:0007501]; metanephros development [GO:0001656]; middle ear morphogenesis [GO:0042474]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; neuron fate specification [GO:0048665]; otic vesicle morphogenesis [GO:0071600]; outer ear morphogenesis [GO:0042473]; outflow tract morphogenesis [GO:0003151]; pattern specification process [GO:0007389]; pharyngeal system development [GO:0060037]; positive regulation of DNA repair [GO:0045739]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of secondary heart field cardioblast proliferation [GO:0072513]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein sumoylation [GO:0016925]; regulation of neuron differentiation [GO:0045664]; response to ionizing radiation [GO:0010212]; semicircular canal morphogenesis [GO:0048752]; sensory perception of sound [GO:0007605]; striated muscle tissue development [GO:0014706],cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993],histone H2AXY142 phosphatase activity [GO:0140793]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0140096,"RNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; nervous system process; catalytic activity, acting on a protein"
OG_14450,FUN_016204-T1,,Pocillopora_meandrina_HIv1___TS.g5780.t1c,apul_ptua,37.363,,,,,,,,,,,,,,,,,
OG_14451,FUN_016218-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5675.t1,apul_ptua,58.427,FUN_016218-T1,Q68CQ4,UTP25_HUMAN,,U3 small nucleolar RNA-associated protein 25 homolog (Digestive organ expansion factor homolog) (UTP25 small subunit processor component),Homo sapiens (Human),48.3,87.0,1.1e-16,87.8,sp|Q68CQ4|UTP25_HUMAN U3 small nucleolar RNA-associated protein 25 homolog OS=Homo sapiens OX=9606 GN=UTP25 PE=1 SV=2,GO:0000462; GO:0003723; GO:0005654; GO:0005730; GO:0019843; GO:0030163; GO:0031648; GO:0032040; GO:0034511; GO:0040019; GO:0048568; GO:1902570,"embryonic organ development [GO:0048568]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; positive regulation of embryonic development [GO:0040019]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; protein localization to nucleolus [GO:1902570]",nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; U3 snoRNA binding [GO:0034511],GO:0003723; GO:0005654; GO:0005730; GO:0030163; GO:0043226; GO:0048856,RNA binding; nucleoplasm; nucleolus; protein catabolic process; organelle; anatomical structure development
OG_14452,FUN_016289-T1,,Pocillopora_meandrina_HIv1___RNAseq.g398.t1,apul_ptua,54.7235,,,,,,,,,,,,,,,,,
OG_14453,FUN_016292-T1,,Pocillopora_meandrina_HIv1___TS.g23724.t1,apul_ptua,52.7745,,,,,,,,,,,,,,,,,
OG_14454,FUN_016318-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9707.t1,apul_ptua,42.9125,FUN_016318-T1,Q9NUQ6,,,,,28.8,514.0,1.9999999999999998e-30,136.0,sp|Q9NUQ6|SPS2L_HUMAN SPATS2-like protein OS=Homo sapiens OX=9606 GN=SPATS2L PE=1 SV=2,,,,,,
OG_14455,FUN_016356-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12666.t1,apul_ptua,51.355500000000006,FUN_016356-T1,Q9QYP1,LRP4_RAT,,Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7),Rattus norvegicus (Rat),50.3,712.0,6.3e-47,192.2,sp|Q9QYP1|LRP4_RAT Low-density lipoprotein receptor-related protein 4 OS=Rattus norvegicus OX=10116 GN=Lrp4 PE=1 SV=2,GO:0001822; GO:0001942; GO:0005509; GO:0005886; GO:0006897; GO:0007167; GO:0008104; GO:0009953; GO:0009954; GO:0009986; GO:0014069; GO:0015026; GO:0016055; GO:0030279; GO:0030326; GO:0030425; GO:0030971; GO:0031594; GO:0034185; GO:0035022; GO:0042475; GO:0042733; GO:0042803; GO:0043025; GO:0043113; GO:0044853; GO:0045202; GO:0048699; GO:0048813; GO:0050771; GO:0050808; GO:0051124; GO:0060173; GO:0071340; GO:0090090; GO:0097060; GO:0097104; GO:0097105; GO:0097110; GO:0150052; GO:0150094; GO:1901631; GO:1904395,amyloid-beta clearance by cellular catabolic process [GO:0150094]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic limb morphogenesis [GO:0030326]; endocytosis [GO:0006897]; enzyme-linked receptor protein signaling pathway [GO:0007167]; generation of neurons [GO:0048699]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; proximal/distal pattern formation [GO:0009954]; receptor clustering [GO:0043113]; regulation of postsynapse assembly [GO:0150052]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; dendrite [GO:0030425]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; synaptic membrane [GO:0097060],apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; coreceptor activity [GO:0015026]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110],GO:0005886; GO:0016192; GO:0030154; GO:0034330; GO:0043226; GO:0048856; GO:0060089; GO:0061024,plasma membrane; vesicle-mediated transport; cell differentiation; cell junction organization; organelle; anatomical structure development; molecular transducer activity; membrane organization
OG_14456,FUN_016376-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9742.t1,apul_ptua,38.023,FUN_016376-T1,P14781,,,,,27.1,188.0,5.2e-06,53.5,sp|P14781|CNTN1_CHICK Contactin-1 OS=Gallus gallus OX=9031 GN=CNTN1 PE=1 SV=1,,,,,,
OG_14457,FUN_016395-T1,,Pocillopora_meandrina_HIv1___TS.g23295.t1,apul_ptua,59.978,,,,,,,,,,,,,,,,,
OG_14458,FUN_016431-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9812.t1,apul_ptua,52.703,,,,,,,,,,,,,,,,,
OG_14459,FUN_016443-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9840.t1,apul_ptua,72.414,FUN_016443-T1,Q99MS8,,,,,33.8,263.0,1.2e-24,115.2,sp|Q99MS8|TPGS1_MOUSE Tubulin polyglutamylase complex subunit 1 OS=Mus musculus OX=10090 GN=Tpgs1 PE=1 SV=1,,,,,,
OG_14460,FUN_016447-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9834.t1,apul_ptua,64.024,FUN_016447-T1,A1A4N1,S29A3_BOVIN,,Equilibrative nucleoside transporter 3 (Solute carrier family 29 member 3),Bos taurus (Bovine),35.8,243.0,2.3e-34,147.9,sp|A1A4N1|S29A3_BOVIN Equilibrative nucleoside transporter 3 OS=Bos taurus OX=9913 GN=SLC29A3 PE=2 SV=1,GO:0005326; GO:0005337; GO:0005765; GO:0005794; GO:0005886; GO:0006837; GO:0008504; GO:0015101; GO:0015205; GO:0015208; GO:0015210; GO:0015212; GO:0015213; GO:0015851; GO:0015858; GO:0015861; GO:0015862; GO:0015872; GO:0015874; GO:0031902; GO:0031966; GO:0032238; GO:0035340; GO:1901642; GO:1903716; GO:1903791; GO:1904082; GO:1904823,adenosine transport [GO:0032238]; cytidine transport [GO:0015861]; dopamine transport [GO:0015872]; guanine transmembrane transport [GO:1903716]; inosine transport [GO:0035340]; norepinephrine transport [GO:0015874]; nucleobase transport [GO:0015851]; nucleoside transmembrane transport [GO:1901642]; nucleoside transport [GO:0015858]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transmembrane transport [GO:1904082]; serotonin transport [GO:0006837]; uracil transmembrane transport [GO:1903791]; uridine transmembrane transport [GO:0015862],Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886],cytidine transmembrane transporter activity [GO:0015212]; guanine transmembrane transporter activity [GO:0015208]; monoamine transmembrane transporter activity [GO:0008504]; neurotransmitter transmembrane transporter activity [GO:0005326]; nucleobase transmembrane transporter activity [GO:0015205]; nucleoside transmembrane transporter activity [GO:0005337]; organic cation transmembrane transporter activity [GO:0015101]; uracil transmembrane transporter activity [GO:0015210]; uridine transmembrane transporter activity [GO:0015213],GO:0005215; GO:0005794; GO:0005886; GO:0043226; GO:0055085,transporter activity; Golgi apparatus; plasma membrane; organelle; transmembrane transport
OG_14461,FUN_016451-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9833.t1,apul_ptua,40.683,FUN_016451-T1,Q13151,ROA0_HUMAN,,Heterogeneous nuclear ribonucleoprotein A0 (hnRNP A0),Homo sapiens (Human),22.6,177.0,2.3e-06,55.1,sp|Q13151|ROA0_HUMAN Heterogeneous nuclear ribonucleoprotein A0 OS=Homo sapiens OX=9606 GN=HNRNPA0 PE=1 SV=1,GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0006397; GO:0006954; GO:0019901; GO:0032496; GO:0035925; GO:0045202; GO:0070935; GO:1990904,3'-UTR-mediated mRNA stabilization [GO:0070935]; inflammatory response [GO:0006954]; mRNA processing [GO:0006397]; response to lipopolysaccharide [GO:0032496],nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA binding [GO:0003729]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005654; GO:0006954; GO:0016071; GO:0043226,RNA binding; nucleus; nucleoplasm; inflammatory response; mRNA metabolic process; organelle
OG_14462,FUN_016480-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10192.t1,apul_ptua,45.0,,,,,,,,,,,,,,,,,
OG_14463,FUN_016488-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9630.t1,apul_ptua,75.676,FUN_016488-T1,P51971,,,,,73.9,111.0,2.7e-39,162.5,sp|P51971|EIF1_CHICK Eukaryotic translation initiation factor 1 OS=Gallus gallus OX=9031 GN=EIF1 PE=3 SV=2,,,,,,
OG_14464,FUN_016498-T2,,Pocillopora_meandrina_HIv1___TS.g6939.t2,apul_ptua,54.965,FUN_016498-T2,Q9ULL1,,,,,50.6,330.0,2.7000000000000003e-87,325.5,sp|Q9ULL1|PKHG1_HUMAN Pleckstrin homology domain-containing family G member 1 OS=Homo sapiens OX=9606 GN=PLEKHG1 PE=1 SV=2,,,,,,
OG_14465,FUN_016509-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9717.t1,apul_ptua,62.924,FUN_016509-T1,P27808,MGAT1_MOUSE,,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)",Mus musculus (Mouse),61.6,333.0,4.1e-121,436.4,"sp|P27808|MGAT1_MOUSE Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase OS=Mus musculus OX=10090 GN=Mgat1 PE=1 SV=1",GO:0000139; GO:0001701; GO:0003827; GO:0006049; GO:0008375; GO:0018279; GO:0030145; GO:0048471,in utero embryonic development [GO:0001701]; protein N-linked glycosylation via asparagine [GO:0018279]; UDP-N-acetylglucosamine catabolic process [GO:0006049],Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471],"acetylglucosaminyltransferase activity [GO:0008375]; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [GO:0003827]; manganese ion binding [GO:0030145]",GO:0003824; GO:0009101; GO:0016740; GO:0048856; GO:0055086; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_14466,FUN_016579-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9695.t1,apul_ptua,62.963,,,,,,,,,,,,,,,,,
OG_14467,FUN_016581-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19686.t1,apul_ptua,45.878,FUN_016581-T1,Q7L1S5,CHST9_HUMAN,,Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2),Homo sapiens (Human),29.1,275.0,7.9e-29,129.4,sp|Q7L1S5|CHST9_HUMAN Carbohydrate sulfotransferase 9 OS=Homo sapiens OX=9606 GN=CHST9 PE=1 SV=2,GO:0000139; GO:0001537; GO:0005576; GO:0006790; GO:0008146; GO:0016020; GO:0016051; GO:0030166; GO:0030203; GO:0042446; GO:0047756,carbohydrate biosynthetic process [GO:0016051]; glycosaminoglycan metabolic process [GO:0030203]; hormone biosynthetic process [GO:0042446]; proteoglycan biosynthetic process [GO:0030166]; sulfur compound metabolic process [GO:0006790],extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; membrane [GO:0016020],chondroitin 4-sulfotransferase activity [GO:0047756]; dermatan 4-sulfotransferase activity [GO:0001537]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005576; GO:0005975; GO:0006790; GO:0009101; GO:0016740; GO:1901135,catalytic activity; extracellular region; carbohydrate metabolic process; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_14468,FUN_016602-T1,,Pocillopora_meandrina_HIv1___RNAseq.g415.t1b,apul_ptua,50.0,,,,,,,,,,,,,,,,,
OG_14469,FUN_016620-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9612.t1,apul_ptua,81.865,FUN_016620-T1,Q91W82,,,,,79.3,179.0,2.2e-81,303.1,sp|Q91W82|UB2E2_MOUSE Ubiquitin-conjugating enzyme E2 E2 OS=Mus musculus OX=10090 GN=Ube2e2 PE=2 SV=1,,,,,,
OG_14470,FUN_016656-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25312.t1b,apul_ptua,70.963,FUN_016656-T1,Q12884,,,,,36.1,762.0,3.1e-137,490.7,sp|Q12884|SEPR_HUMAN Prolyl endopeptidase FAP OS=Homo sapiens OX=9606 GN=FAP PE=1 SV=5,,,,,,
OG_14471,FUN_016694-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24052.t1,apul_ptua,52.991,,,,,,,,,,,,,,,,,
OG_14472,FUN_016721-T2,,Pocillopora_meandrina_HIv1___RNAseq.g228.t1,apul_ptua,42.161,,,,,,,,,,,,,,,,,
OG_14473,FUN_016747-T1,,Pocillopora_meandrina_HIv1___TS.g6898.t1,apul_ptua,38.549,,,,,,,,,,,,,,,,,
OG_14474,FUN_016769-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5337.t1,apul_ptua,38.636,FUN_016769-T1,Q8WY91,THAP4_HUMAN,,Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (Ferric Homo sapiens nitrobindin) (Hs-Nb(III)) (THAP domain-containing protein 4),Homo sapiens (Human),31.0,116.0,6.8e-06,53.1,sp|Q8WY91|THAP4_HUMAN Peroxynitrite isomerase THAP4 OS=Homo sapiens OX=9606 GN=THAP4 PE=1 SV=2,GO:0003677; GO:0005654; GO:0005829; GO:0006570; GO:0008270; GO:0020037; GO:0042126; GO:0042802; GO:0062213; GO:0070026,nitrate metabolic process [GO:0042126]; tyrosine metabolic process [GO:0006570],cytosol [GO:0005829]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; nitric oxide binding [GO:0070026]; peroxynitrite isomerase activity [GO:0062213]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005654; GO:0005829; GO:0006520; GO:0016853,DNA binding; catalytic activity; nucleoplasm; cytosol; amino acid metabolic process; isomerase activity
OG_14475,FUN_016852-T1,,Pocillopora_meandrina_HIv1___TS.g14497.t1,apul_ptua,62.857,,,,,,,,,,,,,,,,,
OG_14476,FUN_016859-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3766.t1,apul_ptua,40.0025,,,,,,,,,,,,,,,,,
OG_14477,FUN_016870-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9920.t1,apul_ptua,47.3975,,,,,,,,,,,,,,,,,
OG_14478,FUN_016881-T1,,Pocillopora_meandrina_HIv1___TS.g3979.t1,apul_ptua,46.766,,,,,,,,,,,,,,,,,
OG_14479,FUN_016883-T1,,Pocillopora_meandrina_HIv1___TS.g15717.t1,apul_ptua,40.5965,,,,,,,,,,,,,,,,,
OG_14480,FUN_016897-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13792.t1,apul_ptua,60.241,FUN_016897-T1,Q7TXJ7,,,,,28.8,215.0,5e-14,80.1,sp|Q7TXJ7|RNMT_MYCBO Rhamnosyl O-methyltransferase OS=Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) OX=233413 GN=BQ2027_MB2983C PE=3 SV=1,,,,,,
OG_14481,FUN_016977-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21550.t1,apul_ptua,38.462,FUN_016977-T1,P14184,,,,,23.7,211.0,1.1e-10,68.9,sp|P14184|LICD_HAEIN Lipopolysaccharide cholinephosphotransferase LicD OS=Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) OX=71421 GN=licD PE=3 SV=2,,,,,,
OG_14482,FUN_016990-T1,,Pocillopora_meandrina_HIv1___TS.g23426.t1,apul_ptua,43.823,FUN_016990-T1,G5EDW2,LPLT1_CAEEL,,Latrophilin-like protein 1,Caenorhabditis elegans,21.8,422.0,4.3e-15,87.0,sp|G5EDW2|LPLT1_CAEEL Latrophilin-like protein 1 OS=Caenorhabditis elegans OX=6239 GN=lat-1 PE=1 SV=1,GO:0004175; GO:0004888; GO:0004930; GO:0005886; GO:0007166; GO:0009792; GO:0009952; GO:0019953; GO:0030246; GO:0097264,anterior/posterior pattern specification [GO:0009952]; cell surface receptor signaling pathway [GO:0007166]; embryo development ending in birth or egg hatching [GO:0009792]; self proteolysis [GO:0097264]; sexual reproduction [GO:0019953],plasma membrane [GO:0005886],carbohydrate binding [GO:0030246]; endopeptidase activity [GO:0004175]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888],GO:0003824; GO:0005886; GO:0016787; GO:0022414; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; reproductive process; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_14483,FUN_017024-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28152.t1,apul_ptua,50.877,,,,,,,,,,,,,,,,,
OG_14484,FUN_017205-T1,,Pocillopora_meandrina_HIv1___TS.g7191.t1,apul_ptua,80.723,,,,,,,,,,,,,,,,,
OG_14485,FUN_017209-T1,,Pocillopora_meandrina_HIv1___RNAseq.g158.t1,apul_ptua,50.98,,,,,,,,,,,,,,,,,
OG_14486,FUN_017210-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23107.t1,apul_ptua,44.615,,,,,,,,,,,,,,,,,
OG_14487,FUN_017215-T1,,Pocillopora_meandrina_HIv1___TS.g18736.t1,apul_ptua,40.323,,,,,,,,,,,,,,,,,
OG_14488,FUN_017272-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9220.t1,apul_ptua,48.772,,,,,,,,,,,,,,,,,
OG_14489,FUN_017280-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11127.t1,apul_ptua,76.768,,,,,,,,,,,,,,,,,
OG_14490,FUN_017292-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3289.t1,apul_ptua,74.8845,,,,,,,,,,,,,,,,,
OG_14491,FUN_017615-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14533.t1,apul_ptua,46.296,,,,,,,,,,,,,,,,,
OG_14492,FUN_017685-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8385.t1,apul_ptua,64.085,,,,,,,,,,,,,,,,,
OG_14493,FUN_017686-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26832.t1,apul_ptua,40.895,FUN_017686-T1,Q17RP2,,,,,32.7,431.0,1.9e-53,211.5,sp|Q17RP2|TIGD6_HUMAN Tigger transposable element-derived protein 6 OS=Homo sapiens OX=9606 GN=TIGD6 PE=1 SV=2,,,,,,
OG_14494,FUN_017695-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12912.t1,apul_ptua,79.167,,,,,,,,,,,,,,,,,
OG_14495,FUN_017698-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26932.t1,apul_ptua,71.342,,,,,,,,,,,,,,,,,
OG_14496,FUN_017712-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25377.t1,apul_ptua,96.97,FUN_017712-T1,P60604,UB2G2_HUMAN,,Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2),Homo sapiens (Human),85.5,165.0,1.7e-77,290.0,sp|P60604|UB2G2_HUMAN Ubiquitin-conjugating enzyme E2 G2 OS=Homo sapiens OX=9606 GN=UBE2G2 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005524; GO:0005783; GO:0005811; GO:0005829; GO:0006511; GO:0035458; GO:0036503; GO:0042802; GO:0061631; GO:0070936; GO:1904153,"cellular response to interferon-beta [GO:0035458]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005783; GO:0005811; GO:0005829; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; lipid droplet; cytosol; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_14497,FUN_017747-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24919.t1,apul_ptua,75.824,,,,,,,,,,,,,,,,,
OG_14498,FUN_017763-T1,,Pocillopora_meandrina_HIv1___RNAseq.g443.t1,apul_ptua,60.0,,,,,,,,,,,,,,,,,
OG_14499,FUN_017778-T2,,Pocillopora_meandrina_HIv1___RNAseq.g9512.t1,apul_ptua,79.276,FUN_017778-T2,Q5BKY9,,,,,68.8,80.0,3.1999999999999998e-24,112.8,sp|Q5BKY9|F133B_HUMAN Protein FAM133B OS=Homo sapiens OX=9606 GN=FAM133B PE=1 SV=1,,,,,,
OG_14500,FUN_017790-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9524.t1,apul_ptua,38.304,,,,,,,,,,,,,,,,,
OG_14501,FUN_017801-T1,,Pocillopora_meandrina_HIv1___TS.g23062.t1,apul_ptua,50.139,FUN_017801-T1,P26255,ADRB3_RAT,,Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor),Rattus norvegicus (Rat),32.5,114.0,3.8e-07,57.4,sp|P26255|ADRB3_RAT Beta-3 adrenergic receptor OS=Rattus norvegicus OX=10116 GN=Adrb3 PE=2 SV=2,GO:0002024; GO:0002025; GO:0004939; GO:0005886; GO:0007189; GO:0009409; GO:0015052; GO:0016020; GO:0031649; GO:0031699; GO:0040015; GO:0042755; GO:0042803; GO:0043235; GO:0043410; GO:0050873; GO:0051379; GO:0051380; GO:0071880; GO:0120162,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brown fat cell differentiation [GO:0050873]; diet induced thermogenesis [GO:0002024]; eating behavior [GO:0042755]; heat generation [GO:0031649]; negative regulation of multicellular organism growth [GO:0040015]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of MAPK cascade [GO:0043410]; response to cold [GO:0009409],membrane [GO:0016020]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],beta-3 adrenergic receptor binding [GO:0031699]; beta-adrenergic receptor activity [GO:0004939]; beta3-adrenergic receptor activity [GO:0015052]; epinephrine binding [GO:0051379]; norepinephrine binding [GO:0051380]; protein homodimerization activity [GO:0042803],GO:0003013; GO:0005886; GO:0030154; GO:0060089,circulatory system process; plasma membrane; cell differentiation; molecular transducer activity
OG_14502,FUN_017811-T2,,Pocillopora_meandrina_HIv1___RNAseq.g9545.t1,apul_ptua,38.5065,FUN_017811-T2,Q9H2Y7,,,,,43.8,249.0,1.9e-33,147.5,sp|Q9H2Y7|ZN106_HUMAN Zinc finger protein 106 OS=Homo sapiens OX=9606 GN=ZNF106 PE=1 SV=1,,,,,,
OG_14503,FUN_017838-T2,,Pocillopora_meandrina_HIv1___RNAseq.g9602.t1,apul_ptua,67.13749999999999,FUN_017838-T2,Q9UPV9,,,,,27.0,545.0,6.3e-23,111.3,sp|Q9UPV9|TRAK1_HUMAN Trafficking kinesin-binding protein 1 OS=Homo sapiens OX=9606 GN=TRAK1 PE=1 SV=1,,,,,,
OG_14504,FUN_017842-T2,,Pocillopora_meandrina_HIv1___TS.g23120.t1,apul_ptua,49.333,FUN_017842-T2,Q5EA66,ANGL7_BOVIN,,Angiopoietin-related protein 7 (Angiopoietin-like protein 7),Bos taurus (Bovine),38.3,183.0,1.7000000000000003e-28,128.6,sp|Q5EA66|ANGL7_BOVIN Angiopoietin-related protein 7 OS=Bos taurus OX=9913 GN=ANGPTL7 PE=2 SV=1,GO:0005576; GO:0005615; GO:0007596; GO:0042802; GO:0062023; GO:1901346; GO:1903053,blood coagulation [GO:0007596]; negative regulation of vasculature development involved in avascular cornea development in camera-type eye [GO:1901346]; regulation of extracellular matrix organization [GO:1903053],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615],identical protein binding [GO:0042802],GO:0005576; GO:0005615,extracellular region; extracellular space
OG_14505,FUN_017857-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9577.t1,apul_ptua,76.946,FUN_017857-T1,A0A1S4F2V5,,,,,57.9,335.0,1.7e-108,394.0,sp|A0A1S4F2V5|CATL_AEDAE Cathepsin L-like peptidase OS=Aedes aegypti OX=7159 PE=1 SV=1,,,,,,
OG_14506,FUN_017863-T2,,Pocillopora_meandrina_HIv1___TS.g23093.t1,apul_ptua,51.852,,,,,,,,,,,,,,,,,
OG_14507,FUN_017865-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9559.t1,apul_ptua,52.2375,FUN_017865-T1,Q6DKN2,,,,,69.0,87.0,2.5e-26,120.6,sp|Q6DKN2|OTX2B_XENLA Homeobox protein OTX2-B OS=Xenopus laevis OX=8355 GN=otx2-b PE=2 SV=1,,,,,,
OG_14508,FUN_017866-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9558.t2,apul_ptua,47.059,FUN_017866-T1,Q9PVM0,,,,,77.0,74.0,1.2999999999999998e-24,114.8,sp|Q9PVM0|OTX5A_XENLA Homeobox protein otx5-A OS=Xenopus laevis OX=8355 GN=otx5-a PE=2 SV=1,,,,,,
OG_14509,FUN_017884-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9669.t1,apul_ptua,72.449,FUN_017884-T1,Q5EAB6,PMGT1_BOVIN,,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-)",Bos taurus (Bovine),49.7,563.0,4.9000000000000004e-170,599.4,"sp|Q5EAB6|PMGT1_BOVIN Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 OS=Bos taurus OX=9913 GN=POMGNT1 PE=2 SV=1",GO:0000139; GO:0006493; GO:0008375; GO:0016020; GO:0016266; GO:0030145; GO:0030246; GO:0047223,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi membrane [GO:0000139]; membrane [GO:0016020],"acetylglucosaminyltransferase activity [GO:0008375]; beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity [GO:0047223]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]",GO:0003824; GO:0009101; GO:0016740; GO:0140096; GO:1901135,"catalytic activity; glycoprotein biosynthetic process; transferase activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_14510,FUN_017892-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9663.t1,apul_ptua,43.434,,,,,,,,,,,,,,,,,
OG_14511,FUN_017913-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2667.t1,apul_ptua,64.124,,,,,,,,,,,,,,,,,
OG_14512,FUN_017922-T1,,Pocillopora_meandrina_HIv1___RNAseq.g310.t1,apul_ptua,47.478,FUN_017922-T1,Q62415,,,,,52.4,212.0,1.2e-36,157.5,sp|Q62415|ASPP1_MOUSE Apoptosis-stimulating of p53 protein 1 OS=Mus musculus OX=10090 GN=Ppp1r13b PE=1 SV=2,,,,,,
OG_14513,FUN_017931-T1,,Pocillopora_meandrina_HIv1___RNAseq.g390.t1,apul_ptua,84.741,FUN_017931-T1,Q9NZM3,,,,,26.4,390.0,5.3e-21,105.5,sp|Q9NZM3|ITSN2_HUMAN Intersectin-2 OS=Homo sapiens OX=9606 GN=ITSN2 PE=1 SV=3,,,,,,
OG_14514,FUN_017937-T1,,Pocillopora_meandrina_HIv1___RNAseq.g217.t1,apul_ptua,78.339,FUN_017937-T1,Q9NZW5,,,,,52.8,517.0,8.8e-163,575.1,sp|Q9NZW5|PALS2_HUMAN Protein PALS2 OS=Homo sapiens OX=9606 GN=PALS2 PE=1 SV=2,,,,,,
OG_14515,FUN_017956-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25241.t1,apul_ptua,46.399,FUN_017956-T1,Q2T9J0,TYSD1_HUMAN,,"Peroxisomal leader peptide-processing protease (EC 3.4.21.-) (Trypsin domain-containing protein 1) [Cleaved into: Peroxisomal leader peptide-processing protease, 15 kDa form; Peroxisomal leader peptide-processing protease, 45 kDa form]",Homo sapiens (Human),29.5,431.0,8.699999999999998e-39,163.3,sp|Q2T9J0|TYSD1_HUMAN Peroxisomal leader peptide-processing protease OS=Homo sapiens OX=9606 GN=TYSND1 PE=1 SV=3,GO:0002020; GO:0004252; GO:0005777; GO:0005782; GO:0005829; GO:0006508; GO:0016020; GO:0016485; GO:0031998; GO:0042802,protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of fatty acid beta-oxidation [GO:0031998],cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],identical protein binding [GO:0042802]; protease binding [GO:0002020]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005777; GO:0005829; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"catalytic activity; peroxisome; cytosol; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_14516,FUN_017962-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25235.t1,apul_ptua,58.261,FUN_017962-T1,O80731,,,,,26.2,256.0,6.4e-13,77.0,sp|O80731|PAE3_ARATH Pectin acetylesterase 3 OS=Arabidopsis thaliana OX=3702 GN=PAE3 PE=2 SV=1,,,,,,
OG_14517,FUN_017969-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25248.t1,apul_ptua,52.261,,,,,,,,,,,,,,,,,
OG_14518,FUN_017987-T1,,Pocillopora_meandrina_HIv1___TS.g25552.t1,apul_ptua,48.073,FUN_017987-T1,Q8R151,ZNFX1_MOUSE,,NFX1-type zinc finger-containing protein 1,Mus musculus (Mouse),33.0,594.0,3.5e-70,267.7,sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3,GO:0002218; GO:0003723; GO:0004386; GO:0005634; GO:0005741; GO:0008270; GO:0010494; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0016853; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; nucleus; isomerase activity; organelle; defense response to other organism; ATP-dependent activity
OG_14519,FUN_017998-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25271.t1,apul_ptua,45.017,FUN_017998-T1,Q9XWB9,,,,,27.6,174.0,2.2e-11,71.2,sp|Q9XWB9|BAT36_CAEEL BTB and MATH domain-containing protein 36 OS=Caenorhabditis elegans OX=6239 GN=bath-36 PE=4 SV=1,,,,,,
OG_14520,FUN_018020-T2,,Pocillopora_meandrina_HIv1___RNAseq.29614_t,apul_ptua,80.44,FUN_018020-T2,G8JYB2,CTNL1_CAEEL,,Alpha-catulin,Caenorhabditis elegans,35.2,710.0,1e-102,375.9,sp|G8JYB2|CTNL1_CAEEL Alpha-catulin OS=Caenorhabditis elegans OX=6239 GN=ctn-1 PE=1 SV=1,GO:0005886; GO:0007155; GO:0007266; GO:0040012; GO:0045296; GO:0051015; GO:0055120,cell adhesion [GO:0007155]; regulation of locomotion [GO:0040012]; Rho protein signal transduction [GO:0007266],plasma membrane [GO:0005886]; striated muscle dense body [GO:0055120],actin filament binding [GO:0051015]; cadherin binding [GO:0045296],GO:0005886; GO:0007155; GO:0008092,plasma membrane; cell adhesion; cytoskeletal protein binding
OG_14521,FUN_018024-T1,,Pocillopora_meandrina_HIv1___TS.g25574.t1,apul_ptua,57.014,FUN_018024-T1,Q90259,ASL1A_DANRE,,Achaete-scute homolog 1a (Zash-1a) (Pituitary-absent protein),Danio rerio (Zebrafish) (Brachydanio rerio),34.8,112.0,6.4e-06,52.8,sp|Q90259|ASL1A_DANRE Achaete-scute homolog 1a OS=Danio rerio OX=7955 GN=ascl1a PE=2 SV=1,GO:0000977; GO:0000981; GO:0002070; GO:0005634; GO:0006357; GO:0007399; GO:0007423; GO:0010629; GO:0021575; GO:0021984; GO:0030182; GO:0031099; GO:0031103; GO:0042246; GO:0043565; GO:0043697; GO:0045666; GO:0045893; GO:0045944; GO:0046983; GO:0048566; GO:0050767; GO:0060575; GO:0061195; GO:0061549; GO:0070654; GO:0090575,adenohypophysis development [GO:0021984]; axon regeneration [GO:0031103]; cell dedifferentiation [GO:0043697]; embryonic digestive tract development [GO:0048566]; epithelial cell maturation [GO:0002070]; hindbrain morphogenesis [GO:0021575]; intestinal epithelial cell differentiation [GO:0060575]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regeneration [GO:0031099]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory epithelium regeneration [GO:0070654]; sensory organ development [GO:0007423]; sympathetic ganglion development [GO:0061549]; taste bud formation [GO:0061195]; tissue regeneration [GO:0042246],nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; protein dimerization activity [GO:0046983]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_14522,FUN_018063-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5961.t1,apul_ptua,30.994,,,,,,,,,,,,,,,,,
OG_14523,FUN_018088-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25345.t1,apul_ptua,68.487,,,,,,,,,,,,,,,,,
OG_14524,FUN_018116-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4230.t1,apul_ptua,38.436,,,,,,,,,,,,,,,,,
OG_14525,FUN_018137-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25309.t2,apul_ptua,66.197,FUN_018137-T1,Q8MSF5,,,,,48.4,91.0,8.9e-15,80.9,sp|Q8MSF5|RNK_DROME Ribonuclease kappa OS=Drosophila melanogaster OX=7227 GN=RNASEK PE=3 SV=1,,,,,,
OG_14526,FUN_018225-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9704.t1,apul_ptua,57.426,FUN_018225-T1,A2AJ76,HMCN2_MOUSE,,Hemicentin-2,Mus musculus (Mouse),31.7,218.0,9.5e-18,92.8,sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0030054; GO:0032154; GO:0062023,,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],calcium ion binding [GO:0005509],GO:0005576; GO:0030312; GO:0031012,extracellular region; external encapsulating structure; extracellular matrix
OG_14527,FUN_018261-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26468.t1,apul_ptua,39.448,,,,,,,,,,,,,,,,,
OG_14528,FUN_018265-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19299.t1b,apul_ptua,30.4555,,,,,,,,,,,,,,,,,
OG_14529,FUN_018393-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10096.t1,apul_ptua,60.297,,,,,,,,,,,,,,,,,
OG_14530,FUN_018400-T2,,Pocillopora_meandrina_HIv1___RNAseq.g9956.t1,apul_ptua,69.748,FUN_018400-T2,Q96DZ1,ERLEC_HUMAN,,Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin) (XTP3-transactivated gene B protein),Homo sapiens (Human),39.9,316.0,1.2e-63,245.0,sp|Q96DZ1|ERLEC_HUMAN Endoplasmic reticulum lectin 1 OS=Homo sapiens OX=9606 GN=ERLEC1 PE=1 SV=1,GO:0005788; GO:0030968; GO:0030970; GO:0036503; GO:0044322; GO:0051082; GO:1904153,"endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; negative regulation of retrograde protein transport, ER to cytosol [GO:1904153]; retrograde protein transport, ER to cytosol [GO:0030970]",endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum quality control compartment [GO:0044322],unfolded protein binding [GO:0051082],GO:0006886; GO:0030163,intracellular protein transport; protein catabolic process
OG_14531,FUN_018417-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10174.t1,apul_ptua,41.5045,,,,,,,,,,,,,,,,,
OG_14532,FUN_018495-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26464.t1,apul_ptua,36.261,,,,,,,,,,,,,,,,,
OG_14533,FUN_018502-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1451.t1,apul_ptua,70.05,FUN_018502-T1,Q8C6L5,CGAS_MOUSE,,Cyclic GMP-AMP synthase (cGAMP synthase) (cGAS) (m-cGAS) (EC 2.7.7.86) (2'3'-cGAMP synthase) (Mab-21 domain-containing protein 1),Mus musculus (Mouse),22.6,411.0,1.6e-07,58.9,sp|Q8C6L5|CGAS_MOUSE Cyclic GMP-AMP synthase OS=Mus musculus OX=10090 GN=Cgas PE=1 SV=1,GO:0002218; GO:0002230; GO:0002637; GO:0003677; GO:0003682; GO:0003690; GO:0005524; GO:0005525; GO:0005546; GO:0005634; GO:0005829; GO:0005886; GO:0006281; GO:0006974; GO:0008340; GO:0016604; GO:0019933; GO:0019934; GO:0031491; GO:0032479; GO:0032481; GO:0035861; GO:0038001; GO:0042803; GO:0045087; GO:0045738; GO:0046872; GO:0050776; GO:0050863; GO:0051607; GO:0061501; GO:0071360; GO:0140693; GO:0140896; GO:0160004; GO:0160049; GO:2000042; GO:2000774,activation of innate immune response [GO:0002218]; cAMP-mediated signaling [GO:0019933]; cellular response to exogenous dsRNA [GO:0071360]; cGAS/STING signaling pathway [GO:0140896]; cGMP-mediated signaling [GO:0019934]; defense response to virus [GO:0051607]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; innate immune response [GO:0045087]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of DNA repair [GO:0045738]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; paracrine signaling [GO:0038001]; positive regulation of cellular senescence [GO:2000774]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of immune response [GO:0050776]; regulation of immunoglobulin production [GO:0002637]; regulation of T cell activation [GO:0050863]; regulation of type I interferon production [GO:0032479],cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861],"2',3'-cyclic GMP-AMP synthase activity [GO:0061501]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; nucleosome binding [GO:0031491]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004]; protein homodimerization activity [GO:0042803]",GO:0002376; GO:0003677; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0006281; GO:0008289; GO:0016740; GO:0023052; GO:0043226; GO:0060090; GO:0098542,immune system process; DNA binding; catalytic activity; nucleus; cytosol; plasma membrane; DNA repair; lipid binding; transferase activity; signaling; organelle; molecular adaptor activity; defense response to other organism
OG_14534,FUN_018509-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26465.t1,apul_ptua,37.977,,,,,,,,,,,,,,,,,
OG_14535,FUN_018518-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14686.t1,apul_ptua,65.625,,,,,,,,,,,,,,,,,
OG_14536,FUN_018552-T4,,Pocillopora_meandrina_HIv1___TS.g23593.t1,apul_ptua,53.5915,,,,,,,,,,,,,,,,,
OG_14537,FUN_018553-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10059.t1b,apul_ptua,47.183,,,,,,,,,,,,,,,,,
OG_14538,FUN_018614-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12608.t1,apul_ptua,36.885,,,,,,,,,,,,,,,,,
OG_14539,FUN_018800-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17569.t1,apul_ptua,56.5435,,,,,,,,,,,,,,,,,
OG_14540,FUN_018864-T1,,Pocillopora_meandrina_HIv1___RNAseq.g370.t1,apul_ptua,64.634,FUN_018864-T1,Q9NZR2,,,,,34.8,1896.0,5.6000000000000005e-123,445.3,sp|Q9NZR2|LRP1B_HUMAN Low-density lipoprotein receptor-related protein 1B OS=Homo sapiens OX=9606 GN=LRP1B PE=1 SV=2,,,,,,
OG_14541,FUN_018925-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6869.t1,apul_ptua,47.931,,,,,,,,,,,,,,,,,
OG_14542,FUN_018946-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3368.t1,apul_ptua,86.207,,,,,,,,,,,,,,,,,
OG_14543,FUN_018982-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16374.t1,apul_ptua,60.9445,,,,,,,,,,,,,,,,,
OG_14544,FUN_018985-T1,,Pocillopora_meandrina_HIv1___TS.g9597.t1,apul_ptua,59.2715,,,,,,,,,,,,,,,,,
OG_14545,FUN_018990-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5984.t1,apul_ptua,36.567,,,,,,,,,,,,,,,,,
OG_14546,FUN_019025-T1,,Pocillopora_meandrina_HIv1___TS.g23519.t2,apul_ptua,73.1945,FUN_019025-T1,Q8NDA2,,,,,29.9,268.0,6.5e-21,104.0,sp|Q8NDA2|HMCN2_HUMAN Hemicentin-2 OS=Homo sapiens OX=9606 GN=HMCN2 PE=1 SV=4,,,,,,
OG_14547,FUN_019026-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5671.t1,apul_ptua,82.882,FUN_019026-T1,Q9NZJ4,,,,,31.4,4641.0,0.0,1970.3,sp|Q9NZJ4|SACS_HUMAN Sacsin OS=Homo sapiens OX=9606 GN=SACS PE=1 SV=2,,,,,,
OG_14548,FUN_019033-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27716.t1,apul_ptua,68.226,FUN_019033-T1,Q5RJY2,G2E3_MOUSE,,G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase),Mus musculus (Mouse),27.5,218.0,3.5e-07,58.2,sp|Q5RJY2|G2E3_MOUSE G2/M phase-specific E3 ubiquitin-protein ligase OS=Mus musculus OX=10090 GN=G2e3 PE=2 SV=2,GO:0000209; GO:0001824; GO:0005730; GO:0005737; GO:0006915; GO:0008270; GO:0061630; GO:2001243,apoptotic process [GO:0006915]; blastocyst development [GO:0001824]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; nucleolus [GO:0005730],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005730; GO:0012501; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; nucleolus; programmed cell death; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_14549,FUN_019057-T1,,Pocillopora_meandrina_HIv1___TS.g26202.t1,apul_ptua,31.405,,,,,,,,,,,,,,,,,
OG_14550,FUN_019059-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5410.t1,apul_ptua,58.3335,,,,,,,,,,,,,,,,,
OG_14551,FUN_019076-T1,,Pocillopora_meandrina_HIv1___RNAseq.g183.t1,apul_ptua,73.333,,,,,,,,,,,,,,,,,
OG_14552,FUN_019085-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24768.t1,apul_ptua,60.8,,,,,,,,,,,,,,,,,
OG_14553,FUN_019113-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28667.t1,apul_ptua,70.423,,,,,,,,,,,,,,,,,
OG_14554,FUN_019117-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9159.t1,apul_ptua,60.526,,,,,,,,,,,,,,,,,
OG_14555,FUN_019127-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25384.t1c,apul_ptua,53.457,,,,,,,,,,,,,,,,,
OG_14556,FUN_019132-T1,,Pocillopora_meandrina_HIv1___TS.g25658.t1b,apul_ptua,53.523,,,,,,,,,,,,,,,,,
OG_14557,FUN_019154-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22480.t1a,apul_ptua,58.824,,,,,,,,,,,,,,,,,
OG_14558,FUN_019155-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19613.t1,apul_ptua,54.6705,,,,,,,,,,,,,,,,,
OG_14559,FUN_019203-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2273.t1b,apul_ptua,72.603,,,,,,,,,,,,,,,,,
OG_14560,FUN_019266-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22076.t1,apul_ptua,46.441,,,,,,,,,,,,,,,,,
OG_14561,FUN_019298-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26298.t1,apul_ptua,47.561,,,,,,,,,,,,,,,,,
OG_14562,FUN_019319-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19609.t1,apul_ptua,82.759,,,,,,,,,,,,,,,,,
OG_14563,FUN_019333-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28982.t1,apul_ptua,53.5705,FUN_019333-T1,B3EWZ6,,,,,40.0,465.0,1.9e-81,304.7,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_14564,FUN_019437-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20867.t1,apul_ptua,43.611,FUN_019437-T1,O08890,,,,,22.3,337.0,3.6e-08,60.8,sp|O08890|5HT1F_CAVPO 5-hydroxytryptamine receptor 1F OS=Cavia porcellus OX=10141 GN=HTR1F PE=3 SV=1,,,,,,
OG_14565,FUN_019457-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11333.t1,apul_ptua,59.302,,,,,,,,,,,,,,,,,
OG_14566,FUN_019462-T1,,Pocillopora_meandrina_HIv1___TS.g2431.t1,apul_ptua,64.231,,,,,,,,,,,,,,,,,
OG_14567,FUN_019463-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13441.t1,apul_ptua,37.048,,,,,,,,,,,,,,,,,
OG_14568,FUN_019468-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9244.t1b,apul_ptua,66.337,,,,,,,,,,,,,,,,,
OG_14569,FUN_019469-T1,,Pocillopora_meandrina_HIv1___RNAseq.g744.t1,apul_ptua,52.136,,,,,,,,,,,,,,,,,
OG_14570,FUN_019724-T1,,Pocillopora_meandrina_HIv1___TS.g27818.t1,apul_ptua,91.061,FUN_019724-T1,Q9DAM2,EFCB9_MOUSE,,EF-hand calcium-binding domain-containing protein 9,Mus musculus (Mouse),47.3,148.0,2.9e-36,153.3,sp|Q9DAM2|EFCB9_MOUSE EF-hand calcium-binding domain-containing protein 9 OS=Mus musculus OX=10090 GN=Efcab9 PE=1 SV=2,GO:0005509; GO:0005516; GO:0005737; GO:0007283; GO:0030317; GO:0036128; GO:0048240; GO:0061891; GO:0097228,flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240]; spermatogenesis [GO:0007283],CatSper complex [GO:0036128]; cytoplasm [GO:0005737]; sperm principal piece [GO:0097228],calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calmodulin binding [GO:0005516],GO:0007018; GO:0022414; GO:0048870; GO:0098772; GO:0140299,microtubule-based movement; reproductive process; cell motility; molecular function regulator activity; molecular sensor activity
OG_14571,FUN_019802-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14685.t1,apul_ptua,39.779,FUN_019802-T1,P53767,VGFR1_RAT,,Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT),Rattus norvegicus (Rat),30.8,130.0,1.8e-08,61.6,sp|P53767|VGFR1_RAT Vascular endothelial growth factor receptor 1 OS=Rattus norvegicus OX=10116 GN=Flt1 PE=2 SV=1,GO:0001525; GO:0001569; GO:0001666; GO:0002040; GO:0002548; GO:0004714; GO:0005021; GO:0005524; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006940; GO:0007565; GO:0008284; GO:0014823; GO:0016477; GO:0018108; GO:0019838; GO:0030154; GO:0030335; GO:0030522; GO:0032355; GO:0035924; GO:0036323; GO:0036332; GO:0042802; GO:0043117; GO:0043235; GO:0043410; GO:0045471; GO:0045766; GO:0046777; GO:0048010; GO:0048514; GO:0048597; GO:0048598; GO:0048661; GO:0051897; GO:0060252; GO:0071456; GO:0097421; GO:1901534; GO:1903671; GO:1904046; GO:1905563; GO:1990384,angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; branching involved in blood vessel morphogenesis [GO:0001569]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic morphogenesis [GO:0048598]; female pregnancy [GO:0007565]; hyaloid vascular plexus regression [GO:1990384]; intracellular receptor signaling pathway [GO:0030522]; liver regeneration [GO:0097421]; monocyte chemotaxis [GO:0002548]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of vascular endothelial growth factor production [GO:1904046]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; regulation of smooth muscle contraction [GO:0006940]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-1 signaling pathway [GO:0036323],endosome [GO:0005768]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; placental growth factor receptor activity [GO:0036332]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor receptor activity [GO:0005021],GO:0002376; GO:0003013; GO:0003824; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0016740; GO:0022414; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"immune system process; circulatory system process; catalytic activity; extracellular space; nucleus; endosome; plasma membrane; transferase activity; reproductive process; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_14572,FUN_020104-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29896.t1a,apul_ptua,45.161,,,,,,,,,,,,,,,,,
OG_14573,FUN_020106-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29096.t1,apul_ptua,52.857,,,,,,,,,,,,,,,,,
OG_14574,FUN_020752-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18378.t1,apul_ptua,41.096,,,,,,,,,,,,,,,,,
OG_14575,FUN_020798-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14596.t1,apul_ptua,32.143,,,,,,,,,,,,,,,,,
OG_14576,FUN_020856-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20814.t1,apul_ptua,38.523,,,,,,,,,,,,,,,,,
OG_14577,FUN_020860-T1,,Pocillopora_meandrina_HIv1___TS.g7028.t1,apul_ptua,37.705,,,,,,,,,,,,,,,,,
OG_14578,FUN_020940-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18972.t1,apul_ptua,30.0,,,,,,,,,,,,,,,,,
OG_14579,FUN_021119-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4463.t1,apul_ptua,34.831,,,,,,,,,,,,,,,,,
OG_14580,FUN_021151-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11407.t1,apul_ptua,56.522,,,,,,,,,,,,,,,,,
OG_14581,FUN_021194-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2968.t1,apul_ptua,61.639,FUN_021194-T1,Q5REX6,CK5P3_PONAB,,CDK5 regulatory subunit-associated protein 3,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),50.4,228.0,1e-55,218.8,sp|Q5REX6|CK5P3_PONAB CDK5 regulatory subunit-associated protein 3 OS=Pongo abelii OX=9601 GN=CDK5RAP3 PE=2 SV=1,GO:0001889; GO:0001933; GO:0005634; GO:0005737; GO:0005789; GO:0005813; GO:0007095; GO:0008283; GO:0010921; GO:0030262; GO:0030968; GO:0031398; GO:0032088; GO:0032790; GO:0034976; GO:0042177; GO:0043407; GO:0044387; GO:0044389; GO:0044818; GO:0060318; GO:0071569; GO:0071901; GO:0140501; GO:1900182; GO:1901798; GO:1990756,apoptotic nuclear changes [GO:0030262]; cell population proliferation [GO:0008283]; definitive erythrocyte differentiation [GO:0060318]; endoplasmic reticulum unfolded protein response [GO:0030968]; liver development [GO:0001889]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of reticulophagy [GO:0140501]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein ufmylation [GO:0071569]; regulation of phosphatase activity [GO:0010921]; response to endoplasmic reticulum stress [GO:0034976]; ribosome disassembly [GO:0032790],centrosome [GO:0005813]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ubiquitin-like ligase-substrate adaptor activity [GO:1990756]; ubiquitin-like protein ligase binding [GO:0044389],GO:0005634; GO:0005815; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090,nucleus; microtubule organizing center; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity
OG_14582,FUN_022012-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3137.t1,apul_ptua,67.507,FUN_022012-T1,Q05360,,,,,42.3,666.0,9.4e-143,508.8,sp|Q05360|WHITE_LUCCU Protein white OS=Lucilia cuprina OX=7375 GN=W PE=2 SV=2,,,,,,
OG_14583,FUN_022020-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10101.t1,apul_ptua,42.683,,,,,,,,,,,,,,,,,
OG_14584,FUN_022045-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9289.t1,apul_ptua,62.415,,,,,,,,,,,,,,,,,
OG_14585,FUN_022058-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4609.t1a,apul_ptua,54.167,FUN_022058-T1,Q9Y7Y3,,,,,44.2,86.0,8.6e-10,65.5,sp|Q9Y7Y3|YGR4_SCHPO Uncharacterized RNA-binding protein C365.04c OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC365.04c PE=4 SV=1,,,,,,
OG_14586,FUN_022080-T1,,Pocillopora_meandrina_HIv1___TS.g19621.t1,apul_ptua,63.96,FUN_022080-T1,Q6PR54,RIF1_MOUSE,,Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) (mRif1),Mus musculus (Mouse),32.8,1199.0,2.1e-150,535.8,sp|Q6PR54|RIF1_MOUSE Telomere-associated protein RIF1 OS=Mus musculus OX=10090 GN=Rif1 PE=1 SV=2,GO:0000122; GO:0000723; GO:0000781; GO:0000785; GO:0000793; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006281; GO:0006974; GO:0031509; GO:0031965; GO:0035019; GO:0035861; GO:0043247; GO:0045814; GO:0045830; GO:0051233; GO:0140445; GO:1990830; GO:2000042; GO:2001034,"cellular response to leukemia inhibitory factor [GO:1990830]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; somatic stem cell population maintenance [GO:0035019]; subtelomeric heterochromatin formation [GO:0031509]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; chromosome, telomeric repeat region [GO:0140445]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]",,GO:0005634; GO:0005654; GO:0005694; GO:0005886; GO:0006281; GO:0006325; GO:0006355; GO:0032200; GO:0043226,nucleus; nucleoplasm; chromosome; plasma membrane; DNA repair; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle
OG_14586,FUN_022080-T1,,Pocillopora_meandrina_HIv1___TS.g19621.t1,apul_ptua,63.96,FUN_022080-T1,Q6PR54,RIF1_MOUSE,,Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) (mRif1),Mus musculus (Mouse),24.4,546.0,1.4e-13,81.3,sp|Q6PR54|RIF1_MOUSE Telomere-associated protein RIF1 OS=Mus musculus OX=10090 GN=Rif1 PE=1 SV=2,GO:0000122; GO:0000723; GO:0000781; GO:0000785; GO:0000793; GO:0001939; GO:0001940; GO:0005634; GO:0005654; GO:0005737; GO:0005886; GO:0006281; GO:0006974; GO:0031509; GO:0031965; GO:0035019; GO:0035861; GO:0043247; GO:0045814; GO:0045830; GO:0051233; GO:0140445; GO:1990830; GO:2000042; GO:2001034,"cellular response to leukemia inhibitory factor [GO:1990830]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of isotype switching [GO:0045830]; somatic stem cell population maintenance [GO:0035019]; subtelomeric heterochromatin formation [GO:0031509]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; chromosome, telomeric repeat region [GO:0140445]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]",,GO:0005634; GO:0005654; GO:0005694; GO:0005886; GO:0006281; GO:0006325; GO:0006355; GO:0032200; GO:0043226,nucleus; nucleoplasm; chromosome; plasma membrane; DNA repair; chromatin organization; regulation of DNA-templated transcription; telomere organization; organelle
OG_14587,FUN_022081-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9327.t1,apul_ptua,46.731,,,,,,,,,,,,,,,,,
OG_14588,FUN_022095-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4122.t1,apul_ptua,56.953,,,,,,,,,,,,,,,,,
OG_14589,FUN_022109-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9227.t1,apul_ptua,62.9445,FUN_022109-T1,Q9BQS8,FYCO1_HUMAN,,FYVE and coiled-coil domain-containing protein 1 (Zinc finger FYVE domain-containing protein 7),Homo sapiens (Human),39.8,201.0,5.0000000000000005e-39,165.2,sp|Q9BQS8|FYCO1_HUMAN FYVE and coiled-coil domain-containing protein 1 OS=Homo sapiens OX=9606 GN=FYCO1 PE=1 SV=3,GO:0005764; GO:0005770; GO:0005776; GO:0005794; GO:0008270; GO:0016020; GO:0043231; GO:0072383; GO:1901098,plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098],autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane [GO:0016020],zinc ion binding [GO:0008270],GO:0005764; GO:0005768; GO:0005773; GO:0005794; GO:0007018; GO:0031410; GO:0043226,lysosome; endosome; vacuole; Golgi apparatus; microtubule-based movement; cytoplasmic vesicle; organelle
OG_14590,FUN_022188-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4793.t1,apul_ptua,94.702,FUN_022188-T1,Q56JX8,,,,,92.1,151.0,2.1e-74,279.6,sp|Q56JX8|RS13_BOVIN Small ribosomal subunit protein uS15 OS=Bos taurus OX=9913 GN=RPS13 PE=2 SV=3,,,,,,
OG_14591,FUN_022196-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4795.t1,apul_ptua,33.333,,,,,,,,,,,,,,,,,
OG_14592,FUN_022205-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4804.t1,apul_ptua,86.871,FUN_022205-T1,P09917,LOX5_HUMAN,,Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34),Homo sapiens (Human),32.7,447.0,1.4e-63,245.4,sp|P09917|LOX5_HUMAN Polyunsaturated fatty acid 5-lipoxygenase OS=Homo sapiens OX=9606 GN=ALOX5 PE=1 SV=2,GO:0001937; GO:0002232; GO:0002523; GO:0002540; GO:0004051; GO:0004052; GO:0005506; GO:0005576; GO:0005615; GO:0005635; GO:0005641; GO:0005654; GO:0005829; GO:0006691; GO:0006959; GO:0016363; GO:0016491; GO:0016525; GO:0016701; GO:0016787; GO:0019369; GO:0019370; GO:0019372; GO:0030501; GO:0031965; GO:0034440; GO:0034774; GO:0036336; GO:0036403; GO:0042593; GO:0042759; GO:0045598; GO:0048471; GO:0050727; GO:0050728; GO:0050796; GO:0061044; GO:0061045; GO:0106014; GO:1900015; GO:1900407; GO:1901753; GO:1903426; GO:1903573; GO:1903671; GO:1904813; GO:1904999; GO:2001301,arachidonate metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426],cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774],"arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO:0016701]",GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005635; GO:0005654; GO:0005829; GO:0006629; GO:0016491; GO:0016787; GO:0048870,immune system process; catalytic activity; extracellular region; extracellular space; nuclear envelope; nucleoplasm; cytosol; lipid metabolic process; oxidoreductase activity; hydrolase activity; cell motility
OG_14593,FUN_022217-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4733.t1a,apul_ptua,76.755,FUN_022217-T1,P55012,S12A2_MOUSE,,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (BSC2) (Na-K-2Cl cotransporter 1) (mNKCC1),Mus musculus (Mouse),47.2,1077.0,1.8e-255,884.0,sp|P55012|S12A2_MOUSE Solute carrier family 12 member 2 OS=Mus musculus OX=10090 GN=Slc12a2 PE=1 SV=2,GO:0006883; GO:0006884; GO:0008511; GO:0010818; GO:0015079; GO:0016323; GO:0016324; GO:0030007; GO:0030644; GO:0035264; GO:0035633; GO:0035865; GO:0042995; GO:0043025; GO:0044297; GO:0046872; GO:0050910; GO:0060444; GO:0060763; GO:0061044; GO:0071222; GO:0071944; GO:0098658; GO:0098719; GO:0150003; GO:1902476; GO:1904450; GO:1904464; GO:1990573; GO:1990869,branching involved in mammary gland duct morphogenesis [GO:0060444]; cell volume homeostasis [GO:0006884]; cellular response to chemokine [GO:1990869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to potassium ion [GO:0035865]; chloride transmembrane transport [GO:1902476]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inorganic anion import across plasma membrane [GO:0098658]; intracellular chloride ion homeostasis [GO:0030644]; intracellular potassium ion homeostasis [GO:0030007]; intracellular sodium ion homeostasis [GO:0006883]; maintenance of blood-brain barrier [GO:0035633]; mammary duct terminal end bud growth [GO:0060763]; multicellular organism growth [GO:0035264]; negative regulation of vascular wound healing [GO:0061044]; positive regulation of aspartate secretion [GO:1904450]; potassium ion import across plasma membrane [GO:1990573]; regulation of matrix metallopeptidase secretion [GO:1904464]; regulation of spontaneous synaptic transmission [GO:0150003]; sodium ion import across plasma membrane [GO:0098719]; T cell chemotaxis [GO:0010818],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell body [GO:0044297]; cell periphery [GO:0071944]; cell projection [GO:0042995]; neuronal cell body [GO:0043025],metal ion binding [GO:0046872]; potassium ion transmembrane transporter activity [GO:0015079]; sodium:potassium:chloride symporter activity [GO:0008511],GO:0002376; GO:0005215; GO:0048870; GO:0050877; GO:0055085,immune system process; transporter activity; cell motility; nervous system process; transmembrane transport
OG_14594,FUN_022223-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4745.t1,apul_ptua,78.866,,,,,,,,,,,,,,,,,
OG_14595,FUN_022257-T1,,Pocillopora_meandrina_HIv1___TS.g22140.t1,apul_ptua,38.022,,,,,,,,,,,,,,,,,
OG_14596,FUN_022290-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4694.t1,apul_ptua,65.538,,,,,,,,,,,,,,,,,
OG_14597,FUN_022294-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4690.t1,apul_ptua,82.387,FUN_022294-T1,Q8BHA0,,,,,52.9,136.0,3e-29,129.8,sp|Q8BHA0|IN80C_MOUSE INO80 complex subunit C OS=Mus musculus OX=10090 GN=Ino80c PE=1 SV=1,,,,,,
OG_14598,FUN_022310-T2,,Pocillopora_meandrina_HIv1___RNAseq.g4626.t1,apul_ptua,82.488,FUN_022310-T2,Q9W719,,,,,63.6,214.0,1.5e-78,293.9,sp|Q9W719|HPRT_CHICK Hypoxanthine-guanine phosphoribosyltransferase OS=Gallus gallus OX=9031 GN=HPRT1 PE=2 SV=1,,,,,,
OG_14599,FUN_022320-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4640.t1,apul_ptua,53.7935,,,,,,,,,,,,,,,,,
OG_14600,FUN_022325-T2,,Pocillopora_meandrina_HIv1___TS.g22060.t1b,apul_ptua,62.595,,,,,,,,,,,,,,,,,
OG_14601,FUN_022326-T2,,Pocillopora_meandrina_HIv1___TS.g22060.t1a,apul_ptua,42.6665,,,,,,,,,,,,,,,,,
OG_14602,FUN_022330-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4650.t2,apul_ptua,52.597,FUN_022330-T1,B8JK39,ITA9_MOUSE,,Integrin alpha-9,Mus musculus (Mouse),29.0,984.0,4.499999999999999e-96,354.4,sp|B8JK39|ITA9_MOUSE Integrin alpha-9 OS=Mus musculus OX=10090 GN=Itga9 PE=1 SV=1,GO:0005518; GO:0007155; GO:0007229; GO:0009925; GO:0030593; GO:0034679; GO:0043236; GO:0045906; GO:0046872; GO:0098640,cell adhesion [GO:0007155]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of vasoconstriction [GO:0045906]; neutrophil chemotaxis [GO:0030593],basal plasma membrane [GO:0009925]; integrin alpha9-beta1 complex [GO:0034679],collagen binding [GO:0005518]; integrin binding involved in cell-matrix adhesion [GO:0098640]; laminin binding [GO:0043236]; metal ion binding [GO:0046872],GO:0002376; GO:0003013; GO:0007155; GO:0048870; GO:0098631,immune system process; circulatory system process; cell adhesion; cell motility; cell adhesion mediator activity
OG_14603,FUN_022427-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4346.t1,apul_ptua,61.333,FUN_022427-T1,Q6PBH5,,,,,43.4,76.0,4.5e-12,71.6,sp|Q6PBH5|NDUA4_DANRE Cytochrome c oxidase subunit NDUFA4 OS=Danio rerio OX=7955 GN=ndufa4 PE=3 SV=1,,,,,,
OG_14604,FUN_022447-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4322.t1,apul_ptua,41.799,,,,,,,,,,,,,,,,,
OG_14605,FUN_022448-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4323.t1,apul_ptua,84.469,,,,,,,,,,,,,,,,,
OG_14606,FUN_022449-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4324.t1,apul_ptua,95.876,,,,,,,,,,,,,,,,,
OG_14607,FUN_022457-T1,,Pocillopora_meandrina_HIv1___TS.g18903.t1,apul_ptua,54.63,,,,,,,,,,,,,,,,,
OG_14608,FUN_022461-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4317.t1,apul_ptua,35.345,,,,,,,,,,,,,,,,,
OG_14609,FUN_022465-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4315.t1,apul_ptua,59.272,,,,,,,,,,,,,,,,,
OG_14610,FUN_022469-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4311.t1,apul_ptua,70.9815,,,,,,,,,,,,,,,,,
OG_14611,FUN_022472-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4308.t1,apul_ptua,53.861,,,,,,,,,,,,,,,,,
OG_14612,FUN_022489-T1,,Pocillopora_meandrina_HIv1___TS.g21693.t1,apul_ptua,58.172,,,,,,,,,,,,,,,,,
OG_14613,FUN_022511-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16726.t1b,apul_ptua,54.76,,,,,,,,,,,,,,,,,
OG_14614,FUN_022528-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4546.t1,apul_ptua,62.5025,,,,,,,,,,,,,,,,,
OG_14615,FUN_022534-T2,,Pocillopora_meandrina_HIv1___RNAseq.g4364.t1b,apul_ptua,33.9485,FUN_022534-T2,B7WFQ1,,,,,97.0,505.0,1.7999999999999997e-300,1032.3,sp|B7WFQ1|USOM2_ACRMI Uncharacterized skeletal organic matrix protein 2 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_14616,FUN_022542-T2,,Pocillopora_meandrina_HIv1___RNAseq.g4149.t1,apul_ptua,54.054,FUN_022542-T2,Q7T3E6,,,,,43.9,205.0,4.999999999999999e-44,180.3,sp|Q7T3E6|BMI1B_DANRE Polycomb complex protein BMI-1-B OS=Danio rerio OX=7955 GN=bmi1b PE=2 SV=1,,,,,,
OG_14617,FUN_022548-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4157.t1,apul_ptua,30.8655,FUN_022548-T1,V6CLA2,HECD1_CAEEL,,E3 ubiquitin-protein ligase hecd-1 (EC 2.3.2.26),Caenorhabditis elegans,34.8,178.0,1.3e-16,89.7,sp|V6CLA2|HECD1_CAEEL E3 ubiquitin-protein ligase hecd-1 OS=Caenorhabditis elegans OX=6239 GN=hecd-1 PE=1 SV=1,GO:0000209; GO:0016607; GO:0032436; GO:0040028; GO:0042659; GO:0043161; GO:0045746; GO:0045747; GO:0046872; GO:0061630; GO:1902882; GO:1905936,negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of cell fate specification [GO:0042659]; regulation of germ cell proliferation [GO:1905936]; regulation of response to oxidative stress [GO:1902882]; regulation of vulval development [GO:0040028],nuclear speck [GO:0016607],metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630],GO:0003824; GO:0016740; GO:0030163; GO:0043226; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; organelle; catalytic activity, acting on a protein"
OG_14618,FUN_022555-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4447.t1,apul_ptua,31.977,,,,,,,,,,,,,,,,,
OG_14619,FUN_022600-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4423.t1,apul_ptua,45.96,FUN_022600-T1,Q9ULF5,S39AA_HUMAN,,Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10),Homo sapiens (Human),36.3,521.0,4.2e-60,234.2,sp|Q9ULF5|S39AA_HUMAN Zinc transporter ZIP10 OS=Homo sapiens OX=9606 GN=SLC39A10 PE=1 SV=2,GO:0001837; GO:0002903; GO:0005385; GO:0005886; GO:0006882; GO:0008160; GO:0016324; GO:0030003; GO:0030890; GO:0050861; GO:0071577; GO:0071578; GO:0140410,epithelial to mesenchymal transition [GO:0001837]; intracellular monoatomic cation homeostasis [GO:0030003]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of B cell apoptotic process [GO:0002903]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of B cell receptor signaling pathway [GO:0050861]; zinc ion import across plasma membrane [GO:0071578]; zinc ion transmembrane transport [GO:0071577],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],monoatomic cation:bicarbonate symporter activity [GO:0140410]; protein tyrosine phosphatase activator activity [GO:0008160]; zinc ion transmembrane transporter activity [GO:0005385],GO:0005215; GO:0005886; GO:0030154; GO:0055085; GO:0098772,transporter activity; plasma membrane; cell differentiation; transmembrane transport; molecular function regulator activity
OG_14620,FUN_022609-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4401.t1,apul_ptua,57.831,FUN_022609-T1,Q14849,STAR3_HUMAN,,StAR-related lipid transfer protein 3 (Metastatic lymph node gene 64 protein) (MLN 64) (Protein CAB1) (START domain-containing protein 3) (StARD3),Homo sapiens (Human),31.8,409.0,1.6999999999999996e-47,191.8,sp|Q14849|STAR3_HUMAN StAR-related lipid transfer protein 3 OS=Homo sapiens OX=9606 GN=STARD3 PE=1 SV=2,GO:0005654; GO:0005737; GO:0005739; GO:0005765; GO:0005768; GO:0005829; GO:0006629; GO:0006701; GO:0006839; GO:0008202; GO:0008203; GO:0015485; GO:0030301; GO:0031902; GO:0042803; GO:0043231; GO:0044232; GO:0099044; GO:0120020; GO:0140284,cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; lipid metabolic process [GO:0006629]; mitochondrial transport [GO:0006839]; progesterone biosynthetic process [GO:0006701]; steroid metabolic process [GO:0008202]; vesicle tethering to endoplasmic reticulum [GO:0099044],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-endosome membrane contact site [GO:0140284]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; organelle membrane contact site [GO:0044232],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; protein homodimerization activity [GO:0042803],GO:0005215; GO:0005654; GO:0005739; GO:0005768; GO:0005829; GO:0006629; GO:0008289; GO:0031410; GO:0043226,transporter activity; nucleoplasm; mitochondrion; endosome; cytosol; lipid metabolic process; lipid binding; cytoplasmic vesicle; organelle
OG_14621,FUN_022611-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4399.t1,apul_ptua,55.696,,,,,,,,,,,,,,,,,
OG_14622,FUN_022643-T2,,Pocillopora_meandrina_HIv1___RNAseq.g9370.t1,apul_ptua,50.4075,FUN_022643-T2,Q96M20,,,,,27.2,533.0,1.2999999999999999e-46,189.9,sp|Q96M20|CNBD2_HUMAN Cyclic nucleotide-binding domain-containing protein 2 OS=Homo sapiens OX=9606 GN=CNBD2 PE=1 SV=2,,,,,,
OG_14623,FUN_022669-T1,,Pocillopora_meandrina_HIv1___TS.g21950.t1,apul_ptua,43.783,FUN_022669-T1,B8UU59,PK1L_ACRMI,,Polycystin-1-related protein (Polycystic kidney disease 1-related protein),Acropora millepora (Staghorn coral) (Heteropora millepora),96.1,2422.0,0.0,4568.5,sp|B8UU59|PK1L_ACRMI Polycystin-1-related protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005261; GO:0005886; GO:0005929; GO:0006816,calcium ion transport [GO:0006816],cilium [GO:0005929]; plasma membrane [GO:0005886],monoatomic cation channel activity [GO:0005261],GO:0005215; GO:0005886; GO:0005929; GO:0043226,transporter activity; plasma membrane; cilium; organelle
OG_14624,FUN_022695-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4830.t1,apul_ptua,64.20599999999999,FUN_022695-T1,Q1RMH8,SNX3_BOVIN,,Sorting nexin-3,Bos taurus (Bovine),38.7,137.0,3.7e-16,87.4,sp|Q1RMH8|SNX3_BOVIN Sorting nexin-3 OS=Bos taurus OX=9913 GN=SNX3 PE=2 SV=3,GO:0005769; GO:0010008; GO:0010314; GO:0010976; GO:0015031; GO:0022615; GO:0030111; GO:0030136; GO:0030904; GO:0031901; GO:0032009; GO:0032266; GO:0032456; GO:0034499; GO:0050765; GO:0070273; GO:0080025; GO:1905394,endocytic recycling [GO:0032456]; late endosome to Golgi transport [GO:0034499]; negative regulation of phagocytosis [GO:0050765]; positive regulation of neuron projection development [GO:0010976]; protein to membrane docking [GO:0022615]; protein transport [GO:0015031]; regulation of Wnt signaling pathway [GO:0030111],clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome membrane [GO:0010008]; retromer complex [GO:0030904],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]",GO:0005768; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_14625,FUN_022719-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3164.t1,apul_ptua,65.9925,FUN_022719-T1,Q9D6X6,,,,,38.2,249.0,1.7e-36,154.8,sp|Q9D6X6|PRS23_MOUSE Serine protease 23 OS=Mus musculus OX=10090 GN=Prss23 PE=2 SV=2,,,,,,
OG_14626,FUN_022760-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3152.t1,apul_ptua,59.184,FUN_022760-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),43.9,294.0,2.0000000000000002e-72,275.0,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_14627,FUN_022798-T3,,Pocillopora_meandrina_HIv1___RNAseq.g3481.t1,apul_ptua,59.432,FUN_022798-T3,Q86WI1,PKHL1_HUMAN,,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1),Homo sapiens (Human),37.6,3206.0,0.0,2034.2,sp|Q86WI1|PKHL1_HUMAN Fibrocystin-L OS=Homo sapiens OX=9606 GN=PKHD1L1 PE=1 SV=2,GO:0005615; GO:0005829; GO:0006955; GO:0007605; GO:0016020; GO:0032426; GO:0038023; GO:0060171; GO:0120234,immune response [GO:0006955]; sensory perception of sound [GO:0007605],cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; stereocilium coat [GO:0120234]; stereocilium membrane [GO:0060171]; stereocilium tip [GO:0032426],signaling receptor activity [GO:0038023],GO:0002376; GO:0005615; GO:0005829; GO:0030312; GO:0050877; GO:0060089,immune system process; extracellular space; cytosol; external encapsulating structure; nervous system process; molecular transducer activity
OG_14628,FUN_022820-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3444.t1,apul_ptua,43.978,FUN_022820-T1,P09851,,,,,27.0,126.0,5.6e-07,57.8,sp|P09851|RASA1_BOVIN Ras GTPase-activating protein 1 OS=Bos taurus OX=9913 GN=RASA1 PE=1 SV=1,,,,,,
OG_14629,FUN_022830-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10660.t1,apul_ptua,35.207,,,,,,,,,,,,,,,,,
OG_14630,FUN_022840-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2192.t1,apul_ptua,50.211,FUN_022840-T1,Q9QXH4,ITAX_MOUSE,,"Integrin alpha-X (CD11 antigen-like family member C) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)",Mus musculus (Mouse),26.1,222.0,3.5e-11,70.5,sp|Q9QXH4|ITAX_MOUSE Integrin alpha-X OS=Mus musculus OX=10090 GN=Itgax PE=1 SV=1,GO:0007160; GO:0007229; GO:0008284; GO:0009897; GO:0010628; GO:0030335; GO:0030971; GO:0031643; GO:0034113; GO:0034689; GO:0045766; GO:0046872; GO:0051607; GO:1905956,cell-matrix adhesion [GO:0007160]; defense response to virus [GO:0051607]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial tube morphogenesis [GO:1905956]; positive regulation of gene expression [GO:0010628]; positive regulation of myelination [GO:0031643],external side of plasma membrane [GO:0009897]; integrin alphaX-beta2 complex [GO:0034689],metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971],GO:0007155,cell adhesion
OG_14631,FUN_022853-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3392.t1,apul_ptua,63.691,,,,,,,,,,,,,,,,,
OG_14632,FUN_022867-T2,,Pocillopora_meandrina_HIv1___RNAseq.g3612.t1,apul_ptua,40.563,FUN_022867-T2,Q795M8,,,,,31.7,101.0,2.2e-06,55.1,sp|Q795M8|YUGO_BACSU Putative potassium channel protein YugO OS=Bacillus subtilis (strain 168) OX=224308 GN=yugO PE=4 SV=2,,,,,,
OG_14633,FUN_022882-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3683.t1,apul_ptua,37.419,,,,,,,,,,,,,,,,,
OG_14634,FUN_022887-T3,,Pocillopora_meandrina_HIv1___RNAseq.g3686.t1,apul_ptua,45.376,FUN_022887-T3,Q8R151,ZNFX1_MOUSE,,NFX1-type zinc finger-containing protein 1,Mus musculus (Mouse),29.9,1250.0,1.4e-125,453.0,sp|Q8R151|ZNFX1_MOUSE NFX1-type zinc finger-containing protein 1 OS=Mus musculus OX=10090 GN=Znfx1 PE=1 SV=3,GO:0002218; GO:0003723; GO:0004386; GO:0005634; GO:0005741; GO:0008270; GO:0010494; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0005634; GO:0016853; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; nucleus; isomerase activity; organelle; defense response to other organism; ATP-dependent activity
OG_14635,FUN_022893-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3692.t1,apul_ptua,68.2635,FUN_022893-T1,B4F6N6,LOXL2_XENTR,,Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),40.3,714.0,1.6e-148,528.1,sp|B4F6N6|LOXL2_XENTR Lysyl oxidase homolog 2 OS=Xenopus tropicalis OX=8364 GN=loxl2 PE=2 SV=2,GO:0000122; GO:0000785; GO:0001666; GO:0001837; GO:0001935; GO:0002040; GO:0004720; GO:0005507; GO:0005509; GO:0005604; GO:0005615; GO:0005634; GO:0005783; GO:0010718; GO:0016020; GO:0018057; GO:0030199; GO:0032332; GO:0036211; GO:0043542; GO:0045892; GO:0046688; GO:0070492; GO:0070828; GO:1902455,collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; protein modification process [GO:0036211]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040],basement membrane [GO:0005604]; chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720],GO:0003824; GO:0005615; GO:0005634; GO:0005783; GO:0006325; GO:0006355; GO:0016491; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048870; GO:0140096,"catalytic activity; extracellular space; nucleus; endoplasmic reticulum; chromatin organization; regulation of DNA-templated transcription; oxidoreductase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; cell motility; catalytic activity, acting on a protein"
OG_14636,FUN_022894-T1,,Pocillopora_meandrina_HIv1___TS.g9867.t1,apul_ptua,71.041,FUN_022894-T1,P58022,,,,,39.1,700.0,5.3e-147,523.1,sp|P58022|LOXL2_MOUSE Lysyl oxidase homolog 2 OS=Mus musculus OX=10090 GN=Loxl2 PE=1 SV=2,,,,,,
OG_14637,FUN_022931-T1,,Pocillopora_meandrina_HIv1___TS.g9905.t1,apul_ptua,59.9665,FUN_022931-T1,Q9JJG9,NOA1_MOUSE,,Nitric oxide-associated protein 1,Mus musculus (Mouse),44.2,199.0,1.2e-38,162.2,sp|Q9JJG9|NOA1_MOUSE Nitric oxide-associated protein 1 OS=Mus musculus OX=10090 GN=Noa1 PE=1 SV=1,GO:0005525; GO:0005739; GO:0005743; GO:0006915; GO:0007005; GO:0061668; GO:0099617,apoptotic process [GO:0006915]; mitochondrial ribosome assembly [GO:0061668]; mitochondrion organization [GO:0007005],matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],GTP binding [GO:0005525],GO:0005739; GO:0007005; GO:0012501; GO:0043226,mitochondrion; mitochondrion organization; programmed cell death; organelle
OG_14638,FUN_022994-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3791.t1,apul_ptua,54.737,,,,,,,,,,,,,,,,,
OG_14639,FUN_023001-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3814.t1,apul_ptua,35.981,,,,,,,,,,,,,,,,,
OG_14640,FUN_023014-T2,,Pocillopora_meandrina_HIv1___RNAseq.g3828.t2,apul_ptua,74.999,,,,,,,,,,,,,,,,,
OG_14641,FUN_023022-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3836.t2,apul_ptua,72.474,FUN_023022-T1,P24046,GBRR1_HUMAN,,Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABAAR subunit rho-1) (GABA(C) receptor),Homo sapiens (Human),35.7,291.0,1.1e-36,155.2,sp|P24046|GBRR1_HUMAN Gamma-aminobutyric acid receptor subunit rho-1 OS=Homo sapiens OX=9606 GN=GABRR1 PE=1 SV=2,GO:0004890; GO:0005886; GO:0007214; GO:0007268; GO:0019904; GO:0022851; GO:0034707; GO:0042734; GO:0042802; GO:0044877; GO:0045211; GO:0050804; GO:0097708; GO:0098978; GO:0098982; GO:0099507; GO:1902476; GO:1902711,chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; modulation of chemical synaptic transmission [GO:0050804],chloride channel complex [GO:0034707]; GABA-A receptor complex [GO:1902711]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851]; identical protein binding [GO:0042802]; ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential [GO:0099507]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877],GO:0005215; GO:0005886; GO:0023052; GO:0043226; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; organelle; transmembrane transport; molecular transducer activity
OG_14642,FUN_023025-T1,,Pocillopora_meandrina_HIv1___TS.g10020.t1a,apul_ptua,66.899,FUN_023025-T1,Q7TMF2,ERI1_MOUSE,,3'-5' exoribonuclease 1 (EC 3.1.13.1) (3'-5' exonuclease ERI1) (Eri-1 homolog) (Histone mRNA 3'-exonuclease 1),Mus musculus (Mouse),47.6,267.0,4.1e-71,269.6,sp|Q7TMF2|ERI1_MOUSE 3'-5' exoribonuclease 1 OS=Mus musculus OX=10090 GN=Eri1 PE=1 SV=2,GO:0000175; GO:0005634; GO:0005730; GO:0005737; GO:0008408; GO:0019843; GO:0031047; GO:0031125; GO:0043022; GO:0046872; GO:0071204; GO:0071207,regulatory ncRNA-mediated gene silencing [GO:0031047]; rRNA 3'-end processing [GO:0031125],cytoplasm [GO:0005737]; histone pre-mRNA 3'end processing complex [GO:0071204]; nucleolus [GO:0005730]; nucleus [GO:0005634],3'-5' exonuclease activity [GO:0008408]; 3'-5'-RNA exonuclease activity [GO:0000175]; histone pre-mRNA stem-loop binding [GO:0071207]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843],GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0016787; GO:0031047; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleolus; hydrolase activity; regulatory ncRNA-mediated gene silencing; organelle; catalytic activity, acting on RNA"
OG_14643,FUN_023052-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20839.t1,apul_ptua,54.667,,,,,,,,,,,,,,,,,
OG_14644,FUN_023055-T1,,Pocillopora_meandrina_HIv1___TS.g10048.t1,apul_ptua,63.082,FUN_023055-T1,O54909,RDH16_MOUSE,,Retinol dehydrogenase 16 (EC 1.1.1.105) (EC 1.1.1.209) (EC 1.1.1.315) (EC 1.1.1.53) (Cis-retinol androgen dehydrogenase 1),Mus musculus (Mouse),42.5,322.0,5.6e-56,219.5,sp|O54909|RDH16_MOUSE Retinol dehydrogenase 16 OS=Mus musculus OX=10090 GN=Rdh16 PE=1 SV=1,GO:0001523; GO:0004745; GO:0005788; GO:0005789; GO:0008202; GO:0031090; GO:0042572; GO:0042802; GO:0042904; GO:0047023; GO:0047044; GO:0106429,9-cis-retinoic acid biosynthetic process [GO:0042904]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090],"11-cis-retinol dehydrogenase [GO:0106429]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase (NAD+) activity [GO:0047044]; androsterone dehydrogenase [NAD(P)+] activity [GO:0047023]; identical protein binding [GO:0042802]",GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_14645,FUN_023082-T2,,Pocillopora_meandrina_HIv1___RNAseq.g1657.t1,apul_ptua,72.059,FUN_023082-T2,Q9WU47,,,,,53.4,262.0,1.8e-78,294.3,sp|Q9WU47|B3GA3_CRIGR Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 OS=Cricetulus griseus OX=10029 GN=B3GAT3 PE=2 SV=1,,,,,,
OG_14646,FUN_023091-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1665.t1,apul_ptua,53.583,FUN_023091-T1,C3ZQF9,,,,,26.2,309.0,3e-19,97.8,sp|C3ZQF9|QRFPR_BRAFL QRFP-like peptide receptor OS=Branchiostoma floridae OX=7739 GN=QRFPR PE=3 SV=1,,,,,,
OG_14647,FUN_023096-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1669.t1,apul_ptua,66.344,FUN_023096-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),48.3,149.0,5e-33,143.7,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_14648,FUN_023103-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1678.t1,apul_ptua,39.286,,,,,,,,,,,,,,,,,
OG_14649,FUN_023105-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1680.t1,apul_ptua,42.241,,,,,,,,,,,,,,,,,
OG_14650,FUN_023117-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1696.t1,apul_ptua,77.941,FUN_023117-T1,Q24K21,,,,,55.1,196.0,3.7000000000000004e-59,229.6,sp|Q24K21|DPCD_BOVIN Protein DPCD OS=Bos taurus OX=9913 GN=DPCD PE=2 SV=1,,,,,,
OG_14651,FUN_023125-T2,,Pocillopora_meandrina_HIv1___TS.g4270.t1,apul_ptua,45.89,FUN_023125-T2,Q9JKF4,CLC6A_MOUSE,,C-type lectin domain family 6 member A (C-type lectin superfamily member 10) (Dendritic cell-associated C-type lectin 2) (DC-associated C-type lectin 2) (Dectin-2),Mus musculus (Mouse),27.7,137.0,2.3e-10,67.0,sp|Q9JKF4|CLC6A_MOUSE C-type lectin domain family 6 member A OS=Mus musculus OX=10090 GN=Clec6a PE=1 SV=1,GO:0001819; GO:0001878; GO:0001879; GO:0002223; GO:0002250; GO:0005509; GO:0005537; GO:0005886; GO:0030246; GO:0038187; GO:0043123; GO:0045087; GO:0050832; GO:0061760; GO:1902533; GO:2000318,adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760]; defense response to fungus [GO:0050832]; detection of yeast [GO:0001879]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production [GO:0001819]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of T-helper 17 type immune response [GO:2000318]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; D-mannose binding [GO:0005537]; pattern recognition receptor activity [GO:0038187],GO:0002376; GO:0005886; GO:0060089; GO:0098542,immune system process; plasma membrane; molecular transducer activity; defense response to other organism
OG_14652,FUN_023161-T1,,Pocillopora_meandrina_HIv1___TS.g25340.t2a,apul_ptua,48.322,,,,,,,,,,,,,,,,,
OG_14653,FUN_023165-T1,,Pocillopora_meandrina_HIv1___RNAseq.g646.t1,apul_ptua,72.238,FUN_023165-T1,Q9QZ08,,,,,45.5,345.0,4.1e-89,329.7,sp|Q9QZ08|NAGK_MOUSE N-acetyl-D-glucosamine kinase OS=Mus musculus OX=10090 GN=Nagk PE=1 SV=3,,,,,,
OG_14654,FUN_023176-T1,,Pocillopora_meandrina_HIv1___RNAseq.g655.t1,apul_ptua,58.547,FUN_023176-T1,Q6GMF8,RHDF1_DANRE,,Inactive rhomboid protein 1 (iRhom1) (Rhomboid family member 1),Danio rerio (Zebrafish) (Brachydanio rerio),29.1,265.0,1.2e-27,125.6,sp|Q6GMF8|RHDF1_DANRE Inactive rhomboid protein 1 OS=Danio rerio OX=7955 GN=rhbdf1 PE=2 SV=1,GO:0000139; GO:0005789; GO:0008283; GO:0015031; GO:0016477; GO:0019838; GO:0042058; GO:0050708; GO:0050709; GO:0061136,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708],endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139],growth factor binding [GO:0019838],GO:0048870,cell motility
OG_14655,FUN_023197-T1,,Pocillopora_meandrina_HIv1___RNAseq.g678.t1,apul_ptua,57.436,FUN_023197-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),39.9,148.0,1.1e-22,108.2,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_14656,FUN_023198-T1,,Pocillopora_meandrina_HIv1___RNAseq.g679.t1,apul_ptua,81.928,FUN_023198-T1,D6REC4,,,,,35.3,635.0,1.2e-68,262.7,sp|D6REC4|CFA99_HUMAN Cilia- and flagella-associated protein 99 OS=Homo sapiens OX=9606 GN=CFAP99 PE=1 SV=3,,,,,,
OG_14657,FUN_023229-T1,,Pocillopora_meandrina_HIv1___TS.g25421.t1,apul_ptua,52.346,FUN_023229-T1,P50429,,,,,41.4,505.0,1.3e-100,369.0,sp|P50429|ARSB_MOUSE Arylsulfatase B OS=Mus musculus OX=10090 GN=Arsb PE=1 SV=3,,,,,,
OG_14658,FUN_023230-T1,,Pocillopora_meandrina_HIv1___RNAseq.g721.t1,apul_ptua,62.542,FUN_023230-T1,P48965,,,,,32.0,563.0,4.599999999999999e-53,210.7,sp|P48965|MPIP1_RAT M-phase inducer phosphatase 1 OS=Rattus norvegicus OX=10116 GN=Cdc25a PE=1 SV=1,,,,,,
OG_14659,FUN_023243-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17395.t1,apul_ptua,65.854,FUN_023243-T1,Q9Y394,DHRS7_HUMAN,,Dehydrogenase/reductase SDR family member 7 (EC 1.1.1.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1) (Protein SDR34C1),Homo sapiens (Human),45.8,325.0,4.4e-69,263.1,sp|Q9Y394|DHRS7_HUMAN Dehydrogenase/reductase SDR family member 7 OS=Homo sapiens OX=9606 GN=DHRS7 PE=1 SV=1,GO:0004090; GO:0005789; GO:0016020; GO:0016616; GO:0052650,,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],"all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",GO:0003824; GO:0016491,catalytic activity; oxidoreductase activity
OG_14660,FUN_023261-T1,,Pocillopora_meandrina_HIv1___RNAseq.g577.t1,apul_ptua,80.805,FUN_023261-T1,Q9H977,WDR54_HUMAN,,WD repeat-containing protein 54,Homo sapiens (Human),39.1,335.0,1.9e-61,237.7,sp|Q9H977|WDR54_HUMAN WD repeat-containing protein 54 OS=Homo sapiens OX=9606 GN=WDR54 PE=1 SV=1,GO:0002091; GO:0005737; GO:0005886; GO:0007338; GO:0007342; GO:0031514; GO:0031982; GO:0042058; GO:0042803; GO:0043408,fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; negative regulation of receptor internalization [GO:0002091]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of MAPK cascade [GO:0043408]; single fertilization [GO:0007338],cytoplasm [GO:0005737]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; vesicle [GO:0031982],protein homodimerization activity [GO:0042803],GO:0005886; GO:0005929; GO:0022414; GO:0043226; GO:0061024,plasma membrane; cilium; reproductive process; organelle; membrane organization
OG_14661,FUN_023266-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10957.t1,apul_ptua,53.776,FUN_023266-T1,Q92179,,,,,29.5,366.0,8.300000000000001e-28,126.3,sp|Q92179|CHST3_CHICK Carbohydrate sulfotransferase 3 OS=Gallus gallus OX=9031 GN=CHST3 PE=1 SV=1,,,,,,
OG_14662,FUN_023274-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17801.t1,apul_ptua,78.829,FUN_023274-T1,Q93ZE5,,,,,47.2,216.0,3.5e-52,206.5,"sp|Q93ZE5|FAHD1_ARATH Oxaloacetate tautomerase FAHD1, mitochondrial OS=Arabidopsis thaliana OX=3702 GN=FAHD1 PE=1 SV=1",,,,,,
OG_14663,FUN_023287-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7138.t1,apul_ptua,56.944,,,,,,,,,,,,,,,,,
OG_14664,FUN_023288-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17457.t1a,apul_ptua,48.428,,,,,,,,,,,,,,,,,
OG_14665,FUN_023317-T2,,Pocillopora_meandrina_HIv1___RNAseq.g17769.t1,apul_ptua,72.613,FUN_023317-T2,O93430,GLRA1_DANRE,,Glycine receptor subunit alphaZ1,Danio rerio (Zebrafish) (Brachydanio rerio),31.2,397.0,4.3e-50,200.3,sp|O93430|GLRA1_DANRE Glycine receptor subunit alphaZ1 OS=Danio rerio OX=7955 GN=glra1 PE=1 SV=1,GO:0004888; GO:0005886; GO:0006811; GO:0007417; GO:0008270; GO:0015276; GO:0016020; GO:0016594; GO:0016933; GO:0016934; GO:0022824; GO:0030425; GO:0034707; GO:0043200; GO:0043204; GO:0045211; GO:0045664; GO:0071230; GO:0071294; GO:0071361; GO:1902476,cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; central nervous system development [GO:0007417]; chloride transmembrane transport [GO:1902476]; monoatomic ion transport [GO:0006811]; regulation of neuron differentiation [GO:0045664]; response to amino acid [GO:0043200],chloride channel complex [GO:0034707]; dendrite [GO:0030425]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],extracellularly glycine-gated chloride channel activity [GO:0016934]; extracellularly glycine-gated ion channel activity [GO:0016933]; glycine binding [GO:0016594]; ligand-gated monoatomic ion channel activity [GO:0015276]; transmembrane signaling receptor activity [GO:0004888]; transmitter-gated monoatomic ion channel activity [GO:0022824]; zinc ion binding [GO:0008270],GO:0005215; GO:0005886; GO:0048856; GO:0055085; GO:0060089,transporter activity; plasma membrane; anatomical structure development; transmembrane transport; molecular transducer activity
OG_14666,FUN_023320-T5,,Pocillopora_meandrina_HIv1___RNAseq.g17824.t1,apul_ptua,50.5235,,,,,,,,,,,,,,,,,
OG_14667,FUN_023323-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17836.t1a,apul_ptua,61.441,FUN_023323-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),33.3,688.0,3.8e-116,420.6,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_14668,FUN_023344-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17426.t1,apul_ptua,49.5,FUN_023344-T1,Q91770,,,,,63.1,65.0,8.4e-16,85.5,sp|Q91770|NOT2_XENLA Homeobox protein not2 OS=Xenopus laevis OX=8355 GN=not2 PE=2 SV=1,,,,,,
OG_14669,FUN_023348-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17429.t1,apul_ptua,51.786,,,,,,,,,,,,,,,,,
OG_14670,FUN_023355-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17433.t1,apul_ptua,74.194,FUN_023355-T1,Q6P0U3,,,,,31.6,209.0,4.7e-23,109.8,sp|Q6P0U3|RSLBB_DANRE Ras-like protein family member 11B OS=Danio rerio OX=7955 GN=rasl11b PE=2 SV=1,,,,,,
OG_14671,FUN_023377-T3,,Pocillopora_meandrina_HIv1___RNAseq.g17525.t1,apul_ptua,57.227,,,,,,,,,,,,,,,,,
OG_14672,FUN_023384-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9845.t1,apul_ptua,45.318,FUN_023384-T1,A0A8B8EY61,,,,,22.6,296.0,4.1e-08,61.6,sp|A0A8B8EY61|CGLR2_CRAVI Cyclic GMP-AMP synthase-like receptor 2 OS=Crassostrea virginica OX=6565 GN=cGLR2 PE=1 SV=1,,,,,,
OG_14673,FUN_023400-T2,,Pocillopora_meandrina_HIv1___RNAseq.g17447.t1,apul_ptua,44.8915,FUN_023400-T2,O60282,KIF5C_HUMAN,,Kinesin heavy chain isoform 5C (EC 3.6.4.-) (Kinesin heavy chain neuron-specific 2) (Kinesin-1),Homo sapiens (Human),59.6,114.0,2.2e-31,140.2,sp|O60282|KIF5C_HUMAN Kinesin heavy chain isoform 5C OS=Homo sapiens OX=9606 GN=KIF5C PE=1 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005871; GO:0005874; GO:0006996; GO:0007411; GO:0008017; GO:0008045; GO:0008298; GO:0008574; GO:0016887; GO:0032839; GO:0034190; GO:0035253; GO:0043025; GO:0044295; GO:0048489; GO:0051028; GO:0098964; GO:0098971; GO:0098982; GO:0099524; GO:0099641; GO:0150034; GO:1904115,anterograde axonal protein transport [GO:0099641]; anterograde dendritic transport of messenger ribonucleoprotein complex [GO:0098964]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; axon guidance [GO:0007411]; intracellular mRNA localization [GO:0008298]; motor neuron axon guidance [GO:0008045]; mRNA transport [GO:0051028]; organelle organization [GO:0006996]; synaptic vesicle transport [GO:0048489],axon cytoplasm [GO:1904115]; axonal growth cone [GO:0044295]; ciliary rootlet [GO:0035253]; cytoplasm [GO:0005737]; dendrite cytoplasm [GO:0032839]; distal axon [GO:0150034]; GABA-ergic synapse [GO:0098982]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic cytosol [GO:0099524],apolipoprotein receptor binding [GO:0034190]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; plus-end-directed microtubule motor activity [GO:0008574],GO:0003774; GO:0003824; GO:0005829; GO:0006886; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; cytosol; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; ATP-dependent activity
OG_14674,FUN_023403-T1,,Pocillopora_meandrina_HIv1___TS.g17142.t1,apul_ptua,70.817,FUN_023403-T1,P14272,KLKB1_RAT,,Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain],Rattus norvegicus (Rat),42.7,253.0,2.9e-52,208.0,sp|P14272|KLKB1_RAT Plasma kallikrein OS=Rattus norvegicus OX=10116 GN=Klkb1 PE=1 SV=1,GO:0004252; GO:0005615; GO:0006954; GO:0007596; GO:0031639; GO:0042730; GO:0051919; GO:0097421,blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; inflammatory response [GO:0006954]; liver regeneration [GO:0097421]; plasminogen activation [GO:0031639]; positive regulation of fibrinolysis [GO:0051919],extracellular space [GO:0005615],serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005615; GO:0006954; GO:0016787; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular space; inflammatory response; hydrolase activity; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_14675,FUN_023412-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17576.t1,apul_ptua,63.636,FUN_023412-T1,Q1LYG0,,,,,27.6,228.0,1.6e-21,104.4,sp|Q1LYG0|SPD2A_DANRE SH3 and PX domain-containing protein 2A OS=Danio rerio OX=7955 GN=sh3pxd2a PE=3 SV=2,,,,,,
OG_14676,FUN_023432-T1,,Pocillopora_meandrina_HIv1___RNAseq.g587.t1,apul_ptua,53.644,FUN_023432-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),36.4,165.0,1.5e-20,102.4,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_14677,FUN_023443-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17639.t1,apul_ptua,64.151,,,,,,,,,,,,,,,,,
OG_14678,FUN_023451-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17629.t1,apul_ptua,54.3595,FUN_023451-T1,Q9Y251,HPSE_HUMAN,,Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit],Homo sapiens (Human),36.0,469.0,1.6e-76,288.5,sp|Q9Y251|HPSE_HUMAN Heparanase OS=Homo sapiens OX=9606 GN=HPSE PE=1 SV=2,GO:0004566; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005765; GO:0006029; GO:0007160; GO:0010575; GO:0030194; GO:0030200; GO:0030202; GO:0030305; GO:0031012; GO:0033690; GO:0035580; GO:0043202; GO:0043231; GO:0045121; GO:0045545; GO:0046677; GO:0051797; GO:0051798; GO:0051897; GO:0060055; GO:0061028; GO:0061042; GO:0071806,angiogenesis involved in wound healing [GO:0060055]; cell-matrix adhesion [GO:0007160]; establishment of endothelial barrier [GO:0061028]; heparan sulfate proteoglycan catabolic process [GO:0030200]; heparin proteoglycan metabolic process [GO:0030202]; positive regulation of blood coagulation [GO:0030194]; positive regulation of hair follicle development [GO:0051798]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein transmembrane transport [GO:0071806]; proteoglycan metabolic process [GO:0006029]; regulation of hair follicle development [GO:0051797]; response to antibiotic [GO:0046677]; vascular wound healing [GO:0061042],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; specific granule lumen [GO:0035580],beta-glucuronidase activity [GO:0004566]; heparanase activity [GO:0030305]; syndecan binding [GO:0045545],GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0007155; GO:0016787; GO:0030163; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0055085; GO:1901135,catalytic activity; extracellular region; extracellular space; nucleus; nucleoplasm; lysosome; vacuole; cell adhesion; hydrolase activity; protein catabolic process; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; transmembrane transport; carbohydrate derivative metabolic process
OG_14679,FUN_023457-T1,,Pocillopora_meandrina_HIv1___TS.g17212.t1,apul_ptua,50.957,,,,,,,,,,,,,,,,,
OG_14680,FUN_023464-T1,,Pocillopora_meandrina_HIv1___TS.g28760.t1b,apul_ptua,49.315,,,,,,,,,,,,,,,,,
OG_14681,FUN_023470-T1,,Pocillopora_meandrina_HIv1___TS.g17155.t1,apul_ptua,53.67,FUN_023470-T1,B8VIU6,,,,,37.1,245.0,2.7e-33,144.4,sp|B8VIU6|USOM5_ACRMI Uncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_14682,FUN_023485-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16284.t1,apul_ptua,35.294,,,,,,,,,,,,,,,,,
OG_14683,FUN_023547-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25902.t1,apul_ptua,59.722,,,,,,,,,,,,,,,,,
OG_14684,FUN_023583-T2,,Pocillopora_meandrina_HIv1___TS.g9734.t1b,apul_ptua,36.38,FUN_023583-T2,Q58EK5,TDRD1_DANRE,,Tudor domain-containing protein 1,Danio rerio (Zebrafish) (Brachydanio rerio),26.2,854.0,4.8e-65,251.9,sp|Q58EK5|TDRD1_DANRE Tudor domain-containing protein 1 OS=Danio rerio OX=7955 GN=tdrd1 PE=1 SV=2,GO:0005737; GO:0007281; GO:0007283; GO:0008270; GO:0030719; GO:0034584; GO:0034587; GO:0043186; GO:0051321; GO:0071546; GO:0141196,germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA processing [GO:0034587]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546],piRNA binding [GO:0034584]; zinc ion binding [GO:0008270],GO:0003723; GO:0006325; GO:0022414; GO:0031047; GO:0043226; GO:0048856,RNA binding; chromatin organization; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development
OG_14685,FUN_023594-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16038.t1,apul_ptua,61.6125,FUN_023594-T1,Q5R5E8,HEPS_PONAB,,Serine protease hepsin (EC 3.4.21.106) (Transmembrane protease serine 1) [Cleaved into: Serine protease hepsin non-catalytic chain; Serine protease hepsin catalytic chain],Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),36.7,270.0,2.1e-40,167.9,sp|Q5R5E8|HEPS_PONAB Serine protease hepsin OS=Pongo abelii OX=9601 GN=HPN PE=2 SV=1,GO:0004252; GO:0005737; GO:0005789; GO:0005886; GO:0005911; GO:0006508; GO:0008236; GO:0008360; GO:0009986; GO:0010628; GO:0010719; GO:0010756; GO:0030307; GO:0034769; GO:0043025; GO:0043066; GO:0043923; GO:0050680; GO:0050910; GO:0070008; GO:0071805; GO:0090103; GO:0097066; GO:0097195; GO:2000347; GO:2000611,basement membrane disassembly [GO:0034769]; cochlea morphogenesis [GO:0090103]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; negative regulation of apoptotic process [GO:0043066]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; pilomotor reflex [GO:0097195]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of cell growth [GO:0030307]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of thyroid hormone generation [GO:2000611]; potassium ion transmembrane transport [GO:0071805]; proteolysis [GO:0006508]; regulation of cell shape [GO:0008360]; response to thyroid hormone [GO:0097066],cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236],GO:0003824; GO:0005886; GO:0016787; GO:0030198; GO:0050877; GO:0055085; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; extracellular matrix organization; nervous system process; transmembrane transport; catalytic activity, acting on a protein"
OG_14686,FUN_023598-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3602.t2,apul_ptua,60.437,FUN_023598-T1,Q9W6S5,,,,,52.6,384.0,1.8e-122,440.7,sp|Q9W6S5|ALLC_XENLA Allantoicase OS=Xenopus laevis OX=8355 GN=allc PE=2 SV=1,,,,,,
OG_14687,FUN_023669-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17763.t1,apul_ptua,78.0585,FUN_023669-T1,Q62824,EXOC4_RAT,,Exocyst complex component 4 (Exocyst complex component Sec8) (rSec8),Rattus norvegicus (Rat),39.7,969.0,9.999999999999999e-183,642.1,sp|Q62824|EXOC4_RAT Exocyst complex component 4 OS=Rattus norvegicus OX=10116 GN=Exoc4 PE=1 SV=1,GO:0000145; GO:0005768; GO:0005813; GO:0005902; GO:0006612; GO:0006887; GO:0006893; GO:0006903; GO:0006904; GO:0007268; GO:0008021; GO:0014069; GO:0030010; GO:0030165; GO:0030425; GO:0030426; GO:0031252; GO:0032584; GO:0032991; GO:0035255; GO:0035748; GO:0043005; GO:0043025; GO:0043198; GO:0044091; GO:0044877; GO:0045202; GO:0048341; GO:0048709; GO:0050850; GO:0051223; GO:0055108; GO:0071806; GO:0090522; GO:0090543; GO:0098685; GO:0098696; GO:0099092,chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; paraxial mesoderm formation [GO:0048341]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; protein transmembrane transport [GO:0071806]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522],"cell leading edge [GO:0031252]; centrosome [GO:0005813]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; endosome [GO:0005768]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; microvillus [GO:0005902]; myelin sheath abaxonal region [GO:0035748]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; postsynaptic density, intracellular component [GO:0099092]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]",ionotropic glutamate receptor binding [GO:0035255]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877],GO:0005768; GO:0005815; GO:0007163; GO:0016192; GO:0023052; GO:0030154; GO:0031410; GO:0043226; GO:0055085,endosome; microtubule organizing center; establishment or maintenance of cell polarity; vesicle-mediated transport; signaling; cell differentiation; cytoplasmic vesicle; organelle; transmembrane transport
OG_14688,FUN_023792-T1,,Pocillopora_meandrina_HIv1___TS.g27941.t1,apul_ptua,63.636,,,,,,,,,,,,,,,,,
OG_14689,FUN_023816-T1,,Pocillopora_meandrina_HIv1___TS.g4126.t1,apul_ptua,32.143,,,,,,,,,,,,,,,,,
OG_14690,FUN_023888-T1,,Pocillopora_meandrina_HIv1___TS.g17586.t1,apul_ptua,53.411,,,,,,,,,,,,,,,,,
OG_14691,FUN_023926-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18512.t1,apul_ptua,70.2185,,,,,,,,,,,,,,,,,
OG_14692,FUN_023929-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18515.t1,apul_ptua,57.231,FUN_023929-T1,O54853,KCNH6_RAT,,Voltage-gated inwardly rectifying potassium channel KCNH6 (Ether-a-go-go-related gene potassium channel 2) (ERG-2) (Eag-related protein 2) (Ether-a-go-go-related protein 2) (Potassium voltage-gated channel subfamily H member 6) (Voltage-gated potassium channel subunit Kv11.2),Rattus norvegicus (Rat),41.3,526.0,5.4e-107,389.8,sp|O54853|KCNH6_RAT Voltage-gated inwardly rectifying potassium channel KCNH6 OS=Rattus norvegicus OX=10116 GN=Kcnh6 PE=1 SV=1,GO:0005242; GO:0005249; GO:0005267; GO:0005886; GO:0006813; GO:0034702; GO:0044877; GO:0060307; GO:0071805; GO:0086013; GO:0086091,membrane repolarization during cardiac muscle cell action potential [GO:0086013]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307],monoatomic ion channel complex [GO:0034702]; plasma membrane [GO:0005886],inward rectifier potassium channel activity [GO:0005242]; potassium channel activity [GO:0005267]; protein-containing complex binding [GO:0044877]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_14693,FUN_023946-T2,,Pocillopora_meandrina_HIv1___RNAseq.g18864.t1,apul_ptua,90.468,FUN_023946-T2,P70704,AT8A1_MOUSE,,Phospholipid-transporting ATPase IA (EC 7.6.2.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1),Mus musculus (Mouse),59.1,1138.0,0.0,1317.8,sp|P70704|AT8A1_MOUSE Phospholipid-transporting ATPase IA OS=Mus musculus OX=10090 GN=Atp8a1 PE=1 SV=2,GO:0000287; GO:0005524; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007612; GO:0016887; GO:0030335; GO:0030672; GO:0031090; GO:0031410; GO:0042584; GO:0045202; GO:0048488; GO:0061092; GO:0090556; GO:0098978; GO:0140331; GO:0140346; GO:1990531,aminophospholipid translocation [GO:0140331]; learning [GO:0007612]; positive regulation of cell migration [GO:0030335]; positive regulation of phospholipid translocation [GO:0061092]; synaptic vesicle endocytosis [GO:0048488],chromaffin granule membrane [GO:0042584]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; organelle membrane [GO:0031090]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle membrane [GO:0030672],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; phosphatidylserine flippase activity [GO:0140346]; phosphatidylserine floppase activity [GO:0090556],GO:0003824; GO:0005215; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0016192; GO:0016787; GO:0031410; GO:0043226; GO:0050877; GO:0061024; GO:0140657,catalytic activity; transporter activity; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle; nervous system process; membrane organization; ATP-dependent activity
OG_14694,FUN_023951-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18524.t1b,apul_ptua,55.932,,,,,,,,,,,,,,,,,
OG_14695,FUN_023968-T3,,Pocillopora_meandrina_HIv1___RNAseq.g18580.t1b,apul_ptua,48.663,FUN_023968-T3,B8NHE3,FLVH_ASPFN,,Methyltransferase flvH (EC 2.1.1.-) (Flavunoidine biosynthesis cluster protein H),Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167),26.2,126.0,2.9e-07,57.0,sp|B8NHE3|FLVH_ASPFN Methyltransferase flvH OS=Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) OX=332952 GN=flvH PE=1 SV=1,GO:0008168; GO:0016114; GO:0032259; GO:0046872,methylation [GO:0032259]; terpenoid biosynthetic process [GO:0016114],,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],GO:0003824; GO:0006629; GO:0016740,catalytic activity; lipid metabolic process; transferase activity
OG_14696,FUN_023996-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19354.t1,apul_ptua,31.897,,,,,,,,,,,,,,,,,
OG_14697,FUN_023997-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8354.t1,apul_ptua,60.0015,FUN_023997-T1,Q9Z222,B3GN2_MOUSE,,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (EC 2.4.1.149) (Beta-1,3-N-acetylglucosaminyltransferase 1) (BGnT-1) (Beta-1,3-Gn-T1) (Beta3Gn-T1) (Beta-1,3-galactosyltransferase 7) (Beta-1,3-GalTase 7) (Beta3Gal-T7) (Beta3GalT7) (b3Gal-T7) (Beta-3-Gx-T7) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 7) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2) (BGnT-2) (Beta-1,3-Gn-T2) (Beta-1,3-N-acetylglucosaminyltransferase 2) (Beta3Gn-T2) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 7)",Mus musculus (Mouse),29.9,174.0,2e-17,90.9,"sp|Q9Z222|B3GN2_MOUSE N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 OS=Mus musculus OX=10090 GN=B3GNT2 PE=1 SV=3",GO:0000139; GO:0006486; GO:0007411; GO:0007608; GO:0008532; GO:0030311; GO:1990830,axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; poly-N-acetyllactosamine biosynthetic process [GO:0030311]; protein glycosylation [GO:0006486]; sensory perception of smell [GO:0007608],Golgi membrane [GO:0000139],"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity [GO:0008532]",GO:0003824; GO:0006486; GO:0016740; GO:0050877; GO:1901135,catalytic activity; protein glycosylation; transferase activity; nervous system process; carbohydrate derivative metabolic process
OG_14698,FUN_024009-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7351.t1,apul_ptua,56.589,,,,,,,,,,,,,,,,,
OG_14699,FUN_024019-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4019.t1a,apul_ptua,43.934,FUN_024019-T1,P26016,,,,,40.0,585.0,3.8e-114,414.1,"sp|P26016|FUR11_DROME Furin-like protease 1, isoforms 1/1-X/2 OS=Drosophila melanogaster OX=7227 GN=Fur1 PE=2 SV=2",,,,,,
OG_14700,FUN_024035-T2,,Pocillopora_meandrina_HIv1___RNAseq.g19277.t1,apul_ptua,90.891,FUN_024035-T2,Q5RGV1,,,,,78.1,517.0,2.6e-233,809.3,sp|Q5RGV1|IMDH3_DANRE Inosine-5'-monophosphate dehydrogenase 1b OS=Danio rerio OX=7955 GN=impdh1b PE=2 SV=1,,,,,,
OG_14701,FUN_024058-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19260.t1,apul_ptua,78.435,FUN_024058-T1,P26630,,,,,40.5,467.0,3e-73,277.7,sp|P26630|PAX6_DANRE Paired box protein Pax-6 OS=Danio rerio OX=7955 GN=pax6a PE=2 SV=1,,,,,,
OG_14702,FUN_024069-T2,,Pocillopora_meandrina_HIv1___RNAseq.g19253.t1,apul_ptua,65.89500000000001,FUN_024069-T2,E9Q236,MRP4_MOUSE,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4),Mus musculus (Mouse),46.4,1301.0,0.0,1100.1,sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1,GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015431; GO:0015432; GO:0015562; GO:0015665; GO:0015721; GO:0015732; GO:0015747; GO:0015850; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0060271; GO:0070730; GO:0071716; GO:0140115; GO:1901571,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; fatty acid derivative transport [GO:1901571]; leukotriene transport [GO:0071716]; organic hydroxy compound transport [GO:0015850]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; alcohol transmembrane transporter activity [GO:0015665]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_14703,FUN_024072-T1,,Pocillopora_meandrina_HIv1___TS.g20901.t1,apul_ptua,61.043000000000006,,,,,,,,,,,,,,,,,
OG_14704,FUN_024120-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19177.t1,apul_ptua,42.718,,,,,,,,,,,,,,,,,
OG_14705,FUN_024137-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19875.t1,apul_ptua,72.471,FUN_024137-T1,P23501,DS1P2_YEAST,,Dihydrosphingosine 1-phosphate phosphatase YSR3 (EC 3.1.3.-) (Long-chain base protein 2) (Sphingolipid resistance protein 3),Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast),26.4,216.0,8e-15,83.2,sp|P23501|DS1P2_YEAST Dihydrosphingosine 1-phosphate phosphatase YSR3 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YSR3 PE=1 SV=2,GO:0005783; GO:0005789; GO:0030148; GO:0042392; GO:0046839; GO:0070780,phospholipid dephosphorylation [GO:0046839]; sphingolipid biosynthetic process [GO:0030148],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],dihydrosphingosine-1-phosphate phosphatase activity [GO:0070780]; sphingosine-1-phosphate phosphatase activity [GO:0042392],GO:0003824; GO:0005783; GO:0006629; GO:0016787; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; hydrolase activity; organelle
OG_14706,FUN_024150-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19860.t1,apul_ptua,62.211,FUN_024150-T1,Q8UW76,TBX20_CHICK,,T-box transcription factor TBX20 (T-box protein 20) (cTbx20),Gallus gallus (Chicken),59.2,284.0,1.3e-88,328.2,sp|Q8UW76|TBX20_CHICK T-box transcription factor TBX20 OS=Gallus gallus OX=9031 GN=TBX20 PE=2 SV=1,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001569; GO:0001708; GO:0001947; GO:0003148; GO:0003175; GO:0003180; GO:0003193; GO:0003207; GO:0003215; GO:0003272; GO:0003344; GO:0005634; GO:0005737; GO:0006357; GO:0006936; GO:0008015; GO:0009953; GO:0010628; GO:0010629; GO:0010718; GO:0014031; GO:0021524; GO:0030335; GO:0030513; GO:0035922; GO:0036302; GO:0036306; GO:0055008; GO:0060045; GO:0060392; GO:0060413; GO:0060577; GO:0060973; GO:0061629; GO:0097475; GO:2000793,aortic valve morphogenesis [GO:0003180]; atrial septum morphogenesis [GO:0060413]; atrioventricular canal development [GO:0036302]; blood circulation [GO:0008015]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac chamber formation [GO:0003207]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right ventricle morphogenesis [GO:0003215]; cell fate specification [GO:0001708]; cell migration involved in heart development [GO:0060973]; cell proliferation involved in heart valve development [GO:2000793]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube elongation [GO:0036306]; endocardial cushion formation [GO:0003272]; foramen ovale closure [GO:0035922]; heart looping [GO:0001947]; mesenchymal cell development [GO:0014031]; motor neuron migration [GO:0097475]; muscle contraction [GO:0006936]; negative regulation of gene expression [GO:0010629]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; outflow tract septum morphogenesis [GO:0003148]; pericardium morphogenesis [GO:0003344]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; pulmonary valve formation [GO:0003193]; pulmonary vein morphogenesis [GO:0060577]; regulation of transcription by RNA polymerase II [GO:0006357]; tricuspid valve development [GO:0003175]; visceral motor neuron differentiation [GO:0021524],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",GO:0003012; GO:0003013; GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,muscle system process; circulatory system process; DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_14707,FUN_024169-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19056.t1,apul_ptua,42.301,,,,,,,,,,,,,,,,,
OG_14708,FUN_024175-T2,,Pocillopora_meandrina_HIv1___TS.g28278.t1,apul_ptua,61.2685,FUN_024175-T2,Q5ZMS6,,,,,52.2,203.0,2.9e-49,198.7,sp|Q5ZMS6|TDRD3_CHICK Tudor domain-containing protein 3 OS=Gallus gallus OX=9031 GN=TDRD3 PE=2 SV=1,,,,,,
OG_14709,FUN_024193-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18882.t1,apul_ptua,54.613,FUN_024193-T1,Q9JLC6,,,,,35.2,216.0,1e-12,75.5,sp|Q9JLC6|TEF_MOUSE Thyrotroph embryonic factor OS=Mus musculus OX=10090 GN=Tef PE=2 SV=1,,,,,,
OG_14710,FUN_024225-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18919.t1b,apul_ptua,45.246,FUN_024225-T1,F1RWC3,CUBN_PIG,,Cubilin (Intrinsic factor-cobalamin receptor),Sus scrofa (Pig),24.8,854.0,9.999999999999999e-55,216.9,sp|F1RWC3|CUBN_PIG Cubilin OS=Sus scrofa OX=9823 GN=CUBN PE=1 SV=3,GO:0004252; GO:0005509; GO:0005615; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419,cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031],apical plasma membrane [GO:0016324]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765],calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005615; GO:0005768; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; extracellular space; endosome; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_14711,FUN_024326-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18918.t1,apul_ptua,44.712500000000006,FUN_024326-T1,Q9TU53,CUBN_CANLF,,Cubilin,Canis lupus familiaris (Dog) (Canis familiaris),24.6,1125.0,6.7e-69,264.2,sp|Q9TU53|CUBN_CANLF Cubilin OS=Canis lupus familiaris OX=9615 GN=CUBN PE=1 SV=1,GO:0005509; GO:0005765; GO:0005768; GO:0005905; GO:0008203; GO:0015031; GO:0016324; GO:0031419; GO:0031526; GO:0043235,cholesterol metabolic process [GO:0008203]; protein transport [GO:0015031],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; endosome [GO:0005768]; lysosomal membrane [GO:0005765]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cobalamin binding [GO:0031419],GO:0005768; GO:0006629; GO:0031410; GO:0043226,endosome; lipid metabolic process; cytoplasmic vesicle; organelle
OG_14712,FUN_024338-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18937.t2,apul_ptua,57.730500000000006,FUN_024338-T1,Q9NPG3,UBN1_HUMAN,,Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein),Homo sapiens (Human),40.4,594.0,1.8e-63,246.1,sp|Q9NPG3|UBN1_HUMAN Ubinuclein-1 OS=Homo sapiens OX=9606 GN=UBN1 PE=1 SV=2,GO:0003677; GO:0005634; GO:0005654; GO:0005923; GO:0006325; GO:0006334; GO:0016604; GO:0016605; GO:0034451,chromatin organization [GO:0006325]; nucleosome assembly [GO:0006334],bicellular tight junction [GO:0005923]; centriolar satellite [GO:0034451]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005654; GO:0006325; GO:0043226; GO:0065003,DNA binding; nucleus; nucleoplasm; chromatin organization; organelle; protein-containing complex assembly
OG_14713,FUN_024341-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18933.t1,apul_ptua,65.035,,,,,,,,,,,,,,,,,
OG_14714,FUN_024346-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18669.t1,apul_ptua,75.03450000000001,FUN_024346-T1,Q9SY14,,,,,32.4,682.0,1.6e-76,288.9,sp|Q9SY14|OSC17_ARATH Hyperosmolality-gated Ca2+ permeable channel 1.7 OS=Arabidopsis thaliana OX=3702 GN=OSCA1.7 PE=1 SV=1,,,,,,
OG_14715,FUN_024379-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13302.t1,apul_ptua,72.656,,,,,,,,,,,,,,,,,
OG_14716,FUN_024438-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18715.t1,apul_ptua,50.917,,,,,,,,,,,,,,,,,
OG_14717,FUN_024560-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18659.t1,apul_ptua,80.653,FUN_024560-T1,Q9W7E7,SMAD5_DANRE,,Mothers against decapentaplegic homolog 5 (MAD homolog 5) (Mothers against DPP homolog 5) (Protein somitabun) (SMAD family member 5) (SMAD 5) (Smad5),Danio rerio (Zebrafish) (Brachydanio rerio),65.0,466.0,7.7e-170,598.2,sp|Q9W7E7|SMAD5_DANRE Mothers against decapentaplegic homolog 5 OS=Danio rerio OX=7955 GN=smad5 PE=2 SV=1,GO:0000976; GO:0000978; GO:0000981; GO:0001945; GO:0001947; GO:0003143; GO:0003700; GO:0005737; GO:0006355; GO:0006357; GO:0007179; GO:0007368; GO:0009653; GO:0009880; GO:0009953; GO:0030154; GO:0030509; GO:0030510; GO:0031099; GO:0036342; GO:0043049; GO:0045893; GO:0046872; GO:0048264; GO:0048514; GO:0048919; GO:0048922; GO:0060021; GO:0060030; GO:0060037; GO:0060395; GO:0070411; GO:0071144,anatomical structure morphogenesis [GO:0009653]; blood vessel morphogenesis [GO:0048514]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; determination of ventral identity [GO:0048264]; dorsal convergence [GO:0060030]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube morphogenesis [GO:0003143]; embryonic pattern specification [GO:0009880]; heart looping [GO:0001947]; lymph vessel development [GO:0001945]; otic placode formation [GO:0043049]; pharyngeal system development [GO:0060037]; positive regulation of DNA-templated transcription [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; posterior lateral line neuromast deposition [GO:0048922]; posterior lateral line neuromast development [GO:0048919]; regeneration [GO:0031099]; regulation of BMP signaling pathway [GO:0030510]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; heteromeric SMAD protein complex [GO:0071144],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]",GO:0003677; GO:0006355; GO:0030154; GO:0048856; GO:0048870; GO:0140110,DNA binding; regulation of DNA-templated transcription; cell differentiation; anatomical structure development; cell motility; transcription regulator activity
OG_14718,FUN_024561-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18660.t1,apul_ptua,79.71,FUN_024561-T1,Q96B26,EXOS8_HUMAN,,Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2) (OIP-2) (Ribosomal RNA-processing protein 43) (p9),Homo sapiens (Human),61.7,266.0,5.2999999999999996e-92,339.0,sp|Q96B26|EXOS8_HUMAN Exosome complex component RRP43 OS=Homo sapiens OX=9606 GN=EXOSC8 PE=1 SV=1,GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0001650; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005737; GO:0005829; GO:0006396; GO:0006401; GO:0016075; GO:0034473; GO:0034475; GO:0034476; GO:0035925; GO:0042802; GO:0043231; GO:0071028; GO:0071035; GO:0071038; GO:0101019,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]",chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],identical protein binding [GO:0042802]; mRNA 3'-UTR AU-rich region binding [GO:0035925],GO:0003723; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0005829; GO:0006399; GO:0016071; GO:0016073; GO:0043226,RNA binding; nucleus; nucleoplasm; chromosome; nucleolus; cytosol; tRNA metabolic process; mRNA metabolic process; snRNA metabolic process; organelle
OG_14719,FUN_024562-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18661.t1,apul_ptua,78.786,FUN_024562-T1,Q5R724,,,,,43.9,412.0,3.8e-83,311.2,sp|Q5R724|SP20H_PONAB Transcription factor SPT20 homolog OS=Pongo abelii OX=9601 GN=SUPT20H PE=2 SV=1,,,,,,
OG_14720,FUN_024576-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19089.t1,apul_ptua,55.616,FUN_024576-T1,P10950,,,,,37.6,335.0,1.9000000000000002e-58,228.0,sp|P10950|ASMT_BOVIN Acetylserotonin O-methyltransferase OS=Bos taurus OX=9913 GN=ASMT PE=1 SV=2,,,,,,
OG_14721,FUN_024600-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19131.t1,apul_ptua,46.233,,,,,,,,,,,,,,,,,
OG_14722,FUN_024631-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18960.t1,apul_ptua,34.501000000000005,,,,,,,,,,,,,,,,,
OG_14723,FUN_024643-T1,,Pocillopora_meandrina_HIv1___RNAseq.g552.t1,apul_ptua,32.857,,,,,,,,,,,,,,,,,
OG_14724,FUN_024646-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13408.t1,apul_ptua,33.564499999999995,,,,,,,,,,,,,,,,,
OG_14725,FUN_024647-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24522.t1,apul_ptua,33.333,,,,,,,,,,,,,,,,,
OG_14726,FUN_024679-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18951.t1,apul_ptua,75.1,FUN_024679-T1,P91580,,,,,59.6,178.0,1e-59,231.5,sp|P91580|RAB33_CIOIN Putative Ras-related protein Rab-33 OS=Ciona intestinalis OX=7719 GN=COS41.2 PE=3 SV=1,,,,,,
OG_14727,FUN_024692-T1,,Pocillopora_meandrina_HIv1___TS.g1560.t1,apul_ptua,31.818,,,,,,,,,,,,,,,,,
OG_14728,FUN_024700-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10953.t1,apul_ptua,35.1155,,,,,,,,,,,,,,,,,
OG_14729,FUN_024718-T2,,Pocillopora_meandrina_HIv1___RNAseq.g18948.t1,apul_ptua,76.1325,FUN_024718-T2,Q6AXC6,DDX11_MOUSE,,ATP-dependent DNA helicase DDX11 (EC 5.6.2.3) (DEAD/H-box protein 11) (DNA 5'-3' helicase DDX11),Mus musculus (Mouse),50.4,913.0,1.1e-237,824.7,sp|Q6AXC6|DDX11_MOUSE ATP-dependent DNA helicase DDX11 OS=Mus musculus OX=10090 GN=Ddx11 PE=1 SV=2,GO:0000785; GO:0000922; GO:0003677; GO:0003682; GO:0003688; GO:0003690; GO:0003697; GO:0003727; GO:0004386; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0005813; GO:0006281; GO:0006974; GO:0007062; GO:0008186; GO:0016887; GO:0030496; GO:0031297; GO:0032091; GO:0035563; GO:0043139; GO:0045142; GO:0045876; GO:0046872; GO:0051539; GO:0051880; GO:0070062; GO:0072711; GO:0072719; GO:0140640; GO:1901838; GO:1904976; GO:1990700; GO:2000781,cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to hydroxyurea [GO:0072711]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of protein binding [GO:0032091]; nucleolar chromatin organization [GO:1990700]; positive regulation of chromatin binding [GO:0035563]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; replication fork processing [GO:0031297]; sister chromatid cohesion [GO:0007062],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; midbody [GO:0030496]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on RNA [GO:0008186]; catalytic activity, acting on a nucleic acid [GO:0140640]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; G-quadruplex DNA binding [GO:0051880]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; triplex DNA binding [GO:0045142]",GO:0003677; GO:0003723; GO:0003824; GO:0005654; GO:0005730; GO:0005815; GO:0006281; GO:0006325; GO:0006355; GO:0016787; GO:0016853; GO:0043226; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleoplasm; nucleolus; microtubule organizing center; DNA repair; chromatin organization; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_14730,FUN_024750-T2,,Pocillopora_meandrina_HIv1___RNAseq.g18850.t1,apul_ptua,62.205,FUN_024750-T2,Q6NTV6,,,,,44.0,1153.0,1e-129,466.8,sp|Q6NTV6|INF2_XENLA Inverted formin-2 OS=Xenopus laevis OX=8355 GN=inf2 PE=2 SV=1,,,,,,
OG_14731,FUN_024750-T4,,Pocillopora_meandrina_HIv1___RNAseq.g18847.t1,apul_ptua,41.153000000000006,FUN_024750-T4,Q6NTV6,,,,,43.1,1146.0,3.5000000000000003e-124,448.0,sp|Q6NTV6|INF2_XENLA Inverted formin-2 OS=Xenopus laevis OX=8355 GN=inf2 PE=2 SV=1,,,,,,
OG_14732,FUN_024788-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22045.t1,apul_ptua,80.899,,,,,,,,,,,,,,,,,
OG_14733,FUN_024789-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27072.t1c,apul_ptua,92.857,,,,,,,,,,,,,,,,,
OG_14734,FUN_024798-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18788.t1,apul_ptua,64.198,FUN_024798-T1,Q3U481,MFS12_MOUSE,,Major facilitator superfamily domain-containing protein 12 (Protein grizzled),Mus musculus (Mouse),37.6,481.0,5.4e-77,290.0,sp|Q3U481|MFS12_MOUSE Major facilitator superfamily domain-containing protein 12 OS=Mus musculus OX=10090 GN=Mfsd12 PE=1 SV=1,GO:0005764; GO:0005765; GO:0005770; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome membrane [GO:0033162],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; cytoplasmic vesicle; organelle; transmembrane transport
OG_14735,FUN_024813-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18774.t1,apul_ptua,52.182500000000005,FUN_024813-T1,P40682,VAS1_BOVIN,,V-type proton ATPase subunit S1 (V-ATPase subunit S1) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1),Bos taurus (Bovine),27.3,477.0,1.3e-26,122.5,sp|P40682|VAS1_BOVIN V-type proton ATPase subunit S1 OS=Bos taurus OX=9913 GN=ATP6AP1 PE=1 SV=1,GO:0001671; GO:0005789; GO:0006879; GO:0030641; GO:0030665; GO:0030672; GO:0033116; GO:0033176; GO:0036295; GO:1902600,cellular response to increased oxygen levels [GO:0036295]; intracellular iron ion homeostasis [GO:0006879]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641],clathrin-coated vesicle membrane [GO:0030665]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; proton-transporting V-type ATPase complex [GO:0033176]; synaptic vesicle membrane [GO:0030672],ATPase activator activity [GO:0001671],GO:0055085; GO:0098772,transmembrane transport; molecular function regulator activity
OG_14736,FUN_024839-T1,,Pocillopora_meandrina_HIv1___TS.g12384.t1,apul_ptua,41.367,,,,,,,,,,,,,,,,,
OG_14737,FUN_024847-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3540.t1,apul_ptua,53.659,,,,,,,,,,,,,,,,,
OG_14738,FUN_024862-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18769.t1,apul_ptua,63.285,,,,,,,,,,,,,,,,,
OG_14739,FUN_024873-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18748.t1,apul_ptua,67.4435,FUN_024873-T1,A0A1B0GTI8,,,,,36.7,150.0,5.2e-14,79.7,sp|A0A1B0GTI8|TM272_HUMAN Transmembrane protein 272 OS=Homo sapiens OX=9606 GN=TMEM272 PE=2 SV=3,,,,,,
OG_14740,FUN_024890-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3864.t1,apul_ptua,30.55,,,,,,,,,,,,,,,,,
OG_14741,FUN_024893-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25685.t1,apul_ptua,40.5155,FUN_024893-T1,M9NDE3,,,,,21.3,1487.0,2.9e-49,200.7,sp|M9NDE3|BARK_DROME Protein bark beetle OS=Drosophila melanogaster OX=7227 GN=bark PE=1 SV=1,,,,,,
OG_14742,FUN_024933-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19414.t1,apul_ptua,64.762,,,,,,,,,,,,,,,,,
OG_14743,FUN_024943-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19444.t1,apul_ptua,38.5045,,,,,,,,,,,,,,,,,
OG_14744,FUN_025090-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10105.t1,apul_ptua,55.085,,,,,,,,,,,,,,,,,
OG_14745,FUN_025114-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3666.t1,apul_ptua,55.5045,,,,,,,,,,,,,,,,,
OG_14746,FUN_025121-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3652.t1,apul_ptua,40.323,,,,,,,,,,,,,,,,,
OG_14747,FUN_025220-T1,,Pocillopora_meandrina_HIv1___TS.g7937.t1,apul_ptua,41.226,FUN_025220-T1,Q55E58,PATS1_DICDI,,Probable serine/threonine-protein kinase pats1 (EC 2.7.11.1) (Protein associated with the transduction of signal 1),Dictyostelium discoideum (Social amoeba),22.6,561.0,2.1e-21,107.5,sp|Q55E58|PATS1_DICDI Probable serine/threonine-protein kinase pats1 OS=Dictyostelium discoideum OX=44689 GN=pats1 PE=3 SV=1,GO:0000281; GO:0004438; GO:0004674; GO:0004721; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0016020; GO:0042641; GO:0046856; GO:0099139; GO:0106310,cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; phosphatidylinositol dephosphorylation [GO:0046856],actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000910; GO:0003824; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0140096,"cytokinesis; catalytic activity; cytosol; lipid metabolic process; transferase activity; hydrolase activity; catalytic activity, acting on a protein"
OG_14748,FUN_025257-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13594.t1,apul_ptua,79.06,FUN_025257-T1,A3KPP4,,,,,59.1,296.0,2.9e-99,363.2,sp|A3KPP4|S2535_DANRE Solute carrier family 25 member 35 OS=Danio rerio OX=7955 GN=slc25a35 PE=2 SV=1,,,,,,
OG_14749,FUN_025258-T1,,Pocillopora_meandrina_HIv1___TS.g2587.t1,apul_ptua,44.978,FUN_025258-T1,A4XJI0,,,,,34.9,146.0,1e-12,75.1,sp|A4XJI0|RL9_CALS8 Large ribosomal subunit protein bL9 OS=Caldicellulosiruptor saccharolyticus (strain ATCC 43494 / DSM 8903 / Tp8T 6331) OX=351627 GN=rplI PE=3 SV=1,,,,,,
OG_14750,FUN_025276-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13582.t1,apul_ptua,44.628,FUN_025276-T1,Q86SQ4,AGRG6_HUMAN,,"Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: Adhesion G-protein coupled receptor G6, N-terminal fragment (ADGRG6 N-terminal fragment) (ADGRG6-NTF); Adhesion G-protein coupled receptor G6, C-terminal fragment (ADGRG6 C-terminal fragment) (ADGRG6-CTF)]",Homo sapiens (Human),26.1,314.0,8.2e-16,87.4,sp|Q86SQ4|AGRG6_HUMAN Adhesion G-protein coupled receptor G6 OS=Homo sapiens OX=9606 GN=ADGRG6 PE=1 SV=3,GO:0001890; GO:0004175; GO:0004930; GO:0005518; GO:0005737; GO:0005789; GO:0005886; GO:0007166; GO:0007186; GO:0007188; GO:0007189; GO:0007193; GO:0007399; GO:0009986; GO:0014037; GO:0016020; GO:0022011; GO:0030500; GO:0042552; GO:0043236; GO:0050840; GO:0051216; GO:0060347; GO:0060856; GO:1903670,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cartilage development [GO:0051216]; cell surface receptor signaling pathway [GO:0007166]; establishment of blood-brain barrier [GO:0060856]; G protein-coupled receptor signaling pathway [GO:0007186]; heart trabecula formation [GO:0060347]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; nervous system development [GO:0007399]; placenta development [GO:0001890]; regulation of bone mineralization [GO:0030500]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; plasma membrane [GO:0005886],collagen binding [GO:0005518]; endopeptidase activity [GO:0004175]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236],GO:0003824; GO:0005886; GO:0016787; GO:0030154; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; hydrolase activity; cell differentiation; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_14751,FUN_025287-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5852.t1,apul_ptua,47.86,FUN_025287-T1,Q58L91,FA5V_OXYSU,,Venom prothrombin activator oscutarin-C non-catalytic subunit (vPA) (Venom coagulation factor Va-like protein) [Cleaved into: Oscutarin-C non-catalytic subunit heavy chain; Oscutarin-C non-catalytic subunit light chain],Oxyuranus scutellatus (Coastal taipan),37.9,177.0,3.5e-24,113.6,sp|Q58L91|FA5V_OXYSU Venom prothrombin activator oscutarin-C non-catalytic subunit OS=Oxyuranus scutellatus OX=8668 PE=1 SV=1,GO:0005507; GO:0005576; GO:0005886; GO:0016504; GO:0032991; GO:0038023; GO:0044469; GO:0090729,venom-mediated blood coagulation [GO:0044469],extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],copper ion binding [GO:0005507]; peptidase activator activity [GO:0016504]; signaling receptor activity [GO:0038023]; toxin activity [GO:0090729],GO:0005576; GO:0005886; GO:0060089; GO:0090729; GO:0098772,extracellular region; plasma membrane; molecular transducer activity; toxin activity; molecular function regulator activity
OG_14752,FUN_025336-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14996.t1,apul_ptua,50.365,,,,,,,,,,,,,,,,,
OG_14753,FUN_025351-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13373.t1,apul_ptua,60.4375,FUN_025351-T1,Q6RFZ7,PKHG5_RAT,,Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Neuronal RhoA GEF protein) (Transcript highly enriched in cortex and hippocampus),Rattus norvegicus (Rat),35.4,758.0,1.2e-101,373.2,sp|Q6RFZ7|PKHG5_RAT Pleckstrin homology domain-containing family G member 5 OS=Rattus norvegicus OX=10116 GN=Plekhg5 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005886; GO:0005911; GO:0007266; GO:0030027; GO:0030139; GO:0030424; GO:0035767; GO:0043542; GO:0048471; GO:0098793; GO:0140251,endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; regulation protein catabolic process at presynapse [GO:0140251]; Rho protein signal transduction [GO:0007266],axon [GO:0030424]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005886; GO:0031410; GO:0043226; GO:0048870; GO:0098772,plasma membrane; cytoplasmic vesicle; organelle; cell motility; molecular function regulator activity
OG_14754,FUN_025359-T1,,Pocillopora_meandrina_HIv1___TS.g2358.t1,apul_ptua,36.765,FUN_025359-T1,Q08DY9,CASP3_BOVIN,,Caspase-3 (CASP-3) (EC 3.4.22.56) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12],Bos taurus (Bovine),34.2,281.0,1.3e-29,132.5,sp|Q08DY9|CASP3_BOVIN Caspase-3 OS=Bos taurus OX=9913 GN=CASP3 PE=2 SV=1,GO:0004175; GO:0004197; GO:0005737; GO:0006508; GO:0006915; GO:0008047; GO:0030182; GO:0030216; GO:0030218; GO:0031264; GO:0031647; GO:0043525; GO:0097194; GO:1902004,apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of neuron apoptotic process [GO:0043525]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytoplasm [GO:0005737]; death-inducing signaling complex [GO:0031264],cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; enzyme activator activity [GO:0008047],GO:0003824; GO:0012501; GO:0016787; GO:0030154; GO:0098772; GO:0140096,"catalytic activity; programmed cell death; hydrolase activity; cell differentiation; molecular function regulator activity; catalytic activity, acting on a protein"
OG_14755,FUN_025367-T2,,Pocillopora_meandrina_HIv1___TS.g2333.t2,apul_ptua,78.641,FUN_025367-T2,P51913,,,,,77.9,430.0,1.3e-194,680.6,sp|P51913|ENOA_CHICK Alpha-enolase OS=Gallus gallus OX=9031 GN=ENO1 PE=2 SV=2,,,,,,
OG_14756,FUN_025428-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13322.t1,apul_ptua,35.862,,,,,,,,,,,,,,,,,
OG_14757,FUN_025434-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13300.t1b,apul_ptua,44.0475,,,,,,,,,,,,,,,,,
OG_14758,FUN_025435-T2,,Pocillopora_meandrina_HIv1___RNAseq.g13299.t1,apul_ptua,51.994,,,,,,,,,,,,,,,,,
OG_14759,FUN_025436-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13298.t1,apul_ptua,47.531,,,,,,,,,,,,,,,,,
OG_14760,FUN_025454-T1,,Pocillopora_meandrina_HIv1___TS.g2245.t1,apul_ptua,57.515,,,,,,,,,,,,,,,,,
OG_14761,FUN_025465-T1,,Pocillopora_meandrina_HIv1___TS.g2235.t1,apul_ptua,80.859,FUN_025465-T1,Q9GRC0,,,,,46.3,259.0,3.6e-58,226.5,sp|Q9GRC0|MOS_PATPE Serine/threonine-protein kinase mos OS=Patiria pectinifera OX=7594 GN=mos PE=1 SV=1,,,,,,
OG_14762,FUN_025512-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13211.t1,apul_ptua,82.716,FUN_025512-T1,E7F4V8,PEX2_DANRE,,Peroxisome biogenesis factor 2 (EC 2.3.2.27) (EC 2.3.2.36) (Peroxin-2),Danio rerio (Zebrafish) (Brachydanio rerio),49.0,153.0,9.1e-36,151.4,sp|E7F4V8|PEX2_DANRE Peroxisome biogenesis factor 2 OS=Danio rerio OX=7955 GN=pex2 PE=3 SV=1,GO:0000425; GO:0005778; GO:0007031; GO:0008270; GO:0016562; GO:0016567; GO:0061630; GO:1990928,"peroxisome organization [GO:0007031]; pexophagy [GO:0000425]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein ubiquitination [GO:0016567]; response to amino acid starvation [GO:1990928]",peroxisomal membrane [GO:0005778],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0006914; GO:0007031; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; autophagy; peroxisome organization; transferase activity; organelle; catalytic activity, acting on a protein"
OG_14763,FUN_025521-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13186.t1,apul_ptua,35.083,FUN_025521-T1,Q2Q421,AGRE2_CANLF,,Adhesion G protein-coupled receptor E2 (EGF-like module receptor 2) (EGF-like module-containing mucin-like hormone receptor-like 2) (CD antigen CD312),Canis lupus familiaris (Dog) (Canis familiaris),41.1,73.0,8.6e-07,58.5,sp|Q2Q421|AGRE2_CANLF Adhesion G protein-coupled receptor E2 OS=Canis lupus familiaris OX=9615 GN=ADGRE2 PE=2 SV=2,GO:0004930; GO:0005509; GO:0005886; GO:0006954; GO:0007155; GO:0007166; GO:0007189; GO:0016477; GO:0031256; GO:0032587; GO:0035374; GO:0071621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954],leading edge membrane [GO:0031256]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; G protein-coupled receptor activity [GO:0004930],GO:0002376; GO:0005886; GO:0006954; GO:0007155; GO:0048870; GO:0060089,immune system process; plasma membrane; inflammatory response; cell adhesion; cell motility; molecular transducer activity
OG_14764,FUN_025559-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13782.t1,apul_ptua,44.7645,,,,,,,,,,,,,,,,,
OG_14765,FUN_025576-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13764.t1,apul_ptua,64.889,FUN_025576-T1,P86009,,,,,46.7,167.0,1.7e-46,187.6,sp|P86009|RBP_DRONO Riboflavin-binding protein OS=Dromaius novaehollandiae OX=8790 PE=1 SV=1,,,,,,
OG_14766,FUN_025587-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13735.t1,apul_ptua,52.82299999999999,FUN_025587-T1,Q5PPM0,ITLN1_XENLA,,Intelectin-1 (Embryonic epidermal lectin) (Xeel),Xenopus laevis (African clawed frog),44.2,52.0,8.6e-07,56.2,sp|Q5PPM0|ITLN1_XENLA Intelectin-1 OS=Xenopus laevis OX=8355 GN=itln1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005615; GO:0030133; GO:0030141; GO:0034214; GO:0070492,protein hexamerization [GO:0034214],extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; transport vesicle [GO:0030133],calcium ion binding [GO:0005509]; oligosaccharide binding [GO:0070492],GO:0005576; GO:0005615; GO:0031410; GO:0043226; GO:0065003,extracellular region; extracellular space; cytoplasmic vesicle; organelle; protein-containing complex assembly
OG_14767,FUN_025592-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13732.t1,apul_ptua,42.191,,,,,,,,,,,,,,,,,
OG_14768,FUN_025606-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23135.t1,apul_ptua,37.5,,,,,,,,,,,,,,,,,
OG_14769,FUN_025625-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23125.t1a,apul_ptua,57.228,FUN_025625-T1,Q6ZMV7,,,,,40.9,115.0,2e-15,85.9,sp|Q6ZMV7|LEKR1_HUMAN Protein LEKR1 OS=Homo sapiens OX=9606 GN=LEKR1 PE=2 SV=3,,,,,,
OG_14770,FUN_025634-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23129.t1,apul_ptua,40.437,FUN_025634-T1,P28824,,,,,32.4,139.0,1.4e-13,78.2,sp|P28824|NRP1_XENLA Neuropilin-1 OS=Xenopus laevis OX=8355 GN=nrp1 PE=2 SV=1,,,,,,
OG_14771,FUN_025685-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13118.t1,apul_ptua,55.263,,,,,,,,,,,,,,,,,
OG_14772,FUN_025688-T1,,Pocillopora_meandrina_HIv1___TS.g2158.t1,apul_ptua,56.19,,,,,,,,,,,,,,,,,
OG_14773,FUN_025695-T1,,Pocillopora_meandrina_HIv1___TS.g2833.t1,apul_ptua,35.616,,,,,,,,,,,,,,,,,
OG_14774,FUN_025698-T1,,Pocillopora_meandrina_HIv1___TS.g2830.t1,apul_ptua,52.554,FUN_025698-T1,Q6P2T7,,,,,44.3,194.0,1.9e-43,178.7,sp|Q6P2T7|CD033_DANRE UPF0462 protein C4orf33 homolog OS=Danio rerio OX=7955 GN=zgc:77739 PE=2 SV=1,,,,,,
OG_14775,FUN_025731-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10435.t1,apul_ptua,37.891,,,,,,,,,,,,,,,,,
OG_14776,FUN_025759-T1,,Pocillopora_meandrina_HIv1___TS.g13837.t2,apul_ptua,68.4935,FUN_025759-T1,Q7PQ25,,,,,24.3,612.0,5.3e-17,91.3,sp|Q7PQ25|CCDCX_ANOGA Coiled-coil domain-containing protein AGAP005037 OS=Anopheles gambiae OX=7165 GN=AGAP005037 PE=4 SV=4,,,,,,
OG_14777,FUN_025781-T2,,Pocillopora_meandrina_HIv1___RNAseq.g10357.t1,apul_ptua,82.353,FUN_025781-T2,Q9W6X3,,,,,63.9,83.0,8.1e-23,107.5,"sp|Q9W6X3|CH10_ORYLA 10 kDa heat shock protein, mitochondrial OS=Oryzias latipes OX=8090 GN=hspe1 PE=3 SV=1",,,,,,
OG_14778,FUN_025789-T2,,Pocillopora_meandrina_HIv1___TS.g13813.t1,apul_ptua,90.014,FUN_025789-T2,E7FAM5,LIN41_DANRE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Danio rerio (Zebrafish) (Brachydanio rerio),31.8,531.0,3.5e-69,264.6,sp|E7FAM5|LIN41_DANRE E3 ubiquitin-protein ligase TRIM71 OS=Danio rerio OX=7955 GN=trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0035198; GO:0035278; GO:0051865; GO:0072089; GO:2000177,fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube development [GO:0021915]; protein autoubiquitination [GO:0051865]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_14779,FUN_025807-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10346.t1,apul_ptua,63.529,,,,,,,,,,,,,,,,,
OG_14780,FUN_025812-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9334.t1,apul_ptua,43.809,,,,,,,,,,,,,,,,,
OG_14781,FUN_025816-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9339.t1,apul_ptua,73.992,FUN_025816-T1,Q60HE9,,,,,49.9,974.0,5.1e-270,932.2,sp|Q60HE9|MA2B1_MACFA Lysosomal alpha-mannosidase OS=Macaca fascicularis OX=9541 GN=MAN2B1 PE=2 SV=1,,,,,,
OG_14782,FUN_025832-T1,,Pocillopora_meandrina_HIv1___TS.g25007.t1,apul_ptua,31.915,,,,,,,,,,,,,,,,,
OG_14783,FUN_025864-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21169.t1,apul_ptua,30.009,FUN_025864-T1,C6FG12,,,,,25.2,539.0,1.3e-25,120.6,sp|C6FG12|NLRC5_ICTPU Protein NLRC5 OS=Ictalurus punctatus OX=7998 GN=nlrc5 PE=2 SV=1,,,,,,
OG_14784,FUN_025869-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14187.t1,apul_ptua,31.048,FUN_025869-T1,Q86WI3,NLRC5_HUMAN,,Protein NLRC5 (Caterpiller protein 16.1) (CLR16.1) (Nucleotide-binding oligomerization domain protein 27) (Nucleotide-binding oligomerization domain protein 4),Homo sapiens (Human),25.7,502.0,7.5e-24,114.8,sp|Q86WI3|NLRC5_HUMAN Protein NLRC5 OS=Homo sapiens OX=9606 GN=NLRC5 PE=1 SV=3,GO:0000978; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0009617; GO:0032088; GO:0043549; GO:0045087; GO:0045345; GO:0045944; GO:0051607; GO:0060335; GO:0060339; GO:0060340,defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; positive regulation of type II interferon-mediated signaling pathway [GO:0060335]; regulation of kinase activity [GO:0043549]; response to bacterium [GO:0009617],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0002376; GO:0003677; GO:0005634; GO:0005815; GO:0005829; GO:0006355; GO:0043226; GO:0098542,immune system process; DNA binding; nucleus; microtubule organizing center; cytosol; regulation of DNA-templated transcription; organelle; defense response to other organism
OG_14785,FUN_025906-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20127.t2,apul_ptua,33.826,FUN_025906-T1,Q8K3Z0,NOD2_MOUSE,,Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15),Mus musculus (Mouse),26.5,257.0,1.8e-18,97.1,sp|Q8K3Z0|NOD2_MOUSE Nucleotide-binding oligomerization domain-containing protein 2 OS=Mus musculus OX=10090 GN=Nod2 PE=1 SV=1,GO:0000165; GO:0001659; GO:0002227; GO:0002250; GO:0002253; GO:0002606; GO:0002710; GO:0002720; GO:0002815; GO:0002830; GO:0002862; GO:0002925; GO:0005524; GO:0005737; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006909; GO:0006952; GO:0006954; GO:0006963; GO:0006965; GO:0007165; GO:0007249; GO:0007254; GO:0009595; GO:0009986; GO:0010508; GO:0010936; GO:0016045; GO:0016323; GO:0019897; GO:0019899; GO:0019901; GO:0031398; GO:0031982; GO:0032098; GO:0032494; GO:0032495; GO:0032496; GO:0032498; GO:0032500; GO:0032689; GO:0032695; GO:0032701; GO:0032703; GO:0032720; GO:0032731; GO:0032733; GO:0032735; GO:0032740; GO:0032755; GO:0032760; GO:0032874; GO:0032991; GO:0034134; GO:0034136; GO:0034976; GO:0035556; GO:0036335; GO:0038187; GO:0042742; GO:0042834; GO:0043123; GO:0043130; GO:0043330; GO:0043410; GO:0043531; GO:0045087; GO:0045089; GO:0045747; GO:0045944; GO:0046330; GO:0048874; GO:0050679; GO:0050700; GO:0050727; GO:0050766; GO:0050830; GO:0051403; GO:0051649; GO:0060907; GO:0070371; GO:0070374; GO:0070431; GO:0071222; GO:0071224; GO:0071225; GO:0071639; GO:0090022; GO:0098792; GO:1901224; GO:1901526; GO:1904417; GO:2000110,activation of immune response [GO:0002253]; adaptive immune response [GO:0002250]; biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0002815]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to peptidoglycan [GO:0071224]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; detection of biotic stimulus [GO:0009595]; detection of muramyl dipeptide [GO:0032498]; ERK1 and ERK2 cascade [GO:0070371]; establishment of localization in cell [GO:0051649]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; intestinal stem cell homeostasis [GO:0036335]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of macrophage apoptotic process [GO:2000110]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of T cell mediated immunity [GO:0002710]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; phagocytosis [GO:0006909]; positive regulation of antibacterial peptide biosynthetic process [GO:0006963]; positive regulation of autophagy [GO:0010508]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria [GO:0006965]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitophagy [GO:1901526]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type 2 immune response [GO:0002830]; positive regulation of xenophagy [GO:1904417]; regulation of appetite [GO:0032098]; regulation of inflammatory response [GO:0050727]; regulation of neutrophil chemotaxis [GO:0090022]; response to endoplasmic reticulum stress [GO:0034976]; response to exogenous dsRNA [GO:0043330]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; response to peptidoglycan [GO:0032494]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; temperature homeostasis [GO:0001659]; toll-like receptor 2 signaling pathway [GO:0034134]; xenophagy [GO:0098792],basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle [GO:0031982],ADP binding [GO:0043531]; ATP binding [GO:0005524]; CARD domain binding [GO:0050700]; enzyme binding [GO:0019899]; muramyl dipeptide binding [GO:0032500]; pattern recognition receptor activity [GO:0038187]; peptidoglycan binding [GO:0042834]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130],GO:0002376; GO:0005739; GO:0005829; GO:0005856; GO:0005886; GO:0006355; GO:0006914; GO:0006954; GO:0016192; GO:0043226; GO:0060089; GO:0098542,immune system process; mitochondrion; cytosol; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; autophagy; inflammatory response; vesicle-mediated transport; organelle; molecular transducer activity; defense response to other organism
OG_14786,FUN_025927-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10526.t1,apul_ptua,74.607,FUN_025927-T1,Q76KP1,B4GN4_HUMAN,,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)",Homo sapiens (Human),40.3,330.0,1.3e-64,248.4,sp|Q76KP1|B4GN4_HUMAN N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 OS=Homo sapiens OX=9606 GN=B4GALNT4 PE=1 SV=1,GO:0008376; GO:0032580; GO:0033842,,Golgi cisterna membrane [GO:0032580],acetylgalactosaminyltransferase activity [GO:0008376]; N-acetyl-beta-glucosaminyl-derivative 4-beta-N-acetylgalactosaminyltransferase activity [GO:0033842],GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_14787,FUN_025932-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10532.t1,apul_ptua,64.734,FUN_025932-T1,Q6NUT3,MFS12_HUMAN,,Major facilitator superfamily domain-containing protein 12,Homo sapiens (Human),32.7,511.0,5.5e-76,287.0,sp|Q6NUT3|MFS12_HUMAN Major facilitator superfamily domain-containing protein 12 OS=Homo sapiens OX=9606 GN=MFSD12 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005886; GO:0008643; GO:0015293; GO:0033162; GO:0033229; GO:0042438; GO:0042470; GO:0043474; GO:0048021; GO:0048022; GO:1903712,carbohydrate transport [GO:0008643]; cysteine transmembrane transport [GO:1903712]; melanin biosynthetic process [GO:0042438]; negative regulation of melanin biosynthetic process [GO:0048022]; pigment metabolic process involved in pigmentation [GO:0043474]; regulation of melanin biosynthetic process [GO:0048021],late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; plasma membrane [GO:0005886],cysteine transmembrane transporter activity [GO:0033229]; symporter activity [GO:0015293],GO:0005215; GO:0005764; GO:0005768; GO:0005773; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; lysosome; endosome; vacuole; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_14788,FUN_025950-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10539.t1,apul_ptua,82.274,FUN_025950-T1,O15144,,,,,67.0,300.0,2.6e-113,409.8,sp|O15144|ARPC2_HUMAN Actin-related protein 2/3 complex subunit 2 OS=Homo sapiens OX=9606 GN=ARPC2 PE=1 SV=1,,,,,,
OG_14789,FUN_025951-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10540.t1,apul_ptua,59.290000000000006,FUN_025951-T1,E2RFJ3,,,,,37.3,608.0,2.9e-94,347.8,sp|E2RFJ3|S40A1_CANLF Ferroportin OS=Canis lupus familiaris OX=9615 GN=SLC40A1 PE=3 SV=3,,,,,,
OG_14790,FUN_025984-T1,,Pocillopora_meandrina_HIv1___TS.g13920.t1,apul_ptua,66.11500000000001,FUN_025984-T1,B8V7R6,,,,,98.8,260.0,4.3e-150,534.3,sp|B8V7R6|COA_ACRMI Collagen alpha chain (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_14791,FUN_025988-T1,,Pocillopora_meandrina_HIv1___TS.g13915.t1,apul_ptua,60.501000000000005,FUN_025988-T1,Q90670,AVR2B_CHICK,,Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB),Gallus gallus (Chicken),48.9,411.0,1.2e-110,401.7,sp|Q90670|AVR2B_CHICK Activin receptor type-2B OS=Gallus gallus OX=9031 GN=ACVR2B PE=2 SV=1,GO:0005524; GO:0005886; GO:0007389; GO:0008283; GO:0009798; GO:0017002; GO:0032924; GO:0043525; GO:0045178; GO:0046872; GO:0048179; GO:0048185; GO:0048333; GO:0061550; GO:0071363,activin receptor signaling pathway [GO:0032924]; axis specification [GO:0009798]; cell population proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; cranial ganglion development [GO:0061550]; mesodermal cell differentiation [GO:0048333]; pattern specification process [GO:0007389]; positive regulation of neuron apoptotic process [GO:0043525],activin receptor complex [GO:0048179]; basal part of cell [GO:0045178]; plasma membrane [GO:0005886],activin binding [GO:0048185]; activin receptor activity [GO:0017002]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],GO:0003824; GO:0005886; GO:0016740; GO:0030154; GO:0048856; GO:0060089; GO:0140096,"catalytic activity; plasma membrane; transferase activity; cell differentiation; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein"
OG_14792,FUN_026008-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10480.t1,apul_ptua,56.912,FUN_026008-T1,O93484,,,,,35.2,247.0,1.1e-32,144.4,sp|O93484|CO1A2_ONCMY Collagen alpha-2(I) chain OS=Oncorhynchus mykiss OX=8022 GN=col1a2 PE=2 SV=2,,,,,,
OG_14793,FUN_026010-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10481.t2,apul_ptua,56.2835,FUN_026010-T1,D3YXG0,HMCN1_MOUSE,,Hemicentin-1 (Fibulin-6) (FIBL-6),Mus musculus (Mouse),46.5,172.0,2.5e-47,193.4,sp|D3YXG0|HMCN1_MOUSE Hemicentin-1 OS=Mus musculus OX=10090 GN=Hmcn1 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005737; GO:0005927; GO:0005938; GO:0009617; GO:0030036; GO:0030054; GO:0032154; GO:0051301; GO:0062023; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; response to bacterium [GO:0009617],basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509],GO:0005576; GO:0007010; GO:0030198; GO:0030312; GO:0031012,extracellular region; cytoskeleton organization; extracellular matrix organization; external encapsulating structure; extracellular matrix
OG_14794,FUN_026017-T1,,Pocillopora_meandrina_HIv1___TS.g13910.t1,apul_ptua,50.35,,,,,,,,,,,,,,,,,
OG_14795,FUN_026065-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10566.t1,apul_ptua,73.188,,,,,,,,,,,,,,,,,
OG_14796,FUN_026116-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10256.t1,apul_ptua,48.958,,,,,,,,,,,,,,,,,
OG_14797,FUN_026143-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10259.t1,apul_ptua,40.299,FUN_026143-T1,Q8C3Q9,CASP9_MOUSE,,Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10],Mus musculus (Mouse),31.5,232.0,4.1e-25,118.2,sp|Q8C3Q9|CASP9_MOUSE Caspase-9 OS=Mus musculus OX=10090 GN=Casp9 PE=1 SV=1,GO:0001666; GO:0001822; GO:0002931; GO:0004197; GO:0005634; GO:0005739; GO:0005829; GO:0006915; GO:0006974; GO:0008233; GO:0008303; GO:0008630; GO:0009411; GO:0016485; GO:0017124; GO:0019901; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0034644; GO:0042770; GO:0043293; GO:0043525; GO:0044346; GO:0051402; GO:0070059; GO:0071549; GO:0071887; GO:0072347; GO:1900119; GO:1904019,apoptotic process [GO:0006915]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to UV [GO:0034644]; DNA damage response [GO:0006974]; epithelial cell apoptotic process [GO:1904019]; fibroblast apoptotic process [GO:0044346]; glial cell apoptotic process [GO:0034349]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; response to anesthetic [GO:0072347]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931]; response to lipopolysaccharide [GO:0032496]; response to UV [GO:0009411]; signal transduction in response to DNA damage [GO:0042770],apoptosome [GO:0043293]; caspase complex [GO:0008303]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],cysteine-type endopeptidase activity [GO:0004197]; peptidase activity [GO:0008233]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124],GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0012501; GO:0016787; GO:0043226; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; nucleus; mitochondrion; cytosol; programmed cell death; hydrolase activity; organelle; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_14798,FUN_026149-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3233.t1,apul_ptua,66.9735,FUN_026149-T1,Q15032,,,,,39.9,398.0,7.700000000000001e-48,194.1,sp|Q15032|R3HD1_HUMAN R3H domain-containing protein 1 OS=Homo sapiens OX=9606 GN=R3HDM1 PE=1 SV=3,,,,,,
OG_14799,FUN_026164-T3,,Pocillopora_meandrina_HIv1___RNAseq.g3174.t1,apul_ptua,58.091,,,,,,,,,,,,,,,,,
OG_14800,FUN_026174-T1,,Pocillopora_meandrina_HIv1___TS.g18146.t2,apul_ptua,74.603,FUN_026174-T1,Q5XGU5,,,,,75.9,58.0,4.8e-20,98.2,sp|Q5XGU5|DNJ6B_XENLA DnaJ homolog subfamily B member 6-B OS=Xenopus laevis OX=8355 GN=dnajb6-b PE=2 SV=1,,,,,,
OG_14801,FUN_026180-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3035.t1,apul_ptua,43.4465,,,,,,,,,,,,,,,,,
OG_14802,FUN_026186-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9452.t1,apul_ptua,48.3695,,,,,,,,,,,,,,,,,
OG_14803,FUN_026203-T1,,Pocillopora_meandrina_HIv1___TS.g18162.t1,apul_ptua,57.8265,FUN_026203-T1,Q21540,,,,,29.2,168.0,8.9e-14,84.7,sp|Q21540|CUT6_CAEEL Cuticlin-6 OS=Caenorhabditis elegans OX=6239 GN=cut-6 PE=1 SV=2,,,,,,
OG_14804,FUN_026231-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24442.t1,apul_ptua,40.072,FUN_026231-T1,D5UJ42,,,,,31.5,146.0,2.3e-08,63.5,sp|D5UJ42|MSHA_CELFN D-inositol 3-phosphate glycosyltransferase OS=Cellulomonas flavigena (strain ATCC 482 / DSM 20109 / BCRC 11376 / JCM 18109 / NBRC 3775 / NCIMB 8073 / NRS 134) OX=446466 GN=mshA PE=3 SV=1,,,,,,
OG_14805,FUN_026255-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29885.t1,apul_ptua,31.224,,,,,,,,,,,,,,,,,
OG_14806,FUN_026272-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18181.t1,apul_ptua,86.452,,,,,,,,,,,,,,,,,
OG_14807,FUN_026344-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17267.t1,apul_ptua,50.558,FUN_026344-T1,Q9W6R5,,,,,39.0,164.0,1.1e-20,102.1,sp|Q9W6R5|XLRS1_TAKRU Retinoschisin OS=Takifugu rubripes OX=31033 GN=xlrs1 PE=3 SV=1,,,,,,
OG_14808,FUN_026362-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3112.t1,apul_ptua,58.115,FUN_026362-T1,Q9UQQ1,NALDL_HUMAN,,Aminopeptidase NAALADL1 (EC 3.4.11.-) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase) (N-acetylated-alpha-linked acidic dipeptidase-like protein) (NAALADase L),Homo sapiens (Human),33.7,745.0,2.2e-103,378.3,sp|Q9UQQ1|NALDL_HUMAN Aminopeptidase NAALADL1 OS=Homo sapiens OX=9606 GN=NAALADL1 PE=1 SV=2,GO:0004177; GO:0004180; GO:0005509; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0016020; GO:0016324; GO:0042803; GO:0043171,peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],apical plasma membrane [GO:0016324]; membrane [GO:0016020],aminopeptidase activity [GO:0004177]; calcium ion binding [GO:0005509]; carboxypeptidase activity [GO:0004180]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_14809,FUN_026365-T1,,Pocillopora_meandrina_HIv1___TS.g18222.t1,apul_ptua,39.017,,,,,,,,,,,,,,,,,
OG_14810,FUN_026379-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2956.t1,apul_ptua,67.116,FUN_026379-T1,Q14863,PO6F1_HUMAN,,"POU domain, class 6, transcription factor 1 (Brain-specific homeobox/POU domain protein 5) (Brain-5) (Brn-5) (mPOU homeobox protein)",Homo sapiens (Human),43.2,146.0,1.9e-23,111.7,"sp|Q14863|PO6F1_HUMAN POU domain, class 6, transcription factor 1 OS=Homo sapiens OX=9606 GN=POU6F1 PE=1 SV=2",GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001227; GO:0003700; GO:0005634; GO:0006357; GO:0007420; GO:0007507; GO:0007517; GO:0043565; GO:1990837,brain development [GO:0007420]; heart development [GO:0007507]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_14811,FUN_026391-T1,,Pocillopora_meandrina_HIv1___TS.g18058.t1,apul_ptua,62.018,FUN_026391-T1,Q91755,,,,,26.6,885.0,3.4e-79,298.1,"sp|Q91755|GRIK2_XENLA Glutamate receptor ionotropic, kainate 2 OS=Xenopus laevis OX=8355 GN=grik2 PE=2 SV=2",,,,,,
OG_14812,FUN_026421-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3018.t1,apul_ptua,58.865,FUN_026421-T1,A3KP77,,,,,48.3,267.0,5.7e-66,252.7,sp|A3KP77|OXND1_DANRE Oxidoreductase NAD-binding domain-containing protein 1 OS=Danio rerio OX=7955 GN=oxnad1 PE=2 SV=1,,,,,,
OG_14813,FUN_026425-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11190.t1,apul_ptua,73.0,,,,,,,,,,,,,,,,,
OG_14814,FUN_026450-T2,,Pocillopora_meandrina_HIv1___TS.g18141.t1,apul_ptua,39.2955,FUN_026450-T2,Q9V477,TOLL8_DROME,,Toll-like receptor Tollo (Toll-like receptor 8),Drosophila melanogaster (Fruit fly),32.4,102.0,9.7e-08,60.1,sp|Q9V477|TOLL8_DROME Toll-like receptor Tollo OS=Drosophila melanogaster OX=7227 GN=Tollo PE=1 SV=1,GO:0003401; GO:0005886; GO:0007165; GO:0016324; GO:0045087; GO:0048018; GO:0048935; GO:0060026; GO:0060049; GO:0061809,axis elongation [GO:0003401]; convergent extension [GO:0060026]; innate immune response [GO:0045087]; peripheral nervous system neuron development [GO:0048935]; regulation of protein glycosylation [GO:0060049]; signal transduction [GO:0007165],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],"NAD+ nucleosidase activity, cyclic ADP-ribose generating [GO:0061809]; receptor ligand activity [GO:0048018]",GO:0002376; GO:0003824; GO:0005886; GO:0016787; GO:0048018; GO:0048856; GO:0098542; GO:0098772,immune system process; catalytic activity; plasma membrane; hydrolase activity; receptor ligand activity; anatomical structure development; defense response to other organism; molecular function regulator activity
OG_14815,FUN_026470-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4187.t1,apul_ptua,72.26,FUN_026470-T1,Q9H3L0,MMAD_HUMAN,,"Cobalamin trafficking protein CblD (CblD) (Methylmalonic aciduria and homocystinuria type D protein, mitochondrial)",Homo sapiens (Human),43.8,283.0,7e-59,229.2,sp|Q9H3L0|MMAD_HUMAN Cobalamin trafficking protein CblD OS=Homo sapiens OX=9606 GN=MMADHC PE=1 SV=2,GO:0005737; GO:0005739; GO:0005829; GO:0009235; GO:0140104,cobalamin metabolic process [GO:0009235],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],molecular carrier activity [GO:0140104],GO:0005739; GO:0005829; GO:0043226; GO:0140104,mitochondrion; cytosol; organelle; molecular carrier activity
OG_14816,FUN_026478-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4180.t1,apul_ptua,70.161,FUN_026478-T1,Q8IVI9,NOSTN_HUMAN,,Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer),Homo sapiens (Human),25.9,491.0,8.4e-40,166.4,sp|Q8IVI9|NOSTN_HUMAN Nostrin OS=Homo sapiens OX=9606 GN=NOSTRIN PE=1 SV=2,GO:0003677; GO:0005634; GO:0005856; GO:0005886; GO:0006897; GO:0007165; GO:0030666; GO:0045892,endocytosis [GO:0006897]; negative regulation of DNA-templated transcription [GO:0045892]; signal transduction [GO:0007165],cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nucleus [GO:0005634]; plasma membrane [GO:0005886],DNA binding [GO:0003677],GO:0003677; GO:0005634; GO:0005856; GO:0005886; GO:0006355; GO:0016192; GO:0043226,DNA binding; nucleus; cytoskeleton; plasma membrane; regulation of DNA-templated transcription; vesicle-mediated transport; organelle
OG_14817,FUN_026479-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4179.t1,apul_ptua,75.157,FUN_026479-T1,P34579,,,,,30.4,401.0,5.5e-44,180.3,sp|P34579|UNC47_CAEEL Vesicular GABA transporter OS=Caenorhabditis elegans OX=6239 GN=unc-47 PE=1 SV=2,,,,,,
OG_14818,FUN_026514-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4208.t1,apul_ptua,48.555,,,,,,,,,,,,,,,,,
OG_14819,FUN_026538-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4244.t1,apul_ptua,75.952,FUN_026538-T1,P30419,NMT1_HUMAN,,Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (HsNMT1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1) (Protein-lysine myristoyltransferase NMT1) (EC 2.3.1.-),Homo sapiens (Human),71.0,428.0,6.800000000000001e-178,625.2,sp|P30419|NMT1_HUMAN Glycylpeptide N-tetradecanoyltransferase 1 OS=Homo sapiens OX=9606 GN=NMT1 PE=1 SV=2,GO:0001701; GO:0004379; GO:0005737; GO:0005829; GO:0005886; GO:0018008; GO:0018030; GO:0019107; GO:0022400; GO:0042180; GO:0072657; GO:1903749,in utero embryonic development [GO:0001701]; ketone metabolic process [GO:0042180]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; positive regulation of establishment of protein localization to mitochondrion [GO:1903749]; protein localization to membrane [GO:0072657]; regulation of opsin-mediated signaling pathway [GO:0022400],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; myristoyltransferase activity [GO:0019107]; peptidyl-lysine N6-myristoyltransferase activity [GO:0018030],GO:0003824; GO:0005829; GO:0005886; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; cytosol; plasma membrane; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_14820,FUN_026565-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4516.t1,apul_ptua,54.942,FUN_026565-T1,P22897,MRC1_HUMAN,,Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206),Homo sapiens (Human),28.7,1060.0,4e-126,455.3,sp|P22897|MRC1_HUMAN Macrophage mannose receptor 1 OS=Homo sapiens OX=9606 GN=MRC1 PE=1 SV=1,GO:0001618; GO:0004888; GO:0005537; GO:0005886; GO:0006898; GO:0009986; GO:0010008; GO:0038023; GO:0038024; GO:0071222; GO:0071346; GO:0071353,cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to type II interferon [GO:0071346]; receptor-mediated endocytosis [GO:0006898],cell surface [GO:0009986]; endosome membrane [GO:0010008]; plasma membrane [GO:0005886],cargo receptor activity [GO:0038024]; D-mannose binding [GO:0005537]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618],GO:0001618; GO:0005886; GO:0016192; GO:0038024; GO:0060089,virus receptor activity; plasma membrane; vesicle-mediated transport; cargo receptor activity; molecular transducer activity
OG_14821,FUN_026583-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4512.t1,apul_ptua,60.734,FUN_026583-T1,Q2TAW0,,,,,32.9,781.0,1.5e-86,322.4,sp|Q2TAW0|CNDG2_XENLA Condensin-2 complex subunit G2 OS=Xenopus laevis OX=8355 GN=ncapg2 PE=1 SV=1,,,,,,
OG_14822,FUN_026595-T4,,Pocillopora_meandrina_HIv1___RNAseq.g4486.t1,apul_ptua,33.251,,,,,,,,,,,,,,,,,
OG_14823,FUN_026600-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6720.t1,apul_ptua,47.807,,,,,,,,,,,,,,,,,
OG_14824,FUN_026670-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2820.t1a,apul_ptua,43.701,,,,,,,,,,,,,,,,,
OG_14825,FUN_026684-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4465.t1,apul_ptua,51.579,,,,,,,,,,,,,,,,,
OG_14826,FUN_026692-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19063.t1,apul_ptua,44.373,,,,,,,,,,,,,,,,,
OG_14827,FUN_026710-T3,,Pocillopora_meandrina_HIv1___TS.g19675.t2,apul_ptua,60.348,,,,,,,,,,,,,,,,,
OG_14828,FUN_026712-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9377.t1,apul_ptua,51.282,,,,,,,,,,,,,,,,,
OG_14829,FUN_026734-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9407.t1,apul_ptua,64.87,FUN_026734-T1,Q8CBH5,,,,,29.5,552.0,4e-51,204.1,sp|Q8CBH5|MFSD6_MOUSE Major facilitator superfamily domain-containing protein 6 OS=Mus musculus OX=10090 GN=Mfsd6 PE=1 SV=1,,,,,,
OG_14830,FUN_026743-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2892.t1,apul_ptua,64.824,,,,,,,,,,,,,,,,,
OG_14831,FUN_026769-T1,,Pocillopora_meandrina_HIv1___RNAseq.g700.t1,apul_ptua,70.588,,,,,,,,,,,,,,,,,
OG_14832,FUN_026781-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3863.t1,apul_ptua,58.915,,,,,,,,,,,,,,,,,
OG_14833,FUN_026792-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27337.t1,apul_ptua,91.705,FUN_026792-T1,Q86TB3,ALPK2_HUMAN,,Alpha-protein kinase 2 (EC 2.7.11.1) (Heart alpha-protein kinase),Homo sapiens (Human),27.4,237.0,3.2e-10,67.8,sp|Q86TB3|ALPK2_HUMAN Alpha-protein kinase 2 OS=Homo sapiens OX=9606 GN=ALPK2 PE=1 SV=3,GO:0003007; GO:0003308; GO:0004674; GO:0005524; GO:0010468; GO:0016323; GO:0030010; GO:0042981; GO:0055013; GO:0106310; GO:1905223,cardiac muscle cell development [GO:0055013]; epicardium morphogenesis [GO:1905223]; establishment of cell polarity [GO:0030010]; heart morphogenesis [GO:0003007]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; regulation of apoptotic process [GO:0042981]; regulation of gene expression [GO:0010468],basolateral plasma membrane [GO:0016323],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0007163; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; establishment or maintenance of cell polarity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_14834,FUN_026800-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10011.t1,apul_ptua,47.378,,,,,,,,,,,,,,,,,
OG_14835,FUN_026893-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9141.t1,apul_ptua,78.049,,,,,,,,,,,,,,,,,
OG_14836,FUN_026901-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9423.t1,apul_ptua,88.352,FUN_026901-T1,Q04400,ADCY5_RAT,,Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5),Rattus norvegicus (Rat),53.3,351.0,7.499999999999999e-96,352.1,sp|Q04400|ADCY5_RAT Adenylate cyclase type 5 OS=Rattus norvegicus OX=10116 GN=Adcy5 PE=1 SV=2,GO:0001973; GO:0004016; GO:0005524; GO:0005768; GO:0005886; GO:0005929; GO:0006171; GO:0007189; GO:0007191; GO:0007195; GO:0007204; GO:0007507; GO:0007626; GO:0008179; GO:0008294; GO:0016020; GO:0035556; GO:0042383; GO:0046872; GO:0050885; GO:0061178; GO:0097110; GO:1904322,adenylate cyclase-activating dopamine receptor signaling pathway [GO:0007191]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cAMP biosynthetic process [GO:0006171]; cellular response to forskolin [GO:1904322]; G protein-coupled adenosine receptor signaling pathway [GO:0001973]; heart development [GO:0007507]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178],cilium [GO:0005929]; endosome [GO:0005768]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],adenylate cyclase activity [GO:0004016]; adenylate cyclase binding [GO:0008179]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110],GO:0003824; GO:0005768; GO:0005886; GO:0005929; GO:0009975; GO:0016829; GO:0031410; GO:0043226; GO:0048856; GO:0050877; GO:0055086; GO:1901135,catalytic activity; endosome; plasma membrane; cilium; cyclase activity; lyase activity; cytoplasmic vesicle; organelle; anatomical structure development; nervous system process; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_14837,FUN_026911-T1,,Pocillopora_meandrina_HIv1___RNAseq.g575.t1,apul_ptua,60.828,FUN_026911-T1,P26794,PIM1_RAT,,Serine/threonine-protein kinase pim-1 (EC 2.7.11.1),Rattus norvegicus (Rat),40.0,275.0,2.8e-47,190.7,sp|P26794|PIM1_RAT Serine/threonine-protein kinase pim-1 OS=Rattus norvegicus OX=10116 GN=Pim1 PE=1 SV=1,GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0007346; GO:0022898; GO:0030145; GO:0043024; GO:0043066; GO:0045824; GO:0045893; GO:0050821; GO:0060045; GO:0070561; GO:0071346; GO:0090336; GO:0106310; GO:1902033; GO:1904263; GO:1905062; GO:1990748,apoptotic process [GO:0006915]; cellular detoxification [GO:1990748]; cellular response to type II interferon [GO:0071346]; negative regulation of apoptotic process [GO:0043066]; negative regulation of innate immune response [GO:0045824]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardioblast proliferation [GO:1905062]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of mitotic cell cycle [GO:0007346]; regulation of transmembrane transporter activity [GO:0022898]; vitamin D receptor signaling pathway [GO:0070561],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; ribosomal small subunit binding [GO:0043024],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0005886; GO:0006355; GO:0012501; GO:0016740; GO:0043226; GO:0098754; GO:0140096,"catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; plasma membrane; regulation of DNA-templated transcription; programmed cell death; transferase activity; organelle; detoxification; catalytic activity, acting on a protein"
OG_14838,FUN_026938-T1,,Pocillopora_meandrina_HIv1___TS.g18013.t1,apul_ptua,30.233,,,,,,,,,,,,,,,,,
OG_14839,FUN_026947-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28793.t1,apul_ptua,68.627,,,,,,,,,,,,,,,,,
OG_14840,FUN_026972-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26793.t1,apul_ptua,39.416,FUN_026972-T1,Q91X34,BAAT_MOUSE,,Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2),Mus musculus (Mouse),38.2,424.0,1.3e-68,261.9,sp|Q91X34|BAAT_MOUSE Bile acid-CoA:amino acid N-acyltransferase OS=Mus musculus OX=10090 GN=Baat PE=1 SV=1,GO:0001889; GO:0002152; GO:0005777; GO:0005829; GO:0006544; GO:0006631; GO:0006637; GO:0006699; GO:0008206; GO:0016410; GO:0019530; GO:0031100; GO:0033882; GO:0047963; GO:0052689; GO:0052815; GO:0052816; GO:0052817,acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530],cytosol [GO:0005829]; peroxisome [GO:0005777],carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; glycine N-choloyltransferase activity [GO:0047963]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; N-acyltransferase activity [GO:0016410]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817],GO:0003824; GO:0005777; GO:0005829; GO:0006520; GO:0006629; GO:0006790; GO:0016740; GO:0016787; GO:0043226; GO:0048856; GO:0055086,catalytic activity; peroxisome; cytosol; amino acid metabolic process; lipid metabolic process; sulfur compound metabolic process; transferase activity; hydrolase activity; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process
OG_14841,FUN_026984-T2,,Pocillopora_meandrina_HIv1___RNAseq.g4366.t1,apul_ptua,56.9535,FUN_026984-T2,Q8WVS4,DC2I1_HUMAN,,Cytoplasmic dynein 2 intermediate chain 1 (Dynein 2 intermediate chain 1) (WD repeat-containing protein 60),Homo sapiens (Human),36.5,666.0,5.099999999999999e-109,397.5,sp|Q8WVS4|DC2I1_HUMAN Cytoplasmic dynein 2 intermediate chain 1 OS=Homo sapiens OX=9606 GN=DYNC2I1 PE=1 SV=3,GO:0000242; GO:0005615; GO:0005813; GO:0005829; GO:0005868; GO:0005929; GO:0035721; GO:0036064; GO:0045503; GO:0045504; GO:0048704; GO:0060271; GO:0097542; GO:0097546,cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; intraciliary retrograde transport [GO:0035721],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; extracellular space [GO:0005615]; pericentriolar material [GO:0000242],dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503],GO:0005615; GO:0005815; GO:0005829; GO:0005929; GO:0007018; GO:0043226; GO:0044782,extracellular space; microtubule organizing center; cytosol; cilium; microtubule-based movement; organelle; cilium organization
OG_14842,FUN_027025-T2,,Pocillopora_meandrina_HIv1___RNAseq.g13919.t1,apul_ptua,52.62,,,,,,,,,,,,,,,,,
OG_14843,FUN_027039-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3632.t1,apul_ptua,92.857,,,,,,,,,,,,,,,,,
OG_14844,FUN_027050-T1,,Pocillopora_meandrina_HIv1___TS.g9978.t1,apul_ptua,54.0,,,,,,,,,,,,,,,,,
OG_14845,FUN_027053-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25075.t1,apul_ptua,34.211,,,,,,,,,,,,,,,,,
OG_14846,FUN_027063-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29908.t1,apul_ptua,88.235,,,,,,,,,,,,,,,,,
OG_14847,FUN_027130-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8124.t1,apul_ptua,73.276,FUN_027130-T1,A3LUX6,,,,,38.0,166.0,4.2e-18,93.2,"sp|A3LUX6|FM521_PICST Protein FMP52-1, mitochondrial OS=Scheffersomyces stipitis (strain ATCC 58785 / CBS 6054 / NBRC 10063 / NRRL Y-11545) OX=322104 GN=FMP521 PE=3 SV=1",,,,,,
OG_14848,FUN_027131-T1,,Pocillopora_meandrina_HIv1___TS.g17290.t1,apul_ptua,86.228,,,,,,,,,,,,,,,,,
OG_14849,FUN_027159-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27152.t1,apul_ptua,72.727,,,,,,,,,,,,,,,,,
OG_14850,FUN_027208-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4019.t1b,apul_ptua,60.44,,,,,,,,,,,,,,,,,
OG_14851,FUN_027215-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15328.t1,apul_ptua,72.2515,FUN_027215-T1,Q5F364,MRP1_CHICK,,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),Gallus gallus (Chicken),52.0,1345.0,0.0,1315.8,sp|Q5F364|MRP1_CHICK Multidrug resistance-associated protein 1 OS=Gallus gallus OX=9031 GN=ABCC1 PE=2 SV=1,GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729,cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908],basolateral plasma membrane [GO:0016323],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; glutathione transmembrane transporter activity [GO:0034634],GO:0003824; GO:0005215; GO:0016787; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; transmembrane transport; ATP-dependent activity
OG_14852,FUN_027228-T1,,Pocillopora_meandrina_HIv1___TS.g5486.t1,apul_ptua,33.298,FUN_027228-T1,A6QLE5,NLRP3_BOVIN,,"NACHT, LRR and PYD domains-containing protein 3 (EC 3.6.4.-)",Bos taurus (Bovine),24.1,489.0,1.2e-16,90.5,"sp|A6QLE5|NLRP3_BOVIN NACHT, LRR and PYD domains-containing protein 3 OS=Bos taurus OX=9913 GN=NLRP3 PE=2 SV=1",GO:0000139; GO:0002830; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0006954; GO:0009595; GO:0016020; GO:0016887; GO:0031021; GO:0032731; GO:0032753; GO:0035591; GO:0043531; GO:0043565; GO:0044546; GO:0045087; GO:0045630; GO:0045944; GO:0050727; GO:0050729; GO:0051260; GO:0070273; GO:0072559; GO:0140297; GO:0140299; GO:1901223; GO:1901981; GO:2000553,detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; protein homooligomerization [GO:0051260]; regulation of inflammatory response [GO:0050727],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; interphase microtubule organizing center [GO:0031021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634],ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; molecular sensor activity [GO:0140299]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-4-phosphate binding [GO:0070273]; sequence-specific DNA binding [GO:0043565]; signaling adaptor activity [GO:0035591],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005634; GO:0005739; GO:0005783; GO:0005815; GO:0006355; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060090; GO:0065003; GO:0098542; GO:0098772; GO:0140299,immune system process; DNA binding; catalytic activity; extracellular region; nucleus; mitochondrion; endoplasmic reticulum; microtubule organizing center; regulation of DNA-templated transcription; inflammatory response; lipid binding; hydrolase activity; organelle; molecular adaptor activity; protein-containing complex assembly; defense response to other organism; molecular function regulator activity; molecular sensor activity
OG_14853,FUN_027242-T1,,Pocillopora_meandrina_HIv1___RNAseq.g961.t1,apul_ptua,33.903,FUN_027242-T1,A6QLE5,NLRP3_BOVIN,,"NACHT, LRR and PYD domains-containing protein 3 (EC 3.6.4.-)",Bos taurus (Bovine),24.2,487.0,1.2e-17,94.0,"sp|A6QLE5|NLRP3_BOVIN NACHT, LRR and PYD domains-containing protein 3 OS=Bos taurus OX=9913 GN=NLRP3 PE=2 SV=1",GO:0000139; GO:0002830; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005739; GO:0005783; GO:0006954; GO:0009595; GO:0016020; GO:0016887; GO:0031021; GO:0032731; GO:0032753; GO:0035591; GO:0043531; GO:0043565; GO:0044546; GO:0045087; GO:0045630; GO:0045944; GO:0050727; GO:0050729; GO:0051260; GO:0070273; GO:0072559; GO:0140297; GO:0140299; GO:1901223; GO:1901981; GO:2000553,detection of biotic stimulus [GO:0009595]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; NLRP3 inflammasome complex assembly [GO:0044546]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type 2 immune response [GO:0002830]; protein homooligomerization [GO:0051260]; regulation of inflammatory response [GO:0050727],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; interphase microtubule organizing center [GO:0031021]; membrane [GO:0016020]; mitochondrion [GO:0005739]; NLRP3 inflammasome complex [GO:0072559]; nucleus [GO:0005634],ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA-binding transcription factor binding [GO:0140297]; molecular sensor activity [GO:0140299]; phosphatidylinositol phosphate binding [GO:1901981]; phosphatidylinositol-4-phosphate binding [GO:0070273]; sequence-specific DNA binding [GO:0043565]; signaling adaptor activity [GO:0035591],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005634; GO:0005739; GO:0005783; GO:0005815; GO:0006355; GO:0006954; GO:0008289; GO:0016787; GO:0043226; GO:0060090; GO:0065003; GO:0098542; GO:0098772; GO:0140299,immune system process; DNA binding; catalytic activity; extracellular region; nucleus; mitochondrion; endoplasmic reticulum; microtubule organizing center; regulation of DNA-templated transcription; inflammatory response; lipid binding; hydrolase activity; organelle; molecular adaptor activity; protein-containing complex assembly; defense response to other organism; molecular function regulator activity; molecular sensor activity
OG_14854,FUN_027254-T2,,Pocillopora_meandrina_HIv1___RNAseq.g14104.t1,apul_ptua,69.4105,FUN_027254-T2,Q8WVM7,,,,,41.9,1041.0,5.700000000000001e-227,789.6,sp|Q8WVM7|STAG1_HUMAN Cohesin subunit SA-1 OS=Homo sapiens OX=9606 GN=STAG1 PE=1 SV=3,,,,,,
OG_14855,FUN_027319-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2992.t1,apul_ptua,95.6235,,,,,,,,,,,,,,,,,
OG_14856,FUN_027403-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14826.t1,apul_ptua,51.24,,,,,,,,,,,,,,,,,
OG_14857,FUN_027412-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14817.t1,apul_ptua,59.283,,,,,,,,,,,,,,,,,
OG_14858,FUN_027456-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26927.t1,apul_ptua,59.322,FUN_027456-T1,Q498E6,KT5AB_XENLA,,N-lysine methyltransferase KMT5A-B (EC 2.1.1.-) (Histone-lysine N-methyltransferase KMT5A-B) (EC 2.1.1.361) (Lysine-specific methylase 5A-B) (Mitotic phosphoprotein 36) (SET domain-containing protein 8-B),Xenopus laevis (African clawed frog),39.7,131.0,3.3e-16,89.0,sp|Q498E6|KT5AB_XENLA N-lysine methyltransferase KMT5A-B OS=Xenopus laevis OX=8355 GN=kmt5a-b PE=1 SV=1,GO:0005634; GO:0005700; GO:0006357; GO:0032259; GO:0042054; GO:0042799; GO:0043516; GO:0051301; GO:0140944,"cell division [GO:0051301]; methylation [GO:0032259]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of transcription by RNA polymerase II [GO:0006357]",nucleus [GO:0005634]; polytene chromosome [GO:0005700],histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone methyltransferase activity [GO:0042054],GO:0003824; GO:0005634; GO:0005694; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; chromosome; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_14859,FUN_027515-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18417.t1,apul_ptua,78.378,,,,,,,,,,,,,,,,,
OG_14860,FUN_027553-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20848.t1,apul_ptua,65.882,,,,,,,,,,,,,,,,,
OG_14861,FUN_027607-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7993.t1,apul_ptua,40.1265,,,,,,,,,,,,,,,,,
OG_14862,FUN_027636-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7679.t1,apul_ptua,53.333,,,,,,,,,,,,,,,,,
OG_14863,FUN_027705-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16314.t1,apul_ptua,85.864,FUN_027705-T1,Q38772,CDC2A_ANTMA,,Cell division control protein 2 homolog A (EC 2.7.11.22) (EC 2.7.11.23),Antirrhinum majus (Garden snapdragon),28.4,243.0,7.7e-16,86.7,sp|Q38772|CDC2A_ANTMA Cell division control protein 2 homolog A OS=Antirrhinum majus OX=4151 GN=CDC2A PE=2 SV=2,GO:0000082; GO:0000307; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0007165; GO:0008353; GO:0010389; GO:0030332; GO:0051301; GO:0051445; GO:0106310,cell division [GO:0051301]; G1/S transition of mitotic cell cycle [GO:0000082]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of meiotic cell cycle [GO:0051445]; signal transduction [GO:0007165],cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine kinase activity [GO:0106310]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_14864,FUN_027788-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16349.t1,apul_ptua,40.826,FUN_027788-T1,Q8WZ42,TITIN_HUMAN,,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),Homo sapiens (Human),21.7,739.0,1.3e-38,162.9,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,GO:0000794; GO:0002020; GO:0003009; GO:0003300; GO:0004672; GO:0004674; GO:0004713; GO:0005509; GO:0005516; GO:0005524; GO:0005576; GO:0005829; GO:0005865; GO:0006936; GO:0006941; GO:0007076; GO:0008307; GO:0010628; GO:0010737; GO:0019887; GO:0019899; GO:0019901; GO:0030018; GO:0030049; GO:0030240; GO:0030241; GO:0031430; GO:0031433; GO:0031674; GO:0035995; GO:0042802; GO:0042803; GO:0042805; GO:0045214; GO:0048769; GO:0050714; GO:0051015; GO:0051371; GO:0051592; GO:0055003; GO:0055008; GO:0055013; GO:0060048; GO:0070062; GO:0097493; GO:0106310; GO:1990733,cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle contraction [GO:0003009]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; titin-telethonin complex [GO:1990733]; Z disc [GO:0030018],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433],GO:0000228; GO:0003012; GO:0003824; GO:0005198; GO:0005576; GO:0005694; GO:0005829; GO:0007010; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"nuclear chromosome; muscle system process; catalytic activity; structural molecule activity; extracellular region; chromosome; cytosol; cytoskeleton organization; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_14865,FUN_027913-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28666.t1,apul_ptua,32.184,,,,,,,,,,,,,,,,,
OG_14866,FUN_027924-T2,,Pocillopora_meandrina_HIv1___RNAseq.g13879.t1a,apul_ptua,60.8525,FUN_027924-T2,Q90X46,GP161_DANRE,,G-protein coupled receptor 161,Danio rerio (Zebrafish) (Brachydanio rerio),35.3,184.0,5.899999999999999e-26,120.2,sp|Q90X46|GP161_DANRE G-protein coupled receptor 161 OS=Danio rerio OX=7955 GN=gpr161 PE=2 SV=2,GO:0004930; GO:0005929; GO:0007186; GO:0007189; GO:0007368; GO:0051924; GO:0055037; GO:0060170; GO:1901621,adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; determination of left/right symmetry [GO:0007368]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901621]; regulation of calcium ion transport [GO:0051924],ciliary membrane [GO:0060170]; cilium [GO:0005929]; recycling endosome [GO:0055037],G protein-coupled receptor activity [GO:0004930],GO:0005768; GO:0005929; GO:0031410; GO:0043226; GO:0060089,endosome; cilium; cytoplasmic vesicle; organelle; molecular transducer activity
OG_14867,FUN_027955-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27020.t1,apul_ptua,35.188,,,,,,,,,,,,,,,,,
OG_14868,FUN_027964-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14046.t1,apul_ptua,51.185,FUN_027964-T1,A2RU54,,,,,39.6,96.0,2e-08,60.8,sp|A2RU54|HMX2_HUMAN Homeobox protein HMX2 OS=Homo sapiens OX=9606 GN=HMX2 PE=1 SV=1,,,,,,
OG_14869,FUN_027974-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14055.t1,apul_ptua,61.556,FUN_027974-T1,Q9QYS2,GRM3_MOUSE,,Metabotropic glutamate receptor 3 (mGluR3),Mus musculus (Mouse),40.6,858.0,3.4e-172,607.1,sp|Q9QYS2|GRM3_MOUSE Metabotropic glutamate receptor 3 OS=Mus musculus OX=10090 GN=Grm3 PE=1 SV=1,GO:0001641; GO:0005246; GO:0005886; GO:0010467; GO:0014069; GO:0019233; GO:0030424; GO:0033554; GO:0035249; GO:0042734; GO:0043005; GO:0043197; GO:0045211; GO:0048786; GO:0051930; GO:0097110; GO:0097449; GO:0098978; GO:0099170,"cellular response to stress [GO:0033554]; gene expression [GO:0010467]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of sensory perception of pain [GO:0051930]; sensory perception of pain [GO:0019233]; synaptic transmission, glutamatergic [GO:0035249]",astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734],calcium channel regulator activity [GO:0005246]; group II metabotropic glutamate receptor activity [GO:0001641]; scaffold protein binding [GO:0097110],GO:0005886; GO:0023052; GO:0043226; GO:0050877; GO:0060089; GO:0098772,plasma membrane; signaling; organelle; nervous system process; molecular transducer activity; molecular function regulator activity
OG_14870,FUN_028029-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13932.t1,apul_ptua,36.485,,,,,,,,,,,,,,,,,
OG_14871,FUN_028038-T1,,Pocillopora_meandrina_HIv1___TS.g11719.t1,apul_ptua,37.717,,,,,,,,,,,,,,,,,
OG_14872,FUN_028043-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15390.t1,apul_ptua,46.885000000000005,FUN_028043-T1,Q5ZK28,DPOD3_CHICK,,DNA polymerase delta subunit 3 (DNA polymerase delta subunit p66),Gallus gallus (Chicken),33.3,489.0,1.2e-33,146.0,sp|Q5ZK28|DPOD3_CHICK DNA polymerase delta subunit 3 OS=Gallus gallus OX=9031 GN=POLD3 PE=1 SV=2,GO:0005654; GO:0005737; GO:0006260; GO:0006281; GO:0043625; GO:0071897,DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA replication [GO:0006260],cytoplasm [GO:0005737]; delta DNA polymerase complex [GO:0043625]; nucleoplasm [GO:0005654],,GO:0005654; GO:0006260; GO:0006281,nucleoplasm; DNA replication; DNA repair
OG_14873,FUN_028079-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15826.t1,apul_ptua,52.521,,,,,,,,,,,,,,,,,
OG_14874,FUN_028083-T2,,Pocillopora_meandrina_HIv1___RNAseq.g15834.t1,apul_ptua,74.2715,FUN_028083-T2,Q5F364,MRP1_CHICK,,Multidrug resistance-associated protein 1 (EC 7.6.2.2) (ATP-binding cassette sub-family C member 1) (Glutathione-S-conjugate-translocating ATPase ABCC1) (EC 7.6.2.3) (Leukotriene C(4) transporter) (LTC4 transporter),Gallus gallus (Chicken),50.4,1404.0,0.0,1293.9,sp|Q5F364|MRP1_CHICK Multidrug resistance-associated protein 1 OS=Gallus gallus OX=9031 GN=ABCC1 PE=2 SV=1,GO:0005524; GO:0006869; GO:0008559; GO:0016323; GO:0016887; GO:0034634; GO:0034775; GO:0042908; GO:0070729,cyclic nucleotide transport [GO:0070729]; glutathione transmembrane transport [GO:0034775]; lipid transport [GO:0006869]; xenobiotic transport [GO:0042908],basolateral plasma membrane [GO:0016323],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; glutathione transmembrane transporter activity [GO:0034634],GO:0003824; GO:0005215; GO:0016787; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; transmembrane transport; ATP-dependent activity
OG_14875,FUN_028109-T1,,Pocillopora_meandrina_HIv1___TS.g10596.t1b,apul_ptua,80.0495,FUN_028109-T1,Q9U5L1,,,,,51.6,647.0,9.5e-161,568.5,sp|Q9U5L1|SRPRA_DROME Signal recognition particle receptor subunit alpha homolog OS=Drosophila melanogaster OX=7227 GN=SrpRalpha PE=1 SV=2,,,,,,
OG_14876,FUN_028119-T1,,Pocillopora_meandrina_HIv1___TS.g10588.t1a,apul_ptua,55.725,FUN_028119-T1,Q60439,,,,,47.4,57.0,2.4e-08,60.5,sp|Q60439|CDN1B_CRIGR Cyclin-dependent kinase inhibitor 1B OS=Cricetulus griseus OX=10029 GN=CDKN1B PE=2 SV=1,,,,,,
OG_14877,FUN_028161-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16499.t1,apul_ptua,39.504,,,,,,,,,,,,,,,,,
OG_14878,FUN_028171-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16469.t2,apul_ptua,40.4925,,,,,,,,,,,,,,,,,
OG_14879,FUN_028197-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13411.t1,apul_ptua,45.977,,,,,,,,,,,,,,,,,
OG_14880,FUN_028209-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4162.t1b,apul_ptua,36.559,,,,,,,,,,,,,,,,,
OG_14881,FUN_028239-T2,,Pocillopora_meandrina_HIv1___RNAseq.g15524.t1,apul_ptua,79.9615,FUN_028239-T2,Q9DBT5,AMPD2_MOUSE,,AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L),Mus musculus (Mouse),61.2,743.0,1.3e-252,874.0,sp|Q9DBT5|AMPD2_MOUSE AMP deaminase 2 OS=Mus musculus OX=10090 GN=Ampd2 PE=1 SV=2,GO:0003876; GO:0005829; GO:0006188; GO:0009117; GO:0032263; GO:0032264; GO:0042632; GO:0046033; GO:0046034; GO:0046039; GO:0046872; GO:0052652; GO:0072015; GO:0097009,AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; cholesterol homeostasis [GO:0042632]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; GMP salvage [GO:0032263]; GTP metabolic process [GO:0046039]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; nucleotide metabolic process [GO:0009117]; podocyte development [GO:0072015],cytosol [GO:0005829],AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872],GO:0003824; GO:0005829; GO:0016787; GO:0048856; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_14882,FUN_028263-T2,,Pocillopora_meandrina_HIv1___RNAseq.g15512.t2,apul_ptua,86.872,FUN_028263-T2,P24140,,,,,62.4,386.0,5.8e-132,472.2,sp|P24140|GPT_CRIGR UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase OS=Cricetulus griseus OX=10029 GN=DPAGT1 PE=1 SV=1,,,,,,
OG_14883,FUN_028376-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16346.t1,apul_ptua,33.333,FUN_028376-T1,Q58DA5,NTRI_BOVIN,,Neurotrimin,Bos taurus (Bovine),29.9,211.0,1.4e-18,95.1,sp|Q58DA5|NTRI_BOVIN Neurotrimin OS=Bos taurus OX=9913 GN=NTM PE=2 SV=1,GO:0005886; GO:0007155; GO:0098552,cell adhesion [GO:0007155],plasma membrane [GO:0005886]; side of membrane [GO:0098552],,GO:0005886; GO:0007155,plasma membrane; cell adhesion
OG_14884,FUN_028384-T1,,Pocillopora_meandrina_HIv1___TS.g7170.t2,apul_ptua,49.664,,,,,,,,,,,,,,,,,
OG_14885,FUN_028404-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15360.t1b,apul_ptua,63.71,,,,,,,,,,,,,,,,,
OG_14886,FUN_028413-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15817.t1,apul_ptua,68.421,FUN_028413-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),44.3,316.0,2.5e-74,281.2,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_14887,FUN_028467-T2,,Pocillopora_meandrina_HIv1___RNAseq.g16130.t1,apul_ptua,42.206500000000005,FUN_028467-T2,O89029,,,,,29.3,215.0,2.6e-11,72.8,sp|O89029|MATN4_MOUSE Matrilin-4 OS=Mus musculus OX=10090 GN=Matn4 PE=1 SV=1,,,,,,
OG_14888,FUN_028471-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16125.t1,apul_ptua,92.955,FUN_028471-T1,P97479,,,,,74.4,430.0,6e-191,668.3,sp|P97479|MYO7A_MOUSE Unconventional myosin-VIIa OS=Mus musculus OX=10090 GN=Myo7a PE=1 SV=2,,,,,,
OG_14889,FUN_028493-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16088.t1,apul_ptua,72.276,FUN_028493-T1,A0A096X8J7,B3A3_DANRE,,Anion exchange protein 3 (AE 3) (Solute carrier family 4 member 3),Danio rerio (Zebrafish) (Brachydanio rerio),45.0,629.0,1.3e-143,511.5,sp|A0A096X8J7|B3A3_DANRE Anion exchange protein 3 OS=Danio rerio OX=7955 GN=Slc4a3 PE=2 SV=1,GO:0005452; GO:0005886; GO:0008509; GO:0015701; GO:0051453; GO:0055085; GO:0086001,bicarbonate transport [GO:0015701]; cardiac muscle cell action potential [GO:0086001]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085],plasma membrane [GO:0005886],monoatomic anion transmembrane transporter activity [GO:0008509]; solute:inorganic anion antiporter activity [GO:0005452],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_14890,FUN_028519-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9438.t1,apul_ptua,67.12,,,,,,,,,,,,,,,,,
OG_14891,FUN_028541-T1,,Pocillopora_meandrina_HIv1___TS.g2022.t1,apul_ptua,65.957,,,,,,,,,,,,,,,,,
OG_14892,FUN_028556-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20738.t1,apul_ptua,63.448,FUN_028556-T1,O75897,ST1C4_HUMAN,,Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2),Homo sapiens (Human),37.7,273.0,2.0000000000000003e-49,197.6,sp|O75897|ST1C4_HUMAN Sulfotransferase 1C4 OS=Homo sapiens OX=9606 GN=SULT1C4 PE=1 SV=2,GO:0004062; GO:0005737; GO:0005829; GO:0006068; GO:0006805; GO:0008146; GO:0009812; GO:0044598; GO:0050427; GO:0051923,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytosol [GO:0005829],aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146],GO:0003824; GO:0005829; GO:0006790; GO:0016740; GO:0055086; GO:1901135,catalytic activity; cytosol; sulfur compound metabolic process; transferase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_14893,FUN_028561-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20733.t1,apul_ptua,51.8335,FUN_028561-T1,Q9EQI8,,,,,32.6,239.0,3.4000000000000003e-22,107.1,sp|Q9EQI8|RM46_MOUSE Large ribosomal subunit protein mL46 OS=Mus musculus OX=10090 GN=Mrpl46 PE=1 SV=1,,,,,,
OG_14894,FUN_028565-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29753.t1,apul_ptua,89.697,,,,,,,,,,,,,,,,,
OG_14895,FUN_028644-T1,,Pocillopora_meandrina_HIv1___TS.g27827.t1,apul_ptua,48.6485,,,,,,,,,,,,,,,,,
OG_14896,FUN_028689-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20734.t1,apul_ptua,53.659,FUN_028689-T1,Q5VWZ2,LYPL1_HUMAN,,Lysophospholipase-like protein 1 (EC 3.1.2.22),Homo sapiens (Human),31.2,202.0,1.2e-24,114.8,sp|Q5VWZ2|LYPL1_HUMAN Lysophospholipase-like protein 1 OS=Homo sapiens OX=9606 GN=LYPLAL1 PE=1 SV=3,GO:0004622; GO:0005737; GO:0005739; GO:0005829; GO:0008474; GO:0016788; GO:0042997; GO:0052689; GO:0160049,negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],"carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]",GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; mitochondrion; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_14897,FUN_028755-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27317.t1,apul_ptua,86.0,,,,,,,,,,,,,,,,,
OG_14898,FUN_028774-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11259.t1,apul_ptua,37.674,FUN_028774-T1,F7J220,,,,,22.9,563.0,7.7e-27,124.4,sp|F7J220|SRCR1_PATPE Scavenger receptor cysteine-rich domain superfamily protein OS=Patiria pectinifera OX=7594 GN=SRCR1 PE=1 SV=1,,,,,,
OG_14899,FUN_028776-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19605.t1,apul_ptua,52.448,,,,,,,,,,,,,,,,,
OG_14900,FUN_028784-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15048.t1,apul_ptua,71.598,,,,,,,,,,,,,,,,,
OG_14901,FUN_028799-T2,,Pocillopora_meandrina_HIv1___RNAseq.g20739.t1,apul_ptua,50.579,,,,,,,,,,,,,,,,,
OG_14902,FUN_028834-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25680.t1,apul_ptua,41.722,,,,,,,,,,,,,,,,,
OG_14903,FUN_028837-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20710.t1,apul_ptua,71.0,FUN_028837-T1,Q90336,MK14A_CYPCA,,Mitogen-activated protein kinase 14A (MAP kinase 14A) (MAPK 14A) (EC 2.7.11.24) (Mitogen-activated protein kinase p38a) (MAP kinase p38a) (cp38a),Cyprinus carpio (Common carp),56.8,88.0,4.6000000000000015e-22,105.1,sp|Q90336|MK14A_CYPCA Mitogen-activated protein kinase 14A OS=Cyprinus carpio OX=7962 GN=mapk14a PE=1 SV=1,GO:0004707; GO:0005524; GO:0005634; GO:0005737; GO:0006357; GO:0010831; GO:0035556; GO:0038066; GO:0045663; GO:0106310; GO:1901741,intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357],cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0006355; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; regulation of DNA-templated transcription; transferase activity; organelle; catalytic activity, acting on a protein"
OG_14904,FUN_028851-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12801.t1,apul_ptua,73.289,FUN_028851-T1,Q09840,,,,,35.6,495.0,3e-82,307.4,sp|Q09840|AMY2_SCHPO Alpha-amylase 2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=aah2 PE=1 SV=1,,,,,,
OG_14905,FUN_028867-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16253.t1,apul_ptua,44.706,,,,,,,,,,,,,,,,,
OG_14906,FUN_028870-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18413.t1,apul_ptua,57.143,,,,,,,,,,,,,,,,,
OG_14907,FUN_028871-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25702.t1,apul_ptua,42.8,,,,,,,,,,,,,,,,,
OG_14908,FUN_028914-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20764.t1,apul_ptua,58.273,,,,,,,,,,,,,,,,,
OG_14909,FUN_028915-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14977.t1,apul_ptua,89.744,FUN_028915-T1,Q3T0Z8,RUXF_BOVIN,,Small nuclear ribonucleoprotein F (snRNP-F) (Sm protein F) (Sm-F) (SmF),Bos taurus (Bovine),88.1,84.0,7.4e-40,164.1,sp|Q3T0Z8|RUXF_BOVIN Small nuclear ribonucleoprotein F OS=Bos taurus OX=9913 GN=SNRPF PE=3 SV=2,GO:0000387; GO:0000398; GO:0003723; GO:0005634; GO:0005683; GO:0005684; GO:0005685; GO:0005687; GO:0005829; GO:0034709; GO:0034715; GO:0034719; GO:0046540; GO:0071005; GO:0071007; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U7 snRNP [GO:0005683],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; protein-containing complex assembly
OG_14910,FUN_028917-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14978.t1,apul_ptua,86.97149999999999,FUN_028917-T1,Q494V2,CP100_HUMAN,,Cilia- and flagella-associated protein 100 (Coiled-coil domain-containing protein 37),Homo sapiens (Human),36.2,486.0,1.6999999999999999e-68,261.9,sp|Q494V2|CP100_HUMAN Cilia- and flagella-associated protein 100 OS=Homo sapiens OX=9606 GN=CFAP100 PE=1 SV=1,GO:0003341; GO:0031514; GO:0036064; GO:0036159; GO:0070840; GO:0097545,cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159],axonemal doublet microtubule [GO:0097545]; ciliary basal body [GO:0036064]; motile cilium [GO:0031514],dynein complex binding [GO:0070840],GO:0005815; GO:0005929; GO:0007018; GO:0043226; GO:0065003,microtubule organizing center; cilium; microtubule-based movement; organelle; protein-containing complex assembly
OG_14911,FUN_028923-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20272.t1,apul_ptua,38.492,,,,,,,,,,,,,,,,,
OG_14912,FUN_028956-T1,,Pocillopora_meandrina_HIv1___TS.g9014.t1b,apul_ptua,83.415,FUN_028956-T1,Q8CG50,,,,,54.1,205.0,4e-60,232.6,sp|Q8CG50|RAB43_MOUSE Ras-related protein Rab-43 OS=Mus musculus OX=10090 GN=Rab43 PE=1 SV=1,,,,,,
OG_14913,FUN_028975-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25604.t1,apul_ptua,66.3545,,,,,,,,,,,,,,,,,
OG_14914,FUN_028982-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25618.t1,apul_ptua,60.424,FUN_028982-T1,Q8R431,MGLL_RAT,,Monoglyceride lipase (MGL) (EC 3.1.1.23) (Monoacylglycerol lipase) (MAGL),Rattus norvegicus (Rat),42.7,274.0,5.7e-65,249.2,sp|Q8R431|MGLL_RAT Monoglyceride lipase OS=Rattus norvegicus OX=10116 GN=Mgll PE=1 SV=1,GO:0005811; GO:0005829; GO:0006633; GO:0009966; GO:0016020; GO:0016787; GO:0019369; GO:0019433; GO:0030424; GO:0030516; GO:0042803; GO:0043196; GO:0045202; GO:0045907; GO:0046464; GO:0047372; GO:0050727; GO:0051930; GO:0052651; GO:0060292; GO:0098688; GO:0098793; GO:0099178; GO:0150053; GO:2000124,acylglycerol catabolic process [GO:0046464]; arachidonate metabolic process [GO:0019369]; fatty acid biosynthetic process [GO:0006633]; long-term synaptic depression [GO:0060292]; monoacylglycerol catabolic process [GO:0052651]; positive regulation of vasoconstriction [GO:0045907]; regulation of axon extension [GO:0030516]; regulation of endocannabinoid signaling pathway [GO:2000124]; regulation of inflammatory response [GO:0050727]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; regulation of sensory perception of pain [GO:0051930]; regulation of signal transduction [GO:0009966]; triglyceride catabolic process [GO:0019433],axon [GO:0030424]; cerebellar climbing fiber to Purkinje cell synapse [GO:0150053]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; parallel fiber to Purkinje cell synapse [GO:0098688]; presynapse [GO:0098793]; synapse [GO:0045202]; varicosity [GO:0043196],hydrolase activity [GO:0016787]; monoacylglycerol lipase activity [GO:0047372]; protein homodimerization activity [GO:0042803],GO:0003013; GO:0003824; GO:0005811; GO:0005829; GO:0006629; GO:0016787; GO:0043226,circulatory system process; catalytic activity; lipid droplet; cytosol; lipid metabolic process; hydrolase activity; organelle
OG_14915,FUN_028988-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5928.t1a,apul_ptua,48.548,FUN_028988-T1,B8VIU6,,,,,80.4,245.0,5.1e-107,389.0,sp|B8VIU6|USOM5_ACRMI Uncharacterized skeletal organic matrix protein 5 OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_14916,FUN_029003-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25764.t1,apul_ptua,45.9375,FUN_029003-T1,Q93109,,,,,46.0,187.0,7.5e-42,172.2,sp|Q93109|ACTP5_ACTEQ DELTA-actitoxin-Aeq1b OS=Actinia equina OX=6106 PE=2 SV=1,,,,,,
OG_14917,FUN_029020-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25818.t1,apul_ptua,51.341,FUN_029020-T1,P0DOX0,,,,,32.3,480.0,2.9e-70,267.7,sp|P0DOX0|C27C1_AQUCT Cytochrome P450 27C1 OS=Aquarana catesbeiana OX=8400 GN=cyp27c1 PE=1 SV=1,,,,,,
OG_14918,FUN_029024-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25814.t1,apul_ptua,59.144,FUN_029024-T1,O18635,,,,,31.6,469.0,5e-59,230.3,sp|O18635|C12A2_MUSDO Cytochrome P450 CYP12A2 OS=Musca domestica OX=7370 GN=CYP12A2 PE=2 SV=1,,,,,,
OG_14919,FUN_029025-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25815.t1,apul_ptua,97.333,FUN_029025-T1,Q3ZCE0,,,,,80.0,75.0,3.8e-29,128.3,sp|Q3ZCE0|LSM8_BOVIN U6 snRNA-associated Sm-like protein LSm8 OS=Bos taurus OX=9913 GN=LSM8 PE=3 SV=3,,,,,,
OG_14920,FUN_029026-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25816.t1,apul_ptua,69.075,FUN_029026-T1,Q93075,,,,,44.4,306.0,1.3e-72,275.0,sp|Q93075|TATD2_HUMAN 3'-5' RNA nuclease TATDN2 OS=Homo sapiens OX=9606 GN=TATDN2 PE=1 SV=2,,,,,,
OG_14921,FUN_029027-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25817.t1,apul_ptua,51.381,FUN_029027-T1,Q5U419,,,,,33.3,427.0,1.1e-43,179.1,sp|Q5U419|MFSD3_MOUSE Major facilitator superfamily domain-containing protein 3 OS=Mus musculus OX=10090 GN=Mfsd3 PE=1 SV=1,,,,,,
OG_14922,FUN_029042-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20767.t3,apul_ptua,67.457,FUN_029042-T1,Q64487,PTPRD_MOUSE,,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),Mus musculus (Mouse),36.9,659.0,1.3e-119,432.2,sp|Q64487|PTPRD_MOUSE Receptor-type tyrosine-protein phosphatase delta OS=Mus musculus OX=10090 GN=Ptprd PE=1 SV=3,GO:0004725; GO:0005102; GO:0007157; GO:0030182; GO:0042734; GO:0046426; GO:0050775; GO:0050776; GO:0050804; GO:0050839; GO:0051965; GO:0061003; GO:0097105; GO:0098685; GO:0098686; GO:0098978; GO:0099151; GO:0099537; GO:0099545; GO:0099560,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; neuron differentiation [GO:0030182]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of synapse assembly [GO:0051965]; presynaptic membrane assembly [GO:0097105]; regulation of immune response [GO:0050776]; regulation of postsynaptic density assembly [GO:0099151]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling [GO:0099537]; trans-synaptic signaling by trans-synaptic complex [GO:0099545],glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],cell adhesion molecule binding [GO:0050839]; protein tyrosine phosphatase activity [GO:0004725]; signaling receptor binding [GO:0005102],GO:0003824; GO:0007155; GO:0016787; GO:0023052; GO:0030154; GO:0061024; GO:0140096,"catalytic activity; cell adhesion; hydrolase activity; signaling; cell differentiation; membrane organization; catalytic activity, acting on a protein"
OG_14923,FUN_029066-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5550.t1,apul_ptua,50.985,,,,,,,,,,,,,,,,,
OG_14924,FUN_029106-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25463.t1,apul_ptua,70.194,FUN_029106-T1,Q6IQ20,NAPEP_HUMAN,,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54),Homo sapiens (Human),51.2,344.0,3.2e-106,386.7,sp|Q6IQ20|NAPEP_HUMAN N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D OS=Homo sapiens OX=9606 GN=NAPEPLD PE=1 SV=2,GO:0000139; GO:0001659; GO:0005635; GO:0005654; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0009395; GO:0030868; GO:0031901; GO:0032052; GO:0035900; GO:0042622; GO:0042734; GO:0042802; GO:0043005; GO:0043025; GO:0045211; GO:0048874; GO:0050729; GO:0070062; GO:0070290; GO:0070291; GO:0070292; GO:0090336; GO:0098686; GO:1903999,host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; temperature homeostasis [GO:0001659],cytoplasm [GO:0005737]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; smooth endoplasmic reticulum membrane [GO:0030868],bile acid binding [GO:0032052]; identical protein binding [GO:0042802]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270],GO:0003824; GO:0005635; GO:0005654; GO:0005768; GO:0005794; GO:0006629; GO:0016787; GO:0031410; GO:0043226,catalytic activity; nuclear envelope; nucleoplasm; endosome; Golgi apparatus; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle
OG_14925,FUN_029135-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25744.t1,apul_ptua,31.915,,,,,,,,,,,,,,,,,
OG_14926,FUN_029147-T2,,Pocillopora_meandrina_HIv1___RNAseq.g25731.t1b,apul_ptua,85.773,FUN_029147-T2,Q14315,FLNC_HUMAN,,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),Homo sapiens (Human),36.4,3083.0,0.0,1695.6,sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005925; GO:0008092; GO:0016528; GO:0030018; GO:0030506; GO:0042383; GO:0042802; GO:0043034; GO:0045171; GO:0045214; GO:0051015,sarcomere organization [GO:0045214],costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intercellular bridge [GO:0045171]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018],actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802],GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0043226,cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_14927,FUN_029172-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25497.t1,apul_ptua,64.878,,,,,,,,,,,,,,,,,
OG_14928,FUN_029201-T2,,Pocillopora_meandrina_HIv1___RNAseq.g25530.t1,apul_ptua,71.58600000000001,FUN_029201-T2,Q96N23,,,,,29.0,3379.0,0.0,1147.1,sp|Q96N23|CFA54_HUMAN Cilia- and flagella-associated protein 54 OS=Homo sapiens OX=9606 GN=CFAP54 PE=1 SV=3,,,,,,
OG_14929,FUN_029202-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25531.t1,apul_ptua,65.337,,,,,,,,,,,,,,,,,
OG_14930,FUN_029210-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25542.t1,apul_ptua,50.4485,FUN_029210-T1,Q9VQ91,TDRKH_DROME,,Tudor and KH domain-containing protein homolog (Partner of PIWIs protein),Drosophila melanogaster (Fruit fly),28.4,141.0,8.2e-11,71.2,sp|Q9VQ91|TDRKH_DROME Tudor and KH domain-containing protein homolog OS=Drosophila melanogaster OX=7227 GN=papi PE=1 SV=1,GO:0003723; GO:0005634; GO:0005739; GO:0007283; GO:0010526; GO:0030719; GO:0032991; GO:0034587; GO:0043186; GO:0140990,P granule organization [GO:0030719]; piRNA processing [GO:0034587]; primary piRNA processing [GO:0140990]; spermatogenesis [GO:0007283]; transposable element silencing [GO:0010526],mitochondrion [GO:0005739]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991],RNA binding [GO:0003723],GO:0003723; GO:0005634; GO:0005739; GO:0022414; GO:0043226,RNA binding; nucleus; mitochondrion; reproductive process; organelle
OG_14931,FUN_029214-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27847.t1,apul_ptua,48.193,,,,,,,,,,,,,,,,,
OG_14932,FUN_029232-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25549.t1,apul_ptua,65.337,FUN_029232-T1,Q91175,,,,,23.0,309.0,2.2e-07,58.2,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_14933,FUN_029248-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15015.t1,apul_ptua,71.74600000000001,FUN_029248-T1,Q6ZMT4,KDM7A_HUMAN,,Lysine-specific demethylase 7A (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7) ([histone H3]-dimethyl-L-lysine9 demethylase 7A) (EC 1.14.11.65),Homo sapiens (Human),53.4,444.0,9.1e-144,512.7,sp|Q6ZMT4|KDM7A_HUMAN Lysine-specific demethylase 7A OS=Homo sapiens OX=9606 GN=KDM7A PE=1 SV=2,GO:0003712; GO:0005506; GO:0005634; GO:0005654; GO:0005730; GO:0006338; GO:0006357; GO:0008270; GO:0016706; GO:0030901; GO:0032452; GO:0032454; GO:0035575; GO:0045893; GO:0051864; GO:0071558; GO:0140683,chromatin remodeling [GO:0006338]; midbrain development [GO:0030901]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],2-oxoglutarate-dependent dioxygenase activity [GO:0016706]; histone demethylase activity [GO:0032452]; histone H3K27me2/H3K27me3 demethylase activity [GO:0071558]; histone H3K36 demethylase activity [GO:0051864]; histone H3K9 demethylase activity [GO:0032454]; histone H3K9me/H3K9me2 demethylase activity [GO:0140683]; histone H4K20 demethylase activity [GO:0035575]; iron ion binding [GO:0005506]; transcription coregulator activity [GO:0003712]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006325; GO:0006355; GO:0016491; GO:0043226; GO:0048856; GO:0060090; GO:0140096; GO:0140110,"catalytic activity; nucleus; nucleoplasm; nucleolus; chromatin organization; regulation of DNA-templated transcription; oxidoreductase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on a protein; transcription regulator activity"
OG_14934,FUN_029251-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15017.t2,apul_ptua,46.0,FUN_029251-T1,Q9NYZ3,GTSE1_HUMAN,,G2 and S phase-expressed protein 1 (GTSE-1) (Protein B99 homolog),Homo sapiens (Human),37.2,121.0,2.5e-10,68.9,sp|Q9NYZ3|GTSE1_HUMAN G2 and S phase-expressed protein 1 OS=Homo sapiens OX=9606 GN=GTSE1 PE=1 SV=4,GO:0005654; GO:0005829; GO:0005881; GO:0007017; GO:0008017; GO:0015630; GO:0016020; GO:0030330,"DNA damage response, signal transduction by p53 class mediator [GO:0030330]; microtubule-based process [GO:0007017]",cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654],microtubule binding [GO:0008017],GO:0005654; GO:0005829; GO:0005856; GO:0008092; GO:0043226,nucleoplasm; cytosol; cytoskeleton; cytoskeletal protein binding; organelle
OG_14935,FUN_029257-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15026.t1,apul_ptua,60.251,,,,,,,,,,,,,,,,,
OG_14936,FUN_029271-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25415.t1,apul_ptua,85.393,FUN_029271-T1,P08537,,,,,79.5,448.0,5.5e-219,761.5,sp|P08537|TBA_XENLA Tubulin alpha chain OS=Xenopus laevis OX=8355 GN=tuba PE=2 SV=2,,,,,,
OG_14937,FUN_029323-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11790.t1,apul_ptua,43.5895,FUN_029323-T1,P10447,,,,,33.8,219.0,9.2e-23,111.7,sp|P10447|ABL_FSVHY Tyrosine-protein kinase transforming protein Abl OS=Feline sarcoma virus (strain Hardy-Zuckerman 2) OX=11776 GN=ABL PE=2 SV=1,,,,,,
OG_14938,FUN_029325-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16714.t1,apul_ptua,41.633,FUN_029325-T1,Q61850,,,,,53.3,120.0,2.6e-27,124.0,sp|Q61850|FOXC2_MOUSE Forkhead box protein C2 OS=Mus musculus OX=10090 GN=Foxc2 PE=1 SV=2,,,,,,
OG_14939,FUN_029328-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17100.t1,apul_ptua,85.176,FUN_029328-T1,Q3ZCV2,,,,,35.2,384.0,3e-56,220.7,sp|Q3ZCV2|CMAP2_HUMAN Ciliary microtubule-associated protein 2 OS=Homo sapiens OX=9606 GN=CIMAP2 PE=1 SV=4,,,,,,
OG_14940,FUN_029329-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17101.t1,apul_ptua,47.445,,,,,,,,,,,,,,,,,
OG_14941,FUN_029338-T1,,Pocillopora_meandrina_HIv1___TS.g3065.t1,apul_ptua,48.222,FUN_029338-T1,Q9Z138,,,,,30.4,762.0,4.1e-87,324.3,sp|Q9Z138|ROR2_MOUSE Tyrosine-protein kinase transmembrane receptor ROR2 OS=Mus musculus OX=10090 GN=Ror2 PE=1 SV=2,,,,,,
OG_14942,FUN_029379-T1,,Pocillopora_meandrina_HIv1___TS.g12627.t1,apul_ptua,49.9005,,,,,,,,,,,,,,,,,
OG_14943,FUN_029435-T1,,Pocillopora_meandrina_HIv1___TS.g2938.t1,apul_ptua,60.55,FUN_029435-T1,Q9QUP4,,,,,24.0,333.0,1.7e-12,75.5,sp|Q9QUP4|CHST5_MOUSE Carbohydrate sulfotransferase 5 OS=Mus musculus OX=10090 GN=Chst5 PE=2 SV=1,,,,,,
OG_14944,FUN_029466-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23093.t1,apul_ptua,51.913,,,,,,,,,,,,,,,,,
OG_14945,FUN_029477-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17151.t1,apul_ptua,73.404,FUN_029477-T1,P53702,,,,,48.6,282.0,5.000000000000001e-66,252.7,sp|P53702|CCHL_MOUSE Holocytochrome c-type synthase OS=Mus musculus OX=10090 GN=Hccs PE=1 SV=2,,,,,,
OG_14946,FUN_029492-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17123.t1,apul_ptua,72.43350000000001,FUN_029492-T1,P70490,,,,,34.4,320.0,6.7e-42,175.3,sp|P70490|MFGM_RAT Lactadherin OS=Rattus norvegicus OX=10116 GN=Mfge8 PE=2 SV=1,,,,,,
OG_14947,FUN_029513-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22195.t1,apul_ptua,45.455,,,,,,,,,,,,,,,,,
OG_14948,FUN_029517-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25990.t1,apul_ptua,44.6175,,,,,,,,,,,,,,,,,
OG_14949,FUN_029544-T2,,Pocillopora_meandrina_HIv1___RNAseq.g17281.t1,apul_ptua,68.595,FUN_029544-T2,Q9UKQ2,ADA28_HUMAN,,"Disintegrin and metalloproteinase domain-containing protein 28 (ADAM 28) (EC 3.4.24.-) (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II) (eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L) (MDC-L)",Homo sapiens (Human),32.5,486.0,4.9e-60,233.8,sp|Q9UKQ2|ADA28_HUMAN Disintegrin and metalloproteinase domain-containing protein 28 OS=Homo sapiens OX=9606 GN=ADAM28 PE=1 SV=3,GO:0004222; GO:0005576; GO:0005739; GO:0005886; GO:0006508; GO:0007283; GO:0008237; GO:0009986; GO:0034987; GO:0046872,proteolysis [GO:0006508]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],immunoglobulin receptor binding [GO:0034987]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],GO:0003824; GO:0005576; GO:0005739; GO:0005886; GO:0016787; GO:0022414; GO:0043226; GO:0140096,"catalytic activity; extracellular region; mitochondrion; plasma membrane; hydrolase activity; reproductive process; organelle; catalytic activity, acting on a protein"
OG_14950,FUN_029664-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17209.t1,apul_ptua,87.008,FUN_029664-T1,A7Z019,SMCA4_BOVIN,,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4 (SMARCA4) (EC 3.6.4.-) (BRG1-associated factor 190A) (BAF190A) (Protein brahma homolog 1) (SNF2-beta) (Transcription activator BRG1),Bos taurus (Bovine),59.2,1060.0,7.9e-245,848.6,sp|A7Z019|SMCA4_BOVIN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4 OS=Bos taurus OX=9913 GN=SMARCA4 PE=2 SV=1,GO:0000785; GO:0003677; GO:0003682; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0007399; GO:0016514; GO:0016787; GO:0042393; GO:0045944; GO:0071564; GO:0071565; GO:0140750,nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],chromatin [GO:0000785]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514],ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; hydrolase activity [GO:0016787]; nucleosome array spacer activity [GO:0140750]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006355; GO:0016787; GO:0016853; GO:0042393; GO:0043226; GO:0048856; GO:0140097; GO:0140657,"DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; histone binding; organelle; anatomical structure development; catalytic activity, acting on DNA; ATP-dependent activity"
OG_14951,FUN_029699-T1,,Pocillopora_meandrina_HIv1___TS.g27055.t1,apul_ptua,45.335,FUN_029699-T1,Q96AY4,TTC28_HUMAN,,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),Homo sapiens (Human),29.1,327.0,2.9e-25,119.4,sp|Q96AY4|TTC28_HUMAN Tetratricopeptide repeat protein 28 OS=Homo sapiens OX=9606 GN=TTC28 PE=1 SV=4,GO:0000922; GO:0005737; GO:0005813; GO:0007346; GO:0019900; GO:0030496; GO:0051301,cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],centrosome [GO:0005813]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle pole [GO:0000922],kinase binding [GO:0019900],GO:0005815,microtubule organizing center
OG_14952,FUN_029711-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17313.t1,apul_ptua,42.357,FUN_029711-T1,Q9UGU5,HMGX4_HUMAN,,HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG),Homo sapiens (Human),42.0,193.0,1.5e-32,143.3,sp|Q9UGU5|HMGX4_HUMAN HMG domain-containing protein 4 OS=Homo sapiens OX=9606 GN=HMGXB4 PE=1 SV=2,GO:0003677; GO:0008333; GO:0016055; GO:0016589; GO:0030178; GO:0042802,endosome to lysosome transport [GO:0008333]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NURF complex [GO:0016589],DNA binding [GO:0003677]; identical protein binding [GO:0042802],GO:0003677; GO:0016192,DNA binding; vesicle-mediated transport
OG_14953,FUN_029718-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28961.t1,apul_ptua,44.407,,,,,,,,,,,,,,,,,
OG_14954,FUN_029742-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28973.t1,apul_ptua,45.4745,FUN_029742-T1,Q9NUV9,GIMA4_HUMAN,,GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein) (IAN-1) (hIAN1) (Immunity-associated protein 4),Homo sapiens (Human),29.8,225.0,1.6e-14,83.2,sp|Q9NUV9|GIMA4_HUMAN GTPase IMAP family member 4 OS=Homo sapiens OX=9606 GN=GIMAP4 PE=1 SV=1,GO:0005525; GO:0005829; GO:0043231,,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231],GTP binding [GO:0005525],GO:0005829; GO:0043226,cytosol; organelle
OG_14955,FUN_029790-T1,,Pocillopora_meandrina_HIv1___TS.g6266.t1,apul_ptua,65.574,,,,,,,,,,,,,,,,,
OG_14956,FUN_029792-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29045.t1,apul_ptua,76.852,,,,,,,,,,,,,,,,,
OG_14957,FUN_029800-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6502.t1,apul_ptua,78.378,,,,,,,,,,,,,,,,,
OG_14958,FUN_029821-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27001.t1,apul_ptua,41.379,,,,,,,,,,,,,,,,,
OG_14959,FUN_029822-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15408.t1,apul_ptua,52.308,,,,,,,,,,,,,,,,,
OG_14960,FUN_029843-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27338.t1a,apul_ptua,89.796,,,,,,,,,,,,,,,,,
OG_14961,FUN_029890-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17342.t2,apul_ptua,59.52,FUN_029890-T1,O75943,RAD17_HUMAN,,Cell cycle checkpoint protein RAD17 (hRad17) (RF-C/activator 1 homolog),Homo sapiens (Human),39.6,626.0,1.2e-113,412.1,sp|O75943|RAD17_HUMAN Cell cycle checkpoint protein RAD17 OS=Homo sapiens OX=9606 GN=RAD17 PE=1 SV=2,GO:0000076; GO:0000077; GO:0003682; GO:0003689; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006974; GO:0008156; GO:0031389; GO:0031573; GO:0033314; GO:0035861; GO:0042325; GO:0140463; GO:1990166,DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; negative regulation of DNA replication [GO:0008156]; protein localization to site of double-strand break [GO:1990166]; regulation of phosphorylation [GO:0042325],nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rad17 RFC-like complex [GO:0031389]; site of double-strand break [GO:0035861],ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin-protein adaptor activity [GO:0140463]; DNA clamp loader activity [GO:0003689],GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0043226; GO:0060090; GO:0140097; GO:0140657,"catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; organelle; molecular adaptor activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_14962,FUN_029918-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15411.t1,apul_ptua,37.7255,,,,,,,,,,,,,,,,,
OG_14963,FUN_029935-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9056.t1,apul_ptua,53.425,,,,,,,,,,,,,,,,,
OG_14964,FUN_029947-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28585.t1,apul_ptua,64.19,,,,,,,,,,,,,,,,,
OG_14965,FUN_030000-T1,,Pocillopora_meandrina_HIv1___TS.g465.t1,apul_ptua,65.385,,,,,,,,,,,,,,,,,
OG_14966,FUN_030005-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21901.t1,apul_ptua,58.065,,,,,,,,,,,,,,,,,
OG_14967,FUN_030033-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11282.t1,apul_ptua,98.54,,,,,,,,,,,,,,,,,
OG_14968,FUN_030036-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16142.t1,apul_ptua,49.048,,,,,,,,,,,,,,,,,
OG_14969,FUN_030041-T1,,Pocillopora_meandrina_HIv1___TS.g10502.t1,apul_ptua,48.405,FUN_030041-T1,Q6XHB2,ROCO4_DICDI,,Probable serine/threonine-protein kinase roco4 (EC 2.7.11.1) (Ras of complex proteins and C-terminal of roc 4),Dictyostelium discoideum (Social amoeba),24.5,469.0,7.1e-14,81.6,sp|Q6XHB2|ROCO4_DICDI Probable serine/threonine-protein kinase roco4 OS=Dictyostelium discoideum OX=44689 GN=roco4 PE=1 SV=1,GO:0000302; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005525; GO:0005737; GO:0005739; GO:0005829; GO:0006120; GO:0007165; GO:0031150; GO:0042331; GO:0106310,"mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; phototaxis [GO:0042331]; response to reactive oxygen species [GO:0000302]; signal transduction [GO:0007165]; sorocarp stalk development [GO:0031150]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; GTP binding [GO:0005525]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005739; GO:0005829; GO:0006091; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; mitochondrion; cytosol; generation of precursor metabolites and energy; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_14970,FUN_030066-T1,,Pocillopora_meandrina_HIv1___TS.g2962.t1,apul_ptua,30.612,,,,,,,,,,,,,,,,,
OG_14971,FUN_030074-T1,,Pocillopora_meandrina_HIv1___TS.g3114.t1,apul_ptua,66.761,,,,,,,,,,,,,,,,,
OG_14972,FUN_030085-T1,,Pocillopora_meandrina_HIv1___TS.g28006.t1b,apul_ptua,91.148,,,,,,,,,,,,,,,,,
OG_14973,FUN_030135-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29665.t1,apul_ptua,62.366,,,,,,,,,,,,,,,,,
OG_14974,FUN_030150-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6095.t1,apul_ptua,74.576,,,,,,,,,,,,,,,,,
OG_14975,FUN_030195-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23693.t1,apul_ptua,43.777,,,,,,,,,,,,,,,,,
OG_14976,FUN_030641-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30305.t1,apul_ptua,33.1775,,,,,,,,,,,,,,,,,
OG_14977,FUN_030657-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30302.t1,apul_ptua,60.6005,,,,,,,,,,,,,,,,,
OG_14978,FUN_030658-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30299.t1,apul_ptua,75.15,FUN_030658-T1,Q9UQ07,MOK_HUMAN,,MAPK/MAK/MRK overlapping kinase (EC 2.7.11.22) (MOK protein kinase) (Renal tumor antigen 1) (RAGE-1),Homo sapiens (Human),69.0,300.0,8.7e-126,451.8,sp|Q9UQ07|MOK_HUMAN MAPK/MAK/MRK overlapping kinase OS=Homo sapiens OX=9606 GN=MOK PE=1 SV=1,GO:0004672; GO:0004674; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005929; GO:0006468; GO:0007165; GO:0035556; GO:0046872; GO:0097546; GO:0106310,intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0005929; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cilium; transferase activity; organelle; catalytic activity, acting on a protein"
OG_14979,FUN_030667-T1,,Pocillopora_meandrina_HIv1___TS.g24915.t1,apul_ptua,76.293,FUN_030667-T1,Q9H079,KTBL1_HUMAN,,KATNB1-like protein 1 (Katanin p80 subunit B-like 1),Homo sapiens (Human),41.8,134.0,8.700000000000001e-22,105.5,sp|Q9H079|KTBL1_HUMAN KATNB1-like protein 1 OS=Homo sapiens OX=9606 GN=KATNBL1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0008017; GO:0008352; GO:0015630; GO:0030496; GO:0031122; GO:0032154; GO:0051495; GO:0072686; GO:0097431,cytoplasmic microtubule organization [GO:0031122]; positive regulation of cytoskeleton organization [GO:0051495],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle pole [GO:0097431]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],microtubule binding [GO:0008017],GO:0005634; GO:0005654; GO:0005730; GO:0005856; GO:0007010; GO:0008092; GO:0043226,nucleus; nucleoplasm; nucleolus; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_14980,FUN_030681-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30327.t2,apul_ptua,52.7,FUN_030681-T1,Q6YHU6,THADA_HUMAN,,tRNA (32-2'-O)-methyltransferase regulator THADA (Gene inducing thyroid adenomas protein) (Thyroid adenoma-associated protein),Homo sapiens (Human),29.5,1986.0,2.3e-213,745.0,sp|Q6YHU6|THADA_HUMAN tRNA (32-2'-O)-methyltransferase regulator THADA OS=Homo sapiens OX=9606 GN=THADA PE=1 SV=1,GO:0002128; GO:0030234; GO:0030488; GO:0032471; GO:0055088; GO:0098554; GO:1990845,adaptive thermogenesis [GO:1990845]; lipid homeostasis [GO:0055088]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; tRNA methylation [GO:0030488]; tRNA nucleoside ribose methylation [GO:0002128],cytoplasmic side of endoplasmic reticulum membrane [GO:0098554],enzyme regulator activity [GO:0030234],GO:0006399; GO:0098772,tRNA metabolic process; molecular function regulator activity
OG_14981,FUN_030858-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18980.t1,apul_ptua,46.269,,,,,,,,,,,,,,,,,
OG_14982,FUN_031025-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8068.t1,apul_ptua,76.923,,,,,,,,,,,,,,,,,
OG_14983,FUN_031029-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5405.t1,apul_ptua,58.027,,,,,,,,,,,,,,,,,
OG_14984,FUN_031031-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29594.t1,apul_ptua,73.256,,,,,,,,,,,,,,,,,
OG_14985,FUN_031042-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1794.t1,apul_ptua,49.237,,,,,,,,,,,,,,,,,
OG_14986,FUN_031047-T1,,Pocillopora_meandrina_HIv1___TS.g25498.t1,apul_ptua,68.889,,,,,,,,,,,,,,,,,
OG_14987,FUN_031050-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1774.t1,apul_ptua,54.58,,,,,,,,,,,,,,,,,
OG_14988,FUN_031051-T1,,Pocillopora_meandrina_HIv1___TS.g16391.t1,apul_ptua,31.0,,,,,,,,,,,,,,,,,
OG_14989,FUN_031207-T1,,Pocillopora_meandrina_HIv1___TS.g23927.t1,apul_ptua,53.602,,,,,,,,,,,,,,,,,
OG_14990,FUN_031243-T1,,Pocillopora_meandrina_HIv1___TS.g278.t1,apul_ptua,54.982,FUN_031243-T1,Q54FD5,,,,,29.0,124.0,1.3e-07,58.9,sp|Q54FD5|Y0931_DICDI TNF receptor-associated factor family protein DDB_G0290931 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0290931 PE=3 SV=1,,,,,,
OG_14991,FUN_031262-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1870.t1,apul_ptua,41.692,,,,,,,,,,,,,,,,,
OG_14992,FUN_031343-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19320.t1,apul_ptua,35.644,,,,,,,,,,,,,,,,,
OG_14993,FUN_031347-T1,,Pocillopora_meandrina_HIv1___TS.g23872.t1,apul_ptua,48.045,FUN_031347-T1,Q5SY80,CTSRE_HUMAN,,Cation channel sperm-associated auxiliary subunit epsilon (CatSper-epsilon) (CatSperepsilon),Homo sapiens (Human),28.4,327.0,2.3e-34,147.9,sp|Q5SY80|CTSRE_HUMAN Cation channel sperm-associated auxiliary subunit epsilon OS=Homo sapiens OX=9606 GN=CATSPERE PE=1 SV=1,GO:0030317; GO:0036128; GO:0048240; GO:0097228,flagellated sperm motility [GO:0030317]; sperm capacitation [GO:0048240],CatSper complex [GO:0036128]; sperm principal piece [GO:0097228],,GO:0007018; GO:0022414; GO:0048870,microtubule-based movement; reproductive process; cell motility
OG_14994,FUN_031361-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7669.t1a,apul_ptua,48.472,,,,,,,,,,,,,,,,,
OG_14995,FUN_031439-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17697.t1,apul_ptua,49.135000000000005,,,,,,,,,,,,,,,,,
OG_14996,FUN_031463-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5154.t1,apul_ptua,79.567,FUN_031463-T1,Q63E45,,,,,46.4,267.0,2.2e-63,244.2,sp|Q63E45|PHNW_BACCZ 2-aminoethylphosphonate--pyruvate transaminase OS=Bacillus cereus (strain ZK / E33L) OX=288681 GN=phnW PE=3 SV=1,,,,,,
OG_14997,FUN_031494-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5093.t1,apul_ptua,62.5,FUN_031494-T1,Q6IRP0,,,,,38.6,44.0,6.3e-06,53.5,sp|Q6IRP0|R126B_XENLA E3 ubiquitin-protein ligase RNF126-B OS=Xenopus laevis OX=8355 GN=rnf126-b PE=2 SV=1,,,,,,
OG_14998,FUN_031495-T1,,Pocillopora_meandrina_HIv1___RNAseq.11314_t,apul_ptua,60.98,FUN_031495-T1,Q8BMT9,HHAT_MOUSE,,Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Skinny hedgehog protein),Mus musculus (Mouse),32.1,489.0,1.8e-56,221.9,sp|Q8BMT9|HHAT_MOUSE Protein-cysteine N-palmitoyltransferase HHAT OS=Mus musculus OX=10090 GN=Hhat PE=1 SV=1,GO:0000139; GO:0005525; GO:0005783; GO:0005789; GO:0005794; GO:0007224; GO:0016409; GO:0018009,N-terminal peptidyl-L-cysteine N-palmitoylation [GO:0018009]; smoothened signaling pathway [GO:0007224],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],GTP binding [GO:0005525]; palmitoyltransferase activity [GO:0016409],GO:0003824; GO:0005783; GO:0005794; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; Golgi apparatus; transferase activity; organelle
OG_14999,FUN_031503-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5107.t1,apul_ptua,68.889,FUN_031503-T1,Q91175,,,,,28.5,326.0,5.3e-14,80.1,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_15000,FUN_031506-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5112.t1,apul_ptua,84.409,FUN_031506-T1,Q8IYT3,CC170_HUMAN,,Coiled-coil domain-containing protein 170,Homo sapiens (Human),37.8,548.0,6.6e-58,227.3,sp|Q8IYT3|CC170_HUMAN Coiled-coil domain-containing protein 170 OS=Homo sapiens OX=9606 GN=CCDC170 PE=1 SV=3,GO:0000226; GO:0005794; GO:0008017; GO:0030054; GO:0036064,microtubule cytoskeleton organization [GO:0000226],cell junction [GO:0030054]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794],microtubule binding [GO:0008017],GO:0005794; GO:0005815; GO:0007010; GO:0008092; GO:0043226,Golgi apparatus; microtubule organizing center; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_15001,FUN_031510-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5117.t1,apul_ptua,70.02600000000001,FUN_031510-T1,Q8CCP0,NEMF_MOUSE,,Ribosome quality control complex subunit NEMF (Nuclear export mediator factor),Mus musculus (Mouse),47.1,1137.0,3.6e-232,806.6,sp|Q8CCP0|NEMF_MOUSE Ribosome quality control complex subunit NEMF OS=Mus musculus OX=10090 GN=Nemf PE=1 SV=2,GO:0005634; GO:0005829; GO:0022626; GO:0043023; GO:0051168; GO:0065003; GO:0140708; GO:1904678; GO:1990112; GO:1990116,CAT tailing [GO:0140708]; nuclear export [GO:0051168]; protein-containing complex assembly [GO:0065003]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; nucleus [GO:0005634]; RQC complex [GO:1990112],alpha-aminoacyl-tRNA binding [GO:1904678]; ribosomal large subunit binding [GO:0043023],GO:0003723; GO:0005634; GO:0005829; GO:0005840; GO:0006913; GO:0030163; GO:0043226; GO:0065003,RNA binding; nucleus; cytosol; ribosome; nucleocytoplasmic transport; protein catabolic process; organelle; protein-containing complex assembly
OG_15002,FUN_031522-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5127.t1,apul_ptua,78.769,FUN_031522-T1,Q9CXR1,,,,,47.3,319.0,1.1e-69,265.0,sp|Q9CXR1|DHRS7_MOUSE Dehydrogenase/reductase SDR family member 7 OS=Mus musculus OX=10090 GN=Dhrs7 PE=1 SV=2,,,,,,
OG_15003,FUN_031531-T2,,Pocillopora_meandrina_HIv1___TS.g23859.t2,apul_ptua,57.487,,,,,,,,,,,,,,,,,
OG_15004,FUN_031536-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5373.t1,apul_ptua,79.327,,,,,,,,,,,,,,,,,
OG_15005,FUN_031554-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6537.t1,apul_ptua,30.216,,,,,,,,,,,,,,,,,
OG_15006,FUN_031569-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5064.t2,apul_ptua,78.624,FUN_031569-T1,Q76L87,,,,,37.3,314.0,4e-33,144.1,sp|Q76L87|DMTA2_ORYLA Doublesex- and mab-3-related transcription factor A2 OS=Oryzias latipes OX=8090 GN=dmrta2 PE=3 SV=1,,,,,,
OG_15007,FUN_031630-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5958.t1,apul_ptua,39.1405,,,,,,,,,,,,,,,,,
OG_15008,FUN_031668-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5725.t1,apul_ptua,66.026,FUN_031668-T1,P11118,,,,,74.4,39.0,2.5e-09,63.5,sp|P11118|CALM_EUGGR Calmodulin OS=Euglena gracilis OX=3039 PE=1 SV=2,,,,,,
OG_15009,FUN_031702-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5761.t1,apul_ptua,54.807500000000005,FUN_031702-T1,Q7Z442,PK1L2_HUMAN,,Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2),Homo sapiens (Human),22.5,1812.0,2.9999999999999997e-106,389.4,sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5,GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982,detection of mechanical stimulus [GO:0050982],membrane [GO:0016020],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246],GO:0005215,transporter activity
OG_15010,FUN_031710-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5754.t1,apul_ptua,70.3785,FUN_031710-T1,Q0V989,,,,,33.4,374.0,6.8e-23,109.8,sp|Q0V989|CC85C_XENTR Coiled-coil domain-containing protein 85C OS=Xenopus tropicalis OX=8364 GN=ccdc85c PE=2 SV=1,,,,,,
OG_15011,FUN_031717-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5469.t1,apul_ptua,91.221,FUN_031717-T1,F7B113,,,,,47.3,547.0,2.1e-127,457.6,sp|F7B113|SL9A9_HORSE Sodium/hydrogen exchanger 9 OS=Equus caballus OX=9796 GN=SLC9A9 PE=1 SV=2,,,,,,
OG_15012,FUN_031746-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5528.t1,apul_ptua,55.112,,,,,,,,,,,,,,,,,
OG_15013,FUN_031747-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5529.t1,apul_ptua,64.841,FUN_031747-T1,Q9VCZ3,OCTB1_DROME,,Octopamine receptor beta-1R (DmOA2) (DmOct-beta-1R),Drosophila melanogaster (Fruit fly),28.3,311.0,7.8e-23,109.8,sp|Q9VCZ3|OCTB1_DROME Octopamine receptor beta-1R OS=Drosophila melanogaster OX=7227 GN=Octbeta1R PE=2 SV=1,GO:0004935; GO:0004989; GO:0005886; GO:0007188; GO:0007189; GO:0016020; GO:0043410; GO:0045886; GO:0071880,adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; positive regulation of MAPK cascade [GO:0043410],membrane [GO:0016020]; plasma membrane [GO:0005886],adrenergic receptor activity [GO:0004935]; octopamine receptor activity [GO:0004989],GO:0005886; GO:0060089,plasma membrane; molecular transducer activity
OG_15014,FUN_031749-T1,,Pocillopora_meandrina_HIv1___TS.g24250.t1,apul_ptua,64.062,,,,,,,,,,,,,,,,,
OG_15015,FUN_031751-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5534.t1,apul_ptua,81.122,FUN_031751-T1,Q32PD0,,,,,72.1,197.0,1.5e-77,290.4,sp|Q32PD0|FCF1_BOVIN rRNA-processing protein FCF1 homolog OS=Bos taurus OX=9913 GN=FCF1 PE=2 SV=1,,,,,,
OG_15016,FUN_031764-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5547.t1,apul_ptua,36.0,,,,,,,,,,,,,,,,,
OG_15017,FUN_031765-T1,,Pocillopora_meandrina_HIv1___TS.g24279.t1,apul_ptua,32.573,,,,,,,,,,,,,,,,,
OG_15018,FUN_031771-T1,,Pocillopora_meandrina_HIv1___TS.g24280.t1,apul_ptua,37.771,,,,,,,,,,,,,,,,,
OG_15019,FUN_031841-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5599.t1,apul_ptua,77.086,FUN_031841-T1,Q9VT65,CANB_DROME,,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],Drosophila melanogaster (Fruit fly),43.0,703.0,3.4e-159,563.5,sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2,GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; membrane [GO:0016020],calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198],GO:0003824; GO:0016787; GO:0048870; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_15020,FUN_031843-T1,,Pocillopora_meandrina_HIv1___TS.g24321.t1,apul_ptua,77.48150000000001,FUN_031843-T1,Q2XVR4,SC4AB_TETNG,,Sodium channel protein type 4 subunit alpha B (Voltage-gated sodium channel subunit alpha Nav1.4b),Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis),36.5,631.0,1.5e-87,325.5,sp|Q2XVR4|SC4AB_TETNG Sodium channel protein type 4 subunit alpha B OS=Tetraodon nigroviridis OX=99883 GN=scn4ab PE=3 SV=1,GO:0001518; GO:0005248; GO:0019228; GO:0086010,membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228],voltage-gated sodium channel complex [GO:0001518],voltage-gated sodium channel activity [GO:0005248],GO:0005215,transporter activity
OG_15021,FUN_031845-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5601.t1,apul_ptua,73.1625,FUN_031845-T1,Q9W0Y8,SCN60_DROME,,Sodium channel protein 60E (Drosophila ion channel 60) (Drosophila sodium channel 1) (Protein smell-impaired 60E) (Sodium channel 2) (DmNav2),Drosophila melanogaster (Fruit fly),48.5,359.0,2.7e-78,294.3,sp|Q9W0Y8|SCN60_DROME Sodium channel protein 60E OS=Drosophila melanogaster OX=7227 GN=NaCP60E PE=2 SV=6,GO:0001518; GO:0005248; GO:0005886; GO:0006814; GO:0007608; GO:0019228; GO:0022843; GO:0035725; GO:0042048; GO:0086010,membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; olfactory behavior [GO:0042048]; sensory perception of smell [GO:0007608]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814],plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518],voltage-gated monoatomic cation channel activity [GO:0022843]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886; GO:0050877; GO:0055085,transporter activity; plasma membrane; nervous system process; transmembrane transport
OG_15022,FUN_031850-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5611.t1,apul_ptua,70.0435,FUN_031850-T1,Q6NXA9,UBXN1_DANRE,,UBX domain-containing protein 1 (SAPK substrate protein 1),Danio rerio (Zebrafish) (Brachydanio rerio),48.7,337.0,8.799999999999999e-25,115.9,sp|Q6NXA9|UBXN1_DANRE UBX domain-containing protein 1 OS=Danio rerio OX=7955 GN=ubxn1 PE=2 SV=1,GO:0005634; GO:0005737; GO:0031397; GO:0032435; GO:0036435; GO:0071796; GO:1903094,negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein K48-linked deubiquitination [GO:1903094]; negative regulation of protein ubiquitination [GO:0031397],cytoplasm [GO:0005737]; nucleus [GO:0005634],K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796],GO:0005634; GO:0043226,nucleus; organelle
OG_15023,FUN_031853-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5615.t1,apul_ptua,53.205,FUN_031853-T1,Q13405,RM49_HUMAN,,"Large ribosomal subunit protein mL49 (39S ribosomal protein L49, mitochondrial) (L49mt) (MRP-L49) (Neighbor of FAU) (NOF) (Protein NOF1)",Homo sapiens (Human),43.0,100.0,1.3e-15,84.3,sp|Q13405|RM49_HUMAN Large ribosomal subunit protein mL49 OS=Homo sapiens OX=9606 GN=MRPL49 PE=1 SV=1,GO:0003735; GO:0005739; GO:0005743; GO:0005761; GO:0005762; GO:0032543,mitochondrial translation [GO:0032543],mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739],structural constituent of ribosome [GO:0003735],GO:0005198; GO:0005739; GO:0005840; GO:0043226,structural molecule activity; mitochondrion; ribosome; organelle
OG_15024,FUN_031890-T1,,Pocillopora_meandrina_HIv1___TS.g24763.t1c,apul_ptua,32.363,FUN_031890-T1,A7MBJ4,PTPRF_BOVIN,,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),Bos taurus (Bovine),28.2,439.0,3.3e-39,165.2,sp|A7MBJ4|PTPRF_BOVIN Receptor-type tyrosine-protein phosphatase F OS=Bos taurus OX=9913 GN=PTPRF PE=2 SV=1,GO:0004725; GO:0007165; GO:0008201; GO:0016020; GO:0016477; GO:0035335; GO:0099560; GO:1900121,cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560],membrane [GO:0016020],heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0007155; GO:0016787; GO:0048870; GO:0140096,"catalytic activity; cell adhesion; hydrolase activity; cell motility; catalytic activity, acting on a protein"
OG_15025,FUN_031893-T1,,Pocillopora_meandrina_HIv1___TS.g24772.t1,apul_ptua,66.6665,FUN_031893-T1,Q94901,,,,,40.4,99.0,3.2e-18,93.6,sp|Q94901|LARK_DROME RNA-binding protein lark OS=Drosophila melanogaster OX=7227 GN=lark PE=1 SV=1,,,,,,
OG_15026,FUN_031906-T1,,Pocillopora_meandrina_HIv1___TS.g10092.t1,apul_ptua,32.995,,,,,,,,,,,,,,,,,
OG_15027,FUN_031914-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29853.t1,apul_ptua,58.871,,,,,,,,,,,,,,,,,
OG_15028,FUN_031915-T2,,Pocillopora_meandrina_HIv1___RNAseq.g3315.t1,apul_ptua,56.481,FUN_031915-T2,O00222,GRM8_HUMAN,,Metabotropic glutamate receptor 8 (mGluR8),Homo sapiens (Human),34.6,792.0,1.8e-130,468.4,sp|O00222|GRM8_HUMAN Metabotropic glutamate receptor 8 OS=Homo sapiens OX=9606 GN=GRM8 PE=1 SV=2,GO:0001642; GO:0004930; GO:0005886; GO:0007193; GO:0007196; GO:0007216; GO:0007601; GO:0008066; GO:0051966,"adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; regulation of synaptic transmission, glutamatergic [GO:0051966]; visual perception [GO:0007601]",plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_15029,FUN_031919-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30190.t1,apul_ptua,64.032,FUN_031919-T1,A9C3R9,RP65B_DANRE,,All-trans-retinyl ester 13-cis isomerohydrolase (13cIMH) (EC 3.1.1.90) (Lutein isomerase) (Meso-zeaxanthin isomerase) (EC 5.3.3.22) (Retinal pigment epithelium-specific 65 kDa protein homolog B) (RPE56b),Danio rerio (Zebrafish) (Brachydanio rerio),39.4,525.0,6.3e-99,362.8,sp|A9C3R9|RP65B_DANRE All-trans-retinyl ester 13-cis isomerohydrolase OS=Danio rerio OX=7955 GN=rpe65b PE=1 SV=1,GO:0001523; GO:0003834; GO:0005789; GO:0005886; GO:0042574; GO:0046872; GO:0050251; GO:0052885; GO:1901827,retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; zeaxanthin biosynthetic process [GO:1901827],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],"all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0052885]; beta-carotene 15,15'-dioxygenase activity [GO:0003834]; metal ion binding [GO:0046872]; retinol isomerase activity [GO:0050251]",GO:0003824; GO:0005886; GO:0006629; GO:0016491; GO:0016787; GO:0016853,catalytic activity; plasma membrane; lipid metabolic process; oxidoreductase activity; hydrolase activity; isomerase activity
OG_15030,FUN_031928-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18234.t1,apul_ptua,55.446,,,,,,,,,,,,,,,,,
OG_15031,FUN_031941-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18207.t1,apul_ptua,32.353,,,,,,,,,,,,,,,,,
OG_15032,FUN_032001-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30260.t1,apul_ptua,55.682,,,,,,,,,,,,,,,,,
OG_15033,FUN_032010-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24552.t1,apul_ptua,66.26,FUN_032010-T1,P12394,,,,,41.3,462.0,2.9e-99,364.0,"sp|P12394|CP17A_CHICK Steroid 17-alpha-hydroxylase/17,20 lyase OS=Gallus gallus OX=9031 GN=CYP17A1 PE=2 SV=1",,,,,,
OG_15034,FUN_032071-T1,,Pocillopora_meandrina_HIv1___TS.g24728.t1,apul_ptua,62.832,FUN_032071-T1,A7YWH9,,,,,36.5,233.0,8.8e-35,149.1,sp|A7YWH9|RHDF1_BOVIN Inactive rhomboid protein 1 OS=Bos taurus OX=9913 GN=RHBDF1 PE=2 SV=1,,,,,,
OG_15035,FUN_032083-T1,,Pocillopora_meandrina_HIv1___TS.g24014.t1,apul_ptua,64.16550000000001,,,,,,,,,,,,,,,,,
OG_15036,FUN_032085-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5300.t1,apul_ptua,62.731,,,,,,,,,,,,,,,,,
OG_15037,FUN_032107-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5394.t1,apul_ptua,43.478,,,,,,,,,,,,,,,,,
OG_15038,FUN_032142-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5347.t1,apul_ptua,54.894,,,,,,,,,,,,,,,,,
OG_15039,FUN_032199-T2,,Pocillopora_meandrina_HIv1___RNAseq.g24411.t1,apul_ptua,30.771500000000003,FUN_032199-T2,Q8BKG4,FZD10_MOUSE,,Frizzled-10 (Fz-10) (CD antigen CD350),Mus musculus (Mouse),43.2,132.0,4.8e-27,124.4,sp|Q8BKG4|FZD10_MOUSE Frizzled-10 OS=Mus musculus OX=10090 GN=Fzd10 PE=1 SV=1,GO:0004930; GO:0005654; GO:0005737; GO:0005886; GO:0009986; GO:0016055; GO:0017147; GO:0032956; GO:0035567; GO:0042813; GO:0046330; GO:0060070,canonical Wnt signaling pathway [GO:0060070]; non-canonical Wnt signaling pathway [GO:0035567]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; Wnt receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147],GO:0005654; GO:0005886; GO:0060089,nucleoplasm; plasma membrane; molecular transducer activity
OG_15040,FUN_032206-T2,,Pocillopora_meandrina_HIv1___RNAseq.g24272.t1,apul_ptua,71.572,,,,,,,,,,,,,,,,,
OG_15041,FUN_032250-T1,,Pocillopora_meandrina_HIv1___TS.g4477.t1,apul_ptua,36.691,,,,,,,,,,,,,,,,,
OG_15042,FUN_032268-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7460.t1,apul_ptua,32.234,FUN_032268-T1,Q99NB2,,,,,27.9,219.0,8.2e-18,92.8,"sp|Q99NB2|B3GN5_RAT Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase OS=Rattus norvegicus OX=10116 GN=B3gnt5 PE=2 SV=2",,,,,,
OG_15043,FUN_032280-T1,,Pocillopora_meandrina_HIv1___RNAseq.30503_t,apul_ptua,55.063,,,,,,,,,,,,,,,,,
OG_15044,FUN_032283-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24295.t1,apul_ptua,56.124,,,,,,,,,,,,,,,,,
OG_15045,FUN_032295-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24289.t1,apul_ptua,68.89349999999999,,,,,,,,,,,,,,,,,
OG_15046,FUN_032298-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24899.t1,apul_ptua,62.0075,,,,,,,,,,,,,,,,,
OG_15047,FUN_032316-T1,,Pocillopora_meandrina_HIv1___TS.g12732.t1,apul_ptua,58.712,,,,,,,,,,,,,,,,,
OG_15048,FUN_032337-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24822.t1,apul_ptua,58.498,FUN_032337-T1,Q9BZ19,,,,,29.8,151.0,1.8e-11,71.6,sp|Q9BZ19|ANR60_HUMAN Ankyrin repeat domain-containing protein 60 OS=Homo sapiens OX=9606 GN=ANKRD60 PE=1 SV=3,,,,,,
OG_15049,FUN_032359-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27874.t1,apul_ptua,51.7865,,,,,,,,,,,,,,,,,
OG_15050,FUN_032370-T1,,Pocillopora_meandrina_HIv1___TS.g12201.t1,apul_ptua,47.8365,FUN_032370-T1,Q04786,,,,,32.0,798.0,7.100000000000001e-106,386.7,sp|Q04786|HEX_VIBVL Beta-hexosaminidase OS=Vibrio vulnificus OX=672 GN=hex PE=3 SV=1,,,,,,
OG_15051,FUN_032376-T1,,Pocillopora_meandrina_HIv1___TS.g12304.t1,apul_ptua,43.243,,,,,,,,,,,,,,,,,
OG_15052,FUN_032390-T1,,Pocillopora_meandrina_HIv1___TS.g24988.t1a,apul_ptua,78.378,,,,,,,,,,,,,,,,,
OG_15053,FUN_032393-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29825.t1,apul_ptua,64.168,FUN_032393-T1,B8JI71,EYS_DANRE,,Protein eyes shut homolog,Danio rerio (Zebrafish) (Brachydanio rerio),31.7,826.0,1.1e-79,300.4,sp|B8JI71|EYS_DANRE Protein eyes shut homolog OS=Danio rerio OX=7955 GN=eys PE=1 SV=2,GO:0005509; GO:0005576; GO:0005737; GO:0005856; GO:0005886; GO:0005929; GO:0007601; GO:0033165; GO:0048731,system development [GO:0048731]; visual perception [GO:0007601],cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; interphotoreceptor matrix [GO:0033165]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005576; GO:0005856; GO:0005886; GO:0005929; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0050877,extracellular region; cytoskeleton; plasma membrane; cilium; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; nervous system process
OG_15054,FUN_032393-T3,,Pocillopora_meandrina_HIv1___TS.g25079.t1,apul_ptua,54.775,,,,,,,,,,,,,,,,,
OG_15055,FUN_032412-T3,,Pocillopora_meandrina_HIv1___RNAseq.g2160.t1,apul_ptua,40.716,FUN_032412-T3,P34579,,,,,26.5,442.0,1e-33,146.0,sp|P34579|UNC47_CAEEL Vesicular GABA transporter OS=Caenorhabditis elegans OX=6239 GN=unc-47 PE=1 SV=2,,,,,,
OG_15056,FUN_032480-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24341.t1,apul_ptua,55.5035,FUN_032480-T1,Q54E24,,,,,30.3,178.0,2e-20,100.9,sp|Q54E24|RS8_DICDI Small ribosomal subunit protein eS8 OS=Dictyostelium discoideum OX=44689 GN=rps8 PE=1 SV=1,,,,,,
OG_15057,FUN_032488-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24338.t2,apul_ptua,70.479,FUN_032488-T1,O75069,TMCC2_HUMAN,,Transmembrane and coiled-coil domains protein 2 (Cerebral protein 11),Homo sapiens (Human),31.6,307.0,4.6000000000000015e-22,107.1,sp|O75069|TMCC2_HUMAN Transmembrane and coiled-coil domains protein 2 OS=Homo sapiens OX=9606 GN=TMCC2 PE=1 SV=3,GO:0005783; GO:0005789; GO:0012505; GO:0042982,amyloid precursor protein metabolic process [GO:0042982],endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],,GO:0005783; GO:0043226,endoplasmic reticulum; organelle
OG_15058,FUN_032493-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29909.t1,apul_ptua,42.742,,,,,,,,,,,,,,,,,
OG_15059,FUN_032514-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24128.t1,apul_ptua,36.364,,,,,,,,,,,,,,,,,
OG_15060,FUN_032524-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24736.t1a,apul_ptua,46.365,,,,,,,,,,,,,,,,,
OG_15061,FUN_032531-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24732.t1,apul_ptua,37.683,,,,,,,,,,,,,,,,,
OG_15062,FUN_032532-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24731.t1,apul_ptua,41.0625,,,,,,,,,,,,,,,,,
OG_15063,FUN_032570-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24715.t1,apul_ptua,58.936,FUN_032570-T1,Q5M7N9,,,,,28.8,778.0,7.000000000000001e-73,276.9,sp|Q5M7N9|ESYT3_XENTR Extended synaptotagmin-3 OS=Xenopus tropicalis OX=8364 GN=esyt3 PE=2 SV=1,,,,,,
OG_15064,FUN_032594-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14464.t1,apul_ptua,61.0105,FUN_032594-T1,P0C6B8,,,,,62.5,40.0,7.8e-06,53.5,"sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1",,,,,,
OG_15065,FUN_032610-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29787.t1,apul_ptua,87.903,FUN_032610-T1,Q13188,STK3_HUMAN,,Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)],Homo sapiens (Human),68.8,490.0,3.6000000000000004e-168,592.8,sp|Q13188|STK3_HUMAN Serine/threonine-protein kinase 3 OS=Homo sapiens OX=9606 GN=STK3 PE=1 SV=2,GO:0000287; GO:0001841; GO:0003157; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0006468; GO:0006606; GO:0006915; GO:0007254; GO:0007417; GO:0008625; GO:0032991; GO:0035265; GO:0035329; GO:0035332; GO:0035556; GO:0042802; GO:0043065; GO:0043408; GO:0043491; GO:0043539; GO:0045600; GO:0046330; GO:0046621; GO:0050673; GO:0050680; GO:0050821; GO:0051262; GO:0051897; GO:0060070; GO:0060215; GO:0060706; GO:0060800; GO:0071539; GO:0090090; GO:0097284; GO:0106310; GO:0140537; GO:1902043,apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; organ growth [GO:0035265]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of hippo signaling [GO:0035332]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein import into nucleus [GO:0006606]; protein localization to centrosome [GO:0071539]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; regulation of MAPK cascade [GO:0043408],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; transcription regulator activator activity [GO:0140537],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0006886; GO:0006913; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0065003; GO:0098772; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; intracellular protein transport; nucleocytoplasmic transport; programmed cell death; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity; catalytic activity, acting on a protein"
OG_15066,FUN_032634-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18323.t1,apul_ptua,86.111,,,,,,,,,,,,,,,,,
OG_15067,FUN_032648-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5051.t1,apul_ptua,53.4635,FUN_032648-T1,Q9Y6N7,ROBO1_HUMAN,,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),Homo sapiens (Human),29.8,188.0,1.8e-14,82.4,sp|Q9Y6N7|ROBO1_HUMAN Roundabout homolog 1 OS=Homo sapiens OX=9606 GN=ROBO1 PE=1 SV=1,GO:0002042; GO:0003129; GO:0003148; GO:0003180; GO:0003184; GO:0003272; GO:0005737; GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0007156; GO:0007399; GO:0008046; GO:0009986; GO:0010628; GO:0010629; GO:0016199; GO:0021836; GO:0030275; GO:0030336; GO:0030424; GO:0030949; GO:0033116; GO:0033600; GO:0035025; GO:0035385; GO:0035904; GO:0042802; GO:0043410; GO:0045747; GO:0050772; GO:0050925; GO:0060412; GO:0070100; GO:1900748,aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; axon midline choice point recognition [GO:0016199]; cell adhesion [GO:0007155]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; endocardial cushion formation [GO:0003272]; heart induction [GO:0003129]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; negative regulation of mammary gland epithelial cell proliferation [GO:0033600]; negative regulation of negative chemotaxis [GO:0050925]; nervous system development [GO:0007399]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of axonogenesis [GO:0050772]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; pulmonary valve morphogenesis [GO:0003184]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412],axon [GO:0030424]; cell surface [GO:0009986]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; plasma membrane [GO:0005886],axon guidance receptor activity [GO:0008046]; identical protein binding [GO:0042802]; LRR domain binding [GO:0030275],GO:0005829; GO:0005886; GO:0005929; GO:0007155; GO:0043226; GO:0048856; GO:0048870; GO:0060089,cytosol; plasma membrane; cilium; cell adhesion; organelle; anatomical structure development; cell motility; molecular transducer activity
OG_15068,FUN_032660-T2,,Pocillopora_meandrina_HIv1___RNAseq.g13624.t1,apul_ptua,48.333,,,,,,,,,,,,,,,,,
OG_15069,FUN_032667-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16537.t1,apul_ptua,45.109,,,,,,,,,,,,,,,,,
OG_15070,FUN_032682-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24098.t1,apul_ptua,72.449,,,,,,,,,,,,,,,,,
OG_15071,FUN_032689-T1,,Pocillopora_meandrina_HIv1___TS.g12046.t1,apul_ptua,55.385,,,,,,,,,,,,,,,,,
OG_15072,FUN_032701-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29942.t1,apul_ptua,92.157,FUN_032701-T1,Q5R616,SDHA_PONAB,,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) (Malate dehydrogenase [quinone] flavoprotein subunit) (EC 1.1.5.-)",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),72.3,664.0,1.1e-289,996.9,"sp|Q5R616|SDHA_PONAB Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial OS=Pongo abelii OX=9601 GN=SDHA PE=2 SV=1",GO:0005739; GO:0005743; GO:0006099; GO:0006105; GO:0006121; GO:0008177; GO:0009055; GO:0022904; GO:0045273; GO:0050660,"mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex II (succinate dehydrogenase) [GO:0045273],electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (quinone) activity [GO:0008177],GO:0003824; GO:0005739; GO:0006091; GO:0016491; GO:0043226,catalytic activity; mitochondrion; generation of precursor metabolites and energy; oxidoreductase activity; organelle
OG_15073,FUN_032705-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29946.t1,apul_ptua,57.322,,,,,,,,,,,,,,,,,
OG_15074,FUN_032733-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24361.t1,apul_ptua,44.928,,,,,,,,,,,,,,,,,
OG_15075,FUN_032757-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29863.t1,apul_ptua,55.665,FUN_032757-T1,P58467,SETD4_MOUSE,,SET domain-containing protein 4 (EC 2.1.1.-) (EC 2.1.1.364),Mus musculus (Mouse),36.1,377.0,2.1999999999999997e-47,191.4,sp|P58467|SETD4_MOUSE SET domain-containing protein 4 OS=Mus musculus OX=10090 GN=Setd4 PE=1 SV=2,GO:0005634; GO:0005829; GO:0006338; GO:0006954; GO:0032259; GO:0032755; GO:0032760; GO:0042799; GO:0042800; GO:0050729; GO:0071863; GO:0140941; GO:0140944; GO:0140945,chromatin remodeling [GO:0006338]; inflammatory response [GO:0006954]; methylation [GO:0032259]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell proliferation in bone marrow [GO:0071863],cytosol [GO:0005829]; nucleus [GO:0005634],histone H3K4 methyltransferase activity [GO:0042800]; histone H3K4 monomethyltransferase activity [GO:0140945]; histone H4K20 methyltransferase activity [GO:0042799]; histone H4K20 monomethyltransferase activity [GO:0140944]; histone H4K20me methyltransferase activity [GO:0140941],GO:0003824; GO:0005634; GO:0005829; GO:0006325; GO:0006954; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; cytosol; chromatin organization; inflammatory response; transferase activity; organelle; catalytic activity, acting on a protein"
OG_15076,FUN_032771-T1,,Pocillopora_meandrina_HIv1___TS.g11888.t1,apul_ptua,38.342,,,,,,,,,,,,,,,,,
OG_15077,FUN_032788-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29716.t1,apul_ptua,50.8395,FUN_032788-T1,Q68LP1,MIB2_RAT,,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (RBSC-skeletrophin/dystrophin-like polypeptide) (RING-type E3 ubiquitin transferase MIB2),Rattus norvegicus (Rat),38.8,500.0,5e-93,344.7,sp|Q68LP1|MIB2_RAT E3 ubiquitin-protein ligase MIB2 OS=Rattus norvegicus OX=10116 GN=Mib2 PE=1 SV=2,GO:0000151; GO:0003779; GO:0004842; GO:0005737; GO:0005769; GO:0005886; GO:0007219; GO:0008270; GO:0016567; GO:0061630; GO:0098794; GO:0098978; GO:0099149; GO:0140252,Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation protein catabolic process at postsynapse [GO:0140252],cytoplasm [GO:0005737]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151],actin binding [GO:0003779]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005768; GO:0005886; GO:0008092; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; endosome; plasma membrane; cytoskeletal protein binding; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_15078,FUN_032796-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29712.t1,apul_ptua,39.157,FUN_032796-T1,P0DQD5,,,,,23.8,302.0,4.7e-07,57.0,sp|P0DQD5|NPY42_HUMAN Neuropeptide Y receptor type 4-2 OS=Homo sapiens OX=9606 GN=NPY4R2 PE=3 SV=1,,,,,,
OG_15079,FUN_032834-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24968.t1,apul_ptua,73.942,FUN_032834-T1,E9Q3T6,PRD14_MOUSE,,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),Mus musculus (Mouse),44.3,296.0,2.7e-69,264.2,sp|E9Q3T6|PRD14_MOUSE PR domain zinc finger protein 14 OS=Mus musculus OX=10090 GN=Prdm14 PE=1 SV=1,GO:0000122; GO:0000902; GO:0000977; GO:0001227; GO:0001708; GO:0001827; GO:0003723; GO:0005634; GO:0005654; GO:0007281; GO:0007566; GO:0008168; GO:0008270; GO:0008543; GO:0009566; GO:0010468; GO:0019827; GO:0030718; GO:0031490; GO:0032259; GO:0040029; GO:0040037; GO:0045814; GO:0048873; GO:0060818; GO:0141107; GO:1902093; GO:1902459; GO:1990226,"cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; embryo implantation [GO:0007566]; epigenetic regulation of gene expression [GO:0040029]; fertilization [GO:0009566]; fibroblast growth factor receptor signaling pathway [GO:0008543]; germ cell development [GO:0007281]; germ-line stem cell population maintenance [GO:0030718]; homeostasis of number of cells within a tissue [GO:0048873]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; inner cell mass cell fate commitment [GO:0001827]; methylation [GO:0032259]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of stem cell population maintenance [GO:1902459]; regulation of gene expression [GO:0010468]; stem cell population maintenance [GO:0019827]",nucleoplasm [GO:0005654]; nucleus [GO:0005634],"chromatin DNA binding [GO:0031490]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; histone methyltransferase binding [GO:1990226]; methyltransferase activity [GO:0008168]; methyltransferase regulator activity [GO:0141107]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0098772; GO:0140110,DNA binding; RNA binding; catalytic activity; nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; transferase activity; reproductive process; organelle; anatomical structure development; molecular function regulator activity; transcription regulator activity
OG_15080,FUN_032852-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24967.t1,apul_ptua,39.323,FUN_032852-T1,O00212,RHOD_HUMAN,,Rho-related GTP-binding protein RhoD (Rho-related protein HP1) (RhoHP1),Homo sapiens (Human),35.3,133.0,5.3e-11,70.5,sp|O00212|RHOD_HUMAN Rho-related GTP-binding protein RhoD OS=Homo sapiens OX=9606 GN=RHOD PE=1 SV=3,GO:0000139; GO:0003924; GO:0005085; GO:0005525; GO:0005741; GO:0005769; GO:0005829; GO:0005886; GO:0006605; GO:0007266; GO:0008543; GO:0010008; GO:0019901; GO:0030032; GO:0030041; GO:0030335; GO:0032956; GO:0042995; GO:0045785; GO:0048041; GO:0051017; GO:0051056; GO:0051893,actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; fibroblast growth factor receptor signaling pathway [GO:0008543]; focal adhesion assembly [GO:0048041]; lamellipodium assembly [GO:0030032]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; protein targeting [GO:0006605]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of focal adhesion assembly [GO:0051893]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],cell projection [GO:0042995]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005768; GO:0005829; GO:0005886; GO:0016787; GO:0031410; GO:0034330; GO:0043226; GO:0065003; GO:0098772,catalytic activity; GTPase activity; endosome; cytosol; plasma membrane; hydrolase activity; cytoplasmic vesicle; cell junction organization; organelle; protein-containing complex assembly; molecular function regulator activity
OG_15081,FUN_032875-T1,,Pocillopora_meandrina_HIv1___TS.g24949.t1,apul_ptua,49.59,,,,,,,,,,,,,,,,,
OG_15082,FUN_032879-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24425.t1,apul_ptua,54.717,,,,,,,,,,,,,,,,,
OG_15083,FUN_032963-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24901.t1,apul_ptua,76.527,FUN_032963-T1,Q01888,,,,,47.8,291.0,1.4e-72,274.6,sp|Q01888|GDC_BOVIN Solute carrier family 25 member 16 OS=Bos taurus OX=9913 GN=SLC25A16 PE=2 SV=1,,,,,,
OG_15084,FUN_033000-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28920.t1,apul_ptua,40.495000000000005,,,,,,,,,,,,,,,,,
OG_15085,FUN_033008-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24470.t1,apul_ptua,36.901,,,,,,,,,,,,,,,,,
OG_15086,FUN_033015-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24466.t1,apul_ptua,69.7115,,,,,,,,,,,,,,,,,
OG_15087,FUN_033017-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24463.t1,apul_ptua,55.78,,,,,,,,,,,,,,,,,
OG_15088,FUN_033018-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12955.t1,apul_ptua,35.22,,,,,,,,,,,,,,,,,
OG_15089,FUN_033043-T2,,Pocillopora_meandrina_HIv1___RNAseq.g13168.t1,apul_ptua,48.478,FUN_033043-T2,P46023,,,,,45.3,338.0,4.3e-76,289.7,sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_15090,FUN_033051-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24262.t1,apul_ptua,55.334,FUN_033051-T1,Q92576,,,,,31.7,741.0,1.5e-84,317.0,sp|Q92576|PHF3_HUMAN PHD finger protein 3 OS=Homo sapiens OX=9606 GN=PHF3 PE=1 SV=3,,,,,,
OG_15091,FUN_033070-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28262.t1,apul_ptua,70.0,,,,,,,,,,,,,,,,,
OG_15092,FUN_033118-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2824.t1b,apul_ptua,57.955,,,,,,,,,,,,,,,,,
OG_15093,FUN_033300-T1,,Pocillopora_meandrina_HIv1___RNAseq.g155.t1,apul_ptua,52.381,,,,,,,,,,,,,,,,,
OG_15094,FUN_033308-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29778.t1,apul_ptua,53.571,,,,,,,,,,,,,,,,,
OG_15095,FUN_033309-T2,,Pocillopora_meandrina_HIv1___TS.g25030.t1,apul_ptua,68.373,FUN_033309-T2,Q8NB78,,,,,47.4,707.0,2.6e-191,670.2,sp|Q8NB78|KDM1B_HUMAN Lysine-specific histone demethylase 2 OS=Homo sapiens OX=9606 GN=KDM1B PE=1 SV=3,,,,,,
OG_15096,FUN_033555-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28612.t1,apul_ptua,66.6825,,,,,,,,,,,,,,,,,
OG_15097,FUN_033606-T1,,Pocillopora_meandrina_HIv1___TS.g7458.t1,apul_ptua,90.441,,,,,,,,,,,,,,,,,
OG_15098,FUN_033624-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16140.t1,apul_ptua,51.099,,,,,,,,,,,,,,,,,
OG_15099,FUN_033682-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5931.t1,apul_ptua,58.442,,,,,,,,,,,,,,,,,
OG_15100,FUN_033699-T1,,Pocillopora_meandrina_HIv1___TS.g8558.t2a,apul_ptua,58.621,FUN_033699-T1,Q9CQU8,,,,,40.3,144.0,3.3e-30,132.9,sp|Q9CQU8|IMP1L_MOUSE Mitochondrial inner membrane protease subunit 1 OS=Mus musculus OX=10090 GN=Immp1l PE=1 SV=1,,,,,,
OG_15101,FUN_033708-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25898.t1,apul_ptua,78.191,FUN_033708-T1,Q4PM04,,,,,69.3,189.0,2.7999999999999997e-68,259.6,sp|Q4PM04|RL18_IXOSC Large ribosomal subunit protein eL18 OS=Ixodes scapularis OX=6945 GN=RpL18 PE=2 SV=1,,,,,,
OG_15102,FUN_033768-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25937.t1,apul_ptua,43.206,,,,,,,,,,,,,,,,,
OG_15103,FUN_033844-T1,,Pocillopora_meandrina_HIv1___TS.g18889.t1,apul_ptua,75.057,FUN_033844-T1,Q5FYB0,ARSJ_HUMAN,,Arylsulfatase J (ASJ) (EC 3.1.6.-),Homo sapiens (Human),43.2,521.0,4.1e-117,423.3,sp|Q5FYB0|ARSJ_HUMAN Arylsulfatase J OS=Homo sapiens OX=9606 GN=ARSJ PE=1 SV=1,GO:0004065; GO:0005576; GO:0005788; GO:0015629; GO:0046872,,actin cytoskeleton [GO:0015629]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872],GO:0003824; GO:0005576; GO:0005856; GO:0016787; GO:0043226,catalytic activity; extracellular region; cytoskeleton; hydrolase activity; organelle
OG_15104,FUN_033868-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28412.t1,apul_ptua,76.64500000000001,FUN_033868-T1,Q5ZL34,CPSF6_CHICK,,Cleavage and polyadenylation specificity factor subunit 6,Gallus gallus (Chicken),42.4,198.0,4.3e-31,137.5,sp|Q5ZL34|CPSF6_CHICK Cleavage and polyadenylation specificity factor subunit 6 OS=Gallus gallus OX=9031 GN=CPSF6 PE=2 SV=1,GO:0003729; GO:0005634; GO:0005654; GO:0005726; GO:0005737; GO:0005847; GO:0005849; GO:0016607; GO:0035061; GO:0042382; GO:0046833; GO:0051290; GO:0110104; GO:0180010,"co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway [GO:0180010]; mRNA alternative polyadenylation [GO:0110104]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290]",cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726],mRNA binding [GO:0003729],GO:0003723; GO:0005634; GO:0005654; GO:0016071; GO:0043226; GO:0065003,RNA binding; nucleus; nucleoplasm; mRNA metabolic process; organelle; protein-containing complex assembly
OG_15105,FUN_033881-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28396.t1,apul_ptua,74.617,,,,,,,,,,,,,,,,,
OG_15106,FUN_033889-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28383.t1,apul_ptua,37.232,,,,,,,,,,,,,,,,,
OG_15107,FUN_033912-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28374.t2,apul_ptua,83.758,FUN_033912-T1,Q4R899,,,,,51.4,111.0,2.3000000000000003e-28,129.0,sp|Q4R899|LMTD1_MACFA Lamin tail domain-containing protein 1 OS=Macaca fascicularis OX=9541 GN=LMNTD1 PE=2 SV=1,,,,,,
OG_15108,FUN_033952-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28361.t1,apul_ptua,55.589,,,,,,,,,,,,,,,,,
OG_15109,FUN_034072-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7940.t1,apul_ptua,39.381,,,,,,,,,,,,,,,,,
OG_15110,FUN_034089-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26060.t1,apul_ptua,72.088,,,,,,,,,,,,,,,,,
OG_15111,FUN_034116-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25953.t1,apul_ptua,62.6805,FUN_034116-T1,Q2KI18,PLPL2_BOVIN,,Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Calcium-independent phospholipase A2-zeta) (iPLA2-zeta) (EC 3.1.1.4),Bos taurus (Bovine),47.6,267.0,3.7e-62,240.4,sp|Q2KI18|PLPL2_BOVIN Patatin-like phospholipase domain-containing protein 2 OS=Bos taurus OX=9913 GN=PNPLA2 PE=2 SV=1,GO:0004623; GO:0004806; GO:0005737; GO:0005811; GO:0005886; GO:0006651; GO:0010891; GO:0010898; GO:0016020; GO:0019433; GO:0035356; GO:0050253; GO:0051264; GO:0051265; GO:0055088; GO:0160077,diacylglycerol biosynthetic process [GO:0006651]; intracellular triglyceride homeostasis [GO:0035356]; lipid droplet fusion [GO:0160077]; lipid homeostasis [GO:0055088]; negative regulation of triglyceride storage [GO:0010891]; positive regulation of triglyceride catabolic process [GO:0010898]; triglyceride catabolic process [GO:0019433],cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886],diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005811; GO:0005886; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; lipid droplet; plasma membrane; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_15112,FUN_034118-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25949.t1,apul_ptua,74.242,,,,,,,,,,,,,,,,,
OG_15113,FUN_034141-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26307.t1,apul_ptua,36.9,,,,,,,,,,,,,,,,,
OG_15114,FUN_034165-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26283.t1,apul_ptua,78.58449999999999,,,,,,,,,,,,,,,,,
OG_15115,FUN_034169-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26281.t1,apul_ptua,65.432,FUN_034169-T1,P21291,CSRP1_HUMAN,,Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1) (Epididymis luminal protein 141) (HEL-141),Homo sapiens (Human),53.0,83.0,1.1e-17,90.5,sp|P21291|CSRP1_HUMAN Cysteine and glycine-rich protein 1 OS=Homo sapiens OX=9606 GN=CSRP1 PE=1 SV=3,GO:0003723; GO:0005634; GO:0005737; GO:0005925; GO:0008270; GO:0008307; GO:0030018; GO:0042805; GO:0045214; GO:0060537; GO:0070062; GO:0070527,muscle tissue development [GO:0060537]; platelet aggregation [GO:0070527]; sarcomere organization [GO:0045214],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; Z disc [GO:0030018],actinin binding [GO:0042805]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; zinc ion binding [GO:0008270],GO:0003723; GO:0005198; GO:0005634; GO:0007010; GO:0007155; GO:0008092; GO:0043226; GO:0048856,RNA binding; structural molecule activity; nucleus; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; organelle; anatomical structure development
OG_15116,FUN_034171-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26280.t1,apul_ptua,70.909,,,,,,,,,,,,,,,,,
OG_15117,FUN_034182-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26295.t1,apul_ptua,77.852,FUN_034182-T1,Q0IH43,,,,,48.8,303.0,2.4000000000000003e-74,280.4,sp|Q0IH43|OTU1_XENLA Ubiquitin thioesterase OTU1 OS=Xenopus laevis OX=8355 GN=yod1 PE=2 SV=1,,,,,,
OG_15118,FUN_034188-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26301.t1,apul_ptua,47.2125,,,,,,,,,,,,,,,,,
OG_15119,FUN_034191-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12680.t1,apul_ptua,33.544,,,,,,,,,,,,,,,,,
OG_15120,FUN_034193-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26302.t1,apul_ptua,35.678,,,,,,,,,,,,,,,,,
OG_15121,FUN_034203-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26177.t1,apul_ptua,71.162,,,,,,,,,,,,,,,,,
OG_15122,FUN_034208-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26170.t1,apul_ptua,49.231,,,,,,,,,,,,,,,,,
OG_15123,FUN_034212-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26164.t2,apul_ptua,39.4735,FUN_034212-T1,P07584,,,,,35.9,184.0,3.8e-23,110.9,sp|P07584|ASTA_ASTAS Astacin OS=Astacus astacus OX=6715 PE=1 SV=2,,,,,,
OG_15124,FUN_034219-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26160.t1b,apul_ptua,39.398,,,,,,,,,,,,,,,,,
OG_15125,FUN_034235-T1,,Pocillopora_meandrina_HIv1___TS.g8235.t1,apul_ptua,32.83,,,,,,,,,,,,,,,,,
OG_15126,FUN_034243-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26608.t1,apul_ptua,31.169,,,,,,,,,,,,,,,,,
OG_15127,FUN_034264-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26633.t1,apul_ptua,32.673,,,,,,,,,,,,,,,,,
OG_15128,FUN_034268-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26634.t1,apul_ptua,63.121,,,,,,,,,,,,,,,,,
OG_15129,FUN_034299-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28502.t1,apul_ptua,68.933,FUN_034299-T1,Q6GPP1,,,,,36.1,801.0,5.4e-135,483.4,sp|Q6GPP1|TELO2_XENLA Telomere length regulation protein TEL2 homolog OS=Xenopus laevis OX=8355 GN=telo2 PE=2 SV=2,,,,,,
OG_15130,FUN_034302-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28499.t1,apul_ptua,70.43,FUN_034302-T1,Q99JX1,,,,,71.2,111.0,2.3e-35,150.2,sp|Q99JX1|TAF11_MOUSE Transcription initiation factor TFIID subunit 11 OS=Mus musculus OX=10090 GN=Taf11 PE=1 SV=1,,,,,,
OG_15131,FUN_034311-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28494.t1,apul_ptua,70.513,FUN_034311-T1,A2A6H3,,,,,30.0,140.0,1.3e-08,61.6,sp|A2A6H3|FBX47_MOUSE F-box only protein 47 OS=Mus musculus OX=10090 GN=Fbxo47 PE=2 SV=2,,,,,,
OG_15132,FUN_034315-T2,,Pocillopora_meandrina_HIv1___RNAseq.g28489.t2,apul_ptua,62.948,FUN_034315-T2,Q8NI77,KI18A_HUMAN,,Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A),Homo sapiens (Human),44.0,659.0,7.499999999999999e-141,503.1,sp|Q8NI77|KI18A_HUMAN Kinesin-like protein KIF18A OS=Homo sapiens OX=9606 GN=KIF18A PE=1 SV=2,GO:0000070; GO:0000776; GO:0001726; GO:0003779; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005828; GO:0005829; GO:0005871; GO:0005901; GO:0007018; GO:0007019; GO:0007080; GO:0007140; GO:0008017; GO:0008574; GO:0015031; GO:0015630; GO:0016887; GO:0051010; GO:0061673; GO:0070463; GO:0070507; GO:0071392; GO:0072520; GO:1990023,cellular response to estradiol stimulus [GO:0071392]; male meiotic nuclear division [GO:0007140]; microtubule depolymerization [GO:0007019]; microtubule-based movement [GO:0007018]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; protein transport [GO:0015031]; regulation of microtubule cytoskeleton organization [GO:0070507]; seminiferous tubule development [GO:0072520],caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; microtubule cytoskeleton [GO:0015630]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; nucleus [GO:0005634]; ruffle [GO:0001726],actin binding [GO:0003779]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; plus-end-directed microtubule motor activity [GO:0008574]; tubulin-dependent ATPase activity [GO:0070463],GO:0003774; GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0007010; GO:0007018; GO:0007059; GO:0008092; GO:0016787; GO:0016853; GO:0022414; GO:0043226; GO:0048856; GO:0140013; GO:0140657,cytoskeletal motor activity; catalytic activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; cytoskeleton organization; microtubule-based movement; chromosome segregation; cytoskeletal protein binding; hydrolase activity; isomerase activity; reproductive process; organelle; anatomical structure development; meiotic nuclear division; ATP-dependent activity
OG_15133,FUN_034317-T1,,Pocillopora_meandrina_HIv1___TS.g8272.t1,apul_ptua,35.454,,,,,,,,,,,,,,,,,
OG_15134,FUN_034325-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28479.t1,apul_ptua,36.226,,,,,,,,,,,,,,,,,
OG_15135,FUN_034326-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28478.t1,apul_ptua,47.879,,,,,,,,,,,,,,,,,
OG_15136,FUN_034344-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26122.t1,apul_ptua,64.935,FUN_034344-T1,P04464,,,,,49.1,108.0,1.5000000000000002e-22,107.8,sp|P04464|CALM_WHEAT Calmodulin OS=Triticum aestivum OX=4565 PE=1 SV=3,,,,,,
OG_15137,FUN_034365-T1,,Pocillopora_meandrina_HIv1___RNAseq.17828_t,apul_ptua,51.205,FUN_034365-T1,B5X4E0,,,,,41.4,336.0,4.4e-61,236.5,sp|B5X4E0|CALUB_SALSA Calumenin-B OS=Salmo salar OX=8030 GN=calub PE=2 SV=1,,,,,,
OG_15138,FUN_034377-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26153.t1,apul_ptua,33.721,,,,,,,,,,,,,,,,,
OG_15139,FUN_034390-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26148.t1,apul_ptua,49.0655,,,,,,,,,,,,,,,,,
OG_15140,FUN_034403-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7495.t1,apul_ptua,71.977,FUN_034403-T1,G8HTB6,,,,,33.4,308.0,1.7e-39,166.4,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_15141,FUN_034412-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28582.t1a,apul_ptua,56.906,FUN_034412-T1,Q9JLB4,CUBN_MOUSE,,Cubilin (Intrinsic factor-cobalamin receptor),Mus musculus (Mouse),30.9,181.0,1.7e-16,87.8,sp|Q9JLB4|CUBN_MOUSE Cubilin OS=Mus musculus OX=10090 GN=Cubn PE=1 SV=3,GO:0005509; GO:0005737; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005903; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043235; GO:0045177; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_15142,FUN_034414-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11184.t1,apul_ptua,85.656,,,,,,,,,,,,,,,,,
OG_15143,FUN_034419-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28576.t1,apul_ptua,51.73,,,,,,,,,,,,,,,,,
OG_15144,FUN_034477-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25837.t1,apul_ptua,64.9245,FUN_034477-T1,Q8QGX4,PRKDC_CHICK,,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1),Gallus gallus (Chicken),40.7,1456.0,7e-308,1058.5,sp|Q8QGX4|PRKDC_CHICK DNA-dependent protein kinase catalytic subunit OS=Gallus gallus OX=9031 GN=PRKDC PE=2 SV=1,GO:0000723; GO:0000724; GO:0004674; GO:0004677; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0006302; GO:0006303; GO:0008630; GO:0031571; GO:0033152; GO:0035979; GO:0042254; GO:0070419; GO:0106310,double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; ribosome biogenesis [GO:0042254]; telomere maintenance [GO:0000723],nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA-dependent protein kinase activity [GO:0004677]; histone H2AXS139 kinase activity [GO:0035979]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0006281; GO:0006310; GO:0016740; GO:0032200; GO:0042254; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; nucleolus; DNA repair; DNA recombination; transferase activity; telomere organization; ribosome biogenesis; organelle; catalytic activity, acting on a protein"
OG_15145,FUN_034626-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2094.t1,apul_ptua,32.9035,,,,,,,,,,,,,,,,,
OG_15146,FUN_034673-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9267.t1,apul_ptua,40.455,FUN_034673-T1,Q8N6F8,MET27_HUMAN,,Methyltransferase-like protein 27 (Williams-Beuren syndrome chromosomal region 27 protein),Homo sapiens (Human),34.7,173.0,2.5e-15,84.0,sp|Q8N6F8|MET27_HUMAN Methyltransferase-like protein 27 OS=Homo sapiens OX=9606 GN=METTL27 PE=1 SV=2,,,,,,
OG_15147,FUN_034708-T1,,Pocillopora_meandrina_HIv1___TS.g28357.t1,apul_ptua,44.706,,,,,,,,,,,,,,,,,
OG_15148,FUN_034786-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12282.t1,apul_ptua,35.526,,,,,,,,,,,,,,,,,
OG_15149,FUN_034845-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27196.t1,apul_ptua,50.595,,,,,,,,,,,,,,,,,
OG_15150,FUN_034853-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12152.t1,apul_ptua,78.519,FUN_034853-T1,Q9WTK3,GPAA1_MOUSE,,GPI-anchor transamidase component GPAA1 (GAA1 protein homolog) (mGAA1) (Glycosylphosphatidylinositol anchor attachment 1 protein) (GPI anchor attachment protein 1),Mus musculus (Mouse),44.4,266.0,1.7e-51,204.5,sp|Q9WTK3|GPAA1_MOUSE GPI-anchor transamidase component GPAA1 OS=Mus musculus OX=10090 GN=Gpaa1 PE=1 SV=3,GO:0003923; GO:0005739; GO:0005813; GO:0005829; GO:0005886; GO:0006506; GO:0016255; GO:0034235; GO:0042765; GO:0180046,attachment of GPI anchor to protein [GO:0016255]; GPI anchor biosynthetic process [GO:0006506]; GPI anchored protein biosynthesis [GO:0180046],centrosome [GO:0005813]; cytosol [GO:0005829]; GPI-anchor transamidase complex [GO:0042765]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],GPI anchor binding [GO:0034235]; GPI-anchor transamidase activity [GO:0003923],GO:0003824; GO:0005739; GO:0005815; GO:0005829; GO:0005886; GO:0006629; GO:0008289; GO:0016740; GO:0016787; GO:0043226; GO:0051604; GO:0140096; GO:1901135,"catalytic activity; mitochondrion; microtubule organizing center; cytosol; plasma membrane; lipid metabolic process; lipid binding; transferase activity; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_15151,FUN_034855-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12154.t1,apul_ptua,67.22,FUN_034855-T1,P33727,,,,,49.6,490.0,1.5e-137,491.1,sp|P33727|ARSB_FELCA Arylsulfatase B OS=Felis catus OX=9685 GN=ARSB PE=2 SV=1,,,,,,
OG_15152,FUN_034864-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27144.t1,apul_ptua,87.27250000000001,FUN_034864-T1,A5YKK6,CNOT1_HUMAN,,CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1),Homo sapiens (Human),60.6,2477.0,0.0,2711.0,sp|A5YKK6|CNOT1_HUMAN CCR4-NOT transcription complex subunit 1 OS=Homo sapiens OX=9606 GN=CNOT1 PE=1 SV=2,GO:0000122; GO:0000288; GO:0000289; GO:0000932; GO:0001829; GO:0003723; GO:0005615; GO:0005634; GO:0005778; GO:0005829; GO:0010606; GO:0016020; GO:0017148; GO:0019904; GO:0030014; GO:0030015; GO:0030331; GO:0033147; GO:0035195; GO:0042974; GO:0048387; GO:0060090; GO:0060213; GO:0061014; GO:0070016; GO:1900153; GO:2000036,"miRNA-mediated post-transcriptional gene silencing [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; trophectodermal cell differentiation [GO:0001829]",CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; peroxisomal membrane [GO:0005778],armadillo repeat domain binding [GO:0070016]; molecular adaptor activity [GO:0060090]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723],GO:0003723; GO:0005615; GO:0005634; GO:0005829; GO:0006355; GO:0016071; GO:0030154; GO:0031047; GO:0043226; GO:0060090,RNA binding; extracellular space; nucleus; cytosol; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; regulatory ncRNA-mediated gene silencing; organelle; molecular adaptor activity
OG_15153,FUN_034895-T2,,Pocillopora_meandrina_HIv1___RNAseq.10925_t,apul_ptua,61.859,FUN_034895-T2,Q54WH2,FORA_DICDI,,Formin-A,Dictyostelium discoideum (Social amoeba),28.3,374.0,1.2e-32,144.1,sp|Q54WH2|FORA_DICDI Formin-A OS=Dictyostelium discoideum OX=44689 GN=forA PE=1 SV=1,GO:0000281; GO:0005522; GO:0005938; GO:0015629; GO:0016477; GO:0030041; GO:0030587; GO:0030866; GO:0031254; GO:0031267; GO:0032154; GO:0035091; GO:0045010; GO:0051015; GO:0070060; GO:1904171,'de novo' actin filament nucleation [GO:0070060]; actin filament polymerization [GO:0030041]; actin nucleation [GO:0045010]; cell migration [GO:0016477]; cortical actin cytoskeleton organization [GO:0030866]; mitotic cytokinesis [GO:0000281]; negative regulation of bleb assembly [GO:1904171]; sorocarp development [GO:0030587],actin cytoskeleton [GO:0015629]; cell cortex [GO:0005938]; cell trailing edge [GO:0031254]; cleavage furrow [GO:0032154],actin filament binding [GO:0051015]; phosphatidylinositol binding [GO:0035091]; profilin binding [GO:0005522]; small GTPase binding [GO:0031267],GO:0000910; GO:0005856; GO:0007010; GO:0008092; GO:0008289; GO:0043226; GO:0048856; GO:0048870; GO:0065003,cytokinesis; cytoskeleton; cytoskeleton organization; cytoskeletal protein binding; lipid binding; organelle; anatomical structure development; cell motility; protein-containing complex assembly
OG_15154,FUN_034897-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27797.t1,apul_ptua,50.526,,,,,,,,,,,,,,,,,
OG_15155,FUN_034898-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27801.t1,apul_ptua,30.2955,,,,,,,,,,,,,,,,,
OG_15156,FUN_034929-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27821.t1,apul_ptua,77.74,FUN_034929-T1,P30051,TEAD1_MOUSE,,Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13),Mus musculus (Mouse),57.8,128.0,8.900000000000001e-34,145.6,sp|P30051|TEAD1_MOUSE Transcriptional enhancer factor TEF-1 OS=Mus musculus OX=10090 GN=Tead1 PE=1 SV=2,GO:0000978; GO:0003143; GO:0003700; GO:0005634; GO:0005667; GO:0006355; GO:0007507; GO:0010468; GO:0014883; GO:0030307; GO:0030903; GO:0035329; GO:0042127; GO:0045893; GO:0045944; GO:0048339; GO:0048368; GO:0071300; GO:0140552; GO:1902459,cellular response to retinoic acid [GO:0071300]; embryonic heart tube morphogenesis [GO:0003143]; heart development [GO:0007507]; hippo signaling [GO:0035329]; lateral mesoderm development [GO:0048368]; notochord development [GO:0030903]; paraxial mesoderm development [GO:0048339]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; transition between fast and slow fiber [GO:0014883],nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552]; transcription regulator complex [GO:0005667],DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978],GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_15157,FUN_034930-T1,,Pocillopora_meandrina_HIv1___TS.g15166.t1b,apul_ptua,84.043,FUN_034930-T1,B5FZ63,,,,,72.8,92.0,1.9e-20,99.8,sp|B5FZ63|ENY2_TAEGU Transcription and mRNA export factor ENY2 OS=Taeniopygia guttata OX=59729 GN=ENY2 PE=3 SV=1,,,,,,
OG_15158,FUN_034939-T2,,Pocillopora_meandrina_HIv1___RNAseq.g12177.t1,apul_ptua,88.235,,,,,,,,,,,,,,,,,
OG_15159,FUN_034964-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12161.t1,apul_ptua,41.049,,,,,,,,,,,,,,,,,
OG_15160,FUN_034965-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12170.t1,apul_ptua,75.0,FUN_034965-T1,O75521,ECI2_HUMAN,,"Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)",Homo sapiens (Human),52.9,393.0,1.5e-111,404.4,sp|O75521|ECI2_HUMAN Enoyl-CoA delta isomerase 2 OS=Homo sapiens OX=9606 GN=ECI2 PE=1 SV=4,GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006635; GO:0009062; GO:0016020; GO:0043231,fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062],GO:0003824; GO:0005739; GO:0005777; GO:0005829; GO:0006629; GO:0008289; GO:0016853; GO:0043226,catalytic activity; mitochondrion; peroxisome; cytosol; lipid metabolic process; lipid binding; isomerase activity; organelle
OG_15161,FUN_034966-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12169.t1,apul_ptua,85.593,FUN_034966-T1,Q9BR09,,,,,31.5,260.0,2.5e-26,120.6,sp|Q9BR09|NEUL2_HUMAN Neuralized-like protein 2 OS=Homo sapiens OX=9606 GN=NEURL2 PE=1 SV=1,,,,,,
OG_15162,FUN_034967-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12168.t1,apul_ptua,82.32,FUN_034967-T1,Q4FZW5,SEH1A_XENLA,,Nucleoporin SEH1-A (GATOR2 complex protein SEH1-A) (Nup107-160 subcomplex subunit seh1-A),Xenopus laevis (African clawed frog),72.6,329.0,1e-143,511.1,sp|Q4FZW5|SEH1A_XENLA Nucleoporin SEH1-A OS=Xenopus laevis OX=8355 GN=seh1l-a PE=1 SV=1,GO:0000776; GO:0005198; GO:0005765; GO:0005829; GO:0006999; GO:0007080; GO:0015031; GO:0031080; GO:0031669; GO:0034198; GO:0035859; GO:0051028; GO:0051301; GO:0051315; GO:0061700; GO:1904263,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; mitotic metaphase chromosome alignment [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859],structural molecule activity [GO:0005198],GO:0005198; GO:0005829; GO:0043226,structural molecule activity; cytosol; organelle
OG_15163,FUN_034968-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12167.t1,apul_ptua,86.9,FUN_034968-T1,Q28165,PABP2_BOVIN,,Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1),Bos taurus (Bovine),69.4,144.0,3e-48,193.4,sp|Q28165|PABP2_BOVIN Polyadenylate-binding protein 2 OS=Bos taurus OX=9913 GN=PABPN1 PE=1 SV=3,GO:0000165; GO:0005634; GO:0005737; GO:0006397; GO:0008143; GO:0016607; GO:0016973; GO:0042405; GO:0042802; GO:0070063; GO:0071222; GO:1904247; GO:1990904,cellular response to lipopolysaccharide [GO:0071222]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247],cytoplasm [GO:0005737]; nuclear inclusion body [GO:0042405]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],identical protein binding [GO:0042802]; poly(A) binding [GO:0008143]; RNA polymerase binding [GO:0070063],GO:0003723; GO:0005634; GO:0006913; GO:0016071; GO:0043226,RNA binding; nucleus; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_15164,FUN_034969-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12166.t1,apul_ptua,94.949,FUN_034969-T1,B5XGE7,,,,,75.8,99.0,1.7e-38,159.8,sp|B5XGE7|TPC2L_SALSA Trafficking protein particle complex subunit 2-like protein OS=Salmo salar OX=8030 GN=trappc2l PE=2 SV=1,,,,,,
OG_15165,FUN_034970-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12165.t1,apul_ptua,81.614,FUN_034970-T1,Q571E4,GALNS_MOUSE,,N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase),Mus musculus (Mouse),71.2,434.0,4.4e-197,688.7,sp|Q571E4|GALNS_MOUSE N-acetylgalactosamine-6-sulfatase OS=Mus musculus OX=10090 GN=Galns PE=1 SV=2,GO:0005764; GO:0008484; GO:0030207; GO:0043890; GO:0046872,chondroitin sulfate proteoglycan catabolic process [GO:0030207],lysosome [GO:0005764],metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890]; sulfuric ester hydrolase activity [GO:0008484],GO:0003824; GO:0005764; GO:0005773; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; lysosome; vacuole; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_15166,FUN_035015-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27776.t1,apul_ptua,46.552,FUN_035015-T1,Q9CYL5,,,,,42.9,147.0,4.3e-22,107.1,sp|Q9CYL5|GAPR1_MOUSE Golgi-associated plant pathogenesis-related protein 1 OS=Mus musculus OX=10090 GN=Glipr2 PE=1 SV=3,,,,,,
OG_15167,FUN_035030-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27583.t1,apul_ptua,64.941,FUN_035030-T1,A4IIW0,,,,,31.6,155.0,1.6e-12,76.3,sp|A4IIW0|MB212_XENTR Protein mab-21-like 2 OS=Xenopus tropicalis OX=8364 GN=mab21l2 PE=2 SV=1,,,,,,
OG_15168,FUN_035037-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27753.t1,apul_ptua,60.727,FUN_035037-T1,Q08331,CALB2_MOUSE,,Calretinin (CR),Mus musculus (Mouse),44.2,260.0,2.9999999999999998e-55,216.9,sp|Q08331|CALB2_MOUSE Calretinin OS=Mus musculus OX=10090 GN=Calb2 PE=1 SV=3,GO:0005829; GO:0005921; GO:0006874; GO:0044293; GO:0048167; GO:0098688; GO:0098793; GO:0099534; GO:0099536,intracellular calcium ion homeostasis [GO:0006874]; regulation of synaptic plasticity [GO:0048167]; synaptic signaling [GO:0099536],cytosol [GO:0005829]; dendriole [GO:0044293]; gap junction [GO:0005921]; parallel fiber to Purkinje cell synapse [GO:0098688]; presynapse [GO:0098793],calcium ion binding involved in regulation of presynaptic cytosolic calcium ion concentration [GO:0099534],GO:0005829; GO:0023052,cytosol; signaling
OG_15169,FUN_035050-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27742.t1,apul_ptua,60.448,,,,,,,,,,,,,,,,,
OG_15170,FUN_035064-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30373.t1,apul_ptua,53.0495,,,,,,,,,,,,,,,,,
OG_15171,FUN_035103-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27702.t1,apul_ptua,44.9,FUN_035103-T1,Q54R58,YTYK2_DICDI,,Probable tyrosine-protein kinase DDB_G0283397 (EC 2.7.10.2),Dictyostelium discoideum (Social amoeba),30.0,263.0,3.2e-19,99.0,sp|Q54R58|YTYK2_DICDI Probable tyrosine-protein kinase DDB_G0283397 OS=Dictyostelium discoideum OX=44689 GN=DDB_G0283397 PE=3 SV=1,GO:0004672; GO:0004715; GO:0005524; GO:0005737; GO:0007165,signal transduction [GO:0007165],cytoplasm [GO:0005737],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_15172,FUN_035152-T2,,Pocillopora_meandrina_HIv1___RNAseq.g27636.t1,apul_ptua,75.945,FUN_035152-T2,P00491,PNPH_HUMAN,,Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase),Homo sapiens (Human),52.8,286.0,2.3e-81,303.9,sp|P00491|PNPH_HUMAN Purine nucleoside phosphorylase OS=Homo sapiens OX=9606 GN=PNP PE=1 SV=2,GO:0000255; GO:0001882; GO:0002060; GO:0004731; GO:0005576; GO:0005737; GO:0005829; GO:0006139; GO:0006148; GO:0006149; GO:0006157; GO:0006166; GO:0006204; GO:0006738; GO:0006955; GO:0009165; GO:0009410; GO:0032743; GO:0034418; GO:0034774; GO:0042102; GO:0042301; GO:0042802; GO:0043101; GO:0046059; GO:0046638; GO:0047975; GO:0070062; GO:1904813,allantoin metabolic process [GO:0000255]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyinosine catabolic process [GO:0006149]; immune response [GO:0006955]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide biosynthetic process [GO:0009165]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of T cell proliferation [GO:0042102]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101]; response to xenobiotic stimulus [GO:0009410]; urate biosynthetic process [GO:0034418],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774],guanosine phosphorylase activity [GO:0047975]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731],GO:0002376; GO:0003824; GO:0005576; GO:0005829; GO:0016740; GO:0043226; GO:0055086; GO:1901135,immune system process; catalytic activity; extracellular region; cytosol; transferase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_15173,FUN_035153-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27635.t1,apul_ptua,69.3895,FUN_035153-T1,Q8IS14,,,,,38.6,236.0,2e-35,154.1,sp|Q8IS14|GEFJ_DICDI Ras guanine nucleotide exchange factor J OS=Dictyostelium discoideum OX=44689 GN=gefJ PE=2 SV=1,,,,,,
OG_15174,FUN_035162-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27908.t1,apul_ptua,49.721,,,,,,,,,,,,,,,,,
OG_15175,FUN_035172-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27921.t1,apul_ptua,77.404,FUN_035172-T1,S4R2K0,DEFM_MOUSE,,"Peptide deformylase, mitochondrial (EC 3.5.1.88) (Polypeptide deformylase)",Mus musculus (Mouse),42.9,177.0,1.2e-35,151.4,"sp|S4R2K0|DEFM_MOUSE Peptide deformylase, mitochondrial OS=Mus musculus OX=10090 GN=Pdf PE=3 SV=1",GO:0005739; GO:0006412; GO:0008284; GO:0042586; GO:0043687; GO:0046872,positive regulation of cell population proliferation [GO:0008284]; post-translational protein modification [GO:0043687]; translation [GO:0006412],mitochondrion [GO:0005739],metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586],GO:0003824; GO:0005739; GO:0016787; GO:0043226,catalytic activity; mitochondrion; hydrolase activity; organelle
OG_15176,FUN_035173-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27923.t1,apul_ptua,56.627,,,,,,,,,,,,,,,,,
OG_15177,FUN_035188-T1,,Pocillopora_meandrina_HIv1___TS.g4556.t1,apul_ptua,55.556,,,,,,,,,,,,,,,,,
OG_15178,FUN_035199-T1,,Pocillopora_meandrina_HIv1___TS.g15308.t1,apul_ptua,37.079,,,,,,,,,,,,,,,,,
OG_15179,FUN_035209-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27631.t1,apul_ptua,52.973,,,,,,,,,,,,,,,,,
OG_15180,FUN_035234-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12559.t1,apul_ptua,46.918,FUN_035234-T1,P08099,OPS2_DROME,,Opsin Rh2 (Ocellar opsin),Drosophila melanogaster (Fruit fly),25.4,279.0,3e-15,84.3,sp|P08099|OPS2_DROME Opsin Rh2 OS=Drosophila melanogaster OX=7227 GN=Rh2 PE=1 SV=1,GO:0004930; GO:0005886; GO:0007186; GO:0007601; GO:0007602; GO:0008020; GO:0016020,G protein-coupled receptor signaling pathway [GO:0007186]; phototransduction [GO:0007602]; visual perception [GO:0007601],membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled photoreceptor activity [GO:0008020]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0050877; GO:0060089,plasma membrane; nervous system process; molecular transducer activity
OG_15181,FUN_035249-T1,,Pocillopora_meandrina_HIv1___TS.g17698.t1,apul_ptua,42.105,FUN_035249-T1,Q032L5,,,,,38.5,221.0,2.6999999999999997e-31,137.9,sp|Q032L5|UNG_LACLS Uracil-DNA glycosylase OS=Lactococcus lactis subsp. cremoris (strain SK11) OX=272622 GN=ung PE=3 SV=1,,,,,,
OG_15182,FUN_035251-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27888.t1,apul_ptua,66.70949999999999,,,,,,,,,,,,,,,,,
OG_15183,FUN_035253-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17669.t1,apul_ptua,42.745,,,,,,,,,,,,,,,,,
OG_15184,FUN_035268-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27877.t1,apul_ptua,74.1225,,,,,,,,,,,,,,,,,
OG_15185,FUN_035338-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12266.t1,apul_ptua,57.353,FUN_035338-T1,Q99MR9,,,,,35.2,193.0,5.4e-17,89.4,sp|Q99MR9|PPR3A_MOUSE Protein phosphatase 1 regulatory subunit 3A OS=Mus musculus OX=10090 GN=Ppp1r3a PE=1 SV=2,,,,,,
OG_15186,FUN_035353-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12246.t1,apul_ptua,33.913,FUN_035353-T1,Q4J9D2,,,,,47.3,182.0,3e-34,149.1,sp|Q4J9D2|Y1252_SULAC Uncharacterized protein Saci_1252 OS=Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) OX=330779 GN=Saci_1252 PE=4 SV=1,,,,,,
OG_15187,FUN_035354-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12245.t1,apul_ptua,37.189,FUN_035354-T1,Q8TDB6,DTX3L_HUMAN,,E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2),Homo sapiens (Human),55.6,189.0,3.1e-56,221.9,sp|Q8TDB6|DTX3L_HUMAN E3 ubiquitin-protein ligase DTX3L OS=Homo sapiens OX=9606 GN=DTX3L PE=1 SV=1,GO:0000077; GO:0002230; GO:0004842; GO:0004857; GO:0005634; GO:0005654; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006302; GO:0006511; GO:0007219; GO:0008270; GO:0008333; GO:0015031; GO:0016567; GO:0019899; GO:0031901; GO:0032092; GO:0032991; GO:0035563; GO:0042393; GO:0044389; GO:0045087; GO:0045893; GO:0051444; GO:0051607; GO:0051865; GO:0061630; GO:0070936; GO:0097677; GO:0140768; GO:0140852; GO:0140861; GO:0141000; GO:1900182; GO:1902966; GO:2000646,defense response to virus [GO:0051607]; DNA damage checkpoint signaling [GO:0000077]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; histone H4K91 ubiquitin ligase activity [GO:0141000]; histone ubiquitin ligase activity [GO:0140852]; protein ADP-ribosyltransferase-substrate adaptor activity [GO:0140768]; STAT family protein binding [GO:0097677]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005764; GO:0005773; GO:0005829; GO:0006281; GO:0006325; GO:0006355; GO:0016192; GO:0016740; GO:0042393; GO:0043226; GO:0060090; GO:0098542; GO:0098772; GO:0140096,"immune system process; catalytic activity; nucleus; nucleoplasm; lysosome; vacuole; cytosol; DNA repair; chromatin organization; regulation of DNA-templated transcription; vesicle-mediated transport; transferase activity; histone binding; organelle; molecular adaptor activity; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_15188,FUN_035376-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12222.t1,apul_ptua,54.1365,FUN_035376-T1,O57342,,,,,40.4,89.0,7.4e-10,65.5,sp|O57342|MAFA_COTJA Transcription factor MafA OS=Coturnix japonica OX=93934 GN=MAFA PE=1 SV=1,,,,,,
OG_15189,FUN_035381-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12216.t1a,apul_ptua,52.685500000000005,FUN_035381-T1,A4IIA2,,,,,41.5,53.0,3e-06,55.1,sp|A4IIA2|IBP2_XENTR Insulin-like growth factor-binding protein 2 OS=Xenopus tropicalis OX=8364 GN=igfbp2 PE=2 SV=1,,,,,,
OG_15190,FUN_035425-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27572.t1,apul_ptua,41.799,,,,,,,,,,,,,,,,,
OG_15191,FUN_035427-T1,,Pocillopora_meandrina_HIv1___TS.g14926.t1,apul_ptua,32.673,,,,,,,,,,,,,,,,,
OG_15192,FUN_035497-T1,,Pocillopora_meandrina_HIv1___TS.g14342.t1,apul_ptua,32.0385,,,,,,,,,,,,,,,,,
OG_15193,FUN_035512-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6641.t1,apul_ptua,34.783,,,,,,,,,,,,,,,,,
OG_15194,FUN_035514-T2,,Pocillopora_meandrina_HIv1___RNAseq.g26973.t1,apul_ptua,60.0,FUN_035514-T2,Q9P209,CEP72_HUMAN,,Centrosomal protein of 72 kDa (Cep72),Homo sapiens (Human),24.8,572.0,1.6e-26,122.5,sp|Q9P209|CEP72_HUMAN Centrosomal protein of 72 kDa OS=Homo sapiens OX=9606 GN=CEP72 PE=1 SV=2,GO:0005813; GO:0005829; GO:0007051; GO:0007099; GO:0033566; GO:0034451; GO:0036064; GO:0042802; GO:1904779,centriole replication [GO:0007099]; gamma-tubulin complex localization [GO:0033566]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829],identical protein binding [GO:0042802],GO:0005815; GO:0005829; GO:0007010,microtubule organizing center; cytosol; cytoskeleton organization
OG_15195,FUN_035556-T1,,Pocillopora_meandrina_HIv1___TS.g15384.t1,apul_ptua,41.538,,,,,,,,,,,,,,,,,
OG_15196,FUN_035610-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28046.t1b,apul_ptua,73.273,,,,,,,,,,,,,,,,,
OG_15197,FUN_035617-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16255.t1,apul_ptua,39.785,,,,,,,,,,,,,,,,,
OG_15198,FUN_035622-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28074.t1b,apul_ptua,67.797,,,,,,,,,,,,,,,,,
OG_15199,FUN_035624-T1,,Pocillopora_meandrina_HIv1___TS.g15419.t1,apul_ptua,88.364,FUN_035624-T1,Q5ZIW5,,,,,66.6,317.0,1.5e-122,440.7,sp|Q5ZIW5|VAC14_CHICK Protein VAC14 homolog OS=Gallus gallus OX=9031 GN=VAC14 PE=2 SV=1,,,,,,
OG_15200,FUN_035697-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11822.t1,apul_ptua,71.042,FUN_035697-T1,Q6NYL5,ALAT2_DANRE,,Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2),Danio rerio (Zebrafish) (Brachydanio rerio),47.6,481.0,1.2e-131,471.5,sp|Q6NYL5|ALAT2_DANRE Alanine aminotransferase 2-like OS=Danio rerio OX=7955 GN=gpt2l PE=2 SV=2,GO:0004021; GO:0006103; GO:0009058; GO:0030170; GO:0042851; GO:0042853,2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],,L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0006520; GO:0016740,catalytic activity; amino acid metabolic process; transferase activity
OG_15201,FUN_035702-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11853.t1,apul_ptua,50.98,,,,,,,,,,,,,,,,,
OG_15202,FUN_035744-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11872.t1,apul_ptua,43.557,FUN_035744-T1,Q9P2E3,ZNFX1_HUMAN,,NFX1-type zinc finger-containing protein 1,Homo sapiens (Human),35.6,1281.0,9.000000000000001e-186,653.7,sp|Q9P2E3|ZNFX1_HUMAN NFX1-type zinc finger-containing protein 1 OS=Homo sapiens OX=9606 GN=ZNFX1 PE=1 SV=2,GO:0002218; GO:0003723; GO:0004386; GO:0005741; GO:0008270; GO:0010494; GO:0031048; GO:0031380; GO:0042742; GO:0045071; GO:0045087; GO:0051607,activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048],cytoplasmic stress granule [GO:0010494]; mitochondrial outer membrane [GO:0005741]; nuclear RNA-directed RNA polymerase complex [GO:0031380],helicase activity [GO:0004386]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0002376; GO:0003723; GO:0003824; GO:0006325; GO:0016853; GO:0031047; GO:0043226; GO:0098542; GO:0140657,immune system process; RNA binding; catalytic activity; chromatin organization; isomerase activity; regulatory ncRNA-mediated gene silencing; organelle; defense response to other organism; ATP-dependent activity
OG_15203,FUN_035763-T2,,Pocillopora_meandrina_HIv1___RNAseq.g11892.t1,apul_ptua,80.229,FUN_035763-T2,Q8K3X3,,,,,71.8,355.0,3.8e-154,545.8,"sp|Q8K3X3|GMDS_CRIGR GDP-mannose 4,6 dehydratase OS=Cricetulus griseus OX=10029 GN=GMDS PE=2 SV=1",,,,,,
OG_15204,FUN_035798-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29759.t1,apul_ptua,36.0,,,,,,,,,,,,,,,,,
OG_15205,FUN_035827-T2,,Pocillopora_meandrina_HIv1___RNAseq.g11937.t2,apul_ptua,55.4315,FUN_035827-T2,B6H3T4,NOP9_PENRW,,Nucleolar protein 9 (Pumilio domain-containing protein nop9),Penicillium rubens (strain ATCC 28089 / DSM 1075 / NRRL 1951 / Wisconsin 54-1255) (Penicillium chrysogenum),23.7,633.0,3.9e-35,151.4,sp|B6H3T4|NOP9_PENRW Nucleolar protein 9 OS=Penicillium rubens (strain ATCC 28089 / DSM 1075 / NRRL 1951 / Wisconsin 54-1255) OX=500485 GN=nop9 PE=3 SV=1,GO:0000056; GO:0000447; GO:0000472; GO:0000480; GO:0003723; GO:0005730; GO:0030686; GO:0030688,"endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000472]; ribosomal small subunit export from nucleus [GO:0000056]","90S preribosome [GO:0030686]; nucleolus [GO:0005730]; preribosome, small subunit precursor [GO:0030688]",RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0006913; GO:0043226,RNA binding; nucleolus; nucleocytoplasmic transport; organelle
OG_15206,FUN_035876-T1,,Pocillopora_meandrina_HIv1___TS.g3329.t1a,apul_ptua,71.585,FUN_035876-T1,Q5EA10,PIGM_BOVIN,,"GPI alpha-1,4-mannosyltransferase I, catalytic subunit (EC 2.4.1.-) (GPI mannosyltransferase I) (GPI-MT-I) (Phosphatidylinositol-glycan biosynthesis class M protein) (PIG-M)",Bos taurus (Bovine),56.4,181.0,4.8e-57,222.2,"sp|Q5EA10|PIGM_BOVIN GPI alpha-1,4-mannosyltransferase I, catalytic subunit OS=Bos taurus OX=9913 GN=PIGM PE=2 SV=1",GO:0000030; GO:0005789; GO:0006506; GO:0180041; GO:1990529,GPI anchor biosynthetic process [GO:0006506],endoplasmic reticulum membrane [GO:0005789]; glycosylphosphatidylinositol-mannosyltransferase I complex [GO:1990529],"glycolipid 1,4-alpha-mannosyltransferase activity [GO:0180041]; mannosyltransferase activity [GO:0000030]",GO:0003824; GO:0006629; GO:0016740; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; carbohydrate derivative metabolic process
OG_15207,FUN_035905-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12030.t1,apul_ptua,57.9635,,,,,,,,,,,,,,,,,
OG_15208,FUN_035910-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12033.t1,apul_ptua,91.165,,,,,,,,,,,,,,,,,
OG_15209,FUN_035912-T1,,Pocillopora_meandrina_HIv1___TS.g3374.t1,apul_ptua,67.669,,,,,,,,,,,,,,,,,
OG_15210,FUN_035918-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12040.t1c,apul_ptua,44.438500000000005,,,,,,,,,,,,,,,,,
OG_15211,FUN_035928-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12055.t1,apul_ptua,74.103,FUN_035928-T1,A3KG59,P20D2_MOUSE,,Xaa-Arg dipeptidase (EC 3.4.13.4),Mus musculus (Mouse),50.6,397.0,2.3e-99,364.0,sp|A3KG59|P20D2_MOUSE Xaa-Arg dipeptidase OS=Mus musculus OX=10090 GN=Pm20d2 PE=1 SV=1,GO:0004180; GO:0005654; GO:0006508; GO:0016805; GO:0042802; GO:0051246,proteolysis [GO:0006508]; regulation of protein metabolic process [GO:0051246],nucleoplasm [GO:0005654],carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; identical protein binding [GO:0042802],GO:0003824; GO:0005654; GO:0016787; GO:0140096,"catalytic activity; nucleoplasm; hydrolase activity; catalytic activity, acting on a protein"
OG_15212,FUN_035968-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12332.t1,apul_ptua,59.198,FUN_035968-T1,Q08BG1,,,,,39.2,398.0,7.9e-71,269.2,sp|Q08BG1|TMPPE_DANRE Transmembrane protein with metallophosphoesterase domain OS=Danio rerio OX=7955 GN=tmppe PE=2 SV=1,,,,,,
OG_15213,FUN_035977-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12334.t1,apul_ptua,70.1305,FUN_035977-T1,O00268,TAF4_HUMAN,,Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit) (TAF(II)130) (TAFII-130) (TAFII130) (Transcription initiation factor TFIID 135 kDa subunit) (TAF(II)135) (TAFII-135) (TAFII135),Homo sapiens (Human),37.0,657.0,3.8e-42,174.9,sp|O00268|TAF4_HUMAN Transcription initiation factor TFIID subunit 4 OS=Homo sapiens OX=9606 GN=TAF4 PE=1 SV=2,GO:0000785; GO:0001541; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005669; GO:0005829; GO:0006282; GO:0006352; GO:0006357; GO:0006366; GO:0006367; GO:0017162; GO:0032991; GO:0033276; GO:0042789; GO:0045893; GO:0046982; GO:0051123; GO:0060261; GO:0071339,DNA-templated transcription initiation [GO:0006352]; mRNA transcription by RNA polymerase II [GO:0042789]; ovarian follicle development [GO:0001541]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription initiation at RNA polymerase II promoter [GO:0006367],chromatin [GO:0000785]; cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276],aryl hydrocarbon receptor binding [GO:0017162]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006351; GO:0006355; GO:0016071; GO:0043226; GO:0048856; GO:0065003,DNA binding; nucleus; nucleoplasm; cytosol; DNA-templated transcription; regulation of DNA-templated transcription; mRNA metabolic process; organelle; anatomical structure development; protein-containing complex assembly
OG_15214,FUN_036001-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12327.t1,apul_ptua,61.266,,,,,,,,,,,,,,,,,
OG_15215,FUN_036019-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12320.t1,apul_ptua,53.874,FUN_036019-T1,Q5R8P3,,,,,26.8,429.0,2.6000000000000003e-32,141.7,sp|Q5R8P3|BBS10_PONAB BBSome complex assembly protein BBS10 OS=Pongo abelii OX=9601 GN=BBS10 PE=2 SV=1,,,,,,
OG_15216,FUN_036024-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27234.t1,apul_ptua,72.622,FUN_036024-T1,Q61382,TRAF4_MOUSE,,TNF receptor-associated factor 4 (EC 2.3.2.27) (Cysteine-rich motif associated to RING and Traf domains protein 1),Mus musculus (Mouse),28.5,487.0,7.3e-64,246.1,sp|Q61382|TRAF4_MOUSE TNF receptor-associated factor 4 OS=Mus musculus OX=10090 GN=Traf4 PE=1 SV=2,GO:0001650; GO:0005164; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005923; GO:0006915; GO:0007165; GO:0007585; GO:0008270; GO:0016740; GO:0019901; GO:0030323; GO:0031625; GO:0031996; GO:0042802; GO:0042981; GO:0043161; GO:0045087; GO:0045860; GO:0046330; GO:0048471; GO:0050699,apoptotic process [GO:0006915]; innate immune response [GO:0045087]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein kinase activity [GO:0045860]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of apoptotic process [GO:0042981]; respiratory gaseous exchange by respiratory system [GO:0007585]; respiratory tube development [GO:0030323]; signal transduction [GO:0007165],bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; transferase activity [GO:0016740]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0030163; GO:0043226; GO:0048856; GO:0098542,immune system process; catalytic activity; nucleus; nucleoplasm; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; protein catabolic process; organelle; anatomical structure development; defense response to other organism
OG_15217,FUN_036032-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27242.t1,apul_ptua,62.295,,,,,,,,,,,,,,,,,
OG_15218,FUN_036052-T1,,Pocillopora_meandrina_HIv1___TS.g14735.t1,apul_ptua,48.608,,,,,,,,,,,,,,,,,
OG_15219,FUN_036084-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27422.t1,apul_ptua,65.286,FUN_036084-T1,Q9CZX2,CEP89_MOUSE,,Centrosomal protein of 89 kDa (Cep89) (Coiled-coil domain-containing protein 123),Mus musculus (Mouse),35.9,387.0,1.4999999999999999e-55,220.3,sp|Q9CZX2|CEP89_MOUSE Centrosomal protein of 89 kDa OS=Mus musculus OX=10090 GN=Cep89 PE=1 SV=1,GO:0000922; GO:0005758; GO:0005813; GO:0005814; GO:0005829; GO:0007268; GO:0016604; GO:0031514; GO:0033617; GO:0036064; GO:0045202; GO:0060271; GO:0097539; GO:0097730; GO:1905515,chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrial cytochrome c oxidase assembly [GO:0033617]; non-motile cilium assembly [GO:1905515],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; spindle pole [GO:0000922]; synapse [GO:0045202],,GO:0005815; GO:0005829; GO:0005929; GO:0023052; GO:0043226; GO:0044782; GO:0065003,microtubule organizing center; cytosol; cilium; signaling; organelle; cilium organization; protein-containing complex assembly
OG_15220,FUN_036091-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27445.t1,apul_ptua,34.3305,,,,,,,,,,,,,,,,,
OG_15221,FUN_036130-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27451.t1,apul_ptua,68.116,FUN_036130-T1,Q9VHT9,,,,,32.8,137.0,1.6e-08,61.6,sp|Q9VHT9|NAZO_DROME Protein Nazo OS=Drosophila melanogaster OX=7227 GN=Nazo PE=2 SV=2,,,,,,
OG_15222,FUN_036268-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14234.t1,apul_ptua,53.543,,,,,,,,,,,,,,,,,
OG_15223,FUN_036451-T1,,Pocillopora_meandrina_HIv1___RNAseq.g872.t1,apul_ptua,67.725,,,,,,,,,,,,,,,,,
OG_15224,FUN_036460-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26872.t1,apul_ptua,73.6,,,,,,,,,,,,,,,,,
OG_15225,FUN_036476-T1,,Pocillopora_meandrina_HIv1___RNAseq.g751.t1,apul_ptua,79.808,,,,,,,,,,,,,,,,,
OG_15226,FUN_036504-T1,,Pocillopora_meandrina_HIv1___TS.g14409.t1,apul_ptua,60.191,FUN_036504-T1,Q08J23,NSUN2_HUMAN,,"RNA cytosine C(5)-methyltransferase NSUN2 (EC 2.1.1.-) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (mRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-) (tRNA cytosine C(5)-methyltransferase) (EC 2.1.1.-, EC 2.1.1.203) (tRNA methyltransferase 4 homolog) (hTrm4)",Homo sapiens (Human),38.2,872.0,5.1e-160,566.6,sp|Q08J23|NSUN2_HUMAN RNA cytosine C(5)-methyltransferase NSUN2 OS=Homo sapiens OX=9606 GN=NSUN2 PE=1 SV=2,GO:0000049; GO:0001701; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005739; GO:0005819; GO:0006397; GO:0006400; GO:0007286; GO:0010793; GO:0016428; GO:0030488; GO:0033313; GO:0033391; GO:0036416; GO:0048820; GO:0051301; GO:0062152; GO:0070062; GO:2000736,cell division [GO:0051301]; hair follicle maturation [GO:0048820]; in utero embryonic development [GO:0001701]; meiotic cell cycle checkpoint signaling [GO:0033313]; mRNA processing [GO:0006397]; regulation of mRNA export from nucleus [GO:0010793]; regulation of stem cell differentiation [GO:2000736]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA stabilization [GO:0036416],chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819],mRNA (cytidine-5-)-methyltransferase activity [GO:0062152]; RNA binding [GO:0003723]; tRNA (cytidine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005739; GO:0006399; GO:0016071; GO:0016740; GO:0022414; GO:0043226; GO:0048856; GO:0140098,"RNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; mitochondrion; tRNA metabolic process; mRNA metabolic process; transferase activity; reproductive process; organelle; anatomical structure development; catalytic activity, acting on RNA"
OG_15227,FUN_036658-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13142.t1,apul_ptua,91.473,,,,,,,,,,,,,,,,,
OG_15228,FUN_036771-T1,,Pocillopora_meandrina_HIv1___RNAseq.g456.t1,apul_ptua,37.168,,,,,,,,,,,,,,,,,
OG_15229,FUN_036808-T4,,Pocillopora_meandrina_HIv1___RNAseq.g10613.t1,apul_ptua,56.764,FUN_036808-T4,Q99MW1,,,,,25.6,727.0,2.6e-42,175.3,sp|Q99MW1|STK31_MOUSE Serine/threonine-protein kinase 31 OS=Mus musculus OX=10090 GN=Stk31 PE=1 SV=2,,,,,,
OG_15230,FUN_036840-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10646.t1,apul_ptua,44.015,FUN_036840-T1,Q9YHV4,,,,,28.6,248.0,3e-18,94.7,sp|Q9YHV4|FSTA_DANRE Follistatin-A OS=Danio rerio OX=7955 GN=fsta PE=2 SV=2,,,,,,
OG_15231,FUN_036846-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27843.t1,apul_ptua,58.442,,,,,,,,,,,,,,,,,
OG_15232,FUN_036847-T1,,Pocillopora_meandrina_HIv1___TS.g2811.t2,apul_ptua,52.553,FUN_036847-T1,P81139,LIPR2_CAVPO,,Pancreatic lipase-related protein 2 (PL-RP2) (Cytotoxic T lymphocyte lipase) (GPL) (Galactolipase) (EC 3.1.1.26) (Triacylglycerol lipase) (EC 3.1.1.3),Cavia porcellus (Guinea pig),44.6,312.0,6.9e-63,243.0,sp|P81139|LIPR2_CAVPO Pancreatic lipase-related protein 2 OS=Cavia porcellus OX=10141 GN=PNLIPRP2 PE=1 SV=1,GO:0004465; GO:0004620; GO:0004806; GO:0005509; GO:0005615; GO:0006629; GO:0006644; GO:0009395; GO:0019376; GO:0019433; GO:0042589; GO:0043005; GO:0047372; GO:0047714,galactolipid catabolic process [GO:0019376]; lipid metabolic process [GO:0006629]; phospholipid catabolic process [GO:0009395]; phospholipid metabolic process [GO:0006644]; triglyceride catabolic process [GO:0019433],extracellular space [GO:0005615]; neuron projection [GO:0043005]; zymogen granule membrane [GO:0042589],calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; lipoprotein lipase activity [GO:0004465]; monoacylglycerol lipase activity [GO:0047372]; phospholipase activity [GO:0004620]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005615; GO:0006629; GO:0016787; GO:1901135,catalytic activity; extracellular space; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_15233,FUN_036859-T1,,Pocillopora_meandrina_HIv1___TS.g14411.t2,apul_ptua,67.929,FUN_036859-T1,P22412,,,,,51.9,368.0,4.6e-105,382.9,sp|P22412|DPEP1_PIG Dipeptidase 1 OS=Sus scrofa OX=9823 GN=DPEP1 PE=1 SV=1,,,,,,
OG_15234,FUN_036877-T2,,Pocillopora_meandrina_HIv1___RNAseq.g10627.t1,apul_ptua,62.4775,FUN_036877-T2,F1RRV3,THYG_PIG,,Thyroglobulin,Sus scrofa (Pig),24.6,1263.0,1.1e-61,243.0,sp|F1RRV3|THYG_PIG Thyroglobulin OS=Sus scrofa OX=9823 GN=TG PE=1 SV=5,GO:0005179; GO:0005615; GO:0006590; GO:0042446; GO:0042802,hormone biosynthetic process [GO:0042446]; thyroid hormone generation [GO:0006590],extracellular space [GO:0005615],hormone activity [GO:0005179]; identical protein binding [GO:0042802],GO:0005615; GO:0006575; GO:0048018; GO:0098772,extracellular space; modified amino acid metabolic process; receptor ligand activity; molecular function regulator activity
OG_15235,FUN_036887-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10796.t1b,apul_ptua,64.409,FUN_036887-T1,A0A2R8QF68,GRIK2_DANRE,,"Glutamate receptor ionotropic, kainate 2 (GluK2)",Danio rerio (Zebrafish) (Brachydanio rerio),28.2,887.0,9.299999999999999e-82,306.6,"sp|A0A2R8QF68|GRIK2_DANRE Glutamate receptor ionotropic, kainate 2 OS=Danio rerio OX=7955 GN=grik2 PE=3 SV=1",GO:0005886; GO:0015277; GO:0022849; GO:0032983; GO:0035249; GO:0042734; GO:0050804; GO:0098839; GO:1904315,"modulation of chemical synaptic transmission [GO:0050804]; synaptic transmission, glutamatergic [GO:0035249]",kainate selective glutamate receptor complex [GO:0032983]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynaptic membrane [GO:0042734],glutamate-gated calcium ion channel activity [GO:0022849]; kainate selective glutamate receptor activity [GO:0015277]; transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1904315],GO:0005215; GO:0005886; GO:0023052; GO:0060089,transporter activity; plasma membrane; signaling; molecular transducer activity
OG_15236,FUN_036894-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10789.t1,apul_ptua,60.221,,,,,,,,,,,,,,,,,
OG_15237,FUN_036920-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10825.t1,apul_ptua,52.684,FUN_036920-T1,Q4V8B8,TYW2_RAT,,tRNA wybutosine-synthesizing protein 2 homolog (tRNA-yW-synthesizing protein 2) (EC 2.5.1.114) (tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase),Rattus norvegicus (Rat),42.5,456.0,1.9e-99,364.4,sp|Q4V8B8|TYW2_RAT tRNA wybutosine-synthesizing protein 2 homolog OS=Rattus norvegicus OX=10116 GN=Trmt12 PE=2 SV=2,GO:0005737; GO:0008175; GO:0030488; GO:0031591; GO:0102522,tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591],cytoplasm [GO:0005737],tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity [GO:0102522]; tRNA methyltransferase activity [GO:0008175],GO:0003824; GO:0006399; GO:0016740; GO:0140098; GO:1901135,"catalytic activity; tRNA metabolic process; transferase activity; catalytic activity, acting on RNA; carbohydrate derivative metabolic process"
OG_15238,FUN_036994-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26711.t1,apul_ptua,88.529,FUN_036994-T1,Q9CWN7,,,,,64.0,408.0,3.9999999999999994e-142,506.1,sp|Q9CWN7|CNO11_MOUSE CCR4-NOT transcription complex subunit 11 OS=Mus musculus OX=10090 GN=Cnot11 PE=1 SV=1,,,,,,
OG_15239,FUN_037028-T1,,Pocillopora_meandrina_HIv1___TS.g5039.t1,apul_ptua,40.909,,,,,,,,,,,,,,,,,
OG_15240,FUN_037043-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26701.t1,apul_ptua,46.009,,,,,,,,,,,,,,,,,
OG_15241,FUN_037045-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26704.t1,apul_ptua,61.853,,,,,,,,,,,,,,,,,
OG_15242,FUN_037051-T1,,Pocillopora_meandrina_HIv1___RNAseq.9845_t,apul_ptua,52.206,,,,,,,,,,,,,,,,,
OG_15243,FUN_037072-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26678.t1,apul_ptua,47.0475,,,,,,,,,,,,,,,,,
OG_15244,FUN_037085-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11111.t1,apul_ptua,47.619,,,,,,,,,,,,,,,,,
OG_15245,FUN_037104-T1,,Pocillopora_meandrina_HIv1___RNAseq.g810.t1,apul_ptua,34.048,,,,,,,,,,,,,,,,,
OG_15246,FUN_037200-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11070.t1,apul_ptua,67.213,FUN_037200-T1,L7YAI7,,,,,41.9,363.0,2.5e-69,264.2,"sp|L7YAI7|B4GA1_DANRE Beta-1,4-glucuronyltransferase 1 OS=Danio rerio OX=7955 GN=b4gat1 PE=1 SV=1",,,,,,
OG_15247,FUN_037234-T1,,Pocillopora_meandrina_HIv1___TS.g8245.t1,apul_ptua,59.559,,,,,,,,,,,,,,,,,
OG_15248,FUN_037244-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11981.t1,apul_ptua,40.645,FUN_037244-T1,Q8WTT0,CLC4C_HUMAN,,C-type lectin domain family 4 member C (Blood dendritic cell antigen 2) (BDCA-2) (C-type lectin superfamily member 7) (Dendritic lectin) (CD antigen CD303),Homo sapiens (Human),27.1,144.0,4.3e-06,53.1,sp|Q8WTT0|CLC4C_HUMAN C-type lectin domain family 4 member C OS=Homo sapiens OX=9606 GN=CLEC4C PE=1 SV=1,GO:0002250; GO:0005886; GO:0009897; GO:0030246; GO:0030667; GO:0038187; GO:0046872; GO:0061760; GO:0070821; GO:0101003,adaptive immune response [GO:0002250]; antifungal innate immune response [GO:0061760],external side of plasma membrane [GO:0009897]; ficolin-1-rich granule membrane [GO:0101003]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; tertiary granule membrane [GO:0070821],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187],GO:0002376; GO:0005886; GO:0060089; GO:0098542,immune system process; plasma membrane; molecular transducer activity; defense response to other organism
OG_15249,FUN_037277-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5498.t1,apul_ptua,60.7655,,,,,,,,,,,,,,,,,
OG_15250,FUN_037284-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1329.t1,apul_ptua,30.9945,,,,,,,,,,,,,,,,,
OG_15251,FUN_037289-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10672.t1,apul_ptua,66.571,FUN_037289-T1,Q6P6X9,NUP35_DANRE,,Nucleoporin NUP35 (35 kDa nucleoporin) (Nuclear pore complex protein Nup53) (Nucleoporin NUP53),Danio rerio (Zebrafish) (Brachydanio rerio),41.8,349.0,2e-56,221.1,sp|Q6P6X9|NUP35_DANRE Nucleoporin NUP35 OS=Danio rerio OX=7955 GN=nup35 PE=1 SV=1,GO:0003676; GO:0005543; GO:0006607; GO:0006999; GO:0017056; GO:0031965; GO:0044613; GO:0044615; GO:0051028,mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999],nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615],nucleic acid binding [GO:0003676]; phospholipid binding [GO:0005543]; structural constituent of nuclear pore [GO:0017056],GO:0005198; GO:0006886; GO:0006913; GO:0008289,structural molecule activity; intracellular protein transport; nucleocytoplasmic transport; lipid binding
OG_15252,FUN_037303-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10724.t1,apul_ptua,46.835,,,,,,,,,,,,,,,,,
OG_15253,FUN_037326-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10695.t1,apul_ptua,69.8885,FUN_037326-T1,Q02953,HSF_SCHPO,,Heat shock factor protein (HSF) (Heat shock transcription factor) (HSTF),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),40.4,109.0,1.4e-13,78.6,sp|Q02953|HSF_SCHPO Heat shock factor protein OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=hsf1 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0005634; GO:0005737; GO:0005829; GO:0034605; GO:0045944,cellular response to heat [GO:0034605]; positive regulation of transcription by RNA polymerase II [GO:0045944],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0005829; GO:0006355; GO:0043226; GO:0140110,DNA binding; nucleus; cytosol; regulation of DNA-templated transcription; organelle; transcription regulator activity
OG_15254,FUN_037329-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10693.t1,apul_ptua,74.729,,,,,,,,,,,,,,,,,
OG_15255,FUN_037335-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10740.t1,apul_ptua,66.834,FUN_037335-T1,A0JNA8,,,,,30.7,978.0,4.6e-120,433.7,sp|A0JNA8|PAXI1_BOVIN PAX-interacting protein 1 OS=Bos taurus OX=9913 GN=PAXIP1 PE=2 SV=1,,,,,,
OG_15256,FUN_037382-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11001.t1,apul_ptua,76.996,FUN_037382-T1,Q7M6Z5,KIF27_RAT,,Kinesin-like protein KIF27,Rattus norvegicus (Rat),33.2,1379.0,1.2e-160,569.3,sp|Q7M6Z5|KIF27_RAT Kinesin-like protein KIF27 OS=Rattus norvegicus OX=10116 GN=Kif27 PE=1 SV=1,GO:0003351; GO:0003777; GO:0005524; GO:0005576; GO:0005737; GO:0005871; GO:0005874; GO:0005929; GO:0007018; GO:0008017; GO:0016887; GO:0021591; GO:0051649; GO:0060271,cilium assembly [GO:0060271]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; establishment of localization in cell [GO:0051649]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591],cilium [GO:0005929]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; kinesin complex [GO:0005871]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005576; GO:0005929; GO:0007018; GO:0008092; GO:0016787; GO:0016853; GO:0043226; GO:0044782; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; extracellular region; cilium; microtubule-based movement; cytoskeletal protein binding; hydrolase activity; isomerase activity; organelle; cilium organization; anatomical structure development; ATP-dependent activity
OG_15257,FUN_037388-T1,,Pocillopora_meandrina_HIv1___TS.g14235.t1,apul_ptua,82.609,,,,,,,,,,,,,,,,,
OG_15258,FUN_037398-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10924.t1,apul_ptua,70.242,FUN_037398-T1,A9Y006,AQP3_PIG,,Aquaporin-3 (Aquaglyceroporin-3),Sus scrofa (Pig),52.7,260.0,8.900000000000001e-74,278.5,sp|A9Y006|AQP3_PIG Aquaporin-3 OS=Sus scrofa OX=9823 GN=AQP3 PE=2 SV=1,GO:0005886; GO:0006833; GO:0015166; GO:0015250; GO:0015254; GO:0015791; GO:0015793; GO:0016323,glycerol transmembrane transport [GO:0015793]; polyol transmembrane transport [GO:0015791]; water transport [GO:0006833],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],glycerol channel activity [GO:0015254]; polyol transmembrane transporter activity [GO:0015166]; water channel activity [GO:0015250],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_15259,FUN_037399-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10925.t1,apul_ptua,79.377,FUN_037399-T1,Q6P0T2,,,,,41.4,268.0,5.1e-49,196.1,sp|Q6P0T2|TAF8_DANRE Transcription initiation factor TFIID subunit 8 OS=Danio rerio OX=7955 GN=taf8 PE=1 SV=1,,,,,,
OG_15260,FUN_037402-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10938.t1,apul_ptua,39.623,,,,,,,,,,,,,,,,,
OG_15261,FUN_037430-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10959.t1b,apul_ptua,45.1805,,,,,,,,,,,,,,,,,
OG_15262,FUN_037436-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10961.t1,apul_ptua,32.0,,,,,,,,,,,,,,,,,
OG_15263,FUN_037443-T3,,Pocillopora_meandrina_HIv1___RNAseq.g10975.t1,apul_ptua,87.335,FUN_037443-T3,Q9QXL1,KI21B_MOUSE,,Kinesin-like protein KIF21B (Kinesin-like protein KIF6),Mus musculus (Mouse),44.3,1585.0,6.5999999999999986e-245,849.4,sp|Q9QXL1|KI21B_MOUSE Kinesin-like protein KIF21B OS=Mus musculus OX=10090 GN=Kif21b PE=1 SV=2,GO:0003777; GO:0005524; GO:0005874; GO:0007420; GO:0008017; GO:0022038; GO:0030426; GO:0032839; GO:0098845; GO:0098934; GO:0098978; GO:0099072,brain development [GO:0007420]; corpus callosum development [GO:0022038]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; retrograde dendritic transport [GO:0098934],dendrite cytoplasm [GO:0032839]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; microtubule [GO:0005874]; postsynaptic endosome [GO:0098845],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005768; GO:0007018; GO:0008092; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0140657,cytoskeletal motor activity; catalytic activity; endosome; microtubule-based movement; cytoskeletal protein binding; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; ATP-dependent activity
OG_15264,FUN_037446-T1,,Pocillopora_meandrina_HIv1___TS.g13383.t1,apul_ptua,53.942,,,,,,,,,,,,,,,,,
OG_15265,FUN_037462-T1,,Pocillopora_meandrina_HIv1___TS.g22783.t1,apul_ptua,53.879,FUN_037462-T1,Q6PBD4,,,,,34.0,250.0,1.6e-20,101.3,sp|Q6PBD4|HES4_XENTR Transcription factor HES-4 OS=Xenopus tropicalis OX=8364 GN=hes4 PE=2 SV=1,,,,,,
OG_15266,FUN_037524-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1324.t1b,apul_ptua,36.68,FUN_037524-T1,Q96A99,,,,,31.5,143.0,4.9e-12,73.2,sp|Q96A99|PTX4_HUMAN Pentraxin-4 OS=Homo sapiens OX=9606 GN=PTX4 PE=2 SV=2,,,,,,
OG_15267,FUN_037570-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1587.t1,apul_ptua,70.968,,,,,,,,,,,,,,,,,
OG_15268,FUN_037580-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8249.t1,apul_ptua,53.892,FUN_037580-T1,O64411,,,,,33.3,483.0,1.7e-64,248.4,sp|O64411|PAO1_MAIZE Polyamine oxidase 1 OS=Zea mays OX=4577 GN=MPAO1 PE=1 SV=1,,,,,,
OG_15269,FUN_037582-T1,,Pocillopora_meandrina_HIv1___TS.g3878.t1,apul_ptua,38.333,,,,,,,,,,,,,,,,,
OG_15270,FUN_037583-T2,,Pocillopora_meandrina_HIv1___RNAseq.g3720.t1,apul_ptua,78.077,FUN_037583-T2,Q58A42,DD3_DICDI,,Protein DD3-3,Dictyostelium discoideum (Social amoeba),32.7,566.0,3.7e-60,234.2,sp|Q58A42|DD3_DICDI Protein DD3-3 OS=Dictyostelium discoideum OX=44689 GN=DD3-3 PE=2 SV=1,GO:0016020,,membrane [GO:0016020],,,
OG_15271,FUN_037591-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1597.t1,apul_ptua,84.589,FUN_037591-T1,A7SEP9,RU1C_NEMVE,,U1 small nuclear ribonucleoprotein C (U1 snRNP C) (U1-C) (U1C),Nematostella vectensis (Starlet sea anemone),89.8,59.0,9.1e-27,121.3,sp|A7SEP9|RU1C_NEMVE U1 small nuclear ribonucleoprotein C OS=Nematostella vectensis OX=45351 GN=v1g244745 PE=3 SV=1,GO:0000243; GO:0000387; GO:0000395; GO:0003729; GO:0005685; GO:0008270; GO:0030619; GO:0030627; GO:0071004,mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387],commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004],mRNA binding [GO:0003729]; pre-mRNA 5'-splice site binding [GO:0030627]; U1 snRNA binding [GO:0030619]; zinc ion binding [GO:0008270],GO:0003723; GO:0065003,RNA binding; protein-containing complex assembly
OG_15272,FUN_037695-T1,,Pocillopora_meandrina_HIv1___RNAseq.22573_t,apul_ptua,31.471,FUN_037695-T1,P0C6B8,,,,,40.8,211.0,1.7e-37,158.3,"sp|P0C6B8|SVEP1_RAT Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 OS=Rattus norvegicus OX=10116 GN=Svep1 PE=1 SV=1",,,,,,
OG_15273,FUN_037711-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1404.t1,apul_ptua,60.1495,,,,,,,,,,,,,,,,,
OG_15274,FUN_037747-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1337.t1,apul_ptua,44.5865,FUN_037747-T1,Q9Z277,BAZ1B_MOUSE,,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor homolog) (Williams-Beuren syndrome chromosomal region 9 protein homolog),Mus musculus (Mouse),31.8,362.0,3.5e-38,161.8,sp|Q9Z277|BAZ1B_MOUSE Tyrosine-protein kinase BAZ1B OS=Mus musculus OX=10090 GN=Baz1b PE=1 SV=2,GO:0000793; GO:0004715; GO:0005524; GO:0005634; GO:0005654; GO:0005721; GO:0005730; GO:0006325; GO:0006338; GO:0006974; GO:0008270; GO:0042393; GO:0043596; GO:0043687; GO:0045943; GO:0045944; GO:0045945; GO:0090535; GO:0110016; GO:0140801; GO:1905213,chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; negative regulation of mitotic chromosome condensation [GO:1905213]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; post-translational protein modification [GO:0043687],B-WICH complex [GO:0110016]; condensed chromosome [GO:0000793]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; WICH complex [GO:0090535],ATP binding [GO:0005524]; histone binding [GO:0042393]; histone H2AXY142 kinase activity [GO:0140801]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; zinc ion binding [GO:0008270],GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005730; GO:0006325; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; chromosome; nucleolus; chromatin organization; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_15275,FUN_037754-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1342.t1,apul_ptua,62.814,,,,,,,,,,,,,,,,,
OG_15276,FUN_037770-T1,,Pocillopora_meandrina_HIv1___RNAseq.27147_t,apul_ptua,79.231,FUN_037770-T1,E2RKA8,,,,,74.2,132.0,1.5999999999999998e-49,196.8,sp|E2RKA8|RL32_CANLF Large ribosomal subunit protein eL32 OS=Canis lupus familiaris OX=9615 GN=RPL32 PE=1 SV=1,,,,,,
OG_15277,FUN_037783-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1518.t1,apul_ptua,84.743,FUN_037783-T1,Q9VCA2,,,,,34.4,410.0,1.9e-63,245.0,sp|Q9VCA2|ORCT_DROME Organic cation transporter protein OS=Drosophila melanogaster OX=7227 GN=Orct PE=1 SV=1,,,,,,
OG_15278,FUN_037804-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1564.t1,apul_ptua,74.672,FUN_037804-T1,Q9XS37,,,,,62.8,86.0,1.7999999999999997e-24,114.4,sp|Q9XS37|SRY_BOSMU Sex-determining region Y protein OS=Bos mutus grunniens OX=30521 GN=SRY PE=3 SV=1,,,,,,
OG_15279,FUN_037811-T1,,Pocillopora_meandrina_HIv1___TS.g22972.t1,apul_ptua,50.886,,,,,,,,,,,,,,,,,
OG_15280,FUN_037842-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1432.t1,apul_ptua,54.111,,,,,,,,,,,,,,,,,
OG_15281,FUN_037919-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26499.t1,apul_ptua,67.178,,,,,,,,,,,,,,,,,
OG_15282,FUN_037930-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26221.t1,apul_ptua,39.834,FUN_037930-T1,Q5ZIE8,,,,,26.2,454.0,2.4e-12,75.9,sp|Q5ZIE8|MCAF1_CHICK Activating transcription factor 7-interacting protein 1 OS=Gallus gallus OX=9031 GN=ATF7IP PE=2 SV=1,,,,,,
OG_15283,FUN_037939-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26200.t1,apul_ptua,99.468,FUN_037939-T1,P41340,,,,,97.1,376.0,2.7e-216,752.3,sp|P41340|ACT3_LIMPO Actin-3 OS=Limulus polyphemus OX=6850 PE=1 SV=1,,,,,,
OG_15284,FUN_037959-T1,,Pocillopora_meandrina_HIv1___TS.g19258.t1,apul_ptua,62.8965,FUN_037959-T1,Q08E50,GBRA5_BOVIN,,Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) (GABAAR subunit alpha-5),Bos taurus (Bovine),28.3,453.0,8.1e-51,203.0,sp|Q08E50|GBRA5_BOVIN Gamma-aminobutyric acid receptor subunit alpha-5 OS=Bos taurus OX=9913 GN=GABRA5 PE=2 SV=1,GO:0004890; GO:0007214; GO:0022851; GO:0032590; GO:0034707; GO:0045211; GO:0051932; GO:0098794; GO:1902476; GO:1902711; GO:1904862,"chloride transmembrane transport [GO:1902476]; gamma-aminobutyric acid signaling pathway [GO:0007214]; inhibitory synapse assembly [GO:1904862]; synaptic transmission, GABAergic [GO:0051932]",chloride channel complex [GO:0034707]; dendrite membrane [GO:0032590]; GABA-A receptor complex [GO:1902711]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211],GABA-A receptor activity [GO:0004890]; GABA-gated chloride ion channel activity [GO:0022851],GO:0005215; GO:0023052; GO:0034330; GO:0055085; GO:0060089,transporter activity; signaling; cell junction organization; transmembrane transport; molecular transducer activity
OG_15285,FUN_037972-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26179.t1,apul_ptua,59.407,FUN_037972-T1,P15870,,,,,49.5,99.0,1.6e-12,74.3,sp|P15870|H1D_STRPU Histone H1-delta OS=Strongylocentrotus purpuratus OX=7668 PE=3 SV=1,,,,,,
OG_15286,FUN_037981-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26194.t1,apul_ptua,87.5,FUN_037981-T1,O19137,,,,,57.1,261.0,2.7000000000000004e-32,140.6,sp|O19137|CPSF4_BOVIN Cleavage and polyadenylation specificity factor subunit 4 OS=Bos taurus OX=9913 GN=CPSF4 PE=1 SV=1,,,,,,
OG_15287,FUN_037984-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26189.t1,apul_ptua,81.818,FUN_037984-T1,Q5PQ53,PEF1_XENLA,,Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1),Xenopus laevis (African clawed frog),50.0,106.0,4.3e-25,115.9,sp|Q5PQ53|PEF1_XENLA Peflin OS=Xenopus laevis OX=8355 GN=pef1 PE=1 SV=1,GO:0005509; GO:0005783; GO:0006888; GO:0014029; GO:0014032; GO:0030127; GO:0031463; GO:0048208; GO:0048306; GO:1902527; GO:1990756,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527],COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; endoplasmic reticulum [GO:0005783],calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0005783; GO:0016192; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0065003,endoplasmic reticulum; vesicle-mediated transport; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; protein-containing complex assembly
OG_15288,FUN_038005-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26251.t1,apul_ptua,92.47,FUN_038005-T1,Q8BW94,,,,,63.9,4066.0,0.0,5168.6,sp|Q8BW94|DYH3_MOUSE Dynein axonemal heavy chain 3 OS=Mus musculus OX=10090 GN=Dnah3 PE=1 SV=2,,,,,,
OG_15289,FUN_038008-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26247.t1,apul_ptua,67.769,,,,,,,,,,,,,,,,,
OG_15290,FUN_038009-T1,,Pocillopora_meandrina_HIv1___TS.g18996.t1,apul_ptua,67.706,,,,,,,,,,,,,,,,,
OG_15291,FUN_038025-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26537.t1,apul_ptua,52.222,,,,,,,,,,,,,,,,,
OG_15292,FUN_038054-T1,,Pocillopora_meandrina_HIv1___RNAseq.g780.t1,apul_ptua,84.63300000000001,FUN_038054-T1,Q29S22,DDX47_BOVIN,,Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47),Bos taurus (Bovine),77.5,396.0,2.5e-176,619.8,sp|Q29S22|DDX47_BOVIN Probable ATP-dependent RNA helicase DDX47 OS=Bos taurus OX=9913 GN=DDX47 PE=2 SV=1,GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005730; GO:0006364; GO:0006397; GO:0008380; GO:0008625; GO:0016887,extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],nucleolus [GO:0005730]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005730; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleolus; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_15293,FUN_038083-T1,,Pocillopora_meandrina_HIv1___RNAseq.g807.t1,apul_ptua,70.476,FUN_038083-T1,Q6DDU5,,,,,38.3,81.0,2.7e-07,56.2,sp|Q6DDU5|SMAP_XENLA Small acidic protein OS=Xenopus laevis OX=8355 GN=smap PE=2 SV=1,,,,,,
OG_15294,FUN_038097-T1,,Pocillopora_meandrina_HIv1___RNAseq.g821.t1,apul_ptua,48.718,,,,,,,,,,,,,,,,,
OG_15295,FUN_038115-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28341.t1,apul_ptua,54.936,FUN_038115-T1,Q9BYK8,,,,,44.8,279.0,2.3000000000000002e-58,227.3,sp|Q9BYK8|HELZ2_HUMAN 3'-5' exoribonuclease HELZ2 OS=Homo sapiens OX=9606 GN=HELZ2 PE=1 SV=7,,,,,,
OG_15296,FUN_038120-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28331.t1,apul_ptua,57.884,FUN_038120-T1,Q708S7,ASI1A_DANRE,,"Acid-sensing ion channel 1A (ASIC1-A) (Acid-sensing ion channel 1.2-A) (Amiloride-sensitive cation channel 2-B, neuronal-A) (ZASIC1.2)",Danio rerio (Zebrafish) (Brachydanio rerio),30.7,486.0,1.3e-48,195.7,sp|Q708S7|ASI1A_DANRE Acid-sensing ion channel 1A OS=Danio rerio OX=7955 GN=asic1a PE=1 SV=1,GO:0005261; GO:0005886; GO:0015280; GO:0030425; GO:0035725; GO:0045211; GO:0071467; GO:0160128,cellular response to pH [GO:0071467]; sodium ion transmembrane transport [GO:0035725],dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],ligand-gated sodium channel activity [GO:0015280]; monoatomic cation channel activity [GO:0005261]; pH-gated monoatomic ion channel activity [GO:0160128],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
OG_15297,FUN_038130-T1,,Pocillopora_meandrina_HIv1___RNAseq.g767.t1,apul_ptua,61.5,FUN_038130-T1,F1LV46,,,,,38.2,401.0,1e-78,295.4,"sp|F1LV46|I23O2_RAT Indoleamine 2,3-dioxygenase 2 OS=Rattus norvegicus OX=10116 GN=Ido2 PE=2 SV=4",,,,,,
OG_15298,FUN_038137-T1,,Pocillopora_meandrina_HIv1___TS.g5292.t2,apul_ptua,49.8725,,,,,,,,,,,,,,,,,
OG_15299,FUN_038155-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1150.t1,apul_ptua,41.096,,,,,,,,,,,,,,,,,
OG_15300,FUN_038156-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1151.t1,apul_ptua,57.8155,,,,,,,,,,,,,,,,,
OG_15301,FUN_038190-T1,,Pocillopora_meandrina_HIv1___RNAseq.g944.t1,apul_ptua,51.748,FUN_038190-T1,A8QZJ5,MCTX1_MILDI,,Millepora cytotoxin-1 (MCTx-1),Millepora dichotoma (Net fire coral),26.5,147.0,3.8e-07,56.6,sp|A8QZJ5|MCTX1_MILDI Millepora cytotoxin-1 OS=Millepora dichotoma OX=544484 PE=1 SV=1,GO:0005615; GO:0030199; GO:0031012; GO:0042151,collagen fibril organization [GO:0030199],extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nematocyst [GO:0042151],,GO:0005615; GO:0030198; GO:0030312; GO:0031012; GO:0043226,extracellular space; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle
OG_15302,FUN_038215-T1,,Pocillopora_meandrina_HIv1___RNAseq.g30349.t1,apul_ptua,48.5505,,,,,,,,,,,,,,,,,
OG_15303,FUN_038219-T1,,Pocillopora_meandrina_HIv1___TS.g5438.t1,apul_ptua,50.234,FUN_038219-T1,Q7Z442,PK1L2_HUMAN,,Polycystin-1-like protein 2 (Polycystin-1L2) (PC1-like 2 protein) (Polycystic kidney disease protein 1-like 2),Homo sapiens (Human),24.2,1767.0,2.7e-140,503.4,sp|Q7Z442|PK1L2_HUMAN Polycystin-1-like protein 2 OS=Homo sapiens OX=9606 GN=PKD1L2 PE=1 SV=5,GO:0005262; GO:0005509; GO:0016020; GO:0030246; GO:0050982,detection of mechanical stimulus [GO:0050982],membrane [GO:0016020],calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246],GO:0005215,transporter activity
OG_15304,FUN_038220-T1,,Pocillopora_meandrina_HIv1___RNAseq.g904.t1,apul_ptua,63.504,FUN_038220-T1,P42125,ECI1_MOUSE,,"Enoyl-CoA delta isomerase 1, mitochondrial (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase)",Mus musculus (Mouse),40.2,256.0,1.8e-47,191.0,"sp|P42125|ECI1_MOUSE Enoyl-CoA delta isomerase 1, mitochondrial OS=Mus musculus OX=10090 GN=Eci1 PE=1 SV=2",GO:0004165; GO:0005739; GO:0005743; GO:0005759; GO:0006635,fatty acid beta-oxidation [GO:0006635],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],delta(3)-delta(2)-enoyl-CoA isomerase activity [GO:0004165],GO:0003824; GO:0005739; GO:0006629; GO:0016853; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; isomerase activity; organelle
OG_15305,FUN_038237-T1,,Pocillopora_meandrina_HIv1___RNAseq.g909.t1,apul_ptua,47.6045,,,,,,,,,,,,,,,,,
OG_15306,FUN_038239-T1,,Pocillopora_meandrina_HIv1___TS.g27245.t2,apul_ptua,82.353,,,,,,,,,,,,,,,,,
OG_15307,FUN_038240-T1,,Pocillopora_meandrina_HIv1___RNAseq.g908.t1,apul_ptua,47.932,,,,,,,,,,,,,,,,,
OG_15308,FUN_038254-T1,,Pocillopora_meandrina_HIv1___RNAseq.g921.t1,apul_ptua,64.592,FUN_038254-T1,Q80T11,USH1G_MOUSE,,pre-mRNA splicing regulator USH1G (Jackson shaker protein) (Scaffold protein containing ankyrin repeats and SAM domain) (Usher syndrome type-1G protein homolog),Mus musculus (Mouse),38.2,477.0,2.2e-18,95.1,sp|Q80T11|USH1G_MOUSE pre-mRNA splicing regulator USH1G OS=Mus musculus OX=10090 GN=Ush1g PE=1 SV=1,GO:0001917; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0007605; GO:0015030; GO:0015629; GO:0016020; GO:0016607; GO:0030507; GO:0032391; GO:0036064; GO:0042472; GO:0042802; GO:0045494; GO:0050953; GO:0050957; GO:0060113; GO:0060122; GO:0097546; GO:2000369,equilibrioception [GO:0050957]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; photoreceptor cell maintenance [GO:0045494]; regulation of clathrin-dependent endocytosis [GO:2000369]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin cytoskeleton [GO:0015629]; Cajal body [GO:0015030]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; spectrin binding [GO:0030507],GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0008092; GO:0030154; GO:0043226; GO:0050877,microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cytoskeletal protein binding; cell differentiation; organelle; nervous system process
OG_15309,FUN_038267-T1,,Pocillopora_meandrina_HIv1___RNAseq.g912.t1,apul_ptua,60.208,FUN_038267-T1,P97434,MPRIP_MOUSE,,Myosin phosphatase Rho-interacting protein (Rho-interacting protein 3) (RIP3) (p116Rip),Mus musculus (Mouse),26.0,169.0,3.4e-12,76.6,sp|P97434|MPRIP_MOUSE Myosin phosphatase Rho-interacting protein OS=Mus musculus OX=10090 GN=Mprip PE=1 SV=2,GO:0003779; GO:0005737; GO:0005856,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],actin binding [GO:0003779],GO:0005856; GO:0008092; GO:0043226,cytoskeleton; cytoskeletal protein binding; organelle
OG_15310,FUN_038272-T2,,Pocillopora_meandrina_HIv1___TS.g8102.t1,apul_ptua,55.30500000000001,FUN_038272-T2,F1QAM1,,,,,25.2,258.0,7.4e-11,69.7,sp|F1QAM1|ZDHC4_DANRE Palmitoyltransferase ZDHHC4 OS=Danio rerio OX=7955 GN=zdhhc4 PE=2 SV=1,,,,,,
OG_15311,FUN_038297-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28297.t1,apul_ptua,85.483,FUN_038297-T1,Q27991,MYH10_BOVIN,,"Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)",Bos taurus (Bovine),67.9,882.0,0.0,1233.4,sp|Q27991|MYH10_BOVIN Myosin-10 OS=Bos taurus OX=9913 GN=MYH10 PE=2 SV=2,GO:0000146; GO:0000281; GO:0005516; GO:0005524; GO:0005737; GO:0007155; GO:0008360; GO:0016460; GO:0030027; GO:0031032; GO:0032982; GO:0051015,actomyosin structure organization [GO:0031032]; cell adhesion [GO:0007155]; mitotic cytokinesis [GO:0000281]; regulation of cell shape [GO:0008360],cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; myosin filament [GO:0032982]; myosin II complex [GO:0016460],actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146],GO:0000910; GO:0003774; GO:0003824; GO:0007010; GO:0007155; GO:0008092; GO:0016853; GO:0140657,cytokinesis; cytoskeletal motor activity; catalytic activity; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_15312,FUN_038364-T1,,Pocillopora_meandrina_HIv1___TS.g5628.t1,apul_ptua,52.432,FUN_038364-T1,Q7TN88,,,,,24.3,1072.0,1.5e-88,329.7,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_15313,FUN_038411-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28286.t1,apul_ptua,80.386,FUN_038411-T1,Q9UIC8,,,,,53.2,312.0,1.3e-94,347.8,sp|Q9UIC8|LCMT1_HUMAN Leucine carboxyl methyltransferase 1 OS=Homo sapiens OX=9606 GN=LCMT1 PE=1 SV=2,,,,,,
OG_15314,FUN_038434-T1,,Pocillopora_meandrina_HIv1___RNAseq.g881.t1,apul_ptua,67.791,FUN_038434-T1,Q92820,GGH_HUMAN,,Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase),Homo sapiens (Human),44.6,316.0,4.9e-73,276.2,sp|Q92820|GGH_HUMAN Gamma-glutamyl hydrolase OS=Homo sapiens OX=9606 GN=GGH PE=1 SV=2,GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0008238; GO:0008242; GO:0034722; GO:0035578; GO:0035580; GO:0042470; GO:0046900; GO:0070062; GO:1904724,tetrahydrofolylpolyglutamate metabolic process [GO:0046900],azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; vacuole [GO:0005773],exopeptidase activity [GO:0008238]; gamma-glutamyl-peptidase activity [GO:0034722]; omega peptidase activity [GO:0008242],GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005773; GO:0006575; GO:0016787; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; extracellular region; extracellular space; nucleus; vacuole; modified amino acid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_15315,FUN_038442-T1,,Pocillopora_meandrina_HIv1___TS.g8031.t1,apul_ptua,45.223,,,,,,,,,,,,,,,,,
OG_15316,FUN_038497-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28198.t1,apul_ptua,83.333,FUN_038497-T1,Q17MI0,,,,,51.6,213.0,9e-55,214.9,sp|Q17MI0|MED7_AEDAE Mediator of RNA polymerase II transcription subunit 7 OS=Aedes aegypti OX=7159 GN=MED7 PE=3 SV=1,,,,,,
OG_15317,FUN_038526-T1,,Pocillopora_meandrina_HIv1___TS.g7974.t1,apul_ptua,37.194500000000005,,,,,,,,,,,,,,,,,
OG_15318,FUN_038558-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1022.t1,apul_ptua,65.672,FUN_038558-T1,A6LB99,,,,,52.9,280.0,1.3999999999999998e-82,308.1,sp|A6LB99|END4_PARD8 Probable endonuclease 4 OS=Parabacteroides distasonis (strain ATCC 8503 / DSM 20701 / CIP 104284 / JCM 5825 / NCTC 11152) OX=435591 GN=nfo PE=3 SV=1,,,,,,
OG_15319,FUN_038573-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1014.t2,apul_ptua,43.096500000000006,FUN_038573-T1,Q32LP7,SKAP2_BOVIN,,Src kinase-associated phosphoprotein 2 (Src family-associated phosphoprotein 2),Bos taurus (Bovine),53.7,67.0,1.1e-12,76.6,sp|Q32LP7|SKAP2_BOVIN Src kinase-associated phosphoprotein 2 OS=Bos taurus OX=9913 GN=SKAP2 PE=2 SV=1,GO:0005654; GO:0005737; GO:0005829; GO:0005886; GO:0008285; GO:0042113,B cell activation [GO:0042113]; negative regulation of cell population proliferation [GO:0008285],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],,GO:0002376; GO:0005654; GO:0005829; GO:0005886,immune system process; nucleoplasm; cytosol; plasma membrane
OG_15320,FUN_038588-T1,,Pocillopora_meandrina_HIv1___RNAseq.g994.t1,apul_ptua,51.603,FUN_038588-T1,Q9EQD2,NPFF2_RAT,,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (Neuropeptide G-protein coupled receptor),Rattus norvegicus (Rat),28.7,307.0,9.1e-25,115.9,sp|Q9EQD2|NPFF2_RAT Neuropeptide FF receptor 2 OS=Rattus norvegicus OX=10116 GN=Npffr2 PE=2 SV=1,GO:0004930; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0015629; GO:0031628; GO:0032870; GO:0043408,cellular response to hormone stimulus [GO:0032870]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; regulation of MAPK cascade [GO:0043408],actin cytoskeleton [GO:0015629]; plasma membrane [GO:0005886],G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; opioid receptor binding [GO:0031628],GO:0005856; GO:0005886; GO:0043226; GO:0060089,cytoskeleton; plasma membrane; organelle; molecular transducer activity
OG_15321,FUN_038597-T1,,Pocillopora_meandrina_HIv1___RNAseq.g992.t1,apul_ptua,65.672,FUN_038597-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),33.2,184.0,7.5e-10,65.9,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_15322,FUN_038623-T1,,Pocillopora_meandrina_HIv1___TS.g9702.t1,apul_ptua,39.655,,,,,,,,,,,,,,,,,
OG_15323,FUN_038653-T1,,Pocillopora_meandrina_HIv1___TS.g12379.t1,apul_ptua,78.049,,,,,,,,,,,,,,,,,
OG_15324,FUN_038658-T1,,Pocillopora_meandrina_HIv1___TS.g19233.t1,apul_ptua,52.327,FUN_038658-T1,Q1LYL8,,,,,29.5,631.0,8.8e-58,226.5,sp|Q1LYL8|ASTE1_DANRE Single-strand DNA endonuclease ASTE1 OS=Danio rerio OX=7955 GN=aste1a PE=2 SV=1,,,,,,
OG_15325,FUN_038690-T2,,Pocillopora_meandrina_HIv1___TS.g19229.t1a,apul_ptua,58.824,FUN_038690-T2,Q4V7Q8,,,,,40.9,93.0,4.6e-13,75.5,sp|Q4V7Q8|TM220_XENLA Transmembrane protein 220 OS=Xenopus laevis OX=8355 GN=tmem220 PE=2 SV=1,,,,,,
OG_15326,FUN_038692-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26475.t1,apul_ptua,33.5885,,,,,,,,,,,,,,,,,
OG_15327,FUN_038694-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26474.t1,apul_ptua,32.4605,,,,,,,,,,,,,,,,,
OG_15328,FUN_038708-T2,,Pocillopora_meandrina_HIv1___RNAseq.g26442.t1b,apul_ptua,42.857,,,,,,,,,,,,,,,,,
OG_15329,FUN_038711-T1,,Pocillopora_meandrina_HIv1___RNAseq.7220_t,apul_ptua,49.57,,,,,,,,,,,,,,,,,
OG_15330,FUN_038741-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26427.t1,apul_ptua,40.56,,,,,,,,,,,,,,,,,
OG_15331,FUN_038744-T2,,Pocillopora_meandrina_HIv1___TS.g19176.t1,apul_ptua,58.417,,,,,,,,,,,,,,,,,
OG_15332,FUN_038752-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26416.t1,apul_ptua,84.227,FUN_038752-T1,P42620,,,,,59.5,311.0,1.6e-101,370.9,sp|P42620|YQJG_ECOLI Glutathionyl-hydroquinone reductase YqjG OS=Escherichia coli (strain K12) OX=83333 GN=yqjG PE=1 SV=1,,,,,,
OG_15333,FUN_038794-T2,,Pocillopora_meandrina_HIv1___RNAseq.g26389.t1,apul_ptua,51.718,,,,,,,,,,,,,,,,,
OG_15334,FUN_038814-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28536.t1,apul_ptua,74.394,FUN_038814-T1,Q86WA9,S2611_HUMAN,,Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11),Homo sapiens (Human),47.4,538.0,2.2e-127,457.6,sp|Q86WA9|S2611_HUMAN Sodium-independent sulfate anion transporter OS=Homo sapiens OX=9606 GN=SLC26A11 PE=1 SV=2,GO:0005254; GO:0005654; GO:0005765; GO:0005783; GO:0005794; GO:0005886; GO:0006811; GO:0008271; GO:0008509; GO:0015116; GO:0016020; GO:0016323; GO:0016324; GO:0019532; GO:0043231; GO:0070062; GO:0140900; GO:1902358; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transport [GO:0006811]; oxalate transport [GO:0019532]; sulfate transmembrane transport [GO:1902358],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; chloride:bicarbonate antiporter activity [GO:0140900]; monoatomic anion transmembrane transporter activity [GO:0008509]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116],GO:0005215; GO:0005654; GO:0005783; GO:0005794; GO:0005886; GO:0043226; GO:0055085,transporter activity; nucleoplasm; endoplasmic reticulum; Golgi apparatus; plasma membrane; organelle; transmembrane transport
OG_15335,FUN_038815-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28535.t1,apul_ptua,91.739,FUN_038815-T1,P33947,ERD22_HUMAN,,ER lumen protein-retaining receptor 2 (ERD2-like protein 1) (ELP-1) (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2),Homo sapiens (Human),73.0,230.0,2e-89,330.1,sp|P33947|ERD22_HUMAN ER lumen protein-retaining receptor 2 OS=Homo sapiens OX=9606 GN=KDELR2 PE=1 SV=1,GO:0000139; GO:0005046; GO:0005783; GO:0005789; GO:0005801; GO:0006621; GO:0006890; GO:0015031; GO:0016020; GO:0030133; GO:0030663; GO:0035437; GO:0046923,"maintenance of protein localization in endoplasmic reticulum [GO:0035437]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cis-Golgi network [GO:0005801]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; transport vesicle [GO:0030133],ER retention sequence binding [GO:0046923]; KDEL sequence binding [GO:0005046],GO:0005783; GO:0016192; GO:0031410; GO:0043226,endoplasmic reticulum; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_15336,FUN_038817-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28530.t1,apul_ptua,49.931,,,,,,,,,,,,,,,,,
OG_15337,FUN_038835-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28644.t2,apul_ptua,64.4725,FUN_038835-T1,Q0V8S0,HGS_BOVIN,,Hepatocyte growth factor-regulated tyrosine kinase substrate,Bos taurus (Bovine),46.4,498.0,1e-99,366.3,sp|Q0V8S0|HGS_BOVIN Hepatocyte growth factor-regulated tyrosine kinase substrate OS=Bos taurus OX=9913 GN=HGS PE=2 SV=1,GO:0005769; GO:0008270; GO:0015031; GO:0031623; GO:0031901; GO:0032456; GO:0032585; GO:0035091; GO:0043130,endocytic recycling [GO:0032456]; protein transport [GO:0015031]; receptor internalization [GO:0031623],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; multivesicular body membrane [GO:0032585],phosphatidylinositol binding [GO:0035091]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270],GO:0005768; GO:0008289; GO:0016192; GO:0031410; GO:0043226,endosome; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_15338,FUN_038853-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29006.t1,apul_ptua,45.37,,,,,,,,,,,,,,,,,
OG_15339,FUN_038877-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16190.t1,apul_ptua,49.693,,,,,,,,,,,,,,,,,
OG_15340,FUN_038905-T1,,Pocillopora_meandrina_HIv1___TS.g14653.t1a,apul_ptua,65.116,,,,,,,,,,,,,,,,,
OG_15341,FUN_038921-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1054.t1,apul_ptua,85.948,FUN_038921-T1,Q627N3,,,,,68.1,298.0,1.1e-122,441.0,sp|Q627N3|GLC7B_CAEBR Serine/threonine-protein phosphatase PP1-beta OS=Caenorhabditis briggsae OX=6238 GN=gsp-2 PE=3 SV=1,,,,,,
OG_15342,FUN_038955-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7929.t1,apul_ptua,54.762,,,,,,,,,,,,,,,,,
OG_15343,FUN_038964-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19735.t1,apul_ptua,61.194,,,,,,,,,,,,,,,,,
OG_15344,FUN_038990-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6072.t1,apul_ptua,54.037,,,,,,,,,,,,,,,,,
OG_15345,FUN_039030-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28690.t1,apul_ptua,71.733,FUN_039030-T1,P12276,,,,,46.3,1414.0,0.0,1162.9,sp|P12276|FAS_CHICK Fatty acid synthase OS=Gallus gallus OX=9031 GN=FASN PE=1 SV=5,,,,,,
OG_15346,FUN_039088-T1,,Pocillopora_meandrina_HIv1___TS.g8498.t1,apul_ptua,64.5305,FUN_039088-T1,Q7Z6E9,RBBP6_HUMAN,,E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),Homo sapiens (Human),48.0,333.0,2.1e-74,282.3,sp|Q7Z6E9|RBBP6_HUMAN E3 ubiquitin-protein ligase RBBP6 OS=Homo sapiens OX=9606 GN=RBBP6 PE=1 SV=1,GO:0001701; GO:0003723; GO:0004842; GO:0005634; GO:0005694; GO:0005730; GO:0005813; GO:0005829; GO:0006260; GO:0006275; GO:0006397; GO:0006511; GO:0006974; GO:0008270; GO:0016567; GO:0016607; GO:0019901; GO:0032991; GO:0035264; GO:0048568; GO:0061053; GO:0061630,DNA damage response [GO:0006974]; DNA replication [GO:0006260]; embryonic organ development [GO:0048568]; in utero embryonic development [GO:0001701]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; protein ubiquitination [GO:0016567]; regulation of DNA replication [GO:0006275]; somite development [GO:0061053]; ubiquitin-dependent protein catabolic process [GO:0006511],centrosome [GO:0005813]; chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0005694; GO:0005730; GO:0005815; GO:0005829; GO:0006260; GO:0016071; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"RNA binding; catalytic activity; nucleus; chromosome; nucleolus; microtubule organizing center; cytosol; DNA replication; mRNA metabolic process; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_15347,FUN_039097-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6132.t1,apul_ptua,50.0,,,,,,,,,,,,,,,,,
OG_15348,FUN_039196-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27316.t1,apul_ptua,39.957,,,,,,,,,,,,,,,,,
OG_15349,FUN_039293-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13581.t1,apul_ptua,79.641,FUN_039293-T1,P17244,,,,,76.9,333.0,1.3000000000000002e-145,517.3,sp|P17244|G3P_CRIGR Glyceraldehyde-3-phosphate dehydrogenase OS=Cricetulus griseus OX=10029 GN=GAPDH PE=2 SV=2,,,,,,
OG_15350,FUN_039295-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13604.t1,apul_ptua,74.033,FUN_039295-T1,Q0IIF0,,,,,50.7,355.0,3e-95,350.1,sp|Q0IIF0|ILKAP_BOVIN Integrin-linked kinase-associated serine/threonine phosphatase 2C OS=Bos taurus OX=9913 GN=ILKAP PE=2 SV=1,,,,,,
OG_15351,FUN_039299-T1,,Pocillopora_meandrina_HIv1___TS.g2595.t1,apul_ptua,46.465,,,,,,,,,,,,,,,,,
OG_15352,FUN_039303-T1,,Pocillopora_meandrina_HIv1___TS.g28408.t1,apul_ptua,44.521,,,,,,,,,,,,,,,,,
OG_15353,FUN_039308-T1,,Pocillopora_meandrina_HIv1___TS.g14420.t1,apul_ptua,90.446,,,,,,,,,,,,,,,,,
OG_15354,FUN_039317-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13598.t1,apul_ptua,74.564,,,,,,,,,,,,,,,,,
OG_15355,FUN_039321-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13596.t1,apul_ptua,52.797,FUN_039321-T1,A0JN69,MARH3_BOVIN,,E3 ubiquitin-protein ligase MARCHF3 (EC 2.3.2.27) (Membrane-associated RING finger protein 3) (Membrane-associated RING-CH protein III) (MARCH-III) (RING-type E3 ubiquitin transferase MARCHF3),Bos taurus (Bovine),28.3,159.0,1.2e-11,72.0,sp|A0JN69|MARH3_BOVIN E3 ubiquitin-protein ligase MARCHF3 OS=Bos taurus OX=9913 GN=MARCHF3 PE=2 SV=1,GO:0004842; GO:0005764; GO:0005768; GO:0006897; GO:0008270; GO:0016567; GO:0031901,endocytosis [GO:0006897]; protein ubiquitination [GO:0016567],early endosome membrane [GO:0031901]; endosome [GO:0005768]; lysosome [GO:0005764],ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0016192; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; lysosome; endosome; vacuole; vesicle-mediated transport; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_15356,FUN_039322-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13595.t1,apul_ptua,69.02250000000001,FUN_039322-T1,Q5TIE3,,,,,26.3,1255.0,9.299999999999999e-82,307.0,sp|Q5TIE3|VW5B1_HUMAN von Willebrand factor A domain-containing protein 5B1 OS=Homo sapiens OX=9606 GN=VWA5B1 PE=1 SV=2,,,,,,
OG_15357,FUN_039437-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12989.t1,apul_ptua,41.772,,,,,,,,,,,,,,,,,
OG_15358,FUN_039482-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8732.t1,apul_ptua,47.328,,,,,,,,,,,,,,,,,
OG_15359,FUN_039484-T1,,Pocillopora_meandrina_HIv1___TS.g28003.t1a,apul_ptua,65.517,,,,,,,,,,,,,,,,,
OG_15360,FUN_039501-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8911.t1,apul_ptua,50.282,FUN_039501-T1,Q80SX8,PIF1_MOUSE,,ATP-dependent DNA helicase PIF1 (EC 5.6.2.3) (DNA 5'-3' helicase PIF1) (DNA repair and recombination helicase PIF1) (Pif1/Rrm3 DNA helicase-like protein),Mus musculus (Mouse),32.5,206.0,4.8e-15,83.2,sp|Q80SX8|PIF1_MOUSE ATP-dependent DNA helicase PIF1 OS=Mus musculus OX=10090 GN=Pif1 PE=1 SV=2,GO:0000002; GO:0000723; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0010521; GO:0016887; GO:0032211; GO:0043139; GO:0051880,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; negative regulation of telomere maintenance via telomerase [GO:0032211]; telomere maintenance [GO:0000723],mitochondrion [GO:0005739]; nucleus [GO:0005634],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; G-quadruplex DNA binding [GO:0051880]; telomerase inhibitor activity [GO:0010521],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0098772; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; DNA recombination; hydrolase activity; isomerase activity; telomere organization; organelle; molecular function regulator activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_15361,FUN_039517-T1,,Pocillopora_meandrina_HIv1___TS.g24916.t1,apul_ptua,78.049,,,,,,,,,,,,,,,,,
OG_15362,FUN_039604-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27312.t1,apul_ptua,49.224,FUN_039604-T1,P50947,,,,,51.7,58.0,1.2e-09,67.4,sp|P50947|PHO23_YEAST Transcriptional regulatory protein PHO23 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=PHO23 PE=1 SV=1,,,,,,
OG_15363,FUN_039642-T1,,Pocillopora_meandrina_HIv1___RNAseq.g129.t1,apul_ptua,50.8145,,,,,,,,,,,,,,,,,
OG_15364,FUN_039652-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6724.t1,apul_ptua,66.667,,,,,,,,,,,,,,,,,
OG_15365,FUN_039727-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9035.t1a,apul_ptua,47.183,,,,,,,,,,,,,,,,,
OG_15366,FUN_039728-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12254.t1,apul_ptua,83.462,,,,,,,,,,,,,,,,,
OG_15367,FUN_039790-T1,,Pocillopora_meandrina_HIv1___TS.g1218.t1,apul_ptua,73.852,FUN_039790-T1,Q6DE75,S2538_XENLA,,Mitochondrial glycine transporter (Solute carrier family 25 member 38),Xenopus laevis (African clawed frog),53.4,281.0,4.2e-79,296.2,sp|Q6DE75|S2538_XENLA Mitochondrial glycine transporter OS=Xenopus laevis OX=8355 GN=slc25a38 PE=2 SV=1,GO:0005739; GO:0005743; GO:0015187; GO:0030218; GO:1904983,erythrocyte differentiation [GO:0030218]; glycine import into mitochondrion [GO:1904983],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],glycine transmembrane transporter activity [GO:0015187],GO:0005215; GO:0005739; GO:0030154; GO:0043226; GO:0055085,transporter activity; mitochondrion; cell differentiation; organelle; transmembrane transport
OG_15368,FUN_039794-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7473.t1,apul_ptua,63.372,FUN_039794-T1,Q8R1J3,,,,,33.2,217.0,1.1e-17,92.0,sp|Q8R1J3|ZCHC9_MOUSE Zinc finger CCHC domain-containing protein 9 OS=Mus musculus OX=10090 GN=Zcchc9 PE=2 SV=2,,,,,,
OG_15369,FUN_039804-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7482.t1,apul_ptua,74.091,FUN_039804-T1,Q4P4U7,,,,,25.6,403.0,4e-09,64.3,sp|Q4P4U7|BTN1_MYCMD Protein BTN1 OS=Mycosarcoma maydis OX=5270 GN=BTN1 PE=3 SV=2,,,,,,
OG_15370,FUN_039831-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7309.t1a,apul_ptua,40.6495,,,,,,,,,,,,,,,,,
OG_15371,FUN_039843-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20009.t1,apul_ptua,30.0,,,,,,,,,,,,,,,,,
OG_15372,FUN_039909-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1786.t1,apul_ptua,66.0,,,,,,,,,,,,,,,,,
OG_15373,FUN_039970-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7520.t1a,apul_ptua,46.865,FUN_039970-T1,Q91175,,,,,26.9,335.0,1.7e-12,75.1,sp|Q91175|ADA1A_ORYLA Alpha-1A adrenergic receptor OS=Oryzias latipes OX=8090 GN=adra1a PE=3 SV=1,,,,,,
OG_15374,FUN_039983-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7549.t1,apul_ptua,72.727,FUN_039983-T1,P00747,PLMN_HUMAN,,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]",Homo sapiens (Human),45.2,228.0,8.9e-45,181.8,sp|P00747|PLMN_HUMAN Plasminogen OS=Homo sapiens OX=9606 GN=PLG PE=1 SV=2,GO:0002020; GO:0004175; GO:0004252; GO:0005102; GO:0005576; GO:0005615; GO:0005886; GO:0006508; GO:0007596; GO:0008236; GO:0008285; GO:0009897; GO:0009986; GO:0010812; GO:0016485; GO:0019899; GO:0019900; GO:0019904; GO:0022617; GO:0031093; GO:0034185; GO:0042246; GO:0042730; GO:0043536; GO:0045445; GO:0046716; GO:0048771; GO:0051087; GO:0051702; GO:0051918; GO:0051919; GO:0060707; GO:0060716; GO:0062023; GO:0070062; GO:0071674; GO:0072562; GO:0098685; GO:0098978; GO:0099183; GO:1990405; GO:2000048,"biological process involved in interaction with symbiont [GO:0051702]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; protein processing [GO:0016485]; proteolysis [GO:0006508]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]",blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; Schaffer collateral - CA1 synapse [GO:0098685],apolipoprotein binding [GO:0034185]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; protease binding [GO:0002020]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; protein-folding chaperone binding [GO:0051087]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102],GO:0002376; GO:0003824; GO:0005576; GO:0005615; GO:0005886; GO:0016787; GO:0022414; GO:0023052; GO:0030154; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0051604; GO:0140096,"immune system process; catalytic activity; extracellular region; extracellular space; plasma membrane; hydrolase activity; reproductive process; signaling; cell differentiation; extracellular matrix organization; organelle; anatomical structure development; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_15375,FUN_040013-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8424.t1,apul_ptua,62.031,FUN_040013-T1,P40313,,,,,41.6,245.0,5.3e-43,176.4,sp|P40313|CTRL_HUMAN Chymotrypsin-like protease CTRL-1 OS=Homo sapiens OX=9606 GN=CTRL PE=1 SV=1,,,,,,
OG_15376,FUN_040016-T3,,Pocillopora_meandrina_HIv1___RNAseq.g8431.t1,apul_ptua,42.0545,FUN_040016-T3,Q7Z3E1,PARPT_HUMAN,,Protein mono-ADP-ribosyltransferase TIPARP (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (Poly [ADP-ribose] polymerase 7) (PARP-7) (TCDD-inducible poly [ADP-ribose] polymerase),Homo sapiens (Human),37.4,235.0,1.1999999999999999e-39,167.2,sp|Q7Z3E1|PARPT_HUMAN Protein mono-ADP-ribosyltransferase TIPARP OS=Homo sapiens OX=9606 GN=TIPARP PE=1 SV=1,GO:0000987; GO:0001570; GO:0001822; GO:0003950; GO:0005634; GO:0008209; GO:0008210; GO:0008270; GO:0008585; GO:0009791; GO:0010629; GO:0016779; GO:0030097; GO:0045732; GO:0048008; GO:0048705; GO:0048745; GO:0060021; GO:0060325; GO:0140803; GO:0140806; GO:0140807; GO:1904612; GO:1990404,"androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; female gonad development [GO:0008585]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; negative regulation of gene expression [GO:0010629]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of protein catabolic process [GO:0045732]; post-embryonic development [GO:0009791]; response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904612]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; smooth muscle tissue development [GO:0048745]; vasculogenesis [GO:0001570]",nucleus [GO:0005634],cis-regulatory region sequence-specific DNA binding [GO:0000987]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-cysteine ADP-ribosyltransferase activity [GO:0140803]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0006629; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0140096,"DNA binding; catalytic activity; nucleus; lipid metabolic process; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_15377,FUN_040043-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8465.t1,apul_ptua,46.85,,,,,,,,,,,,,,,,,
OG_15378,FUN_040052-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8470.t1,apul_ptua,41.9785,FUN_040052-T1,P25291,,,,,48.3,118.0,6.599999999999998e-29,130.6,sp|P25291|GP2_CANLF Pancreatic secretory granule membrane major glycoprotein GP2 OS=Canis lupus familiaris OX=9615 GN=GP2 PE=1 SV=1,,,,,,
OG_15379,FUN_040066-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7702.t1,apul_ptua,53.556,,,,,,,,,,,,,,,,,
OG_15380,FUN_040108-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8721.t1,apul_ptua,32.037,,,,,,,,,,,,,,,,,
OG_15381,FUN_040109-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8717.t1,apul_ptua,38.333,,,,,,,,,,,,,,,,,
OG_15382,FUN_040110-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8722.t1,apul_ptua,33.1065,,,,,,,,,,,,,,,,,
OG_15383,FUN_040121-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6672.t1,apul_ptua,50.271,FUN_040121-T1,G8HTB6,,,,,30.3,356.0,1.9e-33,146.4,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_15384,FUN_040122-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6652.t1,apul_ptua,36.22,,,,,,,,,,,,,,,,,
OG_15385,FUN_040167-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8482.t1,apul_ptua,44.444,,,,,,,,,,,,,,,,,
OG_15386,FUN_040190-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2785.t1,apul_ptua,34.641,,,,,,,,,,,,,,,,,
OG_15387,FUN_040196-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28601.t1,apul_ptua,81.039,,,,,,,,,,,,,,,,,
OG_15388,FUN_040200-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28604.t1b,apul_ptua,77.397,,,,,,,,,,,,,,,,,
OG_15389,FUN_040213-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3145.t1,apul_ptua,45.603,,,,,,,,,,,,,,,,,
OG_15390,FUN_040294-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1823.t1,apul_ptua,61.111,,,,,,,,,,,,,,,,,
OG_15391,FUN_040303-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9078.t1,apul_ptua,77.039,FUN_040303-T1,P22770,,,,,35.0,494.0,1.1e-71,272.3,sp|P22770|ACHA7_CHICK Neuronal acetylcholine receptor subunit alpha-7 OS=Gallus gallus OX=9031 GN=CHRNA7 PE=1 SV=1,,,,,,
OG_15392,FUN_040308-T1,,Pocillopora_meandrina_HIv1___TS.g709.t1,apul_ptua,50.898,FUN_040308-T1,O70244,,,,,36.4,118.0,7.9e-13,77.4,sp|O70244|CUBN_RAT Cubilin OS=Rattus norvegicus OX=10116 GN=Cubn PE=1 SV=2,,,,,,
OG_15393,FUN_040356-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1270.t1,apul_ptua,30.065,,,,,,,,,,,,,,,,,
OG_15394,FUN_040427-T2,,Pocillopora_meandrina_HIv1___RNAseq.g6513.t1,apul_ptua,46.6995,FUN_040427-T2,O60140,,,,,27.8,263.0,4.7000000000000005e-28,128.3,sp|O60140|YNS9_SCHPO Uncharacterized protein C18H10.09 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=SPBC18H10.09 PE=4 SV=2,,,,,,
OG_15395,FUN_040482-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25654.t2,apul_ptua,31.4905,,,,,,,,,,,,,,,,,
OG_15396,FUN_040486-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13573.t1,apul_ptua,62.156,FUN_040486-T1,P0DXB8,,,,,29.7,172.0,8.5e-08,60.1,sp|P0DXB8|CGLR_AETTU Cyclic GMP-AMP synthase-like receptor OS=Aethina tumida OX=116153 GN=cGLR PE=1 SV=1,,,,,,
OG_15397,FUN_040543-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3592.t1,apul_ptua,34.524,,,,,,,,,,,,,,,,,
OG_15398,FUN_040614-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6471.t1,apul_ptua,58.571,FUN_040614-T1,Q00174,LAMA_DROME,,Laminin subunit alpha (Laminin A chain),Drosophila melanogaster (Fruit fly),34.3,356.0,5.3000000000000003e-45,183.3,sp|Q00174|LAMA_DROME Laminin subunit alpha OS=Drosophila melanogaster OX=7227 GN=LanA PE=1 SV=2,GO:0005102; GO:0005201; GO:0005576; GO:0005604; GO:0007411; GO:0007498; GO:0007507; GO:0008021; GO:0009887; GO:0009888; GO:0030155; GO:0030334; GO:0030424; GO:0031012; GO:0033627; GO:0034446; GO:0035001; GO:0035011; GO:0036062; GO:0045886; GO:0045995; GO:0071711,"animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth, open tracheal system [GO:0035001]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]",axon [GO:0030424]; basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021],extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102],GO:0002376; GO:0005198; GO:0005576; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0031410; GO:0043226; GO:0048856; GO:0098542,immune system process; structural molecule activity; extracellular region; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; cytoplasmic vesicle; organelle; anatomical structure development; defense response to other organism
OG_15399,FUN_040627-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7881.t1,apul_ptua,40.0,,,,,,,,,,,,,,,,,
OG_15400,FUN_040640-T1,,Pocillopora_meandrina_HIv1___TS.g6879.t1,apul_ptua,49.524,,,,,,,,,,,,,,,,,
OG_15401,FUN_040665-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6467.t1,apul_ptua,33.486,,,,,,,,,,,,,,,,,
OG_15402,FUN_040679-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6453.t1,apul_ptua,35.9135,,,,,,,,,,,,,,,,,
OG_15403,FUN_040681-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13307.t1,apul_ptua,72.826,,,,,,,,,,,,,,,,,
OG_15404,FUN_040682-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6448.t1,apul_ptua,48.4665,,,,,,,,,,,,,,,,,
OG_15405,FUN_040684-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6450.t1,apul_ptua,63.5515,FUN_040684-T1,Q98SJ2,,,,,42.0,245.0,8.999999999999999e-43,176.0,sp|Q98SJ2|DAZP1_XENLA DAZ-associated protein 1 OS=Xenopus laevis OX=8355 GN=dazap1 PE=1 SV=1,,,,,,
OG_15406,FUN_040689-T1,,Pocillopora_meandrina_HIv1___TS.g6758.t1,apul_ptua,90.476,,,,,,,,,,,,,,,,,
OG_15407,FUN_040700-T1,,Pocillopora_meandrina_HIv1___TS.g27426.t1b,apul_ptua,78.652,,,,,,,,,,,,,,,,,
OG_15408,FUN_040709-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9098.t1,apul_ptua,64.507,FUN_040709-T1,P06601,,,,,42.0,281.0,5.9999999999999995e-53,209.5,sp|P06601|PRD_DROME Segmentation protein paired OS=Drosophila melanogaster OX=7227 GN=prd PE=1 SV=1,,,,,,
OG_15409,FUN_040719-T1,,Pocillopora_meandrina_HIv1___TS.g20812.t1,apul_ptua,60.36,FUN_040719-T1,O18381,PAX6_DROME,,Paired box protein Pax-6 (Protein eyeless),Drosophila melanogaster (Fruit fly),57.9,57.0,3.9e-09,62.4,sp|O18381|PAX6_DROME Paired box protein Pax-6 OS=Drosophila melanogaster OX=7227 GN=ey PE=1 SV=3,GO:0000977; GO:0000978; GO:0000981; GO:0001745; GO:0005634; GO:0006357; GO:0007420; GO:0007423; GO:0007455; GO:0007628; GO:0008284; GO:0008347; GO:0016319; GO:0030182; GO:0030307; GO:0040018; GO:0042593; GO:0043565; GO:0043567; GO:0043704; GO:0045893; GO:0045944; GO:0048036; GO:0048749; GO:0048854,adult walking behavior [GO:0007628]; brain development [GO:0007420]; brain morphogenesis [GO:0048854]; central complex development [GO:0048036]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; eye-antennal disc morphogenesis [GO:0007455]; glial cell migration [GO:0008347]; glucose homeostasis [GO:0042593]; mushroom body development [GO:0016319]; neuron differentiation [GO:0030182]; photoreceptor cell fate specification [GO:0043704]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ development [GO:0007423],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0048870; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; cell motility; transcription regulator activity
OG_15410,FUN_040720-T1,,Pocillopora_meandrina_HIv1___TS.g20811.t1,apul_ptua,64.045,FUN_040720-T1,P23757,,,,,54.0,126.0,4.5e-37,156.0,sp|P23757|POXM_DROME Paired box pox-meso protein OS=Drosophila melanogaster OX=7227 GN=Poxm PE=2 SV=3,,,,,,
OG_15411,FUN_040722-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6439.t1,apul_ptua,78.61,FUN_040722-T1,P55166,,,,,53.8,143.0,4.7999999999999997e-39,162.9,sp|P55166|PAX9_CHICK Paired box protein Pax-9 (Fragment) OS=Gallus gallus OX=9031 GN=PAX9 PE=2 SV=1,,,,,,
OG_15412,FUN_040723-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6438.t1,apul_ptua,67.47,FUN_040723-T1,P23760,PAX3_HUMAN,,Paired box protein Pax-3 (HuP2),Homo sapiens (Human),61.3,142.0,2.3e-47,190.3,sp|P23760|PAX3_HUMAN Paired box protein Pax-3 OS=Homo sapiens OX=9606 GN=PAX3 PE=1 SV=2,GO:0000785; GO:0000978; GO:0000981; GO:0003700; GO:0005654; GO:0006357; GO:0006915; GO:0007399; GO:0007517; GO:0007605; GO:0009887; GO:0043565; GO:0045893; GO:0045944; GO:1990837,animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory perception of sound [GO:0007605],chromatin [GO:0000785]; nucleoplasm [GO:0005654],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",GO:0003677; GO:0005654; GO:0006355; GO:0012501; GO:0048856; GO:0050877; GO:0140110,DNA binding; nucleoplasm; regulation of DNA-templated transcription; programmed cell death; anatomical structure development; nervous system process; transcription regulator activity
OG_15413,FUN_040789-T1,,Pocillopora_meandrina_HIv1___TS.g6600.t1,apul_ptua,58.194,,,,,,,,,,,,,,,,,
OG_15414,FUN_040815-T1,,Pocillopora_meandrina_HIv1___TS.g3994.t1,apul_ptua,44.062,,,,,,,,,,,,,,,,,
OG_15415,FUN_040819-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21768.t1,apul_ptua,54.264,,,,,,,,,,,,,,,,,
OG_15416,FUN_040866-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6570.t1,apul_ptua,80.667,FUN_040866-T1,P24369,PPIB_MOUSE,,Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP),Mus musculus (Mouse),67.3,156.0,3.9e-54,212.6,sp|P24369|PPIB_MOUSE Peptidyl-prolyl cis-trans isomerase B OS=Mus musculus OX=10090 GN=Ppib PE=1 SV=2,GO:0003755; GO:0005654; GO:0005788; GO:0005790; GO:0030593; GO:0032991; GO:0034663; GO:0040018; GO:0042470; GO:0044829; GO:0048471; GO:0050821; GO:0060348; GO:0061077; GO:0070063,bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; neutrophil chemotaxis [GO:0030593]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein stabilization [GO:0050821],endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; smooth endoplasmic reticulum [GO:0005790],peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063],GO:0002376; GO:0003824; GO:0005654; GO:0005783; GO:0016853; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0140096,"immune system process; catalytic activity; nucleoplasm; endoplasmic reticulum; isomerase activity; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_15417,FUN_040952-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22344.t1,apul_ptua,69.37549999999999,FUN_040952-T1,Q99PT0,,,,,50.3,598.0,3.5e-157,556.6,sp|Q99PT0|DDX52_RAT Probable ATP-dependent RNA helicase DDX52 OS=Rattus norvegicus OX=10116 GN=Ddx52 PE=2 SV=1,,,,,,
OG_15418,FUN_040962-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27114.t1,apul_ptua,75.96,FUN_040962-T1,Q7ZVE6,PLGT2_DANRE,,Protein O-glucosyltransferase 2 (EC 2.4.1.-) (KDEL motif-containing protein 1) (Protein O-xylosyltransferase POGLUT2) (EC 2.4.2.-),Danio rerio (Zebrafish) (Brachydanio rerio),60.0,470.0,3.3e-169,596.3,sp|Q7ZVE6|PLGT2_DANRE Protein O-glucosyltransferase 2 OS=Danio rerio OX=7955 GN=poglut2 PE=2 SV=1,GO:0005788; GO:0007399; GO:0012505; GO:0018242; GO:0035251; GO:0035252; GO:0046527; GO:0140561; GO:0140562,nervous system development [GO:0007399]; protein O-linked glycosylation via serine [GO:0018242],endomembrane system [GO:0012505]; endoplasmic reticulum lumen [GO:0005788],EGF-domain serine glucosyltransferase activity [GO:0140561]; EGF-domain serine xylosyltransferase activity [GO:0140562]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252],GO:0003824; GO:0016740; GO:0048856,catalytic activity; transferase activity; anatomical structure development
OG_15419,FUN_040965-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12096.t1,apul_ptua,90.811,FUN_040965-T1,A7SGU3,,,,,79.3,184.0,3.4e-79,295.8,sp|A7SGU3|DCTN6_NEMVE Dynactin subunit 6 OS=Nematostella vectensis OX=45351 GN=dctn6 PE=3 SV=1,,,,,,
OG_15420,FUN_041057-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17702.t1,apul_ptua,82.609,,,,,,,,,,,,,,,,,
OG_15421,FUN_041069-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3543.t1,apul_ptua,40.881,,,,,,,,,,,,,,,,,
OG_15422,FUN_041085-T1,,Pocillopora_meandrina_HIv1___TS.g8709.t1,apul_ptua,60.377,,,,,,,,,,,,,,,,,
OG_15423,FUN_041091-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16211.t1,apul_ptua,43.226,,,,,,,,,,,,,,,,,
OG_15424,FUN_041115-T1,,Pocillopora_meandrina_HIv1___RNAseq.g19242.t1,apul_ptua,30.4995,,,,,,,,,,,,,,,,,
OG_15425,FUN_041153-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3447.t1,apul_ptua,40.0,,,,,,,,,,,,,,,,,
OG_15426,FUN_041171-T1,,Pocillopora_meandrina_HIv1___RNAseq.g874.t1,apul_ptua,59.331500000000005,,,,,,,,,,,,,,,,,
OG_15427,FUN_041194-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21162.t1,apul_ptua,31.1875,,,,,,,,,,,,,,,,,
OG_15428,FUN_041322-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13311.t1,apul_ptua,38.491,FUN_041322-T1,Q98894,,,,,21.3,314.0,2e-07,58.2,sp|Q98894|CNR1A_TAKRU Cannabinoid receptor type 1A OS=Takifugu rubripes OX=31033 GN=cnr1a PE=3 SV=1,,,,,,
OG_15429,FUN_041358-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27273.t1,apul_ptua,35.802,,,,,,,,,,,,,,,,,
OG_15430,FUN_041372-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6255.t1,apul_ptua,47.748,FUN_041372-T1,Q8R100,,,,,30.8,247.0,3.3e-16,88.6,sp|Q8R100|CAHM5_MOUSE Calcium homeostasis modulator protein 5 OS=Mus musculus OX=10090 GN=Calhm5 PE=2 SV=1,,,,,,
OG_15431,FUN_041373-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29298.t1,apul_ptua,49.524,FUN_041373-T1,P81237,,,,,50.9,110.0,2.3e-24,112.8,sp|P81237|PA2B2_ACAAN Basic phospholipase A2 acanthin-2 OS=Acanthophis antarcticus OX=8605 PE=1 SV=1,,,,,,
OG_15432,FUN_041376-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15708.t1,apul_ptua,50.993,FUN_041376-T1,Q76MS7,,,,,26.6,290.0,2.0000000000000002e-23,111.3,sp|Q76MS7|HRH2_GORGO Histamine H2 receptor OS=Gorilla gorilla gorilla OX=9595 GN=HRH2 PE=3 SV=1,,,,,,
OG_15433,FUN_041387-T1,,Pocillopora_meandrina_HIv1___TS.g10740.t2,apul_ptua,84.17699999999999,FUN_041387-T1,Q8BIK4,DOCK9_MOUSE,,Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1),Mus musculus (Mouse),42.8,2059.0,0.0,1516.1,sp|Q8BIK4|DOCK9_MOUSE Dedicator of cytokinesis protein 9 OS=Mus musculus OX=10090 GN=Dock9 PE=1 SV=2,GO:0005085; GO:0007264; GO:0012505; GO:0016020; GO:0031267; GO:0043547,positive regulation of GTPase activity [GO:0043547]; small GTPase-mediated signal transduction [GO:0007264],endomembrane system [GO:0012505]; membrane [GO:0016020],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0098772,molecular function regulator activity
OG_15434,FUN_041397-T1,,Pocillopora_meandrina_HIv1___TS.g18007.t1,apul_ptua,64.653,,,,,,,,,,,,,,,,,
OG_15435,FUN_041403-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15719.t1,apul_ptua,44.286,,,,,,,,,,,,,,,,,
OG_15436,FUN_041412-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20115.t1,apul_ptua,50.6555,,,,,,,,,,,,,,,,,
OG_15437,FUN_041473-T2,,Pocillopora_meandrina_HIv1___TS.g9327.t1,apul_ptua,53.101,,,,,,,,,,,,,,,,,
OG_15438,FUN_041500-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15657.t1,apul_ptua,43.182,,,,,,,,,,,,,,,,,
OG_15439,FUN_041508-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16081.t1,apul_ptua,66.877,FUN_041508-T1,Q54MC6,,,,,26.1,176.0,1.1e-09,65.9,sp|Q54MC6|LRLA_DICDI Latrophilin receptor-like protein A OS=Dictyostelium discoideum OX=44689 GN=lrlA PE=3 SV=1,,,,,,
OG_15440,FUN_041554-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15990.t1b,apul_ptua,47.189,FUN_041554-T1,Q8TAE7,KCNG3_HUMAN,,Voltage-gated potassium channel regulatory subunit KCNG3 (Potassium voltage-gated channel subfamily G member 3) (Voltage-gated potassium channel subunit Kv10.1) (Voltage-gated potassium channel subunit Kv6.3),Homo sapiens (Human),26.2,202.0,2.3e-07,59.3,sp|Q8TAE7|KCNG3_HUMAN Voltage-gated potassium channel regulatory subunit KCNG3 OS=Homo sapiens OX=9606 GN=KCNG3 PE=1 SV=1,GO:0001508; GO:0005249; GO:0005783; GO:0005886; GO:0008076; GO:0015459; GO:0016020; GO:0043266; GO:0051260; GO:0071805; GO:1901379,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of potassium ion transport [GO:0043266],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076],potassium channel regulator activity [GO:0015459]; voltage-gated potassium channel activity [GO:0005249],GO:0005215; GO:0005783; GO:0005886; GO:0043226; GO:0055085; GO:0065003; GO:0098772,transporter activity; endoplasmic reticulum; plasma membrane; organelle; transmembrane transport; protein-containing complex assembly; molecular function regulator activity
OG_15441,FUN_041577-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15932.t1,apul_ptua,59.801,,,,,,,,,,,,,,,,,
OG_15442,FUN_041583-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15922.t1,apul_ptua,65.875,FUN_041583-T1,Q5XLR4,,,,,25.1,334.0,2e-08,61.6,sp|Q5XLR4|BORE1_DANRE Borealin OS=Danio rerio OX=7955 GN=cdca8 PE=2 SV=2,,,,,,
OG_15443,FUN_041587-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15267.t1,apul_ptua,54.139,,,,,,,,,,,,,,,,,
OG_15444,FUN_041600-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15301.t1,apul_ptua,51.718,FUN_041600-T1,P37089,SCNNA_RAT,,Epithelial sodium channel subunit alpha (Alpha-ENaC) (Epithelial Na(+) channel subunit alpha) (Alpha-NaCH) (Amiloride-sensitive sodium channel subunit alpha) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA),Rattus norvegicus (Rat),27.2,551.0,9.000000000000001e-45,183.0,sp|P37089|SCNNA_RAT Epithelial sodium channel subunit alpha OS=Rattus norvegicus OX=10116 GN=Scnn1a PE=1 SV=2,GO:0001669; GO:0003779; GO:0005737; GO:0005829; GO:0005886; GO:0006814; GO:0006883; GO:0008217; GO:0009897; GO:0015280; GO:0016020; GO:0016324; GO:0030864; GO:0031514; GO:0034706; GO:0035725; GO:0050699; GO:0050878; GO:0050891; GO:0050914; GO:0050915; GO:0055078; GO:0060170; GO:0070062; GO:0071468; GO:0097228; GO:0098719; GO:1904045; GO:1904117,cellular response to acidic pH [GO:0071468]; cellular response to aldosterone [GO:1904045]; cellular response to vasopressin [GO:1904117]; intracellular sodium ion homeostasis [GO:0006883]; multicellular organismal-level water homeostasis [GO:0050891]; regulation of blood pressure [GO:0008217]; regulation of body fluid levels [GO:0050878]; sensory perception of salty taste [GO:0050914]; sensory perception of sour taste [GO:0050915]; sodium ion homeostasis [GO:0055078]; sodium ion import across plasma membrane [GO:0098719]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814],acrosomal vesicle [GO:0001669]; apical plasma membrane [GO:0016324]; ciliary membrane [GO:0060170]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; motile cilium [GO:0031514]; plasma membrane [GO:0005886]; sodium channel complex [GO:0034706]; sperm principal piece [GO:0097228],actin binding [GO:0003779]; ligand-gated sodium channel activity [GO:0015280]; WW domain binding [GO:0050699],GO:0005215; GO:0005829; GO:0005856; GO:0005886; GO:0005929; GO:0008092; GO:0031410; GO:0043226; GO:0050877; GO:0055085,transporter activity; cytosol; cytoskeleton; plasma membrane; cilium; cytoskeletal protein binding; cytoplasmic vesicle; organelle; nervous system process; transmembrane transport
OG_15445,FUN_041603-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15303.t1,apul_ptua,68.768,FUN_041603-T1,G4WMX4,,,,,32.6,316.0,5.4e-36,153.3,sp|G4WMX4|RYAR_TRICA RYamide receptor OS=Tribolium castaneum OX=7070 GN=RYa-R PE=2 SV=1,,,,,,
OG_15446,FUN_041611-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15294.t1,apul_ptua,92.413,FUN_041611-T1,Q3V096,,,,,58.2,409.0,2.8e-43,177.9,sp|Q3V096|ANR42_MOUSE Ankyrin repeat domain-containing protein 42 OS=Mus musculus OX=10090 GN=Ankrd42 PE=1 SV=1,,,,,,
OG_15447,FUN_041621-T1,,Pocillopora_meandrina_HIv1___TS.g10312.t1a,apul_ptua,73.913,FUN_041621-T1,Q1RMP0,RPA12_BOVIN,,DNA-directed RNA polymerase I subunit RPA12 (DNA-directed RNA polymerase I subunit H),Bos taurus (Bovine),51.2,121.0,1.9e-30,133.3,sp|Q1RMP0|RPA12_BOVIN DNA-directed RNA polymerase I subunit RPA12 OS=Bos taurus OX=9913 GN=POLR1H PE=2 SV=1,GO:0003676; GO:0003899; GO:0005736; GO:0006363; GO:0008270,termination of RNA polymerase I transcription [GO:0006363],RNA polymerase I complex [GO:0005736],DNA-directed RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140098,"catalytic activity; transferase activity; catalytic activity, acting on RNA"
OG_15448,FUN_041624-T1,,Pocillopora_meandrina_HIv1___TS.g10325.t1,apul_ptua,47.34,FUN_041624-T1,P9WMV8,,,,,25.1,589.0,4.2e-22,107.8,sp|P9WMV8|CHOD_MYCTO Cholesterol oxidase OS=Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) OX=83331 GN=choD PE=3 SV=1,,,,,,
OG_15449,FUN_041649-T1,,Pocillopora_meandrina_HIv1___TS.g11936.t1,apul_ptua,81.119,FUN_041649-T1,A7RR04,EFGM_NEMVE,,"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1)",Nematostella vectensis (Starlet sea anemone),74.0,131.0,6.4e-51,201.8,"sp|A7RR04|EFGM_NEMVE Elongation factor G, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g236547 PE=3 SV=1",GO:0003746; GO:0003924; GO:0005525; GO:0005739; GO:0070125,mitochondrial translational elongation [GO:0070125],mitochondrion [GO:0005739],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746],GO:0003824; GO:0003924; GO:0005739; GO:0016787; GO:0043226,catalytic activity; GTPase activity; mitochondrion; hydrolase activity; organelle
OG_15450,FUN_041654-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5356.t1,apul_ptua,72.191,FUN_041654-T1,P83775,,,,,34.3,353.0,7.900000000000001e-32,139.4,sp|P83775|GRP2_CANAL Putative NADPH-dependent methylglyoxal reductase GRP2 OS=Candida albicans (strain SC5314 / ATCC MYA-2876) OX=237561 GN=GRP2 PE=1 SV=2,,,,,,
OG_15451,FUN_041677-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14006.t1,apul_ptua,60.606,FUN_041677-T1,P42577,,,,,60.4,149.0,1.4999999999999998e-43,177.9,sp|P42577|FRIS_LYMST Soma ferritin OS=Lymnaea stagnalis OX=6523 PE=2 SV=2,,,,,,
OG_15452,FUN_041693-T1,,Pocillopora_meandrina_HIv1___TS.g11766.t1b,apul_ptua,61.071,,,,,,,,,,,,,,,,,
OG_15453,FUN_041704-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13971.t1,apul_ptua,54.5725,FUN_041704-T1,Q9UJA9,ENPP5_HUMAN,,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-),Homo sapiens (Human),35.7,429.0,1.7e-72,275.0,sp|Q9UJA9|ENPP5_HUMAN Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 OS=Homo sapiens OX=9606 GN=ENPP5 PE=1 SV=1,GO:0000210; GO:0005576; GO:0005886; GO:0007154; GO:0008270,cell communication [GO:0007154],extracellular region [GO:0005576]; plasma membrane [GO:0005886],NAD+ diphosphatase activity [GO:0000210]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005886; GO:0016787,catalytic activity; extracellular region; plasma membrane; hydrolase activity
OG_15454,FUN_041716-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13946.t1,apul_ptua,47.129,FUN_041716-T1,P36425,,,,,42.4,132.0,1.9e-13,78.2,sp|P36425|SP17_RABIT Sperm surface protein Sp17 OS=Oryctolagus cuniculus OX=9986 GN=SPA17 PE=1 SV=2,,,,,,
OG_15455,FUN_041752-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15093.t1,apul_ptua,67.647,,,,,,,,,,,,,,,,,
OG_15456,FUN_041797-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15858.t1,apul_ptua,52.332,FUN_041797-T1,Q4VSN1,DUSTY_DANRE,,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (Receptor-interacting serine/threonine-protein kinase 5),Danio rerio (Zebrafish) (Brachydanio rerio),34.9,149.0,6.9e-22,105.5,sp|Q4VSN1|DUSTY_DANRE Dual serine/threonine and tyrosine protein kinase OS=Danio rerio OX=7955 GN=dstyk PE=2 SV=1,GO:0004674; GO:0004712; GO:0004713; GO:0005524; GO:0005737; GO:0016323; GO:0016324; GO:0043066; GO:0044344; GO:0045743; GO:0048568; GO:0048570; GO:0060036; GO:0070161; GO:0070374; GO:0106310,cellular response to fibroblast growth factor stimulus [GO:0044344]; embryonic organ development [GO:0048568]; negative regulation of apoptotic process [GO:0043066]; notochord cell vacuolation [GO:0060036]; notochord morphogenesis [GO:0048570]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0048856; GO:0140096,"catalytic activity; transferase activity; anatomical structure development; catalytic activity, acting on a protein"
OG_15457,FUN_041804-T1,,Pocillopora_meandrina_HIv1___TS.g23455.t1,apul_ptua,62.222,,,,,,,,,,,,,,,,,
OG_15458,FUN_041811-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15861.t1,apul_ptua,49.578,FUN_041811-T1,Q811B3,ATS12_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAM-TS 12) (ADAM-TS12) (ADAMTS-12) (EC 3.4.24.-),Mus musculus (Mouse),29.8,961.0,3.2e-102,374.8,sp|Q811B3|ATS12_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 12 OS=Mus musculus OX=10090 GN=Adamts12 PE=2 SV=2,GO:0001503; GO:0002062; GO:0004222; GO:0005576; GO:0006029; GO:0007160; GO:0016477; GO:0030167; GO:0030199; GO:0032331; GO:0043931; GO:0046872; GO:0050727; GO:0051603; GO:0071347; GO:0071356; GO:0071773; GO:1901509; GO:1902203; GO:1902548; GO:2001113,cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to BMP stimulus [GO:0071773]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; negative regulation of cellular response to hepatocyte growth factor stimulus [GO:2001113]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of hepatocyte growth factor receptor signaling pathway [GO:1902203]; ossification [GO:0001503]; ossification involved in bone maturation [GO:0043931]; proteoglycan catabolic process [GO:0030167]; proteoglycan metabolic process [GO:0006029]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of inflammatory response [GO:0050727],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0007155; GO:0016787; GO:0030154; GO:0030163; GO:0030198; GO:0048870; GO:0140096; GO:1901135,"catalytic activity; extracellular region; cell adhesion; hydrolase activity; cell differentiation; protein catabolic process; extracellular matrix organization; cell motility; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_15459,FUN_041813-T1,,Pocillopora_meandrina_HIv1___TS.g10820.t1,apul_ptua,70.066,,,,,,,,,,,,,,,,,
OG_15460,FUN_041816-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15800.t1,apul_ptua,75.177,FUN_041816-T1,Q9JI46,NUDT3_MOUSE,,Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP-1) (muDIPP1) (EC 3.6.1.52) (Diadenosine hexaphosphate hydrolase) (Ap6A hydrolase) (EC 3.6.1.61) (Endopolyphosphatase) (EC 3.6.1.10) (Nucleoside diphosphate-linked moiety X motif 3) (Nudix motif 3) (m7GpppN-mRNA hydrolase) (EC 3.6.1.62) (m7GpppX diphosphatase) (EC 3.6.1.59),Mus musculus (Mouse),56.1,139.0,2e-37,157.1,sp|Q9JI46|NUDT3_MOUSE Diphosphoinositol polyphosphate phosphohydrolase 1 OS=Mus musculus OX=10090 GN=Nudt3 PE=1 SV=1,GO:0000287; GO:0000298; GO:0005634; GO:0005737; GO:0005829; GO:0008270; GO:0008486; GO:0030145; GO:0045202; GO:0052840; GO:0052845; GO:0052848; GO:0071544; GO:0098978; GO:0110154; GO:0140932; GO:0140933; GO:1901909,diadenosine hexaphosphate catabolic process [GO:1901909]; diphosphoinositol polyphosphate catabolic process [GO:0071544]; RNA decapping [GO:0110154],cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; synapse [GO:0045202],"5'-(N(7)-methyl 5'-triphosphoguanosine)-[mRNA] diphosphatase activity [GO:0140932]; 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity [GO:0140933]; diphosphoinositol-polyphosphate diphosphatase activity [GO:0008486]; endopolyphosphatase activity [GO:0000298]; inositol diphosphate tetrakisphosphate diphosphatase activity [GO:0052840]; inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity [GO:0052848]; inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity [GO:0052845]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005634; GO:0005829; GO:0016787; GO:0043226; GO:0055086,catalytic activity; nucleus; cytosol; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process
OG_15461,FUN_041825-T1,,Pocillopora_meandrina_HIv1___RNAseq.6514_t,apul_ptua,67.939,FUN_041825-T1,Q12305,,,,,35.0,80.0,9.7e-07,54.7,sp|Q12305|RDL1_YEAST Thiosulfate:glutathione sulfurtransferase OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=RDL1 PE=1 SV=1,,,,,,
OG_15462,FUN_041831-T2,,Pocillopora_meandrina_HIv1___RNAseq.g15815.t1,apul_ptua,57.759,FUN_041831-T2,P69526,,,,,33.2,590.0,1.7e-86,322.4,sp|P69526|TMPS9_RAT Transmembrane protease serine 9 OS=Rattus norvegicus OX=10116 GN=Tmprss9 PE=3 SV=1,,,,,,
OG_15463,FUN_041867-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15115.t1,apul_ptua,32.416,,,,,,,,,,,,,,,,,
OG_15464,FUN_041868-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15114.t1,apul_ptua,55.868,,,,,,,,,,,,,,,,,
OG_15465,FUN_041892-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15392.t1,apul_ptua,67.614,FUN_041892-T1,P15384,,,,,42.7,337.0,1.5999999999999996e-53,211.5,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_15466,FUN_041954-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15254.t1,apul_ptua,93.877,FUN_041954-T1,Q6P4K8,,,,,82.2,101.0,3.8e-43,175.6,sp|Q6P4K8|PIN4_XENTR Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 OS=Xenopus tropicalis OX=8364 GN=pin4 PE=2 SV=1,,,,,,
OG_15467,FUN_041955-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15255.t1,apul_ptua,63.518,FUN_041955-T1,Q5R863,,,,,36.6,262.0,3.5e-28,127.1,sp|Q5R863|GPAM1_PONAB GPALPP motifs-containing protein 1 OS=Pongo abelii OX=9601 GN=GPALPP1 PE=2 SV=1,,,,,,
OG_15468,FUN_041987-T1,,Pocillopora_meandrina_HIv1___TS.g10259.t1,apul_ptua,52.188,,,,,,,,,,,,,,,,,
OG_15469,FUN_041990-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15230.t1,apul_ptua,48.87,,,,,,,,,,,,,,,,,
OG_15470,FUN_041997-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13319.t1,apul_ptua,66.171,,,,,,,,,,,,,,,,,
OG_15471,FUN_042014-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15200.t1,apul_ptua,76.611,FUN_042014-T1,P50429,,,,,49.7,499.0,2.7000000000000003e-134,480.3,sp|P50429|ARSB_MOUSE Arylsulfatase B OS=Mus musculus OX=10090 GN=Arsb PE=1 SV=3,,,,,,
OG_15472,FUN_042016-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15195.t1,apul_ptua,51.389,,,,,,,,,,,,,,,,,
OG_15473,FUN_042021-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15190.t1,apul_ptua,99.363,FUN_042021-T1,P56377,AP1S2_HUMAN,,AP-1 complex subunit sigma-2 (Adaptor protein complex AP-1 subunit sigma-1B) (Adaptor-related protein complex 1 subunit sigma-1B) (Clathrin assembly protein complex 1 sigma-1B small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1B subunit) (Sigma 1B subunit of AP-1 clathrin) (Sigma-adaptin 1B) (Sigma1B-adaptin),Homo sapiens (Human),82.1,156.0,3.1e-65,249.2,sp|P56377|AP1S2_HUMAN AP-1 complex subunit sigma-2 OS=Homo sapiens OX=9606 GN=AP1S2 PE=1 SV=1,GO:0000139; GO:0005765; GO:0005769; GO:0005794; GO:0005829; GO:0005905; GO:0006886; GO:0016192; GO:0030119; GO:0030121; GO:0030659; GO:0032588; GO:0035615; GO:0043231; GO:0060155; GO:1903232,intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155]; vesicle-mediated transport [GO:0016192],AP-1 adaptor complex [GO:0030121]; AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588],clathrin adaptor activity [GO:0035615],GO:0005768; GO:0005794; GO:0005829; GO:0006886; GO:0016192; GO:0031410; GO:0043226; GO:0060090,endosome; Golgi apparatus; cytosol; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular adaptor activity
OG_15474,FUN_042024-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15169.t1,apul_ptua,59.0515,FUN_042024-T1,P07919,QCR6_HUMAN,,"Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III subunit 6) (Complex III subunit VIII) (Cytochrome c1 non-heme 11 kDa protein) (Mitochondrial hinge protein) (Ubiquinol-cytochrome c reductase complex 11 kDa protein)",Homo sapiens (Human),55.9,59.0,2.9e-12,72.8,"sp|P07919|QCR6_HUMAN Cytochrome b-c1 complex subunit 6, mitochondrial OS=Homo sapiens OX=9606 GN=UQCRH PE=1 SV=2",GO:0005739; GO:0005743; GO:0006119; GO:0006122; GO:0008121; GO:0009060; GO:0045275; GO:0045333; GO:0098803,"aerobic respiration [GO:0009060]; cellular respiration [GO:0045333]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]; oxidative phosphorylation [GO:0006119]",mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respiratory chain complex [GO:0098803]; respiratory chain complex III [GO:0045275],ubiquinol-cytochrome-c reductase activity [GO:0008121],GO:0005215; GO:0005739; GO:0006091; GO:0043226,transporter activity; mitochondrion; generation of precursor metabolites and energy; organelle
OG_15475,FUN_042026-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15171.t1,apul_ptua,65.90899999999999,FUN_042026-T1,Q63406,MCF2L_RAT,,Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein) (OST oncogene),Rattus norvegicus (Rat),30.8,1090.0,2.4e-135,485.0,sp|Q63406|MCF2L_RAT Guanine nucleotide exchange factor DBS OS=Rattus norvegicus OX=10116 GN=Mcf2l PE=1 SV=3,GO:0005085; GO:0005545; GO:0005737; GO:0005886; GO:0007266; GO:0016020; GO:0030027; GO:0035091; GO:0035556; GO:0045944,intracellular signal transduction [GO:0035556]; positive regulation of transcription by RNA polymerase II [GO:0045944]; Rho protein signal transduction [GO:0007266],cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886],1-phosphatidylinositol binding [GO:0005545]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol binding [GO:0035091],GO:0005886; GO:0006355; GO:0008289; GO:0098772,plasma membrane; regulation of DNA-templated transcription; lipid binding; molecular function regulator activity
OG_15476,FUN_042044-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15138.t1,apul_ptua,77.352,FUN_042044-T1,Q2KHS5,MOG2A_XENLA,,2-acylglycerol O-acyltransferase 2-A (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2-A) (MGAT2-A) (Monoacylglycerol O-acyltransferase 2-A),Xenopus laevis (African clawed frog),55.4,285.0,1.1e-87,324.7,sp|Q2KHS5|MOG2A_XENLA 2-acylglycerol O-acyltransferase 2-A OS=Xenopus laevis OX=8355 GN=mogat2-a PE=2 SV=1,GO:0003846; GO:0004144; GO:0005789; GO:0006071; GO:0006640; GO:0006651; GO:0019432; GO:1990578,diacylglycerol biosynthetic process [GO:0006651]; glycerol metabolic process [GO:0006071]; monoacylglycerol biosynthetic process [GO:0006640]; triglyceride biosynthetic process [GO:0019432],endoplasmic reticulum membrane [GO:0005789]; perinuclear endoplasmic reticulum membrane [GO:1990578],2-acylglycerol O-acyltransferase activity [GO:0003846]; diacylglycerol O-acyltransferase activity [GO:0004144],GO:0003824; GO:0005975; GO:0006629; GO:0016740,catalytic activity; carbohydrate metabolic process; lipid metabolic process; transferase activity
OG_15477,FUN_042061-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22314.t1,apul_ptua,72.674,FUN_042061-T1,Q8BHL3,,,,,53.7,328.0,5.8e-104,379.0,sp|Q8BHL3|TB10B_MOUSE TBC1 domain family member 10B OS=Mus musculus OX=10090 GN=Tbc1d10b PE=1 SV=2,,,,,,
OG_15478,FUN_042062-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22291.t2,apul_ptua,52.09,FUN_042062-T1,Q29A33,,,,,32.8,238.0,6.5e-19,97.4,sp|Q29A33|ATX2_DROPS Ataxin-2 homolog OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=Atx2 PE=3 SV=2,,,,,,
OG_15479,FUN_042074-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6236.t1,apul_ptua,46.853,,,,,,,,,,,,,,,,,
OG_15480,FUN_042081-T1,,Pocillopora_meandrina_HIv1___TS.g15795.t1,apul_ptua,40.278,,,,,,,,,,,,,,,,,
OG_15481,FUN_042094-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22293.t1,apul_ptua,60.55,,,,,,,,,,,,,,,,,
OG_15482,FUN_042098-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21787.t1,apul_ptua,80.0,FUN_042098-T1,Q4WUR1,PP2B_ASPFU,,Serine/threonine-protein phosphatase 2B catalytic subunit (EC 3.1.3.16) (Calmodulin-dependent calcineurin A subunit),Aspergillus fumigatus (strain ATCC MYA-4609 / CBS 101355 / FGSC A1100 / Af293) (Neosartorya fumigata),35.6,90.0,7.1e-09,61.6,sp|Q4WUR1|PP2B_ASPFU Serine/threonine-protein phosphatase 2B catalytic subunit OS=Aspergillus fumigatus (strain ATCC MYA-4609 / CBS 101355 / FGSC A1100 / Af293) OX=330879 GN=cnaA PE=1 SV=2,GO:0005516; GO:0005737; GO:0005955; GO:0031505; GO:0033192; GO:0046872; GO:0097720,calcineurin-mediated signaling [GO:0097720]; fungal-type cell wall organization [GO:0031505],calcineurin complex [GO:0005955]; cytoplasm [GO:0005737],calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; metal ion binding [GO:0046872],GO:0003824; GO:0016787; GO:0071554; GO:0140096,"catalytic activity; hydrolase activity; cell wall organization or biogenesis; catalytic activity, acting on a protein"
OG_15483,FUN_042101-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21790.t1,apul_ptua,46.969,FUN_042101-T1,Q6ZQF0,TOPB1_MOUSE,,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),Mus musculus (Mouse),28.0,250.0,2.9e-22,109.0,sp|Q6ZQF0|TOPB1_MOUSE DNA topoisomerase 2-binding protein 1 OS=Mus musculus OX=10090 GN=Topbp1 PE=1 SV=2,GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006281; GO:0006974; GO:0007131; GO:0010212; GO:0015629; GO:0016605; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166,broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; protein localization to site of double-strand break [GO:1990166]; reciprocal meiotic recombination [GO:0007131]; response to ionizing radiation [GO:0010212],actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922],chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0000228; GO:0003677; GO:0005634; GO:0005694; GO:0005815; GO:0005856; GO:0005886; GO:0006281; GO:0006310; GO:0022414; GO:0043226; GO:0060090; GO:0098772,nuclear chromosome; DNA binding; nucleus; chromosome; microtubule organizing center; cytoskeleton; plasma membrane; DNA repair; DNA recombination; reproductive process; organelle; molecular adaptor activity; molecular function regulator activity
OG_15484,FUN_042105-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21782.t1,apul_ptua,78.099,,,,,,,,,,,,,,,,,
OG_15485,FUN_042106-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21780.t1,apul_ptua,48.81,,,,,,,,,,,,,,,,,
OG_15486,FUN_042130-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10956.t1,apul_ptua,33.297,FUN_042130-T1,E9Q236,MRP4_MOUSE,,ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (Multidrug resistance-associated protein 4),Mus musculus (Mouse),28.8,929.0,1.1e-90,336.3,sp|E9Q236|MRP4_MOUSE ATP-binding cassette sub-family C member 4 OS=Mus musculus OX=10090 GN=Abcc4 PE=1 SV=1,GO:0001409; GO:0005524; GO:0005730; GO:0005794; GO:0005886; GO:0006855; GO:0008559; GO:0015132; GO:0015143; GO:0015431; GO:0015432; GO:0015562; GO:0015665; GO:0015721; GO:0015732; GO:0015747; GO:0015850; GO:0016020; GO:0016323; GO:0016324; GO:0016887; GO:0031088; GO:0032310; GO:0034634; GO:0042626; GO:0042910; GO:0060271; GO:0070730; GO:0071716; GO:0140115; GO:1901571,bile acid and bile salt transport [GO:0015721]; cAMP transport [GO:0070730]; cilium assembly [GO:0060271]; export across plasma membrane [GO:0140115]; fatty acid derivative transport [GO:1901571]; leukotriene transport [GO:0071716]; organic hydroxy compound transport [GO:0015850]; prostaglandin secretion [GO:0032310]; prostaglandin transport [GO:0015732]; urate transport [GO:0015747]; xenobiotic transmembrane transport [GO:0006855],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088],ABC-type bile acid transporter activity [GO:0015432]; ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; alcohol transmembrane transporter activity [GO:0015665]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; guanine nucleotide transmembrane transporter activity [GO:0001409]; prostaglandin transmembrane transporter activity [GO:0015132]; urate transmembrane transporter activity [GO:0015143]; xenobiotic transmembrane transporter activity [GO:0042910],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005886; GO:0016787; GO:0043226; GO:0044782; GO:0055085; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; plasma membrane; hydrolase activity; organelle; cilium organization; transmembrane transport; ATP-dependent activity
OG_15487,FUN_042136-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22352.t1,apul_ptua,68.53399999999999,FUN_042136-T1,Q689Z5,SBNO1_MOUSE,,Protein strawberry notch homolog 1 (mSno1),Mus musculus (Mouse),61.3,1172.0,0.0,1344.7,sp|Q689Z5|SBNO1_MOUSE Protein strawberry notch homolog 1 OS=Mus musculus OX=10090 GN=Sbno1 PE=1 SV=2,GO:0005634; GO:0006355; GO:0043124; GO:0043409; GO:0090263; GO:0150079; GO:2000179,negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroinflammatory response [GO:0150079]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of neural precursor cell proliferation [GO:2000179]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],,GO:0005634; GO:0006355; GO:0043226,nucleus; regulation of DNA-templated transcription; organelle
OG_15488,FUN_042167-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22664.t1,apul_ptua,81.25,,,,,,,,,,,,,,,,,
OG_15489,FUN_042206-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18180.t1,apul_ptua,71.25,,,,,,,,,,,,,,,,,
OG_15490,FUN_042272-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1785.t1,apul_ptua,90.854,,,,,,,,,,,,,,,,,
OG_15491,FUN_042295-T1,,Pocillopora_meandrina_HIv1___TS.g22083.t1,apul_ptua,35.556,,,,,,,,,,,,,,,,,
OG_15492,FUN_042364-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27311.t1,apul_ptua,38.356,,,,,,,,,,,,,,,,,
OG_15493,FUN_042425-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22276.t1,apul_ptua,57.2105,,,,,,,,,,,,,,,,,
OG_15494,FUN_042467-T1,,Pocillopora_meandrina_HIv1___TS.g9833.t1b,apul_ptua,76.657,,,,,,,,,,,,,,,,,
OG_15495,FUN_042471-T1,,Pocillopora_meandrina_HIv1___TS.g9975.t1,apul_ptua,30.189,,,,,,,,,,,,,,,,,
OG_15496,FUN_042522-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6107.t1,apul_ptua,34.783,,,,,,,,,,,,,,,,,
OG_15497,FUN_042584-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16883.t1,apul_ptua,53.870000000000005,FUN_042584-T1,Q6DF94,SPICE_XENLA,,Spindle and centriole-associated protein 1 (Coiled-coil domain-containing protein 52),Xenopus laevis (African clawed frog),37.5,192.0,2.2e-24,116.3,sp|Q6DF94|SPICE_XENLA Spindle and centriole-associated protein 1 OS=Xenopus laevis OX=8355 GN=spice1 PE=2 SV=1,GO:0005737; GO:0005813; GO:0005814; GO:0005819; GO:0046599; GO:0051301; GO:0051310; GO:0090307,cell division [GO:0051301]; metaphase chromosome alignment [GO:0051310]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle [GO:0005819],,GO:0005815; GO:0007010; GO:0043226,microtubule organizing center; cytoskeleton organization; organelle
OG_15498,FUN_042601-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16852.t2,apul_ptua,52.676,FUN_042601-T1,O75899,GABR2_HUMAN,,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),Homo sapiens (Human),26.8,497.0,2.6e-42,176.0,sp|O75899|GABR2_HUMAN Gamma-aminobutyric acid type B receptor subunit 2 OS=Homo sapiens OX=9606 GN=GABBR2 PE=1 SV=1,GO:0004888; GO:0004965; GO:0005737; GO:0005886; GO:0007186; GO:0007193; GO:0007194; GO:0007214; GO:0007268; GO:0038039; GO:0043005; GO:0045211; GO:0046982; GO:0051932; GO:0150099; GO:1902710; GO:1902712,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway [GO:0007186]; gamma-aminobutyric acid signaling pathway [GO:0007214]; negative regulation of adenylate cyclase activity [GO:0007194]; neuron-glial cell signaling [GO:0150099]; synaptic transmission, GABAergic [GO:0051932]",cytoplasm [GO:0005737]; G protein-coupled GABA receptor complex [GO:1902712]; G protein-coupled receptor heterodimeric complex [GO:0038039]; GABA receptor complex [GO:1902710]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211],G protein-coupled GABA receptor activity [GO:0004965]; protein heterodimerization activity [GO:0046982]; transmembrane signaling receptor activity [GO:0004888],GO:0005886; GO:0023052; GO:0060089,plasma membrane; signaling; molecular transducer activity
OG_15499,FUN_042612-T2,,Pocillopora_meandrina_HIv1___RNAseq.g17024.t1,apul_ptua,70.642,FUN_042612-T2,Q6DID7,WLS_MOUSE,,Protein wntless homolog (Integral membrane protein GPR177) (Protein evenness interrupted homolog) (EVI),Mus musculus (Mouse),45.0,553.0,2e-127,457.6,sp|Q6DID7|WLS_MOUSE Protein wntless homolog OS=Mus musculus OX=10090 GN=Wls PE=1 SV=1,GO:0000139; GO:0001707; GO:0005634; GO:0005783; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0006886; GO:0009948; GO:0016055; GO:0017147; GO:0030177; GO:0030901; GO:0030902; GO:0031017; GO:0031410; GO:0031852; GO:0031901; GO:0032590; GO:0032839; GO:0050775; GO:0061355; GO:0061357; GO:0071529; GO:0090263,anterior/posterior axis specification [GO:0009948]; cementum mineralization [GO:0071529]; exocrine pancreas development [GO:0031017]; hindbrain development [GO:0030902]; intracellular protein transport [GO:0006886]; mesoderm formation [GO:0001707]; midbrain development [GO:0030901]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt protein secretion [GO:0061355]; Wnt signaling pathway [GO:0016055],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendrite membrane [GO:0032590]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],mu-type opioid receptor binding [GO:0031852]; Wnt-protein binding [GO:0017147],GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006886; GO:0031410; GO:0043226; GO:0048856,nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; intracellular protein transport; cytoplasmic vesicle; organelle; anatomical structure development
OG_15500,FUN_042618-T2,,Pocillopora_meandrina_HIv1___RNAseq.g17031.t1,apul_ptua,56.813500000000005,FUN_042618-T2,P54317,LIPR2_HUMAN,,Pancreatic lipase-related protein 2 (PL-RP2) (Cytotoxic T lymphocyte lipase) (Galactolipase) (EC 3.1.1.26) (Triacylglycerol lipase) (EC 3.1.1.3),Homo sapiens (Human),35.6,458.0,1.1e-68,262.3,sp|P54317|LIPR2_HUMAN Pancreatic lipase-related protein 2 OS=Homo sapiens OX=9606 GN=PNLIPRP2 PE=1 SV=2,GO:0004465; GO:0004620; GO:0004806; GO:0005509; GO:0005576; GO:0005615; GO:0006633; GO:0006641; GO:0008970; GO:0009395; GO:0019376; GO:0019433; GO:0034375; GO:0034638; GO:0042589; GO:0042632; GO:0043005; GO:0044241; GO:0047372; GO:0047714,cholesterol homeostasis [GO:0042632]; fatty acid biosynthetic process [GO:0006633]; galactolipid catabolic process [GO:0019376]; high-density lipoprotein particle remodeling [GO:0034375]; lipid digestion [GO:0044241]; phosphatidylcholine catabolic process [GO:0034638]; phospholipid catabolic process [GO:0009395]; triglyceride catabolic process [GO:0019433]; triglyceride metabolic process [GO:0006641],extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; zymogen granule membrane [GO:0042589],calcium ion binding [GO:0005509]; galactolipase activity [GO:0047714]; lipoprotein lipase activity [GO:0004465]; monoacylglycerol lipase activity [GO:0047372]; phospholipase A1 activity [GO:0008970]; phospholipase activity [GO:0004620]; triacylglycerol lipase activity [GO:0004806],GO:0003824; GO:0005576; GO:0005615; GO:0006629; GO:0016787; GO:1901135,catalytic activity; extracellular region; extracellular space; lipid metabolic process; hydrolase activity; carbohydrate derivative metabolic process
OG_15501,FUN_042619-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17032.t1,apul_ptua,75.342,FUN_042619-T1,Q9ERZ8,TRPV4_RAT,,Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Osm-9-like TRP channel 4) (OTRPC4) (Vanilloid receptor-related osmotically-activated channel) (VR-OAC),Rattus norvegicus (Rat),20.3,349.0,1.5e-07,59.7,sp|Q9ERZ8|TRPV4_RAT Transient receptor potential cation channel subfamily V member 4 OS=Rattus norvegicus OX=10116 GN=Trpv4 PE=1 SV=1,GO:0000122; GO:0001666; GO:0002024; GO:0003779; GO:0005034; GO:0005080; GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005886; GO:0005912; GO:0005925; GO:0005929; GO:0006816; GO:0006874; GO:0006970; GO:0006971; GO:0007015; GO:0007043; GO:0007204; GO:0007231; GO:0008017; GO:0008289; GO:0009986; GO:0010628; GO:0010759; GO:0010977; GO:0015275; GO:0015867; GO:0016324; GO:0019901; GO:0030027; GO:0030036; GO:0030103; GO:0030175; GO:0030426; GO:0030864; GO:0031117; GO:0032308; GO:0032587; GO:0032755; GO:0032868; GO:0034605; GO:0042169; GO:0042538; GO:0042593; GO:0042802; GO:0043014; GO:0043117; GO:0043622; GO:0045794; GO:0045989; GO:0046330; GO:0046785; GO:0046872; GO:0047484; GO:0048487; GO:0050729; GO:0050891; GO:0051015; GO:0060087; GO:0060351; GO:0070374; GO:0070509; GO:0070588; GO:0071470; GO:0071476; GO:0071477; GO:0071639; GO:0071642; GO:0071651; GO:0090316; GO:0097009; GO:0097497; GO:0098703; GO:1902632; GO:1902656; GO:1903444; GO:1903715; GO:1904669; GO:1990079; GO:2000340,actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; ATP export [GO:1904669]; ATP transport [GO:0015867]; blood vessel endothelial cell delamination [GO:0097497]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion import into cytosol [GO:1902656]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cartilage homeostasis [GO:1990079]; cell-cell junction assembly [GO:0007043]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; cellular response to heat [GO:0034605]; cellular response to osmotic stress [GO:0071470]; cortical microtubule organization [GO:0043622]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; glucose homeostasis [GO:0042593]; hyperosmotic salinity response [GO:0042538]; hypotonic response [GO:0006971]; intracellular calcium ion homeostasis [GO:0006874]; microtubule polymerization [GO:0046785]; multicellular organismal-level water homeostasis [GO:0050891]; negative regulation of brown fat cell differentiation [GO:1903444]; negative regulation of cell volume [GO:0045794]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osmosensory signaling pathway [GO:0007231]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage inflammatory protein 1 alpha production [GO:0071642]; positive regulation of membrane hyperpolarization [GO:1902632]; positive regulation of microtubule depolymerization [GO:0031117]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of striated muscle contraction [GO:0045989]; positive regulation of vascular permeability [GO:0043117]; regulation of aerobic respiration [GO:1903715]; regulation of response to osmotic stress [GO:0047484]; relaxation of vascular associated smooth muscle [GO:0060087]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to osmotic stress [GO:0006970]; vasopressin secretion [GO:0030103],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; monoatomic cation channel activity [GO:0005261]; osmosensor activity [GO:0005034]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; stretch-activated, monoatomic cation-selective, calcium channel activity [GO:0015275]",GO:0003012; GO:0003013; GO:0005215; GO:0005856; GO:0005886; GO:0005929; GO:0006355; GO:0007010; GO:0008092; GO:0008289; GO:0034330; GO:0043226; GO:0048856; GO:0055085; GO:0060089; GO:0065003; GO:0098772; GO:0140299,muscle system process; circulatory system process; transporter activity; cytoskeleton; plasma membrane; cilium; regulation of DNA-templated transcription; cytoskeleton organization; cytoskeletal protein binding; lipid binding; cell junction organization; organelle; anatomical structure development; transmembrane transport; molecular transducer activity; protein-containing complex assembly; molecular function regulator activity; molecular sensor activity
OG_15502,FUN_042638-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4879.t1,apul_ptua,50.271,FUN_042638-T1,Q8CE72,CPLN1_MOUSE,,Ciliogenesis and planar polarity effector 1 (Protein C5orf42 homolog) (Protein JBTS17),Mus musculus (Mouse),40.0,125.0,1.6e-18,97.8,sp|Q8CE72|CPLN1_MOUSE Ciliogenesis and planar polarity effector 1 OS=Mus musculus OX=10090 GN=Cplane1 PE=1 SV=4,GO:0001736; GO:0001822; GO:0003279; GO:0003281; GO:0007507; GO:0016020; GO:0021549; GO:0035869; GO:0042733; GO:0060021; GO:0060271; GO:0060976; GO:1904491,cardiac septum development [GO:0003279]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; kidney development [GO:0001822]; protein localization to ciliary transition zone [GO:1904491]; roof of mouth development [GO:0060021]; ventricular septum development [GO:0003281],ciliary transition zone [GO:0035869]; membrane [GO:0016020],,GO:0044782; GO:0048856,cilium organization; anatomical structure development
OG_15503,FUN_042649-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11516.t1,apul_ptua,35.511,,,,,,,,,,,,,,,,,
OG_15504,FUN_042662-T1,,Pocillopora_meandrina_HIv1___RNAseq.g4897.t1,apul_ptua,75.767,FUN_042662-T1,F1MV99,,,,,27.1,299.0,8.2e-20,99.4,sp|F1MV99|SSR5_BOVIN Somatostatin receptor type 5 OS=Bos taurus OX=9913 GN=SSTR5 PE=3 SV=2,,,,,,
OG_15505,FUN_042666-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15584.t1,apul_ptua,82.716,FUN_042666-T1,Q6PHY8,,,,,53.9,102.0,2.5e-26,119.4,sp|Q6PHY8|SELTB_DANRE Thioredoxin reductase-like selenoprotein T1b OS=Danio rerio OX=7955 GN=selenot1b PE=2 SV=3,,,,,,
OG_15506,FUN_042806-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15149.t1,apul_ptua,60.199,FUN_042806-T1,P61315,,,,,39.3,247.0,1.2e-38,162.2,sp|P61315|G3ST3_MOUSE Galactose-3-O-sulfotransferase 3 OS=Mus musculus OX=10090 GN=Gal3st3 PE=2 SV=1,,,,,,
OG_15507,FUN_042826-T1,,Pocillopora_meandrina_HIv1___TS.g1022.t1,apul_ptua,83.67,FUN_042826-T1,L0N7N1,,,,,53.3,525.0,7e-137,489.2,sp|L0N7N1|KIF14_MOUSE Kinesin-like protein KIF14 OS=Mus musculus OX=10090 GN=Kif14 PE=1 SV=1,,,,,,
OG_15508,FUN_042831-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7269.t1,apul_ptua,30.707,,,,,,,,,,,,,,,,,
OG_15509,FUN_042857-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7243.t1,apul_ptua,88.0,FUN_042857-T1,Q1JQB2,BUB3_BOVIN,,Mitotic checkpoint protein BUB3,Bos taurus (Bovine),74.7,320.0,2.8e-145,516.2,sp|Q1JQB2|BUB3_BOVIN Mitotic checkpoint protein BUB3 OS=Bos taurus OX=9913 GN=BUB3 PE=2 SV=1,GO:0000776; GO:0005654; GO:0007059; GO:0007094; GO:0033597; GO:0043130; GO:0051301; GO:0051321; GO:0051983; GO:1990298,cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321]; mitotic spindle assembly checkpoint signaling [GO:0007094]; regulation of chromosome segregation [GO:0051983],bub1-bub3 complex [GO:1990298]; kinetochore [GO:0000776]; mitotic checkpoint complex [GO:0033597]; nucleoplasm [GO:0005654],ubiquitin binding [GO:0043130],GO:0005654; GO:0007059; GO:0022414; GO:0043226,nucleoplasm; chromosome segregation; reproductive process; organelle
OG_15510,FUN_042891-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7222.t1,apul_ptua,42.831,FUN_042891-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),26.2,854.0,3.9e-81,305.1,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_15511,FUN_042903-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7224.t1,apul_ptua,70.293,FUN_042903-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),26.2,2354.0,1.1999999999999999e-205,719.9,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_15512,FUN_042908-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7201.t1,apul_ptua,68.085,FUN_042908-T1,Q9AVQ1,,,,,28.3,198.0,1.4000000000000002e-22,108.2,sp|Q9AVQ1|DES_SOLTU Divinyl ether synthase CYP74D2 OS=Solanum tuberosum OX=4113 GN=DES PE=1 SV=1,,,,,,
OG_15513,FUN_042995-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28138.t1,apul_ptua,44.03,,,,,,,,,,,,,,,,,
OG_15514,FUN_043012-T2,,Pocillopora_meandrina_HIv1___RNAseq.g7036.t1,apul_ptua,62.946,FUN_043012-T2,Q91VE0,S27A4_MOUSE,,Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (Arachidonate--CoA ligase) (EC 6.2.1.15) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 4) (Very long-chain acyl-CoA synthetase 4) (ACSVL4) (EC 6.2.1.-),Mus musculus (Mouse),44.7,638.0,6.6e-154,545.8,sp|Q91VE0|S27A4_MOUSE Long-chain fatty acid transport protein 4 OS=Mus musculus OX=10090 GN=Slc27a4 PE=1 SV=1,GO:0000038; GO:0000166; GO:0001579; GO:0001676; GO:0004467; GO:0005324; GO:0005783; GO:0005789; GO:0005886; GO:0005902; GO:0006631; GO:0007584; GO:0015909; GO:0031526; GO:0031957; GO:0042760; GO:0043065; GO:0043588; GO:0044381; GO:0044539; GO:0046627; GO:0047676; GO:0051649; GO:0062003; GO:0090433; GO:0090434; GO:1990379,"establishment of localization in cell [GO:0051649]; fatty acid metabolic process [GO:0006631]; glucose import in response to insulin stimulus [GO:0044381]; lipid transport across blood-brain barrier [GO:1990379]; long-chain fatty acid import into cell [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity [GO:0062003]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of apoptotic process [GO:0043065]; response to nutrient [GO:0007584]; skin development [GO:0043588]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]",brush border membrane [GO:0031526]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; plasma membrane [GO:0005886],arachidonate-CoA ligase activity [GO:0047676]; long-chain fatty acid transmembrane transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; nucleotide binding [GO:0000166]; oleoyl-CoA ligase activity [GO:0090434]; palmitoyl-CoA ligase activity [GO:0090433]; very long-chain fatty acid-CoA ligase activity [GO:0031957],GO:0003013; GO:0003824; GO:0005215; GO:0005783; GO:0005886; GO:0006629; GO:0016874; GO:0043226; GO:0048856; GO:0055085; GO:0140657,circulatory system process; catalytic activity; transporter activity; endoplasmic reticulum; plasma membrane; lipid metabolic process; ligase activity; organelle; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_15515,FUN_043107-T2,,Pocillopora_meandrina_HIv1___RNAseq.g7897.t1,apul_ptua,85.687,FUN_043107-T2,Q8N9R8,SCAI_HUMAN,,Protein SCAI (Suppressor of cancer cell invasion protein),Homo sapiens (Human),52.3,518.0,4.2e-146,519.6,sp|Q8N9R8|SCAI_HUMAN Protein SCAI OS=Homo sapiens OX=9606 GN=SCAI PE=1 SV=2,GO:0003714; GO:0005634; GO:0005654; GO:0005737; GO:0006351; GO:0030336; GO:0031965; GO:0035024,DNA-templated transcription [GO:0006351]; negative regulation of cell migration [GO:0030336]; negative regulation of Rho protein signal transduction [GO:0035024],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006351; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_15516,FUN_043132-T2,,Pocillopora_meandrina_HIv1___RNAseq.g6876.t2,apul_ptua,85.6865,FUN_043132-T2,Q9NU02,,,,,49.2,541.0,1.2e-89,332.4,sp|Q9NU02|ANKE1_HUMAN Ankyrin repeat and EF-hand domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKEF1 PE=1 SV=2,,,,,,
OG_15517,FUN_043156-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6837.t1,apul_ptua,87.59899999999999,FUN_043156-T1,Q16513,,,,,51.0,1006.0,1.7e-262,907.1,sp|Q16513|PKN2_HUMAN Serine/threonine-protein kinase N2 OS=Homo sapiens OX=9606 GN=PKN2 PE=1 SV=1,,,,,,
OG_15518,FUN_043168-T2,,Pocillopora_meandrina_HIv1___TS.g534.t1,apul_ptua,58.587,FUN_043168-T2,P47775,,,,,24.9,285.0,1.7e-06,56.2,sp|P47775|GPR12_HUMAN G-protein coupled receptor 12 OS=Homo sapiens OX=9606 GN=GPR12 PE=1 SV=1,,,,,,
OG_15519,FUN_043197-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7696.t1,apul_ptua,47.123,FUN_043197-T1,Q8N0V5,GNT2A_HUMAN,,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT)",Homo sapiens (Human),37.0,316.0,2.1e-52,208.0,"sp|Q8N0V5|GNT2A_HUMAN N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase OS=Homo sapiens OX=9606 GN=GCNT2 PE=1 SV=1",GO:0000139; GO:0006024; GO:0006486; GO:0007179; GO:0007275; GO:0008109; GO:0008284; GO:0008375; GO:0010608; GO:0010718; GO:0010812; GO:0016020; GO:0030335; GO:0034116; GO:0036438; GO:0051897; GO:0070374,glycosaminoglycan biosynthetic process [GO:0006024]; maintenance of lens transparency [GO:0036438]; multicellular organism development [GO:0007275]; negative regulation of cell-substrate adhesion [GO:0010812]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; post-transcriptional regulation of gene expression [GO:0010608]; protein glycosylation [GO:0006486]; transforming growth factor beta receptor signaling pathway [GO:0007179],Golgi membrane [GO:0000139]; membrane [GO:0016020],"acetylglucosaminyltransferase activity [GO:0008375]; N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity [GO:0008109]",GO:0003824; GO:0006486; GO:0016740; GO:0048856; GO:1901135,catalytic activity; protein glycosylation; transferase activity; anatomical structure development; carbohydrate derivative metabolic process
OG_15520,FUN_043205-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6813.t1,apul_ptua,72.519,FUN_043205-T1,Q7SYM0,,,,,61.1,244.0,1.3e-79,297.7,sp|Q7SYM0|UCK2A_DANRE Uridine-cytidine kinase 2-A OS=Danio rerio OX=7955 GN=uck2a PE=2 SV=1,,,,,,
OG_15521,FUN_043213-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6784.t1,apul_ptua,58.491,,,,,,,,,,,,,,,,,
OG_15522,FUN_043218-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6780.t1,apul_ptua,56.1745,FUN_043218-T1,Q9YHD3,,,,,25.2,1219.0,4.5e-20,102.1,sp|Q9YHD3|BAG6A_XENLA Large proline-rich protein bag6-A OS=Xenopus laevis OX=8355 GN=Bag6-a PE=2 SV=1,,,,,,
OG_15523,FUN_043219-T2,,Pocillopora_meandrina_HIv1___RNAseq.g6779.t1,apul_ptua,52.456,FUN_043219-T2,Q9QXW2,FBXW5_MOUSE,,F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5),Mus musculus (Mouse),31.5,569.0,2.6e-65,251.1,sp|Q9QXW2|FBXW5_MOUSE F-box/WD repeat-containing protein 5 OS=Mus musculus OX=10090 GN=Fbxw5 PE=1 SV=1,GO:0005737; GO:0007088; GO:0010824; GO:0016567; GO:0019005; GO:0019901; GO:0031146; GO:0043161; GO:0080008,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic nuclear division [GO:0007088]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005],protein kinase binding [GO:0019901],GO:0030163,protein catabolic process
OG_15524,FUN_043223-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6774.t1b,apul_ptua,53.251,,,,,,,,,,,,,,,,,
OG_15525,FUN_043225-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6772.t1,apul_ptua,56.096,FUN_043225-T1,Q8NDI1,EHBP1_HUMAN,,EH domain-binding protein 1,Homo sapiens (Human),24.5,1495.0,1.6e-61,240.0,sp|Q8NDI1|EHBP1_HUMAN EH domain-binding protein 1 OS=Homo sapiens OX=9606 GN=EHBP1 PE=1 SV=3,GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0006897; GO:0015031,endocytosis [GO:0006897]; protein transport [GO:0015031],cytosol [GO:0005829]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],,GO:0005654; GO:0005768; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226,nucleoplasm; endosome; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_15526,FUN_043230-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6762.t1,apul_ptua,91.304,FUN_043230-T1,P70195,PSB7_MOUSE,,Proteasome subunit beta type-7 (EC 3.4.25.1) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z) (Proteasome subunit beta-2) (beta-2),Mus musculus (Mouse),69.3,277.0,1.9e-108,393.7,sp|P70195|PSB7_MOUSE Proteasome subunit beta type-7 OS=Mus musculus OX=10090 GN=Psmb7 PE=1 SV=1,GO:0004298; GO:0005654; GO:0005829; GO:0005839; GO:0005929; GO:0016604; GO:0019774; GO:0051603,proteolysis involved in protein catabolic process [GO:0051603],"cilium [GO:0005929]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; proteasome core complex [GO:0005839]; proteasome core complex, beta-subunit complex [GO:0019774]",threonine-type endopeptidase activity [GO:0004298],GO:0003824; GO:0005654; GO:0005829; GO:0005929; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; cytosol; cilium; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_15527,FUN_043233-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6755.t1,apul_ptua,74.57,,,,,,,,,,,,,,,,,
OG_15528,FUN_043246-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8848.t1,apul_ptua,61.1485,FUN_043246-T1,E1BEA8,,,,,42.3,215.0,4.7999999999999997e-39,163.7,sp|E1BEA8|TBX6_BOVIN T-box transcription factor TBX6 OS=Bos taurus OX=9913 GN=TBX6 PE=3 SV=2,,,,,,
OG_15529,FUN_043302-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8921.t1,apul_ptua,43.478,,,,,,,,,,,,,,,,,
OG_15530,FUN_043364-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27928.t1,apul_ptua,44.227,,,,,,,,,,,,,,,,,
OG_15531,FUN_043378-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8984.t1,apul_ptua,72.37,FUN_043378-T1,Q6GN42,CTL4_XENLA,,Choline transporter-like protein 4 (Solute carrier family 44 member 4),Xenopus laevis (African clawed frog),41.7,695.0,2.8e-145,517.3,sp|Q6GN42|CTL4_XENLA Choline transporter-like protein 4 OS=Xenopus laevis OX=8355 GN=slc44a4 PE=2 SV=1,GO:0005886; GO:0008292; GO:0015220; GO:0015297; GO:0015871; GO:0016324; GO:0030307; GO:0030974; GO:0032475; GO:0035675; GO:0061526; GO:0090422,acetylcholine biosynthetic process [GO:0008292]; acetylcholine secretion [GO:0061526]; choline transport [GO:0015871]; neuromast hair cell development [GO:0035675]; otolith formation [GO:0032475]; positive regulation of cell growth [GO:0030307]; thiamine pyrophosphate transmembrane transport [GO:0030974],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],antiporter activity [GO:0015297]; choline transmembrane transporter activity [GO:0015220]; thiamine pyrophosphate transmembrane transporter activity [GO:0090422],GO:0005215; GO:0005886; GO:0048856; GO:0055085,transporter activity; plasma membrane; anatomical structure development; transmembrane transport
OG_15532,FUN_043386-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8997.t1,apul_ptua,52.6515,FUN_043386-T1,O09118,NET1_MOUSE,,Netrin-1,Mus musculus (Mouse),33.6,458.0,3.6e-72,275.8,sp|O09118|NET1_MOUSE Netrin-1 OS=Mus musculus OX=10090 GN=Ntn1 PE=1 SV=3,GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0007409; GO:0007411; GO:0008283; GO:0014009; GO:0015629; GO:0030334; GO:0030517; GO:0030879; GO:0032488; GO:0033564; GO:0042472; GO:0045202; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0062023; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147,"anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]",actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; synapse [GO:0045202],,GO:0005576; GO:0005654; GO:0005829; GO:0005856; GO:0007155; GO:0012501; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870,extracellular region; nucleoplasm; cytosol; cytoskeleton; cell adhesion; programmed cell death; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility
OG_15533,FUN_043391-T1,,Pocillopora_meandrina_HIv1___TS.g20721.t1,apul_ptua,61.367,FUN_043391-T1,Q99020,,,,,32.6,172.0,1.7e-19,98.2,sp|Q99020|ROAA_MOUSE Heterogeneous nuclear ribonucleoprotein A/B OS=Mus musculus OX=10090 GN=Hnrnpab PE=1 SV=1,,,,,,
OG_15534,FUN_043394-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11287.t1,apul_ptua,62.745,,,,,,,,,,,,,,,,,
OG_15535,FUN_043402-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9067.t1,apul_ptua,69.737,,,,,,,,,,,,,,,,,
OG_15536,FUN_043419-T3,,Pocillopora_meandrina_HIv1___RNAseq.g7832.t1,apul_ptua,77.451,FUN_043419-T3,Q80ZI6,LRSM1_MOUSE,,E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase),Mus musculus (Mouse),38.8,730.0,3.9e-70,267.7,sp|Q80ZI6|LRSM1_MOUSE E3 ubiquitin-protein ligase LRSAM1 OS=Mus musculus OX=10090 GN=Lrsam1 PE=1 SV=1,GO:0000209; GO:0004842; GO:0005737; GO:0005829; GO:0006914; GO:0008270; GO:0016020; GO:0030163; GO:0045806; GO:0046755; GO:0051865; GO:0061630; GO:0070086; GO:1904417; GO:2000786,autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006914; GO:0016192; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; cytosol; autophagy; vesicle-mediated transport; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_15537,FUN_043426-T3,,Pocillopora_meandrina_HIv1___RNAseq.g7841.t1,apul_ptua,58.333,FUN_043426-T3,Q1ZZU3,SWI5_HUMAN,,DNA repair protein SWI5 homolog (HBV DNAPTP1-transactivated protein A) (Protein SAE3 homolog),Homo sapiens (Human),46.1,115.0,3.4e-15,82.8,sp|Q1ZZU3|SWI5_HUMAN DNA repair protein SWI5 homolog OS=Homo sapiens OX=9606 GN=SWI5 PE=1 SV=1,GO:0000724; GO:0005634; GO:0032798; GO:0071479,cellular response to ionizing radiation [GO:0071479]; double-strand break repair via homologous recombination [GO:0000724],nucleus [GO:0005634]; Swi5-Sfr1 complex [GO:0032798],,GO:0005634; GO:0006281; GO:0006310; GO:0043226,nucleus; DNA repair; DNA recombination; organelle
OG_15538,FUN_043493-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7960.t1,apul_ptua,80.645,FUN_043493-T1,Q3SZB4,ACADM_BOVIN,,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7)",Bos taurus (Bovine),72.0,403.0,2.4e-168,593.2,"sp|Q3SZB4|ACADM_BOVIN Medium-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Bos taurus OX=9913 GN=ACADM PE=2 SV=1",GO:0003995; GO:0005737; GO:0005739; GO:0005759; GO:0006635; GO:0033539; GO:0050660; GO:0051793; GO:0070991,fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; medium-chain fatty acid catabolic process [GO:0051793],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; medium-chain fatty acyl-CoA dehydrogenase activity [GO:0070991],GO:0003824; GO:0005739; GO:0006629; GO:0016491; GO:0043226,catalytic activity; mitochondrion; lipid metabolic process; oxidoreductase activity; organelle
OG_15539,FUN_043507-T1,,Pocillopora_meandrina_HIv1___TS.g1722.t1,apul_ptua,63.123,FUN_043507-T1,A7SNR3,COQ4_NEMVE,,"Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase) (EC 4.1.1.130) (Coenzyme Q biosynthesis protein 4 homolog)",Nematostella vectensis (Starlet sea anemone),60.0,205.0,2.9e-64,246.9,"sp|A7SNR3|COQ4_NEMVE Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial OS=Nematostella vectensis OX=45351 GN=v1g191789 PE=3 SV=1",GO:0005739; GO:0006744; GO:0031314,ubiquinone biosynthetic process [GO:0006744],extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrion [GO:0005739],,GO:0005739; GO:0043226,mitochondrion; organelle
OG_15540,FUN_043509-T2,,Pocillopora_meandrina_HIv1___RNAseq.g7992.t1,apul_ptua,51.1445,FUN_043509-T2,Q0P5H2,,,,,38.5,200.0,1.6999999999999996e-31,138.3,sp|Q0P5H2|TDIF2_BOVIN Deoxynucleotidyltransferase terminal-interacting protein 2 OS=Bos taurus OX=9913 GN=DNTTIP2 PE=2 SV=1,,,,,,
OG_15541,FUN_043511-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7995.t1,apul_ptua,58.0205,FUN_043511-T1,E7F9T0,MICA1_DANRE,,[F-actin]-monooxygenase mical1 (EC 1.14.13.225) (EC 1.6.3.1) (Molecule interacting with CasL protein 1) (MICAL-1),Danio rerio (Zebrafish) (Brachydanio rerio),50.0,512.0,1.1e-144,516.9,sp|E7F9T0|MICA1_DANRE [F-actin]-monooxygenase mical1 OS=Danio rerio OX=7955 GN=mical1 PE=3 SV=1,GO:0003779; GO:0005737; GO:0005829; GO:0005856; GO:0010008; GO:0016709; GO:0019417; GO:0030042; GO:0030496; GO:0046872; GO:0071949; GO:0106294; GO:0120501,actin filament depolymerization [GO:0030042]; sulfur oxidation [GO:0019417],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; midbody [GO:0030496],"actin binding [GO:0003779]; F-actin monooxygenase activity [GO:0120501]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; NADPH oxidase H202-forming activity [GO:0106294]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",GO:0003824; GO:0005829; GO:0005856; GO:0006790; GO:0008092; GO:0016491; GO:0043226,catalytic activity; cytosol; cytoskeleton; sulfur compound metabolic process; cytoskeletal protein binding; oxidoreductase activity; organelle
OG_15542,FUN_043512-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7996.t1,apul_ptua,50.667,,,,,,,,,,,,,,,,,
OG_15543,FUN_043540-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8019.t1,apul_ptua,79.514,FUN_043540-T1,Q95LZ5,,,,,39.1,458.0,1.3e-99,365.5,sp|Q95LZ5|TTC16_MACFA Tetratricopeptide repeat protein 16 OS=Macaca fascicularis OX=9541 GN=TTC16 PE=2 SV=1,,,,,,
OG_15544,FUN_043547-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8011.t1,apul_ptua,69.224,FUN_043547-T1,B3EWZ9,HEPHL_ACRMI,,Hephaestin-like protein (EC 1.-.-.-),Acropora millepora (Staghorn coral) (Heteropora millepora),54.2,1103.0,0.0,1262.7,sp|B3EWZ9|HEPHL_ACRMI Hephaestin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,GO:0005507; GO:0005886; GO:0006825; GO:0006826; GO:0016491,copper ion transport [GO:0006825]; iron ion transport [GO:0006826],plasma membrane [GO:0005886],copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005886; GO:0016491,catalytic activity; plasma membrane; oxidoreductase activity
OG_15545,FUN_043555-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8046.t1,apul_ptua,86.242,FUN_043555-T1,Q27433,MEC2_CAEEL,,Mechanosensory protein 2,Caenorhabditis elegans,73.6,269.0,6.4e-104,378.6,sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1,GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792,detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612],neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289,transporter activity; plasma membrane; lipid binding
OG_15546,FUN_043566-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8053.t1b,apul_ptua,90.278,FUN_043566-T1,Q27433,MEC2_CAEEL,,Mechanosensory protein 2,Caenorhabditis elegans,72.0,257.0,1.2e-99,364.4,sp|Q27433|MEC2_CAEEL Mechanosensory protein 2 OS=Caenorhabditis elegans OX=6239 GN=mec-2 PE=1 SV=1,GO:0005272; GO:0005886; GO:0006813; GO:0007638; GO:0009612; GO:0015485; GO:0032589; GO:0043005; GO:0050976; GO:1905789; GO:1905792,detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; potassium ion transport [GO:0006813]; response to mechanical stimulus [GO:0009612],neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; sodium channel activity [GO:0005272],GO:0005215; GO:0005886; GO:0008289,transporter activity; plasma membrane; lipid binding
OG_15547,FUN_043568-T3,,Pocillopora_meandrina_HIv1___RNAseq.g8055.t2,apul_ptua,53.3765,FUN_043568-T3,Q9HCU4,CELR2_HUMAN,,Cadherin EGF LAG seven-pass G-type receptor 2 (Cadherin family member 10) (Epidermal growth factor-like protein 2) (EGF-like protein 2) (Flamingo homolog 3) (Multiple epidermal growth factor-like domains protein 3) (Multiple EGF-like domains protein 3),Homo sapiens (Human),24.7,598.0,2.4e-29,133.3,sp|Q9HCU4|CELR2_HUMAN Cadherin EGF LAG seven-pass G-type receptor 2 OS=Homo sapiens OX=9606 GN=CELSR2 PE=1 SV=1,GO:0003341; GO:0004930; GO:0005509; GO:0005737; GO:0005886; GO:0006355; GO:0007156; GO:0007186; GO:0016020; GO:0016055; GO:0021591; GO:0021999; GO:0022407; GO:0032880; GO:0033326; GO:0048813; GO:0060071; GO:0060271; GO:0097475; GO:0098609,"cell-cell adhesion [GO:0098609]; cerebrospinal fluid secretion [GO:0033326]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; dendrite morphogenesis [GO:0048813]; G protein-coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; motor neuron migration [GO:0097475]; neural plate anterior/posterior regionalization [GO:0021999]; regulation of cell-cell adhesion [GO:0022407]; regulation of DNA-templated transcription [GO:0006355]; regulation of protein localization [GO:0032880]; ventricular system development [GO:0021591]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0006355; GO:0007018; GO:0007155; GO:0044782; GO:0048856; GO:0048870; GO:0060089,plasma membrane; regulation of DNA-templated transcription; microtubule-based movement; cell adhesion; cilium organization; anatomical structure development; cell motility; molecular transducer activity
OG_15548,FUN_043571-T1,,Pocillopora_meandrina_HIv1___TS.g1777.t2,apul_ptua,58.744,,,,,,,,,,,,,,,,,
OG_15549,FUN_043580-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7014.t1,apul_ptua,80.775,FUN_043580-T1,Q5T4S7,UBR4_HUMAN,,E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (p600) (N-recognin-4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600),Homo sapiens (Human),47.1,5346.0,0.0,4162.1,sp|Q5T4S7|UBR4_HUMAN E3 ubiquitin-protein ligase UBR4 OS=Homo sapiens OX=9606 GN=UBR4 PE=1 SV=1,GO:0004842; GO:0005516; GO:0005654; GO:0005737; GO:0005768; GO:0005813; GO:0005829; GO:0005886; GO:0006511; GO:0006979; GO:0007032; GO:0008270; GO:0010508; GO:0016020; GO:0035579; GO:0043161; GO:0044314; GO:0045717; GO:0050821; GO:0061630; GO:0070821; GO:0070936; GO:0070979; GO:0071596; GO:0071629; GO:0101003; GO:0140455; GO:0141191; GO:0141198,cytoplasm protein quality control [GO:0140455]; cytoplasm protein quality control by the ubiquitin-proteasome system [GO:0071629]; endosome organization [GO:0007032]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of HRI-mediated signaling [GO:0141191]; positive regulation of autophagy [GO:0010508]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein branched polyubiquitination [GO:0141198]; protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; response to oxidative stress [GO:0006979]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; ficolin-1-rich granule membrane [GO:0101003]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821],calmodulin binding [GO:0005516]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005654; GO:0005768; GO:0005815; GO:0005829; GO:0005886; GO:0016740; GO:0030163; GO:0031410; GO:0043226; GO:0140096,"catalytic activity; nucleoplasm; endosome; microtubule organizing center; cytosol; plasma membrane; transferase activity; protein catabolic process; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_15550,FUN_043596-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6954.t1,apul_ptua,69.014,FUN_043596-T1,P25155,,,,,26.8,366.0,4.3e-32,140.6,sp|P25155|FA10_CHICK Coagulation factor X OS=Gallus gallus OX=9031 GN=F10 PE=1 SV=1,,,,,,
OG_15551,FUN_043637-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7414.t1,apul_ptua,54.054,,,,,,,,,,,,,,,,,
OG_15552,FUN_043648-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7403.t1a,apul_ptua,44.203,,,,,,,,,,,,,,,,,
OG_15553,FUN_043653-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7397.t1,apul_ptua,58.115,,,,,,,,,,,,,,,,,
OG_15554,FUN_043725-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26332.t1,apul_ptua,90.741,,,,,,,,,,,,,,,,,
OG_15555,FUN_043800-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5008.t1,apul_ptua,65.574,,,,,,,,,,,,,,,,,
OG_15556,FUN_043833-T1,,Pocillopora_meandrina_HIv1___TS.g14424.t1,apul_ptua,43.878,,,,,,,,,,,,,,,,,
OG_15557,FUN_044245-T1,,Pocillopora_meandrina_HIv1___RNAseq.g361.t1,apul_ptua,43.563,,,,,,,,,,,,,,,,,
OG_15558,FUN_044374-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3673.t1b,apul_ptua,44.091,FUN_044374-T1,Q6XKE6,,,,,26.9,427.0,1.3e-31,140.6,sp|Q6XKE6|POLG_PVCV2 Genome polyprotein OS=Petunia vein clearing virus (isolate Hohn) OX=492095 PE=3 SV=1,,,,,,
OG_15559,FUN_044424-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3334.t1,apul_ptua,41.509,,,,,,,,,,,,,,,,,
OG_15560,FUN_044438-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2794.t1,apul_ptua,42.697,,,,,,,,,,,,,,,,,
OG_15561,FUN_044446-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6138.t1b,apul_ptua,47.388000000000005,FUN_044446-T1,Q96JS3,,,,,26.2,393.0,2.4e-24,115.2,sp|Q96JS3|PGBD1_HUMAN PiggyBac transposable element-derived protein 1 OS=Homo sapiens OX=9606 GN=PGBD1 PE=1 SV=1,,,,,,
OG_15562,FUN_044482-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2894.t1,apul_ptua,88.652,,,,,,,,,,,,,,,,,
OG_15563,FUN_044484-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21876.t1,apul_ptua,43.103,,,,,,,,,,,,,,,,,
OG_15564,FUN_044485-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11984.t1,apul_ptua,37.279,FUN_044485-T1,Q9NBX4,,,,,26.5,445.0,4.7999999999999997e-39,164.9,sp|Q9NBX4|RTXE_DROME Probable RNA-directed DNA polymerase from transposon X-element OS=Drosophila melanogaster OX=7227 GN=X-element\ORF2 PE=3 SV=1,,,,,,
OG_15565,FUN_044493-T2,,Pocillopora_meandrina_HIv1___TS.g12579.t1,apul_ptua,45.955,,,,,,,,,,,,,,,,,
OG_15566,FUN_044505-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16632.t1,apul_ptua,84.127,FUN_044505-T1,Q0R4F1,PIF1_XENLA,,ATP-dependent DNA helicase PIF1 (EC 5.6.2.3) (DNA 5'-3' helicase PIF1) (DNA repair and recombination helicase PIF1),Xenopus laevis (African clawed frog),51.5,627.0,8.3e-178,625.2,sp|Q0R4F1|PIF1_XENLA ATP-dependent DNA helicase PIF1 OS=Xenopus laevis OX=8355 GN=pif1 PE=2 SV=1,GO:0000002; GO:0000723; GO:0003677; GO:0005524; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0016887; GO:0043139,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; mitochondrial genome maintenance [GO:0000002]; telomere maintenance [GO:0000723],mitochondrion [GO:0005739]; nucleus [GO:0005634],5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0006281; GO:0006310; GO:0016787; GO:0016853; GO:0032200; GO:0043226; GO:0140097; GO:0140657,"DNA binding; catalytic activity; nucleus; mitochondrion; DNA repair; DNA recombination; hydrolase activity; isomerase activity; telomere organization; organelle; catalytic activity, acting on DNA; ATP-dependent activity"
OG_15567,FUN_044517-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15866.t1,apul_ptua,63.6955,,,,,,,,,,,,,,,,,
OG_15568,FUN_044519-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6134.t1,apul_ptua,31.604,,,,,,,,,,,,,,,,,
OG_15569,FUN_044537-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28862.t1,apul_ptua,49.123,,,,,,,,,,,,,,,,,
OG_15570,FUN_044558-T1,,Pocillopora_meandrina_HIv1___TS.g20735.t1,apul_ptua,46.13,,,,,,,,,,,,,,,,,
OG_15571,FUN_044589-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27677.t1,apul_ptua,45.544,FUN_044589-T1,Q9M2U3,,,,,28.4,292.0,2.2000000000000002e-30,134.4,sp|Q9M2U3|ALPL_ARATH Protein ALP1-like OS=Arabidopsis thaliana OX=3702 GN=At3g55350 PE=2 SV=1,,,,,,
OG_15572,FUN_044612-T2,,Pocillopora_meandrina_HIv1___RNAseq.g13920.t1,apul_ptua,60.363,,,,,,,,,,,,,,,,,
OG_15573,FUN_044617-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18422.t1,apul_ptua,87.2635,FUN_044617-T1,Q2KID4,,,,,81.5,189.0,7.7e-58,224.9,sp|Q2KID4|DNAL1_BOVIN Dynein axonemal light chain 1 OS=Bos taurus OX=9913 GN=DNAL1 PE=2 SV=1,,,,,,
OG_15574,FUN_044650-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17476.t1,apul_ptua,86.916,,,,,,,,,,,,,,,,,
OG_15575,FUN_044652-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9091.t1,apul_ptua,40.37,FUN_044652-T1,P0DP91,ERPG3_HUMAN,,Chimeric ERCC6-PGBD3 protein (Chimeric CSB-PGBD3 protein),Homo sapiens (Human),27.5,466.0,6.1e-33,144.1,sp|P0DP91|ERPG3_HUMAN Chimeric ERCC6-PGBD3 protein OS=Homo sapiens OX=9606 GN=ERCC6 PE=1 SV=1,GO:0002230; GO:0005654; GO:0010628; GO:0016604; GO:0033141; GO:0043565; GO:0045739,positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA repair [GO:0045739]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141],nuclear body [GO:0016604]; nucleoplasm [GO:0005654],sequence-specific DNA binding [GO:0043565],GO:0003677; GO:0005654; GO:0043226,DNA binding; nucleoplasm; organelle
OG_15576,FUN_044679-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27294.t1a,apul_ptua,38.742,,,,,,,,,,,,,,,,,
OG_15577,FUN_044703-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6080.t1,apul_ptua,67.12,,,,,,,,,,,,,,,,,
OG_15578,FUN_044711-T1,,Pocillopora_meandrina_HIv1___TS.g14389.t1a,apul_ptua,48.969,,,,,,,,,,,,,,,,,
OG_15579,FUN_044721-T1,,Pocillopora_meandrina_HIv1___TS.g25782.t3,apul_ptua,80.756,FUN_044721-T1,O94818,NOL4_HUMAN,,Nucleolar protein 4 (Nucleolar-localized protein),Homo sapiens (Human),47.3,241.0,2.2e-36,155.2,sp|O94818|NOL4_HUMAN Nucleolar protein 4 OS=Homo sapiens OX=9606 GN=NOL4 PE=1 SV=2,GO:0003723; GO:0005730,,nucleolus [GO:0005730],RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0043226,RNA binding; nucleolus; organelle
OG_15580,FUN_044730-T1,,Pocillopora_meandrina_HIv1___TS.g24097.t1,apul_ptua,38.559,,,,,,,,,,,,,,,,,
OG_15581,FUN_044753-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9179.t1,apul_ptua,48.333,,,,,,,,,,,,,,,,,
OG_15582,FUN_044754-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23211.t1,apul_ptua,52.5,,,,,,,,,,,,,,,,,
OG_15583,FUN_044768-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25970.t1,apul_ptua,50.088,FUN_044768-T1,Q95SX7,,,,,22.2,594.0,1.1e-19,100.1,sp|Q95SX7|RTBS_DROME Probable RNA-directed DNA polymerase from transposon BS OS=Drosophila melanogaster OX=7227 GN=RTase PE=2 SV=1,,,,,,
OG_15584,FUN_044797-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28804.t2,apul_ptua,51.0,FUN_044797-T1,P10978,,,,,47.6,231.0,7.699999999999999e-63,241.9,sp|P10978|POLX_TOBAC Retrovirus-related Pol polyprotein from transposon TNT 1-94 OS=Nicotiana tabacum OX=4097 PE=2 SV=1,,,,,,
OG_15585,FUN_044830-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9147.t1,apul_ptua,44.97,,,,,,,,,,,,,,,,,
OG_15586,FUN_044859-T1,,Pocillopora_meandrina_HIv1___TS.g5848.t1,apul_ptua,67.045,,,,,,,,,,,,,,,,,
OG_15587,FUN_044870-T1,,Pocillopora_meandrina_HIv1___TS.g28084.t1,apul_ptua,74.82,,,,,,,,,,,,,,,,,
OG_15588,FUN_044887-T2,,Pocillopora_meandrina_HIv1___RNAseq.g982.t1,apul_ptua,59.8395,,,,,,,,,,,,,,,,,
OG_15589,FUN_044898-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5918.t1,apul_ptua,80.186,,,,,,,,,,,,,,,,,
OG_15590,FUN_044940-T1,,Pocillopora_meandrina_HIv1___RNAseq.g21295.t1,apul_ptua,71.95400000000001,FUN_044940-T1,Q96DM1,,,,,33.6,375.0,3.5e-53,210.7,sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3,,,,,,
OG_15591,FUN_044943-T1,,Pocillopora_meandrina_HIv1___TS.g6461.t1,apul_ptua,53.957,,,,,,,,,,,,,,,,,
OG_15592,FUN_044963-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12255.t1,apul_ptua,43.521,FUN_044963-T1,P14381,,,,,27.1,1004.0,4.7999999999999995e-105,384.4,sp|P14381|YTX2_XENLA Transposon TX1 uncharacterized 149 kDa protein OS=Xenopus laevis OX=8355 PE=4 SV=1,,,,,,
OG_15593,FUN_044971-T1,,Pocillopora_meandrina_HIv1___TS.g6470.t1,apul_ptua,55.172,,,,,,,,,,,,,,,,,
OG_15594,FUN_044981-T1,,Pocillopora_meandrina_HIv1___RNAseq.g29581.t1,apul_ptua,60.753,,,,,,,,,,,,,,,,,
OG_15595,FUN_044990-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24234.t1,apul_ptua,62.64,,,,,,,,,,,,,,,,,
OG_15596,FUN_045001-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20874.t1,apul_ptua,83.439,FUN_045001-T1,Q96DM1,,,,,30.9,395.0,9.9e-46,186.4,sp|Q96DM1|PGBD4_HUMAN PiggyBac transposable element-derived protein 4 OS=Homo sapiens OX=9606 GN=PGBD4 PE=1 SV=3,,,,,,
OG_15597,FUN_045003-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13414.t1,apul_ptua,52.764,,,,,,,,,,,,,,,,,
OG_15598,FUN_045055-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8067.t1,apul_ptua,59.091,,,,,,,,,,,,,,,,,
OG_15599,FUN_045061-T1,,Pocillopora_meandrina_HIv1___RNAseq.g44.t1,apul_ptua,73.4835,,,,,,,,,,,,,,,,,
OG_15600,FUN_045069-T1,,Pocillopora_meandrina_HIv1___RNAseq.g14555.t1,apul_ptua,41.212,,,,,,,,,,,,,,,,,
OG_15601,FUN_045088-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3743.t1,apul_ptua,62.304,FUN_045088-T1,Q8R3N1,,,,,39.8,906.0,5.4e-114,413.7,sp|Q8R3N1|NOP14_MOUSE Nucleolar protein 14 OS=Mus musculus OX=10090 GN=Nop14 PE=1 SV=2,,,,,,
OG_15602,FUN_045092-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1663.t1,apul_ptua,50.685,FUN_045092-T1,O97665,,,,,23.4,290.0,6.8e-11,69.7,sp|O97665|CCR8_MACMU C-C chemokine receptor type 8 OS=Macaca mulatta OX=9544 GN=CCR8 PE=3 SV=1,,,,,,
OG_15603,FUN_045101-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17550.t1,apul_ptua,48.724,,,,,,,,,,,,,,,,,
OG_15604,FUN_045117-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27028.t1,apul_ptua,72.052,,,,,,,,,,,,,,,,,
OG_15605,FUN_045118-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16063.t1,apul_ptua,47.331,,,,,,,,,,,,,,,,,
OG_15606,FUN_045123-T1,,Pocillopora_meandrina_HIv1___RNAseq.g20783.t1,apul_ptua,72.6255,,,,,,,,,,,,,,,,,
OG_15607,FUN_045140-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22690.t1,apul_ptua,36.62,,,,,,,,,,,,,,,,,
OG_15608,FUN_045149-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25918.t1,apul_ptua,78.9,,,,,,,,,,,,,,,,,
OG_15609,FUN_045155-T1,,Pocillopora_meandrina_HIv1___RNAseq.g22830.t1,apul_ptua,65.333,,,,,,,,,,,,,,,,,
OG_15610,FUN_045174-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25036.t1,apul_ptua,41.085,,,,,,,,,,,,,,,,,
OG_15611,FUN_045179-T2,,Pocillopora_meandrina_HIv1___RNAseq.g13236.t1,apul_ptua,59.937,FUN_045179-T2,Q8K1P8,MOT8_RAT,,Monocarboxylate transporter 8 (MCT 8) (Solute carrier family 16 member 2),Rattus norvegicus (Rat),28.6,329.0,5.4e-35,149.8,sp|Q8K1P8|MOT8_RAT Monocarboxylate transporter 8 OS=Rattus norvegicus OX=10116 GN=SLC16A2 PE=1 SV=2,GO:0005886; GO:0006520; GO:0006590; GO:0009914; GO:0015171; GO:0015349; GO:0016324; GO:0042403; GO:0042802; GO:0070327; GO:0070460; GO:0089718; GO:0150104; GO:2000178,amino acid import across plasma membrane [GO:0089718]; amino acid metabolic process [GO:0006520]; hormone transport [GO:0009914]; negative regulation of neural precursor cell proliferation [GO:2000178]; thyroid hormone generation [GO:0006590]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327]; thyroid-stimulating hormone secretion [GO:0070460]; transport across blood-brain barrier [GO:0150104],apical plasma membrane [GO:0016324]; plasma membrane [GO:0005886],amino acid transmembrane transporter activity [GO:0015171]; identical protein binding [GO:0042802]; thyroid hormone transmembrane transporter activity [GO:0015349],GO:0003013; GO:0005215; GO:0005886; GO:0006520; GO:0006575; GO:0055085,circulatory system process; transporter activity; plasma membrane; amino acid metabolic process; modified amino acid metabolic process; transmembrane transport
OG_15612,FUN_045230-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9235.t1,apul_ptua,57.381,,,,,,,,,,,,,,,,,
OG_15613,FUN_045233-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15835.t1,apul_ptua,47.0,,,,,,,,,,,,,,,,,
OG_15614,FUN_045240-T1,,Pocillopora_meandrina_HIv1___RNAseq.g2947.t1,apul_ptua,83.099,FUN_045240-T1,O60290,,,,,37.5,72.0,3.3e-07,55.5,sp|O60290|ZN862_HUMAN Zinc finger protein 862 OS=Homo sapiens OX=9606 GN=ZNF862 PE=1 SV=2,,,,,,
OG_15615,FUN_045251-T1,,Pocillopora_meandrina_HIv1___RNAseq.g11879.t1,apul_ptua,40.275,FUN_045251-T1,Q9P215,,,,,38.9,416.0,2.5e-83,310.8,sp|Q9P215|POGK_HUMAN Pogo transposable element with KRAB domain OS=Homo sapiens OX=9606 GN=POGK PE=1 SV=2,,,,,,
OG_15616,FUN_045257-T1,,Pocillopora_meandrina_HIv1___TS.g23396.t1,apul_ptua,81.098,FUN_045257-T1,Q9M2U3,,,,,31.1,238.0,3.3e-23,110.2,sp|Q9M2U3|ALPL_ARATH Protein ALP1-like OS=Arabidopsis thaliana OX=3702 GN=At3g55350 PE=2 SV=1,,,,,,
OG_15617,FUN_045305-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8471.t1,apul_ptua,69.366,,,,,,,,,,,,,,,,,
OG_15618,FUN_045312-T1,,Pocillopora_meandrina_HIv1___TS.g4296.t1,apul_ptua,54.545,,,,,,,,,,,,,,,,,
OG_15619,FUN_045316-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12618.t1,apul_ptua,45.652,,,,,,,,,,,,,,,,,
OG_15620,FUN_045317-T1,,Pocillopora_meandrina_HIv1___TS.g14245.t1,apul_ptua,84.73,,,,,,,,,,,,,,,,,
OG_15621,FUN_045328-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25330.t1c,apul_ptua,39.586,,,,,,,,,,,,,,,,,
OG_15622,FUN_045335-T1,,Pocillopora_meandrina_HIv1___TS.g2389.t1,apul_ptua,53.633,,,,,,,,,,,,,,,,,
OG_15623,FUN_045343-T1,,Pocillopora_meandrina_HIv1___RNAseq.g3958.t1,apul_ptua,71.2,,,,,,,,,,,,,,,,,
OG_15624,FUN_045352-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6920.t1a,apul_ptua,39.2795,,,,,,,,,,,,,,,,,
OG_15625,FUN_045356-T1,,Pocillopora_meandrina_HIv1___TS.g16958.t1,apul_ptua,73.958,,,,,,,,,,,,,,,,,
OG_15626,FUN_045365-T1,,Pocillopora_meandrina_HIv1___TS.g12716.t1,apul_ptua,49.697,,,,,,,,,,,,,,,,,
OG_15627,FUN_045383-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18404.t1,apul_ptua,96.25,,,,,,,,,,,,,,,,,
OG_15628,FUN_045384-T1,,Pocillopora_meandrina_HIv1___RNAseq.g8472.t1,apul_ptua,59.08,,,,,,,,,,,,,,,,,
OG_15629,FUN_045397-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16378.t1,apul_ptua,64.935,,,,,,,,,,,,,,,,,
OG_15630,FUN_045402-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10464.t1,apul_ptua,37.709,FUN_045402-T1,Q8NBJ9,SIDT2_HUMAN,,SID1 transmembrane family member 2,Homo sapiens (Human),24.4,402.0,6.4e-13,77.8,sp|Q8NBJ9|SIDT2_HUMAN SID1 transmembrane family member 2 OS=Homo sapiens OX=9606 GN=SIDT2 PE=1 SV=2,GO:0000902; GO:0003323; GO:0003677; GO:0003725; GO:0005764; GO:0005765; GO:0005886; GO:0006401; GO:0009749; GO:0035612; GO:0035650; GO:0042593; GO:0044342; GO:0050658; GO:0051032; GO:0051033; GO:0061178,cell morphogenesis [GO:0000902]; glucose homeostasis [GO:0042593]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; response to glucose [GO:0009749]; RNA catabolic process [GO:0006401]; RNA transport [GO:0050658]; type B pancreatic cell development [GO:0003323]; type B pancreatic cell proliferation [GO:0044342],lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; nucleic acid transmembrane transporter activity [GO:0051032]; RNA transmembrane transporter activity [GO:0051033],GO:0003677; GO:0003723; GO:0005215; GO:0005764; GO:0005773; GO:0005886; GO:0043226; GO:0048856,DNA binding; RNA binding; transporter activity; lysosome; vacuole; plasma membrane; organelle; anatomical structure development
OG_15631,FUN_045403-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5546.t1a,apul_ptua,73.427,,,,,,,,,,,,,,,,,
OG_15632,FUN_045405-T1,,Pocillopora_meandrina_HIv1___RNAseq.g5612.t1,apul_ptua,51.634,,,,,,,,,,,,,,,,,
OG_15633,FUN_045425-T1,,Pocillopora_meandrina_HIv1___TS.g21317.t1,apul_ptua,75.432,FUN_045425-T1,Q91DM0,,,,,29.1,385.0,1.6000000000000002e-33,146.4,sp|Q91DM0|POLG_PVCV1 Genome polyprotein OS=Petunia vein clearing virus (isolate Shepherd) OX=492094 PE=3 SV=1,,,,,,
OG_15634,FUN_045434-T1,,Pocillopora_meandrina_HIv1___TS.g8816.t1,apul_ptua,64.631,FUN_045434-T1,P04323,,,,,34.1,258.0,6.8e-37,156.8,sp|P04323|POL3_DROME Retrovirus-related Pol polyprotein from transposon 17.6 OS=Drosophila melanogaster OX=7227 GN=pol PE=4 SV=1,,,,,,
OG_15635,FUN_045444-T1,,Pocillopora_meandrina_HIv1___RNAseq.g18186.t1,apul_ptua,32.452,FUN_045444-T1,O60290,,,,,29.8,682.0,2.4e-67,258.5,sp|O60290|ZN862_HUMAN Zinc finger protein 862 OS=Homo sapiens OX=9606 GN=ZNF862 PE=1 SV=2,,,,,,
OG_15636,FUN_045465-T1,,Pocillopora_meandrina_HIv1___RNAseq.g17465.t1,apul_ptua,51.485,,,,,,,,,,,,,,,,,
OG_15637,FUN_045479-T1,,Pocillopora_meandrina_HIv1___RNAseq.g975.t1,apul_ptua,69.231,,,,,,,,,,,,,,,,,
OG_15638,FUN_045503-T1,,Pocillopora_meandrina_HIv1___RNAseq.g12130.t1,apul_ptua,58.4925,,,,,,,,,,,,,,,,,
OG_15639,FUN_045504-T1,,Pocillopora_meandrina_HIv1___RNAseq.g27766.t1,apul_ptua,49.541,FUN_045504-T1,Q8IN35,SIFAR_DROME,,Neuropeptide SIFamide receptor,Drosophila melanogaster (Fruit fly),25.7,342.0,2.5e-23,111.3,sp|Q8IN35|SIFAR_DROME Neuropeptide SIFamide receptor OS=Drosophila melanogaster OX=7227 GN=SIFaR PE=2 SV=2,GO:0004930; GO:0004983; GO:0005886; GO:0007186; GO:0007218; GO:0008188; GO:0008340; GO:0008528; GO:0016020; GO:0032870; GO:0048047,"cellular response to hormone stimulus [GO:0032870]; determination of adult lifespan [GO:0008340]; G protein-coupled receptor signaling pathway [GO:0007186]; mating behavior, sex discrimination [GO:0048047]; neuropeptide signaling pathway [GO:0007218]",membrane [GO:0016020]; plasma membrane [GO:0005886],G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; neuropeptide Y receptor activity [GO:0004983],GO:0005886; GO:0022414; GO:0060089,plasma membrane; reproductive process; molecular transducer activity
OG_15640,FUN_045534-T1,,Pocillopora_meandrina_HIv1___RNAseq.g610.t1a,apul_ptua,45.402,,,,,,,,,,,,,,,,,
OG_15641,FUN_045562-T1,,Pocillopora_meandrina_HIv1___TS.g21406.t1,apul_ptua,37.898,,,,,,,,,,,,,,,,,
OG_15642,FUN_045568-T1,,Pocillopora_meandrina_HIv1___TS.g14449.t1,apul_ptua,70.831,FUN_045568-T1,Q9P215,,,,,37.8,381.0,8.000000000000001e-76,285.8,sp|Q9P215|POGK_HUMAN Pogo transposable element with KRAB domain OS=Homo sapiens OX=9606 GN=POGK PE=1 SV=2,,,,,,
OG_15643,FUN_045570-T1,,Pocillopora_meandrina_HIv1___RNAseq.g10623.t1,apul_ptua,62.416,FUN_045570-T1,O14718,,,,,25.7,319.0,2.9e-06,54.3,sp|O14718|OPSX_HUMAN Visual pigment-like receptor peropsin OS=Homo sapiens OX=9606 GN=RRH PE=1 SV=1,,,,,,
OG_15644,FUN_045585-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26893.t1,apul_ptua,70.423,FUN_045585-T1,Q95LI2,,,,,25.3,162.0,1.2e-11,72.4,sp|Q95LI2|VITRN_BOVIN Vitrin OS=Bos taurus OX=9913 GN=VIT PE=2 SV=2,,,,,,
OG_15645,FUN_045590-T1,,Pocillopora_meandrina_HIv1___RNAseq.g1629.t1,apul_ptua,55.96,,,,,,,,,,,,,,,,,
OG_15646,FUN_045599-T1,,Pocillopora_meandrina_HIv1___RNAseq.g24939.t1,apul_ptua,69.128,,,,,,,,,,,,,,,,,
OG_15647,FUN_045620-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26421.t1,apul_ptua,64.346,FUN_045620-T1,O94889,KLH18_HUMAN,,Kelch-like protein 18,Homo sapiens (Human),32.1,343.0,8.2e-42,173.3,sp|O94889|KLH18_HUMAN Kelch-like protein 18 OS=Homo sapiens OX=9606 GN=KLHL18 PE=1 SV=3,GO:0005737; GO:0016567; GO:0031463; GO:0043161; GO:0051301; GO:1901992; GO:1990756,cell division [GO:0051301]; positive regulation of mitotic cell cycle phase transition [GO:1901992]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567],Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737],ubiquitin-like ligase-substrate adaptor activity [GO:1990756],GO:0030163; GO:0060090,protein catabolic process; molecular adaptor activity
OG_15648,FUN_045622-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6296.t1,apul_ptua,75.895,,,,,,,,,,,,,,,,,
OG_15649,FUN_045641-T1,,Pocillopora_meandrina_HIv1___RNAseq.g9477.t1,apul_ptua,47.917,,,,,,,,,,,,,,,,,
OG_15650,FUN_045661-T1,,Pocillopora_meandrina_HIv1___TS.g14686.t1b,apul_ptua,47.701,,,,,,,,,,,,,,,,,
OG_15651,FUN_045691-T1,,Pocillopora_meandrina_HIv1___RNAseq.g7760.t1,apul_ptua,80.0,FUN_045691-T1,A0JPI9,,,,,39.5,86.0,8.5e-08,60.1,sp|A0JPI9|LR74A_RAT Leucine-rich repeat-containing protein 74A OS=Rattus norvegicus OX=10116 GN=Lrrc74a PE=2 SV=1,,,,,,
OG_15652,FUN_045694-T1,,Pocillopora_meandrina_HIv1___RNAseq.g26687.t1,apul_ptua,75.98849999999999,,,,,,,,,,,,,,,,,
OG_15653,FUN_045701-T1,,Pocillopora_meandrina_HIv1___RNAseq.g16252.t1,apul_ptua,43.75,,,,,,,,,,,,,,,,,
OG_15654,FUN_045726-T1,,Pocillopora_meandrina_HIv1___RNAseq.g6540.t1,apul_ptua,78.856,FUN_045726-T1,B4JM29,NCBP1_DROGR,,Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit),Drosophila grimshawi (Hawaiian fruit fly) (Idiomyia grimshawi),50.0,800.0,8.099999999999999e-234,811.6,sp|B4JM29|NCBP1_DROGR Nuclear cap-binding protein subunit 1 OS=Drosophila grimshawi OX=7222 GN=Cbp80 PE=3 SV=1,GO:0000184; GO:0000339; GO:0003729; GO:0005634; GO:0005846; GO:0006370; GO:0006406; GO:0008380; GO:0031047,"7-methylguanosine mRNA capping [GO:0006370]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; regulatory ncRNA-mediated gene silencing [GO:0031047]; RNA splicing [GO:0008380]",nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA cap binding [GO:0000339],GO:0003723; GO:0005634; GO:0006913; GO:0016071; GO:0031047; GO:0043226,RNA binding; nucleus; nucleocytoplasmic transport; mRNA metabolic process; regulatory ncRNA-mediated gene silencing; organelle
OG_15655,FUN_045733-T1,,Pocillopora_meandrina_HIv1___RNAseq.g28813.t1b,apul_ptua,83.523,,,,,,,,,,,,,,,,,
OG_15656,FUN_045754-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25838.t1,apul_ptua,43.137,,,,,,,,,,,,,,,,,
OG_15657,FUN_045775-T1,,Pocillopora_meandrina_HIv1___RNAseq.g15915.t1,apul_ptua,57.182,FUN_045775-T1,Q9H6Y7,,,,,35.7,277.0,4e-38,160.2,sp|Q9H6Y7|RN167_HUMAN E3 ubiquitin-protein ligase RNF167 OS=Homo sapiens OX=9606 GN=RNF167 PE=1 SV=1,,,,,,
OG_15658,FUN_045780-T1,,Pocillopora_meandrina_HIv1___TS.g28613.t1,apul_ptua,49.846,,,,,,,,,,,,,,,,,
OG_15659,FUN_045791-T2,,Pocillopora_meandrina_HIv1___RNAseq.g19595.t1,apul_ptua,33.971500000000006,,,,,,,,,,,,,,,,,
OG_15660,FUN_045794-T1,,Pocillopora_meandrina_HIv1___RNAseq.g13219.t1,apul_ptua,76.364,,,,,,,,,,,,,,,,,
OG_15661,FUN_045799-T1,,Pocillopora_meandrina_HIv1___TS.g24853.t1,apul_ptua,95.211,FUN_045799-T1,P21329,,,,,22.0,878.0,1.1e-21,107.5,sp|P21329|RTJK_DROFU RNA-directed DNA polymerase from mobile element jockey OS=Drosophila funebris OX=7221 GN=jockey\pol PE=1 SV=1,,,,,,
OG_15662,FUN_045826-T3,,Pocillopora_meandrina_HIv1___RNAseq.g6753.t1,apul_ptua,50.0,,,,,,,,,,,,,,,,,
OG_15663,FUN_045828-T1,,Pocillopora_meandrina_HIv1___RNAseq.g23263.t1,apul_ptua,92.079,,,,,,,,,,,,,,,,,
OG_15664,FUN_045855-T1,,Pocillopora_meandrina_HIv1___RNAseq.g25094.t1,apul_ptua,53.689,,,,,,,,,,,,,,,,,
OG_15665,,Peve_00000010,Pocillopora_meandrina_HIv1___RNAseq.g1189.t1,peve_ptua,72.973,,,,,,,,,,,,,,,,,
OG_15666,,Peve_00000014,Pocillopora_meandrina_HIv1___RNAseq.g28284.t1,peve_ptua,30.939,,,,,,,,,,,,,,,,,
OG_15667,,Peve_00000038,Pocillopora_meandrina_HIv1___TS.g11911.t1,peve_ptua,51.807,,,,,,,,,,,,,,,,,
OG_15668,,Peve_00000040,Pocillopora_meandrina_HIv1___RNAseq.g28269.t1,peve_ptua,67.082,,,,,,,,,,,,,,,,,
OG_15669,,Peve_00000049,Pocillopora_meandrina_HIv1___RNAseq.g28263.t2,peve_ptua,81.058,,,,,,,,,,,,,,,,,
OG_15670,,Peve_00000052,Pocillopora_meandrina_HIv1___RNAseq.g13179.t1,peve_ptua,41.556,,,,,,,,,,,,,,,,,
OG_15671,,Peve_00000087,Pocillopora_meandrina_HIv1___TS.g5631.t1,peve_ptua,43.6025,,,,,,,,,,,,,,,,,
OG_15672,,Peve_00000100,Pocillopora_meandrina_HIv1___RNAseq.g1112.t1,peve_ptua,54.286,,,,,,,,,,,,,,,,,
OG_15673,,Peve_00000102,Pocillopora_meandrina_HIv1___RNAseq.g1114.t1,peve_ptua,57.062,,,,,,,,,,,,,,,,,
OG_15674,,Peve_00000109,Pocillopora_meandrina_HIv1___TS.g5594.t1,peve_ptua,65.693,,,,,,,,,,,,,,,,,
OG_15675,,Peve_00000125,Pocillopora_meandrina_HIv1___RNAseq.g19207.t1,peve_ptua,38.272,,,,,,,,,,,,,,,,,
OG_15676,,Peve_00000131,Pocillopora_meandrina_HIv1___RNAseq.g19211.t1,peve_ptua,46.216,,,,,,,,,,,,,,,,,
OG_15677,,Peve_00000141,Pocillopora_meandrina_HIv1___RNAseq.g9860.t1b,peve_ptua,54.7,,,,,,,,,,,,,,,,,
OG_15678,,Peve_00000146,Pocillopora_meandrina_HIv1___RNAseq.g7407.t1,peve_ptua,44.936,,,,,,,,,,,,,,,,,
OG_15679,,Peve_00000149,Pocillopora_meandrina_HIv1___TS.g28552.t2,peve_ptua,78.771,,,,,,,,,,,,,,,,,
OG_15680,,Peve_00000168,Pocillopora_meandrina_HIv1___RNAseq.g19261.t1,peve_ptua,47.9035,,,,,,,,,,,,,,,,,
OG_15681,,Peve_00000173,Pocillopora_meandrina_HIv1___RNAseq.g19034.t1,peve_ptua,39.167,,,,,,,,,,,,,,,,,
OG_15682,,Peve_00000174,Pocillopora_meandrina_HIv1___RNAseq.g19046.t1,peve_ptua,65.071,,,,,,,,,,,,,,,,,
OG_15683,,Peve_00000183,Pocillopora_meandrina_HIv1___RNAseq.g19185.t1,peve_ptua,61.538,,,,,,,,,,,,,,,,,
OG_15684,,Peve_00000193,Pocillopora_meandrina_HIv1___RNAseq.g19202.t1,peve_ptua,59.9935,,,,,,,,,,,,,,,,,
OG_15685,,Peve_00000204,Pocillopora_meandrina_HIv1___RNAseq.g21680.t1,peve_ptua,35.072,,,,,,,,,,,,,,,,,
OG_15686,,Peve_00000226,Pocillopora_meandrina_HIv1___RNAseq.g21688.t1,peve_ptua,38.0205,,,,,,,,,,,,,,,,,
OG_15687,,Peve_00000228,Pocillopora_meandrina_HIv1___RNAseq.g21686.t1,peve_ptua,52.632,,,,,,,,,,,,,,,,,
OG_15688,,Peve_00000274,Pocillopora_meandrina_HIv1___RNAseq.g2890.t1,peve_ptua,50.0,,,,,,,,,,,,,,,,,
OG_15689,,Peve_00000334,Pocillopora_meandrina_HIv1___TS.g10122.t1,peve_ptua,60.676,,,,,,,,,,,,,,,,,
OG_15690,,Peve_00000346,Pocillopora_meandrina_HIv1___RNAseq.g22579.t1,peve_ptua,58.947,,,,,,,,,,,,,,,,,
OG_15691,,Peve_00000347,Pocillopora_meandrina_HIv1___RNAseq.g22569.t1,peve_ptua,63.793,,,,,,,,,,,,,,,,,
OG_15692,,Peve_00000396,Pocillopora_meandrina_HIv1___TS.g7185.t1,peve_ptua,64.972,,,,,,,,,,,,,,,,,
OG_15693,,Peve_00000407,Pocillopora_meandrina_HIv1___RNAseq.g25227.t1,peve_ptua,73.529,,,,,,,,,,,,,,,,,
OG_15694,,Peve_00000411,Pocillopora_meandrina_HIv1___RNAseq.g7540.t1,peve_ptua,69.784,,,,,,,,,,,,,,,,,
OG_15695,,Peve_00000434,Pocillopora_meandrina_HIv1___RNAseq.g23040.t1,peve_ptua,62.624,,,,,,,,,,,,,,,,,
OG_15696,,Peve_00000439,Pocillopora_meandrina_HIv1___RNAseq.g23031.t1,peve_ptua,58.37,,,,,,,,,,,,,,,,,
OG_15697,,Peve_00000444,Pocillopora_meandrina_HIv1___TS.g12957.t1,peve_ptua,54.0,,,,,,,,,,,,,,,,,
OG_15698,,Peve_00000447,Pocillopora_meandrina_HIv1___RNAseq.g29889.t1,peve_ptua,42.857,,,,,,,,,,,,,,,,,
OG_15699,,Peve_00000453,Pocillopora_meandrina_HIv1___RNAseq.g23225.t1,peve_ptua,56.589,,,,,,,,,,,,,,,,,
OG_15700,,Peve_00000459,Pocillopora_meandrina_HIv1___RNAseq.g13119.t1,peve_ptua,76.482,,,,,,,,,,,,,,,,,
OG_15701,,Peve_00000460,Pocillopora_meandrina_HIv1___RNAseq.g13120.t1,peve_ptua,79.574,,,,,,,,,,,,,,,,,
OG_15702,,Peve_00000462,Pocillopora_meandrina_HIv1___TS.g2111.t1,peve_ptua,74.14699999999999,,,,,,,,,,,,,,,,,
OG_15703,,Peve_00000463,Pocillopora_meandrina_HIv1___RNAseq.g13123.t1,peve_ptua,61.652,,,,,,,,,,,,,,,,,
OG_15704,,Peve_00000464,Pocillopora_meandrina_HIv1___RNAseq.g13126.t1,peve_ptua,64.804,,,,,,,,,,,,,,,,,
OG_15705,,Peve_00000468,Pocillopora_meandrina_HIv1___TS.g11052.t1,peve_ptua,75.0,,,,,,,,,,,,,,,,,
OG_15706,,Peve_00000474,Pocillopora_meandrina_HIv1___RNAseq.g14155.t1,peve_ptua,58.025,,,,,,,,,,,,,,,,,
OG_15707,,Peve_00000509,Pocillopora_meandrina_HIv1___RNAseq.g25731.t1a,peve_ptua,55.215,,,,,,,,,,,,,,,,,
OG_15708,,Peve_00000534,Pocillopora_meandrina_HIv1___RNAseq.g24017.t1,peve_ptua,55.67,,,,,,,,,,,,,,,,,
OG_15709,,Peve_00000582,Pocillopora_meandrina_HIv1___RNAseq.g9710.t1,peve_ptua,84.742,,,,,,,,,,,,,,,,,
OG_15710,,Peve_00000586,Pocillopora_meandrina_HIv1___RNAseq.g9690.t1,peve_ptua,74.153,,,,,,,,,,,,,,,,,
OG_15711,,Peve_00000587,Pocillopora_meandrina_HIv1___RNAseq.g8843.t1,peve_ptua,44.72,,,,,,,,,,,,,,,,,
OG_15712,,Peve_00000601,Pocillopora_meandrina_HIv1___RNAseq.g3374.t1,peve_ptua,97.5,,,,,,,,,,,,,,,,,
OG_15713,,Peve_00000604,Pocillopora_meandrina_HIv1___RNAseq.g1805.t1,peve_ptua,81.081,,,,,,,,,,,,,,,,,
OG_15714,,Peve_00000633,Pocillopora_meandrina_HIv1___RNAseq.g26418.t1,peve_ptua,44.492,,,,,,,,,,,,,,,,,
OG_15715,,Peve_00000635,Pocillopora_meandrina_HIv1___RNAseq.g4505.t1,peve_ptua,39.531,,,,,,,,,,,,,,,,,
OG_15716,,Peve_00000649,Pocillopora_meandrina_HIv1___RNAseq.g17975.t1,peve_ptua,61.7485,,,,,,,,,,,,,,,,,
OG_15717,,Peve_00000665,Pocillopora_meandrina_HIv1___RNAseq.g24663.t1,peve_ptua,73.373,,,,,,,,,,,,,,,,,
OG_15718,,Peve_00000668,Pocillopora_meandrina_HIv1___RNAseq.g24684.t1,peve_ptua,69.231,,,,,,,,,,,,,,,,,
OG_15719,,Peve_00000694,Pocillopora_meandrina_HIv1___RNAseq.g24728.t1,peve_ptua,44.6675,,,,,,,,,,,,,,,,,
OG_15720,,Peve_00000695,Pocillopora_meandrina_HIv1___RNAseq.g24727.t1,peve_ptua,58.904,,,,,,,,,,,,,,,,,
OG_15721,,Peve_00000747,Pocillopora_meandrina_HIv1___TS.g15556.t2,peve_ptua,64.0095,,,,,,,,,,,,,,,,,
OG_15722,,Peve_00000754,Pocillopora_meandrina_HIv1___RNAseq.g5033.t1,peve_ptua,65.152,,,,,,,,,,,,,,,,,
OG_15723,,Peve_00000785,Pocillopora_meandrina_HIv1___RNAseq.g4013.t1,peve_ptua,75.879,,,,,,,,,,,,,,,,,
OG_15724,,Peve_00000819,Pocillopora_meandrina_HIv1___RNAseq.g11456.t1,peve_ptua,45.455,,,,,,,,,,,,,,,,,
OG_15725,,Peve_00000847,Pocillopora_meandrina_HIv1___RNAseq.g16204.t1,peve_ptua,62.016,,,,,,,,,,,,,,,,,
OG_15726,,Peve_00000851,Pocillopora_meandrina_HIv1___RNAseq.g3646.t1,peve_ptua,38.182,,,,,,,,,,,,,,,,,
OG_15727,,Peve_00000872,Pocillopora_meandrina_HIv1___TS.g11553.t1,peve_ptua,35.714,,,,,,,,,,,,,,,,,
OG_15728,,Peve_00000876,Pocillopora_meandrina_HIv1___RNAseq.g27008.t1,peve_ptua,54.63,,,,,,,,,,,,,,,,,
OG_15729,,Peve_00000885,Pocillopora_meandrina_HIv1___TS.g10137.t1a,peve_ptua,87.406,,,,,,,,,,,,,,,,,
OG_15730,,Peve_00000922,Pocillopora_meandrina_HIv1___TS.g15321.t1,peve_ptua,30.769,,,,,,,,,,,,,,,,,
OG_15731,,Peve_00000943,Pocillopora_meandrina_HIv1___RNAseq.25719_t,peve_ptua,71.15,,,,,,,,,,,,,,,,,
OG_15732,,Peve_00000947,Pocillopora_meandrina_HIv1___TS.g5327.t1,peve_ptua,79.048,,,,,,,,,,,,,,,,,
OG_15733,,Peve_00000953,Pocillopora_meandrina_HIv1___RNAseq.g12835.t1,peve_ptua,51.149,,,,,,,,,,,,,,,,,
OG_15734,,Peve_00001006,Pocillopora_meandrina_HIv1___RNAseq.g15312.t1,peve_ptua,56.14,,,,,,,,,,,,,,,,,
OG_15735,,Peve_00001046,Pocillopora_meandrina_HIv1___RNAseq.g5696.t1c,peve_ptua,86.62,,,,,,,,,,,,,,,,,
OG_15736,,Peve_00001063,Pocillopora_meandrina_HIv1___RNAseq.g27063.t1,peve_ptua,71.543,,,,,,,,,,,,,,,,,
OG_15737,,Peve_00001068,Pocillopora_meandrina_HIv1___TS.g3454.t2,peve_ptua,57.5435,,,,,,,,,,,,,,,,,
OG_15738,,Peve_00001069,Pocillopora_meandrina_HIv1___RNAseq.g27067.t1,peve_ptua,98.611,,,,,,,,,,,,,,,,,
OG_15739,,Peve_00001077,Pocillopora_meandrina_HIv1___TS.g26492.t1,peve_ptua,80.769,,,,,,,,,,,,,,,,,
OG_15740,,Peve_00001078,Pocillopora_meandrina_HIv1___RNAseq.g21742.t1,peve_ptua,56.374,,,,,,,,,,,,,,,,,
OG_15741,,Peve_00001088,Pocillopora_meandrina_HIv1___TS.g25859.t1,peve_ptua,38.182,,,,,,,,,,,,,,,,,
OG_15742,,Peve_00001100,Pocillopora_meandrina_HIv1___RNAseq.g23869.t1,peve_ptua,38.725,,,,,,,,,,,,,,,,,
OG_15743,,Peve_00001118,Pocillopora_meandrina_HIv1___RNAseq.g23845.t1,peve_ptua,43.6355,,,,,,,,,,,,,,,,,
OG_15744,,Peve_00001127,Pocillopora_meandrina_HIv1___RNAseq.g10453.t1,peve_ptua,37.956,,,,,,,,,,,,,,,,,
OG_15745,,Peve_00001129,Pocillopora_meandrina_HIv1___RNAseq.g10445.t1,peve_ptua,68.063,,,,,,,,,,,,,,,,,
OG_15746,,Peve_00001132,Pocillopora_meandrina_HIv1___TS.g13863.t1,peve_ptua,69.192,,,,,,,,,,,,,,,,,
OG_15747,,Peve_00001157,Pocillopora_meandrina_HIv1___TS.g13882.t1,peve_ptua,75.714,,,,,,,,,,,,,,,,,
OG_15748,,Peve_00001161,Pocillopora_meandrina_HIv1___RNAseq.g10455.t1,peve_ptua,57.971,,,,,,,,,,,,,,,,,
OG_15749,,Peve_00001192,Pocillopora_meandrina_HIv1___RNAseq.g13341.t1,peve_ptua,67.327,,,,,,,,,,,,,,,,,
OG_15750,,Peve_00001203,Pocillopora_meandrina_HIv1___RNAseq.g13335.t1,peve_ptua,80.447,,,,,,,,,,,,,,,,,
OG_15751,,Peve_00001208,Pocillopora_meandrina_HIv1___RNAseq.g22998.t1,peve_ptua,67.1485,,,,,,,,,,,,,,,,,
OG_15752,,Peve_00001223,Pocillopora_meandrina_HIv1___TS.g2157.t1,peve_ptua,55.963,,,,,,,,,,,,,,,,,
OG_15753,,Peve_00001231,Pocillopora_meandrina_HIv1___RNAseq.g13167.t1,peve_ptua,53.465,,,,,,,,,,,,,,,,,
OG_15754,,Peve_00001250,Pocillopora_meandrina_HIv1___RNAseq.g13771.t1,peve_ptua,65.757,,,,,,,,,,,,,,,,,
OG_15755,,Peve_00001253,Pocillopora_meandrina_HIv1___RNAseq.g13767.t1,peve_ptua,89.509,,,,,,,,,,,,,,,,,
OG_15756,,Peve_00001261,Pocillopora_meandrina_HIv1___TS.15164_t,peve_ptua,66.17699999999999,,,,,,,,,,,,,,,,,
OG_15757,,Peve_00001287,Pocillopora_meandrina_HIv1___RNAseq.g16513.t1,peve_ptua,68.951,,,,,,,,,,,,,,,,,
OG_15758,,Peve_00001296,Pocillopora_meandrina_HIv1___RNAseq.g16517.t1,peve_ptua,69.1645,,,,,,,,,,,,,,,,,
OG_15759,,Peve_00001303,Pocillopora_meandrina_HIv1___RNAseq.7251_t,peve_ptua,59.452,,,,,,,,,,,,,,,,,
OG_15760,,Peve_00001329,Pocillopora_meandrina_HIv1___TS.g5822.t1,peve_ptua,33.073,,,,,,,,,,,,,,,,,
OG_15761,,Peve_00001368,Pocillopora_meandrina_HIv1___RNAseq.g17112.t1,peve_ptua,53.192,,,,,,,,,,,,,,,,,
OG_15762,,Peve_00001407,Pocillopora_meandrina_HIv1___RNAseq.g3779.t1,peve_ptua,61.183,,,,,,,,,,,,,,,,,
OG_15763,,Peve_00001431,Pocillopora_meandrina_HIv1___RNAseq.g7448.t1,peve_ptua,73.79,,,,,,,,,,,,,,,,,
OG_15764,,Peve_00001454,Pocillopora_meandrina_HIv1___RNAseq.g8841.t1,peve_ptua,50.5915,,,,,,,,,,,,,,,,,
OG_15765,,Peve_00001458,Pocillopora_meandrina_HIv1___TS.g494.t2,peve_ptua,74.39,,,,,,,,,,,,,,,,,
OG_15766,,Peve_00001472,Pocillopora_meandrina_HIv1___RNAseq.g5185.t1,peve_ptua,53.1075,,,,,,,,,,,,,,,,,
OG_15767,,Peve_00001490,Pocillopora_meandrina_HIv1___RNAseq.g22724.t1,peve_ptua,90.374,,,,,,,,,,,,,,,,,
OG_15768,,Peve_00001495,Pocillopora_meandrina_HIv1___TS.g27482.t1,peve_ptua,73.198,,,,,,,,,,,,,,,,,
OG_15769,,Peve_00001548,Pocillopora_meandrina_HIv1___RNAseq.g15164.t1,peve_ptua,53.9075,,,,,,,,,,,,,,,,,
OG_15770,,Peve_00001552,Pocillopora_meandrina_HIv1___RNAseq.g5921.t1,peve_ptua,35.644,,,,,,,,,,,,,,,,,
OG_15771,,Peve_00001574,Pocillopora_meandrina_HIv1___RNAseq.g13273.t1,peve_ptua,44.366,,,,,,,,,,,,,,,,,
OG_15772,,Peve_00001575,Pocillopora_meandrina_HIv1___RNAseq.g21978.t1,peve_ptua,71.724,,,,,,,,,,,,,,,,,
OG_15773,,Peve_00001590,Pocillopora_meandrina_HIv1___RNAseq.g396.t1,peve_ptua,67.1625,,,,,,,,,,,,,,,,,
OG_15774,,Peve_00001597,Pocillopora_meandrina_HIv1___RNAseq.g391.t1,peve_ptua,66.876,,,,,,,,,,,,,,,,,
OG_15775,,Peve_00001618,Pocillopora_meandrina_HIv1___RNAseq.25388_t,peve_ptua,66.887,,,,,,,,,,,,,,,,,
OG_15776,,Peve_00001620,Pocillopora_meandrina_HIv1___TS.g11731.t1,peve_ptua,73.939,,,,,,,,,,,,,,,,,
OG_15777,,Peve_00001631,Pocillopora_meandrina_HIv1___RNAseq.g26886.t1,peve_ptua,72.362,,,,,,,,,,,,,,,,,
OG_15778,,Peve_00001632,Pocillopora_meandrina_HIv1___RNAseq.g10909.t1,peve_ptua,56.507,,,,,,,,,,,,,,,,,
OG_15779,,Peve_00001633,Pocillopora_meandrina_HIv1___RNAseq.g26880.t1,peve_ptua,66.099,,,,,,,,,,,,,,,,,
OG_15780,,Peve_00001656,Pocillopora_meandrina_HIv1___RNAseq.g25307.t1,peve_ptua,87.652,,,,,,,,,,,,,,,,,
OG_15781,,Peve_00001671,Pocillopora_meandrina_HIv1___RNAseq.29625_t,peve_ptua,75.0,,,,,,,,,,,,,,,,,
OG_15782,,Peve_00001701,Pocillopora_meandrina_HIv1___TS.g7304.t1,peve_ptua,44.484,,,,,,,,,,,,,,,,,
OG_15783,,Peve_00001704,Pocillopora_meandrina_HIv1___RNAseq.g12864.t1,peve_ptua,51.376,,,,,,,,,,,,,,,,,
OG_15784,,Peve_00001739,Pocillopora_meandrina_HIv1___RNAseq.g3684.t2,peve_ptua,72.0,,,,,,,,,,,,,,,,,
OG_15785,,Peve_00001744,Pocillopora_meandrina_HIv1___RNAseq.g3623.t1,peve_ptua,50.0,,,,,,,,,,,,,,,,,
OG_15786,,Peve_00001757,Pocillopora_meandrina_HIv1___RNAseq.g1778.t1,peve_ptua,53.623,,,,,,,,,,,,,,,,,
OG_15787,,Peve_00001797,Pocillopora_meandrina_HIv1___RNAseq.g9170.t1,peve_ptua,46.067,,,,,,,,,,,,,,,,,
OG_15788,,Peve_00001828,Pocillopora_meandrina_HIv1___RNAseq.g3708.t1,peve_ptua,46.929,,,,,,,,,,,,,,,,,
OG_15789,,Peve_00001830,Pocillopora_meandrina_HIv1___RNAseq.g3707.t1,peve_ptua,30.711,,,,,,,,,,,,,,,,,
OG_15790,,Peve_00001870,Pocillopora_meandrina_HIv1___RNAseq.g21761.t1,peve_ptua,64.228,,,,,,,,,,,,,,,,,
OG_15791,,Peve_00001881,Pocillopora_meandrina_HIv1___RNAseq.g25398.t1,peve_ptua,74.138,,,,,,,,,,,,,,,,,
OG_15792,,Peve_00001888,Pocillopora_meandrina_HIv1___RNAseq.g6868.t1,peve_ptua,61.05,,,,,,,,,,,,,,,,,
OG_15793,,Peve_00001910,Pocillopora_meandrina_HIv1___RNAseq.g17421.t1,peve_ptua,62.937,,,,,,,,,,,,,,,,,
OG_15794,,Peve_00001921,Pocillopora_meandrina_HIv1___RNAseq.g9670.t1,peve_ptua,68.776,,,,,,,,,,,,,,,,,
OG_15795,,Peve_00001944,Pocillopora_meandrina_HIv1___RNAseq.g27525.t1,peve_ptua,61.364,,,,,,,,,,,,,,,,,
OG_15796,,Peve_00001974,Pocillopora_meandrina_HIv1___TS.g4194.t1a,peve_ptua,68.864,,,,,,,,,,,,,,,,,
OG_15797,,Peve_00001977,Pocillopora_meandrina_HIv1___TS.g380.t1,peve_ptua,69.867,,,,,,,,,,,,,,,,,
OG_15798,,Peve_00001989,Pocillopora_meandrina_HIv1___RNAseq.g6585.t1,peve_ptua,68.065,,,,,,,,,,,,,,,,,
OG_15799,,Peve_00002003,Pocillopora_meandrina_HIv1___RNAseq.g22065.t1b,peve_ptua,52.74,,,,,,,,,,,,,,,,,
OG_15800,,Peve_00002007,Pocillopora_meandrina_HIv1___RNAseq.g5477.t1,peve_ptua,76.19,,,,,,,,,,,,,,,,,
OG_15801,,Peve_00002033,Pocillopora_meandrina_HIv1___RNAseq.g6625.t1,peve_ptua,56.818,,,,,,,,,,,,,,,,,
OG_15802,,Peve_00002040,Pocillopora_meandrina_HIv1___TS.g366.t1,peve_ptua,75.385,,,,,,,,,,,,,,,,,
OG_15803,,Peve_00002128,Pocillopora_meandrina_HIv1___RNAseq.g11113.t1,peve_ptua,49.1325,,,,,,,,,,,,,,,,,
OG_15804,,Peve_00002130,Pocillopora_meandrina_HIv1___TS.g19287.t1b,peve_ptua,70.681,,,,,,,,,,,,,,,,,
OG_15805,,Peve_00002135,Pocillopora_meandrina_HIv1___TS.g14047.t1,peve_ptua,56.788,,,,,,,,,,,,,,,,,
OG_15806,,Peve_00002143,Pocillopora_meandrina_HIv1___RNAseq.g1353.t1,peve_ptua,61.977,,,,,,,,,,,,,,,,,
OG_15807,,Peve_00002147,Pocillopora_meandrina_HIv1___RNAseq.g10922.t1,peve_ptua,70.0,,,,,,,,,,,,,,,,,
OG_15808,,Peve_00002156,Pocillopora_meandrina_HIv1___RNAseq.g26733.t1,peve_ptua,57.488,,,,,,,,,,,,,,,,,
OG_15809,,Peve_00002159,Pocillopora_meandrina_HIv1___RNAseq.g18319.t1b,peve_ptua,62.264,,,,,,,,,,,,,,,,,
OG_15810,,Peve_00002171,Pocillopora_meandrina_HIv1___RNAseq.g28338.t1,peve_ptua,35.2585,,,,,,,,,,,,,,,,,
OG_15811,,Peve_00002193,Pocillopora_meandrina_HIv1___RNAseq.g15786.t1,peve_ptua,78.306,,,,,,,,,,,,,,,,,
OG_15812,,Peve_00002215,Pocillopora_meandrina_HIv1___RNAseq.g27724.t1,peve_ptua,57.438,,,,,,,,,,,,,,,,,
OG_15813,,Peve_00002227,Pocillopora_meandrina_HIv1___RNAseq.g14982.t1,peve_ptua,57.282,,,,,,,,,,,,,,,,,
OG_15814,,Peve_00002240,Pocillopora_meandrina_HIv1___RNAseq.g12975.t1,peve_ptua,74.448,,,,,,,,,,,,,,,,,
OG_15815,,Peve_00002251,Pocillopora_meandrina_HIv1___RNAseq.g14189.t1,peve_ptua,53.846,,,,,,,,,,,,,,,,,
OG_15816,,Peve_00002255,Pocillopora_meandrina_HIv1___RNAseq.g14450.t1,peve_ptua,45.588,,,,,,,,,,,,,,,,,
OG_15817,,Peve_00002270,Pocillopora_meandrina_HIv1___RNAseq.g6564.t2,peve_ptua,80.0,,,,,,,,,,,,,,,,,
OG_15818,,Peve_00002286,Pocillopora_meandrina_HIv1___TS.g271.t1,peve_ptua,77.037,,,,,,,,,,,,,,,,,
OG_15819,,Peve_00002295,Pocillopora_meandrina_HIv1___TS.g19780.t1,peve_ptua,43.827,,,,,,,,,,,,,,,,,
OG_15820,,Peve_00002328,Pocillopora_meandrina_HIv1___TS.g13926.t1,peve_ptua,70.178,,,,,,,,,,,,,,,,,
OG_15821,,Peve_00002346,Pocillopora_meandrina_HIv1___RNAseq.g3968.t1,peve_ptua,51.264,,,,,,,,,,,,,,,,,
OG_15822,,Peve_00002348,Pocillopora_meandrina_HIv1___RNAseq.g3966.t1,peve_ptua,58.974,,,,,,,,,,,,,,,,,
OG_15823,,Peve_00002366,Pocillopora_meandrina_HIv1___RNAseq.g4234.t1,peve_ptua,61.538,,,,,,,,,,,,,,,,,
OG_15824,,Peve_00002402,Pocillopora_meandrina_HIv1___RNAseq.g22774.t1,peve_ptua,67.551,,,,,,,,,,,,,,,,,
OG_15825,,Peve_00002407,Pocillopora_meandrina_HIv1___TS.g27545.t1,peve_ptua,58.14,,,,,,,,,,,,,,,,,
OG_15826,,Peve_00002413,Pocillopora_meandrina_HIv1___RNAseq.g22783.t1,peve_ptua,80.417,,,,,,,,,,,,,,,,,
OG_15827,,Peve_00002426,Pocillopora_meandrina_HIv1___RNAseq.g22794.t1,peve_ptua,83.333,,,,,,,,,,,,,,,,,
OG_15828,,Peve_00002427,Pocillopora_meandrina_HIv1___RNAseq.g22795.t1,peve_ptua,58.292,,,,,,,,,,,,,,,,,
OG_15829,,Peve_00002446,Pocillopora_meandrina_HIv1___RNAseq.g28919.t1,peve_ptua,56.699,,,,,,,,,,,,,,,,,
OG_15830,,Peve_00002486,Pocillopora_meandrina_HIv1___RNAseq.g20416.t1,peve_ptua,67.405,,,,,,,,,,,,,,,,,
OG_15831,,Peve_00002488,Pocillopora_meandrina_HIv1___RNAseq.g20404.t1,peve_ptua,40.1515,,,,,,,,,,,,,,,,,
OG_15832,,Peve_00002536,Pocillopora_meandrina_HIv1___RNAseq.g23080.t1,peve_ptua,53.521,,,,,,,,,,,,,,,,,
OG_15833,,Peve_00002564,Pocillopora_meandrina_HIv1___RNAseq.g24276.t1,peve_ptua,62.46,,,,,,,,,,,,,,,,,
OG_15834,,Peve_00002592,Pocillopora_meandrina_HIv1___RNAseq.g11962.t1a,peve_ptua,66.6115,,,,,,,,,,,,,,,,,
OG_15835,,Peve_00002639,Pocillopora_meandrina_HIv1___RNAseq.g12206.t1,peve_ptua,65.414,,,,,,,,,,,,,,,,,
OG_15836,,Peve_00002682,Pocillopora_meandrina_HIv1___RNAseq.g2920.t1,peve_ptua,75.273,,,,,,,,,,,,,,,,,
OG_15837,,Peve_00002694,Pocillopora_meandrina_HIv1___RNAseq.g25874.t1,peve_ptua,51.765,,,,,,,,,,,,,,,,,
OG_15838,,Peve_00002698,Pocillopora_meandrina_HIv1___RNAseq.g23616.t1,peve_ptua,58.333,,,,,,,,,,,,,,,,,
OG_15839,,Peve_00002715,Pocillopora_meandrina_HIv1___RNAseq.g9250.t1,peve_ptua,60.784,,,,,,,,,,,,,,,,,
OG_15840,,Peve_00002748,Pocillopora_meandrina_HIv1___RNAseq.g21383.t1,peve_ptua,55.0,,,,,,,,,,,,,,,,,
OG_15841,,Peve_00002775,Pocillopora_meandrina_HIv1___TS.g856.t1,peve_ptua,58.311,,,,,,,,,,,,,,,,,
OG_15842,,Peve_00002796,Pocillopora_meandrina_HIv1___RNAseq.g28122.t1,peve_ptua,71.154,,,,,,,,,,,,,,,,,
OG_15843,,Peve_00002837,Pocillopora_meandrina_HIv1___RNAseq.g852.t1,peve_ptua,54.0,,,,,,,,,,,,,,,,,
OG_15844,,Peve_00002850,Pocillopora_meandrina_HIv1___RNAseq.g1903.t1,peve_ptua,61.303,,,,,,,,,,,,,,,,,
OG_15845,,Peve_00002875,Pocillopora_meandrina_HIv1___RNAseq.g1909.t1,peve_ptua,45.992,,,,,,,,,,,,,,,,,
OG_15846,,Peve_00002889,Pocillopora_meandrina_HIv1___TS.g23398.t1,peve_ptua,41.758,,,,,,,,,,,,,,,,,
OG_15847,,Peve_00002921,Pocillopora_meandrina_HIv1___RNAseq.g4297.t1,peve_ptua,74.194,,,,,,,,,,,,,,,,,
OG_15848,,Peve_00002928,Pocillopora_meandrina_HIv1___RNAseq.g6322.t1,peve_ptua,37.299,,,,,,,,,,,,,,,,,
OG_15849,,Peve_00002951,Pocillopora_meandrina_HIv1___RNAseq.g20392.t1,peve_ptua,82.288,,,,,,,,,,,,,,,,,
OG_15850,,Peve_00002964,Pocillopora_meandrina_HIv1___RNAseq.g20877.t1,peve_ptua,80.628,,,,,,,,,,,,,,,,,
OG_15851,,Peve_00002965,Pocillopora_meandrina_HIv1___TS.g4016.t1,peve_ptua,69.231,,,,,,,,,,,,,,,,,
OG_15852,,Peve_00002971,Pocillopora_meandrina_HIv1___RNAseq.g15478.t1,peve_ptua,61.61,,,,,,,,,,,,,,,,,
OG_15853,,Peve_00002984,Pocillopora_meandrina_HIv1___RNAseq.g27143.t2,peve_ptua,82.251,,,,,,,,,,,,,,,,,
OG_15854,,Peve_00003001,Pocillopora_meandrina_HIv1___TS.g8110.t2,peve_ptua,61.507,,,,,,,,,,,,,,,,,
OG_15855,,Peve_00003012,Pocillopora_meandrina_HIv1___RNAseq.g28336.t1,peve_ptua,54.123,,,,,,,,,,,,,,,,,
OG_15856,,Peve_00003014,Pocillopora_meandrina_HIv1___RNAseq.g20516.t1,peve_ptua,38.788,,,,,,,,,,,,,,,,,
OG_15857,,Peve_00003038,Pocillopora_meandrina_HIv1___RNAseq.g774.t1,peve_ptua,55.48,,,,,,,,,,,,,,,,,
OG_15858,,Peve_00003057,Pocillopora_meandrina_HIv1___RNAseq.g10396.t1,peve_ptua,88.039,,,,,,,,,,,,,,,,,
OG_15859,,Peve_00003064,Pocillopora_meandrina_HIv1___RNAseq.g10394.t1,peve_ptua,61.064,,,,,,,,,,,,,,,,,
OG_15860,,Peve_00003071,Pocillopora_meandrina_HIv1___RNAseq.g7422.t1,peve_ptua,77.778,,,,,,,,,,,,,,,,,
OG_15861,,Peve_00003105,Pocillopora_meandrina_HIv1___RNAseq.g16131.t1,peve_ptua,44.022000000000006,,,,,,,,,,,,,,,,,
OG_15862,,Peve_00003109,Pocillopora_meandrina_HIv1___TS.g28760.t1a,peve_ptua,37.143,,,,,,,,,,,,,,,,,
OG_15863,,Peve_00003112,Pocillopora_meandrina_HIv1___RNAseq.g25821.t1,peve_ptua,70.934,,,,,,,,,,,,,,,,,
OG_15864,,Peve_00003120,Pocillopora_meandrina_HIv1___RNAseq.g25719.t1,peve_ptua,69.313,,,,,,,,,,,,,,,,,
OG_15865,,Peve_00003129,Pocillopora_meandrina_HIv1___TS.g23484.t1,peve_ptua,58.584500000000006,,,,,,,,,,,,,,,,,
OG_15866,,Peve_00003133,Pocillopora_meandrina_HIv1___RNAseq.g16056.t1,peve_ptua,65.818,,,,,,,,,,,,,,,,,
OG_15867,,Peve_00003137,Pocillopora_meandrina_HIv1___RNAseq.g9994.t1,peve_ptua,68.813,,,,,,,,,,,,,,,,,
OG_15868,,Peve_00003139,Pocillopora_meandrina_HIv1___RNAseq.g26605.t1,peve_ptua,75.13,,,,,,,,,,,,,,,,,
OG_15869,,Peve_00003141,Pocillopora_meandrina_HIv1___TS.g19204.t1,peve_ptua,74.627,,,,,,,,,,,,,,,,,
OG_15870,,Peve_00003142,Pocillopora_meandrina_HIv1___RNAseq.g29274.t1,peve_ptua,62.264,,,,,,,,,,,,,,,,,
OG_15871,,Peve_00003144,Pocillopora_meandrina_HIv1___TS.g19304.t1,peve_ptua,42.424,,,,,,,,,,,,,,,,,
OG_15872,,Peve_00003158,Pocillopora_meandrina_HIv1___RNAseq.g29376.t1,peve_ptua,77.228,,,,,,,,,,,,,,,,,
OG_15873,,Peve_00003159,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1a,peve_ptua,71.237,,,,,,,,,,,,,,,,,
OG_15874,,Peve_00003171,Pocillopora_meandrina_HIv1___TS.g11593.t1,peve_ptua,34.677,,,,,,,,,,,,,,,,,
OG_15875,,Peve_00003198,Pocillopora_meandrina_HIv1___RNAseq.g703.t1,peve_ptua,74.843,,,,,,,,,,,,,,,,,
OG_15876,,Peve_00003201,Pocillopora_meandrina_HIv1___TS.g3010.t1,peve_ptua,52.139,,,,,,,,,,,,,,,,,
OG_15877,,Peve_00003205,Pocillopora_meandrina_HIv1___RNAseq.g2598.t1,peve_ptua,36.0155,,,,,,,,,,,,,,,,,
OG_15878,,Peve_00003226,Pocillopora_meandrina_HIv1___TS.g17994.t1,peve_ptua,90.476,,,,,,,,,,,,,,,,,
OG_15879,,Peve_00003242,Pocillopora_meandrina_HIv1___RNAseq.g6038.t1,peve_ptua,54.085,,,,,,,,,,,,,,,,,
OG_15880,,Peve_00003248,Pocillopora_meandrina_HIv1___RNAseq.g1478.t1,peve_ptua,54.226,,,,,,,,,,,,,,,,,
OG_15881,,Peve_00003256,Pocillopora_meandrina_HIv1___RNAseq.g11081.t1,peve_ptua,70.463,,,,,,,,,,,,,,,,,
OG_15882,,Peve_00003259,Pocillopora_meandrina_HIv1___RNAseq.g6211.t1,peve_ptua,32.609,,,,,,,,,,,,,,,,,
OG_15883,,Peve_00003261,Pocillopora_meandrina_HIv1___RNAseq.g27078.t1,peve_ptua,94.444,,,,,,,,,,,,,,,,,
OG_15884,,Peve_00003332,Pocillopora_meandrina_HIv1___RNAseq.g8166.t1,peve_ptua,73.659,,,,,,,,,,,,,,,,,
OG_15885,,Peve_00003337,Pocillopora_meandrina_HIv1___RNAseq.g8165.t1,peve_ptua,45.052,,,,,,,,,,,,,,,,,
OG_15886,,Peve_00003342,Pocillopora_meandrina_HIv1___RNAseq.g11181.t1,peve_ptua,47.059,,,,,,,,,,,,,,,,,
OG_15887,,Peve_00003369,Pocillopora_meandrina_HIv1___RNAseq.g14416.t1,peve_ptua,32.02,,,,,,,,,,,,,,,,,
OG_15888,,Peve_00003388,Pocillopora_meandrina_HIv1___RNAseq.g167.t1,peve_ptua,48.583,,,,,,,,,,,,,,,,,
OG_15889,,Peve_00003397,Pocillopora_meandrina_HIv1___RNAseq.g411.t1,peve_ptua,74.851,,,,,,,,,,,,,,,,,
OG_15890,,Peve_00003420,Pocillopora_meandrina_HIv1___TS.g3897.t1,peve_ptua,68.243,,,,,,,,,,,,,,,,,
OG_15891,,Peve_00003425,Pocillopora_meandrina_HIv1___RNAseq.g8243.t1,peve_ptua,38.697,,,,,,,,,,,,,,,,,
OG_15892,,Peve_00003464,Pocillopora_meandrina_HIv1___RNAseq.g22174.t1,peve_ptua,68.0235,,,,,,,,,,,,,,,,,
OG_15893,,Peve_00003469,Pocillopora_meandrina_HIv1___RNAseq.g3060.t1,peve_ptua,47.9315,,,,,,,,,,,,,,,,,
OG_15894,,Peve_00003475,Pocillopora_meandrina_HIv1___TS.g16312.t1b,peve_ptua,69.492,,,,,,,,,,,,,,,,,
OG_15895,,Peve_00003490,Pocillopora_meandrina_HIv1___RNAseq.g26052.t1,peve_ptua,64.171,,,,,,,,,,,,,,,,,
OG_15896,,Peve_00003498,Pocillopora_meandrina_HIv1___RNAseq.g6110.t1,peve_ptua,70.748,,,,,,,,,,,,,,,,,
OG_15897,,Peve_00003512,Pocillopora_meandrina_HIv1___RNAseq.g16216.t1,peve_ptua,45.607,,,,,,,,,,,,,,,,,
OG_15898,,Peve_00003517,Pocillopora_meandrina_HIv1___RNAseq.g17102.t1,peve_ptua,57.6,,,,,,,,,,,,,,,,,
OG_15899,,Peve_00003585,Pocillopora_meandrina_HIv1___RNAseq.g12065.t1,peve_ptua,60.0895,,,,,,,,,,,,,,,,,
OG_15900,,Peve_00003637,Pocillopora_meandrina_HIv1___RNAseq.g27913.t1,peve_ptua,39.189,,,,,,,,,,,,,,,,,
OG_15901,,Peve_00003638,Pocillopora_meandrina_HIv1___RNAseq.g27911.t1,peve_ptua,43.878,,,,,,,,,,,,,,,,,
OG_15902,,Peve_00003650,Pocillopora_meandrina_HIv1___RNAseq.g15499.t1,peve_ptua,50.725,,,,,,,,,,,,,,,,,
OG_15903,,Peve_00003662,Pocillopora_meandrina_HIv1___RNAseq.g9492.t1,peve_ptua,74.112,,,,,,,,,,,,,,,,,
OG_15904,,Peve_00003693,Pocillopora_meandrina_HIv1___TS.g14779.t1,peve_ptua,73.796,,,,,,,,,,,,,,,,,
OG_15905,,Peve_00003707,Pocillopora_meandrina_HIv1___RNAseq.g5697.t1,peve_ptua,61.084,,,,,,,,,,,,,,,,,
OG_15906,,Peve_00003739,Pocillopora_meandrina_HIv1___RNAseq.g19724.t1,peve_ptua,54.235,,,,,,,,,,,,,,,,,
OG_15907,,Peve_00003753,Pocillopora_meandrina_HIv1___RNAseq.g4018.t2,peve_ptua,53.5775,,,,,,,,,,,,,,,,,
OG_15908,,Peve_00003755,Pocillopora_meandrina_HIv1___RNAseq.g25651.t1,peve_ptua,62.181,,,,,,,,,,,,,,,,,
OG_15909,,Peve_00003762,Pocillopora_meandrina_HIv1___RNAseq.g25784.t1,peve_ptua,48.913,,,,,,,,,,,,,,,,,
OG_15910,,Peve_00003781,Pocillopora_meandrina_HIv1___RNAseq.g20454.t1,peve_ptua,50.447,,,,,,,,,,,,,,,,,
OG_15911,,Peve_00003783,Pocillopora_meandrina_HIv1___RNAseq.g20455.t1,peve_ptua,54.237,,,,,,,,,,,,,,,,,
OG_15912,,Peve_00003787,Pocillopora_meandrina_HIv1___TS.g29288.t1,peve_ptua,46.1265,,,,,,,,,,,,,,,,,
OG_15913,,Peve_00003790,Pocillopora_meandrina_HIv1___RNAseq.g19904.t1,peve_ptua,61.513,,,,,,,,,,,,,,,,,
OG_15914,,Peve_00003791,Pocillopora_meandrina_HIv1___RNAseq.g19905.t1,peve_ptua,59.075,,,,,,,,,,,,,,,,,
OG_15915,,Peve_00003808,Pocillopora_meandrina_HIv1___TS.g13887.t1,peve_ptua,87.234,,,,,,,,,,,,,,,,,
OG_15916,,Peve_00003820,Pocillopora_meandrina_HIv1___RNAseq.g29592.t1,peve_ptua,51.802,,,,,,,,,,,,,,,,,
OG_15917,,Peve_00003843,Pocillopora_meandrina_HIv1___RNAseq.g25683.t1,peve_ptua,78.07,,,,,,,,,,,,,,,,,
OG_15918,,Peve_00003910,Pocillopora_meandrina_HIv1___RNAseq.g1999.t1,peve_ptua,61.483,,,,,,,,,,,,,,,,,
OG_15919,,Peve_00003914,Pocillopora_meandrina_HIv1___RNAseq.g2066.t1,peve_ptua,80.0,,,,,,,,,,,,,,,,,
OG_15920,,Peve_00003920,Pocillopora_meandrina_HIv1___RNAseq.2731_t,peve_ptua,68.293,,,,,,,,,,,,,,,,,
OG_15921,,Peve_00003935,Pocillopora_meandrina_HIv1___RNAseq.g16286.t1,peve_ptua,36.923,,,,,,,,,,,,,,,,,
OG_15922,,Peve_00003938,Pocillopora_meandrina_HIv1___RNAseq.g18176.t1,peve_ptua,94.872,,,,,,,,,,,,,,,,,
OG_15923,,Peve_00003955,Pocillopora_meandrina_HIv1___RNAseq.g12641.t1,peve_ptua,78.462,,,,,,,,,,,,,,,,,
OG_15924,,Peve_00003998,Pocillopora_meandrina_HIv1___RNAseq.g23995.t1,peve_ptua,76.786,,,,,,,,,,,,,,,,,
OG_15925,,Peve_00004017,Pocillopora_meandrina_HIv1___RNAseq.g21781.t1,peve_ptua,57.2365,,,,,,,,,,,,,,,,,
OG_15926,,Peve_00004033,Pocillopora_meandrina_HIv1___RNAseq.g15474.t1,peve_ptua,57.018,,,,,,,,,,,,,,,,,
OG_15927,,Peve_00004053,Pocillopora_meandrina_HIv1___RNAseq.g11124.t1,peve_ptua,47.451,,,,,,,,,,,,,,,,,
OG_15928,,Peve_00004080,Pocillopora_meandrina_HIv1___RNAseq.g15667.t1,peve_ptua,66.6485,,,,,,,,,,,,,,,,,
OG_15929,,Peve_00004091,Pocillopora_meandrina_HIv1___RNAseq.g23633.t1a,peve_ptua,82.89,,,,,,,,,,,,,,,,,
OG_15930,,Peve_00004113,Pocillopora_meandrina_HIv1___RNAseq.g14940.t1,peve_ptua,63.462,,,,,,,,,,,,,,,,,
OG_15931,,Peve_00004120,Pocillopora_meandrina_HIv1___RNAseq.g10619.t1,peve_ptua,41.739,,,,,,,,,,,,,,,,,
OG_15932,,Peve_00004121,Pocillopora_meandrina_HIv1___RNAseq.g10624.t1,peve_ptua,70.69,,,,,,,,,,,,,,,,,
OG_15933,,Peve_00004124,Pocillopora_meandrina_HIv1___TS.g13136.t1,peve_ptua,63.074,,,,,,,,,,,,,,,,,
OG_15934,,Peve_00004131,Pocillopora_meandrina_HIv1___RNAseq.g10557.t1,peve_ptua,79.197,,,,,,,,,,,,,,,,,
OG_15935,,Peve_00004143,Pocillopora_meandrina_HIv1___RNAseq.g1989.t1,peve_ptua,74.302,,,,,,,,,,,,,,,,,
OG_15936,,Peve_00004144,Pocillopora_meandrina_HIv1___RNAseq.g1990.t1a,peve_ptua,93.354,,,,,,,,,,,,,,,,,
OG_15937,,Peve_00004163,Pocillopora_meandrina_HIv1___RNAseq.g18718.t1,peve_ptua,84.286,,,,,,,,,,,,,,,,,
OG_15938,,Peve_00004175,Pocillopora_meandrina_HIv1___RNAseq.g26227.t1,peve_ptua,77.178,,,,,,,,,,,,,,,,,
OG_15939,,Peve_00004236,Pocillopora_meandrina_HIv1___RNAseq.g18239.t1,peve_ptua,65.909,,,,,,,,,,,,,,,,,
OG_15940,,Peve_00004240,Pocillopora_meandrina_HIv1___RNAseq.g18235.t1,peve_ptua,82.282,,,,,,,,,,,,,,,,,
OG_15941,,Peve_00004251,Pocillopora_meandrina_HIv1___RNAseq.g22588.t1,peve_ptua,37.302,,,,,,,,,,,,,,,,,
OG_15942,,Peve_00004295,Pocillopora_meandrina_HIv1___RNAseq.g1729.t1,peve_ptua,58.249,,,,,,,,,,,,,,,,,
OG_15943,,Peve_00004301,Pocillopora_meandrina_HIv1___RNAseq.g22067.t1,peve_ptua,74.096,,,,,,,,,,,,,,,,,
OG_15944,,Peve_00004313,Pocillopora_meandrina_HIv1___RNAseq.g23628.t1,peve_ptua,76.515,,,,,,,,,,,,,,,,,
OG_15945,,Peve_00004321,Pocillopora_meandrina_HIv1___RNAseq.g13351.t1,peve_ptua,63.8635,,,,,,,,,,,,,,,,,
OG_15946,,Peve_00004335,Pocillopora_meandrina_HIv1___RNAseq.g20269.t1,peve_ptua,59.259,,,,,,,,,,,,,,,,,
OG_15947,,Peve_00004378,Pocillopora_meandrina_HIv1___TS.g11736.t1,peve_ptua,75.426,,,,,,,,,,,,,,,,,
OG_15948,,Peve_00004421,Pocillopora_meandrina_HIv1___RNAseq.g7563.t1,peve_ptua,64.0295,,,,,,,,,,,,,,,,,
OG_15949,,Peve_00004430,Pocillopora_meandrina_HIv1___RNAseq.g23298.t1,peve_ptua,39.149,,,,,,,,,,,,,,,,,
OG_15950,,Peve_00004438,Pocillopora_meandrina_HIv1___RNAseq.g27967.t1,peve_ptua,53.608,,,,,,,,,,,,,,,,,
OG_15951,,Peve_00004441,Pocillopora_meandrina_HIv1___RNAseq.g29193.t1,peve_ptua,83.62,,,,,,,,,,,,,,,,,
OG_15952,,Peve_00004443,Pocillopora_meandrina_HIv1___RNAseq.g2926.t1,peve_ptua,83.562,,,,,,,,,,,,,,,,,
OG_15953,,Peve_00004467,Pocillopora_meandrina_HIv1___RNAseq.g21642.t1a,peve_ptua,57.812,,,,,,,,,,,,,,,,,
OG_15954,,Peve_00004489,Pocillopora_meandrina_HIv1___RNAseq.g21205.t1,peve_ptua,64.41,,,,,,,,,,,,,,,,,
OG_15955,,Peve_00004495,Pocillopora_meandrina_HIv1___TS.g25947.t1,peve_ptua,56.907,,,,,,,,,,,,,,,,,
OG_15956,,Peve_00004497,Pocillopora_meandrina_HIv1___TS.g25959.t1,peve_ptua,68.75,,,,,,,,,,,,,,,,,
OG_15957,,Peve_00004502,Pocillopora_meandrina_HIv1___TS.g26041.t1,peve_ptua,63.136,,,,,,,,,,,,,,,,,
OG_15958,,Peve_00004513,Pocillopora_meandrina_HIv1___RNAseq.g1079.t1,peve_ptua,69.318,,,,,,,,,,,,,,,,,
OG_15959,,Peve_00004522,Pocillopora_meandrina_HIv1___RNAseq.g1841.t1,peve_ptua,34.899,,,,,,,,,,,,,,,,,
OG_15960,,Peve_00004539,Pocillopora_meandrina_HIv1___RNAseq.g21368.t1,peve_ptua,50.1645,,,,,,,,,,,,,,,,,
OG_15961,,Peve_00004544,Pocillopora_meandrina_HIv1___RNAseq.g21374.t1,peve_ptua,96.482,,,,,,,,,,,,,,,,,
OG_15962,,Peve_00004548,Pocillopora_meandrina_HIv1___RNAseq.g25283.t1,peve_ptua,79.592,,,,,,,,,,,,,,,,,
OG_15963,,Peve_00004609,Pocillopora_meandrina_HIv1___RNAseq.g6442.t1,peve_ptua,61.538,,,,,,,,,,,,,,,,,
OG_15964,,Peve_00004612,Pocillopora_meandrina_HIv1___TS.g7343.t2,peve_ptua,57.345,,,,,,,,,,,,,,,,,
OG_15965,,Peve_00004676,Pocillopora_meandrina_HIv1___RNAseq.g2305.t1,peve_ptua,64.516,,,,,,,,,,,,,,,,,
OG_15966,,Peve_00004678,Pocillopora_meandrina_HIv1___TS.g4816.t1,peve_ptua,50.16,,,,,,,,,,,,,,,,,
OG_15967,,Peve_00004685,Pocillopora_meandrina_HIv1___TS.g4811.t1,peve_ptua,45.5595,,,,,,,,,,,,,,,,,
OG_15968,,Peve_00004698,Pocillopora_meandrina_HIv1___TS.g20764.t1,peve_ptua,95.62,,,,,,,,,,,,,,,,,
OG_15969,,Peve_00004748,Pocillopora_meandrina_HIv1___RNAseq.g11074.t1,peve_ptua,61.716,,,,,,,,,,,,,,,,,
OG_15970,,Peve_00004765,Pocillopora_meandrina_HIv1___RNAseq.g11098.t1,peve_ptua,51.8305,,,,,,,,,,,,,,,,,
OG_15971,,Peve_00004766,Pocillopora_meandrina_HIv1___RNAseq.g11099.t1,peve_ptua,65.605,,,,,,,,,,,,,,,,,
OG_15972,,Peve_00004781,Pocillopora_meandrina_HIv1___RNAseq.g21177.t1,peve_ptua,73.333,,,,,,,,,,,,,,,,,
OG_15973,,Peve_00004812,Pocillopora_meandrina_HIv1___RNAseq.g5113.t1,peve_ptua,92.5,,,,,,,,,,,,,,,,,
OG_15974,,Peve_00004841,Pocillopora_meandrina_HIv1___RNAseq.g8902.t1,peve_ptua,39.941,,,,,,,,,,,,,,,,,
OG_15975,,Peve_00004844,Pocillopora_meandrina_HIv1___RNAseq.g26108.t1,peve_ptua,57.692,,,,,,,,,,,,,,,,,
OG_15976,,Peve_00004854,Pocillopora_meandrina_HIv1___RNAseq.g14321.t1,peve_ptua,35.465,,,,,,,,,,,,,,,,,
OG_15977,,Peve_00004862,Pocillopora_meandrina_HIv1___RNAseq.g17011.t1,peve_ptua,56.637,,,,,,,,,,,,,,,,,
OG_15978,,Peve_00004884,Pocillopora_meandrina_HIv1___RNAseq.g23814.t1,peve_ptua,75.529,,,,,,,,,,,,,,,,,
OG_15979,,Peve_00004890,Pocillopora_meandrina_HIv1___RNAseq.g15568.t1,peve_ptua,58.2715,,,,,,,,,,,,,,,,,
OG_15980,,Peve_00004893,Pocillopora_meandrina_HIv1___RNAseq.g15579.t1a,peve_ptua,70.175,,,,,,,,,,,,,,,,,
OG_15981,,Peve_00004906,Pocillopora_meandrina_HIv1___RNAseq.g8982.t1,peve_ptua,70.332,,,,,,,,,,,,,,,,,
OG_15982,,Peve_00004914,Pocillopora_meandrina_HIv1___RNAseq.g28748.t1,peve_ptua,50.041,,,,,,,,,,,,,,,,,
OG_15983,,Peve_00004917,Pocillopora_meandrina_HIv1___RNAseq.g28745.t1,peve_ptua,66.304,,,,,,,,,,,,,,,,,
OG_15984,,Peve_00004958,Pocillopora_meandrina_HIv1___RNAseq.g8434.t1,peve_ptua,55.051,,,,,,,,,,,,,,,,,
OG_15985,,Peve_00004961,Pocillopora_meandrina_HIv1___RNAseq.g8429.t1b,peve_ptua,70.904,,,,,,,,,,,,,,,,,
OG_15986,,Peve_00004962,Pocillopora_meandrina_HIv1___RNAseq.g8429.t1a,peve_ptua,78.486,,,,,,,,,,,,,,,,,
OG_15987,,Peve_00004964,Pocillopora_meandrina_HIv1___TS.g20176.t1,peve_ptua,49.843,,,,,,,,,,,,,,,,,
OG_15988,,Peve_00004990,Pocillopora_meandrina_HIv1___TS.g15723.t1,peve_ptua,58.647,,,,,,,,,,,,,,,,,
OG_15989,,Peve_00005017,Pocillopora_meandrina_HIv1___RNAseq.g18625.t1,peve_ptua,50.639,,,,,,,,,,,,,,,,,
OG_15990,,Peve_00005036,Pocillopora_meandrina_HIv1___TS.g27316.t1,peve_ptua,62.4,,,,,,,,,,,,,,,,,
OG_15991,,Peve_00005040,Pocillopora_meandrina_HIv1___RNAseq.g16154.t1,peve_ptua,61.864,,,,,,,,,,,,,,,,,
OG_15992,,Peve_00005071,Pocillopora_meandrina_HIv1___RNAseq.g29871.t1,peve_ptua,33.333,,,,,,,,,,,,,,,,,
OG_15993,,Peve_00005091,Pocillopora_meandrina_HIv1___RNAseq.g8791.t1,peve_ptua,39.286,,,,,,,,,,,,,,,,,
OG_15994,,Peve_00005112,Pocillopora_meandrina_HIv1___RNAseq.g19873.t1,peve_ptua,53.392,,,,,,,,,,,,,,,,,
OG_15995,,Peve_00005120,Pocillopora_meandrina_HIv1___TS.g25658.t1c,peve_ptua,41.8,,,,,,,,,,,,,,,,,
OG_15996,,Peve_00005177,Pocillopora_meandrina_HIv1___RNAseq.g12209.t1,peve_ptua,81.346,,,,,,,,,,,,,,,,,
OG_15997,,Peve_00005184,Pocillopora_meandrina_HIv1___RNAseq.g7319.t1,peve_ptua,49.964,,,,,,,,,,,,,,,,,
OG_15998,,Peve_00005186,Pocillopora_meandrina_HIv1___RNAseq.g20688.t1,peve_ptua,53.968,,,,,,,,,,,,,,,,,
OG_15999,,Peve_00005192,Pocillopora_meandrina_HIv1___TS.g27698.t1,peve_ptua,46.3155,,,,,,,,,,,,,,,,,
OG_16000,,Peve_00005199,Pocillopora_meandrina_HIv1___RNAseq.g20694.t1,peve_ptua,40.7285,,,,,,,,,,,,,,,,,
OG_16001,,Peve_00005271,Pocillopora_meandrina_HIv1___RNAseq.g30185.t1,peve_ptua,74.157,,,,,,,,,,,,,,,,,
OG_16002,,Peve_00005281,Pocillopora_meandrina_HIv1___RNAseq.g26659.t1,peve_ptua,59.387,,,,,,,,,,,,,,,,,
OG_16003,,Peve_00005315,Pocillopora_meandrina_HIv1___RNAseq.g11300.t1,peve_ptua,42.568,,,,,,,,,,,,,,,,,
OG_16004,,Peve_00005317,Pocillopora_meandrina_HIv1___TS.g28742.t1,peve_ptua,34.831,,,,,,,,,,,,,,,,,
OG_16005,,Peve_00005337,Pocillopora_meandrina_HIv1___RNAseq.g17442.t1,peve_ptua,79.503,,,,,,,,,,,,,,,,,
OG_16006,,Peve_00005377,Pocillopora_meandrina_HIv1___RNAseq.9048_t,peve_ptua,54.476,,,,,,,,,,,,,,,,,
OG_16007,,Peve_00005390,Pocillopora_meandrina_HIv1___RNAseq.11538_t,peve_ptua,41.3055,,,,,,,,,,,,,,,,,
OG_16008,,Peve_00005395,Pocillopora_meandrina_HIv1___TS.g16137.t1,peve_ptua,68.919,,,,,,,,,,,,,,,,,
OG_16009,,Peve_00005399,Pocillopora_meandrina_HIv1___RNAseq.g991.t1,peve_ptua,73.158,,,,,,,,,,,,,,,,,
OG_16010,,Peve_00005409,Pocillopora_meandrina_HIv1___TS.g6823.t1,peve_ptua,57.542,,,,,,,,,,,,,,,,,
OG_16011,,Peve_00005475,Pocillopora_meandrina_HIv1___RNAseq.g3012.t1,peve_ptua,61.8545,,,,,,,,,,,,,,,,,
OG_16012,,Peve_00005497,Pocillopora_meandrina_HIv1___RNAseq.g5439.t1b,peve_ptua,58.763,,,,,,,,,,,,,,,,,
OG_16013,,Peve_00005515,Pocillopora_meandrina_HIv1___RNAseq.g18394.t1,peve_ptua,54.120000000000005,,,,,,,,,,,,,,,,,
OG_16014,,Peve_00005524,Pocillopora_meandrina_HIv1___RNAseq.g26942.t1,peve_ptua,45.263,,,,,,,,,,,,,,,,,
OG_16015,,Peve_00005541,Pocillopora_meandrina_HIv1___RNAseq.g5733.t1,peve_ptua,47.2655,,,,,,,,,,,,,,,,,
OG_16016,,Peve_00005565,Pocillopora_meandrina_HIv1___RNAseq.g6651.t1a,peve_ptua,36.661,,,,,,,,,,,,,,,,,
OG_16017,,Peve_00005569,Pocillopora_meandrina_HIv1___RNAseq.g7849.t1,peve_ptua,36.012,,,,,,,,,,,,,,,,,
OG_16018,,Peve_00005579,Pocillopora_meandrina_HIv1___TS.g2814.t1,peve_ptua,63.889,,,,,,,,,,,,,,,,,
OG_16019,,Peve_00005589,Pocillopora_meandrina_HIv1___RNAseq.g21588.t1,peve_ptua,99.134,,,,,,,,,,,,,,,,,
OG_16020,,Peve_00005693,Pocillopora_meandrina_HIv1___RNAseq.g13962.t1,peve_ptua,80.0,,,,,,,,,,,,,,,,,
OG_16021,,Peve_00005694,Pocillopora_meandrina_HIv1___RNAseq.g13963.t1,peve_ptua,75.439,,,,,,,,,,,,,,,,,
OG_16022,,Peve_00005699,Pocillopora_meandrina_HIv1___RNAseq.g22530.t1,peve_ptua,37.5,,,,,,,,,,,,,,,,,
OG_16023,,Peve_00005720,Pocillopora_meandrina_HIv1___RNAseq.g17178.t1,peve_ptua,59.164,,,,,,,,,,,,,,,,,
OG_16024,,Peve_00005728,Pocillopora_meandrina_HIv1___RNAseq.g17179.t1,peve_ptua,61.5385,,,,,,,,,,,,,,,,,
OG_16025,,Peve_00005742,Pocillopora_meandrina_HIv1___RNAseq.g15297.t1,peve_ptua,70.443,,,,,,,,,,,,,,,,,
OG_16026,,Peve_00005743,Pocillopora_meandrina_HIv1___RNAseq.g14007.t1,peve_ptua,55.9425,,,,,,,,,,,,,,,,,
OG_16027,,Peve_00005770,Pocillopora_meandrina_HIv1___RNAseq.g27158.t1,peve_ptua,69.149,,,,,,,,,,,,,,,,,
OG_16028,,Peve_00005771,Pocillopora_meandrina_HIv1___TS.g14495.t1a,peve_ptua,67.644,,,,,,,,,,,,,,,,,
OG_16029,,Peve_00005773,Pocillopora_meandrina_HIv1___RNAseq.g27153.t1,peve_ptua,62.648,,,,,,,,,,,,,,,,,
OG_16030,,Peve_00005777,Pocillopora_meandrina_HIv1___RNAseq.g27147.t1,peve_ptua,41.078,,,,,,,,,,,,,,,,,
OG_16031,,Peve_00005795,Pocillopora_meandrina_HIv1___RNAseq.g21941.t1,peve_ptua,32.569500000000005,,,,,,,,,,,,,,,,,
OG_16032,,Peve_00005804,Pocillopora_meandrina_HIv1___RNAseq.g27700.t1,peve_ptua,57.393,,,,,,,,,,,,,,,,,
OG_16033,,Peve_00005838,Pocillopora_meandrina_HIv1___RNAseq.g7770.t1,peve_ptua,34.513,,,,,,,,,,,,,,,,,
OG_16034,,Peve_00005851,Pocillopora_meandrina_HIv1___RNAseq.g10664.t1,peve_ptua,70.64,,,,,,,,,,,,,,,,,
OG_16035,,Peve_00005862,Pocillopora_meandrina_HIv1___TS.g21309.t1,peve_ptua,75.904,,,,,,,,,,,,,,,,,
OG_16036,,Peve_00005864,Pocillopora_meandrina_HIv1___RNAseq.g19315.t1,peve_ptua,40.625,,,,,,,,,,,,,,,,,
OG_16037,,Peve_00005933,Pocillopora_meandrina_HIv1___RNAseq.g18842.t1,peve_ptua,70.732,,,,,,,,,,,,,,,,,
OG_16038,,Peve_00005946,Pocillopora_meandrina_HIv1___RNAseq.g24807.t1,peve_ptua,67.183,,,,,,,,,,,,,,,,,
OG_16039,,Peve_00005992,Pocillopora_meandrina_HIv1___TS.g27211.t1a,peve_ptua,67.742,,,,,,,,,,,,,,,,,
OG_16040,,Peve_00006073,Pocillopora_meandrina_HIv1___RNAseq.g13184.t1,peve_ptua,68.966,,,,,,,,,,,,,,,,,
OG_16041,,Peve_00006111,Pocillopora_meandrina_HIv1___RNAseq.g27969.t1,peve_ptua,38.436,,,,,,,,,,,,,,,,,
OG_16042,,Peve_00006122,Pocillopora_meandrina_HIv1___RNAseq.g23295.t1,peve_ptua,80.165,,,,,,,,,,,,,,,,,
OG_16043,,Peve_00006123,Pocillopora_meandrina_HIv1___RNAseq.g23291.t1,peve_ptua,75.0,,,,,,,,,,,,,,,,,
OG_16044,,Peve_00006126,Pocillopora_meandrina_HIv1___RNAseq.g23161.t1,peve_ptua,69.266,,,,,,,,,,,,,,,,,
OG_16045,,Peve_00006127,Pocillopora_meandrina_HIv1___RNAseq.g23167.t1,peve_ptua,73.934,,,,,,,,,,,,,,,,,
OG_16046,,Peve_00006143,Pocillopora_meandrina_HIv1___RNAseq.g1171.t1,peve_ptua,40.0,,,,,,,,,,,,,,,,,
OG_16047,,Peve_00006151,Pocillopora_meandrina_HIv1___RNAseq.g18412.t1,peve_ptua,95.062,,,,,,,,,,,,,,,,,
OG_16048,,Peve_00006152,Pocillopora_meandrina_HIv1___RNAseq.g10708.t1,peve_ptua,82.857,,,,,,,,,,,,,,,,,
OG_16049,,Peve_00006157,Pocillopora_meandrina_HIv1___RNAseq.g10744.t2,peve_ptua,53.1985,,,,,,,,,,,,,,,,,
OG_16050,,Peve_00006169,Pocillopora_meandrina_HIv1___TS.g13494.t1,peve_ptua,76.09,,,,,,,,,,,,,,,,,
OG_16051,,Peve_00006177,Pocillopora_meandrina_HIv1___RNAseq.g10995.t1,peve_ptua,63.859,,,,,,,,,,,,,,,,,
OG_16052,,Peve_00006190,Pocillopora_meandrina_HIv1___RNAseq.22564_t,peve_ptua,35.971,,,,,,,,,,,,,,,,,
OG_16053,,Peve_00006198,Pocillopora_meandrina_HIv1___TS.g13503.t1,peve_ptua,54.185,,,,,,,,,,,,,,,,,
OG_16054,,Peve_00006239,Pocillopora_meandrina_HIv1___RNAseq.g21085.t1,peve_ptua,79.36,,,,,,,,,,,,,,,,,
OG_16055,,Peve_00006247,Pocillopora_meandrina_HIv1___TS.g25872.t1,peve_ptua,84.0955,,,,,,,,,,,,,,,,,
OG_16056,,Peve_00006271,Pocillopora_meandrina_HIv1___RNAseq.g21083.t1,peve_ptua,75.0,,,,,,,,,,,,,,,,,
OG_16057,,Peve_00006283,Pocillopora_meandrina_HIv1___TS.g25191.t1,peve_ptua,63.733,,,,,,,,,,,,,,,,,
OG_16058,,Peve_00006313,Pocillopora_meandrina_HIv1___RNAseq.g7302.t1,peve_ptua,93.333,,,,,,,,,,,,,,,,,
OG_16059,,Peve_00006345,Pocillopora_meandrina_HIv1___RNAseq.g947.t1,peve_ptua,70.37,,,,,,,,,,,,,,,,,
OG_16060,,Peve_00006408,Pocillopora_meandrina_HIv1___RNAseq.g9754.t1,peve_ptua,74.114,,,,,,,,,,,,,,,,,
OG_16061,,Peve_00006426,Pocillopora_meandrina_HIv1___TS.g25948.t1,peve_ptua,65.84,,,,,,,,,,,,,,,,,
OG_16062,,Peve_00006437,Pocillopora_meandrina_HIv1___TS.g18281.t1,peve_ptua,33.802499999999995,,,,,,,,,,,,,,,,,
OG_16063,,Peve_00006459,Pocillopora_meandrina_HIv1___RNAseq.g4514.t1,peve_ptua,36.462,,,,,,,,,,,,,,,,,
OG_16064,,Peve_00006486,Pocillopora_meandrina_HIv1___RNAseq.g17523.t1,peve_ptua,68.977,,,,,,,,,,,,,,,,,
OG_16065,,Peve_00006492,Pocillopora_meandrina_HIv1___RNAseq.g22553.t1,peve_ptua,85.778,,,,,,,,,,,,,,,,,
OG_16066,,Peve_00006517,Pocillopora_meandrina_HIv1___RNAseq.g20906.t1,peve_ptua,63.934,,,,,,,,,,,,,,,,,
OG_16067,,Peve_00006531,Pocillopora_meandrina_HIv1___RNAseq.g10615.t1,peve_ptua,65.9,,,,,,,,,,,,,,,,,
OG_16068,,Peve_00006649,Pocillopora_meandrina_HIv1___RNAseq.g18151.t1,peve_ptua,43.22,,,,,,,,,,,,,,,,,
OG_16069,,Peve_00006661,Pocillopora_meandrina_HIv1___RNAseq.g17236.t1,peve_ptua,77.41,,,,,,,,,,,,,,,,,
OG_16070,,Peve_00006688,Pocillopora_meandrina_HIv1___RNAseq.g11054.t1,peve_ptua,65.574,,,,,,,,,,,,,,,,,
OG_16071,,Peve_00006696,Pocillopora_meandrina_HIv1___RNAseq.g10567.t1,peve_ptua,55.35,,,,,,,,,,,,,,,,,
OG_16072,,Peve_00006705,Pocillopora_meandrina_HIv1___RNAseq.g9984.t1,peve_ptua,52.0,,,,,,,,,,,,,,,,,
OG_16073,,Peve_00006718,Pocillopora_meandrina_HIv1___RNAseq.g12047.t1,peve_ptua,70.628,,,,,,,,,,,,,,,,,
OG_16074,,Peve_00006772,Pocillopora_meandrina_HIv1___RNAseq.g6030.t1,peve_ptua,44.172,,,,,,,,,,,,,,,,,
OG_16075,,Peve_00006775,Pocillopora_meandrina_HIv1___TS.g23236.t1,peve_ptua,68.903,,,,,,,,,,,,,,,,,
OG_16076,,Peve_00006787,Pocillopora_meandrina_HIv1___RNAseq.g2617.t1,peve_ptua,73.96,,,,,,,,,,,,,,,,,
OG_16077,,Peve_00006789,Pocillopora_meandrina_HIv1___RNAseq.g2619.t1,peve_ptua,83.23,,,,,,,,,,,,,,,,,
OG_16078,,Peve_00006817,Pocillopora_meandrina_HIv1___RNAseq.g26140.t1,peve_ptua,63.844,,,,,,,,,,,,,,,,,
OG_16079,,Peve_00006819,Pocillopora_meandrina_HIv1___RNAseq.g10311.t1,peve_ptua,51.539,,,,,,,,,,,,,,,,,
OG_16080,,Peve_00006823,Pocillopora_meandrina_HIv1___TS.g13789.t1,peve_ptua,67.601,,,,,,,,,,,,,,,,,
OG_16081,,Peve_00006836,Pocillopora_meandrina_HIv1___TS.g27323.t1,peve_ptua,65.698,,,,,,,,,,,,,,,,,
OG_16082,,Peve_00006842,Pocillopora_meandrina_HIv1___TS.g27314.t1,peve_ptua,62.5545,,,,,,,,,,,,,,,,,
OG_16083,,Peve_00006858,Pocillopora_meandrina_HIv1___RNAseq.g9546.t1,peve_ptua,65.517,,,,,,,,,,,,,,,,,
OG_16084,,Peve_00006861,Pocillopora_meandrina_HIv1___RNAseq.g9544.t1,peve_ptua,60.797,,,,,,,,,,,,,,,,,
OG_16085,,Peve_00006867,Pocillopora_meandrina_HIv1___RNAseq.g9509.t1,peve_ptua,82.865,,,,,,,,,,,,,,,,,
OG_16086,,Peve_00006869,Pocillopora_meandrina_HIv1___RNAseq.g465.t2,peve_ptua,58.371,,,,,,,,,,,,,,,,,
OG_16087,,Peve_00006878,Pocillopora_meandrina_HIv1___RNAseq.g27595.t1,peve_ptua,52.25,,,,,,,,,,,,,,,,,
OG_16088,,Peve_00006889,Pocillopora_meandrina_HIv1___RNAseq.g4811.t1,peve_ptua,76.087,,,,,,,,,,,,,,,,,
OG_16089,,Peve_00006890,Pocillopora_meandrina_HIv1___RNAseq.g4813.t1,peve_ptua,68.217,,,,,,,,,,,,,,,,,
OG_16090,,Peve_00006910,Pocillopora_meandrina_HIv1___RNAseq.g7443.t1,peve_ptua,51.989,,,,,,,,,,,,,,,,,
OG_16091,,Peve_00006917,Pocillopora_meandrina_HIv1___RNAseq.g27462.t1,peve_ptua,61.856,,,,,,,,,,,,,,,,,
OG_16092,,Peve_00006922,Pocillopora_meandrina_HIv1___RNAseq.g27464.t1,peve_ptua,53.7705,,,,,,,,,,,,,,,,,
OG_16093,,Peve_00006930,Pocillopora_meandrina_HIv1___RNAseq.g11609.t1,peve_ptua,55.918,,,,,,,,,,,,,,,,,
OG_16094,,Peve_00006944,Pocillopora_meandrina_HIv1___RNAseq.g14261.t1,peve_ptua,66.058,,,,,,,,,,,,,,,,,
OG_16095,,Peve_00006981,Pocillopora_meandrina_HIv1___RNAseq.g1674.t1,peve_ptua,44.041,,,,,,,,,,,,,,,,,
OG_16096,,Peve_00006983,Pocillopora_meandrina_HIv1___RNAseq.g1666.t1,peve_ptua,56.386,,,,,,,,,,,,,,,,,
OG_16097,,Peve_00006995,Pocillopora_meandrina_HIv1___TS.g10866.t1,peve_ptua,58.262,,,,,,,,,,,,,,,,,
OG_16098,,Peve_00007011,Pocillopora_meandrina_HIv1___RNAseq.g26079.t1,peve_ptua,78.831,,,,,,,,,,,,,,,,,
OG_16099,,Peve_00007014,Pocillopora_meandrina_HIv1___RNAseq.g26081.t1,peve_ptua,46.197,,,,,,,,,,,,,,,,,
OG_16100,,Peve_00007046,Pocillopora_meandrina_HIv1___RNAseq.g18797.t1,peve_ptua,38.255,,,,,,,,,,,,,,,,,
OG_16101,,Peve_00007066,Pocillopora_meandrina_HIv1___RNAseq.g7552.t1,peve_ptua,65.441,,,,,,,,,,,,,,,,,
OG_16102,,Peve_00007074,Pocillopora_meandrina_HIv1___RNAseq.g14101.t1,peve_ptua,65.625,,,,,,,,,,,,,,,,,
OG_16103,,Peve_00007096,Pocillopora_meandrina_HIv1___RNAseq.g27899.t1,peve_ptua,83.203,,,,,,,,,,,,,,,,,
OG_16104,,Peve_00007143,Pocillopora_meandrina_HIv1___RNAseq.g1784.t1,peve_ptua,61.321,,,,,,,,,,,,,,,,,
OG_16105,,Peve_00007185,Pocillopora_meandrina_HIv1___RNAseq.g9041.t1a,peve_ptua,63.592,,,,,,,,,,,,,,,,,
OG_16106,,Peve_00007198,Pocillopora_meandrina_HIv1___RNAseq.g14251.t1,peve_ptua,72.203,,,,,,,,,,,,,,,,,
OG_16107,,Peve_00007200,Pocillopora_meandrina_HIv1___RNAseq.g4064.t1,peve_ptua,70.815,,,,,,,,,,,,,,,,,
OG_16108,,Peve_00007233,Pocillopora_meandrina_HIv1___RNAseq.g26386.t1,peve_ptua,71.517,,,,,,,,,,,,,,,,,
OG_16109,,Peve_00007246,Pocillopora_meandrina_HIv1___RNAseq.g7187.t1,peve_ptua,66.432,,,,,,,,,,,,,,,,,
OG_16110,,Peve_00007269,Pocillopora_meandrina_HIv1___RNAseq.g7493.t1,peve_ptua,32.877,,,,,,,,,,,,,,,,,
OG_16111,,Peve_00007271,Pocillopora_meandrina_HIv1___TS.g14688.t1,peve_ptua,39.252,,,,,,,,,,,,,,,,,
OG_16112,,Peve_00007272,Pocillopora_meandrina_HIv1___RNAseq.g22430.t1,peve_ptua,49.901,,,,,,,,,,,,,,,,,
OG_16113,,Peve_00007274,Pocillopora_meandrina_HIv1___RNAseq.g11616.t1,peve_ptua,52.3315,,,,,,,,,,,,,,,,,
OG_16114,,Peve_00007342,Pocillopora_meandrina_HIv1___RNAseq.g3916.t1,peve_ptua,55.017,,,,,,,,,,,,,,,,,
OG_16115,,Peve_00007375,Pocillopora_meandrina_HIv1___RNAseq.g20334.t1,peve_ptua,42.361,,,,,,,,,,,,,,,,,
OG_16116,,Peve_00007390,Pocillopora_meandrina_HIv1___RNAseq.g14214.t1,peve_ptua,65.143,,,,,,,,,,,,,,,,,
OG_16117,,Peve_00007436,Pocillopora_meandrina_HIv1___RNAseq.g9567.t1,peve_ptua,60.438,,,,,,,,,,,,,,,,,
OG_16118,,Peve_00007444,Pocillopora_meandrina_HIv1___RNAseq.g13198.t1,peve_ptua,56.971,,,,,,,,,,,,,,,,,
OG_16119,,Peve_00007452,Pocillopora_meandrina_HIv1___TS.g20595.t1a,peve_ptua,60.251,,,,,,,,,,,,,,,,,
OG_16120,,Peve_00007454,Pocillopora_meandrina_HIv1___RNAseq.g27401.t1,peve_ptua,38.947,,,,,,,,,,,,,,,,,
OG_16121,,Peve_00007467,Pocillopora_meandrina_HIv1___RNAseq.g8271.t1,peve_ptua,32.462,,,,,,,,,,,,,,,,,
OG_16122,,Peve_00007506,Pocillopora_meandrina_HIv1___RNAseq.g8943.t1,peve_ptua,47.977500000000006,,,,,,,,,,,,,,,,,
OG_16123,,Peve_00007508,Pocillopora_meandrina_HIv1___RNAseq.g8946.t1,peve_ptua,44.203,,,,,,,,,,,,,,,,,
OG_16124,,Peve_00007514,Pocillopora_meandrina_HIv1___RNAseq.g12310.t1,peve_ptua,76.699,,,,,,,,,,,,,,,,,
OG_16125,,Peve_00007515,Pocillopora_meandrina_HIv1___RNAseq.g12308.t1,peve_ptua,69.267,,,,,,,,,,,,,,,,,
OG_16126,,Peve_00007541,Pocillopora_meandrina_HIv1___RNAseq.g12197.t1,peve_ptua,31.818,,,,,,,,,,,,,,,,,
OG_16127,,Peve_00007554,Pocillopora_meandrina_HIv1___RNAseq.g12303.t1,peve_ptua,78.5875,,,,,,,,,,,,,,,,,
OG_16128,,Peve_00007568,Pocillopora_meandrina_HIv1___RNAseq.g7823.t1,peve_ptua,56.768,,,,,,,,,,,,,,,,,
OG_16129,,Peve_00007599,Pocillopora_meandrina_HIv1___RNAseq.g13652.t1,peve_ptua,83.582,,,,,,,,,,,,,,,,,
OG_16130,,Peve_00007633,Pocillopora_meandrina_HIv1___RNAseq.g27571.t1,peve_ptua,44.444,,,,,,,,,,,,,,,,,
OG_16131,,Peve_00007655,Pocillopora_meandrina_HIv1___RNAseq.g21862.t1,peve_ptua,89.881,,,,,,,,,,,,,,,,,
OG_16132,,Peve_00007684,Pocillopora_meandrina_HIv1___RNAseq.g4706.t1,peve_ptua,69.955,,,,,,,,,,,,,,,,,
OG_16133,,Peve_00007685,Pocillopora_meandrina_HIv1___RNAseq.g4705.t1,peve_ptua,78.146,,,,,,,,,,,,,,,,,
OG_16134,,Peve_00007699,Pocillopora_meandrina_HIv1___RNAseq.g15653.t1,peve_ptua,68.262,,,,,,,,,,,,,,,,,
OG_16135,,Peve_00007702,Pocillopora_meandrina_HIv1___RNAseq.g15659.t1,peve_ptua,57.009,,,,,,,,,,,,,,,,,
OG_16136,,Peve_00007728,Pocillopora_meandrina_HIv1___RNAseq.g10405.t1,peve_ptua,60.248,,,,,,,,,,,,,,,,,
OG_16137,,Peve_00007729,Pocillopora_meandrina_HIv1___RNAseq.g10404.t1,peve_ptua,86.344,,,,,,,,,,,,,,,,,
OG_16138,,Peve_00007734,Pocillopora_meandrina_HIv1___RNAseq.g29478.t1,peve_ptua,44.545,,,,,,,,,,,,,,,,,
OG_16139,,Peve_00007746,Pocillopora_meandrina_HIv1___TS.g15931.t1,peve_ptua,68.487,,,,,,,,,,,,,,,,,
OG_16140,,Peve_00007749,Pocillopora_meandrina_HIv1___RNAseq.g2874.t1,peve_ptua,53.299,,,,,,,,,,,,,,,,,
OG_16141,,Peve_00007750,Pocillopora_meandrina_HIv1___TS.g20179.t1,peve_ptua,58.845,,,,,,,,,,,,,,,,,
OG_16142,,Peve_00007771,Pocillopora_meandrina_HIv1___RNAseq.g8811.t1,peve_ptua,37.209,,,,,,,,,,,,,,,,,
OG_16143,,Peve_00007772,Pocillopora_meandrina_HIv1___TS.g20531.t2,peve_ptua,37.778,,,,,,,,,,,,,,,,,
OG_16144,,Peve_00007804,Pocillopora_meandrina_HIv1___RNAseq.g29140.t1,peve_ptua,40.399,,,,,,,,,,,,,,,,,
OG_16145,,Peve_00007857,Pocillopora_meandrina_HIv1___RNAseq.g26470.t1,peve_ptua,47.12,,,,,,,,,,,,,,,,,
OG_16146,,Peve_00007858,Pocillopora_meandrina_HIv1___RNAseq.g9886.t1,peve_ptua,75.564,,,,,,,,,,,,,,,,,
OG_16147,,Peve_00007883,Pocillopora_meandrina_HIv1___RNAseq.g15644.t1,peve_ptua,53.144,,,,,,,,,,,,,,,,,
OG_16148,,Peve_00007885,Pocillopora_meandrina_HIv1___RNAseq.g15646.t1,peve_ptua,53.3145,,,,,,,,,,,,,,,,,
OG_16149,,Peve_00007894,Pocillopora_meandrina_HIv1___RNAseq.g15369.t1,peve_ptua,74.038,,,,,,,,,,,,,,,,,
OG_16150,,Peve_00007920,Pocillopora_meandrina_HIv1___RNAseq.g9154.t1,peve_ptua,48.597,,,,,,,,,,,,,,,,,
OG_16151,,Peve_00007921,Pocillopora_meandrina_HIv1___RNAseq.g21967.t1,peve_ptua,70.245,,,,,,,,,,,,,,,,,
OG_16152,,Peve_00007926,Pocillopora_meandrina_HIv1___TS.g14315.t1,peve_ptua,51.493,,,,,,,,,,,,,,,,,
OG_16153,,Peve_00007929,Pocillopora_meandrina_HIv1___RNAseq.g26961.t1a,peve_ptua,39.368,,,,,,,,,,,,,,,,,
OG_16154,,Peve_00007932,Pocillopora_meandrina_HIv1___RNAseq.g26958.t1,peve_ptua,71.19,,,,,,,,,,,,,,,,,
OG_16155,,Peve_00007955,Pocillopora_meandrina_HIv1___RNAseq.g6852.t1,peve_ptua,43.396,,,,,,,,,,,,,,,,,
OG_16156,,Peve_00008020,Pocillopora_meandrina_HIv1___RNAseq.g27718.t1b,peve_ptua,57.614,,,,,,,,,,,,,,,,,
OG_16157,,Peve_00008046,Pocillopora_meandrina_HIv1___RNAseq.g27089.t1,peve_ptua,40.678,,,,,,,,,,,,,,,,,
OG_16158,,Peve_00008076,Pocillopora_meandrina_HIv1___RNAseq.g5340.t1,peve_ptua,56.648,,,,,,,,,,,,,,,,,
OG_16159,,Peve_00008079,Pocillopora_meandrina_HIv1___RNAseq.11571_t,peve_ptua,49.279,,,,,,,,,,,,,,,,,
OG_16160,,Peve_00008086,Pocillopora_meandrina_HIv1___TS.g14488.t1,peve_ptua,54.321,,,,,,,,,,,,,,,,,
OG_16161,,Peve_00008090,Pocillopora_meandrina_HIv1___TS.g11901.t1,peve_ptua,37.173,,,,,,,,,,,,,,,,,
OG_16162,,Peve_00008091,Pocillopora_meandrina_HIv1___RNAseq.g14119.t1,peve_ptua,34.455,,,,,,,,,,,,,,,,,
OG_16163,,Peve_00008093,Pocillopora_meandrina_HIv1___TS.g10613.t1b,peve_ptua,59.948,,,,,,,,,,,,,,,,,
OG_16164,,Peve_00008108,Pocillopora_meandrina_HIv1___RNAseq.g14112.t1,peve_ptua,60.956,,,,,,,,,,,,,,,,,
OG_16165,,Peve_00008121,Pocillopora_meandrina_HIv1___RNAseq.g16866.t1,peve_ptua,83.714,,,,,,,,,,,,,,,,,
OG_16166,,Peve_00008130,Pocillopora_meandrina_HIv1___TS.g17678.t1,peve_ptua,62.24,,,,,,,,,,,,,,,,,
OG_16167,,Peve_00008202,Pocillopora_meandrina_HIv1___RNAseq.g19228.t1,peve_ptua,58.779,,,,,,,,,,,,,,,,,
OG_16168,,Peve_00008216,Pocillopora_meandrina_HIv1___TS.g29486.t2,peve_ptua,59.028,,,,,,,,,,,,,,,,,
OG_16169,,Peve_00008267,Pocillopora_meandrina_HIv1___RNAseq.g4521.t1,peve_ptua,46.7105,,,,,,,,,,,,,,,,,
OG_16170,,Peve_00008331,Pocillopora_meandrina_HIv1___RNAseq.g16215.t1,peve_ptua,48.121,,,,,,,,,,,,,,,,,
OG_16171,,Peve_00008337,Pocillopora_meandrina_HIv1___RNAseq.g14872.t1,peve_ptua,89.062,,,,,,,,,,,,,,,,,
OG_16172,,Peve_00008393,Pocillopora_meandrina_HIv1___TS.g1481.t1a,peve_ptua,32.645,,,,,,,,,,,,,,,,,
OG_16173,,Peve_00008419,Pocillopora_meandrina_HIv1___TS.g23238.t1,peve_ptua,45.968,,,,,,,,,,,,,,,,,
OG_16174,,Peve_00008497,Pocillopora_meandrina_HIv1___RNAseq.g3851.t1,peve_ptua,31.214,,,,,,,,,,,,,,,,,
OG_16175,,Peve_00008540,Pocillopora_meandrina_HIv1___RNAseq.26297_t,peve_ptua,53.595,,,,,,,,,,,,,,,,,
OG_16176,,Peve_00008574,Pocillopora_meandrina_HIv1___RNAseq.g9613.t1,peve_ptua,48.507,,,,,,,,,,,,,,,,,
OG_16177,,Peve_00008596,Pocillopora_meandrina_HIv1___RNAseq.g17305.t1,peve_ptua,85.135,,,,,,,,,,,,,,,,,
OG_16178,,Peve_00008599,Pocillopora_meandrina_HIv1___RNAseq.g4764.t1,peve_ptua,82.69,,,,,,,,,,,,,,,,,
OG_16179,,Peve_00008623,Pocillopora_meandrina_HIv1___RNAseq.g23447.t1,peve_ptua,49.675,,,,,,,,,,,,,,,,,
OG_16180,,Peve_00008644,Pocillopora_meandrina_HIv1___RNAseq.g8464.t2,peve_ptua,63.604,,,,,,,,,,,,,,,,,
OG_16181,,Peve_00008676,Pocillopora_meandrina_HIv1___RNAseq.g6209.t1,peve_ptua,42.069,,,,,,,,,,,,,,,,,
OG_16182,,Peve_00008688,Pocillopora_meandrina_HIv1___RNAseq.g7983.t1,peve_ptua,45.493,,,,,,,,,,,,,,,,,
OG_16183,,Peve_00008694,Pocillopora_meandrina_HIv1___RNAseq.g7962.t1,peve_ptua,74.79,,,,,,,,,,,,,,,,,
OG_16184,,Peve_00008726,Pocillopora_meandrina_HIv1___TS.g6357.t1,peve_ptua,40.404,,,,,,,,,,,,,,,,,
OG_16185,,Peve_00008741,Pocillopora_meandrina_HIv1___TS.g6815.t1,peve_ptua,52.7135,,,,,,,,,,,,,,,,,
OG_16186,,Peve_00008763,Pocillopora_meandrina_HIv1___RNAseq.g2110.t1,peve_ptua,78.973,,,,,,,,,,,,,,,,,
OG_16187,,Peve_00008778,Pocillopora_meandrina_HIv1___RNAseq.g2186.t1,peve_ptua,59.028,,,,,,,,,,,,,,,,,
OG_16188,,Peve_00008785,Pocillopora_meandrina_HIv1___RNAseq.g2176.t1,peve_ptua,57.882,,,,,,,,,,,,,,,,,
OG_16189,,Peve_00008799,Pocillopora_meandrina_HIv1___TS.g4540.t1,peve_ptua,59.801,,,,,,,,,,,,,,,,,
OG_16190,,Peve_00008826,Pocillopora_meandrina_HIv1___RNAseq.g14983.t1,peve_ptua,43.137,,,,,,,,,,,,,,,,,
OG_16191,,Peve_00008828,Pocillopora_meandrina_HIv1___TS.g20730.t1,peve_ptua,41.72,,,,,,,,,,,,,,,,,
OG_16192,,Peve_00008841,Pocillopora_meandrina_HIv1___RNAseq.g4467.t1,peve_ptua,52.031,,,,,,,,,,,,,,,,,
OG_16193,,Peve_00008852,Pocillopora_meandrina_HIv1___RNAseq.g9136.t1,peve_ptua,54.167,,,,,,,,,,,,,,,,,
OG_16194,,Peve_00008877,Pocillopora_meandrina_HIv1___RNAseq.g19944.t1,peve_ptua,62.2725,,,,,,,,,,,,,,,,,
OG_16195,,Peve_00008880,Pocillopora_meandrina_HIv1___RNAseq.g17164.t1,peve_ptua,57.266000000000005,,,,,,,,,,,,,,,,,
OG_16196,,Peve_00008948,Pocillopora_meandrina_HIv1___TS.g16575.t1,peve_ptua,41.3265,,,,,,,,,,,,,,,,,
OG_16197,,Peve_00008951,Pocillopora_meandrina_HIv1___RNAseq.g17105.t1,peve_ptua,67.7755,,,,,,,,,,,,,,,,,
OG_16198,,Peve_00008956,Pocillopora_meandrina_HIv1___RNAseq.g12513.t1,peve_ptua,68.276,,,,,,,,,,,,,,,,,
OG_16199,,Peve_00008960,Pocillopora_meandrina_HIv1___RNAseq.g11547.t1,peve_ptua,58.427,,,,,,,,,,,,,,,,,
OG_16200,,Peve_00009045,Pocillopora_meandrina_HIv1___RNAseq.g26429.t1,peve_ptua,90.0,,,,,,,,,,,,,,,,,
OG_16201,,Peve_00009069,Pocillopora_meandrina_HIv1___TS.g9738.t1,peve_ptua,45.101,,,,,,,,,,,,,,,,,
OG_16202,,Peve_00009090,Pocillopora_meandrina_HIv1___TS.g9526.t1,peve_ptua,44.348,,,,,,,,,,,,,,,,,
OG_16203,,Peve_00009121,Pocillopora_meandrina_HIv1___RNAseq.g6192.t1,peve_ptua,76.544,,,,,,,,,,,,,,,,,
OG_16204,,Peve_00009123,Pocillopora_meandrina_HIv1___RNAseq.g6196.t1,peve_ptua,79.464,,,,,,,,,,,,,,,,,
OG_16205,,Peve_00009124,Pocillopora_meandrina_HIv1___RNAseq.g6190.t1,peve_ptua,77.415,,,,,,,,,,,,,,,,,
OG_16206,,Peve_00009127,Pocillopora_meandrina_HIv1___RNAseq.g15434.t1,peve_ptua,32.767,,,,,,,,,,,,,,,,,
OG_16207,,Peve_00009130,Pocillopora_meandrina_HIv1___TS.g10460.t1,peve_ptua,32.515,,,,,,,,,,,,,,,,,
OG_16208,,Peve_00009138,Pocillopora_meandrina_HIv1___RNAseq.g17955.t1,peve_ptua,52.174,,,,,,,,,,,,,,,,,
OG_16209,,Peve_00009143,Pocillopora_meandrina_HIv1___RNAseq.g8427.t1,peve_ptua,79.0685,,,,,,,,,,,,,,,,,
OG_16210,,Peve_00009152,Pocillopora_meandrina_HIv1___RNAseq.g24124.t1,peve_ptua,76.736,,,,,,,,,,,,,,,,,
OG_16211,,Peve_00009170,Pocillopora_meandrina_HIv1___RNAseq.g24180.t1,peve_ptua,62.385,,,,,,,,,,,,,,,,,
OG_16212,,Peve_00009174,Pocillopora_meandrina_HIv1___RNAseq.g24176.t1,peve_ptua,44.737,,,,,,,,,,,,,,,,,
OG_16213,,Peve_00009177,Pocillopora_meandrina_HIv1___RNAseq.g24171.t1,peve_ptua,33.918,,,,,,,,,,,,,,,,,
OG_16214,,Peve_00009183,Pocillopora_meandrina_HIv1___RNAseq.g16274.t1,peve_ptua,65.185,,,,,,,,,,,,,,,,,
OG_16215,,Peve_00009206,Pocillopora_meandrina_HIv1___RNAseq.g133.t1,peve_ptua,61.29,,,,,,,,,,,,,,,,,
OG_16216,,Peve_00009212,Pocillopora_meandrina_HIv1___TS.g14448.t1,peve_ptua,47.456,,,,,,,,,,,,,,,,,
OG_16217,,Peve_00009231,Pocillopora_meandrina_HIv1___RNAseq.g4326.t1,peve_ptua,62.325,,,,,,,,,,,,,,,,,
OG_16218,,Peve_00009252,Pocillopora_meandrina_HIv1___RNAseq.g28738.t1,peve_ptua,76.829,,,,,,,,,,,,,,,,,
OG_16219,,Peve_00009291,Pocillopora_meandrina_HIv1___RNAseq.g25989.t1a,peve_ptua,34.314,,,,,,,,,,,,,,,,,
OG_16220,,Peve_00009329,Pocillopora_meandrina_HIv1___RNAseq.g1452.t1,peve_ptua,63.472,,,,,,,,,,,,,,,,,
OG_16221,,Peve_00009340,Pocillopora_meandrina_HIv1___TS.g8720.t1,peve_ptua,64.9805,,,,,,,,,,,,,,,,,
OG_16222,,Peve_00009360,Pocillopora_meandrina_HIv1___RNAseq.g4976.t1a,peve_ptua,30.488,,,,,,,,,,,,,,,,,
OG_16223,,Peve_00009378,Pocillopora_meandrina_HIv1___RNAseq.g15768.t1,peve_ptua,54.337,,,,,,,,,,,,,,,,,
OG_16224,,Peve_00009401,Pocillopora_meandrina_HIv1___RNAseq.g14531.t1,peve_ptua,52.9055,,,,,,,,,,,,,,,,,
OG_16225,,Peve_00009412,Pocillopora_meandrina_HIv1___RNAseq.g19299.t1d,peve_ptua,72.185,,,,,,,,,,,,,,,,,
OG_16226,,Peve_00009423,Pocillopora_meandrina_HIv1___TS.g17057.t1a,peve_ptua,84.892,,,,,,,,,,,,,,,,,
OG_16227,,Peve_00009432,Pocillopora_meandrina_HIv1___RNAseq.g11411.t1,peve_ptua,44.5545,,,,,,,,,,,,,,,,,
OG_16228,,Peve_00009497,Pocillopora_meandrina_HIv1___RNAseq.g22325.t1,peve_ptua,80.998,,,,,,,,,,,,,,,,,
OG_16229,,Peve_00009507,Pocillopora_meandrina_HIv1___RNAseq.g20980.t1,peve_ptua,70.95,,,,,,,,,,,,,,,,,
OG_16230,,Peve_00009515,Pocillopora_meandrina_HIv1___RNAseq.g17166.t1,peve_ptua,62.364,,,,,,,,,,,,,,,,,
OG_16231,,Peve_00009521,Pocillopora_meandrina_HIv1___RNAseq.g27977.t1,peve_ptua,46.2875,,,,,,,,,,,,,,,,,
OG_16232,,Peve_00009525,Pocillopora_meandrina_HIv1___RNAseq.g21739.t1,peve_ptua,72.383,,,,,,,,,,,,,,,,,
OG_16233,,Peve_00009566,Pocillopora_meandrina_HIv1___RNAseq.g9686.t1,peve_ptua,76.836,,,,,,,,,,,,,,,,,
OG_16234,,Peve_00009567,Pocillopora_meandrina_HIv1___RNAseq.g9685.t1,peve_ptua,54.739,,,,,,,,,,,,,,,,,
OG_16235,,Peve_00009580,Pocillopora_meandrina_HIv1___RNAseq.g6495.t1,peve_ptua,47.857,,,,,,,,,,,,,,,,,
OG_16236,,Peve_00009612,Pocillopora_meandrina_HIv1___RNAseq.g22834.t1,peve_ptua,74.94550000000001,,,,,,,,,,,,,,,,,
OG_16237,,Peve_00009644,Pocillopora_meandrina_HIv1___RNAseq.g15077.t1,peve_ptua,74.0835,,,,,,,,,,,,,,,,,
OG_16238,,Peve_00009657,Pocillopora_meandrina_HIv1___TS.g27324.t1a,peve_ptua,54.453,,,,,,,,,,,,,,,,,
OG_16239,,Peve_00009663,Pocillopora_meandrina_HIv1___RNAseq.g24576.t1,peve_ptua,60.0,,,,,,,,,,,,,,,,,
OG_16240,,Peve_00009692,Pocillopora_meandrina_HIv1___RNAseq.g22701.t1,peve_ptua,73.333,,,,,,,,,,,,,,,,,
OG_16241,,Peve_00009697,Pocillopora_meandrina_HIv1___RNAseq.g22706.t1,peve_ptua,86.932,,,,,,,,,,,,,,,,,
OG_16242,,Peve_00009735,Pocillopora_meandrina_HIv1___RNAseq.g4095.t1,peve_ptua,60.317,,,,,,,,,,,,,,,,,
OG_16243,,Peve_00009761,Pocillopora_meandrina_HIv1___TS.g25777.t1,peve_ptua,51.444,,,,,,,,,,,,,,,,,
OG_16244,,Peve_00009767,Pocillopora_meandrina_HIv1___RNAseq.g25002.t1,peve_ptua,40.881,,,,,,,,,,,,,,,,,
OG_16245,,Peve_00009792,Pocillopora_meandrina_HIv1___RNAseq.g18047.t1,peve_ptua,46.018,,,,,,,,,,,,,,,,,
OG_16246,,Peve_00009822,Pocillopora_meandrina_HIv1___TS.g5566.t1,peve_ptua,36.387,,,,,,,,,,,,,,,,,
OG_16247,,Peve_00009861,Pocillopora_meandrina_HIv1___RNAseq.g18240.t1,peve_ptua,46.2995,,,,,,,,,,,,,,,,,
OG_16248,,Peve_00009862,Pocillopora_meandrina_HIv1___TS.g21219.t1,peve_ptua,65.541,,,,,,,,,,,,,,,,,
OG_16249,,Peve_00009870,Pocillopora_meandrina_HIv1___RNAseq.g18243.t1,peve_ptua,66.8485,,,,,,,,,,,,,,,,,
OG_16250,,Peve_00009881,Pocillopora_meandrina_HIv1___RNAseq.g18275.t1,peve_ptua,33.498,,,,,,,,,,,,,,,,,
OG_16251,,Peve_00009885,Pocillopora_meandrina_HIv1___RNAseq.g18277.t1,peve_ptua,35.4815,,,,,,,,,,,,,,,,,
OG_16252,,Peve_00009887,Pocillopora_meandrina_HIv1___RNAseq.g18306.t1,peve_ptua,63.716,,,,,,,,,,,,,,,,,
OG_16253,,Peve_00009897,Pocillopora_meandrina_HIv1___RNAseq.g6577.t1,peve_ptua,71.351,,,,,,,,,,,,,,,,,
OG_16254,,Peve_00009912,Pocillopora_meandrina_HIv1___RNAseq.g19834.t1,peve_ptua,56.15,,,,,,,,,,,,,,,,,
OG_16255,,Peve_00009930,Pocillopora_meandrina_HIv1___RNAseq.g29509.t1,peve_ptua,50.224,,,,,,,,,,,,,,,,,
OG_16256,,Peve_00009940,Pocillopora_meandrina_HIv1___RNAseq.g26032.t1,peve_ptua,67.456,,,,,,,,,,,,,,,,,
OG_16257,,Peve_00009944,Pocillopora_meandrina_HIv1___RNAseq.g20727.t1,peve_ptua,38.587,,,,,,,,,,,,,,,,,
OG_16258,,Peve_00009960,Pocillopora_meandrina_HIv1___TS.g11788.t1,peve_ptua,79.67,,,,,,,,,,,,,,,,,
OG_16259,,Peve_00010004,Pocillopora_meandrina_HIv1___RNAseq.g684.t1,peve_ptua,48.953,,,,,,,,,,,,,,,,,
OG_16260,,Peve_00010011,Pocillopora_meandrina_HIv1___TS.g4226.t1,peve_ptua,39.1755,,,,,,,,,,,,,,,,,
OG_16261,,Peve_00010031,Pocillopora_meandrina_HIv1___RNAseq.g649.t1,peve_ptua,45.2645,,,,,,,,,,,,,,,,,
OG_16262,,Peve_00010039,Pocillopora_meandrina_HIv1___RNAseq.g29488.t1,peve_ptua,78.007,,,,,,,,,,,,,,,,,
OG_16263,,Peve_00010042,Pocillopora_meandrina_HIv1___RNAseq.g29493.t1,peve_ptua,64.912,,,,,,,,,,,,,,,,,
OG_16264,,Peve_00010058,Pocillopora_meandrina_HIv1___RNAseq.g29504.t1,peve_ptua,33.831,,,,,,,,,,,,,,,,,
OG_16265,,Peve_00010068,Pocillopora_meandrina_HIv1___RNAseq.g15466.t1,peve_ptua,58.249,,,,,,,,,,,,,,,,,
OG_16266,,Peve_00010085,Pocillopora_meandrina_HIv1___RNAseq.g22740.t1,peve_ptua,72.20400000000001,,,,,,,,,,,,,,,,,
OG_16267,,Peve_00010134,Pocillopora_meandrina_HIv1___RNAseq.g25098.t1,peve_ptua,73.941,,,,,,,,,,,,,,,,,
OG_16268,,Peve_00010156,Pocillopora_meandrina_HIv1___RNAseq.g6210.t1,peve_ptua,50.0,,,,,,,,,,,,,,,,,
OG_16269,,Peve_00010160,Pocillopora_meandrina_HIv1___RNAseq.g7333.t1,peve_ptua,73.264,,,,,,,,,,,,,,,,,
OG_16270,,Peve_00010264,Pocillopora_meandrina_HIv1___RNAseq.g8542.t1,peve_ptua,58.136,,,,,,,,,,,,,,,,,
OG_16271,,Peve_00010281,Pocillopora_meandrina_HIv1___RNAseq.g7761.t1,peve_ptua,62.673,,,,,,,,,,,,,,,,,
OG_16272,,Peve_00010296,Pocillopora_meandrina_HIv1___RNAseq.g16466.t1,peve_ptua,36.905,,,,,,,,,,,,,,,,,
OG_16273,,Peve_00010302,Pocillopora_meandrina_HIv1___RNAseq.g15533.t1,peve_ptua,73.973,,,,,,,,,,,,,,,,,
OG_16274,,Peve_00010315,Pocillopora_meandrina_HIv1___RNAseq.g18576.t1,peve_ptua,70.701,,,,,,,,,,,,,,,,,
OG_16275,,Peve_00010330,Pocillopora_meandrina_HIv1___TS.g18049.t1,peve_ptua,63.228,,,,,,,,,,,,,,,,,
OG_16276,,Peve_00010331,Pocillopora_meandrina_HIv1___RNAseq.g2935.t1,peve_ptua,59.491,,,,,,,,,,,,,,,,,
OG_16277,,Peve_00010341,Pocillopora_meandrina_HIv1___RNAseq.g22411.t1,peve_ptua,86.458,,,,,,,,,,,,,,,,,
OG_16278,,Peve_00010348,Pocillopora_meandrina_HIv1___RNAseq.g5970.t1,peve_ptua,66.346,,,,,,,,,,,,,,,,,
OG_16279,,Peve_00010372,Pocillopora_meandrina_HIv1___RNAseq.g29715.t1,peve_ptua,72.872,,,,,,,,,,,,,,,,,
OG_16280,,Peve_00010375,Pocillopora_meandrina_HIv1___TS.g24977.t1,peve_ptua,47.826,,,,,,,,,,,,,,,,,
OG_16281,,Peve_00010378,Pocillopora_meandrina_HIv1___RNAseq.g29727.t1,peve_ptua,66.272,,,,,,,,,,,,,,,,,
OG_16282,,Peve_00010383,Pocillopora_meandrina_HIv1___TS.g19745.t1,peve_ptua,81.6,,,,,,,,,,,,,,,,,
OG_16283,,Peve_00010456,Pocillopora_meandrina_HIv1___RNAseq.g6972.t1,peve_ptua,80.325,,,,,,,,,,,,,,,,,
OG_16284,,Peve_00010483,Pocillopora_meandrina_HIv1___RNAseq.g28520.t1,peve_ptua,53.973,,,,,,,,,,,,,,,,,
OG_16285,,Peve_00010496,Pocillopora_meandrina_HIv1___RNAseq.g15887.t1,peve_ptua,73.741,,,,,,,,,,,,,,,,,
OG_16286,,Peve_00010526,Pocillopora_meandrina_HIv1___TS.g16453.t1,peve_ptua,61.443,,,,,,,,,,,,,,,,,
OG_16287,,Peve_00010567,Pocillopora_meandrina_HIv1___RNAseq.g5872.t1,peve_ptua,45.455,,,,,,,,,,,,,,,,,
OG_16288,,Peve_00010571,Pocillopora_meandrina_HIv1___RNAseq.g5884.t1b,peve_ptua,53.633,,,,,,,,,,,,,,,,,
OG_16289,,Peve_00010574,Pocillopora_meandrina_HIv1___TS.g24607.t1,peve_ptua,44.497,,,,,,,,,,,,,,,,,
OG_16290,,Peve_00010586,Pocillopora_meandrina_HIv1___RNAseq.g4253.t1,peve_ptua,62.0395,,,,,,,,,,,,,,,,,
OG_16291,,Peve_00010650,Pocillopora_meandrina_HIv1___RNAseq.g23112.t1,peve_ptua,37.872,,,,,,,,,,,,,,,,,
OG_16292,,Peve_00010678,Pocillopora_meandrina_HIv1___RNAseq.g17106.t1,peve_ptua,71.639,,,,,,,,,,,,,,,,,
OG_16293,,Peve_00010680,Pocillopora_meandrina_HIv1___RNAseq.g17118.t1,peve_ptua,47.573,,,,,,,,,,,,,,,,,
OG_16294,,Peve_00010757,Pocillopora_meandrina_HIv1___RNAseq.g25086.t1,peve_ptua,34.694,,,,,,,,,,,,,,,,,
OG_16295,,Peve_00010779,Pocillopora_meandrina_HIv1___RNAseq.g21583.t1,peve_ptua,39.697,,,,,,,,,,,,,,,,,
OG_16296,,Peve_00010780,Pocillopora_meandrina_HIv1___RNAseq.g21581.t1,peve_ptua,69.701,,,,,,,,,,,,,,,,,
OG_16297,,Peve_00010854,Pocillopora_meandrina_HIv1___RNAseq.g29994.t1,peve_ptua,90.361,,,,,,,,,,,,,,,,,
OG_16298,,Peve_00010855,Pocillopora_meandrina_HIv1___RNAseq.g30003.t1,peve_ptua,92.308,,,,,,,,,,,,,,,,,
OG_16299,,Peve_00010876,Pocillopora_meandrina_HIv1___TS.g18603.t1,peve_ptua,70.763,,,,,,,,,,,,,,,,,
OG_16300,,Peve_00010878,Pocillopora_meandrina_HIv1___RNAseq.g6621.t1a,peve_ptua,40.909,,,,,,,,,,,,,,,,,
OG_16301,,Peve_00010912,Pocillopora_meandrina_HIv1___RNAseq.g27957.t1c,peve_ptua,44.444,,,,,,,,,,,,,,,,,
OG_16302,,Peve_00010934,Pocillopora_meandrina_HIv1___RNAseq.g23314.t1,peve_ptua,74.899,,,,,,,,,,,,,,,,,
OG_16303,,Peve_00010942,Pocillopora_meandrina_HIv1___RNAseq.g790.t1,peve_ptua,40.13,,,,,,,,,,,,,,,,,
OG_16304,,Peve_00010962,Pocillopora_meandrina_HIv1___RNAseq.g2316.t1,peve_ptua,34.906,,,,,,,,,,,,,,,,,
OG_16305,,Peve_00010967,Pocillopora_meandrina_HIv1___RNAseq.g26803.t1,peve_ptua,75.854,,,,,,,,,,,,,,,,,
OG_16306,,Peve_00010993,Pocillopora_meandrina_HIv1___RNAseq.g26003.t1,peve_ptua,79.435,,,,,,,,,,,,,,,,,
OG_16307,,Peve_00011002,Pocillopora_meandrina_HIv1___RNAseq.g18078.t1,peve_ptua,51.368,,,,,,,,,,,,,,,,,
OG_16308,,Peve_00011016,Pocillopora_meandrina_HIv1___RNAseq.g1705.t1,peve_ptua,42.073,,,,,,,,,,,,,,,,,
OG_16309,,Peve_00011037,Pocillopora_meandrina_HIv1___RNAseq.g14401.t1,peve_ptua,43.063,,,,,,,,,,,,,,,,,
OG_16310,,Peve_00011046,Pocillopora_meandrina_HIv1___RNAseq.g11216.t1,peve_ptua,70.498,,,,,,,,,,,,,,,,,
OG_16311,,Peve_00011053,Pocillopora_meandrina_HIv1___RNAseq.g13661.t1,peve_ptua,67.108,,,,,,,,,,,,,,,,,
OG_16312,,Peve_00011063,Pocillopora_meandrina_HIv1___RNAseq.g5633.t1,peve_ptua,48.619,,,,,,,,,,,,,,,,,
OG_16313,,Peve_00011068,Pocillopora_meandrina_HIv1___RNAseq.g17908.t1,peve_ptua,83.6115,,,,,,,,,,,,,,,,,
OG_16314,,Peve_00011092,Pocillopora_meandrina_HIv1___RNAseq.g27263.t1,peve_ptua,46.473,,,,,,,,,,,,,,,,,
OG_16315,,Peve_00011094,Pocillopora_meandrina_HIv1___TS.g14607.t1,peve_ptua,39.873,,,,,,,,,,,,,,,,,
OG_16316,,Peve_00011102,Pocillopora_meandrina_HIv1___RNAseq.g27243.t1,peve_ptua,53.271,,,,,,,,,,,,,,,,,
OG_16317,,Peve_00011113,Pocillopora_meandrina_HIv1___RNAseq.g27233.t1,peve_ptua,33.333,,,,,,,,,,,,,,,,,
OG_16318,,Peve_00011131,Pocillopora_meandrina_HIv1___RNAseq.g27363.t1,peve_ptua,46.6465,,,,,,,,,,,,,,,,,
OG_16319,,Peve_00011151,Pocillopora_meandrina_HIv1___TS.g19470.t1,peve_ptua,51.5055,,,,,,,,,,,,,,,,,
OG_16320,,Peve_00011186,Pocillopora_meandrina_HIv1___RNAseq.g4055.t1,peve_ptua,72.345,,,,,,,,,,,,,,,,,
OG_16321,,Peve_00011196,Pocillopora_meandrina_HIv1___RNAseq.g2324.t1,peve_ptua,38.983,,,,,,,,,,,,,,,,,
OG_16322,,Peve_00011205,Pocillopora_meandrina_HIv1___RNAseq.g12019.t1,peve_ptua,56.0115,,,,,,,,,,,,,,,,,
OG_16323,,Peve_00011220,Pocillopora_meandrina_HIv1___RNAseq.g13133.t1,peve_ptua,43.137,,,,,,,,,,,,,,,,,
OG_16324,,Peve_00011226,Pocillopora_meandrina_HIv1___TS.g22545.t1,peve_ptua,54.38,,,,,,,,,,,,,,,,,
OG_16325,,Peve_00011242,Pocillopora_meandrina_HIv1___RNAseq.g13686.t1,peve_ptua,37.569,,,,,,,,,,,,,,,,,
OG_16326,,Peve_00011258,Pocillopora_meandrina_HIv1___RNAseq.g7249.t1,peve_ptua,55.488,,,,,,,,,,,,,,,,,
OG_16327,,Peve_00011272,Pocillopora_meandrina_HIv1___RNAseq.g24539.t1,peve_ptua,36.693,,,,,,,,,,,,,,,,,
OG_16328,,Peve_00011282,Pocillopora_meandrina_HIv1___RNAseq.g5998.t1,peve_ptua,76.144,,,,,,,,,,,,,,,,,
OG_16329,,Peve_00011308,Pocillopora_meandrina_HIv1___RNAseq.g28497.t1,peve_ptua,80.597,,,,,,,,,,,,,,,,,
OG_16330,,Peve_00011317,Pocillopora_meandrina_HIv1___RNAseq.g20402.t1,peve_ptua,47.945,,,,,,,,,,,,,,,,,
OG_16331,,Peve_00011323,Pocillopora_meandrina_HIv1___RNAseq.g20400.t1,peve_ptua,86.842,,,,,,,,,,,,,,,,,
OG_16332,,Peve_00011340,Pocillopora_meandrina_HIv1___RNAseq.g30355.t1,peve_ptua,58.228,,,,,,,,,,,,,,,,,
OG_16333,,Peve_00011353,Pocillopora_meandrina_HIv1___RNAseq.g25859.t1,peve_ptua,83.333,,,,,,,,,,,,,,,,,
OG_16334,,Peve_00011417,Pocillopora_meandrina_HIv1___TS.g11577.t1,peve_ptua,37.946,,,,,,,,,,,,,,,,,
OG_16335,,Peve_00011449,Pocillopora_meandrina_HIv1___RNAseq.g20445.t1,peve_ptua,61.143,,,,,,,,,,,,,,,,,
OG_16336,,Peve_00011460,Pocillopora_meandrina_HIv1___RNAseq.g20310.t1,peve_ptua,73.046,,,,,,,,,,,,,,,,,
OG_16337,,Peve_00011463,Pocillopora_meandrina_HIv1___RNAseq.g20270.t2,peve_ptua,58.636,,,,,,,,,,,,,,,,,
OG_16338,,Peve_00011476,Pocillopora_meandrina_HIv1___RNAseq.g16332.t1,peve_ptua,35.833,,,,,,,,,,,,,,,,,
OG_16339,,Peve_00011491,Pocillopora_meandrina_HIv1___RNAseq.g18407.t1,peve_ptua,69.608,,,,,,,,,,,,,,,,,
OG_16340,,Peve_00011500,Pocillopora_meandrina_HIv1___RNAseq.g758.t1,peve_ptua,41.803,,,,,,,,,,,,,,,,,
OG_16341,,Peve_00011503,Pocillopora_meandrina_HIv1___TS.g8043.t1,peve_ptua,54.167,,,,,,,,,,,,,,,,,
OG_16342,,Peve_00011508,Pocillopora_meandrina_HIv1___RNAseq.g19627.t1,peve_ptua,48.691,,,,,,,,,,,,,,,,,
OG_16343,,Peve_00011560,Pocillopora_meandrina_HIv1___TS.g1765.t1,peve_ptua,47.863,,,,,,,,,,,,,,,,,
OG_16344,,Peve_00011572,Pocillopora_meandrina_HIv1___RNAseq.g10893.t1,peve_ptua,70.588,,,,,,,,,,,,,,,,,
OG_16345,,Peve_00011595,Pocillopora_meandrina_HIv1___RNAseq.g23464.t1,peve_ptua,44.49,,,,,,,,,,,,,,,,,
OG_16346,,Peve_00011609,Pocillopora_meandrina_HIv1___TS.g28076.t1,peve_ptua,59.77,,,,,,,,,,,,,,,,,
OG_16347,,Peve_00011628,Pocillopora_meandrina_HIv1___RNAseq.g22504.t1,peve_ptua,34.486999999999995,,,,,,,,,,,,,,,,,
OG_16348,,Peve_00011633,Pocillopora_meandrina_HIv1___RNAseq.g6015.t1,peve_ptua,74.658,,,,,,,,,,,,,,,,,
OG_16349,,Peve_00011644,Pocillopora_meandrina_HIv1___RNAseq.g6730.t1,peve_ptua,44.0175,,,,,,,,,,,,,,,,,
OG_16350,,Peve_00011667,Pocillopora_meandrina_HIv1___RNAseq.g18174.t1,peve_ptua,41.237,,,,,,,,,,,,,,,,,
OG_16351,,Peve_00011693,Pocillopora_meandrina_HIv1___RNAseq.g8405.t1,peve_ptua,63.448,,,,,,,,,,,,,,,,,
OG_16352,,Peve_00011740,Pocillopora_meandrina_HIv1___RNAseq.g10711.t1,peve_ptua,98.286,,,,,,,,,,,,,,,,,
OG_16353,,Peve_00011756,Pocillopora_meandrina_HIv1___RNAseq.g10741.t1,peve_ptua,43.103,,,,,,,,,,,,,,,,,
OG_16354,,Peve_00011764,Pocillopora_meandrina_HIv1___RNAseq.g3411.t1,peve_ptua,47.17,,,,,,,,,,,,,,,,,
OG_16355,,Peve_00011795,Pocillopora_meandrina_HIv1___RNAseq.g21773.t1,peve_ptua,73.541,,,,,,,,,,,,,,,,,
OG_16356,,Peve_00011801,Pocillopora_meandrina_HIv1___RNAseq.g21642.t1b,peve_ptua,67.316,,,,,,,,,,,,,,,,,
OG_16357,,Peve_00011804,Pocillopora_meandrina_HIv1___RNAseq.g21645.t1,peve_ptua,79.091,,,,,,,,,,,,,,,,,
OG_16358,,Peve_00011809,Pocillopora_meandrina_HIv1___RNAseq.g21650.t1,peve_ptua,44.981,,,,,,,,,,,,,,,,,
OG_16359,,Peve_00011819,Pocillopora_meandrina_HIv1___RNAseq.g21658.t1,peve_ptua,68.97550000000001,,,,,,,,,,,,,,,,,
OG_16360,,Peve_00011856,Pocillopora_meandrina_HIv1___RNAseq.1881_t,peve_ptua,71.429,,,,,,,,,,,,,,,,,
OG_16361,,Peve_00011868,Pocillopora_meandrina_HIv1___RNAseq.g12943.t1,peve_ptua,81.034,,,,,,,,,,,,,,,,,
OG_16362,,Peve_00011873,Pocillopora_meandrina_HIv1___RNAseq.g8135.t1,peve_ptua,67.688,,,,,,,,,,,,,,,,,
OG_16363,,Peve_00011880,Pocillopora_meandrina_HIv1___TS.g21852.t1,peve_ptua,71.849,,,,,,,,,,,,,,,,,
OG_16364,,Peve_00011884,Pocillopora_meandrina_HIv1___RNAseq.g23727.t1,peve_ptua,70.765,,,,,,,,,,,,,,,,,
OG_16365,,Peve_00011894,Pocillopora_meandrina_HIv1___RNAseq.g27845.t1,peve_ptua,62.366,,,,,,,,,,,,,,,,,
OG_16366,,Peve_00011905,Pocillopora_meandrina_HIv1___TS.g9934.t1,peve_ptua,82.941,,,,,,,,,,,,,,,,,
OG_16367,,Peve_00011920,Pocillopora_meandrina_HIv1___RNAseq.g18144.t1,peve_ptua,75.1805,,,,,,,,,,,,,,,,,
OG_16368,,Peve_00011933,Pocillopora_meandrina_HIv1___RNAseq.g1763.t1,peve_ptua,84.375,,,,,,,,,,,,,,,,,
OG_16369,,Peve_00011942,Pocillopora_meandrina_HIv1___RNAseq.g23301.t1,peve_ptua,50.813,,,,,,,,,,,,,,,,,
OG_16370,,Peve_00011947,Pocillopora_meandrina_HIv1___RNAseq.g19105.t1,peve_ptua,73.636,,,,,,,,,,,,,,,,,
OG_16371,,Peve_00011948,Pocillopora_meandrina_HIv1___TS.g28261.t1,peve_ptua,86.9,,,,,,,,,,,,,,,,,
OG_16372,,Peve_00011965,Pocillopora_meandrina_HIv1___RNAseq.g8000.t1,peve_ptua,56.354,,,,,,,,,,,,,,,,,
OG_16373,,Peve_00011969,Pocillopora_meandrina_HIv1___RNAseq.g8033.t2,peve_ptua,41.505,,,,,,,,,,,,,,,,,
OG_16374,,Peve_00011974,Pocillopora_meandrina_HIv1___RNAseq.g26922.t1,peve_ptua,69.62,,,,,,,,,,,,,,,,,
OG_16375,,Peve_00011976,Pocillopora_meandrina_HIv1___RNAseq.g28059.t1,peve_ptua,33.051,,,,,,,,,,,,,,,,,
OG_16376,,Peve_00011994,Pocillopora_meandrina_HIv1___RNAseq.g20319.t1,peve_ptua,58.156,,,,,,,,,,,,,,,,,
OG_16377,,Peve_00012001,Pocillopora_meandrina_HIv1___RNAseq.g17624.t1,peve_ptua,46.1695,,,,,,,,,,,,,,,,,
OG_16378,,Peve_00012019,Pocillopora_meandrina_HIv1___RNAseq.g28937.t1,peve_ptua,48.8,,,,,,,,,,,,,,,,,
OG_16379,,Peve_00012048,Pocillopora_meandrina_HIv1___RNAseq.g30242.t1,peve_ptua,62.202,,,,,,,,,,,,,,,,,
OG_16380,,Peve_00012086,Pocillopora_meandrina_HIv1___RNAseq.g10676.t2,peve_ptua,63.453,,,,,,,,,,,,,,,,,
OG_16381,,Peve_00012094,Pocillopora_meandrina_HIv1___RNAseq.g4617.t1,peve_ptua,58.47,,,,,,,,,,,,,,,,,
OG_16382,,Peve_00012096,Pocillopora_meandrina_HIv1___TS.g21999.t1,peve_ptua,80.462,,,,,,,,,,,,,,,,,
OG_16383,,Peve_00012112,Pocillopora_meandrina_HIv1___TS.g4407.t1,peve_ptua,66.045,,,,,,,,,,,,,,,,,
OG_16384,,Peve_00012121,Pocillopora_meandrina_HIv1___RNAseq.g1865.t1,peve_ptua,61.747,,,,,,,,,,,,,,,,,
OG_16385,,Peve_00012133,Pocillopora_meandrina_HIv1___RNAseq.g1892.t1,peve_ptua,71.23,,,,,,,,,,,,,,,,,
OG_16386,,Peve_00012145,Pocillopora_meandrina_HIv1___RNAseq.g16778.t1,peve_ptua,72.794,,,,,,,,,,,,,,,,,
OG_16387,,Peve_00012175,Pocillopora_meandrina_HIv1___RNAseq.g3017.t1,peve_ptua,64.628,,,,,,,,,,,,,,,,,
OG_16388,,Peve_00012242,Pocillopora_meandrina_HIv1___RNAseq.g2811.t1,peve_ptua,45.854,,,,,,,,,,,,,,,,,
OG_16389,,Peve_00012296,Pocillopora_meandrina_HIv1___RNAseq.g3618.t1,peve_ptua,70.312,,,,,,,,,,,,,,,,,
OG_16390,,Peve_00012302,Pocillopora_meandrina_HIv1___RNAseq.g5442.t1,peve_ptua,80.157,,,,,,,,,,,,,,,,,
OG_16391,,Peve_00012312,Pocillopora_meandrina_HIv1___RNAseq.g3843.t1,peve_ptua,37.931,,,,,,,,,,,,,,,,,
OG_16392,,Peve_00012334,Pocillopora_meandrina_HIv1___RNAseq.g19010.t1,peve_ptua,50.402,,,,,,,,,,,,,,,,,
OG_16393,,Peve_00012335,Pocillopora_meandrina_HIv1___RNAseq.g7135.t1,peve_ptua,46.875,,,,,,,,,,,,,,,,,
OG_16394,,Peve_00012338,Pocillopora_meandrina_HIv1___RNAseq.g19008.t1b,peve_ptua,52.39,,,,,,,,,,,,,,,,,
OG_16395,,Peve_00012346,Pocillopora_meandrina_HIv1___RNAseq.g20022.t1,peve_ptua,91.829,,,,,,,,,,,,,,,,,
OG_16396,,Peve_00012379,Pocillopora_meandrina_HIv1___RNAseq.g19857.t1,peve_ptua,88.172,,,,,,,,,,,,,,,,,
OG_16397,,Peve_00012399,Pocillopora_meandrina_HIv1___RNAseq.g6594.t2,peve_ptua,56.201,,,,,,,,,,,,,,,,,
OG_16398,,Peve_00012401,Pocillopora_meandrina_HIv1___TS.g329.t1,peve_ptua,58.113,,,,,,,,,,,,,,,,,
OG_16399,,Peve_00012431,Pocillopora_meandrina_HIv1___RNAseq.g4751.t1,peve_ptua,53.03,,,,,,,,,,,,,,,,,
OG_16400,,Peve_00012433,Pocillopora_meandrina_HIv1___RNAseq.g4753.t1,peve_ptua,63.1965,,,,,,,,,,,,,,,,,
OG_16401,,Peve_00012458,Pocillopora_meandrina_HIv1___TS.g29586.t1,peve_ptua,45.859,,,,,,,,,,,,,,,,,
OG_16402,,Peve_00012479,Pocillopora_meandrina_HIv1___RNAseq.g2187.t1,peve_ptua,64.94,,,,,,,,,,,,,,,,,
OG_16403,,Peve_00012486,Pocillopora_meandrina_HIv1___RNAseq.g3997.t1,peve_ptua,59.243,,,,,,,,,,,,,,,,,
OG_16404,,Peve_00012487,Pocillopora_meandrina_HIv1___RNAseq.g29178.t1,peve_ptua,35.7085,,,,,,,,,,,,,,,,,
OG_16405,,Peve_00012506,Pocillopora_meandrina_HIv1___RNAseq.g10934.t1,peve_ptua,41.577,,,,,,,,,,,,,,,,,
OG_16406,,Peve_00012511,Pocillopora_meandrina_HIv1___RNAseq.g5965.t1,peve_ptua,73.891,,,,,,,,,,,,,,,,,
OG_16407,,Peve_00012559,Pocillopora_meandrina_HIv1___RNAseq.g10365.t1,peve_ptua,57.798,,,,,,,,,,,,,,,,,
OG_16408,,Peve_00012576,Pocillopora_meandrina_HIv1___RNAseq.g30189.t1,peve_ptua,64.91300000000001,,,,,,,,,,,,,,,,,
OG_16409,,Peve_00012578,Pocillopora_meandrina_HIv1___RNAseq.g22495.t1,peve_ptua,81.452,,,,,,,,,,,,,,,,,
OG_16410,,Peve_00012585,Pocillopora_meandrina_HIv1___RNAseq.g20350.t1,peve_ptua,76.995,,,,,,,,,,,,,,,,,
OG_16411,,Peve_00012599,Pocillopora_meandrina_HIv1___RNAseq.g29013.t1,peve_ptua,77.8875,,,,,,,,,,,,,,,,,
OG_16412,,Peve_00012606,Pocillopora_meandrina_HIv1___RNAseq.g11979.t1,peve_ptua,64.559,,,,,,,,,,,,,,,,,
OG_16413,,Peve_00012614,Pocillopora_meandrina_HIv1___RNAseq.g21466.t1,peve_ptua,53.659,,,,,,,,,,,,,,,,,
OG_16414,,Peve_00012645,Pocillopora_meandrina_HIv1___RNAseq.g5649.t1,peve_ptua,61.429,,,,,,,,,,,,,,,,,
OG_16415,,Peve_00012652,Pocillopora_meandrina_HIv1___RNAseq.g26238.t1,peve_ptua,79.443,,,,,,,,,,,,,,,,,
OG_16416,,Peve_00012653,Pocillopora_meandrina_HIv1___RNAseq.g26239.t1,peve_ptua,58.904,,,,,,,,,,,,,,,,,
OG_16417,,Peve_00012663,Pocillopora_meandrina_HIv1___RNAseq.g26940.t1,peve_ptua,75.652,,,,,,,,,,,,,,,,,
OG_16418,,Peve_00012708,Pocillopora_meandrina_HIv1___RNAseq.g18946.t1,peve_ptua,57.237,,,,,,,,,,,,,,,,,
OG_16419,,Peve_00012716,Pocillopora_meandrina_HIv1___TS.g24487.t1,peve_ptua,71.505,,,,,,,,,,,,,,,,,
OG_16420,,Peve_00012718,Pocillopora_meandrina_HIv1___RNAseq.g18956.t1,peve_ptua,69.652,,,,,,,,,,,,,,,,,
OG_16421,,Peve_00012737,Pocillopora_meandrina_HIv1___RNAseq.g10941.t1,peve_ptua,99.417,,,,,,,,,,,,,,,,,
OG_16422,,Peve_00012752,Pocillopora_meandrina_HIv1___RNAseq.g17566.t1,peve_ptua,56.2205,,,,,,,,,,,,,,,,,
OG_16423,,Peve_00012786,Pocillopora_meandrina_HIv1___RNAseq.g4946.t1,peve_ptua,74.018,,,,,,,,,,,,,,,,,
OG_16424,,Peve_00012812,Pocillopora_meandrina_HIv1___RNAseq.g5305.t1,peve_ptua,67.593,,,,,,,,,,,,,,,,,
OG_16425,,Peve_00012814,Pocillopora_meandrina_HIv1___TS.g5099.t1,peve_ptua,86.164,,,,,,,,,,,,,,,,,
OG_16426,,Peve_00012822,Pocillopora_meandrina_HIv1___RNAseq.g5275.t1,peve_ptua,67.487,,,,,,,,,,,,,,,,,
OG_16427,,Peve_00012827,Pocillopora_meandrina_HIv1___RNAseq.g5751.t1,peve_ptua,51.613,,,,,,,,,,,,,,,,,
OG_16428,,Peve_00012828,Pocillopora_meandrina_HIv1___RNAseq.g5750.t1,peve_ptua,40.41,,,,,,,,,,,,,,,,,
OG_16429,,Peve_00012838,Pocillopora_meandrina_HIv1___TS.g24459.t1,peve_ptua,57.8715,,,,,,,,,,,,,,,,,
OG_16430,,Peve_00012869,Pocillopora_meandrina_HIv1___RNAseq.g21336.t2,peve_ptua,72.5155,,,,,,,,,,,,,,,,,
OG_16431,,Peve_00012877,Pocillopora_meandrina_HIv1___RNAseq.g13230.t2,peve_ptua,58.429,,,,,,,,,,,,,,,,,
OG_16432,,Peve_00012927,Pocillopora_meandrina_HIv1___RNAseq.g9360.t1,peve_ptua,40.779,,,,,,,,,,,,,,,,,
OG_16433,,Peve_00012974,Pocillopora_meandrina_HIv1___RNAseq.g18009.t1a,peve_ptua,73.077,,,,,,,,,,,,,,,,,
OG_16434,,Peve_00012979,Pocillopora_meandrina_HIv1___TS.g25792.t1,peve_ptua,57.831,,,,,,,,,,,,,,,,,
OG_16435,,Peve_00013003,Pocillopora_meandrina_HIv1___RNAseq.g10477.t1,peve_ptua,43.5075,,,,,,,,,,,,,,,,,
OG_16436,,Peve_00013034,Pocillopora_meandrina_HIv1___RNAseq.g22679.t1,peve_ptua,80.519,,,,,,,,,,,,,,,,,
OG_16437,,Peve_00013076,Pocillopora_meandrina_HIv1___RNAseq.g23342.t1,peve_ptua,41.04,,,,,,,,,,,,,,,,,
OG_16438,,Peve_00013093,Pocillopora_meandrina_HIv1___RNAseq.g2565.t1,peve_ptua,77.551,,,,,,,,,,,,,,,,,
OG_16439,,Peve_00013095,Pocillopora_meandrina_HIv1___RNAseq.g2564.t1,peve_ptua,50.98,,,,,,,,,,,,,,,,,
OG_16440,,Peve_00013096,Pocillopora_meandrina_HIv1___TS.13577_t,peve_ptua,80.556,,,,,,,,,,,,,,,,,
OG_16441,,Peve_00013115,Pocillopora_meandrina_HIv1___RNAseq.g3572.t1,peve_ptua,79.221,,,,,,,,,,,,,,,,,
OG_16442,,Peve_00013116,Pocillopora_meandrina_HIv1___RNAseq.g6254.t1,peve_ptua,44.02,,,,,,,,,,,,,,,,,
OG_16443,,Peve_00013154,Pocillopora_meandrina_HIv1___TS.g16086.t1,peve_ptua,44.483,,,,,,,,,,,,,,,,,
OG_16444,,Peve_00013172,Pocillopora_meandrina_HIv1___RNAseq.g18580.t1a,peve_ptua,62.545,,,,,,,,,,,,,,,,,
OG_16445,,Peve_00013179,Pocillopora_meandrina_HIv1___RNAseq.g28641.t1,peve_ptua,85.052,,,,,,,,,,,,,,,,,
OG_16446,,Peve_00013199,Pocillopora_meandrina_HIv1___RNAseq.g11280.t1,peve_ptua,51.929,,,,,,,,,,,,,,,,,
OG_16447,,Peve_00013223,Pocillopora_meandrina_HIv1___RNAseq.g9306.t1,peve_ptua,77.38650000000001,,,,,,,,,,,,,,,,,
OG_16448,,Peve_00013227,Pocillopora_meandrina_HIv1___TS.g19597.t1,peve_ptua,64.8475,,,,,,,,,,,,,,,,,
OG_16449,,Peve_00013233,Pocillopora_meandrina_HIv1___RNAseq.g9297.t1,peve_ptua,68.272,,,,,,,,,,,,,,,,,
OG_16450,,Peve_00013235,Pocillopora_meandrina_HIv1___RNAseq.g9294.t1,peve_ptua,61.202,,,,,,,,,,,,,,,,,
OG_16451,,Peve_00013240,Pocillopora_meandrina_HIv1___RNAseq.g9413.t1,peve_ptua,63.975,,,,,,,,,,,,,,,,,
OG_16452,,Peve_00013275,Pocillopora_meandrina_HIv1___RNAseq.g10432.t1,peve_ptua,94.444,,,,,,,,,,,,,,,,,
OG_16453,,Peve_00013335,Pocillopora_meandrina_HIv1___RNAseq.g10576.t1,peve_ptua,58.844,,,,,,,,,,,,,,,,,
OG_16454,,Peve_00013361,Pocillopora_meandrina_HIv1___RNAseq.g21546.t1,peve_ptua,52.336,,,,,,,,,,,,,,,,,
OG_16455,,Peve_00013372,Pocillopora_meandrina_HIv1___RNAseq.g21575.t1,peve_ptua,66.901,,,,,,,,,,,,,,,,,
OG_16456,,Peve_00013389,Pocillopora_meandrina_HIv1___RNAseq.g13528.t1,peve_ptua,40.663,,,,,,,,,,,,,,,,,
OG_16457,,Peve_00013402,Pocillopora_meandrina_HIv1___RNAseq.g21960.t1,peve_ptua,55.363,,,,,,,,,,,,,,,,,
OG_16458,,Peve_00013428,Pocillopora_meandrina_HIv1___RNAseq.g22090.t1,peve_ptua,58.025,,,,,,,,,,,,,,,,,
OG_16459,,Peve_00013430,Pocillopora_meandrina_HIv1___TS.g26853.t1,peve_ptua,64.371,,,,,,,,,,,,,,,,,
OG_16460,,Peve_00013431,Pocillopora_meandrina_HIv1___RNAseq.g21482.t1,peve_ptua,79.856,,,,,,,,,,,,,,,,,
OG_16461,,Peve_00013438,Pocillopora_meandrina_HIv1___RNAseq.g22033.t1,peve_ptua,78.698,,,,,,,,,,,,,,,,,
OG_16462,,Peve_00013442,Pocillopora_meandrina_HIv1___RNAseq.g21479.t1,peve_ptua,68.486,,,,,,,,,,,,,,,,,
OG_16463,,Peve_00013445,Pocillopora_meandrina_HIv1___RNAseq.g21477.t1,peve_ptua,76.7895,,,,,,,,,,,,,,,,,
OG_16464,,Peve_00013465,Pocillopora_meandrina_HIv1___RNAseq.g28193.t1,peve_ptua,100.0,,,,,,,,,,,,,,,,,
OG_16465,,Peve_00013469,Pocillopora_meandrina_HIv1___RNAseq.g26460.t1,peve_ptua,42.857,,,,,,,,,,,,,,,,,
OG_16466,,Peve_00013473,Pocillopora_meandrina_HIv1___RNAseq.g26459.t1,peve_ptua,63.5565,,,,,,,,,,,,,,,,,
OG_16467,,Peve_00013504,Pocillopora_meandrina_HIv1___RNAseq.g26528.t1,peve_ptua,88.71,,,,,,,,,,,,,,,,,
OG_16468,,Peve_00013515,Pocillopora_meandrina_HIv1___TS.g7977.t1,peve_ptua,69.587,,,,,,,,,,,,,,,,,
OG_16469,,Peve_00013516,Pocillopora_meandrina_HIv1___RNAseq.g28200.t1,peve_ptua,49.559,,,,,,,,,,,,,,,,,
OG_16470,,Peve_00013536,Pocillopora_meandrina_HIv1___TS.g18896.t1,peve_ptua,66.246,,,,,,,,,,,,,,,,,
OG_16471,,Peve_00013546,Pocillopora_meandrina_HIv1___TS.g9950.t1,peve_ptua,41.935,,,,,,,,,,,,,,,,,
OG_16472,,Peve_00013550,Pocillopora_meandrina_HIv1___RNAseq.g5929.t1,peve_ptua,100.0,,,,,,,,,,,,,,,,,
OG_16473,,Peve_00013569,Pocillopora_meandrina_HIv1___RNAseq.g5942.t1,peve_ptua,74.419,,,,,,,,,,,,,,,,,
OG_16474,,Peve_00013576,Pocillopora_meandrina_HIv1___RNAseq.g5955.t1b,peve_ptua,54.443,,,,,,,,,,,,,,,,,
OG_16475,,Peve_00013598,Pocillopora_meandrina_HIv1___RNAseq.g13547.t1,peve_ptua,46.1865,,,,,,,,,,,,,,,,,
OG_16476,,Peve_00013616,Pocillopora_meandrina_HIv1___RNAseq.g18888.t1,peve_ptua,61.4845,,,,,,,,,,,,,,,,,
OG_16477,,Peve_00013620,Pocillopora_meandrina_HIv1___TS.g28274.t1,peve_ptua,82.776,,,,,,,,,,,,,,,,,
OG_16478,,Peve_00013669,Pocillopora_meandrina_HIv1___TS.g8036.t1,peve_ptua,55.165,,,,,,,,,,,,,,,,,
OG_16479,,Peve_00013713,Pocillopora_meandrina_HIv1___RNAseq.g8587.t1,peve_ptua,62.581,,,,,,,,,,,,,,,,,
OG_16480,,Peve_00013734,Pocillopora_meandrina_HIv1___RNAseq.g24063.t1,peve_ptua,66.207,,,,,,,,,,,,,,,,,
OG_16481,,Peve_00013743,Pocillopora_meandrina_HIv1___RNAseq.g23412.t1,peve_ptua,60.062,,,,,,,,,,,,,,,,,
OG_16482,,Peve_00013749,Pocillopora_meandrina_HIv1___RNAseq.g25405.t1,peve_ptua,76.562,,,,,,,,,,,,,,,,,
OG_16483,,Peve_00013783,Pocillopora_meandrina_HIv1___RNAseq.g9050.t1,peve_ptua,66.438,,,,,,,,,,,,,,,,,
OG_16484,,Peve_00013798,Pocillopora_meandrina_HIv1___RNAseq.g24274.t1,peve_ptua,90.909,,,,,,,,,,,,,,,,,
OG_16485,,Peve_00013808,Pocillopora_meandrina_HIv1___RNAseq.g23026.t1,peve_ptua,69.5735,,,,,,,,,,,,,,,,,
OG_16486,,Peve_00013821,Pocillopora_meandrina_HIv1___RNAseq.g387.t1,peve_ptua,49.505,,,,,,,,,,,,,,,,,
OG_16487,,Peve_00013825,Pocillopora_meandrina_HIv1___RNAseq.g4591.t1,peve_ptua,33.594,,,,,,,,,,,,,,,,,
OG_16488,,Peve_00013841,Pocillopora_meandrina_HIv1___RNAseq.g4231.t1,peve_ptua,49.658,,,,,,,,,,,,,,,,,
OG_16489,,Peve_00013849,Pocillopora_meandrina_HIv1___RNAseq.g29943.t1,peve_ptua,38.703,,,,,,,,,,,,,,,,,
OG_16490,,Peve_00013854,Pocillopora_meandrina_HIv1___RNAseq.g8940.t1,peve_ptua,67.5,,,,,,,,,,,,,,,,,
OG_16491,,Peve_00013870,Pocillopora_meandrina_HIv1___TS.g9845.t1,peve_ptua,32.402,,,,,,,,,,,,,,,,,
OG_16492,,Peve_00013883,Pocillopora_meandrina_HIv1___RNAseq.g22639.t1,peve_ptua,97.222,,,,,,,,,,,,,,,,,
OG_16493,,Peve_00013898,Pocillopora_meandrina_HIv1___RNAseq.g10055.t1,peve_ptua,44.737,,,,,,,,,,,,,,,,,
OG_16494,,Peve_00013900,Pocillopora_meandrina_HIv1___RNAseq.g2019.t1,peve_ptua,66.92,,,,,,,,,,,,,,,,,
OG_16495,,Peve_00013921,Pocillopora_meandrina_HIv1___RNAseq.g8025.t1,peve_ptua,54.956500000000005,,,,,,,,,,,,,,,,,
OG_16496,,Peve_00013938,Pocillopora_meandrina_HIv1___RNAseq.g505.t1,peve_ptua,60.219,,,,,,,,,,,,,,,,,
OG_16497,,Peve_00013948,Pocillopora_meandrina_HIv1___RNAseq.g23424.t1,peve_ptua,49.488,,,,,,,,,,,,,,,,,
OG_16498,,Peve_00013949,Pocillopora_meandrina_HIv1___RNAseq.g28507.t1,peve_ptua,37.4755,,,,,,,,,,,,,,,,,
OG_16499,,Peve_00013961,Pocillopora_meandrina_HIv1___RNAseq.g28515.t2b,peve_ptua,66.961,,,,,,,,,,,,,,,,,
OG_16500,,Peve_00013968,Pocillopora_meandrina_HIv1___RNAseq.g28517.t1,peve_ptua,58.286,,,,,,,,,,,,,,,,,
OG_16501,,Peve_00013998,Pocillopora_meandrina_HIv1___RNAseq.g26341.t1,peve_ptua,55.916,,,,,,,,,,,,,,,,,
OG_16502,,Peve_00014002,Pocillopora_meandrina_HIv1___TS.g3893.t1,peve_ptua,31.185,,,,,,,,,,,,,,,,,
OG_16503,,Peve_00014005,Pocillopora_meandrina_HIv1___RNAseq.g14741.t1,peve_ptua,41.033,,,,,,,,,,,,,,,,,
OG_16504,,Peve_00014021,Pocillopora_meandrina_HIv1___RNAseq.g4601.t1,peve_ptua,86.0085,,,,,,,,,,,,,,,,,
OG_16505,,Peve_00014027,Pocillopora_meandrina_HIv1___RNAseq.g28842.t1,peve_ptua,45.033,,,,,,,,,,,,,,,,,
OG_16506,,Peve_00014037,Pocillopora_meandrina_HIv1___TS.g10251.t1,peve_ptua,67.073,,,,,,,,,,,,,,,,,
OG_16507,,Peve_00014043,Pocillopora_meandrina_HIv1___RNAseq.g9353.t1,peve_ptua,45.455,,,,,,,,,,,,,,,,,
OG_16508,,Peve_00014067,Pocillopora_meandrina_HIv1___TS.g22754.t1,peve_ptua,48.299,,,,,,,,,,,,,,,,,
OG_16509,,Peve_00014141,Pocillopora_meandrina_HIv1___RNAseq.g17750.t1,peve_ptua,70.723,,,,,,,,,,,,,,,,,
OG_16510,,Peve_00014147,Pocillopora_meandrina_HIv1___TS.g17303.t1,peve_ptua,56.213,,,,,,,,,,,,,,,,,
OG_16511,,Peve_00014151,Pocillopora_meandrina_HIv1___RNAseq.g17725.t1,peve_ptua,74.295,,,,,,,,,,,,,,,,,
OG_16512,,Peve_00014217,Pocillopora_meandrina_HIv1___RNAseq.g364.t1,peve_ptua,60.55,,,,,,,,,,,,,,,,,
OG_16513,,Peve_00014245,Pocillopora_meandrina_HIv1___RNAseq.g4096.t1,peve_ptua,75.362,,,,,,,,,,,,,,,,,
OG_16514,,Peve_00014261,Pocillopora_meandrina_HIv1___RNAseq.g29151.t1,peve_ptua,77.713,,,,,,,,,,,,,,,,,
OG_16515,,Peve_00014285,Pocillopora_meandrina_HIv1___RNAseq.g29666.t1,peve_ptua,35.432,,,,,,,,,,,,,,,,,
OG_16516,,Peve_00014299,Pocillopora_meandrina_HIv1___RNAseq.g22210.t1,peve_ptua,66.86,,,,,,,,,,,,,,,,,
OG_16517,,Peve_00014302,Pocillopora_meandrina_HIv1___RNAseq.g22206.t1,peve_ptua,66.99,,,,,,,,,,,,,,,,,
OG_16518,,Peve_00014309,Pocillopora_meandrina_HIv1___RNAseq.g261.t1,peve_ptua,43.7745,,,,,,,,,,,,,,,,,
OG_16519,,Peve_00014325,Pocillopora_meandrina_HIv1___RNAseq.g1484.t1,peve_ptua,74.236,,,,,,,,,,,,,,,,,
OG_16520,,Peve_00014359,Pocillopora_meandrina_HIv1___RNAseq.g28613.t1,peve_ptua,91.241,,,,,,,,,,,,,,,,,
OG_16521,,Peve_00014363,Pocillopora_meandrina_HIv1___RNAseq.g5894.t1a,peve_ptua,61.538,,,,,,,,,,,,,,,,,
OG_16522,,Peve_00014406,Pocillopora_meandrina_HIv1___RNAseq.g28523.t1,peve_ptua,72.869,,,,,,,,,,,,,,,,,
OG_16523,,Peve_00014410,Pocillopora_meandrina_HIv1___TS.g22579.t1,peve_ptua,48.101,,,,,,,,,,,,,,,,,
OG_16524,,Peve_00014478,Pocillopora_meandrina_HIv1___RNAseq.g27717.t1,peve_ptua,63.789,,,,,,,,,,,,,,,,,
OG_16525,,Peve_00014480,Pocillopora_meandrina_HIv1___RNAseq.g5705.t1,peve_ptua,59.8215,,,,,,,,,,,,,,,,,
OG_16526,,Peve_00014483,Pocillopora_meandrina_HIv1___RNAseq.g5703.t1,peve_ptua,76.604,,,,,,,,,,,,,,,,,
OG_16527,,Peve_00014506,Pocillopora_meandrina_HIv1___RNAseq.g22657.t1,peve_ptua,59.226,,,,,,,,,,,,,,,,,
OG_16528,,Peve_00014515,Pocillopora_meandrina_HIv1___TS.g24952.t1,peve_ptua,54.2225,,,,,,,,,,,,,,,,,
OG_16529,,Peve_00014523,Pocillopora_meandrina_HIv1___RNAseq.g29695.t1,peve_ptua,54.249,,,,,,,,,,,,,,,,,
OG_16530,,Peve_00014532,Pocillopora_meandrina_HIv1___RNAseq.g24989.t1,peve_ptua,70.33,,,,,,,,,,,,,,,,,
OG_16531,,Peve_00014538,Pocillopora_meandrina_HIv1___TS.g12933.t1c,peve_ptua,35.071,,,,,,,,,,,,,,,,,
OG_16532,,Peve_00014551,Pocillopora_meandrina_HIv1___RNAseq.g17074.t2,peve_ptua,60.892,,,,,,,,,,,,,,,,,
OG_16533,,Peve_00014599,Pocillopora_meandrina_HIv1___RNAseq.g22433.t1,peve_ptua,52.349,,,,,,,,,,,,,,,,,
OG_16534,,Peve_00014602,Pocillopora_meandrina_HIv1___TS.g27327.t1,peve_ptua,94.178,,,,,,,,,,,,,,,,,
OG_16535,,Peve_00014603,Pocillopora_meandrina_HIv1___RNAseq.g22564.t1,peve_ptua,38.564,,,,,,,,,,,,,,,,,
OG_16536,,Peve_00014617,Pocillopora_meandrina_HIv1___RNAseq.g15477.t1,peve_ptua,66.023,,,,,,,,,,,,,,,,,
OG_16537,,Peve_00014625,Pocillopora_meandrina_HIv1___RNAseq.g8248.t1,peve_ptua,66.759,,,,,,,,,,,,,,,,,
OG_16538,,Peve_00014641,Pocillopora_meandrina_HIv1___TS.g12810.t1b,peve_ptua,73.984,,,,,,,,,,,,,,,,,
OG_16539,,Peve_00014651,Pocillopora_meandrina_HIv1___RNAseq.g12145.t1,peve_ptua,67.284,,,,,,,,,,,,,,,,,
OG_16540,,Peve_00014669,Pocillopora_meandrina_HIv1___RNAseq.g19197.t1,peve_ptua,51.6295,,,,,,,,,,,,,,,,,
OG_16541,,Peve_00014676,Pocillopora_meandrina_HIv1___RNAseq.g246.t1,peve_ptua,76.19,,,,,,,,,,,,,,,,,
OG_16542,,Peve_00014693,Pocillopora_meandrina_HIv1___RNAseq.g26717.t1,peve_ptua,81.034,,,,,,,,,,,,,,,,,
OG_16543,,Peve_00014712,Pocillopora_meandrina_HIv1___RNAseq.g23567.t1,peve_ptua,41.045,,,,,,,,,,,,,,,,,
OG_16544,,Peve_00014736,Pocillopora_meandrina_HIv1___TS.g6449.t1,peve_ptua,61.026,,,,,,,,,,,,,,,,,
OG_16545,,Peve_00014743,Pocillopora_meandrina_HIv1___RNAseq.g23960.t1,peve_ptua,59.406,,,,,,,,,,,,,,,,,
OG_16546,,Peve_00014771,Pocillopora_meandrina_HIv1___TS.g8871.t1,peve_ptua,54.902,,,,,,,,,,,,,,,,,
OG_16547,,Peve_00014841,Pocillopora_meandrina_HIv1___RNAseq.g16033.t1,peve_ptua,81.579,,,,,,,,,,,,,,,,,
OG_16548,,Peve_00014853,Pocillopora_meandrina_HIv1___RNAseq.g17098.t1,peve_ptua,51.979,,,,,,,,,,,,,,,,,
OG_16549,,Peve_00014854,Pocillopora_meandrina_HIv1___RNAseq.g17099.t1,peve_ptua,63.711,,,,,,,,,,,,,,,,,
OG_16550,,Peve_00014858,Pocillopora_meandrina_HIv1___RNAseq.g10287.t1,peve_ptua,51.544,,,,,,,,,,,,,,,,,
OG_16551,,Peve_00014863,Pocillopora_meandrina_HIv1___RNAseq.g22689.t1a,peve_ptua,32.653,,,,,,,,,,,,,,,,,
OG_16552,,Peve_00014930,Pocillopora_meandrina_HIv1___RNAseq.g7286.t1,peve_ptua,56.471,,,,,,,,,,,,,,,,,
OG_16553,,Peve_00014940,Pocillopora_meandrina_HIv1___RNAseq.g4609.t1b,peve_ptua,89.9005,,,,,,,,,,,,,,,,,
OG_16554,,Peve_00014943,Pocillopora_meandrina_HIv1___RNAseq.19082_t,peve_ptua,65.891,,,,,,,,,,,,,,,,,
OG_16555,,Peve_00014988,Pocillopora_meandrina_HIv1___RNAseq.g13539.t1,peve_ptua,58.81,,,,,,,,,,,,,,,,,
OG_16556,,Peve_00015026,Pocillopora_meandrina_HIv1___RNAseq.g4155.t1,peve_ptua,78.974,,,,,,,,,,,,,,,,,
OG_16557,,Peve_00015027,Pocillopora_meandrina_HIv1___RNAseq.g4151.t1,peve_ptua,65.1705,,,,,,,,,,,,,,,,,
OG_16558,,Peve_00015054,Pocillopora_meandrina_HIv1___RNAseq.g19788.t1,peve_ptua,64.019,,,,,,,,,,,,,,,,,
OG_16559,,Peve_00015068,Pocillopora_meandrina_HIv1___RNAseq.g28992.t2,peve_ptua,51.247,,,,,,,,,,,,,,,,,
OG_16560,,Peve_00015071,Pocillopora_meandrina_HIv1___TS.g28504.t1,peve_ptua,30.407,,,,,,,,,,,,,,,,,
OG_16561,,Peve_00015075,Pocillopora_meandrina_HIv1___RNAseq.g19116.t1,peve_ptua,32.331500000000005,,,,,,,,,,,,,,,,,
OG_16562,,Peve_00015109,Pocillopora_meandrina_HIv1___RNAseq.g5672.t1,peve_ptua,80.769,,,,,,,,,,,,,,,,,
OG_16563,,Peve_00015145,Pocillopora_meandrina_HIv1___RNAseq.g15974.t1,peve_ptua,61.972,,,,,,,,,,,,,,,,,
OG_16564,,Peve_00015147,Pocillopora_meandrina_HIv1___RNAseq.g11574.t1,peve_ptua,89.549,,,,,,,,,,,,,,,,,
OG_16565,,Peve_00015169,Pocillopora_meandrina_HIv1___TS.g8931.t1,peve_ptua,78.862,,,,,,,,,,,,,,,,,
OG_16566,,Peve_00015197,Pocillopora_meandrina_HIv1___RNAseq.g11910.t1b,peve_ptua,57.297,,,,,,,,,,,,,,,,,
OG_16567,,Peve_00015199,Pocillopora_meandrina_HIv1___RNAseq.g1839.t1,peve_ptua,50.0,,,,,,,,,,,,,,,,,
OG_16568,,Peve_00015259,Pocillopora_meandrina_HIv1___RNAseq.g13929.t1,peve_ptua,67.532,,,,,,,,,,,,,,,,,
OG_16569,,Peve_00015264,Pocillopora_meandrina_HIv1___RNAseq.g15527.t1,peve_ptua,68.493,,,,,,,,,,,,,,,,,
OG_16570,,Peve_00015282,Pocillopora_meandrina_HIv1___RNAseq.g29170.t1,peve_ptua,43.774,,,,,,,,,,,,,,,,,
OG_16571,,Peve_00015331,Pocillopora_meandrina_HIv1___RNAseq.g22819.t1,peve_ptua,67.876,,,,,,,,,,,,,,,,,
OG_16572,,Peve_00015346,Pocillopora_meandrina_HIv1___TS.g18044.t1,peve_ptua,68.261,,,,,,,,,,,,,,,,,
OG_16573,,Peve_00015353,Pocillopora_meandrina_HIv1___RNAseq.g18558.t1,peve_ptua,42.1495,,,,,,,,,,,,,,,,,
OG_16574,,Peve_00015358,Pocillopora_meandrina_HIv1___RNAseq.g18545.t1,peve_ptua,59.528,,,,,,,,,,,,,,,,,
OG_16575,,Peve_00015365,Pocillopora_meandrina_HIv1___RNAseq.g9169.t1,peve_ptua,48.973,,,,,,,,,,,,,,,,,
OG_16576,,Peve_00015370,Pocillopora_meandrina_HIv1___RNAseq.g17781.t1,peve_ptua,43.728,,,,,,,,,,,,,,,,,
OG_16577,,Peve_00015405,Pocillopora_meandrina_HIv1___RNAseq.g6476.t1,peve_ptua,45.455,,,,,,,,,,,,,,,,,
OG_16578,,Peve_00015409,Pocillopora_meandrina_HIv1___RNAseq.g6472.t1,peve_ptua,36.194,,,,,,,,,,,,,,,,,
OG_16579,,Peve_00015448,Pocillopora_meandrina_HIv1___RNAseq.26738_t,peve_ptua,62.452,,,,,,,,,,,,,,,,,
OG_16580,,Peve_00015455,Pocillopora_meandrina_HIv1___TS.g15521.t1,peve_ptua,52.5,,,,,,,,,,,,,,,,,
OG_16581,,Peve_00015493,Pocillopora_meandrina_HIv1___RNAseq.g23759.t1,peve_ptua,56.025,,,,,,,,,,,,,,,,,
OG_16582,,Peve_00015503,Pocillopora_meandrina_HIv1___RNAseq.g9500.t1,peve_ptua,30.3055,,,,,,,,,,,,,,,,,
OG_16583,,Peve_00015525,Pocillopora_meandrina_HIv1___RNAseq.g29661.t1,peve_ptua,64.143,,,,,,,,,,,,,,,,,
OG_16584,,Peve_00015550,Pocillopora_meandrina_HIv1___RNAseq.g9911.t1,peve_ptua,56.229,,,,,,,,,,,,,,,,,
OG_16585,,Peve_00015572,Pocillopora_meandrina_HIv1___RNAseq.g24468.t1,peve_ptua,58.992,,,,,,,,,,,,,,,,,
OG_16586,,Peve_00015573,Pocillopora_meandrina_HIv1___RNAseq.g24469.t1,peve_ptua,63.2835,,,,,,,,,,,,,,,,,
OG_16587,,Peve_00015585,Pocillopora_meandrina_HIv1___RNAseq.g24840.t1,peve_ptua,30.682,,,,,,,,,,,,,,,,,
OG_16588,,Peve_00015593,Pocillopora_meandrina_HIv1___RNAseq.g27378.t1,peve_ptua,74.009,,,,,,,,,,,,,,,,,
OG_16589,,Peve_00015603,Pocillopora_meandrina_HIv1___RNAseq.g24436.t1,peve_ptua,51.967,,,,,,,,,,,,,,,,,
OG_16590,,Peve_00015617,Pocillopora_meandrina_HIv1___TS.g29658.t1,peve_ptua,84.936,,,,,,,,,,,,,,,,,
OG_16591,,Peve_00015631,Pocillopora_meandrina_HIv1___RNAseq.g25143.t1,peve_ptua,63.281,,,,,,,,,,,,,,,,,
OG_16592,,Peve_00015650,Pocillopora_meandrina_HIv1___RNAseq.g23895.t1,peve_ptua,72.872,,,,,,,,,,,,,,,,,
OG_16593,,Peve_00015669,Pocillopora_meandrina_HIv1___RNAseq.g25200.t1,peve_ptua,67.1225,,,,,,,,,,,,,,,,,
OG_16594,,Peve_00015677,Pocillopora_meandrina_HIv1___RNAseq.g7392.t1a,peve_ptua,58.647,,,,,,,,,,,,,,,,,
OG_16595,,Peve_00015683,Pocillopora_meandrina_HIv1___RNAseq.g27554.t1,peve_ptua,77.083,,,,,,,,,,,,,,,,,
OG_16596,,Peve_00015685,Pocillopora_meandrina_HIv1___RNAseq.g27556.t1,peve_ptua,75.287,,,,,,,,,,,,,,,,,
OG_16597,,Peve_00015743,Pocillopora_meandrina_HIv1___TS.g26027.t1a,peve_ptua,67.834,,,,,,,,,,,,,,,,,
OG_16598,,Peve_00015753,Pocillopora_meandrina_HIv1___RNAseq.g19667.t1,peve_ptua,93.955,,,,,,,,,,,,,,,,,
OG_16599,,Peve_00015761,Pocillopora_meandrina_HIv1___RNAseq.g19673.t1,peve_ptua,43.6,,,,,,,,,,,,,,,,,
OG_16600,,Peve_00015768,Pocillopora_meandrina_HIv1___RNAseq.g19678.t1,peve_ptua,72.84,,,,,,,,,,,,,,,,,
OG_16601,,Peve_00015821,Pocillopora_meandrina_HIv1___RNAseq.g7902.t1,peve_ptua,72.692,,,,,,,,,,,,,,,,,
OG_16602,,Peve_00015823,Pocillopora_meandrina_HIv1___RNAseq.g19970.t1,peve_ptua,49.511,,,,,,,,,,,,,,,,,
OG_16603,,Peve_00015826,Pocillopora_meandrina_HIv1___RNAseq.g19962.t1,peve_ptua,45.748,,,,,,,,,,,,,,,,,
OG_16604,,Peve_00015827,Pocillopora_meandrina_HIv1___RNAseq.g19963.t1,peve_ptua,31.496,,,,,,,,,,,,,,,,,
OG_16605,,Peve_00015830,Pocillopora_meandrina_HIv1___RNAseq.g19959.t1,peve_ptua,80.902,,,,,,,,,,,,,,,,,
OG_16606,,Peve_00015843,Pocillopora_meandrina_HIv1___RNAseq.g7406.t1,peve_ptua,85.47,,,,,,,,,,,,,,,,,
OG_16607,,Peve_00015855,Pocillopora_meandrina_HIv1___RNAseq.g8642.t1,peve_ptua,68.619,,,,,,,,,,,,,,,,,
OG_16608,,Peve_00015892,Pocillopora_meandrina_HIv1___RNAseq.g757.t1,peve_ptua,87.037,,,,,,,,,,,,,,,,,
OG_16609,,Peve_00015895,Pocillopora_meandrina_HIv1___RNAseq.g23338.t1,peve_ptua,59.02,,,,,,,,,,,,,,,,,
OG_16610,,Peve_00015935,Pocillopora_meandrina_HIv1___RNAseq.g17175.t1,peve_ptua,62.252,,,,,,,,,,,,,,,,,
OG_16611,,Peve_00015977,Pocillopora_meandrina_HIv1___RNAseq.g1624.t1,peve_ptua,50.554,,,,,,,,,,,,,,,,,
OG_16612,,Peve_00015989,Pocillopora_meandrina_HIv1___RNAseq.g22983.t2a,peve_ptua,69.231,,,,,,,,,,,,,,,,,
OG_16613,,Peve_00016005,Pocillopora_meandrina_HIv1___RNAseq.g16828.t1,peve_ptua,79.11500000000001,,,,,,,,,,,,,,,,,
OG_16614,,Peve_00016006,Pocillopora_meandrina_HIv1___RNAseq.g16826.t1,peve_ptua,59.979,,,,,,,,,,,,,,,,,
OG_16615,,Peve_00016007,Pocillopora_meandrina_HIv1___RNAseq.g16846.t1,peve_ptua,68.966,,,,,,,,,,,,,,,,,
OG_16616,,Peve_00016009,Pocillopora_meandrina_HIv1___RNAseq.g16881.t1,peve_ptua,82.5,,,,,,,,,,,,,,,,,
OG_16617,,Peve_00016011,Pocillopora_meandrina_HIv1___RNAseq.g11210.t1,peve_ptua,42.045,,,,,,,,,,,,,,,,,
OG_16618,,Peve_00016012,Pocillopora_meandrina_HIv1___RNAseq.g16878.t1,peve_ptua,50.583,,,,,,,,,,,,,,,,,
OG_16619,,Peve_00016027,Pocillopora_meandrina_HIv1___RNAseq.g3736.t1,peve_ptua,71.875,,,,,,,,,,,,,,,,,
OG_16620,,Peve_00016043,Pocillopora_meandrina_HIv1___RNAseq.g8229.t1,peve_ptua,74.074,,,,,,,,,,,,,,,,,
OG_16621,,Peve_00016054,Pocillopora_meandrina_HIv1___RNAseq.g21976.t1,peve_ptua,85.714,,,,,,,,,,,,,,,,,
OG_16622,,Peve_00016074,Pocillopora_meandrina_HIv1___RNAseq.g10690.t1,peve_ptua,63.964,,,,,,,,,,,,,,,,,
OG_16623,,Peve_00016088,Pocillopora_meandrina_HIv1___RNAseq.g5223.t1,peve_ptua,66.525,,,,,,,,,,,,,,,,,
OG_16624,,Peve_00016091,Pocillopora_meandrina_HIv1___RNAseq.g5224.t1,peve_ptua,46.467,,,,,,,,,,,,,,,,,
OG_16625,,Peve_00016096,Pocillopora_meandrina_HIv1___RNAseq.g17549.t1,peve_ptua,62.054,,,,,,,,,,,,,,,,,
OG_16626,,Peve_00016100,Pocillopora_meandrina_HIv1___RNAseq.g17554.t1,peve_ptua,59.74,,,,,,,,,,,,,,,,,
OG_16627,,Peve_00016142,Pocillopora_meandrina_HIv1___RNAseq.g19691.t1,peve_ptua,37.221,,,,,,,,,,,,,,,,,
OG_16628,,Peve_00016209,Pocillopora_meandrina_HIv1___RNAseq.g12223.t1,peve_ptua,42.975,,,,,,,,,,,,,,,,,
OG_16629,,Peve_00016224,Pocillopora_meandrina_HIv1___RNAseq.g12237.t1,peve_ptua,49.951,,,,,,,,,,,,,,,,,
OG_16630,,Peve_00016257,Pocillopora_meandrina_HIv1___RNAseq.g710.t1,peve_ptua,62.535,,,,,,,,,,,,,,,,,
OG_16631,,Peve_00016287,Pocillopora_meandrina_HIv1___RNAseq.g10821.t1,peve_ptua,68.323,,,,,,,,,,,,,,,,,
OG_16632,,Peve_00016308,Pocillopora_meandrina_HIv1___RNAseq.g18923.t1,peve_ptua,79.08,,,,,,,,,,,,,,,,,
OG_16633,,Peve_00016313,Pocillopora_meandrina_HIv1___RNAseq.g17130.t1,peve_ptua,62.252,,,,,,,,,,,,,,,,,
OG_16634,,Peve_00016316,Pocillopora_meandrina_HIv1___TS.g28316.t1,peve_ptua,48.496,,,,,,,,,,,,,,,,,
OG_16635,,Peve_00016335,Pocillopora_meandrina_HIv1___RNAseq.g2918.t1,peve_ptua,57.225,,,,,,,,,,,,,,,,,
OG_16636,,Peve_00016392,Pocillopora_meandrina_HIv1___TS.g5095.t1c,peve_ptua,49.231,,,,,,,,,,,,,,,,,
OG_16637,,Peve_00016428,Pocillopora_meandrina_HIv1___RNAseq.g9831.t1,peve_ptua,72.803,,,,,,,,,,,,,,,,,
OG_16638,,Peve_00016441,Pocillopora_meandrina_HIv1___RNAseq.g2014.t1,peve_ptua,36.196,,,,,,,,,,,,,,,,,
OG_16639,,Peve_00016465,Pocillopora_meandrina_HIv1___TS.g10245.t1,peve_ptua,54.335,,,,,,,,,,,,,,,,,
OG_16640,,Peve_00016468,Pocillopora_meandrina_HIv1___RNAseq.g15216.t1,peve_ptua,77.8615,,,,,,,,,,,,,,,,,
OG_16641,,Peve_00016498,Pocillopora_meandrina_HIv1___RNAseq.g17509.t1,peve_ptua,38.491,,,,,,,,,,,,,,,,,
OG_16642,,Peve_00016508,Pocillopora_meandrina_HIv1___TS.g7903.t1,peve_ptua,67.931,,,,,,,,,,,,,,,,,
OG_16643,,Peve_00016520,Pocillopora_meandrina_HIv1___RNAseq.22446_t,peve_ptua,50.0,,,,,,,,,,,,,,,,,
OG_16644,,Peve_00016528,Pocillopora_meandrina_HIv1___RNAseq.g12551.t1,peve_ptua,44.428,,,,,,,,,,,,,,,,,
OG_16645,,Peve_00016541,Pocillopora_meandrina_HIv1___RNAseq.g12504.t1,peve_ptua,37.348,,,,,,,,,,,,,,,,,
OG_16646,,Peve_00016544,Pocillopora_meandrina_HIv1___RNAseq.g12525.t1,peve_ptua,73.653,,,,,,,,,,,,,,,,,
OG_16647,,Peve_00016547,Pocillopora_meandrina_HIv1___RNAseq.g12526.t1,peve_ptua,58.553,,,,,,,,,,,,,,,,,
OG_16648,,Peve_00016548,Pocillopora_meandrina_HIv1___RNAseq.g12527.t1,peve_ptua,65.134,,,,,,,,,,,,,,,,,
OG_16649,,Peve_00016549,Pocillopora_meandrina_HIv1___RNAseq.g12528.t1,peve_ptua,45.978,,,,,,,,,,,,,,,,,
OG_16650,,Peve_00016553,Pocillopora_meandrina_HIv1___RNAseq.g3165.t1,peve_ptua,38.843,,,,,,,,,,,,,,,,,
OG_16651,,Peve_00016575,Pocillopora_meandrina_HIv1___TS.g10182.t1b,peve_ptua,83.537,,,,,,,,,,,,,,,,,
OG_16652,,Peve_00016576,Pocillopora_meandrina_HIv1___TS.g10182.t1a,peve_ptua,67.91,,,,,,,,,,,,,,,,,
OG_16653,,Peve_00016621,Pocillopora_meandrina_HIv1___RNAseq.g9279.t1,peve_ptua,84.0,,,,,,,,,,,,,,,,,
OG_16654,,Peve_00016632,Pocillopora_meandrina_HIv1___RNAseq.g26471.t1,peve_ptua,43.019,,,,,,,,,,,,,,,,,
OG_16655,,Peve_00016634,Pocillopora_meandrina_HIv1___TS.g23123.t1,peve_ptua,57.8445,,,,,,,,,,,,,,,,,
OG_16656,,Peve_00016635,Pocillopora_meandrina_HIv1___RNAseq.g9591.t1,peve_ptua,50.416,,,,,,,,,,,,,,,,,
OG_16657,,Peve_00016659,Pocillopora_meandrina_HIv1___RNAseq.g8972.t1,peve_ptua,85.986,,,,,,,,,,,,,,,,,
OG_16658,,Peve_00016665,Pocillopora_meandrina_HIv1___RNAseq.g6926.t1,peve_ptua,45.724,,,,,,,,,,,,,,,,,
OG_16659,,Peve_00016701,Pocillopora_meandrina_HIv1___TS.g18042.t2,peve_ptua,56.728,,,,,,,,,,,,,,,,,
OG_16660,,Peve_00016706,Pocillopora_meandrina_HIv1___TS.g20432.t1,peve_ptua,36.032,,,,,,,,,,,,,,,,,
OG_16661,,Peve_00016725,Pocillopora_meandrina_HIv1___RNAseq.g8304.t1,peve_ptua,76.071,,,,,,,,,,,,,,,,,
OG_16662,,Peve_00016726,Pocillopora_meandrina_HIv1___RNAseq.g8305.t1,peve_ptua,63.8105,,,,,,,,,,,,,,,,,
OG_16663,,Peve_00016764,Pocillopora_meandrina_HIv1___RNAseq.g14870.t1,peve_ptua,73.42750000000001,,,,,,,,,,,,,,,,,
OG_16664,,Peve_00016774,Pocillopora_meandrina_HIv1___RNAseq.g19709.t1,peve_ptua,80.788,,,,,,,,,,,,,,,,,
OG_16665,,Peve_00016783,Pocillopora_meandrina_HIv1___RNAseq.g22571.t1,peve_ptua,57.9375,,,,,,,,,,,,,,,,,
OG_16666,,Peve_00016799,Pocillopora_meandrina_HIv1___RNAseq.g8828.t1,peve_ptua,73.579,,,,,,,,,,,,,,,,,
OG_16667,,Peve_00016810,Pocillopora_meandrina_HIv1___RNAseq.g168.t1,peve_ptua,78.261,,,,,,,,,,,,,,,,,
OG_16668,,Peve_00016821,Pocillopora_meandrina_HIv1___RNAseq.g22862.t1,peve_ptua,32.947,,,,,,,,,,,,,,,,,
OG_16669,,Peve_00016823,Pocillopora_meandrina_HIv1___RNAseq.g22860.t1,peve_ptua,76.741,,,,,,,,,,,,,,,,,
OG_16670,,Peve_00016868,Pocillopora_meandrina_HIv1___RNAseq.g850.t1,peve_ptua,45.441,,,,,,,,,,,,,,,,,
OG_16671,,Peve_00016917,Pocillopora_meandrina_HIv1___TS.g19804.t1,peve_ptua,88.587,,,,,,,,,,,,,,,,,
OG_16672,,Peve_00016947,Pocillopora_meandrina_HIv1___RNAseq.g27181.t1,peve_ptua,65.73,,,,,,,,,,,,,,,,,
OG_16673,,Peve_00016959,Pocillopora_meandrina_HIv1___RNAseq.g13234.t1,peve_ptua,49.4165,,,,,,,,,,,,,,,,,
OG_16674,,Peve_00016967,Pocillopora_meandrina_HIv1___RNAseq.g21794.t1,peve_ptua,34.968500000000006,,,,,,,,,,,,,,,,,
OG_16675,,Peve_00016969,Pocillopora_meandrina_HIv1___RNAseq.g10254.t1,peve_ptua,56.702,,,,,,,,,,,,,,,,,
OG_16676,,Peve_00016981,Pocillopora_meandrina_HIv1___RNAseq.g842.t1,peve_ptua,38.7795,,,,,,,,,,,,,,,,,
OG_16677,,Peve_00017018,Pocillopora_meandrina_HIv1___RNAseq.g27000.t1,peve_ptua,58.065,,,,,,,,,,,,,,,,,
OG_16678,,Peve_00017053,Pocillopora_meandrina_HIv1___RNAseq.g12886.t1,peve_ptua,72.332,,,,,,,,,,,,,,,,,
OG_16679,,Peve_00017058,Pocillopora_meandrina_HIv1___RNAseq.g12884.t1,peve_ptua,33.8455,,,,,,,,,,,,,,,,,
OG_16680,,Peve_00017069,Pocillopora_meandrina_HIv1___RNAseq.g23254.t1,peve_ptua,59.366,,,,,,,,,,,,,,,,,
OG_16681,,Peve_00017074,Pocillopora_meandrina_HIv1___RNAseq.g15662.t1,peve_ptua,94.595,,,,,,,,,,,,,,,,,
OG_16682,,Peve_00017076,Pocillopora_meandrina_HIv1___TS.g27702.t1,peve_ptua,87.2235,,,,,,,,,,,,,,,,,
OG_16683,,Peve_00017095,Pocillopora_meandrina_HIv1___RNAseq.g12414.t1,peve_ptua,35.262,,,,,,,,,,,,,,,,,
OG_16684,,Peve_00017125,Pocillopora_meandrina_HIv1___RNAseq.g14400.t1,peve_ptua,60.163,,,,,,,,,,,,,,,,,
OG_16685,,Peve_00017126,Pocillopora_meandrina_HIv1___RNAseq.g14399.t1,peve_ptua,74.80850000000001,,,,,,,,,,,,,,,,,
OG_16686,,Peve_00017156,Pocillopora_meandrina_HIv1___RNAseq.g8100.t2,peve_ptua,76.758,,,,,,,,,,,,,,,,,
OG_16687,,Peve_00017159,Pocillopora_meandrina_HIv1___RNAseq.g8098.t1,peve_ptua,70.115,,,,,,,,,,,,,,,,,
OG_16688,,Peve_00017180,Pocillopora_meandrina_HIv1___TS.g8711.t1,peve_ptua,91.6925,,,,,,,,,,,,,,,,,
OG_16689,,Peve_00017183,Pocillopora_meandrina_HIv1___RNAseq.30071_t,peve_ptua,79.62,,,,,,,,,,,,,,,,,
OG_16690,,Peve_00017197,Pocillopora_meandrina_HIv1___RNAseq.g9513.t1,peve_ptua,58.654,,,,,,,,,,,,,,,,,
OG_16691,,Peve_00017200,Pocillopora_meandrina_HIv1___RNAseq.g9510.t1,peve_ptua,69.553,,,,,,,,,,,,,,,,,
OG_16692,,Peve_00017202,Pocillopora_meandrina_HIv1___RNAseq.g14035.t1,peve_ptua,58.894,,,,,,,,,,,,,,,,,
OG_16693,,Peve_00017238,Pocillopora_meandrina_HIv1___RNAseq.g17131.t1,peve_ptua,85.795,,,,,,,,,,,,,,,,,
OG_16694,,Peve_00017266,Pocillopora_meandrina_HIv1___RNAseq.g15515.t1,peve_ptua,81.111,,,,,,,,,,,,,,,,,
OG_16695,,Peve_00017276,Pocillopora_meandrina_HIv1___TS.g21788.t1c,peve_ptua,98.99,,,,,,,,,,,,,,,,,
OG_16696,,Peve_00017278,Pocillopora_meandrina_HIv1___RNAseq.g13323.t1,peve_ptua,51.852,,,,,,,,,,,,,,,,,
OG_16697,,Peve_00017286,Pocillopora_meandrina_HIv1___RNAseq.g15906.t1,peve_ptua,77.147,,,,,,,,,,,,,,,,,
OG_16698,,Peve_00017299,Pocillopora_meandrina_HIv1___RNAseq.g15546.t1,peve_ptua,67.879,,,,,,,,,,,,,,,,,
OG_16699,,Peve_00017371,Pocillopora_meandrina_HIv1___TS.g8886.t2,peve_ptua,30.977,,,,,,,,,,,,,,,,,
OG_16700,,Peve_00017372,Pocillopora_meandrina_HIv1___RNAseq.g25449.t1,peve_ptua,39.091,,,,,,,,,,,,,,,,,
OG_16701,,Peve_00017396,Pocillopora_meandrina_HIv1___RNAseq.g528.t1,peve_ptua,95.89,,,,,,,,,,,,,,,,,
OG_16702,,Peve_00017403,Pocillopora_meandrina_HIv1___RNAseq.g529.t1,peve_ptua,53.836,,,,,,,,,,,,,,,,,
OG_16703,,Peve_00017410,Pocillopora_meandrina_HIv1___RNAseq.g530.t1,peve_ptua,53.108,,,,,,,,,,,,,,,,,
OG_16704,,Peve_00017412,Pocillopora_meandrina_HIv1___RNAseq.g17590.t1,peve_ptua,79.00999999999999,,,,,,,,,,,,,,,,,
OG_16705,,Peve_00017413,Pocillopora_meandrina_HIv1___RNAseq.g17591.t1,peve_ptua,56.908,,,,,,,,,,,,,,,,,
OG_16706,,Peve_00017414,Pocillopora_meandrina_HIv1___TS.g17176.t1,peve_ptua,68.307,,,,,,,,,,,,,,,,,
OG_16707,,Peve_00017425,Pocillopora_meandrina_HIv1___RNAseq.g17598.t1,peve_ptua,35.838,,,,,,,,,,,,,,,,,
OG_16708,,Peve_00017429,Pocillopora_meandrina_HIv1___RNAseq.g17605.t1,peve_ptua,42.966,,,,,,,,,,,,,,,,,
OG_16709,,Peve_00017432,Pocillopora_meandrina_HIv1___RNAseq.g17611.t1,peve_ptua,46.765,,,,,,,,,,,,,,,,,
OG_16710,,Peve_00017439,Pocillopora_meandrina_HIv1___TS.g17198.t1,peve_ptua,49.576,,,,,,,,,,,,,,,,,
OG_16711,,Peve_00017444,Pocillopora_meandrina_HIv1___RNAseq.g22020.t1,peve_ptua,35.616,,,,,,,,,,,,,,,,,
OG_16712,,Peve_00017467,Pocillopora_meandrina_HIv1___RNAseq.g17563.t1,peve_ptua,65.079,,,,,,,,,,,,,,,,,
OG_16713,,Peve_00017483,Pocillopora_meandrina_HIv1___RNAseq.g24400.t2,peve_ptua,56.44,,,,,,,,,,,,,,,,,
OG_16714,,Peve_00017485,Pocillopora_meandrina_HIv1___RNAseq.g24402.t1,peve_ptua,44.8,,,,,,,,,,,,,,,,,
OG_16715,,Peve_00017488,Pocillopora_meandrina_HIv1___RNAseq.g24409.t1,peve_ptua,75.162,,,,,,,,,,,,,,,,,
OG_16716,,Peve_00017496,Pocillopora_meandrina_HIv1___RNAseq.g24443.t1,peve_ptua,47.172,,,,,,,,,,,,,,,,,
OG_16717,,Peve_00017529,Pocillopora_meandrina_HIv1___RNAseq.g240.t1,peve_ptua,72.358,,,,,,,,,,,,,,,,,
OG_16718,,Peve_00017567,Pocillopora_meandrina_HIv1___RNAseq.g27937.t1,peve_ptua,42.1005,,,,,,,,,,,,,,,,,
OG_16719,,Peve_00017618,Pocillopora_meandrina_HIv1___RNAseq.g8404.t1,peve_ptua,52.1585,,,,,,,,,,,,,,,,,
OG_16720,,Peve_00017627,Pocillopora_meandrina_HIv1___RNAseq.g3461.t3,peve_ptua,32.095,,,,,,,,,,,,,,,,,
OG_16721,,Peve_00017650,Pocillopora_meandrina_HIv1___RNAseq.g26439.t1,peve_ptua,80.46,,,,,,,,,,,,,,,,,
OG_16722,,Peve_00017667,Pocillopora_meandrina_HIv1___RNAseq.g20033.t1,peve_ptua,65.4985,,,,,,,,,,,,,,,,,
OG_16723,,Peve_00017679,Pocillopora_meandrina_HIv1___RNAseq.g25402.t1,peve_ptua,30.159,,,,,,,,,,,,,,,,,
OG_16724,,Peve_00017698,Pocillopora_meandrina_HIv1___RNAseq.g25511.t1,peve_ptua,74.545,,,,,,,,,,,,,,,,,
OG_16725,,Peve_00017710,Pocillopora_meandrina_HIv1___RNAseq.g11920.t1,peve_ptua,48.4975,,,,,,,,,,,,,,,,,
OG_16726,,Peve_00017757,Pocillopora_meandrina_HIv1___RNAseq.g5673.t1,peve_ptua,84.507,,,,,,,,,,,,,,,,,
OG_16727,,Peve_00017781,Pocillopora_meandrina_HIv1___RNAseq.g7025.t1,peve_ptua,48.9525,,,,,,,,,,,,,,,,,
OG_16728,,Peve_00017795,Pocillopora_meandrina_HIv1___RNAseq.g29443.t1,peve_ptua,64.917,,,,,,,,,,,,,,,,,
OG_16729,,Peve_00017796,Pocillopora_meandrina_HIv1___RNAseq.g29439.t1,peve_ptua,47.959,,,,,,,,,,,,,,,,,
OG_16730,,Peve_00017895,Pocillopora_meandrina_HIv1___RNAseq.g4333.t1,peve_ptua,74.298,,,,,,,,,,,,,,,,,
OG_16731,,Peve_00017902,Pocillopora_meandrina_HIv1___RNAseq.g330.t1,peve_ptua,50.316,,,,,,,,,,,,,,,,,
OG_16732,,Peve_00017921,Pocillopora_meandrina_HIv1___TS.g7873.t1,peve_ptua,44.578,,,,,,,,,,,,,,,,,
OG_16733,,Peve_00017931,Pocillopora_meandrina_HIv1___RNAseq.g10379.t1,peve_ptua,47.368,,,,,,,,,,,,,,,,,
OG_16734,,Peve_00017943,Pocillopora_meandrina_HIv1___RNAseq.g9348.t2,peve_ptua,67.508,,,,,,,,,,,,,,,,,
OG_16735,,Peve_00017958,Pocillopora_meandrina_HIv1___TS.g1481.t1b,peve_ptua,53.788,,,,,,,,,,,,,,,,,
OG_16736,,Peve_00018012,Pocillopora_meandrina_HIv1___RNAseq.g11912.t1,peve_ptua,42.969,,,,,,,,,,,,,,,,,
OG_16737,,Peve_00018045,Pocillopora_meandrina_HIv1___RNAseq.g18619.t1,peve_ptua,66.143,,,,,,,,,,,,,,,,,
OG_16738,,Peve_00018051,Pocillopora_meandrina_HIv1___RNAseq.g8948.t1,peve_ptua,74.84649999999999,,,,,,,,,,,,,,,,,
OG_16739,,Peve_00018075,Pocillopora_meandrina_HIv1___RNAseq.g2612.t1b,peve_ptua,66.975,,,,,,,,,,,,,,,,,
OG_16740,,Peve_00018086,Pocillopora_meandrina_HIv1___RNAseq.g17826.t1,peve_ptua,60.36,,,,,,,,,,,,,,,,,
OG_16741,,Peve_00018087,Pocillopora_meandrina_HIv1___RNAseq.g16493.t1,peve_ptua,56.389,,,,,,,,,,,,,,,,,
OG_16742,,Peve_00018091,Pocillopora_meandrina_HIv1___TS.g19794.t1,peve_ptua,36.615,,,,,,,,,,,,,,,,,
OG_16743,,Peve_00018115,Pocillopora_meandrina_HIv1___TS.g19283.t1,peve_ptua,61.086,,,,,,,,,,,,,,,,,
OG_16744,,Peve_00018120,Pocillopora_meandrina_HIv1___RNAseq.g26205.t1,peve_ptua,51.418,,,,,,,,,,,,,,,,,
OG_16745,,Peve_00018126,Pocillopora_meandrina_HIv1___RNAseq.g3964.t1,peve_ptua,45.616,,,,,,,,,,,,,,,,,
OG_16746,,Peve_00018128,Pocillopora_meandrina_HIv1___RNAseq.g16299.t1,peve_ptua,52.0365,,,,,,,,,,,,,,,,,
OG_16747,,Peve_00018146,Pocillopora_meandrina_HIv1___RNAseq.g777.t1,peve_ptua,98.67,,,,,,,,,,,,,,,,,
OG_16748,,Peve_00018150,Pocillopora_meandrina_HIv1___RNAseq.g781.t1,peve_ptua,61.611,,,,,,,,,,,,,,,,,
OG_16749,,Peve_00018169,Pocillopora_meandrina_HIv1___RNAseq.g13482.t1,peve_ptua,53.6215,,,,,,,,,,,,,,,,,
OG_16750,,Peve_00018175,Pocillopora_meandrina_HIv1___RNAseq.g22972.t1,peve_ptua,77.434,,,,,,,,,,,,,,,,,
OG_16751,,Peve_00018183,Pocillopora_meandrina_HIv1___RNAseq.g13499.t1,peve_ptua,44.169,,,,,,,,,,,,,,,,,
OG_16752,,Peve_00018208,Pocillopora_meandrina_HIv1___RNAseq.g9786.t1,peve_ptua,48.694,,,,,,,,,,,,,,,,,
OG_16753,,Peve_00018273,Pocillopora_meandrina_HIv1___RNAseq.g2838.t1,peve_ptua,51.385,,,,,,,,,,,,,,,,,
OG_16754,,Peve_00018300,Pocillopora_meandrina_HIv1___RNAseq.g23520.t1,peve_ptua,64.35,,,,,,,,,,,,,,,,,
OG_16755,,Peve_00018310,Pocillopora_meandrina_HIv1___RNAseq.g3521.t1,peve_ptua,35.593,,,,,,,,,,,,,,,,,
OG_16756,,Peve_00018365,Pocillopora_meandrina_HIv1___RNAseq.g10805.t1,peve_ptua,57.933,,,,,,,,,,,,,,,,,
OG_16757,,Peve_00018368,Pocillopora_meandrina_HIv1___RNAseq.g10804.t1,peve_ptua,70.894,,,,,,,,,,,,,,,,,
OG_16758,,Peve_00018369,Pocillopora_meandrina_HIv1___RNAseq.g10803.t1,peve_ptua,80.172,,,,,,,,,,,,,,,,,
OG_16759,,Peve_00018382,Pocillopora_meandrina_HIv1___TS.g13337.t2,peve_ptua,68.75,,,,,,,,,,,,,,,,,
OG_16760,,Peve_00018385,Pocillopora_meandrina_HIv1___RNAseq.g10794.t1,peve_ptua,75.632,,,,,,,,,,,,,,,,,
OG_16761,,Peve_00018401,Pocillopora_meandrina_HIv1___RNAseq.g10833.t1,peve_ptua,62.373000000000005,,,,,,,,,,,,,,,,,
OG_16762,,Peve_00018407,Pocillopora_meandrina_HIv1___TS.g10405.t1,peve_ptua,71.49549999999999,,,,,,,,,,,,,,,,,
OG_16763,,Peve_00018414,Pocillopora_meandrina_HIv1___TS.g13331.t1,peve_ptua,62.805,,,,,,,,,,,,,,,,,
OG_16764,,Peve_00018429,Pocillopora_meandrina_HIv1___RNAseq.g25061.t1,peve_ptua,59.492,,,,,,,,,,,,,,,,,
OG_16765,,Peve_00018476,Pocillopora_meandrina_HIv1___RNAseq.g22914.t1,peve_ptua,64.113,,,,,,,,,,,,,,,,,
OG_16766,,Peve_00018523,Pocillopora_meandrina_HIv1___RNAseq.g9375.t1a,peve_ptua,69.626,,,,,,,,,,,,,,,,,
OG_16767,,Peve_00018529,Pocillopora_meandrina_HIv1___TS.g19680.t1,peve_ptua,58.371,,,,,,,,,,,,,,,,,
OG_16768,,Peve_00018610,Pocillopora_meandrina_HIv1___RNAseq.g239.t1,peve_ptua,73.77199999999999,,,,,,,,,,,,,,,,,
OG_16769,,Peve_00018619,Pocillopora_meandrina_HIv1___RNAseq.g237.t3,peve_ptua,61.269,,,,,,,,,,,,,,,,,
OG_16770,,Peve_00018630,Pocillopora_meandrina_HIv1___RNAseq.g29183.t1,peve_ptua,66.512,,,,,,,,,,,,,,,,,
OG_16771,,Peve_00018675,Pocillopora_meandrina_HIv1___RNAseq.g29998.t1,peve_ptua,51.161,,,,,,,,,,,,,,,,,
OG_16772,,Peve_00018682,Pocillopora_meandrina_HIv1___TS.g22233.t1,peve_ptua,56.911,,,,,,,,,,,,,,,,,
OG_16773,,Peve_00018703,Pocillopora_meandrina_HIv1___RNAseq.g19858.t2,peve_ptua,78.12950000000001,,,,,,,,,,,,,,,,,
OG_16774,,Peve_00018718,Pocillopora_meandrina_HIv1___TS.g9590.t1,peve_ptua,65.75049999999999,,,,,,,,,,,,,,,,,
OG_16775,,Peve_00018730,Pocillopora_meandrina_HIv1___RNAseq.g12193.t1,peve_ptua,48.649,,,,,,,,,,,,,,,,,
OG_16776,,Peve_00018806,Pocillopora_meandrina_HIv1___RNAseq.g12809.t1,peve_ptua,42.819,,,,,,,,,,,,,,,,,
OG_16777,,Peve_00018816,Pocillopora_meandrina_HIv1___RNAseq.g19616.t1,peve_ptua,57.554,,,,,,,,,,,,,,,,,
OG_16778,,Peve_00018822,Pocillopora_meandrina_HIv1___RNAseq.g17253.t1a,peve_ptua,81.679,,,,,,,,,,,,,,,,,
OG_16779,,Peve_00018828,Pocillopora_meandrina_HIv1___RNAseq.g19127.t1,peve_ptua,59.738,,,,,,,,,,,,,,,,,
OG_16780,,Peve_00018845,Pocillopora_meandrina_HIv1___RNAseq.g23395.t1,peve_ptua,78.522,,,,,,,,,,,,,,,,,
OG_16781,,Peve_00018897,Pocillopora_meandrina_HIv1___RNAseq.g11327.t1,peve_ptua,85.156,,,,,,,,,,,,,,,,,
OG_16782,,Peve_00018902,Pocillopora_meandrina_HIv1___TS.g17439.t1a,peve_ptua,53.1,,,,,,,,,,,,,,,,,
OG_16783,,Peve_00018927,Pocillopora_meandrina_HIv1___TS.g11312.t1,peve_ptua,47.02,,,,,,,,,,,,,,,,,
OG_16784,,Peve_00018935,Pocillopora_meandrina_HIv1___RNAseq.g4537.t1,peve_ptua,76.967,,,,,,,,,,,,,,,,,
OG_16785,,Peve_00018937,Pocillopora_meandrina_HIv1___RNAseq.g16352.t2b,peve_ptua,42.954,,,,,,,,,,,,,,,,,
OG_16786,,Peve_00018972,Pocillopora_meandrina_HIv1___RNAseq.g27409.t1,peve_ptua,66.962,,,,,,,,,,,,,,,,,
OG_16787,,Peve_00018978,Pocillopora_meandrina_HIv1___RNAseq.g27408.t1,peve_ptua,70.046,,,,,,,,,,,,,,,,,
OG_16788,,Peve_00018992,Pocillopora_meandrina_HIv1___RNAseq.g24082.t1,peve_ptua,68.9,,,,,,,,,,,,,,,,,
OG_16789,,Peve_00018993,Pocillopora_meandrina_HIv1___RNAseq.g24081.t1,peve_ptua,60.183,,,,,,,,,,,,,,,,,
OG_16790,,Peve_00019021,Pocillopora_meandrina_HIv1___RNAseq.g19301.t1,peve_ptua,50.667,,,,,,,,,,,,,,,,,
OG_16791,,Peve_00019068,Pocillopora_meandrina_HIv1___RNAseq.g30200.t1,peve_ptua,63.185,,,,,,,,,,,,,,,,,
OG_16792,,Peve_00019083,Pocillopora_meandrina_HIv1___RNAseq.g3897.t1,peve_ptua,80.231,,,,,,,,,,,,,,,,,
OG_16793,,Peve_00019098,Pocillopora_meandrina_HIv1___TS.g19025.t1,peve_ptua,72.561,,,,,,,,,,,,,,,,,
OG_16794,,Peve_00019105,Pocillopora_meandrina_HIv1___RNAseq.g238.t1,peve_ptua,55.728,,,,,,,,,,,,,,,,,
OG_16795,,Peve_00019117,Pocillopora_meandrina_HIv1___RNAseq.g20687.t1,peve_ptua,53.7445,,,,,,,,,,,,,,,,,
OG_16796,,Peve_00019140,Pocillopora_meandrina_HIv1___TS.g8257.t1,peve_ptua,30.968,,,,,,,,,,,,,,,,,
OG_16797,,Peve_00019149,Pocillopora_meandrina_HIv1___RNAseq.g28461.t1,peve_ptua,33.333,,,,,,,,,,,,,,,,,
OG_16798,,Peve_00019154,Pocillopora_meandrina_HIv1___RNAseq.g13415.t1,peve_ptua,33.01,,,,,,,,,,,,,,,,,
OG_16799,,Peve_00019172,Pocillopora_meandrina_HIv1___RNAseq.g12673.t1,peve_ptua,60.821,,,,,,,,,,,,,,,,,
OG_16800,,Peve_00019183,Pocillopora_meandrina_HIv1___RNAseq.g666.t1,peve_ptua,73.357,,,,,,,,,,,,,,,,,
OG_16801,,Peve_00019233,Pocillopora_meandrina_HIv1___RNAseq.g17617.t1,peve_ptua,68.999,,,,,,,,,,,,,,,,,
OG_16802,,Peve_00019242,Pocillopora_meandrina_HIv1___RNAseq.g17638.t1,peve_ptua,75.758,,,,,,,,,,,,,,,,,
OG_16803,,Peve_00019248,Pocillopora_meandrina_HIv1___TS.g6876.t1,peve_ptua,74.457,,,,,,,,,,,,,,,,,
OG_16804,,Peve_00019251,Pocillopora_meandrina_HIv1___RNAseq.g9029.t1,peve_ptua,71.795,,,,,,,,,,,,,,,,,
OG_16805,,Peve_00019276,Pocillopora_meandrina_HIv1___RNAseq.g7210.t1,peve_ptua,62.933,,,,,,,,,,,,,,,,,
OG_16806,,Peve_00019283,Pocillopora_meandrina_HIv1___RNAseq.g7204.t1,peve_ptua,52.066,,,,,,,,,,,,,,,,,
OG_16807,,Peve_00019296,Pocillopora_meandrina_HIv1___RNAseq.g7192.t1,peve_ptua,36.765,,,,,,,,,,,,,,,,,
OG_16808,,Peve_00019307,Pocillopora_meandrina_HIv1___RNAseq.g1426.t1,peve_ptua,60.261,,,,,,,,,,,,,,,,,
OG_16809,,Peve_00019323,Pocillopora_meandrina_HIv1___RNAseq.g5574.t1,peve_ptua,82.022,,,,,,,,,,,,,,,,,
OG_16810,,Peve_00019345,Pocillopora_meandrina_HIv1___RNAseq.g2131.t1,peve_ptua,55.274,,,,,,,,,,,,,,,,,
OG_16811,,Peve_00019362,Pocillopora_meandrina_HIv1___RNAseq.g2115.t1,peve_ptua,45.333,,,,,,,,,,,,,,,,,
OG_16812,,Peve_00019377,Pocillopora_meandrina_HIv1___RNAseq.g13736.t1,peve_ptua,48.246,,,,,,,,,,,,,,,,,
OG_16813,,Peve_00019404,Pocillopora_meandrina_HIv1___RNAseq.g480.t1,peve_ptua,38.875,,,,,,,,,,,,,,,,,
OG_16814,,Peve_00019405,Pocillopora_meandrina_HIv1___RNAseq.g25315.t1,peve_ptua,56.643,,,,,,,,,,,,,,,,,
OG_16815,,Peve_00019416,Pocillopora_meandrina_HIv1___RNAseq.g8588.t1,peve_ptua,55.71,,,,,,,,,,,,,,,,,
OG_16816,,Peve_00019422,Pocillopora_meandrina_HIv1___RNAseq.g8614.t1,peve_ptua,59.574,,,,,,,,,,,,,,,,,
OG_16817,,Peve_00019426,Pocillopora_meandrina_HIv1___RNAseq.g8615.t1,peve_ptua,71.895,,,,,,,,,,,,,,,,,
OG_16818,,Peve_00019433,Pocillopora_meandrina_HIv1___TS.g20351.t2,peve_ptua,65.438,,,,,,,,,,,,,,,,,
OG_16819,,Peve_00019449,Pocillopora_meandrina_HIv1___RNAseq.g6759.t1,peve_ptua,61.538,,,,,,,,,,,,,,,,,
OG_16820,,Peve_00019471,Pocillopora_meandrina_HIv1___RNAseq.g3975.t1,peve_ptua,80.508,,,,,,,,,,,,,,,,,
OG_16821,,Peve_00019496,Pocillopora_meandrina_HIv1___RNAseq.g17317.t1,peve_ptua,30.676,,,,,,,,,,,,,,,,,
OG_16822,,Peve_00019519,Pocillopora_meandrina_HIv1___RNAseq.g20205.t1a,peve_ptua,31.825000000000003,,,,,,,,,,,,,,,,,
OG_16823,,Peve_00019538,Pocillopora_meandrina_HIv1___RNAseq.g6918.t1,peve_ptua,32.941,,,,,,,,,,,,,,,,,
OG_16824,,Peve_00019548,Pocillopora_meandrina_HIv1___RNAseq.g17215.t1,peve_ptua,65.584,,,,,,,,,,,,,,,,,
OG_16825,,Peve_00019567,Pocillopora_meandrina_HIv1___RNAseq.g7432.t1,peve_ptua,84.615,,,,,,,,,,,,,,,,,
OG_16826,,Peve_00019568,Pocillopora_meandrina_HIv1___RNAseq.g7437.t2,peve_ptua,61.979,,,,,,,,,,,,,,,,,
OG_16827,,Peve_00019569,Pocillopora_meandrina_HIv1___TS.g1185.t1,peve_ptua,58.613,,,,,,,,,,,,,,,,,
OG_16828,,Peve_00019577,Pocillopora_meandrina_HIv1___RNAseq.g7441.t1,peve_ptua,76.52199999999999,,,,,,,,,,,,,,,,,
OG_16829,,Peve_00019629,Pocillopora_meandrina_HIv1___RNAseq.g19623.t1,peve_ptua,75.0,,,,,,,,,,,,,,,,,
OG_16830,,Peve_00019712,Pocillopora_meandrina_HIv1___RNAseq.g8749.t1,peve_ptua,60.853,,,,,,,,,,,,,,,,,
OG_16831,,Peve_00019713,Pocillopora_meandrina_HIv1___RNAseq.g8750.t1,peve_ptua,42.005,,,,,,,,,,,,,,,,,
OG_16832,,Peve_00019718,Pocillopora_meandrina_HIv1___RNAseq.g22265.t1,peve_ptua,63.0915,,,,,,,,,,,,,,,,,
OG_16833,,Peve_00019744,Pocillopora_meandrina_HIv1___RNAseq.g28860.t1,peve_ptua,45.528,,,,,,,,,,,,,,,,,
OG_16834,,Peve_00019765,Pocillopora_meandrina_HIv1___RNAseq.g2556.t1,peve_ptua,50.45,,,,,,,,,,,,,,,,,
OG_16835,,Peve_00019840,Pocillopora_meandrina_HIv1___RNAseq.g9797.t1,peve_ptua,42.857,,,,,,,,,,,,,,,,,
OG_16836,,Peve_00019847,Pocillopora_meandrina_HIv1___TS.g23322.t1,peve_ptua,70.84,,,,,,,,,,,,,,,,,
OG_16837,,Peve_00019855,Pocillopora_meandrina_HIv1___RNAseq.g23977.t1,peve_ptua,85.714,,,,,,,,,,,,,,,,,
OG_16838,,Peve_00019869,Pocillopora_meandrina_HIv1___RNAseq.g28906.t1,peve_ptua,55.446,,,,,,,,,,,,,,,,,
OG_16839,,Peve_00019875,Pocillopora_meandrina_HIv1___RNAseq.g19631.t1,peve_ptua,56.315,,,,,,,,,,,,,,,,,
OG_16840,,Peve_00019920,Pocillopora_meandrina_HIv1___TS.g12167.t1,peve_ptua,65.529,,,,,,,,,,,,,,,,,
OG_16841,,Peve_00019976,Pocillopora_meandrina_HIv1___RNAseq.g7148.t1,peve_ptua,74.205,,,,,,,,,,,,,,,,,
OG_16842,,Peve_00019979,Pocillopora_meandrina_HIv1___RNAseq.g7149.t1,peve_ptua,37.201,,,,,,,,,,,,,,,,,
OG_16843,,Peve_00019981,Pocillopora_meandrina_HIv1___TS.g890.t1,peve_ptua,62.62,,,,,,,,,,,,,,,,,
OG_16844,,Peve_00020005,Pocillopora_meandrina_HIv1___RNAseq.g11234.t1,peve_ptua,57.692,,,,,,,,,,,,,,,,,
OG_16845,,Peve_00020071,Pocillopora_meandrina_HIv1___RNAseq.g24646.t1,peve_ptua,45.697,,,,,,,,,,,,,,,,,
OG_16846,,Peve_00020096,Pocillopora_meandrina_HIv1___RNAseq.g15316.t1,peve_ptua,61.545,,,,,,,,,,,,,,,,,
OG_16847,,Peve_00020111,Pocillopora_meandrina_HIv1___RNAseq.g13879.t1b,peve_ptua,65.306,,,,,,,,,,,,,,,,,
OG_16848,,Peve_00020121,Pocillopora_meandrina_HIv1___RNAseq.g23798.t1,peve_ptua,67.593,,,,,,,,,,,,,,,,,
OG_16849,,Peve_00020129,Pocillopora_meandrina_HIv1___RNAseq.g24897.t3,peve_ptua,71.703,,,,,,,,,,,,,,,,,
OG_16850,,Peve_00020139,Pocillopora_meandrina_HIv1___RNAseq.g29418.t1,peve_ptua,42.703,,,,,,,,,,,,,,,,,
OG_16851,,Peve_00020190,Pocillopora_meandrina_HIv1___RNAseq.g1023.t1,peve_ptua,58.681,,,,,,,,,,,,,,,,,
OG_16852,,Peve_00020223,Pocillopora_meandrina_HIv1___RNAseq.g20125.t1b,peve_ptua,68.056,,,,,,,,,,,,,,,,,
OG_16853,,Peve_00020262,Pocillopora_meandrina_HIv1___RNAseq.g4433.t1,peve_ptua,40.0715,,,,,,,,,,,,,,,,,
OG_16854,,Peve_00020270,Pocillopora_meandrina_HIv1___RNAseq.g27027.t1,peve_ptua,54.808,,,,,,,,,,,,,,,,,
OG_16855,,Peve_00020276,Pocillopora_meandrina_HIv1___RNAseq.g17756.t1,peve_ptua,72.558,,,,,,,,,,,,,,,,,
OG_16856,,Peve_00020287,Pocillopora_meandrina_HIv1___TS.g21211.t1,peve_ptua,51.677,,,,,,,,,,,,,,,,,
OG_16857,,Peve_00020327,Pocillopora_meandrina_HIv1___RNAseq.g4996.t1,peve_ptua,60.09,,,,,,,,,,,,,,,,,
OG_16858,,Peve_00020330,Pocillopora_meandrina_HIv1___RNAseq.g11668.t1,peve_ptua,55.29,,,,,,,,,,,,,,,,,
OG_16859,,Peve_00020341,Pocillopora_meandrina_HIv1___RNAseq.g19270.t1,peve_ptua,67.095,,,,,,,,,,,,,,,,,
OG_16860,,Peve_00020365,Pocillopora_meandrina_HIv1___RNAseq.g18242.t2,peve_ptua,41.586,,,,,,,,,,,,,,,,,
OG_16861,,Peve_00020372,Pocillopora_meandrina_HIv1___TS.g12320.t1b,peve_ptua,43.307,,,,,,,,,,,,,,,,,
OG_16862,,Peve_00020388,Pocillopora_meandrina_HIv1___RNAseq.30927_t,peve_ptua,40.572,,,,,,,,,,,,,,,,,
OG_16863,,Peve_00020394,Pocillopora_meandrina_HIv1___RNAseq.g13687.t1,peve_ptua,53.968,,,,,,,,,,,,,,,,,
OG_16864,,Peve_00020398,Pocillopora_meandrina_HIv1___RNAseq.14959_t,peve_ptua,37.5,,,,,,,,,,,,,,,,,
OG_16865,,Peve_00020407,Pocillopora_meandrina_HIv1___RNAseq.g10395.t1,peve_ptua,78.707,,,,,,,,,,,,,,,,,
OG_16866,,Peve_00020419,Pocillopora_meandrina_HIv1___RNAseq.g28230.t1,peve_ptua,36.066,,,,,,,,,,,,,,,,,
OG_16867,,Peve_00020431,Pocillopora_meandrina_HIv1___RNAseq.g1393.t1,peve_ptua,35.5255,,,,,,,,,,,,,,,,,
OG_16868,,Peve_00020432,Pocillopora_meandrina_HIv1___RNAseq.g1392.t1,peve_ptua,83.301,,,,,,,,,,,,,,,,,
OG_16869,,Peve_00020439,Pocillopora_meandrina_HIv1___RNAseq.g11392.t1,peve_ptua,73.729,,,,,,,,,,,,,,,,,
OG_16870,,Peve_00020442,Pocillopora_meandrina_HIv1___RNAseq.g16711.t1b,peve_ptua,70.992,,,,,,,,,,,,,,,,,
OG_16871,,Peve_00020463,Pocillopora_meandrina_HIv1___RNAseq.g28089.t1,peve_ptua,58.621,,,,,,,,,,,,,,,,,
OG_16872,,Peve_00020468,Pocillopora_meandrina_HIv1___RNAseq.g2062.t1,peve_ptua,56.156,,,,,,,,,,,,,,,,,
OG_16873,,Peve_00020491,Pocillopora_meandrina_HIv1___RNAseq.g18820.t2,peve_ptua,84.326,,,,,,,,,,,,,,,,,
OG_16874,,Peve_00020492,Pocillopora_meandrina_HIv1___RNAseq.g28243.t1,peve_ptua,91.86,,,,,,,,,,,,,,,,,
OG_16875,,Peve_00020512,Pocillopora_meandrina_HIv1___RNAseq.g23511.t1,peve_ptua,57.756,,,,,,,,,,,,,,,,,
OG_16876,,Peve_00020517,Pocillopora_meandrina_HIv1___TS.g16398.t1,peve_ptua,53.091,,,,,,,,,,,,,,,,,
OG_16877,,Peve_00020522,Pocillopora_meandrina_HIv1___RNAseq.g23519.t1a,peve_ptua,61.5405,,,,,,,,,,,,,,,,,
OG_16878,,Peve_00020537,Pocillopora_meandrina_HIv1___TS.g20801.t1b,peve_ptua,42.4605,,,,,,,,,,,,,,,,,
OG_16879,,Peve_00020542,Pocillopora_meandrina_HIv1___RNAseq.g13989.t1,peve_ptua,41.801,,,,,,,,,,,,,,,,,
OG_16880,,Peve_00020574,Pocillopora_meandrina_HIv1___RNAseq.g11050.t1,peve_ptua,62.257000000000005,,,,,,,,,,,,,,,,,
OG_16881,,Peve_00020575,Pocillopora_meandrina_HIv1___RNAseq.g23524.t1,peve_ptua,56.637,,,,,,,,,,,,,,,,,
OG_16882,,Peve_00020600,Pocillopora_meandrina_HIv1___RNAseq.g14466.t1,peve_ptua,79.53,,,,,,,,,,,,,,,,,
OG_16883,,Peve_00020608,Pocillopora_meandrina_HIv1___TS.g22257.t1,peve_ptua,57.962,,,,,,,,,,,,,,,,,
OG_16884,,Peve_00020645,Pocillopora_meandrina_HIv1___TS.g1040.t1,peve_ptua,54.444,,,,,,,,,,,,,,,,,
OG_16885,,Peve_00020690,Pocillopora_meandrina_HIv1___RNAseq.g1141.t1,peve_ptua,89.637,,,,,,,,,,,,,,,,,
OG_16886,,Peve_00020696,Pocillopora_meandrina_HIv1___RNAseq.g1144.t1,peve_ptua,57.143,,,,,,,,,,,,,,,,,
OG_16887,,Peve_00020708,Pocillopora_meandrina_HIv1___RNAseq.g9355.t1,peve_ptua,48.171,,,,,,,,,,,,,,,,,
OG_16888,,Peve_00020843,Pocillopora_meandrina_HIv1___RNAseq.g24459.t1,peve_ptua,59.314,,,,,,,,,,,,,,,,,
OG_16889,,Peve_00020868,Pocillopora_meandrina_HIv1___TS.g28809.t1,peve_ptua,73.865,,,,,,,,,,,,,,,,,
OG_16890,,Peve_00020891,Pocillopora_meandrina_HIv1___RNAseq.g19408.t1,peve_ptua,74.943,,,,,,,,,,,,,,,,,
OG_16891,,Peve_00020936,Pocillopora_meandrina_HIv1___TS.g16110.t1,peve_ptua,52.722,,,,,,,,,,,,,,,,,
OG_16892,,Peve_00020973,Pocillopora_meandrina_HIv1___RNAseq.g15988.t1,peve_ptua,31.538,,,,,,,,,,,,,,,,,
OG_16893,,Peve_00020987,Pocillopora_meandrina_HIv1___RNAseq.g26591.t1,peve_ptua,40.277,,,,,,,,,,,,,,,,,
OG_16894,,Peve_00021000,Pocillopora_meandrina_HIv1___TS.g25026.t1,peve_ptua,57.526,,,,,,,,,,,,,,,,,
OG_16895,,Peve_00021027,Pocillopora_meandrina_HIv1___RNAseq.g20431.t1,peve_ptua,86.957,,,,,,,,,,,,,,,,,
OG_16896,,Peve_00021036,Pocillopora_meandrina_HIv1___RNAseq.g11653.t1,peve_ptua,88.24600000000001,,,,,,,,,,,,,,,,,
OG_16897,,Peve_00021049,Pocillopora_meandrina_HIv1___RNAseq.g19057.t1,peve_ptua,89.296,,,,,,,,,,,,,,,,,
OG_16898,,Peve_00021059,Pocillopora_meandrina_HIv1___RNAseq.g14293.t1,peve_ptua,64.11,,,,,,,,,,,,,,,,,
OG_16899,,Peve_00021076,Pocillopora_meandrina_HIv1___RNAseq.g19090.t1,peve_ptua,95.815,,,,,,,,,,,,,,,,,
OG_16900,,Peve_00021125,Pocillopora_meandrina_HIv1___RNAseq.g13650.t1,peve_ptua,40.886,,,,,,,,,,,,,,,,,
OG_16901,,Peve_00021130,Pocillopora_meandrina_HIv1___RNAseq.g13407.t1,peve_ptua,39.474,,,,,,,,,,,,,,,,,
OG_16902,,Peve_00021153,Pocillopora_meandrina_HIv1___RNAseq.g143.t1,peve_ptua,31.765,,,,,,,,,,,,,,,,,
OG_16903,,Peve_00021255,Pocillopora_meandrina_HIv1___RNAseq.g26256.t1,peve_ptua,100.0,,,,,,,,,,,,,,,,,
OG_16904,,Peve_00021268,Pocillopora_meandrina_HIv1___RNAseq.g27906.t1,peve_ptua,44.796,,,,,,,,,,,,,,,,,
OG_16905,,Peve_00021276,Pocillopora_meandrina_HIv1___TS.g22139.t1b,peve_ptua,61.12,,,,,,,,,,,,,,,,,
OG_16906,,Peve_00021285,Pocillopora_meandrina_HIv1___RNAseq.20165_t,peve_ptua,34.351,,,,,,,,,,,,,,,,,
OG_16907,,Peve_00021294,Pocillopora_meandrina_HIv1___TS.g12437.t1,peve_ptua,63.7785,,,,,,,,,,,,,,,,,
OG_16908,,Peve_00021302,Pocillopora_meandrina_HIv1___RNAseq.g17703.t1,peve_ptua,60.215,,,,,,,,,,,,,,,,,
OG_16909,,Peve_00021318,Pocillopora_meandrina_HIv1___RNAseq.g1837.t1,peve_ptua,53.737,,,,,,,,,,,,,,,,,
OG_16910,,Peve_00021324,Pocillopora_meandrina_HIv1___RNAseq.g10370.t1,peve_ptua,79.229,,,,,,,,,,,,,,,,,
OG_16911,,Peve_00021349,Pocillopora_meandrina_HIv1___RNAseq.g21995.t1a,peve_ptua,43.939,,,,,,,,,,,,,,,,,
OG_16912,,Peve_00021383,Pocillopora_meandrina_HIv1___RNAseq.g27997.t1,peve_ptua,50.0155,,,,,,,,,,,,,,,,,
OG_16913,,Peve_00021427,Pocillopora_meandrina_HIv1___TS.g27313.t1,peve_ptua,67.01,,,,,,,,,,,,,,,,,
OG_16914,,Peve_00021438,Pocillopora_meandrina_HIv1___RNAseq.g16084.t1,peve_ptua,84.142,,,,,,,,,,,,,,,,,
OG_16915,,Peve_00021475,Pocillopora_meandrina_HIv1___RNAseq.g24162.t1,peve_ptua,75.0,,,,,,,,,,,,,,,,,
OG_16916,,Peve_00021478,Pocillopora_meandrina_HIv1___RNAseq.g13981.t1,peve_ptua,41.766,,,,,,,,,,,,,,,,,
OG_16917,,Peve_00021479,Pocillopora_meandrina_HIv1___RNAseq.g13979.t1,peve_ptua,75.82,,,,,,,,,,,,,,,,,
OG_16918,,Peve_00021511,Pocillopora_meandrina_HIv1___RNAseq.g5066.t1,peve_ptua,75.472,,,,,,,,,,,,,,,,,
OG_16919,,Peve_00021518,Pocillopora_meandrina_HIv1___RNAseq.g8024.t1,peve_ptua,49.388,,,,,,,,,,,,,,,,,
OG_16920,,Peve_00021542,Pocillopora_meandrina_HIv1___RNAseq.g26540.t1,peve_ptua,68.471,,,,,,,,,,,,,,,,,
OG_16921,,Peve_00021551,Pocillopora_meandrina_HIv1___RNAseq.g24074.t1,peve_ptua,57.321,,,,,,,,,,,,,,,,,
OG_16922,,Peve_00021649,Pocillopora_meandrina_HIv1___RNAseq.g4649.t1,peve_ptua,61.032,,,,,,,,,,,,,,,,,
OG_16923,,Peve_00021674,Pocillopora_meandrina_HIv1___RNAseq.g9401.t1,peve_ptua,60.05,,,,,,,,,,,,,,,,,
OG_16924,,Peve_00021676,Pocillopora_meandrina_HIv1___RNAseq.g9400.t1,peve_ptua,34.956500000000005,,,,,,,,,,,,,,,,,
OG_16925,,Peve_00021681,Pocillopora_meandrina_HIv1___RNAseq.g4588.t1,peve_ptua,51.374,,,,,,,,,,,,,,,,,
OG_16926,,Peve_00021684,Pocillopora_meandrina_HIv1___RNAseq.g4622.t1,peve_ptua,68.481,,,,,,,,,,,,,,,,,
OG_16927,,Peve_00021698,Pocillopora_meandrina_HIv1___RNAseq.g4637.t1,peve_ptua,42.529,,,,,,,,,,,,,,,,,
OG_16928,,Peve_00021708,Pocillopora_meandrina_HIv1___RNAseq.g7935.t1,peve_ptua,89.933,,,,,,,,,,,,,,,,,
OG_16929,,Peve_00021722,Pocillopora_meandrina_HIv1___RNAseq.g23848.t1,peve_ptua,44.898,,,,,,,,,,,,,,,,,
OG_16930,,Peve_00021767,Pocillopora_meandrina_HIv1___RNAseq.g16788.t1,peve_ptua,69.0955,,,,,,,,,,,,,,,,,
OG_16931,,Peve_00021779,Pocillopora_meandrina_HIv1___RNAseq.g25352.t1,peve_ptua,80.374,,,,,,,,,,,,,,,,,
OG_16932,,Peve_00021793,Pocillopora_meandrina_HIv1___RNAseq.g27796.t1a,peve_ptua,60.696,,,,,,,,,,,,,,,,,
OG_16933,,Peve_00021859,Pocillopora_meandrina_HIv1___RNAseq.g7365.t1,peve_ptua,76.151,,,,,,,,,,,,,,,,,
OG_16934,,Peve_00021905,Pocillopora_meandrina_HIv1___TS.g9646.t1a,peve_ptua,41.908,,,,,,,,,,,,,,,,,
OG_16935,,Peve_00021909,Pocillopora_meandrina_HIv1___RNAseq.g20866.t1,peve_ptua,52.615,,,,,,,,,,,,,,,,,
OG_16936,,Peve_00021932,Pocillopora_meandrina_HIv1___RNAseq.g4362.t1,peve_ptua,81.113,,,,,,,,,,,,,,,,,
OG_16937,,Peve_00021949,Pocillopora_meandrina_HIv1___TS.g14486.t1a,peve_ptua,77.863,,,,,,,,,,,,,,,,,
OG_16938,,Peve_00021983,Pocillopora_meandrina_HIv1___TS.g8561.t1,peve_ptua,58.084,,,,,,,,,,,,,,,,,
OG_16939,,Peve_00021986,Pocillopora_meandrina_HIv1___RNAseq.g27080.t1,peve_ptua,55.844,,,,,,,,,,,,,,,,,
OG_16940,,Peve_00022026,Pocillopora_meandrina_HIv1___RNAseq.g21103.t1,peve_ptua,74.06,,,,,,,,,,,,,,,,,
OG_16941,,Peve_00022031,Pocillopora_meandrina_HIv1___RNAseq.g11986.t1,peve_ptua,62.795,,,,,,,,,,,,,,,,,
OG_16942,,Peve_00022032,Pocillopora_meandrina_HIv1___RNAseq.g11970.t1,peve_ptua,61.785,,,,,,,,,,,,,,,,,
OG_16943,,Peve_00022045,Pocillopora_meandrina_HIv1___RNAseq.g11390.t1,peve_ptua,69.215,,,,,,,,,,,,,,,,,
OG_16944,,Peve_00022132,Pocillopora_meandrina_HIv1___RNAseq.g24673.t1,peve_ptua,43.829,,,,,,,,,,,,,,,,,
OG_16945,,Peve_00022133,Pocillopora_meandrina_HIv1___RNAseq.g26525.t1,peve_ptua,63.451,,,,,,,,,,,,,,,,,
OG_16946,,Peve_00022142,Pocillopora_meandrina_HIv1___RNAseq.g9365.t1,peve_ptua,78.6765,,,,,,,,,,,,,,,,,
OG_16947,,Peve_00022200,Pocillopora_meandrina_HIv1___RNAseq.g7844.t1,peve_ptua,32.113,,,,,,,,,,,,,,,,,
OG_16948,,Peve_00022207,Pocillopora_meandrina_HIv1___RNAseq.g22402.t1,peve_ptua,60.623,,,,,,,,,,,,,,,,,
OG_16949,,Peve_00022219,Pocillopora_meandrina_HIv1___RNAseq.g23297.t1,peve_ptua,48.663,,,,,,,,,,,,,,,,,
OG_16950,,Peve_00022234,Pocillopora_meandrina_HIv1___RNAseq.g14122.t1,peve_ptua,75.088,,,,,,,,,,,,,,,,,
OG_16951,,Peve_00022238,Pocillopora_meandrina_HIv1___RNAseq.g14124.t1,peve_ptua,58.491,,,,,,,,,,,,,,,,,
OG_16952,,Peve_00022256,Pocillopora_meandrina_HIv1___RNAseq.g7768.t1,peve_ptua,37.5,,,,,,,,,,,,,,,,,
OG_16953,,Peve_00022288,Pocillopora_meandrina_HIv1___RNAseq.g27269.t1,peve_ptua,45.614,,,,,,,,,,,,,,,,,
OG_16954,,Peve_00022310,Pocillopora_meandrina_HIv1___RNAseq.g24591.t1,peve_ptua,66.176,,,,,,,,,,,,,,,,,
OG_16955,,Peve_00022312,Pocillopora_meandrina_HIv1___RNAseq.g24614.t1,peve_ptua,65.5475,,,,,,,,,,,,,,,,,
OG_16956,,Peve_00022315,Pocillopora_meandrina_HIv1___RNAseq.g3038.t1,peve_ptua,75.419,,,,,,,,,,,,,,,,,
OG_16957,,Peve_00022336,Pocillopora_meandrina_HIv1___RNAseq.g29746.t1b,peve_ptua,58.725,,,,,,,,,,,,,,,,,
OG_16958,,Peve_00022367,Pocillopora_meandrina_HIv1___RNAseq.g13758.t1,peve_ptua,56.731,,,,,,,,,,,,,,,,,
OG_16959,,Peve_00022379,Pocillopora_meandrina_HIv1___TS.g14809.t1,peve_ptua,77.368,,,,,,,,,,,,,,,,,
OG_16960,,Peve_00022405,Pocillopora_meandrina_HIv1___RNAseq.g12992.t1,peve_ptua,59.963,,,,,,,,,,,,,,,,,
OG_16961,,Peve_00022414,Pocillopora_meandrina_HIv1___TS.g9659.t1,peve_ptua,58.389,,,,,,,,,,,,,,,,,
OG_16962,,Peve_00022445,Pocillopora_meandrina_HIv1___RNAseq.g12982.t1,peve_ptua,66.532,,,,,,,,,,,,,,,,,
OG_16963,,Peve_00022483,Pocillopora_meandrina_HIv1___RNAseq.g5017.t1,peve_ptua,75.214,,,,,,,,,,,,,,,,,
OG_16964,,Peve_00022491,Pocillopora_meandrina_HIv1___RNAseq.g22041.t1,peve_ptua,68.69,,,,,,,,,,,,,,,,,
OG_16965,,Peve_00022492,Pocillopora_meandrina_HIv1___RNAseq.g22040.t1,peve_ptua,79.104,,,,,,,,,,,,,,,,,
OG_16966,,Peve_00022545,Pocillopora_meandrina_HIv1___RNAseq.g12909.t1,peve_ptua,84.559,,,,,,,,,,,,,,,,,
OG_16967,,Peve_00022546,Pocillopora_meandrina_HIv1___RNAseq.g9869.t1,peve_ptua,77.936,,,,,,,,,,,,,,,,,
OG_16968,,Peve_00022551,Pocillopora_meandrina_HIv1___RNAseq.g12411.t1,peve_ptua,95.05,,,,,,,,,,,,,,,,,
OG_16969,,Peve_00022562,Pocillopora_meandrina_HIv1___RNAseq.g21012.t1,peve_ptua,74.194,,,,,,,,,,,,,,,,,
OG_16970,,Peve_00022575,Pocillopora_meandrina_HIv1___RNAseq.g7686.t1,peve_ptua,63.158,,,,,,,,,,,,,,,,,
OG_16971,,Peve_00022613,Pocillopora_meandrina_HIv1___RNAseq.g20956.t1,peve_ptua,86.092,,,,,,,,,,,,,,,,,
OG_16972,,Peve_00022620,Pocillopora_meandrina_HIv1___TS.g25764.t1,peve_ptua,49.492,,,,,,,,,,,,,,,,,
OG_16973,,Peve_00022621,Pocillopora_meandrina_HIv1___RNAseq.g21013.t1,peve_ptua,51.475,,,,,,,,,,,,,,,,,
OG_16974,,Peve_00022632,Pocillopora_meandrina_HIv1___TS.g19347.t2b,peve_ptua,45.137,,,,,,,,,,,,,,,,,
OG_16975,,Peve_00022642,Pocillopora_meandrina_HIv1___RNAseq.g8029.t1,peve_ptua,97.143,,,,,,,,,,,,,,,,,
OG_16976,,Peve_00022665,Pocillopora_meandrina_HIv1___TS.g8204.t1,peve_ptua,39.418,,,,,,,,,,,,,,,,,
OG_16977,,Peve_00022677,Pocillopora_meandrina_HIv1___RNAseq.g4834.t1a,peve_ptua,74.751,,,,,,,,,,,,,,,,,
OG_16978,,Peve_00022726,Pocillopora_meandrina_HIv1___RNAseq.g26410.t1,peve_ptua,86.893,,,,,,,,,,,,,,,,,
OG_16979,,Peve_00022732,Pocillopora_meandrina_HIv1___RNAseq.g3987.t1,peve_ptua,47.716,,,,,,,,,,,,,,,,,
OG_16980,,Peve_00022747,Pocillopora_meandrina_HIv1___RNAseq.g18825.t1,peve_ptua,34.846999999999994,,,,,,,,,,,,,,,,,
OG_16981,,Peve_00022756,Pocillopora_meandrina_HIv1___RNAseq.g13109.t1,peve_ptua,73.7835,,,,,,,,,,,,,,,,,
OG_16982,,Peve_00022773,Pocillopora_meandrina_HIv1___RNAseq.g5085.t1,peve_ptua,66.29,,,,,,,,,,,,,,,,,
OG_16983,,Peve_00022796,Pocillopora_meandrina_HIv1___RNAseq.g11947.t1,peve_ptua,48.229,,,,,,,,,,,,,,,,,
OG_16984,,Peve_00022806,Pocillopora_meandrina_HIv1___RNAseq.g10225.t1b,peve_ptua,93.294,,,,,,,,,,,,,,,,,
OG_16985,,Peve_00022809,Pocillopora_meandrina_HIv1___TS.g29374.t1a,peve_ptua,44.811,,,,,,,,,,,,,,,,,
OG_16986,,Peve_00022811,Pocillopora_meandrina_HIv1___RNAseq.g19984.t1,peve_ptua,45.816,,,,,,,,,,,,,,,,,
OG_16987,,Peve_00022812,Pocillopora_meandrina_HIv1___RNAseq.g19985.t1,peve_ptua,45.1535,,,,,,,,,,,,,,,,,
OG_16988,,Peve_00022824,Pocillopora_meandrina_HIv1___RNAseq.g28107.t1,peve_ptua,59.8245,,,,,,,,,,,,,,,,,
OG_16989,,Peve_00022844,Pocillopora_meandrina_HIv1___RNAseq.g321.t1,peve_ptua,43.7715,,,,,,,,,,,,,,,,,
OG_16990,,Peve_00022887,Pocillopora_meandrina_HIv1___RNAseq.g6133.t1,peve_ptua,85.437,,,,,,,,,,,,,,,,,
OG_16991,,Peve_00022901,Pocillopora_meandrina_HIv1___RNAseq.g9769.t1,peve_ptua,71.64699999999999,,,,,,,,,,,,,,,,,
OG_16992,,Peve_00022902,Pocillopora_meandrina_HIv1___RNAseq.g23251.t1,peve_ptua,66.5135,,,,,,,,,,,,,,,,,
OG_16993,,Peve_00022903,Pocillopora_meandrina_HIv1___TS.g23270.t1,peve_ptua,45.054,,,,,,,,,,,,,,,,,
OG_16994,,Peve_00022907,Pocillopora_meandrina_HIv1___RNAseq.g9767.t1,peve_ptua,75.377,,,,,,,,,,,,,,,,,
OG_16995,,Peve_00022973,Pocillopora_meandrina_HIv1___TS.g8451.t1,peve_ptua,92.771,,,,,,,,,,,,,,,,,
OG_16996,,Peve_00022985,Pocillopora_meandrina_HIv1___RNAseq.g20326.t1,peve_ptua,35.943,,,,,,,,,,,,,,,,,
OG_16997,,Peve_00023002,Pocillopora_meandrina_HIv1___RNAseq.g22081.t1,peve_ptua,75.476,,,,,,,,,,,,,,,,,
OG_16998,,Peve_00023015,Pocillopora_meandrina_HIv1___RNAseq.g6426.t1,peve_ptua,86.863,,,,,,,,,,,,,,,,,
OG_16999,,Peve_00023091,Pocillopora_meandrina_HIv1___RNAseq.g14765.t1,peve_ptua,74.834,,,,,,,,,,,,,,,,,
OG_17000,,Peve_00023118,Pocillopora_meandrina_HIv1___RNAseq.g14013.t1,peve_ptua,46.479,,,,,,,,,,,,,,,,,
OG_17001,,Peve_00023125,Pocillopora_meandrina_HIv1___RNAseq.g14021.t1,peve_ptua,41.975,,,,,,,,,,,,,,,,,
OG_17002,,Peve_00023129,Pocillopora_meandrina_HIv1___RNAseq.g14024.t1,peve_ptua,54.688,,,,,,,,,,,,,,,,,
OG_17003,,Peve_00023133,Pocillopora_meandrina_HIv1___RNAseq.g14012.t1,peve_ptua,73.214,,,,,,,,,,,,,,,,,
OG_17004,,Peve_00023146,Pocillopora_meandrina_HIv1___RNAseq.g14029.t1,peve_ptua,52.176,,,,,,,,,,,,,,,,,
OG_17005,,Peve_00023171,Pocillopora_meandrina_HIv1___RNAseq.g12313.t1,peve_ptua,81.9105,,,,,,,,,,,,,,,,,
OG_17006,,Peve_00023182,Pocillopora_meandrina_HIv1___RNAseq.g27374.t1,peve_ptua,61.6755,,,,,,,,,,,,,,,,,
OG_17007,,Peve_00023232,Pocillopora_meandrina_HIv1___RNAseq.g1992.t1,peve_ptua,67.969,,,,,,,,,,,,,,,,,
OG_17008,,Peve_00023241,Pocillopora_meandrina_HIv1___RNAseq.g23126.t2b,peve_ptua,43.458,,,,,,,,,,,,,,,,,
OG_17009,,Peve_00023245,Pocillopora_meandrina_HIv1___RNAseq.g29758.t1,peve_ptua,44.667,,,,,,,,,,,,,,,,,
OG_17010,,Peve_00023248,Pocillopora_meandrina_HIv1___TS.g24992.t1,peve_ptua,39.331,,,,,,,,,,,,,,,,,
OG_17011,,Peve_00023283,Pocillopora_meandrina_HIv1___RNAseq.g7233.t1,peve_ptua,49.638,,,,,,,,,,,,,,,,,
OG_17012,,Peve_00023284,Pocillopora_meandrina_HIv1___RNAseq.g863.t1,peve_ptua,58.561,,,,,,,,,,,,,,,,,
OG_17013,,Peve_00023297,Pocillopora_meandrina_HIv1___TS.g27169.t2,peve_ptua,71.765,,,,,,,,,,,,,,,,,
OG_17014,,Peve_00023311,Pocillopora_meandrina_HIv1___RNAseq.g15484.t1,peve_ptua,98.45,,,,,,,,,,,,,,,,,
OG_17015,,Peve_00023327,Pocillopora_meandrina_HIv1___RNAseq.g17304.t1,peve_ptua,44.275,,,,,,,,,,,,,,,,,
OG_17016,,Peve_00023330,Pocillopora_meandrina_HIv1___RNAseq.g17290.t1,peve_ptua,53.1155,,,,,,,,,,,,,,,,,
OG_17017,,Peve_00023344,Pocillopora_meandrina_HIv1___TS.g3040.t1,peve_ptua,39.32,,,,,,,,,,,,,,,,,
OG_17018,,Peve_00023348,Pocillopora_meandrina_HIv1___RNAseq.g17270.t1,peve_ptua,50.7245,,,,,,,,,,,,,,,,,
OG_17019,,Peve_00023352,Pocillopora_meandrina_HIv1___RNAseq.g17262.t1,peve_ptua,58.462,,,,,,,,,,,,,,,,,
OG_17020,,Peve_00023365,Pocillopora_meandrina_HIv1___RNAseq.g17298.t1,peve_ptua,57.407,,,,,,,,,,,,,,,,,
OG_17021,,Peve_00023371,Pocillopora_meandrina_HIv1___RNAseq.g8816.t1,peve_ptua,71.739,,,,,,,,,,,,,,,,,
OG_17022,,Peve_00023387,Pocillopora_meandrina_HIv1___RNAseq.g1881.t1,peve_ptua,72.18,,,,,,,,,,,,,,,,,
OG_17023,,Peve_00023409,Pocillopora_meandrina_HIv1___TS.g4386.t1,peve_ptua,66.892,,,,,,,,,,,,,,,,,
OG_17024,,Peve_00023436,Pocillopora_meandrina_HIv1___RNAseq.g11592.t1,peve_ptua,72.5275,,,,,,,,,,,,,,,,,
OG_17025,,Peve_00023466,Pocillopora_meandrina_HIv1___RNAseq.g23674.t1,peve_ptua,34.862,,,,,,,,,,,,,,,,,
OG_17026,,Peve_00023467,Pocillopora_meandrina_HIv1___TS.g16548.t1,peve_ptua,37.387,,,,,,,,,,,,,,,,,
OG_17027,,Peve_00023470,Pocillopora_meandrina_HIv1___RNAseq.g23669.t1,peve_ptua,50.1705,,,,,,,,,,,,,,,,,
OG_17028,,Peve_00023474,Pocillopora_meandrina_HIv1___TS.g16544.t1,peve_ptua,48.624,,,,,,,,,,,,,,,,,
OG_17029,,Peve_00023545,Pocillopora_meandrina_HIv1___RNAseq.g22705.t1,peve_ptua,90.141,,,,,,,,,,,,,,,,,
OG_17030,,Peve_00023573,Pocillopora_meandrina_HIv1___RNAseq.g23874.t1,peve_ptua,48.7545,,,,,,,,,,,,,,,,,
OG_17031,,Peve_00023577,Pocillopora_meandrina_HIv1___TS.g11538.t1,peve_ptua,32.394,,,,,,,,,,,,,,,,,
OG_17032,,Peve_00023587,Pocillopora_meandrina_HIv1___RNAseq.g15704.t1,peve_ptua,73.506,,,,,,,,,,,,,,,,,
OG_17033,,Peve_00023594,Pocillopora_meandrina_HIv1___TS.g10663.t1,peve_ptua,43.005,,,,,,,,,,,,,,,,,
OG_17034,,Peve_00023618,Pocillopora_meandrina_HIv1___RNAseq.g1056.t1,peve_ptua,74.026,,,,,,,,,,,,,,,,,
OG_17035,,Peve_00023622,Pocillopora_meandrina_HIv1___RNAseq.g1057.t1,peve_ptua,54.514,,,,,,,,,,,,,,,,,
OG_17036,,Peve_00023631,Pocillopora_meandrina_HIv1___RNAseq.g4960.t1,peve_ptua,56.842,,,,,,,,,,,,,,,,,
OG_17037,,Peve_00023632,Pocillopora_meandrina_HIv1___RNAseq.g4959.t1,peve_ptua,44.389,,,,,,,,,,,,,,,,,
OG_17038,,Peve_00023634,Pocillopora_meandrina_HIv1___RNAseq.g4968.t1,peve_ptua,73.239,,,,,,,,,,,,,,,,,
OG_17039,,Peve_00023636,Pocillopora_meandrina_HIv1___TS.g8749.t1,peve_ptua,61.572,,,,,,,,,,,,,,,,,
OG_17040,,Peve_00023650,Pocillopora_meandrina_HIv1___RNAseq.g1405.t1,peve_ptua,67.532,,,,,,,,,,,,,,,,,
OG_17041,,Peve_00023651,Pocillopora_meandrina_HIv1___RNAseq.g15998.t1,peve_ptua,52.229,,,,,,,,,,,,,,,,,
OG_17042,,Peve_00023656,Pocillopora_meandrina_HIv1___RNAseq.g16119.t1,peve_ptua,58.964,,,,,,,,,,,,,,,,,
OG_17043,,Peve_00023697,Pocillopora_meandrina_HIv1___RNAseq.g14072.t1,peve_ptua,60.2835,,,,,,,,,,,,,,,,,
OG_17044,,Peve_00023698,Pocillopora_meandrina_HIv1___RNAseq.g14070.t1,peve_ptua,58.904,,,,,,,,,,,,,,,,,
OG_17045,,Peve_00023719,Pocillopora_meandrina_HIv1___RNAseq.g24668.t1,peve_ptua,44.796,,,,,,,,,,,,,,,,,
OG_17046,,Peve_00023738,Pocillopora_meandrina_HIv1___RNAseq.g20464.t1,peve_ptua,58.104,,,,,,,,,,,,,,,,,
OG_17047,,Peve_00023741,Pocillopora_meandrina_HIv1___RNAseq.g20489.t1,peve_ptua,70.265,,,,,,,,,,,,,,,,,
OG_17048,,Peve_00023758,Pocillopora_meandrina_HIv1___RNAseq.g29999.t1,peve_ptua,53.079,,,,,,,,,,,,,,,,,
OG_17049,,Peve_00023767,Pocillopora_meandrina_HIv1___RNAseq.g20479.t1,peve_ptua,63.128,,,,,,,,,,,,,,,,,
OG_17050,,Peve_00023771,Pocillopora_meandrina_HIv1___RNAseq.g20473.t1,peve_ptua,51.464,,,,,,,,,,,,,,,,,
OG_17051,,Peve_00023812,Pocillopora_meandrina_HIv1___RNAseq.g3892.t1,peve_ptua,80.171,,,,,,,,,,,,,,,,,
OG_17052,,Peve_00023815,Pocillopora_meandrina_HIv1___RNAseq.g29861.t1,peve_ptua,58.78,,,,,,,,,,,,,,,,,
OG_17053,,Peve_00023857,Pocillopora_meandrina_HIv1___RNAseq.g15882.t1,peve_ptua,47.727,,,,,,,,,,,,,,,,,
OG_17054,,Peve_00023892,Pocillopora_meandrina_HIv1___RNAseq.g19606.t1,peve_ptua,91.667,,,,,,,,,,,,,,,,,
OG_17055,,Peve_00023934,Pocillopora_meandrina_HIv1___TS.g18078.t3,peve_ptua,67.615,,,,,,,,,,,,,,,,,
OG_17056,,Peve_00023942,Pocillopora_meandrina_HIv1___RNAseq.g10002.t1,peve_ptua,64.234,,,,,,,,,,,,,,,,,
OG_17057,,Peve_00023963,Pocillopora_meandrina_HIv1___TS.g18624.t1,peve_ptua,79.412,,,,,,,,,,,,,,,,,
OG_17058,,Peve_00023981,Pocillopora_meandrina_HIv1___TS.g26480.t1,peve_ptua,55.228,,,,,,,,,,,,,,,,,
OG_17059,,Peve_00023988,Pocillopora_meandrina_HIv1___RNAseq.g21721.t1,peve_ptua,69.984,,,,,,,,,,,,,,,,,
OG_17060,,Peve_00024020,Pocillopora_meandrina_HIv1___RNAseq.g21407.t1,peve_ptua,77.273,,,,,,,,,,,,,,,,,
OG_17061,,Peve_00024023,Pocillopora_meandrina_HIv1___RNAseq.g12615.t1,peve_ptua,78.409,,,,,,,,,,,,,,,,,
OG_17062,,Peve_00024033,Pocillopora_meandrina_HIv1___RNAseq.g24833.t1,peve_ptua,63.71,,,,,,,,,,,,,,,,,
OG_17063,,Peve_00024040,Pocillopora_meandrina_HIv1___RNAseq.g14863.t1,peve_ptua,56.771,,,,,,,,,,,,,,,,,
OG_17064,,Peve_00024115,Pocillopora_meandrina_HIv1___RNAseq.g11388.t1,peve_ptua,57.483,,,,,,,,,,,,,,,,,
OG_17065,,Peve_00024143,Pocillopora_meandrina_HIv1___RNAseq.g15597.t1,peve_ptua,69.295,,,,,,,,,,,,,,,,,
OG_17066,,Peve_00024179,Pocillopora_meandrina_HIv1___RNAseq.g20421.t1,peve_ptua,44.059,,,,,,,,,,,,,,,,,
OG_17067,,Peve_00024182,Pocillopora_meandrina_HIv1___RNAseq.g20423.t1,peve_ptua,66.923,,,,,,,,,,,,,,,,,
OG_17068,,Peve_00024199,Pocillopora_meandrina_HIv1___RNAseq.g280.t1,peve_ptua,46.0,,,,,,,,,,,,,,,,,
OG_17069,,Peve_00024203,Pocillopora_meandrina_HIv1___TS.g2667.t1,peve_ptua,58.333,,,,,,,,,,,,,,,,,
OG_17070,,Peve_00024241,Pocillopora_meandrina_HIv1___RNAseq.g14384.t1,peve_ptua,41.465500000000006,,,,,,,,,,,,,,,,,
OG_17071,,Peve_00024253,Pocillopora_meandrina_HIv1___RNAseq.g8998.t1,peve_ptua,67.532,,,,,,,,,,,,,,,,,
OG_17072,,Peve_00024307,Pocillopora_meandrina_HIv1___RNAseq.g15002.t1,peve_ptua,82.336,,,,,,,,,,,,,,,,,
OG_17073,,Peve_00024312,Pocillopora_meandrina_HIv1___RNAseq.g4973.t1,peve_ptua,46.632,,,,,,,,,,,,,,,,,
OG_17074,,Peve_00024314,Pocillopora_meandrina_HIv1___RNAseq.g5042.t1,peve_ptua,69.12,,,,,,,,,,,,,,,,,
OG_17075,,Peve_00024342,Pocillopora_meandrina_HIv1___RNAseq.g20667.t1,peve_ptua,54.743,,,,,,,,,,,,,,,,,
OG_17076,,Peve_00024343,Pocillopora_meandrina_HIv1___RNAseq.g20666.t1,peve_ptua,59.348,,,,,,,,,,,,,,,,,
OG_17077,,Peve_00024346,Pocillopora_meandrina_HIv1___RNAseq.g19031.t1,peve_ptua,31.2,,,,,,,,,,,,,,,,,
OG_17078,,Peve_00024364,Pocillopora_meandrina_HIv1___RNAseq.g15030.t1,peve_ptua,88.197,,,,,,,,,,,,,,,,,
OG_17079,,Peve_00024367,Pocillopora_meandrina_HIv1___RNAseq.g15031.t1a,peve_ptua,80.071,,,,,,,,,,,,,,,,,
OG_17080,,Peve_00024410,Pocillopora_meandrina_HIv1___RNAseq.g16616.t1,peve_ptua,45.103,,,,,,,,,,,,,,,,,
OG_17081,,Peve_00024416,Pocillopora_meandrina_HIv1___RNAseq.g6775.t1,peve_ptua,84.068,,,,,,,,,,,,,,,,,
OG_17082,,Peve_00024468,Pocillopora_meandrina_HIv1___RNAseq.g9619.t1,peve_ptua,66.7045,,,,,,,,,,,,,,,,,
OG_17083,,Peve_00024478,Pocillopora_meandrina_HIv1___RNAseq.g2558.t1,peve_ptua,51.327,,,,,,,,,,,,,,,,,
OG_17084,,Peve_00024495,Pocillopora_meandrina_HIv1___RNAseq.g18687.t1,peve_ptua,68.639,,,,,,,,,,,,,,,,,
OG_17085,,Peve_00024513,Pocillopora_meandrina_HIv1___RNAseq.g25546.t1,peve_ptua,59.357,,,,,,,,,,,,,,,,,
OG_17086,,Peve_00024518,Pocillopora_meandrina_HIv1___RNAseq.g1419.t1,peve_ptua,71.7765,,,,,,,,,,,,,,,,,
OG_17087,,Peve_00024521,Pocillopora_meandrina_HIv1___RNAseq.g1414.t1,peve_ptua,73.6765,,,,,,,,,,,,,,,,,
OG_17088,,Peve_00024527,Pocillopora_meandrina_HIv1___RNAseq.g1413.t1,peve_ptua,97.561,,,,,,,,,,,,,,,,,
OG_17089,,Peve_00024530,Pocillopora_meandrina_HIv1___TS.g22813.t1,peve_ptua,45.875,,,,,,,,,,,,,,,,,
OG_17090,,Peve_00024532,Pocillopora_meandrina_HIv1___RNAseq.g1421.t1,peve_ptua,78.333,,,,,,,,,,,,,,,,,
OG_17091,,Peve_00024567,Pocillopora_meandrina_HIv1___RNAseq.g15133.t1,peve_ptua,63.664,,,,,,,,,,,,,,,,,
OG_17092,,Peve_00024577,Pocillopora_meandrina_HIv1___RNAseq.1526_t,peve_ptua,81.0745,,,,,,,,,,,,,,,,,
OG_17093,,Peve_00024590,Pocillopora_meandrina_HIv1___TS.g3471.t1,peve_ptua,59.341,,,,,,,,,,,,,,,,,
OG_17094,,Peve_00024605,Pocillopora_meandrina_HIv1___RNAseq.g12123.t1,peve_ptua,36.538,,,,,,,,,,,,,,,,,
OG_17095,,Peve_00024610,Pocillopora_meandrina_HIv1___TS.g15097.t1,peve_ptua,62.389,,,,,,,,,,,,,,,,,
OG_17096,,Peve_00024612,Pocillopora_meandrina_HIv1___RNAseq.g17693.t1,peve_ptua,58.757,,,,,,,,,,,,,,,,,
OG_17097,,Peve_00024617,Pocillopora_meandrina_HIv1___RNAseq.g23084.t1,peve_ptua,54.023,,,,,,,,,,,,,,,,,
OG_17098,,Peve_00024627,Pocillopora_meandrina_HIv1___RNAseq.g27761.t1a,peve_ptua,78.544,,,,,,,,,,,,,,,,,
OG_17099,,Peve_00024658,Pocillopora_meandrina_HIv1___RNAseq.g27091.t1,peve_ptua,53.571,,,,,,,,,,,,,,,,,
OG_17100,,Peve_00024679,Pocillopora_meandrina_HIv1___TS.g24518.t1,peve_ptua,37.848,,,,,,,,,,,,,,,,,
OG_17101,,Peve_00024698,Pocillopora_meandrina_HIv1___RNAseq.g26014.t1,peve_ptua,67.701,,,,,,,,,,,,,,,,,
OG_17102,,Peve_00024705,Pocillopora_meandrina_HIv1___RNAseq.g17623.t1,peve_ptua,64.05,,,,,,,,,,,,,,,,,
OG_17103,,Peve_00024722,Pocillopora_meandrina_HIv1___RNAseq.g3491.t1,peve_ptua,87.597,,,,,,,,,,,,,,,,,
OG_17104,,Peve_00024756,Pocillopora_meandrina_HIv1___RNAseq.g386.t2,peve_ptua,71.7525,,,,,,,,,,,,,,,,,
OG_17105,,Peve_00024769,Pocillopora_meandrina_HIv1___RNAseq.g13360.t1,peve_ptua,35.906,,,,,,,,,,,,,,,,,
OG_17106,,Peve_00024781,Pocillopora_meandrina_HIv1___RNAseq.g19816.t3,peve_ptua,48.982,,,,,,,,,,,,,,,,,
OG_17107,,Peve_00024824,Pocillopora_meandrina_HIv1___RNAseq.g21022.t1,peve_ptua,62.338,,,,,,,,,,,,,,,,,
OG_17108,,Peve_00024836,Pocillopora_meandrina_HIv1___RNAseq.g24971.t1,peve_ptua,37.41,,,,,,,,,,,,,,,,,
OG_17109,,Peve_00024837,Pocillopora_meandrina_HIv1___RNAseq.g21141.t1,peve_ptua,42.489,,,,,,,,,,,,,,,,,
OG_17110,,Peve_00024852,Pocillopora_meandrina_HIv1___RNAseq.g15959.t1,peve_ptua,55.084,,,,,,,,,,,,,,,,,
OG_17111,,Peve_00024862,Pocillopora_meandrina_HIv1___RNAseq.g22733.t1a,peve_ptua,62.883,,,,,,,,,,,,,,,,,
OG_17112,,Peve_00024906,Pocillopora_meandrina_HIv1___RNAseq.g7965.t1,peve_ptua,59.777,,,,,,,,,,,,,,,,,
OG_17113,,Peve_00024909,Pocillopora_meandrina_HIv1___RNAseq.g7955.t1,peve_ptua,63.51,,,,,,,,,,,,,,,,,
OG_17114,,Peve_00024934,Pocillopora_meandrina_HIv1___RNAseq.g20290.t1,peve_ptua,48.199,,,,,,,,,,,,,,,,,
OG_17115,,Peve_00024952,Pocillopora_meandrina_HIv1___RNAseq.g19280.t1,peve_ptua,80.41,,,,,,,,,,,,,,,,,
OG_17116,,Peve_00024964,Pocillopora_meandrina_HIv1___TS.g1989.t1,peve_ptua,94.886,,,,,,,,,,,,,,,,,
OG_17117,,Peve_00024965,Pocillopora_meandrina_HIv1___RNAseq.g17836.t1b,peve_ptua,32.151,,,,,,,,,,,,,,,,,
OG_17118,,Peve_00025000,Pocillopora_meandrina_HIv1___TS.g19408.t1,peve_ptua,77.895,,,,,,,,,,,,,,,,,
OG_17119,,Peve_00025015,Pocillopora_meandrina_HIv1___RNAseq.g9947.t1,peve_ptua,53.896,,,,,,,,,,,,,,,,,
OG_17120,,Peve_00025039,Pocillopora_meandrina_HIv1___RNAseq.g14944.t1b,peve_ptua,55.556,,,,,,,,,,,,,,,,,
OG_17121,,Peve_00025086,Pocillopora_meandrina_HIv1___RNAseq.g20029.t1a,peve_ptua,89.062,,,,,,,,,,,,,,,,,
OG_17122,,Peve_00025090,Pocillopora_meandrina_HIv1___TS.g4643.t1,peve_ptua,48.93,,,,,,,,,,,,,,,,,
OG_17123,,Peve_00025107,Pocillopora_meandrina_HIv1___RNAseq.g25569.t1,peve_ptua,68.01650000000001,,,,,,,,,,,,,,,,,
OG_17124,,Peve_00025114,Pocillopora_meandrina_HIv1___RNAseq.g24462.t1,peve_ptua,62.937,,,,,,,,,,,,,,,,,
OG_17125,,Peve_00025125,Pocillopora_meandrina_HIv1___RNAseq.g8203.t1,peve_ptua,58.0375,,,,,,,,,,,,,,,,,
OG_17126,,Peve_00025130,Pocillopora_meandrina_HIv1___RNAseq.g16012.t1,peve_ptua,48.324,,,,,,,,,,,,,,,,,
OG_17127,,Peve_00025144,Pocillopora_meandrina_HIv1___RNAseq.g23823.t1,peve_ptua,74.4495,,,,,,,,,,,,,,,,,
OG_17128,,Peve_00025149,Pocillopora_meandrina_HIv1___RNAseq.g23810.t1,peve_ptua,46.029,,,,,,,,,,,,,,,,,
OG_17129,,Peve_00025153,Pocillopora_meandrina_HIv1___TS.g16689.t1,peve_ptua,67.532,,,,,,,,,,,,,,,,,
OG_17130,,Peve_00025163,Pocillopora_meandrina_HIv1___RNAseq.g20451.t1,peve_ptua,47.5035,,,,,,,,,,,,,,,,,
OG_17131,,Peve_00025194,Pocillopora_meandrina_HIv1___TS.g7260.t1,peve_ptua,50.725,,,,,,,,,,,,,,,,,
OG_17132,,Peve_00025203,Pocillopora_meandrina_HIv1___TS.g10840.t1,peve_ptua,72.802,,,,,,,,,,,,,,,,,
OG_17133,,Peve_00025205,Pocillopora_meandrina_HIv1___RNAseq.g15488.t1,peve_ptua,59.871,,,,,,,,,,,,,,,,,
OG_17134,,Peve_00025281,Pocillopora_meandrina_HIv1___RNAseq.g16562.t1,peve_ptua,43.75,,,,,,,,,,,,,,,,,
OG_17135,,Peve_00025296,Pocillopora_meandrina_HIv1___RNAseq.g9908.t1,peve_ptua,42.391,,,,,,,,,,,,,,,,,
OG_17136,,Peve_00025316,Pocillopora_meandrina_HIv1___RNAseq.g7922.t1,peve_ptua,53.8475,,,,,,,,,,,,,,,,,
OG_17137,,Peve_00025335,Pocillopora_meandrina_HIv1___RNAseq.g3120.t1,peve_ptua,72.013,,,,,,,,,,,,,,,,,
OG_17138,,Peve_00025376,Pocillopora_meandrina_HIv1___RNAseq.g4983.t1,peve_ptua,46.281,,,,,,,,,,,,,,,,,
OG_17139,,Peve_00025412,Pocillopora_meandrina_HIv1___RNAseq.g15140.t1,peve_ptua,72.358,,,,,,,,,,,,,,,,,
OG_17140,,Peve_00025424,Pocillopora_meandrina_HIv1___RNAseq.g15185.t1,peve_ptua,48.58,,,,,,,,,,,,,,,,,
OG_17141,,Peve_00025428,Pocillopora_meandrina_HIv1___TS.g8958.t1,peve_ptua,62.5,,,,,,,,,,,,,,,,,
OG_17142,,Peve_00025454,Pocillopora_meandrina_HIv1___TS.g3820.t1,peve_ptua,66.761,,,,,,,,,,,,,,,,,
OG_17143,,Peve_00025458,Pocillopora_meandrina_HIv1___RNAseq.g16135.t2,peve_ptua,39.659,,,,,,,,,,,,,,,,,
OG_17144,,Peve_00025629,Pocillopora_meandrina_HIv1___RNAseq.g16715.t1,peve_ptua,67.513,,,,,,,,,,,,,,,,,
OG_17145,,Peve_00025637,Pocillopora_meandrina_HIv1___RNAseq.g25728.t1,peve_ptua,47.781,,,,,,,,,,,,,,,,,
OG_17146,,Peve_00025643,Pocillopora_meandrina_HIv1___RNAseq.g28043.t1,peve_ptua,56.796,,,,,,,,,,,,,,,,,
OG_17147,,Peve_00025697,Pocillopora_meandrina_HIv1___RNAseq.g5453.t1,peve_ptua,73.109,,,,,,,,,,,,,,,,,
OG_17148,,Peve_00025700,Pocillopora_meandrina_HIv1___RNAseq.g9231.t1,peve_ptua,72.246,,,,,,,,,,,,,,,,,
OG_17149,,Peve_00025721,Pocillopora_meandrina_HIv1___RNAseq.g15305.t1,peve_ptua,72.2,,,,,,,,,,,,,,,,,
OG_17150,,Peve_00025727,Pocillopora_meandrina_HIv1___RNAseq.g15308.t1,peve_ptua,74.5925,,,,,,,,,,,,,,,,,
OG_17151,,Peve_00025730,Pocillopora_meandrina_HIv1___TS.g10865.t1,peve_ptua,47.284,,,,,,,,,,,,,,,,,
OG_17152,,Peve_00025734,Pocillopora_meandrina_HIv1___RNAseq.g15841.t1,peve_ptua,55.611,,,,,,,,,,,,,,,,,
OG_17153,,Peve_00025743,Pocillopora_meandrina_HIv1___RNAseq.g1599.t2,peve_ptua,76.549,,,,,,,,,,,,,,,,,
OG_17154,,Peve_00025766,Pocillopora_meandrina_HIv1___RNAseq.g25645.t1,peve_ptua,69.923,,,,,,,,,,,,,,,,,
OG_17155,,Peve_00025779,Pocillopora_meandrina_HIv1___RNAseq.g1158.t1,peve_ptua,47.778,,,,,,,,,,,,,,,,,
OG_17156,,Peve_00025805,Pocillopora_meandrina_HIv1___RNAseq.g6922.t1,peve_ptua,53.665,,,,,,,,,,,,,,,,,
OG_17157,,Peve_00025819,Pocillopora_meandrina_HIv1___TS.g27929.t1,peve_ptua,80.208,,,,,,,,,,,,,,,,,
OG_17158,,Peve_00025841,Pocillopora_meandrina_HIv1___TS.g9734.t1a,peve_ptua,48.077,,,,,,,,,,,,,,,,,
OG_17159,,Peve_00025870,Pocillopora_meandrina_HIv1___RNAseq.g2967.t1,peve_ptua,80.899,,,,,,,,,,,,,,,,,
OG_17160,,Peve_00025872,Pocillopora_meandrina_HIv1___RNAseq.g2966.t1,peve_ptua,59.259,,,,,,,,,,,,,,,,,
OG_17161,,Peve_00025902,Pocillopora_meandrina_HIv1___RNAseq.g13147.t1,peve_ptua,42.982,,,,,,,,,,,,,,,,,
OG_17162,,Peve_00025906,Pocillopora_meandrina_HIv1___RNAseq.g25903.t1,peve_ptua,32.4555,,,,,,,,,,,,,,,,,
OG_17163,,Peve_00025951,Pocillopora_meandrina_HIv1___RNAseq.g25832.t1a,peve_ptua,55.303,,,,,,,,,,,,,,,,,
OG_17164,,Peve_00026000,Pocillopora_meandrina_HIv1___RNAseq.g15146.t1,peve_ptua,42.46,,,,,,,,,,,,,,,,,
OG_17165,,Peve_00026008,Pocillopora_meandrina_HIv1___RNAseq.g11644.t1,peve_ptua,68.94,,,,,,,,,,,,,,,,,
OG_17166,,Peve_00026018,Pocillopora_meandrina_HIv1___RNAseq.g15175.t1,peve_ptua,66.6155,,,,,,,,,,,,,,,,,
OG_17167,,Peve_00026047,Pocillopora_meandrina_HIv1___RNAseq.g25207.t1,peve_ptua,76.744,,,,,,,,,,,,,,,,,
OG_17168,,Peve_00026075,Pocillopora_meandrina_HIv1___RNAseq.g18771.t1,peve_ptua,59.868,,,,,,,,,,,,,,,,,
OG_17169,,Peve_00026079,Pocillopora_meandrina_HIv1___RNAseq.g18776.t1,peve_ptua,41.224,,,,,,,,,,,,,,,,,
OG_17170,,Peve_00026083,Pocillopora_meandrina_HIv1___RNAseq.g18779.t1,peve_ptua,76.382,,,,,,,,,,,,,,,,,
OG_17171,,Peve_00026084,Pocillopora_meandrina_HIv1___RNAseq.g18780.t1,peve_ptua,45.296,,,,,,,,,,,,,,,,,
OG_17172,,Peve_00026085,Pocillopora_meandrina_HIv1___RNAseq.g18782.t1,peve_ptua,51.643,,,,,,,,,,,,,,,,,
OG_17173,,Peve_00026087,Pocillopora_meandrina_HIv1___RNAseq.g11637.t1,peve_ptua,48.416,,,,,,,,,,,,,,,,,
OG_17174,,Peve_00026088,Pocillopora_meandrina_HIv1___RNAseq.g18785.t1,peve_ptua,58.333,,,,,,,,,,,,,,,,,
OG_17175,,Peve_00026089,Pocillopora_meandrina_HIv1___RNAseq.g18767.t1,peve_ptua,56.383,,,,,,,,,,,,,,,,,
OG_17176,,Peve_00026118,Pocillopora_meandrina_HIv1___RNAseq.g2633.t1,peve_ptua,60.998,,,,,,,,,,,,,,,,,
OG_17177,,Peve_00026121,Pocillopora_meandrina_HIv1___RNAseq.g9228.t1,peve_ptua,61.143,,,,,,,,,,,,,,,,,
OG_17178,,Peve_00026139,Pocillopora_meandrina_HIv1___TS.g22928.t1,peve_ptua,53.644,,,,,,,,,,,,,,,,,
OG_17179,,Peve_00026146,Pocillopora_meandrina_HIv1___RNAseq.g15889.t1,peve_ptua,54.71,,,,,,,,,,,,,,,,,
OG_17180,,Peve_00026157,Pocillopora_meandrina_HIv1___TS.g10607.t1,peve_ptua,49.0625,,,,,,,,,,,,,,,,,
OG_17181,,Peve_00026171,Pocillopora_meandrina_HIv1___RNAseq.g15393.t1,peve_ptua,49.869,,,,,,,,,,,,,,,,,
OG_17182,,Peve_00026195,Pocillopora_meandrina_HIv1___RNAseq.g19602.t1,peve_ptua,44.34,,,,,,,,,,,,,,,,,
OG_17183,,Peve_00026201,Pocillopora_meandrina_HIv1___RNAseq.g12366.t1,peve_ptua,46.875,,,,,,,,,,,,,,,,,
OG_17184,,Peve_00026202,Pocillopora_meandrina_HIv1___TS.g9976.t1,peve_ptua,63.21,,,,,,,,,,,,,,,,,
OG_17185,,Peve_00026241,Pocillopora_meandrina_HIv1___RNAseq.g16198.t1,peve_ptua,37.338,,,,,,,,,,,,,,,,,
OG_17186,,Peve_00026244,Pocillopora_meandrina_HIv1___RNAseq.g6387.t1,peve_ptua,70.513,,,,,,,,,,,,,,,,,
OG_17187,,Peve_00026248,Pocillopora_meandrina_HIv1___RNAseq.g16197.t1,peve_ptua,55.735,,,,,,,,,,,,,,,,,
OG_17188,,Peve_00026261,Pocillopora_meandrina_HIv1___RNAseq.g1912.t1,peve_ptua,67.105,,,,,,,,,,,,,,,,,
OG_17189,,Peve_00026262,Pocillopora_meandrina_HIv1___RNAseq.g22995.t1,peve_ptua,42.087,,,,,,,,,,,,,,,,,
OG_17190,,Peve_00026264,Pocillopora_meandrina_HIv1___RNAseq.g22994.t1,peve_ptua,68.182,,,,,,,,,,,,,,,,,
OG_17191,,Peve_00026285,Pocillopora_meandrina_HIv1___RNAseq.g7876.t1,peve_ptua,52.941,,,,,,,,,,,,,,,,,
OG_17192,,Peve_00026289,Pocillopora_meandrina_HIv1___RNAseq.g7880.t1,peve_ptua,60.584,,,,,,,,,,,,,,,,,
OG_17193,,Peve_00026323,Pocillopora_meandrina_HIv1___RNAseq.g4773.t1,peve_ptua,72.201,,,,,,,,,,,,,,,,,
OG_17194,,Peve_00026335,Pocillopora_meandrina_HIv1___RNAseq.g8341.t1,peve_ptua,52.116,,,,,,,,,,,,,,,,,
OG_17195,,Peve_00026342,Pocillopora_meandrina_HIv1___RNAseq.g5727.t1,peve_ptua,52.7615,,,,,,,,,,,,,,,,,
OG_17196,,Peve_00026343,Pocillopora_meandrina_HIv1___RNAseq.g12657.t1,peve_ptua,80.814,,,,,,,,,,,,,,,,,
OG_17197,,Peve_00026365,Pocillopora_meandrina_HIv1___RNAseq.g23159.t1,peve_ptua,57.447,,,,,,,,,,,,,,,,,
OG_17198,,Peve_00026375,Pocillopora_meandrina_HIv1___RNAseq.g20931.t1,peve_ptua,51.34,,,,,,,,,,,,,,,,,
OG_17199,,Peve_00026377,Pocillopora_meandrina_HIv1___RNAseq.g9020.t1,peve_ptua,44.0,,,,,,,,,,,,,,,,,
OG_17200,,Peve_00026399,Pocillopora_meandrina_HIv1___RNAseq.g18559.t1,peve_ptua,74.819,,,,,,,,,,,,,,,,,
OG_17201,,Peve_00026404,Pocillopora_meandrina_HIv1___RNAseq.g24698.t1,peve_ptua,55.975,,,,,,,,,,,,,,,,,
OG_17202,,Peve_00026406,Pocillopora_meandrina_HIv1___RNAseq.g6103.t1,peve_ptua,77.174,,,,,,,,,,,,,,,,,
OG_17203,,Peve_00026419,Pocillopora_meandrina_HIv1___RNAseq.g18430.t1,peve_ptua,38.524,,,,,,,,,,,,,,,,,
OG_17204,,Peve_00026481,Pocillopora_meandrina_HIv1___TS.g4143.t1,peve_ptua,45.4605,,,,,,,,,,,,,,,,,
OG_17205,,Peve_00026497,Pocillopora_meandrina_HIv1___RNAseq.g25610.t1,peve_ptua,64.238,,,,,,,,,,,,,,,,,
OG_17206,,Peve_00026503,Pocillopora_meandrina_HIv1___TS.g27215.t1,peve_ptua,55.43,,,,,,,,,,,,,,,,,
OG_17207,,Peve_00026513,Pocillopora_meandrina_HIv1___RNAseq.g5156.t1,peve_ptua,57.729,,,,,,,,,,,,,,,,,
OG_17208,,Peve_00026521,Pocillopora_meandrina_HIv1___RNAseq.g5166.t1,peve_ptua,71.287,,,,,,,,,,,,,,,,,
OG_17209,,Peve_00026532,Pocillopora_meandrina_HIv1___RNAseq.g5097.t1,peve_ptua,50.588,,,,,,,,,,,,,,,,,
OG_17210,,Peve_00026600,Pocillopora_meandrina_HIv1___TS.g20985.t1,peve_ptua,76.262,,,,,,,,,,,,,,,,,
OG_17211,,Peve_00026626,Pocillopora_meandrina_HIv1___RNAseq.g25366.t1,peve_ptua,63.532,,,,,,,,,,,,,,,,,
OG_17212,,Peve_00026653,Pocillopora_meandrina_HIv1___TS.g2510.t1,peve_ptua,54.545,,,,,,,,,,,,,,,,,
OG_17213,,Peve_00026654,Pocillopora_meandrina_HIv1___RNAseq.g13523.t1,peve_ptua,66.22200000000001,,,,,,,,,,,,,,,,,
OG_17214,,Peve_00026716,Pocillopora_meandrina_HIv1___RNAseq.g3566.t1,peve_ptua,46.359,,,,,,,,,,,,,,,,,
OG_17215,,Peve_00026721,Pocillopora_meandrina_HIv1___RNAseq.g10494.t1,peve_ptua,40.684,,,,,,,,,,,,,,,,,
OG_17216,,Peve_00026724,Pocillopora_meandrina_HIv1___RNAseq.g10497.t1,peve_ptua,55.844,,,,,,,,,,,,,,,,,
OG_17217,,Peve_00026731,Pocillopora_meandrina_HIv1___RNAseq.g7828.t1,peve_ptua,43.797,,,,,,,,,,,,,,,,,
OG_17218,,Peve_00026732,Pocillopora_meandrina_HIv1___RNAseq.g7826.t1,peve_ptua,72.587,,,,,,,,,,,,,,,,,
OG_17219,,Peve_00026743,Pocillopora_meandrina_HIv1___TS.g27181.t1,peve_ptua,70.321,,,,,,,,,,,,,,,,,
OG_17220,,Peve_00026746,Pocillopora_meandrina_HIv1___RNAseq.g28781.t1,peve_ptua,72.906,,,,,,,,,,,,,,,,,
OG_17221,,Peve_00026779,Pocillopora_meandrina_HIv1___RNAseq.g19838.t1,peve_ptua,40.099,,,,,,,,,,,,,,,,,
OG_17222,,Peve_00026782,Pocillopora_meandrina_HIv1___RNAseq.g19273.t1,peve_ptua,79.104,,,,,,,,,,,,,,,,,
OG_17223,,Peve_00026783,Pocillopora_meandrina_HIv1___RNAseq.g14973.t1,peve_ptua,50.259,,,,,,,,,,,,,,,,,
OG_17224,,Peve_00026787,Pocillopora_meandrina_HIv1___RNAseq.g28399.t1,peve_ptua,54.819,,,,,,,,,,,,,,,,,
OG_17225,,Peve_00026797,Pocillopora_meandrina_HIv1___RNAseq.g23339.t1,peve_ptua,38.217,,,,,,,,,,,,,,,,,
OG_17226,,Peve_00026833,Pocillopora_meandrina_HIv1___RNAseq.g16319.t1,peve_ptua,36.522,,,,,,,,,,,,,,,,,
OG_17227,,Peve_00026845,Pocillopora_meandrina_HIv1___RNAseq.g28640.t1,peve_ptua,48.4845,,,,,,,,,,,,,,,,,
OG_17228,,Peve_00026852,Pocillopora_meandrina_HIv1___RNAseq.g17156.t1,peve_ptua,45.902,,,,,,,,,,,,,,,,,
OG_17229,,Peve_00026870,Pocillopora_meandrina_HIv1___RNAseq.g25585.t2,peve_ptua,60.0,,,,,,,,,,,,,,,,,
OG_17230,,Peve_00026873,Pocillopora_meandrina_HIv1___RNAseq.g25557.t1,peve_ptua,56.136,,,,,,,,,,,,,,,,,
OG_17231,,Peve_00026880,Pocillopora_meandrina_HIv1___RNAseq.g15000.t1,peve_ptua,73.569,,,,,,,,,,,,,,,,,
OG_17232,,Peve_00026915,Pocillopora_meandrina_HIv1___RNAseq.g24007.t1a,peve_ptua,75.66,,,,,,,,,,,,,,,,,
OG_17233,,Peve_00026916,Pocillopora_meandrina_HIv1___RNAseq.g23692.t1,peve_ptua,70.14,,,,,,,,,,,,,,,,,
OG_17234,,Peve_00026953,Pocillopora_meandrina_HIv1___RNAseq.g7157.t1,peve_ptua,62.963,,,,,,,,,,,,,,,,,
OG_17235,,Peve_00026956,Pocillopora_meandrina_HIv1___TS.g22815.t1,peve_ptua,56.981,,,,,,,,,,,,,,,,,
OG_17236,,Peve_00026961,Pocillopora_meandrina_HIv1___RNAseq.g7054.t1,peve_ptua,65.964,,,,,,,,,,,,,,,,,
OG_17237,,Peve_00026977,Pocillopora_meandrina_HIv1___RNAseq.g7074.t1,peve_ptua,69.524,,,,,,,,,,,,,,,,,
OG_17238,,Peve_00027011,Pocillopora_meandrina_HIv1___RNAseq.g23918.t1,peve_ptua,39.701,,,,,,,,,,,,,,,,,
OG_17239,,Peve_00027013,Pocillopora_meandrina_HIv1___RNAseq.g23286.t1,peve_ptua,36.508,,,,,,,,,,,,,,,,,
OG_17240,,Peve_00027016,Pocillopora_meandrina_HIv1___RNAseq.g23283.t1,peve_ptua,58.009,,,,,,,,,,,,,,,,,
OG_17241,,Peve_00027021,Pocillopora_meandrina_HIv1___RNAseq.g22123.t1,peve_ptua,73.878,,,,,,,,,,,,,,,,,
OG_17242,,Peve_00027043,Pocillopora_meandrina_HIv1___RNAseq.g7101.t1,peve_ptua,77.644,,,,,,,,,,,,,,,,,
OG_17243,,Peve_00027044,Pocillopora_meandrina_HIv1___RNAseq.g7100.t1,peve_ptua,52.647,,,,,,,,,,,,,,,,,
OG_17244,,Peve_00027050,Pocillopora_meandrina_HIv1___RNAseq.g13378.t1,peve_ptua,51.473,,,,,,,,,,,,,,,,,
OG_17245,,Peve_00027101,Pocillopora_meandrina_HIv1___TS.g4479.t1b,peve_ptua,57.947,,,,,,,,,,,,,,,,,
OG_17246,,Peve_00027102,Pocillopora_meandrina_HIv1___RNAseq.g1960.t1,peve_ptua,52.1015,,,,,,,,,,,,,,,,,
OG_17247,,Peve_00027151,Pocillopora_meandrina_HIv1___TS.g22361.t1,peve_ptua,76.543,,,,,,,,,,,,,,,,,
OG_17248,,Peve_00027187,Pocillopora_meandrina_HIv1___RNAseq.g18628.t1,peve_ptua,78.035,,,,,,,,,,,,,,,,,
OG_17249,,Peve_00027188,Pocillopora_meandrina_HIv1___RNAseq.g18629.t1,peve_ptua,76.316,,,,,,,,,,,,,,,,,
OG_17250,,Peve_00027200,Pocillopora_meandrina_HIv1___TS.g14848.t1,peve_ptua,67.35849999999999,,,,,,,,,,,,,,,,,
OG_17251,,Peve_00027213,Pocillopora_meandrina_HIv1___RNAseq.g27509.t1,peve_ptua,67.063,,,,,,,,,,,,,,,,,
OG_17252,,Peve_00027239,Pocillopora_meandrina_HIv1___RNAseq.g10966.t1,peve_ptua,82.195,,,,,,,,,,,,,,,,,
OG_17253,,Peve_00027259,Pocillopora_meandrina_HIv1___TS.g25750.t1,peve_ptua,57.1305,,,,,,,,,,,,,,,,,
OG_17254,,Peve_00027262,Pocillopora_meandrina_HIv1___RNAseq.g28239.t1,peve_ptua,79.091,,,,,,,,,,,,,,,,,
OG_17255,,Peve_00027274,Pocillopora_meandrina_HIv1___TS.g24742.t1,peve_ptua,43.4615,,,,,,,,,,,,,,,,,
OG_17256,,Peve_00027286,Pocillopora_meandrina_HIv1___RNAseq.g25691.t1,peve_ptua,53.631,,,,,,,,,,,,,,,,,
OG_17257,,Peve_00027306,Pocillopora_meandrina_HIv1___RNAseq.g2003.t1,peve_ptua,75.235,,,,,,,,,,,,,,,,,
OG_17258,,Peve_00027309,Pocillopora_meandrina_HIv1___RNAseq.g17188.t1,peve_ptua,41.731,,,,,,,,,,,,,,,,,
OG_17259,,Peve_00027311,Pocillopora_meandrina_HIv1___RNAseq.g23070.t1,peve_ptua,43.523,,,,,,,,,,,,,,,,,
OG_17260,,Peve_00027317,Pocillopora_meandrina_HIv1___RNAseq.g6435.t1a,peve_ptua,58.75,,,,,,,,,,,,,,,,,
OG_17261,,Peve_00027333,Pocillopora_meandrina_HIv1___TS.g6037.t1,peve_ptua,54.515,,,,,,,,,,,,,,,,,
OG_17262,,Peve_00027362,Pocillopora_meandrina_HIv1___RNAseq.g27011.t1,peve_ptua,38.655,,,,,,,,,,,,,,,,,
OG_17263,,Peve_00027381,Pocillopora_meandrina_HIv1___RNAseq.g10917.t1,peve_ptua,35.613,,,,,,,,,,,,,,,,,
OG_17264,,Peve_00027387,Pocillopora_meandrina_HIv1___RNAseq.g11545.t1,peve_ptua,62.311,,,,,,,,,,,,,,,,,
OG_17265,,Peve_00027390,Pocillopora_meandrina_HIv1___RNAseq.g13108.t1,peve_ptua,70.44,,,,,,,,,,,,,,,,,
OG_17266,,Peve_00027401,Pocillopora_meandrina_HIv1___RNAseq.g11408.t1,peve_ptua,54.0,,,,,,,,,,,,,,,,,
OG_17267,,Peve_00027481,Pocillopora_meandrina_HIv1___RNAseq.g28030.t1,peve_ptua,58.29,,,,,,,,,,,,,,,,,
OG_17268,,Peve_00027491,Pocillopora_meandrina_HIv1___RNAseq.g28042.t1,peve_ptua,55.825,,,,,,,,,,,,,,,,,
OG_17269,,Peve_00027496,Pocillopora_meandrina_HIv1___RNAseq.g29202.t1,peve_ptua,32.308,,,,,,,,,,,,,,,,,
OG_17270,,Peve_00027497,Pocillopora_meandrina_HIv1___RNAseq.g29204.t1,peve_ptua,38.991,,,,,,,,,,,,,,,,,
OG_17271,,Peve_00027498,Pocillopora_meandrina_HIv1___RNAseq.g29206.t1,peve_ptua,44.277,,,,,,,,,,,,,,,,,
OG_17272,,Peve_00027515,Pocillopora_meandrina_HIv1___RNAseq.g13743.t1,peve_ptua,52.738,,,,,,,,,,,,,,,,,
OG_17273,,Peve_00027518,Pocillopora_meandrina_HIv1___RNAseq.g28951.t1,peve_ptua,64.871,,,,,,,,,,,,,,,,,
OG_17274,,Peve_00027531,Pocillopora_meandrina_HIv1___RNAseq.17868_t,peve_ptua,75.481,,,,,,,,,,,,,,,,,
OG_17275,,Peve_00027575,Pocillopora_meandrina_HIv1___RNAseq.g28773.t1,peve_ptua,74.815,,,,,,,,,,,,,,,,,
OG_17276,,Peve_00027579,Pocillopora_meandrina_HIv1___RNAseq.g25889.t1,peve_ptua,88.839,,,,,,,,,,,,,,,,,
OG_17277,,Peve_00027585,Pocillopora_meandrina_HIv1___RNAseq.g26357.t1,peve_ptua,56.677,,,,,,,,,,,,,,,,,
OG_17278,,Peve_00027602,Pocillopora_meandrina_HIv1___RNAseq.g26100.t1,peve_ptua,51.572,,,,,,,,,,,,,,,,,
OG_17279,,Peve_00027603,Pocillopora_meandrina_HIv1___RNAseq.g26096.t1,peve_ptua,73.103,,,,,,,,,,,,,,,,,
OG_17280,,Peve_00027609,Pocillopora_meandrina_HIv1___RNAseq.g28822.t3,peve_ptua,62.846,,,,,,,,,,,,,,,,,
OG_17281,,Peve_00027662,Pocillopora_meandrina_HIv1___RNAseq.g18735.t1,peve_ptua,73.333,,,,,,,,,,,,,,,,,
OG_17282,,Peve_00027697,Pocillopora_meandrina_HIv1___RNAseq.g8669.t1,peve_ptua,58.125,,,,,,,,,,,,,,,,,
OG_17283,,Peve_00027705,Pocillopora_meandrina_HIv1___RNAseq.g10989.t1,peve_ptua,52.994,,,,,,,,,,,,,,,,,
OG_17284,,Peve_00027779,Pocillopora_meandrina_HIv1___RNAseq.g23902.t1,peve_ptua,42.466,,,,,,,,,,,,,,,,,
OG_17285,,Peve_00027793,Pocillopora_meandrina_HIv1___TS.g6340.t1,peve_ptua,74.012,,,,,,,,,,,,,,,,,
OG_17286,,Peve_00027836,Pocillopora_meandrina_HIv1___TS.g16293.t1,peve_ptua,57.9465,,,,,,,,,,,,,,,,,
OG_17287,,Peve_00027861,Pocillopora_meandrina_HIv1___TS.g20727.t1,peve_ptua,53.647,,,,,,,,,,,,,,,,,
OG_17288,,Peve_00027917,Pocillopora_meandrina_HIv1___RNAseq.19013_t,peve_ptua,90.055,,,,,,,,,,,,,,,,,
OG_17289,,Peve_00027934,Pocillopora_meandrina_HIv1___RNAseq.g3227.t1,peve_ptua,52.914,,,,,,,,,,,,,,,,,
OG_17290,,Peve_00027958,Pocillopora_meandrina_HIv1___RNAseq.g22051.t1,peve_ptua,58.962,,,,,,,,,,,,,,,,,
OG_17291,,Peve_00027972,Pocillopora_meandrina_HIv1___RNAseq.g14618.t1,peve_ptua,56.444,,,,,,,,,,,,,,,,,
OG_17292,,Peve_00027983,Pocillopora_meandrina_HIv1___RNAseq.g30178.t1,peve_ptua,45.276,,,,,,,,,,,,,,,,,
OG_17293,,Peve_00027986,Pocillopora_meandrina_HIv1___RNAseq.g28490.t1,peve_ptua,57.353,,,,,,,,,,,,,,,,,
OG_17294,,Peve_00028019,Pocillopora_meandrina_HIv1___RNAseq.g11585.t1,peve_ptua,72.619,,,,,,,,,,,,,,,,,
OG_17295,,Peve_00028061,Pocillopora_meandrina_HIv1___RNAseq.g4289.t1,peve_ptua,72.755,,,,,,,,,,,,,,,,,
OG_17296,,Peve_00028068,Pocillopora_meandrina_HIv1___RNAseq.g11744.t1,peve_ptua,37.367,,,,,,,,,,,,,,,,,
OG_17297,,Peve_00028090,Pocillopora_meandrina_HIv1___RNAseq.g22933.t1,peve_ptua,62.992,,,,,,,,,,,,,,,,,
OG_17298,,Peve_00028096,Pocillopora_meandrina_HIv1___RNAseq.g22947.t1,peve_ptua,39.434,,,,,,,,,,,,,,,,,
OG_17299,,Peve_00028103,Pocillopora_meandrina_HIv1___RNAseq.g25261.t1,peve_ptua,67.921,,,,,,,,,,,,,,,,,
OG_17300,,Peve_00028104,Pocillopora_meandrina_HIv1___RNAseq.g25262.t1,peve_ptua,81.517,,,,,,,,,,,,,,,,,
OG_17301,,Peve_00028105,Pocillopora_meandrina_HIv1___TS.g25542.t1c,peve_ptua,90.0925,,,,,,,,,,,,,,,,,
OG_17302,,Peve_00028121,Pocillopora_meandrina_HIv1___RNAseq.g12752.t1,peve_ptua,52.672,,,,,,,,,,,,,,,,,
OG_17303,,Peve_00028139,Pocillopora_meandrina_HIv1___RNAseq.g26864.t1,peve_ptua,40.675,,,,,,,,,,,,,,,,,
OG_17304,,Peve_00028177,Pocillopora_meandrina_HIv1___TS.g10111.t1,peve_ptua,32.537,,,,,,,,,,,,,,,,,
OG_17305,,Peve_00028208,Pocillopora_meandrina_HIv1___RNAseq.g22746.t2,peve_ptua,65.248,,,,,,,,,,,,,,,,,
OG_17306,,Peve_00028216,Pocillopora_meandrina_HIv1___TS.g24530.t1,peve_ptua,61.05,,,,,,,,,,,,,,,,,
OG_17307,,Peve_00028220,Pocillopora_meandrina_HIv1___RNAseq.g16447.t1,peve_ptua,37.5,,,,,,,,,,,,,,,,,
OG_17308,,Peve_00028239,Pocillopora_meandrina_HIv1___RNAseq.g19720.t1,peve_ptua,67.093,,,,,,,,,,,,,,,,,
OG_17309,,Peve_00028287,Pocillopora_meandrina_HIv1___RNAseq.g320.t1,peve_ptua,42.302,,,,,,,,,,,,,,,,,
OG_17310,,Peve_00028295,Pocillopora_meandrina_HIv1___RNAseq.g22554.t1,peve_ptua,30.836,,,,,,,,,,,,,,,,,
OG_17311,,Peve_00028298,Pocillopora_meandrina_HIv1___RNAseq.g6335.t1,peve_ptua,34.810500000000005,,,,,,,,,,,,,,,,,
OG_17312,,Peve_00028320,Pocillopora_meandrina_HIv1___RNAseq.19030_t,peve_ptua,50.27,,,,,,,,,,,,,,,,,
OG_17313,,Peve_00028325,Pocillopora_meandrina_HIv1___RNAseq.g13666.t1,peve_ptua,54.397,,,,,,,,,,,,,,,,,
OG_17314,,Peve_00028331,Pocillopora_meandrina_HIv1___RNAseq.g28852.t1,peve_ptua,50.862,,,,,,,,,,,,,,,,,
OG_17315,,Peve_00028359,Pocillopora_meandrina_HIv1___RNAseq.g12179.t1b,peve_ptua,58.025,,,,,,,,,,,,,,,,,
OG_17316,,Peve_00028366,Pocillopora_meandrina_HIv1___RNAseq.g12179.t1a,peve_ptua,55.263,,,,,,,,,,,,,,,,,
OG_17317,,Peve_00028399,Pocillopora_meandrina_HIv1___TS.g5870.t1,peve_ptua,42.857,,,,,,,,,,,,,,,,,
OG_17318,,Peve_00028407,Pocillopora_meandrina_HIv1___RNAseq.g12777.t1,peve_ptua,49.372,,,,,,,,,,,,,,,,,
OG_17319,,Peve_00028446,Pocillopora_meandrina_HIv1___TS.g13087.t1,peve_ptua,51.923,,,,,,,,,,,,,,,,,
OG_17320,,Peve_00028469,Pocillopora_meandrina_HIv1___RNAseq.g15265.t1,peve_ptua,82.857,,,,,,,,,,,,,,,,,
OG_17321,,Peve_00028470,Pocillopora_meandrina_HIv1___RNAseq.g20856.t1,peve_ptua,64.613,,,,,,,,,,,,,,,,,
OG_17322,,Peve_00028504,Pocillopora_meandrina_HIv1___TS.g17556.t1,peve_ptua,44.344,,,,,,,,,,,,,,,,,
OG_17323,,Peve_00028571,Pocillopora_meandrina_HIv1___RNAseq.g1306.t1,peve_ptua,94.798,,,,,,,,,,,,,,,,,
OG_17324,,Peve_00028584,Pocillopora_meandrina_HIv1___TS.g27296.t1,peve_ptua,55.901,,,,,,,,,,,,,,,,,
OG_17325,,Peve_00028590,Pocillopora_meandrina_HIv1___RNAseq.g7161.t1,peve_ptua,34.568,,,,,,,,,,,,,,,,,
OG_17326,,Peve_00028592,Pocillopora_meandrina_HIv1___RNAseq.g26890.t1,peve_ptua,44.928,,,,,,,,,,,,,,,,,
OG_17327,,Peve_00028613,Pocillopora_meandrina_HIv1___RNAseq.g2743.t1,peve_ptua,33.577,,,,,,,,,,,,,,,,,
OG_17328,,Peve_00028631,Pocillopora_meandrina_HIv1___TS.g30075.t1,peve_ptua,57.237,,,,,,,,,,,,,,,,,
OG_17329,,Peve_00028634,Pocillopora_meandrina_HIv1___RNAseq.g18031.t1,peve_ptua,69.663,,,,,,,,,,,,,,,,,
OG_17330,,Peve_00028671,Pocillopora_meandrina_HIv1___RNAseq.g1940.t1,peve_ptua,76.51,,,,,,,,,,,,,,,,,
OG_17331,,Peve_00028674,Pocillopora_meandrina_HIv1___RNAseq.g20435.t1b,peve_ptua,75.445,,,,,,,,,,,,,,,,,
OG_17332,,Peve_00028677,Pocillopora_meandrina_HIv1___RNAseq.g16703.t1,peve_ptua,88.485,,,,,,,,,,,,,,,,,
OG_17333,,Peve_00028681,Pocillopora_meandrina_HIv1___TS.g17489.t1,peve_ptua,79.933,,,,,,,,,,,,,,,,,
OG_17334,,Peve_00028688,Pocillopora_meandrina_HIv1___RNAseq.g26342.t1,peve_ptua,80.362,,,,,,,,,,,,,,,,,
OG_17335,,Peve_00028689,Pocillopora_meandrina_HIv1___RNAseq.g24072.t1,peve_ptua,59.4075,,,,,,,,,,,,,,,,,
OG_17336,,Peve_00028709,Pocillopora_meandrina_HIv1___RNAseq.g28658.t1,peve_ptua,70.968,,,,,,,,,,,,,,,,,
OG_17337,,Peve_00028721,Pocillopora_meandrina_HIv1___RNAseq.g24122.t1,peve_ptua,54.876,,,,,,,,,,,,,,,,,
OG_17338,,Peve_00028735,Pocillopora_meandrina_HIv1___RNAseq.g26349.t1,peve_ptua,64.7575,,,,,,,,,,,,,,,,,
OG_17339,,Peve_00028754,Pocillopora_meandrina_HIv1___RNAseq.g28706.t1,peve_ptua,58.065,,,,,,,,,,,,,,,,,
OG_17340,,Peve_00028769,Pocillopora_meandrina_HIv1___RNAseq.g28559.t1,peve_ptua,30.0,,,,,,,,,,,,,,,,,
OG_17341,,Peve_00028771,Pocillopora_meandrina_HIv1___RNAseq.g26356.t1,peve_ptua,58.824,,,,,,,,,,,,,,,,,
OG_17342,,Peve_00028777,Pocillopora_meandrina_HIv1___RNAseq.g26361.t2,peve_ptua,68.498,,,,,,,,,,,,,,,,,
OG_17343,,Peve_00028778,Pocillopora_meandrina_HIv1___RNAseq.g28633.t1,peve_ptua,59.63,,,,,,,,,,,,,,,,,
OG_17344,,Peve_00028788,Pocillopora_meandrina_HIv1___RNAseq.g30383.t1,peve_ptua,85.263,,,,,,,,,,,,,,,,,
OG_17345,,Peve_00028813,Pocillopora_meandrina_HIv1___RNAseq.g30259.t1,peve_ptua,55.583,,,,,,,,,,,,,,,,,
OG_17346,,Peve_00028829,Pocillopora_meandrina_HIv1___RNAseq.27688_t,peve_ptua,49.569,,,,,,,,,,,,,,,,,
OG_17347,,Peve_00028852,Pocillopora_meandrina_HIv1___TS.g736.t1,peve_ptua,57.071,,,,,,,,,,,,,,,,,
OG_17348,,Peve_00028858,Pocillopora_meandrina_HIv1___RNAseq.g23261.t1,peve_ptua,50.382,,,,,,,,,,,,,,,,,
OG_17349,,Peve_00028863,Pocillopora_meandrina_HIv1___TS.g25465.t1,peve_ptua,36.946,,,,,,,,,,,,,,,,,
OG_17350,,Peve_00028889,Pocillopora_meandrina_HIv1___RNAseq.g3400.t1,peve_ptua,45.994,,,,,,,,,,,,,,,,,
OG_17351,,Peve_00028903,Pocillopora_meandrina_HIv1___TS.g9608.t1,peve_ptua,75.0,,,,,,,,,,,,,,,,,
OG_17352,,Peve_00028906,Pocillopora_meandrina_HIv1___RNAseq.g25540.t1,peve_ptua,60.759,,,,,,,,,,,,,,,,,
OG_17353,,Peve_00028915,Pocillopora_meandrina_HIv1___TS.g6508.t1,peve_ptua,57.0265,,,,,,,,,,,,,,,,,
OG_17354,,Peve_00028916,Pocillopora_meandrina_HIv1___RNAseq.g5355.t1,peve_ptua,66.769,,,,,,,,,,,,,,,,,
OG_17355,,Peve_00028927,Pocillopora_meandrina_HIv1___RNAseq.g30094.t1,peve_ptua,39.557,,,,,,,,,,,,,,,,,
OG_17356,,Peve_00028941,Pocillopora_meandrina_HIv1___TS.g4661.t1b,peve_ptua,40.404,,,,,,,,,,,,,,,,,
OG_17357,,Peve_00028991,Pocillopora_meandrina_HIv1___RNAseq.g12643.t1,peve_ptua,59.5345,,,,,,,,,,,,,,,,,
OG_17358,,Peve_00028992,Pocillopora_meandrina_HIv1___RNAseq.g6825.t1,peve_ptua,44.329,,,,,,,,,,,,,,,,,
OG_17359,,Peve_00029045,Pocillopora_meandrina_HIv1___RNAseq.g19960.t1,peve_ptua,59.601,,,,,,,,,,,,,,,,,
OG_17360,,Peve_00029051,Pocillopora_meandrina_HIv1___RNAseq.g19975.t1,peve_ptua,44.7145,,,,,,,,,,,,,,,,,
OG_17361,,Peve_00029083,Pocillopora_meandrina_HIv1___RNAseq.g2353.t1,peve_ptua,82.422,,,,,,,,,,,,,,,,,
OG_17362,,Peve_00029084,Pocillopora_meandrina_HIv1___RNAseq.g2354.t1,peve_ptua,41.936,,,,,,,,,,,,,,,,,
OG_17363,,Peve_00029178,Pocillopora_meandrina_HIv1___RNAseq.g30163.t1,peve_ptua,81.481,,,,,,,,,,,,,,,,,
OG_17364,,Peve_00029193,Pocillopora_meandrina_HIv1___TS.g10922.t1,peve_ptua,76.654,,,,,,,,,,,,,,,,,
OG_17365,,Peve_00029228,Pocillopora_meandrina_HIv1___RNAseq.10990_t,peve_ptua,63.889,,,,,,,,,,,,,,,,,
OG_17366,,Peve_00029257,Pocillopora_meandrina_HIv1___RNAseq.g18736.t1,peve_ptua,69.836,,,,,,,,,,,,,,,,,
OG_17367,,Peve_00029263,Pocillopora_meandrina_HIv1___RNAseq.g18648.t1,peve_ptua,71.482,,,,,,,,,,,,,,,,,
OG_17368,,Peve_00029294,Pocillopora_meandrina_HIv1___RNAseq.g25596.t1,peve_ptua,44.154,,,,,,,,,,,,,,,,,
OG_17369,,Peve_00029304,Pocillopora_meandrina_HIv1___RNAseq.g25574.t1,peve_ptua,64.34,,,,,,,,,,,,,,,,,
OG_17370,,Peve_00029318,Pocillopora_meandrina_HIv1___RNAseq.g25501.t1,peve_ptua,70.19800000000001,,,,,,,,,,,,,,,,,
OG_17371,,Peve_00029336,Pocillopora_meandrina_HIv1___RNAseq.g29335.t1,peve_ptua,66.45400000000001,,,,,,,,,,,,,,,,,
OG_17372,,Peve_00029362,Pocillopora_meandrina_HIv1___RNAseq.g29358.t1,peve_ptua,67.808,,,,,,,,,,,,,,,,,
OG_17373,,Peve_00029364,Pocillopora_meandrina_HIv1___RNAseq.g29356.t1,peve_ptua,61.632,,,,,,,,,,,,,,,,,
OG_17374,,Peve_00029436,Pocillopora_meandrina_HIv1___RNAseq.g23756.t1,peve_ptua,61.034,,,,,,,,,,,,,,,,,
OG_17375,,Peve_00029445,Pocillopora_meandrina_HIv1___RNAseq.g884.t1,peve_ptua,84.0,,,,,,,,,,,,,,,,,
OG_17376,,Peve_00029482,Pocillopora_meandrina_HIv1___RNAseq.g5352.t1,peve_ptua,48.341,,,,,,,,,,,,,,,,,
OG_17377,,Peve_00029485,Pocillopora_meandrina_HIv1___RNAseq.g13300.t1a,peve_ptua,90.2,,,,,,,,,,,,,,,,,
OG_17378,,Peve_00029497,Pocillopora_meandrina_HIv1___TS.g23176.t1,peve_ptua,49.6375,,,,,,,,,,,,,,,,,
OG_17379,,Peve_00029509,Pocillopora_meandrina_HIv1___RNAseq.g10032.t1,peve_ptua,49.04,,,,,,,,,,,,,,,,,
OG_17380,,Peve_00029532,Pocillopora_meandrina_HIv1___RNAseq.g19425.t1,peve_ptua,68.367,,,,,,,,,,,,,,,,,
OG_17381,,Peve_00029533,Pocillopora_meandrina_HIv1___RNAseq.g12080.t1,peve_ptua,70.3725,,,,,,,,,,,,,,,,,
OG_17382,,Peve_00029536,Pocillopora_meandrina_HIv1___RNAseq.g3551.t1,peve_ptua,40.146,,,,,,,,,,,,,,,,,
OG_17383,,Peve_00029566,Pocillopora_meandrina_HIv1___RNAseq.g9057.t1,peve_ptua,42.268,,,,,,,,,,,,,,,,,
OG_17384,,Peve_00029571,Pocillopora_meandrina_HIv1___RNAseq.g22232.t1,peve_ptua,42.647,,,,,,,,,,,,,,,,,
OG_17385,,Peve_00029604,Pocillopora_meandrina_HIv1___RNAseq.g27430.t1,peve_ptua,68.12,,,,,,,,,,,,,,,,,
OG_17386,,Peve_00029651,Pocillopora_meandrina_HIv1___RNAseq.g28076.t1,peve_ptua,63.782,,,,,,,,,,,,,,,,,
OG_17387,,Peve_00029666,Pocillopora_meandrina_HIv1___RNAseq.g906.t1,peve_ptua,74.941,,,,,,,,,,,,,,,,,
OG_17388,,Peve_00029688,Pocillopora_meandrina_HIv1___RNAseq.g26320.t1,peve_ptua,48.57,,,,,,,,,,,,,,,,,
OG_17389,,Peve_00029697,Pocillopora_meandrina_HIv1___RNAseq.g26639.t1,peve_ptua,58.111,,,,,,,,,,,,,,,,,
OG_17390,,Peve_00029731,Pocillopora_meandrina_HIv1___RNAseq.g12278.t1,peve_ptua,80.335,,,,,,,,,,,,,,,,,
OG_17391,,Peve_00029761,Pocillopora_meandrina_HIv1___RNAseq.g24892.t1,peve_ptua,50.0,,,,,,,,,,,,,,,,,
OG_17392,,Peve_00029767,Pocillopora_meandrina_HIv1___RNAseq.g16348.t1,peve_ptua,38.956500000000005,,,,,,,,,,,,,,,,,
OG_17393,,Peve_00029769,Pocillopora_meandrina_HIv1___RNAseq.g16217.t1,peve_ptua,50.383,,,,,,,,,,,,,,,,,
OG_17394,,Peve_00029789,Pocillopora_meandrina_HIv1___TS.g9735.t1,peve_ptua,82.692,,,,,,,,,,,,,,,,,
OG_17395,,Peve_00029790,Pocillopora_meandrina_HIv1___RNAseq.g16172.t1,peve_ptua,71.429,,,,,,,,,,,,,,,,,
OG_17396,,Peve_00029813,Pocillopora_meandrina_HIv1___RNAseq.g697.t1,peve_ptua,91.753,,,,,,,,,,,,,,,,,
OG_17397,,Peve_00029818,Pocillopora_meandrina_HIv1___RNAseq.g694.t1,peve_ptua,77.661,,,,,,,,,,,,,,,,,
OG_17398,,Peve_00029856,Pocillopora_meandrina_HIv1___TS.g18576.t1,peve_ptua,60.073,,,,,,,,,,,,,,,,,
OG_17399,,Peve_00029886,Pocillopora_meandrina_HIv1___RNAseq.g28035.t1,peve_ptua,50.746,,,,,,,,,,,,,,,,,
OG_17400,,Peve_00029888,Pocillopora_meandrina_HIv1___RNAseq.g4994.t1,peve_ptua,55.34,,,,,,,,,,,,,,,,,
OG_17401,,Peve_00029935,Pocillopora_meandrina_HIv1___RNAseq.g21511.t1,peve_ptua,56.7075,,,,,,,,,,,,,,,,,
OG_17402,,Peve_00030016,Pocillopora_meandrina_HIv1___RNAseq.5861_t,peve_ptua,63.205,,,,,,,,,,,,,,,,,
OG_17403,,Peve_00030032,Pocillopora_meandrina_HIv1___TS.g9559.t1,peve_ptua,56.643,,,,,,,,,,,,,,,,,
OG_17404,,Peve_00030035,Pocillopora_meandrina_HIv1___RNAseq.g11501.t2,peve_ptua,54.6875,,,,,,,,,,,,,,,,,
OG_17405,,Peve_00030044,Pocillopora_meandrina_HIv1___RNAseq.g11520.t1,peve_ptua,89.619,,,,,,,,,,,,,,,,,
OG_17406,,Peve_00030070,Pocillopora_meandrina_HIv1___RNAseq.g4713.t1,peve_ptua,87.181,,,,,,,,,,,,,,,,,
OG_17407,,Peve_00030076,Pocillopora_meandrina_HIv1___RNAseq.g30009.t1,peve_ptua,53.527,,,,,,,,,,,,,,,,,
OG_17408,,Peve_00030077,Pocillopora_meandrina_HIv1___RNAseq.g30010.t1,peve_ptua,36.5505,,,,,,,,,,,,,,,,,
OG_17409,,Peve_00030082,Pocillopora_meandrina_HIv1___RNAseq.g30018.t1,peve_ptua,41.5715,,,,,,,,,,,,,,,,,
OG_17410,,Peve_00030089,Pocillopora_meandrina_HIv1___RNAseq.g30024.t1,peve_ptua,50.73,,,,,,,,,,,,,,,,,
OG_17411,,Peve_00030118,Pocillopora_meandrina_HIv1___RNAseq.g15117.t1,peve_ptua,82.059,,,,,,,,,,,,,,,,,
OG_17412,,Peve_00030125,Pocillopora_meandrina_HIv1___RNAseq.g16393.t1,peve_ptua,67.48,,,,,,,,,,,,,,,,,
OG_17413,,Peve_00030155,Pocillopora_meandrina_HIv1___TS.g25775.t2,peve_ptua,87.815,,,,,,,,,,,,,,,,,
OG_17414,,Peve_00030164,Pocillopora_meandrina_HIv1___RNAseq.g2385.t1b,peve_ptua,67.9405,,,,,,,,,,,,,,,,,
OG_17415,,Peve_00030193,Pocillopora_meandrina_HIv1___TS.g14194.t1,peve_ptua,32.787,,,,,,,,,,,,,,,,,
OG_17416,,Peve_00030214,Pocillopora_meandrina_HIv1___RNAseq.g23580.t1,peve_ptua,62.817,,,,,,,,,,,,,,,,,
OG_17417,,Peve_00030223,Pocillopora_meandrina_HIv1___RNAseq.g5396.t1,peve_ptua,49.901,,,,,,,,,,,,,,,,,
OG_17418,,Peve_00030233,Pocillopora_meandrina_HIv1___RNAseq.g5381.t1,peve_ptua,51.418,,,,,,,,,,,,,,,,,
OG_17419,,Peve_00030240,Pocillopora_meandrina_HIv1___RNAseq.g5378.t1,peve_ptua,67.375,,,,,,,,,,,,,,,,,
OG_17420,,Peve_00030274,Pocillopora_meandrina_HIv1___RNAseq.g5590.t1,peve_ptua,65.642,,,,,,,,,,,,,,,,,
OG_17421,,Peve_00030287,Pocillopora_meandrina_HIv1___RNAseq.g5602.t1,peve_ptua,63.918,,,,,,,,,,,,,,,,,
OG_17422,,Peve_00030289,Pocillopora_meandrina_HIv1___RNAseq.g11432.t1,peve_ptua,42.9565,,,,,,,,,,,,,,,,,
OG_17423,,Peve_00030309,Pocillopora_meandrina_HIv1___RNAseq.g24645.t1,peve_ptua,48.571,,,,,,,,,,,,,,,,,
OG_17424,,Peve_00030314,Pocillopora_meandrina_HIv1___RNAseq.g10388.t1,peve_ptua,47.286,,,,,,,,,,,,,,,,,
OG_17425,,Peve_00030348,Pocillopora_meandrina_HIv1___RNAseq.g15892.t1,peve_ptua,74.561,,,,,,,,,,,,,,,,,
OG_17426,,Peve_00030358,Pocillopora_meandrina_HIv1___RNAseq.g9552.t1,peve_ptua,63.843,,,,,,,,,,,,,,,,,
OG_17427,,Peve_00030369,Pocillopora_meandrina_HIv1___RNAseq.g15168.t1,peve_ptua,56.569,,,,,,,,,,,,,,,,,
OG_17428,,Peve_00030394,Pocillopora_meandrina_HIv1___RNAseq.g23613.t1,peve_ptua,78.926,,,,,,,,,,,,,,,,,
OG_17429,,Peve_00030407,Pocillopora_meandrina_HIv1___TS.g27692.t1,peve_ptua,53.846,,,,,,,,,,,,,,,,,
OG_17430,,Peve_00030416,Pocillopora_meandrina_HIv1___TS.g16473.t1,peve_ptua,61.611,,,,,,,,,,,,,,,,,
OG_17431,,Peve_00030426,Pocillopora_meandrina_HIv1___TS.g16904.t1,peve_ptua,75.796,,,,,,,,,,,,,,,,,
OG_17432,,Peve_00030427,Pocillopora_meandrina_HIv1___TS.g16906.t1,peve_ptua,52.598,,,,,,,,,,,,,,,,,
OG_17433,,Peve_00030432,Pocillopora_meandrina_HIv1___RNAseq.g24038.t1,peve_ptua,35.572500000000005,,,,,,,,,,,,,,,,,
OG_17434,,Peve_00030438,Pocillopora_meandrina_HIv1___RNAseq.g24041.t1,peve_ptua,71.456,,,,,,,,,,,,,,,,,
OG_17435,,Peve_00030444,Pocillopora_meandrina_HIv1___RNAseq.g15068.t1,peve_ptua,89.362,,,,,,,,,,,,,,,,,
OG_17436,,Peve_00030453,Pocillopora_meandrina_HIv1___RNAseq.g15121.t2,peve_ptua,73.63499999999999,,,,,,,,,,,,,,,,,
OG_17437,,Peve_00030455,Pocillopora_meandrina_HIv1___RNAseq.g15116.t1,peve_ptua,91.089,,,,,,,,,,,,,,,,,
OG_17438,,Peve_00030467,Pocillopora_meandrina_HIv1___RNAseq.g3442.t1,peve_ptua,81.122,,,,,,,,,,,,,,,,,
OG_17439,,Peve_00030579,Pocillopora_meandrina_HIv1___RNAseq.g13313.t1,peve_ptua,66.751,,,,,,,,,,,,,,,,,
OG_17440,,Peve_00030721,Pocillopora_meandrina_HIv1___TS.g22287.t1,peve_ptua,34.0655,,,,,,,,,,,,,,,,,
OG_17441,,Peve_00030729,Pocillopora_meandrina_HIv1___RNAseq.g11831.t1,peve_ptua,56.944,,,,,,,,,,,,,,,,,
OG_17442,,Peve_00030740,Pocillopora_meandrina_HIv1___RNAseq.g15052.t1,peve_ptua,53.9375,,,,,,,,,,,,,,,,,
OG_17443,,Peve_00030747,Pocillopora_meandrina_HIv1___RNAseq.g4198.t1,peve_ptua,31.1735,,,,,,,,,,,,,,,,,
OG_17444,,Peve_00030748,Pocillopora_meandrina_HIv1___RNAseq.g4197.t1,peve_ptua,38.2,,,,,,,,,,,,,,,,,
OG_17445,,Peve_00030780,Pocillopora_meandrina_HIv1___RNAseq.g10107.t1a,peve_ptua,31.061,,,,,,,,,,,,,,,,,
OG_17446,,Peve_00030827,Pocillopora_meandrina_HIv1___RNAseq.g3492.t1,peve_ptua,64.112,,,,,,,,,,,,,,,,,
OG_17447,,Peve_00030834,Pocillopora_meandrina_HIv1___RNAseq.g9939.t1,peve_ptua,62.7825,,,,,,,,,,,,,,,,,
OG_17448,,Peve_00030835,Pocillopora_meandrina_HIv1___RNAseq.g3513.t1,peve_ptua,66.369,,,,,,,,,,,,,,,,,
OG_17449,,Peve_00030838,Pocillopora_meandrina_HIv1___TS.g9691.t1,peve_ptua,52.35,,,,,,,,,,,,,,,,,
OG_17450,,Peve_00030881,Pocillopora_meandrina_HIv1___RNAseq.g14704.t1,peve_ptua,44.218,,,,,,,,,,,,,,,,,
OG_17451,,Peve_00030900,Pocillopora_meandrina_HIv1___RNAseq.g17018.t1,peve_ptua,56.267,,,,,,,,,,,,,,,,,
OG_17452,,Peve_00030906,Pocillopora_meandrina_HIv1___RNAseq.g16817.t1,peve_ptua,60.434,,,,,,,,,,,,,,,,,
OG_17453,,Peve_00030921,Pocillopora_meandrina_HIv1___RNAseq.g12930.t1,peve_ptua,93.103,,,,,,,,,,,,,,,,,
OG_17454,,Peve_00030925,Pocillopora_meandrina_HIv1___RNAseq.g17004.t1,peve_ptua,47.159,,,,,,,,,,,,,,,,,
OG_17455,,Peve_00031023,Pocillopora_meandrina_HIv1___RNAseq.g12630.t1,peve_ptua,50.407,,,,,,,,,,,,,,,,,
OG_17456,,Peve_00031028,Pocillopora_meandrina_HIv1___RNAseq.g25062.t1,peve_ptua,61.842,,,,,,,,,,,,,,,,,
OG_17457,,Peve_00031066,Pocillopora_meandrina_HIv1___RNAseq.g24629.t1,peve_ptua,49.02,,,,,,,,,,,,,,,,,
OG_17458,,Peve_00031125,Pocillopora_meandrina_HIv1___TS.g17903.t1,peve_ptua,34.286,,,,,,,,,,,,,,,,,
OG_17459,,Peve_00031174,Pocillopora_meandrina_HIv1___TS.g3096.t1,peve_ptua,62.7325,,,,,,,,,,,,,,,,,
OG_17460,,Peve_00031221,Pocillopora_meandrina_HIv1___RNAseq.g12795.t1,peve_ptua,60.439,,,,,,,,,,,,,,,,,
OG_17461,,Peve_00031231,Pocillopora_meandrina_HIv1___RNAseq.g15723.t1,peve_ptua,65.3765,,,,,,,,,,,,,,,,,
OG_17462,,Peve_00031290,Pocillopora_meandrina_HIv1___RNAseq.8567_t,peve_ptua,66.828,,,,,,,,,,,,,,,,,
OG_17463,,Peve_00031325,Pocillopora_meandrina_HIv1___RNAseq.g26104.t1,peve_ptua,83.238,,,,,,,,,,,,,,,,,
OG_17464,,Peve_00031328,Pocillopora_meandrina_HIv1___RNAseq.g16426.t1,peve_ptua,32.224999999999994,,,,,,,,,,,,,,,,,
OG_17465,,Peve_00031376,Pocillopora_meandrina_HIv1___TS.g15067.t2,peve_ptua,73.148,,,,,,,,,,,,,,,,,
OG_17466,,Peve_00031392,Pocillopora_meandrina_HIv1___TS.g22652.t1,peve_ptua,58.4125,,,,,,,,,,,,,,,,,
OG_17467,,Peve_00031397,Pocillopora_meandrina_HIv1___RNAseq.g12100.t1,peve_ptua,81.325,,,,,,,,,,,,,,,,,
OG_17468,,Peve_00031404,Pocillopora_meandrina_HIv1___RNAseq.g12105.t1,peve_ptua,61.628,,,,,,,,,,,,,,,,,
OG_17469,,Peve_00031434,Pocillopora_meandrina_HIv1___RNAseq.g17453.t1,peve_ptua,42.202,,,,,,,,,,,,,,,,,
OG_17470,,Peve_00031437,Pocillopora_meandrina_HIv1___RNAseq.g21362.t1,peve_ptua,66.964,,,,,,,,,,,,,,,,,
OG_17471,,Peve_00031477,Pocillopora_meandrina_HIv1___RNAseq.g1442.t1,peve_ptua,30.579,,,,,,,,,,,,,,,,,
OG_17472,,Peve_00031479,Pocillopora_meandrina_HIv1___RNAseq.g3448.t2,peve_ptua,62.26,,,,,,,,,,,,,,,,,
OG_17473,,Peve_00031481,Pocillopora_meandrina_HIv1___RNAseq.g18030.t1,peve_ptua,79.429,,,,,,,,,,,,,,,,,
OG_17474,,Peve_00031500,Pocillopora_meandrina_HIv1___RNAseq.g22892.t1,peve_ptua,67.591,,,,,,,,,,,,,,,,,
OG_17475,,Peve_00031554,Pocillopora_meandrina_HIv1___RNAseq.g16777.t1,peve_ptua,78.161,,,,,,,,,,,,,,,,,
OG_17476,,Peve_00031568,Pocillopora_meandrina_HIv1___RNAseq.g16774.t1,peve_ptua,87.103,,,,,,,,,,,,,,,,,
OG_17477,,Peve_00031571,Pocillopora_meandrina_HIv1___RNAseq.g27892.t1a,peve_ptua,67.961,,,,,,,,,,,,,,,,,
OG_17478,,Peve_00031601,Pocillopora_meandrina_HIv1___TS.g2867.t2b,peve_ptua,44.627,,,,,,,,,,,,,,,,,
OG_17479,,Peve_00031620,Pocillopora_meandrina_HIv1___TS.g9636.t1,peve_ptua,54.4045,,,,,,,,,,,,,,,,,
OG_17480,,Peve_00031623,Pocillopora_meandrina_HIv1___RNAseq.g3469.t1,peve_ptua,57.386,,,,,,,,,,,,,,,,,
OG_17481,,Peve_00031652,Pocillopora_meandrina_HIv1___RNAseq.g15833.t1,peve_ptua,72.604,,,,,,,,,,,,,,,,,
OG_17482,,Peve_00031653,Pocillopora_meandrina_HIv1___RNAseq.g15838.t1,peve_ptua,66.248,,,,,,,,,,,,,,,,,
OG_17483,,Peve_00031656,Pocillopora_meandrina_HIv1___RNAseq.g16566.t1,peve_ptua,88.964,,,,,,,,,,,,,,,,,
OG_17484,,Peve_00031666,Pocillopora_meandrina_HIv1___RNAseq.g21157.t1,peve_ptua,54.5405,,,,,,,,,,,,,,,,,
OG_17485,,Peve_00031677,Pocillopora_meandrina_HIv1___RNAseq.g21578.t1,peve_ptua,64.388,,,,,,,,,,,,,,,,,
OG_17486,,Peve_00031703,Pocillopora_meandrina_HIv1___TS.g23687.t1,peve_ptua,69.085,,,,,,,,,,,,,,,,,
OG_17487,,Peve_00031732,Pocillopora_meandrina_HIv1___RNAseq.g11905.t1,peve_ptua,66.015,,,,,,,,,,,,,,,,,
OG_17488,,Peve_00031740,Pocillopora_meandrina_HIv1___RNAseq.g6124.t1,peve_ptua,74.206,,,,,,,,,,,,,,,,,
OG_17489,,Peve_00031765,Pocillopora_meandrina_HIv1___RNAseq.g7454.t1,peve_ptua,88.194,,,,,,,,,,,,,,,,,
OG_17490,,Peve_00031768,Pocillopora_meandrina_HIv1___TS.g20336.t1,peve_ptua,77.222,,,,,,,,,,,,,,,,,
OG_17491,,Peve_00031782,Pocillopora_meandrina_HIv1___RNAseq.g17941.t1,peve_ptua,63.526,,,,,,,,,,,,,,,,,
OG_17492,,Peve_00031809,Pocillopora_meandrina_HIv1___TS.g10735.t2,peve_ptua,85.63300000000001,,,,,,,,,,,,,,,,,
OG_17493,,Peve_00031813,Pocillopora_meandrina_HIv1___RNAseq.g25043.t1,peve_ptua,56.314,,,,,,,,,,,,,,,,,
OG_17494,,Peve_00031814,Pocillopora_meandrina_HIv1___RNAseq.g22196.t1,peve_ptua,63.256,,,,,,,,,,,,,,,,,
OG_17495,,Peve_00031816,Pocillopora_meandrina_HIv1___RNAseq.g22202.t1,peve_ptua,44.1465,,,,,,,,,,,,,,,,,
OG_17496,,Peve_00031829,Pocillopora_meandrina_HIv1___TS.g24767.t1,peve_ptua,57.397,,,,,,,,,,,,,,,,,
OG_17497,,Peve_00031834,Pocillopora_meandrina_HIv1___RNAseq.g6049.t1,peve_ptua,78.197,,,,,,,,,,,,,,,,,
OG_17498,,Peve_00031837,Pocillopora_meandrina_HIv1___TS.g11050.t1,peve_ptua,64.01,,,,,,,,,,,,,,,,,
OG_17499,,Peve_00031869,Pocillopora_meandrina_HIv1___RNAseq.g27364.t1,peve_ptua,37.16,,,,,,,,,,,,,,,,,
OG_17500,,Peve_00031876,Pocillopora_meandrina_HIv1___RNAseq.g18902.t1,peve_ptua,44.626000000000005,,,,,,,,,,,,,,,,,
OG_17501,,Peve_00031879,Pocillopora_meandrina_HIv1___RNAseq.g18900.t1,peve_ptua,68.9485,,,,,,,,,,,,,,,,,
OG_17502,,Peve_00031884,Pocillopora_meandrina_HIv1___RNAseq.g18896.t1,peve_ptua,92.105,,,,,,,,,,,,,,,,,
OG_17503,,Peve_00031906,Pocillopora_meandrina_HIv1___RNAseq.g17579.t1,peve_ptua,41.9225,,,,,,,,,,,,,,,,,
OG_17504,,Peve_00031922,Pocillopora_meandrina_HIv1___RNAseq.g24790.t1,peve_ptua,60.7,,,,,,,,,,,,,,,,,
OG_17505,,Peve_00031955,Pocillopora_meandrina_HIv1___RNAseq.g6337.t1,peve_ptua,40.559,,,,,,,,,,,,,,,,,
OG_17506,,Peve_00031958,Pocillopora_meandrina_HIv1___RNAseq.g6336.t1,peve_ptua,41.135,,,,,,,,,,,,,,,,,
OG_17507,,Peve_00031995,Pocillopora_meandrina_HIv1___RNAseq.g22633.t1,peve_ptua,59.915,,,,,,,,,,,,,,,,,
OG_17508,,Peve_00032055,Pocillopora_meandrina_HIv1___RNAseq.g17367.t1,peve_ptua,37.5335,,,,,,,,,,,,,,,,,
OG_17509,,Peve_00032056,Pocillopora_meandrina_HIv1___RNAseq.g17368.t1,peve_ptua,73.881,,,,,,,,,,,,,,,,,
OG_17510,,Peve_00032068,Pocillopora_meandrina_HIv1___RNAseq.g5975.t1a,peve_ptua,65.217,,,,,,,,,,,,,,,,,
OG_17511,,Peve_00032083,Pocillopora_meandrina_HIv1___RNAseq.g28579.t1,peve_ptua,62.84,,,,,,,,,,,,,,,,,
OG_17512,,Peve_00032099,Pocillopora_meandrina_HIv1___RNAseq.g21256.t1,peve_ptua,63.12049999999999,,,,,,,,,,,,,,,,,
OG_17513,,Peve_00032102,Pocillopora_meandrina_HIv1___RNAseq.g28373.t1,peve_ptua,69.745,,,,,,,,,,,,,,,,,
OG_17514,,Peve_00032115,Pocillopora_meandrina_HIv1___RNAseq.g28352.t1,peve_ptua,50.0,,,,,,,,,,,,,,,,,
OG_17515,,Peve_00032146,Pocillopora_meandrina_HIv1___RNAseq.g9561.t1,peve_ptua,60.631,,,,,,,,,,,,,,,,,
OG_17516,,Peve_00032148,Pocillopora_meandrina_HIv1___RNAseq.g23111.t1,peve_ptua,74.157,,,,,,,,,,,,,,,,,
OG_17517,,Peve_00032153,Pocillopora_meandrina_HIv1___RNAseq.g25916.t1,peve_ptua,61.261,,,,,,,,,,,,,,,,,
OG_17518,,Peve_00032157,Pocillopora_meandrina_HIv1___RNAseq.g25020.t1,peve_ptua,41.8885,,,,,,,,,,,,,,,,,
OG_17519,,Peve_00032170,Pocillopora_meandrina_HIv1___TS.g22930.t1,peve_ptua,42.553,,,,,,,,,,,,,,,,,
OG_17520,,Peve_00032179,Pocillopora_meandrina_HIv1___RNAseq.g15776.t2,peve_ptua,88.889,,,,,,,,,,,,,,,,,
OG_17521,,Peve_00032183,Pocillopora_meandrina_HIv1___RNAseq.g27446.t1,peve_ptua,40.42,,,,,,,,,,,,,,,,,
OG_17522,,Peve_00032222,Pocillopora_meandrina_HIv1___RNAseq.g1626.t1,peve_ptua,49.9115,,,,,,,,,,,,,,,,,
OG_17523,,Peve_00032223,Pocillopora_meandrina_HIv1___RNAseq.g1627.t1,peve_ptua,59.6325,,,,,,,,,,,,,,,,,
OG_17524,,Peve_00032231,Pocillopora_meandrina_HIv1___RNAseq.g1636.t1,peve_ptua,60.897,,,,,,,,,,,,,,,,,
OG_17525,,Peve_00032241,Pocillopora_meandrina_HIv1___RNAseq.g10412.t1,peve_ptua,83.0525,,,,,,,,,,,,,,,,,
OG_17526,,Peve_00032276,Pocillopora_meandrina_HIv1___TS.g10286.t1,peve_ptua,56.642,,,,,,,,,,,,,,,,,
OG_17527,,Peve_00032284,Pocillopora_meandrina_HIv1___TS.g10848.t1,peve_ptua,36.264,,,,,,,,,,,,,,,,,
OG_17528,,Peve_00032296,Pocillopora_meandrina_HIv1___RNAseq.g10044.t1,peve_ptua,66.486,,,,,,,,,,,,,,,,,
OG_17529,,Peve_00032305,Pocillopora_meandrina_HIv1___RNAseq.g10048.t1,peve_ptua,53.865,,,,,,,,,,,,,,,,,
OG_17530,,Peve_00032327,Pocillopora_meandrina_HIv1___RNAseq.g26792.t1,peve_ptua,71.642,,,,,,,,,,,,,,,,,
OG_17531,,Peve_00032334,Pocillopora_meandrina_HIv1___RNAseq.g26699.t1,peve_ptua,67.262,,,,,,,,,,,,,,,,,
OG_17532,,Peve_00032340,Pocillopora_meandrina_HIv1___RNAseq.g26696.t1,peve_ptua,65.6815,,,,,,,,,,,,,,,,,
OG_17533,,Peve_00032354,Pocillopora_meandrina_HIv1___RNAseq.27597_t,peve_ptua,58.863,,,,,,,,,,,,,,,,,
OG_17534,,Peve_00032367,Pocillopora_meandrina_HIv1___RNAseq.g9750.t1,peve_ptua,67.606,,,,,,,,,,,,,,,,,
OG_17535,,Peve_00032392,Pocillopora_meandrina_HIv1___RNAseq.g9916.t1,peve_ptua,39.519,,,,,,,,,,,,,,,,,
OG_17536,,Peve_00032414,Pocillopora_meandrina_HIv1___RNAseq.g2944.t1,peve_ptua,43.189,,,,,,,,,,,,,,,,,
OG_17537,,Peve_00032429,Pocillopora_meandrina_HIv1___TS.g26744.t1d,peve_ptua,96.563,,,,,,,,,,,,,,,,,
OG_17538,,Peve_00032465,Pocillopora_meandrina_HIv1___RNAseq.g20607.t1,peve_ptua,69.091,,,,,,,,,,,,,,,,,
OG_17539,,Peve_00032518,Pocillopora_meandrina_HIv1___RNAseq.g27952.t1,peve_ptua,49.402,,,,,,,,,,,,,,,,,
OG_17540,,Peve_00032523,Pocillopora_meandrina_HIv1___RNAseq.g16415.t1,peve_ptua,42.56,,,,,,,,,,,,,,,,,
OG_17541,,Peve_00032527,Pocillopora_meandrina_HIv1___TS.g10961.t1,peve_ptua,42.248,,,,,,,,,,,,,,,,,
OG_17542,,Peve_00032550,Pocillopora_meandrina_HIv1___TS.g13231.t1,peve_ptua,39.024,,,,,,,,,,,,,,,,,
OG_17543,,Peve_00032569,Pocillopora_meandrina_HIv1___RNAseq.g30157.t1a,peve_ptua,77.605,,,,,,,,,,,,,,,,,
OG_17544,,Peve_00032582,Pocillopora_meandrina_HIv1___RNAseq.g12964.t1,peve_ptua,68.182,,,,,,,,,,,,,,,,,
OG_17545,,Peve_00032612,Pocillopora_meandrina_HIv1___RNAseq.g8890.t1,peve_ptua,46.7505,,,,,,,,,,,,,,,,,
OG_17546,,Peve_00032617,Pocillopora_meandrina_HIv1___RNAseq.g8886.t1,peve_ptua,48.0775,,,,,,,,,,,,,,,,,
OG_17547,,Peve_00032627,Pocillopora_meandrina_HIv1___RNAseq.g8854.t1,peve_ptua,76.259,,,,,,,,,,,,,,,,,
OG_17548,,Peve_00032641,Pocillopora_meandrina_HIv1___RNAseq.g27880.t1,peve_ptua,50.0,,,,,,,,,,,,,,,,,
OG_17549,,Peve_00032644,Pocillopora_meandrina_HIv1___RNAseq.g27883.t1,peve_ptua,77.745,,,,,,,,,,,,,,,,,
OG_17550,,Peve_00032648,Pocillopora_meandrina_HIv1___RNAseq.g27886.t1,peve_ptua,76.313,,,,,,,,,,,,,,,,,
OG_17551,,Peve_00032655,Pocillopora_meandrina_HIv1___RNAseq.g27871.t1,peve_ptua,59.707,,,,,,,,,,,,,,,,,
OG_17552,,Peve_00032657,Pocillopora_meandrina_HIv1___RNAseq.g27873.t1,peve_ptua,59.169,,,,,,,,,,,,,,,,,
OG_17553,,Peve_00032659,Pocillopora_meandrina_HIv1___RNAseq.g4740.t1,peve_ptua,62.013000000000005,,,,,,,,,,,,,,,,,
OG_17554,,Peve_00032688,Pocillopora_meandrina_HIv1___RNAseq.g12901.t1,peve_ptua,85.333,,,,,,,,,,,,,,,,,
OG_17555,,Peve_00032690,Pocillopora_meandrina_HIv1___TS.g23487.t1,peve_ptua,68.966,,,,,,,,,,,,,,,,,
OG_17556,,Peve_00032707,Pocillopora_meandrina_HIv1___RNAseq.g21507.t1,peve_ptua,51.9865,,,,,,,,,,,,,,,,,
OG_17557,,Peve_00032708,Pocillopora_meandrina_HIv1___RNAseq.g25076.t1,peve_ptua,67.206,,,,,,,,,,,,,,,,,
OG_17558,,Peve_00032720,Pocillopora_meandrina_HIv1___RNAseq.g21498.t1,peve_ptua,51.705,,,,,,,,,,,,,,,,,
OG_17559,,Peve_00032729,Pocillopora_meandrina_HIv1___RNAseq.g21474.t1,peve_ptua,56.92,,,,,,,,,,,,,,,,,
OG_17560,,Peve_00032732,Pocillopora_meandrina_HIv1___RNAseq.g21524.t1,peve_ptua,75.789,,,,,,,,,,,,,,,,,
OG_17561,,Peve_00032736,Pocillopora_meandrina_HIv1___RNAseq.g21521.t1,peve_ptua,78.6625,,,,,,,,,,,,,,,,,
OG_17562,,Peve_00032750,Pocillopora_meandrina_HIv1___RNAseq.g16290.t1,peve_ptua,74.763,,,,,,,,,,,,,,,,,
OG_17563,,Peve_00032754,Pocillopora_meandrina_HIv1___RNAseq.g27097.t1,peve_ptua,49.5,,,,,,,,,,,,,,,,,
OG_17564,,Peve_00032757,Pocillopora_meandrina_HIv1___RNAseq.g25586.t1,peve_ptua,62.759,,,,,,,,,,,,,,,,,
OG_17565,,Peve_00032778,Pocillopora_meandrina_HIv1___TS.g19282.t1,peve_ptua,56.19,,,,,,,,,,,,,,,,,
OG_17566,,Peve_00032782,Pocillopora_meandrina_HIv1___TS.g29444.t1,peve_ptua,72.059,,,,,,,,,,,,,,,,,
OG_17567,,Peve_00032793,Pocillopora_meandrina_HIv1___TS.g16458.t1a,peve_ptua,87.288,,,,,,,,,,,,,,,,,
OG_17568,,Peve_00032821,Pocillopora_meandrina_HIv1___RNAseq.g1244.t1,peve_ptua,51.497,,,,,,,,,,,,,,,,,
OG_17569,,Peve_00032829,Pocillopora_meandrina_HIv1___RNAseq.g10169.t1,peve_ptua,63.281,,,,,,,,,,,,,,,,,
OG_17570,,Peve_00032882,Pocillopora_meandrina_HIv1___TS.g1278.t1,peve_ptua,45.494,,,,,,,,,,,,,,,,,
OG_17571,,Peve_00032889,Pocillopora_meandrina_HIv1___RNAseq.g24503.t1,peve_ptua,57.733,,,,,,,,,,,,,,,,,
OG_17572,,Peve_00032900,Pocillopora_meandrina_HIv1___RNAseq.g20863.t1,peve_ptua,74.753,,,,,,,,,,,,,,,,,
OG_17573,,Peve_00032902,Pocillopora_meandrina_HIv1___RNAseq.g20801.t1,peve_ptua,78.226,,,,,,,,,,,,,,,,,
OG_17574,,Peve_00032911,Pocillopora_meandrina_HIv1___RNAseq.g20799.t1,peve_ptua,71.588,,,,,,,,,,,,,,,,,
OG_17575,,Peve_00032922,Pocillopora_meandrina_HIv1___RNAseq.g14860.t1,peve_ptua,70.497,,,,,,,,,,,,,,,,,
OG_17576,,Peve_00032942,Pocillopora_meandrina_HIv1___TS.g17951.t1,peve_ptua,37.288,,,,,,,,,,,,,,,,,
OG_17577,,Peve_00032977,Pocillopora_meandrina_HIv1___RNAseq.g19163.t1,peve_ptua,42.349,,,,,,,,,,,,,,,,,
OG_17578,,Peve_00032985,Pocillopora_meandrina_HIv1___RNAseq.g21222.t1,peve_ptua,58.749,,,,,,,,,,,,,,,,,
OG_17579,,Peve_00032997,Pocillopora_meandrina_HIv1___RNAseq.g16752.t1,peve_ptua,46.491,,,,,,,,,,,,,,,,,
OG_17580,,Peve_00033016,Pocillopora_meandrina_HIv1___RNAseq.g3985.t1,peve_ptua,60.0,,,,,,,,,,,,,,,,,
OG_17581,,Peve_00033025,Pocillopora_meandrina_HIv1___RNAseq.g10390.t1,peve_ptua,71.526,,,,,,,,,,,,,,,,,
OG_17582,,Peve_00033030,Pocillopora_meandrina_HIv1___TS.g6675.t1,peve_ptua,36.667,,,,,,,,,,,,,,,,,
OG_17583,,Peve_00033035,Pocillopora_meandrina_HIv1___TS.g29561.t3a,peve_ptua,78.484,,,,,,,,,,,,,,,,,
OG_17584,,Peve_00033038,Pocillopora_meandrina_HIv1___RNAseq.g5502.t1,peve_ptua,64.062,,,,,,,,,,,,,,,,,
OG_17585,,Peve_00033059,Pocillopora_meandrina_HIv1___TS.g10928.t1,peve_ptua,60.58,,,,,,,,,,,,,,,,,
OG_17586,,Peve_00033060,Pocillopora_meandrina_HIv1___RNAseq.g15909.t1,peve_ptua,63.676,,,,,,,,,,,,,,,,,
OG_17587,,Peve_00033076,Pocillopora_meandrina_HIv1___RNAseq.g7727.t1a,peve_ptua,51.923,,,,,,,,,,,,,,,,,
OG_17588,,Peve_00033096,Pocillopora_meandrina_HIv1___RNAseq.g15739.t1,peve_ptua,58.652,,,,,,,,,,,,,,,,,
OG_17589,,Peve_00033108,Pocillopora_meandrina_HIv1___RNAseq.g15982.t1,peve_ptua,78.235,,,,,,,,,,,,,,,,,
OG_17590,,Peve_00033118,Pocillopora_meandrina_HIv1___RNAseq.g15973.t1,peve_ptua,78.462,,,,,,,,,,,,,,,,,
OG_17591,,Peve_00033140,Pocillopora_meandrina_HIv1___RNAseq.g23133.t1,peve_ptua,68.144,,,,,,,,,,,,,,,,,
OG_17592,,Peve_00033147,Pocillopora_meandrina_HIv1___RNAseq.g23136.t1,peve_ptua,52.083,,,,,,,,,,,,,,,,,
OG_17593,,Peve_00033157,Pocillopora_meandrina_HIv1___TS.g6331.t1,peve_ptua,34.6495,,,,,,,,,,,,,,,,,
OG_17594,,Peve_00033161,Pocillopora_meandrina_HIv1___TS.g27517.t1,peve_ptua,73.182,,,,,,,,,,,,,,,,,
OG_17595,,Peve_00033177,Pocillopora_meandrina_HIv1___RNAseq.g5857.t1,peve_ptua,72.297,,,,,,,,,,,,,,,,,
OG_17596,,Peve_00033182,Pocillopora_meandrina_HIv1___RNAseq.g5855.t1,peve_ptua,47.528000000000006,,,,,,,,,,,,,,,,,
OG_17597,,Peve_00033192,Pocillopora_meandrina_HIv1___RNAseq.g29774.t1,peve_ptua,75.0,,,,,,,,,,,,,,,,,
OG_17598,,Peve_00033244,Pocillopora_meandrina_HIv1___RNAseq.g5174.t1,peve_ptua,67.816,,,,,,,,,,,,,,,,,
OG_17599,,Peve_00033285,Pocillopora_meandrina_HIv1___TS.g24733.t1,peve_ptua,59.722,,,,,,,,,,,,,,,,,
OG_17600,,Peve_00033297,Pocillopora_meandrina_HIv1___RNAseq.g1609.t1,peve_ptua,75.292,,,,,,,,,,,,,,,,,
OG_17601,,Peve_00033309,Pocillopora_meandrina_HIv1___RNAseq.g7430.t1,peve_ptua,76.804,,,,,,,,,,,,,,,,,
OG_17602,,Peve_00033331,Pocillopora_meandrina_HIv1___RNAseq.g20386.t1,peve_ptua,71.369,,,,,,,,,,,,,,,,,
OG_17603,,Peve_00033395,Pocillopora_meandrina_HIv1___RNAseq.g15419.t1,peve_ptua,94.975,,,,,,,,,,,,,,,,,
OG_17604,,Peve_00033398,Pocillopora_meandrina_HIv1___RNAseq.g15417.t1,peve_ptua,61.8015,,,,,,,,,,,,,,,,,
OG_17605,,Peve_00033402,Pocillopora_meandrina_HIv1___RNAseq.g15423.t1,peve_ptua,70.635,,,,,,,,,,,,,,,,,
OG_17606,,Peve_00033411,Pocillopora_meandrina_HIv1___RNAseq.g15397.t1,peve_ptua,69.435,,,,,,,,,,,,,,,,,
OG_17607,,Peve_00033415,Pocillopora_meandrina_HIv1___RNAseq.g4966.t1,peve_ptua,73.262,,,,,,,,,,,,,,,,,
OG_17608,,Peve_00033431,Pocillopora_meandrina_HIv1___RNAseq.g29545.t1,peve_ptua,57.33,,,,,,,,,,,,,,,,,
OG_17609,,Peve_00033432,Pocillopora_meandrina_HIv1___RNAseq.g11884.t1,peve_ptua,52.3725,,,,,,,,,,,,,,,,,
OG_17610,,Peve_00033433,Pocillopora_meandrina_HIv1___RNAseq.g11885.t1,peve_ptua,62.394,,,,,,,,,,,,,,,,,
OG_17611,,Peve_00033434,Pocillopora_meandrina_HIv1___RNAseq.g11886.t1,peve_ptua,53.1,,,,,,,,,,,,,,,,,
OG_17612,,Peve_00033441,Pocillopora_meandrina_HIv1___RNAseq.g11893.t1,peve_ptua,53.004,,,,,,,,,,,,,,,,,
OG_17613,,Peve_00033496,Pocillopora_meandrina_HIv1___TS.g14057.t1,peve_ptua,72.034,,,,,,,,,,,,,,,,,
OG_17614,,Peve_00033561,Pocillopora_meandrina_HIv1___RNAseq.g29072.t1,peve_ptua,62.539,,,,,,,,,,,,,,,,,
OG_17615,,Peve_00033563,Pocillopora_meandrina_HIv1___RNAseq.g2538.t1b,peve_ptua,46.053,,,,,,,,,,,,,,,,,
OG_17616,,Peve_00033577,Pocillopora_meandrina_HIv1___RNAseq.g2537.t1,peve_ptua,77.027,,,,,,,,,,,,,,,,,
OG_17617,,Peve_00033582,Pocillopora_meandrina_HIv1___RNAseq.g2536.t1,peve_ptua,59.346,,,,,,,,,,,,,,,,,
OG_17618,,Peve_00033584,Pocillopora_meandrina_HIv1___RNAseq.g2533.t1c,peve_ptua,58.02,,,,,,,,,,,,,,,,,
OG_17619,,Peve_00033608,Pocillopora_meandrina_HIv1___RNAseq.g484.t1,peve_ptua,32.384,,,,,,,,,,,,,,,,,
OG_17620,,Peve_00033610,Pocillopora_meandrina_HIv1___RNAseq.g22275.t1,peve_ptua,76.6035,,,,,,,,,,,,,,,,,
OG_17621,,Peve_00033620,Pocillopora_meandrina_HIv1___RNAseq.g1415.t1,peve_ptua,59.602,,,,,,,,,,,,,,,,,
OG_17622,,Peve_00033646,Pocillopora_meandrina_HIv1___RNAseq.g12474.t1,peve_ptua,63.717,,,,,,,,,,,,,,,,,
OG_17623,,Peve_00033660,Pocillopora_meandrina_HIv1___RNAseq.g29855.t1,peve_ptua,69.585,,,,,,,,,,,,,,,,,
OG_17624,,Peve_00033673,Pocillopora_meandrina_HIv1___RNAseq.g26838.t1,peve_ptua,54.769,,,,,,,,,,,,,,,,,
OG_17625,,Peve_00033683,Pocillopora_meandrina_HIv1___RNAseq.g1584.t1,peve_ptua,32.3795,,,,,,,,,,,,,,,,,
OG_17626,,Peve_00033757,Pocillopora_meandrina_HIv1___RNAseq.g6161.t1a,peve_ptua,49.074,,,,,,,,,,,,,,,,,
OG_17627,,Peve_00033788,Pocillopora_meandrina_HIv1___RNAseq.g19051.t1,peve_ptua,48.9345,,,,,,,,,,,,,,,,,
OG_17628,,Peve_00033797,Pocillopora_meandrina_HIv1___TS.g29613.t1,peve_ptua,63.1855,,,,,,,,,,,,,,,,,
OG_17629,,Peve_00033837,Pocillopora_meandrina_HIv1___RNAseq.g21164.t1,peve_ptua,77.174,,,,,,,,,,,,,,,,,
OG_17630,,Peve_00033857,Pocillopora_meandrina_HIv1___TS.g15543.t1,peve_ptua,48.036,,,,,,,,,,,,,,,,,
OG_17631,,Peve_00033897,Pocillopora_meandrina_HIv1___RNAseq.g7699.t1b,peve_ptua,66.242,,,,,,,,,,,,,,,,,
OG_17632,,Peve_00033909,Pocillopora_meandrina_HIv1___RNAseq.g7721.t1,peve_ptua,38.71,,,,,,,,,,,,,,,,,
OG_17633,,Peve_00033921,Pocillopora_meandrina_HIv1___RNAseq.g15787.t1,peve_ptua,67.008,,,,,,,,,,,,,,,,,
OG_17634,,Peve_00033938,Pocillopora_meandrina_HIv1___RNAseq.g16900.t1,peve_ptua,80.597,,,,,,,,,,,,,,,,,
OG_17635,,Peve_00033969,Pocillopora_meandrina_HIv1___TS.g14338.t1,peve_ptua,54.95,,,,,,,,,,,,,,,,,
OG_17636,,Peve_00033972,Pocillopora_meandrina_HIv1___TS.g14334.t1a,peve_ptua,66.055,,,,,,,,,,,,,,,,,
OG_17637,,Peve_00034056,Pocillopora_meandrina_HIv1___RNAseq.g19659.t1,peve_ptua,69.753,,,,,,,,,,,,,,,,,
OG_17638,,Peve_00034063,Pocillopora_meandrina_HIv1___TS.g29039.t2,peve_ptua,78.221,,,,,,,,,,,,,,,,,
OG_17639,,Peve_00034067,Pocillopora_meandrina_HIv1___RNAseq.g19647.t1,peve_ptua,73.6,,,,,,,,,,,,,,,,,
OG_17640,,Peve_00034068,Pocillopora_meandrina_HIv1___RNAseq.g19079.t1,peve_ptua,53.082,,,,,,,,,,,,,,,,,
OG_17641,,Peve_00034071,Pocillopora_meandrina_HIv1___RNAseq.g19080.t1,peve_ptua,48.333,,,,,,,,,,,,,,,,,
OG_17642,,Peve_00034108,Pocillopora_meandrina_HIv1___RNAseq.g23890.t1,peve_ptua,69.403,,,,,,,,,,,,,,,,,
OG_17643,,Peve_00034140,Pocillopora_meandrina_HIv1___RNAseq.g22508.t1,peve_ptua,38.346,,,,,,,,,,,,,,,,,
OG_17644,,Peve_00034154,Pocillopora_meandrina_HIv1___RNAseq.g24397.t1,peve_ptua,70.554,,,,,,,,,,,,,,,,,
OG_17645,,Peve_00034188,Pocillopora_meandrina_HIv1___RNAseq.g19351.t1,peve_ptua,75.829,,,,,,,,,,,,,,,,,
OG_17646,,Peve_00034212,Pocillopora_meandrina_HIv1___RNAseq.g23591.t1,peve_ptua,59.856,,,,,,,,,,,,,,,,,
OG_17647,,Peve_00034218,Pocillopora_meandrina_HIv1___RNAseq.g23627.t1,peve_ptua,55.789,,,,,,,,,,,,,,,,,
OG_17648,,Peve_00034221,Pocillopora_meandrina_HIv1___RNAseq.g15014.t1,peve_ptua,73.026,,,,,,,,,,,,,,,,,
OG_17649,,Peve_00034234,Pocillopora_meandrina_HIv1___RNAseq.g27390.t2,peve_ptua,49.296,,,,,,,,,,,,,,,,,
OG_17650,,Peve_00034240,Pocillopora_meandrina_HIv1___TS.g7272.t1a,peve_ptua,56.116,,,,,,,,,,,,,,,,,
OG_17651,,Peve_00034264,Pocillopora_meandrina_HIv1___RNAseq.g26270.t1,peve_ptua,55.691,,,,,,,,,,,,,,,,,
OG_17652,,Peve_00034306,Pocillopora_meandrina_HIv1___RNAseq.g3126.t1,peve_ptua,81.605,,,,,,,,,,,,,,,,,
OG_17653,,Peve_00034336,Pocillopora_meandrina_HIv1___RNAseq.g11205.t1,peve_ptua,80.435,,,,,,,,,,,,,,,,,
OG_17654,,Peve_00034389,Pocillopora_meandrina_HIv1___RNAseq.g23384.t1,peve_ptua,61.639,,,,,,,,,,,,,,,,,
OG_17655,,Peve_00034400,Pocillopora_meandrina_HIv1___RNAseq.g21910.t1b,peve_ptua,52.727,,,,,,,,,,,,,,,,,
OG_17656,,Peve_00034477,Pocillopora_meandrina_HIv1___RNAseq.g6306.t1,peve_ptua,86.111,,,,,,,,,,,,,,,,,
OG_17657,,Peve_00034480,Pocillopora_meandrina_HIv1___RNAseq.g25722.t1,peve_ptua,60.262,,,,,,,,,,,,,,,,,
OG_17658,,Peve_00034483,Pocillopora_meandrina_HIv1___RNAseq.g20715.t1,peve_ptua,71.5275,,,,,,,,,,,,,,,,,
OG_17659,,Peve_00034486,Pocillopora_meandrina_HIv1___TS.g15477.t1b,peve_ptua,76.221,,,,,,,,,,,,,,,,,
OG_17660,,Peve_00034494,Pocillopora_meandrina_HIv1___RNAseq.g25717.t1,peve_ptua,66.0225,,,,,,,,,,,,,,,,,
OG_17661,,Peve_00034504,Pocillopora_meandrina_HIv1___RNAseq.g7254.t1,peve_ptua,40.119,,,,,,,,,,,,,,,,,
OG_17662,,Peve_00034515,Pocillopora_meandrina_HIv1___RNAseq.g28584.t1,peve_ptua,40.994,,,,,,,,,,,,,,,,,
OG_17663,,Peve_00034538,Pocillopora_meandrina_HIv1___RNAseq.g25643.t1,peve_ptua,77.396,,,,,,,,,,,,,,,,,
OG_17664,,Peve_00034540,Pocillopora_meandrina_HIv1___RNAseq.g25608.t1,peve_ptua,56.912,,,,,,,,,,,,,,,,,
OG_17665,,Peve_00034554,Pocillopora_meandrina_HIv1___TS.g28486.t1,peve_ptua,48.12,,,,,,,,,,,,,,,,,
OG_17666,,Peve_00034555,Pocillopora_meandrina_HIv1___RNAseq.g23619.t1,peve_ptua,50.94,,,,,,,,,,,,,,,,,
OG_17667,,Peve_00034637,Pocillopora_meandrina_HIv1___RNAseq.g35.t1,peve_ptua,66.23,,,,,,,,,,,,,,,,,
OG_17668,,Peve_00034639,Pocillopora_meandrina_HIv1___TS.g25787.t1,peve_ptua,49.404,,,,,,,,,,,,,,,,,
OG_17669,,Peve_00034645,Pocillopora_meandrina_HIv1___RNAseq.g22065.t1a,peve_ptua,60.173,,,,,,,,,,,,,,,,,
OG_17670,,Peve_00034672,Pocillopora_meandrina_HIv1___RNAseq.g18220.t1,peve_ptua,68.605,,,,,,,,,,,,,,,,,
OG_17671,,Peve_00034676,Pocillopora_meandrina_HIv1___RNAseq.g21161.t1,peve_ptua,54.9525,,,,,,,,,,,,,,,,,
OG_17672,,Peve_00034677,Pocillopora_meandrina_HIv1___RNAseq.g21160.t1,peve_ptua,59.766,,,,,,,,,,,,,,,,,
OG_17673,,Peve_00034690,Pocillopora_meandrina_HIv1___RNAseq.g21241.t1,peve_ptua,86.082,,,,,,,,,,,,,,,,,
OG_17674,,Peve_00034711,Pocillopora_meandrina_HIv1___RNAseq.g2329.t1,peve_ptua,52.931,,,,,,,,,,,,,,,,,
OG_17675,,Peve_00034747,Pocillopora_meandrina_HIv1___TS.g23263.t1,peve_ptua,54.7215,,,,,,,,,,,,,,,,,
OG_17676,,Peve_00034752,Pocillopora_meandrina_HIv1___RNAseq.g2427.t1,peve_ptua,55.256,,,,,,,,,,,,,,,,,
OG_17677,,Peve_00034753,Pocillopora_meandrina_HIv1___RNAseq.g2357.t1,peve_ptua,47.337,,,,,,,,,,,,,,,,,
OG_17678,,Peve_00034814,Pocillopora_meandrina_HIv1___RNAseq.g2373.t1,peve_ptua,58.201,,,,,,,,,,,,,,,,,
OG_17679,,Peve_00034859,Pocillopora_meandrina_HIv1___RNAseq.g25952.t1,peve_ptua,55.971,,,,,,,,,,,,,,,,,
OG_17680,,Peve_00034873,Pocillopora_meandrina_HIv1___RNAseq.g153.t1,peve_ptua,57.593,,,,,,,,,,,,,,,,,
OG_17681,,Peve_00034874,Pocillopora_meandrina_HIv1___TS.g2832.t1c,peve_ptua,50.157,,,,,,,,,,,,,,,,,
OG_17682,,Peve_00034881,Pocillopora_meandrina_HIv1___RNAseq.g20019.t1,peve_ptua,66.109,,,,,,,,,,,,,,,,,
OG_17683,,Peve_00034900,Pocillopora_meandrina_HIv1___RNAseq.g18664.t1,peve_ptua,63.879000000000005,,,,,,,,,,,,,,,,,
OG_17684,,Peve_00034901,Pocillopora_meandrina_HIv1___TS.g28057.t1,peve_ptua,57.789,,,,,,,,,,,,,,,,,
OG_17685,,Peve_00034916,Pocillopora_meandrina_HIv1___RNAseq.g16825.t1,peve_ptua,78.829,,,,,,,,,,,,,,,,,
OG_17686,,Peve_00034925,Pocillopora_meandrina_HIv1___RNAseq.g17025.t1,peve_ptua,61.25,,,,,,,,,,,,,,,,,
OG_17687,,Peve_00034926,Pocillopora_meandrina_HIv1___RNAseq.g17027.t1,peve_ptua,51.923,,,,,,,,,,,,,,,,,
OG_17688,,Peve_00034935,Pocillopora_meandrina_HIv1___RNAseq.g15025.t1,peve_ptua,82.8125,,,,,,,,,,,,,,,,,
OG_17689,,Peve_00034951,Pocillopora_meandrina_HIv1___RNAseq.g4875.t1,peve_ptua,55.779,,,,,,,,,,,,,,,,,
OG_17690,,Peve_00034977,Pocillopora_meandrina_HIv1___RNAseq.g16666.t1,peve_ptua,45.646,,,,,,,,,,,,,,,,,
OG_17691,,Peve_00035006,Pocillopora_meandrina_HIv1___RNAseq.g15577.t1,peve_ptua,48.309,,,,,,,,,,,,,,,,,
OG_17692,,Peve_00035024,Pocillopora_meandrina_HIv1___TS.g4846.t1,peve_ptua,40.714,,,,,,,,,,,,,,,,,
OG_17693,,Peve_00035025,Pocillopora_meandrina_HIv1___RNAseq.g3923.t1,peve_ptua,67.317,,,,,,,,,,,,,,,,,
OG_17694,,Peve_00035047,Pocillopora_meandrina_HIv1___TS.g14660.t1b,peve_ptua,34.483,,,,,,,,,,,,,,,,,
OG_17695,,Peve_00035063,Pocillopora_meandrina_HIv1___RNAseq.g20595.t1,peve_ptua,38.136,,,,,,,,,,,,,,,,,
OG_17696,,Peve_00035083,Pocillopora_meandrina_HIv1___RNAseq.g8326.t1,peve_ptua,54.415,,,,,,,,,,,,,,,,,
OG_17697,,Peve_00035148,Pocillopora_meandrina_HIv1___RNAseq.g17848.t1,peve_ptua,62.295,,,,,,,,,,,,,,,,,
OG_17698,,Peve_00035149,Pocillopora_meandrina_HIv1___RNAseq.g17850.t1,peve_ptua,36.425,,,,,,,,,,,,,,,,,
OG_17699,,Peve_00035151,Pocillopora_meandrina_HIv1___RNAseq.g1742.t1,peve_ptua,76.63,,,,,,,,,,,,,,,,,
OG_17700,,Peve_00035153,Pocillopora_meandrina_HIv1___RNAseq.g1740.t1,peve_ptua,63.755,,,,,,,,,,,,,,,,,
OG_17701,,Peve_00035159,Pocillopora_meandrina_HIv1___RNAseq.g2135.t1,peve_ptua,53.298,,,,,,,,,,,,,,,,,
OG_17702,,Peve_00035161,Pocillopora_meandrina_HIv1___RNAseq.g2134.t1,peve_ptua,55.224,,,,,,,,,,,,,,,,,
OG_17703,,Peve_00035218,Pocillopora_meandrina_HIv1___RNAseq.g26412.t1,peve_ptua,70.37,,,,,,,,,,,,,,,,,
OG_17704,,Peve_00035228,Pocillopora_meandrina_HIv1___RNAseq.g22922.t1,peve_ptua,76.6,,,,,,,,,,,,,,,,,
OG_17705,,Peve_00035235,Pocillopora_meandrina_HIv1___RNAseq.g16330.t1,peve_ptua,78.873,,,,,,,,,,,,,,,,,
OG_17706,,Peve_00035331,Pocillopora_meandrina_HIv1___RNAseq.g7950.t1,peve_ptua,42.325,,,,,,,,,,,,,,,,,
OG_17707,,Peve_00035358,Pocillopora_meandrina_HIv1___RNAseq.g2523.t1,peve_ptua,59.838,,,,,,,,,,,,,,,,,
OG_17708,,Peve_00035370,Pocillopora_meandrina_HIv1___RNAseq.g9431.t1,peve_ptua,54.188,,,,,,,,,,,,,,,,,
OG_17709,,Peve_00035373,Pocillopora_meandrina_HIv1___TS.g9626.t1,peve_ptua,87.812,,,,,,,,,,,,,,,,,
OG_17710,,Peve_00035383,Pocillopora_meandrina_HIv1___RNAseq.g22636.t1,peve_ptua,77.91499999999999,,,,,,,,,,,,,,,,,
OG_17711,,Peve_00035408,Pocillopora_meandrina_HIv1___RNAseq.g4479.t1,peve_ptua,63.0185,,,,,,,,,,,,,,,,,
OG_17712,,Peve_00035426,Pocillopora_meandrina_HIv1___RNAseq.g29824.t1,peve_ptua,60.401,,,,,,,,,,,,,,,,,
OG_17713,,Peve_00035477,Pocillopora_meandrina_HIv1___RNAseq.g19891.t1,peve_ptua,65.289,,,,,,,,,,,,,,,,,
OG_17714,,Peve_00035489,Pocillopora_meandrina_HIv1___RNAseq.g8130.t1,peve_ptua,51.592,,,,,,,,,,,,,,,,,
OG_17715,,Peve_00035498,Pocillopora_meandrina_HIv1___RNAseq.g8127.t1,peve_ptua,48.387,,,,,,,,,,,,,,,,,
OG_17716,,Peve_00035502,Pocillopora_meandrina_HIv1___TS.g20948.t1,peve_ptua,93.706,,,,,,,,,,,,,,,,,
OG_17717,,Peve_00035585,Pocillopora_meandrina_HIv1___RNAseq.g2676.t1,peve_ptua,53.925,,,,,,,,,,,,,,,,,
OG_17718,,Peve_00035588,Pocillopora_meandrina_HIv1___TS.g466.t1,peve_ptua,62.963,,,,,,,,,,,,,,,,,
OG_17719,,Peve_00035619,Pocillopora_meandrina_HIv1___RNAseq.g17439.t1,peve_ptua,58.607,,,,,,,,,,,,,,,,,
OG_17720,,Peve_00035635,Pocillopora_meandrina_HIv1___RNAseq.g20062.t1,peve_ptua,41.4385,,,,,,,,,,,,,,,,,
OG_17721,,Peve_00035644,Pocillopora_meandrina_HIv1___RNAseq.g20067.t1,peve_ptua,70.803,,,,,,,,,,,,,,,,,
OG_17722,,Peve_00035669,Pocillopora_meandrina_HIv1___TS.g2881.t1,peve_ptua,50.973,,,,,,,,,,,,,,,,,
OG_17723,,Peve_00035719,Pocillopora_meandrina_HIv1___RNAseq.g29948.t1,peve_ptua,52.174,,,,,,,,,,,,,,,,,
OG_17724,,Peve_00035753,Pocillopora_meandrina_HIv1___RNAseq.g24838.t1,peve_ptua,48.12,,,,,,,,,,,,,,,,,
OG_17725,,Peve_00035788,Pocillopora_meandrina_HIv1___RNAseq.g16704.t1,peve_ptua,53.186,,,,,,,,,,,,,,,,,
OG_17726,,Peve_00035801,Pocillopora_meandrina_HIv1___TS.g7126.t1,peve_ptua,51.4265,,,,,,,,,,,,,,,,,
OG_17727,,Peve_00035812,Pocillopora_meandrina_HIv1___RNAseq.g385.t2,peve_ptua,70.455,,,,,,,,,,,,,,,,,
OG_17728,,Peve_00035841,Pocillopora_meandrina_HIv1___RNAseq.g21043.t2c,peve_ptua,43.062,,,,,,,,,,,,,,,,,
OG_17729,,Peve_00035874,Pocillopora_meandrina_HIv1___RNAseq.g27850.t1,peve_ptua,69.912,,,,,,,,,,,,,,,,,
OG_17730,,Peve_00035898,Pocillopora_meandrina_HIv1___TS.g12149.t1,peve_ptua,59.587,,,,,,,,,,,,,,,,,
OG_17731,,Peve_00035903,Pocillopora_meandrina_HIv1___RNAseq.g407.t1,peve_ptua,81.481,,,,,,,,,,,,,,,,,
OG_17732,,Peve_00035928,Pocillopora_meandrina_HIv1___RNAseq.g15687.t1,peve_ptua,88.864,,,,,,,,,,,,,,,,,
OG_17733,,Peve_00035944,Pocillopora_meandrina_HIv1___RNAseq.g28375.t1,peve_ptua,37.108,,,,,,,,,,,,,,,,,
OG_17734,,Peve_00035978,Pocillopora_meandrina_HIv1___RNAseq.g14282.t1,peve_ptua,49.531,,,,,,,,,,,,,,,,,
OG_17735,,Peve_00036001,Pocillopora_meandrina_HIv1___TS.g27362.t1,peve_ptua,69.97200000000001,,,,,,,,,,,,,,,,,
OG_17736,,Peve_00036003,Pocillopora_meandrina_HIv1___RNAseq.g22599.t1,peve_ptua,76.923,,,,,,,,,,,,,,,,,
OG_17737,,Peve_00036004,Pocillopora_meandrina_HIv1___TS.g27364.t1,peve_ptua,52.313,,,,,,,,,,,,,,,,,
OG_17738,,Peve_00036009,Pocillopora_meandrina_HIv1___RNAseq.17805_t,peve_ptua,71.212,,,,,,,,,,,,,,,,,
OG_17739,,Peve_00036018,Pocillopora_meandrina_HIv1___TS.g22787.t1,peve_ptua,42.1195,,,,,,,,,,,,,,,,,
OG_17740,,Peve_00036044,Pocillopora_meandrina_HIv1___RNAseq.g19924.t1,peve_ptua,60.4535,,,,,,,,,,,,,,,,,
OG_17741,,Peve_00036050,Pocillopora_meandrina_HIv1___RNAseq.g19940.t1,peve_ptua,85.4675,,,,,,,,,,,,,,,,,
OG_17742,,Peve_00036066,Pocillopora_meandrina_HIv1___RNAseq.g8783.t1,peve_ptua,33.766,,,,,,,,,,,,,,,,,
OG_17743,,Peve_00036075,Pocillopora_meandrina_HIv1___RNAseq.g15289.t1,peve_ptua,59.918,,,,,,,,,,,,,,,,,
OG_17744,,Peve_00036091,Pocillopora_meandrina_HIv1___RNAseq.g12091.t2,peve_ptua,54.7135,,,,,,,,,,,,,,,,,
OG_17745,,Peve_00036092,Pocillopora_meandrina_HIv1___RNAseq.g15284.t1,peve_ptua,57.093,,,,,,,,,,,,,,,,,
OG_17746,,Peve_00036098,Pocillopora_meandrina_HIv1___RNAseq.g12090.t1,peve_ptua,38.624,,,,,,,,,,,,,,,,,
OG_17747,,Peve_00036102,Pocillopora_meandrina_HIv1___RNAseq.g12085.t1,peve_ptua,30.244,,,,,,,,,,,,,,,,,
OG_17748,,Peve_00036117,Pocillopora_meandrina_HIv1___RNAseq.g15309.t1,peve_ptua,57.034,,,,,,,,,,,,,,,,,
OG_17749,,Peve_00036141,Pocillopora_meandrina_HIv1___TS.g21321.t1,peve_ptua,89.458,,,,,,,,,,,,,,,,,
OG_17750,,Peve_00036203,Pocillopora_meandrina_HIv1___RNAseq.g12695.t1,peve_ptua,52.803,,,,,,,,,,,,,,,,,
OG_17751,,Peve_00036268,Pocillopora_meandrina_HIv1___TS.g27962.t1a,peve_ptua,54.873,,,,,,,,,,,,,,,,,
OG_17752,,Peve_00036345,Pocillopora_meandrina_HIv1___RNAseq.g7039.t1,peve_ptua,46.7265,,,,,,,,,,,,,,,,,
OG_17753,,Peve_00036353,Pocillopora_meandrina_HIv1___RNAseq.g23548.t1,peve_ptua,65.269,,,,,,,,,,,,,,,,,
OG_17754,,Peve_00036355,Pocillopora_meandrina_HIv1___RNAseq.g23550.t1,peve_ptua,75.0,,,,,,,,,,,,,,,,,
OG_17755,,Peve_00036361,Pocillopora_meandrina_HIv1___RNAseq.g23554.t1,peve_ptua,48.235,,,,,,,,,,,,,,,,,
OG_17756,,Peve_00036362,Pocillopora_meandrina_HIv1___RNAseq.g23547.t1,peve_ptua,57.818,,,,,,,,,,,,,,,,,
OG_17757,,Peve_00036367,Pocillopora_meandrina_HIv1___RNAseq.g5818.t1,peve_ptua,37.931,,,,,,,,,,,,,,,,,
OG_17758,,Peve_00036372,Pocillopora_meandrina_HIv1___RNAseq.g23539.t1,peve_ptua,64.481,,,,,,,,,,,,,,,,,
OG_17759,,Peve_00036384,Pocillopora_meandrina_HIv1___RNAseq.g23544.t2,peve_ptua,47.94,,,,,,,,,,,,,,,,,
OG_17760,,Peve_00036410,Pocillopora_meandrina_HIv1___RNAseq.g14658.t1,peve_ptua,61.809,,,,,,,,,,,,,,,,,
OG_17761,,Peve_00036420,Pocillopora_meandrina_HIv1___RNAseq.g23299.t1,peve_ptua,44.231,,,,,,,,,,,,,,,,,
OG_17762,,Peve_00036440,Pocillopora_meandrina_HIv1___RNAseq.g25363.t1,peve_ptua,66.751,,,,,,,,,,,,,,,,,
OG_17763,,Peve_00036455,Pocillopora_meandrina_HIv1___TS.g12183.t1,peve_ptua,46.798,,,,,,,,,,,,,,,,,
OG_17764,,Peve_00036460,Pocillopora_meandrina_HIv1___RNAseq.g24832.t1,peve_ptua,52.198,,,,,,,,,,,,,,,,,
OG_17765,,Peve_00036462,Pocillopora_meandrina_HIv1___RNAseq.g24761.t1,peve_ptua,56.842,,,,,,,,,,,,,,,,,
OG_17766,,Peve_00036463,Pocillopora_meandrina_HIv1___TS.g12199.t1,peve_ptua,58.86,,,,,,,,,,,,,,,,,
OG_17767,,Peve_00036477,Pocillopora_meandrina_HIv1___TS.g11655.t1,peve_ptua,55.405,,,,,,,,,,,,,,,,,
OG_17768,,Peve_00036482,Pocillopora_meandrina_HIv1___RNAseq.g13896.t1,peve_ptua,48.75,,,,,,,,,,,,,,,,,
OG_17769,,Peve_00036496,Pocillopora_meandrina_HIv1___RNAseq.g13907.t1,peve_ptua,65.03399999999999,,,,,,,,,,,,,,,,,
OG_17770,,Peve_00036497,Pocillopora_meandrina_HIv1___RNAseq.g13908.t1,peve_ptua,62.424,,,,,,,,,,,,,,,,,
OG_17771,,Peve_00036515,Pocillopora_meandrina_HIv1___TS.g16671.t1,peve_ptua,68.947,,,,,,,,,,,,,,,,,
OG_17772,,Peve_00036538,Pocillopora_meandrina_HIv1___RNAseq.g10655.t1,peve_ptua,81.105,,,,,,,,,,,,,,,,,
OG_17773,,Peve_00036545,Pocillopora_meandrina_HIv1___RNAseq.g11209.t2,peve_ptua,81.207,,,,,,,,,,,,,,,,,
OG_17774,,Peve_00036546,Pocillopora_meandrina_HIv1___RNAseq.g11206.t1b,peve_ptua,79.029,,,,,,,,,,,,,,,,,
OG_17775,,Peve_00036547,Pocillopora_meandrina_HIv1___RNAseq.g11164.t1,peve_ptua,85.632,,,,,,,,,,,,,,,,,
OG_17776,,Peve_00036549,Pocillopora_meandrina_HIv1___RNAseq.g4995.t1,peve_ptua,85.944,,,,,,,,,,,,,,,,,
OG_17777,,Peve_00036554,Pocillopora_meandrina_HIv1___RNAseq.g11208.t1,peve_ptua,86.275,,,,,,,,,,,,,,,,,
OG_17778,,Peve_00036567,Pocillopora_meandrina_HIv1___RNAseq.g11207.t1,peve_ptua,75.211,,,,,,,,,,,,,,,,,
OG_17779,,Peve_00036579,Pocillopora_meandrina_HIv1___RNAseq.g4453.t1,peve_ptua,71.984,,,,,,,,,,,,,,,,,
OG_17780,,Peve_00036581,Pocillopora_meandrina_HIv1___RNAseq.g4452.t1,peve_ptua,66.923,,,,,,,,,,,,,,,,,
OG_17781,,Peve_00036582,Pocillopora_meandrina_HIv1___RNAseq.g4455.t1,peve_ptua,65.164,,,,,,,,,,,,,,,,,
OG_17782,,Peve_00036608,Pocillopora_meandrina_HIv1___RNAseq.g4777.t1,peve_ptua,71.344,,,,,,,,,,,,,,,,,
OG_17783,,Peve_00036616,Pocillopora_meandrina_HIv1___RNAseq.156_t,peve_ptua,90.284,,,,,,,,,,,,,,,,,
OG_17784,,Peve_00036646,Pocillopora_meandrina_HIv1___RNAseq.g7646.t1,peve_ptua,42.767,,,,,,,,,,,,,,,,,
OG_17785,,Peve_00036651,Pocillopora_meandrina_HIv1___TS.g28328.t1b,peve_ptua,52.475,,,,,,,,,,,,,,,,,
OG_17786,,Peve_00036656,Pocillopora_meandrina_HIv1___RNAseq.g16250.t1,peve_ptua,35.354,,,,,,,,,,,,,,,,,
OG_17787,,Peve_00036667,Pocillopora_meandrina_HIv1___RNAseq.g26249.t1,peve_ptua,60.0,,,,,,,,,,,,,,,,,
OG_17788,,Peve_00036681,Pocillopora_meandrina_HIv1___RNAseq.g27835.t1,peve_ptua,79.9445,,,,,,,,,,,,,,,,,
OG_17789,,Peve_00036722,Pocillopora_meandrina_HIv1___RNAseq.g12707.t1,peve_ptua,38.342,,,,,,,,,,,,,,,,,
OG_17790,,Peve_00036760,Pocillopora_meandrina_HIv1___RNAseq.g2145.t1,peve_ptua,86.164,,,,,,,,,,,,,,,,,
OG_17791,,Peve_00036763,Pocillopora_meandrina_HIv1___RNAseq.g22741.t1,peve_ptua,49.622,,,,,,,,,,,,,,,,,
OG_17792,,Peve_00036772,Pocillopora_meandrina_HIv1___RNAseq.g1712.t1,peve_ptua,78.014,,,,,,,,,,,,,,,,,
OG_17793,,Peve_00036792,Pocillopora_meandrina_HIv1___RNAseq.g16123.t2,peve_ptua,62.6535,,,,,,,,,,,,,,,,,
OG_17794,,Peve_00036800,Pocillopora_meandrina_HIv1___TS.g7574.t1,peve_ptua,53.055,,,,,,,,,,,,,,,,,
OG_17795,,Peve_00036810,Pocillopora_meandrina_HIv1___RNAseq.g3022.t1,peve_ptua,77.667,,,,,,,,,,,,,,,,,
OG_17796,,Peve_00036833,Pocillopora_meandrina_HIv1___RNAseq.g19864.t1,peve_ptua,69.178,,,,,,,,,,,,,,,,,
OG_17797,,Peve_00036849,Pocillopora_meandrina_HIv1___RNAseq.g3083.t1,peve_ptua,53.114,,,,,,,,,,,,,,,,,
OG_17798,,Peve_00036852,Pocillopora_meandrina_HIv1___RNAseq.g3079.t1,peve_ptua,56.9195,,,,,,,,,,,,,,,,,
OG_17799,,Peve_00036859,Pocillopora_meandrina_HIv1___TS.g18200.t1,peve_ptua,62.309,,,,,,,,,,,,,,,,,
OG_17800,,Peve_00036861,Pocillopora_meandrina_HIv1___RNAseq.g3086.t2,peve_ptua,56.51,,,,,,,,,,,,,,,,,
OG_17801,,Peve_00036885,Pocillopora_meandrina_HIv1___RNAseq.g22121.t1,peve_ptua,85.583,,,,,,,,,,,,,,,,,
OG_17802,,Peve_00036897,Pocillopora_meandrina_HIv1___RNAseq.g3946.t1,peve_ptua,39.011,,,,,,,,,,,,,,,,,
OG_17803,,Peve_00036899,Pocillopora_meandrina_HIv1___RNAseq.g27957.t1b,peve_ptua,69.62,,,,,,,,,,,,,,,,,
OG_17804,,Peve_00036918,Pocillopora_meandrina_HIv1___RNAseq.g28022.t1,peve_ptua,67.802,,,,,,,,,,,,,,,,,
OG_17805,,Peve_00036921,Pocillopora_meandrina_HIv1___RNAseq.g28017.t1,peve_ptua,49.0,,,,,,,,,,,,,,,,,
OG_17806,,Peve_00036953,Pocillopora_meandrina_HIv1___TS.g4783.t1,peve_ptua,41.403,,,,,,,,,,,,,,,,,
OG_17807,,Peve_00036957,Pocillopora_meandrina_HIv1___RNAseq.g2269.t1,peve_ptua,72.277,,,,,,,,,,,,,,,,,
OG_17808,,Peve_00036960,Pocillopora_meandrina_HIv1___RNAseq.g2266.t1,peve_ptua,87.572,,,,,,,,,,,,,,,,,
OG_17809,,Peve_00036969,Pocillopora_meandrina_HIv1___RNAseq.g6089.t1,peve_ptua,32.558,,,,,,,,,,,,,,,,,
OG_17810,,Peve_00036978,Pocillopora_meandrina_HIv1___TS.g4572.t1,peve_ptua,49.022,,,,,,,,,,,,,,,,,
OG_17811,,Peve_00036982,Pocillopora_meandrina_HIv1___RNAseq.g2259.t1,peve_ptua,71.628,,,,,,,,,,,,,,,,,
OG_17812,,Peve_00036987,Pocillopora_meandrina_HIv1___RNAseq.g2246.t1,peve_ptua,33.578,,,,,,,,,,,,,,,,,
OG_17813,,Peve_00036990,Pocillopora_meandrina_HIv1___RNAseq.g2242.t1,peve_ptua,32.021,,,,,,,,,,,,,,,,,
OG_17814,,Peve_00037007,Pocillopora_meandrina_HIv1___RNAseq.g2224.t1,peve_ptua,36.923,,,,,,,,,,,,,,,,,
OG_17815,,Peve_00037012,Pocillopora_meandrina_HIv1___RNAseq.g2220.t1,peve_ptua,42.609,,,,,,,,,,,,,,,,,
OG_17816,,Peve_00037024,Pocillopora_meandrina_HIv1___RNAseq.g2299.t1,peve_ptua,58.214,,,,,,,,,,,,,,,,,
OG_17817,,Peve_00037051,Pocillopora_meandrina_HIv1___RNAseq.g25173.t1,peve_ptua,59.146,,,,,,,,,,,,,,,,,
OG_17818,,Peve_00037054,Pocillopora_meandrina_HIv1___TS.g18673.t1,peve_ptua,42.651,,,,,,,,,,,,,,,,,
OG_17819,,Peve_00037057,Pocillopora_meandrina_HIv1___TS.g18675.t1,peve_ptua,39.001,,,,,,,,,,,,,,,,,
OG_17820,,Peve_00037061,Pocillopora_meandrina_HIv1___RNAseq.g28728.t1,peve_ptua,66.782,,,,,,,,,,,,,,,,,
OG_17821,,Peve_00037073,Pocillopora_meandrina_HIv1___RNAseq.17752_t,peve_ptua,83.6195,,,,,,,,,,,,,,,,,
OG_17822,,Peve_00037085,Pocillopora_meandrina_HIv1___RNAseq.g25909.t1,peve_ptua,58.3545,,,,,,,,,,,,,,,,,
OG_17823,,Peve_00037088,Pocillopora_meandrina_HIv1___RNAseq.g25912.t1,peve_ptua,66.571,,,,,,,,,,,,,,,,,
OG_17824,,Peve_00037097,Pocillopora_meandrina_HIv1___RNAseq.g29842.t1,peve_ptua,77.143,,,,,,,,,,,,,,,,,
OG_17825,,Peve_00037101,Pocillopora_meandrina_HIv1___TS.g529.t1,peve_ptua,66.174,,,,,,,,,,,,,,,,,
OG_17826,,Peve_00037104,Pocillopora_meandrina_HIv1___RNAseq.g6782.t1,peve_ptua,46.188,,,,,,,,,,,,,,,,,
OG_17827,,Peve_00037119,Pocillopora_meandrina_HIv1___RNAseq.g17879.t1,peve_ptua,44.601,,,,,,,,,,,,,,,,,
OG_17828,,Peve_00037139,Pocillopora_meandrina_HIv1___RNAseq.g21094.t1,peve_ptua,40.331500000000005,,,,,,,,,,,,,,,,,
OG_17829,,Peve_00037177,Pocillopora_meandrina_HIv1___RNAseq.g17935.t1,peve_ptua,66.3665,,,,,,,,,,,,,,,,,
OG_17830,,Peve_00037199,Pocillopora_meandrina_HIv1___RNAseq.g13127.t1,peve_ptua,52.941,,,,,,,,,,,,,,,,,
OG_17831,,Peve_00037200,Pocillopora_meandrina_HIv1___RNAseq.g7608.t1,peve_ptua,90.769,,,,,,,,,,,,,,,,,
OG_17832,,Peve_00037212,Pocillopora_meandrina_HIv1___RNAseq.g6726.t1,peve_ptua,90.141,,,,,,,,,,,,,,,,,
OG_17833,,Peve_00037243,Pocillopora_meandrina_HIv1___RNAseq.g24527.t1,peve_ptua,42.5015,,,,,,,,,,,,,,,,,
OG_17834,,Peve_00037250,Pocillopora_meandrina_HIv1___RNAseq.g524.t1,peve_ptua,84.109,,,,,,,,,,,,,,,,,
OG_17835,,Peve_00037253,Pocillopora_meandrina_HIv1___TS.g25223.t1,peve_ptua,55.668,,,,,,,,,,,,,,,,,
OG_17836,,Peve_00037286,Pocillopora_meandrina_HIv1___RNAseq.g8716.t1,peve_ptua,37.2215,,,,,,,,,,,,,,,,,
OG_17837,,Peve_00037288,Pocillopora_meandrina_HIv1___RNAseq.g1045.t1,peve_ptua,39.4855,,,,,,,,,,,,,,,,,
OG_17838,,Peve_00037313,Pocillopora_meandrina_HIv1___RNAseq.g28456.t1,peve_ptua,39.717,,,,,,,,,,,,,,,,,
OG_17839,,Peve_00037347,Pocillopora_meandrina_HIv1___RNAseq.g12136.t1,peve_ptua,47.897,,,,,,,,,,,,,,,,,
OG_17840,,Peve_00037363,Pocillopora_meandrina_HIv1___RNAseq.g24692.t2,peve_ptua,49.195,,,,,,,,,,,,,,,,,
OG_17841,,Peve_00037371,Pocillopora_meandrina_HIv1___RNAseq.g28169.t1b,peve_ptua,58.853,,,,,,,,,,,,,,,,,
OG_17842,,Peve_00037377,Pocillopora_meandrina_HIv1___TS.g14544.t2,peve_ptua,44.0645,,,,,,,,,,,,,,,,,
OG_17843,,Peve_00037420,Pocillopora_meandrina_HIv1___RNAseq.g4754.t1,peve_ptua,88.843,,,,,,,,,,,,,,,,,
OG_17844,,Peve_00037446,Pocillopora_meandrina_HIv1___RNAseq.g23043.t1,peve_ptua,87.234,,,,,,,,,,,,,,,,,
OG_17845,,Peve_00037465,Pocillopora_meandrina_HIv1___RNAseq.g22988.t1,peve_ptua,60.942,,,,,,,,,,,,,,,,,
OG_17846,,Peve_00037471,Pocillopora_meandrina_HIv1___RNAseq.g13602.t1,peve_ptua,69.5025,,,,,,,,,,,,,,,,,
OG_17847,,Peve_00037500,Pocillopora_meandrina_HIv1___RNAseq.g17696.t1,peve_ptua,60.563,,,,,,,,,,,,,,,,,
OG_17848,,Peve_00037522,Pocillopora_meandrina_HIv1___TS.g17893.t1,peve_ptua,92.0,,,,,,,,,,,,,,,,,
OG_17849,,Peve_00037536,Pocillopora_meandrina_HIv1___TS.g14930.t1,peve_ptua,53.4205,,,,,,,,,,,,,,,,,
OG_17850,,Peve_00037556,Pocillopora_meandrina_HIv1___RNAseq.g20249.t1,peve_ptua,60.367,,,,,,,,,,,,,,,,,
OG_17851,,Peve_00037579,Pocillopora_meandrina_HIv1___RNAseq.g11821.t1,peve_ptua,50.442,,,,,,,,,,,,,,,,,
OG_17852,,Peve_00037582,Pocillopora_meandrina_HIv1___RNAseq.g4341.t1,peve_ptua,71.9025,,,,,,,,,,,,,,,,,
OG_17853,,Peve_00037600,Pocillopora_meandrina_HIv1___RNAseq.g9314.t1,peve_ptua,70.93,,,,,,,,,,,,,,,,,
OG_17854,,Peve_00037609,Pocillopora_meandrina_HIv1___RNAseq.g4336.t1,peve_ptua,85.938,,,,,,,,,,,,,,,,,
OG_17855,,Peve_00037627,Pocillopora_meandrina_HIv1___RNAseq.g8408.t1,peve_ptua,41.424,,,,,,,,,,,,,,,,,
OG_17856,,Peve_00037669,Pocillopora_meandrina_HIv1___RNAseq.g9232.t1,peve_ptua,67.653,,,,,,,,,,,,,,,,,
OG_17857,,Peve_00037676,Pocillopora_meandrina_HIv1___RNAseq.g15627.t1,peve_ptua,66.412,,,,,,,,,,,,,,,,,
OG_17858,,Peve_00037685,Pocillopora_meandrina_HIv1___TS.g14626.t1,peve_ptua,97.468,,,,,,,,,,,,,,,,,
OG_17859,,Peve_00037697,Pocillopora_meandrina_HIv1___RNAseq.g30044.t1,peve_ptua,87.619,,,,,,,,,,,,,,,,,
OG_17860,,Peve_00037698,Pocillopora_meandrina_HIv1___RNAseq.g30043.t1,peve_ptua,58.621,,,,,,,,,,,,,,,,,
OG_17861,,Peve_00037705,Pocillopora_meandrina_HIv1___RNAseq.g30279.t1,peve_ptua,43.206,,,,,,,,,,,,,,,,,
OG_17862,,Peve_00037709,Pocillopora_meandrina_HIv1___RNAseq.g17913.t1,peve_ptua,68.406,,,,,,,,,,,,,,,,,
OG_17863,,Peve_00037745,Pocillopora_meandrina_HIv1___RNAseq.g6692.t1,peve_ptua,60.123,,,,,,,,,,,,,,,,,
OG_17864,,Peve_00037751,Pocillopora_meandrina_HIv1___RNAseq.g16689.t1,peve_ptua,41.111,,,,,,,,,,,,,,,,,
OG_17865,,Peve_00037769,Pocillopora_meandrina_HIv1___RNAseq.g28571.t1,peve_ptua,49.189,,,,,,,,,,,,,,,,,
OG_17866,,Peve_00037794,Pocillopora_meandrina_HIv1___RNAseq.g20503.t1,peve_ptua,48.087,,,,,,,,,,,,,,,,,
OG_17867,,Peve_00037808,Pocillopora_meandrina_HIv1___TS.g15374.t1,peve_ptua,44.703,,,,,,,,,,,,,,,,,
OG_17868,,Peve_00037810,Pocillopora_meandrina_HIv1___RNAseq.g24699.t2,peve_ptua,68.687,,,,,,,,,,,,,,,,,
OG_17869,,Peve_00037853,Pocillopora_meandrina_HIv1___RNAseq.g17875.t1c,peve_ptua,62.719,,,,,,,,,,,,,,,,,
OG_17870,,Peve_00037898,Pocillopora_meandrina_HIv1___RNAseq.g17247.t1,peve_ptua,72.321,,,,,,,,,,,,,,,,,
OG_17871,,Peve_00037921,Pocillopora_meandrina_HIv1___RNAseq.g19129.t1,peve_ptua,64.12549999999999,,,,,,,,,,,,,,,,,
OG_17872,,Peve_00037929,Pocillopora_meandrina_HIv1___RNAseq.g23308.t1,peve_ptua,90.347,,,,,,,,,,,,,,,,,
OG_17873,,Peve_00037930,Pocillopora_meandrina_HIv1___RNAseq.11966_t,peve_ptua,81.166,,,,,,,,,,,,,,,,,
OG_17874,,Peve_00037933,Pocillopora_meandrina_HIv1___RNAseq.g22167.t1,peve_ptua,66.216,,,,,,,,,,,,,,,,,
OG_17875,,Peve_00037939,Pocillopora_meandrina_HIv1___RNAseq.g16524.t1,peve_ptua,49.341,,,,,,,,,,,,,,,,,
OG_17876,,Peve_00037991,Pocillopora_meandrina_HIv1___RNAseq.g23676.t1,peve_ptua,61.216,,,,,,,,,,,,,,,,,
OG_17877,,Peve_00038013,Pocillopora_meandrina_HIv1___RNAseq.g9272.t1,peve_ptua,58.854,,,,,,,,,,,,,,,,,
OG_17878,,Peve_00038019,Pocillopora_meandrina_HIv1___TS.g15284.t1,peve_ptua,61.818,,,,,,,,,,,,,,,,,
OG_17879,,Peve_00038025,Pocillopora_meandrina_HIv1___RNAseq.g6484.t1b,peve_ptua,53.3085,,,,,,,,,,,,,,,,,
OG_17880,,Peve_00038043,Pocillopora_meandrina_HIv1___RNAseq.g18023.t1,peve_ptua,69.38,,,,,,,,,,,,,,,,,
OG_17881,,Peve_00038061,Pocillopora_meandrina_HIv1___TS.g8927.t1,peve_ptua,46.494,,,,,,,,,,,,,,,,,
OG_17882,,Peve_00038080,Pocillopora_meandrina_HIv1___RNAseq.g14429.t1,peve_ptua,54.894,,,,,,,,,,,,,,,,,
OG_17883,,Peve_00038099,Pocillopora_meandrina_HIv1___RNAseq.g8508.t1,peve_ptua,48.106,,,,,,,,,,,,,,,,,
OG_17884,,Peve_00038106,Pocillopora_meandrina_HIv1___RNAseq.g8504.t1,peve_ptua,34.978,,,,,,,,,,,,,,,,,
OG_17885,,Peve_00038107,Pocillopora_meandrina_HIv1___RNAseq.g7731.t1,peve_ptua,43.564,,,,,,,,,,,,,,,,,
OG_17886,,Peve_00038118,Pocillopora_meandrina_HIv1___TS.g425.t2,peve_ptua,84.333,,,,,,,,,,,,,,,,,
OG_17887,,Peve_00038120,Pocillopora_meandrina_HIv1___RNAseq.g6682.t1,peve_ptua,61.8725,,,,,,,,,,,,,,,,,
OG_17888,,Peve_00038122,Pocillopora_meandrina_HIv1___TS.g420.t1,peve_ptua,33.186,,,,,,,,,,,,,,,,,
OG_17889,,Peve_00038125,Pocillopora_meandrina_HIv1___RNAseq.g7733.t1,peve_ptua,87.027,,,,,,,,,,,,,,,,,
OG_17890,,Peve_00038191,Pocillopora_meandrina_HIv1___RNAseq.g12346.t1,peve_ptua,49.524,,,,,,,,,,,,,,,,,
OG_17891,,Peve_00038195,Pocillopora_meandrina_HIv1___RNAseq.g12347.t1,peve_ptua,47.581500000000005,,,,,,,,,,,,,,,,,
OG_17892,,Peve_00038230,Pocillopora_meandrina_HIv1___TS.g4858.t1,peve_ptua,48.004,,,,,,,,,,,,,,,,,
OG_17893,,Peve_00038232,Pocillopora_meandrina_HIv1___RNAseq.g2345.t1,peve_ptua,63.636,,,,,,,,,,,,,,,,,
OG_17894,,Peve_00038243,Pocillopora_meandrina_HIv1___RNAseq.g29279.t1,peve_ptua,67.235,,,,,,,,,,,,,,,,,
OG_17895,,Peve_00038250,Pocillopora_meandrina_HIv1___RNAseq.g25797.t1,peve_ptua,54.862,,,,,,,,,,,,,,,,,
OG_17896,,Peve_00038256,Pocillopora_meandrina_HIv1___RNAseq.g12577.t1,peve_ptua,63.056,,,,,,,,,,,,,,,,,
OG_17897,,Peve_00038258,Pocillopora_meandrina_HIv1___RNAseq.g10393.t1,peve_ptua,69.286,,,,,,,,,,,,,,,,,
OG_17898,,Peve_00038281,Pocillopora_meandrina_HIv1___RNAseq.g4580.t1,peve_ptua,71.505,,,,,,,,,,,,,,,,,
OG_17899,,Peve_00038286,Pocillopora_meandrina_HIv1___TS.g21995.t1,peve_ptua,55.41,,,,,,,,,,,,,,,,,
OG_17900,,Peve_00038332,Pocillopora_meandrina_HIv1___RNAseq.g26040.t1,peve_ptua,73.6,,,,,,,,,,,,,,,,,
OG_17901,,Peve_00038336,Pocillopora_meandrina_HIv1___RNAseq.g29199.t1,peve_ptua,39.934,,,,,,,,,,,,,,,,,
OG_17902,,Peve_00038339,Pocillopora_meandrina_HIv1___RNAseq.g24952.t1,peve_ptua,53.846,,,,,,,,,,,,,,,,,
OG_17903,,Peve_00038369,Pocillopora_meandrina_HIv1___RNAseq.g19577.t1,peve_ptua,40.951,,,,,,,,,,,,,,,,,
OG_17904,,Peve_00038371,Pocillopora_meandrina_HIv1___TS.g28958.t1,peve_ptua,50.725,,,,,,,,,,,,,,,,,
OG_17905,,Peve_00038377,Pocillopora_meandrina_HIv1___RNAseq.g19421.t1,peve_ptua,42.331,,,,,,,,,,,,,,,,,
OG_17906,,Peve_00038425,Pocillopora_meandrina_HIv1___RNAseq.g20303.t1,peve_ptua,87.018,,,,,,,,,,,,,,,,,
OG_17907,,Peve_00038468,Pocillopora_meandrina_HIv1___RNAseq.g28896.t1,peve_ptua,80.319,,,,,,,,,,,,,,,,,
OG_17908,,Peve_00038469,Pocillopora_meandrina_HIv1___RNAseq.g28897.t1,peve_ptua,49.594,,,,,,,,,,,,,,,,,
OG_17909,,Peve_00038477,Pocillopora_meandrina_HIv1___RNAseq.g28900.t1,peve_ptua,96.939,,,,,,,,,,,,,,,,,
OG_17910,,Peve_00038487,Pocillopora_meandrina_HIv1___RNAseq.g6230.t1,peve_ptua,71.115,,,,,,,,,,,,,,,,,
OG_17911,,Peve_00038488,Pocillopora_meandrina_HIv1___RNAseq.g6231.t1,peve_ptua,50.997,,,,,,,,,,,,,,,,,
OG_17912,,Peve_00038491,Pocillopora_meandrina_HIv1___RNAseq.g6233.t1,peve_ptua,71.619,,,,,,,,,,,,,,,,,
OG_17913,,Peve_00038492,Pocillopora_meandrina_HIv1___RNAseq.g6234.t1,peve_ptua,49.495,,,,,,,,,,,,,,,,,
OG_17914,,Peve_00038497,Pocillopora_meandrina_HIv1___RNAseq.g6250.t1,peve_ptua,43.581,,,,,,,,,,,,,,,,,
OG_17915,,Peve_00038529,Pocillopora_meandrina_HIv1___RNAseq.g16361.t1,peve_ptua,49.423,,,,,,,,,,,,,,,,,
OG_17916,,Peve_00038556,Pocillopora_meandrina_HIv1___TS.g15459.t1a,peve_ptua,60.254,,,,,,,,,,,,,,,,,
OG_17917,,Peve_00038560,Pocillopora_meandrina_HIv1___RNAseq.g28128.t1,peve_ptua,46.429,,,,,,,,,,,,,,,,,
OG_17918,,Peve_00038580,Pocillopora_meandrina_HIv1___RNAseq.g22970.t1,peve_ptua,85.235,,,,,,,,,,,,,,,,,
OG_17919,,Peve_00038581,Pocillopora_meandrina_HIv1___RNAseq.g22969.t1,peve_ptua,81.25,,,,,,,,,,,,,,,,,
OG_17920,,Peve_00038583,Pocillopora_meandrina_HIv1___RNAseq.g10673.t1,peve_ptua,76.543,,,,,,,,,,,,,,,,,
OG_17921,,Peve_00038594,Pocillopora_meandrina_HIv1___RNAseq.g24078.t1,peve_ptua,72.368,,,,,,,,,,,,,,,,,
OG_17922,,Peve_00038650,Pocillopora_meandrina_HIv1___TS.g3019.t1,peve_ptua,54.455,,,,,,,,,,,,,,,,,
OG_17923,,Peve_00038652,Pocillopora_meandrina_HIv1___RNAseq.g17556.t1,peve_ptua,68.916,,,,,,,,,,,,,,,,,
OG_17924,,Peve_00038662,Pocillopora_meandrina_HIv1___RNAseq.g17443.t1,peve_ptua,64.458,,,,,,,,,,,,,,,,,
OG_17925,,Peve_00038669,Pocillopora_meandrina_HIv1___RNAseq.g17444.t1,peve_ptua,87.2355,,,,,,,,,,,,,,,,,
OG_17926,,Peve_00038712,Pocillopora_meandrina_HIv1___RNAseq.g18131.t1,peve_ptua,59.545,,,,,,,,,,,,,,,,,
OG_17927,,Peve_00038714,Pocillopora_meandrina_HIv1___RNAseq.g28827.t1,peve_ptua,81.25,,,,,,,,,,,,,,,,,
OG_17928,,Peve_00038715,Pocillopora_meandrina_HIv1___TS.g18602.t1,peve_ptua,60.3035,,,,,,,,,,,,,,,,,
OG_17929,,Peve_00038722,Pocillopora_meandrina_HIv1___RNAseq.g24127.t1,peve_ptua,55.869,,,,,,,,,,,,,,,,,
OG_17930,,Peve_00038725,Pocillopora_meandrina_HIv1___TS.g12963.t1,peve_ptua,68.75,,,,,,,,,,,,,,,,,
OG_17931,,Peve_00038738,Pocillopora_meandrina_HIv1___RNAseq.g27362.t1,peve_ptua,53.247,,,,,,,,,,,,,,,,,
OG_17932,,Peve_00038765,Pocillopora_meandrina_HIv1___RNAseq.g17308.t1,peve_ptua,58.594,,,,,,,,,,,,,,,,,
OG_17933,,Peve_00038771,Pocillopora_meandrina_HIv1___RNAseq.g15634.t1,peve_ptua,84.615,,,,,,,,,,,,,,,,,
OG_17934,,Peve_00038774,Pocillopora_meandrina_HIv1___RNAseq.g13633.t1,peve_ptua,47.229,,,,,,,,,,,,,,,,,
OG_17935,,Peve_00038848,Pocillopora_meandrina_HIv1___RNAseq.g896.t1,peve_ptua,38.938,,,,,,,,,,,,,,,,,
OG_17936,,Peve_00038856,Pocillopora_meandrina_HIv1___RNAseq.g4449.t1,peve_ptua,73.621,,,,,,,,,,,,,,,,,
OG_17937,,Peve_00038867,Pocillopora_meandrina_HIv1___RNAseq.g3023.t1,peve_ptua,79.741,,,,,,,,,,,,,,,,,
OG_17938,,Peve_00038873,Pocillopora_meandrina_HIv1___TS.g22451.t1,peve_ptua,74.76,,,,,,,,,,,,,,,,,
OG_17939,,Peve_00038893,Pocillopora_meandrina_HIv1___TS.g11357.t1,peve_ptua,31.894,,,,,,,,,,,,,,,,,
OG_17940,,Peve_00038903,Pocillopora_meandrina_HIv1___RNAseq.g20782.t1,peve_ptua,75.0,,,,,,,,,,,,,,,,,
OG_17941,,Peve_00038926,Pocillopora_meandrina_HIv1___RNAseq.g25443.t1,peve_ptua,57.971,,,,,,,,,,,,,,,,,
OG_17942,,Peve_00038944,Pocillopora_meandrina_HIv1___RNAseq.g1658.t1,peve_ptua,63.707,,,,,,,,,,,,,,,,,
OG_17943,,Peve_00038948,Pocillopora_meandrina_HIv1___RNAseq.g10912.t1,peve_ptua,78.912,,,,,,,,,,,,,,,,,
OG_17944,,Peve_00039002,Pocillopora_meandrina_HIv1___RNAseq.g30133.t1,peve_ptua,93.75,,,,,,,,,,,,,,,,,
OG_17945,,Peve_00039016,Pocillopora_meandrina_HIv1___RNAseq.g21877.t1,peve_ptua,61.111,,,,,,,,,,,,,,,,,
OG_17946,,Peve_00039026,Pocillopora_meandrina_HIv1___RNAseq.g10528.t1,peve_ptua,34.848,,,,,,,,,,,,,,,,,
OG_17947,,Peve_00039031,Pocillopora_meandrina_HIv1___RNAseq.g7510.t1,peve_ptua,54.264,,,,,,,,,,,,,,,,,
OG_17948,,Peve_00039034,Pocillopora_meandrina_HIv1___RNAseq.g7511.t1,peve_ptua,50.549,,,,,,,,,,,,,,,,,
OG_17949,,Peve_00039042,Pocillopora_meandrina_HIv1___RNAseq.g7109.t1,peve_ptua,78.571,,,,,,,,,,,,,,,,,
OG_17950,,Peve_00039061,Pocillopora_meandrina_HIv1___RNAseq.g7496.t1,peve_ptua,49.057,,,,,,,,,,,,,,,,,
OG_17951,,Peve_00039062,Pocillopora_meandrina_HIv1___RNAseq.g7497.t1,peve_ptua,80.167,,,,,,,,,,,,,,,,,
OG_17952,,Peve_00039064,Pocillopora_meandrina_HIv1___TS.g1253.t1,peve_ptua,75.21799999999999,,,,,,,,,,,,,,,,,
OG_17953,,Peve_00039065,Pocillopora_meandrina_HIv1___RNAseq.g7500.t1,peve_ptua,75.532,,,,,,,,,,,,,,,,,
OG_17954,,Peve_00039077,Pocillopora_meandrina_HIv1___RNAseq.g13561.t1,peve_ptua,46.591,,,,,,,,,,,,,,,,,
OG_17955,,Peve_00039091,Pocillopora_meandrina_HIv1___RNAseq.14834_t,peve_ptua,58.8065,,,,,,,,,,,,,,,,,
OG_17956,,Peve_00039107,Pocillopora_meandrina_HIv1___RNAseq.g5869.t1,peve_ptua,64.375,,,,,,,,,,,,,,,,,
OG_17957,,Peve_00039126,Pocillopora_meandrina_HIv1___TS.g10829.t1,peve_ptua,66.129,,,,,,,,,,,,,,,,,
OG_17958,,Peve_00039144,Pocillopora_meandrina_HIv1___RNAseq.g3909.t1,peve_ptua,52.917,,,,,,,,,,,,,,,,,
OG_17959,,Peve_00039178,Pocillopora_meandrina_HIv1___RNAseq.g24945.t1,peve_ptua,46.154,,,,,,,,,,,,,,,,,
OG_17960,,Peve_00039184,Pocillopora_meandrina_HIv1___TS.g17799.t1,peve_ptua,49.167,,,,,,,,,,,,,,,,,
OG_17961,,Peve_00039185,Pocillopora_meandrina_HIv1___TS.g22372.t1b,peve_ptua,73.529,,,,,,,,,,,,,,,,,
OG_17962,,Peve_00039207,Pocillopora_meandrina_HIv1___RNAseq.g9996.t1,peve_ptua,68.709,,,,,,,,,,,,,,,,,
OG_17963,,Peve_00039246,Pocillopora_meandrina_HIv1___RNAseq.g6461.t1,peve_ptua,32.051,,,,,,,,,,,,,,,,,
OG_17964,,Peve_00039252,Pocillopora_meandrina_HIv1___RNAseq.g8091.t1,peve_ptua,66.667,,,,,,,,,,,,,,,,,
OG_17965,,Peve_00039253,Pocillopora_meandrina_HIv1___TS.g27971.t1,peve_ptua,59.788,,,,,,,,,,,,,,,,,
OG_17966,,Peve_00039267,Pocillopora_meandrina_HIv1___RNAseq.g7600.t1,peve_ptua,65.982,,,,,,,,,,,,,,,,,
OG_17967,,Peve_00039269,Pocillopora_meandrina_HIv1___RNAseq.g7598.t1,peve_ptua,57.527,,,,,,,,,,,,,,,,,
OG_17968,,Peve_00039333,Pocillopora_meandrina_HIv1___RNAseq.g18154.t1,peve_ptua,38.119,,,,,,,,,,,,,,,,,
OG_17969,,Peve_00039353,Pocillopora_meandrina_HIv1___RNAseq.g28588.t1,peve_ptua,42.141000000000005,,,,,,,,,,,,,,,,,
OG_17970,,Peve_00039369,Pocillopora_meandrina_HIv1___RNAseq.g13667.t1,peve_ptua,51.2,,,,,,,,,,,,,,,,,
OG_17971,,Peve_00039374,Pocillopora_meandrina_HIv1___RNAseq.g23326.t2,peve_ptua,66.159,,,,,,,,,,,,,,,,,
OG_17972,,Peve_00039449,Pocillopora_meandrina_HIv1___RNAseq.g30193.t1,peve_ptua,67.61,,,,,,,,,,,,,,,,,
OG_17973,,Peve_00039455,Pocillopora_meandrina_HIv1___RNAseq.g17160.t1,peve_ptua,48.447,,,,,,,,,,,,,,,,,
OG_17974,,Peve_00039501,Pocillopora_meandrina_HIv1___TS.g28403.t1,peve_ptua,50.466,,,,,,,,,,,,,,,,,
OG_17975,,Peve_00039547,Pocillopora_meandrina_HIv1___RNAseq.g19757.t1,peve_ptua,61.5,,,,,,,,,,,,,,,,,
OG_17976,,Peve_00039559,Pocillopora_meandrina_HIv1___RNAseq.g22221.t1,peve_ptua,61.667,,,,,,,,,,,,,,,,,
OG_17977,,Peve_00039608,Pocillopora_meandrina_HIv1___TS.g7359.t1,peve_ptua,49.485,,,,,,,,,,,,,,,,,
OG_17978,,Peve_00039649,Pocillopora_meandrina_HIv1___RNAseq.g23099.t1,peve_ptua,46.6475,,,,,,,,,,,,,,,,,
OG_17979,,Peve_00039650,Pocillopora_meandrina_HIv1___RNAseq.g23098.t1,peve_ptua,36.1295,,,,,,,,,,,,,,,,,
OG_17980,,Peve_00039654,Pocillopora_meandrina_HIv1___RNAseq.g23088.t1,peve_ptua,70.721,,,,,,,,,,,,,,,,,
OG_17981,,Peve_00039656,Pocillopora_meandrina_HIv1___RNAseq.g6516.t1,peve_ptua,52.809,,,,,,,,,,,,,,,,,
OG_17982,,Peve_00039701,Pocillopora_meandrina_HIv1___RNAseq.g10753.t1,peve_ptua,41.667,,,,,,,,,,,,,,,,,
OG_17983,,Peve_00039702,Pocillopora_meandrina_HIv1___RNAseq.g23853.t1,peve_ptua,69.29,,,,,,,,,,,,,,,,,
OG_17984,,Peve_00039734,Pocillopora_meandrina_HIv1___RNAseq.g28917.t1,peve_ptua,70.602,,,,,,,,,,,,,,,,,
OG_17985,,Peve_00039735,Pocillopora_meandrina_HIv1___TS.g11103.t3,peve_ptua,80.165,,,,,,,,,,,,,,,,,
OG_17986,,Peve_00039742,Pocillopora_meandrina_HIv1___RNAseq.g20859.t1,peve_ptua,84.407,,,,,,,,,,,,,,,,,
OG_17987,,Peve_00039788,Pocillopora_meandrina_HIv1___RNAseq.g28346.t1,peve_ptua,35.7655,,,,,,,,,,,,,,,,,
OG_17988,,Peve_00039800,Pocillopora_meandrina_HIv1___RNAseq.g2388.t1,peve_ptua,49.937,,,,,,,,,,,,,,,,,
OG_17989,,Peve_00039802,Pocillopora_meandrina_HIv1___RNAseq.g2376.t1,peve_ptua,56.522,,,,,,,,,,,,,,,,,
OG_17990,,Peve_00039806,Pocillopora_meandrina_HIv1___RNAseq.g2379.t1,peve_ptua,53.599,,,,,,,,,,,,,,,,,
OG_17991,,Peve_00039807,Pocillopora_meandrina_HIv1___RNAseq.g2380.t1,peve_ptua,73.571,,,,,,,,,,,,,,,,,
OG_17992,,Peve_00039810,Pocillopora_meandrina_HIv1___TS.g4718.t1,peve_ptua,52.17400000000001,,,,,,,,,,,,,,,,,
OG_17993,,Peve_00039818,Pocillopora_meandrina_HIv1___RNAseq.g2358.t1,peve_ptua,72.078,,,,,,,,,,,,,,,,,
OG_17994,,Peve_00039821,Pocillopora_meandrina_HIv1___RNAseq.g2360.t1,peve_ptua,44.275,,,,,,,,,,,,,,,,,
OG_17995,,Peve_00039822,Pocillopora_meandrina_HIv1___RNAseq.g2361.t1,peve_ptua,40.957,,,,,,,,,,,,,,,,,
OG_17996,,Peve_00039825,Pocillopora_meandrina_HIv1___RNAseq.g2364.t1,peve_ptua,60.909,,,,,,,,,,,,,,,,,
OG_17997,,Peve_00039834,Pocillopora_meandrina_HIv1___RNAseq.g27565.t1,peve_ptua,74.112,,,,,,,,,,,,,,,,,
OG_17998,,Peve_00039863,Pocillopora_meandrina_HIv1___TS.g530.t1,peve_ptua,64.159,,,,,,,,,,,,,,,,,
OG_17999,,Peve_00039865,Pocillopora_meandrina_HIv1___RNAseq.g6788.t1,peve_ptua,61.644,,,,,,,,,,,,,,,,,
OG_18000,,Peve_00039882,Pocillopora_meandrina_HIv1___RNAseq.g18443.t1,peve_ptua,44.0,,,,,,,,,,,,,,,,,
OG_18001,,Peve_00039911,Pocillopora_meandrina_HIv1___RNAseq.g29631.t2,peve_ptua,50.5195,,,,,,,,,,,,,,,,,
OG_18002,,Peve_00039930,Pocillopora_meandrina_HIv1___RNAseq.g12910.t1,peve_ptua,31.915,,,,,,,,,,,,,,,,,
OG_18003,,Peve_00039937,Pocillopora_meandrina_HIv1___RNAseq.g21147.t1,peve_ptua,62.585,,,,,,,,,,,,,,,,,
OG_18004,,Peve_00039967,Pocillopora_meandrina_HIv1___RNAseq.g30196.t1,peve_ptua,57.855,,,,,,,,,,,,,,,,,
OG_18005,,Peve_00039984,Pocillopora_meandrina_HIv1___TS.g12784.t1b,peve_ptua,64.114,,,,,,,,,,,,,,,,,
OG_18006,,Peve_00040012,Pocillopora_meandrina_HIv1___TS.g13355.t1,peve_ptua,77.234,,,,,,,,,,,,,,,,,
OG_18007,,Peve_00040042,Pocillopora_meandrina_HIv1___RNAseq.g10847.t1,peve_ptua,55.145,,,,,,,,,,,,,,,,,
OG_18008,,Peve_00040073,Pocillopora_meandrina_HIv1___RNAseq.g14657.t2,peve_ptua,46.341,,,,,,,,,,,,,,,,,
OG_18009,,Peve_00040080,Pocillopora_meandrina_HIv1___RNAseq.g19851.t1,peve_ptua,66.0365,,,,,,,,,,,,,,,,,
OG_18010,,Peve_00040087,Pocillopora_meandrina_HIv1___RNAseq.g6350.t1,peve_ptua,51.875,,,,,,,,,,,,,,,,,
OG_18011,,Peve_00040097,Pocillopora_meandrina_HIv1___RNAseq.g25704.t1,peve_ptua,55.172,,,,,,,,,,,,,,,,,
OG_18012,,Peve_00040142,Pocillopora_meandrina_HIv1___RNAseq.g515.t1,peve_ptua,51.25,,,,,,,,,,,,,,,,,
OG_18013,,Peve_00040143,Pocillopora_meandrina_HIv1___RNAseq.g27064.t1,peve_ptua,62.3815,,,,,,,,,,,,,,,,,
OG_18014,,Peve_00040145,Pocillopora_meandrina_HIv1___RNAseq.g28626.t1,peve_ptua,49.4045,,,,,,,,,,,,,,,,,
OG_18015,,Peve_00040172,Pocillopora_meandrina_HIv1___RNAseq.g14216.t1,peve_ptua,71.721,,,,,,,,,,,,,,,,,
OG_18016,,Peve_00040204,Pocillopora_meandrina_HIv1___RNAseq.g4229.t1,peve_ptua,46.154,,,,,,,,,,,,,,,,,
OG_18017,,Peve_00040216,Pocillopora_meandrina_HIv1___RNAseq.g16272.t1,peve_ptua,46.774,,,,,,,,,,,,,,,,,
OG_18018,,Peve_00040258,Pocillopora_meandrina_HIv1___RNAseq.g14534.t1,peve_ptua,57.91,,,,,,,,,,,,,,,,,
OG_18019,,Peve_00040291,Pocillopora_meandrina_HIv1___RNAseq.g14517.t1,peve_ptua,55.832,,,,,,,,,,,,,,,,,
OG_18020,,Peve_00040293,Pocillopora_meandrina_HIv1___RNAseq.g3379.t1,peve_ptua,41.692,,,,,,,,,,,,,,,,,
OG_18021,,Peve_00040294,Pocillopora_meandrina_HIv1___RNAseq.g14624.t1,peve_ptua,33.488,,,,,,,,,,,,,,,,,
OG_18022,,Peve_00040319,Pocillopora_meandrina_HIv1___RNAseq.g6267.t1,peve_ptua,51.643,,,,,,,,,,,,,,,,,
OG_18023,,Peve_00040355,Pocillopora_meandrina_HIv1___RNAseq.g14519.t1,peve_ptua,63.793,,,,,,,,,,,,,,,,,
OG_18024,,Peve_00040398,Pocillopora_meandrina_HIv1___RNAseq.g21804.t1,peve_ptua,63.018,,,,,,,,,,,,,,,,,
OG_18025,,Peve_00040404,Pocillopora_meandrina_HIv1___RNAseq.g19998.t1,peve_ptua,66.49199999999999,,,,,,,,,,,,,,,,,
OG_18026,,Peve_00040440,Pocillopora_meandrina_HIv1___RNAseq.g20591.t1,peve_ptua,45.2975,,,,,,,,,,,,,,,,,
OG_18027,,Peve_00040443,Pocillopora_meandrina_HIv1___RNAseq.g19288.t1,peve_ptua,70.652,,,,,,,,,,,,,,,,,
OG_18028,,Peve_00040444,Pocillopora_meandrina_HIv1___RNAseq.g18311.t1,peve_ptua,63.636,,,,,,,,,,,,,,,,,
OG_18029,,Peve_00040485,Pocillopora_meandrina_HIv1___RNAseq.g19003.t1,peve_ptua,88.542,,,,,,,,,,,,,,,,,
OG_18030,,Peve_00040531,Pocillopora_meandrina_HIv1___RNAseq.16160_t,peve_ptua,58.194,,,,,,,,,,,,,,,,,
OG_18031,,Peve_00040548,Pocillopora_meandrina_HIv1___RNAseq.g27208.t1,peve_ptua,72.391,,,,,,,,,,,,,,,,,
OG_18032,,Peve_00040551,Pocillopora_meandrina_HIv1___RNAseq.g10787.t1,peve_ptua,45.819,,,,,,,,,,,,,,,,,
OG_18033,,Peve_00040553,Pocillopora_meandrina_HIv1___RNAseq.g18906.t1,peve_ptua,54.701,,,,,,,,,,,,,,,,,
OG_18034,,Peve_00040554,Pocillopora_meandrina_HIv1___RNAseq.g18905.t1a,peve_ptua,41.7195,,,,,,,,,,,,,,,,,
OG_18035,,Peve_00040562,Pocillopora_meandrina_HIv1___RNAseq.g15110.t1,peve_ptua,71.178,,,,,,,,,,,,,,,,,
OG_18036,,Peve_00040567,Pocillopora_meandrina_HIv1___RNAseq.g15109.t1,peve_ptua,37.767,,,,,,,,,,,,,,,,,
OG_18037,,Peve_00040574,Pocillopora_meandrina_HIv1___RNAseq.g15108.t1,peve_ptua,68.807,,,,,,,,,,,,,,,,,
OG_18038,,Peve_00040579,Pocillopora_meandrina_HIv1___RNAseq.g3499.t1,peve_ptua,67.713,,,,,,,,,,,,,,,,,
OG_18039,,Peve_00040596,Pocillopora_meandrina_HIv1___TS.g933.t1,peve_ptua,62.214,,,,,,,,,,,,,,,,,
OG_18040,,Peve_00040605,Pocillopora_meandrina_HIv1___TS.g11599.t1,peve_ptua,50.6695,,,,,,,,,,,,,,,,,
OG_18041,,Peve_00040639,Pocillopora_meandrina_HIv1___RNAseq.g9950.t1,peve_ptua,59.105,,,,,,,,,,,,,,,,,
OG_18042,,Peve_00040688,Pocillopora_meandrina_HIv1___RNAseq.g18107.t1,peve_ptua,72.0215,,,,,,,,,,,,,,,,,
OG_18043,,Peve_00040699,Pocillopora_meandrina_HIv1___TS.g21110.t1,peve_ptua,70.4165,,,,,,,,,,,,,,,,,
OG_18044,,Peve_00040708,Pocillopora_meandrina_HIv1___RNAseq.g10608.t1,peve_ptua,72.545,,,,,,,,,,,,,,,,,
OG_18045,,Peve_00040712,Pocillopora_meandrina_HIv1___TS.g24077.t1,peve_ptua,43.968,,,,,,,,,,,,,,,,,
OG_18046,,Peve_00040725,Pocillopora_meandrina_HIv1___RNAseq.g5377.t1,peve_ptua,70.833,,,,,,,,,,,,,,,,,
OG_18047,,Peve_00040727,Pocillopora_meandrina_HIv1___RNAseq.g5379.t1,peve_ptua,56.8,,,,,,,,,,,,,,,,,
OG_18048,,Peve_00040739,Pocillopora_meandrina_HIv1___RNAseq.g26519.t1,peve_ptua,95.135,,,,,,,,,,,,,,,,,
OG_18049,,Peve_00040787,Pocillopora_meandrina_HIv1___RNAseq.g23441.t1,peve_ptua,37.339,,,,,,,,,,,,,,,,,
OG_18050,,Peve_00040800,Pocillopora_meandrina_HIv1___RNAseq.g12592.t1,peve_ptua,59.649,,,,,,,,,,,,,,,,,
OG_18051,,Peve_00040813,Pocillopora_meandrina_HIv1___TS.g2690.t1,peve_ptua,89.047,,,,,,,,,,,,,,,,,
OG_18052,,Peve_00040825,Pocillopora_meandrina_HIv1___RNAseq.g22606.t1,peve_ptua,60.164,,,,,,,,,,,,,,,,,
OG_18053,,Peve_00040834,Pocillopora_meandrina_HIv1___RNAseq.g22605.t1,peve_ptua,68.01849999999999,,,,,,,,,,,,,,,,,
OG_18054,,Peve_00040840,Pocillopora_meandrina_HIv1___RNAseq.g19359.t1,peve_ptua,30.695,,,,,,,,,,,,,,,,,
OG_18055,,Peve_00040862,Pocillopora_meandrina_HIv1___RNAseq.g20505.t1,peve_ptua,61.194,,,,,,,,,,,,,,,,,
OG_18056,,Peve_00040866,Pocillopora_meandrina_HIv1___RNAseq.g19360.t1,peve_ptua,30.547,,,,,,,,,,,,,,,,,
OG_18057,,Peve_00040879,Pocillopora_meandrina_HIv1___TS.g396.t1,peve_ptua,65.6165,,,,,,,,,,,,,,,,,
OG_18058,,Peve_00040882,Pocillopora_meandrina_HIv1___TS.g11409.t1,peve_ptua,43.4495,,,,,,,,,,,,,,,,,
OG_18059,,Peve_00040924,Pocillopora_meandrina_HIv1___RNAseq.g13215.t1,peve_ptua,55.591,,,,,,,,,,,,,,,,,
OG_18060,,Peve_00040927,Pocillopora_meandrina_HIv1___RNAseq.g13228.t1,peve_ptua,49.398,,,,,,,,,,,,,,,,,
OG_18061,,Peve_00040941,Pocillopora_meandrina_HIv1___RNAseq.g2837.t1,peve_ptua,36.879,,,,,,,,,,,,,,,,,
OG_18062,,Peve_00040957,Pocillopora_meandrina_HIv1___RNAseq.g13470.t1,peve_ptua,35.754,,,,,,,,,,,,,,,,,
OG_18063,,Peve_00040958,Pocillopora_meandrina_HIv1___RNAseq.g13471.t1,peve_ptua,44.311,,,,,,,,,,,,,,,,,
OG_18064,,Peve_00040959,Pocillopora_meandrina_HIv1___RNAseq.g17140.t1,peve_ptua,52.817,,,,,,,,,,,,,,,,,
OG_18065,,Peve_00040963,Pocillopora_meandrina_HIv1___RNAseq.g13618.t1,peve_ptua,36.25,,,,,,,,,,,,,,,,,
OG_18066,,Peve_00041008,Pocillopora_meandrina_HIv1___TS.g7612.t1a,peve_ptua,35.959,,,,,,,,,,,,,,,,,
OG_18067,,Peve_00041035,Pocillopora_meandrina_HIv1___TS.g6808.t1,peve_ptua,50.0,,,,,,,,,,,,,,,,,
OG_18068,,Peve_00041037,Pocillopora_meandrina_HIv1___RNAseq.g29634.t1,peve_ptua,74.272,,,,,,,,,,,,,,,,,
OG_18069,,Peve_00041045,Pocillopora_meandrina_HIv1___TS.g6381.t1,peve_ptua,81.593,,,,,,,,,,,,,,,,,
OG_18070,,Peve_00041054,Pocillopora_meandrina_HIv1___RNAseq.g29608.t1,peve_ptua,34.2945,,,,,,,,,,,,,,,,,
OG_18071,,Peve_00041092,Pocillopora_meandrina_HIv1___RNAseq.g23144.t1,peve_ptua,73.237,,,,,,,,,,,,,,,,,
OG_18072,,Peve_00041094,Pocillopora_meandrina_HIv1___TS.g16035.t1,peve_ptua,35.052,,,,,,,,,,,,,,,,,
OG_18073,,Peve_00041104,Pocillopora_meandrina_HIv1___RNAseq.g13145.t1,peve_ptua,97.205,,,,,,,,,,,,,,,,,
OG_18074,,Peve_00041140,Pocillopora_meandrina_HIv1___RNAseq.g19151.t1,peve_ptua,60.6325,,,,,,,,,,,,,,,,,
OG_18075,,Peve_00041142,Pocillopora_meandrina_HIv1___RNAseq.g18829.t1,peve_ptua,57.962,,,,,,,,,,,,,,,,,
OG_18076,,Peve_00041147,Pocillopora_meandrina_HIv1___RNAseq.g18849.t1,peve_ptua,87.5,,,,,,,,,,,,,,,,,
OG_18077,,Peve_00041153,Pocillopora_meandrina_HIv1___TS.g1443.t1,peve_ptua,34.307,,,,,,,,,,,,,,,,,
OG_18078,,Peve_00041156,Pocillopora_meandrina_HIv1___RNAseq.g7624.t1,peve_ptua,65.182,,,,,,,,,,,,,,,,,
OG_18079,,Peve_00041162,Pocillopora_meandrina_HIv1___RNAseq.g7625.t1,peve_ptua,46.154,,,,,,,,,,,,,,,,,
OG_18080,,Peve_00041222,Pocillopora_meandrina_HIv1___RNAseq.g30079.t1,peve_ptua,88.618,,,,,,,,,,,,,,,,,
OG_18081,,Peve_00041224,Pocillopora_meandrina_HIv1___RNAseq.g18087.t1,peve_ptua,61.768,,,,,,,,,,,,,,,,,
OG_18082,,Peve_00041263,Pocillopora_meandrina_HIv1___RNAseq.g29283.t1,peve_ptua,72.575,,,,,,,,,,,,,,,,,
OG_18083,,Peve_00041308,Pocillopora_meandrina_HIv1___RNAseq.g17802.t1,peve_ptua,52.201,,,,,,,,,,,,,,,,,
OG_18084,,Peve_00041357,Pocillopora_meandrina_HIv1___RNAseq.g27418.t1,peve_ptua,65.986,,,,,,,,,,,,,,,,,
OG_18085,,Peve_00041380,Pocillopora_meandrina_HIv1___RNAseq.g11753.t1,peve_ptua,66.49600000000001,,,,,,,,,,,,,,,,,
OG_18086,,Peve_00041392,Pocillopora_meandrina_HIv1___RNAseq.g29212.t1,peve_ptua,49.49,,,,,,,,,,,,,,,,,
OG_18087,,Peve_00041406,Pocillopora_meandrina_HIv1___TS.g9097.t1,peve_ptua,78.417,,,,,,,,,,,,,,,,,
OG_18088,,Peve_00041431,Pocillopora_meandrina_HIv1___RNAseq.g20752.t1,peve_ptua,76.667,,,,,,,,,,,,,,,,,
OG_18089,,Peve_00041435,Pocillopora_meandrina_HIv1___RNAseq.g14976.t1,peve_ptua,45.611,,,,,,,,,,,,,,,,,
OG_18090,,Peve_00041451,Pocillopora_meandrina_HIv1___RNAseq.g21690.t1,peve_ptua,62.9075,,,,,,,,,,,,,,,,,
OG_18091,,Peve_00041455,Pocillopora_meandrina_HIv1___RNAseq.g10424.t1,peve_ptua,75.063,,,,,,,,,,,,,,,,,
OG_18092,,Peve_00041471,Pocillopora_meandrina_HIv1___RNAseq.g4972.t1,peve_ptua,86.207,,,,,,,,,,,,,,,,,
OG_18093,,Peve_00041507,Pocillopora_meandrina_HIv1___RNAseq.g27222.t1,peve_ptua,69.444,,,,,,,,,,,,,,,,,
OG_18094,,Peve_00041508,Pocillopora_meandrina_HIv1___RNAseq.g10609.t1,peve_ptua,58.801,,,,,,,,,,,,,,,,,
OG_18095,,Peve_00041519,Pocillopora_meandrina_HIv1___RNAseq.g26831.t1,peve_ptua,95.714,,,,,,,,,,,,,,,,,
OG_18096,,Peve_00041520,Pocillopora_meandrina_HIv1___TS.g18028.t1,peve_ptua,77.39,,,,,,,,,,,,,,,,,
OG_18097,,Peve_00041521,Pocillopora_meandrina_HIv1___RNAseq.g2965.t1,peve_ptua,63.158,,,,,,,,,,,,,,,,,
OG_18098,,Peve_00041562,Pocillopora_meandrina_HIv1___TS.g15783.t1,peve_ptua,59.113,,,,,,,,,,,,,,,,,
OG_18099,,Peve_00041564,Pocillopora_meandrina_HIv1___RNAseq.g16615.t1,peve_ptua,52.365,,,,,,,,,,,,,,,,,
OG_18100,,Peve_00041580,Pocillopora_meandrina_HIv1___RNAseq.g8691.t1,peve_ptua,35.569,,,,,,,,,,,,,,,,,
OG_18101,,Peve_00041657,Pocillopora_meandrina_HIv1___RNAseq.g19700.t1,peve_ptua,42.522000000000006,,,,,,,,,,,,,,,,,
OG_18102,,Peve_00041672,Pocillopora_meandrina_HIv1___RNAseq.g26683.t1,peve_ptua,54.426,,,,,,,,,,,,,,,,,
OG_18103,,Peve_00041695,Pocillopora_meandrina_HIv1___RNAseq.g28158.t1,peve_ptua,74.7015,,,,,,,,,,,,,,,,,
OG_18104,,Peve_00041703,Pocillopora_meandrina_HIv1___RNAseq.g20901.t1,peve_ptua,47.9615,,,,,,,,,,,,,,,,,
OG_18105,,Peve_00041719,Pocillopora_meandrina_HIv1___RNAseq.g28426.t1,peve_ptua,50.0,,,,,,,,,,,,,,,,,
OG_18106,,Peve_00041730,Pocillopora_meandrina_HIv1___RNAseq.g29932.t1,peve_ptua,46.867,,,,,,,,,,,,,,,,,
OG_18107,,Peve_00041742,Pocillopora_meandrina_HIv1___RNAseq.g3438.t1a,peve_ptua,85.135,,,,,,,,,,,,,,,,,
OG_18108,,Peve_00041756,Pocillopora_meandrina_HIv1___RNAseq.g29852.t1b,peve_ptua,59.072,,,,,,,,,,,,,,,,,
OG_18109,,Peve_00041791,Pocillopora_meandrina_HIv1___RNAseq.g24377.t1,peve_ptua,70.229,,,,,,,,,,,,,,,,,
OG_18110,,Peve_00041792,Pocillopora_meandrina_HIv1___RNAseq.g24378.t1,peve_ptua,73.9255,,,,,,,,,,,,,,,,,
OG_18111,,Peve_00041811,Pocillopora_meandrina_HIv1___TS.g8398.t1,peve_ptua,88.5,,,,,,,,,,,,,,,,,
OG_18112,,Peve_00041834,Pocillopora_meandrina_HIv1___RNAseq.g7278.t1,peve_ptua,61.0185,,,,,,,,,,,,,,,,,
OG_18113,,Peve_00041868,Pocillopora_meandrina_HIv1___RNAseq.g5208.t1,peve_ptua,44.851,,,,,,,,,,,,,,,,,
OG_18114,,Peve_00041869,Pocillopora_meandrina_HIv1___RNAseq.g2776.t1a,peve_ptua,47.273,,,,,,,,,,,,,,,,,
OG_18115,,Peve_00041874,Pocillopora_meandrina_HIv1___RNAseq.g27623.t1,peve_ptua,62.08,,,,,,,,,,,,,,,,,
OG_18116,,Peve_00041889,Pocillopora_meandrina_HIv1___RNAseq.g2458.t1,peve_ptua,59.394,,,,,,,,,,,,,,,,,
OG_18117,,Peve_00041898,Pocillopora_meandrina_HIv1___RNAseq.g23110.t1,peve_ptua,76.364,,,,,,,,,,,,,,,,,
OG_18118,,Peve_00041906,Pocillopora_meandrina_HIv1___TS.g28432.t1,peve_ptua,53.44,,,,,,,,,,,,,,,,,
OG_18119,,Peve_00041930,Pocillopora_meandrina_HIv1___RNAseq.g13124.t1,peve_ptua,69.231,,,,,,,,,,,,,,,,,
OG_18120,,Peve_00041935,Pocillopora_meandrina_HIv1___RNAseq.g17010.t1,peve_ptua,43.411,,,,,,,,,,,,,,,,,
OG_18121,,Peve_00041946,Pocillopora_meandrina_HIv1___TS.g11194.t1,peve_ptua,64.467,,,,,,,,,,,,,,,,,
OG_18122,,Peve_00041992,Pocillopora_meandrina_HIv1___TS.g2169.t1,peve_ptua,66.463,,,,,,,,,,,,,,,,,
OG_18123,,Peve_00042008,Pocillopora_meandrina_HIv1___RNAseq.g25860.t1,peve_ptua,86.567,,,,,,,,,,,,,,,,,
OG_18124,,Peve_00042015,Pocillopora_meandrina_HIv1___RNAseq.g20149.t1,peve_ptua,78.246,,,,,,,,,,,,,,,,,
OG_18125,,Peve_00042044,Pocillopora_meandrina_HIv1___TS.g5694.t1,peve_ptua,47.682,,,,,,,,,,,,,,,,,
OG_18126,,Peve_00042052,Pocillopora_meandrina_HIv1___RNAseq.g1169.t1,peve_ptua,35.8975,,,,,,,,,,,,,,,,,
OG_18127,,Peve_00042073,Pocillopora_meandrina_HIv1___RNAseq.g17966.t1,peve_ptua,62.538,,,,,,,,,,,,,,,,,
OG_18128,,Peve_00042081,Pocillopora_meandrina_HIv1___RNAseq.g17967.t1,peve_ptua,45.213,,,,,,,,,,,,,,,,,
OG_18129,,Peve_00042103,Pocillopora_meandrina_HIv1___RNAseq.g9655.t1,peve_ptua,58.073,,,,,,,,,,,,,,,,,
OG_18130,,Peve_00042153,Pocillopora_meandrina_HIv1___RNAseq.g11965.t1,peve_ptua,61.404,,,,,,,,,,,,,,,,,
OG_18131,,Peve_00042188,Pocillopora_meandrina_HIv1___RNAseq.g13265.t1,peve_ptua,56.701,,,,,,,,,,,,,,,,,
OG_18132,,Peve_00042201,Pocillopora_meandrina_HIv1___RNAseq.g5478.t1,peve_ptua,36.7755,,,,,,,,,,,,,,,,,
OG_18133,,Peve_00042229,Pocillopora_meandrina_HIv1___RNAseq.g27895.t1,peve_ptua,72.222,,,,,,,,,,,,,,,,,
OG_18134,,Peve_00042238,Pocillopora_meandrina_HIv1___RNAseq.g27897.t1,peve_ptua,83.846,,,,,,,,,,,,,,,,,
OG_18135,,Peve_00042296,Pocillopora_meandrina_HIv1___RNAseq.g17714.t1,peve_ptua,33.716,,,,,,,,,,,,,,,,,
OG_18136,,Peve_00042309,Pocillopora_meandrina_HIv1___RNAseq.g22875.t1,peve_ptua,72.78550000000001,,,,,,,,,,,,,,,,,
OG_18137,,Peve_00042310,Pocillopora_meandrina_HIv1___RNAseq.g27549.t1,peve_ptua,74.846,,,,,,,,,,,,,,,,,
OG_18138,,Peve_00042311,Pocillopora_meandrina_HIv1___RNAseq.g7181.t1,peve_ptua,69.12,,,,,,,,,,,,,,,,,
OG_18139,,Peve_00042351,Pocillopora_meandrina_HIv1___RNAseq.g11330.t1a,peve_ptua,46.531,,,,,,,,,,,,,,,,,
OG_18140,,Peve_00042356,Pocillopora_meandrina_HIv1___RNAseq.g11239.t1,peve_ptua,88.312,,,,,,,,,,,,,,,,,
OG_18141,,Peve_00042416,Pocillopora_meandrina_HIv1___RNAseq.g19591.t1,peve_ptua,52.448,,,,,,,,,,,,,,,,,
OG_18142,,Peve_00042431,Pocillopora_meandrina_HIv1___RNAseq.g6319.t2,peve_ptua,37.755,,,,,,,,,,,,,,,,,
OG_18143,,Peve_00042437,Pocillopora_meandrina_HIv1___RNAseq.g24153.t1,peve_ptua,48.858,,,,,,,,,,,,,,,,,
OG_18144,,Peve_00042475,Pocillopora_meandrina_HIv1___RNAseq.g545.t1,peve_ptua,55.263,,,,,,,,,,,,,,,,,
OG_18145,,Peve_00042485,Pocillopora_meandrina_HIv1___RNAseq.g19744.t1,peve_ptua,60.0,,,,,,,,,,,,,,,,,
OG_18146,,Peve_00042486,Pocillopora_meandrina_HIv1___RNAseq.g19743.t1b,peve_ptua,46.667,,,,,,,,,,,,,,,,,
OG_18147,,Peve_00042487,Pocillopora_meandrina_HIv1___RNAseq.g19741.t1,peve_ptua,60.884,,,,,,,,,,,,,,,,,
OG_18148,,Peve_00042492,Pocillopora_meandrina_HIv1___RNAseq.g19747.t1,peve_ptua,40.485,,,,,,,,,,,,,,,,,
OG_18149,,Peve_00042493,Pocillopora_meandrina_HIv1___RNAseq.g19746.t1,peve_ptua,83.369,,,,,,,,,,,,,,,,,
OG_18150,,Peve_00042513,Pocillopora_meandrina_HIv1___TS.g25924.t1,peve_ptua,39.886,,,,,,,,,,,,,,,,,
OG_18151,,Peve_00042528,Pocillopora_meandrina_HIv1___RNAseq.g23355.t1,peve_ptua,40.2755,,,,,,,,,,,,,,,,,
OG_18152,,Peve_00042532,Pocillopora_meandrina_HIv1___RNAseq.g23927.t1,peve_ptua,57.188,,,,,,,,,,,,,,,,,
OG_18153,,Peve_00042536,Pocillopora_meandrina_HIv1___RNAseq.g5121.t1,peve_ptua,65.254,,,,,,,,,,,,,,,,,
OG_18154,,Peve_00042537,Pocillopora_meandrina_HIv1___RNAseq.g5123.t1,peve_ptua,67.01,,,,,,,,,,,,,,,,,
OG_18155,,Peve_00042550,Pocillopora_meandrina_HIv1___RNAseq.g23358.t1b,peve_ptua,56.028,,,,,,,,,,,,,,,,,
OG_18156,,Peve_00042594,Pocillopora_meandrina_HIv1___TS.g25476.t1,peve_ptua,66.327,,,,,,,,,,,,,,,,,
OG_18157,,Peve_00042597,Pocillopora_meandrina_HIv1___RNAseq.g12684.t1,peve_ptua,43.852,,,,,,,,,,,,,,,,,
OG_18158,,Peve_00042608,Pocillopora_meandrina_HIv1___RNAseq.g1327.t1,peve_ptua,37.273,,,,,,,,,,,,,,,,,
OG_18159,,Peve_00042634,Pocillopora_meandrina_HIv1___RNAseq.g17646.t1,peve_ptua,61.728,,,,,,,,,,,,,,,,,
OG_18160,,Peve_00042660,Pocillopora_meandrina_HIv1___RNAseq.g16281.t1,peve_ptua,36.398,,,,,,,,,,,,,,,,,
OG_18161,,Peve_00042700,Pocillopora_meandrina_HIv1___RNAseq.g30168.t1,peve_ptua,43.859,,,,,,,,,,,,,,,,,
OG_18162,,Peve_00042723,Pocillopora_meandrina_HIv1___RNAseq.g15092.t1,peve_ptua,73.233,,,,,,,,,,,,,,,,,
OG_18163,,Peve_00042727,Pocillopora_meandrina_HIv1___RNAseq.g19765.t1a,peve_ptua,73.708,,,,,,,,,,,,,,,,,
OG_18164,,Peve_00042761,Pocillopora_meandrina_HIv1___RNAseq.g9714.t1,peve_ptua,68.248,,,,,,,,,,,,,,,,,
OG_18165,,Peve_00042764,Pocillopora_meandrina_HIv1___RNAseq.16352_t,peve_ptua,88.701,,,,,,,,,,,,,,,,,
OG_18166,,Peve_00042791,Pocillopora_meandrina_HIv1___RNAseq.g13628.t1,peve_ptua,91.353,,,,,,,,,,,,,,,,,
OG_18167,,Peve_00042796,Pocillopora_meandrina_HIv1___RNAseq.g13689.t1,peve_ptua,54.661,,,,,,,,,,,,,,,,,
OG_18168,,Peve_00042854,Pocillopora_meandrina_HIv1___RNAseq.g25881.t1,peve_ptua,40.773,,,,,,,,,,,,,,,,,
OG_18169,,Peve_00042872,Pocillopora_meandrina_HIv1___TS.g595.t1,peve_ptua,65.948,,,,,,,,,,,,,,,,,
OG_18170,,Peve_00042912,Pocillopora_meandrina_HIv1___RNAseq.g24517.t1,peve_ptua,61.983,,,,,,,,,,,,,,,,,
OG_18171,,Peve_00042926,Pocillopora_meandrina_HIv1___TS.g8889.t1,peve_ptua,33.248,,,,,,,,,,,,,,,,,
OG_18172,,Peve_00042933,Pocillopora_meandrina_HIv1___RNAseq.g7682.t1,peve_ptua,51.502,,,,,,,,,,,,,,,,,
OG_18173,,Peve_00042937,Pocillopora_meandrina_HIv1___RNAseq.g7645.t1b,peve_ptua,54.3355,,,,,,,,,,,,,,,,,
OG_18174,,Peve_00042962,Pocillopora_meandrina_HIv1___RNAseq.g8079.t1,peve_ptua,70.0,,,,,,,,,,,,,,,,,
OG_18175,,Peve_00042964,Pocillopora_meandrina_HIv1___RNAseq.g8080.t1,peve_ptua,72.507,,,,,,,,,,,,,,,,,
OG_18176,,Peve_00042969,Pocillopora_meandrina_HIv1___TS.g14257.t1,peve_ptua,37.654,,,,,,,,,,,,,,,,,
OG_18177,,Peve_00042975,Pocillopora_meandrina_HIv1___RNAseq.g3655.t1,peve_ptua,87.728,,,,,,,,,,,,,,,,,
OG_18178,,Peve_00043025,Pocillopora_meandrina_HIv1___RNAseq.g3412.t1,peve_ptua,53.509,,,,,,,,,,,,,,,,,
OG_18179,,Peve_00043034,Pocillopora_meandrina_HIv1___TS.g21686.t1,peve_ptua,66.61,,,,,,,,,,,,,,,,,
OG_18180,,Peve_00043042,Pocillopora_meandrina_HIv1___RNAseq.g8954.t1,peve_ptua,86.853,,,,,,,,,,,,,,,,,
OG_18181,,Peve_00043075,Pocillopora_meandrina_HIv1___RNAseq.g4520.t1,peve_ptua,40.278,,,,,,,,,,,,,,,,,
OG_18182,,Peve_00043077,Pocillopora_meandrina_HIv1___RNAseq.g4475.t1,peve_ptua,57.246,,,,,,,,,,,,,,,,,
OG_18183,,Peve_00043114,Pocillopora_meandrina_HIv1___RNAseq.g17528.t1,peve_ptua,38.494,,,,,,,,,,,,,,,,,
OG_18184,,Peve_00043120,Pocillopora_meandrina_HIv1___RNAseq.g5734.t1,peve_ptua,97.881,,,,,,,,,,,,,,,,,
OG_18185,,Peve_00043144,Pocillopora_meandrina_HIv1___RNAseq.g28134.t1,peve_ptua,73.418,,,,,,,,,,,,,,,,,
OG_18186,,Peve_00043148,Pocillopora_meandrina_HIv1___TS.g1665.t1,peve_ptua,41.353,,,,,,,,,,,,,,,,,
OG_18187,,Peve_00043152,Pocillopora_meandrina_HIv1___RNAseq.g7790.t1,peve_ptua,37.963,,,,,,,,,,,,,,,,,
OG_18188,,Peve_00043162,Pocillopora_meandrina_HIv1___RNAseq.g500.t1,peve_ptua,73.276,,,,,,,,,,,,,,,,,
OG_18189,,Peve_00043207,Pocillopora_meandrina_HIv1___RNAseq.g4162.t1a,peve_ptua,51.744,,,,,,,,,,,,,,,,,
OG_18190,,Peve_00043233,Pocillopora_meandrina_HIv1___RNAseq.4915_t,peve_ptua,43.9915,,,,,,,,,,,,,,,,,
OG_18191,,Peve_00043234,Pocillopora_meandrina_HIv1___RNAseq.g28574.t1,peve_ptua,63.761,,,,,,,,,,,,,,,,,
OG_18192,,Peve_00043235,Pocillopora_meandrina_HIv1___RNAseq.g28570.t1,peve_ptua,64.47,,,,,,,,,,,,,,,,,
OG_18193,,Peve_00043239,Pocillopora_meandrina_HIv1___RNAseq.g28573.t1,peve_ptua,50.413,,,,,,,,,,,,,,,,,
OG_18194,,Peve_00043250,Pocillopora_meandrina_HIv1___TS.g19721.t1,peve_ptua,39.785,,,,,,,,,,,,,,,,,
OG_18195,,Peve_00043251,Pocillopora_meandrina_HIv1___TS.27124_t,peve_ptua,64.214,,,,,,,,,,,,,,,,,
OG_18196,,Peve_00043253,Pocillopora_meandrina_HIv1___RNAseq.g25802.t1a,peve_ptua,70.306,,,,,,,,,,,,,,,,,
OG_18197,,Peve_00043282,Pocillopora_meandrina_HIv1___RNAseq.g16716.t1,peve_ptua,95.954,,,,,,,,,,,,,,,,,
OG_18198,,Peve_00043294,Pocillopora_meandrina_HIv1___RNAseq.g28387.t1,peve_ptua,64.359,,,,,,,,,,,,,,,,,
OG_18199,,Peve_00043317,Pocillopora_meandrina_HIv1___RNAseq.g28407.t2,peve_ptua,56.204,,,,,,,,,,,,,,,,,
OG_18200,,Peve_00043345,Pocillopora_meandrina_HIv1___RNAseq.g27298.t1,peve_ptua,30.12,,,,,,,,,,,,,,,,,
OG_18201,,Peve_00043384,Pocillopora_meandrina_HIv1___RNAseq.g4728.t1,peve_ptua,43.236,,,,,,,,,,,,,,,,,
OG_18202,,Peve_00043387,Pocillopora_meandrina_HIv1___RNAseq.g4722.t1,peve_ptua,75.40950000000001,,,,,,,,,,,,,,,,,
OG_18203,,Peve_00043393,Pocillopora_meandrina_HIv1___RNAseq.g4770.t1,peve_ptua,94.286,,,,,,,,,,,,,,,,,
OG_18204,,Peve_00043407,Pocillopora_meandrina_HIv1___RNAseq.g5370.t1,peve_ptua,72.183,,,,,,,,,,,,,,,,,
OG_18205,,Peve_00043425,Pocillopora_meandrina_HIv1___RNAseq.g24829.t1,peve_ptua,69.444,,,,,,,,,,,,,,,,,
OG_18206,,Peve_00043439,Pocillopora_meandrina_HIv1___TS.g12770.t1,peve_ptua,68.029,,,,,,,,,,,,,,,,,
OG_18207,,Peve_00043444,Pocillopora_meandrina_HIv1___TS.g21812.t1,peve_ptua,36.522,,,,,,,,,,,,,,,,,
OG_18208,,Peve_00043499,Pocillopora_meandrina_HIv1___RNAseq.g15156.t1,peve_ptua,83.9675,,,,,,,,,,,,,,,,,
OG_18209,,Peve_00043518,Pocillopora_meandrina_HIv1___RNAseq.g5457.t1,peve_ptua,59.966,,,,,,,,,,,,,,,,,
OG_18210,,Peve_00043520,Pocillopora_meandrina_HIv1___TS.g3112.t1,peve_ptua,59.551,,,,,,,,,,,,,,,,,
OG_18211,,Peve_00043530,Pocillopora_meandrina_HIv1___RNAseq.g6436.t1,peve_ptua,30.899,,,,,,,,,,,,,,,,,
OG_18212,,Peve_00043579,Pocillopora_meandrina_HIv1___RNAseq.g5678.t1,peve_ptua,85.616,,,,,,,,,,,,,,,,,
OG_18213,,Peve_00043583,Pocillopora_meandrina_HIv1___TS.g24404.t1,peve_ptua,49.638000000000005,,,,,,,,,,,,,,,,,
OG_18214,,Peve_00043584,Pocillopora_meandrina_HIv1___RNAseq.g15460.t1,peve_ptua,35.876,,,,,,,,,,,,,,,,,
OG_18215,,Peve_00043598,Pocillopora_meandrina_HIv1___RNAseq.g15436.t1,peve_ptua,37.695,,,,,,,,,,,,,,,,,
OG_18216,,Peve_00043602,Pocillopora_meandrina_HIv1___RNAseq.g25657.t1,peve_ptua,35.383,,,,,,,,,,,,,,,,,
OG_18217,,Peve_00043623,Pocillopora_meandrina_HIv1___RNAseq.g30290.t1,peve_ptua,66.235,,,,,,,,,,,,,,,,,
OG_18218,,Peve_00043629,Pocillopora_meandrina_HIv1___RNAseq.g12925.t1,peve_ptua,46.429,,,,,,,,,,,,,,,,,
OG_18219,,Peve_00043645,Pocillopora_meandrina_HIv1___RNAseq.g7053.t1,peve_ptua,69.231,,,,,,,,,,,,,,,,,
OG_18220,,Peve_00043650,Pocillopora_meandrina_HIv1___RNAseq.g21904.t1,peve_ptua,60.993,,,,,,,,,,,,,,,,,
OG_18221,,Peve_00043672,Pocillopora_meandrina_HIv1___TS.g20897.t1,peve_ptua,48.406,,,,,,,,,,,,,,,,,
OG_18222,,Peve_00043682,Pocillopora_meandrina_HIv1___RNAseq.g6187.t2,peve_ptua,42.21,,,,,,,,,,,,,,,,,
OG_18223,,Peve_00043691,Pocillopora_meandrina_HIv1___RNAseq.g5674.t1c,peve_ptua,75.427,,,,,,,,,,,,,,,,,
OG_18224,,Peve_00043693,Pocillopora_meandrina_HIv1___RNAseq.g18312.t1,peve_ptua,59.346,,,,,,,,,,,,,,,,,
OG_18225,,Peve_00043698,Pocillopora_meandrina_HIv1___TS.g24903.t1,peve_ptua,63.455,,,,,,,,,,,,,,,,,
OG_18226,,Peve_00043705,Pocillopora_meandrina_HIv1___TS.g16529.t1,peve_ptua,32.453,,,,,,,,,,,,,,,,,
OG_18227,,Peve_00043708,Pocillopora_meandrina_HIv1___RNAseq.g8632.t1,peve_ptua,72.0,,,,,,,,,,,,,,,,,
OG_18228,,Peve_00043711,Pocillopora_meandrina_HIv1___RNAseq.g8630.t1,peve_ptua,43.59,,,,,,,,,,,,,,,,,
OG_18229,,Peve_00043713,Pocillopora_meandrina_HIv1___RNAseq.g8627.t1,peve_ptua,65.929,,,,,,,,,,,,,,,,,
OG_18230,,Peve_00043732,Pocillopora_meandrina_HIv1___RNAseq.g8654.t1,peve_ptua,68.293,,,,,,,,,,,,,,,,,
OG_18231,,Peve_00043737,Pocillopora_meandrina_HIv1___RNAseq.g8645.t1,peve_ptua,63.223,,,,,,,,,,,,,,,,,
OG_18232,,Peve_00043761,Pocillopora_meandrina_HIv1___RNAseq.g14483.t1,peve_ptua,93.301,,,,,,,,,,,,,,,,,
OG_18233,,Peve_00043793,Pocillopora_meandrina_HIv1___TS.g4024.t1,peve_ptua,55.952,,,,,,,,,,,,,,,,,
OG_18234,,Peve_00043800,Pocillopora_meandrina_HIv1___RNAseq.g19013.t1,peve_ptua,49.339,,,,,,,,,,,,,,,,,
OG_18235,,Peve_00043810,Pocillopora_meandrina_HIv1___RNAseq.g19014.t1,peve_ptua,56.7525,,,,,,,,,,,,,,,,,
OG_18236,,Peve_00043847,Pocillopora_meandrina_HIv1___RNAseq.g24824.t1,peve_ptua,68.041,,,,,,,,,,,,,,,,,
OG_18237,,Peve_00043862,Pocillopora_meandrina_HIv1___RNAseq.g1924.t1,peve_ptua,69.507,,,,,,,,,,,,,,,,,
OG_18238,,Peve_00043909,Pocillopora_meandrina_HIv1___RNAseq.g4490.t1,peve_ptua,33.992,,,,,,,,,,,,,,,,,
OG_18239,,Peve_00043959,Pocillopora_meandrina_HIv1___RNAseq.g1046.t1b,peve_ptua,65.04599999999999,,,,,,,,,,,,,,,,,
OG_18240,,Peve_00043967,Pocillopora_meandrina_HIv1___RNAseq.g1040.t1,peve_ptua,65.306,,,,,,,,,,,,,,,,,
OG_18241,,Peve_00043973,Pocillopora_meandrina_HIv1___RNAseq.g1053.t1,peve_ptua,58.025,,,,,,,,,,,,,,,,,
OG_18242,,Peve_00043979,Pocillopora_meandrina_HIv1___TS.g27978.t1,peve_ptua,56.36,,,,,,,,,,,,,,,,,
OG_18243,,Peve_00043984,Pocillopora_meandrina_HIv1___RNAseq.g18533.t1,peve_ptua,42.857,,,,,,,,,,,,,,,,,
OG_18244,,Peve_00044004,Pocillopora_meandrina_HIv1___RNAseq.g10778.t1,peve_ptua,45.437,,,,,,,,,,,,,,,,,
OG_18245,,Peve_00044008,Pocillopora_meandrina_HIv1___TS.g13290.t1,peve_ptua,45.531,,,,,,,,,,,,,,,,,
OG_18246,,Peve_00044041,Pocillopora_meandrina_HIv1___RNAseq.g24461.t1,peve_ptua,51.1435,,,,,,,,,,,,,,,,,
OG_18247,,Peve_00044043,Pocillopora_meandrina_HIv1___RNAseq.g28994.t1,peve_ptua,45.872,,,,,,,,,,,,,,,,,
OG_18248,,Peve_00044045,Pocillopora_meandrina_HIv1___RNAseq.g28995.t2,peve_ptua,84.722,,,,,,,,,,,,,,,,,
OG_18249,,Peve_00044047,Pocillopora_meandrina_HIv1___RNAseq.g28997.t1,peve_ptua,76.724,,,,,,,,,,,,,,,,,
OG_18250,,Peve_00044049,Pocillopora_meandrina_HIv1___RNAseq.g28986.t1,peve_ptua,33.913,,,,,,,,,,,,,,,,,
OG_18251,,Peve_00044051,Pocillopora_meandrina_HIv1___RNAseq.g28987.t1,peve_ptua,47.619,,,,,,,,,,,,,,,,,
OG_18252,,Peve_00044081,Pocillopora_meandrina_HIv1___RNAseq.g11835.t1,peve_ptua,49.275000000000006,,,,,,,,,,,,,,,,,
OG_18253,,Peve_00044091,Pocillopora_meandrina_HIv1___RNAseq.g11841.t1,peve_ptua,54.1425,,,,,,,,,,,,,,,,,
OG_18254,,Peve_00044107,Pocillopora_meandrina_HIv1___RNAseq.g11858.t1a,peve_ptua,59.733,,,,,,,,,,,,,,,,,
OG_18255,,Peve_00044109,Pocillopora_meandrina_HIv1___RNAseq.g11858.t1b,peve_ptua,68.384,,,,,,,,,,,,,,,,,
OG_18256,,Peve_00044165,Pocillopora_meandrina_HIv1___RNAseq.g12109.t1,peve_ptua,37.163,,,,,,,,,,,,,,,,,
OG_18257,,Peve_00044166,Pocillopora_meandrina_HIv1___RNAseq.g12115.t1,peve_ptua,59.209,,,,,,,,,,,,,,,,,
OG_18258,,Peve_00044195,Pocillopora_meandrina_HIv1___RNAseq.g10007.t1,peve_ptua,68.9545,,,,,,,,,,,,,,,,,
OG_18259,,Peve_00044202,Pocillopora_meandrina_HIv1___RNAseq.g11878.t1,peve_ptua,86.713,,,,,,,,,,,,,,,,,
OG_18260,,Peve_00044226,Pocillopora_meandrina_HIv1___RNAseq.g23006.t1,peve_ptua,39.881,,,,,,,,,,,,,,,,,
OG_18261,,Peve_00044238,Pocillopora_meandrina_HIv1___RNAseq.g14960.t1,peve_ptua,70.94,,,,,,,,,,,,,,,,,
OG_18262,,Peve_00044240,Pocillopora_meandrina_HIv1___RNAseq.g14970.t1a,peve_ptua,73.514,,,,,,,,,,,,,,,,,
OG_18263,,Peve_00044241,Pocillopora_meandrina_HIv1___RNAseq.g14971.t1,peve_ptua,43.9715,,,,,,,,,,,,,,,,,
OG_18264,,Peve_00044242,Pocillopora_meandrina_HIv1___RNAseq.g8238.t1,peve_ptua,56.557,,,,,,,,,,,,,,,,,
OG_18265,,Peve_00044281,Pocillopora_meandrina_HIv1___RNAseq.g5101.t1,peve_ptua,71.171,,,,,,,,,,,,,,,,,
OG_18266,,Peve_00044285,Pocillopora_meandrina_HIv1___RNAseq.g5102.t1,peve_ptua,65.0,,,,,,,,,,,,,,,,,
OG_18267,,Peve_00044305,Pocillopora_meandrina_HIv1___RNAseq.g11034.t1,peve_ptua,69.619,,,,,,,,,,,,,,,,,
OG_18268,,Peve_00044310,Pocillopora_meandrina_HIv1___TS.g13538.t1,peve_ptua,60.438500000000005,,,,,,,,,,,,,,,,,
OG_18269,,Peve_00044317,Pocillopora_meandrina_HIv1___RNAseq.g28711.t1,peve_ptua,97.674,,,,,,,,,,,,,,,,,
OG_18270,,Peve_00044358,Pocillopora_meandrina_HIv1___RNAseq.g17458.t1,peve_ptua,42.029,,,,,,,,,,,,,,,,,
OG_18271,,Peve_00044392,Pocillopora_meandrina_HIv1___RNAseq.g20112.t1,peve_ptua,36.20399999999999,,,,,,,,,,,,,,,,,
OG_18272,,Peve_00044397,Pocillopora_meandrina_HIv1___TS.g29215.t1,peve_ptua,49.438,,,,,,,,,,,,,,,,,
OG_18273,,Peve_00044402,Pocillopora_meandrina_HIv1___RNAseq.g19840.t1,peve_ptua,77.108,,,,,,,,,,,,,,,,,
OG_18274,,Peve_00044423,Pocillopora_meandrina_HIv1___RNAseq.g11685.t1,peve_ptua,34.328,,,,,,,,,,,,,,,,,
OG_18275,,Peve_00044434,Pocillopora_meandrina_HIv1___RNAseq.g20111.t1,peve_ptua,67.86,,,,,,,,,,,,,,,,,
OG_18276,,Peve_00044436,Pocillopora_meandrina_HIv1___RNAseq.g6253.t2,peve_ptua,65.436,,,,,,,,,,,,,,,,,
OG_18277,,Peve_00044441,Pocillopora_meandrina_HIv1___RNAseq.g6235.t1,peve_ptua,69.966,,,,,,,,,,,,,,,,,
OG_18278,,Peve_00044443,Pocillopora_meandrina_HIv1___RNAseq.g18126.t1,peve_ptua,50.746,,,,,,,,,,,,,,,,,
OG_18279,,Peve_00044446,Pocillopora_meandrina_HIv1___RNAseq.g18125.t1,peve_ptua,58.2715,,,,,,,,,,,,,,,,,
OG_18280,,Peve_00044485,Pocillopora_meandrina_HIv1___RNAseq.g22521.t1,peve_ptua,42.5,,,,,,,,,,,,,,,,,
OG_18281,,Peve_00044487,Pocillopora_meandrina_HIv1___TS.g15247.t2,peve_ptua,77.103,,,,,,,,,,,,,,,,,
OG_18282,,Peve_00044493,Pocillopora_meandrina_HIv1___RNAseq.g6832.t1,peve_ptua,87.5,,,,,,,,,,,,,,,,,
OG_18283,,Peve_00044549,Pocillopora_meandrina_HIv1___RNAseq.g9844.t1,peve_ptua,70.281,,,,,,,,,,,,,,,,,
OG_18284,,Peve_00044612,Pocillopora_meandrina_HIv1___RNAseq.g27274.t1a,peve_ptua,47.143,,,,,,,,,,,,,,,,,
OG_18285,,Peve_00044637,Pocillopora_meandrina_HIv1___RNAseq.g6970.t1,peve_ptua,58.231,,,,,,,,,,,,,,,,,
OG_18286,,Peve_00044651,Pocillopora_meandrina_HIv1___RNAseq.g27950.t1,peve_ptua,56.297,,,,,,,,,,,,,,,,,
OG_18287,,Peve_00044674,Pocillopora_meandrina_HIv1___TS.g20499.t1,peve_ptua,61.905,,,,,,,,,,,,,,,,,
OG_18288,,Peve_00044695,Pocillopora_meandrina_HIv1___RNAseq.g6857.t1,peve_ptua,66.51599999999999,,,,,,,,,,,,,,,,,
OG_18289,,Peve_00044710,Pocillopora_meandrina_HIv1___RNAseq.g65.t1,peve_ptua,46.8185,,,,,,,,,,,,,,,,,
OG_18290,,Peve_00044724,Pocillopora_meandrina_HIv1___RNAseq.g12786.t1,peve_ptua,38.462,,,,,,,,,,,,,,,,,
OG_18291,,Peve_00044782,Pocillopora_meandrina_HIv1___RNAseq.g21348.t1,peve_ptua,88.77,,,,,,,,,,,,,,,,,
OG_18292,,Peve_00044790,Pocillopora_meandrina_HIv1___RNAseq.g20216.t1,peve_ptua,45.36,,,,,,,,,,,,,,,,,
OG_18293,,Peve_00044803,Pocillopora_meandrina_HIv1___TS.g29589.t2,peve_ptua,41.369,,,,,,,,,,,,,,,,,
OG_18294,,Peve_00044826,Pocillopora_meandrina_HIv1___RNAseq.g28068.t1,peve_ptua,73.188,,,,,,,,,,,,,,,,,
OG_18295,,Peve_00044829,Pocillopora_meandrina_HIv1___RNAseq.g28066.t1,peve_ptua,43.793,,,,,,,,,,,,,,,,,
OG_18296,,Peve_00044866,Pocillopora_meandrina_HIv1___RNAseq.g27115.t1,peve_ptua,64.348,,,,,,,,,,,,,,,,,
OG_18297,,Peve_00044881,Pocillopora_meandrina_HIv1___RNAseq.g20887.t2,peve_ptua,47.619,,,,,,,,,,,,,,,,,
OG_18298,,Peve_00044897,Pocillopora_meandrina_HIv1___RNAseq.g11705.t1,peve_ptua,37.036,,,,,,,,,,,,,,,,,
OG_18299,,Peve_00044908,Pocillopora_meandrina_HIv1___RNAseq.g21986.t1,peve_ptua,43.644,,,,,,,,,,,,,,,,,
OG_18300,,Peve_00044911,Pocillopora_meandrina_HIv1___RNAseq.g16647.t1,peve_ptua,47.196,,,,,,,,,,,,,,,,,
OG_18301,,Peve_00044927,Pocillopora_meandrina_HIv1___RNAseq.g13620.t1,peve_ptua,55.49,,,,,,,,,,,,,,,,,
OG_18302,,Peve_00044936,Pocillopora_meandrina_HIv1___RNAseq.g20994.t1,peve_ptua,91.515,,,,,,,,,,,,,,,,,
OG_18303,,Peve_00044938,Pocillopora_meandrina_HIv1___RNAseq.g20996.t1,peve_ptua,96.896,,,,,,,,,,,,,,,,,
OG_18304,,Peve_00044962,Pocillopora_meandrina_HIv1___RNAseq.g29479.t1,peve_ptua,53.9735,,,,,,,,,,,,,,,,,
OG_18305,,Peve_00044964,Pocillopora_meandrina_HIv1___RNAseq.g29475.t1,peve_ptua,51.765,,,,,,,,,,,,,,,,,
OG_18306,,Peve_00044967,Pocillopora_meandrina_HIv1___RNAseq.g29473.t1,peve_ptua,41.178,,,,,,,,,,,,,,,,,
OG_18307,,Peve_00044971,Pocillopora_meandrina_HIv1___RNAseq.g29468.t1,peve_ptua,57.66,,,,,,,,,,,,,,,,,
OG_18308,,Peve_00044998,Pocillopora_meandrina_HIv1___RNAseq.g7843.t1,peve_ptua,60.372,,,,,,,,,,,,,,,,,
OG_18309,,Peve_00045011,Pocillopora_meandrina_HIv1___RNAseq.g9058.t1,peve_ptua,39.024,,,,,,,,,,,,,,,,,
OG_18310,,Peve_00045031,Pocillopora_meandrina_HIv1___RNAseq.g29815.t1,peve_ptua,88.75,,,,,,,,,,,,,,,,,
OG_18311,,Peve_00045059,Pocillopora_meandrina_HIv1___RNAseq.g25551.t1,peve_ptua,54.235,,,,,,,,,,,,,,,,,
OG_18312,,Peve_00045073,Pocillopora_meandrina_HIv1___RNAseq.g18509.t1,peve_ptua,89.123,,,,,,,,,,,,,,,,,
OG_18313,,Peve_00045082,Pocillopora_meandrina_HIv1___RNAseq.g12343.t1,peve_ptua,79.927,,,,,,,,,,,,,,,,,
OG_18314,,Peve_00045096,Pocillopora_meandrina_HIv1___RNAseq.g12294.t1,peve_ptua,70.281,,,,,,,,,,,,,,,,,
OG_18315,,Peve_00045107,Pocillopora_meandrina_HIv1___RNAseq.g4834.t1b,peve_ptua,43.983,,,,,,,,,,,,,,,,,
OG_18316,,Peve_00045141,Pocillopora_meandrina_HIv1___RNAseq.g27558.t1,peve_ptua,80.496,,,,,,,,,,,,,,,,,
OG_18317,,Peve_00045151,Pocillopora_meandrina_HIv1___RNAseq.g30359.t1,peve_ptua,30.151,,,,,,,,,,,,,,,,,
OG_18318,,Peve_00045152,Pocillopora_meandrina_HIv1___RNAseq.g30358.t1,peve_ptua,43.429,,,,,,,,,,,,,,,,,
OG_18319,,Peve_00045177,Pocillopora_meandrina_HIv1___TS.g11188.t1,peve_ptua,45.238,,,,,,,,,,,,,,,,,
OG_18320,,Peve_00045190,Pocillopora_meandrina_HIv1___RNAseq.g6987.t2,peve_ptua,61.325,,,,,,,,,,,,,,,,,
OG_18321,,Peve_00045241,Pocillopora_meandrina_HIv1___RNAseq.g23943.t1,peve_ptua,67.733,,,,,,,,,,,,,,,,,
OG_18322,,Peve_00045245,Pocillopora_meandrina_HIv1___TS.g10159.t1,peve_ptua,55.132,,,,,,,,,,,,,,,,,
OG_18323,,Peve_00045288,Pocillopora_meandrina_HIv1___RNAseq.g11942.t1,peve_ptua,53.731,,,,,,,,,,,,,,,,,
OG_18324,,Peve_00045289,Pocillopora_meandrina_HIv1___RNAseq.g27589.t1,peve_ptua,84.327,,,,,,,,,,,,,,,,,
OG_18325,,Peve_00045329,Pocillopora_meandrina_HIv1___RNAseq.g24447.t1b,peve_ptua,39.13,,,,,,,,,,,,,,,,,
OG_18326,,Peve_00045331,Pocillopora_meandrina_HIv1___RNAseq.g29927.t1,peve_ptua,51.2105,,,,,,,,,,,,,,,,,